PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Garcia-Manyes, S; Giganti, D; Badilla, CL; Lezamiz, A; Perales-Calvo, J; Beedle, AEM; Fernandez, JM				Garcia-Manyes, Sergi; Giganti, David; Badilla, Carmen L.; Lezamiz, Ainhoa; Perales-Calvo, Judit; Beedle, Amy E. M.; Fernandez, Julio M.			Single-molecule Force Spectroscopy Predicts a Misfolded, Domain-swapped Conformation in human D-Crystallin Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						atomic force microscopy (AFM); cataract; crystallin; protein misfolding; single-molecule biophysics	GAMMA-D-CRYSTALLIN; MULTIDOMAIN PROTEINS; ALPHA(1)-ANTITRYPSIN DEFICIENCY; CONGENITAL CATARACTS; CLAMP SPECTROSCOPY; AMYLOID FIBRILS; IN-VITRO; AGGREGATION; EVOLUTION; MUTANT	Cataract is a protein misfolding disease where the size of the aggregate is directly related to the severity of the disorder. However, the molecular mechanisms that trigger the onset of aggregation remain unknown. Here we use a combination of protein engineering techniques and single-molecule force spectroscopy using atomic force microscopy to study the individual unfolding pathways of the human D-crystallin, a multidomain protein that must remain correctly folded during the entire lifetime to guarantee lens transparency. When stretching individual polyproteins containing two neighboring HD-crystallin monomers, we captured an anomalous misfolded conformation in which the 1 and 2 strands of the N terminus domain of two adjacent monomers swap. This experimentally elusive domain-swapped conformation is likely to be responsible for the increase in molecular aggregation that we measure in vitro. Our results demonstrate the power of force spectroscopy at capturing rare misfolded conformations with potential implications for the understanding of the molecular onset of protein aggregation.	[Garcia-Manyes, Sergi; Lezamiz, Ainhoa; Perales-Calvo, Judit; Beedle, Amy E. M.] Kings Coll London, Dept Phys, London WC2R 2LS, England; [Garcia-Manyes, Sergi; Lezamiz, Ainhoa; Perales-Calvo, Judit; Beedle, Amy E. M.] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England; [Giganti, David; Badilla, Carmen L.; Fernandez, Julio M.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	University of London; King's College London; University of London; King's College London; Columbia University	Garcia-Manyes, S (corresponding author), Kings Coll London, Dept Phys, London WC2R 2LS, England.; Garcia-Manyes, S (corresponding author), Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England.	sergi.garcia-manyes@kcl.ac.uk		beedle, amy/0000-0001-9908-0597; Garcia-Manyes, Sergi/0000-0001-5140-2606	Marie Curie Intra-European Fellowships for Career Development Grant [329308]; Marie Curie Carrier Integration Grants [293462]; Biotechnology and Biological Sciences Research Council [BB/J00992X/1]; Engineering and Physical Sciences Research Council [K00641X/1]; Royal Society [RG120038]; National Institutes of Health [HL66030, HL61228]; BBSRC [BB/J00992X/1] Funding Source: UKRI; EPSRC [EP/K00641X/1] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066030, R01HL061228] Funding Source: NIH RePORTER; Engineering and Physical Sciences Research Council [EP/K00641X/1, 1406913] Funding Source: researchfish	Marie Curie Intra-European Fellowships for Career Development Grant; Marie Curie Carrier Integration Grants; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society(Royal Society of London); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by Marie Curie Intra-European Fellowships for Career Development Grant 329308 (to J. P. C.); Marie Curie Carrier Integration Grants 293462, Biotechnology and Biological Sciences Research Council Grant BB/J00992X/1, and Engineering and Physical Sciences Research Council Grant K00641X/1 (to S. G. M.); Royal Society Grant RG120038 (to S. G. M.); and National Institutes of Health Grants HL66030 and HL61228 (to J. M. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Basak A, 2003, J MOL BIOL, V328, P1137, DOI 10.1016/S0022-2836(03)00375-9; BAX B, 1990, NATURE, V347, P776, DOI 10.1038/347776a0; BENNETT MJ, 1995, PROTEIN SCI, V4, P2455, DOI 10.1002/pro.5560041202; Borgia A, 2008, ANNU REV BIOCHEM, V77, P101, DOI 10.1146/annurev.biochem.77.060706.093102; Borgia MB, 2011, NATURE, V474, P662, DOI 10.1038/nature10099; Brockwell DJ, 2003, NAT STRUCT BIOL, V10, P731, DOI 10.1038/nsb968; Carrell RW, 2002, NEW ENGL J MED, V346, P45, DOI 10.1056/NEJMra010772; Carrion-Vazquez M, 2003, NAT STRUCT BIOL, V10, P738, DOI 10.1038/nsb965; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Das P, 2011, P NATL ACAD SCI USA, V108, P10514, DOI 10.1073/pnas.1019152108; Dietz H, 2006, P NATL ACAD SCI USA, V103, P12724, DOI 10.1073/pnas.0602995103; Dougan L, 2009, P NATL ACAD SCI USA, V106, P12605, DOI 10.1073/pnas.0900678106; Eakin CM, 2004, BIOCHEMISTRY-US, V43, P7808, DOI 10.1021/bi049792q; Fernandez JM, 2010, SPRINGER SER CHEM PH, V96, P317, DOI 10.1007/978-3-642-02597-6_17; Fernandez VI, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3252982; Fisher TE, 1999, TRENDS BIOCHEM SCI, V24, P379, DOI 10.1016/S0968-0004(99)01453-X; Flaugh SL, 2005, PROTEIN SCI, V14, P2030, DOI 10.1110/ps.051460505; Flaugh SL, 2005, PROTEIN SCI, V14, P571, DOI 10.1110/ps.041111405; Graw J, 2009, EXP EYE RES, V88, P173, DOI 10.1016/j.exer.2008.10.011; Han JH, 2007, NAT REV MOL CELL BIO, V8, P319, DOI 10.1038/nrm2144; Hejtmancik JF, 2008, SEMIN CELL DEV BIOL, V19, P134, DOI 10.1016/j.semcdb.2007.10.003; Itoh K, 2008, P NATL ACAD SCI USA, V105, P13865, DOI 10.1073/pnas.0804512105; Jung J, 2009, BIOCHEMISTRY-US, V48, P2597, DOI 10.1021/bi802292q; Knaus KJ, 2001, NAT STRUCT BIOL, V8, P770, DOI 10.1038/nsb0901-770; Kosinski-Collins MS, 2004, PROTEIN SCI, V13, P2223, DOI 10.1110/ps.04627004; Kosinski-Collins MS, 2003, PROTEIN SCI, V12, P480, DOI 10.1110/ps.0225503; Li HB, 2003, J MOL BIOL, V334, P75, DOI 10.1016/j.jmb.2003.09.036; Liu C, 2011, NAT STRUCT MOL BIOL, V18, P49, DOI 10.1038/nsmb.1948; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Mayr EM, 1997, J MOL BIOL, V269, P260, DOI 10.1006/jmbi.1997.1033; MAYR EM, 1994, J MOL BIOL, V235, P84, DOI 10.1016/S0022-2836(05)80017-8; Mohr BG, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4816367; Moreau KL, 2012, TRENDS MOL MED, V18, P273, DOI 10.1016/j.molmed.2012.03.005; Mulligan VK, 2013, PROTEINS, V81, P1285, DOI 10.1002/prot.24285; Oberhauser AF, 1999, NAT STRUCT BIOL, V6, P1025; Pande A, 2005, BIOCHEMISTRY-US, V44, P2491, DOI 10.1021/bi0479611; Pande A, 2000, P NATL ACAD SCI USA, V97, P1993, DOI 10.1073/pnas.040554397; Papanikolopoulou K, 2008, MOL VIS, V14, P81; Peng Q, 2009, J AM CHEM SOC, V131, P14050, DOI 10.1021/ja903589t; Popa I, 2013, NAT PROTOC, V8, P1261, DOI 10.1038/nprot.2013.056; Ramanujam V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094513; Rousseau F, 2003, STRUCTURE, V11, P243, DOI 10.1016/S0969-2126(03)00029-7; Sandilands A, 2002, EMBO J, V21, P6005, DOI 10.1093/emboj/cdf609; Santhiya ST, 2002, J MED GENET, V39, P352, DOI 10.1136/jmg.39.5.352; Schlierf M, 2004, P NATL ACAD SCI USA, V101, P7299, DOI 10.1073/pnas.0400033101; Serebryany E, 2014, PROG BIOPHYS MOL BIO, V115, P32, DOI 10.1016/j.pbiomolbio.2014.05.002; Sikora M, 2011, PROTEINS, V79, P1786, DOI 10.1002/prot.23001; Slingsby C, 1999, EYE, V13, P395, DOI 10.1038/eye.1999.113; Slingsby C, 2014, PROG BIOPHYS MOL BIO, V115, P52, DOI 10.1016/j.pbiomolbio.2014.02.006; Slingsby C, 2013, PROTEIN SCI, V22, P367, DOI 10.1002/pro.2229; Wahlbom M, 2007, J BIOL CHEM, V282, P18318, DOI 10.1074/jbc.M611368200; Wang YZ, 2010, ECS TRANSACTIONS, V33, P487, DOI 10.1149/1.3481638; WETZEL R, 1994, TRENDS BIOTECHNOL, V12, P193, DOI 10.1016/0167-7799(94)90082-5; Wright CF, 2005, NATURE, V438, P878, DOI 10.1038/nature04195; Yamasaki M, 2011, EMBO REP, V12, P1011, DOI 10.1038/embor.2011.171; Yu H, 2012, P NATL ACAD SCI USA, V109, P5283, DOI 10.1073/pnas.1107736109	56	27	29	0	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					4226	4235		10.1074/jbc.M115.673871	http://dx.doi.org/10.1074/jbc.M115.673871			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26703476	Green Published, hybrid			2022-12-26	WOS:000371338400045
J	Shen, XM; Brengman, J; Neubauer, D; Sine, SM; Engel, AG				Shen, Xin-Ming; Brengman, Joan; Neubauer, David; Sine, Steven M.; Engel, Andrew G.			Investigation of Congenital Myasthenia Reveals Functional Asymmetry of Invariant Acetylcholine Receptor (AChR) Cys-loop Aspartates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ion channel; nicotinic acetylcholine receptors (nAChR); patch clamp; receptor structure-function; structure-function; Cys-loop receptor superfamily; congenital myasthenic syndrome; invariant Cys-loop aspartate; invariant pre-M1 arginine; mutant cycle analysis	DELTA-SUBUNIT MUTATION; AGONIST BINDING; SINGLE-CHANNEL; GABA(A) RECEPTOR; END-PLATE; RESIDUES; TRANSMITTER; ACTIVATION; PROTEINS; DOMAIN	We identify two heteroallelic mutations in the acetylcholine receptor -subunit from a patient with severe myasthenic symptoms since birth: a novel D140N mutation in the signature Cys-loop and a mutation in intron 7 of the -subunit gene that disrupts splicing of exon 8. The mutated Asp residue, which determines the disease phenotype, is conserved in all eukaryotic members of the Cys-loop receptor superfamily. Studies of the mutant acetylcholine receptor expressed in HEK 293 cells reveal that D140N attenuates cell surface expression and apparent channel gating, predicting a reduced magnitude and an accelerated decay of the synaptic response, thus reducing the safety margin for neuromuscular transmission. Substituting Asn for Asp at equivalent positions in the -, -, and E-subunits also suppresses apparent channel gating, but the suppression is much greater in the -subunit. Mutant cycle analysis applied to single and pairwise mutations reveals that Asp-138 is energetically coupled to Arg-209 in the neighboring pre-M1 domain. Our findings suggest that the conserved Asp-138 and Arg-209 contribute to a principal pathway that functionally links the ligand binding and pore domains.	[Shen, Xin-Ming; Brengman, Joan; Sine, Steven M.; Engel, Andrew G.] Mayo Clin, Dept Neurol, Rochester, MN 55905 USA; [Shen, Xin-Ming; Brengman, Joan; Sine, Steven M.; Engel, Andrew G.] Mayo Clin, Neuromuscular Res Lab, Rochester, MN 55905 USA; [Neubauer, David] Univ Childrens Hosp, Dept Pediat Neurol, Ljubljana 1525, Slovenia; [Sine, Steven M.] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; University Medical Centre Ljubljana; Mayo Clinic	Shen, XM (corresponding author), Mayo Clin, Dept Neurol, Rochester, MN 55905 USA.; Shen, XM (corresponding author), Mayo Clin, Neuromuscular Res Lab, Rochester, MN 55905 USA.	shen.xinming@mayo.edu			National Institutes of Health [NS6277, NS31744]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS006277, R01NS031744, R37NS031744, R01NS006277] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants NS6277 (to A. G. E.) and NS31744 (to S. M. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BLOUNT P, 1989, NEURON, V3, P349, DOI 10.1016/0896-6273(89)90259-6; COLQUHOUN D, 1985, J PHYSIOL-LONDON, V369, P501, DOI 10.1113/jphysiol.1985.sp015912; Colquhoun David, 1995, P397; Engel AG, 2015, LANCET NEUROL, V14, P420, DOI 10.1016/S1474-4422(14)70201-7; GU Y, 1991, J CELL BIOL, V114, P799, DOI 10.1083/jcb.114.4.799; Hassaine G, 2014, NATURE, V512, P276, DOI 10.1038/nature13552; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; HOROVITZ A, 1990, J MOL BIOL, V214, P613, DOI 10.1016/0022-2836(90)90275-Q; KARLIN A, 1983, J BIOL CHEM, V258, P6678; Kash TL, 2004, J BIOL CHEM, V279, P4887, DOI 10.1074/jbc.M311441200; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; KUFFLER SW, 1975, J PHYSIOL-LONDON, V251, P465, DOI 10.1113/jphysiol.1975.sp011103; Lape R, 2008, NATURE, V454, P722, DOI 10.1038/nature07139; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; MATHIE A, 1987, PROC R SOC SER B-BIO, V232, P239, DOI 10.1098/rspb.1987.0072; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; Mukhtasimova N, 2013, BIOPHYS J, V104, P355, DOI 10.1016/j.bpj.2012.12.013; Mukhtasimova N, 2009, NATURE, V459, P451, DOI 10.1038/nature07923; Ohno K, 1996, NEURON, V17, P157, DOI 10.1016/S0896-6273(00)80289-5; PENNEFATHER P, 1981, J GEN PHYSIOL, V78, P313, DOI 10.1085/jgp.78.3.313; Pless SA, 2011, J BIOL CHEM, V286, P35129, DOI 10.1074/jbc.M111.269027; Qin F, 1997, P ROY SOC B-BIOL SCI, V264, P375, DOI 10.1098/rspb.1997.0054; SAKMANN B, 1980, NATURE, V286, P71, DOI 10.1038/286071a0; Schofield CM, 2003, J BIOL CHEM, V278, P34079, DOI 10.1074/jbc.M302416200; Shen XM, 2008, J CLIN INVEST, V118, P1867, DOI 10.1172/JCI34527; Shen XM, 2005, BRAIN, V128, P345, DOI 10.1093/brain/awh364; Shen XM, 2002, NEUROLOGY, V59, P1881, DOI 10.1212/01.WNL.0000042422.87384.2F; Shen XM, 2003, J CLIN INVEST, V111, P497, DOI 10.1172/JC1200316997; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; Sine SM, 2002, J BIOL CHEM, V277, P29210, DOI 10.1074/jbc.M203396200; Stiles JR, 1996, P NATL ACAD SCI USA, V93, P5747, DOI 10.1073/pnas.93.12.5747; WELLS JA, 1990, BIOCHEMISTRY-US, V29, P8509, DOI 10.1021/bi00489a001; Xiu XN, 2005, J BIOL CHEM, V280, P41655, DOI 10.1074/jbc.M508635200; Zhou M, 1999, P NATL ACAD SCI USA, V96, P10466, DOI 10.1073/pnas.96.18.10466; Zouridakis M, 2014, NAT STRUCT MOL BIOL, V21, P976, DOI 10.1038/nsmb.2900	35	7	7	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3291	3301		10.1074/jbc.M115.683995	http://dx.doi.org/10.1074/jbc.M115.683995			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26698174	Green Published, hybrid			2022-12-26	WOS:000370854500015
J	Poidevin, L; Andreeva, K; Khachatoorian, C; Judelson, HS				Poidevin, Laetitia; Andreeva, Kalina; Khachatoorian, Careen; Judelson, Howard S.			Comparisons of Ribosomal Protein Gene Promoters Indicate Superiority of Heterologous Regulatory Sequences for Expressing Transgenes in Phytophthora infestans	PLOS ONE			English	Article							FUNCTIONAL GENOMICS; BREMIA-LACTUCAE; PLANT PATHOGEN; DNA; ARABIDOPSIS; DISCOVERY; VECTORS; RNAS; PARASITICA; EVOLUTION	Molecular genetics approaches in Phytophthora research can be hampered by the limited number of known constitutive promoters for expressing transgenes and the instability of transgene activity. We have therefore characterized genes encoding the cytoplasmic ribosomal proteins of Phytophthora and studied their suitability for expressing transgenes in P. infestans. Phytophthora spp. encode a standard complement of 79 cytoplasmic ribosomal proteins. Several genes are duplicated, and two appear to be pseudogenes. Half of the genes are expressed at similar levels during all stages of asexual development, and we discovered that the majority share a novel promoter motif named the PhRiboBox. This sequence is enriched in genes associated with transcription, translation, and DNA replication, including tRNA and rRNA biogenesis. Promoters from the three P. infestans genes encoding ribosomal proteins S9, L10, and L23 and their orthologs from P. capsici were tested for their ability to drive transgenes in stable transformants of P. infestans. Five of the six promoters yielded strong expression of a GUS reporter, but the stability of expression was higher using the P. capsici promoters. With the RPS9 and RPL10 promoters of P. infestans, about half of transformants stopped making GUS over two years of culture, while their P. capsici orthologs conferred stable expression. Since cross-talk between native and transgene loci may trigger gene silencing, we encourage the use of heterologous promoters in transformation studies.	[Poidevin, Laetitia; Andreeva, Kalina; Khachatoorian, Careen; Judelson, Howard S.] Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA	University of California System; University of California Riverside	Judelson, HS (corresponding author), Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA.	howard.judelson@ucr.edu	Poidevin, Laetitia/AAJ-9009-2020	Poidevin, Laetitia/0000-0002-0348-4405	National Science Foundation of the United States [1004793, 1120225]	National Science Foundation of the United States(National Science Foundation (NSF))	This work was supported by grants 1004793 and 1120225 to HSJ from the National Science Foundation of the United States. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapito-Tenfen SZ, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0346-8; Ah-Fong AMV, 2008, FUNGAL GENET BIOL, V45, P1197, DOI 10.1016/j.fgb.2008.05.009; Ah-Fong AMV, 2007, EUKARYOT CELL, V6, P2222, DOI 10.1128/EC.00328-07; Ah-Fong AMV, 2011, FUNGAL BIOL-UK, V115, P882, DOI 10.1016/j.funbio.2011.07.001; Amaldi F, 1995, BIOCHEM CELL BIOL, V73, P969, DOI 10.1139/o95-104; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barakat A, 2001, PLANT PHYSIOL, V127, P398, DOI 10.1104/pp.010265; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Bhullar S, 2003, PLANT PHYSIOL, V132, P988, DOI 10.1104/pp.103.020602; Bottin A, 1999, FEMS MICROBIOL LETT, V176, P51, DOI 10.1111/j.1574-6968.1999.tb13641.x; Daxinger L, 2008, TRENDS PLANT SCI, V13, P4, DOI 10.1016/j.tplants.2007.10.007; Dou DL, 2008, PLANT CELL, V20, P1118, DOI 10.1105/tpc.107.057067; Ellis J, 2005, HUM GENE THER, V16, P1241, DOI 10.1089/hum.2005.16.1241; Feng BZ, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-126; Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Hodges BL, 2004, MOL THER, V10, P269, DOI 10.1016/j.ymthe.2004.04.018; Horstick EJ, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv035; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Judelson HS, 2008, MOL PLANT MICROBE IN, V21, P433, DOI 10.1094/MPMI-21-4-0433; JUDELSON HS, 1995, CURR GENET, V28, P571, DOI 10.1007/BF00518171; JUDELSON HS, 1990, MOL PLANT MICROBE IN, V3, P225, DOI 10.1094/MPMI-3-225; JUDELSON HS, 1993, GENE, V133, P63, DOI 10.1016/0378-1119(93)90225-R; JUDELSON HS, 1992, MOL GEN GENET, V234, P138, DOI 10.1007/BF00272355; JUDELSON HS, 1989, GENE, V79, P207, DOI 10.1016/0378-1119(89)90203-5; JUDELSON HS, 1993, MOL GEN GENET, V239, P241, DOI 10.1007/BF00281624; Judelson HS, PLANT PATHOL, V16, P83; Jupe J, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r63; Kamoun S, 2015, MOL PLANT PATHOL, V16, P413, DOI 10.1111/mpp.12190; Kim JH, 2009, GENOME RES, V19, P533, DOI 10.1101/gr.086496.108; Kishimoto N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054670; Koia J, 2013, PLANT MOL BIOL, V81, P327, DOI 10.1007/s11103-012-0002-3; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Marygold SJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r216; Matzke AJM, 1998, CURR OPIN PLANT BIOL, V1, P142, DOI 10.1016/S1369-5266(98)80016-2; Nakao A, 2004, NUCLEIC ACIDS RES, V32, pD168, DOI 10.1093/nar/gkh004; Natesan S, 1997, NATURE, V390, P349, DOI 10.1038/37019; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Panabieres F, 1998, MICROBIOL-UK, V144, P3343, DOI 10.1099/00221287-144-12-3343; Qutob D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2354; Rach EA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001274; Randall E, 2014, MOL PLANT PATHOL, V15, P664, DOI 10.1111/mpp.12124; Roy S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003182; Roy S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-106; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Scrable H, 1999, MUTAT RES-FUND MOL M, V429, P225, DOI 10.1016/S0027-5107(99)00114-1; Stajich JE, 2012, NUCLEIC ACIDS RES, V40, pD675, DOI 10.1093/nar/gkr918; Tanay A, 2005, P NATL ACAD SCI USA, V102, P7203, DOI 10.1073/pnas.0502521102; Thines M, 2014, EUR J PLANT PATHOL, V138, P431, DOI 10.1007/s10658-013-0366-5; van West P, 1999, MOL CELL, V3, P339, DOI 10.1016/S1097-2765(00)80461-X; van West P, 1999, FEMS MICROBIOL LETT, V178, P71, DOI 10.1111/j.1574-6968.1999.tb13761.x; Vetukuri RR, 2011, MOL PLANT PATHOL, V12, P772, DOI [10.1111/J.1364-3703.2011.00710.X, 10.1111/j.1364-3703.2011.00710.x]; Xiang QJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092086; Yan HZ, 2006, FUNGAL GENET BIOL, V43, P430, DOI 10.1016/j.fgb.2006.01.010; Zhou J, 2009, CURR GENET, V55, P485, DOI 10.1007/s00294-009-0261-y	55	2	2	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145612	10.1371/journal.pone.0145612	http://dx.doi.org/10.1371/journal.pone.0145612			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716454	gold, Green Published, Green Submitted			2022-12-26	WOS:000367510500047
J	Flores-Pliego, A; Espejel-Nunez, A; Castillo-Castrejon, M; Meraz-Cruz, N; Beltran-Montoya, J; Zaga-Clavellina, V; Nava-Salazar, S; Sanchez-Martinez, M; Vadillo-Ortega, F; Estrada-Gutierrez, G				Flores-Pliego, Arturo; Espejel-Nunez, Aurora; Castillo-Castrejon, Marisol; Meraz-Cruz, Noemi; Beltran-Montoya, Jorge; Zaga-Clavellina, Veronica; Nava-Salazar, Sonia; Sanchez-Martinez, Maribel; Vadillo-Ortega, Felipe; Estrada-Gutierrez, Guadalupe			Matrix Metalloproteinase-3 (MMP-3) Is an Endogenous Activator of the MMP-9 Secreted by Placental Leukocytes: Implication in Human Labor	PLOS ONE			English	Article							HUMAN FETAL MEMBRANES; PREMATURE RUPTURE; MATRIX-METALLOPROTEINASE-9 MMP-9; PRETERM LABOR; GELATINASE-B; EXPRESSION; TERM; DECIDUA; BIOLOGY; CELLS	Background The activity of matrix degrading enzymes plays a leading role in the rupture of the fetal membranes under normal and pathological human labor, and matrix metalloproteinase-9 (MMP-9) it is considered a biomarker of this event. To gain further insight into local MMP-9 origin and activation, in this study we analyzed the contribution of human placental leukocytes to MMP-9 secretion and explored the local mechanisms of the pro-enzyme activation. Methods Placental blood leukocytes were obtained from women at term gestation without labor and maintained in culture up to 72 h. MMP-9 activity in the culture supernatants was determined by zymography and using a specific substrate. The presence of a potential pro-MMP-9 activator in the culture supernatants was monitored using a recombinant biotin-labeled human pro-MMP-9. To characterize the endogenous pro-MMP-9 activator, MMP-1, -3, -7 and -9 were measured by multiplex assay in the supernatants, and an inhibition assay of MMP-9 activation was performed using an anti-human MMP-3 and a specific MMP-3 inhibitor. Finally, production of MMP-9 and MMP-3 in placental leukocytes obtained from term pregnancies with and without labor was assessed by immunofluorescence. Results Placental leukocytes spontaneously secreted pro-MMP-9 after 24 h of culture, increasing significantly at 48 h (P <= 0.05), when the active form of MMP-9 was detected. Culture supernatants activated the recombinant pro-MMP-9 showing that placental leukocytes secrete the activator. A significant increase in MMP-3 secretion by placental leukocytes was observed since 48 h in culture (P <= 0.05) and up to 72 h (P <= 0.001), when concentration reached its maximum value. Specific activity of MMP-9 decreased significantly (P <= 0.005) when an anti-MMP-3 antibody or a specific MMP-3 inhibitor were added to the culture media. Placental leukocytes from term labor produced more MMP-9 and MMP-3 compared to term non-labor cells. Conclusions In this work we confirm that placental leukocytes from human term pregnancies are able to secrete large amounts of MMP-9, and that the production of the enzyme it is enhanced by labor. We also demonstrate for the first time that endogenous MMP-3 plays a major role in MMP-9 activation process. These findings support the contribution of placental leukocytes to create the collagenolytic microenvironment that induces the rupture of the fetal membranes during human labor.	[Flores-Pliego, Arturo; Espejel-Nunez, Aurora; Beltran-Montoya, Jorge; Zaga-Clavellina, Veronica; Nava-Salazar, Sonia; Sanchez-Martinez, Maribel; Estrada-Gutierrez, Guadalupe] Inst Nacl Perinatol Isidro Espinosa Reyes, Mexico City, DF, Mexico; [Castillo-Castrejon, Marisol; Meraz-Cruz, Noemi; Vadillo-Ortega, Felipe] Univ Nacl Autonoma Mexico, Fac Med, Unidad Vinculac, Inst Nacl Med Genom, Mexico City, DF, Mexico	Instituto Nacional de Medicina Genomica; Universidad Nacional Autonoma de Mexico	Estrada-Gutierrez, G (corresponding author), Inst Nacl Perinatol Isidro Espinosa Reyes, Mexico City, DF, Mexico.	gpestrad@gmail.com	Estrada-Gutierrez, Guadalupe/AAM-4642-2021; Flores-Pliego, Arturo/GPK-6349-2022; Castillo-Castrejon, Marisol/GMX-4189-2022; Espejel, Aurora/AAO-6510-2021; Zaga-Clavellina, Veronica/ABB-9954-2020; Vadillo-Ortega, Felipe/I-5273-2017; Estrada, Guadalupe/AAT-3970-2021	Estrada-Gutierrez, Guadalupe/0000-0001-9551-9021; Flores-Pliego, Arturo/0000-0001-7876-6098; Zaga-Clavellina, Veronica/0000-0002-3365-2932; Vadillo-Ortega, Felipe/0000-0001-7137-4200; ESPEJEL NUNEZ, AURORA/0000-0001-9087-8017	Instituto Nacional de Perinatologia [212250-02081]	Instituto Nacional de Perinatologia	GEG was funded by the Instituto Nacional de Perinatologia, grant 212250-02081. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arechavaleta-Velasco F, 2004, AM J OBSTET GYNECOL, V190, P843, DOI 10.1016/j.ajog.2003.09.032; Caldeyro-Barcia R, 1974, ADVERSE PERINATAL EF, P431; Castillo-Castrejon M, 2014, AM J REPROD IMMUNOL, V71, P86, DOI 10.1111/aji.12179; Estrada-Gutierrez G, 2005, MATRIX BIOL, V24, P306, DOI 10.1016/j.matbio.2005.05.001; Fortunato SJ, 2003, AM J REPROD IMMUNOL, V49, P120, DOI 10.1034/j.1600-0897.2003.00012.x; Goldman S, 2003, MOL HUM REPROD, V9, P367, DOI 10.1093/molehr/gag040; Gomez-Lopez N, 2009, J REPROD IMMUNOL, V80, P122, DOI 10.1016/j.jri.2009.01.002; Hahn-Dantona E, 1999, ANN NY ACAD SCI, V878, P372, DOI 10.1111/j.1749-6632.1999.tb07696.x; IMAI K, 1995, J BIOL CHEM, V270, P6691, DOI 10.1074/jbc.270.12.6691; KLEINER DE, 1994, ANAL BIOCHEM, V218, P325, DOI 10.1006/abio.1994.1186; Meraz-Cruz N, 2006, MOL HUM REPROD, V12, P633, DOI 10.1093/molehr/gal072; Moore RM, 2006, PLACENTA, V27, P1037, DOI 10.1016/j.placenta.2006.01.002; MORODOMI T, 1992, BIOCHEM J, V285, P603, DOI 10.1042/bj2850603; Murphy G, 1999, APMIS, V107, P38, DOI 10.1111/j.1699-0463.1999.tb01524.x; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nishihara S, 2008, REPROD SCI, V15, P156, DOI 10.1177/1933719107310308; O'Brien M, 2007, MOL HUM REPROD, V13, P655, DOI 10.1093/molehr/gam047; OGATA Y, 1992, J BIOL CHEM, V267, P3581; Olson MW, 2000, J BIOL CHEM, V275, P2661, DOI 10.1074/jbc.275.4.2661; Opdenakker G, 2001, J LEUKOCYTE BIOL, V69, P851; Osman I, 2006, J SOC GYNECOL INVEST, V13, P97, DOI 10.1016/j.jsgi.2005.12.002; Osman I, 2003, MOL HUM REPROD, V9, P41, DOI 10.1093/molehr/gag001; Owen CA, 1999, J LEUKOCYTE BIOL, V65, P137, DOI 10.1002/jlb.65.2.137; Park KH, 2003, J PERINAT MED, V31, P12, DOI 10.1515/JPM.2003.002; PEI DQ, 1995, NATURE, V375, P244, DOI 10.1038/375244a0; Ramos-DeSimone N, 1999, J BIOL CHEM, V274, P13066, DOI 10.1074/jbc.274.19.13066; SANG QX, 1995, BBA-PROTEIN STRUCT M, V1251, P99, DOI 10.1016/0167-4838(95)00086-A; Snoek-van Beurden PAM, 2005, BIOTECHNIQUES, V38, P73, DOI 10.2144/05381RV01; Toth Marta, 2012, Methods Mol Biol, V878, P121, DOI 10.1007/978-1-61779-854-2_8; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vadillo-Ortega F, 2005, BJOG-INT J OBSTET GY, V112, P19, DOI 10.1111/j.1471-0528.2005.00579.x; VADILLOORTEGA F, 1995, AM J PATHOL, V146, P148; VADILLOORTEGA F, 1990, OBSTET GYNECOL, V75, P84; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; Vega-Sanchez R, 2010, J REPROD IMMUNOL, V84, P100, DOI 10.1016/j.jri.2009.08.002; Vu TD, 2008, REPROD SCI, V15, P420, DOI 10.1177/1933719108314625; WEINGARTEN H, 1985, ANAL BIOCHEM, V147, P437, DOI 10.1016/0003-2697(85)90294-5; Weiss A, 2007, FRONT BIOSCI-LANDMRK, V12, P649, DOI 10.2741/2089; Xu P, 2002, J CLIN ENDOCR METAB, V87, P1353, DOI 10.1210/jc.87.3.1353; Yan L, 2001, J BIOL CHEM, V276, P37258, DOI 10.1074/jbc.M106089200; Yonemoto H, 2006, PLACENTA, V27, P669, DOI 10.1016/j.placenta.2005.05.014	41	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145366	10.1371/journal.pone.0145366	http://dx.doi.org/10.1371/journal.pone.0145366			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713439	gold, Green Submitted, Green Published			2022-12-26	WOS:000367481900037
J	France, B; Bell, W; Chang, E; Scholten, T				France, Brian; Bell, William; Chang, Emily; Scholten, Trudy			Composite Sampling Approaches for Bacillus anthracis Surrogate Extracted from Soil	PLOS ONE			English	Article								Any release of anthrax spores in the U.S. would require action to decontaminate the site and restore its use and operations as rapidly as possible. The remediation activity would require environmental sampling, both initially to determine the extent of contamination (hazard mapping) and post-decon to determine that the site is free of contamination (clearance sampling). Whether the spore contamination is within a building or outdoors, collecting and analyzing what could be thousands of samples can become the factor that limits the pace of restoring operations. To address this sampling and analysis bottleneck and decrease the time needed to recover from an anthrax contamination event, this study investigates the use of composite sampling. Pooling or compositing of samples is an established technique to reduce the number of analyses required, and its use for anthrax spore sampling has recently been investigated. However, use of composite sampling in an anthrax spore remediation event will require well-documented and accepted methods. In particular, previous composite sampling studies have focused on sampling from hard surfaces; data on soil sampling are required to extend the procedure to outdoor use. Further, we must consider whether combining liquid samples, thus increasing the volume, lowers the sensitivity of detection and produces false negatives. In this study, methods to composite bacterial spore samples from soil are demonstrated. B. subtilis spore suspensions were used as a surrogate for anthrax spores. Two soils (Arizona Test Dust and sterilized potting soil) were contaminated and spore recovery with composites was shown to match individual sample performance. Results show that dilution can be overcome by concentrating bacterial spores using standard filtration methods. This study shows that composite sampling can be a viable method of pooling samples to reduce the number of analysis that must be performed during anthrax spore remediation.	[France, Brian; Bell, William; Chang, Emily; Scholten, Trudy] TDA Res Inc, Wheat Ridge, CO 80033 USA		France, B (corresponding author), TDA Res Inc, Wheat Ridge, CO 80033 USA.	bfrance@tda.com			Defense Threat Reduction Agency (DTRA) [HDTRA1-12-C-0071]	Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency)	The funder provided support in the form of salaries for all the authors [BF, WB, EC, TS]. The specific roles of these authors are articulated in the 'author contributions' section. This work was also supported by the Defense Threat Reduction Agency (DTRA) under contract HDTRA1-12-C-0071. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Defense Threat Reduction Agency (DTRA) under contract HDTRA1-12-C-0071.	Buhr TL, 2011, J APPL MICROBIOL, V111, P1057, DOI 10.1111/j.1365-2672.2011.05122.x; CAHOONYOUNG B, 1989, J CLIN MICROBIOL, V27, P1893, DOI 10.1128/JCM.27.8.1893-1895.1989; Dorfman R, 1943, ANN MATH STAT, V14, P436, DOI 10.1214/aoms/1177731363; Drielak S., 2004, HOT ZONE FORENSICS C; Emanuel P, 2008, SAMPLING BIOL AGENTS; EPA, 2013, EPA600R13168; EPA, 1995, EPA230R95005; Lancaster VA, 1998, J AM STAT ASSOC, V93, P1216, DOI 10.2307/2669863; Patil GP, 2010, COMPOSITE SAMPLING N; Piepel GF, 2009, PNNL18187; PNNL, 2011, VIS SAMPL PLAN; Rose L, 2004, EMERG INFECT DIS, V10, P1023, DOI 10.3201/eid1006.030716; Shah, 2012, EPA TECHNICAL BRIEF; Tufts JAM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114082	14	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145799	10.1371/journal.pone.0145799	http://dx.doi.org/10.1371/journal.pone.0145799			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714315	Green Published, gold, Green Submitted			2022-12-26	WOS:000367481900084
J	Kim, D; Hwang, G; Liu, Y; Wang, YF; Singh, AP; Vorsa, N; Koo, H				Kim, Dongyeop; Hwang, Geelsu; Liu, Yuan; Wang, Yifei; Singh, Ajay P.; Vorsa, Nicholi; Koo, Hyun			Cranberry Flavonoids Modulate Cariogenic Properties of Mixed-Species Biofilm through Exopolysaccharides-Matrix Disruption	PLOS ONE			English	Article							STREPTOCOCCUS-MUTANS BIOFILMS; AMERICAN CRANBERRY; NATURAL-PRODUCTS; GLUCAN SYNTHESIS; CARIES; SURFACE; PROANTHOCYANIDINS; MODEL; GLUCOSYLTRANSFERASES; ACIDOGENICITY	The exopolysaccharides (EPS) produced by Streptococcus mutans-derived glucosyltransferases (Gtfs) are essential virulence factors associated with the initiation of cariogenic biofilms. EPS forms the core of the biofilm matrix-scaffold, providing mechanical stability while facilitating the creation of localized acidic microenvironments. Cranberry flavonoids, such as A-type proanthocyanidins (PACs) and myricetin, have been shown to inhibit the activity of Gtfs and EPS-mediated bacterial adhesion without killing the organisms. Here, we investigated whether a combination of cranberry flavonoids disrupts EPS accumulation and S. mutans survival using a mixed-species biofilm model under cariogenic conditions. We also assessed the impact of cranberry flavonoids on mechanical stability and the in situ pH at the biofilm-apatite interface. Topical application of an optimized combination of PACs oligomers (100-300 mu M) with myricetin (2 mM) twice daily was used to simulate treatment regimen experienced clinically. Treatments with cranberry flavonoids effectively reduced the insoluble EPS content (>80% reduction vs. vehicle-control; p<0.001), while hindering S. mutans outgrowth within mixed-species biofilms. As a result, the 3D architecture of cranberry-treated biofilms was severely compromised, showing a defective EPS-matrix and failure to develop microcolonies on the saliva-coated hydroxyapatite (sHA) surface. Furthermore, topical applications of cranberry flavonoids significantly weaken the mechanical stability of the biofilms; nearly 90% of the biofilm was removed from sHA surface after exposure to a shear stress of 0.449 N/m(2) (vs. 36% removal in vehicle-treated biofilms). Importantly, in situ pH measurements in cranberry-treated biofilms showed significantly higher pH values (5.2 +/- 0.1) at the biofilm-apatite interface vs. vehicle-treated biofilms (4.6 +/- 0.1). Altogether, the data provide important insights on how cranberry flavonoids treatments modulate virulence properties by disrupting the biochemical and ecological changes associated with cariogenic biofilm development, which could lead to new alternative or adjunctive antibiofilm/anticaries chemotherapeutic formulations.	[Kim, Dongyeop; Hwang, Geelsu; Liu, Yuan; Koo, Hyun] Univ Penn, Biofilm Res Labs, Dept Orthodont, Philadelphia, PA 19104 USA; [Kim, Dongyeop; Hwang, Geelsu; Liu, Yuan; Koo, Hyun] Univ Penn, Div Pediat Dent, Philadelphia, PA 19104 USA; [Kim, Dongyeop; Hwang, Geelsu; Liu, Yuan; Koo, Hyun] Univ Penn, Div Community Oral Hlth, Philadelphia, PA 19104 USA; [Wang, Yifei; Singh, Ajay P.; Vorsa, Nicholi] Rutgers State Univ, Dept Plant Biol & Plant Pathol, New Brunswick, NJ 08903 USA; [Vorsa, Nicholi] Rutgers State Univ, Philip E Marucci Ctr Blueberry & Cranberry Res &, Chatsworth, NJ USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Koo, H (corresponding author), Univ Penn, Biofilm Res Labs, Dept Orthodont, Philadelphia, PA 19104 USA.	koohy@dental.upenn.edu	Hwang, Geelsu/F-9484-2011; Liu, Yuan/M-2801-2017; Singh, Ajay/AAF-4414-2020	Hwang, Geelsu/0000-0001-7277-5639; Liu, Yuan/0000-0003-0213-606X	NIH [5R01DE016139, S10RR027128]; School of Veterinary Medicine, the University of Pennsylvania; Commonwealth of Pennsylvania; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016139] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); School of Veterinary Medicine, the University of Pennsylvania; Commonwealth of Pennsylvania; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by NIH grant 5R01DE016139. Imaging experiments were performed in the PennVet Imaging Core Facility on instrumentation supported by NIH S10RR027128, the School of Veterinary Medicine, the University of Pennsylvania, and the Commonwealth of Pennsylvania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by NIH grant 5R01DE016139. Imaging experiments were performed in the PennVet Imaging Core Facility on instrumentation supported by NIH S10RR027128, the School of Veterinary Medicine, the University of Pennsylvania, and the Commonwealth of Pennsylvania. APS and NV are thankful to Susan Butterworth for their help in isolation of PACs	Bowen WH, 2011, CARIES RES, V45, P69, DOI 10.1159/000324598; Bowen WH, 2013, ODONTOLOGY, V101, P2, DOI 10.1007/s10266-012-0092-z; Cross SE, 2007, MICROBIOL-SGM, V153, P3124, DOI 10.1099/mic.0.2007/007625-0; Dawes Colin, 2003, J Can Dent Assoc, V69, P722; Duarte S, 2006, FEMS MICROBIOL LETT, V257, P50, DOI 10.1111/j.1574-6968.2006.00147.x; Fajardo D, 2013, PLANT MOL BIOL REP, V31, P264, DOI 10.1007/s11105-012-0497-4; Fears KP, 2015, LANGMUIR, V31, P4654, DOI 10.1021/la504461h; Feng GP, 2013, BIOFOULING, V29, P629, DOI 10.1080/08927014.2013.794456; Gregoire S, 2007, J APPL MICROBIOL, V103, P1960, DOI 10.1111/j.1365-2672.2007.03441.x; Guo LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057182; Hall-Stoodley L, 2009, CELL MICROBIOL, V11, P1034, DOI 10.1111/j.1462-5822.2009.01323.x; Harvey A, 2000, DRUG DISCOV TODAY, V5, P294, DOI 10.1016/S1359-6446(00)01511-7; Hope CK, 2004, ANTIMICROB AGENTS CH, V48, P1461, DOI 10.1128/AAC.48.5.1461-1468.2004; Hwang G, 2014, BIOFOULING, V30, P1079, DOI 10.1080/08927014.2014.969249; Jeon JG, 2011, CARIES RES, V45, P243, DOI 10.1159/000327250; Jobstl E, 2004, BIOMACROMOLECULES, V5, P942, DOI 10.1021/bm0345110; Kassebaum NJ, 2015, J DENT RES, V94, P650, DOI 10.1177/0022034515573272; Kim D, 2012, INNOV FOOD SCI EMERG, V16, P191, DOI 10.1016/j.ifset.2012.05.014; Klein MI, 2011, JOVE-J VIS EXP, V47, pe2512, DOI DOI 10.3791/2512; Koo H, 2002, ANTIMICROB AGENTS CH, V46, P1302, DOI 10.1128/AAC.46.5.1302-1309.2002; Koo H, 2010, CARIES RES, V44, P116, DOI 10.1159/000296306; Kreth J, 2008, ORAL MICROBIOL IMMUN, V23, P213, DOI 10.1111/j.1399-302X.2007.00413.x; La VD, 2010, ANTIMICROB AGENTS CH, V54, P1778, DOI 10.1128/AAC.01432-09; Leme AFP, 2006, J DENT RES, V85, P878, DOI 10.1177/154405910608501002; Lemos JA, 2008, MICROBIOL-SGM, V154, P3247, DOI 10.1099/mic.0.2008/023770-0; Lynch DJ, 2007, FEMS MICROBIOL LETT, V268, P158, DOI 10.1111/j.1574-6968.2006.00576.x; Marsh PD, 2011, PERIODONTOL 2000, V55, P16, DOI 10.1111/j.1600-0757.2009.00339.x; Mattos-Graner RO, 2000, J DENT RES, V79, P1371, DOI 10.1177/00220345000790060401; Sato Y, 1997, INFECT IMMUN, V65, P668, DOI 10.1128/IAI.65.2.668-675.1997; Schlafer S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025299; Singh AP, 2009, PHYTOTHER RES, V23, P1066, DOI 10.1002/ptr.2667; Takahashi N, 2011, J DENT RES, V90, P294, DOI 10.1177/0022034510379602; Vinogradov A., 2004, BIOFILMS, V1, P49, DOI DOI 10.1017/S1479050503001078; Vroom JM, 1999, APPL ENVIRON MICROB, V65, P3502; Vvedenskaya IO, 2004, PLANT SCI, V167, P1043, DOI 10.1016/j.plantsci.2004.06.001; Vvedenskaya IO, 2004, J AGR FOOD CHEM, V52, P188, DOI 10.1021/jf034970s; Waters MS, 2014, ACS APPL MATER INTER, V6, P327, DOI 10.1021/am404344h; Xiao J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002623; YAMASHITA Y, 1993, INFECT IMMUN, V61, P3811, DOI 10.1128/IAI.61.9.3811-3817.1993; Yanagida A, 2000, J AGR FOOD CHEM, V48, P5666, DOI 10.1021/jf000363i	40	29	29	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145844	10.1371/journal.pone.0145844	http://dx.doi.org/10.1371/journal.pone.0145844			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713438	Green Published, gold, Green Submitted			2022-12-26	WOS:000367481900093
J	Huang, W; Xu, F; Qu, T; Zhang, R; Li, L; Que, HY; Zhang, GF				Huang, Wen; Xu, Fei; Qu, Tao; Zhang, Rui; Li, Li; Que, Huayong; Zhang, Guofan			Identification of Thyroid Hormones and Functional Characterization of Thyroid Hormone Receptor in the Pacific Oyster Crassostrea gigas Provide Insight into Evolution of the Thyroid Hormone System	PLOS ONE			English	Article							GENE-EXPRESSION; METAMORPHOSIS; REVEALS; BETA; METABOLISM; HOMOLOGS; GROWTH; MODEL; T-3	Thyroid hormones (THs) play important roles in development, metamorphosis, and metabolism in vertebrates. During the past century, TH functions were regarded as a synapomorphy of vertebrates. More recently, accumulating evidence has gradually convinced us that TH functions also occur in invertebrate chordates. To date, however, TH-related studies in non-chordate invertebrates have been limited. In this study, THs were qualitatively detected by two reliable methods (HPLC and LC/MS) in a well-studied molluscan species, the Pacific oyster Crassostrea gigas. Quantitative measurement of THs during the development of C. gigas showed high TH contents during embryogenesis and that oyster embryos may synthesize THs endogenously. As a first step in elucidating the TH signaling cascade, an ortholog of vertebrate TH receptor (TR), the most critical gene mediating TH effects, was cloned in C. gigas. The sequence of CgTR has conserved DNA-binding and ligand-binding domains that normally characterize these receptors. Experimental results demonstrated that CgTR can repress gene expression through binding to promoters of target genes and can interact with oyster retinoid X receptor. Moreover, CgTR mRNA expression was activated by T4 and the transcriptional activity of CgTR promoter was repressed by unliganded CgTR protein. An atypical thyroid hormone response element (CgDR5) was found in the promoter of CgTR, which was verified by electrophoretic mobility shift assay (EMSA). These results indicated that some of the CgTR function is conserved. However, the EMSA assay showed that DNA binding specificity of CgTR was different from that of the vertebrate TR and experiments with two dual-luciferase reporter systems indicated that L-thyroxine, 3,30,5-triiodothyronine, and triiodothyroacetic acid failed to activate the transcriptional activity of CgTR. This is the first study to functionally characterize TR in mollusks. The presence of THs and the functions of CgTR in mollusks contribute to better understanding of the evolution of the TH system.	[Huang, Wen; Xu, Fei; Qu, Tao; Zhang, Rui; Li, Li; Que, Huayong; Zhang, Guofan] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China; [Huang, Wen; Zhang, Rui] Univ Chinese Acad Sci, Beijing, Peoples R China; [Huang, Wen; Xu, Fei; Qu, Tao; Zhang, Rui; Li, Li; Que, Huayong; Zhang, Guofan] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China; [Huang, Wen; Xu, Fei; Qu, Tao; Zhang, Rui; Li, Li; Que, Huayong; Zhang, Guofan] Chinese Acad Sci, Inst Oceanol, Natl & Local Joint Engn Lab Ecol Mariculture, Qingdao, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Qingdao National Laboratory for Marine Science & Technology; Chinese Academy of Sciences; Institute of Oceanology, CAS	Que, HY (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China.	hque@qdio.ac.cn; gfzhang@qdio.ac.cn	Li, Li/AEM-3636-2022; LI, LI/GVS-5344-2022; Xu, Fei/A-1736-2012; li, li/GPX-3938-2022; li, li/HII-4157-2022; huang, wen/GXW-0661-2022	Xu, Fei/0000-0002-0981-8429; 	National Natural Science Foundation of China [31372515, 31402285]; National Basic Research Program of China (973 Program) [2010CB126401]; National High Technology Research and Development Program (863 program) [2012AA10A405]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National High Technology Research and Development Program (863 program)(National High Technology Research and Development Program of China)	This research was financially supported by the National Natural Science Foundation of China (No.31372515 and 31402285), the National Basic Research Program of China (973 Program, 2010CB126401), and the National High Technology Research and Development Program (863 program, 2012AA10A405). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antheunisse LJ, 1956, KONINKLYKE NEDERLAND, V59, P562; AYSON FG, 1993, AQUACULTURE, V109, P83, DOI 10.1016/0044-8486(93)90488-K; Barucchi VC, 2013, CYTOGENET GENOME RES, V141, P80, DOI 10.1159/000354098; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Campinho MA, 2014, MOL ENDOCRINOL, V28, P1136, DOI 10.1210/me.2014-1032; Crane HM, 2004, GEN COMP ENDOCR, V139, P55, DOI 10.1016/j.ygcen.2004.07.004; Das B, 2009, J BIOL CHEM, V284, P34167, DOI 10.1074/jbc.M109.066084; Du YS, 2013, FISH SHELLFISH IMMUN, V34, P939, DOI 10.1016/j.fsi.2012.12.007; Escriva H, 2002, MOL BIOL EVOL, V19, P1440, DOI 10.1093/oxfordjournals.molbev.a004207; Fukazawa H, 2001, FISHERIES SCI, V67, P985, DOI 10.1046/j.1444-2906.2001.00351.x; Heyland A, 2005, J EXP BIOL, V208, P4355, DOI 10.1242/jeb.01877; Heyland A, 2006, J EXP ZOOL PART B, V306B, P551, DOI 10.1002/jez.b.21113; Huang W, 2015, CHIN J OCEANOL LIMN; Keay J, 2006, ENDOCRINOLOGY, V147, P3861, DOI 10.1210/en.2006-0363; Klootwijk W, 2011, ENDOCRINOLOGY, V152, P3259, DOI 10.1210/en.2010-1408; Kuraku S, 2008, ZOOL SCI, V25, P960, DOI 10.2108/zsj.25.960; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laudet V, 2011, CURR BIOL, V21, pR726, DOI 10.1016/j.cub.2011.07.030; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Morvan-Dubois G, 2008, MOL CELL ENDOCRINOL, V293, P71, DOI 10.1016/j.mce.2008.06.012; Nagy L, 1999, GENE DEV, V13, P3209, DOI 10.1101/gad.13.24.3209; Nakajima K, 2012, GENES CELLS, V17, P645, DOI 10.1111/j.1365-2443.2012.01614.x; Novac Natalia, 2004, Current Drug Targets - Inflammation and Allergy, V3, P335; Ogasawara M, 1999, J EXP ZOOL, V285, P158, DOI 10.1002/(SICI)1097-010X(19990815)285:2<158::AID-JEZ8>3.0.CO;2-0; Ogasawara M, 2000, DEV GENES EVOL, V210, P231, DOI 10.1007/s004270050309; Paris M, 2008, CURR BIOL, V18, P825, DOI 10.1016/j.cub.2008.04.078; Paris M, 2010, INTEGR COMP BIOL, V50, P63, DOI 10.1093/icb/icq052; Paris M, 2008, DEV GENES EVOL, V218, P667, DOI 10.1007/s00427-008-0255-7; Qiu CH, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-172; Qu T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089040; RANJAN M, 1994, J BIOL CHEM, V269, P24699; Samanidou VF, 2000, J LIQ CHROMATOGR R T, V23, P681, DOI 10.1081/JLC-100101481; Shepherdley CA, 2004, ENDOCRINOLOGY, V145, P1255, DOI 10.1210/en.2003-1248; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tata JR, 2006, MOL CELL ENDOCRINOL, V246, P10, DOI 10.1016/j.mce.2005.11.024; TATA JR, 1993, J STEROID BIOCHEM, V46, P105, DOI 10.1016/0960-0760(93)90286-6; TONG W, 1961, BIOCHIM BIOPHYS ACTA, V48, P347, DOI 10.1016/0006-3002(61)90485-1; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; Vogeler S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-369; Wagner RL, 2001, MOL ENDOCRINOL, V15, P398, DOI 10.1210/me.15.3.398; Wang L, 2010, J BONE MINER RES, V25, P1138, DOI 10.1002/jbmr.5; Wang SH, 2009, MOL CELL ENDOCRINOL, V313, P57, DOI 10.1016/j.mce.2009.08.024; Wu TT, 2012, FISH SHELLFISH IMMUN, V33, P286, DOI 10.1016/j.fsi.2012.05.011; Wu W, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-150; Wu WJ, 2007, FEBS J, V274, P390, DOI 10.1111/j.1742-4658.2006.05587.x; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413	47	31	32	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0144991	10.1371/journal.pone.0144991	http://dx.doi.org/10.1371/journal.pone.0144991			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710071	Green Published, Green Submitted, gold			2022-12-26	WOS:000367451400017
J	Rajpal, DK; Klein, JL; Mayhew, D; Boucheron, J; Spivak, AT; Kumar, V; Ingraham, K; Paulik, M; Chen, LH; Van Horn, S; Thomas, E; Sathe, G; Livi, GP; Holmes, DJ; Brown, JR				Rajpal, Deepak K.; Klein, Jean-Louis; Mayhew, David; Boucheron, Joyce; Spivak, Aaron T.; Kumar, Vinod; Ingraham, Karen; Paulik, Mark; Chen, Lihong; Van Horn, Stephanie; Thomas, Elizabeth; Sathe, Ganesh; Livi, George P.; Holmes, David J.; Brown, James R.			Selective Spectrum Antibiotic Modulation of the Gut Microbiome in Obesity and Diabetes Rodent Models	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; INCREASES; DIET; CONSEQUENCES; NORFLOXACIN; VANCOMYCIN; METAGENOME; PREBIOTICS; TOLERANCE; INULIN	The gastrointestinal tract microbiome has been suggested as a potential therapeutic target for metabolic diseases such as obesity and Type 2 diabetes mellitus (T2DM). However, the relationship between changes in microbial communities and metabolic disease-phenotypes are still poorly understood. In this study, we used antibiotics with markedly different antibacterial spectra to modulate the gut microbiome in a diet-induced obesity mouse model and then measured relevant biochemical, hormonal and phenotypic biomarkers of obesity and T2DM. Mice fed a high-fat diet were treated with either ceftazidime (a primarily anti-Gram negative bacteria antibiotic) or vancomycin (mainly anti-Gram positive bacteria activity) in an escalating three-dose regimen. We also dosed animals with a well-known prebiotic weight-loss supplement, 10% oligofructose saccharide (10% OFS). Vancomycin treated mice showed little weight change and no improvement in glycemic control while ceftazidime and 10% OFS treatments induced significant weight loss. However, only ceftazidime showed significant, dose dependent improvement in key metabolic variables including glucose, insulin, protein tyrosine tyrosine (PYY) and glucagon-like peptide-1 (GLP-1). Subsequently, we confirmed the positive hyperglycemic control effects of ceftazidime in the Zucker diabetic fatty (ZDF) rat model. Metagenomic DNA sequencing of bacterial 16S rRNA gene regions V1-V3 showed that the microbiomes of ceftazidime dosed mice and rats were enriched for the phylum Firmicutes while 10% OFS treated mice had a greater abundance of Bacteroidetes. We show that specific changes in microbial community composition are associated with obesity and glycemic control phenotypes. More broadly, our study suggests that in vivo modulation of the microbiome warrants further investigation as a potential therapeutic strategy for metabolic diseases.	[Rajpal, Deepak K.; Mayhew, David; Spivak, Aaron T.; Kumar, Vinod; Brown, James R.] GlaxoSmithKline, Res & Dev, Target Sci, Computat Biol, Collegeville, PA USA; [Klein, Jean-Louis; Van Horn, Stephanie; Thomas, Elizabeth; Sathe, Ganesh; Livi, George P.] GlaxoSmithKline, Res & Dev, Target & Pathway Validat, Target Sci, Collegeville, PA USA; [Boucheron, Joyce; Paulik, Mark; Chen, Lihong] GlaxoSmithKline, Enteroendocrine Discovery Performance Unit, Res & Dev, Res Triangle Pk, NC USA; [Ingraham, Karen; Holmes, David J.] GlaxoSmithKline, Antibacterial Discovery Performance Unit, Res & Dev, Collegeville, PA USA	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Brown, JR (corresponding author), GlaxoSmithKline, Res & Dev, Target Sci, Computat Biol, Collegeville, PA USA.	James.R.Brown@gsk.com		Brown, James/0000-0002-9368-627X	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	The study was funded by GlaxoSmithKline. The funder provided support in the form of salaries for authors [DR, JLK, DM, JB, AS, VK, KI, MP, LC, SVH, ET, GS, GPL, DJH, JRB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blaser M, 2011, NATURE, V476, P393, DOI 10.1038/476393a; Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0; Cani PD, 2009, AM J CLIN NUTR, V90, P1236, DOI 10.3945/ajcn.2009.28095; Caporaso J Gregory, 2010, NAT METHODS, V7, P335, DOI [10.1038/nmeth.f.303, DOI 10.1038/NMETH.F.303]; Chou CJ, 2008, NESTLE NUTR WORKS SE, V62, P127, DOI 10.1159/000146256; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; Cox A. J., 2014, LANCET DIABETES ENDO; Dallinga-Thie GM, 2015, ARTERIOSCL THROM VAS, V35, P1048, DOI 10.1161/ATVBAHA.115.305479; Delzenne NM, 2007, J NUTR, V137, p2547S, DOI 10.1093/jn/137.11.2547S; Delzenne NM, 2011, NAT REV ENDOCRINOL, V7, P639, DOI 10.1038/nrendo.2011.126; Derrien M, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00166; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; HAYES MV, 1983, J ANTIMICROB CHEMOTH, V12, P119, DOI 10.1093/jac/12.2.119; Holmes E, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004244; Holzer P, 2014, ADV EXP MED BIOL, V817, P195, DOI 10.1007/978-1-4939-0897-4_9; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Loh K, 2015, TRENDS ENDOCRIN MET, V26, P125, DOI 10.1016/j.tem.2015.01.003; Membrez M, 2008, FASEB J, V22, P2416, DOI 10.1096/fj.07-102723; Meyer D, 2009, EUR J CLIN NUTR, V63, P1277, DOI 10.1038/ejcn.2009.64; Moellering RC, 2006, CLIN INFECT DIS, V42, pS3, DOI 10.1086/491708; Murphy EF, 2013, GUT, V62, P220, DOI 10.1136/gutjnl-2011-300705; Napolitano A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100778; Navas-Molina JA, 2013, METHOD ENZYMOL, V531, P371, DOI 10.1016/B978-0-12-407863-5.00019-8; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; R Core Team, 2021, R LANGUAGE ENV STAT; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Sweeney TE, 2013, JAMA SURG, V148, P563, DOI 10.1001/jamasurg.2013.5; Tarini J, 2010, APPL PHYSIOL NUTR ME, V35, P9, DOI 10.1139/H09-119; Thuny F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009074; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Ueda Y, 2010, INT IMMUNOL, V22, P953, DOI 10.1093/intimm/dxq449; van Passel MWJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016876; Wang BX, 2014, CURR DIABETES REV, V10, P131, DOI 10.2174/1573399810666140508121012	46	32	37	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145499	10.1371/journal.pone.0145499	http://dx.doi.org/10.1371/journal.pone.0145499			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709835	gold, Green Published, Green Submitted			2022-12-26	WOS:000367451400055
J	Fortin, E; Quach, C; Fontela, PS; Buckeridge, DL; Platt, RW				Fortin, Elise; Quach, Caroline; Fontela, Patricia S.; Buckeridge, David L.; Platt, Robert W.			A Simulation Study to Assess Indicators of Antimicrobial Use as Predictors of Resistance: Does It Matter Which Indicator Is Used?	PLOS ONE			English	Article							ANTIBIOTIC USE; HOSPITALS; TRENDS	Objective Indicators of antimicrobial use have been described previously, but few studies have compared their accuracy in prediction of antimicrobial resistance in hospital settings. This study aimed to identify conditions under which significant differences would be observed in the predictive accuracy of indicators in the context of surveillance of intensive care units (ICUs). Methods Ten resistance / antimicrobial use combinations were studied. We used simulation to determine if Quebec's network of 81 ICUs or the National Healthcare Safety Network (NHSN) of 2952 ICUs are large enough to allow the detection of predetermined differences between the most accurate and 1) the second most accurate indicator, and 2) the least accurate indicator, in more than 80% of simulations. For each indicator, we simulated absolute errors in prediction for each ICU and each 4-week period, for surveillance lasting up to 5 years. Absolute errors were generated following a binomial distribution, using mean absolute errors (MAEs) observed in 9 ICUs as the average proportion; simulated MAEs were compared using t-tests. This was repeated 1000 times per scenario. Results When comparing the two most accurate indicators, 80% power was reached less often with the Quebec network versus the NHSN (0/20 versus 2/20 scenarios, with 5 years of surveillance data), a finding reinforced when comparing the most and least accurate indicators (3/20 versus 20/20 scenarios). When simulating 1 year of data, scenarios reaching an 80% power dropped to 0/20, comparing the two most accurate indicators with the larger network, and to 1/20, comparing the most and least accurate indicators with the smaller network. Conclusion Most of the time (72%), identifying an indicator of antimicrobial use predicting antimicrobial resistance with a better accuracy was not possible. The choice of an indicator for an eventual surveillance system should rely on criteria other that predictive accuracy.	[Fortin, Elise; Quach, Caroline; Fontela, Patricia S.; Buckeridge, David L.; Platt, Robert W.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Fortin, Elise; Quach, Caroline] Inst Natl Sante Publ Quebec, Direct Risques Biol & Sante Travail, Quebec City, PQ, Canada; [Fortin, Elise; Quach, Caroline] Inst Natl Sante Publ Quebec, Direct Risques Biol & Sante Travail, Montreal, PQ, Canada; [Quach, Caroline; Fontela, Patricia S.] McGill Univ, Montreal Childrens Hosp, Dept Pediat, Montreal, PQ H3H 1P3, Canada	McGill University; Institut national de sante publique du Quebec (INSPQ); Institut national de sante publique du Quebec (INSPQ); McGill University	Platt, RW (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.	robert.platt@mcgill.ca	Quach, Caroline/AAT-6987-2021; Fontela, Patricia/S-6455-2019	Quach, Caroline/0000-0002-1170-9475; 	Fonds de recherche du Quebec - Sante [22282]	Fonds de recherche du Quebec - Sante(Fonds de la Recherche en Sante du Quebec)	This project was funded by the Fonds de recherche du Quebec - Sante (record number 22282; http://www.frqs.gouv.qc.ca/fr/index.shtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antachopoulos C, 2004, 14 EUR C CLIN MICR I; Berrington A, 2010, J ANTIMICROB CHEMOTH, V65, P163, DOI 10.1093/jac/dkp399; de With K, 2006, INFECTION, V34, P91, DOI 10.1007/s15010-006-5085-9; Di Pentima M, 2011, IDSA 49 ANN M 2011 B; Dudeck MA, 2011, AM J INFECT CONTROL, V39, P349, DOI 10.1016/j.ajic.2011.04.011; Filius PMG, 2005, J ANTIMICROB CHEMOTH, V55, P805, DOI 10.1093/jac/dki093; Fortin E, 2014, J ANTIMICROB CHEMOTH, V69, P1447, DOI 10.1093/jac/dku003; Fortin E, PLOS ONE IN PRESS; Fortin E, 2012, INFECT CONT HOSP EP, V33, P456, DOI 10.1086/665323; Haug JB, 2013, J ANTIMICROB CHEMOTH, V68, P2940, DOI 10.1093/jac/dkt268; Hyndman R.J., 2006, FORESIGHT INT J APPL, V4, P43; Ibrahim OM, 2012, EXPERT REV ANTI-INFE, V10, P445, DOI 10.1586/eri.12.18; ISAACS D, 1987, ARCH DIS CHILD, V62, P204, DOI 10.1136/adc.62.2.204; Lagace-Wiens PRS, 2013, J ANTIMICROB CHEMOTH, V68, pi23, DOI 10.1093/jac/dkt023; Liem TBY, 2010, ACTA PAEDIATR, V99, P1900, DOI 10.1111/j.1651-2227.2010.01957.x; Mataseje LF, 2012, J ANTIMICROB CHEMOTH, V67, P1359, DOI 10.1093/jac/dks046; Monnet DL, 2007, CLIN INFECT DIS, V44, P671, DOI 10.1086/511649; MSSS, 2011, MIS OEUVR PROGR SURV; National Healthcare Safety Network (NHSN), 2014, ANT US RES AUR MOD; Raz R, 1998, J INFECTION, V37, P224, DOI 10.1016/S0163-4453(98)91890-4; Ruef C, 2006, INFECTION, V34, P53, DOI 10.1007/s15010-006-7206-x; Schechner V, 2013, CLIN MICROBIOL REV, V26, P289, DOI 10.1128/CMR.00001-13; SPIN, 2014, SURV PROV INF NOS SP; World Health Organisation Collaborating Center for Drug Statistics Methodology, 2011, GUID ATC CLASS DDD A; Zarb P, 2011, J ANTIMICROB CHEMOTH, V66, P443, DOI 10.1093/jac/dkq430	25	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145761	10.1371/journal.pone.0145761	http://dx.doi.org/10.1371/journal.pone.0145761			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700185	Green Published, gold			2022-12-26	WOS:000367092600131
J	Prudden, HJ; Beattie, TS; Bobrova, N; Panovska-Griffiths, J; Mukandavire, Z; Gorgens, M; Wilson, D; Watts, CH				Prudden, Holly J.; Beattie, Tara S.; Bobrova, Natalia; Panovska-Griffiths, Jasmina; Mukandavire, Zindoga; Gorgens, Marelize; Wilson, David; Watts, Charlotte H.			Factors Associated with Variations in Population HIV Prevalence across West Africa: Findings from an Ecological Analysis	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; FEMALE SEX WORKERS; MALE CLIENTS; RISK; TRANSMISSION; INFECTION; DYNAMICS; COUNTRIES; BEHAVIOR; BENIN	Background Population HIV prevalence across West Africa varies substantially. We assess the national epidemiological and behavioural factors associated with this. Methods National, urban and rural data on HIV prevalence, the percentage of younger (15-24) and older (25-49) women and men reporting multiple (2+) partners in the past year, HIV prevalence among female sex workers (FSWs), men who have bought sex in the past year (clients), and ART coverage, were compiled for 13 countries. An Ecological analysis using linear regression assessed which factors are associated with national variations in population female and male HIV prevalence, and with each other. Findings National population HIV prevalence varies between 0 4-2 9% for men and 0 4-5.6% for women. ART coverage ranges from 6-23%. National variations in HIV prevalence are not shown to be associated with variations in HIV prevalence among FSWs or clients. Instead they are associated with variations in the percentage of younger and older males and females reporting multiple partners. HIV prevalence is weakly negatively associated with ART coverage, implying it is not increased survival that is the cause of variations in HIV prevalence. FSWs and younger female HIV prevalence are associated with client population sizes, especially older men. Younger female HIV prevalence is strongly associated with older male and female HIV prevalence. Interpretation In West Africa, population HIV prevalence is not significantly higher in countries with high FSW HIV prevalence. Our analysis suggests, higher prevalence occurs where more men buy sex, and where a higher percentage of younger women, and older men and women have multiple partnerships. If a sexual network between clients and young females exists, clients may potentially bridge infection to younger females. HIV prevention should focus both on commercial sex and transmission between clients and younger females with multiple partners. have multiple partnerships. If a sexual network between clients and young females exists, clients may potentially bridge infection to younger females. HIV prevention should focus both on commercial sex and transmission between clients and younger females with multiple partners.	[Prudden, Holly J.; Beattie, Tara S.; Bobrova, Natalia; Panovska-Griffiths, Jasmina; Mukandavire, Zindoga; Watts, Charlotte H.] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England; [Gorgens, Marelize; Wilson, David] World Bank, Washington, DC 20433 USA	University of London; London School of Hygiene & Tropical Medicine; The World Bank	Prudden, HJ (corresponding author), London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England.	Holly.Prudden@lshtm.ac.uk		Panovska-Griffiths, Jasmina/0000-0002-7720-1121; Beattie, Tara/0000-0001-9156-7341; Mukandavire, Zindoga/0000-0002-8108-1441	STRIVE research programme consortium - UKaid from the Department for International Development; World Bank; Department for International Development (DFID) [201447] Funding Source: researchfish	STRIVE research programme consortium - UKaid from the Department for International Development; World Bank(The World Bank India); Department for International Development (DFID)	The authors wish to acknowledge funders for this work, The World Bank. This study was also supported by the STRIVE research programme consortium funded by UKaid from the Department for International Development. However, the views expressed do not necessarily reflect the views of the funders.; We wish to acknowledge our funders for this work, The World Bank. This study was also supported by the STRIVE research programme consortium funded by UKaid from the Department for International Development. However, the views expressed do not necessarily reflect the views of the funders.	Alary M, 2004, AIDS, V18, P945, DOI 10.1097/00002030-200404090-00013; Alary M, 2003, SEX TRANSM INFECT, V79, P388, DOI 10.1136/sti.79.5.388; Avert, 2012, HIV AIDS SUBS AFR; Baird SJ, 2012, LANCET, V379, P1320, DOI 10.1016/S0140-6736(11)61709-1; Beattie T, 2011, SEX WORK TYPOLOGIES; Boily MC, 2015, JAIDS-J ACQ IMM DEF, V68, pS74, DOI 10.1097/QAI.0000000000000437; Comite National de Lutte contre le SIDA, 2012, RAPP UNGASS 2012 GUI; Dupas P, 2011, AM ECON J-APPL ECON, V3, P1, DOI 10.1257/app.3.1.1; Fenton KA, 2001, SEX TRANSM INFECT, V77, P84, DOI 10.1136/sti.77.2.84; Garnett GP, 1998, AIDS PATIENT CARE ST, V12, P435, DOI 10.1089/apc.1998.12.435; Godin G, 2008, AIDS BEHAV, V12, P441, DOI 10.1007/s10461-007-9296-6; Harcourt C, 2005, SEX TRANSM INFECT, V81, P201, DOI 10.1136/sti.2004.012468; Harling G, 2014, JAIDS-J ACQ IMM DEF, V66, P443, DOI 10.1097/QAI.0000000000000198; Jewkes R, 2012, AIDS CLIN RES, V3; Kim J, 2009, B WORLD HEALTH ORGAN, V87, P824, DOI 10.2471/BLT.08.056580; Laga M, 2010, SEX TRANSM INFECT, V86, pI6, DOI 10.1136/sti.2009.039255; Lowndes CM, 2002, SEX TRANSM INFECT, V78, pI69, DOI 10.1136/sti.78.suppl_1.i69; Mishra S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050691; Moore Ann M, 2007, Afr J Reprod Health, V11, P44, DOI 10.2307/25549731; Morison L, 2001, AIDS, V15; Odeyemi Kofoworola, 2009, Int J Adolesc Med Health, V21, P101, DOI 10.1515/IJAMH.2009.21.1.101; Owoaje E T, 2009, East Afr J Public Health, V6, P274; Peltzer K, 2013, ANN GEN PSYCHIATR, V12, DOI 10.1186/1744-859X-12-18; Roianapithayakorn W, 2006, REPROD HEALTH MATTER, V14, P41; Santo MEGD, 2005, SEX TRANSM INFECT, V81, P342, DOI 10.1136/sti.2004.011940; Sobela F, 2009, JAIDS-J ACQ IMM DEF, V51, P216, DOI 10.1097/QAI.0b013e31819c170f; The World Bank, 2008, W AFR HIV AIDS EP RE; The World Bank, 2012, DAT STAT; The World Bank, 2015, PREV HIV TOT POP AG; UNAIDS, 2013, UNAIDS SPEC REP AFR; Vinod M, 2009, CHANGES HIV RELATED; Weiss HA, 2000, AIDS, V14, P2361, DOI 10.1097/00002030-200010200-00018; YORKE JA, 1978, SEX TRANSM DIS, V5, P51, DOI 10.1097/00007435-197804000-00003	33	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0142601	10.1371/journal.pone.0142601	http://dx.doi.org/10.1371/journal.pone.0142601			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26698854	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000367092600004
J	Wang, L; Kofler, M; Brosch, G; Melesina, J; Sippl, W; Martinez, ED; Easmon, J				Wang, Lei; Kofler, Marina; Brosch, Gerald; Melesina, Jelena; Sippl, Wolfgang; Martinez, Elisabeth D.; Easmon, Johnny			2-Benzazolyl-4-Piperazin-1-Ylsulfonylbenzenecarbohydroxamic Acids as Novel Selective Histone Deacetylase-6 Inhibitors with Antiproliferative Activity	PLOS ONE			English	Article							TRICHOSTATIN; DERIVATIVES; POTENT; R306465	We have screened our compound collection in an established cell based assay that measures the derepression of an epigenetically silenced transgene, the locus derepression assay. The screen led to the identification of 4-[4-(1-methylbenzimidazol-2-yl)piperazin-1-yl] sulfonylbenzenecarbohydroxamic acid (9b) as an active which was found to inhibit HDAC1. In initial structure activity relationships study, the 1-methylbenzimidazole ring was replaced by the isosteric heterocycles benzimidazole, benzoxazole, and benzothiazole and the position of the hydroxamic acid substituent on the phenyl ring was varied. Whereas compounds bearing a para substituted hydroxamic acid (9a-d) were active HDAC inhibitors, the meta substituted analogues (8a-d) were appreciably inactive. Compounds 9a-d selectively inhibited HDAC6 (IC50 = 0.1-1.0 mu M) over HDAC1 (IC50 = 0.9-6 mu M) and moreover, also selectively inhibited the growth of lung cancer cells vs. patient matched normal cells. The compounds induce a cell cycle arrest in the S-phase while induction of apoptosis is neglible as compared to controls. Molecular modeling studies uncovered that the MM-GBSA energy for interaction of 9a-d with HDAC6 was higher than for HDAC1 providing structural rationale for the HDAC6 selectivity.	[Wang, Lei; Martinez, Elisabeth D.] UT Southwestern Med Ctr, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA; [Kofler, Marina; Easmon, Johnny] Univ Innsbruck, Ctr Chem & Biomed, Inst Pharm, Dept Pharmaceut Chem, A-6020 Innsbruck, Austria; [Brosch, Gerald] Med Univ Innsbruck, Ctr Chem & Biomed, Div Mol Biol, A-6020 Innsbruck, Austria; [Melesina, Jelena; Sippl, Wolfgang] Univ Halle Wittenberg, Dept Med Chem, Inst Pharm, D-06099 Halle, Germany; [Martinez, Elisabeth D.] UT Southwestern Med Ctr, Dept Pharmacol, Dallas, TX USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Innsbruck; Medical University of Innsbruck; Martin Luther University Halle Wittenberg; University of Texas System; University of Texas Southwestern Medical Center Dallas	Martinez, ED (corresponding author), UT Southwestern Med Ctr, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA.	elisabeth.martinez@utsouthwestern.edu; johnny.easmon@uibk.ac.at	Melesina, Jelena/AAI-1787-2019; Sippl, Wolfgang/P-5944-2014	Sippl, Wolfgang/0000-0002-5985-9261; Melesina, Jelena/0000-0001-7335-7041	NIH [R01CA12526901, 1R21AI11622201, P50-CA70907]; Doctor's Cancer Foundation (Nolan Miller Lung Cancer grant); Welch Foundation; National Cancer Institut [R01CA12526901]; CPRIT [RP120717]; NATIONAL CANCER INSTITUTE [P50CA070907] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doctor's Cancer Foundation (Nolan Miller Lung Cancer grant); Welch Foundation(The Welch Foundation); National Cancer Institut(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CPRIT; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was partly funded by the NIH (R01CA12526901 to E.D.M., 1R21AI11622201 to I.D./E.D.M. P50-CA70907 to J.D.M., subaward to E.D.M.) by the Doctor's Cancer Foundation (Nolan Miller Lung Cancer grant to E.D.M.), by the Friends of the Cancer Center, by the Welch Foundation (grants to E.D.M.), by the National Cancer Institut R01CA12526901 to E.D.M., and by CPRIT (RP120717). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Jianjun Chang for technical assistance with proliferation assays. This project was partly funded by the NIH (R01CA12526901 to E.D.M., 1R21AI11622201 to I.D./E.D.M. P50-CA70907 to J.D.M., subaward to E.D.M.) by the Doctor's Cancer Foundation (Nolan Miller Lung Cancer grant to E.D.M.), by the Friends of the Cancer Center, by the Welch Foundation (grants to E.D.M.) and by CPRIT (RP120717).	[Anonymous], 2012, ROTEIN PREPARATION W; Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Arts J, 2007, BRIT J CANCER, V97, P1344, DOI 10.1038/sj.bjc.6604025; Best AM, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/868095; Burli RW, 2013, J MED CHEM, V56, P9934, DOI 10.1021/jm4011884; Butler KV, 2010, J AM CHEM SOC, V132, P10842, DOI 10.1021/ja102758v; Chang J, 2012, BRIT J CANCER, V106, P116, DOI 10.1038/bjc.2011.532; Dallavalle S, 2012, BIOCHEM PHARMACOL, V84, P756, DOI 10.1016/j.bcp.2012.06.014; Fong PC, 2007, J CLIN ONCOL, V25; Furumai R, 2001, P NATL ACAD SCI USA, V98, P87, DOI 10.1073/pnas.011405598; Grassadonia Antonino, 2013, Cancers (Basel), V5, P919, DOI 10.3390/cancers5030919; Hofer S, 2013, BIOORG MED CHEM LETT, V23, P5397, DOI 10.1016/j.bmcl.2013.07.047; Johnson RL, 2008, ANAL BIOCHEM, V375, P237, DOI 10.1016/j.ab.2007.12.028; Lin HY, 2006, MED RES REV, V26, P397, DOI 10.1002/med.20056; Martinez ED, 2006, METHOD ENZYMOL, V414, P21, DOI 10.1016/S0076-6879(06)14002-1; Millard CJ, 2013, MOL CELL, V51, P57, DOI 10.1016/j.molcel.2013.05.020; Monga M, 2002, LEUKEMIA, V16, P520, DOI 10.1038/sj.leu.2402464; Ononye SN, 2012, PHARM PAT ANAL, V1, DOI [10.4144/ppa.12.21, DOI 10.4144/PPA.12.21]; Orjales A, 1997, J MED CHEM, V40, P586, DOI 10.1021/jm960442e; Paris M, 2008, J MED CHEM, V51, P1505, DOI 10.1021/jm7011408; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Reddy AS, 2000, TETRAHEDRON LETT, V41, P6285, DOI 10.1016/S0040-4039(00)01058-3; Sato Y, 1998, J MED CHEM, V41, P3015, DOI 10.1021/jm9801004; Schaefer S, 2009, CHEMMEDCHEM, V4, P283, DOI 10.1002/cmdc.200800196; SENDRA R, 1988, PLANT MOL BIOL, V11, P857, DOI 10.1007/BF00019525; Shafik RM, 2003, ALEX J PHARM SCI, V17, P137; Silvestri L, 2012, J CHEM INF MODEL, V52, P2215, DOI 10.1021/ci300160y; Ververis K, 2013, BIOL-TARGETS THER, V7, P47, DOI 10.2147/BTT.S29965; Walczynski K, 1999, FARMACO, V54, P684, DOI 10.1016/S0014-827X(99)00081-6; Wang L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3035; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174	32	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0134556	10.1371/journal.pone.0134556	http://dx.doi.org/10.1371/journal.pone.0134556			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26698121	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092600001
J	Herzog, S; Wemheuer, F; Wemheuer, B; Daniel, R				Herzog, Sarah; Wemheuer, Franziska; Wemheuer, Bernd; Daniel, Rolf			Effects of Fertilization and Sampling Time on Composition and Diversity of Entire and Active Bacterial Communities in German Grassland Soils	PLOS ONE			English	Article							RIBOSOMAL-RNA GENE; MICROBIAL COMMUNITIES; SEASONAL-CHANGES; PLANT DIVERSITY; NITROGEN; BACILLUS; PH; IDENTIFICATION; PREDOMINANT; ABUNDANCE	Soil bacteria are major players in driving and regulating ecosystem processes. Thus, the identification of factors shaping the diversity and structure of these communities is crucial for understanding bacterial-mediated processes such as nutrient transformation and cycling. As most studies only target the entire soil bacterial community, the response of active community members to environmental changes is still poorly understood. The objective of this study was to investigate the effect of fertilizer application and sampling time on structure and diversity of potentially active (RNA-based) and the entire (DNA-based) bacterial communities in German grassland soils. Analysis of more than 2.3 million 16S rRNA transcripts and gene sequences derived from amplicon-based sequencing of 16S rRNA genes revealed that fertilizer application and sampling time significantly altered the diversity and composition of entire and active bacterial communities. Although the composition of both the entire and the active bacterial community was correlated with environmental factors such as pH or C/N ratio, the active community showed a higher sensitivity to environmental changes than the entire community. In addition, functional analyses were performed based on predictions derived from 16S rRNA data. Genes encoding the uptake of nitrate/nitrite, nitrification, and denitrification were significantly more abundant in fertilized plots compared to non-fertilized plots. Hence, this study provided novel insights into changes in dynamics and functions of soil bacterial communities as response to season and fertilizer application.	[Herzog, Sarah; Wemheuer, Bernd; Daniel, Rolf] Univ Gottingen, Dept Genom & Appl Microbiol, D-37077 Gottingen, Germany; [Herzog, Sarah; Wemheuer, Bernd; Daniel, Rolf] Univ Gottingen, Inst Microbiol & Genet, Gottingen Genom Lab, D-37077 Gottingen, Germany; [Wemheuer, Franziska] Univ Gottingen, Dept Crop Sci, Sect Agr Entomol, D-37077 Gottingen, Germany	University of Gottingen; University of Gottingen; University of Gottingen	Daniel, R (corresponding author), Univ Gottingen, Dept Genom & Appl Microbiol, Grisebachstr 8, D-37077 Gottingen, Germany.	rdaniel@gwdg.de	Daniel, Rolf/AAQ-5933-2021	Daniel, Rolf/0000-0002-8646-7925	Ministry of Science and Culture of Lower Saxony (Germany); "Niedersachsisches Vorab" as part of the Cluster of Excellence "Functional Biodiversity Research" of Georg-August-University; DFG; Gottingen University; "Niedersachsisches Vorab" as part of the Cluster of Excellence "Functional Biodiversity Research"	Ministry of Science and Culture of Lower Saxony (Germany); "Niedersachsisches Vorab" as part of the Cluster of Excellence "Functional Biodiversity Research" of Georg-August-University; DFG(German Research Foundation (DFG)); Gottingen University; "Niedersachsisches Vorab" as part of the Cluster of Excellence "Functional Biodiversity Research"	This study was funded by the Ministry of Science and Culture of Lower Saxony (Germany) and the "Niedersachsisches Vorab" as part of the Cluster of Excellence "Functional Biodiversity Research" of Georg-August-University. Additionally, the authors acknowledge support by DFG and the Open Access Publication Funds of the Gottingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all persons who were involved in the installation and maintenance of the GrassMan experiment in the Solling. We thank Klaus Schutzenmeister for providing assistance with the sampling. The data on soil properties were kindly provided by Till Heller (Department of Forest Botany and Tree Physiology at the Georg-August-University Gottingen). This study was funded by the Ministry of Science and Culture of Lower Saxony (Germany) and the "Niedersachsisches Vorab" as part of the Cluster of Excellence "Functional Biodiversity Research". Additionally, we acknowledge support by DFG and the Open Access Publication Funds of the Gottingen University.	Alexander M.J.S.S., 1978, SOIL SCI, V125, P331, DOI [10.1097/00010694-197805000-00012, DOI 10.1097/00010694-197805000-00012]; Anandham R, 2008, J BASIC MICROB, V48, P439, DOI 10.1002/jobm.200700380; Angel R, 2013, FEMS MICROBIOL ECOL, V86, P130, DOI 10.1111/1574-6941.12155; Asshauer KP, 2015, BIOINFORMATICS, V31, P2882, DOI 10.1093/bioinformatics/btv287; Baldrian P, 2012, ISME J, V6, P248, DOI 10.1038/ismej.2011.95; Barberan Albert, 2014, Front Microbiol, V5, P203, DOI 10.3389/fmicb.2014.00203; Bardgett RD, 1999, SOIL BIOL BIOCHEM, V31, P1021, DOI 10.1016/S0038-0717(99)00016-4; Blazewicz SJ, 2013, ISME J, V7, P2061, DOI 10.1038/ismej.2013.102; Bragg L, 2012, NAT METHODS, V9, P425, DOI 10.1038/nmeth.1990; Broszat M, 2014, APPL ENVIRON MICROB, V80, P5282, DOI 10.1128/AEM.01295-14; Campbell BJ, 2010, ENVIRON MICROBIOL, V12, P1842, DOI 10.1111/j.1462-2920.2010.02189.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cruz-Martinez K, 2009, ISME J, V3, P738, DOI 10.1038/ismej.2009.16; de Vries FT, 2012, ECOL LETT, V15, P1230, DOI 10.1111/j.1461-0248.2012.01844.x; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; Garbeva P, 2003, MICROB ECOL, V45, P302, DOI 10.1007/s00248-002-2034-8; Gardener BBM, 2004, PHYTOPATHOLOGY, V94, P1252, DOI 10.1094/PHYTO.2004.94.11.1252; Griffiths RI, 2003, FEMS MICROBIOL ECOL, V43, P35, DOI 10.1111/j.1574-6941.2003.tb01043.x; Habekost M, 2008, SOIL BIOL BIOCHEM, V40, P2588, DOI 10.1016/j.soilbio.2008.06.019; Hayat R, 2010, ANN MICROBIOL, V60, P579, DOI 10.1007/s13213-010-0117-1; Jones RT, 2009, ISME J, V3, P442, DOI 10.1038/ismej.2008.127; Kennedy N, 2004, ENVIRON MICROBIOL, V6, P1070, DOI 10.1111/j.1462-2920.2004.00638.x; Kennedy NM, 2005, FEMS MICROBIOL ECOL, V53, P329, DOI 10.1016/j.femsec.2005.01.013; Keuter A, 2013, PLANT SOIL, V364, P193, DOI 10.1007/s11104-012-1344-y; Lauber CL, 2013, ISME J, V7, P1641, DOI 10.1038/ismej.2013.50; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lennon JT, 2011, NAT REV MICROBIOL, V9, P119, DOI 10.1038/nrmicro2504; Lueders T, 2006, APPL ENVIRON MICROB, V72, P5342, DOI 10.1128/AEM.00400-06; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mooshammer M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4694; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Nannipieri P, 2003, EUR J SOIL SCI, V54, P655, DOI 10.1046/j.1351-0754.2003.0556.x; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Petersen U, 2012, BASIC APPL ECOL, V13, P1, DOI 10.1016/j.baae.2011.10.003; Pfeiffer B, 2013, APPL SOIL ECOL, V72, P150, DOI 10.1016/j.apsoil.2013.06.008; POPHAM DL, 1995, APPL ENVIRON MICROB, V61, P3633, DOI 10.1128/AEM.61.10.3633-3638.1995; Poulsen PHB, 2013, SOIL BIOL BIOCHEM, V57, P784, DOI 10.1016/j.soilbio.2011.12.023; Prosser JI, 2012, FEMS MICROBIOL ECOL, V81, P507, DOI 10.1111/j.1574-6941.2012.01435.x; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Ramirez KS, 2010, ECOLOGY, V91, P3463, DOI 10.1890/10-0426.1; Rampelotto PH, 2013, MICROB ECOL, V66, P593, DOI 10.1007/s00248-013-0235-y; Ruiz A, 2000, INT J SYST EVOL MICR, V50, P1981, DOI 10.1099/00207713-50-6-1981; Schloss PD, 2004, MICROBIOL MOL BIOL R, V68, P686, DOI 10.1128/MMBR.68.4.686-691.2004; Schmalenberger A, 2001, APPL ENVIRON MICROB, V67, P3557, DOI 10.1128/AEM.67.8.3557-3563.2001; Schneider D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066662; Sengun IY, 2011, FOOD CONTROL, V22, P647, DOI 10.1016/j.foodcont.2010.11.008; Shange RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040338; Sievers M., 2005, BERGEYS MAN SYSTMATI, V2, P41; Smit E, 2001, APPL ENVIRON MICROB, V67, P2284, DOI 10.1128/AEM.67.5.2284-2291.2001; Stevens RJ, 1998, SOIL BIOL BIOCHEM, V30, P1119, DOI 10.1016/S0038-0717(97)00227-7; Team RDC, 2012, R LANG ENV STAT COM; Tripathi BM, 2012, MICROB ECOL, V64, P474, DOI 10.1007/s00248-012-0028-8; Udikovic-Kolic N, 2014, P NATL ACAD SCI USA, V111, P15202, DOI 10.1073/pnas.1409836111; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; Wemheuer B, 2014, FEMS MICROBIOL ECOL, V87, P378, DOI 10.1111/1574-6941.12230; Wemheuer B, 2012, ARCHAEA, V2012, DOI 10.1155/2012/695826; Wietz M, 2015, ENVIRON MICROBIOL, V17, P3822, DOI 10.1111/1462-2920.12842; Will C, 2010, APPL ENVIRON MICROB, V76, P6751, DOI 10.1128/AEM.01063-10; Zhou XW, 2014, ENV MICROBIOL REP, V6, P45, DOI 10.1111/1758-2229.12107	61	31	34	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145575	10.1371/journal.pone.0145575	http://dx.doi.org/10.1371/journal.pone.0145575			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26694644	gold, Green Published, Green Submitted			2022-12-26	WOS:000367092500058
J	Ngoh, SY; Tan, D; Shen, XY; Kathiresan, P; Jiang, JH; Liew, WC; Thevasagayam, NM; Kwan, HY; Saju, JM; Prakki, SRS; Goh, CH; Wong, HC; Chan, TT; Mezes, M; Orban, L				Ngoh, Si Yan; Tan, Daniel; Shen, Xueyan; Kathiresan, Purushothaman; Jiang, Junhui; Liew, Woei Chang; Thevasagayam, Natascha May; Kwan, Hsiao Yuen; Saju, Jolly M.; Prakki, Sridatta R. S.; Goh, Chin Heng; Wong, Hong Ching; Chan, Tai Teck; Mezes, Miklos; Orban, Laszlo			Nutrigenomic and Nutritional Analyses Reveal the Effects of Pelleted Feeds on Asian Seabass (Lates calcarifer)	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; DIETARY FISH-OIL; VEGETABLE-OILS; GILTHEAD SEABREAM; GENE-EXPRESSION; SOYBEAN-MEAL; BARRAMUNDI; GROWTH; CHAIN; OMEGA-3-FATTY-ACIDS	As nutrition-related expenses constitute the majority of the costs for aquaculture farms, it is essential for them to use feeds that provide an ideal combination of nutrients for the species of choice. In this study, the relative effect of consuming three different pelleted feeds (B, C and D) in comparison to frozen baitfish (A; control) were compared on juvenile Asian sea-bass (77.3 +/- 22.4g) that were selected for increased growth rate over two generations. Our objectives were: 1) to evaluate the effects of different pelleted feeds based on overall physiological changes and nutritional quality of fillets; 2) improve our understanding of the underlying mechanisms with transcriptomic analysis; 3) if possible, identify the feed type that supports the growth of these fishes without substantially reducing the nutritional quality of fillet. The growth performance, fatty acid composition of fillet, hepatic histology and transcriptome of the fishes (Groups A-D) were analyzed. The majority of fatty acids of the fillets, except.-linolenic acid (GLA, C18:3n6), correlated significantly with the respective diets. Asian seabass fed Feed C showed highest specific growth rate (SGR) and feed conversion efficiency (FCE) with closest histology and transcriptomic profile to control, but their fillet contained the highest n6/n3 ratio. When the liver-based transcriptomes were analyzed, a complex set of differentially expressed genes were detected between groups fed pelleted feeds and controls as well as among the pellet-fed groups themselves. Significant enrichment of genes with growth-related function tallied with the morphological data measured. When compared with control (Group A), 'Biosynthesis of unsaturated fatty acids' and 'Steroid biosynthesis' pathways were significantly enriched in pellet-fed groups. Reduced goblet cell numbers were observed in the gut of pellet-fed fish compared to controls and fads6 was found to be a suitable candidate gene to separate wild-caught Asian seabass, from pelletfed ones. These results provide insights for researchers on the various effects of feeds on the biochemistry and global gene expression of the fish and potentially for seabass farms to make more informed feed choices.	[Ngoh, Si Yan; Tan, Daniel; Shen, Xueyan; Kathiresan, Purushothaman; Jiang, Junhui; Liew, Woei Chang; Thevasagayam, Natascha May; Kwan, Hsiao Yuen; Saju, Jolly M.; Prakki, Sridatta R. S.; Wong, Hong Ching; Chan, Tai Teck; Orban, Laszlo] Natl Univ Singapore, Reprod Genom Grp, Temasek Life Sci Lab, Singapore 117548, Singapore; [Ngoh, Si Yan] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Jiang, Junhui] Agri Food & Vet Author, Marine Aquaculture Ctr, St Johns Isl, Singapore; [Jiang, Junhui] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Goh, Chin Heng] Natl Univ Singapore, Temasek Life Sci Lab, Fish Facil, Singapore 117548, Singapore; [Mezes, Miklos] Szent Istvan Univ, Dept Nutr, Godollo, Hungary; [Orban, Laszlo] Univ Pannonia, Georgikon Fac, Dept Anim Sci & Breeding, Keszthely, Hungary; [Orban, Laszlo] Murdoch Univ, Ctr Comparat Genom, Murdoch, WA 6150, Australia; [Orban, Laszlo] Szent Istvan Univ, Dept Aquaculture, Godollo, Hungary	National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; National University of Singapore; Hungarian University of Agriculture & Life Sciences; University of Pannonia; Murdoch University; Hungarian University of Agriculture & Life Sciences	Orban, L (corresponding author), Natl Univ Singapore, Reprod Genom Grp, Temasek Life Sci Lab, 1 Res Link, Singapore 117548, Singapore.	Mezes.Miklos@mkk.szie.hu; laszlo@tll.org.sg	Orbán, László/A-3030-2009	Orbán, László/0000-0001-5435-5948; Liew, Woei Chang/0000-0001-9354-1647; Jiang, Junhui/0000-0003-1319-8813; Thevasagayam, Natascha May/0000-0003-2630-3600	National Research Foundation, Prime Minister's Office, Singapore [NRF-CRP7-2010-001]; Research Centre of Excellence - (Szent Istvan University) [8526-9878/2015/FEKUT]	National Research Foundation, Prime Minister's Office, Singapore(National Research Foundation, Singapore); Research Centre of Excellence - (Szent Istvan University)	This study was supported by the National Research Foundation, Prime Minister's Office, Singapore under its competitive Research Program (Award No: NRF-CRP7-2010-001) for LO and his team. During the course of this study, MM was supported by the Research Centre of Excellence -8526-9878/2015/FEKUT project (Szent Istvan University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adarme-Vega TC, 2014, CURR OPIN BIOTECH, V26, P14, DOI 10.1016/j.copbio.2013.08.003; Alhazzaa R, 2011, J AGR FOOD CHEM, V59, P8423, DOI 10.1021/jf201871w; [Anonymous], 2011, FAO YB FISH AQ STAT; Arslan M, 2012, TURK J FISH AQUAT SC, V12, P575, DOI 10.4194/1303-2712-v12_3_04; BOONYARATPALIN M, 1993, COLLOQ INRA, V61, P819; Boonyaratpalin M, 1988, 7 NAT I COAST AQ DEP; Bowyer JN, 2012, AQUACULTURE, V356, P211, DOI 10.1016/j.aquaculture.2012.05.014; Caballero MJ, 2002, AQUACULTURE, V214, P253, DOI 10.1016/S0044-8486(01)00852-3; Catacutan MR, 1997, AQUACULTURE, V149, P137, DOI 10.1016/S0044-8486(96)01432-9; CATACUTAN MR, 1995, AQUACULTURE, V131, P125, DOI 10.1016/0044-8486(94)00358-U; Chaimongkol A, 2001, AQUAC RES, V32, P53, DOI 10.1046/j.1355-557x.2001.00035_32_s1.x; Chen YB, 2012, J SURG ONCOL, V106, P286, DOI 10.1002/jso.22150; CHRISTIE WW, 1982, J LIPID RES, V23, P1072; Dastani Z, 2006, ATHEROSCLEROSIS, V185, P127, DOI 10.1016/j.atherosclerosis.2005.05.028; Daviglus M., 2002, COMMENTS TOXICOL, V8, P345, DOI DOI 10.1080/08865140215064; de Mello H, 2013, PESQUI VET BRASIL, V33, P724, DOI 10.1590/S0100-736X2013000600006; Domingos JA, 2015, ANIM GENET, V46, P468, DOI 10.1111/age.12312; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; European Commission, 1998, OFF J EUR COMMUNITIE, V257, P14; FERNANDES G, 1993, NUTR RES, V13, pS19, DOI 10.1016/S0271-5317(05)80282-9; FOLCH J, 1957, J BIOL CHEM, V226, P497; Froese R, 2006, J APPL ICHTHYOL, V22, P241, DOI 10.1111/j.1439-0426.2006.00805.x; Gang J., 2006, FRONT BIOL CHINA, V1, P9, DOI DOI 10.1007/s11515-005-0002-7; Glencross B, 2006, AQUACULT NUTR, V12, P291, DOI 10.1111/j.1365-2095.2006.00410.x; Glencross B, 2012, AQUACULT NUTR, V18, P388, DOI 10.1111/j.1365-2095.2011.00903.x; Glencross B, 2011, AQUACULT NUTR, V17, pE536, DOI 10.1111/j.1365-2095.2010.00795.x; Glencross B, 2013, BIOL CULTURE ASIAN S, P179; Greenwood PH, 1976, REV FAMILY CENTROPOM; Hansson GC, 2012, CURR OPIN MICROBIOL, V15, P57, DOI 10.1016/j.mib.2011.11.002; Harel M, 2002, AQUACULTURE, V213, P347, DOI 10.1016/S0044-8486(02)00047-9; HOFFMAN CJ, 1994, ARTERIOSCLER THROMB, V14, P1737, DOI 10.1161/01.ATV.14.11.1737; Horibe H, 2014, MOL MED REP, V9, P808, DOI 10.3892/mmr.2014.1902; Kim JJ, 2013, PATHOGENS, V2, P55, DOI 10.3390/pathogens2010055; Kris-Etherton PM, 2003, ARTERIOSCL THROM VAS, V23, pE20, DOI 10.1161/01.ATV.0000038493.65177.94; Kris-Etherton PM, 2000, AM J CLIN NUTR, V71, p179S, DOI 10.1093/ajcn/71.1.179S; Kunisawa J, 2015, SCI REP-UK, V5, DOI 10.1038/srep09750; Leaver MJ, 2008, REV FISH SCI, V16, P73, DOI 10.1080/10641260802325278; Liu P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051142; McCarthy FM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-229; MCCLEARY BV, 1994, J CEREAL SCI, V20, P51, DOI 10.1006/jcrs.1994.1044; MOORE R, 1982, AUST J MAR FRESH RES, V33, P671, DOI 10.1071/MF9820671; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Morris MC, 2003, ARCH NEUROL-CHICAGO, V60, P940, DOI 10.1001/archneur.60.7.940; Mourente G, 2006, COMP BIOCHEM PHYS B, V145, P389, DOI 10.1016/j.cbpb.2006.08.012; Mukaka MM, 2012, MALAWI MED J, V24, P69; Naylor RL, 2009, P NATL ACAD SCI USA, V106, P15103, DOI 10.1073/pnas.0905235106; NRC (National Research Council), 2011, NUTR REQ FISH SHRIMP; O'Fallon JV, 2007, J ANIM SCI, V85, P1511, DOI 10.2527/jas.2006-491; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Pethiyagoda R, 2012, ZOOTAXA, P1; Phromkunthong W, 1997, AQUACULTURE, V151, P225, DOI 10.1016/S0044-8486(96)01489-5; Raso S, 2003, AQUAC RES, V34, P813, DOI 10.1046/j.1365-2109.2003.00885.x; Ravi P, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-5; Rimmer M.A., 2014, LATES CALCARIFER CUL; Robaina L, 1998, AQUACULTURE, V161, P281, DOI 10.1016/S0044-8486(97)00276-7; Sahlmann C, 2013, FISH SHELLFISH IMMUN, V34, P599, DOI 10.1016/j.fsi.2012.11.031; Sargent JR, 1997, AQUACULTURE, V155, P117, DOI 10.1016/S0044-8486(97)00122-1; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmitz G, 2008, PROG LIPID RES, V47, P147, DOI 10.1016/j.plipres.2007.12.004; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Silva SD., 1995, FISH NUTR AQUACULTUR, P103; Simopoulos AP, 2006, BIOMED PHARMACOTHER, V60, P502, DOI 10.1016/j.biopha.2006.07.080; Simopoulos AP, 2002, BIOMED PHARMACOTHER, V56, P365, DOI 10.1016/S0753-3322(02)00253-6; Sorci-Thomas MG, 2002, TRENDS CARDIOVAS MED, V12, P121, DOI 10.1016/S1050-1738(01)00163-3; SPECIAN RD, 1991, AM J PHYSIOL, V260, pC183, DOI 10.1152/ajpcell.1991.260.2.C183; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Thevasagayam NM, 2015, J MAR SCI ENG, V3, P382, DOI 10.3390/jmse3020382; Tocher DR, 2003, REV FISH SCI, V11, P107, DOI 10.1080/713610925; Torrecillas S, 2013, FISH SHELLFISH IMMUN, V34, P1485, DOI 10.1016/j.fsi.2013.03.351; Tu WC, 2013, COMP BIOCHEM PHYS B, V164, P29, DOI 10.1016/j.cbpb.2012.10.001; Tukey JW, 1977, EXPLORATORY DATA ANA; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vij S, 2015, GENOME ASIAN SEABASS; Vij S, 2014, FRONT MAR SCI, V1, DOI 10.3389/fmars.2014.00030; Wang CM, 2008, AQUAC RES, V39, P1612, DOI 10.1111/j.1365-2109.2008.02034.x; Wang CM, 2007, GENETICS, V175, P907, DOI 10.1534/genetics.106.059972; Ward RD, 2008, J FISH BIOL, V72, P458, DOI 10.1111/j.1095-8649.2007.01703.x; Wassef EA, 2007, AQUAC RES, V38, P852, DOI 10.1111/j.1365-2109.2007.01738.x; Williams KC, 2003, AQUACULTURE, V225, P191, DOI 10.1016/S0044-8486(03)00278-3; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	83	11	12	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145456	10.1371/journal.pone.0145456	http://dx.doi.org/10.1371/journal.pone.0145456			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26696533	Green Submitted, Green Published, gold			2022-12-26	WOS:000367092500051
J	Aiken, CE; Tarry-Adkins, JL; Penfold, NC; Dearden, L; Ozanne, SE				Aiken, Catherine E.; Tarry-Adkins, Jane L.; Penfold, Naomi C.; Dearden, Laura; Ozanne, Susan E.			Decreased ovarian reserve, dysregulation of mitochondrial biogenesis, and increased lipid peroxidation in female mouse offspring exposed to an obesogenic maternal diet	FASEB JOURNAL			English	Article						developmental programming; reproductive potential; primordial follicle; lipoxygenase	NF-KAPPA-B; X-LINKED INHIBITOR; HIGH-FAT-DIET; NATURAL MENOPAUSE; DNA-DAMAGE; OBESITY; EXPRESSION; NUTRITION; PREGNANCY; APOPTOSIS	Maternal diet during pregnancy influences the later life reproductive potential of female offspring. We investigate the molecular mechanisms underlying the depletion of ovarian follicular reserve in young adult females following exposure to obesogenic diet in early life. Furthermore, we explore the interaction between adverse maternal diet and post-weaning diet in generating reduced ovarian reserve. Female mice were exposed to either maternal obesogenic (high fat/high sugar) or maternal control diet in utero and during lactation, then weaned onto either obesogenic or control diet. At 12 wk of age, the offspring ovarian reserve was depleted following exposure to maternal obesogenic diet (P < 0.05), but not postweaning obesogenic diet. Maternal obesogenic diet was associated with increased mitochondrial DNA biogenesis (copy number P < 0.05; transcription factor A, mitochondrial expression P < 0.05), increased mitochondrial antioxidant defenses [manganese superoxide dismutase (MnSOD) P < 0.05; copper/zinc superoxide dismutase P < 0.05; glutathione peroxidase 4 P < 0.01] and increased lipoxygenase expression (arachidonate 12lipoxygenaseP< 0.05; arachidonate 15-lipoxygenase P < 0.05) in the ovary. There was also significantly increased expression of the transcriptional regulator NF-kappa B (P < 0.05). There was no effect of postweaning diet on any measured ovarian parameters. Maternal diet thus plays a central role in determining follicular reserve in adult female offspring. Our observations suggest that lipid peroxidation and mitochondrial biogenesis are the key intracellular pathways involved in programming of ovarian reserve.-Aiken, C. E., Tarry-Adkins, J. L., Penfold, N. C., Dearden, L., Ozanne, S. E. Decreased ovarian reserve, dysregulation of mitochondrial biogenesis, and increased lipid peroxidation in female mouse offspring exposed to an obesogenic maternal diet. FASEB J. 30, 1548-1556 (2016). www.fasebj.org	[Aiken, Catherine E.; Tarry-Adkins, Jane L.; Penfold, Naomi C.; Dearden, Laura; Ozanne, Susan E.] Univ Cambridge, Metab Res Labs, Level 4,Box 289,Hills Rd, Cambridge CB2 OQQ, England; [Aiken, Catherine E.; Tarry-Adkins, Jane L.; Penfold, Naomi C.; Dearden, Laura; Ozanne, Susan E.] Addenbrookes Hosp, MRC Metab Dis Unit, Inst Metab Sci, Cambridge, England; [Aiken, Catherine E.] Univ Cambridge, Dept Obstet & Gynaecol, Rosie Hosp, Cambridge, England; [Aiken, Catherine E.] Cambridge Comprehens Biomed Res Ctr, Natl Inst Hlth Res, Cambridge, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of Cambridge	Aiken, CE (corresponding author), Univ Cambridge, Metab Res Labs, Level 4,Box 289,Hills Rd, Cambridge CB2 OQQ, England.; Aiken, CE (corresponding author), Addenbrookes Hosp, Addenbrookes Treatment Ctr, MRC Metab Dis Unit, Inst Metab Sci, Level 4,Box 289,Hills Rd, Cambridge CB2 OQQ, England.	cema2@cam.ac.uk		Dearden, Laura/0000-0002-0804-074X; Ozanne, Susan/0000-0001-8753-5144; Penfold, Naomi/0000-0003-0568-1194	Academy of Medical Sciences; Addenbrooke's Charitable Trust; Isaac Newton Trust/Wellcome Trust ISSF/University of Cambridge Joint Research Grant; MRC [MRC_MC_UU_12012/4]; MRC [MC_UU_12012/5, MC_UU_12012/4] Funding Source: UKRI; Academy of Medical Sciences (AMS) [AMS-SGCL11-AikenC] Funding Source: researchfish; British Heart Foundation [FS/09/029/27902, PG/09/037/27387] Funding Source: researchfish; Medical Research Council [MC_UU_12012/4, MC_UU_12012/5/B, MC_UU_12012/5] Funding Source: researchfish; National Institute for Health Research [CL-2014-14-501] Funding Source: researchfish	Academy of Medical Sciences(Academy of Medical Sciences (AMS)); Addenbrooke's Charitable Trust; Isaac Newton Trust/Wellcome Trust ISSF/University of Cambridge Joint Research Grant; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The authors thank Adrian Wayman for technical assistance. This study was funded jointly by grants from the Academy of Medical Sciences, the Addenbrooke's Charitable Trust, an Isaac Newton Trust/Wellcome Trust ISSF/University of Cambridge Joint Research Grant and the MRC (MRC_MC_UU_12012/4). The authors declare no conflicts of interest.	Aiken CE, 2015, SCI REP-UK, V5, DOI 10.1038/srep16175; Aiken CE, 2014, HUM REPROD UPDATE, V20, P63, DOI 10.1093/humupd/dmt043; Aiken CE, 2013, FASEB J, V27, P3959, DOI 10.1096/fj.13-234484; Aimo L, 2010, J NUTR BIOCHEM, V21, P1069, DOI 10.1016/j.jnutbio.2009.09.003; Alfaradhi MZ, 2014, AM J PHYSIOL-REG I, V307, pR26, DOI 10.1152/ajpregu.00049.2014; Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7; Aune D, 2014, JAMA-J AM MED ASSOC, V311, P1536, DOI 10.1001/jama.2014.2269; Boynton-Jarrett R, 2011, J WOMENS HEALTH, V20, P1193, DOI 10.1089/jwh.2010.2517; Brenseke B, 2015, ENDOCRINOLOGY, V156, P182, DOI 10.1210/en.2014-1523; Buelna-Chontal M, 2013, CELL SIGNAL, V25, P2548, DOI 10.1016/j.cellsig.2013.08.007; Chan KA, 2015, J ENDOCRINOL, V224, pR45, DOI 10.1530/JOE-14-0469; Chan KA, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.124149; Connor KL, 2012, J PHYSIOL-LONDON, V590, P2167, DOI 10.1113/jphysiol.2011.223305; de Bruin JP, 1998, EARLY HUM DEV, V51, P39, DOI 10.1016/S0378-3782(97)00073-X; Eberle C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045361; Field SL, 2014, MOL REPROD DEV, V81, P284, DOI 10.1002/mrd.22285; Fisher SC, 2013, PREV MED, V56, P372, DOI 10.1016/j.ypmed.2013.02.015; Forman HJ, 2014, J MOL CELL CARDIOL, V73, P2, DOI 10.1016/j.yjmcc.2014.01.018; Gardebjer EM, 2015, FASEB J, V29, P2690, DOI 10.1096/fj.14-268979; Gloire G, 2009, ANTIOXID REDOX SIGN, V11, P2209, DOI [10.1089/ars.2009.2463, 10.1089/ARS.2009.2463]; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Heslehurst N, 2010, INT J OBESITY, V34, P420, DOI 10.1038/ijo.2009.250; Huang CF, 2015, NEUROSCIENCE, V286, P364, DOI 10.1016/j.neuroscience.2014.12.002; Ingvorsen C, 2015, ACTA PHYSIOL, V214, P440, DOI 10.1111/apha.12533; King V, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-73; Knight M, 2010, OBSTET GYNECOL, V115, P989, DOI 10.1097/AOG.0b013e3181da8f09; Kuhn H, 2015, BBA-MOL CELL BIOL L, V1851, P308, DOI 10.1016/j.bbalip.2014.10.002; Kurusu S, 2009, REPRODUCTION, V137, P59, DOI 10.1530/REP-08-0257; Li ML, 2015, ENDOCRINOLOGY, V156, P3228, DOI 10.1210/en.2015-1041; Liang HY, 2007, BIOCHEM BIOPH RES CO, V356, P893, DOI 10.1016/j.bbrc.2007.03.045; Lismont C, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00035; Liu PY, 2010, MENOPAUSE, V17, P152, DOI 10.1097/gme.0b013e3181b63c68; Nicholas LM, 2016, INT J OBESITY, V40, P229, DOI 10.1038/ijo.2015.178; Niki E, 2009, FREE RADICAL BIO MED, V47, P469, DOI 10.1016/j.freeradbiomed.2009.05.032; Nteeba J, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.121343; Reynolds CM, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.125047; Reynolds RM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4539; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Skodras A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120242; Sloboda DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006744; TANAKA N, 1989, ENDOCRINOLOGY, V125, P1373, DOI 10.1210/endo-125-3-1373; Tarry-Adkins JL, 2014, FASEB J, V28, P5398, DOI 10.1096/fj.14-259473; Tarry-Adkins JL, 2013, MOL METAB, V2, P480, DOI 10.1016/j.molmet.2013.09.004; Tarry-Adkins JL, 2013, FASEB J, V27, P379, DOI 10.1096/fj.12-218685; Wang YF, 2002, ENDOCRINOLOGY, V143, P2732, DOI 10.1210/en.143.7.2732; Xiao CW, 2001, ENDOCRINOLOGY, V142, P557, DOI 10.1210/en.142.2.557; Xiao WJ, 2012, MENOPAUSE, V19, P1029, DOI 10.1097/gme.0b013e31824e6160; Yamashita T, 2006, CIRC RES, V99, pE51, DOI 10.1161/01.RES.0000244003.08127.cc; Yan X, 2011, INFLAMM BOWEL DIS, V17, P1513, DOI 10.1002/ibd.21539; Ziko I, 2014, BRAIN BEHAV IMMUN, V41, P32, DOI 10.1016/j.bbi.2014.06.014	50	42	44	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2016	30	4					1548	1556		10.1096/fj.15-280800	http://dx.doi.org/10.1096/fj.15-280800			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DH2PR	26700734	Green Published, hybrid			2022-12-26	WOS:000372629100016
J	Sorensen, AB; Madsen, JJ; Svensson, LA; Pedersen, AA; Ostergaard, H; Overgaard, MT; Olsen, OH; Gandhi, PS				Sorensen, Anders B.; Madsen, Jesper J.; Svensson, L. Anders; Pedersen, Anette A.; Ostergaard, Henrik; Overgaard, Michael T.; Olsen, Ole H.; Gandhi, Prafull S.			Molecular Basis of Enhanced Activity in Factor VIIa-Trypsin Variants Conveys Insights into Tissue Factor-mediated Allosteric Regulation of Factor VIIa Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-COAGULATION FACTOR; SUBSTRATE-ASSISTED ACTIVATION; CRYSTAL-STRUCTURE; DRAMATIC ENHANCEMENT; CATALYTIC-ACTIVITY; NA+ BINDING; FACTOR IXA; DYNAMICS; SITE; COFACTOR	The complex of coagulation factor VIIa (FVIIa), a trypsin-like serine protease, and membrane-bound tissue factor (TF) initiates blood coagulation upon vascular injury. Binding of TF to FVIIa promotes allosteric conformational changes in the FVIIa protease domain and improves its catalytic properties. Extensive studies have revealed two putative pathways for this allosteric communication. Here we provide further details of this allosteric communication by investigating FVIIa loop swap variants containing the 170 loop of trypsin that display TF-independent enhanced activity. Using x-ray crystallography, we show that the introduced 170 loop from trypsin directly interacts with the FVIIa active site, stabilizing segment 215-217 and activation loop 3, leading to enhanced activity. Molecular dynamics simulations and novel fluorescence quenching studies support that segment 215-217 conformation is pivotal to the enhanced activity of the FVIIa variants. We speculate that the allosteric regulation of FVIIa activity by TF binding follows a similar path in conjunction with protease domainNterminus insertion, suggesting a more complete molecular basis of TF-mediated allosteric enhancement of FVIIa activity.	[Sorensen, Anders B.; Madsen, Jesper J.; Svensson, L. Anders; Pedersen, Anette A.; Ostergaard, Henrik; Olsen, Ole H.; Gandhi, Prafull S.] Novo Nordisk AS, Global Res, DK-2760 Malov, Denmark; [Sorensen, Anders B.; Overgaard, Michael T.] Aalborg Univ, Dept Chem & Biosci, DK-9220 Aalborg, Denmark; [Madsen, Jesper J.] Tech Univ Denmark, Dept Chem, DK-2800 Lyngby, Denmark; [Madsen, Jesper J.] Univ Chicago, Dept Chem, 5735 S Ellis Ave, Chicago, IL 60637 USA	Novo Nordisk; Aalborg University; Technical University of Denmark; University of Chicago	Gandhi, PS (corresponding author), Novo Nordisk AS, Prot Interact, Novo Nordisk Pk G8 2-61, DK-2760 Malov, Denmark.	pgan@novonordisk.com	Madsen, Jesper J/E-7233-2015; Madsen, Jesper Jonasson/AAU-5858-2020; Overgaard, Michael Toft/E-1354-2011	Madsen, Jesper J/0000-0003-1411-9080; Madsen, Jesper Jonasson/0000-0003-1411-9080; Overgaard, Michael Toft/0000-0002-1423-2481	Danish Agency for Science, Technology and Innovation; Novo Nordisk Research and Development Science Talent Attraction and Recruitment (STAR) program	Danish Agency for Science, Technology and Innovation; Novo Nordisk Research and Development Science Talent Attraction and Recruitment (STAR) program	Supported by grants from the Danish Agency for Science, Technology and Innovation and the Novo Nordisk Research and Development Science Talent Attraction and Recruitment (STAR) program.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Bah A, 2006, J BIOL CHEM, V281, P40049, DOI 10.1074/jbc.M608600200; Banner DW, 1996, NATURE, V380, P41, DOI 10.1038/380041a0; Carter WJ, 2004, J BIOL CHEM, V279, P26387, DOI 10.1074/jbc.M402364200; COHEN GH, 1981, J MOL BIOL, V148, P449, DOI 10.1016/0022-2836(81)90186-8; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; EFTINK MR, 1981, ANAL BIOCHEM, V114, P199, DOI 10.1016/0003-2697(81)90474-7; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Freskgard PO, 1996, PROTEIN SCI, V5, P1531, DOI 10.1002/pro.5560050809; Gaboriaud C, 1996, J MOL BIOL, V259, P995, DOI 10.1006/jmbi.1996.0376; Gandhi PS, 2008, P NATL ACAD SCI USA, V105, P1832, DOI 10.1073/pnas.0710894105; Gohara DW, 2011, TRENDS BIOTECHNOL, V29, P577, DOI 10.1016/j.tibtech.2011.06.001; HEDSTROM L, 1994, BIOCHEMISTRY-US, V33, P8757, DOI 10.1021/bi00195a017; HIGASHI S, 1994, J BIOL CHEM, V269, P18891; Hopfner KP, 1997, EMBO J, V16, P6626, DOI 10.1093/emboj/16.22.6626; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Huntington JA, 2003, STRUCTURE, V11, P469, DOI 10.1016/S0969-2126(03)00049-2; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Lakowicz J.R., 2007, PRINCIPLES FLUORESCE, P277; Lechtenberg BC, 2010, P NATL ACAD SCI USA, V107, P14087, DOI 10.1073/pnas.1005255107; LUTZ HP, 1983, HELV CHIM ACTA, V66, P1929, DOI 10.1002/hlca.19830660704; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Madsen JJ, 2015, J THROMB HAEMOST, V13, P262, DOI 10.1111/jth.12791; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; McCallum CD, 1996, J BIOL CHEM, V271, P28168, DOI 10.1074/jbc.271.45.28168; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Niu WL, 2011, BIOCHEMISTRY-US, V50, P6301, DOI 10.1021/bi200878c; Ohkubo YZ, 2010, J THROMB HAEMOST, V8, P1044, DOI 10.1111/j.1538-7836.2010.03826.x; Olsen OH, 2007, PROTEIN SCI, V16, P671, DOI 10.1110/ps.062504907; Page MJ, 2006, BIOCHEMISTRY-US, V45, P2987, DOI 10.1021/bi052481a; Persson E, 2004, BIOCHEM J, V379, P497, DOI 10.1042/BJ20031596; Persson E, 2001, BIOCHEMISTRY-US, V40, P3251, DOI 10.1021/bi001612z; Persson E, 2001, P NATL ACAD SCI USA, V98, P13583, DOI 10.1073/pnas.241339498; Persson E, 2011, FRONT BIOSCI-LANDMRK, V16, P3156, DOI 10.2741/3903; Persson E, 2009, FEBS J, V276, P3099, DOI 10.1111/j.1742-4658.2009.07028.x; Petrovan RJ, 2000, BIOCHEMISTRY-US, V39, P14457, DOI 10.1021/bi0009486; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pike ACW, 1999, P NATL ACAD SCI USA, V96, P8925, DOI 10.1073/pnas.96.16.8925; Pineda AO, 2004, J BIOL CHEM, V279, P31842, DOI 10.1074/jbc.M401756200; Pozzi N, 2012, CURR OPIN STRUC BIOL, V22, P421, DOI 10.1016/j.sbi.2012.05.006; Rand KD, 2008, J BIOL CHEM, V283, P13378, DOI 10.1074/jbc.M709716200; Salonen LM, 2009, ANGEW CHEM INT EDIT, V48, P811, DOI 10.1002/anie.200804695; Sichler K, 2002, J MOL BIOL, V322, P591, DOI 10.1016/S0022-2836(02)00747-7; Soejima K, 2001, J BIOL CHEM, V276, P17229, DOI 10.1074/jbc.M009206200; Song HJ, 2014, J BIOL CHEM, V289, P35388, DOI 10.1074/jbc.M114.614297; Sturzebecher J, 1997, FEBS LETT, V412, P295, DOI 10.1016/S0014-5793(97)00811-9; Ursby T, 2013, J SYNCHROTRON RADIAT, V20, P648, DOI 10.1107/S0909049513011734; Vogt AD, 2015, J BIOL CHEM, V290, P22435, DOI 10.1074/jbc.M115.675538; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Zogg T, 2009, STRUCTURE, V17, P1669, DOI 10.1016/j.str.2009.10.011	56	12	13	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4671	4683		10.1074/jbc.M115.698613	http://dx.doi.org/10.1074/jbc.M115.698613			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26694616	Green Published, hybrid			2022-12-26	WOS:000371604600034
J	Ogawa, N; Kurokawa, T; Fujiwara, K; Polat, OK; Badr, H; Takahashi, N; Mori, Y				Ogawa, Nozomi; Kurokawa, Tatsuki; Fujiwara, Kenji; Polat, Onur Kerem; Badr, Heba; Takahashi, Nobuaki; Mori, Yasuo			Functional and Structural Divergence in Human TRPV1 Channel Subunits by Oxidative Cysteine Modification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						dimerization; pain; post-translational modification (PTM); reactive oxygen species (ROS); redox regulation; transient receptor potential channels (TRP channels); disulfide bond	RECEPTOR POTENTIAL CHANNELS; TRANSIENT RECEPTOR; CAPSAICIN RECEPTOR; ION-CHANNEL; VANILLOID RECEPTOR; RESINIFERATOXIN BINDING; INFLAMMATORY PAIN; DISULFIDE BOND; ACTIVATION; TRPA1	Transient receptor potential vanilloid 1 (TRPV1) channel is a tetrameric protein that acts as a sensor for noxious stimuli such as heat and for diverse inflammatory mediators such as oxidative stress to mediate nociception in a subset of sensory neurons. In TRPV1 oxidation sensing, cysteine (Cys) oxidation has been considered as the principle mechanism; however, its biochemical basis remains elusive. Here, we characterize the oxidative status of Cys residues in differential redox environments and propose a model of TRPV1 activation by oxidation. Through employing a combination of non-reducing SDS-PAGE, electrophysiology, and mass spectrometry we have identified the formation of subunit dimers carrying a stable intersubunit disulfide bond between Cys-258 and Cys-742 of human TRPV1 (hTRPV1). C258S and C742S hTRPV1 mutants have a decreased protein half-life, reflecting the role of the intersubunit disulfide bond in supporting channel stability. Interestingly, the C258S hTRPV1 mutant shows an abolished response to oxidants. Mass spectrometric analysis of Cys residues of hTRPV1 treated with hydrogen peroxide shows that Cys-258 is highly sensitive to oxidation. Our results suggest that Cys-258 residues are heterogeneously modified in the hTRPV1 tetrameric complex and comprise Cys-258 with free thiol for oxidation sensing and Cys-258, which is involved in the disulfide bond for assisting subunit dimerization. Thus, the hTRPV1 channel has a heterogeneous subunit composition in terms of both redox status and function.	[Ogawa, Nozomi; Kurokawa, Tatsuki; Fujiwara, Kenji; Polat, Onur Kerem; Badr, Heba; Mori, Yasuo] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Kyoto 6158510, Japan; [Takahashi, Nobuaki] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Mori, Yasuo] Kyoto Univ, Dept Technol & Ecol, Hall Global Environm Studies, Kyoto 6158510, Japan	Kyoto University; Harvard University; Harvard Medical School; Kyoto University	Mori, Y (corresponding author), Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Mol Biol Lab, Kyoto 6158510, Japan.	mori@sbchem.kyoto-u.ac.jp	Polat, Onur Kerem/AAK-3761-2021; Takahashi, Nobuaki/AAG-9411-2019	Takahashi, Nobuaki/0000-0002-0606-3921	Ministry of Education, Culture, Sports, Science, and Technology, Japan [26111004]; Japan Society for the Promotion of Science [24249017]	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-aid for Scientific Research on Innovative Areas "Oxygen biology: a new criterion for integrated understanding of life" 26111004 of the Ministry of Education, Culture, Sports, Science, and Technology, Japan and Grant-in-aid for Scientific Research (A) 24249017 of the Japan Society for the Promotion of Science. The authors declare that they have no conflicts of interest with the contents of this article.	Andersson DA, 2008, J NEUROSCI, V28, P2485, DOI 10.1523/JNEUROSCI.5369-07.2008; Bessac BF, 2008, J CLIN INVEST, V118, P1899, DOI 10.1172/JCI34192; Bezerra MM, 2007, N-S ARCH PHARMACOL, V374, P265, DOI 10.1007/s00210-006-0123-9; Bodo E, 2005, AM J PATHOL, V166, P985, DOI 10.1016/S0002-9440(10)62320-6; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cho HC, 2000, BIOCHEMISTRY-US, V39, P4649, DOI 10.1021/bi992469g; Chuang HH, 2009, P NATL ACAD SCI USA, V106, P20097, DOI 10.1073/pnas.0902675106; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Clapham DE, 2005, PHARMACOL REV, V57, P427, DOI 10.1124/pr.57.4.6; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Flynn R, 2014, J BIOL CHEM, V289, P16675, DOI 10.1074/jbc.M114.558668; Gronborg M, 2004, J PROTEOME RES, V3, P1042, DOI 10.1021/pr0499085; Hansen RE, 2009, P NATL ACAD SCI USA, V106, P422, DOI 10.1073/pnas.0812149106; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Hong C, 2015, PFLUG ARCH EUR J PHY, V467, P703, DOI 10.1007/s00424-014-1540-0; Hwang SW, 2000, P NATL ACAD SCI USA, V97, P6155, DOI 10.1073/pnas.97.11.6155; Kashio M, 2012, P NATL ACAD SCI USA, V109, P6745, DOI 10.1073/pnas.1114193109; Keeble JE, 2009, PAIN, V141, P135, DOI 10.1016/j.pain.2008.10.025; KERRIDGE D, 1958, J GEN MICROBIOL, V19, P497, DOI 10.1099/00221287-19-3-497; Khattab MM, 2006, EUR J PHARMACOL, V548, P167, DOI 10.1016/j.ejphar.2006.08.007; Kozai D, 2014, ANTIOXID REDOX SIGN, V21, P971, DOI 10.1089/ars.2013.5616; Lee YM, 2008, EXP DERMATOL, V17, P864, DOI 10.1111/j.1600-0625.2008.00738.x; Lesage F, 1996, EMBO J, V15, P6400, DOI 10.1002/j.1460-2075.1996.tb01031.x; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Littler DR, 2004, J BIOL CHEM, V279, P9298, DOI 10.1074/jbc.M308444200; Liu BY, 2013, PULM PHARMACOL THER, V26, P364, DOI 10.1016/j.pupt.2013.01.010; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Ndengele MM, 2008, FASEB J, V22, P3154, DOI 10.1096/fj.08-108159; Nishida M, 1999, BIOCHEM BIOPH RES CO, V262, P350, DOI 10.1006/bbrc.1999.1218; Okada T, 1999, J BIOL CHEM, V274, P27359, DOI 10.1074/jbc.274.39.27359; Patapoutian A, 2009, NAT REV DRUG DISCOV, V8, P55, DOI 10.1038/nrd2757; Premkumar LS, 2000, NATURE, V408, P985, DOI 10.1038/35050121; Reisz JA, 2013, FEBS J, V280, P6150, DOI 10.1111/febs.12535; Ryle A. P., 1954, BIOCHEM J, V58, pv; SULLIVAN JM, 1994, NEURON, V13, P929, DOI 10.1016/0896-6273(94)90258-5; Susankova K, 2006, MOL PHARMACOL, V70, P383, DOI 10.1124/mol.106.023069; SZALLASI A, 1993, J PHARMACOL EXP THER, V266, P678; SZALLASI A, 1993, N-S ARCH PHARMACOL, V347, P84; Takahashi N, 2008, CHANNELS, V2, P287, DOI 10.4161/chan.2.4.6745; Takahashi N, 2011, NAT CHEM BIOL, V7, P701, DOI [10.1038/NCHEMBIO.640, 10.1038/nchembio.640]; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Toth BI, 2011, J INVEST DERMATOL, V131, P1095, DOI 10.1038/jid.2010.421; Vyklicky L, 2002, NEUROSCIENCE, V111, P435, DOI 10.1016/S0306-4522(02)00051-9; Wang LW, 2012, J BIOL CHEM, V287, P6169, DOI 10.1074/jbc.M111.329748; Wang S, 2011, J BIOL CHEM, V286, P40601, DOI 10.1074/jbc.M111.256669; Wang ZQ, 2004, J PHARMACOL EXP THER, V309, P869, DOI 10.1124/jpet.103.064154; WHIFFEN AJ, 1948, J BACTERIOL, V56, P283, DOI 10.1128/JB.56.3.283-291.1948; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Wo ZG, 1996, MOL PHARMACOL, V50, P770; Xu HX, 2005, J NEUROSCI, V25, P8924, DOI 10.1523/JNEUROSCI.2574-05.2005; Xu SZ, 2008, NATURE, V451, P69, DOI 10.1038/nature06414; Yoshida T, 2006, NAT CHEM BIOL, V2, P596, DOI 10.1038/nchembio821; Zissimopoulos S, 2013, J CELL SCI, V126, P5042, DOI 10.1242/jcs.133538; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	58	38	38	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					4197	4210		10.1074/jbc.M115.700278	http://dx.doi.org/10.1074/jbc.M115.700278			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26702055	Green Published, hybrid			2022-12-26	WOS:000371338400043
J	Park, G; Tan, JQ; Garcia, G; Kang, YY; Salvesen, G; Zhang, ZH				Park, Goonho; Tan, Jieqiong; Garcia, Guillermina; Kang, Yunyi; Salvesen, Guy; Zhang, Zhuohua			Regulation of Histone Acetylation by Autophagy in Parkinson Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epigenetics; histone acetylation; histone deacetylase (HDAC); neurodegenerative disease; neurotoxin	IN-VIVO; MOUSE MODEL; CELLS; NEUROTOXICITY; INHIBITORS; REVEALS; PATHWAY	Parkinson disease (PD) is the most common age-dependent neurodegenerative movement disorder. Accumulated evidence indicates both environmental and genetic factors play important roles in PD pathogenesis, but the potential interaction between environment and genetics in PD etiology remains largely elusive. Here, we report that PD-related neurotoxins induce both expression and acetylation of multiple sites of histones in cultured human cells and mouse midbrain dopaminergic (DA) neurons. Consistently, levels of histone acetylation are markedly higher in midbrain DA neurons of PD patients compared to those of their matched control individuals. Further analysis reveals that multiple histone deacetylases (HDACs) are concurrently decreased in 1-methyl-4-phenylpyridinium (MPP+)-treated cells and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse brains, as well as midbrain tissues of human PD patients. Finally, inhibition of histone acetyltransferase (HAT) protects, whereas inhibition of HDAC1 and HDAC2 potentiates, MPP+-induced cell death. Pharmacological and genetic inhibition of autophagy suppresses MPP+-induced HDACs degradation. The study reveals that PD environmental factors induce HDACs degradation and histone acetylation increase in DA neurons via autophagy and identifies an epigenetic mechanism in PD pathogenesis.	[Park, Goonho; Salvesen, Guy; Zhang, Zhuohua] Sanford Burnham Med Res Inst, Grad Program Biomed Sci, La Jolla, CA 92037 USA; [Park, Goonho] Univ Calif San Diego, La Jolla, CA 92037 USA; [Tan, Jieqiong; Zhang, Zhuohua] Cent S Univ, Xiangya Med Sch, State Key Lab Med Genet, Changsha 410078, Hunan, Peoples R China; [Garcia, Guillermina; Kang, Yunyi; Salvesen, Guy; Zhang, Zhuohua] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego; Central South University; Sanford Burnham Prebys Medical Discovery Institute	Zhang, ZH (corresponding author), Cent S Univ, Xiangya Med Sch, 110 Xiangya Rd, Changsha 410078, Hunan, Peoples R China.	zhangzhuohua@sklmg.edu.cn			National Institutes of Health [NS057289]; Natural Science Foundation of China [313300257, 81429002, 81161120498]; Ministry of Science and Technology [2011CB51000]; "111 Program" of Foreign Expert Bureau of China [B10036]; Mogam Science Scholarship Foundation; NATIONAL CANCER INSTITUTE [P30CA030199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057289] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); "111 Program" of Foreign Expert Bureau of China; Mogam Science Scholarship Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS057289 (to Z. Z.), Natural Science Foundation of China Grants 313300257, 81429002, and 81161120498 (to Z. Z.), "973 Program" of Ministry of Science and Technology Grant 2011CB51000 (to Z. Z.), "111 Program" of Foreign Expert Bureau of China Grant B10036 (to Z. Z.), and the Mogam Science Scholarship Foundation (to G. P.). The authors declare that they have no competing interests.	Abe T, 2008, CURR OPIN PHARMACOL, V8, P57, DOI 10.1016/j.coph.2007.12.002; Ayyanathan K, 2003, GENE DEV, V17, P1855, DOI 10.1101/gad.1102803; Cicchetti F, 2009, TRENDS PHARMACOL SCI, V30, P475, DOI 10.1016/j.tips.2009.06.005; Di Monte DA, 2003, LANCET NEUROL, V2, P531, DOI 10.1016/S1474-4422(03)00501-5; Dokmanovic M, 2007, MOL CANCER RES, V5, P981, DOI 10.1158/1541-7786.MCR-07-0324; Francis YI, 2009, J ALZHEIMERS DIS, V18, P131, DOI 10.3233/JAD-2009-1134; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Graeff J, 2011, PHYSIOL REV, V91, P603, DOI 10.1152/physrev.00012.2010; Gu XL, 2013, NEUROBIOL AGING, V34, P1069, DOI 10.1016/j.neurobiolaging.2012.10.013; Haberland M, 2009, P NATL ACAD SCI USA, V106, P7751, DOI 10.1073/pnas.0903139106; Harrison IF, 2013, PHARMACOL THERAPEUT, V140, P34, DOI 10.1016/j.pharmthera.2013.05.010; Hung KC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091074; Jackson-Lewis V, 2007, NAT PROTOC, V2, P141, DOI 10.1038/nprot.2006.342; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Kim D, 2008, NEURON, V60, P803, DOI 10.1016/j.neuron.2008.10.015; Kim SJ, 2011, P NATL ACAD SCI USA, V108, P3371, DOI 10.1073/pnas.1019755108; Klein C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a008888; Kontopoulos E, 2006, HUM MOL GENET, V15, P3012, DOI 10.1093/hmg/ddl243; LANGSTON JW, 1983, NEW ENGL J MED, V309, P310; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Manikkam M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031901; Monti B, 2010, NEUROTOX RES, V17, P130, DOI 10.1007/s12640-009-9090-5; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Ropero S, 2007, MOL ONCOL, V1, P19, DOI 10.1016/j.molonc.2007.01.001; Sheen JH, 2011, CANCER CELL, V19, P613, DOI 10.1016/j.ccr.2011.03.012; Skinner MK, 2010, TRENDS ENDOCRIN MET, V21, P214, DOI 10.1016/j.tem.2009.12.007; Song C, 2011, NEUROTOXICOLOGY, V32, P586, DOI 10.1016/j.neuro.2011.05.018; Song C, 2010, MOL PHARMACOL, V77, P621, DOI 10.1124/mol.109.062174; Vincow ES, 2013, P NATL ACAD SCI USA, V110, P6400, DOI 10.1073/pnas.1221132110; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115; Zhu JH, 2007, AM J PATHOL, V170, P75, DOI 10.2353/ajpath.2007.060524	32	83	87	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3531	3540		10.1074/jbc.M115.675488	http://dx.doi.org/10.1074/jbc.M115.675488			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26699403	Green Published, hybrid			2022-12-26	WOS:000370854500033
J	Cui, HX; Yang, MY; Wang, LP; Xian, CJ				Cui, Hongxia; Yang, Muyang; Wang, Liping; Xian, Cory J.			Identification of a New Marine Bacterial Strain SD8 and Optimization of Its Culture Conditions for Producing Alkaline Protease	PLOS ONE			English	Article							PURIFICATION; ISOLATE; BRAN; SP.	While much attention has been given to marine microorganisms for production of enzymes, which in general are relatively more stable and active compared to those from plants and animals, studies on alkaline protease production from marine microorganisms have been very limited. In the present study, the alkaline protease producing marine bacterial strain SD8 isolated from sea muds in the Geziwo Qinhuangdao sea area of China was characterized and its optimal culture conditions were investigated. Strain SD8 was initially classified to belong to genus Pseudomonas by morphological, physiological and biochemical characterizations, and then through 16S rDNA sequence it was identified to be likely Pseudomonas hibiscicola. In addition, the culture mediums, carbon sources and culture conditions of strain SD8 were optimized for maximum production of alkaline protease. Optimum enzyme production (236U/mL when cultured bacteria being at 0.75 mg dry weight/mL fermentation broth) was obtained when the isolate at a 3% inoculum size was grown in LB medium at 20 mL medium/100mL Erlenmeyer flask for 48h culture at 30 degrees C with an initial of pH 7.5. This was the first report of strain Pseudomonas hibiscicola secreting alkaline protease, and the data for its optimal cultural conditions for alkaline protease production has laid a foundation for future exploration for the potential use of SD8 strain for alkaline protease production.	[Cui, Hongxia; Yang, Muyang] Yanshan Univ, Coll Environm & Chem Engn, Qinhuangdao 066004, Peoples R China; [Cui, Hongxia] Hebei Prov Key Lab Appl Chem, Qinhuangdao 066004, Peoples R China; [Wang, Liping; Xian, Cory J.] Univ S Australia, Sansom Inst Hlth Res, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia	Yanshan University; University of South Australia	Cui, HX (corresponding author), Yanshan Univ, Coll Environm & Chem Engn, Qinhuangdao 066004, Peoples R China.	hxcui@ysu.edu.cn; cory.xian@unisa.edu.au	Xian, Cory/D-2646-2009	Xian, Cory/0000-0002-8467-2845; /0000-0001-9355-1167	Natural Science Foundation of Hebei Province [D2014203102]; Ministry of Education Specialized Research Fund for the Doctoral Program of Higher Education [20131333120010]; Australian National Health and Medical Research Council (NHMRC)	Natural Science Foundation of Hebei Province(Natural Science Foundation of Hebei Province); Ministry of Education Specialized Research Fund for the Doctoral Program of Higher Education; Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This study is financially supported by Natural Science Foundation of Hebei Province (D2014203102 to HC) and Ministry of Education Specialized Research Fund for the Doctoral Program of Higher Education (20131333120010 to HC). LW is supported by Australian National Health and Medical Research Council (NHMRC) Postgraduate Research Scholarship, and CJX is supported by NHMRC Senior Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal D, 2005, PROCESS BIOCHEM, V40, P1131, DOI 10.1016/j.procbio.2004.03.006; Annamalai N, 2014, PROCESS BIOCHEM, V49, P1012, DOI 10.1016/j.procbio.2014.03.007; Annamalai N, 2013, BIOPROC BIOSYST ENG, V36, P873, DOI 10.1007/s00449-012-0820-3; Badoei-Dalfard A, 2013, J MOL CATAL B-ENZYM, V89, P15, DOI 10.1016/j.molcatb.2012.11.016; Chatterjee J, 2015, BIOTECHNOL APPL BIOC, V62, P709, DOI 10.1002/bab.1309; Chi Z, 2007, BIORESOURCE TECHNOL, V98, P534, DOI 10.1016/j.biortech.2006.02.006; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; Gupta R, 2002, APPL MICROBIOL BIOT, V60, P381, DOI 10.1007/s00253-002-1142-1; Gupta R, 2002, APPL MICROBIOL BIOT, V59, P15, DOI 10.1007/s00253-002-0975-y; Hameed A, 1999, J CHEM TECHNOL BIOT, V74, P5, DOI 10.1002/(SICI)1097-4660(199901)74:1<5::AID-JCTB979>3.0.CO;2-T; Holt GL, 1984, BERGEYS MANUAL SYSTE; Kalaiarasi K, 2009, AFR J BIOTECHNOL, V8, P7035; Kandasamy N, 2012, J CLEAN PROD, V25, P27, DOI 10.1016/j.jclepro.2011.12.007; Kumar RS, 2014, BIOCATAL AGR BIOTECH, V3, P191, DOI 10.1010/j.bcab.2013.11.005; KUNITZ M, 1947, J GEN PHYSIOL, V30, P291, DOI 10.1085/jgp.30.4.291; Lee BH, 2010, ENZYME MICROB TECH, V46, P38, DOI 10.1016/j.enzmictec.2009.07.009; Liu ZQ, 2005, COLL PAP NAT C HIGH, V3, P243; Meena P, 2013, BIOCATAL AGRIC BIOTE, V2, P210, DOI 10.1016/j.bcab.2013.05.003; Miyaji T, 2006, LETT APPL MICROBIOL, V42, P242, DOI 10.1111/j.1472-765X.2005.01851.x; Olofsson TC, 2007, INT J FOOD MICROBIOL, V118, P233, DOI 10.1016/j.ijfoodmicro.2007.07.017; Pant G, 2015, J TAIBAH UNIV SCI, V9, P50, DOI 10.1016/j.jtusci.2014.04.010; Patel R, 2005, PROCESS BIOCHEM, V40, P3569, DOI 10.1016/j.procbio.2005.03.049; Rao MB, 1998, MICROBIOL MOL BIOL R, V62, P597, DOI 10.1128/MMBR.62.3.597-635.1998; Rasmussen RS, 2007, ADV FOOD NUTR RES, V52, P237, DOI 10.1016/S1043-4526(06)52005-4; Raval VH, 2014, PROCESS BIOCHEM, V49, P955, DOI 10.1016/j.procbio.2014.03.014; REDBURN AC, 1993, FEMS MICROBIOL LETT, V113, P81, DOI 10.1111/j.1574-6968.1993.tb06492.x; Saba I, 2012, WORLD J MICROB BIOT, V28, P1071, DOI 10.1007/s11274-011-0905-1; Singh SK, 2011, PROCESS BIOCHEM, V46, P1430, DOI 10.1016/j.procbio.2011.03.012; Smibert Robert M., 1994, P607; Wang L, 2014, J CHEM PHARM RES, V6, P1236	30	6	8	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0146067	10.1371/journal.pone.0146067	http://dx.doi.org/10.1371/journal.pone.0146067			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716833	Green Published, gold, Green Accepted			2022-12-26	WOS:000367510500129
J	Fan, YG; Weng, ZY; Gao, HG; Hu, JH; Wang, HY; Li, LH; Liu, H				Fan, Yonggang; Weng, Zhiyong; Gao, Hongguo; Hu, Jiehua; Wang, Hongyan; Li, Lihua; Liu, Hua			Isoalantolactone Enhances the Radiosensitivity of UMSCC-10A Cells via Specific Inhibition of Erk1/2 Phosphorylation	PLOS ONE			English	Article								Background Although radiotherapy is one of the mainstream approaches for the treatment of head and neck squamous cell carcinoma (HNSCC), this cancer is always associated with resistance to radiation. In this study, the mechanism of action of isoalantolactone as well as its radio-sensitizing effect was investigated in UMSCC-10A cells. Methods The radiosensitization of UMSCC-10A cells treated with isoalantolactone was analyzed by colony formation assay. The radiosensitization effects of isoalantolactone on cell proliferation, cell cycle and apoptosis regulation were examined by BrdU incorporation assay, DNA content assay and flow cytometry, respectively. Western blotting was performed to determine the effects of isoalantolactone combined with radiation on the protein expression of Mek, extracellular signal-regulated kinase (Erk1/2) as well as phosphorylated Mek and Erk1/2. Erk1/2 knockdown by siRNA was used to confirm that isoalantolactone specifically inhibited the activation of Erk1/2 signaling pathway in UMSCC-10A cells. Results Isoalantolactone enhanced the radiosensitivity of UMSCC-10A cells; the sensitivity enhanced ratios (SERs) were 1.44 and 1.63, respectively, for 2.5 and 5 mu M. Moreover, isoalantolactone enhanced radiation-induced cell proliferation and apoptosis and cell cycle arrested at G2/M phase. Furthermore, no marked changes were observed in the expression of total Erk1/2 and Mek protein after radiation treatment. However, isoalantolactone was significantly reduced radiation-induced the phosphorylation of Erk1/2, whereas it altered the phosphorylation of Mek to a lesser extent. In addition, the radiosensitivity of UMSCC-10A cells with Erk1/2 knockdown was increased. Isoalantolactone cannot further prevent the proliferation of UMSCC-10A cells with Erk1/2 knockdown which other mechanism regulated cell proliferation. Conclusion Our results suggested that isoalantolactone enhanced radiation-induced apoptosis, cell cycle arrested and reduced the cell proliferation of UMSCC-10A cells via specifically inhibited the phosphorylation of Erk1/2. Thus a low concentration of isoalantolactone may be used to overcome the resistance of UMSCC-10A cells to radiation and may be a promising radiosensitizer in cancer therapy.	[Fan, Yonggang; Weng, Zhiyong; Li, Lihua; Liu, Hua] Liaoning Med Univ, Dept Cell Biol, Jinzhou, Liaoning, Peoples R China; [Gao, Hongguo; Wang, Hongyan] Daqing Oilfield Gen Hosp, Dept Clin Lab, Daqing, Heilongjiang, Peoples R China; [Hu, Jiehua] Naval Univ Engn, Logist Coll, Informat Ctr, Tianjin, Peoples R China	Jinzhou Medical University; Wuhan Naval University of Engineering	Li, LH (corresponding author), Liaoning Med Univ, Dept Cell Biol, Jinzhou, Liaoning, Peoples R China.	lilihua1018@sina.com; lh509515@163.com	shi, zhensheng/GXN-3967-2022		National Natural Science Foundation of China [31571184]; Aohongboze Graduate Sci-tech Innovation Foundation; Liaoning Medical University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Aohongboze Graduate Sci-tech Innovation Foundation; Liaoning Medical University	This study was supported by grants from the National Natural Science Foundation of China (31571184, recipient: Lihua Li) and Aohongboze Graduate Sci-tech Innovation Foundation, the President Fund of Liaoning Medical University (recipient: Yonggan Fan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger B, 2010, STRAHLENTHER ONKOL, V186, P255, DOI 10.1007/s00066-010-2082-9; Bieri S, 2003, STRAHLENTHER ONKOL, V179, P390, DOI 10.1007/s00066-003-1077-1; Bozec A, 2013, ANTICANCER AGENTS ME, V13; Caron RW, 2005, CELL CYCLE, V4, P456, DOI 10.4161/cc.4.3.1249; Curado MP, 2009, CURR OPIN ONCOL, V21, P194, DOI 10.1097/CCO.0b013e32832a68ca; Dent P, 2003, ONCOGENE, V22, P5885, DOI 10.1038/sj.onc.1206701; Drigotas M, 2013, J ORAL PATHOL MED, V42, P612, DOI 10.1111/jop.12056; Du Y, 2014, PHARM THER, V142; Eder-Czembirek C, 2010, STRAHLENTHER ONKOL, V186, P143, DOI 10.1007/s00066-010-2069-6; Farahabadi SS, 2015, NEUROSCIENCE; Gallo O, 1999, INT J CANC, V84; Garg AK, 2005, ANTIOXID REDOX SIGN, V7, P1630, DOI 10.1089/ars.2005.7.1630; Ghantous A, 2010, DRUG DISCOV TODAY, V15, P668, DOI 10.1016/j.drudis.2010.06.002; Han S, 2014, BR J CANC, V111; HONG JJ, 2013, PLOS ONE, V8; Jeggo PA, 2007, NAT REV CANC, V7; Khan M, 2012, INT J BIOL SCI, V8, P533, DOI 10.7150/ijbs.3753; Kotowski U, 2011, STRAHLENTHER ONKOL, V187, P575, DOI 10.1007/s00066-011-2218-6; Li Y, 2012, Z NATURFORSCH C, V67, P375; Liu Y, 2013, ADV MATH PHYS, V2013, DOI 10.1155/2013/787891; Oh YT, 2015, ONCOGENE; Pal HC, 2010, TOXICOL IN VITRO, V24, P1599, DOI 10.1016/j.tiv.2010.06.007; Qian Y, 2015, CELL PHYSL BIOCH, V35; Rasul A, 2013, ARCH PHARM RES, V36, P1262, DOI 10.1007/s12272-013-0217-0; Saki M, 2013, RADIOTHER ONCOL, V108, P473, DOI 10.1016/j.radonc.2013.06.023; Samatar AA, 2014, NAT REV DRUG DISCOV, V13, P928, DOI 10.1038/nrd4281; Schultz DR, 2003, SEMIN ARTHRITIS RHEU, V32, P345, DOI 10.1053/sarh.2003.50005; Tan TH, 2005, CELL BIOCH BIOPHYS, V43; Wolff HA, 2010, STRAHLENTHER ONKOL, V186; Wu MS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0080668, 10.1371/journal.pone.0083412]; Yang J, 2011, MOL CANC THER, V10; Yin X, 2011, HEAD NECK, V33; Zheng M, 2008, CANC RES, V68	33	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145790	10.1371/journal.pone.0145790	http://dx.doi.org/10.1371/journal.pone.0145790			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716456	Green Submitted, Green Published, gold			2022-12-26	WOS:000367510500071
J	Yin, SH; Wang, T; Pan, WG; Liu, YJ; Chen, AT				Yin, Shouhang; Wang, Ting; Pan, Weigang; Liu, Yijun; Chen, Antao			Task-switching Cost and Intrinsic Functional Connectivity in the Human Brain: Toward Understanding Individual Differences in Cognitive Flexibility	PLOS ONE			English	Article							INFERIOR FRONTAL JUNCTION; PARIETAL CORTICES; PREFRONTAL CORTEX; NEURAL MECHANISMS; MOTOR CORTEX; NETWORKS; COMPONENTS; INTERFERENCE; ACTIVATION	The human ability to flexibly alternate between tasks (i.e., task-switching) represents a critical component of cognitive control. Many functional magnetic resonance imaging (fMRI) studies have explored the neural basis of the task-switching. However, no study to date has examined how individual differences in intrinsic functional architecture of the human brain are related to that of the task-switching. In the present study, we took 11 task-switching relevant areas from a meta-analysis study as the regions of interests (ROIs) and estimated their intrinsic functional connectivity (iFC) with the whole brain. This procedure was repeated for 32 healthy adults based upon their fMRI scans during resting-state (rfMRI) to investigate the correlations between switching cost and the iFC strength across these participants. This analysis found that switch cost was negatively correlated with a set of iFC involved ROIs including left inferior frontal junction, bilateral superior posterior parietal cortex, left precuneus, bilateral inferior parietal lobule, right middle frontal gyrus and bilateral middle occipital gyrus. These connectivity profiles represent an intrinsic functional architecture of task-switching where the left inferior frontal junction plays a hub role in this brain-behavior association. These findings are highly reproducible in another validation independent sample and provide a novel perspective for understanding the neural basis of individual differences in task-switching behaviors reflected in the intrinsic architecture of the human brain.	[Yin, Shouhang; Wang, Ting; Pan, Weigang; Liu, Yijun; Chen, Antao] Southwest Univ, Fac Psychol, Minist Educ, Key Lab Cognit & Personal, Chongqing, Peoples R China	Southwest University - China	Chen, AT (corresponding author), Southwest Univ, Fac Psychol, Minist Educ, Key Lab Cognit & Personal, Chongqing, Peoples R China.	xscat@swu.edu.cn		, Shouhang/0000-0001-5647-369X	National Natural Science Foundation of China [31170980, 81271477, 61431013]; Foundation for the Author of National Excellent Doctoral Dissertation of PR China [201107]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for the Author of National Excellent Doctoral Dissertation of PR China(Foundation for the Author of National Excellent Doctoral Dissertation of China)	This work was supported by grants from the National Natural Science Foundation of China (31170980, 81271477, 61431013), and the Foundation for the Author of National Excellent Doctoral Dissertation of PR China (201107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allport A., 1994, ATTENTION PERFORMANC; Berkman ET, 2013, CURR DIR PSYCHOL SCI, V22, P45, DOI 10.1177/0963721412469394; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bode S, 2009, NEUROIMAGE, V45, P606, DOI 10.1016/j.neuroimage.2008.11.031; Brass M, 2005, TRENDS COGN SCI, V9, P314, DOI 10.1016/j.tics.2005.05.001; Brass M, 2002, CEREB CORTEX, V12, P908, DOI 10.1093/cercor/12.9.908; Braver TS, 2003, NEURON, V39, P713, DOI 10.1016/S0896-6273(03)00466-5; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Bunge SA, 2002, NEUROIMAGE, V17, P1562, DOI 10.1006/nimg.2002.1252; Catani M, 2005, ANN NEUROL, V57, P8, DOI 10.1002/ana.20319; Cole MW, 2014, NEURON, V83, P238, DOI 10.1016/j.neuron.2014.05.014; Cordes D, 2000, AM J NEURORADIOL, V21, P1636; Crone EA, 2006, CEREB CORTEX, V16, P475, DOI 10.1093/cercor/bhi127; De Baene W, 2012, NEUROIMAGE, V63, P203, DOI 10.1016/j.neuroimage.2012.06.050; Derrfuss J, 2005, HUM BRAIN MAPP, V25, P22, DOI 10.1002/hbm.20127; Dove A, 2000, COGNITIVE BRAIN RES, V9, P103, DOI 10.1016/S0926-6410(99)00029-4; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Fox PT, 2014, ANNU REV NEUROSCI, V37, P409, DOI 10.1146/annurev-neuro-062012-170320; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Gold BT, 2010, NEUROBIOL AGING, V31, P512, DOI 10.1016/j.neurobiolaging.2008.04.005; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hampson M, 2002, HUM BRAIN MAPP, V15, P247, DOI 10.1002/hbm.10022; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; He BJ, 2007, NEURON, V53, P905, DOI 10.1016/j.neuron.2007.02.013; Hebb D. O., 2005, ORG BEHAV NEUROPSYCH; Hester R, 2007, NEUROIMAGE, V34, P446, DOI 10.1016/j.neuroimage.2006.08.001; Kiesel A, 2010, PSYCHOL BULL, V136, P849, DOI 10.1037/a0019842; Kim C, 2011, J NEUROSCI, V31, P4771, DOI 10.1523/JNEUROSCI.5923-10.2011; Kim C, 2012, HUM BRAIN MAPP, V33, P130, DOI 10.1002/hbm.21199; Lewisa CM, 2009, P NATL ACAD SCI USA, V106, P17558, DOI 10.1073/pnas.0902455106; Liston C, 2006, NEURON, V50, P643, DOI 10.1016/j.neuron.2006.04.015; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Meiran N, 2000, COGNITIVE PSYCHOL, V41, P211, DOI 10.1006/cogp.2000.0736; Meiran N, 1996, J EXP PSYCHOL LEARN, V22, P1423, DOI 10.1037/0278-7393.22.6.1423; Mennes M, 2010, NEUROIMAGE, V50, P1690, DOI 10.1016/j.neuroimage.2010.01.002; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Muhle-Karbe PS, 2014, NEUROIMAGE, V99, P332, DOI 10.1016/j.neuroimage.2014.05.058; Power JD, 2014, NEURON, V84, P681, DOI 10.1016/j.neuron.2014.09.007; Power JD, 2013, NEUROIMAGE, V76, P439, DOI 10.1016/j.neuroimage.2012.03.017; Powers AR, 2012, J NEUROSCI, V32, P6263, DOI 10.1523/JNEUROSCI.6138-11.2012; ROGERS RD, 1995, J EXP PSYCHOL GEN, V124, P207, DOI 10.1037/0096-3445.124.2.207; Rombouts SARB, 2003, NEUROIMAGE, V20, P1236, DOI 10.1016/S1053-8119(03)00386-0; Ruge H, 2005, NEUROPSYCHOLOGIA, V43, P340, DOI 10.1016/j.neuropsychologia.2004.06.014; Rushworth MFS, 2002, J NEUROPHYSIOL, V87, P2577, DOI 10.1152/jn.2002.87.5.2577; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sohn MH, 2000, P NATL ACAD SCI USA, V97, P13448, DOI 10.1073/pnas.240460497; Song M, 2008, NEUROIMAGE, V41, P1168, DOI 10.1016/j.neuroimage.2008.02.036; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Stelzel C, 2011, J COGNITIVE NEUROSCI, V23, P3529, DOI 10.1162/jocn_a_00062; Vahdat S, 2011, J NEUROSCI, V31, P16907, DOI 10.1523/JNEUROSCI.2737-11.2011; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Xiong JH, 1999, HUM BRAIN MAPP, V8, P151, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<151::AID-HBM13>3.0.CO;2-5; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013	58	14	15	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145826	10.1371/journal.pone.0145826	http://dx.doi.org/10.1371/journal.pone.0145826			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA0TN	26716447	Green Published, Green Submitted, gold			2022-12-26	WOS:000367510500079
J	Alvarez-Romero, JG; Pressey, RL; Ban, NC; Brodie, J				Alvarez-Romero, Jorge G.; Pressey, Robert L.; Ban, Natalie C.; Brodie, Jon			Advancing Land-Sea Conservation Planning: Integrating Modelling of Catchments, Land-Use Change, and River Plumes to Prioritise Catchment Management and Protection	PLOS ONE			English	Article							GREAT-BARRIER-REEF; COASTAL-MARINE ECOSYSTEMS; GULF-OF-CALIFORNIA; WATER-QUALITY; HUMAN IMPACT; FRESH-WATER; TRADE-OFFS; TERRESTRIAL; SEDIMENT; BIODIVERSITY	Human-induced changes to river loads of nutrients and sediments pose a significant threat to marine ecosystems. Ongoing land-use change can further increase these loads, and amplify the impacts of land-based threats on vulnerable marine ecosystems. Consequently, there is a need to assess these threats and prioritise actions to mitigate their impacts. A key question regarding prioritisation is whether actions in catchments tomaintain coastal-marine water quality can be spatially congruent with actions for other management objectives, such as conserving terrestrial biodiversity. In selected catchments draining into the Gulf of California, Mexico, we employed Land Change Modeller to assess the vulnerability of areas with native vegetation to conversion into crops, pasture, and urban areas. We then used SedNet, a catchment modelling tool, to map the sources and estimate pollutant loads delivered to the Gulf by these catchments. Following these analyses, we used modelled river plumes to identify marine areas likely influenced by land-based pollutants. Finally, we prioritised areas for catchment management based on objectives for conservation of terrestrial biodiversity and objectives for water quality that recognised links between pollutant sources and affected marine areas. Our objectives for coastal-marine water quality were to reduce sediment and nutrient discharges from anthropic areas, and minimise future increases in coastal sedimentation and eutrophication. Our objectives for protection of terrestrial biodiversity covered species of vertebrates. We used Marxan, a conservation planning tool, to prioritise interventions and explore spatial differences in priorities for both objectives. Notable differences in the distributions of land values for terrestrial biodiversity and coastal-marine water quality indicated the likely need for trade-offs between catchment management objectives. However, there were priority areas that contributed to both sets of objectives. Our study demonstrates a practical approach to integrating models of catchments, land-use change, and river plumes with conservation planning software to inform prioritisation of catchment management.	[Alvarez-Romero, Jorge G.; Pressey, Robert L.; Ban, Natalie C.] James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Ban, Natalie C.] Univ Victoria, Sch Environm Studies, Victoria, BC, Canada; [Brodie, Jon] James Cook Univ, Ctr Trop Water & Aquat Ecosyst Res TropWater, Catchment Reef Res Grp, Townsville, Qld 4811, Australia	James Cook University; University of Victoria; James Cook University	Alvarez-Romero, JG (corresponding author), James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	jorge.alvarez.romero@gmail.com	Alvarez-Romero, Jorge G./A-4557-2009	Alvarez-Romero, Jorge G./0000-0002-1141-0588; Ban, Natalie/0000-0002-4682-2144	Mexico's Consejo Nacional de Ciencia y Tecnologia; Secretaria de Educacion Publica; Australian Research Council Centre of Excellence for Coral Reef Studies; Mexico's Consejo Nacional de Ciencia y Tecnologia (CONACYT); Secretaria de Educacion Publica (SEP); Australian Research Council	Mexico's Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Secretaria de Educacion Publica; Australian Research Council Centre of Excellence for Coral Reef Studies(Australian Research Council); Mexico's Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Secretaria de Educacion Publica (SEP); Australian Research Council(Australian Research Council)	Mexico's Consejo Nacional de Ciencia y Tecnologia (www.conacyt.mx) and Secretaria de Educacion Publica (www.sep.gob.mx) provided the main funding through PhD scholarships. JGAR, RLP and NCB also acknowledge the support of the Australian Research Council Centre of Excellence for Coral Reef Studies.; We thank Kirsten Oleson and an anonymous reviewer for their very helpful comments and suggestions. We thank the following persons for providing information and technical advice: Scott Wilkinson (CSIRO), Johnathan Kool (Geoscience Australia), Michelle Devlin (Trop-Water, James Cook University); Hector Cortes-Torres, Juan Francisco Gomez-Martinez and Pedro Rivera-Ruiz (IMTA); Rafael Hernandez (CIAD); Stephen Lewis (TropWater, James Cook University); Eusebio Ventura (UQRO); Alejandro Gonzalez-Serratos (CONAGUA); Arturo Flores-Martinez and Cleotilde Arellano (SEMARNAT); Jose Luis Perez-Damian (INE); and Melanie Kolb (CONABIO). We also thank the following organizations for providing software: Australia's Commonwealth Scientific and Industrial Research Organization (CSIRO) Land and Water (SedNet/ANNEX), and datasets: Servicio de Informacion Agroalimentaria y Pesquera (SIAP-SAGARPA); Comision Nacional para el Conocimiento y Uso de la Biodiversidad (CONABIO); Secretaria de Medio Ambiente y Recursos Naturales (SEMARNAT); Instituto Nacional de Ecologia (INE-SEMARNAT), and Instituto Nacional de Estadistica, Geografia e Informatica (INEGI). We also thank P. Visconti for support in scripting to analyse gauge data, Gordon Bailey for providing IT support, and the High Performance Computing Unit at James Cook University for computational facilities. JGAR gratefully acknowledges support from Mexico's Consejo Nacional de Ciencia y Tecnologia (CONACYT) and Secretaria de Educacion Publica (SEP), as well as from the Australian Research Council Centre of Excellence for Coral Reef Studies. RLP and NCB acknowledge the support of the Australian Research Council.	Adams VM, 2014, CONSERV LETT, V7, P425, DOI 10.1111/conl.12080; Alvarez-Cobelas M, 2008, ENVIRON POLLUT, V156, P261, DOI 10.1016/j.envpol.2008.02.016; Alvarez-Romero JG, 2015, BIOL CONSERV, V191, P799, DOI 10.1016/j.biocon.2015.07.003; Alvarez-Romero JG, 2014, J ENVIRON MANAGE, V146, P164, DOI 10.1016/j.jenvman.2014.07.007; Alvarez-Romero JG, 2013, AQUAT CONSERV, V23, P483, DOI 10.1002/aqc.2334; Alvarez-Romero JG, 2013, J ENVIRON MANAGE, V119, P194, DOI 10.1016/j.jenvman.2013.01.036; Alvarez-Romero JG, 2011, ANNU REV ECOL EVOL S, V42, P381, DOI 10.1146/annurev-ecolsys-102209-144702; Anderson BJ, 2009, J APPL ECOL, V46, P888, DOI 10.1111/j.1365-2664.2009.01666.x; Ardron J. A., 2008, MARXAN GOOD PRACTICE; Bai Y, 2011, ECOL COMPLEX, V8, P177, DOI 10.1016/j.ecocom.2011.01.007; Ball I. R., 2009, SPATIAL CONSERVATION, P185, DOI DOI 10.1111/EVA.12631; Ban N. C., 2013, CONSERVATION PLANNIN, P175; Bartley R, 2014, RANGELAND J, V36, P67, DOI 10.1071/RJ13013; Bartley R, 2014, SCI TOTAL ENVIRON, V468, P1138, DOI 10.1016/j.scitotenv.2013.09.030; Bartley R, 2012, MAR POLLUT BULL, V65, P101, DOI 10.1016/j.marpolbul.2011.08.009; Beger M, 2010, CONSERV LETT, V3, P359, DOI 10.1111/j.1755-263X.2010.00123.x; Beger M, 2010, BIOL CONSERV, V143, P565, DOI 10.1016/j.biocon.2009.11.006; Beman JM, 2005, NATURE, V434, P211, DOI 10.1038/nature03370; Bennett F, 2015, WATER QUALITY IMPROV; Bohnet IC, 2011, LANDSCAPE ECOL, V26, P1179, DOI 10.1007/s10980-011-9640-0; Brodie J, 2014, 1433 TROPWATER J COO; Brodie JE, 2012, MAR POLLUT BULL, V65, P81, DOI 10.1016/j.marpolbul.2011.12.012; Brodie J, 2009, MAR FRESHWATER RES, V60, P1141, DOI 10.1071/MF08339; Brown DG, 2013, CURR OPIN ENV SUST, V5, P452, DOI 10.1016/j.cosust.2013.07.012; Burke L., 2006, HYDROLOGIC MODELING; Carroll C, 2012, MAR POLLUT BULL, V65, P136, DOI 10.1016/j.marpolbul.2011.11.022; Ceballos G., 2006, MODELADO DISTRIBUCIO; CEC (Commission for Environmental Cooperation), 1997, EC REG N AM COMM PER; Chan JCW, 2001, PHOTOGRAMM ENG REM S, V67, P213; Cimon-Morin J, 2013, BIOL CONSERV, V166, P144, DOI 10.1016/j.biocon.2013.06.023; CONABIO, 2007, AN VAC OM CONS BIOD; CONANP, 2010, CART COB AR NAT PROT; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; Crist P., 2013, J CONSERV PLAN, V9, P21; De Almeida CM, 2005, INT J REMOTE SENS, V26, P759, DOI 10.1080/01431160512331316865; Devlin MJ, 2012, MAR POLLUT BULL, V65, P224, DOI 10.1016/j.marpolbul.2012.03.001; Devlin MJ, 2015, REMOTE SENS-BASEL, V7, P12909, DOI 10.3390/rs71012909; DGVS-SEMARNAT, 2010, CART SIST UN MAN APR; Djodjic F, 2002, J ENVIRON QUAL, V31, P937, DOI 10.2134/jeq2002.0937; Eastman R., 2007, LAND CHANGE MODELER; Egoh BN, 2011, J ENVIRON MANAGE, V92, P1642, DOI 10.1016/j.jenvman.2011.01.019; ESRI, 2006, ARCGIS 9 2; Geneletti D, 2008, LANDSCAPE URBAN PLAN, V85, P97, DOI 10.1016/j.landurbplan.2007.10.004; Gurney GG, 2015, CONSERV BIOL, V29, P1378, DOI 10.1111/cobi.12514; Gurney GG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080137; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Halpern BS, 2007, CONSERV BIOL, V21, P1301, DOI 10.1111/j.1523-1739.2007.00752.x; Halpern BS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8615; Halpern BS, 2012, NATURE, V488, P615, DOI 10.1038/nature11397; Halpern BS, 2009, CONSERV LETT, V2, P189, DOI 10.1111/j.1755-263X.2009.00060.x; Harris LR, 2014, J APPL ECOL, V51, P1504, DOI 10.1111/1365-2664.12345; Holland RA, 2011, ECOL APPL, V21, P2034, DOI 10.1890/09-2195.1; INEGI-INE-CONABIO, 2007, CART EC TERR MEX NIV, V4; Kemp WM, 2005, MAR ECOL PROG SER, V303, P1, DOI 10.3354/meps303001; Kim OS, 2010, T GIS, V14, P631, DOI 10.1111/j.1467-9671.2010.01227.x; Klein CJ, 2014, MAR POLICY, V44, P360, DOI 10.1016/j.marpol.2013.10.001; Klein CJ, 2012, ECOL APPL, V22, P1246, DOI 10.1890/11-1718.1; Klein CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012431; Kroon FJ, 2012, MAR POLLUT BULL, V65, P167, DOI 10.1016/j.marpolbul.2011.10.018; Langford WT, 2009, ECOL INFORM, V4, P123, DOI 10.1016/j.ecoinf.2009.04.002; Laurance WF, 2002, J BIOGEOGR, V29, P737, DOI 10.1046/j.1365-2699.2002.00721.x; Lluch-Cota SE, 2007, PROG OCEANOGR, V73, P1, DOI 10.1016/j.pocean.2007.01.013; Maina J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023064; Mainstone CP, 2008, J HYDROL, V350, P131, DOI 10.1016/j.jhydrol.2007.10.035; Makino A, 2013, BIOL CONSERV, V165, P35, DOI 10.1016/j.biocon.2013.05.027; McKenzie E, 2012, DEV SCENARIOS ASSESS; Moilanen A, 2011, ECOL APPL, V21, P1419, DOI 10.1890/10-1865.1; Moravec J., 1998, Applied Vegetation Science, V1, P173, DOI 10.2307/1478946; Naidoo R, 2006, TRENDS ECOL EVOL, V21, P681, DOI 10.1016/j.tree.2006.10.003; Navarro AG, 2007, MAPAS DISTRIBUCION P; Nelson E, 2009, FRONT ECOL ENVIRON, V7, P4, DOI 10.1890/080023; Ochoa-Ochoa L, 2006, MUSEO ZOOLOGIA FDC; Olson DM, 2002, ANN MO BOT GARD, V89, P199, DOI 10.2307/3298564; Onaindia M, 2013, FOREST ECOL MANAG, V289, P1, DOI 10.1016/j.foreco.2012.10.010; Paez-Osuna F, 2005, B ENVIRON CONTAM TOX, V74, P681, DOI 10.1007/s00128-005-0637-8; Paris CB, 2008, CORAL REEFS, V27, P773, DOI 10.1007/s00338-008-0396-1; Partelow S, 2015, MAR POLLUT BULL, V100, P352, DOI 10.1016/j.marpolbul.2015.08.026; Peterson GD, 2003, CONSERV BIOL, V17, P358, DOI 10.1046/j.1523-1739.2003.01491.x; Petus C, 2014, J ENVIRON MANAGE, V137, P163, DOI 10.1016/j.jenvman.2013.11.050; Pfeifer M, 2012, GLOBAL ECOL BIOGEOGR, V21, P603, DOI 10.1111/j.1466-8238.2011.00712.x; Pressey RL, 2009, ORYX, V43, P464, DOI 10.1017/S0030605309990500; Qiu JX, 2013, P NATL ACAD SCI USA, V110, P12149, DOI 10.1073/pnas.1310539110; RENARD KG, 1994, J HYDROL, V157, P287, DOI 10.1016/0022-1694(94)90110-4; Rouget M, 2003, BIOL CONSERV, V112, P63, DOI 10.1016/S0006-3207(02)00395-6; Rude J, 2016, AQUAT CONSERV, V26, P251, DOI 10.1002/aqc.2548; Rzedowski J., 1978, VEGETACION MEXICO; Schulz JJ, 2010, APPL GEOGR, V30, P436, DOI 10.1016/j.apgeog.2009.12.003; SEMARNAT-INE, 1991, IND US AGR MUN; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; Stoeckl N, 2015, BIOL CONSERV, V191, P478, DOI 10.1016/j.biocon.2015.07.032; Stoms DM, 2005, FRONT ECOL ENVIRON, V3, P429, DOI 10.1890/1540-9295(2005)003[0429:ICRPMT]2.0.CO;2; Tallis H, 2008, CONSERV BIOL, V22, P120, DOI 10.1111/j.1523-1739.2007.00861.x; Thorburn PJ, 2013, AGR ECOSYST ENVIRON, V180, P4, DOI 10.1016/j.agee.2013.07.006; Thorburn PJ, 2013, AGR ECOSYST ENVIRON, V180, P192, DOI 10.1016/j.agee.2011.12.021; Urquiza-Haas T, 2009, GAP ANAL PROGRAM BRI, V61; Vanacker V, 2003, GEOMORPHOLOGY, V52, P299, DOI 10.1016/S0169-555X(02)00263-5; VELAZQUEZ A, 2002, ANALISIS CAMBIO USO; Visconti P, 2010, CONSERV LETT, V3, P404, DOI 10.1111/j.1755-263X.2010.00130.x; Walling DE, 2006, GEOMORPHOLOGY, V79, P192, DOI 10.1016/j.geomorph.2006.06.019; Waterhouse J, 2014, 1427 TROPWATER J COO; Weber M, 2006, WILDLIFE SOC B, V34, P1480, DOI 10.2193/0091-7648(2006)34[1480:TTOTCW]2.0.CO;2; Wilkinson C., 2011, CATCHMENT MANAGEMENT; Wilkinson S., 2004, SEDNET USER GUIDE VE; Wooldridge SA, 2015, MAR POLLUT BULL, V97, P262, DOI 10.1016/j.marpolbul.2015.06.007; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	105	29	31	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145574	10.1371/journal.pone.0145574	http://dx.doi.org/10.1371/journal.pone.0145574			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714166	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000367481900058
J	Gouvea, DY; Aprison, EZ; Ruvinsky, I				Gouvea, Devin Y.; Aprison, Erin Z.; Ruvinsky, Ilya			Experience Modulates the Reproductive Response to Heat Stress in C-elegans via Multiple Physiological Processes	PLOS ONE			English	Article							OOCYTE MEIOTIC MATURATION; CAENORHABDITIS-ELEGANS; NATURAL VARIATION; THERMAL PREFERENCE; SEX DETERMINATION; MOLECULAR-BASIS; SHOCK RESPONSE; MODEL SYSTEM; CELL LINEAGE; GERM-LINE	Natural environments are considerably more variable than laboratory settings and often involve transient exposure to stressful conditions. To fully understand how organisms have evolved to respond to any given stress, prior experience must therefore be considered. We investigated the effects of individual and ancestral experience on C. elegans reproduction. We documented ways in which cultivation at 15 degrees C or 25 degrees C affects developmental time, lifetime fecundity, and reproductive performance after severe heat stress that exceeds the fertile range of the organism but is compatible with survival and future fecundity. We found that experience modulates multiple aspects of reproductive physiology, including the male and female germ lines and the interaction between them. These responses vary in their environmental sensitivity, suggesting the existence of complex mechanisms for coping with unpredictable and stressful environments.	[Gouvea, Devin Y.] Univ Chicago, Comm Conceptual & Hist Studies Sci, Chicago, IL 60637 USA; [Gouvea, Devin Y.; Ruvinsky, Ilya] Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA; [Aprison, Erin Z.; Ruvinsky, Ilya] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Ruvinsky, Ilya] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago	Ruvinsky, I (corresponding author), Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA.	ruvinsky@uchicago.edu			Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust [C-051]; Jacob K. Javits Fellowship	Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; Jacob K. Javits Fellowship	The work was partly funded by the Chicago Biomedical Consortium with support from The Searle Funds at The Chicago Community Trust (award #C-051 to IR). DYG was supported by a Jacob K. Javits Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JL, 2007, J EXP BIOL, V210, P3107, DOI 10.1242/jeb.007351; Anderson JL, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-157; Andux S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000295; Angelo G, 2009, SCIENCE, V326, P954, DOI 10.1126/science.1178343; Aprison EZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105513; Artyukhin AB, 2013, SCI REP-UK, V3, DOI 10.1038/srep02777; AVERY L, 1993, GENETICS, V133, P897; Bao ZR, 2008, DEV BIOL, V318, P65, DOI 10.1016/j.ydbio.2008.02.054; Bao ZR, 2006, P NATL ACAD SCI USA, V103, P2707, DOI 10.1073/pnas.0511111103; Barriere A, 2005, CURR BIOL, V15, P1176, DOI 10.1016/j.cub.2005.06.022; Barriere A, 2007, GENETICS, V176, P999, DOI 10.1534/genetics.106.067223; Baugh LR, 2013, GENETICS, V194, P539, DOI 10.1534/genetics.113.150847; Begasse ML, 2015, CELL REP, V10, P647, DOI 10.1016/j.celrep.2015.01.006; Berry DB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002353; Braendle C, 2008, DEV CELL, V15, P714, DOI 10.1016/j.devcel.2008.09.011; Braendle C, 2008, CURR TOP DEV BIOL, V80, P171, DOI 10.1016/S0070-2153(07)80005-6; BYERLY L, 1976, DEV BIOL, V51, P23, DOI 10.1016/0012-1606(76)90119-6; Calabrese EJ, 2002, HUM EXP TOXICOL, V21, P91, DOI 10.1191/0960327102ht217oa; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Chen JJ, 2004, J NEMATOL, V36, P107; Chen JJ, 2003, NEMATOLOGY, V5, P641, DOI 10.1163/156854103322683355; Chisholm Andrew D, 2005, WormBook, P1; Cypser JR, 2006, EXP GERONTOL, V41, P935, DOI 10.1016/j.exger.2006.09.004; Dalfo D, 2012, CURR BIOL, V22, P712, DOI 10.1016/j.cub.2012.02.064; Dawe AS, 2006, BIOELECTROMAGNETICS, V27, P88, DOI 10.1002/bem.20192; DEPPE U, 1978, P NATL ACAD SCI USA, V75, P376, DOI 10.1073/pnas.75.1.376; Dolgin ES, 2008, HEREDITY, V100, P304, DOI 10.1038/sj.hdy.6801079; Ellis R, 2006, C ELEGANS RES COMMUN, DOI [10.1895/wormbook.1.82.1, DOI 10.1895/W0RMB00K.1.82.1]; Feder ME, 1997, J THERM BIOL, V22, P1, DOI 10.1016/S0306-4565(96)00028-9; Felix MA, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-59; Felix MA, 2010, CURR BIOL, V20, pR965, DOI 10.1016/j.cub.2010.09.050; Fielenbach N, 2008, GENE DEV, V22, P2149, DOI 10.1101/gad.1701508; Frand AR, 2005, PLOS BIOL, V3, P1719, DOI 10.1371/journal.pbio.0030312; Frazier HN, 2009, CURR BIOL, V19, P859, DOI 10.1016/j.cub.2009.03.066; Frezal L, 2015, ELIFE, V4, DOI 10.7554/eLife.05849; FRIEDMAN S, 1972, PEABODY J EDUC, V49, P314, DOI 10.1080/01619567209537872; Gaertner BE, 2012, GENETICS, V192, P1533, DOI 10.1534/genetics.112.142877; Garigan D, 2002, GENETICS, V161, P1101; Ghosh R, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-85; Glauser Dominique A, 2013, Worm, V2, pe27285, DOI 10.4161/worm.27285; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; Goodwin EB, 2002, CURR BIOL, V12, pR111, DOI 10.1016/S0960-9822(02)00675-9; GREWAL PS, 1991, NEMATOLOGICA, V37, P72, DOI 10.1163/187529291X00079; Harvey SC, 2007, J EXP ZOOL PART B, V308B, P409, DOI 10.1002/jez.b.21161; Harvey SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025840; Hayward SAL, 2007, ADV EXP MED BIOL, V594, P132; Hayward SAL, 2014, J EXP BIOL, V217, P6, DOI 10.1242/jeb.096537; HAZEL JR, 1991, LIPIDS, V26, P277, DOI 10.1007/BF02537137; HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061; HIRSH D, 1976, DEV BIOL, V49, P200, DOI 10.1016/0012-1606(76)90267-0; Hodgkin J, 1997, GENETICS, V146, P149; HODGKIN J, 1991, P ROY SOC B-BIOL SCI, V246, P19, DOI 10.1098/rspb.1991.0119; Hu PJ, 2007, WORMBOOK, DOI [10.1895/wormbook.1.144.1, DOI 10.1895/WORMBOOK.1.144.1]; James W., 1890, PRINCIPLES PSYCHOL, V1, DOI [10.1037/10538-000, DOI 10.1037/10538-000]; JOHNSON TE, 1984, MECH AGEING DEV, V28, P23, DOI 10.1016/0047-6374(84)90150-7; Jurado P, 2010, GENES BRAIN BEHAV, V9, P120, DOI 10.1111/j.1601-183X.2009.00549.x; KIMBLE JE, 1981, DEV BIOL, V81, P208, DOI 10.1016/0012-1606(81)90284-0; Kimble Judith, 2005, WormBook, P1; Kiontke KC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-339; Kourtis N, 2012, NATURE, V490, P213, DOI 10.1038/nature11417; Kuntz SG, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004293; Lee RYN, 1997, EMBO J, V16, P6066, DOI 10.1093/emboj/16.20.6066; Lee SJ, 2009, CURR BIOL, V19, P715, DOI 10.1016/j.cub.2009.03.041; Leroy M, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-187; Levy SF, 2012, ADV EXP MED BIOL, V751, P431, DOI 10.1007/978-1-4614-3567-9_20; Levy SF, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001325; Link CD, 1999, CELL STRESS CHAPERON, V4, P235, DOI 10.1379/1466-1268(1999)004<0235:DOOSRI>2.3.CO;2; Luo SJ, 2011, GENESIS, V49, P53, DOI 10.1002/dvg.20694; Luo SJ, 2010, CELL, V143, P299, DOI 10.1016/j.cell.2010.09.013; Ma DKK, 2015, CELL, V161, P1152, DOI 10.1016/j.cell.2015.04.026; Maman M, 2013, J NEUROSCI, V33, P6102, DOI 10.1523/JNEUROSCI.4023-12.2013; McCarter J, 1999, DEV BIOL, V205, P111, DOI 10.1006/dbio.1998.9109; McGovern M, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-41; McMullen PD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002338; Meyers LA, 2002, TRENDS ECOL EVOL, V17, P551, DOI 10.1016/S0169-5347(02)02633-2; Miller MA, 2001, SCIENCE, V291, P2144, DOI 10.1126/science.1057586; Mori I, 2007, CURR OPIN NEUROBIOL, V17, P712, DOI 10.1016/j.conb.2007.11.010; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Murray P, 2007, P NATL ACAD SCI USA, V104, P5489, DOI 10.1073/pnas.0609590104; Murray RL, 2011, J EXP BIOL, V214, P1740, DOI 10.1242/jeb.053181; Neves A, 2015, ELIFE, V4, DOI 10.7554/eLife.04810; Ohta A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5412; Casanueva MO, 2012, SCIENCE, V335, P82, DOI 10.1126/science.1213491; Parker S, 2009, MOL BIOL CELL, V20, P1763, DOI 10.1091/mbc.E08-08-0837; Petrella LN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112377; Prahlad V, 2008, SCIENCE, V320, P811, DOI 10.1126/science.1156093; Prasad A, 2011, EVOLUTION, V65, P52, DOI 10.1111/j.1558-5646.2010.01110.x; Richards JL, 2013, DEV BIOL, V374, P12, DOI 10.1016/j.ydbio.2012.11.034; Rodriguez M, 2012, EXP GERONTOL, V47, P581, DOI 10.1016/j.exger.2012.05.005; Ruaud AF, 2006, DEVELOPMENT, V133, P2211, DOI 10.1242/dev.02392; Schaedel ON, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001306; SCHEDL T, 1988, GENETICS, V119, P43; Schindler AJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004426; Schnabel R, 1997, DEV BIOL, V184, P234, DOI 10.1006/dbio.1997.8509; Schott D, 2014, SCI REP-UK, V4, DOI 10.1038/srep07387; Seidel HS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028074; Sikkink KL, 2014, G3-GENES GENOM GENET, V4, P1103, DOI 10.1534/g3.114.010553; Simons AM, 2011, P ROY SOC B-BIOL SCI, V278, P1601, DOI 10.1098/rspb.2011.0176; SINGH RN, 1978, NEMATOLOGICA, V24, P63, DOI 10.1163/187529278X00074; Sivasundar A, 2005, CURR BIOL, V15, P1598, DOI 10.1016/j.cub.2005.08.034; Stiernagle Theresa, 2006, WormBook, P1; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Sutphin GL, 2008, EXP GERONTOL, V43, P130, DOI 10.1016/j.exger.2007.10.019; Svensk E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003801; Svensson E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021343; Tanaka T, 1996, LIPIDS, V31, P1173, DOI 10.1007/BF02524292; Tauffenberger A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004346; Thevenaz P, 2007, MICROSC RES TECHNIQ, V70, P135, DOI 10.1002/jemt.20393; Thummel CS, 2001, DEV CELL, V1, P453, DOI 10.1016/S1534-5807(01)00060-0; WARD S, 1979, DEV BIOL, V73, P304, DOI 10.1016/0012-1606(79)90069-1; Wolke U, 2007, DEVELOPMENT, V134, P2227, DOI 10.1242/dev.004952; Xiao R, 2013, CELL, V152, P806, DOI 10.1016/j.cell.2013.01.020; Zevian SC, 2014, METHODS, V68, P450, DOI 10.1016/j.ymeth.2014.04.015; Zhang B, 2015, CELL REP, V11, P1414, DOI 10.1016/j.celrep.2015.04.066	114	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145925	10.1371/journal.pone.0145925	http://dx.doi.org/10.1371/journal.pone.0145925			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713620	Green Submitted, Green Published, gold			2022-12-26	WOS:000367481900102
J	LaFaro, RJ; Pothula, S; Kubal, KP; Inchiosa, ME; Pothula, VM; Yuan, SC; Maerz, DA; Montes, L; Oleszkiewicz, SM; Yusupov, A; Perline, R; Inchiosa, MA				LaFaro, Rocco J.; Pothula, Suryanarayana; Kubal, Keshar Paul; Inchiosa, Mario Emil; Pothula, Venu M.; Yuan, Stanley C.; Maerz, David A.; Montes, Lucresia; Oleszkiewicz, Stephen M.; Yusupov, Albert; Perline, Richard; Inchiosa, Mario Anthony, Jr.			Neural Network Prediction of ICU Length of Stay Following Cardiac Surgery Based on Pre-Incision Variables	PLOS ONE			English	Article							MODEL	Background Advanced predictive analytical techniques are being increasingly applied to clinical risk assessment. This study compared a neural network model to several other models in predicting the length of stay (LOS) in the cardiac surgical intensive care unit (ICU) based on pre-incision patient characteristics. Methods Thirty six variables collected from 185 cardiac surgical patients were analyzed for contribution to ICU LOS. The Automatic Linear Modeling (ALM) module of IBM-SPSS software identified 8 factors with statistically significant associations with ICU LOS; these factors were also analyzed with the Artificial Neural Network (ANN) module of the same software. The weighted contributions of each factor ("trained" data) were then applied to data for a "new" patient to predict ICU LOS for that individual. Results Factors identified in the ALM model were: use of an intra-aortic balloon pump; O-2 delivery index; age; use of positive cardiac inotropic agents; hematocrit; serum creatinine >= 1.3 mg/deciliter; gender; arterial pCO(2). The r(2) value for ALM prediction of ICU LOS in the initial (training) model was 0.356, p < 0.0001. Cross validation in prediction of a "new" patient yielded r(2) = 0.200, p < 0.0001. The same 8 factors analyzed with ANN yielded a training prediction r(2) of 0.535 (p < 0.0001) and a cross validation prediction r(2) of 0.410, p < 0.0001. Two additional predictive algorithms were studied, but they had lower prediction accuracies. Our validated neural network model identified the upper quartile of ICU LOS with an odds ratio of 9.8(p < 0.0001). Conclusions ANN demonstrated a 2-fold greater accuracy than ALM in prediction of observed ICU LOS. This greater accuracy would be presumed to result from the capacity of ANN to capture nonlinear effects and higher order interactions. Predictive modeling may be of value in early anticipation of risks of post-operative morbidity and utilization of ICU facilities.	[LaFaro, Rocco J.] New York Med Coll, Dept Surg, Valhalla, NY 10595 USA; [Pothula, Suryanarayana; Yuan, Stanley C.; Yusupov, Albert] New York Med Coll, Dept Anesthesiol, Valhalla, NY 10595 USA; [Kubal, Keshar Paul; Pothula, Venu M.; Maerz, David A.; Montes, Lucresia; Oleszkiewicz, Stephen M.; Inchiosa, Mario Anthony, Jr.] New York Med Coll, Dept Pharmacol, Valhalla, NY 10595 USA; [Inchiosa, Mario Emil] Revolut Analyt Inc, Mountain View, CA USA; [Perline, Richard] SAS Inst, Cary, NC USA	New York Medical College; New York Medical College; New York Medical College; SAS Institute Inc	Inchiosa, MA (corresponding author), New York Med Coll, Dept Pharmacol, Valhalla, NY 10595 USA.	mario_inchiosa@nymc.edu		Pothula, Venu/0000-0002-5162-007X				Amato F, 2013, J APPL BIOMED, V11, P47, DOI 10.2478/v10136-012-0031-x; Atkov OY, 2012, J CARDIOL, V59, P190, DOI 10.1016/j.jjcc.2011.11.005; Atoui H, 2010, IEEE T INF TECHNOL B, V14, P883, DOI 10.1109/TITB.2010.2047754; Barili F, 2013, INT J CARDIOL, V168, P219, DOI 10.1016/j.ijcard.2012.09.091; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; BUCHMAN TG, 1994, CRIT CARE MED, V22, P750, DOI 10.1097/00003246-199405000-00008; Deng ZH, 2015, IEEE T FUZZY SYST, V23, P813, DOI 10.1109/TFUZZ.2014.2328014; Geisser S., 2017, PREDICTIVE INFERENCE; Gholipour C, 2015, J CLIN DIAGN RES, V9, pOC19, DOI 10.7860/JCDR/2015/9467.5828; Hall LO, 2003, IEEE SYS MAN CYBERN, P2851; Harrison RF, 2005, ANN EMERG MED, V46, P431, DOI 10.1016/j.annemergmed.2004.09.012; Hashem S, 1997, NEURAL NETWORKS, V10, P599, DOI 10.1016/S0893-6080(96)00098-6; Mateo J., 2012, Journal of Medical Engineering & Technology, V36, P90, DOI 10.3109/03091902.2011.636859; Najafi Mahdi, 2012, J Tehran Heart Cent, V7, P170; Peng SY, 2008, ANAESTHESIA, V63, P705, DOI 10.1111/j.1365-2044.2008.05478.x; R Core Team, 2013, R LANG ENV STAT COMP; Rowan M, 2007, ARTIF INTELL MED, V40, P211, DOI 10.1016/j.artmed.2007.04.005; Tejera E, 2011, J MATERN-FETAL NEO M, V24, P1147, DOI 10.3109/14767058.2010.545916; TU JV, 1993, COMPUT BIOMED RES, V26, P220, DOI 10.1006/cbmr.1993.1015; Walsh P, 2004, EUR J EMERG MED, V11, P259, DOI 10.1097/00063110-200410000-00004; Zhang RX, 2007, IEEE ACM T COMPUT BI, V4, P485, DOI 10.1109/TCBB.2007.1012	21	33	33	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145395	10.1371/journal.pone.0145395	http://dx.doi.org/10.1371/journal.pone.0145395			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710254	Green Submitted, Green Published, gold			2022-12-26	WOS:000367451400043
J	Chen, XP; Wang, JM; Zhu, HJ; Li, YH; Ding, JT; Peng, YF				Chen, Xiuping; Wang, Jiamei; Zhu, Haojun; Li, Yunhe; Ding, Jiatong; Peng, Yufa			Effects of Transgenic cry1Ca Rice on the Development of Xenopus laevis	PLOS ONE			English	Article							GENETICALLY-MODIFIED RICE; BT RICE; SAFETY ASSESSMENT; BY-PRODUCTS; PROTEIN; RESPONSES; EXPOSURE; LINES; GENE; METAMORPHOSIS	In fields of genetically modified, insect-resistant rice expressing Bacillus thuringiensis (Bt) proteins, frogs are exposed to Bt Cry proteins by consuming both target and non-target insects, and through their highly permeable skin. In the present study, we assessed the potential risk posed by transgenic cry1Ca rice (T1C-19) on the development of a frog species by adding purified Cry1Ca protein or T1C-19 rice straw into the rearing water of Xenopus laevis tadpoles, and by feeding X. laevis froglets diets containing rice grains of T1C-19 or its non-transformed counterpart MH63. Our results showed that there were no significant differences among groups receiving 100 mu g L-1 or 10 mu g L-1 Cry1Ca and the blank control in terms of time to completed metamorphosis, survival rate, body weight, body length, organ weight and liver enzyme activity after being exposed to the Cry1Ca (P > 0.05). Although some detection indices in the rice straw groups were significantly different from those of the blank control group (P < 0.05), there was no significant difference between the T1C-19 and MH63 rice straw groups. Moreover, there were no significant differences in the mortality rate, body weight, daily weight gain, liver and fat body weight of the froglets between the T1C-19 and MH63 dietary groups after 90 days, and there were no abnormal pathological changes in the stomach, intestines, livers, spleens and gonads. Thus, we conclude that the planting of transgenic cry1Ca rice will not adversely affect frog development.	[Chen, Xiuping; Wang, Jiamei; Zhu, Haojun; Li, Yunhe; Peng, Yufa] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Wang, Jiamei; Zhu, Haojun; Ding, Jiatong] Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou 225009, Jiangsu, Peoples R China; [Wang, Jiamei] Jiangsu Agrianim Husb Vocat Coll, Taizhou 225300, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Yangzhou University; Jiangsu Agri-animal Husbandry Vocational College	Chen, XP (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	cxpyuan@gmail.com; yfpeng@vip.qq.com	peng, yu/GXW-2071-2022		National GMO New Variety Breeding Program of the People's Republic of China [2012ZX08011-002, 2014ZX08011-001]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National GMO New Variety Breeding Program of the People's Republic of China; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National GMO New Variety Breeding Program of the People's Republic of China (2012ZX08011-002 and 2014ZX08011-001), and a Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Akhtar ZR, 2010, ENVIRON ENTOMOL, V39, P715, DOI 10.1603/EN09095; Avisar D, 2009, PLANT SCI, V176, P315, DOI 10.1016/j.plantsci.2008.12.010; Blaustein AR, 2011, ANN NY ACAD SCI, V1223, P108, DOI 10.1111/j.1749-6632.2010.05909.x; Bohn T, 2008, ARCH ENVIRON CON TOX, V55, P584, DOI 10.1007/s00244-008-9150-5; Bohn T, 2010, ECOTOXICOLOGY, V19, P419, DOI 10.1007/s10646-009-0427-x; Cao SS, 2010, REGUL TOXICOL PHARM, V58, P474, DOI 10.1016/j.yrtph.2010.08.018; Cao ZhengHui, 2014, Chinese Journal of Animal Nutrition, V26, P1908; Carstens K, 2012, TRANSGENIC RES, V21, P813, DOI 10.1007/s11248-011-9569-8; Chambers CP, 2010, ECOL APPL, V20, P1949, DOI 10.1890/09-0598.1; Coady KK, 2005, ECOTOX ENVIRON SAFE, V62, P160, DOI 10.1016/j.ecoenv.2004.10.010; Dobrovoljc K, 2012, BIOL TRACE ELEM RES, V150, P178, DOI 10.1007/s12011-012-9461-2; Douville M, 2009, ECOTOX ENVIRON SAFE, V72, P17, DOI 10.1016/j.ecoenv.2008.02.006; Douville M, 2007, ECOTOX ENVIRON SAFE, V66, P195, DOI 10.1016/j.ecoenv.2006.01.002; Geng BR, 2005, B ENVIRON CONTAM TOX, V75, P343, DOI 10.1007/s00128-005-0759-z; Hayes TB, 2006, ENVIRON HEALTH PERSP, V114, P40, DOI 10.1289/ehp.8051; HOFMANN C, 1988, P NATL ACAD SCI USA, V85, P7844, DOI 10.1073/pnas.85.21.7844; Indermaur L, 2010, OECOLOGIA, V163, P637, DOI 10.1007/s00442-010-1586-4; Jensen PD, 2010, ENVIRON ENTOMOL, V39, P707, DOI 10.1603/EN09037; Jones DK, 2009, ENVIRON TOXICOL CHEM, V28, P1939, DOI 10.1897/09-033.1; Li YH, 2014, INSECT SCI, V21, P125, DOI 10.1111/1744-7917.12044; Li YH, 2014, ENVIRON TOXICOL CHEM, V33, P1391, DOI 10.1002/etc.2567; Liu W, 2008, SOIL BIOL BIOCHEM, V40, P475, DOI 10.1016/j.soilbio.2007.09.017; Lu Changming, 2010, GM Crops, V1, P113, DOI 10.4161/gmcr.1.3.12377; Lu YH, 2010, SCIENCE, V328, P1151, DOI 10.1126/science.1187881; Mannakkara A, 2013, J INSECT PHYSIOL, V59, P985, DOI 10.1016/j.jinsphys.2013.07.009; Morey S, 2001, ECOLOGY, V82, P510, DOI 10.2307/2679876; O'Rourke DP, 2007, ILAR J, V48, P183, DOI 10.1093/ilar.48.3.183; Oka T, 2008, AQUAT TOXICOL, V87, P215, DOI 10.1016/j.aquatox.2008.02.009; Qin HF, 2012, THESIS; Raybould A, 2011, TRANSGENIC RES, V20, P599, DOI 10.1007/s11248-010-9442-1; Rimando AM, 2002, W CROP SCI, P221; Rosi-Marshall EJ, 2007, P NATL ACAD SCI USA, V104, P16204, DOI 10.1073/pnas.0707177104; Schroder M, 2007, FOOD CHEM TOXICOL, V45, P339, DOI 10.1016/j.fct.2006.09.001; Sparling DW, 2007, ENVIRON POLLUT, V147, P535, DOI 10.1016/j.envpol.2006.10.036; Tank JL, 2010, P NATL ACAD SCI USA, V107, P17645, DOI 10.1073/pnas.1006925107; Tian JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035164; Viktorov AG, 2011, RUSS J PLANT PHYSL+, V58, P543, DOI 10.1134/S1021443711040224; Wang JM, 2014, ENVIRON TOXICOL CHEM, V33, P1156, DOI 10.1002/etc.2535; Wang YN, 2016, INSECT SCI, V23, P78, DOI 10.1111/1744-7917.12178; Wang YM, 2013, SOIL BIOL BIOCHEM, V58, P107, DOI 10.1016/j.soilbio.2012.11.007; Wang YY, 2012, BIOL CONTROL, V61, P246, DOI 10.1016/j.biocontrol.2012.02.011; Wang ZH, 2002, J SCI FOOD AGR, V82, P738, DOI 10.1002/jsfa.1105; Yang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102302; Yao HW, 2008, ENVIRON ENTOMOL, V37, P825, DOI 10.1603/0046-225X(2008)37[825:TAOPFD]2.0.CO;2; Zhang Qing-ling, 2013, Yingyong Shengtai Xuebao, V24, P1647; Zheng XS, 2011, J ECON ENTOMOL, V104, P1730, DOI 10.1603/EC10389; Zhou J, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0084724, 10.1371/journal.pone.0096989, 10.1371/journal.pone.0087161]; Zhu HJ, 2015, J AGR FOOD CHEM, V63, P3627, DOI 10.1021/jf5055547	48	5	5	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145412	10.1371/journal.pone.0145412	http://dx.doi.org/10.1371/journal.pone.0145412			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26695426	gold, Green Published, Green Submitted			2022-12-26	WOS:000367092500044
J	Heylman, C; Datta, R; Sobrino, A; George, S; Gratton, E				Heylman, Christopher; Datta, Rupsa; Sobrino, Agua; George, Steven; Gratton, Enrico			Supervised Machine Learning for Classification of the Electrophysiological Effects of Chronotropic Drugs on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes	PLOS ONE			English	Article							VOLTAGE; CARDIOTOXICITY; TOXICITY	Supervised machine learning can be used to predict which drugs human cardiomyocytes have been exposed to. Using electrophysiological data collected from human cardiomyocytes with known exposure to different drugs, a supervised machine learning algorithm can be trained to recognize and classify cells that have been exposed to an unknown drug. Furthermore, the learning algorithm provides information on the relative contribution of each data parameter to the overall classification. Probabilities and confidence in the accuracy of each classification may also be determined by the algorithm. In this study, the electrophysiological effects of beta-adrenergic drugs, propranolol and isoproterenol, on cardiomyocytes derived from human induced pluripotent stem cells (hiPS-CM) were assessed. The electrophysiological data were collected using high temporal resolution 2-photon microscopy of voltage sensitive dyes as a reporter of membrane voltage. The results demonstrate the ability of our algorithm to accurately assess, classify, and predict hiPS-CM membrane depolarization following exposure to chronotropic drugs.	[Heylman, Christopher; Datta, Rupsa; George, Steven; Gratton, Enrico] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92697 USA; [Heylman, Christopher; Datta, Rupsa; Gratton, Enrico] Univ Calif Irvine, Fluorescence Dynam Lab, Irvine, CA USA; [Heylman, Christopher; George, Steven] Univ Calif Irvine, Edwards Lifesci Ctr Adv Cardiovasc Technol, Irvine, CA USA; [Sobrino, Agua] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA; [George, Steven] Washington Univ, Dept Biomed Engn, St Louis, MO USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; Washington University (WUSTL)	Gratton, E (corresponding author), Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92697 USA.	egratton@uci.edu	Datta, Rupsa/I-5436-2019	Datta, Rupsa/0000-0002-6432-2389	George E. Hewitt Foundation for Medical Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH3TR000481] Funding Source: NIH RePORTER	George E. Hewitt Foundation for Medical Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	CH received fellowship from the George E. Hewitt Foundation for Medical Research.	Albini A, 2010, JNCI-J NATL CANCER I, V102, P14, DOI 10.1093/jnci/djp440; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Cerignoli F, 2012, J PHARMACOL TOX MET, V66, P246, DOI 10.1016/j.vascn.2012.08.167; Colombo A, 2013, CURR CARDIOL REP, V15, DOI 10.1007/s11886-013-0362-6; Dague E, 2014, J MOL CELL CARDIOL, V74, P162, DOI 10.1016/j.yjmcc.2014.05.006; Ewer MS, 2010, NAT REV CARDIOL, V7, P564, DOI 10.1038/nrcardio.2010.121; Ferri N, 2013, PHARMACOL THERAPEUT, V138, P470, DOI 10.1016/j.pharmthera.2013.03.005; Geurts P, 2009, MOL BIOSYST, V5, P1593, DOI 10.1039/b907946g; Ghouri I, 2013, J BIOPHOTONICS, V123, P112; Goldsmith CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103459; Herron TJ, 2012, CIRC RES, V110, P609, DOI 10.1161/CIRCRESAHA.111.247494; Heylman C, 2014, EXP BIOL MED, V239, P1240, DOI 10.1177/1535370214525295; James G, 2013, SPRINGER TEXTS STAT, V103, P1, DOI 10.1007/978-1-4614-7138-7_1; Juhola M, 2014, IEEE ENG MED BIO, P1444, DOI 10.1109/EMBC.2014.6943872; LaConte SM, 2011, NEUROIMAGE, V56, P440, DOI 10.1016/j.neuroimage.2010.06.052; Leyton-Mange JS, 2014, STEM CELL REP, V2, P163, DOI 10.1016/j.stemcr.2014.01.003; Lian XJ, 2013, NAT PROTOC, V8, P162, DOI 10.1038/nprot.2012.150; Lopez-Izquierdo A, 2014, AM J PHYSIOL-HEART C, V307, pH1370, DOI 10.1152/ajpheart.00344.2014; Mordwinkin NM, 2013, J CARDIOVASC TRANSL, V6, P22, DOI 10.1007/s12265-012-9423-2; Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679; Navarrete EG, 2013, CIRCULATION, V128, pS3, DOI 10.1161/CIRCULATIONAHA.112.000570; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Raschi E, 2010, PHARMACOL THERAPEUT, V125, P196, DOI 10.1016/j.pharmthera.2009.10.002; Redmond SJ, 2012, IEEE ENG MED BIO, P57, DOI 10.1109/EMBC.2012.6345870; Scheel O, 2014, ASSAY DRUG DEV TECHN, V12, P457, DOI 10.1089/adt.2014.601; Sinnecker D, 2014, PHARMACOL THERAPEUT, V143, P246, DOI 10.1016/j.pharmthera.2014.03.004; Veerman CC, 2015, STEM CELLS DEV, V24, P1035, DOI 10.1089/scd.2014.0533; Yan P, 2012, P NATL ACAD SCI USA, V109, P20443, DOI 10.1073/pnas.1214850109; Yeh ETH, 2009, J AM COLL CARDIOL, V53, P2231, DOI 10.1016/j.jacc.2009.02.050; Zeevi-Levin N, 2012, PHARMACOL THERAPEUT, V134, P180, DOI 10.1016/j.pharmthera.2012.01.005	30	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0144572	10.1371/journal.pone.0144572	http://dx.doi.org/10.1371/journal.pone.0144572			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26695765	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092500007
J	Torres-Perez, M; Tellez-Ballesteros, RI; Ortiz-Lopez, L; Ichwan, M; Vega-Rivera, NM; Castro-Garcia, M; Gomez-Sanchez, A; Kempermann, G; Ramirez-Rodriguez, GB				Torres-Perez, Mario; Ivonne Tellez-Ballesteros, Ruth; Ortiz-Lopez, Leonardo; Ichwan, Muhammad; Maritza Vega-Rivera, Nelly; Castro-Garcia, Mario; Gomez-Sanchez, Ariadna; Kempermann, Gerd; Bernabe Ramirez-Rodriguez, Gerardo			Resveratrol Enhances Neuroplastic Changes, Including Hippocampal Neurogenesis, and Memory in Balb/C Mice at Six Months of Age	PLOS ONE			English	Article							DENTATE GYRUS; ENVIRONMENTAL ENRICHMENT; NEUROTROPHIC FACTOR; NITRIC-OXIDE; BRAIN; EXPRESSION; MECHANISM; SIRT1; PKC; ACTIVATION	Resveratrol (RVTL) is a flavonoid found in red wine and has been publicized heavily as an anti-aging compound. Indeed, basic research confirms that although there is much hype in the promotion of RVTL, flavonoids such as RVTL have a wide range of biological effects. We here investigated the effects of RVTL treatment on hippocampal plasticity and memory performance in female Balb/C mice, a strain with low baseline levels of adult neurogenesis. Two weeks of treatment with RVTL (40 mg/kg) induced the production of new neurons in vivo by increasing cell survival and possibly precursor cell proliferation. In addition, RVTL decreased the number of apoptotic cells. The number of doublecortin (DCX)-expressing intermediate cells was increased. RVTL stimulated neuronal differentiation in vitro without effects on proliferation. In the dentate gyrus, RVTL promoted the formation and maturation of spines on granule cell dendrites. RVTL also improved performance in the step down passive avoidance test. The RVTL-treated mice showed increase in the levels of two key signaling proteins, phospho-Akt and phospho-PKC, suggesting the involvement of these signaling pathways. Our results support the vision that flavonoids such as resveratrol deserve further examination as plasticity-inducing compounds in the context of successful cognitive aging.	[Torres-Perez, Mario; Ivonne Tellez-Ballesteros, Ruth; Ortiz-Lopez, Leonardo; Gomez-Sanchez, Ariadna; Bernabe Ramirez-Rodriguez, Gerardo] Natl Inst Psychiat Ramon de la Fuente Muniz, Lab Neurogenesis, Div Clin Invest, Mexico City 14370, DF, Mexico; [Ichwan, Muhammad; Kempermann, Gerd] CRTD Ctr Regenerat Therapies Dresden, D-01307 Dresden, Germany; [Ichwan, Muhammad] Univ Sumatera Utara, Fac Med, Dept Pharmacol & Therapeut, Medan, Indonesia; [Maritza Vega-Rivera, Nelly; Castro-Garcia, Mario] Natl Inst Psychiat Ramon de la Fuente Muniz, Lab Neuropsychopharmacol, Div Neurosci, Mexico City 14370, DF, Mexico; [Kempermann, Gerd] DZNE, German Ctr Neurodegenerat Dis, D-01307 Dresden, Germany	Instituto Nacional de Psiquiatria Ramon de la Fuente Muniz; Technische Universitat Dresden; University of North Sumatra; Instituto Nacional de Psiquiatria Ramon de la Fuente Muniz; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technische Universitat Dresden	Kempermann, G (corresponding author), CRTD Ctr Regenerat Therapies Dresden, Tatzberg 47-79, D-01307 Dresden, Germany.	gerd.kempermann@dzne.de; gbernabe@imp.edu.mx	Kempermann, Gerd/F-5416-2010; Ichwan, muhammad/AAE-3802-2020; Ichwan, Muhammad/AAF-9949-2021; Ramirez-Rodriguez, Gerardo Bernabe/GQG-9370-2022	Kempermann, Gerd/0000-0002-5304-4061; Ichwan, Muhammad/0000-0001-8380-9099; Vega-Rivera, Nelly Maritza/0000-0003-0516-3880; ramirez-rodriguez, gerardo/0000-0003-3243-1588	"Instituto de Ciencia y Tecnologia de la Ciudad de Mexico, Distrito Federal" (ICYTDF) [PICSA-1170]; Ministry of Health (SSA) through the Program for Initiation in Scientific Research (PROBEI); "Consejo Nacional de Ciencia y Tecnologia" (CONACYT) [119182]; CONACYT-BMBF [147377, 01DN12086]	"Instituto de Ciencia y Tecnologia de la Ciudad de Mexico, Distrito Federal" (ICYTDF); Ministry of Health (SSA) through the Program for Initiation in Scientific Research (PROBEI); "Consejo Nacional de Ciencia y Tecnologia" (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACYT-BMBF	This work was supported by the "Instituto de Ciencia y Tecnologia de la Ciudad de Mexico, Distrito Federal" (ICYTDF; grant PICSA-1170). MTP was a fellowship-recipient of the Ministry of Health (SSA) through the Program for Initiation in Scientific Research (PROBEI). RTB was a fellowship of "Consejo Nacional de Ciencia y Tecnologia" (CONACYT; Grant 119182). MI, LOL, NMVR, GRR and GK were supported by a CONACYT-BMBF cooperation project for exchange researchers (GRR: 147377; GK: 01DN12086). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An L, 2008, PROG NEURO-PSYCHOPH, V32, P1484, DOI 10.1016/j.pnpbp.2008.05.005; Babu H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000388; Babu H, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00089; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Beltran-Campos V, 2011, BRAIN RES, V1369, P119, DOI 10.1016/j.brainres.2010.10.105; Ben Abdallah NMB, 2010, NEUROBIOL AGING, V31, P151, DOI 10.1016/j.neurobiolaging.2008.03.002; Bhullar KS, 2015, BBA-MOL BASIS DIS, V1852, P1209, DOI 10.1016/j.bbadis.2015.01.012; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Catley MC, 2004, J BIOL CHEM, V279, P18457, DOI 10.1074/jbc.M400765200; Clark PJ, 2011, GENES BRAIN BEHAV, V10, P345, DOI 10.1111/j.1601-183X.2010.00674.x; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; Dias GP, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/541971; Donmez G, 2012, TRENDS PHARMACOL SCI, V33, P494, DOI 10.1016/j.tips.2012.05.007; Giacosa A, 2014, CRIT REV FOOD SCI NU; Granados-Soto V, 2000, PAIN, V85, P395, DOI 10.1016/S0304-3959(99)00281-X; Harada N, 2011, J NUTR BIOCHEM, V22, P1150, DOI 10.1016/j.jnutbio.2010.09.016; Hoshi N, 2010, MOL CELL, V37, P541, DOI 10.1016/j.molcel.2010.01.014; Huang HM, 2005, ANN NY ACAD SCI, V1042, P349, DOI 10.1196/annals.1338.032; Hubbard BP, 2013, SCIENCE, V339, P1216, DOI 10.1126/science.1231097; Kang OH, 2009, PHARMACOL RES, V59, P330, DOI 10.1016/j.phrs.2009.01.009; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 1997, P NATL ACAD SCI USA, V94, P10409, DOI 10.1073/pnas.94.19.10409; Kempermann G, 2008, TRENDS NEUROSCI, V31, P163, DOI 10.1016/j.tins.2008.01.002; Kim JY, 2009, NEURON, V63, P761, DOI 10.1016/j.neuron.2009.08.008; Kim YA, 2007, J MED FOOD, V10, P218, DOI 10.1089/jmf.2006.143; Kodali M, 2015, SCI REP-UK, V5, DOI 10.1038/srep08075; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Kulkarni SS, 2015, BBA-MOL BASIS DIS, V1852, P1114, DOI 10.1016/j.bbadis.2014.10.005; Madhyastha S, 2013, INT J DEV NEUROSCI, V31, P580, DOI 10.1016/j.ijdevneu.2013.06.010; Maurice T, 1997, EUR J PHARMACOL, V328, P9, DOI 10.1016/S0014-2999(97)83020-8; Menard C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00281; Moriya J, 2011, BIOL PHARM BULL, V34, P354, DOI 10.1248/bpb.34.354; Myhrer T, 2003, BRAIN RES REV, V41, P268, DOI 10.1016/S0165-0173(02)00268-0; Oh YC, 2009, AM J CHINESE MED, V37, P1203, DOI 10.1142/S0192415X09007600; Pallauf K, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/707421; Park HR, 2012, J BIOL CHEM, V287, P42588, DOI 10.1074/jbc.M112.406413; Perkins GA, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-17; Ramirez-Rodriguez G, 2014, NEUROSCIENCE, V260, P158, DOI 10.1016/j.neuroscience.2013.12.026; Ramirez-Rodriguez G, 2014, EXP GERONTOL, V60, P147, DOI 10.1016/j.exger.2014.10.014; Ramirez-Rodriguez G, 2012, NEUROSCI LETT, V530, P53, DOI 10.1016/j.neulet.2012.09.045; Russo MA, 2014, ENDOCR METAB IMMUNE, V14, P300, DOI 10.2174/1871530314666140709093305; Saharan S, 2013, J NEUROSCI RES, V91, P642, DOI 10.1002/jnr.23199; Sharma M, 2002, LIFE SCI, V71, P2489, DOI 10.1016/S0024-3205(02)02083-0; Singh CK, 2015, BBA-MOL BASIS DIS, V1852, P1178, DOI 10.1016/j.bbadis.2014.11.004; Sonmez U, 2007, NEUROSCI LETT, V420, P133, DOI 10.1016/j.neulet.2007.04.070; Stangl D, 2009, GENES NUTR, V4, P271, DOI 10.1007/s12263-009-0134-5; Toth LA, 2011, COMPARATIVE MED, V61, P314; Tsai SK, 2007, J VASC SURG, V46, P346, DOI 10.1016/j.jvs.2007.04.044; Um JH, 2010, DIABETES, V59, P554, DOI 10.2337/db09-0482; van Praag H, 2007, J NEUROSCI, V27, P5869, DOI 10.1523/JNEUROSCI.0914-07.2007; Vingtdeux V, 2010, J BIOL CHEM, V285, P9100, DOI 10.1074/jbc.M109.060061; Witte AV, 2014, J NEUROSCI, V34, P7862, DOI 10.1523/JNEUROSCI.0385-14.2014; Xu Y, 2007, BRAIN RES, V1162, P9, DOI 10.1016/j.brainres.2007.05.071; Zainuddin MSA, 2012, BRIT MED BULL, V103, P89, DOI 10.1093/bmb/lds021; Zordoky BNM, 2015, BBA-MOL BASIS DIS, V1852, P1155, DOI 10.1016/j.bbadis.2014.10.016	55	29	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145687	10.1371/journal.pone.0145687	http://dx.doi.org/10.1371/journal.pone.0145687			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26695764	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092500067
J	Shestov, AA; Mancuso, A; Lee, SC; Guo, LL; Nelson, DS; Roman, JC; Henry, PG; Leeper, DB; Blair, IA; Glickson, JD				Shestov, Alexander A.; Mancuso, Anthony; Lee, Seung-Cheol; Guo, Lili; Nelson, David S.; Roman, Jeffrey C.; Henry, Pierre-Gilles; Leeper, Dennis B.; Blair, Ian A.; Glickson, Jerry D.			Bonded Cumomer Analysis of Human Melanoma Metabolism Monitored by C-13 NMR Spectroscopy of Perfused Tumor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bioenergy; cancer biology; glucose metabolism; glutaminase; isotopic tracer; mathematical modeling; metabolism; mitochondrial metabolism; nuclear magnetic resonance (NMR); transport	MITOCHONDRIAL PYRUVATE CARRIER; KETOGLUTARATE GLUTAMATE EXCHANGE; CITRIC-ACID CYCLE; ALPHA-KETOGLUTARATE; HUMAN BRAIN; TCA CYCLE; IN-VIVO; GLIOMA-CELLS; RAT HEARTS; FLUX	A network model for the determination of tumor metabolic fluxes from C-13 NMR kinetic isotopomer data has been developed and validated with perfused human DB-1 melanoma cells carrying the BRAF V600E mutation, which promotes oxidative metabolism. The model generated in the bonded cumomer formalism describes key pathways of tumor intermediary metabolism and yields dynamic curves for positional isotopic enrichment and spin-spin multiplets. Cells attached to microcarrier beads were perfused with 26 mm [1,6-C-13(2)]glucose under normoxic conditions at 37 degrees C and monitored by C-13 NMR spectroscopy. Excellent agreement between model-predicted and experimentally measured values of the rates of oxygen and glucose consumption, lactate production, and glutamate pool size validated the model. ATP production by glycolytic and oxidative metabolism were compared under hyperglycemic normoxic conditions; 51% of the energy came from oxidative phosphorylation and 49% came from glycolysis. Even though the rate of glutamine uptake was approximate to 50% of the tricarboxylic acid cycle flux, the rate of ATP production from glutamine was essentially zero (no glutaminolysis). De novo fatty acid production was approximate to 6% of the tricarboxylic acid cycle flux. The oxidative pentose phosphate pathway flux was 3.6% of glycolysis, and three non-oxidative pentose phosphate pathway exchange fluxes were calculated. Mass spectrometry was then used to compare fluxes through various pathways under hyperglycemic (26 mm) and euglycemic (5 mm) conditions. Under euglycemic conditions glutamine uptake doubled, but ATP production from glutamine did not significantly change. A new parameter measuring the Warburg effect (the ratio of lactate production flux to pyruvate influx through the mitochondrial pyruvate carrier) was calculated to be 21, close to upper limit of oxidative metabolism.	[Shestov, Alexander A.; Lee, Seung-Cheol; Nelson, David S.; Roman, Jeffrey C.; Glickson, Jerry D.] Perelman Sch Med, Dept Radiol, Lab Mol Imaging, Philadelphia, PA 19104 USA; [Mancuso, Anthony] Perelman Sch Med, Dept Radiol, Philadelphia, PA 19104 USA; [Mancuso, Anthony] Perelman Sch Med, Abramson Comprehens Canc Ctr, Philadelphia, PA 19104 USA; [Glickson, Jerry D.] Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Guo, Lili; Blair, Ian A.] Perelman Sch Med, Dept Syst Pharmacol, Philadelphia, PA 19104 USA; [Henry, Pierre-Gilles] Univ Minnesota, Sch Med, Dept Radiol, Ctr Magnet Resonance Res, Minneapolis, MN 55455 USA; [Leeper, Dennis B.] Thomas Jefferson Univ, Dept Radiat Oncol, Philadelphia, PA 19107 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Minnesota System; University of Minnesota Twin Cities; Jefferson University	Shestov, AA (corresponding author), Univ Penn, Sch Med, Lab Mol Imaging, Dept Radiol, B-6 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.; Glickson, JD (corresponding author), Univ Penn, Dept Radiol, B-6 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	ashestov@mail.med.upenn.edu; glickson@mail.med.upenn.edu	Glickson, Jerry/AAR-7116-2021		National Institutes of Health [R01 CA129544, R01 CA172820]; NATIONAL CANCER INSTITUTE [R01CA172820, R01CA129544] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grants R01 CA129544 (to J. D. G.) and R01 CA172820 (to J. D. G.).	Beckmann N, 1995, CARBON 13 NMR SPECTR, P269; Befroy DE, 2014, NAT MED, V20, P98, DOI 10.1038/nm.3415; Berg J. M., 2002, BIOCHEMISTRY-US, P1; Berliner L. J., 1999, IN VIVO CARBON 13 NM, P1; Bricker DK, 2012, SCIENCE, V337, P96, DOI 10.1126/science.1218099; CHANCE EM, 1983, J BIOL CHEM, V258, P3785; CHATHAM JC, 1995, J BIOL CHEM, V270, P7999, DOI 10.1074/jbc.270.14.7999; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Fan J, 2014, NATURE, V510, P298, DOI 10.1038/nature13236; Fan J, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.65; FITZPATRICK SM, 1990, J CEREBR BLOOD F MET, V10, P170, DOI 10.1038/jcbfm.1990.32; Glickson J. D., 1996, ENCY NUCL MAGNETIC R, P1209; Gruetter R, 2001, AM J PHYSIOL-ENDOC M, V281, pE100, DOI 10.1152/ajpendo.2001.281.1.E100; Halestrap AP, 2012, CELL METAB, V16, P141, DOI 10.1016/j.cmet.2012.07.013; Hensley CT, 2015, J CLIN INVEST, V125, P495, DOI 10.1172/JCI79188; Hensley CT, 2013, J CLIN INVEST, V123, P3678, DOI 10.1172/JCI69600; Herzig S, 2012, SCIENCE, V337, P93, DOI 10.1126/science.1218530; HILL LL, 1991, CANCER RES, V51, P4937; Jeffrey FMH, 1999, AM J PHYSIOL-ENDOC M, V277, pE1111, DOI 10.1152/ajpendo.1999.277.6.E1111; Jones JG, 2001, AM J PHYSIOL-ENDOC M, V281, pE848, DOI 10.1152/ajpendo.2001.281.4.E848; Jucker BM, 1998, J BIOL CHEM, V273, P12187, DOI 10.1074/jbc.273.20.12187; Kaplon J, 2013, NATURE, V498, P109, DOI 10.1038/nature12154; Kunnecke B., 1995, CARBON 13 NMR SPECTR, P159; Le A, 2013, METHODS MOL BIOL, V1012, P213, DOI 10.1007/978-1-62703-429-6_14; LEEPER DB, 1994, INT J RADIAT ONCOL, V28, P935, DOI 10.1016/0360-3016(94)90114-7; Maher EA, 2012, NMR BIOMED, V25, P1234, DOI 10.1002/nbm.2794; MALLOY CR, 1987, FEBS LETT, V212, P58, DOI 10.1016/0014-5793(87)81556-9; Mancuso A, 2005, MAGN RESON MED, V54, P67, DOI 10.1002/mrm.20545; Mancuso A, 2004, BIOTECHNOL BIOENG, V87, P835, DOI 10.1002/bit.20191; MANCUSO A, 1990, BIO-TECHNOL, V8, P1282, DOI 10.1038/nbt1290-1282; MASON GF, 1995, J CEREBR BLOOD F MET, V15, P12, DOI 10.1038/jcbfm.1995.2; MASON GF, 1992, J CEREBR BLOOD F MET, V12, P434, DOI 10.1038/jcbfm.1992.61; MCNAMARA R, 1994, NMR BIOMED, V7, P237, DOI 10.1002/nbm.1940070507; Mehrmohamadi M, 2014, CELL REP, V9, P1507, DOI 10.1016/j.celrep.2014.10.026; Mullen AR, 2014, CELL REP, V7, P1679, DOI 10.1016/j.celrep.2014.04.037; MUZYKANTOV VS, 1986, REACT KINET CATAL L, V32, P307, DOI 10.1007/BF02068328; PORTAIS JC, 1993, EUR J BIOCHEM, V217, P457, DOI 10.1111/j.1432-1033.1993.tb18265.x; Rajagopalan KN, 2011, J NUCL MED, V52, P1005, DOI 10.2967/jnumed.110.084244; Schug ZT, 2015, CANCER CELL, V27, P57, DOI 10.1016/j.ccell.2014.12.002; Scott DA, 2011, J BIOL CHEM, V286, P42626, DOI 10.1074/jbc.M111.282046; Shestov AA, 2013, ADV EXP MED BIOL, V765, P265, DOI 10.1007/978-1-4614-4989-8_37; Shestov AA, 2007, J NEUROSCI RES, V85, P3294, DOI 10.1002/jnr.21269; Shestov AA, 2014, ELIFE, V3, DOI 10.7554/eLife.03342; Shestov AA, 2013, WIRES SYST BIOL MED, V5, P733, DOI 10.1002/wsbm.1238; Shestov AA, 2012, NEUROCHEM RES, V37, P2388, DOI 10.1007/s11064-012-0782-5; SHUNGU DC, 1992, MAGN RESON MED, V28, P105, DOI 10.1002/mrm.1910280111; TANNOCK IF, 1989, CANCER RES, V49, P4373; VANZIJL PCM, 1991, P NATL ACAD SCI USA, V88, P3228, DOI 10.1073/pnas.88.8.3228; Wahl ML, 2002, MOL CANCER THER, V1, P617; WEISS RG, 1993, CIRCULATION, V87, P270, DOI 10.1161/01.CIR.87.1.270; Wiechert W, 1999, BIOTECHNOL BIOENG, V66, P69; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Yu X, 1995, BIOPHYS J, V69, P2090, DOI 10.1016/S0006-3495(95)80080-9	53	21	21	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					5157	5171		10.1074/jbc.M115.701862	http://dx.doi.org/10.1074/jbc.M115.701862			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26703469	Green Published, hybrid			2022-12-26	WOS:000371640600028
J	Angeler, DG; Allen, CR; Garmestani, AS; Gunderson, LH; Hjerne, O; Winder, M				Angeler, David G.; Allen, Craig R.; Garmestani, Ahjond S.; Gunderson, Lance H.; Hjerne, Olle; Winder, Monika			Quantifying the Adaptive Cycle	PLOS ONE			English	Article							BALTIC SEA; PEG-MODEL; PHYTOPLANKTON; RESILIENCE; ECOSYSTEM; PLANKTON; MECHANISMS; SUCCESSION; SYSTEMS	The adaptive cycle was proposed as a conceptual model to portray patterns of change in complex systems. Despite the model having potential for elucidating change across systems, it has been used mainly as a metaphor, describing system dynamics qualitatively. We use a quantitative approach for testing premises (reorganisation, conservatism, adaptation) in the adaptive cycle, using Baltic Sea phytoplankton communities as an example of such complex system dynamics. Phytoplankton organizes in recurring spring and summer blooms, a well-established paradigm in planktology and succession theory, with characteristic temporal trajectories during blooms that may be consistent with adaptive cycle phases. We used long-term (1994-2011) data and multivariate analysis of community structure to assess key components of the adaptive cycle. Specifically, we tested predictions about: reorganisation: spring and summer blooms comprise distinct community states; conservatism: community trajectories during individual adaptive cycles are conservative; and adaptation: phytoplankton species during blooms change in the long term. All predictions were supported by our analyses. Results suggest that traditional ecological paradigms such as phytoplankton successional models have potential for moving the adaptive cycle from a metaphor to a framework that can improve our understanding how complex systems organize and reorganize following collapse. Quantifying reorganization, conservatism and adaptation provides opportunities to cope with the intricacies and uncertainties associated with fast ecological change, driven by shifting system controls. Ultimately, combining traditional ecological paradigms with heuristics of complex system dynamics using quantitative approaches may help refine ecological theory and improve our understanding of the resilience of ecosystems.	[Angeler, David G.; Hjerne, Olle; Winder, Monika] Stockholm Univ, Dept Ecol Evolut & Plant Sci, SE-10691 Stockholm, Sweden; [Angeler, David G.] Swedish Univ Agr Sci, Dept Aquat Sci & Assessment, SE-75007 Uppsala, Sweden; [Allen, Craig R.] Univ Nebraska, US Geol Survey, Nebraska Cooperat Fish & Wildlife Res Unit, Lincoln, NE 68583 USA; [Garmestani, Ahjond S.] US EPA, Natl Risk Management Res Lab, Cincinnati, OH 45268 USA; [Gunderson, Lance H.] Emory Univ, Dept Environm Sci, Atlanta, GA 30322 USA	Stockholm University; Swedish University of Agricultural Sciences; United States Department of the Interior; United States Geological Survey; University of Nebraska System; University of Nebraska Lincoln; United States Environmental Protection Agency; Emory University	Angeler, DG (corresponding author), Stockholm Univ, Dept Ecol Evolut & Plant Sci, SE-10691 Stockholm, Sweden.	david.angeler@slu.se		Garmestani, Ahjond/0000-0001-5678-7293	Department of Ecology, Environment and Plant Sciences, Stockholm University; Stockholm University's Strategic Marine Environmental Research Programme on Baltic Ecosystem Adaptive Management (BEAM); BONUS project [BIO-C3]; EU; Swedish Research Council FORMAS [2014-1193]; Swedish Research Council VR [2014-5828]	Department of Ecology, Environment and Plant Sciences, Stockholm University; Stockholm University's Strategic Marine Environmental Research Programme on Baltic Ecosystem Adaptive Management (BEAM); BONUS project; EU(European Commission); Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas); Swedish Research Council VR(Swedish Research Council)	Financial support from the Department of Ecology, Environment and Plant Sciences, Stockholm University, and by Stockholm University's Strategic Marine Environmental Research Programme on Baltic Ecosystem Adaptive Management (BEAM) and from the BONUS project BIO-C3, funded jointly by the EU and FORMAS is acknowledged. Additional support was provided by grants from the Swedish Research Councils VR (2014-5828) and FORMAS (2014-1193). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel N, 2006, ECOL SOC, V11; Allen CR, 2016, JOURNAL OF APPLIED E; Allen CR, 2014, ECOSYSTEMS, V17, P578, DOI 10.1007/s10021-013-9744-2; Anderson M.J., 2005, PERMANOVA A FORTRAN; Angeler DG, 2016, J APPL ECOL, V53, P688, DOI 10.1111/1365-2664.12494; Angeler DG, 2014, AMBIO, V43, P113, DOI 10.1007/s13280-014-0566-z; Angeler DG, 2011, ECOL SOC, V16, DOI 10.5751/ES-04175-160305; Angeler DG, 2010, OECOLOGIA, V164, P231, DOI 10.1007/s00442-010-1640-2; [Anonymous], 2001, PANARCHY UNDERSTANDI; Bass B., 1998, ECOTARGETS GOAL FUNC, P193; Behrenfeld MJ, 2014, ANNU REV MAR SCI, V6, P167, DOI 10.1146/annurev-marine-052913-021325; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; Burkhard B, 2011, ECOL MODEL, V222, P2878, DOI 10.1016/j.ecolmodel.2011.05.016; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clements F.E, 1916, PLANT SUCCESSION ANA, DOI [10.5962/bhl.title.56234, DOI 10.5962/BHL.TITLE.56234]; Cumming GS, 2005, ECOL SOC, V10; Daedlow K, 2011, ECOL SOC, V16; Diamond J., 2005, COLLAPSE HOW SOCIETI; ELMGREN R, 1989, AMBIO, V18, P326; Gilpin R, 2000, THE CHALLENGE OF GLO; Grundmann P, 2012, ENERG POLICY, V48, P118, DOI 10.1016/j.enpol.2012.04.051; Gunderson L, 2010, ECOL SOC, V15; Gunderson LH, 2000, ANNU REV ECOL SYST, V31, P425, DOI 10.1146/annurev.ecolsys.31.1.425; Hajdu S., 2002, THESIS; HELCOM, 2008, MANUAL FOR MARINE MO; Hoglander H, 2004, MAR ECOL PROG SER, V283, P15, DOI 10.3354/meps283015; Holling C.S., 1986, SUSTAINABLE DEV BIOS, V14, P292; Hukkinen JI, 2012, ECOL SOC, V17, DOI 10.5751/ES-05241-170430; Jaanus A, 2011, BOREAL ENVIRON RES, V16, P191; Janssen F, 2004, MAR ECOL PROG SER, V275, P59, DOI 10.3354/meps275059; Jorgensen Sven E., 2007, P1, DOI 10.1016/B978-044453160-5/50001-5; Klais R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021567; Leibold MA, 2004, LIMNOL OCEANOGR, V49, P1278, DOI 10.4319/lo.2004.49.4_part_2.1278; Lyon C, 2013, RURAL SOCIOL, V78, P528, DOI 10.1111/ruso.12018; MacGill V, 2011, SYST RES BEHAV SCI, V28, P526, DOI 10.1002/sres.1121; Moen J, 2010, ECOL SOC, V15; Olenina I, 2006, BALT SEA ENV P, V106, P1; Osterblom H, 2007, ECOSYSTEMS, V10, P877, DOI 10.1007/s10021-007-9069-0; Paina L, 2012, HEALTH POLICY PLANN, V27, P365, DOI 10.1093/heapol/czr054; Sinclair K, 2014, AGR HUM VALUES, V31, P371, DOI 10.1007/s10460-014-9488-4; SOMMER U, 1981, ACTA OECOL-OEC GEN, V2, P327; SOMMER U, 1986, ARCH HYDROBIOL, V106, P433; Sommer U, 2012, ANNU REV ECOL EVOL S, V43, P429, DOI 10.1146/annurev-ecolsys-110411-160251; Suikkanen S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066475; Waaland JR, 2007, WAALAND JR ALGAE AND; Wasmund N, 2003, ICES J MAR SCI, V60, P177, DOI 10.1016/S1054-3139(02)00280-1; WILLEN T, 1962, OIKOS, V13, P169, DOI 10.2307/3565084; Winder M, 2010, PHILOS T R SOC B, V365, P3215, DOI 10.1098/rstb.2010.0125	48	17	20	7	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0146053	10.1371/journal.pone.0146053	http://dx.doi.org/10.1371/journal.pone.0146053			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA0TN	26716453	Green Published, gold, Green Accepted			2022-12-26	WOS:000367510500127
J	Forrester, GE; Flynn, RL; Forrester, LM; Jarecki, LL				Forrester, Graham E.; Flynn, Rebecca L.; Forrester, Linda M.; Jarecki, Lianna L.			Episodic Disturbance from Boat Anchoring Is a Major Contributor to, but Does Not Alter the Trajectory of, Long-Term Coral Reef Decline	PLOS ONE			English	Article							REGION-WIDE DECLINES; MULTIPLE STRESSORS; ECOLOGICAL SURPRISES; FISH COMMUNITIES; HABITAT; ECOSYSTEMS; RESILIENCE; ABUNDANCE; DYNAMICS; IMPACTS	Isolating the relative effects of episodic disturbances and chronic stressors on long-term community change is challenging. We assessed the impact of an episodic disturbance associated with human visitation (boat anchoring) relative to other drivers of long-term change on coral reefs. A one-time anchoring event at Crab Cove, British Virgin Islands, in 2004 caused rapid losses of coral and reef structural complexity that were equal to the cumulative decline over 23 years observed at an adjacent site. The abundance of small site-attached reef fishes dropped by approximately one quarter after the anchoring event, but this drop was not immediate and only fully apparent two years after the anchoring event. There was no obvious recovery from the impact, and no evidence that this episodic impact accelerated or retarded subsequent declines from other causes. This apparent lack of synergism between the effect of this episodic human impact and other chronic stressors is consistent with the few other long-term studies of episodic impacts, and suggests that action to mitigate anchor damage should yield predictable benefits.	[Forrester, Graham E.; Flynn, Rebecca L.; Jarecki, Lianna L.] Univ Rhode Isl, Dept Nat Resources Sci, Kingston, RI 02881 USA; [Forrester, Linda M.] Univ Rhode Isl, Dept Biol Sci, Kingston, RI 02881 USA	University of Rhode Island; University of Rhode Island	Forrester, GE (corresponding author), Univ Rhode Isl, Dept Nat Resources Sci, 1 Greenhouse Rd, Kingston, RI 02881 USA.	gforrester@uri.edu		Forrester, Graham/0000-0001-5253-773X	Falconwood Foundation; Nature Conservancy's Global Marine Initiative; US National Science Foundation [HSD 0527304]	Falconwood Foundation; Nature Conservancy's Global Marine Initiative; US National Science Foundation(National Science Foundation (NSF))	This work was supported by the Falconwood Foundation, The Nature Conservancy's Global Marine Initiative (http://www.nature.org/ourinitiatives/habitats/oceanscoasts/), US National Science Foundation (http://www.nsf.gov/) grant # HSD 0527304. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Filip L, 2011, GLOBAL CHANGE BIOL, V17, P2470, DOI 10.1111/j.1365-2486.2010.02385.x; Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; [Anonymous], 2007, PRAIRIE PERSPECTIVES; Ault TR, 1998, ECOL MONOGR, V68, P25, DOI 10.1890/0012-9615(1998)068[0025:SATPFO]2.0.CO;2; Ban SS, 2014, GLOBAL CHANGE BIOL, V20, P681, DOI 10.1111/gcb.12453; Bonin MC, 2011, ECOLOGY, V92, P1503, DOI 10.1890/10-0627.1; Bostrom-Einarsson L, 2013, J EXP MAR BIOL ECOL, V448, P85, DOI 10.1016/j.jembe.2013.06.017; Brown CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065765; Burgin S, 2011, BIODIVERS CONSERV, V20, P683, DOI 10.1007/s10531-011-0003-6; Burke LM, 2011, REEFS AT RISK REVISI; Caley MJ, 1996, J ANIM ECOL, V65, P414, DOI 10.2307/5777; Coker DJ, 2012, CORAL REEFS, V31, P919, DOI 10.1007/s00338-012-0920-1; Council WTaT, 2014, TRAVEL AND TOURISM E; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; Darling ES, 2008, ECOL LETT, V11, P1278, DOI 10.1111/j.1461-0248.2008.01243.x; Darling ES, 2010, CONSERV LETT, V3, P122, DOI 10.1111/j.1755-263X.2009.00089.x; Davenport J, 2006, ESTUAR COAST SHELF S, V67, P280, DOI 10.1016/j.ecss.2005.11.026; Dayton PK, 1972, COLLOQUIUM ON CONSER; Didham RK, 2007, TRENDS ECOL EVOL, V22, P489, DOI 10.1016/j.tree.2007.07.001; Doak DF, 2008, ECOLOGY, V89, P952, DOI 10.1890/07-0965.1; Flynn RL, 2015, BOAT ANCHORING CONTR; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Folt CL, 1999, LIMNOL OCEANOGR, V44, P864, DOI 10.4319/lo.1999.44.3_part_2.0864; Forrester G, 2015, J NAT CONSERV, V24, P1, DOI 10.1016/j.jnc.2015.01.002; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Gardner TA, 2005, ECOLOGY, V86, P174, DOI 10.1890/04-0141; GOENAGA C, 1991, INTERCIENCIA, V16, P12; Graham NAJ, 2009, BIODIVERS CONSERV, V18, P3325, DOI 10.1007/s10531-009-9633-3; Halpern BS, 2008, OCEAN COAST MANAGE, V51, P203, DOI 10.1016/j.ocecoaman.2007.08.002; Halpern BS, 2007, CONSERV BIOL, V21, P1301, DOI 10.1111/j.1523-1739.2007.00752.x; Hawkins JP, 2004, CONSERV BIOL, V18, P215, DOI 10.1111/j.1523-1739.2004.00328.x; Holbrook SJ, 2000, OECOLOGIA, V122, P109, DOI 10.1007/PL00008826; Holmstrup M, 2010, SCI TOTAL ENVIRON, V408, P3746, DOI 10.1016/j.scitotenv.2009.10.067; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Hughes TP, 1999, LIMNOL OCEANOGR, V44, P932, DOI 10.4319/lo.1999.44.3_part_2.0932; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jackson JBC, 2014, STATUS AND TRENDS OF; Johnstone RW, 1998, AMBIO, V27, P700; Lewis AR, 1998, J EXP MAR BIOL ECOL, V230, P91, DOI 10.1016/S0022-0981(98)00087-2; Lindenmayer DB, 2010, P NATL ACAD SCI USA, V107, P21957, DOI 10.1073/pnas.1015696107; LUCKHURST BE, 1978, MAR BIOL, V49, P317, DOI 10.1007/BF00455026; McCormick MI, 2012, P ROY SOC B-BIOL SCI, V279, P3899, DOI 10.1098/rspb.2012.0854; MCCORMICK MI, 1994, MAR ECOL PROG SER, V112, P87, DOI 10.3354/meps112087; Mora C, 2008, P R SOC B, V275, P767, DOI 10.1098/rspb.2007.1472; Nystrom M, 2000, TRENDS ECOL EVOL, V15, P413, DOI 10.1016/S0169-5347(00)01948-0; ODUM EP, 1985, BIOSCIENCE, V35, P419, DOI 10.2307/1310021; Ohlhorst SL, 1988, P 6 INT COR REEF S T, V2, P319; Paddack MJ, 2009, CURR BIOL, V19, P590, DOI 10.1016/j.cub.2009.02.041; Paine RT, 1998, ECOSYSTEMS, V1, P535, DOI 10.1007/s100219900049; Pandolfi JM, 2005, SCIENCE, V307, P1725, DOI 10.1126/science.1104258; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Piggott JJ, 2015, ECOL EVOL, V5, P1538, DOI 10.1002/ece3.1465; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Schutte VGW, 2010, MAR ECOL PROG SER, V402, P115, DOI 10.3354/meps08438; Souter D, 2008, STATUS OF CARIBBEAN, P1; Stewart-Oaten A, 2001, ECOL MONOGR, V71, P305, DOI 10.1890/0012-9615(2001)071[0305:TASVIE]2.0.CO;2; Syms C, 2000, ECOLOGY, V81, P2714, DOI 10.1890/0012-9658(2000)081[2714:DHSATD]2.0.CO;2; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Wackernagel M, 2002, P NATL ACAD SCI USA, V99, P9266, DOI 10.1073/pnas.142033699; Wilkinson C., 2008, STATUS OF CORAL REEF; Wilkinson CR, 2000, STATUS OF CORAL REEF	62	12	12	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0144498	10.1371/journal.pone.0144498	http://dx.doi.org/10.1371/journal.pone.0144498			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717208	Green Published, Green Submitted, gold			2022-12-26	WOS:000367510500011
J	Ishaq, SL; Kim, CJ; Reis, D; Wright, ADG				Ishaq, Suzanne L.; Kim, Christina J.; Reis, Doug; Wright, Andre-Denis G.			Fibrolytic Bacteria Isolated from the Rumen of North American Moose (Alces alces) and Their Use as a Probiotic in Neonatal Lambs	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; COMPLETE GENOME; MILK-YIELD; DAIRY-COWS; BACILLUS; DIVERSITY; CALVES; BIFIDOBACTERIA; ESTABLISHMENT; FERMENTATION	Fibrolytic bacteria were isolated from the rumen of North American moose (Alces alces), which eat a high-fiber diet of woody browse. It was hypothesized that fibrolytic bacteria isolated from the moose rumen could be used as probiotics to improve fiber degradation and animal production. Thirty-one isolates (Bacillus, n = 26; Paenibacillus, n = 1; and Staphylococcus, n = 4) were cultured from moose rumen digesta samples collected in Vermont. Using Sanger sequencing of the 16S rRNA gene, culturing techniques, and optical densities, isolates were identified and screened for biochemical properties important to plant carbohydrate degradation. Five isolates were selected as candidates for use as a probiotic, which was administered daily to neonate lambs for 9 weeks. It was hypothesized that regular administration of a probiotic to improve fibrolysis to neonate animals through weaning would increase the developing rumen bacterial diversity, increase animal production, and allow for long-term colonization of the probiotic species. Neither weight gain nor wool quality was improved in lambs given a probiotic, however, dietary efficiency was increased as evidenced by the reduced feed intake (and rearing costs) without a loss to weight gain. Experimental lambs had a lower acetate to propionate ratio than control lambs, which was previously shown to indicate increased dietary efficiency. Fibrolytic bacteria made up the majority of sequences, mainly Prevotella, Butyrivibrio, and Ruminococcus. While protozoal densities increased over time and were stable, methanogen densities varied greatly in the first six months of life for lambs. This is likely due to the changing diet and bacterial populations in the developing rumen.	[Ishaq, Suzanne L.; Kim, Christina J.; Wright, Andre-Denis G.] Univ Vermont, Coll Agr & Life Sci, Dept Anim Sci, Burlington, VT USA; [Reis, Doug] Univ Vermont, Dept Microbiol & Mol Genet, Coll Agr & Life Sci, Burlington, VT 05405 USA	University of Vermont; University of Vermont	Ishaq, SL (corresponding author), Montana State Univ, Dept Anim & Range Sci, Bozeman, MT 59717 USA.	suzanne.pellegrini@montana.edu	WRIGHT, ANDRE-DENIS/ABI-2584-2020	Ishaq, Suzanne/0000-0002-2615-8055	USDA National Institute of Food and Agriculture's Agriculture and Food Research Initiative [2013-67011-21152]	USDA National Institute of Food and Agriculture's Agriculture and Food Research Initiative	This project was funded by a Graduate Fellowship from the USDA National Institute of Food and Agriculture's Agriculture and Food Research Initiative (Grant #2013-67011-21152) to Suzanne Ishaq, http://nifa.usda.gov/grants. NIFA did not have any part in the concept, design, sample collection, or sample analysis of this project.	Abe F, 1995, J DAIRY SCI, V78, P2838, DOI 10.3168/jds.S0022-0302(95)76914-4; Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Aikman PC, 2011, J DAIRY SCI, V94, P2840, DOI 10.3168/jds.2010-3783; Archana A, 1997, ENZYME MICROB TECH, V21, P12, DOI 10.1016/S0141-0229(96)00207-4; AUSTIN PJ, 1989, J CHEM ECOL, V15, P1335, DOI 10.1007/BF01014834; Bandounas L, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-94; BELOVSKY GE, 1981, ECOLOGY, V62, P1020, DOI 10.2307/1937001; BELOVSKY GE, 1981, J MAMMAL, V62, P613, DOI 10.2307/1380408; Boyd J, 2011, J DAIRY SCI, V94, P4616, DOI 10.3168/jds.2010-3984; Carberry CA, 2012, APPL ENVIRON MICROB, V78, P4949, DOI 10.1128/AEM.07759-11; Chang ZL, 2008, CHINESE SCI BULL, V53, P1121, DOI 10.1007/s11434-008-0184-x; Chao A, 2003, ENVIRON ECOL STAT, V10, P429, DOI 10.1023/A:1026096204727; Chao A, 2010, PROGRAM USERS GUIDE; Committee on the Nutrient Requirements of Small Ruminants, 2007, N R C NUTRIENT REQUI, P384; Cotta M, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 4, THIRD EDITION, P1002, DOI 10.1007/0-387-30744-3_35; Dailey RN, 2008, VET PATHOL, V45, P19, DOI 10.1354/vp.45-1-19; Dehority B.A., 1986, P307; DEHORITY BA, 1976, APPL ENVIRON MICROB, V32, P703, DOI 10.1128/AEM.32.5.703-710.1976; DEHORITY BA, 1974, J PROTOZOOL, V21, P26, DOI 10.1111/j.1550-7408.1974.tb03612.x; Denman SE, 2007, FEMS MICROBIOL ECOL, V62, P313, DOI 10.1111/j.1574-6941.2007.00394.x; DURIX A, 1991, CAN J ANIM SCI, V71, P115, DOI 10.4141/cjas91-013; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Evans J, 2006, J MOL EVOL, V62, P785, DOI 10.1007/s00239-005-0176-2; FONTY G, 1987, J GEN MICROBIOL, V133, P1835; FRANZMANN A W, 1984, Journal of Wildlife Diseases, V20, P333; GASAWAY W C, 1974, Naturaliste Canadien (Quebec), V101, P227; Georgalaki MD, 2002, APPL ENVIRON MICROB, V68, P5891, DOI 10.1128/AEM.68.12.5891-5903.2002; Georgalaki MD, 2000, J APPL MICROBIOL, V88, P817, DOI 10.1046/j.1365-2672.2000.01055.x; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Gordon RE, 1973, THE GENUS BACILLUS, P283; Hobson P. N., 1997, RUMEN MICROBIAL ECOS, P661; Ishaq SL, 2014, MICROB ECOL, V68, P185, DOI 10.1007/s00248-014-0399-0; Ishaq SL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-212; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Kittelmann S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0047879; Kleta S, 2006, J APPL MICROBIOL, V101, P1357, DOI 10.1111/j.1365-2672.2006.03019.x; Kmet V, 1993, Arch Tierernahr, V44, P1, DOI 10.1080/17450399309386053; Kovacs N., 1928, IMMUNITATSFORSCH, V55, P311; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Kumar B, 2013, VET WORLD, V6, P14, DOI 10.5455/vetworld.2013.14-17; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; LAUKOVA A, 1992, ZBL MIKROBIOL, V147, P489, DOI 10.1016/S0232-4393(11)80322-7; Lee JC, 2008, INT J SYST EVOL MICR, V58, P612, DOI 10.1099/ijs.0.65350-0; Lopez S, 1999, ANIM FEED SCI TECH, V78, P1, DOI 10.1016/S0377-8401(98)00273-9; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; MAGLIONE G, 1992, APPL ENVIRON MICROB, V58, P3593, DOI 10.1128/AEM.58.11.3593-3597.1992; MINATO H, 1992, J GEN APPL MICROBIOL, V38, P447, DOI 10.2323/jgam.38.447; MOLVAR EM, 1993, OECOLOGIA, V94, P472, DOI 10.1007/BF00566961; Morgavi DP, 2012, BRIT J NUTR, V107, P388, DOI 10.1017/S0007114511002935; MORVAN B, 1994, FEMS MICROBIOL LETT, V117, P249, DOI 10.1111/j.1574-6968.1994.tb06775.x; Norouzian MA, 2001, TROP ANIM HEALTH PRO, V43, P1169; Odenyo AA, 2001, ANAEROBE, V7, P5, DOI 10.1006/anae.2000.0367; Pajarillo EA, 2015, ANIM FEED SCI TECHNO; Pattnaik P, 2001, J APPL MICROBIOL, V91, P636, DOI 10.1046/j.1365-2672.2001.01429.x; PAUL J, 1986, CURR SCI INDIA, V55, P710; Peter H., 1986, BERGEYS MANUAL SYSTE, V2, P1104; POE SE, 1971, J ANIM SCI, V32, P740; Prsteng KE, 2013, MICROB ECOL, V66, P840, DOI 10.1007/s00248-013-0279-z; Qiao GH, 2010, J ANIM PHYSIOL AN N, V94, P429, DOI 10.1111/j.1439-0396.2009.00926.x; Ripamonti B, 2011, ANAEROBE, V17, P97, DOI 10.1016/j.anaerobe.2011.05.001; Routledge Robert G., 2004, Alces, V40, P95; SAITO N, 1973, ARCH BIOCHEM BIOPHYS, V155, P290, DOI 10.1016/0003-9861(73)90117-3; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Seo JK, 2013, ASIAN AUSTRAL J ANIM, V26, P50, DOI 10.5713/ajas.2012.12506; Shannon C.E., 1949, MATH THEORY COMMUNIC, P144; Shimada Y, 2013, PLOS ONE, DOI [10.1371/journal.pone.0080604, DOI 10.1371/J0URNAL.P0NE.0080604]; Shipley Lisa A., 2010, Alces, V46, P1; Simmons JS, 1926, J INFECT DIS, V39, P209, DOI 10.1093/infdis/39.3.209; SINHA RN, 1983, J APPL BACTERIOL, V54, P1, DOI 10.1111/j.1365-2672.1983.tb01294.x; Suen G, 2011, J BACTERIOL, V193, P5574, DOI 10.1128/JB.05621-11; Sun P, 2010, J DAIRY SCI, V93, P5851, DOI 10.3168/jds.2010-3263; Sundset MA, 2008, NATURWISSENSCHAFTEN, V95, P741, DOI 10.1007/s00114-008-0381-0; Sylvester JT, 2004, J NUTR, V134, P3378, DOI 10.1093/jn/134.12.3378; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Van Soest P.J., 1982, NUTR ECOLOGY RUMINAN, V2nd, P488; Veith B, 2004, J MOL MICROB BIOTECH, V7, P204, DOI 10.1159/000079829; Veresegyhazy T, 2003, ACTA VET HUNG, V51, P189, DOI 10.1556/AVet.51.2003.2.7; Vlkova E, 2010, FOLIA MICROBIOL, V55, P390, DOI 10.1007/s12223-010-0066-x; Yanez-Ruiz DR, 2010, FEMS MICROBIOL ECOL, V72, P272, DOI 10.1111/j.1574-6941.2010.00852.x; Zuur AF, 2007, STAT BIOL HEALTH, P259	81	14	19	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0144804	10.1371/journal.pone.0144804	http://dx.doi.org/10.1371/journal.pone.0144804			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716685	Green Submitted, Green Published, gold			2022-12-26	WOS:000367510500016
J	Li, N; Richoux, R; Perruchot, MH; Boutinaud, M; Mayol, JF; Gagnaire, V				Li, Na; Richoux, Romain; Perruchot, Marie-Halene; Boutinaud, Marion; Mayol, Jean-Francois; Gagnaire, Valerie			Flow Cytometry Approach to Quantify the Viability of Milk Somatic Cell Counts after Various Physico-Chemical Treatments	PLOS ONE			English	Article							MAMMARY-GLAND; LYMPHOCYTE SUBPOPULATIONS; ESCHERICHIA-COLI; BOVINE; NEUTROPHIL; MASTITIS; CD14; MACROPHAGES; EXPRESSION; LEUKOCYTES	Flow cytometry has been used as a routine method to count somatic cells in milk, and to ascertain udder health and milk quality. However, few studies investigate the viability of somatic cells and even fewer at a subpopulation level to follow up how the cells can resist to various stresses that can be encountered during technological processes. To address this issue, a flow cytometry approach was used to simultaneously identify cell types of bovine milk using cell-specific antibodies and to measure the cell viability among the identified sub-populations by using a live/dead cell viability kit. Confirmation of the cell viability was performed by using conventional microscopy. Different physico-chemical treatments were carried out on standardized cell samples, such as heat treatment, various centrifugation rates and storage in milk or in PBS pH 7.4 for three days. Cytometry gating strategy was developed by using blood cell samples stored at 4 degrees C in PBS and milk cell samples heat-treated at 80 degrees C for 30 min as a control for the maximum (95.9%) and minimum (0.7%) values of cell viability respectively. Cell viability in the initial samples was 39.5% for all cells and varied for each cell population from 26.7% for PMNs, to 32.6% for macrophages, and 58.3% for lymphocytes. Regarding the physico-chemical treatments applied, somatic cells did not sustain heat treatment at 60 degrees C and 80 degrees C in contrast to changes in centrifugation rates, for which only the higher level, i. e. 5000xg led to a cell viability decrease, down to 9.4%, but no significant changes within the cell subpopulation distribution were observed. Finally, the somatic cells were better preserved in milk after 72h storage, in particular PMNs, that maintained a viability of 34.0 +/- 2.9% compared to 4.9 +/- 1.9% in PBS, while there was almost no changes for macrophages (41.7 +/- 5.7% in milk vs 31.2 +/- 2.4% in PBS) and lymphocytes (25.3 +/- 3.0% in milk vs 11.4 +/- 3.1% in PBS). This study provides a new array to better understand milk cell biology and to establish the relationship between the cell viability and the release of their endogenous enzymes in dairy matrix.	[Li, Na; Gagnaire, Valerie] INRA, UMR 1253, Sci & Technol Lait & OEuf, F-35042 Rennes, France; [Li, Na; Gagnaire, Valerie] Agrocampus Ouest, UMR 1253, Sci & Technol Lait & OEuf, F-35042 Rennes, France; [Li, Na; Richoux, Romain] Actalia, F-35009 Rennes, France; [Perruchot, Marie-Halene; Boutinaud, Marion] INRA, UMR 1348, Physiol Environm & Genet Anim & Syst Elevage, F-35590 St Gilles, France; [Perruchot, Marie-Halene; Boutinaud, Marion] Agrocampus Ouest, UMR 1348, Physiol Environm & Genet Anim & Syst Elevage, F-35000 Rennes, France; [Mayol, Jean-Francois] R&D TranscureBioserv, F-74160 Archamps, France	INRAE; Institut Agro; Agrocampus Ouest; INRAE; Institut Agro; Agrocampus Ouest	Gagnaire, V (corresponding author), INRA, UMR 1253, Sci & Technol Lait & OEuf, F-35042 Rennes, France.	valerie.gagnaire@rennes.inra.fr	Gagnaire, Valérie/V-1338-2017	Gagnaire, Valérie/0000-0003-3186-0620; Perruchot, Marie-Helene/0000-0002-6608-9445	Agence Nationale de la Recherche et de la Technologie [2011/0574]	Agence Nationale de la Recherche et de la Technologie(French National Research Agency (ANR))	Agence Nationale de la Recherche et de la Technologie funded the phD work of Na Li (Cifre contract reference 2011/0574), http://www.anrt.asso.fr/. JFM, with commercial affiliation R&D Transcure Bioservices, participated in the design of the study, the antibodies choices for flow cytometry and the corrections of the manuscript. No funding from R&D Transcure Bioservices was received for this study.	Albenzio M, 2011, J DAIRY RES, V78, P43, DOI 10.1017/S0022029910000798; Asai K, 2000, VET IMMUNOL IMMUNOP, V73, P233, DOI 10.1016/S0165-2427(00)00158-6; Blagitz MG, 2015, J DAIRY SCI, V98, P2401, DOI 10.3168/jds.2014-8727; Blagitz MG, 2015, J DAIRY RES, V82, P460, DOI 10.1017/S0022029915000308; Boisclair G, 2007, MED VET, V1, P45; Boulaaba A, 2011, SMALL RUMINANT RES, V97, P117, DOI 10.1016/j.smallrumres.2011.02.002; Burton JL, 2003, VET CLIN N AM-FOOD A, V19, P1, DOI 10.1016/S0749-0720(02)00073-7; CAPIAUMONT J, 1994, LAIT, V74, P127, DOI 10.1051/lait:1994211; Caroprese M, 2007, J DAIRY SCI, V90, P2767, DOI 10.3168/jds.2006-691; Dumas E, 2012, BBA-MOL CELL RES, V1823, P358, DOI 10.1016/j.bbamcr.2011.12.002; FAO, 1998, LAIT PROD LAIT NUTR; Harp JA, 2004, VET IMMUNOL IMMUNOP, V98, P69, DOI 10.1016/j.vetimm.2003.10.007; ISO, 2006, 14040 ISO, V2006, P1, DOI DOI 10.1136/BMJ.332.7550.1107; Kehrli ME, 2001, VET CLIN N AM-FOOD A, V17, P495, DOI 10.1016/S0749-0720(15)30003-7; Kelly AL, 2006, INT DAIRY J, V16, P563, DOI 10.1016/j.idairyj.2005.10.019; la Libera AMMP, 2015, VET RES, P46; Larsen LB, 2000, INT DAIRY J, V10, P67, DOI 10.1016/S0958-6946(00)00020-0; Lee JW, 2003, J DAIRY SCI, V86, P2382, DOI 10.3168/jds.S0022-0302(03)73832-6; Leitner G, 2000, J VET MED B, V47, P133, DOI 10.1046/j.1439-0450.2000.00329.x; Li N, 2014, DAIRY SCI TECHNOL, V94, P517, DOI 10.1007/s13594-014-0176-3; Lun S, 2007, REPROD DOMEST ANIM, V42, P126, DOI 10.1111/j.1439-0531.2006.00741.x; Mehne D, 2010, MILCHWISSENSCHAFT, V65, P235; Olechnowicz J, 2012, J VET MED SCI, V74, P681, DOI 10.1292/jvms.11-0506; Paape MJ, 1996, AM J VET RES, V57, P477; PAAPE MJ, 1979, J DAIRY SCI, V62, P135, DOI 10.3168/jds.S0022-0302(79)83215-4; Paape MJ, 2003, VET RES, V34, P597, DOI 10.1051/vetres:2003024; Piepers S, 2009, J DAIRY SCI, V92, P626, DOI 10.3168/jds.2008-1393; Schwarz D, 2011, J DAIRY SCI, V94, P5033, DOI 10.3168/jds.2011-4348; Sharma N, 2012, ASIAN J ANIM VET ADV, V7, P454, DOI 10.3923/ajava.2012.454.476; Sladek Z, 2006, COMP IMMUNOL MICROB, V29, P243, DOI 10.1016/j.cimid.2006.06.006; Sladek Z, 2006, ANAT HISTOL EMBRYOL, V35, P116, DOI 10.1111/j.1439-0264.2005.00647.x; Sladek Z, 2011, RES VET SCI, V90, P226, DOI 10.1016/j.rvsc.2010.06.017; WANG DIC, 1968, BIOTECHNOL BIOENG, V10, P641, DOI 10.1002/bit.260100509; Wauters J, 2012, RES VET SCI, V92, P132, DOI 10.1016/j.rvsc.2010.10.007; Yamaguchi T, 1999, J DAIRY SCI, V82, P1459, DOI 10.3168/jds.S0022-0302(99)75373-7	35	14	15	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0146071	10.1371/journal.pone.0146071	http://dx.doi.org/10.1371/journal.pone.0146071			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717151	Green Submitted, Green Published, gold			2022-12-26	WOS:000367510500131
J	Vernon, PJ; Schaub, LJ; Dallelucca, JJ; Pusateri, AE; Sheppard, FR				Vernon, Philip J.; Schaub, Leasha J.; Dallelucca, Jurandir J.; Pusateri, Anthony E.; Sheppard, Forest R.			Rapid Detection of Neutrophil Oxidative Burst Capacity is Predictive of Whole Blood Cytokine Responses	PLOS ONE			English	Article							NADPH OXIDASE; REPERFUSION INJURY; INTERFERON-GAMMA; T-CELLS; MECHANISMS; ISCHEMIA; ACCUMULATION	Background Maladaptive immune responses, particularly cytokine and chemokine-driven, are a significant contributor to the deleterious inflammation present in many types of injury and infection. Widely available applications to rapidly assess individual inflammatory capacity could permit identification of patients at risk for exacerbated immune responses and guide therapy. Here we evaluate neutrophil oxidative burst (NOX) capacity measured by plate reader to immuno-type Rhesus Macaques as an acute strategy to rapidly detect inflammatory capacity and predict maladaptive immune responses as assayed by cytokine array. Methods Whole blood was collected from anesthetized Rhesus Macaques (n = 25) and analyzed for plasma cytokine secretion (23-plex Luminex assay) and NOX capacity. For cytokine secretion, paired samples were either unstimulated or ex-vivo lipopolysaccharide (LPS)-stimulated (100 mu g/mL/24h). NOX capacity was measured in dihydrorhodamine-123 loaded samples following phorbol 12-myristate 13-acetate (PMA)/ionomycin treatment. Pearson's test was utilized to correlate NOX capacity with cytokine secretion, p< 0.05 considered significant. Results LPS stimulation induced secretion of the inflammatory molecules G-CSF, IL-1 beta, IL-1RA, IL6, IL-10, IL-12/23(p40), IL-18, MIP-1 alpha, MIP-1 beta, and TNF alpha. Although values were variable, several cytokines correlated with NOX capacity, p-values <= 0.0001. Specifically, IL-1 beta (r = 0.66), IL-6 (r = 0.74), the Th1-polarizing cytokine IL-12/23(p40) (r = 0.78), and TNF alpha (r = 0.76) were strongly associated with NOX. Conclusion NOX capacity correlated with Th1-polarizing cytokine secretion, indicating its ability to rapidly predict inflammatory responses. These data suggest that NOX capacity may quickly identify patients at risk for maladaptive immune responses and who may benefit from immuno-modulatory therapies. Future studies will assess the in-vivo predictive value of NOX in animal models of immune-mediated pathologies.	[Vernon, Philip J.; Schaub, Leasha J.; Sheppard, Forest R.] JBSA Ft Sam Houston, Naval Med Res Unit San Antonio, Duarte, CA 91010 USA; [Dallelucca, Jurandir J.] US Air Force, JBSA Ft Sam Houston, Houston, TX USA; [Pusateri, Anthony E.] US Army, Med Res & Mat Command, Ft Detrick, MD USA	Naval Medical Research Center (NMRC); United States Department of Defense; United States Air Force	Sheppard, FR (corresponding author), JBSA Ft Sam Houston, Naval Med Res Unit San Antonio, Duarte, CA 91010 USA.	forest.r.sheppard.mil@mail.mil			Department of Defense (DOD) Office of Naval Research (ONR) [G1017]	Department of Defense (DOD) Office of Naval Research (ONR)	This study was supported from funds from the Department of Defense (DOD) Office of Naval Research (ONR) under the work unit number G1017. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batal I, 2014, J LEUKOCYTE BIOL, V96, P283, DOI 10.1189/jlb.3A0113-033RR; Boehme AK, 2014, J STROKE CEREBROVASC, V23, pE271, DOI 10.1016/j.jstrokecerebrovasdis.2013.11.022; Brinkworth JF, 2014, CURR OPIN IMMUNOL, V31, P66, DOI 10.1016/j.coi.2014.09.008; Chen L, 2014, EXP DERMATOL, V23, P189, DOI 10.1111/exd.12346; Cuinn M, RECONSTITUTION DEFEC, P2438; Furmaga W, 2015, CLIN CHIM ACTA, V440, P87, DOI 10.1016/j.cca.2014.10.045; Gardiner GJ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00295; George PM, 2012, PHARMACOL THERAPEUT, V135, P44, DOI 10.1016/j.pharmthera.2012.03.006; Gibbons D, 2014, NAT MED, V20, P1206, DOI 10.1038/nm.3670; Globig AM, 2014, INFLAMM BOWEL DIS, V20, P2321, DOI 10.1097/MIB.0000000000000210; Hashiba M, 2015, J SURG RES, V194, P248, DOI 10.1016/j.jss.2014.09.033; Ioannou A, 2011, CLIN IMMUNOL, V141, P3, DOI 10.1016/j.clim.2011.07.001; Kasus-Jacobi A, 2015, J LEUKOCYTE BIOL, V97, P341, DOI 10.1189/jlb.3A0214-104RR; Kearns SR, 2001, J BONE JOINT SURG BR, V83B, P1202, DOI 10.1302/0301-620X.83B8.11754; Li QS, 2015, PLATELETS, V26, P453, DOI 10.3109/09537104.2014.934217; Li XR, 2015, MOL CELL BIOCHEM, V399, P167, DOI 10.1007/s11010-014-2243-8; Lumsdaine W, 2014, INJURY, V45, P1144, DOI 10.1016/j.injury.2014.04.019; Mitroulis I, 2015, PHARMACOL THERAPEUT, V147, P123, DOI 10.1016/j.pharmthera.2014.11.008; Najarian K, 2009, ENG MED BIOL SOC 200; Oestreich KJ, 2012, CURR OPIN IMMUNOL, V24, P191, DOI 10.1016/j.coi.2011.12.004; Pandey GS, 2014, J INTERF CYTOK RES, V34, P931, DOI 10.1089/jir.2012.0136; Pliyev BK, 2015, EUR J CELL BIOL, V94, P67, DOI 10.1016/j.ejcb.2014.11.001; Rao JH, 2014, CURR OPIN ORGAN TRAN, V19, P115, DOI 10.1097/MOT.0000000000000064; Raphael I, 2015, CYTOKINE, V74, P5, DOI 10.1016/j.cyto.2014.09.011; Richardson MP, 1998, J IMMUNOL METHODS, V219, P187, DOI 10.1016/S0022-1759(98)00136-7; Roos D, 2014, CLIN EXP IMMUNOL, V175, P139, DOI 10.1111/cei.12202; Rubartelli A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00398; Santos EOL, J PHARM TOXICOLOGICA; Segel GB, 2011, J LEUKOCYTE BIOL, V89, P359, DOI 10.1189/jlb.0910538; Simone S, 2014, FREE RADICAL BIO MED, V74, P263, DOI 10.1016/j.freeradbiomed.2014.07.003; Toss A, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2014.09.06; Valparaiso AP, 2015, J SURG RES, V194, P220, DOI 10.1016/j.jss.2014.10.025; Vernon PJ, 2013, J IMMUNOL, V190, P1372, DOI 10.4049/jimmunol.1201151; Wang H, 2014, IMMUNOL REV, V258, P30, DOI 10.1111/imr.12151; Wang QS, 2014, GLIA, V62, P2034, DOI 10.1002/glia.22724; Wong HR, 2014, CRIT CARE MED, V42, P781, DOI 10.1097/CCM.0000000000000106; Wong YC, 2015, SHOCK, V43, P157, DOI 10.1097/SHK.0000000000000279; Yeh WI, 2014, J NEUROIMMUNOL, V267, P20, DOI 10.1016/j.jneuroim.2013.12.001; Zaidi MR, 2011, CLIN CANCER RES, V17, P6118, DOI 10.1158/1078-0432.CCR-11-0482; Zhai Y, 2011, AM J TRANSPLANT, V11, P1563, DOI 10.1111/j.1600-6143.2011.03579.x	40	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0146105	10.1371/journal.pone.0146105	http://dx.doi.org/10.1371/journal.pone.0146105			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716449	gold, Green Submitted, Green Published			2022-12-26	WOS:000367510500135
J	Chang, C; Lu, J; Zhang, HP; Ma, CX; Sun, GL				Chang, Cheng; Lu, Jie; Zhang, Hai-Ping; Ma, Chuan-Xi; Sun, Genlou			Copy Number Variation of Cytokinin Oxidase Gene Tackx4 Associated with Grain Weight and Chlorophyll Content of Flag Leaf in Common Wheat	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; RICE ORYZA-SATIVA; FLUORESCENCE PARAMETERS; YIELD COMPONENTS; SENESCENCE; ACCUMULATION; EXPRESSION; 6-BENZYLAMINOPURINE; PHOTOSYNTHESIS; TRANSLATION	As the main pigment in photosynthesis, chlorophyll significantly affects grain filling and grain weight of crop. Cytokinin (CTK) can effectively increase chlorophyll content and chloroplast stability, but it is irreversibly inactivated by cytokinin oxidase (CKX). In this study, therefore, twenty-four pairs of primers were designed to identify variations of wheat CKX (Tackx) genes associated with flag leaf chlorophyll content after anthesis, as well as grain weight in 169 recombinant inbred lines (RIL) derived from Triticum aestivum Jing 411 x Hongmangchun 21. Results indicated variation of Tackx4, identified by primer pair T19-20, was proven to significantly associate with chlorophyll content and grain weight in the RIL population. Here, two Tackx4 patterns were identified: one with two co-segregated fragments (Tackx4-1/Tackx4-2) containing 618 bp and 620 bp in size (as in Jing 411), and another with no PCR product. The two genotypes were designated as genotype-A and genotype-B, respectively. Grain weight and leaf chlorophyll content at 5 similar to 15 days after anthesis (DAA) were significantly higher in genotype-A lines than those in genotype-B lines. Mapping analysis indicated Tackx4 was closely linked to Xwmc169 on chromosome 3AL, as well as co-segregated with a major quantitative trait locus (QTL) for both grain weight and chlorophyll content of flag leaf at 5 similar to 15 DAA. This QTL explained 8.9 similar to 22.3% phenotypic variations of the two traits across four cropping seasons. Among 102 wheat varieties, a third genotype of Tackx4 was found and designated as genotype-C, also having two co-segregated fragments, Tackx4-2 and Tackx4-3 (615bp). The sequences of three fragments, Tackx4-1, Tackx4-2, and Tackx4-3, showed high identity (>98%). Therefore, these fragments could be considered as different copies at Tackx4 locus on chromosome 3AL. The effect of copy number variation (CNV) of Tackx4 was further validated. In general, genotype-A contains both significantly higher grain weight and flag leaf chlorophyll content at 5 similar to 15 DAA than those in genotype-B and genotype-C, among 102 varieties under various environments.	[Chang, Cheng; Lu, Jie; Zhang, Hai-Ping; Ma, Chuan-Xi; Sun, Genlou] Anhui Agr Univ, Coll Agron, Key Lab Wheat Biol & Genet Improvement Southern Y, Minist Agr, Hefei 230036, Peoples R China; [Sun, Genlou] St Marys Univ, Dept Biol, Halifax, NS B3H 3C3, Canada	Anhui Agricultural University; Ministry of Agriculture & Rural Affairs; Saint Marys University - Canada	Zhang, HP (corresponding author), Anhui Agr Univ, Coll Agron, Key Lab Wheat Biol & Genet Improvement Southern Y, Minist Agr, Hefei 230036, Peoples R China.	zhhp20@163.com; genlou.sun@smu.ca			National Natural Science Foundation of China [31000705]; China Agriculture Research System [CARS-03]; Scientific Research Special Program of Agricultural Commonwealth [201203033-04]; Natural Science Foundation of Anhui Province [1508085MC57]; Agriculture Research System of Anhui Province [AHCYTX-02]; Jiangsu Collaborative Innovation Center for Modern Crop Production (JCIC); introduced leading talent research team for Universities in Anhui Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System; Scientific Research Special Program of Agricultural Commonwealth; Natural Science Foundation of Anhui Province(Natural Science Foundation of Anhui Province); Agriculture Research System of Anhui Province; Jiangsu Collaborative Innovation Center for Modern Crop Production (JCIC); introduced leading talent research team for Universities in Anhui Province	This work was supported by grants from the National Natural Science Foundation of China (31000705), the China Agriculture Research System (CARS-03), the Scientific Research Special Program of Agricultural Commonwealth (201203033-04), Natural Science Foundation of Anhui Province (1508085MC57), the Agriculture Research System of Anhui Province (AHCYTX-02), Jiangsu Collaborative Innovation Center for Modern Crop Production (JCIC) and the introduced leading talent research team for Universities in Anhui Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JS, 2006, J FOOD ENG, V77, P951, DOI 10.1016/j.jfoodeng.2005.08.024; Araus JL, 1997, PLANT PHYSIOL BIOCH, V35, P533; Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; AUSTIN RB, 1977, ANN BOT-LONDON, V41, P1309, DOI 10.1093/oxfordjournals.aob.a085419; Avenson TJ, 2005, P NATL ACAD SCI USA, V102, P9709, DOI 10.1073/pnas.0503952102; Huynh BL, 2012, PLANT MOL BIOL, V80, P299, DOI 10.1007/s11103-012-9949-3; BIDINGER F, 1977, NATURE, V270, P431, DOI 10.1038/270431a0; CATSKY J, 1993, BIOL PLANTARUM, V35, P393, DOI 10.1007/BF02928516; Chang C, 2010, MOL BREEDING, V25, P481, DOI 10.1007/s11032-009-9346-z; Chang C, 2007, EUPHYTICA, V154, P181, DOI 10.1007/s10681-006-9285-2; Chang C, 2011, EUPHYTICA, V179, P343, DOI 10.1007/s10681-011-0348-7; CLARKE SF, 1994, PLANT GROWTH REGUL, V14, P21, DOI 10.1007/BF00024137; Cuthbert JL, 2008, THEOR APPL GENET, V117, P595, DOI 10.1007/s00122-008-0804-5; Czyczylo-Mysza I, 2013, MOL BREEDING, V32, P189, DOI 10.1007/s11032-013-9862-8; Czyczylo-Mysza I, 2011, PLANT GENET RESOUR-C, V9, P291, DOI 10.1017/S1479262111000207; De La Torre CM, 2015, PLANT CELL REP, V34, P111, DOI 10.1007/s00299-014-1691-7; Ding XT, 2013, ACTA PHYSIOL PLANT, V35, P1427, DOI 10.1007/s11738-012-1182-9; Evans LT., 1993, CROP EVOLUTION ADAPT; Feng DS, 2008, PLANT MOL BIOL REP, V26, P143, DOI 10.1007/s11105-008-0033-8; Fischer RA, 1998, CROP SCI, V38, P1467, DOI 10.2135/cropsci1998.0011183X003800060011x; FLETCHER RA, 1971, PLANTA, V101, P88, DOI 10.1007/BF00387693; Galuszka P, 2004, EUR J BIOCHEM, V271, P3990, DOI 10.1111/j.1432-1033.2004.04334.x; Gandikota M, 2007, PLANT J, V49, P683, DOI 10.1111/j.1365-313X.2006.02983.x; Groos C, 2003, THEOR APPL GENET, V106, P1032, DOI 10.1007/s00122-002-1111-1; Gupta NK, 2000, CEREAL RES COMMUN, V28, P287; Han Y, 2007, GENETICS, V176, P2625, DOI 10.1534/genetics.107.073650; Hanikenne M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003707; Huang XQ, 2004, THEOR APPL GENET, V109, P933, DOI 10.1007/s00122-004-1708-7; Kamo K, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-79; Kang HW, 1998, PLANT MOL BIOL REP, V16, P90, DOI 10.1023/A:1007418606098; Kumar N, 2007, MOL BREEDING, V19, P163, DOI 10.1007/s11032-006-9056-8; Lee Eung Gwan, 2002, Journal of Plant Biology, V45, P71; Ma QH, 2009, PLANT CELL REP, V28, P1759, DOI 10.1007/s00299-009-0776-1; Ma X, 2011, PLANT MOL BIOL REP, V29, P98, DOI 10.1007/s11105-010-0209-x; Manly KF, 2001, MAMM GENOME, V12, P930, DOI 10.1007/s00335-001-1016-3; Monde RA, 2000, PLANT MOL BIOL, V44, P529, DOI 10.1023/A:1026540310934; Ookawa T, 2004, CROP SCI, V44, P2107, DOI 10.2135/cropsci2004.2107; Paradkar MR, 2001, J PLANT PHYSIOL, V158, P929, DOI 10.1078/0176-1617-00369; Ramesh K, 2002, J AGRON CROP SCI, V188, P102, DOI 10.1046/j.1439-037X.2002.00532.x; Riou-Khamlichi C, 1999, SCIENCE, V283, P1541, DOI 10.1126/science.283.5407.1541; Rosyara UR, 2010, EUPHYTICA, V174, P377, DOI 10.1007/s10681-010-0136-9; Schluter T, 2011, J PLANT PHYSIOL, V168, P694, DOI 10.1016/j.jplph.2010.10.004; Shao GQ, 2013, J PLANT NUTR SOIL SC, V176, P595, DOI 10.1002/jpln.201100185; Shao RX, 2012, J FOOD AGRIC ENVIRON, V10, P1451; Simons G, 1998, PLANT CELL, V10, P1055, DOI 10.1105/tpc.10.6.1055; Sukumaran S, 2015, THEOR APPL GENET, V128, P353, DOI 10.1007/s00122-014-2435-3; Swartzberg D, 2008, EUR J PLANT PATHOL, V120, P289, DOI 10.1007/s10658-007-9217-6; Todorova D, 2006, ACTA PHYSIOL PLANT, V28, P613, DOI 10.1007/s11738-006-0057-3; Vignesh M, 2013, J PLANT BIOCHEM BIOT, V22, P401, DOI 10.1007/s13562-012-0168-4; Wang FH, 2008, J PLANT PHYSIOL, V165, P324, DOI 10.1016/j.jplph.2006.11.006; Wang RX, 2009, THEOR APPL GENET, V118, P313, DOI 10.1007/s00122-008-0901-5; Wingler A, 1998, PLANT PHYSIOL, V116, P329, DOI 10.1104/pp.116.1.329; Wu FB, 1998, FIELD CROP RES, V56, P309, DOI 10.1016/S0378-4290(97)00108-1; Yang DL, 2007, J INTEGR PLANT BIOL, V49, P646, DOI 10.1111/j.1744-7909.2007.00443.x; Zalewski W, 2010, J EXP BOT, V61, P1839, DOI 10.1093/jxb/erq052; ZENG ZB, 1994, GENETICS, V136, P1457; ZENG ZB, 1993, P NATL ACAD SCI USA, V90, P10972, DOI 10.1073/pnas.90.23.10972; Zhang HaiPing, 2010, Acta Agronomica Sinica, V36, P1649, DOI 10.1016/S1875-2780(09)60077-8; Zhang JP, 2011, MOL BIOL REP, V38, P2337, DOI 10.1007/s11033-010-0367-9; Zhang K, 2009, CEREAL RES COMMUN, V37, P499, DOI 10.1556/CRC.37.2009.4.3; Zhang Lei, 2008, Scientia Agricultura Sinica, V41, P636; Zhang Lei, 2007, Acta Agronomica Sinica, V33, P1419; Zhang L, 2012, NEW PHYTOL, V195, P574, DOI 10.1111/j.1469-8137.2012.04194.x; Zhao H, 2007, PLANT GROWTH REGUL, V51, P149, DOI 10.1007/s10725-006-9157-8; Zmienko A, 2014, THEOR APPL GENET, V127, P1, DOI 10.1007/s00122-013-2177-7	65	26	28	5	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145970	10.1371/journal.pone.0145970	http://dx.doi.org/10.1371/journal.pone.0145970			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714276	gold, Green Published, Green Submitted			2022-12-26	WOS:000367481900107
J	Esterhammer, R; Seppi, K; Reiter, E; Pinter, B; Mueller, C; Kremser, C; Zitzelsberger, T; Nocker, M; Scherfler, C; Poewe, W; Schocke, M				Esterhammer, Regina; Seppi, Klaus; Reiter, Eva; Pinter, Bernadette; Mueller, Christoph; Kremser, Christian; Zitzelsberger, Tanja; Nocker, Michael; Scherfler, Christoph; Poewe, Werner; Schocke, Michael			Potential of Diffusion Tensor Imaging and Relaxometry for the Detection of Specific Pathological Alterations in Parkinson's Disease (PD)	PLOS ONE			English	Article							MULTIPLE SYSTEM ATROPHY; SUBSTANTIA-NIGRA; IRON DEPOSITION; ALPHA-SYNUCLEIN; PATHOANATOMICAL CORRELATION; PUTAMINAL DEGENERATION; SIGNAL CHANGES; BASAL GANGLIA; NIGROSOME 1; BRAIN IRON	The purpose of the present study was to evaluate the potential of multimodal MR imaging including mean diffusivity (MD), fractional anisotropy (FA), relaxation rates R2 and R2* to detect disease specific alterations in Parkinson's Disease (PD). We enrolled 82 PD patients (PD-all) with varying disease durations (<= 5 years: PD <= 5, n = 43; >5 years: PD>5, n = 39) and 38 matched healthy controls (HC), receiving diffusion tensor imaging as well as R2 and R2* relaxometry calculated from multi-echo T2*-weighted and dual-echo TSE imaging, respectively. ROIs were drawn to delineate caudate nucleus (CN), putamen (PU), globus pallidus (GP) and substantia nigra (SN) on the co-registered maps. The SN was divided in 3 descending levels (SL 1-3). The most significant parameters were used for a flexible discrimination analysis (FDA) in a training collective consisting of 25 randomized subjects from each group in order to predict the classification of remaining subjects. PD-all showed significant increases in MD, R2 and R2* within SN and its subregions as well as in MD and R2* within different basal ganglia regions. Compared to the HC group, the PD <= 5 and the PD>5 group showed significant MD increases within the SN and its lower two subregions, while the PD <= 5 group exhibited significant increases in R2 and R2* within SN and its subregions, and tended to elevation within the basal ganglia. The PD>5 group had significantly increased MD in PU and GP, whereas the PD <= 5 group presented normal MD within the basal ganglia. FDA achieved right classification in 84% of study participants. Micro-structural damage affects primarily the SN of PD patients and in later disease stages the basal ganglia. Iron contents of PU, GP and SN are increased at early disease stages of PD.	[Esterhammer, Regina; Kremser, Christian; Zitzelsberger, Tanja; Schocke, Michael] Med Univ Innsbruck, Univ Hosp, Dept Radiol, A-6020 Innsbruck, Austria; [Seppi, Klaus; Reiter, Eva; Pinter, Bernadette; Mueller, Christoph; Nocker, Michael; Scherfler, Christoph; Poewe, Werner] Med Univ Innsbruck, Univ Hosp, Dept Neurol, A-6020 Innsbruck, Austria; [Zitzelsberger, Tanja] Univ Tubingen, Univ Hosp, Dept Radiol, D-72076 Tubingen, Germany	Medical University of Innsbruck; Medical University of Innsbruck; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Schocke, M (corresponding author), Med Univ Innsbruck, Univ Hosp, Dept Radiol, Anichstr 35, A-6020 Innsbruck, Austria.	michael.schocke@i-med.ac.at	Schocke, Michael/AAC-3666-2020	Scherfler, Christoph/0000-0002-4885-5265; Seppi, Klaus/0000-0001-6503-1455	Oesterreichische Nationalbank (Austrian Central Bank, Anniversary Fund) [14171]; Austrian Science Fund (FWF: Der Wissenschaftsfonds) [KLI82-B00]; Austrian Science Fund (FWF) [KLI 82] Funding Source: researchfish	Oesterreichische Nationalbank (Austrian Central Bank, Anniversary Fund); Austrian Science Fund (FWF: Der Wissenschaftsfonds); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported by funds of the Oesterreichische Nationalbank (Austrian Central Bank, Anniversary Fund, project number: 14171) and of the Austrian Science Fund (FWF: Der Wissenschaftsfonds, project number: KLI82-B00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by funds of the Oesterreichische Nationalbank (Austrian Central Bank, Anniversary Fund, project number: 14171) and of the Austrian Science Fund (FWF: Der Wissenschaftsfonds, project number: KLI82-B00).	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; ANTONINI A, 1993, NEUROLOGY, V43, P697, DOI 10.1212/WNL.43.4.697; Awasthi R, 2010, AM J NEURORADIOL, V31, P442, DOI 10.3174/ajnr.A1849; Baudrexel S, 2010, NEUROIMAGE, V51, P512, DOI 10.1016/j.neuroimage.2010.03.005; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Blazejewska AI, 2013, NEUROLOGY, V81, P534, DOI 10.1212/WNL.0b013e31829e6fd2; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Chan LL, 2007, J NEUROL NEUROSUR PS, V78, P1383, DOI 10.1136/jnnp.2007.121525; Collingwood JF, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00191; Delgado R, 2011, J MAGN RESON IMAGING; Desai SV, 2007, J MAGN RESON IMAGING, V25, P715, DOI 10.1002/jmri.20830; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; Du GW, 2011, MOVEMENT DISORD, V26, P1627, DOI 10.1002/mds.23643; FEARNLEY JM, 1990, BRAIN, V113, P1823, DOI 10.1093/brain/113.6.1823; GORELL JM, 1995, NEUROLOGY, V45, P1138, DOI 10.1212/WNL.45.6.1138; Gotz ME, 2004, ANN NY ACAD SCI, V1012, P193, DOI 10.1196/annals.1306.017; Graham JM, 2000, BRAIN, V123, P2423, DOI 10.1093/brain/123.12.2423; Gupta RK, 2012, NEURORADIOLOGY, V54, P565, DOI 10.1007/s00234-011-0952-1; Haacke EM, 2005, MAGN RESON IMAGING, V23, P1, DOI 10.1016/j.mri.2004.10.001; HASTIE T, 1994, J AM STAT ASSOC, V89, P1255, DOI 10.2307/2290989; HASTIE T, 1995, ANN STAT, V23, P73, DOI 10.1214/aos/1176324456; Hwang Onyou, 2013, Exp Neurobiol, V22, P11, DOI 10.5607/en.2013.22.1.11; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kraft E, 1999, ARCH NEUROL-CHICAGO, V56, P225, DOI 10.1001/archneur.56.2.225; Langkammer C, 2010, RADIOLOGY, V257, P455, DOI 10.1148/radiol.10100495; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Martin WRW, 2008, NEUROLOGY, V70, P1411, DOI 10.1212/01.wnl.0000286384.31050.b5; Mascalchi M, 2005, RADIOL MED, V109, P155; Menke RA, 2009, NEUROIMAGE, V47, P435, DOI 10.1016/j.neuroimage.2009.05.017; Mori F, 2008, ACTA NEUROPATHOL, V115, P453, DOI 10.1007/s00401-007-0316-4; Mueller C, 2014, NEUROLOGY, V82, P1752, DOI 10.1212/WNL.0000000000000398; Nowosielski M, 2011, NEURORADIOLOGY, V53, P291, DOI 10.1007/s00234-010-0808-0; Peel S, 2011, J MAGN RESON IMAGING; Peran P, 2010, BRAIN, V133, P3423, DOI 10.1093/brain/awq212; Pieper S, 2004, IEEE INT S BIOMED IM, V26, P632, DOI DOI 10.1109/ISBI.2004.1398617; Pieper S, 2006, P 3 IEEE INT S BIOM; Razek AAKA, 2011, ACAD RADIOL, V18, P70, DOI 10.1016/j.acra.2010.08.023; Reichmann H, 2010, NEURODEGENER DIS, V7, P284, DOI 10.1159/000314478; ROYSTON P, 1991, STAT MED, V10, P1283, DOI 10.1002/sim.4780100811; Scherfler C, 2013, BRAIN, V136, P3028, DOI 10.1093/brain/awt234; Schocke MFH, 2004, NEUROIMAGE, V21, P1443, DOI 10.1016/j.neuroimage.2003.12.005; Schocke MFH, 2002, NEUROLOGY, V58, P575, DOI 10.1212/WNL.58.4.575; Schwarz J, 1996, J NEUROL NEUROSUR PS, V60, P98, DOI 10.1136/jnnp.60.1.98; Schwarz ST, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093814; Schwarz ST, 2013, NEUROIMAGE-CLIN, V3, P481, DOI 10.1016/j.nicl.2013.10.006; Seppi K, 2005, CURR OPIN NEUROL, V18, P370, DOI 10.1097/01.wco.0000173141.74137.63; Seppi K, 2003, NEUROLOGY, V60, P922, DOI 10.1212/01.WNL.0000049911.91657.9D; Seppi K, 2006, MOVEMENT DISORD, V21, P847, DOI 10.1002/mds.20843; Seppi K, 2006, NEUROIMAGE, V31, P240, DOI 10.1016/j.neuroimage.2005.12.006; Sian-Hulsmann J, 2011, J NEUROCHEM, V118, P939, DOI 10.1111/j.1471-4159.2010.07132.x; Team R Development Core, 2009, R LANG ENV STAT COMP; Ulla M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057904; Vaillancourt DE, 2009, NEUROLOGY, V72, P1378, DOI 10.1212/01.wnl.0000340982.01727.6e; Wallis LI, 2008, J MAGN RESON IMAGING, V28, P1061, DOI 10.1002/jmri.21563; Xu SL, 2015, BIOMOLECULES, V5, P1122, DOI 10.3390/biom5021122; Yamada H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112411; Yoshikawa K, 2004, J NEUROL NEUROSUR PS, V75, P481, DOI 10.1136/jnnp.2003.021873; Zhang JQ, 2010, BRAIN RES, V1330, P124, DOI 10.1016/j.brainres.2010.03.036	62	12	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145493	10.1371/journal.pone.0145493	http://dx.doi.org/10.1371/journal.pone.0145493			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713760	gold, Green Published, Green Submitted			2022-12-26	WOS:000367481900047
J	Hayat, T; Aziz, A; Muhammad, T; Ahmad, B				Hayat, Tasawar; Aziz, Arsalan; Muhammad, Taseer; Ahmad, Bashir			Influence of Magnetic Field in Three-Dimensional Flow of Couple Stress Nanofluid over a Nonlinearly Stretching Surface with Convective Condition	PLOS ONE			English	Article							BOUNDARY-LAYER-FLOW; HEAT-TRANSFER; MHD FLOW; MASS-TRANSFER; VISCOUS-FLOW; FLUID; RADIATION; SHEET; SLIP; MAGNETOHYDRODYNAMICS	This article investigates the magnetohydrodynamic (MHD) three-dimensional flow of couple stress nanofluid subject to the convective boundary condition. Flow is generated due to a nonlinear stretching of the surface in two lateral directions. Temperature and nanoparticles concentration distributions are studied through the Brownian motion and thermophoresis effects. Couple stress fluid is considered electrically conducting through a non-uniform applied magnetic field. Mathematical formulation is developed via boundary layer approach. Nonlinear ordinary differential systems are constructed by employing suitable transformations. The resulting systems have been solved for the convergent series solutions of velocities, temperature and nanoparticles concentration profiles. Graphs are sketched to see the effects of different interesting flow parameters on the temperature and nanoparticles concentration distributions. Numerical values are computed to analyze the values of skin-friction coefficients and Nusselt number.	[Hayat, Tasawar; Aziz, Arsalan; Muhammad, Taseer] Quaid I Azam Univ, Dept Math, Islamabad 45320, Pakistan; [Hayat, Tasawar; Ahmad, Bashir] King Abdulaziz Univ, Fac Sci, Nonlinear Anal & Appl Math NAAM Res Grp, Jeddah, Saudi Arabia	Quaid I Azam University; King Abdulaziz University	Muhammad, T (corresponding author), Quaid I Azam Univ, Dept Math, Islamabad 45320, Pakistan.	taseer_qau@yahoo.com	Muhammad, Taseer/F-9103-2018; Hayat, Tasawar/A-3853-2013; Ahmad, Bashir/B-1977-2012; Hayat, Tasawar/Y-2524-2019	Muhammad, Taseer/0000-0002-0838-2731; Ahmad, Bashir/0000-0001-5350-2977; Aziz, Arsalan/0000-0002-1985-7392				Abbasbandy S, 2014, INT J NUMER METHOD H, V24, P390, DOI 10.1108/HFF-05-2012-0096; [Anonymous], 1995, ENHANCING THERMAL CO; Buongiorno J, 2006, J HEAT TRANS-T ASME, V128, P240, DOI 10.1115/1.2150834; Cortell R, 2008, PHYS LETT A, V372, P631, DOI 10.1016/j.physleta.2007.08.005; Cortell R, 2007, APPL MATH COMPUT, V184, P864, DOI 10.1016/j.amc.2006.06.077; Dong RY, 2015, MICROFLUID NANOFLUID, V19, P805, DOI 10.1007/s10404-015-1605-1; Dong RY, 2014, SCI REP-UK, V4, DOI 10.1038/srep06120; Ellahi R, 2015, INT J HEAT MASS TRAN, V81, P449, DOI 10.1016/j.ijheatmasstransfer.2014.10.041; Gireesha BJ, 2015, J NANOFLUIDS, V4, P474, DOI 10.1166/jon.2015.1177; Hayat T, 2015, J MOL LIQ, V212, P272, DOI 10.1016/j.molliq.2015.09.023; Hayat T, 2015, J MAGN MAGN MATER, V389, P48, DOI 10.1016/j.jmmm.2015.04.019; Hayat T, 2015, J MAGN MAGN MATER, V385, P222, DOI 10.1016/j.jmmm.2015.02.046; Hayat T, 2013, APPL MATH MECH-ENGL, V34, P167, DOI 10.1007/s10483-013-1661-9; Hayat T, 2009, NONLINEAR ANAL-REAL, V10, P966, DOI 10.1016/j.nonrwa.2007.11.020; Hayat T, 2015, Z NATURFORSCH A, V70, P225, DOI 10.1515/zna-2014-0331; Hayat T, 2015, J MAGN MAGN MATER, V395, P294, DOI 10.1016/j.jmmm.2015.07.092; Hayat T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127646; Hsiao KL, 2014, COMPUT FLUIDS, V104, P1, DOI 10.1016/j.compfluid.2014.08.001; Ibrahim W, 2013, COMPUT FLUIDS, V86, P433, DOI 10.1016/j.compfluid.2013.07.029; Khan WA, 2010, INT J HEAT MASS TRAN, V53, P2477, DOI 10.1016/j.ijheatmasstransfer.2010.01.032; Kuznetsov AV, 2014, INT J THERM SCI, V77, P126, DOI 10.1016/j.ijthermalsci.2013.10.007; Liao S., 2012, HOMOTOPY ANAL METHOD; Lin YH, 2014, INT J HEAT MASS TRAN, V77, P708, DOI 10.1016/j.ijheatmasstransfer.2014.06.028; Mabood F, 2015, J MAGN MAGN MATER, V374, P569, DOI 10.1016/j.jmmm.2014.09.013; Makinde OD, 2011, INT J THERM SCI, V50, P1326, DOI 10.1016/j.ijthermalsci.2011.02.019; Mukhopadhyay S, 2013, ALEX ENG J, V52, P563, DOI 10.1016/j.aej.2013.07.004; Mustafa M, 2015, J MOL LIQ, V211, P119, DOI 10.1016/j.molliq.2015.06.065; Mustafa M, 2015, IEEE T NANOTECHNOL, V14, P159, DOI 10.1109/TNANO.2014.2374732; Pujari S, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3139446; Ramzan M, 2013, EUR PHYS J PLUS, V128, DOI 10.1140/epjp/i2013-13049-5; Rana P, 2012, COMMUN NONLINEAR SCI, V17, P212, DOI 10.1016/j.cnsns.2011.05.009; Sheikholeslami M, 2014, J MOL LIQ, V194, P30, DOI 10.1016/j.molliq.2014.01.005; Sheikholeslami M, 2014, J MAGN MAGN MATER, V349, P188, DOI 10.1016/j.jmmm.2013.08.040; Sheikholeslami M, 2015, J MAGN MAGN MATER, V374, P36, DOI 10.1016/j.jmmm.2014.08.021; Srinivasacharya D, 2012, J APPL SCI ENG, V15, P415; STOKES VK, 1966, PHYS FLUIDS, V9, P1709, DOI 10.1063/1.1761925; Sui JZ, 2015, INT J HEAT MASS TRAN, V85, P1023, DOI 10.1016/j.ijheatmasstransfer.2015.02.014; Turkyilmazoglu M, 2014, INT J HEAT MASS TRAN, V72, P1, DOI 10.1016/j.ijheatmasstransfer.2014.01.009; Turkyilmazoglu M, 2012, CHEM ENG SCI, V84, P182, DOI 10.1016/j.ces.2012.08.029; Turkyilmazoglu M, 2012, COMMUN NONLINEAR SCI, V17, P4097, DOI 10.1016/j.cnsns.2012.01.030; Vajravelu K, 2001, APPL MATH COMPUT, V124, P281, DOI 10.1016/S0096-3003(00)00062-X; Wang ZL, 2013, SOFT MATTER, V9, P8697, DOI 10.1039/c3sm51456k; Zeeshan A, 2014, J COMPUT THEOR NANOS, V11, P646, DOI 10.1166/jctn.2014.3408; Zhang CL, 2015, APPL MATH MODEL, V39, P165, DOI 10.1016/j.apm.2014.05.023; Zhao YG, 2013, SOFT MATTER, V9, P7726, DOI 10.1039/c3sm27720h	45	64	64	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145332	10.1371/journal.pone.0145332	http://dx.doi.org/10.1371/journal.pone.0145332			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714259	Green Submitted, Green Published, gold			2022-12-26	WOS:000367481900035
J	Kikuta, A; Furukawa, E; Ogawa, R; Suganuma, N; Saitoh, M; Nishimaki, T; Katsumura, T; Oota, H; Kawamoto, T; Tatsukawa, H; Hashimoto, H; Hitomi, K				Kikuta, Ayaka; Furukawa, Eri; Ogawa, Ryota; Suganuma, Natsuki; Saitoh, Mai; Nishimaki, Toshiyuki; Katsumura, Takafumi; Oota, Hiroki; Kawamoto, Tadafumi; Tatsukawa, Hideki; Hashimoto, Hisashi; Hitomi, Kiyotaka			Biochemical Characterization of Medaka (Oryzias latipes) Transglutaminases, OlTGK1 and OlTGK2, as Orthologues of Human Keratinocyte-Type Transglutaminase	PLOS ONE			English	Article							IDENTIFICATION; PEPTIDE; DEATH; GENE	Calcium-dependent transglutaminases (TGs) are a family of enzymes that catalyze protein cross-linking and/or attachment of primary amines in a variety of organisms. Mammalian TGs are implicated in multiple biological events such as skin formation, blood coagulation, and extracellular matrix stabilization. Medaka (Oryzias latipes) has been used as a model fish to investigate the physiological functions of mammalian proteins. By analysis of the medaka genome, we found seven TGs orthologues, some of which apparently corresponded to the mammalian TG isozymes, TG1, TG2, and Factor XIII. All orthologues had preserved amino acid residues essential for enzymatic activity in their deduced primary structures. In this study, we analyzed biochemical properties of two orthologues (OlTGK1 and OlTGK2) of mammalian epithelium-specific TG (TG1) that are significantly expressed at the transcriptional level. Using purified recombinant proteins for OlTGK1 and OlTGK2, we characterized their catalytic reactions. Furthermore, immunohistochemical analyses of fish sections revealed higher expression in the pancreas (OTGK1), intervertebral disk (OlTGK2) and pharyngeal teeth (OlTGK2) as well as in the skin epidermis.	[Kikuta, Ayaka; Furukawa, Eri; Ogawa, Ryota; Suganuma, Natsuki; Saitoh, Mai; Tatsukawa, Hideki; Hitomi, Kiyotaka] Nagoya Univ, Grad Sch Pharmaceut Sci, Nagoya, Aichi 4648601, Japan; [Nishimaki, Toshiyuki; Katsumura, Takafumi; Oota, Hiroki] Kitasato Univ, Sch Med, Sagamihara, Kanagawa 2520734, Japan; [Kawamoto, Tadafumi] Tsurumi Univ, Sch Dent Med, Radioisotope Res Inst, Yokohama, Kanagawa 2308501, Japan; [Hashimoto, Hisashi] Nagoya Univ, Biosci & Biotechnol Ctr, Nagoya, Aichi 4648601, Japan	Nagoya University; Kitasato University; Tsurumi University; Nagoya University	Hitomi, K (corresponding author), Nagoya Univ, Grad Sch Pharmaceut Sci, Nagoya, Aichi 4648601, Japan.	hitomi@ps.nagoya-u.ac.jp	Tatsukawa, Hideki/AAE-8377-2020		Ministry of Education, Sports, Science and Technology (JSPS, KAKENHI, Japan) [23380200, 26292912]; Japanese Science and Technology agency [23380200, 26292912]	Ministry of Education, Sports, Science and Technology (JSPS, KAKENHI, Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japanese Science and Technology agency(Japan Science & Technology Agency (JST))	This work was supported by Grant-in-Aid for Scientific Research (B) (No. 23380200 and No. 26292912 to K.H.) from the Ministry of Education, Sports, Science and Technology (JSPS, KAKENHI, Japan), from the Japanese Science and Technology agency (to K.H.).	Bachle LA, 2000, J PEPT RES, V56, P47, DOI 10.1034/j.1399-3011.2000.00742.x; Barut BA, 2000, PHYSIOL GENOMICS, V2, P49, DOI 10.1152/physiolgenomics.2000.2.2.49; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Deasey S, 2013, CELL SIGNAL, V25, P2646, DOI 10.1016/j.cellsig.2013.08.016; Deasey S, 2012, AMINO ACIDS, V42, P1065, DOI 10.1007/s00726-011-1021-0; Eckert RL, 2014, PHYSIOL REV, V94, P383, DOI 10.1152/physrev.00019.2013; Eckert RL, 2005, J INVEST DERMATOL, V124, P481, DOI 10.1111/j.0022-202X.2005.23627.x; Fukui M, 2013, FEBS J, V280, P1420, DOI 10.1111/febs.12133; Hiiragi T, 1999, J BIOL CHEM, V274, P34148, DOI 10.1074/jbc.274.48.34148; Hitomi K, 2005, EUR J DERMATOL, V15, P313; Hitomi K, 2009, ANAL BIOCHEM, V394, P281, DOI 10.1016/j.ab.2009.07.039; Itoh M, 2013, J HISTOCHEM CYTOCHEM, V61, P793, DOI 10.1369/0022155413501676; Itoh M, 2011, J HISTOCHEM CYTOCHEM, V59, P180, DOI 10.1369/jhc.2010.957225; Kanchan K, 2015, CELL MOL LIFE SCI, V72, P3009, DOI 10.1007/s00018-015-1909-z; Kawamoto T, 2014, METHODS MOL BIOL, V1130, P149, DOI 10.1007/978-1-62703-989-5_11; Kinoshita M., 2012, MEDAKA BIOL MANAGEME; Kirchmaier S, 2015, GENETICS, V199, P905, DOI 10.1534/genetics.114.173849; Koh D, 2004, GENE EXPR PATTERNS, V4, P263, DOI 10.1016/j.modgep.2003.11.004; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Matsuki M, 1998, P NATL ACAD SCI USA, V95, P1044, DOI 10.1073/pnas.95.3.1044; Naruse K, 2011, MEDAKA: A MODEL FOR ORGANOGENESIS, HUMAN DISEASE, AND EVOLUTION, P19, DOI 10.1007/978-4-431-92691-7_2; Ponnusamy M, 2009, AM J PHYSIOL-RENAL, V297, pF1361, DOI 10.1152/ajprenal.00251.2009; Stieler M, 2013, ANGEW CHEM INT EDIT, V52, P11930, DOI 10.1002/anie.201305133; Sugimura Y, 2008, FEBS J, V275, P5667, DOI 10.1111/j.1742-4658.2008.06692.x	24	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0144194	10.1371/journal.pone.0144194	http://dx.doi.org/10.1371/journal.pone.0144194			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713442	gold, Green Submitted, Green Published			2022-12-26	WOS:000367481900005
J	Latham, K; Baranian, M; Timmis, M; Pardhan, S				Latham, Keziah; Baranian, Mohammad; Timmis, Matthew; Pardhan, Shahina			Emotional Health of People with Visual Impairment Caused by Retinitis Pigmentosa	PLOS ONE			English	Article							QUALITY-OF-LIFE; ICF ACTIVITY INVENTORY; SELF-MANAGEMENT; MACULAR DEGENERATION; VISION LOSS; DEPRESSION; AGE; DISABILITY; ADJUSTMENT; MORTALITY	Purpose To understand the emotional difficulties associated with living with the ocular condition Retinitis Pigmentosa, and to examine the functioning of a self-report instrument used to assess this construct. Methods The difficulty of goals and tasks in the emotional health domain of the Dutch ICF Activity Inventory were rated by 166 people with Retinitis Pigmentosa in a cross-sectional study. Demographic factors were also assessed. Results Responses to the 23 emotional health tasks were Rasch analysed and could be used to form either one 20 item overview scale with some multidimensionality, or three unidimensional subscales addressing feelings (4 items), communicating visual loss (5 items) and fatigue (7 items). The most difficult individual tasks related to communicating visual loss to other people, and dealing with feelings such as frustration, anxiety and stress. The use of mobility aids and female gender were associated with increased difficulty with emotional health, explaining 19% of the variance in the overview scale. Conclusions The emotional health domain of the Dutch ICF Activity Inventory is a valid tool to assess emotional difficulties arising from visual loss. Interventions to aid people with Retinitis Pigmentosa deal with emotional difficulties should particularly address communicating vision loss effectively to others and coping with negative feelings.	[Latham, Keziah] Anglia Ruskin Univ, Visual Funct & Physiol Res Grp, Cambridge, England; [Latham, Keziah; Baranian, Mohammad; Timmis, Matthew; Pardhan, Shahina] Anglia Ruskin Univ, Vis & Eye Res Unit, Cambridge, England; [Baranian, Mohammad; Timmis, Matthew] Anglia Ruskin Univ, Sport & Exercise Sci Res Grp, Cambridge, England	Anglia Ruskin University; Anglia Ruskin University; Anglia Ruskin University	Latham, K (corresponding author), Anglia Ruskin Univ, Visual Funct & Physiol Res Grp, Cambridge, England.	Keziah.latham@anglia.ac.uk	Pardhan, Shahina/AAZ-7509-2020; Latham, Keziah/ABC-5905-2021	Latham, Keziah/0000-0002-4060-0006	Anglia Ruskin University Bursary	Anglia Ruskin University Bursary	MB was supported by an Anglia Ruskin University Bursary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRICH D, 1978, PSYCHOMETRIKA, V43, P561, DOI 10.1007/BF02293814; Azoulay L, 2015, OPHTHALMIC RES, V54, P78, DOI 10.1159/000435886; Bittner AK, 2010, OPTOMETRY, V81, P461, DOI 10.1016/j.optm.2010.03.006; Bond T., 2001, APPL RASCH MODEL FUN; Brody BL, 2006, J AM GERIATR SOC, V54, P1557, DOI 10.1111/j.1532-5415.2006.00881.x; Brody BL, 2002, ARCH OPHTHALMOL-CHIC, V120, P1477, DOI 10.1001/archopht.120.11.1477; Bruijning J, 2012, OPTOMETRY VISION SCI, V89, P203, DOI 10.1097/OPX.0b013e31823e3217; Bruijning J, 2010, OPHTHAL EPIDEMIOL, V17, P366, DOI 10.3109/09286586.2010.528133; Bruijning JE, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0182-4; Bruijning JE, 2013, OPTOMETRY VISION SCI, V90, P806, DOI 10.1097/OPX.0b013e318282cdce; Bruijning JE, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-318; Bruijning JE, 2013, DEV DUTCH ICF ACTIVI; CARABELLESE C, 1993, J AM GERIATR SOC, V41, P401, DOI 10.1111/j.1532-5415.1993.tb06948.x; Christ SL, 2014, JAMA OPHTHALMOL, V132, P1400, DOI 10.1001/jamaophthalmol.2014.2847; De Leo D, 1999, PSYCHOSOMATICS, V40, P339, DOI 10.1016/S0033-3182(99)71229-6; Department of Health, 2013, CERT VIS IMP EXPL NO; Dogs Guide, 2014, MY GUID OP BUS 2014; Evans JR, 2007, OPHTHALMOLOGY, V114, P283, DOI 10.1016/j.ophtha.2006.10.006; Fahim AT, 1993, RETINITIS PIGMENTOSA; Gothwal VK, 2009, OPTOMETRY VISION SCI, V86, P1160, DOI 10.1097/OPX.0b013e3181bab10c; Guerin E, 2014, EYE, V28, P808, DOI 10.1038/eye.2014.66; HAIM M, 1992, ACTA OPHTHALMOL, V70, P417; Hayeems RZ, 2005, BRIT J OPHTHALMOL, V89, P615, DOI 10.1136/bjo.2003.036046; Herse Peter, 2005, Clin Exp Optom, V88, P335; Holloway EE, 2015, PATIENT EDUC COUNS, V98, P553, DOI 10.1016/j.pec.2015.01.013; Jangra D, 2007, OPHTHALMIC GENET, V28, P25, DOI 10.1080/13816810701201930; Karpa MJ, 2009, ARCH OPHTHALMOL-CHIC, V127, P1347, DOI 10.1001/archophthalmol.2009.240; Khadka J, 2013, OPTOMETRY VISION SCI, V90, P720, DOI 10.1097/OPX.0000000000000001; Kiser AK, 2008, CLIN EXP OPTOM, V91, P166, DOI 10.1111/j.1444-0938.2007.00224.x; Lam BL, 2008, ARCH OPHTHALMOL-CHIC, V126, P975, DOI 10.1001/archopht.126.7.975; Latham K, 2014, IMPLEMENTATION DUTCH; Latham K, 2015, INVEST OPHTH VIS SCI, V56, P2381, DOI 10.1167/iovs.14-16237; Latham K, 2013, OPTOMETRY VISION SCI, V90, P836, DOI 10.1097/OPX.0b013e31829d99ae; Liew G, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004015; Linacre J., 2015, RELIABILITY SEPARATI; Linacre J. M., 2015, DIF DPF BIAS INTERAC; Linacre JM, 2008, WINSTEPS RASCH MEASU; Linacre JM, 2014, DIMENSIONALITY INVES; Marella M, 2009, OPTOMETRY VISION SCI, V86, P826, DOI 10.1097/OPX.0b013e3181ae1b3f; Nyman SR, 2012, DISABIL REHABIL, V34, P971, DOI 10.3109/09638288.2011.626487; Pesudovs K, 2007, OPTOMETRY VISION SCI, V84, P663, DOI 10.1097/OPX.0b013e318141fe75; Piccinelli M, 2000, BRIT J PSYCHIAT, V177, P486, DOI 10.1192/bjp.177.6.486; Rees G, 2015, PATIENT EDUC COUNS, V98, P174, DOI 10.1016/j.pec.2014.11.008; Rovner BW, 1996, J AM GERIATR SOC, V44, P181, DOI 10.1111/j.1532-5415.1996.tb02436.x; Rovner BW, 2002, AM J GERIAT PSYCHIAT, V10, P305; Rovner BW, 2001, J AM GERIATR SOC, V49, P1097, DOI 10.1046/j.1532-5415.2001.49215.x; Rovner BW, 1998, J AM GERIATR SOC, V46, P617, DOI 10.1111/j.1532-5415.1998.tb01080.x; Senra H, 2015, OPHTHALMOLOGY, V122, P851, DOI 10.1016/j.ophtha.2014.10.022; Tabrett DR, 2012, INVEST OPHTH VIS SCI, V53, P7227, DOI 10.1167/iovs.12-10404; Waern M, 2002, BMJ-BRIT MED J, V324, P1355, DOI 10.1136/bmj.324.7350.1355; WHO, 2001, WHO INT CLASS FUNCT; Wright BD., 1994, RASCH MEASUREMENT T, V8, P370, DOI DOI 10.1177/01461672012710004	52	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145866	10.1371/journal.pone.0145866	http://dx.doi.org/10.1371/journal.pone.0145866			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA0IX	26713624	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000367481900094
J	Melzer, TR; Myall, DJ; MacAskill, MR; Pitcher, TL; Livingston, L; Watts, R; Keenan, RJ; Dalrymple-Alford, JC; Anderson, TJ				Melzer, Tracy R.; Myall, Daniel J.; MacAskill, Michael R.; Pitcher, Toni L.; Livingston, Leslie; Watts, Richard; Keenan, Ross J.; Dalrymple-Alford, John C.; Anderson, Tim J.			Tracking Parkinson's Disease over One Year with Multimodal Magnetic Resonance Imaging in a Group of Older Patients with Moderate Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; GREY-MATTER HYPOMETABOLISM; WHITE-MATTER; DIAGNOSTIC-CRITERIA; ALZHEIMERS-DISEASE; BRAIN ATROPHY; PERFUSION; RATES; MRI; RELIABILITY	Background & Objectives Cross-sectional magnetic resonance imaging (MRI) suggests that Parkinson's disease (PD) is associated with changes in cerebral tissue volume, diffusion tensor imaging metrics, and perfusion values. Here, we performed a longitudinal multimodal MRI study-including structural, diffusion tensor imaging (DTI), and perfusion MRI-to investigate progressive brain changes over one year in a group of older PD patients at a moderate stage of disease. Methods Twenty-three non-demented PD (mean age (SD) = 69.5 (6.4) years, disease duration (SD) = 5.6 (4.3) years) and 23 matched control participants (mean age: 70.6 (6.8)) completed extensive neuropsychological and clinical assessment, and multimodal 3T MRI scanning at baseline and one year later. We used a voxel-based approach to assess change over time and group-by-time interactions for cerebral structural and perfusion metrics. Results Compared to controls, in PD participants there was localized grey matter atrophy over time in bilateral inferior and right middle temporal, and left orbito-frontal cortices. Using a voxel-based approach that focused on the centers of principal white matter tracts, the PD and control cohorts exhibited similar levels of change in DTI metrics. There was no significant change in perfusion, cognitive, or motor severity measures. Conclusions In a cohort of older, non-demented PD participants, macrostructural MRI detected atrophy in the PD group compared with the control group in temporal and orbito-frontal cortices. Changes in diffusion MRI along principal white matter tracts over one year were found, but this was not differentially affected by PD.	[Melzer, Tracy R.; Myall, Daniel J.; MacAskill, Michael R.; Pitcher, Toni L.; Livingston, Leslie; Keenan, Ross J.; Dalrymple-Alford, John C.; Anderson, Tim J.] New Zealand Brain Res Inst, Christchurch, New Zealand; [Melzer, Tracy R.; MacAskill, Michael R.; Pitcher, Toni L.; Livingston, Leslie; Dalrymple-Alford, John C.; Anderson, Tim J.] Univ Otago, Dept Med, Christchurch, New Zealand; [Watts, Richard] Univ Vermont, Coll Med, Burlington, VT USA; [Keenan, Ross J.] Christchurch Radiol Grp, Christchurch, New Zealand; [Dalrymple-Alford, John C.] Univ Canterbury, Dept Psychol, Canterbury, New Zealand; [Anderson, Tim J.] Christchurch Hosp, Dept Neurol, Christchurch, New Zealand	University of Otago; University of Vermont; University of Canterbury; Christchurch Hospital New Zealand	Melzer, TR (corresponding author), New Zealand Brain Res Inst, Christchurch, New Zealand.	tracy.melzer@otago.ac.nz		Myall, Daniel/0000-0002-0032-6567; Pitcher, Toni/0000-0003-4661-5038	Neurological Foundation of New Zealand [1327-WF]; New Zealand Brain Research Institute; Canterbury Medical Research Foundation [12/01, 14/04]; Neurology Trust	Neurological Foundation of New Zealand; New Zealand Brain Research Institute; Canterbury Medical Research Foundation; Neurology Trust	This work was funded by the Neurological Foundation of New Zealand (http://www.neurological.org.nz) to TRM (No. 1327-WF) MRM, TLP, JCDA, and TJA; the New Zealand Brain Research Institute (www.nzbri.org) to TRM, MRM, and TJA; the Canterbury Medical Research Foundation (www.cmrf.org.nz) to TRM (No. 12/01 & 14/04), DJM, MRM, JCDA, and TJA; and the Neurology Trust to TJA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2013, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00197; Baba T, 2012, BRAIN, V135, P161, DOI 10.1093/brain/awr321; Beyer MK, 2007, J NEUROL NEUROSUR PS, V78, P254, DOI 10.1136/jnnp.2006.093849; Bohnen NI, 2011, J NUCL MED, V52, P848, DOI 10.2967/jnumed.111.089946; Borghammer P, 2010, BRAIN STRUCT FUNCT, V214, P303, DOI 10.1007/s00429-010-0246-0; Burton EJ, 2005, MOVEMENT DISORD, V20, P1571, DOI 10.1002/mds.20652; Camicioli R, 2011, MOVEMENT DISORD, V26, P1443, DOI 10.1002/mds.23700; Chetelat G, 2008, BRAIN, V131, P60, DOI 10.1093/brain/awm288; Compta Y, 2013, PARKINSONISM RELAT D, V19, P717, DOI 10.1016/j.parkreldis.2013.03.009; Dai WY, 2008, MAGN RESON MED, V60, P1488, DOI 10.1002/mrm.21790; Dalrymple-Alford JC, 2010, NEUROLOGY, V75, P1717, DOI 10.1212/WNL.0b013e3181fc29c9; Dalrymple-Alford JC, 2011, MOVEMENT DISORD, V26, P629, DOI 10.1002/mds.23592; Di Filippo M, 2010, J NEUROL NEUROSUR PS, V81, P204, DOI 10.1136/jnnp.2009.171769; Duncan GW, 2013, MOVEMENT DISORD, V28, P425, DOI 10.1002/mds.25352; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; Engvig A, 2012, HUM BRAIN MAPP, V33, P2390, DOI 10.1002/hbm.21370; Firbank MJ, 2005, J NEUROL NEUROSUR PS, V76, P1448, DOI 10.1136/jnnp.2004.058685; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Gonzalez-Redondo R, 2014, BRAIN, V137, P2356, DOI 10.1093/brain/awu159; Haller S, 2010, J ALZHEIMERS DIS, V22, P315, DOI 10.3233/JAD-2010-100840; Hanganu A, 2014, BRAIN, V137, P1120, DOI 10.1093/brain/awu036; Hattori T, 2012, HUM BRAIN MAPP, V33, P727, DOI 10.1002/hbm.21245; Hu MTM, 2001, J NEURAL TRANSM, V108, P571, DOI 10.1007/s007020170057; Huang CR, 2007, BRAIN, V130, P1834, DOI 10.1093/brain/awm086; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Ibarretxe-Bilbao N, 2012, MOVEMENT DISORD, V27, P1746, DOI 10.1002/mds.25240; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Jack CR, 2009, BRAIN, V132, P1355, DOI 10.1093/brain/awp062; Kamagata K, 2011, J MAGN RESON IMAGING, V33, P803, DOI 10.1002/jmri.22515; Lewis MM, 2009, EUR J NEUROL, V16, P475, DOI 10.1111/j.1468-1331.2008.02430.x; Ling J, 2012, HUM BRAIN MAPP, V33, P50, DOI 10.1002/hbm.21192; Litvan I, 2012, MOVEMENT DISORD, V27, P349, DOI 10.1002/mds.24893; Melzer TR, 2013, NEUROLOGY, V80, P1841, DOI 10.1212/WNL.0b013e3182929f62; Melzer TR, 2012, J NEUROL NEUROSUR PS, V83, P188, DOI 10.1136/jnnp-2011-300828; Melzer TR, 2011, BRAIN, V134, P845, DOI 10.1093/brain/awq377; Nishio Y, 2010, EUR J NEUROL, V17, P1090, DOI 10.1111/j.1468-1331.2010.02980.x; Osaki Y, 2009, MOVEMENT DISORD, V24, P1475, DOI 10.1002/mds.22623; Paviour DC, 2006, BRAIN, V129, P1040, DOI 10.1093/brain/awl021; Poudel GR, 2012, SLEEP, V35, P1085, DOI 10.5665/sleep.1994; Ramirez-Ruiz B, 2005, J NEUROL, V252, P1345, DOI 10.1007/s00415-005-0864-2; Rossi ME, 2014, ACAD RADIOL, V21, P64, DOI 10.1016/j.acra.2013.09.018; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Song SK, 2011, MOVEMENT DISORD, V26, P289, DOI 10.1002/mds.23477; Tabrizi SJ, 2011, LANCET NEUROL, V10, P31, DOI 10.1016/S1474-4422(10)70276-3; Tessa C, 2014, HUM BRAIN MAPP, V35, P3932, DOI 10.1002/hbm.22449; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Weintraub D, 2011, ARCH NEUROL-CHICAGO, V68, P1562, DOI 10.1001/archneurol.2011.725; Wen MC, 2015, PARKINSONISM RELAT D, V21, P483, DOI 10.1016/j.parkreldis.2015.02.014; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Wu B, 2014, J MAGN RESON IMAGING, V39, P402, DOI 10.1002/jmri.24175; Xu GF, 2010, NMR BIOMED, V23, P286, DOI 10.1002/nbm.1462	53	14	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0143923	10.1371/journal.pone.0143923	http://dx.doi.org/10.1371/journal.pone.0143923			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714266	gold, Green Published			2022-12-26	WOS:000367481900003
J	Natoli, L; Guy, RJ; Shephard, M; Causer, L; Badman, SG; Hengel, B; Tangey, A; Ward, J; Coburn, T; Anderson, D; Kaldor, J; Maher, L				Natoli, Lisa; Guy, Rebecca J.; Shephard, Mark; Causer, Louise; Badman, Steven G.; Hengel, Belinda; Tangey, Annie; Ward, James; Coburn, Tony; Anderson, David; Kaldor, John; Maher, Lisa		TTANGO Investigators	"I Do Feel Like a Scientist at Times": A Qualitative Study of the Acceptability of Molecular Point-Of-Care Testing for Chlamydia and Gonorrhoea to Primary Care Professionals in a Remote High STI Burden Setting	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; ABORIGINAL COMMUNITIES; NEISSERIA-GONORRHOEAE; SOUTH-AFRICA; RISK-FACTORS; HEALTH-CARE; TRACHOMATIS; PROGRAMS; GENEXPERT	Background Point-of-care tests for chlamydia (CT) and gonorrhoea (NG) could increase the uptake and timeliness of testing and treatment, contribute to improved disease control and reduce reproductive morbidity. The GeneXpert (Xpert CT/NG assay), suited to use at the point-of-care, is being used in the TTANGO randomised controlled trial (RCT) in 12 remote Australian health services with a high burden of sexually transmissible infections (STIs). This represents the first ever routine use of a molecular point-of-care diagnostic for STIs in primary care. The purpose of this study was to explore the acceptability of the GeneXpert to primary care staff in remote Australia. Methods In-depth qualitative interviews were conducted with 16 staff (registered or enrolled nurses and Aboriginal Health Workers/Practitioners) trained and experienced with GeneXpert testing. Interviews were digitally-recorded and transcribed verbatim prior to content analysis. Results Most participants displayed positive attitudes, indicating the test was both easy to use and useful in their clinical context. Participants indicated that point-of-care testing had improved management of STIs, resulting in more timely and targeted treatment, earlier commencement of partner notification, and reduced follow up efforts associated with client recall. Staff expressed confidence in point-of-care test results and treating patients on this basis, and reported greater job satisfaction. While point-of-care testing did not negatively impact on client flow, several found the manual documentation processes time consuming, suggesting that improved electronic connectivity and test result transfer between the GeneXpert and patient management systems could overcome this. Managing positive test results in a shorter time frame was challenging for some but most found it satisfying to complete episodes of care more quickly. Conclusions In the context of a RCT, health professionals working in remote primary care in Australia found the GeneXpert highly acceptable. These findings have implications for use in other primary care settings around the world.	[Natoli, Lisa; Guy, Rebecca J.; Causer, Louise; Badman, Steven G.; Kaldor, John; Maher, Lisa] UNSW Australia, Kirby Inst, Sydney, NSW, Australia; [Natoli, Lisa; Anderson, David] Burnet Inst, Melbourne, Vic, Australia; [Shephard, Mark] Flinders Univ S Australia, Int Ctr Point Of Care Testing, Adelaide, SA 5001, Australia; [Hengel, Belinda] Apunipima Cape York Hlth Council, Cairns, Qld, Australia; [Tangey, Annie] Ngaanyatjarra Hlth Serv, Alice Springs, NT, Australia; [Ward, James] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia; [Coburn, Tony] Queensland Aboriginal & Islander Hlth Council, Brisbane, Qld, Australia	University of New South Wales Sydney; Kirby Institute; Burnet Institute; Flinders University South Australia; South Australian Health & Medical Research Institute (SAHMRI)	Natoli, L (corresponding author), UNSW Australia, Kirby Inst, Sydney, NSW, Australia.	lisan@burnet.edu.au	Ward, James/ABD-1439-2020; Whiley, David M/E-8955-2011	Ward, James/0000-0002-2892-4542; Whiley, David M/0000-0001-5969-3161; Regan, David/0000-0002-2893-0969; Christopher, Fairley/0000-0001-9081-1664; Causer, Louise/0000-0002-8814-0678; Donovan, Basil/0000-0001-8851-4126; Shephard, Mark DS/0000-0002-9181-1874; Anderson, David/0000-0002-9969-3905; Badman, Steven G/0000-0003-4222-3176; Guy, Rebecca/0000-0002-2929-4634; Maher, Lisa/0000-0001-6020-6519; Hengel, Belinda/0000-0002-3013-7716; Tangey, Annie/0000-0003-0798-0542	National Health and Medical Research Council (NHMRC) [109902]; Australian Government Department of Health and Ageing	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing)	TTANGO is funded by a National Health and Medical Research Council (NHMRC) Project Grant #109902. The Kirby Institute receives funding from the Australian Government Department of Health and Ageing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; TTANGO is funded by a National Health and Medical Research Council (NHMRC) Project Grant #109902. The Kirby Institute receives funding from the Australian Government Department of Health and Ageing. We gratefully acknowledge the contribution to this work of the Victorian Operational Infrastructure Support Program received by the Burnet Institute.	Al-Humaidan OS, 2015, SAUDI MED J, V36, P1084, DOI 10.15537/smj.2015.9.12460; Alakarppa I, 2011, INT J MARKETING STUD, V3, P13; Benzaken AS, 2008, SEX TRANSM INFECT, V84, P297, DOI 10.1136/sti.2007.029462; Benzaken AS, 2006, SEX TRANSM INFECT, V82, pV26, DOI 10.1136/sti.2006.022566; Causer LM, 2013, STI AIDS WORLD C VIE; Causer LM, 2014, SEX HLTH; Cecil JA, 2001, J INFECT DIS, V184, P1216, DOI 10.1086/323662; Centre for Disease Control, 2008, NT GUID MAN SEX TRAN; Chikkodi SV, 2015, CL LYMPH MYELOM LEUK, V15, pS114, DOI 10.1016/j.clml.2015.03.014; Communicable Disease Control Directorate, 2006, GUID MAN SEX TRANSM; Detels R, 2011, SEX TRANSM DIS, V38, P503, DOI 10.1097/OLQ.0b013e318206c288; Drobniewski F, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19340; Engel N, 2015, TROP MED INT HEALTH, V20, P493, DOI 10.1111/tmi.12450; Engel N, 2015, EXPERT REV MOL DIAGN, V15, P71, DOI 10.1586/14737159.2015.960518; Fagan P, 2001, VENEREOLOGY, V14, P55; Farley TA, 2003, PREV MED, V36, P502, DOI 10.1016/S0091-7435(02)00058-0; Gibbs L, 2007, AUST NZ J PUBL HEAL, V31, P540, DOI 10.1111/j.1753-6405.2007.00140.x; Goldenberg SD, 2014, INFECT DIS THER; Guy R, 2015, SEX TRANSM INFECT, V91, P201, DOI 10.1136/sextrans-2014-051535; Guy R, 2012, SEX HEALTH, V9, P205, DOI 10.1071/SH11074; Guy RJ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-485; Hengel B, 2015, SEX HLTH; Hengel B, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1040; Holden RJ, 2010, J BIOMED INFORM, V43, P159, DOI 10.1016/j.jbi.2009.07.002; Hsieh YH, 2012, POINT CARE, V11, P126; Hsieh YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019263; Hsieh YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014144; Huang RL, 2008, MED J AUSTRALIA, V189, P442, DOI 10.5694/j.1326-5377.2008.tb02117.x; Korenromp EL, 2002, INT J STD AIDS, V13, P91, DOI 10.1258/0956462021924712; Lebina L, 2015, TUBERCULOSIS, V95, P625, DOI 10.1016/j.tube.2015.05.006; Lenthall S, 2009, AUST J RURAL HEALTH, V17, P208, DOI 10.1111/j.1440-1584.2009.01073.x; Lorent N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130179; Natoli L, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006922; Natoli LJ, 2011, PAPUA NEW GUINEA MED, V54, P123; Opie T, 2010, AUST J RURAL HEALTH, V18, P235, DOI 10.1111/j.1440-1584.2010.01161.x; Pai NP, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001306; Peeling RW, 2013, SEX TRANSM INFECT, V89, P115, DOI 10.1136/sextrans-2012-050617; Peeling RW, 2011, SEX TRANSM INFECT, V87, pII28, DOI 10.1136/sti.2010.047647; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Shephard M SB, 2014, GLOBAL POINT OF CARE, P527; Shephard Mark D S, 2006, Clin Biochem Rev, V27, P161; Speers DJ, 2013, J ANTIMICROB CHEMOTH; Tabrizi SN, 2013, J CLIN MICROBIOL, V51, P1945, DOI 10.1128/JCM.00806-13; Yarbrough AK, 2007, MED CARE RES REV, V64, P650, DOI 10.1177/1077558707305942	44	31	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145993	10.1371/journal.pone.0145993	http://dx.doi.org/10.1371/journal.pone.0145993			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713441	Green Published, gold			2022-12-26	WOS:000367481900109
J	Tzeng, HH; Hsu, CH; Chung, TH; Lee, WC; Lin, CH; Wang, WC; Hsiao, CY; Leu, YW; Wang, TH				Tzeng, Hui-Hung; Hsu, Chi-Hung; Chung, Ting-Hao; Lee, Wen-Chien; Lin, Chi-Hsien; Wang, Wan-Chen; Hsiao, Chen-Yu; Leu, Yu-Wei; Wang, Tzu-Hsien			Cell Signaling and Differential Protein Expression in Neuronal Differentiation of Bone Marrow Mesenchymal Stem Cells with Hypermethylated Salvador/Warts/Hippo (SWH) Pathway Genes	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; STROMAL CELLS; NEUROTROPHIC FACTOR; FACTOR RECEPTOR; MAP KINASE; PC12 CELLS; IN-VITRO; ACTIVATION; SURVIVAL; PROLIFERATION	Human mesenchymal stem cells (MSCs) modified by targeting DNA hypermethylation of genes in the Salvador/Warts/Hippo pathway were induced to differentiate into neuronal cells in vitro. The differentiated cells secreted a significant level of brain-derived neurotrophy factor (BDNF) and the expression of BDNF receptor tyrosine receptor kinase B (TrkB) correlated well with the secretion of BDNF. In the differentiating cells, CREB was active after the binding of growth factors to induce phosphorylation of ERK in the MAPK/ERK pathway. Downstream of phosphorylated CREB led to the functional maturation of differentiated cells and secretion of BDNF, which contributed to the sustained expression of pERK and pCREB. In summary, both PI3K/Akt and MAPK/ERK signaling pathways play important roles in the neuronal differentiation of MSCs. The main function of the PI3K/Akt pathway is to maintain cell survival during neural differentiation; whereas the role of the MAPK/ERK pathway is probably to promote the maturation of differentiated MSCs. Further, cellular levels of protein kinase C epsilon type (PKC-epsilon) and kinesin heavy chain (KIF5B) increased with time of induction, whereas the level of NME/NM23 nucleoside diphosphate kinase 1 (Nm23-H1) decreased during the time course of differentiation. The correlation between PKC-e and TrkB suggested that there is cross-talk between PKC-e and the PI3K/Akt signaling pathway.	[Tzeng, Hui-Hung; Hsu, Chi-Hung; Chung, Ting-Hao; Lee, Wen-Chien; Lin, Chi-Hsien; Wang, Wan-Chen; Hsiao, Chen-Yu; Wang, Tzu-Hsien] Natl Chung Cheng Univ, Dept Chem Engn, Syst Biol & Tissue Engn Res Ctr, Chiayi 621, Taiwan; [Leu, Yu-Wei] Natl Chung Cheng Univ, Dept Life Sci, Chiayi 621, Taiwan	National Chung Cheng University; National Chung Cheng University	Lee, WC (corresponding author), Natl Chung Cheng Univ, Dept Chem Engn, Syst Biol & Tissue Engn Res Ctr, Chiayi 621, Taiwan.	chmwcl@ccu.edu.tw		Lee, Wen-Chien/0000-0001-9041-1396				Barzilay R, 2008, STEM CELLS DEV, V17, P547, DOI 10.1089/scd.2007.0172; Blondheim NR, 2006, STEM CELLS DEV, V15, P141, DOI 10.1089/scd.2006.15.141; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Cai Q, 2009, NEUROSCIENTIST, V15, P78, DOI 10.1177/1073858408329511; Cheng CH, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-63; Greco SJ, 2007, STEM CELLS DEV, V16, P811, DOI 10.1089/scd.2007.0011; Greco SJ, 2008, BIOL PROCED ONLINE, V10, P90, DOI 10.1251/bpo147; Heo JS, 2007, STEM CELLS, V25, P3069, DOI 10.1634/stemcells.2007-0550; Hermann A, 2004, J CELL SCI, V117, P4411, DOI 10.1242/jcs.01307; Hermann Andreas, 2006, Expert Opin Biol Ther, V6, P653, DOI 10.1517/14712598.6.7.653; Kan I, 2007, NEUROSCI LETT, V419, P28, DOI 10.1016/j.neulet.2007.03.070; Kao SC, 2001, J BIOL CHEM, V276, P18169, DOI 10.1074/jbc.M008870200; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Kvezereli M, 2008, TRANSPL P, V40, P375, DOI 10.1016/j.transproceed.2008.01.014; Lee KD, 2004, HEPATOLOGY, V40, P1275, DOI 10.1002/hep.20469; Lu P, 2004, J NEUROSCI RES, V77, P174, DOI 10.1002/jnr.20148; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mishra A, 2009, PROTEOMICS, V9, P4017, DOI 10.1002/pmic.200800813; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Peltier J, 2007, DEV NEUROBIOL, V67, P1348, DOI 10.1002/dneu.20506; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Sossin WS, 2007, NAT NEUROSCI, V10, P537, DOI 10.1038/nn0507-537; Sung JY, 2001, J BIOL CHEM, V276, P13858, DOI 10.1074/jbc.M010610200; Tatard VM, 2007, BONE, V40, P360, DOI 10.1016/j.bone.2006.09.013; Teng IW, 2011, CANCER RES, V71, P4653, DOI 10.1158/0008-5472.CAN-10-3418; Tondreau T, 2004, DIFFERENTIATION, V72, P319, DOI 10.1111/j.1432-0436.2004.07207003.x; Tondreau T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-166; TRAVERSE S, 1992, BIOCHEM J, V288, P351, DOI 10.1042/bj2880351; Trzaska KA, 2007, STEM CELLS, V25, P2797, DOI 10.1634/stemcells.2007-0212; Trzaska KA, 2009, J NEUROCHEM, V110, P1058, DOI 10.1111/j.1471-4159.2009.06201.x; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Vignali G, 1997, J NEUROCHEM, V69, P1840; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Yan JX, 2000, ELECTROPHORESIS, V21, P3666, DOI 10.1002/1522-2683(200011)21:17<3666::AID-ELPS3666>3.0.CO;2-6; Zheng WH, 2004, J NEUROCHEM, V89, P844, DOI 10.1111/j.1471-4159.2004.02350.x	36	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145542	10.1371/journal.pone.0145542	http://dx.doi.org/10.1371/journal.pone.0145542			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713735	gold, Green Published, Green Submitted			2022-12-26	WOS:000367481900055
J	Choudhary, A; Sinha, S				Choudhary, Anshul; Sinha, Sudeshna			Balance of Interactions Determines Optimal Survival in Multi-Species Communities	PLOS ONE			English	Article							STABILITY; PROMOTES; SYNCHRONIZATION; BIODIVERSITY; DIVERSITY	We consider a multi-species community modelled as a complex network of populations, where the links are given by a random asymmetric connectivity matrix J, with fraction 1 - C of zero entries, where C reflects the over-all connectivity of the system. The non-zero elements of J are drawn from a Gaussian distribution with mean mu and standard deviation sigma. The signs of the elements J(ij) reflect the nature of density-dependent interactions, such as predatory-prey, mutualism or competition, and their magnitudes reflect the strength of the interaction. In this study we try to uncover the broad features of the inter-species interactions that determine the global robustness of this network, as indicated by the average number of active nodes (i.e. non-extinct species) in the network, and the total population, reflecting the biomass yield. We find that the network transitions from a completely extinct system to one where all nodes are active, as the mean interaction strength goes from negative to positive, with the transition getting sharper for increasing C and decreasing s. We also find that the total population, displays distinct non-monotonic scaling behaviour with respect to the product mu C, implying that survival is dependent not merely on the number of links, but rather on the combination of the sparseness of the connectivity matrix and the net interaction strength. Interestingly, in an intermediate window of positive mu C, the total population is maximal, indicating that too little or too much positive interactions is detrimental to survival. Rather, the total population levels are optimal when the network has intermediate net positive connection strengths. At the local level we observe marked qualitative changes in dynamical patterns, ranging from anti-phase clusters of period 2 cycles and chaotic bands, to fixed points, under the variation of mean mu of the interaction strengths. We also study the correlation between synchronization and survival, and find that synchronization does not necessarily lead to extinction. Lastly, we propose an effective low dimensional map to capture the behavior of the entire network, and this provides a broad understanding of the interplay of the local dynamical patterns and the global robustness trends in the network.	[Choudhary, Anshul; Sinha, Sudeshna] IISER Mohali, Dept Phys Sci, Manauli Po 140306, Punjab, India	Indian Institute of Science Education & Research (IISER) - Mohali	Sinha, S (corresponding author), IISER Mohali, Dept Phys Sci, Sect 81, Manauli Po 140306, Punjab, India.	sudeshna@iisermohali.ac.in		Choudhary, Anshul/0000-0001-6651-5224; Sinha, Sudeshna/0000-0002-1364-5276	Department of Biotechnology (DBT), India [BT/PR3260/BRB/10/967/2011]; project entitled: SysTB: A network program for resolving the intracellular dynamics of host-pathogen interactions in TB infection - Department of Biotechnology (DBT), India [BT/PR3260/BRB/10/967/2011]	Department of Biotechnology (DBT), India(Department of Biotechnology (DBT) India); project entitled: SysTB: A network program for resolving the intracellular dynamics of host-pathogen interactions in TB infection - Department of Biotechnology (DBT), India	SS was supported by funds from the Department of Biotechnology (DBT), India, Grant no. No. BT/PR3260/BRB/10/967/2011, project title "SysTB: A network program for resolving the intracellular dynamics of host-pathogen interactions in TB infection."; SS was supported by funds from a project entitled: SysTB: A network program for resolving the intracellular dynamics of host-pathogen interactions in TB infection, funded by the Department of Biotechnology (DBT), India, Grant no. No. BT/PR3260/BRB/10/967/2011.	Allesina S, 2015, POPUL ECOL, V57, P63, DOI 10.1007/s10144-014-0471-0; Allesina S, 2012, NATURE, V483, P205, DOI 10.1038/nature10832; Amritkar RE, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.258102; Blasius B, 1999, NATURE, V399, P354, DOI 10.1038/20676; BROWN JH, 1977, ECOLOGY, V58, P445, DOI 10.2307/1935620; Cazelles B, 2001, P ROY SOC B-BIOL SCI, V268, P2595, DOI 10.1098/rspb.2001.1843; Choudhary A, 2014, EUR PHYS J B, V87, DOI 10.1140/epjb/e2014-50382-y; Dey S, 2006, SCIENCE, V312, P434, DOI 10.1126/science.1125317; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258; Jacopo G, 2015, PLOS COMPUT BIOL, V11.5; Kamal NK, 2011, CHAOS SOLITON FRACT, V44, P71, DOI 10.1016/j.chaos.2010.12.002; Kerr B, 2006, NATURE, V442, P75, DOI 10.1038/nature04864; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; Levins R., 1970, SOME MATH PROBLEMS B, P77; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; MAY RM, 1973, ECOLOGY, V54, P638, DOI 10.2307/1935352; Mougi A, 2012, SCIENCE, V337, P349, DOI 10.1126/science.1220529; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Reichenbach T, 2007, NATURE, V448, P1046, DOI 10.1038/nature06095; Scheffer M, 1997, ECOLOGY, V78, P272; Sinha S, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.020902; Sorrentino F, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.114101; Stephens PA, 1999, OIKOS, V87, P185, DOI 10.2307/3547011; Taylor CM, 2012, BIOL LETTERS, V8, P477, DOI 10.1098/rsbl.2011.0916	27	3	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145278	10.1371/journal.pone.0145278	http://dx.doi.org/10.1371/journal.pone.0145278			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710077	Green Published, gold, Green Submitted			2022-12-26	WOS:000367451400033
J	Fajemila, OT; Langer, MR; Lipps, JH				Fajemila, Olugbenga T.; Langer, Martin R.; Lipps, Jere H.			Spatial Patterns in the Distribution, Diversity and Abundance of Benthic Foraminifera around Moorea (Society Archipelago, French Polynesia)	PLOS ONE			English	Article							INNER NERITIC SAND; CORAL-REEFS; NATURAL DISTURBANCES; PAPUAN-LAGOON; MUD FACIES; ASSEMBLAGES; COMMUNITIES; VARIABILITY; ISLAND; ATOLL	Coral reefs are now subject to global threats and influences from numerous anthropogenic sources. Foraminifera, a group of unicellular shelled organisms, are excellent indicators of water quality and reef health. Thus we studied a set of samples taken in 1992 to provide a foraminiferal baseline for future studies of environmental change. Our study provides the first island-wide analysis of shallow benthic foraminifera from around Moorea (Society Archipelago). We analyzed the composition, species richness, patterns of distribution and abundance of unstained foraminiferal assemblages from bays, fringing reefs, nearshore and back-and fore-reef environments. A total of 380 taxa of foraminifera were recorded, a number that almost doubles previous species counts. Spatial patterns of foraminiferal assemblages are characterized by numerical abundances of individual taxa, cluster groups and gradients of species richness, as documented by cluster, Fisher a, ternary plot and Principal Component Analyses (PCA). The inner bay inlets are dominated by stress-tolerant, mostly thin-shelled taxa of Bolivina, Bolivinella, Nonionoides, Elongobula, and Ammonia preferring low-oxygen and/or nutrient-rich habitats influenced by coastal factors such as fresh-water runoff and overhanging mangroves. The larger symbiont-bearing foraminifera (Borelis, Amphistegina, Heterostegina, Peneroplis) generally live in the oligotrophic, well-lit back- and fore-reef environments. Amphisteginids and peneroplids were among the few taxa found in the bay environments, probably due to their preferences for phytal substrates and tolerance to moderate levels of eutrophication. The fringing reef environments along the outer bay are characterized by Borelis schlumbergeri, Heterostegina depressa, Textularia spp. and various miliolids which represent a hotspot of diversity within the complex reef-lagoon system of Moorea. The high foraminiferal Fisher a and species richness diversity in outer bay fringing reefs is consistent with the disturbance-mosaic (microhabitat heterogeneity) hypothesis. Calculations of the FORAM Index (FI), a single metric index to assess reef vitality, indicate that all fore- and most back-reef environments support active carbonate accretion and provide habitat suitability for carbonate producers dependent on algal symbiosis. Lowest suitability values were recorded within the innermost bays, an area where natural and increasing anthropogenic influences continue to impact the reefs. The presence of habitat specific assemblages and numerical abundance values of individual taxa show that benthic foraminifera are excellent recorders of environmental perturbations and good indicators useful in modern and ancient ecological and environmental studies.	[Fajemila, Olugbenga T.; Langer, Martin R.] Univ Bonn, Steinmann Inst Geol Mineral & Palaontol, Bonn, Germany; [Fajemila, Olugbenga T.] Osun State Univ, Dept Geol Sci, Osogbo, Nigeria; [Lipps, Jere H.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Lipps, Jere H.] Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA; [Lipps, Jere H.] JD Cooper Ctr, Santa Ana, CA USA	University of Bonn; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Langer, MR (corresponding author), Univ Bonn, Steinmann Inst Geol Mineral & Palaontol, Bonn, Germany.	martin.langer@uni-bonn.de	Fajemila, Olugbenga T./AAT-7453-2021	Fajemila, Olugbenga T./0000-0002-9949-0091; Lipps, Jere/0000-0003-0592-7537	Swiss Science Foundation [8220-028385]; Deutsche Forschungsgemeinschaft [La884/5-1, La884/5-2, La884/10-1]; TETFund, Nigeria; Committee on Research, UC Berkeley; Museum of Paleontology, Berkeley; UC Pacific Rim Project; German Science Foundation [La884/5-1, La884/5-2, La884/10-1]	Swiss Science Foundation(Swiss National Science Foundation (SNSF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); TETFund, Nigeria; Committee on Research, UC Berkeley; Museum of Paleontology, Berkeley; UC Pacific Rim Project; German Science Foundation(German Research Foundation (DFG))	Financial support for MRL was provided by the Swiss Science Foundation (#8220-028385) and the Deutsche Forschungsgemeinschaft (La884/5-1,5-2, 10-1). OTF was supported by the TETFund, Nigeria. JHL received support from the Committee on Research, UC Berkeley, the Museum of Paleontology, Berkeley, and the UC Pacific Rim Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; M. R. Langer and J. H. Lipps are grateful for the support of the Museum of Paleontology, Berkeley. Financial support for M. R. Langer also was provided by the Swiss Science Foundation (8220-028385) and the Deutsche Forschungsgemeinschaft. O. T. Fajemila gratefully acknowledges support by the TETFund, Nigeria. This study is part of the Shallow-Water Biogeographic Key Regions project and was supported by a grant from the German Science Foundation awarded to ML (La884/5-1,5-2, 10-1). J. H. Lipps thanks the Committee on Research, UC Berkeley, the Museum of Paleontology, Berkeley, and the UC Pacific Rim Project for support of this project. This is UC Museum of Paleontology publication 2070, and a University of California, Berkeley, Richard B. Gump Biological Research Station contribution.	Adjeroud M, 2005, AQUAT LIVING RESOUR, V18, P111, DOI 10.1051/alr:2005014; Adjeroud M, 1997, MAR ECOL PROG SER, V159, P105, DOI 10.3354/meps159105; Adjeroud M, 2002, MAR ECOL PROG SER, V237, P121, DOI 10.3354/meps237121; Adjeroud M, 2007, HYDROBIOLOGIA, V589, P117, DOI 10.1007/s10750-007-0726-2; Adjeroud M, 2007, J EXP MAR BIOL ECOL, V341, P204, DOI 10.1016/j.jembe.2006.10.048; Baccaert J., 1987, DISTRIBUTION PATTERN; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Barbosa CF, 2009, MAR MICROPALEONTOL, V73, P62, DOI 10.1016/j.marmicro.2009.07.002; Bernhard JM, 1999, MODERN FORAMINIFERA, P201; BERNHARD JM, 1986, J FORAMIN RES, V16, P207, DOI 10.2113/gsjfr.16.3.207; Bessat F, 2001, PALAEOGEOGR PALAEOCL, V175, P381, DOI 10.1016/S0031-0182(01)00381-9; Bicchi E, 2002, CORAL REEFS, V21, P275, DOI 10.1007/s00338-002-0245-6; BRADY HB, 1884, REPORT SCI RESULTS V, V9, P1; BRASIER M D, 1975, Journal of Foraminiferal Research, V5, P193; Caley MJ, 1997, ECOLOGY, p[78, 30]; CAMERON AM, 1991, MAR ECOL PROG SER, V75, P251, DOI 10.3354/meps075251; Carilli J, 2012, MAR ECOL PROG SER, V456, P87, DOI 10.3354/meps09684; CHAZOTTES V, 1995, PALAEOGEOGR PALAEOCL, V113, P189, DOI 10.1016/0031-0182(95)00043-L; Cushman J. A., 1933, Bulletin United States National Museum, V161, P1; Cushman J. A., 1932, Bulletin United States National Museum, V161, P1; CUSHMAN JOSEPH AUGUSTINE, 1942, BULL U S NATION MUS, V161, P1; Debenay JP, 2015, MAR POLLUT BULL, V93, P103, DOI 10.1016/j.marpolbul.2015.02.009; Debenay JP, 2000, MICROPALEONTOLOGY, V46, P153; Debenay JP, 2012, GUIDE 1000 FORAMINIF; DELESALLE B, 1992, CONT SHELF RES, V12, P939, DOI 10.1016/0278-4343(92)90053-M; DONE TJ, 1991, CORAL REEFS, V9, P183, DOI 10.1007/BF00290420; Engle V.D., 2000, EVALUATION GUIDELINE, V3, P1; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; Fujita K, 2015, ISL ARC, V24, P47, DOI 10.1111/iar.12069; GALZIN R, 1987, MAR ECOL PROG SER, V41, P137, DOI 10.3354/meps041137; GLEASON MG, 1993, CORAL REEFS, V12, P193, DOI 10.1007/BF00334479; Gleason MG, 1996, J EXP MAR BIOL ECOL, V207, P79, DOI 10.1016/S0022-0981(96)02647-0; HAIG DW, 1993, J FORAMIN RES, V23, P162, DOI 10.2113/gsjfr.23.3.162; HAIG DW, 1988, J FORAMIN RES, V18, P203, DOI 10.2113/gsjfr.18.3.203; Hallock P, 2003, ENVIRON MONIT ASSESS, V81, P221, DOI 10.1023/A:1021337310386; HALLOCK P, 1981, J SEDIMENT PETROL, V51, P467; Hallock P, 2000, MICROPALEONTOLOGY, V46, P95; HALLOCK P., 2012, INT COR REEF S CAIRN, P9; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harmelin-Vivien M.L., 1994, J COASTAL RES, V12, P211, DOI DOI 10.1111/NYAS.13322; Hayward B. W., 1999, I GEOLOGICAL NUCL SC, P1; Hodgson G, 1999, MAR POLLUT BULL, V38, P345, DOI 10.1016/S0025-326X(99)00002-8; HOEGHGULDBERG O, 1995, MAR ECOL PROG SER, V121, P181, DOI 10.3354/meps121181; Hottinger Lukas, 1993, Slovenska Akademija Znanosti in Umetnosti Razred za Naravoslovne Vede Dela, V33, P1; JOKIEL PL, 1990, CORAL REEFS, V8, P155, DOI 10.1007/BF00265006; Juhasz A, 2010, MAR POLLUT BULL, V60, P2251, DOI 10.1016/j.marpolbul.2010.08.011; Kelmo F, 2013, ECOL INDIC, V30, P148, DOI 10.1016/j.ecolind.2013.02.009; Koukousioura O, 2011, J MARINE SYST, V88, P489, DOI 10.1016/j.jmarsys.2011.06.004; Langer MR, 2008, J EUKARYOT MICROBIOL, V55, P163, DOI 10.1111/j.1550-7408.2008.00321.x; Langer MR, 2006, MICROPALEONTOLOGY, V52, P343, DOI 10.2113/gsmicropal.52.4.343; Langer MR, 2013, NEUES JAHRB GEOL P-A, V267, P155, DOI 10.1127/0077-7749/2013/0302; Langer MR, 2000, MICROPALEONTOLOGY, V46, P105; Langer MR, 1997, J FORAMIN RES, V27, P271, DOI 10.2113/gsjfr.27.4.271; Langer MR, 2003, CORAL REEFS, V22, P143, DOI 10.1007/s00338-003-0298-1; Le Calvez Y., 1980, CAH MICROPALEONTOL, V4, P1; Lenhardt X, 1991, THESIS; Lipps JH, 1999, MICROPALEONTOLOGY, V45, P278, DOI 10.2307/1486137; Lipps JH, 2011, PALEONTOL SOC PAPERS, V17, P139; Lobegeier MK, 2002, J FORAMIN RES, V32, P201, DOI 10.2113/32.3.201; Loeblich Alfred R. Jr, 1994, Cushman Foundation for Foraminiferal Research Special Publication, V31, P1; Loeblich AR., 1987, FORAMINIFERAL GENERA; Makled WA, 2011, NEUES JAHRB GEOL P-A, V259, P231, DOI 10.1127/0077-7749/2011/0119; MARIE PIERRE, 1940, BULL MUS NATION HIST NAT [PARIS], V12, P348; MARTIN RE, 1986, J FORAMIN RES, V16, P201, DOI 10.2113/gsjfr.16.3.201; Millett FW, 1898, J ROY MICROSC SOC, V5, P1; Murray, 1973, DISTRIBUTION ECOLOGY; Murray J. W., 1991, ECOLOGY PALEOECOLOGY; Parker JH, 2011, MAR MICROPALEONTOL, V78, P30, DOI 10.1016/j.marmicro.2010.09.007; Parker Justin H., 2009, Memoir of the Association of Australasian Palaeontologists, V36, P1; Parker WC, 1999, MODERN FORAMINIFERA, P71; PAYRI CE, 1987, BOT MAR, V30, P141, DOI 10.1515/botm.1987.30.2.141; Penin L, 2007, CR BIOL, V330, P171, DOI 10.1016/j.crvi.2006.12.003; Richard G., 1982, THESIS; Richard G., 1985, P 5 INT COR REEF C, V1, P379; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Salvat B., 1982, Proceedings of the International Coral Reef Symposium, P767; Salvat B., 1987, HUMAN IMPACTS CORAL, P166; Salvat B, 2008, REV ECOL-TERRE VIE, V63, P145; SCOTT D. B., 2001, MONITORING COASTAL E; SOURNIA A, 1976, MAR BIOL, V37, P29, DOI 10.1007/BF00386775; Stephenson CM, 2015, ECOL INDIC, V48, P1, DOI 10.1016/j.ecolind.2014.07.004; Todd R., 1965, B US NAT MUS, V161, P1; Trapon Melanie L., 2011, Journal of Marine Biology, V2011, P1, DOI 10.1155/2011/807625; Venec-Peyre M.-T., 1984, Bulletin Centre de Recherches Exploration-Production Elf-Aquitaine Memoire, P573; Venec-Peyre M.T., 1985, P 5 INT COR REEF S, V5, P227; Venec-Peyre MT, 1985, P 5 INT COR REEF C T, V1, P393; VENECPEYRE MT, 1987, CORAL REEFS, V5, P205, DOI 10.1007/BF00300966; VENECPEYRE MT, 1981, ANN I OCEANOGR PARIS, V57, P79; VENECPEYRE MT, 1991, CORAL REEFS, V9, P193, DOI 10.1007/BF00290421; VENECPEYRE MT, 1988, J FORAMIN RES, V18, P1; VERON JEN, 1995, CORALS SPACE TIME BI; Yanko V, 1999, MODERN FORAMINIFERA, P217; [No title captured]	93	42	45	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145752	10.1371/journal.pone.0145752	http://dx.doi.org/10.1371/journal.pone.0145752			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710320	gold, Green Published, Green Submitted			2022-12-26	WOS:000367451400076
J	Park, SH; Kim, HS; Park, MS; Moon, S; Song, MK; Park, HS; Hahn, H; Kim, SJ; Bae, E; Kim, HJ; Han, BW				Park, Sang Ho; Kim, Hyoun Sook; Park, Mi Seul; Moon, Sojin; Song, Mi Kyung; Park, Han Su; Hahn, Hyunggu; Kim, Soon-Jong; Bae, Euiyoung; Kim, Hyun-Jung; Han, Byung Woo			Structure and Stability of the Dimeric Triosephosphate Isomerase from the Thermophilic Archaeon Thermoplasma acidophilum	PLOS ONE			English	Article							TRIOSE-PHOSPHATE ISOMERASE; CRYSTAL-STRUCTURE; BACILLUS-STEAROTHERMOPHILUS; TIM; DEFICIENCY; THERMOSTABILITY; FEATURES; SUBSTITUTION; INTERFACE; PROTEINS	Thermoplasma acidophilum is a thermophilic archaeon that uses both non-phosphorylative Entner-Doudoroff (ED) pathway and Embden-Meyerhof-Parnas (EMP) pathway for glucose degradation. While triosephosphate isomerase (TPI), a well-known glycolytic enzyme, is not involved in the ED pathway in T. acidophilum, it has been considered to play an important role in the EMP pathway. Here, we report crystal structures of apo- and glycerol-3-phosphate-bound TPI from T. acidophilum (TaTPI). TaTPI adopts the canonical TIM-barrel fold with eight alpha-helices and parallel eight beta-strands. Although TaTPI shares similar to 30% sequence identity to other TPIs from thermophilic species that adopt tetrameric conformation for enzymatic activity in their harsh physiological environments, TaTPI exists as a dimer in solution. We confirmed the dimeric conformation of TaTPI by analytical ultracentrifugation and size-exclusion chromatography. Helix 5 as well as helix 4 of thermostable tetrameric TPIs have been known to play crucial roles in oligomerization, forming a hydrophobic interface. However, TaTPI contains unique charged-amino acid residues in the helix 5 and adopts dimer conformation. TaTPI exhibits the apparent T-d value of 74.6 degrees C and maintains its overall structure with some changes in the secondary structure contents at extremely acidic conditions (pH 1-2). Based on our structural and biophysical analyses of TaTPI, more compact structure of the protomer with reduced length of loops and certain patches on the surface could account for the robust nature of Thermoplasma acidophilum TPI.	[Park, Sang Ho; Kim, Hyoun Sook; Park, Mi Seul; Song, Mi Kyung; Park, Han Su; Hahn, Hyunggu; Han, Byung Woo] Seoul Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Seoul, South Korea; [Moon, Sojin; Bae, Euiyoung] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Kim, Soon-Jong] Mokpo Natl Univ, Dept Chem, Chungnam, South Korea; [Kim, Hyun-Jung] Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea	Seoul National University (SNU); Seoul National University (SNU); Mokpo National University; Chung Ang University	Han, BW (corresponding author), Seoul Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Seoul, South Korea.	bwhan@snu.ac.kr		Park, Mi Seul/0000-0003-2519-7121	Ministry of Science, ICT and Future Planning of Korea [NRF-2011-0030001, NRF-2013M-3A6A-4043695]	Ministry of Science, ICT and Future Planning of Korea	This work was supported by Ministry of Science, ICT and Future Planning of Korea; Grant number: NRF-2011-0030001 and NRF-2013M-3A6A-4043695 (Tumor Microenvironment Global Core Research Center and Global Frontier Project funded through the National Research Foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez M, 1999, J BIOL CHEM, V274, P19181, DOI 10.1074/jbc.274.27.19181; Alvarez M, 1998, J BIOL CHEM, V273, P2199, DOI 10.1074/jbc.273.4.2199; Arya R, 1997, HUM MUTAT, V10, P290; BORCHERT TV, 1993, EUR J BIOCHEM, V211, P703, DOI 10.1111/j.1432-1033.1993.tb17599.x; Celotto AM, 2006, GENETICS, V174, P1237, DOI 10.1534/genetics.106.063206; DAAR IO, 1986, P NATL ACAD SCI USA, V83, P7903, DOI 10.1073/pnas.83.20.7903; Dams T, 2000, J MOL BIOL, V297, P659, DOI 10.1006/jmbi.2000.3570; DELBONI LF, 1995, PROTEIN SCI, V4, P2594, DOI 10.1002/pro.5560041217; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gayathri P, 2007, ACTA CRYSTALLOGR D, V63, P206, DOI 10.1107/S0907444906046488; Gopal B, 1999, BIOCHEMISTRY-US, V38, P478, DOI 10.1021/bi981495w; HOLLAN S, 1993, HUM GENET, V92, P486, DOI 10.1007/BF00216456; John DM, 2000, PROTEIN SCI, V9, P1416, DOI 10.1110/ps.9.7.1416; KNOTT GD, 1979, COMPUT PROG BIOMED, V10, P271, DOI 10.1016/0010-468X(79)90075-8; Laue TM, 1995, METHOD ENZYMOL, V259, P427; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Maes D, 1999, PROTEINS, V37, P441, DOI 10.1002/(SICI)1097-0134(19991115)37:3<441::AID-PROT11>3.3.CO;2-Z; Mainfroid V, 1996, J MOL BIOL, V257, P441, DOI 10.1006/jmbi.1996.0174; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NOBLE MEM, 1993, PROTEINS, V16, P311, DOI 10.1002/prot.340160402; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Romero-Romero S, 2015, PHYS CHEM CHEM PHYS, V17, P20699, DOI 10.1039/c5cp01599e; Ruepp A, 2000, NATURE, V407, P508, DOI 10.1038/35035069; Schneider AS, 2000, BEST PRACT RES CL HA, V13, P119, DOI 10.1053/beha.2000.0061; Szilagyi A, 2000, STRUCTURE, V8, P493, DOI 10.1016/S0969-2126(00)00133-7; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Walden H, 2004, J MOL BIOL, V342, P861, DOI 10.1016/j.jmb.2004.07.067; Walden H, 2001, J MOL BIOL, V306, P745, DOI 10.1006/jmbi.2000.4433; Wierenga RK, 2010, CELL MOL LIFE SCI, V67, P3961, DOI 10.1007/s00018-010-0473-9; Wierenga RK, 2001, FEBS LETT, V492, P193, DOI 10.1016/S0014-5793(01)02236-0; Williams JC, 1999, PROTEIN ENG, V12, P243, DOI 10.1093/protein/12.3.243; Xiao L, 1999, J MOL BIOL, V289, P1435, DOI 10.1006/jmbi.1999.2810; ZHANG ZD, 1994, BIOCHEMISTRY-US, V33, P2830, DOI 10.1021/bi00176a012	35	0	0	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145331	10.1371/journal.pone.0145331	http://dx.doi.org/10.1371/journal.pone.0145331			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709515	Green Published, Green Submitted, gold			2022-12-26	WOS:000367451400037
J	Wang, FF; Okawa, H; Kamano, Y; Niibe, K; Kayashima, H; Osathanon, T; Pavasant, P; Saeki, M; Yatani, H; Egusa, H				Wang, Fangfang; Okawa, Hiroko; Kamano, Yuya; Niibe, Kunimichi; Kayashima, Hiroki; Osathanon, Thanaphum; Pavasant, Prasit; Saeki, Makio; Yatani, Hirofumi; Egusa, Hiroshi			Controlled Osteogenic Differentiation of Mouse Mesenchymal Stem Cells by Tetracycline-Controlled Transcriptional Activation of Amelogenin	PLOS ONE			English	Article							BONE SIALOPROTEIN BSP; IN-VITRO; OSTEOBLAST DIFFERENTIATION; RECOMBINANT AMELOGENIN; PERIODONTAL-LIGAMENT; OSTERIX EXPRESSION; CALCIUM-PHOSPHATE; MATRIX PROTEINS; GENE-EXPRESSION; STROMAL CELLS	Regenerative dental therapies for bone tissues rely on efficient targeting of endogenous and transplanted mesenchymal stem cells (MSCs) to guide bone formation. Amelogenin is the primary component of Emdogain, which is used to regenerate periodontal defects; however, the mechanisms underlying the therapeutic effects on alveolar bone remain unclear. The tetracycline (Tet)-dependent transcriptional regulatory system is a good candidate to investigate distinct roles of genes of interest during stem cell differentiation. Here, we investigated amelogenin-dependent regulation of osteogenesis in MSCs by establishing a Tet-controlled transcriptional activation system. Clonal mouse bone marrow-derived MSCs were lentivirally transduced with the Tet repressor (TetR) expression vector followed by drug selection to obtain MSCs constitutively expressing TetR (MSCs-TetR). Expression vectors that contained the Tet operator and amelogenin-coding (Amelx) cDNA fragments were constructed using the Gateway system and lentivirally introduced into MSCs-TetR to generate a Tet regulation system in MSCs (MSCs-TetR/Amelx). MSCs-TetR/Amelx significantly overexpressed the Amelx gene and protein in the presence of the tetracycline derivative doxycycline. Concomitant expression of osterix, bone sialoprotein (BSP), osteopontin, and osteocalcin was modulated by addition or removal of doxycycline under osteogenic guidance. During osteogenic induction, MSCs-TetR/Amelx treated with doxycycline showed significantly increased gene expression of osterix, type I collagen, BSP, and osteocalcin in addition to increased alkaline phosphatase activity and mineralized nodule formation. Enhanced extracellular matrix calcification was observed when forced Amelx expression commenced at the early stage but not at the intermediate or late stages of osteogenesis. These results suggest that a Tet-controlled Amelx gene regulation system for mouse MSCs was successfully established, in which transcriptional activation of Amelx was associated with enhanced osteogenic differentiation, especially in the early stage of biomineralization.	[Wang, Fangfang; Okawa, Hiroko; Kayashima, Hiroki; Yatani, Hirofumi; Egusa, Hiroshi] Osaka Univ, Grad Sch Dent, Dept Fixed Prosthodont, Suita, Osaka, Japan; [Okawa, Hiroko; Kamano, Yuya; Niibe, Kunimichi; Egusa, Hiroshi] Tohoku Univ, Grad Sch Dent, Div Mol & Regenerat Prosthodont, Sendai, Miyagi 980, Japan; [Osathanon, Thanaphum; Pavasant, Prasit] Chulalongkorn Univ, Fac Dent, Res Unit Mineralized Tissue, Bangkok, Thailand; [Saeki, Makio] Niigata Univ, Grad Sch Med & Dent Sci, Div Dent Pharmacol, Niigata, Japan	Osaka University; Tohoku University; Chulalongkorn University; Niigata University	Egusa, H (corresponding author), Osaka Univ, Grad Sch Dent, Dept Fixed Prosthodont, Suita, Osaka, Japan.	egu@dent.tohoku.ac.jp	Egusa, Hiroshi/AFT-9694-2022; wang, fang/GYD-4295-2022	Egusa, Hiroshi/0000-0002-0200-8132; Osathanon, Thanaphum/0000-0003-1649-6357	Japan Society for the Promotion of Science; National Research Council of Thailand; Grants-in-Aid for Scientific Research [24792151] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Research Council of Thailand(National Research Council of Thailand (NRCT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This investigation was supported in part by a Grant-in Aid for the 2013-2015 Bilateral Joint Research Projects from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/index.html) (HE) and the National Research Council of Thailand (http://www.nrct.go.th/) (PP) (no numbers for the grants).	BIANCO P, 1993, J HISTOCHEM CYTOCHEM, V41, P193, DOI 10.1177/41.2.8419459; Boabaid F, 2004, J PERIODONTOL, V75, P1126, DOI 10.1902/jop.2004.75.8.1126; Bonucci E, 2012, FRONT BIOSCI-LANDMRK, V17, P100, DOI 10.2741/3918; BROOKES SJ, 1995, ARCH ORAL BIOL, V40, P1, DOI 10.1016/0003-9969(94)00135-X; Crane NJ, 2006, BONE, V39, P434, DOI 10.1016/j.bone.2006.02.059; Deshpande AS, 2010, J BIOL CHEM, V285, P19277, DOI 10.1074/jbc.M109.079939; Egusa H, 2005, J BIOL CHEM, V280, P23691, DOI 10.1074/jbc.M413796200; Egusa H, 2007, TISSUE ENG, V13, P2589, DOI 10.1089/ten.2007.0080; Egusa H, 2014, STEM CELLS DEV, V23, P2156, DOI 10.1089/scd.2013.0344; Egusa H, 2013, TISSUE ENG PT A, V19, P770, DOI [10.1089/ten.tea.2012.0164, 10.1089/ten.TEA.2012.0164]; Egusa H, 2012, J PROSTHODONT RES, V56, P229, DOI 10.1016/j.jpor.2012.10.001; Egusa H, 2012, J PROSTHODONT RES, V56, P151, DOI 10.1016/j.jpor.2012.06.001; Egusa H, 2011, BONE, V49, P264, DOI 10.1016/j.bone.2011.04.003; FINCHAM AG, 1994, J STRUCT BIOL, V112, P103, DOI 10.1006/jsbi.1994.1011; Ganss B, 1999, CRIT REV ORAL BIOL M, V10, P79, DOI 10.1177/10454411990100010401; Gibson CW, 2008, CRIT REV EUKAR GENE, V18, P345, DOI 10.1615/CritRevEukarGeneExpr.v18.i4.30; Grandin HM, 2012, TISSUE ENG PART B-RE, V18, P181, DOI [10.1089/ten.teb.2011.0365, 10.1089/ten.TEB.2011.0365]; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Haze A, 2009, J CELL MOL MED, V13, P1110, DOI 10.1111/j.1582-4934.2009.00700.x; Hu JC, 2011, BIOCHEM BIOPH RES CO, V408, P437, DOI 10.1016/j.bbrc.2011.04.042; Kafri T, 2000, MOL THER, V1, P516, DOI 10.1006/mthe.2000.0083; Kaku M, 2015, J PROSTHODONT RES, V59, P96, DOI 10.1016/j.jpor.2015.02.001; Kaku M, 2014, J PROSTHODONT RES, V58, P193, DOI 10.1016/j.jpor.2014.08.003; Komori T, 2010, ADV EXP MED BIOL, V658, P43, DOI 10.1007/978-1-4419-1050-9_5; LAU EC, 1989, GENOMICS, V4, P162, DOI 10.1016/0888-7543(89)90295-4; Lee DS, 2014, STEM CELLS, V32, P2467, DOI 10.1002/stem.1733; Lee MH, 2003, BIOCHEM BIOPH RES CO, V309, P689, DOI 10.1016/j.bbrc.2003.08.058; Mahamid J, 2008, P NATL ACAD SCI USA, V105, P12748, DOI 10.1073/pnas.0803354105; Margolis HC, 2006, J DENT RES, V85, P775, DOI 10.1177/154405910608500902; Margolis H. C., 2010, AMELOGENINS MULTIFAC, P133, DOI 10.2174/978160805171711001010133; Masaki C, 2015, J PROSTHODONT RES, V59, P220, DOI 10.1016/j.jpor.2015.04.005; Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200; Matsuzawa M, 2009, J PERIODONTAL RES, V44, P289, DOI 10.1111/j.1600-0765.2008.01091.x; Naidoo J, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/595410; Nakano M, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.7.e40; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Olivares-Navarrete R, 2014, EUR CELLS MATER, V28, P1; Piper SL, 2012, J ORTHOP RES, V30, P1879, DOI 10.1002/jor.22162; ROBINSON C, 1988, CARIES RES, V22, P321, DOI 10.1159/000261131; Sasaki JI, 2015, J BIOMED MATER RES A, V103, P622, DOI 10.1002/jbm.a.35212; Sasaki JI, 2012, INTEGR BIOL-UK, V4, P1207, DOI 10.1039/c2ib20027a; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shimizu E, 2005, J PERIODONTOL, V76, P1482, DOI 10.1902/jop.2005.76.9.1482; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; Sun SK, 2003, STEM CELLS, V21, P527, DOI 10.1634/stemcells.21-5-527; Sun Y, 2007, ACTA BIOCH BIOPH SIN, V39, P235, DOI 10.1111/j.1745-7270.2007.00258.x; Swanson EC, 2006, EUR J ORAL SCI, V114, P239, DOI 10.1111/j.1600-0722.2006.00321.x; Tanimoto K, 2012, CELLS TISSUES ORGANS, V196, P411, DOI 10.1159/000335912; TERMINE JD, 1980, J BIOL CHEM, V255, P9760; Veis A, 2000, J BIOL CHEM, V275, P41263, DOI 10.1074/jbc.M002308200; Viswanathan HL, 2003, J PERIODONTOL, V74, P1423, DOI 10.1902/jop.2003.74.10.1423; Warotayanont R, 2008, BIOCHEM BIOPH RES CO, V367, P1, DOI 10.1016/j.bbrc.2007.12.048; Wen X, 2011, BIOMATERIALS, V32, P6478, DOI 10.1016/j.biomaterials.2011.05.045; Zhou BY, 2007, STEM CELLS, V25, P779, DOI 10.1634/stemcells.2006-0128	54	10	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145677	10.1371/journal.pone.0145677	http://dx.doi.org/10.1371/journal.pone.0145677			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709694	Green Published, gold, Green Submitted			2022-12-26	WOS:000367451400070
J	Burke, AK; Duong, DA; Jensen, RV; Stevens, AM				Burke, Alison Kernell; Duong, Duy An; Jensen, Roderick V.; Stevens, Ann M.			Analyzing the Transcriptomes of Two Quorum-Sensing Controlled Transcription Factors, RcsA and LrhA, Important for Pantoea stewartii Virulence	PLOS ONE			English	Article							ESCHERICHIA-COLI; PHOSPHORELAY SYSTEM; EXPRESSION; GENE; ESAR; REGULATOR; EXOPOLYSACCHARIDE; IDENTIFICATION; PROMOTER; BACTERIA	The Gram-negative proteobacterium Pantoea stewartii subsp. stewartii causes wilt disease in corn plants. Wilting is primarily due to bacterial exopolysaccharide (EPS) production that blocks water transport in the xylem during the late stages of infection. EsaR, the master quorum-sensing (QS) regulator in P. stewartii, modulates EPS levels. At low cell densities EsaR represses or activates expression of a number of genes in the absence of its acyl homoserine lactone (AHL) ligand. At high cell densities, binding of AHL inactivates EsaR leading to derepression or deactivation of its direct targets. Two of these direct targets are the key transcription regulators RcsA and LrhA, which in turn control EPS production and surface motility/adhesion, respectively. In this study, RNA-Seq was used to further examine the physiological impact of deleting the genes encoding these two second-tier regulators. Quantitative reverse transcription PCR (qRT-PCR) was used to validate the regulation observed in the RNA-Seq data. A GFP transcriptional fusion reporter confirmed the existence of a regulatory feedback loop in the system between LrhA and RcsA. Plant virulence assays carried out with rcsA and lrhA deletion and complementation strains demonstrated that both transcription factors play roles during establishment of wilt disease in corn. These efforts further define the hierarchy of the QS-regulated network controlling plant virulence in P. stewartii.	[Burke, Alison Kernell; Duong, Duy An; Jensen, Roderick V.; Stevens, Ann M.] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Stevens, AM (corresponding author), Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA.	ams@vt.edu		Stevens, Ann/0000-0002-4942-0124	National Science Foundation [MCB-0919984]	National Science Foundation(National Science Foundation (NSF))	This work was initiated with support from National Science Foundation grant MCB-0919984 (A.M.S). Additional support to complete the work was provided by a Virginia Tech Graduate Student Association Graduate Research Development Program award (A.K.B), a Biological Sciences Graduate Student Development Award fellowship (A.K.B.), the Life Sciences I Building Fund, and Virginia Tech's Open Access Subvention Fund supported its publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Awano N, 2005, APPL ENVIRON MICROB, V71, P4149, DOI 10.1128/AEM.71.7.4149-4152.2005; Blumer C, 2005, MICROBIOL-SGM, V151, P3287, DOI 10.1099/mic.0.28098-0; BRAUN EJ, 1982, PHYTOPATHOLOGY, V72, P159, DOI 10.1094/Phyto-72-159; Burbank L, 2014, MOL PLANT MICROBE IN, V27, P479, DOI 10.1094/MPMI-11-13-0348-R; Carlier A, 2009, MOL MICROBIOL, V74, P903, DOI 10.1111/j.1365-2958.2009.06906.x; Carlier AL, 2006, J BACTERIOL, V188, P4581, DOI 10.1128/JB.00211-06; Choi KH, 2005, NAT METHODS, V2, P443, DOI 10.1038/NMETH765; Clemmer KM, 2007, RES MICROBIOL, V158, P295, DOI 10.1016/j.resmic.2006.11.010; de Kievit TR, 2000, INFECT IMMUN, V68, P4839, DOI 10.1128/IAI.68.9.4839-4849.2000; DOLPH PJ, 1988, J BACTERIOL, V170, P865, DOI 10.1128/jb.170.2.865-871.1988; Ebel W, 1999, J BACTERIOL, V181, P577, DOI 10.1128/JB.181.2.577-584.1999; Esker PD, 2002, PHYTOPATHOLOGY, V92, P668, DOI 10.1094/PHYTO.2002.92.6.668; Francez-Charlot A, 2003, MOL MICROBIOL, V49, P823, DOI 10.1046/j.1365-2958.2003.03601.x; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; Hagiwara D, 2003, J BACTERIOL, V185, P5735, DOI 10.1128/JB.185.19.5735-5746.2003; Herrera CM, 2008, MOL PLANT MICROBE IN, V21, P1359, DOI 10.1094/MPMI-21-10-1359; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; Joint I, 2007, PHILOS T R SOC B, V362, P1115, DOI 10.1098/rstb.2007.2038; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; KEENLEYSIDE WJ, 1992, J BACTERIOL, V174, P8, DOI 10.1128/jb.174.1.8-16.1992; Kvitko Brian H, 2012, BMC Res Notes, V5, P157, DOI 10.1186/1756-0500-5-157; LABES M, 1990, GENE, V89, P37, DOI 10.1016/0378-1119(90)90203-4; Lehnen D, 2002, MOL MICROBIOL, V45, P521, DOI 10.1046/j.1365-2958.2002.03032.x; LEYH TS, 1988, J BIOL CHEM, V263, P2409; LUDOVICE M, 1992, J BACTERIOL, V174, P4606, DOI 10.1128/JB.174.14.4606-4613.1992; MALO MS, 1990, GENE, V87, P127, DOI 10.1016/0378-1119(90)90504-K; Miller WG, 2000, MOL PLANT MICROBE IN, V13, P1243, DOI 10.1094/MPMI.2000.13.11.1243; Minogue TD, 2005, MOL MICROBIOL, V56, P189, DOI 10.1111/j.1365-2958.2004.04529.x; PARSOT C, 1988, GENE, V68, P275, DOI 10.1016/0378-1119(88)90030-3; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; RALEIGH EA, 1988, NUCLEIC ACIDS RES, V16, P1563, DOI 10.1093/nar/16.4.1563; Ramachandran R, 2014, APPL ENVIRON MICROB, V80, P5790, DOI 10.1128/AEM.01489-14; Ramachandran R, 2013, APPL ENVIRON MICROB, V79, P6244, DOI 10.1128/AEM.01744-13; Roper MC, 2011, MOL PLANT PATHOL, V12, P628, DOI [10.1111/j.1364-3703.2010.00698.x, 10.1111/J.1364-3703.2010.00698.X]; Shong J, 2013, ACS CHEM BIOL, V8, P789, DOI 10.1021/cb3006402; Stabb EV, 2002, METHOD ENZYMOL, V358, P413; Virlogeux I, 1996, J BACTERIOL, V178, P1691, DOI 10.1128/jb.178.6.1691-1698.1996; von Bodman SB, 2003, J BACTERIOL, V185, P7001, DOI 10.1128/JB.185.23.7001-7007.2003; von Bodman SB, 1998, P NATL ACAD SCI USA, V95, P7687, DOI 10.1073/pnas.95.13.7687; von Bodman SB, 2008, J BACTERIOL, V190, P4377, DOI 10.1128/JB.00486-08; VONBODMAN SB, 1995, J BACTERIOL, V177, P5000, DOI 10.1128/JB.177.17.5000-5008.1995; Wang QF, 2007, J BACTERIOL, V189, P8447, DOI 10.1128/JB.01198-07; Whitehead NA, 2001, FEMS MICROBIOL REV, V25, P365, DOI 10.1111/j.1574-6976.2001.tb00583.x	46	14	15	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145358	10.1371/journal.pone.0145358	http://dx.doi.org/10.1371/journal.pone.0145358			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26699719	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092600068
J	Staton, M; Best, T; Khodwekar, S; Owusu, S; Xu, T; Xu, Y; Jennings, T; Cronn, R; Arumuganathan, AK; Coggeshall, M; Gailing, O; Liang, HY; Romero-Severson, J; Schlarbaum, S; Carlson, JE				Staton, Margaret; Best, Teodora; Khodwekar, Sudhir; Owusu, Sandra; Xu, Tao; Xu, Yi; Jennings, Tara; Cronn, Richard; Arumuganathan, A. Kathiravetpilla; Coggeshall, Mark; Gailing, Oliver; Liang, Haiying; Romero-Severson, Jeanne; Schlarbaum, Scott; Carlson, John E.			Preliminary Genomic Characterization of Ten Hardwood Tree Species from Multiplexed Low Coverage Whole Genome Sequencing	PLOS ONE			English	Article							NUCLEAR-DNA AMOUNTS; MICROSATELLITE MARKERS; CLIMATE-CHANGE; RESOURCES; SELECTION; DATABASE; FLOW	Forest health issues are on the rise in the United States, resulting from introduction of alien pests and diseases, coupled with abiotic stresses related to climate change. Increasingly, forest scientists are finding genetic/genomic resources valuable in addressing forest health issues. For a set of ten ecologically and economically important native hardwood tree species representing a broad phylogenetic spectrum, we used low coverage whole genome sequencing from multiplex Illumina paired ends to economically profile their genomic content. For six species, the genome content was further analyzed by flow cytometry in order to determine the nuclear genome size. Sequencing yielded a depth of 0.8X to 7.5X, from which in silico analysis yielded preliminary estimates of gene and repetitive sequence content in the genome for each species. Thousands of genomic SSRs were identified, with a clear predisposition toward dinucleotide repeats and AT-rich repeat motifs. Flanking primers were designed for SSR loci for all ten species, ranging from 891 loci in sugar maple to 18,167 in redbay. In summary, we have demonstrated that useful preliminary genome information including repeat content, gene content and useful SSR markers can be obtained at low cost and time input from a single lane of Illumina multiplex sequence.	[Staton, Margaret] Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37901 USA; [Best, Teodora; Carlson, John E.] Penn State Univ, Schatz Ctr Tree Mol Genet, University Pk, PA 16802 USA; [Khodwekar, Sudhir; Owusu, Sandra; Gailing, Oliver] Michigan Technol Univ, Sch Forest Resources & Environm Sci, Houghton, MI 49931 USA; [Xu, Tao; Xu, Yi; Liang, Haiying] Clemson Univ, Dept Biochem & Genet, Clemson, SC USA; [Jennings, Tara; Cronn, Richard] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Arumuganathan, A. Kathiravetpilla] Benaroya Res Inst Virginia Mason, Flow Cytometry & Imaging Core Lab, Seattle, WA USA; [Coggeshall, Mark] Univ Missouri, Dept Forestry, Columbia, MO USA; [Romero-Severson, Jeanne] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Schlarbaum, Scott] Univ Tennessee, Dept Forestry Wildlife & Fisheries, Knoxville, TN USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Michigan Technological University; Clemson University; Oregon State University; Benaroya Research Institute; Virginia Mason Medical Center; University of Missouri System; University of Missouri Columbia; University of Notre Dame; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Staton, M (corresponding author), Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37901 USA.	mstaton1@utk.edu	Gailing, Oliver/X-2690-2019; Romero-Severson, Jeanne/B-5259-2011	Gailing, Oliver/0000-0002-4572-2408; Romero-Severson, Jeanne/0000-0003-4112-7238; Staton, Margaret/0000-0003-2971-9353; Cronn, Richard/0000-0001-5342-3494	National Science Foundation Plant Genome Research Program [TRPGRA2 IOS-1025974)]	National Science Foundation Plant Genome Research Program(National Science Foundation (NSF)NSF - Office of the Director (OD))	MS, MC, OG, HL, JR-S, SS, and JEC received funding from the National Science Foundation Plant Genome Research Program (grant no. TRPGRA2 IOS-1025974) for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], NATL STRATEGY IMPLEM; Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P229, DOI [10.1007/BF02672073, DOI 10.1007/BF02672073]; Barbara T, 2007, MOL ECOL, V16, P3759, DOI 10.1111/j.1365-294X.2007.03439.x; Bennett MD, 2000, ANN BOT-LONDON, V86, P859, DOI 10.1006/anbo.2000.1253; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Castoe TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030953; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chase MR, 1996, NATURE, V383, P398, DOI 10.1038/383398a0; Chen C-C, 2015, J PLANT SCI MOL BREE, V4; Cho YG, 2000, THEOR APPL GENET, V100, P713, DOI 10.1007/s001220051343; Chornesky EA, 2005, BIOSCIENCE, V55, P335, DOI 10.1641/0006-3568(2005)055[0335:SPFRTT]2.0.CO;2; Dayanandan S, 1999, MOL ECOL, V8, P1585, DOI 10.1046/j.1365-294x.1999.00735.x; DICKSON EE, 1992, AM J BOT, V79, P1081, DOI 10.2307/2444917; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Eujayl I, 2001, EUPHYTICA, V119, P39, DOI 10.1023/A:1017537720475; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Horjales M, 2003, NUCL DNA AMOUNTS TRE, P13; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jenczewski E, 1997, THEOR APPL GENET, V94, P682, DOI 10.1007/s001220050466; Jennings TN, 2011, MOL ECOL RESOUR, V11, P1060, DOI 10.1111/j.1755-0998.2011.03033.x; Jennings TN, 2011, AM J BOT, V98, pE323, DOI 10.3732/ajb.1100317; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kalia RK, 2011, EUPHYTICA, V177, P309, DOI 10.1007/s10681-010-0286-9; Khodwekar S, 2015, ANN FOR RES, V58, P193; Kirkness EF, 2003, SCIENCE, V301, P1898, DOI 10.1126/science.1086432; Koskela J, 2013, BIOL CONSERV, V157, P39, DOI 10.1016/j.biocon.2012.07.023; Kremer Antoine, 2007, V7, P161; Kron P, 2007, ANNU REV ECOL EVOL S, V38, P847, DOI 10.1146/annurev.ecolsys.38.091206.095504; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019; Logan JA, 2003, FRONT ECOL ENVIRON, V1, P130, DOI 10.2307/3867985; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Metzgar D, 2000, GENOME RES, V10, P72; Morgulis A, 2006, J COMPUT BIOL, V13, P1028, DOI 10.1089/cmb.2006.13.1028; Neale D, 2011, BMC P, V5, P14, DOI [10.1186/1753-6561-5-S7-I4, DOI 10.1186/1753-6561-5-S7-I4]; Neale DB, 2011, NAT REV GENET, V12, P111, DOI 10.1038/nrg2931; Ochatt SJ, 2008, CYTOM PART A, V73A, P581, DOI 10.1002/cyto.a.20562; OHRI D, 1986, CARYOLOGIA, V39, P303, DOI 10.1080/00087114.1986.10797792; Owusu SA, 2013, APPL PLANT SCI, V1, DOI 10.3732/apps.1300050; Pimentel D., 2002, BIOL INVASIONS EC EN; Rasmussen DA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-382; Rungis D, 2004, THEOR APPL GENET, V109, P1283, DOI 10.1007/s00122-004-1742-5; Schlarbaum SE, 2002, FADING FORESTS 2 TRA; Segelbacher G, 2010, CONSERV GENET, V11, P375, DOI 10.1007/s10592-009-0044-5; Siljak-Yakovlev S, 2010, ADV SCI LETT, V3, P190, DOI 10.1166/asl.2010.1115; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Slavov GT, 2012, NEW PHYTOL, V196, P713, DOI 10.1111/j.1469-8137.2012.04258.x; Smit A, 1996, REPEATMASKER OPEN 30; Sonah H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021298; Sork VL, 2013, TREE GENET GENOMES, V9, P901, DOI 10.1007/s11295-013-0596-x; Staub JE, 1996, HORTSCIENCE, V31, P729, DOI 10.21273/HORTSCI.31.5.729; Straub SCK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-211; STRAUSS SH, 1992, CAN J FOREST RES, V22, P1050, DOI 10.1139/x92-140; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Wernersson R, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-70; Wicker T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-518; Wolf PG, 2015, GENOME BIOL EVOL, V7, P2533, DOI 10.1093/gbe/evv163	60	19	19	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145031	10.1371/journal.pone.0145031	http://dx.doi.org/10.1371/journal.pone.0145031			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26698853	Green Submitted, Green Published, gold			2022-12-26	WOS:000367092600044
J	Schneck, H; Gierke, B; Uppenkamp, F; Behrens, B; Niederacher, D; Stoecklein, NH; Templin, MF; Pawlak, M; Fehm, T; Neubauer, H				Schneck, Helen; Gierke, Berthold; Uppenkamp, Frauke; Behrens, Bianca; Niederacher, Dieter; Stoecklein, Nikolas H.; Templin, Markus F.; Pawlak, Michael; Fehm, Tanja; Neubauer, Hans		Disseminated Canc Cell Network DCC	EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer	PLOS ONE			English	Article							ADHESION MOLECULE EXPRESSION; SURFACE CYTOKERATIN 8; STEM-CELL; PROSTATE-CANCER; E-CADHERIN; EP-CAM; BLOOD; PLASMINOGEN; SURVIVAL; PROTEIN	Circulating tumor cells (CTCs) are the potential precursors of metastatic disease. Most assays established for the enumeration of CTCs so far-including the gold standard Cell-Search-rely on the expression of the cell surface marker epithelial cell adhesion molecule (EpCAM). But, these approaches may not detect CTCs that express no/low levels of EpCAM, e.g. by undergoing epithelial-to-mesenchymal transition (EMT). Here we present an enrichment strategy combining different antibodies specific for surface proteins and extracellular matrix (ECM) components to capture an EpCAM(low/neg) cell line and EpCAM(neg) CTCs from blood samples of breast cancer patients depleted for EpCAM-positive cells. The expression of respective proteins (Trop2, CD49f, c-Met, CK8, CD44, ADAM8, CD146, TEM8, CD47) was verified by immunofluorescence on EpCAM(pos) (e.g. MCF7, SKBR3) and EpCAM(low/neg) (MDA-MB-231) breast cancer cell lines. To test antibodies and ECM proteins (e.g. hyaluronic acid (HA), collagen I, laminin) for capturing EpCAMneg cells, the capture molecules were first spotted in a single-and multi-array format onto aldehyde-coated glass slides. Tumor cell adhesion of EpCAM(pos/neg) cell lines was then determined and visualized by Coomassie/MitoTracker staining. In consequence, marginal binding of EpCAM(low/neg) MDA-MB-231 cells to EpCAM-antibodies could be observed. However, efficient adhesion/capturing of EpCAM(low/neg) cells could be achieved via HA and immobilized antibodies against CD49f and Trop2. Optimal capture conditions were then applied to immunomagnetic beads to detect EpCAMneg CTCs from clinical samples. Captured CTCs were verified/quantified by immunofluorescence staining for anti-pan-Cytokeratin (CK)-FITC/anti-CD45 AF647/DAPI. In total, in 20 out of 29 EpCAM-depleted fractions (69%) from 25 metastatic breast cancer patients additional EpCAMneg CTCs could be identified [range of 1-24 CTCs per sample] applying Trop2, CD49f, c-Met, CK8 and/or HA magnetic enrichment. EpCAMneg dual-positive (CKpos/CD45(pos)) cells could be traced in 28 out of 29 samples [range 1-480]. By single-cell array-based comparative genomic hybridization we were able to demonstrate the malignant nature of one EpCAM(neg) subpopulation. In conclusion, we established a novel enhanced CTC enrichment strategy to capture EpCAM(neg) CTCs from clinical blood samples by targeting various cell surface antigens with antibody mixtures and ECM components.	[Schneck, Helen; Uppenkamp, Frauke; Niederacher, Dieter; Fehm, Tanja; Neubauer, Hans] Univ Dusseldorf, Univ Hosp, Dept Obstet & Gynecol, Dusseldorf, Germany; [Schneck, Helen; Uppenkamp, Frauke; Behrens, Bianca; Niederacher, Dieter; Stoecklein, Nikolas H.; Fehm, Tanja; Neubauer, Hans] Univ Dusseldorf, Fac Med, Dusseldorf, Germany; [Gierke, Berthold; Templin, Markus F.; Pawlak, Michael] Univ Tubingen, NMI Nat & Med Sci Inst, Reutlingen, Germany; [Behrens, Bianca; Stoecklein, Nikolas H.] Univ Dusseldorf, Univ Hosp, Dept Gen Visceral & Pediat Surg, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Eberhard Karls University of Tubingen; Heinrich Heine University Dusseldorf	Neubauer, H (corresponding author), Univ Dusseldorf, Univ Hosp, Dept Obstet & Gynecol, Dusseldorf, Germany.	Hans.Neubauer@med.uni-duesseldorf.de	Neubauer, Hans/C-4467-2016	Neubauer, Hans/0000-0002-3467-4105; Fehm, Tanja/0000-0002-4926-0108	German Ministry for Research and Education ('CTC-Detect') [16SV5121K]	German Ministry for Research and Education ('CTC-Detect')	This project was funded by the German Ministry for Research and Education ('CTC-Detect', no. 16SV5121K).	Aceto N, 2014, CELL, V158, P1110, DOI 10.1016/j.cell.2014.07.013; Alix-Panabieres Catherine, 2012, Recent Results Cancer Res, V195, P69, DOI 10.1007/978-3-642-28160-0_6; Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Baccelli I, 2014, ONCOTARGET, V5, P8147, DOI 10.18632/oncotarget.2385; Baccelli I, 2013, NAT BIOTECHNOL, V31, P539, DOI 10.1038/nbt.2576; Balzar M, 1999, J MOL MED, V77, P699, DOI 10.1007/s001099900038; Barradas Ana M C, 2013, Cancers (Basel), V5, P1619, DOI 10.3390/cancers5041619; Bidard FC, 2014, LANCET ONCOL, V15, P406, DOI 10.1016/S1470-2045(14)70069-5; Brown TJ, 2009, HYALURONAN CANC BIOL; Budd GT, 2006, CLIN CANCER RES, V12, P6403, DOI 10.1158/1078-0432.CCR-05-1769; BUTLER TP, 1975, CANCER RES, V35, P512; Cariati M, 2008, INT J CANCER, V122, P298, DOI 10.1002/ijc.23103; Chen DH, 2013, CANCER RES, V73, P5821, DOI 10.1158/0008-5472.CAN-13-1080; Cho EH, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/1/016001; Choi H, 2013, LAB CHIP, V13, P970, DOI 10.1039/c2lc41376k; Coumans FAW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061770; Coumans FAW, 2012, CLIN CANCER RES, V18, P5711, DOI 10.1158/1078-0432.CCR-12-1585; Driemel C, 2014, ONCOGENE, V33, P4904, DOI 10.1038/onc.2013.441; Fischer JC, 2013, P NATL ACAD SCI USA, V110, P16580, DOI 10.1073/pnas.1313594110; FORNARO M, 1995, INT J CANCER, V62, P610, DOI 10.1002/ijc.2910620520; Gancberg D, 2002, ANN ONCOL, V13, P1036, DOI 10.1093/annonc/mdf252; Gasch C, 2013, CLIN CHEM, V59, P252, DOI 10.1373/clinchem.2012.188557; Gires O, 2014, CELL MOL LIFE SCI, V71, P4393, DOI 10.1007/s00018-014-1693-1; GODFROID E, 1991, J CELL SCI, V99, P595; Gonias Steven L., 2001, Frontiers in Bioscience, V6, pd1403, DOI 10.2741/Gonias; Gorges TM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-178; Gosens MJEM, 2007, MODERN PATHOL, V20, P221, DOI 10.1038/modpathol.3800733; Gozgit JM, 2006, MOL CANCER RES, V4, P905, DOI 10.1158/1541-7786.MCR-06-0147; Grossman HB, 2000, ONCOL REP, V7, P13; Guerra E, 2013, ONCOGENE, V32, P1594, DOI 10.1038/onc.2012.151; Hamilton SR, 2007, J BIOL CHEM, V282, P16667, DOI 10.1074/jbc.M702078200; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harb W, 2013, TRANSL ONCOL, V6, P528, DOI 10.1593/tlo.13367; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; HEMBROUGH TA, 1995, J CELL SCI, V108, P1071; Hembrough TA, 1996, J BIOL CHEM, V271, P25684, DOI 10.1074/jbc.271.41.25684; Honeth G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2108; Joosse SA, 2015, EMBO MOL MED, V7, P1, DOI 10.15252/emmm.201303698; Khoo BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099409; Kim YJ, 2014, BIOMATERIALS, V35, P7501, DOI 10.1016/j.biomaterials.2014.05.039; Lawson DA, 2007, P NATL ACAD SCI USA, V104, P181, DOI 10.1073/pnas.0609684104; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Liu F, 2008, NEOPLASIA, V10, P1275, DOI 10.1593/neo.08810; Lu J, 2010, INT J CANCER, V126, P669, DOI 10.1002/ijc.24814; Massoner P, 2014, BRIT J CANCER, V111, P955, DOI 10.1038/bjc.2014.366; Meng SD, 2004, CLIN CANCER RES, V10, P8152, DOI 10.1158/1078-0432.CCR-04-1110; Mikolajczyk SD, 2011, J ONCOL, V2011, DOI 10.1155/2011/252361; Mohlendick B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067031; Mohlendick Birte, 2014, Curr Protoc Cell Biol, V65, DOI 10.1002/0471143030.cb2219s65; Mostert B, 2012, CANCER LETT, V319, P49, DOI 10.1016/j.canlet.2011.12.031; Mostert B, 2011, BREAST CANCER RES TR, V127, P33, DOI 10.1007/s10549-010-0879-y; Muller V, 2009, BREAST CANCER RES TR, V117, P535, DOI 10.1007/s10549-008-0276-y; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Nel I, 2014, TRANSL LUNG CANCER R, V3, P100, DOI 10.3978/j.issn.2218-6751.2014.03.05; Neves RPL, 2014, CLIN CHEM, V60, P1290, DOI 10.1373/clinchem.2014.222331; Obermajer N, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-88; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Ozkumur E, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005616; Pantel K, 2010, TRENDS MOL MED, V16, P398, DOI 10.1016/j.molmed.2010.07.001; Patriarca C, 2012, CANCER TREAT REV, V38, P68, DOI 10.1016/j.ctrv.2011.04.002; PEACH RJ, 1993, J CELL BIOL, V122, P257, DOI 10.1083/jcb.122.1.257; Powell AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033788; Punnoose EA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012517; Qu Q, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-93; Ramakrishnan M, 2013, CANCER RES, V73, P5360, DOI 10.1158/0008-5472.CAN-13-0896; Rao CG, 2005, INT J ONCOL, V27, P49; Romagnoli M, 2014, EMBO MOL MED, V6, P278, DOI 10.1002/emmm.201303373; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneck H, 2013, MOL ONCOL, V7, P976, DOI 10.1016/j.molonc.2013.07.007; Songun I, 2005, BRIT J CANCER, V92, P1767, DOI 10.1038/sj.bjc.6602519; Stott SL, 2010, P NATL ACAD SCI USA, V107, P18392, DOI 10.1073/pnas.1012539107; Tai KY, 2007, ONCOGENE, V26, P3989, DOI 10.1038/sj.onc.1210176; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thurm H, 2003, CLIN CANCER RES, V9, P2598; Trerotola M, 2013, CANCER RES, V73, P3155, DOI 10.1158/0008-5472.CAN-12-3266; van der Gun BTF, 2010, CARCINOGENESIS, V31, P1913, DOI 10.1093/carcin/bgq187; Vanharanta S, 2013, CANCER CELL, V24, P410, DOI 10.1016/j.ccr.2013.09.007; Vannier C, 2013, J BIOL CHEM, V288, P18643, DOI 10.1074/jbc.M113.467787; Vieira AF, 2012, STEM CELLS, V30, P854, DOI 10.1002/stem.1075; Wang C, 1998, CLIN CANCER RES, V4, P567; Wang Y, 2011, INT CONF ACOUST SPEE, P1, DOI 10.1109/PLASMA.2011.5993071; Welm BE, 2002, DEV BIOL, V245, P42, DOI 10.1006/dbio.2002.0625; Went PT, 2004, HUM PATHOL, V35, P122, DOI 10.1016/j.humpath.2003.08.026; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Yu M, 2011, J CELL BIOL, V192, P373, DOI 10.1083/jcb.201010021; Zhang LL, 2012, CLIN CANCER RES, V18, P5701, DOI 10.1158/1078-0432.CCR-12-1587	87	69	72	3	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0144535	10.1371/journal.pone.0144535	http://dx.doi.org/10.1371/journal.pone.0144535			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26695635	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092500006
J	Dong, L; Zou, HC; Yuan, C; Hong, YH; Kuklev, DV; Smith, WL				Dong, Liang; Zou, Hechang; Yuan, Chong; Hong, Yu H.; Kuklev, Dmitry V.; Smith, William L.			Different Fatty Acids Compete with Arachidonic Acid for Binding to the Allosteric or Catalytic Subunits of Cyclooxygenases to Regulate Prostanoid Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; cyclooxygenase (COX); eicosanoid; fatty acid; prostaglandin; docosahexaenoic acid; eicosapentaenoic acid; half-sites; -3 fatty acid; palmitic acid	PROSTAGLANDIN-H SYNTHASE; ENDOCANNABINOID OXYGENATION; CROSS-TALK; ENDOPLASMIC-RETICULUM; PROTEIN-DEGRADATION; SEQUENCE HOMODIMER; PATHWAYS; PEROXIDASE; MONOMERS; COX-2	Prostaglandin endoperoxide H synthases (PGHSs), also called cyclooxygenases (COXs), convert arachidonic acid (AA) to PGH(2). PGHS-1 and PGHS-2 are conformational heterodimers, each composed of an (E-allo) and a catalytic (E-cat) monomer. Previous studies suggested that the binding to E-allo of saturated or monounsaturated fatty acids (FAs) that are not COX substrates differentially regulate PGHS-1 versus PGHS-2. Here, we substantiate and expand this concept to include polyunsaturated FAs known to modulate COX activities. Non-substrate FAs like palmitic acid bind E-allo of PGHSs stimulating human (hu) PGHS-2 but inhibiting huPGHS-1. We find the maximal effects of non-substrate FAs on both huPGHSs occurring at the same physiologically relevant FA/AA ratio of approximate to 20. This inverse allosteric regulation likely underlies the ability of PGHS-2 to operate at low AA concentrations, when PGHS-1 is effectively latent. Unlike FAs tested previously, we observe that C-22 FAs, including -3 fish oil FAs, have higher affinities for E-cat than E-allo subunits of PGHSs. Curiously, C-20 -3 eicosapentaenoate preferentially binds E-cat of huPGHS-1 but E-allo of huPGHS-2. PGE(2) production decreases 50% when fish oil consumption produces tissue EPA/AA ratios of 0.2. However, 50% inhibition of huPGHS-1 itself is only seen with -3 FA/AA ratios of 5.0. This suggests that fish oil-enriched diets disfavor AA oxygenation by altering the composition of the FA pool in which PGHS-1 functions. The distinctive binding specificities of PGHS subunits permit different combinations of non-esterified FAs, which can be manipulated dietarily, to regulate AA binding to E-allo and/or E-cat thereby controlling COX activities.	[Dong, Liang; Zou, Hechang; Yuan, Chong; Hong, Yu H.; Kuklev, Dmitry V.; Smith, William L.] Univ Michigan, Dept Biol Chem, 5301 MSRB III,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Smith, WL (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, 5301 MSRB III,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	smithww@umich.edu	Zou, He/GXH-0280-2022		National Institutes of Health [GM68848, CA130810, HL117798]; NATIONAL CANCER INSTITUTE [P50CA130810] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL117798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068848] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants GM68848, CA130810, and HL117798. W. L. S. serves a consultant for Cayman Chemical Co., products from which were used in this study. The other authors have no conflicts of interest. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Brash AR, 2001, J CLIN INVEST, V107, P1339, DOI 10.1172/JCI13210; Burian M, 2005, PHARMACOL THERAPEUT, V107, P139, DOI 10.1016/j.pharmthera.2005.02.004; Dong L, 2013, J BIOL CHEM, V288, P28641, DOI 10.1074/jbc.M113.505503; Dong L, 2011, J BIOL CHEM, V286, P19035, DOI 10.1074/jbc.M111.231969; Duggan KC, 2011, NAT CHEM BIOL, V7, P803, DOI 10.1038/nchembio.663; Grosser T, 2010, ANNU REV MED, V61, P17, DOI 10.1146/annurev-med-011209-153129; HABIB A, 1993, J BIOL CHEM, V268, P23448; Jiang Y, 2014, CANCER PREV RES, V7, P1011, DOI 10.1158/1940-6207.CAPR-14-0134; Jump DB, 2012, J LIPID RES, V53, P2525, DOI 10.1194/jlr.R027904; Kang YJ, 2007, PROG LIPID RES, V46, P108, DOI 10.1016/j.plipres.2007.01.001; Kiefer JR, 2000, NATURE, V405, P97, DOI 10.1038/35011103; Kingma PB, 1998, BIOCHEMISTRY-US, V37, P3250, DOI 10.1021/bi972520l; Kudalkar SN, 2015, J BIOL CHEM, V290, P7897, DOI 10.1074/jbc.M114.634014; Kuklev DV, 2013, J LIPID RES, V54, P1906, DOI 10.1194/jlr.M037192; KULMACZ RJ, 1984, J BIOL CHEM, V259, P6358; KULMACZ RJ, 1994, J BIOL CHEM, V269, P5527; KULMACZ RJ, 1985, J BIOL CHEM, V260, P2572; Lapicque F, 2000, CLIN PHARMACOKINET, V39, P369, DOI 10.2165/00003088-200039050-00005; Liu JY, 2007, J BIOL CHEM, V282, P18233, DOI 10.1074/jbc.M701235200; Liu W, 2006, FASEB J, V20, P1097, DOI 10.1096/fj.05-5273com; Mbonye UR, 2008, J BIOL CHEM, V283, P8611, DOI 10.1074/jbc.M710137200; Mbonye UR, 2006, J BIOL CHEM, V281, P35770, DOI 10.1074/jbc.M608281200; McIntosh AL, 2010, J BIOL CHEM, V285, P18693, DOI 10.1074/jbc.M109.079897; Muth-Selbach US, 1999, ANESTHESIOLOGY, V91, P231, DOI 10.1097/00000542-199907000-00032; Norris PC, 2012, P NATL ACAD SCI USA, V109, P8517, DOI 10.1073/pnas.1200189109; OTTO JC, 1993, J BIOL CHEM, V268, P18234; Prusakiewicz JJ, 2009, BIOCHEMISTRY-US, V48, P7353, DOI 10.1021/bi900999z; REDDY ST, 1994, J BIOL CHEM, V269, P15473; Rimon G, 2010, P NATL ACAD SCI USA, V107, P28, DOI 10.1073/pnas.0909765106; Rouzer CA, 2011, CHEM REV, V111, P5899, DOI 10.1021/cr2002799; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Sharma NP, 2010, MOL PHARMACOL, V77, P979, DOI 10.1124/mol.109.063115; Shitashige M, 1998, BBA-LIPID LIPID MET, V1389, P57, DOI 10.1016/S0005-2760(97)00129-X; Sidhu RS, 2010, BIOCHEMISTRY-US, V49, P7069, DOI 10.1021/bi1003298; Smith WL, 2011, CHEM REV, V111, P5821, DOI 10.1021/cr2002992; Song I, 2001, BIOCHEM BIOPH RES CO, V289, P869, DOI 10.1006/bbrc.2001.6071; Surette ME, 1998, BIOCHEM J, V330, P915; Swinney DC, 1997, J BIOL CHEM, V272, P12393, DOI 10.1074/jbc.272.19.12393; Tanabe T, 2002, PROSTAG OTH LIPID M, V68-9, P95, DOI 10.1016/S0090-6980(02)00024-2; Tsai AL, 2010, ARCH BIOCHEM BIOPHYS, V493, P103, DOI 10.1016/j.abb.2009.08.019; VANDEROUDERAA FJ, 1977, BIOCHIM BIOPHYS ACTA, V487, P315, DOI 10.1016/0005-2760(77)90008-X; Vecchio AJ, 2010, J BIOL CHEM, V285, P22152, DOI 10.1074/jbc.M110.119867; Wada M, 2007, J BIOL CHEM, V282, P22254, DOI 10.1074/jbc.M703169200; Wada M, 2009, J BIOL CHEM, V284, P30742, DOI 10.1074/jbc.M109.052415; Yu Y, 2005, J CLIN INVEST, V115, P986, DOI 10.1172/JCI23683; Yuan C, 2006, P NATL ACAD SCI USA, V103, P6142, DOI 10.1073/pnas.0601805103; Yuan C, 2015, J BIOL CHEM, V290, P5606, DOI 10.1074/jbc.M114.632463; Yuan C, 2009, J BIOL CHEM, V284, P10046, DOI 10.1074/jbc.M808634200; Zou HC, 2012, J LIPID RES, V53, P1336, DOI 10.1194/jlr.M026856	49	49	50	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					4069	4078		10.1074/jbc.M115.698001	http://dx.doi.org/10.1074/jbc.M115.698001			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26703471	Green Published, hybrid			2022-12-26	WOS:000371338400032
J	Sharma, NR; Wang, XH; Majerciak, V; Ajiro, M; Kruhlak, M; Meyers, C; Zheng, ZM				Sharma, Nishi R.; Wang, Xiaohong; Majerciak, Vladimir; Ajiro, Masahiko; Kruhlak, Michael; Meyers, Craig; Zheng, Zhi-Ming			Cell Type- and Tissue Context-dependent Nuclear Distribution of Human Ago2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARGONAUTE PROTEINS; HERPESVIRUS ORF57; GENE-EXPRESSION; RNA; LOCALIZATION; STRESS; ONCOPROTEIN; MICRORNAS; CLEAVAGE	Argonaute-2 protein (Ago2), a major component of RNA-induced silencing complex (RISC), has been viewed as a cytoplasmic protein. In this study, we demonstrated by immunofluorescence confocal microscopy that Ago2 is distributed mainly as a nuclear protein in primary human foreskin keratinocytes in monolayer cultures and their derived organotypic (raft) cultures, although it exhibits only a minimal level of nuclear distribution in continuous cell lines such as HeLa and HaCaT cells. Oncogenic human papillomavirus type 16 (HPV16) or type 18 (HPV18) infection of the keratinocytes does not affect the nuclear Ago2 distribution. Examination of human tissues reveals that Ago2 exhibits primarily as a nuclear protein in skin, normal cervix, and cervical cancer tissues, but not in larynx. Together, our data provide the first convincing evidence that the subcellular distribution of Ago2 occurs in a cell type-and tissue context-dependent manner and may correlate with its various functions in regulation of gene expression.	[Sharma, Nishi R.; Wang, Xiaohong; Majerciak, Vladimir; Zheng, Zhi-Ming] NCI, Tumor Virus RNA Biol Sect,Gene Regulat & Chromoso, Ctr Canc Res, NIH, Frederick, MD 21702 USA; [Kruhlak, Michael] NCI, Expt Immunol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Meyers, Craig] Penn State Univ, Sch Med, Dept Microbiol & Immunol, Hershey, PA 17033 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Zheng, ZM (corresponding author), NCI, Tumor Virus RNA Biol Sect,Gene Regulat & Chromoso, Ctr Canc Res, NIH, Frederick, MD 21702 USA.	zhengt@exchange.nih.gov	Zheng, Zhi-Ming/L-6383-2019	Zheng, Zhi-Ming/0000-0001-5547-7912; Majerciak, Vladimir/0000-0003-2907-4583	NCI Investigator-initiated Intramural Research Project [1ZIASC010357-15]; Center for Cancer Research, NCI, National Institutes of Health; National Institutes of Health [U01 CA179724]; NATIONAL CANCER INSTITUTE [ZICBC010915, U01CA179724, ZIASC010357] Funding Source: NIH RePORTER	NCI Investigator-initiated Intramural Research Project; Center for Cancer Research, NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the NCI Investigator-initiated Intramural Research Project 1ZIASC010357-15, the Center for Cancer Research, NCI, National Institutes of Health (to Z. M. Z.). This work was also supported partially by National Institutes of Health Grant U01 CA179724 (to C. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Ahlenstiel CL, 2012, NUCLEIC ACIDS RES, V40, P1579, DOI 10.1093/nar/gkr891; Ando Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023385; Benhamed M, 2012, NAT CELL BIOL, V14, P266, DOI 10.1038/ncb2443; Chu YJ, 2010, NUCLEIC ACIDS RES, V38, P7736, DOI 10.1093/nar/gkq648; Detzer A, 2011, NUCLEIC ACIDS RES, V39, P2727, DOI 10.1093/nar/gkq1216; Doyle M, 2013, RNA, V19, P1238, DOI 10.1261/rna.039255.113; Gagnon KT, 2014, CELL REP, V6, P211, DOI 10.1016/j.celrep.2013.12.013; Gagnon KT, 2012, NUCLEIC ACID THER, V22, P3, DOI 10.1089/nat.2011.0330; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Kang JG, 2011, J VIROL, V85, P2620, DOI 10.1128/JVI.02144-10; Karginov FV, 2013, GENE DEV, V27, P1624, DOI 10.1101/gad.215939.113; Leung AKL, 2006, P NATL ACAD SCI USA, V103, P18125, DOI 10.1073/pnas.0608845103; Longworth MS, 2004, MICROBIOL MOL BIOL R, V68, P362, DOI 10.1128/MMBR.68.2.362-372.2004; Majerciak V, 2010, J BIOL CHEM, V285, P11297, DOI 10.1074/jbc.M109.068221; Massimelli MJ, 2013, J VIROL, V87, P243, DOI 10.1128/JVI.01693-12; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Tang S, 2006, J VIROL, V80, P4249, DOI 10.1128/JVI.80.9.4249-4263.2006; Wang XH, 2014, P NATL ACAD SCI USA, V111, P4262, DOI 10.1073/pnas.1401430111; Wang X, 2009, RNA, V15, P637, DOI 10.1261/rna.1442309; Wei Y, 2014, J BIOL CHEM, V289, P10270, DOI 10.1074/jbc.C113.541417; Weinmann L, 2009, CELL, V136, P496, DOI 10.1016/j.cell.2008.12.023	21	25	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2302	2309		10.1074/jbc.C115.695049	http://dx.doi.org/10.1074/jbc.C115.695049			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26699195	Green Published, hybrid			2022-12-26	WOS:000369610400020
J	Dassah, S; Sakyi, SA; Frempong, MT; Luuse, AT; Ephraim, RKD; Anto, EO; Oduro, A				Dassah, Sylvester; Sakyi, Samuel A.; Frempong, Margaret T.; Luuse, Arnold T.; Ephraim, Richard K. D.; Anto, Enoch O.; Oduro, Abraham			Seroconversion of Hepatitis B Vaccine in Young Children in the Kassena Nankana District of Ghana: A Cross-Sectional Study	PLOS ONE			English	Article							EPIDEMIOLOGY; PERSISTENCE; PROTECTION; DISEASE; IMPACT	Background Hepatitis B Virus (HBV) infection is an important public health problem that requires high priority efforts towards prevention and control. Active immunization is the single most important and effective preventive measure against HBV infection. As a protective measure, Ghana introduced the mass immunization program against hepatitis B infection in children in 2002 in her Expanded Programme on Immunization (EPI). This study evaluated seroconversion (the point in time when the amount of antibody in the blood becomes detectable) and seroprotection (the point in time when the amount of antibody in the blood is enough to confer protection from the antigen that induced it production) status of children under this mass immunization program and measured their antibody levels five years after immunization. Materials and Method 200 archived plasma samples of children between the ages of 1-10 years were retrieved from a previous cross-sectional study by researchers from NHRC between 2009 and 2010. Of these, 104 have completed the EPI and were screened for HBsAg. Those found to be HBsAg-seronegative were stratified into three groups according to their age at which the last vaccine was administered. Their anti-HBsAg titer levels were estimated by enzyme linked immunosorbant assay (ELISA). Results Two (1.9%) samples were HBsAg seropositive and were excluded from further analyses. 10 more samples were excluded from analyses because they were insufficient. The antiHBs titers recorded ranged from 1.021 IU/L to 751.64 IU/L indicating a 100% seroconversion rate. In group one (0-6 months), 87.9% were seroprotected. Group two (2-3yrs) had 78.3% seroprotection and group three (3-5yrs) had 41.7% seroprotection. There was no significant difference between group 1 and 2. However, there was a significant difference between group 1 and 3 (p = 0.0137) and between group 2 and 3 (p = 0.0390) respectively. There was no significant difference between male and female children. Conclusion All the children who received doses of hepatitis B vaccine at 6, 10 and 14 weeks in the immunization program seroconverted, but their levels of protection waned with increasing years. Booster doses are therefore recommended after 5 years.	[Sakyi, Samuel A.; Frempong, Margaret T.; Anto, Enoch O.] Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Dept Mol Med, Kumasi, Ghana; [Dassah, Sylvester; Oduro, Abraham] Navrongo Hlth Res Ctr, Navrongo, Upper East, Ghana; [Luuse, Arnold T.] Univ Hlth & Allied Sci, Fac Allied Hlth Sci, Ho, Ghana; [Ephraim, Richard K. D.] Univ Cape Coast, Dept Med Lab Technol, Cape Coast, Ghana	Kwame Nkrumah University Science & Technology; Navrongo Health Research Center; University of Cape Coast	Sakyi, SA (corresponding author), Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Dept Mol Med, Kumasi, Ghana.	samasamoahsakyi@yahoo.co.uk	Sakyi, Samuel Asamoah/AAQ-3998-2021; Anto, Enoch Odame/AAJ-7426-2020; Ephraim, Richard KD/X-3000-2019	Anto, Enoch Odame/0000-0001-9023-6612; sakyi, samuel/0000-0001-5168-4762; Dassah, Sylvester/0000-0002-1880-5507; ODURO, ABRAHAM/0000-0002-4191-7419				Abhijit Guho, 2010, Journal of Medicine, V11, P143; Advanced Life Support Group, 2011, CTR DIS CONTROL, P1; Chakraborty B, 2011, STAMFORD J MICROBIOL, V1, P37; Cho Y, 2012, GUT LIVER, V6, P235, DOI 10.5009/gnl.2012.6.2.235; da Motta MSF, 2002, VACCINE, V20, P1557, DOI 10.1016/S0264-410X(01)00493-5; Dentinger CM, 2005, PEDIATR INFECT DIS J, V24, P786, DOI 10.1097/01.inf.0000176617.63457.9f; El Mazahi MM, 2014, J AM SCI, V10; El-Sayed B., 2009, ZAGAZIG J OCCUP HLTH, V2, P17; Gomber S, 2000, Indian Pediatr, V37, P411; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Lu CY, 2008, J INFECT DIS, V197, P1419, DOI 10.1086/587695; Luo ZB, 2012, INT J INFECT DIS, V16, pE82, DOI 10.1016/j.ijid.2011.10.009; Puvacic Sandra, 2005, Bosn J Basic Med Sci, V5, P50; Ribeiro Tereza Monteiro, 2006, Clinics, V61, P387, DOI 10.1590/S1807-59322006000500004; Rufai T, 2014, PAN AFR MED J, V17, DOI 10.11604/pamj.2014.17.53.3390; Salama Iman I, 2014, Egypt J Immunol, V21, P13; Shepard CW, 2006, EPIDEMIOL REV, V28, P112, DOI 10.1093/epirev/mxj009; Tsebe KV, 2001, VACCINE, V19, P3919, DOI 10.1016/S0264-410X(01)00120-7; Yazdanpanah B, 2010, HEPAT MON, V10, P17; Zanetti AR, 2008, VACCINE, V26, P6266, DOI 10.1016/j.vaccine.2008.09.056	20	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145209	10.1371/journal.pone.0145209	http://dx.doi.org/10.1371/journal.pone.0145209			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716979	Green Submitted, Green Published, gold			2022-12-26	WOS:000367510500026
J	Forati, E; Sabouni, A; Ray, S; Head, B; Schoen, C; Sievenpiper, D				Forati, Ebrahim; Sabouni, Abas; Ray, Supriyo; Head, Brian; Schoen, Christian; Sievenpiper, Dan			Neurotransmitter Specific, Cellular-Resolution Functional Brain Mapping Using Receptor Coated Nanoparticles: Assessment of the Possibility	PLOS ONE			English	Article							SURFACE-PLASMON RESONANCE; BIOMEDICAL APPLICATIONS; DOPAMINE TRANSPORTERS; NEURONS; METAMATERIALS; SPECTROSCOPY; DISEASE; SITES	Receptor coated resonant nanoparticles and quantum dots are proposed to provide a cellular-level resolution image of neural activities inside the brain. The functionalized nanoparticles and quantum dots in this approach will selectively bind to different neurotransmitters in the extra-synaptic regions of neurons. This allows us to detect neural activities in real time by monitoring the nanoparticles and quantum dots optically. Gold nanoparticles (GNPs) with two different geometries (sphere and rod) and quantum dots (QDs) with different sizes were studied along with three different neurotransmitters: dopamine, gamma-Aminobutyric acid (GABA), and glycine. The absorption/emission spectra of GNPs and QDs before and after binding of neurotransmitters and their corresponding receptors are reported. The results using QDs and nanorods with diameter 25nm and aspect rations larger than three were promising for the development of the proposed functional brain mapping approach.	[Forati, Ebrahim; Sabouni, Abas; Sievenpiper, Dan] Univ Calif San Diego, Elect & Comp Engn Dept, La Jolla, CA 92098 USA; [Ray, Supriyo] Univ Calif San Diego, Biomed Sci, La Jolla, CA 92098 USA; [Head, Brian] Univ Calif San Diego, Dept Anesthesiol, La Jolla, CA 92098 USA; [Schoen, Christian] Nanopartz Inc, Loveland, CO 80537 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Forati, E (corresponding author), Univ Calif San Diego, Elect & Comp Engn Dept, La Jolla, CA 92098 USA.	forati@ieee.org	Ray, Supriyo/L-1020-2019		UC San Diego Center for Brain Activity Mapping	UC San Diego Center for Brain Activity Mapping	This work was funded by UC San Diego Center for Brain Activity Mapping. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AQUILONIUS SM, 1987, ACTA NEUROL SCAND, V76, P283, DOI 10.1111/j.1600-0404.1987.tb03582.x; Atwater HA, 2007, SCI AM, V296, P56, DOI 10.1038/scientificamerican0407-56; Badgaiyan RD, 2011, CURR MED IMAGING, V7, P98; Bohren C. F., 2008, ABSORPTION SCATTERIN, DOI DOI 10.1002/9783527618156; Devasena T, 2015, BRAIN, V29, P31; Fischman AJ, 2006, PEDIATRIC PET IMAGING, P385, DOI 10.1007/0-387-34641-4_21; Forati E, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.085414; FOWLER JS, 1989, SYNAPSE, V4, P371, DOI 10.1002/syn.890040412; Gangaraj SAH, 2015, OPT EXPRESS, V23, P22330, DOI 10.1364/OE.23.022330; Ge RC, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.205425; GROVES PM, 1975, SCIENCE, V190, P522, DOI 10.1126/science.242074; Hanson GW, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.235440; Hanson GW, 2009, J APPL PHYS, V106, DOI 10.1063/1.3204653; Howes O, 2015, J PSYCHOPHARMACOL, V29, P97, DOI 10.1177/0269881114563634; INNIS RB, 1993, P NATL ACAD SCI USA, V90, P11965, DOI 10.1073/pnas.90.24.11965; Khurgin JB, 2015, NAT NANOTECHNOL, V10, P2, DOI 10.1038/nnano.2014.310; Khurgin JB, 2014, NAT PHOTONICS, V8, P468, DOI 10.1038/nphoton.2014.94; Khurgin JB, 2012, MRS BULL, V37, P768, DOI 10.1557/mrs.2012.173; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Kruss S, 2014, J AM CHEM SOC, V136, P713, DOI 10.1021/ja410433b; LARUELLE M, 1993, SYNAPSE, V13, P295, DOI 10.1002/syn.890130402; Lee J, 2014, NANOSCALE, V6, P616, DOI [10.1039/c3nr04752, 10.1039/c3nr04752k]; Li DX, 2012, IEEE T BIO-MED ENG, V59, P3468, DOI 10.1109/TBME.2012.2219049; Liao HW, 2006, NANOMEDICINE-UK, V1, P201, DOI 10.2217/17435889.1.2.201; Maier S.A., 2007, PLASMONICS FUNDAMENT, DOI DOI 10.1007/0-387-37825-1; Maier SA, 2005, J APPL PHYS, V98, DOI 10.1063/1.1951057; Mozley PD, 1998, J NUCL MED, V39, p221P; Nath N, 2004, ANAL CHEM, V76, P5370, DOI 10.1021/ac049741z; PURCELL EM, 1946, PHYS REV, V69, P681; Raether H., 1988, SURFACE PLASMONS SMO, DOI 10.1007/BFb0048319; SALLER CF, 1980, SCIENCE, V210, P1269, DOI 10.1126/science.6254155; Shariatgorji M, 2014, NEURON, V84, P697, DOI 10.1016/j.neuron.2014.10.011; Tsai GE, 2014, AM J PSYCHIAT, V155, P726; Vollmer F, 2008, NAT METHODS, V5, P591, DOI 10.1038/nmeth.1221; West PR, 2010, LASER PHOTONICS REV, V4, P795, DOI 10.1002/lpor.200900055; Willets KA, 2007, ANNU REV PHYS CHEM, V58, P267, DOI 10.1146/annurev.physchem.58.032806.104607; Zayats AV, 2003, J OPT A-PURE APPL OP, V5, pS16, DOI 10.1088/1464-4258/5/4/353; Zhang JZ, 2010, J PHYS CHEM LETT, V1, P686, DOI 10.1021/jz900366c	38	2	2	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145852	10.1371/journal.pone.0145852	http://dx.doi.org/10.1371/journal.pone.0145852			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717196	Green Published, Green Submitted, gold			2022-12-26	WOS:000367510500083
J	Ritz, C; Baty, F; Streibig, JC; Gerhard, D				Ritz, Christian; Baty, Florent; Streibig, Jens C.; Gerhard, Daniel			Dose-Response Analysis Using R	PLOS ONE			English	Article							NONLINEAR-REGRESSION; SIMULTANEOUS INFERENCE; MODEL; TRANSFORMATIONS; BIOASSAY; POTENCY; PACKAGE; GROWTH	Dose-response analysis can be carried out using multi-purpose commercial statistical software, but except for a few special cases the analysis easily becomes cumbersome as relevant, non-standard output requires manual programming. The extension package drc for the statistical environment R provides a flexible and versatile infrastructure for dose-response analyses in general. The present version of the package, reflecting extensions and modifications over the last decade, provides a user-friendly interface to specify the model assumptions about the dose-response relationship and comes with a number of extractors for summarizing fitted models and carrying out inference on derived parameters. The aim of the present paper is to provide an overview of state-of-the-art dose-response analysis, both in terms of general concepts that have evolved and matured over the years and by means of concrete examples.	[Ritz, Christian] Univ Copenhagen, Dept Nutr Exercise & Sports, DK-1958 Frederiksberg C, Denmark; [Baty, Florent] Kantonsspital St Gallen, Pneumol, CH-9007 St Gallen, Switzerland; [Streibig, Jens C.] Univ Copenhagen, Dept Plant & Environm Sci, DK-2630 Taastrup, Denmark; [Gerhard, Daniel] Univ Canterbury, Sch Math & Stat, Christchurch 8140, New Zealand	University of Copenhagen; Kantonsspital St. Gallen; University of Copenhagen; University of Canterbury	Ritz, C (corresponding author), Univ Copenhagen, Dept Nutr Exercise & Sports, Rolighedsvej 26, DK-1958 Frederiksberg C, Denmark.	ritz@nexs.ku.dk	Gerhard, Daniel/J-7193-2017; He, Liye/C-8843-2015; Ritz, Christian/P-6159-2014; Streibig, Jens Carl/G-5959-2014	Gerhard, Daniel/0000-0002-9336-3454; He, Liye/0000-0002-6632-2112; Ritz, Christian/0000-0002-5095-0624; Streibig, Jens Carl/0000-0002-6204-4004				Altop EK, 2014, CROP PROT, V65, P202, DOI 10.1016/j.cropro.2014.07.011; Andersen Jens Strodl, 1998, Journal of Agricultural Biological and Environmental Statistics, V3, P405, DOI 10.2307/1400573; Andreasen C, 2014, HORTSCIENCE, V49, P538, DOI 10.21273/HORTSCI.49.5.538; Baty F, 2015, J STAT SOFTW, V66, P1; Belz RG, 2015, ENVIRON TOXICOL CHEM, V34, P1169, DOI 10.1002/etc.2857; Bornkamp B, 2009, J STAT SOFTW, V29, P1; BRAIN P, 1989, WEED RES, V29, P93, DOI 10.1111/j.1365-3180.1989.tb00845.x; CARROLL RJ, 1984, J AM STAT ASSOC, V79, P321, DOI 10.2307/2288271; Cedergreen N, 2005, ENVIRON TOXICOL CHEM, V24, P3166, DOI 10.1897/05-014R.1; Christensen MG, 2003, PEST MANAG SCI, V59, P1303, DOI 10.1002/ps.763; Cornou C, 2013, ANIM PROD SCI, V53, P585, DOI 10.1071/AN12091; Finney D.J., 1971, PROBIT ANAL; FINNEY DJ, 1979, INT STAT REV, V47, P1, DOI 10.2307/1403201; Garnier-Laplace J, 2010, J RADIOL PROT, V30, P215, DOI 10.1088/0952-4746/30/2/S02; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Huber P. H., 1981, ROBUST STAT; Jensen JE, 2000, HERBICIDES THEIR MEC; Jensen SM, 2015, RISK ANAL, V35, P68, DOI 10.1111/risa.12242; Kahm M, 2010, J STAT SOFTW, V33, P1; Kang SH, 2000, REGUL TOXICOL PHARM, V32, P68, DOI 10.1006/rtph.2000.1404; Kniss AR, 2011, WEED SCI, V59, P601, DOI 10.1614/WS-D-11-00034.1; Martin-Betancor K, 2015, SCI REP-UK, V5, DOI 10.1038/srep17200; Motulsky HJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-123; Namata H, 2008, RISK ANAL, V28, P891, DOI 10.1111/j.1539-6924.2008.01063.x; Nash JC, 2014, J STAT SOFTW, V60, P1; NORMOLLE DP, 1993, STAT MED, V12, P2025, DOI 10.1002/sim.4780122106; Pinheiro J, 2015, NLME LINEAR NONLINEA; Pinheiro J, 2014, STAT MED, V33, P1646, DOI 10.1002/sim.6052; Pires AM, 2002, ENVIRONMETRICS, V13, P15, DOI 10.1002/env.501; R Core Team, 2013, R LANG ENV STAT COMP; Ranke J., 2006, R NEWS, V3, P7; Ricketts JH, 1999, AM J PHYSIOL-REG I, V277, pR441, DOI 10.1152/ajpregu.1999.277.2.R441; Ritz C, 2005, J STAT SOFTW, V12, P1; Ritz C, 2015, MARGINALIZATIO UNPUB; Ritz C, 2006, WEED SCI, V54, P407, DOI 10.1614/WS-05-185R.1; Ritz C, 2013, STAT BIOPHARM RES, V5, P79, DOI 10.1080/19466315.2012.757559; Ritz C, 2013, EUR J AGRON, V45, P1, DOI 10.1016/j.eja.2012.10.003; Ritz C, 2008, USE R, P1; Ritz C, 2010, ENVIRON TOXICOL CHEM, V29, P220, DOI 10.1002/etc.7; Ritz C, 2009, ENVIRON TOXICOL CHEM, V28, P2009, DOI 10.1897/08-480.1; RUDEMO M, 1989, BIOMETRICS, V45, P349, DOI 10.2307/2531482; Streibig, 2014, SYNERGY, V1, P22, DOI [10.1016/j.synres.2014.07.010, DOI 10.1016/J.SYNRES.2014.07.010]; Streibig J. C., 1993, Herbicide bioassays., P29; STREIBIG JC, 1981, WEED SCI, V29, P469, DOI 10.1017/S0043174500040017; Streibig JC, 1998, PESTIC SCI, V53, P21, DOI 10.1002/(SICI)1096-9063(199805)53:1&lt;21::AID-PS748&gt;3.0.CO;2-L; STROMBERG AJ, 1993, J AM STAT ASSOC, V88, P237, DOI 10.2307/2290718; Therneau T.M., 2000, MODELING SURVIVAL DA; Van der Vaart AW, 2000, ASYMPTOTIC STAT, V3; Van der Vliet L, 2013, ENCY AQUATIC ECOTOXI, P1081, DOI [10.1007/978-94-007-5704-2_98, DOI 10.1007/978-94-007-5704-2_98]; Venables WN., 2002, MODERN APPL STAT S 4; Weimer M, 2012, TOXICOL LETT, V213, P292, DOI 10.1016/j.toxlet.2012.07.012; Weisberg S., 2005, APPL LINEAR REGRESSI, DOI DOI 10.1002/0471704091; Wheeler MW, 2009, ENVIRON ECOL STAT, V16, P37, DOI 10.1007/s10651-007-0071-7; Zeileis A., 2002, R NEWS, V2, P7, DOI DOI 10.HTTPS://CRAN.R-PR0JECT.0RG/D0C/RNEWS/; ZEILEIS A., 2006, J STAT SOFTW, V16, P1, DOI DOI 10.18637/JSS.V016.I09	55	1458	1488	10	145	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0146021	10.1371/journal.pone.0146021	http://dx.doi.org/10.1371/journal.pone.0146021			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717316	Green Published, gold, Green Submitted			2022-12-26	WOS:000367510500116
J	Tokuda, S; Kim, YH; Matsumoto, H; Muro, S; Hirai, T; Mishima, M; Furuse, M				Tokuda, Shinsaku; Kim, Young Hak; Matsumoto, Hisako; Muro, Shigeo; Hirai, Toyohiro; Mishima, Michiaki; Furuse, Mikio			Effects of Hydrostatic Pressure on Carcinogenic Properties of Epithelia	PLOS ONE			English	Article							INTERSTITIAL FLUID PRESSURE; TIGHT JUNCTION; ZONULAE-OCCLUDENTES; BARRIER FUNCTION; 2 STRAINS; IDENTIFICATION; EXPRESSION; CANCER; CELLS; INFLAMMATION	The relationship between chronic inflammation and cancer is well known. The inflammation increases the permeability of blood vessels and consequently elevates pressure in the interstitial tissues. However, there have been only a few reports on the effects of hydrostatic pressure on cultured cells, and the relationship between elevated hydrostatic pressure and cell properties related to malignant tumors is less well understood. Therefore, we investigated the effects of hydrostatic pressure on the cultured epithelial cells seeded on permeable filters. Surprisingly, hydrostatic pressure from basal to apical side induced epithelial stratification in Madin-Darby canine kidney (MDCK) I and Caco-2 cells, and cavities with microvilli and tight junctions around their surfaces were formed within the multi-layered epithelia. The hydrostatic pressure gradient also promoted cell proliferation, suppressed cell apoptosis, and increased transepithelial ion permeability. The inhibition of protein kinase A (PKA) promoted epithelial stratification by the hydrostatic pressure whereas the activation of PKA led to suppressed epithelial stratification. These results indicate the role of the hydrostatic pressure gradient in the regulation of various epithelial cell functions. The findings in this study may provide clues for the development of a novel strategy for the treatment of the carcinoma.	[Tokuda, Shinsaku; Kim, Young Hak; Matsumoto, Hisako; Muro, Shigeo; Hirai, Toyohiro; Mishima, Michiaki] Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto, Japan; [Furuse, Mikio] Natl Inst Physiol Sci, Div Cerebral Struct, Okazaki, Aichi 444, Japan	Kyoto University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS)	Tokuda, S (corresponding author), Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto, Japan.	tokku@kuhp.kyoto-u.ac.jp; furuse@nips.ac.jp		Furuse, Mikio/0000-0003-2847-8156	Funding Program for Next Generation World Leading Researchers from the Japan Society for the Promotion of Science [LS084]; Japan Society for the Promotion of Science [26291043]	Funding Program for Next Generation World Leading Researchers from the Japan Society for the Promotion of Science; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Funding Program for Next Generation World Leading Researchers from the Japan Society for the Promotion of Science, LS084, http://www.jsps.go.jp/, MF; The Grant-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science, 26291043, http://www.jsps.go.jp/, MF.	Amasheh S, 2002, J CELL SCI, V115, P4969, DOI 10.1242/jcs.00165; Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; Aung KZ, 2012, J ORTHOP RES, V30, P2038, DOI 10.1002/jor.22154; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; BARKER G, 1981, Q J EXP PHYSIOL CMS, V66, P61, DOI 10.1113/expphysiol.1981.sp002529; Chen YH, 1997, J CELL BIOL, V138, P891, DOI 10.1083/jcb.138.4.891; CLAUDE P, 1973, J CELL BIOL, V58, P390, DOI 10.1083/jcb.58.2.390; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; DiResta GR, 2005, ANN BIOMED ENG, V33, P1270, DOI 10.1007/s10439-005-5732-9; DRAGSTEN PR, 1981, NATURE, V294, P718, DOI 10.1038/294718a0; EAGLE H, 1967, NATURE, V213, P1102, DOI 10.1038/2131102a0; FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Furuse M, 1999, J CELL BIOL, V147, P891, DOI 10.1083/jcb.147.4.891; Furuse M, 2001, J CELL BIOL, V153, P263, DOI 10.1083/jcb.153.2.263; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; Gunzel D, 2013, PHYSIOL REV, V93, P525, DOI 10.1152/physrev.00019.2012; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; ITOH M, 1991, J CELL BIOL, V115, P1449, DOI 10.1083/jcb.115.5.1449; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; KIMIZUKA H, 1964, J THEOR BIOL, V6, P290, DOI 10.1016/0022-5193(64)90035-9; Lunt SJ, 2008, FUTURE ONCOL, V4, P793, DOI 10.2217/14796694.4.6.793; Mantovani A, 2010, CURR MOL MED, V10, P369, DOI 10.2174/156652410791316968; Michel CC, 1999, PHYSIOL REV, V79, P703, DOI 10.1152/physrev.1999.79.3.703; Milosevic M, 2001, CANCER RES, V61, P6400; POWELL DW, 1981, AM J PHYSIOL, V241, pG275, DOI 10.1152/ajpgi.1981.241.4.G275; Puliafito A, 2012, P NATL ACAD SCI USA, V109, P739, DOI 10.1073/pnas.1007809109; Reuss L., 2001, TIGHT JUNCTIONS, V2, P61; Saitou M, 1997, EUR J CELL BIOL, V73, P222; STAEHELIN LA, 1973, J CELL SCI, V13, P763; STEVENSON BR, 1988, J CELL BIOL, V107, P2401, DOI 10.1083/jcb.107.6.2401; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Tokuda S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119869; Tokuda S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104994; Tokuda S, 2009, BIOCHEM BIOPH RES CO, V390, P1315, DOI 10.1016/j.bbrc.2009.10.144; Turksen K, 2011, BBA-REV CANCER, V1816, P73, DOI 10.1016/j.bbcan.2011.04.001; Van Itallie CM, 2008, J CELL SCI, V121, P298, DOI 10.1242/jcs.021485; Van Itallie CM, 2003, AM J PHYSIOL-RENAL, V285, pF1078, DOI 10.1152/ajprenal.00116.2003; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Vendramini-Costa DB, 2012, CURR PHARM DESIGN, V18, P3831; Weinberg R. A., 2013, BIOL CANC; Wu CJ, 2013, J BIOL CHEM, V288, P12253, DOI 10.1074/jbc.M113.457499; Yu ASL, 2009, J GEN PHYSIOL, V133, P111, DOI 10.1085/jgp.200810154	45	5	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145522	10.1371/journal.pone.0145522	http://dx.doi.org/10.1371/journal.pone.0145522			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716691	Green Submitted, Green Published, gold			2022-12-26	WOS:000367510500040
J	Toscano, H; Schubert, TW				Toscano, Hugo; Schubert, Thomas W.			Judged and Remembered Trustworthiness of Faces Is Enhanced by Experiencing Multisensory Synchrony and Asynchrony in the Right Order	PLOS ONE			English	Article							SELF-OTHER BOUNDARIES; MOVEMENT SYNCHRONY; MIMICRY; TRUST; CATEGORIZATION; ENTITATIVITY; RECOGNITION; INTEGRATION; ILLUSION; AMYGDALA	This work builds on the enfacement effect. This effect occurs when experiencing a rhythmic stimulation on one's cheek while seeing someone else's face being touched in a synchronous way. This typically leads to cognitive and social-cognitive effects similar to self-other merging. In two studies, we demonstrate that this multisensory stimulation can change the evaluation of the other's face. In the first study, participants judged the stranger's face and similar faces as being more trustworthy after synchrony, but not after asynchrony. Synchrony interacted with the order of the stroking; hence trustworthiness only changed when the synchronous stimulation occurred before the asynchronous one. In the second study, a synchronous stimulation caused participants to remember the stranger's face as more trustworthy, but again only when the synchronous stimulation came before the asynchronous one. The results of both studies show that order of stroking creates a context in which multisensory synchrony can affect the trustworthiness of faces.	[Toscano, Hugo; Schubert, Thomas W.] Inst Univ Lisboa ISCTE IUL, Ctr Invest & Intervencao Social, Lisbon, Portugal; [Schubert, Thomas W.] Univ Oslo, Dept Psychol, Oslo, Norway	Instituto Universitario de Lisboa; University of Oslo	Schubert, TW (corresponding author), Inst Univ Lisboa ISCTE IUL, Ctr Invest & Intervencao Social, Lisbon, Portugal.	thomas.wolfgang.schubert@gmail.com		Schubert, Thomas/0000-0002-3797-4568	Fundacao para a Ciencia e a Tecnologia (FCT) grant SFRH(Science Foundation Research) [BD/75435/2010]	Fundacao para a Ciencia e a Tecnologia (FCT) grant SFRH(Science Foundation Research)	This research and development was supported by Fundacao para a Ciencia e a Tecnologia (FCT) grant SFRH(Science Foundation Research)/BD/75435/2010. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, FAC MAIN SOFTW DEV K; Blair IV, 2004, PSYCHOL SCI, V15, P674, DOI 10.1111/j.0956-7976.2004.00739.x; Blanke O, 2009, TRENDS COGN SCI, V13, P7, DOI 10.1016/j.tics.2008.10.003; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Cumming G, 2014, PSYCHOL SCI, V25, P7, DOI 10.1177/0956797613504966; DeBruine LM, 2002, P ROY SOC B-BIOL SCI, V269, P1307, DOI 10.1098/rspb.2002.2034; DONALDSON TS, 1968, J AM STAT ASSOC, V63, P660, DOI 10.2307/2284037; Engell AD, 2007, J COGNITIVE NEUROSCI, V19, P1508, DOI 10.1162/jocn.2007.19.9.1508; Epley N, 2008, PERS SOC PSYCHOL B, V34, P1159, DOI 10.1177/0146167208318601; Farmer H, 2014, PSYCHOL SCI, V25, P290, DOI 10.1177/0956797613494852; Fiske AP, 2004, RELATIONAL MODELS THEORY: CONTEMPORARY OVERVIEW, P61; GLASS GV, 1972, REV EDUC RES, V42, P237, DOI 10.2307/1169991; Hall C.C., 2009, POLITICAL PSYCHOL DE, P73, DOI DOI 10.1093/ACPROF:OSO/9780195335453.001.0001; Hess U, 2013, PERS SOC PSYCHOL REV, V17, P142, DOI 10.1177/1088868312472607; Jacques C, 2006, PSYCHOL SCI, V17, P485, DOI 10.1111/j.1467-9280.2006.01733.x; Jones BC, 2007, J EVOL PSYCHOL, V5, P119, DOI DOI 10.1556/JEP.2007.1001; Kraus MW, 2010, PSYCHOL SCI, V21, P518, DOI 10.1177/0956797610364949; Kret ME, 2015, PSYCHOL SCI, V26, P1401, DOI 10.1177/0956797615588306; Lakens D, 2011, SOC COGNITION, V29, P1, DOI 10.1521/soco.2011.29.1.1; Lakens D, 2010, J EXP SOC PSYCHOL, V46, P701, DOI 10.1016/j.jesp.2010.03.015; Lakin JL, 2003, J NONVERBAL BEHAV, V27, P145, DOI 10.1023/A:1025389814290; Levin DT, 2000, PERCEPT PSYCHOPHYS, V62, P386, DOI 10.3758/BF03205558; Longo MR, 2008, COGNITION, V107, P978, DOI 10.1016/j.cognition.2007.12.004; Maravita A, 2003, CURR BIOL, V13, pR531, DOI 10.1016/S0960-9822(03)00449-4; Mazzurega M, 2011, EXP BRAIN RES, V213, P213, DOI 10.1007/s00221-011-2744-6; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; Paladino MP, 2010, PSYCHOL SCI, V21, P1202, DOI 10.1177/0956797610379234; Schubert TW, 2002, SELF IDENTITY, V1, P353, DOI 10.1080/152988602760328012; Schubert TW, 2015, ORDER EFFECTS UNPUB; Seibt B, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01122; Sforza A, 2010, SOC NEUROSCI-UK, V5, P148, DOI 10.1080/17470910903205503; Tajadura-Jimenez A, 2013, CONSCIOUS COGN, V22, P1352, DOI 10.1016/j.concog.2013.09.002; Tajadura-Jimenez A, 2012, CONSCIOUS COGN, V21, P1725, DOI 10.1016/j.concog.2012.10.004; Tajadura-Jimenez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040682; Todorov A, 2008, SOC COGN AFFECT NEUR, V3, P303, DOI 10.1093/scan/nsn033; Tsakiris M, 2005, J EXP PSYCHOL HUMAN, V31, P80, DOI 10.1037/0096-1523.31.1.80; Tsakiris M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004040; Valdesolo P, 2010, J EXP SOC PSYCHOL, V46, P693, DOI 10.1016/j.jesp.2010.03.004; Verosky SC, 2013, J EXP SOC PSYCHOL, V49, P661, DOI 10.1016/j.jesp.2013.02.004; Verosky SC, 2010, PSYCHOL SCI, V21, P779, DOI 10.1177/0956797610371965; Wegner DM, 2004, J PERS SOC PSYCHOL, V86, P838, DOI 10.1037/0022-3514.86.6.838; Willis J, 2006, PSYCHOL SCI, V17, P592, DOI 10.1111/j.1467-9280.2006.01750.x; Wiltermuth SS, 2009, PSYCHOL SCI, V20, P1, DOI 10.1111/j.1467-9280.2008.02253.x; Zebrowitz L A, 1997, Pers Soc Psychol Rev, V1, P204, DOI 10.1207/s15327957pspr0103_2; Zebrowitz L. A., 1997, READING FACES WINDOW; ZEBROWITZ LA, 1991, LAW HUMAN BEHAV, V15, P603, DOI 10.1007/BF01065855	46	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145664	10.1371/journal.pone.0145664	http://dx.doi.org/10.1371/journal.pone.0145664			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA0TN	26716682	gold, Green Submitted, Green Published			2022-12-26	WOS:000367510500056
J	Cammaerts, S; Strazisar, M; Smets, B; Weckhuysen, S; Nordin, A; De Jonghe, P; Adolfsson, R; De Rijk, P; Del Favero, J				Cammaerts, Sophia; Strazisar, Mojca; Smets, Bart; Weckhuysen, Sarah; Nordin, Annelie; De Jonghe, Peter; Adolfsson, Rolf; De Rijk, Peter; Del Favero, Jurgen			Schizophrenia-Associated MIR204 Regulates Noncoding RNAs and Affects Neurotransmitter and Ion Channel Gene Sets	PLOS ONE			English	Article							PROSPECTIVE COHORT; NMDA RECEPTOR; MICRORNA; MIR-204; EXPRESSION; CELLS; PROLIFERATION; MECHANISMS; INVASION; MIR-618	As regulators of gene expression, microRNAs (miRNAs) are likely to play an important role in the development of disease. In this study we present a large-scale strategy to identify miRNAs with a role in the regulation of neuronal processes. Thereby we found variant rs7861254 located near the MIR204 gene to be significantly associated with schizophrenia. This variant resulted in reduced expression of miR-204 in neuronal-like SH-SY5Y cells. Analysis of the consequences of the altered miR-204 expression on the transcriptome of these cells uncovered a new mode of action for miR-204, being the regulation of noncoding RNAs (ncRNAs), including several miRNAs, such as MIR296. Furthermore, pathway analysis showed downstream effects of miR-204 on neurotransmitter and ion channel related gene sets, potentially mediated by miRNAs regulated through miR-204.	[Cammaerts, Sophia; Strazisar, Mojca; Smets, Bart; Weckhuysen, Sarah; De Jonghe, Peter; De Rijk, Peter; Del Favero, Jurgen] Univ Antwerp, B-2020 Antwerp, Belgium; [Cammaerts, Sophia; Strazisar, Mojca; De Rijk, Peter; Del Favero, Jurgen] VIB, Appl Mol Genom Unit, Dept Mol Genet, Antwerp, Belgium; [Smets, Bart] VIB, Dept Mol Genet, Centralized Serv Facil, Antwerp, Belgium; [Weckhuysen, Sarah; De Jonghe, Peter] VIB, Dept Mol Genet, Neurogenet Grp, Antwerp, Belgium; [Nordin, Annelie; Adolfsson, Rolf] Umea Univ, Dept Clin Sci, Div Psychiat, Umea, Sweden; [De Jonghe, Peter] Univ Antwerp Hosp, Antwerp, Belgium; [Del Favero, Jurgen] Multiplicom NV, Niel, Belgium	University of Antwerp; Flanders Institute for Biotechnology (VIB); Flanders Institute for Biotechnology (VIB); Flanders Institute for Biotechnology (VIB); Umea University; University of Antwerp	Del Favero, J (corresponding author), Univ Antwerp, B-2020 Antwerp, Belgium.	jurgen.delfavero@molgen.vib-ua.be	De Rijk, Peter/GXH-9837-2022; Weckhuysen, Sarah/HGB-9957-2022; Strazisar, Mojca/Z-2361-2019	De Rijk, Peter/0000-0001-8558-9288; Weckhuysen, Sarah/0000-0003-2878-1147; Strazisar, Mojca/0000-0001-8046-3408; Adolfsson, Rolf/0000-0001-9785-8473; /0000-0002-8114-7615	Research Foundation-Flanders [G027410N]; University Research Fund [UA-KP BOF/MS-2013 6264]; Multiplicom N.V.	Research Foundation-Flanders(FWO); University Research Fund; Multiplicom N.V.	This work was supported by Research Foundation-Flanders (G027410N to JDF, http://www.fwo.be/) and by the University Research Fund (UA-KP BOF/MS-2013 6264 to MS, https://www.uantwerpen.be/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JDF is besides his tenure track position at the University of Antwerp also acting CTO of Multiplicom N.V. Both mandates are independent from each other and Multiplicom N.V. has no financial interest nor investment in the current study. Multiplicom N.V. provided support in the form of salaries for author JDF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Almeida-Souza L, 2010, J BIOL CHEM, V285, P12778, DOI 10.1074/jbc.M109.082644; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; Cammaerts S, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv921; Chen PS, 2011, J CLIN INVEST, V121, P3442, DOI 10.1172/JCI45390; Cheng QP, 2014, ANN ENDOCRINOL-PARIS, V75, P187, DOI 10.1016/j.ando.2014.01.002; Chung TKH, 2012, INT J CANCER, V130, P1036, DOI 10.1002/ijc.26060; Conte I, 2015, P NATL ACAD SCI USA, V112, pE3236, DOI 10.1073/pnas.1401464112; Conte I, 2014, NUCLEIC ACIDS RES, V42, P7793, DOI 10.1093/nar/gku498; Conte I, 2010, P NATL ACAD SCI USA, V107, P15491, DOI 10.1073/pnas.0914785107; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; Feliciano A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076247; Feng JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006121; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fu A, 2014, EPIGENETICS-US, V9, P730, DOI 10.4161/epi.27996; Goossens D, 2009, HUM MUTAT, V30, P472, DOI 10.1002/humu.20873; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hall DP, 2014, CANCER CELL, V26, P738, DOI 10.1016/j.ccell.2014.09.015; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Helwak A, 2013, CELL, V153, P654, DOI 10.1016/j.cell.2013.03.043; Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266; Huang V, 2012, RNA BIOL, V9, P269, DOI 10.4161/rna.19354; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jo K, 1999, J NEUROSCI, V19, P4189, DOI 10.1523/jneurosci.19-11-04189.1999; Kan AA, 2012, CELL MOL LIFE SCI, V69, P3127, DOI 10.1007/s00018-012-0992-7; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Liao JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010563; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Marin RM, 2011, NUCLEIC ACIDS RES, V39, P19, DOI 10.1093/nar/gkq768; Matkovich SJ, 2013, CIRC RES, V113, P62, DOI 10.1161/CIRCRESAHA.113.300975; Mencia A, 2009, NAT GENET, V41, P609, DOI 10.1038/ng.355; Moens LN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023450; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nilsson LG, 1997, AGING NEUROPSYCHOL C, V4, P1, DOI 10.1080/13825589708256633; Nilsson LG, 2004, AGING NEUROPSYCHOL C, V11, P134, DOI 10.1080/13825580490511026; Olsen O, 2005, J CELL BIOL, V170, P1127, DOI 10.1083/jcb.200503011; Pallante P, 2006, ENDOCR-RELAT CANCER, V13, P497, DOI 10.1677/erc.1.01209; Paylakhi SH, 2013, EXP EYE RES, V111, P112, DOI 10.1016/j.exer.2013.03.009; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Reumers J, 2012, NAT BIOTECHNOL, V30, P61, DOI 10.1038/nbt.2053; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Strazisar M, 2015, MOL PSYCHIATR, V20, P472, DOI 10.1038/mp.2014.53; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tang R, 2012, CELL RES, V22, P504, DOI 10.1038/cr.2011.137; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vriens J, 2011, NEURON, V70, P482, DOI 10.1016/j.neuron.2011.02.051; Wei Y, 2014, J BIOL CHEM, V289, P10270, DOI 10.1074/jbc.C113.541417; Wu XJ, 2015, FEBS LETT, V589, P645, DOI 10.1016/j.febslet.2015.01.030; Xu GL, 2013, NAT MED, V19, P1141, DOI 10.1038/nm.3287; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Yin Y, 2014, CLIN CANCER RES, V20, P6187, DOI 10.1158/1078-0432.CCR-14-1030; Ying Z, 2013, CANCER RES, V73, P990, DOI 10.1158/0008-5472.CAN-12-2895	57	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0144428	10.1371/journal.pone.0144428	http://dx.doi.org/10.1371/journal.pone.0144428			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714269	Green Published, gold, Green Submitted			2022-12-26	WOS:000367481900011
J	dos Santos, AB; do Nascimento, FS				dos Santos, Aline Borba; do Nascimento, Fabio Santos			Cuticular Hydrocarbons of Orchid Bees Males: Interspecific and Chemotaxonomy Variation	PLOS ONE			English	Article							APIS-MELLIFERA; INSECT HYDROCARBONS; HONEY-BEE; DISCRIMINATION; LIPIDS; DIFFERENTIATION; BIOCHEMISTRY; HYMENOPTERA; CHARACTERS; EUGLOSSINI	Recent studies have investigated the composition of compounds that cover the cuticle in social insects, but few studies have focused on solitary bees. Cuticular hydrocarbons may provide a tool for chemotaxonomy, and perhaps they can be used as a complement to morphology and genetic characters in phylogenetic studies. Orchid bees (Tribe Euglossini) are a highly diverse group of Neotropical bees with more than 200 species. Here, the cuticular hydrocarbons of 17 species were identified and statistical analysis revealed 108 compounds, which allowed for the taxonomic classification according to the genera. The most significant compounds discriminating the four genera were (Z)-9-pentacosene, (Z, Z)-pentatriacontene- 3, (Z)-9-tricosene, and (Z)-9-heptacosene. The analyses demonstrated the potential use of CHCs to identify different species.	[dos Santos, Aline Borba; do Nascimento, Fabio Santos] Univ Sao Paulo, FFCLRP, Dept Biol, Lab Comportamento & Ecol Insetos Sociais, BR-14040901 Sao Paulo, Brazil	Universidade de Sao Paulo	dos Santos, AB (corresponding author), Univ Sao Paulo, FFCLRP, Dept Biol, Lab Comportamento & Ecol Insetos Sociais, Av Bandeirantes 3900, BR-14040901 Sao Paulo, Brazil.	alineborba.s@gmail.com	Nascimento, Fabio S/E-4191-2013	Nascimento, Fabio S/0000-0002-3731-7111	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2010/10027-5, 2010/19449-0]; FAPESP [2010/10027-5, 2010/19449-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo: grantes 2010/10027-5 and 2010/19449-0 to FSN and ABS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are thankful to FAPESP 2010/19449-0 and 2010/10027-5 for the financial support, to the SEMARH/SE (Secretaria de Estado de Meio Ambiente e Recursos Hidricos de Sergipe) for permission to work in the protect area as well as to Izabel C. C. Turatti for collaborating during the identification of compounds, and to Jennifer R. R. Jesus, Mayane Menezes and Eduarda G. Barreto for the helping during the bee collection.	Andrade-Silva ACR, 2012, NEOTROP ENTOMOL, V41, P296, DOI 10.1007/s13744-012-0053-9; Andrade-Silva ACR, ANIM BEHAV, V106, P43; BLOMQUIST GJ, 1987, ARCH INSECT BIOCHEM, V6, P227, DOI 10.1002/arch.940060404; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; BREED MD, 1992, ANIM BEHAV, V43, P875, DOI 10.1016/S0003-3472(06)80001-1; BREED MD, 1988, BEHAV GENET, V18, P439, DOI 10.1007/BF01065513; Buckner JS, 2009, COMP BIOCHEM PHYS B, V153, P200, DOI 10.1016/j.cbpb.2009.02.018; CARLSON DA, 1989, ANAL CHEM, V61, P1564, DOI 10.1021/ac00189a019; CHAPMAN RF, 1995, BIOCHEM SYST ECOL, V23, P383, DOI 10.1016/0305-1978(95)00032-P; Cruz-Landim C., 2009, ABELHAS MORFOLOGIA F; Dani FR, 2005, CHEM SENSES, V30, P477, DOI 10.1093/chemse/bji040; DRESSLER RL, 1982, ANNU REV ECOL SYST, V13, P373, DOI 10.1146/annurev.es.13.110182.002105; Eltz T, 2011, ZOOL J LINN SOC-LOND, V163, P1064, DOI 10.1111/j.1096-3642.2011.00740.x; ESPELIE KE, 1994, J CHEM ECOL, V20, P1677, DOI 10.1007/BF02059889; Gemeno C, 2012, B ENTOMOL RES, V102, P624, DOI 10.1017/S0007485312000193; GETZ WM, 1987, J COMP PHYSIOL A, V160, P239, DOI 10.1007/BF00609729; GIBBS A, 1995, COMP BIOCHEM PHYS B, V112, P243, DOI 10.1016/0305-0491(95)00081-X; Gibbs AG, 1998, AM ZOOL, V38, P471; GOROPASHNAYA A, 2003, PHYLOGEOGRAPHIC STRU; HAVERTY MI, 1990, J CHEM ECOL, V16, P1635, DOI 10.1007/BF01014096; HAVERTY MI, 1988, J CHEM ECOL, V14, P1035, DOI 10.1007/BF01018791; HOWARD RW, 1982, ANNU REV ENTOMOL, V27, P149, DOI 10.1146/annurev.en.27.010182.001053; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; JALLON JM, 1987, EVOLUTION, V41, P294, DOI 10.1111/j.1558-5646.1987.tb05798.x; Kather R, 2015, J CHEM ECOL, V41, P871, DOI 10.1007/s10886-015-0631-5; Kather R, 2012, PHYSIOL ENTOMOL, V37, P25, DOI 10.1111/j.1365-3032.2011.00826.x; Kather R, 2011, J CHEM ECOL, V37, P205, DOI 10.1007/s10886-011-9909-4; Martin S, 2009, J CHEM ECOL, V35, P1151, DOI 10.1007/s10886-009-9695-4; Martin SJ, 2007, P ROY SOC B-BIOL SCI, V274, P2717, DOI 10.1098/rspb.2007.0795; Michener C.D., 2000, BEES WORLD, V1st, DOI DOI 10.7171/JBT.12-2303-004; PAMILO P, 1978, HEREDITAS, V88, P93; Pokorny T, 2014, APIDOLOGIE, V45, P276, DOI 10.1007/s13592-013-0250-5; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ramirez SR, 2010, BIOL J LINN SOC, V100, P552, DOI 10.1111/j.1095-8312.2010.01440.x; Singer Theresa L., 1998, P104; Sokal R., 1958, U KANSAS SCI B, V38, P1409; Ye GY, 2007, J MED ENTOMOL, V44, P450, DOI 10.1603/0022-2585(2007)44[450:CHCIPE]2.0.CO;2; Zimmermann Y, 2009, ECOLOGY, V90, P2994, DOI 10.1890/08-1858.1	39	6	6	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145070	10.1371/journal.pone.0145070	http://dx.doi.org/10.1371/journal.pone.0145070			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713612	gold, Green Published			2022-12-26	WOS:000367481900030
J	Kawelke, S; Feussner, I				Kawelke, Steffen; Feussner, Ivo			Two Predicted Transmembrane Domains Exclude Very Long Chain Fatty acyl-CoAs from the Active Site of Mouse Wax Synthase	PLOS ONE			English	Article							TRIACYLGLYCEROL SYNTHESIS; ENZYME; ESTERS; DGAT2; ACID; ACYLTRANSFERASE-2; BIOSYNTHESIS; PURIFICATION; TOPOLOGY; BINDING	Wax esters are used as coatings or storage lipids in all kingdoms of life. They are synthesized from a fatty alcohol and an acyl-CoA by wax synthases. In order to get insights into the structure-function relationships of a wax synthase from Mus musculus, a domain swap experiment between the mouse acyl-CoA: wax alcohol acyltransferase (AWAT2) and the homologous mouse acyl-CoA: diacylglycerol O-acyltransferase 2 (DGAT2) was performed. This showed that the substrate specificity of AWAT2 is partially determined by two predicted transmembrane domains near the amino terminus of AWAT2. Upon exchange of the two domains for the respective part of DGAT2, the resulting chimeric enzyme was capable of incorporating up to 20% of very long acyl chains in the wax esters upon expression in S. cerevisiae strain H1246. The amount of very long acyl chains in wax esters synthesized by wild type AWAT2 was negligible. The effect was narrowed down to a single amino acid position within one of the predicted membrane domains, the AWAT2 N36R variant. Taken together, we provide first evidence that two predicted transmembrane domains in AWAT2 are involved in determining its acyl chain length specificity.	[Kawelke, Steffen; Feussner, Ivo] Univ Gottingen, Albrecht von Haller Inst Plant Sci, Dept Plant Biochem, D-37077 Gottingen, Germany; [Feussner, Ivo] Univ Gottingen, Dept Plant Biochem, Goettingen Ctr Mol Biosci GZMB, D-37077 Gottingen, Germany; [Feussner, Ivo] Univ Gottingen, Dept Plant Biochem, Int Ctr Adv Studies Energy Convers, D-37077 Gottingen, Germany	University of Gottingen; University of Gottingen; University of Gottingen	Feussner, I (corresponding author), Univ Gottingen, Albrecht von Haller Inst Plant Sci, Dept Plant Biochem, Justus von Liebig Weg 11, D-37077 Gottingen, Germany.	ifeussn@gwdg.de	Feussner, Ivo/H-9320-2013	Feussner, Ivo/0000-0002-9888-7003	Fond of the Chemical Industry (FCI); Biomolecules Ph.D. program of the Gottingen Graduate School of Neurosciences, Biophysics and Molecular Biology (GGNB); EU grant "Industrial crops producing value added oils for novel chemicals and energy (ICON)" from the 7th framework program (FP7-KBBE-1)	Fond of the Chemical Industry (FCI); Biomolecules Ph.D. program of the Gottingen Graduate School of Neurosciences, Biophysics and Molecular Biology (GGNB); EU grant "Industrial crops producing value added oils for novel chemicals and energy (ICON)" from the 7th framework program (FP7-KBBE-1)	SK received a stipend from the Fond of the Chemical Industry (FCI). SK was supported by the Biomolecules Ph.D. program of the Gottingen Graduate School of Neurosciences, Biophysics and Molecular Biology (GGNB). This work was supported by the EU grant "Industrial crops producing value added oils for novel chemicals and energy (ICON)" from the 7th framework program (FP7-KBBE-2007 1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam M, 2006, J LIPID RES, V47, P375, DOI 10.1194/jlr.M500344-JLR200; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; AUYOUNG J, 1992, P NATL ACAD SCI USA, V89, P4094, DOI 10.1073/pnas.89.9.4094; Barney BM, 2013, APPL ENVIRON MICROB, V79, P396, DOI 10.1128/AEM.02523-12; Barney BM, 2012, APPL ENVIRON MICROB, V78, P5734, DOI 10.1128/AEM.00534-12; Biester EM, 2012, BMC BIOCHEM, V13, DOI 10.1186/1471-2091-13-4; Butovich IA, 2009, J LIPID RES, V50, P2471, DOI 10.1194/jlr.M900252-JLR200; Camera E, 2010, J LIPID RES, V51, P3377, DOI 10.1194/jlr.D008391; Cheng JB, 2004, J BIOL CHEM, V279, P37798, DOI 10.1074/jbc.M406226200; Hagstrom AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037230; Heilmann M, 2012, J LIPID RES, V53, P2153, DOI 10.1194/jlr.M029512; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hornung E, 2005, BBA-MOL CELL BIOL L, V1686, P181, DOI 10.1016/j.bbalip.2004.11.001; HUTCHISON CA, 1978, J BIOL CHEM, V253, P6551; Iven T, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-24; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Lardizabal KD, 2000, PLANT PHYSIOL, V122, P645, DOI 10.1104/pp.122.3.645; Larson TR, 2001, PLANT J, V25, P115, DOI 10.1046/j.1365-313x.2001.00929.x; LEHNER R, 1995, J BIOL CHEM, V270, P13630, DOI 10.1074/jbc.270.23.13630; Liu Q, 2011, J BIOL CHEM, V286, P13115, DOI 10.1074/jbc.M110.204412; McFie PJ, 2011, J BIOL CHEM, V286, P28235, DOI 10.1074/jbc.M111.256008; Metz JG, 2000, PLANT PHYSIOL, V122, P635, DOI 10.1104/pp.122.3.635; Miklaszewska M, 2013, ACTA BIOCHIM POL, V60, P209; Rottig A, 2013, MICROBIOL MOL BIOL R, V77, P277, DOI 10.1128/MMBR.00010-13; ROSENDAL J, 1992, ANAL BIOCHEM, V207, P63, DOI 10.1016/0003-2697(92)90500-7; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Samuels L, 2008, ANNU REV PLANT BIOL, V59, P683, DOI 10.1146/annurev.arplant.59.103006.093219; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shockey JM, 2006, PLANT CELL, V18, P2294, DOI 10.1105/tpc.106.043695; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Stoeveken T, 2009, EUR J LIPID SCI TECH, V111, P112, DOI 10.1002/ejlt.200800167; Stone SJ, 2009, J BIOL CHEM, V284, P5352, DOI 10.1074/jbc.M805768200; Stone SJ, 2006, J BIOL CHEM, V281, P40273, DOI 10.1074/jbc.M607986200; Turchetto-Zolet AC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-263; Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013; Zhang J, 2014, J BIOL CHEM, V289, P10909, DOI 10.1074/jbc.M113.530022	38	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145797	10.1371/journal.pone.0145797	http://dx.doi.org/10.1371/journal.pone.0145797			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714272	gold, Green Submitted, Green Published			2022-12-26	WOS:000367481900083
J	Messeri, A; Morabito, M; Messeri, G; Brandani, G; Petralli, M; Natali, F; Grifoni, D; Crisci, A; Gensini, G; Orlandini, S				Messeri, Alessandro; Morabito, Marco; Messeri, Gianni; Brandani, Giada; Petralli, Martina; Natali, Francesca; Grifoni, Daniele; Crisci, Alfonso; Gensini, Gianfranco; Orlandini, Simone			Weather-Related Flood and Landslide Damage: A Risk Index for Italian Regions	PLOS ONE			English	Article							PRECIPITATION EXTREMES; HEALTH IMPACTS; VARIABILITY; CLIMATE; FREQUENCY; PATTERNS; TRENDS	The frequency of natural hazards has been increasing in the last decades in Europe and specifically in Mediterranean regions due to climate change. For example heavy precipitation events can lead to disasters through the interaction with exposed and vulnerable people and natural systems. It is therefore necessary a prevention planning to preserve human health and to reduce economic losses. Prevention should mainly be carried out with more adequate land management, also supported by the development of an appropriate risk prediction tool based on weather forecasts. The main aim of this study is to investigate the relationship between weather types (WTs) and the frequency of floods and landslides that have caused damage to properties, personal injuries, or deaths in the Italian regions over recent decades. In particular, a specific risk index (WT-FLARI) for each WT was developed at national and regional scale. This study has identified a specific risk index associated with each weather type, calibrated for each Italian region and applicable to both annual and seasonal levels. The risk index represents the seasonal and annual vulnerability of each Italian region and indicates that additional preventive actions are necessary for some regions. The results of this study represent a good starting point towards the development of a tool to support policy-makers, local authorities and health agencies in planning actions, mainly in the medium to long term, aimed at the weather damage reduction that represents an important issue of the World Meteorological Organization mission.	[Messeri, Alessandro; Morabito, Marco; Brandani, Giada; Petralli, Martina; Natali, Francesca; Orlandini, Simone] Univ Florence, Interdept Ctr Bioclimatol, I-50144 Florence, Italy; [Messeri, Alessandro; Brandani, Giada; Petralli, Martina; Natali, Francesca; Orlandini, Simone] Univ Florence, Dept Agrifood Prod & Environm Sci, DISPAA, I-50144 Florence, Italy; [Morabito, Marco; Messeri, Gianni; Grifoni, Daniele; Crisci, Alfonso] CNR, Inst Biometeorol, I-50145 Florence, Italy; [Messeri, Gianni; Grifoni, Daniele; Crisci, Alfonso] Consortium LaMMa Lab Monitoring & Environm Modell, I-50019 Florence, Italy; [Gensini, Gianfranco] Univ Florence, Clin Med & Cardiol, I-50134 Florence, Italy	University of Florence; University of Florence; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biometeorologia (IBIMET-CNR); University of Florence	Messeri, A (corresponding author), Univ Florence, Interdept Ctr Bioclimatol, Piazzale Cascine 18, I-50144 Florence, Italy.	cpneme@tin.it	Crisci, Alfonso/AAX-3314-2020; Morabito, Marco/AAX-7261-2020; Grifoni, Daniele/B-8612-2011; petralli, martina/H-7244-2012	Morabito, Marco/0000-0002-8799-4866; Grifoni, Daniele/0000-0002-0811-1624; petralli, martina/0000-0003-0221-0776	European Project Horizon (H-DRS) Culture And RISkmanagement in Man-made And Natural Disasters (CARISMAND-G.A.) [635748]	European Project Horizon (H-DRS) Culture And RISkmanagement in Man-made And Natural Disasters (CARISMAND-G.A.)	This study was funded by the European Project Horizon 2020 (H2020-DRS-2014) Culture And RISkmanagement in Man-made and Natural Disasters (CARISMAND-G.A. 635748-Horizon 2020).; The authors wish to thank AVI Project(Inventory of areas affected by landslides and floods in Italy), carried out by CNR, which allows data consultation available at http://avi.gndci.cnr.it/welcome_en.htm. Our study was funded by the European Project Horizon 2020 (H2020-DRS2014) Culture And RISkmanagement in Man-made And Natural Disasters (CARISMAND-G.A. 635748-Horizon 2020). Thank you also the Regional MeteoSalute Project and the Regional Health System of Tuscany.	Adeola FO, 2009, HUM ECOL REV, V16, P195; Ahern M., 2006, FLOOD HAZARDS HLTH R, P28; ALPERT P, 1990, J CLIMATE, V3, P1474, DOI 10.1175/1520-0442(1990)003<1474:IVOCTI>2.0.CO;2; Alpert P., 1990, Tellus, Series A (Dynamic Meteorology and Oceanography), V42A, P65, DOI 10.1034/j.1600-0870.1990.00007.x; Armstrong WH, 2012, J AM WATER RESOUR AS, V48, P306, DOI 10.1111/j.1752-1688.2011.00613.x; Beck C, 2007, INT J CLIMATOL, V27, P473, DOI 10.1002/joc.1410; Benestad RE, 2012, NAT CLIM CHANGE, V2, P544, DOI 10.1038/NCLIMATE1497; Benestad RE, 2012, TELLUS A, V64, DOI 10.3402/tellusa.v64i0.14981; Brooks HE, 2009, ATMOS RES, V93, P546, DOI 10.1016/j.atmosres.2008.10.005; Cartwright L, 2005, J CONTEMP WAT RES ED, V130, P20, DOI 10.1111/j.1936-704X.2005.mp130001004.x; Cemaden, 2013, REP CTR NAT MON AL D; Christiansen B, 2007, J CLIMATE, V20, P2229, DOI [10.1175/JCLI4107.1, 10.1175/JCL14107.1]; Colon L, 2013, THESIS; Dankers R, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD011523; Deser C, 2012, NAT CLIM CHANGE, V2, P775, DOI 10.1038/NCLIMATE1562; Dilley M, 2006, PHILOS T R SOC A, V364, P2217, DOI 10.1098/rsta.2006.1823; Dotzek N, 2009, ATMOS RES, V93, P575, DOI 10.1016/j.atmosres.2008.10.020; EASAC-European Academies' Science Advisory Council, 2013, EXTR WEATH EV EUR PR; EM-DAT, 2010, INT DIS DAT; Erpicum M., 2008, COST 733 MIDT C ADV, P33; Few R., 2014, 63 NORW TYND CTR CLI; Fewtrell L, 2008, PUBLIC HEALTH, V122, P446, DOI 10.1016/j.puhe.2007.09.010; Field CB, 2012, SPECIAL REPORT WORKI; Galea S, 2005, EPIDEMIOL REV, V27, P78, DOI 10.1093/epirev/mxi003; Gentle J. E., 2007, MATRIX ALGEBRA THEOR; Guha-Sapir D, 2011, NAT HAZARDS, V58, P845, DOI 10.1007/s11069-011-9775-y; Hannah DM, 2011, HYDROL PROCESS, V25, P1191, DOI 10.1002/hyp.7794; Harmeling S, 2010, GLOBAL CLIMATE RISK; Hawley K., 2012, UNDERSTANDING EC FLO; Huth R, 2000, THEOR APPL CLIMATOL, V67, P1, DOI 10.1007/s007040070012; Huth R, 2008, ANN NY ACAD SCI, V1146, P105, DOI 10.1196/annals.1446.019; Integracao, 2013, SIST INT INF DES S2I; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; ISPRA, 2013, ISPRA MAN LIN GUID; ISPRA, 2008, LANDSL IT; Jakubicka, 2010, HLTH IMPACTS FLOODS; Jonkman SN, 2005, DISASTERS, V29, P75, DOI 10.1111/j.0361-3666.2005.00275.x; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kharin VV, 2007, J CLIMATE, V20, P1419, DOI 10.1175/JCLI4066.1; Kirch W, 2005, EXTREME WEATHER EVEN, VXLVI, P303; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Kumpulainen S., 2006, GEOLOGICAL SURVEY FI, V42, P65; Kundzewicz ZW, 2006, CLIM RES, V31, P51, DOI 10.3354/cr031051; Kunkel KE, 1999, B AM METEOROL SOC, V80, P1077, DOI 10.1175/1520-0477(1999)080<1077:TFIWAC>2.0.CO;2; Kunz M, 2009, INT J CLIMATOL, V29, P2283, DOI 10.1002/joc.1865; Lowe D, 2013, INT J ENV RES PUB HE, V10, P7015, DOI [10.3390/ijerph10127015, 10.3390/ijerph110100030]; Maheras P, 2001, INT J CLIMATOL, V21, P109, DOI 10.1002/joc.599; Maynard-Ford MC, 2008, 20081924 USG; Michelozzi Paola, 2014, Recenti Prog Med, V105, P48, DOI 10.1701/1417.15695; Milojevic A, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-11; Neumayer E, 2011, GLOBAL ENVIRON CHANG, V21, P13, DOI 10.1016/j.gloenvcha.2010.10.004; Philipp A, 2009, THEOR APPL CLIMATOL, V96, P31, DOI 10.1007/s00704-008-0037-1; Philipp A, 2016, INT J CLIMATOL, V36, P2673, DOI 10.1002/joc.3920; Philipp A, 2010, PHYS CHEM EARTH, V35, P360, DOI 10.1016/j.pce.2009.12.010; Salinger MJ, 2015, INT J BIOMETEOROL, V59, P1799, DOI 10.1007/s00484-015-0988-8; Selvin S, 1991, STAT ANAL EPIDEMIOLO, P499; Svensson C, 2006, IAHS-AISH P, V305, P1; Trenberth KE, 2011, CLIM RES, V47, P123, DOI 10.3354/cr00953; United Nations Development Programme, 2004, REP RED DIS RISK CHA; Uppala SM, 2005, Q J ROY METEOR SOC, V131, P2961, DOI 10.1256/qj.04.176; Vorosmarty CJ, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2012.0408; Wang L, 2016, ASIA-PAC J PUBLIC HE, V28, p59S, DOI 10.1177/1010539514549763; Weisheimer A, 2014, R SOC INTERFACE, V11; WHO, 2013, REP FLOODS WHO EUR R; WHO, 2010, REP CLIM CHANG EXTR; Wynne-Evans E, 2011, CHEM HAZARDS POISONS, V20, P44	66	31	31	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0144468	10.1371/journal.pone.0144468	http://dx.doi.org/10.1371/journal.pone.0144468			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714309	Green Published, gold			2022-12-26	WOS:000367481900012
J	Hang, JJ; Cai, BX; Xue, P; Wang, L; Hu, H; Zhou, YY; Ren, SJ; Wu, JJ; Zhu, MY; Chen, DH; Yang, HY; Wang, LW				Hang, Junjie; Cai, Binxin; Xue, Peng; Wang, Lei; Hu, Hai; Zhou, Yangyang; Ren, Shujuan; Wu, Jiajin; Zhu, Meiying; Chen, Donghui; Yang, Haiyan; Wang, Liwei			The Joint Effects of Lifestyle Factors and Comorbidities on the Risk of Colorectal Cancer: A Large Chinese Retrospective Case-Control Study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; SLEEP DURATION; EPIDEMIOLOGIC EVIDENCE; ALCOHOL-CONSUMPTION; METABOLIC SYNDROME; METAANALYSIS; PREVENTION; RECOMMENDATIONS; ASSOCIATION; POLYPHENOLS	Background Colorectal cancer (CRC) is a major cause of cancer morbidity and mortality. In previous epidemiologic studies, the respective correlation between lifestyle factors and comorbidity and CRC has been extensively studied. However, little is known about their joint effects on CRC. Methods We conducted a retrospective case-control study of 1,144 diagnosed CRC patients and 60,549 community controls. A structured questionnaire was administered to the participants about their socio-demographic factors, anthropometric measures, comorbidity history and lifestyle factors. Logistic regression model was used to calculate the odds ratio (ORs) and 95% confidence intervals (95% CIs) for each factor. According to the results from logistic regression model, we further developed healthy lifestyle index (HLI) and comorbidity history index (CHI) to investigate their independent and joint effects on CRC risk. Results Four lifestyle factors (including physical activities, sleep, red meat and vegetable consumption) and four types of comorbidity (including diabetes, hyperlipidemia, history of inflammatory bowel disease and polyps) were found to be independently associated with the risk of CRC in multivariant logistic regression model. Intriguingly, their combined pattern-HLI and CHI demonstrated significant correlation with CRC risk independently (ORHLI: 3.91, 95% CI: 3.13-4.88; ORCHI: 2.49, 95% CI: 2.11-2.93) and jointly (OR: 10.33, 95% CI: 6.59-16.18). Conclusions There are synergistic effects of lifestyle factors and comorbidity on the risk of colorectal cancer in the Chinese population.	[Hang, Junjie; Xue, Peng; Wang, Lei; Hu, Hai; Zhou, Yangyang; Ren, Shujuan; Chen, Donghui; Yang, Haiyan; Wang, Liwei] Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Oncol, Shanghai 200030, Peoples R China; [Hang, Junjie; Xue, Peng; Wang, Lei; Hu, Hai; Zhou, Yangyang; Ren, Shujuan; Chen, Donghui; Yang, Haiyan; Wang, Liwei] Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Pancreat Canc Ctr, Shanghai 200030, Peoples R China; [Hang, Junjie; Xue, Peng; Wang, Lei; Hu, Hai; Zhou, Yangyang; Ren, Shujuan; Chen, Donghui; Yang, Haiyan; Wang, Liwei] Shanghai Key Lab Pancreat Dis, Shanghai, Peoples R China; [Cai, Binxin; Wu, Jiajin; Zhu, Meiying] Shanghai Municipal Ctr Dis Control & Prevent, Songjiang Ctr, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Center for Disease Control & Prevention	Yang, HY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Oncol, Shanghai 200030, Peoples R China.	13916708215@163.com; yzwlw@hotmail.com			Songjiang Liandong Program [0702N14002]; National Key Clinical Discipline-Oncology; National Natural Science Foundation of China [81502017, 81502018, 81572315, 81171887, 91229117]	Songjiang Liandong Program; National Key Clinical Discipline-Oncology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by Songjiang Liandong Program (0702N14002), by National Key Clinical Discipline-Oncology, and in part by the National Natural Science Foundation of China (grant nos. 81502017, 81502018, 81572315, 81171887 and 91229117), http://isisn.nsfc.gov.cn/egrantweb/. LW and LWW received the funding. The funder had a role in study design.	Ahmed RL, 2006, CANCER-AM CANCER SOC, V107, P28, DOI 10.1002/cncr.21950; Aleksandrova K, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0168-4; Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; Arranz S, 2012, NUTRIENTS, V4, P759, DOI 10.3390/nu4070759; Bener A, 2010, ASIAN PAC J CANCER P, V11, P963; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Chan DSM, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020456, 10.1371/journal.pone.0027218]; Chen WQ, 2015, CHINESE J CANCER RES, V27, P2, DOI 10.3978/j.issn.1000-9604.2015.01.06; Colangelo LA, 2002, CANCER EPIDEM BIOMAR, V11, P385; Dai Zhen, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P598; Derry MM, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00119; Giovannucci E, 2001, J NUTR, V131, p3109S, DOI 10.1093/jn/131.11.3109S; Haas SL, 2012, CURR OPIN CLIN NUTR, V15, P457, DOI 10.1097/MCO.0b013e3283566699; Hassan MM, 2007, AM J GASTROENTEROL, V102, P2696, DOI 10.1111/j.1572-0241.2007.01510.x; He S, 2008, INT J MOL SCI, V9, P842, DOI 10.3390/ijms9050842; Hebels DGAJ, 2012, FOOD CHEM TOXICOL, V50, P95, DOI 10.1016/j.fct.2011.10.038; Huxley RR, 2009, INT J CANCER, V125, P171, DOI 10.1002/ijc.24343; Inoue I, 2014, WORLD J GASTROENTERO, V20, P1485, DOI 10.3748/wjg.v20.i6.1485; Jiao L, 2013, BRIT J CANCER, V108, P213, DOI 10.1038/bjc.2012.561; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kirkegaard H, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c5504; Larsson SC, 2005, JNCI-J NATL CANCER I, V97, P1679, DOI 10.1093/jnci/dji375; Odegaard AO, 2013, CANCER PREV RES, V6, P360, DOI 10.1158/1940-6207.CAPR-12-0384; Pais R, 2009, WORLD J GASTROENTERO, V15, P5141, DOI 10.3748/wjg.15.5141; ROTHMAN KJ, 1976, AM J EPIDEMIOL, V103, P506, DOI 10.1093/oxfordjournals.aje.a112252; Russo P, 2012, LIFE SCI, V91, P1087, DOI 10.1016/j.lfs.2012.05.003; Salim OEH, 2010, WORLD J SURG ONCOL, V8, DOI 10.1186/1477-7819-8-68; Samad AKA, 2005, COLORECTAL DIS, V7, P204, DOI 10.1111/j.1463-1318.2005.00747.x; Sauer J, 2010, BRIT J NUTR, V104, P24, DOI 10.1017/S0007114510000322; Signorello LB, 2009, AM J EPIDEMIOL, V170, P104, DOI 10.1093/aje/kwp098; Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Tsoi KKF, 2009, CLIN GASTROENTEROL H, V7, P682, DOI 10.1016/j.cgh.2009.02.016; Vucenik I, 2012, ANN NY ACAD SCI, V1271, P37, DOI 10.1111/j.1749-6632.2012.06750.x; WATSON SA, 1988, BRIT J SURG, V75, P342, DOI 10.1002/bjs.1800750416; Winzer BM, 2011, CANCER CAUSE CONTROL, V22, P811, DOI 10.1007/s10552-011-9761-4; Wiseman M, 2008, P NUTR SOC, V67, P253, DOI 10.1017/S002966510800712X; Zhang XH, 2013, SLEEP, V36, P681, DOI 10.5665/sleep.2626; Zhang Y, 2012, AM J EPIDEMIOL, V175, P441, DOI 10.1093/aje/kwr331; Zhao H, 2013, ASIAN PAC J CANCER P, V14, P7509, DOI 10.7314/APJCP.2013.14.12.7509; Zhiqin W, 2014, INTEST RES, V12, P194, DOI 10.5217/ir.2014.12.3.194; Zoratto F, 2014, TUMOR BIOL, V35, P6195, DOI 10.1007/s13277-014-1845-9	42	23	26	5	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0143696	10.1371/journal.pone.0143696	http://dx.doi.org/10.1371/journal.pone.0143696			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710070	Green Published, gold, Green Submitted			2022-12-26	WOS:000367451400001
J	Lima, NBD; Silva, AIS; Gerson, PC; Goncalves, SMC; Simas, AM				Lima, Nathalia B. D.; Silva, Anderson I. S.; Gerson, P. C., Jr.; Goncalves, Simone M. C.; Simas, Alfredo M.			Faster Synthesis of Beta-Diketonate Ternary Europium Complexes: Elapsed Times & Reaction Yields	PLOS ONE			English	Article							EMISSION QUANTUM YIELD; LUMINESCENCE; PHOTOLUMINESCENT; DIPHENYLETHYNE; NANOPARTICLES; SENSORS	beta-diketonates are customary bidentate ligands in highly luminescent ternary europium complexes, such as Eu(beta-diketonate)(3)(L)(2), where L stands for a nonionic ligand. Usually, the syntheses of these complexes start by adding, to an europium salt such as EuCl3(H2O)(6), three equivalents of beta-diketonate ligands to form the complexes Eu(beta-diketonate)(3)(H2O)(2). The nonionic ligands are subsequently added to form the target complexes Eu(beta-diketonate)(3)(L)(2). However, the Eu(beta-diketonate)(3)(H2O)(2) intermediates are frequently both difficult and slow to purify by recrystallization, a step which usually takes a long time, varying from days to several weeks, depending on the chosen beta-diketonate. In this article, we advance a novel synthetic technique which does not use Eu(beta-diketonate)(3)(H2O)(2) as an intermediate. Instead, we start by adding 4 equivalents of a monodentate nonionic ligand L straight to EuCl3(H2O)(6) to form a new intermediate: EuCl3(L)(4)(H2O)(n), with n being either 3 or 4. The advantage is that these intermediates can now be easily, quickly, and efficiently purified. The beta-diketonates are then carefully added to this intermediate to form the target complexes Eu(beta-diketonate)(3)(L)(2). For the cases studied, the 20-day average elapsed time reduced to 10 days for the faster synthesis, together with an improvement in the overall yield from 42% to 69%.	[Lima, Nathalia B. D.; Silva, Anderson I. S.; Gerson, P. C., Jr.; Goncalves, Simone M. C.; Simas, Alfredo M.] Univ Fed Pernambuco, Dept Quim Fundamental, Recife, PE, Brazil	Universidade Federal de Pernambuco	Goncalves, SMC (corresponding author), Univ Fed Pernambuco, Dept Quim Fundamental, Recife, PE, Brazil.	simone@ufpe.br; simas@ufpe.br	Simas, Alfredo M/B-1096-2008; Lima, Nathalia/AAC-3530-2021; Castro, Gerson P/AAQ-1752-2021; Lima, Nathalia/O-8783-2015	Simas, Alfredo M/0000-0003-3653-6328; Lima, Nathalia/0000-0002-1550-5859; Castro, Gerson P/0000-0003-1548-8398; Lima, Nathalia/0000-0002-1550-5859; Goncalves, Simone/0000-0003-2009-8765	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), agency of the Brazilian Government; Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco FACEPE (Pronex), agency of the Brazilian Government	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), agency of the Brazilian Government; Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco FACEPE (Pronex), agency of the Brazilian Government	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco FACEPE (Pronex), agencies of the Brazilian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Centro de Tecnologias Estrategicas do Nordeste, CETENE, and Dr. Julia F. Campos for the MALDI-TOF mass spectrometry measurements. The authors also appreciate the financial support of Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE), agencies of the Brazilian Government.	Binnemans K, 2005, HBK PHYS CHEM RARE, V35, P107, DOI 10.1016/S0168-1273(05)35003-3; Binnemans K, 2009, CHEM REV, V109, P4283, DOI 10.1021/cr8003983; Duarte AP, 2013, LANGMUIR, V29, P5878, DOI 10.1021/la400365c; He H, 2011, SPECTROCHIM ACTA A, V82, P493, DOI 10.1016/j.saa.2011.07.085; Hu WP, 2000, JPN J APPL PHYS 1, V39, P6445, DOI 10.1143/JJAP.39.6445; Hu ZJ, 2011, CHEM COMMUN, V47, P12467, DOI 10.1039/c1cc14968g; Khalil GE, 2004, REV SCI INSTRUM, V75, P192, DOI 10.1063/1.1632997; Li P, 2014, CHEM COMMUN, V50, P13680, DOI 10.1039/c4cc05635c; Lima NBD, 2016, J LUMIN, V170, P505, DOI 10.1016/j.jlumin.2015.04.044; Lima NBD, 2013, SCI REP-UK, V3, DOI 10.1038/srep02395; Lima PP, 2014, ORG ELECTRON, V15, P798, DOI 10.1016/j.orgel.2014.01.009; Liu Y, 2014, MATER CHEM PHYS, V143, P1265, DOI 10.1016/j.matchemphys.2013.11.032; Lu Y, 2014, CHEM COMMUN, V50, P13323, DOI 10.1039/c4cc05508j; Malta OL, 1998, CHEM PHYS LETT, V282, P233, DOI 10.1016/S0009-2614(97)01283-9; Niyama E, 2005, SPECTROCHIM ACTA A, V61, P2643, DOI 10.1016/j.saa.2004.10.006; Panayiotidou L, 2013, POLYHEDRON, V52, P856, DOI 10.1016/j.poly.2012.07.029; Quirino W, 2011, SYNTHETIC MET, V161, P964, DOI 10.1016/j.synthmet.2011.03.001; Ratnakar SJ, 2012, J AM CHEM SOC, V134, P5798, DOI 10.1021/ja211601k; Ryu SJ, 2014, APPL CLAY SCI, V101, P52, DOI 10.1016/j.clay.2014.07.010; Shao G, 2014, PHYS CHEM CHEM PHYS, V16, P695, DOI 10.1039/c3cp53871k; Shao G, 2013, J LUMIN, V138, P195, DOI 10.1016/j.jlumin.2013.01.020; Shao G, 2012, SENSOR ACTUAT B-CHEM, V173, P692, DOI 10.1016/j.snb.2012.07.075; Shao YF, 2014, MICROPOR MESOPOR MAT, V193, P85, DOI 10.1016/j.micromeso.2014.03.019; Silva FRGE, 2000, J ALLOY COMPD, V303, P364, DOI 10.1016/S0925-8388(00)00642-3; Tambornino F, 2014, ACTA CRYSTALLOGR E, V70, pI27, DOI 10.1107/S1600536814010307; Teotonio EES, 2008, J LUMIN, V128, P190, DOI 10.1016/j.jlumin.2007.07.005; Urbain G., 1897, C R CHIMIE, V124, P618; Wang LP, 2011, J AGR FOOD CHEM, V59, P1607, DOI 10.1021/jf104484v; Wu YQ, 2014, BIOMATERIALS, V35, P5830, DOI 10.1016/j.biomaterials.2014.03.080	29	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0143998	10.1371/journal.pone.0143998	http://dx.doi.org/10.1371/journal.pone.0143998			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710103	Green Published, Green Submitted, gold			2022-12-26	WOS:000367451400002
J	Bank, S; Andersen, PS; Burisch, J; Pedersen, N; Roug, S; Galsgaard, J; Turino, SY; Brodersen, JB; Rashid, S; Rasmussen, BK; Avlund, S; Olesen, TB; Hoffmann, HJ; Nexo, BA; Sode, J; Vogel, U; Andersen, V				Bank, Steffen; Andersen, Paal Skytt; Burisch, Johan; Pedersen, Natalia; Roug, Stine; Galsgaard, Julied; Turino, Stine Ydegaard; Brodersen, Jacob Broder; Rashid, Shaista; Rasmussen, Britt Kaiser; Avlund, Sara; Olesen, Thomas Bastholm; Hoffmann, Hans Jurgen; Nexo, Bjorn Andersen; Sode, Jacob; Vogel, Ulla; Andersen, Vibeke			Polymorphisms in the Toll-Like Receptor and the IL-23/IL-17 Pathways Were Associated with Susceptibility to Inflammatory Bowel Disease in a Danish Cohort	PLOS ONE			English	Article							ULCERATIVE-COLITIS RISK; CROHNS-DISEASE; GENE-EXPRESSION; NUMBER	Background The inflammatory bowel diseases (IBD), Crohn's disease (CD) and ulcerative colitis (UC), result from the combined effects of susceptibility genes and environmental factors. Previous studies have shown that polymorphisms in the Toll-like receptor (TLR), the apoptosis, the IL-23/IL-17 and the interferon gamma (IFNG) pathways are associated with risk of both CD and UC. Methods Using a candidate gene approach, 21 functional single nucleotide polymorphisms (SNPs) in 15 genes were assessed in a clinical homogeneous group of severely diseased ethnic Danish patients consisting of 624 patients with CD, 411 patients with UC and 795 controls. The results were analysed using logistic regression. Results The polymorphisms TLR5 (rs5744174) and IL12B (rs6887695) were associated with risk of CD, and TLR1 (rs4833095) and IL18 (rs187238) were associated with risk of both CD and UC (p<0.05). After Bonferroni correction for multiple testing, the homozygous variant genotype of TLR1 743 T>C (rs4833095) was associated with increased risk CD (OR: 3.15, 95% CI: 1.59-6.26, p = 0.02) and CD and UC combined (OR: 2.96, 95% CI: 1.64-5.32, p = 0.005). Conclusion Our results suggest that genetically determined high activity of TLR1 and TLR5 was associated with increased risk of both CD and UC and CD, respectively. This supports that the host microbial composition or environmental factors in the gut are involved in risk of IBD. Furthermore, genetically determined high activity of the IL-23/IL-17 pathway was associated with increased risk of CD and UC. Overall, our results support that genetically determined high inflammatory response was associated with increased risk of both CD and UC.	[Bank, Steffen; Andersen, Vibeke] Viborg Reg Hosp, Dept Med, Viborg, Denmark; [Bank, Steffen; Nexo, Bjorn Andersen] Univ Aarhus, Biomed, Aarhus, Denmark; [Andersen, Paal Skytt] Statens Serum Inst, Microbiol & Infect Control, DK-2300 Copenhagen, Denmark; [Andersen, Paal Skytt] Univ Copenhagen, Vet Dis Biol, Copenhagen, Denmark; [Burisch, Johan; Pedersen, Natalia] Herlev Hosp, Dept Gastroenterol, DK-2730 Herlev, Denmark; [Roug, Stine] Univ Copenhagen, Hvidovre Hosp, Dept Gastroenterol, DK-2650 Hvidovre, Denmark; [Galsgaard, Julied] Koge Hosp, Dept Med, Koge, Denmark; [Turino, Stine Ydegaard] Hillerod Hosp, Dept Med, Hillerod, Denmark; [Brodersen, Jacob Broder] Sydvestjysk Hosp, Dept Med, Esbjerg, Denmark; [Brodersen, Jacob Broder] Odense Univ Hosp, Dept Med Gastroenterol, DK-5000 Odense, Denmark; [Rashid, Shaista] Bispebjerg Hosp, Dept Med, Bispebjerg, Denmark; [Rasmussen, Britt Kaiser] Nykobing Falster Hosp, Dept Med, Nykobing, Denmark; [Avlund, Sara] Aarhus Univ Hosp, Med Dept 5, DK-8000 Aarhus, Denmark; [Olesen, Thomas Bastholm] Slagelse Hosp, Dept Med, Slagelse, Denmark; [Hoffmann, Hans Jurgen] Aarhus Univ Hosp, Dept Resp Dis B, Inst Clin Med, DK-8000 Aarhus, Denmark; [Sode, Jacob; Andersen, Vibeke] Univ Southern Denmark, Inst Reg Hlth Res, Odense, Denmark; [Sode, Jacob] Statens Serum Inst, Dept Autoimmunol & Biomarkers, DK-2300 Copenhagen, Denmark; [Sode, Jacob] Frederiksberg Univ Hosp, Dept Rheumatol, Frederiksberg, Denmark; [Vogel, Ulla] Natl Res Ctr Working Environm, Copenhagen, Denmark; [Andersen, Vibeke] Hosp Southern Jutland Aabenraa, Res Unit Mol Diagnost, Aabenraa, Denmark; [Andersen, Vibeke] Odense Univ Hosp, OPEN Odense Patient Data Explorat Network, Odense, Denmark	Aarhus University; Aarhus University; Statens Serum Institut; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; University of Copenhagen; University of Southern Denmark; Odense University Hospital; University of Copenhagen; Bispebjerg Hospital; Aarhus University; Aarhus University; University of Southern Denmark; Statens Serum Institut; National Research Centre for the Working Environment; University of Southern Denmark; Odense University Hospital	Bank, S (corresponding author), Viborg Reg Hosp, Dept Med, Viborg, Denmark.	stb@mb.au.dk	Andersen, Vibeke/I-7932-2012; Olesen, Thomas/AFS-2588-2022; Sode, Jacob/AAD-9615-2020; Vogel, Ulla B/I-5048-2012; Burisch, Johan/AGJ-3893-2022; Hoffman, Hans Jurgen/I-6969-2018; Andersen, Paal S/H-2087-2015; Vogel, Ulla/ABC-2212-2020	Andersen, Vibeke/0000-0002-0127-2863; Olesen, Thomas/0000-0003-1464-7342; Sode, Jacob/0000-0002-2718-9320; Vogel, Ulla B/0000-0001-6807-1524; Burisch, Johan/0000-0002-3312-5139; Hoffman, Hans Jurgen/0000-0002-6743-7931; Andersen, Paal S/0000-0001-5656-0427; Vogel, Ulla/0000-0001-6807-1524; Brodersen, Jacob Broder/0000-0003-2530-7554	Health Research Fund of Central Denmark Region; Colitis-Crohn Foreningen; University of Aarhus	Health Research Fund of Central Denmark Region; Colitis-Crohn Foreningen; University of Aarhus	The work was funded by Health Research Fund of Central Denmark Region, Colitis-Crohn Foreningen and University of Aarhus (PhD grant).	Aguilera M, 2014, CYTOKINE GROWTH F R, P10; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Bank S, 2014, PHARMACOGENOMICS J, V14, P526, DOI 10.1038/tpj.2014.19; Bank S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098815; Bank S, 2013, GENET TEST MOL BIOMA, V17, P501, DOI 10.1089/gtmb.2012.0429; Buning C, 2008, INFLAMM BOWEL DIS, V14, P332, DOI 10.1002/ibd.20337; Cario E, 2010, INFLAMM BOWEL DIS, V16, P1583, DOI 10.1002/ibd.21282; Chang HD, 2007, ANN NY ACAD SCI, V1109, P40, DOI 10.1196/annals.1398.006; D'Osualdo A, 2012, PIGM CELL MELANOMA R, V25, P5, DOI 10.1111/j.1755-148X.2011.00942.x; Dinarello CA, 2012, FRONT IMMUNOL, P289; Ernst A, 2007, SCAND J GASTROENTERO, V42, P1445, DOI 10.1080/00365520701427102; Fowler EV, 2008, AM J GASTROENTEROL, V103, P2519, DOI 10.1111/j.1572-0241.2008.02023.x; Franke A, 2007, GASTROENTEROLOGY, V132, P2080, DOI 10.1053/j.gastro.2007.03.087; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gologan S, 2013, J CROHNS COLITIS, V7, P622, DOI 10.1016/j.crohns.2012.08.015; Hoeve MA, 2006, EUR J IMMUNOL, V36, P661, DOI 10.1002/eji.200535239; Hong GS, 2002, J BIOCHEM MOL BIOL, V35, P19; Kappelman MD, 2013, DIGEST DIS SCI, V58, P519, DOI 10.1007/s10620-012-2371-5; Li JG, 2012, IMMUNOGENETICS, V64, P361, DOI 10.1007/s00251-011-0597-6; Liu ZJ, 2011, J LEUKOCYTE BIOL, V89, P597, DOI 10.1189/jlb.0810456; Ng SC, 2011, INFLAMM BOWEL DIS, V17, P2027, DOI 10.1002/ibd.21590; Paramel GV, 2013, CLIN SCI, V125, P401, DOI 10.1042/CS20120572; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Pugazhendhi S, 2013, INT J TUBERC LUNG D, V17, P662, DOI 10.5588/ijtld.12.0600; Sagulenko V, 2013, CELL DEATH DIFFER, V20, P1149, DOI 10.1038/cdd.2013.37; Sandborn WJ, 2012, NEW ENGL J MED, V367, P1519, DOI 10.1056/NEJMoa1203572; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Sheridan J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061326; Sode J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100361; Thompson AI, 2011, INFLAMM BOWEL DIS, V17, P831, DOI 10.1002/ibd.21375; Verstrepen L, 2008, CELL MOL LIFE SCI, V65, P2964, DOI 10.1007/s00018-008-8064-8; Wang Y, 2014, DNA CELL BIOL, V33, P438, DOI 10.1089/dna.2013.2310; Yamazaki K, 2009, GUT, V58, P228, DOI 10.1136/gut.2007.140764	34	40	45	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145302	10.1371/journal.pone.0145302	http://dx.doi.org/10.1371/journal.pone.0145302			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26698117	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092600061
J	Reblova, M; Jaklitsch, WM; Reblova, K; Stepanek, V				Reblova, Martina; Jaklitsch, Walter M.; Reblova, Kamila; Stepanek, Vaclav			Phylogenetic Reconstruction of the Calosphaeriales and Togniniales Using Five Genes and Predicted RNA Secondary Structures of ITS, and Flabellascus tenuirostris gen. et sp nov.	PLOS ONE			English	Article							RIBOSOMAL-RNA; BETA-TUBULIN; SUBCUTANEOUS PHEOHYPHOMYCOSIS; 3-WAY JUNCTIONS; ESCA DISEASE; PHAEOACREMONIUM; GRAPEVINE; TREES; ITS2; PLEUROSTOMOPHORA	The Calosphaeriales is revisited with new collection data, living cultures, morphological studies of ascoma centrum, secondary structures of the internal transcribed spacer (ITS) rDNA and phylogeny based on novel DNA sequences of five nuclear ribosomal and protein-coding loci. Morphological features, molecular evidence and information from predicted RNA secondary structures of ITS converged upon robust phylogenies of the Calosphaeriales and Togniniales. The current concept of the Calosphaeriales includes the Calosphaeriaceae and Pleurostomataceae encompassing five monophyletic genera, Calosphaeria, Flabellascus gen. nov., Jattaea, Pleurostoma and Togniniella, strongly supported by Bayesian and Maximum Likelihood methods. The structural elements of ITS1 form characteristic patterns that are phylogenetically conserved, corroborate observations based on morphology and have a high predictive value at the generic level. Three major clades containing 44 species of Phaeoacremonium were recovered in the closely related Togniniales based on ITS, actin and beta-tubulin sequences. They are newly characterized by sexual and RNA structural characters and ecology. This approach is a first step towards understanding of the molecular systematics of Phaeoacremonium and possibly its new classification. In the Calosphaeriales, Jattaea aphanospora sp. nov. and J. ribicola sp. nov. are introduced, Calosphaeria taediosa is combined in Jattaea and epitypified. The sexual morph of Phaeoacremonium cinereum was encountered for the first time on decaying wood and obtained in vitro. In order to achieve a single nomenclature, the genera of asexual morphs linked with the Calosphaeriales are transferred to synonymy of their sexual morphs following the principle of priority, i.e. Calosphaeriophora to Calosphaeria, Phaeocrella to Togniniella and Pleurostomophora to Pleurostoma. Three new combinations are proposed, i.e. Pleurostoma ochraceum comb. nov., P. repens comb. nov. and P. richardsiae comb. nov. The morphology-based key is provided to facilitate identification of genera accepted in the Calosphaeriales.	[Reblova, Martina] Acad Sci Czech Republ, Inst Bot, Dept Taxon, CS-25243 Pruhonice, Czech Republic; [Jaklitsch, Walter M.] BOKU Univ Nat Resources & Life Sci, Inst Forest Entomol, Dept Forest & Soil Sci Forest Pathol & Forest Pro, Vienna, Austria; [Jaklitsch, Walter M.] Univ Vienna, Div Systemat & Evolutionary Bot, Dept Bot & Biodivers Res, Vienna, Austria; [Reblova, Kamila] Masaryk Univ, Fac Med, Brno, Czech Republic; [Reblova, Kamila] Masaryk Univ, Cent European Inst Technol, Brno, Czech Republic; [Stepanek, Vaclav] Acad Sci Czech Republ, Inst Microbiol, Lab Enzyme Technol, Prague, Czech Republic	Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; University of Natural Resources & Life Sciences, Vienna; University of Vienna; Masaryk University Brno; Masaryk University Brno; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Reblova, M (corresponding author), Acad Sci Czech Republ, Inst Bot, Dept Taxon, CS-25243 Pruhonice, Czech Republic.	martina.reblova@ibot.cas.cz	Jaklitsch, Walter M/B-4970-2013; Štěpánek, Václav/H-7456-2014; Réblová, Martina/H-1620-2014	Jaklitsch, Walter M./0000-0002-4999-9199	Czech Science Foundation [GA CR 506/12/0038]; Institute of Botany, Academy of Sciences [RVO 67985939]; Faculty of Medicine Masaryk University; Project CEITEC - Central European Institute of Technology from European Regional Development Fund [CZ.1.05/1.1.00/02.0068]; Ministry of Education, Youth, and Sports of the Czech Republic [LM2010005]; Institute of Microbiology, Academy of Sciences [RVO 61388971]	Czech Science Foundation(Grant Agency of the Czech Republic); Institute of Botany, Academy of Sciences; Faculty of Medicine Masaryk University; Project CEITEC - Central European Institute of Technology from European Regional Development Fund; Ministry of Education, Youth, and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Institute of Microbiology, Academy of Sciences	This work was supported by the Czech Science Foundation (GA CR 506/12/0038; www.gacr.cz). Additional support was provided to MR by a longterm research development project of the Institute of Botany, Academy of Sciences (RVO 67985939). KR was funded by the Faculty of Medicine Masaryk University and the Project CEITEC - Central European Institute of Technology from European Regional Development Fund (CZ.1.05/1.1.00/02.0068; www.ceitec.eu). Access to the MetaCentrum computing facilities provided under the program "Projects of Large Infrastructure for Research, Development, and Innovations" (LM2010005) funded by the Ministry of Education, Youth, and Sports of the Czech Republic to KR is acknowledged. VS was funded by a long-term research development project of the Institute of Microbiology, Academy of Sciences (RVO 61388971). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalberts DP, 2010, RNA, V16, P1350, DOI 10.1261/rna.1831710; AJELLO L, 1974, MYCOLOGIA, V66, P490, DOI 10.2307/3758492; BARR ME, 1983, MYCOLOGIA, V75, P1, DOI 10.2307/3792917; Barr ME, 1998, CRYPTOGAMIE BRYOL L, V19, P169; BARR ME, 1993, MYCOTAXON, V48, P529; BARR ME, 1985, MYCOLOGIA, V77, P549, DOI 10.2307/3793354; Batey RT, 2004, NATURE, V432, P411, DOI 10.1038/nature03037; Berlese AN, 1900, ICONES FUNGORUM OMNI, V3; Besseova I, 2010, NUCLEIC ACIDS RES, V38, P6247, DOI 10.1093/nar/gkq414; Bridge PD, 2008, MYCOPATHOLOGIA, V166, P1, DOI 10.1007/s11046-008-9094-3; Chen CA, 2004, ZOOL STUD, V43, P759; Choi J, 2011, KOREAN J LAB MED, V31, P201, DOI 10.3343/kjlm.2011.31.3.201; Coleman AW, 2008, J MOL EVOL, V67, P389, DOI 10.1007/s00239-008-9160-y; Coleman AW, 1998, PROTIST, V149, P135, DOI 10.1016/S1434-4610(98)70018-5; Crous PW, 1996, MYCOLOGIA, V88, P786, DOI 10.2307/3760973; Cui JL, 2011, PHYTOTHER RES, V25, P1189, DOI 10.1002/ptr.3361; Damm U, 2008, PERSOONIA, V20, P87, DOI 10.3767/003158508X324227; Damm U, 2008, PERSOONIA, V20, P39, DOI 10.3767/003158508X313940; Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250; De Hoog GS, 2000, GENUS PHAEOACREMONIU, P846; Dupont J, 2000, MYCOLOGIA, V92, P499, DOI 10.2307/3761508; Ellis JB, 1890, P ACAD NAT SCI PHILA, V42, P219; Ellis JB, 1892, N AM PYRENOMYCETES; ERIKSSON O, 1981, OPERA BOT, V60, P1, DOI DOI 10.1111/J.1756-1051.1981.TB01167.X; Eriksson Ove E., 1994, Systema Ascomycetum, V13, P183; Essakhi S, 2008, PERSOONIA, V21, P119, DOI 10.3767/003158508X374385; Fernandez FA, 2004, MYCOLOGIA, V96, P175, DOI 10.2307/3762000; FORSTER AC, 1987, CELL, V49, P211, DOI 10.1016/0092-8674(87)90562-9; Gams W., 1971, CEPHALOSPORIUM ARTIG; Gams W, 1998, CBS COURSE MYCOLOGY; Geiser DM, 1998, MYCOLOGIA, V90, P831, DOI 10.2307/3761325; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; Gottschling M, 2004, NUCLEIC ACIDS RES, V32, P307, DOI 10.1093/nar/gkh168; Gottschling M, 2001, PLANT BIOLOGY, V3, P629, DOI 10.1055/s-2001-19371; Graham AB, 2009, AUSTRALAS PLANT PATH, V38, P505, DOI 10.1071/AP09035; Gramaje D, 2012, PERSOONIA, V28, P1, DOI 10.3767/003158512X626155; Gramaje D, 2015, FUNGAL BIOL-UK, V119, P759, DOI 10.1016/j.funbio.2015.06.004; Gramaje D, 2014, IMA FUNGUS, V5, P67, DOI 10.5598/imafungus.2014.05.01.08; Gramaje D, 2009, MYCOLOGIA, V101, P920, DOI 10.3852/08-222; Groenewald M, 2001, MYCOL RES, V105, P651, DOI 10.1017/S0953756201004282; Guarro J, 2003, J CLIN MICROBIOL, V41, P1332, DOI 10.1128/JCM.41.3.1332-1336.2003; GUTELL RR, 1993, NUCLEIC ACIDS RES, V21, P3051, DOI 10.1093/nar/21.13.3051; GUTELL RR, 1993, NUCLEIC ACIDS RES, V21, P3055, DOI 10.1093/nar/21.13.3055; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HAUSNER G, 1992, CAN J BOT, V70, P724, DOI 10.1139/b92-093; Hawksworth DL, 2011, MYCOKEYS, P7, DOI 10.3897/mycokeys.1.2062; Hawksworth DL, 2011, IMA FUNGUS, V2, P105, DOI 10.5598/imafungus.2011.02.01.14; HIRONAGA M, 1989, J CLIN MICROBIOL, V27, P394, DOI 10.1128/JCM.27.3.394-399.1989; Holbrook SR, 2005, CURR OPIN STRUC BIOL, V15, P302, DOI 10.1016/j.sbi.2005.04.005; Hu DM, 2012, MYCOLOGIA, V104, P1478, DOI 10.3852/11-430; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huhndorf SM, 2009, MYCOLOGIA, V101, P904, DOI 10.3852/08-213; Kruger D, 2008, MYCOL RES, V112, P316, DOI 10.1016/j.mycres.2007.10.019; Kruger D., 2004, Feddes Repertorium, V115, P530, DOI 10.1002/fedr.200311052; Laing C, 2012, NUCLEIC ACIDS RES, V40, P487, DOI 10.1093/nar/gkr629; Lamiable A, 2012, COMPUT BIOL CHEM, V37, P1, DOI 10.1016/j.compbiolchem.2011.11.001; Larget B, 1999, MOL BIOL EVOL, V16, P750, DOI 10.1093/oxfordjournals.molbev.a026160; Lee SB, 1990, PCR PROTOCOLS GUIDE; LEONTIS NB, 1995, BIOPHYS J, V68, P251, DOI 10.1016/S0006-3495(95)80182-7; Leontis NB, 2003, CURR OPIN STRUC BIOL, V13, P300, DOI 10.1016/S0959-440X(03)00076-9; Leontis NB, 2006, CURR OPIN STRUC BIOL, V16, P279, DOI 10.1016/j.sbi.2006.05.009; Lescoute A, 2006, RNA, V12, P83, DOI 10.1261/rna.2208106; LILLEY DMJ, 1995, NUCLEIC ACIDS RES, V23, P3363, DOI 10.1093/nar/23.17.3363; Lumbsch H. Thorsten, 2010, Fieldiana-Life and Earth Sciences, V1, P1, DOI 10.3158/1557.1; Malloch D, 1981, MOULDS THEIR ISOLATI; MARINCOWITZ S, 2008, CBS BIODIVERSITY SER, V7; MasonGamer RJ, 1996, SYST BIOL, V45, P524, DOI 10.1093/sysbio/45.4.524; Matsui T, 1999, Nihon Ishinkin Gakkai Zasshi, V40, P99; MEYERS WM, 1975, AM J CLIN PATHOL, V64, P549; Mhmoud NA, 2012, J CLIN MICROBIOL, V50, P2987, DOI 10.1128/JCM.01470-12; Mostert L, 2006, STUD MYCOL, P1; Mostert L, 2003, MYCOLOGIA, V95, P646, DOI 10.2307/3761941; Mostert L, 2005, J CLIN MICROBIOL, V43, P1752, DOI 10.1128/JCM.43.4.1752-1767.2005; MUNK A., 1957, DANSK BOT ARKIV, V17, P1; Nitschke T., 1867, BRESLAU, V1, P1; NOLLER HF, 1984, ANNU REV BIOCHEM, V53, P119, DOI 10.1146/annurev.bi.53.070184.001003; NOLLER HF, 1991, ANNU REV BIOCHEM, V60, P191, DOI 10.1146/annurev.biochem.60.1.191; Nylander J, 2008, MRMODELTEST2 V 2 3 P; Online Auction Color Chart C, 2004, ONL AUCT COL CHART N; Padhye AA, 1998, J CLIN MICROBIOL, V36, P2763, DOI 10.1128/JCM.36.9.2763-2765.1998; PIROZYNSKI KA, 1974, CAN J BOT, V52, P2129, DOI 10.1139/b74-274; Raimondo ML, 2014, MYCOLOGIA, V106, P1119, DOI 10.3852/14-080; Ramaley AW, 2005, MYCOTAXON, V93, P139; Rambaut A, 2013, MCMC TRACE ANAL TOOL; Rappaz F., 1987, Mycologia Helvetica, V2, P285; Reblova K, 2012, NUCLEIC ACIDS RES, V40, P6290, DOI 10.1093/nar/gks258; Reblova M, 2000, MYCOLOGIA, V92, P939, DOI 10.2307/3761589; Reblova M, 2004, STUD MYCOL, P533; Reblova M, 2015, PERSOONIA, V35, P21, DOI 10.3767/003158515X687434; Reblova M, 2011, STUD MYCOL, P163, DOI 10.3114/sim.2011.68.07; Reblova M, MYCOLOGIA, V207, P723; Reblova M, 2007, MYCOL RES, V111, P299, DOI 10.1016/j.mycres.2006.12.002; Reblova M, 2006, MYCOLOGIA, V98, P68, DOI 10.3852/mycologia.98.1.68; Reblova M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063547; Reblova M, 2013, MYCOL PROG, V12, P305, DOI 10.1007/s11557-012-0836-8; Reblova M, 2011, FUNGAL DIVERS, V49, P167, DOI 10.1007/s13225-011-0099-8; Reblova M, 2009, MYCOL RES, V113, P991, DOI 10.1016/j.mycres.2009.06.003; Rodrigues A, 2011, FEMS MICROBIOL ECOL, V78, P244, DOI 10.1111/j.1574-6941.2011.01152.x; ROMERO A I, 1991, Sydowia, V43, P228; Saccardo PA, 1878, FUNGI ITALICI AUTOGR, P9; Samuels GJ, 1996, NOVA HEDWIGIA, V62, P47; Sanchez JA, 2007, MOL PHYLLOGENET EVOL, V43, P784; SCHOL-SCHWARZ M. BEATRICE., 1970, Persoonia, V6, P59; Scott WG, 1996, SCIENCE, V274, P2065, DOI 10.1126/science.274.5295.2065; Smith GJD, 2003, FUNGAL DIVERS, V13, P175; Spegazzini CL, 1888, FUNGI GUARANITIC PUG, pII; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sukosd Z, 2012, BIOINFORMATICS, V28, P2691, DOI 10.1093/bioinformatics/bts488; Takamatsu Susumu, 1998, Mycoscience, V39, P441, DOI 10.1007/BF02460905; Tegli S., 2000, Phytopathologia Mediterranea, V39, P134; To KKW, 2012, DIAGN MICR INFEC DIS, V74, P190, DOI 10.1016/j.diagmicrobio.2012.06.014; Trouillas FP, 2010, PLANT DIS, V94, P1167, DOI 10.1094/PDIS-94-9-1167A; Tulasne LR., 1863, SELECTA FUNGORUM CAR, V2; Ullrich B, 2010, J ZOOL SYST EVOL RES, V48, P219, DOI 10.1111/j.1439-0469.2009.00553.x; Vijaykrishna D, 2004, STUD MYCOL, P387; WALTER AE, 1994, BIOCHEMISTRY-US, V33, P12715, DOI 10.1021/bi00208a024; WEITZMAN I, 1984, SABOURAUDIA, V22, P331; Wieland M, 2009, RNA, V15, P968, DOI 10.1261/rna.1220309; Wingfield MJ, 2012, MOL PLANT PATHOL, V13, P604, DOI 10.1111/j.1364-3703.2011.00768.x; YAN ZH, 1995, MYCOLOGIA, V87, P72, DOI 10.2307/3760949; YANG JH, 1992, BIOCHEMISTRY-US, V31, P5005, DOI 10.1021/bi00136a013; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	123	27	28	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0144616	10.1371/journal.pone.0144616	http://dx.doi.org/10.1371/journal.pone.0144616			46	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26699541	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092600027
J	Stark, AY; Palecek, AM; Argenbright, CW; Bernard, C; Brennan, AB; Niewiarowski, PH; Dhinojwala, A				Stark, Alyssa Y.; Palecek, Amanda M.; Argenbright, Clayton W.; Bernard, Craig; Brennan, Anthony B.; Niewiarowski, Peter H.; Dhinojwala, Ali			Gecko Adhesion on Wet and Dry Patterned Substrates	PLOS ONE			English	Article							LOCOMOTOR PERFORMANCE; CLINGING ABILITY; SETAL FIELDS; MORPHOLOGY; ATTACHMENT; REPTILIA; SYSTEM; WATER; TOKAY; TOE	Perhaps one of the most astounding characteristics of the gecko adhesive system is its versatility. Geckos can locomote across complex substrates in a variety of conditions with apparent ease. In contrast, many of our synthetic pressure sensitive adhesives fail on substrates that are dirty, wet or rough. Although many studies have investigated the effect of environmental challenges on performance, the interaction of multiple, potentially compromising variables is studied less often. Here we focus on substrate structure and surface water, both of which are highly relevant to the biological system and to synthetic design. To do this we utilized a highly controlled, patterned substrate (Sharklet (R), by Sharklet (R) Technologies Inc.). This allowed us to test independently and jointly the effects of reduced surface area substrates, with a defined pattern, on adhesion in both air and water. Our results show that adhesion is not significantly impaired in air, whereas surface area and pattern significantly affect adhesion in water. These findings highlight the need to study multiple parameters that are relevant to the gecko adhesive system to further improve our understanding of the biological system and to design better, more versatile synthetics.	[Stark, Alyssa Y.; Palecek, Amanda M.; Bernard, Craig; Niewiarowski, Peter H.] Univ Akron, Integrated Biosci Program, Akron, OH 44325 USA; [Argenbright, Clayton W.; Brennan, Anthony B.] Univ Florida, Dept Mat Sci & Engn, Gainesville, FL 32611 USA; [Dhinojwala, Ali] Univ Akron, Dept Polymer Sci, Akron, OH 44325 USA	University System of Ohio; University of Akron; State University System of Florida; University of Florida; University System of Ohio; University of Akron	Stark, AY (corresponding author), Univ Louisville, Dept Biol, Louisville, KY 40292 USA.	ays3@zips.uakron.edu	niewiarowski, peter/AAA-7060-2022	niewiarowski, peter/0000-0002-8952-3013; Stark, Alyssa/0000-0002-4217-2850; Palecek, Amanda/0000-0002-9908-3103	Office of Naval Research [N000141310443]	Office of Naval Research(Office of Naval Research)	CWA and ABB wish to acknowledge the support of the Office of Naval Research Grant #N000141310443; http://www.onr.navy.mil/en.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autumn K, 2006, J EXP BIOL, V209, P3558, DOI 10.1242/jeb.02469; Autumn K, 2006, AM SCI, V94, P124, DOI 10.1511/2006.58.124; Autumn K, 2002, P NATL ACAD SCI USA, V99, P12252, DOI 10.1073/pnas.192252799; Badge I, 2014, SCI REP-UK, V4, DOI 10.1038/srep06643; Bergmann PJ, 2005, J EXP ZOOL PART A, V303A, P785, DOI 10.1002/jez.a.210; Boesel LF, 2010, ADV MATER, V22, P2125, DOI 10.1002/adma.200903200; Chung KK, 2007, BIOINTERPHASES, V2, P89, DOI 10.1116/1.2751405; Collins CE, 2015, FUNCT ECOL, V29, P66, DOI 10.1111/1365-2435.12312; Defante AP, 2015, LANGMUIR, V31, P2398, DOI 10.1021/la504564w; Ditsche P, 2014, J EXP BIOL, V217, P2548, DOI 10.1242/jeb.100149; Ditsche-Kuru P, 2010, J EXP BIOL, V213, P1950, DOI 10.1242/jeb.037218; Endlein T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073810; Gillies AG, 2014, J EXP BIOL, V217, P283, DOI 10.1242/jeb.092015; GREEN DM, 1988, CAN J ZOOL, V66, P1610, DOI 10.1139/z88-235; Hansen WR, 2005, P NATL ACAD SCI USA, V102, P385, DOI 10.1073/pnas.0408304102; Higham TE, 2010, BIOL J LINN SOC, V101, P860, DOI 10.1111/j.1095-8312.2010.01539.x; Hsu PY, 2012, J R SOC INTERFACE, V9, P657, DOI 10.1098/rsif.2011.0370; Hu SH, 2012, J R SOC INTERFACE, V9, P2781, DOI 10.1098/rsif.2012.0108; Huber G, 2007, ACTA BIOMATER, V3, P607, DOI 10.1016/j.actbio.2007.01.007; Irschick DJ, 1996, BIOL J LINN SOC, V59, P21, DOI 10.1111/j.1095-8312.1996.tb01451.x; Jain D, 2015, SCI REP-UK, V5, DOI 10.1038/srep09594; Johnson MK, 2009, J ANAT, V214, P937, DOI 10.1111/j.1469-7580.2009.01075.x; Lepore E, 2008, J NANOMATER, V2008, DOI 10.1155/2008/194524; Long CJ, 2009, LANGMUIR, V25, P12982, DOI 10.1021/la901836w; Losos J.B., 1990, Asiatic Herpetological Research, V3, P54; MADERSON PF, 1964, NATURE, V203, P780, DOI 10.1038/203780a0; Magin CM, 2010, MATER TODAY, V13, P36, DOI 10.1016/S1369-7021(10)70058-4; Niewiarowski PH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002192; Pugno NM, 2008, J ADHESION, V84, P949, DOI 10.1080/00218460802505374; Pugno NM, 2008, BIOSYSTEMS, V94, P218, DOI 10.1016/j.biosystems.2008.06.009; Rizzo NW, 2006, J R SOC INTERFACE, V3, P441, DOI 10.1098/rsif.2005.0097; RUIBAL R, 1965, J MORPHOL, V117, P271, DOI 10.1002/jmor.1051170302; Russell AP, 2007, CAN J ZOOL, V85, P1228, DOI 10.1139/Z07-103; Russell AP, 2014, ACTA ZOOL-STOCKHOLM, V95, P299, DOI 10.1111/azo.12028; RUSSELL AP, 1975, J ZOOL, V176, P437, DOI 10.1111/j.1469-7998.1975.tb03215.x; Russell AP, 2002, INTEGR COMP BIOL, V42, P1154, DOI 10.1093/icb/42.6.1154; RUSSELL AP, 1981, J MORPHOL, V169, P293, DOI 10.1002/jmor.1051690305; RUSSELL AP, 1986, CAN J ZOOL, V64, P948, DOI 10.1139/z86-144; Schumacher JF, 2008, LANGMUIR, V24, P4931, DOI 10.1021/la703421v; Stark AY, 2015, J EXP BIOL, V218, P2435, DOI 10.1242/jeb.120683; Stark AY, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0464; Stark AY, 2014, INTEGR COMP BIOL, V54, P1026, DOI 10.1093/icb/icu066; Stark AY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101885; Stark AY, 2013, P NATL ACAD SCI USA, V110, P6340, DOI 10.1073/pnas.1219317110; Stark AY, 2012, J EXP BIOL, V215, P3080, DOI 10.1242/jeb.070912; Vanhooydonck B, 2005, BIOL J LINN SOC, V85, P385, DOI 10.1111/j.1095-8312.2005.00495.x; Wainwright DK, 2013, STICK TIGHT SUCTION; WILLIAMS EE, 1982, SCIENCE, V215, P1509, DOI 10.1126/science.215.4539.1509; Zani PA, 2000, J EVOLUTION BIOL, V13, P316, DOI 10.1046/j.1420-9101.2000.00166.x	49	14	14	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145756	10.1371/journal.pone.0145756	http://dx.doi.org/10.1371/journal.pone.0145756			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26696412	Green Submitted, gold, Green Published			2022-12-26	WOS:000367092500071
J	Borgogno, MV; Monti, MR; Zhao, WX; Sung, P; Argarana, CE; Pezza, RJ				Borgogno, Maria V.; Monti, Mariela R.; Zhao, Weixing; Sung, Patrick; Argarana, Carlos E.; Pezza, Roberto J.			Tolerance of DNA Mismatches in Dmc1 Recombinase-mediated DNA Strand Exchange	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA-binding protein; DNA damage; DNA recombination; homologous recombination; meiosis; DNA mismatches; DNA strand exchange; Dmc1; Hop2-Mnd1; heterologous DNA sequences	NEAREST-NEIGHBOR THERMODYNAMICS; CENTER-DOT-C; MEIOTIC RECOMBINATION; HUMAN RAD51; HOP2-MND1 COMPLEX; ESCHERICHIA-COLI; HOP2 PROTEIN; RECA PROTEIN; MEIOSIS; FAMILY	Recombination between homologous chromosomes is required for the faithful meiotic segregation of chromosomes and leads to the generation of genetic diversity. The conserved meiosis-specific Dmc1 recombinase catalyzes homologous recombination triggered by DNA double strand breaks through the exchange of parental DNA sequences. Although providing an efficient rate of DNA strand exchange between polymorphic alleles, Dmc1 must also guard against recombination between divergent sequences. How DNA mismatches affect Dmc1-mediated DNA strand exchange is not understood. We have used fluorescence resonance energy transfer to study the mechanism of Dmc1-mediated strand exchange between DNA oligonucleotides with different degrees of heterology. The efficiency of strand exchange is highly sensitive to the location, type, and distribution of mismatches. Mismatches near the 3 end of the initiating DNA strand have a small effect, whereas most mismatches near the 5 end impede strand exchange dramatically. The Hop2-Mnd1 protein complex stimulates Dmc1-catalyzed strand exchange on homologous DNA or containing a single mismatch. We observed that Dmc1 can reject divergent DNA sequences while bypassing a few mismatches in the DNA sequence. Our findings have important implications in understanding meiotic recombination. First, Dmc1 acts as an initial barrier for heterologous recombination, with the mismatch repair system providing a second level of proofreading, to ensure that ectopic sequences are not recombined. Second, Dmc1 stepping over infrequent mismatches is likely critical for allowing recombination between the polymorphic sequences of homologous chromosomes, thus contributing to gene conversion and genetic diversity.	[Borgogno, Maria V.; Monti, Mariela R.; Argarana, Carlos E.] Univ Nacl Cordoba, Fac Ciencias Quim, Dept Quim Biol, Ctr Invest Quim Biol Cordoba CIQUIBIC,CONICET, Ciudad Univ, RA-5000 Cordoba, Argentina; [Zhao, Weixing; Sung, Patrick] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Pezza, Roberto J.] Oklahoma Med Res Fdn, Cell Cycle & Canc Biol Program, 825 NE 13th St, Oklahoma City, OK 73104 USA; [Pezza, Roberto J.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73126 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Yale University; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center	Pezza, RJ (corresponding author), Oklahoma Med Res Fdn, 825 NE 13th St, Oklahoma City, OK 73104 USA.	Roberto-Pezza@omrf.org		zhao, weixing/0000-0001-5746-3696	National Institutes of Health Grants [ES015252, GM103636]; March of Dimes Grant [FY14-256]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103636] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Grant(March of Dimes); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES015252 (to P. S.) and GM103636 and March of Dimes Grant FY14-256 (to R. J. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Allawi HT, 1998, BIOCHEMISTRY-US, V37, P9435, DOI 10.1021/bi9803729; Bazemore LR, 1997, P NATL ACAD SCI USA, V94, P11863, DOI 10.1073/pnas.94.22.11863; BENSON FE, 1994, EMBO J, V13, P5764, DOI 10.1002/j.1460-2075.1994.tb06914.x; Brown J, 2003, BIOCHEM J, V371, P697, DOI 10.1042/BJ20021847; Chen YK, 2004, P NATL ACAD SCI USA, V101, P10572, DOI 10.1073/pnas.0404195101; Chi P, 2007, GENE DEV, V21, P1747, DOI 10.1101/gad.1563007; Dumousseau M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-101; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Garcia V, 2011, NATURE, V479, P241, DOI 10.1038/nature10515; Gupta RC, 1999, MOL CELL, V4, P705, DOI 10.1016/S1097-2765(00)80381-0; Gupta RC, 1998, P NATL ACAD SCI USA, V95, P9843, DOI 10.1073/pnas.95.17.9843; Gupta RC, 2001, P NATL ACAD SCI USA, V98, P8433, DOI 10.1073/pnas.121005298; HASSOLD T, 1979, HUM GENET, V46, P285, DOI 10.1007/BF00273312; HASSOLD TJ, 1984, ANNU REV GENET, V18, P69, DOI 10.1146/annurev.genet.18.1.69; Hunt PA, 2008, TRENDS GENET, V24, P86, DOI 10.1016/j.tig.2007.11.010; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kleckner N, 1996, P NATL ACAD SCI USA, V93, P8167, DOI 10.1073/pnas.93.16.8167; Lee JY, 2015, SCIENCE, V349, P977, DOI 10.1126/science.aab2666; Masson JY, 1999, EMBO J, V18, P6552, DOI 10.1093/emboj/18.22.6552; Moktan H, 2014, J BIOL CHEM, V289, P14682, DOI 10.1074/jbc.M114.548180; Neale MJ, 2006, NATURE, V442, P153, DOI 10.1038/nature04885; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Nishinaka T, 1997, P NATL ACAD SCI USA, V94, P6623, DOI 10.1073/pnas.94.13.6623; PATEL DJ, 1984, FED PROC, V43, P2663; Petukhova GV, 2005, NAT STRUCT MOL BIOL, V12, P449, DOI 10.1038/nsmb923; Petukhova GV, 2003, DEV CELL, V5, P927, DOI 10.1016/S1534-5807(03)00369-1; Peyret N, 1999, BIOCHEMISTRY-US, V38, P3468, DOI 10.1021/bi9825091; Pezza RJ, 2007, GENE DEV, V21, P1758, DOI 10.1101/gad.1562907; Pezza RJ, 2006, J BIOL CHEM, V281, P18426, DOI 10.1074/jbc.M601073200; Pezza RJ, 2014, NUCLEIC ACIDS RES, V42, P2346, DOI 10.1093/nar/gkt1234; Pezza RJ, 2010, BIOPHYS J, V99, P3763, DOI 10.1016/j.bpj.2010.10.028; Pratto F, 2014, SCIENCE, V346, P826, DOI 10.1126/science.1256442; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; Sagi D, 2006, NUCLEIC ACIDS RES, V34, P5021, DOI 10.1093/nar/gkl586; Sansam CL, 2015, FEBS J, V282, P2431, DOI 10.1111/febs.13317; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharma M, 2013, J PHYS CHEM B, V117, P6194, DOI 10.1021/jp403127a; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Uanschou C, 2013, PLANT CELL, V25, P4924, DOI 10.1105/tpc.113.118521; Urena DE, 2011, J MOL BIOL, V405, P77, DOI 10.1016/j.jmb.2010.10.042; Volodin AA, 2009, J BIOL CHEM, V284, P1495, DOI 10.1074/jbc.M800612200; Voloshin ON, 1996, SCIENCE, V272, P868, DOI 10.1126/science.272.5263.868; WANG YH, 1993, J BIOL CHEM, V268, P17571; WEBSTER GD, 1990, P NATL ACAD SCI USA, V87, P6693, DOI 10.1073/pnas.87.17.6693; Zhao WX, 2014, NUCLEIC ACIDS RES, V42, P906, DOI 10.1093/nar/gkt924	45	9	10	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					4928	4938		10.1074/jbc.M115.704718	http://dx.doi.org/10.1074/jbc.M115.704718			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26709229	Green Published, hybrid			2022-12-26	WOS:000371640600009
J	Aguilera, MA; Valdivia, N; Broitman, BR				Aguilera, Moises A.; Valdivia, Nelson; Broitman, Bernardo R.			Facilitative Effect of a Generalist Herbivore on the Recovery of a Perennial Alga: Consequences for Persistence at the Edge of Their Geographic Range	PLOS ONE			English	Article							STRESS-GRADIENT HYPOTHESIS; SPECIES INTERACTIONS; BOTTOM-UP; INTERSPECIFIC COMPETITION; MAZZAELLA-LAMINARIOIDES; POSITIVE INTERACTIONS; INTERACTION STRENGTH; UNIFIED APPROACH; ROCKY SHORES; MARINE	Understanding the impacts of consumers on the abundance, growth rate, recovery and persistence of their resources across their distributional range can shed light on the role of trophic interactions in determining species range shifts. Here, we examined if consumptive effects of the intertidal grazer Scurria viridula positively influences the abundance and recovery from disturbances of the alga Mazzaella laminarioides at the edge of its geographic distributions in northern-central Chilean rocky shores. Through field experiments conducted at a site in the region where M. laminarioides overlaps with the polar range edge of S. viridula, we estimated the effects of grazing on different life stages of M. laminarioides. We also used long-term abundance surveys conducted across similar to 700 km of the shore to evaluate co-occurrence patterns of the study species across their range overlap. We found that S. viridula had positive net effects on M. laminarioides by increasing its cover and re-growth from perennial basal crusts. Probability of occurrence of M. laminarioides increased significantly with increasing density of S. viridula across the range overlap. The negative effect of S. viridula on the percentage cover of opportunistic green algae-shown to compete for space with corticated algae-suggests that competitive release may be part of the mechanism driving the positive effect of the limpet on the abundance and recovery from disturbance of M. laminarioides. We suggest that grazer populations contribute to enhance the abundance of M. laminarioides, facilitating its recolonization and persistence at its distributional range edge. Our study highlights that indirect facilitation can determine the recovery and persistence of a resource at the limit of its distribution, and may well contribute to the ecological mechanisms governing species distributions and range shifts.	[Aguilera, Moises A.; Broitman, Bernardo R.] Univ Catolica Norte, CEAZA, Coquimbo, Chile; [Valdivia, Nelson] Univ Austral Chile, Fac Ciencias, Inst Ciencias Marinas & Limnol, Valdivia, Chile	Universidad Catolica del Norte; Universidad Austral de Chile	Aguilera, MA (corresponding author), Univ Catolica Norte, Fac Ciencias Mar, Dept Biol Marina, Larrondo 1281, Coquimbo, Chile.	moises.aguilera@ceaza.cl	Aguilera, Moisés/AAC-2981-2020; Broitman, Bernardo R/D-6007-2013; Valdivia, Nelson/C-3613-2009	Aguilera, Moisés/0000-0002-3517-6255; Broitman, Bernardo R/0000-0001-6582-3188; Valdivia, Nelson/0000-0002-5394-2072	Fondo Nacional de Desarrollo Cientifico y Tecnologico of Chile (FONDECYT) [11121360, 1090488, 1120988, 3100014, 1141037]; Programa de Mejoramiento de la Calidad y la Equidad de la Educacion Superior (MECESUP) [AU50805]	Fondo Nacional de Desarrollo Cientifico y Tecnologico of Chile (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Programa de Mejoramiento de la Calidad y la Equidad de la Educacion Superior (MECESUP)	Research was supported by grants from the Fondo Nacional de Desarrollo Cientifico y Tecnologico of Chile (FONDECYT) to MM (grant #11121360), BRB (grant #1090488 and 1120988) and NV (grant #3100014 and 1141037), and by the Programa de Mejoramiento de la Calidad y la Equidad de la Educacion Superior (MECESUP) to NV (grant #AU50805).	Aguilera MA, 2007, J EXP MAR BIOL ECOL, V349, P84, DOI 10.1016/j.jembe.2007.05.002; Aguilera MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137287; Aguilera MA, 2013, MAR ECOL PROG SER, V483, P185, DOI 10.3354/meps10293; Aguilera MA, 2012, ECOLOGY, V93, P75, DOI 10.1890/11-0434.1; Aguilera MA, 2011, MAR ECOL PROG SER, V431, P119, DOI 10.3354/meps09100; Aquilino KM, 2009, LIMNOL OCEANOGR, V54, P309, DOI 10.4319/lo.2009.54.1.0309; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Araujo MB, 2014, ECOGRAPHY, V37, P406, DOI 10.1111/j.1600-0587.2013.00643.x; Benedetti-Cecchi L, 2000, ECOL MONOGR, V70, P45, DOI 10.1890/0012-9615(2000)070[0045:PDAIID]2.0.CO;2; Berlow EL, 1999, ECOLOGY, V80, P2206, DOI 10.1890/0012-9658(1999)080[2206:QVITSO]2.0.CO;2; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; BRANCH GM, 1976, J ANIM ECOL, V45, P507, DOI 10.2307/3888; Broitman BR, 2011, REV CHIL HIST NAT, V84, P143, DOI 10.4067/S0716-078X2011000100011; Broitman BR, 2001, MAR ECOL PROG SER, V224, P21, DOI 10.3354/meps224021; Camus PA, 2008, MAR ECOL PROG SER, V361, P35, DOI 10.3354/meps07421; Case TJ, 2000, AM NAT, V155, P583, DOI 10.1086/303351; Coleman RA, 2006, OECOLOGIA, V147, P556, DOI 10.1007/s00442-005-0296-9; Coulson LA, 2011, BIOL J LINN SOC, V103, P849, DOI 10.1111/j.1095-8312.2011.01676.x; Daleo P, 2009, ECOLOGY, V90, P2368, DOI 10.1890/08-2330.1; DUTILLEUL P, 1993, ECOLOGY, V74, P1646, DOI 10.2307/1939923; Espoz C, 2004, REV CHIL HIST NAT, V77, P257; Fortin MJ., 2005, SPATIAL ANAL GUIDE E, P365, DOI [10.1017/CBO9780511542039, DOI 10.1017/CBO9780511542039]; GAINES SD, 1982, ANNU REV ECOL SYST, V13, P111, DOI 10.1146/annurev.es.13.110182.000551; Gaylord B, 2006, ECOL MONOGR, V76, P481, DOI 10.1890/0012-9615(2006)076[0481:MSDICE]2.0.CO;2; Ghedini G, 2015, ECOL LETT, V18, P182, DOI 10.1111/ele.12405; Godsoe W, 2012, ECOGRAPHY, V35, P811, DOI 10.1111/j.1600-0587.2011.07103.x; Gorman D, 2009, J APPL ECOL, V46, P1258, DOI 10.1111/j.1365-2664.2009.01711.x; Guidone M, 2010, MAR ECOL PROG SER, V420, P83, DOI 10.3354/meps08894; HANNACH G, 1985, MAR ECOL PROG SER, V22, P291, DOI 10.3354/meps022291; Harley CDG, 2003, ECOLOGY, V84, P1477, DOI 10.1890/0012-9658(2003)084[1477:ASAHIT]2.0.CO;2; HAWKINS SJ, 1983, OCEANOGR MAR BIOL, V21, P195; He Q, 2014, ECOLOGY, V95, P1437, DOI 10.1890/13-2226.1; Helmuth B, 2006, ANNU REV ECOL EVOL S, V37, P373, DOI 10.1146/annurev.ecolsys.37.091305.110149; Holt RD, 2009, P R SOC B, V276, P1435, DOI 10.1098/rspb.2008.1536; HORMAZABAL S, 2004, J GEOPHYS RES, P109; Jenkins SR, 2001, MAR ECOL PROG SER, V211, P193, DOI 10.3354/meps211193; Johnson MP, 2008, J EXP MAR BIOL ECOL, V365, P136, DOI 10.1016/j.jembe.2008.08.006; Jonsson PR, 2006, ECOLOGY, V87, P1169, DOI 10.1890/0012-9658(2006)87[1169:IBWAAG]2.0.CO;2; Kinlan BP, 2003, ECOLOGY, V84, P2007, DOI 10.1890/01-0622; Lavergne S, 2010, ANNU REV ECOL EVOL S, V41, P321, DOI 10.1146/annurev-ecolsys-102209-144628; Lima F. P., 2012, NATURE COMMUNICATION, V3; Lima FP, 2006, J BIOGEOGR, V33, P812, DOI 10.1111/j.1365-2699.2006.01457.x; Littler MM, 2006, HARMFUL ALGAE, V5, P565, DOI 10.1016/j.hal.2005.11.003; LITTLER MM, 1995, ECOLOGY, V76, P1666, DOI 10.2307/1938167; LUBCHENCO J, 1978, AM NAT, V112, P23, DOI 10.1086/283250; LUBCHENCO J, 1981, ANNU REV ECOL SYST, V12, P405, DOI 10.1146/annurev.es.12.110181.002201; Maestre FT, 2009, J ECOL, V97, P199, DOI 10.1111/j.1365-2745.2008.01476.x; Manly B.F.J., 2006, RANDOMIZATION BOOTST, P480; MENGE BA, 1995, ECOL MONOGR, V65, P21, DOI 10.2307/2937158; Montecinos A, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-97; Navarrete SA, 2005, P NATL ACAD SCI USA, V102, P18046, DOI 10.1073/pnas.0509119102; Navarrete SA, 1996, ECOL MONOGR, V66, P409, DOI 10.2307/2963488; Nielsen KJ, 2004, ECOL LETT, V7, P31, DOI 10.1046/j.1461-0248.2003.00542.x; O'Connor MI, 2009, ECOLOGY, V90, P388, DOI 10.1890/08-0034.1; Osenberg Craig W., 1996, P134; Parmesan C, 2005, OIKOS, V108, P58, DOI 10.1111/j.0030-1299.2005.13150.x; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Plaganyi EE, 2000, MAR ECOL PROG SER, V194, P113, DOI 10.3354/meps194113; Poore AGB, 2014, OECOLOGIA, V174, P789, DOI 10.1007/s00442-013-2795-4; Poore AGB, 2012, ECOL LETT, V15, P912, DOI 10.1111/j.1461-0248.2012.01804.x; Rivadeneira MM, 2005, J BIOGEOGR, V32, P203, DOI 10.1111/j.1365-2699.2004.01133.x; Rivadeneira MM, 2002, MAR ECOL PROG SER, V245, P123, DOI 10.3354/meps245123; Sagarin RD, 2006, TRENDS ECOL EVOL, V21, P524, DOI 10.1016/j.tree.2006.06.008; Sala E, 2002, P NATL ACAD SCI USA, V99, P3678, DOI 10.1073/pnas.052028499; SANTELICES B, 1990, HYDROBIOLOGIA, V192, P35, DOI 10.1007/BF00006226; Santelices B, 1992, THE SYSTEMATICS ASSO, V46, P363; Schmitz OJ, 2008, ANNU REV ECOL EVOL S, V39, P133, DOI 10.1146/annurev.ecolsys.39.110707.173418; Scrosati R, 1998, J APPL PHYCOL, V10, P531, DOI 10.1023/A:1008029632351; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; Stanton-Geddes J, 2012, ECOLOGY, V93, P1604, DOI 10.1890/11-1701.1; STENECK RS, 1982, MAR BIOL, V68, P299, DOI 10.1007/BF00409596; STENECK RS, 1994, OIKOS, V69, P476, DOI 10.2307/3545860; Thornber C, 2006, ECOLOGY, V87, P2255, DOI 10.1890/0012-9658(2006)87[2255:TTMSHO]2.0.CO;2; UNDERWOOD AJ, 1981, OECOLOGIA, V48, P221, DOI 10.1007/BF00347968; Varela DA, 2006, J APPL PHYCOL, V18, P827, DOI 10.1007/s10811-006-9102-2; Von Ende C, 1993, DESIGN ANAL ECOLOGIC, P445; Wieters EA, 2005, MAR ECOL PROG SER, V301, P43, DOI 10.3354/meps301043; Worm B, 2000, MAR ECOL PROG SER, V202, P283, DOI 10.3354/meps202283; Zacherl D, 2003, J BIOGEOGR, V30, P913, DOI 10.1046/j.1365-2699.2003.00899.x	79	7	7	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0146069	10.1371/journal.pone.0146069	http://dx.doi.org/10.1371/journal.pone.0146069			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716986	gold, Green Published, Green Submitted			2022-12-26	WOS:000367510500130
J	Hori, K; Nagai, T; Shan, W; Sakamoto, A; Abe, M; Yamazaki, M; Sakimura, K; Yamada, K; Hoshino, M				Hori, Kei; Nagai, Taku; Shan, Wei; Sakamoto, Asami; Abe, Manabu; Yamazaki, Maya; Sakimura, Kenji; Yamada, Kiyofumi; Hoshino, Mikio			Heterozygous Disruption of Autism susceptibility candidate 2 Causes Impaired Emotional Control and Cognitive Memory	PLOS ONE			English	Article							NEURONAL MIGRATION; AUTISM-SUSCEPTIBILITY-CANDIDATE-2 AUTS2; GENE; DOUBLECORTIN; TRANSLOCATION; LAMINATION; CORTEX; MICE	Mutations in the Autism susceptibility candidate 2 gene (AUTS2) have been associated with a broad range of psychiatric illnesses including autism spectrum disorders, intellectual disability and schizophrenia. We previously demonstrated that the cytoplasmic AUTS2 acts as an upstream factor for the Rho family small GTPase Rac1 and Cdc42 that regulate the cytoskeletal rearrangements in neural cells. Moreover, genetic ablation of the Auts2 gene in mice has resulted in defects in neuronal migration and neuritogenesis in the developing cerebral cortex caused by inactivation of Rac1-signaling pathway, suggesting that AUTS2 is required for neural development. In this study, we conducted a battery of behavioral analyses on Auts2 heterozygous mutant mice to examine the involvement of Auts2 in adult cognitive brain functions. Auts2-deficient mice displayed a decrease in exploratory behavior as well as lower anxiety-like behaviors in the absence of any motor dysfunction. Furthermore, the capability for novel object recognition and cued associative memory were impaired in Auts2 mutant mice. Social behavior and sensory motor gating functions were, however, normal in the mutant mice as assessed by the three-chamber test and prepulse inhibition test, respectively. Together, our findings indicate that AUTS2 is critical for the acquisition of neurocognitive function.	[Hori, Kei; Sakamoto, Asami; Hoshino, Mikio] NCNP, Natl Inst Neurosci, Dept Biochem & Cellular Biol, Tokyo, Japan; [Nagai, Taku; Shan, Wei; Yamada, Kiyofumi] Nagoya Univ, Grad Sch Med, Dept Neuropsychopharmacol & Hosp Pharm, Nagoya, Aichi 4648601, Japan; [Abe, Manabu; Yamazaki, Maya; Sakimura, Kenji] Niigata Univ, Dept Cellular Neurobiol, Brain Res Inst, Niigata, Japan	National Center for Neurology & Psychiatry - Japan; Nagoya University; Niigata University	Hoshino, M (corresponding author), NCNP, Natl Inst Neurosci, Dept Biochem & Cellular Biol, Tokyo, Japan.	hoshino@ncnp.go.jp	Yamazaki, Maya/C-6952-2012; Nagai, Taku/I-7507-2014; Abe, Manabu/A-9221-2008; Sokabe, Masahiro/I-1565-2012	Nagai, Taku/0000-0001-5050-7748; 	Ministry of Education, Culture, Sports, Science, and Technology of Japan [25115733, 25110742]; MEXT (Ministry of Education, Culture, Sports, Science and Technology); Astellas foundation; Naito foundation; Takeda foundation; Uehara foundation; NCNP (National Center of Neurology and Psychiatry) [24-12, 25-3]; Japanese Ministry of Health, Labor and Welfare [H23-001]; JSPS (Japan Society for the Promotion of Science) KAKENHI [23700406, 25840030]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT (Ministry of Education, Culture, Sports, Science and Technology)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Astellas foundation(Astellas Pharmaceuticals); Naito foundation(Naito Memorial Foundation); Takeda foundation(Takeda Science Foundation (TSF)); Uehara foundation(Uehara Memorial Foundation); NCNP (National Center of Neurology and Psychiatry); Japanese Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); JSPS (Japan Society for the Promotion of Science) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work is supported by Grants-in-Aid for Scientific Research on Innovative Areas "Mesoscopic Neurocircuitry" (Grant 25115733) and "Synapse and Neurocircuit Pathology" (Grant 25110742) of the Ministry of Education, Culture, Sports, Science, and Technology of Japan; grants from MEXT (Ministry of Education, Culture, Sports, Science and Technology), Astellas foundation, Naito foundation, Takeda foundation, Uehara foundation, Intramural Research Grants (M.H., 24-12, 25-3) for Neurological and Psychiatric Disorders of NCNP (National Center of Neurology and Psychiatry), Health Science Research Grant for Research on Psychiatric and Neurological Diseases and Mental Health (M.H., H23-001) from the Japanese Ministry of Health, Labor and Welfare, and JSPS (Japan Society for the Promotion of Science) KAKENHI Grant Numbers 23700406, 25840030 (K.H.).	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Bedogni F, 2010, P NATL ACAD SCI USA, V107, P13129, DOI 10.1073/pnas.1002285107; Bedogni F, 2010, GENE EXPR PATTERNS, V10, P9, DOI 10.1016/j.gep.2009.11.005; Beunders G, 2013, AM J HUM GENET, V92, P210, DOI 10.1016/j.ajhg.2012.12.011; Chen YH, 2013, DRUG ALCOHOL DEPEN, V128, P238, DOI 10.1016/j.drugalcdep.2012.08.029; Corbo JC, 2002, J NEUROSCI, V22, P7548; Dang W, 2014, J MOL NEUROSCI, V54, P811, DOI 10.1007/s12031-014-0421-5; des Portes V, 1998, CELL, V92, P51; Deuel TAS, 2006, NEURON, V49, P41, DOI 10.1016/j.neuron.2005.10.038; Elia J, 2010, MOL PSYCHIATR, V15, P637, DOI 10.1038/mp.2009.57; Feng YY, 2000, NEURON, V28, P665, DOI 10.1016/S0896-6273(00)00145-8; Gao ZH, 2014, NATURE, V516, P349, DOI 10.1038/nature13921; Girirajan S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002334; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Hori K, 2014, CELL REP, V9, P2166, DOI 10.1016/j.celrep.2014.11.045; Ibi D, 2010, BEHAV BRAIN RES, V206, P32, DOI 10.1016/j.bbr.2009.08.027; Jolley A, 2013, AM J MED GENET A, V161A, P1508, DOI 10.1002/ajmg.a.35922; Kalscheuer VM, 2007, HUM GENET, V121, P501, DOI 10.1007/s00439-006-0284-0; Koike H, 2009, BEHAV BRAIN RES, V202, P114, DOI 10.1016/j.bbr.2009.03.028; Koizumi H, 2006, NAT NEUROSCI, V9, P779, DOI 10.1038/nn1704; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lee PR, 2005, NEUROPSYCHOPHARMACOL, V30, P1883, DOI 10.1038/sj.npp.1300722; Liu JS, 2011, CURR NEUROL NEUROSCI, V11, P171, DOI 10.1007/s11910-010-0176-5; Mefford HC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000962; Nadler JJ, 2004, GENES BRAIN BEHAV, V3, P303, DOI 10.1111/j.1601-183X.2004.00071.x; Nagai T, 2007, LEARN MEMORY, V14, P117, DOI 10.1101/lm.461407; Nagai T, 2010, NEUROSCI LETT, V470, P134, DOI 10.1016/j.neulet.2009.12.071; Oksenberg N, 2013, TRENDS GENET, V29, P600, DOI 10.1016/j.tig.2013.08.001; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Schumann G, 2011, P NATL ACAD SCI USA, V108, P7119, DOI 10.1073/pnas.1017288108; Sultana R, 2002, GENOMICS, V80, P129, DOI 10.1006/geno.2002.6810; Takahashi K, 2007, BIOL PSYCHIAT, V62, P148, DOI 10.1016/j.biopsych.2006.06.035; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Valiente M, 2010, CURR OPIN NEUROBIOL, V20, P68, DOI 10.1016/j.conb.2009.12.003; Wu QF, 2012, CELL, V149, P1549, DOI 10.1016/j.cell.2012.04.046	35	20	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145979	10.1371/journal.pone.0145979	http://dx.doi.org/10.1371/journal.pone.0145979			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA0TN	26717414	Green Submitted, Green Published, gold			2022-12-26	WOS:000367510500108
J	Neal, ML; Carlson, BE; Thompson, CT; James, RC; Kim, KG; Tran, K; Crampin, EJ; Cook, DL; Gennari, JH				Neal, Maxwell L.; Carlson, Brian E.; Thompson, Christopher T.; James, Ryan C.; Kim, Karam G.; Tran, Kenneth; Crampin, Edmund J.; Cook, Daniel L.; Gennari, John H.			Semantics-Based Composition of Integrated Cardiomyocyte Models Motivated by Real-World Use Cases	PLOS ONE			English	Article							VENTRICULAR MYOCYTES; MATHEMATICAL-MODEL; ONTOLOGY; DATABASE; INFORMATICS; LANGUAGE; RESOURCE; NETWORK	Semantics-based model composition is an approach for generating complex biosimulation models from existing components that relies on capturing the biological meaning of model elements in a machine-readable fashion. This approach allows the user to work at the biological rather than computational level of abstraction and helps minimize the amount of manual effort required for model composition. To support this compositional approach, we have developed the SemGen software, and here report on SemGen's semantics-based merging capabilities using real-world modeling use cases. We successfully reproduced a large, manually-encoded, multi-model merge: the "Pandit-Hinch-Niederer" (PHN) cardiomyocyte excitation-contraction model, previously developed using CellML. We describe our approach for annotating the three component models used in the PHN composition and for merging them at the biological level of abstraction within SemGen. We demonstrate that we were able to reproduce the original PHN model results in a semi-automated, semantics-based fashion and also rapidly generate a second, novel cardiomyocyte model composed using an alternative, independently-developed tension generation component. We discuss the time-saving features of our compositional approach in the context of these merging exercises, the limitations we encountered, and potential solutions for enhancing the approach.	[Neal, Maxwell L.; James, Ryan C.; Kim, Karam G.; Gennari, John H.] Univ Washington, Dept Biomed Informat & Med Educ, Seattle, WA 98195 USA; [Carlson, Brian E.; Thompson, Christopher T.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Tran, Kenneth] Univ Auckland, Auckland Bioengn Inst, Auckland 1, New Zealand; [Crampin, Edmund J.] Univ Melbourne, Melbourne Sch Engn, Syst Biol Lab, Melbourne, Vic 3010, Australia; [Crampin, Edmund J.] Univ Melbourne, Melbourne Sch Engn, ARC Ctr Excellence Convergent Bionano Sci & Techn, Melbourne, Vic 3010, Australia; [Crampin, Edmund J.] Univ Melbourne, Sch Math & Stat, Melbourne, Vic 3010, Australia; [Crampin, Edmund J.] Univ Melbourne, Sch Med, Melbourne, Vic 3010, Australia; [Cook, Daniel L.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; University of Auckland; University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; University of Washington; University of Washington Seattle	Neal, ML (corresponding author), Univ Washington, Dept Biomed Informat & Med Educ, Seattle, WA 98195 USA.	mneal@uw.edu		Kim, Karam/0000-0001-8063-6081; Neal, Maxwell/0000-0002-2390-6572; Carlson, Brian/0000-0002-1353-5907; Gennari, John/0000-0001-8254-4957; Tran, Kenneth/0000-0002-8651-3557	National Institutes of Health [R01LM011969, P50GM094503, T15LM007442]; Australian Research Council Centre of Excellence in Convergent Bio-Nano Science and Technology [CE140100036]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM094503] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007442, R01LM011969] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council Centre of Excellence in Convergent Bio-Nano Science and Technology(Australian Research Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was funded by National Institutes of Health (http://www.nih.gov/) grants R01LM011969 (MLN, BEC, CTT, KGK, DLC, JHG), P50GM094503 (BEC, CTT, KT, EJC) and T15LM007442 (RCJ) as well as Australian Research Council Centre of Excellence in Convergent Bio-Nano Science and Technology (http://www.bionano.org.au/ grant CE140100036 (EJC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bard J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r21; Beard DA, 2012, ANN BIOMED ENG, V40, P2365, DOI 10.1007/s10439-012-0611-7; Bechhofer S., 2004, W3C RECOMM, V10; Brinkman Ryan R, 2010, J Biomed Semantics, V1 Suppl 1, pS7, DOI 10.1186/2041-1480-1-S1-S7; Butterworth Erik, 2013, F1000Res, V2, P288, DOI 10.12688/f1000research.2-288.v1; Cook DL, 2013, J BIOMED SEMANT, V4, DOI 10.1186/2041-1480-4-41; Cook Daniel L, 2013, J Biomed Semantics, V4 Suppl 1, pS2, DOI 10.1186/2041-1480-4-S1-S2; Cook DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028708; Cuellar AA, 2003, SIMUL-T SOC MOD SIM, V79, P740, DOI 10.1177/0037549703040939; Garny A, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00026; Gennari JH, 2011, J BIOMED INFORM, V44, P146, DOI 10.1016/j.jbi.2010.06.007; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hastings J, 2013, NUCLEIC ACIDS RES, V41, pD456, DOI 10.1093/nar/gks1146; Hayamizu TF, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r29; Hinch R, 2004, BIOPHYS J, V87, P3723, DOI 10.1529/biophysj.104.049973; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Li C, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-92; Natale DA, 2014, NUCLEIC ACIDS RES, V42, pD415, DOI 10.1093/nar/gkt1173; Neal M, 2013, P ICBO, P16; Neal ML, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003849; Neal ML, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P304; Niederer SA, 2006, BIOPHYS J, V90, P1697, DOI 10.1529/biophysj.105.069534; Niederer SA, 2007, BIOPHYS J, V92, P4030, DOI 10.1529/biophysj.106.095463; Pandit SV, 2001, BIOPHYS J, V81, P3029, DOI 10.1016/S0006-3495(01)75943-7; Rice JJ, 2008, BIOPHYS J, V95, P2368, DOI 10.1529/biophysj.107.119487; Rosse C, 2003, J BIOMED INFORM, V36, P478, DOI 10.1016/j.jbi.2003.11.007; Schulz M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-18; Schulz M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.41; Terkildsen JR, 2008, EXP PHYSIOL, V93, P919, DOI 10.1113/expphysiol.2007.041871; Tran K, 2010, BIOPHYS J, V98, P267, DOI 10.1016/j.bpj.2009.10.011	30	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145621	10.1371/journal.pone.0145621	http://dx.doi.org/10.1371/journal.pone.0145621			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716837	Green Published, gold			2022-12-26	WOS:000367510500049
J	Thomas, RG; Moon, MJ; Kim, JH; Lee, JH; Jeong, YY				Thomas, Reju George; Moon, Myeong Ju; Kim, Jo Heon; Lee, Jae Hyuk; Jeong, Yong Yeon			Effectiveness of Losartan-Loaded Hyaluronic Acid (HA) Micelles for the Reduction of Advanced Hepatic Fibrosis in C3H/HeN Mice Model	PLOS ONE			English	Article							RENIN-ANGIOTENSIN SYSTEM; STELLATE CELLS; RECEPTOR ANTAGONIST; TARGETED DELIVERY; LIVER FIBROSIS; CIRRHOSIS; RAT; NANOPARTICLES; PATHOGENESIS; SUPPRESSION	Advanced hepatic fibrosis therapy using drug-delivering nanoparticles is a relatively unexplored area. Angiotensin type 1 (AT1) receptor blockers such as losartan can be delivered to hepatic stellate cells (HSC), blocking their activation and thereby reducing fibrosis progression in the liver. In our study, we analyzed the possibility of utilizing drug-loaded vehicles such as hyaluronic acid (HA) micelles carrying losartan to attenuate HSC activation. Losartan, which exhibits inherent lipophilicity, was loaded into the hydrophobic core of HA micelles with a 19.5% drug loading efficiency. An advanced liver fibrosis model was developed using C3H/HeN mice subjected to 20 weeks of prolonged TAA/ethanol weight-adapted treatment. The cytocompatibility and cell uptake profile of losartan-HA micelles were studied in murine fibroblast cells (NIH3T3), human hepatic stellate cells (hHSC) and FL83B cells (hepatocyte cell line). The ability of these nanoparticles to attenuate HSC activation was studied in activated HSC cells based on alpha smooth muscle actin (alpha-sma) expression. Mice treated with oral losartan or losartan-HA micelles were analyzed for serum enzyme levels (ALT/AST, CK and LDH) and collagen deposition (hydroxyproline levels) in the liver. The accumulation of HA micelles was observed in fibrotic livers, which suggests increased delivery of losartan compared to normal livers and specific uptake by HSC. Active reduction of alpha-sma was observed in hHSC and the liver sections of losartan-HA micelle-treated mice. The serum enzyme levels and collagen deposition of losartan-HA micelle-treated mice was reduced significantly compared to the oral losartan group. Losartan-HA micelles demonstrated significant attenuation of hepatic fibrosis via an HSC-targeting mechanism in our in vitro and in vivo studies. These nanoparticles can be considered as an alternative therapy for liver fibrosis.	[Thomas, Reju George; Jeong, Yong Yeon] Chonnam Natl Univ, Sch Med, Hwasun Hosp, Dept Radiol, Gwangju, South Korea; [Moon, Myeong Ju] DKC Corp BioActs, Inchon, South Korea; [Kim, Jo Heon; Lee, Jae Hyuk] Chonnam Natl Univ, Sch Med, Hwasun Hosp, Dept Pathol, Gwangju, South Korea	Chonnam National University; Chonnam National University	Jeong, YY (corresponding author), Chonnam Natl Univ, Sch Med, Hwasun Hosp, Dept Radiol, Gwangju, South Korea.	yjeong@jnu.ac.kr	Thomas, Reju/R-9111-2019		Basic Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science and future Planning [2015R1A2A2A01007798]; DKC Corporation (BioActs)	Basic Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science and future Planning; DKC Corporation (BioActs)	This research was supported by Basic Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science and future Planning (2015R1A2A2A01007798). The funder (DKC Corporation (BioActs)) provided support in the form of salaries for authors and/or research materials [MMJ], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Bahde R, 2011, LIVER INT, V31, P642, DOI 10.1111/j.1478-3231.2011.02493.x; Bakris G, 2008, KIDNEY INT, V74, P364, DOI 10.1038/ki.2008.204; Bataller R, 2005, ANTIOXID REDOX SIGN, V7, P1346, DOI 10.1089/ars.2005.7.1346; Bataller R, 2003, GASTROENTEROLOGY, V125, P117, DOI 10.1016/S0016-5085(03)00695-4; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Beljaars L, 2001, LIVER, V21, P320, DOI 10.1034/j.1600-0676.2001.210504.x; Bisht S, 2011, LAB INVEST, V91, P1383, DOI 10.1038/labinvest.2011.86; Bosetti C, 2007, J HEPATOL, V46, P827, DOI 10.1016/j.jhep.2007.01.025; Choi KY, 2009, J MATER CHEM, V19, P4102, DOI 10.1039/b900456d; Colmenero J, 2009, AM J PHYSIOL-GASTR L, V297, pG726, DOI 10.1152/ajpgi.00162.2009; Guerra R. R., 2010, Brazilian Journal of Veterinary Pathology, V3, P9; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Jin Yu-Jin, 2010, Journal of Pharmaceutical Investigation, V40, P33, DOI 10.4333/KPS.2010.40.S.033; Kabir N, 2014, RSC ADV, V4, P9012, DOI 10.1039/c3ra46093b; Kikuchi S, 2005, J BIOL CHEM, V280, P15398, DOI 10.1074/jbc.M414048200; Kim KS, 2010, ACS NANO, V4, P3005, DOI 10.1021/nn100589y; Kim M, 2008, J GASTROENTEROL, V43, P889, DOI 10.1007/s00535-008-2239-9; Kornek M, 2006, J HEPATOL, V45, P370, DOI 10.1016/j.jhep.2006.03.017; Kurikawa N, 2003, BRIT J PHARMACOL, V139, P1085, DOI 10.1038/sj.bjp.0705339; Levy BI, 2008, CIRCULATION, V118, P968, DOI 10.1161/CIRCULATIONAHA.107.763730; Li XN, 2002, J HEPATOL, V36, P488, DOI 10.1016/S0168-8278(02)00011-9; Liu YH, 2011, INT J PHARMACEUT, V421, P160, DOI 10.1016/j.ijpharm.2011.09.006; Moreno M, 2010, HEPATOLOGY, V51, P942, DOI 10.1002/hep.23419; Munshi MK, 2011, EXP BIOL MED, V236, P557, DOI 10.1258/ebm.2011.010375; Pereira RM, 2009, WORLD J GASTROENTERO, V15, P2579, DOI 10.3748/wjg.15.2579; Rehm J, 2013, J HEPATOL, V59, P160, DOI 10.1016/j.jhep.2013.03.007; Satoh T, 2000, J GASTROEN HEPATOL, V15, P402, DOI 10.1046/j.1440-1746.2000.02164.x; Schneider AW, 1999, HEPATOLOGY, V29, P334, DOI 10.1002/hep.510290203; Takei Y, 2004, FASEB J, V10; Thomas RG, 2015, INT J BIOL MACROMOL, V72, P510, DOI 10.1016/j.ijbiomac.2014.08.054; Urashima S, 2000, ALCOHOL CLIN EXP RES, V24, p34S, DOI 10.1111/j.1530-0277.2000.tb00009.x	31	35	36	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145512	10.1371/journal.pone.0145512	http://dx.doi.org/10.1371/journal.pone.0145512			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714035	Green Published, gold, Green Submitted			2022-12-26	WOS:000367481900049
J	Zhang, YY				Zhang, Yong-Yuan			Duck Hepatitis B Virus cccDNA Amplification Efficiency in Natural Infection Is Regulated by Virus Secretion Efficiency	PLOS ONE			English	Article							CLOSED CIRCULAR DNA; AVIAN HEPADNAVIRUS; ENVELOPE PROTEINS; VIRAL-DNA; GENOME; REPLICATION; LIVER; HEPATOCYTES; THERAPY; INTERMEDIATE	Previous mutation based studies showed that ablating synthesis of viral envelope proteins led to elevated hepadnaviral covalently closed circular DNA (cccDNA) amplification, but it remains unknown how cccDNA amplification is regulated in natural hepadnaviral infection because of a lack of research system. In this study we report a simple procedure to prepare two identical duck hepatitis B virus inocula, but they possess 10-100-fold difference in cccDNA amplification in infected cell culture. We demonstrate that the infected cells with higher cccDNA amplification significantly reduce the virus secretion efficiency that results in higher accumulation of relaxed circular DNA (rcDNA) and DHBsAg in the cells. The infected cells with lower cccDNA amplification significantly increase the virus secretion efficiency that leads to lower intracellular rcDNA and DHBsAg accumulation. In contrast with the findings generated in the mutation based experimental system, the regulation of cccDNA amplification in natural hepadnaviral infection bypasses direct regulation of the cellular envelope proteins concentration, instead it modulates virus secretion efficiency that ultimately impacts the intracellular rcDNA concentration, an important factor determining the destination of the synthesized rcDNA in infected cells.	[Zhang, Yong-Yuan] HBVtech, Germantown, MD 20874 USA		Zhang, YY (corresponding author), HBVtech, Germantown, MD 20874 USA.	yongyuanzhang50@gmail.com						BARTENSCHLAGER R, 1990, J VIROL, V64, P5324, DOI 10.1128/JVI.64.11.5324-5332.1990; Bourne EJ, 2007, J VIRAL HEPATITIS, V14, P55, DOI 10.1111/j.1365-2893.2006.00775.x; Funk A, 2004, J VIROL, V78, P8289, DOI 10.1128/jvi.78.15.8289-8300.2004; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Gao WF, 2007, J VIROL, V81, P6164, DOI 10.1128/JVI.02721-06; Gerlich WH, 2007, J VIRAL HEPATITIS, V14, P16, DOI 10.1111/j.1365-2893.2007.00912.x; Ghany MG, 2012, ALIMENT PHARM THER, V35, P1027, DOI 10.1111/j.1365-2036.2012.05059.x; Guo H, 2007, J VIROL, V81, P12472, DOI 10.1128/JVI.01123-07; HADZIYANNIS S, 1973, ARCH PATHOL, V96, P327; HEERMANN KH, 1984, J VIROL, V52, P396, DOI 10.1128/JVI.52.2.396-402.1984; Kwon H, 2011, NAT REV GASTRO HEPAT, V8, P275, DOI 10.1038/nrgastro.2011.33; Lee JM, 2011, HEPATOLOGY, V53, P1486, DOI 10.1002/hep.24221; Lenhoff RJ, 1999, HEPATOLOGY, V29, P563, DOI 10.1002/hep.510290236; LENHOFF RJ, 1994, J VIROL, V68, P5706, DOI 10.1128/JVI.68.9.5706-5713.1994; Lenhoff RJ, 1998, VIROLOGY, V251, P85, DOI 10.1006/viro.1998.9394; LENHOFF RJ, 1994, J VIROL, V68, P4565, DOI 10.1128/JVI.68.7.4565-4571.1994; Lentz TB, 2011, J VIROL, V85, P11916, DOI 10.1128/JVI.05373-11; MANDART E, 1984, J VIROL, V49, P782, DOI 10.1128/JVI.49.3.782-792.1984; MASON WS, 1983, VIROLOGY, V131, P375, DOI 10.1016/0042-6822(83)90505-6; Miller Darren S, 2004, Methods Mol Med, V96, P3; MILLER RH, 1989, HEPATOLOGY, V9, P322, DOI 10.1002/hep.1840090226; MILLER RH, 1984, VIROLOGY, V137, P390, DOI 10.1016/0042-6822(84)90231-9; PUGH JC, 1995, J VIROL, V69, P4814, DOI 10.1128/JVI.69.8.4814-4822.1995; SEEGER C, 1986, SCIENCE, V232, P477, DOI 10.1126/science.3961490; SUMMERS J, 1981, HEPATOLOGY, V1, P179, DOI 10.1002/hep.1840010215; SUMMERS J, 1990, J VIROL, V64, P2819, DOI 10.1128/JVI.64.6.2819-2824.1990; SUMMERS J, 1982, CELL, V29, P403, DOI 10.1016/0092-8674(82)90157-X; SUMMERS J, 1991, J VIROL, V65, P1310, DOI 10.1128/JVI.65.3.1310-1317.1991; SUMMERS J, 1975, P NATL ACAD SCI USA, V72, P4597, DOI 10.1073/pnas.72.11.4597; TUTTLEMAN JS, 1986, J VIROL, V58, P17, DOI 10.1128/JVI.58.1.17-25.1986; TUTTLEMAN JS, 1986, CELL, V47, P451, DOI 10.1016/0092-8674(86)90602-1; Werle-Lapostolle B, 2004, GASTROENTEROLOGY, V126, P1750, DOI 10.1053/j.gastro.2004.03.018; WU TT, 1990, VIROLOGY, V175, P255, DOI 10.1016/0042-6822(90)90206-7; Wursthorn K, 2006, HEPATOLOGY, V44, P675, DOI 10.1002/hep.21282; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049; Zhang YY, 2000, J VIROL, V74, P5257, DOI 10.1128/JVI.74.11.5257-5265.2000; Zhang YY, 2005, J VIROL, V79, P9896, DOI 10.1128/JVI.79.15.9896-9903.2005; Zhang YY, 1999, J VIROL, V73, P3616, DOI 10.1128/JVI.73.5.3616-3622.1999; Zhang YZ, 2003, P NATL ACAD SCI USA, V100, P12372, DOI 10.1073/pnas.2033898100; Zhu Y, 2001, J VIROL, V75, P311, DOI 10.1128/JVI.75.1.311-322.2001	40	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145465	10.1371/journal.pone.0145465	http://dx.doi.org/10.1371/journal.pone.0145465			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713436	Green Published, Green Submitted, gold			2022-12-26	WOS:000367481900045
J	Lee, YA; Kim, HR; Lee, JS; Jung, HW; Kim, HY; Lee, GM; Lee, J; Sim, JH; Oh, SJ; Chung, DH; Shin, CH; Yang, SW				Lee, Young Ah; Kim, Hang-Rae; Lee, Jeong Seon; Jung, Hae Woon; Kim, Hwa Young; Lee, Gyung Min; Lee, Jieun; Sim, Ji Hyun; Oh, Sae Jin; Chung, Doo Hyun; Shin, Choong Ho; Yang, Sei Won			CD4(+)FOXP3(+) Regulatory T Cells Exhibit Impaired Ability to Suppress Effector T Cell Proliferation in Patients with Turner Syndrome	PLOS ONE			English	Article							WOMEN; LYMPHOCYTES; FOXP3	Objective We investigated whether the frequency, phenotype, and suppressive function of CD4(+)FOXP3(+) regulatory T cells (Tregs) are altered in young TS patients with the 45, X karyotype compared to age-matched controls. Design and Methods Peripheral blood mononuclear cells from young TS patients (n = 24, 17.4-35.9 years) and healthy controls (n = 16) were stained with various Treg markers to characterize their phenotypes. Based on the presence of thyroid autoimmunity, patients were categorized into TS (-) (n = 7) and TS (+) (n = 17). Tregs sorted for CD4(+)CD25(bright) were co-cultured with autologous CD4(+)CD25(-) target cells in the presence of anti-CD3 and -CD28 antibodies to assess their suppressive function. Results Despite a lower frequency of CD4(+) T cells in the TS (-) and TS (+) patients (mean 30.8% and 31.7%, vs. 41.2%; P = 0.003 and P < 0.001, respectively), both groups exhibited a higher frequency of FOXP3(+) Tregs among CD4(+) T cells compared with controls (means 1.99% and 2.05%, vs. 1.33%; P = 0.029 and P = 0.004, respectively). There were no differences in the expression of CTLA-4 and the frequency of Tregs expressing CXCR3(+), and CCR4(+)CCR6(+) among the three groups. However, the ability of Tregs to suppress the in vitro proliferation of autologous CD4(+)CD25(-) T cells was significantly impaired in the TS (-) and TS (+) patients compared to controls (P = 0.003 and P = 0.041). Meanwhile, both the TS (-) and TS (+) groups had lower frequencies of naive cells (P = 0.001 for both) but higher frequencies of effector memory cells (P = 0.004 and P = 0.002) than did the healthy control group. Conclusions The Tregs of the TS patients could not efficiently suppress the proliferation of autologous effector T cells, despite their increased frequency in peripheral CD4(+) T cells.	[Lee, Young Ah; Lee, Jeong Seon; Jung, Hae Woon; Kim, Hwa Young; Lee, Gyung Min; Lee, Jieun; Shin, Choong Ho; Yang, Sei Won] Seoul Natl Univ, Coll Med, Childrens Hosp, Dept Pediat, Seoul, South Korea; [Kim, Hang-Rae; Sim, Ji Hyun] Seoul Natl Univ, Coll Med, Dept Anat, Seoul, South Korea; [Kim, Hang-Rae; Oh, Sae Jin; Chung, Doo Hyun] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Chung, Doo Hyun] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Pathol, Seoul, South Korea; [Chung, Doo Hyun] Seoul Natl Univ, Coll Med, Ischemic Hypoxia Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Shin, CH (corresponding author), Seoul Natl Univ, Coll Med, Childrens Hosp, Dept Pediat, 103 Daehak Ro, Seoul, South Korea.	chshinpd@snu.ac.kr	Kim, Hang-Rae/J-5448-2012; Jung, Hae Woon/AAR-6728-2020	Jung, Hae Woon/0000-0003-0494-4626; Kim, Hang-Rae/0000-0002-3983-6193; Lee, Jieun/0000-0002-9776-4204	Seoul National University Hospital Research Fund [04-2011-1050]	Seoul National University Hospital Research Fund	This work was supported by from the Seoul National University Hospital Research Fund (Grant number 04-2011-1050).	Bakalov VK, 2012, J AUTOIMMUN, V38, P315, DOI 10.1016/j.jaut.2012.01.015; Bondy CA, 2007, J CLIN ENDOCR METAB, V92, P10, DOI 10.1210/jc.2006-1374; Booth NJ, 2010, J IMMUNOL, V184, P4317, DOI 10.4049/jimmunol.0903781; Brusko TM, 2008, IMMUNOL REV, V223, P371, DOI 10.1111/j.1600-065X.2008.00637.x; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; El-Mansoury M, 2005, J CLIN ENDOCR METAB, V90, P2131, DOI 10.1210/jc.2004-1262; Fan HY, 2012, ARCH GYNECOL OBSTET, V285, P749, DOI 10.1007/s00404-011-2049-9; Figueroa-Vega N, 2010, J CLIN ENDOCR METAB, V95, P953, DOI 10.1210/jc.2009-1719; Hwang KA, 2009, MECH AGEING DEV, V130, P509, DOI 10.1016/j.mad.2009.06.003; Jez Waclaw, 2010, Pol Merkur Lekarski, V29, P247; Jorgensen KT, 2010, ARTHRITIS RHEUM-US, V62, P658, DOI 10.1002/art.27270; Livadas S, 2005, THYROID, V15, P1061, DOI 10.1089/thy.2005.15.1061; Marazuela M, 2006, J CLIN ENDOCR METAB, V91, P3639, DOI 10.1210/jc.2005-2337; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Shin Choong Ho, 2008, Clinical and Experimental Pediatrics, V51, P569; Stenberg Annika E, 2004, J Negat Results Biomed, V3, P6, DOI 10.1186/1477-5751-3-6; Su MA, 2009, CLIN IMMUNOL, V131, P139, DOI 10.1016/j.clim.2008.11.007; Wing K, 2011, TRENDS IMMUNOL, V32, P428, DOI 10.1016/j.it.2011.06.002; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455; Zinn AR, 1998, AM J HUM GENET, V63, P1757, DOI 10.1086/302152	23	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0144549	10.1371/journal.pone.0144549	http://dx.doi.org/10.1371/journal.pone.0144549			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709833	Green Published, gold, Green Submitted			2022-12-26	WOS:000367451400007
J	Ortega, A; Tarazon, E; Rosello-Lleti, E; Gil-Cayuela, C; Lago, F; Gonzalez-Juanatey, JR; Cinca, J; Jorge, E; Martinez-Dolz, L; Portoles, M; Rivera, M				Ortega, Ana; Tarazon, Estefania; Rosello-Lleti, Esther; Gil-Cayuela, Carolina; Lago, Francisca; Gonzalez-Juanatey, Jose-Ramon; Cinca, Juan; Jorge, Esther; Martinez-Dolz, Luis; Portoles, Manuel; Rivera, Miguel			Patients with Dilated Cardiomyopathy and Sustained Monomorphic Ventricular Tachycardia Show Up-Regulation of KCNN3 and KCNJ2 Genes and CACNG8-Linked Left Ventricular Dysfunction	PLOS ONE			English	Article							SHORT QT SYNDROME; HEART-FAILURE; ATRIAL-FIBRILLATION; POTASSIUM CHANNELS; MOLECULAR-BASIS; EXPRESSION; GUIDELINES; CARDIOLOGY; TRANSPORT; MUTATION	Aims Disruptions in cardiac ion channels have shown to influence the impaired cardiac contraction in heart failure. We sought to determine the altered gene expression profile of this category in dilated cardiomyopathy (DCM) patients and relate the altered gene expression with the clinical signs present in our patients, such as ventricular dysfunction and sustained monomorphic ventricular tachycardia (SMVT). Methods and Results Left ventricular (LV) tissue samples were used in RNA-sequencing technique to elucidate the transcriptomic changes of 13 DCM patients compared to controls (n = 10). We analyzed the differential gene expression of cardiac ion channels, and we found a total of 34 altered genes. We found that the calcium channel CACNG8 mRNA and protein levels were down-regulated and highly and inversely related with LV ejection fraction (LVEF) (r = -0.78, P<0.01). Furthermore, the potassium channels KCNN3 and KCNJ2 mRNA and protein levels were up-regulated and showed also a significant and inverse correlation with LVEF (r = -0.61, P<0.05; r = -0.60, P<0.05) in patients with SMVT. Conclusion A broad set of deregulated genes have been identified by RNA-sequencing technique. The relationship of CACNG8, KCNN3 and KCNJ2 with LVEF, and the up-regulation of KCNN3 and KCNJ2 in all patients with SMVT, irrespective of CACNG8 expression, suggest a significant role for these three ion flux related genes in the LV dysfunction present in this cardiomyopathy and an important relationship between KCNN3 and KCNJ2 up-regulation and the presence of SMVT.	[Ortega, Ana; Tarazon, Estefania; Rosello-Lleti, Esther; Gil-Cayuela, Carolina; Portoles, Manuel; Rivera, Miguel] La Fe Univ Hosp, Hlth Res Inst, Cardiocirculatory Unit, IIS La Fe, Valencia, Spain; [Lago, Francisca; Gonzalez-Juanatey, Jose-Ramon] Univ Clin Hosp, Dept Cardiol, Cellular & Mol Cardiol Res Unit, Santiago De Compostela, Spain; [Lago, Francisca; Gonzalez-Juanatey, Jose-Ramon] Univ Clin Hosp, Inst Biomed Res, Santiago De Compostela, Spain; [Cinca, Juan; Jorge, Esther] Santa Creu & St Pau Hosp, Serv Cardiol, Barcelona, Spain; [Martinez-Dolz, Luis] La Fe Univ Hosp, Dept Cardiol, Heart Failure & Transplantat Unit, Valencia, Spain	Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela	Rivera, M (corresponding author), La Fe Univ Hosp, Hlth Res Inst, Cardiocirculatory Unit, IIS La Fe, Valencia, Spain.	miguelrivera492@gmail.com	Roselló Lletí, Esther/ABG-8503-2020; Ortega, Ana/AAG-5941-2020; Gil-Cayuela, Carolina/D-6996-2017; PORTOLES, MANUEL/B-4789-2009; Ortega, Ana AO/D-3027-2017; Dolz, Luis Martinez/X-4627-2018; Tarazón, Estefanía/D-6950-2017; jorge, esther/D-4206-2014; Roselló-Lletí, Esther/B-2695-2017	Roselló Lletí, Esther/0000-0003-2627-6104; Ortega, Ana/0000-0002-9763-0505; Gil-Cayuela, Carolina/0000-0002-1106-7935; PORTOLES, MANUEL/0000-0002-4415-7160; Ortega, Ana AO/0000-0002-9763-0505; Dolz, Luis Martinez/0000-0001-5145-8191; Tarazón, Estefanía/0000-0003-3466-2558; jorge, esther/0000-0002-2777-0000; Roselló-Lletí, Esther/0000-0003-2627-6104; Gonzalez Juanatey, Jose Ramon/0000-0001-9681-3388	National Institute of Health "Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III" [PI13/00100, PI14/01506]; European Regional Development Fund (FEDER); RETICS (Red Tematica en Investigacion Cooperativa en Salud) [12/0042/0003]	National Institute of Health "Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III"; European Regional Development Fund (FEDER)(European Commission); RETICS (Red Tematica en Investigacion Cooperativa en Salud)	This work was supported by the National Institute of Health "Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III" [PI13/00100; PI14/01506], the European Regional Development Fund (FEDER), and RETICS (Red Tematica en Investigacion Cooperativa en Salud) [12/0042/0003] (AO, ET, ERL, CGC, FL, MP, MR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronsen JM, 2013, J MOL CELL CARDIOL, V61, P11, DOI 10.1016/j.yjmcc.2013.06.003; Bonilla IM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108824; Chang PC, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.004713; Cho CH, 2007, NEURON, V55, P890, DOI 10.1016/j.neuron.2007.08.024; Chua SK, 2011, CIRC RES, V108, P971, DOI 10.1161/CIRCRESAHA.110.238386; Decher N, 2001, CARDIOVASC RES, V52, P255, DOI 10.1016/S0008-6363(01)00374-1; Despa S, 2013, J MOL CELL CARDIOL, V61, P2, DOI 10.1016/j.yjmcc.2013.04.011; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ertl G, 2014, EUR HEART J, V35, P470, DOI 10.1093/eurheartj/eht555; Fischer TH, 2014, EUR J HEART FAIL, V16, P1292, DOI 10.1002/ejhf.163; Grubb S, 2014, J CARDIOVASC ELECTR, V25, P896, DOI 10.1111/jce.12422; Gui L, 2013, AM J PHYSIOL-HEART C, V304, pH118, DOI 10.1152/ajpheart.00820.2011; Hardziyenka M, 2012, J AM COLL CARDIOL, V59, P2193, DOI 10.1016/j.jacc.2012.01.063; Iqbal K, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.113928; Jankowska EA, 2013, EUR HEART J, V34, P816, DOI 10.1093/eurheartj/ehs224; Kaab S, 1998, CIRCULATION, V98, P1383, DOI 10.1161/01.CIR.98.14.1383; Li N, 2009, J PHYSIOL-LONDON, V587, P1087, DOI 10.1113/jphysiol.2008.167718; Macrae Duncan J, 2007, Proc Am Thorac Soc, V4, P176, DOI 10.1513/pats.200701-011GC; Mahida S, 2014, CARDIOVASC RES, V101, P326, DOI 10.1093/cvr/cvt269; Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Molina-Navarro MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079792; Nerbonne JM, 2000, J PHYSIOL-LONDON, V525, P285, DOI 10.1111/j.1469-7793.2000.t01-1-00285.x; Ni YJ, 2013, MOL CELL BIOCHEM, V384, P95, DOI 10.1007/s11010-013-1785-5; Ortega A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107635; Patel C, 2010, CIRC-ARRHYTHMIA ELEC, V3, P401, DOI 10.1161/CIRCEP.109.921056; Priori SG, 2005, CIRC RES, V96, P800, DOI 10.1161/01.RES.0000162101.76263.8c; Qi XY, 2015, CIRC RES, V116, P836, DOI 10.1161/CIRCRESAHA.116.305326; Radicke S, 2006, CARDIOVASC RES, V71, P695, DOI 10.1016/j.cardiores.2006.06.017; Rosello-Lleti E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112971; Speerschneider T, 2013, J PHYSIOL-LONDON, V591, P5923, DOI 10.1113/jphysiol.2013.263483; Szuts V, 2013, CAN J PHYSIOL PHARM, V91, P648, DOI 10.1139/cjpp-2012-0413; Tarazon E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048957; Walmsley J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056359; Xia M, 2005, BIOCHEM BIOPH RES CO, V332, P1012, DOI 10.1016/j.bbrc.2005.05.054; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Yang DD, 2015, J MEMBRANE BIOL, V248, P1181, DOI 10.1007/s00232-015-9839-0; Yanni J, 2011, CIRC-HEART FAIL, V4, P496, DOI 10.1161/CIRCHEARTFAILURE.110.957647	38	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145518	10.1371/journal.pone.0145518	http://dx.doi.org/10.1371/journal.pone.0145518			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710323	Green Submitted, Green Published, gold			2022-12-26	WOS:000367451400060
J	Onken, A; Said, AK; Jorstad, M; Jenum, PA; Blomberg, B				Onken, Annette; Said, Abdulrahman K.; Jorstad, Melissa; Jenum, Pal A.; Blomberg, Bjorn			Prevalence and Antimicrobial Resistance of Microbes Causing Bloodstream Infections in Unguja, Zanzibar	PLOS ONE			English	Article							SPECTRUM BETA-LACTAMASES; GRAM-NEGATIVE BACTERIA; HEALTH-CARE; AFRICA; ENTEROBACTERIACEAE; COUNTRIES; TANZANIA; HOSPITALS; SEPSIS; DEATH	Background Bloodstream infections (BSI) are frequent and cause high case-fatality rates. Urgent antibiotic treatment can save patients' lives, but antibiotic resistance can render antibiotic therapy futile. This study is the first to collect epidemiological data on BSI from Unguja, Zanzibar. Methods Clinical data and blood for culturing and susceptibility testing of isolated microbes were obtained from 469 consecutively enrolled neonates, children and adults presenting with signs of systemic infections at Mnazi Mmoja Hospital (MMH), Zanzibar. Results Pathogenic bacteria were recovered from the blood of 14% of the patients (66/469). The most frequently isolated microbes were Klebsiella pneumoniae, Escherichia coli, Acinetobacter spp. and Staphylococcus aureus. Infections were community-acquired in 56 patients (85%) and hospital-acquired in 8 (12%) (data missing for 2 patients). BSI caused by extended-spectrum beta-lactamase (ESBL) producing Enterobacteriaceae (E. coli, K. pneumoniae) was found in 5 cases, of which 3 were community-acquired and 2 hospital-acquired. Three of these patients died. Six of 7 Salmonella Typhi isolates were multidrug resistant. Streptococcus pneumoniae was found in one patient only. Conclusions This is the first report of ESBL-producing bacteria causing BSI from the Zanzibar archipelago. Our finding of community-acquired BSI caused by ESBL-producing bacteria is alarming, as it implies that these difficult-to-treat bacteria have already spread in the society. In the local setting these infections are virtually impossible to cure. The findings call for increased awareness of rational antibiotic use, infection control and surveillance to counteract the problem of emerging antimicrobial resistance.	[Onken, Annette; Jenum, Pal A.] Vestre Viken Hlth Trust, Dept Med Microbiol, Drammen, Norway; [Said, Abdulrahman K.] Mnazi Mmoja Hosp, Dept Med, Zanzibar, Tanzania; [Jorstad, Melissa; Blomberg, Bjorn] Haukeland Hosp, Dept Med, N-5021 Bergen, Norway; [Blomberg, Bjorn] Haukeland Hosp, Natl Ctr Trop Infect Dis, N-5021 Bergen, Norway; [Blomberg, Bjorn] Univ Bergen, Dept Clin Sci, Bergen, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen	Onken, A (corresponding author), Vestre Viken Hlth Trust, Dept Med Microbiol, Drammen, Norway.	annetteonken@yahoo.com	; Blomberg, Bjorn/B-9605-2015	Davidsen Jorstad, Melissa/0000-0003-3516-5297; Blomberg, Bjorn/0000-0001-5647-4297	National Center for Tropical Infectious Diseases; Haukeland University Hospital, Bergen, Norway	National Center for Tropical Infectious Diseases; Haukeland University Hospital, Bergen, Norway	The National Center for Tropical Infectious Diseases, Haukeland University Hospital, Bergen, Norway funded all material used in the study including analysis of the samples in Zanzibar and Norway and transport of the samples from Zanzibar to Norway as well as payment to the local collaborators in Zanzibar, both at the laboratory and at the wards, and part of the travel expenses and accommodation expenses of AO.	Aisenberg G, 2004, CANCER-AM CANCER SOC, V101, P2134, DOI 10.1002/cncr.20604; Alp E, 2011, ANN CLIN MICROB ANTI, V10, DOI 10.1186/1476-0711-10-36; [Anonymous], 1981, Scand J Infect Dis, V13, P148; [Anonymous], 2005, PRINCIPLES PRACTICE; Archibald LK, 2001, EMERG INFECT DIS, V7, P302, DOI 10.3201/eid0702.010232; Archibald LK, 2000, J CLIN MICROBIOL, V38, P2994, DOI 10.1128/JCM.38.8.2994-2997.2000; Aregawi MW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-46; Becker JU, 2009, LANCET INFECT DIS, V9, P577, DOI 10.1016/S1473-3099(09)70135-5; Birkett CI, 2007, J MED MICROBIOL, V56, P52, DOI 10.1099/jmm.0.46909-0; Blomberg B, 2005, J CLIN MICROBIOL, V43, P745, DOI 10.1128/JCM.43.2.745-749.2005; Blomberg B, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-43; Collee JG, 1996, MACKIE MCCARTNEY PRA, V14th; Cosgrove SE, 2006, CLIN INFECT DIS, V42, pS82, DOI 10.1086/499406; Feasey NA, 2012, LANCET, V379, P2489, DOI 10.1016/S0140-6736(11)61752-2; Silva BNG, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007934.pub2; Kothari C, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-136; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Mnyika Kagoma S, 2012, East Afr J Public Health, V9, P123; Moyo S, 2015, ANTIMICROB AGENTS CH, V59, P682, DOI 10.1128/AAC.01436-13; Mshana SE, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-466; Mshana Stephen E, 2009, BMC Res Notes, V2, P49, DOI 10.1186/1756-0500-2-49; Munoz-Price LS, 2008, NEW ENGL J MED, V358, P1271, DOI 10.1056/NEJMra070741; Paterson DL, 2006, AM J INFECT CONTROL, V34, pS20, DOI 10.1016/j.ajic.2006.05.238; Petti CA, 2006, CLIN INFECT DIS, V42, P377, DOI 10.1086/499363; Reddy EA, 2010, LANCET INFECT DIS, V10, P417, DOI 10.1016/S1473-3099(10)70072-4; Saied T, 2011, AM J INFECT CONTROL, V39, pE61, DOI 10.1016/j.ajic.2011.04.009; Sturod K, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0217-3; Tansarli GS, 2014, J ANTIMICROB CHEMOTH, V69, P1177, DOI 10.1093/jac/dkt500; Tansarli GS, 2013, EXPERT REV ANTI-INFE, V11, P321, DOI [10.1586/eri.13.4, 10.1586/ERI.13.4]; Thriemer K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030350; Vlieghe E, 2009, INT J ANTIMICROB AG, V34, P295, DOI 10.1016/j.ijantimicag.2009.04.015	31	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145632	10.1371/journal.pone.0145632	http://dx.doi.org/10.1371/journal.pone.0145632			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700032	gold, Green Published			2022-12-26	WOS:000367092600110
J	Liu, XQ; Liu, CY; Guo, Q; Zhang, M; Cao, BN; Xiang, ZH; Zhao, AC				Liu, Xue-Qin; Liu, Chang-Ying; Guo, Qing; Zhang, Meng; Cao, Bo-Ning; Xiang, Zhong-Huai; Zhao, Ai-Chun			Mulberry Transcription Factor MnDREB4A Confers Tolerance to Multiple Abiotic Stresses in Transgenic Tobacco	PLOS ONE			English	Article							GENE-EXPRESSION; SALT-STRESS; ARABIDOPSIS-THALIANA; LOW-TEMPERATURE; MOLECULAR-CLONING; CROP IMPROVEMENT; WATER-DEFICIT; AP2 DOMAIN; DROUGHT; PLANTS	The dehydration responsive element binding (DREB) transcription factors have been reported to be involved in stress responses. Most studies have focused on DREB genes in subgroups A-1 and A-2 in herbaceous plants, but there have been few reports on the functions of DREBs from the A-3-A-6 subgroups and in woody plants. Moreover, mulberry trees are ecologically and economically important perennial woody plants, but there has been little research on its stress physiology, biochemistry and molecular biology. In this study, a DREB gene from the mulberry tree, designated as MnDREB4A, classified into the A-4 subgroup by our previous study, was selected for further characterization. Our results showed that the MnDREB4A protein was localized to the nucleus where it activated transcription. The promoter of MnDREB4A can direct prominent expression downstream of the beta-glucuronidase (GUS) gene under heat, cold, drought and salt stress, and GUS staining was deepest after 12 h of stress treatment. The MnDREB4A-overexpression transgenic tobacco showed the improved growth phenotype under untreated conditions, such as greener leaves, longer roots, and lower water loss and senescence rates. Overexpression of MnDREB4A in tobacco can significantly enhance tolerance to heat, cold, drought, and salt stresses in transgenic plants. The leaf discs and seedlings of transgenic plants reduced leaf wilting and senescence rates compared to the wild type plants under the different stress conditions. Further investigation showed that transgenic plants also had higher water contents and proline contents, and lower malondialdehyde contents under untreated condition and stress conditions. Our results indicate that the MnDREB4A protein plays an important role in plant stress tolerance.	[Liu, Xue-Qin; Liu, Chang-Ying; Guo, Qing; Zhang, Meng; Cao, Bo-Ning; Xiang, Zhong-Huai; Zhao, Ai-Chun] Southwest Univ, State Key Lab Silkworm Genome Biol, Key Lab Sericulture Funct Genom & Biotechnol, Minist Agr, Chongqing 400716, Peoples R China	Ministry of Agriculture & Rural Affairs; Southwest University - China	Zhao, AC (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Key Lab Sericulture Funct Genom & Biotechnol, Minist Agr, Chongqing 400716, Peoples R China.	zhaoaichun@hotmail.com	Zhao, Aichun/T-4308-2018	Zhao, Aichun/0000-0001-6140-0102	National Hi-Tech Research and Development Program of China [2013AA100605-3]; China Agriculture Research System [CARS-22-ZJ0102]	National Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); China Agriculture Research System	The National Hi-Tech Research and Development Program of China (No. 2013AA100605-3) and the China Agriculture Research System (No. CARS-22-ZJ0102).	Agarwal PK, 2010, BIOL PLANTARUM, V54, P201, DOI 10.1007/s10535-010-0038-7; Allen MD, 1998, EMBO J, V17, P5484, DOI 10.1093/emboj/17.18.5484; Ashraf M, 2009, BIOTECHNOL ADV, V27, P744, DOI 10.1016/j.biotechadv.2009.05.026; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bais HP, 2002, PLANT CELL TISS ORG, V69, P1, DOI 10.1023/A:1015064227278; BARRS HD, 1962, AUST J BIOL SCI, V15, P413, DOI 10.1071/BI9620413; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Bhatnagar-Mathur P, 2008, PLANT CELL REP, V27, P411, DOI 10.1007/s00299-007-0474-9; Bohnert HJ, 2001, PLANT PHYSIOL BIOCH, V39, P295, DOI 10.1016/S0981-9428(00)01237-7; Bouaziz D, 2013, MOL BIOTECHNOL, V54, P803, DOI 10.1007/s12033-012-9628-2; Checker VG, 2013, PLANT CELL REP, V32, P1729, DOI 10.1007/s00299-013-1483-5; CHEN H, 1994, BIOTECHNIQUES, V16, P664; Chen H, 2012, J INTEGR PLANT BIOL, V54, P640, DOI 10.1111/j.1744-7909.2012.01137.x; Chen JR, 2009, IN VITRO CELL DEV-PL, V45, P1, DOI 10.1007/s11627-008-9163-9; Chen P, 2008, J CEREAL SCI, V48, P734, DOI 10.1016/j.jcs.2008.04.002; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dubouzet JG, 2003, PLANT J, V33, P751, DOI 10.1046/j.1365-313X.2003.01661.x; Dunwell JM, 2000, J EXP BOT, V51, P487, DOI 10.1093/jexbot/51.suppl_1.487; FUJIMOTO H, 1993, BIO-TECHNOL, V11, P1151, DOI 10.1038/nbt1093-1151; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Huang GT, 2012, MOL BIOL REP, V39, P969, DOI 10.1007/s11033-011-0823-1; Hussain SS, 2011, BIOTECHNOL PROGR, V27, P297, DOI 10.1002/btpr.514; Jin XF, 2013, MOL BIOL REP, V40, P1743, DOI 10.1007/s11033-012-2228-1; Kizis D, 2001, FEBS LETT, V498, P187, DOI 10.1016/S0014-5793(01)02460-7; KOZIEL MG, 1993, BIO-TECHNOL, V11, P194, DOI 10.1038/nbt0293-194; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li XS, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-44; Liu JP, 1997, PLANT PHYSIOL, V114, P591, DOI 10.1104/pp.114.2.591; Liu LQ, 2008, J PLANT RES, V121, P215, DOI 10.1007/s10265-007-0140-x; Liu XQ, 2015, BIOL PLANTARUM, V59, P253, DOI 10.1007/s10535-015-0498-x; Lodhi M. A., 1994, Plant Molecular Biology Reporter, V12, P6, DOI 10.1007/BF02668658; Mizoi J, 2013, PLANT PHYSIOL, V161, P346, DOI 10.1104/pp.112.204875; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Oh SJ, 2005, PLANT PHYSIOL, V138, P341, DOI 10.1104/pp.104.059147; Okamuro JK, 1997, P NATL ACAD SCI USA, V94, P7076, DOI 10.1073/pnas.94.13.7076; Rae L, 2011, PLANTA, V234, P429, DOI 10.1007/s00425-011-1414-z; Rashid M, 2001, EVOLUTIONARY BIOINFO, V8, P321; Reddy AR, 2004, ENVIRON EXP BOT, V52, P33, DOI 10.1016/j.envexpbot.2004.01.002; Reguera M, 2012, BBA-GENE REGUL MECH, V1819, P186, DOI 10.1016/j.bbagrm.2011.08.005; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Sathiyaraj G, 2011, MOL BIOL REP, V38, P2761, DOI 10.1007/s11033-010-0421-7; Seki M, 2007, CURR OPIN PLANT BIOL, V10, P296, DOI 10.1016/j.pbi.2007.04.014; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Stockinger EJ, 1997, P NATL ACAD SCI USA, V94, P1035, DOI 10.1073/pnas.94.3.1035; Tong Z, 2009, PLANT MOL BIOL, V71, P115, DOI 10.1007/s11103-009-9513-y; Varshney RK, 2011, TRENDS PLANT SCI, V16, P363, DOI 10.1016/j.tplants.2011.03.004; VASIL V, 1992, BIO-TECHNOL, V10, P667, DOI 10.1038/nbt0692-667; Vinocur B, 2005, CURR OPIN BIOTECH, V16, P123, DOI 10.1016/j.copbio.2005.02.001; VOELKER T, 1987, EMBO J, V6, P3571, DOI 10.1002/j.1460-2075.1987.tb02687.x; Wang C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0065120, 10.1371/journal.pone.0068807]; Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5; WANG ZL, 2008, FOREST STUD CHINA, V10, P143; Wei CJ, 2014, PLANT PHYSIOL BIOCH, V77, P108, DOI 10.1016/j.plaphy.2014.02.002; WU GS, 1995, PLANT CELL, V7, P1357, DOI 10.1105/tpc.7.9.1357; Xu DP, 1996, PLANT PHYSIOL, V110, P249, DOI 10.1104/pp.110.1.249; Xue GP, 2003, PLANT J, V33, P373, DOI 10.1046/j.1365-313X.2003.01630.x; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Ye XD, 2000, SCIENCE, V287, P303, DOI 10.1126/science.287.5451.303; Zhang HX, 2001, NAT BIOTECHNOL, V19, P765, DOI 10.1038/90824	60	19	27	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145619	10.1371/journal.pone.0145619	http://dx.doi.org/10.1371/journal.pone.0145619			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26695076	Green Published, gold, Green Submitted			2022-12-26	WOS:000367092500062
J	Saulou-Berion, C; Gonzalez, I; Enjalbert, B; Audinot, JN; Fourquaux, I; Jamme, F; Cocaign-Bousquet, M; Mercier-Bonin, M; Girbal, L				Saulou-Berion, Claire; Gonzalez, Ignacio; Enjalbert, Brice; Audinot, Jean-Nicolas; Fourquaux, Isabelle; Jamme, Frederic; Cocaign-Bousquet, Muriel; Mercier-Bonin, Muriel; Girbal, Laurence			Escherichia coli under Ionic Silver Stress: An Integrative Approach to Explore Transcriptional, Physiological and Biochemical Responses	PLOS ONE			English	Article							UNSATURATED FATTY-ACIDS; RESPIRATORY-CHAIN; NANOPARTICLES; TOXICITY; PSEUDOMONAS; NANOSIMS; IDENTIFICATION; LOCALIZATION; MECHANISMS; EXPRESSION	For a better understanding of the systemic effect of sub-lethal micromolar concentrations of ionic silver on Escherichia coli, we performed a multi-level characterization of cells under Ag+-mediated stress using an integrative biology approach combining physiological, biochemical and transcriptomic data. Physiological parameters, namely bacterial growth and survival after Ag+ exposure, were first quantified and related to the accumulation of intracellular silver, probed for the first time by nano secondary ion mass spectroscopy at submicrometer lateral resolution. Modifications in E. coli biochemical composition were evaluated under Ag+-mediated stress by in situ synchrotron Fourier-transform infrared microspectroscopy and a comprehensive transcriptome response was also determined. Using multivariate statistics, correlations between the physiological parameters, the extracellular concentration of AgNO3 and the intracellular silver content, gene expression profiles and micro-spectroscopic data were investigated. We identified Ag+-dependent regulation of gene expression required for growth (e.g. transporter genes, transcriptional regulators, ribosomal proteins), for ionic silver transport and detoxification (e.g. copA, cueO, mgtA, nhaR) and for coping with various types of stress (dnaK, pspA, metA, R, oxidoreductase genes). The silver-induced shortening of the acyl chain of fatty acids, mostly encountered in cell membrane, was highlighted by microspectroscopy and correlated with the down-regulated expression of genes involved in fatty acid transport (fadL) and synthesis/modification of lipid A (lpxA and arnA). The increase in the disordered secondary structure of proteins in the presence of Ag+ was assessed through the conformational shift shown for amides I and II, and further correlated with the up-regulated expression of peptidase (hfq) and chaperone (dnaJ), and regulation of transpeptidase expression (ycfS and ycbB). Interestingly, as these transpeptidases act on the structural integrity of the cell wall, regulation of their expression may explain the morphological damage reported under Ag+-mediated stress. This result clearly demonstrates that the cell membrane is a key target of ionic silver.	[Saulou-Berion, Claire; Gonzalez, Ignacio; Enjalbert, Brice; Cocaign-Bousquet, Muriel; Mercier-Bonin, Muriel; Girbal, Laurence] Univ Toulouse, INSA, UPS, INPT,LISBP, Toulouse, France; [Saulou-Berion, Claire; Gonzalez, Ignacio; Enjalbert, Brice; Cocaign-Bousquet, Muriel; Mercier-Bonin, Muriel; Girbal, Laurence] INRA, Ingn Syst Biol & Proc UMR792, F-31931 Toulouse, France; [Saulou-Berion, Claire; Gonzalez, Ignacio; Enjalbert, Brice; Cocaign-Bousquet, Muriel; Mercier-Bonin, Muriel; Girbal, Laurence] CNRS, UMR5504, Toulouse, France; [Audinot, Jean-Nicolas] Luxembourg Inst Sci & Technol LIST, Mat Res & Technol Dept MRT, Belvaux, Luxembourg; [Fourquaux, Isabelle] CMEAB, Fac Med Rangueil, Toulouse, France; [Jamme, Frederic] INRA, UAR1008, CEPIA, F-44026 Nantes, France; [Jamme, Frederic] Synchrotron SOLEIL, Gif Sur Yvette, France	Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Luxembourg Institute of Science & Technology; INRAE; SOLEIL Synchrotron	Girbal, L (corresponding author), Univ Toulouse, INSA, UPS, INPT,LISBP, Toulouse, France.	Laurence.girbal@insa-toulouse.fr	JAMME, Frederic/E-2170-2011; Audinot, Jean-Nicolas/I-5114-2013; MERCIER-BONIN, Muriel/AAO-5286-2021	JAMME, Frederic/0000-0002-7398-7868; Audinot, Jean-Nicolas/0000-0002-4966-7653; Enjalbert, Brice/0000-0003-1291-1373; GIRBAL, Laurence/0000-0002-8773-4829; SAULOU, Claire/0000-0003-4843-6076	French National Research Agency [ANR-07-BLAN-0196-01]	French National Research Agency(French National Research Agency (ANR))	Funding was received from the French National Research Agency (http://www.agence-nationale-recherche.fr/), grant number: ANR-07-BLAN-0196-01 to CSB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A., 2019, TOPGO ENRICHMENT ANA; Audinot JN, 2013, SURF INTERFACE ANAL, V45, P230, DOI 10.1002/sia.5099; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Di Pasqua R, 2006, J AGR FOOD CHEM, V54, P2745, DOI 10.1021/jf052722l; Du HM, 2012, BIOCHEM BIOPH RES CO, V424, P657, DOI 10.1016/j.bbrc.2012.06.134; Eybe T, 2009, CHEMOSPHERE, V76, P134, DOI 10.1016/j.chemosphere.2009.02.005; Fantino JR, 2010, ENVIRON MICROBIOL, V12, P2846, DOI 10.1111/j.1462-2920.2010.02265.x; Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3; Flatley J, 2005, J BIOL CHEM, V280, P10065, DOI 10.1074/jbc.M410393200; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Georgantzopoulou A, 2013, NANOTOXICOLOGY, V7, P1168, DOI 10.3109/17435390.2012.715312; Gonzalez I, 2012, BIODATA MIN, V5, DOI 10.1186/1756-0381-5-19; Gordon O, 2010, ANTIMICROB AGENTS CH, V54, P4208, DOI 10.1128/AAC.01830-09; Gutleb AC, 2012, ANAL BIOANAL CHEM, V404, P2693, DOI 10.1007/s00216-012-6066-8; Hartig C, 2005, APPL ENVIRON MICROB, V71, P1915, DOI 10.1128/AEM.71.4.1915-1922.2005; Heath RJ, 1996, J BIOL CHEM, V271, P27795, DOI 10.1074/jbc.271.44.27795; Helbig K, 2008, J BACTERIOL, V190, P5439, DOI 10.1128/JB.00272-08; Holt KB, 2005, BIOCHEMISTRY-US, V44, P13214, DOI 10.1021/bi0508542; Hoppe P, 2013, GEOSTAND GEOANAL RES, V37, P111, DOI 10.1111/j.1751-908X.2013.00239.x; Inoue Y, 2002, J INORG BIOCHEM, V92, P37, DOI 10.1016/S0162-0134(02)00489-0; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067; Ivask A, 2014, ACS NANO, V8, P374, DOI 10.1021/nn4044047; Jozefczuk S, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.18; Kershaw CJ, 2005, MICROBIOL-SGM, V151, P1187, DOI 10.1099/mic.0.27650-0; KIERANS M, 1991, BIOL MET, V4, P100, DOI 10.1007/BF01135386; Klasen HJ, 2000, BURNS, V26, P117, DOI 10.1016/S0305-4179(99)00108-4; Lansdown A B G, 2002, J Wound Care, V11, P173; Lansdown A B G, 2002, J Wound Care, V11, P125; Le Cao KA, 2009, BIOINFORMATICS, V25, P2855, DOI 10.1093/bioinformatics/btp515; Le Cao KA, 2008, STAT APPL GENET MOL, V7, DOI 10.2202/1544-6115.1390; Lechene Claude, 2006, J Biol, V5, P20, DOI 10.1186/jbiol42; Lee LJ, 2005, J BACTERIOL, V187, P1124, DOI 10.1128/JB.187.3.1124-1134.2005; Liau SY, 1997, LETT APPL MICROBIOL, V25, P279, DOI 10.1046/j.1472-765X.1997.00219.x; Loffeld B, 1996, LIPIDS, V31, P811, DOI 10.1007/BF02522976; Magnet S, 2008, J BACTERIOL, V190, P4782, DOI 10.1128/JB.00025-08; MAGNUSON K, 1993, MICROBIOL REV, V57, P522, DOI 10.1128/MMBR.57.3.522-542.1993; Matsumura Y, 2003, APPL ENVIRON MICROB, V69, P4278, DOI 10.1128/AEM.69.7.4278-4281.2003; McLean S, 2010, J BIOL CHEM, V285, P20724, DOI 10.1074/jbc.M109.085506; Moen B, 2009, CAN J MICROBIOL, V55, P714, DOI [10.1139/W09-016, 10.1139/w09-016]; Movasaghi Z, 2008, APPL SPECTROSC REV, V43, P134, DOI 10.1080/05704920701829043; Mueller CW, 2013, ADV AGRON, V121, P1, DOI 10.1016/B978-0-12-407685-3.00001-3; Park HJ, 2009, WATER RES, V43, P1027, DOI 10.1016/j.watres.2008.12.002; Partridge JD, 2006, J BIOL CHEM, V281, P27806, DOI 10.1074/jbc.M603450200; Patrignani F, 2008, INT J FOOD MICROBIOL, V123, P1, DOI 10.1016/j.ijfoodmicro.2007.09.009; R Core Team, 2012, R LANG ENV STAT COMP; Radzig MA, 2013, COLLOID SURFACE B, V102, P300, DOI 10.1016/j.colsurfb.2012.07.039; Saulou C, 2013, ANAL BIOANAL CHEM, V405, P2685, DOI 10.1007/s00216-013-6725-4; Saulou C, 2012, PLASMA PROCESS POLYM, V9, P324, DOI 10.1002/ppap.201100033; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Silver S, 2006, J IND MICROBIOL BIOT, V33, P627, DOI 10.1007/s10295-006-0139-7; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Wu MY, 2007, WATER SCI TECHNOL, V55, P413, DOI 10.2166/wst.2007.285; Yang HC, 2003, DRUG CHEM TOXICOL, V26, P75, DOI 10.1081/DCT-120020403	57	14	15	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145748	10.1371/journal.pone.0145748	http://dx.doi.org/10.1371/journal.pone.0145748			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26696268	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092500070
J	Liu, SB; Ikenaga, N; Peng, ZW; Sverdlov, DY; Greenstein, A; Smith, V; Schuppan, D; Popov, Y				Liu, Susan B.; Ikenaga, Naoki; Peng, Zhen-Wei; Sverdlov, Deanna Y.; Greenstein, Andrew; Smith, Victoria; Schuppan, Detlef; Popov, Yury			Lysyl oxidase activity contributes to collagen stabilization during liver fibrosis progression and limits spontaneous fibrosis reversal in mice	FASEB JOURNAL			English	Article						BAPN; CCl4; collagen cross-linking; hepatic stellate cells	HEPATIC STELLATE CELLS; ANTIFIBROTIC THERAPIES; EXTRACELLULAR-MATRIX; BILIARY FIBROSIS; CROSS-LINKING; ACTIVATION; MECHANISMS; DEPOSITION; STIFFNESS; CIRRHOSIS	Collagen stabilization through irreversible cross-linking is thought to promote hepatic fibrosis progression and limit its reversibility. However, the mechanism of this process remains poorly defined. We studied the functional contribution of lysyl oxidase (LOX) to collagen stabilization and hepatic fibrosis progression/reversal in vivo using chronic administration of irreversible LOX inhibitor beta-aminopropionitrile (BAPN, or vehicle as control) in C57Bl/6J mice with carbon tetrachloride (CCl4)-induced fibrosis. Fibrotic matrix stability was directly assessed using a stepwise collagen extraction assay and fibrotic septae morphometry. Liver cells and fibrosis were studied by histologic, biochemical methods and quantitative real-time reverse-transcription PCR. During fibrosis progression, BAPN administration suppressed accumulation of cross-linked collagens, and fibrotic septae showed widening and collagen fibrils splitting, reminiscent of remodeling signs observed during fibrosis reversal. LOX inhibition attenuated hepatic stellate cell activation markers and promoted F4/80-positive scar-associated macrophage infiltration without an increase in liver injury. In reversal experiments, BAPN-treated fibrotic mice demonstrated accelerated fibrosis reversal after CCl4 withdrawal. Our findings demonstrate for the first time that LOX contributes significantly to collagen stabilization in liver fibrosis, promotes fibrogenic activation of attenuated hepatic stellate cells, and limits fibrosis reversal. Our data support the concept of pharmacologic targeting of LOX pathway to inhibit liver fibrosis and promote its resolution.-Liu, S. B., Ikenaga, N., Peng, Z.-W., Sverdlov, D. Y., Greenstein, A., Smith, V., Schuppan, D., Popov, Y. Lysyl oxidase activity contributes to collagen stabilization during liver fibrosis progression and limits spontaneous fibrosis reversal in mice. FASEB J. 30, 1599-1609 (2016). www.fasebj.org	[Liu, Susan B.; Ikenaga, Naoki; Peng, Zhen-Wei; Sverdlov, Deanna Y.; Schuppan, Detlef; Popov, Yury] Harvard Univ, Beth Israel Deaconess Med Ctr, Div Gastroenterol & Hepatol, Sch Med, 330 Brookline Ave, Boston, MA 02115 USA; [Peng, Zhen-Wei] Sun Yat Sen Univ, Dept Oncol, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Greenstein, Andrew; Smith, Victoria] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA; [Schuppan, Detlef] Univ Med Ctr, Inst Translat Immunol, Mainz, Germany	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Sun Yat Sen University; Gilead Sciences; Johannes Gutenberg University of Mainz	Popov, Y (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Div Gastroenterol & Hepatol, Sch Med, 330 Brookline Ave, Boston, MA 02115 USA.	ypopov@bidmc.harvard.edu	Popov, Yury V./A-7781-2008	Popov, Yury V./0000-0001-7973-942X; Greenstein, Andrew/0000-0002-1470-1970				Barker HE, 2012, NAT REV CANCER, V12, P540, DOI 10.1038/nrc3319; Barry-Hamilton V, 2010, NAT MED, V16, P1009, DOI 10.1038/nm.2208; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Elbjeirami WM, 2003, J BIOMED MATER RES A, V66A, P513, DOI 10.1002/jbm.a.10021; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; FRIEDMAN SL, 1989, J BIOL CHEM, V264, P10756; Gaca MDA, 2003, MATRIX BIOL, V22, P229, DOI 10.1016/S0945-053X(03)00017-9; Georges PC, 2007, AM J PHYSIOL-GASTR L, V293, pG1147, DOI 10.1152/ajpgi.00032.2007; HUANG D, 1993, ANN BIOMED ENG, V21, P289, DOI 10.1007/BF02368184; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Issa R, 2004, GASTROENTEROLOGY, V126, P1795, DOI 10.1053/j.gastro.2004.03.009; KAGAN HM, 1994, PATHOL RES PRACT, V190, P910; Kagan HM, 2003, J CELL BIOCHEM, V88, P660, DOI 10.1002/jcb.10413; Kuramitsu K, 2013, AM J PATHOL, V183, P182, DOI 10.1016/j.ajpath.2013.03.018; Li ZD, 2007, HEPATOLOGY, V46, P1246, DOI 10.1002/hep.21792; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; Lopez B, 2010, AM J PHYSIOL-HEART C, V299, pH1, DOI 10.1152/ajpheart.00335.2010; Lucero HA, 2006, CELL MOL LIFE SCI, V63, P2304, DOI 10.1007/s00018-006-6149-9; Marcellin P, 2013, LANCET, V381, P468, DOI 10.1016/S0140-6736(12)61425-1; Olsen AL, 2011, AM J PHYSIOL-GASTR L, V301, pG110, DOI 10.1152/ajpgi.00412.2010; Parker MW, 2014, J CLIN INVEST, V124, P1622, DOI 10.1172/JCI71386; Perepelyuk M, 2013, AM J PHYSIOL-GASTR L, V304, pG605, DOI 10.1152/ajpgi.00222.2012; Popov Y, 2005, J HEPATOL, V43, P1045, DOI 10.1016/j.jhep.2005.06.025; Popov Y, 2008, J HEPATOL, V48, P453, DOI 10.1016/j.jhep.2007.11.021; Popov Y, 2006, J BIOL CHEM, V281, P15090, DOI 10.1074/jbc.M600030200; Popov Y, 2011, GASTROENTEROLOGY, V140, P1642, DOI 10.1053/j.gastro.2011.01.040; Popov Y, 2010, AM J PHYSIOL-GASTR L, V298, pG323, DOI 10.1152/ajpgi.00394.2009; Popov Y, 2009, HEPATOLOGY, V50, P1294, DOI 10.1002/hep.23123; ROSENBLOOM J, 1993, FASEB J, V7, P1208, DOI 10.1096/fasebj.7.13.8405806; Vadasz Z, 2005, J HEPATOL, V43, P499, DOI 10.1016/j.jhep.2005.02.052	31	121	123	2	30	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2016	30	4					1599	1609		10.1096/fj.14-268425	http://dx.doi.org/10.1096/fj.14-268425			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DH2PR	26700732				2022-12-26	WOS:000372629100021
J	Kretschmer, I; Freudenberger, T; Twarock, S; Yamaguchi, Y; Grandoch, M; Fischer, JW				Kretschmer, Inga; Freudenberger, Till; Twarock, Soeren; Yamaguchi, Yu; Grandoch, Maria; Fischer, Jens W.			Esophageal Squamous Cell Carcinoma Cells Modulate Chemokine Expression and Hyaluronan Synthesis in Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer; cell-cell interaction; chemokine; fibroblast; hyaluronan; CCL11; CCL5	CANCER-ASSOCIATED FIBROBLASTS; LUNG-CANCER; SELECTIVE EXPRESSION; EOTAXIN CCL11; COLON-CANCER; TGF-BETA; GROWTH; PROMOTES; TRANSCRIPTION; EOSINOPHILS	The aim of this study was to characterize the interaction of KYSE-410, an esophageal squamous cell carcinoma cell line, and fibroblasts with respect to the extracellular matrix component hyaluronan (HA) and chemokine expression. KYSE-410 cells induced the mRNA expression of HA synthase 2 (Has2) in normal skin fibroblasts (SF) only in direct co-cultures. Parallel to Has2 mRNA, Has2 antisense RNA (Has2os2) was up-regulated in co-cultures. Knockdown of LEF1, a downstream target of Wnt signaling, abrogated Has2 and Has2os2 induction. After knockdown of Has2 in SF, significantly less -smooth muscle actin expression was detected in co-cultures. Moreover, it was investigated whether the phenotype of KYSE-410 was affected in co-culture with SF and whether Has2 knockdown in SF had an impact on KYSE-410 cells in co-culture. However, no effects on epithelial-mesenchymal transition markers, proliferation, and migration were detected. In addition to Has2 mRNA, the chemokine CCL5 was up-regulated and CCL11 was down-regulated in SF in co-culture. Furthermore, co-cultures of KYSE-410 cells and cancer-associated fibroblasts (CAF) were investigated. Similar to SF, Has2 and Ccl5 were up-regulated and Ccl11 was down-regulated in CAF in co-culture. Importantly and in contrast to SF, inhibiting HA synthesis by 4-methylumbelliferone abrogated the effect of co-culture on Ccl5 in CAF. Moreover, HA was found to promote adhesion of CD4(+) but not CD8(+) cells to xenogaft tumor tissues. In conclusion, direct co-culture of esophageal squamous cell carcinoma and fibroblasts induced stromal HA synthesis via Wnt/LEF1 and altered the chemokine profile of stromal fibroblasts, which in turn may affect the tumor immune response.	[Kretschmer, Inga; Freudenberger, Till; Twarock, Soeren; Grandoch, Maria; Fischer, Jens W.] Univ Dusseldorf, Univ Klinikum, Inst Pharmakol & Klin Pharmakol, Moorenstr 5, D-40225 Dusseldorf, Germany; [Yamaguchi, Yu] Sanford Burnham Prebys Med Discovery Inst, Human Genet Program, La Jolla, CA 92037 USA	Heinrich Heine University Dusseldorf; Sanford Burnham Prebys Medical Discovery Institute	Kretschmer, I (corresponding author), Univ Dusseldorf, Univ Klinikum, Inst Pharmakol & Klin Pharmakol, Moorenstr 5, D-40225 Dusseldorf, Germany.	jens.fischer@uni-duesseldorf.de	Twarock, Sören/AAB-7705-2020	Twarock, Sören/0000-0001-9252-1353	Deutsche Forschungsgemeinschaft [FI682/4-1, GRK 1739]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by Deutsche Forschungsgemeinschaft Grants FI682/4-1 and GRK 1739. The authors declare that they have no conflicts of interest with the contents of this article.	Alaniz L, 2009, CANCER LETT, V278, P9, DOI 10.1016/j.canlet.2008.12.029; Aldinucci D, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/292376; Augsten M, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00062; Auvinen P, 2000, AM J PATHOL, V156, P529, DOI 10.1016/S0002-9440(10)64757-8; Black KE, 2013, J INFLAMM-LOND, V10, DOI 10.1186/1476-9255-10-23; Bollyky PL, 2007, J IMMUNOL, V179, P744, DOI 10.4049/jimmunol.179.2.744; Bollyky PL, 2009, J IMMUNOL, V183, P2232, DOI 10.4049/jimmunol.0900191; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chang LY, 2012, CANCER RES, V72, P1092, DOI 10.1158/0008-5472.CAN-11-2493; Cirri P, 2011, AM J CANCER RES, V1, P482; Evanko SP, 2012, MATRIX BIOL, V31, P90, DOI 10.1016/j.matbio.2011.10.004; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Golshani R, 2008, CANCER RES, V68, P483, DOI 10.1158/0008-5472.CAN-07-2140; Gooden MJM, 2011, BRIT J CANCER, V105, P93, DOI 10.1038/bjc.2011.189; Harper J, 2014, SEMIN CANCER BIOL, V25, P69, DOI 10.1016/j.semcancer.2013.12.005; HodgeDufour J, 1997, J IMMUNOL, V159, P2492; Itano N, 2004, J BIOL CHEM, V279, P18679, DOI 10.1074/jbc.M313178200; Jameson JM, 2005, J EXP MED, V201, P1269, DOI 10.1084/jem.20042057; Jamieson C, 2012, INT J BIOCHEM CELL B, V44, P847, DOI 10.1016/j.biocel.2012.03.001; Jayasinghe MM, 2008, BREAST CANCER RES TR, V111, P511, DOI 10.1007/s10549-007-9802-6; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kataoka S, 2004, DNA CELL BIOL, V23, P549, DOI 10.1089/dna.2004.23.549; Kim SH, 2013, ANTICANCER RES, V33, P2001; Kobayashi N, 2010, CANCER RES, V70, P7073, DOI 10.1158/0008-5472.CAN-09-4687; Koyama H, 2007, AM J PATHOL, V170, P1086, DOI 10.2353/ajpath.2007.060793; Li YJ, 2007, INT J CANCER, V120, P2557, DOI 10.1002/ijc.22550; Liu JY, 2015, ONCOTARGET, V6, P24978, DOI 10.18632/oncotarget.4617; Liu NF, 2001, CANCER RES, V61, P5207; Maeda-Sano K, 2014, BBA-MOL CELL BIOL L, V1841, P1256, DOI 10.1016/j.bbalip.2014.05.004; Marieb EA, 2004, CANCER RES, V64, P1229, DOI 10.1158/0008-5472.CAN-03-2832; Matsumoto K, 2009, DEVELOPMENT, V136, P2825, DOI 10.1242/dev.038505; Mattes J, 2003, J EXP MED, V197, P387, DOI 10.1084/jem.20021683; Menzies-Gow A, 2002, J IMMUNOL, V169, P2712, DOI 10.4049/jimmunol.169.5.2712; Mi ZY, 2011, CARCINOGENESIS, V32, P477, DOI 10.1093/carcin/bgr009; Michael DR, 2011, J BIOL CHEM, V286, P19523, DOI 10.1074/jbc.M111.233916; Mitra AK, 2012, CANCER DISCOV, V2, P1100, DOI 10.1158/2159-8290.CD-12-0206; Muller J, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0440-y; Noma K, 2008, GASTROENTEROLOGY, V134, P1981, DOI 10.1053/j.gastro.2008.02.061; Ohlund D, 2014, J EXP MED, V211, P1503, DOI 10.1084/jem.20140692; Pasonen-Seppanen S, 2012, HISTOCHEM CELL BIOL, V138, P895, DOI 10.1007/s00418-012-1000-x; Pirinen R, 2001, INT J CANCER, V95, P12, DOI 10.1002/1097-0215(20010120)95:1<12::AID-IJC1002>3.0.CO;2-E; Rajaram M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003789; Rock K, 2011, J BIOL CHEM, V286, P18268, DOI 10.1074/jbc.M110.201665; Sakko AJ, 2001, CANCER RES, V61, P926; Salcedo R, 2001, J IMMUNOL, V166, P7571, DOI 10.4049/jimmunol.166.12.7571; Sallusto F, 1997, SCIENCE, V277, P2005, DOI 10.1126/science.277.5334.2005; Scheibner KA, 2006, J IMMUNOL, V177, P1272, DOI 10.4049/jimmunol.177.2.1272; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Seibler J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng012; Serrels A, 2015, CELL, V163, P160, DOI 10.1016/j.cell.2015.09.001; Servais C, 2013, J PATHOL, V229, P198, DOI 10.1002/path.4103; Simpson MA, 2002, AM J PATHOL, V161, P849, DOI 10.1016/S0002-9440(10)64245-9; Simpson RML, 2010, AM J PATHOL, V176, P1215, DOI 10.2353/ajpath.2010.090802; Simson L, 2007, J IMMUNOL, V178, P4222, DOI 10.4049/jimmunol.178.7.4222; Soon PSH, 2013, ENDOCR-RELAT CANCER, V20, P1, DOI 10.1530/ERC-12-0227; Suga H, 2014, J DERMATOL SCI, V73, P117, DOI 10.1016/j.jdermsci.2013.10.009; Tammi RH, 2011, FEBS J, V278, P1419, DOI 10.1111/j.1742-4658.2011.08070.x; Teng BP, 2011, ANTI-CANCER AGENT ME, V11, P620; Tian X, 2013, NATURE, V499, P346, DOI 10.1038/nature12234; Twarock S, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-30; Udabage L, 2005, CANCER RES, V65, P6139, DOI 10.1158/0008-5472.CAN-04-1622; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vicent S, 2012, CANCER RES, V72, P5744, DOI 10.1158/0008-5472.CAN-12-1097; Vigetti D, 2014, J BIOL CHEM, V289, P28816, DOI 10.1074/jbc.M114.597401; Wan XH, 2012, CLIN CANCER RES, V18, P726, DOI 10.1158/1078-0432.CCR-11-2521; Webber J, 2009, AM J PATHOL, V175, P148, DOI 10.2353/ajpath.2009.080837; Willenberg A, 2012, J INVEST DERMATOL, V132, P385, DOI 10.1038/jid.2011.325; Xu J, 2013, CANCER LETT, V335, P380, DOI 10.1016/j.canlet.2013.02.054; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zhang CY, 2009, CLIN CANCER RES, V15, P4017, DOI 10.1158/1078-0432.CCR-08-2824; Zhang QF, 2015, CANCER RES, V75, P4312, DOI 10.1158/0008-5472.CAN-14-3590; Zoltan-Jones A, 2003, J BIOL CHEM, V278, P45801, DOI 10.1074/jbc.M308168200	72	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					4091	4106		10.1074/jbc.M115.708909	http://dx.doi.org/10.1074/jbc.M115.708909			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26699196	Green Published, hybrid			2022-12-26	WOS:000371338400034
J	Oue, K; Zhang, J; Harada-Hada, K; Asano, S; Yamawaki, Y; Hayashiuchi, M; Furusho, H; Takata, T; Irifune, M; Hirata, M; Kanematsu, T				Oue, Kana; Zhang, Jun; Harada-Hada, Kae; Asano, Satoshi; Yamawaki, Yosuke; Hayashiuchi, Masaki; Furusho, Hisako; Takata, Takashi; Irifune, Masahiro; Hirata, Masato; Kanematsu, Takashi			Phospholipase C-related Catalytically Inactive Protein Is a New Modulator of Thermogenesis Promoted by -Adrenergic Receptors in Brown Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adipocyte; adipose tissue metabolism; lipolysis; obesity; uncoupling protein; thermogenesis	HORMONE-SENSITIVE LIPASE; ADIPOSE-TISSUE; UPSTREAM ENHANCER; BINDING-PROTEIN; FAT DEVELOPMENT; PHOSPHATASE 2A; PPAR-ALPHA; RAT; EXPRESSION; TRANSCRIPTION	Phospholipase C-related catalytically inactive protein (PRIP) was first identified as an inositol 1,4,5-trisphosphate-binding protein, and was later found to be involved in a variety of cellular events, particularly those related to protein phosphatases. We previously reported that Prip knock-out (KO) mice exhibit a lean phenotype with a small amount of white adipose tissue. In the present study, we examined whether PRIP is involved in energy metabolism, which could explain the lean phenotype, using high-fat diet (HFD)-fed mice. Prip-KO mice showed resistance to HFD-induced obesity, resulting in protection from glucose metabolism dysfunction and insulin resistance. Energy expenditure and body temperature at night were significantly higher in Prip-KO mice than in wild-type mice. Gene and protein expression of uncoupling protein 1 (UCP1), a thermogenic protein, was up-regulated in Prip-KO brown adipocytes in thermoneutral or cold environments. These phenotypes were caused by the promotion of lipolysis in Prip-KO brown adipocytes, which is triggered by up-regulation of phosphorylation of the lipolysis-related proteins hormone-sensitive lipase and perilipin, followed by activation of UCP1 and/or up-regulation of thermogenesis-related genes (e.g. peroxisome proliferator-activated receptor- coactivator-1). The results indicate that PRIP negatively regulates UCP1-mediated thermogenesis in brown adipocytes.	[Oue, Kana; Zhang, Jun; Harada-Hada, Kae; Asano, Satoshi; Yamawaki, Yosuke; Hayashiuchi, Masaki; Kanematsu, Takashi] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Cellular & Mol Pharmacol, Hiroshima 7348553, Japan; [Oue, Kana; Irifune, Masahiro] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Dent Anesthesiol, Hiroshima 7348553, Japan; [Furusho, Hisako; Takata, Takashi] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Oral & Maxillofacial Pathobiol, Hiroshima 7348553, Japan; [Hirata, Masato] Kyushu Univ, Fac Dent Sci, Lab Mol & Cellular Biochem, Fukuoka 8128582, Japan; [Zhang, Jun] Univ Tokushima, Inst Genome Res, Div Mol Biol, Tokushima 770, Japan	Hiroshima University; Hiroshima University; Hiroshima University; Kyushu University; Tokushima University	Kanematsu, T (corresponding author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Cellular & Mol Pharmacol, Hiroshima 7348553, Japan.	tkanema2@hiroshima-u.ac.jp	Yamawaki, Yosuke/AAE-9868-2020; Asano, Satoshi/AAQ-3817-2020; Furusho, Hisako/H-2351-2019; Yamawaki, Yosuke/Q-1796-2019; Harada, Kae/AAT-1162-2020	Yamawaki, Yosuke/0000-0002-7247-8295; Harada, Kae/0000-0001-7620-9212; Asano, Satoshi/0000-0003-1537-4307	Funding Program for Next Generation World-Leading Researchers Grant [LS087]; JSPS KAKENHI [266708090, 15H06433, 24229009]; Grants-in-Aid for Scientific Research [15K11313, 15K11039, 15H06433] Funding Source: KAKEN	Funding Program for Next Generation World-Leading Researchers Grant; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Funding Program for Next Generation World-Leading Researchers Grant LS087 (to T.K.) and JSPS KAKENHI Grants 266708090 (to T.K.), 15H06433 (to O.K.), and 24229009 (to M.H.). The authors declare that they have no conflicts of interest with the contents of this article.	Anthonsen MW, 1998, J BIOL CHEM, V273, P215, DOI 10.1074/jbc.273.1.215; Barbera MJ, 2001, J BIOL CHEM, V276, P1486, DOI 10.1074/jbc.M006246200; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004; Clifford GM, 1998, FEBS LETT, V435, P125, DOI 10.1016/S0014-5793(98)01052-7; Collins S, 2001, RECENT PROG HORM RES, V56, P309, DOI 10.1210/rp.56.1.309; Fedorenko A, 2012, CELL, V151, P400, DOI 10.1016/j.cell.2012.09.010; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Fujii M, 2010, J BIOL CHEM, V285, P4837, DOI 10.1074/jbc.M109.070045; Galmozzi A, 2014, CELL REPORT, V9, P1; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; Harada-Hada K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098285; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Hernandez A, 2011, CELL PHYSIOL BIOCHEM, V28, P969, DOI 10.1159/000335810; Hirata M, 2011, DIABETES, V60, P1926, DOI 10.2337/db10-1500; Hondares E, 2011, J BIOL CHEM, V286, P43112, DOI 10.1074/jbc.M111.252775; Kajimura S, 2014, ANNU REV PHYSIOL, V76, P225, DOI 10.1146/annurev-physiol-021113-170252; Kanematsu T, 1996, BIOCHEM J, V313, P319, DOI 10.1042/bj3130319; KANEMATSU T, 1992, J BIOL CHEM, V267, P6518; Kanematsu T, 2000, EUR J BIOCHEM, V267, P2731, DOI 10.1046/j.1432-1327.2000.01291.x; Kanematsu T, 2002, EMBO J, V21, P1004, DOI 10.1093/emboj/21.5.1004; Kanematsu T, 2006, J BIOL CHEM, V281, P22180, DOI 10.1074/jbc.M603118200; Kinney BP, 2010, ENDOCRINOLOGY, V151, P3624, DOI 10.1210/en.2010-0245; Kitayama T, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-23; KOZAK UC, 1994, MOL CELL BIOL, V14, P59, DOI 10.1128/MCB.14.1.59; Lampidonis AD, 2011, GENE, V477, P1, DOI 10.1016/j.gene.2011.01.007; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; MCLEAN JA, 1987, MED BIOL ENG COMPUT, V25, P239; Mizokami A, 2007, J NEUROSCI, V27, P1692, DOI 10.1523/JNEUROSCI.3155-06.2007; Mottillo EP, 2012, J BIOL CHEM, V287, P25038, DOI 10.1074/jbc.M112.374041; NICHOLLS DG, 1974, EUR J BIOCHEM, V49, P585, DOI 10.1111/j.1432-1033.1974.tb03862.x; Okumura T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100559; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rim JS, 2002, J BIOL CHEM, V277, P34589, DOI 10.1074/jbc.M108866200; Robidoux J, 2005, MOL CELL BIOL, V25, P5466, DOI 10.1128/MCB.25.13.5466-5479.2005; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Sugiyama G, 2012, BIOCHEMISTRY-US, V51, P3394, DOI 10.1021/bi2018128; Takenaka K, 2003, MOL CELL BIOL, V23, P7329, DOI 10.1128/MCB.23.20.7329-7338.2003; Takeuchi H, 1996, BIOCHEM J, V318, P561, DOI 10.1042/bj3180561; Terunuma M, 2004, J NEUROSCI, V24, P7074, DOI 10.1523/JNEUROSCI.1323-04.2004; Umebayashi H, 2013, BIOCHEM BIOPH RES CO, V432, P268, DOI 10.1016/j.bbrc.2013.01.119; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; WOOD SL, 1993, BIOCHEM J, V295, P531, DOI 10.1042/bj2950531; Woods SC, 2008, J CLIN ENDOCR METAB, V93, pS37, DOI 10.1210/jc.2008-1630; Wu QW, 2006, DIABETES, V55, P3229, DOI 10.2337/db06-0749; YOSHIDA M, 1994, J BIOCHEM, V115, P973, DOI 10.1093/oxfordjournals.jbchem.a124447; Yoshimura K, 2001, J BIOL CHEM, V276, P17908, DOI 10.1074/jbc.M009677200; ZURLO F, 1990, J CLIN INVEST, V86, P1423, DOI 10.1172/JCI114857	49	15	15	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					4185	4196		10.1074/jbc.M115.705723	http://dx.doi.org/10.1074/jbc.M115.705723			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26706316	Green Published, hybrid			2022-12-26	WOS:000371338400042
J	Hecker, J; Prokopenko, D; Lange, C; Fier, HL				Hecker, Julian; Prokopenko, Dmitry; Lange, Christoph; Fier, Heide Loehlein			On the Recombination Rate Estimation in the Presence of Population Substructure	PLOS ONE			English	Article							GEOGRAPHICALLY STRUCTURED POPULATIONS; 2-LOCUS SAMPLING DISTRIBUTIONS; STRONG-MIGRATION LIMIT; HUMAN GENOME; GENETIC-VARIATION; COALESCENT; DIFFUSION; NUMBER; SITES; MODEL	As recombination events are not uniformly distributed along the human genome, the estimation of fine-scale recombination maps, e.g. HapMap Project, has been one of the major research endeavors over the last couple of years. For simulation studies, these estimates provide realistic reference scenarios to design future study and to develop novel methodology. To achieve a feasible framework for the estimation of such recombination maps, existing methodology uses sample probabilities for a two-locus model with recombination, with recent advances allowing for computationally fast implementations. In this work, we extend the existing theoretical framework for the recombination rate estimation to the presence of population substructure. We show under which assumptions the existing methodology can still be applied. We illustrate our extension of the methodology by an extensive simulation study.	[Hecker, Julian; Prokopenko, Dmitry; Lange, Christoph; Fier, Heide Loehlein] Univ Bonn, Inst Genom Math, Bonn, Germany; [Lange, Christoph; Fier, Heide Loehlein] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Lange, Christoph] Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; [Lange, Christoph] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany	University of Bonn; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Hecker, J (corresponding author), Univ Bonn, Inst Genom Math, Bonn, Germany.	julian.heckerIGM@uni-bonn.de		Prokopenko, Dmitry/0000-0002-1844-5652	Cure Alzheimer's fund from the National Institute of Mental Health [R01 MH081862, R01 MH087590]; National Heart, Lung, and Blood Institute [R01 HL089856, R01 HL089897]; National Research Foundation of Korea Grant - Korean Government [NRF-2014S1A2A2028559]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089856, R01HL089897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH087590, R01MH081862] Funding Source: NIH RePORTER	Cure Alzheimer's fund from the National Institute of Mental Health; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Research Foundation of Korea Grant - Korean Government; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	HLF and CL were supported by Cure Alzheimer's fund, Award Number (R01 MH081862, R01 MH087590) from the National Institute of Mental Health. The project described was supported by the National Heart, Lung, and Blood Institute, Award Number (R01 HL089856, R01 HL089897). The research of C. Lange was supported by the National Research Foundation of Korea Grant funded by the Korean Government (NRF-2014S1A2A2028559).	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Auton A, 2007, THESIS; Auton A, 2007, GENOME RES, V17, P1219, DOI 10.1101/gr.6386707; Bahlo M, 2001, J MATH BIOL, V43, P397, DOI 10.1007/s002850100104; ETHIER SN, 1990, ADV APPL PROBAB, V22, P773, DOI 10.2307/1427561; ETHIER SN, 1989, J MATH BIOL, V27, P17, DOI 10.1007/BF00276078; Ewens W.J., 2004, MATH POPULATION GENE; Fearnhead P, 2001, GENETICS, V159, P1299; Hudson RR, 2001, GENETICS, V159, P1805; Jeffreys AJ, 2005, NAT GENET, V37, P601, DOI 10.1038/ng1565; Jenkins PA, 2012, ANN APPL PROBAB, V22, P576, DOI 10.1214/11-AAP780; Jenkins PA, 2010, ANN APPL PROBAB, V20, P1005, DOI 10.1214/09-AAP646; Jenkins PA, 2009, GENETICS, V183, P1087, DOI 10.1534/genetics.109.107995; Kauppi L, 2004, NAT REV GENET, V5, P413, DOI 10.1038/nrg1346; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kurtz TG, 2005, WILES SERIES PROBABI; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; NAGYLAKI T, 1983, THEOR POPUL BIOL, V24, P268, DOI 10.1016/0040-5809(83)90029-1; NAGYLAKI T, 1980, J MATH BIOL, V9, P101, DOI 10.1007/BF00275916; Nagylaki T, 1998, GENETICS, V149, P1599; Nordborg M, 1997, GENETICS, V146, P1501; NOTOHARA M, 1993, J MATH BIOL, V31, P115; Notohara M, 1997, J MATH BIOL, V36, P188, DOI 10.1007/s002850050097; Notohara M, 2000, J APPL PROBAB, V37, P148, DOI 10.1017/S002190020001531X; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305	26	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145152	10.1371/journal.pone.0145152	http://dx.doi.org/10.1371/journal.pone.0145152			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716445	Green Submitted, gold, Green Published			2022-12-26	WOS:000367510500023
J	Lindsay, KL; Hellmuth, C; Uhl, O; Buss, C; Wadhwa, PD; Koletzko, B; Entringer, S				Lindsay, Karen L.; Hellmuth, Christian; Uhl, Olaf; Buss, Claudia; Wadhwa, Pathik D.; Koletzko, Berthold; Entringer, Sonja			Longitudinal Metabolomic Profiling of Amino Acids and Lipids across Healthy Pregnancy	PLOS ONE			English	Article							FATTY-ACID; L-CARNITINE; PLASMA CARNITINE; METABOLITES; STARVATION; CLEARANCE; LEUCINE; TAURINE; PROTEIN; OBESITY	Pregnancy is characterized by a complexity of metabolic processes that may impact fetal development and ultimately, infant health outcomes. However, our understanding of whole body maternal and fetal metabolism during this critical life stage remains incomplete. The objective of this study is to utilize metabolomics to profile longitudinal patterns of fasting maternal metabolites among a cohort of non-diabetic, healthy pregnant women in order to advance our understanding of changes in protein and lipid concentrations across gestation, the biochemical pathways by which they are metabolized and to describe variation in maternal metabolites between ethnic groups. Among 160 pregnant women, amino acids, tricarboxylic acid (TCA) cycle intermediates, keto-bodies and non-esterified fatty acids were detected by liquid chromatography coupled with mass spectrometry, while polar lipids were detected through flow-injected mass spectrometry. The maternal plasma concentration of several essential and non-essential amino acids, long-chain polyunsaturated fatty acids, free carnitine, acetylcarnitine, phosphatidylcholines and sphingomyelins significantly decreased across pregnancy. Concentrations of several TCA intermediates increase as pregnancy progresses, as well as the keto-body beta-hydroxybutyrate. Ratios of specific acylcarnitines used as indicators of metabolic pathways suggest a decreased beta-oxidation rate and increased carnitine palmitoyltransferase-1 enzyme activity with advancing gestation. Decreasing amino acid concentrations likely reflects placental uptake and tissue biosynthesis. The absence of any increase in plasma non-esterified fatty acids is unexpected in the catabolic phase of later pregnancy and may reflect enhanced placental fatty acid uptake and utilization for fetal tissue growth. While it appears that energy production through the TCA cycle increases as pregnancy progresses, decreasing patterns of free carnitine and acetylcarnitine as well as increased carnitine palmitoyltransferase-1 rate and beta-hydroxybutyrate levels suggest a concomitant upregulation of ketogenesis to ensure sufficient energy supply in the fasting state. Several differences in metabolomic profiles between Hispanic and non-Hispanic women demonstrate phenotypic variations in prenatal metabolism which should be considered in future studies.	[Lindsay, Karen L.; Buss, Claudia; Wadhwa, Pathik D.; Entringer, Sonja] Univ Calif Irvine, Sch Med, Dev Hlth & Dis Res Program, Irvine, CA 92697 USA; [Hellmuth, Christian; Uhl, Olaf; Koletzko, Berthold] Univ Munich, Div Metab & Nutr Med, Dr von Hauner Childrens Hosp, Med Ctr, D-80337 Munich, Germany; [Buss, Claudia; Entringer, Sonja] Charite, Inst Med Psychol, D-13353 Berlin, Germany	University of California System; University of California Irvine; University of Munich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Hellmuth, C (corresponding author), Univ Munich, Div Metab & Nutr Med, Dr von Hauner Childrens Hosp, Med Ctr, Lindwurmstr 4, D-80337 Munich, Germany.	christian.hellmuth@med.uni-muenchen.de	Buss, Claudia/ABC-3687-2020; Lindsay, Karen/J-4383-2019; Entringer, Sonja/ABB-9405-2020; Hellmuth, Christian/C-2575-2017	Lindsay, Karen/0000-0002-4481-9363; Buss, Claudia/0000-0002-8738-3133; Entringer, Sonja/0000-0002-9926-7076; Hellmuth, Christian/0000-0001-9778-497X; Uhl, Olaf/0000-0001-8064-7717	Commission of the European Communities [FP7-289346-EARLY NUTRITION]; European Research Council Advanced Grant [322605 META-GROWTH]; National Competence Network on Obesity [01 GI 0825]; University of Munich Innovative Research Priority Project MC-Health; US National Institutes of Health [R01 HD-060628, RO1 HD-065825, R01 MH-091351, R21 RDK-098765]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065825, R01HD060628] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091351] Funding Source: NIH RePORTER	Commission of the European Communities(European Commission); European Research Council Advanced Grant(European Research Council (ERC)); National Competence Network on Obesity; University of Munich Innovative Research Priority Project MC-Health; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research is supported by the Commission of the European Communities, the 7th Framework Programme, contract FP7-289346-EARLY NUTRITION and the European Research Council Advanced Grant ERC-2012-AdG-no. 322605 META-GROWTH. This manuscript does not necessarily reflect the views of the Commission and in no way anticipates the future policy in this area. Additional support is gratefully acknowledged from the National Competence Network on Obesity, Grant Nr. 01 GI 0825, German Ministry of Education and Research, Berlin; the University of Munich Innovative Research Priority Project MC-Health (sub-project I); and the US National Institutes of Health Grants R01 HD-060628, RO1 HD-065825, R01 MH-091351 and R21 RDK-098765. The funders had no role in study design data collection and analysis, decision to publish, or preparation of the manuscript.	Arenas J, 1998, EARLY HUM DEV, V53, pS43, DOI 10.1016/S0378-3782(98)00064-4; Battaglia FC, 2001, PLACENTA, V22, P145, DOI 10.1053/plac.2000.0612; Birkler RID, 2010, J PHARMACEUT BIOMED, V53, P983, DOI 10.1016/j.jpba.2010.06.005; Butte NF, 2000, AM J CLIN NUTR, V71, p1256S, DOI 10.1093/ajcn/71.5.1256s; CAMPBELL FM, 1995, BIOCHEM BIOPH RES CO, V209, P1011, DOI 10.1006/bbrc.1995.1598; CEDERBLAD G, 1986, AM J CLIN NUTR, V44, P379, DOI 10.1093/ajcn/44.3.379; Cetin I, 2005, AM J OBSTET GYNECOL, V192, P610, DOI 10.1016/j.ajog.2004.08.011; Cetina I, 2008, CURR OPIN CLIN NUTR, V11, P297, DOI 10.1097/MCO.0b013e3282f795e6; Cho SW, 2005, BRIT J NUTR, V93, P685, DOI 10.1079/BJN20041403; DARMAUN D, 1991, AM J PHYSIOL, V260, pE326, DOI 10.1152/ajpendo.1991.260.2.E326; Di Giulio A M, 2004, J Matern Fetal Neonatal Med, V15, P356, DOI 10.1080/14767050410001725578; Diaz SO, 2013, J PROTEOME RES, V12, P969, DOI 10.1021/pr301022e; Ditchfield AM, 2015, INT J OBESITY, V39, P557, DOI 10.1038/ijo.2014.212; Duggleby SL, 2002, AM J CLIN NUTR, V76, P852, DOI 10.1093/ajcn/76.4.852; Dumas ME, 2006, ANAL CHEM, V78, P2199, DOI 10.1021/ac0517085; ELLIOTT JA, 1975, EUR J CLIN INVEST, V5, P159, DOI 10.1111/j.1365-2362.1975.tb00442.x; FELIG P, 1972, J CLIN INVEST, V51, P1195, DOI 10.1172/JCI106913; Gibbons H, 2015, CURR OPIN LIPIDOL, V26, P30, DOI 10.1097/MOL.0000000000000140; Grube M, 2005, DRUG METAB DISPOS, V33, P31, DOI 10.1124/dmd.104.001560; Hadden DR, 2009, SEMIN FETAL NEONAT M, V14, P66, DOI 10.1016/j.siny.2008.09.004; Harder U, 2011, J CHROMATOGR B, V879, P495, DOI 10.1016/j.jchromb.2011.01.010; Hellmuth C, 2012, ANAL CHEM, V84, P1483, DOI 10.1021/ac202602u; Herrera E, 2006, HORM RES, V65, P59, DOI 10.1159/000091507; Herrera E, 2002, ENDOCRINE, V19, P43, DOI 10.1385/ENDO:19:1:43; Herrera E, 2000, EUR J CLIN NUTR, V54, pS47, DOI 10.1038/sj.ejcn.1600984; Houten SM, 2010, J INHERIT METAB DIS, V33, P469, DOI 10.1007/s10545-010-9061-2; Iva SK, 2013, RES OBSTET GYNECOL, V2, P37, DOI DOI 10.5923/J.R0G.20130204.01; Kalhan SC, 2006, J NUTR, V136, p281S, DOI 10.1093/jn/136.1.281S; Kalhan SC, 2000, AM J CLIN NUTR, V71, p1249S, DOI 10.1093/ajcn/71.5.1249s; Krajcovicova-Kudlackova M, 2000, PHYSIOL RES, V49, P399; Larque E, 2011, AM J CLIN NUTR, V94, p1908S, DOI 10.3945/ajcn.110.001230; Longo VD, 2014, CELL METAB, V19, P181, DOI 10.1016/j.cmet.2013.12.008; Luan HM, 2014, J PROTEOME RES, V13, P1527, DOI 10.1021/pr401068k; Luo B, 2007, J CHROMATOGR A, V1147, P153, DOI 10.1016/j.chroma.2007.02.034; MARZO A, 1994, GYNECOL ENDOCRINOL, V8, P115, DOI 10.3109/09513599409058032; McCormack SE, 2013, PEDIATR OBES, V8, P52, DOI 10.1111/j.2047-6310.2012.00087.x; METZGER BE, 1982, LANCET, V1, P588; NAISMITH DJ, 1987, HUM NUTR-CLIN NUTR, V41C, P37; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Nochera CL, 2011, NUTR CLIN PRACT, V26, P445, DOI 10.1177/0884533611406133; Oey NA, 2006, PLACENTA, V27, P841, DOI 10.1016/j.placenta.2005.10.002; Pappa KI, 2007, AM J OBSTET GYNECOL, V196, P65, DOI 10.1016/j.ajog.2006.06.094; Pinto J, 2015, J PROTEOME RES, V14, P1263, DOI 10.1021/pr5011982; Rauschert S, 2014, ANN NUTR METAB, V64, P314, DOI 10.1159/000365040; Rees WD, 2006, REPROD NUTR DEV, V46, P227, DOI 10.1051/rnd:2006015; Reuter SE, 2012, CLIN PHARMACOKINET, V51, P553, DOI 10.2165/11633940-000000000-00000; Scholtens DM, 2014, DIABETES CARE, V37, P158, DOI 10.2337/dc13-0989; van den Akker CHP, 2009, AM J CLIN NUTR, V89, P153, DOI 10.3945/ajcn.2008.26553; Violante S, 2013, BBA-MOL BASIS DIS, V1832, P773, DOI 10.1016/j.bbadis.2013.02.012; Whittaker PG, 1999, METABOLISM, V48, P849, DOI 10.1016/S0026-0495(99)90217-2	50	99	102	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145794	10.1371/journal.pone.0145794	http://dx.doi.org/10.1371/journal.pone.0145794			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716698	Green Published, Green Submitted, gold			2022-12-26	WOS:000367510500072
J	Chen, HW; Hu, HM; Wu, SH; Chiang, CY; Hsiao, YJ; Wu, CK; Hsieh, CH; Chung, HH; Chong, P; Leng, CH; Pan, CH				Chen, Hsin-Wei; Hu, Hui-Mei; Wu, Szu-Hsien; Chiang, Chen-Yi; Hsiao, Yu-Ju; Wu, Chia-Kai; Hsieh, Chun-Hsiang; Chung, Han-Hsuan; Chong, Pele; Leng, Chih-Hsiang; Pan, Chien-Hsiung			The Immunodominance Change and Protection of CD4(+) T-Cell Responses Elicited by an Envelope Protein Domain III-Based Tetravalent Dengue Vaccine in Mice	PLOS ONE			English	Article							NEUTRALIZING ANTIBODIES; VIRUS-INFECTION; LYMPHOCYTE RESPONSES; NONHUMAN-PRIMATES; EPITOPES; INDUCTION; IMMUNITY; GLYCOPROTEIN; HIERARCHY; SEROTYPES	Dengue is the leading cause of mosquito-borne viral infections and no vaccine is available now. Envelope protein domain III (ED3) is the major target for the binding of dengue virus neutralizing antibodies; however, the ED3-specifc T-cell response is less well understood. To investigate the T-cell responses to four serotypes of dengue virus (DENV-1 to 4), we immunized mice using either a tetravalent ED3-based DNA or protein vaccine, or combined both as a DNA prime-protein boost strategy (prime-boost). A significant serotype-dependent IFN-gamma or IL-4 response was observed in mice immunized with either the DNA or protein vaccine. TheIFN-gamma response was dominant to DENV-1 to 3, whereas the IL-4 response was dominant to DENV-4. Although the similar IgG titers for the four serotypes were observed in mice immunized with the tetravalent vaccines, the neutralizing antibody titers varied and followed the order of 2 = 3>1>4. Interestingly, the lower IFN-gamma response to DENV-4 is attributable to the immunodominance change between two CD4(+) T-cell epitopes; one T-cell epitope located at E349-363 of DENV-1 to 3 was more immunogenic than the DENV-4 epitope E313-327. Despite DENV-4 specific IFN-gamma responses were suppressed by immunodominance change, either DENV-4-specific IFN-gamma or neutralizing antibody responses were still recalled after DENV-4 challenge and contributed to virus clearance. Immunization with the prime-boost elicited both IFN-gamma and neutralizing antibody responses and provided better protection than either DNA or protein immunization. Our findings shed light on how ED3-based tetravalent dengue vaccines sharpen host CD4 T-cell responses and contribute to protection against dengue virus.	[Chen, Hsin-Wei; Hu, Hui-Mei; Wu, Szu-Hsien; Chiang, Chen-Yi; Hsiao, Yu-Ju; Wu, Chia-Kai; Hsieh, Chun-Hsiang; Chung, Han-Hsuan; Chong, Pele; Leng, Chih-Hsiang; Pan, Chien-Hsiung] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Miaoli, Taiwan; [Chen, Hsin-Wei; Chong, Pele; Leng, Chih-Hsiang; Pan, Chien-Hsiung] China Med Univ, Grad Inst Immunol, Taichung, Taiwan	National Health Research Institutes - Taiwan; China Medical University Taiwan	Leng, CH (corresponding author), Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Miaoli, Taiwan.	leoleng@nhri.org.tw; cpan@nhri.org.tw	Chen, Hsin-Wei/ABA-7436-2021	Chen, Hsin-Wei/0000-0002-3207-2397	National Health Research Institutes [00A1-VCPP09, 01A1-IVPP29]; Ministry of Science and Technology, Taiwan [NSC99-2320-B-400-004-MY3]	National Health Research Institutes(National Health Research Institutes, Japan); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by grants 00A1-VCPP09 and 01A1-IVPP29 (CHP) from the National Health Research Institutes (www.nhri.org.tw) and NSC99-2320-B-400-004-MY3 (CHP) from the Ministry of Science and Technology, Taiwan (www.most.gov.tw). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apt D, 2006, VACCINE, V24, P335, DOI 10.1016/j.vaccine.2005.07.100; Azevedo AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020528; Bashyam HS, 2006, J IMMUNOL, V176, P2817, DOI 10.4049/jimmunol.176.5.2817; Chen HW, 2013, ARCH VIROL, V158, P1523, DOI 10.1007/s00705-013-1639-1; Chen WS, 2000, IMMUNITY, V12, P83, DOI 10.1016/S1074-7613(00)80161-2; Chiang CY, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002432; Fuchs J, 2014, VACCINE, V32, P6537, DOI 10.1016/j.vaccine.2014.08.087; Hatch S, 2011, J INFECT DIS, V203, P1282, DOI 10.1093/infdis/jir012; Hermida L, 2006, VACCINE, V24, P3165, DOI 10.1016/j.vaccine.2006.01.036; Im EJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002041; Kastenmuller W, 2007, J EXP MED, V204, P2187, DOI 10.1084/jem.20070489; Khanam S, 2006, VACCINE, V24, P6513, DOI 10.1016/j.vaccine.2006.06.031; KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411; Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005; La Gruta NL, 2006, P NATL ACAD SCI USA, V103, P994, DOI 10.1073/pnas.0510429103; Leng CH, 2009, MICROBES INFECT, V11, P288, DOI 10.1016/j.micinf.2008.12.004; Li SF, 2011, VACCINE, V29, P3695, DOI 10.1016/j.vaccine.2011.03.002; Lin LCW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003329; Manuel ER, 2009, J VIROL, V83, P10028, DOI 10.1128/JVI.01015-09; McArthur MA, 2013, EXPERT REV VACCINES, V12, P933, DOI 10.1586/14760584.2013.815412; Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011; Modis Y, 2005, J VIROL, V79, P1223, DOI 10.1128/JVI.79.2.1223-1231.2005; Mota J, 2005, VACCINE, V23, P3469, DOI 10.1016/j.vaccine.2004.12.028; Nascimento EJM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002497; Pan CH, 2010, J VIROL, V84, P3798, DOI 10.1128/JVI.01566-09; Rivino L, 2013, J VIROL, V87, P2693, DOI 10.1128/JVI.02675-12; ROEHRIG JT, 1994, VIROLOGY, V198, P31, DOI 10.1006/viro.1994.1005; Rothman AL, 1996, J VIROL, V70, P6540, DOI 10.1128/JVI.70.10.6540-6546.1996; Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014; Rothman AL, 2009, ANN NY ACAD SCI, V1171, pE36, DOI 10.1111/j.1749-6632.2009.05055.x; Schneeweiss A, 2011, VACCINE, V29, P6352, DOI 10.1016/j.vaccine.2011.04.116; Sewell AK, 2012, NAT REV IMMUNOL, V12, P668, DOI 10.1038/nri3279; Thomas SJ, 2011, HUM VACCINES, V7, P674, DOI 10.4161/hv.7.6.14985; Wahala WMPB, 2009, VIROLOGY, V392, P103, DOI 10.1016/j.virol.2009.06.037; Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374; Webby RJ, 2003, P NATL ACAD SCI USA, V100, P7235, DOI 10.1073/pnas.1232449100; Weiskopf D, 2015, P NATL ACAD SCI USA, V112, pE4256, DOI 10.1073/pnas.1505956112; Yamanaka A, 2009, VACCINE, V27, P3735, DOI 10.1016/j.vaccine.2009.03.083; Yauch LE, 2010, J IMMUNOL, V185, P5405, DOI 10.4049/jimmunol.1001709; Zellweger RM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003723; Zuest R, 2015, VACCINE, V33, P1474, DOI 10.1016/j.vaccine.2015.01.074	41	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145717	10.1371/journal.pone.0145717	http://dx.doi.org/10.1371/journal.pone.0145717			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714037	gold, Green Published, Green Submitted			2022-12-26	WOS:000367481900073
J	Clark, MW; Yie, AM; Eder, EK; Dennis, RG; Basting, PJ; Martinez, KA; Jones, BD; Slonczewski, JL				Clark, Michelle W.; Yie, Anna M.; Eder, Elizabeth K.; Dennis, Richard G.; Basting, Preston J.; Martinez, Keith A., II; Jones, Brian D.; Slonczewski, Joan L.			Periplasmic Acid Stress Increases Cell Division Asymmetry (Polar Aging) of Escherichia coli	PLOS ONE			English	Article							PH HOMEOSTASIS; BACTERIA; RESISTANCE; GROWTH; CONSEQUENCES; REJUVENATION; MICROSCOPY; MECHANISMS; CHAPERONE; HDEB	Under certain kinds of cytoplasmic stress, Escherichia coli selectively reproduce by distributing the newer cytoplasmic components to new-pole cells while sequestering older, damaged components in cells inheriting the old pole. This phenomenon is termed polar aging or cell division asymmetry. It is unknown whether cell division asymmetry can arise from a periplasmic stress, such as the stress of extracellular acid, which is mediated by the periplasm. We tested the effect of periplasmic acid stress on growth and division of adherent single cells. We tracked individual cell lineages over five or more generations, using fluorescence microscopy with ratiometric pHluorin to measure cytoplasmic pH. Adherent colonies were perfused continually with LBK medium buffered at pH 6.00 or at pH 7.50; the external pH determines periplasmic pH. In each experiment, cell lineages were mapped to correlate division time, pole age and cell generation number. In colonies perfused at pH 6.0, the cells inheriting the oldest pole divided significantly more slowly than the cells inheriting the newest pole. In colonies perfused at pH 7.50 (near or above cytoplasmic pH), no significant cell division asymmetry was observed. Under both conditions (periplasmic pH 6.0 or pH 7.5) the cells maintained cytoplasmic pH values at 7.2-7.3. No evidence of cytoplasmic protein aggregation was seen. Thus, periplasmic acid stress leads to cell division asymmetry with minimal cytoplasmic stress.	[Clark, Michelle W.; Yie, Anna M.; Eder, Elizabeth K.; Dennis, Richard G.; Basting, Preston J.; Martinez, Keith A., II; Slonczewski, Joan L.] Kenyon Coll, Dept Biol, Gambier, OH 43022 USA; [Jones, Brian D.] Kenyon Coll, Dept Math & Stat, Gambier, OH 43022 USA	Kenyon College; Kenyon College	Slonczewski, JL (corresponding author), Kenyon Coll, Dept Biol, Gambier, OH 43022 USA.	slonczewski@kenyon.edu		Eder, Elizabeth/0000-0002-1486-7591; Basting, Preston/0000-0001-9290-8339	National Science Foundation (US) [MCB 1329815]; National Science Foundation [MCB-1329815]; Div Of Molecular and Cellular Bioscience [1329815] Funding Source: National Science Foundation	National Science Foundation (US)(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	National Science Foundation (US) awarded the grant MCB 1329815 to JLS and the grant is the sole funding source of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by National Science Foundation grant MCB-1329815.	Ackermann M, 2008, BIOTECHNIQUES, V44, P564, DOI 10.2144/000112829; Ackermann M, 2007, AGING CELL, V6, P235, DOI 10.1111/j.1474-9726.2007.00281.x; Aldridge BB, 2012, SCIENCE, V335, P100, DOI 10.1126/science.1216166; Brown PJB, 2012, P NATL ACAD SCI USA, V109, P1697, DOI 10.1073/pnas.1114476109; Dahl JU, 2015, J BIOL CHEM, V290, P65, DOI 10.1074/jbc.M114.612986; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Hong WZ, 2012, TRENDS MICROBIOL, V20, P328, DOI 10.1016/j.tim.2012.03.001; Johnson LR, 2006, MECH AGEING DEV, V127, P786, DOI 10.1016/j.mad.2006.07.004; Kanjee U, 2013, ANNU REV MICROBIOL, V67, P65, DOI 10.1146/annurev-micro-092412-155708; Krulwich TA, 2011, NAT REV MICROBIOL, V9, P330, DOI 10.1038/nrmicro2549; Kysela DT, 2013, ANNU REV MICROBIOL, V67, P417, DOI 10.1146/annurev-micro-092412-155622; Lambert LA, 1997, J BACTERIOL, V179, P7595, DOI 10.1128/jb.179.23.7595-7599.1997; Lele UN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014516; Lindner AB, 2008, P NATL ACAD SCI USA, V105, P3076, DOI 10.1073/pnas.0708931105; Lloyd-Price J, 2012, J BACTERIOL, V194, P1747, DOI 10.1128/JB.06500-11; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lybarger SR, 2001, J BACTERIOL, V183, P3261, DOI 10.1128/JB.183.11.3261-3267.2001; Macara IG, 2008, CELL, V135, P801, DOI 10.1016/j.cell.2008.11.006; Malki A, 2008, J BIOL CHEM, V283, P13679, DOI 10.1074/jbc.M800869200; Martinez KA, 2012, APPL ENVIRON MICROB, V78, P3706, DOI 10.1128/AEM.00354-12; Maurer LM, 2005, J BACTERIOL, V187, P304, DOI 10.1128/JB.187.1.304-319.2005; Moore T, 2005, INTRO PRACTICE STAT; PRATT JW, 1959, J AM STAT ASSOC, V54, P655, DOI 10.2307/2282543; Rang CU, 2012, MICROBIOL-SGM, V158, P1553, DOI 10.1099/mic.0.057240-0; Rang CU, 2011, CURR BIOL, V21, P1813, DOI 10.1016/j.cub.2011.09.018; SALMOND CV, 1984, J GEN MICROBIOL, V130, P2845; SLONCZEWSKI JL, 1981, P NATL ACAD SCI-BIOL, V78, P6271, DOI 10.1073/pnas.78.10.6271; Slonczewski JL, 2009, ADV MICROB PHYSIOL, V55, P1, DOI 10.1016/S0065-2911(09)05501-5; Stewart EJ, 2005, PLOS BIOL, V3, P295, DOI 10.1371/journal.pbio.0030045; Watve M, 2006, P NATL ACAD SCI USA, V103, P14831, DOI 10.1073/pnas.0606499103; Wilks JC, 2007, J BACTERIOL, V189, P5601, DOI 10.1128/JB.00615-07; Winkler J, 2010, EMBO J, V29, P910, DOI 10.1038/emboj.2009.412; Wolfe D. A., 1973, NONPARAMETRIC STAT M	33	6	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0144650	10.1371/journal.pone.0144650	http://dx.doi.org/10.1371/journal.pone.0144650			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713733	Green Submitted, Green Published, gold			2022-12-26	WOS:000367481900015
J	Kim, KJ; Wen, XY; Yang, HK; Kim, WH; Kang, GH				Kim, Kyung-Ju; Wen, Xian-Yu; Yang, Han Kwang; Kim, Woo Ho; Kang, Gyeong Hoon			Prognostic Implication of M2 Macrophages Are Determined by the Proportional Balance of Tumor Associated Macrophages and Tumor Infiltrating Lymphocytes in Microsatellite-Unstable Gastric Carcinoma	PLOS ONE			English	Article							COLORECTAL-CANCER; T-CELLS; POOR-PROGNOSIS; SURVIVAL; INSTABILITY; IMMUNOSCORE; LOCATION	Tumor associated macrophages are major inflammatory cells that play an important role in the tumor microenvironment. In this study, we investigated the prognostic significance of tumor associated macrophages (TAMs) in MSI-high gastric cancers using immunohistochemistry. CD68 and CD163 were used as markers for total infiltrating macrophages and M2-polarized macrophages, respectively. The density of CD68+ or CD163+ TAMs in four different areas (epithelial and stromal compartments of both the tumor center and invasive front) were analyzed in 143 cases of MSI-high advanced gastric cancers using a computerized image analysis system. Gastric cancers were scored as "0" or "1" in each area when the density of CD68+ and CD163+ TAMs was below or above the median value. Low density of CD68+ or CD163+ macrophages in four combined areas was closely associated with more frequent low-grade histology and the intestinal type tumor of the Lauren classification. In survival analysis, the low density of CD163+ TAMs was significantly associated with poor disease-free survival. In multivariate survival analysis, CD163+ TAMs in four combined areas, stromal and epithelial compartments of both tumor center and invasive front were independent prognostic indicator in MSI-high gastric cancers. In addition, the density of CD163+ TAMs correlated with tumor infiltrating lymphocytes (TILs). Our results indicate that the high density of CD163+ TAMs is an independent prognostic marker heralding prolonged disease-free survival and that the prognostic implication of CD163+ TAMs might be determined by the proportional balance of TAMs and TILs in MSI-high gastric cancers.	[Kim, Kyung-Ju; Wen, Xian-Yu; Kang, Gyeong Hoon] Seoul Natl Univ, Coll Med, Canc Res Inst, Lab Epigenet, Seoul, South Korea; [Kim, Kyung-Ju] Soonchunhyang Univ, Cheonan Hosp, Dept Pathol, Cheonan, South Korea; [Yang, Han Kwang] Seoul Natl Univ, Coll Med, Dept Gen Surg, Seoul, South Korea; [Kim, Woo Ho; Kang, Gyeong Hoon] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea; [Kim, Woo Ho; Kang, Gyeong Hoon] Seoul Natl Univ, Coll Med, Seoul, South Korea	Seoul National University (SNU); Soonchunhyang University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kang, GH (corresponding author), Seoul Natl Univ, Coll Med, Canc Res Inst, Lab Epigenet, Seoul, South Korea.	ghkang@snu.ac.kr	Kang, Gyeong Hoon/F-1051-2010	Kang, Gyeong Hoon/0000-0003-2380-6675	Priority Research Center Program through the National Research Foundation of Korea (NRF) - MEST [2009-0093820]; NRF grant - Ministry of Science, ICT and Future Planning (MSIP) [2011-0030049]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI14C1277]	Priority Research Center Program through the National Research Foundation of Korea (NRF) - MEST; NRF grant - Ministry of Science, ICT and Future Planning (MSIP); Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant from the Priority Research Center Program through the National Research Foundation of Korea (NRF) funded by MEST (2009-0093820), a NRF grant funded by the Ministry of Science, ICT and Future Planning (MSIP) (2011-0030049), and a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI14C1277).; This study was supported by a grant from the Priority Research Center Program through the National Research Foundation of Korea (NRF) funded by MEST (2009-0093820), a NRF grant funded by the Ministry of Science, ICT and Future Planning (MSIP) (2011-0030049), and a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI14C1277).	Algars A, 2012, INT J CANCER, V131, P864, DOI 10.1002/ijc.26457; Anitei MG, 2014, CLIN CANCER RES, V20, P1891, DOI 10.1158/1078-0432.CCR-13-2830; Bauer K, 2011, FAM CANCER, V10, P557, DOI 10.1007/s10689-011-9449-7; Behnes CL, 2014, VIRCHOWS ARCH, V464, P191, DOI 10.1007/s00428-013-1523-0; Biswas SK, 2013, SEMIN IMMUNOPATHOL, V35, P585, DOI 10.1007/s00281-013-0367-7; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Busuttil RA, 2014, CLIN CANCER RES, V20, P2761, DOI 10.1158/1078-0432.CCR-13-3049; Chiaravalli AM, 2006, VIRCHOWS ARCH, V448, P344, DOI 10.1007/s00428-005-0066-4; Choi YY, 2014, J SURG ONCOL, V110, P129, DOI 10.1002/jso.23618; Dannenmann SR, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23562; Edin S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074982; Edin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047045; Erreni M, 2011, CANCER MICROENVIRON, V4, P141, DOI 10.1007/s12307-010-0052-5; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Forssell J, 2007, CLIN CANCER RES, V13, P1472, DOI 10.1158/1078-0432.CCR-06-2073; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Galon J, 2014, J PATHOL, V232, P199, DOI 10.1002/path.4287; Hernandez C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098458; Ishigami S, 2003, ANTICANCER RES, V23, P4079; Kim KJ, 2014, HUM PATHOL, V45, P285, DOI 10.1016/j.humpath.2013.09.004; Komohara Y, 2014, CANCER SCI, V105, P1, DOI 10.1111/cas.12314; Kubler K, 2014, GYNECOL ONCOL, V135, P176, DOI 10.1016/j.ygyno.2014.08.028; Kumagai S, 2014, LUNG CANCER, V85; MacDonald WC, 2008, HUM PATHOL, V39, P641, DOI 10.1016/j.humpath.2007.10.003; Mantovani A, 2014, CURR OPIN PHARMACOL, V17, P38, DOI 10.1016/j.coph.2014.07.004; Nam SJ, 2014, LEUKEMIA LYMPHOMA, V55, P2466, DOI 10.3109/10428194.2013.879713; Ong SM, 2012, EUR J IMMUNOL, V42, P89, DOI 10.1002/eji.201141825; Pei BX, 2014, J THORAC CARDIOV SUR, V148, P1208, DOI 10.1016/j.jtcvs.2014.05.003; Phillips SM, 2004, BRIT J SURG, V91, P469, DOI 10.1002/bjs.4472; Ramanathan S, 2014, IRAN J CANCER PREV, V7, P1; Reinartz S, 2014, INT J CANCER, V134, P32, DOI 10.1002/ijc.28335; Shokal U, 2012, INDIAN J MED RES, V135, P599; Tham M, 2014, ONCOTARGET, V5, P12027, DOI 10.18632/oncotarget.2482; Wang B, 2011, ANN SURG ONCOL, V18, P2585, DOI 10.1245/s10434-011-1609-3; Wu H, 2012, J SURG ONCOL, V106, P462, DOI 10.1002/jso.23110; Yang L, 2015, ONCOTARGET, V6, P10592, DOI 10.18632/oncotarget.3547; Yuan ZY, 2014, ONCOTARGETS THER, V7, P1, DOI 10.2147/OTT.S61838; Zhang H, 2015, GASTRIC CANCER, V18, P740, DOI 10.1007/s10120-014-0422-7; Zhang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076147; Zilberstein Bruno, 2004, Gastric Cancer, V7, P254, DOI 10.1007/s10120-004-0301-8	40	47	53	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0144192	10.1371/journal.pone.0144192	http://dx.doi.org/10.1371/journal.pone.0144192			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714314	gold, Green Published, Green Submitted			2022-12-26	WOS:000367481900004
J	Konitzer, JD; Sieron, A; Wacker, A; Enenkel, B				Koenitzer, Jennifer D.; Sieron, Annette; Wacker, Angelika; Enenkel, Barbara			Reformatting Rituximab into Human IgG2 and IgG4 Isotypes Dramatically Improves Apoptosis Induction In Vitro	PLOS ONE			English	Article							DEPENDENT CELLULAR CYTOTOXICITY; FIBROBLAST ACTIVATION PROTEIN; MONOCLONAL-ANTIBODIES; EFFECTOR FUNCTIONS; CD20 ANTIBODIES; TYROSINE PHOSPHORYLATION; SEGMENTAL FLEXIBILITY; GLYCOFORM SELECTION; CASPASE ACTIVATION; LEUKEMIA-CELLS	The direct induction of cell death, or apoptosis, in target cells is one of the effector mechanisms for the anti CD20 antibody Rituximab. Here we provide evidence that Rituximab's apoptotic ability is linked to the antibody IgG isotype. Reformatting Rituximab from the standard human IgG1 heavy chain into IgG2 or IgG4 boosted in vitro apoptosis induction in the Burkitt's lymphoma B cell line Ramos five and four-fold respectively. The determinants for this behavior are located in the hinge region and CH1 domain of the heavy chain. By transplanting individual IgG2 or IgG4 specific amino acid residues onto otherwise IgG1 like backbones, thereby creating hybrid antibodies, the same enhancement of apoptosis induction could be achieved. The cysteines at position 131 of the CH1 domain and 219 in the hinge region, involved in IgG2 and IgG4 disulfide formation, were found to be of particular structural importance. Our data indicates that the hybrid antibodies possess a different CD20 binding mode than standard Rituximab, which appears to be key in enhancing apoptotic ability. The presented work opens up an interesting engineering route for enhancing the direct cytotoxic ability of therapeutic antibodies.	[Koenitzer, Jennifer D.] Boehringer Ingelheim GmbH & Co KG, Div Res Germany, Immune Modulat & Biotherapeut Discovery, Biberach, Germany; [Wacker, Angelika; Enenkel, Barbara] Boehringer Ingelheim GmbH & Co KG, Bioproc & Pharmaceut Dev, Biberach, Germany; [Sieron, Annette] Boehringer Ingelheim GmbH & Co KG, Biopharma Operat Germany, Biberach, Germany	Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim	Konitzer, JD (corresponding author), Boehringer Ingelheim GmbH & Co KG, Div Res Germany, Immune Modulat & Biotherapeut Discovery, Biberach, Germany.	jennifer.koenitzer@boehringer-ingelheim.com			Boehringer Ingelheim	Boehringer Ingelheim(Boehringer Ingelheim)	Boehringer Ingelheim provided all funding for this study.	Alduaij W, 2011, BLOOD, V117, P4519, DOI 10.1182/blood-2010-07-296913; ANGAL S, 1993, MOL IMMUNOL, V30, P105, DOI 10.1016/0161-5890(93)90432-B; Boross P, 2012, AM J CANCER RES, V2, P676; Braman J, 1996, Methods Mol Biol, V57, P31; BREKKE OH, 1995, IMMUNOL TODAY, V16, P85, DOI 10.1016/0167-5699(95)80094-8; Byrd JC, 2002, BLOOD, V99, P1038, DOI 10.1182/blood.V99.3.1038; Cai QQ, 2014, ANN HEMATOL, V93, P541, DOI 10.1007/s00277-013-1979-7; Cardarelli PM, 2002, CANCER IMMUNOL IMMUN, V51, P15, DOI 10.1007/s00262-001-0247; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Cartron G, 2004, BLOOD, V104, P2635, DOI 10.1182/blood-2004-03-1110; Chan HTC, 2003, CANCER RES, V63, P5480; Cragg MS, 2011, BLOOD, V118, P219, DOI 10.1182/blood-2011-04-346700; DANGL JL, 1988, EMBO J, V7, P1989, DOI 10.1002/j.1460-2075.1988.tb03037.x; DEANS JP, 1993, J IMMUNOL, V151, P4494; Deans JP, 2002, IMMUNOLOGY, V107, P176, DOI 10.1046/j.1365-2567.2002.01495.x; Durocher Y, 2011, US Patent, Patent No. [2011/0039339 A1, 20110039339]; EDELMAN GM, 1969, P NATL ACAD SCI USA, V63, P78, DOI 10.1073/pnas.63.1.78; Glennie MJ, 2007, MOL IMMUNOL, V44, P3823, DOI 10.1016/j.molimm.2007.06.151; Hagihara Y, 2014, BBA-PROTEINS PROTEOM, V1844, P2016, DOI 10.1016/j.bbapap.2014.07.005; Hofmeister JK, 2000, BLOOD CELL MOL DIS, V26, P133, DOI 10.1006/bcmd.2000.0287; Holland M, 2004, CLIN EXP IMMUNOL, V138, P183, DOI 10.1111/j.1365-2249.2004.02566.x; Honeychurch J, 2012, BLOOD, V119, P3523, DOI 10.1182/blood-2011-12-395541; Iida S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-58; Ivanov A, 2009, J CLIN INVEST, V119, P2143, DOI 10.1172/JCI37884; Jefferis R, 2007, EXPERT OPIN BIOL TH, V7, P1401, DOI 10.1517/14712598.7.9.1401; Jefferis R, 2012, ARCH BIOCHEM BIOPHYS, V526, P159, DOI 10.1016/j.abb.2012.03.021; Johnson P, 2003, SEMIN ONCOL, V30, P3, DOI 10.1053/sonc.2003.50025; Kaneko E, 2011, BIODRUGS, V25, P1, DOI 10.2165/11537830-000000000-00000; Kellner C, 2014, METHODS, V65, P105, DOI 10.1016/j.ymeth.2013.06.036; Klein C, 2013, MABS-AUSTIN, V5, P22, DOI 10.4161/mabs.22771; Kubota T, 2009, CANCER SCI, V100, P1566, DOI 10.1111/j.1349-7006.2009.01222.x; Lazar GA, 2006, P NATL ACAD SCI USA, V103, P4005, DOI 10.1073/pnas.0508123103; LICHTENFELS R, 1994, J IMMUNOL METHODS, V172, P227, DOI 10.1016/0022-1759(94)90110-4; Lightle S, 2010, PROTEIN SCI, V19, P753, DOI 10.1002/pro.352; Liu HC, 2012, MABS-AUSTIN, V4, P17, DOI 10.4161/mabs.4.1.18347; Ludwig DL, 2003, ONCOGENE, V22, P9097, DOI 10.1038/sj.onc.1207104; Maloney DG, 2001, ANTI-CANCER DRUG, V12, pS1; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; McCloskey N, 1996, IMMUNOLOGY, V88, P169, DOI 10.1111/j.1365-2567.1996.tb00001.x; Mossner E, 2010, BLOOD, V115, P4393, DOI 10.1182/blood-2009-06-225979; Moore GL, 2010, MABS-AUSTIN, V2, P181, DOI 10.4161/mabs.2.2.11158; Niederfellner G, 2011, BLOOD, V118, P358, DOI 10.1182/blood-2010-09-305847; Niwa R, 2005, J IMMUNOL METHODS, V306, P151, DOI 10.1016/j.jim.2005.08.009; Niwa R, 2005, CLIN CANCER RES, V11, P2327, DOI 10.1158/1078-0432.CCR-04-2263; OI VT, 1984, NATURE, V307, P136, DOI 10.1038/307136a0; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Peipp M, 2011, BEST PRACT RES CL HA, V24, P217, DOI 10.1016/j.beha.2011.03.004; Rayner LE, 2014, J BIOL CHEM, V289, P20740, DOI 10.1074/jbc.M114.572404; Reddy MP, 2000, J IMMUNOL, V164, P1925, DOI 10.4049/jimmunol.164.4.1925; RETTIG WJ, 1993, CANCER RES, V53, P3327; Robertson MJ, 1996, EXP HEMATOL, V24, P406; Roux KH, 1997, J IMMUNOL, V159, P3372; Salfeld JG, 2007, NAT BIOTECHNOL, V25, P1369, DOI 10.1038/nbt1207-1369; Sambrook J., 2001, MOL CLONING; Scott AM, 2003, CLIN CANCER RES, V9, P1639; Semac I, 2003, CANCER RES, V63, P534; Shan D, 1998, BLOOD, V91, P1644, DOI 10.1182/blood.V91.5.1644.1644_1644_1652; Teeling JL, 2006, J IMMUNOL, V177, P362, DOI 10.4049/jimmunol.177.1.362; Teeling JL, 2004, BLOOD, V104, P1793, DOI 10.1182/blood-2004-01-0039; van der Kolk LE, 2002, LEUKEMIA, V16, P1735, DOI 10.1038/sj.leu.2402559; van MT, 2010, SEMIN HEMATOL, V47, P199, DOI [10.1053/j.seminhematol.2010.01.007, DOI 10.1053/J.SEMINHEMATOL.2010.01.007]; von Pawel-Rammingen U, 2002, EMBO J, V21, P1607, DOI 10.1093/emboj/21.7.1607; Weiner GJ, 2010, SEMIN HEMATOL, V47, P115, DOI 10.1053/j.seminhematol.2010.01.011; White AL, 2015, CANCER CELL, V27, P138, DOI 10.1016/j.ccell.2014.11.001; Wildes TM, 2014, THER ADV HEMATOL, V5, P3, DOI 10.1177/2040620713514682	65	21	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145633	10.1371/journal.pone.0145633	http://dx.doi.org/10.1371/journal.pone.0145633			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713448	Green Submitted, Green Published, gold			2022-12-26	WOS:000367481900061
J	Bowers, LW; Wiese, M; Brenner, AJ; Rossi, EL; Tekmal, RR; Hursting, SD; deGraffenried, LA				Bowers, Laura W.; Wiese, Megan; Brenner, Andrew J.; Rossi, Emily L.; Tekmal, Rajeshwar R.; Hursting, Stephen D.; deGraffenried, Linda A.			Obesity Suppresses Estrogen Receptor Beta Expression in Breast Cancer Cells via a HER2-Mediated Pathway	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; FACTOR-I RECEPTOR; ER-BETA; NEOADJUVANT CHEMOTHERAPY; TAMOXIFEN THERAPY; POOLED ANALYSIS; GROWTH; ALPHA; CARCINOMA; INSULIN	Obesity is associated with a worse breast cancer prognosis, while greater breast tumor estrogen receptor beta (ER beta) expression is correlated with improved therapy response and survival. The objective of this study was to determine the impact of obesity on breast cancer cell ER beta expression, which is currently unknown. We utilized an in vitro model of obesity in which breast cancer cells were exposed to patient serum pooled by body mass index category (obese (OB): >= 30 kg/m(2); normal weight (N): 18.5-24.9 kg/m(2)). Four human mammary tumor cell lines representing the major breast cancer subtypes (SKBR3, MCF-7, ZR75, MDA-MB-231) and mammary tumor cells from MMTV-neu mice were used. ER beta expression, assessed by qPCR and western blotting, was suppressed in the two HER2-overexpressing cell lines (SKBR3, MMTV-neu) following OB versus N sera exposure, but did not vary in the other cell lines. Expression of Bcl-2 and cyclin D1, two genes negatively regulated by ER beta, was elevated in SKBR3 cells following exposure to OB versus N sera, but this difference was eliminated when the ER beta gene was silenced with siRNA. Herceptin, a HER2 antagonist, and siRNA to HER2 were used to evaluate the role of HER2 in sera-induced ER beta modulation. SKBR3 cell treatment with OB sera plus Herceptin increased ER beta expression three-fold. Similar results were obtained when HER2 expression was silenced with siRNA. OB sera also promoted greater SKBR3 cell viability and growth, but this variance was not present when ER beta was silenced or the cells were modified to overexpress ER beta. Based on this data, we conclude that obesity-associated systemic factors suppress ER beta expression in breast cancer cells via a HER2-mediated pathway, leading to greater cell viability and growth. Elucidation of the mechanism(s) mediating this effect could provide important insights into how ER beta expression is regulated as well as how obesity promotes a more aggressive disease.	[Bowers, Laura W.; Rossi, Emily L.; Hursting, Stephen D.] Univ N Carolina, Dept Nutr, Chapel Hill, NC USA; [Wiese, Megan; deGraffenried, Linda A.] Univ Texas Austin, Dept Nutr Sci, Austin, TX 78712 USA; [Brenner, Andrew J.] Univ Texas Hlth Sci Ctr San Antonio, Div Hematol & Med Oncol, San Antonio, TX 78229 USA; [Tekmal, Rajeshwar R.] Univ Texas Hlth Sci Ctr San Antonio, Dept Obstet & Gynecol, San Antonio, TX 78229 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	deGraffenried, LA (corresponding author), Univ Texas Austin, Dept Nutr Sci, Austin, TX 78712 USA.	degraffenried@austin.utexas.edu		Rossi, Emily/0000-0002-2312-4239	National Cancer Institute [R25CA057726]; United States Department of Defense, Breast Cancer Research Program of the Congressionally Directed Medical Research Programs [W81XWH-11-1-0132]; NATIONAL CANCER INSTITUTE [P30CA016086, R25CA057726] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); United States Department of Defense, Breast Cancer Research Program of the Congressionally Directed Medical Research Programs(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	LB is supported by a grant from the National Cancer Institute (http://www.cancer.gov/; R25CA057726) and was previously supported by a Predoctoral Traineeship Award from the United States Department of Defense, Breast Cancer Research Program of the Congressionally Directed Medical Research Programs (http://cdmrp.army.mil/bcrp/; W81XWH-11-1-0132). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowers LW, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3453; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Camirand Anne, 2002, Med Sci Monit, V8, pBR521; Chakraborty AK, 2008, CANCER RES, V68, P1538, DOI 10.1158/0008-5472.CAN-07-5935; Chang EC, 2006, ENDOCRINOLOGY, V147, P4831, DOI 10.1210/en.2006-0563; Chen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041380; Cortez V, 2010, Minerva Ginecol, V62, P573; Del Fabbro E, 2012, ONCOLOGIST, V17, P1240, DOI 10.1634/theoncologist.2012-0169; Dotzlaw H, 1997, J CLIN ENDOCR METAB, V82, P2371, DOI 10.1210/jc.82.7.2371; Esslimani-Sahla M, 2004, CLIN CANCER RES, V10, P5769, DOI 10.1158/1078-0432.CCR-04-0389; Esteva FJ, 2004, BREAST CANCER RES, V6, P109, DOI 10.1186/bcr777; Fiorio E, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-305; FRYSTYK J, 1995, METABOLISM, V44, P37, DOI 10.1016/0026-0495(95)90219-8; Galang CK, 1996, J BIOL CHEM, V271, P7992, DOI 10.1074/jbc.271.14.7992; Hartman J, 2006, CANCER RES, V66, P11207, DOI 10.1158/0008-5472.CAN-06-0017; Honma N, 2008, J CLIN ONCOL, V26, P3727, DOI 10.1200/JCO.2007.14.2968; Hopp TA, 2004, CLIN CANCER RES, V10, P7490, DOI 10.1158/1078-0432.CCR-04-1114; Howlader N, 2014, SEER CANC STAT REV; Iwao K, 2000, CANCER, V89, P1732, DOI 10.1002/1097-0142(20001015)89:8<1732::AID-CNCR13>3.0.CO;2-2; Iwase H, 2003, CANCER CHEMOTH PHARM, V52, pS34, DOI 10.1007/s00280-003-0592-1; Lazennec G, 2001, ENDOCRINOLOGY, V142, P4120, DOI 10.1210/en.142.9.4120; Leygue E, 1998, CANCER RES, V58, P3197; Li LC, 2000, BIOCHEM BIOPH RES CO, V275, P682, DOI 10.1006/bbrc.2000.3363; Litton JK, 2008, J CLIN ONCOL, V26, P4072, DOI 10.1200/JCO.2007.14.4527; Majed B, 2008, BREAST CANCER RES TR, V111, P329, DOI 10.1007/s10549-007-9785-3; Mann S, 2001, HUM PATHOL, V32, P113, DOI 10.1053/hupa.2001.21506; Mazzarella L, 2013, EUR J CANCER, V49, P3588, DOI 10.1016/j.ejca.2013.07.016; Mendoza RA, 2011, J ENDOCRINOL, V208, P1, DOI 10.1677/JOE-10-0235; Murphy L, 2003, ANN MED, V35, P614, DOI 10.1080/07853890310014579; Myers E, 2004, BRIT J CANCER, V91, P1687, DOI 10.1038/sj.bjc.6602156; Nahta R, 2005, CANCER RES, V65, P11118, DOI 10.1158/0008-5472.CAN-04-3841; Nakopoulou L, 2004, J CLIN PATHOL, V57, P523, DOI 10.1136/jcp.2003.008599; Nam SY, 1997, INT J OBESITY, V21, P355, DOI 10.1038/sj.ijo.0800412; Pajares B, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3572; Paruthiyil S, 2004, CANCER RES, V64, P423, DOI 10.1158/0008-5472.CAN-03-2446; Protani M, 2010, BREAST CANCER RES TR, V123, P627, DOI 10.1007/s10549-010-0990-0; Qiu Y, 1998, NATURE, V393, P83, DOI 10.1038/30012; Rody A, 2005, ENDOCR-RELAT CANCER, V12, P903, DOI 10.1677/erc.1.01088; Roger P, 2001, CANCER RES, V61, P2537; SENIE RT, 1992, ANN INTERN MED, V116, P26, DOI 10.7326/0003-4819-116-1-26; Shaw JA, 2002, J PATHOL, V198, P450, DOI 10.1002/path.1230; Sims AH, 2007, NAT CLIN PRACT ONCOL, V4, P516, DOI 10.1038/ncponc0908; Strom A, 2004, P NATL ACAD SCI USA, V101, P1566, DOI 10.1073/pnas.0308319100; Travis RC, 2003, BREAST CANCER RES, V5, P239, DOI 10.1186/bcr628; Yang XR, 2011, JNCI-J NATL CANCER I, V103, P250, DOI 10.1093/jnci/djq526; Zhao Chunyan, 2008, Nucl Recept Signal, V6, pe003, DOI 10.1621/nrs.06003; Zhao CY, 2003, ONCOGENE, V22, P7600, DOI 10.1038/sj.onc.1207100	47	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145452	10.1371/journal.pone.0145452	http://dx.doi.org/10.1371/journal.pone.0145452			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709918	Green Submitted, Green Published, gold			2022-12-26	WOS:000367451400048
J	Chen, EI; Crew, KD; Trivedi, M; Awad, D; Maurer, M; Kalinsky, K; Koller, A; Patel, P; Kim, JK; Hershman, DL				Chen, Emily I.; Crew, Katherine D.; Trivedi, Meghna; Awad, Danielle; Maurer, Mathew; Kalinsky, Kevin; Koller, Antonius; Patel, Purvi; Kim, Jenny Kim; Hershman, Dawn L.			Identifying Predictors of Taxane-Induced Peripheral Neuropathy Using Mass Spectrometry-Based Proteomics Technology	PLOS ONE			English	Article							NEUROTOXICITY CIPN; BETA; MICROPARTICLES; INTERLEUKIN-6; INFLAMMATION; ASSOCIATION; PACLITAXEL; PROTEINS; EXOSOMES; DISTINCT	Major advances in early detection and therapy have significantly increased the survival of breast cancer patients. Unfortunately, most cancer therapies are known to carry a substantial risk of adverse long-term treatment-related effects. Little is known about patient susceptibility to severe side effects after chemotherapy. Chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect of taxanes. Recent advances in genome-wide genotyping and sequencing technologies have supported the discoveries of a number of pharmacogenetic markers that predict response to chemotherapy. However, effectively implementing these pharmacogenetic markers in the clinic remains a major challenge. On the other hand, recent advances in proteomic technologies incorporating mass spectrometry (MS) for biomarker discovery show great promise to provide clinically relevant protein biomarkers. In this study, we evaluated the association between protein content in serum exosomes and severity of CIPN. Women with early stage breast cancer receiving adjuvant taxane chemotherapy were assessed with the FACT-Ntx score and serum was collected before and after the taxane treatment. Based on the change in FACT-Ntx score from baseline to 12 month follow-up, we separated patients into two groups: those who had no change (Group 1, N = 9) and those who had a >= 20% worsening (Group 1, N = 8). MS-based proteomics technology was used to identify proteins present in serum exosomes to determine potential biomarkers. Mann-Whitney-Wilcoxon analysis was applied and maximum FDR was controlled at 20%. From the serum exosomes derived from this cohort, we identified over 700 proteins known to be in different subcellular locations and have different functions. Statistical analysis revealed a 12-protein signature that resulted in a distinct separation between baseline serum samples of both groups (q<0.2) suggesting that the baseline samples can predict subsequent neurotoxicity. These toxicity-associated biomarkers can be further validated in larger retrospective cohorts for their utility in identifying patients at high risk for CIPN.	[Chen, Emily I.] Columbia Univ, Med Ctr, Dept Pharmacol, New York, NY USA; [Crew, Katherine D.; Trivedi, Meghna; Maurer, Mathew; Kalinsky, Kevin; Hershman, Dawn L.] Columbia Univ, Dept Med, Med Ctr, New York, NY 10027 USA; [Crew, Katherine D.; Hershman, Dawn L.] Columbia Univ, Med Ctr, Dept Epidemiol, New York, NY USA; [Chen, Emily I.; Crew, Katherine D.; Awad, Danielle; Maurer, Mathew; Kalinsky, Kevin; Koller, Antonius; Patel, Purvi; Kim, Jenny Kim; Hershman, Dawn L.] Columbia Univ, Med Ctr, Prote Shared Resource, Herbert Irving Comprehens Canc Ctr, New York, NY USA	Columbia University; Columbia University; Columbia University; Columbia University	Hershman, DL (corresponding author), Columbia Univ, Dept Med, Med Ctr, New York, NY 10027 USA.	dlh23@cumc.columbia.edu	Patel, Purvi/AAE-1804-2020; Hershman, Dawn/AAG-2114-2020	Patel, Purvi/0000-0003-1914-3004; 	Breast Cancer Research Foundation; Thompson Family Foundation; NIH/NCI [5 P30 CA013696-39S3]; NATIONAL CANCER INSTITUTE [P30CA013696] Funding Source: NIH RePORTER	Breast Cancer Research Foundation; Thompson Family Foundation; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by the following: Breast Cancer Research Foundation (DLH), The Thompson Family Foundation (DLH), and NIH/NCI 5 P30 CA013696-39S3 (EC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham JE, 2014, CLIN CANCER RES, V20, P2466, DOI 10.1158/1078-0432.CCR-13-3232; Alonzi T, 1997, IMMUNOBIOLOGY, V198, P144, DOI 10.1016/S0171-2985(97)80035-6; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Argyriou AA, 2012, CRIT REV ONCOL HEMAT, V82, P51, DOI 10.1016/j.critrevonc.2011.04.012; Bakhti M, 2011, J BIOL CHEM, V286, P787, DOI 10.1074/jbc.M110.190009; Baldwin RM, 2012, CLIN CANCER RES, V18, P5099, DOI 10.1158/1078-0432.CCR-12-1590; Beutler AS, 2014, ANN NEUROL, V76, P727, DOI 10.1002/ana.24265; Boukouris S, 2015, PROTEOM CLIN APPL, V9, P358, DOI 10.1002/prca.201400114; Bruno S, 2009, J AM SOC NEPHROL, V20, P1053, DOI 10.1681/ASN.2008070798; Cata JP, 2006, MINERVA ANESTESIOL, V72, P151; Cavaletti G, 2014, J PERIPHER NERV SYST, V19, P66, DOI 10.1111/jns5.12073; Cavaletti G, 2011, LANCET ONCOL, V12, P1151, DOI 10.1016/S1470-2045(11)70131-0; Cavaletti G, 2010, NAT REV NEUROL, V6, P657, DOI 10.1038/nrneurol.2010.160; Cella D, 2010, GYNECOL ONCOL, V119, P538, DOI 10.1016/j.ygyno.2010.08.022; Chen EI, 2006, MOL CELL PROTEOMICS, V5, P53, DOI 10.1074/mcp.T500013-MCP200; Chen EI, 2007, J PROTEOME RES, V6, P2529, DOI 10.1021/pr060682a; Dalli J, 2013, MOL CELL PROTEOMICS, V12, P2205, DOI 10.1074/mcp.M113.028589; Dawes JM, 2013, NEUROSCI LETT, V557, P1, DOI 10.1016/j.neulet.2013.10.004; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Flatters SJL, 2004, EUR J PHARMACOL, V484, P183, DOI 10.1016/j.ejphar.2003.11.013; Hershman DL, 2013, J CLIN ONCOL, V31, P2627, DOI 10.1200/JCO.2012.44.8738; Hershman DL, 2011, BREAST CANCER RES TR, V125, P767, DOI 10.1007/s10549-010-1278-0; Hertz DL, 2013, ANN ONCOL, V24, P1472, DOI 10.1093/annonc/mdt018; Hulsmans M, 2013, CARDIOVASC RES, V100, P7, DOI 10.1093/cvr/cvt161; Markman M, 1996, J CANCER RES CLIN, V122, P511, DOI 10.1007/BF01213547; Meckes DG, 2013, P NATL ACAD SCI USA, V110, pE2925, DOI 10.1073/pnas.1303906110; Miltenburg NC, 2014, CANCER TREAT REV, V40, P872, DOI 10.1016/j.ctrv.2014.04.004; Moen EL, 2012, GENOME MED, V4, DOI 10.1186/gm391; Neurath MF, 2011, CYTOKINE GROWTH F R, V22, P83, DOI 10.1016/j.cytogfr.2011.02.003; Ng YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058502; Poli V, 1998, J BIOL CHEM, V273, P29279, DOI 10.1074/jbc.273.45.29279; Popernack PM, 2001, J HEMATOTH STEM CELL, V10, P631, DOI 10.1089/152581601753193841; Prokopi M, 2009, BLOOD, V114, P723, DOI 10.1182/blood-2009-02-205930; Richter F, 2009, J COMP NEUROL, V515, P538, DOI 10.1002/cne.22062; Seretny M, 2014, PAIN, V155, P2461, DOI 10.1016/j.pain.2014.09.020; Shimozuma K, 2009, SUPPORT CARE CANCER, V17, P1483, DOI 10.1007/s00520-009-0613-7; Sisignano M, 2014, NAT REV NEUROL, V10, P694, DOI 10.1038/nrneurol.2014.211; Smith EML, 2013, JAMA-J AM MED ASSOC, V309, P1359, DOI 10.1001/jama.2013.2813; Starkweather A, 2010, NURS RES PRACT, V2010, DOI 10.1155/2010/281531; Sucheston LE, 2011, BREAST CANCER RES TR, V130, P993, DOI 10.1007/s10549-011-1671-3; Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309; Thery Clotilde, 2011, F1000 Biol Rep, V3, P15, DOI 10.3410/B3-15; Ung TH, 2014, CANCER SCI, V105, P1384, DOI 10.1111/cas.12534; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Washburn MP, 2002, ANAL CHEM, V74, P1650, DOI 10.1021/ac015704l; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020	47	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145816	10.1371/journal.pone.0145816	http://dx.doi.org/10.1371/journal.pone.0145816			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710119	Green Published, Green Submitted, gold			2022-12-26	WOS:000367451400082
J	Crown, SB; Marze, N; Antoniewicz, MR				Crown, Scott B.; Marze, Nicholas; Antoniewicz, Maciek R.			Catabolism of Branched Chain Amino Acids Contributes Significantly to Synthesis of Odd-Chain and Even-Chain Fatty Acids in 3T3-L1 Adipocytes	PLOS ONE			English	Article							PARALLEL LABELING EXPERIMENTS; METABOLIC FLUX ANALYSIS; MASS ISOTOPOMER DISTRIBUTIONS; MODEL; LIPOGENESIS; EXPRESSION; GROWTH; LIPIDS; ALPHA; CELLS	The branched chain amino acids (BCAA) valine, leucine and isoleucine have been implicated in a number of diseases including obesity, insulin resistance, and type 2 diabetes mellitus, although the mechanisms are still poorly understood. Adipose tissue plays an important role in BCAA homeostasis by actively metabolizing circulating BCAA. In this work, we have investigated the link between BCAA catabolism and fatty acid synthesis in 3T3-L1 adipocytes using parallel C-13-labeling experiments, mass spectrometry and model-based isotopomer data analysis. Specifically, we performed parallel labeling experiments with four fully C-13-labeled tracers, [U-C-13] valine, [U-C-13] leucine, [U-C-13] isoleucine and [U-C-13] glutamine. We measured mass isotopomer distributions of fatty acids and intracellular metabolites by GC-MS and analyzed the data using the isotopomer spectral analysis (ISA) framework. We demonstrate that 3T3-L1 adipocytes accumulate significant amounts of even chain length (C14:0, C16:0 and C18:0) and odd chain length (C15:0 and C17:0) fatty acids under standard cell culture conditions. Using a novel GC-MS method, we demonstrate that propionyl-CoA acts as the primer on fatty acid synthase for the production of odd chain fatty acids. BCAA contributed significantly to the production of all fatty acids. Leucine and isoleucine contributed at least 25% to lipogenic acetyl-CoA pool, and valine and isoleucine contributed 100% to lipogenic propionyl-CoA pool. Our results further suggest that low activity of methylmalonyl-CoA mutase and mass action kinetics of propionyl-CoA on fatty acid synthase result in high rates of odd chain fatty acid synthesis in 3T3-L1 cells. Overall, this work provides important new insights into the connection between BCAA catabolism and fatty acid synthesis in adipocytes and underscores the high capacity of adipocytes for metabolizing BCAA.	[Crown, Scott B.; Marze, Nicholas; Antoniewicz, Maciek R.] Univ Delaware, Metab Engn & Syst Biol Lab, Dept Chem & Biomol Engn, Newark, DE USA	University of Delaware	Antoniewicz, MR (corresponding author), Univ Delaware, Metab Engn & Syst Biol Lab, Dept Chem & Biomol Engn, Newark, DE USA.	mranton@udel.edu		Crown, Scott/0000-0002-1983-2101; Antoniewicz, Maciek/0000-0002-0087-2875	University of Delaware Research Foundation (UDRF) Strategic Initiatives Grant; NSF CAREER Award [CBET-1054120]; NSF; HHMI Undergraduate Science Education Grant at the University of Delaware	University of Delaware Research Foundation (UDRF) Strategic Initiatives Grant; NSF CAREER Award(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF(National Science Foundation (NSF)); HHMI Undergraduate Science Education Grant at the University of Delaware	This work was supported by the University of Delaware Research Foundation (UDRF) Strategic Initiatives Grant and NSF CAREER Award (CBET-1054120). SBC was supported by NSF Graduate Fellowship. NM was supported by HHMI Undergraduate Science Education Grant at the University of Delaware. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn WS, 2013, METAB ENG, V15, P34, DOI 10.1016/j.ymben.2012.10.001; Ahn WS, 2012, BIOTECHNOL J, V7, P61, DOI 10.1002/biot.201100052; Ahn WS, 2011, METAB ENG, V13, P598, DOI 10.1016/j.ymben.2011.07.002; Antoniewicz MR, 2007, ANAL CHEM, V79, P7554, DOI 10.1021/ac0708893; Antoniewicz MR, 2007, METAB ENG, V9, P68, DOI 10.1016/j.ymben.2006.09.001; Antoniewicz MR, 2006, METAB ENG, V8, P324, DOI 10.1016/j.ymben.2006.01.004; Antoniewicz MR, 2015, CURR OPIN BIOTECH, V36, P91, DOI 10.1016/j.copbio.2015.08.014; Antoniewicz MR, 2015, J IND MICROBIOL BIOT, V42, P317, DOI 10.1007/s10295-015-1585-x; Au J, 2014, METAB ENG, V26, P23, DOI 10.1016/j.ymben.2014.08.002; CHUANG DT, 1983, BIOCHEM J, V214, P177, DOI 10.1042/bj2140177; Clifton P, 2010, NAT REV ENDOCRINOL, V6, P191, DOI 10.1038/nrendo.2010.23; Coker M, 1996, PRENATAL DIAG, V16, P941, DOI 10.1002/(SICI)1097-0223(199610)16:10<941::AID-PD965>3.0.CO;2-T; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Crown SB, 2015, METAB ENG, V28, P151, DOI 10.1016/j.ymben.2015.01.001; Crown SB, 2013, METAB ENG, V20, P42, DOI 10.1016/j.ymben.2013.08.005; Crown SB, 2013, METAB ENG, V16, P21, DOI 10.1016/j.ymben.2012.11.010; Decsi T, 1997, J INHERIT METAB DIS, V20, P778, DOI 10.1023/A:1005315717106; Destaillats F, 2002, J AM OIL CHEM SOC, V79, P253, DOI 10.1007/s11746-002-0469-7; Fernandez CA, 1996, J MASS SPECTROM, V31, P255, DOI 10.1002/(SICI)1096-9888(199603)31:3<255::AID-JMS290>3.0.CO;2-3; Fiehn O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015234; FRERMAN FE, 1983, J BIOL CHEM, V258, P7087; Guo L, 2010, J BIOL CHEM, V285, P25438, DOI 10.1074/jbc.M110.119933; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Herman MA, 2010, J BIOL CHEM, V285, P11348, DOI 10.1074/jbc.M109.075184; Huffman KM, 2009, DIABETES CARE, V32, P1678, DOI 10.2337/dc08-2075; Kajimoto K, 2006, RNA, V12, P1626, DOI 10.1261/rna.7228806; KEDISHVILI NY, 1994, ARCH BIOCHEM BIOPHYS, V315, P317, DOI 10.1006/abbi.1994.1506; KHARROUBI AT, 1992, AM J PHYSIOL, V263, pE667, DOI 10.1152/ajpendo.1992.263.4.E667; Lackey DE, 2013, AM J PHYSL ENDOCRINO; Laferrere B, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002043; Layman DK, 2003, J NUTR, V133, p261S, DOI 10.1093/jn/133.1.261S; Leighty RW, 2013, METAB ENG, V20, P56, DOI 10.1016/j.ymben.2013.08.006; Long CP, 2014, ANAL CHEM, V86, P9423, DOI 10.1021/ac502734e; MASORO EJ, 1961, J LIPID RES, V2, P177; Muoio DM, 2006, ANNU REV BIOCHEM, V75, P367, DOI 10.1146/annurev.biochem.75.103004.142512; Newgard CB, 2012, CELL METAB, V15, P606, DOI 10.1016/j.cmet.2012.01.024; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pietilainen KH, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050051; Roberts LD, 2009, PHYSIOL GENOMICS, V39, P109, DOI 10.1152/physiolgenomics.90365.2008; Shah SH, 2012, DIABETOLOGIA, V55, P321, DOI 10.1007/s00125-011-2356-5; She P, 2007, CELL METAB, V6, P181, DOI 10.1016/j.cmet.2007.08.003; Simicevic J, 2013, NAT METHODS; Su X, 2004, BIOCHEMISTRY-US, V43, P5033, DOI 10.1021/bi035867z; Suryawan A, 1998, AM J CLIN NUTR, V68, P72, DOI 10.1093/ajcn/68.1.72; WAHREN J, 1976, J CLIN INVEST, V57, P987, DOI 10.1172/JCI108375; Wang GL, 2006, MOL CELL BIOL, V26, P2570, DOI 10.1128/MCB.26.7.2570-2582.2006; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Yang SM, 2006, J AM SOC MASS SPECTR, V17, P1620, DOI 10.1016/j.jasms.2006.07.004; Yoo H, 2004, J LIPID RES, V45, P1324, DOI 10.1194/jlr.M400031-JLR200; Yoo H, 2008, J BIOL CHEM, V283, P20621, DOI 10.1074/jbc.M706494200	51	111	115	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145850	10.1371/journal.pone.0145850	http://dx.doi.org/10.1371/journal.pone.0145850			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710334	Green Published, Green Submitted, gold			2022-12-26	WOS:000367451400084
J	Hesketh, AJ; Maloney, C; Behr, CA; Edelman, MC; Glick, RD; Al-Abed, Y; Symons, M; Soffer, SZ; Steinberg, BM				Hesketh, Anthony J.; Maloney, Caroline; Behr, Christopher A.; Edelman, Morris C.; Glick, Richard D.; Al-Abed, Yousef; Symons, Marc; Soffer, Samuel Z.; Steinberg, Bettie M.			The Macrophage Inhibitor CNI-1493 Blocks Metastasis in a Mouse Model of Ewing Sarcoma through Inhibition of Extravasation	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; IN-VITRO; CANCER METASTASIS; CELL MIGRATION; POOR-PROGNOSIS; VAGUS NERVE; POLARIZATION; SUPPRESSION; PROGRESSION; MONOCYTES	Metastatic Ewing Sarcoma carries a poor prognosis, and novel therapeutics to prevent and treat metastatic disease are greatly needed. Recent evidence demonstrates that tumor-associated macrophages in Ewing Sarcoma are associated with more advanced disease. While some macrophage phenotypes (M1) exhibit anti-tumor activity, distinct phenotypes (M2) may contribute to malignant progression and metastasis. In this study, we show that M2 macrophages promote Ewing Sarcoma invasion and extravasation, pointing to a potential target of anti-metastatic therapy. CNI-1493 is a selective inhibitor of macrophage function and has shown to be safe in clinical trials as an anti-inflammatory agent. In a xenograft mouse model of metastatic Ewing Sarcoma, CNI-1493 treatment dramatically reduces metastatic tumor burden. Furthermore, metastases in treated animals have a less invasive morphology. We show in vitro that CNI-1493 decreases M2-stimulated Ewing Sarcoma tumor cell invasion and extravasation, offering a functional mechanism through which CNI-1493 attenuates metastasis. These data indicate that CNI-1493 may be a safe and effective adjuvant agent for the prevention and treatment of metastatic Ewing Sarcoma.	[Hesketh, Anthony J.; Maloney, Caroline; Al-Abed, Yousef; Symons, Marc; Steinberg, Bettie M.] North Shore LIJ Hlth Syst, Elmezzi Grad Sch Mol Med, Manhasset, NY USA; [Hesketh, Anthony J.; Maloney, Caroline; Behr, Christopher A.; Symons, Marc; Soffer, Samuel Z.; Steinberg, Bettie M.] North Shore LIJ Hlth Syst, Feinstein Inst Med Res, Ctr Oncol & Cell Biol, Manhasset, NY USA; [Maloney, Caroline; Behr, Christopher A.; Glick, Richard D.; Soffer, Samuel Z.] Hofstra North Shore LIJ Sch Med, Dept Surg, New Hyde Pk, NY USA; [Edelman, Morris C.] Hofstra North Shore LIJ Sch Med, Dept Pathol & Lab Med, New Hyde Pk, NY USA; [Al-Abed, Yousef] North Shore LIJ Hlth Syst, Feinstein Inst Med Res, Ctr Mol Innovat, Manhasset, NY USA; [Al-Abed, Yousef; Symons, Marc; Steinberg, Bettie M.] Hofstra North Shore LIJ Sch Med, Dept Mol Med, Manhasset, NY USA	Northwell Health; Northwell Health; Hofstra University; Northwell Health; Hofstra University; Northwell Health; Northwell Health; Hofstra University; Northwell Health	Steinberg, BM (corresponding author), North Shore LIJ Hlth Syst, Elmezzi Grad Sch Mol Med, Manhasset, NY USA.	bsteinbe@nshs.edu	Steinberg, Bettie/K-3414-2012	Steinberg, Bettie/0000-0003-2372-8099	Elmezzi Foundation; Feinstein Institute for Medical Research	Elmezzi Foundation; Feinstein Institute for Medical Research	This study was supported by The Elmezzi Foundation (AJH) (elmezzi.org) and The Feinstein Institute for Medical Research (www.FeinsteinInstitute.org). The sponsors had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambarus CA, 2012, J IMMUNOL METHODS, V375, P196, DOI 10.1016/j.jim.2011.10.013; Atkins HB, 2001, CLIN CANCER RES, V7, P486; Balamuth NJ, 2010, LANCET ONCOL, V11, P184, DOI 10.1016/S1470-2045(09)70286-4; Barlow M, 2012, J PEDIATR SURG, V47, P1223, DOI 10.1016/j.jpedsurg.2012.03.031; Batra S, 2004, CANCER RES, V64, P5415, DOI 10.1158/0008-5472.CAN-04-0377; Bernik TR, 2002, J EXP MED, V195, P781, DOI 10.1084/jem.20011714; Bianchi M, 1996, J EXP MED, V183, P927, DOI 10.1084/jem.183.3.927; BIANCHI M, 1995, MOL MED, V1, P254, DOI 10.1007/BF03401550; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Biswas SK, 2013, SEMIN IMMUNOPATHOL, V35, P585, DOI 10.1007/s00281-013-0367-7; Bjork L, 1997, J INFECT DIS, V176, P1303; Borovikova LV, 2000, AUTON NEUROSCI-BASIC, V85, P141, DOI 10.1016/S1566-0702(00)00233-2; Chan A, 2007, MOL MED, V13, P297, DOI 10.2119/2007-00025.Chan; Chernoguz A, 2012, J SURG RES, V173, P1, DOI 10.1016/j.jss.2011.04.041; Cohen PS, 1996, P NATL ACAD SCI USA, V93, P3967, DOI 10.1073/pnas.93.9.3967; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Condeelis J, 2005, ANNU REV CELL DEV BI, V21, P695, DOI 10.1146/annurev.cellbio.21.122303.120306; Coniglio SJ, 2012, MOL MED, V18, P519, DOI 10.2119/molmed.2011.00217; Coussens LM, 2013, SCIENCE, V339, P286, DOI 10.1126/science.1232227; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Dotan I, 2010, GUT, V59, P760, DOI 10.1136/gut.2009.179994; Dovas A, 2013, J MICROSC-OXFORD, V251, P261, DOI 10.1111/j.1365-2818.2012.03667.x; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Erin N, 2012, REGUL PEPTIDES, V179, P101, DOI 10.1016/j.regpep.2012.08.001; Feng MY, 2015, P NATL ACAD SCI USA, V112, P2145, DOI 10.1073/pnas.1424907112; Flexman ML, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.1.016014; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; Franklin RA, 2014, SCIENCE, V344, P921, DOI 10.1126/science.1252510; Fujiwara T, 2011, AM J PATHOL, V179, P1157, DOI 10.1016/j.ajpath.2011.05.034; Gendy AS, 2011, J PEDIATR SURG, V46, P108, DOI 10.1016/j.jpedsurg.2010.09.074; Germano G, 2013, CANCER CELL, V23, P249, DOI 10.1016/j.ccr.2013.01.008; Gil-Bernabe AM, 2012, BLOOD, V119, P3164, DOI 10.1182/blood-2011-08-376426; HOLMGREN L, 1995, NAT MED, V1, P149, DOI 10.1038/nm0295-149; Hommes D, 2002, GASTROENTEROLOGY, V122, P7, DOI 10.1053/gast.2002.30770; Kang MH, 2011, PEDIATR BLOOD CANCER, V56, P239, DOI 10.1002/pbc.22801; Kovar H, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00054; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Krump-Konvalinkova V, 2001, LAB INVEST, V81, P1717, DOI 10.1038/labinvest.3780385; Lin EY, 2002, J MAMMARY GLAND BIOL, V7, P147, DOI 10.1023/A:1020399802795; Lipskar AM, 2009, J PEDIATR SURG, V44, P1139, DOI 10.1016/j.jpedsurg.2009.02.037; Lowenberg M, 2005, J IMMUNOL, V175, P2293, DOI 10.4049/jimmunol.175.4.2293; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; May WA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080060; McGovern M, 2009, P NATL ACAD SCI USA, V106, P11617, DOI 10.1073/pnas.0903768106; Meyers PA, 2014, ADV EXP MED BIOL, V804, P307, DOI 10.1007/978-3-319-04843-7_17; Miller IS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095885; Mu W, 2013, NEOPLASIA, V15, P875, DOI 10.1593/neo.13786; Murdoch C, 2004, MECH REGULATING RECR, V2004, P2224; Nabeshima A, 2015, BRIT J CANCER, V112, P547, DOI 10.1038/bjc.2014.637; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Potratz J, 2012, PEDIATR HEMAT ONCOL, V29, P1, DOI 10.3109/08880018.2011.622034; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Qian BZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006562; Qin HW, 2012, J IMMUNOL, V189, P3439, DOI 10.4049/jimmunol.1201168; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Rana S, 2013, NEOPLASIA, V15, P281, DOI 10.1593/neo.122010; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Ruffell B, 2012, TRENDS IMMUNOL, V33, P119, DOI 10.1016/j.it.2011.12.001; Sierra-Filardi E, 2010, IMMUNOBIOLOGY, V215, P788, DOI 10.1016/j.imbio.2010.05.020; Smith MA, 2008, PEDIATR BLOOD CANCER, V50, P703, DOI 10.1002/pbc.21099; Swierczak A, 2014, CANCER IMMUNOL RES, V2, P765, DOI 10.1158/2326-6066.CIR-13-0190; Thompson PM, 2001, CANCER RES, V61, P679; van Deventer HW, 2013, J IMMUNOL, V190, P4861, DOI 10.4049/jimmunol.1202857; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Wang YL, 2000, CLIN CANCER RES, V6, P551; WHANGPENG J, 1986, CANCER GENET CYTOGEN, V21, P185, DOI 10.1016/0165-4608(86)90001-4; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Wyckoff JB, 2007, CANCER RES, V67, P2649, DOI 10.1158/0008-5472.CAN-06-1823; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Zinser E, 2004, IMMUNOBIOLOGY, V209, P89, DOI 10.1016/j.imbio.2004.04.004	75	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145197	10.1371/journal.pone.0145197	http://dx.doi.org/10.1371/journal.pone.0145197			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709919	gold, Green Submitted, Green Published			2022-12-26	WOS:000367451400024
J	Li, LH; Zhao, D; Jin, Z; Zhang, J; Paul, C; Wang, YG				Li, Longhu; Zhao, Dong; Jin, Zhe; Zhang, Jian; Paul, Christian; Wang, Yigang			Phosphodiesterase 5a Inhibition with Adenoviral Short Hairpin RNA Benefits Infarcted Heart Partially through Activation of Akt Signaling Pathway and Reduction of Inflammatory Cytokines	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; MYOCARDIAL-INFARCTION; FAILURE; CELLS; DYSFUNCTION; NEURONS; PHOSPHORYLATION; HYPERTENSION; MODULATION; EXPRESSION	Introduction Treatment with short hairpin RNA (shRNA) interference therapy targeting phosphodiesterase 5a after myocardial infarction (MI) has been shown to mitigate post-MI heart failure. We investigated the mechanisms that underpin the beneficial effects of PDE5a inhibition through shRNA on post-MI heart failure. Methods An adenoviral vector with an shRNA sequence inserted was adopted for the inhibition of phosphodiesterase 5a (Ad-shPDE5a) in vivo and in vitro. Myocardial infarction (MI) was induced in male C57BL/6J mice by left coronary artery ligation, and immediately after that, the Ad-shPDE5a was injected intramyocardially around the MI region and border areas. Results Four weeks post-MI, the Ad-shPDE5a-treated mice showed significant mitigation of the left ventricular (LV) dilatation and dysfunction compared to control mice. Infarction size and fibrosis were also significantly reduced in Ad-shPDE5a-treated mice. Additionally, AdshPDE5a treatment decreased the MI-induced inflammatory cytokines interleukin (IL)-1 beta, IL-6, tumor necrosis factor-a, and transforming growth factor-beta 1, which was confirmed in vitro in Ad-shPDE5a transfected myofibroblasts cultured under oxygen glucose deprivation. Finally, Ad-shPDE5a treatment was found to activate the myocardial Akt signaling pathway in both in vivo and in vitro experiments. Conclusion These findings indicate that PDE5a inhibition by Ad-shPDE5a via the Akt signal pathway could be of significant value in the design of future therapeutics for post-MI heart failure.	[Li, Longhu; Jin, Zhe] First Hosp Qiqihaer City, Dept Cardiol, Qiqihar, Peoples R China; [Li, Longhu] Dalian Univ, Affiliated Zhongshan Hosp, Dept Cardiol, Dalian 116012, Peoples R China; [Zhao, Dong] China Univ Polit Sci & Law, Collaborat Innovat Ctr Judicial Civilizat, Key Lab Evidence Sci, Minist Educ, Beijing, Peoples R China; [Zhang, Jian] Dalian Univ, Affiliated Zhongshan Hosp, Dept EICU, Dalian 116012, Peoples R China; [Paul, Christian; Wang, Yigang] Univ Cincinnati, Med Ctr, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA	Dalian University; China University of Political Science & Law; Dalian University; University System of Ohio; University of Cincinnati	Wang, YG (corresponding author), Univ Cincinnati, Med Ctr, Dept Pathol & Lab Med, 231 Albert Sabin Way, Cincinnati, OH 45267 USA.	yi-gang.wang@uc.edu			National Natural Science Foundation of China [81170187]; National Heart, Lung and Blood Institute [HL-107957, HL-110740]; Program for Young Innovative Research Team in China University of Political Science and Law [1000-10814344]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110740, R01HL107957] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Program for Young Innovative Research Team in China University of Political Science and Law; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Natural Science Foundation of China, No.81170187 (to LL). The authors thank the Program for Young Innovative Research Team in China University of Political Science and Law, No. 1000-10814344 (to DZ). This work was supported by National Heart, Lung and Blood Institute grants HL-107957 and HL-110740 (YW).; This work was supported by National Natural Science Foundation of China, No.81170187 (to L. Li). We thank the Program for Young Innovative Research Team in China University of Political Science and Law, No. 1000-10814344 (to D. Zhao). This work was supported by National Heart, Lung and Blood Institute grants HL-107957 and HL-110740 (Y Wang).	Aldashev AA, 2005, THORAX, V60, P683, DOI 10.1136/thx.2005.041954; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Boerrigter Guido, 2009, V191, P485, DOI 10.1007/978-3-540-68964-5_21; BOURASSA MG, 1993, J AM COLL CARDIOL, V22, pA14, DOI 10.1016/0735-1097(93)90456-B; Choi DH, 2012, BIOCHEM BIOPH RES CO, V422, P274, DOI 10.1016/j.bbrc.2012.04.147; Deswal A, 2001, CIRCULATION, V103, P2055; Deswal A, 2001, Heart Fail Rev, V6, P143; Devaux B, 1997, EUR HEART J, V18, P470; Fiedler B, 2006, J BIOL CHEM, V281, P32831, DOI 10.1074/jbc.M603416200; Garcia LA, 2014, INT J MOL SCI, V15, P17204, DOI 10.3390/ijms151017204; Gheorghiade M, 2006, CIRCULATION, V114, P1202, DOI 10.1161/CIRCULATIONAHA.106.623199; Gou D, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh129; Guazzi M, 2007, CURR MED CHEM, V14, P2181; Isele NB, 2007, NEUROCHEM INT, V50, P243, DOI 10.1016/j.neuint.2006.08.007; JALIL JE, 1989, CIRC RES, V64, P1041, DOI 10.1161/01.RES.64.6.1041; Kanwar Manreet, 2013, Curr Heart Fail Rep, V10, P26, DOI 10.1007/s11897-012-0121-9; Kass DA, 2007, CIRC RES, V101, P1084, DOI 10.1161/CIRCRESAHA.107.162511; Knight W, 2013, FUTURE MED CHEM, V5, P1607, DOI 10.4155/fmc.13.127; Lee SH, 2010, KOREAN J PHYSIOL PHA, V14, P37, DOI 10.4196/kjpp.2010.14.1.37; Li LH, 2012, AM J PHYSIOL-HEART C, V302, pH2112, DOI 10.1152/ajpheart.00339.2011; Li LH, 2009, AM J PHYSIOL-HEART C, V297, pH1504, DOI 10.1152/ajpheart.00194.2009; Mann DL, 2002, CIRC RES, V91, P988, DOI 10.1161/01.RES.0000043825.01705.1B; Mejia-Garcia TA, 2013, CELL SIGNAL, V25, P2424, DOI 10.1016/j.cellsig.2013.08.001; Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; Ono K, 1998, CIRCULATION, V98, P149, DOI 10.1161/01.CIR.98.2.149; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Pokreisz P, 2009, CIRCULATION, V119, P408, DOI 10.1161/CIRCULATIONAHA.108.822072; REIMER KA, 1993, AM J CARDIOL, V72, P13; Takimoto E, 2005, NAT MED, V11, P214, DOI 10.1038/nm1175; Testa M, 1996, J AM COLL CARDIOL, V28, P964, DOI 10.1016/S0735-1097(96)00268-9; TorreAmione G, 1996, J AM COLL CARDIOL, V27, P1201, DOI 10.1016/0735-1097(95)00589-7; Uemura R, 2006, CIRC RES, V98, P1414, DOI 10.1161/01.RES.0000225952.61196.39; Wang L, 1996, CIRC RES, V79, P79, DOI 10.1161/01.RES.79.1.79	33	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145766	10.1371/journal.pone.0145766	http://dx.doi.org/10.1371/journal.pone.0145766			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709517	Green Published, gold, Green Submitted			2022-12-26	WOS:000367451400077
J	Lu, Y; Starkey, N; Lei, W; Li, JL; Cheng, JL; Folk, WR; Lubahn, DB				Lu, Yuan; Starkey, Nicholas; Lei, Wei; Li, Jilong; Cheng, Jianlin; Folk, William R.; Lubahn, Dennis B.			Inhibition of Hedgehog-Signaling Driven Genes in Prostate Cancer Cells by Sutherlandia frutescens Extract	PLOS ONE			English	Article							PATHWAY	Sutherlandia frutescens (L) R. Br. (Sutherlandia) is a South African botanical that is traditionally used to treat a variety of health conditions, infections and diseases, including cancer. We hypothesized Sutherlandia might act through Gli/Hedgehog (Hh)-signaling in prostate cancer cells and used RNA-Seq transcription profiling to profile gene expression in TRAMPC2 murine prostate cancer cells with or without Sutherlandia extracts. We found 50% of Hh-responsive genes can be repressed by Sutherlandia ethanol extract, including the canonical Hh-responsive genes Gli1 and Ptch1 as well as newly distinguished Hh-responsive genes Hsd11b1 and Penk.	[Lu, Yuan; Starkey, Nicholas; Folk, William R.; Lubahn, Dennis B.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA; [Lu, Yuan; Starkey, Nicholas; Lei, Wei; Li, Jilong; Cheng, Jianlin; Folk, William R.; Lubahn, Dennis B.] Univ Missouri, MU Ctr Bot Interact Studies, Columbia, MO 65211 USA; [Lei, Wei] Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA; [Li, Jilong; Cheng, Jianlin] Univ Missouri, Dept Comp Sci, Columbia, MO 65211 USA; [Li, Jilong; Cheng, Jianlin] Univ Missouri, Inst Informat, Columbia, MO 65211 USA; [Lu, Yuan] Texas State Univ, Xiphophorus Genet Stock Ctr, San Marcos, TX 78666 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Texas State University System; Texas State University San Marcos	Lubahn, DB (corresponding author), Univ Missouri, Dept Biochem, Columbia, MO 65211 USA.	lubahnd@missouri.edu	Cheng, Jianlin/N-8209-2013	Lei, Wei/0000-0002-0374-8642; Cheng, Jianlin/0000-0003-0305-2853; Folk, William/0000-0003-2216-3233	National Center for Complementary and Integrative Health (NCCIH) [P50AT006273]; Office of Dietary Supplements (ODS); National Cancer Institute (NCI); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [P50AT006273] Funding Source: NIH RePORTER	National Center for Complementary and Integrative Health (NCCIH); Office of Dietary Supplements (ODS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This publication or project was made possible in part by Grant Number P50AT006273 from the National Center for Complementary and Integrative Health (NCCIH), the Office of Dietary Supplements (ODS), and the National Cancer Institute (NCI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This publication or project was made possible in part by Grant Number P50AT006273 from the National Center for Complementary and Integrative Health (NCCIH), the Office of Dietary Supplements (ODS), and the National Cancer Institute (NCI). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NCCAM, ODS, NCI, or the National Institutes of Health.	Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Bisi-Johnson MA, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-14; Chadwick WA, 2007, J ETHNOPHARMACOL, V109, P121, DOI 10.1016/j.jep.2006.07.012; Chen M, 2011, EXPERT REV ENDOCRINO, V6, P453, DOI 10.1586/EEM.11.24; Chinkwo KA, 2005, J ETHNOPHARMACOL, V98, P163, DOI 10.1016/j.jep.2005.01.016; De Smaele E, 2010, CURR OPIN INVEST DR, V11, P707; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Dormoy V, 2012, CARCINOGENESIS, V33, P2084, DOI 10.1093/carcin/bgs255; Dovio A, 2009, J STEROID BIOCHEM, V116, P29, DOI 10.1016/j.jsbmb.2009.04.007; Goo Young Ah, 2005, BMC Urol, V5, P17, DOI 10.1186/1471-2490-5-17; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Karhadkar SS, 2004, NATURE, V431, P707, DOI 10.1038/nature02962; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lei W, 2015, J ETHNOPHARMACOL; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lin H, 2015, CELL BIOL INT; Lu Y, 2015, BMC MOL BIOL, V16, DOI 10.1186/s12867-015-0049-1; Lu Y, 2015, BMC MOL BIOL, V16, DOI 10.1186/s12867-015-0047-3; Maity T, 2005, P NATL ACAD SCI USA, V102, P17026, DOI 10.1073/pnas.0507848102; Muller AC, 2012, J PHARM PHARM SCI, V15, P221; NATH N, 1993, PROSTATE, V23, P225, DOI 10.1002/pros.2990230305; Ng JMY, 2011, NAT REV CANCER, V11, P493, DOI 10.1038/nrc3079; Prevoo D, 2004, ENDOCR RES, V30, P745, DOI 10.1081/ERC-200044020; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; Sanchez P, 2004, P NATL ACAD SCI USA, V101, P12561, DOI 10.1073/pnas.0404956101; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Slusarz A, 2010, CANCER RES, V70, P3382, DOI 10.1158/0008-5472.CAN-09-3012; Tai J, 2004, J ETHNOPHARMACOL, V93, P9, DOI 10.1016/j.jep.2004.02.028; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; van Wyk BE, 2008, J ETHNOPHARMACOL, V119, P620, DOI 10.1016/j.jep.2008.08.003; VANKAMPE.KR, 1972, J ENDOCRINOL, V52, P549, DOI 10.1677/joe.0.0520549; Von Hoff DD, 2009, NEW ENGL J MED, V361, P1164, DOI 10.1056/NEJMoa0905360; Vorster C, 2012, J ETHNOPHARMACOL, V140, P123, DOI 10.1016/j.jep.2011.12.045; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; Yu M, 2009, J BIOL CHEM, V284, P5620, DOI 10.1074/jbc.M809172200	37	5	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145507	10.1371/journal.pone.0145507	http://dx.doi.org/10.1371/journal.pone.0145507			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710108	gold, Green Published, Green Submitted			2022-12-26	WOS:000367451400058
J	Qu, LH; Yu, L; Wang, YL; Jin, X; Zhang, QL; Lu, P; Yu, XF; Zhong, WW; Zheng, XD; Cui, NR; Jiang, C; Zhu, DL				Qu, Lihui; Yu, Lei; Wang, Yanli; Jin, Xin; Zhang, Qianlong; Lu, Ping; Yu, Xiufeng; Zhong, Weiwei; Zheng, Xiaodong; Cui, Ningren; Jiang, Chun; Zhu, Daling			Inward Rectifier K+ Currents Are Regulated by CaMKII in Endothelial Cells of Primarily Cultured Bovine Pulmonary Arteries	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; POTASSIUM CHANNELS; KINASE-II; SHEAR-STRESS; MODULATION; ACTIVATION; EXPRESSION; CALCIUM; PH	Endothelium lines the interior surface of vascular walls and regulates vascular tones. The endothelial cells sense and respond to chemical and mechanical stimuli in the circulation, and couple the stimulus signals to vascular smooth muscles, in which inward rectifier K+ currents (Kir) play an important role. Here we applied several complementary strategies to determine the Kir subunit in primarily cultured pulmonary arterial endothelial cells (PAECs) that was regulated by the Ca2+/calmodulin (CaM)-dependent protein kinase II (CaMKII). In whole-cell voltage clamp, the Kir currents were sensitive to micromolar concentrations of extracellular Ba2+. In excised inside-out patches, an inward rectifier K+ current was observed with single-channel conductance 32.43 +/- 0.45 pS and Popen 0.27 +/- 0.04, which were consistent with known unitary conductance of Kir 2.1. RT-PCR and western blot results showed that expression of Kir 2.1 was significantly stronger than that of other sub-types in PAECs. Pharmacological analysis of the Kir currents demonstrated that insensitivity to intracellular ATP, pinacidil, glibenclamide, pH, GDP-beta-S and choleratoxin suggested that currents weren't determined by K-ATP, Kir2.3, Kir2.4 and Kir3.x. The currents were strongly suppressed by exposure to CaMKII inhibitor W-7 and KN-62. The expression of Kir2.1 was inhibited by knocking down CaMKII. Consistently, vasodilation was suppressed by Ba2+, W-7 and KN-62 in isolated and perfused pulmonary arterial rings. These results suggest that the PAECs express an inward rectifier K+ current that is carried dominantly by Kir2.1, and this K+ channel appears to be targeted by CaMKII-dependent intracellular signaling systems.	[Qu, Lihui; Wang, Yanli; Zhang, Qianlong] Harbin Med Univ Daqing, Dept Physiol, Coll Basic Med Sci, Daqing 163319, Heilongjiang, Peoples R China; [Yu, Lei] Harbin Med Univ Daqing, Dept Biopharmaceut Sci, Coll Pharm, Daqing 163319, Heilongjiang, Peoples R China; [Yu, Lei; Lu, Ping; Yu, Xiufeng; Zheng, Xiaodong; Zhu, Daling] Biopharmaceut Key Lab Heilongjiang Prov, Harbin 150086, Heilongjiang, Peoples R China; [Yu, Lei; Jin, Xin; Zhong, Weiwei; Cui, Ningren; Jiang, Chun] Georgia State Univ, Dept Biol, Atlanta, GA 30302 USA; [Wang, Yanli] Harbin Med Univ, Dept Rheumatol & Immunol, Affiliated Hosp 1, Harbin 150086, Heilongjiang, Peoples R China	Harbin Medical University; Harbin Medical University; University System of Georgia; Georgia State University; Harbin Medical University	Jiang, C (corresponding author), Georgia State Univ, Dept Biol, 50 Decatur St, Atlanta, GA 30302 USA.	biocjj@gmail.com; dalingz@yahoo.com			National Natural Science Foundation of China [81270113, 31471095]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding provided by National Natural Science Foundation of China grants 81270113 and 31471095 (http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DJ, 2004, J CARDIOVASC ELECTR, V15, P598, DOI 10.1046/j.1540-8167.2004.03277.x; Cai H, 2008, CARDIOVASC RES, V77, P30, DOI 10.1093/cvr/cvm010; COULTER KL, 1995, NEURON, V15, P1157, DOI 10.1016/0896-6273(95)90103-5; Dries E, 2013, CIRC RES, V113, P1242, DOI 10.1161/CIRCRESAHA.113.301896; Edwards G, 1998, NATURE, V396, P269, DOI 10.1038/24388; Fang Y, 2005, AM J PHYSIOL-CELL PH, V289, pC1134, DOI 10.1152/ajpcell.00077.2005; FORSTERMANN U, 1991, P NATL ACAD SCI USA, V88, P1788, DOI 10.1073/pnas.88.5.1788; Jang SS, 2011, AM J PHYSIOL-CELL PH, V301, pC150, DOI 10.1152/ajpcell.00002.2010; Kamouchi M, 1997, J PHYSIOL-LONDON, V504, P545, DOI 10.1111/j.1469-7793.1997.545bd.x; Kobayashi T, 2012, CLIN SCI, V123, P375, DOI 10.1042/CS20110621; Kofuji P, 2002, GLIA, V39, P292, DOI 10.1002/glia.10112; Levitan I, 2000, ANN BIOMED ENG, V28, P1184, DOI 10.1114/1.1317529; Lieu DK, 2004, AM J PHYSIOL-CELL PH, V286, pC1367, DOI 10.1152/ajpcell.00243.2003; Ma C, 2011, HYPERTENSION, V58, P679, DOI 10.1161/HYPERTENSIONAHA.111.171561; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Nilius B, 2001, PHYSIOL REV, V81, P1415, DOI 10.1152/physrev.2001.81.4.1415; OLESEN SP, 1988, NATURE, V331, P168, DOI 10.1038/331168a0; Ramirez-Sanchez I, 2010, HYPERTENSION, V55, P1398, DOI 10.1161/HYPERTENSIONAHA.109.147892; Reichenbach A, 2007, GRAEF ARCH CLIN EXP, V245, P627, DOI 10.1007/s00417-006-0516-y; Romanenko VG, 2002, BIOPHYS J, V83, P3211, DOI 10.1016/S0006-3495(02)75323-X; RUSKO J, 1992, J PHYSIOL-LONDON, V455, P601, DOI 10.1113/jphysiol.1992.sp019318; Scharbrodt W, 2004, ARTERIOSCL THROM VAS, V24, P1229, DOI 10.1161/01.ATV.0000130663.37663.6a; Sorensen CM, 2012, AM J PHYSIOL-RENAL, V302, pF505, DOI 10.1152/ajprenal.00052.2011; vonBeckerath N, 1996, J PHYSIOL-LONDON, V491, P357, DOI 10.1113/jphysiol.1996.sp021221; Wang WH, 2009, PFLUG ARCH EUR J PHY, V458, P157, DOI 10.1007/s00424-008-0593-3; Yang ZJ, 2000, J GEN PHYSIOL, V116, P33, DOI 10.1085/jgp.116.1.33	26	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145508	10.1371/journal.pone.0145508	http://dx.doi.org/10.1371/journal.pone.0145508			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700160	Green Submitted, gold, Green Published			2022-12-26	WOS:000367092600091
J	Gache, Y; Brellier, F; Rouanet, S; Al-Qaraghuli, S; Goncalves-Maia, M; Burty-Valin, E; Barnay, S; Scarzello, S; Ruat, M; Sevenet, N; Avril, MF; Magnaldo, T				Gache, Yannick; Brellier, Florence; Rouanet, Sophie; Al-Qaraghuli, Sahar; Goncalves-Maia, Maria; Burty-Valin, Elodie; Barnay, Stephanie; Scarzello, Sabine; Ruat, Martial; Sevenet, Nicolas; Avril, Marie-Francoise; Magnaldo, Thierry			Basal Cell Carcinoma in Gorlin's Patients: a Matter of Fibroblasts-Led Protumoral Microenvironment?	PLOS ONE			English	Article							HUMAN EPIDERMAL-KERATINOCYTES; ANGIOPOIETIN-LIKE 4; SONIC HEDGEHOG; EPITHELIAL-CELLS; PTCH MUTATIONS; NEVUS SYNDROME; GROWTH-FACTOR; CANCER; SKIN; GENE	Basal cell carcinoma (BCC) is the commonest tumor in human. About 70% sporadic BCCs bear somatic mutations in the PATCHED1 tumor suppressor gene which encodes the receptor for the Sonic Hedgehog morphogen (SHH). PATCHED1 germinal mutations are associated with the dominant Nevoid Basal Cell Carcinoma Syndrome (NBCCS), a major hallmark of which is a high susceptibility to BCCs. Although the vast majority of sporadic BCCs arises exclusively in sun exposed skin areas, 40 to 50% BCCs from NBCCS patients develop in non photo-exposed skin. Since overwhelming evidences indicate that microenvironment may both be modified by-and influence the-epithelial tumor, we hypothesized that NBCCS fibroblasts could contribute to BCCs in NBCCS patients, notably those developing in non photo-exposed skin areas. The functional impact of NBCCS fibroblasts was then assessed in organotypic skin cultures with control keratinocytes. Onset of epidermal differentiation was delayed in the presence of primary NBCCS fibroblasts. Unexpectedly, keratinocyte proliferation was severely reduced and showed high levels of nuclear P53 in both organotypic skin cultures and in fibroblast-led conditioning experiments. However, in spite of increased levels of senescence associated beta-galactosidase activity in keratinocytes cultured in the presence of medium conditioned by NBCCS fibroblasts, we failed to observe activation of P16 and P21 and then of bona fide features of senescence. Constitutive extinction of P53 in WT keratinocytes resulted in an invasive phenotype in the presence of NBCCS fibroblasts. Finally, we found that expression of SHH was limited to fibroblasts but was dependent on the presence of keratinocytes. Inhibition of SHH binding resulted in improved epidermal morphogenesis. Altogether, these data suggest that the repertoire of diffusible factors (including SHH) expressed by primary NBCCS fibroblasts generate a stress affecting keratinocytes behavior and epidermal homeostasis. Our findings suggest that defects in dermo/epidermal interactions could contribute to BCC susceptibility in NBCCS patients.	[Gache, Yannick; Rouanet, Sophie; Al-Qaraghuli, Sahar; Goncalves-Maia, Maria; Scarzello, Sabine; Magnaldo, Thierry] UNS, UMR7284, CNRS, INSERM,U1081, Nice, France; [Gache, Yannick; Rouanet, Sophie; Al-Qaraghuli, Sahar; Goncalves-Maia, Maria; Scarzello, Sabine; Magnaldo, Thierry] Univ Nice Sophia Antipolis, Fac Med, F-06189 Nice, France; [Brellier, Florence; Burty-Valin, Elodie] Univ Paris 11, CNRS, FRE2939, Inst Gustave Roussy, Villejuif, France; [Ruat, Martial] CNRS, UMR9197, Neurosci Paris Saclay Inst, Gif Sur Yvette, France; [Sevenet, Nicolas] INSERM, U916, Bordeaux, France; [Sevenet, Nicolas] Inst Bergonie, Lab Genet Mol, Bordeaux, France; [Avril, Marie-Francoise] Univ Paris 05, APHP, Serv Dermatol, Paris, France; [Barnay, Stephanie] Univ Paris 06, UMR 7138, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UNICANCER; Institut Bergonie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Magnaldo, T (corresponding author), UNS, UMR7284, CNRS, INSERM,U1081, Nice, France.	thierry.magnaldo@unice.fr	Ruat, Martial/E-5544-2016	Gache, Yannick/0000-0002-5638-4854; Brellier, Florence/0000-0002-0143-472X; Barnay-Verdier, Stephanie/0000-0002-4615-3059; Thierry, Magnaldo/0000-0001-9174-8599	CNRS; Galderma Research International; Institut Gustave Roussy; French Government (National Research Agency, ANR) through the Investments for the Future "LABEX SIGNALIFE: program [ANR-11-LABX-0028-01]; Ligue Contre le Cancer; Comite de l'Essonne; Fondation ARC [SFI201212055859]; Fondation de l'Avenir; Societe Francaise de Dermatologie; Institut National du Cancer	CNRS(Centre National de la Recherche Scientifique (CNRS)); Galderma Research International; Institut Gustave Roussy; French Government (National Research Agency, ANR) through the Investments for the Future "LABEX SIGNALIFE: program(French National Research Agency (ANR)); Ligue Contre le Cancer(Ligue nationale contre le cancer); Comite de l'Essonne; Fondation ARC; Fondation de l'Avenir; Societe Francaise de Dermatologie; Institut National du Cancer(Institut National du Cancer (INCA) France)	FB was supported by a PhD fellowship from CNRS; EB-V was supported by a PhD fellowship from Galderma Research International; SB was supported by a post-doctoral fellowship from the Institut Gustave Roussy. This work was supported by the French Government (National Research Agency, ANR) through the Investments for the Future "LABEX SIGNALIFE: program reference # ANR-11-LABX-0028-01; MR was supported by the Ligue Contre le Cancer, Comite de l'Essonne and the Fondation ARC. TM was supported by the Fondation ARC (SFI201212055859), the Fondation de l'Avenir, the Societe Francaise de Dermatologie, and The Institut National du Cancer.	Adolphe C, 2004, DEVELOPMENT, V131, P5009, DOI 10.1242/dev.01367; ASSELINEAU D, 1985, EXP CELL RES, V159, P536, DOI 10.1016/S0014-4827(85)80027-6; BERNERD F, 1992, J INVEST DERMATOL, V98, P902, DOI 10.1111/1523-1747.ep12460344; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; BONIFAS JM, 1994, HUM MOL GENET, V3, P447, DOI 10.1093/hmg/3.3.447; Boone MALM, 2012, BRIT J DERMATOL, V167, P856, DOI 10.1111/j.1365-2133.2012.11194.x; Brellier F, 2008, ONCOGENE, V27, P6601, DOI 10.1038/onc.2008.260; Brellier F, 2008, BRIT J DERMATOL, V159, P445, DOI 10.1111/j.1365-2133.2008.08650.x; Brellier F, 2004, CANCER RES, V64, P2699, DOI 10.1158/0008-5472.CAN-03-3477; Campisi J, 2009, AGING CELL, V8, P221, DOI 10.1111/j.1474-9726.2009.00475.x; Cleaver JE, 2009, NAT REV GENET, V10, P756, DOI 10.1038/nrg2663; de Gruijl FR, 2002, SKIN PHARMACOL APPL, V15, P316, DOI 10.1159/000064535; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; Fine JD, 2009, J AM ACAD DERMATOL, V60, P203, DOI 10.1016/j.jaad.2008.09.035; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Galaup A, 2006, P NATL ACAD SCI USA, V103, P18721, DOI 10.1073/pnas.0609025103; GOLDSTEIN AM, 1993, J AM ACAD DERMATOL, V29, P34, DOI 10.1016/0190-9622(93)70148-M; Grachtchouk M, 2000, NAT GENET, V24, P216, DOI 10.1038/73417; HALBERT CL, 1991, J VIROL, V65, P473, DOI 10.1128/JVI.65.1.473-478.1991; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kim RH, 2015, AGING CELL, V14, P838, DOI 10.1111/acel.12364; Lane D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000893; Lindstrom E, 2006, HUM MUTAT, V27, P215, DOI 10.1002/humu.20296; LYLES TW, 1960, J INVEST DERMATOL, V34, P353, DOI 10.1038/jid.1960.61; MAGNALDO T, 1992, DIFFERENTIATION, V49, P39, DOI 10.1111/j.1432-0436.1992.tb00767.x; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Micke P, 2007, J INVEST DERMATOL, V127, P1516, DOI 10.1038/sj.jid.5700714; Nilsson M, 2000, P NATL ACAD SCI USA, V97, P3438, DOI 10.1073/pnas.050467397; Nishigori C, 2004, ANTIOXID REDOX SIGN, V6, P561, DOI 10.1089/152308604773934314; Oro AE, 1997, SCIENCE, V276, P817, DOI 10.1126/science.276.5313.817; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Pilarsky C, 2008, J CELL MOL MED, V12, P2823, DOI 10.1111/j.1582-4934.2008.00289.x; Pourreyron C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031827; Pruvost-Balland C, 2006, ANN DERMATOL VENER, V133, P117, DOI 10.1016/S0151-9638(06)70861-4; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; RHEINWALD JG, 1977, NATURE, V265, P421, DOI 10.1038/265421a0; RHEINWALD JG, 1981, CANCER RES, V41, P1657; Sarasin A, 1999, MUTAT RES-FUND MOL M, V428, P5, DOI 10.1016/S1383-5742(99)00025-3; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; SHANLEY S, 1994, AM J MED GENET, V50, P282, DOI 10.1002/ajmg.1320500312; Soufir N, 2006, BRIT J CANCER, V95, P548, DOI 10.1038/sj.bjc.6603303; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Tan MJ, 2012, MOL CANCER RES, V10, P677, DOI 10.1158/1541-7786.MCR-11-0519; Traiffort E, 2001, EUR J NEUROSCI, V14, P839, DOI 10.1046/j.0953-816x.2001.01708.x; Ulrich M, 2011, J CUTAN PATHOL, V38, P190, DOI 10.1111/j.1600-0560.2010.01632.x; Valin A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004818; VANSCOTT EJ, 1961, J INVEST DERMATOL, V36, P109, DOI 10.1038/jid.1961.21; Ng YZ, 2012, CANCER RES, V72, P3522, DOI 10.1158/0008-5472.CAN-11-2996; Zhang YQ, 2006, BIOCHEM BIOPH RES CO, V347, P100, DOI 10.1016/j.bbrc.2006.06.053; Zhu PC, 2011, CANCER CELL, V19, P401, DOI 10.1016/j.ccr.2011.01.018; Zuniga A, 2014, SCIENCE, V345, P516, DOI 10.1126/science.1257501	52	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145369	10.1371/journal.pone.0145369	http://dx.doi.org/10.1371/journal.pone.0145369			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26694869	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092500040
J	James, K; Al-Ali, S; Tarn, J; Cockell, SJ; Gillespie, CS; Hindmarsh, V; Locke, J; Mitchell, S; Lendrem, D; Bowman, S; Price, E; Pease, CT; Emery, P; Lanyon, P; Hunter, JA; Gupta, M; Bombardieri, M; Sutcliffe, N; Pitzalis, C; McLaren, J; Cooper, A; Regan, M; Giles, I; Isenberg, D; Saravanan, V; Coady, D; Dasgupta, B; McHugh, N; Young-Min, S; Moots, R; Gendi, N; Akil, M; Griffiths, B; Wipat, A; Newton, J; Jones, DE; Isaacs, J; Hallinan, J; Ng, WF				James, Katherine; Al-Ali, Shereen; Tarn, Jessica; Cockell, Simon J.; Gillespie, Colin S.; Hindmarsh, Victoria; Locke, James; Mitchell, Sheryl; Lendrem, Dennis; Bowman, Simon; Price, Elizabeth; Pease, Colin T.; Emery, Paul; Lanyon, Peter; Hunter, John A.; Gupta, Monica; Bombardieri, Michele; Sutcliffe, Nurhan; Pitzalis, Costantino; McLaren, John; Cooper, Annie; Regan, Marian; Giles, Ian; Isenberg, David; Saravanan, Vadivelu; Coady, David; Dasgupta, Bhaskar; McHugh, Neil; Young-Min, Steven; Moots, Robert; Gendi, Nagui; Akil, Mohammed; Griffiths, Bridget; Wipat, Anil; Newton, Julia; Jones, David E.; Isaacs, John; Hallinan, Jennifer; Ng, Wan-Fai		UK Primary Sjogren's Syndrome	A Transcriptional Signature of Fatigue Derived from Patients with Primary Sjogren's Syndrome	PLOS ONE			English	Article							HETEROTRIMERIC G-PROTEINS; GENE-EXPRESSION; CLASSIFICATION CRITERIA; DISEASE-ACTIVITY; CANCER; ASSOCIATION; PREVALENCE; ACTIVATION; ACTIN; IDENTIFICATION	Background Fatigue is a debilitating condition with a significant impact on patients' quality of life. Fatigue is frequently reported by patients suffering from primary Sjogren's Syndrome (pSS), a chronic autoimmune condition characterised by dryness of the eyes and the mouth. However, although fatigue is common in pSS, it does not manifest in all sufferers, providing an excellent model with which to explore the potential underpinning biological mechanisms. Methods Whole blood samples from 133 fully-phenotyped pSS patients stratified for the presence of fatigue, collected by the UK primary Sjogren's Syndrome Registry, were used for whole genome microarray. The resulting data were analysed both on a gene by gene basis and using pre-defined groups of genes. Finally, gene set enrichment analysis (GSEA) was used as a feature selection technique for input into a support vector machine (SVM) classifier. Classification was assessed using area under curve (AUC) of receiver operator characteristic and standard error of Wilcoxon statistic, SE(W). Results Although no genes were individually found to be associated with fatigue, 19 metabolic pathways were enriched in the high fatigue patient group using GSEA. Analysis revealed that these enrichments arose from the presence of a subset of 55 genes. A radial kernel SVM classifier with this subset of genes as input displayed significantly improved performance over classifiers using all pathway genes as input. The classifiers had AUCs of 0.866 (SE(W) 0.002) and 0.525 (SE(W) 0.006), respectively. Conclusions Systematic analysis of gene expression data from pSS patients discordant for fatigue identified 55 genes which are predictive of fatigue level using SVM classification. This list represents the first step in understanding the underlying pathophysiological mechanisms of fatigue in patients with pSS.	[James, Katherine; Wipat, Anil; Hallinan, Jennifer] Newcastle Univ, Interdisciplinary Comp & Complex BioSyst Res Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [James, Katherine; Al-Ali, Shereen; Tarn, Jessica; Locke, James; Lendrem, Dennis; Jones, David E.; Isaacs, John; Ng, Wan-Fai] Newcastle Univ, Inst Cellular Med, Musculoskeletal Res Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Al-Ali, Shereen] Univ Basrah, Dept Biol, Coll Sci, Basrah, Iraq; [Cockell, Simon J.] Newcastle Univ, Bioinformat Support Unit, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Gillespie, Colin S.] Newcastle Univ, Dept Math & Stat, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Hindmarsh, Victoria; Mitchell, Sheryl; Griffiths, Bridget; Newton, Julia] Newcastle Upon Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England; [Bowman, Simon] Univ Hosp Birmingham, Dept Rheumatol, Birmingham, W Midlands, England; [Price, Elizabeth] Great Western Hosp NHS Fdn Trust, Swindon, Wilts, England; [Pease, Colin T.; Emery, Paul] Univ Leeds, Sect Musculoskeletal Dis, Leeds Inst Mol Med, Leeds, W Yorkshire, England; [Pease, Colin T.; Emery, Paul] Leeds Teaching Hosp Trust, NIHR Leeds Musculoskeletal Biomed Res Unit, Leeds, W Yorkshire, England; [Lanyon, Peter] Univ Nottingham Hosp, Nottingham NG7 2UH, England; [Hunter, John A.; Gupta, Monica] Gartnavel Royal Hosp, Glasgow, Lanark, Scotland; [Bombardieri, Michele; Sutcliffe, Nurhan; Pitzalis, Costantino] Barts & London NHS Trust, London, England; [Bombardieri, Michele; Sutcliffe, Nurhan; Pitzalis, Costantino] Barts & London Queen Marys Sch Med & Dent, London, England; [McLaren, John] Whytemans Brae Hosp, NHS Fife, Kirkcaldy, Scotland; [Cooper, Annie] Royal Hampshire Cty Hosp, Winchester, Hants, England; [Cooper, Annie; Young-Min, Steven] Portsmouth Hosp NHS Trust, Portsmouth, Hants, England; [Regan, Marian] Royal Derby Hosp, Derby, England; [Giles, Ian; Isenberg, David] Univ Coll London Hosp NHS Fdn Trust, London, England; [Saravanan, Vadivelu] Queen Elizabeth Hosp, Gateshead, England; [Coady, David] Sunderland Royal Hosp, Sunderland, England; [Dasgupta, Bhaskar] Southend Univ Hosp, Southend On Sea, England; [McHugh, Neil] Royal Natl Hosp Rheumat Dis, Bath BA1 1RL, Avon, England; [Moots, Robert] Aintree Univ Hosp NHS Fdn Trust, Liverpool L9 7AL, Merseyside, England; [Gendi, Nagui] Basildon Hosp, Basildon, England; [Akil, Mohammed] Royal Hallamshire Hosp, Sheffield S10 2JF, S Yorkshire, England; [Newton, Julia] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Isaacs, John; Ng, Wan-Fai] Newcastle Biomed Res Ctr, Natl Inst Hlth Res, Newcastle Upon Tyne, Tyne & Wear, England; [Hallinan, Jennifer] BioThink Pty Ltd, Brisbane, Qld, Australia	Newcastle University - UK; Newcastle University - UK; University of Basrah; Newcastle University - UK; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; University of Birmingham; University of Leeds; Leeds Biomedical Research Centre; University of Leeds; University of Nottingham; Gartnavel Royal Hospital; Barts Health NHS Trust; University of London; Queen Mary University London; University of Dundee; Portsmouth Hospitals NHS Trust; University of Nottingham; University College London Hospitals NHS Foundation Trust; University of London; University College London; Sunderland Royal Hospital; Royal National Hospital for Rheumatic Diseases (RNHRD); Aintree University Hospitals NHS Foundation Trust; University of Sheffield; Newcastle University - UK	James, K (corresponding author), Newcastle Univ, Interdisciplinary Comp & Complex BioSyst Res Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.		Lanyon, Peter/K-8100-2019; emery, paul/B-3560-2013; Price, Elizabeth/Y-7061-2019; Moots, Robert/AAM-8091-2020; Giles, Ian/G-7471-2015; Lendrem, Dennis/H-2590-2013; Ng, Wan-Fai/R-8083-2016	Lanyon, Peter/0000-0002-9855-6802; James, Katherine/0000-0003-0167-8393; Andrews, Jacqueline/0000-0001-9888-8690; Young-Min, Steven/0000-0001-8270-6207; Rauz, Saaeha/0000-0003-4627-3496; Giles, Ian/0000-0001-8913-3894; Gillespie, Colin/0000-0003-1787-0275; Pitzalis, Costantino/0000-0003-1326-5051; Pauling, John/0000-0002-2793-2364; Symmons, Deborah/0000-0002-8625-1200; Lendrem, Dennis/0000-0001-6268-5509; Newton, Julia/0000-0002-1249-5253; Al-Ali, Shereen/0000-0003-4722-7125; Dimitroulas, Theodoros/0000-0002-0364-1642; Fedele, Stefano/0000-0001-9006-9412; Wipat, Anil/0000-0001-7310-4191; KITAS, GEORGE/0000-0002-0828-6176; Porter, Stephen/0000-0002-3328-2759; Cockell, Simon/0000-0002-6831-9806; Isaacs, John/0000-0002-6103-7056; Ng, Wan-Fai/0000-0002-5539-388X	Medical Research Council UK [MR/J002720/1]; Higher Committee of Education Development in Iraq (HCED); Biothink; Medical Research Council [MR/J002720/1, G0800629, MR/N003063/1] Funding Source: researchfish; Versus Arthritis [18475] Funding Source: researchfish; MRC [G0800629, MR/N003063/1, MR/J002720/1] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Higher Committee of Education Development in Iraq (HCED); Biothink; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work is supported by a grant from the Medical Research Council UK, http://www.mrc.ac.uk, Grant No. MR/J002720/1 to W-FN, AW, JH, CG, SC, JN, DEJ, JDI, SB & EP. This project also received infrastructural support from the Newcastle NIHR Biomedical Research Centre. SA-A sponsored by the Higher Committee of Education Development in Iraq (HCED), http://hcediraq.org/HCED_english_website/homeen.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Biothink provided support in the form of salaries for an author [JH], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the "author contributions" section.	Baraniuk James N, 2010, Allergy Asthma Clin Immunol, V6, P8, DOI 10.1186/1710-1492-6-8; Barendregt PJ, 1998, ANN RHEUM DIS, V57, P291, DOI 10.1136/ard.57.5.291; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beuschlein F, 2014, NEW ENGL J MED, V370, P1019, DOI 10.1056/NEJMoa1310359; Bower JE, 2014, NAT REV CLIN ONCOL, V11, P597, DOI 10.1038/nrclinonc.2014.127; Bowman SJ, 2004, RHEUMATOLOGY, V43, P758, DOI 10.1093/rheumatology/keh170; Brkic Z, 2013, ANN RHEUM DIS, V72, P728, DOI 10.1136/annrheumdis-2012-201381; Burks TF, 2001, CANCER, V92, P1714, DOI 10.1002/1097-0142(20010915)92:6+<1714::AID-CNCR1502>3.0.CO;2-N; Byrnes A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005805; CARLSON KE, 1986, MOL PHARMACOL, V30, P463; Carlson M, LUMIHUMANALL DB R PA; Cauch-Dudek K, 1998, GUT, V43, P705, DOI 10.1136/gut.43.5.705; Cockell S, 2014, MICROARRAY IMAGE DAT, P459; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cotta-de-Almeida V, 2007, P NATL ACAD SCI USA, V104, P15424, DOI 10.1073/pnas.0706881104; DAVID A, 1990, BMJ-BRIT MED J, V301, P1199, DOI 10.1136/bmj.301.6762.1199; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Emamian ES, 2009, GENES IMMUN, V10, P285, DOI 10.1038/gene.2009.20; Fletcher MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010817; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; Frampton D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016872; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gottenberg JE, 2006, P NATL ACAD SCI USA, V103, P2770, DOI 10.1073/pnas.0510837103; Gow JW, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-38; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Harhammer R, 1996, FEBS LETT, V399, P211, DOI 10.1016/S0014-5793(96)01327-0; HENDERSON AR, 1993, ANN CLIN BIOCHEM, V30, P521, DOI 10.1177/000456329303000601; Hjelmervik TOR, 2005, ARTHRITIS RHEUM, V52, P1534, DOI 10.1002/art.21006; Huyser BA, 1998, ARTHRITIS RHEUM, V41, P2230, DOI 10.1002/1529-0131(199812)41:12<2230::AID-ART19>3.3.CO;2-4; IRVINE D, 1994, CANCER NURS, V17, P367; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Jones GE, 2000, J LEUKOCYTE BIOL, V68, P593; KAMEOKA J, 1993, SCIENCE, V261, P466, DOI 10.1126/science.8101391; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Kerr JR, 2008, J INFECT DIS, V197, P1171, DOI 10.1086/533453; Kirou KA, 2004, ARTHRITIS RHEUM, V50, P3958, DOI 10.1002/art.20798; KLIMAS NG, 1990, J CLIN MICROBIOL, V28, P1403, DOI 10.1128/JCM.28.6.1403-1410.1990; Krupp L B, 2001, Curr Neurol Neurosci Rep, V1, P294, DOI 10.1007/s11910-001-0033-7; KRUPP LB, 1990, J RHEUMATOL, V17, P1450; KRUPP LB, 1988, ARCH NEUROL-CHICAGO, V45, P435, DOI 10.1001/archneur.1988.00520280085020; Kuhn M., 2021, CARET CLASSIFICATION; Landmark-Hoyvik H, 2009, PHARMACOGENOMICS J, V9, P333, DOI 10.1038/tpj.2009.27; LEE KA, 1991, PSYCHIAT RES, V36, P291, DOI 10.1016/0165-1781(91)90027-M; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Light AR, 2012, J INTERN MED, V271, P64, DOI 10.1111/j.1365-2796.2011.02405.x; Light KC, 2013, PSYCHONEUROENDOCRINO, V38, P2983, DOI 10.1016/j.psyneuen.2013.08.008; Lorusso L, 2009, AUTOIMMUN REV, V8, P287, DOI 10.1016/j.autrev.2008.08.003; Malik UR, 2001, CANCER, V92, P1664, DOI 10.1002/1097-0142(20010915)92:6+<1664::AID-CNCR1494>3.0.CO;2-9; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Ng WF, 2011, RHEUMATOLOGY, V50, P32, DOI 10.1093/rheumatology/keq240; Ng WF, 2010, RHEUMATOLOGY, V49, P844, DOI 10.1093/rheumatology/keq009; Nishimura D, 2001, BIOTECH SOFTWARE INT, V2, P117, DOI DOI 10.1089/152791601750294344; Piche T, 2002, GUT, V51, P434, DOI 10.1136/gut.51.3.434; Pihur V, 2011, BIOINFORMATION, V6, P120, DOI 10.6026/97320630006120; Qin B, 2014, ANN RHEUM DIS; Raison CL, 2009, BRAIN BEHAV IMMUN, V23, P327, DOI 10.1016/j.bbi.2008.11.005; Reeves WC, 2003, BMC HEALTH SERV RES, V3, DOI 10.1186/1472-6963-3-25; Rosenbaum M, 2014, J ENDOCRINOL, V223, pT83, DOI 10.1530/JOE-14-0358; Schappi JM, 2014, BBA-BIOMEMBRANES, V1838, P674, DOI 10.1016/j.bbamem.2013.08.026; Scholkopf C, 1999, ADV KERNEL METHODS; Segal B, 2008, ARTHRIT RHEUM-ARTHR, V59, P1780, DOI 10.1002/art.24311; Seror R, 2011, ANN RHEUM DIS, V70, P968, DOI 10.1136/ard.2010.143743; Seror R, 2010, ANN RHEUM DIS, V69, P1103, DOI 10.1136/ard.2009.110619; Shiboski SC, 2012, ARTHRIT CARE RES, V64, P475, DOI 10.1002/acr.21591; Smets EMA, 1996, BRIT J CANCER, V73, P241, DOI 10.1038/bjc.1996.42; Smith AK, 2011, NEUROPSYCHOBIOLOGY, V64, P183, DOI 10.1159/000326692; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Staines D, 2005, MED HYPOTHESES, V65, P29, DOI 10.1016/j.mehy.2005.02.013; Stone P, 1999, BRIT J CANCER, V79, P1479, DOI 10.1038/sj.bjc.6690236; Stone P, 1998, EUR J CANCER, V34, P1670, DOI 10.1016/S0959-8049(98)00167-1; Stringer EA, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-93; Strombeck B, 2003, ARTHRIT RHEUM-ARTHR, V49, P681, DOI 10.1002/art.11384; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tejera-Alhambra M, 2014, CLIN IMMUNOL, V150, P170, DOI 10.1016/j.clim.2013.11.011; van't Leven M, 2010, EUR J PUBLIC HEALTH, V20, P251, DOI 10.1093/eurpub/ckp113; Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Vitali C, 2007, ARTHRITIS RHEUM-US, V56, P2223, DOI 10.1002/art.22658; Wang YT, 2013, ARCH IMMUNOL THER EX, V61, P309, DOI 10.1007/s00005-013-0230-5; Welch MD, 1997, J CELL BIOL, V138, P375, DOI 10.1083/jcb.138.2.375; Wildenberg ME, 2008, EUR J IMMUNOL, V38, P2024, DOI 10.1002/eji.200738008; Zhang LH, 2010, J CLIN PATHOL, V63, P156, DOI 10.1136/jcp.2009.072561; Zhu Y, 2003, P NATL ACAD SCI USA, V100, P2237, DOI 10.1073/pnas.0436133100; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	86	28	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0143970	10.1371/journal.pone.0143970	http://dx.doi.org/10.1371/journal.pone.0143970			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26694930	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000367092500001
J	Nishitsuji, H; Sugiyama, R; Abe, M; Takaku, H				Nishitsuji, Hironori; Sugiyama, Ryuichi; Abe, Makoto; Takaku, Hiroshi			ATP1B3 Protein Modulates the Restriction of HIV-1 Production and Nuclear Factor kappa Light Chain Enhancer of Activated B Cells (NF-kappa B) Activation by BST-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS ENVELOPE GLYCOPROTEIN; RETROVIRUS RELEASE; PARTICLE RELEASE; DENDRITIC CELLS; MARFAN-SYNDROME; TYPE-1 HIV-1; VPU PROTEIN; TETHERIN; IDENTIFICATION; SUBUNIT	Here, we identify ATP1B3 and fibrillin-1 as novel BST-2-binding proteins. ATP1B3 depletion in HeLa cells (BST-2-positive cells), but not 293T cells (BST-2-negative cells), induced the restriction of HIV-1 production in a BST-2-dependent manner. In contrast, fibrillin-1 knockdown reduced HIV-1 production in 293T and HeLa cells in a BST-2-independent manner. Moreover, NF-kappa B activation was enhanced by siATP1B3 treatment in HIV-1-and HIV-1 triangle Vpu-infected HeLa cells. In addition, ATP1B3 silencing induced high level BST-2 expression on the surface of HeLa cells. These results indicate that ATP1B3 is a co-factor that accelerates BST-2 degradation and reduces BST-2-mediated restriction of HIV-1 production and NF-kappa B activation.	[Nishitsuji, Hironori] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Ichikawa, Chiba 2728516, Japan; [Sugiyama, Ryuichi; Abe, Makoto; Takaku, Hiroshi] Chiba Inst Technol, Dept Life & Environm Sci, 2-17-1 Tsudanuma, Narashino, Chiba 2750016, Japan; [Takaku, Hiroshi] Chiba Inst Technol, Res Inst, 2-17-1 Tsudanuma, Narashino, Chiba 2750016, Japan; [Sugiyama, Ryuichi] Yokohama City Univ, Sch Med, Dept Microbiol, Kanagawa 2360004, Japan	National Center for Global Health & Medicine - Japan; Chiba Institute of Technology; Chiba Institute of Technology; Yokohama City University	Takaku, H (corresponding author), Chiba Inst Technol, Dept Life & Environm Sci, 2-17-1 Tsudanuma, Narashino, Chiba 2750016, Japan.	hiroshi.takaku@it-chiba.ac.jp			Japan Society for the Promotion of Science (JSPS), Japan; Ministry of Health, Labor, and Welfare of Japan; Strategic Research Foundation from the Ministry of Education, Culture, Sport, Science, and Technology of Japan (MEXT); Grants-in-Aid for Scientific Research [26860309] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Strategic Research Foundation from the Ministry of Education, Culture, Sport, Science, and Technology of Japan (MEXT); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant-in-aid for science research (C) from the Japan Society for the Promotion of Science (JSPS), Japan; by a grant-in-aid for AIDS research from the Ministry of Health, Labor, and Welfare of Japan; and by a grant from the Strategic Research Foundation grant-aided project for Private Universities from the Ministry of Education, Culture, Sport, Science, and Technology of Japan (MEXT). The authors declare that they have no conflicts of interest with the contents of this article.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Caillet M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002347; Cao W, 2009, J EXP MED, V206, P1603, DOI 10.1084/jem.20090547; Celestino M, 2012, J VIROL, V86, P6688, DOI 10.1128/JVI.07037-11; Cocka LJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002931; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; Douglas JL, 2009, J VIROL, V83, P7931, DOI 10.1128/JVI.00242-09; Dube M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000856; Evans DT, 2010, TRENDS MICROBIOL, V18, P388, DOI 10.1016/j.tim.2010.06.010; Galao RP, 2012, CELL HOST MICROBE, V12, P633, DOI 10.1016/j.chom.2012.10.007; Goffinet C, 2010, J VIROL, V84, P4089, DOI 10.1128/JVI.01549-09; Goffinet C, 2009, CELL HOST MICROBE, V5, P285, DOI 10.1016/j.chom.2009.01.009; Gupta RK, 2009, P NATL ACAD SCI USA, V106, P20889, DOI 10.1073/pnas.0907075106; Habermann A, 2010, J VIROL, V84, P4646, DOI 10.1128/JVI.02421-09; Hauser H, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-51; Iwabu Y, 2009, J BIOL CHEM, V284, P35060, DOI 10.1074/jbc.M109.058305; Ju XS, 2004, GENE, V331, P159, DOI 10.1016/j.gene.2004.02.018; Kielty CM, 2002, PHILOS T R SOC B, V357, P207, DOI 10.1098/rstb.2001.1029; Le Tortorec A, 2009, J VIROL, V83, P11966, DOI 10.1128/JVI.01515-09; LINNENBACH AJ, 1989, P NATL ACAD SCI USA, V86, P27, DOI 10.1073/pnas.86.1.27; LITVINOV SV, 1994, J CELL BIOL, V125, P437, DOI 10.1083/jcb.125.2.437; Malik N, 1996, J BIOL CHEM, V271, P22754, DOI 10.1074/jbc.271.37.22754; Malik N, 1998, MAMM GENOME, V9, P136, DOI 10.1007/s003359900704; Mangeat B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000574; Matsuda A, 2003, ONCOGENE, V22, P3307, DOI 10.1038/sj.onc.1206406; Mitchell RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000450; Miyakawa K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000700; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Morrison JH, 2014, J VIROL, V88, P3255, DOI 10.1128/JVI.03814-13; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Ni J, 2012, CANCER METAST REV, V31, P779, DOI 10.1007/s10555-012-9389-1; Nishitsuji H, 2015, FEBS LETT, V589, P2019, DOI 10.1016/j.febslet.2015.06.013; Nityanandam R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004151; Pacyniak E, 2005, AIDS RES HUM RETROV, V21, P379, DOI 10.1089/aid.2005.21.379; Pardieu C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000843; Pyeritz RE, 2000, ANNU REV MED, V51, P481, DOI 10.1146/annurev.med.51.1.481; REUBEN MA, 1990, P NATL ACAD SCI USA, V87, P6767, DOI 10.1073/pnas.87.17.6767; Tavano B, 2013, J IMMUNOL, V190, P2622, DOI 10.4049/jimmunol.1202391; Tokarev A, 2013, J VIROL, V87, P2046, DOI 10.1128/JVI.02272-12; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Varthakavi V, 2006, TRAFFIC, V7, P298, DOI 10.1111/j.1600-0854.2005.00380.x; Yin X, 2014, J VIROL, V88, P1259, DOI 10.1128/JVI.03148-13	42	11	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4754	4762		10.1074/jbc.M115.679357	http://dx.doi.org/10.1074/jbc.M115.679357			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26694617	hybrid, Green Published			2022-12-26	WOS:000371604600041
J	Sun, XL; Sun, MZ; Jia, BW; Chen, C; Qin, ZW; Yang, KJ; Shen, Y; Zhang, MP; Cong, MY; Zhu, YM				Sun, Xiaoli; Sun, Mingzhe; Jia, Bowei; Chen, Chao; Qin, Zhiwei; Yang, Kejun; Shen, Yang; Zhang Meiping; Cong Mingyang; Zhu, Yanming			A 14-3-3 Family Protein from Wild Soybean (Glycine Soja) Regulates ABA Sensitivity in Arabidopsis	PLOS ONE			English	Article							ABSCISIC-ACID ABA; ROOT-GROWTH; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; PSEUDOMONAS-SYRINGAE; SIGNAL-TRANSDUCTION; DROUGHT TOLERANCE; PLASMA-MEMBRANE; OSMOTIC-STRESS; CRITICAL ROLES	It is widely accepted that the 14-3-3 family proteins are key regulators of multiple stress signal transduction cascades. By conducting genome-wide analysis, researchers have identified the soybean 14-3-3 family proteins; however, until now, there is still no direct genetic evidence showing the involvement of soybean 14-3-3s in ABA responses. Hence, in this study, based on the latest Glycine max genome on Phytozome v10.3, we initially analyzed the evolutionary relationship, genome organization, gene structure and duplication, and three-dimensional structure of soybean 14-3-3 family proteins systematically. Our results suggested that soybean 14-3-3 family was highly evolutionary conserved and possessed segmental duplication in evolution. Then, based on our previous functional characterization of a Glycine soja 14-3-3 protein GsGF14o in drought stress responses, we further investigated the expression characteristics of GsGF14o in detail, and demonstrated its positive roles in ABA sensitivity. Quantitative real-time PCR analyses in Glycine soja seedlings and GUS activity assays in PGsGF14O: GUS transgenic Arabidopsis showed that GsGF14o expression was moderately and rapidly induced by ABA treatment. As expected, GsGF14o overexpression in Arabidopsis augmented the ABA inhibition of seed germination and seedling growth, promoted the ABA induced stomata closure, and up-regulated the expression levels of ABA induced genes. Moreover, through yeast two hybrid analyses, we further demonstrated that GsGF14o physically interacted with the AREB/ABF transcription factors in yeast cells. Taken together, results presented in this study strongly suggested that GsGF14o played an important role in regulation of ABA sensitivity in Arabidopsis.	[Sun, Xiaoli; Sun, Mingzhe; Jia, Bowei; Qin, Zhiwei; Yang, Kejun; Shen, Yang; Zhang Meiping; Cong Mingyang; Zhu, Yanming] Heilongjiang Bayi Agr Univ, Crop Stress Mol Biol Lab, Daqing, Peoples R China; [Sun, Mingzhe; Jia, Bowei; Chen, Chao; Qin, Zhiwei; Zhu, Yanming] Northeast Agr Univ, Key Lab Agr Biol Funct Genes, Harbin, Peoples R China	Heilongjiang Bayi Agricultural University; Northeast Agricultural University - China	Zhu, YM (corresponding author), Heilongjiang Bayi Agr Univ, Crop Stress Mol Biol Lab, Daqing, Peoples R China.	ymzhu@neau.edu.cn	Sun, Xiaoli/AAH-2265-2020	Sun, Xiaoli/0000-0003-1134-3976; Sun, Mingzhe/0000-0001-7557-623X	Natural Science Foundation of Heilongjiang Province [C2015035]; National Natural Science Foundation of China [31500204]; China Postdoctoral Science Foundation [2015M581494]; Postdoctoral Science Foundation of Heilongjiang Province [LBH-Z15186]; Startup Foundation of Heilongjiang Bayi Agricultural University [XYB 2015-01]; Student's Platform for Innovation and Entrepreneurship Training Program [XC2015003]	Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Postdoctoral Science Foundation of Heilongjiang Province(China Postdoctoral Science Foundation); Startup Foundation of Heilongjiang Bayi Agricultural University; Student's Platform for Innovation and Entrepreneurship Training Program	Funded by Natural Science Foundation of Heilongjiang Province (C2015035 to XLS) http://nsf.hlkj.cn/zrjj/, National Natural Science Foundation of China (31500204 to XLS) http://www.nsfc.gov.cn/, China Postdoctoral Science Foundation (2015M581494 to XLS) http://www.chinapostdoctor.org.cn/WebSite/program/Default asps, Postdoctoral Science Foundation of Heilongjiang Province (LBH-Z15186 to XLS) http://www.hljbsh.org/index.asp, Startup Foundation of Heilongjiang Bayi Agricultural University (XYB 2015-01 to XLS) http://www.hlau.cn/, and Student's Platform for Innovation and Entrepreneurship Training Program (XC2015003 to YS) http://www.hlau.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams E, 2014, INT J MOL SCI, V15, P22801, DOI 10.3390/ijms151222801; Arc E, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00063; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Benesova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038017; Cai SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116646; Chang IF, 2009, PROTEOMICS, V9, P2967, DOI 10.1002/pmic.200800445; Chen F, 2006, DNA RES, V13, P53, DOI 10.1093/dnares/dsl001; Chen JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139466; Chen Q, 2015, PLANT CELL PHYSIOL, V56, P1144, DOI 10.1093/pcp/pcv038; Chi JC, 2015, J BIOL INORG CHEM, V20, P277, DOI 10.1007/s00775-014-1232-4; de Boer AH, 2013, PROTOPLASMA, V250, P425, DOI 10.1007/s00709-012-0437-z; de Ollas C, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2015.1078953; del Viso F, 2007, PLANTA, V227, P167, DOI 10.1007/s00425-007-0604-1; DeLille JM, PLANT PHYSL; Denison FC, 2011, SEMIN CELL DEV BIOL, V22, P720, DOI 10.1016/j.semcdb.2011.08.006; DuanMu HZ, 2015, FUNCT INTEGR GENOMIC, V15, P651, DOI 10.1007/s10142-015-0439-y; Ferl RJ, 2004, PHYSIOL PLANTARUM, V120, P173, DOI 10.1111/j.0031-9317.2004.0239.x; Finkelstein R, 2005, PLANT MOL BIOL, V59, P253, DOI 10.1007/s11103-005-8767-2; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Finkelstein R, 2008, ANNU REV PLANT BIOL, V59, P387, DOI 10.1146/annurev.arplant.59.032607.092740; Finkelstein Ruth, 2013, Arabidopsis Book, V11, pe0166, DOI 10.1199/tab.0166; Fujii H, 2007, PLANT CELL, V19, P485, DOI 10.1105/tpc.106.048538; Fujii H, 2009, P NATL ACAD SCI USA, V106, P8380, DOI 10.1073/pnas.0903144106; Fujita Y, 2013, PHYSIOL PLANTARUM, V147, P15, DOI 10.1111/j.1399-3054.2012.01635.x; Fujita Y, 2009, PLANT CELL PHYSIOL, V50, P2123, DOI 10.1093/pcp/pcp147; Giska F, 2013, PLANT PHYSIOL, V161, P2049, DOI 10.1104/pp.112.209023; Gonzalez-Garcia MP, 2003, PLANT PHYSIOL, V133, P135, DOI 10.1104/pp.103.025569; Hattori T, 2002, PLANT CELL PHYSIOL, V43, P136, DOI 10.1093/pcp/pcf014; He YC, 2015, J EXP BOT, V66, P2271, DOI 10.1093/jxb/erv149; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; Ichimura T, 2008, FEBS LETT, V582, P661, DOI 10.1016/j.febslet.2008.01.037; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kaplan B, 2006, PLANT CELL, V18, P2733, DOI 10.1105/tpc.106.042713; Kobayashi Y, 2005, PLANT J, V44, P939, DOI 10.1111/j.1365-313X.2005.02583.x; Lee TH, 2013, NUCLEIC ACIDS RES, V41, pD1152, DOI 10.1093/nar/gks1104; Leung J, 1997, PLANT CELL, V9, P759, DOI 10.1105/tpc.9.5.759; Li W, 2013, PLANT PHYSIOL, V161, P2062, DOI 10.1104/pp.112.211748; Li XY, 2012, PLANT SIGNAL BEHAV, V7, P965, DOI 10.4161/psb.20940; Li XY, 2011, PLANTA, V233, P569, DOI 10.1007/s00425-010-1315-6; Lim S, 2014, PLANT MOL BIOL, V86, P513, DOI 10.1007/s11103-014-0242-5; Liu Q, 2015, ENVIRON MICROBIOL, V17, P1444, DOI 10.1111/1462-2920.12634; Lopez-Molina L, 2002, PLANT J, V32, P317, DOI 10.1046/j.1365-313X.2002.01430.x; Lozano-Duran R, MOL PLANT MICROBE IN; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Mayfield JD, 2007, PLANT PHYSIOL, V145, P1692, DOI 10.1104/pp.107.108654; Mayfield JD, 2012, J EXP BOT, V63, P3061, DOI 10.1093/jxb/ers022; Nakashima K, 2006, PLANT MOL BIOL, V60, P51, DOI 10.1007/s11103-005-2418-5; Nakashima K, 2009, PLANT CELL PHYSIOL, V50, P1345, DOI 10.1093/pcp/pcp083; Nambara E, 2003, TRENDS PLANT SCI, V8, P213, DOI 10.1016/S1360-1385(03)00060-8; Narusaka Y, 2003, PLANT J, V34, P137, DOI 10.1046/j.1365-313X.2003.01708.x; Nishimura N, 2009, SCIENCE, V326, P1373, DOI 10.1126/science.1181829; Okamoto M, 2013, P NATL ACAD SCI USA, V110, P12132, DOI 10.1073/pnas.1305919110; Osakabe Y, 2014, NEW PHYTOL, V202, P35, DOI 10.1111/nph.12613; Ou XB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101587; Radwan O, 2012, PLANT PHYSIOL, V160, P2125, DOI 10.1104/pp.112.207027; Raghavendra AS, 2010, TRENDS PLANT SCI, V15, P395, DOI 10.1016/j.tplants.2010.04.006; Ren XZ, 2010, PLANT J, V63, P417, DOI 10.1111/j.1365-313X.2010.04248.x; Roberts MR, 2003, TRENDS PLANT SCI, V8, P218, DOI 10.1016/S1360-1385(03)00056-6; Rogozin IB, 2005, BRIEF BIOINFORM, V6, P118, DOI 10.1093/bib/6.2.118; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schoonheim PJ, 2007, PLANT PHYSIOL, V143, P670, DOI 10.1104/pp.106.090159; Schoonheim PJ, 2007, PLANT J, V49, P289, DOI 10.1111/j.1365-313X.2006.02955.x; Schoonheim PJ, 2009, PLANT CELL ENVIRON, V32, P439, DOI 10.1111/j.1365-3040.2009.01932.x; Sehnke PC, 2002, PLANT MOL BIOL, V50, P1011, DOI 10.1023/A:1021289127519; Sharma S, 2010, PLANT CELL ENVIRON, V33, P1838, DOI 10.1111/j.1365-3040.2010.02188.x; Singh A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125168; Sirichandra C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013935; Sridha S, 2006, PLANT J, V46, P124, DOI 10.1111/j.1365-313X.2006.02678.x; Sun GL, 2011, FUNCT INTEGR GENOMIC, V11, P627, DOI 10.1007/s10142-011-0242-3; Sun XL, 2014, PLANT CELL PHYSIOL, V55, P99, DOI 10.1093/pcp/pct161; Takahashi Y, 2007, PLANT CELL PHYSIOL, V48, P1182, DOI 10.1093/pcp/pcm093; Tian FX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123225; Tocquin Pierre, 2003, BMC Plant Biology, V3, P2, DOI 10.1186/1471-2229-3-2; Tseng TS, 2012, PLANT CELL, V24, P1114, DOI 10.1105/tpc.111.092130; Umezawa T, 2010, PLANT CELL PHYSIOL, V51, P1821, DOI 10.1093/pcp/pcq156; van Kleeff PJM, 2014, J EXP BOT, V65, P5877, DOI 10.1093/jxb/eru338; Vysotskii DA, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.22672; Wang JG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124442; Wang YZ, 2013, PLANT PHYSIOL, V163, P566, DOI 10.1104/pp.113.219758; Wu K, 1997, PLANT PHYSIOL, V114, P1421, DOI 10.1104/pp.114.4.1421; Xu DB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116385; Xu DQ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004197; Xu GX, 2012, P NATL ACAD SCI USA, V109, P1187, DOI 10.1073/pnas.1109047109; Xu WF, 2006, ANN BOT-LONDON, V98, P965, DOI 10.1093/aob/mcl189; Yang CY, 2005, PLANT PHYSIOL, V139, P836, DOI 10.1104/pp.105.065458; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033838; Yang X, 2011, PLANT PHYSIOL, V156, P1397, DOI 10.1104/pp.111.173427; Yang Y, 2015, PLANT MOL BIOL REP I; Yao Y, 2007, J BIOCHEM MOL BIOL, V40, P349; Yi JX, 2010, PLANT J, V62, P1019, DOI 10.1111/j.1365-313X.2010.04214.x; Yoshida R, 2006, J BIOL CHEM, V281, P5310, DOI 10.1074/jbc.M509820200; Yoshida T, 2015, PLANT CELL ENVIRON, V38, P35, DOI 10.1111/pce.12351; Zhan GM, 2010, AGR SCI CHINA, V9, P942, DOI 10.1016/S1671-2927(09)60175-9	95	3	5	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0146163	10.1371/journal.pone.0146163	http://dx.doi.org/10.1371/journal.pone.0146163			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717241	Green Submitted, Green Published, gold			2022-12-26	WOS:000367510500139
J	Zhang, DM; Cheng, D; Liu, T; Zhang, YC; Chen, ZJ; Zhang, C				Zhang, Dongmei; Cheng, Dong; Liu, Tao; Zhang, Yachao; Chen, Zi-Jiang; Zhang, Cong			Dysfunction of Liver Receptor Homo log-1 in Decidua: Possible Relevance to the Pathogenesis of Preeclampsia	PLOS ONE			English	Article							STEROIDOGENIC-FACTOR-I; PREGNANCY COMPLICATIONS; SIGNALING PATHWAY; EXPRESSION; DECIDUALIZATION; ENDOMETRIUM; MECHANISMS; HOMOLOG-1; MOUSE; LRH-1	Preeclampsia (PE) is a multisystem disorder unique to Homo sapiens that is known to cause maternal and perinatal mortality and morbidity. Between 5-7% of all pregnancies are affected by PE and it is responsible for approximately 50,000 maternal deaths annually. The pathogenesis of PE remains poorly understood. However, the results of this study indicated that insufficient decidualization plays a significant role. NR5A1 and NR5A2 are orphan members of the Ftz-F1 subfamily of nuclear receptors and are involved in mammal follicular development, female reproduction, steroidogenesis, and decidualization. The expression of NR5A1 and NR5A2 in the human decidua and their functions during decidualization were investigated using in vitro cultured cells by real-time PCR, immunohistochemistry, western blotting, and siRNA techniques. The results demonstrated that the levels of NR5A2 mRNA and protein in the decidual tissues of women with PE were lower than those of normal pregnant women. However, the levels of NR5A1 mRNA and protein did not significantly differ between groups. The expression of NR5A2 was upregulated after in vitro decidualization, but the expression of NR5A1 remained low and showed no difference compared with that of the control cells. Knocking down of NR5A2 in human endometrial stromal cells (hESC) resulted in a significant reduction in their expression of decidualization markers (IGFBP1 and PRL) and signaling pathway molecules (WNT4 and BMP2) (P < 0.05). From these data, we concluded that NR5A2 is pivotal for the decidualization of decidual tissues and cultured human endometrial stromal cells. Disorders of the endometrium in decidual tissues may be associated with the abnormal decidualization thought to cause PE.	[Zhang, Dongmei; Liu, Tao; Chen, Zi-Jiang; Zhang, Cong] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Ctr Reprod Med, Shanghai 200030, Peoples R China; [Zhang, Dongmei; Liu, Tao; Chen, Zi-Jiang; Zhang, Cong] Shanghai Key Lab Assisted Reprod & Reprod Genet, Shanghai, Peoples R China; [Cheng, Dong] Shandong Ctr Dis Control & Prevent, Jinan 250014, Shandong, Peoples R China; [Zhang, Dongmei; Liu, Tao; Zhang, Yachao] Shandong Normal Univ, Coll Life Sci, Key Lab Anim Resistance Res, Jinan, Shandong, Peoples R China	Shanghai Jiao Tong University; Shandong Normal University	Zhang, C (corresponding author), Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Ctr Reprod Med, Shanghai 200030, Peoples R China.	zhangxinyunlife@163.com	Chen, Zi-Jiang/GOE-6119-2022; Yan, Junhao/AAH-8310-2019		National Natural Science Foundation of China [31172040, 31471399, 81490743]; Shanghai Commission of Science and Technology [12DZ2260600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Commission of Science and Technology(Shanghai Science & Technology Committee)	This study was supported by the National Natural Science Foundation of China (31172040 and 31471399) to C. Z., and by the Major Program of National Natural Science Foundation of China (81490743) to Z.-J. C., as well as by the Shanghai Commission of Science and Technology (12DZ2260600). Dr. CongZhang had an important role in study design.	Duggavathi R, 2008, GENE DEV, V22, P1871, DOI 10.1101/gad.472008; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Dunn Carolyn L, 2003, Reprod Biomed Online, V7, P151; Falender AE, 2003, ENDOCRINOLOGY, V144, P3598, DOI 10.1210/en.2002-0137; Fayard E, 2004, TRENDS CELL BIOL, V14, P250, DOI 10.1016/j.tcb.2004.03.008; Ferretti C, 2007, HUM REPROD UPDATE, V13, P121, DOI 10.1093/humupd/dml048; Gellersen B, 2007, SEMIN REPROD MED, V25, P445, DOI 10.1055/s-2007-991042; Giguere V, 1999, ENDOCR REV, V20, P689, DOI 10.1210/er.20.5.689; Gu PL, 2005, MOL CELL BIOL, V25, P3492, DOI 10.1128/MCB.25.9.3492-3505.2005; Hinshelwood MM, 2003, MOL CELL ENDOCRINOL, V207, P39, DOI 10.1016/S0303-7207(03)00257-0; Krikun G, 2004, ENDOCRINOLOGY, V145, P2291, DOI 10.1210/en.2003-1606; Labelle-Dumais C, 2007, BIOL REPROD, V77, P217, DOI 10.1095/biolreprod.106.059121; Lash GE, 2015, J REPROD IMMUNOL, V108, P83, DOI 10.1016/j.jri.2015.02.003; Li QX, 2007, J BIOL CHEM, V282, P31725, DOI 10.1074/jbc.M704723200; Li QX, 2013, ENDOCRINOLOGY, V154, P446, DOI 10.1210/en.2012-1585; Lin L, 2008, SEX DEV, V2, P200, DOI 10.1159/000152036; Liu DL, 2003, BIOL REPROD, V69, P508, DOI 10.1095/biolreprod.102.011767; Loke YW, 1995, HUM REPROD, V10, P14, DOI 10.1093/humrep/10.suppl_2.14; Louwen F, 2012, ONCOTARGET, V3, P759; Maruyama T, 2008, ENDOCR J, V55, P795, DOI 10.1507/endocrj.K08E-067; Mouzat K, 2013, MOL CELL ENDOCRINOL, V368, P47, DOI 10.1016/j.mce.2012.06.009; Noris M, 2005, NAT CLIN PRACT NEPHR, V1, P98, DOI 10.1038/ncpneph0035; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rabaglino MB, 2015, HYPERTENSION, V65, P421, DOI 10.1161/HYPERTENSIONAHA.114.04481; Ramathal CY, 2010, SEMIN REPROD MED, V28, P17, DOI 10.1055/s-0029-1242989; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; REDMAN CWG, 1991, PLACENTA, V12, P301, DOI 10.1016/0143-4004(91)90339-H; Sadovsky Y, 1998, J SOC GYNECOL INVEST, V5, P6, DOI 10.1016/S1071-5576(97)00096-8; Sattar N, 2002, BMJ-BRIT MED J, V325, P157, DOI 10.1136/bmj.325.7356.157; Sirianni R, 2002, J ENDOCRINOL, V174, pR13, DOI 10.1677/joe.0.174R013; Sones JL, 2014, AM J PHYSIOL-REG I, V307, pR490, DOI 10.1152/ajpregu.00176.2014; Tang XF, 2011, ENDOCRINE, V40, P187, DOI 10.1007/s12020-011-9477-y; Winn VD, 2009, ENDOCRINOLOGY, V150, P452, DOI 10.1210/en.2008-0990; Xue Q, 2007, J CLIN ENDOCR METAB, V92, P3261, DOI 10.1210/jc.2007-0494; Zeitoun K, 1999, MOL ENDOCRINOL, V13, P239, DOI 10.1210/me.13.2.239; Zhang C, 2013, NAT MED, V19, P1061, DOI 10.1038/nm.3192; Zhang T, 2014, REPRODUCTION, V147, P141, DOI 10.1530/REP-13-0470	37	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145968	10.1371/journal.pone.0145968	http://dx.doi.org/10.1371/journal.pone.0145968			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717016	Green Submitted, Green Published, gold			2022-12-26	WOS:000367510500106
J	Benbaba, S; Isaakidis, P; Das, M; Jadhav, S; Reid, T; Furin, J				Benbaba, Stella; Isaakidis, Petros; Das, Mrinalini; Jadhav, Sonakshi; Reid, Tony; Furin, Jennifer			Direct Observation (DO) for Drug-Resistant Tuberculosis: Do We Really DO?	PLOS ONE			English	Article							EXPERIENCES; ADHERENCE; THERAPY; HIV	Introduction Directly-observed therapy (DOT) is recommended for drug-resistant tuberculosis (DR-TB) patients during their entire treatment duration. However, there is limited published evidence on implementation of direct observation (DO) in the field. This study aims to detail whether DO was followed with DR-TB patients in a Medecins Sans Frontieres (MSF) tuberculosis program in Mumbai, India. Methods This was a cross-sectional, mixed-methods study. Existing qualitative data from a purposively-selected subset of 12 patients, 5 DOT-providers and 5 family members, were assessed in order to determine how DO was implemented. A questionnaire-based survey of DR-TB patients, their DOT-providers and MSF staff was completed between June and August 2014. Patients were defined as "following Strict DO" and "following DO" if a DOT-provider had seen the patient swallow his/her medications "every day" or "most of the days" respectively. If DO was not followed, reasons were also recorded. The qualitative data were analysed for theme and content and used to supplement the questionnaire-based data. Results A total of 70 DR-TB patients, 65 DOT-providers and 21 MSF health staff were included. Fifty-five per cent of the patients were HIV-co-infected and 41% had multidrug-resistant-TB plus additional resistance to a fluoroquinolone. Among all patients, only 14% (10/70) and 20% (14/70) self-reported "following Strict DO" and "following DO" respectively. Among DOT-providers, 46% (30/65) reported that their patients "followed DO". MSF health staff reported none of the patients "followed DO". Reasons for not implementing DO included the unavailability of DOT-provider, time spent, stigma and treatment adverse events. The qualitative data also revealed that "Strict DO" was rarely followed and noted the same reasons for lack of implementation. Conclusion This mixed-methods study has found that a majority of patients with DR-TB in Mumbai did not follow DO, and this was reported by patients and care-providers. These data likely reflect the reality of DO implementation in many high-burden settings, since this relatively small cohort was supported and closely monitored by a skilled team with access to multiple resources. The findings raise important concerns about the necessity of DO as a "pillar" of DR-TB treatment which need further validation in other settings. They also suggest that patient-centred adherence strategies might be better approaches for supporting patients on treatment.	[Benbaba, Stella; Isaakidis, Petros; Das, Mrinalini; Jadhav, Sonakshi] Medecins Sans Frontieres, Bombay, Maharashtra, India; [Isaakidis, Petros; Reid, Tony] Medecins Sans Frontieres, Operat Res Unit, Luxembourg, Luxembourg; [Furin, Jennifer] Case Western Reserve Univ, TB Res Unit, Cleveland, OH 44106 USA	Doctors Without Borders; Case Western Reserve University	Isaakidis, P (corresponding author), Medecins Sans Frontieres, Bombay, Maharashtra, India.	msfocb-asia-epidemio@brussels.msf.org		Isaakidis, Petros/0000-0002-7881-1554				Curry International Tuberculosis Center California Department of Public Health, 2011, DRUG RES TUB SURV GU; Daftary A, 2014, GLOB PUBLIC HEALTH, V9, P1107, DOI 10.1080/17441692.2014.934266; Furin J, 2014, INT J TUBERC LUNG D, V18, P1479, DOI 10.5588/ijtld.14.0277; Isaakidis P, 2013, TROP MED INT HEALTH, V18, P1128, DOI 10.1111/tmi.12146; O'Donnell MR, 2014, JAIDS-J ACQ IMM DEF, V67, P22, DOI 10.1097/QAI.0000000000000221; Okanurak K, 2007, INT J TUBERC LUNG D, V11, P762; Pasipanodya JG, 2013, CLIN INFECT DIS, V57, P21, DOI 10.1093/cid/cit167; Toczek A, 2013, INT J TUBERC LUNG D, V17, P299, DOI 10.5588/ijtld.12.0537; Volmink J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003510.pub2; World Health Organization, 2013, GLOB STRAT TARG TUB; World Health Organization, 2014, TUB COUNTR PROF; World Health Organization, 2014, COMP HDB WHO GUID PR; Wright CM, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0945-5	13	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0144936	10.1371/journal.pone.0144936	http://dx.doi.org/10.1371/journal.pone.0144936			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713873	Green Published, gold			2022-12-26	WOS:000367481900024
J	Daniel, AE; Timmerman, I; Kovacevic, I; Hordijk, PL; Adriaanse, L; Paatero, I; Belting, HG; van Buul, JD				Daniel, Anna E.; Timmerman, Ilse; Kovacevic, Igor; Hordijk, Peter L.; Adriaanse, Luc; Paatero, Ilkka; Belting, Heinz-Georg; van Buul, Jaap D.			Plasminogen Activator Inhibitor-1 Controls Vascular Integrity by Regulating VE-Cadherin Trafficking	PLOS ONE			English	Article							ENDOTHELIAL-CELL JUNCTIONS; BETA-CATENIN; TUMOR-GROWTH; PERMEABILITY; EXPRESSION; TIPLAXTININ; ZEBRAFISH; APOPTOSIS; CLEAVAGE; MODEL	Background Plasminogen activator inhibitor-1 (PAI-1), a serine protease inhibitor, is expressed and secreted by endothelial cells. Patients with PAI-1 deficiency show a mild to moderate bleeding diathesis, which has been exclusively ascribed to the function of PAI-1 in down-regulating fibrinolysis. We tested the hypothesis that PAI-1 function plays a direct role in controlling vascular integrity and permeability by keeping endothelial cell-cell junctions intact. Methodology/Principal Findings We utilized PAI-039, a specific small molecule inhibitor of PAI-1, to investigate the role of PAI-1 in protecting endothelial integrity. In vivo inhibition of PAI-1 resulted in vascular leakage from intersegmental vessels and in the hindbrain of zebrafish embryos. In addition PAI-1 inhibition in human umbilical vein endothelial cell (HUVEC) monolayers leads to a marked decrease of transendothelial resistance and disrupted endothelial junctions. The total level of the endothelial junction regulator VE-cadherin was reduced, whereas surface VE-cadherin expression was unaltered. Moreover, PAI-1 inhibition reduced the shedding of VE-cadherin. Finally, we detected an accumulation of VE-cadherin at the Golgi apparatus. Conclusions/Significance Our findings indicate that PAI-1 function is important for the maintenance of endothelial monolayer and vascular integrity by controlling VE-cadherin trafficking to and from the plasma membrane. Our data further suggest that therapies using PAI-1 antagonists like PAI-039 ought to be used with caution to avoid disruption of the vessel wall.	[Daniel, Anna E.; Timmerman, Ilse; Kovacevic, Igor; Hordijk, Peter L.; Adriaanse, Luc; van Buul, Jaap D.] Univ Amsterdam, Acad Med Ctr, Dept Mol Cell Biol, Sanquin Res & Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands; [Paatero, Ilkka; Belting, Heinz-Georg] Univ Basel, Biozentrum, Dept Cell Biol, Basel, Switzerland	University of Amsterdam; Academic Medical Center Amsterdam; University of Basel	van Buul, JD (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Mol Cell Biol, Sanquin Res & Landsteiner Lab, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.vanbuul@sanquin.nl	van Buul, Jaap D/AAJ-4371-2021; Paatero, Ilkka/AAE-7542-2019	van Buul, Jaap D/0000-0003-0054-7949; Paatero, Ilkka/0000-0001-5926-2396; Hordijk, Peter/0000-0002-3348-078X; Belting, Heinz-Georg/0000-0002-1538-4364; Kovacevic, Igor/0000-0003-1834-2378	Landsteiner Foundation for Blood Transfusion Research [1701, 1311]; Finnish Cultural Foundation [00140020, 00151103]; LSBR fellowship [1701]; LSBR grant [1311]	Landsteiner Foundation for Blood Transfusion Research; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); LSBR fellowship; LSBR grant	This work was supported by AED (awarded to JDvB): Landsteiner Foundation for Blood Transfusion Research, Grant number 1701, http://www.lsbr.nl/; IP: The Finnish Cultural Foundation, Grant numbers: 00140020 and 00151103, https://skr.fi/en/finnish-cultural-foundation; IK (awarded to Prof Peter Hordijk): Landsteiner Foundation for Blood Transfusion Research, Grant number 1311, http://www.lsbr.nl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Sacha Zeerleder for providing rabbit polyclonal PAI-1 antibody. AED is supported by a LSBR fellowship(#1701). IK is supported by a LSBR grant (#1311). IP is supported by a post-doctoral fellowship from Finnish Cultural Foundation (00140020 and 00151103).	Aimes RT, 2003, THROMB HAEMOSTASIS, V89, P561, DOI 10.1055/s-0037-1613388; Amerongen GPV, 2000, CIRC RES, V87, P335, DOI 10.1161/01.RES.87.4.335; Attali C, 2008, INFECT IMMUN, V76, P5350, DOI 10.1128/IAI.00184-08; Bager R, 2013, J MOL BIOL, V425, P2867, DOI 10.1016/j.jmb.2013.05.007; Baxi S, 2008, THROMB HAEMOSTASIS, V99, P749, DOI 10.1160/TH07-11-0669; Boncela J, 2011, J BIOL CHEM, V286, P6820, DOI 10.1074/jbc.M110.173781; Chen SC, 2008, MOL CANCER THER, V7, P1227, DOI 10.1158/1535-7163.MCT-08-0051; Corada M, 1999, P NATL ACAD SCI USA, V96, P9815, DOI 10.1073/pnas.96.17.9815; Czekay RP, 2003, J CELL BIOL, V160, P781, DOI 10.1083/jcb.200208117; Degryse B, 2004, J BIOL CHEM, V279, P22595, DOI 10.1074/jbc.M313004200; Dejana E, 2009, CELL TISSUE RES, V335, P1, DOI 10.1007/s00441-008-0697-2; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Dellas C, 2005, THROMB HAEMOSTASIS, V93, P631, DOI 10.1160/TH05-01-0033; Elokdah H, 2004, J MED CHEM, V47, P3491, DOI 10.1021/jm049766q; Fernandez-Martin L, 2012, ARTERIOSCLERTHROMBVA; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Gorlatova NV, 2007, J BIOL CHEM, V282, P9288, DOI 10.1074/jbc.M611642200; Hennan JK, 2008, J THROMB HAEMOST, V6, P1558, DOI 10.1111/j.1538-7836.2008.03063.x; Herren B, 1998, MOL BIOL CELL, V9, P1589, DOI 10.1091/mbc.9.6.1589; Hofmann S, 2002, EUR J MED RES, V7, P171; Hordijk PL, 1999, J CELL SCI, V112, P1915; Huveneers S, 2012, J CELL BIOL, V196, P641, DOI 10.1083/jcb.201108120; Isogai C, 2001, CANCER RES, V61, P5587; Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995; Izuhara Y, 2010, J CEREBR BLOOD F MET, V30, P904, DOI 10.1038/jcbfm.2009.272; Jinn SW, 2005, DEVELOPMENT, V132, P5199, DOI 10.1242/dev.02087; Kooistra MRH, 2005, FEBS LETT, V579, P4966, DOI 10.1016/j.febslet.2005.07.080; LAMPUGNANI MG, 1995, J CELL BIOL, V129, P203, DOI 10.1083/jcb.129.1.203; Lang MR, 2010, J THROMB HAEMOST, V8, P1159, DOI 10.1111/j.1538-7836.2010.03815.x; Mehta R, 2008, HAEMOPHILIA, V14, P1255, DOI 10.1111/j.1365-2516.2008.01834.x; Montero-Balaguer M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005772; Nanes BA, 2012, J CELL BIOL, V199, P365, DOI 10.1083/jcb.201205029; Navaratna D, 2007, DIABETES, V56, P2380, DOI 10.2337/db06-1694; Noda K, 2010, MOL BIOL CELL, V21, P584, DOI 10.1091/mbc.E09-07-0580; Nwariaku FE, 2002, SHOCK, V18, P82, DOI 10.1097/00024382-200207000-00015; Ploplis VA, 2004, J BIOL CHEM, V279, P6143, DOI 10.1074/jbc.M307297200; Rudini N, 2008, EMBO J, V27, P993, DOI 10.1038/emboj.2008.46; Sidibe A, 2012, ARTHRITIS RHEUM-US, V64, P77, DOI 10.1002/art.33336; Soeda S, 2001, MOL BRAIN RES, V91, P96, DOI 10.1016/S0169-328X(01)00133-4; Timmerman I, 2015, LOCAL VE CADHERIN TR; Trani M, 2015, CURR OPIN HEMATOL, V22, P267, DOI 10.1097/MOH.0000000000000137; Ukropec JA, 2002, EXP CELL RES, V273, P240, DOI 10.1006/excr.2001.5453; Vaughan Douglas E, 2011, Trans Am Clin Climatol Assoc, V122, P312; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001; Zanetta L, 2005, THROMB HAEMOSTASIS, V93, P1041, DOI 10.1160/TH04-10-0680	47	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145684	10.1371/journal.pone.0145684	http://dx.doi.org/10.1371/journal.pone.0145684			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714278	gold, Green Submitted, Green Published			2022-12-26	WOS:000367481900067
J	Dirks, JAMC; van Liere, GAFS; Bogers, S; Dukers-Muijrers, NHTM; Wolffs, PFG; Hoebe, CJPA				Dirks, J. A. M. C.; van Liere, G. A. F. S.; Bogers, S.; Dukers-Muijrers, N. H. T. M.; Wolffs, P. F. G.; Hoebe, C. J. P. A.			Natural Course of Chlamydia trachomatis Bacterial Load in the Time Interval between Screening and Treatment in Anogenital Samples	PLOS ONE			English	Article							GENITAL-TRACT; IMMUNE-RESPONSES; INFECTION; MURIDARUM; DURATION; TRANSMISSION; RESOLUTION; HISTORY; WOMEN	Introduction Although Chlamydia trachomatis (CT) is the most common bacterial sexually transmitted infection worldwide, little is known about the natural course of the bacterial load during infection. We investigated the natural course of the bacterial load in the interval between screening and returning for treatment in genital and anorectal CT-infections. Materials & Methods CT-positive patients, visiting our STI-clinic in the Netherlands from June 2011-January 2014, provided a second urogenital and/or anorectal sample when returning for treatment (diagnostic sample = T1; treatment sample = T2). Patient-record provided data about the days between samples and the date of last unsafe sex. Included patients were >= 18 years old, HIV-negative and did not report antibiotic use in the study-interval. CT load was quantified using qPCR. CT load was log-transformed, and a CT load difference (Delta-CT load) of > 1 log was deemed clinically relevant. Chi-square test compared load category distributions over time (decrease/equal/increase), between sample types. Results 274 patients provided 296 paired samples. Majority of samples had a stable CT load in the interval T1-T2 (66.3%, 73.1% and 48.6% for vaginal swabs, urine and anorectal swabs resp. p = 0.07). Load decreased in 17-41% of patients, while +/- 10% of patients showed an increase in CT load. No association between Delta-CT load and the interval T1-T2 was observed. Large variations can be seen in CT load at T1 and over time. Discussion The majority (+/- 90%) of patients have a stable or decreasing CT load in the time interval between screening and returning for treatment. The number of days between sampling was not associated with change in CT load. In the first month after the last unsafe sex, only stable CT loads were seen. Our data seems to indicate that when most patients visit an STI-clinic, recommended 2 weeks after infection, the infection has already been established or is in its downward phase.	[Dirks, J. A. M. C.; van Liere, G. A. F. S.; Bogers, S.; Dukers-Muijrers, N. H. T. M.; Wolffs, P. F. G.; Hoebe, C. J. P. A.] Maastricht Univ, Med Ctr, Sch Publ Hlth & Primary Care, Dept Med Microbiol, NL-6200 MD Maastricht, Netherlands; [Dirks, J. A. M. C.; van Liere, G. A. F. S.; Dukers-Muijrers, N. H. T. M.; Hoebe, C. J. P. A.] Publ Hlth Serv South Limburg, Dept Sexual Hlth Infect Dis & Environm Hlth, Geleen, Netherlands	Maastricht University	Dirks, JAMC (corresponding author), Maastricht Univ, Med Ctr, Sch Publ Hlth & Primary Care, Dept Med Microbiol, NL-6200 MD Maastricht, Netherlands.	anne.dirks@mumc.nl	Dukers-Muijrers, Nicole/M-7178-2014	Wolffs, Petra/0000-0002-5326-3985; Dukers-Muijrers, Nicole/0000-0003-4896-758X; van Liere, Genevieve/0000-0002-9286-4548; Hoebe, Christian/0000-0003-1815-0974	Public Health Service South Limburg; Department of Medical Microbiology, Maastricht University Medical Center	Public Health Service South Limburg; Department of Medical Microbiology, Maastricht University Medical Center	This work was supported by the Public Health Service South Limburg and the Department of Medical Microbiology, Maastricht University Medical Center.	Agrawal T, 2013, BRIT J BIOMED SCI, V70, P51, DOI 10.1080/09674845.2013.11669935; Anglemyer A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009153.pub3; [Anonymous], 2011, PREVALENCE INCIDENCE; Apewokin SK, 2010, SEX TRANSM DIS, V37, P343, DOI 10.1097/OLQ.0b013e3181d73639; Brocail M., 2015, SOON CAN I GET TESTE; Carey AJ, 2009, IMMUNOL CELL BIOL, V87, P337, DOI 10.1038/icb.2009.3; Chappell CA, 2014, INFECT DIS CLIN N AM, V28, P529, DOI 10.1016/j.idc.2014.08.002; Cook RL, 2005, ANN INTERN MED, V142, P914, DOI 10.7326/0003-4819-142-11-200506070-00010; Dionne-Odom J, 2016, AM J OBSTET GYNECOL, V214, P6, DOI 10.1016/j.ajog.2015.09.100; Dirks JAMC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121433; Family Planning Association, 2014, CHLAM LOOK YOUR SEX; Garcia-Tejedor A, 2015, EUR J OBSTET GYN R B, V194, P173, DOI 10.1016/j.ejogrb.2015.09.009; Geisler WM, 2008, SEX TRANSM INFECT, V84, P541, DOI 10.1136/sti.2008.030825; Geisler WM, 2008, SEX TRANSM DIS, V35, P119, DOI 10.1097/OLQ.0b013e318151497d; Geisler WM, 2013, J INFECT DIS, V207, P1850, DOI 10.1093/infdis/jit094; Geisler WM, 2010, J INFECT DIS, V201, pS104, DOI 10.1086/652402; Golden MR, 2000, SEX TRANSM DIS, V27, P329, DOI 10.1097/00007435-200007000-00006; Gomes JP, 2006, MICROBES INFECT, V8, P16, DOI 10.1016/j.micinf.2005.05.014; Gupta R, 2014, MOL IMAGING BIOL, V16, P635, DOI 10.1007/s11307-014-0732-5; Hafner LM, 2013, MUCOSAL IMMUNOL, V6, P859, DOI 10.1038/mi.2013.46; Haggerty CL, 2010, J INFECT DIS, V201, pS134, DOI 10.1086/652395; HANDSFIELD H H, 1976, Journal of the American Venereal Disease Association, V2, P5; He Q, 2013, J STEROID BIOCHEM, V135, P7, DOI 10.1016/j.jsbmb.2012.11.002; Hobbs MM, 2008, SEX TRANSM DIS, V35, P8, DOI 10.1097/OLQ.0b013e31815d968d; Iwasaki A, 2010, NAT REV IMMUNOL, V10, P699, DOI 10.1038/nri2836; Ljubin-Sternak S, 2014, J PATHOG, V2014, DOI 10.1155/2014/183167; Marrazzo J, 2014, CLIN MANIFESTATIONS; Maxion HK, 2004, INFECT IMMUN, V72, P6330, DOI 10.1128/IAI.72.11.6330-6340.2004; Molano M, 2005, J INFECT DIS, V191, P907, DOI 10.1086/428287; Morre SA, 2002, INT J STD AIDS, V13, P12, DOI 10.1258/095646202762226092; Price MJ, 2013, STAT MED, V32, P1547, DOI 10.1002/sim.5603; Radcliffe K, 2008, TESTING CHLAMYDIA WI; Russell AN, 2016, J INFECT DIS, V213, P523, DOI 10.1093/infdis/jiv438; Schachter J, 1997, IMMUNOL INVEST, V26, P157, DOI 10.3109/08820139709048923; Su H, 2000, INFECT IMMUN, V68, P192, DOI 10.1128/IAI.68.1.192-196.2000; Van Der Pol B, 2013, SEX TRANSM DIS, V40, P247, DOI 10.1097/OLQ.0b013e3182717833; van Rooijen MS, 2015, SEX TRANSM INFECT, V91, P157, DOI 10.1136/sextrans-2014-051633; Vodstrcil LA, 2014, J INFECT DIS; Walker J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037778; Wan C, 2014, AM J REPROD IMMUNOL, V71, P165, DOI 10.1111/aji.12168	40	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145693	10.1371/journal.pone.0145693	http://dx.doi.org/10.1371/journal.pone.0145693			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713628	Green Published, Green Submitted, gold			2022-12-26	WOS:000367481900070
J	Duncan, RN; Panahi, S; Piotrowski, T; Dorsky, RI				Duncan, Robert N.; Panahi, Samin; Piotrowski, Tatjana; Dorsky, Richard I.			Identification of Wnt Genes Expressed in Neural Progenitor Zones during Zebrafish Brain Development	PLOS ONE			English	Article							STEM-CELLS; DIFFERENTIATION; NEUROGENESIS; PATHWAY; CNS; PROLIFERATION; TELENCEPHALON; MORPHOGENESIS; MAINTENANCE; INITIATION	Wnt signaling regulates multiple aspects of vertebrate central nervous system (CNS) development, including neurogenesis. However, vertebrate genomes can contain up to 25 Wnt genes, the functions of which are poorly characterized partly due to redundancy in their expression. To identify candidate Wnt genes as candidate mediators of pathway activity in specific brain progenitor zones, we have performed a comprehensive expression analysis at three different stages during zebrafish development. Antisense RNA probes for 21 Wnt genes were generated from existing and newly synthesized cDNA clones and used for in situ hybridization on whole embryos and dissected brains. As in other species, we found that Wnt expression patterns in the embryonic zebrafish CNS are complex and often redundant. We observed that progenitor zones in the telencephalon, dorsal diencephalon, hypothalamus, midbrain, midbrain-hindbrain boundary, cerebellum and retina all express multiple Wnt genes. Our data identify 12 specific ligands that can now be tested using loss-of-function approaches.	[Duncan, Robert N.; Panahi, Samin; Dorsky, Richard I.] Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT 84112 USA; [Piotrowski, Tatjana] Stowers Inst Med Res, Kansas City, MO USA	Utah System of Higher Education; University of Utah; Stowers Institute for Medical Research	Dorsky, RI (corresponding author), Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT 84112 USA.	Richard.Dorsky@neuro.utah.edu			National Institutes of Health [R01NS082645, T32DC008553]; NIH [RO1NS082645]; NIDCD [5T32 DC008553]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC008553] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health, R01NS082645 (R.I.D.), T32DC008553 (R.N.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Wilson Clements, Elke Ober, Matthias Carl, Gilbert Weidinger and Arne Lekven for generously sharing plasmid templates for in situ probes. R.I.D. was funded by NIH RO1NS082645 and R.N.D. was funded by NIDCD 5T32 DC008553.	Agathocleous M, 2009, DEVELOPMENT, V136, P3289, DOI 10.1242/dev.040451; Beretta CA, 2011, GENE EXPR PATTERNS, V11, P277, DOI 10.1016/j.gep.2011.01.004; Carl M, 2007, NEURON, V55, P393, DOI 10.1016/j.neuron.2007.07.007; Clements WK, 2011, NATURE, V474, P220, DOI 10.1038/nature10107; Clements WK, 2009, DEV DYNAM, V238, P1788, DOI 10.1002/dvdy.21977; Dorsky RI, 1998, NATURE, V396, P370, DOI 10.1038/24620; Farin HF, 2012, GASTROENTEROLOGY, V143, P1518, DOI 10.1053/j.gastro.2012.08.031; Fotaki V, 2010, DEV DYNAM, V239, P284, DOI 10.1002/dvdy.22137; Gordon LR, 2012, DEVELOPMENT, V139, P1023, DOI 10.1242/dev.071555; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Ikeya M, 1997, NATURE, V389, P966, DOI 10.1038/40146; Imura T, 2010, STEM CELLS, V28, P2053, DOI 10.1002/stem.524; Ito Y, 2010, DEV BIOL, V342, P26, DOI 10.1016/j.ydbio.2010.03.008; Jing LL, 2009, NEURON, V61, P721, DOI 10.1016/j.neuron.2008.12.025; Kaslin J, 2009, J NEUROSCI, V29, P6142, DOI 10.1523/JNEUROSCI.0072-09.2009; Katoh M, 2008, CURR DRUG TARGETS, V9, P565, DOI 10.2174/138945008784911750; KELLY GM, 1995, DEVELOPMENT, V121, P1787; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Leucht C, 2008, NAT NEUROSCI, V11, P641, DOI 10.1038/nn.2115; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Lu FI, 2011, P NATL ACAD SCI USA, V108, P15876, DOI 10.1073/pnas.1106801108; Marz M, 2010, GLIA, V58, P870, DOI 10.1002/glia.20971; Megason SG, 2002, DEVELOPMENT, V129, P2087; Mueller T, 2003, DEV BRAIN RES, V140, P137, DOI 10.1016/S0165-3806(02)00583-7; Munji RN, 2011, J NEUROSCI, V31, P1676, DOI 10.1523/JNEUROSCI.5404-10.2011; Ober EA, 2006, NATURE, V442, P688, DOI 10.1038/nature04888; Postlethwait JH, 1998, NAT GENET, V18, P345, DOI 10.1038/ng0498-345; Qu QH, 2010, NAT CELL BIOL, V12, P31, DOI 10.1038/ncb2001; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Ulrich F, 2003, DEVELOPMENT, V130, P5375, DOI 10.1242/dev.00758; UNGAR AR, 1995, MECH DEVELOP, V52, P153, DOI 10.1016/0925-4773(95)00386-F; Veien ES, 2008, DEVELOPMENT, V135, P4101, DOI 10.1242/dev.027367; Wang X, 2012, DEV CELL, V23, P624, DOI 10.1016/j.devcel.2012.07.012; Wehman AM, 2005, DEV BIOL, V281, P53, DOI 10.1016/j.ydbio.2005.02.010	36	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145810	10.1371/journal.pone.0145810	http://dx.doi.org/10.1371/journal.pone.0145810			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713625	gold, Green Published, Green Submitted			2022-12-26	WOS:000367481900086
J	Lopes, JS; Abril-de-Abreu, R; Oliveira, RF				Lopes, Joao Sollari; Abril-de-Abreu, Rodrigo; Oliveira, Rui F.			Brain Transcriptomic Response to Social Eavesdropping in Zebrafish (Danio rerio)	PLOS ONE			English	Article							C-FOS; GENE; EXPRESSION; MEMORY; FAMILY; NKX3.1; DIFFERENTIATION; INFORMATION; PLASTICITY; MULTIPLE	Public information is widely available at low cost to animals living in social groups. For instance, bystanders may eavesdrop on signaling interactions between conspecifics and use it to adapt their subsequent behavior towards the observed individuals. This social eavesdropping ability is expected to require specialized mechanisms such as social attention, which selects social information available for learning. To begin exploring the genetic basis of social eavesdropping, we used a previously established attention paradigm in the lab to study the brain gene expression profile of male zebrafish (Danio rerio) in relation to the attention they paid towards conspecifics involved or not involved in agonistic interactions. Microarray gene chips were used to characterize their brain transcriptomes based on differential expression of single genes and gene sets. These analyses were complemented by promoter region-based techniques. Using data from both approaches, we further drafted protein interaction networks. Our results suggest that attentiveness towards conspecifics, whether interacting or not, activates pathways linked to neuronal plasticity and memory formation. The network analyses suggested that fos and jun are key players on this response, and that npas4a, nr4a1 and egr4 may also play an important role. Furthermore, specifically observing fighting interactions further triggered pathways associated to a change in the alertness status (dnajb5) and to other genes related to memory formation (btg2, npas4b), which suggests that the acquisition of eavesdropped information about social relationships activates specific processes on top of those already activated just by observing conspecifics.	[Lopes, Joao Sollari; Abril-de-Abreu, Rodrigo; Oliveira, Rui F.] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Lopes, Joao Sollari; Abril-de-Abreu, Rodrigo; Oliveira, Rui F.] ISPA Inst Univ, Lisbon, Portugal; [Abril-de-Abreu, Rodrigo; Oliveira, Rui F.] Champalimaud Ctr Unknown, Champalimaud Neurosci Programme, Lisbon, Portugal	Instituto Gulbenkian de Ciencia; Instituto Superior Psicologia Aplicada (ISPA); Fundacao Champalimaud	Oliveira, RF (corresponding author), Inst Gulbenkian Ciencias, Oeiras, Portugal.	ruiol@ispa.pt	Lopes, Joao S/A-1493-2013; Oliveira, Rui/A-3581-2013	Lopes, Joao S/0000-0001-5670-2069; Oliveira, Rui/0000-0003-1528-618X	Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BD/33280/2007]; Champalimaud Neuroscience Programme; FCT [EXCL/BIA-ANM/0549/2012, PTDC/PSI-PCO/118776/2010]; Fundação para a Ciência e a Tecnologia [EXCL/BIA-ANM/0549/2012, PTDC/PSI-PCO/118776/2010] Funding Source: FCT	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Champalimaud Neuroscience Programme; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundação para a Ciência e a Tecnologia	RA was supported by a Ph.D. fellowship from Fundacao para a Ciencia e a Tecnologia (FCT, reference SFRH/BD/33280/2007) and by the Champalimaud Neuroscience Programme. JSL was supported by a post-doc fellowship within the FCT research grant EXCL/BIA-ANM/0549/2012. This work was funded by FCT research grant PTDC/PSI-PCO/118776/2010 given to RFO.	Abril-de-Abreu R, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150220; Abril-de-Abreu R, 2015, SCI REP-UK, V5, DOI 10.1038/srep12678; Ament SA, 2012, P NATL ACAD SCI USA, V109, pE1801, DOI 10.1073/pnas.1205283109; [Anonymous], NUCLEIC ACIDS RES; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Basheer R, 2001, MOL BRAIN RES, V89, P153, DOI 10.1016/S0169-328X(01)00045-6; Ben-Tov M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7476; Byrne RW, 1989, MACHIAVELLIAN INTELL, P599, DOI [10.1016/0003-3472(89)90054-7, DOI 10.1016/0003-3472(89)90054-7]; Cardoso SD, 2015, J EXP BIOL, V218, P140, DOI 10.1242/jeb.106997; Chen WV, 2013, DEVELOPMENT, V140, P3297, DOI 10.1242/dev.090621; Choe SK, 2008, ZEBRAFISH, V5, P179, DOI 10.1089/zeb.2008.0534; Cole CJ, 2012, NAT NEUROSCI, V15, P1255, DOI 10.1038/nn.3189; Crockford C, 2007, ANIM BEHAV, V73, P885, DOI 10.1016/j.anbehav.2006.10.016; Dunbar RIM, 2007, SCIENCE, V317, P1344, DOI 10.1126/science.1145463; Earley RL, 2002, P ROY SOC B-BIOL SCI, V269, P943, DOI 10.1098/rspb.2002.1973; Etkin A, 2006, NEURON, V50, P127, DOI 10.1016/j.neuron.2006.03.013; Farioli-Vecchioli S, 2008, PLOS BIOL, V6, P2188, DOI 10.1371/journal.pbio.0060246; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Hawk JD, 2011, BRAIN RES BULL, V85, P21, DOI 10.1016/j.brainresbull.2011.02.001; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Heyes C, 2012, J COMP PSYCHOL, V126, P193, DOI 10.1037/a0025180; Huang YF, 1999, NAT NEUROSCI, V2, P867, DOI 10.1038/13165; Humphrey N., 1976, GROWING POINTS ETHOL, P303; Kala K, 2009, DEVELOPMENT, V136, P253, DOI 10.1242/dev.029900; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kelder T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006447; Laitinen S, 1999, J LIPID RES, V40, P2204; Lee HG, 2009, AM J PATHOL, V174, P891, DOI 10.2353/ajpath.2009.080583; Li L, 2005, MOL CELL BIOL, V25, P10286, DOI 10.1128/MCB.25.23.10286-10300.2005; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Maciejewski H, 2014, BRIEF BIOINFORM, V15, P504, DOI 10.1093/bib/bbt002; Marquer C, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-60; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; McClintock TS, 2008, PHYSIOL GENOMICS, V32, P198, DOI 10.1152/physiolgenomics.00128.2007; MCGREGOR PK, 1993, PHILOS T ROY SOC B, V340, P237, DOI 10.1098/rstb.1993.0063; Mennill DJ, 2002, SCIENCE, V296, P873, DOI 10.1126/science.296.5569.873; Muroyama Y, 2005, NATURE, V438, P360, DOI 10.1038/nature04139; Nagoshi E, 2010, NAT NEUROSCI, V13, P60, DOI 10.1038/nn.2451; Oliveira RF, 1998, P ROY SOC B-BIOL SCI, V265, P1045, DOI 10.1098/rspb.1998.0397; Peake Tom M., 2005, P13, DOI 10.1017/CBO9780511610363.004; Ploski JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023760; Popov N, 2007, CELL CYCLE, V6, P2327, DOI 10.4161/cc.6.19.4804; Possner M, 2008, INT J ONCOL, V32, P877; Potter CS, 2006, J BIOL CHEM, V281, P29245, DOI 10.1074/jbc.M603646200; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Ramamoorthi K, 2011, SCIENCE, V334, P1669, DOI 10.1126/science.1208049; Robinson GE, 2008, SCIENCE, V322, P896, DOI 10.1126/science.1159277; Sanogo YO, 2012, P ROY SOC B-BIOL SCI, V279, P4929, DOI 10.1098/rspb.2012.2087; Schwartz PT, 2000, J BIOL CHEM, V275, P19106, DOI 10.1074/jbc.M000655200; Shipp S, 2004, TRENDS COGN SCI, V8, P223, DOI 10.1016/j.tics.2004.03.004; Sinha S, 2003, BIOINFORMATICS, V19, pi292, DOI 10.1093/bioinformatics/btg1040; Spence R, 2008, BIOL REV, V83, P13, DOI 10.1111/j.1469-185X.2007.00030.x; Strekalova T, 2003, GENES BRAIN BEHAV, V2, P3, DOI 10.1034/j.1601-183X.2003.00001.x; Sumbre G, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00091; Tanaka M, 1999, MECH DEVELOP, V85, P179, DOI 10.1016/S0925-4773(99)00084-2; Tariq H, 2002, BIOANALYZER SOFTWARE; Terao A, 2003, NEUROSCIENCE, V120, P1115, DOI 10.1016/S0306-4522(03)00395-6; Tribioli C, 1999, DEVELOPMENT, V126, P5699; Wang L, 2007, J NEUROSCI, V27, P12555, DOI 10.1523/JNEUROSCI.3681-07.2007; Wang P, 2009, CANCER INVEST, V27, P369, DOI 10.1080/07357900802232749; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Yang HJ, 2008, J BIOL CHEM, V283, P5287, DOI 10.1074/jbc.M706917200; Zearfoss NR, 2008, J NEUROSCI, V28, P8502, DOI 10.1523/JNEUROSCI.1756-08.2008; Zhao M, 1999, MOL CELL BIOL, V19, P21; Zhao TY, 2014, DEVELOPMENT, V141, P148, DOI 10.1242/dev.101550	66	10	10	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145801	10.1371/journal.pone.0145801	http://dx.doi.org/10.1371/journal.pone.0145801			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713440	Green Published, Green Submitted, gold			2022-12-26	WOS:000367481900085
J	Lu, PY; Hontecillas, R; Abedi, V; Kale, S; Leber, A; Heltzel, C; Langowski, M; Godfrey, V; Philipson, C; Tubau-Juni, N; Carbo, A; Girardin, S; Uren, A; Bassaganya-Riera, J				Lu, Pinyi; Hontecillas, Raquel; Abedi, Vida; Kale, Shiv; Leber, Andrew; Heltzel, Chase; Langowski, Mark; Godfrey, Victoria; Philipson, Casandra; Tubau-Juni, Nuria; Carbo, Adria; Girardin, Stephen; Uren, Aykut; Bassaganya-Riera, Josep			Modeling-Enabled Characterization of Novel NLRX1 Ligands	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; NF-KAPPA-B; OXYGEN SPECIES PRODUCTION; DOMAIN-LIKE RECEPTORS; FAMILY-MEMBER NLRX1; NUCLEOTIDE-BINDING; PUNICIC ACID; PPAR-GAMMA; MEDIATES PROTECTION; ANTIVIRAL IMMUNITY	Nucleotide-binding domain and leucine-rich repeat containing (NLR) family are intracellular sentinels of cytosolic homeostasis that orchestrate immune and inflammatory responses in infectious and immune-mediated diseases. NLRX1 is a mitochondrial-associated NOD-like receptor involved in the modulation of immune and metabolic responses. This study utilizes molecular docking approaches to investigate the structure of NLRX1 and experimentally assesses binding to naturally occurring compounds from several natural product and lipid databases. Screening of compound libraries predicts targeting of NLRX1 by conjugated trienes, polyketides, prenol lipids, sterol lipids, and coenzyme A-containing fatty acids for activating the NLRX1 pathway. The ligands of NLRX1 were identified by docking punicic acid (PUA), eleostearic acid (ESA), and docosahexaenoic acid (DHA) to the C-terminal fragment of the human NLRX1 (cNLRX1). Their binding and that of positive control RNA to cNLRX1 were experimentally determined by surface plasmon resonance (SPR) spectroscopy. In addition, the ligand binding sites of cNLRX1 were predicted in silico and validated experimentally. Target mutagenesis studies demonstrate that mutation of 4 critical residues ASP677, PHE680, PHE681, and GLU684 to alanine resulted in diminished affinity of PUA, ESA, and DHA to NLRX1. Consistent with the regulatory actions of NLRX1 on the NF-kappa B pathway, treatment of bone marrow derived macrophages (BMDM)s with PUA and DHA suppressed NF-kappa B activity in a NLRX1 dependent mechanism. In addition, a series of preclinical efficacy studies were performed using a mouse model of dextran sodium sulfate (DSS)-induced colitis. Our findings showed that the regulatory function of PUA on colitis is NLRX1 dependent. Thus, we identified novel small molecules that bind to NLRX1 and exert anti-inflammatory actions.	[Lu, Pinyi; Hontecillas, Raquel; Abedi, Vida; Kale, Shiv; Leber, Andrew; Heltzel, Chase; Langowski, Mark; Godfrey, Victoria; Tubau-Juni, Nuria; Bassaganya-Riera, Josep] Virginia Tech, Virginia Bioinformat Inst, Ctr Modeling Immun Enter Pathogens, Blacksburg, VA 24061 USA; [Lu, Pinyi; Hontecillas, Raquel; Abedi, Vida; Kale, Shiv; Leber, Andrew; Heltzel, Chase; Langowski, Mark; Godfrey, Victoria; Tubau-Juni, Nuria; Bassaganya-Riera, Josep] Virginia Tech, Virginia Bioinformat Inst, Nutr Immunol & Mol Med Lab Www Nimml Org, Blacksburg, VA 24061 USA; [Philipson, Casandra; Carbo, Adria] BioTherapeutics, Blacksburg, VA 24060 USA; [Girardin, Stephen] Univ Toronto, Lab Med & Pathobiol, Toronto, ON, Canada; [Uren, Aykut] Georgetown Univ, Med Ctr, Washington, DC 20057 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; University of Toronto; Georgetown University	Bassaganya-Riera, J (corresponding author), Virginia Tech, Virginia Bioinformat Inst, Ctr Modeling Immun Enter Pathogens, Blacksburg, VA 24061 USA.	jbassaga@vt.edu	Philipson, Casandra/AAY-5746-2021; Lu, Pinyi/U-4513-2017	Abedi, Vida/0000-0001-7689-933X	National Institute of Allergy and Infectious Diseases [HHSN272201000056C]; Nutritional Immunology and Molecular Medicine Laboratory; BioTherapeutics; NATIONAL CANCER INSTITUTE [P30CA051008] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Nutritional Immunology and Molecular Medicine Laboratory; BioTherapeutics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institute of Allergy and Infectious Diseases Contract No. HHSN272201000056C to JB-R and funds from the Nutritional Immunology and Molecular Medicine Laboratory (www.nimml.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. BioTherapeutics provided support in the form of salary for author [AC] after he graduated from NIMML with a PhD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abdul-Sater AA, 2010, J BIOL CHEM, V285, P41637, DOI 10.1074/jbc.M110.137885; Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; AHLERS NHE, 1954, NATURE, V173, P1045, DOI 10.1038/1731045a0; Allen IC, 2011, IMMUNITY, V34, P854, DOI 10.1016/j.immuni.2011.03.026; Anighoro A, 2014, J MED CHEM, V57, P7874, DOI 10.1021/jm5006463; Asrat S, 2015, CELLULAR MICROBIOLOG; Badami R C, 1980, Prog Lipid Res, V19, P119; Bassaganya-Riera J, 2004, GASTROENTEROLOGY, V127, P777, DOI 10.1053/j.gastro.2004.06.049; Bassaganya-Riera J, 2011, BRIT J NUTR, V106, P878, DOI 10.1017/S0007114511001188; Brodsky IE, 2009, SEMINARS IMMUNOLOGY; Brull F, 2009, CLIN LIPIDOL, V4, P355, DOI 10.2217/CLP.09.26; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Conti BJ, 2005, J BIOL CHEM, V280, P18375, DOI 10.1074/jbc.M413169200; de Zoete MR, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00462; Durai P, 2013, FEBS J, V280, P6196, DOI 10.1111/febs.12541; Eitas TK, 2014, J BIOL CHEM, V289, P4173, DOI 10.1074/jbc.M113.533034; Faergeman NJ, 1997, BIOCHEM J, V323, P1; Franchi L, 2006, J IMMUNOL, V177, P3507, DOI 10.4049/jimmunol.177.6.3507; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Fukata M, 2009, SEMIN IMMUNOL, V21, P242, DOI 10.1016/j.smim.2009.06.005; Guesnet P, 2011, BIOCHIMIE, V93, P7, DOI 10.1016/j.biochi.2010.05.005; Harton JA, 2002, J IMMUNOL, V169, P4088, DOI 10.4049/jimmunol.169.8.4088; Hong M, 2012, IMMUNITY, V36, P337, DOI 10.1016/j.immuni.2011.12.018; Hontecillas R, 2009, J AM COLL NUTR, V28, P184, DOI 10.1080/07315724.2009.10719770; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Huss JM, 2005, J CLIN INVEST, V115, P547, DOI 10.1172/JCI200524405; Jaworska J, 2014, P NATL ACAD SCI USA, V111, pE2110, DOI 10.1073/pnas.1322118111; Jha Sushmita, 2015, F1000Prime Rep, V7, P15, DOI 10.12703/P7-15; Jin CC, 2013, J ALLERGY CLIN IMMUN, V132, P287, DOI 10.1016/j.jaci.2013.06.022; JOH YG, 1995, J AM OIL CHEM SOC, V72, P1037, DOI 10.1007/BF02660718; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kuzuyama T, 2003, NAT PROD REP, V20, P171, DOI 10.1039/b109860h; Lara-Tejero M, 2006, J EXP MED, V203, P1407, DOI 10.1084/jem.20060206; Lei Y, 2012, IMMUNITY, V36, P933, DOI 10.1016/j.immuni.2012.03.025; Lesage S, 2002, AM J HUM GENET, V70, P845, DOI 10.1086/339432; Lewis SN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024031; Lich JD, 2007, J IMMUNOL, V178, P1256, DOI 10.4049/jimmunol.178.3.1256; Lu PY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034643; Lu PY, 2011, J MOL MODEL, V17, P543, DOI 10.1007/s00894-010-0748-y; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Mason DR, 2012, J INNATE IMMUN, V4, P16, DOI 10.1159/000334247; Minto RE, 2008, PROG LIPID RES, V47, P233, DOI 10.1016/j.plipres.2008.02.002; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Neal MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065779; Oehlers SH, 2011, DIS MODEL MECH, V4, P832, DOI 10.1242/dmm.006122; Philipson CW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137839; Rao AV, 2007, PHARMACOL RES, V55, P207, DOI 10.1016/j.phrs.2007.01.012; Russell RK, 2008, GENES IMMUN, V9, P556, DOI 10.1038/gene.2008.44; Sassano G, 2009, J SCI FOOD AGR, V89, P1046, DOI 10.1002/jsfa.3552; Savar Nastaran Sadat, 2014, Adv Biomed Res, V3, P41, DOI 10.4103/2277-9175.125730; Saxena M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00327; Shaw PJ, 2011, TRENDS MOL MED, V17, P57, DOI 10.1016/j.molmed.2010.11.001; Shoichet BK, 2004, NATURE, V432, P862, DOI 10.1038/nature03197; Soares F, 2014, J BIOL CHEM, V289, P19317, DOI 10.1074/jbc.M114.550111; Tattoli I, 2008, EMBO REP, V9, P293, DOI 10.1038/sj.embor.7401161; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Ting JPY, 2008, NAT REV IMMUNOL, V8, P372, DOI 10.1038/nri2296; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Van Limbergen J, 2015, GUT, V64, P353, DOI 10.1136/gutjnl-2013-305077; Viladomiu M, 2013, J NUTR BIOCHEM, V24, P929, DOI 10.1016/j.jnutbio.2013.01.006; Wang YL, 2014, NUCLEIC ACIDS RES, V42, pD1075, DOI 10.1093/nar/gkt978; Xia XJ, 2011, IMMUNITY, V34, P843, DOI 10.1016/j.immuni.2011.02.022	63	16	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145420	10.1371/journal.pone.0145420	http://dx.doi.org/10.1371/journal.pone.0145420			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714018	Green Published, gold, Green Submitted			2022-12-26	WOS:000367481900041
J	Jin, ZX; Li, J,M; Li, YL				Jin, Zexin; Li, Junmin; Li, Yueling			Interactive Effects of Arbuscular Mycorrhizal Fungi and Copper Stress on Flowering Phenology and Reproduction of Elsholtzia splendens	PLOS ONE			English	Article							METAL-CONTAMINATED SOIL; AGRICULTURAL PLANTS; GROWTH; TOLERANCE; INOCULATION; ACCUMULATION; METALLOPHYTE; GLOMALIN; PROTEIN; SIZE	Plant responses to heavy metal contamination may depend on the presence of arbuscular mycorrhizal fungi (AMF). Elsholtzia splendens is an indicator species for the presence of copper (Cu) mines because both its flowering phenology and reproduction are tolerant to heavy metals. To test whether effects of Cu on the flowering phenology and reproduction of E. splendens depend on the presence of AMF, we conducted a factorial experiment with two Cu treatments (with or without Cu addition) crossed with two AMF treatments (with or without AMF inoculation). Without AMF, Cu addition significantly delayed the onset dates, ending dates and peak dates of flowering and decreased flowering duration. However, AMF inoculation reversed the effects of Cu stress, with recovered flowering onset and ending dates and increased the flowering duration. Cu addition significantly decreased inflorescence width and number, inflorescence biomass, vegetative biomass and total seed number, but significantly increased 1000-seed weight. AMF inoculation significantly increased vegetative biomass. Two-way ANOVA results showed that the interactive effects between Cu addition and AMF inoculation were significant on the inflorescence number, vegetative biomass and total seed number. These results indicate that AMF can alleviate the Cu stress on the flowering phenology and reproduction of E. splendens.	[Jin, Zexin; Li, Junmin; Li, Yueling] Zhejiang Prov Key Lab Plant Evolutionary & Conser, Taizhou, Peoples R China; [Jin, Zexin; Li, Junmin; Li, Yueling] Taizhou Univ, Inst Ecol, Taizhou, Peoples R China	Taizhou University	Li, J,M (corresponding author), Zhejiang Prov Key Lab Plant Evolutionary & Conser, Taizhou, Peoples R China.	lijmtzc@126.com	李, 钧敏/L-7390-2019		Zhejiang Provincial National Natural Science Foundation of China [LY12C03002]; Zhejiang Provincial Nature Science Foundation [LY12C03002]	Zhejiang Provincial National Natural Science Foundation of China; Zhejiang Provincial Nature Science Foundation	Support was provided by the Zhejiang Provincial National Natural Science Foundation of China (No. LY12C03002) [http://www.zjnsf.gov.cn/]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to W.S. Ke and M. Guan for their help in sampling soil and seeds. We also thank the editors and reviewers for their valuable comments. This study was financially supported by Zhejiang Provincial Nature Science Foundation (LY12C03002).	Andrade SAL, 2009, CHEMOSPHERE, V75, P1363, DOI 10.1016/j.chemosphere.2009.02.008; Andre CM, 2010, CURR NUTR FOOD SCI, V6, P2, DOI 10.2174/157340110790909563; Arunakumara KKIU, 2013, J KOREAN SOC APPL BI, V56, P505, DOI 10.1007/s13765-013-3126-5; Barber NA, 2015, J PLANT ECOL, V8, P1, DOI 10.1093/jpe/rtu012; Bhakuni G, 2009, J PLANT NUTR, V32, P703, DOI 10.1080/01904160902743258; Brun LA, 2003, ENVIRON POLLUT, V122, P361, DOI 10.1016/S0269-7491(02)00312-3; Carvalho LM, 2006, PLANT SOIL, V285, P161, DOI 10.1007/s11104-006-9001-y; Cornejo P, 2008, SCI TOTAL ENVIRON, V406, P154, DOI 10.1016/j.scitotenv.2008.07.045; Ferrol N, 2009, PHYTOCHEM REV, V8, P551, DOI 10.1007/s11101-009-9133-9; Gan JH, 2013, ECOTOX ENVIRON SAFE, V89, P204, DOI 10.1016/j.ecoenv.2012.11.033; Gaur A, 2000, SCI HORTIC-AMSTERDAM, V84, P151, DOI 10.1016/S0304-4238(99)00105-3; Gonzalez-Chavez MC, 2004, ENVIRON POLLUT, V130, P317, DOI 10.1016/j.envpol.2004.01.004; GRAHAM JH, 1985, NEW PHYTOL, V101, P667, DOI 10.1111/j.1469-8137.1985.tb02872.x; Gutierrez HF, 2006, NEW ZEAL J BOT, V44, P47, DOI 10.1080/0028825X.2006.9513005; Hildebrandt U, 2007, PHYTOCHEMISTRY, V68, P139, DOI 10.1016/j.phytochem.2006.09.023; Huang WX, 2011, ECOTOX ENVIRON SAFE, V74, P1043, DOI 10.1016/j.ecoenv.2011.01.020; Jiang LY, 2008, J PLANT NUTR, V31, P1382, DOI 10.1080/01904160802206257; Kamali M, 2012, J ORNA HORTI PLANTS, V2, P95; KORMANIK PP, 1980, CAN J MICROBIOL, V26, P536, DOI 10.1139/m80-090; Kovacik J, 2010, PLANT SCI, V178, P307, DOI 10.1016/j.plantsci.2010.01.009; Liu TT, 2014, BIOL TRACE ELEM RES, V160, P418, DOI 10.1007/s12011-014-0043-3; Lou LQ, 2004, ENVIRON EXP BOT, V51, P111, DOI 10.1016/j.envexpbot.2003.08.002; Meier S, 2012, APPL SOIL ECOL, V61, P280, DOI 10.1016/j.apsoil.2011.10.018; Ollerton J, 1999, OECOLOGIA, V119, P340, DOI 10.1007/s004420050794; Ryser P, 2006, ENVIRON POLLUT, V140, P52, DOI 10.1016/j.envpol.2005.06.026; Sadras VO, 2007, FIELD CROP RES, V100, P125, DOI 10.1016/j.fcr.2006.07.004; Shamshiri MH, 2012, ISRN AGRON, DOI [10.5402/2012/535846, DOI 10.5402/2012/535846]; Sohn BK, 2003, SCI HORTIC-AMSTERDAM, V98, P173, DOI 10.1016/S0304-4238(02)00210-8; Song H., 2007, THESIS; Sun Y, 2008, SYMBIOSIS, V46, P121; Tang SR, 1999, PLANT SOIL, V209, P225, DOI 10.1023/A:1004599715411; Torimaru T, 2006, CAN J BOT, V84, P1860, DOI 10.1139/B06-129; Wang FY, 2006, APPL SOIL ECOL, V31, P110, DOI 10.1016/j.apsoil.2005.03.002; Yang RY, 2010, APPL SOIL ECOL, V44, P191, DOI 10.1016/j.apsoil.2009.12.005; Zafar S, 2007, BIORESOURCE TECHNOL, V98, P2557, DOI 10.1016/j.biortech.2006.09.051	35	16	16	6	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145793	10.1371/journal.pone.0145793	http://dx.doi.org/10.1371/journal.pone.0145793			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709921	Green Published, Green Submitted, gold			2022-12-26	WOS:000367451400080
J	McKimpson, WM; Yuan, ZQ; Zheng, M; Crabtree, JS; Libutti, SK; Kitsis, RN				McKimpson, Wendy M.; Yuan, Ziqiang; Zheng, Min; Crabtree, Judy S.; Libutti, Steven K.; Kitsis, Richard N.			The Cell Death Inhibitor ARC Is Induced in a Tissue-Specific Manner by Deletion of the Tumor Suppressor Gene Men1, but Not Required for Tumor Development and Growth	PLOS ONE			English	Article							MULTIPLE ENDOCRINE NEOPLASIA; CASPASE RECRUITMENT DOMAIN; APOPTOSIS REPRESSOR; ANTIAPOPTOTIC PROTEIN; EXPRESSION; TYPE-1; CANCER; DEGRADATION; RADIATION; CLONING	Multiple endocrine neoplasia type 1 (MEN1) is a genetic disorder characterized by tissue-specific tumors in the endocrine pancreas, parathyroid, and pituitary glands. Although tumor development in these tissues is dependent upon genetic inactivation of the tumor suppressor Men1, loss of both alleles of this gene is not sufficient to induce these cancers. Men1 encodes menin, a nuclear protein that influences transcription. A previous ChIP on chip analysis suggested that menin binds promoter sequences of nol3, encoding ARC, which is a cell death inhibitor that has been implicated in cancer pathogenesis. We hypothesized that ARC functions as a co-factor with Men1 loss to induce the tissue-restricted distribution of tumors seen in MEN1. Using mouse models that recapitulate this syndrome, we found that biallelic deletion of Men1 results in selective induction of ARC expression in tissues that develop tumors. Specifically, loss of Men1 in all cells of the pancreas resulted inmarked increases in ARC mRNA and protein in the endocrine, but not exocrine, pancreas. Similarly, ARC expression increased in the parathyroid with inactivation of Men1 in that tissue. To test if ARC contributes to MEN1 tumor development in the endocrine pancreas, we generated mice that lacked none, one, or both copies of ARC in the context of Men1 deletion. Studies in a cohort of 126 mice demonstrated that, although mice lacking Men1 developed insulinomas as expected, elimination of ARC in this context did not significantly alter tumor load. Cellular rates of proliferation and death in these tumors were also not perturbed in the absence of ARC. These results indicate that ARC is upregulated by loss Men1 in the tissue-restricted distribution of MEN1 tumors, but that ARC is not required for tumor development in this syndrome.	[McKimpson, Wendy M.; Zheng, Min; Kitsis, Richard N.] Albert Einstein Coll Med, Dept Med Cardiol, Bronx, NY 10461 USA; [McKimpson, Wendy M.; Kitsis, Richard N.] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; [Yuan, Ziqiang; Libutti, Steven K.] Albert Einstein Coll Med, Dept Surg, Bronx, NY 10461 USA; [Libutti, Steven K.] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [McKimpson, Wendy M.; Zheng, Min; Kitsis, Richard N.] Albert Einstein Coll Med, Wilf Family Cardiovasc Res Inst, Bronx, NY 10461 USA; [Libutti, Steven K.; Kitsis, Richard N.] Albert Einstein Coll Med, Albert Einstein Canc Ctr, Bronx, NY 10461 USA; [Kitsis, Richard N.] Albert Einstein Coll Med, Einstein Sinai Diabet Res Ctr, Bronx, NY 10461 USA; [Crabtree, Judy S.] Louisiana State Univ, Hlth Sci Ctr, Dept Genet, New Orleans, LA 70112 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Kitsis, RN (corresponding author), Albert Einstein Coll Med, Dept Med Cardiol, Bronx, NY 10461 USA.	richard.kitsis@einstein.yu.edu		McKimpson, Wendy/0000-0002-2262-5998	National Institute of Health [R01CA170911, R01HL060665, P30CA013330, P30DK020541, T32GM007491]; Louisiana State Board of Regents [LSQSF(2013-2015)-RD-A-04]; NIH [R01CA170911, R01HL060665, P30CA013330, P30DK020541, T32GM007491]; Dr. Gerald and Myra Dorris Chair in Cardiovascular Disease; NATIONAL CANCER INSTITUTE [P30CA013330, R01CA170911] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001073] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060665] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041296, P30DK020541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007491] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana State Board of Regents; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr. Gerald and Myra Dorris Chair in Cardiovascular Disease; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institute of Health: R01CA170911 to RNK and SKL, R01HL060665 to RNK, P30CA013330 (institutional core facilities), P30DK020541 (pilot project) to RNK, and T32GM007491 to WMM. This work was also supported by Louisiana State Board of Regents funding #LSQSF(2013-2015)-RD-A-04 to JSC. RNK is supported by the Dr. Gerald and Myra Dorros Chair in Cardiovascular Disease. The authors thank the generosity of the Wilf Family for their ongoing support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the technical assistance of Asha Adem and Carmen Sanchez Claros. This work was supported by NIH grants R01CA170911, R01HL060665, P30CA013330, P30DK020541, and T32GM007491; and Louisiana State Board of Regents funding #LSQSF (2013-2015)-RD-A-04. R.N.K. is supported by the Dr. Gerald and Myra Dorris Chair in Cardiovascular Disease. We thank the generosity of the Wilf Family for their support.	Bassett JHD, 1998, AM J HUM GENET, V62, P232, DOI 10.1086/301729; Bertolino P, 2003, MOL ENDOCRINOL, V17, P1880, DOI 10.1210/me.2003-0154; Bertolino P, 2003, CANCER RES, V63, P4836; Carter BZ, 2011, BLOOD, V117, P780, DOI 10.1182/blood-2010-04-280503; Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; Crabtree JS, 2003, MOL CELL BIOL, V23, P6075, DOI 10.1128/MCB.23.17.6075-6085.2003; Crabtree JS, 2001, P NATL ACAD SCI USA, V98, P1118, DOI 10.1073/pnas.98.3.1118; Foo RSY, 2007, P NATL ACAD SCI USA, V104, P20826, DOI 10.1073/pnas.0710017104; Foo RSY, 2007, J BIOL CHEM, V282, P5529, DOI 10.1074/jbc.M609046200; Friedman E. LC, 1994, THE PARATHYROIDS, P647; Gallo A, 2002, ONCOGENE, V21, P6434, DOI 10.1038/sj.onc.1205822; Geertman R, 1996, BBA-GENE STRUCT EXPR, V1306, P147, DOI 10.1016/0167-4781(96)00036-X; Guru SC, 1998, P NATL ACAD SCI USA, V95, P1630, DOI 10.1073/pnas.95.4.1630; Gustafsson AB, 2004, J BIOL CHEM, V279, P21233, DOI 10.1074/jbc.M400695200; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heikaus S, 2008, APOPTOSIS, V13, P938, DOI 10.1007/s10495-008-0225-6; Hunter AM, 2007, APOPTOSIS, V12, P1543, DOI 10.1007/s10495-007-0087-3; Karnik SK, 2005, P NATL ACAD SCI USA, V102, P14659, DOI 10.1073/pnas.0503484102; Koseki T, 1998, P NATL ACAD SCI USA, V95, P5156, DOI 10.1073/pnas.95.9.5156; LARSSON C, 1988, NATURE, V332, P85, DOI 10.1038/332085a0; Li J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6177; Li YZ, 2008, MOL CELL BIOL, V28, P564, DOI 10.1128/MCB.00738-07; Libutti SK, 2003, CANCER RES, V63, P8022; Lin WC, 2015, MOL CANCER RES, V13, P689, DOI 10.1158/1541-7786.MCR-14-0457; Mak PY, 2014, BRIT J HAEMATOL, V167, P376, DOI 10.1111/bjh.13054; Matkar S, 2013, TRENDS BIOCHEM SCI, V38, P394, DOI [10.1016/j.tibs.2013.0S.005, 10.1016/j.tibs.2013.05.005]; McKimpson WM, 2013, DIABETES, V62, P183, DOI 10.2337/db12-0504; Medina-Ramirez CM, 2011, CANCER RES, V71, P7705, DOI 10.1158/0008-5472.CAN-11-2192; Mercier I, 2005, CELL DEATH DIFFER, V12, P682, DOI 10.1038/sj.cdd.4401631; Mercier I, 2008, CELL CYCLE, V7, P1640, DOI 10.4161/cc.7.11.5979; Milne TA, 2005, P NATL ACAD SCI USA, V102, P749, DOI 10.1073/pnas.0408836102; Nam YJ, 2004, MOL CELL, V15, P901, DOI 10.1016/j.molcel.2004.08.020; Nam YJ, 2007, J BIOL CHEM, V282, P5522, DOI 10.1074/jbc.M609186200; Scacheri PC, 2004, MAMM GENOME, V15, P872, DOI 10.1007/s00335-004-2395-z; Scacheri PC, 2006, PLOS GENET, V2, P406, DOI 10.1371/journal.pgen.0020051; Shen HCJ, 2009, CANCER RES, V69, P1858, DOI 10.1158/0008-5472.CAN-08-3662; Stewart C, 1998, ONCOGENE, V17, P2485, DOI 10.1038/sj.onc.1202164; Subramaniam K, 2013, CANCER LETT, V332, P151, DOI 10.1016/j.canlet.2012.07.005; Wang M, 2005, FEBS LETT, V579, P2411, DOI 10.1016/j.febslet.2005.03.040; Wu L, 2010, J BIOL CHEM, V285, P19235, DOI 10.1074/jbc.M110.114892; Wu P, 2013, ONCOL REP, V30, P1807, DOI 10.3892/or.2013.2622; Yip KW, 2008, ONCOGENE, V27, P6398, DOI 10.1038/onc.2008.307; Zaiman AL, 2011, CIRCULATION, V124, P2533, DOI 10.1161/CIRCULATIONAHA.111.034512	44	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145792	10.1371/journal.pone.0145792	http://dx.doi.org/10.1371/journal.pone.0145792			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709830	gold, Green Published, Green Submitted			2022-12-26	WOS:000367451400079
J	Zheng, PX; Chan, YC; Chiou, CS; Chuan, CN; Wang, SY; Tsai, PJ; Chuang, WJ; Lin, YS; Liu, CC; Wu, JJ				Zheng, Po-Xing; Chan, Yuen-Chi; Chiou, Chien-Shun; Chuan Chiang-Ni; Wang, Shu-Ying; Tsai, Pei-Jane; Chuang, Woei-Jer; Lin, Yee-Shin; Liu, Ching-Chuan; Wu, Jiunn-Jong			Clustered Regularly Interspaced Short Palindromic Repeats Are emm Type-Specific in Highly Prevalent Group A Streptococci	PLOS ONE			English	Article							TYPING METHODS; DIVERSITY; STRAINS; EPIDEMIOLOGY; DISEASE; SYSTEMS; CRISPRS; TAIWAN; TIME; TOOL	Clustered regularly interspaced short palindromic repeats (CRISPR) are the bacterial adaptive immune system against foreign nucleic acids. Given the variable nature of CRISPR, it could be a good marker for molecular epidemiology. Group A streptococcus is one of the major human pathogens. It has two CRISPR loci, including CRISPR01 and CRISPR02. The aim of this study was to analyze the distribution of CRISPR-associated gene cassettes (cas) and CRISPR arrays in highly prevalent emm types. The cas cassette and CRISPR array in two CRISPR loci were analyzed in a total of 332 strains, including emm1, emm3, emm4, emm12, and emm28 strains. The CRISPR type was defined by the spacer content of each CRISPR array. All strains had at least one cas cassette or CRISPR array. More than 90% of the spacers were found in one emm type, specifically. Comparing the consistency between emm and CRISPR types by Simpson's index of diversity and the adjusted Wallace coefficient, CRISPR01 type was concordant to emm type, and CRISPR02 showed unidirectional congruence to emm type, suggesting that at least for the majority of isolates causing infection in high income countries, the emm type can be inferred from CRISPR analysis, which can further discriminate isolates sharing the same emm type.	[Zheng, Po-Xing; Wu, Jiunn-Jong] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan; [Chan, Yuen-Chi; Tsai, Pei-Jane; Wu, Jiunn-Jong] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan 70101, Taiwan; [Chiou, Chien-Shun] Ctr Dis Control, Ctr Res Diagnost & Vaccine Dev, Taichung, Taiwan; [Chuan Chiang-Ni] Chang Gung Univ, Dept Microbiol & Immunol, Coll Med, Taoyuan, Taiwan; [Wang, Shu-Ying; Lin, Yee-Shin] Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan 70101, Taiwan; [Chuang, Woei-Jer] Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol, Tainan 70101, Taiwan; [Liu, Ching-Chuan] Natl Cheng Kung Univ, Coll Med, Dept Pediat, Tainan 70101, Taiwan; [Wu, Jiunn-Jong] Natl Cheng Kung Univ, Ctr Infect Dis & Signaling Res, Tainan 70101, Taiwan; [Wu, Jiunn-Jong] Natl Yang Ming Univ, Sch Biomed Sci & Engn, Dept Biotechnol & Lab Sci Med, Taipei 112, Taiwan	National Cheng Kung University; National Cheng Kung University; Centers For Disease Control - Taiwan; Chang Gung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Yang Ming Chiao Tung University	Wu, JJ (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan.	jjwu@mail.ncku.edu.tw	wang, shuying/HHZ-4516-2022; Zheng, Po Xing/M-3244-2014; Chiang-Ni, Chuan/ABD-9765-2021; Chiou, Chien-Shun/I-5355-2014	Zheng, Po Xing/0000-0001-5827-5865; Chiang-Ni, Chuan/0000-0002-0753-035X; Chiou, Chien-Shun/0000-0003-3674-1030	National Science Council in Taiwan [NSC101-2320-B-006-020-MY3, NSC101-2320-B-006-029-MY3]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported in part by grants NSC101-2320-B-006-020-MY3 and NSC101-2320-B-006-029-MY3 from the National Science Council in Taiwan (http://www.most.gov.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beall B, 2000, MICROBIOL-SGM, V146, P1195, DOI 10.1099/00221287-146-5-1195; Bland C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-209; Chiou CS, 2004, J CLIN MICROBIOL, V42, P3998, DOI 10.1128/JCM.42.9.3998-4006.2004; Cole JN, 2011, NAT REV MICROBIOL, V9, P724, DOI 10.1038/nrmicro2648; Davies MR, 2015, NAT GENET, V47, P84, DOI 10.1038/ng.3147; Delannoy S, 2012, J CLIN MICROBIOL, V50, P4035, DOI 10.1128/JCM.02097-12; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Friaes A, 2013, EUR J CLIN MICROBIOL, V32, P115, DOI 10.1007/s10096-012-1726-3; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Grundmann H, 2001, J CLIN MICROBIOL, V39, P4190, DOI 10.1128/JCM.39.11.4190-4192.2001; Hoe N, 1999, EMERG INFECT DIS, V5, P254, DOI 10.3201/eid0502.990210; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Lin HC, 2008, EUR J CLIN MICROBIOL, V27, P1253, DOI 10.1007/s10096-008-0561-z; McMillan DJ, 2013, CLIN MICROBIOL INFEC, V19, pE222, DOI 10.1111/1469-0691.12134; Mick E, 2013, RNA BIOL, V10, P900, DOI 10.4161/rna.23929; Nasser W, 2014, P NATL ACAD SCI USA, V111, pE1768, DOI 10.1073/pnas.1403138111; Nozawa T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019543; Plainvert C, 2012, CLIN MICROBIOL INFEC, V18, P702, DOI 10.1111/j.1469-0691.2011.03624.x; Pride DT, 2011, GENOME RES, V21, P126, DOI 10.1101/gr.111732.110; Rezzonico F, 2011, APPL ENVIRON MICROB, V77, P3819, DOI 10.1128/AEM.00177-11; Rho M, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002441; Sesto N, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004065; Severiano A, 2011, J CLIN MICROBIOL, V49, P3997, DOI 10.1128/JCM.00624-11; Severiano A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019539; Shariat N, 2014, APPL ENVIRON MICROB, V80, P430, DOI 10.1128/AEM.02790-13; Steer AC, 2009, LANCET INFECT DIS, V9, P611, DOI 10.1016/S1473-3099(09)70178-1; Stern A, 2012, GENOME RES, V22, P1985, DOI 10.1101/gr.138297.112; Vale PF, 2010, P ROY SOC B-BIOL SCI, V277, P2097, DOI 10.1098/rspb.2010.0055; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Zheng PX, 2014, CLIN MICROBIOL INFEC, V20, P516, DOI 10.1111/1469-0691.12379; Zheng PX, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00149-12	33	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145223	10.1371/journal.pone.0145223	http://dx.doi.org/10.1371/journal.pone.0145223			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710228	Green Published, gold, Green Submitted			2022-12-26	WOS:000367451400027
J	Islam, A; Teo, SH; Rahman, MA; Taufiq-Yap, YH				Islam, Aminul; Teo, Siow Hwa; Rahman, M. Aminur; Taufiq-Yap, Yun Hin			Seeded Growth Route to Noble Calcium Carbonate Nanocrystal	PLOS ONE			English	Article							CRYSTAL-GROWTH; FABRICATION; NETWORKS; NANOPARTICLES; SURFACTANT; MODEL; SHAPE; SIZE	A solution-phase route has been considered as the most promising route to synthesize noble nanostructures. A majority of their synthesis approaches of calcium carbonate (CaCO3) are based on either using fungi or the CO2 bubbling methods. Here, we approached the preparation of nano-precipitated calcium carbonate single crystal from salmacis sphaeroides in the presence of zwitterionic or cationic biosurfactants without external source of CO2. The calcium carbonate crystals were rhombohedron structure and regularly shaped with side dimension ranging from 33-41 nm. The high degree of morphological control of CaCO3 nanocrystals suggested that surfactants are capable of strongly interacting with the CaCO3 surface and control the nucleation and growth direction of calcium carbonate nanocrystals. Finally, the mechanism of formation of nanocrystals in light of proposed routes was also discussed.	[Islam, Aminul; Teo, Siow Hwa; Taufiq-Yap, Yun Hin] Univ Putra Malaysia, Catalysis & Sci Res Ctr, Fac Sci, Upm Serdang 43400, Selangor, Malaysia; [Islam, Aminul; Teo, Siow Hwa; Taufiq-Yap, Yun Hin] Univ Putra Malaysia, Dept Chem, Fac Sci, Upm Serdang 43400, Selangor, Malaysia; [Rahman, M. Aminur] Univ Putra Malaysia, Lab Marine Biotechnol, Inst Biosci, Upm Serdang 43400, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia	Islam, A (corresponding author), Univ Putra Malaysia, Catalysis & Sci Res Ctr, Fac Sci, Upm Serdang 43400, Selangor, Malaysia.	aminul@upm.edu.my; taufiq@upm.edu.my	Teo, Siow Hwa/B-2099-2016; Islam, Aminul/J-1628-2016; Islam, Aminul/W-6383-2019; Yap, Yun Hin Taufiq/AAB-8959-2019	Teo, Siow Hwa/0000-0001-9927-8309; Yap, Yun Hin Taufiq/0000-0002-3994-6720; Islam, Aminul/0000-0001-9933-143X	Catalysis Science and Technology Research Centre, Faculty of Science, University Putra Malaysia, Malaysia	Catalysis Science and Technology Research Centre, Faculty of Science, University Putra Malaysia, Malaysia	The authors gratefully acknowledge the financial support from Catalysis Science and Technology Research Centre, Faculty of Science, University Putra Malaysia, Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The authors gratefully acknowledge the financial support from Catalysis Science and Technology Research Centre, Faculty of Science, University Putra Malaysia, Malaysia.	Asenath-Smith E, 2012, ADV FUNCT MATER, V22, P2891, DOI 10.1002/adfm.201200300; CASES JM, 1992, LANGMUIR, V8, P1251, DOI 10.1021/la00041a005; Cushing BL, 2004, CHEM REV, V104, P3893, DOI 10.1021/cr030027b; El-Sheikh SM, 2013, COLLOID SURFACE A, V422, P44, DOI 10.1016/j.colsurfa.2013.01.020; Falini G, 1996, SCIENCE, V271, P67, DOI 10.1126/science.271.5245.67; Gao F, 2012, CHEM SOC REV, V41, P8009, DOI 10.1039/c2cs35160a; Han SJ, 2011, ENERG FUEL, V25, P3825, DOI 10.1021/ef200415p; Helgason T, 2009, J COLLOID INTERF SCI, V334, P75, DOI 10.1016/j.jcis.2009.03.012; Islam A, 2014, RSC ADV, V4, P65127, DOI 10.1039/c4ra11653d; Kim YY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5341; Kinge S, 2006, APPL ORGANOMET CHEM, V20, P784, DOI 10.1002/aoc.1126; Li D, 2006, J AM CHEM SOC, V128, P968, DOI 10.1021/ja056609n; Li DS, 2012, SCIENCE, V336, P1014, DOI 10.1126/science.1219643; Min W, 2000, MATER RES BULL, V35, P2199, DOI 10.1016/S0025-5408(00)00429-3; Mishra YK, 2013, PART PART SYST CHAR, V30, P775, DOI 10.1002/ppsc.201300197; Mishra YK, 2015, ACS APPL MATER INTER, V7, P14303, DOI 10.1021/acsami.5b02816; Mishra YK, 2014, KONA POWDER PART J, P92; NARSIMHAN G, 1961, CHEM ENG SCI, V16, P7, DOI 10.1016/0009-2509(61)87002-4; Pastoriza-Santos I, 2006, CHEM MATER, V18, P2465, DOI 10.1021/cm060293g; Penn RL, 1998, SCIENCE, V281, P969, DOI 10.1126/science.281.5379.969; Perrault SD, 2009, NANO LETT, V9, P1909, DOI 10.1021/nl900031y; Rautaray D, 2004, J MATER CHEM, V14, P2333, DOI 10.1039/b401431f; Ribeiro C, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2779932; ROMERO B, 1994, INORG CHEM, V33, P1869, DOI 10.1021/ic00087a023; Song RQ, 2009, ACS NANO, V3, P1966, DOI 10.1021/nn900377d; Vagenas NV, 2003, TALANTA, V59, P831, DOI 10.1016/S0039-9140(02)00638-0; Xu XJ, 2011, SMALL, V7, P445, DOI 10.1002/smll.201001849; Zeng HB, 2009, ADV FUNCT MATER, V19, P3165, DOI 10.1002/adfm.200900714	28	8	8	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0144805	10.1371/journal.pone.0144805	http://dx.doi.org/10.1371/journal.pone.0144805			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700479	Green Submitted, gold, Green Published			2022-12-26	WOS:000367092600033
J	Ntokou, E; Hansen, LH; Kongsted, J; Vester, B				Ntokou, Eleni; Hansen, Lykke Haastrup; Kongsted, Jacob; Vester, Birte			Biochemical and Computational Analysis of the Substrate Specificities of Cfr and RlmN Methyltransferases	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; CONFERS ANTIBIOTIC-RESISTANCE; RADICAL SAM ENZYMES; 23S RIBOSOMAL-RNA; LINEZOLID RESISTANCE; MEDIATED RESISTANCE; METHYL TRANSFER; IDENTIFICATION; MECHANISM; PLASMID	Cfr and RlmN methyltransferases both modify adenine 2503 in 23S rRNA (Escherichia coli numbering). RlmN methylates position C2 of adenine while Cfr methylates position C8, and to a lesser extent C2, conferring antibiotic resistance to peptidyl transferase inhibitors. Cfr and RlmN show high sequence homology and may be evolutionarily linked to a common ancestor. To explore their individual specificity and similarity we performed two sets of experiments. We created a homology model of Cfr and explored the C2/C8 specificity using docking and binding energy calculations on the Cfr homology model and an X-ray structure of RlmN. We used a trinucleotide as target sequence and assessed its positioning at the active site for methylation. The calculations are in accordance with different poses of the trinucleotide in the two enzymes indicating major evolutionary changes to shift the C2/C8 specificities. To explore interchangeability between Cfr and RlmN we constructed various combinations of their genes. The function of the mixed genes was investigated by RNA primer extension analysis to reveal methylation at 23S rRNA position A2503 and by MIC analysis to reveal antibiotic resistance. The catalytic site is expected to be responsible for the C2/C8 specificity and most of the combinations involve interchanging segments at this site. Almost all replacements showed no function in the primer extension assay, apart from a few that had a weak effect. Thus Cfr and RlmN appear to be much less similar than expected from their sequence similarity and common target.	[Ntokou, Eleni; Hansen, Lykke Haastrup; Vester, Birte] Univ Southern Denmark, Dept Biochem & Mol Biol, Odense, Denmark; [Kongsted, Jacob] Univ Southern Denmark, Dept Phys Chem & Pharm, Odense, Denmark	University of Southern Denmark; University of Southern Denmark	Ntokou, E (corresponding author), Univ Southern Denmark, Dept Biochem & Mol Biol, Odense, Denmark.	elenin@bmb.sdu.dk	Kongsted, Jacob/AAD-3458-2022	Kongsted, Jacob/0000-0002-7725-2164; Vester, Birte/0000-0002-5368-0500; Ntokou, Eleni/0000-0003-1869-1121	Danish Council for Independent Research - Natural Sciences [12-125943]	Danish Council for Independent Research - Natural Sciences(Det Frie Forskningsrad (DFF))	This work was supported by the Danish Council for Independent Research - Natural Sciences, Grant 12-125943 (http://ufm.dk/forskning-og-innovation/rad-og-udvalg/det-frie-forskningsrad). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson GC, 2013, ANTIMICROB AGENTS CH, V57, P4019, DOI 10.1128/AAC.00448-13; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Baos E, 2013, DIAGN MICR INFEC DIS, V76, P325, DOI 10.1016/j.diagmicrobio.2013.04.002; Bender J, 2015, J ANTIMICROB CHEMOTH, V70, P1630, DOI 10.1093/jac/dkv025; Benitez-Paez A, 2012, RNA, V18, P1783, DOI 10.1261/rna.033266.112; Boal AK, 2011, SCIENCE, V332, P1089, DOI 10.1126/science.1205358; Cai JC, 2015, ANTIMICROB AGENTS CH, V59, P3669, DOI 10.1128/AAC.04580-14; Cui LQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057096; Deshpande LM, 2015, ANTIMICROB AGENTS CH, V59, P6256, DOI 10.1128/AAC.01473-15; Diaz L, 2012, ANTIMICROB AGENTS CH, V56, P3917, DOI 10.1128/AAC.00419-12; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Giessing AMB, 2009, RNA, V15, P327, DOI 10.1261/rna.1371409; Grove TL, 2013, NAT CHEM BIOL, V9, P422, DOI [10.1038/NCHEMBIO.1251, 10.1038/nchembio.1251]; Grove TL, 2011, J AM CHEM SOC, V133, P19586, DOI 10.1021/ja207327v; Grove TL, 2011, SCIENCE, V332, P604, DOI 10.1126/science.1200877; Hansen LH, 2015, ANTIMICROB AGENTS CH, V59, P5841, DOI 10.1128/AAC.01274-15; Hansen LH, 2012, ANTIMICROB AGENTS CH, V56, P3563, DOI 10.1128/AAC.00673-12; Kaminska KH, 2010, NUCLEIC ACIDS RES, V38, P1652, DOI 10.1093/nar/gkp1142; Kehrenberg C, 2005, MOL MICROBIOL, V57, P1064, DOI 10.1111/j.1365-2958.2005.04754.x; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; KOWALAK JA, 1995, J BIOL CHEM, V270, P17758, DOI 10.1074/jbc.270.30.17758; Layer G, 2004, CURR OPIN CHEM BIOL, V8, P468, DOI 10.1016/j.cbpa.2004.08.001; Livermore DM, 2003, J ANTIMICROB CHEMOTH, V51, P9, DOI 10.1093/jac/dkg249; Long KS, 2006, ANTIMICROB AGENTS CH, V50, P2500, DOI 10.1128/AAC.00131-06; Mendes RE, 2008, ANTIMICROB AGENTS CH, V52, P2244, DOI 10.1128/AAC.00231-08; Motorin Y, 2007, METHOD ENZYMOL, V425, P21; Patel SN, 2013, DIAGN MICR INFEC DIS, V77, P350, DOI 10.1016/j.diagmicrobio.2013.08.012; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schwarz S, 2000, ANTIMICROB AGENTS CH, V44, P2530, DOI 10.1128/AAC.44.9.2530-2533.2000; SEKIGUCHI M, 1967, P NATL ACAD SCI USA, V58, P2315, DOI 10.1073/pnas.58.6.2315; Smith LK, 2008, ANTIMICROB AGENTS CH, V52, P1703, DOI 10.1128/AAC.01583-07; Srinivasan J, 1998, J AM CHEM SOC, V120, P9401, DOI 10.1021/ja981844+; STERN S, 1988, METHOD ENZYMOL, V164, P481; SUTCLIFFE JG, 1979, COLD SPRING HARB SYM, V43, P77, DOI 10.1101/SQB.1979.043.01.013; Toh SM, 2007, MOL MICROBIOL, V64, P1506, DOI 10.1111/j.1365-2958.2007.05744.x; Toh SM, 2008, RNA, V14, P98, DOI 10.1261/rna.814408; Vazquez-Laslop N, 2010, EMBO J, V29, P3108, DOI 10.1038/emboj.2010.180; Yan F, 2011, P NATL ACAD SCI USA, V108, P3930, DOI 10.1073/pnas.1017781108	38	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145655	10.1371/journal.pone.0145655	http://dx.doi.org/10.1371/journal.pone.0145655			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700482	gold, Green Published, Green Submitted			2022-12-26	WOS:000367092600113
J	Uchida, S; Chang, WX; Ota, T; Tamura, Y; Shiraishi, T; Kumagai, T; Shibata, S; Fujigaki, Y; Hosoyamada, M; Kaneko, K; Shen, ZY; Fujimori, S				Uchida, Shunya; Chang, Wen Xiu; Ota, Tatsuru; Tamura, Yoshifuru; Shiraishi, Takeshi; Kumagai, Takanori; Shibata, Shigeru; Fujigaki, Yoshihide; Hosoyamada, Makoto; Kaneko, Kiyoko; Shen, Zhong Yang; Fujimori, Shin			Targeting Uric Acid and the Inhibition of Progression to End-Stage Renal Disease-A Propensity Score Analysis	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CARDIOVASCULAR EVENTS; TREAT; CKD; TIME; ALLOPURINOL; OUTCOMES; HYPERURICEMIA; METAANALYSIS; REDUCTION	Background The role of uric acid (UA) in the progression of chronic kidney disease (CKD) remains controversial due to the unavoidable cause and result relationship. This study was aimed to clarify the independent impact of UA on the subsequent risk of end-stage renal disease (ESRD) by a propensity score analysis. Methods A retrospective CKD cohort was used (n = 803). Baseline 23 covariates were subjected to a multivariate binary logistic regression with the targeted time-averaged UA of 6.0, 6.5 or 7.0 mg/dL. The participants trimmed 2.5 percentile from the extreme ends of the cohort underwent propensity score analyses consisting of matching, stratification on quintile and covariate adjustment. Covariate balances after 1: 1 matching without replacement were tested for by paired analysis and standardized differences. A stratified Cox regression and a Cox regression adjusted for logit of propensity scores were examined. Results After propensity score matching, the higher UA showed elevated hazard ratios (HRs) by Kaplan-Meier analysis (>= 6.0 mg/dL, HR 4.53, 95% CI 1.79-11.43; >= 6.5 mg/dL, HR 3.39, 95% CI 1.55-7.42; >= 7.0 mg/dL, HR 2.19, 95% CI 1.28-3.75). The number needed to treat was 8 to 9 over 5 years. A stratified Cox regression likewise showed significant crude HRs (>= 6.0 mg/dL, HR 3.63, 95% CI 1.25-10.58; >= 6.5 mg/dL, HR 3.46, 95% CI 1.56-7.68; >= 7.0 mg/dL, HR 2.05, 95% CI 1.21-3.48). Adjusted HR lost its significance at 6.0 mg/dL. The adjustment for the logit of the propensity scores showed the similar results but with worse model fittings than the stratification method. Upon further adjustment for other covariates the significance was attained at 6.5 mg/dL. Conclusions Three different methods of the propensity score analysis showed consistent results that the higher UA accelerates the progression to the subsequent ESRD. A stratified Cox regression outperforms other methods in generalizability and adjusting for residual bias. Serum UA should be targeted less than 6.5 mg/dL.	[Uchida, Shunya; Ota, Tatsuru; Tamura, Yoshifuru; Shiraishi, Takeshi; Kumagai, Takanori; Shibata, Shigeru; Fujigaki, Yoshihide; Fujimori, Shin] Teikyo Univ, Sch Med, Dept Internal Med, Tokyo 173, Japan; [Chang, Wen Xiu] Tianjin First Cent Hosp, Dept Nephrol, Tianjin, Peoples R China; [Shiraishi, Takeshi; Kumagai, Takanori] Teikyo Univ, Sch Med, Tokyo 173, Japan; [Hosoyamada, Makoto] Teikyo Univ, Fac Pharma Sci, Human Physiol & Pathol, Tokyo 173, Japan; [Kaneko, Kiyoko] Teikyo Univ, Fac Pharma Sci, Biomed & Analyt Sci, Tokyo 173, Japan; [Shen, Zhong Yang] Tianjin First Cent Hosp, Dept Organ Transplantat, Tianjin, Peoples R China	Teikyo University; Tianjin Medical University; Teikyo University; Teikyo University; Teikyo University; Tianjin Medical University	Uchida, S (corresponding author), Teikyo Univ, Sch Med, Dept Internal Med, Tokyo 173, Japan.	s_uchida@netjoy.ne.jp		, wen xiu/0000-0001-6269-5694; Shibata, Shigeru/0000-0002-6868-0626	Ministry of Health, Labour and Welfare of Japan; Gout Research Foundation	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Gout Research Foundation	This study was supported in part by a Grant-in-Aid for Progressive Renal Diseases Research, Research on Rare and Intractable Disease, from the Ministry of Health, Labour and Welfare of Japan (to SU) and Gout Research Foundation (to SU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 1999, BRIT MED J, V319, P1492, DOI 10.1136/bmj.319.7223.1492; Altman DG, 1998, BRIT MED J, V317, P1309, DOI 10.1136/bmj.317.7168.1309; Austin PC, 2008, STAT MED, V27, P2037, DOI 10.1002/sim.3150; Austin PC, 2014, STAT MED, V33, P1242, DOI 10.1002/sim.5984; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Bellomo G, 2015, AM J KIDNEY DIS, V65, P525, DOI 10.1053/j.ajkd.2015.01.001; Borghi C, 2015, J HYPERTENS, V33, P1729, DOI 10.1097/HJH.0000000000000701; Bose B, 2014, NEPHROL DIAL TRANSPL, V29, P406, DOI 10.1093/ndt/gft378; Chang WX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132927; Chang WX, 2016, CLIN EXP NEPHROL, V20, P58, DOI 10.1007/s10157-015-1132-0; COOK RJ, 1995, BRIT MED J, V310, P452, DOI 10.1136/bmj.310.6977.452; Cookson J, 2006, INT CLIN PSYCHOPHARM, V21, P267, DOI 10.1097/00004850-200609000-00004; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; De Cosmo S, 2015, CLIN J AM SOC NEPHRO, V10, P1921, DOI 10.2215/CJN.03140315; Dousdampanis P, 2014, RENAL FAILURE, V36, P1351, DOI 10.3109/0886022X.2014.947516; Giordano C, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/382918; Goicoechea M, 2015, AM J KIDNEY DIS, V65, P543, DOI 10.1053/j.ajkd.2014.11.016; Goicoechea M, 2010, CLIN J AM SOC NEPHRO, V5, P1388, DOI 10.2215/CJN.01580210; Hosoya T, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-26; Inker LA, 2014, AM J KIDNEY DIS, V63, P713, DOI 10.1053/j.ajkd.2014.01.416; Jalal DI, 2013, AM J KIDNEY DIS, V61, P134, DOI 10.1053/j.ajkd.2012.07.021; Johnson RJ, 2013, NEPHROL DIAL TRANSPL, V28, P2221, DOI 10.1093/ndt/gft029; Kanbay M, 2010, BLOOD PURIFICAT, V30, P288, DOI 10.1159/000321074; Kuriyama S, 2015, CLIN EXP NEPHROL, V19, P1127, DOI 10.1007/s10157-015-1120-4; Little RJ, 2000, ANNU REV PUBL HEALTH, V21, P121, DOI 10.1146/annurev.publhealth.21.1.121; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Nacak H, 2015, NEPHROL DIAL TRANSPL, V30, P2039, DOI 10.1093/ndt/gfv225; Nacak H, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-91; Nakhoul GN, 2015, CLIN J AM SOC NEPHRO, V10, P1119, DOI 10.2215/CJN.11121114; Normand SLT, 2001, J CLIN EPIDEMIOL, V54, P387, DOI 10.1016/S0895-4356(00)00321-8; Petersen ML, 2012, STAT METHODS MED RES, V21, P31, DOI 10.1177/0962280210386207; Rosenbaum P, 1983, BIOGEOSCIENCES, V40, P41; Rubin DB, 2004, PHARMACOEPIDEM DR S, V13, P855, DOI 10.1002/pds.968; Santos RD, 2009, CARDIOLOGY, V114, P298, DOI 10.1159/000239859; Sinclair JC, 2001, J CLIN EPIDEMIOL, V54, P253, DOI 10.1016/S0895-4356(01)00347-X; Tangri N, 2011, JAMA-J AM MED ASSOC, V305, P1553, DOI 10.1001/jama.2011.451; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Uno H, 2011, STAT MED, V30, P1105, DOI 10.1002/sim.4154; Vansteelandt S, 2014, STAT MED, V33, P4053, DOI 10.1002/sim.6207; Yamamoto R, 2010, AM J KIDNEY DIS, V56, P313, DOI 10.1053/j.ajkd.2010.02.351; Zhu P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100801	42	38	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145506	10.1371/journal.pone.0145506	http://dx.doi.org/10.1371/journal.pone.0145506			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700005	Green Submitted, Green Published, gold			2022-12-26	WOS:000367092600090
J	Yu, WJ; Zhu, H; Wang, YM; Li, GJ; Wang, LH; Li, HF				Yu, Wenjuan; Zhu, Hao; Wang, Yueming; Li, Guanjun; Wang, Lihua; Li, Huafang			Reactive Transformation and Increased BDNF Signaling by Hippocampal Astrocytes in Response to MK-801	PLOS ONE			English	Article							NEUROTROPHIC FACTOR BDNF; RAT FRONTAL-CORTEX; PROTEIN-SYNTHESIS; SCHIZOPHRENIA; BRAIN; RECEPTOR; EXPRESSION; ROLES; ACTIVATION; MECHANISMS	MK-801, also known as dizocilpine, is a noncompetitive N-methyl-D-aspartic acid (NMDA) receptor antagonist that induces schizophrenia-like symptoms. While astrocytes have been implicated in the pathophysiology of psychiatric disorders, including schizophrenia, astrocytic responses to MK-801 and their significance to schizotypic symptoms are unclear. Changes in the expression levels of glial fibrillary acid protein (GFAP), a marker of astrocyte activation in response to a variety of pathogenic stimuli, were examined in the hippocampus of rats treated with the repeated MK-801 injection (0.5 mg/10ml/kg body weight for 6 days) and in primary cultured hippocampal astrocytes incubated with MK-801 (5 or 20 mu M for 24 h). Moreover, the expression levels of BDNF and its receptors TrkB and p75 were examined in MK-801-treated astrocyte cultures. MK-801 treatment enhanced GFAP expression in the rat hippocampus and also increased the levels of GFAP protein and mRNA in hippocampal astrocytes in vitro. Treatment of cultured hippocampal astrocytes with MK-801 enhanced protein and mRNA levels of BDNF, TrkB, and p75. Collectively, our results suggest that hippocampal astrocytes may contribute to the pathophysiology of schizophrenia symptoms associated with NMDA receptor hypofunction by reactive transformation and altered BDNF signaling.	[Yu, Wenjuan; Li, Guanjun; Wang, Lihua; Li, Huafang] Shanghai Jiao Tong Univ, Shanghai Mental Hlth Ctr, Sch Med, Shanghai 200030, Peoples R China; [Zhu, Hao] Shanghai Jiao Tong Univ, Dept Anesthesiol, Sch Med, Renji Hosp, Shanghai 200030, Peoples R China; [Wang, Yueming] Shanghai Jiao Tong Univ, Dept Anat, Sch Med, Shanghai 200030, Peoples R China; [Li, Huafang] Shanghai Key Lab Psychot Disorders, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Li, HF (corresponding author), Shanghai Jiao Tong Univ, Shanghai Mental Hlth Ctr, Sch Med, Shanghai 200030, Peoples R China.	smhcmict@163.com			national key project [2012ZX09303-003]; national natural science foundation of China [81201505, 31100782]; Shanghai natural science foundation [12ZR1446000]; Shanghai municipal incubation grant for talented researcher of health care [XBR2011049]; Shanghai health bureau scientific research foundation [20134Y066]; Shanghai mental health center research foundation [2013-YJ-06]	national key project; national natural science foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai natural science foundation(Natural Science Foundation of Shanghai); Shanghai municipal incubation grant for talented researcher of health care; Shanghai health bureau scientific research foundation; Shanghai mental health center research foundation	This study was supported by the national key project (2012ZX09303-003), national natural science foundation of China (81201505, 31100782), Shanghai natural science foundation (12ZR1446000), Shanghai municipal incubation grant for talented researcher of health care (XBR2011049), Shanghai health bureau scientific research foundation (20134Y066), and Shanghai mental health center research foundation (2013-YJ-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YM, 2005, INT J NEUROPSYCHOPH, V8, P607, DOI 10.1017/S1461145705005353; Andrews JL, 2015, PROG NEURO-PSYCHOPH, V63, P91, DOI 10.1016/j.pnpbp.2015.06.003; Aroeira RI, 2015, GLIA, V63, P2181, DOI 10.1002/glia.22884; Autry AE, 2012, PHARMACOL REV, V64, P238, DOI 10.1124/pr.111.005108; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; Capuano B, 2002, CURR MED CHEM, V9, P521, DOI 10.2174/0929867024606939; Cardile V, 2003, BRAIN RES, V976, P227, DOI 10.1016/S0006-8993(03)02720-3; Clarke LE, 2013, NAT REV NEUROSCI, V14, P311, DOI 10.1038/nrn3484; Cohen-Cory S, 2010, DEV NEUROBIOL, V70, P271, DOI 10.1002/dneu.20774; Cragnolini AB, 2008, TRENDS NEUROSCI, V31, P99, DOI 10.1016/j.tins.2007.11.005; Balderas PMD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126314; Eyjolfsson EM, 2006, NEUROCHEM INT, V48, P541, DOI 10.1016/j.neuint.2005.11.019; FIX AS, 1995, NEUROTOXICOLOGY, V16, P229; Fulmer CG, 2014, J NEUROSCI, V34, P8186, DOI 10.1523/JNEUROSCI.4267-13.2014; Fumagalli F, 2003, J NEUROSCI RES, V72, P622, DOI 10.1002/jnr.10609; Gomes FV, 2015, SCHIZOPHR RES, V164, P155, DOI 10.1016/j.schres.2015.01.015; Guest PC, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00180; Gui T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082449; Guo CM, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/783297; Hansen HH, 2004, NEUROBIOL DIS, V16, P440, DOI 10.1016/j.nbd.2004.03.013; Heja L, 2014, CURR MED CHEM, V21, P755, DOI 10.2174/0929867320666131119160445; Kato H, 2006, SYNAPSE, V59, P10, DOI 10.1002/syn.20213; Kondziella D, 2006, NEUROPSYCHOPHARMACOL, V31, P1880, DOI 10.1038/sj.npp.1300993; Kornhuber J, 1997, BIOL PSYCHIAT, V41, P135, DOI 10.1016/S0006-3223(96)00047-9; Koyama Y, 2003, EUR J NEUROSCI, V18, P887, DOI 10.1046/j.1460-9568.2003.02797.x; Kuczewski N, 2010, EUR J NEUROSCI, V32, P1239, DOI 10.1111/j.1460-9568.2010.07378.x; Lu Bai, 2008, Novartis Found Symp, V289, P119; Lu Y, 2008, NEUROBIOL LEARN MEM, V89, P312, DOI 10.1016/j.nlm.2007.08.018; Martins-de-Souza D, 2011, EUR ARCH PSY CLIN N, V261, P217, DOI 10.1007/s00406-010-0166-2; OLNEY JW, 1995, NEUROPSYCHOPHARMACOL, V13, P335, DOI 10.1038/sj.npp.1380292; Parpura V, 2010, BRAIN RES REV, V63, P83, DOI 10.1016/j.brainresrev.2009.11.008; Quesseveur G, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.30; Seo MS, 2007, INT J NEUROPSYCHOPH, V10, P359, DOI 10.1017/S1461145706006869; Takahashi N, 2013, NEUROBIOL DIS, V53, P49, DOI 10.1016/j.nbd.2012.11.001; Theberge J, 2002, AM J PSYCHIAT, V159, P1944, DOI 10.1176/appi.ajp.159.11.1944; van Elst LT, 2005, BIOL PSYCHIAT, V58, P724, DOI 10.1016/j.biopsych.2005.04.041; Vaz SH, 2011, J BIOL CHEM, V286, P40464, DOI 10.1074/jbc.M111.232009; WONG EHF, 1986, P NATL ACAD SCI USA, V83, P7104, DOI 10.1073/pnas.83.18.7104; Xia Y, 2010, NEUROPHARMACOLOGY, V58, P330, DOI 10.1016/j.neuropharm.2009.10.009; [于文娟 Yu Wenjuan], 2011, [中国神经精神疾病杂志, Chinese Journal of Nervous and Mental Diseases], V37, P621; Zaccaro MC, 2001, J BIOL CHEM, V276, P31023, DOI 10.1074/jbc.M104630200; Zhang XY, 2012, HUM GENET, V131, P1187, DOI 10.1007/s00439-012-1150-x; Zhou XF, 2007, J NEUROSCI RES, V85, P1601, DOI 10.1002/jnr.21220; Zhu H, 2012, BRAIN RES, V1439, P1, DOI 10.1016/j.brainres.2011.12.035; Zhu SH, 2014, NEUROCHEM RES, V39, P2385, DOI 10.1007/s11064-014-1441-9	45	16	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145651	10.1371/journal.pone.0145651	http://dx.doi.org/10.1371/journal.pone.0145651			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700309	gold, Green Published, Green Submitted			2022-12-26	WOS:000367092600112
J	Astone, M; Pizzi, M; Peron, M; Domenichini, A; Guzzardo, V; Tochterle, S; Tiso, N; Rugge, M; Meyer, D; Argenton, F; Vettori, A				Astone, Matteo; Pizzi, Marco; Peron, Margherita; Domenichini, Alice; Guzzardo, Vincenza; Toechterle, Sonja; Tiso, Natascia; Rugge, Massimo; Meyer, Dirk; Argenton, Francesco; Vettori, Andrea			A GFP-Tagged Gross Deletion on Chromosome 1 Causes Malignant Peripheral Nerve Sheath Tumors and Carcinomas in Zebrafish	PLOS ONE			English	Article							MUTATIONS; CANCER; GENE	Malignant peripheral nerve sheath tumors (MPNSTs) are highly aggressive soft-tissue sarcomas, characterized by complex karyotypes. The molecular bases of such malignancy are poorly understood and efficient targeted molecular therapies are currently lacking. Here we describe a novel zebrafish model of MPNSTs, represented by the transgenic mutant line Tg (-8.5nkx2.2a:GFP)(ia2). ia2 homozygous animals displayed embryonic lethality by 72 hpf, while the heterozygotes develop visible tumor masses with high frequency in adulthood. Histological and immunohistochemical examination revealed aggressive tumors with either mesenchymal or epithelial features. The former (54% of the cases) arose either in the abdominal cavity, or as intrathecal/intraspinal lesions and is composed of cytokeratin-negative spindle cells with fascicular/storiform growth pattern consistent with zebrafish MPNSTs. The second histotype was composed by polygonal or elongated cells, immunohistochemically positive for the pan-cytokeratin AE1/AE3. The overall histologic and immunohistochemical features were consistent with a malignant epithelial neoplasm of possible gastrointestinal/pancreatic origin. With an integrated approach, based on microsatellite (VNTR) and STS markers, we showed that ia2 insertion, in Tg(-8.5nkx2.2a:GFP)(ia2) embryos, is associated with a deletion of 15.2 Mb in the telomeric portion of chromosome 1. Interestingly, among ia2 deleted genes we identified the presence of the 40S ribosomal protein S6 gene that may be one of the possible drivers for the MPNSTs in ia2 mutants. Thanks to the peculiar features of zebrafish as animal model of human cancer (cellular and genomic similarity, transparency and prolificacy) and the GFP tag, the Tg(-8.5nkx2.2a:GFP)(ia2) line provides a manageable tool to study in vivo with high frequency MPNST biology and genetics, and to identify, in concert with the existing zebrafish MPNST models, conserved relevant mechanisms in zebrafish and human cancer development.	[Astone, Matteo; Peron, Margherita; Domenichini, Alice; Tiso, Natascia; Argenton, Francesco; Vettori, Andrea] Univ Padua, Dept Biol, Padua, Italy; [Pizzi, Marco; Guzzardo, Vincenza; Rugge, Massimo] Univ Padua, Dept Med DIMED, Gen Pathol & Cytopathol Unit, Padua, Italy; [Toechterle, Sonja; Meyer, Dirk] Univ Innsbruck, Inst Mol Biol, CMBI, A-6020 Innsbruck, Austria	University of Padua; University of Padua; University of Innsbruck	Argenton, F (corresponding author), Univ Padua, Dept Biol, Padua, Italy.	francesco.argenton@unipd.it	Tiso, Natascia/E-2182-2011; Argenton, Francesco/AAS-8494-2021; Rugge, Massimo/K-7525-2016; Vettori, Andrea/J-3951-2014; Pizzi, Marco/H-6273-2016	Tiso, Natascia/0000-0002-5444-9853; Argenton, Francesco/0000-0002-0803-8236; Vettori, Andrea/0000-0003-4958-0619; Pizzi, Marco/0000-0003-4006-7317; Astone, Matteo/0000-0003-3294-9942; Meyer, Dirk/0000-0002-4020-4484	Associazione Italiana per la Ricerca sul Cancro Project [IG 10274]; European Union Grant [ZF-HEALTH CT-2010-242048]; Italian Ministry of Health project Trambigen [RF-2010-2309484]; AFM-Telethon project Polygon [18572]	Associazione Italiana per la Ricerca sul Cancro Project(Fondazione AIRC per la ricerca sul cancro); European Union Grant; Italian Ministry of Health project Trambigen; AFM-Telethon project Polygon	This work was supported by Associazione Italiana per la Ricerca sul Cancro Project IG 10274, European Union Grant ZF-HEALTH CT-2010-242048, Italian Ministry of Health project Trambigen (RF-2010-2309484), and the AFM-Telethon project Polygon (18572). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu E, 2013, EUR J RADIOL, V82, P38, DOI 10.1016/j.ejrad.2011.04.036; Amsterdam A, 2004, PLOS BIOL, V2, P690, DOI 10.1371/journal.pbio.0020139; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; Cagan R, 2014, DIS MODEL MECH, V7, P735, DOI 10.1242/dmm.016642; CHAKRABARTI S, 1983, GENETICS, V103, P109; Feitsma H, 2008, CANCER RES, V68, P5059, DOI 10.1158/0008-5472.CAN-08-0019; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lai K, 2009, DEV DYNAM, V238, P76, DOI 10.1002/dvdy.21815; MacInnes AW, 2008, P NATL ACAD SCI USA, V105, P10408, DOI 10.1073/pnas.0805036105; Nielsen GP, 2013, WHO CLASSIFICATION T, P187; Pauls S, 2007, DEV BIOL, V304, P875, DOI 10.1016/j.ydbio.2007.01.024; Pizzi M, 2015, ONCOTARGET, V6, P6544, DOI 10.18632/oncotarget.3446; Rhodes J, 2009, MOL CELL BIOL, V29, P5911, DOI 10.1128/MCB.00558-09; Shimoda N, 1999, GENOMICS, V58, P219, DOI 10.1006/geno.1999.5824; Subramanian S, 2010, J PATHOL, V220, P58, DOI 10.1002/path.2633; THISSE C, 1993, DEVELOPMENT, V119, P1203; Thway K, 2014, ANN DIAGN PATHOL, V18, P109, DOI 10.1016/j.anndiagpath.2013.10.007; White R, 2013, NAT REV CANCER, V13, P624, DOI 10.1038/nrc3589; Yu JS, 2011, CLIN CANCER RES, V17, P1924, DOI 10.1158/1078-0432.CCR-10-1551; Zhang GJ, 2010, P NATL ACAD SCI USA, V107, P16940, DOI 10.1073/pnas.1011548107	21	6	6	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145178	10.1371/journal.pone.0145178	http://dx.doi.org/10.1371/journal.pone.0145178			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26695815	Green Submitted, Green Published, gold			2022-12-26	WOS:000367092500027
J	He, ZH; Xu, M; Wu, YZ; Lv, J; Fu, PC; Mi, HL				He, Zhihui; Xu, Min; Wu, Yaozong; Lv, Jing; Fu, Pengcheng; Mi, Hualing			NdhM Subunit Is Required for the Stability and the Function of NAD(P)H Dehydrogenase Complexes Involved in CO2 Uptake in Synechocystis sp Strain PCC 6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbon fixation; cyanobacteria; electron transfer complex; photosynthesis; respiration	CYCLIC ELECTRON-TRANSPORT; PYRIDINE-NUCLEOTIDE DEHYDROGENASE; INORGANIC CARBON TRANSPORT; DOMAIN-LIKE FOLD; NADH DEHYDROGENASE; PHOTOSYSTEM-I; THERMOSYNECHOCOCCUS-ELONGATUS; EFFICIENT OPERATION; GENE-PRODUCTS; CYANOBACTERIUM	The cyanobacterial type I NAD(P)H dehydrogenase (NDH-1) complexes play a crucial role in a variety of bioenergetic reactions such as respiration, CO2 uptake, and cyclic electron transport around photosystem I. Two types of NDH-1 complexes, NDH-1MS and NDH-1MS, are involved in the CO2 uptake system. However, the composition and function of the complexes still remain largely unknown. Here, we found that deletion of ndhM caused inactivation of NDH-1-dependent cyclic electron transport around photosystem I and abolishment of CO2 uptake, resulting in a lethal phenotype under air CO2 condition. The mutation of NdhM abolished the accumulation of the hydrophilic subunits of the NDH-1, such as NdhH, NdhI, NdhJ, and NdhK, in the thylakoid membrane, resulting in disassembly of NDH-1MS and NDH-1MS as well as NDH-1L. In contrast, the accumulation of the hydrophobic subunits was not affected in the absence of NdhM. In the cytoplasm, the NDH-1 subcomplex assembly intermediates including NdhH and NdhK were seriously affected in the ndhM mutant but not in the NdhI-deleted mutant ndhI. In vitro protein interaction analysis demonstrated that NdhM interacts with NdhK, NdhH, NdhI, and NdhJ but not with other hydrophilic subunits of the NDH-1 complex. These results suggest that NdhM localizes in the hydrophilic subcomplex of NDH-1 complexes as a core subunit and is essential for the function of NDH-1MS and NDH-1MS involved in CO2 uptake in Synechocystis sp. strain PCC 6803.	[He, Zhihui; Xu, Min; Wu, Yaozong; Mi, Hualing] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Natl Key Lab Plant Mol Genet, 300 Fenglin Rd, Shanghai 200032, Peoples R China; [Lv, Jing; Fu, Pengcheng] China Univ Petr, Renewable Energy Res Ctr, 18 Fuxue Rd, Beijing 102249, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; China University of Petroleum	Mi, HL (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Natl Key Lab Plant Mol Genet, 300 Fenglin Rd, Shanghai 200032, Peoples R China.	mihl@sippe.ac.cn			State Key Basic Research and Development Plant 973 [2015CB150104, 2013CB127005, 2011C13200902]; National Natural Science Foundation of China [31270286]; Shanghai Science Foundation [13DJ1400102]	State Key Basic Research and Development Plant 973(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science Foundation	This work was supported by State Key Basic Research and Development Plant 973 Grants 2015CB150104, 2013CB127005, and 2011C13200902; National Natural Science Foundation of China Grant 31270286; and Shanghai Science Foundation Grant 13DJ1400102. The authors declare that they have no conflicts of interest with the contents of this article.	ALLEN MM, 1968, J PHYCOL, V4, P1, DOI 10.1111/j.1529-8817.1968.tb04667.x; Arteni AA, 2006, BBA-BIOENERGETICS, V1757, P1469, DOI 10.1016/j.bbabio.2006.05.042; Battchikova N, 2005, J BIOL CHEM, V280, P2587, DOI 10.1074/jbc.M410914200; Battchikova N, 2011, BBA-BIOENERGETICS, V1807, P935, DOI 10.1016/j.bbabio.2010.10.017; Battchikova N, 2011, J BIOL CHEM, V286, P36992, DOI 10.1074/jbc.M111.263780; BERGER S, 1993, FEBS LETT, V326, P246, DOI 10.1016/0014-5793(93)81800-F; Birungi M, 2010, BBA-BIOENERGETICS, V1797, P1681, DOI 10.1016/j.bbabio.2010.06.004; Dai HL, 2013, PLANT J, V75, P858, DOI 10.1111/tpj.12251; Deng Y, 2003, PLANT CELL PHYSIOL, V44, P534, DOI 10.1093/pcp/pcg067; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Folea IM, 2008, FEBS LETT, V582, P249, DOI 10.1016/j.febslet.2007.12.012; FRIEDRICH T, 1995, FEBS LETT, V367, P107, DOI 10.1016/0014-5793(95)00548-N; Friedrich T, 2000, FEBS LETT, V479, P1, DOI 10.1016/S0014-5793(00)01867-6; GOMBOS Z, 1994, P NATL ACAD SCI USA, V91, P8787, DOI 10.1073/pnas.91.19.8787; He ZH, 2015, PHOTOSYNTH RES, V126, P341, DOI 10.1007/s11120-015-0090-4; Klughammer B, 1999, MOL MICROBIOL, V32, P1305, DOI 10.1046/j.1365-2958.1999.01457.x; Kugler M, 1997, PHOTOSYNTH RES, V53, P35, DOI 10.1023/A:1005882406718; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Maeda S, 2002, MOL MICROBIOL, V43, P425, DOI 10.1046/j.1365-2958.2002.02753.x; MI HL, 1992, PLANT CELL PHYSIOL, V33, P1233; MI HL, 1995, PLANT CELL PHYSIOL, V36, P661; Munekaga Y, 2004, NATURE, V429, P579, DOI 10.1038/nature02598; Nowaczyk MM, 2011, BIOCHEMISTRY-US, V50, P1121, DOI 10.1021/bi102044b; OGAWA T, 1992, PLANT PHYSIOL, V99, P1604, DOI 10.1104/pp.99.4.1604; OGAWA T, 1991, P NATL ACAD SCI USA, V88, P4275, DOI 10.1073/pnas.88.10.4275; Ogawa T, 2007, PHOTOSYNTH RES, V93, P69, DOI 10.1007/s11120-006-9128-y; Ohkawa H, 2000, J BIOL CHEM, V275, P31630, DOI 10.1074/jbc.M003706200; Peltier G, 2002, ANNU REV PLANT BIOL, V53, P523, DOI 10.1146/annurev.arplant.53.100301.135242; Peng LW, 2012, PLANT CELL, V24, P202, DOI 10.1105/tpc.111.090597; Peng LW, 2009, PLANT CELL, V21, P3623, DOI 10.1105/tpc.109.068791; Prommeenate P, 2004, J BIOL CHEM, V279, P28165, DOI 10.1074/jbc.M401107200; Rumeau D, 2005, PLANT CELL, V17, P219, DOI 10.1105/tpc.104.028282; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Schwarz D, 2013, PLANT PHYSIOL, V163, P1191, DOI 10.1104/pp.113.224287; Shibata M, 2001, P NATL ACAD SCI USA, V98, P11789, DOI 10.1073/pnas.191258298; Vinothkumar KR, 2014, NATURE, V515, P80, DOI 10.1038/nature13686; WILLIAMS JGK, 1983, GENE, V24, P37, DOI 10.1016/0378-1119(83)90129-4; Wulfhorst H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103584; Xu M, 2008, PLANT CELL PHYSIOL, V49, P994, DOI 10.1093/pcp/pcn074; Yamamoto H, 2013, J BIOL CHEM, V288, P36328, DOI 10.1074/jbc.M113.511584; Yamamoto H, 2011, PLANT CELL, V23, P1480, DOI 10.1105/tpc.110.080291; Zhang JS, 2014, J BIOL CHEM, V289, P18770, DOI 10.1074/jbc.M114.553404; Zhang PP, 2005, BIOCHEM J, V390, P513, DOI 10.1042/BJ20050390; Zhang PP, 2004, PLANT CELL, V16, P3326, DOI 10.1105/tpc.104.026526; Zhao JH, 2014, J BIOL CHEM, V289, P26669, DOI 10.1074/jbc.M114.553925	45	14	17	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5902	5912		10.1074/jbc.M115.698084	http://dx.doi.org/10.1074/jbc.M115.698084			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26703473	Green Published, hybrid			2022-12-26	WOS:000372551800036
J	Richards, J; Belasco, JG				Richards, Jamie; Belasco, Joel G.			Distinct Requirements for 5-Monophosphate-assisted RNA Cleavage by Escherichia coli RNase E and RNase G	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoribonuclease; mRNA decay; ribonuclease; RNA turnover; RNA-protein interaction; 5 monophosphate; 5 terminus	MESSENGER-RNA; RIBONUCLEASE-E; IN-VIVO; PYROPHOSPHOHYDROLASE RPPH; QUATERNARY STRUCTURE; CATALYTIC DOMAIN; DEGRADATION; SPECIFICITY; PROTEIN; DECAY	RNase E and RNase G are homologous endonucleases that play important roles in RNA processing and decay in Escherichia coli and related bacterial species. Rapid mRNA degradation is facilitated by the preference of both enzymes for decay intermediates whose 5 end is monophosphorylated. In this report we identify key characteristics of RNA that influence the rate of 5-monophosphate-assisted cleavage by these two ribonucleases. In vitro, both require at least two and prefer three or more unpaired 5-terminal nucleotides for such cleavage; however, RNase G is impeded more than RNase E when fewer than four unpaired nucleotides are present at the 5 end. Each can tolerate any unpaired nucleotide (A, G, C, or U) at either of the first two positions, with only modest biases. The optimal spacing between the 5 end and the scissile phosphate appears to be eight nucleotides for RNase E but only six for RNase G. 5-Monophosphate-assisted cleavage also occurs, albeit more slowly, when that spacing is greater or at most one nucleotide shorter than the optimum, but there is no simple inverse relationship between increased spacing and the rate of cleavage. These properties are also manifested during 5-end-dependent mRNA degradation in E. coli.	NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, New York, NY 10016 USA; [Belasco, Joel G.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA	New York University; New York University	Belasco, JG (corresponding author), NYU, Sch Med, Skirball Inst, 540 First Ave, New York, NY 10016 USA.	joel.belasco@med.nyu.edu			National Institutes of Health [R01GM035769]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035769] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by Grant R01GM035769 from the National Institutes of Health (to J. G. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	APIRION D, 1978, GENETICS, V90, P659; BOUVET P, 1992, NATURE, V360, P488, DOI 10.1038/360488a0; Briant DJ, 2003, MOL MICROBIOL, V50, P1381, DOI 10.1046/j.1365-2958.2003.03775.x; Callaghan AJ, 2005, NATURE, V437, P1187, DOI 10.1038/nature04084; Callaghan AJ, 2003, BIOCHEMISTRY-US, V42, P13848, DOI 10.1021/bi0351099; Celesnik H, 2007, MOL CELL, V27, P79, DOI 10.1016/j.molcel.2007.05.038; Celesnik H, 2008, METHOD ENZYMOL, V447, P83, DOI 10.1016/S0076-6879(08)02205-2; Deana A, 2008, NATURE, V451, P355, DOI 10.1038/nature06475; EMORY SA, 1992, GENE DEV, V6, P135, DOI 10.1101/gad.6.1.135; Foley PL, 2015, J BIOL CHEM, V290, P9478, DOI 10.1074/jbc.M114.634659; Garrey SM, 2011, MOL MICROBIOL, V80, P1613, DOI 10.1111/j.1365-2958.2011.07670.x; Garrey SM, 2009, J BIOL CHEM, V284, P31843, DOI 10.1074/jbc.M109.063263; Hui MP, 2014, ANNU REV GENET, V48, P537, DOI 10.1146/annurev-genet-120213-092340; Jiang XQ, 2000, J BACTERIOL, V182, P2468, DOI 10.1128/JB.182.9.2468-2475.2000; Jourdan SS, 2008, MOL MICROBIOL, V67, P102, DOI 10.1111/j.1365-2958.2007.06028.x; Kaberdin VR, 2003, NUCLEIC ACIDS RES, V31, P4710, DOI 10.1093/nar/gkg690; Kaga N, 2002, BIOSCI BIOTECH BIOCH, V66, P2216, DOI 10.1271/bbb.66.2216; Khemici V, 2008, MOL MICROBIOL, V70, P799, DOI 10.1111/j.1365-2958.2008.06454.x; Lee K, 2002, MOL MICROBIOL, V43, P1445, DOI 10.1046/j.1365-2958.2002.02848.x; Liou GG, 2001, P NATL ACAD SCI USA, V98, P63, DOI 10.1073/pnas.011535498; Luciano DJ, 2012, J BACTERIOL, V194, P6233, DOI 10.1128/JB.01223-12; Mackie GA, 1998, NATURE, V395, P720, DOI 10.1038/27246; MCDOWALL KJ, 1994, J BIOL CHEM, V269, P10790; Ow MC, 2003, MOL MICROBIOL, V49, P607, DOI 10.1046/j.1365-2958.2003.03587.x; Redko Y, 2003, J BIOL CHEM, V278, P44001, DOI 10.1074/jbc.M306760200; Richards J, 2012, MOL MICROBIOL, V86, P1063, DOI 10.1111/mmi.12040; Spickler C, 2001, J BACTERIOL, V183, P1106, DOI 10.1128/JB.183.3.1106-1109.2001; Tock MR, 2000, J BIOL CHEM, V275, P8726, DOI 10.1074/jbc.275.12.8726; TOMCSANYI T, 1985, J MOL BIOL, V185, P713, DOI 10.1016/0022-2836(85)90056-7; Umitsuki G, 2001, GENES CELLS, V6, P403, DOI 10.1046/j.1365-2443.2001.00430.x; Vanzo NF, 1998, GENE DEV, V12, P2770, DOI 10.1101/gad.12.17.2770; Vasilyev N, 2015, J BIOL CHEM, V290, P9487, DOI 10.1074/jbc.M114.634824; Walsh AP, 2001, NUCLEIC ACIDS RES, V29, P1864, DOI 10.1093/nar/29.9.1864	33	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					5038	5048		10.1074/jbc.M115.702555	http://dx.doi.org/10.1074/jbc.M115.702555			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26694614	hybrid, Green Published			2022-12-26	WOS:000371640600018
J	Koiwai, K; Hartmann, MD; Linke, D; Lupas, AN; Hori, K				Koiwai, Kotaro; Hartmann, Marcus D.; Linke, Dirk; Lupas, Andrei N.; Hori, Katsutoshi			Structural Basis for Toughness and Flexibility in the C-terminal Passenger Domain of an Acinetobacter Trimeric Autotransporter Adhesin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adhesin; bacterial adhesion; crystal structure; Gram-negative bacteria; membrane protein; protein domain; protein structure; structure-function; Acinetobacter; autotransporter	NEISSERIA-MENINGITIDIS; OUTER-MEMBRANE; DIFFRACTION DATA; PROTEIN; YERSINIA; BINDING; BAUMANNII; YADA; CRYSTALLIZATION; MODEL	Trimeric autotransporter adhesins (TAAs) on the cell surface of Gram-negative pathogens mediate bacterial adhesion to host cells and extracellular matrix proteins. However, AtaA, a TAA in the nonpathogenic Acinetobacter sp. strain Tol 5, shows nonspecific high adhesiveness to abiotic material surfaces as well as to biotic surfaces. It consists of a passenger domain secreted by the C-terminal transmembrane anchor domain (TM), and the passenger domain contains an N-terminal head, N-terminal stalk, C-terminal head (Chead), and C-terminal stalk (Cstalk). The Chead-Cstalk-TM fragment, which is conserved in many Acinetobacter TAAs, has by itself the head-stalk-anchor architecture of a complete TAA. Here, we show the crystal structure of the Chead-Cstalk fragment, AtaA_C-terminal passenger domain (CPSD), providing the first view of several conserved TAA domains. The YadA-like head (Ylhead) of the fragment is capped by a unique structure (headCap), composed of three -hairpins and a connector motif; it also contains a head insert motif (HIM1) before its last inner -strand. The headCap, Ylhead, and HIM1 integrally form a stable Chead structure. Some of the major domains of the CPSD fragment are inherently flexible and provide bending sites for the fiber between segments whose toughness is ensured by topological chain exchange and hydrophobic core formation inside the trimer. Thus, although adherence assays using in-frame deletion mutants revealed that the characteristic adhesive sites of AtaA reside in its N-terminal part, the flexibility and toughness of the CPSD part provide the resilience that enables the adhesive properties of the full-length fiber across a wide range of conditions.	[Koiwai, Kotaro; Hori, Katsutoshi] Nagoya Univ, Grad Sch Engn, Dept Biotechnol, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Koiwai, Kotaro] High Energy Accelerator Res Org, Inst Mat Struct Sci, Photon Factory, Struct Biol Res Ctr, Tsukuba, Ibaraki 3050801, Japan; [Hartmann, Marcus D.; Linke, Dirk; Lupas, Andrei N.] Max Planck Inst Dev Biol, Dept Prot Evolut, D-72076 Tubingen, Germany; [Linke, Dirk] Univ Oslo, Dept Biosci, N-0316 Oslo, Norway	Nagoya University; High Energy Accelerator Research Organization (KEK); Max Planck Society; University of Oslo	Hori, K (corresponding author), Nagoya Univ, Grad Sch Engn, Dept Biotechnol, Chikusa Ku, Nagoya, Aichi 4648603, Japan.	khori@nubio.nagoya-u.ac.jp	Linke, Dirk/F-9147-2010; Hartmann, Marcus/L-8759-2019; Hori, Katsutoshi/K-5289-2012	Linke, Dirk/0000-0003-3150-6752; Hartmann, Marcus/0000-0001-6937-5677; Hori, Katsutoshi/0000-0003-1994-3124; Koiwai, Kotaro/0000-0002-9684-3699	Japan Society for the Promotion of Science through Funding Program for Next Generation World-Leading Researchers (NEXT Program); Max Planck Society; Deutsche Forschungsgemeinschaft [SFB766]	Japan Society for the Promotion of Science through Funding Program for Next Generation World-Leading Researchers (NEXT Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Max Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by funds from the Japan Society for the Promotion of Science through the Funding Program for Next Generation World-Leading Researchers (NEXT Program), institutional funds of the Max Planck Society, and Grant SFB766 of the Deutsche Forschungsgemeinschaft. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Agnew C, 2011, P NATL ACAD SCI USA, V108, P15174, DOI 10.1073/pnas.1106341108; Alvarez BH, 2008, PROTEIN ENG DES SEL, V21, P11, DOI 10.1093/protein/gzm071; Bassler J, 2015, INT J MED MICROBIOL, V305, P265, DOI 10.1016/j.ijmm.2014.12.010; Benanti EL, 2015, CELL, V161, P348, DOI 10.1016/j.cell.2015.02.044; Bentancor LV, 2012, INFECT IMMUN, V80, P3381, DOI 10.1128/IAI.06096-11; Bentancor LV, 2012, J BACTERIOL, V194, P3950, DOI 10.1128/JB.06769-11; Bernstein HD, 2015, MOL MICROBIOL, V97, P205, DOI 10.1111/mmi.13031; BOUVET PJM, 1986, INT J SYST BACTERIOL, V36, P228, DOI 10.1099/00207713-36-2-228; Capecchi B, 2005, MOL MICROBIOL, V55, P687, DOI 10.1111/j.1365-2958.2004.04423.x; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Cotter SE, 2005, J BACTERIOL, V187, P4656, DOI 10.1128/JB.187.13.4656-4664.2005; Cotter SE, 2006, J BACTERIOL, V188, P5400, DOI 10.1128/JB.00164-06; Deiss S, 2014, J STRUCT BIOL, V186, P380, DOI 10.1016/j.jsb.2014.01.013; Edwards TE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012803; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hartmann MD, 2012, P NATL ACAD SCI USA, V109, P20907, DOI 10.1073/pnas.1211872110; Hartmann MD, 2009, P NATL ACAD SCI USA, V106, P16950, DOI 10.1073/pnas.0907256106; Hoiczyk E, 2000, EMBO J, V19, P5989, DOI 10.1093/emboj/19.22.5989; Ishikawa M., 2012, PLOS ONE, V7; Ishikawa M, 2012, J BIOSCI BIOENG, V113, P719, DOI 10.1016/j.jbiosc.2012.01.011; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leo JC, 2012, PHILOS T R SOC B, V367, P1088, DOI 10.1098/rstb.2011.0208; Leo JC, 2011, STRUCTURE, V19, P1021, DOI 10.1016/j.str.2011.03.021; Leo JC, 2011, ADV EXP MED BIOL, V715, P1, DOI 10.1007/978-94-007-0940-9_1; Linke D, 2006, TRENDS MICROBIOL, V14, P264, DOI 10.1016/j.tim.2006.04.005; Meng GY, 2006, EMBO J, V25, P2297, DOI 10.1038/sj.emboj.7601132; Meng G, 2008, J MOL BIOL, V384, P824, DOI 10.1016/j.jmb.2008.09.085; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Nagele V, 2011, J BIOL CHEM, V286, P20536, DOI 10.1074/jbc.M110.188326; Nummelin H, 2004, EMBO J, V23, P701, DOI 10.1038/sj.emboj.7600100; Nummelin H, 2002, ACTA CRYSTALLOGR D, V58, P1042, DOI 10.1107/S0907444902005231; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peak IRA, 2000, FEMS IMMUNOL MED MIC, V28, P329, DOI 10.1111/j.1574-695X.2000.tb01494.x; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Ruiz-Ranwez V, 2013, INFECT IMMUN, V81, P996, DOI 10.1128/IAI.01241-12; Sandt CH, 2000, INFECT IMMUN, V68, P2205, DOI 10.1128/IAI.68.4.2205-2214.2000; Schutz M, 2010, INFECT IMMUN, V78, P2677, DOI 10.1128/IAI.01350-09; Serruto D, 2009, CELL MICROBIOL, V11, P1044, DOI 10.1111/j.1462-5822.2009.01306.x; Snitkin ES, 2011, P NATL ACAD SCI USA, V108, P13758, DOI 10.1073/pnas.1104404108; Szczesny P, 2008, BIOINFORMATICS, V24, P1251, DOI 10.1093/bioinformatics/btn118; Szczesny P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000119; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Voss NR, 2010, NUCLEIC ACIDS RES, V38, pW555, DOI 10.1093/nar/gkq395; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wollmann P, 2006, INT J BIOL MACROMOL, V39, P3, DOI 10.1016/j.ijbiomac.2005.11.009; Xiao LW, 2012, J BASIC MICROB, V52, P598, DOI 10.1002/jobm.201100365; Yeo HJ, 2004, EMBO J, V23, P1245, DOI 10.1038/sj.emboj.7600142; Yu CX, 2009, J BACTERIOL, V191, P6253, DOI 10.1128/JB.00563-09	50	32	34	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					3705	3724		10.1074/jbc.M115.701698	http://dx.doi.org/10.1074/jbc.M115.701698			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26698633	Green Published, hybrid			2022-12-26	WOS:000371338400003
J	Bu, ZQ; Sun, YP				Bu, Zhiqin; Sun, Yingpu			The Impact of Endometrial Thickness on the Day of Human Chorionic Gonadotrophin (hCG) Administration on Ongoing Pregnancy Rate in Patients with Different Ovarian Response	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; EMBRYO-TRANSFER; PATTERN; COHORT; IVF; WOMEN	In order to explore the impact of endometrial thickness on hCG administration day on ongoing pregnancy rate (OPR) in IVF-ET cycles, we retrospectively analyzed data from 10,406 patients undergoing their first IVF cycles with standard gonadotropin releasing hormone analogue (GnRH-a) long protocol. Firstly, patients were divided into poor (<= 5 oocytes), medium (6-14 oocytes), and high (>= 15 oocytes) ovarian responders based on the number of oocytes retrieved. In each group, patients were sub-divided into three groups according to the endometrial thickness on the day of hCG administration: Group A, thin endometrial thickness (<= 7 mm); Group B, medium endometrial thickness (8-13 mm); Group C, thick endometrial thickness (>= 14 mm). (1) For poor responders, OPRs were significantly different in the three endometrial thickness groups (28.57%, 44.25%, and 51.34%; P = 0.008). The association between thin endometrial thickness and OPR was significant after controlling for age, number of embryos transferred by multivariate logistic regression analysis (adjusted OR: 0.408; 95% CI: 0.186-0.898; P = 0.026. Reference = thick endometrial thickness). (2) For medium responders, OPRs were 31.58%, 55.56%, and 63.01% (P = 0.000) in the three groups. Adjusted OR for thin endometrial thickness was 0.284 (95% CI: 0.182-0.444; P = 0.000). (3) For high responders, OPRs were also significantly different in the three groups (28.13%, 52.63%, and 63.18; P = 0.000). Adjusted OR for thin endometrial thickness was 0.233 (95% CI: 0.105-0.514; P = 0.000). For patients undergoing IVF with different ovarian response, a thin endometrium on the day of hCG administration adversely affects ongoing pregnancy rate.	[Bu, Zhiqin; Sun, Yingpu] Zhengzhou Univ, Affiliated Hosp 1, Reprod Med Ctr, Zhengzhou 450052, Peoples R China	Zhengzhou University	Sun, YP (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Reprod Med Ctr, Zhengzhou 450052, Peoples R China.	syp2008@vip.sina.com			Youth Foundation of The First Affiliated Hospital of Zhengzhou University; National Natural Science Foundation of China [31271605]	Youth Foundation of The First Affiliated Hospital of Zhengzhou University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Youth Foundation of The First Affiliated Hospital of Zhengzhou University, and the National Natural Science Foundation of China (Grant No. 31271605). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ghamdi A, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-37; Barker MA, 2009, J ASSIST REPROD GEN, V26, P243, DOI 10.1007/s10815-009-9312-z; Bassil S, 2001, ULTRASOUND OBST GYN, V18, P258, DOI 10.1046/j.1469-0705.2001.00502.x; Casper RF, 2011, FERTIL STERIL, V96, P519, DOI 10.1016/j.fertnstert.2011.07.1096; De Geyter C, 2000, FERTIL STERIL, V73, P106, DOI 10.1016/S0015-0282(99)00484-7; Gleicher N, 2013, HUM REPROD, V28, P172, DOI 10.1093/humrep/des370; Hu LL, 2014, INT J CLIN EXP MED, V7, P1128; Jin HX, 2015, SYST BIOL REPROD MED, V61, P96, DOI 10.3109/19396368.2014.986693; Kasius A, 2014, HUM REPROD UPDATE, V20, P530, DOI 10.1093/humupd/dmu011; Kovacs P, 2003, HUM REPROD, V18, P2337, DOI 10.1093/humrep/deg461; Momeni Mazdak, 2011, J Hum Reprod Sci, V4, P130, DOI 10.4103/0974-1208.92287; Reynolds K, 2010, FERTIL STERIL, V93, P2091, DOI 10.1016/j.fertnstert.2009.08.038; Traub ML, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-33; Zhao J, 2014, REPROD BIOMED ONLINE, V29, P291, DOI 10.1016/j.rbmo.2014.05.011	14	21	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145703	10.1371/journal.pone.0145703	http://dx.doi.org/10.1371/journal.pone.0145703			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717148	Green Published, Green Submitted, gold			2022-12-26	WOS:000367510500059
J	Gupta, N; Benjamin, M; Kar, A; Munjal, SD; Sarangi, AN; Dalal, A; Aggarwal, R				Gupta, Neha; Benjamin, Mercilena; Kar, Anjana; Munjal, Sachin Dev; Sarangi, Aditya N.; Dalal, Ashwin; Aggarwal, Rakesh			Identification of Promotor and Exonic Variations, and Functional Characterization of a Splice Site Mutation in Indian Patients with Unconjugated Hyperbilirubinemia	PLOS ONE			English	Article							DIPHOSPHATE-GLUCURONOSYLTRANSFERASE GENE; CRIGLER-NAJJAR-SYNDROME; UGT1A1 GENE; GILBERTS-SYNDROME; UDP-GLUCURONOSYLTRANSFERASE; BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE-1; PROTEIN MUTATIONS; POLYMORPHISMS; VARIANTS; ALLELE	Background Mild unconjugated hyperbilirubinemia (UH), due to reduced activity of the enzyme uridine diphosphoglucuronate-glucuronosyltransferase family, polypeptide 1 (UGT1A1), is a common clinical condition. Most cases are caused by presence in homozygous form of an A (TA)(7)TAA nucleotide sequence instead of the usual A(TA)(6)TAA sequence in promoter region of the UGT1A1 gene. In some cases, other genetic variations have been identified which differ between populations. There is need for more data on such genetic variations from India. Methods DNA from subjects with unexplained persistent or recurrent UH was tested for the presence of TA promoter insertions. In addition, all five exons and splicing site regions of UGT1A1 gene were sequenced. Several bioinformatics tools were used to determine the biological significance of the observed genetic changes. Functional analysis was done to look for effect of a splice site mutation in UGT1A1. Results Of 71 subjects with UH (68 male; median age [range], 26 [16-63] years; serum bilirubin 56 [26-219] mu M/L, predominantly unconjugated) studied, 65 (91.5%) subjects were homozygous for A(TA)7TAA allele, five (7.0%) were heterozygous, and one (1.4%) lacked this change. Fifteen subjects with UH had missense exonic single nucleotide changes (14 heterozygous, 1 homozygous), including one subject with a novel nucleotide change (p. Thr205Asn). Bioinformatics tools predicted some of these variations (p.Arg108Cys, p. lle159Thr and p.Glu463Val) to be deleterious. Functional characterization of an exonic variation (c.1084G>A) located at a splice site revealed that it results in frameshift deletion of 31 nucleotides and premature truncation of the protein. Conclusion Our study revealed several single nucleotide variations in UGT1A1 gene in Indian subjects with UH. Functional characterization of a splice site variation indicated that it leads to disordered splicing. These variations may explain UH in subjects who lacked homozygous A (TA)(7)TAA promoter alleles.	[Gupta, Neha; Benjamin, Mercilena; Munjal, Sachin Dev; Aggarwal, Rakesh] Sanjay Gandhi Postgrad Inst Med Sci, Dept Gastroenterol, Lucknow 226014, Uttar Pradesh, India; [Sarangi, Aditya N.; Aggarwal, Rakesh] Sanjay Gandhi Postgrad Inst Med Sci, Biomed Informat Ctr, Lucknow 226014, Uttar Pradesh, India; [Kar, Anjana; Dalal, Ashwin] Ctr DNA Fingerprinting & Diagnost, Div Diagnost, Hyderabad 500001, Andhra Pradesh, India; [Kar, Anjana] Manipal Univ, Grad Studies, Manipal 576104, Karnataka, India	Sanjay Gandhi Postgraduate Institute of Medical Sciences; Sanjay Gandhi Postgraduate Institute of Medical Sciences; Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Manipal Academy of Higher Education (MAHE)	Aggarwal, R (corresponding author), Sanjay Gandhi Postgrad Inst Med Sci, Dept Gastroenterol, Lucknow 226014, Uttar Pradesh, India.	aggarwal.ra@gmail.com	Aggarwal, Rakesh/D-1583-2009; BENJAMIN, MERCILENA/X-4459-2019; DALAL, ASHWIN/GXF-0028-2022	Aggarwal, Rakesh/0000-0001-9689-494X; BENJAMIN, MERCILENA/0000-0003-3919-0254; DALAL, ASHWIN/0000-0001-5929-745X; MUNJAL, SACHIN/0000-0002-5330-1603; Sarangi, Arkaprabha/0000-0002-9820-679X	Department of Science and Technology, Government of India under FIST program; Indian Council of Medical Research (ICMR), New Delhi; University Grants Commission, New Delhi	Department of Science and Technology, Government of India under FIST program; Indian Council of Medical Research (ICMR), New Delhi(Indian Council of Medical Research (ICMR)); University Grants Commission, New Delhi(University Grants Commission, India)	The sequencing facility at the authors' institution is supported by the Department of Science and Technology, Government of India, under its FIST program, and Biomedical Informatics Center is supported by the Indian Council of Medical Research (ICMR), New Delhi. During this work, NG was supported by University Grants Commission, New Delhi, and MB and ANS by ICMR, New Delhi.	Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Aggarwal V, 2010, PEDIATR BLOOD CANCER, V54, P627, DOI 10.1002/pbc.22313; Agrawal SK, 2009, PEDIATR RES, V65, P675, DOI 10.1203/PDR.0b013e31819ed5de; Akaba K, 1999, J HUM GENET, V44, P22, DOI 10.1007/s100380050100; Balram C, 2002, PHARMACOGENETICS, V12, P81, DOI 10.1097/00008571-200201000-00012; Beutler E, 1998, P NATL ACAD SCI USA, V95, P8170, DOI 10.1073/pnas.95.14.8170; BOSMA PJ, 1995, NEW ENGL J MED, V333, P1171, DOI 10.1056/NEJM199511023331802; Canu G, 2013, BLOOD CELL MOL DIS, V50, P273, DOI 10.1016/j.bcmd.2013.01.003; Capriotti E, 2006, BIOINFORMATICS, V22, P2729, DOI 10.1093/bioinformatics/btl423; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Farheen S, 2006, WORLD J GASTROENTERO, V12, P2269, DOI 10.3748/wjg.v12.i14.2269; Gaildrat P, 2012, J MED GENET, V49, P609, DOI 10.1136/jmedgenet-2012-100965; Gong QH, 2001, PHARMACOGENETICS, V11, P357, DOI 10.1097/00008571-200106000-00011; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kadakol A, 2000, HUM MUTAT, V16, P297, DOI 10.1002/1098-1004(200010)16:4<297::AID-HUMU2>3.0.CO;2-Z; Kadakol A, 2001, J MED GENET, V38, P244, DOI 10.1136/jmg.38.4.244; Lin JP, 2006, CIRCULATION, V114, P1476, DOI 10.1161/CIRCULATIONAHA.106.633206; Liu X, 2014, PHARMACOGENOMICS J, V14, P120, DOI 10.1038/tpj.2013.10; Mort M, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-1-r19; POWELL LW, 1967, NEW ENGL J MED, V277, P1108, DOI 10.1056/NEJM196711232772102; Premawardhena A, 2003, BLOOD CELL MOL DIS, V31, P98, DOI 10.1016/S1079-9796(03)00071-8; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Rodrigues C, 2012, BLOOD CELL MOL DIS, V48, P166, DOI 10.1016/j.bcmd.2012.01.004; Rotger M, 2005, J INFECT DIS, V192, P1381, DOI 10.1086/466531; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; Skierka JM, 2013, J PEDIATR-US, V162, P1146, DOI 10.1016/j.jpeds.2012.11.042; Takeuchi K, 2004, J GASTROEN HEPATOL, V19, P1023, DOI 10.1111/j.1440-1746.2004.03370.x; Tournier I, 2008, HUM MUTAT, V29, P1412, DOI 10.1002/humu.20796; Yamamoto K, 1998, BBA-MOL BASIS DIS, V1406, P267, DOI 10.1016/S0925-4439(98)00013-1	31	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145967	10.1371/journal.pone.0145967	http://dx.doi.org/10.1371/journal.pone.0145967			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716871	gold, Green Submitted, Green Published			2022-12-26	WOS:000367510500105
J	Hoffmann, LS; Kretschmer, A; Lawrenz, B; Hocher, B; Stasch, JP				Hoffmann, Linda S.; Kretschmer, Axel; Lawrenz, Bettina; Hocher, Berthold; Stasch, Johannes-Peter			Chronic Activation of Heme Free Guanylate Cyclase Leads to Renal Protection in Dahl Salt-Sensitive Rats	PLOS ONE			English	Article							NITRIC-OXIDE; OXIDATIVE STRESS; INDEPENDENT ACTIVATION; ENDOTHELIAL DYSFUNCTION; PULMONARY-HYPERTENSION; CARDIOVASCULAR-DISEASE; NO; CGMP; RECEPTOR; BINDING	The nitric oxide (NO)/soluble guanylate cyclase (sGC)/cyclic guanosine monophasphate (cGMP)-signalling pathway is impaired under oxidative stress conditions due to oxidation and subsequent loss of the prosthetic sGC heme group as observed in particular in chronic renal failure. Thus, the pool of heme free sGC is increased under pathological conditions. sGC activators such as cinaciguat selectively activate the heme free form of sGC and target the disease associated enzyme. In this study, a therapeutic effect of long-term activation of heme free sGC by the sGC activator cinaciguat was investigated in an experimental model of salt-sensitive hypertension, a condition that is associated with increased oxidative stress, heme loss from sGC and development of chronic renal failure. For that purpose Dahl/ss rats, which develop severe hypertension upon high salt intake, were fed a high salt diet (8% NaCl) containing either placebo or cinaciguat for 21 weeks. Cinaciguat markedly improved survival and ameliorated the salt-induced increase in blood pressure upon treatment with cinaciguat compared to placebo. Renal function was significantly improved in the cinaciguat group compared to the placebo group as indicated by a significantly improved glomerular filtration rate and reduced urinary protein excretion. This was due to anti-fibrotic and antiinflammatory effects of the cinaciguat treatment. Taken together, this is the first study showing that long-term activation of heme free sGC leads to renal protection in an experimental model of hypertension and chronic kidney disease. These results underline the promising potential of cinaciguat to treat renal diseases by targeting the disease associated heme free form of sGC.	[Hoffmann, Linda S.; Kretschmer, Axel; Lawrenz, Bettina; Stasch, Johannes-Peter] Bayer HealthCare, Pharma Res Ctr, Wuppertal, Germany; [Hocher, Berthold] Univ Potsdam, Instute Nutr Sci, Potsdam, Germany; [Hocher, Berthold] IFLb Labs Med Berlin GmbH, Berlin, Germany; [Stasch, Johannes-Peter] Univ Halle Wittenberg, Sch Pharm, D-06108 Halle, Germany	Bayer AG; Bayer Healthcare Pharmaceuticals; University of Potsdam; Martin Luther University Halle Wittenberg	Hoffmann, LS (corresponding author), Bayer HealthCare, Pharma Res Ctr, Wuppertal, Germany.	linda.s.hoffmann@uni-bonn.de	Hocher, Berthold/AAC-3510-2020	Hocher, Berthold/0000-0001-8143-0579	Bayer Pharma AG	Bayer Pharma AG	The authors received no specific funding for this work. Bayer Pharma AG provided support in the form of salaries for authors LSH, AK, BL, and JPS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions section.	Alfadda AA, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/936486; Armitage ME, 2009, J MOL MED, V87, P1071, DOI 10.1007/s00109-009-0544-2; Beckman JS, 2009, ARCH BIOCHEM BIOPHYS, V484, P114, DOI 10.1016/j.abb.2009.03.013; Boerrigter G, 2007, HYPERTENSION, V49, P1128, DOI 10.1161/HYPERTENSIONAHA.106.083832; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Chirkov YY, 2007, PHARMACOL THERAPEUT, V116, P287, DOI 10.1016/j.pharmthera.2007.06.012; Cosyns SM, 2014, NEUROGASTROENT MOTIL, V8, P12424; Derbyshire ER, 2012, ANNU REV BIOCHEM, V81, P533, DOI 10.1146/annurev-biochem-050410-100030; Dumitrascu R, 2006, CIRCULATION, V113, P286, DOI 10.1161/CIRCULATIONAHA.105.581405; Evgenov OV, 2006, NAT REV DRUG DISCOV, V5, P755, DOI 10.1038/nrd2038; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Geschka S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021853; Gladwin MT, 2006, J CLIN INVEST, V116, P2330, DOI 10.1172/JCI29807; Glynos C, 2013, AM J RESP CRIT CARE, V188, P789, DOI 10.1164/rccm.201210-1884OC; Grossman E, 2008, DIABETES CARE, V31, pS185, DOI 10.2337/dc08-s246; Haffner D, 2005, J HYPERTENS, V23, P1067, DOI 10.1097/01.hjh.0000166849.72721.1c; Han WK, 2008, KIDNEY INT, V73, P863, DOI 10.1038/sj.ki.5002715; Harrison DG, 2009, MED CLIN N AM, V93, P621, DOI 10.1016/j.mcna.2009.02.015; Hobbs AJ, 1996, METHOD ENZYMOL, V269, P134; Hobbs AJ, 2002, BRIT J PHARMACOL, V136, P637, DOI 10.1038/sj.bjp.0704779; Hobbs AJ, 1999, ANNU REV PHARMACOL, V39, P191, DOI 10.1146/annurev.pharmtox.39.1.191; Hocher B, 2000, J HYPERTENS, V18, P1807, DOI 10.1097/00004872-200018120-00015; Hoffmann LS, 2009, BRIT J PHARMACOL, V157, P781, DOI 10.1111/j.1476-5381.2009.00263.x; Hoffmann LS, 2014, N-S ARCH PHARMACOL, V387, P707, DOI 10.1007/s00210-014-0999-8; Hsia HC, 2005, J BIOL CHEM, V280, P26641, DOI 10.1074/jbc.R500005200; Kalk P, 2006, BRIT J PHARMACOL, V148, P853, DOI 10.1038/sj.bjp.0706792; Knorr A, 2008, ARZNEIMITTEL-FORSCH, V58, P71, DOI 10.1055/s-0031-1296471; Korkmaz S, 2013, J CARDIOVASC PHARM T, V18, P70, DOI 10.1177/1074248412455696; LIVAK KJ, 1995, PCR METH APPL, V4, P357; Lucas KA, 2000, PHARMACOL REV, V52, P375; Melichar VO, 2004, P NATL ACAD SCI USA, V101, P16671, DOI 10.1073/pnas.0405509101; Meng SM, 2003, HYPERTENSION, V41, P1346, DOI 10.1161/01.HYP.0000070028.99408.E8; Meurer S, 2009, CIRC RES, V105, P33, DOI 10.1161/CIRCRESAHA.109.198234; Niu JL, 2009, CLIN SCI, V117, P95, DOI 10.1042/CS20080581; Okamoto H, 2007, MOL CELL BIOCHEM, V300, P1, DOI 10.1007/s11010-006-9368-3; Rosenberg M, 2008, CIRC-HEART FAIL, V1, P43, DOI 10.1161/CIRCHEARTFAILURE.107.746172; Rothkegel C, 2006, FEBS LETT, V580, P4205, DOI 10.1016/j.febslet.2006.06.079; Roy B, 2008, BRIT J PHARMACOL, V153, P1495, DOI 10.1038/sj.bjp.0707687; Santos Maria Gisele dos, 2008, Arq Bras Cardiol, V90, P276; Schmidt Harald H. H. W., 2009, V191, P309, DOI 10.1007/978-3-540-68964-5_14; SCHMIDT HHHW, 1993, BIOCHIM BIOPHYS ACTA, V1178, P153, DOI 10.1016/0167-4889(93)90006-B; Schmidt P, 2003, ANAL BIOCHEM, V314, P162, DOI 10.1016/S0003-2697(02)00660-7; Schmidt PM, 2004, J BIOL CHEM, V279, P3025, DOI 10.1074/jbc.M310141200; Schulz E, 2008, ANTIOXID REDOX SIGN, V10, P1115, DOI 10.1089/ars.2007.1989; Schwarz ER, 1998, BASIC RES CARDIOL, V93, P477, DOI 10.1007/s003950050118; Simchon S, 1996, HYPERTENSION, V27, P653, DOI 10.1161/01.HYP.27.3.653; Stasch JP, 2006, J CLIN INVEST, V116, P2552, DOI 10.1172/JCI28371; Stasch JP, 2015, CURR OPIN PHARMACOL, V21, P95, DOI 10.1016/j.coph.2014.12.014; Stasch Johannes-Peter, 2009, V191, P277, DOI 10.1007/978-3-540-68964-5_13; Stasch JP, 2002, BRIT J PHARMACOL, V136, P773, DOI 10.1038/sj.bjp.0704778; Stasch JP, 2002, BRIT J PHARMACOL, V135, P344, DOI 10.1038/sj.bjp.0704483; Stasch JP, 1997, ARZNEIMITTELFORSCH, V47, P1016; Surmeli NB, 2012, CHEMBIOCHEM, V13, P977, DOI 10.1002/cbic.201100809; Taylor NE, 2006, HYPERTENSION, V47, P692, DOI 10.1161/01.HYP.0000203161.02046.8d; Wang YR, 2006, AM J PHYSIOL-RENAL, V290, pF167, DOI 10.1152/ajprenal.00197.2005; Wedgwood S, 2005, AM J PHYSIOL-LUNG C, V289, pL660, DOI 10.1152/ajplung.00369.2004	56	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145048	10.1371/journal.pone.0145048	http://dx.doi.org/10.1371/journal.pone.0145048			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717150	Green Published, gold, Green Submitted			2022-12-26	WOS:000367510500019
J	Liu, XM; He, C; Huang, T; Gu, J				Liu, Xingmu; He, Chao; Huang, Tao; Gu, Jiang			Development of a New Technique for Reconstruction of Hepatic Artery during Liver Transplantation in Sprague-Dawley Rat	PLOS ONE			English	Article							FACTOR-KAPPA-B; SLEEVE ANASTOMOSIS; REPERFUSION INJURY; REARTERIALIZATION; GRAFT; ARTERIALIZATION; COMPLICATIONS; EXPERIENCE; ISCHEMIA; SYSTEM	Background Sleeve anastomosis is the most common technique used to rearterialize orthotopic liver transplants (OLT). However, this technique has a number of disadvantages, including difficulty of performance of the technique visually unaided. We herein describe a novel rearterialized OLT model in the rat. Materials and Methods Forty-six male Sprague Dawley rats (300-400 g) were used as donors and recipients. Based on Kamada's cuff technique, the new model involved performing a modified "sleeve" anastomosis between the celiac trunk of the donor and common hepatic artery of the recipient to reconstruct blood flow to the hepatic artery. An additional ten male Sprague Dawley rats underwent liver transplantation without artery reconstruction. Liver grafts were retrieved from the two groups and histological examination was performed following surgery. Results Total mean operating times were similar to 42 minutes for the donor liver extraction and 57 minutes for the recipient transplantation. Graft preparation took an additional 15 minutes and the time to fix the arterial bracket was similar to 3 minutes. During transplantation, the anhepatic phase lasted 18 +/- 2.5 min and the artery reconstruction only required similar to 3 minutes. The patency rate was 94.44% and the 4-week survival rate was 90%. Histology indicated obvious fibrosis in the liver grafts without artery reconstruction, while normal histology was observed in the arterialized graft. Conclusions This new method allows for the surgical procedure to be performed visually unaided with good survival and patency rates and represents an alternative model investigating OLT in rats.	[Liu, Xingmu; Huang, Tao; Gu, Jiang] Shantou Univ, Coll Med, Dept Pathol, Guangdong Prov Key Lab Infect Dis & Mol Immunopat, Shantou, Guangdong, Peoples R China; [Liu, Xingmu; Huang, Tao; Gu, Jiang] Shantou Univ, Coll Med, Collaborat & Creat Ctr, Shantou, Guangdong, Peoples R China; [Liu, Xingmu; Huang, Tao; Gu, Jiang] Shantou Univ, Coll Med, Ctr Translat Med, Shantou, Guangdong, Peoples R China; [Liu, Xingmu; He, Chao] Shantou Univ, Coll Med, Affiliated Hosp 2, Dept Gen Surg, Shantou, Guangdong, Peoples R China	Shantou University; Shantou University; Shantou University; Shantou University	Gu, J (corresponding author), Shantou Univ, Coll Med, Dept Pathol, Guangdong Prov Key Lab Infect Dis & Mol Immunopat, Shantou, Guangdong, Peoples R China.	2523381625@qq.com	Huang, Tao/AHE-8511-2022	Gu, Jiang/0000-0002-0706-8329	National Natural Science Foundation of China [81030033]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the Major Program of National Natural Science Foundation of China (No. 81030033 to JG), [http://isisn.nsfc.gov.cn/egrantweb/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariyakhagorn V, 2009, J SURG RES, V153, P332, DOI 10.1016/j.jss.2008.04.003; Bierhaus A, 2001, DIABETES, V50, P2792, DOI 10.2337/diabetes.50.12.2792; CHALAND P, 1990, TRANSPLANTATION, V49, P675, DOI 10.1097/00007890-199004000-00003; DUMINY FJ, 1989, J SURG RES, V46, P189, DOI 10.1016/0022-4804(89)90054-1; ENGEMANN R, 1982, TRANSPLANTATION, V33, P566; HOWDEN B, 1989, TRANSPLANTATION, V47, P428, DOI 10.1097/00007890-198903000-00005; Imamura H, 1997, HEPATOLOGY, V26, P198; KAMADA N, 1983, SURGERY, V93, P64; KNOOP M, 1994, AM J SURG, V167, P360, DOI 10.1016/0002-9610(94)90215-1; LAURITZEN C, 1978, SCAND J PLAST RECONS, V12, P291, DOI 10.3109/02844317809013008; LEE S, 1973, TRANSPLANTATION, V16, P664, DOI 10.1097/00007890-197312000-00019; Li J, 2002, MICROSURG, V22, P62, DOI 10.1002/micr.21726; LIU T, 1992, TRANSPLANTATION, V54, P179; Lu JL, 2014, J SURG RES, V187, P690, DOI 10.1016/j.jss.2013.11.1080; Malhi H, 2006, HEPATOLOGY, V43, pS31, DOI 10.1002/hep.21062; NOACK K, 1993, TRANSPLANTATION, V56, P495, DOI 10.1097/00007890-199309000-00001; Nosaka T, 1999, SURG TODAY, V29, P963; Oldani G, 2008, J SURG RES, V149, P303, DOI 10.1016/j.jss.2007.12.779; POST S, 1992, TRANSPLANTATION, V54, P789, DOI 10.1097/00007890-199211000-00005; Reck T, 1996, TRANSPLANTATION, V62, P582, DOI 10.1097/00007890-199609150-00007; Sato Y, 1996, EASY PHYSL ARTERIAL; Spiegel HU, 1998, J INVEST SURG, V11, P83, DOI 10.3109/08941939809032187; STEFFEN R, 1989, TRANSPLANTATION, V48, P166, DOI 10.1097/00007890-198907000-00044; Vivarelli M, 2004, ARCH SURG-CHICAGO, V139, P1069, DOI 10.1001/archsurg.139.10.1069; Yoshidome H, 1999, HEPATOLOGY, V30, P203, DOI 10.1002/hep.510300120; Zhai Y, 2011, AM J TRANSPLANT, V11, P1563, DOI 10.1111/j.1600-6143.2011.03579.x; Zhang XY, 1996, MICROSURG, V17, P472, DOI 10.1002/(SICI)1098-2752(1996)17:8<472::AID-MICR11>3.3.CO;2-P; ZHAO D, 1993, EUR SURG RES, V25, P294, DOI 10.1159/000129292	28	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145662	10.1371/journal.pone.0145662	http://dx.doi.org/10.1371/journal.pone.0145662			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716457	gold, Green Submitted, Green Published			2022-12-26	WOS:000367510500055
J	Nam, KH; Kim, J; Ra, G; Lee, CH; Paeng, DG				Nam, Kweon-Ho; Kim, Juho; Ra, Gicheol; Lee, Chong Hyun; Paeng, Dong-Guk			Feasibility Study of Ex Ovo Chick Chorioallantoic Artery Model for Investigating Pulsatile Variation of Arterial Geometry	PLOS ONE			English	Article							ENDOTHELIAL SHEAR-STRESS; CAROTID-ARTERY; BLOOD-FLOW; IN-VIVO; WALL-MOTION; VESSEL WALL; INTRAVASCULAR ULTRASOUND; ATHEROSCLEROTIC PLAQUES; VELOCITY PROFILES; BIFURCATION MODEL	Despite considerable research efforts on the relationship between arterial geometry and cardiovascular pathology, information is lacking on the pulsatile geometrical variation caused by arterial distensibility and cardiomotility because of the lack of suitable in vivo experimental models and the methodological difficulties in examining the arterial dynamics. We aimed to investigate the feasibility of using a chick embryo system as an experimental model for basic research on the pulsatile variation of arterial geometry. Optical microscope video images of various arterial shapes in chick chorioallantoic circulation were recorded from different locations and different embryo samples. The high optical transparency of the chorioallantoic membrane (CAM) allowed clear observation of tiny vessels and their movements. Systolic and diastolic changes in arterial geometry were visualized by detecting the wall boundaries from binary images. Several to hundreds of microns of wall displacement variations were recognized during a pulsatile cycle. The spatial maps of the wall motion harmonics and magnitude ratio of harmonic components were obtained by analyzing the temporal brightness variation at each pixel in sequential grayscale images using spectral analysis techniques. The local variations in the spectral characteristics of the arterial wall motion were reflected well in the analysis results. In addition, mapping the phase angle of the fundamental frequency identified the regional variations in the wall motion directivity and phase shift. Regional variations in wall motion phase angle and fundamental-to-second harmonic ratio were remarkable near the bifurcation area. In summary, wall motion in various arterial geometry including straight, curved and bifurcated shapes was well observed in the CAM artery model, and their local and cyclic variations could be characterized by Fourier and wavelet transforms of the acquired video images. The CAM artery model with the spectral analysis method is a useful in vivo experimental model for studying pulsatile variation in arterial geometry.	[Nam, Kweon-Ho; Paeng, Dong-Guk] Jeju Natl Univ, Interdisciplinary Postgrad Program Biomed Engn, Jeju, South Korea; [Nam, Kweon-Ho; Kim, Juho; Ra, Gicheol; Lee, Chong Hyun; Paeng, Dong-Guk] Jeju Natl Univ, Dept Ocean Syst Engn, Jeju, South Korea	Jeju National University; Jeju National University	Paeng, DG (corresponding author), Jeju Natl Univ, Interdisciplinary Postgrad Program Biomed Engn, Jeju, South Korea.	paeng@jejunu.ac.kr	Paeng, Dong-Guk/AAJ-2143-2021; Lee, Chong Hyun/AHA-8514-2022	Lee, Chong Hyun/0000-0003-0268-5333	MSIP (Ministry of Science, ICT and Future Planning), Korea under C-ITRC (Convergence Information Technology Research Center) [IITP-2015-H8601-15-1004]; Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2012R1A1A2043478]	MSIP (Ministry of Science, ICT and Future Planning), Korea under C-ITRC (Convergence Information Technology Research Center); Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This research was supported by the MSIP (Ministry of Science, ICT and Future Planning), Korea, under the C-ITRC (Convergence Information Technology Research Center) (IITP-2015-H8601-15-1004) supervised by the IITP (Institute for Information & communications Technology Promotion). This research was also supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A1A2043478).	Addison PS, 2005, PHYSIOL MEAS, V26, pR155, DOI 10.1088/0967-3334/26/5/R01; Bishop JJ, 2001, AM J PHYSIOL-HEART C, V280, pH222, DOI 10.1152/ajpheart.2001.280.1.H222; BRINKMAN AM, 1994, ANN BIOMED ENG, V22, P34, DOI 10.1007/BF02368220; Chatzizisis YS, 2008, CIRCULATION, V117, P993, DOI 10.1161/CIRCULATIONAHA.107.695254; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; Danilouchkine MG, 2009, PHYS MED BIOL, V54, P1397, DOI 10.1088/0031-9155/54/6/002; DEFOUW DO, 1989, MICROVASC RES, V38, P136, DOI 10.1016/0026-2862(89)90022-8; DELEON H, 1995, CIRC RES, V77, P64, DOI 10.1161/01.RES.77.1.64; Deryugina EI, 2008, HISTOCHEM CELL BIOL, V130, P1119, DOI 10.1007/s00418-008-0536-2; Feaver RE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2530; FISHER M, 1990, STROKE, V21, P267, DOI 10.1161/01.STR.21.2.267; Fisher M, 2012, NAT REV NEUROL, V8, P127, DOI 10.1038/nrneurol.2012.1; Geyer MJ, 2004, J REHABIL RES DEV, V41, P797, DOI 10.1682/JRRD.2003.10.0159; Ha H, 2012, MICROVASC RES, V84, P242, DOI 10.1016/j.mvr.2012.07.004; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hartley CJ, 2004, AM J PHYSIOL-HEART C, V287, pH1426, DOI 10.1152/ajpheart.01185.2003; Hoskins PR, 2009, BRIT J RADIOL, V82, pS3, DOI 10.1259/bjr/96847348; Huo YL, 2009, J BIOMECH, V42, P594, DOI 10.1016/j.jbiomech.2008.12.011; Jimenez RF, 1997, BIOL RES, V30, P53; Kanai H, 2000, ULTRASONICS, V38, P381, DOI 10.1016/S0041-624X(99)00118-3; Kim S, 2007, AM J PHYSIOL-HEART C, V293, pH1526, DOI 10.1152/ajpheart.01090.2006; Kim YH, 2008, ANN BIOMED ENG, V36, P1753, DOI 10.1007/s10439-008-9558-0; Klanchar M, 1990, CIRC RES, V66, P1624; KU DN, 1985, ARTERIOSCLEROSIS, V5, P293, DOI 10.1161/01.ATV.5.3.293; Latka M, 2005, AM J PHYSIOL-HEART C, V289, pH2272, DOI 10.1152/ajpheart.01307.2004; Lee Grace S, 2010, J Angiogenes Res, V2, P11, DOI 10.1186/2040-2384-2-11; Lee SJ, 2011, MICROVASC RES, V82, P296, DOI 10.1016/j.mvr.2011.09.005; Liu Y, 2008, AM J PHYSIOL-HEART C, V294, pH514, DOI 10.1152/ajpheart.00670.2007; Liu Y, 2007, AM J PHYSIOL-HEART C, V293, pH3290, DOI 10.1152/ajpheart.00666.2007; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; Markl M, 2010, CIRC-CARDIOVASC IMAG, V3, P647, DOI 10.1161/CIRCIMAGING.110.958504; Martinsen BJ, 2005, DEV DYNAM, V233, P1217, DOI 10.1002/dvdy.20468; Nam KH, 2014, ULTRASONICS, V54, P233, DOI 10.1016/j.ultras.2013.04.012; Nelson TR, 2000, ULTRASOUND OBST GYN, V16, P374, DOI 10.1046/j.1469-0705.2000.00180.x; NGUYEN M, 1994, MICROVASC RES, V47, P31, DOI 10.1006/mvre.1994.1003; Nowak-Sliwinska P, 2010, ANGIOGENESIS, V13, P281, DOI 10.1007/s10456-010-9185-x; PERKTOLD K, 1995, J BIOMECH, V28, P845, DOI 10.1016/0021-9290(95)95273-8; Potter DR, 2009, CIRC RES, V104, P1318, DOI 10.1161/CIRCRESAHA.108.191585; Rabben SI, 2002, ULTRASOUND MED BIOL, V28, P507, DOI 10.1016/S0301-5629(02)00487-8; Stone PH, 2003, CIRCULATION, V108, P438, DOI 10.1161/01.CIR.0000080882.35274.AD; Svedlund S, 2011, CLIN PHYSIOL FUNCT I, V31, P32, DOI 10.1111/j.1475-097X.2010.00976.x; Vargas A, 2007, ADV DRUG DELIVER REV, V59, P1162, DOI 10.1016/j.addr.2007.04.019; WEIZSACKER HW, 1983, J BIOMECH, V16, P703, DOI 10.1016/0021-9290(83)90080-5; Woods RE, 2004, DIGITAL IMAGE PROCES, Vxiv; Yalcin Huseyin C, 2010, J Vis Exp, DOI 10.3791/2154; ZARINS CK, 1983, CIRC RES, V53, P502, DOI 10.1161/01.RES.53.4.502; Zhao SZ, 2000, J BIOMECH, V33, P975, DOI 10.1016/S0021-9290(00)00043-9	47	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145969	10.1371/journal.pone.0145969	http://dx.doi.org/10.1371/journal.pone.0145969			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717244	Green Published, gold, Green Submitted			2022-12-26	WOS:000367510500107
J	Patrick, WG; Nielsen, AAK; Keating, SJ; Levy, TJ; Wang, W; Rivera, JJ; Mondragn-Palomino, O; Carr, PA; Voigt, CA; Oxman, N; Kong, DS				Patrick, William G.; Nielsen, Alec A. K.; Keating, Steven J.; Levy, Taylor J.; Wang, Wei; Rivera, Jaime J.; Mondragn-Palomino, Octavio; Carr, Peter A.; Voigt, Christopher A.; Oxman, Neri; Kong, David S.			DNA Assembly in 3D Printed Fluidics	PLOS ONE			English	Article							GENE SYNTHESIS; SYNTHETIC BIOLOGY; ESCHERICHIA-COLI; CHIP; OPTIMIZATION; SEQUENCE; DEVICES; DESIGN; LAB	The process of connecting genetic parts-DNA assembly-is a foundational technology for synthetic biology. Microfluidics present an attractive solution for minimizing use of costly reagents, enabling multiplexed reactions, and automating protocols by integrating multiple protocol steps. However, microfluidics fabrication and operation can be expensive and requires expertise, limiting access to the technology. With advances in commodity digital fabrication tools, it is now possible to directly print fluidic devices and supporting hardware. 3D printed micro-and millifluidic devices are inexpensive, easy to make and quick to produce. We demonstrate Golden Gate DNA assembly in 3D-printed fluidics with reaction volumes as small as 490 nL, channel widths as fine as 220 microns, and per unit part costs ranging from $0.61 to $ 5.71. A 3D-printed syringe pump with an accompanying programmable software interface was designed and fabricated to operate the devices. Quick turnaround and inexpensive materials allowed for rapid exploration of device parameters, demonstrating a manufacturing paradigm for designing and fabricating hardware for synthetic biology.	[Patrick, William G.; Keating, Steven J.; Levy, Taylor J.; Wang, Wei; Oxman, Neri] MIT, Media Lab, Sch Architecture & Planning, Cambridge, MA 02139 USA; [Nielsen, Alec A. K.; Rivera, Jaime J.; Mondragn-Palomino, Octavio; Voigt, Christopher A.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Keating, Steven J.] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Carr, Peter A.; Kong, David S.] MIT, Lincoln Lab, Lexington, MA 02173 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Lincoln Laboratory; Massachusetts Institute of Technology (MIT)	Kong, DS (corresponding author), MIT, Lincoln Lab, 244 Wood St, Lexington, MA 02173 USA.	dkong@ll.mit.edu			Defense for Research & Engineering under Air Force [FA8721-05-C-0002]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F32ES027306, F31ES027304] Funding Source: NIH RePORTER	Defense for Research & Engineering under Air Force; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was sponsored by the Assistant Secretary of Defense for Research & Engineering under Air Force Contract #FA8721-05-C-0002. Opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the United States Government. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn CH, 2004, P IEEE, V92, P154, DOI 10.1109/JPROC.2003.820548; Anderson KB, 2013, ANAL CHEM, V85, P5622, DOI 10.1021/ac4009594; [Anonymous], 2009, DREMELFUGE A ONE PIE; Anzalone GC, 2013, SENSORS-BASEL, V13, P5338, DOI 10.3390/s130405338; Au AK, 2015, LAB CHIP, V15, P1934, DOI 10.1039/c5lc00126a; Au AK, 2014, LAB CHIP, V14, P1294, DOI 10.1039/c3lc51360b; Baden T, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002086; Bhargava KC, 2014, P NATL ACAD SCI USA, V111, P15013, DOI 10.1073/pnas.1414764111; Carriere P, 2007, PHYS FLUIDS, V19, DOI 10.1063/1.2804959; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chen CP, 2014, ANALYST, V139, P3219, DOI 10.1039/c3an02357e; Chen YJ, 2013, NAT METHODS, V10, P659, DOI [10.1038/NMETH.2515, 10.1038/nmeth.2515]; Chen ZY, 2007, ANN NY ACAD SCI, V1098, P429, DOI 10.1196/annals.1384.024; Cheng AA, 2012, ANNU REV BIOMED ENG, V14, P155, DOI [10.1146/annurev-bioeng-071811-150118, 10.1146/annurev.bioeng-071811-150118]; Chin CD, 2012, LAB CHIP, V12, P2118, DOI 10.1039/c2lc21204h; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Engler C, 2009, PLOS ONE, P4, DOI [DOI 10.1371/J0URNAL.P0NE.0005553, 10.1371/journal.pone.0005553]; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Erkal JL, 2014, LAB CHIP, V14, P2023, DOI 10.1039/c4lc00171k; Farasat I, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20134955; Follett J, 2015, DESIGNING FOR EMERGI, P379; Huang MC, 2009, LAB CHIP, V9, P276, DOI 10.1039/b807688j; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Kitson PJ, 2012, LAB CHIP, V12, P3267, DOI 10.1039/c2lc40761b; Kong DS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm121; Krejcova L, 2014, BIOSENS BIOELECTRON, V54, P421, DOI 10.1016/j.bios.2013.10.031; Kuo JS, 2011, LAB CHIP, V11, P2656, DOI 10.1039/c1lc20125e; Lee KG, 2014, RSC ADV, V4, P32876, DOI 10.1039/c4ra05072j; Liao Y, 2012, LAB CHIP, V12, P746, DOI 10.1039/c2lc21015k; Linshiz G, 2014, ACS SYNTH BIOL, V3, P515, DOI 10.1021/sb4001728; Lou CB, 2012, NAT BIOTECHNOL, V30, P1137, DOI 10.1038/nbt.2401; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Quan JY, 2011, NAT BIOTECHNOL, V29, P449, DOI 10.1038/nbt.1847; Rogers C., 2015, B CKLUND DARBOUX TRA, P1; Shallan A.I., 2014, ANAL CHEM; Smanski MJ, 2014, NAT BIOTECHNOL, V32, P1241, DOI 10.1038/nbt.3063; SUTCLIFFE JG, 1978, P NATL ACAD SCI USA, V75, P3737, DOI 10.1073/pnas.75.8.3737; Takahashi CN, 2015, ACS SYNTH BIOL; Wang J, 2006, LAB CHIP, V6, P46, DOI 10.1039/b511494b; Weber E, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016765, DOI 10.1371/J0URNAL.P0NE.0016765]; Weber W, 2012, NAT REV GENET, V13, P21, DOI 10.1038/nrg3094; Wijnen B, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0107216, DOI 10.1371/J0URNAL.P0NE.0107216]; Zhang CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059840; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775	44	35	35	3	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0143636	10.1371/journal.pone.0143636	http://dx.doi.org/10.1371/journal.pone.0143636			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716448	Green Published, Green Submitted, gold			2022-12-26	WOS:000367510500007
J	Spellmon, N; Sun, XN; Sirinupong, N; Edwards, B; Li, CY; Yang, Z				Spellmon, Nicholas; Sun, Xiaonan; Sirinupong, Nualpun; Edwards, Brian; Li, Chunying; Yang, Zhe			Molecular Dynamics Simulation Reveals Correlated Inter-Lobe Motion in Protein Lysine Methyltransferase SMYD2	PLOS ONE			English	Article							HISTONE METHYLTRANSFERASE; MYND DOMAIN; STRUCTURAL INSIGHTS; METHYLATION; SET; RECOGNITION; ENCODES	SMYD proteins are an exciting field of study as they are linked to many types of cancer-related pathways. Cardiac and skeletal muscle development and function also depend on SMYD proteins opening a possible avenue for cardiac-related treatment. Previous crystal structure studies have revealed that this special class of protein lysine methyltransferases have a bilobal structure, and an open-closed motion may regulate substrate specificity. Here we use the molecular dynamics simulation to investigate the still-poorly-understood SMYD2 dynamics. Cross-correlation analysis reveals that SMYD2 exhibits a negative correlated inter-lobe motion. Principle component analysis suggests that this correlated dynamic is contributed to by a twisting motion of the C-lobe with respect to the N-lobe and a clamshell-like motion between the lobes. Dynamical network analysis defines possible allosteric paths for the correlated dynamics. There are nine communities in the dynamical network with six in the N-lobe and three in the C-lobe, and the communication between the lobes is mediated by a lobe-bridging beta hairpin. This study provides insight into the dynamical nature of SMYD2 and could facilitate better understanding of SMYD2 substrate specificity.	[Spellmon, Nicholas; Sun, Xiaonan; Edwards, Brian; Li, Chunying; Yang, Zhe] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48202 USA; [Sirinupong, Nualpun] Prince Songkla Univ, Nutraceut & Funct Food Res & Dev Ctr, Hat Yai, Songkhla, Thailand	Wayne State University; Prince of Songkla University	Li, CY (corresponding author), Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48202 USA.	cl@med.wayne.edu; zyang@med.wayne.edu	Sirinupong, Nualpun/AAX-4886-2020	Sirinupong, Nualpun/0000-0002-9986-3011	National Institutes of Health [1R01HL128647-01]; National Science Foundation [ACI-1053575]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL128647] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by the National Institutes of Health grant number 1R01HL128647-01 (to CL and ZY). This work used the Extreme Science and Engineering Discovery Environment (XSEDE), which is supported by the National Science Foundation grant number ACI-1053575. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Farha M, 2008, MOL CELL PROTEOMICS, V7, P560, DOI 10.1074/mcp.M700271-MCP200; Abu-Farha M, 2011, J MOL CELL BIOL, V3, P301, DOI 10.1093/jmcb/mjr025; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Fenwick RB, 2011, EUR BIOPHYS J BIOPHY, V40, P1339, DOI 10.1007/s00249-011-0754-8; Cho HS, 2012, NEOPLASIA, V14, P476, DOI 10.1593/neo.12656; del Sol A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100063; Esteban-Martin S, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003721; Glykos NM, 2006, J COMPUT CHEM, V27, P1765, DOI 10.1002/jcc.20482; Gottlieb PD, 2002, NAT GENET, V31, P25, DOI 10.1038/ng866; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jiang YY, 2014, J MOL BIOL, V426, P3413, DOI 10.1016/j.jmb.2014.02.019; Jiang YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021640; Liu YZ, 2007, CANCER CELL, V11, P483, DOI 10.1016/j.ccr.2007.04.010; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Saddic LA, 2010, J BIOL CHEM, V285, P37733, DOI 10.1074/jbc.M110.137612; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sethi A, 2009, P NATL ACAD SCI USA, V106, P6620, DOI 10.1073/pnas.0810961106; Sirinupong N, 2011, J MOL BIOL, V406, P149, DOI 10.1016/j.jmb.2010.12.014; Sirinupong N, 2010, J BIOL CHEM, V285, P40635, DOI 10.1074/jbc.M110.168187; Spadaccini R, 2006, J MOL BIOL, V358, P498, DOI 10.1016/j.jmb.2006.01.087; Spellmon N, 2015, INT J MOL SCI, V16, P1406, DOI 10.3390/ijms16011406; Tan XG, 2006, P NATL ACAD SCI USA, V103, P2713, DOI 10.1073/pnas.0509503103; Wang L, 2011, J BIOL CHEM, V286, P38725, DOI 10.1074/jbc.M111.262410; Xu ST, 2011, NUCLEIC ACIDS RES, V39, P4438, DOI 10.1093/nar/gkr019	27	10	11	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145758	10.1371/journal.pone.0145758	http://dx.doi.org/10.1371/journal.pone.0145758			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717235	Green Published, gold			2022-12-26	WOS:000367510500067
J	Zeng, HL; Tan, FX; Shu, YH; Zhang, YY; Feng, YJ; Wang, JW				Zeng, Huilan; Tan, Fengxiao; Shu, Yinghua; Zhang, Yanyan; Feng, Yuanjiao; Wang, Jianwu			The Cry1Ab Protein Has Minor Effects on the Arbuscular Mycorrhizal Fungal Communities after Five Seasons of Continuous Bt Maize Cultivation	PLOS ONE			English	Article							IN-FIELD PLOTS; BACILLUS-THURINGIENSIS; SOIL; CORN; DIVERSITY; IMPACT; NEMATODES; REPRODUCTION; RESPONSES; PLANTS	The cultivation of genetically modified plants (GMP) has raised concerns regarding the plants' ecological safety. A greenhouse experiment was conducted to assess the impact of five seasons of continuous Bt (Bacillus thuringiensis) maize cultivation on the colonisation and community structure of the non-target organisms arbuscular mycorrhizal fungi (AMF) in the maize roots, bulk soils and rhizospheric soils using the terminal restriction fragment length polymorphism (T-RFLP) analysis of the 28S ribosomal DNA and sequencing methods. AMF colonisation was significantly higher in the two Bt maize lines that express Cry1Ab, 5422Bt1 (event Bt11) and 5422CBCL (MON810) than in the non-Bt isoline 5422. No significant differences were observed in the diversity of the AMF community between the roots, bulk soils and rhizospheric soils of the Bt and non-Bt maize cultivars. The AMF genus Glomus was dominant in most of the samples, as detected by DNA sequencing. A clustering analysis based on the DNA sequence data suggested that the sample types (i. e., the samples from the roots, bulk soils or rhizospheric soils) might have greater influence on the AMF community phylotypes than the maize cultivars. This study indicated that the Cry1Ab protein has minor effects on the AMF communities after five seasons of continuous Bt maize cultivation.	[Zeng, Huilan; Tan, Fengxiao; Shu, Yinghua; Zhang, Yanyan; Feng, Yuanjiao; Wang, Jianwu] South China Agr Univ, Dept Ecol, Coll Agr, Guangzhou 510642, Guangdong, Peoples R China; [Zeng, Huilan; Tan, Fengxiao; Shu, Yinghua; Zhang, Yanyan; Feng, Yuanjiao; Wang, Jianwu] South China Agr Univ, Key Lab Agroecol & Rural Environm Guangdong Regul, Guangzhou 510642, Guangdong, Peoples R China; [Zeng, Huilan; Tan, Fengxiao; Shu, Yinghua; Zhang, Yanyan; Feng, Yuanjiao; Wang, Jianwu] South China Agr Univ, Key Lab Agroenvironm Trop, Minist Agr, Guangzhou 510642, Guangdong, Peoples R China	South China Agricultural University; South China Agricultural University; Ministry of Agriculture & Rural Affairs; South China Agricultural University	Wang, JW (corresponding author), South China Agr Univ, Dept Ecol, Coll Agr, Guangzhou 510642, Guangdong, Peoples R China.	wangjw@scau.edu.cn	Wang, Jianwu/E-4994-2011	Wang, Jianwu/0000-0002-4421-8058	National Natural Science Foundation of China [31170506]; Science and Technology Program of Guangdong province, China [2015B090903077]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Program of Guangdong province, China	The present work was supported by grants from National Natural Science Foundation of China (31170506) received by Jianwu Wang and the Science and Technology Program of Guangdong province, China (No. 2015B090903077). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alguacil MM, 2008, ECOL APPL, V18, P527, DOI 10.1890/07-0521.1; Bainard LD, 2012, SOIL BIOL BIOCHEM, V45, P172, DOI 10.1016/j.soilbio.2011.10.008; Barriuso J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035481; Carvalho LM, 2003, PLANT SOIL, V251, P227, DOI 10.1023/A:1023016317269; Castaldini M, 2005, APPL ENVIRON MICROB, V71, P6719, DOI 10.1128/AEM.71.11.6719-6729.2005; Cheeke TE, 2012, AM J BOT, V99, P700, DOI 10.3732/ajb.1100529; Cheeke TE, 2013, ADV AGROECOL, P1; Crecchio C, 1998, SOIL BIOL BIOCHEM, V30, P463, DOI 10.1016/S0038-0717(97)00147-8; de Vaufleury A, 2007, PEDOBIOLOGIA, V51, P185, DOI 10.1016/j.pedobi.2007.04.005; Donegan KK, 1996, TRANSGENIC RES, V5, P25, DOI 10.1007/BF01979919; Ferreira LHPL, 2003, PLANT SOIL, V256, P161, DOI 10.1023/A:1026256700237; Griffiths BS, 2008, PLANT SOIL, V308, P93, DOI 10.1007/s11104-008-9609-1; Griffiths BS, 2007, PLANT BIOTECHNOL J, V5, P60, DOI 10.1111/j.1467-7652.2006.00215.x; Griffiths BS, 2006, J ENVIRON QUAL, V35, P734, DOI 10.2134/jeq2005.0344; Griffiths BS, 2005, PLANT SOIL, V275, P135, DOI 10.1007/s11104-005-1093-2; Hajiboland R, 2010, PLANT SOIL, V331, P313, DOI 10.1007/s11104-009-0255-z; Hannula SE, 2010, SOIL BIOL BIOCHEM, V42, P2211, DOI 10.1016/j.soilbio.2010.08.020; Hannula SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033819; Hijri I, 2006, MOL ECOL, V15, P2277, DOI 10.1111/j.1365-294X.2006.02921.x; Honemann L, 2009, EUR J SOIL BIOL, V45, P351, DOI 10.1016/j.ejsobi.2009.03.001; Hoss S, 2008, ECOTOX ENVIRON SAFE, V70, P334, DOI 10.1016/j.ecoenv.2007.10.017; Hoss S, 2011, SCI TOTAL ENVIRON, V409, P2674, DOI 10.1016/j.scitotenv.2011.03.041; James C, 2012, GLOBAL STATUS COMMER, P44; JASPER DA, 1989, NEW PHYTOL, V112, P93, DOI 10.1111/j.1469-8137.1989.tb00313.x; Jurat-Fuentes JL, 2012, BACILLUS THURINGIENS, P283, DOI DOI 10.1007/978-94-007-3021-2_15; Karasawa T, 2012, PLANT CELL ENVIRON, V35, P819, DOI 10.1111/j.1365-3040.2011.02455.x; Khan MQ, 2010, PAK J BOT, V42, P2903; Kruger M, 2012, NEW PHYTOL, V193, P970, DOI 10.1111/j.1469-8137.2011.03962.x; Liu B, 2009, FRONT BIOSCI, V14, P4008, DOI [10.2741/3508, 10.2735/3508]; Liu B, 2009, SOIL BIOL BIOCHEM, V41, P1841, DOI 10.1016/j.soilbio.2009.06.004; Liu W, 2008, ACTA AGR SCAND B-S P, V58, P187, DOI 10.1080/09064710701478339; Lopez-Garcia A, 2013, PLANT SOIL, V370, P355, DOI 10.1007/s11104-013-1625-0; Oehl F, 2004, OECOLOGIA, V138, P574, DOI 10.1007/s00442-003-1458-2; Oehl F, 2003, APPL ENVIRON MICROB, V69, P2816, DOI 10.1128/AEM.69.5.2816-2824.2003; Oliveira AP, 2008, SCI TOTAL ENVIRON, V405, P351, DOI 10.1016/j.scitotenv.2008.05.046; Parniske M, 2008, NAT REV MICROBIOL, V6, P763, DOI 10.1038/nrmicro1987; Santos-Gonzalez JC, 2011, MICROB ECOL, V62, P25, DOI 10.1007/s00248-011-9834-7; Saxena D, 2002, PLANT SOIL, V239, P165, DOI 10.1023/A:1015057509357; Saxena D, 2001, AM J BOT, V88, P1704, DOI 10.2307/3558416; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Smith S., 1997, MYCORRHIZAL SYMBIOSI, V2nd Edn; Stanley-Horn DE, 2001, P NATL ACAD SCI USA, V98, P11931, DOI 10.1073/pnas.211277798; Steinkellner S, 2012, MYCORRHIZA, V22, P189, DOI 10.1007/s00572-011-0393-z; Stotzky G, 2004, PLANT SOIL, V266, P77; Sturmer SL, 2011, MYCORRHIZA, V21, P255, DOI 10.1007/s00572-010-0330-6; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tan FX, 2011, SOIL BIOL BIOCHEM, V43, P2473, DOI 10.1016/j.soilbio.2011.08.014; Torrecillas E, 2012, APPL ENVIRON MICROB, V78, P6180, DOI 10.1128/AEM.01287-12; Turrini A, 2004, PLANT SOIL, V266, P69; van der Gast CJ, 2011, ENVIRON MICROBIOL, V13, P241, DOI 10.1111/j.1462-2920.2010.02326.x; Verbruggen E, 2012, APPL ENVIRON MICROB, V78, P7384, DOI 10.1128/AEM.01372-12; Wang B, 2006, MYCORRHIZA, V16, P299, DOI 10.1007/s00572-005-0033-6; Wetzel K, 2014, SOIL BIOL BIOCHEM, V72, P88, DOI 10.1016/j.soilbio.2014.01.033; Willis A, 2013, CRIT REV PLANT SCI, V32, P1, DOI 10.1080/07352689.2012.683375; Wu WX, 2004, SOIL BIOL BIOCHEM, V36, P289, DOI 10.1016/j.soilbio.2003.09.014; Zeng HL, 2014, SOIL BIOL BIOCHEM, V75, P254, DOI 10.1016/j.soilbio.2014.04.024	56	9	12	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0146041	10.1371/journal.pone.0146041	http://dx.doi.org/10.1371/journal.pone.0146041			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717324	Green Published, gold, Green Submitted			2022-12-26	WOS:000367510500124
J	Engelke, W; Lazzarini, M; Stuhmer, W; Beltran, V				Engelke, Wilfried; Lazzarini, Marcio; Stuehmer, Walter; Beltran, Victor			Support Immersion Endoscopy in Post-Extraction Alveolar Bone Chambers: A New Window for Microscopic Bone Imaging In Vivo	PLOS ONE			English	Article							IMPLANT SITES; DENSITY; ASSESSMENTS	Using an endoscopic approach, small intraoral bone chambers, which are routinely obtained during tooth extraction and implantation, provide visual in vivo access to internal bone structures. The aim of the present paper is to present a new method to quantify bone microstructure and vascularisation in vivo. Ten extraction sockets and 6 implant sites in 14 patients (6 men / 8 women) were examined by support immersion endoscopy (SIE). After tooth extraction or implant site preparation, microscopic bone analysis (MBA) was performed using short distance SIE video sequences of representative bone areas for off-line analysis with ImageJ. Quantitative assessment of the microstructure and vascularisation of the bone in dental extraction and implant sites in vivo was performed using ImageJ. MBA revealed bone morphology details such as unmineralised and mineralised areas, vascular canals and the presence of bleeding through vascular canals. Morphometric examination revealed that there was more unmineralised bone and less vascular canal area in the implant sites than in the extraction sockets.	[Engelke, Wilfried; Beltran, Victor] Georg August Univ Hosp, Dept Oral & Maxillofacial Surg, Gottingen, Germany; [Lazzarini, Marcio; Stuehmer, Walter] Max Planck Inst Expt Med, Dept Mol Biol Neuronal Signals, D-37075 Gottingen, Germany; [Beltran, Victor] Univ La Frontera, Sch Dent, Res Ctr Dent Sci CICO, Temuco, Chile	University of Gottingen; Max Planck Society; Universidad de La Frontera	Engelke, W (corresponding author), Georg August Univ Hosp, Dept Oral & Maxillofacial Surg, Gottingen, Germany.	wengelke@med.uni-oettingen.de	Stuehmer, Walter/A-2176-2009	Stuehmer, Walter/0000-0002-0642-7764				[Anonymous], 2011, J STAT MODELING ANAL, DOI DOI 10.1515/BILE-2015-0008; Beltran V., 2012, J ORAL MAXILLOFAC SU, V70, P6; BRANEMARK P I, 1959, Scand J Clin Lab Invest, V11 Supp 38, P1; BRANEMARK P I, 1964, Blut, V10, P236, DOI 10.1007/BF01630647; Brown E, 2010, COLD SPRING HARB PRO, P5452; DEMPSTER WT, 1959, ANAT REC, V135, P189, DOI 10.1002/ar.1091350305; Desmons SO, 2010, LASER SURG MED, V42, P631, DOI 10.1002/lsm.20971; Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023; Engelke W, 2005, INT J ORAL MAX IMPL, V20, P891; Engelke W, 2008, INT J ODONTOSTOMATOL, V2, P153; Engelke WGH, 2002, INT J ORAL MAX IMPL, V17, P703; Engelke W, 2014, J CRANIO MAXILL SURG, V42, P213, DOI 10.1016/j.jcms.2013.05.003; Engelke W, 2011, CLIN ORAL INVEST, V15, P165, DOI 10.1007/s00784-009-0367-0; de Oliveira RCG, 2012, CLIN ORAL IMPLAN RES, V23, P981, DOI 10.1111/j.1600-0501.2011.02243.x; Hao Y, 2014, EUR REV MED PHARMACO, V18, P1398; Hsieh AS, 2001, BONE, V28, P94, DOI 10.1016/S8756-3282(00)00415-4; Juodzbalys G, 2008, J PERIODONTOL, V79, P64, DOI 10.1902/jop.2008.070253 ; Kingsmill VJ, 2007, J DENT RES, V86, P368, DOI 10.1177/154405910708600413; Mishra Awadhesh Kumar, 2014, Med J Armed Forces India, V70, P257, DOI 10.1016/j.mjafi.2014.04.007; Miyamoto W, 2013, ARTHROSC TEC, V2, pE467, DOI 10.1016/j.eats.2013.07.001; Nahlieli O, 2011, J ORAL MAXIL SURG, V69, P186, DOI 10.1016/j.joms.2010.07.071; Nkenke E, 2003, J CRANIO MAXILL SURG, V31, P362, DOI 10.1016/j.jcms.2003.07.001; Norton MR, 2001, CLIN ORAL IMPLAN RES, V12, P79, DOI 10.1034/j.1600-0501.2001.012001079.x; Nyarady J, 2012, J ORTHOP TRAUMA, V26, P200, DOI 10.1097/BOT.0b013e31822c8376; PARFITT AM, 1987, AM J MED, V82, P68, DOI 10.1016/0002-9343(87)90274-9; Pautke C, 2010, J ANAT, V217, P76, DOI 10.1111/j.1469-7580.2010.01237.x; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Taleb C, 2010, CHIR MAIN, V29, P78, DOI 10.1016/j.main.2009.12.001; Turkyilmaz I, 2007, J ORAL REHABIL, V34, P267, DOI 10.1111/j.1365-2842.2006.01689.x; Turkyilmaz I, 2006, J ORAL REHABIL, V33, P881, DOI 10.1111/j.1365-2842.2006.01692.x; Villa MM, 2013, TISSUE ENG PART C-ME, V19, P839, DOI [10.1089/ten.tec.2012.0490, 10.1089/ten.TEC.2012.0490]; von Arx T, 2003, INT ENDOD J, V36, P691, DOI 10.1046/j.1365-2591.2003.00718.x; WINET H, 1990, J BONE MINER RES, V5, P19, DOI 10.1002/jbmr.5650050106	33	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145767	10.1371/journal.pone.0145767	http://dx.doi.org/10.1371/journal.pone.0145767			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713617	Green Published, gold, Green Submitted			2022-12-26	WOS:000367481900078
J	Raza, H; John, A				Raza, Haider; John, Annie			Differential Cytotoxicity of Acetaminophen in Mouse Macrophage J774.2 and Human Hepatoma HepG2 Cells: Protection by Diallyl Sulfide	PLOS ONE			English	Article							RESPIRATORY ENZYME-ACTIVITIES; INDUCED HEPATOTOXICITY; OXIDATIVE STRESS; INDUCED TOXICITY; MICE; APOPTOSIS; PARACETAMOL; GLUTATHIONE; MECHANISMS; HEPATOCYTES	Non-steroidal anti-inflammatory drugs (NSAIDs), including acetaminophen (APAP), have been reported to induce cytotoxicity in cancer and non-cancerous cells. Overdose of acetaminophen (APAP) causes liver injury in humans and animals. Hepatic glutathione (GSH) depletion followed by oxidative stress and mitochondrial dysfunction are believed to be the main causes of APAP toxicity. The precise molecular mechanism of APAP toxicity in different cellular systems is, however, not clearly understood. Our previous studies on mouse macrophage J774.2 cells treated with APAP strongly suggest induction of apoptosis associated with mitochondrial dysfunction and oxidative stress. In the present study, using human hepatoma HepG2 cells, we have further demonstrated that macrophages are a more sensitive target for APAP-induced toxicity than HepG2 cells. Using similar dose- and time-point studies, a marked increase in apoptosis and DNA fragmentation were seen in macrophages compared to HepG2 cells. Differential effects of APAP on mitochondrial respiratory functions and oxidative stress were observed in the two cell lines which are presumably dependent on the varying degree of drug metabolism by the different cytochrome P450s and detoxification by glutathione S-transferase enzyme systems. Our results demonstrate a marked increase in the activity and expression of glutathione transferase (GST) and multidrug resistance (MDR1) proteins in APAP-treated HepG2 cells compared to macrophages. This may explain the apparent resistance of HepG2 cells to APAP toxicity. However, treatment of these cells with diallyl sulfide (DAS, 200 mu M), a known chemopreventive agent from garlic extract, 24 h prior to APAP (10 mu mol/ml for 18h) exhibited comparable cytoprotective effects in the two cell lines. These results may help in better understanding the mechanism of cytotoxicity caused by APAP and cytoprotection by chemopreventive agents in cancer and non-cancerous cellular systems.	[Raza, Haider; John, Annie] UAE Univ, Dept Biochem, Coll Med & Hlth Sci, Al Ain, U Arab Emirates	United Arab Emirates University	Raza, H (corresponding author), UAE Univ, Dept Biochem, Coll Med & Hlth Sci, POB 17666, Al Ain, U Arab Emirates.	h.raza@uaeu.ac.ae		Raza, Haider/0000-0001-9680-5388	Research Committee Grant, CMHS (College of Medicine and Health Sciences), UAE University, UAE; Sheikh Hamdan bin Rashid Al Maktoum Medical Research Award; Terry Fox Cancer Research Fund (UAE)	Research Committee Grant, CMHS (College of Medicine and Health Sciences), UAE University, UAE; Sheikh Hamdan bin Rashid Al Maktoum Medical Research Award; Terry Fox Cancer Research Fund (UAE)	Authors wish to acknowledge the support from the Research Committee Grant, CMHS (College of Medicine and Health Sciences), UAE University, UAE. Supports from Sheikh Hamdan bin Rashid Al Maktoum Medical Research Award and Terry Fox Cancer Research Fund (UAE) are also acknowledged.	Al-Belooshi T., 2010, AM J BIOMED LIFE SCI, V2, P142, DOI [10.5099/aj100200142, DOI 10.5099/AJ100200142]; Al-Belooshi T, 2010, FOOD CHEM TOXICOL, V48, P2624, DOI 10.1016/j.fct.2010.06.031; Andringa KK, 2008, TOXICOL LETT, V177, P188, DOI 10.1016/j.toxlet.2008.01.010; Arakawa S, 2012, J TOXICOL SCI, V37, P595; Bajt ML, 2004, TOXICOL SCI, V80, P343, DOI 10.1093/toxsci/kfh151; BOOBIS AR, 1990, BIOCHEM PHARMACOL, V39, P1277, DOI 10.1016/0006-2952(90)90003-4; BOOBIS AR, 1986, FOOD CHEM TOXICOL, V24, P731, DOI 10.1016/0278-6915(86)90172-9; BURCHAM PC, 1991, J BIOL CHEM, V266, P5049; DAI Y, 1995, J PHARMACOL EXP THER, V273, P1497; Dambach DM, 2006, TOXICOL APPL PHARM, V211, P157, DOI 10.1016/j.taap.2005.06.024; Ghanem CI, 2011, BIOCHEM PHARMACOL, V81, P244, DOI 10.1016/j.bcp.2010.10.006; Gujral JS, 2002, TOXICOL SCI, V67, P322, DOI 10.1093/toxsci/67.2.322; HARVISON PJ, 1988, CHEM RES TOXICOL, V1, P47, DOI 10.1021/tx00001a009; Hinz B, 2008, FASEB J, V22, P383, DOI 10.1096/fj.07-8506com; Hoffman DL, 2009, J BIOL CHEM, V284, P16236, DOI 10.1074/jbc.M809512200; Holt MP, 2008, J LEUKOCYTE BIOL, V84, P1410, DOI 10.1189/jlb.0308173; Hu JJ, 1996, FOOD CHEM TOXICOL, V34, P963, DOI 10.1016/S0278-6915(96)00057-9; Imaeda AB, 2009, J CLIN INVEST, V119, P305, DOI 10.1172/JCI35958; Ishida Y, 2006, EUR J IMMUNOL, V36, P1028, DOI 10.1002/eji.200535261; Jaeschke H, 2010, COMPREHENSIVE TOXICOLOGY, VOL 9: HEPATIC TOXICOLOGY, 2ND EDITION, P457; Jaeschke H, 2004, LIVER INT, V24, P85, DOI 10.1111/j.1478-3231.2004.0906.x; James LP, 2003, DRUG METAB DISPOS, V31, P1499, DOI 10.1124/dmd.31.12.1499; Kon K, 2007, J GASTROEN HEPATOL, V22, pS49, DOI 10.1111/j.1440-1746.2007.04962.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lazerow SK, 2005, CURR OPIN GASTROEN, V21, P283, DOI 10.1097/01.mog.0000160043.10804.60; Lee WM, 2004, HEPATOLOGY, V40, P6, DOI 10.1002/hep.20293; Liu ZX, 2004, GASTROENTEROLOGY, V127, P1760, DOI 10.1053/j.gastro.2004.08.053; Maity P, 2009, J BIOL CHEM, V284, P3058, DOI 10.1074/jbc.M805329200; Manov I, 2006, BASIC CLIN PHARMACOL, V99, P213, DOI 10.1111/j.1742-7843.2006.pto_443.x; Ni HM, 2012, HEPATOLOGY, V55, P222, DOI 10.1002/hep.24690; Pachkoria K, 2007, CURR DRUG SAF, V2, P97, DOI 10.2174/157488607780598287; Raza H., 2014, HAMDAN MED J, V7, P219, DOI DOI 10.7707/HMJ.V7I2.316); Raza H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103379; Raza H, 2013, CELL PHYSIOL BIOCHEM, V31, P683, DOI 10.1159/000350087; Raza H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036325; Raza H, 2011, EUR J PHARMACOL, V668, P15, DOI 10.1016/j.ejphar.2011.06.016; Reid AB, 2005, J PHARMACOL EXP THER, V312, P509, DOI 10.1124/jpet.104.075945; Russmann S, 2009, CURR MED CHEM, V16, P3041, DOI 10.2174/092986709788803097; Saito C, 2010, HEPATOLOGY, V51, P246, DOI 10.1002/hep.23267; Sener G, 2003, J PINEAL RES, V35, P61, DOI 10.1034/j.1600-079X.2003.00050.x; Shaik IH, 2008, PHARM RES-DORDR, V25, P2231, DOI 10.1007/s11095-008-9601-8; Taylor ER, 2003, J BIOL CHEM, V278, P19603, DOI 10.1074/jbc.M209359200; THUMMEL KE, 1993, BIOCHEM PHARMACOL, V45, P1563, DOI 10.1016/0006-2952(93)90295-8; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VERMEULEN NPE, 1992, DRUG METAB REV, V24, P367, DOI 10.3109/03602539208996298	45	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145965	10.1371/journal.pone.0145965	http://dx.doi.org/10.1371/journal.pone.0145965			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714183	Green Submitted, gold, Green Published			2022-12-26	WOS:000367481900106
J	Schkolnik, G; Schmidt, M; Mazza, MG; Harnisch, F; Musat, N				Schkolnik, Gal; Schmidt, Matthias; Mazza, Marco G.; Harnisch, Falk; Musat, Niculina			In Situ Analysis of a Silver Nanoparticle-Precipitating Shewanella Biofilm by Surface Enhanced Confocal Raman Microscopy	PLOS ONE			English	Article							INTERFACIAL ELECTRON-TRANSFER; BACTERIAL NANOWIRES; MICROBIAL BIOFILMS; ANAEROBIC RESPIRATION; PROTEIN DYNAMICS; CYTOCHROME-C; ONEIDENSIS; SPECTROSCOPY; MR-1; SCATTERING	Shewanella oneidensis MR-1 is an electroactive bacterium, capable of reducing extracellular insoluble electron acceptors, making it important for both nutrient cycling in nature and microbial electrochemical technologies, such as microbial fuel cells and microbial electrosynthesis. When allowed to anaerobically colonize an Ag/AgCl solid interface, S. oneidensis has precipitated silver nanoparticles (AgNp), thus providing the means for a surface enhanced confocal Raman microscopy (SECRaM) investigation of its biofilm. The result is the in-situ chemical mapping of the biofilm as it developed over time, where the distribution of cytochromes, reduced and oxidized flavins, polysaccharides and phosphate in the undisturbed biofilm is monitored. Utilizing AgNp bio-produced by the bacteria colonizing the Ag/AgCl interface, we could perform SECRaM while avoiding the use of a patterned or roughened support or the introduction of noble metal salts and reducing agents. This new method will allow a spatially and temporally resolved chemical investigation not only of Shewanella biofilms at an insoluble electron acceptor, but also of other noble metal nanoparticle-precipitating bacteria in laboratory cultures or in complex microbial communities in their natural habitats.	[Schkolnik, Gal; Mazza, Marco G.] Max Planck Inst Dynam & Self Org, Dept Dynam Complex Fluids, Gottingen, Germany; [Schkolnik, Gal; Harnisch, Falk] Helmholtz Ctr Environm Res, Dept Environm Microbiol, Leipzig, Germany; [Schkolnik, Gal; Schmidt, Matthias; Musat, Niculina] Helmholtz Ctr Environm Res, Dept Isotope Biogeochem, Leipzig, Germany	Max Planck Society; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Schkolnik, G (corresponding author), Max Planck Inst Dynam & Self Org, Dept Dynam Complex Fluids, Gottingen, Germany.	gal.schkonik@ufz.de	Harnisch, Falk/J-5888-2012; Mazza, Marco/AAL-3983-2021; Rudich, Yinon/K-1498-2012; Musat, Niculina/ABA-2180-2021	Harnisch, Falk/0000-0002-0014-4640; Rudich, Yinon/0000-0003-3149-0201; Musat, Niculina/0000-0001-9539-189X; Schmidt, Matthias/0000-0002-0161-8326; Mazza, Marco/0000-0002-5625-9121; Schkolnik, Gal/0000-0002-5422-4566	Europaischer Fonds fur regionale Entwicklung (EFRE) Sachsen [SAB 100112100]; Initiative and Networking Fund of the Helmholtz Association [PD - 165]; Max Planck Society; Helmholtz Centre for Environmental Research	Europaischer Fonds fur regionale Entwicklung (EFRE) Sachsen; Initiative and Networking Fund of the Helmholtz Association; Max Planck Society(Max Planck SocietyFoundation CELLEX); Helmholtz Centre for Environmental Research	This work was supported by Europaischer Fonds fur regionale Entwicklung (EFRE) Sachsen, grant number SAB 100112100 (http://www.eu-info.de/foerderprogramme/strukturfonds/EFRE/); the Initiative and Networking Fund of the Helmholtz Association, funding number PD - 165 (http://www.helmholtz.de/en/about_us/initiating_and_networking/); the Max Planck Society, no funding number (http://www.mpg.de/en); and the Helmholtz Centre for Environmental Research, no funding number (http://www.ufz.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Paggi D, 2013, J PHYS CHEM B, V117, P6061, DOI 10.1021/jp400832m; Bewley KD, 2013, BBA-BIOENERGETICS, V1827, P938, DOI 10.1016/j.bbabio.2013.03.010; Biju V, 2007, LANGMUIR, V23, P1333, DOI 10.1021/la061343z; BLAKE RC, 1993, ENVIRON TOXICOL CHEM, V12, P1365, DOI 10.1002/etc.5620120806; Bowler MW, 2010, NEW J CHEM, V34, P784, DOI 10.1039/b9nj00718k; Brayner R, 2007, J NANOSCI NANOTECHNO, V7, P2696, DOI 10.1166/jnn.2007.600; Bretschger O, 2007, APPL ENVIRON MICROB, V73, P7003, DOI 10.1128/AEM.01087-07; Bretschger O, 2010, ELECTROANAL, V22, P883, DOI 10.1002/elan.200800016; Breuer M, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1117; Cao B, 2011, ENVIRON MICROBIOL, V13, P1018, DOI 10.1111/j.1462-2920.2010.02407.x; Cescutti P, 2010, MICROBIAL GLYCOBIOLO, P93; Coursolle D, 2010, J BACTERIOL, V192, P467, DOI 10.1128/JB.00925-09; Creamer NJ, 2006, BIOTECHNOL LETT, V28, P1475, DOI 10.1007/s10529-006-9120-9; Dym O, 2001, PROTEIN SCI, V10, P1712, DOI 10.1110/ps.12801; Edwards MJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11677; Edwards MJ, 2012, STRUCTURE, V20, P1275, DOI 10.1016/j.str.2012.04.016; Efrima S, 2009, J RAMAN SPECTROSC, V40, P277, DOI 10.1002/jrs.2121; El-Naggar MY, 2010, P NATL ACAD SCI USA, V107, P18127, DOI 10.1073/pnas.1004880107; Fredrickson JK, 2008, NAT REV MICROBIOL, V6, P592, DOI 10.1038/nrmicro1947; Gorby YA, 2006, P NATL ACAD SCI USA, V103, P11358, DOI 10.1073/pnas.0604517103; GREAVES SJ, 1988, J RAMAN SPECTROSC, V19, P503, DOI 10.1002/jrs.1250190803; Guerrini L, 2015, ANGEW CHEM INT EDIT, V54, P1144, DOI 10.1002/anie.201408558; Haes AJ, 2004, ANAL BIOANAL CHEM, V379, P920, DOI 10.1007/s00216-004-2708-9; Haider S, 2010, MOL MICROBIOL, V77, P687, DOI 10.1111/j.1365-2958.2010.07241.x; Halbhuber KJ, 2003, ANN ANAT, V185, P1, DOI 10.1016/S0940-9602(03)80002-X; Haynes CL, 2005, ANAL CHEM, V77, p338A, DOI 10.1021/ac053456d; Hennebel T, 2009, TRENDS BIOTECHNOL, V27, P90, DOI 10.1016/j.tibtech.2008.11.002; Holmes DE, 2004, APPL ENVIRON MICROB, V70, P1234, DOI 10.1128/AEM.70.2.1234-1237.2004; HU SZ, 1993, J AM CHEM SOC, V115, P12446, DOI 10.1021/ja00079a028; Hua X, 2014, ANALYST, V139, P1609, DOI 10.1039/c3an02262e; Ivleva NP, 2010, J PHYS CHEM B, V114, P10184, DOI 10.1021/jp102466c; Jarvis RM, 2008, ANAL CHEM, V80, P6741, DOI 10.1021/ac800838v; Jarvis RM, 2008, CHEM SOC REV, V37, P931, DOI 10.1039/b705973f; Jin RC, 2003, NATURE, V425, P487, DOI 10.1038/nature02020; Jones ME, 2010, ENVIRON MICROBIOL, V12, P938, DOI 10.1111/j.1462-2920.2009.02137.x; Kalaivani G, 2012, LANGMUIR, V28, P14357, DOI 10.1021/la303136v; Kalathil S, 2014, CHEMELECTROCHEM, V1, P1840, DOI 10.1002/celc.201402195; Karthikeyan S, 2002, ENVIRON MICROBIOL, V4, P667, DOI 10.1046/j.1462-2920.2002.00353.x; Kazanci M, 2009, APPL SPECTROSC, V63, P214, DOI 10.1366/000370209787391987; Kelly KL, 2003, J PHYS CHEM B, V107, P668, DOI 10.1021/jp026731y; Kim M, 2012, ACS APPL MATER INTER, V4, P5038, DOI 10.1021/am3015058; Klaus T, 1999, P NATL ACAD SCI USA, V96, P13611, DOI 10.1073/pnas.96.24.13611; Klupfel L, 2014, NAT GEOSCI, V7, P195, DOI 10.1038/NGEO2084; Kniggendorf AK, 2011, WATER RES, V45, P4571, DOI 10.1016/j.watres.2011.06.007; Knirel YA, 2009, MICROBIAL GLYCOBIOLOGY: STRUCTURES, RELEVANCE AND APPLICATIONS, P57; Kotloski NJ, 2013, MBIO, V4, DOI 10.1128/mBio.00553-12; Kouzuma A, 2010, APPL ENVIRON MICROB, V76, P4151, DOI 10.1128/AEM.00117-10; Kranich A, 2008, J AM CHEM SOC, V130, P9844, DOI 10.1021/ja8016895; Kurouski D, 2013, ANALYST, V138, P1665, DOI 10.1039/c2an36478f; Lanekoff I, 2015, ANAL BIOANAL CHEM, V407, P2063, DOI 10.1007/s00216-014-8174-0; Lanni EJ, 2014, ANAL CHEM, V86, P9139, DOI 10.1021/ac5020222; Lebedev N, 2014, CHEMPHYSCHEM, V15, P320, DOI 10.1002/cphc.201300984; Leung KM, 2011, SOFT MATTER, V7, P6617, DOI 10.1039/c1sm05611e; Li R, 2012, ENVIRON SCI TECHNOL, V46, P2813, DOI 10.1021/es204302w; Liang YL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0015295, 10.1371/journal.pone.0012860]; Lide David R., C R C HDB CHEM PHYS; Liu JT, 2015, NATURE, V523, P550, DOI 10.1038/nature14660; Logan BE, 2012, SCIENCE, V337, P686, DOI 10.1126/science.1217412; Logan BE, 2009, NAT REV MICROBIOL, V7, P375, DOI 10.1038/nrmicro2113; Lovley DR, 2006, CURR OPIN BIOTECH, V17, P327, DOI 10.1016/j.copbio.2006.04.006; LOVLEY DR, 1991, MICROBIOL REV, V55, P259, DOI 10.1128/MMBR.55.2.259-287.1991; Ly HK, 2011, J ELECTROANAL CHEM, V660, P367, DOI 10.1016/j.jelechem.2010.12.020; Ly HK, 2013, CHEMSUSCHEM, V6, P487, DOI 10.1002/cssc.201200626; Macheroux P, 2011, FEBS J, V278, P2625, DOI 10.1111/j.1742-4658.2011.08202.x; Marshall MJ, 2006, PLOS BIOL, V4, P1324, DOI 10.1371/journal.pbio.0040268; Marsili E, 2008, P NATL ACAD SCI USA, V105, P3968, DOI 10.1073/pnas.0710525105; Melton ED, 2014, NAT REV MICROBIOL, V12, P797, DOI 10.1038/nrmicro3347; Melzer S, 2015, MICROB BIOTECHNOL, V8, P379, DOI 10.1111/1751-7915.12154; Millo D, 2011, ANGEW CHEM INT EDIT, V50, P2625, DOI 10.1002/anie.201006046; Murgida DH, 2001, J MOL STRUCT, V565, P97, DOI 10.1016/S0022-2860(00)00781-X; Nair B, 2002, CRYST GROWTH DES, V2, P293, DOI 10.1021/cg0255164; Nealson KH, 2002, ANTON LEEUW INT J G, V81, P215, DOI 10.1023/A:1020518818647; NEALSON KH, 1994, ANNU REV MICROBIOL, V48, P311, DOI 10.1146/annurev.mi.48.100194.001523; Neu TR, 2015, TRENDS MICROBIOL, V23, P233, DOI 10.1016/j.tim.2014.12.010; Neu TR, 2014, METHODS MOL BIOL, V1147, P43, DOI 10.1007/978-1-4939-0467-9_4; Neu TR, MICROBIAL GLYCOBIOLO, P733; Oates TWH, 2009, J PHYS CHEM C, V113, P4820, DOI 10.1021/jp8097654; Oellerich S, 2002, J PHYS CHEM B, V106, P6566, DOI 10.1021/jp013841g; Okamoto A, 2013, P NATL ACAD SCI USA, V110, P7856, DOI 10.1073/pnas.1220823110; Patzold R, 2008, J MICROBIOL METH, V72, P241, DOI 10.1016/j.mimet.2007.12.003; Pagba CV, 2010, J RAMAN SPECTROSC, V41, P241, DOI 10.1002/jrs.2428; Paquete CM, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00318; Parikh RY, 2008, CHEMBIOCHEM, V9, P1415, DOI 10.1002/cbic.200700592; Pemberton RM, 2010, MICROCHIM ACTA, V170, P321, DOI 10.1007/s00604-010-0326-0; Pirbadian S, 2014, P NATL ACAD SCI USA, V111, P12883, DOI 10.1073/pnas.1410551111; Preciado-Flores S, 2011, CHEM COMMUN, V47, P4129, DOI 10.1039/c0cc05517d; Ramanathan R, 2011, LANGMUIR, V27, P714, DOI 10.1021/la1036162; Rang M, 2008, NANO LETT, V8, P3357, DOI 10.1021/nl801808b; Ray R, 2010, J MICROBIOL METH, V82, P187, DOI 10.1016/j.mimet.2010.05.011; Renslow RS, 2013, ENERG ENVIRON SCI, V6, P1827, DOI 10.1039/c3ee40203g; Renslow RS, 2013, ENERG ENVIRON SCI, V6, P595, DOI 10.1039/c2ee23394k; Roden EE, 2010, NAT GEOSCI, V3, P417, DOI 10.1038/NGEO870; Rosenbaum MA, 2014, APPL MICROBIOL BIOT, V98, P509, DOI 10.1007/s00253-013-5396-6; Rycenga M, 2011, CHEM REV, V111, P3669, DOI 10.1021/cr100275d; Salas EC, 2010, GEOCHIM COSMOCHIM AC, V74, P574, DOI 10.1016/j.gca.2009.10.039; Sandt C, 2009, APPL MICROBIOL BIOT, V83, P1171, DOI 10.1007/s00253-009-2072-y; Schroder U, 2015, ENERG ENVIRON SCI, V8, P513, DOI 10.1039/c4ee03359k; Shakibaie MR, 1999, CAN J MICROBIOL, V45, P995, DOI 10.1139/cjm-45-12-995; SHOTTON DM, 1989, J CELL SCI, V94, P175; Siebert F., 2008, VIB SPECTROSC, P11, DOI DOI 10.1002/9783527621347.CH2; Smith-Palmer T, 2010, VIB SPECTROSC, V53, P103, DOI 10.1016/j.vibspec.2010.02.012; Strycharz-Glaven SM, 2011, ENERG ENVIRON SCI, V4, P4366, DOI 10.1039/c1ee01753e; Sturm G, 2015, ISME J, V9, P1802, DOI 10.1038/ismej.2014.264; Suresh AK, 2010, ENVIRON SCI TECHNOL, V44, P5210, DOI 10.1021/es903684r; Taillefert M, 2007, J INORG BIOCHEM, V101, P1760, DOI 10.1016/j.jinorgbio.2007.07.020; Teal TK, 2006, APPL ENVIRON MICROB, V72, P7324, DOI 10.1128/AEM.01163-06; Valle L, 2012, PHOTOCH PHOTOBIO SCI, V11, P1051, DOI 10.1039/c2pp05385c; Vigneshwaran N, 2007, MATER LETT, V61, P1413, DOI 10.1016/j.matlet.2006.07.042; Virdis B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089918; Virdis B, 2012, ENERG ENVIRON SCI, V5, P7017, DOI 10.1039/c2ee03374g; Wang H, 2010, J BACTERIOL, V192, P1143, DOI 10.1128/JB.01277-09; Xie CG, 2003, J APPL PHYS, V93, P2982, DOI 10.1063/1.1542654; Xu LJ, 2015, J AM CHEM SOC, V137, P5149, DOI 10.1021/jacs.5b01426; Zeiri L, 2004, APPL SPECTROSC, V58, P33, DOI 10.1366/000370204322729441; Zhang YD, 2014, MOL BIOSYST, V10, P1035, DOI 10.1039/c3mb70520j	115	10	10	3	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145871	10.1371/journal.pone.0145871	http://dx.doi.org/10.1371/journal.pone.0145871			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709923	Green Published, gold, Green Submitted			2022-12-26	WOS:000367451400088
J	Shin, KC; Choi, HY; Seo, MJ; Oh, DK				Shin, Kyung-Chul; Choi, Hye-Yeon; Seo, Min-Ju; Oh, Deok-Kun			Compound K Production from Red Ginseng Extract by beta-Glycosidase from Sulfolobus solfataricus Supplemented with alpha-L-Arabinofuranosidase from Caldicellulosiruptor saccharolyticus	PLOS ONE			English	Article							PANAX-GINSENG; PROTOPANAXADIOL GINSENOSIDES; MICROBIAL TRANSFORMATION; INTESTINAL BACTERIA; UVB IRRADIATION; BIOTRANSFORMATION; SAPONINS; RB1; GLUCOSIDASE; METABOLITE	Ginsenoside compound K (C-K) is attracting a lot of interest because of its biological and pharmaceutical activities, including hepatoprotective, antitumor, anti-wrinkling, and anti-skin aging activities. C-K has been used as the principal ingredient in skin care products. For the effective application of ginseng extracts to the manufacture of cosmetics, the PPD-type ginsenosides in ginseng extracts should be converted to C-K by enzymatic conversion. For increased yield of C-K from the protopanaxadiol (PPD)-type ginsenosides in red-ginseng extract (RGE), the alpha-L-arabinofuranoside-hydrolyzing alpha-L-arabinofuranosidase from Caldicellulosiruptor saccharolyticus (CS-abf) was used along with the beta-D-glucopyranoside/alpha-L-arabinopyranoside-hydrolyzing beta-glycosidase from Sulfolobus solfataricus (SS-bgly) because SS-bgly showed very low hydrolytic activity on the alpha-L-arabinofuranoside linkage in ginsenosides. The optimal reaction conditions for C-K production were as follows: pH 6.0, 80 degrees C, 2 U/mL SS-bgly, 3 U/mL CS-abf, and 7.5 g/L PPD-type ginsenosides in RGE. Under these optimized conditions, SS-bgly supplemented with CS-abf produced 4.2 g/L C-K from 7.5 g/L PPD-type ginsenosides in 12 h without other ginsenosides, with a molar yield of 100% and a productivity of 348 mg/L/h. To the best of our knowledge, this is the highest concentration and productivity of C-K from ginseng extract ever published in literature.	[Shin, Kyung-Chul; Choi, Hye-Yeon; Seo, Min-Ju; Oh, Deok-Kun] Konkuk Univ, Dept Biosci & Biotechnol, Seoul 05029, South Korea	Konkuk University	Oh, DK (corresponding author), Konkuk Univ, Dept Biosci & Biotechnol, Seoul 05029, South Korea.	deokkun@konkuk.ac.kr	Shin, Kyung-Chul/E-9681-2017	Shin, Kyung-Chul/0000-0002-1527-0164				Akao T, 1998, BIOL PHARM BULL, V21, P245, DOI 10.1248/bpb.21.245; Bae EA, 2002, BIOL PHARM BULL, V25, P743, DOI 10.1248/bpb.25.743; Bang CS, 2014, J GINSENG RES, V38, P167, DOI 10.1016/j.jgr.2014.04.002; Chi H, 2005, BIOL PHARM BULL, V28, P2102, DOI 10.1248/bpb.28.2102; Chi H, 2005, BIOTECHNOL LETT, V27, P765, DOI 10.1007/s10529-005-5632-y; Cho WCS, 2006, EUR J PHARMACOL, V550, P173, DOI 10.1016/j.ejphar.2006.08.056; Choi HJ, 2014, MYCOBIOLOGY, V42, P256, DOI 10.5941/MYCO.2014.42.3.256; Fu Y, 2014, LETT APPL MICROBIOL, V58, P138, DOI 10.1111/lam.12166; Hou JG, 2012, J APPL MICROBIOL, V113, P807, DOI 10.1111/j.1365-2672.2012.05400.x; Hsu BY, 2013, FOOD CHEM, V141, P4186, DOI 10.1016/j.foodchem.2013.06.134; Hwang E, 2013, J GINSENG RES, V37, P425, DOI 10.5142/jgr.2013.37.425; Jin XF, 2012, J MICROBIOL BIOTECHN, V22, P343, DOI 10.4014/jmb.1107.07066; Kang TH, 2009, J ETHNOPHARMACOL, V123, P446, DOI 10.1016/j.jep.2009.03.022; Kim BH, 2006, BIOL PHARM BULL, V29, P2472, DOI 10.1248/bpb.29.2472; Kim BG, 2011, APPL BIOCHEM BIOTECH, V165, P1107, DOI 10.1007/s12010-011-9328-6; Kim EH, 2013, BIOSCI BIOTECH BIOCH, V77, P1138, DOI 10.1271/bbb.120823; Kim MK, 2005, J MICROBIOL, V43, P456; Kimura Y, 2006, BRIT J PHARMACOL, V148, P860, DOI 10.1038/sj.bjp.0706794; Ko S, 2007, CHEM PHARM BULL, V55, P1522, DOI 10.1248/cpb.55.1522; Lee HU, 2005, LIVER INT, V25, P1069, DOI 10.1111/j.1478-3231.2005.01068.x; Lee HS, 2012, J MED FOOD, V15, P1015, DOI 10.1089/jmf.2012.2187; Lee SY, 2009, PHARMAZIE, V64, P242, DOI 10.1691/ph.2009.8734; Li W, 2011, MOLECULES, V16, P10093, DOI 10.3390/molecules161210093; Lim TG, 2015, INT J MOL MED, V35, P1388, DOI 10.3892/ijmm.2015.2121; Lim YR, 2010, J APPL MICROBIOL, V109, P1188, DOI 10.1111/j.1365-2672.2010.04744.x; Liu C-Y, 2014, J GINSENG RES; Liu CY, 2014, PROCESS BIOCHEM, V49, P813, DOI 10.1016/j.procbio.2014.02.011; Lu JM, 2009, CURR VASC PHARMACOL, V7, P293, DOI 10.2174/157016109788340767; Noh KH, 2009, BIOL PHARM BULL, V32, P1830, DOI 10.1248/bpb.32.1830; Noh KH, 2009, BIOSCI BIOTECH BIOCH, V73, P316, DOI 10.1271/bbb.80525; Oh SH, 2004, ARCH PHARM RES, V27, P402, DOI 10.1007/BF02980081; Park AR, 2010, APPL BIOCHEM BIOTECH, V160, P2236, DOI 10.1007/s12010-009-8705-x; Park CS, 2010, APPL MICROBIOL BIOT, V87, P9, DOI 10.1007/s00253-010-2567-6; Park SY, 2001, BIOSCI BIOTECH BIOCH, V65, P1163, DOI 10.1271/bbb.65.1163; Qin Y, 2008, J MICROBIOL BIOTECHN, V18, P1081; Quan LH, 2013, WORLD J MICROB BIOT, V29, P1001, DOI 10.1007/s11274-013-1260-1; Quan LH, 2012, J AGR FOOD CHEM, V60, P3776, DOI 10.1021/jf300186a; Shin DJ, 2014, J CELL BIOCHEM, V115, P1702, DOI 10.1002/jcb.24833; Shin KC, 2013, J BIOTECHNOL, V167, P33, DOI 10.1016/j.jbiotec.2013.06.003; Shin KC, 2013, J MICROBIOL BIOTECHN, V23, P483, DOI 10.4014/jmb.1211.11012; Son JW, 2008, BIOTECHNOL LETT, V30, P713, DOI 10.1007/s10529-007-9590-4; Wakabayashi C, 1998, BIOCHEM BIOPH RES CO, V246, P725, DOI 10.1006/bbrc.1998.8690; Wang L, 2012, J SURG RES, V176, P267, DOI 10.1016/j.jss.2011.06.038; Wu LP, 2012, J IND MICROBIOL BIOT, V39, P521, DOI 10.1007/s10295-011-1058-9; Yan X, 2014, CELL RES, V24, P770, DOI 10.1038/cr.2014.28; Yoshikawa M, 2003, J NAT PROD, V66, P922, DOI 10.1021/np030015l; Yu HS, 2007, CHEM PHARM BULL, V55, P231, DOI 10.1248/cpb.55.231; Zhou W, 2008, J APPL MICROBIOL, V104, P699, DOI 10.1111/j.1365-2672.2007.03586.x	48	27	28	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145876	10.1371/journal.pone.0145876	http://dx.doi.org/10.1371/journal.pone.0145876			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710074	gold, Green Submitted, Green Published			2022-12-26	WOS:000367451400089
J	Hendrickson, C; Euler, CW; Nguyen, SV; Rahman, M; McCullor, KA; King, CJ; Fischetti, VA; McShan, WM				Hendrickson, Christina; Euler, Chad W.; Nguyen, Scott V.; Rahman, Maliha; McCullor, Kimberly A.; King, Catherine J.; Fischetti, Vincent A.; McShan, W. Michael			Elimination of Chromosomal Island SpyCIM1 from Streptococcus pyogenes Strain SF370 Reverses the Mutator Phenotype and Alters Global Transcription	PLOS ONE			English	Article							GROUP-A STREPTOCOCCUS; COMPLETE GENOME SEQUENCE; FLUOROQUINOLONE RESISTANCE; CYSTEINE PROTEINASE; M3 STRAIN; IN-VITRO; VIRULENCE; GENE; PATHOGEN; CLONE	Streptococcus pyogenes chromosomal island M1 (SpyCIM1) integrates by site-specific recombination into the 5' end of DNA mismatch repair (MMR) gene mutL in strain SF370SmR, blocking transcription of it and the downstream operon genes. During exponential growth, SpyCIM1 excises from the chromosome and replicates as an episome, restoring mutL transcription. This process is reversed in stationary phase with SpyCIM1 re-integrating into mutL, returning the cells to a mutator phenotype. Here we show that elimination of SpyCIM1 relieves this mutator phenotype. The downstream MMR operon genes, multidrug efflux pump lmrP, Holliday junction resolution helicase ruvA, and DNA base excision repair glycosylase tag, are also restored to constitutive expression by elimination of SpyCIM1. The presence of SpyCIM1 alters global transcription patterns in SF370SmR. RNA sequencing (RNA-Seq) demonstrated that loss of SpyCIM1 in the SpyCIM1 deletion mutant, CEM1 Delta 4, impacted the expression of over 100 genes involved in virulence and metabolism both in early exponential phase, when the SpyCIM1 is episomal, as well as at the onset of stationary phase, when SpyCIM1 has reintegrated into mutL. Among these changes, the up-regulation of the genes for the antiphagocytic M protein (emm1), streptolysin O (slo), capsule operon (hasABC), and streptococcal pyrogenic exotoxin (speB), are particularly notable. The expression pattern of the MMR operon confirmed our earlier observations that these genes are transcribed in early exponential phase but silenced as stationary phase is approached. Thus, the direct role of SpyCIM1 in causing the mutator phenotype is confirmed, and further, its influence upon the biology of S. pyogenes was found to impact multiple genes in addition to the MMR operon, which is a novel function for a mobile genetic element. We suggest that such chromosomal islands are a remarkable evolutionary adaptation to promote the survival of its S. pyogenes host cell in changing environments.	[Hendrickson, Christina; Nguyen, Scott V.; Rahman, Maliha; McCullor, Kimberly A.; King, Catherine J.; McShan, W. Michael] Univ Oklahoma, Hlth Sci Ctr, Dept Pharmaceut Sci, Oklahoma City, OK 73190 USA; [Nguyen, Scott V.; McShan, W. Michael] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA; [Hendrickson, Christina] Univ Cent Oklahoma, Dept Biol, Edmond, OK USA; [Euler, Chad W.; Fischetti, Vincent A.] Rockefeller Univ, Lab Bacterial Pathogenesis & Immunol, New York, NY 10021 USA; [Euler, Chad W.] CUNY Hunter Coll, Dept Med Lab Sci, New York, NY 10021 USA; [Euler, Chad W.] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Central Oklahoma; Rockefeller University; City University of New York (CUNY) System; Hunter College (CUNY); Cornell University	McShan, WM (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Pharmaceut Sci, Oklahoma City, OK 73190 USA.	William-McShan@ouhsc.edu	Nguyen, Scott/H-8721-2019	Nguyen, Scott/0000-0001-6498-2232	NIH [R15A1072718, AI11822]; OCAST [HR11-133]; Oklahoma Center for the Advancement of Science and Technology (OCAST) [HR11-133]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI011822, R01AI011822] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OCAST; Oklahoma Center for the Advancement of Science and Technology (OCAST); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NIH Grant R15A1072718 www.nih.gov WMM, NIH Grant AI11822 www.nih.gov VAF, and OCAST grant HR11-133 www.ok.gov/ocast/ WMM.; This work was made possible by an Oklahoma Center for the Advancement of Science and Technology (OCAST) grant HR11-133 and by NIH Grant Number R15A1072718 to WMM and NIH Grant AI11822 to VAF.	Banks DJ, 2004, J INFECT DIS, V190, P727, DOI 10.1086/422697; BARKSDALE L, 1974, ANNU REV MICROBIOL, V28, P265, DOI 10.1146/annurev.mi.28.100174.001405; Beres SB, 2006, P NATL ACAD SCI USA, V103, P7059, DOI 10.1073/pnas.0510279103; Beres SB, 2002, P NATL ACAD SCI USA, V99, P10078, DOI 10.1073/pnas.152298499; Berge M, 2002, MOL MICROBIOL, V45, P411, DOI 10.1046/j.1365-2958.2002.03013.x; Bessen DE, 2011, J BACTERIOL, V193, P6651, DOI 10.1128/JB.05263-11; BOLHUIS H, 1995, J BIOL CHEM, V270, P26092, DOI 10.1074/jbc.270.44.26092; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Canchaya C, 2002, VIROLOGY, V302, P245, DOI 10.1006/viro.2002.1570; CAPARON MG, 1991, INFECT IMMUN, V59, P1811, DOI 10.1128/IAI.59.5.1811-1817.1991; Carroll RK, 2011, MOL MICROBIOL, V81, P588, DOI 10.1111/j.1365-2958.2011.07709.x; Chang JC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002190; Chaussee MS, 1997, INFECT IMMUN, V65, P1956, DOI 10.1128/IAI.65.5.1956-1959.1997; Chaussee MS, 1999, INFECT IMMUN, V67, P1715; COULONDRE C, 1977, J MOL BIOL, V117, P577, DOI 10.1016/0022-2836(77)90059-6; Cusumano ZT, 2015, J BACTERIOL, V197, P1288, DOI 10.1128/JB.02517-14; Desiere F, 2001, VIROLOGY, V288, P325, DOI 10.1006/viro.2001.1085; Euler CW, 2015, TARGETED CURING OF A; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Fittipaldi N, 2012, AM J PATHOL, V180, P1522, DOI 10.1016/j.ajpath.2011.12.037; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Gonzalez K, 2012, MOL MICROBIOL, V85, P361, DOI 10.1111/j.1365-2958.2012.08116.x; Green NM, 2005, J INFECT DIS, V192, P760, DOI 10.1086/430618; GRZESIUK E, 1993, MUTAT RES, V297, P313, DOI 10.1016/0165-1110(93)90022-F; Hause LL, 2012, J BACTERIOL, V194, P4904, DOI 10.1128/JB.00809-12; Holden MTG, 2007, J BACTERIOL, V189, P1473, DOI 10.1128/JB.01227-06; Kietzman CC, 2010, INFECT IMMUN, V78, P241, DOI 10.1128/IAI.00746-09; KJEMS EBBE, 1958, ACTA PATHOL ET MICROBIOL SCAND, V44, P429; Kreikemeyer B, 2003, TRENDS MICROBIOL, V11, P224, DOI 10.1016/S0966-842X(03)00098-2; Kreikemeyer B, 2007, INFECT IMMUN, V75, P5698, DOI 10.1128/IAI.00175-07; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lindsay JA, 1998, MOL MICROBIOL, V29, P527, DOI 10.1046/j.1365-2958.1998.00947.x; Luria SE, 1943, GENETICS, V28, P491; Lyon WR, 1998, EMBO J, V17, P6263, DOI 10.1093/emboj/17.21.6263; MA WT, 1992, J APPL PROBAB, V29, P255, DOI 10.2307/3214564; Malhotra-Kumar S, 2009, J ANTIMICROB CHEMOTH, V63, P886, DOI 10.1093/jac/dkp057; Marks LR, 2014, J INFECT DIS, V210, P25, DOI 10.1093/infdis/jiu058; Mazurkiewicz P, 2004, J BIOL CHEM, V279, P103, DOI 10.1074/jbc.M306579200; McClure R, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt444; McShan WM, 2008, J BACTERIOL, V190, P7773, DOI 10.1128/JB.00672-08; McShan W. Michael, 2007, P229; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Mirouze N, 2013, P NATL ACAD SCI USA, V110, P352, DOI 10.1073/pnas.1219868110; Nakagawa I, 2003, GENOME RES, V13, P1042, DOI 10.1101/gr.1096703; NEYFAKH AA, 1993, ANTIMICROB AGENTS CH, V37, P128, DOI 10.1128/AAC.37.1.128; Nguyen Scott V, 2014, Front Cell Infect Microbiol, V4, P109, DOI 10.3389/fcimb.2014.00109; Novick RP, 2010, NAT REV MICROBIOL, V8, P541, DOI 10.1038/nrmicro2393; Paluscio E, 2015, INFECT IMMUN, V83, P1162, DOI 10.1128/IAI.02814-14; PITCHER DG, 1989, LETT APPL MICROBIOL, V8, P151, DOI 10.1111/j.1472-765X.1989.tb00262.x; Pletz MWR, 2006, ANTIMICROB AGENTS CH, V50, P943, DOI 10.1128/AAC.50.3.943-948.2006; Putman M, 2001, MICROBIOL-SGM, V147, P2873, DOI 10.1099/00221287-147-10-2873; Rosche WA, 2000, METHODS, V20, P4, DOI 10.1006/meth.1999.0901; Rudan M, 2015, ELIFE, V4, DOI 10.7554/eLife.04745; Sambrook J., 2001, MOL CLONING LAB MANU; Scott J, 2008, J BACTERIOL, V190, P6290, DOI 10.1128/JB.01569-07; Scott J, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00317; Shaver AC, 2003, J BACTERIOL, V185, P6076, DOI 10.1128/JB.185.20.6076-6082.2003; Smoot JC, 2002, P NATL ACAD SCI USA, V99, P4668, DOI 10.1073/pnas.062526099; STEWART FM, 1994, GENETICS, V137, P1139; Sumby P, 2005, J INFECT DIS, V192, P771, DOI 10.1086/432514; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Wagner PL, 2002, INFECT IMMUN, V70, P3985, DOI 10.1128/IAI.70.8.3985-3993.2002; Watson ME, 2013, INFECT IMMUN, V81, P1606, DOI 10.1128/IAI.00021-13; WINKLE SA, 1982, NUCLEIC ACIDS RES, V10, P8211, DOI 10.1093/nar/10.24.8211	64	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145884	10.1371/journal.pone.0145884	http://dx.doi.org/10.1371/journal.pone.0145884			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26701803	Green Published, gold			2022-12-26	WOS:000367092600139
J	Williams, AD; Brown, BE; Putchim, L; Sweet, MJ				Williams, Alex D.; Brown, Barbara E.; Putchim, Lalita; Sweet, Michael J.			Age-Related Shifts in Bacterial Diversity in a Reef Coral	PLOS ONE			English	Article							MICROBIAL COMMUNITY; GONIASTREA-ASPERA; WHITE SYNDROME; BAND DISEASE; MUCUS; ALGAE; SUSCEPTIBILITY; SUCCESSION; MORTALITY; CILIATE	This study investigated the relationship between microbial communities in differently sized colonies of the massive coral Coelastrea aspera at Phuket, Thailand where colony size could be used as a proxy for age. Results indicated significant differences between the bacterial diversity (ANOSIM, R = 0.76, p = 0.001) of differently sized colonies from the same intertidal reef habitat. Juvenile and small colonies (<6cm mean diam) harboured a lower bacterial richness than medium (similar to 10cm mean diam) and large colonies (>28 cm mean diam). Bacterial diversity increased in a step-wise pattern from juveniles<small<medium colonies, which was then followed by a slight decrease in the two largest size classes. These changes appear to resemble a successional process which occurs over time, similar to that observed in the ageing human gut. Furthermore, the dominant bacterial ribotypes present in the tissues of medium and large sized colonies of C. aspera, (such as Halomicronema, an Oscillospira and an unidentified cyanobacterium) were also the dominant ribotypes found within the endolithic algal band of the coral skeleton; a result providing some support for the hypothesis that the endolithic algae of corals may directly influence the bacterial community present in coral tissues.	[Williams, Alex D.; Sweet, Michael J.] Univ Derby, Coll Life & Nat Sci, Mol Hlth & Dis Lab, Environm Sustainabil Res Ctr, Derby DE22 1GB, England; [Brown, Barbara E.] Newcastle Univ, Sch Biol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Brown, Barbara E.] North Highland Coll, Environm Res Inst, Caithness, England; [Putchim, Lalita] Phuket Marine Biol Ctr, Phuket 83000, Thailand	University of Derby; Newcastle University - UK	Williams, AD (corresponding author), Univ Derby, Coll Life & Nat Sci, Mol Hlth & Dis Lab, Environm Sustainabil Res Ctr, Derby DE22 1GB, England.	alexdwilliams@virginmedia.com	Brown, Barbara/AAT-7991-2021; Sweet, Michael/E-9661-2012	Sweet, Michael/0000-0003-4983-8333	Leverhulme Trust [EM-2013-058]	Leverhulme Trust(Leverhulme Trust)	Barbara Brown recieved funding from the Leverhulme Trust [www.leverhulme.ac.uk]; Grant number: EM-2013-058. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the Director and staff of Phuket Marine Biological Centre for support of this work. Thanks also to Richard Dunne for preparation of S1 Fig and to the Leverhulme Trust for support of BEB.	Agostini S, 2012, CORAL REEFS, V31, P147, DOI 10.1007/s00338-011-0831-6; Ainsworth TD, 2015, ISME J, V9, P2261, DOI 10.1038/ismej.2015.39; Anthony KRN, 2002, LIMNOL OCEANOGR, V47, P1417, DOI 10.4319/lo.2002.47.5.1417; Apprill A, 2009, ISME J, V3, P685, DOI 10.1038/ismej.2009.3; BABCOCK RC, 1991, ECOL MONOGR, V61, P225, DOI 10.2307/2937107; Baigi E, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0010667, DOI 10.1371/J0URNAL.P0NE.0010667]; Baker BJ, 2003, FEMS MICROBIOL ECOL, V44, P139, DOI 10.1016/S0168-6496(03)00028-X; Biebl H, 2005, INT J SYST EVOL MICR, V55, P1089, DOI 10.1099/ijs.0.63511-0; Brown BE, 2008, MAR ECOL PROG SER, V362, P99, DOI 10.3354/meps07439; Brown BE, 2014, CORAL REEFS, V33, P395, DOI 10.1007/s00338-013-1120-3; Brown BE, 2005, MAR ECOL PROG SER, V296, P291, DOI 10.3354/meps296291; Brown BE, 2002, CORAL REEFS, V21, P119, DOI 10.1007/s00338-002-0215-z; Brown BE, 1997, ADV MAR BIOL, V31, P221, DOI 10.1016/S0065-2881(08)60224-2; BROWN BE, 1994, MAR ECOL PROG SER, V105, P219, DOI 10.3354/meps105219; Brown BE, 2002, MAR ECOL PROG SER, V242, P119, DOI 10.3354/meps242119; Brown BE, 1999, MAR ECOL PROG SER, V191, P53, DOI 10.3354/meps191053; Buffie CG, 2012, INFECT IMMUN, V80, P62, DOI 10.1128/IAI.05496-11; Bythell J.C., 1988, P535; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Ceh J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036920; Darzynkiewicz Z, 1990, Methods Cell Biol, V33, P285; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; EDMUNDS PJ, 1986, MAR BIOL, V92, P339, DOI 10.1007/BF00392674; Elahi R, 2007, BIOL BULL-US, V212, P20, DOI 10.2307/25066577; Fine M, 2006, CORAL REEFS, V25, P577, DOI 10.1007/s00338-006-0143-4; Fine M, 2002, P ROY SOC B-BIOL SCI, V269, P1205, DOI 10.1098/rspb.2002.1983; Garren M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007319; Gorley C.K., 2006, GETTING STARTED PRIM; Hawkridge JM, 1998, THESIS U NEWCASTLE U, P354; HUGHES TP, 1980, SCIENCE, V209, P713, DOI 10.1126/science.209.4457.713; Jatkar A, 2008, THESIS; Jessen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062091; Kvennefors ECE, 2012, MICROB ECOL, V63, P605, DOI 10.1007/s00248-011-9946-0; LEYDEN JJ, 1975, J INVEST DERMATOL, V65, P379, DOI 10.1111/1523-1747.ep12607630; Li N, 2015, ANTON LEEUW INT J G, V107, P305, DOI 10.1007/s10482-014-0327-9; Li SJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep06205; Lillie RD, 1963, HISTOPATHOLOGIC TECH, P506; Lu JR, 2003, APPL ENVIRON MICROB, V69, P6816, DOI 10.1128/AEM.69.11.6816-6824.2003; Mackie RI, 1999, AM J CLIN NUTR, V69, p1035S, DOI 10.1093/ajcn/69.5.1035s; Martinez JM, 2014, ISME J, V8, P1079, DOI 10.1038/ismej.2013.214; MassolDeya A, 1997, APPL ENVIRON MICROB, V63, P270; MEESTERS EH, 1995, MAR ECOL PROG SER, V121, P203, DOI 10.3354/meps121203; Meron D, 2011, ISME J, V5, P51, DOI 10.1038/ismej.2010.102; Miller AW, 2011, DIS AQUAT ORGAN, V93, P179, DOI 10.3354/dao02305; Morrow KM, 2012, APPL ENVIRON MICROB, V78, P6438, DOI 10.1128/AEM.01162-12; Mouchka ME, 2010, INTEGR COMP BIOL, V50, P662, DOI 10.1093/icb/icq061; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Nissimov J, 2009, FEMS MICROBIOL LETT, V292, P210, DOI 10.1111/j.1574-6968.2009.01490.x; Nugues MM, 2004, ECOL LETT, V7, P919, DOI 10.1111/j.1461-0248.2004.00651.x; Ovreas L, 2003, MICROB ECOL, V46, P291, DOI 10.1007/s00248-003-3006-3; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; RINKEVICH B, 1986, EXPERIENTIA, V42, P320, DOI 10.1007/BF01942521; Ritchie KB, 2006, MAR ECOL PROG SER, V322, P1, DOI 10.3354/meps322001; Rohwer F, 2002, MAR ECOL PROG SER, V243, P1, DOI 10.3354/meps243001; Sakai K, 1998, BIOL BULL, V195, P319, DOI 10.2307/1543143; Sakai K, 1998, RES POPUL ECOL, V40, P287, DOI 10.1007/BF02763460; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Sanchez O, 2007, APPL ENVIRON MICROB, V73, P5962, DOI 10.1128/AEM.00817-07; Sekar R, 2008, MAR ECOL PROG SER, V362, P85, DOI 10.3354/meps07496; Sharp KH, 2012, ISME J, V6, P790, DOI 10.1038/ismej.2011.144; Sharp KH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010898; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; Sweet MJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0094; Sweet MJ, 2011, CORAL REEFS, V30, P39, DOI 10.1007/s00338-010-0695-1; Sweet M, 2015, MOL ECOL, V24, P1150, DOI 10.1111/mec.13097; Sweet M, 2012, ENVIRON MICROBIOL, V14, P2184, DOI 10.1111/j.1462-2920.2012.02746.x; Sweet MJ, 2010, AQUAT MICROB ECOL, V61, P1, DOI 10.3354/ame01433; Taniguchi A, 2015, J EXP MAR BIOL ECOL, V469, P105, DOI 10.1016/j.jembe.2015.04.020; Thompson JR, 2015, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00176; Tremblay P, 2012, J EXP BIOL, V215, P1384, DOI 10.1242/jeb.065201; van Dongen WFD, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-11; Woodmansey EJ, 2007, J APPL MICROBIOL, V102, P1178, DOI 10.1111/j.1365-2672.2007.03400.x	72	28	28	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0144902	10.1371/journal.pone.0144902	http://dx.doi.org/10.1371/journal.pone.0144902			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700869	gold, Green Published, Green Submitted			2022-12-26	WOS:000367092600035
J	Gantner, P; Treger, M; De Miscault, C; Batard, ML; Bernard-Henry, C; Cheneau, C; De Mautort, E; Partisani, M; Priester, M; Rey, D				Gantner, Pierre; Treger, Michele; De Miscault, Constance; Batard, Marie-Laure; Bernard-Henry, Claudine; Cheneau, Christine; De Mautort, Erik; Partisani, Marialuisa; Priester, Michele; Rey, David			Predictors of Standard Follow-Up Completion after Sexual Exposure to HIV: Five-Year Retrospective Analysis in a French HIV-Infection Care Center	PLOS ONE			English	Article							NONOCCUPATIONAL POSTEXPOSURE PROPHYLAXIS; COMMUNITY-HEALTH CENTER; ADHERENCE; MEN; PERCEPTION; GUIDELINES; ADULTS; TRIAL	Objectives The care of exposed individuals to HIV remains a challenge regarding follow-up completion and HIV-testing of the partner. Identifying patients with risk of not fulfilling HIV-testing follow-up completion (FC), among patients demanding non-occupational post-exposure prophylaxis (nPEP), may improve clinical practice. Methods A retrospective chart review was conducted in a single French HIV-infection care center. FC predictors were assessed in a multivariate logistic regression model (Likelihood ratios test). Results Between 2009 and 2013, 646 sexual exposures to HIV were evaluated for nPEP, of which 507 effectively received nPEP (78%). FC rate was 30% (194/646). In the multivariate analysis, FC rates rose with age of exposed individuals (OR, 1.04 [0.25-4.28]; p<0.001) and decreased with the year of sexual exposure (OR, 0.74 [0.65-0.85]; p<0.001). FC was associated with sexual encounter with a sex worker (OR, 4.07 [0.98-16.82]; p<0.001) and nPEP use (OR, 2.69 [2.37-3.06]; p<0.001). nPEP early discontinuation was associated with decreased FC rates (OR, 0.18 [0.08-0.39]; p<0.001). No documented nPEP failure was identified. However, five Men who have Sex with Men (MSM) nPEP recipients for unprotected anal receptive intercourse subsequently seroconverted to HIV more than 6 months after nPEP. Seroconversion to HIV was associated with the lack of FC (p = 0.04) and multiple presentations for nPEP over the study period (p = 0.002). Conclusions We identified significant predictors of not fulfilling sequential HIV-testing. They appear to be linked with a self-perceived HIV risk, especially in young adults recently exposed. Enhanced counseling in targeted individuals with high risk behaviors and using smartphone and internet-based strategies may be interesting retention in care options.	[Gantner, Pierre; De Miscault, Constance; Batard, Marie-Laure; Bernard-Henry, Claudine; Cheneau, Christine; De Mautort, Erik; Partisani, Marialuisa; Priester, Michele; Rey, David] Hop Univ Strasbourg, Le Trait Union, HIV Infect Care Ctr, Strasbourg, France; [Treger, Michele] Univ Strasbourg, Fac Med, Biostat Lab, Strasbourg, France	CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Gantner, P (corresponding author), Hop Univ Strasbourg, Le Trait Union, HIV Infect Care Ctr, Strasbourg, France.	pierre.gantner@chru-strasbourg.fr		Gantner, Pierre/0000-0002-3984-883X				Beltzer N, 2013, AIDS, V27, P1011, DOI 10.1097/QAD.0b013e32835e1583; Bennett A, 2015, INT J STD AIDS, V26, P746, DOI 10.1177/0956462414556329; Bentz L, 2010, AIDS CARE, V22, P1509, DOI 10.1080/09540121.2010.484457; Bogowicz P, 2015, INT J STD AIDS IN PR; Casalino E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104350; Clumeck N, 2008, HIV MED, V9, P65, DOI 10.1111/j.1468-1293.2007.00533.x; Fletcher JB, 2013, J SEX TRANSM DIS, V2013, DOI 10.1155/2013/210403; Gulholm T, 2013, SEX HEALTH, V10, P438, DOI 10.1071/SH13018; Jain S, 2015, AIDS PATIENT CARE ST, V29, P20, DOI 10.1089/apc.2014.0154; Jain S, 2015, JAIDS-J ACQ IMM DEF, V68, P97, DOI 10.1097/QAI.0000000000000403; Jain S, 2014, AIDS, V28, P1545, DOI 10.1097/QAD.0000000000000301; Kaai S, 2012, PATIENT EDUC COUNS, V88, P4, DOI 10.1016/j.pec.2011.11.011; Katz MH, 1997, NEW ENGL J MED, V336, P1097, DOI 10.1056/NEJM199704103361512; Krause KH, 2014, WOMEN HEALTH ISS, V24, pE407, DOI 10.1016/j.whi.2014.04.003; Livrozet JM, 2002, 6 INT C DRUG THER HI; McAllister J, 2014, HIV MED, V15, P13, DOI 10.1111/hiv.12075; McDougal SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105030; McFaul K, 2015, INT J STD AIDS, V26, P521, DOI 10.1177/0956462414547525; Morlat P, ACTUALISATION 2014 R; Muessig KE, 2015, CURR HIV-AIDS REP, V12, P173, DOI 10.1007/s11904-014-0239-3; Mulieri I, 2014, ANN I SUPER SANITA, V50, P363, DOI 10.4415/ANN_14_04_12; Pugliese P, 2009, HIV MED, V10, P504, DOI 10.1111/j.1468-1293.2009.00719.x; Rey D, 2004, JAIDS-J ACQ IMM DEF, V37, P1454, DOI 10.1097/01.qai.0000136732.00354.bd; Rey D, 2011, EXPERT REV ANTI-INFE, V9, P431, DOI [10.1586/ERI.11.20, 10.1586/eri.11.20]; Roland ME, 2011, CLIN INFECT DIS, V53, P76, DOI 10.1093/cid/cir333; Smith Dawn K., 2005, Morbidity and Mortality Weekly Report, V54, P1; Sultan B, 2014, HIV AIDS-RES PALLIAT, V6, P147, DOI 10.2147/HIV.S46585; Takahashi TA, 2005, J GEN INTERN MED, V20, P618, DOI 10.1111/j.1525-1497.2005.0112.x; Tissot F, 2010, HIV MED, V11, P584, DOI 10.1111/j.1468-1293.2010.00826.x; Tosini W, 2010, AIDS, V24, P2375, DOI 10.1097/QAD.0b013e32833dfad1	30	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145440	10.1371/journal.pone.0145440	http://dx.doi.org/10.1371/journal.pone.0145440			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ4SH	26696009	Green Submitted, Green Published, gold			2022-12-26	WOS:000367092500048
J	Green, EM; Coleman, JA; Gouaux, E				Green, Evan M.; Coleman, Jonathan A.; Gouaux, Eric			Thermostabilization of the Human Serotonin Transporter in an Antidepressant-Bound Conformation	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; SCINTILLATION PROXIMITY ASSAY; SIZE-EXCLUSION CHROMATOGRAPHY; X-RAY STRUCTURES; MEMBRANE-PROTEINS; NEUROTRANSMITTER TRANSPORTERS; DOPAMINE TRANSPORTER; CRYSTAL-STRUCTURE; BACTERIAL HOMOLOG; SUBSTRATE-BINDING	Serotonin is a ubiquitous chemical transmitter with particularly important roles in the gastrointestinal, cardiovascular and central nervous systems. Modulation of serotonergic signaling occurs, in part, by uptake of the transmitter by the serotonin transporter (SERT). In the brain, SERT is the target for numerous antidepressants including tricyclic antidepressants and selective serotonin reuptake inhibitors (SSRIs). Despite the importance of SERT in human physiology, biochemical, biophysical and high-resolution structural studies have been hampered due to the instability of SERT in detergent micelles. To identify a human SERT (hSERT) construct suitable for detailed biochemical and structural studies, we developed an efficient thermostability screening protocol and rapidly screened 219 mutations for thermostabilization of hSERT in complex with the SSRI paroxetine. We discovered three mutations-Y110A, I291A and T439S -that, when combined into a single construct, deemed TS3, yielded a hSERT variant with an apparent melting temperature (Tm) 19 degrees C greater than that of the wild-type transporter, albeit with a loss of transport activity. Further investigation yielded a double mutant-I291A and T439S-defined as TS2, with a 12 degrees C increase in Tm and retention of robust transport activity. Both TS2 and TS3 were more stable in short-chain detergents in comparison to the wild-type transporter. This thermostability screening protocol, as well as the specific hSERT variants, will prove useful in studies of other integral membrane receptors and transporters and in the investigation of structure and function relationships in hSERT.	[Green, Evan M.; Coleman, Jonathan A.; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97201 USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, L474, Portland, OR 97201 USA.	gouauxe@ohsu.edu	Gouaux, Eric/Y-4370-2019	Gouaux, Eric/0000-0002-8549-2360; Coleman, Jonathan/0000-0003-0001-6195	NIMH/NIH [5R37MH070039]; Government of Canada, Banting Fellowship Program [317369]; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH070039] Funding Source: NIH RePORTER	NIMH/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Government of Canada, Banting Fellowship Program; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The following funding supported this research: NIMH/NIH, 5R37MH070039 (EG): https://www.nimh.nih.gov/index.shtml. Government of Canada, Banting Fellowship Program, 317369 (JAC): http://banting.fellowships-bourses.gc.ca/home-accueil-eng.html. Howard Hughes Medical Institute: https://www.hhmi.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Hussein S, 2013, J MOL BIOL, V425, P2198, DOI 10.1016/j.jmb.2013.03.025; Alexandrov AI, 2008, STRUCTURE, V16, P351, DOI 10.1016/j.str.2008.02.004; BARKER EL, 1994, MOL PHARMACOL, V46, P799; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Chae PS, 2010, NAT METHODS, V7, P1003, DOI 10.1038/NMETH.1526; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Cool DR, 1990, AM J PHYSIOL, V259, P196; Dukkipati A, 2008, PROTEIN EXPRES PURIF, V62, P160, DOI 10.1016/j.pep.2008.08.004; Goehring A, 2014, NAT PROTOC, V9, P2574, DOI 10.1038/nprot.2014.173; Harder D, 2012, NAT PROTOC, V7, P1569, DOI 10.1038/nprot.2012.090; Hattori M, 2012, STRUCTURE, V20, P1293, DOI 10.1016/j.str.2012.06.009; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kazmier K, 2014, NAT STRUCT MOL BIOL, V21, P472, DOI 10.1038/nsmb.2816; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Penmatsa A, 2015, NAT STRUCT MOL BIOL, V22, P506, DOI 10.1038/nsmb.3029; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; Quick M, 2009, P NATL ACAD SCI USA, V106, P5563, DOI 10.1073/pnas.0811322106; RAMAMOORTHY S, 1993, P NATL ACAD SCI USA, V90, P2542, DOI 10.1073/pnas.90.6.2542; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rothman RB, 2003, EUR J PHARMACOL, V479, P23, DOI 10.1016/j.ejphar.2003.08.054; RUDNICK G, 1993, BIOCHIM BIOPHYS ACTA, V1144, P249, DOI 10.1016/0005-2728(93)90109-S; Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; SWILLENS S, 1995, MOL PHARMACOL, V47, P1197; Tate CG, 2012, TRENDS BIOCHEM SCI, V37, P343, DOI 10.1016/j.tibs.2012.06.003; UDENFRIEND S, 1987, ANAL BIOCHEM, V161, P494, DOI 10.1016/0003-2697(87)90479-9; Wang H, 2013, NATURE, V503, P141, DOI 10.1038/nature12648; Wang H, 2012, NAT STRUCT MOL BIOL, V19, P212, DOI 10.1038/nsmb.2215; Wang KH, 2015, NATURE, V521, P322, DOI 10.1038/nature14431; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978	32	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145688	10.1371/journal.pone.0145688	http://dx.doi.org/10.1371/journal.pone.0145688			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26695939	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092500068
J	Chong, WM; Hsu, SC; Kao, WT; Lo, CW; Lee, KY; Shao, JS; Chen, YH; Chang, J; Chen, SSL; Yu, MJ				Chong, Weng Man; Hsu, Shih-Chin; Kao, Wei-Ting; Lo, Chieh-Wen; Lee, Kuan-Ying; Shao, Jheng-Syuan; Chen, Yi-Hung; Chang, Justin; Chen, Steve S. -L.; Yu, Ming-Jiun			Phosphoproteomics Identified an NS5A Phosphorylation Site Involved in Hepatitis C Virus Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody; Hepatitis C virus (HCV); phosphoproteomics; phosphorylation; proteomics; casein kinase; serine 235	NONSTRUCTURAL PROTEIN 5A; VIRAL-RNA REPLICATION; KINASE-I-ALPHA; CELL-CULTURE; HYPERPHOSPHORYLATION; COMPLEX; ESTABLISHMENT; INHIBITORS; THERAPIES; SUBSTRATE	The non-structural protein 5A (NS5A) is a hepatitis C virus (HCV) protein indispensable for the viral life cycle. Many prior papers have pinpointed several serine residues in the low complexity sequence I region of NS5A responsible for NS5A phosphorylation; however, the functions of specific phosphorylation sites remained obscure. Using phosphoproteomics, we identified three phosphorylation sites (serines 222, 235, and 238) in the NS5A low complexity sequence I region. Reporter virus and replicon assays using phosphorylation-ablated alanine mutants of these sites showed that Ser-235 dominated over Ser-222 and Ser-238 in HCV replication. Immunoblotting using an Ser-235 phosphorylation-specific antibody showed a time-dependent increase in Ser-235 phosphorylation that correlated with the viral replication activity. Ser-235 phosphorylated NS5A co-localized with double-stranded RNA, consistent with its role in HCV replication. Mechanistically, Ser-235 phosphorylation probably promotes the replication complex formation via increasing NS5A interaction with the human homologue of the 33-kDa vesicle-associated membrane protein-associated protein. Casein kinase I (CKI) directly phosphorylated Ser-235 in vitro. Inhibition of CKI reduced Ser-235 phosphorylation and the HCV RNA levels in the infected cells. We concluded that NS5A Ser-235 phosphorylated by CKI probably promotes HCV replication via increasing NS5A interaction with the 33-kDa vesicle-associated membrane protein-associated protein.	[Chong, Weng Man; Hsu, Shih-Chin; Kao, Wei-Ting; Lo, Chieh-Wen; Lee, Kuan-Ying; Shao, Jheng-Syuan; Chen, Yi-Hung; Chang, Justin; Yu, Ming-Jiun] Natl Taiwan Univ, Coll Med, Inst Biochem & Mol Biol, Rm 816,1 Sec 1 Jen Ai Rd, Taipei 10051, Taiwan; [Chen, Steve S. -L.] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan	National Taiwan University; Academia Sinica - Taiwan	Yu, MJ (corresponding author), Natl Taiwan Univ, Coll Med, Inst Biochem & Mol Biol, Rm 816,1 Sec 1 Jen Ai Rd, Taipei 10051, Taiwan.	mjyu@ntu.edu.tw	Chen, Yi-Chen/GVU-0551-2022	Chong, Weng Man/0000-0002-5548-1628; YU, MING-JIUN/0000-0003-0393-4696	National Health Research Institutes [NHRI-EX104-10213BI]	National Health Research Institutes(National Health Research Institutes, JapanNational Health Research Institutes - Taiwan)	This work was supported by National Health Research Institutes Grant NHRI-EX104-10213BI (to M. J. Y.). The authors declare that they have no conflicts of interest with the contents of this article.	Appel N, 2005, J VIROL, V79, P3187, DOI 10.1128/JVI.79.5.3187-3194.2005; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Chen YC, 2010, J VIROL, V84, P7983, DOI 10.1128/JVI.00068-10; Coito C, 2004, J VIROL, V78, P3502, DOI 10.1128/JVI.78.7.3502-3513.2004; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Evans MJ, 2004, P NATL ACAD SCI USA, V101, P13038, DOI 10.1073/pnas.0405152101; FLOTOW H, 1990, J BIOL CHEM, V265, P14264; Fridell RA, 2013, J VIROL, V87, P2320, DOI 10.1128/JVI.02861-12; Gao L, 2004, J VIROL, V78, P3480, DOI 10.1128/JVI.78.7.3480-3488.2004; Gilliver AN, 2010, J GEN VIROL, V91, P2428, DOI 10.1099/vir.0.023614-0; Hill A, 2014, SCIENCE, V345, P141, DOI 10.1126/science.1257737; Huang Y, 2007, VIROLOGY, V364, P1, DOI 10.1016/j.virol.2007.01.042; Kambara H, 2012, J VIROL, V86, P1382, DOI 10.1128/JVI.06242-11; KANEKO T, 1994, BIOCHEM BIOPH RES CO, V205, P320, DOI 10.1006/bbrc.1994.2667; Katze MG, 2000, VIROLOGY, V278, P501, DOI 10.1006/viro.2000.0662; Kim J, 1999, BIOCHEM BIOPH RES CO, V257, P777, DOI 10.1006/bbrc.1999.0460; Lemay KL, 2013, J VIROL, V87, P1255, DOI 10.1128/JVI.02154-12; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Masaki T, 2008, J VIROL, V82, P7964, DOI 10.1128/JVI.00826-08; Masaki T, 2014, J VIROL, V88, P7541, DOI 10.1128/JVI.03170-13; Neddermann P, 2004, J VIROL, V78, P13306, DOI 10.1128/JVI.78.23.13306-13314.2004; Pawlotsky JM, 2014, GASTROENTEROLOGY, V146, P1176, DOI 10.1053/j.gastro.2014.03.003; Quintavalle M, 2007, J BIOL CHEM, V282, P5536, DOI 10.1074/jbc.M610486200; Quintavalle M, 2006, J VIROL, V80, P11305, DOI 10.1128/JVI.01465-06; Reed KE, 1999, J BIOL CHEM, V274, P28011, DOI 10.1074/jbc.274.39.28011; Reed KE, 1997, J VIROL, V71, P7187, DOI 10.1128/JVI.71.10.7187-7197.1997; Reghellin V, 2014, ANTIMICROB AGENTS CH, V58, P7128, DOI 10.1128/AAC.03293-14; Rinschen MM, 2010, P NATL ACAD SCI USA, V107, P3882, DOI 10.1073/pnas.0910646107; Ross-Thriepland D, 2015, J GEN VIROL, V96, P727, DOI 10.1099/jgv.0.000009; Ross-Thriepland D, 2015, J VIROL, V89, P3123, DOI 10.1128/JVI.02995-14; Ross-Thriepland D, 2014, J VIROL, V88, P1421, DOI 10.1128/JVI.03017-13; Scheel TKH, 2013, NAT MED, V19, P837, DOI 10.1038/nm.3248; Supekova L, 2008, J BIOL CHEM, V283, P29, DOI 10.1074/jbc.M703988200; TANJI Y, 1995, J VIROL, V69, P3980, DOI 10.1128/JVI.69.7.3980-3986.1995; Tellinghuisen TL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000032; Thomas DL, 2013, NAT MED, V19, P850, DOI 10.1038/nm.3184; Tu H, 1999, VIROLOGY, V263, P30, DOI 10.1006/viro.1999.9893; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	41	18	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					3918	3931		10.1074/jbc.M115.675413	http://dx.doi.org/10.1074/jbc.M115.675413			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26702051	Green Published, hybrid			2022-12-26	WOS:000371338400020
J	Di Giacomo, M; Camaioni, A; Klinger, FG; Bonfiglio, R; Salustri, A				Di Giacomo, Monica; Camaioni, Antonella; Klinger, Francesca G.; Bonfiglio, Rita; Salustri, Antonietta			Cyclic AMP-elevating Agents Promote Cumulus Cell Survival and Hyaluronan Matrix Stability, Thereby Prolonging the Time of Mouse Oocyte Fertilizability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; cyclic AMP (cAMP); extracellular matrix; fertilization; hyaluronan; cumulus cells	FOLLICLE-STIMULATING-HORMONE; EPIDERMAL-GROWTH-FACTOR; PROTEIN-KINASE-A; GENE-EXPRESSION PROFILES; IN-VITRO MATURATION; GRANULOSA-CELLS; PHOSPHODIESTERASE INHIBITORS; EXTRACELLULAR-MATRIX; INDUCED APOPTOSIS; DEVELOPMENTAL COMPETENCE	Cumulus cells sustain the development and fertilization of the mammalian oocyte. These cells are retained around the oocyte by a hyaluronan-rich extracellular matrix synthesized before ovulation, a process called cumulus cell-oocyte complex (COC) expansion. Hyaluronan release and dispersion of the cumulus cells progressively occur after ovulation, paralleling the decline of oocyte fertilization. We show here that, in mice, postovulatory changes of matrix are temporally correlated to cumulus cell death. Cumulus cell apoptosis and matrix disassembly also occurred in ovulated COCs cultured in vitro. COCs expanded in vitro with FSH or EGF underwent the same changes, whereas those expanded with 8-bromo-adenosine-3,5-cyclic monophosphate (8-Br-cAMP) maintained integrity for a longer time. It is noteworthy that 8-Br-cAMP treatment was also effective on ovulated COCs cultured in vitro, prolonging the vitality of the cumulus cells and the stability of the matrix from a few hours to >2 days. Stimulation of endogenous adenylate cyclase with forskolin or inhibition of phosphodiesterase with rolipram produced similar effects. The treatment with selective cAMP analogues suggests that the effects of cAMP elevation are exerted through an EPAC-independent, PKA type II-dependent signaling pathway, probably acting at the post-transcriptional level. Finally, overnight culture of ovulated COCs with 8-Br-cAMP significantly counteracted the decrease of fertilization rate, doubling the number of fertilized oocytes compared with control conditions. In conclusion, these studies suggest that cAMP-elevating agents prevent cumulus cell senescence and allow them to continue to exert beneficial effects on oocyte and sperm, thereby extending in vitro the time frame of oocyte fertilizability.	[Di Giacomo, Monica; Camaioni, Antonella; Klinger, Francesca G.; Bonfiglio, Rita; Salustri, Antonietta] Univ Roma Tor Vergata, Sect Histol & Embryol, Dept Biomed & Prevent, Via Montpellier 1, I-00133 Rome, Italy	University of Rome Tor Vergata	Salustri, A (corresponding author), Univ Roma Tor Vergata, Sect Histol & Embryol, Dept Biomed & Prevent, Via Montpellier 1, I-00133 Rome, Italy.	salustri@med.uniroma2.it	Camaioni, Antonella/AAB-5285-2020; Klinger, Francesca Gioia/AAO-5349-2021; Camaioni, Antonella/AAB-5294-2020	Camaioni, Antonella/0000-0002-7059-2617; Klinger, Francesca Gioia/0000-0001-6744-0850; Camaioni, Antonella/0000-0002-7059-2617; Bonfiglio, Rita/0000-0003-4172-2977; Di Giacomo, Monica/0000-0002-4075-0725; SALUSTRI, ANTONIETTA/0000-0002-8731-1041				Assidi M, 2008, BIOL REPROD, V79, P209, DOI 10.1095/biolreprod.108.067686; Assou S, 2008, MOL HUM REPROD, V14, P711, DOI 10.1093/molehr/gan067; BIGGERS JD, 1967, P NATL ACAD SCI USA, V58, P560, DOI 10.1073/pnas.58.2.560; Bourguignon LYW, 2009, J BIOL CHEM, V284, P26533, DOI 10.1074/jbc.M109.027466; Brown HM, 2010, BIOL REPROD, V83, P549, DOI 10.1095/biolreprod.110.084434; BUCCIONE R, 1990, DEV BIOL, V138, P16, DOI 10.1016/0012-1606(90)90172-F; CAMAIONI A, 1993, J BIOL CHEM, V268, P20473; CAMPBELL S, 1995, HUM REPROD, V10, P425, DOI 10.1093/oxfordjournals.humrep.a135955; Chang HC, 2005, HUM REPROD, V20, P1958, DOI 10.1093/humrep/dei003; Chen J, 2013, NAT CELL BIOL, V15, P1415, DOI 10.1038/ncb2873; Cheng XD, 2008, ACTA BIOCH BIOPH SIN, V40, P651, DOI 10.1111/j.1745-7270.2008.00438.x; Chian RC, 2004, CURR OPIN OBSTET GYN, V16, P211, DOI 10.1097/00001703-200406000-00003; Christensen AE, 2003, J BIOL CHEM, V278, P35394, DOI 10.1074/jbc.M302179200; Conti M, 2012, MOL CELL ENDOCRINOL, V356, P65, DOI 10.1016/j.mce.2011.11.002; Coticchio G, 2012, INT J DEV BIOL, V56, P909, DOI 10.1387/ijdb.120135gv; D'Alessandris C, 2001, ENDOCRINOLOGY, V142, P3033, DOI 10.1210/en.142.7.3033; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; De la Fuente R, 1999, HUM REPROD, V14, P3060, DOI 10.1093/humrep/14.12.3060; Dong JM, 1998, J BIOL CHEM, V273, P22554, DOI 10.1074/jbc.273.35.22554; DOWNS SM, 1995, DEV BIOL, V172, P72, DOI 10.1006/dbio.1995.0006; Eisenbach M, 2006, NAT REV MOL CELL BIO, V7, P276, DOI 10.1038/nrm1893; Ellerbroek SM, 2003, J BIOL CHEM, V278, P19023, DOI 10.1074/jbc.M213066200; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Familiari G, 1996, MOL REPROD DEV, V43, P392, DOI 10.1002/(SICI)1098-2795(199603)43:3<392::AID-MRD14>3.0.CO;2-3; Fan HY, 2012, MOL CELL ENDOCRINOL, V356, P74, DOI 10.1016/j.mce.2011.12.005; Fissore RA, 2002, REPRODUCTION, V124, P745, DOI 10.1530/rep.0.1240745; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; Gilchrist RB, 2008, HUM REPROD UPDATE, V14, P159, DOI 10.1093/humupd/dmm040; Gilchrist RB, 2011, REPROD FERT DEVELOP, V23, P23, DOI 10.1071/RD10225; Gonzalez-Robayna IJ, 2000, MOL ENDOCRINOL, V14, P1283, DOI 10.1210/me.14.8.1283; Hernandez-Gonzalez I, 2006, MOL ENDOCRINOL, V20, P1300, DOI 10.1210/me.2005-0420; Hunzicker-Dunn M, 2006, CELL SIGNAL, V18, P1351, DOI 10.1016/j.cellsig.2006.02.011; Hussein TS, 2005, J CELL SCI, V118, P5257, DOI 10.1242/jcs.02644; Ievoli E, 2011, MATRIX BIOL, V30, P330, DOI 10.1016/j.matbio.2011.05.002; Ishizuya-Oka A, 2010, APOPTOSIS, V15, P350, DOI 10.1007/s10495-009-0422-y; Jin M, 2011, P NATL ACAD SCI USA, V108, P4892, DOI 10.1073/pnas.1018202108; Kaneko T, 2000, J ASSIST REPROD GEN, V17, P162, DOI 10.1023/A:1009470206468; Keller KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048523; Lam X, 2000, BIOL REPROD, V62, P579, DOI 10.1095/biolreprod62.3.579; Leemhuis J, 2002, J PHARMACOL EXP THER, V300, P1000, DOI 10.1124/jpet.300.3.1000; Lisignoli G, 2001, ARTHRITIS RHEUM-US, V44, P1800, DOI 10.1002/1529-0131(200108)44:8<1800::AID-ART317>3.0.CO;2-1; Lochner A, 2006, CARDIOVASC DRUG REV, V24, P261, DOI 10.1111/j.1527-3466.2006.00261.x; LOKESHWAR VB, 1994, J CELL BIOL, V126, P1099, DOI 10.1083/jcb.126.4.1099; LONGO FJ, 1980, GAMETE RES, V3, P379, DOI 10.1002/mrd.1120030409; Luciano AM, 2005, MOL REPROD DEV, V71, P389, DOI 10.1002/mrd.20304; Lopez-Campos JL, 2013, EXPERT REV RESP MED, V7, P43, DOI [10.1586/ers.13.17, 10.1586/ERS.13.17]; Lund LR, 2000, DEVELOPMENT, V127, P4481; Markstrom E, 2002, REPRODUCTION, V123, P23, DOI 10.1530/rep.0.1230023; MARSTON JH, 1964, J EXP ZOOL, V155, P237, DOI 10.1002/jez.1401550211; Martin MC, 2005, J BIOL CHEM, V280, P15449, DOI 10.1074/jbc.M414325200; Matsuda-Minehata F, 2006, J REPROD DEVELOP, V52, P695, DOI 10.1262/jrd.18069; McCulloch DR, 2009, DEV CELL, V17, P687, DOI 10.1016/j.devcel.2009.09.008; Merriman JA, 1998, HUM REPROD, V13, P690, DOI 10.1093/humrep/13.3.690; Miao YL, 2009, HUM REPROD UPDATE, V15, P573, DOI 10.1093/humupd/dmp014; Murphy G, 2011, FEBS J, V278, P2, DOI 10.1111/j.1742-4658.2010.07918.x; Naderi EH, 2009, BLOOD, V114, P608, DOI 10.1182/blood-2009-02-204883; Onoda M, 2009, HEMATOLOGY, V14, P213, DOI 10.1179/102453309X426236; Ouandaogo ZG, 2012, HUM REPROD, V27, P2438, DOI 10.1093/humrep/des172; Page CP, 2011, HANDB EXP PHARMACOL, V204, P391, DOI 10.1007/978-3-642-17969-3_17; Petrey AC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00101; Puthalakath H, 2001, SCIENCE, V293, P1829, DOI 10.1126/science.1062257; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Russell DL, 2006, SEMIN REPROD MED, V24, P217, DOI 10.1055/s-2006-948551; Russell DL, 2003, J BIOL CHEM, V278, P42330, DOI 10.1074/jbc.M300519200; Russell DL, 2003, ENDOCRINOLOGY, V144, P1020, DOI 10.1210/en.2002-220434; Ruvolo G, 2013, J ASSIST REPROD GEN, V30, P207, DOI 10.1007/s10815-013-9943-y; SALUSTRI A, 1989, J BIOL CHEM, V264, P13840; SALUSTRI A, 1990, DEV BIOL, V138, P26, DOI 10.1016/0012-1606(90)90173-G; SALUSTRI A, 1985, BIOL REPROD, V33, P797, DOI 10.1095/biolreprod33.4.797; Salustri A, 2004, DEVELOPMENT, V131, P1577, DOI 10.1242/dev.01056; Scarchilli L, 2007, J BIOL CHEM, V282, P30161, DOI 10.1074/jbc.M703738200; Shimada M, 2006, MOL ENDOCRINOL, V20, P1352, DOI 10.1210/me.2005-0504; Su YQ, 2002, ENDOCRINOLOGY, V143, P2221, DOI 10.1210/en.143.6.2221; SUTOVSKY P, 1995, MOL REPROD DEV, V41, P521, DOI 10.1002/mrd.1080410415; Sutton-McDowall ML, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102061; Szotys M., 2000, ANAT EMBRYOL BERL, V202, P523, DOI 10.1007/s004290000122; Taddei ML, 2012, J PATHOL, V226, P380, DOI 10.1002/path.3000; TALBOT P, 1983, J EXP ZOOL, V225, P141, DOI 10.1002/jez.1402250117; Tarin JJ, 2002, BIOL REPROD, V66, P495, DOI 10.1095/biolreprod66.2.495; Tarin JJ, 2000, HUM REPROD UPDATE, V6, P532, DOI 10.1093/humupd/6.6.532; Taylor SS, 2012, NAT REV MOL CELL BIO, V13, P646, DOI 10.1038/nrm3432; Tirone E, 1997, J BIOL CHEM, V272, P4787, DOI 10.1074/jbc.272.8.4787; Titus DJ, 2015, CURR PHARM DESIGN, V21, P332; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Tsafriri A, 1996, DEV BIOL, V178, P393, DOI 10.1006/dbio.1996.0226; TSUKITA S, 1994, J CELL BIOL, V126, P391, DOI 10.1083/jcb.126.2.391; Tunjung WAS, 2009, BIOCHEM BIOPH RES CO, V382, P160, DOI 10.1016/j.bbrc.2009.02.163; Vigetti D, 2011, J BIOL CHEM, V286, P34497, DOI 10.1074/jbc.M111.266312; Wilcox AJ, 1998, HUM REPROD, V13, P394, DOI 10.1093/humrep/13.2.394; Wu YJ, 2005, CELL RES, V15, P483, DOI 10.1038/sj.cr.7290318; Yeo CX, 2008, HUM REPROD, V23, P67, DOI 10.1093/humrep/dem140; Yodoi R, 2009, ENDOCRINOLOGY, V150, P3345, DOI 10.1210/en.2008-1449; Yokoo M, 2002, BIOL REPROD, V67, P1165, DOI 10.1095/biolreprod67.4.1165; Zhang AJ, 2012, J ASSIST REPROD GEN, V29, P313, DOI 10.1007/s10815-012-9712-3; Zhuo LS, 2001, J BIOL CHEM, V276, P7693, DOI 10.1074/jbc.C000899200	95	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					3821	3836		10.1074/jbc.M115.680983	http://dx.doi.org/10.1074/jbc.M115.680983			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26694612	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000371338400012
J	Fatehchand, K; Ren, L; Elavazhagan, S; Fang, HQ; Mo, XK; Vasilakos, JP; Dietsch, GN; Hershberg, RM; Tridandapani, S; Butchar, JP				Fatehchand, Kavin; Ren, Li; Elavazhagan, Saranya; Fang, Huiqing; Mo, Xiaokui; Vasilakos, John P.; Dietsch, Gregory N.; Hershberg, Robert M.; Tridandapani, Susheela; Butchar, Jonathan P.			Toll-like Receptor 4 Ligands Down-regulate Fc gamma Receptor IIb (Fc gamma RIIb) via MARCH3 Protein-mediated Ubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell biology; Fc receptor; immunology; monocyte; signal transduction; Toll-like receptor 4 (TLR4); ubiquitylation (ubiquitination)	NON-HODGKINS-LYMPHOMA; DEPENDENT CELLULAR CYTOTOXICITY; CHRONIC LYMPHOCYTIC-LEUKEMIA; NATURAL-KILLER-CELL; IN-VIVO; RHEUMATOID-ARTHRITIS; ANTITUMOR-ACTIVITY; ANTIBODY THERAPY; MYELOID CELLS; COMBINATION IMMUNOTHERAPY	Monocytes and macrophages are critical for the effectiveness of monoclonal antibody therapy. Responses to antibody-coated tumor cells are largely mediated by Fc receptors (FcRs), which become activated upon binding to immune complexes. FcRIIb is an inhibitory FcR that negatively regulates these responses, and it is expressed on monocytes and macrophages. Therefore, deletion or down-regulation of this receptor may substantially enhance therapeutic outcomes. Here we screened a panel of Toll-like receptor (TLR) agonists and found that those selective for TLR4 and TLR8 could significantly down-regulate the expression of FcRIIb. Upon further examination, we found that treatment of monocytes with TLR4 agonists could lead to the ubiquitination of FcRIIb protein. A search of our earlier microarray database of monocytes activated with the TLR7/8 agonist R-848 (in which FcRIIb was down-regulated) revealed an up-regulation of membrane-associated ring finger (C3HC4) 3 (MARCH3), an E3 ubiquitin ligase. Therefore, we tested whether LPS treatment could up-regulate MARCH3 in monocytes and whether this E3 ligase was involved with LPS-mediated FcRIIb down-regulation. The results showed that LPS activation of TLR4 significantly increased MARCH3 expression and that siRNA against MARCH3 prevented the decrease in FcRIIb following LPS treatment. These data suggest that activation of TLR4 on monocytes can induce a rapid down-regulation of FcRIIb protein and that this involves ubiquitination.	[Fatehchand, Kavin] Ohio State Univ, Med Scientist Training Program, Columbus, OH 43210 USA; [Elavazhagan, Saranya; Fang, Huiqing; Tridandapani, Susheela; Butchar, Jonathan P.] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Mo, Xiaokui] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA; [Ren, Li] Jilin Univ, Minist Educ, Key Lab Mol Enzymol & Engn, Changchun 130000, Jilin, Peoples R China; [Vasilakos, John P.] 3M Drug Delivery Syst Div, St Paul, MN 55144 USA; [Dietsch, Gregory N.; Hershberg, Robert M.] VentiRx Pharmaceut, Seattle, WA 98101 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Jilin University; 3M	Tridandapani, S; Butchar, JP (corresponding author), Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA.	tridandapani.2@osu.edu; butchar.2@osu.edu	Butchar, Jonathan/E-2825-2011		National Institutes of Health [P01-CA095426, R01 CA162411, K12 CA133250]; Ohio State University College of Medicine McWhinney Bridge Fund Grant [244749]; American Cancer Society [IRG-67-003-47]; NATIONAL CANCER INSTITUTE [P01CA095426, R01CA162411, K12CA133250, P30CA016058] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio State University College of Medicine McWhinney Bridge Fund Grant; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grants P01-CA095426 and R01 CA162411 (to S. T.) and K12 CA133250 (to J. P. B.), Ohio State University College of Medicine McWhinney Bridge Fund Grant 244749 (to J. P. B.), and American Cancer Society Institutional Research Grant IRG-67-003-47 (to J. P. B.). J. P. V. is an employee of 3M. G. N. D. and R. M. H. are employees of VentiRx Pharmaceuticals. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Ansell SM, 2002, BLOOD, V99, P67, DOI 10.1182/blood.V99.1.67; Ansell SM, 2006, CLIN CANCER RES, V12, P6056, DOI 10.1158/1078-0432.CCR-06-1245; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Beers SA, 2010, BLOOD, V115, P5191, DOI 10.1182/blood-2010-01-263533; Berte R, 2001, ACTA HAEMATOL-BASEL, V106, P141, DOI 10.1159/000046607; Bevaart L, 2006, CANCER RES, V66, P1261, DOI 10.1158/0008-5472.CAN-05-2856; Butchar JP, 2010, CLIN CANCER RES, V16, P2065, DOI 10.1158/1078-0432.CCR-09-2591; Byrd JC, 2001, J CLIN ONCOL, V19, P2153, DOI 10.1200/JCO.2001.19.8.2153; Chacko GW, 1996, J IMMUNOL, V157, P2234; CHOQUET D, 1994, J BIOL CHEM, V269, P6491; Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012; Clynes R, 1998, P NATL ACAD SCI USA, V95, P652, DOI 10.1073/pnas.95.2.652; Clynes R, 1999, J EXP MED, V189, P179, DOI 10.1084/jem.189.1.179; CLYNES R, 1995, IMMUNITY, V3, P21, DOI 10.1016/1074-7613(95)90155-8; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Cox D, 2001, J EXP MED, V193, P61, DOI 10.1084/jem.193.1.61; Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; Davis TA, 2000, CLIN CANCER RES, V6, P2644; Duan GJ, 2014, FRONT BIOSCI-LANDMRK, V19, P904, DOI 10.2741/4256; Elavazhagan S, 2015, J IMMUNOL, V194, P2786, DOI 10.4049/jimmunol.1402316; ERNST LK, 1993, P NATL ACAD SCI USA, V90, P6023, DOI 10.1073/pnas.90.13.6023; Friedberg JW, 2002, BRIT J HAEMATOL, V117, P828, DOI 10.1046/j.1365-2141.2002.03535.x; Ganesan LP, 2003, J BIOL CHEM, V278, P35710, DOI 10.1074/jbc.M305078200; Gavrilin MA, 2006, P NATL ACAD SCI USA, V103, P141, DOI 10.1073/pnas.0504271103; Gong Q, 2005, J IMMUNOL, V174, P817, DOI 10.4049/jimmunol.174.2.817; GUYRE PM, 1983, J CLIN INVEST, V72, P393, DOI 10.1172/JCI110980; Hainsworth JD, 2003, J CLIN ONCOL, V21, P1746, DOI 10.1200/JCO.2003.09.027; Hor S, 2009, MOL CELL PROTEOMICS, V8, P1959, DOI 10.1074/mcp.M900174-MCP200; Hunter S, 1998, BLOOD, V91, P1762, DOI 10.1182/blood.V91.5.1762.1762_1762_1768; Hutchins JT, 1995, P NATL ACAD SCI USA, V92, P11980, DOI 10.1073/pnas.92.26.11980; Joshi T, 2006, MOL IMMUNOL, V43, P839, DOI 10.1016/j.molimm.2005.06.037; Khan KD, 2006, CLIN CANCER RES, V12, P7046, DOI 10.1158/1078-0432.CCR-06-1571; Lazar GA, 2006, P NATL ACAD SCI USA, V103, P4005, DOI 10.1073/pnas.0508123103; MALEFYT RD, 1993, J IMMUNOL, V151, P6370; MELLMAN IS, 1983, J CELL BIOL, V96, P887, DOI 10.1083/jcb.96.3.887; Minard-Colin V, 2008, BLOOD, V112, P1205, DOI 10.1182/blood-2008-01-135160; Moga E, 2008, EXP HEMATOL, V36, P69, DOI 10.1016/j.exphem.2007.08.012; MUTA T, 1994, NATURE, V368, P70, DOI 10.1038/368070a0; O'Brien SM, 2001, J CLIN ONCOL, V19, P2165, DOI 10.1200/JCO.2001.19.8.2165; Oflazoglu E, 2009, BRIT J CANCER, V100, P113, DOI 10.1038/sj.bjc.6604812; Oflazoglu E, 2007, BLOOD, V110, P4370, DOI 10.1182/blood-2007-06-097014; Ono M, 1997, CELL, V90, P293, DOI 10.1016/S0092-8674(00)80337-2; Pricop L, 2001, J IMMUNOL, V166, P531, DOI 10.4049/jimmunol.166.1.531; Radstake TRDJ, 2006, ARTHRITIS RHEUM-US, V54, P3828, DOI 10.1002/art.22275; Reddy N, 2008, BRIT J HAEMATOL, V140, P36, DOI 10.1111/j.1365-2141.2007.06841.x; Roghanian A, 2015, CANCER CELL, V27, P473, DOI 10.1016/j.ccell.2015.03.005; Savva A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00387; Shah P, 2013, J BIOL CHEM, V288, P12345, DOI 10.1074/jbc.M113.449983; STEINMAN RM, 1976, J CELL BIOL, V68, P665, DOI 10.1083/jcb.68.3.665; Tai YT, 2005, CANCER RES, V65, P11712, DOI 10.1158/0008-5472.CAN-05-1657; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Tridandapani S, 2002, J BIOL CHEM, V277, P5082, DOI 10.1074/jbc.M110277200; Tridandapani S, 2002, J IMMUNOL, V169, P4370, DOI 10.4049/jimmunol.169.8.4370; Tridandapani S, 1999, J IMMUNOL, V162, P1408; Uchida JJ, 2004, J EXP MED, V199, P1659, DOI 10.1084/jem.20040119; UKKONEN P, 1986, J EXP MED, V163, P952, DOI 10.1084/jem.163.4.952; Van Roon JAG, 2003, J RHEUMATOL, V30, P648; VANDENHERIKOUDIJK IE, 1995, BLOOD, V85, P2202, DOI 10.1182/blood.V85.8.2202.bloodjournal8582202; VOGEL SN, 1983, J IMMUNOL, V130, P1210; Wang SZ, 2012, CANCER IMMUNOL IMMUN, V61, P49, DOI 10.1007/s00262-011-1090-7; Wijngaarden S, 2004, ARTHRITIS RHEUM-US, V50, P3878, DOI 10.1002/art.20672; Wu L, 2008, CLIN CANCER RES, V14, P4650, DOI 10.1158/1078-0432.CCR-07-4405; Yazawa N, 2005, P NATL ACAD SCI USA, V102, P15178, DOI 10.1073/pnas.0505539102; Yuasa T, 1999, J EXP MED, V189, P187, DOI 10.1084/jem.189.1.187	65	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					3895	3904		10.1074/jbc.M115.701151	http://dx.doi.org/10.1074/jbc.M115.701151			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26694610	Green Published, hybrid			2022-12-26	WOS:000371338400018
J	Kugler, G; 't Hart, BM; Kohlbecher, S; Einhauser, W; Schneider, E				Kugler, Guenter; 't Hart, Bernard Marius; Kohlbecher, Stefan; Einhaeuser, Wolfgang; Schneider, Erich			Gaze in Visual Search Is Guided More Efficiently by Positive Cues than by Negative Cues	PLOS ONE			English	Article							WORKING-MEMORY; ATTENTION; MODEL; SELECTION; MECHANISM	Visual search can be accelerated when properties of the target are known. Such knowledge allows the searcher to direct attention to items sharing these properties. Recent work indicates that information about properties of non-targets (i.e., negative cues) can also guide search. In the present study, we examine whether negative cues lead to different search behavior compared to positive cues. We asked observers to search for a target defined by a certain shape singleton (broken line among solid lines). Each line was embedded in a colored disk. In "positive cue" blocks, participants were informed about possible colors of the target item. In "negative cue" blocks, the participants were informed about colors that could not contain the target. Search displays were designed such that with both the positive and negative cues, the same number of items could potentially contain the broken line ("relevant items"). Thus, both cues were equally informative. We measured response times and eye movements. Participants exhibited longer response times when provided with negative cues compared to positive cues. Although negative cues did guide the eyes to relevant items, there were marked differences in eye movements. Negative cues resulted in smaller proportions of fixations on relevant items, longer duration of fixations and in higher rates of fixations per item as compared to positive cues. The effectiveness of both cue types, as measured by fixations on relevant items, increased over the course of each search. In sum, a negative color cue can guide attention to relevant items, but it is less efficient than a positive cue of the same informational value.	[Kugler, Guenter; Kohlbecher, Stefan] Univ Munich, Inst Clin Neurosci, Munich, Germany; [Kugler, Guenter; Kohlbecher, Stefan] Univ Munich, German Ctr Vertigo & Balance Disorders, Munich, Germany; ['t Hart, Bernard Marius; Einhaeuser, Wolfgang] Univ Marburg, Neurophys, Marburg, Germany; ['t Hart, Bernard Marius] York Univ, Ctr Vis Res, Toronto, ON M3J 2R7, Canada; [Einhaeuser, Wolfgang] Tech Univ Chemnitz, Inst Phys, Chemnitz, Germany; [Schneider, Erich] Brandenburg Univ Technol Cottbus Senftenberg, Inst Med Technol, Senftenberg, Germany	University of Munich; University of Munich; Philipps University Marburg; York University - Canada; Technische Universitat Chemnitz; Brandenburg University of Technology Cottbus	't Hart, BM (corresponding author), Univ Marburg, Neurophys, Marburg, Germany.	thartbm@gmail.com	't Hart, Bernard/AHD-9519-2022; Einhäuser, Wolfgang/A-3041-2012	't Hart, Bernard/0000-0002-0045-3769; Einhäuser, Wolfgang/0000-0001-7516-9589	German Federal Ministry of Education and Research [01 EO0901]; DFG cluster of excellence CoTeSys [SFB/TRR135, HA 6861/2-1]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); DFG cluster of excellence CoTeSys	The study was supported by the German Federal Ministry of Education and Research (Grant 01 EO0901), and by DFG cluster of excellence CoTeSys (www.cotesys.org), SFB/TRR135 (WE) and HA 6861/2-1 (BMtH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. EyeSeeTec GmbH did not provide salaries for any author during the study design, data collection and analysis, or decision to publish. EyeSeeTec did provide salaries for two authors [GK, SK] in the final stage of the revision, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions section.	Arita JT, 2012, J EXP PSYCHOL HUMAN, V38, P580, DOI 10.1037/a0027885; Brainard DH, 1997, SPAT VIS; BUNDESEN C, 1990, PSYCHOL REV, V97, P523, DOI 10.1037/0033-295X.97.4.523; Cave KR, 1999, PSYCHOL RES-PSYCH FO, V62, P182, DOI 10.1007/s004260050050; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; Eckstein MP, 2011, J VISION, V11, DOI 10.1167/11.5.14; EGETH HE, 1966, PERCEPT PSYCHOPHYS, V1, P245, DOI 10.3758/BF03207389; HOFFMAN JE, 1979, PERCEPT PSYCHOPHYS, V25, P319, DOI 10.3758/BF03198811; Hollingworth A, 2014, J VIS, V14, P1050; Kleiner M., 2007, WHATS NEW PSYCHTOOLB; Kohlbecher S, 2010, LOW LATENCY COMBINED, P117; Kristjansson A, 2008, VISION RES, V48, P1217, DOI 10.1016/j.visres.2008.02.007; Logan GD, 2004, ANNU REV PSYCHOL, V55, P207, DOI 10.1146/annurev.psych.55.090902.141415; Marini F, 2013, J EXP PSYCHOL GEN, V142, P906, DOI 10.1037/a0029905; Moher J, 2012, ATTEN PERCEPT PSYCHO, V74, P1590, DOI 10.3758/s13414-012-0358-0; Munneke J, 2008, ACTA PSYCHOL AMST; Noudoost B, 2010, CURR OPIN NEUROBIOL, V20, P183, DOI 10.1016/j.conb.2010.02.003; Olds ES, 2009, VISION RES, V49, P1428, DOI 10.1016/j.visres.2009.02.008; Olivers CNL, 2011, TRENDS COGN SCI, V15, P327, DOI 10.1016/j.tics.2011.05.004; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; R Core Team, 2013, R VERS 3 0, P1; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; Rutishauser U, 2007, J VISION, V7, DOI 10.1167/7.6.5; Salvucci D.D., 2000, P EYE TRACKING RES A, DOI [10.1145/355017.355028, DOI 10.1145/355017.355028]; TREISMAN A, 1988, PSYCHOL REV, V95, P15, DOI 10.1037/0033-295X.95.1.15; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; WASON PC, 1959, Q J EXP PSYCHOL, V11, P92, DOI 10.1080/17470215908416296; WILLIAMS LG, 1967, ACTA PSYCHOL, V27, P355, DOI 10.1016/0001-6918(67)90080-7; WOLFE JM, 1989, J EXP PSYCHOL HUMAN, V15, P419, DOI 10.1037/0096-1523.15.3.419; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774; Wolfe JM, 2004, NAT REV NEUROSCI, V5, P495, DOI 10.1038/nrn1411; Wolff Jerry O., 2007, P99; Woodman GF, 2007, J EXP PSYCHOL HUMAN, V33, P363, DOI 10.1037/0096-1523.33.2.363	36	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145910	10.1371/journal.pone.0145910	http://dx.doi.org/10.1371/journal.pone.0145910			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA0TN	26717307	Green Published, gold, Green Submitted			2022-12-26	WOS:000367510500092
J	Myers, T; Szucs, D				Myers, Timothy; Szuecs, Denes			Arithmetic Memory Is Modality Specific	PLOS ONE			English	Article							NUMBER; REPRESENTATION; INFORMATION; ADULTS	In regards to numerical cognition and working memory, it is an open question as to whether numbers are stored into and retrieved from a central abstract representation or from separate notation-specific representations. This study seeks to help answer this by utilizing the numeral modality effect (NME) in three experiments to explore how numbers are processed by the human brain. The participants were presented with numbers (1-9) as either Arabic digits or written number words (Arabic digits and dot matrices in Experiment 2) at the first (S1) and second (S2) stimuli. The participant's task was to add the first two stimuli together and verify whether the answer (S3), presented simultaneously with S2, was correct. We hypothesized that if reaction time (RT) at S2/S3 depends on the modality of S1 then numbers are retrieved from modality specific memory stores. Indeed, RT depended on the modality of S1 whenever S2 was an Arabic digit which argues against the concept of numbers being stored and retrieved from a central, abstract representation.	[Myers, Timothy; Szuecs, Denes] Univ Cambridge, Dept Psychol, Ctr Neurosci Educ, Cambridge, England	University of Cambridge	Myers, T (corresponding author), Univ Cambridge, Dept Psychol, Ctr Neurosci Educ, Cambridge, England.	tm471@cam.ac.uk; ds377@cam.ac.uk		Szucs, Denes/0000-0002-9477-0801				Campbell JID, 2004, CAN J EXP PSYCHOL, V58, P229, DOI 10.1037/h0087447; Campbell JID, 2004, J EXP PSYCHOL LEARN, V30, P51, DOI 10.1037/0278-7393.30.1.51; CAMPBELL JID, 1988, J EXP PSYCHOL GEN, V117, P204, DOI 10.1037/0096-3445.117.2.204; Campbell JID, 2001, COGNITION, V80, pB21, DOI 10.1016/S0010-0277(01)00115-9; Cantlon JF, 2006, PLOS BIOL, V4, P844, DOI 10.1371/journal.pbio.0040125; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Dehaene S, 1999, SCIENCE, V284, P970, DOI 10.1126/science.284.5416.970; DEHAENE S, 1995, J EXP PSYCHOL LEARN, V21, P314, DOI 10.1037/0278-7393.21.2.314; DEHAENE S, 1992, COGNITION, V44, P1, DOI 10.1016/0010-0277(92)90049-N; Dehaene S, 1998, TRENDS NEUROSCI, V21, P355, DOI 10.1016/S0166-2236(98)01263-6; Dehaene S., 1995, MATH COGNITION, V1, P83, DOI DOI 10.1155/2014/461647; Eger E, 2003, NEURON, V37, P719, DOI 10.1016/S0896-6273(03)00036-9; ERIKSEN CW, 1979, PERCEPT PSYCHOPHYS, V25, P249, DOI 10.3758/BF03198804; Gebuis T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025405; Ito Y, 2003, MEM COGNITION, V31, P360, DOI 10.3758/BF03194394; Jarmasz J., 2010, CANADIAN J EXPT PSYC, V63, P124; Kadosh RC, 2008, NEUROPSYCHOLOGIA, V46, P2872, DOI 10.1016/j.neuropsychologia.2008.05.025; Kadosh RC, 2009, BEHAV BRAIN SCI, V32, P313, DOI 10.1017/S0140525X09990938; MCCLOSKEY M, 1995, AM PSYCHOL, V50, P351, DOI 10.1037/0003-066X.50.5.351; MCCLOSKEY M, 1991, BRAIN COGNITION, V17, P154, DOI 10.1016/0278-2626(91)90074-I; MCCLOSKEY M, 1985, BRAIN COGNITION, V4, P171, DOI 10.1016/0278-2626(85)90069-7; Naccache L, 2001, CEREB CORTEX, V11, P966, DOI 10.1093/cercor/11.10.966; Nieder A, 2009, ANNU REV NEUROSCI, V32, P185, DOI 10.1146/annurev.neuro.051508.135550; Peirce J., 2007, J NEUROSCI METH, V13, P1621; Piazza M, 2007, NEURON, V53, P293, DOI 10.1016/j.neuron.2006.11.022; Pinel P, 2001, NEUROIMAGE, V14, P1013, DOI 10.1006/nimg.2001.0913; Soltesz F, 2014, BIOL PSYCHOL, V103, P203, DOI 10.1016/j.biopsycho.2014.09.006; Szucs D, 2004, COGNITIVE BRAIN RES, V19, P10, DOI 10.1016/j.cogbrainres.2003.11.002; Szucs D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00444; Szucs D, 2009, BEHAV BRAIN SCI, V32, P352, DOI 10.1017/S0140525X09990884; Thevenot C, 2006, MEM COGNITION, V34, P938, DOI 10.3758/BF03193439; Thevenot C, 2010, EUR J COGN PSYCHOL, V22, P348, DOI 10.1080/09541440903130743; Venkatraman V, 2005, NEUROPSYCHOLOGIA, V43, P744, DOI 10.1016/j.neuropsychologia.2004.08.005	33	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145614	10.1371/journal.pone.0145614	http://dx.doi.org/10.1371/journal.pone.0145614			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA0TN	26716692	Green Published, Green Submitted, gold			2022-12-26	WOS:000367510500048
J	Picq, JL; Villain, N; Gary, C; Pifferi, F; Dhenain, M				Picq, Jean-Luc; Villain, Nicolas; Gary, Charlotte; Pifferi, Fabien; Dhenain, Marc			Jumping Stand Apparatus Reveals Rapidly Specific Age-Related Cognitive Impairments in Mouse Lemur Primates	PLOS ONE			English	Article							VISUAL-DISCRIMINATION; NONHUMAN PRIMATE; RHESUS-MONKEY; OBJECT MEMORY; HIPPOCAMPUS; ACQUISITION; RETENTION; AMNESIA; SYSTEMS; CORTEX	The mouse lemur (Microcebus murinus) is a promising primate model for investigating normal and pathological cerebral aging. The locomotor behavior of this arboreal primate is characterized by jumps to and from trunks and branches. Many reports indicate insufficient adaptation of the mouse lemur to experimental devices used to evaluate its cognition, which is an impediment to the efficient use of this animal in research. In order to develop cognitive testing methods appropriate to the behavioral and biological traits of this species, we adapted the Lashley jumping stand apparatus, initially designed for rats, to the mouse lemur. We used this jumping stand apparatus to compare performances of young (n = 12) and aged (n = 8) adults in acquisition and long-term retention of visual discriminations. All mouse lemurs completed the tasks and only 25 trials, on average, were needed to master the first discrimination problem with no age-related differences. A month later, all mouse lemurs made progress for acquiring the second discrimination problem but only the young group reached immediately the criterion in the retention test of the first discrimination problem. This study shows that the jumping stand apparatus allows rapid and efficient evaluation of cognition in mouse lemurs and demonstrates that about half of the old mouse lemurs display a specific deficit in long-term retention but not in acquisition of visual discrimination.	[Picq, Jean-Luc] Univ Paris 08, EA 2027, Lab Psychopathol & Neuropsychol, F-93000 St Denis, France; [Picq, Jean-Luc; Gary, Charlotte; Dhenain, Marc] Univ Paris Saclay, Univ Paris Sud, CNRS, Neurodegenerat Dis Lab,UMR 9199, F-92265 Fontenay Aux Roses, France; [Picq, Jean-Luc; Gary, Charlotte; Dhenain, Marc] Commissariat Energie Atom & Energies Alternat CEA, MIRCen, Inst Imagerie Biomed I2BM, DSV, F-92265 Fontenay Aux Roses, France; [Villain, Nicolas; Pifferi, Fabien] CNRS, Adapt Mech & Evolut MECADEV, MNHN, UMR 7179, F-91800 Brunoy, France	Universite Paris-VIII; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN)	Picq, JL (corresponding author), Univ Paris 08, EA 2027, Lab Psychopathol & Neuropsychol, 2 Rue Liberte, F-93000 St Denis, France.	jean_lucpicq@hotmail.com	Dhenain, Marc/K-5630-2013	Dhenain, Marc/0000-0001-8804-4101; Pifferi, Fabien/0000-0001-9316-1935	Association France Alzheimer	Association France Alzheimer	This work was supported by the Association France Alzheimer. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTUS RT, 1979, J GERONTOL, V34, P209, DOI 10.1093/geronj/34.2.209; BONS N, 1992, NEUROBIOL AGING, V13, P99, DOI 10.1016/0197-4580(92)90016-Q; COHEN NJ, 1980, SCIENCE, V210, P207, DOI 10.1126/science.7414331; DELACOURTE A, 1995, CR ACAD SCI III-VIE, V318, P85; Dhenain M, 2000, NEUROBIOL AGING, V21, P81, DOI 10.1016/S0197-4580(00)00098-1; Dhenain M, 1998, NEUROBIOL AGING, V19, P65, DOI 10.1016/S0197-4580(98)00005-0; Dias R, 1997, J NEUROSCI, V17, P9285; Epp J, 2008, LEARN MEMORY, V15, P214, DOI 10.1101/lm.788008; Gabrieli JDE, 1996, P NATL ACAD SCI USA, V93, P13534, DOI 10.1073/pnas.93.24.13534; Gilbert PE, 2009, ANN NY ACAD SCI, V1170, P718, DOI 10.1111/j.1749-6632.2009.03929.x; Jallageas V, 1998, ANN NY ACAD SCI, V839, P628, DOI 10.1111/j.1749-6632.1998.tb10899.x; Joly M, 2004, PHYSIOL BEHAV, V82, P325, DOI 10.1016/j.physbeh.2004.03.019; Joly M, 2006, NEUROBIOL AGING, V27, P1045, DOI 10.1016/j.neurobiolaging.2005.05.001; Joly M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109393; Kappeler PM, 1998, AM J PRIMATOL, V46, P7; LAI ZC, 1995, NEUROBIOL AGING, V16, P947, DOI 10.1016/0197-4580(95)02014-4; Languille S, 2012, AGEING RES REV, V11, P150, DOI 10.1016/j.arr.2011.07.001; Languille S, 2015, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00446; Lashley KS, 1930, PEDAGOG SEMIN J GEN, V37, P453; LEVISOHN LF, 1991, BRAIN RES, V564, P230, DOI 10.1016/0006-8993(91)91458-D; MESTRE N, 1993, NEURODEGENERATION, V2, P25; Mestre-Frances N., 1996, ALZHEIMERS RES, V2, P19; Moore TL, 2002, BEHAV NEUROSCI, V116, P387, DOI 10.1037//0735-7044.116.3.387; Moore TL, 2003, NEUROBIOL AGING, V24, P125, DOI 10.1016/S0197-4580(02)00054-4; Petri HL, 1984, NEUROPSYCHOLOGY MEMO, P287; Picq JL, 2007, EXP GERONTOL, V42, P223, DOI 10.1016/j.exger.2006.09.013; Picq JL, 2012, NEUROBIOL AGING, V33, P1096, DOI 10.1016/j.neurobiolaging.2010.09.009; RAPP PR, 1990, BEHAV NEUROSCI, V104, P876, DOI 10.1037/0735-7044.104.6.876; RITCHIE K, 1997, ALZHEIMERS RES, V3, P37; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Sutherland NS., 1971, MECH ANIMAL DISCRIMI; Trouche SG, 2010, NEUROBIOL LEARN MEM, V94, P100, DOI 10.1016/j.nlm.2010.04.006; Vinot N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020491; Vnek N, 1996, J NEUROSCI, V16, P2780; VNEK N, 1995, J NEUROSCI, V15, P3193	35	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0146238	10.1371/journal.pone.0146238	http://dx.doi.org/10.1371/journal.pone.0146238			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA0TN	26716699	Green Submitted, Green Published, gold			2022-12-26	WOS:000367510500144
J	Aktas, B; De Wolfe, TJ; Tandee, K; Safdar, N; Darien, BJ; Steele, JL				Aktas, Busra; De Wolfe, Travis J.; Tandee, Kanokwan; Safdar, Nasia; Darien, Benjamin J.; Steele, James L.			The Effect of Lactobacillus casei 32G on the Mouse Cecum Microbiota and Innate Immune Response Is Dose and Time Dependent	PLOS ONE			English	Article							GUT MICROBIOTA; INTESTINAL MICROBIOTA; EXPRESSION; RECOGNITION; DEFENSINS; PLANTARUM; BACTERIA; OBESITY; SYSTEM; IMPACT	Lactobacilli have been associated with a variety of immunomodulatory effects and some of these effects have been related to changes in gastrointestinal microbiota. However, the relationship between probiotic dose, time since probiotic consumption, changes in the microbiota, and immune system requires further investigation. The objective of this study was to determine if the effect of Lactobacillus casei 32G on the murine gastrointestinal microbiota and immune function are dose and time dependent. Mice were fed L. casei 32G at doses of 10(6), 10(7), or 10(8) CFU/day/ mouse for seven days and were sacrificed 0.5h, 3.5h, 12h, or 24h after the last administration. The ileum tissue and the cecal content were collected for immune profiling by qPCR and microbiota analysis, respectively. The time required for L. casei 32G to reach the cecum was monitored by qPCR and the 32G bolus reaches the cecum 3.5h after the last administration. L. casei 32G altered the cecal microbiota with the predominance of Lachnospiraceae IS, and Oscillospira decreasing significantly (p < 0.05) in the mice receiving 108 CFU/mouse 32G relative to the control mice, while a significant (p < 0.05) increase was observed in the prevalence of lactobacilli. The lactobacilli that increased were determined to be a commensal lactobacilli. Interestingly, no significant difference in the overall microbiota composition, regardless of 32G doses, was observed at the 12h time point. A likely explanation for this observation is the level of feed derived-nutrients resulting from the 12h light/dark cycle. 32G results in consistent increases in Clec2h expression and reductions in TLR-2, alpha-defensins, and lysozyme. Changes in expression of these components of the innate immune system are one possible explanation for the observed changes in the cecal microbiota. Additionally, 32G administration was observed to alter the expression of cytokines (IL-10rb and TNF-alpha) in a manner consistent with an anti-inflammatory response.	[Aktas, Busra; De Wolfe, Travis J.; Steele, James L.] Univ Wisconsin, Dept Food Sci, Madison, WI 53706 USA; [Tandee, Kanokwan] Maejo Univ, Food Sci & Technol, Chiangmai, Thailand; [Safdar, Nasia] Univ Wisconsin, Dept Med, Div Infect Dis, Madison, WI USA; [Safdar, Nasia] William S Middleton Vet Affairs Hosp, Madison, WI USA; [Darien, Benjamin J.] Univ Wisconsin, Anim Hlth & Biomed Sci, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; Maejo University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Steele, JL (corresponding author), Univ Wisconsin, Dept Food Sci, 1605 Linden Dr, Madison, WI 53706 USA.	JLSteele@wisc.edu	De Wolfe, Travis J/C-6827-2013	De Wolfe, Travis J/0000-0001-6261-1235; Aktas, Busra/0000-0001-9863-683X	DuPont Inc [PRJ19MQ]; WARF [PRJ66JZ]	DuPont Inc; WARF	This work was funded by the DuPont Inc (Grant no. PRJ19MQ) and by the WARF (Grant no. PRJ66JZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; [Anonymous], 2015, YAK 80 ANN REP; [Anonymous], 2013, R LANG ENV STAT COMP; [Anonymous], 2013, DIVERSITY-BASEL, DOI DOI 10.3390/d5030627; Anukam K.-C, 2007, COMMUNICATING CURREN, V1, P466; Aoki T, 2014, SCAND J GASTROENTERO, V49, P552, DOI 10.3109/00365521.2013.848469; Batista ML, 2010, CYTOKINE, V49, P102, DOI 10.1016/j.cyto.2009.10.007; Brandl K, 2007, J EXP MED, V204, P1891, DOI 10.1084/jem.20070563; Britton RA, 2014, GASTROENTEROLOGY, V146, P1547, DOI 10.1053/j.gastro.2014.01.059; Broadbent JR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-533; Bruzzese E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087796; Busch RA, 2014, ANN SURG, V260, P432, DOI 10.1097/SLA.0000000000000871; Cai H, 2007, MICROBIOL-SGM, V153, P2655, DOI 10.1099/mic.0.2007/006452-0; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Ceapa C, 2013, BEST PRACT RES CL GA, V27, P139, DOI 10.1016/j.bpg.2013.04.004; Chen X, 2013, FORMATEX, V2, P1154; Chu HT, 2013, NAT IMMUNOL, V14, P668, DOI 10.1038/ni.2635; Corridoni D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042067; Cunliffe RN, 2003, MOL IMMUNOL, V40, P463, DOI 10.1016/S0161-5890(03)00157-3; Daniel C, 2013, APPL ENVIRON MICROB, V79, P1086, DOI 10.1128/AEM.03221-12; de Carcer DA, 2011, ISME J, V5, P801, DOI 10.1038/ismej.2010.177; Derrien M, 2015, TRENDS MICROBIOL, V23, P354, DOI 10.1016/j.tim.2015.03.002; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dietrich CG, 2014, WORLD J GASTROENTERO, V20, P15837, DOI 10.3748/wjg.v20.i42.15837; DiGiulio DB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003056; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Eloe-Fadrosh EA, 2015, MBIO, V6, DOI 10.1128/mBio.00231-15; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Hormannsperger G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004365; Hotel ACP., 2001, PREVENTION, V5, P1; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Kamada N, 2014, GASTROENTEROLOGY, V146, P1477, DOI 10.1053/j.gastro.2014.01.060; Kandler O, 1986, BERGEYS MANUAL SYSTE, V2, P1063; Kearney N, 2008, FUNCT FOOD NUTRA SER, P25; Kekkonen RA, 2008, WORLD J GASTROENTERO, V14, P2029, DOI 10.3748/wjg.14.2029; Kirschning CJ, 2002, TOLL LIKE RECEPTOR F; Kohl KD, 2014, FEMS MICROBIOL ECOL, V90, P883, DOI 10.1111/1574-6941.12442; Kondepudi KK, 2014, MICROBIOL IMMUNOL, V58, P552, DOI 10.1111/1348-0421.12184; Lacy P, 2011, BLOOD, V118, P9, DOI 10.1182/blood-2010-08-265892; Leyer GJ, 2009, PEDIATRICS, V124, pE172, DOI 10.1542/peds.2008-2666; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344; Mackie RI, 2003, APPL ENVIRON MICROB, V69, P6808, DOI 10.1128/AEM.69.11.6808-6815.2003; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Marco ML, 2007, APPL ENVIRON MICROB, V73, P124, DOI 10.1128/AEM.01475-06; Mayer EA, 2014, GASTROENTEROLOGY, V146, P1500, DOI 10.1053/j.gastro.2014.02.037; Menendez A, 2013, J INNATE IMMUN, V5, P39, DOI 10.1159/000341630; Nieuwdorp M, 2014, GASTROENTEROLOGY, V146, P1525, DOI 10.1053/j.gastro.2014.02.008; Ohno H, 2015, SEMIN IMMUNOPATHOL, V37, P1, DOI 10.1007/s00281-014-0472-2; Ostaff MJ, 2013, EMBO MOL MED, V5, P1465, DOI 10.1002/emmm.201201773; Otte JM, 2004, GASTROENTEROLOGY, V126, P1054, DOI 10.1053/j.gastro.2004.01.007; Owyang C, 2014, GASTROENTEROLOGY, V146, P1433, DOI 10.1053/j.gastro.2014.03.032; Paul W. E., 2003, FUNDAMENTAL IMMUNOLO, V5th; Pridmore RD, 2004, P NATL ACAD SCI USA, V101, P2512, DOI 10.1073/pnas.0307327101; Proctor LM, 2011, CELL HOST MICROBE, V10, P287, DOI 10.1016/j.chom.2011.10.001; Ravussin Y, 2012, OBESITY, V20, P738, DOI 10.1038/oby.2011.111; Reeves AE, 2011, GUT MICROBES, V2, P145, DOI 10.4161/gmic.2.3.16333; Salminen SJ, 2005, J NUTR, V135, P1294, DOI 10.1093/jn/135.5.1294; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Sanchez-Alavez M, 2007, P NATL ACAD SCI USA, V104, P3009, DOI 10.1073/pnas.0611209104; Schauber J, 2003, GUT, V52, P735, DOI 10.1136/gut.52.5.735; Schuijt TJ, 2013, TRENDS MICROBIOL, V21, P221, DOI 10.1016/j.tim.2013.02.001; Schwab M, 2008, IMMUNOLOGY, V125, P241, DOI 10.1111/j.1365-2567.2008.02834.x; Sohn M, 2010, P NATL ACAD SCI USA, V107, P21943, DOI [10.1073/pnas.1016618107, DOI 10.1073/PNAS.1016618107]; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Sunkara LT, 2014, MOL IMMUNOL, V57, P171, DOI 10.1016/j.molimm.2013.09.003; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tandee K., 2013, THESIS; Thaiss CA, 2014, CELL, V159, P514, DOI 10.1016/j.cell.2014.09.048; Thomas CM, 2010, GUT MICROBES, V1, P148, DOI 10.4161/gmic.1.3.11712; Ukena SN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001308; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; Vogler I, 2011, J INNATE IMMUN, V3, P227, DOI 10.1159/000324112; Wagner RD, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-58; Walters WA, 2014, FEBS LETT, V588, P4223, DOI 10.1016/j.febslet.2014.09.039; Yoon JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044053; Zakostelska Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027961; Zeng XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072922; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106; Zhu LX, 2013, HEPATOLOGY, V57, P601, DOI 10.1002/hep.26093	82	21	24	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145784	10.1371/journal.pone.0145784	http://dx.doi.org/10.1371/journal.pone.0145784			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714177	Green Submitted, Green Published, gold			2022-12-26	WOS:000367481900082
J	Chrzanowska-Wodnicka, M; White, GC; Quilliam, LA; Whitehead, KJ				Chrzanowska-Wodnicka, Magdalena; White, Gilbert C., II; Quilliam, Lawrence A.; Whitehead, Kevin J.			Small GTPase Rap1 Is Essential for Mouse Development and Formation of Functional Vasculature	PLOS ONE			English	Article							CEREBRAL CAVERNOUS MALFORMATIONS; CELL-CELL JUNCTIONS; DROSOPHILA EMBRYO; ENCODING KRIT1; KEY REGULATOR; GROWTH-FACTOR; PROTEIN; CCM1; MICE; GENE	Background Small GTPase Rap1 has been implicated in a number of basic cellular functions, including cell-cell and cell-matrix adhesion, proliferation and regulation of polarity. Evolutionarily conserved, Rap1 has been studied in model organisms: yeast, Drosophila and mice. Mouse in vivo studies implicate Rap1 in the control of multiple stem cell, leukocyte and vascular cell functions. In vitro, several Rap1 effectors and regulatory mechanisms have been proposed. In particular, Rap1 has been implicated in maintaining epithelial and endothelial cell junction integrity and linked with cerebral cavernous malformations. Rationale How Rap1 signaling network controls mammalian development is not clear. As a first step in addressing this question, we present phenotypes of murine total and vascular-specific Rap1a, Rap1b and double Rap1a and Rap1b (Rap1) knockout (KO) mice. Results and Conclusions The majority of total Rap1 KO mice die before E10.5, consistent with the critical role of Rap1 in epithelial morphogenesis. At that time point, about 50% of Tie2-double Rap1 KOs appear grossly normal and develop normal vasculature, while the remaining 50% suffer tissue degeneration and show vascular abnormalities, including hemorrhages and engorgement of perineural vessels, albeit with normal branchial arches. However, no Tie2-double Rap1 KO embryos are present at E15.5, with hemorrhages a likely cause of death. Therefore, at least one Rap1 allele is required for development prior to the formation of the vascular system; and in endothelium-for the life-supporting function of the vasculature.	[Chrzanowska-Wodnicka, Magdalena; White, Gilbert C., II] BloodCtr Wisconsin, Blood Res Inst, Milwaukee, WI 53201 USA; [Quilliam, Lawrence A.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Whitehead, Kevin J.] Univ Utah, Div Cardiovasc Med, Program Mol Med, Pediat Cardiol, Salt Lake City, UT 84112 USA	Versiti Blood Center of Wisconsin; Indiana University System; Indiana University Bloomington; Utah System of Higher Education; University of Utah	Chrzanowska-Wodnicka, M (corresponding author), BloodCtr Wisconsin, Blood Res Inst, Milwaukee, WI 53201 USA.	Magdalena.Chrzanowska@bcw.edu	Quilliam, Lawrence/Q-4987-2019	Chrzanowska, Magdalena/0000-0003-4182-2126	American Heart Association [0950118G]; National Institutes of Health [HL111583, NS075168]; Biomedical Research Grant from Indiana University School of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL079095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075168] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biomedical Research Grant from Indiana University School of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by American Heart Association grant 0950118G (to M.C.-W.), the National Institutes of Health grants (HL111583 to M.C.-W. and NS075168 to K.J.W.) and a Biomedical Research Grant from Indiana University School of Medicine (to L.A.Q.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asha H, 1999, EMBO J, V18, P605, DOI 10.1093/emboj/18.3.605; Awasthi A, 2010, J EXP MED, V207, P1923, DOI 10.1084/jem.20100040; Beraud-Dufour S, 2007, FEBS J, V274, P5518, DOI 10.1111/j.1742-4658.2007.06068.x; Bergametti F, 2005, AM J HUM GENET, V76, P42, DOI 10.1086/426952; Boettner B, 2003, GENETICS, V165, P159; Boettner B, 2000, P NATL ACAD SCI USA, V97, P9064, DOI 10.1073/pnas.97.16.9064; Boulday G, 2011, J EXP MED, V208, P1835, DOI 10.1084/jem.20110571; Boulday G, 2009, DIS MODEL MECH, V2, P168, DOI 10.1242/dmm.001263; Carmena Ana, 2012, Small GTPases, V3, P159, DOI 10.4161/sgtp.19631; Choi WS, 2013, MOL BIOL CELL, V24, P945, DOI 10.1091/mbc.E12-10-0736; Chrzanowska-Wodnicka M, 2005, J CLIN INVEST, V115, P680, DOI 10.1172/JCI200522973; Chrzanowska-Wodnicka M, 2008, BLOOD, V111, P2647, DOI 10.1182/blood-2007-08-109710; Chrzanowska-Wodnicka M, 2013, EXP CELL RES, V319, P2350, DOI 10.1016/j.yexcr.2013.07.022; Chu H, 2008, J IMMUNOL, V181, P3373, DOI 10.4049/jimmunol.181.5.3373; Cunningham K, 2011, HUM MOL GENET, V20, P3198, DOI 10.1093/hmg/ddr225; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Duchniewicz M, 2006, MOL CELL BIOL, V26, P643, DOI 10.1128/MCB.26.2.643-653.2006; Glading A, 2007, J CELL BIOL, V179, P247, DOI 10.1083/jcb.200705175; Gloerich M, 2011, TRENDS CELL BIOL, V21, P615, DOI 10.1016/j.tcb.2011.07.001; Gore AV, 2008, DIS MODEL MECH, V1, P275, DOI 10.1242/dmm.000513; He Y, 2003, SCI SIGNAL, V3; Ikeda W, 1999, J CELL BIOL, V146, P1117, DOI 10.1083/jcb.146.5.1117; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; Kleaveland B, 2009, NAT MED, V15, P169, DOI 10.1038/nm.1918; Knox AL, 2002, SCIENCE, V295, P1285, DOI 10.1126/science.1067549; Kooistra MRH, 2007, J CELL SCI, V120, P17, DOI 10.1242/jcs.03306; Kumar S, 2014, J EXP MED, V211, P1741, DOI 10.1084/jem.20131706; Laberge-le Couteulx S, 1999, NAT GENET, V23, P189, DOI 10.1038/13815; Lakshmikanthan S, 2015, EMBO REP, V16, P628, DOI 10.15252/embr.201439846; Lakshmikanthan S, 2014, ARTERIOSCL THROM VAS, V34, P1486, DOI 10.1161/ATVBAHA.114.303678; Lakshmikanthan S, 2011, BLOOD, V118, P2015, DOI 10.1182/blood-2011-04-349282; Li XF, 2012, J BIOL CHEM, V287, P22317, DOI 10.1074/jbc.M112.361295; Li Y, 2007, J IMMUNOL, V179, P8322, DOI 10.4049/jimmunol.179.12.8322; Liquori CL, 2003, AM J HUM GENET, V73, P1459, DOI 10.1086/380314; Liu JJ, 2011, MOL BIOL CELL, V22, P2509, DOI 10.1091/mbc.E11-02-0157; Minato N, 2007, ADV IMMUNOL, V93, P229, DOI 10.1016/S0065-2776(06)93006-5; Mitin NY, 2004, J BIOL CHEM, V279, P22353, DOI 10.1074/jbc.M312867200; Mleynek TM, 2014, HUM MOL GENET, V23, P6223, DOI 10.1093/hmg/ddu342; Pan BX, 2008, J NEUROSCI, V28, P2089, DOI 10.1523/JNEUROSCI.5156-07.2008; Park HO, 2007, MICROBIOL MOL BIOL R, V71, P48, DOI 10.1128/MMBR.00028-06; PIZON V, 1988, NUCLEIC ACIDS RES, V16, P7719, DOI 10.1093/nar/16.15.7719; Plummer NW, 2004, AM J PATHOL, V165, P1509, DOI 10.1016/S0002-9440(10)63409-8; Sahoo T, 1999, HUM MOL GENET, V8, P2325, DOI 10.1093/hmg/8.12.2325; Sawyer JK, 2009, J CELL BIOL, V186, P57, DOI 10.1083/jcb.200904001; Serebriiskii I, 1997, ONCOGENE, V15, P1043, DOI 10.1038/sj.onc.1201268; Tawa H, 2010, CIRC RES, V106, P1731, DOI 10.1161/CIRCRESAHA.110.216747; Tsai IC, 2007, DEV CELL, V12, P335, DOI 10.1016/j.devcel.2007.02.009; Whitehead KJ, 2009, NAT MED, V15, P177, DOI 10.1038/nm.1911; Whitehead KJ, 2004, DEVELOPMENT, V131, P1437, DOI 10.1242/dev.01036; Wilson CW, 2013, BLOOD, V122, P3678, DOI 10.1182/blood-2013-02-483156; Wodarz A, 2007, NAT CELL BIOL, V9, P1016, DOI 10.1038/ncb433; Xu K, 2011, DEV CELL, V20, P526, DOI 10.1016/j.devcel.2011.02.010; Xu K, 2009, DEV BIOL, V329, P269, DOI 10.1016/j.ydbio.2009.02.033; Yan JL, 2008, MOL CELL BIOL, V28, P5803, DOI 10.1128/MCB.00393-08; Zawistowski JS, 2005, HUM MOL GENET, V14, P2521, DOI 10.1093/hmg/ddi256	55	30	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145689	10.1371/journal.pone.0145689	http://dx.doi.org/10.1371/journal.pone.0145689			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714318	Green Published, Green Submitted, gold			2022-12-26	WOS:000367481900068
J	Cunning, R; Yost, DM; Guarinello, ML; Putnam, HM; Gates, RD				Cunning, Ross; Yost, Denise M.; Guarinello, Marisa L.; Putnam, Hollie M.; Gates, Ruth D.			Variability of Symbiodinium Communities in Waters, Sediments, and Corals of Thermally Distinct Reef Pools in American Samoa	PLOS ONE			English	Article							FREE-LIVING SYMBIODINIUM; POCILLOPORA-DAMICORNIS; SCLERACTINIAN CORALS; ACROPORA CORALS; CLADE-D; DIVERSITY; SPECIFICITY; SYMBIONTS; ENDOSYMBIONTS; ZOOXANTHELLAE	Reef-building corals host assemblages of symbiotic algae (Symbiodinium spp.) whose diversity and abundance may fluctuate under different conditions, potentially facilitating acclimatization to environmental change. The composition of free-living Symbiodinium in reef waters and sediments may also be environmentally labile and may influence symbiotic assemblages by mediating supply and dispersal. The magnitude and spatial scales of environmental influence over Symbiodinium composition in different reef habitat compartments are, however, not well understood. We used pyrosequencing to compare Symbiodinium in sediments, water, and ten coral species between two backreef pools in American Samoa with contrasting thermal environments. We found distinct compartmental assemblages of clades A, C, D, F, and/or G Symbiodinium types, with strong differences between pools in water, sediments, and two coral species. In the pool with higher and more variable temperatures, abundance of various clade A and C types differed compared to the other pool, while abundance of D types was lower in sediments but higher in water and in Pavona venosa, revealing an altered habitat distribution and potential linkages among compartments. The lack of between-pool effects in other coral species was due to either low overall variability (in the case of Porites) or high within-pool variability. Symbiodinium communities in water and sediment also showed within-pool structure, indicating that environmental influences may operate over multiple, small spatial scales. This work suggests that Symbiodinium composition is highly labile in reef waters, sediments, and some corals, but the underlying drivers and functional consequences of this plasticity require further testing with high spatial resolution biological and environmental sampling.	[Cunning, Ross; Yost, Denise M.; Putnam, Hollie M.; Gates, Ruth D.] Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA; [Guarinello, Marisa L.] Univ Idaho, Northwest Knowledge Network, Moscow, ID 83844 USA	University of Hawaii System; Idaho; University of Idaho	Cunning, R (corresponding author), Univ Hawaii, Hawaii Inst Marine Biol, POB 1346, Kaneohe, HI 96744 USA.	ross.cunning@gmail.com		Guarinello, Marisa/0000-0002-8334-2166; Cunning, Ross/0000-0001-7241-1181; Putnam, Hollie/0000-0003-2322-3269	National Park Service; United States Geological Survey; National Park of American Samoa; Division Of Ocean Sciences [1323822] Funding Source: National Science Foundation; Div Of Biological Infrastructure [1400787] Funding Source: National Science Foundation	National Park Service; United States Geological Survey(United States Geological Survey); National Park of American Samoa; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded by the National Park Service in a collaboration between RDG and the National Park of American Samoa. Additional funding was provided by the United States Geological Survey to RDG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrego D, 2009, MOL ECOL, V18, P3532, DOI 10.1111/j.1365-294X.2009.04276.x; Amend AS, 2010, MOL ECOL, V19, P5555, DOI 10.1111/j.1365-294X.2010.04898.x; [Anonymous], 2014, R LANG ENV STAT COMP; Arif C, 2014, MOL ECOL, V23, P4418, DOI 10.1111/mec.12869; Baird AH, 2009, ANNU REV ECOL EVOL S, V40, P551, DOI 10.1146/annurev.ecolsys.110308.120220; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Barshis DJ, 2013, P NATL ACAD SCI USA, V110, P1387, DOI 10.1073/pnas.1210224110; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Castro-Sanguino C, 2012, BIOL LETTERS, V8, P282, DOI 10.1098/rsbl.2011.0836; Coffroth MA, 2006, CURR BIOL, V16, pR985, DOI 10.1016/j.cub.2006.10.049; Coffroth MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013258; Correa AMS, 2011, GLOBAL CHANGE BIOL, V17, P68, DOI 10.1111/j.1365-2486.2010.02242.x; Craig P, 2001, CORAL REEFS, V20, P185, DOI 10.1007/s003380100159; Cunning R, 2015, CORAL REEFS, V34, P155, DOI 10.1007/s00338-014-1216-4; Edmunds PJ, 2014, MAR ECOL PROG SER, V506, P129, DOI 10.3354/meps10808; Frade PR, 2008, CORAL REEFS, V27, P913, DOI 10.1007/s00338-008-0406-3; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Green EA, 2014, PEERJ, V2, DOI 10.7717/peerj.386; Gu Z., CIRCLIZE CIRCULAR VI; Hoegh-Guldberg O, 2014, CURR OPIN ENV SUST, V7, P127, DOI 10.1016/j.cosust.2014.01.005; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Iglesias-Prieto R, 2004, P ROY SOC B-BIOL SCI, V271, P1757, DOI 10.1098/rspb.2004.2757; Jones AM, 2008, P ROY SOC B-BIOL SCI, V275, P1359, DOI 10.1098/rspb.2008.0069; Jones Alison M., 2011, Journal of Marine Biology, V2011, P1; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Manning MM, 2008, LIMNOL OCEANOGR, V53, P1853, DOI 10.4319/lo.2008.53.5.1853; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Matz MV., MCMC OTU BAYESIAN AN; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mieog JC, 2007, CORAL REEFS, V26, P449, DOI 10.1007/s00338-007-0244-8; Mihaljevic JR, 2012, TRENDS ECOL EVOL, V27, P323, DOI 10.1016/j.tree.2012.01.011; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; MUSCATINE L, 1977, BIOSCIENCE, V27, P454, DOI 10.2307/1297526; Oksanen J., **DATA OBJECT**; Oliver TA, 2011, CORAL REEFS, V30, P429, DOI 10.1007/s00338-011-0721-y; Pochon X, 2010, J PHYCOL, V46, P53, DOI 10.1111/j.1529-8817.2009.00797.x; Putnam HM, 2012, P R SOC B, V279, P226; Quigley KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094297; Research and Testing Laboratory, DAT AN METH; Robert J.H., **DATA OBJECT**; ROWAN R, 1995, P NATL ACAD SCI USA, V92, P2850, DOI 10.1073/pnas.92.7.2850; Rowan R, 2004, NATURE, V430, P742, DOI 10.1038/430742a; Rowan R, 1997, NATURE, V388, P265, DOI 10.1038/40843; Sampayo EM, 2007, MOL ECOL, V16, P3721, DOI 10.1111/j.1365-294X.2007.03403.x; Silverstein RN, 2015, GLOBAL CHANGE BIOL, V21, P236, DOI 10.1111/gcb.12706; Silverstein RN, 2012, P ROY SOC B-BIOL SCI, V279, P2609, DOI 10.1098/rspb.2012.0055; Silverstein RN, 2011, MAR ECOL PROG SER, V422, P63, DOI 10.3354/meps08934; Smith LW, 2007, J EXP MAR BIOL ECOL, V341, P282, DOI 10.1016/j.jembe.2006.10.053; Stat M, 2008, BIOL INVASIONS, V10, P579, DOI 10.1007/s10530-007-9167-0; Stat M, 2013, ECOL EVOL, V3, P1317, DOI 10.1002/ece3.556; Stat M, 2012, ADV MAR BIOL, V63, P1, DOI 10.1016/B978-0-12-394282-1.00001-6; Stat Michael, 2011, Journal of Marine Biology, V2011, P1; Stat M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015854; Stat M, 2009, MAR ECOL PROG SER, V386, P83, DOI 10.3354/meps08080; STIMSON J, 1991, J EXP MAR BIOL ECOL, V153, P63, DOI 10.1016/S0022-0981(05)80006-1; Sweet MJ, 2013, MAR ECOL, V35, P343, DOI DOI 10.1111/MAEC.12092; Takabayashi M, 2012, CORAL REEFS, V31, P157, DOI 10.1007/s00338-011-0832-5; Thomas L, 2014, MOL ECOL, V23, P3113, DOI 10.1111/mec.12801; Thornhill DJ, 2007, MOL ECOL, V16, P5326, DOI 10.1111/j.1365-294X.2007.03576.x; van Hooidonk R, 2013, NAT CLIM CHANGE, V3, P508, DOI [10.1038/NCLIMATE1829, 10.1038/nclimate1829]; Wilkinson SP, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0325-1; Wirshing HH, 2013, MOL ECOL, V22, P4413, DOI 10.1111/mec.12405	63	47	47	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145099	10.1371/journal.pone.0145099	http://dx.doi.org/10.1371/journal.pone.0145099			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713847	Green Published, gold, Green Submitted			2022-12-26	WOS:000367481900032
J	Garcia, T; Zamalloa, CZ; Jackson, PR; Murphy, EA; Garcia, MH				Garcia, Tatiana; Zamalloa, Carlo Zuniga; Jackson, P. Ryan; Murphy, Elizabeth A.; Garcia, Marcelo H.			A Laboratory Investigation of the Suspension, Transport, and Settling of Silver Carp Eggs Using Synthetic Surrogates	PLOS ONE			English	Article							WATER HARDNESS; HATCHING SUCCESS; SUITABILITY; TURBULENCE; SIZE	Asian carp eggs are semi-buoyant and must remain suspended in the water to survive, supported by the turbulence of the flow, until they hatch and develop the ability to swim. Analysis of the transport and dispersal patterns of Asian carp eggs will facilitate the development and implementation of control strategies to target the early life stages. Experimenting with Asian carp eggs is complicated due to practical issues of obtaining eggs in close proximity to experimental facilities and extensive handling of eggs tends to damage them. Herein, we describe laboratory experiments using styrene beads (4.85 mm diameter) as synthetic surrogate eggs to mimic the physical properties of water-hardened silver carp eggs. The first set of experiments was completed in a rectangular vertical column filled with salt water. The salinity of the water was adjusted in an iterative fashion to obtain a close approximation of the fall velocity of the styrene beads to the mean fall velocity of silver carp water-hardened eggs. The terminal fall velocity of synthetic eggs was measured using an image processing method. The second set of experiments was performed in a temperature-controlled recirculatory flume with a sediment bed. The flume was filled with salt water, and synthetic eggs were allowed to drift under different flow conditions. Drifting behavior, suspension conditions, and settling characteristics of synthetic eggs were observed. At high velocities, eggs were suspended and distributed through the water column. Eggs that touched the sediment bed were re-entrained by the flow. Eggs saltated when they touched the bed, especially at moderate velocities and with a relatively flat bed. At lower velocities, some settling of the eggs was observed. With lower velocities and a flat bed, eggs were trapped near the walls of the flume. When bedforms were present, eggs were trapped in the lee of the bedforms in addition to being trapped near the flume walls. Results of this research study provide insights about transport, suspension, and dispersion of silver carp eggs. The knowledge gained from this study is useful to characterize the critical hydrodynamic conditions of the flow at which surrogates for silver carp water-hardened eggs settle out of suspension, and provides insight into how eggs may interact with riverbed sediments and morphology.	[Garcia, Tatiana; Jackson, P. Ryan; Murphy, Elizabeth A.] US Geol Survey, Illinois Water Sci Ctr, Urbana, IL 61801 USA; [Garcia, Tatiana; Zamalloa, Carlo Zuniga; Garcia, Marcelo H.] Univ Illinois, Dept Civil & Environm Engn, Urbana, IL 61801 USA	United States Department of the Interior; United States Geological Survey; University of Illinois System; University of Illinois Urbana-Champaign	Garcia, T (corresponding author), US Geol Survey, Illinois Water Sci Ctr, Urbana, IL 61801 USA.	tgarcia@usgs.gov	Garcia, Marcelo H/A-9982-2016	Garcia, Marcelo H/0000-0003-0643-489X; Jackson, P. Ryan/0000-0002-3154-6108	U. S. Geological Survey; U.S. Environmental Protection Agency-Great Lakes Restoration Initiative; National Great Rivers Research and Educational Center	U. S. Geological Survey(United States Geological Survey); U.S. Environmental Protection Agency-Great Lakes Restoration Initiative; National Great Rivers Research and Educational Center	This work was supported by the U. S. Geological Survey, the U.S. Environmental Protection Agency-Great Lakes Restoration Initiative, and the National Great Rivers Research and Educational Center.	Brammeier J., 2008, PRELIMINARY FEASIBIL; Chapman D. C, 2006, US GEOLOGICAL SURVEY, V239; Chapman D.C., 2011, 20115076 USGS; Chapman DC, SPECIFIC GRAVI UNPUB; Chapman DC, 2013, J GREAT LAKES RES, V39, P547, DOI 10.1016/j.jglr.2013.09.019; Chapman DC, 2009, T AM FISH SOC, V138, P1226, DOI 10.1577/T09-004.1; Chick JH, 2001, SCIENCE, V292, P2250, DOI 10.1126/science.292.5525.2250; DEGRANDCHAMP KA, 2006, HABITAT SELECTION MO; Dudley RK, 1999, J FRESHWATER ECOL, V14, P423, DOI 10.1080/02705060.1999.9663700; Garcia CM, 2005, J HYDRAUL ENG, V131, P1062, DOI 10.1061/(ASCE)0733-9429(2005)131:12(1062); Garcia M.H, 2008, SEDIMENTATION ENG PR; Garcia T, 2015, J GREAT LAKES RES, V41, P374, DOI 10.1016/j.jglr.2015.02.003; Garcia T, 2013, ECOL MODEL, V263, P211, DOI 10.1016/j.ecolmodel.2013.05.005; GONZAL AC, 1987, AQUACULTURE, V64, P111, DOI 10.1016/0044-8486(87)90347-4; Hearn C. J., 2008, DYNAMICS COASTAL MOD; Jackson PR, 2014, J PHYS OCEANOGR, V44, P2661, DOI 10.1175/JPO-D-14-0027.1; Jennings DP, 1988, US FISH WILD SERV BI, V88, P35; Kim SC, 2000, J HYDRAUL ENG-ASCE, V126, P399, DOI 10.1061/(ASCE)0733-9429(2000)126:6(399); Kocovsky PM, 2012, J GREAT LAKES RES, V38, P159, DOI 10.1016/j.jglr.2011.11.015; KOLAR CS, 2007, BIGHEADED CARPS BIOL; Lenaerts AW, 2015, AQUATIC INV IN PRESS, P10; Lohmeyer AM, 2008, LARVAL ASIAN CARP UP; Murphy EA., 2013, SCI INVESTIGATIONS R; ODELL GM, 1971, J FLUID MECH, V50, P535, DOI 10.1017/S002211207100274X; Rach JJ, 2010, N AM J FISH MANAGE, V30, P230, DOI 10.1577/M09-067.1; Ruebush B.C., 2011, IN SITU TESTS SOUND; Soulsby R.L., 1983, ELSEVIER OCEANOG SER, V35, P189, DOI DOI 10.1016/S0422-9894(08)70503-8; U S Army Corps of Engineers, 2012, GREAT LAK MISS RIV I; VANRIJN LC, 1984, J HYDRAUL ENG-ASCE, V110, P1613, DOI 10.1061/(ASCE)0733-9429(1984)110:11(1613); Yi YJ, 2010, J HYDROL, V387, P283, DOI 10.1016/j.jhydrol.2010.04.018; Yih P., 1964, ACTA HYDROBIOL, V5, P1, DOI DOI 10.2108/ZSJ.30.296	31	12	14	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145775	10.1371/journal.pone.0145775	http://dx.doi.org/10.1371/journal.pone.0145775			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713855	gold, Green Published, Green Submitted			2022-12-26	WOS:000367481900080
J	Micheal, S; Ayub, H; Islam, F; Siddiqui, SN; Khan, WA; Akhtar, F; Qamar, R; Khan, MI; den Hollander, AI				Micheal, Shazia; Ayub, Humaira; Islam, Farrah; Siddiqui, Sorath Noorani; Khan, Wajid Ali; Akhtar, Farah; Qamar, Raheel; Khan, Muhammad Imran; den Hollander, Anneke I.			Variants in the ASB10 Gene Are Associated with Primary Open Angle Glaucoma	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; NUMBER; IDENTIFICATION; MUTATIONS; WORLDWIDE; PEOPLE	Background Recently nonsynonymous coding variants in the ankyrin repeats and suppressor of cytokine signaling box-containing protein 10 (ASB10) gene were found to be associated with primary open angle glaucoma (POAG) in cohorts from Oregon and Germany, but this finding was not confirmed in an independent cohort from Iowa. The aim of the current study was to assess the role of ASB10 gene variants in Pakistani glaucoma patients. Methods Sanger sequencing of the coding exons and splice junctions of the ASB10 gene was performed in 30 probands of multiplex POAG families, 208 sporadic POAG patients and 151 healthy controls from Pakistan. Genotypic associations of individual variants with POAG were analyzed with the Fisher's exact or Chi-square test. Results In total 24 variants were identified in POAG probands and sporadic patients, including 11 novel variants and 13 known variants. 13 of the variants were nonsynonymous, 6 were synonymous, and 5 were intronic. Three nonsynonymous variants (p.Arg49Cys, p.Arg237Gly, p.Arg453Cys) identified in the probands were not segregating in the respective families. This is not surprising since glaucoma is a multifactorial disease, and multiple factors are likely to be involved in the disease manifestation in these families. However a nonsynonymous variant, p.Arg453Cys (rs3800791), was found in 6 sporadic POAG patients but not in controls, suggesting that it infers increased risk for the disease. In addition, one synonymous variant was found to be associated with sporadic POAG: p.Ala290Ala and the association of the variant with POAG remained significant after correction for multiple testing (uncorrected p-value 0.002, corrected p-value 0.047). The cumulative burden of rare, nonsynonymous variants was significantly higher in sporadic POAG patients compared to control individuals (p-value 0.000006). Conclusions Variants in ASB10 were found to be significantly associated with sporadic POAG in the Pakistani population. This supports previous findings that sequence variants in the ASB10 gene may act as a risk factor for glaucoma.	[Micheal, Shazia; Ayub, Humaira; den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, NL-6525 ED Nijmegen, Netherlands; [Ayub, Humaira; Qamar, Raheel] COMSATS Inst Informat Technol, Dept Biosci, Islamabad, Pakistan; [Islam, Farrah; Siddiqui, Sorath Noorani; Khan, Wajid Ali; Akhtar, Farah] Al Shifa Eye Trust Hosp, Rawalpindi 46000, Pakistan; [Qamar, Raheel] Isra Univ, Al Nafees Med Coll & Hosp, Islamabad 45600, Pakistan; [Khan, Muhammad Imran; den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; COMSATS University Islamabad (CUI); Radboud University Nijmegen	den Hollander, AI (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, NL-6525 ED Nijmegen, Netherlands.	Anneke.denHollander@radboudumc.nl	Hollander, Anneke den/N-4911-2014; Siddiqui, Sorath Noorani/AAT-9861-2020	Khan, Muhammad Imran/0000-0003-0276-5480	Stichting Blindenhulp; Glaucoma Research Foundation; Glaucoomfonds; Oogfonds; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid	Stichting Blindenhulp; Glaucoma Research Foundation; Glaucoomfonds; Oogfonds; Algemene Nederlandse Vereniging ter Voorkoming van Blindheid	This study was supported by the Stichting Blindenhulp, a Shaffer grant from the Glaucoma Research Foundation, the Glaucoomfonds, Oogfonds, and the Algemene Nederlandse Vereniging ter Voorkoming van Blindheid (awarded to A. I. den Hollander and S. Micheal). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allingham RR, 2009, EXP EYE RES, V88, P837, DOI 10.1016/j.exer.2008.11.003; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Burdon KP, 2011, NAT GENET, V43, P574, DOI 10.1038/ng.824; Chen R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013574; Fingert JH, 2012, HUM MOL GENET, V21, P4543, DOI 10.1093/hmg/dds288; Fingert JH, 2011, HUM MOL GENET, V20, P2482, DOI 10.1093/hmg/ddr123; Francis BA, 2011, INVEST OPHTH VIS SCI, V52, P6257, DOI 10.1167/iovs.09-5126; Keller KE, 2013, MOL VIS, V19, P1639; Khor CC, 2011, HUM MOL GENET, V20, P1864, DOI 10.1093/hmg/ddr060; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; Liu YT, 2011, EXP EYE RES, V93, P331, DOI 10.1016/j.exer.2011.08.007; Melki R, 2004, J MED GENET, V41, P647, DOI 10.1136/jmg.2004.020024; Micheal S, 2015, CLIN EXP OPHTHALMOL, V43, P31, DOI 10.1111/ceo.12369; Monemi S, 2005, HUM MOL GENET, V14, P725, DOI 10.1093/hmg/ddi068; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Pasutto F, 2012, HUM MOL GENET, V21, P1336, DOI 10.1093/hmg/ddr572; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; Ramdas WD, 2011, OPHTHALMOLOGY, V118, P2389, DOI 10.1016/j.ophtha.2011.05.040; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Sambrook J., 2006, CONDENSED PROTOCOLS; SHEFFIELD VC, 1993, NAT GENET, V4, P47, DOI 10.1038/ng0593-47; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Thorleifsson G, 2010, NAT GENET, V42, P906, DOI 10.1038/ng.661	24	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145005	10.1371/journal.pone.0145005	http://dx.doi.org/10.1371/journal.pone.0145005			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713451	Green Submitted, Green Published, gold			2022-12-26	WOS:000367481900029
J	Raffegerst, S; Steer, B; Hohloch, M; Adler, H				Raffegerst, S.; Steer, B.; Hohloch, M.; Adler, H.			Prevention of Tumor Formation by Latent Gammaherpesvirus Infection	PLOS ONE			English	Article							BACTERIAL-INFECTION; MICE; VIRUS; ESTABLISHMENT; REPLICATION; PROTECTION; HIV-1	Recent reports suggested that chronic herpesvirus infection, as a constituent of the so-called virome, may not only exert harmful effects but may also be beneficial to the host, for example mediating increased resistance to secondary infections or to tumors. To further challenge this concept, specifically regarding increased resistance to tumors, we infected chimeric HLA-DR4-H2-E (DR4) mice, a mouse strain which spontaneously develops hematological tumors, with the rodent herpesvirus murine gammaherpesvirus 68 (MHV-68). Using this model, we observed that infection with wildtype MHV-68 completely prevented tumor formation. This happened, however, at the cost of hyposplenism. In contrast to wildtype infection, infection with a latency-deficient mutant of MHV-68 neither prevented tumor formation nor induced hyposplenism. The underlying mechanisms are not known but might be related to an infection-mediated priming of the immune response, resulting in the suppression of a tumor promoting endogenous retrovirus. Thus, under certain circumstances, chronic herpesvirus infection may prevent the development of tumors.	[Raffegerst, S.; Hohloch, M.] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Mol Immunol, Munich, Germany; [Steer, B.; Adler, H.] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Res Unit Gene Vectors, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Raffegerst, S (corresponding author), Medigene Immunotherapies GmbH, Lochhamer Str 11, D-82152 Martinsried, Germany.	silke.raffegerst@helmholtz-muenchen.de; h.adler@helmholtz-muenchen.de			Bundesministerium fur Bildung und Forschung (NGFNplus) [FKZ PIM-01GS0802-3]; Wilhelm Sander-Stiftung [2009.046.1+2]	Bundesministerium fur Bildung und Forschung (NGFNplus)(Federal Ministry of Education & Research (BMBF)); Wilhelm Sander-Stiftung	This work was supported by grants from the Bundesministerium fur Bildung und Forschung (NGFNplus, FKZ PIM-01GS0802-3) and the Wilhelm Sander-Stiftung (grant 2009.046.1+2) to HA.	AB RICKINSON, 2001, FIELDS VIROLOGY, P2575; Adler H, 2000, J VIROL, V74, P6964, DOI 10.1128/JVI.74.15.6964-6974.2000; Auger S, 2014, EUR J HAEMATOL, V92, P421, DOI 10.1111/ejh.12260; Barton E, 2011, ANNU REV IMMUNOL, V29, P351, DOI 10.1146/annurev-immunol-072710-081639; Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; Chauhan VS, 2012, INFECT AGENTS CANCER, V7, DOI 10.1186/1750-9378-7-11; Crowley RW, 1996, J IMMUNOL, V156, P2004; Ebrahimi B, 2001, AM J PATHOL, V158, P2117, DOI 10.1016/S0002-9440(10)64683-4; Fowler P, 2003, J GEN VIROL, V84, P3405, DOI 10.1099/vir.0.19594-0; Guggemoos S, 2008, J IMMUNOL, V180, P438, DOI 10.4049/jimmunol.180.1.438; Ito K, 1996, J EXP MED, V183, P2635, DOI 10.1084/jem.183.6.2635; Larson JD, 2012, P NATL ACAD SCI USA, V109, pE1092, DOI 10.1073/pnas.1203019109; Lisco A, 2007, J VIROL, V81, P708, DOI 10.1128/JVI.01367-06; Moorman NJ, 2003, J VIROL, V77, P10295, DOI 10.1128/JVI.77.19.10295-10303.2003; Raffegerst SH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008539; Raymond AD, 2007, CURR HIV RES, V5, P79, DOI 10.2174/157016207779316314; Saghafian-Hedengren S, 2010, J ALLERGY CLIN IMMUN, V125, P433, DOI 10.1016/j.jaci.2009.09.033; Saito F, 2013, INFLAMMATION, V36, P1295, DOI 10.1007/s10753-013-9668-1; Schulz TF, 1998, J GEN VIROL, V79, P1573, DOI 10.1099/0022-1317-79-7-1573; Virgin HW, 2014, CELL, V157, P142, DOI 10.1016/j.cell.2014.02.032; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; White DW, 2010, BLOOD, V115, P4377, DOI 10.1182/blood-2009-09-245464; Yager EJ, 2009, VIRAL IMMUNOL, V22, P67, DOI 10.1089/vim.2008.0086; Yu P, 2012, IMMUNITY, V37, P867, DOI 10.1016/j.immuni.2012.07.018	24	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145678	10.1371/journal.pone.0145678	http://dx.doi.org/10.1371/journal.pone.0145678			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714031	gold, Green Published, Green Submitted			2022-12-26	WOS:000367481900065
J	Zhao, XQ; Zhang, GL; Wang, Y; Zhang, F; Wang, WS; Zhang, WH; Fu, BY; Xu, JL; Li, ZK				Zhao, Xiuqin; Zhang, Guilian; Wang, Yun; Zhang, Fan; Wang, Wensheng; Zhang, Wenhao; Fu, Binying; Xu, Jianlong; Li, Zhikang			Metabolic Profiling and Physiological Analysis of a Novel Rice Introgression Line with Broad Leaf Size	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; DROUGHT TOLERANCE; NATURAL VARIATION; GRAIN WIDTH; YIELD; PRODUCTIVITY; ENCODES; WEIGHT; GENE; DISSECTION	A rice introgression line, NIL-SS1, and its recurrent parent, Teqing, were used to investigate the influence of the introgression segment on plant growth. The current research showed NIL-SS1 had an increased flag leaf width, total leaf area, spikelet number per panicle and grain yield, but a decreased photosynthetic rate. The metabolite differences in NIL-SS1 and Teqing at different developmental stages were assessed using gas chromatography-mass spectrometry technology. Significant metabolite differences were observed across the different stages. NIL-SS1 increased the plant leaf nitrogen content, and the greatest differences between NIL-SS1 and Teqing occurred at the booting stage. Compared to Teqing, the metabolic phenotype of NIL-SS1 at the booting stage has closer association with those at the flowering stage. The introgression segment induced more active competition for sugars and organic acids (OAs) from leaves to the growing young spikes, which resulted in more spikelet number per plant (SNP). The results indicated the introgression segment could improve rice grain yield by increasing the SNP and total leaf area per plant, which resulted from the higher plant nitrogen content across growth stages and stronger competition for sugars and OAs of young spikes at the booting stage.	[Zhao, Xiuqin; Zhang, Fan; Wang, Wensheng; Fu, Binying; Xu, Jianlong; Li, Zhikang] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100081, Peoples R China; [Zhang, Guilian] Shanghai Landscape Gardening Res Inst, Shanghai 200232, Peoples R China; [Wang, Yun] Shenyang Agr Univ, Rice Inst, Key Lab Crop Physiol Ecol Genet & Breeding, Minist Agr, Shenyang 110866, Peoples R China; [Zhang, Wenhao] China Univ Min & Technol, Beijing 100083, Peoples R China; [Fu, Binying; Xu, Jianlong; Li, Zhikang] Chinese Acad Agr Sci, Shenzhen Inst Innovat Breeding, Shenzhen 518120, Peoples R China; [Xu, Jianlong] Chinese Acad Agr Sci, Agr Genom Inst, Shenzhen 518120, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Ministry of Agriculture & Rural Affairs; Shenyang Agricultural University; China University of Mining & Technology; Chinese Academy of Agricultural Sciences; Chinese Academy of Agricultural Sciences; Agriculture Genomes Institute at Shenzhen, CAAS	Fu, BY (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100081, Peoples R China.	fubinying@caas.cn; xujianlong@caas.cn	Xu, Jianlong/AAI-8310-2020		National Natural Science Foundation [31261140369]; Shenzhen Technology Research Development [JSGG20121026152117750]; "948" Project from the Chinese Ministry of Agriculture [2011-G2B]; Bill & Melinda Gates Foundation [OPP51587]; 863 key Project from the Chinese Ministry of Science Technology [2014AA10A601]; Shenzhen Peacock Plan [20130415095710361]; CAAS Innovative Team Award	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Shenzhen Technology Research Development; "948" Project from the Chinese Ministry of Agriculture; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); 863 key Project from the Chinese Ministry of Science Technology; Shenzhen Peacock Plan; CAAS Innovative Team Award	This research was funded by the National Natural Science Foundation (31261140369) to JLX; the Shenzhen Technology Research & Development (JSGG20121026152117750) to JLX; "948" Project (2011-G2B) from the Chinese Ministry of Agriculture to ZKL; the Bill & Melinda Gates Foundation Project (OPP51587) to ZKL; 863 key Project (2014AA10A601) from the Chinese Ministry of Science & Technology to JLX; the Shenzhen Peacock Plan (20130415095710361) to ZKL, and the CAAS Innovative Team Award to ZK Li's team. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Barneix AJ, 1996, J PLANT PHYSIOL, V149, P358; Borras L, 2004, FIELD CROP RES, V86, P131, DOI 10.1016/j.fcr.2003.08.002; Bowne JB, 2012, MOL PLANT, V5, P418, DOI 10.1093/mp/ssr114; Bush D R, 1993, ANN REV PLANT PHYSL; Cameron K. C., 1986, Mineral nitrogen in the plant-soil system., P166; Cassman KG, 2003, ANNU REV ENV RESOUR, V28, P315, DOI 10.1146/annurev.energy.28.040202.122858; CHARLESEDWARDS DA, 1978, ANN BOT-LONDON, V42, P717, DOI 10.1093/oxfordjournals.aob.a085506; Chen ML, 2012, PLANT CELL REP, V31, P863, DOI 10.1007/s00299-011-1207-7; Cock J. H., 1972, Proceedings of the Crop Science Society of Japan, V41, P226; EARLY EB, 1967, CROP SCI, V7, P151, DOI 10.2135/cropsci1967.0011183X000700020018x; EVANS LT, 1970, AUST J BIOL SCI, V23, P725, DOI 10.1071/BI9700725; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Fernie AR, 2009, TRENDS GENET, V25, P39, DOI 10.1016/j.tig.2008.10.010; FISCHER RA, 1975, CROP SCI, V15, P607, DOI 10.2135/cropsci1975.0011183X001500050002x; GIFFORD RM, 1981, ANNU REV PLANT PHYS, V32, P485, DOI 10.1146/annurev.pp.32.060181.002413; HO LC, 1988, ANNU REV PLANT PHYS, V39, P355, DOI 10.1146/annurev.arplant.39.1.355; Huang XZ, 2009, NAT GENET, V41, P494, DOI 10.1038/ng.352; Ingestad TKM, 1985, PHYSIOL PLANTARUM, V45, P37; Ishimaru K, 2007, PLANT PHYSIOL BIOCH, V45, P799, DOI 10.1016/j.plaphy.2007.07.004; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Jung HW, 2009, SCIENCE, V324, P89, DOI 10.1126/science.1170025; Junker BH, 2004, PLANT MOL BIOL, V56, P91, DOI 10.1007/s11103-004-2525-8; Korn M, 2010, MOL PLANT, V3, P224, DOI 10.1093/mp/ssp105; Li ZK, 2005, PLANT MOL BIOL, V59, P33, DOI 10.1007/s11103-005-8519-3; Long S. P., 1998, P124; Marcelis LFM, 1996, J EXP BOT, V47, P1281, DOI 10.1093/jxb/47.Special_Issue.1281; Meyer RC, 2007, P NATL ACAD SCI USA, V104, P4759, DOI 10.1073/pnas.0609709104; Miura K, 2010, NAT GENET, V42, P545, DOI 10.1038/ng.592; Morino K, 2005, PLANT CELL PHYSIOL, V46, P514, DOI 10.1093/pcp/pci051; OAKS A, 1994, CAN J BOT, V72, P739, DOI 10.1139/b94-094; Qi J, 2008, PLANT PHYSIOL, V147, P1947, DOI 10.1104/pp.108.118778; Roessner U, 2001, PLANT CELL, V13, P11, DOI 10.1105/tpc.13.1.11; Schauer N, 2006, TRENDS PLANT SCI, V11, P508, DOI 10.1016/j.tplants.2006.08.007; Seck PA, 2012, FOOD SECUR, V4, P7, DOI 10.1007/s12571-012-0168-1; Settle WH, 1996, ECOLOGY, V77, P1975, DOI 10.2307/2265694; Shah J, 2009, CURR OPIN PLANT BIOL, V12, P459, DOI 10.1016/j.pbi.2009.05.011; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Takai T, 2013, SCI REP-UK, V3, DOI 10.1038/srep02149; Ujiie K, 2012, EUPHYTICA, V187, P325, DOI 10.1007/s10681-012-0660-x; Wang E, 2008, NAT GENET, V40, P1370, DOI 10.1038/ng.220; Xing YZ, 2008, THEOR APPL GENET, V116, P789, DOI 10.1007/s00122-008-0711-9; Xu JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132060; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yan WH, 2011, MOL PLANT, V4, P319, DOI 10.1093/mp/ssq070; Zhang GH, 2014, MOL PLANT, V7, P1350, DOI 10.1093/mp/ssu055; Zhao XQ, 2008, PLANT SCI, V174, P618, DOI 10.1016/j.plantsci.2008.03.009; Zhao XQ, 2013, RICE, V6, DOI 10.1186/1939-8433-6-23	49	3	3	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145646	10.1371/journal.pone.0145646	http://dx.doi.org/10.1371/journal.pone.0145646			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713754	Green Submitted, Green Published, gold			2022-12-26	WOS:000367481900063
J	Hsiao, WY; Lin, YC; Liao, FH; Chan, YC; Huang, CY				Hsiao, Wan-Yi; Lin, Yu-Chun; Liao, Fang-Hsuean; Chan, Yi-Chiao; Huang, Ching-Yu			Dual-Specificity Phosphatase 4 Regulates STAT5 Protein Stability and Helper T Cell Polarization	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; KINASE PHOSPHATASE-2; TYROSINE DEPHOSPHORYLATION; IMMUNE-RESPONSES; ACTIVATED STAT5A; CUTTING EDGE; IN-VIVO; TRANSCRIPTION; EXPRESSION	Immune responses are critically regulated by the functions of CD4 helper T cells. Based on their secreted cytokines, helper T cells are further categorized into different subsets like Treg or Th17 cells, which suppress or promote inflammatory responses, respectively. Signals from IL-2 activate the transcription factor STAT5 to promote Treg but suppress Th17 cell differentiation. Our previous results found that the deficiency of a dual-specificity phosphatase, DUSP4, induced STAT5 hyper-activation, enhanced IL-2 signaling, and increased T cell proliferation. In this report, we examined the effects of DUSP4 deficiency on helper T cell differentiation and STAT5 regulation. Our in vivo data showed that DUSP4 mice were more resistant to the induction of autoimmune encephalitis, while in vitro differentiations revealed enhanced iTreg and reduced Th17 polarization in DUSP4-deficient T cells. To study the cause of this altered helper T cell polarization, we performed luciferase reporter assays and confirmed that, as predicted by our previous report, DUSP4 over-expression suppressed the transcription factor activity of STAT5. Surprisingly, we also found that DUSP4-deficient T but not B cells exhibited elevated STAT5 protein levels, and over-expressed DUSP4 destabilized STAT5 in vitro; moreover, this destabilization required the phosphatase activity of DUSP4, and was insensitive to MG132 treatment. Finally, domain-mapping results showed that both the substrate-interacting and the phosphatase domains of DUSP4 were required for its optimal interaction with STAT5, while the coiled-coil domain of STAT5 appeared to hinder this interaction. Our data thus provide the first genetic evidence that DUSP4 is important for helper T cell development. In addition, they also help uncover the novel, DUSP4-mediated regulation of STAT5 protein stability.	[Hsiao, Wan-Yi; Lin, Yu-Chun; Liao, Fang-Hsuean; Chan, Yi-Chiao; Huang, Ching-Yu] Natl Hlth Res Inst, Immunol Res Ctr, Zhunan, Miaoli County, Taiwan	National Health Research Institutes - Taiwan	Huang, CY (corresponding author), Natl Hlth Res Inst, Immunol Res Ctr, Zhunan, Miaoli County, Taiwan.	cyhuang@nhri.org.tw	Liao, Fang-Hsuean/H-4373-2018	Liao, Fang-Hsuean/0000-0001-5085-3763; Huang, Ching-yu/0000-0002-5758-281X	National Health Research Institutes, Taiwan [104-A1-IMPP03-014]; Ministry of Science and Technology, Taiwan [101-2320-B-400-004-MY3]	National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported in whole or in part by grant 104-A1-IMPP03-014 from the National Health Research Institutes (http://www.nhri.org.tw/), Taiwan, as well as grants 101-2320-B-400-004-MY3 from the Ministry of Science and Technology (http://www.most.gov.tw/), Taiwan to CH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; F. L. was supported by a post-doctoral grant from the Ministry of Science and Technology, Taiwan. W. H. and Y. L. designed and performed experiments as well as analyzed data. F. L. and Y. C. performed experiments. C. H. designed and performed experiments, analyzed data, and prepared the manuscript. We wish to thank Dr. Toshio Kitamura at the University of Tokyo for the STAT5a cDNA construct, Dr. Richard J. Ross at the University of Sheffield for the STAT5 LHRE reporter construct, Dr. Robert E. Campbell at the University of Alberta for the ametrine construct, Dr. Alexander Rudensky at the Memorial Sloan Kettering Cancer Center for the FOXP3-GFP mice, Dr. Yi-Rong Chen for help in the generation of tetracycline-inducible cells, and Claire Y. Huang for proofreading the manuscript. We also thank the staff at the flow cytometry, sequencing and animal core facilities at the NHRI for their services.	Ai HW, 2008, NAT METHODS, V5, P401, DOI [10.1038/nmeth.1207, 10.1038/NMETH.1207]; Al-Mutairi MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001192; Aoki N, 2000, J BIOL CHEM, V275, P39718, DOI 10.1074/jbc.M005615200; Auger-Messier M, 2013, CIRC RES, V112, P48, DOI 10.1161/CIRCRESAHA.112.272963; Beadling C, 1996, EMBO J, V15, P1902, DOI 10.1002/j.1460-2075.1996.tb00541.x; Bettini ML, 2007, P NATL ACAD SCI USA, V104, P16257, DOI 10.1073/pnas.0705321104; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Chang CF, 2012, J IMMUNOL, V189, P721, DOI 10.4049/jimmunol.1103015; Chen Q, 2011, J IMMUNOL, V186, P6329, DOI 10.4049/jimmunol.1100061; Chen XM, 1998, CELL, V93, P827, DOI 10.1016/S0092-8674(00)81443-9; Chu YF, 1996, J BIOL CHEM, V271, P6497, DOI 10.1074/jbc.271.11.6497; Cornell TT, 2010, INFECT IMMUN, V78, P2868, DOI 10.1128/IAI.00018-10; de la Rosa M, 2004, EUR J IMMUNOL, V34, P2480, DOI 10.1002/eji.200425274; Domingues HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015531; Ferraro A, 2014, P NATL ACAD SCI USA, V111, pE1111, DOI 10.1073/pnas.1401343111; Fievez L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000727; Floyd ZE, 2007, AM J PHYSIOL-ENDOC M, V292, pE461, DOI 10.1152/ajpendo.00334.2006; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; GOUILLEUX F, 1994, EMBO J, V13, P4361, DOI 10.1002/j.1460-2075.1994.tb06756.x; GUAN KL, 1995, J BIOL CHEM, V270, P7197, DOI 10.1074/jbc.270.13.7197; Hoyt R, 2007, J IMMUNOL, V179, P3402, DOI 10.4049/jimmunol.179.6.3402; Huang CY, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-24; Huang CY, 2012, EUR J IMMUNOL, V42, P476, DOI 10.1002/eji.201041295; Iyer J, 2008, FASEB J, V22, P391, DOI 10.1096/fj.07-8965com; Jeffrey KL, 2006, NAT IMMUNOL, V7, P274, DOI 10.1038/ni1310; Jeong DG, 2014, ACTA CRYSTALLOGR D, V70, P421, DOI 10.1107/S1399004713029866; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Ke SA, 1999, PROG BIOPHYS MOL BIO, V71, P405, DOI 10.1016/S0079-6107(98)00051-0; Keyse SM, 2008, CANCER METAST REV, V27, P253, DOI 10.1007/s10555-008-9123-1; Kim HP, 2006, CYTOKINE GROWTH F R, V17, P349, DOI 10.1016/j.cytogfr.2006.07.003; King AG, 1995, ONCOGENE, V11, P2553; Kohm AP, 2002, J IMMUNOL, V169, P4712, DOI 10.4049/jimmunol.169.9.4712; Kovanen PE, 2008, J BIOL CHEM, V283, P17362, DOI 10.1074/jbc.M709887200; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Malek TR, 2010, IMMUNITY, V33, P153, DOI 10.1016/j.immuni.2010.08.004; Meier A, 2007, EMBO J, V26, P2707, DOI 10.1038/sj.emboj.7601719; Meinke A, 1996, MOL CELL BIOL, V16, P6937; Moon SJ, 2014, ARTHRITIS RHEUMATOL, V66, P3083, DOI 10.1002/art.38787; Neculai D, 2005, J BIOL CHEM, V280, P40782, DOI 10.1074/jbc.M507682200; O'Connor RA, 2008, J IMMUNOL, V181, P3750, DOI 10.4049/jimmunol.181.6.3750; Oda A, 2002, BLOOD, V99, P1850, DOI 10.1182/blood.V99.5.1850; Ramesh S, 2008, EMBO REP, V9, P990, DOI 10.1038/embor.2008.158; Reich Nancy C, 2013, JAKSTAT, V2, pe27080, DOI 10.4161/jkst.27080; Reiner SL, 2007, CELL, V129, P33, DOI 10.1016/j.cell.2007.03.019; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Shen WH, 2006, CANCER RES, V66, P6033, DOI 10.1158/0008-5472.CAN-05-3878; Shin HY, 2013, J CELL SCI, V126, P3333, DOI 10.1242/jcs.123042; Sloss CM, 2005, CELL SIGNAL, V17, P709, DOI 10.1016/j.cellsig.2004.10.010; Teng CH, 2007, J BIOL CHEM, V282, P28395, DOI 10.1074/jbc.M705142200; Torres C, 2003, EXP CELL RES, V290, P195, DOI 10.1016/S0014-4827(03)00309-4; von Laue S, 2000, J ENDOCRINOL, V165, P301, DOI 10.1677/joe.0.1650301; Wang DM, 2000, EMBO J, V19, P392, DOI 10.1093/emboj/19.3.392; Wang H, 2007, J BIOL CHEM, V282, P16164, DOI 10.1074/jbc.M610556200; Wei L, 2008, SEMIN CELL DEV BIOL, V19, P394, DOI 10.1016/j.semcdb.2008.07.011; Xiao WB, 2009, CANCER CELL, V16, P161, DOI 10.1016/j.ccr.2009.05.018; Yamashita H, 2001, MOL CELL ENDOCRINOL, V183, P151, DOI 10.1016/S0303-7207(01)00546-9; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Yu CL, 2000, J BIOL CHEM, V275, P599, DOI 10.1074/jbc.275.1.599; Yu MC, 2012, P NATL ACAD SCI USA, V109, pE879, DOI 10.1073/pnas.1109797109; Zhang YL, 2004, NATURE, V430, P793, DOI 10.1038/nature02764	60	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145880	10.1371/journal.pone.0145880	http://dx.doi.org/10.1371/journal.pone.0145880			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710253	Green Published, gold, Green Submitted			2022-12-26	WOS:000367451400091
J	Rahman, SA; Adjeroh, D				Rahman, Syed Ashiqur; Adjeroh, Donald			Surface-Based Body Shape Index and Its Relationship with All-Cause Mortality	PLOS ONE			English	Article							TO-HEIGHT RATIO; MASS INDEX; WAIST CIRCUMFERENCE; FAT DISTRIBUTION; CARDIOMETABOLIC RISK; CARDIOVASCULAR RISK; CENTRAL OBESITY; SCREENING TOOL; WEIGHT-GAIN; MEN	Background Obesity is a global public health challenge. In the US, for instance, obesity prevalence remains high at more than one-third of the adult population, while over two-thirds are obese or overweight. Obesity is associated with various health problems, such as diabetes, cardiovascular diseases (CVDs), depression, some forms of cancer, sleep apnea, osteoarthritis, among others. The body mass index (BMI) is one of the best known measures of obesity. The BMI, however, has serious limitations, for instance, its inability to capture the distribution of lean mass and adipose tissue, which is a better predictor of diabetes and CVDs, and its curved ("U-shaped") relationship with mortality hazard. Other anthropometric measures and their relation to obesity have been studied, each with its advantages and limitations. In this work, we introduce a new anthropometric measure (called Surface-based Body Shape Index, SBSI) that accounts for both body shape and body size, and evaluate its performance as a predictor of all-cause mortality. Methods and Findings We analyzed data on 11,808 subjects (ages 18-85), from the National Health and Human Nutrition Examination Survey (NHANES) 1999-2004, with 8-year mortality follow up. Based on the analysis, we introduce a new body shape index constructed from four important anthropometric determinants of body shape and body size: body surface area (BSA), vertical trunk circumference (VTC), height (H) and waist circumference (WC). The surface-based body shape index (SBSI) is defined as follows: SBSI = (H-7/4) (WC5/6)/BSA VTC (1) SBSI has negative correlation with BMI and weight respectively, no correlation with WC, and shows a generally linear relationship with age. Results on mortality hazard prediction using both the Cox proportionality model, and Kaplan-Meier curves each show that SBSI outperforms currently popular body shape indices (e.g., BMI, WC, waist-to-height ratio (WHtR), waist-to-hip ratio (WHR), A Body Shape Index (ABSI)) in predicting all-cause mortality. Conclusions We combine measures of both body shape and body size to construct a novel anthropometric measure, the surface-based body shape index (SBSI). SBSI is generally linear with age, and increases with increasing mortality, when compared with other popular anthropometric indices of body shape.	[Rahman, Syed Ashiqur; Adjeroh, Donald] W Virginia Univ, Lane Dept Comp Sci & Elect Engn, Morgantown, WV 26506 USA	West Virginia University	Rahman, SA (corresponding author), W Virginia Univ, Lane Dept Comp Sci & Elect Engn, Morgantown, WV 26506 USA.	srahman2@mix.wvu.edu; don@csee.wvu.edu						Adjeroh D, 2010, P 2010 IEEE INT WORK, P1; Allison DB, 1997, AM J EPIDEMIOL, V146, P339, DOI 10.1093/oxfordjournals.aje.a009275; Allison DB, 2002, INT J OBESITY, V26, P410, DOI 10.1038/sj.ijo.0801925; [Anonymous], 2011, IEEE C DEC CONTR EUR; ASHWELL M, 1985, BRIT MED J, V290, P1692, DOI 10.1136/bmj.290.6483.1692; Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Bigaard J, 2004, OBES RES, V12, P1042, DOI 10.1038/oby.2004.131; Bigaard J, 2003, OBES RES, V11, P895, DOI 10.1038/oby.2003.123; Browning LM, 2010, NUTR RES REV, V23, P247, DOI 10.1017/S0954422410000144; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Carnethon MR, 2012, JAMA-J AM MED ASSOC, V308, P581, DOI 10.1001/jama.2012.9282; CHAN JM, 1994, DIABETES CARE, V17, P961, DOI 10.2337/diacare.17.9.961; COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001; Cox D. R., 1984, ANAL SURVIVAL DATA, V21; Daniell N, 2012, AM J PHYS ANTHROPOL, V148, P148, DOI 10.1002/ajpa.22051; Deng Cao, 2012, 2012 IEEE Fifth International Conference On Biometrics: Theory, Applications And Systems (BTAS 2012), P162, DOI 10.1109/BTAS.2012.6374572; Doehner W, 2009, EUROPEAN HEART J; Eckel RH, 1998, CIRCULATION, V97, P2099, DOI 10.1161/01.CIR.97.21.2099; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Gallicchio L, 2007, CANCER DETECT PREV, V31, P95, DOI 10.1016/j.cdp.2007.02.004; Han TS, 1997, INT J OBESITY, V21, P587, DOI 10.1038/sj.ijo.0800446; He S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050573; Hsieh SD, 2003, INT J OBESITY, V27, P610, DOI 10.1038/sj.ijo.0802259; Janssen I, 2007, OBES REV, V8, P41, DOI 10.1111/j.1467-789X.2006.00248.x; Janssen I, 2002, AM J CLIN NUTR, V75, P683, DOI 10.1093/ajcn/75.4.683; Kanaya AM, 2003, AM J EPIDEMIOL, V158, P1161, DOI 10.1093/aje/kwg271; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Korn EL, 1997, AM J EPIDEMIOL, V145, P72; Krakauer NY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039504; Lainscak M, 2012, J CACHEXIA SARCOPENI, V3, P1, DOI 10.1007/s13539-012-0059-5; LEW EA, 1979, J CHRON DIS, V32, P563, DOI 10.1016/0021-9681(79)90119-X; Li WC, 2013, EUR J NUTR, V52, P57, DOI 10.1007/s00394-011-0286-0; MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101; Mcgee DL, 2005, ANN EPIDEMIOL, V15, P87, DOI 10.1016/j.annepidem.2004.05.012; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI [10.1001/jama.289.1.76, DOI 10.1001/JAMA.289.1.76]; Morkedal B, 2011, EUR J EPIDEMIOL, V26, P457, DOI 10.1007/s10654-011-9572-7; National Center for Health Statistics (NCHS), 2011, NAT HLTH NUTR EX SUR; NCHS, 2006, TECHNICAL REPORT; NHANES, 2002, TECHNICAL REPORT; Ogden CL, 2012, PREVALENCE OBESITY U; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Ohrvall M, 2000, INT J OBESITY, V24, P497, DOI 10.1038/sj.ijo.0801186; Onat A, 2009, CLIN NUTR, V28, P46, DOI 10.1016/j.clnu.2008.10.006; Padwal RS, 2011, CAN MED ASSOC J, V183, pE1059, DOI 10.1503/cmaj.110387; Petursson H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026621; POULIOT MC, 1994, AM J CARDIOL, V73, P460, DOI 10.1016/0002-9149(94)90676-9; Racette SB, 2003, PHYS THER, V83, P276, DOI 10.1093/ptj/83.3.276; Raghuveer G, 2010, AM J CLIN NUTR, V91, p1514S, DOI 10.3945/ajcn.2010.28701D; Robinette K. M., 1999, Second International Conference on 3-D Digital Imaging and Modeling (Cat. No.PR00062), P380, DOI 10.1109/IM.1999.805368; Romero-Corral A, 2008, OBESITY, V16, pS124; Schneider HJ, 2010, J CLIN ENDOCR METAB, V95, P1777, DOI 10.1210/jc.2009-1584; Shuter B, 2000, EUR J APPL PHYSIOL, V82, P250, DOI 10.1007/s004210050679; Snijder MB, 2006, INT J EPIDEMIOL, V35, P83, DOI 10.1093/ije/dyi253; Tahrani A, 2008, BODY VOLUME INDEX TI; Treleaven P, 2007, COMPUTER, V40, P28, DOI 10.1109/MC.2007.225; Wells JCK, 2007, AM J CLIN NUTR, V85, P419, DOI 10.1093/ajcn/85.2.419; World Health Organization, 2000, WHO TECHN REP SER, P894; Yu CY, 2010, BURNS, V36, P616, DOI 10.1016/j.burns.2009.05.013; Zhang ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070893	62	25	26	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0144639	10.1371/journal.pone.0144639	http://dx.doi.org/10.1371/journal.pone.0144639			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709925	Green Submitted, Green Published, gold			2022-12-26	WOS:000367451400008
J	Sekhar, S; Gharat, SA; Panda, BB; Mohaptra, T; Das, K; Kariali, E; Mohapatra, PK; Shaw, BP				Sekhar, Sudhanshu; Gharat, Sachin Ashruba; Panda, Binay Bhushan; Mohaptra, Trupti; Das, Kaushik; Kariali, Ekamber; Mohapatra, Pravat Kumar; Shaw, Birendra Prasad			Identification and Characterization of Differentially Expressed Genes in Inferior and Superior Spikelets of Rice Cultivars with Contrasting Panicle-Compactness and Grain-Filling Properties	PLOS ONE			English	Article							ENDOSPERM; GROWTH; RISBZ1; PROGRESS; REVEALS; RPBF	Breeding programs for increasing spikelet number in rice have resulted in compactness of the panicle, accompanied by poor grain filling in inferior spikelets. Although the inefficient utilization of assimilate has been indicated as responsible for this poor grain filling, the underlying cause remains elusive. The current study utilized the suppression subtractive hybridization technique to identify 57 and 79 genes that overexpressed in the superior and inferior spikelets (with respect to each other), respectively, of the compact-panicle rice cultivar Mahalaxmi. Functional categorization of these differentially expressed genes revealed a marked metabolic difference between the spikelets according to their spatial location on the panicle. The expression of genes encoding seed storage proteins was dominant in inferior spikelets, whereas genes encoding regulatory proteins, such as serine- threonine kinase, zinc finger protein and E3 ligase, were highly expressed in superior spikelets. The expression patterns of these genes in the inferior and superior spikelets of Mahalaxmi were similar to those observed in another compact-panicle cultivar, OR-1918, but differed from those obtained in two lax-panicle cultivars, Upahar and Lalat. The results first suggest that the regulatory proteins abundantly expressed in the superior spikelets of compact-panicle cultivars and in both the superior and inferior spikelets of lax-panicle cultivars but poorly expressed in the inferior spikelets of compact-panicle cultivars promote grain filling. Second, the high expression of seed-storage proteins observed in the inferior spikelets of compact-panicle cultivars appears to inhibit the grain filling process. Third, the low expression of enzymes of the Krebs cycle in inferior spikelets compared with superior spikelets of compact-panicle cultivars is bound to lead to poor ATP generation in the former and consequently limit starch biosynthesis, an ATP-consuming process, resulting in poor grain filling.	[Sekhar, Sudhanshu; Gharat, Sachin Ashruba; Panda, Binay Bhushan; Mohaptra, Trupti; Das, Kaushik; Shaw, Birendra Prasad] Inst Life Sci, Environm Biotechnol Lab, Bhubaneswar, Orissa, India; [Kariali, Ekamber; Mohapatra, Pravat Kumar] Sambalpur Univ, Sch Life Sci, Sambalpur, Odisha, India	Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS); Sambalpur University	Shaw, BP (corresponding author), Inst Life Sci, Environm Biotechnol Lab, Bhubaneswar, Orissa, India.	bpshaw@ils.res.in	Shaw, Birendra Prasad/AAU-1232-2020	Shaw, Birendra Prasad/0000-0003-0541-3296; SEKHAR, SUDHANSHU/0000-0003-2045-4520; Gharat, Sachin Ashruba/0000-0002-2888-6371	Department of Biotechnology, Ministry of Science and Technology [BT/PR-10975/AGR/02/619/2008]	Department of Biotechnology, Ministry of Science and Technology	This work was supported by BT/PR-10975/AGR/02/619/2008, from the Department of Biotechnology, Ministry of Science and Technology, http://www.dbtindia.nic.in, to BPS and PKM.	Araujo WL, 2008, PLANT PHYSIOL, V148, P1782, DOI 10.1104/pp.108.126219; Duan MJ, 2005, PLANT MOL BIOL, V59, P165, DOI 10.1007/s11103-004-7507-3; Frickey T, 2004, J STRUCT BIOL, V146, P2, DOI 10.1016/j.jsb.2003.11.020; Gupta M., 2014, SYNTH LECT DATA MIN, V5, P1, DOI DOI 10.2200/S00573ED1V01Y201403DMK008; Kang BH, 2009, PLANT PHYSIOL, V151, P1366, DOI 10.1104/pp.109.142331; Kato T, 2004, J AGR SCI, V142, P177, DOI 10.1017/S0021859604004265; Kawakatsu T, 2009, PLANT J, V59, P908, DOI 10.1111/j.1365-313X.2009.03925.x; Khush G, 2003, NUTR REV, V61, pS114, DOI 10.1301/nr.2003.jun.S114-S116; Khush GS, 1996, INCREASING YIELD POT, P36; Kobayashi H, 2013, PLANTA, V237, P1393, DOI 10.1007/s00425-013-1854-8; Liu XL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-730; Mohapatra PK, 2009, PLANT SCI, V176, P256, DOI 10.1016/j.plantsci.2008.11.001; Mohapatra PK, 2004, FUNCT PLANT BIOL, V31, P131, DOI 10.1071/FP03177; Mohapatra PK, 2000, AUST J PLANT PHYSIOL, V27, P311, DOI 10.1071/PP99057; Mohapatra PK, 2011, ADV AGRON, V110, P333, DOI 10.1016/B978-0-12-385531-2.00005-0; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Onodera Y, 2001, J BIOL CHEM, V276, P14139, DOI 10.1074/jbc.M007405200; OPARKA KJ, 1981, PLANT CELL ENVIRON, V4, P355, DOI 10.1111/j.1365-3040.1981.tb02112.x; Panda BB, 2015, FUNCT PLANT BIOL, V42, P875, DOI 10.1071/FP14363; Panda B, 2009, PLANT GROWTH REGUL, V58, P141, DOI 10.1007/s10725-009-9362-3; Peng SB, 2008, FIELD CROP RES, V108, P32, DOI 10.1016/j.fcr.2008.04.001; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Sahu BB, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-69; Santos L., 2006, ADV AGRIL FOOD BIOTE, V37, P1; Tichtinsky G, 1998, BBA-GENE STRUCT EXPR, V1442, P261, DOI 10.1016/S0167-4781(98)00187-0; UMEMOTO T, 1994, PHYTOCHEMISTRY, V36, P843, DOI 10.1016/S0031-9422(00)90448-5; United Nations. Department of Economic and Social Affairs P. D., 2012, ESAPWP228; Virk P. S., 2004, International Rice Research Notes, V29, P5; Wang F, 2008, J SCI FOOD AGR, V88, P897, DOI 10.1002/jsfa.3167; YAMAGATA H, 1982, PLANT PHYSIOL, V70, P1094, DOI 10.1104/pp.70.4.1094; Yamamoto MP, 2006, PLANT PHYSIOL, V141, P1694, DOI 10.1104/pp.106.082826; YAMAMOTO Y, 1991, JPN J CROP SCI, V60, P365, DOI 10.1626/jcs.60.365; Yang JC, 2006, J EXP BOT, V57, P149, DOI 10.1093/jxb/erj018; Yang JC, 2010, J EXP BOT, V61, P1, DOI 10.1093/jxb/erp348; Zhang ZX, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0100416, 10.1371/journal.pone.0089140, 10.1371/journal.pone.0099511]	36	15	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145749	10.1371/journal.pone.0145749	http://dx.doi.org/10.1371/journal.pone.0145749			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710230	Green Published, gold, Green Submitted			2022-12-26	WOS:000367451400075
J	Trampe, D; Quoidbach, J; Taquet, M				Trampe, Debra; Quoidbach, Jordi; Taquet, Maxime			Emotions in Everyday Life	PLOS ONE			English	Article							CIRCUMPLEX MODEL; EXPERIENCE; SELF	Despite decades of research establishing the causes and consequences of emotions in the laboratory, we know surprisingly little about emotions in everyday life. We developed a smartphone application that monitored real-time emotions of an exceptionally large (N = 11,000+) and heterogeneous participants sample. People's everyday life seems profoundly emotional: participants experienced at least one emotion 90% of the time. The most frequent emotion was joy, followed by love and anxiety. People experienced positive emotions 2.5 times more often than negative emotions, but also experienced positive and negative emotions simultaneously relatively frequently. We also characterized the interconnections between people's emotions using network analysis. This novel approach to emotion research suggests that specific emotions can fall into the following categories 1) connector emotions (e.g., joy), which stimulate same valence emotions while inhibiting opposite valence emotions, 2) provincial emotions (e.g., gratitude), which stimulate same valence emotions only, or 3) distal emotions (e.g., embarrassment), which have little interaction with other emotions and are typically experienced in isolation. Providing both basic foundations and novel tools to the study of emotions in everyday life, these findings demonstrate that emotions are ubiquitous to life and can exist together and distinctly, which has important implications for both emotional interventions and theory.	[Trampe, Debra] Univ Groningen, Fac Econ & Business, Dept Mkt, Groningen, Netherlands; [Quoidbach, Jordi] Pompeu Fabra Univ, Dept Econ & Business, Barcelona, Spain; [Taquet, Maxime] Harvard Univ, Sch Med, Computat Radiol Lab, Boston Childrens Hosp, Boston, MA USA	University of Groningen; Pompeu Fabra University; Harvard University; Boston Children's Hospital; Harvard Medical School	Quoidbach, J (corresponding author), Pompeu Fabra Univ, Dept Econ & Business, Barcelona, Spain.	Jordi.quoidbach@upf.edu		Taquet, Maxime/0000-0002-8987-952X	Barcelona School of Management; Spanish Ministry of Science and Education [PSI2013-41909-P]; Helaers Foundation	Barcelona School of Management; Spanish Ministry of Science and Education(Spanish Government); Helaers Foundation	JQ was supported by the Barcelona School of Management and grant PSI2013-41909-P from the Spanish Ministry of Science and Education. MT was supported by the Helaers Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to Jennifer Jordan, Yating Le, Hans Risselada, Yves-Alexandre de Monjoye, and Martin Desseilles for their help during various stages of the research. JQ was supported by the Barcelona School of Management and grant PSI2013-41909-P from the Spanish Ministry of Science and Education. MT was supported by the Helaers Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	aan het Rot M, 2012, CLIN PSYCHOL REV, V32, P510, DOI 10.1016/j.cpr.2012.05.007; Barrett LF, 2000, PERS SOC PSYCHOL B, V26, P1027, DOI 10.1177/01461672002611001; Barrett LF, 2001, COGNITION EMOTION, V15, P713, DOI 10.1080/02699930143000239; Barrett LF, 2006, PERSPECT PSYCHOL SCI, V1, P28, DOI 10.1111/j.1745-6916.2006.00003.x; BERKOWITZ L, 1990, AM PSYCHOL, V45, P494, DOI 10.1037/0003-066X.45.4.494; Bigot R., 2013, DIFFUSION TECHNOLOGI; Carstensen LL, 2000, J PERS SOC PSYCHOL, V79, P644, DOI 10.1037//0022-3514.79.4.644; CHAIKEN S, 1989, P212; Diener E, 2014, PERS SOC PSYCHOL REV, P1; Emmons RA, 2003, J PERS SOC PSYCHOL, V84, P377, DOI 10.1037/0022-3514.84.2.377; FORGAS JP, 1995, PSYCHOL BULL, V117, P39, DOI 10.1037/0033-2909.117.1.39; Fredrickson B., 2013, LOVE 2 0 CREATING HA; Fredrickson BL, 2003, J PERS SOC PSYCHOL, V84, P365, DOI 10.1037/0022-3514.84.2.365; Frijda N. H., 1986, EMOTIONS STUDIES EMO; Heiy JE, 2014, EMOTION, V14, P878, DOI 10.1037/a0037231; Hutcherson CA, 2008, EMOTION, V8, P720, DOI 10.1037/a0013237; Izard C. E., 1977, HUMAN EMOTIONS; Larsen JT, 2011, J PERS SOC PSYCHOL, V100, P1095, DOI 10.1037/a0021846; Lerner J. S., 2015, PSYCHOLOGY, P66; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; PHILIPPOT P, 1993, COGNITION EMOTION, V7, P171, DOI 10.1080/02699939308409183; Philippot P, 2003, EMOTION, V3, P270, DOI 10.1037/1528-3542.3.3.270; Quoidbach J, 2014, J EXP PSYCHOL GEN, V143, P2057, DOI 10.1037/a0038025; Remington NA, 2000, J PERS SOC PSYCHOL, V79, P286, DOI 10.1037//0022-3514.79.2.286; Rudd M, 2012, PSYCHOL SCI, V23, P1130, DOI 10.1177/0956797612438731; Russell JA, 1999, J PERS SOC PSYCHOL, V76, P805, DOI 10.1037/0022-3514.76.5.805; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Schaefer A, 2010, COGNITION EMOTION, V24, P1153, DOI 10.1080/02699930903274322; SCHLOSBERG H, 1952, J EXP PSYCHOL, V44, P229, DOI 10.1037/h0055778; SMITH CA, 1993, COGNITION EMOTION, V7, P233, DOI 10.1080/02699939308409189; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Tichy N. M., 1979, ACAD MANAGE REV, V4, P507, DOI [10.5465/AMR.1979.4498309, DOI 10.5465/AMR.1979.4498309]; Tugade MM, 2004, J PERS, V72, P1161, DOI 10.1111/j.1467-6494.2004.00294.x; van den Heuvel MP, 2013, J NEUROSCI, V33, P14489, DOI 10.1523/JNEUROSCI.2128-13.2013; Vansteelandt K, 2005, J RES PERS, V39, P325, DOI 10.1016/j.jrp.2004.05.006; Weis R, 2011, PSYCHOL WELL-BEING, V1, DOI 10.1186/2211-1522-1-5; Wood AM, 2010, CLIN PSYCHOL REV, V30, P890, DOI 10.1016/j.cpr.2010.03.005; Youngstrom EA, 2003, EDUC PSYCHOL MEAS, V63, P279, DOI 10.1177/0013164403253226; Zelenski JM, 2000, J RES PERS, V34, P178, DOI 10.1006/jrpe.1999.2275	39	73	74	10	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145450	10.1371/journal.pone.0145450	http://dx.doi.org/10.1371/journal.pone.0145450			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ4SI	26698124	Green Published, gold, Green Submitted			2022-12-26	WOS:000367092600081
J	Wagner, T; Bartelt, A; Schlein, C; Heeren, J				Wagner, Tobias; Bartelt, Alexander; Schlein, Christian; Heeren, Joerg			Genetic Dissection of Tissue-Specific Apolipoprotein E Function for Hypercholesterolemia and Diet-Induced Obesity	PLOS ONE			English	Article							E-DEFICIENT MICE; BONE-MARROW-TRANSPLANTATION; FATTY LIVER-DISEASE; ADIPOSE-TISSUE; CHOLESTEROL EFFLUX; METABOLIC SYNDROME; IN-VIVO; ATHEROSCLEROSIS; EXPRESSION; MOUSE	ApoE deficiency in mice (Apoe(-/-)) results in severe hypercholesterolemia and atherosclerosis. In diet-induced obesity, Apoe(-/-) display steatohepatitis but reduced accumulation of triacylglycerides and enhanced insulin sensitivity in white adipose tissue (WAT). Although the vast majority of apoE is expressed by hepatocytes apoE is also abundantly expressed in WAT. As liver and adipose tissue play important roles for metabolism, this study aims to outline functions of both hepatocyte- and adipocyte-derived apoE separately by investigating a novel mouse model of tissue-specific apoE deficiency. Therefore we generated transgenic mice carrying homozygous floxed Apoe alleles. Mice lacking apoE either in hepatocytes (Apoe(Delta Hep)) or in adipose tissue (Apoe(Delta AT)) were fed experimental diets. Apoe(Delta Hep) exhibited slightly higher body weights, adiposity and liver weights on diabetogenic high fat diet (HFD). Accordingly, hepatic steatosis and markers of inflammation were more pronounced compared to controls. Hypercholesterolemia evoked by lipoprotein remnant accumulation was present in Apoe(Delta Hep) mice fed a Western type diet (WTD). Lipidation of VLDL particles and tissue uptake of VLDL were disturbed in Apoe(Delta Hep) while the plasma clearance rate remained unaltered. Apoe(Delta AT) did not display any detectable phenotype, neither on HFD nor on WTD. In conclusion, our novel conditional apoE deletion model has proven here the role of hepatocyte apoE for VLDL production and diet-induced dyslipidemia. Specific deletion of apoE in adipocytes cannot reproduce the adipose phenotype of global Apoe(-/-) mice, suggesting that apoE produced in other cell types than hepatocytes or adipocytes explains the lean and insulin-sensitive phenotype described for Apoe(-/-) mice.	[Wagner, Tobias; Bartelt, Alexander; Schlein, Christian; Heeren, Joerg] Univ Med Ctr Hamburg Eppendorf, Dept Biochem & Mol Cell Biol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Heeren, J (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Biochem & Mol Cell Biol, Hamburg, Germany.	heeren@uke.uni-hamburg.de	Bartelt, Alexander/ABC-2525-2020		Deutsche Forschungsgemeinschaft [SFB 841, GRK1459]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was financially supported by grants of the Deutsche Forschungsgemeinschaft (SFB 841) to JH. The work of TW and CS was supported by doctoral fellowships of the Deutsche Forschungsgemeinschaft (SFB 841, GRK1459).; The authors thank S. Ehret, E. Azizi and B. Henkel for excellent technical assistance. The development of the Apoe conditional mouse model was assisted by genOway. This work was financially supported by grants of the DFG (SFB 841) to J. H. The work of T. W. and C. S. was supported by doctoral fellowships of DFG (SFB 841, GRK1459).	Adiels M, 2008, ARTERIOSCL THROM VAS, V28, P1225, DOI 10.1161/ATVBAHA.107.160192; Bartelt A., 2012, Journal of Molecular Medicine, V90, P887, DOI 10.1007/s00109-012-0858-3; Bartelt A, 2011, DIABETOLOGIA, V54, P2900, DOI 10.1007/s00125-011-2274-6; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Bartelt A, 2010, BONE, V47, P736, DOI 10.1016/j.bone.2010.07.002; BOISVERT WA, 1995, J CLIN INVEST, V96, P1118, DOI 10.1172/JCI118098; DASHTI N, 1980, BIOCHIM BIOPHYS ACTA, V618, P347, DOI 10.1016/0005-2760(80)90041-7; Foley EM, 2013, ARTERIOSCL THROM VAS, V33, P2065, DOI 10.1161/ATVBAHA.113.301637; HAYEK T, 1994, BIOCHEM BIOPH RES CO, V205, P1072, DOI 10.1006/bbrc.1994.2775; Heeren J, 2006, ARTERIOSCL THROM VAS, V26, P442, DOI 10.1161/01.ATV.0000201282.64751.47; Hofmann SM, 2008, DIABETES, V57, P5, DOI 10.2337/db07-0403; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Huang YD, 2004, J MOL NEUROSCI, V23, P189, DOI 10.1385/JMN:23:3:189; Huang YD, 1998, J BIOL CHEM, V273, P26388, DOI 10.1074/jbc.273.41.26388; Huang ZH, 2013, J LIPID RES, V54, P202, DOI 10.1194/jlr.M031906; Huang ZH, 2006, DIABETES, V55, P3394, DOI 10.2337/db06-0354; Huang ZH, 2009, AM J PHYSIOL-ENDOC M, V296, pE1110, DOI 10.1152/ajpendo.90964.2008; Krueger KC, 2014, STEM CELL REP, V3, P1147, DOI 10.1016/j.stemcr.2014.10.009; Kuipers F, 1997, J CLIN INVEST, V100, P2915, DOI 10.1172/JCI119841; Laatsch A, 2009, ATHEROSCLEROSIS, V204, P105, DOI 10.1016/j.atherosclerosis.2008.07.046; LINTON MF, 1995, SCIENCE, V267, P1034, DOI 10.1126/science.7863332; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marchesini G, 2005, CURR OPIN LIPIDOL, V16, P421, DOI 10.1097/01.mol.0000174153.53683.f2; Meir KS, 2004, ARTERIOSCL THROM VAS, V24, P1006, DOI 10.1161/01.ATV.0000128849.12617.f4; Mensenkamp AR, 1999, J BIOL CHEM, V274, P35711, DOI 10.1074/jbc.274.50.35711; Mensenkamp AR, 2001, J HEPATOL, V35, P816, DOI 10.1016/S0168-8278(01)00249-5; Mullican SE, 2013, MOL ENDOCRINOL, V27, P127, DOI 10.1210/me.2012-1267; Nilsson SK, 2011, ATHEROSCLEROSIS, V219, P15, DOI 10.1016/j.atherosclerosis.2011.07.019; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Rellin L, 2008, BBA-MOL CELL BIOL L, V1781, P232, DOI 10.1016/j.bbalip.2008.02.001; Surendran RP, 2012, J INTERN MED, V272, P185, DOI 10.1111/j.1365-2796.2012.02516.x; Tilg H, 2006, GASTROENTEROLOGY, V131, P934, DOI 10.1053/j.gastro.2006.05.054; WILLIAMS DL, 1985, ANN NY ACAD SCI, V454, P222, DOI 10.1111/j.1749-6632.1985.tb11861.x; Wouters K, 2008, HEPATOLOGY, V48, P474, DOI 10.1002/hep.22363; ZECHNER R, 1991, J BIOL CHEM, V266, P10583; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543	36	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145102	10.1371/journal.pone.0145102	http://dx.doi.org/10.1371/journal.pone.0145102			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26695075	Green Published, gold, Green Submitted			2022-12-26	WOS:000367092500022
J	Patrone, M; Coroadinha, AS; Teixeira, AP; Alves, PM				Patrone, Marco; Coroadinha, Ana Sofia; Teixeira, Ana P.; Alves, Paula M.			Palmitoylation Strengthens Cholesterol- dependent Multimerization and Fusion Activity of Human Cytomegalovirus Glycoprotein B (gB)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; MEMBRANE; ENTRY; PROTEINS; CELLS; HERPESVIRUSES; INFECTION; TOOLS; RAFTS	Herpesviruses are a large order of animal enveloped viruses displaying a virion fusion mechanism of unusual complexity. Their multipartite machinery has a conserved core made of the gH/gL ancillary complexes and the homo-trimeric fusion protein glycoprotein B (gB). Despite its essential role in starting the viral infection, gB interaction with membrane lipids is still poorly understood. Here, evidence is provided demonstrating that human cytomegalovirus (HCMV) gB depends on the S-palmitoylation of its endodomain for an efficient interaction with cholesterol-rich membrane patches. We found that, unique among herpesviral gB proteins, the HCMV fusion factor has a Cys residue in the C-terminal region that is palmitoylated and mediates methyl-beta-cyclodextrin-sensitive self-association of purified gB. A cholesterol-dependent virus-like particle trap assay, based on co-expression of the HIV Gag protein, confirmed that this post-translational modification is functional in the context of cellular membranes. Mutation of the palmitoylated Cys residue to Ala or inhibition of protein palmitoylation decreased HCMV gB export via Gag particles. Moreover, purified gBC777A showed an increased kinetic sensitivity in a cholesterol depletion test, demonstrating that palmitoyl-gB limits outward cholesterol diffusion. Finally, gB palmitoylation was required for full fusogenic activity in human epithelial cells. Altogether, these results uncover the palmitoylation of HCMV gB and its role in gB multimerization and activity.	[Patrone, Marco; Coroadinha, Ana Sofia; Teixeira, Ana P.; Alves, Paula M.] iBET Inst Biol Expt & Tecnol, Anim Cell Technol Unit, P-2780901 Oeiras, Portugal; [Patrone, Marco] DIBIT Fdn Ctr San Raffaele, Biocrystallog Unit, I-20132 Milan, Italy; [Coroadinha, Ana Sofia; Teixeira, Ana P.; Alves, Paula M.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2784505 Oeiras, Portugal	Universidade Nova de Lisboa	Patrone, M (corresponding author), DIBIT San Raffaele Sci Inst, Biocrystallog Unit, Div Immunol Transplantat & Infect Dis, Via Olgettina 58, I-20132 Milan, Italy.	patrone.marco@hsr.it	Patrone, Marco/M-5672-2013; Coroadinha, Ana/AAS-5733-2021; Alves, Paula M/C-1070-2008; Coroadinha, Ana/L-5693-2013; Palma Teixeira, Ana/F-5594-2011	Patrone, Marco/0000-0002-5164-2877; Alves, Paula M/0000-0003-1445-3556; Coroadinha, Ana/0000-0001-9728-6890; Palma Teixeira, Ana/0000-0002-9208-8737	European Union (EU) project ComplexINC [270089]; Marie Curie Postdoctoral Grant SHerpA [251982]; Fundacao para a Ciencia e a Tecnologia (FCT) [EXPL/BBB-BIO/1541/2013]	European Union (EU) project ComplexINC; Marie Curie Postdoctoral Grant SHerpA; Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by the European Union (EU) project ComplexINC FP7/2007-2013, Grant 270089 (to P. M. A.) and by Marie Curie Postdoctoral Grant SHerpA FP7-PEOPLE-2009-IEF Grant 251982 and Fundacao para a Ciencia e a Tecnologia (FCT) Grant EXPL/BBB-BIO/1541/2013 (to M. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Atanasiu D, 2010, J VIROL, V84, P12292, DOI 10.1128/JVI.01700-10; Bender FC, 2003, J VIROL, V77, P9542, DOI 10.1128/JVI.77.17.9542-9552.2003; Bentz J, 2000, BIOPHYS J, V78, P227, DOI 10.1016/S0006-3495(00)76587-8; Brigidi GS, 2013, JOVE-J VIS EXP, DOI 10.3791/50031; Britt W, 2008, CURR TOP MICROBIOL, V325, P417; Carmo M, 2009, HUM GENE THER, V20, P1168, DOI 10.1089/hum.2009.068; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Davison AJ, 2009, ARCH VIROL, V154, P171, DOI 10.1007/s00705-008-0278-4; Drisdel RC, 2004, BIOTECHNIQUES, V36, P276, DOI 10.2144/04362RR02; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Fulop T, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00271; GHEYSEN D, 1989, CELL, V59, P103, DOI 10.1016/0092-8674(89)90873-8; Hahn G, 2004, J VIROL, V78, P10023, DOI 10.1128/JVI.78.18.10023-10033.2004; Hannah BP, 2007, J VIROL, V81, P4858, DOI 10.1128/JVI.02755-06; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Heimburg T, 2003, MEMBR SCI T, V7, P269, DOI 10.1016/S0927-5193(03)80032-3; Heldwein EE, 2006, SCIENCE, V313, P217, DOI 10.1126/science.1126548; Heldwein EE, 2009, STRUCTURE, V17, P147, DOI 10.1016/j.str.2009.01.003; Jarvis MA, 2002, J VIROL, V76, P5147, DOI 10.1128/JVI.76.10.5147-5155.2002; Key T, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004023; Krummenacher C, 2013, ADV EXP MED BIOL, V790, P178, DOI 10.1007/978-1-4614-7651-1_10; Levental I, 2010, P NATL ACAD SCI USA, V107, P22050, DOI 10.1073/pnas.1016184107; Mach M, 2007, J VIROL, V81, P5212, DOI 10.1128/JVI.01463-06; Maurer UE, 2013, STRUCTURE, V21, P1396, DOI 10.1016/j.str.2013.05.018; Patrone M, 2005, J VIROL, V79, P8361, DOI 10.1128/JVI.79.13.8361-8373.2005; Patrone M, 2007, J VIROL, V81, P11479, DOI 10.1128/JVI.00788-07; Patrone M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090753; Persaud-Sawin DA, 2009, J LIPID RES, V50, P759, DOI 10.1194/jlr.D800037-JLR200; Schindler J, 2006, PROTEOMICS, V6, P5409, DOI 10.1002/pmic.200600243; Sengupta D, 2015, BBA-BIOMEMBRANES, V1848, P1775, DOI 10.1016/j.bbamem.2015.03.018; Sharma S, 2013, VIROLOGY, V435, P239, DOI 10.1016/j.virol.2012.09.024; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Sinzger C, 2008, CURR TOP MICROBIOL, V325, P63; Vanarsdall AL, 2012, CURR OPIN VIROL, V2, P37, DOI 10.1016/j.coviro.2012.01.001; Veit M, 2012, BIOL CELL, V104, P493, DOI 10.1111/boc.201200006; Waheed AA, 2010, VIRUSES-BASEL, V2, P1146, DOI 10.3390/v2051146; Wang D, 2005, P NATL ACAD SCI USA, V102, P18153, DOI 10.1073/pnas.0509201102; Woolf PJ, 2003, BIOPHYS CHEM, V104, P217, DOI 10.1016/S0301-4622(02)00369-1; Yang ST, 2015, NAT CHEM BIOL, V11, P424, DOI [10.1038/NCHEMBIO.1800, 10.1038/nchembio.1800]; Yang W, 2010, MOL CELL PROTEOMICS, V9, P54, DOI 10.1074/mcp.M800448-MCP200	40	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4711	4722		10.1074/jbc.M115.682252	http://dx.doi.org/10.1074/jbc.M115.682252			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26694613	Green Published, hybrid			2022-12-26	WOS:000371604600037
J	Pszenny, V; Ehrenman, K; Romano, JD; Kennard, A; Schultz, A; Roos, DS; Grigg, ME; Carruthers, VB; Coppens, I				Pszenny, Viviana; Ehrenman, Karen; Romano, Julia D.; Kennard, Andrea; Schultz, Aric; Roos, David S.; Grigg, Michael E.; Carruthers, Vern B.; Coppens, Isabelle			A Lipolytic Lecithin:Cholesterol Acyltransferase Secreted by Toxoplasma Facilitates Parasite Replication and Egress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell surface enzyme; host-pathogen interaction; parasitology; Phospholipase A; Toxoplasma gondii	LECITHIN-CHOLESTEROL ACYLTRANSFERASE; PHOSPHOLIPASE A(2); PLASMA LECITHIN; HOST-CELLS; DIACYLGLYCEROL ACYLTRANSFERASE; HEADGROUP SPECIFICITY; GONDII; PROTEIN; LYSOPHOSPHATIDYLCHOLINE; CLONING	The protozoan parasite Toxoplasma gondii develops within a parasitophorous vacuole (PV) in mammalian cells, where it scavenges cholesterol. When cholesterol is present in excess in its environment, the parasite expulses this lipid into the PV or esterifies it for storage in lipid bodies. Here, we characterized a unique T. gondii homologue of mammalian lecithin:cholesterol acyltransferase (LCAT), a key enzyme that produces cholesteryl esters via transfer of acyl groups from phospholipids to the 3-OH of free cholesterol, leading to the removal of excess cholesterol from tissues. TgLCAT contains a motif characteristic of serine lipases AHSLG and the catalytic triad consisting of serine, aspartate, and histidine (SDH) from LCAT enzymes. TgLCAT is secreted by the parasite, but unlike other LCAT enzymes it is cleaved into two proteolytic fragments that share the residues of the catalytic triad and need to be reassembled to reconstitute enzymatic activity. TgLCAT uses phosphatidylcholine as substrate to form lysophosphatidylcholine that has the potential to disrupt membranes. The released fatty acid is transferred to cholesterol, but with a lower transesterification activity than mammalian LCAT. TgLCAT is stored in a subpopulation of dense granule secretory organelles, and following secretion, it localizes to the PV and parasite plasma membrane. LCAT-null parasites have impaired growth in vitro, reduced virulence in animals, and exhibit delays in egress from host cells. Parasites overexpressing LCAT show increased virulence and faster egress. These observations demonstrate that TgLCAT influences the outcome of an infection, presumably by facilitating replication and egress depending on the developmental stage of the parasite.	[Pszenny, Viviana; Ehrenman, Karen; Romano, Julia D.; Coppens, Isabelle] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Pszenny, Viviana; Kennard, Andrea; Grigg, Michael E.] NIAID, Mol Parasitol Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Schultz, Aric; Carruthers, Vern B.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Roos, David S.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Michigan System; University of Michigan; University of Pennsylvania	Coppens, I (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA.	icoppens@jhsph.edu		Romano, Julia/0000-0001-8956-7377; Roos, David Siker/0000-0001-6725-4089; Kennard, Andrea/0000-0001-9419-3680	National Institutes of Health from NIAID [AI060767]; NIAID [AI001018]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI001018, ZIAAI001017, R01AI060767, R01AI046675] Funding Source: NIH RePORTER	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant AI060767 from NIAID (to I. C.) and in part by the Intramural Research Program Grant AI001018 from NIAID (to M. E. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arisue N, 2015, PARASITOL INT, V64, P254, DOI 10.1016/j.parint.2014.10.005; ARON L, 1978, J BIOL CHEM, V253, P7220; Bhanot P, 2005, J BIOL CHEM, V280, P6752, DOI 10.1074/jbc.M411465200; BIERBAUM TJ, 1979, BIOCHIM BIOPHYS ACTA, V555, P102, DOI 10.1016/0005-2736(79)90075-0; Blackman MJ, 2013, CURR OPIN MICROBIOL, V16, P459, DOI 10.1016/j.mib.2013.04.008; Bougdour A, 2014, CELL MICROBIOL, V16, P334, DOI 10.1111/cmi.12255; Burda PC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004760; Caffaro CE, 2011, EUKARYOT CELL, V10, P1095, DOI 10.1128/EC.00002-11; Carruthers VB, 2007, CURR OPIN MICROBIOL, V10, P82; CHAWLA D, 1995, BIOCHEM J, V309, P249, DOI 10.1042/bj3090249; Christiaens B, 2000, BBA-MOL CELL BIOL L, V1486, P321, DOI 10.1016/S1388-1981(00)00075-5; Coppens I, 2006, CELL, V125, P261, DOI 10.1016/j.cell.2006.01.056; Coppens I, 2003, MOL BIOL CELL, V14, P3804, DOI 10.1091/mbc.E02-12-0830; Coppens I, 2000, J CELL BIOL, V149, P167, DOI 10.1083/jcb.149.1.167; Coppens I, 2013, NAT REV MICROBIOL, V11, P823, DOI 10.1038/nrmicro3139; Corbin JD, 2002, INT J CLIN PRACT, V56, P453; Dahlqvist A, 2000, P NATL ACAD SCI USA, V97, P6487, DOI 10.1073/pnas.120067297; deMelo EJT, 1996, CELL STRUCT FUNCT, V21, P47, DOI 10.1247/csf.21.47; Donald RGK, 1996, J BIOL CHEM, V271, P14010, DOI 10.1074/jbc.271.24.14010; Ehrenman K, 2010, MOL MICROBIOL, V76, P1232, DOI 10.1111/j.1365-2958.2010.07169.x; Fisher AB, 2001, AM J PHYSIOL-LUNG C, V280, pL748, DOI 10.1152/ajplung.2001.280.4.L748; FRANCONE OL, 1991, P NATL ACAD SCI USA, V88, P1716, DOI 10.1073/pnas.88.5.1716; GLOMSET JA, 1968, J LIPID RES, V9, P155; Glukhova A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7250; Grzelczyk A, 2013, BIOCHIMIE, V95, P667, DOI 10.1016/j.biochi.2012.10.009; Guerardel Y, 2005, MICROBES INFECT, V7, P41, DOI 10.1016/j.micinf.2004.09.007; Gupta N, 2012, J BIOL CHEM, V287, P22938, DOI 10.1074/jbc.M112.373639; Heffernan BJ, 2006, INFECT IMMUN, V74, P3756, DOI 10.1128/IAI.00307-06; Hiraoka M, 2002, J BIOL CHEM, V277, P10090, DOI 10.1074/jbc.M111977200; Huynh MH, 2003, EMBO J, V22, P2082, DOI 10.1093/emboj/cdg217; Istivan TS, 2006, MICROBIOL-SGM, V152, P1263, DOI 10.1099/mic.0.28609-0; Kabarowski JHS, 2002, BIOCHEM PHARMACOL, V64, P161, DOI 10.1016/S0006-2952(02)01179-6; Kafsack BFC, 2004, MOL BIOCHEM PARASIT, V136, P309, DOI 10.1016/j.molbiopara.2004.04.004; Kafsack BFC, 2009, SCIENCE, V323, P530, DOI 10.1126/science.1165740; Lambeau G, 2008, ANNU REV BIOCHEM, V77, P495, DOI 10.1146/annurev.biochem.76.062405.154007; Lige B, 2013, MOL MICROBIOL, V87, P951, DOI 10.1111/mmi.12142; Lourido S, 2012, EMBO J, V31, P4524, DOI 10.1038/emboj.2012.299; LUFT BJ, 1992, CLIN INFECT DIS, V15, P211, DOI 10.1093/clinids/15.2.211; MARTIN GP, 1992, J PHARM PHARMACOL, V44, P646, DOI 10.1111/j.2042-7158.1992.tb05486.x; MARTIN I, 1993, FEBS LETT, V333, P325, DOI 10.1016/0014-5793(93)80680-S; Mercier C, 2002, MOL BIOL CELL, V13, P2397, DOI 10.1091/mbc.E02-01-0021; Mercier C, 2015, TRENDS PARASITOL, V31, P60, DOI 10.1016/j.pt.2014.12.002; Murakami M, 2011, J BIOCHEM, V150, P233, DOI 10.1093/jb/mvr088; Nishi M, 2008, J CELL SCI, V121, P1559, DOI 10.1242/jcs.021089; Nishikawa Y, 2005, CELL MICROBIOL, V7, P849, DOI 10.1111/j.1462-5822.2005.00518.x; Nissapatorn V, 2004, JPN J INFECT DIS, V57, P160; Oelkers P, 2000, J BIOL CHEM, V275, P15609, DOI 10.1074/jbc.C000144200; Okada T, 2013, MOL BIOCHEM PARASIT, V189, P5, DOI 10.1016/j.molbiopara.2013.04.005; Peelman F, 1998, PROTEIN SCI, V7, P587, DOI 10.1002/pro.5560070307; POWNALL HJ, 1985, J BIOL CHEM, V260, P2146; Ramakrishnan S, 2013, PROG LIPID RES, V52, P488, DOI 10.1016/j.plipres.2013.06.003; Roiko MS, 2013, J BIOL CHEM, V288, P8712, DOI 10.1074/jbc.M113.450932; Romano JD, 2013, MOL BIOL CELL, V24, P1974, DOI 10.1091/mbc.E12-11-0827; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Rousset X, 2009, CURR OPIN ENDOCRINOL, V16, P163, DOI 10.1097/MED.0b013e328329233b; Saeedi R, 2015, CLIN BIOCHEM, V48, P472, DOI 10.1016/j.clinbiochem.2014.08.014; Safeukui I, 2012, BLOOD, V120, P424, DOI 10.1182/blood-2012-01-404103; Schaefer EJ, 2014, CURR OPIN LIPIDOL, V25, P194, DOI 10.1097/MOL.0000000000000074; Seabra SH, 2004, BIOCHEM BIOPH RES CO, V324, P744, DOI 10.1016/j.bbrc.2004.09.114; SILVERMAN BA, 1984, J IMMUNOL, V132, P386; Sitkiewicz I, 2007, TRENDS MICROBIOL, V15, P63, DOI 10.1016/j.tim.2006.12.003; SMITH GA, 1995, INFECT IMMUN, V63, P4231, DOI 10.1128/IAI.63.11.4231-4237.1995; Soldati D, 1995, MOL BIOCHEM PARASIT, V74, P87, DOI 10.1016/0166-6851(95)02487-5; SORCITHOMAS M, 1993, J BIOL CHEM, V268, P21403; Stahl U, 2004, PLANT PHYSIOL, V135, P1324, DOI 10.1104/pp.104.044354; Striepen B, 2013, TOXOPLASMA GONDII MO, P408; dos Santos TAT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027867; Walzer KA, 2013, P NATL ACAD SCI USA, V110, P7446, DOI 10.1073/pnas.1304322110; Wang JC, 1997, J BIOL CHEM, V272, P280; Welti R, 2007, BIOCHEMISTRY-US, V46, P13882, DOI 10.1021/bi7011993; WELTZIEN HU, 1979, BIOCHIM BIOPHYS ACTA, V559, P259, DOI 10.1016/0304-4157(79)90004-2; Yeoh LM, 2015, NUCLEIC ACIDS RES, V43, P4661, DOI 10.1093/nar/gkv311	73	30	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					3725	3746		10.1074/jbc.M115.671974	http://dx.doi.org/10.1074/jbc.M115.671974			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26694607	Green Published, hybrid			2022-12-26	WOS:000371338400004
J	Cao, WL; Li, LN; Tran, B; Kajiura, S; Amoh, Y; Liu, F; Hoffman, RM				Cao, Wenluo; Li, Lingna; Tran, Benjamin; Kajiura, Satoshi; Amoh, Yasuyuki; Liu, Fang; Hoffman, Robert M.			Extensive Hair Shaft Growth after Mouse Whisker Follicle Isolation, Cryopreservation and Transplantation in Nude Mice	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; PERIPHERAL-NERVE INJURY; DERMAL PAPILLA; PROMOTE REGENERATION; PROGENITOR CELLS; HFPS CELLS; REPAIR; RECOVERY; SHEATH	We previously demonstrated that whole hair follicles could be cryopreserved to maintain their stem-cells differentation potential. In the present study, we demonstrated that cryopreserved mouse whisker hair follicles maintain their hair growth potential. DMSO better cryopreserved mouse whisker follicles compared to glycerol. Cryopreserved hair follicles also maintained the hair follicle-associated-pluripotent (HAP) stem cells, evidenced by p75(NTR) expression. Subcutaneous transplantation of DMSO-cryopreserved hair follicles in nude mice resulted in extensive hair fiber growth over 8 weeks, indicating the functional recovery of hair shaft growth of cryopreserved hair follicles.	[Cao, Wenluo; Li, Lingna; Tran, Benjamin; Kajiura, Satoshi; Hoffman, Robert M.] AntiCancer Inc, San Diego, CA 92111 USA; [Cao, Wenluo; Kajiura, Satoshi; Hoffman, Robert M.] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Cao, Wenluo; Liu, Fang] Second Mil Med Univ, Dept Anat, Shanghai 200433, Peoples R China; [Kajiura, Satoshi; Amoh, Yasuyuki] Kitasato Univ, Dept Dermatol, Sagamihara 2288555, Japan	Anti Cancer Inc; University of California System; University of California San Diego; Naval Medical University; Kitasato University	Amoh, Y (corresponding author), Kitasato Univ, Dept Dermatol, Sagamihara 2288555, Japan.	yasuyukiamoh@yahoo.co.jp; liu_fang403@163.com; all@anticancer.com			National Institute of Neurological Disorders and Stroke [NS086217]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R43NS086217] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the National Institute of Neurological Disorders and Stroke grant NS086217. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Lingna Li is an employee of AntiCancer Inc. Wenluo Cao, Satoshi Kajiura and Robert M. Hoffman are unpaid affiliates of AntiCancer Inc. Benjamin Tran, Yasuyuki Amoh and Fang Liu were former unpaid affiliates of AntiCancer Inc. Robert M. Hoffman is a PLOS ONE Editorial Board Member. Anti Cancer Inc. markets animal models of cancer. There are no other competing interests. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials. This does not alter the authors' adherence to PLOS ONE Editorial policies and criteria.	Amoh Y, 2005, P NATL ACAD SCI USA, V102, P5530, DOI 10.1073/pnas.0501263102; Amoh Y, 2005, P NATL ACAD SCI USA, V102, P17734, DOI 10.1073/pnas.0508440102; Amoh Y, 2008, CELL CYCLE, V7, P1865, DOI 10.4161/cc.7.12.6056; Amoh Y, 2012, J DERMATOL, V39, P33, DOI 10.1111/j.1346-8138.2011.01413.x; Amoh Y, 2010, J CELL BIOCHEM, V110, P272, DOI 10.1002/jcb.22534; Amoh Y, 2009, J CELL BIOCHEM, V107, P1016, DOI 10.1002/jcb.22204; Duong J, 2012, IN VITRO CELL DEV-AN, V48, P301, DOI 10.1007/s11626-012-9514-z; Hiroshima Y, 2014, J SURG RES, V187, P510, DOI 10.1016/j.jss.2013.11.1083; Hoffman RM, 2014, CELLS TISSUES ORGANS, V200, P42, DOI 10.1159/000366098; JAHODA CAB, 1984, NATURE, V311, P560, DOI 10.1038/311560a0; Kajiura S, 2015, TISSUE ENG PART C-ME, V21, P825, DOI [10.1089/ten.tec.2014.0500, 10.1089/ten.TEC.2014.0500]; Li LN, 2003, P NATL ACAD SCI USA, V100, P9958, DOI 10.1073/pnas.1733025100; Liu F, 2011, CELL CYCLE, V10, P830, DOI 10.4161/cc.10.5.14969; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Mii S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067153; Mii S, 2013, J CELL BIOCHEM, V114, P1674, DOI 10.1002/jcb.24509; Rahmani W, 2014, DEV CELL, V31, P543, DOI 10.1016/j.devcel.2014.10.022; Yashiro M, 2015, CELL CYCLE, V14, P2362, DOI 10.1080/15384101.2015.1042633	18	4	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145997	10.1371/journal.pone.0145997	http://dx.doi.org/10.1371/journal.pone.0145997			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716690	Green Published, Green Submitted, gold			2022-12-26	WOS:000367510500112
J	Chung, BH; Kim, KW; Kim, BM; Doh, KC; Cho, ML; Yang, CW				Chung, Byung Ha; Kim, Kyoung Woon; Kim, Bo-Mi; Doh, Kyoung Chan; Cho, Mi-La; Yang, Chul Woo			Increase of Th17 Cell Phenotype in Kidney Transplant Recipients with Chronic Allograft Dysfunction	PLOS ONE			English	Article							REGULATORY T-CELLS; RENAL EPITHELIAL-CELLS; PREDICTIVE PARAMETER; GRAFT FUNCTION; REJECTION; INTERLEUKIN-17; LYMPHOCYTES; EXPRESSION; MEMORY; T(H)17	This study was performed to determine the association of Th17 cell phenotype with chronic allograft dysfunction in kidney transplant recipients (KTRs). We compared the expression of Th17 cell phenotype in KTRs with chronic allograft dysfunction group (CAD, n = 52) with four control groups (long-term stable KTRs (LTS, n = 67), early stable KTRs (ES, n = 28), end stage renal disease (ESRD, n = 45), and healthy control (HC, n = 26). We also performed in vitro study using human proximal renal tubular epithelial cell line (HPRTEpiC) to evaluate the effect of IL-17 on human renal tubular epithelial cells. The CAD group showed increased percentage of Th17 cells out of CD4(+)T cells and also increased proportion of IL-17 producing cells out of effector memory T cells or out of CCR4+ CCR6(+)/CD4(+)T cells compared to the LTS group and other control groups. Also, the serum level of IL-17, IL-33, and RAGE, and the expression of IL-1beta, RAGE, and HMGB1 mRNA showed an increase in the CAD group compared to the LTS group. In vitro study revealed that IL-17 increased production of IL-6 and IL-8 and up-regulated profibrotic gene expression such as ACTA-2 and CTGF in HPRTEpiC in a dose-dependent manner, which suggests that IL-17 has a role in the development of renal tubular cell injury. The results of our study may suggest that increase of Th17 cell phenotype could be a marker for the chronic allograft injury; hence there is a need to develop diagnostic and therapeutic tools targeting the Th17 cells pathway.	[Chung, Byung Ha; Kim, Kyoung Woon; Kim, Bo-Mi; Doh, Kyoung Chan; Cho, Mi-La; Yang, Chul Woo] Catholic Univ Korea Seoul, Coll Med, St Marys Hosp, Convergent Res Consortium Immunol Dis, Seoul, South Korea; [Chung, Byung Ha; Kim, Kyoung Woon; Kim, Bo-Mi; Doh, Kyoung Chan; Yang, Chul Woo] Catholic Univ Korea Seoul, Coll Med, St Marys Hosp, Transplant Res Ctr, Seoul, South Korea; [Chung, Byung Ha; Yang, Chul Woo] Catholic Univ Korea Seoul, Coll Med, Seoul St Marys Hosp, Div Nephrol,Dept Internal Med, Seoul, South Korea	Catholic University of Korea; Catholic University Korea Hospital; Seoul St. Mary's Hospital; Catholic University of Korea; Catholic University Korea Hospital; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital	Yang, CW (corresponding author), Catholic Univ Korea Seoul, Coll Med, St Marys Hosp, Convergent Res Consortium Immunol Dis, Seoul, South Korea.	yangch@catholic.ac.kr			Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI13C1232]	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by a grant (HI13C1232) of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Alvarez-Lara MA, 2004, NEPHROL DIAL TRANSPL, V19, P3084, DOI 10.1093/ndt/gfh382; Andrew DP, 1998, J IMMUNOL, V161, P5027; Bererhi L, 2012, TRANSPL INT, V25, P545, DOI 10.1111/j.1432-2277.2012.01451.x; Bestard O, 2008, J AM SOC NEPHROL, V19, P1419, DOI 10.1681/ASN.2007050539; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Braudeau C, 2007, TRANSPL INT, V20, P845, DOI 10.1111/j.1432-2277.2007.00537.x; Bunnag S, 2008, AM J TRANSPLANT, V8, P1423, DOI 10.1111/j.1600-6143.2008.02268.x; Chung BH, 2011, IMMUNOL LETT; Chung BH, 2011, EXP MOL MED; Chung BH, 2012, IMMUNOLOGY, V136, P344, DOI 10.1111/j.1365-2567.2012.03588.x; Chung BH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042011; Coenen JJA, 2006, BLOOD, V107, P1018, DOI 10.1182/blood-2005-07-3032; Crispim JCO, 2009, TRANSPL P, V41, P1562, DOI 10.1016/j.transproceed.2009.01.092; Eastaff-Leung N, 2010, J CLIN IMMUNOL, V30, P80, DOI 10.1007/s10875-009-9345-1; Eckardt KU, 2009, AM J TRANSPLANT, V9, pS1, DOI 10.1111/j.1600-6143.2009.02834.x; Emoto T, 2014, CIRC J, V78, P2935, DOI 10.1253/circj.CJ-14-0644; Gore-Hyer E, 2002, AM J PHYSIOL-RENAL, V283, pF707, DOI 10.1152/ajprenal.00007.2002; Gupta S, 2004, EXP GERONTOL, V39, P545, DOI 10.1016/j.exger.2003.08.013; Hsieh HG, 2001, TRANSPL INT, V14, P287; Jagger A, 2014, GERONTOLOGY, V60, P130, DOI 10.1159/000355303; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Lee YK, 2009, CURR OPIN IMMUNOL, V21, P274, DOI 10.1016/j.coi.2009.05.021; Li Y, 2011, INT IMMUNOPHARMACOL, V11, P2033, DOI 10.1016/j.intimp.2011.08.015; Lohr J, 2006, J EXP MED, V203, P2785, DOI 10.1084/jem.20061341; Loong CC, 2000, TRANSPL P, V32, P1773, DOI 10.1016/S0041-1345(00)01382-8; Louis S, 2006, TRANSPLANTATION, V81, P398, DOI 10.1097/01.tp.0000203166.44968.86; Maluf DG, 2014, AM J TRANSPLANT, V14, P1152, DOI 10.1111/ajt.12696; Mitchell P, 2009, CURR OPIN ORGAN TRAN, V14, P326, DOI 10.1097/MOT.0b013e32832ce88e; Muthukumar T, 2005, NEW ENGL J MED, V353, P2342, DOI 10.1056/NEJMoa051907; Nistala K, 2009, RHEUMATOLOGY, V48, P602, DOI 10.1093/rheumatology/kep028; Ochs HD, 2009, J ALLERGY CLIN IMMUN, V123, P977, DOI 10.1016/j.jaci.2009.03.030; Paantjens AWM, 2011, CLIN EXP IMMUNOL, V166, P103, DOI 10.1111/j.1365-2249.2011.04450.x; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pearl JP, 2005, AM J TRANSPLANT, V5, P465, DOI 10.1111/j.1600-6143.2005.00759.x; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Segundo DS, 2008, TRANSPL P, V40, P2885, DOI 10.1016/j.transproceed.2008.09.043; Schiffrin EL, 2014, CLIN SCI, V126, P267, DOI 10.1042/CS20130407; Segundo DS, 2006, TRANSPLANTATION, V82, P550, DOI 10.1097/01.tp.0000229473.95202.50; Solez K, 2008, AM J TRANSPLANT, V8, P753, DOI 10.1111/j.1600-6143.2008.02159.x; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Taflin C, 2010, TRANSPLANTATION, V89, P194, DOI 10.1097/TP.0b013e3181c3ca11; Trzonkowski P, 2008, AM J TRANSPLANT, V8, P338, DOI 10.1111/j.1600-6143.2007.02078.x; Van Kooten C, 1998, J AM SOC NEPHROL, V9, P1526; Weaver CT, 2009, NAT REV IMMUNOL, V9, P883, DOI 10.1038/nri2660; Woltman AM, 2000, J AM SOC NEPHROL, V11, P2044, DOI 10.1681/ASN.V11112044; Yamazaki T, 2008, J IMMUNOL, V181, P8391, DOI 10.4049/jimmunol.181.12.8391	47	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145258	10.1371/journal.pone.0145258	http://dx.doi.org/10.1371/journal.pone.0145258			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717145	Green Published, gold, Green Submitted			2022-12-26	WOS:000367510500027
J	Alcantara, BK; Machemer-Noonan, K; Silva, FG; Azevedo, RA				Alcantara, Berenice Kussumoto; Machemer-Noonan, Katja; Silva Junior, Francides Gomes; Azevedo, Ricardo Antunes			Dry Priming of Maize Seeds Reduces Aluminum Stress	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; L-ASCORBIC-ACID; TRANSCRIPTION FACTORS; SUPEROXIDE-DISMUTASE; ANTIOXIDANT RESPONSES; PHOSPHORUS EFFICIENCY; ARABIDOPSIS-THALIANA; PEROXIDASE-ACTIVITY; SULFUR EFFICIENCY; SENSITIVE METHOD	Aluminum (Al) toxicity is directly related to acidic soils and substantially limits maize yield. Earlier studies using hormones and other substances to treat the seeds of various crops have been carried out with the aim of inducing tolerance to abiotic stress, especially chilling, drought and salinity. However, more studies regarding the effects of seed treatments on the induction of Al tolerance are necessary. In this study, two independent experiments were performed to determine the effect of ascorbic acid (AsA) seed treatment on the tolerance response of maize to acidic soil and Al stress. In the first experiment (greenhouse), the AsA seed treatment was tested in B73 (Al-sensitive genotype). This study demonstrates the potential of AsA for use as a pre-sowing seed treatment (seed priming) because this metabolite increased root and shoot growth under acidic and Al stress conditions. In the second test, the evidence from field experiments using an Al-sensitive genotype (Mo17) and an Altolerant genotype (DA) suggested that prior AsA seed treatment increased the growth of both genotypes. Enhanced productivity was observed for DA under Al stress after priming the seeds. Furthermore, the AsA treatment decreased the activity of oxidative stress-related enzymes in the DA genotype. In this study, remarkable effects using AsA seed treatment in maize were observed, demonstrating the potential future use of AsA in seed priming.	[Alcantara, Berenice Kussumoto; Azevedo, Ricardo Antunes] Univ Sao Paulo, Dept Genet, Escola Super Agr Luiz de Queiroz, Sao Paulo, Brazil; [Machemer-Noonan, Katja] Ohio State Univ, Ctr Appl Plant Sci, Columbus, OH 43210 USA; [Silva Junior, Francides Gomes] Univ Sao Paulo, Dept Ciencias Florestais, Escola Super Agr Luiz de Queiroz, Sao Paulo, Brazil	Universidade de Sao Paulo; University System of Ohio; Ohio State University; Universidade de Sao Paulo	Azevedo, RA (corresponding author), Univ Sao Paulo, Dept Genet, Escola Super Agr Luiz de Queiroz, Sao Paulo, Brazil.	raa@usp.br	JUNIOR, FRANCIDES G SILVA/F-1946-2013; de Alcântara da Silva, Berenice Kussumoto/AAT-1857-2020; Azevedo, Ricardo Antunes/F-8863-2011	JUNIOR, FRANCIDES G SILVA/0000-0002-9142-7442; de Alcântara da Silva, Berenice Kussumoto/0000-0002-5758-7530; Azevedo, Ricardo Antunes/0000-0001-7316-125X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Brazil) [2009/54676-0, 2010/50497-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); FAPESP; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; FULBRIGHT Institution (CAPES-FULBRIGHT) [15112171]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FULBRIGHT Institution (CAPES-FULBRIGHT)	This work was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Brazil, Grants 2009/54676-0 and 2010/50497-0). We thank Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (RAA) (http://www.cnpq.br/) and FAPESP (BKA) (http://www.fapesp.br/) for the fellowship and scholarships granted, respectively. BKA also thanks the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior and FULBRIGHT Institution (CAPES-FULBRIGHT) (http://www.capes.gov.br/cooperacao-internacional/estados-unidos/capescomissao-fulbright) for financial support during Sandwich Program in United States of America (Grant. 15112171).	ACEVEDO A, 1991, DEV GENET, V12, P423, DOI 10.1002/dvg.1020120607; Ahmad A, 2005, PLANT SCI, V169, P842, DOI 10.1016/j.plantsci.2005.05.036; Alexieva V, 2001, PLANT CELL ENVIRON, V24, P1337, DOI 10.1046/j.1365-3040.2001.00778.x; ARAKAWA N, 1981, AGR BIOL CHEM TOKYO, V45, P1289, DOI 10.1080/00021369.1981.10864697; Arrigoni O, 2002, BBA-GEN SUBJECTS, V1569, P1, DOI 10.1016/S0304-4165(01)00235-5; Ashraf M, 2005, ADV AGRON, V88, P223, DOI 10.1016/S0065-2113(05)88006-X; Ashraf M, 2001, ACTA PHYSIOL PLANT, V23, P407, DOI 10.1007/s11738-001-0050-9; Azevedo RA, 1998, PHYSIOL PLANTARUM, V104, P280, DOI 10.1034/j.1399-3054.1998.1040217.x; Balint T, 2009, CROP PASTURE SCI, V60, P262, DOI 10.1071/CP08224; Barinaga M, 1997, SCIENCE, V276, P1497, DOI 10.1126/science.276.5318.1497; Barth C, 2006, J EXP BOT, V57, P1657, DOI 10.1093/jxb/erj198; BASU U, 1994, PLANT PHYSIOL, V106, P151, DOI 10.1104/pp.106.1.151; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Boscolo PRS, 2003, PHYTOCHEMISTRY, V62, P181, DOI 10.1016/S0031-9422(02)00491-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Branduardi P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001092; Braun EL, 1999, PLANT PHYSIOL, V121, P21, DOI 10.1104/pp.121.1.21; CAKMAK I, 1991, PHYSIOL PLANTARUM, V83, P463, DOI 10.1111/j.1399-3054.1991.tb00121.x; Carvalho RF, 2011, SCI AGR, V68, P598, DOI 10.1590/S0103-90162011000500014; Cassiolato ME, 2000, BRAZ ARCH BIOL TECHN, V43, P533, DOI 10.1590/S1516-89132000000500014; Cia MC, 2012, ANN APPL BIOL, V161, P313, DOI 10.1111/j.1744-7348.2012.00575.x; Conrath U, 2006, MOL PLANT MICROBE IN, V19, P1062, DOI 10.1094/MPMI-19-1062; Corrales I, 2007, J PLANT NUTR, V30, P887, DOI 10.1080/15226510701375085; Cosio C, 2009, J EXP BOT, V60, P391, DOI 10.1093/jxb/ern318; Davey MW, 2000, J SCI FOOD AGR, V80, P825, DOI [10.1002/(SICI)1097-0010(20000515)80:7<825::AID-JSFA598>3.0.CO;2-6, 10.1002/(SICI)1097-0010(20000515)80:7&lt;825::AID-JSFA598&gt;3.0.CO;2-6]; de Alcantara BK, 2015, AN ACAD BRAS CIENC, V87, P1063, DOI 10.1590/0001-3765201520140322; Degenhardt J, 1998, PLANT PHYSIOL, V117, P19, DOI 10.1104/pp.117.1.19; Dourado MN, 2013, ANN APPL BIOL, V163, P494, DOI 10.1111/aab.12066; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Erdal S, 2012, PLANT PHYSIOL BIOCH, V57, P1, DOI 10.1016/j.plaphy.2012.04.016; Ezaki B, 2005, J EXP BOT, V56, P2661, DOI 10.1093/jxb/eri259; Farooq M, 2008, J AGRON CROP SCI, V194, P438, DOI 10.1111/j.1439-037X.2008.00334.x; Farooq M, 2013, J AGRON CROP SCI, V199, P12, DOI 10.1111/j.1439-037X.2012.00521.x; Feller A, 2011, PLANT J, V66, P94, DOI 10.1111/j.1365-313X.2010.04459.x; Fornale S, 2006, PLANT MOL BIOL, V62, P809, DOI 10.1007/s11103-006-9058-2; Fornale S, 2010, PLANT J, V64, P633, DOI 10.1111/j.1365-313X.2010.04363.x; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; GRANADOS G, 1995, CROP SCI, V35, P1236, DOI 10.2135/cropsci1995.0011183X003500040099x; Gratao PL, 2008, ANN APPL BIOL, V153, P321, DOI 10.1111/j.1744-7348.2008.00299.x; Gratao PL, 2005, FUNCT PLANT BIOL, V32, P481, DOI 10.1071/FP05016; Gratao PL, 2015, BIOMETALS, V28, P803, DOI 10.1007/s10534-015-9867-3; Hiraga S, 2001, PLANT CELL PHYSIOL, V42, P462, DOI 10.1093/pcp/pce061; Horemans N, 2000, PLANT PHYSIOL BIOCH, V38, P531, DOI 10.1016/S0981-9428(00)00782-8; Kochian Leon V., 2009, P367, DOI 10.1007/978-0-387-79418-1_18; Kochian LV, 2004, ANNU REV PLANT BIOL, V55, P459, DOI 10.1146/annurev.arplant.55.031903.141655; Krill AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009958; Kubala S, 2015, PLANT SCI, V231, P94, DOI 10.1016/j.plantsci.2014.11.008; Kumari M, 2008, MOL GENET GENOMICS, V279, P339, DOI 10.1007/s00438-007-0316-z; LAWRENCE GB, 1995, NATURE, V378, P162, DOI 10.1038/378162a0; Lidon FC, 1999, J PLANT NUTR, V22, P397, DOI 10.1080/01904169909365637; Lorence A, 2004, PLANT PHYSIOL, V134, P1200, DOI 10.1104/pp.103.033936; Ma JF, 2001, TRENDS PLANT SCI, V6, P273, DOI 10.1016/S1360-1385(01)01961-6; Ma JF, 2007, INT REV CYTOL, V264, P225, DOI 10.1016/S0074-7696(07)64005-4; Malavolta E., 1997, AVALIA O ESTADO NUTR, V2nd; MATHRE DE, 1995, PLANT DIS, V79, P1145, DOI 10.1094/PD-79-1145; McCue P, 2000, PROCESS BIOCHEM, V35, P603, DOI 10.1016/S0032-9592(99)00111-9; Medici LO, 2004, FUNCT PLANT BIOL, V31, P1, DOI 10.1071/FP03130; MITTLER R, 1993, ANAL BIOCHEM, V212, P540, DOI 10.1006/abio.1993.1366; Morohashi K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000396; Nault BA, 2006, CROP PROT, V25, P58, DOI 10.1016/j.cropro.2005.03.020; Nguyen NT, 2003, TREE PHYSIOL, V23, P1041, DOI 10.1093/treephys/23.15.1041; Nogueirol RC, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-015-4282-3; Nogueirol RC, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-015-4366-0; Obst J.R., 1988, METHOD ENZYMOL, V161, P87, DOI 10.1016/0076-6879(88)61014-7; Ogawa K, 1997, PLANT CELL PHYSIOL, V38, P1118, DOI 10.1093/oxfordjournals.pcp.a029096; Patade VY, 2012, MOL BIOL REP, V39, P10603, DOI 10.1007/s11033-012-1948-6; Pavet V, 2005, PLANT PHYSIOL, V139, P1291, DOI 10.1104/pp.105.067686; PELLET DM, 1995, PLANTA, V196, P788, DOI 10.1007/BF01106775; Pineros MA, 2002, PLANT PHYSIOL, V129, P1194, DOI 10.1104/pp.002295; Pineros MA, 2005, PLANT PHYSIOL, V137, P231, DOI 10.1104/pp.104.047357; PRASAD TK, 1995, PLANT PHYSIOL, V108, P1597, DOI 10.1104/pp.108.4.1597; Reddy SK, 2014, J PLANT PHYSIOL, V171, P1289, DOI 10.1016/j.jplph.2014.05.005; Scandalios JG, 2005, BRAZ J MED BIOL RES, V38, P995, DOI 10.1590/S0100-879X2005000700003; Shaul O, 2002, BIOMETALS, V15, P309, DOI 10.1023/A:1016091118585; Shenoy VV, 2005, BIOTECHNOL ADV, V23, P501, DOI 10.1016/j.biotechadv.2005.01.004; Sonbol FM, 2009, PLANT MOL BIOL, V70, P283, DOI 10.1007/s11103-009-9473-2; Tahara K, 2008, PLANT SOIL, V302, P175, DOI 10.1007/s11104-007-9464-5; Talaar NB, 2014, PLANT PHYSIOL BIOCH, V80, P136, DOI 10.1016/j.plaphy.2014.03.035; Taylor GJ, 1997, PLANT PHYSIOL, V114, P363, DOI 10.1104/pp.114.1.363; Traber MG, 2011, FREE RADICAL BIO MED, V51, P1000, DOI 10.1016/j.freeradbiomed.2011.05.017; Valadez-Gonzalez N, 2007, J PLANT GROWTH REGUL, V26, P69, DOI 10.1007/s00344-006-0039-0; Valpuesta V, 2004, TRENDS PLANT SCI, V9, P573, DOI 10.1016/j.tplants.2004.10.002; Wang JW, 2007, BIOL PLANTARUM, V51, P493, DOI 10.1007/s10535-007-0104-y; Wheeler GL, 1998, NATURE, V393, P365, DOI 10.1038/30728; Xue YJ, 2008, J AGR FOOD CHEM, V56, P9676, DOI 10.1021/jf802001v; Yachandra VK, 1996, CHEM REV, V96, P2927, DOI 10.1021/cr950052k; Yamada T, 2005, SOIL SCI PLANT NUTR, V51, P617, DOI 10.1111/j.1747-0765.2005.tb00076.x; Yi M., 2009, ENVIRON TOXICOL, V25, P124; Yin LN, 2010, PLANTA, V231, P609, DOI 10.1007/s00425-009-1075-3; Zamocky M, 2000, GENE, V256, P169, DOI 10.1016/S0378-1119(00)00358-9	90	19	19	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145742	10.1371/journal.pone.0145742	http://dx.doi.org/10.1371/journal.pone.0145742			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714286	Green Published, Green Submitted, gold			2022-12-26	WOS:000367481900075
J	Caballero, A; Gregori, J; Homs, M; Tabernero, D; Gonzalez, C; Quer, J; Blasi, M; Casillas, R; Nieto, L; Riveiro-Barciela, M; Esteban, R; Buti, M; Rodriguez-Frias, F				Caballero, Andrea; Gregori, Josep; Homs, Maria; Tabernero, David; Gonzalez, Carolina; Quer, Josep; Blasi, Maria; Casillas, Rosario; Nieto, Leonardo; Riveiro-Barciela, Mar; Esteban, Rafael; Buti, Maria; Rodriguez-Frias, Francisco			Complex Genotype Mixtures Analyzed by Deep Sequencing in Two Different Regions of Hepatitis B Virus	PLOS ONE			English	Article							INNO-LIPA HBV; MUTATIONS; INFECTION; IDENTIFICATION; RECOMBINANTS; RESISTANCE; EVOLUTION; GENESIS; ASSAY; LOAD	This study assesses the presence and outcome of genotype mixtures in the polymerase/surface and X/preCore regions of the HBV genome in patients with chronic hepatitis B virus (HBV) infection. Thirty samples from ten chronic hepatitis B patients were included. The polymerase/surface and X/preCore regions were analyzed by deep sequencing (UDPS) in the first available sample at diagnosis, a pre-treatment sample, and a sample while under treatment. HBV genotype was determined by phylogenesis. Quasispecies complexity was evaluated by mutation frequency and nucleotide diversity. The polymerase/surface and X/preCore regions were validated for genotyping from 113 GenBank reference sequences. UDPS yielded a median of 10,960 sequences per sample (IQR 16,645) in the polymerase/surface region and 11,595 sequences per sample (IQR 14,682) in X/preCore. Genotype mixtures were more common in X/preCore (90%) than in polymerase/surface (30%) (p<0.001). On X/preCore genotyping, all samples were genotype A, whereas polymerase/surface yielded genotypes A (80%), D (16.7%), and F (3.3%) (p = 0.036). Genotype changes in polymerase/surface were observed in four patients during natural quasispecies dynamics and in two patients during treatment. There were no genotype changes in X/preCore. Quasispecies complexity was higher in X/preCore than in polymerase/surface (p = 0.004). The results provide evidence of genotype mixtures and differential genotype proportions in the polymerase/surface and X/preCore regions. The genotype dynamics in HBV infection and the different patterns of quasispecies complexity in the HBV genome suggest a new paradigm for HBV genotype classification.	[Caballero, Andrea; Homs, Maria; Tabernero, David; Gonzalez, Carolina; Blasi, Maria; Nieto, Leonardo; Rodriguez-Frias, Francisco] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Dept Biochem, Liver Pathol Unit, E-08193 Barcelona, Spain; [Caballero, Andrea; Homs, Maria; Tabernero, David; Gonzalez, Carolina; Blasi, Maria; Nieto, Leonardo; Rodriguez-Frias, Francisco] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Dept Microbiol, Liver Pathol Unit, E-08193 Barcelona, Spain; [Gregori, Josep; Homs, Maria; Tabernero, David; Quer, Josep; Blasi, Maria; Riveiro-Barciela, Mar; Esteban, Rafael; Buti, Maria; Rodriguez-Frias, Francisco] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain; [Gregori, Josep; Quer, Josep; Casillas, Rosario] Vall dHebron Res Inst, Liver Dis Unit, Barcelona, Spain; [Gregori, Josep] Roche Diagnost SL, Sant Cugat Del Valles, Spain; [Riveiro-Barciela, Mar; Esteban, Rafael; Buti, Maria] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Liver Unit, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Roche Holding; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron	Rodriguez-Frias, F (corresponding author), Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Dept Biochem, Liver Pathol Unit, E-08193 Barcelona, Spain.	frarodri@vhebron.net	Gregori, Josep/J-2586-2015; Fernandez, Carolina González/Z-6166-2019; Tabernero, David/AAB-3848-2019; Quer, Josep/A-6741-2012; Rodriguez-Frias, Francisco/AAC-3507-2020	Gregori, Josep/0000-0002-4253-8015; Tabernero, David/0000-0002-1146-4084; Quer, Josep/0000-0003-0014-084X; Casillas, Rosario/0000-0002-6758-6734; rodriguez-frias, francisco/0000-0002-9128-7013; Nieto, Leonardo/0000-0002-1336-5645; CABALLERO, ANDREA/0000-0003-2891-6347; esteban, rafael/0000-0001-5280-392X; Buti Ferret, Maria/0000-0002-0732-3078; Gonzalez-Fernandez, Carolina/0000-0002-7458-0090; Gonzalez Fernandez, Carolina/0000-0002-0169-5874; Homs, Maria/0000-0002-8370-8375	Instituto de Salud Carlos III [PI12/01893]; European Regional Development Fund (ERDF); Roche Diagnostics	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Regional Development Fund (ERDF)(European Commission); Roche Diagnostics	Dr F Rodriguez-Frias received a fund from the Instituto de Salud Carlos III (grant PI12/01893) for supplies and reagents. The study was cofinanced by the European Regional Development Fund (ERDF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Roche Diagnostics provided support in the form of a salary for JG, but did not have any role in the study design or execution, data collection or analysis, decision to publish, or preparation of the manuscript. The specific roles of JG are described in the Author Contributions section.	Araujo NM, 2013, J GEN VIROL, V94, P150, DOI 10.1099/vir.0.047324-0; Bekondi C, 2007, J CLIN VIROL, V40, P31, DOI 10.1016/j.jcv.2007.05.009; Borg I, 2010, MODERN MULTIDIMENSIO; Bull RA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002243; Bunnik EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002106; Buti M, 2007, J HEPATOL, V47, P366, DOI 10.1016/j.jhep.2007.04.011; Cuadras C, 1991, MATH PREPRINT SERIES; Cuadras C, 1989, STAT DATA ANAL INFER, P459; Deterding K, 2008, J MED VIROL, V80, P1707, DOI 10.1002/jmv.21294; GEORGIGEISBERGER P, 1992, ONCOLOGY, V49, P386; Ghedin E, 2009, J VIROL, V83, P8832, DOI 10.1128/JVI.00773-09; Gregori J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083361; Hoffmann C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm435; Homs M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112306; Homs M, 2011, NUCLEIC ACIDS RES, V39, P8457, DOI 10.1093/nar/gkr451; Hsieh TH, 2009, ANTIVIR THER, V14, P1157, DOI 10.3851/IMP1454; Jardi R, 2008, J HEPATOL, V49, P695, DOI 10.1016/j.jhep.2008.03.030; Kao JH, 2001, HEPATOLOGY, V34, P817, DOI 10.1053/jhep.2001.28188; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kramvis A, 2005, J VIRAL HEPATITIS, V12, P456, DOI 10.1111/j.1365-2893.2005.00624.x; Kramvis A, 2014, INTERVIROLOGY, V57, P141, DOI 10.1159/000360947; Kumar S, 2000, J MOL EVOL, V51, P544, DOI 10.1007/s002390010118; Lin CL, 2011, J GASTROEN HEPATOL, V26, P123, DOI 10.1111/j.1440-1746.2010.06541.x; Marcellin P, 2009, J HEPATOL, V50, P227, DOI 10.1016/j.jhep.2008.10.001; Mese S, 2013, J GEN VIROL, V94, P2729, DOI 10.1099/vir.0.053041-0; Neumann AU, 2005, HEPATOLOGY, V42, P249, DOI 10.1002/hep.20831; OKAMOTO H, 1988, J GEN VIROL, V69, P2575, DOI 10.1099/0022-1317-69-10-2575; Osiowy C, 2003, J CLIN MICROBIOL, V41, P5473, DOI 10.1128/JCM.41.12.5473-5477.2003; Pages H, BIOCONDUCTOR BIOSTRI; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Ramirez C, 2013, ANTIVIR RES, V98, P273, DOI 10.1016/j.antiviral.2013.03.007; Rodriguez-Frias F, 2006, J VIRAL HEPATITIS, V13, P343, DOI 10.1111/j.1365-2893.2005.00691.x; Shi WF, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-116; Shi WF, 2012, VIROLOGY, V427, P51, DOI 10.1016/j.virol.2012.01.030; Simmonds P, 2005, J VIROL, V79, P15467, DOI 10.1128/JVI.79.24.15467-15476.2005; Solmone M, 2009, J VIROL, V83, P1718, DOI 10.1128/JVI.02011-08; World Health Organization, 2015, WHO HEP B; Yang J, 2006, J GEN VIROL, V87, P2203, DOI 10.1099/vir.0.81752-0; Zhang Q, 2011, HEPAT MON, V11, P86	39	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0144816	10.1371/journal.pone.0144816	http://dx.doi.org/10.1371/journal.pone.0144816			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714168	Green Submitted, Green Published, gold			2022-12-26	WOS:000367481900018
J	Chai, WM; Wang, R; Wei, MK; Zou, ZR; Deng, RG; Liu, WS; Peng, YY				Chai, Wei-Ming; Wang, Rui; Wei, Man-Kun; Zou, Zheng-Rong; Deng, Rong-Gen; Liu, Wei-Sheng; Peng, Yi-Yuan			Proanthocyanidins Extracted from Rhododendron pulchrum Leaves as Source of Tyrosinase Inhibitors: Structure, Activity, and Mechanism	PLOS ONE			English	Article							MUSHROOM TYROSINASE; CONDENSED TANNINS; MELANOGENESIS; ANTITYROSINASE	The objective of this study was to assess the structure, anti-tyrosinase activity, and mechanism of proanthocyanidins extracted from Rhododendron pulchrum leaves. Results obtained from mass spectra of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) and high performance liquid chromatography electrospray ionization mass spectrometry (HPLC-ESI-MS) revealed that proanthocyanidins were complex mixtures of procyanidins, prodelphinidins, propelargonidins, and their derivatives, among which procyanidins were the main components. The anti-tyrosinase analysis results indicated that the mixtures were reversible and mixed competitive inhibitors of tyrosinase. Interactions between proanthocyanidins with substrate (L-tyrosine and 3,4-dihydroxyphenylalanine) and with copper ions were the important molecular mechanisms for explaining their efficient inhibition. This research would provide scientific evidence for the use of R. pulchrum leaf proanthocyanidins as new novel tyrosinase inhibitors.	[Chai, Wei-Ming; Wang, Rui; Wei, Man-Kun; Zou, Zheng-Rong; Deng, Rong-Gen; Liu, Wei-Sheng; Peng, Yi-Yuan] Jiangxi Normal Univ, Minist Educ, Coll Life Sci, Nanchang 330022, Jiangxi, Peoples R China; [Chai, Wei-Ming; Wang, Rui; Wei, Man-Kun; Zou, Zheng-Rong; Deng, Rong-Gen; Liu, Wei-Sheng; Peng, Yi-Yuan] Jiangxi Normal Univ, Minist Educ, Key Lab Small Funct Organ Mol, Nanchang 330022, Jiangxi, Peoples R China; [Chai, Wei-Ming] Jiangxi Normal Univ, Key Lab Poyang Lake Wetland & Watershed Res, Nanchang 330022, Jiangxi, Peoples R China	Jiangxi Normal University; Jiangxi Normal University; Jiangxi Normal University	Chai, WM (corresponding author), Jiangxi Normal Univ, Minist Educ, Coll Life Sci, Nanchang 330022, Jiangxi, Peoples R China.	chaiweiming@jxnu.edu.cn; yiyuanpeng@jxnu.edu.cn			Natural Science Foundation of China [31501414, 21362014, 31260082]; Open Project Program of Key Laboratory of Functional Small Organic Molecule, Ministry of Education, Jiangxi Normal University [KLFSKF-201419]; Dr. Start-up fund projects, Jiangxi Normal University; Open Project Program of Key Laboratory of Functional Small Organic Molecule, Ministry of Education; Jiangxi Normal University [KLFSKF-201419]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Project Program of Key Laboratory of Functional Small Organic Molecule, Ministry of Education, Jiangxi Normal University; Dr. Start-up fund projects, Jiangxi Normal University; Open Project Program of Key Laboratory of Functional Small Organic Molecule, Ministry of Education; Jiangxi Normal University	The present investigation was supported by the Natural Science Foundation of China (No. 31501414, 21362014, 31260082), the Open Project Program of Key Laboratory of Functional Small Organic Molecule, Ministry of Education, Jiangxi Normal University (KLFSKF-201419). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The present investigation was supported by the Natural Science Foundation of China (No. 31501414, 21362014, 31260082), the Open Project Program of Key Laboratory of Functional Small Organic Molecule, Ministry of Education, and Jiangxi Normal University (KLFSKF-201419) and Dr. Start-up fund projects, Jiangxi Normal University.	Brozyna AA, 2008, INT J CANCER, V123, P1448, DOI 10.1002/ijc.23664; Brozyna AA, 2013, HUM PATHOL, V44, P2071, DOI 10.1016/j.humpath.2013.02.022; Chai WM, 2014, J AGR FOOD CHEM, V62, P6382, DOI 10.1021/jf501009v; Chai WM, 2014, J AGR FOOD CHEM, V62, P123, DOI 10.1021/jf405385j; Chai WM, 2012, J AGR FOOD CHEM, V60, P5013, DOI 10.1021/jf300740d; Chase MR, 2000, INSECT BIOCHEM MOLEC, V30, P953, DOI 10.1016/S0965-1748(00)00068-0; Chen XF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0091830, 10.1371/journal.pone.0085716, 10.1371/journal.pone.0115462, 10.1371/journal.pone.0103330, 10.1371/journal.pone.0091809, 10.1371/journal.pone.0087752]; Fu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096162; Gowda LR, 2002, J AGR FOOD CHEM, V50, P1608, DOI 10.1021/jf010913s; Gupta SD, 2013, CHIN J NAT MEDICINES, V11, P616, DOI 10.1016/S1875-5364(13)60071-0; Hummer W, 2008, MOL NUTR FOOD RES, V52, P1381, DOI 10.1002/mnfr.200700463; Khanbabaee K, 2001, NAT PROD REP, V18, P641, DOI 10.1039/b101061l; KORNER A, 1982, SCIENCE, V217, P1163, DOI 10.1126/science.6810464; Lv Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120480; MARTINEZ MV, 1995, TRENDS FOOD SCI TECH, V6, P195, DOI 10.1016/S0924-2244(00)89054-8; Pan ZZ, 2011, J AGR FOOD CHEM, V59, P6645, DOI 10.1021/jf200990g; Reed JD, 2005, PHYTOCHEMISTRY, V66, P2248, DOI 10.1016/j.phytochem.2005.05.015; Schallreuter KU, 2008, EXP DERMATOL, V17, P395, DOI 10.1111/j.1600-0625.2007.00675.x; Seo SY, 2003, J AGR FOOD CHEM, V51, P2837, DOI 10.1021/jf020826f; Slominski A, 1998, ANTICANCER RES, V18, P3709; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2012, PIGM CELL MELANOMA R, V25, P14, DOI 10.1111/j.1755-148X.2011.00898.x; Wu LC, 2003, J AGR FOOD CHEM, V51, P4240, DOI 10.1021/jf034064f; Xiang P, 2007, J APPL POLYM SCI, V105, P859, DOI 10.1002/app.26373; Yi W, 2010, EUR J MED CHEM, V45, P639, DOI 10.1016/j.ejmech.2009.11.007; Zhang Mei, 2012, Medicinal Plant, V3, P21; Zhou HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107606; Zhou HC, 2011, FOOD CHEM, V129, P1710, DOI 10.1016/j.foodchem.2011.06.036	28	16	17	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145483	10.1371/journal.pone.0145483	http://dx.doi.org/10.1371/journal.pone.0145483			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713623	gold, Green Published, Green Submitted			2022-12-26	WOS:000367481900046
J	Haines, JD; Fulton, DL; Richard, S; Almazan, G				Haines, Jeffery D.; Fulton, Debra L.; Richard, Stephane; Almazan, Guillermina			p38 Mitogen-Activated Protein Kinase Pathway Regulates Genes during Proliferation and Differentiation in Oligodendrocytes	PLOS ONE			English	Article							FYN TYROSINE KINASE; TRANSCRIPTION FACTOR; MYELINATION; CELLS; IDENTIFICATION; EXPRESSION; IDENTITY; DATABASE; NEURONS; GROWTH	We have previously shown that p38 mitogen-activated protein kinase (p38 MAPK) is important for oligodendrocyte (OLG) differentiation and myelination. However, the precise cellular mechanisms by which p38 regulates OLG differentiation remain largely unknown. To determine whether p38 functions in part through transcriptional events in regulating OLG identity, we performed microarray analysis on differentiating oligodendrocyte progenitors (OLPs) treated with a p38 inhibitor. Consistent with a role in OLG differentiation, pharmacological inhibition of p38 down-regulated the transcription of genes that are involved in myelin biogenesis, transcriptional control and cell cycle. Proliferation assays showed that OLPs treated with the p38 inhibitor retained a proliferative capacity which could be induced upon application of mitogens demonstrating that after two days of p38-inhibition OLGs remained poised to continue mitosis. Together, our results suggest that the p38 pathway regulates gene transcription which can coordinate OLG differentiation. Our microarray dataset will provide a useful resource for future studies investigating the molecular mechanisms by which p38 regulates oligodendrocyte differentiation and myelination.	[Haines, Jeffery D.; Almazan, Guillermina] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada; [Fulton, Debra L.; Almazan, Guillermina] McGill Univ, Dept Neurol & Neurosurg, Montreal Neurol Inst & Hosp, Montreal, PQ H3A 2B4, Canada; [Richard, Stephane] McGill Univ, Terry Fox Mol Oncol Grp, Bloomfield Ctr Res Aging, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Richard, Stephane] McGill Univ, Dept Oncol, Montreal, PQ H3T 1E2, Canada; [Richard, Stephane] McGill Univ, Dept Med, Montreal, PQ H3T 1E2, Canada	McGill University; McGill University; Lady Davis Institute; McGill University; McGill University; McGill University	Almazan, G (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, 3655 Sir William Osler Promenade, Montreal, PQ H3G 1Y6, Canada.	guillermina.almazan@mcgill.ca			Multiple Sclerosis Society of Canada (MSSC); Canadian Institutes of Health Research (CIHR); MSSC	Multiple Sclerosis Society of Canada (MSSC); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); MSSC	This work was supported by operating grants from the Multiple Sclerosis Society of Canada (MSSC) to SR and GA and Canadian Institutes of Health Research (CIHR) to GA. JDH held a studentship from the MSSC. DLF held a postdoctoral fellowship from MSSC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by two operating grants from the Multiple Sclerosis Society of Canada (MSSC) to SR and GA and one operating grant from the Canadian Institutes of Health Research (CIHR) to GA. JDH held a doctoral studentship from the MSSC. DLF held a postdoctoral fellowship from MSSC.	Abe I, 2007, BIOCHEM BIOPH RES CO, V352, P259, DOI 10.1016/j.bbrc.2006.11.014; Almazan G, 2001, MICROSC RES TECHNIQ, V52, P753, DOI 10.1002/jemt.1060; Ambrosino C, 2003, MOL CELL BIOL, V23, P370, DOI 10.1128/MCB.23.1.370-381.2003; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ayllon V, 2007, ONCOGENE, V26, P3451, DOI 10.1038/sj.onc.1210142; Baroti T, 2016, GLIA, V64, P122, DOI 10.1002/glia.22919; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Billon N, 2002, EMBO J, V21, P6452, DOI 10.1093/emboj/cdf662; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cai J, 2010, GLIA, V58, P458, DOI 10.1002/glia.20937; Casaccia-Bonnefil P, 1999, DEVELOPMENT, V126, P4027; Chew LJ, 2010, J NEUROSCI, V30, P11011, DOI 10.1523/JNEUROSCI.2546-10.2010; Chung SH, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.119; Dougherty JD, 2005, J NEUROSCI, V25, P10773, DOI 10.1523/JNEUROSCI.3207-05.2005; Engel FB, 2005, GENE DEV, V19, P1175, DOI 10.1101/gad.1306705; Engel FB, 2006, J MOL CELL CARDIOL, V41, P601, DOI 10.1016/j.yjmcc.2006.06.012; Ferreiro I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-144; Fragoso G, 2007, GLIA, V55, P1531, DOI 10.1002/glia.20567; Haines JD, 2008, J MOL NEUROSCI, V35, P23, DOI 10.1007/s12031-007-9011-0; Haines JD, 2010, GLIA, V58, P1384, DOI 10.1002/glia.21014; Hammond E, 2015, J NEUROSCI, V35, P5007, DOI 10.1523/JNEUROSCI.4787-14.2015; HOLZMAN LB, 1994, J BIOL CHEM, V269, P30808; Lavoie J N, 1996, Prog Cell Cycle Res, V2, P49; Li HL, 2009, CURR OPIN NEUROBIOL, V19, P479, DOI 10.1016/j.conb.2009.08.004; Liu H, 2009, GLIA, V57, P1, DOI 10.1002/glia.20729; Liu RG, 2003, DEVELOPMENT, V130, P6221, DOI 10.1242/dev.00868; Miki H, 2001, P NATL ACAD SCI USA, V98, P7004, DOI 10.1073/pnas.111145398; Nakata K, 2005, CELL, V120, P407, DOI 10.1016/j.cell.2004.12.017; Saher G, 2005, NAT NEUROSCI, V8, P468, DOI 10.1038/nn1426; Samanta J, 2004, DEVELOPMENT, V131, P4131, DOI 10.1242/dev.01273; Stolt CC, 2006, DEV CELL, V11, P697, DOI 10.1016/j.devcel.2006.08.011; Tenhunen O, 2006, CIRC RES, V99, P485, DOI 10.1161/01.RES.0000238387.85144.92; Thornton TM, 2009, INT J BIOL SCI, V5, P44, DOI 10.7150/ijbs.5.44; UMEMORI H, 1994, NATURE, V367, P572, DOI 10.1038/367572a0; Umemori H, 1999, J NEUROSCI, V19, P1393; Wang SZ, 2006, DEVELOPMENT, V133, P3389, DOI 10.1242/dev.02522; Wegner M, 2008, J MOL NEUROSCI, V35, P3, DOI 10.1007/s12031-007-9008-8; White R, 2008, J CELL BIOL, V181, P579, DOI 10.1083/jcb.200706164; Yu Y, 2010, EPIGENETICS-US, V5, P124, DOI 10.4161/epi.5.2.11160; Zezula J, 2001, EMBO REP, V2, P27, DOI 10.1093/embo-reports/kve008; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]	41	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145843	10.1371/journal.pone.0145843	http://dx.doi.org/10.1371/journal.pone.0145843			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714323	Green Published, Green Submitted, gold			2022-12-26	WOS:000367481900092
J	Laceulle, OM; Kleber, RJ; Alisic, E				Laceulle, Odilia M.; Kleber, Rolf J.; Alisic, Eva			Children's Experience of Posttraumatic Growth: Distinguishing General from Domain-Specific Correlates	PLOS ONE			English	Article							QUALITY-OF-LIFE; GENDER-DIFFERENCES; ADOLESCENTS; BENEFIT; INVENTORY; SURVIVORS; CANCER	Although the five domains of posttraumatic growth (new possibilities, relating to others, personal strength, spiritual change and appreciation of life) have been studied extensively in adults, little is known about these domains and their correlates in children. We aimed to examine whether demographic and/or social characteristics are related to children's reports of overall posttraumatic growth and of growth in specific domains. In a general population study, children aged 8-12 years who had been exposed to adverse events (N = 1290) filled out questionnaires on their experiences, demographic characteristics (gender, age, time lag since event), stress reactions, peer support, religiosity and posttraumatic growth. All demographic and social characteristics were related to overall posttraumatic growth, except time lag. Associations varied across the five domains with the strongest effects being found for stress reactions and religiosity. A higher level of stress reactions was related to more growth in all domains (general effect), whereas religious children experienced more spiritual growth than non-religious children without differences on other domains (domain specific effect). Other effects were small, and some did not remain significant after Bonferroni corrections. These findings suggest the presence of both general and domain-specific correlates of child posttraumatic growth. Although effects were generally small, the current findings show the need to differentiate between the domains of posttraumatic growth in both further research and clinical practice. This will allow a better understanding of the mechanisms of posttraumatic growth in children as well as more tailored assessment and intervention.	[Laceulle, Odilia M.] Tilburg Univ, Med & Clin Psychol, NL-5000 LE Tilburg, Netherlands; [Kleber, Rolf J.] Univ Utrecht, Clin & Hlth Psychol, Utrecht, Netherlands; [Kleber, Rolf J.] Netherlands & Fdn Arq, Diemen, Netherlands; [Alisic, Eva] Monash Univ, UMC Utrecht, Australia & Natl Psychotrauma Ctr Children & Yout, Monash Injury Res Insititute, Utrecht, Netherlands	Tilburg University; Utrecht University; Utrecht University; Utrecht University Medical Center	Alisic, E (corresponding author), Monash Univ, UMC Utrecht, Australia & Natl Psychotrauma Ctr Children & Yout, Monash Injury Res Insititute, Utrecht, Netherlands.	eva.alisic@monash.edu	Laceulle, Odilia M./R-5049-2018	Laceulle, Odilia M./0000-0002-4305-512X; Alisic, Eva/0000-0002-7225-606X	Madurodamfonds (The Hague, the Netherlands); Fonds Slachtofferhulp (The Hague, the Netherlands); Stichting Achmea Slachtoffer en Samenleving (Zeist, the Netherlands); Monash University (Australia)	Madurodamfonds (The Hague, the Netherlands)(Netherlands Government); Fonds Slachtofferhulp (The Hague, the Netherlands)(Netherlands Government); Stichting Achmea Slachtoffer en Samenleving (Zeist, the Netherlands)(Netherlands Government); Monash University (Australia)(Monash University)	This study was supported by grants from Prof. H.A. Wijerstichting (Utrecht, the Netherlands), Madurodamfonds (The Hague, the Netherlands), Fonds Slachtofferhulp (The Hague, the Netherlands), Stichting Achmea Slachtoffer en Samenleving (Zeist, the Netherlands), and Monash University (Australia).	Alisic E, 2010, J CHILD ADOLESCENT T, V3, P192, DOI DOI 10.1080/19361521.2010.500979; Alisic E, 2008, J CLIN PSYCHIAT, V69, P1455, DOI 10.4088/JCP.v69n0913; Barakat LP, 2006, J PEDIATR PSYCHOL, V31, P413, DOI 10.1093/jpepsy/jsj058; Calhoun L. G., 2006, HDB POSTTRAUMATIC GR, P3; Cohen LH, 1998, LEA SER PER CLIN PSY, P23; Currier JM, 2009, J PEDIATR PSYCHOL, V34, P1129, DOI 10.1093/jpepsy/jsp021; Gallaway MS, 2011, J CLIN PSYCHOL, V67, P1151, DOI 10.1002/jclp.20837; Hafstad GS, 2010, AM J ORTHOPSYCHIAT, V80, P248, DOI 10.1111/j.1939-0025.2010.01028.x; Helgeson VS, 2006, J CONSULT CLIN PSYCH, V74, P797, DOI 10.1037/0022-006X.74.5.797; Janoff-Bulman R, 2004, PSYCHOL INQ, V15, P30; Karanci AN, 2012, EUROPEAN J PSYCHOTRA, P3; Kilmer R. P., 2006, HDB POSTTRAUMATIC GR, P264; Kilmer RP, 2009, J TRAUMA STRESS, V22, P248, DOI 10.1002/jts.20410; Kimhi S, 2010, COMMUNITY MENT HLT J, V46, P10, DOI 10.1007/s10597-009-9183-x; Laufer A, 2006, J SOC CLIN PSYCHOL, V25, P429, DOI 10.1521/jscp.2006.25.4.429; Laufer A, 2009, J SOC CLIN PSYCHOL, V28, P862, DOI 10.1521/jscp.2009.28.7.862; MCMILLEN C, 1995, J CONSULT CLIN PSYCH, V63, P1037, DOI 10.1037/0022-006X.63.6.1037; Meyerson DA, 2011, CLIN PSYCHOL REV, V31, P949, DOI 10.1016/j.cpr.2011.06.003; Milam JE, 2004, J ADOLESCENT RES, V19, P192, DOI 10.1177/0743558403258273; Morris BA, 2005, J TRAUMA STRESS, V18, P575, DOI 10.1002/jts.20067; Nishi D, 2010, RES POSTTRAUMATIC GR; Nolen-Hoeksema S, 2004, PSYCHOL INQ, V15, P60; NOLENHOEKSEMA S, 1994, PSYCHOL BULL, V115, P424, DOI 10.1037/0033-2909.115.3.424; Prati G, 2009, J LOSS TRAUMA, V14, P364, DOI 10.1080/15325020902724271; Ravens-Sieberer U, 2007, QUAL LIFE RES, V16, P1347, DOI 10.1007/s11136-007-9240-2; Salter E, 2004, J TRAUMA STRESS, V17, P335, DOI 10.1023/B:JOTS.0000038482.53911.01; Stanton AL, 2006, POSTTRAUMATIC GROWTH; Tedeschi R.G., 1995, TRAUMA TRANSFORMATIO, V1st; Tedeschi RG, 2004, PSYCHOL INQ, V15, P1, DOI 10.1207/s15327965pli1501_01; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1007/BF02103658; Vishnevsky T, 2010, PSYCHOL WOMEN QUART, V34, P110, DOI 10.1111/j.1471-6402.2009.01546.x; Wolchik SA, 2008, OMEGA-J DEATH DYING, V58, P107, DOI 10.2190/OM.58.2.b; Yu XN, 2010, J AFFECT DISORDERS, V123, P327, DOI 10.1016/j.jad.2009.09.019	33	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145736	10.1371/journal.pone.0145736	http://dx.doi.org/10.1371/journal.pone.0145736			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA0IX	26714193	Green Published, gold			2022-12-26	WOS:000367481900074
J	Wu, HY; Cao, DN; Liu, TX; Zhao, JM; Hu, XX; Li, N				Wu, Hanyu; Cao, Dainan; Liu, Tongxin; Zhao, Jianmin; Hu, Xiaoxiang; Li, Ning			Purification and Characterization of Recombinant Human Lysozyme from Eggs of Transgenic Chickens	PLOS ONE			English	Article							PRIMORDIAL GERM-CELLS; OVERCOMING ANTIMICROBIAL RESISTANCE; IMPROVES GROWTH-PERFORMANCE; OVIDUCT-SPECIFIC EXPRESSION; SMALL-INTESTINAL MORPHOLOGY; MAMMARY-GLAND; NURSERY PIGS; WHITE; MILK; ANTIBACTERIAL	Transgenic chickens as bioreactors have several advantages, such as the simple establishment procedure, correct glycosylation profile of expressed proteins, etc. Lysozyme is widely used in food industry, livestock farming, and medical field as a replacement of antibiotics because of its antibacterial and complement system-modulating activity. In this study, we used RT-PCR, Western blot, and immunofluorescence to detect the expression of recombinant human lysozyme (rhLY) in the transgenic chicken. We demonstrated that the transgene of rhLY was genetically stable across different generations. We next optimized the purification procedure of rhLY from the transgenic eggs by utilizing two steps of cationex-change chromatography and one gel-filtration chromatography. About 6 mg rhLY with the purity exceeding 90% was obtained from ten eggs, and the purification efficiency was about 75%. The purified rhLY had similar physicochemical and biological properties in molecular mass and antibacterial activity compared to the commercial human lysozyme. Additionally, both of them exhibited thermal stability at 60 degrees C and tolerated an extensive pH range of 2 to 11. In conclusion, our study proved that the transgenic chickens we have previously generated were genetically stable and suitable for the production of active rhLY. We also provided a pipeline for purifying the recombinant proteins from transgenic eggs, which could be useful for other studies.	[Wu, Hanyu; Cao, Dainan; Liu, Tongxin; Hu, Xiaoxiang; Li, Ning] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China; [Zhao, Jianmin] Wuxi KGBIO Biotechnol Ltd Liabil Co, Wuxi 214145, Jiangsu, Peoples R China	China Agricultural University	Hu, XX (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China.	huxx@cau.edu.cn		Cao, Dainan/0000-0001-6119-9357	Key Technology Research and Development Program of Guangdong Emerging Strategic Industries [2012A020800005]; National Advanced Technology Research and Development Program of China [2011AA100301]; National Key Technology RD Program [2011BAD28B03]	Key Technology Research and Development Program of Guangdong Emerging Strategic Industries; National Advanced Technology Research and Development Program of China; National Key Technology RD Program(National Key Technology R&D Program)	This work was financially supported by Key Technology Research and Development Program of Guangdong Emerging Strategic Industries (2012A020800005), National Advanced Technology Research and Development Program of China (2011AA100301), and National Key Technology R&D Program (2011BAD28B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDERTON G, 1945, J BIOL CHEM, V157, P43; Baase WA, 2010, PROTEIN SCI, V19, P631, DOI 10.1002/pro.344; BLAKE CCF, 1965, NATURE, V206, P757, DOI 10.1038/206757a0; Cao DN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118626; ELLISON RT, 1991, J CLIN INVEST, V88, P1080, DOI 10.1172/JCI115407; Fang EF, 2012, ARCH TOXICOL, V86, P293, DOI 10.1007/s00204-011-0751-9; FAURE A, 1970, FEBS LETT, V10, P237, DOI 10.1016/0014-5793(70)80637-8; Fleming A, 1922, P R SOC LOND B-CONTA, V93, P306, DOI 10.1098/rspb.1922.0023; GRUTTER MG, 1979, J MOL BIOL, V135, P1029, DOI 10.1016/0022-2836(79)90527-8; Huang JM, 2002, TRANSGENIC RES, V11, P229, DOI 10.1023/A:1015663706259; Humphrey BD, 2002, J NUTR, V132, P1214, DOI 10.1093/jn/132.6.1214; JOLLES J, 1967, BIOCHEMISTRY-US, V6, P411, DOI 10.1021/bi00854a007; Kaleri HA, 2011, GENET MOL RES, V10, P3046, DOI 10.4238/2011.December.8.1; Larsen MR, 2006, BIOTECHNIQUES, V40, P790, DOI 10.2144/000112201; Leclercq R, 2001, J ANTIMICROB CHEMOTH, V48, P9, DOI 10.1093/jac/48.suppl_2.9; Lee M, 2009, J AGR FOOD CHEM, V57, P2233, DOI 10.1021/jf803133b; Lee-Huang S, 1999, P NATL ACAD SCI USA, V96, P2678, DOI 10.1073/pnas.96.6.2678; LI YM, 1995, NAT MED, V1, P1057, DOI 10.1038/nm1095-1057; LICHAN E, 1985, CAN I FOOD SC TECH J, V18, pR38; Lillico SG, 2007, P NATL ACAD SCI USA, V104, P1771, DOI 10.1073/pnas.0610401104; Lillico SG, 2005, DRUG DISCOV TODAY, V10, P191, DOI 10.1016/S1359-6446(04)03317-3; Liu S, 2012, TRANSGENIC RES, V21, P407, DOI 10.1007/s11248-011-9536-4; Liu TX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127922; Lu D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089130; Macdonald J, 2012, P NATL ACAD SCI USA, V109, pE1466, DOI 10.1073/pnas.1118715109; Maga EA, 2006, J DAIRY SCI, V89, P518, DOI 10.3168/jds.S0022-0302(06)72114-2; Maga EA, 1995, J DAIRY SCI, V78, P2645, DOI 10.3168/jds.S0022-0302(95)76894-1; Maullu C, 1999, APPL ENVIRON MICROB, V65, P2745; May KD, 2012, J ANIM SCI, V90, P1118, DOI 10.2527/jas.2011-4297; McGrew MJ, 2004, EMBO REP, V5, P728, DOI 10.1038/sj.embor.7400171; MINE Y, 1995, TRENDS FOOD SCI TECH, V6, P225, DOI 10.1016/S0924-2244(00)89083-4; Nakajima H, 1997, PLANT CELL REP, V16, P674, DOI 10.1007/s002990050300; Ogundele MO, 1998, MEDIAT INFLAMM, V7, P363, DOI 10.1080/09629359890893; Oka C, 1999, BIOSCI BIOTECH BIOCH, V63, P1977, DOI 10.1271/bbb.63.1977; Oliver WT, 2014, J ANIM SCI, V92, P4927, DOI 10.2527/jas.2014-8033; Oliver WT, 2013, J ANIM SCI, V91, P3129, DOI 10.2527/jas.2012-5782; Park TS, 2015, FASEB J, V29, P2386, DOI 10.1096/fj.14-264739; Park TS, 2014, P NATL ACAD SCI USA, V111, P12716, DOI 10.1073/pnas.1410555111; Park TS, 2012, P NATL ACAD SCI USA, V109, P9337, DOI 10.1073/pnas.1203823109; Phillips JC, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.051916; Poole K, 2001, J PHARM PHARMACOL, V53, P283, DOI 10.1211/0022357011775514; PROCTOR VA, 1988, CRC CR REV FOOD SCI, V26, P359, DOI 10.1080/10408398809527473; SALTON MRJ, 1957, BACTERIOL REV, V21, P82, DOI 10.1128/MMBR.21.2.82-100.1957; Schusser B, 2013, P NATL ACAD SCI USA, V110, P20170, DOI 10.1073/pnas.1317106110; SHUGAR D, 1952, BIOCHIM BIOPHYS ACTA, V8, P302, DOI 10.1016/0006-3002(52)90045-0; Spencer A, 1999, PROTEIN EXPRES PURIF, V16, P171, DOI 10.1006/prep.1999.1036; Su CK, 2006, PROCESS BIOCHEM, V41, P257, DOI 10.1016/j.procbio.2005.06.026; Tong J, 2011, TRANSGENIC RES, V20, P417, DOI 10.1007/s11248-010-9409-2; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Wang SY, 2005, BIOCHEM BIOPH RES CO, V327, P820, DOI 10.1016/j.bbrc.2004.12.077; Wilken LR, 2006, BIOTECHNOL PROGR, V22, P745, DOI 10.1021/bp0600536; Yang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017593; Ye XJ, 2011, J AGR FOOD CHEM, V59, P10232, DOI 10.1021/jf201874j; Yu Z, 2006, J DAIRY SCI, V89, P2911, DOI 10.3168/jds.S0022-0302(06)72563-2	54	13	15	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0146032	10.1371/journal.pone.0146032	http://dx.doi.org/10.1371/journal.pone.0146032			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713728	Green Published, gold, Green Submitted			2022-12-26	WOS:000367481900111
J	Brassine, E; Parker, D				Brassine, Eleanor; Parker, Daniel			Trapping Elusive Cats: Using Intensive Camera Trapping to Estimate the Density of a Rare African Felid	PLOS ONE			English	Article							CHEETAH ACINONYX-JUBATUS; RANGING BEHAVIOR; POPULATION; PARDALIS; BOLIVIA; EXAMPLE; LAND	Camera trapping studies have become increasingly popular to produce population estimates of individually recognisable mammals. Yet, monitoring techniques for rare species which occur at extremely low densities are lacking. Additionally, species which have unpredictable movements may make obtaining reliable population estimates challenging due to low detectability. Our study explores the effectiveness of intensive camera trapping for estimating cheetah (Acinonyx jubatus) numbers. Using both a more traditional, systematic grid approach and pre-determined, targeted sites for camera placement, the cheetah population of the Northern Tuli Game Reserve, Botswana was sampled between December 2012 and October 2013. Placement of cameras in a regular grid pattern yielded very few (n = 9) cheetah images and these were insufficient to estimate cheetah density. However, pre-selected cheetah scent-marking posts provided 53 images of seven adult cheetahs (0.61 +/- 0.18 cheetahs/100km(2)). While increasing the length of the camera trapping survey from 90 to 130 days increased the total number of cheetah images obtained (from 53 to 200), no new individuals were recorded and the estimated population density remained stable. Thus, our study demonstrates that targeted camera placement (irrespective of survey duration) is necessary for reliably assessing cheetah densities where populations are naturally very low or dominated by transient individuals. Significantly our approach can easily be applied to other rare predator species.	[Brassine, Eleanor; Parker, Daniel] Rhodes Univ, Dept Zool & Entomol, Wildlife & Reserve Management Res Grp, ZA-6140 Grahamstown, South Africa	Rhodes University	Brassine, E (corresponding author), Rhodes Univ, Dept Zool & Entomol, Wildlife & Reserve Management Res Grp, ZA-6140 Grahamstown, South Africa.	alienor.brassine@gmail.com	Parker, Daniel/J-2649-2019	Parker, Daniel/0000-0001-7555-5674	National Geographic Society's Big Cat Initiative Grants [B4-12]; Rufford Small Grants Foundation [11858-1]; Idea Wild; Zoofari Foundation; Mashatu Game Reserve; Botswana Ministry of Environment, Wildlife and Tourism; Department of Wildlife and National Park; Northern Tuli Game Reserve	National Geographic Society's Big Cat Initiative Grants; Rufford Small Grants Foundation; Idea Wild; Zoofari Foundation; Mashatu Game Reserve; Botswana Ministry of Environment, Wildlife and Tourism; Department of Wildlife and National Park; Northern Tuli Game Reserve	This work was supported by the National Geographic Society's Big Cat Initiative Grants, Grant B4-12, http://animals.nationalgeographic.com/animals/big-cats-initiative/. The funds were received by EB. It also received support from the Rufford Small Grants Foundation, Grant 11858-1, http://www.rufford.org/; Idea Wild, www.ideawild.org/; Zoofari Foundation, http://www.wildwonders.org/zoofari-foundation/; and Mashatu Game Reserve, http://mashatu.com/. The funds from each of these sources were received by EB. The authors are also thankful to The Northern Tuli Game Reserve landowners. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the Botswana Ministry of Environment, Wildlife and Tourism and the Department of Wildlife and National Park for granting permission to conduct research in Botswana. We are also thankful to Mashatu Game Reserve and The Northern Tuli Game Reserve landowners for authorising and supporting this research. Thanks to the field guides of Mashatu Game Reserve, particularly Fish Maila, Bashi Patane and Elvis Ramogale for assisting with finding of scent marking posts. We would like to thank particularly Mike Dexter for help with data collection in the field and Andy Royle for assistance with the SPACECAP program.	Balme GA, 2009, J WILDLIFE MANAGE, V73, P433, DOI 10.2193/2007-368; Belbachir F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115136; Blake John G, 2014, Mastozool. neotrop., V21, P17; Borah J, 2014, ORYX, V48, P149, DOI 10.1017/S0030605312000373; Bothma J.d.P., 1999, LARGER CARNIVORES AF, P22, DOI [10.1007/978-3-662-03766-9_2/COVER, DOI 10.1007/978-3-662-03766-9_2/COVER]; Brassine E. I., 2014, THESIS; Buk K., 2010, Africa Insight, V39, P212; Burton AC, 2015, J APPL ECOL, V52, P675, DOI 10.1111/1365-2664.12432; Carbone C, 2001, ANIM CONSERV, V4, P75, DOI 10.1017/S1367943001001081; Caro T., 1994, CHEETAHS SERENGETI P; Dillon A, 2007, ORYX, V41, P469, DOI 10.1017/S0030605307000518; Durant SM, 2007, CONSERV BIOL, V21, P602, DOI 10.1111/j.1523-1739.2007.00702.x; Durant Sarah M., 2010, P373; Durant SM, 1998, J ANIM ECOL, V67, P370, DOI 10.1046/j.1365-2656.1998.00202.x; Gray TNE, 2012, J WILDLIFE MANAGE, V76, P163, DOI 10.1002/jwmg.230; Foster RJ, 2012, J WILDLIFE MANAGE, V76, P224, DOI 10.1002/jwmg.275; Götze Albie R., 2008, Koedoe, V50, P72; Gopalaswamy AM, 2013, PACKAGE SPACECAP PRO; Gopalaswamy AM, 2012, METHODS ECOL EVOL, V3, P1067, DOI 10.1111/j.2041-210X.2012.00241.x; Gros PM, 1998, BIOL CONSERV, V85, P137, DOI 10.1016/S0006-3207(97)00135-3; Hayward MW, 2009, S AFR J WILDL RES, V39, P109, DOI 10.3957/056.039.0207; Heilbrun RD, 2003, WILDLIFE SOC B, V31, P748; Henschel P, 2003, LEOPARDS AFRICAN RAI; Houser A, 2009, S AFR J WILDL RES, V39, P11, DOI 10.3957/056.039.0102; Hunter L., 1998, CHEETAHS GAME RANCH, P72; IUCN, 2013, IUCN RED LIST THREAT; Jackson CR, 2012, WILDLIFE RES, V39, P31, DOI 10.1071/WR11070; Jenness J., 2012, REPEATING SHAPES ARC; Karanth K.U., 2002, MONITORING TIGERS TH, DOI [10.1111/j.1523-1739.2003.01769.x, DOI 10.1111/J.1523-1739.2003.01769.X]; KARANTH KU, 1995, BIOL CONSERV, V71, P333, DOI 10.1016/0006-3207(94)00057-W; Karanth KU, 1998, ECOLOGY, V79, P2852; Kelly MJ, 2008, J MAMMAL, V89, P408, DOI 10.1644/06-MAMM-A-424R.1; Kelly MJ, 1998, J ZOOL, V244, P473, DOI 10.1017/S0952836998004014; Kelly MJ, 2001, J MAMMAL, V82, P440, DOI 10.1644/1545-1542(2001)082<0440:CAPMIS>2.0.CO;2; Lind P, 1974, UNPUB; Long RA, 2008, NONINVASIVE SURVEY M; Maffei L, 2005, J TROP ECOL, V21, P349, DOI 10.1017/S0266467405002397; Marker LL, 2008, J ZOOL, V274, P226, DOI 10.1111/j.1469-7998.2007.00375.x; Marker L.L., 2002, THESIS; Marker Laurie L., 2008, Cat News, V49, P22; Marnewick KA, 2006, S AFR J WILDL RES, V36, P139; Marnewick K, 2008, S AFR J WILDL RES, V38, P59, DOI 10.3957/0379-4369-38.1.59; McKenzie AA, 1990, THESIS; Mills M.G.L., 1984, Koedoe, V27, P237; Negroes N, 2012, ECOL RES, V27, P639, DOI 10.1007/s11284-012-0938-4; Negroes N, 2010, J WILDLIFE MANAGE, V74, P1195, DOI 10.2193/2009-256; Noss A, 2013, EVALUATING JAGUAR DE; O'Brien TG, 2011, ECOL APPL, V21, P2908, DOI 10.1890/10-2284.1; OConnell AF, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P1, DOI 10.1007/978-4-431-99495-4; OTIS DL, 1978, WILDLIFE MONOGR, P1; Otis DL., 1982, CAPTURE RECAPTURE RE; Pettorelli N, 2009, J ZOOL, V277, P141, DOI 10.1111/j.1469-7998.2008.00522.x; Ray JC, 2005, 24 WCS; Royle JA, 2009, ECOLOGY, V90, P3233, DOI 10.1890/08-1481.1; Silvers S, 2004, ASSESSING JAGUAR ABU; Soisalo MK, 2006, BIOL CONSERV, V129, P487, DOI 10.1016/j.biocon.2005.11.023; Stanley TR, 1999, ENVIRON ECOL STAT, V6, P197, DOI 10.1023/A:1009674322348; Steyn T., 2004, NO TULI GAME RESERVE; Thompson SK, 1998, MONITORING VERTEBRAT; Trolle M, 2003, J MAMMAL, V84, P607, DOI 10.1644/1545-1542(2003)084<0607:EOODIT>2.0.CO;2; Walker CH, 1971, FIELD IMPRESS UNPUB; Wilson K., 2006, THESIS	62	35	35	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0142508	10.1371/journal.pone.0142508	http://dx.doi.org/10.1371/journal.pone.0142508			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26698574	gold, Green Published, Green Submitted			2022-12-26	WOS:000367092600003
J	Cornman, RS; Otto, CRV; Iwanowicz, D; Pettis, JS				Cornman, R. Scott; Otto, Clint R. V.; Iwanowicz, Deborah; Pettis, Jeffery S.			Taxonomic Characterization of Honey Bee (Apis mellifera) Pollen Foraging Based on Non-Overlapping Paired-End Sequencing of Nuclear Ribosomal Loci	PLOS ONE			English	Article							NORTHERN GREAT-PLAINS; READ ALIGNMENT; PLANTS; POLLINATORS; VISITATION; PHYLOGENY; FORAGERS; BEHAVIOR; TRENDS	Identifying plant taxa that honey bees (Apis mellifera) forage upon is of great apicultural interest, but traditional methods are labor intensive and may lack resolution. Here we evaluate a high-throughput genetic barcoding approach to characterize trap-collected pollen from multiple North Dakota apiaries across multiple years. We used the Illumina MiSeq platform to generate sequence scaffolds from non-overlapping 300-bp paired-end sequencing reads of the ribosomal internal transcribed spacers (ITS). Full-length sequence scaffolds represented similar to 530 bp of ITS sequence after adapter trimming, drawn from the 5' of ITS1 and the 3' of ITS2, while skipping the uninformative 5.8S region. Operational taxonomic units (OTUs) were picked from scaffolds clustered at 97% identity, searched by BLAST against the nt database, and given taxonomic assignments using the paired-read lowest common ancestor approach. Taxonomic assignments and quantitative patterns were consistent with known plant distributions, phenology, and observational reports of pollen foraging, but revealed an unexpected contribution from non-crop graminoids and wetland plants. The mean number of plant species assignments per sample was 23.0 (+/-5.5) and the mean species diversity (effective number of equally abundant species) was 3.3 (+/-1.2). Bray-Curtis similarities showed good agreement among samples from the same apiary and sampling date. Rarefaction plots indicated that fewer than 50,000 reads are typically needed to characterize pollen samples of this complexity. Our results show that a pre-compiled, curated reference database is not essential for genus-level assignments, but species-level assignments are hindered by database gaps, reference length variation, and probable errors in the taxonomic assignment, requiring post-hoc evaluation. Although the effective per-sample yield achieved using custom MiSeq amplicon primers was less than the machine maximum, primarily due to lower "read2" quality, further protocol optimization and/or a modest reduction in multiplex scale should offset this difficulty. As small quantities of pollen are sufficient for amplification, our approach might be extendable to other questions or species for which large pollen samples are not available.	[Cornman, R. Scott] US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO 80526 USA; [Otto, Clint R. V.] US Geol Survey, Northern Prairie Wildlife Res Ctr, Jamestown, ND 58401 USA; [Iwanowicz, Deborah] US Geol Survey, Leetown Sci Ctr, Kearneysville, WV 25430 USA; [Pettis, Jeffery S.] USDA ARS, Beltsville Agr Res Ctr, Bee Res Lab, Beltsville, MD 20705 USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of Agriculture (USDA)	Cornman, RS (corresponding author), US Geol Survey, Ft Collins Sci Ctr, 2150 Ctr Ave, Ft Collins, CO 80526 USA.	rcornman@usgs.gov			US Department of Agriculture-Farm Service Agency; USDA-Natural Resources Conservation Service; US Geological Survey Ecosystems Mission Area	US Department of Agriculture-Farm Service Agency; USDA-Natural Resources Conservation Service(United States Department of Agriculture (USDA)); US Geological Survey Ecosystems Mission Area	Funding was provided by the US Department of Agriculture-Farm Service Agency and USDA-Natural Resources Conservation Service (JSP, CRVO), and by the US Geological Survey Ecosystems Mission Area (CRVO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2009, ANN BOT-LONDON, V103, P1579, DOI 10.1093/aob/mcp076; Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Anderson DL, 2000, EXP APPL ACAROL, V24, P165, DOI 10.1023/A:1006456720416; Arnheim N., 1983, P38; Aronstein KA, 2010, J INVERTEBR PATHOL, V103, pS20, DOI 10.1016/j.jip.2009.06.018; Becher MA, 2014, J APPL ECOL, V51, P470, DOI 10.1111/1365-2664.12222; Bik HM, 2012, TRENDS ECOL EVOL, V27, P233, DOI 10.1016/j.tree.2011.11.010; Bosch J, 2009, ECOL LETT, V12, P409, DOI 10.1111/j.1461-0248.2009.01296.x; Brosi BJ, 2009, FOREST ECOL MANAG, V258, P1846, DOI 10.1016/j.foreco.2009.02.027; Buckler ES, 1997, GENETICS, V145, P821; Calderone NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037235; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Coissac E, 2012, MOL ECOL, V21, P1834, DOI 10.1111/j.1365-294X.2012.05550.x; CORRIVEAU JL, 1991, DEV BIOL, V147, P271, DOI 10.1016/S0012-1606(05)80024-7; CRAILSHEIM K, 1992, J INSECT PHYSIOL, V38, P409, DOI 10.1016/0022-1910(92)90117-V; Di Pasquale G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072016; Doyle J. J., 1991, Molecular techniques in taxonomy., P283; Dunnell KL, 2011, AM J BOT, V98, P935, DOI 10.3732/ajb.1000363; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; FEWELL JH, 1992, BEHAV ECOL SOCIOBIOL, V30, P387, DOI 10.1007/BF00176173; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Harano K, 2014, NATURWISSENSCHAFTEN, V101, P595, DOI 10.1007/s00114-014-1185-z; Herbert E.W., 1992, HIVE HONEY BEE, P197; Hooper T, 1985, ILLUSTRATED ENCY BEE; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Jeffree E., 1957, J ECON ENTOMOL, V50, P211, DOI 10.1093/jee/50.2.211; Kalle Elena, 2014, Biomol Detect Quantif, V2, P11; Kearns CA, 1998, ANNU REV ECOL SYST, V29, P83, DOI 10.1146/annurev.ecolsys.29.1.83; Keller A, 2015, PLANT BIOLOGY, V17, P558, DOI 10.1111/plb.12251; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Kraaijeveld K, 2015, MOL ECOL RESOUR, V15, P8, DOI 10.1111/1755-0998.12288; Kremen C, 2007, ECOL LETT, V10, P299, DOI 10.1111/j.1461-0248.2007.01018.x; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Larson DL, 2006, BIOL CONSERV, V130, P148, DOI 10.1016/j.biocon.2005.12.009; Larson DL, 2014, J APPL ECOL, V51, P1024, DOI 10.1111/1365-2664.12273; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lihoreau Mathieu, 2013, Commun Integr Biol, V6, pe22701, DOI 10.4161/cib.22701; Marcon E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090289; Mitra S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S12; Morandin LA, 2013, RESTOR ECOL, V21, P26, DOI 10.1111/j.1526-100X.2012.00876.x; National Honey Bee Health Stakeholder Conference Steering Committee, 2012, REP NAT STAK C HON B; North Dakota Department of Agriculture, ABS WORMW ART ABS; Noyes RD, 1999, AM J BOT, V86, P398, DOI 10.2307/2656761; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Osborne JL, 2008, J ANIM ECOL, V77, P406, DOI 10.1111/j.1365-2656.2007.01333.x; Pankiw T, 1998, BEHAV ECOL SOCIOBIOL, V44, P193, DOI 10.1007/s002650050531; Pernal SF, 2001, BEHAV ECOL SOCIOBIOL, V51, P53, DOI 10.1007/s002650100412; Pollinator Health Task Force, 2015, POLL RES ACT PLAN; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Reiter R., 1947, OHIO JOUR SCI, V47, P137; Richardson RT, 2015, APPL PLANT SCI, V3, DOI 10.3732/apps.1400066; Ross MG, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r51; Sakamoto Wataru, 2008, Arabidopsis Book, V6, pe0110, DOI 10.1199/tab.0110; Seeley T. D., 2009, WISDOM HIVE SOCIAL P; Shipunov A, 2012, FLORA N DAKOTA CHECK; Sickel W, 2015, BMC ECOL, V15, DOI 10.1186/s12898-015-0051-y; Simone-Finstrom M, 2010, APIDOLOGIE, V41, P295, DOI 10.1051/apido/2010016; SIMS PL, 2000, N AM TERRESTRIAL VEG, P324; Slagle MW, 2009, OECOLOGIA, V161, P813, DOI 10.1007/s00442-009-1429-3; Slotta Tracey A. Bodo, 2012, Plants-Basel, V1, P61, DOI 10.3390/plants1020061; Smart MD, 2015, THESIS; Stanford AM, 2000, AM J BOT, V87, P872, DOI 10.2307/2656895; Travers S. E., 2009, Ecology, V90, P2332, DOI 10.1890/08-2135.1; Tuell JK, 2008, ENVIRON ENTOMOL, V37, P707, DOI 10.1603/0046-225X(2008)37[707:VBWAMB]2.0.CO;2; US Department of Agriculture National Resources Conservation Service, USDA NRCS PLANTS DAT; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; Vaughan DM, 2002, INSECT SOC, V49, P23, DOI 10.1007/s00040-002-8273-3; Wang H, 2014, APIDOLOGIE, V45, P618, DOI 10.1007/s13592-014-0276-3; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wilson EE, 2010, MOL ECOL, V19, P4823, DOI 10.1111/j.1365-294X.2010.04849.x; Wright CK, 2013, P NATL ACAD SCI USA, V110, P4134, DOI 10.1073/pnas.1215404110	76	36	36	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145365	10.1371/journal.pone.0145365	http://dx.doi.org/10.1371/journal.pone.0145365			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700168	gold, Green Submitted, Green Published			2022-12-26	WOS:000367092600071
J	Greene, SL; Kesoju, SR; Martin, RC; Kramer, M				Greene, Stephanie L.; Kesoju, Sandya R.; Martin, Ruth C.; Kramer, Matthew			Occurrence of Transgenic Feral Alfalfa (Medicago sativa subsp sativa L.) in Alfalfa Seed Production Areas in the United States	PLOS ONE			English	Article							GENE FLOW; OILSEED RAPE; HERBICIDE RESISTANCE; BRASSICA-NAPUS; CREEPING BENTGRASS; TRAIT CONFINEMENT; WESTERN CANADA; POPULATIONS; ORIGIN; PLANTS	The potential environmental risks of transgene exposure are not clear for alfalfa (Medicago sativa subsp. sativa), a perennial crop that is cross-pollinated by insects. We gathered data on feral alfalfa in major alfalfa seed-production areas in the western United States to (1) evaluate evidence that feral transgenic plants spread transgenes and (2) determine environmental and agricultural production factors influencing the location of feral alfalfa, especially transgenic plants. Road verges in Fresno, California; Canyon, Idaho; and Walla Walla, Washington were surveyed in 2011 and 2012 for feral plants, and samples were tested for the CP4 EPSPS protein that conveys resistance to glyphosate. Of 4580 sites surveyed, feral plants were observed at 404 sites. Twenty-seven percent of these sites had transgenic plants. The frequency of sites having transgenic feral plants varied among our study areas. Transgenic plants were found in 32.7%, 21.4.7% and 8.3% of feral plant sites in Fresno, Canyon and Walla Walla, respectively. Spatial analysis suggested that feral populations started independently and tended to cluster in seed and hay production areas, places where seed tended to drop. Significant but low spatial auto correlation suggested that in some instances, plants colonized nearby locations. Neighboring feral plants were frequently within pollinator foraging range; however, further research is needed to confirm transgene flow. Locations of feral plant clusters were not well predicted by environmental and production variables. However, the likelihood of seed spillage during production and transport had predictive value in explaining the occurrence of transgenic feral populations. Our study confirms that genetically engineered alfalfa has dispersed into the environment, and suggests that minimizing seed spillage and eradicating feral alfalfa along road sides would be effective strategies to minimize transgene dispersal.	[Greene, Stephanie L.] ARS, Plant & Anim Genet Resource Preservat Unit, USDA, Ft Collins, CO 80521 USA; [Kesoju, Sandya R.] Washington State Univ, Irrigated Agr Res & Extens Ctr, Prosser, WA 99350 USA; [Martin, Ruth C.] ARS, Forage Seed & Cereal Res Unit, USDA, Corvallis, OR USA; [Kramer, Matthew] ARS, Stat Grp, USDA, Beltsville, MD USA	United States Department of Agriculture (USDA); Washington State University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Greene, SL (corresponding author), ARS, Plant & Anim Genet Resource Preservat Unit, USDA, Ft Collins, CO 80521 USA.	stephanie.greene@ars.usda.gov		Greene, Stephanie/0000-0002-3624-5021	USDA Office of the Secretary Biotechnology Funds; Biotechnology Risk Assessment Grant Program competitive grant from the USDA NIFA [2011-33522-30733]; USDA, Agricultural Research Service	USDA Office of the Secretary Biotechnology Funds; Biotechnology Risk Assessment Grant Program competitive grant from the USDA NIFA; USDA, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by the USDA Office of the Secretary Biotechnology Funds, Biotechnology Risk Assessment Grant Program competitive grant no. 2011-33522-30733 from the USDA NIFA, and the USDA, Agricultural Research Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amand PCS, 2000, THEOR APPL GENET, V101, P107, DOI 10.1007/s001220051457; [Anonymous], 2000, CROP POLLINATION BEE; AOSCA, 2015, AOSCA ALF SEED STEW; Bagavathiannan MV, 2008, AGR ECOSYST ENVIRON, V127, P1, DOI 10.1016/j.agee.2008.03.009; Bagavathiannan MV, 2009, CRIT REV PLANT SCI, V28, P69, DOI 10.1080/07352680902753613; Bagavathiannan MV, 2010, TRANSGENIC RES, DOI [10.1007/s11248-010-9425-2.42, DOI 10.1007/S11248-010-9425-2.42]; Beekman M, 2000, FUNCT ECOL, V14, P490, DOI 10.1046/j.1365-2435.2000.00443.x; Booker H., 2012, AgBioForum, V15, P31; Booker H. M., 2014, AgBioForum, V17, P75; Burgeff C., 2014, AgBioForum, V17, P90; Council for Agricultural Science (CAST), 2008, CAST SPEC PUBL, V28; Devos Y, 2012, TRANSGENIC RES, V21, P1, DOI 10.1007/s11248-011-9515-9; Ellstrand NC, 2014, AM J BOT, V101, P737, DOI 10.3732/ajb.1400024; Ellstrand NC, 2013, ANNU REV ECOL EVOL S, V44, P325, DOI 10.1146/annurev-ecolsys-110512-135840; Engels JMM, 2006, GENET RESOUR CROP EV, V53, P1675, DOI 10.1007/s10722-005-1215-y; Franz J., 1997, MONOGRAFIS ACS, V189, P27; Friesen LF, 2003, AGRON J, V95, P1342, DOI 10.2134/agronj2003.1342; Gesch D, 2002, PHOTOGRAMM ENG REM S, V68, P5; Gesch D., 2007, DIGITAL ELEVATION MO, P99; Getis A, 1995, GEOGR ANAL, V27, P287; Hecht M, 2014, ENVIRON SCI POLLUT R, V21, P1455, DOI 10.1007/s11356-013-1881-9; Heuberger Shannon, 2008, Environmental Biosafety Research, V7, P87, DOI 10.1051/ebr:2008005; Heuberger S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014128; Kendrick DL, 2005, P 60 N CENTR WEED SC; Knispel AL, 2008, WEED SCI, V56, P72, DOI 10.1614/WS-07-097.1; Knispel AL, 2010, ENVIRON SCI POLLUT R, V17, P13, DOI 10.1007/s11356-009-0219-0; Mallory-Smith C, 2008, PEST MANAG SCI, V64, P428, DOI 10.1002/ps.1517; Mitchell A., 2005, ESRI GUIDE GIS ANAL, V2; National Alfalfa and Forage Alliance (NAFA), 2015, GROW OPP ZON NONGE S; National Alfalfa and Forage Alliance (NAFA), 2015, NAFA COEX DOC; National Resources Conservation Services (NRCS), 2015, PLANTS DAT MED SAT F; Packer JS, 1971, THESIS; Padon SA, 2015, J STAT SOFTW, V63, P1; Pivard S, 2008, J APPL ECOL, V45, P476, DOI 10.1111/j.1365-2664.2007.01358.x; Reichman JR, MOL ECOL, V15; Rissler J, 2004, GONE SEED TRANSGENIC, P40; Schoenenberger Nicola, 2012, Environmental Sciences Europe, V24, P23, DOI 10.1186/2190-4715-24-23; Schulze J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114477; Shafer MG, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone0025736, DOI 10.1371/J0URNAL.P0NE.0025736]; Small E., 2011, ALFALFA RELATIVES EV; STEINER JJ, 1995, NUCLEIC ACIDS RES, V23, P2569, DOI 10.1093/nar/23.13.2569-a; Stevens DL, 2004, J AM STAT ASSOC, V99, P262, DOI 10.1198/016214504000000250; TEPEDINO VJ, 1983, J APICULT RES, V22, P64, DOI 10.1080/00218839.1983.11100561; Theobald DM, 2007, ENVIRON MANAGE, V40, P134, DOI 10.1007/s00267-005-0199-x; United States Department of Agriculture (USDA), 2014, AD GEN ENG CROPS US; WADDINGTON KD, 1994, BEHAV ECOL SOCIOBIOL, V35, P423, DOI 10.1007/BF00165845; Warwick SI, 2008, MOL ECOL, V17, P1387, DOI 10.1111/j.1365-294X.2007.03567.x; Watrud LS, 2004, P NATL ACAD SCI USA, V101, P14533, DOI 10.1073/pnas.0405154101; Wegier A, 2011, MOL ECOL, V20, P4182, DOI 10.1111/j.1365-294X.2011.05258.x; Wolfenbarger LL, 2000, SCIENCE, V290, P2088, DOI 10.1126/science.290.5499.2088; Yoshimura Yasuyuki, 2006, Environmental Biosafety Research, V5, P67, DOI 10.1051/ebr:2006019; Zapiola ML, 2008, J APPL ECOL, V45, P486, DOI 10.1111/j.1365-2664.2007.01430.x	52	19	20	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0143296	10.1371/journal.pone.0143296	http://dx.doi.org/10.1371/journal.pone.0143296			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26699337	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092600006
J	Gruchattka, E; Kayser, O				Gruchattka, Evamaria; Kayser, Oliver			In Vivo Validation of In Silico Predicted Metabolic Engineering Strategies in Yeast: Disruption of alpha-Ketoglutarate Dehydrogenase and Expression of ATP-Citrate Lyase for Terpenoid Production	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; HIGH-LEVEL PRODUCTION; COENZYME-A REDUCTASE; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; CATALYTIC DOMAIN; ACETYL-COENZYME; ACID; PRECURSOR; SESQUITERPENES	Background Engineering of the central carbon metabolism of Saccharomyces cerevisiae to redirect metabolic flux towards cytosolic acetyl-CoA has become a central topic in yeast biotechnology. A cell factory with increased flux into acetyl-CoA can be used for heterologous production of terpenoids for pharmaceuticals, biofuels, fragrances, or other acetyl-CoA derived compounds. In a previous study, we identified promising metabolic engineering targets in S. cerevisiae using an in silico stoichiometric metabolic network analysis. Here, we validate selected in silico strategies in vivo. Results Patchoulol was produced by yeast via a heterologous patchoulol synthase of Pogostemon cablin. To increase the metabolic flux from acetyl-CoA towards patchoulol, a truncated HMG-CoA reductase was overexpressed and farnesyl diphosphate synthase was fused with patchoulol synthase. The highest increase in production could be achieved by modifying the carbon source; sesquiterpenoid titer increased from glucose to ethanol by a factor of 8.4. Two strategies predicted in silico were chosen for validation in this work. Disruption of a-ketoglutarate dehydrogenase gene (KGD1) was predicted to redirect the metabolic flux via the pyruvate dehydrogenase bypass towards acetyl-CoA. The metabolic flux was redirected as predicted, however, the effect was dependent on cultivation conditions and the flux was interrupted at the level of acetate. High amounts of acetate were produced. As an alternative pathway to synthesize cytosolic acetyl-CoA, ATP-citrate lyase was expressed as a polycistronic construct, however, in vivo performance of the enzyme needs to be optimized to increase terpenoid production. Conclusions Stoichiometric metabolic network analysis can be used successfully as a metabolic prediction tool. However, this study highlights that kinetics, regulation and cultivation conditions may interfere, resulting in poor in vivo performance. Main sites of regulation need to be released and improved enzymes are essential to meet the required activities for an increased product formation in vivo.	[Gruchattka, Evamaria; Kayser, Oliver] TU Dortmund Univ, Dept Biochem & Chem Engn, Tech Biochem, D-44227 Dortmund, Germany	Dortmund University of Technology	Kayser, O (corresponding author), TU Dortmund Univ, Dept Biochem & Chem Engn, Tech Biochem, Emil Figge Str 66, D-44227 Dortmund, Germany.	Oliver.Kayser@bci.tu-dortmund.de	Kayser, Oliver/B-1431-2016; Gruchattka, Evamaria/K-2687-2016	Kayser, Oliver/0000-0001-6131-2495; Gruchattka, Evamaria/0000-0002-8160-4118	Ministry of Innovation, Science and Research of the German Federal State of North Rhine-Westphalia (NRW); TU Dortmund through CLIB-Graduate Cluster Industrial Biotechnology (CLIB)	Ministry of Innovation, Science and Research of the German Federal State of North Rhine-Westphalia (NRW); TU Dortmund through CLIB-Graduate Cluster Industrial Biotechnology (CLIB)	This work was partly funded by the Ministry of Innovation, Science and Research of the German Federal State of North Rhine-Westphalia (NRW) and by TU Dortmund through a scholarship to EG from the CLIB-Graduate Cluster Industrial Biotechnology (CLIB2021; www.graduatecluster.net). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertsen L, 2011, APPL ENVIRON MICROB, V77, P1033, DOI 10.1128/AEM.01361-10; Asadollahi MA, 2008, BIOTECHNOL BIOENG, V99, P666, DOI 10.1002/bit.21581; Asadollahi MA, 2010, BIOTECHNOL BIOENG, V106, P86, DOI 10.1002/bit.22668; Asadollahi MA, 2009, METAB ENG, V11, P328, DOI 10.1016/j.ymben.2009.07.001; Becker J, 2003, APPL ENVIRON MICROB, V69, P4144, DOI 10.1128/AEM.69.7.4144-4150.2003; Beekwilder J, 2014, J BIOTECHNOL, V192, P383, DOI 10.1016/j.jbiotec.2013.12.016; BOWMAN SB, 1992, MOL GEN GENET, V231, P296, DOI 10.1007/BF00279803; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brodelius M, 2002, EUR J BIOCHEM, V269, P3570, DOI 10.1046/j.1432-1033.2002.03044.x; Carvalheiro F, 2008, J SCI IND RES INDIA, V67, P849; Chavez-Cabrera C, 2010, APPL MICROBIOL BIOT, V85, P1953, DOI 10.1007/s00253-009-2271-6; Chen LW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084853; Chen Y, 2015, FEMS YEAST RES, DOI [10.1093/femsyr/fov015, DOI 10.1093/FEMSYR/F0V015]; Chen Y, 2014, METAB ENG, V22, P104, DOI 10.1016/j.ymben.2014.01.005; Chen Y, 2013, METAB ENG, V15, P48, DOI 10.1016/j.ymben.2012.11.002; Chen Y, 2012, FEMS YEAST RES, V12, P598, DOI 10.1111/j.1567-1364.2012.00809.x; CIRIACY M, 1975, MOL GEN GENET, V138, P157, DOI 10.1007/BF02428119; de Jong BW, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-39; Deguerry F, 2006, ARCH BIOCHEM BIOPHYS, V454, P123, DOI 10.1016/j.abb.2006.08.006; Donald KAG, 1997, APPL ENVIRON MICROB, V63, P3341, DOI 10.1128/AEM.63.9.3341-3344.1997; Engels B, 2008, METAB ENG, V10, P201, DOI 10.1016/j.ymben.2008.03.001; Farhi M, 2011, METAB ENG, V13, P474, DOI 10.1016/j.ymben.2011.05.001; Fatland BL, 2002, PLANT PHYSIOL, V130, P740, DOI 10.1104/pp.008110; George KW, 2015, ADV BIOCHEM ENG BIOT, V148, P469, DOI 10.1007/10_2015_310; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Guaragnella N, 2011, BIOCHEM SOC T, V39, P1538, DOI 10.1042/BST0391538; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Hadicke O, 2011, METAB ENG, V13, P204, DOI 10.1016/j.ymben.2010.12.004; HEIPIEPER HJ, 1994, TRENDS BIOTECHNOL, V12, P409, DOI 10.1016/0167-7799(94)90029-9; Ignea C, 2014, ACS SYNTH BIOL, V3, P298, DOI 10.1021/sb400115e; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Jackson BE, 2003, ORG LETT, V5, P1629, DOI 10.1021/ol034231x; Jullesson D, 2015, BIOTECHNOL ADV, V33, P1395, DOI 10.1016/j.biotechadv.2015.02.011; Kirby J, 2009, ANNU REV PLANT BIOL, V60, P335, DOI 10.1146/annurev.arplant.043008.091955; Knorre DA, 2005, BIOCHEMISTRY-MOSCOW+, V70, P264, DOI 10.1007/s10541-005-0110-7; Koch B, 2014, FEMS MICROBIOL REV, V38, P892, DOI 10.1111/1574-6976.12069; Kocharin K, 2013, BIOTECHNOL BIOENG, V110, P2216, DOI 10.1002/bit.24888; Kocharin K, 2012, AMB EXPRESS, V2, DOI 10.1186/2191-0855-2-52; Kozak BU, 2014, MBIO, V5, DOI 10.1128/mBio.01696-14; Kozak BU, 2014, METAB ENG, V21, P46, DOI 10.1016/j.ymben.2013.11.005; Krivoruchko A, 2013, J IND MICROBIOL BIOT, V40, P1051, DOI 10.1007/s10295-013-1296-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lian JZ, 2014, METAB ENG, V24, P139, DOI 10.1016/j.ymben.2014.05.010; Liesen T, 1996, MOL MICROBIOL, V21, P621, DOI 10.1111/j.1365-2958.1996.tb02570.x; LOGRASSO PV, 1993, ARCH BIOCHEM BIOPHYS, V307, P193, DOI 10.1006/abbi.1993.1578; MUNCK SL, 1990, ARCH BIOCHEM BIOPHYS, V282, P58, DOI 10.1016/0003-9861(90)90086-E; Navarro-Avino JP, 1999, YEAST, V15, P829, DOI 10.1002/(SICI)1097-0061(199907)15:10A<829::AID-YEA423>3.0.CO;2-9; Nielsen J, 2011, NAT BIOTECHNOL, V29, P693, DOI 10.1038/nbt.1937; Papini M, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-136; Papini M, 2012, APPL MICROBIOL BIOT, V95, P1001, DOI 10.1007/s00253-012-3936-0; Paradise EM, 2008, BIOTECHNOL BIOENG, V100, P371, DOI 10.1002/bit.21766; Peralta-Yahya PP, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1494; Polakowski T, 1998, APPL MICROBIOL BIOT, V49, P66, DOI 10.1007/s002530051138; Pronk JT, 1996, YEAST, V12, P1607, DOI 10.1002/(SICI)1097-0061(199612)12:16<1607::AID-YEA70>3.0.CO;2-4; Przybyla-Zawislak B, 1999, GENETICS, V152, P153; Rico J, 2010, APPL ENVIRON MICROB, V76, P6449, DOI 10.1128/AEM.02987-09; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Sarria S, 2014, ACS SYNTH BIOL, V3, P466, DOI 10.1021/sb4001382; Scalcinati G, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-117; Scalcinati G, 2012, METAB ENG, V14, P91, DOI 10.1016/j.ymben.2012.01.007; Shiba Y, 2007, METAB ENG, V9, P160, DOI 10.1016/j.ymben.2006.10.005; Tang XL, 2013, METAB ENG, V16, P95, DOI 10.1016/j.ymben.2013.01.003; Tippmann S, 2013, BIOTECHNOL J, V8, P1435, DOI 10.1002/biot.201300028; vandenBerg MA, 1996, J BIOL CHEM, V271, P28953, DOI 10.1074/jbc.271.46.28953; VERDUYN C, 1991, ANTON LEEUW INT J G, V60, P325, DOI 10.1007/BF00430373; Verwaal R, 2007, APPL ENVIRON MICROB, V73, P4342, DOI 10.1128/AEM.02759-06; Westfall PJ, 2012, P NATL ACAD SCI USA, V109, P111, DOI 10.1073/pnas.1110740109	68	19	21	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0144981	10.1371/journal.pone.0144981	http://dx.doi.org/10.1371/journal.pone.0144981			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26701782	gold, Green Submitted, Green Published			2022-12-26	WOS:000367092600039
J	Herberich, SE; Klose, R; Moll, I; Yang, WJ; Wustehube-Lausch, J; Fischer, A				Herberich, Stefanie E.; Klose, Ralph; Moll, Iris; Yang, Wan-Jen; Wuestehube-Lausch, Joycelyn; Fischer, Andreas			ANKS1B Interacts with the Cerebral Cavernous Malformation Protein-1 and Controls Endothelial Permeability but Not Sprouting Angiogenesis	PLOS ONE			English	Article							CELL-CELL JUNCTIONS; VASCULAR INTEGRITY; RHO KINASE; KRIT1; PATHOGENESIS; CCM2; MECHANISM; COMPLEX; RAP1; STABILIZATION	Cerebral cavernous malformations are fragile blood vessel conglomerates in the central nervous system that are caused by mutations in the CCM1/KRIT1, CCM2 or CCM3 genes. The gene products form a protein complex at adherens junctions and loss of either CCM protein disrupts endothelial cell quiescence leading to increased permeability and excessive angiogenesis. We performed a yeast 2-hybrid screen to identify novel proteins directly interacting with KRIT1. The ankyrin repeat and sterile alpha motif domain-containing protein 1B (ANKS1B) was identified as a novel binding partner of KRIT1. Silencing of ANKS1B or the related gene ANKS1A in primary human endothelial cells had no significant effects on cellular proliferation, migration and sprouting angiogenesis. However, silencing of ANKS1B expression disturbed endothelial cell barrier functions leading to increased permeability. Forced ANKS1B expression reduced permeability. This was independent of Rho kinase activity and the presence of KRIT1. Taken together, ANKS1B was identified as a novel KRIT1-interacting protein that selectively controls endothelial permeability but not angiogenesis.	[Herberich, Stefanie E.; Klose, Ralph; Moll, Iris; Yang, Wan-Jen; Wuestehube-Lausch, Joycelyn; Fischer, Andreas] German Canc Res Ctr DKFZ ZMBH Alliance, Vasc Signaling & Canc A270, D-69120 Heidelberg, Germany; [Herberich, Stefanie E.; Wuestehube-Lausch, Joycelyn; Fischer, Andreas] Heidelberg Univ, Med Fac Mannheim CBTM, Vasc Biol & Tumor Angiogenesis, D-68167 Mannheim, Germany; [Fischer, Andreas] Univ Heidelberg Hosp, Dept Med & Clin Chem 1, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Klose, R (corresponding author), German Canc Res Ctr DKFZ ZMBH Alliance, Vasc Signaling & Canc A270, D-69120 Heidelberg, Germany.	r.klose@dkfz-heidelberg.de; a.fischer@dkfz-heidelberg.de			EU; BMBF (ERA-NET Neuron grant CCM); Deutsche Forschungsgemeinschaft (DFG) [SFB-TR23]	EU(European Commission); BMBF (ERA-NET Neuron grant CCM)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by grants of the EU and BMBF (ERA-NET Neuron grant CCM) and the Deutsche Forschungsgemeinschaft (DFG; SFB-TR23). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Batra S, 2009, NAT REV NEUROL, V5, P659, DOI 10.1038/nrneurol.2009.177; Borikova AL, 2010, J BIOL CHEM, V285, P11760, DOI 10.1074/jbc.C109.097220; Boulday G, 2009, DIS MODEL MECH, V2, P168, DOI 10.1242/dmm.001263; Brutsch R, 2010, CIRC RES, V107, P592, DOI 10.1161/CIRCRESAHA.110.217257; Chan AC, 2011, J CLIN INVEST, V121, P1871, DOI 10.1172/JCI44393; Cunningham K, 2011, HUM MOL GENET, V20, P3198, DOI 10.1093/hmg/ddr225; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Faurobert E, 2013, J CELL BIOL, V202, P545, DOI 10.1083/jcb.201303044; Faurobert E, 2010, FEBS J, V277, P1084, DOI 10.1111/j.1742-4658.2009.07537.x; Fischer A, 2013, TRENDS MOL MED, V19, P302, DOI 10.1016/j.molmed.2013.02.004; Fisher OS, 2015, J BIOL CHEM, V290, P2842, DOI 10.1074/jbc.M114.616433; Fu XY, 1999, ONCOGENE, V18, P4920, DOI 10.1038/sj.onc.1202874; Glading A, 2007, J CELL BIOL, V179, P247, DOI 10.1083/jcb.200705175; Glading AJ, 2010, DIS MODEL MECH, V3, P73, DOI 10.1242/dmm.003293; Gunel M, 2002, P NATL ACAD SCI USA, V99, P10677, DOI 10.1073/pnas.122354499; He Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000722; Hilder TL, 2007, J PROTEOME RES, V6, P4343, DOI 10.1021/pr0704276; Jordan BA, 2007, NAT NEUROSCI, V10, P427, DOI 10.1038/nn1867; Kim J, 2010, MOL CELL BIOL, V30, P1582, DOI 10.1128/MCB.01605-09; Kristiansen TZ, 2004, DNA RES, V11, P285; Labouge P, 2007, LANCET NEUROL, V6, P237, DOI 10.1016/S1474-4422(07)70053-4; Liu JJ, 2011, MOL BIOL CELL, V22, P2509, DOI 10.1091/mbc.E11-02-0157; Liu WZ, 2013, MOL CELL, V49, P719, DOI 10.1016/j.molcel.2012.12.005; Maddaluno L, 2013, NATURE, V498, P492, DOI 10.1038/nature12207; Pagenstecher A, 2009, HUM MOL GENET, V18, P911, DOI 10.1093/hmg/ddn420; Pandey A, 2002, ONCOGENE, V21, P8029, DOI 10.1038/sj.onc.1205988; Stockton RA, 2010, J EXP MED, V207, P881, DOI 10.1084/jem.20091258; Whitehead KJ, 2009, NAT MED, V15, P177, DOI 10.1038/nm.1911; Wustehube J, 2010, P NATL ACAD SCI USA, V107, P12640, DOI 10.1073/pnas.1000132107; Zawistowski JS, 2002, HUM MOL GENET, V11, P389, DOI 10.1093/hmg/11.4.389; Zawistowski JS, 2005, HUM MOL GENET, V14, P2521, DOI 10.1093/hmg/ddi256; Zhang J, 2001, HUM MOL GENET, V10, P2953, DOI 10.1093/hmg/10.25.2953; Zhang J, 2007, NEUROSURGERY, V60, P353, DOI 10.1227/01.NEU.0000249268.11074.83; Zheng XJ, 2010, J CLIN INVEST, V120, P2795, DOI 10.1172/JCI39679; Zhong J, 2011, J PROTEOMICS, V74, P294, DOI 10.1016/j.jprot.2010.11.006	36	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145304	10.1371/journal.pone.0145304	http://dx.doi.org/10.1371/journal.pone.0145304			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26698571	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092600063
J	Holldorf, ET; Siers, SR; Richmond, JQ; Klug, PE; Reed, RN				Holldorf, Elden T.; Siers, Shane R.; Richmond, Jonathan Q.; Klug, Page E.; Reed, Robert N.			Invaded Invaders: Infection of Invasive Brown Treesnakes on Guam by an Exotic Larval Cestode with a Life Cycle Comprised of Non-Native Hosts	PLOS ONE			English	Article							ENEMY RELEASE HYPOTHESIS; REPRODUCTIVE SUCCESS; CYSTEINE PROTEINASE; BOIGA-IRREGULARIS; CONDITION INDEXES; PACIFIC ISLAND; PARASITE LOAD; SELECTION; ECOLOGY; FITNESS	Background Multiple host introductions to the same non-native environment have the potential to complete life cycles of parasites incidentally transported with them. Our goal was to identify a recently detected parasitic flatworm in the invasive Brown Treesnake (Boiga irregularis) on the remote Pacific island of Guam. We considered possible factors influencing parasite transmission, and tested for correlations between infection status and potential indicators of host fitness. We used genetic data from the parasite and information about the native ranges of other possible non-native hosts to hypothesize how it arrived on Guam and how its life cycle may be currently supported. Methods We identified the parasite by comparing larval morphology and mtDNA sequences with other Pseudophyllid tapeworms. We assessed probability of infection in individual snakes using logistic regression and examined different factors influencing presence of parasites in hosts. Results We identified the parasite as the pseudophyllid cestode Spirometra erinaceieuropaei, with all sampled worms from multiple snakes sharing a single mtDNA haplotype. Infection appears to be limited to the only freshwater watershed on the island, where infection prevalence was high (77.5%). Larger snakes had a higher probability of being infected, consistent with the chronic nature of such infections. While infection status was positively correlated with body condition, infected snakes tended to have lower intra-peritoneal fat body mass, potentially indicating a negative effect on energy stores. Conclusions We discovered that B. irregularis inhabiting a small area of forested habitat in a freshwater watershed on Guam are often infected by a novel parasite of Asian origin. While further work is needed, this species of Spirometra, itself a non-native species, likely depends on a suite of recently introduced hosts from different parts of the world to complete the life cycle. This baseline study provides little evidence of any effects on host fitness, but additional data are needed to more thoroughly explore the consequences of infection in this invasive snake population.	[Holldorf, Elden T.] Cherokee Serv Grp LLC, Yigo, GU 96929 USA; [Siers, Shane R.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Richmond, Jonathan Q.] US Geol Survey, Western Ecol Res Ctr, San Diego, CA USA; [Klug, Page E.; Reed, Robert N.] US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO USA	Colorado State University; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Holldorf, ET (corresponding author), Cherokee Serv Grp LLC, Yigo, GU 96929 USA.	eholldorf@usgs.gov	Morand, Serge/M-5433-2018	Morand, Serge/0000-0003-3986-7659; Klug, Page/0000-0002-0836-3901	U.S. Department of the Navy (MIPR) [N61755-13-MP-001GS]; U.S. Department of the Interior's Office of Insular Affairs; Invasive Species Program of the U.S. Geological Survey	U.S. Department of the Navy (MIPR); U.S. Department of the Interior's Office of Insular Affairs; Invasive Species Program of the U.S. Geological Survey	Funding for this project was provided by the U.S. Department of the Navy (MIPR #N61755-13-MP-001GS; navy.mil), U.S. Department of the Interior's Office of Insular Affairs (doi.gov//oia), and the Invasive Species Program of the U.S. Geological Survey (usgs.gov/ecosystems/invasive_species). No funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altizer SM, 2011, PATHOGENS CONSERVATI; Amundsen PA, 2013, OECOLOGIA, V171, P993, DOI 10.1007/s00442-012-2461-2; [Anonymous], 2014, TRACER V1 6; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Brown GP, 2006, CAN J ZOOL, V84, P668, DOI 10.1139/Z06-044; Brown GP, 1996, CAN J ZOOL, V74, P1671; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Caudell JN, 2002, INT BIODETER BIODEGR, V49, P113, DOI 10.1016/S0964-8305(01)00111-1; Centers for Disease Control and Prevention, ATL DPDX LAB ID PAR; Christy MT, 2007, DIVERS DISTRIB, V13, P598, DOI 10.1111/j.1472-4642.2007.00378.x; Christy MT, 2010, J APPL ECOL, V47, P106, DOI 10.1111/j.1365-2664.2009.01753.x; Colautti RI, 2004, ECOL LETT, V7, P721, DOI 10.1111/j.1461-0248.2004.00616.x; Congdon J.D., 1982, Biology of Reptilia, V13, P233; Doherty PF, 2012, J ORNITHOL, V152, pS317, DOI 10.1007/s10336-010-0598-5; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; DUNLAP KD, 1995, PHYSIOL ZOOL, V68, P608, DOI 10.1086/physzool.68.4.30166347; Hadley N. F., 1985, ADAPTIVE ROLE LIPIDS; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Jakob EM, 1996, OIKOS, V77, P61, DOI 10.2307/3545585; KENNEDY CEJ, 1987, BEHAV ECOL SOCIOBIOL, V21, P291, DOI 10.1007/BF00299966; KENNEDY CR, 1994, PARASITOLOGY, V109, P187, DOI 10.1017/S0031182000076290; Klein SL, 2005, BEHAV PROCESS, V68, P219, DOI 10.1016/j.beproc.2004.07.009; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lee S.-H., 1990, Korean Journal of Parasitology, V28, P161, DOI 10.3347/kjp.1990.28.3.161; Lemey P, 2010, MOL BIOL EVOL, V27, P1877, DOI 10.1093/molbev/msq067; Li MW, 2008, ELECTROPHORESIS, V29, P2912, DOI 10.1002/elps.200700752; Liu H, 2006, BIOL INVASIONS, V8, P1535, DOI 10.1007/s10530-005-5845-y; Liu W, 2010, VET PARASITOL, V173, P152, DOI 10.1016/j.vetpar.2010.06.005; Mankin RW, 2010, J ECON ENTOMOL, V103, P1135, DOI 10.1603/EC09214; MARLER T. E., 2011, J ENVIRON SCI ENG, V5, P1198; Mayer M, 2015, AUSTR ECOL IN PRESS; MOLLER AP, 1990, J EVOLUTION BIOL, V3, P319, DOI 10.1046/j.1420-9101.1990.3050319.x; Moore J., 2002, PARASITES BEHAV ANIM; Phares K, 1996, J PARASITOL, V82, P210, DOI 10.2307/3284147; Popovic Vera, 2002, Hormones (Athens), V1, P204; Poulin R, 2003, J BIOGEOGR, V30, P837, DOI 10.1046/j.1365-2699.2003.00868.x; Prenter J, 2004, TRENDS ECOL EVOL, V19, P385, DOI 10.1016/j.tree.2004.05.002; Preston BT, 2003, P ROY SOC B-BIOL SCI, V270, P633, DOI 10.1098/rspb.2002.2268; Reed P, 1968, J PARASITOL, V54, P51; Richmond JQ, 2015, BIOL INVASIONS, V17, P337, DOI 10.1007/s10530-014-0733-y; Richmond JQ, 2012, 10SISEED01007SI1733; Rodda GH, 1997, BIOSCIENCE, V47, P565, DOI 10.2307/1313163; Rodda GH, 1999, PROBLEM SNAKE MANAGEMENT, P44; Rodda GH, 2007, PAC SCI, V61, P307, DOI 10.2984/1534-6188(2007)61[307:BAIOPI]2.0.CO;2; Rodda Gordon H., 2007, P257; SAVIDGE JA, 1987, ECOLOGY, V68, P660, DOI 10.2307/1938471; Schulte-Hostedde AI, 2004, BEHAV ECOL SOCIOBIOL, V55, P272, DOI 10.1007/s00265-003-0707-z; Shaw JC, 2010, J PARASITOL, V96, P482, DOI 10.1645/GE-2188.1; SONG CY, 1993, J PARASITOL, V79, P517, DOI 10.2307/3283376; Sorci G, 1995, J EVOLUTION BIOL, V8, P711, DOI 10.1046/j.1420-9101.1995.8060711.x; Stevenson RD, 2006, INTEGR COMP BIOL, V46, P1169, DOI 10.1093/icb/icl052; Tyrrell CL, 2009, J APPL ECOL, V46, P128, DOI 10.1111/j.1365-2664.2008.01591.x; Wang F, 2014, SCI WORLD J; Wang FM, 2011, J PARASITOL, V97, P170, DOI 10.1645/GE-2519.1; WHITTIER JM, 1998, SURVEY PARASITES DIS; Zhu XQ, 2002, MOL CELL PROBE, V16, P159, DOI 10.1006/mcpr.2001.0406	57	5	5	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0143718	10.1371/journal.pone.0143718	http://dx.doi.org/10.1371/journal.pone.0143718			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26699614	Green Published, gold			2022-12-26	WOS:000367092600007
J	Li, ZG; Fan, KS; Tian, LD; Shi, BL; Zhang, SH; Zhang, JJ				Li, Zhiguo; Fan, Kuangsheng; Tian, Lide; Shi, Benlin; Zhang, Shuhong; Zhang, Jingjing			Response of Glacier and Lake Dynamics in Four Inland Basins to Climate Change at the Transition Zone between the Karakorum And Himalayas	PLOS ONE			English	Article							TIBETAN PLATEAU; IMPACTS; REGION; EXPANSION; EVEREST; CHINA; SHAN	Inland glacier and lake dynamics on the Tibetan Plateau (TP) and its surroundings over recent decades are good indicators of climate change and have a significant impact on the local water supply and ecosystem. The glacier and lake changes in Karakoram are quite different from those of the Himalayas. The mechanisms of the complex and regionally heterogeneous behavior of the glacier and lake changes between the Karakorum and Himalayas are poorly understood. Based on satellite images and meteorological data of Shiquanhe, Hetian, and Yutian stations, we demonstrate that the overall retreat of glaciers and increase of lake area at the transition zone between the Karakoram and Himalayas (TKH) have occurred since 1968 in response to a significant global climate change. Glacial areas in the Songmuxi Co basin, Zepu Co basin, Mang Co basin and Unnamed Co decreased by -1.98 +/- 0.02 km(2), -5.39 +/- 0.02 km(2), -0.01 +/- 0.02 km(2), and -0.12 +/- 0.02 km(2) during the study period, corresponding to losses of -1.42%, -2.86%, -1.54%, and -1.57%, respectively. The lake area of the Songmuxi Co, Zepu Co, Mang Co and Unnamed Co increased by 7.57 +/- 0.02 km(2), 8.53 +/- 0.02 km(2), 1.35 +/- 0.02 km(2), and 0.53 +/- 0.02 km(2), corresponding to growths of 30.22%, 7.55%, 11.39%, and 8.05%, respectively. Increases in temperature was the main reason for glacier retreat, whereas decreases in potential evapotranspiration of lakes, increases in precipitation, and increases in melt water from glaciers and frozen soil all contributed to lake area expansion.	[Li, Zhiguo; Fan, Kuangsheng; Shi, Benlin; Zhang, Jingjing] Shangqiu Normal Univ, Coll Environm & Planning, Shangqiu, Peoples R China; [Li, Zhiguo; Tian, Lide] Chinese Acad Sci, Inst Tibetan Plateau Res, Beijing, Peoples R China; [Zhang, Shuhong] Shangqiu Normal Univ, Coll Life Sci, Shangqiu, Peoples R China	Shangqiu Normal University; Chinese Academy of Sciences; Institute of Tibetan Plateau Research, CAS; Shangqiu Normal University	Li, ZG (corresponding author), Shangqiu Normal Univ, Coll Environm & Planning, Shangqiu, Peoples R China.	lizhiguo999999@163.com			National Natural Science Foundation of China [41101072, 41025002, 31100369]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No. 41101072, No. 41025002 and No. 31100369).	Bao WJ, 2015, J MT SCI-ENGL, V12, P344, DOI 10.1007/s11629-014-3220-0; [CAS Integrated Scientific SurveyTeam of Qinghai-Tibet Plateau], 1984, CLIM IN TIB; Gardelle J, 2011, GLOBAL PLANET CHANGE, V75, P47, DOI 10.1016/j.gloplacha.2010.10.003; Gardner AS, 2013, SCIENCE, V340, P852, DOI 10.1126/science.1234532; Immerzeel WW, 2010, SCIENCE, V328, P1382, DOI 10.1126/science.1183188; Janes TJ, 2012, J CLIMATE, V25, P8308, DOI 10.1175/JCLI-D-11-00436.1; Lei YB, 2014, CLIMATIC CHANGE, V125, P281, DOI 10.1007/s10584-014-1175-3; Li Junli, 2011, Hupo Kexue, V23, P311; Li L, 2014, QUATERN INT, V349, P339, DOI 10.1016/j.quaint.2014.04.051; Li YK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111890; Li Z.G., 2011, GEOGRAPHICAL RES, V26, P836; Li ZhiGuo, 2014, Journal of Resources and Ecology, V5, P123, DOI 10.5814/j.issn.1674-764X.2014.02.004; [李治国 LI Zhiguo], 2011, [地理研究, Geographical Research], V30, P939; Liu SY, 2003, J GLACIOL, V49, P117, DOI 10.3189/172756503781830926; Neckel N, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/1/014009; Nie Y, 2013, ENVIRON EARTH SCI, V68, P251, DOI 10.1007/s12665-012-1736-6; Oerlemans J, 2005, SCIENCE, V308, P675, DOI 10.1126/science.1107046; Piao SL, 2010, NATURE, V467, P43, DOI 10.1038/nature09364; Qiu J, 2008, NATURE, V454, P393, DOI 10.1038/454393a; Raup B, 2007, COMPUT GEOSCI-UK, V33, P104, DOI 10.1016/j.cageo.2006.05.015; Shi Y.F., 2005, CONCISE CHINA GLACIE; Song CQ, 2014, WATER RESOUR RES, V50, P3170, DOI 10.1002/2013WR014724; [王解先 Wang Jiexian], 2003, [大地测量与地球动力学, Journal of Geodesy and Geodynamics], V23, P70; Wang WC, 2015, HYDROL PROCESS, V29, P859, DOI 10.1002/hyp.10199; Wang X, 2012, MT RES DEV, V32, P203, DOI 10.1659/MRD-JOURNAL-D-11-00044.1; Wei JF, 2015, ARCT ANTARCT ALP RES, V47, P301, DOI 10.1657/AAAR00C-13-129; Wiltshire AJ, 2014, CRYOSPHERE, V8, P941, DOI 10.5194/tc-8-941-2014; Xu BQ, 2009, P NATL ACAD SCI USA, V106, P22114, DOI [10.1073/pnas.0910444106, 10.1073/pnas.pnas.0910444106]; Yang K, 2014, GLOBAL PLANET CHANGE, V112, P79, DOI 10.1016/j.gloplacha.2013.12.001; Yang XG, 2011, ARCT ANTARCT ALP RES, V43, P147, DOI 10.1657/1938-4246-43.1.147; Yao TD, 2012, NAT CLIM CHANGE, V2, P663, DOI [10.1038/NCLIMATE1580, 10.1038/nclimate1580]; Yao TD, 2010, CHINESE SCI BULL, V55, P2071, DOI 10.1007/s11434-010-4327-5; Yao XJ, 2014, J GEOGR SCI, V24, P689, DOI 10.1007/s11442-014-1113-3; Ye QH, 2008, J GLACIOL, V54, P933, DOI 10.3189/002214308787779997; Zhang GQ, 2015, GLOBAL PLANET CHANGE, V131, P148, DOI 10.1016/j.gloplacha.2015.05.013; Zhang GQ, 2013, GEOPHYS RES LETT, V40, P2125, DOI 10.1002/grl.50462	36	3	4	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0144696	10.1371/journal.pone.0144696	http://dx.doi.org/10.1371/journal.pone.0144696			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26699717	gold, Green Published, Green Submitted			2022-12-26	WOS:000367092600028
J	Campos, RC; Hernandez, MIM				Campos, Renata Calixto; Medina Hernandez, Malva Isabel			The Importance of Maize Management on Dung Beetle Communities in Atlantic Forest Fragments	PLOS ONE			English	Article							ARTHROPOD PREDATORS; COLEOPTERA; BIODIVERSITY; SCARABAEIDAE; SECONDARY; CONSERVATION; ASSEMBLAGES; HERBIVORES; PROSPECTS; RICHNESS	Dung beetle community structures changes due to the effects of destruction, fragmentation, isolation and decrease in tropical forest area, and therefore are considered ecological indicators. In order to assess the influence of type of maize cultivated and associated maize management on dung beetle communities in Atlantic Forest fragments surrounded by conventional and transgenic maize were evaluated 40 Atlantic Forest fragments of different sizes, 20 surrounded by GM maize and 20 surrounded by conventional maize, in February 2013 and 2014 in Southern Brazil. After applying a sampling protocol in each fragment (10 pitfall traps baited with human feces or carrion exposed for 48 h), a total of 3454 individuals from 44 species were captured: 1142 individuals from 38 species in GM maize surrounded fragments, and 2312 from 42 species in conventional maize surrounded fragments. Differences in dung beetle communities were found between GM and conventional maize communities. As expected for fragmented areas, the covariance analysis showed a greater species richness in larger fragments under both conditions; however species richness was greater in fragments surrounded by conventional maize. Dung beetle structure in the forest fragments was explained by environmental variables, fragment area, spatial distance and also type of maize (transgenic or conventional) associated with maize management techniques. In Southern Brazil's scenario, the use of GM maize combined with associated agricultural management may be accelerating the loss of diversity in Atlantic Forest areas, and consequently, important ecosystem services provided by dung beetles may be lost.	[Campos, Renata Calixto; Medina Hernandez, Malva Isabel] Univ Fed Santa Catarina, Programa Posgrad Ecol, Dept Ecol & Zool, Florianopolis, SC, Brazil	Universidade Federal de Santa Catarina (UFSC)	Campos, RC (corresponding author), Univ Fed Santa Catarina, Programa Posgrad Ecol, Dept Ecol & Zool, Florianopolis, SC, Brazil.	recalixtocampos@gmail.com	Hernandez, Malva I. M./E-3485-2013	Hernandez, Malva I. M./0000-0002-6820-5980	Genok (Centre for Biosafety/Norway); CAPES (Ministry of Education of Brazil); CNPQ (Science and Technology Ministry of Brazil) [309030/2013-7]	Genok (Centre for Biosafety/Norway); CAPES (Ministry of Education of Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPQ (Science and Technology Ministry of Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors thank Genok (Centre for Biosafety/Norway) for project support. RCC thanks CAPES (Ministry of Education of Brazil) for a PhD Grant. MIMH thanks CNPQ (Science and Technology Ministry of Brazil, Proc. 309030/2013-7) for a Productivity Grant.; We would like to thank Dr. Fernando Vaz-de-Mello from Universidade Federal do Mato Grosso/Brazil for confirmation of the dung beetle identification and Dr. Pedro Giovani da Silva and Dr. Eduardo Giehl from Universidade Federal de Santa Catarina/Brazil for helping in data analysis. We are grateful to the farmers for collection permission and Daniel Lira, Moacyr Batilani-Filho, Juliano Bogoni, Georgina Catacora, Leticia Filipini, Victor Michelon Alves and Marcelo Agudelo for helping during fieldwork. We also thank Dr. Rubens Nodari from Universidade Federal de Santa Catarina/Brazil who is the head of the project and GenOk (Centre for Biosafety/Norway) for project support. RCC thanks CAPES (Ministry of Education of Brazil) for a PhD Grant and MIMH thanks CNPQ (Science and Technology Ministry of Brazil, Proc. 309030/2013-7) for a Productivity Grant.	Andresen E, 2007, BIOTROPICA, V39, P141, DOI 10.1111/j.1744-7429.2006.00239.x; Arellano L, 2008, LANDSCAPE ECOL, V23, P69, DOI 10.1007/s10980-007-9165-8; Noriega JA, 2011, J TROP ECOL, V27, P111, DOI 10.1017/S0266467410000581; Barlow J, 2007, P NATL ACAD SCI USA, V104, P18555, DOI 10.1073/pnas.0703333104; Barlow J, 2010, J APPL ECOL, V47, P779, DOI 10.1111/j.1365-2664.2010.01825.x; Bogoni JA, 2014, J INSECT SCI, V14, DOI 10.1093/jisesa/ieu161; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Brower J.E., 1998, FIELD LAB METHODS GE; Campos RC, 2015, ECOL INDIC, V49, P216, DOI 10.1016/j.ecolind.2014.09.043; Campos RC, 2013, REV BRAS ENTOMOL, V57, P47, DOI 10.1590/S0085-56262013000100008; Catarino R, 2015, PLANT BIOTECHNOL J, V13, P601, DOI 10.1111/pbi.12363; Clarke K., 2001, PRIMER V5 USER MANUA; Colwell RK, 2013, ESTIMATES STAT ESTIM; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; Culot L, 2013, BIOL CONSERV, V163, P79, DOI 10.1016/j.biocon.2013.04.004; da Silva PG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126112; da Silva PG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111883; Davis Adrian L. V., 2001, Diversity and Distributions, V7, P161, DOI 10.1111/j.1472-4642.2001.00102.x; Davis AJ, 2001, J APPL ECOL, V38, P593, DOI 10.1046/j.1365-2664.2001.00619.x; Davis ALV, 2005, ENVIRON ENTOMOL, V34, P1081, DOI 10.1603/0046-225X(2005)034[1081:EODOAS]2.0.CO;2; Duan JJ, 2010, BIOL LETTERS, V6, P74, DOI 10.1098/rsbl.2009.0612; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA), 2015, MILH TRANSG MAN PLAT; Estrada A, 1999, AM J PRIMATOL, V48, P253, DOI 10.1002/(SICI)1098-2345(1999)48:4&lt;253::AID-AJP1&gt;3.0.CO;2-D; Favila Mario E., 1997, Acta Zoologica Mexicana Nueva Serie, V72, P1; Filgueiras BKC, 2011, BIOL CONSERV, V144, P362, DOI 10.1016/j.biocon.2010.09.013; Fuck MP, 2009, REV IBEROAM CIENC TE, V12, P9; Galindo-Leal C, 2003, STATE HOTS, P3; Gardner TA, 2008, J APPL ECOL, V45, P883, DOI 10.1111/j.1365-2664.2008.01454.x; Gardner TA, 2008, ECOL LETT, V11, P139, DOI 10.1111/j.1461-0248.2007.01133.x; Gardner TA, 2009, ECOL LETT, V12, P561, DOI 10.1111/j.1461-0248.2009.01294.x; Gronsberg I. M., 2011, Food and Nutrition Sciences, V2, P377; Guertler P, 2010, LIVEST SCI, V131, P250, DOI 10.1016/j.livsci.2010.04.010; Halffter G., 1982, The nesting behavior of dung beetles (Scarabaeinae). An ecological and evolutive approach.; Halffter G, 2002, BIOTROPICA, V34, P144, DOI 10.1111/j.1744-7429.2002.tb00250.x; HALFFTER GONZALO, 1966, FOLIA ENTOMOL MEX, V12/14, P1; Halffter Gonzalo, 1993, Biology International, V27, P15; Hanski I., 1991, DUNG BEETLE ECOLOGY; Harwood JD, 2005, MOL ECOL, V14, P2815, DOI 10.1111/j.1365-294X.2005.02611.x; Hernandez MIM, 2014, J INSECT CONSERV, V18, P539, DOI 10.1007/s10841-014-9645-5; Hilbeck A., 2006, BIOPESTIC INT, V2, P1; Hilbeck A, 2008, EUPHYTICA, V164, P903, DOI 10.1007/s10681-008-9666-9; Karam D, 2008, MANUAL MANEJO CONTRO, P659; KLEIN BC, 1989, ECOLOGY, V70, P1715, DOI 10.2307/1938106; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Leite PF, 1990, GEOGRAFIA BRASIL; Lovei GL, 2009, ENVIRON ENTOMOL, V38, P293, DOI 10.1603/022.038.0201; Lumaret Jean-Pierre, 2005, Acta Zool. Mex, V21, P137; Lumaret JP, 2002, VET RES, V33, P547, DOI 10.1051/vetres:2002038; Lutz B, 2005, J AGR FOOD CHEM, V53, P1453, DOI 10.1021/jf049222x; Martinez IM, 2001, CR ACAD SCI III-VIE, V324, P989, DOI 10.1016/S0764-4469(01)01384-1; Martinez M Imelda, 2009, Acta Zoologica Mexicana Nueva Serie, V25, P673; Martinez-M. Imelda, 1995, Elytron (Barcelona), V9, P5; Marvier M, 2007, SCIENCE, V316, P1475, DOI 10.1126/science.1139208; McGeoch MA, 2002, J APPL ECOL, V39, P661, DOI 10.1046/j.1365-2664.2002.00743.x; Hernandez MIM, 2009, REV BRAS ENTOMOL, V53, P607, DOI 10.1590/S0085-56262009000400010; Naranjo S. E., 2009, CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources, V4, P1, DOI 10.1079/PAVSNNR20094011; Nichols E, 2008, BIOL CONSERV, V141, P1461, DOI 10.1016/j.biocon.2008.04.011; Nichols E, 2007, BIOL CONSERV, V137, P1, DOI 10.1016/j.biocon.2007.01.023; Nichols E, 2009, OIKOS, V118, P481, DOI 10.1111/j.1600-0706.2009.17268.x; Obrist LB, 2006, ECOL ENTOMOL, V31, P143, DOI 10.1111/j.0307-6946.2006.00762.x; Obrycki JJ, 2001, BIOSCIENCE, V51, P353, DOI 10.1641/0006-3568(2001)051[0353:TICBIT]2.0.CO;2; Pandolfo C, 2002, ATLAS CLIMATICO DIGI; Paul V, 2010, TRANSGENIC RES, V19, P683, DOI 10.1007/s11248-009-9339-z; PECK SB, 1982, CAN J ZOOL, V60, P1624, DOI 10.1139/z82-213; R Core Team, 2021, R LANGUAGE ENV STAT; Ramirez-Romero R, 2008, ECOTOX ENVIRON SAFE, V70, P327, DOI 10.1016/j.ecoenv.2007.12.002; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Roslin Tomas, 2011, P220; Simmons L.W., 2011, ECOLOGY EVOLUTION DU, DOI 10.1002/9781444342000; Slade EM, 2007, J ANIM ECOL, V76, P1094, DOI 10.1111/j.1365-2656.2007.01296.x; Tabarelli M, 2010, BIOL CONSERV, V143, P2328, DOI 10.1016/j.biocon.2010.02.005; Then C, 2010, ENVIRON SCI POLLUT R, V17, P791, DOI 10.1007/s11356-009-0208-3; Vachon V, 2012, J INVERTEBR PATHOL, V111, P1, DOI 10.1016/j.jip.2012.05.001; Vaz-de-Mello FZ, 2012, ZOOTAXA, V2854, P1; Verdu JR, 2015, SCI REP-UK, V5, DOI 10.1038/srep13912; Wolfenbarger LL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002118; Zuur Alain F., 2009, P1; Zwahlen Claudia, 2005, Environmental Biosafety Research, V4, P113, DOI 10.1051/ebr:2005014	79	7	9	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145000	10.1371/journal.pone.0145000	http://dx.doi.org/10.1371/journal.pone.0145000			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26694874	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092500020
J	Wang, YY; Surzenko, N; Friday, WB; Zeisel, SH				Wang, Yanyan; Surzenko, Natalia; Friday, Walter B.; Zeisel, Steven H.			Maternal dietary intake of choline in mice regulates development of the cerebral cortex in the offspring	FASEB JOURNAL			English	Article						neurogenesis; EGFR; cortical development	EPIDERMAL-GROWTH-FACTOR; EMBRYONIC-DEVELOPMENT ALTERS; AVAILABILITY ALTERS; MOUSE HIPPOCAMPUS; PROGENITOR CELLS; DNA METHYLATION; GENE-EXPRESSION; FACTOR RECEPTOR; MESSENGER-RNA; EGF RECEPTOR	Maternal diets low in choline, an essential nutrient, increase the risk of neural tube defects and lead to low performance on cognitive tests in children. However, the consequences of maternal dietary choline deficiency for the development and structural organization of the cerebral cortex remain unknown. In this study, we fed mouse dams either control (CT) or low-choline (LC) diets and investigated the effects of choline on cortical development in the offspring. As a result of a low choline supply between embryonic day (E) 11 and E17 of gestation, the number of 2 types of cortical neural progenitor cells (NPCs)-radial glial cells and intermediate progenitor cells-was reduced in fetal brains (P < 0.01). Furthermore, the number of upper layer cortical neurons was decreased in the offspring of dams fed an LC diet at both E17 (P < 0.001) and 4mo of age (P < 0.001). These effects of LC maternal diet were mediated by a decrease in epidermal growth factor receptor (EGFR) signaling in NPCs related to the disruption of EGFR posttranscriptional regulation. Our findings describe a novel mechanism whereby low maternal dietary intake of choline alters brain development.-Wang, Y., Surzenko, N., Friday, W. B., Zeisel, S. H. Maternal dietary intake of choline in mice regulates development of the cerebral cortex in the offspring. FASEB J. 30, 1566-1578 (2016). www.fasebj.org	[Wang, Yanyan; Surzenko, Natalia; Friday, Walter B.; Zeisel, Steven H.] Univ North Carolina Chapel Hill, Inst Nutr Res, Kannapolis, NC 28081 USA; [Wang, Yanyan] Third Mil Med Univ, Dept Med Genet, Chongqing, Peoples R China; [Surzenko, Natalia; Zeisel, Steven H.] Univ N Carolina, Dept Nutr, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; Army Medical University; University of North Carolina; University of North Carolina Chapel Hill	Zeisel, SH (corresponding author), Univ North Carolina Chapel Hill, Inst Nutr Res, Kannapolis, NC 28081 USA.	steven_zeisel@unc.edu			North Carolina Biotechnology Center [2012-CFG-8005]; U.S. National Institutes of Health, Diabetes and Digestive and Kidney Diseases [DK056350]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	North Carolina Biotechnology Center; U.S. National Institutes of Health, Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank Dr. G. Enikolopov for the Nestin-CFP mouse line; Dr. S. Rosenfeld for the EGFR-eGFP and CLE-eGFP; S. Orena for help with flow cytometry; M. G. Mehedint for help with the NPC culture; K. D. Corbin for help with Western blot and immunoprecipitation analysis; and the other members of the Zeisel laboratory for technical assistance. This work was supported by North Carolina Biotechnology Center Grant 2012-CFG-8005 and U.S. National Institutes of Health, Diabetes and Digestive and Kidney Diseases Grant DK056350. S.H.Z. owns equity in Nutrigene Sciences, and is a consultant for Dupont, Metabolon and Nestle. None of these activities are in conflict with this paper. The authors declare no conflicts of interest.	Albright CD, 2005, DEV BRAIN RES, V159, P149, DOI 10.1016/j.devbrainres.2005.07.002; Albright CD, 2005, CELL PHYSIOL BIOCHEM, V15, P59, DOI 10.1159/000083653; Albright CD, 2003, NUTR NEUROSCI, V6, P129, DOI 10.1080/1028415031000084418; Albright CD, 2001, DEV NEUROSCI-BASEL, V23, P100, DOI 10.1159/000048701; Albright CD, 1999, DEV BRAIN RES, V113, P13, DOI 10.1016/S0165-3806(98)00183-7; Boeke CE, 2013, AM J EPIDEMIOL, V177, P1338, DOI 10.1093/aje/kws395; Burrows RC, 1997, NEURON, V19, P251, DOI 10.1016/S0896-6273(00)80937-X; Burrows RT, 2000, DEV NEUROSCI-BASEL, V22, P7, DOI 10.1159/000017422; Caric D, 2001, DEVELOPMENT, V128, P4203; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Craciunescu CN, 2003, J NUTR, V133, P3614, DOI 10.1093/jn/133.11.3614; Dominguez-Salas P, 2013, AM J CLIN NUTR, V97, P1217, DOI 10.3945/ajcn.112.048462; Eagleson KL, 1996, CEREB CORTEX, V6, P540, DOI 10.1093/cercor/6.3.540; Encinas JM, 2006, P NATL ACAD SCI USA, V103, P8233, DOI 10.1073/pnas.0601992103; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Gebhardt ML, 2014, NUCLEIC ACIDS RES, V42, P5436, DOI 10.1093/nar/gku231; Glenn MJ, 2007, EUR J NEUROSCI, V25, P2473, DOI 10.1111/j.1460-9568.2007.05505.x; Gossell-Williams M, 2005, W INDIAN MED J, V54, P355; Guo-Ross SX, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-01-j0005.2002; Henson RNA, 2002, NEUROIMAGE, V17, P543, DOI 10.1006/nimg.2002.1229; Holmes GL, 2002, EPILEPSY RES, V48, P3, DOI 10.1016/S0920-1211(01)00321-7; Ivkovic S, 2008, J NEUROSCI, V28, P914, DOI 10.1523/JNEUROSCI.4327-07.2008; Jones M. W., 2002, Current Molecular Medicine (Hilversum), V2, P639, DOI 10.2174/1566524023361989; Kornblum HI, 1999, EUR J NEUROSCI, V11, P3236, DOI 10.1046/j.1460-9568.1999.00744.x; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; LAZAR LM, 1992, J NEUROSCI, V12, P1688; Lemcke H, 2013, CELL SIGNAL, V25, P2676, DOI 10.1016/j.cellsig.2013.08.030; Lo HW, 2006, BRIT J CANCER, V94, P184, DOI 10.1038/sj.bjc.6602941; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; MECK WH, 1988, DEV PSYCHOBIOL, V21, P339, DOI 10.1002/dev.420210405; MECK WH, 1989, BEHAV NEUROSCI, V103, P1234, DOI 10.1037/0735-7044.103.6.1234; Meck WH, 1999, DEV BRAIN RES, V118, P51, DOI 10.1016/S0165-3806(99)00105-4; Meck WH, 2003, NEUROSCI BIOBEHAV R, V27, P385, DOI 10.1016/S0149-7634(03)00069-1; Mehedint MG, 2010, P NATL ACAD SCI USA, V107, P12834, DOI 10.1073/pnas.0914328107; Mehedint MG, 2010, FASEB J, V24, P184, DOI 10.1096/fj.09-140145; Melemedjian OK, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-12; Mellott TJ, 2004, FASEB J, V18, P545, DOI 10.1096/fj.03-0877fje; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Niculescu MD, 2006, FASEB J, V20, P43, DOI 10.1096/fj.05-4707com; Niculescu MD, 2005, MOL BRAIN RES, V134, P309, DOI 10.1016/j.molbrainres.2004.11.001; Pyapali GK, 1998, J NEUROPHYSIOL, V79, P1790, DOI 10.1152/jn.1998.79.4.1790; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Resseguie M. E., 2011, J BIOL CHEM, V286, P1649; Resseguie M, 2007, FASEB J, V21, P2622, DOI 10.1096/fj.07-8227com; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; Segatto O, 2011, J CELL SCI, V124, P1785, DOI 10.1242/jcs.083303; SEROOGY KB, 1995, BRAIN RES, V670, P157, DOI 10.1016/0006-8993(94)01300-7; Shaw GM, 2006, EPIDEMIOLOGY, V17, P285, DOI 10.1097/01.ede.0000208348.30012.35; Shaw GM, 2004, AM J EPIDEMIOL, V160, P102, DOI 10.1093/aje/kwh187; Sibilia M, 1998, EMBO J, V17, P719, DOI 10.1093/emboj/17.3.719; Silver DL, 2010, NAT NEUROSCI, V13, P551, DOI 10.1038/nn.2527; Sun Y, 2005, NEURON, V45, P873, DOI 10.1016/j.neuron.2005.01.045; Thomas JD, 2007, BEHAV NEUROSCI, V121, P120, DOI 10.1037/0735-7044.121.1.120; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Wallace TC, 2014, J AM COLL NUTR, V33, P94, DOI 10.1080/07315724.2013.846806; Waterland RA, 2006, GENESIS, V44, P401, DOI 10.1002/dvg.20230; Wong RWC, 2004, CYTOKINE GROWTH F R, V15, P147, DOI 10.1016/j.cytogfr.2004.01.004; YAISH P, 1988, SCIENCE, V242, P933, DOI 10.1126/science.3263702; ZEISEL SH, 1995, J NUTR, V125, P3049; Zeisel SH, 2006, J PEDIATR-US, V149, pS131, DOI 10.1016/j.jpeds.2006.06.065; Zeisel SH, 2006, ANNU REV NUTR, V26, P229, DOI 10.1146/annurev.nutr.26.061505.111156	61	36	37	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2016	30	4					1566	1578		10.1096/fj.15-282426	http://dx.doi.org/10.1096/fj.15-282426			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DH2PR	26700730	Green Published, Green Submitted			2022-12-26	WOS:000372629100018
J	Reidy, M; Sharma, R; Roberts, BL; Masison, DC				Reidy, Michael; Sharma, Ruchika; Roberts, Brittany-Lee; Masison, Daniel C.			Human J-protein DnaJB6b Cures a Subset of Saccharomyces cerevisiae Prions and Selectively Blocks Assembly of Structurally Related Amyloids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; chaperone; heat shock protein (HSP); prion; yeast; DnaJB6	YEAST PRIONS; POLYGLUTAMINE AGGREGATION; CHAPERONE SUBFAMILY; HSP104 CHAPERONE; SHUTTLE VECTORS; IN-VITRO; PROPAGATION; HSP40; TOXICITY; HSP70	Human chaperone DnaJB6, an Hsp70 co-chaperone whose defects cause myopathies, protects cells from polyglutamine toxicity and prevents purified polyglutamine and A peptides from forming amyloid. Yeast prions [URE3] and [PSI+] propagate as amyloid forms of Ure2 and Sup35 proteins, respectively. Here we find DnaJB6-protected yeast cells from polyglutamine toxicity and cured yeast of both [URE3] prions and weak variants of [PSI+] prions but not strong [PSI+] prions. Weak and strong variants of [PSI+] differ only in the structural conformation of their amyloid cores. In line with its anti-prion effects, DnaJB6 prevented purified Sup35NM from forming amyloids at 37 degrees C, which produce predominantly weak [PSI+] variants when used to infect yeast, but not at 4 degrees C, which produces mostly strong [PSI+] variants. Thus, structurally distinct amyloids composed of the same protein were differentially sensitive to the anti-amyloid activity of DnaJB6 both in vitro and in vivo. These findings have important implications for strategies using DnaJB6 as a target for therapy in amyloid disorders.	[Reidy, Michael; Sharma, Ruchika; Roberts, Brittany-Lee; Masison, Daniel C.] NIDDK, Lab Biochem & Genet, NIH, Bldg 8,Rd 324, Bethesda, MD 20892 USA; [Sharma, Ruchika] Univ Wisconsin, HF DeLuca Biochem Labs, Madison, WI 53706 USA; [Roberts, Brittany-Lee] Florida Int Univ, Herbert Wertheim Coll Med, Miami, FL 33199 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Wisconsin System; University of Wisconsin Madison; State University System of Florida; Florida International University	Masison, DC (corresponding author), NIDDK, Lab Biochem & Genet, NIH, Bldg 8,Rd 324, Bethesda, MD 20892 USA.	danielmas@helix.nih.gov		Reidy, Michael/0000-0002-9290-7595	National Institutes of Health, NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK024954] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Intramural Program of the National Institutes of Health, NIDDK. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Brachmann A, 2005, EMBO J, V24, P3082, DOI 10.1038/sj.emboj.7600772; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Cox B, 2003, GENETICS, V165, P23; Douglas PM, 2008, P NATL ACAD SCI USA, V105, P7206, DOI 10.1073/pnas.0802593105; Funk M, 2002, METHOD ENZYMOL, V350, P248, DOI 10.1016/S0076-6879(02)50967-8; Genest O, 2013, MOL CELL, V49, P464, DOI 10.1016/j.molcel.2012.11.017; Gillis J, 2013, J BIOL CHEM, V288, P17225, DOI 10.1074/jbc.M112.421685; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Gokhale KC, 2005, J BIOL CHEM, V280, P22809, DOI 10.1074/jbc.M500390200; Gong H, 2012, PLOS GENET, V8, P223, DOI 10.1371/journal.pgen.1002634; Gorkovskiy A, 2014, P NATL ACAD SCI USA, V111, pE4615, DOI 10.1073/pnas.1417974111; Hageman J, 2010, MOL CELL, V37, P355, DOI 10.1016/j.molcel.2010.01.001; Harms MB, 2012, ANN NEUROL, V71, P407, DOI 10.1002/ana.22683; Harris JM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004510; Higurashi T, 2008, P NATL ACAD SCI USA, V105, P16596, DOI 10.1073/pnas.0808934105; Hung GC, 2006, GENETICS, V173, P611, DOI 10.1534/genetics.106.056820; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kirkland PA, 2011, GENETICS, V188, P565, DOI 10.1534/genetics.111.129460; Lian HY, 2007, J BIOL CHEM, V282, P11931, DOI 10.1074/jbc.M606856200; Lopez N, 2003, MOL BIOL CELL, V14, P1172, DOI 10.1091/mbc.E02-09-0593; Mansson C, 2014, J BIOL CHEM, V289, P31066, DOI 10.1074/jbc.M114.595124; Mansson C, 2014, CELL STRESS CHAPERON, V19, P227, DOI 10.1007/s12192-013-0448-5; Mathur V, 2009, J MOL BIOL, V390, P155, DOI 10.1016/j.jmb.2009.04.063; Meriin AB, 2002, J CELL BIOL, V157, P997, DOI 10.1083/jcb.200112104; Moriyama H, 2000, MOL CELL BIOL, V20, P8916, DOI 10.1128/MCB.20.23.8916-8922.2000; Nagai Y, 2010, CURR PHARM BIOTECHNO, V11, P188, DOI 10.2174/138920110790909650; Newnam GP, 2011, J MOL BIOL, V408, P432, DOI 10.1016/j.jmb.2011.02.034; Nigro Vincenzo, 2014, Acta Myol, V33, P1; Ohhashi Y, 2010, NAT CHEM BIOL, V6, P225, DOI 10.1038/NCHEMBIO.306; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; Reidy M, 2014, CURR PHARM BIOTECHNO, V15, P1008, DOI 10.2174/1389201015666141103021035; Reidy M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004720; Reidy M, 2012, GENETICS, V192, P185, DOI 10.1534/genetics.112.142307; Ruggieri A, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0224-0; Sahi C, 2007, P NATL ACAD SCI USA, V104, P7163, DOI 10.1073/pnas.0702357104; Sarparanta J, 2012, NAT GENET, V44, P450, DOI 10.1038/ng.1103; Schlumpberger M, 2001, MOL CELL BIOL, V21, P7035, DOI 10.1128/MCB.21.20.7035-7046.2001; Schwimmer C, 2002, MOL CELL BIOL, V22, P3590, DOI 10.1128/MCB.22.11.3590-3598.2002; Sharma D, 2008, GENETICS, V179, P1301, DOI 10.1534/genetics.108.089458; Sharma D, 2011, P NATL ACAD SCI USA, V108, P13665, DOI 10.1073/pnas.1107421108; Sharma D, 2009, GENETICS, V181, P129, DOI 10.1534/genetics.108.098699; SIKORSKI RS, 1989, GENETICS, V122, P19; Sporn ZA, 2015, PRION, V9, P80, DOI 10.1080/19336896.2015.1020268; Stein KC, 2014, MOL MICROBIOL, V93, P1156, DOI 10.1111/mmi.12725; Stein KC, 2014, J BIOL CHEM, V289, P21120, DOI 10.1074/jbc.M114.572461; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tanaka M, 2006, METHOD ENZYMOL, V412, P185, DOI 10.1016/S0076-6879(06)12012-1; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Taylor KL, 1999, SCIENCE, V283, P1339, DOI 10.1126/science.283.5406.1339; Tessarz P, 2008, MOL MICROBIOL, V68, P87, DOI 10.1111/j.1365-2958.2008.06135.x; Tipton KA, 2008, MOL CELL, V32, P584, DOI 10.1016/j.molcel.2008.11.003; Umland TC, 2001, P NATL ACAD SCI USA, V98, P1459, DOI 10.1073/pnas.041607898; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wong SH, 2015, J BIOL CHEM, V290, P25062, DOI 10.1074/jbc.M115.676379; Zhao XH, 2012, J BIOL CHEM, V287, P23346, DOI 10.1074/jbc.M111.287748	57	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					4035	4047		10.1074/jbc.M115.700393	http://dx.doi.org/10.1074/jbc.M115.700393			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26702057	Green Published, hybrid			2022-12-26	WOS:000371338400029
J	Dolman, MEM; van der Ploeg, I; Koster, J; Bate-Eya, LT; Versteeg, R; Caron, HN; Molenaar, JJ				Dolman, M. Emmy M.; van der Ploeg, Ida; Koster, Jan; Bate-Eya, Laurel Tabe; Versteeg, Rogier; Caron, Huib N.; Molenaar, Jan J.			DNA-Dependent Protein Kinase As Molecular Target for Radiosensitization of Neuroblastoma Cells	PLOS ONE			English	Article							STRAND BREAK REPAIR; CANCER-CELLS; IONIZING-RADIATION; INHIBITION; PK; GEMCITABINE; DAMAGE; IDENTIFICATION; RECOMBINATION; CYTOTOXICITY	Tumor cells might resist therapy with ionizing radiation (IR) by non-homologous end-joining (NHEJ) of IR-induced double-strand breaks. One of the key players in NHEJ is DNA-dependent protein kinase (DNA-PK). The catalytic subunit of DNA-PK, i.e. DNA-PKcs, can be inhibited with the small-molecule inhibitor NU7026. In the current study, the in vitro potential of NU7026 to radiosensitize neuroblastoma cells was investigated. DNA-PKcs is encoded by the PRKDC (protein kinase, DNA-activated, catalytic polypeptide) gene. We showed that PRKDC levels were enhanced in neuroblastoma patients and correlated with a more advanced tumor stage and poor prognosis, making DNA-PKcs an interesting target for radiosensitization of neuroblastoma tumors. Optimal dose finding for combination treatment with NU7026 and IR was performed using NGP cells. One hour pre-treatment with 10 mu M NU7026 synergistically sensitized NGP cells to 0.63 Gy IR. Radiosensitizing effects of NU7026 increased in time, with maximum effects observed from 96 h after IR-exposure on. Combined treatment of NGP cells with 10 mu M NU7026 and 0.63 Gy IR resulted in apoptosis, while no apoptotic response was observed for either of the therapies alone. Inhibition of IR-induced DNA-PK activation by NU7026 confirmed the capability of NGP cells to, at least partially, resist IR by NHEJ. NU7026 also synergistically radiosensitized other neuroblastoma cell lines, while no synergistic effect was observed for low DNA-PKcs-expressing non-cancerous fibroblasts. Results obtained for NU7026 were confirmed by PRKDC knockdown in NGP cells. Taken together, the current study shows that DNA-PKcs is a promising target for neuroblastoma radiosensitization.	[Dolman, M. Emmy M.; van der Ploeg, Ida; Koster, Jan; Bate-Eya, Laurel Tabe; Versteeg, Rogier; Molenaar, Jan J.] Univ Amsterdam, Acad Med Ctr, Dept Oncogen, NL-1105 AZ Amsterdam, Netherlands; [Caron, Huib N.] Univ Amsterdam, Acad Med Ctr, Emma Kinderziekenhuis, Dept Pediat Oncol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam	Dolman, MEM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Oncogen, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	memdolman@gmail.com	Versteeg, Rogier/AAQ-1765-2020; Koster, Jan/C-5934-2008	Koster, Jan/0000-0002-0890-7585; Versteeg, Rogier/0000-0001-7172-0388; Dolman, Emmy/0000-0002-0567-5918	Dutch Cancer Foundation; Dutch Children Cancer Free Foundation; Villa Joep; Tom Voute Fund	Dutch Cancer Foundation(KWF Kankerbestrijding); Dutch Children Cancer Free Foundation; Villa Joep; Tom Voute Fund	The research in this paper was supported by grants from the Dutch Cancer Foundation, the Dutch Children Cancer Free Foundation, Villa Joep and the Tom Voute Fund.	Amrein L, 2007, J PHARMACOL EXP THER, V321, P848, DOI 10.1124/jpet.106.118356; An J, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-18; Burma S, 2004, DNA REPAIR, V3, P909, DOI 10.1016/j.dnarep.2004.03.021; Chen BPC, 2007, J BIOL CHEM, V282, P6582, DOI 10.1074/jbc.M611605200; CHOU TC, 1977, J BIOL CHEM, V252, P6438; Ciszewski WM, 2014, BREAST CANCER RES TR, V143, P47, DOI 10.1007/s10549-013-2785-6; Davidson D, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00005; Davidson D, 2012, INVEST NEW DRUG, V30, P1248, DOI 10.1007/s10637-010-9626-9; Fix A, 2008, GENE CHROMOSOME CANC, V47, P819, DOI 10.1002/gcc.20583; Frosina G, 2009, MOL CANCER RES, V7, P989, DOI 10.1158/1541-7786.MCR-09-0030; Fuhrman CB, 2008, GYNECOL ONCOL, V110, P93, DOI 10.1016/j.ygyno.2007.08.073; Golden EB, 2012, FRONT ONCOL, V2, P1, DOI [10.3389/fonc.2012.00088, 10.3389/fonc.2012.00153]; Gupta AK, 2003, INT J RADIAT ONCOL, V56, P846, DOI 10.1016/S0360-3016(03)00214-1; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Hosoya N, 2014, CANCER SCI, V105, P370, DOI 10.1111/cas.12366; Hsu FM, 2012, TRANSL CANCER RES, V1, P22, DOI 10.3978/j.issn.2218-676X.2012.04.01; Jekimovs C, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00086; LAUREYS G, 1995, ONCOGENE, V10, P1087; Li YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039588; Liu Y, 2011, INT J GYNECOL CANCER, V21, P100, DOI 10.1097/IGC.0b013e3182021bfd; Lord CJ, 2006, CLIN CANCER RES, V12, P4463, DOI 10.1158/1078-0432.CCR-06-1269; Luqmani YA, 2005, MED PRIN PRACT, V14, P35, DOI 10.1159/000086183; Madhusudan S, 2005, TRENDS MOL MED, V11, P503, DOI 10.1016/j.molmed.2005.09.004; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; Molenaar JJ, 2012, NAT GENET, V44, P1199, DOI 10.1038/ng.2436; Molenaar JJ, 2012, GENE CHROMOSOME CANC, V51, P10, DOI 10.1002/gcc.20926; Molenaar JJ, 2009, P NATL ACAD SCI USA, V106, P12968, DOI 10.1073/pnas.0901418106; Moll U, 1999, ONCOGENE, V18, P3114, DOI 10.1038/sj.onc.1202640; Morgan MA, 2008, CLIN CANCER RES, V14, P6744, DOI 10.1158/1078-0432.CCR-08-1032; Morrison R, 2011, J ONCOL, V2011, DOI 10.1155/2011/941876; Mukherjee B, 2010, SEMIN RADIAT ONCOL, V20, P250, DOI 10.1016/j.semradonc.2010.05.002; Niazi MT, 2014, CURR ONCOL, V21, P91, DOI 10.3747/co.21.1509; Nuchtern Jed G, 2006, Semin Pediatr Surg, V15, P10, DOI 10.1053/j.sempedsurg.2005.11.003; Nutley BP, 2005, BRIT J CANCER, V93, P1011, DOI 10.1038/sj.bjc.6602823; O'Connor MJ, 2007, ONCOGENE, V26, P7816, DOI 10.1038/sj.onc.1210879; Pacini S, 1999, TUMORI, V85, P503, DOI 10.1177/030089169908500615; Park JR, 2008, PEDIATR CLIN N AM, V55, P97, DOI 10.1016/j.pcl.2007.10.014; Pauwels B, 2005, RADIAT RES, V164, P642, DOI 10.1667/RR3445.1; Plummer R, 2010, CLIN CANCER RES, V16, P4527, DOI 10.1158/1078-0432.CCR-10-0984; Salles B, 2006, PATHOL BIOL, V54, P185, DOI 10.1016/j.patbio.2006.01.012; Shaheen FS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020311; Shibata A, 2011, EMBO J, V30, P1079, DOI 10.1038/emboj.2011.27; Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022; Tavecchio M, 2012, CANCER CHEMOTH PHARM, V69, P155, DOI 10.1007/s00280-011-1662-4; Thiele CJ, 1999, HUMAN CELL CULTURE, V1, P21; TWENTYMAN PR, 1987, BRIT J CANCER, V56, P279, DOI 10.1038/bjc.1987.190; Valerie K, 2003, ONCOGENE, V22, P5792, DOI 10.1038/sj.onc.1206679; Verissimo CS, 2011, ENDOCR-RELAT CANCER, V18, pR213, DOI 10.1530/ERC-11-0251; Veuger SJ, 2003, CANCER RES, V63, P6008; Yang J, 2003, CARCINOGENESIS, V24, P1571, DOI 10.1093/carcin/bgg137; Yu L, 2015, ONCOTARGET, V6, P3848, DOI 10.18632/oncotarget.2975; Zha S, 2011, P NATL ACAD SCI USA, V108, P2028, DOI 10.1073/pnas.1019293108; Zhao Y, 2006, CANCER RES, V66, P5354, DOI 10.1158/0008-5472.CAN-05-4275	53	17	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145744	10.1371/journal.pone.0145744	http://dx.doi.org/10.1371/journal.pone.0145744			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716839	Green Submitted, gold, Green Published			2022-12-26	WOS:000367510500065
J	Hahn, S; Kim, D				Hahn, Seungsoo; Kim, Dongsup			Identifying and Reducing Systematic Errors in Chromosome Conformation Capture Data	PLOS ONE			English	Article							HI-C DATA; CHROMATIN INTERACTIONS; GENOME; ORGANIZATION; PRINCIPLES; ENSEMBLE; DYNAMICS; BIASES; MODEL	Chromosome conformation capture (3C)-based techniques have recently been used to uncover the mystic genomic architecture in the nucleus. These techniques yield indirect data on the distances between genomic loci in the form of contact frequencies that must be normalized to remove various errors. This normalization process determines the quality of data analysis. In this study, we describe two systematic errors that result from the heterogeneous local density of restriction sites and different local chromatin states, methods to identify and remove those artifacts, and three previously described sources of systematic errors in 3C-based data: fragment length, mappability, and local DNA composition. To explain the effect of systematic errors on the results, we used three different published data sets to show the dependence of the results on restriction enzymes and experimental methods. Comparison of the results from different restriction enzymes shows a higher correlation after removing systematic errors. In contrast, using different methods with the same restriction enzymes shows a lower correlation after removing systematic errors. Notably, the improved correlation of the latter case caused by systematic errors indicates that a higher correlation between results does not ensure the validity of the normalization methods. Finally, we suggest a method to analyze random error and provide guidance for the maximum reproducibility of contact frequency maps.	[Hahn, Seungsoo] Chung Ang Univ, Dept Chem, Seoul 156756, South Korea; [Kim, Dongsup] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon, South Korea	Chung Ang University; Korea Advanced Institute of Science & Technology (KAIST)	Hahn, S (corresponding author), Chung Ang Univ, Dept Chem, Seoul 156756, South Korea.	hahnss@cau.ac.kr; kds@kaist.ac.kr	Hahn, Seungsoo/C-8026-2016; Kim, Dongsup/C-1612-2011	Hahn, Seungsoo/0000-0002-2763-1166; 	Ministry for Health and Welfare [2012M3A9B4027957, A092006]; National Research Foundation of Korea	Ministry for Health and Welfare; National Research Foundation of Korea(National Research Foundation of Korea)	This study was supported by grant number: 2012M3A9B4027957, A092006, (funder: Ministry for Health and Welfare, http://english.mw.go.kr/front_eng/index.jsp) to DK; and grant number: NRF-2010-0012649, (funder: National Research Foundation of Korea, http://www.nrf.re.kr/nrf_eng_cms/) to SH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cournac A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-436; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Fenouil R, 2012, GENOME RES, V22, P2399, DOI 10.1101/gr.138776.112; Fox J., 2019, R COMPANION APPL REG, V.; Glass CK, 2000, GENE DEV, V14, P121; Hahn S, 2013, BIOPHYS J, V105, P1786, DOI 10.1016/j.bpj.2013.08.043; Hair J.F., 2010, MULTIVARIATE DATA AN, V7th; Hilser VJ, 2006, CHEM REV, V106, P1545, DOI 10.1021/cr040423+; Hu M, 2012, BIOINFORMATICS, V28, P3131, DOI 10.1093/bioinformatics/bts570; Imakaev M, 2012, NAT METHODS, V9, P999, DOI [10.1038/NMETH.2148, 10.1038/nmeth.2148]; Kalhor R, 2012, NAT BIOTECHNOL, V30, P90, DOI 10.1038/nbt.2057; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Neph S, 2012, CELL, V150, P1274, DOI 10.1016/j.cell.2012.04.040; Pan H, 2000, P NATL ACAD SCI USA, V97, P12020, DOI 10.1073/pnas.220240297; R Core Team, 2013, R LANG ENV STAT COMP; Rippe K, 2001, TRENDS BIOCHEM SCI, V26, P733, DOI 10.1016/S0968-0004(01)01978-8; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Yaffe E, 2011, NAT GENET, V43, P1059, DOI 10.1038/ng.947; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	24	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0146007	10.1371/journal.pone.0146007	http://dx.doi.org/10.1371/journal.pone.0146007			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717152	Green Published, gold			2022-12-26	WOS:000367510500115
J	Kang, SH; Jung, DJ; Choi, EW; Cho, KH; Park, JW; Do, JY				Kang, Seok Hui; Jung, Da Jung; Choi, Eun Woo; Cho, Kyu Hyang; Park, Jong Won; Do, Jun Young			HbA1c Levels Are Associated with Chronic Kidney Disease in a Non-Diabetic Adult Population: A Nationwide Survey (KNHANES 2011-2013)	PLOS ONE			English	Article							INTENSIVE GLUCOSE CONTROL; METABOLIC SYNDROME; GLYCATED HEMOGLOBIN; GLYCOSYLATED HEMOGLOBIN; CARDIOVASCULAR-DISEASE; DIABETES-MELLITUS; RISK; A1C; ALBUMINURIA	Background Many studies have reported an association between glycated hemoglobin A1c (HbA1c) and metabolic syndrome (MetS) in non-diabetes patients. Each component of MetS is in fact related to chronic kidney disease (CKD) incidence and progression. Therefore, HbA1c in non-diabetic mellitus (DM) may be intrinsically associated with the prevalence of CKD. The hypothesis of the present study was that high HbA1c in non-DM patients is associated with CKD. Patients and Methods The total number of participants in this study was 24,594. The participants were divided into three groups according to their HbA1c levels: a Low group (<5.7% or <39 mmol/mol), a Middle group (5.7-6.0% or 39-42 mmol/mol), and a High group (>6.0% or >42 mmol/mol). The estimated glomerular filtration rate (eGFR) was calculated using the Chronic Kidney Disease Epidemiology Collaboration equation. Results The number of participants allocated to the Low, Middle, and High groups was 8,651, 4,634, and 1,387, respectively. Linear regression analyses were performed to evaluate the association between variables. Standardized beta +/- standard error was 0.25 +/- 0.22 for waist circumference, 0.44 +/- 0.20 for fasting glucose, -0.14 +/- 0.30 for high-density lipoprotein cholesterol levels, 0.15 +/- 2.31 for triglyceride levels, 0.21 +/- 0.00 for systolic blood pressure, 0.10 +/- 0.00 for diastolic blood pressure, and -0.22 +/- 0.42 for eGFR (P < 0.001 for all variables). eGFR in non-diabetes participants was inversely associated with the HbA1c level, where eGFR decreased as HbA1c levels increased. Standardized beta s were -0.04 +/- 0.42 in multivariable analysis (P < 0.001). The proportion of participants with only MetS, only CKD, or both MetS and CKD was higher in the High group than in the Low and Middle groups. Conclusion High HbA1c in non-DM patients may be associated with CKD. Renal function in patients with high HbA1c levels may need to be monitored.	[Kang, Seok Hui; Choi, Eun Woo; Cho, Kyu Hyang; Park, Jong Won; Do, Jun Young] Yeungnam Univ Hosp, Dept Internal Med, Div Nephrol, Daegu, South Korea; [Jung, Da Jung] Kyungpook Natl Univ Hosp, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Daegu, South Korea	Yeungnam University; Yeungnam University Hospital; Kyungpook National University; Kyungpook National University Hospital	Do, JY (corresponding author), Yeungnam Univ Hosp, Dept Internal Med, Div Nephrol, Daegu, South Korea.	jydo@med.yu.ac.kr			Yeungnam University Research Grant	Yeungnam University Research Grant	This work was supported by the 2014 Yeungnam University Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; [Anonymous], 2015, DIABETES CARE, V38, pS1, DOI 10.2337/dc15-S001; Chen J, 2004, ANN INTERN MED, V140, P167, DOI 10.7326/0003-4819-140-3-200402030-00007; Dilley J, 2007, DIABETES CARE, V30, P1527, DOI 10.2337/dc06-2414; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Fox CS, 2005, DIABETES CARE, V28, P2436, DOI 10.2337/diacare.28.10.2436; Gerstein HC, 2005, DIABETOLOGIA, V48, P1749, DOI 10.1007/s00125-005-1858-4; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Grundy SM, 2012, J AM COLL CARDIOL, V59, P635, DOI 10.1016/j.jacc.2011.08.080; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hernandez D, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-151; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Jin DC, 2014, KIDNEY RES CLIN PRAC, V33, P9, DOI 10.1016/j.krcp.2014.01.002; Johnson DW, 2013, NEPHROLOGY, V18, P340, DOI 10.1111/nep.12052; Kim Jin Hwa, 2008, Diabetes and Metabolism Journal, V32, P435; Kim Y, 2016, DIABETIC MED, V33, P428, DOI 10.1111/dme.12970; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Lim AKH, 2014, INT J NEPHROL RENOV, V7, P361, DOI 10.2147/IJNRD.S40172; McNeely MJ, 2009, DIABETES CARE, V32, P1727, DOI 10.2337/dc09-0074; Moebus S, 2009, DIABETOLOGIA, V52, P81, DOI 10.1007/s00125-008-1173-y; NELSON RG, 1989, DIABETOLOGIA, V32, P870, DOI 10.1007/BF00297452; Nguyen QM, 2008, METABOLISM, V57, P1487, DOI 10.1016/j.metabol.2008.04.011; Ong KL, 2010, DIABETES CARE, V33, P1856, DOI 10.2337/dc10-0190; Osei K, 2003, J CLIN ENDOCR METAB, V88, P4596, DOI 10.1210/jc.2003-030686; Park SH, 2012, J KOREAN MED SCI, V27, P1057, DOI 10.3346/jkms.2012.27.9.1057; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Perkovic V, 2013, KIDNEY INT, V83, P517, DOI 10.1038/ki.2012.401; Plantinga LC, 2010, CLIN J AM SOC NEPHRO, V5, P673, DOI 10.2215/CJN.07891109; Prasad G V Ramesh, 2014, World J Nephrol, V3, P210, DOI 10.5527/wjn.v3.i4.210; Rehm J, 2004, COMP QUANTIFICATION, P959; Schottker B, 2013, PREV MED, V57, P596, DOI 10.1016/j.ypmed.2013.08.002; Selvin E, 2014, CIRCULATION, V130, P1374, DOI 10.1161/CIRCULATIONAHA.114.010815; Selvin E, 2011, DIABETES, V60, P298, DOI 10.2337/db10-1198; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Sung KC, 2007, DIABETIC MED, V24, P848, DOI 10.1111/j.1464-5491.2007.02146.x; Thomas SS, 2015, KIDNEY INT, V88, P1233, DOI 10.1038/ki.2015.305; U. S. Renal Data System, 2014, USRDS 2014 ANN DAT R; Veeranna V, 2011, METAB SYNDR RELAT D, V9, P361, DOI 10.1089/met.2011.0032; WISEMAN M, 1984, DIABETOLOGIA, V26, P401; Xing FYF, 2014, DIABETES VASC DIS RE, V11, P11, DOI 10.1177/1479164113514239; Zhang QL, 2009, PREV MED, V48, P122, DOI 10.1016/j.ypmed.2008.10.026	43	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145827	10.1371/journal.pone.0145827	http://dx.doi.org/10.1371/journal.pone.0145827			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716684	Green Published, Green Submitted, gold			2022-12-26	WOS:000367510500080
J	Zhu, GY; Mao, Y; Zhou, WD; Jiang, YL				Zhu, Guiyu; Mao, Yong; Zhou, Wendi; Jiang, Yunliang			Dynamic Changes in the Follicular Transcriptome and Promoter DNA Methylation Pattern of Steroidogenic Genes in Chicken Follicles throughout the Ovulation Cycle	PLOS ONE			English	Article							CASPASE-MEDIATED APOPTOSIS; GRANULOSA-CELLS; DOMESTIC-FOWL; POSTOVULATORY FOLLICLE; MESSENGER-RNA; 3-BETA-HYDROXYSTEROID DEHYDROGENASE; OVARIAN STEROIDOGENESIS; ENZYME-ACTIVITY; BETA-CATENIN; HEN OVARY	The molecular mechanisms associated with follicle maturation and ovulation are not well defined in avian species. In this study, we used RNA-seq to study the gene expression profiles of the chicken follicles from different developmental stages (pre-hierarchical, pre-ovulatory and post-ovulatory). Transcriptomic analysis revealed a total of 1,277 and 2,310 genes were differentially expressed when follicles progressed through the pre-hierarchical to hierarchical and pre-ovulatory to post-ovulatory transitions, respectively. The differentially expressed genes (DEG) were involved in signaling pathways such as adherens junction, apoptosis and steroid biosynthesis. We further investigated the transcriptional regulation of follicular steroidogenesis by examining the follicle-specific methylation profiles of Star (steroidogenic acute regulatory protein), Cyp11a1 (cytochrome P450, family 11, subfamily a, polypeptide 1) and Hsd3b (hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1), genes encoding the key enzymes for progesterone synthesis. The varied patterns of DNA methylation in proximal promoters of Star and Cyp11a1 but not Hsd3b in different follicles could play a major role in controlling gene expression as well as follicular steroidogenic activity. Finally, the promoter-reporter analysis suggests that TGF-beta could be involved in the regulation of Hsd3b expression during ovulation. Together, current data not only provide novel insights into the molecular mechanisms of follicular physiology in chicken follicles, but also present the first evidence of epigenetic regulation of ovarian steroidogenesis in avian species.	[Zhu, Guiyu] Taishan Univ, Dept Biol Sci & Technol, Tai An 271021, Shandong, Peoples R China; [Zhu, Guiyu; Zhou, Wendi; Jiang, Yunliang] Shandong Agr Univ, Coll Anim Sci & Vet Med, Shandong Prov Key Lab Anim Biotechnol & Dis Contr, Tai An 271018, Shandong, Peoples R China; [Mao, Yong] Taian Materal & Child Hlth Hosp, Dept Gynecol, Tai An 271021, Shandong, Peoples R China	Taishan University; Key Laboratory of Animal Biotechnology & Disease Control & Prevention of Shandong Province; Shandong Agricultural University	Zhu, GY (corresponding author), Taishan Univ, Dept Biol Sci & Technol, Tai An 271021, Shandong, Peoples R China.	guiyuzhu@hotmail.com; yljiang723@aliyun.com			National Natural Science Foundation of China [31301974, 31272435]; Natural Science Foundation of Shandong Province [ZR2013CQ002]; Agricultural Elite Breeds Project of Shandong Province; Taishan University [Y-01-2014015]; Science and Technology Development Programme of Taian City [20140630-7]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Agricultural Elite Breeds Project of Shandong Province; Taishan University; Science and Technology Development Programme of Taian City	This work was supported by the National Natural Science Foundation of China (31301974), National Natural Science Foundation of China (31272435), Natural Science Foundation of Shandong Province (ZR2013CQ002), Agricultural Elite Breeds Project of Shandong Province (2015), Talent Project of Taishan University (Y-01-2014015) and the Science and Technology Development Programme of Taian City (20140630-7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG DG, 1977, J REPROD FERTIL, V49, P253, DOI 10.1530/jrf.0.0490253; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; BAHR JM, 1983, BIOL REPROD, V29, P326, DOI 10.1095/biolreprod29.2.326; Bauer MP, 2000, MOL CELL ENDOCRINOL, V168, P119, DOI 10.1016/S0303-7207(00)00316-6; Camacho-Arroyo I, 2007, COMP BIOCHEM PHYS A, V146, P644, DOI 10.1016/j.cbpa.2006.04.023; CHALANA RK, 1978, POULTRY SCI, V57, P814, DOI 10.3382/ps.0570814; Davis DE, 1942, ANAT REC, V82, P297, DOI 10.1002/ar.1090820305; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; DICK HR, 1978, J REPROD FERTIL, V53, P103, DOI 10.1530/jrf.0.0530103; Fan HY, 2010, MOL ENDOCRINOL, V24, P1529, DOI 10.1210/me.2010-0141; GILBERT AB, 1978, J REPROD FERTIL, V52, P227, DOI 10.1530/jrf.0.0520227; Glister C, 2005, ENDOCRINOLOGY, V146, P1883, DOI 10.1210/en.2004-1303; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; HUANG ESR, 1979, BIOL REPROD, V20, P454, DOI 10.1095/biolreprod20.3.454; HUM DW, 1993, CLIN CHEM, V39, P333; Johnson AL, 2007, REPRODUCTION, V133, P609, DOI 10.1530/REP-06-0287; Johnson AL, 2000, BIOL SIGNAL RECEPT, V9, P96; Johnson AL, 2003, ANIM REPROD SCI, V78, P185, DOI 10.1016/S0378-4320(03)00090-3; Johnson AL, 2002, REPRODUCTION, V124, P19, DOI 10.1530/rep.0.1240019; Johnson AL, 2002, BIOL REPROD, V67, P1313, DOI 10.1095/biolreprod67.4.1313; Johnson AL, 1996, ENDOCRINOLOGY, V137, P2059, DOI 10.1210/en.137.5.2059; Johnson AL, 2000, BIOL REPROD, V62, P589, DOI 10.1095/biolreprod62.3.589; Johnson PA, 2012, REPROD DOMEST ANIM, V47, P283, DOI 10.1111/j.1439-0531.2012.02087.x; Johnson PA, 2013, NAT REV CANCER, V13, P432, DOI 10.1038/nrc3535; Knight PG, 2009, POULT SCI S, V29, P89, DOI 10.1079/9781845933753.0089; LaVoie HA, 2009, EXP BIOL MED, V234, P880, DOI 10.3181/0903-MR-97; LAW AS, 1995, GEN COMP ENDOCR, V98, P227, DOI 10.1006/gcen.1995.1064; Lee L, 2013, ENDOCRINOLOGY, V154, P458, DOI 10.1210/en.2012-1610; Li E, 2013, ENDOCR J, V60, P1065, DOI 10.1507/endocrj.EJ13-0045; Li L, 2014, MOL CELL ENDOCRINOL, V382, P915, DOI 10.1016/j.mce.2013.11.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Machell NH, 2000, BIOL REPROD, V63, P797, DOI 10.1095/biolreprod63.3.797; MARRONE BL, 1989, BIOL REPROD, V40, P1007, DOI 10.1095/biolreprod40.5.1007; Mora JM, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096156; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Niswender GD, 2002, REPRODUCTION, V123, P333, DOI 10.1530/rep.0.1230333; NITTA H, 1993, BIOL REPROD, V48, P110, DOI 10.1095/biolreprod48.1.110; NITTA H, 1991, DOMEST ANIM ENDOCRIN, V8, P587, DOI 10.1016/0739-7240(91)90028-I; Onagbesan O, 2009, ANIM REPROD SCI, V111, P121, DOI 10.1016/j.anireprosci.2008.09.017; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; ROBINSON FE, 1986, BIOL REPROD, V35, P1096, DOI 10.1095/biolreprod35.5.1096; Rossetti MF, 2015, MOL CELL ENDOCRINOL, V412, P330, DOI 10.1016/j.mce.2015.05.024; Rowlands TM, 2000, REV REPROD, V5, P53; SAIDAPUR SK, 1982, INT REV CYTOL, V75, P243, DOI 10.1016/S0074-7696(08)61007-4; Sundaresan NR, 2008, VET RES COMMUN, V32, P13, DOI 10.1007/s11259-007-9005-y; TILLY JL, 1991, BIOL REPROD, V45, P967, DOI 10.1095/biolreprod45.6.967; TILLY JL, 1991, ENDOCRINOLOGY, V129, P2799, DOI 10.1210/endo-129-5-2799; TILLY JL, 1991, BIOL REPROD, V44, P305, DOI 10.1095/biolreprod44.2.305; TRUSS M, 1993, ENDOCR REV, V14, P459, DOI 10.1210/er.14.4.459; Usongo M, 2012, REPRODUCTION, V144, P669, DOI 10.1530/REP-12-0291; Vanselow J., 2010, Animal Reproduction, V7, P134; Vanselow J, 2010, DNA METHYLATION IS N, V298, P289, DOI [10.1095/biolreprod.109.079251, DOI 10.1095/BI0LREPR0D.109.079251]; Wang TT, 2011, TOXICOL APPL PHARM, V257, P328, DOI 10.1016/j.taap.2011.09.016; Whittow GC, 2015, AVIAN PHYSL, DOI [10.1016/B978-0-12-407160-5.00028-2, DOI 10.1016/B978-0-12-407160-5.00028-2]; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; YU MW, 1992, POULTRY SCI, V71, P346, DOI 10.3382/ps.0710346; Zheng XF, 2008, REPRODUCTION, V136, P447, DOI 10.1530/REP-07-0316; Zhu GY, 2014, ASIAN AUSTRAL J ANIM, V27, P1526, DOI 10.5713/ajas.2014.14209; Zhu GY, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.114249; Zhu GY, 2012, GEN COMP ENDOCR, V178, P314, DOI 10.1016/j.ygcen.2012.06.018	60	14	14	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0146028	10.1371/journal.pone.0146028	http://dx.doi.org/10.1371/journal.pone.0146028			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716441	gold, Green Published, Green Submitted			2022-12-26	WOS:000367510500119
J	Brookes, VJ; Jordan, D; Davis, S; Ward, MP; Heller, J				Brookes, Victoria J.; Jordan, David; Davis, Stephen; Ward, Michael P.; Heller, Jane			Saltelli Global Sensitivity Analysis and Simulation Modelling to Identify Intervention Strategies to Reduce the Prevalence of Escherichia coli O157 Contaminated Beef Carcasses	PLOS ONE			English	Article							IN-GROUND BEEF; RISK-ASSESSMENT; UNITED-STATES; FEEDLOT CATTLE; AMBIENT-TEMPERATURE; DOMESTIC RUMINANTS; SLAUGHTER; FECES; TRANSMISSION; PATHOGENS	Introduction Strains of Shiga-toxin producing Escherichia coli O157 (STEC O157) are important food-borne pathogens in humans, and outbreaks of illness have been associated with consumption of undercooked beef. Here, we determine the most effective intervention strategies to reduce the prevalence of STEC O157 contaminated beef carcasses using a modelling approach. Method A computational model simulated events and processes in the beef harvest chain. Information from empirical studies was used to parameterise the model. Variance-based global sensitivity analysis (GSA) using the Saltelli method identified variables with the greatest influence on the prevalence of STEC O157 contaminated carcasses. Following a baseline scenario (no interventions), a series of simulations systematically introduced and tested interventions based on influential variables identified by repeated Saltelli GSA, to determine the most effective intervention strategy. Results Transfer of STEC O157 from hide or gastro-intestinal tract to carcass (improved abattoir hygiene) had the greatest influence on the prevalence of contaminated carcases. Due to interactions between inputs (identified by Saltelli GSA), combinations of interventions based on improved abattoir hygiene achieved a greater reduction in maximum prevalence than would be expected from an additive effect of single interventions. The most effective combination was improved abattoir hygiene with vaccination, which achieved a greater than ten-fold decrease in maximum prevalence compared to the baseline scenario. Conclusion Study results suggest that effective interventions to reduce the prevalence of STEC O157 contaminated carcasses should initially be based on improved abattoir hygiene. However, the effect of improved abattoir hygiene on the distribution of STEC O157 concentration on carcasses is an important information gap-further empirical research is required to determine whether reduced prevalence of contaminated carcasses is likely to result in reduced incidence of STEC O157 associated illness in humans. This is the first use of variance-based GSA to assess the drivers of STEC O157 contamination of beef carcasses.	[Brookes, Victoria J.; Heller, Jane] Graham Ctr Agr Innovat, NSW Dept Primary Ind, Wagga Wagga, NSW 2650, Australia; [Brookes, Victoria J.; Heller, Jane] Charles Sturt Univ, Wagga Wagga, NSW 2650, Australia; [Brookes, Victoria J.; Heller, Jane] Charles Sturt Univ, Sch Anim & Vet Sci, Fac Sci, Wagga Wagga, NSW 2678, Australia; [Jordan, David] NSW Dept Primary Ind, Wollongbar, NSW, Australia; [Davis, Stephen] RMIT Univ, Sch Math & Geospatial Sci, Melbourne, Vic 3001, Australia; [Ward, Michael P.] Univ Sydney, Fac Vet Sci, Camden, NSW 2570, Australia	NSW Department of Primary Industries; Charles Sturt University; Charles Sturt University; NSW Department of Primary Industries; Royal Melbourne Institute of Technology (RMIT); University of Sydney	Brookes, VJ (corresponding author), Graham Ctr Agr Innovat, NSW Dept Primary Ind, Pugsley Pl, Wagga Wagga, NSW 2650, Australia.	victoria.brookes@sydney.edu.au	Jordan, David/P-7281-2019; Ward, Michael Patrick/W-1897-2019; Heller, Jane/H-9596-2016; Ward, Michael/C-5758-2009; Brookes, Victoria/W-1311-2019; Ward, Michael Patrick/GRX-1851-2022	Heller, Jane/0000-0003-3993-0160; Ward, Michael/0000-0002-9921-4986; Brookes, Victoria/0000-0003-0963-4926; Ward, Michael Patrick/0000-0002-9921-4986	Meat and Livestock Australia [A.MFS.0247]; National Collaborative Research Infrastructure Strategy (NCRIS)	Meat and Livestock Australia(Meat and Livestock Australia); National Collaborative Research Infrastructure Strategy (NCRIS)(Australian GovernmentDepartment of Industry, Innovation and Science)	This research was funded by Meat and Livestock Australia (A.MFS.0247). The funders reviewed the manuscript prior to submission and made no changes to the content. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.; The authors thank Geraldine Lammers, Karen Williams, Andreas Kiermeier, Salome Durr, Long Huynh (MLA) and Ian Jenson MLA) for information and advice during this study. We also gratefully acknowledge the use of computing resources from the NeCTAR Research Cloud, http://www.nectar.org.au. NeCTAR is an Australian Government project conducted as part of the Super Science initiative and financed by the Education Investment Fund and National Collaborative Research Infrastructure Strategy (NCRIS).	ABBEY HELEN, 1952, HUMAN BIOL, V24, P201; Aperce CC, 2014, J ANIM SCI, V92, P676, DOI 10.2527/jas.2013-6712; Arthur TM, 2007, J FOOD PROTECT, V70, P280, DOI 10.4315/0362-028X-70.2.280; Arthur TM, 2010, MEAT SCI, V86, P32, DOI 10.1016/j.meatsci.2010.04.019; Arthur TM, 2009, APPL ENVIRON MICROB, V75, P6515, DOI 10.1128/AEM.00081-09; Bosilevac JM, 2005, J FOOD PROTECT, V68, P265, DOI 10.4315/0362-028X-68.2.265; Brichta-Harhay DM, 2008, APPL ENVIRON MICROB, V74, P6289, DOI 10.1128/AEM.00700-08; Cassin MH, 1998, INT J FOOD MICROBIOL, V41, P21, DOI 10.1016/S0168-1605(98)00028-2; Cobbold RN, 2007, APPL ENVIRON MICROB, V73, P1563, DOI 10.1128/AEM.01742-06; Crim SM, 2014, MMWR-MORBID MORTAL W, V63, P328; Davis S, 2011, PARASITOLOGY, V138, P516, DOI 10.1017/S0031182010001496; Department of Agriculture Fisheries and Forestry, 2012, AUSTR AN WELF STAND; Dewell GA, 2008, J FOOD PROTECT, V71, P1114, DOI 10.4315/0362-028X-71.6.1114; Duffy G, 2006, MEAT SCI, V74, P76, DOI 10.1016/j.meatsci.2006.04.011; Ebel E, 2004, J FOOD PROTECT, V67, P1991, DOI 10.4315/0362-028X-67.9.1991; Elder RO, 2000, P NATL ACAD SCI USA, V97, P2999, DOI 10.1073/pnas.060024897; Fegan N, 2005, J FOOD PROTECT, V68, P451, DOI 10.4315/0362-028X-68.3.451; Fegan N, 2004, J APPL MICROBIOL, V97, P362, DOI 10.1111/j.1365-2672.2004.02300.x; Fegan N, 2009, FOODBORNE PATHOG DIS, V6, P1113, DOI 10.1089/fpd.2009.0338; Ferens WA, 2011, FOODBORNE PATHOG DIS, V8, P465, DOI 10.1089/fpd.2010.0673; Gautam R, 2015, EPIDEMIOL INFECT, V143, P274, DOI 10.1017/S0950268814000867; Gautam R, 2011, PREV VET MED, V102, P10, DOI 10.1016/j.prevetmed.2011.06.008; Greig JD, 2012, FOOD CONTROL, V27, P385, DOI 10.1016/j.foodcont.2012.03.019; Heller J, 2014, ARBP0015 MEAT LIV AU; Hoffmann S, 2012, J FOOD PROTECT, V75, P1292, DOI 10.4315/0362-028X.JFP-11-417; Homma T, 1995, J NUCL SCI TECHNOL, V32, P1164, DOI 10.3327/jnst.32.1164; Jonsson ME, 2009, ACTA VET SCAND, V51, DOI 10.1186/1751-0147-51-43; Jordan D, 1999, PREV VET MED, V41, P37, DOI 10.1016/S0167-5877(99)00033-1; Jordan D, 1999, PREV VET MED, V41, P55, DOI 10.1016/S0167-5877(99)00032-X; Kiermeier A, 2006, INT J FOOD MICROBIOL, V111, P263, DOI 10.1016/j.ijfoodmicro.2006.05.006; Kiermeier A, 2015, RISK ANAL, V35, P77, DOI 10.1111/risa.12248; Kulow MJ, 2012, APPL ENVIRON MICROB, V78, P8045, DOI 10.1128/AEM.02363-12; Lammers GAC, 2015, EPIDEMIOL INFECT, V143, P3244, DOI 10.1017/S0950268815000588; Masana MO, 2010, J FOOD PROTECT, V73, P649, DOI 10.4315/0362-028X-73.4.649; Nossent J, 2011, ENVIRON MODELL SOFTW, V26, P1515, DOI 10.1016/j.envsoft.2011.08.010; Nou XW, 2003, J FOOD PROT, V66; Pennington H, 2010, LANCET, V376, P1428, DOI 10.1016/S0140-6736(10)60963-4; Peterson RE, 2007, J FOOD PROTECT, V70, P287, DOI 10.4315/0362-028X-70.2.287; Petherick JC, 2005, APPL ANIM BEHAV SCI, V92, P211, DOI 10.1016/j.applanim.2005.05.009; Pollock KGJ, 2008, EPIDEMIOL INFECT, V136, P115, DOI 10.1017/S0950268807008217; Pollock KGJ, 2010, EMERG INFECT DIS, V16, P881, DOI 10.3201/eid1605.091919; Potter AA, 2004, VACCINE, V22, P362, DOI 10.1016/j.vaccine.2003.08.007; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; Saltelli A, 2002, COMPUT PHYS COMMUN, V145, P280, DOI 10.1016/S0010-4655(02)00280-1; Saltelli A, 2010, ENVIRON MODELL SOFTW, V25, P1508, DOI 10.1016/j.envsoft.2010.04.012; Saltelli A, 2010, COMPUT PHYS COMMUN, V181, P259, DOI 10.1016/j.cpc.2009.09.018; Sargeant JM, 2007, ZOONOSES PUBLIC HLTH, V54, P260, DOI 10.1111/j.1863-2378.2007.01059.x; Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.P11101; Smith BA, 2013, FOOD CONTROL, V29, P364, DOI 10.1016/j.foodcont.2012.03.003; Snedeker KG, 2012, ZOONOSES PUBLIC HLTH, V59, P126, DOI 10.1111/j.1863-2378.2011.01426.x; Sobol I.M., 1990, MAT MODEL, V2, P112, DOI DOI 10.18287/0134-2452-2015-39-4-459-461; Sobol IM, 2001, MATH COMPUT SIMULAT, V55, P271, DOI 10.1016/S0378-4754(00)00270-6; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Thomas DE, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-799; Vynnycky E., 2010, INTRO INFECT DIS MOD, DOI DOI 10.1038/NRMICRO1845; Wang XY, 2014, J MATH BIOL, V69, P501, DOI 10.1007/s00285-013-0707-1; Williams KJ, 2015, EPIDEMIOL INFECT, V143, P1388, DOI 10.1017/S0950268814002374; Williams KJ, 2014, VET MICROBIOL, V173, P101, DOI 10.1016/j.vetmic.2014.07.001; Wisener LV, 2015, ZOONOSES PUBLIC HLTH, V62, P75, DOI 10.1111/zph.12112	59	3	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0146016	10.1371/journal.pone.0146016	http://dx.doi.org/10.1371/journal.pone.0146016			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713610	Green Submitted, gold, Green Published			2022-12-26	WOS:000367481900110
J	Altarelli, F; Braunstein, A; Dall'Asta, L; De Bacco, C; Franz, S				Altarelli, Fabrizio; Braunstein, Alfredo; Dall'Asta, Luca; De Bacco, Caterina; Franz, Silvio			The Edge-Disjoint Path Problem on Random Graphs by Message-Passing	PLOS ONE			English	Article							WAVELENGTH ASSIGNMENT; APPROXIMATION ALGORITHMS; OPTICAL NETWORKS; OPTIMIZATION; QOS	We present a message-passing algorithm to solve a series of edge-disjoint path problems on graphs based on the zero-temperature cavity equations. Edge-disjoint paths problems are important in the general context of routing, that can be defined by incorporating under a unique framework both traffic optimization and total path length minimization. The computation of the cavity equations can be performed efficiently by exploiting a mapping of a generalized edge-disjoint path problem on a star graph onto a weighted maximum matching problem. We perform extensive numerical simulations on random graphs of various types to test the performance both in terms of path length minimization and maximization of the number of accommodated paths. In addition, we test the performance on benchmark instances on various graphs by comparison with state-of-the-art algorithms and results found in the literature. Our message-passing algorithm always outperforms the others in terms of the number of accommodated paths when considering non trivial instances (otherwise it gives the same trivial results). Remarkably, the largest improvement in performance with respect to the other methods employed is found in the case of benchmarks with meshes, where the validity hypothesis behind message-passing is expected to worsen. In these cases, even though the exact message-passing equations do not converge, by introducing a reinforcement parameter to force convergence towards a sub optimal solution, we were able to always outperform the other algorithms with a peak of 27% performance improvement in terms of accommodated paths. On random graphs, we numerically observe two separated regimes: one in which all paths can be accommodated and one in which this is not possible. We also investigate the behavior of both the number of paths to be accommodated and their minimum total length.	[Altarelli, Fabrizio; Braunstein, Alfredo; Dall'Asta, Luca] Politecn Torino, DISAT, I-10129 Turin, Italy; [Altarelli, Fabrizio; Braunstein, Alfredo; Dall'Asta, Luca] Politecn Torino, Ctr Computat Sci, I-10129 Turin, Italy; [Altarelli, Fabrizio; Braunstein, Alfredo; Dall'Asta, Luca] Coll Carlo Alberto, I-10024 Moncalieri, Italy; [Braunstein, Alfredo] Human Genet Fdn, I-10126 Turin, Italy; [De Bacco, Caterina; Franz, Silvio] Univ Paris Saclay, Univ Paris Sud, CNRS, LPTMS, F-91405 Orsay, France	Polytechnic University of Turin; Polytechnic University of Turin; Collegio Carlo Alberto; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	De Bacco, C (corresponding author), Univ Paris Saclay, Univ Paris Sud, CNRS, LPTMS, F-91405 Orsay, France.	caterina.de-bacco@lptms.u-psud.fr	Franz, Silvio/B-2137-2019; Braunstein, Alfredo/E-6924-2012	Franz, Silvio/0000-0001-8300-8443; De Bacco, Caterina/0000-0002-8634-0211; Braunstein, Alfredo/0000-0002-4562-3610	Marie Curie Training Network NETADIS (FP7) [413 290038, 290038]; Italian FIRB Project [RBFR10QUW4]; ERC [267915]	Marie Curie Training Network NETADIS (FP7); Italian FIRB Project(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); ERC(European Research Council (ERC)European Commission)	This work was supported by the Marie Curie Training Network NETADIS (FP7, grant 413 290038). L.D. also acknowledges the Italian FIRB Project No. RBFR10QUW4 and 414 ERC grant No. 267915. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thanks P. Quang Dung for kindly providing us the detailed benchmark instances. This work was supported by the Marie Curie Training Network NETADIS (FP7, grant 290038). L.D. also acknowledges the Italian FIRB Project No. RBFR10QUW4 and ERC grant No. 267915.	Akkaya K., 2005, Ad Hoc Networks, V3, P325, DOI 10.1016/j.adhoc.2003.09.010; Altarelli F, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/07/P07002; Ash GR, 2006, TRAFFIC ENG QOS OPTI; AUMANN Y, 1995, PROCEEDINGS OF THE SIXTH ANNUAL ACM-SIAM SYMPOSIUM ON DISCRETE ALGORITHMS, P567; Awerbuch B., 1994, Proceedings. 35th Annual Symposium on Foundations of Computer Science (Cat. No.94CH35717), P412, DOI 10.1109/SFCS.1994.365675; Banerjee D, 1996, IEEE J SEL AREA COMM, V14, P903, DOI 10.1109/49.510913; Baveja A, 2000, MATH OPER RES, V25, P255, DOI 10.1287/moor.25.2.255.12228; Bayati M, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.037208; Bayati M, 2008, IEEE T INFORM THEORY, V54, P1241, DOI 10.1109/TIT.2007.915695; Bayati M, 2008, J MATH PHYS, V49, DOI 10.1063/1.2982805; Belgacem L, 2014, EUR J OPER RES, V232, P298, DOI 10.1016/j.ejor.2013.06.050; Blesa M, 2004, LECT NOTES COMPUT SC, V3005, P160; Braunstein A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.030201; Chan WT, 2003, ALGORITHMICA, V36, P343, DOI 10.1007/s00453-003-1023-8; Chatterjee BC, 2013, IETE TECH REV, V30, P12, DOI 10.4103/0256-4602.107335; Chekuri C., 2006, THEORY COMPUT, V2, P137, DOI DOI 10.4086/T0C.2006.V002A007; Chen C, 1996, IEEE INFOCOM SER, P164, DOI 10.1109/INFCOM.1996.497890; Chuzhoy J, 2005, NEW HARDNESS RESULTS; De Bacco C, 2014, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2014/07/P07009; ERDOS P, 1960, B INT STATIST INST, V38, P343; Erlebach T, 2006, LECT NOTES COMPUT SC, V3484, P97, DOI 10.1007/11671541_4; Erlebach T, 2001, SIAM J DISCRETE MATH, V14, P326, DOI 10.1137/S0895480199361259; GALIL Z, 1986, SIAM J COMPUT, V15, P120, DOI 10.1137/0215009; Gamarnik D, 2010, CMMI0726733 NAT SCI; Garey M.R., 1979, COMPUTERS INTRACTABI; Garg N, 1997, ALGORITHMICA, V18, P3, DOI 10.1007/BF02523685; Gerez S. H, 1999, ALGORITHMS VLSI DESI, V8; Gerla M, 1995, WIREL NETW, V1, P255, DOI 10.1007/BF01200845; Hassan A, 2007, EPSRC POSTGRADATE NE; Hsu CC, 2014, GENETIC EVOLUTIONARY, P95; Hsu CC, 2014, NEUROCOMPUTING; Hummeltenberg W, 2008, NETWORK MODELS OPTIM; Jain S, 2008, AD HOC NETW, V6, P805, DOI 10.1016/j.adhoc.2007.07.002; Karp Richard M, 1972, REDUCIBILITY COMBINA; Kleinberg J, 2005, ANN IEEE SYMP FOUND, P627, DOI 10.1109/SFCS.2005.18; Kleinberg J, 1995, AN S FDN CO, P52, DOI 10.1109/SFCS.1995.492462; Kleinberg JM., 1996, APPROXIMATION ALGORI; Kolliopoulos SG, 2004, MATH PROGRAM, V99, P63, DOI 10.1007/s10107-002-0370-6; Li X, 2004, P 1 ACM INT WORKSH P, P23; Lovasz L, 2009, AMS CHELSEA PUBLISHI; Mahapatra A, 2006, COMPUT COMMUN, V29, P437, DOI 10.1016/j.comcom.2004.12.028; Manohar P, 2002, IEEE COMMUN LETT, V6, P211, DOI 10.1109/4234.1001667; Masip-Bruin X, 2006, COMPUT COMMUN, V29, P563, DOI 10.1016/j.comcom.2005.06.008; Medina A, 2001, NINTH INTERNATIONAL SYMPOSIUM ON MODELING, ANALYSIS AND SIMULATION OF COMPUTER AND TELECOMMUNICATION SYSTEMS, PROCEEDINGS, P346, DOI 10.1109/MASCOT.2001.948886; Mezard M, 2003, J STAT PHYS, V111, P1, DOI 10.1023/A:1022221005097; Mezard M, 2002, SCIENCE, V297, P812, DOI 10.1126/science.1073287; Mezard M, 2001, EUR PHYS J B, V20, P217, DOI 10.1007/PL00011099; Mezard M., 2009, INFORM PHYS COMPUTAT, pp 584, DOI [10.1093/acprof:oso/9780198570837.001.0001, DOI 10.1093/ACPROF:OSO/9780198570837.001, DOI 10.1093/ACPROF:OSO/9780198570837.001.0001]; Newman MEJ, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.026118; Noronha TF, 2011, J GLOBAL OPTIM, V50, P503, DOI 10.1007/s10898-010-9608-7; Ozdaglar AE, 2003, IEEE ACM T NETWORK, V11, P259, DOI 10.1109/TNET.2003.810321; Pham QD, 2012, CONSTRAINTS, V17, P357, DOI 10.1007/s10601-012-9124-0; ROBERTSON N, 1995, J COMB THEORY B, V63, P65, DOI 10.1006/jctb.1995.1006; Salama HF, 1997, IEEE J SEL AREA COMM, V15, P332, DOI 10.1109/49.564132; SHIN KG, 1994, P IEEE, V82, P6, DOI 10.1109/5.259423; Skorin-Kapov N, 2007, EUR J OPER RES, V177, P1167, DOI 10.1016/j.ejor.2006.01.003; Srinivas A, 2003, P 9 ANN INT C MOBILE, P122; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; Sumpter Z, 2013, IEEE GLOBECOM 2013 C; Tanenbaum A. S., 2003, COMPUT NETW; Virasoro M, 1987, SPIN GLASS THEORY, V9; Vygen J., 1994, DISJOINT PATHS; Yeung CH, 2013, P NATL ACAD SCI USA, V110, P13717, DOI 10.1073/pnas.1301111110; Yeung CH, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.208701	64	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145222	10.1371/journal.pone.0145222	http://dx.doi.org/10.1371/journal.pone.0145222			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710102	Green Submitted, gold, Green Published			2022-12-26	WOS:000367451400026
J	Broekgaarden, C; Bucher, J; Bac-Molenaar, J; Keurentjes, JJB; Kruijer, W; Voorrips, RE; Vosman, B				Broekgaarden, Colette; Bucher, Johan; Bac-Molenaar, Johanna; Keurentjes, Joost J. B.; Kruijer, Willem; Voorrips, Roeland E.; Vosman, Ben			Novel Genes Affecting the Interaction between the Cabbage Whitefly and Arabidopsis Uncovered by Genome-Wide Association Mapping	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; INSECT HERBIVORES DRIVE; NATURAL VARIATION; BEMISIA-TABACI; GLUCOSINOLATE ACCUMULATION; SIGNALING PATHWAYS; APHID RESISTANCE; PLANT DEFENSES; THALIANA; POPULATIONS	Plants have evolved a variety of ways to defend themselves against biotic attackers. This has resulted in the presence of substantial variation in defense mechanisms among plants, even within a species. Genome-wide association GWA) mapping is a useful tool to study the genetic architecture of traits, but has so far only had limited exploitation in studies of plant defense. Here, we study the genetic architecture of defense against the phloem-feeding insect cabbage whitefly Aleyrodes proletella) in Arabidopsis thaliana. We determined whitefly performance, i.e. the survival and reproduction of whitefly females, on 360 worldwide selected natural accessions and subsequently performed GWA mapping using 214,051 SNPs. Substantial variation for whitefly adult survival and oviposition rate number of eggs laid per female per day) was observed between the accessions. We identified 39 candidate SNPs for either whitefly adult survival or oviposition rate, all with relatively small effects, underpinning the complex architecture of defense traits. Among the corresponding candidate genes, i.e. genes in linkage disequilibrium LD) with candidate SNPs, none have previously been identified as a gene playing a role in the interaction between plants and phloem-feeding insects. Whitefly performance on knock-out mutants of a number of candidate genes was significantly affected, validating the potential of GWA mapping for novel gene discovery in plant-insect interactions. Our results show that GWA analysis is a very useful tool to gain insight into the genetic architecture of plant defense against herbivorous insects, i.e. we identified and validated several genes affecting whitefly performance that have not previously been related to plant defense against herbivorous insects.	[Broekgaarden, Colette; Bucher, Johan; Voorrips, Roeland E.; Vosman, Ben] Wageningen Univ, Wageningen UR Plant Breeding, NL-6700 AP Wageningen, Netherlands; [Broekgaarden, Colette] Univ Utrecht, Plant Microbe Interact, Dept Biol, Utrecht, Netherlands; [Bac-Molenaar, Johanna] Wageningen Univ, Lab Plant Physiol, NL-6700 AP Wageningen, Netherlands; [Bac-Molenaar, Johanna; Keurentjes, Joost J. B.] Wageningen Univ, Genet Lab, NL-6700 AP Wageningen, Netherlands; [Kruijer, Willem] Wageningen Univ, Biometris Appl Stat, Dept Plant Sci, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research; Utrecht University; Wageningen University & Research; Wageningen University & Research; Wageningen University & Research	Vosman, B (corresponding author), Wageningen Univ, Wageningen UR Plant Breeding, NL-6700 AP Wageningen, Netherlands.	ben.vosman@wur.nl	Vosman, Ben/C-5494-2013; Voorrips, Roeland E/H-3458-2011; Bac-Molenaar, Johanna/R-2265-2016; Kruijer, Willem/AAJ-7245-2020	Vosman, Ben/0000-0003-4942-8342; Voorrips, Roeland E/0000-0003-4388-9244; Keurentjes, Joost/0000-0001-8918-0711	Dutch Technology Foundation STW, Netherlands Organisation for Scientific Research (NWO); Ministry of Economic Affairs [10994, 13087]; Syngenta Seeds BV; Plant Research International BV	Dutch Technology Foundation STW, Netherlands Organisation for Scientific Research (NWO); Ministry of Economic Affairs; Syngenta Seeds BV(Syngenta); Plant Research International BV(Plant Research International)	This research was supported by the Dutch Technology Foundation STW, which is part of the Netherlands Organisation for Scientific Research (NWO) and partly funded by the Ministry of Economic Affairs (Learning from Nature perspective grant no. 10994; VENI grant no. 13087 to CB). The project is financially supported by Syngenta Seeds BV and Plant Research International BV. The funders had an advisory role on the study design, data collection and analysis, and decision to publish. Plant Research International contributed to the preparation of the manuscript, whereas Syngenta had no role in manuscript preparation.	Agrawal AA, 2012, SCIENCE, V338, P113, DOI 10.1126/science.1225977; Assaad FF, 2004, MOL BIOL CELL, V15, P5118, DOI 10.1091/mbc.E04-02-0140; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Baxter I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001193; Bergelson J, 2010, NAT REV GENET, V11, P867, DOI 10.1038/nrg2896; Bhullar NK, 2009, P NATL ACAD SCI USA, V106, P9519, DOI 10.1073/pnas.0904152106; Broekgaarden C, 2012, ENTOMOL EXP APPL, V142, P153, DOI 10.1111/j.1570-7458.2011.01210.x; Broekgaarden C, 2011, PLANT BIOTECHNOL J, V9, P819, DOI 10.1111/j.1467-7652.2011.00635.x; Bruce TJA, 2015, J EXP BOT, V66, P455, DOI 10.1093/jxb/eru391; BYRNE DN, 1991, ANNU REV ENTOMOL, V36, P431, DOI 10.1146/annurev.en.36.010191.002243; Cabrera Y, 1998, PLANT SCI, V138, P209; Chan EKF, 2010, GENETICS, V185, P991, DOI 10.1534/genetics.109.108522; Chen X, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0217-3; Chen X, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0070914, 10.1371/journal.pone.0079652]; Chen X, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-33; Collard BCY, 2005, EUPHYTICA, V142, P169, DOI 10.1007/s10681-005-1681-5; Darrow K, 1997, BIOCHEM SYST ECOL, V25, P1, DOI 10.1016/S0305-1978(96)00090-7; de Vos M, 2007, BIOESSAYS, V29, P871, DOI 10.1002/bies.20624; Domergue F, 2010, PLANT PHYSIOL, V153, P1539, DOI 10.1104/pp.110.158238; Ellis C, 2002, PLANT CELL, V14, P1557, DOI 10.1105/tpc.002022; Firdaus S, 2012, EUPHYTICA, V187, P31, DOI 10.1007/s10681-012-0704-2; Hare JD, 2012, SCIENCE, V338, P50, DOI 10.1126/science.1228893; Hosy E, 2003, P NATL ACAD SCI USA, V100, P5549, DOI 10.1073/pnas.0733970100; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Johansson ON, 2014, PLANT J, V79, P466, DOI 10.1111/tpj.12571; Johnson MTJ, 2011, FUNCT ECOL, V25, P305, DOI 10.1111/j.1365-2435.2011.01838.x; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kempema LA, 2007, PLANT PHYSIOL, V143, P849, DOI 10.1104/pp.106.090662; Kim S, 2007, NAT GENET, V39, P1151, DOI 10.1038/ng2115; Kliebenstein D, 2002, GENETICS, V161, P325; Kliebenstein DJ, 2001, PLANT PHYSIOL, V126, P811, DOI 10.1104/pp.126.2.811; Kroymann J, 2001, PLANT PHYSIOL, V127, P1077, DOI 10.1104/pp.010416; Kruijer W, 2015, GENETICS, V199, P379, DOI 10.1534/genetics.114.167916; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Lee S, 2010, P NATL ACAD SCI USA, V107, P21205, DOI 10.1073/pnas.1009975107; Li Y, 2010, P NATL ACAD SCI USA, V107, P21199, DOI 10.1073/pnas.1007431107; Lucatti AF, 2014, BMC GENET, V15, DOI 10.1186/s12863-014-0142-3; Lucatti AF, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-175; Maharijaya A, 2011, EUPHYTICA, V177, P401, DOI 10.1007/s10681-010-0277-x; Markovich O, 2013, J CHEM ECOL, V39, P1361, DOI 10.1007/s10886-013-0358-0; Mewis I, 2006, PHYTOCHEMISTRY, V67, P2450, DOI 10.1016/j.phytochem.2006.09.004; Mithofer A, 2012, ANNU REV PLANT BIOL, V63, P431, DOI 10.1146/annurev-arplant-042110-103854; Mooney KA, 2010, SCIENCE, V327, P1642, DOI 10.1126/science.1184814; Myles S, 2009, PLANT CELL, V21, P2194, DOI 10.1105/tpc.109.068437; Nordborg M, 2008, NATURE, V456, P720, DOI 10.1038/nature07629; Pegadaraju V, 2005, PLANT PHYSIOL, V139, P1927, DOI 10.1104/pp.105.070433; Pfalz M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000578; Pfalz M, 2009, PLANT CELL, V21, P985, DOI 10.1105/tpc.108.063115; Pieterse CM, 2004, CURR OPIN PLANT BIOL, V7, P456, DOI 10.1016/j.pbi.2004.05.006; Samayoa LF, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-014-0403-3; Scholl RL, 2000, PLANT PHYSIOL, V124, P1477, DOI 10.1104/pp.124.4.1477; Snoeren TAL, 2010, J EXP BOT, V61, P3041, DOI 10.1093/jxb/erq127; Thompson GA, 2006, J EXP BOT, V57, P755, DOI 10.1093/jxb/erj135; Thompson JN, 2005, CURR BIOL, V15, pR992, DOI 10.1016/j.cub.2005.11.046; Van Poecke RMP, 2001, J CHEM ECOL, V27, P1911, DOI 10.1023/A:1012213116515; Xiang T, 2006, ORG LETT, V8, P2835, DOI 10.1021/ol060973p; ZANGERL AR, 1993, ECOLOGY, V74, P47, DOI 10.2307/1939500; Zarate SI, 2007, PLANT PHYSIOL, V143, P866, DOI 10.1104/pp.106.090035; Zhang ZY, 2006, PLANT CELL, V18, P1524, DOI 10.1105/tpc.105.039602; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089; Zust T, 2012, SCIENCE, V338, P116, DOI 10.1126/science.1226397	61	5	5	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145124	10.1371/journal.pone.0145124	http://dx.doi.org/10.1371/journal.pone.0145124			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26699853	gold, Green Submitted, Green Published			2022-12-26	WOS:000367092600049
J	Devi, KR; Bhutia, R; Bhowmick, S; Mukherjee, K; Mahanta, J; Narain, K				Devi, Kangjam Rekha; Bhutia, Rinchenla; Bhowmick, Shovonlal; Mukherjee, Kaustab; Mahanta, Jagadish; Narain, Kanwar			Genetic Diversity of Mycobacterium tuberculosis Isolates from Assam, India: Dominance of Beijing Family and Discovery of Two New Clades Related to CAS1_Delhi and EAI Family Based on Spoligotyping and MIRU-VNTR Typing	PLOS ONE			English	Article							INTERSPERSED REPETITIVE UNITS; MOLECULAR EPIDEMIOLOGY; PULMONARY TUBERCULOSIS; DRUG-RESISTANCE; GENOTYPIC DIVERSITY; SOUTH-INDIA; NORTH-INDIA; STRAINS; COMPLEX; DELHI	Tuberculosis (TB) is one of the major public health concerns in Assam, a remote state located in the northeastern (NE) region of India. The present study was undertaken to explore the circulating genotypes of Mycobacterium tuberculosis complex (MTBC) in this region. A total of 189 MTBC strains were collected from smear positive pulmonary tuberculosis cases from different designated microscopy centres (DMC) from various localities of Assam. AII MTBC isolates were cultured on Lowenstein-Jensen (LJ) media and subsequently genotyped using spoligotyping and 24-loci mycobacterial interspersed repetitive units-variable number of tandem repeats (MIRU-VNTR) typing. Spoligotyping of MTBC isolates revealed 89 distinct spoligo patterns. The most dominant MTBC strain belonged to Beijing lineage and was represented by 35.45%(n = 67) of total isolates, followed by MTBC strains belonging to Central Asian-Delhi (CAS/Delhi) lineage and East African Indian (EAI5) lineage. In addition, in the present study 43 unknown spoligo patterns were detected. The discriminatory power of spoligotyping was found to be 0.8637 based on Hunter Gaston Discriminatory Index (HGDI). On the other hand, 24-loci MIRU-VNTR typing revealed that out of total 189 MTBC isolates from Assam 185 (97.9%) isolates had unique MIRU-VNTR profiles and 4 isolates grouped into 2 clusters. Phylogenetic analysis of 67 Beijing isolates based on 24-loci MIRU-VNTR typing revealed that Beijing isolates from Assam represent two major groups, each comprising of several subgroups. Neighbour-Joining (NJ) phylogenetic tree analysis based on combined spoligotyping and 24-loci MIRU-VNTR data of 78 Non-Beijing isolates was carried out for strain lineage identification as implemented by MIRU-VNTRplus database. The important lineages of MTBC identified were CAS/CAS1_Delhi (41.02%, n = 78) and East-African-Indian (EAI, 33.33%). Interestingly, phylogenetic analysis of orphan (23.28%) MTBC spoligotypes revealed that majority of these orphan isolates from Assam represent two new sub-clades Assam/EAI and Assam/CAS. The prevalence of multidrug resistance (MDR) in Beijing and Non-Beijing strains was found to be 10.44% and 9.01% respectively. In conclusion, the present study has shown the predominance of Beijing isolates in Assam which is a matter of great concern because Beijing strains are considered to be ecologically more fit enabling wider dissemination of M. tuberculosis. Other interesting finding of the present study is the discovery of two new clades of MTBC isolates circulating in Assam. More elaborate longitudinal studies are required to be undertaken in this region to understand the transmission dynamics of MTBC.	[Devi, Kangjam Rekha; Bhutia, Rinchenla; Bhowmick, Shovonlal; Mukherjee, Kaustab; Mahanta, Jagadish; Narain, Kanwar] NE Reg Indian Council Med Res, Reg Med Res Ctr, Dibrugarh 786001, Assam, India	Indian Council of Medical Research (ICMR); ICMR - Regional Medical Research Centre, North East Region (RMRC NE)	Narain, K (corresponding author), NE Reg Indian Council Med Res, Reg Med Res Ctr, Post Box 105, Dibrugarh 786001, Assam, India.	kanwar_narain@hotmail.com	Mukherjee, Kaustab/T-9807-2017	Narain, Kanwar/0000-0002-3463-535X	Indian Council of Medical Research [NER/17/2012-ECD-I]	Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	This work was supported by the Indian Council of Medical Research; NER/17/2012-ECD-I.; The authors are thankful to Indian Council of Medical Research for funding this research project. We also thank Mr. S.K. Rajguru, Mr. Kamal Gogoi and Mr. Rajeev for helping in data entry.	Ahmed N, 2011, TUBERCULOSIS, V91, P407, DOI 10.1016/j.tube.2011.03.006; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Almeida D, 2005, CLIN INFECT DIS, V40, P881, DOI 10.1086/427940; [Anonymous], 2009, TRAIN MAN MYC TUB CU, P1; Arora J, 2009, INFECT GENET EVOL, V9, P832, DOI 10.1016/j.meegid.2009.05.008; Banu S, 2004, J CLIN MICROBIOL, V42, P674, DOI 10.1128/JCM.42.2.674-682.2004; Banu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124976; Bhanu NV, 2002, TUBERCULOSIS, V82, P105, DOI 10.1054/tube.2002.0332; Brudey K, 2006, J CLIN MICROBIOL, V44, P183, DOI 10.1128/JCM.44.1.183-191.2006; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Buu TN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042323; Cerezo I, 2012, INFECT GENET EVOL, V12, P657, DOI 10.1016/j.meegid.2011.07.006; Chang JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043018; Chatterjee A, 2013, TUBERCULOSIS, V93, P250, DOI 10.1016/j.tube.2012.10.004; Chatterjee A, 2010, J CLIN MICROBIOL, V48, P3593, DOI 10.1128/JCM.00430-10; de Steenwinkel JEM, 2012, EMERG INFECT DIS, V18, P660, DOI 10.3201/eid1804.110912; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Desikan P, 2012, INDIAN J MED MICROBI, V30, P470, DOI 10.4103/0255-0857.103774; Diriba B, 2013, INT J TUBERC LUNG D, V17, P246, DOI 10.5588/ijtld.12.0195; Dymova MA, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-77; Fenner L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024737; Gupta A, 2014, INDIAN J MED RES, V139, P892; Hasan Z, 2006, J CLIN MICROBIOL, V44, P1763, DOI 10.1128/JCM.44.5.1763-1768.2006; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; John TJ, 2014, INDIAN PEDIATR, V51, P523, DOI 10.1007/s13312-014-0440-x; Joseph BV, 2013, INFECT GENET EVOL, V16, P157, DOI 10.1016/j.meegid.2013.01.012; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kaplan G, 2003, INFECT IMMUN, V71, P7099, DOI 10.1128/IAI.71.12.7099-7108.2003; Kent PT, 1985, GUIDE LEVEL 3 LAB; Kisa O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030331; Kulkarni S, 2005, RES MICROBIOL, V156, P588, DOI 10.1016/j.resmic.2005.01.005; Le Fleche P, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-37; Liu Y, 2009, ELECT J DIFFERENTIAL, V32, P117, DOI DOI 10.1371/J0URNAL.P0NE.0106787; Mathuria JP, 2008, INFECT GENET EVOL, V8, P346, DOI 10.1016/j.meegid.2008.02.005; Merker M, 2015, NAT GENET, V47, P242, DOI 10.1038/ng.3195; Mokrousov I, 2004, J CLIN MICROBIOL, V42, P2438, DOI 10.1128/JCM.42.6.2438-2444.2004; Nakanishi N, 2013, INFECT GENET EVOL, V16, P174, DOI 10.1016/j.meegid.2013.02.007; Narayanan S, 2008, INFECT GENET EVOL, V8, P474, DOI 10.1016/j.meegid.2007.09.007; Noguti EN, 2010, MEM I OSWALDO CRUZ, V105, P779, DOI 10.1590/S0074-02762010000600008; Oelemann MC, 2007, J CLIN MICROBIOL, V45, P691, DOI 10.1128/JCM.01393-06; Purwar S, 2011, INFECT GENET EVOL, V11, P469, DOI 10.1016/j.meegid.2010.12.010; Rajapaksa US, 2008, T ROY SOC TROP MED H, V102, P997, DOI 10.1016/j.trstmh.2008.04.025; Rao KR, 2006, J CLIN MICROBIOL, V44, P274, DOI 10.1128/JCM.44.1.274-277.2006; Refaya AK, 2012, J MED MICROBIOL, V61, P1352, DOI 10.1099/jmm.0.044453-0; Reyes JF, 2012, INFECT GENET EVOL, V12, P811, DOI 10.1016/j.meegid.2011.05.018; Ribeiro SCM, 2014, J CLIN MICROBIOL, V52, P2615, DOI 10.1128/JCM.00498-14; Rindi L, 2012, INFECT GENET EVOL, V12, P1551, DOI 10.1016/j.meegid.2012.06.008; Roetzer A, 2011, J CLIN MICROBIOL, V49, P4173, DOI 10.1128/JCM.05293-11; Sankar MM, 2013, TUBERCULOSIS, V93, P75, DOI 10.1016/j.tube.2012.10.005; Shanmugam S, 2011, INFECT GENET EVOL, V11, P980, DOI 10.1016/j.meegid.2011.03.011; Sharma P, 2008, INFECT GENET EVOL, V8, P621, DOI 10.1016/j.meegid.2008.05.002; Sharma R, 2008, INT J TUBERC LUNG D, V12, P1122; Singh UB, 2004, EMERG INFECT DIS, V10, P1138, DOI 10.3201/eid1006.030575; Singh UB, 2007, INFECT GENET EVOL, V7, P441, DOI 10.1016/j.meegid.2007.01.003; Somerville W, 2005, J CLIN MICROBIOL, V43, P2996, DOI 10.1128/JCM.43.6.2996-2997.2005; Stavrum R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004540; Supply P, 2001, J CLIN MICROBIOL, V39, P3563, DOI 10.1128/JCM.39.10.3563-3571.2001; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Suresh N, 2007, J MICROBIOL METH, V68, P291, DOI 10.1016/j.mimet.2006.09.001; Thomas SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027584; Vadwai V, 2012, TUBERCULOSIS, V92, P264, DOI 10.1016/j.tube.2012.01.002; Vadwai V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024770; Varma-Basil M, 2011, MEM I OSWALDO CRUZ, V106, P524, DOI 10.1590/S0074-02762011000500002; Vasconcellos SEG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107747; Wang CZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013594; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; WHO, 2014, GLOB TUB REP	67	29	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145860	10.1371/journal.pone.0145860	http://dx.doi.org/10.1371/journal.pone.0145860			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26701129	gold, Green Published, Green Submitted			2022-12-26	WOS:000367092600136
J	Hickson, DA; Truong, NL; Smith-Bankhead, N; Sturdevant, N; Duncan, DT; Schnorr, J; Gipson, JA; Mena, LA				Hickson, DeMarc A.; Truong, Nhan L.; Smith-Bankhead, Neena; Sturdevant, Nikendrick; Duncan, Dustin T.; Schnorr, Jordan; Gipson, June A.; Mena, Leandro A.			Rationale, Design and Methods of the Ecological Study of Sexual Behaviors and HIV/STI among African American Men Who Have Sex with Men in the Southeastern United States (The MARI Study)	PLOS ONE			English	Article							YOUNG BLACK-MEN; HIV-INFECTION; FORMATIVE RESEARCH; WHITE MEN; HEALTH; RISK; SCALE; GAY; MSM; DISCRIMINATION	Background This paper describes the rationale, design, and methodology of the Ecological Study of Sexual Behaviors and HIV/STI among African American Men Who Have Sex with Men (MSM) in the Southeastern United States (U.S.; known locally simply as the MARI Study). Methods Participants are African American MSM aged 18 years and older residing in the deep South. Results Between 2013 and 2015, 800 African American MSM recruited from two study sites (Jackson, MS and Atlanta, GA) will undergo a 1.5-hour examination to obtain anthropometric and blood pressure measures as well as to undergo testing for sexually transmitted infections (STI), including HIV. Intrapersonal, interpersonal, and environmental factors are assessed by audio computer-assisted self-interview survey. Primary outcomes include sexual risk behaviors (e.g., condomless anal sex) and prevalent STIs (HIV, syphilis, gonorrhea, and Chlamydia). Conclusion The MARI Study will typify the HIV environmental 'riskscape' and provide empirical evidence into novel ecological correlates of HIV risk among African American MSM in the deep South, a population most heavily impacted by HIV. The study's anticipated findings will be of interest to a broad audience and lead to more informed prevention efforts, including effective policies and interventions, that achieve the goals of the updated 2020 U.S. National HIV/AIDS Strategy.	[Hickson, DeMarc A.; Truong, Nhan L.; Sturdevant, Nikendrick] My Bros Keeper Inc, Ctr Res Evaluat & Environm & Policy Change, Jackson, MS 39202 USA; [Hickson, DeMarc A.; Mena, Leandro A.] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39213 USA; [Smith-Bankhead, Neena; Schnorr, Jordan] AID Atlanta Inc, RED Inst, Atlanta, GA 30309 USA; [Duncan, Dustin T.] New York Univ, Sch Med, Dept Populat Hlth, New York, NY 10016 USA; [Gipson, June A.] My Bros Keeper Inc, Ctr Community Based Programs, Ridgeland, MS USA	University of Mississippi; University of Mississippi Medical Center; New York University	Hickson, DA (corresponding author), My Bros Keeper Inc, Ctr Res Evaluat & Environm & Policy Change, 510 George St,Unit 100, Jackson, MS 39202 USA.	dhickson@mbk-inc.org			Centers for Disease Control and Prevention [U01PS003315]; Centers for Disease Control and Prevention, Minority HIV/AIDS Research Initiative [U01PS003315]; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) [U01PS003315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103476] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Centers for Disease Control and Prevention, Minority HIV/AIDS Research Initiative(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Ecological Study of Sexual Behaviors and HIV/STI among African American Men Who Have Sex with Men in the Southeastern United States (The MARI Study) is supported by a cooperative agreement U01PS003315 from the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by Centers for Disease Control and Prevention cooperative agreement U01PS003315 as part of the Minority HIV/AIDS Research Initiative. The authors gratefully thank The MARI Study participants. In addition, the authors thank the staff of The MARI Study [Jackson, MS: DeMarc, A. Hickson, PhD (PI); June A. Gipson (co-I); Leandro A. Mena, MD, MPH (co-I); Dantrell L. Simmons, PhD (Data Analyst); Christopher R. Roby, PhD(c) (Data Analyst), Nhan L. Truong, PhD (PostDoc & Data Analyst); Nikendrick Sturdevant (Project Coordinator); Angela D. Johnson (Quality Assurance Manager); William L. Johnson (PostDoc & Data Manager); Cordarian Draper (Recruiter); Obie S. McNair (Research Associate); Atlanta, GA: Neena Smith-Bankhead (co-I; Sub-Award PI); Craig Washington (co-I); John Stanton (Project Coordinator and Quality Assurance Manager); Ricardo Rush (Recruiter); NAESM, Inc: Darwin Thompson (co-I) and Damon Johnson (Project Coordinator)] and CDC Project Officers and Collaborators [Madeline Y. Sutton, MD (Team Lead and Project Officer); Leigh A. Willis, PhD (Project Officer); Kim Elmore (co-I and Mentor); Zaneta Gaul (ACASI Programmer and Data Analyst)] for their contributions and commitment to the successful implementation of the study.	Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P77; Anonymous, 2008, Morbidity and Mortality Weekly Report, V57, P681; [Anonymous], HIV SURV REP; Balaji AB, 2012, AIDS PATIENT CARE ST, V26, P730, DOI 10.1089/apc.2012.0177; Baral S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-482; BAREFOOT JC, 1989, PSYCHOSOM MED, V51, P46, DOI 10.1097/00006842-198901000-00005; BERKMAN LF, 1979, AM J EPIDEMIOL, V109, P186, DOI 10.1093/oxfordjournals.aje.a112674; Bingham TA, 2003, AIDS EDUC PREV, V15, P39, DOI 10.1521/aeap.15.1.5.39.23613; Bogart Laura M, 2013, AIDS Behav, V17, P1431, DOI 10.1007/s10461-012-0397-5; Bowen AM, 2007, HEALTH EDUC RES, V22, P120, DOI 10.1093/her/cyl057; Buchele G, 2005, EPIDEMIOLOGY, V16, P130; Buot MLG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091711; Cash TF, 2002, INT J EAT DISORDER, V31, P455, DOI 10.1002/eat.10033; Centers for Disease Control and Prevention, 2012, DIAGN HIV INF US DEP, V24; CHAVIS DM, 1990, AM J COMMUN PSYCHOL, V18, P55, DOI 10.1007/BF00922689; Clark CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063254; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Coulter RWS, 2014, AM J PUBLIC HEALTH, V104, pE105, DOI 10.2105/AJPH.2013.301501; Crosby RA, 2015, AIDS BEHAV; Duncan DT, 2014, DRUG ALCOHOL DEPEN, V135, P65, DOI 10.1016/j.drugalcdep.2013.11.001; Duncan DT, 2011, GEOSPATIAL HEALTH, V5, P265, DOI 10.4081/gh.2011.179; Egan JE, 2011, AIDS BEHAV, V15, pS35, DOI 10.1007/s10461-011-9902-5; Ellen JM, 2013, INT J STD AIDS, V24, P335, DOI 10.1177/0956462412472459; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Fields EL, 2015, AM J PUBLIC HEALTH, V105, P122, DOI 10.2105/AJPH.2013.301866; Fullilove R. E., 2006, AFRICAN AM HLTH DISP; Georgia Department of Public Health, HIV AIDS EP SECT; Ghanem KG, 2005, SEX TRANSM INFECT, V81, P421, DOI 10.1136/sti.2004.013193; Goldbaum G, 1996, PUBLIC HEALTH REP, V111, P36; Hamlin-Palmer S, 2013, AM PUBL HLTH ASS ANN; HART EA, 1989, J SPORT EXERCISE PSY, V11, P94, DOI 10.1123/jsep.11.1.94; Hickson DA, 2014, 142 ANN M AM PUBL HL; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; Institute of Medicine, 2011, HLTH LESB GAY BISEX; Irvin R, 2014, AIDS BEHAV, V18, P1272, DOI 10.1007/s10461-014-0734-y; Kelly JA, 2013, AIDS EDUC PREV, V25, P49, DOI 10.1521/aeap.2013.25.1.49; Koblin BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075878; Koblin BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070413; Kraft JM, 2000, HEALTH EDUC BEHAV, V27, P430, DOI 10.1177/109019810002700406; Lanier Y, 2013, AM J PUBLIC HEALTH, V103, P262, DOI 10.2105/AJPH.2012.300921; Latkin C, 2012, AIDS BEHAV, V16, P535, DOI 10.1007/s10461-011-0014-z; Lieb S, 2011, AIDS BEHAV, V15, P596, DOI 10.1007/s10461-010-9820-y; Lieb S, 2009, J URBAN HEALTH, V86, P887, DOI 10.1007/s11524-009-9401-4; Magnus M, 2014, J PUBLIC HEALTH MAN, V20, pE1, DOI 10.1097/PHH.0000000000000025; Mansergh G, 2014, SEX TRANSM INFECT; Martinez O, 2014, J MED INTERNET RES, V16, P168, DOI 10.2196/jmir.3311; Maulsby C, 2014, AIDS BEHAV; Maulsby C, 2014, AIDS BEHAV, V18, P10, DOI 10.1007/s10461-013-0476-2; McCree DH, 2010, AFRICAN AMERICANS AND HIV/AIDS: UNDERSTANDING AND ADDRESSING THE EPIDEMIC, P1; Miller R. S., 1991, J PSYCHOL HUMAN SEXU, V4, P43; Millett GA, 2007, AIDS, V21, P2083, DOI 10.1097/QAD.0b013e3282e9a64b; Morello-Frosch R, 2006, ENVIRON HEALTH PERSP, V114, P1150, DOI 10.1289/ehp.8930; Mujahid MS, 2007, AM J EPIDEMIOL, V165, P858, DOI 10.1093/aje/kwm040; O'Leary A, 2014, AIDS BEHAV, V18, P2080, DOI 10.1007/s10461-014-0708-0; [Office of Disease Prevention and Health Promotion U.S. Department of Health and Human Services], OFF DIS PREV HLTH PR; Peterson JL, 2009, HEALTH EDUC RES, V24, P119, DOI 10.1093/her/cyn003; Peterson JL, 2014, JAIDS-J ACQ IMM DEF, V66, P538, DOI 10.1097/QAI.0000000000000203; Phillips G, 2014, ARCH SEX BEHAV, V43, P771, DOI 10.1007/s10508-014-0267-5; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reif S, 2015, J COMMUN HEALTH, V40, P642, DOI 10.1007/s10900-014-9979-7; Reif SS, 2014, AIDS CARE, V26, P351, DOI 10.1080/09540121.2013.824535; Reisner SL, 2009, AIDS BEHAV, V13, P798, DOI 10.1007/s10461-009-9571-9; Robinson JC, 2010, J URBAN HEALTH, V87, P136, DOI 10.1007/s11524-009-9403-2; Rosenberg ES, 2014, LANCET HIV, V1, pE112, DOI 10.1016/S2352-3018(14)00011-3; Ross CE, 2001, J HEALTH SOC BEHAV, V42, P258, DOI 10.2307/3090214; Roux AVD, 2001, ANN EPIDEMIOL, V11, P395, DOI 10.1016/S1047-2797(01)00221-6; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; Sexton ME, 2013, J FAM PRACTICE, V62, P70; Silver E, 2002, SOC SCI MED, V55, P1457, DOI 10.1016/S0277-9536(01)00266-0; Silvera Richard, 2010, Open AIDS J, V4, P76, DOI 10.2174/1874613601004010076; Smith DK, 2012, AIDS EDUC PREV, V24, P408, DOI 10.1521/aeap.2012.24.5.408; Southern AIDS Coalition, 2010, STILL CAUGHT STORM C; Spielberger C.D., 1988, HLTH PSYCHOL INDIVID, P89, DOI DOI 10.1007/978-1-4612-3824-9_5; [STD/HIV Office Mississippi State Department of Health], HIV DIS 2009 ANN SUR; Steele C, 2007, HLTH DISPARITIES HIV; Steptoe A, 2001, ANN BEHAV MED, V23, P177, DOI 10.1207/S15324796ABM2303_5; Stunkard A J, 1983, Res Publ Assoc Res Nerv Ment Dis, V60, P115; Sullivan PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090514; Tieu HV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134085; Truong N, GLOB PUBLIC IN PRESS; Underwood LG, 2002, ANN BEHAV MED, V24, P22, DOI 10.1207/S15324796ABM2401_04; US Census Bureau, 2010, STAT COUNT QUICK FAC; ViiV Healthcare, 2015, IN INV HELP RES ID A; Wheeler DP, 2008, ARCH SEX BEHAV, V37, P697, DOI 10.1007/s10508-008-9372-7; WILLIAMS DR, 1997, J HLTH PSYCHOL, V0002; Wolff LS, 2010, J HEALTH PSYCHOL, V15, P560, DOI 10.1177/1359105309354345; Wylie SA, 2010, SEX ROLES, V63, P264, DOI 10.1007/s11199-010-9798-y; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2	90	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0143823	10.1371/journal.pone.0143823	http://dx.doi.org/10.1371/journal.pone.0143823			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ4SI	26700018	Green Published, gold, Green Submitted			2022-12-26	WOS:000367092600010
J	Kaleebu, P; Kirungi, W; Watera, C; Asio, J; Lyagoba, F; Lutalo, T; Kapaata, AA; Nanyonga, F; Parry, CM; Magambo, B; Nazziwa, J; Nannyonjo, M; Hughes, P; Hladik, W; Ruberantwari, A; Namuwenge, N; Musinguzi, J; Downing, R; Katongole-Mbidde, E				Kaleebu, Pontiano; Kirungi, Wilford; Watera, Christine; Asio, Juliet; Lyagoba, Fred; Lutalo, Tom; Kapaata, Anne A.; Nanyonga, Faith; Parry, Chris M.; Magambo, Brian; Nazziwa, Jamirah; Nannyonjo, Maria; Hughes, Peter; Hladik, Wolfgang; Ruberantwari, Anthony; Namuwenge, Norah; Musinguzi, Joshua; Downing, Robert; Katongole-Mbidde, Edward		HIV Drug Resistance Working Grp	Virological Response and Antiretroviral Drug Resistance Emerging during Antiretroviral Therapy at Three Treatment Centers in Uganda	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; TRANSMISSION CLUSTERS; NAIVE INDIVIDUALS; SURVEILLANCE; PREVENTION; INITIATION; CLINICS	Background With the scale-up of antiretroviral therapy (ART), monitoring programme performance is needed to maximize ART efficacy and limit HIV drug resistance (HIVDR). Methods We implemented a WHO HIVDR prospective survey protocol at three treatment centers between 2012 and 2013. Data were abstracted from patient records at ART start (T1) and after 12 months (T2). Genotyping was performed in the HIV pol region at the two time points. Results Of the 425 patients enrolled, at T2, 20 (4.7%) had died, 66 (15.5%) were lost to follow-up, 313 (73.6%) were still on first-line, 8 (1.9%) had switched to second-line, 17 (4.0%) had transferred out and 1 (0.2%) had stopped treatment. At T2, 272 out of 321 on first and second line (84.7%) suppressed below 1000 copies/ml and the HIV DR prevention rate was 70.1%, just within the WHO threshold of >= 70%. The proportion of participants with potential HIVDR was 20.9%, which is higher than the 18.8% based on pooled analyses from African studies. Of the 35 patients with mutations at T2, 80% had M184V/I, 65.7% Y181C, and 48.6% (54.8% excluding those not on Tenofovir) had K65R mutations. 22.9% had Thymidine Analogue Mutations (TAMs). Factors significantly associated with HIVDR prevention at T2 were: baseline viral load (VL) <100,000 copies/ml [Adjusted odds ratio (AOR) 3.13, 95% confidence interval (CI): 1.36-7.19] and facility. Independent baseline predictors for HIVDR mutations at T2 were: CD4 count <250 cells/mu l (AOR 2.80, 95% CI: 1.08-7.29) and viral load >= 100,000 copies/ml (AOR 2.48, 95% CI: 1.00-6.14). Conclusion Strengthening defaulter tracing, intensified follow-up for patients with low CD4 counts and/or high VL at ART initiation together with early treatment initiation above 250 CD4 cells/ul and adequate patient counselling would improve ART efficacy and HIVDR prevention. The high rate of K65R and TAMs could compromise second line regimens including NRTIs.	[Kaleebu, Pontiano; Watera, Christine; Asio, Juliet; Lyagoba, Fred; Lutalo, Tom; Nanyonga, Faith; Magambo, Brian; Ruberantwari, Anthony; Downing, Robert; Katongole-Mbidde, Edward] Uganda Virus Res Inst, Entebbe, Uganda; [Kaleebu, Pontiano; Lyagoba, Fred; Kapaata, Anne A.; Parry, Chris M.; Magambo, Brian; Nazziwa, Jamirah; Nannyonjo, Maria; Hughes, Peter] MRC UVRI Uganda Res Unit AIDS, Entebbe, Uganda; [Kaleebu, Pontiano] London Sch Hyg & Trop Med, London WC1, England; [Kirungi, Wilford; Namuwenge, Norah; Musinguzi, Joshua] Minist Hlth, AIDS Control Programme, Kampala, Uganda; [Hladik, Wolfgang] US Ctr Dis Control & Prevent, Entebbe, Uganda	Uganda Virus Research Institute; University of London; London School of Hygiene & Tropical Medicine	Kaleebu, P (corresponding author), Uganda Virus Res Inst, Entebbe, Uganda.	Pontiano.kaleebu@mrcuganda.org		Ndagije, Helen/0000-0001-5802-4791; Nazziwa, Jamirah/0000-0001-9029-7976; Nanyonga, Faith Elizabeth/0000-0003-2691-4401	PEPFAR [1U2GGH000785-01, 3U2GPS000586-05S1]; UK Medical Research Council (MRC); UK Department for International Development (DFID) under the MRC/DFID Concordat agreement; Medical Research Council [MC_U950080938] Funding Source: researchfish; MRC [MC_U950080938] Funding Source: UKRI	PEPFAR; UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development (DFID) under the MRC/DFID Concordat agreement; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by PEPFAR grant Nos. 1U2GGH000785-01 and 3U2GPS000586-05S1 to UVRI and by the UK Medical Research Council (MRC) and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement.	Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; Bennett DE, 2008, ANTIVIR THER, V13, P1; Billong SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072680; Commonwealth of Australia, 2015, NAT INV REP 2015, P1; Hamers RL, 2012, LANCET INFECT DIS, V12, P307, DOI 10.1016/S1473-3099(11)70255-9; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; Hamers RL, 2012, CLIN INFECTIOUS DIS; Hong SY, 2015, JAIDS-J ACQ IMM DEF, V68, P463, DOI 10.1097/QAI.0000000000000509; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Jordan MR, 2008, ANTIVIR THER, V13, P15; Kapaata A, 2013, AIDS RES HUM RETROV, V29, P520, DOI [10.1089/aid.2012.0170, 10.1089/AID.2012.0170]; Lahuerta M, 2013, CLIN INFECTIOUS DIS; Liegeois F, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17985; MOH, 2013, UG TREATM GUID ADD N; Nazziwa J, 2013, AIDS RES HUM RETROV, V29, P788, DOI [10.1089/aid.2012.0123, 10.1089/AID.2012.0123]; Ndembi N, 2008, AIDS RES HUM RETROV, V24, P889, DOI 10.1089/aid.2007.0317; Ndembi N, 2011, AIDS, V25, P905, DOI 10.1097/QAD.0b013e328346260f; Ssemwanga D, 2012, CLIN INFECT DIS, V54, pS339, DOI 10.1093/cid/cir937; Ugbena R, 2012, CLIN INFECT DIS, V54, pS375, DOI 10.1093/cid/cir1064; UNAIDS, 2014, UG HIV AIDS COUNTR P; UNAIDS, 2020, UNAIDS 2020 GLOB REP; Wadonda-Kabondo N, 2012, CLIN INFECT DIS, V54, pS355, DOI 10.1093/cid/cis004; Wensing Annemarie M, 2014, Top Antivir Med, V22, P642; WHO, 2012, WHO GLOB STRAT SURV; WHO, 2012, WHO HIV DRUG RES REP	25	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145536	10.1371/journal.pone.0145536	http://dx.doi.org/10.1371/journal.pone.0145536			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700639	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000367092600094
J	Hehle, VK; Paul, MJ; Roberts, VA; van Dolleweerd, CJ; Ma, JKC				Hehle, Verena K.; Paul, Matthew J.; Roberts, Victoria A.; van Dolleweerd, Craig J.; Ma, Julian K. -C.			Site-targeted mutagenesis for stabilization of recombinant monoclonal antibody expressed in tobacco (Nicotiana tabacum) plants	FASEB JOURNAL			English	Article						antibody engineering; degradation; proteolysis	PROTEOLYTIC DEGRADATION; SUSCEPTIBILITY; IDENTIFICATION; MOLECULE; CLEAVAGE; HIV-1; 2G12	This study examined the degradation pattern of amurine IgG1 kappa monoclonal antibody expressed in and extracted from transformed Nicotiana tabacum. Gel electrophoresis of leaf extracts revealed a consistent pattern of recombinant immunoglobulin bands, including intact and full-length antibody, as well as smaller antibody fragments. N-terminal sequencing revealed these smaller fragments to be proteolytic cleavage products and identified a limited number of protease-sensitive sites in the antibody light and heavy chain sequences. No strictly conserved target sequence was evident, although the peptide bonds that were susceptible to proteolysis were predominantly and consistently located within or near to the interdomain or solvent-exposed regions in the antibody structure. Amino acids surrounding identified cleavage sites were mutated in an attempt to increase resistance. Different Guy's 13 antibody heavy and light chain mutant combinations were expressed transiently in N. tabacum and demonstrated intensity shifts in the fragmentation pattern, resulting in alterations to the full-length antibody-tofragment ratio. The work strengthens the understanding of proteolytic cleavage of antibodies expressed in plants and presents a novel approach to stabilize full-length antibody by site-directed mutagenesis.-Hehle, V. K., Paul, M. J., Roberts, V. A., van Dolleweerd, C. J., Ma, J. K.-C. Site-targeted mutagenesis for stabilization of recombinant monoclonal antibody expressed in tobacco (Nicotiana tabacum) plants. FASEB J. 30, 1590-1598 (2016). www.fasebj.org	[Hehle, Verena K.; Paul, Matthew J.; Roberts, Victoria A.; van Dolleweerd, Craig J.; Ma, Julian K. -C.] Univ London, Inst Infect & Immun, Mol Immunol Unit, Cranmer Terrace, London SW17 0RE, England; [Roberts, Victoria A.] Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92093 USA	St Georges University London; University of London; University of California System; University of California San Diego	Ma, JKC (corresponding author), Univ London, Inst Infect & Immun, Mol Immunol Unit, Cranmer Terrace, London SW17 0RE, England.	jma@sgul.ac.uk		Paul, Mathew/0000-0002-0852-8788; van Dolleweerd, Craig/0000-0002-1380-6930; Ma, Julian/0000-0003-0767-0042	European Union; European Research Council Future-Pharma Advanced grant [AdG 2010 269110]; Molecular Farming COST Action [FA804]; Wellcome Trust [WT093092MA]; Hotung Foundation	European Union(European Commission); European Research Council Future-Pharma Advanced grant; Molecular Farming COST Action; Wellcome Trust(Wellcome TrustEuropean Commission); Hotung Foundation	The authors are grateful to M. Weldon (University of Cambridge) for performing the N-terminal sequence analyses. The authors gratefully acknowledge the European Union Framework 6 Pharma-Planta project, a European Research Council Future-Pharma Advanced grant (AdG 2010 269110), the Molecular Farming COST Action (FA804), the Wellcome Trust (Grant WT093092MA), and the Hotung Foundation for supporting for this research project.	Arcalis E, 2013, PLANT MOL BIOL, V83, P105, DOI 10.1007/s11103-013-0049-9; BAUMAL R, 1973, TRANSPLANT REV, V14, P163; De Muynck B, 2010, PLANT BIOTECHNOL J, V8, P529, DOI 10.1111/j.1467-7652.2009.00494.x; Delannoy M, 2008, PROTEOMICS, V8, P2285, DOI 10.1002/pmic.200700507; Faye L, 2005, VACCINE, V23, P1770, DOI 10.1016/j.vaccine.2004.11.003; Floss DM, 2009, PLANT BIOTECHNOL J, V7, P899, DOI 10.1111/j.1467-7652.2009.00452.x; Gomord V, 2010, PLANT BIOTECHNOL J, V8, P564, DOI 10.1111/j.1467-7652.2009.00497.x; Goulet C, 2012, PLANT BIOTECHNOL J, V10, P83, DOI 10.1111/j.1467-7652.2011.00643.x; Gutierrez RA, 1999, TRENDS PLANT SCI, V4, P429, DOI 10.1016/S1360-1385(99)01484-3; Hehle VK, 2015, PLANT BIOTECHNOL J, V13, P235, DOI 10.1111/pbi.12266; Hehle VK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-128; HIATT A, 1989, NATURE, V342, P76, DOI 10.1038/342076a0; Kabat E., 1991, SEQUENCES PROTEINS I, V2; Kim NS, 2008, PLANT MOL BIOL, V68, P263, DOI 10.1007/s11103-008-9367-8; Komarnytsky S, 2006, PLANT PHYSIOL, V141, P1185, DOI 10.1104/pp.105.074419; Koziel MG, 1996, PLANT MOL BIOL, V32, P393, DOI 10.1007/BF00039392; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; MA JKC, 1994, EUR J IMMUNOL, V24, P131, DOI 10.1002/eji.1830240120; Ma JKC, 2015, PLANT BIOTECHNOL J, V13, P1106, DOI 10.1111/pbi.12416; Niemer M, 2014, BIOTECHNOL J, V9, P493, DOI 10.1002/biot.201300207; Obregon P, 2006, PLANT BIOTECHNOL J, V4, P195, DOI 10.1111/j.1467-7652.2005.00171.x; Olsen JV, 2004, MOL CELL PROTEOMICS, V3, P608, DOI 10.1074/mcp.T400003-MCP200; Peters SJ, 2012, J BIOL CHEM, V287, P24525, DOI 10.1074/jbc.M112.369744; Rademacher T, 2008, PLANT BIOTECHNOL J, V6, P189, DOI 10.1111/j.1467-7652.2007.00306.x; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Rivard D, 2006, PLANT BIOTECHNOL J, V4, P359, DOI 10.1111/j.1467-7652.2006.00187.x; Sainsbury F, 2008, PLANT PHYSIOL, V148, P1212, DOI 10.1104/pp.108.126284; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Senior BW, 2005, INFECT IMMUN, V73, P1515, DOI 10.1128/IAI.73.3.1515-1522.2005; Sharp JM, 2001, BIOTECHNOL BIOENG, V73, P338, DOI 10.1002/bit.1067; Taha TA, 2006, FEBS LETT, V580, P6047, DOI 10.1016/j.febslet.2006.09.070; Tekoah Y, 2013, BIOSCIENCE REP, V33, P771, DOI 10.1042/BSR20130081; Tuse D, 2011, HUM VACCINES, V7, P322, DOI 10.4161/hv.7.3.14213; Wongsamuth R, 1997, BIOTECHNOL BIOENG, V54, P401, DOI 10.1002/(SICI)1097-0290(19970605)54:5&lt;401::AID-BIT1&gt;3.0.CO;2-I	34	15	15	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2016	30	4					1590	1598		10.1096/fj.15-283226	http://dx.doi.org/10.1096/fj.15-283226			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DH2PR	26712217	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000372629100020
J	Baranovskiy, AG; Zhang, YB; Suwa, Y; Gu, JY; Babayeva, ND; Pavlov, YI; Tahirov, TH				Baranovskiy, Andrey G.; Zhang, Yinbo; Suwa, Yoshiaki; Gu, Jianyou; Babayeva, Nigar D.; Pavlov, Youri I.; Tahirov, Tahir H.			Insight into the Human DNA Primase Interaction with Template-Primer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; POLYMERASE-ALPHA-PRIMASE; IRON-SULFUR CLUSTER; CRYSTAL-STRUCTURE; P58 SUBUNIT; EUKARYOTIC REPLISOME; CATALYTIC SUBUNIT; CALF THYMUS; REPLICATION; BINDING	DNA replication in almost all organisms depends on the activity of DNA primase, a DNA-dependent RNA polymerase that synthesizes short RNA primers of defined size for DNA polymerases. Eukaryotic and archaeal primases are heterodimers consisting of small catalytic and large accessory subunits, both of which are necessary for the activity. The mode of interaction of primase subunits with substrates during the various steps of primer synthesis that results in the counting of primer length is not clear. Here we show that the C-terminal domain of the large subunit (p58(C)) plays a major role in template-primer binding and also defines the elements of the DNA template and the RNA primer that interact with p58(C). The specific mode of interaction with a template-primer involving the terminal 5'-triphosphate of RNA and the 3'-overhang of DNA results in a stable complex between p58(C) and the DNA/RNA duplex. Our results explain how p58(C) participates in RNA synthesis and primer length counting and also indicate that the binding site for initiating NTP is located on p58(C). These findings provide notable insight into the mechanism of primase function and are applicable for DNA primases from other species.	[Baranovskiy, Andrey G.; Zhang, Yinbo; Suwa, Yoshiaki; Gu, Jianyou; Babayeva, Nigar D.; Pavlov, Youri I.; Tahirov, Tahir H.] Univ Nebraska, Med Ctr, Fred & Pamela Buffett Canc Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Zhang, Yinbo; Pavlov, Youri I.] Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Pavlov, Youri I.] Univ Nebraska, Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Tahirov, TH (corresponding author), Univ Nebraska, Med Ctr, Fred & Pamela Buffett Canc Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA.	ttahirov@unmc.edu	; Pavlov, Youri/T-7532-2017	Gu, Jianyou/0000-0003-0285-8919; Pavlov, Youri/0000-0003-1179-5796; Tahirov, Tahir/0000-0002-1238-0069	National Institutes of Health [GM101167, CA129925]; Fred and Pamela Buffett Cancer Center [P30CA03672]; NATIONAL CANCER INSTITUTE [P30CA036727, R01CA129925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101167] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fred and Pamela Buffett Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM101167 (NIGMS; to T. H. T.) and, in part, by CA129925 (NCI; to Y. I. P.). DNA Sequencing Core and Structural Biology Facilities are supported by the Fred and Pamela Buffett Cancer Center Support Grant P30CA03672 (NCI; to Kenneth H. Cowan). The authors declare that they have no competing conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agarkar VB, 2011, CELL CYCLE, V10, P926, DOI 10.4161/cc.10.6.15010; Arezi B, 1999, BIOCHEMISTRY-US, V38, P12899, DOI 10.1021/bi9908991; Baranovskiy AG, 2015, J BIOL CHEM, V290, P5635, DOI 10.1074/jbc.M114.624742; Baranovskiy AG, 2014, ACTA CRYSTALLOGR F, V70, P206, DOI 10.1107/S2053230X13034432; Baranovskiy AG, 2012, J BIOL CHEM, V287, P17281, DOI 10.1074/jbc.M112.351122; Beck K, 2010, NUCLEIC ACIDS RES, V38, P6707, DOI 10.1093/nar/gkq447; Bianchi J, 2013, MOL CELL, V52, P566, DOI 10.1016/j.molcel.2013.10.035; Cavanaugh NA, 2009, BIOCHEMISTRY-US, V48, P10199, DOI 10.1021/bi9010144; Copeland WC, 1997, PROTEIN EXPRES PURIF, V9, P1, DOI 10.1006/prep.1996.0665; COPELAND WC, 1993, J BIOL CHEM, V268, P26179; Corn JE, 2005, MOL CELL, V20, P391, DOI 10.1016/j.molcel.2005.09.004; Fien K, 2004, J BIOL CHEM, V279, P16144, DOI 10.1074/jbc.M400142200; FOIANI M, 1989, J BIOL CHEM, V264, P2189; FRANCESCONI S, 1991, P NATL ACAD SCI USA, V88, P3877, DOI 10.1073/pnas.88.9.3877; Frick DN, 2001, ANNU REV BIOCHEM, V70, P39, DOI 10.1146/annurev.biochem.70.1.39; Garcia-Gomez S, 2013, MOL CELL, V52, P541, DOI 10.1016/j.molcel.2013.09.025; Garg P, 2005, CRIT REV BIOCHEM MOL, V40, P115, DOI 10.1080/10409230590935433; Geibel S, 2009, P NATL ACAD SCI USA, V106, P7810, DOI 10.1073/pnas.0902910106; GROSSE F, 1985, J BIOL CHEM, V260, P1881; Jozwiakowski SK, 2015, P NATL ACAD SCI USA, V112, pE633, DOI 10.1073/pnas.1412982112; Kato M, 2004, J BIOL CHEM, V279, P30554, DOI 10.1074/jbc.M403485200; Kilkenny ML, 2012, J BIOL CHEM, V287, P23740, DOI 10.1074/jbc.M112.368951; Kilkenny ML, 2013, P NATL ACAD SCI USA, V110, P15961, DOI 10.1073/pnas.1311185110; Kirk BW, 1999, BIOCHEMISTRY-US, V38, P7727, DOI 10.1021/bi990247c; Klinge S, 2007, NAT STRUCT MOL BIOL, V14, P875, DOI 10.1038/nsmb1288; KUCHTA RD, 1990, J BIOL CHEM, V265, P16158; Kuchta RD, 2010, BBA-PROTEINS PROTEOM, V1804, P1180, DOI 10.1016/j.bbapap.2009.06.011; Lee SJ, 2010, NUCLEIC ACIDS RES, V38, P4372, DOI 10.1093/nar/gkq205; Liu LL, 2015, PROTEIN CELL, V6, P194, DOI 10.1007/s13238-015-0134-8; Loeb LA, 2008, NAT REV GENET, V9, P594, DOI 10.1038/nrg2345; Matsui E, 2003, BIOCHEMISTRY-US, V42, P14968, DOI 10.1021/bi035556o; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; Mitchell SF, 2014, METHOD ENZYMOL, V541, P179, DOI 10.1016/B978-0-12-420119-4.00015-X; Muzi-Falconi Marco, 2003, ScientificWorldJournal, V3, P21; Pellegrini Luca, 2012, Subcell Biochem, V62, P157, DOI 10.1007/978-94-007-4572-8_9; PODUST VN, 1992, EUR J BIOCHEM, V206, P7, DOI 10.1111/j.1432-1033.1992.tb16895.x; Sauguet L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010083; SHEAFF RJ, 1993, BIOCHEMISTRY-US, V32, P3027, DOI 10.1021/bi00063a014; Simon AC, 2014, NATURE, V510, P293, DOI 10.1038/nature13234; Suwa Y, 2015, J BIOL CHEM, V290, P14328, DOI 10.1074/jbc.M115.649954; Urban M, 2010, BIOCHEMISTRY-US, V49, P727, DOI 10.1021/bi9019516; Vaithiyalingam S, 2014, J MOL BIOL, V426, P558, DOI 10.1016/j.jmb.2013.11.007; Vaithiyalingam S, 2010, P NATL ACAD SCI USA, V107, P13684, DOI 10.1073/pnas.1002009107; Weiner BE, 2007, J BIOL CHEM, V282, P33444, DOI 10.1074/jbc.M705826200; Zerbe LK, 2002, BIOCHEMISTRY-US, V41, P4891, DOI 10.1021/bi016030b; Zhang YB, 2014, J BIOL CHEM, V289, P22021, DOI 10.1074/jbc.M114.570333	46	34	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4793	4802		10.1074/jbc.M115.704064	http://dx.doi.org/10.1074/jbc.M115.704064			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26710848	Green Published, hybrid			2022-12-26	WOS:000371604600044
J	Charles, R; Namkung, Y; Cotton, M; Laporte, SA; Claing, A				Charles, Ricardo; Namkung, Yoon; Cotton, Mathieu; Laporte, Stephane A.; Claing, Audrey			beta-Arrestin-mediated Angiotensin II Signaling Controls the Activation of ARF6 Protein and Endocytosis in Migration of Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						7-helix receptor; ADP ribosylation factor (ARF); angiotensin II; arrestin; cell migration; vascular smooth muscle cells	GROWTH-FACTOR RECEPTOR; BREAST-CANCER CELLS; B KINASE COMPLEX; BETA(2)-ADRENERGIC RECEPTOR; CLATHRIN ADAPTER; TYPE-1 RECEPTOR; IN-VIVO; MEMBRANE; PHOSPHORYLATION; BETA-ARRESTIN-2	Angiotensin II (Ang II) is a vasopressive hormone but is also a potent activator of cellular migration. We have previously shown that it can promote the activation of the GTPase ARF6 in a heterologous overexpressing system. The molecular mechanisms by which receptors control the activation of this small G protein remain, however, largely unknown. Furthermore, how ARF6 coordinates the activation of complex cellular responses needs to be further elucidated. In this study, we demonstrate that Ang II receptors engage -arrestin, but not G(q), to mediate ARF6 activation in HEK 293 cells. To further confirm the key role of -arrestin proteins, we overexpressed -arrestin2-(1-320), a dominant negative mutant known to block receptor endocytosis. We show that expression of this truncated construct does not support the activation of the GTPase nor cell migration. Interestingly, -arrestin2 can interact with the ARF guanine nucleotide exchange factor ARNO, although the C-terminally lacking mutant does not. We finally examined whether receptor endocytosis controlled ARF6 activation and cell migration. Although the clathrin inhibitor PitStop2 did not impact the ability of Ang II to activate ARF6, cell migration was markedly impaired. To further show that ARF activation regulates key signaling events leading to migration, we also examined MAPK activation. We demonstrate that this signaling axis is relevant in smooth muscle cells of the vasculature. Altogether, our findings show for the first time that Ang II receptor signaling to -arrestin regulates ARF6 activation. These proteins together control receptor endocytosis and ultimately cell migration.	[Charles, Ricardo; Cotton, Mathieu; Claing, Audrey] Univ Montreal, Fac Med, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada; [Namkung, Yoon; Laporte, Stephane A.] McGill Univ, Ctr Hlth, Res Inst, Dept Med, Montreal, PQ H4A 3J1, Canada	Universite de Montreal; McGill University	Claing, A (corresponding author), Univ Montreal, Dept Pharmacol, POB 6128,Downtown Stn, Montreal, PQ H3C 3J7, Canada.	audrey.claing@umontreal.ca	Laporte, Stephane A/F-3282-2012; Laporte, Stephane/ABC-4228-2021	Laporte, Stephane/0000-0002-0633-543X	Canadian Institutes of Health Research [MOP-79470, MOP-74603]; Heart and Stroke Foundation of Canada; Fonds de Recherche du Quebec-Sante	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Fonds de Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec)	This work was supported in part by the Canadian Institutes of Health Research Grants MOP-79470 (to A. C.) and MOP-74603 (to S. A. L.) and the Heart and Stroke Foundation of Canada (to A. C.). The authors declare that they have no conflicts of interest with the contents of this article.r Recipient of a Chercheur-Boursier Senior of the Fonds de Recherche du Quebec-Sante and a member of the Groupe d'Etude des Proteines Membranaires. To whom correspondence should be addressed: Dept. of Pharmacology, Universite de Montreal, P. O. Box 6128, Downtown Station, Montreal, Quebec H3C 3J7, Canada. Tel.: 514-343-6352; Fax: 514-343-2291; E-mail: audrey.claing@umontreal.ca.	Ahn S, 2003, P NATL ACAD SCI USA, V100, P1740, DOI 10.1073/pnas.262789099; Anthony DF, 2011, MOL CELL BIOL, V31, P1066, DOI 10.1128/MCB.00883-10; ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; Barnes WG, 2005, J BIOL CHEM, V280, P8041, DOI 10.1074/jbc.M412924200; BERK BC, 1993, J CELL PHYSIOL, V154, P368, DOI 10.1002/jcp.1041540221; Boulay PL, 2008, J BIOL CHEM, V283, P36425, DOI 10.1074/jbc.M803603200; Brown FD, 2001, J CELL BIOL, V154, P1007, DOI 10.1083/jcb.200103107; Cavenagh MM, 1996, J BIOL CHEM, V271, P21767, DOI 10.1074/jbc.271.36.21767; Chen PW, 2014, J BIOL CHEM, V289, P30237, DOI 10.1074/jbc.M114.596155; Claing A, 2001, J BIOL CHEM, V276, P42509, DOI 10.1074/jbc.M108399200; Cohen LA, 2007, MOL BIOL CELL, V18, P2244, DOI 10.1091/mbc.E06-11-0998; Cotton M, 2007, MOL BIOL CELL, V18, P501, DOI 10.1091/mbc.E06-06-0567; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; DiNitto JP, 2007, MOL CELL, V28, P569, DOI 10.1016/j.molcel.2007.09.017; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Douillette A, 2006, J BIOL CHEM, V281, P13275, DOI 10.1074/jbc.M512815200; Doyon P, 2013, ARTERIOSCL THROM VAS, V33, P2850, DOI 10.1161/ATVBAHA.113.302487; Doyon P, 2010, J BIOL CHEM, V285, P30708, DOI 10.1074/jbc.M110.126433; Eva R, 2012, J NEUROSCI, V32, P10352, DOI 10.1523/JNEUROSCI.1409-12.2012; Fessart D, 2005, MOL ENDOCRINOL, V19, P491, DOI 10.1210/me.2004-0246; Fong AM, 2002, P NATL ACAD SCI USA, V99, P7478, DOI 10.1073/pnas.112198299; Ge L, 2004, J BIOL CHEM, V279, P55419, DOI 10.1074/jbc.M410312200; Giguere P, 2006, CELL SIGNAL, V18, P1988, DOI 10.1016/j.cellsig.2006.03.003; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Goupil E, 2015, J BIOL CHEM, V290, P3137, DOI 10.1074/jbc.M114.631119; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Holloway AC, 2002, MOL PHARMACOL, V61, P768, DOI 10.1124/mol.61.4.768; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Houndolo T, 2005, J BIOL CHEM, V280, P5598, DOI 10.1074/jbc.M411456200; Hunton DL, 2005, MOL PHARMACOL, V67, P1229, DOI 10.1124/mol.104.006270; Karpinsky-Semper D, 2014, MOL PHARMACOL, V85, P758, DOI 10.1124/mol.114.091843; Kawada K, 2009, MOL CELL BIOL, V29, P4508, DOI 10.1128/MCB.00015-09; Kim YJ, 2013, NATURE, V497, P142, DOI 10.1038/nature12133; Krupnick JG, 1997, J BIOL CHEM, V272, P15011, DOI 10.1074/jbc.272.23.15011; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Laursen JB, 1997, CIRCULATION, V95, P588, DOI 10.1161/01.CIR.95.3.588; Lee HM, 2007, J PHARMACOL SCI, V105, P74, DOI 10.1254/jphs.FP0070770; Lefkowitz RJ, 2002, MOL PHARMACOL, V62, P971, DOI 10.1124/mol.62.5.971; Li F, 2005, J PHARMACOL EXP THER, V312, P1043, DOI 10.1124/jpet.104.076588; LOHSE MJ, 1990, SCIENCE, V248, P1547, DOI 10.1126/science.2163110; Louis SF, 2010, EXP CLIN CARDIOL, V15, pE75; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Macia E, 2012, J CELL SCI, V125, P4026, DOI 10.1242/jcs.102343; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Muniz P, 2001, NEPHROL DIAL TRANSPL, V16, P14, DOI 10.1093/ndt/16.suppl_1.14; Myers KR, 2008, TRENDS CELL BIOL, V18, P184, DOI 10.1016/j.tcb.2008.02.002; Orsini MJ, 1998, J BIOL CHEM, V273, P34616, DOI 10.1074/jbc.273.51.34616; Padovani D, 2014, P NATL ACAD SCI USA, V111, P12378, DOI 10.1073/pnas.1409832111; Poupart ME, 2007, CELL SIGNAL, V19, P2370, DOI 10.1016/j.cellsig.2007.07.015; Rajagopalan S, 1996, J CLIN INVEST, V97, P1916, DOI 10.1172/JCI118623; Rappoport JZ, 2003, J CELL SCI, V116, P847, DOI 10.1242/jcs.00289; Sabe H, 2003, J BIOCHEM, V134, P485, DOI 10.1093/jb/mvg181; Schrage R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10156; Scott MGH, 2002, J BIOL CHEM, V277, P37693, DOI 10.1074/jbc.M207552200; Shukla AK, 2013, NATURE, V497, P137, DOI 10.1038/nature12120; Sun Y, 2002, J BIOL CHEM, V277, P49212, DOI 10.1074/jbc.M207294200; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Tilley DG, 2014, CIRCULATION, V130, P1800, DOI 10.1161/CIRCULATIONAHA.114.010434; Touyz RM, 2000, PHARMACOL REV, V52, P639; UshioFukai M, 1996, J BIOL CHEM, V271, P23317, DOI 10.1074/jbc.271.38.23317; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Xiao KH, 2004, J BIOL CHEM, V279, P55744, DOI 10.1074/jbc.M409785200; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104; Zaima K, 2013, J NAT MED-TOKYO, V67, P196, DOI 10.1007/s11418-012-0644-0; Zimmerman B, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002522; Zimmerman B, 2009, CELL SIGNAL, V21, P103, DOI 10.1016/j.cellsig.2008.09.013	68	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					3967	3981		10.1074/jbc.M115.684357	http://dx.doi.org/10.1074/jbc.M115.684357			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26703465	Green Published, hybrid			2022-12-26	WOS:000371338400024
J	Ho, T; Watt, B; Spruce, LA; Seeholzer, SH; Marks, MS				Ho, Tina; Watt, Brenda; Spruce, Lynn A.; Seeholzer, Steven H.; Marks, Michael S.			The Kringle-like Domain Facilitates Post-endoplasmic Reticulum Changes to Premelanosome Protein (PMEL) Oligomerization and Disulfide Bond Configuration and Promotes Amyloid Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cysteine-mediated cross-linking; disulfide; endosome; fibril; melanogenesis; membrane trafficking; oxidation-reduction (redox); protein aggregation; Pmel17; melanosome	MELANOSOME BIOGENESIS; MOLECULAR CHARACTERIZATION; ELECTRON-MICROSCOPY; MELANOCYTE LINEAGE; ME20 ANTIGEN; 17 SILVER; CELLS; MELANOGENESIS; GLYCOPROTEIN; MUTATION	The formation of functional amyloid must be carefully regulated to prevent the accumulation of potentially toxic products. Premelanosome protein (PMEL) forms non-toxic functional amyloid fibrils that assemble into sheets upon which melanins ultimately are deposited within the melanosomes of pigment cells. PMEL is synthesized in the endoplasmic reticulum but forms amyloid only within post-Golgi melanosome precursors; thus, PMEL must traverse the secretory pathway in a non-amyloid form. Here, we identified two pre-amyloid PMEL intermediates that likely regulate the timing of fibril formation. Analyses by non-reducing SDS-PAGE, size exclusion chromatography, and sedimentation velocity revealed two native high M-r disulfide-bonded species that contain Golgi-modified forms of PMEL. These species correspond to disulfide bond-containing dimeric and monomeric PMEL isoforms that contain no other proteins as judged by two-dimensional PAGE of metabolically labeled/immunoprecipitated PMEL and by mass spectrometry of affinity-purified complexes. Metabolic pulse-chase analyses, small molecule inhibitor treatments, and evaluation of site-directed mutants suggest that the PMEL dimer forms around the time of endoplasmic reticulum exit and is resolved by disulfide bond rearrangement into a monomeric form within the late Golgi or a post-Golgi compartment. Mutagenesis of individual cysteine residues within the non-amyloid cysteine-rich Kringle-like domain stabilizes the disulfide-bonded dimer and impairs fibril formation as determined by electron microscopy. Our data show that the Kringle-like domain facilitates the resolution of disulfide-bonded PMEL dimers and promotes PMEL functional amyloid formation, thereby suggesting that PMEL dimers must be resolved to monomers to generate functional amyloid fibrils.	[Ho, Tina; Watt, Brenda; Spruce, Lynn A.; Seeholzer, Steven H.; Marks, Michael S.] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, 816G Abramson Res Ctr,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Ho, Tina; Watt, Brenda; Marks, Michael S.] Univ Penn, Cell & Mol Biol Grad Grp, Philadelphia, PA 19104 USA; [Ho, Tina; Watt, Brenda; Marks, Michael S.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Marks, Michael S.] Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Marks, MS (corresponding author), Childrens Hosp Philadelphia, Dept Pathol & Lab Med, 816G Abramson Res Ctr,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	marksm@mail.med.upenn.edu	Marks, Michael S/Q-7223-2019	Marks, Michael S/0000-0001-7435-7262	National Institutes of Health [R01 AR048155]; National Institutes of Health from NIAMS [T32 AR007465]; National Institutes of Health from NIA [T32 AG000255]; National Institutes of Health from NIGMS [T32 GM007170]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048155, T32AR007465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007170] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000255] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health from NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institutes of Health from NIA; National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grant R01 AR048155 and National Institutes of Health Training Program Grants T32 AR007465 from NIAMS, T32 AG000255 from NIA, and T32 GM007170 from NIGMS. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ADEMA GJ, 1994, J BIOL CHEM, V269, P20126; Anoop A, 2014, J BIOL CHEM, V289, P16884, DOI 10.1074/jbc.M114.548354; Berson JF, 2003, J CELL BIOL, V161, P521, DOI 10.1083/jcb.200302072; Berson JF, 2001, MOL BIOL CELL, V12, P3451, DOI 10.1091/mbc.12.11.3451; BIASELLE CJ, 1975, BIOPHYS CHEM, V3, P355, DOI 10.1016/0301-4622(75)80029-9; Brunberg E, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-46; Burgoyne T, 2015, J CELL SCI, V128, P1400, DOI 10.1242/jcs.164400; Chakraborty AK, 1996, EUR J BIOCHEM, V236, P180, DOI 10.1111/j.1432-1033.1996.t01-1-00180.x; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Chiamenti AM, 1996, MELANOMA RES, V6, P291, DOI 10.1097/00008390-199608000-00003; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chng SS, 2012, SCIENCE, V337, P1665, DOI 10.1126/science.1227215; Clark LA, 2006, P NATL ACAD SCI USA, V103, P1376, DOI 10.1073/pnas.0506940103; Dunn LC, 1930, J HERED, V21, P495, DOI 10.1093/oxfordjournals.jhered.a103275; Evans ML, 2015, MOL CELL, V57, P445, DOI 10.1016/j.molcel.2014.12.025; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Hammer ND, 2007, P NATL ACAD SCI USA, V104, P12494, DOI 10.1073/pnas.0703310104; Harper DC, 2008, J BIOL CHEM, V283, P2307, DOI 10.1074/jbc.M708007200; Hellstrom AR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002285; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hoashi T, 2010, FASEB J, V24, P916, DOI 10.1096/fj.09-140921; Hurbain I, 2008, P NATL ACAD SCI USA, V105, P19726, DOI 10.1073/pnas.0803488105; Kawaguchi M, 2015, J DERMATOL SCI, V78, P133, DOI 10.1016/j.jdermsci.2015.02.020; Kerje S, 2004, GENETICS, V168, P1507, DOI 10.1534/genetics.104.027995; Kummer MP, 2009, J BIOL CHEM, V284, P2296, DOI 10.1074/jbc.M808904200; Kushimoto T, 2001, P NATL ACAD SCI USA, V98, P10698, DOI 10.1073/pnas.191184798; KWON BS, 1987, MOL BIOL MED, V4, P339; Lee ZH, 1996, J INVEST DERMATOL, V106, P605, DOI 10.1111/1523-1747.ep12345163; Leonhardt RM, 2013, MOL BIOL CELL, V24, P964, DOI 10.1091/mbc.E12-10-0742; Leonhardt RM, 2011, J BIOL CHEM, V286, P9321, DOI 10.1074/jbc.M110.168088; Leonhardt RM, 2010, J BIOL CHEM, V285, P16166, DOI 10.1074/jbc.M109.097725; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Li Y, 2012, BIOCHEM BIOPH RES CO, V423, P373, DOI 10.1016/j.bbrc.2012.05.133; Liu YD, 2008, J BIOL CHEM, V283, P29266, DOI 10.1074/jbc.M804787200; LORBER B, 1990, BIOCHIM BIOPHYS ACTA, V1023, P254, DOI 10.1016/0005-2736(90)90421-J; Majumdar A, 2012, CELL, V148, P515, DOI 10.1016/j.cell.2012.01.004; MARESH GA, 1994, ARCH BIOCHEM BIOPHYS, V311, P95, DOI 10.1006/abbi.1994.1213; MARESH GA, 1994, DNA CELL BIOL, V13, P87, DOI 10.1089/dna.1994.13.87; Marks MS, 2001, CURR PROTOC CELL BIO, DOI [10.1002/0471143030.cb0503s00, DOI 10.1002/0471143030.CB0503S00]; Nenninger AA, 2009, P NATL ACAD SCI USA, V106, P900, DOI 10.1073/pnas.0812143106; Nichols SE, 2003, J INVEST DERMATOL, V121, P821, DOI 10.1046/j.1523-1747.2003.12474.x; NISHIGAI M, 1985, BIOCHIM BIOPHYS ACTA, V831, P236, DOI 10.1016/0167-4838(85)90040-8; O'Donnell PW, 2004, J IMMUNOL, V173, P731, DOI 10.4049/jimmunol.173.2.731; Oka OBV, 2013, BBA-MOL CELL RES, V1833, P2425, DOI 10.1016/j.bbamcr.2013.02.007; Raposo G, 2001, J CELL BIOL, V152, P809, DOI 10.1083/jcb.152.4.809; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Rochin L, 2013, P NATL ACAD SCI USA, V110, P10658, DOI 10.1073/pnas.1220748110; Schonthaler HB, 2005, DEV BIOL, V284, P421, DOI 10.1016/j.ydbio.2005.06.001; Skovronsky DM, 2006, ANNU REV PATHOL-MECH, V1, P151, DOI 10.1146/annurev.pathol.1.110304.100113; Stachel SJ, 2004, J MED CHEM, V47, P6447, DOI 10.1021/jm049379g; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; TANFORD C, 1974, BIOCHEMISTRY-US, V13, P2369, DOI 10.1021/bi00708a021; TARTAKOFF AM, 1983, CELL, V32, P1026, DOI 10.1016/0092-8674(83)90286-6; Theos AC, 2006, DEV CELL, V10, P343, DOI 10.1016/j.devcel.2006.01.012; Theos AC, 2005, PIGM CELL RES, V18, P322, DOI 10.1111/j.1600-0749.2005.00269.x; Theos AC, 2006, MOL BIOL CELL, V17, P3598, DOI 10.1091/mbc.E06-01-0081; Valencia JC, 2007, J BIOL CHEM, V282, P11266, DOI 10.1074/jbc.M608449200; van Niel G, 2011, DEV CELL, V21, P708, DOI 10.1016/j.devcel.2011.08.019; VANAKEN T, 1986, METHOD ENZYMOL, V125, P27; VENNEGOOR C, 1988, AM J PATHOL, V130, P179; Walker S, 2012, J BIOL CHEM, V287, P9591, DOI 10.1074/jbc.M111.336107; Watt B, 2013, PIGM CELL MELANOMA R, V26, P300, DOI 10.1111/pcmr.12067; Watt B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002286; Watt B, 2009, J BIOL CHEM, V284, P35543, DOI 10.1074/jbc.M109.047449; West LC, 2013, CURR OPIN IMMUNOL, V25, P103, DOI 10.1016/j.coi.2012.11.006	66	15	17	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3595	3612		10.1074/jbc.M115.692442	http://dx.doi.org/10.1074/jbc.M115.692442			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26694611	hybrid, Green Published			2022-12-26	WOS:000370854500038
J	Pereira, E; Camacho-Vanegas, O; Anand, S; Sebra, R; Camacho, SC; Garnar-Wortzel, L; Nair, N; Moshier, E; Wooten, M; Uzilov, A; Chen, R; Prasad-Hayes, M; Zakashansky, K; Beddoe, AM; Schadt, E; Dottino, P; Martignetti, JA				Pereira, Elena; Camacho-Vanegas, Olga; Anand, Sanya; Sebra, Robert; Camacho, Sandra Catalina; Garnar-Wortzel, Leopold; Nair, Navya; Moshier, Erin; Wooten, Melissa; Uzilov, Andrew; Chen, Rong; Prasad-Hayes, Monica; Zakashansky, Konstantin; Beddoe, Ann Marie; Schadt, Eric; Dottino, Peter; Martignetti, John A.			Personalized Circulating Tumor DNA Biomarkers Dynamically Predict Treatment Response and Survival In Gynecologic Cancers	PLOS ONE			English	Article							EPITHELIAL OVARIAN-CANCER; CA-125	Background High-grade serous ovarian and endometrial cancers are the most lethal female reproductive tract malignancies worldwide. In part, failure to treat these two aggressive cancers successfully centers on the fact that while the majority of patients are diagnosed based on current surveillance strategies as having a complete clinical response to their primary therapy, nearly half will develop disease recurrence within 18 months and the majority will die from disease recurrence within 5 years. Moreover, no currently used biomarkers or imaging studies can predict outcome following initial treatment. Circulating tumor DNA (ctDNA) represents a theoretically powerful biomarker for detecting otherwise occult disease. We therefore explored the use of personalized ctDNA markers as both a surveillance and prognostic biomarker in gynecologic cancers and compared this to current FDA-approved surveillance tools. Methods and Findings Tumor and serum samples were collected at time of surgery and then throughout treatment course for 44 patients with gynecologic cancers, representing 22 ovarian cancer cases, 17 uterine cancer cases, one peritoneal, three fallopian tube, and one patient with synchronous fallopian tube and uterine cancer. Patient/tumor-specific mutations were identified using whole-exome and targeted gene sequencing and ctDNA levels quantified using droplet digital PCR. CtDNA was detected in 93.8% of patients for whom probes were designed and levels were highly correlated with CA-125 serum and computed tomography (CT) scanning results. In six patients, ctDNA detected the presence of cancer even when CT scanning was negative and, on average, had a predictive lead time of seven months over CT imaging. Most notably, undetectable levels of ctDNA at six months following initial treatment was associated with markedly improved progression free and overall survival. Conclusions Detection of residual disease in gynecologic, and indeed all cancers, represents a diagnostic dilemma and a potential critical inflection point in precision medicine. This study suggests that the use of personalized ctDNA biomarkers in gynecologic cancers can identify the presence of residual tumor while also more dynamically predicting response to treatment relative to currently used serum and imaging studies. Of particular interest, ctDNA was an independent predictor of survival in patients with ovarian and endometrial cancers. Earlier recognition of disease persistence and/or recurrence and the ability to stratify into better and worse outcome groups through ctDNA surveillance may open the window for improved survival and quality and life in these cancers.	[Pereira, Elena; Nair, Navya; Prasad-Hayes, Monica; Zakashansky, Konstantin; Beddoe, Ann Marie; Dottino, Peter; Martignetti, John A.] Icahn Sch Med Mt Sinai, Dept Obstet Gynecol & Reprod Sci, New York, NY 10029 USA; [Camacho-Vanegas, Olga; Anand, Sanya; Sebra, Robert; Camacho, Sandra Catalina; Garnar-Wortzel, Leopold; Wooten, Melissa; Uzilov, Andrew; Chen, Rong; Schadt, Eric; Dottino, Peter; Martignetti, John A.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Martignetti, John A.] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA; [Moshier, Erin] Icahn Sch Med Mt Sinai, Dept Biostat, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Martignetti, JA (corresponding author), Icahn Sch Med Mt Sinai, Dept Obstet Gynecol & Reprod Sci, New York, NY 10029 USA.	john.martignetti@mssm.edu		Garnar-Wortzel, Leopold/0000-0001-5055-7817	Varadi Ovarian Initiative in Cancer Education (VOICE); Derald H. Ruttenberg Foundation; M.S. Gordon family	Varadi Ovarian Initiative in Cancer Education (VOICE); Derald H. Ruttenberg Foundation; M.S. Gordon family	These studies were funded, in part, by donations from the Varadi Ovarian Initiative in Cancer Education (VOICE), the Derald H. Ruttenberg Foundation and the M.S. Gordon family. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2015, CANC FACTS FIGS 2015; Bast RC, 2010, CANCER-AM CANCER SOC, V116, P2850, DOI 10.1002/cncr.25203; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Buys SS, 2011, JAMA-J AM MED ASSOC, V305, P2295, DOI 10.1001/jama.2011.766; Chang HW, 2002, JNCI-J NATL CANCER I, V94, P1697; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; Forshew T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003726; Freidin MB, 2015, CLIN CHEM; Garcia-Murillas I, 2015, SCI TRANSL MED, V7, DOI [10.1126/scitranslmed.aab0021, 10.1126/scitranslmed.aac7551]; Hamakawa T, 2015, BRIT J CANCER, V112, P352, DOI 10.1038/bjc.2014.609; Kamat AA, 2006, ANN NY ACAD SCI, V1075, P230, DOI 10.1196/annals.1368.031; Martignetti JA, 2014, NEOPLASIA, V16, P97, DOI 10.1593/neo.131900; McMeekin DS, 2012, CLIN GYNECOLOGIC ONC, pi; Meyer T, 2000, BRIT J CANCER, V82, P1535; National Comprehensive Cancer Network, 2015, NCCN CLIN PRACT GUID; Reinert T, 2015, GUT; Riedinger JM, 2006, ANN ONCOL, V17, P1234, DOI 10.1093/annonc/mdl120; Swisher EM, 2005, AM J OBSTET GYNECOL, V193, P662, DOI 10.1016/j.ajog.2005.01.054; Testa AC, 2014, BEST PRACT RES CL OB, V28, P769, DOI 10.1016/j.bpobgyn.2014.04.008; Ueland FR, 2003, GYNECOL ONCOL, V91, P46, DOI 10.1016/S0090-8258(03)00414-1	20	93	101	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145754	10.1371/journal.pone.0145754	http://dx.doi.org/10.1371/journal.pone.0145754			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717006	Green Submitted, Green Published, gold			2022-12-26	WOS:000367510500066
J	Chattopadhyay, N; Berger, AJ; Koenig, E; Bannerman, B; Garnsey, J; Bernard, H; Hales, P; Lopez, AM; Yang, Y; Donelan, J; Jordan, K; Tirrell, S; Stringer, B; Xia, C; Hather, G; Galvin, K; Manfredi, M; Rhodes, N; Amidon, B				Chattopadhyay, Nibedita; Berger, Allison J.; Koenig, Erik; Bannerman, Bret; Garnsey, James; Bernard, Hugues; Hales, Paul; Lopez, Angel Maldonado; Yang, Yu; Donelan, Jill; Jordan, Kristen; Tirrell, Stephen; Stringer, Bradley; Xia, Cindy; Hather, Greg; Galvin, Katherine; Manfredi, Mark; Rhodes, Nelson; Amidon, Ben			KRAS Genotype Correlates with Proteasome Inhibitor Ixazomib Activity in Preclinical In Vivo Models of Colon and Non-Small Cell Lung Cancer: Potential Role of Tumor Metabolism	PLOS ONE			English	Article							MULTIPLE-MYELOMA CELLS; ANTITUMOR-ACTIVITY; ANTICANCER DRUGS; FATTY-ACID; THERAPY; PATHWAY; MLN9708; SENSITIVITY; MUTATION; STRESS	In non-clinical studies, the proteasome inhibitor ixazomib inhibits cell growth in a broad panel of solid tumor cell lines in vitro. In contrast, antitumor activity in xenograft tumors is model-dependent, with some solid tumors showing no response to ixazomib. In this study we examined factors responsible for ixazomib sensitivity or resistance using mouse xenograft models. A survey of 14 non-small cell lung cancer (NSCLC) and 6 colon xenografts showed a striking relationship between ixazomib activity and KRAS genotype; tumors with wild-type (WT) KRAS were more sensitive to ixazomib than tumors harboring KRAS activating mutations. To confirm the association between KRAS genotype and ixazomib sensitivity, we used SW48 isogenic colon cancer cell lines. Either KRAS-G13D or KRAS-G12V mutations were introduced into KRAS-WT SW48 cells to generate cells that stably express activated KRAS. SW48 KRAS WT tumors, but neither SW48-KRAS-G13D tumors nor SW48-KRAS-G12V tumors, were sensitive to ixazomib in vivo. Since activated KRAS is known to be associated with metabolic reprogramming, we compared metabolite profiling of SW48-WT and SW48-KRAS-G13D tumors treated with or without ixazomib. Prior to treatment there were significant metabolic differences between SW48 WT and SW48-KRAS-G13D tumors, reflecting higher oxidative stress and glucose utilization in the KRAS-G13D tumors. Ixazomib treatment resulted in significant metabolic regulation, and some of these changes were specific to KRAS WT tumors. Depletion of free amino acid pools and activation of GCN2-eIF2 alpha-pathways were observed both in tumor types. However, changes in lipid beta oxidation were observed in only the KRAS WT tumors. The non-clinical data presented here show a correlation between KRAS genotype and ixazomib sensitivity in NSCLC and colon xenografts and provide new evidence of regulation of key metabolic pathways by proteasome inhibition.	[Chattopadhyay, Nibedita; Berger, Allison J.; Koenig, Erik; Bannerman, Bret; Garnsey, James; Bernard, Hugues; Hales, Paul; Lopez, Angel Maldonado; Yang, Yu; Donelan, Jill; Jordan, Kristen; Tirrell, Stephen; Stringer, Bradley; Xia, Cindy; Hather, Greg; Galvin, Katherine; Manfredi, Mark; Amidon, Ben] Takeda Pharmaceut Int Co, Cambridge, MA USA; [Rhodes, Nelson] Metabolon Inc, Durham, NC USA	Takeda Pharmaceutical Company Ltd; Takeda Pharmaceuticals International, Inc.; Metabolon	Chattopadhyay, N (corresponding author), Takeda Pharmaceut Int Co, Cambridge, MA USA.	nibedita.chattopadhyay@takeda.com			Takeda Pharmaceuticals International Co.; Metabolon Inc.; Takeda Pharmaceuticals	Takeda Pharmaceuticals International Co.; Metabolon Inc.; Takeda Pharmaceuticals(Takeda Pharmaceutical Company Ltd)	This study was funded by Takeda Pharmaceuticals International Co. Moreover, Takeda Pharmaceuticals provided support in the form of salaries for authors (NC, AJB, EK, BB, JG, HB, PH, AML, YY, JD, KJ, ST, BS, CX, GK, MM, and BA). Metabolon Inc. provided support in the form of salaries for author NR, but did not have any additional role in the decision to publish or preparation of the manuscript.	Adams J, 2003, DRUG DISCOV TODAY, V8, P307, DOI 10.1016/S1359-6446(03)02647-3; Adams J, 2002, CURR OPIN ONCOL, V14, P628, DOI 10.1097/00001622-200211000-00007; Adams J, 2004, CANCER CELL, V5, P417, DOI 10.1016/S1535-6108(04)00120-5; Balendiran GK, 2004, CELL BIOCHEM FUNCT, V22, P343, DOI 10.1002/cbf.1149; Bianchi G, 2009, BLOOD, V113, P3040, DOI 10.1182/blood-2008-08-172734; Castellano Esther, 2011, Genes Cancer, V2, P216, DOI 10.1177/1947601911408081; Chauhan D, 2011, CLIN CANCER RES, V17, P5311, DOI 10.1158/1078-0432.CCR-11-0476; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; De Roock W, 2010, JAMA-J AM MED ASSOC, V304, P1812, DOI 10.1001/jama.2010.1535; Demo SD, 2007, CANCER RES, V67, P6383, DOI 10.1158/0008-5472.CAN-06-4086; Fernandez-Medarde Alberto, 2011, Genes Cancer, V2, P344, DOI 10.1177/1947601911411084; Finn PF, 2006, NUTRITION, V22, P830, DOI 10.1016/j.nut.2006.04.008; FLIER JS, 1987, SCIENCE, V235, P1492, DOI 10.1126/science.3103217; Frankland-Searby S, 2012, BBA-REV CANCER, V1825, P64, DOI 10.1016/j.bbcan.2011.10.003; Garcia-Gomez A, 2014, CLIN CANCER RES, V20, P1542, DOI 10.1158/1078-0432.CCR-13-1657; Hamburger A W, 1980, Prog Clin Biol Res, V48, P63; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Kim MJ, 2011, J BIOL CHEM, V286, P12924, DOI 10.1074/jbc.M110.138958; Kupperman E, 2010, CANCER RES, V70, P1970, DOI 10.1158/0008-5472.CAN-09-2766; Lock R, 2011, MOL BIOL CELL, V22, P165, DOI 10.1091/mbc.E10-06-0500; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Luo ZJ, 2005, TRENDS PHARMACOL SCI, V26, P69, DOI 10.1016/j.tips.2004.12.011; Moreau P, 2012, BLOOD, V120, P947, DOI 10.1182/blood-2012-04-403733; Mulligan G, 2014, BLOOD, V123, P632, DOI 10.1182/blood-2013-05-504340; Oliva J, 2012, EXP MOL PATHOL, V93, P26, DOI 10.1016/j.yexmp.2012.03.006; Petrocca F, 2013, CANCER CELL, V24, P182, DOI 10.1016/j.ccr.2013.07.008; Poff AM, 2014, INT J CANC; Santos CR, 2012, FEBS J, V279, P2610, DOI 10.1111/j.1742-4658.2012.08644.x; Suraweera A, 2012, MOL CELL, V48, P242, DOI 10.1016/j.molcel.2012.08.003; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Veech RL, 2001, IUBMB LIFE, V51, P241; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229	39	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0144825	10.1371/journal.pone.0144825	http://dx.doi.org/10.1371/journal.pone.0144825			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709701	Green Submitted, gold, Green Published			2022-12-26	WOS:000367451400014
J	Olkkonen, J; Kouri, VP; Hynninen, J; Konttinen, YT; Mandelin, J				Olkkonen, Juri; Kouri, Vesa-Petteri; Hynninen, Joel; Konttinen, Yrjo T.; Mandelin, Jami			Differentially Expressed in Chondrocytes 2 (DEC2) Increases the Expression of IL-1 beta and Is Abundantly Present in Synovial Membrane in Rheumatoid Arthritis	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; CIRCADIAN-RHYTHMS; TNF-ALPHA; TRANSCRIPTION; CLOCK; LOOP; FIBROBLASTS; CYTOKINES; FATIGUE; BIOLOGY	Objective Patients with rheumatoid arthritis (RA) have altered circadian rhythm of circulating serum cortisol, melatonin and IL-6, as well as disturbance in the expression of clock genes ARNTL2 and NPAS2. In humans, TNF alpha increases the expression ARNTL2 and NPAS2 but paradoxically suppresses clock output genes DPB and PER3. Our objective was to investigate the expression of direct clock suppressors DEC1 and DEC2 (BHLHE 40 and 41 proteins) in response to TNF alpha and investigate their role during inflammation. Methods Cultured primary fibroblasts were stimulated with TNF alpha. Effects on DEC2 were studied using RT-qPCR and immunofluorescence staining. The role of NF-kappa B in DEC2 increase was analyzed using IKK-2 specific inhibitor IMD-0354. Cloned DEC2 was transfected into HEK293 cells to study its effects on gene expression. Transfections into primary human fibroblasts were used to confirm the results. The presence of DEC2 was analyzed in (RA) and osteoarthritis (OA) synovial membranes by immunohistochemistry. Results TNF alpha increased DEC2 mRNA and DEC2 was mainly detected at nuclei after the stimulus. The effects of TNF alpha on DEC2 expression were mediated via NF-kappa B. Overexpression, siRNA and promoter activity studies disclosed that DEC2 directly regulates IL-1 beta, in both HEK293 cells and primary human fibroblasts. DEC2 was increased in synovial membrane in RA compared to OA. Conclusion Not only ARNTL2 and NPAS2 but also DEC2 is regulated by TNF alpha in human fibroblasts. NF-kappa B mediates the effect on DEC2, which upregulates IL-1 beta. Circadian clock has a direct effect on inflammation in human fibroblasts.	[Olkkonen, Juri; Kouri, Vesa-Petteri; Konttinen, Yrjo T.; Mandelin, Jami] Univ Helsinki, Dept Med, Helsinki, Finland; [Olkkonen, Juri; Kouri, Vesa-Petteri; Konttinen, Yrjo T.; Mandelin, Jami] Helsinki Univ Hosp, Helsinki, Finland; [Hynninen, Joel] ORTON Orthopaed Hosp, Invalid Fdn, Helsinki, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Mandelin, J (corresponding author), Univ Helsinki, Dept Med, Helsinki, Finland.	jami.mandelin@helsinki.fi	Mandelin, Jami/A-7943-2008; Kouri, Vesa-Petteri/M-7436-2015	Kouri, Vesa-Petteri/0000-0001-6256-0642	Maire Lisko Saatio; University of Helsinki; Reumatautien tutkimussaatio; Orionin Tutkimussaatio; Paulo Foundation; Duodecim; Orionin Tutkimusaatio; Suomen Kulttuurirahasto; Medcare Foundation; Otto Malm's Foundation; Finska Lakaresallskapet; ORTON Orthopaedic Hospital of the ORTON Foundation; Danish Council for Strategic Research; Sigrid Juselius Foundation; Academy of Finland; Finnish Society for Rheumatology; Orion-Farmos Research Fund	Maire Lisko Saatio; University of Helsinki; Reumatautien tutkimussaatio; Orionin Tutkimussaatio; Paulo Foundation; Duodecim; Orionin Tutkimusaatio; Suomen Kulttuurirahasto; Medcare Foundation; Otto Malm's Foundation; Finska Lakaresallskapet; ORTON Orthopaedic Hospital of the ORTON Foundation; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Finnish Society for Rheumatology; Orion-Farmos Research Fund	JO received support from Maire Lisko Saatio, University of Helsinki, Reumatautien tutkimussaatio, Orionin Tutkimussaatio, The Paulo Foundation and Duodecim. VPK received support from Orionin Tutkimusaatio, Reumatautien tutkimussaatio, Suomen Kulttuurirahasto, Medcare Foundation, and Otto Malm's Foundation. YTK received support from Finska Lakaresallskapet, ORTON Orthopaedic Hospital of the ORTON Foundation and Danish Council for Strategic Research, and The Sigrid Juselius Foundation. JM received support from Academy of Finland, Finnish Society for Rheumatology, The Paulo Foundation, University of Helsinki and Orion-Farmos Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Cavadini G, 2007, P NATL ACAD SCI USA, V104, P12843, DOI 10.1073/pnas.0701466104; Cutolo M, 2005, AUTOIMMUN REV, V4, P497, DOI 10.1016/j.autrev.2005.04.019; Czeisler CA, 1999, SCIENCE, V284, P2177, DOI 10.1126/science.284.5423.2177; GUDEWILL S, 1992, EUR ARCH PSY CLIN N, V242, P53, DOI 10.1007/BF02190343; Haas S, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3852; Hamilton K, 2000, Expert Opin Pharmacother, V1, P1041, DOI 10.1517/14656566.1.5.1041; Hashiramoto A, 2010, J IMMUNOL, V184, P1560, DOI 10.4049/jimmunol.0903284; Hewlett S, 2005, ARTHRIT RHEUM-ARTHR, V53, P697, DOI 10.1002/art.21450; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Johnston JD, 2014, EXP PHYSIOL, V99, P1133, DOI 10.1113/expphysiol.2014.078295; Kawamoto T, 2004, BIOCHEM BIOPH RES CO, V313, P117, DOI 10.1016/j.bbrc.2003.11.099; Kouri VP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054049; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Mandelin J, 2005, J RHEUMATOL, V32, P713; Meyer-Hermann M, 2009, ARTHRITIS RHEUM, V60, P2585, DOI 10.1002/art.24797; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Mor A, 2005, CLIN IMMUNOL, V115, P118, DOI 10.1016/j.clim.2004.12.009; Moreland LW, 2006, ARTHRIT RHEUM-ARTHR, V55, P287, DOI 10.1002/art.21838; NEIDEL J, 1995, INFLAMM RES, V44, P217, DOI 10.1007/BF01782262; Nguyen KD, 2013, SCIENCE, V341, P1483, DOI 10.1126/science.1240636; Petrovsky N, 1998, CYTOKINE, V10, P307, DOI 10.1006/cyto.1997.0289; Sierakowski S, 2011, SCAND J RHEUMATOL, V40, P1, DOI 10.3109/03009742.2011.566433; Straub RH, 2007, ARTHRITIS RHEUM, V56, P399, DOI 10.1002/art.22368; Sun H, 2001, NAT IMMUNOL, V2, P1040, DOI 10.1038/ni721; Tak PP, 1996, ARTHRITIS RHEUM, V39, P1077, DOI 10.1002/art.1780390702; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wu YY, 2011, INT J MOL MED, V27, P491, DOI 10.3892/ijmm.2011.617; Yang XO, 2009, NAT IMMUNOL, V10, P1260, DOI 10.1038/ni.1821	29	24	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145279	10.1371/journal.pone.0145279	http://dx.doi.org/10.1371/journal.pone.0145279			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710124	Green Published, Green Submitted, gold			2022-12-26	WOS:000367451400034
J	Wang, XM; Peng, L; Chi, TH; Li, MZ; Yao, XJ; Shao, J				Wang, Xiaomeng; Peng, Ling; Chi, Tianhe; Li, Mengzhu; Yao, Xiaojing; Shao, Jing			A Hidden Markov Model for Urban-Scale Traffic Estimation Using Floating Car Data	PLOS ONE			English	Article							DYNAMICS; SYSTEMS; FLOW	Urban-scale traffic monitoring plays a vital role in reducing traffic congestion. Owing to its low cost and wide coverage, floating car data (FCD) serves as a novel approach to collecting traffic data. However, sparse probe data represents the vast majority of the data available on arterial roads in most urban environments. In order to overcome the problem of data sparseness, this paper proposes a hidden Markov model (HMM)-based traffic estimation model, in which the traffic condition on a road segment is considered as a hidden state that can be estimated according to the conditions of road segments having similar traffic characteristics. An algorithm based on clustering and pattern mining rather than on adjacency relationships is proposed to find clusters with road segments having similar traffic characteristics. A multi-clustering strategy is adopted to achieve a trade-off between clustering accuracy and coverage. Finally, the proposed model is designed and implemented on the basis of a real-time algorithm. Results of experiments based on real FCD confirm the applicability, accuracy, and efficiency of the model. In addition, the results indicate that the model is practicable for traffic estimation on urban arterials and works well even when more than 70% of the probe data are missing.	[Wang, Xiaomeng; Peng, Ling; Chi, Tianhe; Yao, Xiaojing; Shao, Jing] Chinese Acad Sci, Inst Remote Sensing & Digital Earth, Beijing, Peoples R China; [Wang, Xiaomeng; Yao, Xiaojing; Shao, Jing] Chinese Acad Sci, Univ Chinese Acad Sci, Beijing, Peoples R China; [Li, Mengzhu] Southwest Univ, Coll Econ & Management, Chongqing, Peoples R China	Chinese Academy of Sciences; The Institute of Remote Sensing & Digital Earth, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Southwest University - China	Peng, L (corresponding author), Chinese Acad Sci, Inst Remote Sensing & Digital Earth, Beijing, Peoples R China.	pengl20158@163.com	Yao, Xiaojing/HHN-3072-2022	Yao, Xiaojing/0000-0001-9745-3150	National Key Technology Support Program [2015BAJ02B00]; Ministry of Science and Technology Policy Guidance Project [2011FU125Z24]	National Key Technology Support Program(National Key Technology R&D Program); Ministry of Science and Technology Policy Guidance Project	TC is supported by a National Key Technology Support Program (2015BAJ02B00) and Ministry of Science and Technology Policy Guidance Project (2011FU125Z24). URL: http://program.most.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Gera H, 2007, TRANSPORT RES C-EMER, V15, P380, DOI 10.1016/j.trc.2007.06.003; Bejan AI, 2011, IEEE INT C INTELL TR, P746, DOI 10.1109/ITSC.2011.6082904; Bramberger M, 2004, RTAS 2004: 10TH IEEE REAL-TIME AND EMBEDDED TECHNOLOGY AND APPLICATIONS SYMPOSIUM, PROCEEDINGS, P174, DOI 10.1109/RTTAS.2004.1317262; Breitenberger S., 2004, TRAFFIC ENG CONTROL, V45, P396; Chen BY, 2014, INT J GEOGR INF SCI, V28, P22, DOI 10.1080/13658816.2013.816427; de Fabritiis C, 2008, PROCEEDINGS OF THE 11TH INTERNATIONAL IEEE CONFERENCE ON INTELLIGENT TRANSPORTATION SYSTEMS, P197, DOI 10.1109/ITSC.2008.4732534; Fowe AJ, 2013, TRANSPORT RES C-EMER, V36, P245, DOI 10.1016/j.trc.2013.08.011; Ge JI, 2014, TRANSPORT RES C-EMER, V46, P46, DOI 10.1016/j.trc.2014.04.014; Gupta A.K., 2013, INT J MOD PHYS C, P24; Gupta AK, 2014, COMMUN THEOR PHYS, V62, P393, DOI 10.1088/0253-6102/62/3/17; Gupta AK, 2013, PHYS LETT A, V377, P2027, DOI 10.1016/j.physleta.2013.06.009; He ZC, 2013, IET INTELL TRANSP SY, V7, P404, DOI 10.1049/iet-its.2011.0226; Herrera JC, 2007, TRB 87 ANN M COMP; Herrera JC, 2010, TRANSPORT RES C-EMER, V18, P568, DOI 10.1016/j.trc.2009.10.006; Herring Ryan, 2010, 2010 13th International IEEE Conference on Intelligent Transportation Systems (ITSC 2010), P929, DOI 10.1109/ITSC.2010.5624994; Hiribarren G, 2014, TRANSPORT RES B-METH, V69, P19, DOI 10.1016/j.trb.2014.07.003; Hofleitner A, 2012, IEEE T INTELL TRANSP, V13, P1679, DOI 10.1109/TITS.2012.2200474; Kong QJ, 2013, IEEE T INTELL TRANSP, V14, P398, DOI 10.1109/TITS.2012.2218237; Leontiadis I, 2011, IEEE T INTELL TRANSP, V12, P1537, DOI 10.1109/TITS.2011.2161469; Ramezani M, 2015, COMPUT-AIDED CIV INF, V30, P414, DOI 10.1111/mice.12095; Raymond R, 2012, INT C PATT RECOG, P2242; Seo T, 2015, TRANSPORT RES C-EMER, V53, P134, DOI 10.1016/j.trc.2015.01.033; Tang TQ, 2010, PHYS LETT A, V374, P3951, DOI 10.1016/j.physleta.2010.07.062; Tang TQ, 2014, MEASUREMENT, V58, P286, DOI 10.1016/j.measurement.2014.08.051; Tang TQ, 2010, INT J MOD PHYS C, V21, P159, DOI 10.1142/S0129183110015038; Vandenberghe W, 2012, IET INTELL TRANSP SY, V6, P347, DOI 10.1049/iet-its.2011.0221; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Wang J., 2015, MATH PROBL ENG; Work DB, 2010, APPL MATH RES EXPRES, P1, DOI 10.1093/amrx/abq002; Yeon J, 2008, TRANSPORT RES B-METH, V42, P325, DOI 10.1016/j.trb.2007.08.005; Yu SW, 2015, MEASUREMENT, V70, P137, DOI 10.1016/j.measurement.2015.03.031; Yu SW, 2015, PHYSICA A, V421, P1, DOI 10.1016/j.physa.2014.11.008; Yu SW, 2015, MEASUREMENT, V64, P34, DOI 10.1016/j.measurement.2014.12.036; Yu SW, 2014, PHYSICA A, V407, P152, DOI 10.1016/j.physa.2014.03.081; Yu SW, 2013, COMMUN NONLINEAR SCI, V18, P1229, DOI 10.1016/j.cnsns.2012.09.014; Zhu YM, 2013, IEEE T MOBILE COMPUT, V12, P2289, DOI 10.1109/TMC.2012.205	36	3	4	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145348	10.1371/journal.pone.0145348	http://dx.doi.org/10.1371/journal.pone.0145348			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710073	Green Submitted, Green Published, gold			2022-12-26	WOS:000367451400041
J	Dai, MM; Yu, CM; Fang, T; Fu, L; Wang, J; Zhang, J; Ren, J; Xu, JJ; Zhang, XP; Chen, W				Dai, Mengmeng; Yu, Changming; Fang, Ting; Fu, Ling; Wang, Jing; Zhang, Jun; Ren, Jun; Xu, Junjie; Zhang, Xiaopeng; Chen, Wei			Identification and Functional Characterization of Glycosylation of Recombinant Human Platelet- Derived Growth Factor-BB in Pichia pastoris	PLOS ONE			English	Article							PROTEIN O-MANNOSYLATION; LINKED MANNOSYLATION; RECOGNITION; EXPRESSION; INCREASES; GLYCANS; BINDING; PRODUCE; ASSAY	Yeast Pichia pastoris is a widely used system for heterologous protein expression. However, post-translational modifications, especially glycosylation, usually impede pharmaceutical application of recombinant proteins because of unexpected alterations in protein structure and function. The aim of this study was to identify glycosylation sites on recombinant human platelet-derived growth factor-BB (rhPDGF-BB) secreted by P. pastoris, and investigate possible effects of O-linked glycans on PDGF-BB functional activity. PDGF-BB secreted by P. pastoris is very heterogeneous and contains multiple isoforms. We demonstrated that PDGF-BB was O-glycosylated during the secretion process and detected putative O-glycosylation sites using glycosylation staining and immunoblotting. By site-directed mutagenesis and high-resolution LC/MS analysis, we, for the first time, identified two threonine residues at the C-terminus as the major O-glycosylation sites on rhPDGF-BB produced in P. pastoris. Although O-glycosylation resulted in heterogeneous protein expression, the removal of glycosylation sites did not affect rhPDGF-BB mitogenic activity. In addition, the unglycosylated PDGF-BB Delta Gly mutant exhibited the immunogenicity comparable to that of the wild-type form. Furthermore, antiserum against PDGF-BB Delta Gly also recognized glycosylated PDGF-BB, indicating that protein immunogenicity was unaltered by glycosylation. These findings elucidate the effect of glycosylation on PDGF-BB structure and biological activity, and can potentially contribute to the design and production of homogeneously expressed unglycosylated or human-type glycosylated PDGF-BB in P. pastoris for pharmaceutical applications.	[Dai, Mengmeng; Yu, Changming; Fang, Ting; Fu, Ling; Wang, Jing; Zhang, Jun; Ren, Jun; Xu, Junjie; Zhang, Xiaopeng; Chen, Wei] Beijing Inst Biotechnol, Lab Vaccine & Antibody Engn, Beijing, Peoples R China; [Dai, Mengmeng] PLA, Hosp 148, Clin Lab, Zibo, Peoples R China		Zhang, XP (corresponding author), Beijing Inst Biotechnol, Lab Vaccine & Antibody Engn, Beijing, Peoples R China.	zxp8565@aliyun.com; cw0226@foxmail.com	Zhang, XP/AAY-9089-2020		National Natural Science Foundation of China [81301965, 81172980]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grants (81301965, 81172980) from National Natural Science Foundation of China (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlen G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046959; Ahmad M, 2014, APPL MICROBIOL BIOT, V98, P5301, DOI 10.1007/s00253-014-5732-5; Amon R, 2014, CARBOHYD RES, V389, P115, DOI 10.1016/j.carres.2014.02.004; An HJ, 2009, CURR OPIN CHEM BIOL, V13, P421, DOI 10.1016/j.cbpa.2009.07.022; CLEMENTS JM, 1991, EMBO J, V10, P4113, DOI 10.1002/j.1460-2075.1991.tb04988.x; Costa AR, 2014, CRIT REV BIOTECHNOL, V34, P281, DOI 10.3109/07388551.2013.793649; Cukan MC, 2012, J IMMUNOL METHODS, V386, P34, DOI 10.1016/j.jim.2012.08.015; Damasceno LM, 2012, APPL MICROBIOL BIOT, V93, P31, DOI 10.1007/s00253-011-3654-z; De Schutter K, 2009, NAT BIOTECHNOL, V27, P561, DOI 10.1038/nbt.1544; Dicker M, 2015, EXPERT OPIN BIOL TH, V15, P1501, DOI 10.1517/14712598.2015.1069271; Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184; Dobson CM, 2013, CELL MOL LIFE SCI, V70, P2849, DOI 10.1007/s00018-012-1193-0; Gomathinayagam S, 2014, APPL MICROBIOL BIOT, V98, P2545, DOI 10.1007/s00253-013-5478-5; Hamilton SR, 2013, GLYCOBIOLOGY, V23, P1192, DOI 10.1093/glycob/cwt056; HANIU M, 1993, BIOCHEMISTRY-US, V32, P2431, DOI 10.1021/bi00060a039; Hopkins D, 2015, APPL MICROBIOL BIOT, V99, P3913, DOI 10.1007/s00253-014-6189-2; Jacobs PP, 2009, NAT PROTOC, V4, P58, DOI 10.1038/nprot.2008.213; JENTOFT N, 1990, TRENDS BIOCHEM SCI, V15, P291, DOI 10.1016/0968-0004(90)90014-3; Krainer FW, 2013, SCI REP-UK, V3, DOI 10.1038/srep03279; Lam JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001009; Laukens B, 2015, FUTURE MICROBIOL, V10, P21, DOI 10.2217/fmb.14.104; Lommel M, 2009, GLYCOBIOLOGY, V19, P816, DOI 10.1093/glycob/cwp066; Luong M, 2007, VACCINE, V25, P4340, DOI 10.1016/j.vaccine.2007.03.027; Nagai MK, 2002, EXPERT OPIN BIOL TH, V2, P211, DOI 10.1517/14712598.2.2.211; Nakamura N, 2010, SEMIN CELL DEV BIOL, V21, P622, DOI 10.1016/j.semcdb.2010.03.010; Nett JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068325; Oberg F, 2011, J BIOL CHEM, V286, P31915, DOI 10.1074/jbc.M111.242677; Piirainen MA, 2014, NEW BIOTECHNOL, V31, P532, DOI 10.1016/j.nbt.2014.03.001; Spiro RG, 2002, GLYCOBIOLOGY, V12, p43R, DOI 10.1093/glycob/12.4.43R; Stalnaker SH, 2011, CURR OPIN STRUC BIOL, V21, P603, DOI 10.1016/j.sbi.2011.09.001; Tan AS, 2000, J IMMUNOL METHODS, V238, P59, DOI 10.1016/S0022-1759(00)00156-3; Upreti GC, 2012, BIOTECHNIQUES, V52, P159, DOI 10.2144/000113818; Vitt UA, 2001, MOL ENDOCRINOL, V15, P681, DOI 10.1210/me.15.5.681; Vogl T, 2013, CURR OPIN BIOTECH, V24, P1094, DOI 10.1016/j.copbio.2013.02.024; Walsh G, 2014, NAT BIOTECHNOL, V32, P992, DOI 10.1038/nbt.3040; Yin JC, 2007, J BIOTECHNOL, V127, P335, DOI 10.1016/j.jbiotec.2006.07.012; Zauner G, 2012, BIOL CHEM, V393, P687, DOI 10.1515/hsz-2012-0144	37	15	16	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145419	10.1371/journal.pone.0145419	http://dx.doi.org/10.1371/journal.pone.0145419			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26701617	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092600078
J	Elkis, Y; Bel, S; Rahimi, R; Lerer-Goldstein, T; Levin-Zaidman, S; Babushkin, T; Shpungin, S; Nir, U				Elkis, Yoav; Bel, Shai; Rahimi, Roni; Lerer-Goldstein, Tali; Levin-Zaidman, Smadar; Babushkin, Tatiana; Shpungin, Sally; Nir, Uri			TMF/ARA160 Governs the Dynamic Spatial Orientation of the Golgi Apparatus during Sperm Development	PLOS ONE			English	Article							MEMBRANE TRAFFICKING; ACROSOME FORMATION; CHROMATOID BODY; PROTEIN; COMPLEX; MICROTUBULES; MICE; ORGANIZATION; ACROPLAXOME; RAT	TMF/ARA160 is known to be a TATA element Modulatory Factor (TMF). It was initially identified as a DNA-binding factor and a coactivator of the Androgen receptor. It was also characterized as a Golgi-associated protein, which is essential for acrosome formation during functional sperm development. However, the molecular roles of TMF in this intricate process have not been revealed. Here, we show that during spermiogenesis, TMF undergoes a dynamic change of localization throughout the Golgi apparatus. Specifically, TMF translocates from the cis-Golgi to the trans-Golgi network and to the emerging vesicles surface, as the round spermatids develop. Notably, lack of TMF led to an abnormal spatial orientation of the Golgi and to the deviation of the trans-Golgi surface away from the nucleus of the developing round spermatids. Concomitantly, pro-acrosomal vesicles derived from the TMF-/- Golgi lacked targeting properties and did not tether to the spermatid nuclear membrane thereby failing to form the acrosome anchoring scaffold, the acroplaxome, around the cell-nucleus. Absence of TMF also perturbed the positioning of microtubules, which normally lie in proximity to the Golgi and are important for maintaining Golgi spatial orientation and dynamics and for chromatoid body formation, which is impaired in TMF-/- spermatids. In-silico evaluation combined with molecular and electron microscopic analyses revealed the presence of a microtubule interacting domain (MIT) in TMF, and confirmed the association of TMF with microtubules in spermatogenic cells. Furthermore, the MIT domain in TMF, along with microtubules integrity, are required for stable association of TMF with the Golgi apparatus. Collectively, we show here for the first time that a Golgi and microtubules associated protein is crucial for maintaining proper Golgi orientation during a cell developmental process.	[Elkis, Yoav; Bel, Shai; Rahimi, Roni; Lerer-Goldstein, Tali; Babushkin, Tatiana; Shpungin, Sally; Nir, Uri] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel; [Levin-Zaidman, Smadar] Weizmann Inst Sci, Electron Microscopy Unit, IL-7610001 Rehovot, Israel	Bar Ilan University; Weizmann Institute of Science	Nir, U (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel.	uri.nir@biu.ac.il	Bel, Shai/AAH-7870-2021	Bel, Shai/0000-0002-7166-4870	Ihel Foundation	Ihel Foundation	This work was supported by a grant from the Ihel Foundation. This grant is an inner university grant therefore has no number or website.; This work was supported by a grant from the Ihel Foundation.	Abou-Haila A, 2000, ARCH BIOCHEM BIOPHYS, V379, P173, DOI 10.1006/abbi.2000.1880; Barr FA, 2003, CURR OPIN CELL BIOL, V15, P405, DOI 10.1016/S0955-0674(03)00054-1; Berruti Giovanna, 2011, Spermatogenesis, V1, P95; BLOOM GS, 1989, J BIOL CHEM, V264, P16083; Brandizzi F, 2013, NAT REV MOL CELL BIO, V14, P382, DOI 10.1038/nrm3588; Brown A. A., 2014, BIORXIV; Chabin-Brion K, 2001, MOL BIOL CELL, V12, P2047, DOI 10.1091/mbc.12.7.2047; Clermont Y., 1993, FRONT ENDOCRINOL, P332; Cole NB, 1996, MOL BIOL CELL, V7, P631, DOI 10.1091/mbc.7.4.631; Dadoune J P, 1994, Bull Assoc Anat (Nancy), V78, P33; Donkor FF, 2004, J CELL SCI, V117, P4643, DOI 10.1242/jcs.01303; Elkis Y, 2012, MOL CELL ENDOCRINOL; Farquhar MG, 1998, TRENDS CELL BIOL, V8, P2, DOI 10.1016/S0962-8924(97)01187-2; Fridmann-Sirkis Y, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-18; Fujihara Y, 2012, DEVELOPMENT, V139, P3583, DOI 10.1242/dev.081778; GRIFFITHS G, 1981, EUR J CELL BIOL, V26, P52; GRIFFITHS G, 1986, SCIENCE, V234, P438, DOI 10.1126/science.2945253; Hess RA, 2008, ADV EXP MED BIOL, V636, P1, DOI 10.1007/978-0-387-09597-4_1; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Huang WP, 2006, CELL TISSUE RES, V323, P495, DOI 10.1007/s00441-005-0097-9; Kang-Decker N, 2001, SCIENCE, V294, P1531, DOI 10.1126/science.1063665; Kierszenbaum Abraham L, 2011, Spermatogenesis, V1, P221; Kierszenbaum AL, 2004, BIOL REPROD, V70, P1400, DOI 10.1095/biolreprod.103.025346; Kierszenbaum AL, 2004, ARCH HISTOL CYTOL, V67, P271, DOI 10.1679/aohc.67.271; Kierszenbaum AL, 2003, MOL BIOL CELL, V14, P4628, DOI 10.1091/mbc.E03-04-0226; Kotaja N, 2006, J CELL SCI, V119, P2819, DOI 10.1242/jcs.03022; Lerer-Goldshtein T, 2010, DEV BIOL, V348, P12, DOI 10.1016/j.ydbio.2010.07.033; Lippincott-Schwartz J, 1998, CURR OPIN CELL BIOL, V10, P52, DOI 10.1016/S0955-0674(98)80086-0; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Liu G, 2010, ASIAN J ANDROL, V12, P556, DOI 10.1038/aja.2010.47; Mallard F, 1998, J CELL BIOL, V143, P973, DOI 10.1083/jcb.143.4.973; Meikar O, 2011, REPRODUCTION, V142, P195, DOI 10.1530/REP-11-0057; Miller VJ, 2013, J BIOL CHEM, V288, P4229, DOI 10.1074/jbc.M112.426767; MINOTTI AM, 1991, J BIOL CHEM, V266, P3987; Miyazaki T, 2013, HISTOCHEM CELL BIOL, V139, P339, DOI 10.1007/s00418-012-1031-3; Moreno RD, 2000, CELL MOTIL CYTOSKEL, V46, P235, DOI 10.1002/1097-0169(200008)46:4<235::AID-CM1>3.0.CO;2-G; Moreno RD, 2006, DEV BIOL, V293, P218, DOI 10.1016/j.ydbio.2006.02.001; Moreno RD, 2006, MOL REPROD DEV, V73, P1430, DOI 10.1002/mrd.20581; Munro S., 2011, COLD SPRING HARB PER, V3, DOI DOI 10.1101/CSHPERSPECT.A005256; Ng DCH, 2006, J CELL BIOL, V172, P245, DOI 10.1083/jcb.200503021; OAKBERG EF, 1956, AM J ANAT, V99, P391, DOI 10.1002/aja.1000990303; Pathak R, 2012, DEV CELL, V23, P397, DOI 10.1016/j.devcel.2012.06.014; PAVELKA M, 1983, J CELL BIOL, V97, P737, DOI 10.1083/jcb.97.3.737; Perry E, 2004, ONCOGENE, V23, P8908, DOI 10.1038/sj.onc.1208149; Pierre V, 2012, DEVELOPMENT, V139, P2955, DOI 10.1242/dev.077982; Ramalho-Santos J, 2002, BIOL REPROD, V67, P1043, DOI 10.1095/biolreprod67.4.1043; Roll-Mecak A, 2010, CURR OPIN CELL BIOL, V22, P96, DOI 10.1016/j.ceb.2009.11.001; Shao XP, 1999, DEV BIOL, V211, P109, DOI 10.1006/dbio.1999.9297; Skinner MA, 2010, NAT REV MOL CELL BIO, V11, P234, DOI 10.1038/nrm2870; Starr T, 2010, TRAFFIC, V11, P626, DOI 10.1111/j.1600-0854.2010.01051.x; Stephens DJ, 2012, J CELL SCI, V125, P2795, DOI 10.1242/jcs.097675; THORNETJOMSLAND G, 1988, ANAT REC, V221, P591, DOI 10.1002/ar.1092210205; Thyberg J, 1999, EXP CELL RES, V246, P263, DOI 10.1006/excr.1998.4326; TOKUYASU KT, 1986, J MICROSC-OXFORD, V143, P139, DOI 10.1111/j.1365-2818.1986.tb02772.x; TURNER JR, 1989, J CELL BIOL, V109, P2081, DOI 10.1083/jcb.109.5.2081; Ventela S, 2003, MOL BIOL CELL, V14, P2768, DOI 10.1091/mbc.E02-10-0647; Xiao N, 2009, J CLIN INVEST, V119, P802, DOI 10.1172/JCI36230; Yamane J, 2007, EXP CELL RES, V313, P3472, DOI 10.1016/j.yexcr.2007.07.010; Yao RJ, 2002, P NATL ACAD SCI USA, V99, P11211, DOI 10.1073/pnas.162027899	59	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145277	10.1371/journal.pone.0145277	http://dx.doi.org/10.1371/journal.pone.0145277			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26701263	Green Published, gold, Green Submitted			2022-12-26	WOS:000367092600057
J	Kim, KH; Hwang, JH; Han, DY; Park, M; Kim, S; Choi, D; Kim, Y; Lee, GP; Kim, ST; Park, YH				Kim, Kwang-Hwan; Hwang, Ji-Hyun; Han, Dong-Yeup; Park, Minkyu; Kim, Seungill; Choi, Doil; Kim, Yongjae; Lee, Gung Pyo; Kim, Sun-Tae; Park, Young-Hoon			Major Quantitative Trait Loci and Putative Candidate Genes for Powdery Mildew Resistance and Fruit-Related Traits Revealed by an Intraspecific Genetic Map for Watermelon (Citrullus lanatus var. lanatus)	PLOS ONE			English	Article							LINKAGE MAP; GENOME; DIVERSITY; L.; TOMATO; MELON; SUN; RECOMBINATION; COLOCYNTHIS; INHERITANCE	An intraspecific genetic map for watermelon was constructed using an F-2 population derived from 'Arka Manik' x 'TS34' and transcript sequence variants and quantitative trait loci (QTL) for resistance to powdery mildew (PMR), seed size (SS), and fruit shape (FS) were analyzed. The map consists of 14 linkage groups (LGs) defined by 174 cleaved amplified polymorphic sequences (CAPS), 2 derived-cleaved amplified polymorphic sequence markers, 20 sequence-characterized amplified regions, and 8 expressed sequence tag-simple sequence repeat markers spanning 1,404.3 cM, with a mean marker interval of 6.9 cM and an average of 14.6 markers per LG. Genetic inheritance and QTL analyses indicated that each of the PMR, SS, and FS traits is controlled by an incompletely dominant effect of major QTLs designated as pmr2.1, ss2.1, and fsi3.1, respectively. The pmr2.1, detected on chromosome 2 (Chr02), explained 80.0% of the phenotypic variation (LOD = 30.76). This QTL was flanked by two CAPS markers, wsb2-24 (4.00 cM) and wsb2-39 (13.97 cM). The ss2.1, located close to pmr2.1 and CAPS marker wsb2-13 (1.00 cM) on Chr02, explained 92.3% of the phenotypic variation (LOD = 68.78). The fsi3.1, detected on Chr03, explained 79.7% of the phenotypic variation (LOD = 31.37) and was flanked by two CAPS, wsb3-24 (1.91 cM) and wsb3-9 (7.00 cM). Candidate gene-based CAPS markers were developed from the disease resistance and fruit shape gene homologs located on Chr.02 and Chr03 and were mapped on the intraspecific map. Colocalization of these markers with the major QTLs indicated that watermelon orthologs of a nucleotide-binding site-leucine-rich repeat class gene containing an RPW8 domain and a member of SUN containing the IQ67 domain are candidate genes for pmr2.1 and fsi3.1, respectively. The results presented herein provide useful information for marker-assisted breeding and gene cloning for PMR and fruit-related traits.	[Kim, Kwang-Hwan; Hwang, Ji-Hyun; Han, Dong-Yeup; Park, Young-Hoon] Pusan Natl Univ, Dept Hort Biosci, Miryang, South Korea; [Park, Minkyu; Kim, Seungill; Choi, Doil] Seoul Natl Univ, Dept Plant Sci, Seoul, South Korea; [Park, Minkyu] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Kim, Yongjae] Partner Seed, Ansung, South Korea; [Lee, Gung Pyo] Chung Ang Univ, Dept Integrat Plant Sci, Coll Biotechnol & Nat Resources, Ansung, South Korea; [Kim, Sun-Tae] Pusan Natl Univ, Dept Plant Biosci, Miryang, South Korea; [Park, Young-Hoon] Pusan Natl Univ, Life & Ind Convergence Res Inst, Miryang, South Korea	Pusan National University; Seoul National University (SNU); University System of Georgia; University of Georgia; Chung Ang University; Pusan National University; Pusan National University	Park, YH (corresponding author), Pusan Natl Univ, Dept Hort Biosci, Miryang, South Korea.	ypark@pusan.ac.kr	Choi, Doil/F-5002-2011; Kim, Seungill/AAR-1099-2021	Kim, Seungill/0000-0001-6287-8693; Kim, Sun Tae/0000-0002-3853-1419; gim, seontae/0000-0001-9705-6868	Ministry of Agriculture, Food and Rural Affairs (MAFRA), Korea; Vegetable Breeding Research Center [710001-07-5]; Golden Seed Project, MAFRA [213002-04-1-SBR20]; Ministry of Oceans and Fisheries (MOF); Rural Development Administration (RDA); Korea Forest Service (KFS); Vegetable Breeding Research Center through Agriculture, Food and Rural Affairs Research Center Support Program, Ministry of Agriculture, Food and Rural Affairs (MAFRA), Korea [710001-07-5]	Ministry of Agriculture, Food and Rural Affairs (MAFRA), Korea; Vegetable Breeding Research Center; Golden Seed Project, MAFRA; Ministry of Oceans and Fisheries (MOF); Rural Development Administration (RDA)(Rural Development Administration (RDA), Republic of Korea); Korea Forest Service (KFS); Vegetable Breeding Research Center through Agriculture, Food and Rural Affairs Research Center Support Program, Ministry of Agriculture, Food and Rural Affairs (MAFRA), Korea	This research was fully funded by the Ministry of Agriculture, Food and Rural Affairs (MAFRA), Korea, by a grant (710001-07-5) from the Vegetable Breeding Research Center. Further, this research was supported by the Golden Seed Project (213002-04-1-SBR20), MAFRA, the Ministry of Oceans and Fisheries (MOF), Rural Development Administration (RDA), and Korea Forest Service (KFS). The funders provided in the form of salaries for authors (KHK, JHH, and DYH), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section. A commercial affiliation, "Partner Seed" (affiliated author: Yongjae Kim) did not provide financial support, but played a role in the study design and data collection by field evaluation of the F2 population. Phenotyping of the F2 population was conducted by Yongjae Kim (the owner of "Partner Seed") at the breeding field owned by Partner Seed Company which collaborated for this study.; This work was supported by a grant (710001-07-5) from the Vegetable Breeding Research Center through Agriculture, Food and Rural Affairs Research Center Support Program, Ministry of Agriculture, Food and Rural Affairs (MAFRA), Korea. Further, this research was supported by the Golden Seed Project (213002-04-1-SBR20), MAFRA, the Ministry of Oceans and Fisheries (MOF), Rural Development Administration (RDA), and Korea Forest Service (KFS).	Brotman Y, 2002, THEOR APPL GENET, V104, P1055, DOI 10.1007/s00122-001-0808-x; Collard BCY, 2008, PHILOS T R SOC B, V363, P557, DOI 10.1098/rstb.2007.2170; Davis AR, 2007, J AM SOC HORTIC SCI, V132, P790, DOI 10.21273/JASHS.132.6.790; Gowda BS, 2002, EUPHYTICA, V126, P365, DOI 10.1023/A:1019956208240; Guo SG, 2013, NAT GENET, V45, P51, DOI 10.1038/ng.2470; Huang ZJ, 2013, MOL GENET GENOMICS, V288, P111, DOI 10.1007/s00438-013-0733-0; Hwang JH, 2011, SCI HORTIC-AMSTERDAM, V130, P715, DOI 10.1016/j.scienta.2011.08.014; Hwang J, 2014, MOL BREEDING, V34, P949, DOI 10.1007/s11032-014-0088-1; Jae HJ, 2009, KOREAN J HORTIC SCI, V27, P448; JEFFREY C, 1975, Kew Bulletin, V30, P475, DOI 10.2307/4103075; Kim KH, 2013, HORTIC ENVIRON BIOTE, V54, P134, DOI 10.1007/s13580-013-0156-1; Kim S, 2015, DNA RES, V22, P19, DOI 10.1093/dnares/dsu035; Kim S, 2014, NAT GENET, V46, P270, DOI 10.1038/ng.2877; Kim YongJae, 2009, Korean Journal of Breeding Science, V41, P412; Kim YongJae, 2009, Korean Journal of Breeding Science, V41, P403; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee WM, 2010, KOR J HORT SCI TE S2, V28, P73; Levi A, 2006, J AM SOC HORTIC SCI, V131, P393, DOI 10.21273/JASHS.131.3.393; Levi A, 2002, THEOR APPL GENET, V105, P555, DOI [10.1007/s00122-001-0860-6, 10.1007/S00122-001-0860-6]; Levi A, 2001, GENET RESOUR CROP EV, V48, P559, DOI 10.1023/A:1013888418442; Levi A, 2001, HORTSCIENCE, V36, P1096, DOI 10.21273/HORTSCI.36.6.1096; Levi A, 2012, GENETICS GENOMICS BR, P309; McGrath MT, 1996, COMPENDIUM CUCURBIT, P28; McHale L, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-212; Monforte AJ, 2014, J EXP BOT, V65, P4625, DOI 10.1093/jxb/eru017; Moose SP, 2008, PLANT PHYSIOL, V147, P969, DOI 10.1104/pp.108.118232; Park Y, 2012, ISR J PLANT SCI, V60, P415, DOI 10.1560/IJPS.60.4.415; Poole CF, 1941, J AGRIC RES, V63, P0433; Poole CF, 1944, J HERED, V89, P50; Prothro J, 2012, J AM SOC HORTIC SCI, V137, P452, DOI 10.21273/JASHS.137.6.452; Reddy UK, 2014, G3-GENES GENOM GENET, V4, P2219, DOI 10.1534/g3.114.012815; Ren Y, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-33; Ren Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029453; Rodriguez GR, 2011, PLANT PHYSIOL, V156, P275, DOI 10.1104/pp.110.167577; Sandlin K, 2012, THEOR APPL GENET, V125, P1603, DOI 10.1007/s00122-012-1938-z; Tetteh AY, 2010, CROP SCI, V50, P933, DOI 10.2135/cropsci2009.03.0135; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; Van Ooijen J.W., 2004, MAPQTL 6 SOFTWARE MA; Wehner TC, 2003, CUCURBIT GENET COOP, V26, P76; Wei FS, 1999, GENETICS, V153, P1929; Whitaker T. W., 1976, Evolution of crop plants., P64; Whitaker T.W., 1962, CUCURBITS BOT CULTIV; Wu S, 2011, PLANT PHYSIOL, V157, P1175, DOI 10.1104/pp.111.181065; Xiao SY, 2003, PLANT CELL, V15, P33, DOI 10.1105/tpc.006940; Xiao SY, 2001, SCIENCE, V291, P118, DOI 10.1126/science.291.5501.118; Yahiaoui N, 2004, PLANT J, V37, P528, DOI 10.1046/j.1365-313X.2003.01977.x; Yuste-Lisbona FJ, 2011, THEOR APPL GENET, V122, P747, DOI 10.1007/s00122-010-1483-6	49	34	42	9	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145665	10.1371/journal.pone.0145665	http://dx.doi.org/10.1371/journal.pone.0145665			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700647	Green Submitted, gold, Green Published			2022-12-26	WOS:000367092600114
J	Steven, R; Morrison, C; Arthur, JM; Castley, JG				Steven, Rochelle; Morrison, Clare; Arthur, J. Michael; Castley, J. Guy			Avitourism and Australian Important Bird and Biodiversity Areas	PLOS ONE			English	Article							PROTECTED AREAS; TOURISM; AFRICA; CONSERVATION; ECOTOURISM; IMPACTS; SYSTEM	Formal protected areas will not provide adequate protection to conserve all biodiversity, and are not always designated using systematic or strategic criteria. Using a systematic process, the Important Bird and Biodiversity Area (IBA) network was designed to highlight areas of conservation significance for birds (i.e. IBA trigger species), and more recently general biodiversity. Land use activities that take place in IBAs are diverse, including consumptive and non-consumptive activities. Avitourism in Australia, generally a non-consumptive activity, is reliant on the IBA network and the birds IBAs aim to protect. However, companies tend not to mention IBAs in their marketing. Furthermore, avitourism, like other nature-based tourism has the potential to be both a threatening process as well as a conservation tool. We aimed to assess the current use of IBAs among Australian-based avitour companies' marketing, giving some indication of which IBAs are visited by avitourists on organised tours. We reviewed online avitour itineraries, recorded sites featuring in descriptions of avitours and which IBA trigger species are used to sell those tours. Of the 209 avitours reviewed, Queensland is the most featured state (n = 59 tours), and 73% feature at least one IBA. Daintree (n = 22) and Bruny Island (n = 17) IBAs are the most popular, nationally. Trigger species represent 34% (n = 254 out of 747) of species used in avitour descriptions. The most popular trigger species' are wetland species including; Brolga (n = 37), Black-necked Stork (n = 30) and Magpie Goose (n = 27). Opportunities exist to increase collaboration between avitour companies and IBA stakeholders. Our results can provide guidance for managing sustainability of the avitourism industry at sites that feature heavily in avitour descriptions and enhance potential cooperation between avitour companies, IBA stakeholders and bird conservation organisations.	[Steven, Rochelle; Castley, J. Guy] Griffith Univ, Griffith Sch Environm, Environm Futures Res Inst, Gold Coast, Qld 4222, Australia; [Morrison, Clare] Griffith Univ, Griffith Sch Environm, Gold Coast, Qld 4222, Australia; [Arthur, J. Michael] Griffith Univ, Griffith Sch Environm, Australian Rivers Inst, Gold Coast, Qld 4222, Australia	Griffith University; Griffith University; Griffith University	Steven, R (corresponding author), Griffith Univ, Griffith Sch Environm, Environm Futures Res Inst, Gold Coast Campus, Gold Coast, Qld 4222, Australia.	rochelle.steven@griffithuni.edu.au	Steven, Rochelle/AAD-5898-2020; Castley, James Guy/A-7056-2010; Arthur, James Michael/C-3502-2008	Castley, James Guy/0000-0002-8418-5828; Arthur, James Michael/0000-0003-4540-4511; Steven, Rochelle/0000-0002-3474-6818				[Anonymous], 2006, SUSTAINABLE FINANCIN; Arinaitwe JA, 2007, OSTRICH, V78, P139, DOI 10.2989/OSTRICH.2007.78.2.5.85; Ballantyne R, 2007, ENVIRON EDUC RES, V13, P367, DOI DOI 10.1080/13504620701430604; Bennun L, 2005, BIODIVERS CONSERV, V14, P2575, DOI 10.1007/s10531-005-8389-7; Beresford AE, 2011, ANIM CONSERV, V14, P99, DOI 10.1111/j.1469-1795.2010.00398.x; Biggs D., 2011, Conservation and Society, V9, P80, DOI 10.4103/0972-4923.79198; BirdLife International, 2013, IMP BIRD BIOD AR DAN; BirdLife International, 2014, IMP BIRD BIOD AR IBA; BirdLife International, 2007, IBA TOOLB STRA UNPUB; BirdLife International BirdLife International Data Zone, 2014, GLOB IBA CRIT; Bireline HR, 2005, THESIS; Brooks TM, 2004, BIOSCIENCE, V54, P1081, DOI 10.1641/0006-3568(2004)054[1081:CPBTGP]2.0.CO;2; Buchanan GM, 2009, BIRD CONSERV INT, V19, P49, DOI 10.1017/S0959270908007697; Buckley R, 2012, ANN TOURISM RES, V39, P528, DOI 10.1016/j.annals.2012.02.003; Butchart SHM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032529; Castley JG, 2013, GEOGR RES-AUST, V51, P59, DOI 10.1111/j.1745-5871.2012.00767.x; Chape S, 2005, PHILOS T R SOC B, V360, P443, DOI 10.1098/rstb.2004.1592; Choi S, 2007, TOURISM MANAGE, V28, P118, DOI 10.1016/j.tourman.2006.03.002; Dharmaratne GS, 2000, ANN TOURISM RES, V27, P590, DOI 10.1016/S0160-7383(99)00109-7; DTI (The Department of Trade and Industry), 2010, AV S AFR; Dutson G, 2009, AUSTRALIAS IMPORTANT; Gallo JA, 2009, BIOL CONSERV, V142, P446, DOI 10.1016/j.biocon.2008.10.025; Goodwin H, 1996, BIODIVERS CONSERV, V5, P277, DOI 10.1007/BF00051774; Green R., 2010, PRACTICES NEEDS ATTI; Hodur NM, 2004, CHARACTERISTICS EXPE; Hvenegaard GT, 1998, ANN TOURISM RES, V25, P700, DOI 10.1016/S0160-7383(98)00020-6; Jones D. N., 2005, IMPACTS BIRD WATCHIN; Jones D.N., 2001, BIRDWATCHING TOURISM; Li F, 2013, TOURISM ECON, V19, P257, DOI 10.5367/te.2013.0201; Lyons K., 2009, M BEST EN THINK TANK; McLeod EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082008; Mwangi MAK, 2010, BIRD CONSERV INT, V20, P215, DOI 10.1017/S0959270910000456; Pasquini L, 2011, ORYX, V45, P373, DOI 10.1017/S0030605310000876; Puhakka L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026786; Rodger K., 2007, Journal of Sustainable Tourism, V15, P160, DOI 10.2167/jost619.0; Sekercioglu CH, 2002, ENVIRON CONSERV, V29, P282, DOI 10.1017/S0376892902000206; Simango S. S, 2011, THESIS; Steven R, 2015, J SUSTAIN TOUR, V23, P1257, DOI 10.1080/09669582.2014.924955; Steven R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062598; Steven R, 2013, BIODIVERS CONSERV, V22, P1063, DOI 10.1007/s10531-013-0470-z; Steven R, 2011, J ENVIRON MANAGE, V92, P2287, DOI 10.1016/j.jenvman.2011.05.005; Stoll JR, 1999, AVITOURISM TEXAS 2 S; Trainor C. R., 2008, BIRDING ASIA, V9, P16; Welford M, 2013, J NAT CONSERV, V21, P401, DOI 10.1016/j.jnc.2013.05.002; Weston MA, 2012, EMU, V112, P269, DOI 10.1071/MU12026; Willemen L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129785	46	7	9	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0144445	10.1371/journal.pone.0144445	http://dx.doi.org/10.1371/journal.pone.0144445			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ4SI	26701779	Green Published, gold, Green Submitted			2022-12-26	WOS:000367092600019
J	Hansen, GM; Nilsson, M; Nielsen, CH; Holmstrup, P; Helqvist, S; Tolker-Nielsen, T; Givskov, M; Hansen, PR				Hansen, Gorm Mork; Nilsson, Martin; Nielsen, Claus Henrik; Holmstrup, Palle; Helqvist, Steffen; Tolker-Nielsen, Tim; Givskov, Michael; Hansen, Peter Riis			Absence of Bacteria on Coronary Angioplasty Balloons from Unselected Patients: Results with Use of a High Sensitivity Polymerase Chain Reaction Assay	PLOS ONE			English	Article							CHLAMYDIA-PNEUMONIAE; MYOCARDIAL-INFARCTION; SECONDARY PREVENTION; HELICOBACTER-PYLORI; PERIODONTAL-DISEASE; INFECTIOUS BURDEN; ARTERY-DISEASE; ATHEROSCLEROSIS; METAANALYSIS; TRIAL	Periodontitis is a chronic, bacterially-induced inflammatory disease of the tooth-supporting tissues, which may result in transient bacteremia and a systemic inflammatory response. Periodontitis is associated with coronary artery disease independently of established cardiovascular risk factors, and translocation of bacteria from the oral cavity to the coronary arteries may play a role in the development of coronary artery disease. Very few studies have used angioplasty balloons for in vivo sampling from diseased coronary arteries, and with varying results. Therefore, the aim of this study was to assess if bacterial DNA from primarily oral bacteria could be detected on coronary angioplasty balloons by use of an optimized sampling process combined with an internally validated sensitive polymerase chain reaction (PCR) assay. Coronary angioplasty balloons and control samples from a total of 45 unselected patients with stable angina, unstable angina/non-ST elevation myocardial infarction, and ST-elevation myocardial infarction (n = 15 in each group) were collected and analyzed using a PCR assay with high sensitivity and specificity for 16S rRNA genes of the oral microbiome. Despite elimination of extraction and purification steps, and demonstration of sensitivity levels of 25-125 colony forming units (CFU), we did not detect bacterial DNA from any of the coronary angioplasty balloons. A subsequent questionnaire indicated that the prevalence of periodontitis in the study cohort was at least 39.5%. Although coronary angioplasty balloons are unlikely to be useful for detection of bacteria with current PCR techniques in unselected patients with coronary artery disease, more studies are warranted to determine the extent to which bacteria contribute to atherosclerosis and its clinical manifestations and whether the presence of bacteria in the arteries is a transient phenomenon.	[Hansen, Gorm Mork; Hansen, Peter Riis] Gentofte Univ Hosp, Dept Cardiol, Hellerup, Denmark; [Hansen, Gorm Mork; Nilsson, Martin; Tolker-Nielsen, Tim; Givskov, Michael] Univ Copenhagen, Fac Hlth & Med Sci, Dept Immunol & Microbiol, Costerton Biofilm Ctr, Copenhagen, Denmark; [Nielsen, Claus Henrik] Rigshosp, Dept Infect Dis & Rheumatol, Inst Inflammat Res, DK-2100 Copenhagen, Denmark; [Nielsen, Claus Henrik; Holmstrup, Palle] Univ Copenhagen, Dept Odontol, Fac Hlth & Med Sci, Sect Periodontol, Copenhagen, Denmark; [Helqvist, Steffen] Univ Copenhagen, Rigshosp, Dept Cardiol, DK-2100 Copenhagen, Denmark; [Givskov, Michael] Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn SCELSE, Singapore 639798, Singapore	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Hansen, GM (corresponding author), Gentofte Univ Hosp, Dept Cardiol, Hellerup, Denmark.	gorm.moerk.hansen@regionh.dk	Nilsson, Martin/AHH-2943-2022; Hansen, Peter Riis/AAR-7659-2020	Givskov, Michael/0000-0001-5004-8609; Tolker-Nielsen, Tim/0000-0002-9751-474X; Nielsen, Claus Henrik/0000-0001-7543-9016; Mork Hansen, Gorm/0000-0002-6000-8835; Hansen, Peter Riis/0000-0002-9056-535X	University of Copenhagen, Faculty of Health and Medical Sciences [624-0013/12-3000]; Danish Heart Foundation [14-R97-A5031-22857]; Arvid Nilssons Fond; Toyota-Fonden, Denmark [OH/BG-8435]; Danish Medical Research Grant [2013-5480/912523-1]; Aase og Ejnar Danielsens Fond [10-001169]	University of Copenhagen, Faculty of Health and Medical Sciences; Danish Heart Foundation; Arvid Nilssons Fond; Toyota-Fonden, Denmark; Danish Medical Research Grant; Aase og Ejnar Danielsens Fond	This work was supported by grants from University of Copenhagen, Faculty of Health and Medical Sciences (http://www.ku.dk/english; 624-0013/12-3000; Receiver MG); The Danish Heart Foundation (http://www.hjerteforeningen.dk/; 14-R97-A5031-22857; Receiver GMH); Arvid Nilssons Fond (http://arvidnilssonsfond.dk/; Receiver GMH); Toyota-Fonden, Denmark (OH/BG-8435; Receiver GMH); The Danish Medical Research Grant (www.laeger.dk/; 2013-5480/912523-1; Receiver GMH); and Aase og Ejnar Danielsens Fond (http://www.danielsensfond.dk/; 10-001169; Receiver GMH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JL, 1999, CIRCULATION, V99, P1540, DOI 10.1161/01.CIR.99.12.1540; Andraws R, 2005, JAMA-J AM MED ASSOC, V293, P2641, DOI 10.1001/jama.293.21.2641; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Belstrom D, 2012, MICROBES INFECT, V14, P411, DOI 10.1016/j.micinf.2011.12.004; Blaizot A, 2009, INT DENT J, V59, P197, DOI 10.1922/IDJ_2114Sixou13; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; D'Aiuto F, 2013, J CLIN PERIODONTOL, V40, pS85, DOI [10.1902/jop.2013.134007, 10.1111/jcpe.12061]; Daus H, 1998, CARDIOLOGY, V90, P83, DOI 10.1159/000006824; Desvarieux M, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000254; Dietrich T, 2008, CIRCULATION, V117, P1668, DOI 10.1161/CIRCULATIONAHA.107.711507; Dietrich Thomas, 2013, J Periodontol, V84, pS70, DOI [10.1111/jcpe.12062, 10.1902/jop.2013.134008]; Elkind Mitchell S. V., 2010, Infectious Disorders - Drug Targets, V10, P84; Forner L, 2006, J CLIN PERIODONTOL, V33, P401, DOI 10.1111/j.1600-051X.2006.00924.x; Frobert O, 2013, NEW ENGL J MED, V369, P1587, DOI 10.1056/NEJMoa1308789; Galkiewicz JP, 2008, APPL ENVIRON MICROB, V74, P7828, DOI 10.1128/AEM.01303-08; Geismar K, 2006, J PERIODONTOL, V77, P1547, DOI 10.1902/jop.2006.050405; Grayston JT, 2005, NEW ENGL J MED, V352, P1637, DOI 10.1056/NEJMoa043526; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hoiby N, 2011, INT J ORAL SCI, V3, P55, DOI 10.4248/IJOS11026; Honarmand Hamidreza, 2013, Interdiscip Perspect Infect Dis, V2013, P941392, DOI 10.1155/2013/941392; Hong SH, 2009, ISME J, V3, P1365, DOI 10.1038/ismej.2009.89; Huws SA, 2007, J MICROBIOL METH, V70, P565, DOI 10.1016/j.mimet.2007.06.013; Jespersen CM, 2006, BRIT MED J, V332, P22, DOI 10.1136/bmj.38666.653600.55; Jolly SS, 2015, NEW ENGL J MED, V372, P1389, DOI 10.1056/NEJMoa1415098; Joshi Rajnish, 2013, N Am J Med Sci, V5, P169, DOI 10.4103/1947-2714.109178; Ketelhuth DFJ, 2015, CIRC J, V79, P924, DOI 10.1253/circj.CJ-15-0167; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kozarov EV, 2005, ARTERIOSCL THROM VAS, V25, pE17, DOI 10.1161/01.ATV.0000155018.67835.1a; Lanter BB, 2014, MBIO, V5, DOI 10.1128/mBio.01206-14; Latsios G, 2004, ACTA CARDIOL, V59, P652, DOI 10.2143/AC.59.6.2005249; Li L, 2002, CIRCULATION, V105, P861, DOI 10.1161/hc0702.104178; Liu J, 2015, HELICOBACTER, V20, P176, DOI 10.1111/hel.12188; Lockhart PB, 2012, CIRCULATION, V125, P2520, DOI 10.1161/CIR.0b013e31825719f3; Maekawa T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020240; MATTILA KJ, 1989, BRIT MED J, V298, P779, DOI 10.1136/bmj.298.6676.779; Ohki T, 2012, AM HEART J, V163, P164, DOI 10.1016/j.ahj.2011.10.012; Ott SJ, 2006, CIRCULATION, V113, P929, DOI 10.1161/CIRCULATIONAHA.105.579979; Pessi T, 2013, CIRCULATION, V127, P1219, DOI 10.1161/CIRCULATIONAHA.112.001254; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Rafferty B, 2011, J INTERN MED, V270, P273, DOI 10.1111/j.1365-2796.2011.02373.x; Ramirez JA, 1996, ANN INTERN MED, V125, P979, DOI 10.7326/0003-4819-125-12-199612150-00008; Rosenfeld ME, 2011, THROMB HAEMOSTASIS, V106, P858, DOI 10.1160/TH11-06-0392; Silva WSE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109761; Sessa R, 2014, WORLD J CLIN CASES, V2, P240, DOI 10.12998/wjcc.v2.i7.240; Suchankova P, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0076431, 10.1371/journal.pone.0071284]; Tomas I, 2012, J CLIN PERIODONTOL, V39, P213, DOI 10.1111/j.1600-051X.2011.01784.x; Wyplosz B, 2006, J AM COLL CARDIOL, V47, P1229, DOI 10.1016/j.jacc.2005.12.037	47	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145657	10.1371/journal.pone.0145657	http://dx.doi.org/10.1371/journal.pone.0145657			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26695491	gold, Green Published			2022-12-26	WOS:000367092500065
J	Laukka, T; Mariani, CJ; Ihantola, T; Cao, JZ; Hokkanen, J; Kaelin, WG; Godley, LA; Koivunen, P				Laukka, Tuomas; Mariani, Christopher J.; Ihantola, Tuukka; Cao, John Z.; Hokkanen, Juho; Kaelin, William G., Jr.; Godley, Lucy A.; Koivunen, Peppi			Fumarate and Succinate Regulate Expression of Hypoxia-inducible Genes via TET Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						5-hydroxymethylcytosine (5-hmC); epigenetics; hypoxia; hypoxia-inducible factor (HIF); leukemia; AML; TET; fumarate; succinate	HYPERMETHYLATOR PHENOTYPE; PROLYL 4-HYDROXYLASES; SDH MUTATIONS; 5-HYDROXYMETHYLCYTOSINE; PARAGANGLIOMA; CANCER; DNA; PROTEINS; HIF; FH	The TET enzymes are members of the 2-oxoglutarate-dependent dioxygenase family and comprise three isoenzymes in humans: TETs 1-3. These TETs convert 5-methylcytosine to 5-hydroxymethylcytosine (5-hmC) in DNA, and high 5-hmC levels are associated with active transcription. The importance of the balance in these modified cytosines is emphasized by the fact that TET2 is mutated in several human cancers, including myeloid malignancies such as acute myeloid leukemia (AML). We characterize here the kinetic and inhibitory properties of Tets and show that the K-m value of Tets 1 and 2 for O-2 is 30 m, indicating that they retain high activity even under hypoxic conditions. The AML-associated mutations in the Fe2+ and 2-oxoglutarate-binding residues increased the K-m values for these factors 30-80-fold and reduced the V-max values. Fumarate and succinate, which can accumulate to millimolar levels in succinate dehydrogenase and fumarate hydratase-mutant tumors, were identified as potent Tet inhibitors in vitro, with IC50 values approximate to 400-500 m. Fumarate and succinate also down-regulated global 5-hmC levels in neuroblastoma cells and the expression levels of some hypoxia-inducible factor (HIF) target genes via TET inhibition, despite simultaneous HIF stabilization. The combination of fumarate or succinate treatment with TET1 or TET3 silencing caused differential effects on the expression of specific HIF target genes. Altogether these data show that hypoxia-inducible genes are regulated in a multilayered manner that includes epigenetic regulation via TETs and 5-hmC levels in addition to HIF stabilization.	[Laukka, Tuomas; Ihantola, Tuukka; Koivunen, Peppi] Univ Oulu, Fac Biochem & Mol Med, Oulu Ctr Cell Matrix Res, Bioctr Oulu, FIN-90014 Oulu, Finland; [Mariani, Christopher J.; Cao, John Z.; Godley, Lucy A.] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA; [Mariani, Christopher J.] Univ Chicago, Comm Mol Pathogenesis & Mol Med, Chicago, IL 60637 USA; [Cao, John Z.; Godley, Lucy A.] Univ Chicago, Comm Canc Biol, Chicago, IL 60637 USA; [Hokkanen, Juho] Admescope Ltd, Typpitie 1, FIN-90620 Oulu, Finland; [Kaelin, William G., Jr.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Kaelin, William G., Jr.] Brigham & Womens Hosp, Boston, MA 02215 USA; [Kaelin, William G., Jr.; Koivunen, Peppi] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	University of Oulu; University of Chicago; University of Chicago; University of Chicago; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute	Koivunen, P (corresponding author), Univ Oulu, Fac Biochem & Mol Med, Oulu Ctr Cell Matrix Res, Bioctr Oulu, FIN-90014 Oulu, Finland.	peppi.koivunen@oulu.fi		Cao, Zhongyang/0000-0001-7561-235X; Ihantola, Tuukka/0000-0003-4182-2011; Laukka, Tuomas/0000-0003-1152-4515	Academy of Finland [120156, 140765, 218129, 266719]; S. Juselius Foundation; Emil Aaltonen Foundation; Jane and Aatos Erkko Foundation; Finnish Cancer Organizations; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007009] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); S. Juselius Foundation; Emil Aaltonen Foundation; Jane and Aatos Erkko Foundation; Finnish Cancer Organizations; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by Academy of Finland Grants 120156, 140765, 218129, and 266719 (to P. K.), and grants from the S. Juselius Foundation (to P. K.), the Emil Aaltonen Foundation (to P. K.), the Jane and Aatos Erkko Foundation (to P. K.), and the Finnish Cancer Organizations (to P. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Abdel-Wahab O, 2009, BLOOD, V114, P144, DOI 10.1182/blood-2009-03-210039; Astuti D, 2001, AM J HUM GENET, V69, P49, DOI 10.1086/321282; Bayley JP, 2010, LANCET ONCOL, V11, P366, DOI 10.1016/S1470-2045(10)70007-3; Birkler RID, 2010, J PHARMACEUT BIOMED, V53, P983, DOI 10.1016/j.jpba.2010.06.005; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Haffner MC, 2011, ONCOTARGET, V2, P627; Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689; Hirsila M, 2005, FASEB J, V19, P1308, DOI 10.1096/fj.04-3399fje; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Koivunen P, 2007, J BIOL CHEM, V282, P4524, DOI 10.1074/jbc.M610415200; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Langemeijer SMC, 2009, NAT GENET, V41, P838, DOI 10.1038/ng.391; Letouze E, 2013, CANCER CELL, V23, P739, DOI 10.1016/j.ccr.2013.04.018; Lian CG, 2012, CELL, V150, P1135, DOI 10.1016/j.cell.2012.07.033; Losman JA, 2013, GENE DEV, V27, P836, DOI 10.1101/gad.217406.113; Madzo J, 2014, CELL REP, V6, P231, DOI 10.1016/j.celrep.2013.11.044; Mariani CJ, 2014, CELL REP, V7, P1343, DOI 10.1016/j.celrep.2014.04.040; McDonough MA, 2010, CURR OPIN STRUC BIOL, V20, P659, DOI 10.1016/j.sbi.2010.08.006; Murata A, 2015, ONCOTARGET, V6, P23372, DOI 10.18632/oncotarget.4281; Myllyharju J, 1997, EMBO J, V16, P1173, DOI 10.1093/emboj/16.6.1173; Myllyharju J, 2013, BIOL CHEM, V394, P435, DOI 10.1515/hsz-2012-0328; Orr BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041036; Pastor WA, 2013, NAT REV MOL CELL BIO, V14, P341, DOI 10.1038/nrm3589; Pollard PJ, 2005, HUM MOL GENET, V14, P2231, DOI 10.1093/hmg/ddi227; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tefferi A, 2009, LEUKEMIA, V23, P905, DOI 10.1038/leu.2009.47; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Vasanthakumar A, 2015, CANCER GENET-NY, V208, P167, DOI 10.1016/j.cancergen.2015.02.009; Vasanthakumar A, 2013, BLOOD, V121, P2059, DOI 10.1182/blood-2012-04-421065; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Xiao MT, 2012, GENE DEV, V26, P1326, DOI 10.1101/gad.191056.112; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	39	185	191	1	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					4256	4265		10.1074/jbc.M115.688762	http://dx.doi.org/10.1074/jbc.M115.688762			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26703470	hybrid, Green Published			2022-12-26	WOS:000371338400048
J	Ahn, JK; Kim, S; Hwang, J; Kim, J; Lee, YS; Koh, EM; Kim, KH; Cha, HS				Ahn, Joong Kyong; Kim, Sooah; Hwang, Jiwon; Kim, Jungyeon; Lee, You Sun; Koh, Eun-Mi; Kim, Kyoung Heon; Cha, Hoon-Suk			Metabolomic Elucidation of the Effects of Curcumin on Fibroblast-Like Synoviocytes in Rheumatoid Arthritis	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; CELLS; INHIBITION; DISEASES; LONGA	Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease characterized by synovial inflammation and joint disability. Curcumin is known to be effective in ameliorating joint inflammation in RA. To obtain new insights into the effect of curcumin on primary fibroblast-like synoviocytes (FLS, N = 3), which are key effector cells in RA, we employed gas chromatography/time-of-flight mass spectrometry (GC/TOF-MS)-based metabolomics. Metabolomic profiling of tumor necrosis factor (TNF)-alpha-stimulated and curcumin-treated FLS was performed using GC/TOF-MS in conjunction with univariate and multivariate statistical analyses. A total of 119 metabolites were identified. Metabolomic analysis revealed that metabolite profiles were clearly distinct between TNF-alpha-stimulated vs. the control group (not stimulated by TNF-alpha or curcumin). Treatment of FLS with curcumin showed that the metabolic perturbation by TNF-alpha could be reversed to that of the control group to a considerable extent. Curcumin-treated FLS had higher restoration of amino acid and fatty acid metabolism, as indicated by the prominent metabolic restoration of intermediates of amino acid and fatty acid metabolism, compared with that observed in TNF-alpha-stimulated FLS. In particular, the abundance of glycine, citrulline, arachidonic acid, and saturated fatty acids in TNF-alpha-stimulated FLS was restored to the control level after treatment with curcumin, suggesting that the effect of curcumin on preventing joint inflammation may be elucidated with the levels of these metabolites. Our results suggest that GC/TOF-MS-based metabolomic investigation using FLS has the potential for discovering the mechanism of action of curcumin and new targets for therapeutic drugs in RA.	[Ahn, Joong Kyong] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Internal Med,Div Rheumatol, Seoul, South Korea; [Kim, Sooah; Kim, Jungyeon; Kim, Kyoung Heon] Korea Univ, Grad Sch, Dept Biotechnol, Seoul, South Korea; [Hwang, Jiwon] Natl Police Hosp, Dept Internal Med, Seoul, South Korea; [Lee, You Sun] Sungkyunkwan Univ, Sch Med, Samsung Changwon Hosp, Dept Internal Med,Div Rheumatol, Chang Won, South Korea; [Koh, Eun-Mi; Cha, Hoon-Suk] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Rheumatol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Korea University; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, KH (corresponding author), Korea Univ, Grad Sch, Dept Biotechnol, Seoul, South Korea.	khekim@korea.ac.kr; hoonsuk.cha@samsung.com	Kim, Kyoung Heon/F-1059-2013	Kim, Kyoung Heon/0000-0003-4600-8668	Advanced Biomass R&D Center of Korea [2011-0031353]; National Research Foundation of Korea - Ministry of Education [NRF-2013R1A1A2059103]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute - Ministry of Health & Welfare - Korean Government [HI14C2285]	Advanced Biomass R&D Center of Korea; National Research Foundation of Korea - Ministry of Education; Korea Health Technology R&D Project through the Korea Health Industry Development Institute - Ministry of Health & Welfare - Korean Government	This work was supported by the Advanced Biomass R&D Center of Korea (http://www.biomass.re.kr/en, 2011-0031353) to KHK, the National Research Foundation of Korea funded by the Ministry of Education (http://www.nrf.re.kr/nrf_eng_cmsf/, NRF-2013R1A1A2059103) to HSC, and a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute, funded by the Ministry of Health & Welfare (http://www.khidi.or.kr/kps, HI14C2285) to HSC, which are funded by the Korean Government. Experiments were performed using facilities of the Institute of Biomedical Science and Food Safety at the Korea University Food Safety Hall.	AMMON HPT, 1991, PLANTA MED, V57, P1, DOI 10.1055/s-2006-960004; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bartok B, 2010, IMMUNOL REV, V233, P233, DOI 10.1111/j.0105-2896.2009.00859.x; Bayet-Robert M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057971; Bottini N, 2013, NAT REV RHEUMATOL, V9, P24, DOI 10.1038/nrrheum.2012.190; Bullinger Dino, 2007, BMC Biochemistry, V8, P25, DOI 10.1186/1471-2091-8-25; Cao H, 2014, PHYTOTHER RES; Chen XP, 2009, CELL BIOCHEM FUNCT, V27, P407, DOI 10.1002/cbf.1596; Cuperlovic-Culf M, 2010, DRUG DISCOV TODAY, V15, P610, DOI 10.1016/j.drudis.2010.06.012; D'Alessandro A, 2013, EXPERT REV PROTEOMIC, V10, P473, DOI 10.1586/14789450.2013.840440; Frommer KW, 2015, ANN RHEUM DIS, V74, P303, DOI 10.1136/annrheumdis-2013-203755; Funk JL, 2006, J NAT PROD, V69, P351, DOI 10.1021/np050327j; Gallois C, 1998, J BIOL CHEM, V273, P23183, DOI 10.1074/jbc.273.36.23183; Griffin JL, 2004, NAT REV CANCER, V4, P551, DOI 10.1038/nrc1390; Gupta SC, 2014, ARCH BIOCHEM BIOPHYS, V559, P91, DOI 10.1016/j.abb.2014.06.006; Iqbal M, 2009, MOL CELL BIOCHEM, V324, P157, DOI 10.1007/s11010-008-9994-z; Jurenka JS, 2009, ALTERN MED REV, V14, P141; Kim HY, 2003, J IMMUNOL, V171, P6072, DOI 10.4049/jimmunol.171.11.6072; Kim S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097501; Kim S, 2013, ANAL CHEM, V85, P2169, DOI 10.1021/ac302881e; Kloesch B, 2013, INT IMMUNOPHARMACOL, V15, P400, DOI 10.1016/j.intimp.2013.01.003; Lee DY, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-7; Ling S, 2013, ARTHRITIS RHEUM-US, V65, P618, DOI 10.1002/art.37814; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Moon DO, 2010, INT IMMUNOPHARMACOL, V10, P605, DOI 10.1016/j.intimp.2010.02.011; Mun SH, 2009, J PHARMACOL SCI, V111, P13, DOI 10.1254/jphs.09134FP; Noguchi Y, 2011, MOL BIOSYST, V7, P1409, DOI 10.1039/c0mb00309c; Punithavathi D, 2000, BRIT J PHARMACOL, V131, P169, DOI 10.1038/sj.bjp.0703578; Rausch-Fan XH, 2005, J PERIODONTOL, V76, P1182, DOI 10.1902/jop.2005.76.7.1182; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sandur SK, 2007, FREE RADICAL BIO MED, V43, P568, DOI 10.1016/j.freeradbiomed.2007.05.009; Shehzad A, 2013, BIOFACTORS, V39, P69, DOI 10.1002/biof.1066; Surh YJ, 2007, ADV EXP MED BIOL, V595, P149; Visioli F, 2011, CRIT REV FOOD SCI, V51, P524, DOI 10.1080/10408391003698677; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Zhou HY, 2011, CURR DRUG TARGETS, V12, P332, DOI 10.2174/138945011794815356	36	23	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145539	10.1371/journal.pone.0145539	http://dx.doi.org/10.1371/journal.pone.0145539			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716989	Green Published, Green Submitted, gold			2022-12-26	WOS:000367510500042
J	Gerage, AM; Benedetti, TRB; Farah, BQ; Santana, FD; Ohara, D; Andersen, LB; Ritti-Dias, RM				Gerage, Aline M.; Benedetti, Tania R. B.; Farah, Breno Q.; Santana, Fabio da S.; Ohara, David; Andersen, Lars B.; Ritti-Dias, Raphael M.			Sedentary Behavior and Light Physical Activity Are Associated with Brachial and Central Blood Pressure in Hypertensive Patients	PLOS ONE			English	Article							ARTERIAL STIFFNESS; METABOLIC SYNDROME; LIFE-STYLE; EXERCISE; TIME; OBESITY; ADULTS; RISK; METAANALYSIS; MORTALITY	Background Physical activity is recommended as a part of a comprehensive lifestyle approach in the treatment of hypertension, but there is a lack of data about the relationship between different intensities of physical activity and cardiovascular parameters in hypertensive patients. The purpose of this study was to investigate the association between the time spent in physical activities of different intensities and blood pressure levels, arterial stiffness and autonomic modulation in hypertensive patients. Methods In this cross-sectional study, 87 hypertensive patients (57.5 +/- 9.9 years of age) had their physical activity assessed over a 7 day period using an accelerometer and the time spent in sedentary activities, light physical activities, moderate physical activities and moderate-to-vigorous physical activities was obtained. The primary outcomes were brachial and central blood pressure. Arterial stiffness parameters (augmentation index and pulse wave velocity) and cardiac autonomic modulation (sympathetic and parasympathetic modulation in the heart) were also obtained as secondary outcomes. Results Sedentary activities and light physical activities were positively and inversely associated, respectively, with brachial systolic (r = 0.56; P < 0.01), central systolic (r = 0.51; P < 0.05), brachial diastolic (r = 0.45; P < 0.01) and central diastolic (r = 0.42; P < 0.05) blood pressures, after adjustment for sex, age, trunk fat, number of antihypertensive drugs, accelerometer wear time and moderate-to-vigorous physical activities. Arterial stiffness parameters and cardiac autonomic modulation were not associated with the time spent in sedentary activities and in light physical activities (P > 0.05). Conclusion Lower time spent in sedentary activities and higher time spent in light physical activities are associated with lower blood pressure, without affecting arterial stiffness and cardiac autonomic modulation in hypertensive patients.	[Gerage, Aline M.; Benedetti, Tania R. B.] Univ Fed Santa Catarina, Dept Phys Educ, Florianopolis, SC, Brazil; [Farah, Breno Q.; Santana, Fabio da S.] Univ Fed Pernambuco, Super Sch Phys Educ, Recife, PE, Brazil; [Ohara, David] Univ Estadual Londrina, Metab Nutr & Exercise Res Grp, Londrina, Parana, Brazil; [Andersen, Lars B.] Univ Southern Denmark, Dept Exercise Sci & Clin Biomech, Odense, Denmark; [Andersen, Lars B.] Sogn & Fjordane Univ Coll, Sogndal, Norway; [Ritti-Dias, Raphael M.] Hosp Israelita Albert Einstein, Sao Paulo, Brazil	Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Pernambuco; Universidade Estadual de Londrina; University of Southern Denmark; Western Norway University of Applied Sciences; Hospital Israelita Albert Einstein	Gerage, AM (corresponding author), Univ Fed Santa Catarina, Dept Phys Educ, Florianopolis, SC, Brazil.	alinegerage@yahoo.com.br	Farah, Breno Quintella/GSD-8036-2022; Farah, Breno Quintella/O-8933-2017; Gerage, Aline M/G-8545-2016; Ritti-Dias, Raphael/G-4200-2013; Gerage, Aline/GVU-1502-2022; Stefanadis, Christodoulos/ABH-2232-2020; Ohara, David/R-8296-2017; Ohara, David/GQY-8039-2022	Farah, Breno Quintella/0000-0003-2286-5892; Farah, Breno Quintella/0000-0003-2286-5892; Gerage, Aline M/0000-0002-0555-5422; Ritti-Dias, Raphael/0000-0001-7883-6746; Stefanadis, Christodoulos/0000-0001-5974-6454; Ohara, David/0000-0003-0477-8234; 	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	AMG was supported by a grant (PhD scholarship) from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and RMRD from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (grant productivity).	Andersson C, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001528; Ashor AW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110034; Camm AJ, 1996, CIRCULATION, V93, P1043; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Choi L, 2011, MED SCI SPORT EXER, V43, P357, DOI 10.1249/MSS.0b013e3181ed61a3; Ciolac EG, 2010, HYPERTENS RES, V33, P836, DOI 10.1038/hr.2010.72; Cornelissen VA, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.004473; Eckel R. H., 2014, Journal of the American College of Cardiology, V63, P2960, DOI [10.1161/01.cir.0000437740.48606.d1, 10.1016/j.jacc.2013.11.003]; Ellis KJ, 2000, PHYSIOL REV, V80, P649, DOI 10.1152/physrev.2000.80.2.649; Fitzgerald JD, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001288; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Gando Y, 2010, HYPERTENSION, V56, P540, DOI 10.1161/HYPERTENSIONAHA.110.156331; Gomez-Marcos MA, 2014, ATHEROSCLEROSIS, V234, P366, DOI 10.1016/j.atherosclerosis.2014.02.028; Green AN, 2014, EUR J APPL PHYSIOL, V114, P907, DOI 10.1007/s00421-014-2822-0; Hall ME, 2014, INT J NEPHROL RENOV, V7, P75, DOI 10.2147/IJNRD.S39739; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Healy GN, 2008, DIABETES CARE, V31, P369, DOI 10.2337/dc07-1795; Heffernan KS, 2013, HYPERTENS RES, V36, P422, DOI 10.1038/hr.2012.198; Horta BL, 2015, ATHEROSCLEROSIS, V243, P148, DOI 10.1016/j.atherosclerosis.2015.09.005; Joyner MJ, 2014, EUR J APPL PHYSIOL, V114, P445, DOI 10.1007/s00421-013-2636-5; Kawamoto R, 2014, HYPERTENS RES, V37, P933, DOI 10.1038/hr.2014.108; Kim J, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-30; Koster A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037696; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Luke A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-387; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; Manisty CH, 2013, BRIT J CLIN PHARMACO, V75, P79, DOI 10.1111/j.1365-2125.2012.04342.x; Munk PS, 2010, INT J CARDIOL, V145, P312, DOI 10.1016/j.ijcard.2009.11.015; O'Donovan C, 2014, J PHYS ACT HEALTH, V11, P272, DOI 10.1123/jpah.2012-0075; Pescatello LS, 2004, MED SCI SPORT EXER, V36, P533, DOI 10.1249/01.MSS.0000115224.88514.3A; Roman MJ, 2007, HYPERTENSION, V50, P197, DOI 10.1161/HYPERTENSIONAHA.107.089078; Trudeau L, 2014, CAN J CARDIOL, V30, pS23, DOI 10.1016/j.cjca.2014.03.010; Van Bortel LM, 2002, AM J HYPERTENS, V15, P445, DOI 10.1016/S0895-7061(01)02326-3; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Williams B, 2006, CIRCULATION, V113, P1213, DOI 10.1161/CIRCULATIONAHA.105.595496	36	32	34	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0146078	10.1371/journal.pone.0146078	http://dx.doi.org/10.1371/journal.pone.0146078			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717310	Green Published, Green Submitted, gold			2022-12-26	WOS:000367510500132
J	Grealy, R; Herruer, J; Smith, CLE; Hiller, D; Haseler, LJ; Griffiths, LR				Grealy, Rebecca; Herruer, Jasper; Smith, Carl L. E.; Hiller, Doug; Haseler, Luke J.; Griffiths, Lyn R.			Evaluation of a 7-Gene Genetic Profile for Athletic Endurance Phenotype in Ironman Championship Triathletes	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING-ENZYME; CREATINE-KINASE; WORLD-CLASS; HEREDITARY HEMOCHROMATOSIS; MITOCHONDRIAL BIOGENESIS; SPORTS PERFORMANCE; ACTN3 R577X; GENOTYPE; MUTATION; POLYMORPHISM	Polygenic profiling has been proposed for elite endurance performance, using an additive model determining the proportion of optimal alleles in endurance athletes. To investigate this model's utility for elite triathletes, we genotyped seven polymorphisms previously associated with an endurance polygenic profile (ACE Ins/Del, ACTN3 Arg577Ter, AMPD1 Gln12Ter, CKMM 1170bp/985+185bp, HFE His63Asp, GDF8 Lys153Arg and PPARGC1A Gly482Ser) in a cohort of 196 elite athletes who participated in the 2008 Kona Ironman championship triathlon. Mean performance time (PT) was not significantly different in individual marker analysis. Age, sex, and continent of origin had a significant influence on PT and were adjusted for. Only the AMPD1 endurance-optimal Gln allele was found to be significantly associated with an improvement in PT (model p = 5.79 x 10(-17), AMPD1 genotype p = 0.01). Individual genotypes were combined into a total genotype score (TGS); TGS distribution ranged from 28.6 to 92.9, concordant with prior studies in endurance athletes (mean +/- SD: 60.75 +/- 12.95). TGS distribution was shifted toward higher TGS in the top 10% of athletes, though the mean TGS was not significantly different (p = 0.164) and not significantly associated with PT even when adjusted for age, sex, and origin. Receiver operating characteristic curve analysis determined that TGS alone could not significantly predict athlete finishing time with discriminating sensitivity and specificity for three outcomes (less than median PT, less than mean PT, or in the top 10%), though models with the age, sex, continent of origin, and either TGS or AMPD1 genotype could. These results suggest three things: that more sophisticated genetic models may be necessary to accurately predict athlete finishing time in endurance events; that non-genetic factors such as training are hugely influential and should be included in genetic analyses to prevent confounding; and that large collaborations may be necessary to obtain sufficient sample sizes for powerful and complex analyses of endurance performance.	[Grealy, Rebecca; Herruer, Jasper; Smith, Carl L. E.] Griffith Univ, Sch Med Sci, Gold Coast, Australia; [Hiller, Doug] Univ Hawaii, John A Burns Sch Med, North Hawaii Community Hosp, Honolulu, HI 96822 USA; [Haseler, Luke J.] Griffith Univ, Sch Physiotherapy & Exercise Sci, Heart Fdn Res Ctr, Gold Coast, Australia; [Grealy, Rebecca; Herruer, Jasper; Smith, Carl L. E.; Griffiths, Lyn R.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Genom Res Ctr, Kelvin Grove, Australia	Griffith University; University of Hawaii System; Griffith University; Queensland University of Technology (QUT)	Griffiths, LR (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Genom Res Ctr, Kelvin Grove, Australia.	lyn.griffiths@qut.edu.au		Haseler, Luke/0000-0003-1607-4402	Australian International Science Linkages grant; Australian Government EIF Super Science Funds as part of the Therapeutic Innovation Australia - Queensland Node project	Australian International Science Linkages grant(Australian GovernmentDepartment of Industry, Innovation and Science); Australian Government EIF Super Science Funds as part of the Therapeutic Innovation Australia - Queensland Node project(Australian GovernmentDepartment of Industry, Innovation and Science)	This work was supported by an Australian International Science Linkages grant and by infrastructure purchased with Australian Government EIF Super Science Funds as part of the Therapeutic Innovation Australia - Queensland Node project with equipment and technical support staff from the National Collaborative Research Infrastructure Strategy (NCRIS) government funding.	Ahmetov II, 2009, HUM GENET, V126, P751, DOI 10.1007/s00439-009-0728-4; Arnold J, 2008, MED HYPOTHESES, V70, P1197, DOI 10.1016/j.mehy.2007.10.007; Bray MS, 2009, MED SCI SPORT EXER, V41, P34, DOI 10.1249/MSS.0b013e3181844179; Burden RJ, 2015, BRIT J SPORT MED, V49, P1389, DOI 10.1136/bjsports-2014-093624; Buxens A, 2011, SCAND J MED SCI SPOR, V21, P570, DOI 10.1111/j.1600-0838.2009.01079.x; Chicharro JL, 2004, BRIT J SPORT MED, V38, P418, DOI 10.1136/bjsm.2002.003921; Chiu LL, 2012, J PHYSIOL SCI, V62, P115, DOI 10.1007/s12576-011-0189-0; de Diego C, 2007, EUR J HAEMATOL, V78, P66, DOI 10.1111/j.1600-0609.2006.00775.x; Eynon N, 2010, SCAND J MED SCI SPOR, V20, pE145, DOI 10.1111/j.1600-0838.2009.00930.x; Eynon N, 2011, J PHYSIOL-LONDON, V589, P3063, DOI 10.1113/jphysiol.2011.207035; Eynon N, 2011, MITOCHONDRION, V11, P64, DOI 10.1016/j.mito.2010.07.004; Feder JN, 1998, P NATL ACAD SCI USA, V95, P1472, DOI 10.1073/pnas.95.4.1472; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gomez-Gallego F, 2009, INT J SPORTS MED, V30, P66, DOI 10.1055/s-2008-1038677; Gomez-Gallego F, 2010, PHYSIOL GENOMICS, V41, P82, DOI 10.1152/physiolgenomics.00183.2009; Gonzalez-Freire M, 2009, BRIT J SPORT MED, V43, P307, DOI 10.1136/bjsm.2008.049809; Grealy R, 2013, J SCI MED SPORT, V16, P365, DOI 10.1016/j.jsams.2012.08.013; Heled Y, 2007, J APPL PHYSIOL, V103, P504, DOI 10.1152/japplphysiol.00081.2007; Hood MS, 2011, MED SCI SPORT EXER, V43, P1849, DOI 10.1249/MSS.0b013e3182199834; Huygens W, 2004, PHYSIOL GENOMICS, V17, P264, DOI 10.1152/physiolgenomics.00224.2003; Jones A, 2002, EXERC SPORT SCI REV, V30, P184, DOI 10.1097/00003677-200210000-00008; Keavney B, 2000, LANCET, V355, P434; Kostek M, 2011, AM J LIFESTYLE MED, V5, P156, DOI 10.1177/1559827610387251; Lea RA, 2005, MOL BRAIN RES, V136, P112, DOI 10.1016/j.molbrainres.2005.01.006; Little JP, 2010, J PHYSIOL-LONDON, V588, P1011, DOI 10.1113/jphysiol.2009.181743; Lucia A, 2005, J APPL PHYSIOL, V99, P344, DOI 10.1152/japplphysiol.00037.2005; McLaren CE, 2006, TRANSL RES, V148, P196, DOI 10.1016/j.trsl.2006.05.006; Myburgh KH, 2003, COMP BIOCHEM PHYS A, V136, P171, DOI 10.1016/S1095-6433(03)00220-4; De Matos LDNJ, 2013, INT J CARDIOL, V167, P2341, DOI 10.1016/j.ijcard.2012.11.041; Park SH, 2004, KOREAN J RADIOL, V5, P11, DOI 10.3348/kjr.2004.5.1.11; Partridge S, 2008, FORD IRONMAN WORLD C; Rankinen T, 2006, MED SCI SPORT EXER, V38, P1863, DOI 10.1249/01.mss.0000233789.01164.4f; Rivera MA, 1997, MED SCI SPORT EXER, V29, P1311, DOI 10.1097/00005768-199710000-00006; Rubio JC, 2005, J APPL PHYSIOL, V98, P2108, DOI 10.1152/japplphysiol.01371.2004; Ruiz JR, 2010, J APPL PHYSIOL, V108, P561, DOI 10.1152/japplphysiol.01242.2009; Ruiz JR, 2009, J PHYSIOL-LONDON, V587, P1527, DOI 10.1113/jphysiol.2008.166645; Samarasena J, 2006, DIGEST DIS SCI, V51, P803, DOI 10.1007/s10620-006-3210-3; Santiago C, 2010, SCAND J MED SCI SPOR, V20, pE188, DOI 10.1111/j.1600-0838.2009.00943.x; Saunders CJ, 2006, HUM MOL GENET, V15, P979, DOI 10.1093/hmg/ddl014; Sayed-Tabatabaei FA, 2006, CIRC RES, V98, P1123, DOI 10.1161/01.RES.0000223145.74217.e7; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Shizukuda Y, 2012, AM J PHYS MED REHAB, V91, P418, DOI 10.1097/PHM.0b013e3182465f5f; Steinbacher P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123881; TSUJINO S, 1995, NEUROMUSCULAR DISORD, V5, P263, DOI 10.1016/0960-8966(94)00062-E; Williams AG, 2008, J PHYSIOL-LONDON, V586, P113, DOI 10.1113/jphysiol.2007.141887; WILSON IA, 1995, BIOCHEM J, V308, P599, DOI 10.1042/bj3080599; World Triathlon Corporation, 2010, FORD IR WORLD CHAMP; ZWEIG MH, 1993, CLIN CHEM, V39, P561	48	34	35	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145171	10.1371/journal.pone.0145171	http://dx.doi.org/10.1371/journal.pone.0145171			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716680	Green Submitted, Green Published, gold			2022-12-26	WOS:000367510500024
J	Mustafa, DAM; Sieuwerts, AM; Smid, M; de Weerd, V; van der Weiden, M; Meijer-van Gelder, ME; Martens, JWM; Foekens, JA; Kros, JM				Mustafa, Dana A. M.; Sieuwerts, Anieta M.; Smid, Marcel; de Weerd, Vania; van der Weiden, Marcel; Meijer-van Gelder, Marion E.; Martens, John W. M.; Foekens, John A.; Kros, Johan M.			A Method to Correlate mRNA Expression Datasets Obtained from Fresh Frozen and Formalin-Fixed, Paraffin-Embedded Tissue Samples: A Matter of Thresholds	PLOS ONE			English	Article							GENOME-DASL ASSAY; GENE-EXPRESSION; BREAST-CANCER; LIVER-TISSUE; TUMORS; PCR; MICROARRAY; SIGNATURES	Background Gene expression profiling of tumors is a successful tool for the discovery of new cancer bio-markers and potential targets for the development of new therapeutic strategies. Reliable profiling is preferably performed on fresh frozen (FF) tissues in which the quality of nucleic acids is better preserved than in formalin-fixed paraffin-embedded (FFPE) material. However, since snap-freezing of biopsy materials is often not part of daily routine in pathology laboratories, one may have to rely on archival FFPE material. Procedures to retrieve the RNAs from FFPE materials have been developed and therefore, datasets obtained from FFPE and FF materials need to be made compatible to ensure reliable comparisons are possible. Aim To develop an efficient method to compare gene expression profiles obtained from FFPE and FF samples using the same platform. Methods Twenty-six FFPE-FF sample pairs of the same tumors representing various cancer types, and two FFPE-FF sample pairs of breast cancer cell lines, were included. Total RNA was extracted and gene expression profiling was carried out using Illumina's Whole-Genome cDNA-mediated Annealing, Selection, extension and Ligation (WG-DASL) V3 arrays, enabling the simultaneous detection of 24,526 mRNA transcripts. A sample exclusion criterion was created based on the expression of 11 stably expressed reference genes. Pearson correlation at the probe level was calculated for paired FFPE-FF, and three cut-off values were chosen. Spearman correlation coefficients between the matched FFPE and FF samples were calculated for three probe lists with varying levels of significance and compared to the correlation based on all measured probes. Unsupervised hierarchical cluster analysis was performed to verify performance of the included probe lists to compare matched FPPE-FF samples. Results Twenty-seven FFPE-FF pairs passed the sample exclusion criterion. From the profiles of 27 FFPE and FF matched samples, the best correlating probes were identified for various levels of significance (Pearson P<0.01, n = 1,432; P<0.05, n = 2,530; and P<0.10, n = 3,351 probes). Unsupervised hierarchical clustering of the 27 pairs using the resulting probes yielded 25, 21, and 19 correctly clustered pairs, respectively, compared to 1 pair when all probes were used. Conclusion The proposed method enables comparison of gene expression profiles of FFPE and/or FF origin measured on the same platform.	[Mustafa, Dana A. M.; van der Weiden, Marcel; Kros, Johan M.] Erasmus Univ, Dept Pathol, Med Ctr, NL-3000 DR Rotterdam, Netherlands; [Sieuwerts, Anieta M.; Smid, Marcel; de Weerd, Vania; Meijer-van Gelder, Marion E.; Martens, John W. M.; Foekens, John A.] Erasmus Univ, Med Ctr, Dept Med Oncol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Mustafa, DAM (corresponding author), Erasmus Univ, Dept Pathol, Med Ctr, POB 1738, NL-3000 DR Rotterdam, Netherlands.	d.mustafa@erasmusmc.nl	Mustafa, Dana/AAQ-6530-2021	Mustafa, Dana/0000-0003-0644-078X; Smid, Marcel/0000-0003-0605-1901	Dutch Cancer Society (KWF) [EMCR 2009-4553]	Dutch Cancer Society (KWF)(KWF Kankerbestrijding)	The study was supported by the Dutch Cancer Society (KWF Grant EMCR 2009-4553).	Abdueva D, 2010, J MOL DIAGN, V12, P409, DOI 10.2353/jmoldx.2010.090155; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; April C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008162; April CS, 2011, METHODS MOL BIOL, V784, P77, DOI 10.1007/978-1-61779-289-2_6; Berg AO, 2009, GENET MED, V11, P66, DOI 10.1097/GIM.0b013e3181928f56; BRESTERS D, 1994, J VIROL METHODS, V48, P267, DOI 10.1016/0166-0934(94)90125-2; Cotoi CG, 2012, ROM J MORPHOL EMBRYO, V53, P893; De Weerd V S A, 2010, CANC GENERICS CYTOGE; Dominguez-Valentin M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071755; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Erdem-Eraslan L, 2013, J CLIN ONCOL, V31, P328, DOI 10.1200/JCO.2012.44.1444; Fan JB, 2004, GENOME RES, V14, P878, DOI 10.1101/gr.2167504; Farragher SM, 2008, HISTOCHEM CELL BIOL, V130, P435, DOI 10.1007/s00418-008-0479-7; FINKE J, 1993, BIOTECHNIQUES, V14, P448; Freedman JA, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-58; Hall JS, 2012, BRIT J CANCER, V107, P684, DOI 10.1038/bjc.2012.294; Kelly AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025357; Kissel HD, 2013, OBSTET GYNECOL INT, V2013, DOI 10.1155/2013/576842; Kojima K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086961; Kumar R, 2012, J PHARM BIOALLIED SC, V4, P21, DOI 10.4103/0975-7406.92726; Lebbe C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029143; Linton KM, 2008, BRIT J CANCER, V98, P1403, DOI 10.1038/sj.bjc.6604316; Mittempergher L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017163; Oberli A, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-9; Rodriguez-Gonzalez FG, 2013, METHODS, V59, P47, DOI 10.1016/j.ymeth.2012.05.005; Sfakianos GP, 2013, GYNECOL ONCOL, V129, P159, DOI 10.1016/j.ygyno.2012.12.030; Srinivasan M, 2002, AM J PATHOL, V161, P1961, DOI 10.1016/S0002-9440(10)64472-0; Thomas Marlene, 2013, J Clin Bioinforma, V3, P10, DOI 10.1186/2043-9113-3-10; Ton CC, 2011, BREAST CANCER RES TR, V125, P879, DOI 10.1007/s10549-010-1159-6; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vargas AC, 2012, BREAST CANCER RES TR, V135, P153, DOI 10.1007/s10549-012-2123-4; Waddell N, 2010, J PATHOL, V221, P452, DOI 10.1002/path.2728; Winn ME, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-412	34	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0144097	10.1371/journal.pone.0144097	http://dx.doi.org/10.1371/journal.pone.0144097			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716838	Green Submitted, Green Published, gold			2022-12-26	WOS:000367510500009
J	Santoro, ML; do Carmo, T; Cunha, BHL; Alves, AF; Zelanis, A; Serrano, SMD; Grego, KF; Sant'Anna, SS; Barbaro, KC; Fernandes, W				Santoro, Marcelo Larami; do Carmo, Thais; Lopes Cunha, Bruna Heloisa; Alves, Andre Fonseca; Zelanis, Andre; de Toledo Serrano, Solange Maria; Grego, Kathleen Fernandes; Sant'Anna, Savio Stefanini; Barbaro, Katia Cristina; Fernandes, Wilson			Ontogenetic Variation in Biological Activities of Venoms from Hybrids between Bothrops erythromelas and Bothrops neuwiedi Snakes	PLOS ONE			English	Article							SOUTH-AMERICAN PITVIPERS; THROMBIN-LIKE ENZYME; CONTACT ZONE; VIPERA-BERUS; HYBRIDIZATION; VARIABILITY; ATROX; SERPENTES; PHYLOGENY; SPECIMENS	Lance-headed snakes are found in Central and South America, and they account for most snakebites in Brazil. The phylogeny of South American pitvipers has been reviewed, and the presence of natural and non-natural hybrids between different species of Bothrops snakes demonstrates that reproductive isolation of several species is still incomplete. The present study aimed to analyze the biological features, particularly the thrombin-like activity, of venoms from hybrids born in captivity, from the mating of a female Bothrops erythromelas and a male Bothrops neuwiedi, two species whose venoms are known to display ontogenetic variation. Proteolytic activity on azocoll and amidolytic activity on N-benzoyl-DL-arginine-p-nitroanilide hydrochloride (BAPNA) were lowest when hybrids were 3 months old, and increased over body growth, reaching values similar to those of the father when hybrids were 12 months old. The clotting activity on plasma diminished as hybrids grew; venoms from 3- and 6-months old hybrids showed low clotting activity on fibrinogen (i.e., thrombinlike activity), like the mother venom, and such activity was detected only when hybrids were older than 1 year of age. Altogether, these results point out that venom features in hybrid snakes are genetically controlled during the ontogenetic development. Despite the presence of the thrombin-like enzyme gene(s) in hybrid snakes, they are silenced during the first six months of life.	[Santoro, Marcelo Larami; do Carmo, Thais; Lopes Cunha, Bruna Heloisa; Alves, Andre Fonseca] Inst Butantan, Lab Fisiopatol, Sao Paulo, SP, Brazil; [Zelanis, Andre; de Toledo Serrano, Solange Maria] Inst Butantan, Lab Especial Toxinol Aplicada, Sao Paulo, SP, Brazil; [Zelanis, Andre; de Toledo Serrano, Solange Maria] Inst Butantan, Ctr Toxins Immune Response & Cell Signaling, Sao Paulo, SP, Brazil; [Grego, Kathleen Fernandes; Sant'Anna, Savio Stefanini; Fernandes, Wilson] Inst Butantan, Lab Herpetol, Sao Paulo, SP, Brazil; [Barbaro, Katia Cristina] Inst Butantan, Lab Imunopatol, Sao Paulo, SP, Brazil	Instituto Butantan; Instituto Butantan; Instituto Butantan; Instituto Butantan; Instituto Butantan	Santoro, ML (corresponding author), Inst Butantan, Lab Fisiopatol, Sao Paulo, SP, Brazil.	marcelo.santoro@butantan.gov.br	Zelanis, André/AAD-4618-2019; Serrano, Solange/ABB-7569-2021; Santoro, Marcelo L./K-7064-2019; Sant'Anna, Sávio S/I-5217-2016; Barbaro, Katia/M-2664-2013; Grego, Kathleen/GOV-3529-2022; Instituto Butantan, Center of Toxins Immune Response and Cell Signaling CeTICS/J-5731-2015; Grego, Kathleen F/A-6394-2014; Santoro, Marcelo/H-3892-2012; Serrano, Solange M. T./A-7132-2008	Zelanis, André/0000-0003-3066-6527; Serrano, Solange/0000-0001-8994-1904; Santoro, Marcelo L./0000-0001-6364-3757; Sant'Anna, Sávio S/0000-0003-2224-0913; Grego, Kathleen/0000-0003-4769-5818; Grego, Kathleen F/0000-0003-4769-5818; Serrano, Solange M. T./0000-0001-8994-1904	Sao Paulo Research Foundation (FAPESP) [2008/02996-8, 2010/08162-1, 2013/25177-0, 2013/07467-1, 2013/13548-4, 2009/15413-3]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [475924/2010-0]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Sao Paulo Research Foundation (FAPESP, grants # 2008/02996-8, 2010/08162-1, 2013/25177-0, 2013/07467-1, 2013/13548-4, 2009/15413-3), URL: www.fapesp.br; and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, grant # 475924/2010-0), URL: www.cnpq.br.	AIRD SD, 1989, J HERPETOL, V23, P131, DOI 10.2307/1564018; Aird SD, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1832-6; Alape-Giron A, 2008, J PROTEOME RES, V7, P3556, DOI 10.1021/pr800332p; Antunes TC, 2010, TOXICON, V56, P1443, DOI 10.1016/j.toxicon.2010.08.011; Balestrin Rafael Lucchesi, 2002, Iheringia, Sér. Zool., V92, P85, DOI 10.1590/S0073-47212002000100007; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; BULLINI L, 1994, TRENDS ECOL EVOL, V9, P422, DOI 10.1016/0169-5347(94)90124-4; Butantan-British IBothrops/I Systematics Project, 2002, P111; Calvete JJ, 2011, J PROTEOMICS, V74, P510, DOI 10.1016/j.jprot.2011.01.003; Campbell J. A., 2004, VENOMOUS REPTILES W; Carlsson M, 2004, MOL ECOL, V13, P3147, DOI 10.1111/j.1365-294X.2004.02315.x; Carrasco PA, 2012, ZOOL SCR, V41, P109, DOI 10.1111/j.1463-6409.2011.00511.x; Castoe TA, 2006, MOL PHYLOGENET EVOL, V39, P91, DOI 10.1016/j.ympev.2005.12.014; CHIPPAUX JP, 1982, TOXICON, V20, P521, DOI 10.1016/0041-0101(82)90019-8; CHIPPAUX JP, 1991, TOXICON, V29, P1279, DOI 10.1016/0041-0101(91)90116-9; CONANT ROGER, 1963, AMER MUS NOVITATES, V2122, P1; Cook S. F. Jr., 1955, P139; Dias GS, 2013, J PROTEOME RES, V12, P4585, DOI 10.1021/pr4007393; Dirksen Lutz, 1998, Zoologische Abhandlungen (Dresden), V50, P45; Dowling TE, 1997, ANNU REV ECOL SYST, V28, P593, DOI 10.1146/annurev.ecolsys.28.1.593; Durban J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-234; Fenker J, 2014, DIVERS DISTRIB, V20, P1108, DOI 10.1111/ddi.12217; Fenwick AM, 2009, ZOOL J LINN SOC-LOND, V156, P617, DOI 10.1111/j.1096-3642.2008.00495.x; Franca F.O.S., 2009, ANIMAIS PE ONHENTOS, P81; FURTADO FD, 1991, TOXICON, V29, P219, DOI 10.1016/0041-0101(91)90106-2; Gao JF, 2011, TOXICON, V57, P970, DOI 10.1016/j.toxicon.2011.03.019; Gibbs HL, 2006, MOL ECOL, V15, P3755, DOI 10.1111/j.1365-294X.2006.03056.x; GLENN JL, 1990, TOXICON, V28, P857, DOI 10.1016/S0041-0101(09)80008-1; Grazziotin F, 2005, BRAZ ARCH BIOL TECHN, V48, P359, DOI 10.1590/S1516-89132005000300005; Guercio RAP, 2006, PROTEOME SCI, V4, DOI 10.1186/1477-5956-4-11; GUTIERREZ JM, 1980, REV BIOL TROP, V28, P341; Hanna SL, 2000, MICROBIOL-UK, V146, P2495, DOI 10.1099/00221287-146-10-2495; Hey J, 2003, TRENDS ECOL EVOL, V18, P597, DOI 10.1016/j.tree.2003.08.014; HOLLEMAN WH, 1976, J BIOL CHEM, V251, P1663; Holliday TW, 2003, CURR ANTHROPOL, V44, P653, DOI 10.1086/377663; ITOH N, 1987, J BIOL CHEM, V262, P3132; Jorge RJB, 2015, J PROTEOMICS, V114, P93, DOI 10.1016/j.jprot.2014.11.011; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAWSON R, 1991, ALLOZYME VARIATION S, P638; Lopez-Lozano JL, 2002, TOXICON, V40, P997, DOI 10.1016/S0041-0101(02)00096-X; Machado T, 2014, MOL PHYLOGENET EVOL, V71, P1, DOI 10.1016/j.ympev.2013.10.003; Markland FS, 1998, TOXICON, V36, P1749, DOI 10.1016/S0041-0101(98)00126-3; Martinez-Freiria F, 2008, DIVERS DISTRIB, V14, P452, DOI 10.1111/j.1472-4642.2007.00446.x; Martins Marcio, 2002, P307; MARUYAMA M, 1992, ANN TROP MED PARASIT, V86, P549, DOI 10.1080/00034983.1992.11812706; Mayr E, 1996, PHILOS SCI, V63, P262, DOI 10.1086/289912; Mebert K, 2008, MOL ECOL, V17, P1918, DOI 10.1111/j.1365-294X.2008.03725.x; NAHAS L, 1979, THROMB HAEMOSTASIS, V41, P314; Nunez V, 2009, J PROTEOMICS, V73, P57, DOI 10.1016/j.jprot.2009.07.013; Oliveira FN, 2010, REV SOC BRAS MED TRO, V43, P662, DOI 10.1590/S0037-86822010000600012; Pisciolaro AM, 2008, INTERSPECIFIC REPROD, P407; Prudente ALC, 1995, BIOCIENCIAS, V3, P231; Pukac LA, 1997, BIOTECHNIQUES, V23, P385, DOI 10.2144/97233bm08; Queiroz K, 2005, SYSTEMATICS ORIGIN S, P243; REDINBAUGH MG, 1986, ANAL BIOCHEM, V153, P267, DOI 10.1016/0003-2697(86)90091-6; Saint Girons H, 1990, B SOC HERP FR, V54, P62; Saldarriaga MM, 2003, TOXICON, V42, P405, DOI 10.1016/S0041-0101(03)00171-5; SANCHEZ EF, 1992, TOXICON, V30, P95, DOI 10.1016/0041-0101(92)90505-Y; Sazima Ivan, 1992, P199; Serrano SMT, 2005, TOXICON, V45, P1115, DOI 10.1016/j.toxicon.2005.02.020; Silva MMS, 2002, ESTUDO VARIABILIDADE; Stocker K., 1976, Methods Enzymol, V45, P214; Tarroso P, 2014, MOL ECOL, V23, P1108, DOI 10.1111/mec.12671; THEAKSTON RDG, 1983, B WORLD HEALTH ORGAN, V61, P949; Vasconcelos CML, 1996, ESTUDO PECONHA BOTHR, P110; Werman SD, 2002, BIOL VIPERS, P21; Yamashita KM, 2011, J THROMB HAEMOST, V9, P2057, DOI 10.1111/j.1538-7836.2011.04449.x; You WK, 2004, FEBS LETT, V571, P67, DOI 10.1016/j.febslet.2004.06.060; Zappellini A, 1991, ESTUDOS BIOQUIMICO F; Zelanis A, 2007, COMP BIOCHEM PHYS C, V145, P601, DOI 10.1016/j.cbpc.2007.02.009; Zelanis A, 2011, PROTEOMICS, V11, P4218, DOI 10.1002/pmic.201100287; Zelanis A, 2010, J PROTEOME RES, V9, P2278, DOI 10.1021/pr901027r; Zinenko O. I., 2003, Vestnik Zoologii, V37, P101; Zinenko Oleksander, 2004, Mertensiella, V15, P17; Zinenko O, 2010, AMPHIBIA-REPTILIA, V31, P51, DOI 10.1163/156853810790457885	75	15	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145516	10.1371/journal.pone.0145516	http://dx.doi.org/10.1371/journal.pone.0145516			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714190	Green Published, Green Submitted, gold			2022-12-26	WOS:000367481900050
J	Sorte, CJB; Bracken, MES				Sorte, Cascade J. B.; Bracken, Matthew E. S.			Warming and Elevated CO2 Interact to Drive Rapid Shifts in Marine Community Production	PLOS ONE			English	Article							OCEAN ACIDIFICATION; CLIMATE-CHANGE; TEMPERATURE; NITROGEN; RESPONSES; IMPACTS; PHOTOSYNTHESIS; FUTURE	Predicting the outcome of future climate change requires an understanding of how alterations in multiple environmental factors manifest in natural communities and affect ecosystem functioning. We conducted an in situ, fully factorial field manipulation of CO2 and temperature on a rocky shoreline in southeastern Alaska, USA. Warming strongly impacted functioning of tide pool systems within one month, with the rate of net community production (NCP) more than doubling in warmed pools under ambient CO2 levels relative to initial NCP values. However, in pools with added CO2, NCP was unaffected by warming. Productivity responses paralleled changes in the carbon-to-nitrogen ratio of a red alga, the most abundant primary producer species in the system, highlighting the direct link between physiology and ecosystem functioning. These observed changes in algal physiology and community productivity in response to our manipulations indicate the potential for natural systems to shift rapidly in response to changing climatic conditions and for multiple environmental factors to act antagonistically.	[Sorte, Cascade J. B.; Bracken, Matthew E. S.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA	University of California System; University of California Irvine	Sorte, CJB (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, 321 Steinhaus Hall, Irvine, CA 92697 USA.	csorte@uci.edu	Bracken, Matthew E.S./I-9359-2019	Bracken, Matthew E.S./0000-0002-0068-7485	National Science Foundation, Office of Polar Programs; NSF [PLR 1023704]	National Science Foundation, Office of Polar Programs(National Science Foundation (NSF)); NSF(National Science Foundation (NSF))	This work was supported by the National Science Foundation, Office of Polar Programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank L. Tang for capable and cheerful field assistance; G. Bernatchez for help with sample processing and data analyses; and family, friends, and members of the public who joined us in the field. We appreciate the Sitka Sound Science Center hosting us as part of the Scientist-in-Residency Fellowship Program (funded by NSF award PLR 1023704 to J. Straley) and the University of Alaska Southeast for providing office space. We thank the anonymous reviewers for helpful comments that improved the manuscript.	Alsterberg C, 2013, P NATL ACAD SCI USA, V110, P8603, DOI 10.1073/pnas.1303797110; Andria JR, 1999, EUR J PHYCOL, V34, P497, DOI 10.1017/S0967026299002334; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Bracken MES, 2015, OIKOS, V124, P113, DOI 10.1111/oik.01215; Bracken MES, 2013, ECOLOGY, V94, P1944, DOI 10.1890/12-2182.1; Bracken MES, 2004, J PHYCOL, V40, P1032, DOI 10.1111/j.1529-8817.2004.03106.x; Colvard NB, 2014, J EXP MAR BIOL ECOL, V458, P6, DOI 10.1016/j.jembe.2014.05.001; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; DAVISON IR, 1991, MAR BIOL, V110, P449, DOI 10.1007/BF01344363; DELIA CF, 1978, J PHYCOL, V14, P266, DOI 10.1111/j.1529-8817.1978.tb00297.x; Diaz-Pulido G, 2011, ECOL LETT, V14, P156, DOI 10.1111/j.1461-0248.2010.01565.x; DICKSON AG, 1993, DEEP-SEA RES PT I, V40, P107, DOI 10.1016/0967-0637(93)90055-8; Dieleman WIJ, 2012, GLOBAL CHANGE BIOL, V18, P2681, DOI 10.1111/j.1365-2486.2012.02745.x; Ferrari MCO, 2011, ECOL LETT, V14, P1143, DOI 10.1111/j.1461-0248.2011.01683.x; Gedan KB, 2009, ECOL LETT, V12, P842, DOI 10.1111/j.1461-0248.2009.01337.x; Gillis BC, 2014, THESIS; Hale R, 2011, OIKOS, V120, P661, DOI 10.1111/j.1600-0706.2010.19469.x; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; HERNANDEZ I, 1993, MAR ECOL PROG SER, V99, P301, DOI 10.3354/meps099301; IPCC, 2014, CLIM CHANG 2013 IMP; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; JOHNSTON AM, 1990, BRIT PHYCOL J, V25, P75, DOI 10.1080/00071619000650071; Kline DI, 2012, SCI REP-UK, V2, DOI 10.1038/srep00413; Kordas RL, 2011, J EXP MAR BIOL ECOL, V400, P218, DOI 10.1016/j.jembe.2011.02.029; Kroeker KJ, 2013, GLOBAL CHANGE BIOL, V19, P1884, DOI 10.1111/gcb.12179; Langley JA, 2010, NATURE, V466, P96, DOI 10.1038/nature09176; Noel LMLJ, 2010, ESTUAR COAST SHELF S, V88, P153, DOI 10.1016/j.ecss.2010.03.005; O'Connor MI, 2009, ECOLOGY, V90, P388, DOI 10.1890/08-0034.1; Olabarria C, 2013, OIKOS, V122, P1065, DOI 10.1111/j.1600-0706.2012.20825.x; Pedersen O., 2007, AQUAT GARD, V20, P24; Pfister CA, 2014, ENVIRON SCI TECHNOL, V48, P9982, DOI 10.1021/es501936p; Ruesink JL, 1998, J PHYCOL, V34, P29, DOI 10.1046/j.1529-8817.1998.340029.x; SHACHAK M, 1995, LINKING SPECIES & ECOSYSTEMS, P280; Smale DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016050; Smallegange RC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-292; Sorte CJB, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0572; Wernberg T, 2012, GLOBAL CHANGE BIOL, V18, P1491, DOI 10.1111/j.1365-2486.2012.02656.x	37	13	13	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145191	10.1371/journal.pone.0145191	http://dx.doi.org/10.1371/journal.pone.0145191			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714167	Green Published, gold			2022-12-26	WOS:000367481900034
J	Wu, GC; Tey, WG; Li, HW; Chang, CF				Wu, Guan-Chung; Tey, Wei-Guan; Li, Hau-Wen; Chang, Ching-Fong			Sexual Fate Reprogramming in the Steroid-Induced Bi-Directional Sex Change in the Protogynous Orange-Spotted Grouper, Epinephelus coioides	PLOS ONE			English	Article							PROTANDROUS BLACK PORGY; ACANTHOPAGRUS-SCHLEGELI BLEEKER; GONADOTROPIN-RELEASING-HORMONE; GERM-CELLS; TELEOST FISH; THALASSOMA-BIFASCIATUM; LUTEINIZING-HORMONE; HERMAPHRODITIC FISH; MOLECULAR-CLONING; BLUEHEAD WRASSE	Androgen administration has been widely used for masculinization in fish. The mechanism of the sex change in sexual fate regulation is not clear. Oral administration or pellet implantation was applied. We orally applied an aromatase inhibitor (AI, to decrease estrogen levels) and 17 alpha-methyltestosterone (MT, to increase androgen levels) to induce masculinization to clarify the mechanism of the sex change in the protogynous orange-spotted grouper. After 3 mo of AI/MT administration, male characteristics were observed in the female-to-male sex change fish. These male characteristics included increased plasma 11-ketotestosterone (11-KT), decreased estradiol (E2) levels, increased male-related gene (dmrt1, sox9, and cyp11b2) expression, and decreased female-related gene (figla, foxl2, and cyp19a1a) expression. However, the reduced male characteristics and male-to-female sex change occurred after AI/MT-termination in the AI- and MT-induced maleness. Furthermore, the MT-induced oocyte-depleted follicle cells (from MT-implantation) had increased proliferating activity, and the sexual fate in a portion of female gonadal soma cells was altered to male function during the female-to-male sex change. In contrast, the gonadal soma cells were not proliferative during the early process of the male-to-female sex change. Additionally, the male gonadal soma cells did not alter to female function during the male-to-female sex change in the AI/MT-terminated fish. After MT termination in the male-to-female sex-changed fish, the differentiated male germ cells showed increased proliferating activities together with dormancy and did not show characteristics of both sexes in the early germ cells. In conclusion, these findings indicate for the first time in a single species that the mechanism involved in the replacement of soma cells is different between the female-to-male and male-to-female sex change processes in grouper. These results also demonstrate that sexual fate determination (secondary sex determination) is regulated by endogenous sex steroid levels.	[Wu, Guan-Chung; Tey, Wei-Guan; Li, Hau-Wen; Chang, Ching-Fong] Natl Taiwan Ocean Univ, Dept Aquaculture, Keelung 20224, Taiwan; [Wu, Guan-Chung; Chang, Ching-Fong] Natl Taiwan Ocean Univ, Ctr Excellence Oceans, Keelung 20224, Taiwan	National Taiwan Ocean University; National Taiwan Ocean University	Wu, GC (corresponding author), Natl Taiwan Ocean Univ, Dept Aquaculture, Keelung 20224, Taiwan.	gcwu@mail.ntou.edu.tw; b0044@mail.ntou.edu.tw			Ministry of Science and Technology [99-2313-B-019-014-MY3, 102-2628-B-019 -004 -MY3]; Ministry of Education	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Education	This work was supported by the Ministry of Science and Technology Project no. 99-2313-B-019-014-MY3 and no. 102-2628-B-019-004-MY3, and the Ministry of Education.	Alam MA, 2006, MOL REPROD DEV, V73, P206, DOI 10.1002/mrd.20393; Alam MA, 2008, GEN COMP ENDOCR, V157, P75, DOI 10.1016/j.ygcen.2008.03.018; Bahamonde PA, 2013, GEN COMP ENDOCR, V192, P25, DOI 10.1016/j.ygcen.2013.04.005; Bhandari RK, 2005, J EXP ZOOL PART A, V303A, P497, DOI 10.1002/jez.a.178; Bhandari RK, 2003, ZOOL SCI, V20, P1399, DOI 10.2108/zsj.20.1399; Chang Ching-Fong, 1997, Chinese Journal of Physiology, V40, P197; Chao T, 1990, SINGAPORE J PRIMARY, V18, P1; Devlin RH, 2002, AQUACULTURE, V208, P191, DOI 10.1016/S0044-8486(02)00057-1; Du JL, 2005, BIOL REPROD, V72, P922, DOI 10.1095/biolreprod.104.033159; Elofsson U, 1997, J COMP PHYSIOL A, V181, P484, DOI 10.1007/s003590050132; Elofsson UOE, 1999, J COMP NEUROL, V410, P158; Fujimoto T, 2010, P NATL ACAD SCI USA, V107, P17211, DOI 10.1073/pnas.1007032107; Glamuzina B, 1998, AQUAC RES, V29, P563, DOI 10.1111/j.1365-2109.1998.tb01168.x; Goto R, 2012, DEV BIOL, V370, P98, DOI 10.1016/j.ydbio.2012.07.010; GROBER MS, 1994, BRAIN BEHAV EVOLUT, V43, P61, DOI 10.1159/000113625; Guigon CJ, 2006, BIOL REPROD, V74, P450, DOI 10.1095/biolreprod.105.047134; Guiguen Y, 2010, GEN COMP ENDOCR, V165, P352, DOI 10.1016/j.ygcen.2009.03.002; Huang W, 2009, MOL CELL ENDOCRINOL, V307, P224, DOI 10.1016/j.mce.2009.04.003; Kim Y, 2006, DEV DYNAM, V235, P2292, DOI 10.1002/dvdy.20894; Kobayashi Y, 2010, BIOL REPROD, V82, P1030, DOI 10.1095/biolreprod.109.080986; Kobayashi Y, 2009, ENDOCRINOLOGY, V150, P1503, DOI 10.1210/en.2008-0569; KOULISH S, 1989, J EXP ZOOL, V252, P156, DOI 10.1002/jez.1402520207; KRAMER CR, 1993, J FISH BIOL, V42, P185; KUO CM, 1988, AQUACULTURE, V74, P113, DOI 10.1016/0044-8486(88)90091-9; Kurokawa H, 2007, P NATL ACAD SCI USA, V104, P16958, DOI 10.1073/pnas.0609932104; Lau EL, 1997, J FISH BIOL, V51, P327, DOI 10.1006/jfbi.1997.0438; Lee YH, 2004, BIOL REPROD, V71, P1270, DOI 10.1095/biolreprod.104.030221; Lee YH, 2002, BIOL REPROD, V66, P1749, DOI 10.1095/biolreprod66.6.1749; Mei J, 2015, SCI CHINA LIFE SCI, V58, P124, DOI 10.1007/s11427-014-4797-9; Miyake Y, 2012, ZOOL SCI, V29, P690, DOI 10.2108/zsj.29.690; Muncaster S, 2013, J FISH BIOL, V82, P1858, DOI 10.1111/jfb.12113; Munday PL, 2006, TRENDS ECOL EVOL, V21, P89, DOI 10.1016/j.tree.2005.10.020; Murata R, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.113.115378; Nozu R, 2013, FISH PHYSIOL BIOCHEM, V39, P47, DOI 10.1007/s10695-012-9632-2; Sarter K, 2006, AQUACULTURE, V256, P443, DOI 10.1016/j.aquaculture.2006.01.034; Siegfried KR, 2008, DEV BIOL, V324, P277, DOI 10.1016/j.ydbio.2008.09.025; Sun LN, 2014, ENDOCRINOLOGY, V155, P1476, DOI 10.1210/en.2013-1959; TANFERMIN JD, 1994, JPN J ICHTHYOL, V40, P413; Tsai YJ, 2011, ZOOL STUD, V50, P693; WARNER RR, 1975, SCIENCE, V190, P633, DOI 10.1126/science.1188360; Wu GC, 2008, BIOL REPROD, V78, P200, DOI 10.1095/biolreprod.107.062612; Wu GC, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.104398; Wu GC, 2013, FISH PHYSIOL BIOCHEM, V39, P33, DOI 10.1007/s10695-012-9618-0; Wu GC, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095695; Wu GC, 2008, BIOL REPROD, V79, P1111, DOI 10.1095/biolreprod.108.069146; Xia W, 2007, MOL CELL ENDOCRINOL, V263, P156, DOI 10.1016/j.mce.2006.09.014; Yeh SL, 2003, COMP BIOCHEM PHYS C, V135, P375, DOI 10.1016/S1532-0456(03)00136-4; Yoshizaki G, 2010, DEVELOPMENT, V137, P1227, DOI 10.1242/dev.044982; Yue HM, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.108043; Zhang J, 2015, SCI REP-UK, V5, DOI 10.1038/srep10898; Zhang WM, 2007, MOL REPROD DEV, V74, P665, DOI 10.1002/mrd.20642; Zhou L, 2010, FISH PHYSIOL BIOCHEM, V36, P181, DOI 10.1007/s10695-008-9219-0	52	28	31	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145438	10.1371/journal.pone.0145438	http://dx.doi.org/10.1371/journal.pone.0145438			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714271	Green Published, gold, Green Submitted			2022-12-26	WOS:000367481900043
J	Jiang, D; Chen, YP; Li, N; Li, W; Wang, ZG; Zhu, JL; Zhang, H; Liu, B; Xu, S				Jiang, Dan; Chen, Yunping; Li, Na; Li, Wen; Wang, Zhenguo; Zhu, Jingli; Zhang, Hong; Liu, Bin; Xu, Shan			Synthesis of Luminescent Graphene Quantum Dots with High Quantum Yield and Their Toxicity Study	PLOS ONE			English	Article							ONE-STEP SYNTHESIS; FUNCTIONALIZED GRAPHENE; PHOTOVOLTAIC DEVICES; CARBON NANOTUBES; IN-VITRO; OXIDE; PHOTOLUMINESCENCE; FLUORESCENT; REDUCTION; SINGLE	High fluorescence quantum yield graphene quantum dots (GQDs) have showed up as a new generation for bioimaging. In this work, luminescent GQDs were prepared by an ameliorative photo-Fenton reaction and a subsequent hydrothermal process using graphene oxide sheets as the precursor. The as-prepared GQDs were nanomaterials with size ranging from 2.3 to 6.4 nm and emitted intense green luminescence in water. The fluorescence quantum yield was as high as 24.6%(excited at 340 nm) and the fluorescence was strongest at pH 7. Moreover, the influences of low-concentration (12.5, 25 mu g/mL) GQDs on the morphology, viability, membrane integrity, internal cellular reactive oxygen species level and mortality of HeLa cells were relatively weak, and the in vitro imaging demonstrated GQDs were mainly in the cytoplasm region. More strikingly, zebrafish embryos were co-cultured with GQDs for in vivo imaging, and the results of heart rate test showed the intake of small amounts of GQDs brought little harm to the cardiovascular of zebrafish. GQDs with high quantum yield and strong photoluminescence show good biocompatibility, thus they show good promising for cell imaging, biolabeling and other biomedical applications.	[Jiang, Dan; Chen, Yunping; Li, Na; Li, Wen; Wang, Zhenguo; Zhu, Jingli; Liu, Bin] Lanzhou Univ, Sch Stomatol, Lanzhou 730000, Peoples R China; [Jiang, Dan; Chen, Yunping; Xu, Shan] Chinese Acad Sci, Lanzhou Inst Chem Phys, State Key Lab Oxo Synth & Select, Lanzhou 730000, Peoples R China; [Wang, Zhenguo; Zhang, Hong] Chinese Acad Sci, Inst Modern Phys, Dept Heavy Ion Radiat Med, Lanzhou, Peoples R China	Lanzhou University; Chinese Academy of Sciences; Lanzhou Institute of Chemical Physics, CAS; Chinese Academy of Sciences; Institute of Modern Physics, CAS	Liu, B (corresponding author), Lanzhou Univ, Sch Stomatol, Lanzhou 730000, Peoples R China.	liubkq@lzu.edu.cn; xushan@licp.cas.cn			Nature Science Foundations of China [21103205]	Nature Science Foundations of China(National Natural Science Foundation of China (NSFC))	The authors are grateful for the financial support by the Nature Science Foundations of China (21103205).	Asharani PV, 2011, NANOTOXICOLOGY, V5, P43, DOI 10.3109/17435390.2010.489207; Chong Y, 2014, BIOMATERIALS, V35, P5041, DOI 10.1016/j.biomaterials.2014.03.021; Derfus AM, 2004, NANO LETT, V4, P11, DOI 10.1021/nl0347334; Dong YQ, 2013, CARBON, V64, P245, DOI 10.1016/j.carbon.2013.07.059; Favaro M, 2015, ACS CATAL, V5, P129, DOI 10.1021/cs501211h; Feng YQ, 2014, CARBON, V66, P334, DOI 10.1016/j.carbon.2013.09.008; Ge JC, 2015, ADV MATER, V27, P4169, DOI 10.1002/adma.201500323; Ge JC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5596; Gollavelli G, 2012, BIOMATERIALS, V33, P2532, DOI 10.1016/j.biomaterials.2011.12.010; Gupta V, 2011, J AM CHEM SOC, V133, P9960, DOI 10.1021/ja2036749; Habiba K, 2013, CARBON, V64, P341, DOI 10.1016/j.carbon.2013.07.084; Hu CF, 2013, J MATER CHEM B, V1, P39, DOI 10.1039/c2tb00189f; Jiang F, 2013, NANOSCALE, V5, P1137, DOI 10.1039/c2nr33191h; Kang B, 2010, SMALL, V6, P2362, DOI 10.1002/smll.201001260; Lai LF, 2011, CARBON, V49, P3250, DOI 10.1016/j.carbon.2011.03.051; Liu F, 2013, ADV MATER, V25, P3657, DOI 10.1002/adma.201300233; Liu YS, 2015, CHEM MATER, V27, P4319, DOI 10.1021/acs.chemmater.5b00774; Liu YS, 2007, J PHYS CHEM C, V111, P2872, DOI 10.1021/jp0654718; Lovric J, 2005, CHEM BIOL, V12, P1227, DOI 10.1016/j.chembiol.2005.09.008; Markovic ZM, 2012, BIOMATERIALS, V33, P7084, DOI 10.1016/j.biomaterials.2012.06.060; Miao W, 2015, AQUAT TOXICOL, V161, P117, DOI 10.1016/j.aquatox.2015.02.002; Pan DY, 2012, J MATER CHEM, V22, P3314, DOI 10.1039/c2jm16005f; Parimal R, 2013, ACS APPL MATER INTER, V5, P12672, DOI [10.1021/am4040174, DOI 10.1021/AM4040174]; Peng J, 2012, NANO LETT, V12, P844, DOI 10.1021/nl2038979; Ponomarenko LA, 2008, SCIENCE, V320, P356, DOI 10.1126/science.1154663; Qu D, 2014, SCI REP-UK, V4, DOI 10.1038/srep05294; Ran X, 2013, CHEM COMMUN, V49, P1079, DOI 10.1039/c2cc38403e; Sahu S, 2012, CHEM COMMUN, V48, P8835, DOI 10.1039/c2cc33796g; Shen JH, 2012, CHEM COMMUN, V48, P3686, DOI 10.1039/c2cc00110a; Singh SK, 2012, ACS NANO, V6, P2731, DOI 10.1021/nn300172t; Sun HJ, 2015, CHEM-EUR J, V21, P3791, DOI 10.1002/chem.201406345; Sun HJ, 2013, ACS APPL MATER INTER, V5, P1174, DOI 10.1021/am3030849; Sun YQ, 2013, PHYS CHEM CHEM PHYS, V15, P9907, DOI 10.1039/c3cp50691f; Tang LB, 2012, ACS NANO, V6, P5102, DOI 10.1021/nn300760g; Wang SJ, 2015, CARBON, V82, P304, DOI 10.1016/j.carbon.2014.10.075; Wu CY, 2013, ADV HEALTHC MATER, V2, P1613, DOI 10.1002/adhm.201300066; Wu X, 2013, J MATER CHEM C, V1, P4676, DOI 10.1039/c3tc30820k; Xu FZ, 2015, ANALYST, V140, P3925, DOI 10.1039/c5an00468c; Yan L, 2012, J MATER CHEM, V22, P8367, DOI 10.1039/c2jm30961k; Yan XB, 2010, ACS APPL MATER INTER, V2, P2521, DOI 10.1021/am100293r; Yuan XC, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-108; Zhang X, 2014, J BIOMED MATER RES A, V102, P732, DOI 10.1002/jbm.a.34751; Zhou XJ, 2012, ACS NANO, V6, P6592, DOI 10.1021/nn301629v; Zhu SJ, 2012, ADV FUNCT MATER, V22, P4732, DOI 10.1002/adfm.201201499; Zhu SJ, 2012, CHEM COMMUN, V48, P4527, DOI 10.1039/c2cc31201h	45	75	75	1	146	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0144906	10.1371/journal.pone.0144906	http://dx.doi.org/10.1371/journal.pone.0144906			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709828	Green Published, gold, Green Submitted			2022-12-26	WOS:000367451400015
J	Othman, I; Mirand, A; Slama, I; Mastouri, M; Peigue-Lafeuille, H; Aouni, M; Bailly, JL				Othman, Ines; Mirand, Audrey; Slama, Ichrak; Mastouri, Maha; Peigue-Lafeuille, Helene; Aouni, Mahjoub; Bailly, Jean-Luc			Enterovirus Migration Patterns between France and Tunisia	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; MOUTH-DISEASE; PHYLOGENETIC ANALYSIS; POPULATION-DYNAMICS; ASEPTIC-MENINGITIS; COXSACKIEVIRUS A9; PHYLOGEOGRAPHY; EVOLUTION; INFECTION; OUTBREAK	The enterovirus (EV) types echovirus (E-) 5, E-9, and E-18, and coxsackievirus (CV-) A9 are infrequently reported in human diseases and their epidemiologic features are poorly defined. Virus transmission patterns between countries have been estimated with phylogenetic data derived from the 1D/VP1 and 3CD gene sequences of a sample of 74 strains obtained in France (2000-2012) and Tunisia (2011-2013) and from the publicly available sequences. The EV types (E-5, E-9, and E-18) exhibited a lower worldwide genetic diversity (respective number of genogroups: 4, 5, and 3) in comparison to CV-A9 (n = 10). The phylogenetic trees estimated with both 1D/VP1 and 3CD sequence data showed variations in the number of co-circulating lineages over the last 20 years among the four EV types. Despite the low number of genogroups in E-18, the virus exhibited the highest number of recombinant 3CD lineages (n = 10) versus 4 (E-5) to 8 (E-9). The phylogenies provided evidence of multiple transportation events between France and Tunisia involving E-5, E-9, E-18, and CV-A9 strains. Virus spread events between France and 17 other countries in five continents had high probabilities of occurrence as those between Tunisia and two European countries other than France. All transportation events were supported by BF values > 10. Inferring the source of virus transmission from phylogenetic data may provide insights into the patterns of sporadic and epidemic diseases caused by EVs.	[Othman, Ines; Slama, Ichrak; Mastouri, Maha; Aouni, Mahjoub] Univ Monastir, Fac Pharm, LR99 ES27, Monastir, Tunisia; [Othman, Ines; Slama, Ichrak] Univ Carthage, Fac Sci Bizerte, Carthage, Tunisia; [Mirand, Audrey; Peigue-Lafeuille, Helene; Bailly, Jean-Luc] Univ Auvergne, EPIE, EA 4843, Clermont Ferrand, France; [Mirand, Audrey; Peigue-Lafeuille, Helene] CHU Clermont Ferrand, Serv Virol, Ctr Natl Reference Enterovirus Parechovirus, Clermont Ferrand, France; [Mastouri, Maha] Fattouma Bourguiba Univ Hosp, Microbiol Lab, Monastir, Tunisia	Universite de Monastir; Universite de Carthage; Universite Clermont Auvergne (UCA); CHU Clermont Ferrand; Universite de Monastir; Hopital Fattouma Bourguiba	Bailly, JL (corresponding author), Univ Auvergne, EPIE, EA 4843, Clermont Ferrand, France.	j-luc.bailly@udamail.fr	Bailly, Jean-Luc/ABE-9210-2020	Bailly, Jean-Luc/0000-0002-9770-6450	Ministere de l'Enseignement Superieur et de la Recherche Scientifique of Tunisia; Ministere de l'Education Nationale et de la Recherche (France)	Ministere de l'Enseignement Superieur et de la Recherche Scientifique of Tunisia; Ministere de l'Education Nationale et de la Recherche (France)	Ines Othman was enrolled in the Faculty of Sciences in Bizerte, University of Carthage, Tunisia, and received a fellowship grant from the Ministere de l'Enseignement Superieur et de la Recherche Scientifique of Tunisia. The study was funded by the Ministere de l'Education Nationale et de la Recherche (France). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkhalek I, 2015, ARCH VIROL, V160, P2815, DOI 10.1007/s00705-015-2561-5; Allicock OM, 2012, MOL BIOL EVOL, V29, P1533, DOI 10.1093/molbev/msr320; Antona D, 2007, EUR J CLIN MICROBIOL, V26, P403, DOI 10.1007/s10096-007-0306-4; Baek K, 2009, J MICROBIOL BIOTECHN, V19, P1055, DOI 10.4014/jmb.0810.584; Bahri O, 2005, J MED MICROBIOL, V54, P63, DOI 10.1099/jmm.0.45695-0; Bailly JL, 2011, INFECT GENET EVOL, V11, P276, DOI 10.1016/j.meegid.2010.06.019; Bailly JL, 2009, INFECT GENET EVOL, V9, P699, DOI 10.1016/j.meegid.2008.04.009; Bedford T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000918; Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481; Blomqvist S, 2010, J CLIN VIROL, V48, P49, DOI 10.1016/j.jcv.2010.02.002; Brunel D, 2007, J CLIN MICROBIOL, V45, P2068, DOI 10.1128/JCM.00320-07; Cabrerizo M, 2014, CLIN MICROBIOL INFEC, V20, pO150, DOI 10.1111/1469-0691.12361; Chapin M., 2013, TUNISIE SECTEUR TOUR; Chu PY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129272; Cui AL, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-72; Danthanarayana N, 2015, J MED VIROL, V87, P2033, DOI 10.1002/jmv.24267; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; EL Hiar R, 2012, INDIAN J VIROL, V23, P294, DOI 10.1007/s13337-012-0104-1; Faria NR, 2011, CURR OPIN VIROL, V1, P423, DOI 10.1016/j.coviro.2011.10.003; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fischer TK, 2014, EURO SURVEILL, V19; Hassel C, 2015, EUROSURVEILLANCE, V20, P2, DOI 10.2807/1560-7917.ES.2015.20.34.30005; Huang YC, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-33; Ke GM, 2011, VIRUS GENES, V42, P178, DOI 10.1007/s11262-010-0565-5; Khetsuriani N, 2006, MMWR-MORBID MORTAL W, V55, P1; Kyriakopoulou Z, 2015, INFECT GENET EVOL, V32, P305, DOI 10.1016/j.meegid.2015.03.008; Lang M, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.44.20952; Lefterova MI, 2013, J CLIN MICROBIOL, V51, P684, DOI 10.1128/JCM.02405-12; Leitch ECM, 2010, J VIROL, V84, P9292, DOI 10.1128/JVI.00783-10; Lemey P, 2010, MOL BIOL EVOL, V27, P1877, DOI 10.1093/molbev/msq067; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Lindberg AM, 2003, J GEN VIROL, V84, P1223, DOI 10.1099/vir.0.18971-0; Lu QB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052073; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; McMinn PC, 2012, CURR OPIN VIROL, V2, P199, DOI 10.1016/j.coviro.2012.02.009; Meijer A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.42.20935; Messacar K, 2015, LANCET, V385, P1662, DOI 10.1016/S0140-6736(14)62457-0; Mirand A, 2012, CLIN MICROBIOL INFEC, V18, pE110, DOI 10.1111/j.1469-0691.2012.03789.x; Mirand A, 2008, J CLIN MICROBIOL, V46, P87, DOI 10.1128/JCM.01020-07; Moreau Brigitte, 2011, Case Rep Gastroenterol, V5, P617, DOI 10.1159/000333135; Nasri D, 2007, EXPERT REV MOL DIAGN, V7, P419, DOI 10.1586/14737159.7.4.419; Othman I, 2015, DIAGN MICRO IN PRESS; Piralla A, 2014, J MED VIROL, V86, P1590, DOI 10.1002/jmv.23821; Puenpa J, 2013, EMERG INFECT DIS, V19, P641, DOI 10.3201/eid1904.121666; Pybus OG, 2012, P NATL ACAD SCI USA, V109, P15066, DOI 10.1073/pnas.1206598109; RICOHESSE R, 1987, VIROLOGY, V160, P311, DOI 10.1016/0042-6822(87)90001-8; Roda D, 2015, EUR J PEDIATR, V174, P1549, DOI 10.1007/s00431-015-2571-z; Santti J, 2000, J GEN VIROL, V81, P1361, DOI 10.1099/0022-1317-81-5-1361; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; Stack JC, 2010, J R SOC INTERFACE, V7, P1119, DOI 10.1098/rsif.2009.0530; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tryfonos C, 2011, J MED MICROBIOL, V60, P1433, DOI 10.1099/jmm.0.029892-0; Tsai HP, 2011, J MED MICROBIOL, V60, P1360, DOI 10.1099/jmm.0.027698-0; Vedrine H, 2013, PARTNERSHIP FUTURE 1; Volle R, 2014, J INFECT DIS, V210, P576, DOI 10.1093/infdis/jiu178; Yarmolskaya MS, 2015, INFECT GENET EVOL, V30, P244, DOI 10.1016/j.meegid.2014.12.033; Yip Cyril C Y, 2013, Emerg Health Threats J, V6, P19780, DOI 10.3402/ehtj.v6i0.19780	58	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145674	10.1371/journal.pone.0145674	http://dx.doi.org/10.1371/journal.pone.0145674			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709514	Green Published, Green Submitted, gold			2022-12-26	WOS:000367451400069
J	Martinez-Bonet, M; Palladino, C; Briz, V; Rudolph, JM; Fackler, OT; Relloso, M; Munoz-Fernandez, MA; Madrid, R				Martinez-Bonet, Marta; Palladino, Claudia; Briz, Veronica; Rudolph, Jochen M.; Fackler, Oliver T.; Relloso, Miguel; Angeles Munoz-Fernandez, Maria; Madrid, Ricardo			A Conserved GPG-Motif in the HIV-1 Nef Core Is Required for Principal Nef-Activities	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ADAPTER PROTEIN COMPLEXES; PATHOGENICITY FACTOR NEF; CD4 DOWN-REGULATION; TYPE-1 NEF; T-CELLS; DISEASE PROGRESSION; BINDING SURFACE; LCK; TRAFFICKING	To find out new determinants required for Nef activity we performed a functional alanine scanning analysis along a discrete but highly conserved region at the core of HIV-1 Nef. We identified the GPG-motif, located at the 121-137 region of HIV-1 NL4.3 Nef, as a novel protein signature strictly required for the p56(Lck) dependent Nef-induced CD4-downregulation in T-cells. Since the Nef-GPG motif was dispensable for CD4-downregulation in HeLa-CD4 cells, Nef/AP-1 interaction and Nef-dependent effects on Tf-R trafficking, the observed effects on CD4 downregulation cannot be attributed to structure constraints or to alterations on general protein trafficking. Besides, we found that the GPG-motif was also required for Nef-dependent inhibition of ring actin re-organization upon TCR triggering and MHCI downregulation, suggesting that the GPG-motif could actively cooperate with the Nef PxxP motif for these HIV-1 Nef-related effects. Finally, we observed that the Nef-GPG motif was required for optimal infectivity of those viruses produced in T-cells. According to these findings, we propose the conserved GPG-motif in HIV-1 Nef as functional region required for HIV-1 infectivity and therefore with a potential interest for the interference of Nef activity during HIV-1 infection.	[Martinez-Bonet, Marta; Palladino, Claudia; Briz, Veronica; Relloso, Miguel; Angeles Munoz-Fernandez, Maria] Inst Invest Biomed Gregorio Maranon IISGM, Lab Inmunobiol Mol, Madrid 28007, Spain; [Rudolph, Jochen M.; Fackler, Oliver T.] Univ Heidelberg Hosp, Dept Infect Dis, Integrat Virol, Heidelberg, Germany; [Madrid, Ricardo] UAM, CSIC, Ctr Biol Mol Severo Ochoa, Dept Virol, Madrid, Spain	Ruprecht Karls University Heidelberg; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Madrid, R (corresponding author), UAM, CSIC, Ctr Biol Mol Severo Ochoa, Dept Virol, Madrid, Spain.	ricardo-m@cbm.csic.es	iMed.ULisboa, EEPHIV/B-4222-2014; Palladino, Claudia/E-2523-2014; Briz, Veronica VB/T-4183-2017; Relloso, Miguel/K-2238-2014	Palladino, Claudia/0000-0002-8148-0928; Briz, Veronica VB/0000-0003-2297-5098; Martinez Bonet, Marta/0000-0003-0715-403X; Relloso, Miguel/0000-0002-9181-2244; Fackler, Oliver Till/0000-0003-2982-4209; Munoz-Fernandez/0000-0002-0813-4500; Madrid Gonzalez, Ricardo/0000-0002-1350-9864	Ramon y Cajal research program [MICIIN-RYC-2005-002174]; Fondo de Investigacion Sanitaria en Espana [FIS-PS09/01386]; Comunidad de Madrid [S-2010/BMD-2332]; Deutsche Forschungsgemeinschaft [TRR83, 15]; Fondo de Investigacion Sanitaria en Espana (FIS)	Ramon y Cajal research program(Spanish Government); Fondo de Investigacion Sanitaria en Espana; Comunidad de Madrid(Comunidad de Madrid); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fondo de Investigacion Sanitaria en Espana (FIS)	This work was supported by the Ramon y Cajal research program (MICIIN-RYC-2005-002174; http://www.mineco.gob.es/portal/site/mineco/idi), Fondo de Investigacion Sanitaria en Espana (FIS-PS09/01386; http://www.isciii.es/) to RM, and Comunidad de Madrid (S-2010/BMD-2332; http://www.madrimasd.org/) to MAM-F, and the Deutsche Forschungsgemeinschaft (TRR83, project 15 to OTF). MM-B, CP and VB hold a fellowship from the Fondo de Investigacion Sanitaria en Espana (FIS, http://www.isciii.es/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham L, 2012, J IMMUNOL, V189, P1898, DOI 10.4049/jimmunol.1200652; Agopian K, 2006, J VIROL, V80, P3050, DOI 10.1128/JVI.80.6.3050-3061.2006; Atkins KM, 2008, J BIOL CHEM, V283, P11772, DOI 10.1074/jbc.M707572200; BAUR AS, 1994, IMMUNITY, V1, P373, DOI 10.1016/1074-7613(94)90068-X; Birch MR, 2001, J CLIN VIROL, V22, P263, DOI 10.1016/S1386-6532(01)00198-6; Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1; Burtey A, 2007, TRAFFIC, V8, P61, DOI 10.1111/j.1600-0854.2006.00512.x; Carl S, 2001, J VIROL, V75, P3657, DOI 10.1128/JVI.75.8.3657-3665.2001; CHOWERS MY, 1994, J VIROL, V68, P2906, DOI 10.1128/JVI.68.5.2906-2914.1994; Coleman SH, 2006, J VIROL, V80, P1837, DOI 10.1128/JVI.80.4.1837-1849.2006; Collette Y, 1996, J BIOL CHEM, V271, P6333, DOI 10.1074/jbc.271.11.6333; Costa LJ, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-33; Craig HM, 1998, P NATL ACAD SCI USA, V95, P11229, DOI 10.1073/pnas.95.19.11229; Craig HM, 2000, VIROLOGY, V271, P9, DOI 10.1006/viro.2000.0277; Davey NE, 2011, TRENDS BIOCHEM SCI, V36, P159, DOI 10.1016/j.tibs.2010.10.002; Dubey S, 2008, J CLIN VIROL, V43, P25, DOI 10.1016/j.jcv.2008.03.026; GARCIA JV, 1991, NATURE, V350, P508, DOI 10.1038/350508a0; Geyer M, 2001, EMBO REP, V2, P580, DOI 10.1093/embo-reports/kve141; Greenberg ME, 1998, EMBO J, V17, P2777, DOI 10.1093/emboj/17.10.2777; Grzesiek S, 1997, PROTEIN SCI, V6, P1248, DOI 10.1002/pro.5560060613; Guyader M, 2002, J VIROL, V76, P10356, DOI 10.1128/JVI.76.20.10356-10364.2002; Haller C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001212; Haller C, 2006, J BIOL CHEM, V281, P19618, DOI 10.1074/jbc.M513802200; Haller C, 2011, EUR J CELL BIOL, V90, P913, DOI 10.1016/j.ejcb.2010.09.010; Imle A, 2015, MBIO, V6, DOI 10.1128/mBio.01309-15; Janvier K, 2003, J BIOL CHEM, V278, P8725, DOI 10.1074/jbc.M210115200; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Laguette N, 2010, MOL ASPECTS MED, V31, P418, DOI 10.1016/j.mam.2010.05.003; Laguette N, 2009, J VIROL, V83, P7117, DOI 10.1128/JVI.01648-08; Madrid R, 2005, J BIOL CHEM, V280, P5032, DOI 10.1074/jbc.M401202200; Manninen A, 2001, J VIROL, V75, P3034, DOI 10.1128/JVI.75.6.3034-3037.2001; Meuwissen PJ, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-34; Nika K, 2010, IMMUNITY, V32, P766, DOI 10.1016/j.immuni.2010.05.011; Pan XY, 2012, BLOOD, V119, P786, DOI 10.1182/blood-2011-08-373209; Rodes B, 2004, AIDS, V18, P1109, DOI [10.1097/00002030-200405210-00004, 10.1097/01.aids.0000125962.16506.f9]; Roeth JF, 2004, J CELL BIOL, V167, P903, DOI 10.1083/jcb.200407031; Rose JJ, 2005, J BIOL CHEM, V280, P7413, DOI 10.1074/jbc.M409420200; Rudolph JM, 2009, J VIROL, V83, P11528, DOI 10.1128/JVI.01423-09; SAKSELA K, 1995, EMBO J, V14, P484, DOI 10.1002/j.1460-2075.1995.tb07024.x; Saksela K, 2011, CURR HIV RES, V9, P531, DOI 10.2174/157016211798842107; Sarmady M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020735; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; SHUGARS DC, 1993, J VIROL, V67, P4639, DOI 10.1128/JVI.67.8.4639-4650.1993; Sol-Foulon N, 2002, IMMUNITY, V16, P145, DOI 10.1016/S1074-7613(02)00260-1; Stolp B, 2012, P NATL ACAD SCI USA, V109, P18541, DOI 10.1073/pnas.1204322109; Stolp B, 2010, J VIROL, V84, P3935, DOI 10.1128/JVI.02467-09; Stolp B, 2009, CELL HOST MICROBE, V6, P174, DOI 10.1016/j.chom.2009.06.004; Strasner AB, 2008, J IMMUNOL, V181, P3706, DOI 10.4049/jimmunol.181.5.3706; Stumptner-Cuvelette P, 2001, P NATL ACAD SCI USA, V98, P12144, DOI 10.1073/pnas.221256498; Swigut T, 2001, EMBO J, V20, P1593, DOI 10.1093/emboj/20.7.1593; Thoulouze MI, 2006, IMMUNITY, V24, P547, DOI 10.1016/j.immuni.2006.02.016; Venzke S, 2006, J VIROL, V80, P11141, DOI 10.1128/JVI.01556-06; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1	53	2	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145239	10.1371/journal.pone.0145239	http://dx.doi.org/10.1371/journal.pone.0145239			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700863	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092600055
J	Pechey, R; Attwood, AS; Couturier, DL; Munafo, MR; Scott-Samuel, NE; Woods, A; Marteau, TM				Pechey, Rachel; Attwood, Angela S.; Couturier, Dominique-Laurent; Munafo, Marcus R.; Scott-Samuel, Nicholas E.; Woods, Andy; Marteau, Theresa M.			Does Glass Size and Shape Influence Judgements of the Volume of Wine?	PLOS ONE			English	Article							FOOD PORTION SIZE; DIMENSIONS; PERCEPTION; DRINKS; BIAS	Background Judgements of volume may influence the rate of consumption of alcohol and, in turn, the amount consumed. The aim of the current study was to examine the impact of the size and shape of wine glasses on perceptions of wine volume. Methods Online experiment: Participants (n = 360; recruited via Mechanical Turk) were asked to match the volume of wine in two wine glasses, specifically: 1. the Reference glass holding a fixed reference volume, and 2. the Comparison glass, for which the volume could be altered until participants perceived it matched the reference volume. One of three comparison glasses was shown in each trial: 'wider' (20% wider but same capacity); 'larger' (same width but 25% greater capacity); or 'wider-and-larger' (20% wider and 25% greater capacity). Reference volumes were 125ml, 175ml and 250ml, in a fully factorial within-subjects design: 3 (comparison glass) x 3 (reference volume). Non-zero differences between the volumes with which participants filled comparison glasses and the corresponding reference volumes were identified using sign-rank tests. Results Participants under-filled the wider glass relative to the reference glass for larger reference volumes, and over-filled the larger glass relative to the reference glass for all reference volumes. Results for the wider-and-larger glass showed a mixed pattern across reference volume. For all comparison glasses, in trials with larger reference volumes participants tended to fill the comparison glass less, relative to trials with smaller reference volumes for the same comparison glass. Conclusions These results are broadly consistent with people using the relative fullness of glasses to judge volume, and suggest both the shape and capacity of wine glasses may influence perceived volume. Perceptions that smaller glasses contain more than larger ones (despite containing the same volume), could slow drinking speed and overall consumption by serving standard portions in smaller glasses. This hypothesis awaits testing.	[Pechey, Rachel; Couturier, Dominique-Laurent; Marteau, Theresa M.] Univ Cambridge, Behaviour & Hlth Res Unit, Inst Publ Hlth, Cambridge, England; [Attwood, Angela S.; Munafo, Marcus R.] Univ Bristol, UK Ctr Tobacco & Alcohol Studies, Sch Expt Psychol, MRC Integrat Epidemiol Unit IEU, Bristol, Avon, England; [Scott-Samuel, Nicholas E.; Woods, Andy] Univ Bristol, Sch Expt Psychol, Bristol, Avon, England; [Woods, Andy] Univ Oxford, Dept Expt Psychol, Crossmodal Res Lab, Oxford OX1 3UD, England	University of Cambridge; University of Bristol; University of Bristol; University of Oxford	Marteau, TM (corresponding author), Univ Cambridge, Behaviour & Hlth Res Unit, Inst Publ Hlth, Cambridge, England.	tm388@cam.ac.uk	Attwood, Angela S/F-7071-2011; Munafo, Marcus/AAE-2306-2020	Attwood, Angela S/0000-0003-3696-4349; Munafo, Marcus/0000-0002-4049-993X; Woods, Andy/0000-0003-3797-3845; Marteau, Theresa/0000-0003-3025-1129; Couturier, Dominique-Laurent/0000-0001-5774-5036; Scott-Samuel, Nicholas/0000-0002-8270-8437; Pechey, Rachel/0000-0002-6558-388X	Department of Health Policy Research Programme (Policy Research Unit in Behaviour and Health) [PR-UN-0409-10109]; British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Medical Research Council; National Institute for Health Research, under UK Clinical Research Collaboration; MRC [MC_UU_12013/6] Funding Source: UKRI; Medical Research Council [MC_UU_12013/6] Funding Source: researchfish	Department of Health Policy Research Programme (Policy Research Unit in Behaviour and Health); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research, under UK Clinical Research Collaboration(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded by the Department of Health Policy Research Programme (http://prp.dh.gov.uk/) (Policy Research Unit in Behaviour and Health [PR-UN-0409-10109]). ASA and MRM are members of the UK Centre for Tobacco and Alcohol Studies, a UKCRC Public Health Research: Centre of Excellence. Funding from British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, and the National Institute for Health Research, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. None of the funders had a role in the study design, data collection, analysis, interpretation, or decision to submit for publication. The research was conducted independently of the funders, and the views expressed in this paper are those of the authors and not necessarily those of the funders.	Attwood AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043007; Brunstrom JM, 2008, APPETITE, V51, P604, DOI 10.1016/j.appet.2008.04.017; Chandon P, 2009, J MARKETING RES, V46, P739, DOI 10.1509/jmkr.46.6.739; FRAYMAN BJ, 1981, PERCEPT PSYCHOPHYS, V29, P56, DOI 10.3758/BF03198840; Geier AB, 2006, PSYCHOL SCI, V17, P521, DOI 10.1111/j.1467-9280.2006.01738.x; Hock HS, 2010, SEEING PERCEIVING, V23, P173, DOI 10.1163/187847510X503597; Hollands JG, 2000, PSYCHOL REV, V107, P500, DOI 10.1037/0033-295X.107.3.500; Jackson R., 2010, INTERVENTIONS CONTRO; Kerr WC, 2009, DRUG ALCOHOL REV, V28, P360, DOI 10.1111/j.1465-3362.2009.00056.x; McClain AD, 2014, INT J OBESITY, V38, P657, DOI 10.1038/ijo.2013.169; Murray CJL, 2013, LANCET, V381, P997, DOI 10.1016/S0140-6736(13)60355-4; NELSON M, 1994, BRIT J NUTR, V72, P649, DOI 10.1079/BJN19940069; *NICE, 2010, ALC US DIS PREV HARM; NISBETT RE, 1968, SCIENCE, V159, P1254, DOI 10.1126/science.159.3820.1254; PEARSON R G, 1964, Percept Mot Skills, V18, P889; Raghubir P, 1999, J MARKETING RES, V36, P313, DOI 10.2307/3152079; Turconi G, 2005, EUR J CLIN NUTR, V59, P923, DOI 10.1038/sj.ejcn.1602162; van Kleef E, 2014, PSYCHOL HEALTH, V29, P1081, DOI 10.1080/08870446.2014.909426; VAREY CA, 1990, J EXP PSYCHOL HUMAN, V16, P613, DOI 10.1037/0096-1523.16.3.613; Walker D, 2014, SUBST USE MISUSE, V49, P295, DOI 10.3109/10826084.2013.832327; Wansink B, 2003, J CONSUM RES, V30, P455, DOI 10.1086/378621; Wansink B, 2013, J EXP PSYCHOL-APPL, V19, P320, DOI 10.1037/a0035053; White AM, 2003, ALCOHOL CLIN EXP RES, V27, P1750, DOI 10.1097/01.ALC.0000095866.17973.AF; World Health Organization, 2009, EV EFF COST EFF INT; Yang S, 2005, J RETAILING, V81, P269, DOI 10.1016/j.jretai.2004.11.003	25	16	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0144536	10.1371/journal.pone.0144536	http://dx.doi.org/10.1371/journal.pone.0144536			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ4SI	26698577	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092600023
J	Sakashita, A; Kawabata, Y; Jincho, Y; Tajima, S; Kumamoto, S; Kobayashi, H; Matsui, Y; Kono, T				Sakashita, Akihiko; Kawabata, Yukiko; Jincho, Yuko; Tajima, Shiun; Kumamoto, Soichiro; Kobayashi, Hisato; Matsui, Yasuhisa; Kono, Tomohiro			Sex Specification and Heterogeneity of Primordial Germ Cells in Mice	PLOS ONE			English	Article							MEIOTIC PROPHASE; DNA METHYLATION; GENE-EXPRESSION; SERTOLI-CELLS; STEM-CELLS; IN-VIVO; MOUSE; DIFFERENTIATION; MEIOSIS; FETAL	In mice, primordial germ cells migrate into the genital ridges by embryonic day 13.5 (E13.5), where they are then subjected to a sex-specific fate with female and male primordial germ cells undergoing mitotic arrest and meiosis, respectively. However, the sex-specific basis of primordial germ cell differentiation is poorly understood. The aim of this study was to investigate the sex-specific features of mouse primordial germ cells. We performed RNA-sequencing (seq) of E13.5 female and male mouse primordial germ cells using next-generation sequencing. We identified 651 and 428 differentially expressed transcripts (>2-fold, P <0.05) in female and male primordial germ cells, respectively. Of these, many transcription factors were identified. Gene ontology and network analysis revealed differing functions of the identified female-and male-specific genes that were associated with primordial germ cell acquisition of sex-specific properties required for differentiation into germ cells. Furthermore, DNA methylation and ChIP-seq analysis of histone modifications showed that hypo-methylated gene promoter regions were bound with H3K4me3 and H3K27me3. Our global transcriptome data showed that in mice, primordial germ cells are decisively assigned to a sex-specific differentiation program by E13.5, which is necessary for the development of vital germ cells.	[Sakashita, Akihiko; Kawabata, Yukiko; Jincho, Yuko; Tajima, Shiun; Kumamoto, Soichiro; Kono, Tomohiro] Tokyo Univ Agr, Dept Biosci, Setagaya Ku, Tokyo, Japan; [Kobayashi, Hisato; Kono, Tomohiro] Tokyo Univ Agr, NODAI Genome Res Ctr, Setagaya Ku, Tokyo, Japan; [Matsui, Yasuhisa] Tohoku Univ, Cell Resource Ctr Biomed Res, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan	Tokyo University of Agriculture; Tokyo University of Agriculture; Tohoku University	Kono, T (corresponding author), Tokyo Univ Agr, Dept Biosci, Setagaya Ku, Tokyo, Japan.	tomohiro@nodai.ac.jp	Kobayashi, Hisato/AAP-7910-2020	Matsui, Yasuhisa/0000-0001-7026-6355; Kumamoto, Soichiro/0000-0002-3492-117X; Kobayashi, Hisato/0000-0003-3800-4691	JST; CREST; Grants-in-Aid for Scientific Research [25114003] Funding Source: KAKEN	JST(Japan Science & Technology Agency (JST)); CREST(Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	TK was supported by Grants-in-Aid for Scientific Research from JST and from CREST.	Adams IR, 2002, DEVELOPMENT, V129, P1155; Albrecht KH, 2001, DEV BIOL, V240, P92, DOI 10.1006/dbio.2001.0438; Baltus AE, 2006, NAT GENET, V38, P1430, DOI 10.1038/ng1919; Ben-Shushan E, 2015, STEM CELLS, V33, P403, DOI 10.1002/stem.1873; Bowles J, 2007, DEVELOPMENT, V134, P3401, DOI 10.1242/dev.001107; Brind'Amour J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7033; Chickarmane V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003478; COUCOUVANIS EC, 1993, EXP CELL RES, V209, P238, DOI 10.1006/excr.1993.1307; De Gobbi M, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-9; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; Garcia TX, 2013, CELL CYCLE, V12, P2538, DOI 10.4161/cc.25627; Ghafari F, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-87; Grandbarbe L, 2003, DEVELOPMENT, V130, P1391, DOI 10.1242/dev.00374; Green DR, 2000, J CELL BIOL, V150, pF5, DOI 10.1083/jcb.150.1.F5; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; Harris MH, 2000, CELL DEATH DIFFER, V7, P1182, DOI 10.1038/sj.cdd.4400781; Ho DWY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037159; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jameson SA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002575; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Kobayashi H, 2013, GENOME RES, V23, P616, DOI 10.1101/gr.148023.112; Lei L, 2013, DEVELOPMENT, V140, P2075, DOI 10.1242/dev.093864; Lesch BJ, 2013, P NATL ACAD SCI USA, V110, P16061, DOI 10.1073/pnas.1315204110; Malki S, 2014, DEV CELL, V29, P521, DOI 10.1016/j.devcel.2014.04.027; McClellan KA, 2003, DEV BIOL, V258, P334, DOI 10.1016/S0012-1606(03)00132-5; Meek DW, 2004, DNA REPAIR, V3, P1049, DOI 10.1016/j.dnarep.2004.03.027; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Morita Y, 2001, CELL DEATH DIFFER, V8, P614, DOI 10.1038/sj.cdd.4400845; Nakato R, 2013, GENES CELLS, V18, P589, DOI 10.1111/gtc.12058; Ng JH, 2013, DEV CELL, V24, P324, DOI 10.1016/j.devcel.2012.12.011; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Pepling ME, 2001, DEV BIOL, V234, P339, DOI 10.1006/dbio.2001.0269; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Sabour D, 2011, HUM MOL GENET, V20, P115, DOI 10.1093/hmg/ddq450; Sachs M, 2013, CELL REP, V3, P1777, DOI 10.1016/j.celrep.2013.04.032; Saitou M, 2012, DEVELOPMENT, V139, P15, DOI 10.1242/dev.050849; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Scott IC, 2000, MOL CELL BIOL, V20, P530, DOI 10.1128/MCB.20.2.530-541.2000; Seisenberger S, 2012, MOL CELL, V48, P849, DOI 10.1016/j.molcel.2012.11.001; Souquet B, 2012, ENDOCRINOLOGY, V153, P2466, DOI 10.1210/en.2011-2056; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Suzuki A, 2008, GENE DEV, V22, P430, DOI 10.1101/gad.1612708; TAM PPL, 1981, J EMBRYOL EXP MORPH, V64, P133; Tanaka SS, 2014, CELL MOL LIFE SCI, V71, P4781, DOI 10.1007/s00018-014-1703-3; Tanaka SS, 2005, DEV CELL, V9, P745, DOI 10.1016/j.devcel.2005.10.010; Wang RA, 1998, BIOL REPROD, V58, P1250, DOI 10.1095/biolreprod58.5.1250; Western PS, 2008, STEM CELLS, V26, P339, DOI 10.1634/stemcells.2007-0622; Wu Q, 2013, DEVELOPMENT, V140, P291, DOI 10.1242/dev.087882; Xu XN, 2001, NAT IMMUNOL, V2, P384, DOI 10.1038/87682; Yabuta Y, 2006, BIOL REPROD, V75, P705, DOI 10.1095/biolreprod.106.053686; Yokobayashi S, 2013, NATURE, V495, P236, DOI 10.1038/nature11918; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675	53	12	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0144836	10.1371/journal.pone.0144836	http://dx.doi.org/10.1371/journal.pone.0144836			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700643	gold, Green Published, Green Submitted			2022-12-26	WOS:000367092600034
J	Perumal, V; Hashim, U; Gopinath, SCB; Haarindraprasad, R; Liu, WW; Poopalan, P; Balakrishnan, SR; Thivina, V; Ruslinda, AR				Perumal, Veeradasan; Hashim, Uda; Gopinath, Subash C. B.; Haarindraprasad, R.; Liu, Wei-Wen; Poopalan, P.; Balakrishnan, S. R.; Thivina, V.; Ruslinda, A. R.			Thickness Dependent Nanostructural, Morphological, Optical and Impedometric Analyses of Zinc Oxide-Gold Hybrids: Nanoparticle to Thin Film	PLOS ONE			English	Article							ZNO NANORODS; ENHANCED PHOTOLUMINESCENCE; ELECTRICAL-PROPERTIES; REFRACTIVE-INDEX; TEMPERATURE; EMISSION; FABRICATION; NETWORKS; GROWTH; MECHANISMS	The creation of an appropriate thin film is important for the development of novel sensing surfaces, which will ultimately enhance the properties and output of high-performance sensors. In this study, we have fabricated and characterized zinc oxide (ZnO) thin films on silicon substrates, which were hybridized with gold nanoparticles (AuNPs) to obtain ZnO-Au-x (x = 10, 20, 30, 40 and 50 nm) hybrid structures with different thicknesses. Nanoscale imaging by field emission scanning electron microscopy revealed increasing film uniformity and coverage with the Au deposition thickness. Transmission electron microscopy analysis indicated that the AuNPs exhibit an increasing average diameter (5-10 nm). The face center cubic Au were found to co-exist with wurtzite ZnO nanostructure. Atomic force microscopy observations revealed that as the Au content increased, the overall crystallite size increased, which was supported by X-ray diffraction measurements. The structural characterizations indicated that the Au on the ZnO crystal lattice exists without any impurities in a preferred orientation (002). When the ZnO thickness increased from 10 to 40 nm, transmittance and an optical bandgap value decreased. Interestingly, with 50 nm thickness, the band gap value was increased, which might be due to the Burstein-Moss effect. Photoluminescence studies revealed that the overall structural defect (green emission) improved significantly as the Au deposition increased. The impedance measurements shows a decreasing value of impedance arc with increasing Au thicknesses (0 to 40 nm). In contrast, the 50 nm AuNP impedance arc shows an increased value compared to lower sputtering thicknesses, which indicated the presence of larger sized AuNPs that form a continuous film, and its ohmic characteristics changed to rectifying characteristics. This improved hybrid thin film (ZnO/Au) is suitable for a wide range of sensing applications.	[Perumal, Veeradasan; Hashim, Uda; Gopinath, Subash C. B.; Haarindraprasad, R.; Liu, Wei-Wen; Balakrishnan, S. R.; Thivina, V.; Ruslinda, A. R.] Univ Malaysia Perlis, Inst Nano Elect Engn INEE, Biomed Nano Diagnost Res Grp, Kangar, Perlis, Malaysia; [Hashim, Uda; Poopalan, P.] Univ Malaysia Perlis, Sch Microelect Engn, Kuala Perlis, Perlis, Malaysia; [Gopinath, Subash C. B.] Univ Malaysia Perlis, Sch Bioproc Engn, Arau, Perlis, Malaysia	Universiti Malaysia Perlis; Universiti Malaysia Perlis; Universiti Malaysia Perlis	Hashim, U (corresponding author), Univ Malaysia Perlis, Inst Nano Elect Engn INEE, Biomed Nano Diagnost Res Grp, Kangar, Perlis, Malaysia.	uda@unimap.edu.my	Balakrishnan, Sharma Rao/G-4561-2015; Rahim, Ruslinda A/AAR-5069-2020; Balakrishnan, Sharma Rao/AAP-2889-2021; Gopinath, Subash/D-2953-2015; LIU, WEI WEN/D-2098-2015; A.Rahim, Ruslinda/K-7078-2014	Balakrishnan, Sharma Rao/0000-0002-6796-2277; Rahim, Ruslinda A/0000-0001-8549-0077; Balakrishnan, Sharma Rao/0000-0002-6796-2277; Gopinath, Subash/0000-0002-8347-4687; LIU, WEI WEN/0000-0002-7632-9078; A.Rahim, Ruslinda/0000-0002-3511-9509; Perumal, Veeradasan/0000-0003-4492-0282; POOPALAN, PRABAKARAN/0000-0003-1698-0632	Universiti Malaysia Perlis (UniMAP); Ministry of Higher Education Malaysia through MTUN-COE [9016-00004]	Universiti Malaysia Perlis (UniMAP); Ministry of Higher Education Malaysia through MTUN-COE	The authors would like to thank Universiti Malaysia Perlis (UniMAP), and Ministry of Higher Education Malaysia for the financial support through MTUN-COE grant 9016-00004 to conduct the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Douri Y, 2013, PROCEDIA ENGINEER, V53, P400, DOI 10.1016/j.proeng.2013.02.052; Alaeddin AS, 2010, J KOREAN PHYS SOC, V57, P1449, DOI [10.3938/jkps.57.1449, DOI 10.3938/JKPS.57.1449]; Antoine TE, 2012, ANTIVIR RES, V96, P363, DOI 10.1016/j.antiviral.2012.09.020; Arshad M, 2015, J LUMIN, V161, P275, DOI 10.1016/j.jlumin.2014.12.016; Balakrishnan SR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137891; Balakrishnan SR, 2016, BIOSENS BIOELECTRON, V84, P44, DOI 10.1016/j.bios.2015.10.075; Balakrishnan SR, 2014, SENSOR ACTUAT A-PHYS, V220, P101, DOI 10.1016/j.sna.2014.09.027; Chen Y, 2012, J PHYS CHEM SOLIDS, V73, P1259, DOI 10.1016/j.jpcs.2012.06.007; Cheng CW, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3323091; Cheng C, 2014, SCI REP-UK, V4, DOI 10.1038/srep04181; Deki S, 1996, J MATER CHEM, V6, P1879, DOI 10.1039/jm9960601879; Dhara S, 2011, J APPL PHYS, V110, DOI 10.1063/1.3671023; Fabbri F, 2014, SCI REP-UK, V4, DOI 10.1038/srep05158; Foo KL, 2016, MICROSYST TECHNOL, V22, P903, DOI 10.1007/s00542-015-2572-x; Foo KL, 2014, CERAM INT, V40, P753, DOI 10.1016/j.ceramint.2013.06.065; Fujimaki M, 2010, OPT EXPRESS, V18, P15732, DOI 10.1364/OE.18.015732; Gedamu D, 2014, ADV MATER, V26, P1541, DOI 10.1002/adma.201304363; GHOSH DK, 1984, INFRARED PHYS, V24, P43, DOI 10.1016/0020-0891(84)90046-0; Gogurla N, 2014, SCI REP-UK, V4, DOI 10.1038/srep06483; Gopinath SCB, 2008, ACS NANO, V2, P1885, DOI 10.1021/nn800285p; Gopinath SCB, 2012, ANALYST, V137, P3520, DOI 10.1039/c2an35159e; Gopinath SCB, 2011, SENSOR ACTUAT B-CHEM, V155, P239, DOI 10.1016/j.snb.2010.11.054; Guo J, 2014, SENSOR ACTUAT B-CHEM, V199, P339, DOI 10.1016/j.snb.2014.04.010; Haarindraprasad R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132755; HERVE PJL, 1995, J APPL PHYS, V77, P5476, DOI 10.1063/1.359248; Hosseini ZS, 2015, J ALLOY COMPD, V628, P222, DOI 10.1016/j.jallcom.2014.12.163; Jain PK, 2007, NANO TODAY, V2, P18, DOI 10.1016/S1748-0132(07)70016-6; Jiang RB, 2014, ADV MATER, V26, P5274, DOI 10.1002/adma.201400203; Jin X, 2013, ADV MATER, V25, P1342, DOI 10.1002/adma.201203849; Jin ZW, 2014, SCI REP-UK, V4, DOI 10.1038/srep04268; Joseph B, 1999, B MATER SCI, V22, P921, DOI 10.1007/BF02745554; Kahraman S, 2013, J CRYST GROWTH, V363, P86, DOI 10.1016/j.jcrysgro.2012.10.018; Kang DJ, 2005, THIN SOLID FILMS, V475, P160, DOI 10.1016/j.tsf.2004.07.029; Kashif M, 2013, CERAM INT, V39, P6461, DOI 10.1016/j.ceramint.2013.01.075; Kashif M, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-68; Khoa NT, 2015, ACS APPL MATER INTER, V7, P3524, DOI 10.1021/acsami.5b00152; Kim WM, 2013, THIN SOLID FILMS, V531, P430, DOI 10.1016/j.tsf.2013.01.078; Kumar M, 2016, PLASMONICS, V11, P261, DOI 10.1007/s11468-015-0044-x; Kumar M, 2015, SCRIPTA MATER, V105, P46, DOI 10.1016/j.scriptamat.2015.04.030; Kumar M, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4922732; Kumar M, 2014, PLASMONICS, V9, P129, DOI 10.1007/s11468-013-9605-z; Kumar M, 2011, J APPL PHYS, V109, DOI 10.1063/1.3555593; Kumar M, 2010, PHYSICA E, V43, P470, DOI 10.1016/j.physe.2010.08.031; Kumar M, 2009, PHYS STATUS SOLIDI B, V246, P2232, DOI 10.1002/pssb.200844464; Kumar R, 2015, TALANTA, V137, P204, DOI 10.1016/j.talanta.2015.01.039; Lai CW, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1954883; Lakshmipriya T, 2013, LANGMUIR, V29, P15107, DOI 10.1021/la4027283; Li XH, 2009, OPT EXPRESS, V17, P8735, DOI 10.1364/OE.17.008735; Lim ZZJ, 2011, ACTA PHARMACOL SIN, V32, P983, DOI 10.1038/aps.2011.82; Lin HY, 2006, OPT EXPRESS, V14, P2372, DOI 10.1364/OE.14.002372; Lin JH, 2014, SCI REP-UK, V4, DOI 10.1038/srep06967; Mishra YK, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2838302; Mishra YK, 2007, J OPT A-PURE APPL OP, V9, pS410, DOI 10.1088/1464-4258/9/9/S21; Mishra YK, 2012, J APPL PHYS, V112, DOI 10.1063/1.4752469; Mishra YK, 2015, ACS APPL MATER INTER, V7, P14303, DOI 10.1021/acsami.5b02816; Mishra YK, 2014, KONA POWDER PART J, P92; Mishra YK, 2011, ANTIVIR RES, V92, P305, DOI 10.1016/j.antiviral.2011.08.017; Mohapatra S, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2894187; Mohapatra S., 2013, ADV MAT LETT, V4, P444, DOI [DOI 10.5185/AMLETT.2012.IB.111, 10.5185/amlett.2012.ib.111]; Naseri N, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/10/105405; Naseri N, 2010, THIN SOLID FILMS, V518, P2250, DOI 10.1016/j.tsf.2009.08.001; Nomura K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3855; Notes S, 1979, PHYS STATUS SOLIDI, V93, pK115; Nour ES, 2015, AIP ADV, V5, DOI 10.1063/1.4927510; Ozga K, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/18/185709; Park S, 2014, J LUMIN, V147, P5, DOI 10.1016/j.jlumin.2013.10.044; PERUMAL V, 2013, RSM 2013 IEEE REG S, P33, DOI DOI 10.1109/RSM.2013.6706466; Perumal V, 2016, BIOSENS BIOELECTRON, V78, P14, DOI 10.1016/j.bios.2015.10.083; Perumal V, 2015, SCI REP-UK, V5, DOI 10.1038/srep12231; Perumal V, 2014, J APPL BIOMED, V12, P1, DOI 10.1016/j.jab.2013.02.001; Rouhi J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123433; Sahu D, 2014, OPT MATER, V36, P1402, DOI 10.1016/j.optmat.2014.03.041; Saif AA, 2011, SOLID STATE ELECTRON, V62, P25, DOI 10.1016/j.sse.2011.03.004; Saif AA, 2011, J ALLOY COMPD, V509, P7210, DOI 10.1016/j.jallcom.2011.04.068; Sangpour P, 2007, APPL SURF SCI, V253, P7438, DOI 10.1016/j.apsusc.2007.03.050; Shan GY, 2008, J COLLOID INTERF SCI, V326, P392, DOI 10.1016/j.jcis.2008.06.027; Shao DL, 2012, NANO LETT, V12, P5840, DOI 10.1021/nl3031955; Shi XH, 2014, MICROCHIM ACTA, V181, P1, DOI 10.1007/s00604-013-1069-5; Shinde SS, 2013, J ALLOY COMPD, V551, P688, DOI 10.1016/j.jallcom.2012.11.057; Song JZ, 2015, ANGEW CHEM INT EDIT, V54, P9760, DOI 10.1002/anie.201501233; Song JZ, 2015, ANGEW CHEM INT EDIT, V54, P462, DOI 10.1002/anie.201408621; Srivastava S, 2015, J ALLOY COMPD, V644, P597, DOI 10.1016/j.jallcom.2015.04.220; Strunk J, 2009, APPL CATAL A-GEN, V359, P121, DOI 10.1016/j.apcata.2009.02.030; Su L, 2015, CERAM INT, V41, P2673, DOI 10.1016/j.ceramint.2014.10.081; Sun YG, 2003, ANALYST, V128, P686, DOI 10.1039/b212437h; Tan ST, 2005, J APPL PHYS, V98, DOI 10.1063/1.1940137; Tarwal NL, 2013, SENSOR ACTUAT A-PHYS, V199, P67, DOI 10.1016/j.sna.2013.05.003; Tarwal NL, 2012, ELECTROCHIM ACTA, V72, P32, DOI 10.1016/j.electacta.2012.03.135; UNDERWOOD S, 1994, LANGMUIR, V10, P3427, DOI 10.1021/la00022a011; Upadhyayula VKK, 2012, ANAL CHIM ACTA, V715, P1, DOI 10.1016/j.aca.2011.12.008; Wang FH, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-97; Wang XH, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-109; Wang X, 2007, J PHYS CHEM C, V111, P3836, DOI 10.1021/jp064118z; Wu AP, 2015, SCI REP-UK, V5, DOI 10.1038/srep08858; Wu JJ, 2006, APPL CATAL B-ENVIRON, V66, P51, DOI 10.1016/j.apcatb.2006.02.013; Xu JP, 2013, MAT SCI SEMICON PROC, V16, P732, DOI 10.1016/j.mssp.2012.12.016; Xu Y, 2014, J ALLOY COMPD, V585, P479, DOI 10.1016/j.jallcom.2013.09.199; Yuan YJ, 2011, OPT ENG, V50, DOI 10.1117/1.3554392; Zeng HB, 2010, ADV FUNCT MATER, V20, P561, DOI 10.1002/adfm.200901884; Zhang XY, 2014, SCI REP-UK, V4, DOI 10.1038/srep04596	100	25	25	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0144964	10.1371/journal.pone.0144964	http://dx.doi.org/10.1371/journal.pone.0144964			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26694656	Green Submitted, gold, Green Published			2022-12-26	WOS:000367092500018
J	Brodie, BS; Smith, MA; Lawrence, J; Gries, G				Brodie, Bekka S.; Smith, Maia A.; Lawrence, Jason; Gries, Gerhard			Effects of Floral Scent, Color and Pollen on Foraging Decisions and Oocyte Development of Common Green Bottle Flies	PLOS ONE			English	Article							COCHLIOMYIA-HOMINIVORAX DIPTERA; BLOWFLY LUCILIA-SERICATA; OVARIAN DEVELOPMENT; FEEDING PREFERENCES; SARCOPHAGA-BULLATA; OVIPOSITION SITES; RESOURCE-LOCATION; NEW-ZEALAND; CALLIPHORIDAE; CUPRINA	The common green bottle fly Lucilia sericata (Meigen) and other filth flies frequently visit pollen-rich composite flowers such as the Oxeye daisy, Leucanthemum vulgare Lam. In laboratory experiments with L. sericata, we investigated the effect of generic floral scent and color cues, and of Oxeye daisy-specific cues, on foraging decisions by recently eclosed flies. We also tested the effect of a floral pollen diet with 0-35% moisture content on the ability of females to mature their oocytes. Our data indicate that (1) young flies in the presence of generic floral scent respond more strongly to a uniformly yellow cue than to any other uniform color cue (green, white, black, blue, red) except for ultraviolet (UV); (2) the floral scent of Oxeye daisies enhances the attractiveness of a yellow cue; and (3) moisture-rich pollen provides nutrients that facilitate ovary maturation of flies. With evidence that L. sericata exploits floral cues during foraging, and that pollen can be an alternate protein source to animal feces and carrion, Pollen apparently plays a major role in the foraging ecology of L. sericata and possibly other filth flies. These flies, in turn, may play a significant role as pollinators, as supported by a recently published study.	[Brodie, Bekka S.; Smith, Maia A.; Lawrence, Jason; Gries, Gerhard] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Brodie, BS (corresponding author), Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada.	bekkasbrodie@gmail.com			Natural Sciences and Engineering Research Council of Canada (NSERC) - Industrial Research Chair; Scotts Canada Limited [IRCPJ/310420-2013]	Natural Sciences and Engineering Research Council of Canada (NSERC) - Industrial Research Chair(Natural Sciences and Engineering Research Council of Canada (NSERC)); Scotts Canada Limited	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) - Industrial Research Chair to G. G., with Scotts Canada Limited as the industrial partner (Project funding sources number: IRCPJ/310420-2013).	Aak A, 2011, ENTOMOL EXP APPL, V139, P25, DOI 10.1111/j.1570-7458.2011.01103.x; ADAMS TS, 1979, J MED ENTOMOL, V15, P472, DOI 10.1093/jmedent/15.5-6.472; Ahmad A, 2006, J MED ENTOMOL, V43, P1129, DOI 10.1603/0022-2585(2006)43[1129:EOSOBI]2.0.CO;2; Blowflies Erzinclioglu Z., 1996, GREAT BRITAIN RICHMO; Blystone AM, 2014, J MED ENTOMOL, V51, P1296, DOI 10.1603/ME13157; Briscoe AD, 2001, ANNU REV ENTOMOL, V46, P471, DOI 10.1146/annurev.ento.46.1.471; Brodie B, 2014, ENTOMOL EXP APPL, V153, P114, DOI 10.1111/eea.12238; Browne LB, 2001, ENTOMOL EXP APPL, V100, P137, DOI 10.1046/j.1570-7458.2001.00859.x; BROWNE LB, 1979, J INSECT PHYSIOL, V25, P147, DOI 10.1016/0022-1910(79)90093-3; Byrd JH., 2010, FORENSIC ENTOMOLOGY, P41; Carter DO, 2007, NATURWISSENSCHAFTEN, V94, P12, DOI 10.1007/s00114-006-0159-1; Castellanos MC, 2004, J EVOLUTION BIOL, V17, P876, DOI 10.1111/j.1420-9101.2004.00729.x; Chaudhury MF, 2010, J MED ENTOMOL, V47, P349, DOI 10.1603/ME09235; Chittka L, 1997, ISRAEL J PLANT SCI, V45, P115, DOI 10.1080/07929978.1997.10676678; Chittka L, 1996, J THEOR BIOL, V181, P179, DOI 10.1006/jtbi.1996.0124; CLIFT AD, 1976, AUST J ZOOL, V24, P87, DOI 10.1071/ZO9760087; COOK DF, 1991, B ENTOMOL RES, V81, P249, DOI 10.1017/S0007485300033502; CURRAH L, 1984, ANN APPL BIOL, V105, P167, DOI 10.1111/j.1744-7348.1984.tb02812.x; DAY S, 1990, J APICULT RES, V29, P138, DOI 10.1080/00218839.1990.11101210; DESALOMON CH, 1983, J COMP PHYSIOL, V150, P31, DOI 10.1007/BF00605285; Diclaro JW, 2012, J MED ENTOMOL, V49, P94, DOI 10.1603/ME10257; Dinkel T, 2001, J INSECT PHYSIOL, V47, P1111, DOI 10.1016/S0022-1910(01)00080-4; Dobson HEM, 2006, BIOLOGY OF FLORAL SCENT, P147; Dobson Heidi E.M., 1994, P47; Douglas JM, 2007, J EXP BIOL, V210, P788, DOI 10.1242/jeb.02713; Dudareva N, 2006, BIOL FLORAL SCENT; Evans A. C., 1935, Bulletin of Entomological Research London, V26, P115, DOI 10.1017/S0007485300024949; Fuenmayor C, 2014, REV MVZ CORDOBA, V19, P4003, DOI 10.21897/rmvz.120; FUKUSHI T, 1989, J COMP PHYSIOL A, V166, P57, DOI 10.1007/BF00190210; Galloway Alison, 1997, P139; Geraci D, 1989, POLLINOSIS, P240; Gilbert F, 1998, BIOL J LINN SOC, V63, P495, DOI 10.1111/j.1095-8312.1998.tb00327.x; Gomes L, 2007, NEOTROP ENTOMOL, V36, P633, DOI 10.1590/S1519-566X2007000500001; Hall DJ, 1948, BLOW FLIES N AM; HASLETT JR, 1983, PHYSIOL ENTOMOL, V8, P167, DOI 10.1111/j.1365-3032.1983.tb00345.x; HEATH ACG, 1982, NZ ENTOMOL, V7, P343, DOI 10.1080/00779962.1982.9722422; HERBERT EW, 1978, APIDOLOGIE, V9, P33, DOI 10.1051/apido:19780103; Hikl AL, 2011, J INSECT SCI, V11, P1, DOI 10.1673/031.011.9901; Jurgens A, 2013, ECOL LETT, V16, P1157, DOI 10.1111/ele.12152; KARCZEWSKI J, 1967, Fragmenta Faunistica (Warsaw), V13, P407; KAY QON, 1976, NATURE, V261, P230, DOI 10.1038/261230a0; Kessler D, 2008, SCIENCE, V321, P1200, DOI 10.1126/science.1160072; King C, 2013, METHODS ECOL EVOL, V4, P811, DOI 10.1111/2041-210X.12074; Koski MH, 2014, FUNCT ECOL, V28, P868, DOI 10.1111/1365-2435.12242; Kroon G.H., 1974, Journal apic Res, V13, P177; Larson BMH, 2001, CAN ENTOMOL, V133, P439, DOI 10.4039/Ent133439-4; Leonard AS, 2011, J EXP BIOL, V214, P113, DOI 10.1242/jeb.047407; LUNAU K, 1995, J COMP PHYSIOL A, V177, P1; Mackerras M. J., 1933, Bulletin of Entomological Research London, V24, P353, DOI 10.1017/S0007485300031680; Mohr RM, 2015, INT J LEGAL MED, V129, P851, DOI 10.1007/s00414-014-1094-x; Mohr RM, 2014, J MED ENTOMOL, V51, P702, DOI 10.1603/ME13149; Munawar M. S., 2011, Journal of Agricultural Research (Lahore), V49, P49; Nuttman CV, 2006, BIOL J LINN SOC, V87, P427, DOI 10.1111/j.1095-8312.2006.00582.x; Orford KA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2934; Pietro Z, 2013, ARTHROPOD-PLANT INTE, V7, P485; Pombal ECP, 2000, PLANT SYST EVOL, V221, P141, DOI 10.1007/BF01089290; POTTER CF, 1988, AM MIDL NAT, V120, P156, DOI 10.2307/2425896; PRIMACK RB, 1983, NEW ZEAL J BOT, V21, P317, DOI 10.1080/0028825X.1983.10428561; Proctor M., 1996, NATURAL HIST POLLINA; Raguso RA, 2001, COGNITIVE ECOLOGY OF POLLINATION: ANIMAL BEHAVIOUR AND FLORAL EVOLUTION, P83, DOI 10.1017/CBO9780511542268.006; RATHMAN ES, 1990, AM MIDL NAT, V124, P379, DOI 10.2307/2426188; READSHAW JL, 1983, J ANIM ECOL, V52, P879, DOI 10.2307/4461; Richard R, 2012, FUNCT ECOL, V26, P1399, DOI 10.1111/j.1365-2435.2012.02050.x; Roulston TH, 2000, PLANT SYST EVOL, V222, P187, DOI 10.1007/BF00984102; Sasaki H, 2001, APPL ENTOMOL ZOOL, V36, P515, DOI 10.1303/aez.2001.515; Shuttleworth A, 2010, P ROY SOC B-BIOL SCI, V277, P2811, DOI 10.1098/rspb.2010.0491; Singh B, 2015, APPL MICROBIOL BIOT, V99, P869, DOI 10.1007/s00253-014-6115-7; SPIVAK M, 1991, ANN ENTOMOL SOC AM, V84, P447, DOI 10.1093/aesa/84.4.447; Stensmyr MC, 2002, NATURE, V420, P625, DOI 10.1038/420625a; STOFFOLANO JG, 1995, MED VET ENTOMOL, V9, P388, DOI 10.1111/j.1365-2915.1995.tb00010.x; Stone CM, 2009, J MED ENTOMOL, V46, P1327, DOI 10.1603/033.046.0611; Thapa R.B., 2006, Journal of the Institute of Agriculture and Animal Science, V27, P1; Tomberlin JK, 2012, ANIM BEHAV, V84, P1449, DOI 10.1016/j.anbehav.2012.09.013; TORR SJ, 1992, B ENTOMOL RES, V82, P417, DOI 10.1017/S0007485300041213; Urru I, 2010, BIOL J LINN SOC, V101, P991, DOI 10.1111/j.1095-8312.2010.01537.x; Wall R, 1996, MED VET ENTOMOL, V10, P235, DOI 10.1111/j.1365-2915.1996.tb00736.x; WALL R, 1992, MED VET ENTOMOL, V6, P67, DOI 10.1111/j.1365-2915.1992.tb00038.x; Wall R, 2001, PHYSIOL ENTOMOL, V26, P212, DOI 10.1046/j.0307-6962.2001.00237.x; Wardhaugh KG, 2008, ENTOMOL EXP APPL, V126, P179, DOI 10.1111/j.1570-7458.2007.00659.x; Webber LG, 1956, AUST J ZOOL, V5, P164; WILLIAMS KL, 1979, INT J INVER REP DEV, V1, P75	81	15	16	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145055	10.1371/journal.pone.0145055	http://dx.doi.org/10.1371/journal.pone.0145055			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717311	Green Published, Green Submitted, gold			2022-12-26	WOS:000367510500020
J	Liao, TYA; Lau, A; Joseph, S; Hytonen, V; Hmama, Z				Liao, Ting-Yu Angela; Lau, Alice; Joseph, Sunil; Hytonen, Vesa; Hmama, Zakaria			Improving the Immunogenicity of the Mycobacterium bovis BCG Vaccine by NonGenetic Bacterial Surface Decoration Using the Avidin-Biotin System	PLOS ONE			English	Article							ANTIGEN CROSS-PRESENTATION; BACILLUS-CALMETTE-GUERIN; T-CELLS; IN-VIVO; RESISTANT TUBERCULOSIS; PHAGOSOME MATURATION; PROTECTION; EFFICACY; IMMUNITY; EXPRESSION	Current strategies to improve the current BCG vaccine attempt to over-express genes encoding specific M. tuberculosis (Mtb) antigens and/or regulators of antigen presentation function, which indeed have the potential to reshape BCG in many ways. However, these approaches often face serious difficulties, in particular the efficiency and stability of gene expression via nucleic acid complementation and safety concerns associated with the introduction of exogenous DNA. As an alternative, we developed a novel non-genetic approach for rapid and efficient display of exogenous proteins on bacterial cell surface. The technology involves expression of proteins of interest in fusion with a mutant version of monomeric avidin that has the feature of reversible binding to biotin. Fusion proteins are then used to decorate the surface of biotinylated BCG. Surface coating of BCG with recombinant proteins was highly reproducible and stable. It also resisted to the freeze-drying shock routinely used in manufacturing conventional BCG. Modifications of BCG surface did not affect its growth in culture media neither its survival within the host cell. Macrophages phagocytized coated BCG bacteria, which efficiently delivered their surface cargo of avidin fusion proteins to MHC class I and class II antigen presentation compartments. Thereafter, chimeric proteins corresponding to a surrogate antigen derived from ovalbumin and the Mtb specific ESAT6 antigen were generated and tested for immunogenicity in vaccinated mice. We found that BCG displaying ovalbumin antigen induces an immune response with a magnitude similar to that induced by BCG genetically expressing the same surrogate antigen. We also found that BCG decorated with Mtb specific antigen ESAT6 successfully induces the expansion of specific T cell responses. This novel technology, therefore, represents a practical and effective alternative to DNA-based gene expression for upgrading the current BCG vaccine.	[Liao, Ting-Yu Angela; Lau, Alice; Joseph, Sunil; Hmama, Zakaria] Univ British Columbia, Div Infect Dis, Dept Med, Vancouver, BC V5Z 1M9, Canada; [Liao, Ting-Yu Angela; Lau, Alice; Joseph, Sunil; Hmama, Zakaria] Univ British Columbia, Vancouver Costal Hlth Res Inst, Vancouver, BC V5Z 1M9, Canada; [Hytonen, Vesa] Univ Tampere, Inst Biomed Technol, FIN-33101 Tampere, Finland	University of British Columbia; University of British Columbia; Tampere University	Hmama, Z (corresponding author), Univ British Columbia, Div Infect Dis, Dept Med, Vancouver, BC V5Z 1M9, Canada.	hmama@mail.ubc.ca	Hytonen, Vesa P./E-8855-2013	Hytonen, Vesa P./0000-0002-9357-1480	TB Veteran Association; British Columbia Lung Association; Canadian Institute of Health Research [MOP-97898]	TB Veteran Association; British Columbia Lung Association; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	Funding for this research was provided by the TB Veteran Association, British Columbia Lung Association and the Canadian Institute of Health Research Operating Grant MOP-97898. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Zarouni M, 2002, TUBERCULOSIS, V82, P283, DOI 10.1054/tube.2002.0374; Bastos RG, 2009, VACCINE, V27, P6495, DOI 10.1016/j.vaccine.2009.08.044; Basu S, 2008, EPIDEMIOL INFECT, V136, P1585, DOI 10.1017/S0950268808000964; Behar SM, 2013, ADV EXP MED BIOL, V783, P141, DOI 10.1007/978-1-4614-6111-1_8; Bigini P, 2014, ACS NANO, V8, P175, DOI 10.1021/nn402669w; BUBB MO, 1993, IMMUNOL LETT, V35, P277, DOI 10.1016/0165-2478(93)90194-7; Chatterjee S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002378; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Cummings JF, 2014, VACCINE, V32, P2251, DOI 10.1016/j.vaccine.2013.10.017; da Costa AC, 2014, RECOMBINANT BCG INNO, P5; Deghmane AE, 2007, J CELL SCI, V120, P2796, DOI 10.1242/jcs.006221; Dietrich J, 2005, J IMMUNOL, V174, P6332, DOI 10.4049/jimmunol.174.10.6332; Dudani R, 2002, J IMMUNOL, V168, P5737, DOI 10.4049/jimmunol.168.11.5737; English L, 2009, NAT IMMUNOL, V10, P480, DOI 10.1038/ni.1720; FINE PEM, 1989, REV INFECT DIS, V11, pS353; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; GREEN NM, 1990, METHOD ENZYMOL, V184, P51; Grode L, 2005, J CLIN INVEST, V115, P2472, DOI 10.1172/JCI24617; Harries AD, 2010, LANCET, V375, P1906, DOI 10.1016/S0140-6736(10)60409-6; Hinchey J, 2007, J CLIN INVEST, V117, P2279, DOI 10.1172/JCI31947; Horwitz MA, 2003, INFECT IMMUN, V71, P1672, DOI 10.1128/IAI.71.4.1672-1679.2003; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; Howarth M, 2005, P NATL ACAD SCI USA, V102, P7583, DOI 10.1073/pnas.0503125102; Kamath AT, 2005, VACCINE, V23, P3753, DOI 10.1016/j.vaccine.2005.03.001; Kolotilin I, 2014, VET RES, V45, DOI 10.1186/s13567-014-0117-4; LABIDI A, 1985, ANN INST PASTEUR MIC, V136B, P209, DOI 10.1016/S0769-2609(85)80045-4; Laitinen OH, 2003, J BIOL CHEM, V278, P4010, DOI 10.1074/jbc.M205844200; Lesch HP, 2010, EXPERT OPIN DRUG DEL, V7, P551, DOI 10.1517/17425241003677749; Mederle I, 2002, INFECT IMMUN, V70, P303, DOI 10.1128/IAI.70.1.303-314.2002; Moro ML, 1998, AIDS, V12, P1095, DOI 10.1097/00002030-199809000-00017; Oizumi S, 2007, J IMMUNOL, V179, P2310, DOI 10.4049/jimmunol.179.4.2310; Paganelli G, 2006, NEUROL RES, V28, P518, DOI 10.1179/016164106X116782; Petronzelli F, 2010, CANCER BIOTHER RADIO, V25, P563, DOI 10.1089/cbr.2010.0797; Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859; RODRIGUES LC, 1993, INT J EPIDEMIOL, V22, P1154, DOI 10.1093/ije/22.6.1154; Russell MS, 2007, J IMMUNOL, V179, P211, DOI 10.4049/jimmunol.179.1.211; Sendide K, 2005, J IMMUNOL, V174, P4210, DOI 10.4049/jimmunol.174.7.4210; Sharif-Paghaleh E, 2014, EUR J IMMUNOL, V44, P2188, DOI 10.1002/eji.201344337; Snewin VA, 1999, INFECT IMMUN, V67, P4586, DOI 10.1128/IAI.67.9.4586-4593.1999; Soualhine H, 2007, J IMMUNOL, V179, P5137, DOI 10.4049/jimmunol.179.8.5137; Sun J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003499; Sun J, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008769, 10.1371/journal.pone.0011351]; Sun J, 2009, PLASMID, V62, P158, DOI 10.1016/j.plasmid.2009.07.003; Sun R, 2009, VACCINE, V27, P4412, DOI 10.1016/j.vaccine.2009.05.048; Udwadia ZF, 2012, CLIN INFECT DIS, V54, P579, DOI 10.1093/cid/cir889; Winau F, 2006, IMMUNITY, V24, P105, DOI 10.1016/j.immuni.2005.12.001	47	7	10	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145833	10.1371/journal.pone.0145833	http://dx.doi.org/10.1371/journal.pone.0145833			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716832	Green Published, Green Submitted, gold			2022-12-26	WOS:000367510500081
J	Abo, H; Soga, K; Tanaka, A; Tateno, H; Hirabayashi, J; Yamamoto, K				Abo, Hirohito; Soga, Keisuke; Tanaka, Atsuhiro; Tateno, Hiroaki; Hirabayashi, Jun; Yamamoto, Kazuo			Mutated Leguminous Lectin Containing a Heparin-Binding like Motif in a Carbohydrate-Binding Loop Specifically Binds to Heparin	PLOS ONE			English	Article							SULFATE BIOSYNTHESIS; EFFICIENT; PROTEINS; SITE	We previously introduced random mutations in the sugar-binding loops of a leguminous lectin and screened the resulting mutated lectins for novel specificities using cell surface display. Screening of a mutated peanut agglutinin (PNA), revealed a mutated PNA with a distinct preference for heparin. Glycan microarray analyses using the mutated lectin fused to the Fc region of human immunoglobulin, revealed that a particular sulfated glycosaminoglycan (GAG), heparin, had the highest binding affinity for mutated PNA among 97 glycans tested, although wild-type PNA showed affinity towards Gal beta 1-3GalNAc and similar galactosylated glycans. Further analyses of binding specificity using an enzyme-linked immunoadsorbent assay demonstrated that the mutated PNA specifically binds to heparin, and weakly to de-2-O-sulfated heparin, but not to other GAG chains including de-6-O-sulfated and de-N-sulfated heparins. The mutated PNA had six amino acid substitutions within the eight amino acid-long sugar-binding loop. In this loop, the heparin-binding like motif comprised three arginine residues at positions 124, 128, and 129, and a histidine at position 125 was present. Substitution of each arginine or histidine residue to alanine reduced heparin-binding ability, indicating that all of these basic amino acid residues contributed to heparin binding. Inhibition assay demonstrated that heparin and dextran sulfate strongly inhibited mutated PNA binding to heparin in dose-dependent manner. The mutated PNA could distinguish between CHO cells and proteoglycan-deficient mutant cells. This is the first report establishing a novel leguminous lectin that preferentially binds to highly sulfated heparin and may provide novel GAG-binding probes to distinguish between heterogeneous GAG repeating units.	[Abo, Hirohito; Soga, Keisuke; Tanaka, Atsuhiro; Yamamoto, Kazuo] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba 2778562, Japan; [Tateno, Hiroaki; Hirabayashi, Jun] Natl Inst Adv Ind Sci & Technol, Res Ctr Stem Cell Engn, Tsukuba, Ibaraki 3058568, Japan	University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST)	Yamamoto, K (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba 2778562, Japan.	yamamoto@k.u-tokyo.ac.jp	Hirabayashi, Jun/M-3998-2018; Tateno, Hiroaki/M-2706-2018	Hirabayashi, Jun/0000-0002-8571-359X; Tateno, Hiroaki/0000-0003-3006-1659; abo, hirohito/0000-0002-3066-8584; SOGA, Keisuke/0000-0001-7387-468X	Ministry of Education, Culture, Sports, Science, and Technology of Japan [15K14948, 24390015, 24659026, 25117710]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (https://www.jsps.go.jp/j-grantsinaid/) [grant numbers 15K14948 (to KY), 24390015 (to KY), 24659026 (to KY), and 25117710 (to KY)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Ms. Jinko Murakami and Ms. Kayo Suzuki for help in glycan microarray production. This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan [grant numbers 15K14948 (to KY), 24390015 (to KY), 24659026 (to KY), and 25117710 (to KY)].	CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; ESKO JD, 1987, J BIOL CHEM, V262, P12189; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; ESKO JD, 1988, SCIENCE, V241, P1092, DOI 10.1126/science.3137658; Ishihara M, 1997, J BIOCH, V121, P354; Ishitsuka R, 1998, J BIOL CHEM, V273, P9935, DOI 10.1074/jbc.273.16.9935; KONAMI Y, 1994, J BIOCHEM-TOKYO, V115, P767, DOI 10.1093/oxfordjournals.jbchem.a124408; LIDHOLT K, 1992, P NATL ACAD SCI USA, V89, P2267, DOI 10.1073/pnas.89.6.2267; Liener IE, 1986, LECTINS PROPERTIES F, P43; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ohtsuka M, 2004, P NATL ACAD SCI USA, V101, P8126, DOI 10.1073/pnas.0401119101; Proudfoot AEI, 2001, J BIOL CHEM, V276, P10620, DOI 10.1074/jbc.M010867200; Saito A, 2007, BBA-GEN SUBJECTS, V1770, P241, DOI 10.1016/j.bbagen.2006.10.015; Sharma V, 1997, J MOL BIOL, V267, P433, DOI 10.1006/jmbi.1996.0863; Sharon N, 1993, LECTINS, P179; Soga K, 2015, BIOMOLECULES, V5, P1540, DOI 10.3390/biom5031540; Sugahara K, 2002, IUBMB LIFE, V54, P163, DOI 10.1080/15216540214928; Tateno H, 2008, GLYCOBIOLOGY, V18, P789, DOI 10.1093/glycob/cwn068; Torrent M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042692; Yamamoto K, 1997, J BIOCHEM-TOKYO, V121, P756	21	7	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145834	10.1371/journal.pone.0145834	http://dx.doi.org/10.1371/journal.pone.0145834			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714191	Green Submitted, Green Published, gold			2022-12-26	WOS:000367481900090
J	Loffler, SG; Rago, V; Martinez, M; Uhart, M; Florin-Christensen, M; Romero, G; Brihuega, B				Loffler, Sylvia Grune; Rago, Virginia; Martinez, Mara; Uhart, Marcela; Florin-Christensen, Monica; Romero, Graciela; Brihuega, Bibiana			Isolation of a Seawater Tolerant Leptospira spp. from a Southern Right Whale (Eubalaena australis)	PLOS ONE			English	Article							CALIFORNIA SEA LIONS; PATHOGENIC LEPTOSPIRA; ZALOPHUS-CALIFORNIANUS; HARBOR SEALS; PCR; SEROPREVALENCE; IDENTIFICATION; DISEASE	Leptospirosis is the most widespread zoonotic disease in the world. It is caused by pathogenic spirochetes of the genus Leptospira spp. and is maintained in nature through chronic renal infection of carrier animals. Rodents and other small mammals are the main reservoirs. Information on leptospirosis in marine mammals is scarce; however, cases of leptospirosis have been documented in pinniped populations from the Pacific coast of North America from southern California to British Columbia. We report the isolation of a Leptospira spp. strain, here named Manara, from a kidney sample obtained from a Southern Right Whale (Eubalaena australis) calf, which stranded dead in Playa Manara, Peninsula Valdes, Argentina. This strain showed motility and morphology typical of the genus Leptospira spp. under dark-field microscopy; and grew in Ellinghausen-McCullough-Johnson-Harris (EMJH) medium and Fletcher medium after 90 days of incubation at 28 degrees C. Considering the source of this bacterium, we tested its ability to grow in Fletcher medium diluted with seawater at different percentages (1%, 3%, 5%, 7% and 10% v/v). Bacterial growth was detected 48 h after inoculation of Fletcher medium supplemented with 5% sea water, demonstrating the halophilic nature of the strain Manara. Phylogenetic analysis of 16S rRNA gene sequences placed this novel strain within the radiation of the pathogenic species of the genus Leptospira spp., with sequence similarities within the range 97-100%, and closely related to L. interrogans. Two different PCR protocols targeting genus-specific pathogenic genes (G1-G2, B64I-B64II and LigB) gave positive results, which indicates that the strain Manara is likely pathogenic. Further studies are needed to confirm this possibility as well as determine its serogroup. These results could modify our understanding of the epidemiology of this zoonosis. Until now, the resistance and ability to grow in seawater for long periods of time had been proven for the strain Muggia of L. biflexa, a saprophytic species. To the best of our knowledge, this is the first isolation of a Leptospira sp. from cetaceans. Our phenotypic data indicate that strain Manara represents a novel species of the genus Leptospira, for which the name Leptospira brihuegai sp. nov. is proposed.	[Loffler, Sylvia Grune; Martinez, Mara; Florin-Christensen, Monica; Romero, Graciela; Brihuega, Bibiana] Natl Inst Agr Technol, Inst Pathobiol, Buenos Aires, DF, Argentina; [Loffler, Sylvia Grune; Florin-Christensen, Monica] Natl Res Council Argentina CONICET, Buenos Aires, DF, Argentina; [Rago, Virginia] Univ Buenos Aires, Natl Res Council Argentina CONICET, Inst Ecol Genet & Evolut, Buenos Aires, DF, Argentina; [Rago, Virginia; Uhart, Marcela] Southern Right Whale Hlth Monitoring Program, Puerto Madryn, Chubut, Argentina; [Uhart, Marcela] Univ Calif Davis, Sch Vet Med, Hlth Inst 1, Davis, CA 95616 USA	Instituto Nacional de Tecnologia Agropecuaria (INTA); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of California System; University of California Davis	Loffler, SG (corresponding author), Natl Inst Agr Technol, Inst Pathobiol, Buenos Aires, DF, Argentina.	grune.sylvia@inta.gob.ar	Grune, Sylvia/ADH-3537-2022	Grune, Sylvia/0000-0002-3049-289X; Florin-Christensen, Monica/0000-0003-0456-3970				Brihuega B., 2007, Rev. argent. microbiol., V39, P19; Cameron CE, 2008, J CLIN MICROBIOL, V46, P1728, DOI 10.1128/JCM.02022-07; Cerqueira GM, 2009, J MED MICROBIOL, V58, P1173, DOI 10.1099/jmm.0.009175-0; Cerqueira GM, 2009, INFECT GENET EVOL, V9, P760, DOI 10.1016/j.meegid.2009.06.009; CINCO M, 1975, ZBL BAKT-INT J MED M, V233, P400; CINCO M, 1974, INT J SYST BACTERIOL, V24, P131, DOI 10.1099/00207713-24-1-131; Colagross-Schouten AM, 2002, J WILDLIFE DIS, V38, P7, DOI 10.7589/0090-3558-38.1.7; Colegrove KM, 2005, J WILDLIFE DIS, V41, P426, DOI 10.7589/0090-3558-41.2.426; Delgado Patrick Mathews, 2015, Latin American Journal of Aquatic Mammals, V10, P58; Djadid ND, 2009, DIAGN MICR INFEC DIS, V63, P251, DOI 10.1016/j.diagmicrobio.2008.10.017; Pavan ME, 2011, COMP IMMUNOL MICROB, V34, P135, DOI 10.1016/j.cimid.2010.06.002; Faine S., 1982, WHO OFFS PUBL, V67; Francois S, 2013, REV CUBANA MED TROPI; Geraci JR., 2005, MARINE MAMMALS ASHOR, V2; GRAVEKAMP C, 1993, J GEN MICROBIOL, V139, P1691, DOI 10.1099/00221287-139-8-1691; Greig DJ, 2014, DIS AQUAT ORGAN, V111, P93, DOI 10.3354/dao02762; Loffler SG, 2014, REV ARGENT MICROBIOL, V46, P201, DOI 10.1016/S0325-7541(14)70073-2; Loffler SG, 2014, MEM I OSWALDO CRUZ, V109, P163, DOI 10.1590/0074-0276140295; Grune S., 2014, THESIS; Gulland FMD, 1996, J WILDLIFE DIS, V32, P572, DOI 10.7589/0090-3558-32.4.572; Khairani-Bejo S., 2004, Journal of Animal and Veterinary Advances, V3, P123; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Lloyd-Smith JO, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-125; Martinez M, 2014, REVISTA ARGENTINA DE, V9, P41; McClellan WA, 2004, RIGHT WHALE NECROPSY; Nalam K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012637; Norman SA, 2008, J WILDLIFE DIS, V44, P837, DOI 10.7589/0090-3558-44.4.837; Pavan ME, 2008, COMP IMMUNOL MICROB, V31, P37, DOI 10.1016/j.cimid.2007.03.004; Saito M, 2014, APPL ENVIRON MICROB, V80, P6926, DOI 10.1128/AEM.02568-14; Sepulveda MA, 2015, J WILDLIFE DIS, V51, P279, DOI 10.7589/2013-07-161; SMITH AW, 1977, J WILDLIFE DIS, V13, P144, DOI 10.7589/0090-3558-13.2.144; Stamper MA, 1998, J WILDLIFE DIS, V34, P407, DOI 10.7589/0090-3558-34.2.407; STERLING CR, 1981, VET PATHOL, V18, P628, DOI 10.1177/030098588101800508; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Trueba G, 2004, INT MICROBIOL, V7, P35; Waltzek TB, 2012, ZOONOSES PUBLIC HLTH, V59, P521, DOI 10.1111/j.1863-2378.2012.01492.x; Zuerner RL, 2009, VET MICROBIOL, V137, P105, DOI 10.1016/j.vetmic.2008.12.017	37	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0144974	10.1371/journal.pone.0144974	http://dx.doi.org/10.1371/journal.pone.0144974			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714322	Green Published, Green Submitted, gold			2022-12-26	WOS:000367481900028
J	Beam, A; Goede, D; Fox, A; McCool, MJ; Wall, G; Haley, C; Morrison, R				Beam, Andrea; Goede, Dane; Fox, Andrew; McCool, Mary Jane; Wall, Goldlin; Haley, Charles; Morrison, Robert			A Porcine Epidemic Diarrhea Virus Outbreak in One Geographic Region of the United States: Descriptive Epidemiology and Investigation of the Possibility of Airborne Virus Spread	PLOS ONE			English	Article								This study describes a spring 2013 outbreak of porcine epidemic diarrhea virus (PEDv), using data from 222 swine sites in 14 counties area in 4 contiguous states in the United States. During the outbreak, the premises-level incidence of PEDv was 40.5 percent (90/222 sites). One of the three companies from which data were collected had a lower incidence (19.5 percent) than the other two companies (41.1 and 47.2 percent). Sow sites had the highest incidence of PEDv during the outbreak (80.0 percent). Spatial analysis showed that PEDv was clustered rather than randomly distributed, which suggested that sites near a positive site had increased risk of acquiring PEDv infection. Meteorological data were used to investigate the hypothesis that PEDv was spread by air. If airborne dissemination played a role in this outbreak, we would expect the direction of disease spread to correlate with the predominant wind direction. Two methods were used to determine the direction of disease spread-linear direction mean analysis in ArcGIS and the direction test in Cluster-Seer. The former method indicated PEDv spread was south to slightly southwest, and the latter indicated spread was to the southeast. The predominant wind direction during the month of the outbreak was toward the south, with some southeast and southwest winds; the strongest wind gusts were toward the southwest. These findings support the hypothesis that PEDv was spread by air. The results, however, should be interpreted cautiously because we did not have information on direct and indirect contacts between sites, such as movement of trucks, feed, pigs or people. These types of contacts should be evaluated before pathogen spread is attributed to airborne mechanisms. Although this study did not provide a definitive assessment of airborne spread of PEDv, we believe the findings justify additional research to investigate this potential mechanism of transmission.	[Beam, Andrea; Fox, Andrew; McCool, Mary Jane; Wall, Goldlin; Haley, Charles] USDA Anim & Plant Hlth Inspect Serv, Vet Serv Sci Technol & Anal Serv, Ctr Epidemiol & Anim Hlth, Perrine, FL USA; [Goede, Dane; Morrison, Robert] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA	United States Department of Agriculture (USDA); University of Minnesota System; University of Minnesota Twin Cities	Haley, C (corresponding author), USDA Anim & Plant Hlth Inspect Serv, Plant Protect & Quarantine, Ctr Plant Hlth Sci & Technol, Perrine, FL USA.	charles.a.haley@aphis.usda.gov			National Pork Board	National Pork Board	This study was conducted in part with funding from National Pork Board. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the three swine companies for sharing their data. This study was conducted in part with funding from National Pork Board. We are indebted to Peter Davies, Paul Sundberg, Harry Snelson, and Brian McCluskey for their participation in planning the study. We are also grateful to Andres Perez for his guidance in using ClusterSeer.	Alonso C, 2014, VET RES, V45, DOI 10.1186/s13567-014-0073-z; American Association of Swine Veterinarians, 2013, STUD EX ROL TRANSP S; De La Hamaide S, 2014, DEADLY PIG VIRUS EAS; Harris HDL, 2012, THE MERCK MANUAL; Jacquez G.M., 1994, USER MANUAL STAT STA; Kocherhans R, 2001, VIRUS GENES, V23, P137, DOI 10.1023/A:1011831902219; Li WG, 2011, PHYS RES INT, V2011, P1, DOI [10.1155/2011/791545, DOI 10.1155/2011/791545]; National Oceanic and Atmospheric Administration, 2013, NAT CLIM DAT; Pospischil A, 2002, J SWINE HEALTH PROD, V10, P81; Truong QL, 2013, J VET MED SCI, V75, P1647, DOI 10.1292/jvms.12-0568; Stevenson GW, 2013, J VET DIAGN INVEST, V25, P649, DOI 10.1177/1040638713501675; Swine Health Monitoring Project, 2014, PED VIR INF ASS BIRD; Swine Health Monitoring Project, 2013, ENV STAB PEDV; Swine Health Monitoring Project, 2014, PORC EP DIARRH VIR R	14	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0144818	10.1371/journal.pone.0144818	http://dx.doi.org/10.1371/journal.pone.0144818			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709512	gold, Green Submitted, Green Published			2022-12-26	WOS:000367451400013
J	Boore, AL; Hoekstra, RM; Iwamoto, M; Fields, PI; Bishop, RD; Swerdlow, DL				Boore, Amy L.; Hoekstra, R. Michael; Iwamoto, Martha; Fields, Patricia I.; Bishop, Richard D.; Swerdlow, David L.			Salmonella enterica Infections in the United States and Assessment of Coefficients of Variation: A Novel Approach to Identify Epidemiologic Characteristics of Individual Serotypes, 1996-2011	PLOS ONE			English	Article							REPTILE-ASSOCIATED SALMONELLOSIS; ENTERITIDIS INFECTIONS; INCREASING INCIDENCE; MULTISTATE OUTBREAK; CONSUMPTION; CONTACT; DISEASE; EMERGENCE; JAVIANA; BURDEN	Background Despite control efforts, salmonellosis continues to cause an estimated 1.2 million infections in the United States (US) annually. We describe the incidence of salmonellosis in the US and introduce a novel approach to examine the epidemiologic similarities and differences of individual serotypes. Methods Cases of salmonellosis in humans reported to the laboratory-based National Salmonella Surveillance System during 1996-2011 from US states were included. Coefficients of variation were used to describe distribution of incidence rates of common Salmonella serotypes by geographic region, age group and sex of patient, and month of sample isolation. Results During 1996-2011, more than 600,000 Salmonella isolates from humans were reported, with an average annual incidence of 13.1 cases/100,000 persons. The annual reported rate of Salmonella infections did not decrease during the study period. The top five most commonly reported serotypes, Typhimurium, Enteritidis, Newport, Heidelberg, and Javiana, accounted for 62% of fully serotyped isolates. Coefficients of variation showed the most geographically concentrated serotypes were often clustered in Gulf Coast states and were also more frequently found to be increasing in incidence. Serotypes clustered in particular months, age groups, and sex were also identified and described. Conclusions Although overall incidence rates of Salmonella did not change over time, trends and epidemiological factors differed remarkably by serotype. A better understanding of Salmonella, facilitated by this comprehensive description of overall trends and unique characteristics of individual serotypes, will assist in responding to this disease and in planning and implementing prevention activities.	[Boore, Amy L.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Sci Educ & Profess Dev Program Off, Atlanta, GA 30333 USA; [Boore, Amy L.; Hoekstra, R. Michael; Iwamoto, Martha; Fields, Patricia I.; Bishop, Richard D.; Swerdlow, David L.] Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Boore, AL (corresponding author), Ctr Dis Control & Prevent, Div Global HIV AIDS, Maputo, Mozambique.	aboore@cdc.gov		Hoekstra, Robert Michael/0000-0002-0340-8015				ACKMAN DM, 1995, PEDIATR INFECT DIS J, V14, P955, DOI 10.1097/00006454-199511000-00006; Angulo FJ, 1997, AM J PUBLIC HEALTH, V87, P580, DOI 10.2105/AJPH.87.4.580; Behravesh CB, 2011, NEW ENGL J MED, V364, P918, DOI 10.1056/NEJMoa1005741; Boehmer TK, 2009, AM J INFECT CONTROL, V37, P49, DOI 10.1016/j.ajic.2007.12.012; Braden CR, 2006, CLIN INFECT DIS, V43, P512, DOI 10.1086/505973; Brenner FW, 2000, J CLIN MICROBIOL, V38, P2465, DOI 10.1128/JCM.38.7.2465-2467.2000; Campbell JV, 2001, J INFECT DIS, V183, P984, DOI 10.1086/319254; Cavallaro E, 2011, NEW ENGL J MED, V365, P601, DOI 10.1056/NEJMoa1011208; Centers for Disease Control and Prevention, 2011, TYPHOID AND PARATYPH; Centers for Disease Control and Prevention, NATIONAL ENTERIC DIS; Chai SJ, 2012, CLIN INFECT DIS, V54, pS488, DOI 10.1093/cid/cis231; Gould LH, 2013, MMWR SURVEILL SUMM, V62, P1; Gray JT, 1996, APPL ENVIRON MICROB, V62, P141, DOI 10.1128/AEM.62.1.141-146.1996; Greene SK, 2008, EPIDEMIOL INFECT, V136, P157, DOI 10.1017/S095026880700859X; Gupta SK, 2007, EPIDEMIOL INFECT, V135, P1165, DOI 10.1017/S0950268807007911; Hale CR, 2012, CLIN INFECT DIS, V54, pS472, DOI 10.1093/cid/cis051; HEDBERG CW, 1992, JAMA-J AM MED ASSOC, V268, P3203, DOI 10.1001/jama.268.22.3203; Hollander M., 2014, NONPARAMETRIC STAT M, V3rd ed.; Kimura AC, 2004, CLIN INFECT DIS, V38, pS244, DOI 10.1086/381576; Kingsley RA, 2000, MOL MICROBIOL, V36, P1006, DOI 10.1046/j.1365-2958.2000.01907.x; Li R, 2000, AM J PUBLIC HEALTH, V90, P777; Lynch MF, 2009, EPIDEMIOL INFECT, V137, P307, DOI 10.1017/S0950268808001969; Lynch MF, 2009, BACTERIAL INFECT HUM, P677; Mahon BE, 1997, J INFECT DIS, V175, P876, DOI 10.1086/513985; Maurer JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128937; Mermin J, 2004, CLIN INFECT DIS, V38, pS253, DOI 10.1086/381594; Mermin J, 1997, PEDIATRICS, V99, P399, DOI 10.1542/peds.99.3.399; MISHU B, 1994, J INFECT DIS, V169, P547, DOI 10.1093/infdis/169.3.547; [Office of Disease Prevention and Health Promotion US Department of Health and Human Services], FOOD SAF OBJ HLTH PE; Olsen SJ, 2001, J INFECT DIS, V183, P753, DOI 10.1086/318832; Reller ME, 2008, EPIDEMIOL INFECT, V136, P1109, DOI 10.1017/S0950268807009594; Scallan E, 2013, PEDIATR INFECT DIS J, V32, P217, DOI 10.1097/INF.0b013e31827ca763; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Schikora A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002279; Sivapalasingam S, 2003, CLIN INFECT DIS, V37, P1585, DOI 10.1086/379710; SPIKA JS, 1987, NEW ENGL J MED, V316, P565, DOI 10.1056/NEJM198703053161001; Srikantiah P, 2004, EPIDEMIOL INFECT, V132, P273, DOI 10.1017/S0950268803001638; Steinmuller N, 2006, CLIN INFECT DIS, V43, P1596, DOI 10.1086/509576; STLOUIS ME, 1988, JAMA-J AM MED ASSOC, V259, P2103, DOI 10.1001/jama.259.14.2103; Uzzau S, 2000, EPIDEMIOL INFECT, V125, P229, DOI 10.1017/S0950268899004379; Voetsch AC, 2004, CLIN INFECT DIS, V38, pS127, DOI 10.1086/381578	41	57	61	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145416	10.1371/journal.pone.0145416	http://dx.doi.org/10.1371/journal.pone.0145416			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26701276	gold, Green Published, Green Submitted			2022-12-26	WOS:000367092600077
J	Jablonski, KA; Amici, SA; Webb, LM; Ruiz-Rosado, JD; Popovich, PG; Partida-Sanchez, S; Guerau-de-Arellano, M				Jablonski, Kyle A.; Amici, Stephanie A.; Webb, Lindsay M.; Ruiz-Rosado, Juan de Dios; Popovich, Phillip G.; Partida-Sanchez, Santiago; Guerau-de-Arellano, Mireia			Novel Markers to Delineate Murine M1 and M2 Macrophages	PLOS ONE			English	Article							MICROGLIA/MACROPHAGE POLARIZATION DYNAMICS; ALTERNATIVE ACTIVATION; CYTOKINE PRODUCTION; HOST-DEFENSE; IFN-GAMMA; RECEPTOR; CD38; DIFFERENTIATION; MYCOBACTERIA; SALMONELLA	Classically (M1) and alternatively activated (M2) macrophages exhibit distinct phenotypes and functions. It has been difficult to dissect macrophage phenotypes in vivo, where a spectrum of macrophage phenotypes exists, and also in vitro, where low or non-selective M2 marker protein expression is observed. To provide a foundation for the complexity of in vivo macrophage phenotypes, we performed a comprehensive analysis of the transcriptional signature of murine M0, M1 and M2 macrophages and identified genes common or exclusive to either subset. We validated by real-time PCR an M1-exclusive pattern of expression for CD38, G-protein coupled receptor 18 (Gpr18) and Formyl peptide receptor 2 (Fpr2) whereas Early growth response protein 2 (Egr2) and c-Myc were M2-exclusive. We further confirmed these data by flow cytometry and show that M1 and M2 macrophages can be distinguished by their relative expression of CD38 and Egr2. Egr2 labeled more M2 macrophages (similar to 70%) than the canonical M2 macrophage marker Arginase-1, which labels 24% of M2 macrophages. Conversely, CD38 labeled most (71%) in vitro M1 macrophages. In vivo, a similar CD38(+) population greatly increased after LPS exposure. Overall, this work defines exclusive and common M1 and M2 signatures and provides novel and improved tools to distinguish M1 and M2 murine macrophages.	[Jablonski, Kyle A.; Amici, Stephanie A.; Webb, Lindsay M.; Guerau-de-Arellano, Mireia] Ohio State Univ, Med Lab Sci Div, Sch Hlth & Rehabil Sci, Columbus, OH 43210 USA; [Webb, Lindsay M.] Ohio State Univ, Biomed Sci Grad Program, Columbus, OH 43210 USA; [Ruiz-Rosado, Juan de Dios; Partida-Sanchez, Santiago] Nationwide Childrens Hosp, Ctr Microbial Pathogenesis, Res Inst, Columbus, OH USA; [Popovich, Phillip G.] Ohio State Univ, Wexner Med Ctr, Dept Neurosci, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University	Guerau-de-Arellano, M (corresponding author), Ohio State Univ, Med Lab Sci Div, Sch Hlth & Rehabil Sci, Columbus, OH 43210 USA.	mireia.guerau@osumc.edu	Partida-Sanchez, Santiago/B-7523-2008	Partida-Sanchez, Santiago/0000-0003-2996-9440; RUIZ-ROSADO, JUAN DE DIOS/0000-0002-6429-9086	International Foundation for Research on Paraplegia [P 129]; National Institutes of Health [NIH R21 R21NS081413, NIAID R01-AI092117]; Ray W. Poppleton Endowment; Ohio State University Mayer's Undergraduate Summer Research Fellowship; Systems and Integrative Biology Fellowship [NIH T32]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI092117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM068412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS081413] Funding Source: NIH RePORTER	International Foundation for Research on Paraplegia; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ray W. Poppleton Endowment; Ohio State University Mayer's Undergraduate Summer Research Fellowship; Systems and Integrative Biology Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by funds from the International Foundation for Research on Paraplegia (P 129 to PP and MG), the National Institutes of Health (NIH R21 R21NS081413 to PP and MG and NIAID R01-AI092117 to SP-S), and the Ray W. Poppleton Endowment (PP). KJ was supported by the Ohio State University Mayer's Undergraduate Summer Research Fellowship and LW by the Systems and Integrative Biology Fellowship (NIH T32). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder JK, 2008, J IMMUNOL, V180, P5645, DOI 10.4049/jimmunol.180.8.5645; Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Antonios JK, 2013, CELL MOL IMMUNOL, V10, P471, DOI 10.1038/cmi.2013.39; Arpa L, 2009, EUR J IMMUNOL, V39, P514, DOI 10.1002/eji.200838283; Bae YS, 2003, J IMMUNOL, V171, P6807, DOI 10.4049/jimmunol.171.12.6807; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Bost KL, 1997, INFECT IMMUN, V65, P3186, DOI 10.1128/IAI.65.8.3186-3192.1997; Bronte V, 2015, NAT MED, V21, P117, DOI 10.1038/nm.3794; Butovsky O, 2012, J CLIN INVEST, V122, P3063, DOI 10.1172/JCI62636; Chamberlain LM, 2015, J BIOMED MATER RES A, V103, P2864, DOI 10.1002/jbm.a.35415; Dornand J, 2002, VET MICROBIOL, V90, P383, DOI 10.1016/S0378-1135(02)00223-7; El Chartouni C, 2010, IMMUNOBIOLOGY, V215, P780, DOI 10.1016/j.imbio.2010.05.032; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; Feinberg MW, 2005, J BIOL CHEM, V280, P38247, DOI 10.1074/jbc.M509378200; Gabet Y, 2010, BLOOD, V116, P3964, DOI 10.1182/blood-2010-01-263830; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Gow DJ, 2010, J LEUKOCYTE BIOL, V88, P475, DOI 10.1189/jlb.0310158; Hu XM, 2012, STROKE, V43, P3063, DOI 10.1161/STROKEAHA.112.659656; Jouanguy E, 1999, CURR OPIN IMMUNOL, V11, P346, DOI 10.1016/S0952-7915(99)80055-7; Kahnert A, 2006, EUR J IMMUNOL, V36, P631, DOI 10.1002/eji.200535496; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kobayashi T, 2011, J IMMUNOL, V186, P4649, DOI 10.4049/jimmunol.1003888; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Liao XD, 2011, J CLIN INVEST, V121, P2736, DOI 10.1172/JCI45444; Lin CC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4551; Link JM, 2015, BBA-GENE REGUL MECH, V1849, P554, DOI 10.1016/j.bbagrm.2014.04.004; Liu Y, 2013, CANCER RES, V73, P550, DOI 10.1158/0008-5472.CAN-12-2290; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mabbott NA, 2010, IMMUNOBIOLOGY, V215, P724, DOI 10.1016/j.imbio.2010.05.012; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Martinez FO, 2013, BLOOD, V121, pE57, DOI 10.1182/blood-2012-06-436212; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Miller BH, 2004, INFECT IMMUN, V72, P2872, DOI 10.1128/IAI.72.5.2872-2878.2004; Mokarram N, 2014, ANN BIOMED ENG, V42, P338, DOI 10.1007/s10439-013-0941-0; Moreira AP, 2011, J INTERF CYTOK RES, V31, P485, DOI 10.1089/jir.2011.0027; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Musso T, 2001, J LEUKOCYTE BIOL, V69, P605; O'Carroll C, 2014, J IMMUNOL, V192, P427, DOI 10.4049/jimmunol.1301722; Ordway D, 2006, J IMMUNOL, V176, P4931, DOI 10.4049/jimmunol.176.8.4931; Oukka M, 2002, MOL CELL, V9, P121, DOI 10.1016/S1097-2765(01)00434-8; Partida-Sanchez S, 2001, NAT MED, V7, P1209, DOI 10.1038/nm1101-1209; Partida-Sanchez S, 2004, J IMMUNOL, V172, P1896, DOI 10.4049/jimmunol.172.3.1896; Partida-Sanchez S, 2003, MICROBES INFECT, V5, P49, DOI 10.1016/S1286-4579(02)00055-2; Pello OM, 2012, BLOOD, V119, P411, DOI 10.1182/blood-2011-02-339911; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106; Raes G, 2002, J LEUKOCYTE BIOL, V71, P597; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rose S, 2012, CYTOM PART A, V81A, P343, DOI 10.1002/cyto.a.22012; Safford M, 2005, NAT IMMUNOL, V6, P472, DOI 10.1038/ni1193; Schattgen SA, 2011, IMMUNOL REV, V243, P109, DOI 10.1111/j.1600-065X.2011.01053.x; Schroder AJ, 2002, J IMMUNOL, V168, P996, DOI 10.4049/jimmunol.168.3.996; Scotton CJ, 2005, J IMMUNOL, V174, P834, DOI 10.4049/jimmunol.174.2.834; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Takenouchi R, 2012, BIOCHEM BIOPH RES CO, V418, P366, DOI 10.1016/j.bbrc.2012.01.027; Valledor AF, 2010, ADV IMMUNOL, V108, P1, DOI 10.1016/S0065-2776(10)08001_6; Vazquez-Torres A, 2000, SCIENCE, V287, P1655, DOI 10.1126/science.287.5458.1655; Viegas MS, 2007, MICROBES INFECT, V9, P847, DOI 10.1016/j.micinf.2007.03.003; Vogel DYS, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-35; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Weilemann A, 2015, BLOOD, V125, P124, DOI 10.1182/blood-2014-08-594507; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Zhang CY, 2013, CELL MOL IMMUNOL, V10, P84, DOI 10.1038/cmi.2012.57	69	518	536	12	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145342	10.1371/journal.pone.0145342	http://dx.doi.org/10.1371/journal.pone.0145342			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26699615	Green Submitted, gold, Green Published			2022-12-26	WOS:000367092600067
J	Jang, KI; Lee, SH; Huh, HJ; Chae, JH				Jang, Kuk-In; Lee, Seung-Hwan; Huh, Hyu Jung; Chae, Jeong-Ho			Influence of the 5-HT3A Receptor Gene Polymorphism and Childhood Sexual Trauma on Central Serotonin Activity	PLOS ONE			English	Article							AUDITORY-EVOKED-POTENTIALS; MAJOR DEPRESSIVE DISORDER; LOUDNESS DEPENDENCE; BIPOLAR DISORDER; EMOTIONAL BRAIN; HTR3A GENE; ABUSE; ASSOCIATION; DYSFUNCTION; LDAEP	Background Gene-environment interactions are important for understanding alterations in human brain function. The loudness dependence of auditory evoked potential (LDAEP) is known to reflect central serotonergic activity. Single nucleotide polymorphisms (SNPs) in the 5-HT3A serotonin receptor gene are associated with psychiatric disorders. This study aimed to investigate the effect between 5-HT3A receptor gene polymorphisms and childhood sexual trauma on the LDAEP as an electrophysiological marker in healthy subjects. Methods A total of 206 healthy subjects were recruited and evaluated using the childhood trauma questionnaire (CTQ) and hospital anxiety and depression scale (HADS). Peak-to-peak N1/P2 was measured at five stimulus intensities, and the LDAEP was calculated as the linear-regression slope. In addition, the rs1062613 SNPs of 5-HT3A (CC, CT, and TT) were analyzed in healthy subjects. Results There was a significant interaction between scores on the CTQ-sexual abuse subscale and 5-HT3A genotype on the LDAEP. Subjects with the CC polymorphism had a significantly higher LDEAP than T carriers in the sexually abused group. In addition, CC genotype subjects in the sexually abused group showed a significantly higher LDAEP compared with CC genotype subjects in the non-sexually abused group. Conclusions Our findings suggest that people with the CC polymorphism of the 5-HT3A gene have a greater risk of developing mental health problems if they have experienced childhood sexual abuse, possibly due to low central serotonin activity. Conversely, the T polymorphism may be protective against any central serotonergic changes following childhood sexual trauma.	[Jang, Kuk-In; Chae, Jeong-Ho] Catholic Univ Korea, Dept Biomed & Hlth Sci, Coll Med, Seoul, South Korea; [Lee, Seung-Hwan] Inje Univ, Clin Emot & Cognit Res Lab, Goyang, South Korea; [Jang, Kuk-In; Lee, Seung-Hwan] Inje Univ, Clin Emot & Cognit Res Lab, Goyang, South Korea; [Huh, Hyu Jung; Chae, Jeong-Ho] Catholic Univ Korea, Dept Psychiat, Coll Med, Seoul St Marys Hosp, Seoul, South Korea	Catholic University of Korea; Inje University; Inje University; Catholic University of Korea; Seoul St. Mary's Hospital	Chae, JH (corresponding author), Catholic Univ Korea, Dept Biomed & Hlth Sci, Coll Med, Seoul, South Korea.	alberto@catholic.ac.kr			Korea Health Technology R&D project through the Korea Health industry Development Institute (KHIDI) [HM15C1054]	Korea Health Technology R&D project through the Korea Health industry Development Institute (KHIDI)	This work was supported by the grant of the Korea Health Technology R&D project through the Korea Health industry Development Institute (KHIDI) (grant number: HM15C1054). The funders had no role on study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addington J, 2013, EARLY INTERV PSYCHIA, V7, P300, DOI 10.1111/eip.12020; Aguilera M, 2009, PSYCHOL MED, V39, P1425, DOI 10.1017/S0033291709005248; Barnes NM, 2009, NEUROPHARMACOLOGY, V56, P273, DOI 10.1016/j.neuropharm.2008.08.003; Bellani M, 2012, EPIDEMIOL PSYCH SCI, V21, P347, DOI 10.1017/S2045796012000418; Bernstein DP, 2003, CHILD ABUSE NEGLECT, V27, P169, DOI 10.1016/S0145-2134(02)00541-0; Bernstein DP, 1998, MANUAL CHILDHOOD TRA; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Blain LM, 2012, CHILD ABUSE NEGLECT, V36, P413, DOI 10.1016/j.chiabu.2012.03.003; Bublitz MH, 2012, PSYCHONEUROENDOCRINO, V37, P1425, DOI 10.1016/j.psyneuen.2012.01.009; Chen TJ, 2005, NEUROPSYCHOBIOLOGY, V52, P28, DOI 10.1159/000086175; Cicchetti D, 2007, DEV PSYCHOPATHOL, V19, P1161, DOI 10.1017/S0954579407000600; Coles J, 2015, J INTERPERS VIOLENCE, V30, P1929, DOI 10.1177/0886260514555270; Cummings M, 2012, CURR PSYCHIAT REP, V14, P599, DOI 10.1007/s11920-012-0316-5; Drueke B, 2013, EUR NEUROPSYCHOPHARM, V23, P830, DOI 10.1016/j.euroneuro.2013.05.005; Eagle DM, 2008, PSYCHOPHARMACOLOGY, V199, P439, DOI 10.1007/s00213-008-1127-6; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; First MB., 1997, USERS GUIDE STRUCTUR; Fisher HL, 2013, J AFFECT DISORDERS, V145, P136, DOI 10.1016/j.jad.2012.05.032; Gatt JM, 2010, BIOL PSYCHIAT, V68, P818, DOI 10.1016/j.biopsych.2010.06.025; Gatt JM, 2010, DEPRESS ANXIETY, V27, P752, DOI 10.1002/da.20726; Hammer C, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.30; HEGERL U, 1993, BIOL PSYCHIAT, V33, P173, DOI 10.1016/0006-3223(93)90137-3; Heim C, 2001, BIOL PSYCHIAT, V49, P1023, DOI 10.1016/S0006-3223(01)01157-X; Heim C, 2009, ARCH GEN PSYCHIAT, V66, P72, DOI 10.1001/archgenpsychiatry.2008.508; Iidaka T, 2005, J NEUROSCI, V25, P6460, DOI 10.1523/JNEUROSCI.5261-04.2005; Irish L, 2010, J PEDIATR PSYCHOL, V35, P450, DOI 10.1093/jpepsy/jsp118; Isohookana R, 2013, EUR CHILD ADOLES PSY, V22, P13, DOI 10.1007/s00787-012-0311-8; Juckel G, 1997, BIOL PSYCHIAT, V41, P1181, DOI 10.1016/S0006-3223(96)00240-5; Kang SG, 2013, NORD J PSYCHIAT, V67, P214, DOI 10.3109/08039488.2012.732114; Kempke S, 2015, PSYCHONEUROENDOCRINO, V52, P14, DOI 10.1016/j.psyneuen.2014.10.027; Kilpatrick LA, 2011, GASTROENTEROLOGY, V140, P1943, DOI 10.1053/j.gastro.2011.03.011; Kim DH, 2013, J AFFECT DISORDERS, V148, P72, DOI 10.1016/j.jad.2012.11.051; Lau M, 2010, NORD J PSYCHIAT, V64, P4, DOI 10.3109/08039480903191205; Lee IH, 2011, PSYCHOPHARMACOLOGY, V214, P617, DOI 10.1007/s00213-010-2064-8; Lee KS, 2012, PSYCHIAT INVEST, V9, P298, DOI 10.4306/pi.2012.9.3.298; Lee SH, 2014, PROG NEURO-PSYCHOPH, V54, P7, DOI 10.1016/j.pnpbp.2014.05.010; Linka T, 2009, PSYCHIAT RES, V169, P139, DOI 10.1016/j.psychres.2008.06.009; Melke J, 2003, ARCH GEN PSYCHIAT, V60, P1017, DOI 10.1001/archpsyc.60.10.1017; Min JA, 2012, PSYCHIAT RES, V200, P374, DOI 10.1016/j.psychres.2012.06.038; Oliva JL, 2011, HUM PSYCHOPHARM CLIN, V26, P172, DOI 10.1002/hup.1187; Park YM, 2014, J AFFECT DISORDERS, V159, P62, DOI 10.1016/j.jad.2014.01.016; Park YM, 2013, PSYCHIAT INVEST, V10, P233, DOI 10.4306/pi.2013.10.3.233; Park YM, 2013, PSYCHIAT INVEST, V10, P143, DOI 10.4306/pi.2013.10.2.143; Park YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060340; Park YM, 2012, PSYCHIAT INVEST, V9, P80, DOI 10.4306/pi.2012.9.1.80; Park YM, 2011, PSYCHOPHARMACOLOGY, V213, P625, DOI 10.1007/s00213-010-2061-y; Park YM, 2010, PROG NEURO-PSYCHOPH, V34, P313, DOI 10.1016/j.pnpbp.2009.12.004; Scher CD, 2001, J TRAUMA STRESS, V14, P843, DOI 10.1023/A:1013058625719; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Sheffield JM, 2013, COMPR PSYCHIAT, V54, P1098, DOI 10.1016/j.comppsych.2013.05.013; Sigurdardotir S, 2014, SCAND J PUBLIC HEALT, V42, P278, DOI 10.1177/1403494813514645; Smith PN, 2012, J CLIN PSYCHOL, V68, P78, DOI 10.1002/jclp.20852; Spataro J, 2004, BRIT J PSYCHIAT, V184, P416, DOI 10.1192/bjp.184.5.416; Staples J, 2012, ARCH SEX BEHAV, V41, P341, DOI 10.1007/s10508-011-9773-x; Subica AM, 2013, J TRAUMA STRESS, V26, P588, DOI 10.1002/jts.21845; TERR LC, 1991, AM J PSYCHIAT, V148, P10; Uhl I, 2012, EUR ARCH PSY CLIN N, V262, P487, DOI 10.1007/s00406-012-0297-8; Wondie Y, 2011, J INTERPERS VIOLENCE, V26, P2025, DOI 10.1177/0886260510372937; Wyss C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068650; Yamada K, 2006, BIOL PSYCHIAT, V60, P192, DOI 10.1016/j.biopsych.2005.11.008	60	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145269	10.1371/journal.pone.0145269	http://dx.doi.org/10.1371/journal.pone.0145269			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26701104	gold, Green Published, Green Submitted			2022-12-26	WOS:000367092600056
J	Karlsson, E; Magic, I; Bostner, J; Dyrager, C; Lysholm, F; Hallbeck, AL; Stal, O; Lundstrom, P				Karlsson, Elin; Magic, Ivana; Bostner, Josefine; Dyrager, Christine; Lysholm, Fredrik; Hallbeck, Anna-Lotta; Stal, Olle; Lundstrom, Patrik			Revealing Different Roles of the mTOR-Targets S6K1 and S6K2 in Breast Cancer by Expression Profiling and Structural Analysis	PLOS ONE			English	Article							ENDOCRINE RESISTANCE; POOR-PROGNOSIS; GENE LISTS; KINASE; PHOSPHORYLATION; AMPLIFICATION; LOCALIZATION; MECHANISM; CLONING; PATHWAY	Background The AKT/mTORC1/S6K pathway is frequently overstimulated in breast cancer, constituting a promising therapeutic target. The benefit from mTOR inhibitors varies, likely as a consequence of tumour heterogeneity, and upregulation of several compensatory feed-back mechanisms. The mTORC1 downstream effectors S6K1, S6K2, and 4EBP1 are amplified and overexpressed in breast cancer, associated with a poor outcome and divergent endocrine treatment benefit. S6K1 and S6K2 share high sequence homology, but evidence of partly distinct biological functions is emerging. The aim of this work was to explore possible different roles and treatment target potentials of S6K1 and S6K2 in breast cancer. Materials and methods Whole-genome expression profiles were compared for breast tumours expressing high levels of S6K1, S6K2 or 4EBP1, using public datasets, as well as after in vitro siRNA downregulation of S6K1 and/or S6K2 in ZR751 breast cancer cells. In silico homology modelling of the S6K2 kinase domain was used to evaluate its possible structural divergences to S6K1. Results Genome expression profiles were highly different in S6K1 and S6K2 high tumours, whereas S6K2 and 4EBP1 profiles showed significant overlaps, both correlated to genes involved in cell cycle progression, among these the master regulator E2F1. S6K2 and 4EBP1 were inversely associated with IGF1 levels, and their prognostic value was shown to be restricted to tumours positive for IGFR and/or HER2. In vitro, S6K1 and S6K2 silencing resulted in upregulation of genes in the mTORC1 and mTORC2 complexes. Isoform-specific silencing also showed distinct patterns, e.g. S6K2 downregulation lead to upregulation of several cell cycle associated genes. Structural analyses of the S6K2 kinase domain showed unique structure patterns, deviating from those of S6K1, facilitating the development of isoform-specific inhibitors. Our data support emerging proposals of distinct biological features of S6K1 and S6K2, suggesting their importance as separate oncogenes and clinicalmarkers, where specific targeting in different breast cancer subtypes could facilitate further individualised therapies.	[Karlsson, Elin; Magic, Ivana; Bostner, Josefine; Hallbeck, Anna-Lotta; Stal, Olle] Linkoping Univ, Dept Clin & Expt Med, SE-58185 Linkoping, Sweden; [Karlsson, Elin; Magic, Ivana; Bostner, Josefine; Hallbeck, Anna-Lotta; Stal, Olle] Linkoping Univ, Dept Oncol, SE-58185 Linkoping, Sweden; [Magic, Ivana; Dyrager, Christine; Lundstrom, Patrik] Linkoping Univ, Dept Phys Chem & Biol, Div Chem, SE-58183 Linkoping, Sweden; [Lysholm, Fredrik] Linkoping Univ, Dept Phys Chem & Biol, Div Bioinformat, SE-58183 Linkoping, Sweden; [Lysholm, Fredrik] Linkoping Univ, Dept Phys Chem & Biol, SeRC, SE-58183 Linkoping, Sweden	Linkoping University; Linkoping University; Linkoping University; Linkoping University; Linkoping University	Stal, O (corresponding author), Linkoping Univ, Dept Clin & Expt Med, SE-58185 Linkoping, Sweden.	olle.stal@liu.se; patlu@ifm.liu.se			Swedish Research Council [2012-5136, 2007-3475]; Swedish Cancer Foundation; LiU Cancer; LiU Cancer Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; LiU Cancer; LiU Cancer Foundation	This study was supported by The Swedish Research Council (PL OS), Grant numbers: 2012-5136 and 2007-3475, URL: (vr.se); The Swedish Cancer Foundation (OS), LiU Cancer (ALH OS PL), No grant number available, URL: (https://www.liu.se/forskning/liu-cancer). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by grants from the Swedish Cancer Foundation (OS), the Swedish Research Council (OS and PL) and the LiU Cancer Foundation (ALH, OS, and PL)	Armengol G, 2007, CANCER RES, V67, P7551, DOI 10.1158/0008-5472.CAN-07-0881; Arnason T, 2013, CANCER BIOL THER, V14, P672, DOI 10.4161/cbt.25089; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; BLUNDELL TL, 1987, NATURE, V326, P347, DOI 10.1038/326347a0; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P8351, DOI 10.1073/pnas.95.14.8351; Couch FJ, 1999, CANCER RES, V59, P1408; Drury SC, 2011, ENDOCR-RELAT CANCER, V18, P565, DOI 10.1530/ERC-10-0046; Engelmann D, 2012, CANCER RES, V72, P571, DOI 10.1158/0008-5472.CAN-11-2575; Fenton TR, 2011, INT J BIOCHEM CELL B, V43, P47, DOI 10.1016/j.biocel.2010.09.018; Fox EM, 2011, CANCER RES, V71, P6773, DOI 10.1158/0008-5472.CAN-11-1295; Goh ETH, 2010, J BIOL CHEM, V285, P17065, DOI 10.1074/jbc.M109.078782; Gout I, 1998, J BIOL CHEM, V273, P30061, DOI 10.1074/jbc.273.46.30061; GROVE JR, 1991, MOL CELL BIOL, V11, P5541, DOI 10.1128/MCB.11.11.5541; Han SP, 2010, BIOCHEM J, V430, P379, DOI 10.1042/BJ20100396; Hengstschlager M, 2011, ONCOGENE; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Julien LA, 2010, MOL CELL BIOL, V30, P908, DOI 10.1128/MCB.00601-09; Karlsson E, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3557; Karlsson E, 2011, GENE CHROMOSOME CANC, V50, P775, DOI 10.1002/gcc.20900; Kim EK, 2011, BREAST CANCER RES TR, V126, P93, DOI 10.1007/s10549-010-1315-z; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee-Fruman KK, 1999, ONCOGENE, V18, P5108, DOI 10.1038/sj.onc.1202894; Louie MC, 2010, MOL CANCER RES, V8, P343, DOI 10.1158/1541-7786.MCR-09-0395; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Meric-Bernstam F, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3343; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Pardo OE, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00191; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Pearce LR, 2010, BIOCHEM J, V431, P245, DOI 10.1042/BJ20101024; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Pende M, 2000, NATURE, V408, P994, DOI 10.1038/35050135; Perez-Tenorio G, 2011, BREAST CANCER RES TR, V128, P713, DOI 10.1007/s10549-010-1058-x; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Real S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016163; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Reimand J, 2011, NUCLEIC ACIDS RES, V39, pW307, DOI 10.1093/nar/gkr378; Rong L, 2008, RNA, V14, P1318, DOI 10.1261/rna.950608; Rossi R, 2007, FEBS LETT, V581, P4058, DOI 10.1016/j.febslet.2007.07.047; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sridharan S, 2011, CANCER RES, V71, P2590, DOI 10.1158/0008-5472.CAN-10-3253; Sunami T, 2010, J BIOL CHEM, V285, P4587, DOI 10.1074/jbc.M109.040667; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wang JC, 2013, BIOCHEM J, V454, P39, DOI 10.1042/BJ20121863; Williamson M. P., 2012, HOW PROTEINS WORK; Winder T, 2013, THE PHARMACOGENOMICS; Yamnik RL, 2009, J BIOL CHEM, V284, P6361, DOI 10.1074/jbc.M807532200; Yu ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062642; Zhou DJ, 2006, NUCLEIC ACIDS RES, V34, P5974, DOI 10.1093/nar/gkl764; Zhou W, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.110; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	56	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145013	10.1371/journal.pone.0145013	http://dx.doi.org/10.1371/journal.pone.0145013			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26698305	Green Published, gold, Green Submitted			2022-12-26	WOS:000367092600042
J	Kuhn, J; Gripp, T; Flieder, T; Dittrich, M; Hendig, D; Busse, J; Knabbe, C; Birschmann, I				Kuhn, Joachim; Gripp, Tatjana; Flieder, Tobias; Dittrich, Marcus; Hendig, Doris; Busse, Jessica; Knabbe, Cornelius; Birschmann, Ingvild			UPLC-MRM Mass Spectrometry Method for Measurement of the Coagulation Inhibitors Dabigatran and Rivaroxaban in Human Plasma and Its Comparison with Functional Assays	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; FACTOR XA INHIBITOR; DIRECT ORAL ANTICOAGULANTS; DIRECT THROMBIN INHIBITOR; DIAGNOSTIC-ACCURACY; APIXABAN; MS/MS; QUANTIFICATION; VALIDATION; METABOLISM	Introduction The fast, precise, and accurate measurement of the new generation of oral anticoagulants such as dabigatran and rivaroxaban in patients' plasma my provide important information in different clinical circumstances such as in the case of suspicion of overdose, when patients switch from existing oral anticoagulant, in patients with hepatic or renal impairment, by concomitant use of interaction drugs, or to assess anticoagulant concentration in patients' blood before major surgery. Methods Here, we describe a quick and precise method to measure the coagulation inhibitors dabigatran and rivaroxaban using ultra-performance liquid chromatography electrospray ionization-tandem mass spectrometry in multiple reactions monitoring (MRM) mode (UPLC-MRM MS). Internal standards (ISs) were added to the sample and after protein precipitation; the sample was separated on a reverse phase column. After ionization of the analytes the ions were detected using electrospray ionization-tandem mass spectrometry. Run time was 2.5 minutes per injection. Ion suppression was characterized by means of post-column infusion. Results The calibration curves of dabigatran and rivaroxaban were linear over the working range between 0.8 and 800 mu g/L (r > 0.99). Limits of detection (LOD) in the plasma matrix were 0.21 mu g/L for dabigatran and 0.34 mu g/L for rivaroxaban, and lower limits of quantification (LLOQ) in the plasma matrix were 0.46 mu g/L for dabigatran and 0.54 mu g/L for rivaroxaban. The intraassay coefficients of variation (CVs) for dabigatran and rivaroxaban were < 4% and 6%; respectively, the interassay CVs were < 6% for dabigatran and < 9% for rivaroxaban. Inaccuracy was < 5% for both substances. The mean recovery was 104.5% (range 83.8-113.0%) for dabigatran and 87.0%(range 73.6-105.4%) for rivaroxaban. No significant ion suppressions were detected at the elution times of dabigatran or rivaroxaban. Both coagulation inhibitors were stable in citrate plasma at -20 degrees C, 4 degrees C and even at RT for at least one week. A method comparison between our UPLC-MRM MS method, the commercially available automated Direct Thrombin Inhibitor assay (DTI assay) for dabigatran measurement from CoaChrom Diagnostica, as well as the automated anti-Xa assay for rivaroxaban measurement from Chromogenix both performed by ACL-TOP showed a high degree of correlation. However, UPLC-MRM MS measurement of dabigatran and rivaroxaban has a much better selectivity than classical functional assays measuring activities of various coagulation factors which are susceptible to interference by other coagulant drugs. Conclusions Overall, we developed and validated a sensitive and specific UPLC-MRM MS assay for the quick and specific measurement of dabigatran and rivaroxaban in human plasma.	[Kuhn, Joachim; Gripp, Tatjana; Flieder, Tobias; Hendig, Doris; Busse, Jessica; Knabbe, Cornelius; Birschmann, Ingvild] Ruhr Univ Bochum, Heart & Diabet Ctr North Rhine Westphalia, Inst Lab & Transfus Med, Bad Oeynhausen, Germany; [Dittrich, Marcus] Univ Wurzburg, Dept Bioinformat, Bioctr, D-97070 Wurzburg, Germany	Ruhr University Bochum; University of Wurzburg	Kuhn, J (corresponding author), Ruhr Univ Bochum, Heart & Diabet Ctr North Rhine Westphalia, Inst Lab & Transfus Med, Bad Oeynhausen, Germany.	jkuhn@hdz-nrw.de	Hendig, Doris/F-1112-2013	Hendig, Doris/0000-0002-3660-6923				Aucella F, 2013, J PHARMACEUT BIOMED, V86, P123, DOI 10.1016/j.jpba.2013.08.001; Baglin T, 2013, J Thromb Haemost, DOI 10.1111/jth.12149; Blaich C, 2015, CLIN CHEM LAB MED, V53, P1981, DOI 10.1515/cclm-2014-1108; Bland JM, 2012, ANESTHESIOLOGY, V116, P182, DOI 10.1097/ALN.0b013e31823d7784; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Blech S, 2008, DRUG METAB DISPOS, V36, P386, DOI 10.1124/dmd.107.019083; Boehringer Ingelheim Pharmaceuticals, 2020, PRAD DAB PACK INS; Bossuyt PM, 2003, CLIN CHEM, V49, P7, DOI 10.1373/49.1.7; Bossuyt PM, 2003, CLIN CHEM LAB MED, V41, P68, DOI 10.1515/CCLM.2003.012; Buller HR, 2013, NEW ENGL J MED, V369, P1406, DOI 10.1056/NEJMoa1306638; Ceglarek U, 2013, PROTEOM CLIN APPL, V7, P794, DOI 10.1002/prca.201300034; Chappell DL, 2012, BIOANALYSIS, V4, P2843, DOI [10.4155/BIO.12.268, 10.4155/bio.12.268]; Delavenne X, 2012, J PHARMACEUT BIOMED, V58, P152, DOI 10.1016/j.jpba.2011.09.018; Eby C, 2013, INT J LAB HEMATOL, V35, P262, DOI 10.1111/ijlh.12065; Eller T, 2014, CLIN CHEM LAB MED, V52, P835, DOI 10.1515/cclm-2013-0936; Ferrandis R, 2013, THROMB HAEMOSTASIS, V110, P515, DOI 10.1160/TH12-11-0868; Gous T, 2014, THER DRUG MONIT, V36, P597, DOI 10.1097/FTD.0000000000000059; Guyatt GH, 2012, CHEST, V141, p7S, DOI 10.1378/chest.1412S3; Hawes EM, 2013, J THROMB HAEMOST, V11, P1493, DOI 10.1111/jth.12308; Helin TA, 2013, CLIN CHEM, V59, P807, DOI 10.1373/clinchem.2012.198788; Hillarp A, 2014, J THROMB HAEMOST, V12, P1545, DOI 10.1111/jth.12649; Hillarp A, 2011, J THROMB HAEMOST, V9, P133, DOI 10.1111/j.1538-7836.2010.04098.x; Korostelev M, 2014, J PHARMACEUT BIOMED, V100, P230, DOI 10.1016/j.jpba.2014.08.011; Kuhn J, 2015, BIOCHEM BIOPH RES CO, V459, P469, DOI 10.1016/j.bbrc.2015.02.129; Kuhn J, 2013, TALANTA, V110, P71, DOI 10.1016/j.talanta.2013.02.010; Kuhn J, 2012, J PHARMACEUT BIOMED, V67-68, P137, DOI 10.1016/j.jpba.2012.04.036; Kuhn J, 2009, CLIN BIOCHEM, V42, P521, DOI 10.1016/j.clinbiochem.2008.12.009; Kuhn J, 2009, CLIN BIOCHEM, V42, P83, DOI 10.1016/j.clinbiochem.2008.10.004; Lang D, 2009, DRUG METAB DISPOS, V37, P1046, DOI 10.1124/dmd.108.025551; Lassen MR, 2007, J THROMB HAEMOST, V5, P2368, DOI 10.1111/j.1538-7836.2007.02764.x; Leung KSY, 2014, ANAL BIOANAL CHEM, V406, P2289, DOI 10.1007/s00216-013-7542-5; Li JY, 2014, J CHROMATOGR B, V973, P110, DOI 10.1016/j.jchromb.2014.09.025; Li YJ, 2014, CLIN CHEM, V60, P783, DOI 10.1373/clinchem.2013.219931; Mueck W, 2008, CLIN PHARMACOKINET, V47, P203, DOI 10.2165/00003088-200847030-00006; Raghavan N, 2009, DRUG METAB DISPOS, V37, P74, DOI 10.1124/dmd.108.023143; Schmitz EMH, 2014, J THROMB HAEMOST, V12, P1636, DOI 10.1111/jth.12702; Shah V P, 2000, Pharm Res, V17, P1551, DOI 10.1023/A:1007669411738; van den Ouweland JMW, 2012, J CHROMATOGR B, V883, P18, DOI 10.1016/j.jchromb.2011.11.044; Zander J, 2015, CLIN CHEM LAB MED, V53, P781, DOI 10.1515/cclm-2014-0746	39	33	34	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145478	10.1371/journal.pone.0145478	http://dx.doi.org/10.1371/journal.pone.0145478			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26699714	Green Published, gold, Green Submitted			2022-12-26	WOS:000367092600088
J	Lyu, C; Hu, SY; Wei, LQ; Zhang, XM; Talhelm, T				Lyu, Chuang; Hu, Siyuan; Wei, Liuqing; Zhang, Xuemin; Talhelm, Thomas			Brain Activation of Identity Switching in Multiple Identity Tracking Task	PLOS ONE			English	Article							OBJECT TRACKING; WORKING-MEMORY; ATTENTIVE TRACKING; NEURAL MECHANISMS; PUZZLING FINDINGS; FMRI ACTIVATION; BINDING; INFORMATION; INHIBITION; DORSAL	When different objects switch identities in the multiple identity tracking (MIT) task, viewers need to rebind objects' identity and location, which requires attention. This rebinding helps people identify the regions targets are in (where they need to focus their attention) and inhibit unimportant regions (where distractors are). This study investigated the processing of attentional tracking after identity switching in an adapted MIT task. This experiment used three identity-switching conditions: a target-switching condition (where the target objects switched identities), a distractor-switching condition (where the distractor objects switched identities), and a no-switching condition. Compared to the distractor-switching condition, the target-switching condition elicited greater activation in the frontal eye fields (FEF), intraparietal sulcus (IPS), and visual cortex. Compared to the no-switching condition, the target-switching condition elicited greater activation in the FEF, inferior frontal gyrus (pars orbitalis) (IFG-Orb), IPS, visual cortex, middle temporal lobule, and anterior cingulate cortex. Finally, the distractor-switching condition showed greater activation in the IFG-Orb compared to the no-switching condition. These results suggest that, in the target-switching condition, the FEF and IPS (the dorsal attention network) might be involved in goal-driven attention to targets during attentional tracking. In addition, in the distractor-switching condition, the activation of the IFG-Orb may indicate salient change that pulls attention away automatically.	[Lyu, Chuang; Hu, Siyuan; Wei, Liuqing; Zhang, Xuemin] Beijing Normal Univ, Sch Psychol, Beijing Key Lab Appl Expt Psychol, Beijing 100875, Peoples R China; [Hu, Siyuan; Zhang, Xuemin] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Hu, Siyuan; Zhang, Xuemin] Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing 100875, Peoples R China; [Hu, Siyuan; Zhang, Xuemin] Beijing Normal Univ, Ctr Collaborat & Innovat Brain & Learning Sci, Beijing 100875, Peoples R China; [Talhelm, Thomas] Univ Chicago, Booth Sch Business, Chicago, IL 60637 USA	Beijing Normal University; Beijing Normal University; Beijing Normal University; Beijing Normal University; University of Chicago	Zhang, XM (corresponding author), Beijing Normal Univ, Sch Psychol, Beijing Key Lab Appl Expt Psychol, Beijing 100875, Peoples R China.	xmzhang@bnu.edu.cn			National Natural Science Foundation of China [31271083]; National Basic Research Program of China [2011CB711001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was funded by the National Natural Science Foundation of China (31271083) (to XMZ) and the National Basic Research Program of China (2011CB711001) (to XMZ) (http://www.973.gov.cn/English/Index.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez GA, 2009, VIS COGN, V17, P141, DOI 10.1080/13506280802265496; Anderson BA, 2012, ATTEN PERCEPT PSYCHO, V74, P1183, DOI 10.3758/s13414-012-0325-9; Armstrong KM, 2009, J NEUROSCI, V29, P15621, DOI 10.1523/JNEUROSCI.4465-09.2009; Atmaca S, 2013, BRAIN BEHAV, V3, P683, DOI 10.1002/brb3.180; Battelli L, 2009, J COGNITIVE NEUROSCI, V21, P1946, DOI 10.1162/jocn.2008.21149; Campo P, 2010, NEUROIMAGE, V49, P2807, DOI 10.1016/j.neuroimage.2009.10.024; Cohen MA, 2011, ATTEN PERCEPT PSYCHO, V73, P1422, DOI 10.3758/s13414-011-0089-7; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Culham JC, 1998, J NEUROPHYSIOL, V80, P2657, DOI 10.1152/jn.1998.80.5.2657; Culham JC, 2001, NEURON, V32, P737, DOI 10.1016/S0896-6273(01)00499-8; de Fockert JW, 2012, BRAIN COGNITION, V80, P367, DOI 10.1016/j.bandc.2012.07.006; de Lange FP, 2005, J COGNITIVE NEUROSCI, V17, P97, DOI 10.1162/0898929052880039; Doran MM, 2010, ATTEN PERCEPT PSYCHO, V72, P33, DOI 10.3758/APP.72.1.33; Drew T, 2009, PSYCHON B REV, V16, P411, DOI 10.3758/PBR.16.2.411; Farrant K, 2015, DEV COGN NEUROS-NETH, V12, P165, DOI 10.1016/j.dcn.2015.02.001; Giesbrecht B, 2003, NEUROIMAGE, V19, P496, DOI 10.1016/S1053-8119(03)00162-9; Greene CM, 2014, NEUROIMAGE, V84, P290, DOI 10.1016/j.neuroimage.2013.08.060; Hartwigsen G, 2010, P NATL ACAD SCI USA, V107, P16494, DOI 10.1073/pnas.1008121107; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Horowitz TS, 2007, PERCEPT PSYCHOPHYS, V69, P172, DOI 10.3758/BF03193740; Howe PD, 2009, J VISION, V9, DOI 10.1167/9.4.10; Howe PDL, 2015, COGNITIVE SCI, V39, P1622, DOI 10.1111/cogs.12204; Intriligator J, 2001, COGNITIVE PSYCHOL, V43, P171, DOI 10.1006/cogp.2001.0755; Jovicich J, 2001, J COGNITIVE NEUROSCI, V13, P1048, DOI 10.1162/089892901753294347; Ledberg A, 1998, NEUROIMAGE, V8, P113, DOI 10.1006/nimg.1998.0336; Liu TW, 2012, VISION RES, V66, P31, DOI 10.1016/j.visres.2012.06.009; Liu TW, 2009, LECT NOTES ARTIF INT, V5639, P206; Makovski T, 2009, J EXP PSYCHOL HUMAN, V35, P1687, DOI 10.1037/a0016453; Makovski T, 2009, VIS COGN, V17, P180, DOI 10.1080/13506280802211334; Muggleton NG, 2010, CORTEX, V46, P178, DOI 10.1016/j.cortex.2009.01.011; Oksama L, 2008, COGNITIVE PSYCHOL, V56, P237, DOI 10.1016/j.cogpsych.2007.03.001; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Pinto Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042929; Pinto Y, 2010, J VISION, V10, DOI 10.1167/10.10.4; Poch C, 2010, NEUROPSYCHOLOGIA, V48, P3846, DOI 10.1016/j.neuropsychologia.2010.09.015; Postle BR, 2005, MEM COGNITION, V33, P203, DOI 10.3758/BF03195309; Prabhakaran V, 2000, NAT NEUROSCI, V3, P85, DOI 10.1038/71156; PYLYSHYN Z W, 1988, Spatial Vision, V3, P179, DOI 10.1163/156856888X00122; Pylyshyn ZW, 2006, VIS COGN, V14, P175, DOI 10.1080/13506280544000200; Pylyshyn ZW, 2008, VIS COGN, V16, P1011, DOI 10.1080/13506280802247486; Pylyshyn ZW, 2004, VIS COGN, V11, P801, DOI 10.1080/13506280344000518; Ren DG, 2009, J VISION, V9, DOI 10.1167/9.5.18; Rosenberg-Lee M, 2011, NEUROPSYCHOLOGIA, V49, P2592, DOI 10.1016/j.neuropsychologia.2011.04.035; Salmi J, 2009, BRAIN RES, V1286, P155, DOI 10.1016/j.brainres.2009.06.083; Schafer RJ, 2007, NEURON, V56, P541, DOI 10.1016/j.neuron.2007.09.029; Sears CR, 2000, CAN J EXP PSYCHOL, V54, P1, DOI 10.1037/h0087326; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Spinks JA, 2004, NEUROIMAGE, V23, P517, DOI 10.1016/j.neuroimage.2004.06.025; Theeuwes J, 2010, ACTA PSYCHOL, V135, P77, DOI 10.1016/j.actpsy.2010.02.006; Thompson KG, 2005, J NEUROSCI, V25, P9479, DOI 10.1523/JNEUROSCI.0741-05.2005; Vogel SE, 2013, NEUROPSYCHOLOGIA, V51, P979, DOI 10.1016/j.neuropsychologia.2013.02.001; Weissman DH, 2012, NEUROIMAGE, V61, P798, DOI 10.1016/j.neuroimage.2012.03.032; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Xu YD, 2006, NATURE, V440, P91, DOI 10.1038/nature04262; Yamasaki H, 2002, P NATL ACAD SCI USA, V99, P11447, DOI 10.1073/pnas.182176499	56	8	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145489	10.1371/journal.pone.0145489	http://dx.doi.org/10.1371/journal.pone.0145489			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ4SI	26699865	Green Published, gold, Green Submitted			2022-12-26	WOS:000367092600089
J	Reine, TM; Vuong, TT; Rutkovskiy, A; Meen, AJ; Vaage, J; Jenssen, TG; Kolset, SO				Reine, Trine M.; Vuong, Tram T.; Rutkovskiy, Arkady; Meen, Astri J.; Vaage, Jarle; Jenssen, Trond G.; Kolset, Svein O.			Serglycin in Quiescent and Proliferating Primary Endothelial Cells	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; INFLAMMATORY STIMULI; HYPOXIC REGULATION; GROWTH-FACTOR; CORE PROTEIN; EXPRESSION; ANGIOGENESIS; SECRETION; BINDING; GRANULE	Proteoglycans are fundamental components of the endothelial barrier, but the functions of the proteoglycan serglycin in endothelium are less described. Our aim was to describe the roles of serglycin in processes relevant for endothelial dysfunction. Primary human umbilical vein endothelial cells (HUVEC) were cultured in vitro and the expression of proteoglycans was investigated. Dense cell cultures representing the quiescent endothelium coating the vasculature was compared to sparse activated cell cultures, relevant for diabetes, cancer and cardiovascular disease. Secretion of 35S-proteoglycans increased in sparse cultures, and we showed that serglycin is a major component of the cell-density sensitive proteoglycan population. In contrast to the other proteoglycans, serglycin expression and secretion was higher in proliferating compared to quiescent HUVEC. RNAi silencing of serglycin inhibited proliferation and wound healing, and serglycin expression and secretion was augmented by hypoxia, mechanical strain and IL-1 beta induced inflammation. Notably, the secretion of the angiogenic chemokine CCL2 resulting from IL-1 beta activation, was increased in serglycin knockdown cells, while angiopoietin was not affected. Both serglycin and CCL2 were secreted predominantly to the apical side of polarized HUVEC, and serglycin and CCL2 co-localized both in perinuclear areas and in vesicles. These results suggest functions for serglycin in endothelial cells trough interactions with partnermolecules, in biological processes with relevance for diabetic complications, cardiovascular disease and cancer development.	[Reine, Trine M.; Vuong, Tram T.; Meen, Astri J.; Kolset, Svein O.] Univ Oslo, Inst Basic Med Sci, Dept Nutr, N-0316 Oslo, Norway; [Rutkovskiy, Arkady] Univ Oslo, Inst Basic Med Sci, Dept Physiol, N-0316 Oslo, Norway; [Rutkovskiy, Arkady; Vaage, Jarle] Univ Oslo, Inst Clin Med, Dept Emergency & Intens Care, N-0316 Oslo, Norway; [Reine, Trine M.; Jenssen, Trond G.] Univ Oslo, Rikshosp, Dept Organ Transplantat, Sect Renal Dis,Oslo Univ Hosp, N-0027 Oslo, Norway; [Reine, Trine M.; Jenssen, Trond G.] UiT Arctic Univ Norway, Metab & Renal Res Grp, Tromso, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; UiT The Arctic University of Tromso	Reine, TM (corresponding author), Univ Oslo, Inst Basic Med Sci, Dept Nutr, Box 1046, N-0316 Oslo, Norway.	t.m.reine@medisin.uio.no	Vaage, Jarle/H-9079-2016	Vaage, Jarle/0000-0002-8747-5193	South Eastern Norway Regional Health Authority; Throne Holst Foundation; Nansen Foundation; Jahre Foundation; Norwegian Diabetes Association	South Eastern Norway Regional Health Authority; Throne Holst Foundation; Nansen Foundation; Jahre Foundation; Norwegian Diabetes Association	The research leading to these results received funding from The South Eastern Norway Regional Health Authority, The Throne Holst Foundation, The Nansen Foundation, and The Jahre Foundation and The Norwegian Diabetes Association.	Abrink M, 2004, J BIOL CHEM, V279, P40897, DOI 10.1074/jbc.M405856200; Asplund A, 2010, GLYCOBIOLOGY, V20, P33, DOI 10.1093/glycob/cwp139; Azcutia V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010091; Bonapace L, 2014, NATURE, V515, DOI 10.1038/nature13862; Chow MT, 2014, CANCER IMMUNOL RES, V2, P1125, DOI 10.1158/2326-6066.CIR-14-0160; Cines DB, 1998, BLOOD, V91, P3527; Coller HA, 2006, PLOS BIOL, V4, P329, DOI 10.1371/journal.pbio.0040083; De Vriese AS, 2000, BRIT J PHARMACOL, V130, P963, DOI 10.1038/sj.bjp.0703393; Dudley AC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006536; Friden V, 2011, KIDNEY INT, V79, P1322, DOI 10.1038/ki.2011.58; Garcia-Olivas R, 2003, HISTOCHEM CELL BIOL, V120, P371, DOI 10.1007/s00418-003-0576-6; Gharagozlian S, 2006, EUR J NUTR, V45, P369, DOI 10.1007/s00394-006-0608-9; Gharagozlian S, 2009, BMC CLIN PATHOL, V9, DOI 10.1186/1472-6890-9-7; GITAYGOREN H, 1992, J BIOL CHEM, V267, P6093; Grujic M, 2005, J BIOL CHEM, V280, P33411, DOI 10.1074/jbc.M501708200; Hagerling C, 2015, TRENDS CELL BIOL, V25, P214, DOI 10.1016/j.tcb.2014.11.001; Hamilton A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126688; Herder C, 2015, TRENDS ENDOCRIN MET, V26, P551, DOI 10.1016/j.tem.2015.08.001; Hjorth M, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12473; Hoh BL, 2011, CIRCULATION, V124, P2243, DOI 10.1161/CIRCULATIONAHA.111.036061; HUMPHRIES DE, 1986, J CELL PHYSIOL, V126, P249, DOI 10.1002/jcp.1041260214; Imoto-Tsubakimoto H, 2013, BIOCHEM BIOPH RES CO, V432, P105, DOI 10.1016/j.bbrc.2013.01.078; Iozzo RV, 2011, J CELL MOL MED, V15, P1013, DOI 10.1111/j.1582-4934.2010.01236.x; Iozzo RV, 2009, MOL CELLS, V27, P503, DOI 10.1007/s10059-009-0069-0; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Kaji T, 2000, J BIOL CHEM, V275, P1463, DOI 10.1074/jbc.275.2.1463; Keleg S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100178; Khoo CP, 2011, TISSUE ENG PART C-ME, V17, P895, DOI [10.1089/ten.tec.2011.0150, 10.1089/ten.TEC.2011.0150]; KIM CW, 1994, MOL BIOL CELL, V5, P797, DOI 10.1091/mbc.5.7.797; Kim JA, 2012, HEART FAIL CLIN, V8, P589, DOI 10.1016/j.hfc.2012.06.012; Kinsella MG, 1997, J BIOL CHEM, V272, P318; Kolset SO, 1996, J LEUKOCYTE BIOL, V59, P545, DOI 10.1002/jlb.59.4.545; Kolset SO, 2011, J IMMUNOL, V187, P4927, DOI 10.4049/jimmunol.1100806; Korpetinou A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/690721; Korpetinou A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078157; Kuchler AM, 2008, AM J PATHOL, V173, P1229, DOI 10.2353/ajpath.2008.080014; Li S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104107; Li XJ, 2011, CANCER RES, V71, P3162, DOI 10.1158/0008-5472.CAN-10-3557; Liu SH, 2013, J PATHOL, V230, P215, DOI 10.1002/path.4045; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martin A, 2003, MED RES REV, V23, P117, DOI 10.1002/med.10024; Meen AJ, 2011, J BIOL CHEM, V286, P2636, DOI 10.1074/jbc.M110.151944; Melo FR, 2011, J BIOL CHEM, V286, P5423, DOI 10.1074/jbc.M110.176461; MERTENS G, 1992, J BIOL CHEM, V267, P20435; Metkar SS, 2002, IMMUNITY, V16, P417, DOI 10.1016/S1074-7613(02)00286-8; Niemann CU, 2007, LEUKEMIA, V21, P2406, DOI 10.1038/sj.leu.2404975; Niu J, 2008, J BIOL CHEM, V283, P14542, DOI 10.1074/jbc.M802139200; Obika M, 2014, J HISTOCHEM CYTOCHEM, V62, P34, DOI 10.1369/0022155413507727; Oynebraten I, 2005, J IMMUNOL, V175, P5358, DOI 10.4049/jimmunol.175.8.5358; Pichiule P, 2004, J BIOL CHEM, V279, P12171, DOI 10.1074/jbc.M305146200; Purushothaman A, 2014, J BIOL CHEM, V289, P5499, DOI 10.1074/jbc.M113.532143; Reine TM, 2014, BBA-GEN SUBJECTS, V1840, P2498, DOI 10.1016/j.bbagen.2014.02.002; Reine TM, 2012, GLYCOCONJUGATE J, V29, P67, DOI 10.1007/s10719-011-9365-y; Salcedo R, 2000, BLOOD, V96, P34, DOI 10.1182/blood.V96.1.34.013a49_34_40; Salmon AHJ, 2012, J PATHOL, V226, P562, DOI 10.1002/path.3964; Schick BP, 2001, BLOOD, V97, P449, DOI 10.1182/blood.V97.2.449; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; Solomon SD, 2014, THE COCHRANE DATABAS, V8, DOI [10.1002/14651858.CD005139, DOI 10.1002/14651858.CD005139]; STEVENS RL, 1985, J BIOL CHEM, V260, P4194; Suffee N, 2012, ANGIOGENESIS, V15, P727, DOI 10.1007/s10456-012-9285-x; Sumpio BE, 2002, INT J BIOCHEM CELL B, V34, P1508, DOI 10.1016/S1357-2725(02)00075-4; Tsidulko AY, 2015, ONCOTARGET, DOI 10.18632/oncotarget.5984; UHLINHANSEN L, 1988, J BIOL CHEM, V263, P2526; van den Oever IAM, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/792393; Vuong TT, 2015, J HISTOCHEM CYTOCHEM, V63, P280, DOI 10.1369/0022155415568995; Weber KSC, 1999, ARTERIOSCL THROM VAS, V19, P2085, DOI 10.1161/01.ATV.19.9.2085; Weber M, 2013, SCIENCE, V339, P328, DOI 10.1126/science.1228456; Wernersson S, 2009, J LEUKOCYTE BIOL, V85, P401, DOI 10.1189/jlb.1008670; Werth BB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014830; Woulfe DS, 2008, BLOOD, V111, P3458, DOI 10.1182/blood-2007-07-104703; Zernichow L, 2006, J BIOL CHEM, V281, P26792, DOI 10.1074/jbc.M512889200	72	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145584	10.1371/journal.pone.0145584	http://dx.doi.org/10.1371/journal.pone.0145584			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26694746	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092500059
J	Reppe, S; Wang, YP; Thompson, WK; McEvoy, LK; Schork, AJ; Zuber, V; LeBlanc, M; Bettella, F; Mills, IG; Desikan, RS; Djurovic, S; Gautvik, KM; Dale, AM; Andreassen, OA				Reppe, Sjur; Wang, Yunpeng; Thompson, Wesley K.; McEvoy, Linda K.; Schork, Andrew J.; Zuber, Verena; LeBlanc, Marissa; Bettella, Francesco; Mills, Ian G.; Desikan, Rahul S.; Djurovic, Srdjan; Gautvik, Kaare M.; Dale, Anders M.; Andreassen, Ole A.		GEFOS Consortium	Genetic Sharing with Cardiovascular Disease Risk Factors and Diabetes Reveals Novel Bone Mineral Density Loci	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BLOOD-PRESSURE; NUCLEAR FACTOR; COMMON VARIANTS; NATIONAL-HEALTH; FRACTURE RISK; OSTEOPOROSIS; METAANALYSIS; PLEIOTROPY; INSULIN	Bone Mineral Density (BMD) is a highly heritable trait, but genome-wide association studies have identified few genetic risk factors. Epidemiological studies suggest associations between BMD and several traits and diseases, but the nature of the suggestive comorbidity is still unknown. We used a novel genetic pleiotropy-informed conditional False Discovery Rate (FDR) method to identify single nucleotide polymorphisms (SNPs) associated with BMD by leveraging cardiovascular disease (CVD) associated disorders and metabolic traits. By conditioning on SNPs associated with the CVD-related phenotypes, type 1 diabetes, type 2 diabetes, systolic blood pressure, diastolic blood pressure, high density lipoprotein, low density lipoprotein, triglycerides and waist hip ratio, we identified 65 novel independent BMD loci (26 with femoral neck BMD and 47 with lumbar spine BMD) at conditional FDR < 0.01. Many of the loci were confirmed in genetic expression studies. Genes validated at the mRNA levels were characteristic for the osteoblast/osteocyte lineage, Wnt signaling pathway and bone metabolism. The results provide new insight into genetic mechanisms of variability in BMD, and a better understanding of the genetic underpinnings of clinical comorbidity.	[Reppe, Sjur; Gautvik, Kaare M.] Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway; [Reppe, Sjur; Gautvik, Kaare M.] Lovisenberg Diakonale Hosp, Oslo, Norway; [Reppe, Sjur; Gautvik, Kaare M.] Univ Oslo, Inst Basic Med Sci, Oslo, Norway; [Wang, Yunpeng; Zuber, Verena; Bettella, Francesco; Djurovic, Srdjan; Andreassen, Ole A.] Univ Oslo, Inst Clin Med, KG Jebsen Ctr Psychosis Res, NORMENT, Oslo, Norway; [Wang, Yunpeng; Zuber, Verena; Bettella, Francesco; Djurovic, Srdjan; Andreassen, Ole A.] Oslo Univ Hosp, Div Mental Hlth & Addict, Oslo, Norway; [Wang, Yunpeng; Thompson, Wesley K.; Dale, Anders M.; Andreassen, Ole A.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Wang, Yunpeng; Dale, Anders M.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [McEvoy, Linda K.; Schork, Andrew J.; Desikan, Rahul S.; Dale, Anders M.] Univ Calif San Diego, Multimodal Imaging Lab, La Jolla, CA 92093 USA; [McEvoy, Linda K.; Desikan, Rahul S.; Dale, Anders M.] Univ Calif San Diego, Dept Radiol, La Jolla, CA 92093 USA; [Schork, Andrew J.] Univ Calif San Diego, Cognit Sci Grad Program, La Jolla, CA 92093 USA; [LeBlanc, Marissa] Univ Oslo, Inst Clin Med, Dept Clin Mol Biol, Oslo, Norway; [LeBlanc, Marissa] Univ Oslo, Oslo Ctr Biostat & Epidemiol, Dept Biostat, Oslo, Norway; [Mills, Ian G.] Univ Oslo, Ctr Mol Med Norway NCMM, Prostate Canc Res Grp, Oslo, Norway; [Mills, Ian G.] Oslo Univ Hosp, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Andreassen, OA (corresponding author), Univ Oslo, Inst Clin Med, KG Jebsen Ctr Psychosis Res, NORMENT, Oslo, Norway.	o.a.andreassen@medisin.uio.no	Garcia-Giralt, Natalia/AAA-7588-2021; Mills, Ian/AAK-9292-2020; Aulchenko, Yurii/M-8270-2013; Brown, Matthew A/E-5749-2010; Urreizti, Roser/M-6402-2014; Andreassen, Ole A./AAY-7531-2020; Balcells, Susana/C-5222-2017; Wang, Yunpeng/W-8871-2018; Kemp, John P./R-3091-2018; Aspelund, Thor/C-5983-2008; Evans, David/H-6325-2013; /G-9410-2011; Luben, Robert/H-5519-2015; Duncan, Emma/L-1224-2013; Smith, Albert Vernon/K-5150-2015	Garcia-Giralt, Natalia/0000-0001-6507-0147; Mills, Ian/0000-0001-5347-5083; Aulchenko, Yurii/0000-0002-7899-1575; Brown, Matthew A/0000-0003-0538-8211; Urreizti, Roser/0000-0003-3617-7134; Balcells, Susana/0000-0003-1211-1907; Wang, Yunpeng/0000-0001-9831-1090; Kemp, John P./0000-0002-9105-2249; Aspelund, Thor/0000-0002-7998-5433; Leslie, William/0000-0002-1056-1691; brandi, maria luisa/0000-0002-8741-0592; Williams, Frances/0000-0002-2998-2744; Djurovic, Srdjan/0000-0002-8140-8061; Shuldiner, Alan/0000-0001-9921-4305; Reid, Ian/0000-0001-6021-5458; Zarrabeitia, Maria T./0000-0002-2836-7766; Raychaudhuri, Soumya/0000-0002-1901-8265; Amin, Najaf/0000-0002-8944-1771; van Schoor, Natasja/0000-0002-0870-0795; Wilson, Scott/0000-0002-0357-1373; Evans, David/0000-0003-0663-4621; Cauley, Jane A/0000-0003-0752-4408; Center, Jacqueline/0000-0002-5278-4527; Minster, Ryan/0000-0001-7382-6717; Nogues, Xavier/0000-0002-5537-1859; /0000-0002-5608-1589; Koromila, Theodora/0000-0001-5504-1369; Mitchell, Braxton/0000-0003-4920-4744; Ohlsson, Claes/0000-0002-9633-2805; Luben, Robert/0000-0002-5088-6343; Zuber, Verena/0000-0001-9827-1877; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Duncan, Emma/0000-0002-8143-4403; Smith, Albert Vernon/0000-0003-1942-5845; Styrkarsdottir, Unnur/0000-0001-8146-8278; marc, janja/0000-0001-6013-9758; /0000-0001-7061-6837; Kammerer, Candace M/0000-0002-2841-4761; Kahonen, Mika/0000-0002-4510-7341	Research Council of Norway [183782/V50]; South East Norway Health Authority [2010-074, 52009/8029]; National Institutes of Health [T32 EB005970, RC2DA029475, R01HD061414]; Robert J. Glushko and Pamela Samuelson Graduate Fellowship; 6th EU framework program [LSHM-CT-2003-502941]; Oslo University Hospital, Ullevaal [52009/8029]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB005970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [RC2DA029475] Funding Source: NIH RePORTER	Research Council of Norway(Research Council of Norway); South East Norway Health Authority; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert J. Glushko and Pamela Samuelson Graduate Fellowship; 6th EU framework program(European Commission); Oslo University Hospital, Ullevaal; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Research Council of Norway [grant number 183782/V50 to OAA]; the South East Norway Health Authority [grant number 2010-074 to OAA and 52009/8029 to KMG]; the National Institutes of Health [grant number T32 EB005970 to RSD, RC2DA029475 and R01HD061414 to AJS]; the Robert J. Glushko and Pamela Samuelson Graduate Fellowship to AJS; the 6th EU framework program [grant number LSHM-CT-2003-502941 to KMG and SR]; and Oslo University Hospital, Ullevaal [grant number 52009/8029 to KMG]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackert-Bicknell CL, 2012, BONE, V50, P525, DOI 10.1016/j.bone.2011.07.002; Andreassen OA, 2014, INT J EPIDEMIOL, V43, P1205, DOI 10.1093/ije/dyu090; Andreassen OA, 2014, HYPERTENSION, V63, P819, DOI 10.1161/HYPERTENSIONAHA.113.02077; Andreassen OA, 2013, AM J HUM GENET, V92, P197, DOI 10.1016/j.ajhg.2013.01.001; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Billings LK, 2012, DIABETES, V61, P2176, DOI 10.2337/db11-1515; Buizert PJ, 2009, J BONE MINER RES, V24, P1103, DOI [10.1359/JBMR.081262, 10.1359/jbmr.081262]; Compston J, 2010, RADIOL CLIN N AM, V48, P477, DOI 10.1016/j.rcl.2010.02.010; Dallas SL, 2012, METHODS MOL BIOL, V816, P425, DOI 10.1007/978-1-61779-415-5_26; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Fitzpatrick DJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1300-3; Fromigue O, 2010, J BIOL CHEM, V285, P25251, DOI 10.1074/jbc.M110.110502; Garg M K, 2014, Indian J Endocrinol Metab, V18, P325, DOI 10.4103/2230-8210.131165; Ge YQ, 2008, AM J PHYSIOL-RENAL, V295, pF1635, DOI 10.1152/ajprenal.90279.2008; Goettsch C, 2011, DIABETOLOGIA, V54, P2690, DOI 10.1007/s00125-011-2219-0; Gupta M, 2011, J BONE MINER RES, V26, P1261, DOI 10.1002/jbmr.333; Jackuliak P, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/820615; Janicka A, 2007, J CLIN ENDOCR METAB, V92, P143, DOI 10.1210/jc.2006-0794; Jemtland R, 2011, J BONE MINER RES, V26, P1793, DOI 10.1002/jbmr.396; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Kado DM, 2000, J BONE MINER RES, V15, P1974, DOI 10.1359/jbmr.2000.15.10.1974; Kanis JA, 2007, OSTEOPOROSIS INT, V18, P1033, DOI 10.1007/s00198-007-0343-y; Kaplan S, 2010, J WOMENS HEALTH, V19, P1209, DOI 10.1089/jwh.2009.1587; Khan TS, 2015, J OSTEOPOROS, V2015, DOI 10.1155/2015/174186; Kim CJ, 2009, CLIN ENDOCRINOL, V71, P18, DOI 10.1111/j.1365-2265.2008.03452.x; Kim T, 2013, J BONE MINER METAB, V31, P652, DOI 10.1007/s00774-013-0459-4; Kim YH, 2013, ENDOCR J, V60, P1179, DOI 10.1507/endocrj.EJ13-0224; Lawlor DA, 2012, J CLIN ENDOCR METAB, V97, P2068, DOI 10.1210/jc.2011-2721; Lee HT, 2015, CLIN EXP HYPERTENS, V37, P212, DOI 10.3109/10641963.2014.933971; Li S, 2015, CLIN ENDOCRINOL, V82, P53, DOI 10.1111/cen.12616; Lin DY, 2009, AM J HUM GENET, V85, P862, DOI 10.1016/j.ajhg.2009.11.001; Liu J, 2013, BONE, V54, P151, DOI 10.1016/j.bone.2013.01.044; Liu JZ, 2013, NAT GENET, V45, P670, DOI 10.1038/ng.2616; Liu QH, 2012, CIRC RES, V110, P1077, DOI 10.1161/CIRCRESAHA.111.260729; Oei L, 2013, DIABETES CARE, V36, P1619, DOI 10.2337/dc12-1188; Paic F, 2009, BONE, V45, P682, DOI 10.1016/j.bone.2009.06.010; Pidsley R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-293; Reppe S, 2007, AM J PHYSIOL-ENDOC M, V292, pE1465, DOI 10.1152/ajpendo.00487.2006; Reppe S, 2010, BONE, V46, P604, DOI 10.1016/j.bone.2009.11.007; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Saidak Z, 2012, AGING CELL, V11, P467, DOI 10.1111/j.1474-9726.2012.00804.x; Sayers A, 2012, J BONE MINER RES, V27, P610, DOI 10.1002/jbmr.1467; Schork AJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003449; Sivakumaran S, 2011, AM J HUM GENET, V89, P607, DOI 10.1016/j.ajhg.2011.10.004; Strait KA, 2010, J BIOL CHEM, V285, P28520, DOI 10.1074/jbc.M110.153189; Tanko LB, 2005, J BONE MINER RES, V20, P1912, DOI 10.1359/JBMR.050711; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Vestergaard P, 2007, OSTEOPOROSIS INT, V18, P427, DOI 10.1007/s00198-006-0253-4; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Yazici S, 2011, ARCH MED SCI, V7, P264, DOI 10.5114/aoms.2011.22077; Zillikens MC, 2010, CALCIFIED TISSUE INT, V86, P116, DOI 10.1007/s00223-009-9319-6	53	14	16	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0144531	10.1371/journal.pone.0144531	http://dx.doi.org/10.1371/journal.pone.0144531			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26695485	Green Published, gold			2022-12-26	WOS:000367092500005
J	Kang, S; Dahl, R; Hsieh, W; Shin, A; Zsebo, KM; Buettner, C; Hajjar, RJ; Lebeche, D				Kang, Soojeong; Dahl, Russell; Hsieh, Wilson; Shin, Andrew; Zsebo, Krisztina M.; Buettner, Christoph; Hajjar, Roger J.; Lebeche, Djamel			Small Molecular Allosteric Activator of the Sarco/Endoplasmic Reticulum Ca2+-ATPase (SERCA) Attenuates Diabetes and Metabolic Disorders	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated kinase (AMPK); diabetes; endoplasmic reticulum stress (ER stress); glucose metabolism; lipid metabolism; Ca2+ homeostasis; SERCA2b; hepatosteatosis; insulin sensitivity; mitochondria efficiency	UNFOLDED PROTEIN RESPONSE; INSULIN-RESISTANCE; GENE-TRANSFER; MITOCHONDRIAL DYSFUNCTION; HEPATIC GLUCONEOGENESIS; CELL-DEATH; ERR-ALPHA; STRESS; LIVER; EXPRESSION	Dysregulation of endoplasmic reticulum (ER) Ca2+ homeostasis triggers ER stress leading to the development of insulin resistance in obesity and diabetes. Impaired function of the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) has emerged as a major contributor to ER stress. We pharmacologically activated SERCA2b in a genetic model of insulin resistance and type 2 diabetes (ob/ob mice) with a novel allosteric activator, CDN1163, which markedly lowered fasting blood glucose, improved glucose tolerance, and ameliorated hepatosteatosis but did not alter glucose levels or body weight in lean controls. Importantly, CDN1163-treated ob/ob mice maintained euglycemia comparable with that of lean mice for >6 weeks after cessation of CDN1163 administration. CDN1163-treated ob/ob mice showed a significant reduction in adipose tissue weight with no change in lean mass, assessed by magnetic resonance imaging. They also showed an increase in energy expenditure using indirect calorimetry, which was accompanied by increased expression of uncoupling protein 1 (UCP1) and UCP3 in brown adipose tissue. CDN1163 treatment significantly reduced the hepatic expression of genes involved in gluconeogenesis and lipogenesis, attenuated ER stress response and ER stress-induced apoptosis, and improved mitochondrial biogenesis, possibly through SERCA2-mediated activation of AMP-activated protein kinase pathway. The findings suggest that SERCA2b activation may hold promise as an effective therapy for type-2 diabetes and metabolic dysfunction.	[Kang, Soojeong; Hajjar, Roger J.; Lebeche, Djamel] Icahn Sch Med Mt Sinai, Dept Med, Cardiovasc Res Inst, New York, NY 10029 USA; [Kang, Soojeong; Hajjar, Roger J.; Lebeche, Djamel] Icahn Sch Med Mt Sinai, Dept Med, Diabet Obes & Metab Inst, New York, NY 10029 USA; [Dahl, Russell] Rosalind Franklin Univ Med & Sci, Dept Pharmaceut Sci, N Chicago, IL 60064 USA; [Hsieh, Wilson; Shin, Andrew; Buettner, Christoph] Icahn Sch Med Mt Sinai, Diabet Obes & Metab Inst, Dept Med, New York, NY 10029 USA; [Hsieh, Wilson; Shin, Andrew; Buettner, Christoph] Icahn Sch Med Mt Sinai, Diabet Obes & Metab Inst, Dept Neurosci, New York, NY 10029 USA; [Zsebo, Krisztina M.] Celladon Corp, San Diego, CA 92130 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Rosalind Franklin University Medical & Science; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Lebeche, D (corresponding author), Icahn Sch Med Mt Sinai, Cardiovasc Res Inst, One Gustave L Levy Pl,Box 1030, New York, NY 10029 USA.	djamel.lebeche@mssm.edu	Shin, Andrew/T-6225-2019	Dahl, Russell/0000-0002-2939-1004	National Institutes of Health [HL097375, DK020541, DK083658, K01 DK099463]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL129814, R01HL128072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK099463, R01DK083658, P60DK020541, P30DK020541, R56DK083658, R01DK111417, R56DK100624] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA023416] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institutes of Health Grants HL097375 and DK020541 (to D. L.), DK083658 (to C. B.), and K01 DK099463 (to A. S.).	Ashby MC, 2001, SEMIN CELL DEV BIOL, V12, P11, DOI 10.1006/scdb.2000.0212; Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555; Bechmann LP, 2012, J HEPATOL, V56, P952, DOI 10.1016/j.jhep.2011.08.025; Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; CONSOLI A, 1989, DIABETES, V38, P550, DOI 10.2337/diabetes.38.5.550; Cornea RL, 2013, J BIOMOL SCREEN, V18, P97, DOI 10.1177/1087057112456878; Disdier-Flores O M, 2001, P R Health Sci J, V20, P123; Dong YZ, 2010, CIRCULATION, V121, P792, DOI 10.1161/CIRCULATIONAHA.109.900928; Engin F, 2010, DIABETES OBES METAB, V12, P108, DOI 10.1111/j.1463-1326.2010.01282.x; Fonseca SG, 2011, TRENDS ENDOCRIN MET, V22, P266, DOI 10.1016/j.tem.2011.02.008; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; Garcia-Ruiz I, 2006, HEPATOLOGY, V44, P581, DOI 10.1002/hep.21313; Gaspari M, 2004, BBA-BIOENERGETICS, V1659, P148, DOI 10.1016/j.bbabio.2004.10.003; Hadri L, 2010, MOL THER, V18, P1284, DOI 10.1038/mt.2010.77; Hong YH, 2003, J BIOL CHEM, V278, P27495, DOI 10.1074/jbc.M304112200; Jaburek M, 2004, J BIOL CHEM, V279, P53097, DOI 10.1074/jbc.M405339200; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Kars M, 2010, DIABETES, V59, P1899, DOI 10.2337/db10-0308; Kotronen A, 2008, DIABETOLOGIA, V51, P130, DOI 10.1007/s00125-007-0867-x; Kulkarni RN, 2004, DIABETES, V53, P1517, DOI 10.2337/diabetes.53.6.1517; Leemand J, 2012, EXP DIABETES RES, DOI 10.1155/2012/242984; Lim JH, 2009, CELL SIGNAL, V21, P169, DOI 10.1016/j.cellsig.2008.10.004; Lochhead PA, 2000, DIABETES, V49, P896, DOI 10.2337/diabetes.49.6.896; Lustig Y, 2011, GENE DEV, V25, P1232, DOI 10.1101/gad.2054711; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Morton GJ, 2013, J CLIN INVEST, V123, P4799, DOI 10.1172/JCI70710; Ozcan L, 2012, ANNU REV MED, V63, P317, DOI 10.1146/annurev-med-043010-144749; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Park SW, 2010, P NATL ACAD SCI USA, V107, P19320, DOI 10.1073/pnas.1012044107; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Rieusset J, 2011, INT J BIOCHEM CELL B, V43, P1257, DOI 10.1016/j.biocel.2011.05.006; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sakata S, 2007, AM J PHYSIOL-HEART C, V292, pH1204, DOI 10.1152/ajpheart.00892.2006; Sakata S, 2006, MOL THER, V13, P987, DOI 10.1016/j.ymthe.2006.01.002; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Spiegelman Bruce M, 2007, Novartis Found Symp, V287, P60; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Vangheluwe P, 2005, CELL CALCIUM, V38, P291, DOI 10.1016/j.ceca.2005.06.033; Williams LM, 2012, P NUTR SOC, V71, P521, DOI 10.1017/S002966511200078X; Wold LE, 2005, J MOL CELL CARDIOL, V39, P297, DOI 10.1016/j.yjmcc.2005.03.014; Xiao CT, 2011, DIABETES, V60, P918, DOI 10.2337/db10-1433; Yki-Jarvinen H, 2005, ANN MED, V37, P347, DOI 10.1080/07853890510037383; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	48	98	100	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					5185	5198		10.1074/jbc.M115.705012	http://dx.doi.org/10.1074/jbc.M115.705012			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26702054	Green Published, hybrid			2022-12-26	WOS:000371640600030
J	He, ZM; Wu, JY; Su, XN; Zhang, Y; Pan, LX; Wei, HM; Fang, Q; Li, HT; Wang, DL; Sun, FL				He, Zhimin; Wu, Junyu; Su, Xiaonan; Zhang, Ye; Pan, Lixia; Wei, Huimin; Fang, Qiang; Li, Haitao; Wang, Da-Liang; Sun, Fang-Lin			JMJD5 (Jumonji Domain-containing 5) Associates with Spindle Microtubules and Is Required for Proper Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H3K36ME2 HISTONE DEMETHYLASE; CONTAINING PROTEIN; MITOTIC SPINDLE; CELL-CYCLE; LOCALIZES; TUBULIN; COMPLEX; KINETOCHORE; ACETYLATION; MECHANISMS	Precise mitotic spindle assembly is a guarantee of proper chromosome segregation during mitosis. Chromosome instability caused by disturbed mitosis is one of the major features of various types of cancer. JMJD5 has been reported to be involved in epigenetic regulation of gene expression in the nucleus, but little is known about its function in mitotic process. Here we report the unexpected localization and function of JMJD5 in mitotic progression. JMJD5 partially accumulates on mitotic spindles during mitosis, and depletion of JMJD5 results in significant mitotic arrest, spindle assembly defects, and sustained activation of the spindle assembly checkpoint (SAC). Inactivating SAC can efficiently reverse the mitotic arrest caused by JMJD5 depletion. Moreover, JMJD5 is found to interact with tubulin proteins and associate with microtubules during mitosis. JMJD5-depleted cells show a significant reduction of alpha-tubulin acetylation level on mitotic spindles and fail to generate enough interkinetochore tension to satisfy the SAC. Further, JMJD5 depletion also increases the susceptibility of HeLa cells to the antimicrotubule agent. Taken together, these results suggest that JMJD5 plays an important role in regulating mitotic progression, probably by modulating the stability of spindle microtubules.	[He, Zhimin; Wu, Junyu; Su, Xiaonan; Zhang, Ye; Pan, Lixia; Li, Haitao; Wang, Da-Liang; Sun, Fang-Lin] Tsinghua Univ, Sch Med, Dept Basic Med Sci, Beijing 100084, Peoples R China; [Wei, Huimin; Sun, Fang-Lin] Tongji Univ, Sch Life Sci & Technol, Res Ctr Translat Med, East Hosp, Shanghai 200092, Peoples R China	Tsinghua University; Tongji University	Wang, DL; Sun, FL (corresponding author), Tsinghua Univ, Sch Med, Dept Basic Med Sci, Beijing 100084, Peoples R China.; Sun, FL (corresponding author), Tongji Univ, Sch Life Sci & Technol, Res Ctr Translat Med, East Hosp, Shanghai 200092, Peoples R China.	wangdaliang@mail.tsinghua.edu.cn; sfl@tongji.edu.cn	Li, Haitao/B-2668-2012	Li, Haitao/0000-0001-6741-293X; Wu, Junyu/0000-0002-2515-9320	National Natural Science Foundation of China [91419304]; 973 program of the Ministry of Science and Technology of China [2015CB964800, 2015CB856200, 2011CB965300, 2013CB967600, 2013CB967500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 program of the Ministry of Science and Technology of China(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China Grant 91419304 and the 973 program of the Ministry of Science and Technology of China Grant 2015CB964800, 2015CB856200, 2011CB965300, 2013CB967600, and 2013CB967500. The authors declare that they have no conflicts of interest with the contents of this article.	Antrobus R, 2011, METHODS MOL BIOL, V777, P273, DOI 10.1007/978-1-61779-252-6_20; Bailey JK, 2015, J BIOL CHEM, V290, P8987, DOI 10.1074/jbc.M114.623611; Bergo A, 2015, J BIOL CHEM, V290, P3223, DOI 10.1074/jbc.M114.608125; Brownlow N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6685; Butler KV, 2010, J AM CHEM SOC, V132, P10842, DOI 10.1021/ja102758v; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Castro-Castro A, 2012, EUR J CELL BIOL, V91, P950, DOI 10.1016/j.ejcb.2012.07.001; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Coulombe P, 2002, ANAL BIOCHEM, V310, P219, DOI 10.1016/S0003-2697(02)00319-6; Del Rizzo PA, 2012, MOL CELL BIOL, V32, P4044, DOI 10.1128/MCB.00513-12; Farkash-Amar S., 2012, PLOS ONE, P7; Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494; Gordon DJ, 2012, NAT REV GENET, V13, P189, DOI 10.1038/nrg3123; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; Hsia DA, 2010, P NATL ACAD SCI USA, V107, P9671, DOI 10.1073/pnas.1000401107; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang XB, 2015, BBA-MOL CELL RES, V1853, P2286, DOI 10.1016/j.bbamcr.2015.05.026; Huang XB, 2013, BIOCHIMIE, V95, P2114, DOI 10.1016/j.biochi.2013.08.002; Huang YJ, 2012, J BIOL CHEM, V287, P1500, DOI 10.1074/jbc.M111.277194; Ishii S, 2008, P NATL ACAD SCI USA, V105, P4179, DOI 10.1073/pnas.0710140105; Ishimura A, 2012, DEVELOPMENT, V139, P749, DOI 10.1242/dev.074138; Jakel S, 1999, EMBO J, V18, P2411, DOI 10.1093/emboj/18.9.2411; Janke C, 2014, J CELL BIOL, V206, P461, DOI 10.1083/jcb.201406055; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Juan G., 2004, DETECTION MITOTIC CE; Kaverina I, 2011, SEMIN CELL DEV BIOL, V22, P968, DOI 10.1016/j.semcdb.2011.09.017; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Koffa MD, 2006, CURR BIOL, V16, P743, DOI 10.1016/j.cub.2006.03.056; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marcon E, 2014, CELL REP, V8, P297, DOI 10.1016/j.celrep.2014.05.050; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nicklas RB, 1997, SCIENCE, V275, P632, DOI 10.1126/science.275.5300.632; Oh S, 2012, BIOCHEM BIOPH RES CO, V420, P61, DOI 10.1016/j.bbrc.2012.02.115; Raemaekers T, 2003, J CELL BIOL, V162, P1017, DOI 10.1083/jcb.200302129; Rieder CL, 1998, TRENDS CELL BIOL, V8, P310, DOI 10.1016/S0962-8924(98)01299-9; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Szyk A, 2014, CELL, V157, P1405, DOI 10.1016/j.cell.2014.03.061; Wang HP, 2013, ACTA CRYSTALLOGR D, V69, P1911, DOI 10.1107/S0907444913016600; Wang HJ, 2014, P NATL ACAD SCI USA, V111, P279, DOI 10.1073/pnas.1311249111; Wittmann T, 2001, NAT CELL BIOL, V3, pE28, DOI 10.1038/35050669; Youn MY, 2012, J BIOL CHEM, V287, P12994, DOI 10.1074/jbc.M111.323105; Zhu H, 2014, STEM CELLS, V32, P2098, DOI 10.1002/stem.1724	47	13	13	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4684	4697		10.1074/jbc.M115.672642	http://dx.doi.org/10.1074/jbc.M115.672642			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26710852	hybrid, Green Published			2022-12-26	WOS:000371604600035
J	Ghosh, D; Ding, LL; Sivaprasad, U; Geh, E; Myers, JB; Bernstein, JA; Hershey, GKK; Mersha, TB				Ghosh, Debajyoti; Ding, Lili; Sivaprasad, Umasundari; Geh, Esmond; Myers, Jocelyn Biagini; Bernstein, Jonathan A.; Hershey, Gurjit K. Khurana; Mersha, Tesfaye B.			Multiple Transcriptome Data Analysis Reveals Biologically Relevant Atopic Dermatitis Signature Genes and Pathways	PLOS ONE			English	Article							NCBI GEO ARCHIVE; T-CELLS; STAPHYLOCOCCUS-AUREUS; MICROARRAY ANALYSIS; SKIN BARRIER; EXPRESSION; PSORIASIS; DISEASE; DIFFERENTIATION; ACTIVATION	Several studies have identified genes that are differentially expressed in atopic dermatitis (AD) compared to normal skin. However, there is also considerable variation in the list of differentially expressed genes (DEGs) reported by different groups and the exact cause of AD is still not fully understood. Using a rank-based approach, we analyzed gene expression data from five different microarray studies, comprising a total of 127 samples and more than 250,000 transcripts. A total of 89 AD gene expression signatures '89ADGES', including FLG gene, were identified to show dysregulation consistently across these studies. Using a Support Vector Machine, we showed that the '89ADGES' discriminates AD from normal skin with 98% predictive accuracy. Functional annotation of these genes implicated their roles in immune responses (e.g., betadefensin, microseminoprotein), keratinocyte differentiation/epidermal development (e.g., FLG, CORIN, AQP, LOR, KRT16), inflammation (e.g., IL37, IL27RA, CCL18) and lipid metabolism (e.g., AKR1B10, FAD7, FAR2). Subsequently, we validated a subset of signature genes using quantitative PCR in a mouse model. Using a bioinformatic approach, we identified keratinocyte pathway over-represented (P = < 0.0006) among the 89 signature genes. Keratinocytes are known to play a major role in barrier function due to their location in the epidermis. Our result suggests that besides immune-mediated pathway, skin barrier pathways such as the keratinocyte differentiation pathway play a key role in AD pathogenesis. A better understanding of the role of keratinocytes in AD will be important for developing novel "barrier therapy" for this disease.	[Ghosh, Debajyoti; Geh, Esmond; Bernstein, Jonathan A.] Univ Cincinnati, Dept Internal Med, Div Immunol Allergy & Rheumatol, Cincinnati, OH USA; [Ding, Lili] Univ Cincinnati, Dept Pediat, Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH USA; [Sivaprasad, Umasundari; Myers, Jocelyn Biagini; Hershey, Gurjit K. Khurana; Mersha, Tesfaye B.] Univ Cincinnati, Dept Pediat, Cincinnati Childrens Hosp Med Ctr, Div Asthma Res, Cincinnati, OH 45220 USA	University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Mersha, TB (corresponding author), Univ Cincinnati, Dept Pediat, Cincinnati Childrens Hosp Med Ctr, Div Asthma Res, Cincinnati, OH 45220 USA.	tesfaye.mersha@cchmc.org		Biagini, Jocelyn/0000-0002-4378-6133; Bernstein, Jonathan/0000-0002-3476-1196	National Institutes of Health [K01HL103165]; Diversity and Health Disparities Award of the Cincinnati Children's Research Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001425] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL103165] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diversity and Health Disparities Award of the Cincinnati Children's Research Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grant K01HL103165 and Diversity and Health Disparities Award of the Cincinnati Children's Research Foundation to TBM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adema GJ, 1997, NATURE, V387, P713, DOI 10.1038/42716; Akdis CA, 2000, CURR OPIN IMMUNOL, V12, P641, DOI 10.1016/S0952-7915(00)00156-4; Arthur WT, 2001, MOL BIOL CELL, V12, P2711, DOI 10.1091/mbc.12.9.2711; Atamas SP, 2003, AM J RESP CELL MOL, V29, P743, DOI 10.1165/rcmb.2003-0078OC; Bantz Selene K, 2014, J Clin Cell Immunol, V5; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Behshad R, 2008, ARCH DERMATOL, V144, P84, DOI 10.1001/archdermatol.2007.22; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernstein DI, 2013, TOXICOL SCI, V131, P242, DOI 10.1093/toxsci/kfs272; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Boguniewicz M, 2011, IMMUNOL REV, V242, P233, DOI 10.1111/j.1600-065X.2011.01027.x; Bowcock AM, 2004, HUM MOL GENET, V13, pR43, DOI 10.1093/hmg/ddh094; Briot A, 2009, J EXP MED, V206, P1135, DOI 10.1084/jem.20082242; CHRISTOPHERS E, 1987, ARCH DERMATOL RES, V279, pS48, DOI 10.1007/BF00585919; Darlenski R, 2014, CLIN DERMATOL, V32, P409, DOI 10.1016/j.clindermatol.2013.11.007; de Veer SJ, 2014, TRENDS MOL MED, V20, P166, DOI 10.1016/j.molmed.2013.11.005; Denby KS, 2012, CURR OPIN ALLERGY CL, V12, P421, DOI 10.1097/ACI.0b013e3283551da5; Ding LL, 2013, HUM GENOMICS, V7, DOI 10.1186/1479-7364-7-16; Dubrac S, 2011, DERM-ENDOCRINOL, V3, P23, DOI 10.4161/derm.3.1.14615; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Esche C, 2004, CURR ALLERGY ASTHM R, V4, P276, DOI 10.1007/s11882-004-0071-8; Eyre S, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3139; Febbo PG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-461; Garidel P, 2010, BIOPHYS CHEM, V150, P144, DOI 10.1016/j.bpc.2010.03.008; Gittler JK, 2012, J ALLERGY CLIN IMMUN, V130, P1344, DOI 10.1016/j.jaci.2012.07.012; Glaser R, 2009, J INVEST DERMATOL, V129, P641, DOI 10.1038/jid.2008.268; GRICE K, 1975, J INVEST DERMATOL, V64, P313, DOI 10.1111/1523-1747.ep12512258; Gunther C, 2005, J IMMUNOL, V174, P1723, DOI 10.4049/jimmunol.174.3.1723; Guttman-Yassky E, 2013, EXPERT OPIN BIOL TH, V13, P549, DOI 10.1517/14712598.2013.758708; Guttman-Yassky E, 2009, J ALLERGY CLIN IMMUN, V124, P1235, DOI 10.1016/j.jaci.2009.09.031; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Hatano Y, 2011, J INVEST DERMATOL, V131, P1845, DOI 10.1038/jid.2011.144; Hu YH, 2003, J PROTEOME RES, V2, P405, DOI 10.1021/pr0340227; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kim JH, 2011, J CLIN IMMUNOL, V31, P112, DOI 10.1007/s10875-010-9462-x; Kodelja V, 1998, J IMMUNOL, V160, P1411; Kypriotou M, 2012, EXP DERMATOL, V21, P643, DOI 10.1111/j.1600-0625.2012.01472.x; Leung DYM, 2014, J ALLERGY CLIN IMMUN, V134, P769, DOI 10.1016/j.jaci.2014.08.008; Maeda M, 2011, MOL BIOL CELL, V22, P3840, DOI 10.1091/mbc.E11-04-0364; Mancini AJ, 2008, PEDIATR DERMATOL, V25, P1, DOI 10.1111/j.1525-1470.2007.00572.x; Mantel A, 2012, J INVEST DERMATOL, V132, P1103, DOI 10.1038/jid.2011.412; Mao-Qiang M, 2004, J INVEST DERMATOL, V123, P305, DOI 10.1111/j.0022-202X.2004.23235.x; Marenholz I, 1996, GENOMICS, V37, P295, DOI 10.1006/geno.1996.0563; Menzies BE, 2005, INFECT IMMUN, V73, P5241, DOI 10.1128/IAI.73.8.5241-5244.2005; Meyer-Hoffert U, 2009, ARCH IMMUNOL THER EX, V57, P345, DOI 10.1007/s00005-009-0045-6; Nomura I, 2003, J IMMUNOL, V171, P3262, DOI 10.4049/jimmunol.171.6.3262; Olsson M, 2006, ALLERGY, V61, P1132, DOI 10.1111/j.1398-9995.2006.01151.x; PICKER LJ, 1990, AM J PATHOL, V136, P1053; Plager DA, 2007, EXP DERMATOL, V16, P28, DOI 10.1111/j.1600-0625.2006.00504.x; Puya R, 2012, INT J DERMATOL, V51, P115, DOI 10.1111/j.1365-4632.2011.05195.x; Raponi M, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-56; Reginald K, 2011, CLIN EXP ALLERGY, V41, P357, DOI 10.1111/j.1365-2222.2010.03655.x; Rung J, 2013, NAT REV GENET, V14, P89, DOI 10.1038/nrg3394; Saaf AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004017; Schibli DJ, 2002, J BIOL CHEM, V277, P8279, DOI 10.1074/jbc.M108830200; Schutyser E, 2005, J LEUKOCYTE BIOL, V78, P14, DOI 10.1189/jlb.1204712; Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254; Sertznig P, 2011, DERM-ENDOCRINOL, V3, P130, DOI [10.4161/derm.3.3.15025, 10.4161/derm.15025]; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Soderhall C, 2001, HUM GENET, V109, P129, DOI 10.1007/s004390100556; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Suarez-Farinas M, 2011, J ALLERGY CLIN IMMUN, V127, P954, DOI 10.1016/j.jaci.2010.12.1124; Swindell WR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-527; Tan JQ, 1996, J INVEST DERMATOL, V107, P5, DOI 10.1111/1523-1747.ep12294284; Vapnik V., 1998, STAT LEARNING THEORY; Vogl T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5593; Xiao YF, 2014, BIOINFORMATICS, V30, P801, DOI 10.1093/bioinformatics/btr671; Yang LL, 2014, J INVEST DERMATOL, V134, P2105, DOI 10.1038/jid.2014.120; Zeeuwen PLJM, 2009, J INVEST DERMATOL, V129, P1327, DOI 10.1038/jid.2009.40; Zeller S, 2009, J ALLERGY CLIN IMMUN, V124, P278, DOI 10.1016/j.jaci.2009.05.015; Zhang ZH, 2014, J IMMUNOL, V192, P859, DOI 10.4049/jimmunol.1301062; Zheng T, 2011, ALLERGY ASTHMA IMMUN, V3, P67, DOI 10.4168/aair.2011.3.2.67	74	49	51	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0144316	10.1371/journal.pone.0144316	http://dx.doi.org/10.1371/journal.pone.0144316			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717000	gold, Green Submitted, Green Published			2022-12-26	WOS:000367510500010
J	Kanda, K; Pflug, JM; Sproul, JS; Dasenko, MA; Maddison, DR				Kanda, Kojun; Pflug, James M.; Sproul, John S.; Dasenko, Mark A.; Maddison, David R.			Successful Recovery of Nuclear Protein-Coding Genes from Small Insects in Museums Using Illumina Sequencing	PLOS ONE			English	Article							ANCIENT DNA; GENOME SIZE; COLEOPTERA; CARABIDAE; SPECIMENS; BEMBIDION; PRESERVATION; BEETLE; SUBGENUS; COLLECTIONS	In this paper we explore high-throughput Illumina sequencing of nuclear protein-coding, ribosomal, and mitochondrial genes in small, dried insects stored in natural history collections. We sequenced one tenebrionid beetle and 12 carabid beetles ranging in size from 3.7 to 9.7 mm in length that have been stored in various museums for 4 to 84 years. Although we chose a number of old, small specimens for which we expected low sequence recovery, we successfully recovered at least some low-copy nuclear protein-coding genes from all specimens. For example, in one 56-year-old beetle, 4.4 mm in length, our de novo assembly recovered about 63% of approximately 41,900 nucleotides in a target suite of 67 nuclear protein-coding gene fragments, and 70% using a reference-based assembly. Even in the least successfully sequenced carabid specimen, reference-based assembly yielded fragments that were at least 50% of the target length for 34 of 67 nuclear protein-coding gene fragments. Exploration of alternative references for reference-based assembly revealed few signs of bias created by the reference. For all specimens we recovered almost complete copies of ribosomal and mitochondrial genes. We verified the general accuracy of the sequences through comparisons with sequences obtained from PCR and Sanger sequencing, including of conspecific, fresh specimens, and through phylogenetic analysis that tested the placement of sequences in predicted regions. A few possible inaccuracies in the sequences were detected, but these rarely affected the phylogenetic placement of the samples. Although our sample sizes are low, an exploratory regression study suggests that the dominant factor in predicting success at recovering nuclear protein-coding genes is a high number of Illumina reads, with success at PCR of COI and killing by immersion in ethanol being secondary factors; in analyses of only high-read samples, the primary significant explanatory variable was body length, with small beetles being more successfully sequenced.	[Kanda, Kojun; Pflug, James M.; Sproul, John S.; Maddison, David R.] Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97331 USA; [Dasenko, Mark A.] Oregon State Univ, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA	Oregon State University; Oregon State University	Kanda, K (corresponding author), Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97331 USA.	coniontis@gmail.com		Kanda, Kojun/0000-0001-5561-8471	Harold E. and Leona M. Rice Endowment Fund at Oregon State University; National Science Foundation [DEB-1258220]; Direct For Biological Sciences [1258220] Funding Source: National Science Foundation	Harold E. and Leona M. Rice Endowment Fund at Oregon State University; National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded in part by the Harold E. and Leona M. Rice Endowment Fund at Oregon State University, as well as National Science Foundation grant DEB-1258220 to DRM.	Aleksandrova GN, 2008, STRATIGR GEO CORREL+, V16, P295, DOI 10.1134/S0869593808030052; Baker M, 2012, NAT METHODS, V9, P333, DOI 10.1038/nmeth.1935; Bakker FT, 2015, BIOL J LINNEAN SOC; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Besnard G, 2016, BIOL J LINN SOC, V117, P71, DOI 10.1111/bij.12494; Besnard G, 2014, J EXP BOT, V65, P6711, DOI 10.1093/jxb/eru395; Bi K, 2013, MOL ECOL, V22, P6018, DOI 10.1111/mec.12516; Bouchard P, 2011, ZOOKEYS, P1, DOI 10.3897/zookeys.88.807; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Brotherton P, 2007, NUCLEIC ACIDS RES, V35, P5717, DOI 10.1093/nar/gkm588; Burbano HA, 2010, SCIENCE, V328, P723, DOI 10.1126/science.1188046; Burrell AS, 2015, J HUM EVOL, V79, P35, DOI 10.1016/j.jhevol.2014.10.015; Cai GS, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S13-S5; Carpenter ML, 2013, AM J HUM GENET, V93, P852, DOI 10.1016/j.ajhg.2013.10.002; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; DARLINGTON P J JR, 1971, Bulletin of the Museum of Comparative Zoology, V142, P129; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dean MD, 2001, ENTOMOL EXP APPL, V98, P279, DOI 10.1023/A:1018963131302; Enk J, 2013, BIOTECHNIQUES, V55, P300, DOI 10.2144/000114114; Enk JM, 2014, MOL BIOL EVOL, V31, P1292, DOI 10.1093/molbev/msu074; Erwin TL, 1981, ENTOMOL SCAND, V15, P33; Gilbert MTP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000272; Gilbert MTP, 2005, TRENDS ECOL EVOL, V20, P541, DOI 10.1016/j.tree.2005.07.005; Gnerre S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r88; Graham CH, 2004, TRENDS ECOL EVOL, V19, P497, DOI 10.1016/j.tree.2004.07.006; Green P, 2002, PHRED VERSION 002042; Green P, 1999, PHRAP VERSION 099032; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guschanski K, 2013, SYST BIOL, V62, P539, DOI 10.1093/sysbio/syt018; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hanrahan SJ, 2011, CHROMOSOME RES, V19, P809, DOI 10.1007/s10577-011-9231-6; Haynes S, 2002, J ARCHAEOL SCI, V29, P585, DOI 10.1006/jasc.2001.0731; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heintzman PD, 2014, MOL ECOL RESOUR, V14, P606, DOI 10.1111/1755-0998.12205; Hofreiter M, 2015, BIOESSAYS, V37, P284, DOI 10.1002/bies.201400160; Hornett EA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-361; JUAN C, 1991, GENOME, V34, P169, DOI 10.1139/g91-026; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; King GA, 2009, J ARCHAEOL SCI, V36, P1179, DOI 10.1016/j.jas.2009.01.006; King JR, 2004, INSECT SOC, V51, P197, DOI 10.1007/s00040-003-0709-x; Kircher M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr771; Krehenwinkel H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136337; Kuraku S, 2013, NUCLEIC ACIDS RES, V41, pW22, DOI 10.1093/nar/gkt389; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; LINDROTH C H, 1976, New Zealand Journal of Zoology, V3, P161; Maddison DR, 2008, ANN CARNEGIE MUS, V77, P147, DOI 10.2992/0097-4463-77.1.147; Maddison DR, 2014, ZOOL J LINN SOC-LOND, V172, P741, DOI 10.1111/zoj.12188; Maddison DR, 2013, ZOOTAXA, V3636, P547, DOI 10.11646/zootaxa.3636.4.3; Maddison DR, 2012, MOL PHYLOGENET EVOL, V63, P533, DOI 10.1016/j.ympev.2012.01.015; Maddison DR, 2010, ZOOKEYS, P15, DOI 10.3897/zookeys.43.390; MADDISON DR, 1985, GENETICA, V66, P93, DOI 10.1007/BF00139715; Maddison DR, 2014, CHROMASEQ A MESQUITE; Maddison WP, 2014, MESQUITE A MODULAR S; Marchant A, 2015, GENETICA, V143, P225, DOI 10.1007/s10709-014-9790-5; Marciniak S, 2015, J HUMAN EVOLUTION; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Mason VC, 2011, GENOME RES, V21, P1695, DOI 10.1101/gr.120196.111; McCormack J, 2015, BIORXIV 020271; Millar CD, 2008, TRENDS ECOL EVOL, V23, P386, DOI 10.1016/j.tree.2008.04.002; Miller W, 2008, NATURE, V456, P387, DOI 10.1038/nature07446; Mitchell KJ, 2014, SCIENCE, V344, P898, DOI 10.1126/science.1251981; Murienne J, 2015, MITOCHONDR DNA, P1; Orlando L, 2013, NATURE, V499, P74, DOI 10.1038/nature12323; Orlando L, 2011, GENOME RES, V21, P1705, DOI 10.1101/gr.122747.111; Ortuno VM, 2010, ANN SOC ENTOMOL FR, V46, P189, DOI 10.1080/00379271.2010.10697656; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Paijmans JL, 2015, MOL ECOLOGY RESOURCE; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Poinar HN, 1996, SCIENCE, V272, P864, DOI 10.1126/science.272.5263.864; POST RJ, 1993, BIOCHEM SYST ECOL, V21, P85, DOI 10.1016/0305-1978(93)90012-G; Price BW, 2015, PLOS ONE, V10; Pyke GH, 2010, BIOL REV, V85, P247, DOI 10.1111/j.1469-185X.2009.00098.x; Quail MA, 2012, BMC GENOMICS, V13; R Gore Team, 2014, R A LANGUAGE AND ENV; Regier JC, 2008, SYST BIOL, V57, P920, DOI 10.1080/10635150802570791; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; RITZKOWSKI S., 1997, METALLA BOCHUM, V66, P19; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Rowe KC, 2011, MOL ECOL RESOUR, V11, P1082, DOI 10.1111/j.1755-0998.2011.03052.x; Schneeberger K, 2011, P NATL ACAD SCI USA, V108, P10249, DOI 10.1073/pnas.1107739108; Schubert M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-178; Sims D, 2014, NAT REV GENET, V15, P121, DOI 10.1038/nrg3642; Staats M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069189; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Suarez AV, 2004, BIOSCIENCE, V54, P66, DOI 10.1641/0006-3568(2004)054[0066:TVOMCF]2.0.CO;2; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Thomsen PF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005048; Tin MMY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096793; Wales N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045644; Wandeler P, 2007, TRENDS ECOL EVOL, V22, P634, DOI 10.1016/j.tree.2007.08.017; Wang BA, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-180, 10.1186/1471-2164-15-467]; Watts PC, 2007, J INSECT CONSERV, V11, P195, DOI 10.1007/s10841-006-9024-y; Zedane L, 2016, BIOL J LINN SOC, V117, P44, DOI 10.1111/bij.12509	95	48	49	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0143929	10.1371/journal.pone.0143929	http://dx.doi.org/10.1371/journal.pone.0143929			53	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716693	Green Published, gold, Green Submitted			2022-12-26	WOS:000367510500008
J	Knight, GM; Gomez, GB; Dodd, PJ; Dowdy, D; Zwerling, A; Wells, WA; Cobelens, F; Vassall, A; White, RG				Knight, Gwenan M.; Gomez, Gabriela B.; Dodd, Peter J.; Dowdy, David; Zwerling, Alice; Wells, William A.; Cobelens, Frank; Vassall, Anna; White, Richard G.			The Impact and Cost-Effectiveness of a Four-Month Regimen for First-Line Treatment of Active Tuberculosis in South Africa	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; RESISTANT TUBERCULOSIS; HIV-INFECTION; TB TREATMENT; OUTCOMES; COUNTRIES; TRANSMISSION; CHEMOTHERAPY; PREVALENCE; REDUCTION	Background A 4-month first-line treatment regimen for tuberculosis disease (TB) is expected to have a direct impact on patient outcomes and societal costs, as well as an indirect impact on Mycobacterium tuberculosis transmission. We aimed to estimate this combined impact in a high TB-burden country: South Africa. Method An individual based M. tb transmission model was fitted to the TB burden of South Africa using a standard TB natural history framework. We measured the impact on TB burden from 2015-2035 of introduction of a non-inferior 4-month regimen replacing the standard 6-month regimen as first-line therapy. Impact was measured with respect to three separate baselines (Guidelines, Policy and Current), reflecting differences in adherence to TB and HIV treatment guidelines. Further scenario analyses considered the variation in treatment-related parameters and resistance levels. Impact was measured in terms of differences in TB burden and Disability Adjusted Life Years (DALYs) averted. We also examined the highest cost at which the new regimen would be cost-effective for several willingness-to-pay thresholds. Results It was estimated that a 4-month regimen would avert less than 1% of the predicted 6 million person years with TB disease in South Africa between 2015 and 2035. A similarly small impact was seen on deaths and DALYs averted. Despite this small impact, with the health systems and patient cost savings from regimen shortening, the 4-month regimen could be cost-effective at $436 [NA, 5983] (mean [range]) per month at a willingness-to-pay threshold of one GDP per capita ($6,618). Conclusion The introduction of a non-inferior 4-month first-line TB regimen into South Africa would have little impact on the TB burden. However, under several scenarios, it is likely that the averted societal costs would make such a regimen cost-effective in South Africa.	[Knight, Gwenan M.; White, Richard G.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, TB Modeling Grp, Ctr Math Modelling Infect Dis,TB Ctr, London WC1, England; [Gomez, Gabriela B.; Cobelens, Frank] Univ Amsterdam, Acad Med Ctr, Amsterdam Inst Global Hlth & Dev, NL-1105 AZ Amsterdam, Netherlands; [Gomez, Gabriela B.; Cobelens, Frank] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, NL-1105 AZ Amsterdam, Netherlands; [Gomez, Gabriela B.; Vassall, Anna] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1, England; [Dodd, Peter J.] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England; [Dowdy, David; Zwerling, Alice] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Wells, William A.] Global Alliance TB Drug Dev, New York, NY USA; [Cobelens, Frank] KNCV TB Fdn, The Hague, Netherlands	University of London; London School of Hygiene & Tropical Medicine; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of London; London School of Hygiene & Tropical Medicine; University of Sheffield; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; KNCV Tuberculosis Foundation	Knight, GM (corresponding author), Univ London Imperial Coll Sci Technol & Med, London, England.	g.knight@imperial.ac.uk	Knight, Gwen/AGE-2703-2022; Knight, Gwen/AAF-1176-2020; White, Richard G/D-5407-2009	White, Richard G/0000-0003-4410-6635; Vassall, Anna/0000-0002-2911-1375; Cobelens, Frank/0000-0002-4367-1133; Dodd, Pete/0000-0001-5825-9347; Knight, Gwenan/0000-0002-7263-9896	Global Alliance for TB Drug Development, New York, USA; Medical Research Council (UK) [MR/J005088/1]; Bill and Melinda Gates Foundation (TB Modelling and Analysis Consortium) [OPP1084276]; MRC [MR/J005088/1] Funding Source: UKRI; Medical Research Council [MR/J005088/1] Funding Source: researchfish	Global Alliance for TB Drug Development, New York, USA; Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Bill and Melinda Gates Foundation (TB Modelling and Analysis Consortium); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Global Alliance for TB Drug Development, New York, USA (http://www.tballiance.org/). RGW is funded by the Medical Research Council (UK) (MR/J005088/1), and the Bill and Melinda Gates Foundation (TB Modelling and Analysis Consortium: OPP1084276). One of the co-authors, William Wells, was employed by the funders at the start of this work. He contributed to discussions as to the initial directions for the project, the available data and current understanding of TB regimen design. The funders had no other role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Raddad LJ, 2009, P NATL ACAD SCI USA, V106, P13980, DOI 10.1073/pnas.0901720106; Akksilp S, 2007, EMERG INFECT DIS, V13, P1001, DOI 10.3201/eid1307.061506; [Anonymous], 1986, Tubercle, V67, P5; [Anonymous], 2011, GLOB TUB CONTR; Ayles HM, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-63; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Churchyard G, 2013, COMMUNICATION; Cohen T, 2003, LANCET INFECT DIS, V3, P13, DOI 10.1016/S1473-3099(03)00483-3; Department of Health, 2011, MULT RES TUB POL FRA; Department of Health, 2014, NAT TUB MAN GUID 201; Department of Health, 2013, S AFR ANT TREATM GUI; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Fofana MO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096389; Foster N, 2015, SOC SCI MED, V130, P42, DOI 10.1016/j.socscimed.2015.01.046; Fox W, 1999, INT J TUBERC LUNG D, V3, pS231; FOX W, 1986, AM REV RESPIR DIS, V133, P779; Global Alliance for TB drug development, 2015, INT PORTF REG; Gomez GB, 2015, POTENTIAL COST EFFEC; Gospodarevskaya E, 2014, INT J TUBERC LUNG D, V18, P810, DOI 10.5588/ijtld.13.0391; JAMISON DT, 1991, AM J PUBLIC HEALTH, V81, P15, DOI 10.2105/AJPH.81.1.15; Keeton C, 2013, B WORLD HEALTH ORGAN, V91, P163, DOI 10.2471/BLT.13.020313; Knight GM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122514; Long L, 2010, AIDS, V24, P915, DOI 10.1097/QAD.0b013e3283360976; Marseille E, 2015, BULL WORLD HEALTH OR, V93; McNicol MW, 1995, CLINICAL FEATURES AN; Middelkoop K, 2015, J INFECT DIS, V211, P53, DOI 10.1093/infdis/jiu403; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Njeka N, 2013, ESTIMATED LEVELS; Owens JP, 2013, INT J TUBERC LUNG D, V17, P590, DOI 10.5588/ijtld.12.0776; PEPFAR CDC, 2012, SCAL UP IS PREV THER; Pretorius C, 2014, AIDS, V28, pS25, DOI 10.1097/QAD.0000000000000085; Rosen S, 2008, TROP MED INT HEALTH, V13, P1005, DOI 10.1111/j.1365-3156.2008.02114.x; Salomon JA, 2006, PLOS MED, V3, P1302, DOI 10.1371/journal.pmed.0030273; Sepkowitz KA, 1996, CLIN INFECT DIS, V23, P954, DOI 10.1093/clinids/23.5.954; Seung KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007186; Shillcutt SD, 2009, PHARMACOECONOMICS, V27, P903, DOI 10.2165/10899580-000000000-00000; South African National AIDS Council (SANAC), 2012, NAT STRAT PLAN HIV S; Varma JK, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-42; Vassall A, 2015, XPERT MTB RIF SCALEU; Wells CD, 2007, J INFECT DIS, V196, pS86, DOI 10.1086/518665; WHO, 2013, TB DAT; World Health Organization, 2014, GLOB TUB REP; World Health Organization (WHO), 2014, THE STOP TB STRAT; 1984, AM REV RESP DIS, V130, P23	44	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145796	10.1371/journal.pone.0145796	http://dx.doi.org/10.1371/journal.pone.0145796			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717007	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000367510500074
J	Rosales, KR; Reid, MA; Yang, Y; Tran, TQ; Wang, WI; Lowman, X; Pan, M; Kong, M				Rosales, Kimberly Romero; Reid, Michael A.; Yang, Ying; Tran, Thai Q.; Wang, Wen-I; Lowman, Xazmin; Pan, Min; Kong, Mei			TIPRL Inhibits Protein Phosphatase 4 Activity and Promotes H2AX Phosphorylation in the DNA Damage Response	PLOS ONE			English	Article							DEPHOSPHORYLATES GAMMA-H2AX; SIGNALING PATHWAY; CATALYTIC SUBUNIT; COMPLEX; CHECKPOINT; REGULATOR; INTERACTS; RECOVERY; ALPHA-4; PP2A	Despite advances in our understanding of protein kinase regulation in the DNA damage response, the mechanism that controls protein phosphatase activity in this pathway is unclear. Unlike kinases, the activity and specificity of serine/threonine phosphatases is governed largely by their associated proteins. Here we show that Tip41-like protein (TIPRL), an evolutionarily conserved binding protein for PP2A-family phosphatases, is a negative regulator of protein phosphatase 4 (PP4). Knockdown of TIPRL resulted in increased PP4 phosphatase activity and formation of the active PP4-C/PP4R2 complex known to dephosphorylate gamma-H2AX. Thus, overexpression of TIPRL promotes phosphorylation of H2AX, and increases gamma-H2AX positive foci in response to DNA damage, whereas knockdown of TIPRL inhibits gamma-H2AX phosphorylation. In correlation with gamma-H2AX levels, we found that TIPRL overexpression promotes cell death in response to genotoxic stress, and knockdown of TIPRL protects cells from genotoxic agents. Taken together, these data demonstrate that TIPRL inhibits PP4 activity to allow for H2AX phosphorylation and the subsequent DNA damage response.	[Rosales, Kimberly Romero; Reid, Michael A.; Yang, Ying; Tran, Thai Q.; Wang, Wen-I; Lowman, Xazmin; Pan, Min; Kong, Mei] City Hope Canc Ctr, Dept Canc Biol, Beckman Res Inst, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope	Kong, M (corresponding author), City Hope Canc Ctr, Dept Canc Biol, Beckman Res Inst, Duarte, CA 91010 USA.	mekong@coh.org	Yang, Ying/I-8380-2019	Reid, Michael/0000-0001-6222-9538	City of Hope; NIH/NCI [P30CA33572]; National Science Foundation [DBI-1202818]; Ralph M. Parsons Foundation; NATIONAL CANCER INSTITUTE [P30CA033572, R01CA183989] Funding Source: NIH RePORTER	City of Hope; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation(National Science Foundation (NSF)); Ralph M. Parsons Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the City of Hope start-up to MK. Research reported here includes work carried out in Core Facilities, supported by the NIH/NCI under grant number P30CA33572. MK is a Pew Scholar in the Biomedical Sciences and V Scholar for Cancer Research. KR received a National Science Foundation Postdoctoral Fellowship in Biology (DBI-1202818). MR is supported by the Ralph M. Parsons Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BREWIS ND, 1993, EMBO J, V12, P987, DOI 10.1002/j.1460-2075.1993.tb05739.x; Chowdhury D, 2008, MOL CELL, V31, P33, DOI 10.1016/j.molcel.2008.05.016; Douglas P, 2010, MOL CELL BIOL, V30, P1368, DOI 10.1128/MCB.00741-09; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Gingras AC, 2005, MOL CELL PROTEOMICS, V4, P1725, DOI 10.1074/mcp.M500231-MCP200; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Jacinto E, 2001, MOL CELL, V8, P1017, DOI 10.1016/S1097-2765(01)00386-0; Keogh MC, 2006, NATURE, V439, P497, DOI 10.1038/nature04384; Kong M, 2009, MOL CELL, V36, P51, DOI 10.1016/j.molcel.2009.09.025; McConnell JL, 2007, ONCOGENE, V26, P6021, DOI 10.1038/sj.onc.1210406; Moon SH, 2010, J BIOL CHEM, V285, P12935, DOI 10.1074/jbc.M109.071696; Nakada S, 2008, EMBO REP, V9, P1019, DOI 10.1038/embor.2008.162; Nakashima A, 2013, FEBS LETT, V587, P2924, DOI 10.1016/j.febslet.2013.07.027; RONNE H, 1991, MOL CELL BIOL, V11, P4876, DOI 10.1128/MCB.11.10.4876; Smetana JHC, 2007, FEBS J, V274, P5891, DOI 10.1111/j.1742-4658.2007.06112.x; Wang B, 2008, CELL RES, V18, P974, DOI 10.1038/cr.2008.274	16	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145938	10.1371/journal.pone.0145938	http://dx.doi.org/10.1371/journal.pone.0145938			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717153	gold, Green Published, Green Submitted			2022-12-26	WOS:000367510500099
J	Shibata, M; Jintasakul, P; Azuma, Y; You, HL				Shibata, Masateru; Jintasakul, Pratueng; Azuma, Yoichi; You, Hai-Lu			A New Basal Hadrosauroid Dinosaur from the Lower Cretaceous Khok Kruat Formation in Nakhon Ratchasima Province, Northeastern Thailand	PLOS ONE			English	Article							ASIAN ORNITHOPODS DINOSAURIA; ORNITHISCHIA; DEPOSITS	A new basal hadrosauroid dinosaur from the Lower Cretaceous Khok Kruat Formation of Thailand, Sirindhoma khoratensis gen. et sp. nov is described. The new taxon is based on composite skull and mandible including premaxilla, maxilla, jugal, quadrate, braincases, predentary, dentaries, surangular, and maxillary and dentary teeth. It is diagnostic by such characters as, sagittal crest extending along entire dorsal surface of the parietal and reaching the frontoparietal suture (autapomorphy), transversely straight frontoparietal suture, caudodorsally faced supraoccipital, no participation of the supraoccipital in the foramen magnum, mesiodistally wide leaf-shaped dentary tooth with primary and secondary ridges on the lingual surface of the crown, perpendicularly-erected and large coronoid process of dentary, and nonvisible antorbital fossa of the maxilla in lateral view. Phylogenetic analysis revealed S. khoratensis as among the most basal hadrosauroids. Sirindhoma khoratensis is the best-preserved iguanodontian ornithopod in Southeast Asia and sheds new light to resolve the evolution of basal hadrosauriforms.	[Shibata, Masateru; Azuma, Yoichi] Fukui Prefectural Univ, Inst Dinosaur Res, Fukui 9101195, Japan; [Shibata, Masateru; Azuma, Yoichi] Fukui Prefectural Dinosaur Museum, Fukui 9118601, Japan; [Jintasakul, Pratueng] Nakhon Ratchasima Rajabhat Univ, Northeastern Res Inst Petrified Wood & Mineral Re, Nakhon Ratchasima 30000, Thailand; [You, Hai-Lu] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing 100044, Peoples R China	Fukui Prefectural University; Nakhon Ratchasima Rajabhat University; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Shibata, M (corresponding author), Fukui Prefectural Univ, Inst Dinosaur Res, 4-1-1 Kenjojima,Eiheiji Cho, Fukui 9101195, Japan.	sdino@fpu.ac.jp		You, Hai-Lu/0000-0003-2203-6461	Fukui Prefectural Government, Japan; Nakhon Ratchasima Rajabhat University, Thailand	Fukui Prefectural Government, Japan; Nakhon Ratchasima Rajabhat University, Thailand	This work was supported by the Fukui Prefectural Government, Japan, and Nakhon Ratchasima Rajabhat University, Thailand.	Barrett PM, 2009, ACTA PALAEONTOL POL, V54, P35, DOI 10.4202/app.2009.0105; Brill Kathleen, 2007, P49; BUFFETAUT E, 1992, PALAEONTOLOGY, V35, P801; Buffetaut E, 2005, INT C GEOL GEOT MIN, P28; Buffetaut E, 2011, ANN PALEONTOL, V97, P51, DOI 10.1016/j.annpal.2011.08.001; Cappetta H., 1990, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V1990, P659; DOLLO L, 1888, CR HEBD ACAD SCI, V106, P775; Edmund A. G., 1957, Contributions of the Royal Ontario Museum of Zoology, VNo. 48, P1; Godefroit P, 2005, CR PALEVOL, V4, P697, DOI 10.1016/j.crpv.2005.07.004; Godefroit P., 2012, BERNISSART DINOSAURS, P335; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Hasegawa H, 2010, ISL ARC, V19, P605, DOI 10.1111/j.1440-1738.2010.00728.x; Kobayashi Y, 2003, J VERTEBR PALEONTOL, V23, P166, DOI 10.1671/0272-4634(2003)23[166:ANIDOF]2.0.CO;2; Kubota K, 2009, ACTA GEOL SIN-ENGL, V83, P39, DOI 10.1111/j.1755-6724.2009.00005.x; Lu Junchang, 1997, P27; Maddison W.P., MESQUITE MODULAR SYS; McDonal DAT, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0014075, DOI 10.1371/J0URNAL.P0NE.0014075]; Mcdonald AT, 2012, ZOOTAXA, P61; Meesook A, 2011, GEOLOGY OF THAILAND, P169; Norman D.B., 1986, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V56, P281; Norman DB, 2015, ZOOL J LINN SOC-LOND, V173, P92, DOI 10.1111/zoj.12193; Norman DB, 2002, ZOOL J LINN SOC-LOND, V136, P113, DOI 10.1046/j.1096-3642.2002.00027.x; Norman DB, 1998, ZOOL J LINN SOC-LOND, V122, P291; Norman DB., 1980, MEMOIRES I ROYAL SCI, V178, P1; OSTROM JOHN H., 1961, BULL AMER MUS NAT HIST, V122, P33; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; Racey A, 2009, GEOL SOC SPEC PUBL, V315, P41, DOI 10.1144/SP315.5; Racey A, 2009, GEOL SOC SPEC PUBL, V315, P69, DOI 10.1144/SP315.6; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Sereno Paul C., 1998, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V210, P41; SERENO PC, 1986, NATL GEOGR RES, V2, P234; Sereno PC, 1997, ANN REV EARTH PLANET, P434; Sereno PC, 2005, STEM ARCHOSAURIA VER, P534; Shibata M, 2015, ZOOTAXA, V3914, P421, DOI 10.11646/zootaxa.3914.4.3; Shibata M, 2011, ACTA GEOL SIN-ENGL, V85, P969, DOI 10.1111/j.1755-6724.2011.00230.x; Sues HD, 2009, P R SOC B, V276, P2549, DOI 10.1098/rspb.2009.0229; Taquet Philippe, 1999, Annales de Paleontologie, V85, P85, DOI 10.1016/S0753-3969(99)80009-3; Taquet R, 1976, CHAPITRE, P57; Tsogtbaatar Khishigjav, 2014, P108; Wang RF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077058; Wang XL, 2001, CHINESE SCI BULL, V46, P1669, DOI 10.1007/BF02900633; Wu W.H., 2012, BERNISSART DINOSAURS, P293; Xing H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098821; Xu X, 2000, VERTEBRAT PALASIATIC, V38, P186; You Hai-lu, 2014, P73; You HL, 2009, CAN J EARTH SCI, V46, P949, DOI 10.1139/E09-067; [You Hailu 尤海鲁], 2005, [地质通报, Geological Bulletin of China], V24, P785; You H, 2011, ACTA GEOL SIN-ENGL, V85, P51, DOI 10.1111/j.1755-6724.2011.00377.x; You HL, 2003, CRETACEOUS RES, V24, P347, DOI 10.1016/S0195-6671(03)00048-X; You HL, 2003, ACTA GEOL SIN-ENGL, V77, P148	50	16	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145904	10.1371/journal.pone.0145904	http://dx.doi.org/10.1371/journal.pone.0145904			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716981	Green Published, gold			2022-12-26	WOS:000367510500090
J	Belyy, A; Tabakova, I; Lang, AE; Jank, T; Belyi, Y; Aktories, K				Belyy, Alexander; Tabakova, Irina; Lang, Alexander E.; Jank, Thomas; Belyi, Yury; Aktories, Klaus			Roles of Asp179 and Glu270 in ADP-Ribosylation of Actin by Clostridium perfringens Iota Toxin	PLOS ONE			English	Article							YEAST ACTIN; SACCHAROMYCES-CEREVISIAE; ENZYMATIC COMPONENT; SHUTTLE VECTORS; CELLULAR UPTAKE; BINDING; RECOGNITION; RESIDUES; MUTATION; MUTANTS	Clostridium perfringens iota toxin is a binary toxin composed of the enzymatically active component Ia and receptor binding component Ib. Ia is an ADP-ribosyltransferase, which modifies Arg177 of actin. The previously determined crystal structure of the actin-Ia complex suggested involvement of Asp179 of actin in the ADP-ribosylation reaction. To gain more insights into the structural requirements of actin to serve as a substrate for toxin-catalyzed ADP-ribosylation, we engineered Saccharomyces cerevisiae strains, in which wild type actin was replaced by actin variants with substitutions in residues located on the Ia-actin interface. Expression of the actin mutant Arg177Lys resulted in complete resistance towards Ia. Actin mutation of Asp179 did not change Ia-induced ADP-ribosylation and growth inhibition of S. cerevisiae. By contrast, substitution of Glu270 of actin inhibited the toxic action of Ia and the ADP-ribosylation of actin. In vitro transcribed/translated human a-actin confirmed the crucial role of Glu270 in ADP-ribosylation of actin by Ia.	[Belyy, Alexander; Tabakova, Irina; Belyi, Yury] Gamaleya Res Inst, Moscow, Russia; [Belyy, Alexander] Moscow MV Lomonosov State Univ, Fac Biol, Moscow, Russia; [Lang, Alexander E.; Jank, Thomas; Aktories, Klaus] Univ Freiburg, Inst Expt & Clin Pharmacol & Toxicol, D-79106 Freiburg, Germany; [Belyi, Yury; Aktories, Klaus] Univ Freiburg, Freiburg Inst Adv Studies FRIAS, D-79106 Freiburg, Germany; [Aktories, Klaus] Univ Freiburg, Ctr Biol Signalling Studies BIOSS, D-79106 Freiburg, Germany	Russian Academy of Medical Sciences; Gamaleya National Research Center for Epidemiology & Microbiology, RAMS; Lomonosov Moscow State University; University of Freiburg; University of Freiburg; University of Freiburg	Aktories, K (corresponding author), Univ Freiburg, Inst Expt & Clin Pharmacol & Toxicol, Hugstetter Str 55, D-79106 Freiburg, Germany.	klaus.aktories@pharmakol.uni-freiburg.de	Jank, Thomas/R-9627-2017; Aktories, Klaus/CAJ-5682-2022; Belyi, Yury/AAU-8092-2020	Aktories, Klaus/0000-0002-5397-0436; Belyy, Alexander/0000-0003-3106-6574	German Research Foundation (DFG); Albert Ludwigs University Freiburg	German Research Foundation (DFG)(German Research Foundation (DFG)); Albert Ludwigs University Freiburg	The article processing charge was funded by the German Research Foundation (DFG) and the Albert Ludwigs University Freiburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKTORIES K, 1986, NATURE, V322, P390, DOI 10.1038/322390a0; Barth H, 2000, J BIOL CHEM, V275, P18704, DOI 10.1074/jbc.M000596200; Barth H, 2004, MICROBIOL MOL BIOL R, V68, P373, DOI 10.1128/MMBR.68.3.373-402.2004; Bartman T, 2004, PLOS BIOL, V2, P673, DOI 10.1371/journal.pbio.0020129; Belyi Y, 2012, J BIOL CHEM, V287, P26029, DOI 10.1074/jbc.M112.372672; Bennett TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056798; Blocker D, 2001, INFECT IMMUN, V69, P2980, DOI 10.1128/IAI.69.5.2980-2987.2001; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Bosis E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027698; Cavallius J, 1998, J BIOL CHEM, V273, P28752, DOI 10.1074/jbc.273.44.28752; CHEN X, 1995, J BIOL CHEM, V270, P11406, DOI 10.1074/jbc.270.19.11406; Conz C, 2007, J BIOL CHEM, V282, P33977, DOI 10.1074/jbc.M706737200; COOK RK, 1992, J BIOL CHEM, V267, P9430; Fang H, 2006, P NATL ACAD SCI USA, V103, P6958, DOI 10.1073/pnas.0510816103; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Goode BL, 2002, METHOD ENZYMOL, V351, P433; Gulke I, 2001, INFECT IMMUN, V69, P6004, DOI 10.1128/IAI.69.10.6004-6011.2001; Heisler DB, 2015, SCIENCE, V349, P535, DOI 10.1126/science.aab4090; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Jorgensen R, 2005, NATURE, V436, P979, DOI 10.1038/nature03871; KRON SJ, 1992, P NATL ACAD SCI USA, V89, P4466, DOI 10.1073/pnas.89.10.4466; Kudryashova E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045721; Lang AE, 2010, SCIENCE, V327, P1139, DOI 10.1126/science.1184557; Margarit SM, 2006, STRUCTURE, V14, P1219, DOI 10.1016/j.str.2006.05.022; Marvaud JC, 2002, J BIOL CHEM, V277, P43659, DOI 10.1074/jbc.M207828200; Mateyak MK, 2013, J BIOL CHEM, V288, P24647, DOI 10.1074/jbc.M113.488783; Nagahama M, 2004, INFECT IMMUN, V72, P3267, DOI 10.1128/IAI.72.6.3267-3275.2004; Nagahama M, 2000, J BACTERIOL, V182, P2096, DOI 10.1128/JB.182.8.2096-2103.2000; Nagahama M, 2002, INFECT IMMUN, V70, P1909, DOI 10.1128/IAI.70.4.1909-1914.2002; NG R, 1980, P NATL ACAD SCI-BIOL, V77, P3912, DOI 10.1073/pnas.77.7.3912; Papatheodorou P, 2011, P NATL ACAD SCI USA, V108, P16422, DOI 10.1073/pnas.1109772108; Peisker K, 2008, MOL BIOL CELL, V19, P5279, DOI 10.1091/mbc.E08-06-0661; Perelle S, 1996, FEBS LETT, V395, P191, DOI 10.1016/0014-5793(96)01035-6; Satchell KJF, 2009, TOXINS, V1, P123, DOI 10.3390/toxins1020123; Schwan C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000626; SHERMAN F, 1964, GENETICS, V49, P39; Siggers KA, 2008, CELL HOST MICROBE, V4, P8, DOI 10.1016/j.chom.2008.06.004; SIKORSKI RS, 1989, GENETICS, V122, P19; Sisko JL, 2006, MOL MICROBIOL, V60, P51, DOI 10.1111/j.1365-2958.2006.05074.x; Stiles BG, 2011, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00011; Stirling FR, 2006, MICROBIOL-SGM, V152, P2273, DOI 10.1099/mic.0.28831-0; Toda A, 2015, J BIOL CHEM, V290, P19423, DOI 10.1074/jbc.M115.653220; Tsuge H, 2008, P NATL ACAD SCI USA, V105, P7399, DOI 10.1073/pnas.0801215105; Tsurumura T, 2013, P NATL ACAD SCI USA, V110, P4267, DOI 10.1073/pnas.1217227110; von der Ecken J, 2015, NATURE, V519, P114, DOI 10.1038/nature14033; WEGNER A, 1988, J BIOL CHEM, V263, P13739; Wen KK, 2003, J BIOL CHEM, V278, P48386, DOI 10.1074/jbc.M308980200	47	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145708	10.1371/journal.pone.0145708	http://dx.doi.org/10.1371/journal.pone.0145708			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713879	gold, Green Published, Green Submitted			2022-12-26	WOS:000367481900072
J	Boosalis, MS; Sangerman, JI; White, GL; Wolf, RF; Shen, L; Dai, Y; White, E; Makala, LH; Li, BR; Pace, BS; Nouraie, M; Faller, DV; Perrine, SP				Boosalis, Michael S.; Sangerman, Jose I.; White, Gary L.; Wolf, Roman F.; Shen, Ling; Dai, Yan; White, Emily; Makala, Levi H.; Li, Biaoru; Pace, Betty S.; Nouraie, Mehdi; Faller, Douglas V.; Perrine, Susan P.			Novel Inducers of Fetal Globin Identified through High Throughput Screening (HTS) Are Active In Vivo in Anemic Baboons and Transgenic Mice	PLOS ONE			English	Article							SICKLE-CELL-ANEMIA; GENE-EXPRESSION; BETA-THALASSEMIA; HEMOGLOBIN PRODUCTION; INDUCTION; BUTYRATE; TRIAL; ISOBUTYRAMIDE; HQK-1001; THERAPY	High-level fetal (gamma) globin expression ameliorates clinical severity of the beta (beta) hemoglobinopathies, and safe, orally-bioavailable gamma-globin inducing agents would benefit many patients. We adapted a LCR-gamma-globin promoter-GFP reporter assay to a high-throughput robotic system to evaluate five diverse chemical libraries for this activity. Multiple structurally- and functionally-diverse compounds were identified which activate the gamma-globin gene promoter at nanomolar concentrations, including some therapeutics approved for other conditions. Three candidates with established safety profiles were further evaluated in erythroid progenitors, anemic baboons and transgenic mice, with significant induction of gamma-globin expression observed in vivo. A lead candidate, Benserazide, emerged which demonstrated > 20-fold induction of gamma-globin mRNA expression in anemic baboons and increased F-cell proportions by 3.5-fold in transgenic mice. Benserazide has been used chronically to inhibit amino acid decarboxylase to enhance plasma levels of L-dopa. These studies confirm the utility of high-throughput screening and identify previously unrecognized fetal globin inducing candidates which can be developed expediently for treatment of hemoglobinopathies.	[Boosalis, Michael S.; Sangerman, Jose I.; Shen, Ling; Dai, Yan; Faller, Douglas V.; Perrine, Susan P.] Boston Univ, Sch Med, Ctr Canc, Boston, MA 02118 USA; [Boosalis, Michael S.; Sangerman, Jose I.; Shen, Ling; Dai, Yan; Faller, Douglas V.; Perrine, Susan P.] Boston Univ, Sch Med, Hemoglobinopathy Thalassemia Res Unit, Boston, MA 02118 USA; [White, Gary L.; Wolf, Roman F.; White, Emily] Univ Oklahoma, Hlth Sci Ctr, Dept Comparat Med, Oklahoma City, OK USA; [Faller, Douglas V.; Perrine, Susan P.] Phoenicia BioSci, Weston, MA USA; [Makala, Levi H.; Li, Biaoru; Pace, Betty S.] Georgia Regents Univ, Dept Pediat, Augusta, GA USA; [Nouraie, Mehdi] Howard Univ, Dept Med, Ctr Sickle Cell Dis, Washington, DC 20059 USA	Boston University; Boston University; University of Oklahoma System; University of Oklahoma Health Sciences Center; University System of Georgia; Augusta University; Howard University	Perrine, SP (corresponding author), Boston Univ, Sch Med, Ctr Canc, Boston, MA 02118 USA.	sperrine@bu.edu	Nouraie, Seyed Mehdi/O-4071-2018	Nouraie, Seyed Mehdi/0000-0001-7465-0581; Li, Biaoru/0000-0002-5626-9557; Pace, Betty/0000-0002-1275-4112	National Institutes of Health [R01 DK-52962, R41 HL-105816, R42 HL-110727, 2 P40 ODO010988-16, UL1-TR000157]; Phoenicia BioSciences (through NIH);  [P50 HL-118006]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000157] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R42HL110727, P50HL118006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052962] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010988] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Phoenicia BioSciences (through NIH); ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the National Institutes of Health, R01 DK-52962 (SPP, Boston University), R41 HL-105816 (SPP, Phoenicia BioSciences), and R42 HL-110727 (Phoenicia BioSciences), 2 P40 ODO010988-16 (GLW, University of Oklahoma) and UL1-TR000157 (RFW, University of Oklahoma). MN was supported by P50 HL-118006. The funders had no role in study, design, data collection and analysis, decision to publish, or preparation of the manuscript. Phoenicia BioSciences is a commercial organization, which provided partial funding for this work (through NIH grants), and did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials. The funder provided support in the form of partial salaries for authors [SPP, DVF] and experimental expenses, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions' section".; This work was supported by grants from the National Institutes of Health, R01 DK-52962, (SPP, Boston University), R41 HL-105816 (SPP, Phoenicia BioSciences), and R42 HL-110727 (Phoenicia BioSciences), 2 P40 ODO010988-16 (GLW, University of Oklahoma) and UL1-TR000157 (RFW, University of Oklahoma). SMN was supported by P50 HL-118006. The funders had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Atweh GF, 1999, BLOOD, V93, P1790; Bank A, 2006, BLOOD, V107, P435, DOI 10.1182/blood-2005-05-2113; Bauer DE, 2012, BLOOD, V120, P2945, DOI 10.1182/blood-2012-06-292078; Bohacek R, 2006, CHEM BIOL DRUG DES, V67, P318, DOI 10.1111/j.1747-0285.2006.00386.x; Boosalis MS, 2001, BLOOD, V97, P3259, DOI 10.1182/blood.V97.10.3259; Bradner JE, 2010, P NATL ACAD SCI USA, V107, P12617, DOI 10.1073/pnas.1006774107; Cappellini MD, 2000, BLOOD CELL MOL DIS, V26, P105, DOI 10.1006/bcmd.2000.0283; CHARACHE S, 1995, NEW ENGL J MED, V332, P1317, DOI 10.1056/NEJM199505183322001; Chen JJ, 2007, BLOOD, V109, P2693, DOI 10.1182/blood-2006-08-041830; Chen ZY, 2009, BLOOD CELL MOL DIS, V42, P144, DOI 10.1016/j.bcmd.2008.12.003; COLLINS AF, 1995, BLOOD, V85, P43, DOI 10.1182/blood.V85.1.43.bloodjournal85143; CONSTANTOULAKIS P, 1989, BLOOD, V74, P1963; Cui SY, 2015, BLOOD, V126, P386, DOI 10.1182/blood-2015-02-626259; Dai Y, 2007, MOL ENDOCRINOL, V21, P1807, DOI 10.1210/me.2006-0467; DESIMONE J, 1982, P NATL ACAD SCI-BIOL, V79, P4428, DOI 10.1073/pnas.79.14.4428; Fucharoen S, 2013, BRIT J HAEMATOL, V161, P587, DOI 10.1111/bjh.12304; Hoffman-La Roche Limited, PROD MON LEV BENS CO; Kutlar A, 2013, AM J HEMATOL, V88, pE255, DOI 10.1002/ajh.23533; LABIE D, 1985, P NATL ACAD SCI USA, V82, P2111, DOI 10.1073/pnas.82.7.2111; Lettre G, 2008, P NATL ACAD SCI USA, V105, P11869, DOI 10.1073/pnas.0804799105; Liu D, 2014, BLOOD, V124, P803, DOI 10.1182/blood-2014-03-561779; Mabaera R, 2008, EXP HEMATOL, V36, P1057, DOI 10.1016/j.exphem.2008.06.014; Mankidy R, 2006, BLOOD, V108, P3179, DOI 10.1182/blood-2005-12-010934; Manwani D, 2014, BLOOD, V124, P672, DOI 10.1182/blood-2014-05-576967; Nuinoon M, 2010, HUM GENET, V127, P303, DOI 10.1007/s00439-009-0770-2; Pace BS, 2002, BLOOD, V100, P4640, DOI 10.1182/blood-2002-02-0353; Patthamalai P, 2014, BLOOD, V123, P1956, DOI 10.1182/blood-2013-11-538470; PERRINE SP, 1994, BRIT J HAEMATOL, V88, P555, DOI 10.1111/j.1365-2141.1994.tb05073.x; PERRINE SP, 1993, NEW ENGL J MED, V328, P81, DOI 10.1056/NEJM199301143280202; Perrine SP, 2014, HEMATOL ONCOL CLIN N, V28, P233, DOI 10.1016/j.hoc.2013.11.009; Perrine SP, 2009, EUR J HAEMATOL, V82, P466, DOI 10.1111/j.1600-0609.2009.01234.x; Peterson KR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107006; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; Reich S, 2000, BLOOD, V96, P3357, DOI 10.1182/blood.V96.10.3357.h8003357_3357_3363; Resar LMS, 2002, J PEDIAT HEMATOL ONC, V24, P737, DOI 10.1097/00043426-200212000-00011; Saunthararajah Y, 2003, BLOOD, V102, P3865, DOI 10.1182/blood-2003-05-1738; Schaeffer EK, 2014, BLOOD CELL MOL DIS, V52, P214, DOI 10.1016/j.bcmd.2013.10.007; Schrier S L, 1997, Curr Opin Hematol, V4, P75; Sheehan VA, 2013, AM J HEMATOL, V88, P571, DOI 10.1002/ajh.23457; Spyrou P, 2010, BLOOD CELL MOL DIS, V44, P100, DOI 10.1016/j.bcmd.2009.10.008; Steinberg MH, 2010, AM J HEMATOL, V85, P403, DOI 10.1002/ajh.21699; Steinberg MH, 2001, MEDICINE, V80, P328, DOI 10.1097/00005792-200109000-00007; Taher AT, 2010, BLOOD, V115, P1886, DOI 10.1182/blood-2009-09-243154; Testa U, 2009, ANN HEMATOL, V88, P505, DOI 10.1007/s00277-008-0637-y; Thein SL, 2009, BRIT J HAEMATOL, V145, P455, DOI 10.1111/j.1365-2141.2009.07650.x; Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105; Vichinsky EP, 2005, PEDIATRICS, V116, pE818, DOI 10.1542/peds.2005-0843; Wang WC, 2011, LANCET, V377, P1663, DOI 10.1016/S0140-6736(11)60355-3; Weatherall DJ, 2010, BLOOD, V115, P4331, DOI 10.1182/blood-2010-01-251348; Wilber A, 2011, BLOOD, V117, P3945, DOI 10.1182/blood-2010-11-316893	50	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0144660	10.1371/journal.pone.0144660	http://dx.doi.org/10.1371/journal.pone.0144660			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713848	Green Submitted, gold, Green Published			2022-12-26	WOS:000367481900016
J	Findal, G; Stray-Pedersen, B; Holter, EK; Berge, T; Jenum, PA				Findal, Gry; Stray-Pedersen, Babill; Holter, Ellen K.; Berge, Tone; Jenum, Pal A.			Persistent Low Toxoplasma IgG Avidity Is Common in Pregnancy: Experience from Antenatal Testing in Norway	PLOS ONE			English	Article							IMMUNOGLOBULIN-G AVIDITY; GONDII INFECTION; WOMEN; DIAGNOSIS; MATURATION; SYSTEM	The parasite Toxoplasma gondii might harm the fetus if a woman is infected during pregnancy. IgG seroconversion and significant increase in IgG antibody amount in pregnancy indicates maternal infection. Presence of toxoplasma immunoglobulin M (IgM), immunoglobulin G (IgG) and low IgG avidity in a single serum sample indicates possible maternal infection, but positive toxoplasma IgM and low IgG avidity may persist for months and even years. We aimed to evaluate avidity development during pregnancy in a retrospective study. Serial blood samples from 176 pregnant women admitted to Oslo University Hospital 1993-2013 for amniocentesis because of suspected toxoplasma infection were included. Data were obtained from journals and laboratory records. The avidity method used was based on Platelia Toxo IgG assay. Mean maternal age at first serology was 29.9 years (SD 5.2, range 18-42). In 37 (21%) women only the avidity increased from low to high in < 3 months. In 139 (79%) the IgG avidity remained below the high threshold >= 3 months and within this group 74 (42%) women had stable low IgG avidity during the observation period. Median gestational age at first test was 10.6 weeks (range 4.6-28.7). Fetal infection was detected in four children, but none among children whose mother had stable low IgG avidity. The first antenatal toxoplasma serology should ideally be collected in early pregnancy and if stable values of toxoplasma IgM and low IgG-avidity are detected in a second sample after three to four weeks, the need for amniocentesis can be questioned.	[Findal, Gry; Stray-Pedersen, Babill; Jenum, Pal A.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Findal, Gry; Stray-Pedersen, Babill] Oslo Univ Hosp, Div Women & Children, Oslo, Norway; [Holter, Ellen K.; Berge, Tone] Oslo Univ Hosp, Dept Med Microbiol, Oslo, Norway; [Jenum, Pal A.] Vestre Viken Hlth Trust, Dept Med Microbiol, Drammen, Norway	University of Oslo; University of Oslo; University of Oslo	Findal, G (corresponding author), Univ Oslo, Inst Clin Med, Oslo, Norway.	gryfi@medisin.uio.no		findal, gry/0000-0002-0766-6871				Alvarado-Esquivel C, 2011, EUR J MICROBIOL IMMU, V1, P249, DOI 10.1556/EuJMI.1.2011.3.9; [Anonymous], 2011, INFECT DIS FETUS NEW; Ashburn D, 1998, J CLIN PATHOL, V51, P312, DOI 10.1136/jcp.51.4.312; Cozon GJN, 1998, EUR J CLIN MICROBIOL, V17, P32, DOI 10.1007/BF01584360; Dunn D, 1999, LANCET, V353, P1829, DOI 10.1016/S0140-6736(98)08220-8; Eskild A, 2003, J MED SCREEN, V10, P172, DOI 10.1258/096914103771773258; Flori P, 2004, CLIN DIAGN LAB IMMUN, V11, P669, DOI 10.1128/CDLI.11.4.669-674.2004; Hareide Bodolf, 1997, Tidsskrift for den Norske Laegeforening, V117, P327; HEDMAN K, 1989, J INFECT DIS, V159, P736, DOI 10.1093/infdis/159.4.736; Jenum PA, 1997, J CLIN MICROBIOL, V35, P1972, DOI 10.1128/JCM.35.8.1972-1977.1997; Jenum PA, 1998, J CLIN MICROBIOL, V36, P2900, DOI 10.1128/JCM.36.10.2900-2906.1998; Jenum PA, 1995, FOREBYGGING MEDFODT; Khoshnood B, 2007, PRENATAL DIAG, V27, P395, DOI 10.1002/pd.1715; Lachaud L, 2009, DIAGN MICR INFEC DIS, V64, P267, DOI 10.1016/j.diagmicrobio.2009.02.014; Lebech M, 1996, EUR J CLIN MICROBIOL, V15, P799, DOI 10.1007/BF01701522; Lefevre-Pettazzoni M, 2006, EUR J CLIN MICROBIOL, V25, P687, DOI 10.1007/s10096-006-0204-1; Lefevre-Pettazzoni M, 2007, CLIN VACCINE IMMUNOL, V14, P239, DOI 10.1128/CVI.00311-06; Melby KK, 2012, NORSK REFERANSELABOR; Meroni V, 2009, CLIN VACCINE IMMUNOL, V16, P1517, DOI 10.1128/CVI.00253-09; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Murat JB, 2012, CLIN VACCINE IMMUNOL, V19, P1838, DOI 10.1128/CVI.00333-12; Norwegian Institute of Public Health, 2012, ARST MED FODS 2010; Paul M, 1999, CLIN DIAGN LAB IMMUN, V6, P514, DOI 10.1128/CDLI.6.4.514-518.1999; Petersen E, 2005, J CLIN MICROBIOL, V43, P1570, DOI 10.1128/JCM.43.4.1570-1574.2005; Sensini Alessandra, 1996, Clin Microbiol Infect, V2, P25, DOI 10.1111/j.1469-0691.1996.tb00196.x; WONG SY, 1994, CLIN INFECT DIS, V18, P853, DOI 10.1093/clinids/18.6.853	26	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145519	10.1371/journal.pone.0145519	http://dx.doi.org/10.1371/journal.pone.0145519			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714282	Green Published, gold, Green Submitted			2022-12-26	WOS:000367481900051
J	Otoshi, T; Tanaka, T; Morimoto, K; Nakatani, T				Otoshi, Taiyo; Tanaka, Tomoaki; Morimoto, Kazuya; Nakatani, Tatsuya			Cytoplasmic Accumulation of Heterogeneous Nuclear Ribonucleoprotein K Strongly Promotes Tumor Invasion in Renal Cell Carcinoma Cells	PLOS ONE			English	Article							HNRNP-K; INTERFERON-ALPHA; POOR-PROGNOSIS; EXPRESSION; CANCER; IDENTIFICATION; APOPTOSIS; PATTERNS; TARGET; DOMAIN	Heterogeneous nuclear ribonucleoprotein (hnRNP) K is a part of the ribonucleoprotein complex which regulates diverse biological events. While overexpression of hnRNP K has been shown to be related to tumorigenesis in several cancers, both the expression patterns and biological mechanisms of hnRNP K in renal cell carcinoma (RCC) cells remain unclear. In this study, we showed that hnRNP K protein was strongly expressed in selected RCC cell lines (ACHN, A498, Caki-1, 786-0), and knock-down of hnRNP K expression by siRNA induced cell growth inhibition and apoptosis. Based on immunohistochemical (IHC) analysis of hnRNP K expression in human clear cell RCC specimens, we demonstrated that there was a significant positive correlation between hnRNP K staining score and tumor aggressiveness (e.g., Fuhrman grade, metastasis). Particularly, the rate of cytoplasmic localization of hnRNP K in primary RCC with distant metastasis was significantly higher than that in RCC without metastasis. Additionally, our results indicated that the cytoplasmic distribution of hnRNP K induced by TGF-beta stimulus mainly contributed to TGF-beta-triggered tumor cell invasion in RCC cells. Dominant cytoplasmic expression of ectopic hnRNP K markedly suppressed the inhibition of invasion by knock-down of endogenous hnRNP K. The expression level of matrix metalloproteinase protein-2 was decreased by endogenous hnRNP K knock-down, and restored by ectopic hnRNP K. Therefore, hnRNP K may be a key molecule involved in cell motility in RCC cells, and molecular mechanism associated with the subcellular localization of hnRNP K may be a novel target in the treatment of metastatic RCC.	[Otoshi, Taiyo; Tanaka, Tomoaki; Morimoto, Kazuya; Nakatani, Tatsuya] Osaka City Univ, Dept Urol, Grad Sch Med, Osaka 558, Japan	Osaka Metropolitan University	Tanaka, T (corresponding author), Osaka City Univ, Dept Urol, Grad Sch Med, Osaka 558, Japan.	tomoaki826@msic.med.osaka-cu.ac.jp	Tanaka, Tomoaki/H-7837-2019					Baber JL, 1999, J MOL BIOL, V289, P949, DOI 10.1006/jmbi.1999.2818; Barboro P, 2009, BRIT J CANCER, V100, P1608, DOI 10.1038/sj.bjc.6605057; Bomsztyk K, 2004, BIOESSAYS, V26, P629, DOI 10.1002/bies.20048; Carpenter B, 2006, BRIT J CANCER, V95, P921, DOI 10.1038/sj.bjc.6603349; Chen LC, 2008, CLIN CANCER RES, V14, P3807, DOI 10.1158/1078-0432.CCR-08-0155; Chung IC, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-348; Enge M, 2009, CANCER CELL, V15, P171, DOI 10.1016/j.ccr.2009.01.019; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Escudier B, 2010, J CLIN ONCOL, V28, P2144, DOI 10.1200/JCO.2009.26.7849; Gao R, 2013, J BIOL CHEM, V288, P15046, DOI 10.1074/jbc.M113.466136; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Inoue A, 2007, P NATL ACAD SCI USA, V104, P8983, DOI 10.1073/pnas.0607595104; Jonasch E, 2014, CURR MED RES OPIN, V30, P2041, DOI 10.1185/03007995.2014.938730; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Klimek-Tomczak K, 2004, J MOL BIOL, V342, P1131, DOI 10.1016/j.jmb.2004.07.099; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Lam JS, 2005, WORLD J UROL, V23, P202, DOI 10.1007/s00345-004-0466-0; Lynch M, 2005, MOL CELL BIOL, V25, P6436, DOI 10.1128/MCB.25.15.6436-6453.2005; Mandal M, 2001, J BIOL CHEM, V276, P9699, DOI 10.1074/jbc.M008514200; Matta A, 2009, INT J CANCER, V125, P1398, DOI 10.1002/ijc.24517; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Michael WM, 1997, EMBO J, V16, P3587, DOI 10.1093/emboj/16.12.3587; Mikula M, 2006, PROTEOMICS, V6, P2395, DOI 10.1002/pmic.200500632; Motzer RJ, 1996, NEW ENGL J MED, V335, P865, DOI 10.1056/NEJM199609193351207; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Motzer RJ, 2010, CANCER-AM CANCER SOC, V116, P4256, DOI 10.1002/cncr.25219; Moumen A, 2005, CELL, V123, P1065, DOI 10.1016/j.cell.2005.09.032; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pino I, 2003, LUNG CANCER-J IASLC, V41, P131, DOI 10.1016/S0169-5002(03)00193-4; Rini BI, 2011, LANCET, V378, P1931, DOI 10.1016/S0140-6736(11)61613-9; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; Ritchie SA, 2003, NUCLEIC ACIDS RES, V31, P1502, DOI 10.1093/nar/gkg246; Sternberg CN, 2010, J CLIN ONCOL, V28, P1061, DOI 10.1200/JCO.2009.23.9764; Tanaka T, 2003, J BIOL CHEM, V278, P32905, DOI 10.1074/jbc.M212057200; Wada H, 2000, J BIOL CHEM, V275, P17008, DOI 10.1074/jbc.275.22.17008; Wang F, 2012, MED ONCOL, V29, P1780, DOI 10.1007/s12032-011-0037-3; Wen FS, 2010, ANN SURG ONCOL, V17, P2619, DOI 10.1245/s10434-010-1121-1; Xiao ZW, 2013, CARCINOGENESIS, V34, P1458, DOI 10.1093/carcin/bgt085; Zhang YJ, 2012, CELL CYCLE, V11, P594, DOI 10.4161/cc.11.3.19096; Zhou RY, 2010, INT J CANCER, V126, P395, DOI 10.1002/ijc.24744	40	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145769	10.1371/journal.pone.0145769	http://dx.doi.org/10.1371/journal.pone.0145769			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713736	gold, Green Submitted, Green Published			2022-12-26	WOS:000367481900079
J	Ribitsch, W; Schneditz, D; Franssen, CFM; Schilcher, G; Stadlbauer, V; Horina, JH; Rosenkranz, AR				Ribitsch, Werner; Schneditz, Daniel; Franssen, Casper F. M.; Schilcher, Gernot; Stadlbauer, Vanessa; Horina, Joerg H.; Rosenkranz, Alexander R.			Increased Hepato-Splanchnic Vasoconstriction in Diabetics during Regular Hemodialysis	PLOS ONE			English	Article							AUTONOMIC NERVOUS-SYSTEM; CHRONIC KIDNEY-DISEASE; INDOCYANINE GREEN; DIALYSIS HYPOTENSION; ARGININE-VASOPRESSIN; BLOOD-VOLUME; INTRADIALYTIC HYPOTENSION; REFLEX CONTROL; DYSFUNCTION; FLOW	Background and Objectives Ultrafiltration (UF) of excess fluid activates numerous compensatory mechanisms during hemodialysis (HD). The increase of both total peripheral and splanchnic vascular resistance is considered essential in maintaining hemodynamic stability. The aim of this study was to evaluate the extent of UF-induced changes in hepato-splanchnic blood flow and resistance in a group of maintenance HD patients during regular dialysis. Design, Setting, Participants, & Measurements Hepato-splanchnic flow resistance index (RI) and hepato-splanchnic perfusion index (QI) were measured in 12 chronic HD patients using a modified, non-invasive Indocyaningreen (ICG) dilution method. During a midweek dialysis session we determined RI, QI, ICG disappearance rate (k(ICG)), plasma volume (V-p), hematocrit (Hct), mean arterial blood pressure (MAP) and heart rate (HR) at four times in hourly intervals (t(1) to t(4)). Dialysis settings were standardized and all patient studies were done in duplicate. Results In the whole study group mean UF volume was 1.86 +/- 0.46 L, V-p dropped from 3.65 +/- 0.77L at t(1) to 3.40 +/- 0.78L at t(4), and all patients remained hemodynamically stable. In all patients RI significantly increased from 12.40 +/- 4.21 mmHg.s.m(2)/mL at t1 to 14.94 +/- 6.36 mmHg.s.m(2)/mL at t(4) while QI significantly decreased from 0.61 +/- 0.22 at t1 to 0.52 +/- 0.20 L/min/m(2) at t(4), indicating active vasoconstriction. In diabetic subjects, however, RI was significantly larger than in non-diabetics at all time points. QI was lower in diabetic subjects. Conclusions In chronic HD-patients hepato-splanchnic blood flow substantially decreases during moderate UF as a result of an active splanchnic vasoconstriction. Our data indicate that diabetic HD-patients are particularly prone to splanchnic ischemia and might therefore have an increased risk for bacterial translocation, endotoxemia and systemic inflammation.	[Ribitsch, Werner; Schilcher, Gernot; Horina, Joerg H.; Rosenkranz, Alexander R.] Med Univ Graz, Clin Div Nephrol, Dept Internal Med, Graz, Austria; [Schneditz, Daniel] Med Univ Graz, Inst Physiol, Graz, Austria; [Franssen, Casper F. M.] Univ Med Ctr Groningen, Dept Internal Med, Div Nephrol, NL-9713 AV Groningen, Netherlands; [Stadlbauer, Vanessa] Med Univ Graz, Clin Div Gastroenterol & Hepatol, Dept Internal Med, Graz, Austria	Medical University of Graz; Medical University of Graz; University of Groningen; Medical University of Graz	Ribitsch, W (corresponding author), Med Univ Graz, Clin Div Nephrol, Dept Internal Med, Graz, Austria.	werner.ribitsch@medunigraz.at	Schneditz, Daniel/E-6580-2010	Schneditz, Daniel/0000-0002-0124-1012; Franssen, Casper/0000-0003-1004-9994; Stadlbauer, Vanessa/0000-0001-5508-8271	Austrian Science Fund (FWF) [P 23532] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))		ABBOUD FM, 1990, BLOOD VESSELS, V27, P106; Agarwal R, 2012, CURR OPIN NEPHROL HY, V21, P593, DOI 10.1097/MNH.0b013e3283588f3c; Armengol NE, 1997, NEPHROL DIAL TRANSPL, V12, P939, DOI 10.1093/ndt/12.5.939; Burton JO, 2009, CLIN J AM SOC NEPHRO, V4, P914, DOI 10.2215/CJN.03900808; CAMPESE VM, 1981, KIDNEY INT, V20, P246, DOI 10.1038/ki.1981.127; Dasselaar JJ, 2007, CLIN J AM SOC NEPHRO, V2, P669, DOI 10.2215/CJN.00880207; Dasselaar JJ, 2009, NEPHROL DIAL TRANSPL, V24, P604, DOI 10.1093/ndt/gfn501; DAUZAT M, 1994, EUR J APPL PHYSIOL, V68, P373, DOI 10.1007/BF00843732; DIEBEL L, 1993, SURGERY, V113, P520; Dietrich CE, 2007, EUR J RADIOL, V64, P202, DOI 10.1016/j.ejrad.2007.06.034; Dorhout Mees EJ, 2010, CARDIOVASCULAR ASPEC; Du Bois D, 1916, ARCH INTERN MED, V17, P863, DOI 10.1001/archinte.1916.00080130010002; Ettema EM, 2014, AM J NEPHROL, V39, P100, DOI 10.1159/000358203; Ettema EM, 2012, NEPHROL DIAL TRANSPL, V27, P3263, DOI 10.1093/ndt/gfr793; Franssen CMF, 2006, KIDNEY INT, V69, P789, DOI 10.1038/sj.ki.5000232; FRIESS U, 1995, NEPHROL DIAL TRANSPL, V10, P1421; Granger NS, 2009, MORGAN CLAYPOOL LIFE; HARVEY RF, 1980, LANCET, V1, P514; Hauser AB, 2011, NEPHRON CLIN PRACT, V118, pC165, DOI 10.1159/000321438; Hinghofer-Szalkay HG, 2008, AM J PHYSIOL-GASTR L, V295, pG332, DOI 10.1152/ajpgi.00042.2008; Imai E, 2006, KIDNEY INT, V69, P877, DOI 10.1038/sj.ki.5000088; Jakob SM, 2001, CRIT CARE MED, V29, P1393, DOI 10.1097/00003246-200107000-00015; Kimura S, 2001, CRIT CARE MED, V29, P1159, DOI 10.1097/00003246-200106000-00014; Knotzer H, 2005, AM J PHYSIOL-HEART C, V289, pH168, DOI 10.1152/ajpheart.01235.2004; KOOMAN JP, 1992, KIDNEY INT, V42, P718, DOI 10.1038/ki.1992.339; Korotinski S, 2005, AGE AGEING, V34, P10, DOI 10.1093/ageing/afh226; MARTINEZVEA A, 1985, CLIN NEPHROL, V24, P316; McIntyre CW, 2008, CLIN J AM SOC NEPHRO, V3, P19, DOI 10.2215/CJN.03170707; McIntyre CW, 2011, CLIN J AM SOC NEPHRO, V6, P133, DOI 10.2215/CJN.04610510; Mitra S, 2003, J AM SOC NEPHROL, V14, P2345, DOI 10.1097/01.ASN.0000082998.50730.FA; ROTHE CF, 1983, PHYSIOL REV, V63, P1281, DOI 10.1152/physrev.1983.63.4.1281; Rowell L., 1986, HUMAN CIRCULATION RE; SAAD CI, 1988, HYPERTENSION, V11, P217; Sakka SG, 2002, CHEST, V122, P1715, DOI 10.1378/chest.122.5.1715; Schneditz D, 2005, ASAIO J, V51, P376, DOI 10.1097/01.mat.0000169030.37228.82; SCHNEDITZ D, 1992, KIDNEY INT, V42, P1425, DOI 10.1038/ki.1992.437; Schneditz D, 2016, HEMODIAL INT, V20, P120, DOI 10.1111/hdi.12338; Schneditz D, 2014, ASAIO J, V60, P452, DOI 10.1097/MAT.0000000000000075; Shibagaki Y, 1998, CLIN NEPHROL, V49, P49; Silvan Delgado M, 1997, REV ESPANOLA ENFERME, V89, P677; van der Zee S, 2007, KIDNEY INT, V71, P318, DOI 10.1038/sj.ki.5001885; Vaziri ND, 2012, NEPHROL DIAL TRANSPL, V27, P2686, DOI 10.1093/ndt/gfr624; Wang FQ, 2012, NEPHROLOGY, V17, P733, DOI 10.1111/j.1440-1797.2012.01647.x; Yu AW, 1997, KIDNEY INT, V51, P1986, DOI 10.1038/ki.1997.270; ZOCCALI C, 1991, NEPHROL DIAL TRANSPL, V6, P631, DOI 10.1093/ndt/6.9.631	45	19	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145411	10.1371/journal.pone.0145411	http://dx.doi.org/10.1371/journal.pone.0145411			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713734	gold, Green Submitted, Green Published			2022-12-26	WOS:000367481900039
J	Abramson, DH; Fabius, AWM; Issa, R; Francis, JH; Marr, BP; Dunkel, IJ; Gobin, YP				Abramson, David H.; Fabius, Armida W. M.; Issa, Reda; Francis, Jasmine H.; Marr, Brian P.; Dunkel, Ira J.; Gobin, Y. Pierre			Advanced Unilateral Retinoblastoma: The Impact of Ophthalmic Artery Chemosurgery on Enucleation Rate and Patient Survival at MSKCC	PLOS ONE			English	Article							INTRAARTERIAL CHEMOTHERAPY; INTRAOCULAR RETINOBLASTOMA; BILATERAL RETINOBLASTOMA; RETINAL-DETACHMENT; MANAGEMENT; RADIATION; MELPHALAN; RISK; RADIOTHERAPY	Purpose To report on the influence of ophthalmic artery chemosurgery (OAC) on enucleation rates, ocular and patient survival from metastasis and impact on practice patterns at Memorial Sloan Kettering for children with advanced intraocular unilateral retinoblastoma. Patients and Methods Single-center retrospective review of all unilateral retinoblastoma patients with advanced intraocular retinoblastoma treated at MSKCC between our introduction of OAC (May 2006) and December 2014. End points were ocular survival, patient survival from metastases and enucleation rates. Results 156 eyes of 156 retinoblastoma patients were included. Primary enucleation rates have progressively decreased from a rate of >95% before OAC to 66.7% in the first year of OAC use to the present rate of 7.4%. The percent of patients receiving OAC has progressively increased from 33.3% in 2006 to 92.6% in 2014. Overall, ocular survival was significantly better in eyes treated with OAC in the years 2010-2014 compared to 2006-2009 (p = 0.023, 92.7% vs 68.0% ocular survival at 48 months). There have been no metastatic deaths in the OAC group but two patients treated with primary enucleation have died of metastatic disease. Conclusion OAC was introduced in 2006 and its impact on patient management is profound. Enucleation rates have decreased from over 95% to less than 10%. Our ocular survival rate has also significantly and progressively improved since May 2006. Despite treating more advanced eyes rather then enucleating them patient survival has not been compromised (there have been no metastatic deaths in the OAC group). In our institution, enucleation is no longer the most common treatment for advanced unilateral retinoblastoma.	[Abramson, David H.; Fabius, Armida W. M.; Issa, Reda; Francis, Jasmine H.; Marr, Brian P.; Gobin, Y. Pierre] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Abramson, David H.; Francis, Jasmine H.] New York Presbyterian Hosp, Weill Cornell Med Coll, Dept Ophthalmol, New York, NY USA; [Dunkel, Ira J.] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA; [Dunkel, Ira J.] New York Presbyterian Hosp, Weill Cornell Med Coll, Dept Pediat, New York, NY USA; [Gobin, Y. Pierre] New York Presbyterian Hosp, Weill Cornell Med Coll, Dept Radiol, Intervent Neuroradiol, New York, NY USA; [Gobin, Y. Pierre] New York Presbyterian Hosp, Weill Cornell Med Coll, Dept Neurosurg, Intervent Neuroradiol, New York, NY USA; [Gobin, Y. Pierre] New York Presbyterian Hosp, Weill Cornell Med Coll, Dept Neurol, Intervent Neuroradiol, New York, NY USA	Memorial Sloan Kettering Cancer Center; Cornell University; NewYork-Presbyterian Hospital; Memorial Sloan Kettering Cancer Center; Cornell University; NewYork-Presbyterian Hospital; Cornell University; NewYork-Presbyterian Hospital; Cornell University; NewYork-Presbyterian Hospital; Cornell University; NewYork-Presbyterian Hospital	Abramson, DH (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA.	abramsod@mskcc.org		Francis, Jasmine/0000-0002-7637-3108; Dunkel, Ira/0000-0001-8091-6067	Fund for Ophthalmic Knowledge, Inc, N.Y.; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Fund for Ophthalmic Knowledge, Inc, N.Y.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Fund for Ophthalmic Knowledge, Inc, N.Y. awarded a philanthropic grant to the Ocular Oncology service at Memorial Sloan Kettering Cancer Center. This grant does not have grant number and the fund has no URL. DHA is President of the Fund for Ophthalmic Knowledge, Inc. The Fund is a 501c3 public charity. DHA receives no compensation for his position as President of the Fund.	Abramson DH, 2008, OPHTHALMOLOGY, V115, P1398, DOI 10.1016/j.ophtha.2007.12.014; Abramson DH, 2014, ANNU REV MED, V65, P171, DOI 10.1146/annurev-med-061312-123455; Abramson DH, 2011, ARCH OPHTHALMOL-CHIC, V129, P1492, DOI 10.1001/archophthalmol.2011.354; Abramson DH, 2010, ARCH OPHTHALMOL-CHIC, V128, P370, DOI 10.1001/archophthalmol.2010.7; Abramson DH, 1998, OPHTHALMOLOGY, V105, P573, DOI 10.1016/S0161-6420(98)94006-4; Abramson DH, 2004, ARCH OPHTHALMOL-CHIC, V122, P1316, DOI 10.1001/archopht.122.9.1316; ABRAMSON DH, 1976, T AM ACAD OPHTHALMOL, V81, pP454; ABRAMSON DH, 1981, ARCH OPHTHALMOL-CHIC, V99, P1761; Abramson DH, 1982, MANAGEMENT UNILATERA; Abramson DH, 1981, SIMULTANEOUS BILATER; Aziz HA, 2012, CLIN OPHTHALMOL, V6, P1601, DOI 10.2147/OPTH.S33094; Bracco S, 2013, BRIT J OPHTHALMOL, V97, P1219, DOI 10.1136/bjophthalmol-2013-303267; Dunkel IJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108692; Francis JH, 2015, OPHTHALMOLOGY, V122, P1016, DOI 10.1016/j.ophtha.2014.11.029; Gobin YP, 2011, ARCH OPHTHALMOL-CHIC, V129, P732, DOI 10.1001/archophthalmol.2011.5; Gombos DS, 2007, OPHTHALMOLOGY, V114, P1378, DOI 10.1016/j.ophtha.2007.03.074; Grigorovski N, 2014, INT J OPHTHALMOL-CHI, V7, P726, DOI 10.3980/j.issn.2222-3959.2014.04.26; Hadjistilianou T, 2014, J PEDIAT OPHTH STRAB, V51, P32, DOI 10.3928/01913913-20131203-01; Muen WJ, 2012, OPHTHALMOLOGY, V119, P611, DOI 10.1016/j.ophtha.2011.08.045; Palioura S, 2012, PEDIATR BLOOD CANCER, V59, P859, DOI 10.1002/pbc.24170; REESE AB, 1958, ARCH OPHTHALMOL-CHIC, V60, P897; Reese AB, 2013, AM J OPHTHALMOL, V32, P175; Schaiquevich P, 2013, PEDIATR BLOOD CANCER, V60, P766, DOI 10.1002/pbc.24356; Schefler AC, 2008, CURR OPIN OPHTHALMOL; Shields CL, 2012, RETINA-J RET VIT DIS, V32, P799, DOI 10.1097/IAE.0b013e31823d8e1e; Shields JA, 2005, AM J OPHTHALMOL, V140, P505, DOI 10.1016/j.ajo.2005.04.047; Suzuki Shigenobu, 2004, Int J Clin Oncol, V9, P1, DOI 10.1007/s10147-003-0366-0; Thampi S, 2013, CLIN OPHTHALMOL, V7, P981, DOI 10.2147/OPTH.S43398; Wong FL, 1997, JAMA-J AM MED ASSOC, V278, P1262, DOI 10.1001/jama.278.15.1262; Wong JR, 2014, J CLIN ONCOL, V32, P3284, DOI 10.1200/JCO.2013.54.7844; Yannuzzi NA, 2015, JAMA OPHTHALMOL, V133, P1062, DOI 10.1001/jamaophthalmol.2015.2243	31	45	46	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145436	10.1371/journal.pone.0145436	http://dx.doi.org/10.1371/journal.pone.0145436			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709699	Green Published, Green Submitted, gold			2022-12-26	WOS:000367451400046
J	Daly, SC; MacNeela, P; Sarma, KM				Daly, Siobhan C.; MacNeela, Padriag; Sarma, Kiran M.			When Parents Separate and One Parent 'Comes Out' as Lesbian, Gay or Bisexual: Sons and Daughters Engage with the Tension that Occurs When Their Family Unit Changes	PLOS ONE			English	Article							RELATIONSHIP QUALITY; CHILD ADJUSTMENT; GROUNDED THEORY; DIVORCE; PERCEPTIONS; RESILIENCE; DISSONANCE; HYPOCRISY; IDENTITY; SUPPORT	The experiences of Irish sons and daughters born into heterosexually-organised parental partnerships/unions whose parents have separated and one has come out as Lesbian, Gay or Bisexual (LGB) were explored through a grounded theory approach. 15 adult children (over the age of 18 years), who varied in age when their parents separated and one disclosed as LGB, were interviewed. The primary concern that emerged centred on participants having to adjust to their parents' being separated, as opposed to their parent being LGB. This involved engaging with the tension that arose from the loss of the parental union, which involved changes to the home environment and adapting to new parental partners and family units. Heightened reflection on sexual orientation and an increased sensitivity to societal LGB prejudice were specifically associated with a parent coming out as LGB. How parents negotiated disclosing the changes to others, the level of support available to parents, and how capable parents were at maintaining the parent-child relationship had an impact on the tension experienced by sons and daughters. Participants moved from initially avoiding and resisting the family changes that were occurring to gradual consonance with their altered family environments. Concluding directions for research and clinical considerations are suggested.	[Daly, Siobhan C.; MacNeela, Padriag; Sarma, Kiran M.] Natl Univ Ireland, Sch Psychol, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway	Daly, SC (corresponding author), Natl Univ Ireland, Sch Psychol, Galway, Ireland.	s.daly14@nuigalway.ie						Afifi T.D., 2009, J FAMILY COMMUNICATI, V4, P65; Ahrons CR, 2007, FAM PROCESS, V46, P53, DOI 10.1111/j.1545-5300.2006.00191.x; Amato PR, 2006, J MARRIAGE FAM, V68, P222, DOI 10.1111/j.1741-3737.2006.00243.x; [Anonymous], 2013, SURVIVING THRIVING S; [Anonymous], 2007, BRAVE NEW STEPFAMILI; Bauserman R, 2002, J FAM PSYCHOL, V16, P91, DOI 10.1037/0893-3200.16.1.91; Berger R, 2008, FAMILIES SOC, V6, P504; Binger J.J., 2012, HDB LGBT AFFIRMATIVE; Bos HMW, 2007, AM J ORTHOPSYCHIAT, V77, P38, DOI 10.1037/0002-9432.77.1.38; Braithwaite DO, 2006, J APPL COMMUN RES, V34, P30, DOI 10.1080/00909880500420200; Brownell K.D., 2005, WEIGHT BIAS NATURE C; Cartwright C., 2006, J DIVORCE REMARRIAGE, V44, P125, DOI DOI 10.1300/J087; Corbin J., 2007, BASICS QUALITATIVE R, V3rd, DOI DOI 10.4135/9781452230153.N8; CROSBIEBURNETT M, 1993, FAM RELAT, V42, P256, DOI 10.2307/585554; Elizur Y, 2003, PERS RELATIONSHIP, V10, P411, DOI 10.1111/1475-6811.00057; Fassinger RE, 2005, J COUNS PSYCHOL, V52, P156, DOI 10.1037/0022-0167.52.2.156; Frable DES, 1998, J PERS SOC PSYCHOL, V74, P909, DOI 10.1037/0022-3514.74.4.909; Gershon TD, 1999, J ADOLESCENT HEALTH, V24, P437, DOI 10.1016/S1054-139X(98)00154-2; Glaser B. G., 2004, HIST SOCIAL RES S19, V5, P13, DOI [10.1016/j.clae.2007.06.001, DOI 10.1016/J.CLAE.2007.06.001]; Goldberg A. E., 2020, LGBTQ PARENT FAMILIE, V2nd; Heatherington L, 2008, J FAM PSYCHOL, V22, P329, DOI 10.1037/0893-3200.22.3.329; Herek G. M., 2003, STIGMA SEXUAL ORIENT; Jamison TB, 2014, FAM RELAT, V63, P411, DOI 10.1111/fare.12074; Kelly JB, 2003, FAM RELAT, V52, P352, DOI 10.1111/j.1741-3729.2003.00352.x; Kuvalanka K., 2013, J ADOLESCENT RES, V29, P1; Lansford JE, 2009, PERSPECT PSYCHOL SCI, V4, P140, DOI 10.1111/j.1745-6924.2009.01114.x; Lynch J.M., 2010, J HOMOSEXUAL, V40, P81; Malterud K, 2001, LANCET, V358, P397, DOI 10.1016/S0140-6736(01)05548-9; McConnell AR, 2010, J EXP SOC PSYCHOL, V46, P361, DOI 10.1016/j.jesp.2009.10.019; McKenzie, 2004, FAMILY COURT REV, V42, P85, DOI DOI 10.1111/J.174-1617.2004.TB00635.X; Meaney Gerardine, 2010, GENDER IRELAND CULTU; Menning CL, 2002, J FAM ISSUES, V23, P648, DOI 10.1177/0192513X02023005004; Meyer IH, 2003, PSYCHOL BULL, V129, P674, DOI 10.1037/0033-2909.129.5.674; Mohr JJ, 2006, PERS SOC PSYCHOL B, V32, P1085, DOI 10.1177/0146167206288281; Munhall P., 2012, NURSING RES QUALITAT; Patterson Charlotte J., 2005, LESBIAN GAY PARENTIN, P5; Rosenfeld MJ, 2010, DEMOGRAPHY, V47, P755, DOI 10.1353/dem.0.0112; Sasser A., 2006, IMPACT COMING OUT MI, V22, P18; Stone J, 2008, SOC PERSONAL PSYCHOL, V2, P1024, DOI 10.1111/j.1751-9004.2008.00088.x; Strauss A., 1990, BASICS QUALITATIVE R; Strauss A., 1998, BASICS QUALITATIVE R; Suddaby R, 2006, ACAD MANAGE J, V49, P633, DOI 10.5465/AMJ.2006.22083020; Sun YM, 2002, J MARRIAGE FAM, V64, P472, DOI 10.1111/j.1741-3737.2002.00472.x; Tasker F, 2005, J DEV BEHAV PEDIATR, V26, P224, DOI 10.1097/00004703-200506000-00012; van-Eeden-Moorefield B., 2012, EXPLAINING COUPLE CO, V33, P182; Wainright JL, 2006, J FAM PSYCHOL, V20, P526, DOI 10.1037/0893-3200.20.3.526; Willig C., 2008, INTRO QUALITATIVE RE, V(Second edition.)	47	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145491	10.1371/journal.pone.0145491	http://dx.doi.org/10.1371/journal.pone.0145491			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ9XO	26710277	Green Submitted, gold, Green Published			2022-12-26	WOS:000367451400052
J	Saito, K; Pignon, P; Ayyoub, M; Valmori, D				Saito, Kanako; Pignon, Pascale; Ayyoub, Maha; Valmori, Danila			Modulation of Cytokine Secretion Allows CD4 T Cells Secreting IL-10 and IL-17 to Simultaneously Participate in Maintaining Tolerance and Immunity	PLOS ONE			English	Article							REGULATORY FUNCTION; IFN-GAMMA; IDENTIFICATION; INFLAMMATION; IL-1-BETA; BACTERIA; EXPRESS; TREGS; VIVO; TH17	CD4 T cells secreting IL-10 or IL-17 are frequent at mucosal sites, where their equilibrium is important for simultaneously maintaining tolerance and immunity to the resident microbiota. The mode of action of these cells, however, is as yet incompletely understood. In this study, we have combined ex vivo analysis of CD4 T cells producing IL-10 or/and IL-17 with assessment of clonal populations isolated ex vivo using a cytokine catch assay. We found that circulating CD4 T cells secreting IL-10 or/and IL-17 ex vivo include both conventional FOXP3(-)CD4 T cells and FOXP3(+) Helios-Treg. Upon assessment of clonal populations derived from single ex vivo isolated cytokine secreting cells, we found that IL-10 or/and IL-17 secreting cells prevalently secrete one or the other cytokine depending on the type of stimulation, the time after stimulation and the presence of microbial products. Namely, IL-10 secretion by clonal cells was prevalent at early time points after TCR mediated stimulation, was independent of co-stimulation and was increased in the presence of the microbial fermentation product butyrate. In contrast, IL-17 secretion was higher at later time points after TCR mediated stimulation and in the presence of co-stimulatory signals. Taken together, these results provide insights into the mechanisms that, through modulation of cytokine secretion depending on conditions, allow IL-10 and IL-17 producing CD4 T cells to contribute to maintain tolerance to microbes locally, while retaining the ability to participate in protective immune responses at distant sites.	[Saito, Kanako; Pignon, Pascale; Ayyoub, Maha; Valmori, Danila] Inst Cancerol Ouest, Inst Natl Sante & Rech Med, Equipe Labellisee Ligue Canc, Unite 1102, Nantes, France; [Valmori, Danila] Univ Nantes, Fac Med, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut de Cancerologie de l'Ouest (ICO); Nantes Universite	Valmori, D (corresponding author), Inst Cancerol Ouest, Inst Natl Sante & Rech Med, Equipe Labellisee Ligue Canc, Unite 1102, Nantes, France.	Danila.Valmori@univ-nantes.fr	Valmori, Danila/K-2439-2015; Ayyoub, Maha/A-2074-2017; Valmori, Danila/AAL-9766-2021	Ayyoub, Maha/0000-0003-2022-0898; 	Ludwig Institute for Cancer Research (USA); Cancer Research Institute (USA); Ligue contre le Cancer (France); LabeX IGO (France)	Ludwig Institute for Cancer Research (USA); Cancer Research Institute (USA); Ligue contre le Cancer (France); LabeX IGO (France)	This study was supported by the Ludwig Institute for Cancer Research (USA), the Cancer Research Institute (USA), Ligue contre le Cancer (France) and LabeX IGO (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpaia N, 2014, P NATL ACAD SCI USA, V111, P2058, DOI 10.1073/pnas.1323183111; Ayyoub M, 2009, P NATL ACAD SCI USA, V106, P8635, DOI 10.1073/pnas.0900621106; Blaschitz C, 2010, J CLIN IMMUNOL, V30, P196, DOI 10.1007/s10875-010-9368-7; Chalmin F, 2012, IMMUNITY, V36, P362, DOI 10.1016/j.immuni.2011.12.019; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Ganapathy V, 2013, CURR OPIN PHARMACOL, V13, P869, DOI 10.1016/j.coph.2013.08.006; Haringer B, 2009, J EXP MED, V206, P1009, DOI 10.1084/jem.20082238; Hamai A, 2012, CANCER RES, V72, P1059, DOI 10.1158/0008-5472.CAN-11-3432; Kole A, 2014, CURR TOP MICROBIOL, V380, P19, DOI 10.1007/978-3-662-43492-5_2; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Nutsch KM, 2012, CURR OPIN IMMUNOL, V24, P385, DOI 10.1016/j.coi.2012.04.009; Olsen I, 2013, J IMMUNOL METHODS, V390, P106, DOI 10.1016/j.jim.2013.01.015; Pot C, 2011, SEMIN IMMUNOL, V23, P202, DOI 10.1016/j.smim.2011.07.005; Raffin C, 2013, J IMMUNOL, V191, P4619, DOI 10.4049/jimmunol.1301378; Rivino L, 2010, J EXP MED, V207, P565, DOI 10.1084/jem.20091021; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002; Santarlasci V, 2012, IMMUNITY, V36, P201, DOI 10.1016/j.immuni.2011.12.013; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Voo KS, 2009, P NATL ACAD SCI USA, V106, P4793, DOI 10.1073/pnas.0900408106; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Zelante T, 2009, EUR J IMMUNOL, V39, P645, DOI 10.1002/eji.200839102; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zielinski CE, 2012, NATURE, V484, P514, DOI 10.1038/nature10957	23	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145788	10.1371/journal.pone.0145788	http://dx.doi.org/10.1371/journal.pone.0145788			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709703	gold, Green Published			2022-12-26	WOS:000367451400078
J	Headey, DD; Hoddinott, J				Headey, Derek D.; Hoddinott, John			Understanding the Rapid Reduction of Undernutrition in Nepal, 2001-2011	PLOS ONE			English	Article							NUTRITION; INTERVENTIONS; REGRESSION; HELP; BAD	South Asia has long been synonymous with unusually high rates of undernutrition. In the past decade, however, Nepal has arguably achieved the fastest recorded decline in child stunting in the world and has done so in the midst of civil war and post-conflict political instability. Given recent interest in reducing undernutrition-particularly the role of nutrition-sensitive policies-this paper aims to quantitatively understand this surprising success story by analyzing the 2001, 2006, and 2011 rounds of Nepal's Demographic Health Surveys. To do so, we construct models of the intermediate determinants of child and maternal nutritional change and then decompose predicted changes in nutrition outcomes over time. We identify four broad drivers of change: asset accumulation, health and nutrition interventions, maternal educational gains, and improvements in sanitation. Many of these changes were clearly influenced by policy decisions, including increased public investments in health and education and community-led health and sanitation campaigns. Other factors, such as rapid growth in migration-based remittances, are more a reflection of household responses to changing political and economic circumstances.	[Headey, Derek D.; Hoddinott, John] Int Food Policy Res Inst, Poverty Hlth & Nutr Div, Washington, DC 20036 USA; [Hoddinott, John] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Hoddinott, John] Cornell Univ, Charles H Dyson Sch Appl Econ & Management, Ithaca, NY USA	CGIAR; International Food Policy Research Institute (IFPRI); Cornell University; Cornell University	Headey, DD (corresponding author), Int Food Policy Res Inst, Poverty Hlth & Nutr Div, Washington, DC 20036 USA.	D.Headey@cgiar.org			UK aid from the UK government; Department for International Development (DFID) [201448] Funding Source: researchfish	UK aid from the UK government(CGIAR); Department for International Development (DFID)	This paper is a product of the research consortium Transform Nutrition and is funded by UK aid from the UK government.	Acosta A., 2012, FIGHTING MATERNAL CH; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Deaton AS., 2008, ECON POLIT WEEKLY, DOI [DOI 10.2139/SSRN.1135253, 10.2139/ssrn.1135253]; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Gertler P., 2015, 20997 NBER; Headey D, 2015, WORLD DEV, V66, P749, DOI 10.1016/j.worlddev.2014.09.022; Headey D, 2012, FOOD SECUR, V4, P87, DOI 10.1007/s12571-011-0161-0; Heaver R, 2002, INDIAS TAMIL NADU NU; Heaver R., 2002, THAILANDS NATL NUTR; HORTON S, 1988, ECON DEV CULT CHANGE, V36, P341, DOI 10.1086/451655; Jann B, 2008, STATA J, V8, P453, DOI 10.1177/1536867X0800800401; Jayachandran Seema, 2013, WHY ARE INDIAN CHILD; Nepal CBS (Central Bureau of Statistics), 2005, POV TRENDS NEP 1995; Nepal Ministry of Urban Development, 2013, S AS C SAN SAN ALL A; [New ERA ORC Macro Nepal MOHP], 1997, NEP DEM HLTH SURV 19; [New ERA ORC Macro Nepal MOHP], 2002, NEP DEM HLTH SURV 20; [New ERA ICF International Nepal MOHP (Ministry of Health and Population)], 2012, NEP DEM HLTH SURV 20; [New ERA ICF International Nepal MOHP (Ministry of Health and Population)], 2007, NEP DEM HLTH SURV 20; Nube M., 2007, WP0701 CTR WORLD FOO; Onyango AW, 2006, ACTA PAEDIATR, V95, P38, DOI 10.1080/08035320500494464; Pande RP, 2003, DEMOGRAPHY, V40, P395, DOI 10.1353/dem.2003.0029; Ramalingaswami V., 1997, PROGR NATIONS; Royston P, 2006, STAT MED, V25, P127, DOI 10.1002/sim.2331; Ruel MT, 2013, LANCET, V382, P536, DOI 10.1016/S0140-6736(13)60843-0; Rutstein SO, 2005, INT J GYNECOL OBSTET, V89, P26; Shrimpton R, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.5.e75; Spears D., 2013, WORLD BANK POLICY RE; The World Bank, 2010, 55388NP WORLD BANK; [United Nations Nepal CBS], 2013, NEP MILL DEV GOALS P; WEINBERG CR, 1995, EPIDEMIOLOGY, V6, P345; World Bank, 2006, REP NUTR CENTR DEV S	32	55	55	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145738	10.1371/journal.pone.0145738	http://dx.doi.org/10.1371/journal.pone.0145738			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ4SI	26699135	Green Published, gold			2022-12-26	WOS:000367092600125
J	Hu, WG; Zhang, Q; Tian, T; Li, DY; Cheng, G; Mu, J; Wu, QB; Niu, FJ; Stegen, JC; An, LZ; Feng, HY				Hu, Weigang; Zhang, Qi; Tian, Tian; Li, Dingyao; Cheng, Gang; Mu, Jing; Wu, Qingbai; Niu, Fujun; Stegen, James C.; An, Lizhe; Feng, Huyuan			Relative Roles of Deterministic and Stochastic Processes in Driving the Vertical Distribution of Bacterial Communities in a Permafrost Core from the Qinghai-Tibet Plateau, China	PLOS ONE			English	Article							PHYLOGENETIC BETA DIVERSITY; MICROBIAL DIVERSITY; ECOLOGY; SOIL; BIODIVERSITY; PATTERNS; NICHE; BIOGEOGRAPHY; REVEALS; PROFILE	Understanding the processes that influence the structure of biotic communities is one of the major ecological topics, and both stochastic and deterministic processes are expected to be at work simultaneously in most communities. Here, we investigated the vertical distribution patterns of bacterial communities in a 10-m-long soil core taken within permafrost of the Qing-hai-Tibet Plateau. To get a better understanding of the forces that govern these patterns, we examined the diversity and structure of bacterial communities, and the change in community composition along the vertical distance (spatial turnover) from both taxonomic and phylogenetic perspectives. Measures of taxonomic and phylogenetic beta diversity revealed that bacterial community composition changed continuously along the soil core, and showed a vertical distance-decay relationship. Multiple stepwise regression analysis suggested that bacterial alpha diversity and phylogenetic structure were strongly correlated with soil conductivity and pH but weakly correlated with depth. There was evidence that deterministic and stochastic processes collectively drived bacterial vertically-structured pattern. Bacterial communities in five soil horizons (two originated from the active layer and three from permafrost) of the permafrost core were phylogenetically random, indicator of stochastic processes. However, we found a stronger effect of deterministic processes related to soil pH, conductivity, and organic carbon content that were structuring the bacterial communities. We therefore conclude that the vertical distribution of bacterial communities was governed primarily by deterministic ecological selection, although stochastic processes were also at work. Furthermore, the strong impact of environmental conditions ( for example, soil physicochemical parameters and seasonal freeze-thaw cycles) on these communities underlines the sensitivity of permafrost microorganisms to climate change and potentially subsequent permafrost thaw.	[Hu, Weigang; Zhang, Qi; Tian, Tian; Li, Dingyao; Cheng, Gang; Mu, Jing; An, Lizhe; Feng, Huyuan] Lanzhou Univ, Minist Educ, Key Lab Cell Activ & Stress Adaptat, Sch Life Sci, Lanzhou 730000, Peoples R China; [Wu, Qingbai; Niu, Fujun] Chinese Acad Sci, SKLFSE, CAREERI, Lanzhou, Peoples R China; [Stegen, James C.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA	Lanzhou University; Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Wu, QB (corresponding author), Chinese Acad Sci, SKLFSE, CAREERI, Lanzhou, Peoples R China.	qbwu@lzb.ac.cn; fenghy@lzu.edu.cn	Stegen, James/Q-3078-2016; Hu, Weigang/CAH-3530-2022; Yang, Xiaoming/GRJ-9483-2022	Stegen, James/0000-0001-9135-7424; Hu, Weigang/0000-0003-1422-3726; Yang, Xiaoming/0000-0002-1792-6921	National Basic Research Program [2012CB026105]; National Natural Science Foundation [31170482, 31300445, 31370450]; PhD Programs Foundation of Ministry of Education [20130211120005]; Chinese Postdoctoral Science Foundation [2013M540780, 2014T70949]; Fundamental Research Funds for the Central Universities in China [LZUJBKY-2011-119]; State Key Laboratory of Frozen Soil Engineering, Chinese Academy of Sciences [SKLFSE200901]	National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); PhD Programs Foundation of Ministry of Education; Chinese Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Fundamental Research Funds for the Central Universities in China; State Key Laboratory of Frozen Soil Engineering, Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was supported by funding from the National Basic Research Program (2012CB026105), National Natural Science Foundation (31170482, 31300445, 31370450), PhD Programs Foundation of Ministry of Education (20130211120005), the Chinese Postdoctoral Science Foundation (2013M540780, 2014T70949), Fundamental Research Funds for the Central Universities in China (LZUJBKY-2011-119) and State Key Laboratory of Frozen Soil Engineering, Chinese Academy of Sciences (SKLFSE200901).	Amaral-Zettler LA, 2011, ISME J, V5, P42, DOI 10.1038/ismej.2010.101; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Barberan Albert, 2014, Front Microbiol, V5, P203, DOI 10.3389/fmicb.2014.00203; Blaalid R, 2014, MOL ECOL, V23, P649, DOI 10.1111/mec.12622; Bryant JA, 2008, P NATL ACAD SCI USA, V105, P11505, DOI 10.1073/pnas.0801920105; Caruso T, 2011, ISME J, V5, P1406, DOI 10.1038/ismej.2011.21; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Chu HY, 2010, ENVIRON MICROBIOL, V12, P2998, DOI 10.1111/j.1462-2920.2010.02277.x; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Coolen MJL, 2011, ENVIRON MICROBIOL, V13, P2299, DOI 10.1111/j.1462-2920.2011.02489.x; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; Cowan DA, 2010, POLAR MICROBIOLOGY: THE ECOLOGY, BIODIVERSITY AND BIOREMEDIATION POTENTIAL OF MICROORGANISMS IN EXTREMELY COLD ENVIRONMENTS, P1; Dumbrell AJ, 2010, ISME J, V4, P337, DOI 10.1038/ismej.2009.122; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fox J., R COMPANION APPL REG, V3; Gilbert B, 2004, P NATL ACAD SCI USA, V101, P7651, DOI 10.1073/pnas.0400814101; Gilichinsky DA, 2007, ASTROBIOLOGY, V7, P275, DOI 10.1089/ast.2006.0012; Gilichinsky DA, 2002, ENCY ENV MICROBIOLOG, P2367, DOI DOI 10.1128/JB.00395-07; Graham CH, 2008, ECOL LETT, V11, P1265, DOI 10.1111/j.1461-0248.2008.01256.x; Green J, 2006, TRENDS ECOL EVOL, V21, P501, DOI 10.1016/j.tree.2006.06.012; Hanson CA, 2012, NAT REV MICROBIOL, V10, P497, DOI 10.1038/nrmicro2795; Helmus MR, 2010, ECOL LETT, V13, P162, DOI 10.1111/j.1461-0248.2009.01411.x; Horner-Devine MC, 2006, ECOLOGY, V87, pS100, DOI 10.1890/0012-9658(2006)87[100:PCAOIB]2.0.CO;2; Horner-Devine MC, 2004, NATURE, V432, P750, DOI 10.1038/nature03073; Hu WG, 2015, EXTREMOPHILES, V19, P693, DOI 10.1007/s00792-015-0749-y; Hu WG, 2014, J BASIC MICROB, V54, P1331, DOI 10.1002/jobm.201400232; Hubbell SP, 2004, ECOLOGY, V85, P3175, DOI 10.1890/04-0808; Hultman J, 2015, NATURE, V521, P208, DOI 10.1038/nature14238; Jansson JK, 2014, NAT REV MICROBIOL, V12, P414, DOI 10.1038/nrmicro3262; Johnson SS, 2007, P NATL ACAD SCI USA, V104, P14401, DOI 10.1073/pnas.0706787104; Jungblut AD, 2010, ISME J, V4, P191, DOI 10.1038/ismej.2009.113; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kim HM, 2014, FEMS MICROBIOL ECOL, V89, P465, DOI 10.1111/1574-6941.12362; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Koyama A, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00516; Kraft NJB, 2015, FUNCT ECOL, V29, P592, DOI 10.1111/1365-2435.12345; Kubota Y, 2011, J BIOGEOGR, V38, P1006, DOI 10.1111/j.1365-2699.2011.02491.x; Legendre P, 2005, ECOL MONOGR, V75, P435, DOI 10.1890/05-0549; Legendre Pierre, 2007, Zhiwu Shengtai Xuebao, V31, P976; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Mackelprang R, 2011, NATURE, V480, P368, DOI 10.1038/nature10576; Margesin R, 2011, RES MICROBIOL, V162, P346, DOI 10.1016/j.resmic.2010.12.004; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Martiny JBH, 2011, P NATL ACAD SCI USA, V108, P7850, DOI 10.1073/pnas.1016308108; Mattimore V, 1996, J BACTERIOL, V178, P633, DOI 10.1128/jb.178.3.633-637.1996; McCalley CK, 2014, NATURE, V514, P478, DOI 10.1038/nature13798; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI 10.1093/bioinformatics/btp666; Oksanen J., MULTIVARIATE ANAL EC; Ozerskaya Svetlana, 2009, V16, P85; Pommier T, 2012, BIOL LETTERS, V8, P562, DOI 10.1098/rsbl.2011.0990; Ren LJ, 2015, APPL ENVIRON MICROB, V81, P3104, DOI 10.1128/AEM.04042-14; Rominger AJ, 2009, OECOLOGIA, V161, P791, DOI 10.1007/s00442-009-1420-z; Sawicka JE, 2010, ISME J, V4, P585, DOI 10.1038/ismej.2009.140; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schuur EAG, 2015, NATURE, V520, P171, DOI 10.1038/nature14338; Schuur EAG, 2009, NATURE, V459, P556, DOI 10.1038/nature08031; Shen CC, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00582; Smith TW, 2010, ECOGRAPHY, V33, P648, DOI 10.1111/j.1600-0587.2009.06105.x; Soininen J, 2007, ECOGRAPHY, V30, P3, DOI 10.1111/j.2006.0906-7590.04817.x; Stegen JC, 2012, ISME J, V6, P1653, DOI 10.1038/ismej.2012.22; Stegen JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020906; Steven B, 2008, ENVIRON MICROBIOL, V10, P3388, DOI 10.1111/j.1462-2920.2008.01746.x; Steven B, 2006, EXTREMOPHILES, V10, P259, DOI 10.1007/s00792-006-0506-3; Steven Blaire, 2009, V16, P59; Stomeo F, 2012, FEMS MICROBIOL ECOL, V82, P326, DOI 10.1111/j.1574-6941.2012.01360.x; Swenson NG, 2012, ECOLOGY, V93, pS112, DOI 10.1890/11-0402.1; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tuomisto H, 2006, ECOLOGY, V87, P2697, DOI 10.1890/0012-9658(2006)87[2697:AOEBDU]2.0.CO;2; WANG BL, 1995, QUATERNARY SCI REV, V14, P255, DOI 10.1016/0277-3791(95)00006-B; Wang JJ, 2008, ENVIRON MICROBIOL, V10, P2537, DOI 10.1111/j.1462-2920.2008.01678.x; Wang JJ, 2013, ISME J, V7, P1310, DOI 10.1038/ismej.2013.30; Wang JJ, 2012, ENV MICROBIOL REP, V4, P217, DOI 10.1111/j.1758-2229.2011.00324.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Yang DQ, 2008, CAN J MICROBIOL, V54, P270, DOI [10.1139/W08-004, 10.1139/w08-004]; Yang Sienhung, 2012, Evid Based Complement Alternat Med, V2012, P521780, DOI 10.1155/2012/521780; Yergeau E, 2010, ISME J, V4, P1206, DOI 10.1038/ismej.2010.41; Yun JL, 2014, MICROB ECOL, V68, P360, DOI 10.1007/s00248-014-0415-4; Zhang XF, 2013, J APPL MICROBIOL, V114, P1054, DOI 10.1111/jam.12106	79	26	27	11	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145747	10.1371/journal.pone.0145747	http://dx.doi.org/10.1371/journal.pone.0145747			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26699734	Green Submitted, Green Published, gold			2022-12-26	WOS:000367092600128
J	Snell, N; Kattner, F; Rokers, B; Green, CS				Snell, Nathaniel; Kattner, Florian; Rokers, Bas; Green, C. Shawn			Orientation Transfer in Vernier and Stereoacuity Training	PLOS ONE			English	Article							SPECIFICITY; PRECISION	Human performance on various visual tasks can be improved substantially via training. However, the enhancements are frequently specific to relatively low-level stimulus dimensions. While such specificity has often been thought to be indicative of a low-level neural locus of learning, recent research suggests that these same effects can be accounted for by changes in higher-level areas-in particular in the way higher-level areas read out information from lower-level areas in the service of highly practiced decisions. Here we contrast the degree of orientation transfer seen after training on two different tasks-vernier acuity and stereoacuity. Importantly, while the decision rule that could improve vernier acuity (i.e. a discriminant in the image plane) would not be transferable across orientations, the simplest rule that could be learned to solve the stereoacuity task (i.e. a discriminant in the depth plane) would be insensitive to changes in orientation. Thus, given a read-out hypothesis, more substantial transfer would be expected as a result of stereoacuity than vernier acuity training. To test this prediction, participants were trained (7500 total trials) on either a stereoacuity (N = 9) or vernier acuity (N = 7) task with the stimuli in either a vertical or horizontal configuration (balanced across participants). Following training, transfer to the untrained orientation was assessed. As predicted, evidence for relatively orientation specific learning was observed in vernier trained participants, while no evidence of specificity was observed in stereo trained participants. These results build upon the emerging view that perceptual learning (even very specific learning effects) may reflect changes in inferences made by high-level areas, rather than necessarily fully reflecting changes in the receptive field properties of low-level areas.	[Snell, Nathaniel; Kattner, Florian; Rokers, Bas; Green, C. Shawn] Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA; [Snell, Nathaniel] Brown Univ, Dept Neurosci, Providence, RI 02912 USA	University of Wisconsin System; University of Wisconsin Madison; Brown University	Green, CS (corresponding author), Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA.	csgreen2@wisc.edu	Kattner, Florian/H-8671-2019	Kattner, Florian/0000-0003-2124-2829; Snell, Nathaniel/0000-0002-8033-366X; Rokers, Bas/0000-0003-0573-5332				Ahissar M, 1997, NATURE, V387, P401, DOI 10.1038/387401a0; Ahissar M, 2009, PHILOS T R SOC B, V364, P285, DOI 10.1098/rstb.2008.0253; BALL K, 1982, SCIENCE, V218, P697, DOI 10.1126/science.7134968; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Dosher BA, 1998, P NATL ACAD SCI USA, V95, P13988, DOI 10.1073/pnas.95.23.13988; FAHLE M, 1995, VISION RES, V35, P3003, DOI 10.1016/0042-6989(95)00044-Z; FIORENTINI A, 1980, NATURE, V287, P43, DOI 10.1038/287043a0; Green CS, 2015, J VISION, V15, DOI 10.1167/15.10.5; Jeter PE, 2009, J VISION, V9, DOI 10.1167/9.3.1; Kahnt T, 2011, NEURON, V70, P549, DOI 10.1016/j.neuron.2011.02.054; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; Kleiner M, 2007, PERCEPTION, V36, P14; Law CT, 2008, NAT NEUROSCI, V11, P505, DOI 10.1038/nn2070; Law CT, 2009, NAT NEUROSCI, V12, P655, DOI 10.1038/nn.2304; Li S, 2009, NEURON, V62, P441, DOI 10.1016/j.neuron.2009.03.016; MCKEE SP, 1987, J OPT SOC AM A, V4, P1104, DOI 10.1364/JOSAA.4.001104; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; POGGIO T, 1992, SCIENCE, V256, P1018, DOI 10.1126/science.1589770; Saffell T, 2003, VISION RES, V43, P1365, DOI 10.1016/S0042-6989(03)00137-8; SAGI D, 1994, CURR OPIN NEUROBIOL, V4, P195, DOI 10.1016/0959-4388(94)90072-8; Sagi D, 2011, VISION RES, V51, P1552, DOI 10.1016/j.visres.2010.10.019; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; WESTHEIMER G, 1990, P ROY SOC B-BIOL SCI, V241, P42, DOI 10.1098/rspb.1990.0063; Xiao LQ, 2008, CURR BIOL, V18, P1922, DOI 10.1016/j.cub.2008.10.030; Zhang E, 2010, P NATL ACAD SCI USA, V107, P15969, DOI 10.1073/pnas.1003547107; Zhang JY, 2010, J NEUROSCI, V30, P12323, DOI 10.1523/JNEUROSCI.0704-10.2010; Zhang T, 2010, VISION RES, V50, P368, DOI 10.1016/j.visres.2009.08.024	27	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145770	10.1371/journal.pone.0145770	http://dx.doi.org/10.1371/journal.pone.0145770			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700311	Green Submitted, Green Published, gold			2022-12-26	WOS:000367092600132
J	Wang, XC; Blanchard, J; Grundke-Iqbal, I; Iqbal, K				Wang, Xiaochuan; Blanchard, Julie; Grundke-Iqbal, Inge; Iqbal, Khalid			Memantine Attenuates Alzheimer's Disease-Like Pathology and Cognitive Impairment	PLOS ONE			English	Article							PROTEIN PHOSPHATASE 2A; GLYCOGEN-SYNTHASE KINASE-3-BETA; PAIRED HELICAL FILAMENTS; TAU-PHOSPHORYLATION; NEUROBLASTOMA-CELLS; SYNAPTIC PLASTICITY; TRANSGENIC MICE; NMDA RECEPTORS; UP-REGULATION; BETA PEPTIDE	Deficiency of protein phosphatase-2A is a key event in Alzheimer's disease. An endogenous inhibitor of protein phosphatase-2A, inhibitor-1, I-1(PP2A), which inhibits the phosphatase activity by interacting with its catalytic subunit protein phosphatase-2Ac, is known to be upregulated in Alzheimer's disease brain. In the present study, we overexpressed I-1(PP2A) by intracerebroventricular injection with adeno-associated virus vector-1-I-1(PP2A) in Wistar rats. The I-1(PP2A) rats showed a decrease in brain protein phosphatase-2A activity, abnormal hyperphosphorylation of tau, neurodegeneration, an increase in the level of activated glycogen synthase kinase-3beta, enhanced expression of intraneuronal amyloid-beta and spatial reference memory deficit; littermates treated identically but with vector only, i.e., adenoassociated virus vector-1-enhanced GFP, served as a control. Treatment with memantine, a noncompetitive NMDA receptor antagonist which is an approved drug for treatment of Alzheimer's disease, rescued protein phosphatase-2A activity by decreasing its demethylation at Leu309 selectively and attenuated Alzheimer's disease-like pathology and cognitive impairment in adeno-associated virus vector-1-I-1(PP2A) rats. These findings provide new clues into the possible mechanism of the beneficial therapeutic effect of memantine in Alzheimer's disease patients.	[Wang, Xiaochuan; Blanchard, Julie; Grundke-Iqbal, Inge; Iqbal, Khalid] New York State Inst Basic Res Dev Disabil, Dept Neurochem, Staten Isl, NY 10314 USA; [Wang, Xiaochuan] Huazhong Univ Sci & Technol, Dept Pathophysiol, Key Lab Neurol Dis, Natl Educ Minist,Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China	Institute for Basic Research in Developmental Disabilities; Huazhong University of Science & Technology	Iqbal, K (corresponding author), New York State Inst Basic Res Dev Disabil, Dept Neurochem, Inge Grundke Iqbal Res Floor, Staten Isl, NY 10314 USA.	khalid.iqbal.ibr@gmail.com			National Institutes of Health [AG019158, TW008744]; FOGARTY INTERNATIONAL CENTER [R03TW008744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019158] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding for this work came from AG019158, National Institutes of Health, www.nih.gov; and TW008744, National Institutes of Health, www.nih.gov.	Alley GM, 2010, J NEUROSCI RES, V88, P143, DOI 10.1002/jnr.22172; An WL, 2003, AM J PATHOL, V163, P591, DOI 10.1016/S0002-9440(10)63687-5; Bennecib M, 2000, ALZHEIMERS REP, V3, P295; Bennecib M, 2001, FEBS LETT, V490, P15, DOI 10.1016/S0014-5793(01)02127-5; Bolognin S, 2012, ACTA NEUROPATHOL, V123, P133, DOI 10.1007/s00401-011-0908-x; Bozon B, 2003, NEURON, V40, P695, DOI 10.1016/S0896-6273(03)00674-3; Chen S, 2008, J BIOL CHEM, V283, P10513, DOI 10.1074/jbc.M709852200; Cheng LY, 2000, NEUROCHEM RES, V25, P107, DOI 10.1023/A:1007547701518; Chohan MO, 2006, FEBS LETT, V580, P3973, DOI 10.1016/j.febslet.2006.06.021; Farokhnia M, 2014, HUM PSYCHOPHARM CLIN, V29, P351, DOI 10.1002/hup.2412; Floden AM, 2005, J NEUROSCI, V25, P2566, DOI 10.1523/JNEUROSCI.4998-04.2005; Gantier R, 2000, NEUROSCI LETT, V283, P217, DOI 10.1016/S0304-3940(00)00949-6; Gong CX, 2000, J BIOL CHEM, V275, P5535, DOI 10.1074/jbc.275.8.5535; GONG CX, 1995, J NEUROCHEM, V65, P732, DOI 10.1046/j.1471-4159.1995.65020732.x; GONG CX, 1993, J NEUROCHEM, V61, P921, DOI 10.1111/j.1471-4159.1993.tb03603.x; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; GRUNDKEIQBAL I, 1988, MOL BRAIN RES, V4, P43, DOI 10.1016/0169-328X(88)90017-4; Guzowski JF, 1997, P NATL ACAD SCI USA, V94, P2693, DOI 10.1073/pnas.94.6.2693; HAGIWARA M, 1992, CELL, V70, P105, DOI 10.1016/0092-8674(92)90537-M; Harkany T, 2000, EUR J NEUROSCI, V12, P2735, DOI 10.1046/j.1460-9568.2000.00164.x; HASEGAWA M, 1993, J NEUROCHEM, V60, P2068, DOI 10.1111/j.1471-4159.1993.tb03491.x; Henckaerts E, 2009, P NATL ACAD SCI USA, V106, P7571, DOI 10.1073/pnas.0806821106; Hernandez F, 2010, MOL CELL BIOCHEM, V344, P211, DOI 10.1007/s11010-010-0544-0; Ho L, 2004, FASEB J, V18, P902, DOI 10.1096/fj.03-0978fje; Iqbal K, 2010, ALZHEIMERS DEMENT, V6, P420, DOI 10.1016/j.jalz.2010.04.006; Katayose Y, 2000, J BIOL CHEM, V275, P9209, DOI 10.1074/jbc.275.13.9209; Kins S, 2003, AM J PATHOL, V163, P833, DOI 10.1016/S0002-9440(10)63444-X; Korenov M, 2009, J NEUROSCI METH, V177, P108, DOI 10.1016/j.jneumeth.2008.09.027; Kwiecien RA, 2011, ARCH BIOCHEM BIOPHYS, V510, P35, DOI 10.1016/j.abb.2011.03.007; Li M, 1996, BIOCHEMISTRY-US, V35, P6998, DOI 10.1021/bi960581y; LI M, 1995, BIOCHEMISTRY-US, V34, P1988, DOI 10.1021/bi00006a020; Liang L, 2004, FEBS LETT, V566, P261, DOI 10.1016/j.febslet.2004.04.047; Liu F, 2005, EUR J NEUROSCI, V22, P1942, DOI 10.1111/j.1460-9568.2005.04391.x; Lupp A, 2003, EXP TOXICOL PATHOL, V54, P441, DOI 10.1078/0940-2993-00280; Matilla A, 2005, CEREBELLUM, V4, P7, DOI 10.1080/14734220410019020; Mattson MP, 2003, CELL CALCIUM, V34, P385, DOI 10.1016/S0143-4160(03)00128-3; Miguel-Hidalgo JJ, 2002, BRAIN RES, V958, P210, DOI 10.1016/S0006-8993(02)03731-9; Morris RGM, 2003, PHILOS T R SOC B, V358, P773, DOI 10.1098/rstb.2002.1264; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Mount C, 2006, NAT MED, V12, P780, DOI 10.1038/nm0706-780; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; Parsons CG, 1999, NEUROPHARMACOLOGY, V38, P735, DOI 10.1016/S0028-3908(99)00019-2; Pei JJ, 1999, J NEUROPATH EXP NEUR, V58, P1010, DOI 10.1097/00005072-199909000-00011; Planel E, 2001, J BIOL CHEM, V276, P34298, DOI 10.1074/jbc.M102780200; Qian W, 2010, J ALZHEIMERS DIS, V19, P1221, DOI [10.3233/JAD-2009-1317, 10.3233/JAD-2010-1317]; Ray B, 2010, NEUROSCI LETT, V470, P1, DOI 10.1016/j.neulet.2009.11.016; Schmitt F, 2007, EXPERT OPIN DRUG MET, V3, P135, DOI 10.1517/17425255.3.1.135; SEUBERT P, 1995, J BIOL CHEM, V270, P18917, DOI 10.1074/jbc.270.32.18917; Song MS, 2008, EUR J NEUROSCI, V28, P1989, DOI 10.1111/j.1460-9568.2008.06498.x; Sonkusare SK, 2005, PHARMACOL RES, V51, P1, DOI 10.1016/j.phrs.2004.05.005; Szatmari E, 2005, J BIOL CHEM, V280, P37526, DOI 10.1074/jbc.M502699200; Tanaka T, 1998, FEBS LETT, V426, P248, DOI 10.1016/S0014-5793(98)00346-9; Tanimukai H, 2005, AM J PATHOL, V166, P1761, DOI 10.1016/S0002-9440(10)62486-8; Tremblay R, 2000, J NEUROSCI, V20, P7183; Tsujio I, 2005, FEBS LETT, V579, P363, DOI 10.1016/j.febslet.2004.11.097; Tu SC, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-48; Wang XC, 2010, FASEB J, V24, P4420, DOI 10.1096/fj.10-158477; Wang YX, 2015, NEUROBIOL AGING, V36, P188, DOI 10.1016/j.neurobiolaging.2014.07.035; WONG CW, 1985, P NATL ACAD SCI USA, V82, P8729, DOI 10.1073/pnas.82.24.8729; Zadori D, 2014, J ALZHEIMERS DIS, V42, pS177, DOI 10.3233/JAD-132621; Zhou XW, 2008, NEUROBIOL DIS, V31, P386, DOI 10.1016/j.nbd.2008.05.013; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7	63	11	13	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145441	10.1371/journal.pone.0145441	http://dx.doi.org/10.1371/journal.pone.0145441			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26697860	Green Submitted, gold, Green Published			2022-12-26	WOS:000367092600080
J	Ishibashi, R; Kozuki, S; Kamakura, S; Sumimoto, H; Toyoshima, F				Ishibashi, Riki; Kozuki, Satoshi; Kamakura, Sachiko; Sumimoto, Hideki; Toyoshima, Fumiko			c-Rel Regulates Inscuteable Gene Expression during Mouse Embryonic Stem Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell differentiation; cell division; embryonic stem cell; gene transcription; promoter	NF-KAPPA-B; RNA-POLYMERASE-II; DROSOPHILA ASYMMETRIC DIVISIONS; CENTRAL-NERVOUS-SYSTEM; GANGLION MOTHER CELLS; SPINDLE ORIENTATION; SELF-RENEWAL; TRANSCRIPTION FACTOR; ES CELLS; MAINTAINS PLURIPOTENCY	Inscuteable (Insc) regulates cell fate decisions in several types of stem cells. Although it is recognized that the expression levels of mouse INSC govern the balance between symmetric and asymmetric stem cell division, regulation of mouse Insc gene expression remains poorly understood. Here, we showed that mouse Insc expression transiently increases at an early stage of differentiation, when mouse embryonic stem (mES) cells differentiate into bipotent mesendoderm capable of producing both endoderm and mesoderm in defined culture conditions. We identified the minimum transcriptional regulatory element (354 bases) that drives mouse Insc transcription in mES cells within a region >5 kb upstream of the mouse Insc transcription start site. We found that the transcription factor reticuloendotheliosis oncogene (c-Rel) bound to the minimum element and promoted mouse Insc expression in mES cells. In addition, short interfering RNA-mediated knockdown of either mouse INSC or c-Rel protein decreased mesodermal cell populations without affecting differentiation into the mesendoderm or endoderm. Furthermore, overexpression of mouse INSC rescued the mesoderm-reduced phenotype induced by knockdown of c-Rel. We propose that regulation of mouse Insc expression by c-Rel modulates cell fate decisions during mES cell differentiation.	[Ishibashi, Riki; Kozuki, Satoshi; Toyoshima, Fumiko] Kyoto Univ, Inst Virus Res, Dept Cell Biol, Sakyo Ku, Kyoto 6068507, Japan; [Ishibashi, Riki; Kozuki, Satoshi; Toyoshima, Fumiko] Kyoto Univ, Dept Mammalian Regulatory Networks, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan; [Kamakura, Sachiko; Sumimoto, Hideki] Kyushu Univ, Dept Biochem, Grad Sch Med Sci, Fukuoka 8128582, Japan	Kyoto University; Kyoto University; Kyushu University	Toyoshima, F (corresponding author), Kyoto Univ, Inst Virus Res, Dept Cell Biol, Sakyo Ku, Kyoto 6068507, Japan.	ftoyoshi@virus.kyoto-u.ac.jp		Toyoshima, Fumiko/0000-0002-3698-0034	Funding Program for Next Generation World-Leading Researchers [LS069]; Naito Foundation; Platform Project for Dynamic Approaches to Living System from the Japan Agency for Medical Research and Development	Funding Program for Next Generation World-Leading Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Naito Foundation(Naito Memorial Foundation); Platform Project for Dynamic Approaches to Living System from the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This work was supported by grants from the Funding Program for Next Generation World-Leading Researchers (Grant LS069 to F. T.), the Naito Foundation (to F. T.), and the Platform Project for Dynamic Approaches to Living System from the Japan Agency for Medical Research and Development (to A. M. E. D.). The authors declare that they have no conflicts of interest with the contents of this article.	ANG SL, 1993, DEVELOPMENT, V119, P1301; Ballard MS, 2015, CELL REP, V13, P290, DOI 10.1016/j.celrep.2015.09.006; Bello B, 2006, DEVELOPMENT, V133, P2639, DOI 10.1242/dev.02429; Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038; Buescher M, 1998, GENE DEV, V12, P1858, DOI 10.1101/gad.12.12.1858; Chen GB, 2011, J IMMUNOL, V187, P4483, DOI 10.4049/jimmunol.1101757; DOE CQ, 1991, CELL, V65, P451, DOI 10.1016/0092-8674(91)90463-9; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Era T, 2008, STEM CELLS, V26, P401, DOI 10.1634/stemcells.2006-0809; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fullard N, 2013, AM J PATHOL, V182, P2109, DOI 10.1016/j.ajpath.2013.02.016; Gilmore Thomas D, 2011, Genes Cancer, V2, P695, DOI 10.1177/1947601911421925; Habib SJ, 2013, SCIENCE, V339, P1445, DOI 10.1126/science.1231077; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hilliard BA, 2002, J CLIN INVEST, V110, P843, DOI 10.1172/JCI200215254; HIRATA J, 1995, NATURE, V377, P627, DOI 10.1038/377627a0; IkeshimaKataoka H, 1997, NATURE, V390, P625, DOI 10.1038/37641; Isomura I, 2009, J EXP MED, V206, P3001, DOI 10.1084/jem.20091411; Izumi N, 2007, STEM CELLS, V25, P1664, DOI 10.1634/stemcells.2006-0681; Kamakura S, 2013, DEV CELL, V26, P292, DOI 10.1016/j.devcel.2013.06.008; Kanai-Azuma M, 2002, DEVELOPMENT, V129, P2367; Kataoka H, 1997, DEV GROWTH DIFFER, V39, P729; Kim YE, 2008, BMB REP, V41, P705, DOI 10.5483/BMBRep.2008.41.10.705; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; Knoblich JA, 1997, CURR OPIN CELL BIOL, V9, P833, DOI 10.1016/S0955-0674(97)80085-3; Kobori M, 2004, CELL DEATH DIFFER, V11, P123, DOI 10.1038/sj.cdd.4401325; Kraut R, 1996, NATURE, V383, P50, DOI 10.1038/383050a0; Kraut R, 1996, DEV BIOL, V174, P65, DOI 10.1006/dbio.1996.0052; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Lee CY, 2006, DEV CELL, V10, P441, DOI 10.1016/j.devcel.2006.01.017; Li P, 1997, CELL, V90, P437, DOI 10.1016/S0092-8674(00)80504-8; Liou HC, 2003, BIOESSAYS, V25, P767, DOI 10.1002/bies.10306; Lu BW, 2000, ANNU REV NEUROSCI, V23, P531, DOI 10.1146/annurev.neuro.23.1.531; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; MATSUZAKI F, 1992, BIOCHEM BIOPH RES CO, V182, P1326, DOI 10.1016/0006-291X(92)91878-T; NAKAJIMA N, 1988, MOL CELL BIOL, V8, P4028, DOI 10.1128/MCB.8.10.4028; Neumuller RA, 2009, GENE DEV, V23, P2675, DOI 10.1101/gad.1850809; Nishikawa SI, 2007, NAT REV MOL CELL BIO, V8, P502, DOI 10.1038/nrm2189; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; PARKER CS, 1984, CELL, V36, P357, DOI 10.1016/0092-8674(84)90229-0; Parmentier ML, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-14-j0003.2000; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Postiglione MP, 2011, NEURON, V72, P269, DOI 10.1016/j.neuron.2011.09.022; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; SCHOLER HR, 1989, EMBO J, V8, P2551, DOI 10.1002/j.1460-2075.1989.tb08393.x; Shen CP, 1997, CELL, V90, P449, DOI 10.1016/S0092-8674(00)80505-X; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; Skeath JB, 1998, DEVELOPMENT, V125, P1857; SPANA EP, 1995, DEVELOPMENT, V121, P3187; SPANA EP, 1995, DEVELOPMENT, V121, P3489; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Tam PPL, 2003, CURR OPIN GENET DEV, V13, P393, DOI 10.1016/S0959-437X(03)00085-6; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Torres J, 2008, NAT CELL BIOL, V10, P194, DOI 10.1038/ncb1680; UEMURA T, 1989, CELL, V58, P349, DOI 10.1016/0092-8674(89)90849-0; VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8; van den Ameele J, 2012, EMBO REP, V13, P355, DOI 10.1038/embor.2012.23; Wang C, 2011, DEV CELL, V21, P520, DOI 10.1016/j.devcel.2011.08.002; WEIS L, 1992, FASEB J, V6, P3300, DOI 10.1096/fasebj.6.14.1426767; Williams SE, 2014, NAT CELL BIOL, V16, P758, DOI 10.1038/ncb3001; Williams SE, 2011, NATURE, V470, P353, DOI 10.1038/nature09793; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167; Young KM, 2006, J NEUROSCI RES, V83, P39, DOI 10.1002/jnr.20702; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5; Zigman M, 2005, NEURON, V48, P539, DOI 10.1016/j.neuron.2005.09.030	67	3	3	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3333	3345		10.1074/jbc.M115.679563	http://dx.doi.org/10.1074/jbc.M115.679563			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26694615	hybrid, Green Published			2022-12-26	WOS:000370854500018
J	Basu, S; Proweller, A				Basu, Sanchita; Proweller, Aaron			Autoregulatory Control of Smooth Muscle Myosin Light Chain Kinase Promoter by Notch Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; GENE-EXPRESSION; CELL DIFFERENTIATION; MASTER REGULATOR; GROWTH-FACTOR; ALPHA-ACTIN; SRF BINDING; CARG BOX; MYOCARDIN; TRANSCRIPTION	Smooth muscle myosin light chain kinase (SM-MLCK) is the key enzyme responsible for phosphorylation of regulatory myosin light chain (MLC20), resulting in actin-myosin cross-bridging and force generation in vascular smooth muscle required for physiological vasoreactivity and blood pressure control. In this study, we investigated the combinatorial role of myocardin/serum response factor (SRF) and Notch signaling in the transcriptional regulation of MLCK gene expression. Promoter reporter analyses in rat A10 smooth muscle cells revealed a bimodal pattern of MLCK promoter activity and gene expression upon stimulation with constitutively active Notch1 in presence of myocardin or by Jagged1 ligand stimulation. An initial Notch1-induced increase in MLCK transcription was followed by loss in promoter sensitivity, which could be restored with further Notch1 dose escalation. Real-time PCR analyses revealed that endogenous levels of Hairy Related Transcription (HRT) factor 2 (HRT2) peaked concurrently with inhibitory concentrations of Notch1. Forced expression of HRT2 demonstrated simultaneous repression of both myocardin-and Notch1-induced MLCK promoter activity. HRT2-mediated repression was further confirmed by HRT2 truncations and siHRT2 treatments that rescued MLCK promoter activity and gene expression. Chromatin immunoprecipitation studies revealed both Jagged1 ligand-and Notch1-enhanced myocardin/SRF complex formation at the promoter CArG element. In contrast, heightened levels of HRT2 concomitantly disrupted myocardin/SRF and Notch transcription complex formation at respective CArG and CSL binding elements. Taken together, SM-MLCK promoter activity appears highly sensitive to the relative levels of Notch1 signaling, HRT2, and myocardin. These findings identify a novel Notch-dependent HRT2 autoregulatory circuit coordinating transcriptional regulation of SM-MLCK.	Case Western Reserve Univ, Dept Med, Case Cardiovasc Res Inst, Cleveland, OH 44122 USA; Case Western Reserve Univ, Univ Hosp Harrington Heart & Vasc Inst, Cleveland, OH 44122 USA	Case Western Reserve University; Case Western Reserve University	Proweller, A (corresponding author), Case Western Reserve Univ, Dept Med, 4530 Wolstein Res Bldg,2103 Cornell Rd, Cleveland, OH 44122 USA.	aaron.proweller@case.edu			National Institutes of Health [R01 HL096603]; Dominic Visconsi Research Scholars' Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096603] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dominic Visconsi Research Scholars' Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant R01 HL096603 and the Dominic Visconsi Research Scholars' Fund (to A. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andersson ER, 2011, DEVELOPMENT, V138, P3593, DOI 10.1242/dev.063610; Babu GJ, 2001, NAT CELL BIOL, V3, P1025, DOI 10.1038/ncb1101-1025; Basu S, 2013, J BIOL CHEM, V288, P11191, DOI 10.1074/jbc.M112.442996; Boucher JM, 2011, J BIOL CHEM, V286, P28312, DOI 10.1074/jbc.M111.221945; Chen M, 2013, J BIOL CHEM, V288, P34647, DOI 10.1074/jbc.M113.510362; Doi H, 2005, ARTERIOSCL THROM VAS, V25, P2328, DOI 10.1161/01.ATV.0000185829.47163.32; Doi H, 2006, J BIOL CHEM, V281, P28555, DOI 10.1074/jbc.M602749200; Donovan J, 2002, CURR BIOL, V12, P1605, DOI 10.1016/S0960-9822(02)01149-1; Du KL, 2003, MOL CELL BIOL, V23, P2425, DOI 10.1128/MCB.23.7.2425-2437.2003; Fischer A, 2004, GENE DEV, V18, P901, DOI 10.1101/gad.291004; Gao N, 2013, J BIOL CHEM, V288, P7596, DOI 10.1074/jbc.M112.427112; Gridley T, 2010, CURR TOP DEV BIOL, V92, P277, DOI 10.1016/S0070-2153(10)92009-7; He WQ, 2008, GASTROENTEROLOGY, V135, P610, DOI 10.1053/j.gastro.2008.05.032; Herring BP, 2006, AM J PHYSIOL-CELL PH, V291, pC817, DOI 10.1152/ajpcell.00198.2006; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Iso T, 2001, MOL CELL BIOL, V21, P6080, DOI 10.1128/MCB.21.17.6080-6089.2001; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Krebs LT, 2010, GENESIS, V48, P146, DOI 10.1002/dvg.20599; Kumar MS, 2003, ARTERIOSCL THROM VAS, V23, P737, DOI 10.1161/01.ATV.0000065197.07635.BA; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Li SJ, 2003, P NATL ACAD SCI USA, V100, P9366, DOI 10.1073/pnas.1233635100; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long XC, 2008, ARTERIOSCL THROM VAS, V28, P1505, DOI 10.1161/ATVBAHA.108.166066; McDonald OG, 2006, J CLIN INVEST, V116, P36, DOI 10.1172/JCI26505; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Morano I, 2000, NAT CELL BIOL, V2, P371, DOI 10.1038/35014065; Morrow D, 2005, AM J PHYSIOL-CELL PH, V289, pC1188, DOI 10.1152/ajpcell.00198.2005; Nakagawa O, 2000, P NATL ACAD SCI USA, V97, P13655, DOI 10.1073/pnas.250485597; Noseda M, 2006, CIRC RES, V98, P1468, DOI 10.1161/01.RES.0000229683.81357.26; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Proweller A, 2005, J BIOL CHEM, V280, P8994, DOI 10.1074/jbc.M413316200; Proweller A, 2007, P NATL ACAD SCI USA, V104, P16275, DOI 10.1073/pnas.0707950104; Sakata Y, 2002, P NATL ACAD SCI USA, V99, P16197, DOI 10.1073/pnas.252648999; Takata T, 2003, BIOCHEM BIOPH RES CO, V301, P250, DOI 10.1016/S0006-291X(02)03020-6; Tang YF, 2008, CIRC RES, V102, P661, DOI 10.1161/CIRCRESAHA.107.165134; TREISMAN R, 1994, CURR OPIN GENET DEV, V4, P96, DOI 10.1016/0959-437X(94)90097-3; TUN T, 1994, NUCLEIC ACIDS RES, V22, P965, DOI 10.1093/nar/22.6.965; Wang L, 2010, AM J HUM GENET, V87, P701, DOI 10.1016/j.ajhg.2010.10.006; Wang WL, 2002, J BIOL CHEM, V277, P23165, DOI 10.1074/jbc.M201409200; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Yin F, 2006, AM J PHYSIOL-CELL PH, V290, pC1599, DOI 10.1152/ajpcell.00289.2005; Yoshida T, 2003, CIRC RES, V92, P856, DOI 10.1161/01.RES.0000068405.49081.09; Zhong TP, 2000, SCIENCE, V287, P1820, DOI 10.1126/science.287.5459.1820	43	6	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2988	2999		10.1074/jbc.M115.679803	http://dx.doi.org/10.1074/jbc.M115.679803			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26703474	hybrid, Green Published			2022-12-26	WOS:000369626900035
J	Bouras, G; Burns, EM; Howell, AM; Bottle, A; Athanasiou, T; Darzi, A				Bouras, George; Burns, Elaine Marie; Howell, Ann-Marie; Bottle, Alex; Athanasiou, Thanos; Darzi, Ara			Risk of Post-Discharge Venous Thromboembolism and Associated Mortality in General Surgery: A Population-Based Cohort Study Using Linked Hospital and Primary Care Data in England	PLOS ONE			English	Article							CANCER; IMPACT; COMPLICATIONS; PROPHYLAXIS; DURATION	Background Trends towards day case surgery and enhanced recovery mean that postoperative venous thromboembolism (VTE) may increasingly arise after hospital discharge. However, hospital data alone are unable to capture adverse events that occur outside of the hospital setting. The National Institute for Health and Care Excellence has suggested the use of primary care data to quantify hospital care-related VTE. Data in surgical patients using these resources is lacking. The aim of this study was to measure VTE risk and associated mortality in general surgery using linked primary care and hospital databases, to improve our understanding of harm from VTE that arises beyond hospital stay. Methods This was a longitudinal cohort study using nationally linked primary care (Clinical Practice Research Datalink, CPRD), hospital administrative (Hospital Episodes Statistics, HES), population statistics (Office of National Statistics, ONS) and National Cancer Intelligence Network databases. Routinely collected information was used to quantify 90-day in-hospital VTE, 90-day post-discharge VTE and 90-day mortality in adults undergoing one of twelve general surgical procedures between 1st April 1997 and 31st March 2012. The earliest postoperative recording of deep vein thrombosis or pulmonary embolism in CPRD, HES and ONS was counted in each patient. Covariates from multiple datasets were combined to derive detailed prediction models for VTE and mortality. Limitation included the capture of VTE presenting to healthcare only and the lack of information on adherence to pharmacological thromboprophylaxis as there was no data linkage to hospital pharmacy records. Results There were 981 VTE events captured within 90 days of surgery in 168005 procedures (23.7/1000 patient-years). Overall, primary care data increased the detection of postoperative VTE by a factor of 1.38 (981/710) when compared with using HES and ONS only. Total VTE rates ranged between 3.2/1000 patient-years in haemorrhoidectomy to 118.3/1000 patient-years in esophagogastric resection. Predictors of VTE included emergency surgery (OR = 1.91 95% CI 1.60-2.28, p<0.001), age (OR = 1.02 95% CI 1.02-1.03, p<0.001), body mass index (OR = 1.03 95% CI 1.01-1.04, p<0.001), previous VTE (OR = 8.07 95% CI 6.61-9.83, p<0.001), length of stay (OR = 1.00 95% CI 1.00-1.00, p = 0.007) and cancer stages II (OR = 1.38 95% CI 1.03-1.87, p = 0.033), III (OR = 1.50 95% CI 1.11-2.01, p = 0.008) and IV (OR = 1.63 95% CI 1.03-2.59, p = 0.038). Major organ resections had the greatest odds of VTE when adjusted for other risk factors including length of hospital stay. Post-discharge VTE accounted for 64.8% (636/981) of all recorded VTE. In-hospital VTE (165.4/1000 patient-years) was recorded more frequently than post-discharge VTE (16.2/1000 patient-years). Both in-hospital (OR = 2.07 95% CI 1.51-2.85, p<0.001) and post-discharge (OR = 4.03 95% CI 2.95-5.51, p<0.001) VTE independently predicted 90-day mortality. In patients who died and VTE was recorded on HES or CPRD (n = 56), VTE was one of the causes of death in 37.5% (21/56) of cases. Conclusions A large proportion of postoperative VTE was detected in primary care. Evaluation of linked databases was a useful way of measuring postoperative VTE at population level. These resources identified a significant association between post-discharge VTE and mortality in general surgery.	[Bouras, George; Burns, Elaine Marie; Howell, Ann-Marie; Athanasiou, Thanos; Darzi, Ara] Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Dept Surg & Canc, London W2 1NY, England; [Bottle, Alex] Univ London Imperial Coll Sci Technol & Med, Charing Cross Hosp, Dept Epidemiol & Publ Hlth, London EC4Y 8EN, England	Imperial College London; Imperial College London	Bouras, G (corresponding author), Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Dept Surg & Canc, Praed St, London W2 1NY, England.	g.bouras@imperial.ac.uk	Burns, Elaine/V-5416-2019		Sowerby Foundation; National Institute for Health Research [NF-SI-0510-10186] Funding Source: researchfish	Sowerby Foundation; National Institute for Health Research(National Institute for Health Research (NIHR))	This project was supported by the Sowerby Foundation.	Agnelli G, 2004, CIRCULATION, V110, P4, DOI 10.1161/01.CIR.0000150639.98514.6c; Bergqvist D, 2002, NEW ENGL J MED, V346, P975, DOI 10.1056/NEJMoa012385; Bottle A., UNDERSTANDING HSMRS; Bouras G, 2014, ANN SURG; Burns EM, 2012, J PUBLIC HEALTH-UK, V34, P138, DOI 10.1093/pubmed/fdr054; Chen YT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017876, 10.1371/journal.pone.0021428, 10.1371/journal.pone.0017844, 10.1371/journal.pone.0024144, 10.1371/journal.pone.0027163, 10.1371/journal.pone.0027333]; Darzi A., 2008, HIGH QUALITY CARE AL; Dyer J, 2013, ANN ROY COLL SURG, V95, P65, DOI 10.1308/003588413X13511609956219; Eaton SC, 2008, PHARMACOEPIDEMIOL DR, V17; Gangireddy C, 2007, J VASC SURG, V45, P335, DOI 10.1016/j.jvs.2006.10.034; Huerta C, 2007, ARCH INTERN MED, V167, P935, DOI 10.1001/archinte.167.9.935; Jameson SS, 2010, J BONE JOINT SURG BR, V92B, P123, DOI 10.1302/0301-620X.92B1.22751; Kazaure HS, 2012, ARCH SURG-CHICAGO, V147, P1000, DOI 10.1001/2013.jamasurg.114; Lawrenson R, 2000, BRIT J CLIN PHARMACO, V49, P591, DOI 10.1046/j.1365-2125.2000.00199.x; Lester W, 2013, HEART, V99, P1734, DOI 10.1136/heartjnl-2013-304479; LOWE GDO, 1992, BMJ-BRIT MED J, V305, P567; Majeed Azeem, 2004, Health Stat Q, P5; Merkow RP, 2013, CANCER-AM CANCER SOC, V119, P1412, DOI 10.1002/cncr.27891; Merkow RP, 2011, ANN SURG, V254, P131, DOI 10.1097/SLA.0b013e31821b98da; Muntz J, 2010, AM J SURG, V200, P413, DOI 10.1016/j.amjsurg.2009.05.045; National Institute for Health and Care Excellence, 2010, VEN THROMB DEEP VEIN, V92; Pannucci CJ, 2012, ANN SURG, V255, P1093, DOI 10.1097/SLA.0b013e3182519ccf; Raftery J, 2005, HEALTH TECHNOL ASSES, V9, pIII; Reinke CE, 2012, SURGERY, V152, P186, DOI 10.1016/j.surg.2012.05.003; Seaman HE, 2007, BJU INT, V99, P1398, DOI 10.1111/j.1464-410X.2007.06859.x; Sobin L, 2009, TNM CLASSIFICATION M; Sultan AA, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6099; Sutton PA, 2012, ANN ROY COLL SURG, V94, P481, DOI 10.1308/003588412X13171221592096; Sweetland S, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4583; Tsang C, 2013, BRIT J GEN PRACT, V63, pE534, DOI 10.3399/bjgp13X670660; Vinogradova Y, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004499; Walker AJ, 2014, J THROMB HAEMOST, V12, P641, DOI 10.1111/jth.12533; Walker AJ, 2013, EUR J CANCER, V49, P1404, DOI 10.1016/j.ejca.2012.10.021; White RH, 2003, THROMB HAEMOSTASIS, V90, P446, DOI 10.1160/TH03-03-0152	34	30	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145759	10.1371/journal.pone.0145759	http://dx.doi.org/10.1371/journal.pone.0145759			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713434	Green Published, Green Submitted, gold			2022-12-26	WOS:000367481900077
J	Feng, XW; Zhang, N; Zheng, XG; Pan, DJ				Feng, Xiaowei; Zhang, Nong; Zheng, Xigui; Pan, Dongjiang			Strength Restoration of Cracked Sandstone and Coal under a Uniaxial Compression Test and Correlated Damage Source Location Based on Acoustic Emissions	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; BRITTLE-FRACTURE; ROCK; STRESS; PROPAGATION; VELOCITY; CONCRETE; BEHAVIOR; FAILURE; ENERGY	Underground rock masses have shown a general trend of natural balance over billions of years of ground movement. Nonetheless, man-made underground constructions disturb this balance and cause rock stability failure. Fractured rock masses are frequently encountered in underground constructions, and this study aims to restore the strength of rock masses that have experienced considerable fracturing under uniaxial compression. Coal and sandstone from a deep-buried coal mine were chosen as experimental subjects; they were crushed by uniaxial compression and then carefully restored by a chemical adhesive called MEYCO 364 with an innovative self-made device. Finally, the restored specimens were crushed once again by uniaxial compression. Axial stress, axial strain, circumferential strain, and volumetric strain data for the entire process were fully captured and are discussed here. An acoustic emission (AE) testing system was adopted to cooperate with the uniaxial compression system to provide better definitions for crack closure thresholds, crack initiation thresholds, crack damage thresholds, and three-dimensional damage source locations in intact and restored specimens. Several remarkable findings were obtained. The restoration effects of coal are considerably better than those of sandstone because the strength recovery coefficient of the former is 1.20, whereas that of the latter is 0.33, which indicates that MEYCO 364 is particularly valid for fractured rocks whose initial intact peak stress is less than that of MEYCO 364. Secondary cracked traces of restored sandstone almost follow the cracked traces of the initial intact sandstone, and the final failure is mainly caused by decoupling between the adhesive and the rock mass. However, cracked traces of restored coal only partially follow the traces of intact coal, with the final failure of the restored coal being caused by both bonding interface decoupling and self-breakage in coal. Three-dimensional damage source locations manifest such that AE events are highly correlated with a strength recovery coefficient; the AE events show a decreasing tendency when the coefficient is larger than 1, and vice versa. This study provides a feasible scheme for the reinforcement of fractured rock masses in underground constructions and reveals an internal mechanism of the crushing process for restored rock masses, which has certain instructive significance.	[Feng, Xiaowei; Zhang, Nong; Zheng, Xigui; Pan, Dongjiang] China Univ Min & Technol, Sch Mines, Key Lab Deep Coal Resource Min, Minist Educ, Xuzhou, Peoples R China	China University of Mining & Technology	Zhang, N (corresponding author), China Univ Min & Technol, Sch Mines, Key Lab Deep Coal Resource Min, Minist Educ, Xuzhou, Peoples R China.	zhangnong@126.com	Feng, Xiaowei/P-8126-2019; Pan, Dongjiang/ABD-4747-2021; Feng, Xiaowei/E-7039-2015	Pan, Dongjiang/0000-0003-4308-1210; Feng, Xiaowei/0000-0002-9348-9874; Zhang, Nong/0000-0001-6961-0729	Fundamental Research Funds for the Central Universities [2014XT01]; National Natural Science Foundation of China [51274193]; Program for Changjiang Scholars and Innovative Research Team in University [IRT_14R55]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by The Fundamental Research Funds for the Central Universities (NO. 2014XT01), received by NZ, the role of this funding is to provide financial support for our research in this manuscript, it also has data collection and analysis function. This work was also supported by the National Natural Science Foundation of China (51274193), received by NZ, the role of this funding is to provide financial support for possible publishing fees concerning the research, and it had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Lastly it was supported by the Program for Changjiang Scholars and Innovative Research Team in University (IRT_14R55), received by NZ, this funder provides supporting money for all members who joining the research, like transportation fees, accommodation fees, service fees, and the like, this funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge financial support for this project from the Fundamental Research Funds for the Central Universities (NO. 2014XT01), Project 51274193 supported by National Natural Science Foundation of China, and the Program for Changjiang Scholars and Innovative Research Team in University (IRT_14R55). We also appreciate the assistance and suggestions of Yuxin Zhao, an engineer from the BASF HOCK Mining Chemical Company Ltd. (China), Wanxin Song, a lab assistant from State Key Laboratory of Coal Resources and Safe Mining in China University of Mining and Technology, and Xianyang Yu from the Jiangsu Transportation Institute.	Abioye AV, 2015, INT J MIN SCI TECHNO, V25, P205, DOI 10.1016/j.ijmst.2015.02.007; Backblom G, 1999, TUNN UNDERGR SP TECH, V14, P377, DOI 10.1016/S0886-7798(99)00053-X; Bhasin R, 2002, NORTH AMERICAN TUNNELING 2002, P257; Bieniawski Z.T., 1967, INT J ROCK MECH MIN, V4, P425, DOI [DOI 10.1016/0148-9062(67)90032-0, DOI 10.1016/0148-9062(67)90030-7]; BRIDGMAN PW, 1949, J APPL PHYS, V20, P1241, DOI 10.1063/1.1698316; Cai W, 2014, J APPL GEOPHYS, V109, P140, DOI 10.1016/j.jappgeo.2014.07.021; Eberhardt E, 1998, CAN GEOTECH J, V35, P222, DOI 10.1139/cgj-35-2-222; Fairhurst CE, 1999, INT J ROCK MECH MIN, V36, P281; GERMANOVICH LN, 1994, PURE APPL GEOPHYS, V143, P117, DOI 10.1007/BF00874326; Goel RK, 2014, INT J MIN SCI TECHNO, V24, P783, DOI 10.1016/j.ijmst.2014.10.008; Griffith A.A., 1924, P 1 INT C APPL MECH, P55; HOEK E, 1965, INT J FRACT MECH, V1, P137; Huang BX, 2013, INT J ROCK MECH MIN, V61, P23, DOI 10.1016/j.ijrmms.2013.02.002; Kim JS, 2015, ROCK MECH ROCK ENG, V48, P495, DOI 10.1007/s00603-014-0590-0; Lau J, 1992, UNIAXIAL TRIAXIAL CO; Li LP, 2009, ROCK SOIL MECH, V30, P3642; Liu CY, 2015, MINE WATER ENVIRON, V34, P87, DOI 10.1007/s10230-014-0314-4; LOCKNER DA, 1991, NATURE, V350, P39, DOI 10.1038/350039a0; MARTIN CD, 1994, INT J ROCK MECH MIN, V31, P643, DOI 10.1016/0148-9062(94)90005-1; Michlmayr G, 2012, EARTH-SCI REV, V112, P97, DOI 10.1016/j.earscirev.2012.02.009; Paterson M.S., 2005, EXPT ROCK DEFORMATIO; Peng SS, 2015, INT J MIN SCI TECHNO, V25, P1, DOI 10.1016/j.ijmst.2014.12.006; Ranjith PG, 2008, MECH MATER, V40, P453, DOI 10.1016/j.mechmat.2007.11.002; Siren T, 2015, INT J ROCK MECH MIN, V73, P165, DOI 10.1016/j.ijrmms.2014.11.001; Su HZ, 2012, ULTRASONICS, V52, P890, DOI 10.1016/j.ultras.2012.02.011; Vilhelm J, 2008, INT J ROCK MECH MIN, V45, P1068, DOI 10.1016/j.ijrmms.2007.11.004; Villaescusa E, 2004, GROUND SUPPORT MININ; Wang CL, 2014, INT J ROCK MECH MIN, V71, P171, DOI 10.1016/j.ijrmms.2014.06.009; Wang HC, 2015, J APPL GEOPHYS, V117, P111, DOI 10.1016/j.jappgeo.2015.04.002; Wang SH, 2013, GEOTECH TEST J, V36, P903, DOI 10.1520/GTJ20120086; [王银梅 Wang Yinmei], 2005, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V24, P2554; Wasantha PLP, 2014, ULTRASONICS, V54, P217, DOI 10.1016/j.ultras.2013.06.015; Yan CL, 2015, ARAB J GEOSCI, V8, P2467, DOI 10.1007/s12517-014-1373-3; [于少峰 Yu Shaofeng], 2014, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V33, P2396; Zhao XG, 2013, INT J ROCK MECH MIN, V64, P258, DOI 10.1016/j.ijrmms.2013.09.003; [赵兴东 ZHAO Xingdong], 2008, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V27, P990; Zheng XG, 2015, ARAB J GEOSCI, V8, P6709, DOI 10.1007/s12517-014-1697-z; Zolfaghari A, 2015, INT J ROCK MECH MIN, V74, P38, DOI 10.1016/j.ijrmms.2014.12.004; Zong YJ, 2014, INT J MIN SCI TECHNO, V24, P165, DOI 10.1016/j.ijmst.2014.01.004	39	15	15	1	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145757	10.1371/journal.pone.0145757	http://dx.doi.org/10.1371/journal.pone.0145757			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714324	Green Submitted, gold, Green Published			2022-12-26	WOS:000367481900076
J	Pialoux, G; Marcelin, AG; Despiegel, N; Espinas, C; Cawston, H; Finkielsztejn, L; Laurisse, A; Aubin, C				Pialoux, Gilles; Marcelin, Anne-Genevieve; Despiegel, Nicolas; Espinas, Caroline; Cawston, Helene; Finkielsztejn, Laurent; Laurisse, Audrey; Aubin, Celine			Cost-Effectiveness of Dolutegravir in HIV-1 Treatment-Experienced (TE) Patients in France	PLOS ONE			English	Article							OPTIMIZED BACKGROUND THERAPY; ANTIRETROVIRAL-NAIVE ADULTS; ONCE-DAILY DOLUTEGRAVIR; DOUBLE-BLIND; RALTEGRAVIR; MARAVIROC; EFFICACY; SAFETY	Objectives To evaluate the cost-effectiveness of a new generation integrase inhibitor (INI), dolutegravir (DTG), in France, in treatment-experienced (TE) and INI-naive HIV-infected adults with at least two classes resistance compared to raltegravir (RAL), by adapting previously published Anti-Retroviral Analysis by Monte Carlo Individual Simulation (ARAMIS) model. Methods ARAMIS is a microsimulation Markov model with a lifetime time horizon and a monthly cycle length. Health states are defined as with or without opportunistic infection and death. In the initial cohort, efficacy and safety data were derived from a phase III study comparing DTG to RAL. Antiretroviral treatment algorithms, accounting for patient history, were based on French guidelines and experts opinion. Costs are mainly including treatment costs, routine HIV and opportunistic infection care, and death. Utilities depend on CD4+ cell count and the occurrence of opportunistic infections. Results The ARAMIS model indicates in the TE population that DTG compared to RAL over a life time is associated with 0.35 additional quality-adjusted life years (QALY; 10.75 versus 10.41) and additional costs of (sic)7,266 ((sic)390,001 versus (sic)382,735). DTG increased costs are mainly related to a 9.1-month increase in life expectancy for DTG compared with RAL, and consequently a longer time spent on ART. The incremental cost-effectiveness ratio (ICER) for DTG compared with RAL is (sic)21,048 per QALY gained. About 83% and 14% of total lifetime costs are associated with antiretroviral therapy and routine HIV care respectively. Univariate deterministic sensitivity analyses demonstrate the robustness of the model. Conclusion DTG is cost-effective in the management of TE INI naive patients in France, from a collective perspective. These results could be explained by the superior efficacy of DTG in this population and its higher genetic barrier to resistance compared to RAL. These data need to be confirmed with longer-term real life data.	[Pialoux, Gilles] Hop Tenon, AP HP, Serv Malad Infect & Trop, F-75970 Paris, France; [Marcelin, Anne-Genevieve] Univ Paris 06, INSERM, Sorbonne Univ, Hop Pitie Salpetriere,AP HP,Serv Virol,UMR S 1136, Paris, France; [Despiegel, Nicolas; Espinas, Caroline] Optum, Paris, France; [Cawston, Helene] Mapi Grp, Paris, France; [Finkielsztejn, Laurent; Laurisse, Audrey] ViiV, Marly Le Roi, France; [Aubin, Celine] GSK, Marly Le Roi, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; GlaxoSmithKline	Cawston, H (corresponding author), Mapi Grp, Paris, France.	hcawston@mapigroup.com	Marcelin, Anne-Genevieve/D-8272-2014	Marcelin, Anne-Genevieve/0000-0003-4808-8999	ViiV; GSK; Mapi Group; ViiV Healthcare	ViiV; GSK(GlaxoSmithKline); Mapi Group; ViiV Healthcare	The authors confirm that this study was funded by ViiV. Authors LF and AL are employed by Viiv. Author CA is employed by GSK. Authors ND and CE were employed by Optum (now Mapi Group) during the course of the study and author HC is employed by Mapi Group. Viiv, GSK and Mapi Group (formerly Optum) provided support in the form of salaries for authors LF, AL, CA, ND, CE and HC but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; The study was sponsored and funded by ViiV Healthcare.	[Anonymous], 2014, REMBOURSEMENT CONSUL; [Anonymous], 2013, BAS DONN BDM IND PRI; [Anonymous], 2012, TARIFS CONVENTIONNEL; [Anonymous], 2011, TARIFS CONVENTIONNEL; [Anonymous], 2014, BIOL MED NOMENCLATUR; [Anonymous], 2013, DOLUTEGRAVIR 50MG CO; [Anonymous], 2015, BASE MEDICAMENTS INF; [Anonymous], 2015, PHARM GUID WORLD INT; Cahn P, 2013, LANCET, V382, P700, DOI 10.1016/S0140-6736(13)61221-0; Chaudhary MA, 2011, EXPERT REV PHARM OUT, V11, P627, DOI [10.1586/erp.11.79, 10.1586/ERP.11.79]; Clotet B, 2014, LANCET, V383, P2222, DOI 10.1016/S0140-6736(14)60084-2; Cooper DA, 2008, NEW ENGL J MED, V359, P355, DOI 10.1056/NEJMoa0708978; Costagliola D, 2012, LANCET INFECT DIS, V12, P119, DOI 10.1016/S1473-3099(11)70248-1; Despiegel N, ASSESSMENT REAL LIFE; Eron JJ, 2012, 19 INT AIDS C; European Medicines Agency ( EMA), 2013, EPAR SUMM PUBL TIV; Gulick RM, 2008, NEW ENGL J MED, V359, P1429, DOI 10.1056/NEJMoa0803152; Hardy WD, 2010, JAIDS-J ACQ IMM DEF, V55, P558, DOI 10.1097/QAI.0b013e3181ee3d82; Haute Autorite de Sante, 2012, METH GUID CHOIC METH; Kauf TL, 2008, VALUE HEALTH, V11, P1144, DOI 10.1111/j.1524-4733.2008.00326.x; Kuhne FC, 2010, HIV CLIN TRIALS, V11, P80, DOI 10.1310/hct1102-80; Lohse N, 2007, J ANTIMICROB CHEMOTH, V60, P461, DOI 10.1093/jac/dkm241; Magoni M, 2011, HIV MED, V12, P129, DOI 10.1111/j.1468-1293.2010.00861.x; Mauskopf J, 2012, AIDS, V26, P355, DOI 10.1097/QAD.0b013e32834e87e6; Monforte AD, 2005, ARCH INTERN MED, V165, P416; Morlat P., PRISE CHARGE MED PER; Morlat P., 2013, PRISE CHARGE MED PER; Nelson M, 2005, JAIDS-J ACQ IMM DEF, V40, P404, DOI 10.1097/01.qai.0000185314.56556.c3; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Paltiel AD, 1998, MED DECIS MAKING, V18, pS93, DOI 10.1177/0272989X9801800211; Raffi F, 2013, LANCET, V12; Raffi F, 2013, LANCET INFECT DIS, V13, P927, DOI 10.1016/S1473-3099(13)70257-3; Reekie J, 2011, HIV MED, V12, P259, DOI 10.1111/j.1468-1293.2010.00877.x; Schapiro JM, 2011, ANTIVIR THER, V16, P395, DOI 10.3851/IMP1759; Sloan CE, 2012, AIDS, V26, P45, DOI 10.1097/QAD.0b013e32834dce6e; Steigbigel RT, 2008, NEW ENGL J MED, V359, P339, DOI 10.1056/NEJMoa0708975; Steigbigel RT, 2010, CLIN INFECT DIS, V50, P605, DOI 10.1086/650002; van Sighem A, 2010, AIDS, V24, P1527, DOI 10.1097/QAD.0b013e32833a3946; Walmsley S, 2012, 52 INT C ANT AG CHEM	39	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145885	10.1371/journal.pone.0145885	http://dx.doi.org/10.1371/journal.pone.0145885			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714188	Green Published, gold, Green Submitted			2022-12-26	WOS:000367481900098
J	Cui, YN; Ling, Y; Zhou, JH; Li, XJ				Cui, Yaning; Ling, Yu; Zhou, Junhui; Li, Xiaojuan			Interference of the Histone Deacetylase Inhibits Pollen Germination and Pollen Tube Growth in Picea wilsonii Mast	PLOS ONE			English	Article							CELL-WALL CONSTRUCTION; ACTIN-FILAMENTS; CYTOSOLIC CALCIUM; PINUS-BUNGEANA; TIP GROWTH; ARABIDOPSIS; ACETYLATION; CYTOSKELETON; EXPRESSION; RPD3	Histone deacetylase (HDAC) is a crucial component in the regulation of gene expression in various cellular processes in animal and plant cells. HDAC has been reported to play a role in embryogenesis. However, the effect of HDAC on androgamete development remains unclear, especially in gymnosperms. In this study, we used the HDAC inhibitors trichostatin A (TSA) and sodium butyrate (NaB) to examine the role of HDAC in Picea wilsonii pollen germination and pollen tube elongation. Measurements of the tip-focused Ca2+ gradient revealed that TSA and NaB influenced this gradient. Immunofluorescence showed that actin filaments were disrupted into disorganized fragments. As a result, the vesicle trafficking was disturbed, as determined by FM4-64 labeling. Moreover, the distribution of pectins and callose in cell walls was significantly altered in response to TSA and NaB. Our results suggest that HDAC affects pollen germination and polarized pollen tube growth in Picea wilsonii by affecting the intracellular Ca2+ concentration gradient, actin organization patterns, vesicle trafficking, as well as the deposition and configuration of cell wall components.	[Cui, Yaning; Ling, Yu; Zhou, Junhui; Li, Xiaojuan] Beijing Forestry Univ, Coll Biol Sci & Biotechnol, Key Lab Genet & Breeding Forest Trees & Ornamenta, Beijing, Peoples R China; [Cui, Yaning; Ling, Yu; Zhou, Junhui; Li, Xiaojuan] Beijing Forestry Univ, Coll Biol Sci & Biotechnol, Natl Engn Lab Tree Breeding, Beijing, Peoples R China	Beijing Forestry University; Beijing Forestry University	Li, XJ (corresponding author), Beijing Forestry Univ, Coll Biol Sci & Biotechnol, Key Lab Genet & Breeding Forest Trees & Ornamenta, Beijing, Peoples R China.	lixj@bjfu.edu.cn			Fundamental Research Funds for the Central Universities [BLX2012039]; National Natural Science Foundation of China [31370212]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Fundamental Research Funds for the Central Universities (BLX2012039) and the National Natural Science Foundation of China (31370212).; This work was supported by the Fundamental Research Funds for the Central Universities (BLX2012039) and the National Natural Science Foundation of China (31370212). We thank Mr. Kai Song (Key Laboratory of Plant Resources, Institute of Botany, Chinese Academy of Sciences) for supplying the pollen. We also thank Meiqin Liu (Beijing Forest University) for her assistance with confocal laser scanning microscopy.	Betz WJ, 1996, CURR OPIN NEUROBIOL, V6, P365, DOI 10.1016/S0959-4388(96)80121-8; Bhuja P, 2004, PLANT CELL PHYSIOL, V45, P543, DOI 10.1093/pcp/pch068; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Brownell JE, 1996, CURR OPIN GENET DEV, V6, P176, DOI 10.1016/S0959-437X(96)80048-7; Chen T, 2007, PLANT CELL PHYSIOL, V48, P19, DOI 10.1093/pcp/pcl036; Franklin-Tong VE, 1999, PLANT CELL, V11, P727, DOI 10.1105/tpc.11.4.727; Fu Y, 2010, J INTEGR PLANT BIOL, V52, P131, DOI 10.1111/j.1744-7909.2010.00922.x; Hao HQ, 2005, NEW PHYTOL, V165, P721, DOI 10.1111/j.1469-8137.2004.01290.x; Hepler PK, 2001, ANNU REV CELL DEV BI, V17, P159, DOI 10.1146/annurev.cellbio.17.1.159; Nguyen HN, 2013, PLANT CELL REP, V32, P1625, DOI 10.1007/s00299-013-1474-6; HoldawayClarke TL, 1997, PLANT CELL, V9, P1999, DOI 10.1105/tpc.9.11.1999; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Justus CD, 2004, PLANTA, V219, P103, DOI 10.1007/s00425-003-1193-2; Kadosh D, 1998, GENE DEV, V12, P797, DOI 10.1101/gad.12.6.797; Krichevsky A, 2009, J MOL BIOL, V385, P45, DOI 10.1016/j.jmb.2008.09.040; Kuo MH, 2000, MOL CELL, V6, P1309, DOI 10.1016/S1097-2765(00)00129-5; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Lane AA, 2009, J CLIN ONCOL, V27, P5459, DOI 10.1200/JCO.2009.22.1291; Li H, 2014, PLANT CELL, V26, P195, DOI 10.1105/tpc.113.116491; Ling Y, 2013, PLANTA, V238, P831, DOI 10.1007/s00425-013-1938-5; Lovy-Wheeler A, 2005, PLANTA, V221, P95, DOI 10.1007/s00425-004-1423-2; Marton ML, 2012, CURR BIOL, V22, P1194, DOI 10.1016/j.cub.2012.04.061; Michard E, 2009, INT J DEV BIOL, V53, P1609, DOI 10.1387/ijdb.072296em; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Munster PN, 2011, BRIT J CANCER, V104, P1828, DOI 10.1038/bjc.2011.156; Myers C, 2009, PLANT J, V59, P528, DOI 10.1111/j.1365-313X.2009.03894.x; Ou GS, 2002, PROTOPLASMA, V219, P168, DOI 10.1007/s007090200018; Parton RM, 2001, J CELL SCI, V114, P2685; Serrador JM, 2004, IMMUNITY, V20, P417, DOI 10.1016/S1074-7613(04)00078-0; Shi SQ, 2010, PLANT CELL ENVIRON, V33, P149, DOI 10.1111/j.1365-3040.2009.02065.x; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Suka N, 1998, COLD SPRING HARB SYM, V63, P391, DOI 10.1101/sqb.1998.63.391; Tian L, 2003, GENETICS, V165, P399; Tsuji H, 2006, PLANT CELL PHYSIOL, V47, P995, DOI 10.1093/pcp/pcj072; Valenzuela-Fernandez A, 2008, TRENDS CELL BIOL, V18, P291, DOI 10.1016/j.tcb.2008.04.003; Waltregny D, 2005, FASEB J, V19, P966, DOI 10.1096/fj.04-2303fje; Wang YH, 2009, NEW PHYTOL, V182, P851, DOI 10.1111/j.1469-8137.2009.02820.x; Wu KQ, 2000, PLANT MOL BIOL, V44, P167, DOI 10.1023/A:1006498413543; Xu CR, 2005, P NATL ACAD SCI USA, V102, P14469, DOI 10.1073/pnas.0503143102; Zhang WH, 1998, PLANT J, V15, P147, DOI 10.1046/j.1365-313X.1998.00188.x; Zhou CH, 2005, PLANT CELL, V17, P1196, DOI 10.1105/tpc.104.028514	42	6	8	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145661	10.1371/journal.pone.0145661	http://dx.doi.org/10.1371/journal.pone.0145661			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710276	Green Published, gold, Green Submitted			2022-12-26	WOS:000367451400068
J	Dhanasekar, C; Kalaiselvan, S; Rasool, M				Dhanasekar, Chitra; Kalaiselvan, Sowmiya; Rasool, Mahaboobkhan			Morin, a Bioflavonoid Suppresses Monosodium Urate Crystal-Induced Inflammatory Immune Response in RAW 264.7 Macrophages through the Inhibition of Inflammatory Mediators, Intracellular ROS Levels and NF-kappa B Activation	PLOS ONE			English	Article							ACUTE GOUTY-ARTHRITIS; COLORIMETRIC ASSAY; NITRIC-OXIDE; IN-VITRO; CELLS; ACID; PHOSPHORYLATION; CHONDROCYTES; CYTOKINES; EFFICACY	Our previous studies had reported that morin, a bioflavanoid exhibited potent anti-inflammatory effect against adjuvant-induced arthritic rats. In this current study, we investigated the anti-inflammatory mechanism of morin against monosodium urate crystal (MSU)-induced inflammation in RAW 264.7 macrophage cells, an in vitro model for acute gouty arthritis. For comparison purpose, colchicine was used as a reference drug. We have observed that morin (100-300 mu M) treatment significantly suppressed the levels of inflammatory cytokines (TNF-alpha, IL-1 beta, IL-6, MCP-1 and VEGF), inflammatory mediators (NO and PEG(2)), and lysosomal enzymes (acid phosphatase, beta-galactosidase, N-acetyl glucosamindase and cathepsin D) in MSU-crystals stimulated macrophage cells. The mRNA expression of pro-inflammatory cytokines (TNF-alpha, IL-1 beta, IL-6, and MCP-1), inflammatory enzymes (iNOS and COX-2), and NF-kappa Bp65 was found downregulated in MSU crystal stimulated macrophage cells by morin treatment, however, the mRNA expression of hypoxanthine phospho ribosyl transferse (HPRT) was found to be increased. The flow cytometry analysis revealed that morin treatment decreased intracellular reactive oxygen species levels in MSU crystal stimulated macrophage cells. The western blot analysis clearly showed that morin mainly exerts its anti-inflammatory effects by inhibiting the MSU crystal-induced COX-2 and TNF-alpha protein expression through the inactivation of NF-kappa B signaling pathway in RAW264.7 macrophage cells similar to that of BAY 11-7082 (I kappa B kinase inhibitor). Our results collectively suggest that morin can be a potential therapeutic agent for inflammatory disorders like acute gouty arthritis.	[Dhanasekar, Chitra; Kalaiselvan, Sowmiya; Rasool, Mahaboobkhan] VIT Univ, Sch Biosci & Technol, Immunopathol Lab, Vellore 632014, Tamil Nadu, India	Vellore Institute of Technology	Rasool, M (corresponding author), VIT Univ, Sch Biosci & Technol, Immunopathol Lab, Vellore 632014, Tamil Nadu, India.	mkr474@gmail.com		Rasool, Mahaboobkhan/0000-0003-4980-5355; , DR. D. Chitra/0000-0002-2125-1082				Bartosikova L, 2003, ACTA VET BRNO, V72, P191, DOI 10.2754/avb200372020191; Chen LY, 2013, J ETHNOPHARMACOL, V150, P545, DOI 10.1016/j.jep.2013.08.063; Chen WP, 2012, INT IMMUNOPHARMACOL, V12, P447, DOI 10.1016/j.intimp.2011.12.024; Chen YC, 2006, CLIN CHIM ACTA, V369, P89, DOI 10.1016/j.cca.2006.01.018; Choi HK, 2007, CIRCULATION, V116, P894, DOI 10.1161/CIRCULATIONAHA.107.703389; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; ETHERINGTON DJ, 1972, BIOCHEM J, V127, P685, DOI 10.1042/bj1270685; Ghaemi-Oskouie F, 2011, CURR RHEUMATOL REP, V13, P160, DOI 10.1007/s11926-011-0162-1; Jin HM, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4531; Kempuraj D, 2005, BRIT J PHARMACOL, V145, P934, DOI 10.1038/sj.bjp.0706246; Kim JM, 2010, FREE RADICAL RES, V44, P454, DOI 10.3109/10715761003610737; King J., 1965, PRACTICAL CLIN ENZYM, P83; Kodithuwakku ND, 2013, J ETHNOPHARMACOL, V150, P1071, DOI 10.1016/j.jep.2013.10.016; Kuo HM, 2007, ANTICANCER RES, V27, P395; Liu R, 2004, ARTHRITIS RHEUM, V50, P247, DOI 10.1002/art.11486; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARKLUND S, 1974, European Journal of Biochemistry, V47, P469, DOI 10.1111/j.1432-1033.1974.tb03714.x; Martin WJ, 2009, ARTHRITIS RHEUM-US, V60, P281, DOI 10.1002/art.24185; MARUHN D, 1976, CLIN CHIM ACTA, V73, P453, DOI 10.1016/0009-8981(76)90147-9; Murunikkara V, 2014, CELL BIOCHEM FUNCT, V32, P106, DOI 10.1002/cbf.2979; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Ottaviani S, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4303; Pope RM, 2007, ARTHRITIS RHEUM-US, V56, P3183, DOI 10.1002/art.22938; Rahim SS, 2005, IMMUNOLOGY, V114, P313, DOI 10.1111/j.1365-2567.2005.02107.x; RATTY AK, 1988, BIOCHEM PHARMACOL, V37, P989, DOI 10.1016/0006-2952(88)90499-6; ROSENBLI.PD, 1974, P SOC EXP BIOL MED, V145, P244; ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588; Ru LB, 2005, ARTHRITIS RHEUM-US, V52, P2936, DOI 10.1002/art.21238; Sabina Evan Prince, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P128, DOI 10.1016/S2221-1691(11)60206-2; Sabina EP, 2011, INFLAMMATION, V34, P184, DOI 10.1007/s10753-010-9222-3; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shi Y, 2003, NATURE, V425, P516, DOI 10.1038/nature01991; SINHA AK, 1972, ANAL BIOCHEM, V47, P389, DOI 10.1016/0003-2697(72)90132-7; Sultana F, 2015, CHEM-BIOL INTERACT, V230, P58, DOI 10.1016/j.cbi.2015.02.007; Vanltallie TB, 2010, METABOLISM, V59, pS32, DOI 10.1016/j.metabol.2010.07.009; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Yu ZF, 2007, DRUG METAB DISPOS, V35, P981, DOI 10.1124/dmd.106.012187; Zhang R, 2009, CHEM-BIOL INTERACT, V177, P21, DOI 10.1016/j.cbi.2008.08.009; Zhang ZT, 2010, ACTA PHARMACOL SIN, V31, P900, DOI 10.1038/aps.2010.77; Zhao ZZ, 2014, BIOCHEM PHARMACOL, V90, P73, DOI 10.1016/j.bcp.2014.04.015	40	49	52	4	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145093	10.1371/journal.pone.0145093	http://dx.doi.org/10.1371/journal.pone.0145093			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709520	Green Submitted, Green Published, gold			2022-12-26	WOS:000367451400021
J	Hector, S; Willard, K; Bauer, R; Mulako, I; Slabbert, E; Kossmann, J; George, GM				Hector, Stanton; Willard, Kyle; Bauer, Rolene; Mulako, Inonge; Slabbert, Etienne; Kossmann, Jens; George, Gavin M.			Diverse Exopolysaccharide Producing Bacteria Isolated from Milled Sugarcane: Implications for Cane Spoilage and Sucrose Yield	PLOS ONE			English	Article							NEIGHBOR-JOINING METHOD; MOLECULAR CHARACTERIZATION; LEUCONOSTOC-MESENTEROIDES; DEXTRAN; DETERIORATION; PHYLOGENIES; INDICATORS; PROSPECTS; STRAINS; JUICE	Bacterial deterioration of sugarcane during harvesting and processing is correlated with significant loss of sucrose yield and the accumulation of bacterial polysaccharides. Dextran, a homoglucan produced by Leuconostoc mesenteroides, has been cited as the primary polysaccharide associated with sugarcane deterioration. A culture-based approach was used to isolate extracellular polysaccharide (EPS) producing bacterial strains from milled sugarcane stalks. Ribosomal RNA sequencing analysis grouped 25 isolates into 4 genera. This study identified 2 bacterial genera not previously associated with EPS production or sucrose degradation. All isolates produced polysaccharide when grown in the presence of sucrose. Monosaccharide analysis of purified polymers by Gas Chromatography revealed 17 EPSs consisting solely of glucose (homoglucans), while the remainder contained traces of mannose or fructose. Dextranase treatment of polysaccharides yielded full digestion profiles for only 11 extracts. Incomplete hydrolysis profiles of the remaining polysaccharides suggest the release of longer oligosaccharides which may interfere with sucrose crystal formation.	[Hector, Stanton; Willard, Kyle; Mulako, Inonge; Kossmann, Jens; George, Gavin M.] Univ Stellenbosch, Dept Genet, Inst Plant Biotechnol, ZA-7602 Matieland, South Africa; [Bauer, Rolene] Univ Stellenbosch, LaunchLab, ZA-7602 Matieland, South Africa; [Slabbert, Etienne] Univ Stellenbosch, Dept Microbiol, ZA-7602 Matieland, South Africa; [Slabbert, Etienne] Univ Stellenbosch, Cent Analyt Facil, ZA-7602 Matieland, South Africa	Stellenbosch University; Stellenbosch University; Stellenbosch University; Stellenbosch University	George, GM (corresponding author), Swiss Fed Inst Technol, Inst Agr Sci, Univ Str 2, CH-8092 Zurich, Switzerland.	ggeorge@ethz.ch	George, Gavin/E-8578-2016; George, Gavin Mager/N-6205-2019	George, Gavin/0000-0001-7880-3952; George, Gavin Mager/0000-0001-7880-3952; Willard, Kyle/0000-0001-6137-5904; Kossmann, Jens/0000-0001-8895-894X; Hector, Stanton/0000-0001-8895-0710	South African National Research Foundation-Innovation Fund; Zurich-Basel Plant Science Centers' Plant Fellows program [GA-2010-267243]; South African National Research Foundation	South African National Research Foundation-Innovation Fund; Zurich-Basel Plant Science Centers' Plant Fellows program; South African National Research Foundation(National Research Foundation - South Africa)	Funding provided by South African National Research Foundation-Innovation Fund (http://www.nrf.ac.za/) and the Zurich-Basel Plant Science Centers' Plant Fellows program (Grant agreement no GA-2010-267243). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge Dr Sandy Snyman and Dr Derek Watt of the South African Sugarcane Research Institute fro their advice (SASRI, Durban, South Africa). In addition we thank Dr Jan Bekker and Charl Marais for their contributions to this project. A final special thanks to Prof. Samuel C. Zeeman for his support as well as the Zurich-Basel Plant Science Centers' Plant Fellows program (Grant agreement no GA-2010-267243), as well as the South African National Research Foundation for their continuing contributions and support.	Abdel-Rahman EA, 2008, J FOOD ENG, V84, P501, DOI 10.1016/j.jfoodeng.2007.06.014; Aquino FWB, 2009, FOOD CHEM, V114, P1391, DOI 10.1016/j.foodchem.2008.11.019; Arrieta J, 1996, MICROBIOL-UK, V142, P1077, DOI 10.1099/13500872-142-5-1077; Babalola OO, 2010, BIOTECHNOL LETT, V32, P1559, DOI 10.1007/s10529-010-0347-0; Bauer R, 2009, INT J FOOD MICROBIOL, V131, P260, DOI 10.1016/j.ijfoodmicro.2009.02.020; Blanch M., 2006, Sugar Tech, V8, P224, DOI 10.1007/BF02943560; Chauhan MK, 2011, RENEW SUST ENERG REV, V15, P3445, DOI 10.1016/j.rser.2011.04.033; EGAN B. T., 1965, PROC QUEENSLAND SOC SUGAR CANE TECHNOL, V32, P21; Eggleston G, 2006, FOOD CHEM, V98, P366, DOI 10.1016/j.foodchem.2005.07.031; Eggleston G, 2005, PROCESS BIOCHEM, V40, P1881, DOI 10.1016/j.procbio.2004.06.025; Eggleston G, 2004, FOOD CHEM, V87, P119, DOI 10.1016/j.foodchem.2003.11.004; Eggleston G, 2002, FOOD CHEM, V78, P95, DOI 10.1016/S0308-8146(01)00390-9; Eggleston G., 2009, Sugar Tech, V11, P135, DOI 10.1007/s12355-009-0020-x; Fang CT, 2004, J EXP MED, V199, P697, DOI 10.1084/jem.20030857; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Goldemberg J, 2008, ENERG POLICY, V36, P2086, DOI 10.1016/j.enpol.2008.02.028; Kang HK, 2009, FEMS MICROBIOL LETT, V292, P33, DOI 10.1111/j.1574-6968.2008.01460.x; Katina K, 2009, FOOD MICROBIOL, V26, P734, DOI 10.1016/j.fm.2009.07.008; Kulkarni VM, 1987, 37 P DECC SUG TECHN, pM37; Leathers TD, 2011, BIOTECHNOL LETT, V33, P517, DOI 10.1007/s10529-010-0450-2; Lionnet G.R.E., 1986, P S AFR SUGAR TECHNO, V60, P52; MCINERNEY JO, 1995, APPL ENVIRON MICROB, V61, P1646, DOI 10.1128/AEM.61.4.1646-1648.1995; Morel du Boil PG, 1995, P S AFR SUG TECHNOL, V59, P146; Nwodo UU, 2012, INT J MOL SCI, V13, P14002, DOI 10.3390/ijms131114002; Promraksa A, 2009, J CRYST GROWTH, V311, P3667, DOI 10.1016/j.jcrysgro.2009.04.042; Purama RK, 2009, CARBOHYD POLYM, V76, P30, DOI 10.1016/j.carbpol.2008.09.018; Ravno A. B., 2005, Proceedings of the 79th Annual Congress of South African Sugar Technologists' Association, held at Kwa-Shukela, Mount Edgecombe, South Africa, 19-22 July 2005, P28; Rodriguez Jimenez E., 2009, Sugar Tech, V11, P124, DOI 10.1007/s12355-009-0019-3; Roessner U, 2000, PLANT J, V23, P131, DOI 10.1046/j.1365-313x.2000.00774.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Saxena P, 2010, AUST J CROP SCI, V4, P692; Soetaert W, 1995, PROGR BIOTECHNOL, V10, P351, DOI 10.1016/S0921-0423(06)80116-4; Solomon S., 2009, Sugar Tech, V11, P109, DOI 10.1007/s12355-009-0018-4; SUTHERLAND IW, 1979, TRENDS BIOCHEM SCI, V4, P55, DOI 10.1016/0968-0004(79)90262-7; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Watanabe K, 2001, J MICROBIOL METH, V44, P253, DOI 10.1016/S0167-7012(01)00220-2; Yusof S, 2000, FOOD CHEM, V68, P395, DOI 10.1016/S0308-8146(99)00180-6	37	13	15	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145487	10.1371/journal.pone.0145487	http://dx.doi.org/10.1371/journal.pone.0145487			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710215	Green Submitted, gold, Green Published			2022-12-26	WOS:000367451400051
J	Marchowski, D; Neubauer, G; Lawicki, L; Wozniczka, A; Wysocki, D; Guentzel, S; Jarzemski, M				Marchowski, Dominik; Neubauer, Grzegorz; Lawicki, Lukasz; Wozniczka, Adam; Wysocki, Dariusz; Guentzel, Sebastian; Jarzemski, Maciej			The Importance of Non-Native Prey, the Zebra Mussel Dreissena polymorpha, for the Declining Greater Scaup Aythya marila: A Case Study at a Key European Staging and Wintering Site	PLOS ONE			English	Article							SZCZECIN LAGOON; COMMON EIDERS; DIVING DUCKS; FOOD; POPULATION; FULIGULA	The European population of Greater Scaup Aythya marila has experienced an alarming, similar to 60% decline in numbers over the last two decades. The brackish lagoons of the Odra River Estuary (ORE) in the south-western Baltic Sea, represent an important area for the species during the non-breeding season in Europe. The lagoons regularly support over 20 000 Scaup, with peaks exceeding 100 000 (38%-70% of the population wintering in NW Europe and the highest number recorded in April 2011-105 700). In the ORE, Scaup feed almost exclusively on the non-native Zebra Mussel Dreissena polymorpha. This mussel was present in the ORE already in the 19th century and continues to be superabundant. Using the results of 22 Scaup censuses (November to April 2002/2003 to 2013/2014) from the whole ORE (523 km(2) of water), we show that Scaup flocks follow areas with the greatest area of occurrence and biomass of the Zebra Mussel, while areas with low mussel densities are ignored. The numbers of Scaup in the ORE are primarily related to the area of Zebra Mussel occurrence on the lagoon's bottom (km(2)) in a non-linear fashion. Zebra Mussels were absolutely prevalent (97% of biomass) in the digestive tracts of birds unintentionally by-caught in fishing nets (n = 32). We estimate that Scaup alone consume an average of 5 400 tons of Zebra Mussels annually, which represents 5.6% of the total resources of the mussel in the ORE. Our results provide a clear picture of the strong dependence of the declining, migratory duck species on the non-native mussel, its primary food in the ORE. Our findings are particularly important as they can form the basis for the conservation action plan aimed at saving the north-western European populations of Scaup.	[Marchowski, Dominik; Wysocki, Dariusz] Univ Szczecin, Fac Biol, Dept Vertebrate Zool & Anthropol, PL-70453 Szczecin, Poland; [Marchowski, Dominik; Lawicki, Lukasz; Guentzel, Sebastian] West Pomeranian Nat Soc, Szczecin, Poland; [Neubauer, Grzegorz] Polish Acad Sci, Museum & Inst Zool, Ornithol Stn, Gdansk, Poland; [Wozniczka, Adam] Natl Marine Fisheries Res Inst, Res Stn Swinoujscie, Swinoujscie, Poland; [Jarzemski, Maciej] Linus Maciej Jarzemski, Szczecin, Poland	University of Szczecin; Polish Academy of Sciences; Museum & Institute of Zoology of the Polish Academy of Sciences; National Marine Fisheries Research Institute	Marchowski, D (corresponding author), Univ Szczecin, Fac Biol, Dept Vertebrate Zool & Anthropol, PL-70453 Szczecin, Poland.	marchowskid@gmail.com	Marchowski, Dominik/ABC-7494-2021; Marchowski, Dominik/M-8184-2018	Lawicki, Lukasz/0000-0002-9829-0151; Marchowski, Dominik/0000-0001-7508-9466; Neubauer, Grzegorz/0000-0003-2123-0780; Wozniczka, Adam/0000-0001-5050-9145				[Anonymous], 2014, R LANG ENV STAT COMP; Araujo R., 2010, ZEBRA MUSSEL EUROPE, P183; Aunins A, 2013, HELCOM CORE INDICATO; Badzinski SS, 2006, WILDLIFE SOC B, V34, P664, DOI 10.2193/0091-7648(2006)34[664:DOLAGS]2.0.CO;2; Badzinski SS, 2009, ENVIRON POLLUT, V157, P1886, DOI 10.1016/j.envpol.2009.01.012; Beisel J.-N., 2010, ZEBRA MUSSEL EUROPE, P191; Bidwell J. R., 2010, ZEBRA MUSSEL EUROPE, P69; Bijleveld A. I., 2015, THESIS; Cervencl A, 2012, J SEA RES, V73, P41, DOI 10.1016/j.seares.2012.06.006; Czeraszkiewicz R, 2004, WATERBIRDS W POMERAN, P5; Czugala A, 2010, AQUAT INVASIONS, V5, pS61, DOI 10.3391/ai.2010.5.S1.014; De Leeuw JJ, 1999, ARDEA, V87, P15; FRYXELL JM, 1991, AM NAT, V138, P478, DOI 10.1086/285227; Grand JB, 2002, ENVIRON TOXICOL CHEM, V21, P1673, DOI 10.1897/1551-5028(2002)021<1673:COTEIE>2.0.CO;2; Guentzel S, 2012, IMPORTANT BIRD AREAS; Guillemette M, 1996, CAN J ZOOL, V74, P32; HASSELL MP, 1969, NATURE, V223, P1133, DOI 10.1038/2231133a0; HOLLING CS, 1961, ANNU REV ENTOMOL, V6, P163, DOI 10.1146/annurev.en.06.010161.001115; Hornman M, 2012, 3 PAN EUR DUCK S JIN; IZVEKOVA E I, 1972, Polskie Archiwum Hydrobiologii, V19, P203; Jakubas Dariusz, 2003, Ornis Svecica, V13, P75; Johnsgard PA, 1978, DUCKS GEESE SWANS WO; Kaliciuk J, 2003, WATERBIRDS W POMERAN, P14; Kalisinska E., 2005, FOLIA U AGR STETIN Z, V243, P71; Kalisinska E, 2007, OCHR SROD ZAS NAT, V31, P404; Kalisinska E., 2009, BIRDS ENV THREATS PR, P71; Kalisinska E, 2010, POL J ENVIRON STUD, V19, P1213; Kalisinska E, 2010, ECOTOXICOLOGY, V19, P1382, DOI 10.1007/s10646-010-0524-x; Keller I, 2009, J ORNITHOL, V150, P483, DOI 10.1007/s10336-008-0367-x; Kestenholz M., 1999, RING, V21, P26; Komdeur J, 1992, IWRB SPECIAL PUBLICA, V19; Lawicki Lukasz, 2008, Notatki Ornitolgiczne, V49, P235; LEIPE T, 1986, Mitteilungen aus dem Zoologischen Museum in Berlin, V62, P117; LEIPE T, 1989, Beitraege zur Vogelkunde, V35, P24; Marchowski D, 2011, PTAKI POMORZA, V2, P159; Marchowski D., 2012, PTAKI POMORZA, V3, P129; Marchowski D, 2013, PTAKI POMORZA, V4, P149; Marchowski D, 2015, AUK ORNITHOLOGI 1104, V4, P31, DOI [10.1642/AUK-15-62.1, DOI 10.1642/AUK-15-62.1]; Meissner W., 1992, IWRB SEADUCK B, V1, P21; Meissner W, 1994, IWRB SEADUCK RES GRO, V4, P26; Meissner Wlodzimierz, 2010, Ornis Polonica, V51, P275; Meissner Wlodzimierz, 1993, Ring, V15, P375; Mendel B., 2008, PROFILES SEABIRDS WA; Neubauer G., 2015, B MONITORINGU PRZYRO, V13, P1; NILSSON L, 1972, Ornis Scandinavica, V3, P55, DOI 10.2307/3676166; NILSSON L, 1970, OIKOS, V21, P145, DOI 10.2307/3543670; Petrie S, 2007, CONTAMINANT BURDENS, P54; Poulton VK, 2002, CONDOR, V104, P518, DOI 10.1650/0010-5422(2002)104[0518:CDASFB]2.0.CO;2; PREJS A, 1990, OECOLOGIA, V83, P378, DOI 10.1007/BF00317563; Radziejewska T., 2008, V197, P115, DOI 10.1007/978-3-540-73524-3_5; Skov H., 2011, WATERBIRD POPULATION; Stanczykowska A., 1983, Wiadomosci Ekologiczne, V29, P127; STANCZYKOWSKA A, 1993, HYDROBIOLOGIA, V251, P73, DOI 10.1007/BF00007167; Stanczykowska A, 2010, ZEBRA MUSSEL EUROPE, P119; Stempniewicz L., 1974, Acta Univ Nicolai Copernici (Limnol), V34, P83; Stempniewicz Lech, 1995, Ornis Svecica, V5, P133; Stempniewicz Lech, 1999, Ornis Svecica, V9, P143; Van Eerden M. R., 2010, ZEBRA MUSSEL EUROPE, P251; van Eerden M.R., 1997, THESIS U GRONINGEN V; Viksne J., 2010, ATLAS DUCK POPULATIO; Wetlands International, 2010, GUID WAT MON METH FI; Wiktor J, 1969, BIOL DREISSENA POLYM; WINFIELD IJ, 1994, FRESHWATER BIOL, V32, P467, DOI 10.1111/j.1365-2427.1994.tb01140.x; Wolnomiejski N, 2013, SZCZECIN LAGOON ECOSYSTEM: THE BIOTIC COMMUNITY OF THE GREAT LAGOON AND ITS FOOD WEB MODEL, P1, DOI 10.2478/9788376560502; Wolnomiejski Norbert, 2008, Ecological Questions, V9, P103, DOI 10.2478/v10090-009-0025-9; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Wozniczka A, 2015, OCEANOLOGIA IN PRESS; Zuur A.F., 2013, BEGINNERS GUIDE GEN; Zuur AF, 1997, THESIS	69	13	15	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145496	10.1371/journal.pone.0145496	http://dx.doi.org/10.1371/journal.pone.0145496			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709707	Green Published, gold, Green Submitted			2022-12-26	WOS:000367451400054
J	Yu, X; Jaatinen, A; Rintahaka, J; Hynonen, U; Lyytinen, O; Kant, R; Avall-Jaaskelainen, S; von Ossowski, I; Palva, A				Yu, Xia; Jaatinen, Annukka; Rintahaka, Johanna; Hynonen, Ulla; Lyytinen, Outi; Kant, Ravi; Avall-Jaaskelainen, Silja; von Ossowski, Ingemar; Palva, Airi			Human Gut-Commensalic Lactobacillus ruminis ATCC 25644 Displays Sortase-Assembled Surface Piliation: Phenotypic Characterization of Its Fimbrial Operon through In Silico Predictive Analysis and Recombinant Expression in Lactococcus lactis	PLOS ONE			English	Article							CONTROLLED GENE-EXPRESSION; GRAM-POSITIVE BACTERIA; GROUP-B STREPTOCOCCUS; RHAMNOSUS GG; FUNCTIONAL-ANALYSIS; PILI; ADHESION; PROTEIN; SEQUENCE; STRAINS	Sortase-dependent surface pili (or fimbriae) in Gram-positive bacteria are well documented as a key virulence factor for certain harmful opportunistic pathogens. However, it is only recently known that these multi-subunit protein appendages are also belonging to the "friendly" commensals and now, with this new perspective, they have come to be categorized as a niche-adaptation factor as well. In this regard, it was shown earlier that sortase-assembled piliation is a native fixture of two human intestinal commensalics (i.e., Lactobacillus rhamnosus and Bifidobacterium bifidum), and correspondingly where the pili involved have a significant role in cellular adhesion and immunomodulation processes. We now reveal that intestinal indigenous (or autochthonous) Lactobacillus ruminis is another surface-piliated commensal lactobacillar species. Heeding to in silico expectations, the predicted loci for the LrpCBA-called pili are organized tandemly in the L. ruminis genome as a canonical fimbrial operon, which then encodes for three pilin-proteins and a single C-type sortase enzyme. Through electron microscopic means, we showed that these pilus formations are a surface assemblage of tip, basal, and backbone pilin subunits (respectively named LrpC, LrpB, and LrpA) in L. ruminis, and also when expressed recombinantly in Lactococcus lactis. As well, by using the recombinant-piliated lactococci, we could define certain ecologically relevant phenotypic traits, such as the ability to adhere to extracellular matrix proteins and gut epithelial cells, but also to effectuate an induced dampening on Toll-like receptor 2 signaling and interleukin-8 responsiveness in immune-related cells. Within the context of the intestinal microcosm, by wielding such niche-advantageous cell-surface properties the LrpCBA pilus would undoubtedly have a requisite functional role in the colonization dynamics of L. ruminis indigeneity. Our study provides only the second description of a native-piliated Lactobacillus species, but at the same time also involves the structural and functional characterization of a third type of lactobacillar pilus.	[Yu, Xia; Jaatinen, Annukka; Rintahaka, Johanna; Hynonen, Ulla; Lyytinen, Outi; Kant, Ravi; Avall-Jaaskelainen, Silja; von Ossowski, Ingemar; Palva, Airi] Univ Helsinki, Fac Vet Med, Dept Vet Biosci, Helsinki, Finland	University of Helsinki	von Ossowski, I (corresponding author), Univ Helsinki, Fac Vet Med, Dept Vet Biosci, Helsinki, Finland.	ingemar.von.ossowski@helsinki.fi; airi.palva@helsinki.fi	Kant, Ravi/AAF-8495-2021	Kant, Ravi/0000-0003-3878-9775; Pietikainen, Annukka/0000-0003-3554-0683; von Ossowski, Ingemar Eric/0000-0002-9899-671X; Hynonen, Ulla/0000-0002-2002-7804; Avall-Jaaskelainen, Silja Tuulia/0000-0002-9376-8566	Academy of Finland [118602, 141140, 277362]; China Scholarship Council (CSC); Finnish Veterinary Foundation; Finnish Foundation of Veterinary Research; University of Helsinki Applied Bioscience (ABS) Graduate School	Academy of Finland(Academy of Finland); China Scholarship Council (CSC)(China Scholarship Council); Finnish Veterinary Foundation; Finnish Foundation of Veterinary Research; University of Helsinki Applied Bioscience (ABS) Graduate School	Financing for this project (including operating costs and some salaries) was mainly through an Academy of Finland general research grant (No. 277362) (http://www.aka.fi) and the Academy of Finland-funded Center of Excellence in Microbial Food Safety (CoE-MiFoSa) research program (Grant Nos. 118602 and 141140). The China Scholarship Council (CSC), the Finnish Veterinary Foundation (http://www.etts.fi/), and the Finnish Foundation of Veterinary Research (http://www.sels.fi/index_eng.htm) provided personal salary funding to Xia Yu. The University of Helsinki Applied Bioscience (ABS) Graduate School (http://www.vetmed.helsinki.fi/abs/index.htm) supplied some salary support to Ravi Kant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Jassim RAM, 2003, LETT APPL MICROBIOL, V37, P213, DOI 10.1046/j.1472-765X.2003.01380.x; [Anonymous], 2012, ADV MICROBIOL-IRVINE, DOI DOI 10.4236/AIM.2012.23051; Ardita CS, 2014, APPL ENVIRON MICROB, V80, P5068, DOI 10.1128/AEM.01039-14; Basset A, 2013, J BIOL CHEM, V288, P2665, DOI 10.1074/jbc.M112.398875; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Brittan JL, 2015, MICROBES INFECT, V17, P360, DOI 10.1016/j.micinf.2014.12.013; Broadbent JR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-533; Buccato S, 2006, J INFECT DIS, V194, P331, DOI 10.1086/505433; Chang Chungyu, 2013, Methods Mol Biol, V966, P77, DOI 10.1007/978-1-62703-245-2_5; Cheesman SE, 2007, RES MICROBIOL, V158, P2, DOI 10.1016/j.resmic.2006.10.005; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Danne C, 2012, RES MICROBIOL, V163, P645, DOI 10.1016/j.resmic.2012.10.012; deRuyter PGGA, 1996, J BACTERIOL, V178, P3434, DOI 10.1128/jb.178.12.3434-3439.1996; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; Forde BM, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S13; Ganguli K, 2015, PEDIATR RES, V77, P528, DOI 10.1038/pr.2015.5; Garcia CEV, 2015, APPL ENVIRON MICROB, V81, P2050, DOI 10.1128/AEM.03949-14; Gaspar AH, 2006, J BACTERIOL, V188, P1526, DOI 10.1128/JB.188.4.1526-1533.2006; Gorbach SL, 2000, AM J GASTROENTEROL, V95, pS2, DOI 10.1016/S0002-9270(99)00806-0; Harlow E., 1988, ANTIBODIES LAB MANUA; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119, DOI 10.1128/AEM.55.12.3119-3123.1989; Kankainen M, 2009, P NATL ACAD SCI USA, V106, P17193, DOI 10.1073/pnas.0908876106; Kant R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102762; Krishnan V, 2015, IUBMB LIFE, V67, P533, DOI 10.1002/iub.1400; Kuipers OP, 1998, J BIOTECHNOL, V64, P15, DOI 10.1016/S0168-1656(98)00100-X; Lebeer S, 2012, APPL ENVIRON MICROB, V78, P185, DOI 10.1128/AEM.06192-11; Lebeer S, 2009, APPL ENVIRON MICROB, V75, P3554, DOI 10.1128/AEM.02919-08; Lee S, 2011, J BACTERIOL, V193, P5034, DOI 10.1128/JB.05601-11; Lerche M, 1961, ZENTRALBL BAKTERIOL, V180, P324; Maisey HC, 2008, FASEB J, V22, P1715, DOI 10.1096/fj.07-093963; Manetti AGO, 2014, ADV M C M, P151, DOI 10.1079/9781780642550.0151; Neville BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040592; Nishiyama K, 2016, ANIM SCI J, V87, P809, DOI 10.1111/asj.12491; O'Callaghan J, 2013, CURR TOP MICROBIOL, V358, P119, DOI 10.1007/82_2011_187; Oxaran V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050989; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PINTO M, 1983, BIOL CELL, V47, P323; Quigley BR, 2010, INFECT IMMUN, V78, P1294, DOI 10.1128/IAI.01037-09; Rakoff-Nahoum S, 2006, CURR TOP MICROBIOL, V308, P1; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Reunanen J, 2012, APPL ENVIRON MICROB, V78, P2337, DOI 10.1128/AEM.07047-11; Reuter G, 2001, Curr Issues Intest Microbiol, V2, P43; Ribet D, 2015, MICROBES INFECT, V17, P173, DOI 10.1016/j.micinf.2015.01.004; Rintahaka J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113922; Rosini R, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00006; Savijoki K, 1992, HIGH LEVEL HETEROLOG, V186, P255; SHARPE ME, 1973, J GEN MICROBIOL, V77, P37, DOI 10.1099/00221287-77-1-37; Smokvina T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068731; Taweechotipatr M, 2009, FEMS MICROBIOL LETT, V293, P65, DOI 10.1111/j.1574-6968.2009.01506.x; Toh HS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0075073, 10.1371/journal.pone.0064989]; Tripathi P, 2013, ACS NANO, V7, P3685, DOI 10.1021/nn400705u; Turroni F, 2013, P NATL ACAD SCI USA, V110, P11151, DOI 10.1073/pnas.1303897110; Varhimo E, 2011, VET MICROBIOL, V149, P381, DOI 10.1016/j.vetmic.2010.11.010; von Ossowski I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064416; von Ossowski I, 2011, APPL ENVIRON MICROB, V77, P4465, DOI 10.1128/AEM.02497-10; von Ossowski I, 2010, APPL ENVIRON MICROB, V76, P2049, DOI 10.1128/AEM.01958-09	58	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145718	10.1371/journal.pone.0145718	http://dx.doi.org/10.1371/journal.pone.0145718			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709916	Green Submitted, Green Published, gold			2022-12-26	WOS:000367451400072
J	Bryan, R; Aronson, JK; ten Hacken, P; Williams, A; Jordan, S				Bryan, Rachel; Aronson, Jeffrey K.; ten Hacken, Pius; Williams, Alison; Jordan, Sue			Patient Safety in Medication Nomenclature: Orthographic and Semantic Properties of International Nonproprietary Names	PLOS ONE			English	Article							VISUAL WORD RECOGNITION; SOUND-ALIKE DRUGS; LOOK-ALIKE; DOUBLE-BLIND; ERRORS; MEDICINES; SIMILARITY; LENGTH	Background Confusion between look-alike and sound-alike (LASA) medication names (such as mercaptamine and mercaptopurine) accounts for up to one in four medication errors, threatening patient safety. Error reduction strategies include computerized physician order entry interventions, and 'Tall Man' lettering. The purpose of this study is to explore the medication name designation process, to elucidate properties that may prime the risk of confusion. Methods and Findings We analysed the formal and semantic properties of 7,987 International Non-proprietary Names (INNs), in relation to naming guidelines of the World Health Organization (WHO) INN programme, and have identified potential for errors. We explored: their linguistic properties, the underlying taxonomy of stems to indicate pharmacological interrelationships, and similarities between INNs. We used Microsoft Excel for analysis, including calculation of Levenshtein edit distance (LED). Compliance with WHO naming guidelines was inconsistent. Since the 1970s there has been a trend towards compliance in formal properties, such as word length, but longer names published in the 1950s and 1960s are still in use. The stems used to show pharmacological interrelationships are not spelled consistently and the guidelines do not impose an unequivocal order on them, making the meanings of INNs difficult to understand. Pairs of INNs sharing a stem (appropriately or not) often have high levels of similarity (< 5 LED), and thus have greater potential for confusion. Conclusions We have revealed a tension between WHO guidelines stipulating use of stems to denote meaning, and the aim of reducing similarities in nomenclature. To mitigate this tension and reduce the risk of confusion, the stem system should be made clear and well ordered, so as to avoid compounding the risk of confusion at the clinical level. The interplay between the different WHO INN naming principles should be further examined, to better understand their implications for the problem of LASA errors.	[Bryan, Rachel; Williams, Alison; Jordan, Sue] Swansea Univ, Swansea, W Glam, Wales; [Aronson, Jeffrey K.] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [ten Hacken, Pius] Univ Innsbruck, Inst Translat Studies, A-6020 Innsbruck, Austria	Swansea University; University of Oxford; University of Innsbruck	Bryan, R (corresponding author), Swansea Univ, Swansea, W Glam, Wales.	r.bryan@swansea.ac.uk	jordan, sue/O-1297-2019; Bryan, Rachel/Q-9347-2016; Hacken, Pius ten/AAJ-2641-2021	jordan, sue/0000-0002-5691-2987; Bryan, Rachel/0000-0001-8617-3882; 	Arts and Humanities Research Council; AHRC	Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))	The authors report no grants, no funding, no sponsors for the current work. R Bryan was funded by the Arts and Humanities Research Council between 2009 and 2012, for a Master's, during which time she developed an early incantation of this study and presented it in her thesis.; Rachel Bryan was funded by the Arts and Humanities Research Council (AHRC) between 2009 and 2012 to complete a Master's, during which she developed an early incantation of this study. The authors thank the AHRC for their support. We are particularly grateful for the critical remarks of Kent Vrana and an anonymous reviewer, whose suggestions enabled us to improve our paper considerably.	Aronson JK, 2009, QJM-INT J MED, V102, P513, DOI 10.1093/qjmed/hcp052; Bryan R, 2015, WORD FORMATION TRANS; Choi SH, 2002, J NEUROSCI RES, V67, P411, DOI 10.1002/jnr.10102; Coltheart M, 2001, PSYCHOL REV, V108, P204, DOI 10.1037//0033-295X.108.1.204; DAVE NK, 1990, ANN ALLERGY, V65, P298; Dogne Jean-Michel, 2002, Am J Respir Med, V1, P11; Emmerton LM, 2012, INT J CLIN PHARM-NET, V34, P4, DOI 10.1007/s11096-011-9595-x; Galanter WL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101977; Garfield S., 2010, JUST MY TYPE BOOK FO; Ghaleb MA, 2010, ARCH DIS CHILD, V95, P113, DOI 10.1136/adc.2009.158485; Jordan S, 2014, J NURS MANAGE, V22, P271, DOI 10.1111/jonm.12238; Kaushal R, 2001, JAMA-J AM MED ASSOC, V285, P2114, DOI 10.1001/jama.285.16.2114; Kovacic Laurel, 2011, J Oncol Pharm Pract, V17, P104, DOI 10.1177/1078155209354135; Lambert BL, 2005, DRUG SAFETY, V28, P495, DOI 10.2165/00002018-200528060-00003; Lambert BL, 2003, SOC SCI MED, V57, P1939, DOI 10.1016/S0277-9536(03)00059-5; Lambert BL, 2001, DRUG INF J, V35, P163, DOI 10.1177/009286150103500119; Lambert BL, 1999, MED CARE, V37, P1214, DOI 10.1097/00005650-199912000-00005; Low JG, 2014, LANCET INFECT DIS, V14, P706, DOI 10.1016/S1473-3099(14)70730-3; [MHPRA Medicines and Healthcare Products Regulatory Agency], 2002, MERC MERC CONF DRUG; Moorman SM, 2008, GERONTOLOGIST, V48, P811, DOI 10.1093/geront/48.6.811; National Patient Safety Agency NPSA, 2006, GUID GRAPH DES MED P; National Reporting and Learning Service NRLS, 2009, SAF DOS IMPR US MED; New B, 2006, PSYCHON B REV, V13, P45, DOI 10.3758/BF03193811; Nute Christine, 2014, Nurs Stand, V29, P45, DOI 10.7748/ns.29.12.45.e9191; Ostini Remo, 2012, Int J Pharm Pract, V20, P349, DOI 10.1111/j.2042-7174.2012.00210.x; Rastle K, 1998, PSYCHON B REV, V5, P277, DOI 10.3758/BF03212951; Runciman WB, 2003, INT J QUAL HEALTH C, V15, pI49, DOI 10.1093/intqhc/mzg085; Sanders C, 2004, CAMBRIDGE COMPANION; Sauberan JB, 2010, AM J HEALTH-SYST PH, V67, P49, DOI 10.2146/ajhp090122; Tuohy N, 2005, J EMERG NURS, V31, P569, DOI 10.1016/j.jen.2005.07.012; WHO, 1997, GUID US INT NONPR NA; World Health Organization WHO, 2009, WHO STEMB 2009 US ST	32	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145431	10.1371/journal.pone.0145431	http://dx.doi.org/10.1371/journal.pone.0145431			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ4SI	26701761	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092600079
J	Cheng, X; Guan, WW; Sun, S; Li, BS; Li, HJ; Kang, FB; Kang, JW; Yang, DL; Nassal, M; Sun, DX				Cheng, Xin; Guan, Weiwei; Sun, Shuo; Li, Baosheng; Li, Haijun; Kang, Fubiao; Kang, Jiwen; Yang, Dongliang; Nassal, Michael; Sun, Dianxing			Stable Human Hepatoma Cell Lines for Efficient Regulated Expression of Nucleoside/Nucleotide Analog Resistant and Vaccine Escape Hepatitis B Virus Variants and Woolly Monkey Hepatitis B Virus	PLOS ONE			English	Article							PRIMARY TUPAIA HEPATOCYTES; SURFACE-ANTIGEN VARIANTS; CIRCULAR DNA FORMATION; ARGININE-RICH DOMAIN; DRUG-RESISTANT; HEPG2 CELLS; P-PROTEIN; RECOMBINANT BACULOVIRUS; REVERSE-TRANSCRIPTASE; COMMON STRUCTURE	Hepatitis B virus (HBV) causes acute and chronic hepatitis B (CHB). Due to its error-prone replication via reverse transcription, HBV can rapidly evolve variants that escape vaccination and/or become resistant to CHB treatment with nucleoside/nucleotide analogs (NAs). This is particularly problematic for the first generation NAs lamivudine and adefovir. Though now superseded by more potent NAs, both are still widely used. Furthermore, resistance against the older NAs can contribute to cross-resistance against more advanced NAs. For lack of feasible HBV infection systems, the biology of such variants is not well understood. From the recent discovery of Na+-taurocholate cotransporting polypeptide (NTCP) as an HBV receptor new in vitro infection systems are emerging, yet access to the required large amounts of virions, in particular variants, remains a limiting factor. Stably HBV producing cell lines address both issues by allowing to study intracellular viral replication and as a permanent source of defined virions. Accordingly, we generated a panel of new tetracycline regulated TetOFF HepG2 hepatoma cell lines which produce six lamivudine and adefovir resistance-associated and two vaccine escape variants of HBV as well as the model virus woolly monkey HBV (WMHBV). The cell line-borne viruses reproduced the expected NA resistance profiles and all were equally sensitive against a non-NA drug. The new cell lines should be valuable to investigate under standardized conditions HBV resistance and cross-resistance. With titers of secreted virions reaching >3x10(7) viral genome equivalents per ml they should also facilitate exploitation of the new in vitro infection systems.	[Cheng, Xin; Guan, Weiwei; Sun, Shuo; Li, Baosheng; Li, Haijun; Kang, Fubiao; Kang, Jiwen; Sun, Dianxing] Bethune Int Peace Hosp, Liver Dis Diag & Treatment Ctr PLA, Shijiazhuang, Peoples R China; [Sun, Shuo] Troop 66220 PLA, Xingtai, Xingtai Of Hebe, Peoples R China; [Yang, Dongliang] Huazhong Univ Sci & Technol, Dept Infect Dis, Union Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China; [Nassal, Michael] Univ Hosp Freiburg, Dept Internal Med Mol Biol 2, Freiburg, Germany	Huazhong University of Science & Technology; University of Freiburg	Nassal, M (corresponding author), Univ Hosp Freiburg, Dept Internal Med Mol Biol 2, Freiburg, Germany.	nassal2@ukl.uni-freiburg.de; sundianxing@hotmail.com	Nassal, Michael/U-4529-2019	Nassal, Michael/0000-0003-2204-9158	National Major Science and Technology Special Project for Infectious Diseases of China [2012ZX10004503-012, 2008ZX10002-011]; European Commission	National Major Science and Technology Special Project for Infectious Diseases of China; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the National Major Science and Technology Special Project for Infectious Diseases of China (2012ZX10004503-012, 2008ZX10002-011). Initial experiments were supported by the European Commission through project HepBvar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amini-Bavil-Olyaee S, 2010, J VIROL, V84, P1026, DOI 10.1128/JVI.01796-09; Bartholomeusz A, 2004, ANTIVIR THER, V9, P149; Beck J, 2002, NUCLEIC ACIDS RES, V30, P1679, DOI 10.1093/nar/30.7.1679; Beck J, 2007, WORLD J GASTROENTERO, V13, P48, DOI 10.3748/wjg.v13.i1.48; Beck J, 2011, J VIROL, V85, P7742, DOI 10.1128/JVI.00482-11; Bellecave P, 2009, HEPATOLOGY, V50, P46, DOI 10.1002/hep.22951; BIRNBAUM F, 1990, J VIROL, V64, P3319, DOI 10.1128/JVI.64.7.3319-3330.1990; Brezillon N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025096; Brunelle MN, 2005, HEPATOLOGY, V41, P1391, DOI 10.1002/hep.20723; Carman WF, 1999, J HEPATOL, V31, P195, DOI 10.1016/S0168-8278(99)80213-X; Carman WF, 1997, J VIRAL HEPATITIS, V4, P11, DOI 10.1111/j.1365-2893.1997.tb00155.x; Chevaliez S, 2013, J HEPATOL, V58, P676, DOI 10.1016/j.jhep.2012.11.039; Chotiyaputta W, 2009, NAT REV GASTRO HEPAT, V6, P453, DOI 10.1038/nrgastro.2009.107; Christen V, 2007, J VIROL, V81, P159, DOI 10.1128/JVI.01292-06; Dallmeier K, 2008, ADV INFECT DIS; Das K, 2001, J VIROL, V75, P4771, DOI 10.1128/JVI.75.10.4771-4779.2001; Delaney WE, 1998, HEPATOLOGY, V28, P1134, DOI 10.1002/hep.510280432; Deres K, 2003, SCIENCE, V299, P893, DOI 10.1126/science.1077215; Gehring AJ, 2007, J VIROL, V81, P2940, DOI 10.1128/JVI.02415-06; Glebe D, 2005, GASTROENTEROLOGY, V129, P234, DOI 10.1053/j.gastro.2005.03.090; Guo H, 2007, J VIROL, V81, P12472, DOI 10.1128/JVI.01123-07; Ireland JH, 2000, HEPATOLOGY, V31, P1176, DOI 10.1053/he.2000.6407; Iwamoto M, 2014, BIOCHEM BIOPH RES CO, V443, P808, DOI 10.1016/j.bbrc.2013.12.052; Kamili S, 2009, HEPATOLOGY, V49, P1483, DOI 10.1002/hep.22796; Kock J, 2001, J VIROL, V75, P5084, DOI 10.1128/JVI.75.11.5084-5089.2001; Ladner SK, 1997, ANTIMICROB AGENTS CH, V41, P1715, DOI 10.1128/AAC.41.8.1715; Ladner SK, 1998, ANTIVIR CHEM CHEMOTH, V9, P65; Lanford RE, 2003, J VIROL, V77, P7814, DOI 10.1128/JVI.77.14.7814-7819.2003; Le Pogam S, 2005, J VIROL, V79, P1871, DOI 10.1128/JVI.79.3.1871-1887.2005; Liu JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053392; Lo AOS, 2014, EXPERT REV GASTROENT, V8, P607, DOI 10.1586/17474124.2014.909724; Locarnini SA, 2010, ANTIVIR THER, V15, P451, DOI 10.3851/IMP1499; Lucifora J, 2008, J GEN VIROL, V89, P1819, DOI 10.1099/vir.0.83659-0; Lucifora J, 2010, HEPATOLOGY, V51, P63, DOI 10.1002/hep.23230; Marion MJ, 2010, METHODS MOL BIOL, V640, P261, DOI 10.1007/978-1-60761-688-7_13; NASSAL M, 1992, J VIROL, V66, P4107, DOI 10.1128/JVI.66.7.4107-4116.1992; Nassal M, 2008, VIRUS RES, V134, P235, DOI 10.1016/j.virusres.2007.12.024; Nassal M, 2015, GUT, V64, P1972, DOI 10.1136/gutjnl-2015-309809; Nassal M, 2009, FUTURE VIROL, V4, P55, DOI 10.2217/17460794.4.1.55; Ni Y, 2014, GASTROENTEROLOGY, V146, P1070, DOI 10.1053/j.gastro.2013.12.024; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; PASEK M, 1979, NATURE, V282, P575, DOI 10.1038/282575a0; Petersen J, 2008, NAT BIOTECHNOL, V26, P335, DOI 10.1038/nbt1389; Prange R, 2012, MED MICROBIOL IMMUN, V201, P449, DOI 10.1007/s00430-012-0267-9; Protzer-Knolle U, 1998, HEPATOLOGY, V27, P254, DOI 10.1002/hep.510270138; Qi XP, 2007, ANTIVIR THER, V12, P355; Ren ST, 2001, J VIROL, V75, P1104, DOI 10.1128/JVI.75.3.1104-1116.2001; Rodgers MA, 2009, J AM CHEM SOC, V131, P5030, DOI 10.1021/ja809949r; Schonig K, 2010, METHOD ENZYMOL, V477, P429, DOI 10.1016/S0076-6879(10)77022-1; Seigneres B, 2002, HEPATOLOGY, V36, P710, DOI 10.1053/jhep.2002.35070; SELLS MA, 1987, P NATL ACAD SCI USA, V84, P1005, DOI 10.1073/pnas.84.4.1005; SERWER P, 1995, J CHROMATOGR A, V698, P251, DOI 10.1016/0021-9673(94)01259-H; Stray SJ, 2006, J MOL RECOGNIT, V19, P542, DOI 10.1002/jmr.801; Stuyver LJ, 2001, HEPATOLOGY, V33, P751, DOI 10.1053/jhep.2001.22166; Sun DX, 2006, J HEPATOL, V45, P636, DOI 10.1016/j.jhep.2006.05.019; Sun DX, 2010, J HEPATOL, V52, P817, DOI 10.1016/j.jhep.2009.10.038; Sureau C, 2013, HEPATOLOGY, V57, P985, DOI 10.1002/hep.26125; Trepo C, 2014, LANCET, V384, P2053, DOI 10.1016/S0140-6736(14)60220-8; Villet S, 2008, J HEPATOL, V48, P747, DOI 10.1016/j.jhep.2008.01.027; Walker A, 2011, SCI REP-UK, V1, DOI 10.1038/srep00005; Wang TZ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-231; Wang YX, 2012, J VIROL, V86, P6394, DOI 10.1128/JVI.00011-12; Wang ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060306; Warner N, 2008, HEPATOLOGY, V48, P88, DOI 10.1002/hep.22295; Weinberger KM, 2000, J VIROL METHODS, V85, P75, DOI 10.1016/S0166-0934(99)00154-8; Xu CX, 2010, J VIROL, V84, P9332, DOI 10.1128/JVI.00918-10; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049; Zeisel M.B., 2015, GUT; Zhang MS, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-292; Zhao R, 2011, WORLD J GASTROENTERO, V17, P1152, DOI 10.3748/wjg.v17.i9.1152; Zhong GC, 2013, J VIROL, V87, P7176, DOI 10.1128/JVI.03533-12; Zhu Y, 2007, J CLIN MICROBIOL, V45, P3335, DOI 10.1128/JCM.00272-07; Zidek Zdenek, 2005, Biomedical Papers (Olomouc), V149, P315; Zoulim F, 2015, COLD SPRING HARB PER, V5; Zoulim F, 2009, GASTROENTEROLOGY, V137, P1593, DOI 10.1053/j.gastro.2009.08.063	75	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145746	10.1371/journal.pone.0145746	http://dx.doi.org/10.1371/journal.pone.0145746			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26699621	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092600127
J	Dell'Anno, A; Carugati, L; Corinaldesi, C; Riccioni, G; Danovaro, R				Dell'Anno, Antonio; Carugati, Laura; Corinaldesi, Cinzia; Riccioni, Giulia; Danovaro, Roberto			Unveiling the Biodiversity of Deep-Sea Nematodes through Metabarcoding: Are We Ready to Bypass the Classical Taxonomy?	PLOS ONE			English	Article							FREE-LIVING MARINE; POPULATION GENETIC-STRUCTURE; DIVERSITY; MAGNITUDE; SEQUENCES; PATTERNS	Nematodes inhabiting benthic deep-sea ecosystems account for >90% of the total metazoan abundances and they have been hypothesised to be hyper-diverse, but their biodiversity is still largely unknown. Metabarcoding could facilitate the census of biodiversity, especially for those tiny metazoans for which morphological identification is difficult. We compared, for the first time, different DNA extraction procedures based on the use of two commercial kits and a previously published laboratory protocol and tested their suitability for sequencing analyses of 18S rDNA of marine nematodes. We also investigated the reliability of Roche 454 sequencing analyses for assessing the biodiversity of deep-sea nematode assemblages previously morphologically identified. Finally, intra-genomic variation in 18S rRNA gene repeats was investigated by Illumina MiSeq in different deep-sea nematode morphospecies to assess the influence of polymorphisms on nematode biodiversity estimates. Our results indicate that the two commercial kits should be preferred for the molecular analysis of biodiversity of deep-sea nematodes since they consistently provide amplifiable DNA suitable for sequencing. We report that the morphological identification of deep-sea nematodes matches the results obtained by metabarcoding analysis only at the order-family level and that a large portion of Operational Clustered Taxonomic Units (OCTUs) was not assigned. We also show that independently from the cut-off criteria and bioinformatic pipelines used, the number of OCTUs largely exceeds the number of individuals and that 18S rRNA gene of different morpho-species of nematodes displayed intragenomic polymorphisms. Our results indicate that metabarcoding is an important tool to explore the diversity of deep-sea nematodes, but still fails in identifying most of the species due to limited number of sequences deposited in the public databases, and in providing quantitative data on the species encountered. These aspects should be carefully taken into account before using metabarcoding in quantitative ecological research and monitoring programmes of marine biodiversity.	[Dell'Anno, Antonio; Carugati, Laura; Corinaldesi, Cinzia; Riccioni, Giulia; Danovaro, Roberto] Polytech Univ Marche, Dept Life & Environm Sci, I-60131 Ancona, Italy; [Danovaro, Roberto] Stn Zool Anton Dohrn, Naples, Italy	Marche Polytechnic University; Stazione Zoologica Anton Dohrn di Napoli	Danovaro, R (corresponding author), Polytech Univ Marche, Dept Life & Environm Sci, Via Brecce Bianche, I-60131 Ancona, Italy.	r.danovaro@univpm.it	Carugati, Laura/AAM-6614-2021; Dell'Anno, Antonio AD/G-9468-2012	Carugati, Laura/0000-0002-0921-6911; Dell'Anno, Antonio AD/0000-0002-4324-7834; Riccioni, Giulia/0000-0003-3934-8840	EU Project DEVOTES [308392]; EU Project MIDAS (Managing Impacts of Deep-seA reSource exploitation) [603418]; Italian Project RITMARE (MIUR); Italian Project EXPLODIVE (FIRB) [I31J10000060001]	EU Project DEVOTES; EU Project MIDAS (Managing Impacts of Deep-seA reSource exploitation); Italian Project RITMARE (MIUR); Italian Project EXPLODIVE (FIRB)	This research was financially supported by the EU Projects DEVOTES (grant agreement n. 308392), MIDAS (Managing Impacts of Deep-seA reSource exploitation; grant agreement n. 603418) and the Italian Projects RITMARE (MIUR, coordinated by CNR) and EXPLODIVE (FIRB 2008, contract no. I31J10000060001).	Appeltans W, 2012, CURR BIOL, V22, P2189, DOI 10.1016/j.cub.2012.09.036; Bhadury P, 2008, MAR BIOL, V154, P509, DOI 10.1007/s00227-008-0945-8; Bhadury P, 2007, ZOOL SCR, V36, P93, DOI 10.1111/j.1463-6409.2006.00250.x; Bhadury P, 2006, MAR ECOL PROG SER, V320, P1, DOI 10.3354/meps320001; Bik HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078230; Bik HM, 2012, MOL ECOL, V21, P1048, DOI 10.1111/j.1365-294X.2011.05297.x; Bik HM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-389; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; Creer S, 2010, MOL ECOL, V19, P4, DOI 10.1111/j.1365-294X.2009.04473.x; Danovaro R, 2008, CURR BIOL, V18, P1, DOI 10.1016/j.cub.2007.11.056; Danovaro R, 2014, TRENDS ECOL EVOL, V29, P465, DOI 10.1016/j.tree.2014.06.002; De Ley P, 2005, PHILOS T R SOC B, V360, P1945, DOI 10.1098/rstb.2005.1726; De Ley P, 1999, NEMATOLOGY, V1, P591, DOI 10.1163/156854199508559; De Ley P, 2006, QUICK TOUR NEMATODE; Deprez T, 2005, WORLD WIDE WEB ELECT; Derycke S, 2007, MAR BIOL, V151, P1799, DOI 10.1007/s00227-007-0609-0; Derycke S, 2005, MAR ECOL PROG SER, V300, P91, DOI 10.3354/meps300091; Derycke S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013716; Derycke S, 2010, ZOOL SCR, V39, P276, DOI 10.1111/j.1463-6409.2009.00420.x; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Floyd RM, 2005, MOL ECOL NOTES, V5, P611, DOI 10.1111/j.1471-8286.2005.01009.x; Fonseca G, 2008, BIOL J LINN SOC, V94, P737, DOI 10.1111/j.1095-8312.2008.01015.x; Fonseca VG, 2014, GLOBAL ECOL BIOGEOGR, V23, P1293, DOI 10.1111/geb.12223; Fonseca VG, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1095; Glenn TC, 2011, MOL ECOL RESOUR, V11, P759, DOI 10.1111/j.1755-0998.2011.03024.x; HEIP C, 1985, OCEANOGR MAR BIOL, V23, P399; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Lambshead PJD, 2004, NEMATOLOGY: ADVANCES AND PERSPECTIVES, VOL 1: NEMATODE MORPHOLOGY, PHYSIOLOGY AND ECOLOGY, P438, DOI 10.1079/9780851996455.0438; Lecroq B, 2011, P NATL ACAD SCI USA, V108, P13177, DOI 10.1073/pnas.1018426108; Meldal BHM, 2007, MOL PHYLOGENET EVOL, V42, P622, DOI 10.1016/j.ympev.2006.08.025; Moens T, 1998, HELGOLANDER MEERESUN, V52, P115, DOI 10.1007/BF02908742; Platt H.M., 1983, SYNOPSES BRIT FAUNA, V28; PLATT HM, 1988, BRIT CHROMADORIDS 2; Porazinska DL, 2010, ZOOTAXA, P55, DOI 10.11646/zootaxa.2427.1.6; Porazinska DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044641; Porazinska DL, 2010, MOL ECOL, V19, P5521, DOI 10.1111/j.1365-294X.2010.04891.x; Porazinska DL, 2009, MOL ECOL RESOUR, V9, P1439, DOI 10.1111/j.1755-0998.2009.02611.x; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Ramirez-Llodra E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022588; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Shaw AK, 2008, ENVIRON MICROBIOL, V10, P2200, DOI 10.1111/j.1462-2920.2008.01626.x; Snelgrove PVR, 2014, TRENDS ECOL EVOL, V29, P398, DOI 10.1016/j.tree.2014.05.002; THOMAS WK, 2011, MARINE BENTHIC NEMAT, P22; VINCX M, 1994, ADV MAR BIOL, V30, P1, DOI 10.1016/S0065-2881(08)60061-9	49	51	51	3	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0144928	10.1371/journal.pone.0144928	http://dx.doi.org/10.1371/journal.pone.0144928			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26701112	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092600036
J	Lussi, A; Carvalho, TS				Lussi, Adrian; Carvalho, Thiago Saads			Analyses of the Erosive Effect of Dietary Substances and Medications on Deciduous Teeth	PLOS ONE			English	Article							IN-VITRO; DENTAL EROSION; TOOTH WEAR; PERMANENT ENAMEL; CITRIC-ACID; SOFT DRINKS; PH; CALCIUM; DISSOLUTION; CHILDREN	This study aimed at analysing the erosive potential of 30 substances (drinks, candies, and medicaments) on deciduous enamel, and analyse the associated chemical factors with enamel dissolution. We analysed the initial pH, titratable acidity (TA) to pH 5.5, calcium (Ca), inorganic phosphate (P-i), and fluoride (F) concentration, and degree of saturation ((pK-pI)(HAP), (pK-pI)(FAP), and (pK-pI)(CaF2)) of all substances. Then, we randomly distributed 300 specimens of human deciduous enamel into 30 groups (n = 10 for each of the substances tested. We also prepared 20 specimens of permanent enamel for the sake of comparison between the two types of teeth, and we tested them in mineral water and Coca-Cola (R). In all specimens, we measured surface hardness (VHN: Vickers hardness numbers) and surface reflection intensity (SRI) at baseline (SHbaseline and SRIbaseline), after a total of 2 min (SH2min) and after 4 min (SH4min and SRI4min) erosive challenges (60 ml of substance for 6 enamel samples; 30 degrees C, under constant agitation at 95 rpm). There was no significant difference in SHbaseline between deciduous and permanent enamel. Comparing both teeth, we observed that after the first erosive challenge with Coca-Cola (R), a significantly greater hardness loss was seen in deciduous (-90.2 +/- 11.3 VHN) than in permanent enamel (-44.3 +/- 12.2 VHN; p = 0.007), but no differences between the two types of teeth were observed after two challenges (SH4min). After both erosive challenges, all substances except for mineral water caused a significant loss in relative surface reflectivity intensity, and most substances caused a significant loss in surface hardness. Multiple regression analyses showed that pH, TA and Ca concentration play a significant role in initial erosion of deciduous enamel. We conclude that drinks, foodstuffs and medications commonly consumed by children can cause erosion of deciduous teeth and erosion is mainly associated with pH, titratable acidity and calcium concentration in the solution.	[Lussi, Adrian; Carvalho, Thiago Saads] Univ Bern, Dept Prevent Restorat & Pediat Dent, Bern, Switzerland	University of Bern	Lussi, A (corresponding author), Univ Bern, Dept Prevent Restorat & Pediat Dent, Bern, Switzerland.	adrian.lussi@zmk.unibe.ch	Carvalho, Thiago/GWC-7662-2022; Carvalho, Thiago Saads/B-8945-2012	Carvalho, Thiago Saads/0000-0002-2435-1169	Deutsche Gesellschaft fur Zahnerhaltung (DGPZM-Wissenschaftsfonds)	Deutsche Gesellschaft fur Zahnerhaltung (DGPZM-Wissenschaftsfonds)	This study was funded by the Deutsche Gesellschaft fur Zahnerhaltung (DGPZM-Wissenschaftsfonds) to AL and TSC.; The present study was supported by the Deutsche Gesellschaft fur Zahnerhaltung (DGPZM-Wissenschaftsfonds). The authors show their gratitude towards G. Fischer and Prof. Hausler, Institute of Mathematical Statistics, University of Bern, for the statistical analyses, and to Brigitte Megert for her appreciated efforts in the laboratory. We also thank Dr. R.P. Shellis for his valuable comments on this manuscript.	Amaechi BT, 1999, J ORAL REHABIL, V26, P624, DOI 10.1046/j.1365-2842.1999.00433.x; Attin T, 2003, ARCH ORAL BIOL, V48, P753, DOI 10.1016/S0003-9969(03)00156-0; Barbour ME, 2003, EUR J ORAL SCI, V111, P428, DOI 10.1034/j.1600-0722.2003.00059.x; Brevik SC, 2013, J DENT, V41, P428, DOI 10.1016/j.jdent.2013.02.011; Carvalho TS, 2014, MONOGR ORAL SCI, V25, P262, DOI 10.1159/000360712; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; Dawes Colin, 2003, J Can Dent Assoc, V69, P722; Dugmore CR, 2004, BRIT DENT J, V196, P283, DOI 10.1038/sj.bdj.4811041; Featherstone JDB, 2006, MG ORAL SCI, V20, P66, DOI 10.1159/000093351; Ganss C, 2001, COMMUNITY DENT ORAL, V29, P264, DOI 10.1034/j.1600-0528.2001.290405.x; Ganss C, 2014, MONOGR ORAL SCI, V25, P22, DOI 10.1159/000359935; Harding MA, 2010, COMMUNITY DENT HLTH, V27, P41, DOI 10.1922/CDH_2447Harding05; Hemingway C A, 2006, Br Dent J, V201, P447, DOI 10.1038/sj.bdj.4814073; Hughes JA, 1999, J DENT, V27, P285, DOI 10.1016/S0300-5712(98)00069-4; Hughes JA, 2000, J DENT, V28, P147, DOI 10.1016/S0300-5712(99)00060-3; Hunter L, 2009, INT J PAEDIATR DENT, V19, P325, DOI 10.1111/j.1365-263X.2009.00975.x; Hunter ML, 2008, INT J PAEDIATR DENT, V18, P251, DOI 10.1111/j.1365-263X.2008.00917.x; Hunter ML, 2000, J DENT, V28, P257, DOI 10.1016/S0300-5712(99)00079-2; Hunter ML, 2000, J DENT, V28, P265, DOI 10.1016/S0300-5712(99)00074-3; JARVINEN VK, 1991, J DENT RES, V70, P942, DOI 10.1177/00220345910700060601; Jensdottir T, 2005, J DENT, V33, P569, DOI 10.1016/j.jdent.2004.12.002; Johansson AK, 2004, EUR J ORAL SCI, V112, P484, DOI 10.1111/j.1600-0722.2004.00172.x; Johansson AK, 2001, J DENT, V29, P333, DOI 10.1016/S0300-5712(01)00029-X; Kreulen CM, 2010, CARIES RES, V44, P151, DOI 10.1159/000308567; LAGERLOF F, 1984, J DENT RES, V63, P618, DOI 10.1177/00220345840630050201; LARSEN MJ, 1986, ARCH ORAL BIOL, V31, P757, DOI 10.1016/0003-9969(86)90008-7; Larsen MJ, 1999, CARIES RES, V33, P81, DOI 10.1159/000016499; Lippert F, 2004, EUR J ORAL SCI, V112, P61, DOI 10.1111/j.0909-8836.2004.00095.x; LUSSI A, 1995, CARIES RES, V29, P349, DOI 10.1159/000262091; LUSSI A, 1993, CARIES RES, V27, P387, DOI 10.1159/000261569; Lussi A, 2011, CARIES RES, V45, P2, DOI 10.1159/000325915; Lussi A, 2014, MONOGR ORAL SCI, V25, P1, DOI 10.1159/000360380; Lussi A, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.9.097009; Lussi A, 2012, BRIT J NUTR, V107, P252, DOI 10.1017/S0007114511002820; Magalhaes AC, 2009, J APPL ORAL SCI, V17, P56, DOI 10.1590/S1678-77572009000100011; MCCANN HG, 1968, ARCH ORAL BIOL, V13, P987, DOI 10.1016/0003-9969(68)90014-9; MCDOWELL H, 1977, J RES NBS A PHYS CH, V81, P273, DOI 10.6028/jres.081A.017; O'Sullivan EA, 2000, J DENT CHILD, V67, P186; Radlanski RJ, 2001, EUR J ORAL SCI, V109, P409, DOI 10.1034/j.1600-0722.2001.00149.x; Rakhmatullina E, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.11.117009; Rakhmatullina E, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3631791; Rios Daniela, 2007, Oral Health Prev Dent, V5, P167; Shellis RP, 2013, CARIES RES, V47, P601, DOI 10.1159/000351641; Shellis RP, 2011, CARIES RES, V45, P69, DOI 10.1159/000325971; Shellis RP, 2014, MONOGR ORAL SCI, V25, P163, DOI 10.1159/000359943; SHELLIS RP, 1984, ARCH ORAL BIOL, V29, P697, DOI 10.1016/0003-9969(84)90175-4; Shellis RP, 2005, EUR J ORAL SCI, V113, P232, DOI 10.1111/j.1600-0722.2005.00210.x; Sonju Clasen A B, 1997, Adv Dent Res, V11, P523; STACK MV, 1953, BIOCHEM J, V54, pR15; STIEFEL DJ, 1976, J DENT RES, V55, P66, DOI 10.1177/00220345760550012601; TENCATE JM, 1995, EUR J ORAL SCI, V103, P362; Wetton S, 2006, CARIES RES, V40, P213, DOI 10.1159/000092228; WILSON PR, 1989, ARCH ORAL BIOL, V34, P85, DOI 10.1016/0003-9969(89)90130-1; ZERO DT, 1990, CARIES RES, V24, P181, DOI 10.1159/000261263	54	31	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0143957	10.1371/journal.pone.0143957	http://dx.doi.org/10.1371/journal.pone.0143957			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700481	Green Submitted, gold, Green Published			2022-12-26	WOS:000367092600013
J	Menasria, R; Canivet, C; Piret, J; Boivin, G				Menasria, Rafik; Canivet, Coraline; Piret, Jocelyne; Boivin, Guy			Infiltration Pattern of Blood Monocytes into the Central Nervous System during Experimental Herpes Simplex Virus Encephalitis	PLOS ONE			English	Article							TICK-BORNE ENCEPHALITIS; INNATE IMMUNE-RESPONSE; MARROW-DERIVED CELLS; DENDRITIC CELLS; INFLAMMATORY MONOCYTES; TYPE-1 INFECTION; VIRAL MENINGITIS; TNF-ALPHA; MICROGLIA; BRAIN	The kinetics and distribution of infiltrating blood monocytes into the central nervous system and their involvement in the cerebral immune response together with resident macrophages, namely microglia, were evaluated in experimental herpes simplex virus 1 (HSV-1) encephalitis (HSE). To distinguish microglia from blood monocyte-derived macrophages, chimeras were generated by conditioning C57BL/6 recipient mice with chemotherapy regimen followed by transplantation of bone morrow-derived cells that expressed the green fluorescent protein. Mice were infected intranasally with a sub-lethal dose of HSV-1 (1.2x10(6) plaque forming units). Brains were harvested prior to and on days 4, 6, 8 and 10 post-infection for flow cytometry and immunohistochemistry analysis. The amounts of neutrophils (P<0.05) and "Ly6C(hi)" inflammatory monocytes (P<0.001) significantly increased in the CNS compared to non-infected controls on day 6 post-infection, which corresponded to more severe clinical signs of HSE. Levels decreased on day 8 for both leukocytes subpopulations (P<0.05 for inflammatory monocytes compared to non-infected controls) to reach baseline levels on day 10 following infection. The percentage of "Ly6Clow" patrolling monocytes significantly increased (P<0.01) at a later time point (day 8), which correlated with the resolution phase of HSE. Histological analysis demonstrated that blood leukocytes colonized mostly the olfactory bulb and the brainstem, which corresponded to regions where HSV-1 particles were detected. Furthermore, infiltrating cells from the monocytic lineage could differentiate into activated local tissue macrophages that express the microglia marker, ionized calcium-binding adaptor molecule 1. The lack of albumin detection in the brain parenchyma of infected mice showed that the infiltration of blood leukocytes was not necessarily related to a breakdown of the blood-brain barrier but could be the result of a functional recruitment. Thus, our findings suggest that blood monocyte-derived macrophages infiltrate the central nervous system and may contribute, with resident microglia, to the innate immune response seen during experimental HSE.	[Boivin, Guy] CHU Quebec, Res Ctr, Quebec City, PQ, Canada; Univ Laval, Quebec City, PQ, Canada	Laval University; Laval University	Boivin, G (corresponding author), CHU Quebec, Res Ctr, Quebec City, PQ, Canada.	Guy.Boivin@crchudequebec.ulaval.ca		Piret, Jocelyne/0000-0003-4102-0094; Boivin, Guy/0000-0003-3027-4662	Canadian Institutes of Health Research [MOP-89378]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by a grant from the Canadian Institutes of Health Research (grant MOP-89378 to GB). GB is the holder of the Canada research chair on emerging viruses and antiviral resistance. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Armien AG, 2010, BRAIN PATHOL, V20, P738, DOI 10.1111/j.1750-3639.2009.00354.x; Ashhurst TM, 2014, CELL IMMUNOL, V291, P49, DOI 10.1016/j.cellimm.2014.07.002; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Bellavance MA, 2015, BRAIN STRUCT FUNCT, V220, P1759, DOI 10.1007/s00429-014-0759-z; Boivin N, 2013, ANTIVIR RES, V100, P649, DOI 10.1016/j.antiviral.2013.10.007; Boivin N, 2012, J GEN VIROL, V93, P1294, DOI 10.1099/vir.0.041046-0; Casano AM, 2015, DEV CELL, V32, P469, DOI 10.1016/j.devcel.2015.01.018; Chucair-Elliott AJ, 2014, GLIA, V62, P1418, DOI 10.1002/glia.22689; Conrady CD, 2013, J IMMUNOL, V190, P2807, DOI 10.4049/jimmunol.1203265; Conrady CD, 2010, J NEUROIMMUNOL, V220, P1, DOI 10.1016/j.jneuroim.2009.09.013; Daniels BP, 2015, CLIN PHARMACOL THER, V97, P372, DOI 10.1002/cpt.75; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gelpi E, 2005, J NEUROPATH EXP NEUR, V64, P506, DOI 10.1093/jnen/64.6.506; Gelpi E, 2006, J NEUROVIROL, V12, P322, DOI 10.1080/13550280600848746; Getts DR, 2008, J EXP MED, V205, P2319, DOI 10.1084/jem.20080421; Getts DR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-246; Guo YJ, 2015, LIFE SCI, V127, P12, DOI 10.1016/j.lfs.2015.01.036; Hellwig S, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00071; Howe CL, 2012, SCI REP-UK, V2, DOI 10.1038/srep00545; Hu SX, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-123; Jennische E, 2015, J NEUROVIROL, V21, P129, DOI 10.1007/s13365-014-0312-0; Kang SS, 2010, J NEUROIMMUNE PHARM, V5, P370, DOI 10.1007/s11481-010-9208-9; Kastrukoff Lorne F, 2012, Herpesviridae, V3, P4, DOI 10.1186/2042-4280-3-4; Kastrukoff LF, 2010, VIROLOGY, V400, P248, DOI 10.1016/j.virol.2010.02.013; Kaushik DK, 2011, FRONT BIOSCI-LANDMRK, V16, P2187, DOI 10.2741/3847; Kennedy PGE, 2013, J NEUROVIROL, V19, P346, DOI 10.1007/s13365-013-0178-6; Kim JV, 2009, NATURE, V457, P191, DOI 10.1038/nature07591; Lampron A, 2013, J COMP NEUROL, V521, P3863, DOI 10.1002/cne.23363; Lampron A, 2012, CELL TRANSPLANT, V21, P1149, DOI 10.3727/096368911X593154; Lokensgard JR, 2001, J NEUROVIROL, V7, P208; Lundberg P, 2008, J VIROL, V82, P7078, DOI 10.1128/JVI.00619-08; Marques CP, 2008, J IMMUNOL, V181, P6417, DOI 10.4049/jimmunol.181.9.6417; Menasria R, 2013, J VIROL, V87, P7301, DOI 10.1128/JVI.00591-13; Michaud JP, 2014, J CEREBR BLOOD F MET, V34, P1253, DOI 10.1038/jcbfm.2014.80; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Piret J, 2015, REV MED VIROL, V25, P300, DOI 10.1002/rmv.1848; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Prinz M, 2011, GLIA, V59, P177, DOI 10.1002/glia.21104; Prinz M, 2010, J NEUROIMMUNOL, V224, P80, DOI 10.1016/j.jneuroim.2010.05.015; Rock RB, 2004, CLIN MICROBIOL REV, V17, P942, DOI 10.1128/CMR.17.4.942-964.2004; Rozenberg Flore, 2011, Infectious Disorders - Drug Targets, V11, P235; Schachtele SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036216; Sellner J, 2006, BRAIN RES, V1125, P155, DOI 10.1016/j.brainres.2006.09.093; Sergerie Y, 2007, J INFECT DIS, V196, P853, DOI 10.1086/520094; Sergerie Y, 2007, J INFECT DIS, V195, P817, DOI 10.1086/511987; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Shechter R, 2013, NAT REV IMMUNOL, V13, P206, DOI 10.1038/nri3391; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Steiner I, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0414-8; Terry RL, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-270; Tuppeny M, 2013, CRIT CARE NURS CLIN, V25, P363, DOI 10.1016/j.ccell.2013.04.003; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Wilson EH, 2010, J CLIN INVEST, V120, P1368, DOI 10.1172/JCI41911; Wojtasiak M, 2010, J GEN VIROL, V91, P2158, DOI 10.1099/vir.0.021915-0; Wuest TR, 2008, FRONT BIOSCI-LANDMRK, V13, P4862, DOI 10.2741/3045; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zheng M, 2008, INVEST OPHTH VIS SCI, V49, P4018, DOI 10.1167/iovs.08-1914	60	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145773	10.1371/journal.pone.0145773	http://dx.doi.org/10.1371/journal.pone.0145773			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700486	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092600133
J	Sharma, A; Hoover, DR; Shi, QH; Gustafson, D; Plankey, MW; Hershow, RC; Tien, PC; Golub, ET; Anastos, K				Sharma, Anjali; Hoover, Donald R.; Shi, Qiuhu; Gustafson, Deborah; Plankey, Michael W.; Hershow, Ronald C.; Tien, Phyllis C.; Golub, Elizabeth T.; Anastos, Kathryn			Relationship between Body Mass Index and Mortality in HIV-Infected HAART Users in the Women's Interagency HIV Study	PLOS ONE			English	Article							STARTING ANTIRETROVIRAL THERAPY; ALL-CAUSE MORTALITY; IMMUNE CELL COUNTS; DISEASE PROGRESSION; NUTRITIONAL-STATUS; PROSPECTIVE COHORT; UNITED-STATES; OBESITY; IMPACT; OVERWEIGHT	Background Early HIV studies suggested protective associations of overweight against mortality, yet data are lacking for the era of potent highly active antiretroviral therapy (HAART). We evaluated associations of pre-HAART initiation body mass index (BMI) with mortality among HAART-using women. Methods Prospective study of time to death after HAART initiation among continuous HAART users in the Women's Interagency HIV Study. Unadjusted Kaplan-Meier and adjusted proportional hazards survival models assessed time to AIDS and non-AIDS death by last measured pre-HAART BMI. Results Of 1428 continuous HAART users 39 (2.7%) were underweight, 521 (36.5%) normal weight, 441 (30.9%) overweight, and 427 (29.9%) obese at time of HAART initiation. A total of 322 deaths occurred during median follow-up of 10.4 years (IQR 5.9-14.6). Censoring at non-AIDS death, the highest rate of AIDS death was observed among underweight women (p = 0.0003 for all 4 categories). In multivariate models, women underweight prior to HAART died from AIDS more than twice as rapidly vs. normal weight women (aHR 2.04, 95% CI 1.03, 4.04); but being overweight or obese (vs. normal weight) was not independently associated with AIDS death. Cumulative incidence of non-AIDS death was similar across all pre-HAART BMI categories. Conclusions Among continuous HAART-using women, being overweight prior to initiation was not associated with lower risk of AIDS or non-AIDS death. Being underweight prior to HAART was associated with over double the rate of AIDS death in adjusted analyses. Although overweight and obesity may be associated with many adverse health conditions, neither was predictive of mortality among the HAART-using women.	[Sharma, Anjali; Anastos, Kathryn] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Hoover, Donald R.] Rutgers State Univ, Dept Stat & Biostat, Piscataway, NJ USA; [Shi, Qiuhu] New York Med Coll, Dept Epidemiol & Community Hlth, Valhalla, NY 10595 USA; [Gustafson, Deborah] Suny Downstate Med Ctr, Dept Neurol, Brooklyn, NY 11203 USA; [Plankey, Michael W.] Georgetown Univ, Med Ctr, Dept Med, Div Infect Dis, Washington, DC 20007 USA; [Hershow, Ronald C.] Univ Illinois, Dept Epidemiol, Chicago, IL USA; [Tien, Phyllis C.] Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA 94143 USA; [Tien, Phyllis C.] San Francisco VA Med Ctr, San Francisco, CA USA; [Golub, Elizabeth T.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Rutgers State University New Brunswick; New York Medical College; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Georgetown University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Sharma, A (corresponding author), Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA.	anjali.sharma@einstein.yu.edu			National Institute of Allergy and Infectious Diseases [UO1-AI-35004, UO1-AI-31834, UO1-AI-34994, UO1-AI-34989, UO1-AI-34993, UO1-AI-42590]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [UO1-HD-32632]; National Cancer Institute; National Institute on Drug Abuse; National Institute on Deafness and Other Communication Disorders; National Center for Research Resources (UCSF-CTSI Grant) [UL1 RR024131]; National Institutes of Health [K23AR06199301]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD032632] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001073] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI042590, U01AI031834, U01AI034989, U01AI034993, U01AI034994, U01AI035004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR061993] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Center for Research Resources (UCSF-CTSI Grant); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The WIHS is funded by the National Institute of Allergy and Infectious Diseases (UO1-AI-35004, UO1-AI-31834, UO1-AI-34994, UO1-AI-34989, UO1-AI-34993, and UO1-AI-42590) and by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (UO1-HD-32632). The study is co-funded by the National Cancer Institute, the National Institute on Drug Abuse, and the National Institute on Deafness and Other Communication Disorders. Funding is provided by the National Center for Research Resources (UCSF-CTSI Grant Number UL1 RR024131). Contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health. This research was also supported by National Institutes of Health K23AR06199301 (AS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Al-Harthi L, 2006, J INFECT DIS, V193, P1202, DOI 10.1086/500843; Amorosa V, 2005, JAIDS-J ACQ IMM DEF, V39, P557; ANDRES R, 1985, ANN INTERN MED, V103, P1030, DOI 10.7326/0003-4819-103-6-1030; [Anonymous], 1992, MMWR RECOMM REP, V41, P1; Argemi X, 2012, AIDS, V26, P1161, DOI 10.1097/QAD.0b013e328353f363; Bacon MC, 2005, CLIN DIAGN LAB IMMUN, V12, P1013, DOI 10.1128/CDLI.12.9.1013-1019.2005; Boggs DA, 2011, NEW ENGL J MED, V365, P901, DOI 10.1056/NEJMoa1104119; Boodram B, 2009, AIDS PATIENT CARE ST, V23, P1009, DOI 10.1089/apc.2009.0175; Buchacz K, 2013, ANTIVIR THER, V18, P65, DOI 10.3851/IMP2450; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; CALVELLI T, 1993, CYTOMETRY, V14, P702, DOI 10.1002/cyto.990140703; Centers for Disease Control and Prevention, 2011, BEH RISK FACT SURV S; CHLEBOWSKI RT, 1989, AM J GASTROENTEROL, V84, P1288; Cohen MH, 2002, AM J MED, V113, P91, DOI 10.1016/S0002-9343(02)01169-5; Cohen SS, 2012, AM J EPIDEMIOL, V176, P431, DOI 10.1093/aje/kws032; Crum-Cianflone N, 2008, AIDS PATIENT CARE ST, V22, P925, DOI 10.1089/apc.2008.0082; Crum-Cianflone NF, 2011, CLIN VACCINE IMMUNOL, V18, P940, DOI 10.1128/CVI.00020-11; Crum-Cianflone NF, 2010, AIDS, V24, P1069, DOI 10.1097/QAD.0b013e328337fe01; Department for Health and Human Services, GUIDELINES USE ANTIR; Ekali LG, 2013, DIABETES METAB, V39, P71, DOI 10.1016/j.diabet.2012.08.012; Flegal KM, 2014, AM J EPIDEMIOL, V180, P288, DOI 10.1093/aje/kwu111; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; French AL, 2009, JAIDS-J ACQ IMM DEF, V51, P399, DOI 10.1097/QAI.0b013e3181acb4e5; Grabowski DC, 2001, J AM GERIATR SOC, V49, P968, DOI 10.1046/j.1532-5415.2001.49189.x; GUENTER P, 1993, J ACQ IMMUN DEF SYND, V6, P1130; Hodgson LM, 2001, AIDS, V15, P2341, DOI 10.1097/00002030-200111230-00024; Johannessen A, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-52; Jones CY, 2003, CLIN INFECT DIS, V37, pS69, DOI 10.1086/375889; Klein J. P., 2003, SURVIVAL ANAL TECHNI; Koethe JR, 2011, CLIN INFECT DIS, V53, P952, DOI 10.1093/cid/cir606; Lakoski SG, 2011, J CLIN ENDOCR METAB, V96, P1805, DOI 10.1210/jc.2010-3055; Maskew M, 2013, J WOMENS HEALTH, V22, P113, DOI 10.1089/jwh.2012.3585; May M, 2010, LANCET, V376, P449, DOI 10.1016/S0140-6736(10)60666-6; Melchior JC, 1999, NUTRITION, V15, P865, DOI 10.1016/S0899-9007(99)00210-5; Murphy K, 2013, AIDS, V27, P2413, DOI 10.1097/01.aids.0000432537.92958.73; Park SY, 2012, EUR J EPIDEMIOL, V27, P489, DOI 10.1007/s10654-012-9695-5; Paton NI, 2006, HIV MED, V7, P323, DOI 10.1111/j.1468-1293.2006.00383.x; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reis JP, 2009, ANN EPIDEMIOL, V19, P134, DOI 10.1016/j.annepidem.2008.10.008; Seidell JC, 2000, EUR J CLIN NUTR, V54, pS33, DOI 10.1038/sj.ejcn.1601023; Shor-Posner G, 2000, J ACQ IMMUN DEF SYND, V23, P81; Shuter J, 2001, J ACQ IMMUN DEF SYND, V26, P291, DOI 10.1097/00126334-200103010-00013; Stevens J, 1998, OBES RES, V6, P268, DOI 10.1002/j.1550-8528.1998.tb00349.x; STEVENS J, 1992, ARCH INTERN MED, V152, P1257, DOI 10.1001/archinte.152.6.1257; SUTTMANN U, 1995, J ACQ IMMUN DEF SYND, V8, P239, DOI 10.1097/00042560-199503010-00004; Tedaldi EM, 2006, JAIDS-J ACQ IMM DEF, V43, P35, DOI 10.1097/01.qai.0000234084.11291.d4; Tien PC, 2012, JAIDS-J ACQ IMM DEF, V61, P334, DOI 10.1097/QAI.0b013e31826bfc32; Troiano RP, 1996, INT J OBESITY, V20, P63; Womack J, 2007, METABOLISM, V56, P998, DOI 10.1016/j.metabol.2007.03.008; Xiao Q, 2014, OBESITY, V22, P260, DOI 10.1002/oby.20412	54	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0143740	10.1371/journal.pone.0143740	http://dx.doi.org/10.1371/journal.pone.0143740			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26699870	Green Published, gold, Green Submitted			2022-12-26	WOS:000367092600009
J	Winiarczyk, M; Winiarczyk, D; Banach, T; Adaszek, L; Madany, J; Mackiewicz, J; Pietras-Ozga, D; Winiarczyk, S				Winiarczyk, Mateusz; Winiarczyk, Dagmara; Banach, Tomasz; Adaszek, Lukasz; Madany, Jacek; Mackiewicz, Jerzy; Pietras-Ozga, Dorota; Winiarczyk, Stanislaw			Dog Tear Film Proteome In-Depth Analysis	PLOS ONE			English	Article							PROTEINS; FLUID; PROFILES; PATTERNS; HEALTHY; COW	In this study, mass spectrometry was used to explore the canine tear proteome. Tear samples were obtained from six healthy dogs, and one-dimensional sodium dodecyl sulphate polyacrylamide gel electrophoresis (1D SDS-PAGE) was used as a first step to separate intact proteins into 17 bands. Each fraction was then trypsin digested and analysed by matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometry (MALDI-TOF-MS/MS) to characterize the protein components in each fraction. In total, 125 tear proteins were identified, with MCA (Major Canine Allergen), Serum albumin, UPF0557 protein C10orf119 homolog, Collagen alpha-2(I) chain, Tyrosine -protein kinase Fer, Keratine type II cytoskeletal, Beta-crystallin B2, Interleukin-6 and Desmin occuring as the most confident ones with the highest scores. The results showed that the proteomic strategy used in this study was successful in the analysis of the dog tear proteome. To the best of our knowledge, this study is the first to report the comprehensive proteome profile of tears from healthy dogs by 1D SDS PAGE and MALDI-TOF. Data are available via ProteomeX-change with identifier PXD003124.	[Winiarczyk, Mateusz; Mackiewicz, Jerzy] Med Univ Lublin, Dept Vitreoretinal Surg, PL-20079 Lublin, Poland; [Winiarczyk, Dagmara; Madany, Jacek] Univ Life Sci, Dept & Clin Anim Internal Dis, PL-20612 Lublin, Poland; [Banach, Tomasz; Adaszek, Lukasz; Pietras-Ozga, Dorota; Winiarczyk, Stanislaw] Univ Life Sci, Dept Epizootiol, PL-20612 Lublin, Poland; [Banach, Tomasz; Adaszek, Lukasz; Pietras-Ozga, Dorota; Winiarczyk, Stanislaw] Univ Life Sci, Clin Infect Dis, PL-20612 Lublin, Poland	Medical University of Lublin	Winiarczyk, S (corresponding author), Univ Life Sci, Dept Epizootiol, Gleboka 30, PL-20612 Lublin, Poland.	genp53@interia.pl	Winiarczyk, Mateusz/S-9712-2019	Adaszek, Lukasz/0000-0003-0261-2695; Winiarczyk, Dagmara/0000-0002-1257-869X; Winiarczyk, Mateusz/0000-0001-9704-3848; PIETRAS-OZGA, DOROTA/0000-0002-1580-9254; Banach, Tomasz/0000-0003-2567-5592				Adaszek L, 2014, PARASITOL RES, V113, P4293, DOI 10.1007/s00436-014-4124-1; Ananthi S, 2011, EXP EYE RES, V92, P454, DOI 10.1016/j.exer.2011.03.002; Banach T, 2013, POL J VET SCI, V16, P587, DOI 10.2478/pjvs-2013-0083; Bohm D, 2012, ONCOL REP, V28, P429, DOI 10.3892/or.2012.1849; Campos CD, 2008, RES VET SCI, V85, P349, DOI 10.1016/j.rvsc.2007.11.006; Chen ZY, 2011, MOL VIS, V17, P323; DAVIDSON HJ, 1994, ADV EXP MED BIOL, V350, P331; Evans V, 2001, CLIN EXP OPHTHALMOL, V29, P161, DOI 10.1046/j.1442-9071.2001.00408.x; Funke S, 2012, J PROTEOMICS, V75, P3177, DOI 10.1016/j.jprot.2012.03.018; Gonzalez N, 2012, MOL VIS, V18, P1572; Green-Church KB, 2008, MOL VIS, V14, P456; Grus FH, 2007, PROTEOM CLIN APPL, V1, P876, DOI 10.1002/prca.200700105; Hemsley S, 2000, RES VET SCI, V68, P207, DOI 10.1053/rvsc.1999.0358; Herber S, 2002, ADV EXP MED BIOL, V506, P623; Herber S, 2001, ELECTROPHORESIS, V22, P1838, DOI 10.1002/1522-2683(200105)22:9<1838::AID-ELPS1838>3.0.CO;2-7; Kim HJ, 2012, CLIN BIOCHEM, V45, P60, DOI 10.1016/j.clinbiochem.2011.10.006; Li N, 2005, J PROTEOME RES, V4, P2052, DOI 10.1021/pr0501970; Pong JCF, 2010, ANAL BIOCHEM, V404, P82, DOI 10.1016/j.ab.2010.04.036; Shamsi FA, 2011, INVEST OPHTH VIS SCI, V52, P9156, DOI 10.1167/iovs.11-8301; THORIG L, 1985, CURR EYE RES, V4, P913, DOI 10.3109/02713688509095259; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; You JJ, 2013, ADV CLIN CHEM, V62, P151, DOI 10.1016/B978-0-12-800096-0.00004-4; Zhao ZJ, 2010, EXP EYE RES, V90, P344, DOI 10.1016/j.exer.2009.11.013; Zhou L, 2006, ANN ACAD MED SINGAP, V35, P400; Zhou L, 2012, PROG RETIN EYE RES, V31, P527, DOI 10.1016/j.preteyeres.2012.06.002; Zhou L, 2012, J PROTEOMICS, V75, P3877, DOI 10.1016/j.jprot.2012.04.053	27	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0144242	10.1371/journal.pone.0144242	http://dx.doi.org/10.1371/journal.pone.0144242			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26701646	Green Published, gold, Green Submitted			2022-12-26	WOS:000367092600018
J	Cox, F; Baart, M; Huizingh, J; Tolboom, J; Dekking, L; Goudsmit, J; Saeland, E; Radosevic, K				Cox, Freek; Baart, Matthijs; Huizingh, Jeroen; Tolboom, Jeroen; Dekking, Liesbeth; Goudsmit, Jaap; Saeland, Eirikur; Radosevic, Katarina			Protection against H5N1 Influenza Virus Induced by Matrix-M Adjuvanted Seasonal Virosomal Vaccine in Mice Requires Both Antibodies and T Cells	PLOS ONE			English	Article							DEPENDENT CELLULAR CYTOTOXICITY; MONOCLONAL-ANTIBODIES; HETEROSUBTYPIC IMMUNITY; VIRAL NEURAMINIDASE; A VIRUSES; CORRELATE; HEMAGGLUTININ; EFFICACY; ECTODOMAIN; CHALLENGE	Background It remains important to develop the next generation of influenza vaccines that can provide protection against vaccine mismatched strains and to be prepared for potential pandemic outbreaks. To achieve this, the understanding of the immunological parameters that mediate such broad protection is crucial. Method In the current study we assessed the contribution of humoral and cellular immune responses to heterosubtypic protection against H5N1 induced by a Matrix-M (MM) adjuvanted seasonal influenza vaccine by serum transfer and T-cell depletion studies. Results We demonstrate that the heterosubtypic protection against H5N1 induced by MM adjuvanted vaccine is partially mediated by antibodies. The serum contained both H5N1 cross-reactive hemagglutinin (HA)- and neuraminidase (NA)-specific antibodies but with limited virus neutralizing and no hemagglutination inhibiting activity. The cross-reactive antibodies induced antibody-dependent cellular cytotoxicity (ADCC) in vitro, suggesting a role for the Fc part of the antibodies in protection against H5N1. Besides H5N1 specific antibody responses, cross-reactive HA- and NA-specific T-cell responses were induced by the adjuvanted vaccine. T-cell depletion experiments demonstrated that both CD4(+) and CD8(+) T cells contribute to protection. Conclusion Our study demonstrates that cross-protection against H5N1 induced by MM adjuvanted seasonal virosomal influenza vaccine requires both the humoral and cellular arm of the immune system.	[Cox, Freek; Baart, Matthijs; Huizingh, Jeroen; Tolboom, Jeroen; Dekking, Liesbeth; Goudsmit, Jaap; Saeland, Eirikur; Radosevic, Katarina] Pharmaceut Co Johnson & Johnson, Janssen Res & Dev, Ctr Excellence, Janssen Prevent Ctr, Leiden, Netherlands	Johnson & Johnson; Janssen Pharmaceuticals	Saeland, E (corresponding author), Pharmaceut Co Johnson & Johnson, Janssen Res & Dev, Infect Dis & Vaccines Therapeut Area, Leiden, Netherlands.	Esaeland@its.jnj.com						Alberini I, 2009, VACCINE, V27, P5998, DOI 10.1016/j.vaccine.2009.07.079; Altenburg AF, 2014, VACCINE; Altenburg AF, 2015, VACCINE, V33, P500, DOI 10.1016/j.vaccine.2014.11.054; Belser JA, 2009, ADV VIRUS RES, V73, P55, DOI 10.1016/S0065-3527(09)73002-7; BENDER BS, 1992, J EXP MED, V175, P1143, DOI 10.1084/jem.175.4.1143; Cheng ZJ, 2014, J IMMUNOL METHODS, V414, P69, DOI 10.1016/j.jim.2014.07.010; Co MDT, 2009, VACCINE, V27, P319, DOI 10.1016/j.vaccine.2008.09.092; Cox F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135723; Cox RJ, 2011, VACCINE, V29, P8049, DOI 10.1016/j.vaccine.2011.08.042; DiLillo DJ, 2014, NAT MED, V20, P143, DOI 10.1038/nm.3443; Doucet JD, 2011, J GEN VIROL, V92, P1162, DOI 10.1099/vir.0.029777-0; Doyle TM, ANTIVIRAL RES; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Ekiert DC, 2012, CURR OPIN VIROL, V2, P134, DOI 10.1016/j.coviro.2012.02.005; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; El Bakkouri K, 2011, J IMMUNOL, V186, P1022, DOI 10.4049/jimmunol.0902147; Friesen RHE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009106; Fu TM, 2009, VIROLOGY, V385, P218, DOI 10.1016/j.virol.2008.11.035; GERHARD W, 1981, NATURE, V290, P713, DOI 10.1038/290713a0; Guo HL, 2011, J VIROL, V85, P448, DOI 10.1128/JVI.01812-10; Hannoun C, 2004, VIRUS RES, V103, P133, DOI 10.1016/j.virusres.2004.02.025; Hannoun C, 2013, EXPERT REV VACCINES, V12, P1085, DOI 10.1586/14760584.2013.824709; Huber VC, 2001, J IMMUNOL, V166, P7381, DOI 10.4049/jimmunol.166.12.7381; Jegaskanda S, 2014, J INFECT DIS; Jegaskanda S, 2013, J VIROL, V87, P5512, DOI 10.1128/JVI.03030-12; Jegaskanda S, 2013, J IMMUNOL, V190, P1837, DOI 10.4049/jimmunol.1201574; Johansson BE, 2011, EXPERT REV VACCINES, V10, P1683, DOI [10.1586/erv.11.130, 10.1586/ERV.11.130]; Knossow M, 2006, IMMUNOLOGY, V119, P1, DOI 10.1111/j.1365-2567.2006.02421.x; Laidlaw BJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003207; LIANG SH, 1994, J IMMUNOL, V152, P1653; Marshall NB, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/954602; Medina RA, 2011, NAT REV MICROBIOL, V9, P590, DOI 10.1038/nrmicro2613; Mischler R, 2002, VACCINE, V20, pB17, DOI 10.1016/S0264-410X(02)00512-1; Moise L, 2013, HUM VACC IMMUNOTHER, V9, P2060, DOI 10.4161/hv.26511; Pedersen G, 2011, INFLUENZA OTHER RESP, V5, P426, DOI 10.1111/j.1750-2659.2011.00256.x; Pedersen GK, 2012, J INFECT DIS, V206, P158, DOI 10.1093/infdis/jis330; Petsch B, 2012, NAT BIOTECHNOL, V30, P1210, DOI 10.1038/nbt.2436; Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862; Radosevic K, 2008, VACCINE, V26, P3640, DOI 10.1016/j.vaccine.2008.04.071; Rimmelzwaan GF, 2007, CURR OPIN BIOTECH, V18, P529, DOI 10.1016/j.copbio.2007.11.002; Rockman S, 2013, J VIROL, V87, P3053, DOI 10.1128/JVI.02434-12; Roos A, 2015, VACCINE, P7; Sambhara S, 1998, J INFECT DIS, V177, P1266, DOI 10.1086/515285; Sambhara S, 2001, CELL IMMUNOL, V211, P143, DOI 10.1006/cimm.2001.1835; Sandbulte MR, 2007, PLOS MED, V4, P265, DOI 10.1371/journal.pmed.0040059; Schotsaert M, 2013, MUCOSAL IMMUNOL, V6, P276, DOI 10.1038/mi.2012.69; Slutter B, 2013, IMMUNITY, V39, P939, DOI 10.1016/j.immuni.2013.09.013; Sridhar S, 2013, NAT MED; Temperton NJ, 2007, INFLUENZA OTHER RESP, V1, P105, DOI 10.1111/j.1750-2659.2007.00016.x; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Verbist KC, 2011, J IMMUNOL, V186, P6667, DOI 10.4049/jimmunol.1004022; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Wohlbold TJ, 2014, VIRUSES-BASEL, V6, P2465, DOI 10.3390/v6062465; Wood JM, 2003, VACCINE, V21, P1786, DOI 10.1016/S0264-410X(03)00073-2	56	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145243	10.1371/journal.pone.0145243	http://dx.doi.org/10.1371/journal.pone.0145243			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26696245	Green Submitted, gold, Green Published			2022-12-26	WOS:000367092500029
J	Rocha, JMD; Pinto, MP; Boubli, JP; Grelle, CEV				de Almeida Rocha, Juliana Monteiro; Pinto, Miriam Plaza; Boubli, Jean Philippe; Viveiros Grelle, Carlos Eduardo			The Role of Competition in Structuring Primate Communities under Different Productivity Regimes in the Amazon	PLOS ONE			English	Article							FOXS ASSEMBLY RULE; FUNCTIONAL-GROUPS; RAIN-FOREST; NULL MODEL; RIVER; PATTERNS; BRAZIL; ECOLOGY; VEGETATION; EVOLUTION	The factors responsible for the formation of Amazonian primate communities are not well understood. Here we investigated the influence of interspecific competition in the assembly of these communities, specifically whether they follow an assembly rule known as "favored states". According to this rule, interspecific competition influences final species composition, resulting in functional groups that are equally represented in the community. We compiled presence-absence data for primate species at 39 Amazonian sites in Brazil, contrasting two regions with distinct productivity regimes: the eutrophic Jurua River basin and the oligotrophic Negro River basin. We tested two hypotheses: that interspecific competition is a mechanism that influences the structure of Amazonian primate communities, and that competition has had a greater influence on the structure of primate communities in regions with low productivity, where resources are more limited. We used null models to test the statistical significance of the results, and found a non-random pattern compatible with the favored states rule in the two regions. Our findings suggest that interspecific competition is an important force driving primate community assembly regardless of productivity regimes.	[de Almeida Rocha, Juliana Monteiro] Univ Estadual Santa Cruz, Programa Posgrad Ecol & Conservacao Biodiversidad, Ilheus, Brazil; [Pinto, Miriam Plaza] Univ Fed Rio Grande do Norte, Dept Ecol, BR-59072970 Natal, RN, Brazil; [Boubli, Jean Philippe] Univ Salford, Sch Environm & Life Sci, Salford M5 4WT, Lancs, England; [Viveiros Grelle, Carlos Eduardo] Univ Fed Rio de Janeiro, Dept Ecol, Rio De Janeiro, Brazil	Universidade Estadual de Santa Cruz; Universidade Federal do Rio Grande do Norte; University of Salford; Universidade Federal do Rio de Janeiro	Rocha, JMD (corresponding author), Univ Estadual Santa Cruz, Programa Posgrad Ecol & Conservacao Biodiversidad, Ilheus, Brazil.	almeidarocha.jm@gmail.com	Pinto, Míriam Plaza/B-8000-2013; Grelle, Carlos EV/A-9687-2017	Pinto, Míriam Plaza/0000-0002-4030-5015; boubli, Jean/0000-0002-5833-9264	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) fellowship; FAPERJ fellowship; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) productivity fellowship; Louis Leakey Foundation; National Geographic Society; National Science Foundation; New York Zoological Society; World Wildlife Fund for Nature	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) fellowship(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); FAPERJ fellowship(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) productivity fellowship(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Louis Leakey Foundation; National Geographic Society(National Geographic Society); National Science Foundation(National Science Foundation (NSF)); New York Zoological Society; World Wildlife Fund for Nature	JM was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) fellowship; MP by FAPERJ fellowship, and CEV by Grelle by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) productivity fellowship. JP field work on Negro River region was supported by the Sustainable Development of the Brazilian Biodiversity Program (PROBIO/MMA/BIRD/GEF/CNPq), the Zoological Society of San Diego and the University of Auckland. Field work in Pico da Neblina National Park was funded by grants from the Louis Leakey Foundation, National Geographic Society, National Science Foundation, New York Zoological Society and World Wildlife Fund for Nature. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2007, ECOLOGY, V88, P1292, DOI 10.1890/06-0697; [Anonymous], 2012, OCCASIONAL PAPERS CO; AYRES JM, 1992, AM NAT, V140, P531, DOI 10.1086/285427; AYRES JM, 1993, MATAS VARZEA MAMIRAU; Beaudrot L, 2013, AM J PRIMATOL, V75, P170, DOI 10.1002/ajp.22095; Benchimol M, 2014, AM J PRIMATOL, V76, P289, DOI 10.1002/ajp.22233; Booth BD, 2004, ECOLOGICAL ASSEMBLY, P206; Boubli J, 2009, INT J PRIMATOL, V30, P217, DOI 10.1007/s10764-009-9335-4; Boubli JP, 2008, INT J PRIMATOL, V29, P723, DOI 10.1007/s10764-008-9248-7; Boubli JP, 2015, MOL PHYLOGENET EVOL, V82, P400, DOI 10.1016/j.ympev.2014.09.005; Boubli Jean Phillipe, 1997, Neotropical Primates, V5, P113; Brinkmann WLF, 1989, TROPICAL RAINFORES B, P99; Cody M, 2004, ECOLOGICAL ASSEMBLY, P165; Colwell R.K., 1984, P344; CONNOR EF, 1979, ECOLOGY, V60, P1132, DOI 10.2307/1936961; Coomes DA, 2000, ECOL MONOGR, V70, P171, DOI 10.1890/0012-9615(2000)070[0171:IORCIF]2.0.CO;2; DAYAN T, 1994, AM NAT, V143, P462, DOI 10.1086/285613; DECKER BS, 1994, INT J PRIMATOL, V15, P703, DOI 10.1007/BF02737428; Diamond J.M., 1975, P342; DIAMOND JM, 1982, OECOLOGIA, V52, P64, DOI 10.1007/BF00349013; FONSECA GAB, 1996, OCCASIONAL PAPERS CO, V4, P1; Fox BJ, 1987, EVOL ECOL, V1, P201, DOI 10.1007/BF02067551; FOX BJ, 1992, J MAMMAL, V73, P491, DOI 10.2307/1382015; FOX BJ, 1993, OIKOS, V67, P358, DOI 10.2307/3545483; FOX BJ, 1989, SPECIAL PUBLICATION, V28, P91; Franzinelli E, 2002, GEOMORPHOLOGY, V44, P259, DOI 10.1016/S0169-555X(01)00178-7; Furch K., 1989, Mineral nutrients in tropical forest and savanna ecosystems., P189; Ganzhorn JU, 1997, J ZOOL, V241, P533, DOI 10.1111/j.1469-7998.1997.tb04845.x; Gotelli N.J., 1996, NULL MODELS ECOLOGY; Grelle CEV, 2005, ORYX, V39, P347, DOI 10.1017/S0030605305000700; Grelle CEV, 2002, BIOL CONSERV, V108, P101, DOI 10.1016/S0006-3207(02)00094-0; Haugaasen T, 2009, PRIMATES, V50, P239, DOI 10.1007/s10329-009-0135-4; Hawes JE, 2014, OIKOS, V123, P365, DOI 10.1111/j.1600-0706.2013.00745.x; IRION G, 1978, NATURWISSENSCHAFTEN, V65, P515, DOI 10.1007/BF00439791; Iron G, 1978, NATURWISSENSCHAFTEN, V65, P515; IUCN, IUCN RED LIST THREAT; JANSON CH, 1988, BEHAVIOUR, V105, P53, DOI 10.1163/156853988X00449; Kamilar JM, 2011, AM J PHYS ANTHROPOL, V144, P131, DOI 10.1002/ajpa.21380; Keddy P, 2004, ECOLOGICAL ASSEMBLY, P1; KEDDY PA, 1992, J VEG SCI, V3, P157, DOI 10.2307/3235676; KELT DA, 1995, ECOLOGY, V76, P1283, DOI 10.2307/1940935; Klinge H, 1979, HEATLANDS RELATED A, V9A, P483; Latrubesse EM, 2002, GEOMORPHOLOGY, V44, P241, DOI 10.1016/S0169-555X(01)00177-5; McCay TS, 2004, OIKOS, V107, P141, DOI 10.1111/j.0030-1299.2004.13244.x; MEADE RH, 1991, ENVIRON GEOL WATER S, V18, P105, DOI 10.1007/BF01704664; PATTERSON BD, 1986, BIOL J LINN SOC, V28, P65, DOI 10.1111/j.1095-8312.1986.tb01749.x; Peres C.A., 1999, MAMMALS NEOTROPICS, V3, P564; Peres CA, 1997, J TROP ECOL, V13, P259; Pimenta Flavio Eduardo, 2005, Neotropical Primates, V13, P23, DOI 10.1896/1413-4705.13.2.23; PRANCE GT, 1979, BRITTONIA, V31, P26, DOI 10.2307/2806669; Prance GT, 1989, TROPICAL RAINFORES B, P99; PUHAKKA M, 1992, J BIOGEOGR, V19, P651, DOI 10.2307/2845707; R Development Core Team, R LANG ENV STAT COMP; RASANEN ME, 1987, SCIENCE, V238, P1398, DOI 10.1126/science.238.4832.1398; Rylands A. B., 2012, International Zoo Yearbook, V46, P11, DOI 10.1111/j.1748-1090.2011.00152.x; Schreier BM, 2009, BIOTROPICA, V41, P283, DOI 10.1111/j.1744-7429.2008.00486.x; Simberloff Daniel, 1999, P58, DOI 10.1017/CBO9780511542237.003; SOINI P, 1982, FOLIA PRIMATOL, V39, P1, DOI 10.1159/000156066; Stone L, 1996, AM NAT, V148, P997, DOI 10.1086/285968; Terborgh J., 1991, Habitat structure: the physical arrangement of objects in space, based on a symposium held at the Chinsegut Hill Conference Center, University of South Florida, in May 1988., P28; Von Holle B, 2004, OIKOS, V105, P551, DOI 10.1111/j.0030-1299.2004.12597.x; WEIHER E, 1995, OIKOS, V74, P159, DOI 10.2307/3545686; WILSON JB, 1989, OECOLOGIA, V80, P263, DOI 10.1007/BF00380161	63	4	4	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145699	10.1371/journal.pone.0145699	http://dx.doi.org/10.1371/journal.pone.0145699			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26696089	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092500069
J	Sakamoto, A; Akiyama, Y; Shimada, S; Zhu, WG; Yuasa, Y; Tanaka, S				Sakamoto, Ayuna; Akiyama, Yoshimitsu; Shimada, Shu; Zhu, Wei-Guo; Yuasa, Yasuhito; Tanaka, Shinji			DNA Methylation in the Exon 1 Region and Complex Regulation of Twist1 Expression in Gastric Cancer Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-CANCER; PROMOTER METHYLATION; COLORECTAL-CANCER; DIFFUSE-TYPE; TRANSCRIPTION FACTORS; HISTONE METHYLATION; SP1 EXPRESSION; GENE-MUTATIONS; CPG ISLAND	Twist1 overexpression is frequently observed in various cancers including gastric cancer (GC). Although DNA methylation of the Twist1 gene has been reported in cancer cells, the mechanisms underlying transcriptional activation remain uncertain. In this study, we first examined epigenetic alterations of the Twist1 using Twist1 transcription-positive and - negative cell lines that are derived from our established diffuse-type GC mouse model. Treatment with a DNA demethylation agent 5-aza-dC re-activated Twist1 expression in Twist1 expression-negative GC cells. According to methylation-specific PCR and bisulfite sequencing analysis, methylation at the CpG-rich region within Twist1 coding exon 1, rather than its promoter region, was tightly linked to transcriptional silencing of the Twist1 expression in mouse GC cells. Chromatin immunoprecipitation assays revealed that active histone mark H3K4me3 was enriched in Twist1 expression-positive cells, and inactive histone mark H3K9me3 was enriched in Twist1 expression-negative cells. The expression levels of Suv39h1 and Suv39h2, histone methyltransferases for H3K9me3, were inversely correlated with Twist1 expression, and knockdown of Suv39h1 or Suv39h2 induced Twist1 expression. Moreover, Sp1 transcription factor bound to the exon 1 CpG-rich region in Twist1 expression-positive cell lines, and Twist1 expression was diminished by mithramycin, which that interferes with Sp1 binding to CpG-rich regulatory sequences. Our studies suggested that the Twist1 transcription in GC cells might be regulated through potential cooperation of DNA methylation, histone modification in complex with Sp1 binding to CpG-rich regions within the exon 1 region.	[Sakamoto, Ayuna; Akiyama, Yoshimitsu; Shimada, Shu; Yuasa, Yasuhito; Tanaka, Shinji] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Mol Oncol, Tokyo, Japan; [Zhu, Wei-Guo] Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Beijing 100191, Peoples R China	Tokyo Medical & Dental University (TMDU); Peking University	Tanaka, S (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Mol Oncol, Tokyo, Japan.	yakiyama.monc@tmd.ac.jp; tanaka.monc@tmd.ac.jp		Zhu, Wei-Guo/0000-0001-8385-6581	Japan Society for the Promotion of Science (JSPS) [AA005]; Practical Research for Innovative Cancer Control from Japan Agency for Medical Research and Development, AMED [15Ack0106017h0002];  [24590444];  [25253081]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Practical Research for Innovative Cancer Control from Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); ; 	This work was supported by Grants-in-Aid for Scientific Research (C) (24590444) and (A) (25253081), and the A3 Foresight Program (AA005) from the Japan Society for the Promotion of Science (JSPS), and the Practical Research for Innovative Cancer Control (15Ack0106017h0002) from Japan Agency for Medical Research and Development, AMED; https://kaken.nii.ac.jp/d/r/30253420.ja.html, https://kaken.nii.ac.jp/d/r/80262187.ja.html.	Barnes RM, 2009, INT J DEV BIOL, V53, P909, DOI 10.1387/ijdb.082747rb; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; BECKER KF, 1994, CANCER RES, V54, P3845; Benlhabib H, 2011, MOL CELL BIOL, V31, P1949, DOI 10.1128/MCB.01063-10; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Cai LS, 2014, ONCOL REP, V31, P2593, DOI 10.3892/or.2014.3135; Chen RP, 2014, ONCOL REP, V31, P1211, DOI 10.3892/or.2014.2972; Choi ES, 2014, SCI REP-UK, V4, DOI 10.1038/srep07162; Dicken BJ, 2005, ANN SURG, V241, P27, DOI 10.1097/01.sla.0000149300.28588.23; Dong C, 2013, ONCOGENE, V32, P1351, DOI 10.1038/onc.2012.169; Douglas DB, 2004, CANCER RES, V64, P1611, DOI 10.1158/0008-5472.CAN-0318-2; Erfurth FE, 2008, P NATL ACAD SCI USA, V105, P7517, DOI 10.1073/pnas.0800090105; Esteller M, 2007, HUM MOL GENET, V16, pR50, DOI 10.1093/hmg/ddm018; Ezponda T, 2013, ONCOGENE, V32, P2882, DOI 10.1038/onc.2012.297; Gong MZ, 2012, J CELL BIOCHEM, V113, P329, DOI 10.1002/jcb.23359; Gort EH, 2008, CANCER EPIDEM BIOMAR, V17, P3325, DOI 10.1158/1055-9965.EPI-08-0472; Hsu TI, 2012, ONCOGENE, V31, P3973, DOI 10.1038/onc.2011.568; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Kang GH, 2008, LAB INVEST, V88, P161, DOI 10.1038/labinvest.3700707; Kondo Y, 2003, MOL CELL BIOL, V23, P206, DOI 10.1128/MCB.23.1.206-215.2003; Kwon MJ, 2013, HUM PATHOL, V44, P1722, DOI 10.1016/j.humpath.2013.03.004; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Mulero-Navarro S, 2006, CARCINOGENESIS, V27, P1099, DOI 10.1093/carcin/bgi344; O'Carroll D, 2000, MOL CELL BIOL, V20, P9423, DOI 10.1128/MCB.20.24.9423-9433.2000; Ohkuma M, 2007, BIOCHEM BIOPH RES CO, V352, P925, DOI 10.1016/j.bbrc.2006.11.114; Okada T, 2010, GENE CHROMOSOME CANC, V49, P452, DOI 10.1002/gcc.20755; Otsubo T, 2008, BRIT J CANCER, V98, P824, DOI 10.1038/sj.bjc.6604193; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Qin Q, 2012, CELL RES, V22, P90, DOI 10.1038/cr.2011.144; RANZANI GN, 1995, CANCER EPIDEM BIOMAR, V4, P223; Rao X, 2013, ONCOGENE, V32, P4519, DOI 10.1038/onc.2012.474; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Rosivatz E, 2002, AM J PATHOL, V161, P1881, DOI 10.1016/S0002-9440(10)64464-1; Ruppenthal RD, 2011, PATHOL ONCOL RES, V17, P867, DOI 10.1007/s12253-011-9395-6; Shimada S, 2012, GUT, V61, P344, DOI 10.1136/gutjnl-2011-300050; Sleiman SF, 2011, J NEUROSCI, V31, P6858, DOI 10.1523/JNEUROSCI.0710-11.2011; Sone K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6691; Soo K, 2002, DEV BIOL, V247, P251, DOI 10.1006/dbio.2002.0699; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Takahashi Tsunehiro, 2013, Cancers (Basel), V5, P48, DOI 10.3390/cancers5010048; THISSE B, 1988, EMBO J, V7, P2175, DOI 10.1002/j.1460-2075.1988.tb03056.x; Tian HP, 2015, J BIOL CHEM, V290, P19173, DOI 10.1074/jbc.M114.636126; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; van Engeland M, 2003, CANCER RES, V63, P3133; Varier RA, 2011, BBA-REV CANCER, V1815, P75, DOI 10.1016/j.bbcan.2010.10.002; Vuillemenot BR, 2004, CARCINOGENESIS, V25, P623, DOI 10.1093/carcin/bgh038; Wang LW, 2003, CLIN CANCER RES, V9, P6371; Yanagihara K, 2004, CANCER SCI, V95, P575, DOI 10.1111/j.1349-7006.2004.tb02489.x; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yuasa Y, 2003, NAT REV CANCER, V3, P592, DOI 10.1038/nrc1141; Zhang YQ, 2007, PATHOLOGY, V39, P470, DOI 10.1080/00313020701570053; Zheng JB, 2001, NUCLEIC ACIDS RES, V29, P4070, DOI 10.1093/nar/29.19.4070; Zhu WG, 2003, MOL CELL BIOL, V23, P4056, DOI 10.1128/MCB.23.12.4056-4065.2003	53	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145630	10.1371/journal.pone.0145630	http://dx.doi.org/10.1371/journal.pone.0145630			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26695186	Green Published, gold			2022-12-26	WOS:000367092500063
J	Ferre, CA; Davezac, N; Thouard, A; Peyrin, JM; Belenguer, P; Miquel, MC; Gonzalez-Dunia, D; Szelechowski, M				Ferre, Cecile A.; Davezac, Noelie; Thouard, Anne; Peyrin, Jean-Michel; Belenguer, Pascale; Miquel, Marie-Christine; Gonzalez-Dunia, Daniel; Szelechowski, Marion			Manipulation of the N-terminal sequence of the Borna disease virus X protein improves its mitochondrial targeting and neuroprotective potential	FASEB JOURNAL			English	Article						subcellular addressing; neuroprotection; nuclear export	OUTER-MEMBRANE; NUCLEAR IMPORT; HIV REV; DEGENERATION; FISSION; NEURONS; KINASE; SIGNAL; NEURODEGENERATION; LOCALIZATION	To favor their replication, viruses express proteins that target diverse mammalian cellular pathways. Due to the limited size of many viral genomes, such proteins are endowed with multiple functions, which require targeting to different subcellular compartments. One salient example is the X protein of Borna disease virus, which is expressed both at the mitochondria and in the nucleus. Moreover, we recently demonstrated that mitochondrial X protein is neuroprotective. In this study, we sought to examine the mechanisms whereby the X protein transits between subcellular compartments and to define its localization signals, to enhance its mitochondrial accumulation and thus, potentially, its neuroprotective activity. We transfected plasmids expressing fusion proteins bearing different domains of X fused to enhanced green fluorescent protein (eGFP) and compared their subcellular localization to that of eGFP. We observed that the 5-16 domain of X was responsible for both nuclear export and mitochondrial targeting and identified critical residues for mitochondrial localization. We next took advantage of these findings and constructed mutant X proteins that were targeted only to the mitochondria. Such mutants exhibited enhanced neuroprotective properties in compartmented cultures of neurons grown in microfluidic chambers, thereby confirming the parallel between mitochondrial accumulation of the X protein and its neuroprotective potential.-Ferre C. A., Davezac, N., Thouard, A., Peyrin, J. M., Belenguer, P., Miquel, M.-C., Gonzalez-Dunia, D., Szelechowski, M. Manipulation of the N-terminal sequence of the Borna disease virus X protein improves its mitochondrial targeting and neuroprotective potential. FASEB J. 30, 1523-1533 (2016). www.fasebj.org	[Ferre, Cecile A.; Thouard, Anne; Gonzalez-Dunia, Daniel; Szelechowski, Marion] CPTP, INSERM, Unite Mixte Rech UMR 1043, Toulouse, France; [Ferre, Cecile A.; Thouard, Anne; Gonzalez-Dunia, Daniel; Szelechowski, Marion] CNRS, UMR 5282, Toulouse, France; [Ferre, Cecile A.; Davezac, Noelie; Thouard, Anne; Belenguer, Pascale; Miquel, Marie-Christine; Gonzalez-Dunia, Daniel; Szelechowski, Marion] Univ Toulouse 3, F-31062 Toulouse, France; [Davezac, Noelie; Belenguer, Pascale; Miquel, Marie-Christine] Ctr Biol Dev, CNRS, UMR 5547, Toulouse, France; [Peyrin, Jean-Michel] Univ Paris 06, CNRS, UMR 8256, Biol Adaptat & Aging,Inst Biol Paris Seine, Paris, France; [Peyrin, Jean-Michel; Miquel, Marie-Christine] Univ Paris 06, Sorbonne Univ, Paris, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Gonzalez-Dunia, D; Szelechowski, M (corresponding author), Univ Toulouse 3, CPTP, INSERM, UMR 1043,CNRS,UMR 5282,CHU Purpan, BP3028, F-31024 Toulouse 3, France.	daniel.dunia@inserm.fr; mszelechowski@gmail.com	Dunia, Daniel/K-1090-2014; Szelechowski, Marion/X-7343-2019	Dunia, Daniel/0000-0002-2837-7120; Peyrin, Jean-Michel/0000-0002-0108-1266; Peyrin, Jean-Michel/0000-0002-8705-8672; Miquel, Marie-Christine/0000-0002-9332-2572; , Szelechowski/0000-0002-2929-7413; Belenguer, Pascale/0000-0003-0229-5554	INSERM; Centre National de la Recherche Scientifique; INSERM Transfert CoPoC Fund; European Research Area Networks (ERA-NET) Network of European Funding for Neuroscience Research (NEURON) MicroDeg;  [ANR-12-EMMA-0016-01]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); INSERM Transfert CoPoC Fund; European Research Area Networks (ERA-NET) Network of European Funding for Neuroscience Research (NEURON) MicroDeg; 	The authors thank A. Betourne, R. Liblau, C. E. Malnou, and A. Saoudi (all from INSERM UMR 1043, Toulouse, France) for critical reading of the manuscript and insightful editorial comments; S. Allart and A. Canivet (CPTP Imaging platform) for technical assistance; E. Bonnaud (INSERM UMR 1043) for help in preparing primary neuronal cultures; and C. Didier (Centre National de la Recherche Scientifique, Toulouse, France) for the gift of the anti-cyclin B1 antibody. This work was supported by institutional grants from INSERM and Centre National de la Recherche Scientifique (to D.G.D.), funds from Project ANR-12-EMMA-0016-01 (to D.G.D. and J.M.P.), the INSERM Transfert CoPoC Fund (to D.G.D.), and funds from European Research Area Networks (ERA-NET) Network of European Funding for Neuroscience Research (NEURON) MicroDeg (to J.M.P.). The authors declare no conflicts of interest.	Al-Furoukh N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103141; Bertholet AM, 2013, BRAIN, V136, P1518, DOI 10.1093/brain/awt060; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529; Chen CJ, 2010, J VIROL, V84, P10051, DOI 10.1128/JVI.00592-10; Court FA, 2012, TRENDS NEUROSCI, V35, P364, DOI 10.1016/j.tins.2012.04.001; Debaisieux S, 2012, TRAFFIC, V13, P355, DOI 10.1111/j.1600-0854.2011.01286.x; Deleglise B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071103; Dong XH, 2009, NATURE, V458, P1136, DOI 10.1038/nature07975; Gorlich D, 1998, EMBO J, V17, P2721, DOI 10.1093/emboj/17.10.2721; Gu LL, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-17; Guo X, 2013, J CLIN INVEST, V123, P5371, DOI 10.1172/JCI70911; Hay S, 2002, J GEN VIROL, V83, P1547, DOI 10.1099/0022-1317-83-7-1547; Hayashi Y, 2009, MICROBES INFECT, V11, P394, DOI 10.1016/j.micinf.2009.01.006; Honda T, 2013, VIRUSES-BASEL, V5, P1978, DOI 10.3390/v5081978; Hope TJ, 1999, ARCH BIOCHEM BIOPHYS, V365, P186, DOI 10.1006/abbi.1999.1207; Itoh K, 2013, TRENDS CELL BIOL, V23, P64, DOI 10.1016/j.tcb.2012.10.006; JANG SK, 1989, J VIROL, V63, P1651, DOI 10.1128/JVI.63.4.1651-1660.1989; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; Kilinc D, 2011, NEUROTOX RES, V19, P149, DOI 10.1007/s12640-010-9152-8; KITAJEWSKI J, 1986, CELL, V45, P195, DOI 10.1016/0092-8674(86)90383-1; Kuroda R, 1998, J BIOL CHEM, V273, P31097, DOI 10.1074/jbc.273.47.31097; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Li YJ, 2013, INT J BIOCHEM CELL B, V45, P1546, DOI 10.1016/j.biocel.2013.05.012; Liang CY, 2015, NAT REV MICROBIOL, V13, P7, DOI 10.1038/nrmicro3369; Lipkin WI, 2011, VIRUS RES, V162, P162, DOI 10.1016/j.virusres.2011.09.036; Ma JW, 2011, ACTA BIOCH BIOPH SIN, V43, P583, DOI 10.1093/abbs/gmr048; Ma YL, 2008, J BIOL CHEM, V283, P11743, DOI 10.1074/jbc.M710494200; Magnifico S, 2013, FASEB J, V27, P4712, DOI 10.1096/fj.13-229781; MCBRIDE HM, 1992, J CELL BIOL, V119, P1451, DOI 10.1083/jcb.119.6.1451; Nantajit D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012341; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; O'Shea CC, 2005, CELL CYCLE, V4, P883, DOI 10.4161/cc.4.7.1791; Olichon A, 2002, FEBS LETT, V523, P171, DOI 10.1016/S0014-5793(02)02985-X; Otera H., 2012, INT J CELL BIOL, V2012, DOI [10.1155/2012/821676, DOI 10.1155/2012/821676]; Poenisch M, 2004, J GEN VIROL, V85, P1895, DOI 10.1099/vir.0.80002-0; Poenisch M, 2007, J VIROL, V81, P7297, DOI 10.1128/JVI.02468-06; Poenisch M, 2009, J VIROL, V83, P4297, DOI 10.1128/JVI.02321-08; Reddy PH, 2011, BRAIN RES REV, V67, P103, DOI 10.1016/j.brainresrev.2010.11.004; Su SC, 2011, ANNU REV CELL DEV BI, V27, P465, DOI 10.1146/annurev-cellbio-092910-154023; Suzuki H, 2002, J CELL SCI, V115, P1895; Szelechowski M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6181; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Tomonaga K, 2002, MICROBES INFECT, V4, P491, DOI 10.1016/S1286-4579(02)01564-2; Urcuqui-Inchima S, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-83; de Tudela MVP, 2015, J NEUROSCI, V35, P9287, DOI 10.1523/JNEUROSCI.4712-14.2015; Vincent I, 1997, J NEUROSCI, V17, P3588; Volmer R, 2006, PLOS PATHOG, V2, P195, DOI 10.1371/journal.ppat.0020019; Wang WZ, 2015, J BIOL CHEM, V290, P168, DOI 10.1074/jbc.M114.617167; Wolff T, 2002, J BIOL CHEM, V277, P12151, DOI 10.1074/jbc.M109103200; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855	52	16	17	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2016	30	4					1523	1533		10.1096/fj.15-279620	http://dx.doi.org/10.1096/fj.15-279620			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DH2PR	26700735				2022-12-26	WOS:000372629100014
J	Bekal, S; Domier, LL; Gonfa, B; Lakhssassi, N; Meksem, K; Lambert, KN				Bekal, Sadia; Domier, Leslie L.; Gonfa, Biruk; Lakhssassi, Naoufal; Meksem, Khalid; Lambert, Kris N.			A SNARE-Like Protein and Biotin Are Implicated in Soybean Cyst Nematode Virulence	PLOS ONE			English	Article							HETERODERA-GLYCINES; EFFECTOR PROTEIN; GLOBODERA-ROSTOCHIENSIS; MELOIDOGYNE-JAVANICA; CHORISMATE MUTASE; PLANT-RESISTANCE; MEMBRANE-FUSION; HOST-DEFENSE; PARASITISM; EXPRESSION	Phytoparasitic nematodes that are able to infect and reproduce on plants that are considered resistant are referred to as virulent. The mechanism(s) that virulent nematodes employ to evade or suppress host plant defenses are not well understood. Here we report the use of a genetic strategy (allelic imbalance analysis) to associate single nucleotide polymorphisms (SNPs) with nematode virulence genes in Heterodera glycines, the soybean cyst nematode (SCN). To accomplish this analysis, a custom SCN SNP array was developed and used to genotype SCN F3-derived populations grown on resistant and susceptible soybean plants. Three SNPs reproducibly showed allele imbalances between nematodes grown on resistant and susceptible plants. Two candidate SCN virulence genes that were tightly linked to the SNPs were identified. One SCN gene encoded biotin synthase (HgBioB), and the other encoded a bacterial-like protein containing a putative SNARE domain (HgSLP-1). The two genes mapped to two different linkage groups. HgBioB contained sequence polymorphisms between avirulent and virulent nematodes. However, the gene encoding HgSLP-1 had reduced copy number in virulent nematode populations and appears to produce multiple forms of the protein via intron retention and alternative splicing. We show that HgSLP-1 is an esophageal-gland protein that is secreted by the nematode during plant parasitism. Furthermore, in bacterial co-expression experiments, HgSLP-1 co-purified with the SCN resistance protein Rhg1 alpha-SNAP, suggesting that these two proteins physically interact. Collectively our data suggest that multiple SCN genes are involved in SCN virulence, and that HgSLP-1 may function as an avirulence protein and when absent it helps SCN evade host defenses.	[Domier, Leslie L.; Gonfa, Biruk; Lambert, Kris N.] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Bekal, Sadia; Lakhssassi, Naoufal; Meksem, Khalid] So Illinois Univ, Dept Plant Soil & Agr Syst, Carbondale, IL 62901 USA	University of Illinois System; University of Illinois Urbana-Champaign; Southern Illinois University System; Southern Illinois University	Lambert, KN (corresponding author), Univ Illinois, Dept Crop Sci, 1102 S Goodwin Ave, Urbana, IL 61801 USA.	knlamber@illinois.edu	Meksem, Khalid/AAD-3101-2022; Lakhssassi, Naoufal/AAH-4641-2019	Lakhssassi, Naoufal/0000-0002-8255-9419; Meksem, Khalid/0000-0002-9469-9718	United Soybean Board [1420-532-5620]; North Central Soybean Research Program [NCSRP 2010-07360]; Illinois Soybean Association [09ISA354291]; United Stated Department of Agriculture, National Institute of Food and Agriculture, Agricultural and Food Research Initiative [2008-04061]; ARS [ARS-0422909] Funding Source: Federal RePORTER	United Soybean Board; North Central Soybean Research Program; Illinois Soybean Association; United Stated Department of Agriculture, National Institute of Food and Agriculture, Agricultural and Food Research Initiative; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This study was supported by the United Soybean Board (Proposal Number: 1420-532-5620, PI: KNL) (http://unitedsoybean.org/); North Central Soybean Research Program (Proposal Number: NCSRP 2010-07360, PI: KNL) (http://www.ncsrp.com); Illinois Soybean Association (Proposal Number: 09ISA354291, PI KNL) (http://www.ilsoy.org/); United Stated Department of Agriculture, National Institute of Food and Agriculture, Agricultural and Food Research Initiative (Proposal Number: 2008-04061, PI: KNL) (http://nifa.usda.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad P, 2010, ADV BOT RES, V53, P147, DOI 10.1016/S0065-2296(10)53005-2; Atibalentja N, 2005, MOL GENET GENOMICS, V273, P273, DOI 10.1007/s00438-005-1125-x; Barnard RJO, 1996, MOL BIOL CELL, V7, P693, DOI 10.1091/mbc.7.5.693; Bekal S, 2003, MOL PLANT MICROBE IN, V16, P439, DOI 10.1094/MPMI.2003.16.5.439; Callebaut I, 1997, CELL MOL LIFE SCI, V53, P621, DOI 10.1007/s000180050082; Carlson CS, 2006, HUM MOL GENET, V15, P1931, DOI 10.1093/hmg/ddl115; Castagnone-Sereno P, 2009, MOL GENET GENOMICS, V282, P547, DOI 10.1007/s00438-009-0487-x; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Concibido VC, 2004, CROP SCI, V44, P1121, DOI 10.2135/cropsci2004.1121; Cook D, 2014, PLANT PHYSL; Cook DE, 2012, SCIENCE, V338, P1206, DOI 10.1126/science.1228746; Craig JP, 2008, MOL BIOL EVOL, V25, P2085, DOI 10.1093/molbev/msn141; Craig JP, 2009, J NEMATOL, V41, P281; Delevoye C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000022; Dong K, 1997, GENETICS, V146, P1311; Doyle EA, 2003, MOL PLANT MICROBE IN, V16, P123, DOI 10.1094/MPMI.2003.16.2.123; DROPKIN VH, 1969, ANNU REV PHYTOPATHOL, V7, P101, DOI 10.1146/annurev.py.07.090169.000533; Dubreuil G, 2007, NEW PHYTOL, V176, P426, DOI 10.1111/j.1469-8137.2007.02181.x; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; ENDO BY, 1963, PHYTOPATHOLOGY, V53, P622; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Feng YJ, 2014, MOL MICROBIOL, V91, P300, DOI 10.1111/mmi.12460; Gleason CA, 2008, MOL PLANT MICROBE IN, V21, P576, DOI 10.1094/MPMI-21-5-0576; Hamamouch N, 2012, J EXP BOT, V63, P3683, DOI 10.1093/jxb/ers058; HAYASHI T, 1995, EMBO J, V14, P2317, DOI 10.1002/j.1460-2075.1995.tb07226.x; Hewezi T, 2010, PLANT PHYSIOL, V152, P968, DOI 10.1104/pp.109.150557; Hyten DL, 2009, CROP SCI, V49, P265, DOI 10.2135/cropsci2008.08.0511; Jaouannet M, 2013, MOL PLANT MICROBE IN, V26, P97, DOI 10.1094/MPMI-05-12-0130-R; Jones JT, 2004, GENE, V324, P47, DOI 10.1016/j.gene.2003.09.051; Kalde M, 2007, P NATL ACAD SCI USA, V104, P11850, DOI 10.1073/pnas.0701083104; Kim H, 2014, PLANT J, V79, P835, DOI 10.1111/tpj.12591; Lambert KN, 1999, MOL PLANT MICROBE IN, V12, P328, DOI 10.1094/MPMI.1999.12.4.328; Lambert KN, 2005, MOL PLANT MICROBE IN, V18, P593, DOI 10.1094/MPMI-18-0593; Liu Ren-Hu, 2003, Yichuan, V25, P317; Liu SM, 2012, NATURE, V492, P256, DOI 10.1038/nature11651; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lozano-Torres JL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004569; Lozano-Torres JL, 2012, P NATL ACAD SCI USA, V109, P10119, DOI 10.1073/pnas.1202867109; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Matsye PD, 2012, PLANT MOL BIOL, V80, P131, DOI 10.1007/s11103-012-9932-z; Mitchum MG, 2013, NEW PHYTOL, V199, P879, DOI 10.1111/nph.12323; NIBLACK TL, 1993, J NEMATOL, V25, P880; Pant SR, 2014, PLANT MOL BIOL; Patel N, 2010, J EXP BOT, V61, P235, DOI 10.1093/jxb/erp293; Paumet F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007375; Prior A, 2001, BIOCHEM J, V356, P387, DOI 10.1042/0264-6021:3560387; Quentin M, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00053; Rehman S, 2009, MOL PLANT MICROBE IN, V22, P330, DOI 10.1094/MPMI-22-3-0330; Rodriguez F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021925; Sacco MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000564; Schmitt DP, 2004, BIOL MANAGEMENT SOYB, Vxi; Semblat JP, 2001, MOL PLANT MICROBE IN, V14, P72, DOI 10.1094/MPMI.2001.14.1.72; Smant G, 1998, P NATL ACAD SCI USA, V95, P4906, DOI 10.1073/pnas.95.9.4906; Smant G, 2011, GENOMICS AND MOLECULAR GENETICS OF PLANT-NEMATODE INTERACTIONS, P273, DOI 10.1007/978-94-007-0434-3_13; Vivona S, 2013, J BIOL CHEM, V288, P24984, DOI 10.1074/jbc.M113.489807; Wesolowski J, 2010, VIRULENCE, V1, P319, DOI 10.4161/viru.1.4.12195; Williamson VM, 2006, TRENDS GENET, V22, P396, DOI 10.1016/j.tig.2006.05.003; Wong KK, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh072; Wrather JA, 2006, J NEMATOL, V38, P173; Wu Y, 2007, EFFICIENT ACCURATE C, P395; Zempleni J, 2009, BIOFACTORS, V35, P36, DOI 10.1002/biof.8	62	36	39	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145601	10.1371/journal.pone.0145601	http://dx.doi.org/10.1371/journal.pone.0145601			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714307	Green Submitted, Green Published, gold			2022-12-26	WOS:000367481900060
J	Moy, K; Li, WY; Tran, HP; Simonis, V; Story, E; Brandon, C; Furst, J; Raicu, D; Kim, H				Moy, Kyle; Li, Weiyu; Tran, Huu Phuoc; Simonis, Valerie; Story, Evan; Brandon, Christopher; Furst, Jacob; Raicu, Daniela; Kim, Hongkyun			Computational Methods for Tracking, Quantitative Assessment, and Visualization of C-elegans Locomotory Behavior	PLOS ONE			English	Article							LEVY; MOVEMENT; SEROTONIN; SYSTEM; DOPAMINE; PATTERNS; CIRCUIT; SUCCESS; NEURONS	The nematode Caenorhabditis elegans provides a unique opportunity to interrogate the neural basis of behavior at single neuron resolution. In C. elegans, neural circuits that control behaviors can be formulated based on its complete neural connection map, and easily assessed by applying advanced genetic tools that allow for modulation in the activity of specific neurons. Importantly, C. elegans exhibits several elaborate behaviors that can be empirically quantified and analyzed, thus providing a means to assess the contribution of specific neural circuits to behavioral output. Particularly, locomotory behavior can be recorded and analyzed with computational and mathematical tools. Here, we describe a robust single worm-tracking system, which is based on the open-source Python programming language, and an analysis system, which implements path-related algorithms. Our tracking system was designed to accommodate worms that explore a large area with frequent turns and reversals at high speeds. As a proof of principle, we used our tracker to record the movements of wild-type animals that were freshly removed from abundant bacterial food, and determined how wild-type animals change locomotory behavior over a long period of time. Consistent with previous findings, we observed that wild-type animals show a transition from area-restricted local search to global search over time. Intriguingly, we found that wild-type animals initially exhibit short, random movements interrupted by infrequent long trajectories. This movement pattern often coincides with local/global search behavior, and visually resembles Levy flight search, a search behavior conserved across species. Our mathematical analysis showed that while most of the animals exhibited Brownian walks, approximately 20% of the animals exhibited Levy flights, indicating that C. elegans can use Levy flights for efficient food search. In summary, our tracker and analysis software will help analyze the neural basis of the alteration and transition of C. elegans locomotory behavior in a food-deprived condition.	[Moy, Kyle; Li, Weiyu; Tran, Huu Phuoc; Simonis, Valerie; Story, Evan; Furst, Jacob; Raicu, Daniela] Depaul Univ, Sch Comp, Coll Comp & Digital Media, Chicago, IL 60604 USA; [Brandon, Christopher; Kim, Hongkyun] Rosalind Franklin Univ, Dept Cell Biol & Anat, Chicago Med Sch, N Chicago, IL USA	DePaul University; Chicago Medical School; Rosalind Franklin University Medical & Science	Raicu, D (corresponding author), Depaul Univ, Sch Comp, Coll Comp & Digital Media, Chicago, IL 60604 USA.	draicu@cdm.depaul.edu; hongkyun.kim@rosalindfranklin.edu	Cote, Rick H/G-3363-2013	Cote, Rick H/0000-0002-1573-6526; Kim, Hongkyun/0000-0002-4879-7122				Abraham LS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001077; Ben Arous J, 2010, J NEUROSCI METH, V187, P229, DOI 10.1016/j.jneumeth.2010.01.011; Benhamou S, 2007, ECOLOGY, V88, P1962, DOI 10.1890/06-1769.1; Brown AEX, 2013, P NATL ACAD SCI USA, V110, P791, DOI 10.1073/pnas.1211447110; Calhoun AJ, 2015, NEURON, V86, P428, DOI 10.1016/j.neuron.2015.03.026; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Codling EA, 2011, THEOR ECOL-NETH, V4, P397, DOI 10.1007/s12080-010-0086-9; Cronin CJ, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-5; de Jager M, 2011, SCIENCE, V332, P1551, DOI 10.1126/science.1201187; Dray S, 2010, ECOL RES, V25, P673, DOI 10.1007/s11284-010-0701-7; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; Faumont S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024666; Feng ZY, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-115; Flavell SW, 2013, CELL, V154, P1023, DOI 10.1016/j.cell.2013.08.001; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Hills T, 2004, J NEUROSCI, V24, P1217, DOI 10.1523/JNEUROSCI.1569-03.2004; Humphries NE, 2014, J THEOR BIOL, V358, P179, DOI 10.1016/j.jtbi.2014.05.032; Humphries NE, 2012, P NATL ACAD SCI USA, V109, P7169, DOI 10.1073/pnas.1121201109; Humphries NE, 2010, NATURE, V465, P1066, DOI 10.1038/nature09116; Husson Steven J, 2013, WormBook, P1, DOI 10.1895/wormbook.1.156.1; Leifer AM, 2011, NAT METHODS, V8, P147, DOI 10.1038/NMETH.1554; Liewald JF, 2008, NAT METHODS, V5, P895, DOI 10.1038/NMETH.1252; Luo LJ, 2014, NEURON, V82, P1115, DOI 10.1016/j.neuron.2014.05.010; Maye A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000443; Nonet ML, 1998, J NEUROSCI, V18, P70; Peliti Margherita, 2013, PLoS One, V8, pe78535, DOI 10.1371/journal.pone.0078535; Ramot D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002208; Reynolds A, 2015, PHYS LIFE REV; Reynolds AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000354; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; SCHAFER WR, 1995, NATURE, V375, P73, DOI 10.1038/375073a0; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Stephens GJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000028; Stirman JN, 2011, NAT METHODS, V8, P153, DOI 10.1038/NMETH.1555; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; TRENT C, 1983, GENETICS, V104, P619; Viswanathan G, 1996, INDIAN J BIOCHEM BIO, V33, P311; Viswanathan GM, 2010, NATURE, V465, P1018, DOI 10.1038/4651018a; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; Wakabayashi T, 2004, NEUROSCI RES, V50, P103, DOI 10.1016/j.neures.2004.06.005; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Yemini E, 2013, NAT METHODS, V10, P877, DOI [10.1038/NMETH.2560, 10.1038/nmeth.2560]; Zhang M, 2008, CURR BIOL, V18, P1445, DOI 10.1016/j.cub.2008.08.047; Zhao K, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1158; Zheng Y, 1999, NEURON, V24, P347, DOI 10.1016/S0896-6273(00)80849-1	47	8	8	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145870	10.1371/journal.pone.0145870	http://dx.doi.org/10.1371/journal.pone.0145870			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713869	Green Submitted, Green Published, gold			2022-12-26	WOS:000367481900096
J	Okwechime, IO; Roberson, S; Odoi, A				Okwechime, Ifechukwude Obiamaka; Roberson, Shamarial; Odoi, Agricola			Prevalence and Predictors of Pre-Diabetes and Diabetes among Adults 18 Years or Older in Florida: A Multinomial Logistic Modeling Approach	PLOS ONE			English	Article							FASTING PLASMA-GLUCOSE; PHYSICAL-ACTIVITY; RISK-FACTORS; INSULIN-RESISTANCE; HEALTH; HBA(1C); DISPARITIES; CARE; US; TOLERANCE	Background Individuals with pre-diabetes and diabetes have increased risks of developing macro-vascular complications including heart disease and stroke; which are the leading causes of death globally. The objective of this study was to estimate the prevalence of pre-diabetes and diabetes, and to investigate their predictors among adults >= 18 years in Florida. Methods Data covering the time period January-December 2013, were obtained from Florida's Behavioral Risk Factor Surveillance System (BRFSS). Survey design of the study was declared using SVYSET statement of STATA 13.1. Descriptive analyses were performed to estimate the prevalence of pre-diabetes and diabetes. Predictors of pre-diabetes and diabetes were investigated using multinomial logistic regression model. Model goodness-of-fit was evaluated using both the multinomial goodness-of-fit test proposed by Fagerland, Hosmer, and Bofin, as well as, the Hosmer-Lemeshow's goodness of fit test. Results There were approximately 2,983 (7.3%) and 5,189 (12.1%) adults in Florida diagnosed with pre-diabetes and diabetes, respectively. Over half of the study respondents were white, married and over the age of 45 years while 36.4% reported being physically inactive, overweight (36.4%) or obese (26.4%), hypertensive (34.6%), hypercholesteremic (40.3%), and 26% were arthritic. Based on the final multivariable multinomial model, only being overweight (Relative Risk Ratio [RRR] = 1.85, 95% Confidence Interval [95% CI] = 1.41, 2.42), obese (RRR = 3.41, 95% CI = 2.61, 4.45), hypertensive (RRR = 1.69, 95% CI = 1.33, 2.15), hypercholesterolemic (RRR = 1.94, 95% CI = 1.55, 2.43), and arthritic (RRR = 1.24, 95% CI = 1.00, 1.55) had significant associations with pre-diabetes. However, more predictors had significant associations with diabetes and the strengths of associations tended to be higher than for the association with pre-diabetes. For instance, the relative risk ratios for the association between diabetes and being overweight (RRR = 2.00, 95% CI = 1.55, 2.57), or obese (RRR = 4.04, 95% CI = 3.22, 5.07), hypertensive (RRR = 2.66, 95% CI = 2.08, 3.41), hypercholesterolemic (RRR = 1.98, 95% CI = 1.61, 2.45) and arthritic (RRR = 1.28, 95% CI = 1.04, 1.58) were all further away from the null than their associations with pre-diabetes. Moreover, a number of variables such as age, income level, sex, and level of physical activity had significant association with diabetes but not pre-diabetes. The risk of diabetes increased with increasing age, lower income, in males, and with physical inactivity. Insufficient physical activity had no significant association with the risk of diabetes or prediabetes. Conclusions There is evidence of differences in the strength of association of the predictors across levels of diabetes status (pre-diabetes and diabetes) among adults >= 18 years in Florida. It is important to monitor populations at high risk for pre-diabetes and diabetes, so as to help guide health programming decisions and resource allocations to control the condition.	[Okwechime, Ifechukwude Obiamaka; Odoi, Agricola] Univ Tennessee, Coll Vet Med, Dept Biomed & Diagnost Sci, Knoxville, TN 37996 USA; [Roberson, Shamarial] Bur Chron Dis Prevent, Florida Dept Hlth, Tallahassee, FL USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; Florida Department of Health	Odoi, A (corresponding author), Univ Tennessee, Coll Vet Med, Dept Biomed & Diagnost Sci, Knoxville, TN 37996 USA.	aodoi@utk.edu	Odoi, Agricola/I-9532-2019	Odoi, Agricola/0000-0001-5050-6737				Abraham TM, 2013, DIABETES CARE, V36, P2139, DOI 10.2337/dc13-0792; Akter S, 2014, DIABETES CARE, V37, pE9, DOI 10.2337/dc13-1647; Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; [Anonymous], DIAGN DIAB LEARN PRE; Bardenheier BH, 2013, DIABETES CARE, V36, P2655, DOI 10.2337/dc12-2608; Barker LE, 2011, AM J PREV MED, V40, P434, DOI 10.1016/j.amepre.2010.12.019; Bowlin SJ, 1996, J CLIN EPIDEMIOL, V49, P511, DOI 10.1016/0895-4356(96)00010-8; Braveman PA, 2010, AM J PUBLIC HEALTH, V100, pS186, DOI 10.2105/AJPH.2009.166082; Brazeau AS, 2012, DIABETIC MED, V29, pE402, DOI 10.1111/j.1464-5491.2012.03757.x; Centers for Disease Control, 2020, NATL DIABETES STAT R; Centers for Disease Control and Prevention, 2015, ALL STAT PRED NUMB 1; Chasens ER, 2012, CLIN NURS RES, V21, P294, DOI 10.1177/1054773811411295; Chatterjee R, 2013, DIABETES CARE, V36, P1981, DOI 10.2337/dc12-1752; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Diaz-Redondo A, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-014-0216-3; Dinca-Panaitescu M, 2012, MATURITAS, V72, P229, DOI 10.1016/j.maturitas.2012.03.017; Dinca-Panaitescu S, 2011, HEALTH POLICY, V99, P116, DOI 10.1016/j.healthpol.2010.07.018; Dubowitz N, 2014, DIABETIC MED, V31, P927, DOI 10.1111/dme.12459; Fagerland MW, 2012, STATA J, V12, P447, DOI 10.1177/1536867X1201200307; Farni K, 2014, PEERJ, V2, DOI 10.7717/peerj.499; Farr JN, 2012, MED SCI SPORT EXER, V44, P1375, DOI 10.1249/MSS.0b013e31824749b2; Ferguson JF, 2015, METABOLISM, V64, P513, DOI 10.1016/j.metabol.2014.12.007; Gaskin DJ, 2014, AM J PUBLIC HEALTH, V104, P2147, DOI 10.2105/AJPH.2013.301420; Glechner A, 2015, DIABETOLOGIA, V58, P242, DOI 10.1007/s00125-014-3439-x; Graham E, 2015, PREV MED, V77, P74, DOI 10.1016/j.ypmed.2015.05.004; Grundy SM, 2012, J AM COLL CARDIOL, V59, P635, DOI 10.1016/j.jacc.2011.08.080; Harada ND, 2001, MED SCI SPORT EXER, V33, P962, DOI 10.1097/00005768-200106000-00016; Hsu CC, 2012, DIABETES CARE, V35, P2286, DOI 10.2337/dc11-2052; Hu G, 2004, ARCH INTERN MED, V164, P892, DOI 10.1001/archinte.164.8.892; Hu Y, 2014, OBESITY, V22, P2267, DOI 10.1002/oby.20851; International-Diabetes-Federation, IDF DIAB ATL UPD POS; Islam FMA, 2016, J DIABETES, V8, P260, DOI 10.1111/1753-0407.12294; Lee LT, 2014, PREV MED, V63, P43, DOI 10.1016/j.ypmed.2014.02.013; Lipska KJ, 2013, DIABETES CARE, V36, P3923, DOI 10.2337/dc12-2631; Livingood WC, 2010, PREV CHRONIC DIS, V7; Logan H, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-906; Mengesha Addisu Y, 2007, Afr Health Sci, V7, P244; Nelson KM, 2005, HEALTH SERV RES, V40, P361, DOI 10.1111/j.1475-6773.2005.0d362.x; Pani LN, 2008, DIABETES CARE, V31, P1991, DOI 10.2337/dc08-0577; Plantinga LC, 2010, CLIN J AM SOC NEPHRO, V5, P673, DOI 10.2215/CJN.07891109; RaviKumar P, 2011, DIABETIC MED, V28, P590, DOI 10.1111/j.1464-5491.2011.03242.x; Rhee MK, 2006, DIABETIC MED, V23, P1174, DOI 10.1111/j.1464-5491.2006.01956.x; Ridic Goran, 2012, Mater Sociomed, V24, P112, DOI 10.5455/msm.2012.24.112-120; Saltevo JT, 2011, DIABETES RES CLIN PR, V93, P344, DOI 10.1016/j.diabres.2011.05.006; Solomon DH, 2010, ANN RHEUM DIS, V69, P2114, DOI 10.1136/ard.2009.125476; StataCorp, 2013, STATA STAT SOFTW REL; STEIN AD, 1995, AM J EPIDEMIOL, V141, P1097, DOI 10.1093/oxfordjournals.aje.a117375; Stryhn H., 2012, METHODS EPIDEMIOLOGI; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Tester J, 2013, DIABETES METAB SYND, V7, P161, DOI 10.1016/j.dsx.2013.06.002; US Census Bureau, 2010, 2010 CENS INT POP SE; Wang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028962; Woolf SH, 2011, HEALTH AFFAIR, V30, P1852, DOI 10.1377/hlthaff.2011.0685; Xu F, 2014, MMWR SURVEILL SUMM, V63, P1	55	32	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145781	10.1371/journal.pone.0145781	http://dx.doi.org/10.1371/journal.pone.0145781			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA0IX	26714019	Green Published, gold			2022-12-26	WOS:000367481900081
J	Laming, SR; Szafranski, KM; Rodrigues, CF; Gaudron, SM; Cunha, MR; Hilario, A; Le Bris, N; Duperron, S				Laming, Sven R.; Szafranski, Kamil M.; Rodrigues, Clara F.; Gaudron, Sylvie M.; Cunha, Marina R.; Hilario, Ana; Le Bris, Nadine; Duperron, Sebastien			Fickle or Faithful: The Roles of Host and Environmental Context in Determining Symbiont Composition in Two Bathymodioline Mussels	PLOS ONE			English	Article							DEEP-SEA; COLD SEEPS; BIVALVIA; COLONIZATION; MYTILIDAE; DIVERSITY; ATLANTIC; GILLS; COOCCURRENCE; CARBONATES	The Mediterranean Sea and adjoining East Atlantic Ocean host a diverse array of small-sized mussels that predominantly live on sunken, decomposing organic remains. At least two of these, Idas modiolaeformis and Idas simpsoni, are known to engage in gill-associated symbioses; however, the composition, diversity and variability of these symbioses with changing habitat and location is poorly defined. The current study presents bacterial symbiont assemblage data, derived from 454 pyrosequencing carried out on replicate specimens of these two host species, collected across seven sample sites found in three oceanographic regions in the Mediterranean and East Atlantic. The presence of several bacterial OTUs in both the Mediterranean Sea and eastern Atlantic suggests that similar symbiont candidates occur on both sides of the Strait of Gibraltar. The results reveal markedly different symbiotic modes in the two species. Idas modiolaeformis displays high symbiont diversity and flexibility, with strong variation in symbiont composition from the East Mediterranean to the East Atlantic. Idas simpsoni displays low symbiont diversity but high symbiont fidelity, with a single dominant OTU occurring in all specimens analysed. These differences are argued to be a function of the host species, where subtle differences in host evolution, life-history and behaviour could partially explain the observed patterns. The variability in symbiont compositions, particularly in Idas modiolaeformis, is thought to be a function of the nature, context and location of the habitat from which symbiont candidates are sourced.	[Laming, Sven R.; Szafranski, Kamil M.; Rodrigues, Clara F.; Gaudron, Sylvie M.; Duperron, Sebastien] Univ Paris 06, Sorbonne Univ, Lab Biol Organismes & Ecosyst Aquat, UMR7208,UPMC,CNRS,MNHM,IRD,CAEN, Paris, France; [Laming, Sven R.; Rodrigues, Clara F.; Cunha, Marina R.; Hilario, Ana] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Laming, Sven R.; Rodrigues, Clara F.; Cunha, Marina R.; Hilario, Ana] Univ Aveiro, CESAM, P-3800 Aveiro, Portugal; [Le Bris, Nadine] Sorbonne Univ, UPMC Banyuls, Stn Marine Banyuls,Observ Oceanol, UMR8222,Lab Ecogeochim Environm Benth UPMC CNRS, Banyuls Sur Mer, France; [Duperron, Sebastien] Inst Univ France, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Universidade de Aveiro; Universidade de Aveiro; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Institut Universitaire de France	Duperron, S (corresponding author), Univ Paris 06, Sorbonne Univ, Lab Biol Organismes & Ecosyst Aquat, UMR7208,UPMC,CNRS,MNHM,IRD,CAEN, 7 Quai St Bernard, Paris, France.	sebastien.duperron@upmc.fr	Cunha, Marina R/B-7644-2008; Hilário, Ana/C-1260-2008; Laming, Sven/Q-3470-2019; Rodrigues, Clara F./A-4536-2009; Le Bris, Nadine/E-1381-2014	Cunha, Marina R/0000-0001-8833-6980; Hilário, Ana/0000-0001-8287-1528; Laming, Sven/0000-0002-1316-486X; Rodrigues, Clara F./0000-0002-3426-8342; Le Bris, Nadine/0000-0002-0142-4847; Gaudron, Sylvie/0000-0001-6189-3824; duperron, sebastien/0000-0002-6422-6821	CARCACE project (Fundacao para a Ciencia e a Tecnologia, FCT) [PTDC/MAR/099656/2008]; European Regional Development Fund through COMPETE [FCOMP-01-0124-FEDER-010569]; European Commission Seventh Framework Programme (FP7) under the HERMIONE project [226354]; French ANR DeepOases; GDRE-DIWOOD; CHEMECO ESF EURODEEP [EURODEEP/0001/2007]; ITN SYMBIOMICS; UPMC (University Pierre and Marie Currie); Foundation TOTAL; Institut Universitaire de France; MARES Joint Doctorate programme [FPA 2011-0016]; Marie Curie Actions Initial Training Network (ITN) SYMBIOMICS [264774]; FCT (Portugal) [SFRH/BPD/64154/2009]; FCT [SFRH/BPD/64154/2009, PEst-C/MAR/LA0017/2013, UID/AMB/50017/2013]; European Network GDRE-DIWOOD (CNRS)	CARCACE project (Fundacao para a Ciencia e a Tecnologia, FCT); European Regional Development Fund through COMPETE; European Commission Seventh Framework Programme (FP7) under the HERMIONE project; French ANR DeepOases(French National Research Agency (ANR)); GDRE-DIWOOD; CHEMECO ESF EURODEEP; ITN SYMBIOMICS; UPMC (University Pierre and Marie Currie); Foundation TOTAL; Institut Universitaire de France; MARES Joint Doctorate programme; Marie Curie Actions Initial Training Network (ITN) SYMBIOMICS; FCT (Portugal)(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); European Network GDRE-DIWOOD (CNRS)	Sample collection and analyses were supported by the CARCACE project (PTDC/MAR/099656 /2008, co-financed by Fundacao para a Ciencia e a Tecnologia, FCT); the European Regional Development Fund through COMPETE (FCOMP-01-0124-FEDER-010569); the European Commission Seventh Framework Programme (FP7/2007-2013) under the HERMIONE project contract 226354; the French ANR DeepOases; GDRE-DIWOOD; CHEMECO ESF EURODEEP (EURODEEP/0001/2007); ITN SYMBIOMICS; UPMC (University Pierre and Marie Currie), Foundation TOTAL and the Institut Universitaire de France. SRL was also supported by a PhD grant from the MARES Joint Doctorate programme selected under Erasmus Mundus coordinated by Ghent University (FPA 2011-0016), KS was funded through a PhD grant from the Marie Curie Actions Initial Training Network (ITN) SYMBIOMICS (contract number 264774), and CFR was supported by a postdoctoral fellowship (SFRH/BPD/64154/2009) from FCT (Portugal).; We thank the captains, crew, ROVs operators and scientists (including JP. Henriet, A. Boetius, F. Wenzhofer, C. Pierre, L. Corbari, J. Thubaut and C. Borowski) involved in sample collection and fixation during following cruises: MERIAN (RV Maria S Merian), MEDECO (RV Pourquoi Pas?), JC10 (RV James Cook), 64PE284 (RV Pelagia), B09-14b (RV Belgica), Nautilus Expedition NA017 (EV Nautilus), Banyuls LD4-5 (RV Minibex, COMEX) and CARCACE (NRP Almirante Gago Coutinho / RV Belgica). We thank the anonymous reviewers for helpful comments. Sample collection and analyses were supported by the CARCACE project (PTDC/MAR/099656 /2008, co-financed by Fundacao para a Ciencia e a Tecnologia, FCT); the European Regional Development Fund through COMPETE (FCOMP-01-0124-FEDER-010569); the projects PEst-C/MAR/LA0017/2013 and UID/AMB/50017/2013 (FCT); the European Commission Seventh Framework Programme (FP7/2007-2013) under the HERMIONE project contract 226354; the French ANR DeepOases; European Network GDRE-DIWOOD (CNRS); CHEMECO ESF EURODEEP (EURODEEP/0001/2007); ITN SYMBIOMICS; UPMC (University Pierre and Marie Currie), Foundation TOTAL (Chair Biodiversity, extreme marine environment and global change, NLB) and the Institut Universitaire de France. SRL was supported by a PhD grant from the MARES Joint Doctorate programme selected under Erasmus Mundus coordinated by Ghent University (FPA 2011-0016), KS was funded through a PhD grant from the Marie Curie Actions Initial Training Network (ITN) SYMBIOMICS (contract number 264774), and CFR was supported by a postdoctoral fellowship (SFRH/BPD/64154/2009) from FCT.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andreotti R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-6; Bolotin J, 2005, J MAR BIOL ASSOC UK, V85, P977, DOI 10.1017/S0025315405011975; Chevalier N, 2011, MAR GEOL, V288, P112, DOI 10.1016/j.margeo.2011.08.005; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cruaud P, 2014, APPL ENVIRON MICROB, V80, P4626, DOI 10.1128/AEM.00592-14; Cunha MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076688; Dubilier N, 2008, NAT REV MICROBIOL, V6, P725, DOI 10.1038/nrmicro1992; Duperron S, 2013, BIOGEOSCIENCES, V10, P3241, DOI 10.5194/bg-10-3241-2013; Duperron S, 2008, FEMS MICROBIOL ECOL, V63, P338, DOI 10.1111/j.1574-6941.2008.00438.x; Duperron S, 2008, ENVIRON MICROBIOL, V10, P433, DOI 10.1111/j.1462-2920.2007.01465.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gasperini L, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004190; Gaudron SM, 2010, MAR ENVIRON RES, V70, P1, DOI 10.1016/j.marenvres.2010.02.002; Gaudron SM, 2012, BIOL BULL-US, V222, P6, DOI 10.1086/BBLv222n1p6; Genio L, 2015, MAR ECOL-EVOL PERSP, V36, P71, DOI 10.1111/maec.12217; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Kautz S, 2013, APPL ENVIRON MICROB, V79, P525, DOI 10.1128/AEM.03107-12; Kiel S, 2006, J PALEONTOL, V80, P121, DOI 10.1666/0022-3360(2006)080[0121:NRASOM]2.0.CO;2; Kiel S, 2010, ZOOTAXA, P26, DOI 10.11646/zootaxa.2390.1.2; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Laming SR, 2015, MAR ENV RES; Laming SR, 2014, THESIS; Laming SR, 2014, MAR BIOL, V161, P1319, DOI 10.1007/s00227-014-2421-y; Laurent MCZ, 2009, MAR ENVIRON RES, V67, P83, DOI 10.1016/j.marenvres.2008.11.006; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lorion J, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1243; Lorion J, 2012, CAH BIOL MAR, V53, P77; LUTZ RA, 1980, MAR BIOL, V57, P127, DOI 10.1007/BF00387378; Olu-Le Roy K, 2004, DEEP-SEA RES PT I, V51, P1915, DOI 10.1016/j.dsr.2004.07.004; Omoregie EO, 2009, MAR GEOL, V261, P114, DOI 10.1016/j.margeo.2009.02.001; Prosser JI, 2010, ENVIRON MICROBIOL, V12, P1806, DOI 10.1111/j.1462-2920.2010.02201.x; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Quero J-C, 1973, ANN SOC SCI NAT CHAR, V55, P319; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; R Core Team, 2021, R LANGUAGE ENV STAT; Ritt B, 2012, DEEP-SEA RES PT I, V67, P121, DOI 10.1016/j.dsr.2012.05.009; Ritt B, 2011, MAR BIOL, V158, P1187, DOI 10.1007/s00227-011-1679-6; Rodrigues CF, 2015, BIOL J LINN SOC, V114, P398, DOI 10.1111/bij.12431; Rodrigues CF, 2013, NATURWISSENSCHAFTEN, V100, P21, DOI 10.1007/s00114-012-0985-2; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Southward EC, 2008, J SHELLFISH RES, V27, P139, DOI 10.2983/0730-8000(2008)27[139:TMOBSI]2.0.CO;2; Stewart FJ, 2009, ENVIRON MICROBIOL, V11, P2136, DOI 10.1111/j.1462-2920.2009.01933.x; Szafranski KM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00162; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thubaut J, 2012, THESIS; Thubaut J, 2013, ECOL EVOL, V3, P4748, DOI 10.1002/ece3.749; Webster NS, 2012, ENVIRON MICROBIOL, V14, P335, DOI 10.1111/j.1462-2920.2011.02460.x; Won YJ, 2008, J SHELLFISH RES, V27, P129, DOI 10.2983/0730-8000(2008)27[129:AOCBDM]2.0.CO;2; Yucel M, 2013, CHEMOSPHERE, V90, P403, DOI 10.1016/j.chemosphere.2012.07.036	51	8	8	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0144307	10.1371/journal.pone.0144307	http://dx.doi.org/10.1371/journal.pone.0144307			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710314	Green Submitted, Green Published, gold			2022-12-26	WOS:000367451400004
J	Wang, BW; Han, YN; Li, Y; Li, YY; Wang, XY				Wang, Biwen; Han, Yaning; Li, Ye; Li, Yanyan; Wang, Xiaoyuan			Immuno-Stimulatory Activity of Escherichia coli Mutants Producing Kdo(2)-Monophosphoryl-Lipid A or Kdo(2)-Pentaacyl-Monophosphoryl-Lipid A	PLOS ONE			English	Article							OUTER-MEMBRANE PERMEABILITY; MONOPHOSPHORYL-LIPID-A; ANTIBIOTIC-RESISTANCE; STRUCTURAL BASIS; LIPOPOLYSACCHARIDE; ENDOTOXIN; PURIFICATION; MACROPHAGES; KDO(2)-LIPID-A; CONSTRUCTION	Lipid A is the active center of lipopolysaccharide which also known as endotoxin. Monophosphoryl-lipid A (MPLA) has less toxicity but retains potent immunoadjuvant activity; therefore, it can be developed as adjuvant for improving the strength and duration of the immune response to antigens. However, MPLA cannot be chemically synthesized and can only be obtained by hydrolyzing lipopolysaccharide (LPS) purified from Gram-negative bacteria. Purifying LPS is difficult and time-consuming and can damage the structure of MPLA. In this study, Escherichia coli mutant strains HWB01 and HWB02 were constructed by deleting several genes and integrating Francisella novicida gene lpxE into the chromosome of E. coli wild type strain W3110. Compared with W3110, HWB01 and HWB02 synthesized very short LPS, Kdo(2)-monophosphoryl-lipid A (Kdo(2)-MPLA) and Kdo(2)-pentaacyl-monophosphoryl-lipid A (Kdo(2)-pentaacyl-MPLA), respectively. Structural changes of LPS in the outer membranes of HWB01 and HWB02 increased their membrane permeability, surface hydrophobicity, auto-aggregation ability and sensitivity to some antibiotics, but the abilities of these strains to activate the TLR4/MD-2 receptor of HKE-Blue hTLR4 cells were deceased. Importantly, purified Kdo(2)-MPLA and Kdo(2)-pentaacyl-MPLA differed from wild type LPS in their ability to stimulate the mammalian cell lines THP-1 and RAW264.7. The purification of Kdo(2)-MPLA and Kdo(2)-pentaacyl-MPLA from HWB01 and HWB02, respectively, is much easier than the purification of LPS from W3110, and these lipid A derivatives could be important tools for developing future vaccine adjuvants.	[Wang, Biwen; Han, Yaning; Li, Ye; Li, Yanyan; Wang, Xiaoyuan] Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi 214122, Peoples R China; [Wang, Biwen] Jiangnan Univ, Sch Food Sci & Technol, Wuxi 214122, Peoples R China; [Wang, Xiaoyuan] Jiangnan Univ, Synerget Innovat Ctr Food Safety & Nutr, Wuxi 214122, Peoples R China	Jiangnan University; Jiangnan University; Jiangnan University	Wang, XY (corresponding author), Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi 214122, Peoples R China.	xwang@jiangnan.edu.cn			National Natural Science Foundation of China [31170069]; National Key Basic Research Program of China [2012CB725202]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China (31170069) and National Key Basic Research Program of China (2012CB725202) to XW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China (31170069) and the National Key Basic Research Program of China (2012CB725202).	Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5; BAKER PJ, 1992, INFECT IMMUN, V60, P2694, DOI 10.1128/IAI.60.7.2694-2701.1992; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bohannon JK, 2013, SHOCK, V40, P451, DOI 10.1097/SHK.0000000000000042; Brabetz W, 1997, EUR J BIOCHEM, V247, P716, DOI 10.1111/j.1432-1033.1997.00716.x; Chen JZ, 2011, BIOTECHNOL LETT, V33, P1013, DOI 10.1007/s10529-011-0521-z; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Coler RN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016333; Cullen TW, 2013, INFECT IMMUN, V81, P430, DOI 10.1128/IAI.01046-12; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Delcour AH, 2009, BBA-PROTEINS PROTEOM, V1794, P808, DOI 10.1016/j.bbapap.2008.11.005; Desjardins P, 2010, J VIS EXP; DESJARDINS P, 2009, CURR PROTOC PROTEIN, pCH3; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gaekwad J, 2010, J BIOL CHEM, V285, P29375, DOI 10.1074/jbc.M110.115204; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; Garcon N, 2010, METHODS MOL BIOL, V626, P15, DOI 10.1007/978-1-60761-585-9_2; Hambleton J, 1996, P NATL ACAD SCI USA, V93, P2774, DOI 10.1073/pnas.93.7.2774; Han YN, 2013, MAR DRUGS, V11, P363, DOI 10.3390/md11020363; Hankins JV, 2011, MOL MICROBIOL, V81, P1313, DOI 10.1111/j.1365-2958.2011.07765.x; Helander IM, 2000, J APPL MICROBIOL, V88, P213, DOI 10.1046/j.1365-2672.2000.00971.x; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Janusch H, 2002, J ENDOTOXIN RES, V8, P343, DOI 10.1179/096805102125000678; Li YY, 2013, MAR DRUGS, V11, P3197, DOI 10.3390/md11093197; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; Murphy RC, 2005, PROSTAG OTH LIPID M, V77, P131, DOI 10.1016/j.prostaglandins.2004.09.004; Needham BD, 2013, P NATL ACAD SCI USA, V110, P1464, DOI 10.1073/pnas.1218080110; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Nweze EI, 2012, J ANTIMICROB CHEMOTH, V67, P149, DOI 10.1093/jac/dkr429; Oblak A, 2015, MOL IMMUNOL, V63, P134, DOI 10.1016/j.molimm.2014.06.034; Ohto U, 2012, P NATL ACAD SCI USA, V109, P7421, DOI 10.1073/pnas.1201193109; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Raetz CRH, 2006, J LIPID RES, V47, P1097, DOI 10.1194/jlr.M600027-JLR200; Raetz CRH, 2009, J LIPID RES, V50, pS103, DOI 10.1194/jlr.R800060-JLR200; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rahman MM, 2008, ANAEROBE, V14, P73, DOI 10.1016/j.anaerobe.2008.01.002; Reynolds CM, 2009, BIOCHEMISTRY-US, V48, P9627, DOI 10.1021/bi901391g; Sasaki H, 2008, BIOPHYS J, V95, P986, DOI 10.1529/biophysj.108.129197; Thompson BS, 2005, J LEUKOCYTE BIOL, V78, P1273, DOI 10.1189/jlb.0305172; Wang JL, 2014, MAR DRUGS, V12, P1495, DOI 10.3390/md12031495; Wang L, 2012, J APPL MICROBIOL, V112, P985, DOI 10.1111/j.1365-2672.2012.05263.x; Wang XY, 2015, BIOL REV, V90, P408, DOI 10.1111/brv.12114; Wang XY, 2010, SUBCELL BIOCHEM, V53, P27, DOI 10.1007/978-90-481-9078-2_2; Wang XY, 2010, SUBCELL BIOCHEM, V53, P3, DOI 10.1007/978-90-481-9078-2_1; Wang XY, 2010, PROG LIPID RES, V49, P97, DOI 10.1016/j.plipres.2009.06.002; Wang XY, 2004, J BIOL CHEM, V279, P49470, DOI 10.1074/jbc.M409078200; Wang Z, 2015, MAR DRUGS, V13, P3325, DOI 10.3390/md13063325; WEINSTEIN SL, 1993, J IMMUNOL, V151, P3829; Whitfield C, 2014, ANNU REV BIOCHEM, V83, P99, DOI 10.1146/annurev-biochem-060713-035600	51	8	10	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0144714	10.1371/journal.pone.0144714	http://dx.doi.org/10.1371/journal.pone.0144714			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710252	Green Published, gold, Green Submitted			2022-12-26	WOS:000367451400011
J	Yan, XC; Yan, MF; Guo, YH; Singh, G; Chen, YH; Yu, M; Wang, DM; Hillery, CA; Chan, AM				Yan, Xiaocai; Yan, Mingfei; Guo, Yihe; Singh, Gobind; Chen, Yuhong; Yu, Mei; Wang, Demin; Hillery, Cheryl A.; Chan, Andrew M.			R-Ras Regulates Murine T Cell Migration and Intercellular Adhesion Molecule-1 Binding	PLOS ONE			English	Article							INTEGRIN ACTIVATION; PHOSPHATIDYLINOSITOL-3-OH KINASE; LYMPH-NODES; H-RAS; RAP1; TRANSFORMATION; REGENERATION; INFLAMMATION; MEMBRANE; PATHWAYS	The trafficking of T-lymphocytes to peripheral draining lymph nodes is crucial for mounting an adaptive immune response. The role of chemokines in the activation of integrins via Ras-related small GTPases has been well established. R-Ras is a member of the Ras-subfamily of small guanosine-5'-triphosphate-binding proteins and its role in T cell trafficking has been investigated in R-Ras null mice (Rras(-/-)). An examination of the lymphoid organs of Rras(-/-) mice revealed a 40% reduction in the cellularity of the peripheral lymph nodes. Morphologically, the high endothelial venules of Rras(-/-) mice were more disorganized and less mature than those of wild-type mice. Furthermore, CD4(+) and CD8(+) T cells from Rras(-/-) mice had approximately 42% lower surface expression of L-selectin/CD62L. These aberrant peripheral lymph node phenotypes were associated with proliferative and trafficking defects in Rras(-/-) T cells. Furthermore, R-Ras could be activated by the chemokine, CCL21. Indeed, Rras(-/-) T cells had approximately 14.5% attenuation in binding to intercellular adhesion molecule 1 upon CCL21 stimulation. Finally, in a graft-versus host disease model, recipient mice that were transfused with Rras(-/-) T cells showed a significant reduction in disease severity when compared with mice transplanted with wild-type T cells. These findings implicate a role for R-Ras in T cell trafficking in the high endothelial venules during an effective immune response.	[Yan, Xiaocai; Hillery, Cheryl A.] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; [Yan, Mingfei; Chan, Andrew M.] Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China; [Guo, Yihe; Chen, Yuhong; Yu, Mei; Wang, Demin; Hillery, Cheryl A.] BloodCtr Wisconsin, Blood Res Inst, Milwaukee, WI USA; [Singh, Gobind] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY USA	Medical College of Wisconsin; Chinese University of Hong Kong; Versiti Blood Center of Wisconsin; Icahn School of Medicine at Mount Sinai	Chan, AM (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China.	andrewmchan@cuhk.edu.hk	Chan, Andrew/AAC-1145-2020; Yu, Mei/K-2206-2017; Yan, Mingfei/AAQ-9265-2021; Chan, Andrew Man-Lok/J-9497-2013; Wang, Demin/AAX-4449-2020	Chan, Andrew/0000-0001-9923-5464; Yan, Mingfei/0000-0002-2054-5986; Chan, Andrew Man-Lok/0000-0001-9923-5464; Wang, Demin/0000-0001-5549-3795	US National Institutes of Health [HL44612, AI079087, HL090503, HL102836, NS070711, CA78509, MH59771]; Midwest Athletes Against Childhood Cancer Funds; National Cancer Institute [T32CA078207]; Hong Kong PhD Fellowship Scheme [PF12-13584]; Lo Kwee-Seong Seed Fund; NIH [HL44612, AI079087, HL090503, HL102836, CA78509, MH59771, NS00711]; NATIONAL CANCER INSTITUTE [T32CA078207, R29CA078509] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL044612, U54HL090503, R01HL102836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059771] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Midwest Athletes Against Childhood Cancer Funds; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Hong Kong PhD Fellowship Scheme; Lo Kwee-Seong Seed Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the US National Institutes of Health HL44612 (DW), AI079087 (DW), HL090503 (CAH), HL102836 (CAH), NS070711 (CAH), CA78509 (AMC), MH59771 (AMC), and Midwest Athletes Against Childhood Cancer Funds (AMC and CAH). GS was supported by a National Cancer Institute pre-doctoral training grant, T32CA078207, MY was supported by Hong Kong PhD Fellowship Scheme (PF12-13584) and AMC was supported by the Lo Kwee-Seong Seed Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Drs. Yu Huang, Li Wang, Shu-Hsia Chen and Miriam Merad for their helpful advice; and Colin Kennedy, Hong Guan, and Penelope Or for technical support. This work was supported by NIH HL44612 (DW), AI079087 (DW), HL090503 (CAH), HL102836 (CAH), NS00711 (CAH), CA78509 (AMC), MH59771 (AMC), and Midwest Athletes Against Childhood Cancer Funds (AMC and CAH). GS was supported by a National Cancer Institute pre-doctoral training grant, T32CA078207, MY was supported by Hong Kong PhD Fellowship Scheme (PF12-13584) and AMC was supported by the Lo Kwee-Seong Seed Fund.	Ada-Nguema AS, 2006, J CELL SCI, V119, P1307, DOI 10.1242/jcs.02835; Alon R, 2011, EXP CELL RES, V317, P632, DOI 10.1016/j.yexcr.2010.12.007; Boussiotis VA, 1997, SCIENCE, V278, P124, DOI 10.1126/science.278.5335.124; Campbell JJ, 2000, CURR OPIN IMMUNOL, V12, P336, DOI 10.1016/S0952-7915(00)00096-0; COX AD, 1994, ONCOGENE, V9, P3281; Delgado P, 2009, NAT IMMUNOL, V10, P880, DOI 10.1038/ni.1749; Gawecka JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011269; Goldfinger LE, 2006, J CELL BIOL, V174, P877, DOI 10.1083/jcb.200603111; Griffiths GS, 2011, J CELL PHYSIOL, V226, P2287, DOI 10.1002/jcp.22565; Hodkinson PS, 2007, J BIOL CHEM, V282, P28991, DOI 10.1074/jbc.M703601200; Holly SP, 2005, MOL BIOL CELL, V16, P2458, DOI 10.1091/mbc.E03-12-0917; Hughes PE, 2001, METHOD ENZYMOL, V333, P163; Iborra S, 2011, BLOOD, V117, P5102, DOI 10.1182/blood-2010-10-315770; Iwasawa N, 2012, MOL BIOL CELL, V23, P2793, DOI 10.1091/mbc.E12-02-0103; Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950; Katagiri K, 2000, MOL CELL BIOL, V20, P1956, DOI 10.1128/MCB.20.6.1956-1969.2000; Komatsu M, 2005, NAT MED, V11, P1346, DOI 10.1038/nm1324; Koopman WJH, 2003, J BIOL CHEM, V278, P13672, DOI 10.1074/jbc.M211256200; Li Y, 2007, J IMMUNOL, V179, P8322, DOI 10.4049/jimmunol.179.12.8322; McHugh BJ, 2010, J CELL SCI, V123, P51, DOI 10.1242/jcs.056424; Mor A, 2009, MOL CELL BIOL, V29, P3297, DOI 10.1128/MCB.00366-09; Mory A, 2008, BLOOD, V112, P2591, DOI 10.1182/blood-2008-06-163162; Moussion C, 2011, NATURE, V479, P542, DOI 10.1038/nature10540; OCONNELL KA, 1990, J IMMUNOL, V144, P521; Oinuma I, 2004, SCIENCE, V305, P862, DOI 10.1126/science.1097545; Osada M, 1999, MOL CELL BIOL, V19, P6333; Rosen SD, 2004, ANNU REV IMMUNOL, V22, P129, DOI 10.1146/annurev.immunol.21.090501.080131; SAEZ R, 1994, ONCOGENE, V9, P2977; Sawada J, 2012, CANCER CELL, V22, P235, DOI 10.1016/j.ccr.2012.06.013; Scheller J, 2011, TRENDS IMMUNOL, V32, P380, DOI 10.1016/j.it.2011.05.005; Self AJ, 2001, J CELL SCI, V114, P1357; Shang X, 2011, J BIOL CHEM, V286, P24068, DOI 10.1074/jbc.M111.226951; Sinclair LV, 2008, NAT IMMUNOL, V9, P513, DOI 10.1038/ni.1603; Singh G, 2012, BLOOD, V119, P1693, DOI 10.1182/blood-2011-05-357319; Takaya A, 2007, MOL BIOL CELL, V18, P1850, DOI 10.1091/mbc.E06-08-0765; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Wurtzel Jeremy G T, 2012, Small GTPases, V3, P139, DOI 10.4161/sgtp.21084; Zhang ZH, 1996, CELL, V85, P61, DOI 10.1016/S0092-8674(00)81082-X; Zou JX, 1999, P NATL ACAD SCI USA, V96, P13813, DOI 10.1073/pnas.96.24.13813	39	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145218	10.1371/journal.pone.0145218	http://dx.doi.org/10.1371/journal.pone.0145218			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710069	Green Published, gold, Green Submitted			2022-12-26	WOS:000367451400025
J	Zhang, LC; Lv, HC; Zheng, HL; Li, M; Yin, PB; Peng, Y; Gao, Y; Zhang, LH; Tang, PF				Zhang, Licheng; Lv, Houchen; Zheng, Hailiang; Li, Ming; Yin, Pengbin; Peng, Ye; Gao, Yuan; Zhang, Lihai; Tang, Peifu			Correlation between Parameters of Calcaneal Quantitative Ultrasound and Hip Structural Analysis in Osteoporotic Fracture Patients	PLOS ONE			English	Article							BONE-MINERAL DENSITY; ELDERLY-WOMEN; POSTMENOPAUSAL WOMEN; SUBSEQUENT FRACTURE; EUROPEAN GUIDANCE; TRABECULAR BONE; RISK; MEN; DIAGNOSIS; HEEL	Background Calcaneal quantitative ultrasound (QUS), which is used in the evaluation of osteoporosis, is believed to be intimately associated with the characteristics of the proximal femur. However, the specific associations of calcaneal QUS with characteristics of the hip sub-regions remain unclear. Design A cross-sectional assessment of 53 osteoporotic patients was performed for the skeletal status of the heel and hip. Methods We prospectively enrolled 53 female osteoporotic patients with femoral fractures. Calcaneal QUS, dual energy X-ray absorptiometry (DXA), and hip structural analysis (HSA) were performed for each patient. Femoral heads were obtained during the surgery, and principal compressive trabeculae (PCT) were extracted by a three-dimensional printing technique-assisted method. Pearson's correlation between QUS measurement with DXA, HSA-derived parameters and Young's modulus were calculated in order to evaluate the specific association of QUS with the parameters for the hip sub-regions, including the femoral neck, trochanteric and Ward's areas, and the femoral shaft, respectively. Results Significant correlations were found between estimated BMD (Est. BMD) and BMD of different sub-regions of proximal femur. However, the correlation coefficient of trochanteric area (r = 0.356, p = 0.009) was higher than that of the neck area (r = 0.297, p = 0.031) and total proximal femur (r = 0.291, p = 0.034). Furthermore, the quantitative ultrasound index (QUI) was significantly correlated with the HSA-derived parameters of the trochanteric area (r value: 0.315-0.356, all p<0.05) as well as with the Young's modulus of PCT from the femoral head (r = 0.589, p<0.001). Conclusion The calcaneal bone had an intimate association with the trochanteric cancellous bone. To a certain extent, the parameters of the calcaneal QUS can reflect the characteristics of the trochanteric area of the proximal hip, although not specifically reflective of those of the femoral neck or shaft.	[Zhang, Licheng; Lv, Houchen; Li, Ming; Yin, Pengbin; Peng, Ye; Gao, Yuan; Zhang, Lihai; Tang, Peifu] Chinese PLA, Gen Hosp, Dept Orthoped, Beijing, Peoples R China; [Zheng, Hailiang] Capital Med Univ, Beijing Shijitan Hosp, Dept Bioengn, Beijing, Peoples R China	Capital Medical University	Zhang, LH (corresponding author), Chinese PLA, Gen Hosp, Dept Orthoped, Beijing, Peoples R China.	zhanglihai301@gmail.com; pftang301@126.com		Yin, Pengbin/0000-0002-5391-4477; Tang, Peifu/0000-0003-4279-1704	National Natural Science Foundation of China (NSFC) [31370947]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (NSFC) (No.31370947, Lihai Zhang).	Ackerman KE, 2013, J CLIN ENDOCR METAB, V98, P1742, DOI 10.1210/jc.2013-1006; Bliuc D, 2009, JAMA-J AM MED ASSOC, V301, P513, DOI 10.1001/jama.2009.50; Bonnick SL, 2007, BONE, V41, pS9, DOI 10.1016/j.bone.2007.03.007; Bouxsein ML, 1999, BONE, V25, P49, DOI 10.1016/S8756-3282(99)00093-9; Center JR, 2007, JAMA-J AM MED ASSOC, V297, P387, DOI 10.1001/jama.297.4.387; Chan MY, 2012, CALCIFIED TISSUE INT, V90, P128, DOI 10.1007/s00223-011-9556-3; Chiba K, 2013, BONE, V56, P139, DOI 10.1016/j.bone.2013.05.019; Eckstein F, 2002, J BONE MINER RES, V17, P162, DOI 10.1359/jbmr.2002.17.1.162; Emaus N, 2014, J BONE MINER RES, V29, P2080, DOI 10.1002/jbmr.2232; FROST HM, 1994, ANGLE ORTHOD, V64, P175; Frost ML, 2000, OSTEOPOROSIS INT, V11, P321, DOI 10.1007/s001980070121; Hans D, 1996, LANCET, V348, P511, DOI 10.1016/S0140-6736(95)11456-4; Huopio J, 2004, Osteoporos Int, V15, P190; Ikeda Y, 2004, J BONE MINER METAB, V22, P248, DOI 10.1007/s00774-003-0475-x; Ikeda Y, 2002, CALCIFIED TISSUE INT, V71, P1, DOI 10.1007/S00223-001-2079-6; Jorgensen HL, 2001, CLIN PHYSIOL, V21, P51, DOI 10.1046/j.1365-2281.2001.00298.x; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; Kanis JA, 2013, OSTEOPOROSIS INT, V24, P23, DOI 10.1007/s00198-012-2074-y; Keaveny TM, 1997, J ORTHOPAED RES, V15, P101, DOI 10.1002/jor.1100150115; Khaw KT, 2004, LANCET, V363, P197, DOI 10.1016/S0140-6736(03)15325-1; Krieg MA, 2003, J BONE MINER RES, V18, P1261, DOI 10.1359/jbmr.2003.18.7.1261; Kwok T, 2012, OSTEOPOROSIS INT, V23, P1001, DOI 10.1007/s00198-011-1634-x; Langton C M, 1984, Eng Med, V13, P89, DOI 10.1243/EMED_JOUR_1984_013_022_02; Lochmuller EM, 1999, ULTRASOUND OBST GYN, V14, P125, DOI 10.1046/j.1469-0705.1999.14020125.x; Lv H, 2015, OSTEOPOROSIS INT, V26, P1791, DOI 10.1007/s00198-015-3058-5; Maeda Y, 2011, CLIN ORTHOP RELAT R, V469, P884, DOI 10.1007/s11999-010-1529-8; Marin F, 2006, J BONE MINER RES, V21, P1126, DOI 10.1359/JBMR.060417; Misra M, 2013, J CLIN ENDOCR METAB, V98, P2952, DOI 10.1210/jc.2013-1457; Moayyeri A, 2012, OSTEOPOROSIS INT, V23, P143, DOI 10.1007/s00198-011-1817-5; Morin S, 2011, OSTEOPOROSIS INT, V22, P2439, DOI 10.1007/s00198-010-1480-2; Nguyen ND, 2007, J BONE MINER RES, V22, P781, DOI 10.1359/JBMR.070315; Schott AM, 1998, OSTEOPOROSIS INT, V8, P247, DOI 10.1007/s001980050061; Trimpou P, 2010, EUR J RADIOL, V73, P360, DOI 10.1016/j.ejrad.2008.11.024; Turunen MJ, 2013, BONE, V54, P118, DOI 10.1016/j.bone.2013.01.045; Varenna M, 2005, OSTEOPOROSIS INT, V16, P1749, DOI 10.1007/s00198-005-1914-4; Wilsgaard T, 2009, AM J EPIDEMIOL, V169, P877, DOI 10.1093/aje/kwn407; Wuster C, 2005, Technol Health Care, V13, P497	37	11	11	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145879	10.1371/journal.pone.0145879	http://dx.doi.org/10.1371/journal.pone.0145879			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710123	Green Published, gold, Green Submitted			2022-12-26	WOS:000367451400090
J	Ard, R; Mulatz, K; Pomoransky, JL; Parks, RJ; Trinkle-Mulcahy, L; Bell, JC; Gee, SH				Ard, Ryan; Mulatz, Kirk; Pomoransky, Julia L.; Parks, Robin J.; Trinkle-Mulcahy, Laura; Bell, John C.; Gee, Stephen H.			Regulation of Macropinocytosis by Diacylglycerol Kinase zeta	PLOS ONE			English	Article							DENDRITIC CELLS; RAC ACTIVATION; PROTEIN; PHOSPHORYLATION; LOCALIZATION; DISSOCIATION; SALMONELLA; RECEPTOR; FAMILY; ENTRY	Macropinosomes arise from the closure of plasma membrane ruffles to bring about the nonselective uptake of nutrients and solutes into cells. The morphological changes underlying ruffle formation and macropinosome biogenesis are driven by actin cytoskeleton rearrangements under the control of the Rho GTPase Rac1. We showed previously that Rac1 is activated by diacylglycerol kinase zeta (DGK zeta), which phosphorylates diacylglycerol to yield phosphatidic acid. Here, we show DGK zeta is required for optimal macropinocytosis induced by growth factor stimulation of mouse embryonic fibroblasts. Time-lapse imaging of live cells and quantitative analysis revealed DGK zeta was associated with membrane ruffles and nascent macropinosomes. Macropinocytosis was attenuated in DGK zeta-null cells, as determined by live imaging and vaccinia virus uptake experiments. Moreover, macropinosomes that did form in DGK zeta-null cells were smaller than those found in wild type cells. Rescue of this defect required DGK zeta catalytic activity, consistent with it also being required for Rac1 activation. A constitutively membrane bound DGK zeta mutant substantially increased the size of macropinosomes and potentiated the effect of a constitutively active Rac1 mutant on macropinocytosis. Collectively, our results suggest DGK zeta functions in concert with Rac1 to regulate macropinocytosis.	[Ard, Ryan; Mulatz, Kirk; Trinkle-Mulcahy, Laura; Gee, Stephen H.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada; [Ard, Ryan; Mulatz, Kirk; Parks, Robin J.; Gee, Stephen H.] Univ Ottawa, Ctr Neuromuscular Dis, Ottawa, ON, Canada; [Pomoransky, Julia L.; Bell, John C.] Ottawa Hosp Res Inst, Ctr Innovat Canc Res, Ottawa, ON K1H 1C4, Canada; [Pomoransky, Julia L.; Parks, Robin J.; Bell, John C.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Parks, Robin J.] Ottawa Hosp Res Inst, Regenerat Med Program, Ottawa, ON K1H 8L6, Canada; [Trinkle-Mulcahy, Laura] Univ Ottawa, Ottawa Inst Syst Biol, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Gee, SH (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	stevegee@uottawa.ca			Canadian Institutes of Health Research; Ontario Institute for Cancer Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Institute for Cancer Research	This work was supported by grants from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) to SHG, LT-M and RJP. JB is supported by the Ontario Institute for Cancer Research (http://oicr.on.ca/).	Abramovici H, 2003, MOL BIOL CELL, V14, P4499, DOI 10.1091/mbc.E03-03-0190; Abramovici H, 2007, CELL MOTIL CYTOSKEL, V64, P549, DOI 10.1002/cm.20204; Abramovici H, 2009, MOL BIOL CELL, V20, P2049, DOI 10.1091/mbc.E07-12-1248; Akhtar N, 2000, CELL ADHES COMMUN, V7, P465, DOI 10.3109/15419060009040304; ALPUCHEARANDA CM, 1994, J EXP MED, V179, P601, DOI 10.1084/jem.179.2.601; Amstutz B, 2008, EMBO J, V27, P956, DOI 10.1038/emboj.2008.38; Beemiller P, 2006, PLOS BIOL, V4, P987, DOI 10.1371/journal.pbio.0040162; Bohdanowicz M, 2013, MOL BIOL CELL, V24, P1700, DOI 10.1091/mbc.E12-11-0789; Botelho RJ, 2000, J CELL BIOL, V151, P1353, DOI 10.1083/jcb.151.7.1353; Bryant DM, 2007, J CELL SCI, V120, P1818, DOI 10.1242/jcs.000653; Cai JJ, 2009, BBA-MOL CELL BIOL L, V1791, P942, DOI 10.1016/j.bbalip.2009.02.010; Carter GC, 2005, J GEN VIROL, V86, P1279, DOI 10.1099/vir.0.80831-0; Charles-Whitbeck J, 2009, VIROLOGY, V385, P383, DOI 10.1016/j.virol.2008.12.029; Chianale F, 2007, MOL BIOL CELL, V18, P4859, DOI 10.1091/mbc.E07-02-0177; Chianale F, 2010, P NATL ACAD SCI USA, V107, P4182, DOI 10.1073/pnas.0908326107; Commisso C, 2013, NATURE, V497, P633, DOI 10.1038/nature12138; DerMardirossian C, 2004, MOL CELL, V15, P117, DOI 10.1016/j.molcel.2004.05.019; Dharmawardhane S, 2000, MOL BIOL CELL, V11, P3341, DOI 10.1091/mbc.11.10.3341; FRANCIS CL, 1993, NATURE, V364, P639, DOI 10.1038/364639a0; Hall A, 2012, BIOCHEM SOC T, V40, P1378, DOI 10.1042/BST20120103; Law M, 2006, P NATL ACAD SCI USA, V103, P5989, DOI 10.1073/pnas.0601025103; Liberali P, 2008, EMBO J, V27, P970, DOI 10.1038/emboj.2008.59; Luo B, 2003, J BIOL CHEM, V278, P39542, DOI 10.1074/jbc.M307153200; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; McCart JA, 2001, CANCER RES, V61, P8751; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; Mercer J, 2009, NAT CELL BIOL, V11, P510, DOI 10.1038/ncb0509-510; Norbury CC, 1995, IMMUNITY, V3, P783, DOI 10.1016/1074-7613(95)90067-5; RACOOSIN EL, 1993, J CELL BIOL, V121, P1011, DOI 10.1083/jcb.121.5.1011; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Sandgren KJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000866; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; STEINMAN RM, 1972, J CELL BIOL, V55, P186, DOI 10.1083/jcb.55.1.186; Swanson JA, 2008, NAT REV MOL CELL BIO, V9, P639, DOI 10.1038/nrm2447; Topham MK, 1999, J BIOL CHEM, V274, P11447, DOI 10.1074/jbc.274.17.11447; Topham MK, 1998, NATURE, V394, P697, DOI 10.1038/29337; van Blitterswijk WJ, 2000, CELL SIGNAL, V12, P595, DOI 10.1016/S0898-6568(00)00113-3; Wang JTH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013763; Watarai M, 2001, J EXP MED, V194, P1081, DOI 10.1084/jem.194.8.1081; West MA, 2000, CURR BIOL, V10, P839, DOI 10.1016/S0960-9822(00)00595-9; Yakubchyk Y, 2005, MOL CELL BIOL, V25, P7289, DOI 10.1128/MCB.25.16.7289-7302.2005; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517	43	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0144942	10.1371/journal.pone.0144942	http://dx.doi.org/10.1371/journal.pone.0144942			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26701304	gold, Green Published, Green Submitted			2022-12-26	WOS:000367092600037
J	Friggens, MM; Finch, DM				Friggens, Megan M.; Finch, Deborah M.			Implications of Climate Change for Bird Conservation in the Southwestern US under Three Alternative Futures	PLOS ONE			English	Article							LAND-USE; MODELS; NICHE; DISTRIBUTIONS; VARIABILITY; PREDICTION; VEGETATION; ABUNDANCE; IMPACTS	Future expected changes in climate and human activity threaten many riparian habitats, particularly in the southwestern U.S. Using Maximum Entropy (MaxEnt3.3.3) modeling, we characterized habitat relationships and generated spatial predictions of habitat suitability for the Lucy's warbler (Oreothlypis luciae), the Southwestern willow flycatcher (Empidonax traillii extimus) and the Western yellow-billed cuckoo (Coccyzus americanus). Our goal was to provide site- and species-specific information that can be used by managers to identify areas for habitat conservation and/or restoration along the Rio Grande in New Mexico. We created models of suitable habitat for each species based on collection and survey samples and climate, biophysical, and vegetation data. We projected habitat suitability under future climates by applying these models to conditions generated from three climate models for 2030, 2060 and 2090. By comparing current and future distributions, we identified how habitats are likely to change as a result of changing climate and the consequences of those changes for these bird species. We also examined whether land ownership of high value sites shifts under changing climate conditions. Habitat suitability models performed well. Biophysical characteristics were more important that climate conditions for predicting habitat suitability with distance to water being the single most important predictor. Climate, though less important, was still influential and led to declines of suitable habitat of more than 60% by 2090. For all species, suitable habitat tended to shrink over time within the study area leaving a few core areas of high importance. Overall, climate changes will increase habitat fragmentation and reduce breeding habitat patch size. The best strategy for conserving bird species within the Rio Grande will include measures to maintain and restore critical habitat refugia. This study provides an example of a presence-only habitat model that can be used to inform the management of species at intermediate scales.	[Friggens, Megan M.; Finch, Deborah M.] US Forest Serv, Rocky Mt Res Stn, Albuquerque, NM USA	United States Department of Agriculture (USDA); United States Forest Service	Friggens, MM (corresponding author), Albuquerque Forestry Sci Lab, 333 Broadway SE,Suite 115, Albuquerque, NM 87102 USA.	meganfriggens@fs.fed.us			Southern Rockies Landscape Conservation Cooperative [11221632-006]; Desert Landscape Conservation Cooperative [11221632-006]	Southern Rockies Landscape Conservation Cooperative; Desert Landscape Conservation Cooperative	The work being used in this study was jointly funded (IA#11221632-006) by the Southern Rockies Landscape Conservation Cooperative (http://southernrockieslcc.org/) and the Desert Landscape Conservation Cooperative (http://www.usbr.gov/dlcc/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders AD, 2006, J ANIM ECOL, V75, P221, DOI 10.1111/j.1365-2656.2006.01034.x; [Anonymous], 1999, YELL BILL CUCK COCC; [Anonymous], 2012, NEW MEX RAP WAT ASS; Araujo MB, 2009, P NATL ACAD SCI USA, V106, pE45, DOI 10.1073/pnas.0813294106; Baldwin RA, 2009, ENTROPY, V11, P854, DOI 10.3390/e11040854; Beale CM, 2008, P NATL ACAD SCI USA, V105, P14908, DOI 10.1073/pnas.0803506105; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Cloern JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024465; Cole JC, 2002, GROUND WATER RESOURC; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Entling MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045875; Finch D, 2007, ACCOMPLISHING APPL N, P32; Finch DM, 2000, STUD AVIAN BIOL-SER, P88; Finch DM, 2006, MONITORING BIRD POPU; Finch DM, 2000, STATUS ECOLOGY CONSE; Fish NMDoGa, 2006, COMPR WILDL CONS STR; Foldi SE, 2014, SOUTHWEST NAT, V59, P337, DOI 10.1894/F02-JEM-03.1; Friedlaender AS, 2011, DEEP-SEA RES PT II, V58, P1729, DOI 10.1016/j.dsr2.2010.11.018; Friggens M, 2013, RMRSGTR306 US DEP AG, DOI http://dx.doi.org/10.3996/052013-JFWM-039S1; Fullerton W., 2003, ALLIANCE RIO GRANDE; GAINES D, 1974, CONDOR, V76, P204, DOI 10.2307/1366731; Gallardo B, 2013, BIOL CONSERV, V160, P225, DOI 10.1016/j.biocon.2013.02.001; Ganguly AR, 2009, P NATL ACAD SCI USA, V106, P15555, DOI 10.1073/pnas.0904495106; Girvetz EH, 2009, LANDSCAPE ECOL, V24, P1315, DOI 10.1007/s10980-009-9384-2; Hirzel AH, 2006, ECOL MODEL, V199, P142, DOI 10.1016/j.ecolmodel.2006.05.017; Howe WH, 1986, STATUS OF THE YELLOW; Huntley B, 2006, IBIS, V148, P8, DOI 10.1111/j.1474-919X.2006.00523.x; Huntly N, 2011, PLANT ECOL, V212, P1549, DOI 10.1007/s11258-011-9930-2; Jackson ST, 2009, P NATL ACAD SCI USA, V106, P19685, DOI 10.1073/pnas.0901644106; Jimenez-Valverde A, 2011, BIOL INVASIONS, V13, P2785, DOI 10.1007/s10530-011-9963-4; Johnson M, 2012, DEV GIS BASED MODEL; Johnson MJ, 2007, ANN REPORT; Kirkpatrick C, 2009, SURFACE WATER UNPUB; LAYMON SA, 1989, US FOR SERV T R PSW, V110, P272; Levings GW, 1998, WATER QUALITY RIO GR, P1162; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lucys Warbler (Vermivoraluciae), 1997, LUC WARBL VERM LUC; MATTHEWS S, 2004, ATLAS CLIMATE CHANGE; Matthews SN, 2011, ECOGRAPHY, V34, P933, DOI 10.1111/j.1600-0587.2011.06803.x; Mcrae BH, 2008, ECOL MODEL, V219, P77, DOI 10.1016/j.ecolmodel.2008.08.001; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; O'Donnell M.S., 2012, US GEOLOGICAL SURVEY, V691, P10, DOI [DOI 10.3133/DS691, 10.1016/j.mimet.2011.04.001]; Opdam P, 2004, BIOL CONSERV, V117, P285, DOI 10.1016/j.biocon.2003.12.008; Palmer MA, 2009, ENVIRON MANAGE, V44, P1053, DOI 10.1007/s00267-009-9329-1; Parcher J. W, 2010, J TRANSBOUNDARY WATE, V1, P159; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Poole A, 2014, BIRDS N AM ONLINE; Pruitt GST, 2011, W WIDE CLIMATE RISK; Pruitt T., 2011, EOS T AGU, V92, P441, DOI [10.1029/2011EO480001, DOI 10.1029/2011EO480001]; Raupach MR, 2007, P NATL ACAD SCI USA, V104, P10288, DOI 10.1073/pnas.0700609104; Rehfeldt GE, 2006, INT J PLANT SCI, V167, P1123, DOI 10.1086/507711; Rehfeldt GE, 2012, ECOL APPL, V22, P119, DOI 10.1890/11-0495.1; Roberts L, 2005, MIDDLE RIO GRANDE EC; Royle JA, 2012, METHODS ECOL EVOL, V3, P545, DOI 10.1111/j.2041-210X.2011.00182.x; Service USFaW, 2013, FED REGISTER, V78, P344; Shah JJF, 2007, RESTOR ECOL, V15, P550, DOI 10.1111/j.1526-100X.2007.00250.x; Skagen SK, 2005, CONDOR, V107, P212, DOI 10.1650/7807; Smith DM, 2006, ENVIRON ENTOMOL, V35, P1525, DOI 10.1603/0046-225X(2006)35[1525:IODAVO]2.0.CO;2; Smith DM, 2006, WILDFIRE EXOTIC VEGE; Sogge M.K., 1997, NPSNAUCPRSNRTR9712 U; Sohl TL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112251; Stoleson Scott H., 2000, Western Birds, V31, P235; Thorne LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043167; Tingley MW, 2009, P NATL ACAD SCI USA, V106, P19637, DOI 10.1073/pnas.0901562106; Toews MW, 2009, J HYDROL, V374, P265, DOI 10.1016/j.jhydrol.2009.06.022; U.S. Army Corps of Engineers AD, 2011, ENV ASS MIDDL RIO GR; U.S. Fish and Wildlife Service, 1995, FED REGISTER, V60, P10694; van Riper III C, 2014, PROJECTING CLIMATE E; VanDerWal J, 2009, AM NAT, V174, P282, DOI 10.1086/600087; Webb RH, 2007, RIBBON GREEN CHANGE; Williams KK, 2008, ENVIRON ENTOMOL, V37, P94, DOI 10.1603/0046-225X(2008)37[94:IOEOBB]2.0.CO;2; Wong C. M., 2007, WORLDS TOP 10 RIVERS; Yackulic CB, 2013, METHODS ECOL EVOL, V4, P236, DOI 10.1111/2041-210x.12004	76	14	14	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0144089	10.1371/journal.pone.0144089	http://dx.doi.org/10.1371/journal.pone.0144089			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700871	Green Submitted, gold, Green Published			2022-12-26	WOS:000367092600015
J	Ma, FY; Han, YJ; Nikolic-Paterson, DJ; Kolkhof, P; Tesch, GH				Ma, Frank Y.; Han, Yingjie; Nikolic-Paterson, David J.; Kolkhof, Peter; Tesch, Greg H.			Suppression of Rapidly Progressive Mouse Glomerulonephritis with the Non-Steroidal Mineralocorticoid Receptor Antagonist BR-4628	PLOS ONE			English	Article							COLLAGEN GENE-EXPRESSION; RENAL INJURY; DIABETIC-NEPHROPATHY; MESANGIAL CELLS; KIDNEY-DISEASE; ACTIVATION; SPIRONOLACTONE; RATS; PROLIFERATION; INFLAMMATION	Background/Aim Steroidal mineralocorticoid receptor antagonists (MRAs) are effective in the treatment of kidney disease; however, the side effect of hyperkalaemia, particularly in the context of renal impairment, is a major limitation to their clinical use. Recently developed non-steroidal MRAs have distinct characteristics suggesting that they may be superior to steroidal MRAs. Therefore, we explored the benefits of a non-steroidal MRA in a model of rapidly progressive glomerulonephritis. Methods Accelerated anti-glomerular basement membrane (GBM) glomerulonephritis was induced in groups of C57BL/6J mice which received no treatment, vehicle or a non-steroidal MRA (BR-4628, 5mg/kg/bid) from day 0 until being killed on day 15 of disease. Mice were examined for renal injury. Results Mice with anti-GBM glomerulonephritis which received no treatment or vehicle developed similar disease with severe albuminuria, impaired renal function, glomerular tuft damage and crescents in 40% of glomeruli. In comparison, mice which received BR-4628 displayed similar albuminuria, but had improved renal function, reduced severity of glomerular tuft lesions and a 50% reduction in crescents. The protection seen in BR-4628 treated mice was associated with a marked reduction in glomerular macrophages and T-cells and reduced kidney gene expression of proinflammatory (CCL2, TNF-alpha, IFN-gamma) and profibrotic molecules (collagen I, fibronectin). In addition, treatment with BR-4626 did not cause hyperkalaemia or increase urine Na+/K+ excretion (a marker of tubular dysfunction). Conclusions The non-steroidal MRA (BR-4628) provided substantial suppression of mouse crescentic glomerulonephritis without causing tubular dysfunction. This finding warrants further investigation of non-steroidal MRAs as a therapy for inflammatory kidney diseases.	[Ma, Frank Y.; Han, Yingjie; Nikolic-Paterson, David J.; Tesch, Greg H.] Monash Med Ctr, Dept Nephrol, Clayton, Vic 3168, Australia; [Ma, Frank Y.; Han, Yingjie; Nikolic-Paterson, David J.; Tesch, Greg H.] Monash Univ, Dept Med, Clayton, Vic, Australia; [Kolkhof, Peter] Bayer HealthCare, Dept Cardiol Res, Global Drug Discovery, Wuppertal, Germany	Monash University; Monash University; Bayer AG; Bayer Healthcare Pharmaceuticals	Tesch, GH (corresponding author), Monash Med Ctr, Dept Nephrol, 246 Clayton Rd, Clayton, Vic 3168, Australia.	greg.tesch@monash.edu	Tesch, Greg/I-1444-2013	Tesch, Greg/0000-0002-6137-3092; Nikolic-Paterson, David/0000-0001-5734-2931	Bayer Healthcare	Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals)	GHT received funding from Bayer Healthcare to perform the study. PK is an employee of Bayer Healthcare and played a role in study design and manuscript preparation.	Barfacker L, 2012, CHEMMEDCHEM, V7, P1385, DOI 10.1002/cmdc.201200081; Barish GD, 2005, MOL ENDOCRINOL, V19, P2466, DOI 10.1210/me.2004-0529; Bertocchio JP, 2011, KIDNEY INT, V79, P1051, DOI 10.1038/ki.2011.48; Bianchi S, 2010, AM J KIDNEY DIS, V55, P671, DOI 10.1053/j.ajkd.2009.11.006; Blasi ER, 2003, KIDNEY INT, V63, P1791, DOI 10.1046/j.1523-1755.2003.00929.x; Boesby L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026904; Chen D, 2013, GENE, V531, P23, DOI 10.1016/j.gene.2013.08.047; Danjuma MI, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-013-0414-8; Diah S, 2008, EXP CELL RES, V314, P3654, DOI 10.1016/j.yexcr.2008.09.018; Fagart J, 2010, J BIOL CHEM, V285, P29932, DOI 10.1074/jbc.M110.131342; Guo C, 2006, ENDOCRINOLOGY, V147, P5363, DOI 10.1210/en.2006-0944; Han SY, 2006, J AM SOC NEPHROL, V17, P1362, DOI 10.1681/ASN.2005111196; Huang LL, 2012, NEPHRON EXP NEPHROL, V120, pE115, DOI 10.1159/000339500; Huang LL, 2014, J AM SOC NEPHROL, V25, P2231, DOI 10.1681/ASN.2012111094; Huang SM, 2009, AM J PHYSIOL-RENAL, V296, pF1323, DOI 10.1152/ajprenal.90428.2008; Kerr PG, 2007, DIS KIDNEY URINARY T, P1511; Lai L, 2006, BIOCHEM BIOPH RES CO, V348, P70, DOI 10.1016/j.bbrc.2006.07.057; Lian M, 2012, NEPHROL DIAL TRANSPL, V27, P906, DOI 10.1093/ndt/gfr495; Monrad SU, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2353; Nagai Y, 2005, HYPERTENSION, V46, P1039, DOI 10.1161/01.HYP.0000174593.88899.68; Nariai T, 2012, PHARMACOLOGY, V89, P44, DOI 10.1159/000335559; Orena S, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00115; Qin DP, 2013, J NEPHROL, V26, P199, DOI 10.5301/jn.5000125; Rossing K, 2005, DIABETES CARE, V28, P2106, DOI 10.2337/diacare.28.9.2106; Schupp N, 2011, FASEB J, V25, P968, DOI 10.1096/fj.10-173286; Shibata H, 2012, AM J HYPERTENS, V25, P514, DOI 10.1038/ajh.2011.245; Suganami T, 2001, J AM SOC NEPHROL, V12, P2652, DOI 10.1681/ASN.V12122652; Tesch G, 2014, DIABETOLOGIA, V57, P1977, DOI 10.1007/s00125-014-3291-z; Zitt E, 2011, INT J CLIN EXP PATHO, V4, P606	29	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145666	10.1371/journal.pone.0145666	http://dx.doi.org/10.1371/journal.pone.0145666			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700873	Green Published, gold			2022-12-26	WOS:000367092600115
J	Phillips, AC; Carroll, D; Drayson, MT; Der, G				Phillips, Anna C.; Carroll, Douglas; Drayson, Mark T.; Der, Geoff			Salivary Immunoglobulin A Secretion Rate Is Negatively Associated with Cancer Mortality: The West of Scotland Twenty-07 Study	PLOS ONE			English	Article							COMMON VARIABLE IMMUNODEFICIENCY; IGA DEFICIENCY; MUCOSAL IMMUNITY; RISK; HEALTH; COHORT; RESPONSES; SYMPTOMS; EXERCISE; DISEASE	Immunoglobulins are essential for combating infectious disease although very high levels can indicate underlying pathology. The present study examined associations between secretory immunoglobulin A (sIgA) in saliva and mortality rates in the general population. Participants were 639 adults from the eldest cohort of the West of Scotland Twenty-07 Study aged 63 years at the time of saliva sampling in 1995. From unstimulated 2-minute saliva samples, saliva volume and S-IgA concentration were measured, and S-IgA secretion rate determined as their product. Mortality data were tracked for 19 years. Cox proportional hazard models were applied to compute hazard ratios (HR) for all-cause mortality from sIgA secretion rate. Associations were adjusted for gender, assay batch, household occupational group, smoking, medication usage, and self-reported health. There was a negative association between log sIgA secretion rate and all-cause mortality, HR = 0.81, 95% CI = 0.73-0.91, p <.001. Further analysis of specific causes of mortality revealed that the all-cause association was due to an underlying association with cancer mortality and in particular with cancers other than lung cancer. The HR for non-lung cancer was 0.68 (95% CI = 0.54 to 0.85) implying a 32% reduction in mortality risk per standard deviation rise in log sIgA secretion rate. Effects were stronger for men than women. For deaths from respiratory diseases, sIgA secretion had a non-linear relationship with mortality risk whereby only the very lowest levels of secretion were associated with elevated risk. SIgA concentration revealed a similar but weaker pattern of association. In the present study, higher secretion rates of sIgA were associated with a decreased risk of death from cancer, specifically non- lung cancer, as well as from respiratory disease. Thus, it appears that sIgA plays a protective role among older adults, and could serve as a marker of mortality risk, specifically cancer mortality.	[Phillips, Anna C.; Carroll, Douglas] Univ Birmingham, Sch Sport Exercise & Rehabil Sci, Birmingham, W Midlands, England; [Drayson, Mark T.] Univ Birmingham, Coll Med & Dent, Clin Immunol Serv, Birmingham, W Midlands, England; [Der, Geoff] Univ Glasgow, MRC CSO Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland	University of Birmingham; University of Birmingham; MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow	Phillips, AC (corresponding author), Univ Birmingham, Sch Sport Exercise & Rehabil Sci, Birmingham, W Midlands, England.	A.C.Phillips@bham.ac.uk	Whittaker, Anna C./A-3577-2013	Whittaker, Anna C./0000-0002-5461-0598; Der, Geoff/0000-0002-8677-073X; Drayson, Mark/0000-0002-1528-7564	Medical Research Council [MC_UU_12017/5]; ESRC [ES/H043772/1] Funding Source: UKRI; MRC [MC_UU_12017/5, MC_UU_12017/13] Funding Source: UKRI; Economic and Social Research Council [ES/H043772/1] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The work was supported by Medical Research Council (grant number MC_UU_12017/5), http://2007study.sphsu.mrc.ac.uk/. No additional funding was received by AP, the main author. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The West of Scotland Twenty-07 Study data were originally collected by the MRC Social and Public Health Sciences Unit (MC_A540_53462). We are grateful to all of the participants in the Study, and to the survey staff and research nurses who carried it out. The data are employed here with the permission of the Twenty-07 Steering Group. Further information about the data and free access to it can be found at http://2007study.sphsu.mrc.ac.uk/. GD is funded by the Medical Research Council [grant number MC_UU_12017/5].	Ahmadiafshar A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122757; Bathman LM, 2013, BRAIN BEHAV IMMUN, V33, P74, DOI 10.1016/j.bbi.2013.05.010; Benzeval M, 2009, INT J EPIDEMIOL, V38, P1215, DOI 10.1093/ije/dyn213; Bosch JA, 2004, PSYCHOSOM MED, V66, P625, DOI 10.1097/01.psy.0000133254.46947.ac; Brandtzaeg P, 2007, VACCINE, V25, P5467, DOI 10.1016/j.vaccine.2006.12.001; Brandtzaeg P, 2010, CURR OPIN GASTROEN, V26, P554, DOI 10.1097/MOG.0b013e32833dccf8; Carroll D, 1996, INT J BEHAV MED, V3, P266, DOI 10.1207/s15327558ijbm0303_6; Challacombe S J, 2006, Adv Dent Res, V19, P29; COHEN S, 1991, NEW ENGL J MED, V325, P606, DOI 10.1056/NEJM199108293250903; Cunningham-Rundles C, 1999, CLIN IMMUNOL, V92, P34, DOI 10.1006/clim.1999.4725; Cunningham-Rundles C, 2012, HEMATOL-AM SOC HEMAT, P301, DOI 10.1182/asheducation-2012.1.301; Der G, 1998, 60 MRC MED SOC UN; Ecob R, 1987, 6 MRC MED SOC UN; Eliasson L, 2006, EUR J ORAL SCI, V114, P494, DOI 10.1111/j.1600-0722.2006.00413.x; FORD G, 1994, SOC SCI MED, V39, P1037, DOI 10.1016/0277-9536(94)90375-1; Gallagher S, 2008, BRAIN BEHAV IMMUN, V22, P565, DOI 10.1016/j.bbi.2007.11.007; Gleeson M, 2000, EXERC IMMUNOL REV, V6, P5; He CS, 2014, EXERC IMMUNOL REV, V20, P8; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Hood LE, 1978, IMMUNOLOGY; Hurme M, 2005, MECH AGEING DEV, V126, P829, DOI 10.1016/j.mad.2005.02.005; Janeway C., 2005, IMMUNOBIOLOGY IMMUNE; Janket S, 2010, J DENT RES, V89, P389, DOI 10.1177/0022034509359884; Jorgensen GH, 2013, J CLIN IMMUNOL, V33, P742, DOI 10.1007/s10875-012-9858-x; Ludvigsson JF, 2013, J CLIN IMMUNOL, V33, P1317, DOI 10.1007/s10875-013-9948-4; Ludvigsson JF, 2014, J CLIN IMMUNOL, V34, P444, DOI 10.1007/s10875-014-0009-4; Macintyre S, 1987, 7 MRC MED SOC UN; Mellemkjaer L, 2002, CLIN EXP IMMUNOL, V130, P495, DOI 10.1046/j.1365-2249.2002.02004.x; MESTECKY J, 1993, ANN NY ACAD SCI, V694, P184, DOI 10.1111/j.1749-6632.1993.tb18352.x; Mikulska M, 2009, BONE MARROW TRANSPL, V44, P361, DOI 10.1038/bmt.2009.39; Miletic ID, 1996, PHYSIOL BEHAV, V60, P243, DOI 10.1016/0031-9384(95)02161-2; Ng V, 2004, Int J Immunopathol Pharmacol, V17, P49; Office of Population Censuses and Surveys (OPCS), 1980, CLASS OCC; Oikawa J, 2015, J EPIDEMIOL, V25, P470, DOI 10.2188/jea.JE20140088; Papista C, 2011, CELL MOL IMMUNOL, V8, P126, DOI 10.1038/cmi.2010.69; Phillips AC, 2006, BRAIN BEHAV IMMUN, V20, P191, DOI 10.1016/j.bbi.2005.06.006; Phillips AC, 2015, J EPIDEMIOL COMMUN H, V69, P129, DOI 10.1136/jech-2014-204345; Provinciali M, 2005, CANCER IMMUNOL IMMUN, V54, P93, DOI 10.1007/s00262-004-0539-3; Rashkova Maya P, 2010, Folia Med (Plovdiv), V52, P48; Senpuku H, 2010, CLIN LAB, V56, P505; Shimizu K, 2007, EXERC IMMUNOL REV, V13, P55; Teeuw W, 2004, BIOL CHEM, V385, P1137, DOI 10.1515/BC.2004.147; Thoreux K, 2000, IMMUNOLOGY, V101, P161, DOI 10.1046/j.1365-2567.2000.00095.x; Torisu T, 2009, GERONTOLOGY, V55, P179, DOI 10.1159/000162260; Walsh NP, 2011, EXERC IMMUNOL REV, V17, P6; Wang N, 2011, MOL MED, V17, P1383, DOI 10.2119/molmed.2011.00195; Zeier H, 1996, BIOL PSYCHOL, V42, P413, DOI 10.1016/0301-0511(95)05170-8	47	13	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145083	10.1371/journal.pone.0145083	http://dx.doi.org/10.1371/journal.pone.0145083			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26699127	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000367092600045
J	Tan, AX; Kapiga, S; Khoshnood, K; Bruce, RD				Tan, Annabel Xulin; Kapiga, Saidi; Khoshnood, Kaveh; Bruce, R. Douglas			Epidemiology of Drug Use and HIV-Related Risk Behaviors among People Who Inject Drugs in Mwanza, Tanzania	PLOS ONE			English	Article							PREVENTION; PREVALENCE; INFECTION; POPULATIONS; RUSSIA; HEROIN; COHORT; SEX; IDU	Heroin trafficking and consumption has increased steadily over the past decade in Tanzania, but limited information regarding HIV and drug use exists for the city of Mwanza. Our study investigates the epidemiology of drug use, and HIV risk behaviors among drug users in the northwestern city of Mwanza. Using a combination of targeted sampling and participant referral, we recruited 480 participants in Mwanza between June and August 2014. The sample was 92% male. Seventy-nine (16.4%) participants reported injecting heroin, while 434 (90.4%) reported smoking heroin. Unstable housing and cohabitation status were the only socioeconomic characteristics significantly associated with heroin injection. More than half of heroin injectors left syringes in common locations, and half reported sharing needles and syringes. Other risk behaviors such as lack of condom use during sex, and the use of illicit drugs during sex was widely reported as well. Among the study sample, there was poor awareness of health risks posed by needle/syringe sharing and drug use. Our results show that heroin use and HIV risk related behaviors are pressing problems that should not be ignored in Mwanza. Harm reduction programs are urgently needed in this population.	[Tan, Annabel Xulin; Khoshnood, Kaveh] Yale Univ, Sch Publ Hlth, New Haven, CT 06511 USA; [Kapiga, Saidi] Mwanza Intervent Trials Unit, Mwanza, Tanzania; [Bruce, R. Douglas] Cornell Scott Hill Hlth Ctr, New Haven, CT USA; [Bruce, R. Douglas] Yale Univ, Sch Med, New Haven, CT USA	Yale University; Yale University	Tan, AX (corresponding author), Yale Univ, Sch Publ Hlth, New Haven, CT 06511 USA.	xulin.tan@yale.edu	Khoshnood, Kaveh/AAX-1402-2020	Khoshnood, Kaveh/0000-0003-2795-0447; Kapiga, Saidi/0000-0003-1753-4060; Bruce, Robert/0000-0003-4184-8748	Yale Global Health Initiative Field Experience Award; MRC [G0901756] Funding Source: UKRI	Yale Global Health Initiative Field Experience Award; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by the Yale Global Health Initiative Field Experience Award. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, CONSENSUS ESTIMATES; BOOTH RE, 1993, AM J PUBLIC HEALTH, V83, P1144, DOI 10.2105/AJPH.83.8.1144; Bruce RD, 2014, COMMUNICATION; Burchell AN, 2008, SEX TRANSM DIS, V35, P807, DOI 10.1097/OLQ.0b013e3181728a9e; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; Corneil TA, 2006, HEALTH PLACE, V12, P79, DOI 10.1016/j.healthplace.2004.10.004; Dahoma MJU, 2006, AFRICAN J DRUG ALCOH, P5; Doyle AM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000287; Genereux M, 2010, INT J DRUG POLICY, V21, P49, DOI 10.1016/j.drugpo.2009.01.004; Gillies M, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-721; GLEGHORN AA, 1994, J ACQ IMMUN DEF SYND, V7, P767; Gupta GR, 2008, LANCET, V372, P764, DOI 10.1016/S0140-6736(08)60887-9; Hammett TM, 2006, AIDS EDUC PREV, V18, P97, DOI 10.1521/aeap.2006.18.2.97; Jolley E, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001465; Kalichman SC, 2007, PREV SCI, V8, P141, DOI 10.1007/s11121-006-0061-2; Kelley MS, 2004, SOC SCI MED, V58, P2083, DOI 10.1016/j.socscimed.2003.08.006; Kerr T, 2007, DRUG ALCOHOL DEPEN, V87, P39, DOI 10.1016/j.drugalcdep.2006.07.009; Lambdin BH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067062; Maas B, 2007, HEALTH PLACE, V13, P432, DOI 10.1016/j.healthplace.2006.05.005; Mary J., 2014, INT J RES HEAL SCI, V2, P740; Mbatia J, 2009, INT J ENV RES PUB HE, V6, P1991, DOI 10.3390/ijerph6071991; McCurdy SA, 2005, AIDS CARE, V17, pS65, DOI 10.1080/09540120500120930; McCurdy SA, 2006, DRUG ALCOHOL DEPEN, V82, pS23, DOI 10.1016/S0376-8716(06)80004-9; McCurdy SA, 2010, ADDICTION, V105, P1062, DOI 10.1111/j.1360-0443.2010.02908.x; MCELRATH K, 1994, AM J PUBLIC HEALTH, V84, P1965, DOI 10.2105/AJPH.84.12.1965; Mongi AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084447; Obasi AI, 2001, TROP MED INT HEALTH, V6, P517, DOI 10.1046/j.1365-3156.2001.00738.x; Qian H, 2006, HARM REDUCT J, P3; Ratliff E. A, 2013, ADV PREV MED, V2013; Rhodes T, 2005, BMJ-BRIT MED J, V331, P220, DOI 10.1136/bmj.331.7510.220; Ross DA, 2007, AIDS, V21, P1943, DOI 10.1097/QAD.0b013e3282ed3cf5; Senyimba C, 2005, BMJ-BRIT MED J, V331, P778, DOI 10.1136/bmj.331.7519.778-b; Strathdee Steffanie A, 2010, Curr HIV/AIDS Rep, V7, P99, DOI 10.1007/s11904-010-0043-7; Timpson S, 2006, AFRICAN J DRUG ALCOH, V5, P157; United Nations Office of Drug and Crime, 2011, GLOB AFGH OP TRAD; Wall M, 2011, INT J DRUG POLICY, V22, P133, DOI 10.1016/j.drugpo.2010.10.001; WATTERS JK, 1989, SOC PROBL, V36, P416, DOI 10.1525/sp.1989.36.4.03a00070; Williams ML, 2007, AIDS BEHAV, V11, P137, DOI 10.1007/s10461-006-9102-x; [Zanzibar AIDS Commission National Bureau of Statistics Statistician O of the CG Zanzibar International I Tanzania Commission for AIDS], 2011, HIV AIDS MAL IND SUR	39	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145578	10.1371/journal.pone.0145578	http://dx.doi.org/10.1371/journal.pone.0145578			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ4SI	26701616	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000367092600098
J	Mainini, F; Larsen, DS; Webster, GA; Young, SL; Eccles, MR				Mainini, Francesco; Larsen, David S.; Webster, Gill A.; Young, Sarah L.; Eccles, Michael R.			Bridging Small Molecules to Modified Bacterial Microparticles Using a Disulphide Linkage: MIS416 as a Cargo Delivery System	PLOS ONE			English	Article							RECOGNITION; RELEASE; SIRNA; PEG	MIS416 is an intact minimal cell wall skeleton derived from Proprionibacterium acnes that is phagocytosed by antigen presenting cells, including dendritic cells (DCs). This property allows MIS416 to be exploited as a vehicle for the delivery of peptide antigens or other molecules (for example, nucleic acids) to DCs. We previously showed that covalent (non-cleavable) conjugation of OVA, a model antigen derived from ovalbumin, to MIS416 enhanced immune responses in DCs in vivo, compared to unconjugated MIS416 and OVA. Intracellular trafficking promotes the lysosomal degradation of MIS416, leading to the destruction of MIS416 plus the associated cargos conjugated to MIS416. However, lysosomal degradation of cargo may not be desired for some MIS416 conjugates. Here we have investigated whether a cleavable linkage could facilitate release of the cargo in the cytoplasm of DCs to avoid lysosomal degradation. DCs were treated in vitro with disulfide-containing conjugates, and as hypothesised faster release of SIINFEKL peptide in the cytoplasm of DCs was observed with the inclusion of a disulfide bond between MIS416 and cargo. The inclusion of a cleavable disulfide bond in the conjugates did not significantly alter the amount of SIINFEKL antigens presented on MHC I molecules on DCs as compared with conjugates without a disulfide bond. However, the conjugates containing disulfide-linkages performed either slightly better (p<0.05) than, or the same as conjugates without a disulfide bond with respect to in vitro OT-1 T-cell proliferation induced by the presentation of SIINFEKL antigens on DCs, or DC activation studies, respectively. However, disulfide-containing conjugates were less effective than conjugates without a disulfide bond in in vivo cytotoxicity assays. In conclusion, inclusion of a disulfide bond in MIS416-peptide conjugates was associated with efficient release of peptides in the cytoplasm of DCs, an important consideration for MIS416-mediated delivery of degradation-sensitive cargoes. However, treatment of DCs with disulfide-containing conjugates did not significantly alter the presentation of peptide antigens on MHC class I molecules to T-cells, or greatly enhance antigen-associated T-cell proliferation in vitro.	[Mainini, Francesco; Young, Sarah L.; Eccles, Michael R.] Univ Otago, Dept Pathol, Dunedin, New Zealand; [Larsen, David S.] Univ Otago, Dept Chem, Dunedin, New Zealand; [Webster, Gill A.] Innate Immunotherapeut Ltd, Auckland, New Zealand; [Young, Sarah L.; Eccles, Michael R.] Maurice Wilkins Ctr Mol Biodiscovery, Auckland, New Zealand	University of Otago; University of Otago; University of Auckland	Eccles, MR (corresponding author), Univ Otago, Dept Pathol, Dunedin, New Zealand.	michael.eccles@otago.ac.nz	Mainini, Francesco/AAN-1958-2020; Eccles, Michael Roger/AAF-7878-2020	Mainini, Francesco/0000-0001-7743-952X; Eccles, Michael Roger/0000-0002-6824-8761; Young, Sarah/0000-0003-0374-2221	Cancer Society of New Zealand; Maurice Wilkins Centre for Molecular Biodiscovery [MWC14]; Otago Medical Research Foundation [AG303]; Innate Immunotherapeutics Limited	Cancer Society of New Zealand; Maurice Wilkins Centre for Molecular Biodiscovery; Otago Medical Research Foundation; Innate Immunotherapeutics Limited	This research was supported by a Cancer Society of New Zealand (www.cancernz.org.nz) PhD Fellowship to FM, and grants from the Maurice Wilkins Centre for Molecular Biodiscovery (www.mauricewilkinscentre.org.nz; MWC14), and the Otago Medical Research Foundation (www.omrf.org.nz; AG303) to MRE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. With regard to the commercial affiliation of Innate Immunotherapeutics Limited, this organization provided support in the form of salary for the author [GAW], 270 Great King Street, Dunedin 9054, New Zealand Tel: +64 0 34797880; Fax: +64 3 479 7866, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all the authors are articulated in the 'author contributions section'.	Breunig M, 2008, J CONTROL RELEASE, V130, P57, DOI 10.1016/j.jconrel.2008.05.016; Chu TC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl388; Ferrand J, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00344; Geng Q, 2012, BIOCONJUGATE CHEM, V23, P1200, DOI 10.1021/bc300020f; Girvan RC, 2011, VACCINE, V29, P545, DOI 10.1016/j.vaccine.2010.10.040; Gonciarz-Swiatek M, 2006, MOL IMMUNOL, V43, P1993, DOI 10.1016/j.molimm.2005.11.012; He XB, 2013, ACTA BIOCH BIOPH SIN, V45, P241, DOI 10.1093/abbs/gms122; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Kurihara A, 1999, CANCER RES, V59, P6159; Li CJ, 2012, J BIOTECHNOL, V162, P283, DOI 10.1016/j.jbiotec.2012.09.008; Lin C, 2009, EXPERT OPIN DRUG DEL, V6, P421, DOI [10.1517/17425240902878010, 10.1517/17425240902878010 ]; Liu ZY, 2013, BIOMATERIALS, V34, P3870, DOI 10.1016/j.biomaterials.2013.02.003; MYERS DE, 1989, J IMMUNOL METHODS, V121, P129, DOI 10.1016/0022-1759(89)90428-6; Namgung R, 2012, SMALL, V8, P3209, DOI 10.1002/smll.201200496; Ogawa K, 2013, PLOS ONE, V8; WEAVER CT, 1988, P NATL ACAD SCI USA, V85, P8181, DOI 10.1073/pnas.85.21.8181	16	2	2	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145403	10.1371/journal.pone.0145403	http://dx.doi.org/10.1371/journal.pone.0145403			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26695183	gold, Green Submitted, Green Published			2022-12-26	WOS:000367092500043
J	Alagna, F; Geu-Flores, F; Kries, H; Panara, F; Baldoni, L; O'Connor, SE; Osbourn, A				Alagna, Fiammetta; Geu-Flores, Fernando; Kries, Hajo; Panara, Francesco; Baldoni, Luciana; O'Connor, Sarah E.; Osbourn, Anne			Identification and Characterization of the Iridoid Synthase Involved in Oleuropein Biosynthesis in Olive (Olea europaea) Fruits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biosynthesis; enzyme; plant; secondary metabolism; transcriptomics; Oleaceae; monoterpenes; phenolic compounds; secoiridoids	TRANSCRIPTOME COEXPRESSION ANALYSIS; PROGESTERONE 5-BETA-REDUCTASE; PHENOLIC-COMPOUNDS; SECOIRIDOID GLUCOSIDES; 7-DEOXYLOGANETIC ACID; GENE-EXPRESSION; OIL; DEFENSE; SYRINGA; STEP	The secoiridoids are the main class of specialized metabolites present in olive (Olea europaea L.) fruit. In particular, the secoiridoid oleuropein strongly influences olive oil quality because of its bitterness, which is a desirable trait. In addition, oleuropein possesses a wide range of pharmacological properties, including antioxidant, anti-inflammatory, and anti-cancer activities. In accordance, obtaining high oleuropein varieties is a main goal of molecular breeding programs. Here we use a transcriptomic approach to identify candidate genes belonging to the secoiridoid pathway in olive. From these candidates, we have functionally characterized the olive homologue of iridoid synthase (OeISY), an unusual terpene cyclase that couples an NAD (P)H-dependent 1,4-reduction step with a subsequent cyclization, and we provide evidence that OeISY likely generates the monoterpene scaffold of oleuropein in olive fruits. OeISY, the first pathway gene characterized for this type of secoiridoid, is a potential target for breeding programs in a high value secoiridoid-accumulating species.	[Alagna, Fiammetta; Osbourn, Anne] John Innes Ctr, Dept Metab Biol, Norwich NR4 7UH, Norfolk, England; [Kries, Hajo; O'Connor, Sarah E.] John Innes Ctr, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England; [Alagna, Fiammetta; Baldoni, Luciana] Natl Res Council CNR, Inst Biosci & Bioresources, I-06128 Perugia, Italy; [Geu-Flores, Fernando] Univ Copenhagen, Dept Plant & Environm Sci, Copenhagen Plant Sci Ctr, DK-1871 Frederiksberg C, Denmark; [Geu-Flores, Fernando] Univ Copenhagen, Dept Plant & Environm Sci, Sect Plant Biochem, DK-1871 Frederiksberg C, Denmark; [Panara, Francesco] ENEA Trisaia Res Ctr, I-75026 Rotondella, Matera, Italy	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioscienze e Biorisorse (IBBR-CNR); University of Copenhagen; University of Copenhagen	Alagna, F (corresponding author), CREA Res Council Agr & Agr Econ, Via Casamassima 148, I-70010 Bari, Italy.	fiammetta.alagna@crea.gov.it	Panara, Francesco/ABC-2288-2020; Geu-Flores, Fernando/B-2737-2015; O'Connor, Sarah Ellen/X-2893-2019; Baldoni, Luciana/A-4411-2016; Alagna, Fiammetta/AAF-3169-2020; O'Connor, Sarah/O-5850-2016	Geu-Flores, Fernando/0000-0002-5735-9810; Baldoni, Luciana/0000-0002-3221-333X; Panara, Francesco/0000-0001-9596-7262; Kries, Hajo/0000-0002-4919-2811; Alagna, Fiammetta/0000-0003-1878-2023; O'Connor, Sarah/0000-0003-0356-6213; BALDONI, LUCIANA/0000-0002-6636-0055	I-MOVE FP7 Marie Curie COFUND Program - European Union; Regione Umbria (Italy); Biotechnology and Biological Sciences Research Council Institute Strategic Programme Grant [BB/J004561/1]; John Innes Foundation; Biotechnology and Biological Sciences Research Council [BB/L014130/1, BBS/E/J/000CA524, BBS/E/J/00000614] Funding Source: researchfish; BBSRC [BBS/E/J/000CA524, BB/L014130/1] Funding Source: UKRI	I-MOVE FP7 Marie Curie COFUND Program - European Union; Regione Umbria (Italy)(Regione Umbria); Biotechnology and Biological Sciences Research Council Institute Strategic Programme Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); John Innes Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the I-MOVE FP7 Marie Curie COFUND Program funded by the European Union and Regione Umbria (Italy) and also by the Biotechnology and Biological Sciences Research Council Institute Strategic Programme Grant BB/J004561/1 ( Understanding and Exploiting Plant and Microbial Metabolism) and by the John Innes Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Alagna F, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-162; Alagna F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-399; Asada K, 2013, PLANT CELL, V25, P4123, DOI 10.1105/tpc.113.115154; Bauer P, 2012, PHYTOCHEMISTRY, V77, P53, DOI 10.1016/j.phytochem.2012.01.022; Bauer P, 2010, PHYTOCHEMISTRY, V71, P1495, DOI 10.1016/j.phytochem.2010.06.004; Buckland G, 2015, BRIT J NUTR, V113, pS94, DOI 10.1017/S0007114514003936; DAMTOFT S, 1993, PHYTOCHEMISTRY, V34, P1291, DOI 10.1016/0031-9422(91)80018-V; DAMTOFT S, 1995, PHYTOCHEMISTRY, V40, P785, DOI 10.1016/0031-9422(95)00210-X; DAMTOFT S, 1995, PHYTOCHEMISTRY, V40, P773, DOI 10.1016/0031-9422(95)00211-O; Dewick PM, 2002, NAT PROD REP, V19, P181, DOI 10.1039/b002685i; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Field B, 2011, P NATL ACAD SCI USA, V108, P16116, DOI 10.1073/pnas.1109273108; Galla G, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-128; Geu-Flores F, 2012, NATURE, V492, P138, DOI 10.1038/nature11692; Hassen I, 2015, J FUNCT FOODS, V18, P926, DOI 10.1016/j.jff.2014.09.001; Herl V, 2006, PHYTOCHEMISTRY, V67, P225, DOI 10.1016/j.phytochem.2005.11.013; Jensen SR, 2002, PHYTOCHEMISTRY, V60, P213, DOI 10.1016/S0031-9422(02)00102-4; Jensen SR., 1991, P PHYTOCH SOC EUROPE, V31, P133; Konno K, 1999, P NATL ACAD SCI USA, V96, P9159, DOI 10.1073/pnas.96.16.9159; Kries H, 2016, NAT CHEM BIOL, V12, P6, DOI 10.1038/nchembio.1955; KUBO I, 1985, J CHEM ECOL, V11, P251, DOI 10.1007/BF00988207; KUWAJIMA H, 1988, PHYTOCHEMISTRY, V27, P1757, DOI 10.1016/0031-9422(88)80438-2; Lindner S, 2014, CHEM BIOL, V21, P1452, DOI 10.1016/j.chembiol.2014.09.010; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malik NSA, 2008, J FOOD AGRIC ENVIRON, V6, P8; Miettinen K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4606; Munkert J, 2015, MOL PLANT, V8, P136, DOI 10.1016/j.molp.2014.11.005; Munoz-Merida A, 2013, DNA RES, V20, P93, DOI 10.1093/dnares/dss036; Naoumkina MA, 2010, PLANT CELL, V22, P850, DOI 10.1105/tpc.109.073270; Nonis A, 2012, J AGR FOOD CHEM, V60, P6855, DOI 10.1021/jf300419w; Obied HK, 2008, NAT PROD REP, V25, P1167, DOI 10.1039/b719736e; Oh H, 2003, PHYTOTHER RES, V17, P417, DOI 10.1002/ptr.1148; Omar Syed Haris, 2010, Sci Pharm, V78, P133, DOI 10.3797/scipharm.0912-18; Ortega-Garcia F, 2010, J AGR FOOD CHEM, V58, P12440, DOI 10.1021/jf102827m; Owen RW, 2003, FOOD CHEM TOXICOL, V41, P703, DOI 10.1016/S0278-6915(03)00011-5; Ozgenturk NO, 2010, COMP FUNCT GENOM, DOI 10.1155/2010/757512; Perez-Bermudez P, 2010, NEW PHYTOL, V185, P687, DOI 10.1111/j.1469-8137.2009.03080.x; Puel C, 2006, CLIN NUTR, V25, P859, DOI 10.1016/j.clnu.2006.03.009; Ryan D, 2002, J AGR FOOD CHEM, V50, P6716, DOI 10.1021/jf025736p; Saito K, 2008, TRENDS PLANT SCI, V13, P36, DOI 10.1016/j.tplants.2007.10.006; Salim V, 2014, PHYTOCHEMISTRY, V101, P23, DOI 10.1016/j.phytochem.2014.02.009; Salim V, 2013, PLANT J, V76, P754, DOI 10.1111/tpj.12330; Schilmiller AL, 2012, CURR OPIN PLANT BIOL, V15, P338, DOI 10.1016/j.pbi.2011.12.005; Servili M, 2004, J CHROMATOGR A, V1054, P113, DOI 10.1016/S0021-9673(04)01423-2; Servili M, 2002, EUR J LIPID SCI TECH, V104, P602, DOI 10.1002/1438-9312(200210)104:9/10<602::AID-EJLT602>3.0.CO;2-X; Shulaev V, 2008, PHYSIOL PLANTARUM, V132, P199, DOI 10.1111/j.1399-3054.2007.01025.x; Soler-Rivas C, 2000, J SCI FOOD AGR, V80, P1013, DOI [10.1002/(SICI)1097-0010(20000515)80:7<1013::AID-JSFA571>3.0.CO;2-C, 10.1002/(SICI)1097-0010(20000515)80:7&lt;1013::AID-JSFA571&gt;3.0.CO;2-C]; Stekel DJ, 2000, GENOME RES, V10, P2055, DOI 10.1101/gr.GR-1325RR; SUGIYAMA M, 1993, PHYTOCHEMISTRY, V34, P1169, DOI 10.1016/S0031-9422(00)90737-4; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanahashi T, 1996, PHYTOCHEMISTRY, V41, P1341, DOI 10.1016/0031-9422(95)00747-4; Thorn A, 2008, J BIOL CHEM, V283, P17260, DOI 10.1074/jbc.M706185200; Van Moerkercke A, 2013, PLANT CELL PHYSIOL, V54, P673, DOI 10.1093/pcp/pct039; Vezzaro A, 2012, J PLANT PHYSIOL, V169, P908, DOI 10.1016/j.jplph.2012.01.021; Waterman E, 2007, ALTERN MED REV, V12, P331; Yonekura-Sakakibara K, 2008, PLANT CELL, V20, P2160, DOI 10.1105/tpc.108.058040; Yonekura-Sakakibara K, 2007, J BIOL CHEM, V282, P14932, DOI 10.1074/jbc.M611498200	57	50	53	4	50	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2016	291	11					5542	5554		10.1074/jbc.M115.701276	http://dx.doi.org/10.1074/jbc.M115.701276			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH1NN	26709230	Green Published, hybrid			2022-12-26	WOS:000372551800009
J	Roh, SH; Kasembeli, M; Galaz-Montoya, JG; Trnka, M; Lau, WCY; Burlingame, A; Chiu, W; Tweardy, DJ				Roh, Soung-Hun; Kasembeli, Moses; Galaz-Montoya, Jesus G.; Trnka, Mike; Lau, Wilson Chun-Yu; Burlingame, Alma; Chiu, Wah; Tweardy, David J.			Chaperonin TRiC/CCT Modulates the Folding and Activity of Leukemogenic Fusion Oncoprotein AML1-ETO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; EUKARYOTIC CHAPERONIN; TRANSCRIPTION FACTOR; IN-VIVO; CYTOPLASMIC CHAPERONIN; INTRANUCLEAR MOBILITY; PROTEINS; COMPLEX; CCT; DOMAIN	AML1-ETO is the most common fusion oncoprotein causing acute myeloid leukemia (AML), a disease with a 5-year survival rate of only 24%. AML1-ETO functions as a rogue transcription factor, altering the expression of genes critical for myeloid cell development and differentiation. Currently, there are no specific therapies for AML1-ETO-positive AML. While known for decades to be the translational product of a chimeric gene created by the stable chromosome translocation t(8; 21)(q22; q22), it is not known how AML1-ETO achieves its native and functional conformation or whether this process can be targeted for therapeutic benefit. Here, we show that the biosynthesis and folding of the AML1-ETO protein is facilitated by interaction with the essential eukaryotic chaperonin TRiC (or CCT). We demonstrate that a folding intermediate of AML1-ETO binds to TRiC directly, mainly through its beta-strand rich, DNA-binding domain (AML-(1-175)), with the assistance of HSP70. Our results suggest that TRiC contributes to AML1-ETO proteostasis through specific interactions between the oncoprotein's DNA-binding domain, which may be targeted for therapeutic benefit.	[Roh, Soung-Hun; Galaz-Montoya, Jesus G.; Chiu, Wah; Tweardy, David J.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Kasembeli, Moses; Lau, Wilson Chun-Yu; Tweardy, David J.] Baylor Coll Med, Dept Med, Infect Dis Sect, Houston, TX 77030 USA; [Trnka, Mike; Burlingame, Alma] Univ Calif San Francisco, Natl Bioorgan Biomed Mass Spectrometry Resource C, San Francisco, CA 94158 USA; [Lau, Wilson Chun-Yu] Univ Hong Kong, Genome Stabil Res Lab, Hong Kong, Hong Kong, Peoples R China; [Lau, Wilson Chun-Yu] Univ Hong Kong, Dept Anat, LKS Fac Med, Hong Kong, Hong Kong, Peoples R China	Baylor College of Medicine; Baylor College of Medicine; University of California System; University of California San Francisco; University of Hong Kong; University of Hong Kong	Chiu, W; Tweardy, DJ (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.; Tweardy, DJ (corresponding author), Baylor Coll Med, Dept Med, Infect Dis Sect, Houston, TX 77030 USA.	wah@bcm.edu; dtweardy@bcm.edu	Tweardy, David/L-3929-2019; Galaz-Montoya, Jesus G./Q-7245-2019; Galaz-Montoya, Jesus G/A-8091-2017	Galaz-Montoya, Jesus G./0000-0002-0113-9325; Trnka, Michael/0000-0002-8808-5146	National Institutes of Health [P41GM103832, P41GM103481, PN2EY016525]; Cancer Prevention and Research Institute of Texas (CPRIT) [RP110291]; Computational Cancer Biology Training Program of the Gulf Coast Consortia (CPRIT) [RP140113]; NATIONAL EYE INSTITUTE [PN2EY016525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103481, P41GM103832] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas (CPRIT); Computational Cancer Biology Training Program of the Gulf Coast Consortia (CPRIT); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research has been supported by National Institutes of Health Grants (P41GM103832, P41GM103481, and PN2EY016525) and Cancer Prevention and Research Institute of Texas (CPRIT) Grant RP110291, as well as a training fellowship (to J. G. G. M.) from the Computational Cancer Biology Training Program of the Gulf Coast Consortia (CPRIT Grant RP140113). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ASOU H, 1991, BLOOD, V77, P2031; Bartfeld D, 2002, STRUCTURE, V10, P1395, DOI 10.1016/S0969-2126(02)00853-5; Boudiaf-Benmammar C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060895; Cameron ER, 2004, ONCOGENE, V23, P4308, DOI 10.1038/sj.onc.1207130; Cong Y, 2012, EMBO J, V31, P720, DOI 10.1038/emboj.2011.366; Corpora T, 2010, J MOL BIOL, V402, P560, DOI 10.1016/j.jmb.2010.08.007; Cuellar J, 2008, NAT STRUCT MOL BIOL, V15, P858, DOI 10.1038/nsmb.1464; Davis JN, 2003, GENE, V303, P1, DOI 10.1016/S0378-1119(02)01172-1; de Bruijn MFTR, 2004, ONCOGENE, V23, P4238, DOI 10.1038/sj.onc.1207763; Deschler B, 2006, CANCER-AM CANCER SOC, V107, P2099, DOI 10.1002/cncr.22233; Dong S, 2004, MOL CELL BIOL, V24, P4465, DOI 10.1128/MCB.24.10.4465-4475.2004; Downing JR, 1999, BRIT J HAEMATOL, V106, P296, DOI 10.1046/j.1365-2141.1999.01377.x; Feldman DE, 2003, MOL CELL, V12, P1213, DOI 10.1016/S1097-2765(03)00423-4; Feldman DE, 1999, MOL CELL, V4, P1051, DOI 10.1016/S1097-2765(00)80233-6; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; GAO YJ, 1992, CELL, V69, P1043, DOI 10.1016/0092-8674(92)90622-J; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Heidenreich O, 2003, BLOOD, V101, P3157, DOI 10.1182/blood-2002-05-1589; Herzog F, 2012, SCIENCE, V337, P1348, DOI 10.1126/science.1221483; Kasembeli M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001844; Knee KM, 2013, CELL STRESS CHAPERON, V18, P137, DOI 10.1007/s12192-012-0357-z; Leitner A, 2012, STRUCTURE, V20, P814, DOI 10.1016/j.str.2012.03.007; Leitner A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014126; Liu YZ, 2006, CANCER CELL, V9, P249, DOI 10.1016/j.ccr.2006.03.012; Llorca O, 2000, EMBO J, V19, P5971, DOI 10.1093/emboj/19.22.5971; Look AT, 1997, SCIENCE, V278, P1059, DOI 10.1126/science.278.5340.1059; Lutterbach B, 2000, GENE, V245, P223, DOI 10.1016/S0378-1119(00)00014-7; McClellan AJ, 2005, CELL, V121, P739, DOI 10.1016/j.cell.2005.03.024; Melki R, 1997, BIOCHEMISTRY-US, V36, P5817, DOI 10.1021/bi962830o; Melville MW, 2003, MOL CELL BIOL, V23, P3141, DOI 10.1128/MCB.23.9.3141-3151.2003; Meyer AS, 2003, CELL, V113, P369, DOI 10.1016/S0092-8674(03)00307-6; MEYERS S, 1995, MOL CELL BIOL, V15, P1974; Mitani Kinuko, 1997, Leukemia (Basingstoke), V11, P294; Munoz IG, 2011, NAT STRUCT MOL BIOL, V18, P14, DOI 10.1038/nsmb.1971; Priya S, 2013, P NATL ACAD SCI USA, V110, P7199, DOI 10.1073/pnas.1219867110; Qiu J, 2006, ONCOGENE, V25, P3982, DOI 10.1038/sj.onc.1209431; Reikvam H, 2012, BRIT J HAEMATOL, V156, P468, DOI 10.1111/j.1365-2141.2011.08960.x; Russmann F, 2012, P NATL ACAD SCI USA, V109, P21208, DOI 10.1073/pnas.1218836109; Saegusa K, 2014, MOL BIOL CELL, V25, P3095, DOI 10.1091/mbc.E13-09-0530; Saibil HR, 2013, J MOL BIOL, V425, P1476, DOI 10.1016/j.jmb.2012.11.028; Siegers K, 2003, EMBO J, V22, P5230, DOI 10.1093/emboj/cdg483; Spiess C, 2004, TRENDS CELL BIOL, V14, P598, DOI 10.1016/j.tcb.2004.09.015; Spiess C, 2006, MOL CELL, V24, P25, DOI 10.1016/j.molcel.2006.09.003; Thulasiraman V, 2000, METH MOL B, V140, P169; Trinidad AG, 2013, MOL CELL, V50, P805, DOI 10.1016/j.molcel.2013.05.002; Wei YF, 2007, NAT STRUCT MOL BIOL, V14, P653, DOI 10.1038/nsmb1258; Yam AY, 2008, NAT STRUCT MOL BIOL, V15, P1255, DOI 10.1038/nsmb.1515; Yebenes H, 2011, TRENDS BIOCHEM SCI, V36, P424, DOI 10.1016/j.tibs.2011.05.003; Yu WJ, 2011, LEUKEMIA RES, V35, P1212, DOI 10.1016/j.leukres.2011.05.014	49	18	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4732	4741		10.1074/jbc.M115.684878	http://dx.doi.org/10.1074/jbc.M115.684878			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26706127	hybrid, Green Published			2022-12-26	WOS:000371604600039
J	Choudhary, S; Goetjen, A; Estus, T; Jacome-Galarza, CE; Aguila, HL; Lorenzo, J; Pilbeam, C				Choudhary, Shilpa; Goetjen, Alexandra; Estus, Thomas; Jacome-Galarza, Christian E.; Aguila, Hector L.; Lorenzo, Joseph; Pilbeam, Carol			Serum Amyloid A3 Secreted by Preosteoclasts Inhibits Parathyroid Hormone-stimulated cAMP Signaling in Murine Osteoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bone; cyclooxygenase (COX); G protein-coupled receptor (GPCR); macrophage; osteoporosis; prostaglandin; formyl peptide receptor; ptgs2 knockout; receptor activator of nuclear factor B ligand (RANKL)	MAMMALIAN ADENYLYL CYCLASES; BONE-FORMATION; CONTINUOUS-INFUSION; RECEPTOR ACTIVATOR; PROSTAGLANDIN E-2; STEM-CELLS; IN-VITRO; EXPRESSION; PROTEIN; OSTEOCLASTS	Background: Continuous parathyroid hormone (PTH) is anabolic in cyclooxygenase-2 (Cox2) knock-out, but not WT, mice. Results: Preosteoclasts secreted serum amyloid A3 (Saa3) in response to RANKL only in the presence of Cox2. Saa3 blocked PTH-stimulated cAMP production and osteoblast differentiation. Conclusion: Saa3 is a novel means by which osteoclasts inhibit osteoblasts. Significance: Induction of Saa3 may explain why continuous PTH causes bone loss. Continuous parathyroid hormone (PTH) blocks its own osteogenic actions in marrow stromal cell cultures by inducing Cox2 and receptor activator of nuclear factor B ligand (RANKL) in the osteoblastic lineage cells, which then cause the hematopoietic lineage cells to secrete an inhibitor of PTH-stimulated osteoblast differentiation. To identify this inhibitor, we used bone marrow macrophages (BMMs) and primary osteoblasts (POBs) from WT and Cox2 knock-out (KO) mice. Conditioned medium (CM) from RANKL-treated WT, but not KO, BMMs blocked PTH-stimulated cAMP production in POBs. Inhibition was reversed by pertussis toxin (PTX), which blocks G(i/o) activation. Saa3 was the most highly differentially expressed gene in a microarray comparison of RANKL-treated WT versus Cox2 KO BMMs, and RANKL induced Saa3 protein secretion only from WT BMMs. CM from RANKL-stimulated BMMs with Saa3 knockdown did not inhibit PTH-stimulated responses in POBs. SAA added to POBs inhibited PTH-stimulated cAMP responses, which was reversed by PTX. Selective agonists and antagonists of formyl peptide receptor 2 (Fpr2) suggested that Fpr2 mediated the inhibitory actions of Saa3 on osteoblasts. In BMMs committed to become osteoclasts by RANKL treatment, Saa3 expression peaked prior to appearance of multinucleated cells. Flow sorting of WT marrow revealed that Saa3 was secreted only from the RANKL-stimulated B220(-) CD3(-)CD11b(-/low) CD115(+) preosteoclast population. We conclude that Saa3 secretion from preosteoclasts, induced by RANKL in a Cox2-dependent manner, inhibits PTH-stimulated cAMP signaling and osteoblast differentiation via G(i/o) signaling. The induction of Saa3 by PTH may explain the suppression of bone formation when PTH is applied continuously and may be a new therapeutic target for osteoporosis.	[Choudhary, Shilpa; Lorenzo, Joseph; Pilbeam, Carol] Univ Connecticut Hlth, Dept Med, Farmington, CT 06030 USA; [Jacome-Galarza, Christian E.; Aguila, Hector L.] Univ Connecticut Hlth, Dept Immunol, Farmington, CT 06030 USA; [Choudhary, Shilpa; Goetjen, Alexandra; Estus, Thomas; Lorenzo, Joseph; Pilbeam, Carol] Univ Connecticut Hlth, New England Musculoskeletal Inst, Farmington, CT 06030 USA	University of Connecticut; University of Connecticut; University of Connecticut	Pilbeam, C (corresponding author), MC 5456,263 Farmington Ave, Farmington, CT 06030 USA.	pilbeam@uchc.edu			National Institutes of Health, NIAMS [AR060286, T90DE021]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060286] Funding Source: NIH RePORTER	National Institutes of Health, NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health, NIAMS Grant AR060286 (to C. P.) and NIDCR Grant T90DE021 (to T. E.). The authors declare that they have no conflicts of interest with the contents of this article.	Arai F, 1999, J EXP MED, V190, P1741, DOI 10.1084/jem.190.12.1741; Augustine M, 2013, CURR OSTEOPOROS REP, V11, P400, DOI 10.1007/s11914-013-0171-2; Bae YS, 2004, J IMMUNOL, V173, P607, DOI 10.4049/jimmunol.173.1.607; Baron R, 2012, J CLIN ENDOCR METAB, V97, P311, DOI 10.1210/jc.2011-2332; Blackwell KA, 2010, TRENDS ENDOCRIN MET, V21, P294, DOI 10.1016/j.tem.2009.12.004; Boyce BF, 2008, ARCH BIOCHEM BIOPHYS, V473, P139, DOI 10.1016/j.abb.2008.03.018; Cattaneo F, 2013, INT J MOL SCI, V14, P7193, DOI 10.3390/ijms14047193; Chen KD, 2013, J CLIN INVEST, V123, P1694, DOI 10.1172/JCI65569; Choudhary S, 2008, BIOCHEM BIOPH RES CO, V372, P536, DOI 10.1016/j.bbrc.2008.05.050; Choudhary S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120164; Choudhary S, 2013, BONE, V56, P31, DOI 10.1016/j.bone.2013.04.017; den Hartigh LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108564; Eklund KK, 2012, CRIT REV IMMUNOL, V32, P335; Fields TA, 1997, BIOCHEM J, V321, P561, DOI 10.1042/bj3210561; Giebeler A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100522; Han SY, 2005, BLOOD, V106, P1240, DOI 10.1182/blood-2004-12-4975; Henriksen K, 2012, BONE, V51, P353, DOI 10.1016/j.bone.2012.06.007; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Horwitz MJ, 2011, J BONE MINER RES, V26, P2287, DOI 10.1002/jbmr.415; Iida-Klein A, 2005, J ENDOCRINOL, V186, P549, DOI 10.1677/joe.1.06270; Jacome-Galarza CE, 2013, J BONE MINER RES, V28, P1203, DOI 10.1002/jbmr.1822; Jacome-Galarza CE, 2011, J BONE MINER RES, V26, P1207, DOI 10.1002/jbmr.324; Jacquin C, 2006, J BONE MINER RES, V21, P67, DOI 10.1359/JBMR.051007; Karsdal MA, 2007, J BONE MINER RES, V22, P487, DOI 10.1359/JBMR.070109; Kinugawa S, 2012, J IMMUNOL, V188, P1772, DOI 10.4049/jimmunol.1101174; Kisilevsky R, 2012, AMYLOID, V19, P5, DOI 10.3109/13506129.2011.654294; Kovacevic A, 2008, J CELL BIOCHEM, V103, P994, DOI 10.1002/jcb.21472; Kreja L, 2010, J CELL BIOCHEM, V109, P347, DOI 10.1002/jcb.22406; Lee HY, 2010, EXP MOL MED, V42, P302, DOI 10.3858/emm.2010.42.4.029; Lee SK, 2002, BONE, V31, P252, DOI 10.1016/S8756-3282(02)00804-9; Li X, 2007, J BIOL CHEM, V282, P33086, DOI 10.1074/jbc.M705194200; McCauley LK, 1997, ENDOCRINOLOGY, V138, P5427, DOI 10.1210/en.138.12.5427; MEEK RL, 1992, P NATL ACAD SCI USA, V89, P7949, DOI 10.1073/pnas.89.17.7949; Migeotte I, 2006, CYTOKINE GROWTH F R, V17, P501, DOI 10.1016/j.cytogfr.2006.09.009; Migita K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096703; Millard SM, 2011, J BONE MINER RES, V26, P822, DOI 10.1002/jbmr.273; MORHAM SG, 1995, CELL, V83, P473, DOI 10.1016/0092-8674(95)90125-6; Negishi-Koga T, 2011, NAT MED, V17, P1473, DOI 10.1038/nm.2489; Niemi K, 2011, J IMMUNOL, V186, P6119, DOI 10.4049/jimmunol.1002843; Oldekamp S, 2014, IMMUNOLOGY, V143, P447, DOI 10.1111/imm.12324; Olsen HG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076695; Pederson L, 2008, P NATL ACAD SCI USA, V105, P20764, DOI 10.1073/pnas.0805133106; Peng J, 2008, ENDOCRINOLOGY, V149, P1329, DOI 10.1210/en.2007-0235; Phelps E, 2005, CALCIFIED TISSUE INT, V77, P96, DOI 10.1007/s00223-004-0239-1; Pilbeam CC, 2008, PRINCIPLES OF BONE BIOLOGY, VOL 2, 3RD EDITION, P1235, DOI 10.1016/B978-0-12-373884-4.00072-0; Reigstad CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005842; Robling AG, 2011, ENDOCRINOLOGY, V152, P2963, DOI 10.1210/en.2011-0049; Sadana R, 2009, NEUROSIGNALS, V17, P5, DOI 10.1159/000166277; SELLAR GC, 1994, GENOMICS, V23, P492, DOI 10.1006/geno.1994.1530; Silva BC, 2015, CURR OPIN PHARMACOL, V22, P41, DOI 10.1016/j.coph.2015.03.005; Sipe J, 1999, AMYLOID, V6, P67, DOI 10.3109/13506129908993291; Son DS, 2010, ENDOCRINOLOGY, V151, P3407, DOI 10.1210/en.2009-1321; Takahashi N, 2011, FRONT BIOSCI-LANDMRK, V16, P21, DOI 10.2741/3673; Tang WJ, 1998, MOL PHARMACOL, V54, P231, DOI 10.1124/mol.54.2.231; TAUSSIG R, 1994, J BIOL CHEM, V269, P6093; Tetradis S, 2001, ENDOCRINOLOGY, V142, P663, DOI 10.1210/en.142.2.663; Thaler R, 2015, FASEB J, V29, P1344, DOI 10.1096/fj.14-265512; Thorn CF, 2002, AMYLOID, V9, P229, DOI 10.3109/13506120209114098; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; UHLAR CM, 1994, GENOMICS, V19, P228, DOI 10.1006/geno.1994.1052; Walker EC, 2008, J BONE MINER RES, V23, P2025, DOI 10.1359/JBMR.080706; Wang DZ, 2013, CANCER J, V19, P502, DOI 10.1097/PPO.0000000000000003; Xu MS, 2010, BONE, V47, P341, DOI 10.1016/j.bone.2010.05.006; Yang D, 2007, BONE, V40, P1453, DOI 10.1016/j.bone.2007.02.001; Ye RD, 2015, J LEUKOCYTE BIOL, V98, P923, DOI 10.1189/jlb.3VMR0315-080R	65	6	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					3882	3894		10.1074/jbc.M115.686576	http://dx.doi.org/10.1074/jbc.M115.686576			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26703472	hybrid, Green Published			2022-12-26	WOS:000371338400017
J	Furukawa, Y; Anzai, I; Akiyama, S; Imai, M; Cruz, FJC; Saio, T; Nagasawa, K; Nomura, T; Ishimori, K				Furukawa, Yoshiaki; Anzai, Itsuki; Akiyama, Shuji; Imai, Mizue; Cruz, Fatima Joy C.; Saio, Tomohide; Nagasawa, Kenichi; Nomura, Takao; Ishimori, Koichiro			Conformational Disorder of the Most Immature Cu, Zn-Superoxide Dismutase Leading to Amyotrophic Lateral Sclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease); protein aggregation; protein folding; protein misfolding; superoxide dismutase (SOD)	MOTOR-NEURON DEGENERATION; TRANSGENIC MICE; FAMILIAL FORM; COPPER; SOD1; PROTEINS; MUTATIONS; METAL; AGGREGATION; SCATTERING	Misfolding of Cu,Zn-superoxide dismutase (SOD1) is a pathological change in the familial form of amyotrophic lateral sclerosis caused by mutations in the SOD1 gene. SOD1 is an enzyme that matures through the binding of copper and zinc ions and the formation of an intramolecular disulfide bond. Pathogenic mutations are proposed to retard the post-translational maturation, decrease the structural stability, and hence trigger the misfolding of SOD1 proteins. Despite this, a misfolded and potentially pathogenic conformation of immature SOD1 remains obscure. Here, we show significant and distinct conformational changes of apoSOD1 that occur only upon reduction of the intramolecular disulfide bond in solution. In particular, loop regions in SOD1 lose their restraint and become significantly disordered upon dissociation of metal ions and reduction of the disulfide bond. Such drastic changes in the solution structure of SOD1 may trigger misfolding and fibrillar aggregation observed as pathological changes in the familial form of amyotrophic lateral sclerosis.	[Furukawa, Yoshiaki; Anzai, Itsuki; Nagasawa, Kenichi; Nomura, Takao] Keio Univ, Dept Chem, Lab Mechanist Chem Biomol, Yokohama, Kanagawa 2238522, Japan; [Akiyama, Shuji] Res Ctr Integrat Mol Syst CIMoS, Inst Mol Sci, Okazaki, Aichi 4448585, Japan; [Akiyama, Shuji] Grad Univ Adv Studies, SOKENDAI, Dept Funct Mol Sci, Okazaki, Aichi 4448585, Japan; [Imai, Mizue; Cruz, Fatima Joy C.; Saio, Tomohide; Ishimori, Koichiro] Hokkaido Univ, Grad Sch Chem Sci & Engn, Sapporo, Hokkaido 0608628, Japan; [Ishimori, Koichiro] Hokkaido Univ, Fac Sci, Dept Chem, Sapporo, Hokkaido 0600810, Japan	Keio University; National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); Graduate University for Advanced Studies - Japan; Hokkaido University; Hokkaido University	Furukawa, Y (corresponding author), Keio Univ, Dept Chem, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	furukawa@chem.keio.ac.jp	Ishimori, Koichiro/AAQ-4434-2021; Furukawa, Yoshiaki/F-2871-2014; Ishimori, Koichiro/S-1247-2016	Ishimori, Koichiro/0000-0002-5868-0462; Furukawa, Yoshiaki/0000-0002-1918-372X; Ishimori, Koichiro/0000-0002-5868-0462; AKIYAMA, Shuji/0000-0002-7184-189X; Anzai, Itsuki/0000-0001-9307-943X; Saio, Tomohide/0000-0003-3639-7399	Ministry of Education, Culture, Sports, Science, and Technology of Japan [25291028, 15H01566]; Cooperative Research in Joint Studies at Institute for Molecular Science, Japan; Grants-in-Aid for Scientific Research [15K14480] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Cooperative Research in Joint Studies at Institute for Molecular Science, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid 25291028 for Scientific Research (B) and 15H01566 for Scientific Research on Innovative Areas (to Y. F.) and a Nanotechnology Platform Program (Molecule and Material Synthesis) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and in part by Cooperative Research in Joint Studies at Institute for Molecular Science, Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Akiyama S, 2010, J APPL CRYSTALLOGR, V43, P237, DOI 10.1107/S002188981000138X; Arnesano F, 2004, J BIOL CHEM, V279, P47998, DOI 10.1074/jbc.M406021200; Banci L, 2003, BIOCHEMISTRY-US, V42, P9543, DOI 10.1021/bi034324m; Banci L, 2006, J BIOL CHEM, V281, P2333, DOI 10.1074/jbc.M506497200; Banci L, 2002, PROTEIN SCI, V11, P2479, DOI 10.1110/ps.0210802; Banci L, 2011, J AM CHEM SOC, V133, P345, DOI 10.1021/ja1069689; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; BERTINI I, 1994, EUR BIOPHYS J BIOPHY, V23, P167, DOI 10.1007/BF01007608; Borchelt DR, 1998, NEUROBIOL DIS, V5, P27, DOI 10.1006/nbdi.1998.0178; BOWLING AC, 1995, J NEUROCHEM, V64, P2366; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Doucette PA, 2004, J BIOL CHEM, V279, P54558, DOI 10.1074/jbc.M409744200; Elam JS, 2003, NAT STRUCT BIOL, V10, P461, DOI 10.1038/nsb935; FORMAN HJ, 1973, J BIOL CHEM, V248, P2645; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; Fujiwara N, 2007, J BIOL CHEM, V282, P35933, DOI 10.1074/jbc.M702941200; Furukawa Y, 2005, J BIOL CHEM, V280, P17266, DOI 10.1074/jbc.M500482200; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; Furukawa Y, 2008, J BIOL CHEM, V283, P24167, DOI 10.1074/jbc.M802083200; Furukawa Y, 2011, AMYOTROPHIC LATERAL SCLEROSIS, P335; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Hayward LJ, 2002, J BIOL CHEM, V277, P15923, DOI 10.1074/jbc.M112087200; Jonsson PA, 2006, J NEUROPATH EXP NEUR, V65, P1126, DOI 10.1097/01.jnen.0000248545.36046.3c; Jonsson PA, 2006, BRAIN, V129, P451, DOI 10.1093/brain/awh704; Kato S, 2000, AMYOTROPH LATERAL SC, V1, P163, DOI 10.1080/14660820050515160; Kayatekin C, 2010, J MOL BIOL, V398, P320, DOI 10.1016/j.jmb.2010.02.034; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lelie HL, 2011, J BIOL CHEM, V286, P2795, DOI 10.1074/jbc.M110.186999; Lindberg MJ, 2004, P NATL ACAD SCI USA, V101, P15893, DOI 10.1073/pnas.0403979101; Nagai M, 2001, J NEUROSCI, V21, P9246, DOI 10.1523/JNEUROSCI.21-23-09246.2001; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Potter SZ, 2007, J AM CHEM SOC, V129, P4575, DOI 10.1021/ja066690+; Rakhit R, 2002, J BIOL CHEM, V277, P47551, DOI 10.1074/jbc.M207356200; Rodriguez JA, 2002, J BIOL CHEM, V277, P15932, DOI 10.1074/jbc.M112088200; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sekhar A, 2015, ELIFE, V4, DOI 10.7554/eLife.07296; Shaw BF, 2006, J BIOL CHEM, V281, P18167, DOI 10.1074/jbc.M600623200; Strange RW, 2003, J MOL BIOL, V328, P877, DOI 10.1016/S0022-2836(03)00355-3; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Teilum K, 2009, P NATL ACAD SCI USA, V106, P18273, DOI 10.1073/pnas.0907387106; Tiwari A, 2003, J BIOL CHEM, V278, P5984, DOI 10.1074/jbc.M210419200; Toichi K, 2013, J BIOL CHEM, V288, P4970, DOI 10.1074/jbc.M112.414235; Vivian JT, 2001, BIOPHYS J, V80, P2093, DOI 10.1016/S0006-3495(01)76183-8; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang J, 2002, NEUROBIOL DIS, V10, P128, DOI 10.1006/nbdi.2002.0498; Watanabe M, 2001, NEUROBIOL DIS, V8, P933, DOI 10.1006/nbdi.2001.0443; Wriggers W, 2001, STRUCTURE, V9, P779, DOI 10.1016/S0969-2126(01)00648-7	54	27	28	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					4144	4155		10.1074/jbc.M115.683763	http://dx.doi.org/10.1074/jbc.M115.683763			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26694608	hybrid, Green Published			2022-12-26	WOS:000371338400038
J	Barman, RK; Jana, T; Das, S; Saha, S				Barman, Ranjan Kumar; Jana, Tanmoy; Das, Santasabuj; Saha, Sudipto			Prediction of Intra-Species Protein-Protein Interactions in Enteropathogens Facilitating Systems Biology Study	PLOS ONE			English	Article							ESCHERICHIA-COLI; INTERACTION NETWORKS; SEQUENCES	Protein-protein interactions in Escherichia coli (E. coli) has been studied extensively using high throughput methods such as tandem affinity purification followed by mass spectrometry and yeast two-hybrid method. This can in turn be used to understand the mechanisms of bacterial cellular processes. However, experimental characterization of such huge amount of interactions data is not available for other important enteropathogens. Here, we propose a support vector machine (SVM)-based prediction model using the known PPIs data of E. coli that can be used to predict PPIs in other enteropathogens, such as Vibrio cholerae, Salmonella Typhi, Shigella flexneri and Yersinia entrocolitica. Different features such as domain-domain association (DDA), network topology, and sequence information were used in developing the SVM model. The proposed model using DDA, degree and amino acid composition features has achieved an accuracy of 82% and 62% on 5-fold cross validation and blind E. coli datasets, respectively. The predicted interactions were validated by Gene Ontology (GO) semantic similarity measure and String PPIs database (experimental PPIs only). Finally, we have developed a user-friendly webserver named EnPPIpred to predict intra-species PPIs in enteropathogens, which will be of great help for the experimental biologists. The webserver EnPPIpred is freely available at http://bicresources.jcbose.ac.in/ssaha4/EnPPIpred/.	[Barman, Ranjan Kumar; Das, Santasabuj] Natl Inst Cholera & Enter Dis, Biomed Informat Ctr, Kolkata, W Bengal, India; [Jana, Tanmoy; Saha, Sudipto] Bose Inst, Bioinformat Ctr, Kolkata, W Bengal, India; [Das, Santasabuj] Natl Inst Cholera & Enter Dis, Div Clin Med, Kolkata, W Bengal, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Department of Science & Technology (India); Bose Institute; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED)	Das, S (corresponding author), Natl Inst Cholera & Enter Dis, Biomed Informat Ctr, Kolkata, W Bengal, India.	dasss@icmr.org.in; ssaha4@jcbose.ac.in	Saha, Sudipto/AAF-1034-2020; Barman, Ranjan Kumar/GXZ-8073-2022	Barman, Ranjan Kumar/0000-0001-9901-3108; Saha, Sudipto/0000-0001-9433-8894; Jana, Tanmoy/0000-0003-1321-2240	Department of Biotechnology [BT/RLF/Re-entry/11/2011]; Indian Council of Medical Research [2013-1551G]	Department of Biotechnology; Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	This project was supported by Department of Biotechnology for Ramalingaswami fellowship (BT/RLF/Re-entry/11/2011). RKB and SD thank Indian Council of Medical Research [extramural project (IRIS ID: 2013-1551G)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Arifuzzaman M, 2006, GENOME RES, V16, P686, DOI 10.1101/gr.4527806; Barman RK, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0112034, DOI 10.1371/J0URNAL.P0NE.0112034]; Ben-Hur A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S2; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Chou KC, 2006, J PROTEOME RES, V5, P316, DOI 10.1021/pr050331g; Du ZD, 2009, NUCLEIC ACIDS RES, V37, pW345, DOI 10.1093/nar/gkp463; Guo YZ, 2008, NUCLEIC ACIDS RES, V36, P3025, DOI 10.1093/nar/gkn159; Guo Yanzhi, 2010, BMC Res Notes, V3, P145, DOI 10.1186/1756-0500-3-145; Hu PZ, 2009, PLOS BIOL, V7, P929, DOI 10.1371/journal.pbio.1000096; Joachims T Thorsten, 2002, LEARNING CLASSIFY TE; Memisevic V, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-154; Rajagopala SV, 2014, NAT BIOTECHNOL, V32, P285, DOI 10.1038/nbt.2831; Rashid M, 2010, CURR PROTEIN PEPT SC, V11, P589, DOI 10.2174/138920310794109120; Rathaur VK, 2014, J CLIN DIAGN RES, V8, pPC1, DOI 10.7860/JCDR/2014/6677.4319; Roy S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007813; Shen JW, 2007, P NATL ACAD SCI USA, V104, P4337, DOI 10.1073/pnas.0607879104; Shoemaker BA, 2007, PLOS COMPUT BIOL, V3, P595, DOI 10.1371/journal.pcbi.0030043; Skrabanek L, 2008, MOL BIOTECHNOL, V38, P1, DOI 10.1007/s12033-007-0069-2; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Soltan-Dallal M.M., 2001, ARCH IRAN MED, V4, P201, DOI [10.1023/a:1017472726251, DOI 10.1023/A:1017472726251]; Sprinzak E, 2001, J MOL BIOL, V311, P681, DOI 10.1006/jmbi.2001.4920; Su C, 2008, NUCLEIC ACIDS RES, V36, pD632, DOI 10.1093/nar/gkm807; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003	25	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145648	10.1371/journal.pone.0145648	http://dx.doi.org/10.1371/journal.pone.0145648			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717407	Green Published, Green Submitted, gold			2022-12-26	WOS:000367510500052
J	Conway, MJ				Conway, Michael J.			Identification of a Flavivirus Sequence in a Marine Arthropod	PLOS ONE			English	Article							EVOLUTION; PHYLOGENY; ARBOVIRUS; POLY(A); VIRUS; TRANSMISSION; GENOME	Phylogenetic analysis has yet to uncover the early origins of flaviviruses. In this study, I mined a database of expressed sequence tags in order to discover novel flavivirus sequences. Flavivirus sequences were identified in a pool of mRNA extracted from the sea spider Endeis spinosa (Pycnogonida, Pantopoda). Reconstruction of the translated sequences and BLAST analysis matched the sequence to the flavivirus NS5 gene. Additional sequences corresponding to envelope and the NS5 MTase domain were also identified. Phylogenetic analysis of homologous NS5 sequences revealed that Endeis spinosa NS5 (ESNS5) is likely related to classical insect-specific flaviviruses. It is unclear if ESNS5 represents genetic material from an active viral infection or an integrated viral genome. These data raise the possibility that classical insect-specific flaviviruses and perhaps medically relevant flaviviruses, evolved from progenitors that infected marine arthropods.	[Conway, Michael J.] Cent Michigan Univ, Coll Med, Foundat Sci, Mt Pleasant, MI 48859 USA	Central Michigan University	Conway, MJ (corresponding author), Cent Michigan Univ, Coll Med, Foundat Sci, Mt Pleasant, MI 48859 USA.	michael.conway@cmich.edu			Central Michigan University College of Medicine	Central Michigan University College of Medicine	This work was supported by Start-up funds from Central Michigan University College of Medicine. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arango CP, 2007, CLADISTICS, V23, P255, DOI 10.1111/j.1096-0031.2007.00143.x; Beilharz TH, 2007, RNA, V13, P982, DOI 10.1261/rna.569407; Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927; Bolling BG, 2012, VIROLOGY, V427, P90, DOI 10.1016/j.virol.2012.02.016; Calzolari M, 2016, INFECT GENET EVOL, V40, P381, DOI 10.1016/j.meegid.2015.07.032; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Coffey LL, 2008, P NATL ACAD SCI USA, V105, P6970, DOI 10.1073/pnas.0712130105; Cook S, 2012, J GEN VIROL, V93, P223, DOI 10.1099/vir.0.036525-0; Crochu S, 2004, J GEN VIROL, V85, P1971, DOI 10.1099/vir.0.79850-0; Forrester NL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002897; Gaunt MW, 2001, J GEN VIROL, V82, P1867, DOI 10.1099/0022-1317-82-8-1867; Gould EA, 2003, ADV VIRUS RES, V59, P277, DOI 10.1016/S0065-3527(03)59008-X; Grard G, 2010, J GEN VIROL, V91, P87, DOI 10.1099/vir.0.014506-0; Hobson-Peters J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056534; Holmes EC, 2003, J VIROL, V77, P3893, DOI 10.1128/JVI.77.7.3893-3897.2003; Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; MANDL CW, 1991, J VIROL, V65, P4070, DOI 10.1128/JVI.65.8.4070-4077.1991; MARIN MS, 1995, VIROLOGY, V206, P1133, DOI 10.1006/viro.1995.1038; Nam DK, 2002, P NATL ACAD SCI USA, V99, P6152, DOI 10.1073/pnas.092140899; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Pettersson JHO, 2014, J GEN VIROL, V95, P1969, DOI 10.1099/vir.0.065227-0; Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742; Stock JH, EXPT FOOD PREFERENCE; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Turpaeva EP, DEEP SEA PYCNOGONIDS; Vasilakis N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000467; WALLNER G, 1995, VIROLOGY, V213, P169, DOI 10.1006/viro.1995.1557; Weaver SC, 1999, J VIROL, V73, P4316, DOI 10.1128/JVI.73.5.4316-4326.1999; Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003	30	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0146037	10.1371/journal.pone.0146037	http://dx.doi.org/10.1371/journal.pone.0146037			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717191	Green Submitted, gold, Green Published			2022-12-26	WOS:000367510500123
J	Chen, B; Xu, T; Zhou, CL; Wang, LY; Yang, N; Wang, Z; Dong, HM; Yang, Z; Zang, YF; Zuo, XN; Weng, XC				Chen, Bing; Xu, Ting; Zhou, Changle; Wang, Luoyu; Yang, Ning; Wang, Ze; Dong, Hao-Ming; Yang, Zhi; Zang, Yu-Feng; Zuo, Xi-Nian; Weng, Xu-Chu			Individual Variability and Test-Retest Reliability Revealed by Ten Repeated Resting-State Brain Scans over One Month	PLOS ONE			English	Article							SURFACE-BASED ANALYSIS; FUNCTIONAL CONNECTIVITY; TOPOLOGICAL ORGANIZATION; NETWORK STRUCTURE; FMRI; CONNECTOME; CORTEX; SEGMENTATION; FLEXIBILITY; HOMOGENEITY	Individual differences in mind and behavior are believed to reflect the functional variability of the human brain. Due to the lack of a large-scale longitudinal dataset, the full landscape of variability within and between individual functional connectomes is largely unknown. We collected 300 resting-state functional magnetic resonance imaging (rfMRI) datasets from 30 healthy participants who were scanned every three days for one month. With these data, both intra-and inter-individual variability of six common rfMRI metrics, as well as their test-retest reliability, were estimated across multiple spatial scales. Global metrics were more dynamic than local regional metrics. Cognitive components involving working memory, inhibition, attention, language and related neural networks exhibited high intra-individual variability. In contrast, inter-individual variability demonstrated a more complex picture across the multiple scales of metrics. Limbic, default, frontoparietal and visual networks and their related cognitive components were more differentiable than somatomotor and attention networks across the participants. Analyzing both intra-and inter-individual variability revealed a set of high-resolution maps on test-retest reliability of the multi-scale connectomic metrics. These findings represent the first collection of individual differences in multi-scale and multimetric characterization of the human functional connectomes in-vivo, serving as normal references for the field to guide the use of common functional metrics in rfMRI-based applications.	[Chen, Bing; Zhou, Changle; Weng, Xu-Chu] Xiamen Univ, Sch Informat Sci & Engn, Fujian Prov Key Lab Brain Like Intelligent Syst, Xiamen 361005, Fujian, Peoples R China; [Chen, Bing; Wang, Luoyu; Wang, Ze; Zang, Yu-Feng; Weng, Xu-Chu] Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Zhejiang Key Lab Res Assessment Cognit Impairment, Hangzhou 311121, Zhejiang, Peoples R China; [Xu, Ting; Yang, Ning; Dong, Hao-Ming; Yang, Zhi; Zuo, Xi-Nian] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Xu, Ting; Yang, Ning; Dong, Hao-Ming; Yang, Zhi; Zuo, Xi-Nian] Chinese Acad Sci, Inst Psychol, Magnet Resonance Imaging Res Ctr, Beijing 100101, Peoples R China; [Yang, Ning; Dong, Hao-Ming] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Yang, Ning; Dong, Hao-Ming; Yang, Zhi; Zuo, Xi-Nian] Chinese Acad Sci, Inst Psychol, Lab Funct Connectome & Dev, Beijing 100101, Peoples R China; [Zuo, Xi-Nian] Southwest Univ, Fac Psychol, Chongqing 400715, Peoples R China; [Zuo, Xi-Nian] Guangxi Teachers Educ Univ, Sch Educ Sci, Dept Psychol, Nanning 530001, Guangxi, Peoples R China	Xiamen University; Hangzhou Normal University; Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Psychology, CAS; Southwest University - China; Nanning Normal University	Zuo, XN (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.	zuoxn@psych.ac.cn; wengxc@psych.ac.cn	Yang, Zhi/W-6459-2019; Zuo, Xi-Nian/A-7273-2009	Yang, Zhi/0000-0002-2222-2312; Zuo, Xi-Nian/0000-0001-9110-585X	National Key Basic Research and Development (973) Program [2015CB351702]; Major Joint Fund for International Cooperation and Exchange of the National Natural Science Foundation [81220108014]; Hundred Talents Program; Chinese Academy of Sciences [KSZD-EW-TZ-002]; Natural Science Foundation of China [31070905, 31371134, 81171409, 81471740]; National Social Science Foundation of China [11AZD119]	National Key Basic Research and Development (973) Program(National Basic Research Program of China); Major Joint Fund for International Cooperation and Exchange of the National Natural Science Foundation; Hundred Talents Program(Chinese Academy of Sciences); Chinese Academy of Sciences(Chinese Academy of Sciences); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Social Science Foundation of China	This work was partially supported by the National Key Basic Research and Development (973) Program (2015CB351702, X-NZ), the Major Joint Fund for International Cooperation and Exchange of the National Natural Science Foundation (81220108014, X-NZ), the Hundred Talents Program and the Key Research Program (KSZD-EW-TZ-002, X-NZ) of the Chinese Academy of Sciences, the Natural Science Foundation of China (31070905, 31371134, 81171409 and 81471740) and the National Social Science Foundation of China (11AZD119).; This work was partially supported by the National Key Basic Research and Development (973) Program (2015CB351702, X-NZ), the Major Joint Fund for International Cooperation and Exchange of the National Natural Science Foundation (81220108014, X-NZ), the Hundred Talents Program and the Key Research Program (KSZD-EW-TZ-002, X-NZ) of the Chinese Academy of Sciences, the Natural Science Foundation of China (31070905, 31371134, 81171409 and 81471740) and the National Social Science Foundation of China (11AZD119). The computations were performed on the Dell Blade Cluster System at the Institute of Psychology, Chinese Academy of Sciences. We thank Dr. B.T. Thomas Yeo for discussions about the use of the cognitive ontology and Dr. Richard F. Betzel for proof-reading of the final version of the manuscript.	Allen EA, 2014, CEREB CORTEX, V24, P663, DOI 10.1093/cercor/bhs352; Anderson JS, 2014, HUM BRAIN MAPP, V35, P1273, DOI 10.1002/hbm.22251; Anderson ML, 2014, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00918; Baker AP, 2014, ELIFE, V3, DOI 10.7554/eLife.01867; Barttfeld P, 2015, P NATL ACAD SCI USA, V112, P887, DOI 10.1073/pnas.1418031112; Bassett DS, 2011, TRENDS COGN SCI, V15, P200, DOI 10.1016/j.tics.2011.03.006; Betzel RF, 2016, NEUROIMAGE, V127, P287, DOI 10.1016/j.neuroimage.2015.12.001; Betzel RF, 2016, NEUROIMAGE, V124, P1054, DOI 10.1016/j.neuroimage.2015.09.041; Betzel RF, 2014, NEUROIMAGE, V102, P345, DOI 10.1016/j.neuroimage.2014.07.067; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2012, NEUROIMAGE, V62, P938, DOI 10.1016/j.neuroimage.2012.01.090; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Blautzik J, 2013, J ALZHEIMERS DIS, V34, P741, DOI 10.3233/JAD-111970; Buckner RL, 2013, NAT NEUROSCI, V16, P832, DOI 10.1038/nn.3423; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Calhoun VD, 2014, NEURON, V84, P262, DOI 10.1016/j.neuron.2014.10.015; Cao M, 2014, DEV COGN NEUROS-NETH, V7, P76, DOI 10.1016/j.dcn.2013.11.004; Carp J, 2013, NEUROIMAGE, V76, P436, DOI 10.1016/j.neuroimage.2011.12.061; Chan MY, 2014, P NATL ACAD SCI USA, V111, pE4997, DOI 10.1073/pnas.1415122111; Choe AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140134; Cox RW, 2012, NEUROIMAGE, V62, P743, DOI 10.1016/j.neuroimage.2011.08.056; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Deco G, 2014, J NEUROSCI, V34, P7910, DOI 10.1523/JNEUROSCI.4423-13.2014; Deco G, 2013, J NEUROSCI, V33, P11239, DOI 10.1523/JNEUROSCI.1091-13.2013; Di Martino A, 2014, Mol Psychiatry, V19, P659, DOI 10.1038/mp.2013.78; Du HX, 2015, CNS NEUROSCI THER, V21, P802, DOI 10.1111/cns.12431; Fukushima M, 2015, ARXIV151106427V1; Gao W, 2014, J NEUROSCI, V34, P11288, DOI 10.1523/JNEUROSCI.5072-13.2014; Gonzalez-Castillo J, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00138; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Gu S, 2015, P NATL ACAD SCI USA, V112, P13681, DOI 10.1073/pnas.1502829112; Guo CC, 2012, NEUROIMAGE, V61, P1471, DOI 10.1016/j.neuroimage.2012.03.027; He Y, 2016, HUM BRAIN M IN PRESS; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Hellyer PJ, 2015, J NEUROSCI, V35, P9050, DOI 10.1523/JNEUROSCI.4648-14.2015; Holmes AJ, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.31; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Hutchison RM, 2013, NEUROIMAGE, V80, P360, DOI 10.1016/j.neuroimage.2013.05.079; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jiang L, 2015, NEUROSCENTI IN PRESS; Jiang LL, 2015, BRAIN STRUCT FUNCT, V220, P2485, DOI 10.1007/s00429-014-0795-8; Jo HJ, 2010, NEUROIMAGE, V52, P571, DOI 10.1016/j.neuroimage.2010.04.246; Keilholz SD, 2014, BRAIN CONNECT, V4, P769, DOI 10.1089/brain.2014.0250; Kelly C, 2012, TRENDS COGN SCI, V16, P181, DOI 10.1016/j.tics.2012.02.001; Kraemer HC, 2014, ANNU REV CLIN PSYCHO, V10, P111, DOI 10.1146/annurev-clinpsy-032813-153739; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Laumann TO, 2015, NEURON, V87, P657, DOI 10.1016/j.neuron.2015.06.037; Li ZJ, 2012, J MAGN RESON IMAGING, V36, P344, DOI 10.1002/jmri.23670; Liao XH, 2013, NEUROIMAGE, V83, P969, DOI 10.1016/j.neuroimage.2013.07.058; Lohmann G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010232; Messe A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003530; Mueller S, 2015, HUM BRAIN MAPP, V36, P4664, DOI 10.1002/hbm.22947; Mueller S, 2013, NEURON, V77, P586, DOI 10.1016/j.neuron.2012.12.028; Murphy K, 2013, NEUROIMAGE, V80, P349, DOI 10.1016/j.neuroimage.2013.04.001; Orban P, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.43; Park HJ, 2013, SCIENCE, V342, P579, DOI 10.1126/science.1238411; Petanjek Z, 2011, P NATL ACAD SCI USA, V108, P13281, DOI 10.1073/pnas.1105108108; Poldrack RA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9885; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Saad ZS, 2013, BRAIN CONNECT, V3, P339, DOI 10.1089/brain.2013.0156; Saad ZS, 2012, BRAIN CONNECT, V2, P25, DOI 10.1089/brain.2012.0080; Schaefer A, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00195; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Shen K, 2015, J NEUROSCI, V35, P5579, DOI 10.1523/JNEUROSCI.4903-14.2015; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Smith DV, 2014, NEUROIMAGE, V95, P1, DOI 10.1016/j.neuroimage.2014.03.042; Smith SM, 2013, TRENDS COGN SCI, V17, P666, DOI 10.1016/j.tics.2013.09.016; Smith SM, 2013, NEUROIMAGE, V80, P144, DOI 10.1016/j.neuroimage.2013.05.039; Somandepalli K, 2015, DEV COGN NEUROS-NETH, V15, P83, DOI 10.1016/j.dcn.2015.08.003; Song J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049847; Thomason ME, 2011, NEUROIMAGE, V55, P165, DOI 10.1016/j.neuroimage.2010.11.080; Wang DH, 2015, NAT NEUROSCI, V18, P1853, DOI 10.1038/nn.4164; Wang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021976; Wang JH, 2013, BIOL PSYCHIAT, V73, P472, DOI 10.1016/j.biopsych.2012.03.026; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Wink AM, 2012, BRAIN CONNECT, V2, P265, DOI 10.1089/brain.2012.0087; Xing XX, 2011, MAGN RESON IMAGING, V29, P731, DOI 10.1016/j.mri.2011.02.007; Xu T, 2015, SCI BULL, V60, P86, DOI 10.1007/s11434-014-0698-3; Yan CG, 2013, NEUROIMAGE, V80, P246, DOI 10.1016/j.neuroimage.2013.04.081; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004; Yan CG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005743; Yang Z, 2014, NEUROIMAGE, V89, P45, DOI 10.1016/j.neuroimage.2013.10.039; Yeo BTT, 2015, CEREB CORTEX, V25, P3654, DOI 10.1093/cercor/bhu217; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zalesky A, 2014, P NATL ACAD SCI USA, V111, P10341, DOI 10.1073/pnas.1400181111; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; Zhao TD, 2015, HUM BRAIN MAPP, V36, P3777, DOI 10.1002/hbm.22877; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012; Zuo XN, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.49; Zuo XN, 2014, NEUROSCI BIOBEHAV R, V45, P100, DOI 10.1016/j.neubiorev.2014.05.009; Zuo XN, 2013, NEUROIMAGE, V65, P374, DOI 10.1016/j.neuroimage.2012.10.017; Zuo XN, 2012, CEREB CORTEX, V22, P1862, DOI 10.1093/cercor/bhr269; Zuo XN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026703; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	99	74	75	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0144963	10.1371/journal.pone.0144963	http://dx.doi.org/10.1371/journal.pone.0144963			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714192	Green Published, Green Submitted, gold			2022-12-26	WOS:000367481900026
J	Nayar, R; Schutten, E; Jangalwe, S; Durost, PA; Kenney, LL; Conley, JM; Daniels, K; Brehm, MA; Welsh, RM; Berg, LJ				Nayar, Ribhu; Schutten, Elizabeth; Jangalwe, Sonal; Durost, Philip A.; Kenney, Laurie L.; Conley, James M.; Daniels, Keith; Brehm, Michael A.; Welsh, Raymond M.; Berg, Leslie J.			IRF4 Regulates the Ratio of T-Bet to Eomesodermin in CD8(+) T Cells Responding to Persistent LCMV Infection	PLOS ONE			English	Article							CHRONIC VIRAL-INFECTION; TRANSCRIPTION FACTOR IRF4; INHIBITORY RECEPTOR PD-1; EFFECTOR FUNCTION; TCR AFFINITY; MEMORY; DIFFERENTIATION; RESPONSES; EXHAUSTION; ANTIGEN	CD8(+) T cell exhaustion commonly occurs in chronic infections and cancers. During T cell exhaustion there is a progressive and hierarchical loss of effector cytokine production, upregulation of inhibitory co-stimulatory molecules, and eventual deletion of antigen specific cells by apoptosis. A key factor that regulates T cell exhaustion is persistent TCR stimulation. Loss of this interaction results in restoration of CD8(+) T cell effector functions in previously exhausted CD8(+) T cells. TCR stimulation is also important for the differentiation of Eomes(hi) anti-viral CD8(+) effector T cells from T-bet(hi) precursors, both of which are required for optimal viral control. However, the molecular mechanisms regulating the differentiation of these two cell subsets and the relative ratios required for viral clearance have not been described. We show that TCR signal strength regulates the relative expression of T-bet and Eomes in antigen-specific CD8(+) T cells by modulating levels of IRF4. Reduced IRF4 expression results in skewing of this ratio in the favor of Eomes, leading to lower proportions and numbers of T-bet(+) Eomes(-) precursors and poor control of LCMV-clone 13 infection. Manipulation of this ratio in the favor of T-bet restores the differentiation of T-bet(+) Eomes(-) precursors and the protective balance of T-bet to Eomes required for efficient viral control. These data highlight a critical role for IRF4 in regulating protective anti-viral CD8(+) T cell responses by ensuring a balanced ratio of T-bet to Eomes, leading to the ultimate control of this chronic viral infection.	[Nayar, Ribhu; Schutten, Elizabeth; Kenney, Laurie L.; Conley, James M.; Daniels, Keith; Welsh, Raymond M.; Berg, Leslie J.] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA; [Jangalwe, Sonal; Durost, Philip A.; Brehm, Michael A.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Berg, LJ (corresponding author), Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA.	Leslie.Berg@umassmed.edu	Jangalwe, Sonal/Y-9319-2019	Jangalwe, Sonal/0000-0002-2464-4711; Conley, James/0000-0001-8901-4713; Brehm, Michael/0000-0001-6813-3262	National Institutes of Health [AI084987, AI106833, AI046629, AI017672, AI081678]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI046629, R01AI101048, P01AI081678, R01AI017672, T32AI007349, R01AI084987, R37AI017672, R01AI106833] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health AI084987 (LJB), National Institutes of Health AI106833 (LJB), National Institutes of Health AI046629 (MAB), National Institutes of Health AI017672 (RMW), and National Institutes of Health AI081678 (RMW).	[Anonymous], 2003, VIRAL PERSISTENCE AL, V77, P4911, DOI [10.1128/JVI.77.8.4911-4927.2003, DOI 10.1128/JVI.77.8.4911-4927.2003]; Aubert RD, 2011, P NATL ACAD SCI USA, V108, P21182, DOI 10.1073/pnas.1118450109; Banerjee A, 2010, J IMMUNOL, V185, P4988, DOI 10.4049/jimmunol.1002042; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bergthaler A, 2009, PLOS BIOL, V7, P789, DOI 10.1371/journal.pbio.1000080; Brooks DG, 2006, J CLIN INVEST, V116, P1675, DOI 10.1172/JCI26856; Cornberg M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00475; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Fuller MJ, 2003, J IMMUNOL, V170, P477, DOI 10.4049/jimmunol.170.1.477; Gronski MA, 2004, NAT MED, V10, P1234, DOI 10.1038/nm1114; Grusdat M, 2014, CELL DEATH DIFFER, V21, P1050, DOI 10.1038/cdd.2014.19; Huber M, 2014, EUR J IMMUNOL, V44, P1886, DOI 10.1002/eji.201344279; Huber M, 2013, J CLIN INVEST, V123, P247, DOI 10.1172/JCI63681; Intlekofer AM, 2007, J EXP MED, V204, P2015, DOI 10.1084/jem.20070841; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kao C, 2011, NAT IMMUNOL, V12, P663, DOI 10.1038/ni.2046; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Kurachi M, 2014, NAT IMMUNOL, V15, P373, DOI 10.1038/ni.2834; Man K, 2013, NAT IMMUNOL, V14, P1155, DOI 10.1038/ni.2710; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; Mueller SN, 2009, P NATL ACAD SCI USA, V106, P8623, DOI 10.1073/pnas.0809818106; Nayar R, 2014, J IMMUNOL, V192, P5881, DOI 10.4049/jimmunol.1303187; Nayar R, 2012, P NATL ACAD SCI USA, V109, pE2794, DOI 10.1073/pnas.1205742109; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Popescu I, 2014, J IMMUNOL, V193, P5709, DOI 10.4049/jimmunol.1401436; Raczkowski F, 2013, P NATL ACAD SCI USA, V110, P15019, DOI 10.1073/pnas.1309378110; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Shin H, 2007, J EXP MED, V204, P941, DOI 10.1084/jem.20061937; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; Staron MM, 2014, IMMUNITY, V41, P802, DOI 10.1016/j.immuni.2014.10.013; Thomsen AR, 1996, J IMMUNOL, V157, P3074; Welsh RM, 2005, LYMPHOCYTIC CHORIOME, DOI [10.1002/9780471729259.mc15a01s8, DOI 10.1002/9780471729259.MC15A01S8]; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wherry EJ, 2004, P NATL ACAD SCI USA, V101, P16004, DOI 10.1073/pnas.0407192101; Yao SY, 2013, IMMUNITY, V39, P833, DOI 10.1016/j.immuni.2013.10.007; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhu YB, 2010, J IMMUNOL, V185, P3174, DOI 10.4049/jimmunol.1000749	39	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0144826	10.1371/journal.pone.0144826	http://dx.doi.org/10.1371/journal.pone.0144826			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714260	gold, Green Published, Green Submitted			2022-12-26	WOS:000367481900019
J	Tabisz, L; Tukibayeva, A; Pankiewicz, R; Dobielska, M; Leska, B				Tabisz, Lukasz; Tukibayeva, Ainur; Pankiewicz, Radoslaw; Dobielska, Marta; Leska, Boguslawa			Disiloxanes and Functionalized Silica Gels: One Route, Two Complementary Outcomes-Guanidinium and Pyridinium Ion-Exchangers	PLOS ONE			English	Article							ANION; IMMOBILIZATION; EXTRACTION; RECEPTORS; COMPLEXES; SILOXANES; CATALYSTS; BINDING	Five novel disiloxane compounds comprising guanidinium and pyridinium moieties were obtained with high yields and purity. The verified synthetic pathways were then applied for modification of pre-functionalized silica gel, producing materials with the analogous organic side-chains. These halide-containing compounds and materials were then compared as to their ion-exchange properties: two disiloxanes proved to be effective in leaching different anions (nitrate, benzoate and ascorbate) from solid to organic phase, and pyridinium-functionalized silica gels showed selectivity towards perchlorate ion, removing it from methanolic solutions with preference to other singly charged anions. The results presented demonstrate that both compounds and materials containing silicon-carbon bonds can be produced using the same methodology, but offer strikingly different application opportunities. Comparison of their properties provides additional insight into the binding mode of different anions and hints at how the transition from a flexible siloxane bridge to immobilization on solid surface influences anion-binding selectivity. Additionally, one of the siloxane dipodands was found to form a crystalline and poorly soluble nitrate salt (1.316 g/L, water), although it was miscible with a wide range of solvents as a hydrochloride. A possible explanation is given with the help of semi-empirical calculations. A simple, time-and cost-efficient automated potentiometric titration methodology was used as a viable analytical tool for studying ion-exchange processes for both compounds and materials, in addition to standard NMR, FT-IR and ESI-MS methods.	[Tabisz, Lukasz; Pankiewicz, Radoslaw; Dobielska, Marta; Leska, Boguslawa] Adam Mickiewicz Univ, Fac Chem, PL-61614 Poznan, Poland; [Tukibayeva, Ainur] M Auezov South Kazakhstan State Univ, Dept Chem, Shymkent 160012, Kazakhstan	Adam Mickiewicz University; M. Auezov South Kazakhstan State University	Leska, B (corresponding author), Adam Mickiewicz Univ, Fac Chem, Umultowska 89b, PL-61614 Poznan, Poland.	bogunial@amu.edu.pl	Tabisz, Łukasz/AAW-3738-2020; Sabirov, Vakhobjan/K-4761-2015; Tukibayeva, Ainur S/N-8994-2017	Tabisz, Łukasz/0000-0002-5281-3826; Leska, Boguslawa/0000-0002-9504-5265; Pankiewicz, Radoslaw/0000-0002-0929-6018	Kazakh Committee of Science MES [68-35]	Kazakh Committee of Science MES(Government of the Republic of KazakhstanMinistry of Education and Science of the Republic of Kazakhstan)	Financial support was given under Grant No. 68-35, realized from 12.02.2015, by the Kazakh Committee of Science MES, http://control.edu.gov.kz/en, AT. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belcher WJ, 2006, ORG BIOMOL CHEM, V4, P781, DOI 10.1039/b516027h; COLVIN EW, 1978, CHEM SOC REV, V7, P15, DOI 10.1039/cs9780700015; Cypryk M, 2002, ORGANOMETALLICS, V21, P2165, DOI 10.1021/om011055s; Houk RJT, 2005, TOP CURR CHEM, V255, P199, DOI 10.1007/b101167; Ibrahim I.A.M., 2010, J AM SCI, V6, P985, DOI 10.7537/marsjas061110.133; Ikem VO, 2008, ANGEW CHEM INT EDIT, V47, P8277, DOI 10.1002/anie.200802244; Jal PK, 2004, TALANTA, V62, P1005, DOI 10.1016/j.talanta.2003.10.028; Kittappa S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130253; Kubota LT, 1996, ELECTROCHIM ACTA, V41, P1465, DOI 10.1016/0013-4686(95)00395-9; Maia A, 2003, TETRAHEDRON LETT, V44, P4149, DOI 10.1016/S0040-4039(03)00838-4; Maiga DT, 2014, PHYS CHEM EARTH, V72-75, P83, DOI 10.1016/j.pce.2014.09.012; Pankiewicz R, 2007, J MOL STRUCT, V829, P120, DOI 10.1016/j.molstruc.2006.06.013; Patai S, 2001, CHEM ORGANIC SILICON, V3; Pu QS, 1998, ANALYST, V123, P239, DOI 10.1039/a706135h; Rosciszewski P, 2004, WLASCIWOSCI ZASTOSOW; Seo Y, 2015, MICROPOR MESOPOR MAT, V207, P156, DOI 10.1016/j.micromeso.2015.01.021; Shu XZ, 2015, J AM CHEM SOC, V137, P7083, DOI 10.1021/jacs.5b04294; Soroceanu A, 2013, EUR J INORG CHEM, P1458, DOI 10.1002/ejic.201201080; Tabisz L, 2015, TETRAHEDRON, V71, P2267, DOI 10.1016/j.tet.2015.02.056; Tabisz L, 2014, TETRAHEDRON LETT, V55, P6416, DOI 10.1016/j.tetlet.2014.09.117; Van der Voort P, 2013, CHEM SOC REV, V42, P3913, DOI 10.1039/c2cs35222b; Vlad A, 2012, EUR J INORG CHEM, P5078, DOI 10.1002/ejic.201200612; Wang N, 2015, RSC ADV, V5, P15500, DOI 10.1039/c4ra13861a; Weinhold F, 2013, J AM CHEM SOC, V135, P5762, DOI 10.1021/ja312222k; Zaltariov MF, 2014, EUR J INORG CHEM, P4946, DOI 10.1002/ejic.201402578	25	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145680	10.1371/journal.pone.0145680	http://dx.doi.org/10.1371/journal.pone.0145680			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714187	Green Published, Green Submitted, gold			2022-12-26	WOS:000367481900066
J	Zuo, YC; Lv, Y; Wei, ZY; Yang, L; Li, GP; Fan, GL				Zuo, Yongchun; Lv, Yang; Wei, Zhuying; Yang, Lei; Li, Guangpeng; Fan, Guoliang			iDPF-PseRAAAC: A Web-Server for Identifying the Defensin Peptide Family and Subfamily Using Pseudo Reduced Amino Acid Alphabet Composition	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDES; SUBCELLULAR-LOCALIZATION; MEMBRANE-PROTEINS; PREDICTION; INNATE; SEQUENCE; DIVERSITY; COMPONENT; DISTANCE; FEATURES	Defensins as one of the most abundant classes of antimicrobial peptides are an essential part of the innate immunity that has evolved in most living organisms from lower organisms to humans. To identify specific defensins as interesting antifungal leads, in this study, we constructed a more rigorous benchmark dataset and the iDPF-PseRAAAC server was developed to predict the defensin family and subfamily. Using reduced dipeptide compositions were used, the overall accuracy of proposed method increased to 95.10% for the defensin family, and 98.39% for the vertebrate subfamily, which is higher than the accuracy from other methods. The jackknife test shows that more than 4% improvement was obtained comparing with the previous method. A free online server was further established for the convenience of most experimental scientists at http://wlxy.imu.edu.cn/college/biostation/fuwu/iDPF-PseRAAAC/index.asp. A friendly guide is provided to describe how to use the web server. We anticipate that iDPF-PseRAAAC may become a useful high-throughput tool for both basic research and drug design.	[Zuo, Yongchun; Lv, Yang; Wei, Zhuying; Li, Guangpeng] Inner Mongolia Univ, Key Lab Mammalian Reprod Biol & Biotechnol, Minist Educ, Coll Life Sci, Hohhot, Peoples R China; [Yang, Lei] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China; [Fan, Guoliang] Inner Mongolia Univ, Sch Phys Sci & Technol, Lab Theoret Biophys, Hohhot, Peoples R China	Inner Mongolia University; Harbin Medical University; Inner Mongolia University	Zuo, YC (corresponding author), Inner Mongolia Univ, Key Lab Mammalian Reprod Biol & Biotechnol, Minist Educ, Coll Life Sci, Hohhot, Peoples R China.	yczuo@imu.edu.cn; eeguoliangfan@sina.com	Zuo, Yongchun/J-2703-2014	Zuo, Yongchun/0000-0002-6065-7835	National Nature Scientific Foundation of China [11447201, 61561036]; Specialized Research Fund for the Doctoral Program of Higher Education [20131501120009]; Natural Science Foundation of Inner Mongolia Autonomous Region [2013MS0503]	National Nature Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of Inner Mongolia Autonomous Region	This work was supported by The National Nature Scientific Foundation of China (No: 11447201, 61561036), the Specialized Research Fund for the Doctoral Program of Higher Education (20131501120009) and the Natural Science Foundation of Inner Mongolia Autonomous Region (No: 2013MS0503).	Aerts AM, 2008, CELL MOL LIFE SCI, V65, P2069, DOI 10.1007/s00018-008-8035-0; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen W, 2009, J MICROBIOL METH, V78, P94, DOI 10.1016/j.mimet.2009.03.013; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2013, MOL BIOSYST, V9, P1092, DOI 10.1039/c3mb25555g; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; de Brevern Alexandre G., 2005, In Silico Biology, V5, P283; de Medeiros LN, 2010, BBA-BIOMEMBRANES, V1798, P105, DOI 10.1016/j.bbamem.2009.07.013; Ding C, 2012, J PROTEOMICS, V77, P321, DOI 10.1016/j.jprot.2012.09.006; Du PF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086879; Du PF, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/263829; Du PF, 2012, J THEOR BIOL, V313, P61, DOI 10.1016/j.jtbi.2012.08.016; Etchebest C, 2007, EUR BIOPHYS J BIOPHY, V36, P1059, DOI 10.1007/s00249-007-0188-5; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Hsu CW, 2002, IEEE T NEURAL NETWOR, V13, P415, DOI 10.1109/72.991427; Jarczak J, 2013, HUM IMMUNOL, V74, P1069, DOI 10.1016/j.humimm.2013.05.008; Kumari SR, 2012, PROTEIN PEPTIDE LETT, V19, P1318; Lay FT, 2005, CURR PROTEIN PEPT SC, V6, P85, DOI 10.2174/1389203053027575; Li DY, 2014, MOL BIOL REP, V41, P3859, DOI 10.1007/s11033-014-3253-z; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lin H, 2011, J THEOR BIOL, V269, P64, DOI 10.1016/j.jtbi.2010.10.019; Lin HH, 2006, PROTEINS, V62, P218, DOI 10.1002/prot.20605; Liu B, 2015, MOL GENET GENOMICS, V290, P1919, DOI 10.1007/s00438-015-1044-4; Liu B, 2014, BIOINFORMATICS, V30, P472, DOI 10.1093/bioinformatics/btt709; Martin J, 2008, PROTEINS, V71, P92, DOI 10.1002/prot.21659; Menendez A, 2007, CURR OPIN IMMUNOL, V19, P385, DOI 10.1016/j.coi.2007.06.008; Mirny LA, 1999, J MOL BIOL, V291, P177, DOI 10.1006/jmbi.1999.2911; Oppenheim JJ, 2003, ANN RHEUM DIS, V62, P17, DOI 10.1136/ard.62.suppl_2.ii17; Palma M, 2011, AMINO ACIDS, V40, P1, DOI 10.1007/s00726-010-0726-9; Seebah S, 2007, NUCLEIC ACIDS RES, V35, pD265, DOI 10.1093/nar/gkl866; Thomas PD, 1996, P NATL ACAD SCI USA, V93, P11628, DOI 10.1073/pnas.93.21.11628; Thomma BPHJ, 2002, PLANTA, V216, P193, DOI 10.1007/s00425-002-0902-6; Tyagi M, 2008, PROTEINS, V71, P920, DOI 10.1002/prot.21776; Tyagi M, 2006, NUCLEIC ACIDS RES, V34, pW119, DOI 10.1093/nar/gkl199; Xiao X, 2013, ANAL BIOCHEM, V436, P168, DOI 10.1016/j.ab.2013.01.019; Xiao X, 2011, CURR PROTEIN PEPT SC, V12, P508, DOI 10.2174/138920311796957720; Zhao XM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-57; Zhao XM, 2008, PROTEINS, V70, P1125, DOI 10.1002/prot.21870; Zhao XM, 2006, INT J PATTERN RECOGN, V20, P271, DOI 10.1142/S021800140600465X; Zhao XM, 2005, NEURAL NETWORKS, V18, P1019, DOI 10.1016/j.neunet.2005.07.002; Zuo YC, 2014, ANAL BIOCHEM, V458, P14, DOI 10.1016/j.ab.2014.04.032; Zuo YC, 2013, AMINO ACIDS, V44, P573, DOI 10.1007/s00726-012-1374-z; Zuo YC, 2010, AMINO ACIDS, V38, P859, DOI 10.1007/s00726-009-0292-1; Zuo YC, 2009, PEPTIDES, V30, P1788, DOI 10.1016/j.peptides.2009.06.032	45	37	38	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145541	10.1371/journal.pone.0145541	http://dx.doi.org/10.1371/journal.pone.0145541			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713618	Green Submitted, gold, Green Published			2022-12-26	WOS:000367481900054
J	Chang, YC; Reddy, MV; Umemoto, H; Sato, Y; Kang, MH; Yajima, Y; Kikuchi, S				Chang, Young-Cheol; Reddy, M. Venkateswar; Umemoto, Honoka; Sato, Yuki; Kang, Mi-Hye; Yajima, Yuka; Kikuchi, Shintaro			Bio-Augmentation of Cupriavidus sp CY-1 into 2,4-D Contaminated Soil: Microbial Community Analysis by Culture Dependent and Independent Techniques	PLOS ONE			English	Article							2,4-DICHLOROPHENOXYACETIC ACID DEGRADATION; RIBOSOMAL-RNA GENES; BACTERIAL COMMUNITY; DIVERSITY; BIOAUGMENTATION; REMEDIATION; HERBICIDES; STRATEGY; IMPACTS; REGION	In the present study, a 2,4-dichlorophenoxyacetic acid (2,4-D) degrading bacterial strain CY-1 was isolated from the forest soil. Based on physiological, biochemical and 16S rRNA gene sequence analysis it was identified as Cupriavidus sp. CY-1. Further 2,4-D degradation experiments at different concentrations (200 to 800 mg l(-1)) were carried out using CY-1. Effect of NaCl and KNO3 on 2,4-D degradation was also evaluated. Degradation of 2,4-D and the metabolites produced during degradation process were analyzed using high pressure liquid chromatography (HPLC) and GC-MS respectively. The amount of chloride ions produced during the 2,4-D degradation were analyzed by Ion chromatography (IC) and it is stoichiometric with 2,4-D dechlorination. Furthermore two different types of soils collected from two different sources were used for 2,4-D degradation studies. The isolated strain CY1 was bio-augmented into 2,4-D contaminated soils to analyze its degradation ability. Culture independent methods like denaturing gradient gel electrophoresis (DGGE) and terminal restriction fragment length polymorphism (T-RFLP), and culture dependent methods like colony forming units (CFU) and most probable number (MPN) were used to analyze the survivability of strain CY-1 in contaminated soil. Results of T-RFLP were coincident with the DGGE analysis. From the DGGE, T-RFLP, MPN and HPLC results it was concluded that strain CY-1 effectively degraded 2,4-D without disturbing the ecosystem of soil indigenous microorganisms.	[Chang, Young-Cheol; Reddy, M. Venkateswar; Umemoto, Honoka; Sato, Yuki; Kikuchi, Shintaro] Muroran Inst Technol, Div Sustainable & Environm Engn, Coll Environm Technol, Course Chem & Biol Engn, Muroran, Hokkaido 0508585, Japan; [Kang, Mi-Hye] Seoul Metropolitan Govt Res Inst Publ Hlth & Envi, Seoul 137893, South Korea; [Yajima, Yuka] Kyoto Univ, Grad Sch Med, Kyoto, Kyoto 6068501, Japan	Muroran Institute of Technology; Kyoto University	Chang, YC (corresponding author), Muroran Inst Technol, Div Sustainable & Environm Engn, Coll Environm Technol, Course Chem & Biol Engn, 27-1 Mizumoto, Muroran, Hokkaido 0508585, Japan.	ychang@mmm.muroran-it.ac.jp	Chang, Young-Cheol/U-4910-2017; Reddy, M Venkateswar/E-5535-2012; Motakatla, Venkateswer Reddy/AAT-4203-2021	Chang, Young-Cheol/0000-0002-6197-5974; Motakatla, Venkateswer Reddy/0000-0001-5944-5395	Ministry of Education, Culture, Sports, Science and Technology of Japan [26340067]; Muroran Institute Technology, Japan; Grants-in-Aid for Scientific Research [15F15352] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Muroran Institute Technology, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research (No. 26340067) from the Ministry of Education, Culture, Sports, Science and Technology of Japan and Research fund of Muroran Institute Technology, Japan.	Alexander M., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P815; Barreto DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110128; Bouseba B, 2009, PEST MANAG SCI, V65, P1021, DOI 10.1002/ps.1789; Celis E, 2008, WATER RES, V42, P3218, DOI 10.1016/j.watres.2008.04.008; Chang YC, 2011, J IND MICROBIOL BIOT, V38, P1667, DOI 10.1007/s10295-011-0956-1; Chen WM, 2008, J HAZARD MATER, V151, P364, DOI 10.1016/j.jhazmat.2007.05.082; Cheng L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113253; Cupples AM, 2007, SOIL BIOL BIOCHEM, V39, P232, DOI 10.1016/j.soilbio.2006.07.011; de Morais MG, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/967814; Dunbar J, 1997, APPL ENVIRON MICROB, V63, P1326, DOI 10.1128/AEM.63.4.1326-1331.1997; Dunbar J, 2001, APPL ENVIRON MICROB, V67, P190, DOI 10.1128/AEM.67.1.190-197.2001; FUKUMORI F, 1993, J BIOL CHEM, V268, P24311; Gauri SS, 2012, BIORESOURCE TECHNOL, V126, P350, DOI 10.1016/j.biortech.2012.09.097; Gonod LV, 2006, FEMS MICROBIOL ECOL, V58, P529, DOI 10.1111/j.1574-6941.2006.00159.x; GREER CW, 1990, ARCH MICROBIOL, V154, P317, DOI 10.1007/BF00276525; Han LZ, 2014, WORLD J MICROB BIOT, V30, P2567, DOI 10.1007/s11274-014-1680-6; Heuer H, 2012, FEMS MICROBIOL REV, V36, P1083, DOI 10.1111/j.1574-6976.2012.00337.x; Inoue D, 2012, BIODEGRADATION, V23, P263, DOI 10.1007/s10532-011-9505-x; Itoh K, 2004, APPL ENVIRON MICROB, V70, P2110, DOI 10.1128/AEM.70.4.2110-2118.2004; Kitagawa W, 2002, J BACTERIOL, V184, P509, DOI 10.1128/JB.184.2.509-518.2002; Lee EH, 2011, J ENVIRON SCI HEAL A, V46, P281, DOI 10.1080/10934529.2011.535435; Lee TH, 2005, MICROB ECOL, V49, P151, DOI 10.1007/s00248-003-1035-6; Macur RE, 2007, MICROBIOL RES, V162, P37, DOI 10.1016/j.micres.2006.05.007; Manzano M, 2007, ANTON LEEUW INT J G, V91, P115, DOI 10.1007/s10482-006-9101-y; Martin-Laurent F, 2001, APPL ENVIRON MICROB, V67, P2354, DOI 10.1128/AEM.67.5.2354-2359.2001; Martinez-Alonso M, 2010, INT MICROBIOL, V13, P123, DOI 10.2436/20.1501.01.117; Merini LJ, 2007, CHEMOSPHERE, V68, P259, DOI 10.1016/j.chemosphere.2007.01.012; Mohan SV, 2010, BIORESOURCE TECHNOL, V101, P9382, DOI 10.1016/j.biortech.2010.06.109; Newby DT, 2000, APPL ENVIRON MICROB, V66, P3399, DOI 10.1128/AEM.66.8.3399-3407.2000; Nunan N, 2005, APPL ENVIRON MICROB, V71, P6784, DOI 10.1128/AEM.71.11.6784-6792.2005; Perez-Pantoja D, 2008, FEMS MICROBIOL REV, V32, P736, DOI 10.1111/j.1574-6976.2008.00122.x; Reddy MV, 2015, GREEN CHEM, V17, P4560, DOI [10.1039/C5GC01156F, 10.1039/c5gc01156f]; Reddy MV, 2015, BIORESOURCE TECHNOL, V192, P711, DOI 10.1016/j.biortech.2015.06.043; Reddy MV, 2011, J HAZARD MATER, V197, P80, DOI 10.1016/j.jhazmat.2011.09.061; Roane TM, 2001, APPL ENVIRON MICROB, V67, P3208, DOI 10.1128/AEM.67.7.3208-3215.2001; Sakai Y, 2007, MICROBES ENVIRON, V22, P145, DOI 10.1264/jsme2.22.145; Shimojo M, 2009, J BIOSCI BIOENG, V108, P56, DOI 10.1016/j.jbiosc.2009.02.018; Shiozaki A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111374; Singh BK, 2006, APPL ENVIRON MICROB, V72, P7278, DOI 10.1128/AEM.00510-06; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Top EM, 2002, FEMS MICROBIOL ECOL, V42, P199, DOI 10.1111/j.1574-6941.2002.tb01009.x; Zabaloy MC, 2008, APPL SOIL ECOL, V40, P1, DOI 10.1016/j.apsoil.2008.02.004	43	8	8	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145057	10.1371/journal.pone.0145057	http://dx.doi.org/10.1371/journal.pone.0145057			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710231	Green Published, gold, Green Submitted			2022-12-26	WOS:000367451400019
J	Gurdziel, K; Lorberbaum, DS; Udager, AM; Song, JY; Richards, N; Parker, DS; Johnson, LA; Allen, BL; Barolo, S; Gumucio, DL				Gurdziel, Katherine; Lorberbaum, David S.; Udager, Aaron M.; Song, Jane Y.; Richards, Neil; Parker, David S.; Johnson, Lisa A.; Allen, Benjamin L.; Barolo, Scott; Gumucio, Deborah L.			Identification and Validation of Novel Hedgehog-Responsive Enhancers Predicted by Computational Analysis of Ci/Gli Binding Site Density	PLOS ONE			English	Article							CIS-REGULATORY MODULES; NEURAL-TUBE; PATTERN-FORMATION; GENE-EXPRESSION; DROSOPHILA; TRANSCRIPTION; ELEMENTS; PATHWAY; SEQUENCES; WINGLESS	The Hedgehog (Hh) signaling pathway directs a multitude of cellular responses during embryogenesis and adult tissue homeostasis. Stimulation of the pathway results in activation of Hh target genes by the transcription factor Ci/Gli, which binds to specific motifs in genomic enhancers. In Drosophila, only a few enhancers (patched, decapentaplegic, wingless, stripe, knot, hairy, orthodenticle) have been shown by in vivo functional assays to depend on direct Ci/Gli regulation. All but one (orthodenticle) contain more than one Ci/Gli site, prompting us to directly test whether homotypic clustering of Ci/Gli binding sites is sufficient to define a Hh-regulated enhancer. We therefore developed a computational algorithm to identify Ci/Gli clusters that are enriched over random expectation, within a given region of the genome. Candidate genomic regions containing Ci/Gli clusters were functionally tested in chicken neural tube electroporation assays and in transgenic flies. Of the 22 Ci/Gli clusters tested, seven novel enhancers (and the previously known patched enhancer) were identified as Hh-responsive and Ci/Gli-dependent in one or both of these assays, including: Cuticular protein 100A (Cpr100A); invected (inv), which encodes an engrailed-related transcription factor expressed at the anterior/posterior wing disc boundary; roadkill (rdx), the fly homolog of vertebrate Spop; the segment polarity gene gooseberry (gsb); and two previously untested regions of the Hh receptor-encoding patched (ptc) gene. We conclude that homotypic Ci/Gli clustering is not sufficient information to ensure Hh-responsiveness; however, it can provide a clue for enhancer recognition within putative Hedgehog target gene loci.	[Gurdziel, Katherine; Lorberbaum, David S.; Udager, Aaron M.; Song, Jane Y.; Richards, Neil; Parker, David S.; Johnson, Lisa A.; Allen, Benjamin L.; Barolo, Scott; Gumucio, Deborah L.] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Gurdziel, Katherine] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Lorberbaum, David S.; Song, Jane Y.] Univ Michigan, Cellular & Mol Biol Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Allen, BL (corresponding author), Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA.	benallen@umich.edu; sbarolo@umich.edu; dgumucio@umich.edu			University of Michigan Center for Organogenesis; NIH [R01-DK65850, P01-DK062041, T32 DK094775, F30DK082144, GM076509, R21 CA167122, R01 DC014428]; Training Program in Bioinformatics [NIH T32 GM070499]; Medical Scientist Training Program [NIH T32GM007863]; Cellular and Molecular Biology Training Grant [NIH T32-GM007315]; Center for Organogenesis predoctoral fellowship [NIH T32-HD007505]; NSF [MCB-1157800]; AHA scientist development grant [11SDG6380000]; NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007505] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R21CA167122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE007057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK082144, P30DK034933, R01DK065850, P01DK062041, T32DK094775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007863, T32GM007315, R01GM076509] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC014428] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1157800] Funding Source: National Science Foundation	University of Michigan Center for Organogenesis(University of Michigan System); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Training Program in Bioinformatics; Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cellular and Molecular Biology Training Grant; Center for Organogenesis predoctoral fellowship; NSF(National Science Foundation (NSF)); AHA scientist development grant(American Heart Association); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	DLG, SB and BLA were funded by a Research Team Grant from The University of Michigan Center for Organogenesis. DLG is grateful for support from NIH R01-DK65850 and NIH P01-DK062041. KG was supported by NIH T32 DK094775 and the Training Program in Bioinformatics (NIH T32 GM070499). AMU was supported by NIH F30DK082144 and the Medical Scientist Training Program (NIH T32GM007863). DSL was supported by the Cellular and Molecular Biology Training Grant (NIH T32-GM007315) and a Center for Organogenesis predoctoral fellowship (NIH T32-HD007505); the Barolo lab was supported by NIH grant GM076509 and NSF grant MCB-1157800. Work in the Allen lab is supported by an AHA scientist development grant (11SDG6380000) and by NIH R21 CA167122 and NIH R01 DC014428.; The NKX6.1 antibody was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biological Sciences, Iowa City, IA. Confocal microscopy was performed in the Microscopy and Image Analysis Laboratory at the University of Michigan. Sequencing of enhancer constructs was performed at the University of Michigan Sequencing Core. The authors would like to thank Dr. Mark Rebeiz for generously sharing scripts and Dr. William J. Zacharias for helpful discussions.	Alexandre C, 1996, GENE DEV, V10, P2003, DOI 10.1101/gad.10.16.2003; Barakat MT, 2010, TRENDS MOL MED, V16, P337, DOI 10.1016/j.molmed.2010.05.003; Berman BP, 2002, P NATL ACAD SCI USA, V99, P757, DOI 10.1073/pnas.231608898; Biehs B, 2010, DEV CAMBRIDGE ENGLAN, V137, P1; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Blanco J, 2009, DEV BIOL, V329, P104, DOI 10.1016/j.ydbio.2009.02.027; Bouchard M, 2000, DEV BIOL, V222, P135, DOI 10.1006/dbio.2000.9702; Boy AL, 2010, GENESIS, V48, P452, DOI 10.1002/dvg.20637; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Celniker SE, 2002, GENOME BIOL, V3, DOI DOI 10.1186/GB-2002-3-12-RESEARCH0079; Coward E, 1999, BIOINFORMATICS, V15, P1058, DOI 10.1093/bioinformatics/15.12.1058; de Sauvage F, 2007, Bull Mem Acad R Med Belg, V162, P219; Dessaud E, 2008, DEVELOPMENT, V135, P2489, DOI 10.1242/dev.009324; FITCH WM, 1983, J MOL BIOL, V163, P171, DOI 10.1016/0022-2836(83)90002-5; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Gotea V, 2010, GENOME RES, V20, P565, DOI 10.1101/gr.104471.109; Halfon MS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-578; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Hammonds AS, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r140; Hersh BM, 2005, DEVELOPMENT, V132, P1567, DOI 10.1242/dev.01737; Holohan EE, 2007, PLOS GENET, V3, P1211, DOI 10.1371/journal.pgen.0030112; Jeong JH, 2005, DEVELOPMENT, V132, P143, DOI 10.1242/dev.01566; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Jory A, 2012, CELL REP, V2, P1014, DOI 10.1016/j.celrep.2012.09.010; Keightley PD, 2009, GENOME RES, V19, P1195, DOI 10.1101/gr.091231.109; Kent D, 2006, DEVELOPMENT, V133, P2001, DOI 10.1242/dev.02370; Lang M, 2010, EVODEVO, V1, DOI 10.1186/2041-9139-1-11; Lee EY, 2010, P NATL ACAD SCI USA, V107, P9736, DOI 10.1073/pnas.1004602107; Lei QB, 2006, DEV CELL, V11, P325, DOI 10.1016/j.devcel.2006.06.013; LI XL, 1993, EMBO J, V12, P4499, DOI 10.1002/j.1460-2075.1993.tb06139.x; Lifanov AP, 2003, GENOME RES, V13, P579, DOI 10.1101/gr.668403; Lipinski RJ, 2010, BIRTH DEFECTS RES A, V88, P232, DOI 10.1002/bdra.20656; Markstein M, 2002, P NATL ACAD SCI USA, V99, P763, DOI 10.1073/pnas.012591199; McKay DJ, 2013, DEV CELL, V27, P306, DOI 10.1016/j.devcel.2013.10.009; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; McQuilton P, 2012, NUCLEIC ACIDS RES, V40, pD706, DOI 10.1093/nar/gkr1030; Megason SG, 2002, DEVELOPMENT, V129, P2087; Michel M, 2012, DEVELOPMENT, V139, P2663, DOI 10.1242/dev.075242; Muller B, 2000, DEV CAMBRIDGE ENGLAN, V127, P1; Murdoch JN, 2010, BIRTH DEFECTS RES A, V88, P633, DOI 10.1002/bdra.20686; Ngan ESW, 2013, MOL SYNDROMOL, V4, P32, DOI 10.1159/000345725; Nishi Y, 2015, DEVELOPMENT, V142, P3286, DOI 10.1242/dev.124636; Ohlen T, 1997, MECH DEVELOP, V68, P1; Oosterveen T, 2012, DEV CELL, V23, P1006, DOI 10.1016/j.devcel.2012.09.015; Peterson KA, 2012, GENE DEV, V26, P2802, DOI 10.1101/gad.207142.112; Piepenburg O, 2000, MOL CELL, V6, P203, DOI 10.1016/S1097-2765(00)00022-8; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Ramos AI, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0018; Rebeiz M, 2002, P NATL ACAD SCI USA, V99, P9888, DOI 10.1073/pnas.152320899; Richards S, 2005, GENOME RES, V15, P1, DOI 10.1101/gr.3059305; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Sawaya S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054710; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; Schachter KA, 2008, CURR TOP DEV BIOL, V84, P139, DOI 10.1016/S0070-2153(08)00603-0; Sekulic A, 2012, NEW ENGL J MED, V366, P2171, DOI 10.1056/NEJMoa1113713; Suryamohan K, 2014, WILEY INTERDISCIPLIN; Swanson CI, 2008, GENE, V408, P180, DOI 10.1016/j.gene.2007.11.003; Swanson CI, 2010, DEV CELL, V18, P359, DOI 10.1016/j.devcel.2009.12.026; Taher L, 2015, COLD SPRING HARB PRO, V2015; Tang JY, 2012, NEW ENGL J MED, V366, P2180, DOI 10.1056/NEJMoa1113538; Teglund S, 2010, BBA-REV CANCER, V1805, P181, DOI 10.1016/j.bbcan.2010.01.003; Tenzen T, 2006, DEV CELL, V10, P647, DOI 10.1016/j.devcel.2006.04.004; Timmer J, 2001, GENESIS, V29, P123, DOI 10.1002/gene.1015; Tomancak P, 2002, GENOME BIOL, V3, P88, DOI 10.1186/gb-2002-3-12-research0088; Tomancak P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r145; Uchikawa M, 2003, DEV CELL, V4, P509, DOI 10.1016/S1534-5807(03)00088-1; Vadasz S, 2013, DEVELOPMENT, V140, P3691, DOI 10.1242/dev.088328; Vokes SA, 2008, GENE DEV, V22, P2651, DOI 10.1101/gad.1693008; Vokes SA, 2007, DEVELOPMENT, V134, P1977, DOI 10.1242/dev.001966; VonOhlen T, 1997, P NATL ACAD SCI USA, V94, P2404, DOI 10.1073/pnas.94.6.2404; Wang H, 2011, DEVELOPMENT, V138, P3711, DOI 10.1242/dev.068270; Winklmayr M, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-2; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201	75	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145225	10.1371/journal.pone.0145225	http://dx.doi.org/10.1371/journal.pone.0145225			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710299	gold, Green Published, Green Submitted			2022-12-26	WOS:000367451400028
J	Massett, MP; Avila, JJ; Kim, SK				Massett, Michael P.; Avila, Joshua J.; Kim, Seung Kyum			Exercise Capacity and Response to Training Quantitative Trait Loci in a NZW X 129S1 Intercross and Combined Cross Analysis of Inbred Mouse Strains	PLOS ONE			English	Article							MITOCHONDRIAL INTERMEDIATE PEPTIDASE; ENDURANCE EXERCISE; SPINOCEREBELLAR ATAXIA; PHYSICAL-FITNESS; AEROBIC CAPACITY; SKELETAL-MUSCLE; OXYGEN-UPTAKE; QTL; MORTALITY; TDP1	Genetic factors determining exercise capacity and the magnitude of the response to exercise training are poorly understood. The aim of this study was to identify quantitative trait loci (QTL) associated with exercise training in mice. Based on marked differences in training responses in inbred NZW (-0.65 +/- 1.73 min) and 129S1 (6.18 +/- 3.81 min) mice, a reciprocal intercross breeding scheme was used to generate 285 F-2 mice. All F-2 mice completed an exercise performance test before and after a 4-week treadmill running program, resulting in an increase in exercise capacity of 1.54 +/- 3.69 min (range = -10 to + 12 min). Genome-wide linkage scans were performed for pre-training, post-training, and change in run time. For pre-training exercise time, suggestive QTL were identified on Chromosomes 5 (57.4 cM, 2.5 LOD) and 6 (47.8 cM, 2.9 LOD). A significant QTL for post-training exercise capacity was identified on Chromosome 5 (43.4 cM, 4.1 LOD) and a suggestive QTL on Chromosomes 1 (55.7 cM, 2.3 LOD) and 8 (66.1 cM, 2.2 LOD). A suggestive QTL for the change in run time was identified on Chromosome 6 (37.8 cM, 2.7 LOD). To identify shared QTL, this data set was combined with data from a previous F-2 cross between B6 and FVB strains. In the combined cross analysis, significant novel QTL for pre-training exercise time and change in exercise time were identified on Chromosome 12 (54.0 cM, 3.6 LOD) and Chromosome 6 (28.0 cM, 3.7 LOD), respectively. Collectively, these data suggest that combined cross analysis can be used to identify novel QTL and narrow the confidence interval of QTL for exercise capacity and responses to training. Furthermore, these data support the use of larger and more diverse mapping populations to identify the genetic basis for exercise capacity and responses to training.	[Massett, Michael P.; Avila, Joshua J.; Kim, Seung Kyum] Texas A&M Univ, Dept Hlth & Kinesiol, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station	Massett, MP (corresponding author), Texas A&M Univ, Dept Hlth & Kinesiol, College Stn, TX USA.	mmassett@hlkn.tamu.edu	Kim, Seung/ABC-8404-2020	Kim, Seung/0000-0002-1708-9393; Massett, Michael/0000-0001-5356-4959	National Institutes of Health [R01 HL085918]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085918] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by National Institutes of Health grant R01 HL085918 (M.P.M.). No individuals employed or contracted by the funders played any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackert-Bicknell CL, 2012, BONE, V50, P1188, DOI 10.1016/j.bone.2012.01.011; Al-Jarrah M, 2007, NEUROSCIENCE, V149, P28, DOI 10.1016/j.neuroscience.2007.07.038; Barlow CE, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.001354; BLAIR SN, 1995, JAMA-J AM MED ASSOC, V273, P1093, DOI 10.1001/jama.273.14.1093; Bouchard C, 2000, J APPL PHYSIOL, V88, P551, DOI 10.1152/jappl.2000.88.2.551; Bouchard C, 1999, J APPL PHYSIOL, V87, P1003, DOI 10.1152/jappl.1999.87.3.1003; Bouchard C, 2001, MED SCI SPORT EXER, V33, pS446, DOI 10.1097/00005768-200106001-00013; Bouchard C, 2011, J APPL PHYSIOL, V110, P1160, DOI 10.1152/japplphysiol.00973.2010; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Broman KW, 2001, LAB ANIMAL, V30, P44; Chaillou T, 2015, J APPL PHYSIOL, V118, P86, DOI 10.1152/japplphysiol.00351.2014; Cheverud JM, 2012, HEREDITY, V108, P441, DOI 10.1038/hdy.2011.94; Chew A, 1997, GENOMICS, V40, P493, DOI 10.1006/geno.1996.4586; Chew A, 2000, GENOMICS, V65, P104, DOI 10.1006/geno.2000.6162; CHURCHILL GA, 1994, GENETICS, V138, P963; Courtney Sean M, 2014, F1000Res, V3, P9, DOI 10.12688/f1000research.3-9.v1; Courtney SM, 2012, PHYSIOL GENOMICS, V44, P948, DOI 10.1152/physiolgenomics.00051.2012; CRYSTAL RG, 1990, J CLIN INVEST, V85, P1343, DOI 10.1172/JCI114578; Das BB, 2010, P NATL ACAD SCI USA, V107, P19790, DOI 10.1073/pnas.1009814107; De Angelis K, 2004, J APPL PHYSIOL, V96, P2174, DOI 10.1152/japplphysiol.00870.2003; Dias RG, 2015, PHYSIOL GENOMICS, V47, P13, DOI 10.1152/physiolgenomics.00072.2014; Dunn-Lewis C, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-90; Erikssen G, 1998, LANCET, V352, P759, DOI 10.1016/S0140-6736(98)02268-5; Farber CR, 2007, GENETICS, V175, P349, DOI 10.1534/genetics.106.063693; Green DJ, 2014, J APPL PHYSIOL, V117, P345, DOI 10.1152/japplphysiol.00354.2014; Hagberg JM, 2011, MED SCI SPORT EXER, V43, P743, DOI 10.1249/MSS.0b013e3182155d21; Heit C, 2013, HUM GENOMICS, V7, DOI 10.1186/1479-7364-7-22; Hirano R, 2007, EMBO J, V26, P4732, DOI 10.1038/sj.emboj.7601885; Jagodic M, 2006, GENOMICS, V88, P737, DOI 10.1016/j.ygeno.2006.08.013; Koch LG, 2005, AM J PHYSIOL-REG I, V288, pR466, DOI 10.1152/ajpregu.00621.2004; Kokkinos P, 2008, CIRCULATION, V117, P614, DOI 10.1161/CIRCULATIONAHA.107.734764; Kokkinos P, 2010, CIRCULATION, V122, P790, DOI 10.1161/CIRCULATIONAHA.110.938852; Korstanje R, 2004, J LIPID RES, V45, P881, DOI 10.1194/jlr.M300460-JLR200; Li RH, 2005, GENETICS, V169, P1699, DOI 10.1534/genetics.104.033993; Lightfoot JT, 2007, J APPL PHYSIOL, V103, P105, DOI 10.1152/japplphysiol.01328.2006; Lightfoot JT, 2010, J APPL PHYSIOL, V109, P623, DOI 10.1152/japplphysiol.00525.2010; LORTIE G, 1984, INT J SPORTS MED, V5, P232, DOI 10.1055/s-2008-1025911; Martin-Sanchez FJ, 2011, J SPORT SCI MED, V10, P45; Massett MP, 2009, PHYSIOL GENOMICS, V40, P15, DOI 10.1152/physiolgenomics.00116.2009; Massett MP, 2005, AM J PHYSIOL-REG I, V288, pR1006, DOI 10.1152/ajpregu.00476.2004; Meier P, 2013, CELL BIOCHEM FUNCT, V31, P51, DOI 10.1002/cbf.2859; Nehrenberg DL, 2010, J HERED, V101, P42, DOI 10.1093/jhered/esp066; Petkov PM, 2004, GENOME RES, V14, P1806, DOI 10.1101/gr.2825804; Petkov PM, 2004, GENOMICS, V83, P902, DOI 10.1016/j.ygeno.2003.11.007; Rampersaud E, 2013, ANN HUM GENET, V77, P147, DOI 10.1111/ahg.12006; Rice TK, 2012, EUR J APPL PHYSIOL, V112, P2969, DOI 10.1007/s00421-011-2274-8; Rico-Sanz J, 2004, PHYSIOL GENOMICS, V16, P256, DOI 10.1152/physiolgenomics.00035.2003; Savage KJ, 2010, MUSCLE NERVE, V42, P355, DOI 10.1002/mus.21688; Semple SJ, 2006, BRIT J SPORT MED, V40, P124, DOI 10.1136/bjsm.2005.019489; Sisson SB, 2009, MED SCI SPORT EXER, V41, P539, DOI 10.1249/MSS.0b013e3181896c4e; Solberg LC, 2004, MAMM GENOME, V15, P648, DOI 10.1007/s00335-004-2326-z; Su ZG, 2009, J LIPID RES, V50, P2083, DOI 10.1194/jlr.M900076-JLR200; Takashima H, 2002, NAT GENET, V32, P267, DOI 10.1038/ng987; Timmons JA, 2010, J APPL PHYSIOL, V108, P1487, DOI 10.1152/japplphysiol.01295.2009; Vollaard NBJ, 2009, J APPL PHYSIOL, V106, P1479, DOI 10.1152/japplphysiol.91453.2008; Ways JA, 2002, GENOMICS, V80, P13, DOI 10.1006/geno.2002.6797; Wergedal JE, 2007, J LIPID RES, V48, P1724, DOI 10.1194/jlr.M700015-JLR200; Wu CL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000070; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130	59	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145741	10.1371/journal.pone.0145741	http://dx.doi.org/10.1371/journal.pone.0145741			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710100	Green Published, gold, Green Submitted			2022-12-26	WOS:000367451400074
J	Belle-van Meerkerk, G; de Jong, PA; de Valk, HW; Neefjes, T; Pameijer, FA; Kwakkel-van Erp, JM; van de Graaf, EA				Belle-van Meerkerk, Gerdien; de Jong, Pim A.; de Valk, Harold W.; Neefjes, Tim; Pameijer, Frank A.; Kwakkel-van Erp, Johanna M.; van de Graaf, Ed A.			Pretransplant HRCT Characteristics Are Associated with Worse Outcome of Lung Transplantation for Cystic Fibrosis Patients	PLOS ONE			English	Article							DIABETES-MELLITUS; EXACERBATION; CT	Objectives Peri-and postoperative complications diminish the outcome of lung transplantation (LTx) in patients with cystic fibrosis (CF). We hypothesized that the degree of pathological findings on pre-LTx high resolution computed tomography (HRCT) is associated with higher morbidity and mortality in CF. Methods All our CF patients undergoing LTx between 2001 and 2011 were included. HRCT examinations were evaluated according to a scoring system for pulmonary disease in CF patients, the Severe Advanced Lung Disease (SALD) score and for pleural involvement. Results Fifty-three patients were included. Dominant infectious/inflammatory disease according to the SALD score was observed in 10 patients (19%). Five (50%) of those patients died within one week after LTx, compared to 2 (5%) patients without dominant infectious/inflammatory disease (p<0.001). This difference in survival percentage remained also significant in multivariate analysis. Patients with infectious/inflammatory disease received more packed red blood cells; 26 versus 8 in the first week (p<0.001). Pleural thickening was associated with higher requirement (10 units) for blood transfusion during LTx, compared to patients with normal pleura (4 units). Conclusions The analysis of HRCT in CF patients according to the SALD score showed that dominant infectious/inflammatory disease is associated with a higher mortality after LTx. If confirmed in other studies, HRCT might aid estimation of surgical risk in some adult CF patients.	[Belle-van Meerkerk, Gerdien; Kwakkel-van Erp, Johanna M.; van de Graaf, Ed A.] Univ Med Ctr Utrecht, Dept Resp Med, Utrecht, Netherlands; [Belle-van Meerkerk, Gerdien; de Valk, Harold W.] Univ Med Ctr Utrecht, Dept Internal Med, Utrecht, Netherlands; [de Jong, Pim A.; Neefjes, Tim; Pameijer, Frank A.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Belle-van Meerkerk, G (corresponding author), Univ Med Ctr Utrecht, Dept Resp Med, Utrecht, Netherlands.	G.vanMeerkerk@umcutrecht.nl						Aratari MT, 2008, TRANSPL P, V40, P2001, DOI 10.1016/j.transproceed.2008.05.029; Belle-van Meerkerk G, 2012, DIABETIC MED, V29, pE159, DOI 10.1111/j.1464-5491.2012.03676.x; Bradbury RA, 2009, INTERN MED J, V39, P384, DOI 10.1111/j.1445-5994.2008.01786.x; Bremner RM, 2001, AM SURGEON, V67, P1136; Christie JD, 2011, J HEART LUNG TRANSPL, V30, P1104, DOI 10.1016/j.healun.2011.08.004; Dosanjh A, 1998, Pediatr Transplant, V2, P283; Ferkol T, 2006, J PEDIATR-US, V148, P259, DOI 10.1016/j.jpeds.2005.10.019; Hackman KL, 2014, AM J TRANSPLANT, V14, P438, DOI 10.1111/ajt.12561; Hofer M, 2012, J CYST FIBROS, V11, P131, DOI 10.1016/j.jcf.2011.10.005; Kelly A, 2013, J CYST FIBROS, V12, P318, DOI 10.1016/j.jcf.2013.02.008; Loeve M, 2009, THORAX, V64, P876, DOI 10.1136/thx.2008.110908; Loeve M, 2012, AM J RESP CRIT CARE, V185, P1096, DOI 10.1164/rccm.201111-2065OC; Marom EM, 1999, RADIOLOGY, V213, P283, DOI 10.1148/radiology.213.1.r99oc12283; Meachery G, 2008, THORAX, V63, P725, DOI 10.1136/thx.2007.092056; Moran A, 2010, DIABETES CARE, V33, P2697, DOI 10.2337/dc10-1768; Moran A, 2009, DIABETES CARE, V32, P1626, DOI 10.2337/dc09-0586; Moreno P, 2016, EUR J CARDIO-THORAC, V49, P1334, DOI 10.1093/ejcts/ezv377; Parkins MD, 2012, CHEST, V141, P485, DOI 10.1378/chest.11-0917; Quattrucci Serena, 2005, J Cyst Fibros, V4, P107, DOI 10.1016/j.jcf.2005.01.003; Shah RM, 1997, AM J ROENTGENOL, V169, P375, DOI 10.2214/ajr.169.2.9242738	20	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145597	10.1371/journal.pone.0145597	http://dx.doi.org/10.1371/journal.pone.0145597			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26698308	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092600102
J	He, YM; Makovicky, PJ; Wang, KB; Chen, SQ; Sullivan, C; Han, FL; Xu, X				He, Yiming; Makovicky, Peter J.; Wang, Kebai; Chen, Shuqing; Sullivan, Corwin; Han, Fenglu; Xu, Xing			A New Leptoceratopsid (Ornithischia, Ceratopsia) with a Unique Ischium from the Upper Cretaceous of Shandong Province, China	PLOS ONE			English	Article							DINOSAUR; PHYLOGENY; MUSCULATURE; ANATOMY; PARVUS	The partial skeleton of a leptoceratopsid dinosaur, Ischioceratops zhuchengensis gen. et sp. nov., was excavated from the bone-beds of the Upper Cretaceous Wangshi Group of Zhucheng, Shandong Province, China. This fossil represents the second leptoceratopsid dinosaur specimen recovered from the Kugou locality, a highly productive site in Zhucheng. The ischium of the new taxon is morphologically unique among known Dinosauria, flaring gradually to form an obturator process in its middle portion and resembling the shaft of a recurve bow. An elliptical fenestra perforates the obturator process, and the distal end of the shaft forms an axehead-shaped expansion. The discovery of Ischioceratops increases the known taxonomic diversity and morphological disparity of the Leptoceratopsidae.	[He, Yiming; Sullivan, Corwin; Xu, Xing] Chinese Acad Sci, Inst Vertebrate Palaeontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China; [Makovicky, Peter J.] Field Museum, Dept Geol, Chicago, IL USA; [Wang, Kebai; Chen, Shuqing] Zhucheng Dinosaur Museum, Zhucheng, Shandong, Peoples R China; [Han, Fenglu] China Univ Geosci, Sch Earth Sci, Wuhan 430074, Peoples R China; [He, Yiming] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Field Museum of Natural History (Chicago); China University of Geosciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	He, YM (corresponding author), Chinese Acad Sci, Inst Vertebrate Palaeontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China.	15210674219@126.com		Sullivan, Corwin/0000-0002-5488-6797	National Natural Science Foundation of China [41120124002]; 973 program [2012CB821900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 program(National Basic Research Program of China)	This research was supported by grants from the National Natural Science Foundation of China (grant number: 41120124002) and 973 program (2012CB821900, http://www.cas.cn/).	Adams JS, 2005, J VERTEBR PALEONTOL, V25, P614, DOI 10.1671/0272-4634(2005)025[0614:HDOOPA]2.0.CO;2; [Anonymous], 1923, FORTSCHRITTE GEOLOGI; Averianov AO, 2006, J SYST PALAEONTOL, V4, P359, DOI 10.1017/S1477201906001933; Barrett PM, 2005, J VERTEBR PALEONTOL, V25, P823, DOI 10.1671/0272-4634(2005)025[0823:SODFTM]2.0.CO;2; Brett-Surman Michael K., 2007, P135; Brochu CA, 2003, J VERTEBR PALEONTOL, V22; Broom R, 1913, RECORDS ALBANY MUSEU, V2, P394; Brown B, 1914, B AM MUS NAT HIST, V33, P567; Brown B., 1940, Annals of the New York Academy of Sciences, V40, P133; Brown B, 1916, B AM MUS NAT HIST, V35, P709; Brown B, 1937, AM MUS NOVIT, V955, P1; Brown Barnum, 1942, AMER MUS NOVITATES, V1169, P1; Butler RJ, 2008, J SYST PALAEONTOL, V6, P1, DOI 10.1017/S1477201907002271; Butler RJ, 2011, PALAEONTOLOGY, V54, P667, DOI 10.1111/j.1475-4983.2011.01046.x; Butler RJ, 2010, ZOOL J LINN SOC-LOND, V160, P648, DOI 10.1111/j.1096-3642.2009.00631.x; Butler RJ, 2005, ZOOL J LINN SOC-LOND, V145, P175, DOI 10.1111/j.1096-3642.2005.00182.x; Butler RJ, 2007, P ROYAL SOC B, P2041; Cai KJ, 1984, ORNITHOPOD DINOSAURS, V1, P71; Carpenter Kenneth, 2001, P90; Chinnery B, 2004, J VERTEBR PALEONTOL, V24, P572, DOI 10.1671/0272-4634(2004)024[0572:DOPPGE]2.0.CO;2; Chinnery BJ, 1998, J VERTEBR PALEONTOL, V18, P569, DOI 10.1080/02724634.1998.10011085; Chinnery BJ, 2007, J VERTEBR PALEONTOL, V27, P625, DOI 10.1671/0272-4634(2007)27[625:ANNDLN]2.0.CO;2; Coria RA, 1996, J VERTEBR PALEONTOL, V16, P445, DOI 10.1080/02724634.1996.10011333; Dodson P., 1996, THE HORNED DINOSAURS; Dodson P, 2004, DINOSAURIA, 2ND EDITION, P494; Dong Zhiming, 1997, P68; EWER RF, 1965, PHILOS T ROY SOC B, V248, P379, DOI 10.1098/rstb.1965.0003; Farke AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112055; Forster C.A., 1990, Journal of Vertebrate Paleontology, V10, P273; GALTON P M, 1981, Palaeontologische Zeitschrift, V55, P271; Galton PM., 1974, B BRIT MUS NAT HIS A, V25, P1; Gilmore CW, 1909, OSTEOLOGY JURASSIC R, P197; Godefroit P, 2012, NEW SAUROLOPHINE DIN, V7; Goloboff P, 2008, CLADISTICS, V24, P91; Granger W., 1923, American Museum Novitates, VNo. 72, P1; Guenther MF, 2009, ANAT REC, V292, P1427, DOI 10.1002/ar.20988; Han FL, 2012, J VERTEBR PALEONTOL, V32, P1370, DOI 10.1080/02724634.2012.694385; Hatcher J. B., 1907, MONOGRAPHS US GEOLOG, VXLIX, DOI DOI 10.5962/BHL.TITLE.60500; Hone DWE, 2011, CRETACEOUS RES, V32, P495, DOI 10.1016/j.cretres.2011.03.005; Horner JR, 2004, DINOSAURIA, 2ND EDITION, P438; Hu C.Z., 1973, ACTA GEOL SINICA, V2, P179; Hu CZ, 2001, SHANTUNGOSAURUS GIGA, P139; Huxley T.H., 1869, ABSTRACTS P GEOLOGIC, V204, P3; KURZANOV SM, 1992, PALEONTOL ZH, P81; Lee YN, 2011, NATURWISSENSCHAFTEN, V98, P39, DOI 10.1007/s00114-010-0739-y; Lehman T.M., 1989, Journal of Vertebrate Paleontology, V9, P137; Lindgren J, 2007, PALAEONTOLOGY, V50, P929, DOI 10.1111/j.1475-4983.2007.00690.x; Liu J, 2004, J VERTEBR PALEONTOL, V24, p84A; [柳永清 Liu Yongqing], 2010, [地质论评, Geological Review], V56, P457; Lull R.S., 1942, GEOLOGICAL SOC AM SP, V40, P242; Maidment SCR, 2011, J VERTEBR PALEONTOL, V31, P1265, DOI 10.1080/02724634.2011.606857; Makovicky PJ, 2011, J VERTEBR PALEONTOL, V31, P626, DOI 10.1080/02724634.2011.557114; Makovicky Peter J., 2010, P68; Makovicky PJ, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3530[1:YDANPC]2.0.CO;2; Makovicky Peter J., 2001, P243; Makovicky PJ, 2002, TAXONOMIC REVISION P, P297; Marsh O.C., 1890, AM J SCI, V39, P418, DOI DOI 10.2475/AJS.S3-39.233.418; MARYANSKA T, 1985, Acta Palaeontologica Polonica, V30, P137; Maryanska T, 1974, Palaeontologia Polonica, VNo. 30, P45; MARYANSKA T, 1975, Palaeontologia Polonica, V33, P133; Morschhauser EM, 2012, THESIS; Nesov L.A., 1989, T 33 SESSII VSESOYUZ, P144; Norman D.B., 1986, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V56, P281; Norman D.B., 1990, P510; Norman DB, 2004, DINOSAURIA, 2ND EDITION, P393; NORMAN DB, 1980, I ROYAL SCI NATURELL, V178, P1; PARKS WA, 1920, U TORONTO STUDIES GE, V11, P1; Peng Guangzhao, 1992, Vertebrata Palasiatica, V30, P39; Rozhdestvensky AK, 1966, PALEONTOL ZH, V1966, P103; Russell DA, 1996, CAN J EARTH SCI, V33, P637, DOI 10.1139/e96-047; RUSSELL DA, 1970, CAN J EARTH SCI, V7, P181, DOI 10.1139/e70-014; Ryan MJ, 2012, CRETACEOUS RES, V35, P69, DOI 10.1016/j.cretres.2011.11.018; Santa Luca A. P., 1980, ANN S AFR MUS, V79, P159, DOI DOI 10.1038/264324A0; Seeley H.G., 1888, REPORT BRIT ASS ADV, V57, P698; Sereno P.C., 1990, P579; Sereno Paul C., 2000, P480; Sereno PC, 2012, ZOOKEYS, P1, DOI [10.3897/zookeys.226.2840, 10.3897/zookeys.223.2840]; SERENO PC, 1986, NATL GEOGR RES, V2, P234; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; Sternberg CM, 1951, NATIONAL MUSEUM CANA, V123, P225; THULBORN R A, 1972, Palaeontology (Oxford), V15, P29; Weishampel D.B., 1992, Historical Biology, V6, P159; Xu X, 2006, P ROY SOC B-BIOL SCI, V273, P2135, DOI 10.1098/rspb.2006.3566; Xu X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013835; Xu X, 2010, CHINESE SCI BULL, V55, P1631, DOI 10.1007/s11434-009-3614-5; You Hailu, 2004, P478	86	14	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0144148	10.1371/journal.pone.0144148	http://dx.doi.org/10.1371/journal.pone.0144148			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26701114	Green Published, gold, Green Submitted			2022-12-26	WOS:000367092600016
J	Kang, S; Ma, WJ; Li, FY; Zhang, Q; Niu, JM; Ding, Y; Han, F; Sun, XL				Kang, Saruul; Ma, Wenjing; Li, Frank Yonghong; Zhang, Qing; Niu, Jianming; Ding, Yong; Han, Fang; Sun, Xiaoli			Functional Redundancy Instead of Species Redundancy Determines Community Stability in a Typical Steppe of Inner Mongolia	PLOS ONE			English	Article							ECOSYSTEM STABILITY; RESPONSE DIVERSITY; BIODIVERSITY; PRODUCTIVITY; POPULATIONS; VEGETATION; PATTERNS	Background The redundancy hypothesis predicts that the species redundancy in a plant community enhances community stability. However, numerous studies in recent years questioned the positive correlation between redundancy and stability. Methodology We explored the relationship between the species redundancy, functional redundancy and community stability in typical steppe grassland in Northern China by sampling grassland vegetation along a gradient of resource availability caused by micro-topography. We aimed to test whether community redundancy enhanced community stability, and to quantify the relative importance of species redundancy and functional redundancy in maintaining community stability. Results Our results showed that the spatial stability of plant community production increases with increased supply of soil resources, and the functional redundancy instead of species diversity or species redundancy is correlated with the community stability. Our results supported the redundancy hypothesis and have implications for sustainable grassland management.	[Kang, Saruul; Ma, Wenjing; Li, Frank Yonghong; Zhang, Qing; Niu, Jianming; Sun, Xiaoli] Inner Mongolia Univ, Sch Life Sci, Ecol, Hohhot, Peoples R China; [Niu, Jianming] Inner Mongolia Univ, SinoUS Ctr Conservat Energy & Sustainabil Sci, Hohhot, Peoples R China; [Ding, Yong] Chinese Acad Agr Sci, Grassland Res Inst, Hohhot, Peoples R China; [Han, Fang] Inner Mongolian Meteorol Bur, Hohhot, Peoples R China	Inner Mongolia University; Inner Mongolia University; Chinese Academy of Agricultural Sciences; Institute of Grassland Research, CAAS	Zhang, Q (corresponding author), Inner Mongolia Univ, Sch Life Sci, Ecol, Hohhot, Peoples R China.	qzhang82@163.com	Niu, Jianming/K-3597-2019; Li, Frank Yonghong/AAN-3093-2020	Li, Frank Yonghong/0000-0002-5137-8017	National Basic Research Programme of China [31200414]; State Key Basic Research Development Programme of China [2014CB138802]; Specialized Research Fund for the Doctoral Programme of Higher Education of China [20121501120006]	National Basic Research Programme of China(National Basic Research Program of China); State Key Basic Research Development Programme of China; Specialized Research Fund for the Doctoral Programme of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	The National Basic Research Programme of China (Grant no. 31200414); State Key Basic Research Development Programme of China (Grant nos. 2014CB138802); The Specialized Research Fund for the Doctoral Programme of Higher Education of China (Grant no. 20121501120006). All sources of funding that have supported this work. The funders also contributed in study design (QZ) and data collection (YD).	Arno S.F., 1977, METHOD DETERMINING F; Bai YF, 2004, NATURE, V431, P181, DOI 10.1038/nature02850; Bai YF, 2007, J APPL ECOL, V44, P1023, DOI 10.1111/j.1365-2664.2007.01351.x; Bengtsson J, 1998, APPL SOIL ECOL, V10, P191, DOI 10.1016/S0929-1393(98)00120-6; Chollet S, 2014, ECOLOGY, V95, P737, DOI 10.1890/13-0751.1; de Bello F, 2007, COMMUNITY ECOL, V8, P163, DOI 10.1556/ComEc.8.2007.2.3; Diaz S, 2001, J APPL ECOL, V38, P497, DOI 10.1046/j.1365-2664.2001.00635.x; Dovciak M, 2010, ECOL LETT, V13, P1300, DOI 10.1111/j.1461-0248.2010.01524.x; Ehrlich AH, 1981, EXTINCTION, P384; Elmqvist T, 2003, FRONT ECOL ENVIRON, V1, P488, DOI 10.2307/3868116; Elton C.S., 2000, ECOLOGY INVASIONS AN; Fang JY, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024231; Flynn DFB, 2009, ECOL LETT, V12, P22, DOI 10.1111/j.1461-0248.2008.01255.x; Fonseca CR, 2001, J ECOL, V89, P118, DOI 10.1046/j.1365-2745.2001.00528.x; Godron M., 1971, STAT ECOL, V3, P397; Gonzalez A, 2009, ANNU REV ECOL EVOL S, V40, P393, DOI 10.1146/annurev.ecolsys.39.110707.173349; Griffin JN, 2009, OIKOS, V118, P37, DOI 10.1111/j.1600-0706.2008.16960.x; Heinselman ML, 1981, FOREST SUCCESSION, P374, DOI [10.1007/978-1-4612-5950-3_23, DOI 10.1007/978-1-4612-5950-3_23]; Hooper DU, 1994, BIOL DIVERSITY TERRE; Johnson KH, 1996, TRENDS ECOL EVOL, V11, P372, DOI 10.1016/0169-5347(96)10040-9; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; LAWTON JH, 1994, OIKOS, V71, P367, DOI 10.2307/3545824; Lawton JH, 1994, REDUNDANCY ECOSYSTEM; Leps J, 2006, PRESLIA, V78, P481; MACARTHUR R, 1955, ECOLOGY, V36, P533, DOI 10.2307/1929601; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; MCNAUGHTON SJ, 1977, AM NAT, V111, P515, DOI 10.1086/283181; Micheli F, 2005, ECOL LETT, V8, P391, DOI 10.1111/j.1461-0248.2005.00731.x; Mori AS, 2013, BIOL REV, V88, P349, DOI 10.1111/brv.12004; Mougi A, 2012, SCIENCE, V337, P349, DOI 10.1126/science.1220529; Naeem S, 1998, CONSERV BIOL, V12, P39, DOI 10.1046/j.1523-1739.1998.96379.x; Ochoa-Ochoa LM, 2014, BIOL J LINN SOC, V111, P305, DOI 10.1111/bij.12201; Petchey OL, 2007, J ANIM ECOL, V76, P977, DOI 10.1111/j.1365-2656.2007.01271.x; Piao SL, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002274; Pillar VD, 2013, J VEG SCI, V24, P963, DOI 10.1111/jvs.12047; Qiao S., 2012, EXPT INSTRUCTION SOI; RAO CR, 1982, THEOR POPUL BIOL, V21, P24, DOI 10.1016/0040-5809(82)90004-1; Sala O. E., 1996, Functional roles of biodiversity: a global perspective., P129; Santoro FR, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0119826, DOI 10.1371/J0URNAL.P0NE.0119826]; Schulze E, 1994, BIODIVERSITY ECOSYST; Sternberg M, 2000, J APPL ECOL, V37, P224, DOI 10.1046/j.1365-2664.2000.00491.x; Thibaut LM, 2012, ECOLOGY, V93, P891, DOI 10.1890/11-1753.1; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; WALKER BH, 1992, CONSERV BIOL, V6, P18, DOI 10.1046/j.1523-1739.1992.610018.x; Zhang J.T., 2004, QUANTITATIVE ECOLOGY, V2nd ed.	46	35	40	11	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145605	10.1371/journal.pone.0145605	http://dx.doi.org/10.1371/journal.pone.0145605			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26699133	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092600105
J	Pedrosa, AM; Martins, CDS; Goncalves, LP; Costa, MGC				Pedrosa, Andresa Muniz; Santos Martins, Cristina de Paula; Goncalves, Luana Pereira; Cardoso Costa, Marcio Gilberto			Late Embryogenesis Abundant (LEA) Constitutes a Large and Diverse Family of Proteins Involved in Development and Abiotic Stress Responses in Sweet Orange (Citrus sinensis L. Osb.)	PLOS ONE			English	Article							COTTONSEED EMBRYOGENESIS; DEHYDRATION TOLERANCE; ADAPTIVE RESPONSE; GENE FAMILY; MAIZE DHN1; BINDING; EXPRESSION; DEHYDRIN; REVEALS; DROUGHT	Late Embryogenesis Abundant (LEA) proteins are an ubiquitous group of polypeptides that were first described to accumulate during plant seed dehydration, at the later stages of embryogenesis. Since then they have also been recorded in vegetative plant tissues experiencing water limitation and in anhydrobiotic bacteria and invertebrates and, thereby, correlated with the acquisition of desiccation tolerance. This study provides the first comprehensive study about the LEA gene family in sweet orange (Citrus sinensis L. Osb.), the most important and widely grown fruit crop around the world. A surprisingly high number (72) of genes encoding C. sinensis LEAs (CsLEAs) were identified and classified into seven groups (LEA_1, LEA_2, LEA_3 and LEA_4, LEA_5, DEHYDRIN and SMP) based on their predicted amino acid sequences and also on their phylogenetic relationships with the complete set of Arabidopsis thaliana LEA proteins (AtLEAs). Approximately 60% of the CsLEAs identified in this study belongs to the unusual LEA_2 group of more hydrophobic LEA proteins, while the other LEA groups contained a relatively small number of members typically hydrophilic. A correlation between gene structure and motif composition was observed within each LEA group. Investigation of their chromosomal localizations revealed that the CsLEAs were non-randomly distributed across all nine chromosomes and that 33% of all CsLEAs are segmentally or tandemly duplicated genes. Analysis of the upstream sequences required for transcription revealed the presence of various stress-responsive cis-acting regulatory elements in the promoter regions of CsLEAs, including ABRE, DRE/CRT, MYBS and LTRE. Expression analysis using both RNA-seq data and quantitative real-time RT-PCR (qPCR) revealed that the CsLEA genes are widely expressed in various tissues, and that many genes containing the ABRE promoter sequence are induced by drought, salt and PEG. These results provide a useful reference for further exploration of the CsLEAs functions and applications on crop improvement.	[Pedrosa, Andresa Muniz; Santos Martins, Cristina de Paula; Goncalves, Luana Pereira; Cardoso Costa, Marcio Gilberto] Univ Estadual Santa Cruz, Dept Ciencias Biol, Ctr Biotecnol & Genet, Ilheus, BA, Brazil	Universidade Estadual de Santa Cruz	Costa, MGC (corresponding author), Univ Estadual Santa Cruz, Dept Ciencias Biol, Ctr Biotecnol & Genet, Ilheus, BA, Brazil.	marciogc.costa@gmail.com	martins, cristina/AFV-5571-2022; Costa, Marcio/AAG-3285-2020	Costa, Marcio/0000-0002-4358-5489	CNPq (Brasilia, Brazil); CAPES (Brasilia, Brazil); FAPESP (Sao Paulo, Brazil)	CNPq (Brasilia, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Brasilia, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP (Sao Paulo, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported in part by research grants from CNPq (Brasilia, Brazil), CAPES (Brasilia, Brazil) and FAPESP (Sao Paulo, Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu RC, 2004, PLANT SCI, V166, P855, DOI 10.1016/j.plantsci.2003.11.023; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Cao J, 2015, PLANTA, V241, P757, DOI 10.1007/s00425-014-2215-y; Chakrabortee S, 2007, P NATL ACAD SCI USA, V104, P18073, DOI 10.1073/pnas.0706964104; Charfeddine S, 2015, MOL BIOL REP, V42, P1163, DOI 10.1007/s11033-015-3853-2; Checker VG, 2012, TRANSGENIC RES, V21, P939, DOI 10.1007/s11248-011-9577-8; Covarrubias AA, 2013, FRONT PLANT SCI, P25; Cuming AC, 1999, SEED PROTEINS, P753; de Oliveira TM, 2011, TREE GENET GENOMES, V7, P1123, DOI 10.1007/s11295-011-0400-8; Du DL, 2013, MOL BIOL REP, V40, P1937, DOI 10.1007/s11033-012-2250-3; Duan JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045117; DURE L, 1981, BIOCHEMISTRY-US, V20, P4162, DOI 10.1021/bi00517a033; DURE L, 1981, PLANT PHYSIOL, V68, P187, DOI 10.1104/pp.68.1.187; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gong XQ, 2013, PLANT CELL TISS ORG, V113, P137, DOI 10.1007/s11240-012-0267-x; Goyal K, 2005, BIOCHEM J, V388, P151, DOI 10.1042/BJ20041931; Gu ZL, 2002, MOL BIOL EVOL, V19, P256, DOI 10.1093/oxfordjournals.molbev.a004079; Hanada K, 2008, PLANT PHYSIOL, V148, P993, DOI 10.1104/pp.108.122457; Hara M, 2005, J EXP BOT, V56, P2695, DOI 10.1093/jxb/eri262; Hara M, 2003, PLANTA, V217, P290, DOI 10.1007/s00425-003-0986-7; Hara M, 1999, BIOSCI BIOTECH BIOCH, V63, P433, DOI 10.1271/bbb.63.433; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hundertmark M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-118; Ingram J, 1996, ANNU REV PLANT PHYS, V47, P377, DOI 10.1146/annurev.arplant.47.1.377; Ismail AM, 1999, PLANT PHYSIOL, V120, P237, DOI 10.1104/pp.120.1.237; Jeffares DC, 2008, TRENDS GENET, V24, P375, DOI 10.1016/j.tig.2008.05.006; Kim HS, 2005, GENE, V344, P115, DOI 10.1016/j.gene.2004.09.012; Koag MC, 2003, PLANT PHYSIOL, V131, P309, DOI 10.1104/pp.011171; Koag MC, 2009, PLANT PHYSIOL, V150, P1503, DOI 10.1104/pp.109.136697; Kosova K, 2007, BIOL PLANTARUM, V51, P601, DOI 10.1007/s10535-007-0133-6; Lan T, 2013, TREE GENET GENOMES, V9, P253, DOI 10.1007/s11295-012-0551-2; Li CN, 2015, ENVIRON EXP BOT, V114, P80, DOI 10.1016/j.envexpbot.2014.06.014; Liu GB, 2011, PLANT CELL PHYSIOL, V52, P994, DOI 10.1093/pcp/pcr052; Liu Y, 2013, PLANT CELL PHYSIOL, V54, P944, DOI 10.1093/pcp/pct047; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; Mizoi Junya, 2013, Methods Mol Biol, V956, P269, DOI 10.1007/978-1-62703-194-3_20; NAOT D, 1995, PLANT MOL BIOL, V27, P619, DOI 10.1007/BF00019327; Olvera-Carrillo Y, 2011, PLANT SIGNAL BEHAV, V6, P586, DOI 10.4161/psb.6.4.15042; Olvera-Carrillo Y, 2010, PLANT PHYSIOL, V154, P373, DOI 10.1104/pp.110.158964; Reddy PS, 2012, MOL BIOL REP, V39, P7163, DOI 10.1007/s11033-012-1548-5; Reyes JL, 2005, PLANT CELL ENVIRON, V28, P709, DOI 10.1111/j.1365-3040.2005.01317.x; Reyes JL, 2008, PLANT CELL ENVIRON, V31, P1781, DOI 10.1111/j.1365-3040.2008.01879.x; Rorat T, 2006, CELL MOL BIOL LETT, V11, P536, DOI 10.2478/s11658-006-0044-0; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanchez-Ballesta MT, 2004, J AGR FOOD CHEM, V52, P1950, DOI 10.1021/jf035216+; Shao HB, 2005, COLLOID SURFACE B, V45, P131, DOI 10.1016/j.colsurfb.2005.07.017; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tunnacliffe A, 2007, NATURWISSENSCHAFTEN, V94, P791, DOI 10.1007/s00114-007-0254-y; Umezawa T, 2006, CURR OPIN BIOTECH, V17, P113, DOI 10.1016/j.copbio.2006.02.002; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang J, 2014, COMP BIOCHEM PHYS D, V11, P1, DOI 10.1016/j.cbd.2014.05.001; Wang XS, 2007, PLANT SCI, V172, P414, DOI 10.1016/j.plantsci.2006.10.004; Wu GA, 2014, NAT BIOTECHNOL, V32, P656, DOI 10.1038/nbt.2906; Xu Q, 2013, NAT GENET, V45, P59, DOI 10.1038/ng.2472; Yamaguchi-Shinozaki K, 2005, TRENDS PLANT SCI, V10, P88, DOI 10.1016/j.tplants.2004.12.012	59	64	68	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145785	10.1371/journal.pone.0145785	http://dx.doi.org/10.1371/journal.pone.0145785			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700652	gold, Green Published, Green Submitted			2022-12-26	WOS:000367092600134
J	Zhao, GY; Jiang, YT; Qiu, HJ; Gao, TT; Zeng, Y; Guo, Y; Yu, H; Li, JF; Kou, ZH; Du, LY; Tan, WJ; Jiang, SB; Sun, SH; Zhou, YS				Zhao, Guangyu; Jiang, Yuting; Qiu, Hongjie; Gao, Tongtong; Zeng, Yang; Guo, Yan; Yu, Hong; Li, Junfeng; Kou, Zhihua; Du, Lanying; Tan, Wenjie; Jiang, Shibo; Sun, Shihui; Zhou, Yusen			Multi-Organ Damage in Human Dipeptidyl Peptidase 4 Transgenic Mice Infected with Middle East Respiratory Syndrome-Coronavirus	PLOS ONE			English	Article							MOUSE MODEL; CLINICAL-FEATURES; PATHOGENESIS; RECEPTOR; GENERATION; PNEUMONIA; PATHOLOGY; OUTBREAK; PROTEIN; INNATE	The Middle East Respiratory Syndrome Coronavirus (MERS-CoV) causes severe acute respiratory failure and considerable extrapumonary organ dysfuction with substantial high mortality. For the limited number of autopsy reports, small animal models are urgently needed to study the mechanisms of MERS-CoV infection and pathogenesis of the disease and to evaluate the efficacy of therapeutics against MERS-CoV infection. In this study, we developed a transgenic mouse model globally expressing codon-optimized human dipeptidyl peptidase 4 (hDPP4), the receptor for MERS-CoV. After intranasal inoculation with MERS-CoV, the mice rapidly developed severe pneumonia and multi-organ damage, with viral replication being detected in the lungs on day 5 and in the lungs, kidneys and brains on day 9 post-infection. In addition, the mice exhibited systemic inflammation with mild to severe pneumonia accompanied by the injury of liver, kidney and spleen with neutrophil and macrophage infiltration. Importantly, the mice exhibited symptoms of paralysis with high viral burden and viral positive neurons on day 9. Taken together, this study characterizes the tropism of MERS-CoV upon infection. Importantly, this hDPP4-expressing transgenic mouse model will be applicable for studying the pathogenesis of MERS-CoV infection and investigating the efficacy of vaccines and antiviral agents designed to combat MERS-CoV infection.	[Zhao, Guangyu; Jiang, Yuting; Qiu, Hongjie; Gao, Tongtong; Zeng, Yang; Guo, Yan; Yu, Hong; Li, Junfeng; Kou, Zhihua; Sun, Shihui; Zhou, Yusen] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China; [Du, Lanying; Jiang, Shibo] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10065 USA; [Jiang, Shibo] Fudan Univ, Shanghai Med Coll, Key Lab Med Mol Virol, Minist Educ, Shanghai 200433, Peoples R China; [Jiang, Shibo] Fudan Univ, Shanghai Med Coll, Key Lab Med Mol Virol, Minist Hlth, Shanghai 200433, Peoples R China; [Tan, Wenjie] China CDC, Key Lab Med Virol, Minist Hlth, Natl Inst Viral Dis Control & Prevent, Beijing 102206, Peoples R China	Beijing Institute of Microbiology & Epidemiology; New York Blood Center; Fudan University; Fudan University; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Sun, SH (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.	sunsh01@163.com; yszhou@bmi.ac.cn	Jiang, Shibo/L-4500-2014	Jiang, Shibo/0000-0001-8283-7135	National Project of Infectious Disease [2014ZX10004001004, 2012ZX10004502]; Basic Research 973 Project [2011CB504706]; National Natural Science Foundation of China [81371805]	National Project of Infectious Disease; Basic Research 973 Project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Project of Infectious Disease (2014ZX10004001004, 2012ZX10004502), the Basic Research 973 Project (2011CB504706), and the National Natural Science Foundation of China (81371805). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AS, 2015, J VIROL, V89, P3659, DOI 10.1128/JVI.03427-14; Al-Abdallat MM, 2014, CLIN INFECT DIS, V59, P1225, DOI 10.1093/cid/ciu359; Arabi YM, 2015, INFECTION, V43, P495, DOI 10.1007/s15010-015-0720-y; Arabi YM, 2014, ANN INTERN MED, V160, P389, DOI 10.7326/M13-2486; Arden KE, 2015, VIRUS RES; Assiri A, 2013, LANCET INFECT DIS, V13, P752, DOI 10.1016/S1473-3099(13)70204-4; Assiri A, 2013, NEW ENGL J MED, V369, P407, DOI 10.1056/NEJMoa1306742; Baskin CR, 2009, P NATL ACAD SCI USA, V106, P3455, DOI 10.1073/pnas.0813234106; Boonacker E, 2003, EUR J CELL BIOL, V82, P53, DOI 10.1078/0171-9335-00302; Cameron MJ, 2007, J VIROL, V81, P8692, DOI 10.1128/JVI.00527-07; Cao B, 2013, EXPERT REV ANTI-INFE, V11, P1123, DOI 10.1586/14787210.2013.847787; Coleman CM, 2014, J GEN VIROL, V95, P408, DOI 10.1099/vir.0.060640-0; Corman VM, 2012, EUROSURVEILLANCE, V17, P3; de Wit E, 2013, P NATL ACAD SCI USA, V110, P16598, DOI 10.1073/pnas.1310744110; de Wit E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069127; Drosten C, 2013, LANCET INFECT DIS, V13, P745, DOI 10.1016/S1473-3099(13)70154-3; Du LY, 2014, J VIROL, V88, P7045, DOI 10.1128/JVI.00433-14; Eckerle I, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-359; Falzarano D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004250; Falzarano D, 2013, NAT MED, V19, P1313, DOI 10.1038/nm.3362; Gralinski LE, 2015, J PATHOL, V235, P185, DOI 10.1002/path.4454; Gu J, 2005, J EXP MED, V202, P415, DOI 10.1084/jem.20050828; Gu J, 2007, AM J PATHOL, V170, P1136, DOI 10.2353/ajpath.2007.061088; Guery B, 2013, LANCET, V381, P2265, DOI 10.1016/S0140-6736(13)60982-4; Lau KK, 2004, EMERG INFECT DIS, V10, P342, DOI 10.3201/eid1002.030638; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu XY, 2014, J CLIN MICROBIOL, V52, P67, DOI 10.1128/JCM.02533-13; Memish ZA, 2013, NEW ENGL J MED, V368, P2487, DOI 10.1056/NEJMoa1303729; Pascal KE, 2015, P NATL ACAD SCI USA, V112, P8738, DOI 10.1073/pnas.1510830112; Pollack MP, 2013, INT J INFECT DIS, V17, pE143, DOI 10.1016/j.ijid.2012.12.001; Raj VS, 2014, J VIROL, V88, P1834, DOI 10.1128/JVI.02935-13; Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005; Scobey T, 2013, P NATL ACAD SCI USA, V110, P16157, DOI 10.1073/pnas.1311542110; Sun SH, 2013, AM J RESP CELL MOL, V49, P221, DOI 10.1165/rcmb.2012-0428OC; van den Brand JMA, 2015, J PATHOL, V235, P175, DOI 10.1002/path.4458; van Doremalen N, 2014, J VIROL, V88, P9220, DOI 10.1128/JVI.00676-14; Who Mers-Cov Research Group, 2013, PLoS Curr, V5, DOI 10.1371/currents.outbreaks.0bf719e352e7478f8ad85fa30127ddb8; Wong GWK, 2003, PEDIATR PULM, V36, P261, DOI 10.1002/ppul.10367; Xu J, 2005, CLIN INFECT DIS, V41, P1089, DOI 10.1086/444461; Yamashita M, 2005, BIOCHEM BIOPH RES CO, V334, P79, DOI 10.1016/j.bbrc.2005.06.061; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhao JC, 2014, P NATL ACAD SCI USA, V111, P4970, DOI 10.1073/pnas.1323279111	42	54	56	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145561	10.1371/journal.pone.0145561	http://dx.doi.org/10.1371/journal.pone.0145561			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26701103	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092600096
J	Shin, HC; Ju, DH; Jeon, BS; Choi, O; Kim, HW; Um, Y; Lee, DH; Sang, BI				Shin, Hyun Chul; Ju, Dong-Hun; Jeon, Byoung Seung; Choi, Okkyoung; Kim, Hyun Wook; Um, Youngsoon; Lee, Dong-Hoon; Sang, Byoung-In			Analysis of the Microbial Community in an Acidic Hollow-Fiber Membrane Biofilm Reactor (Hf-MBfR) Used for the Biological Conversion of Carbon Dioxide to Methane	PLOS ONE			English	Article							SP-NOV; METHANOTHERMOBACTER-MARBURGENSIS; HYDROGENOTROPHIC METHANOGENESIS; ANAEROBIC OXIDATION; CONTINUOUS-CULTURE; CATTLE MANURE; SPOROMUSA; PERFORMANCE; BACTERIA; WASTE	Hydrogenotrophic methanogens can use gaseous substrates, such as H-2 and CO2, in CH4 production. H-2 gas is used to reduce CO2. We have successfully operated a hollow-fiber membrane biofilm reactor (Hf-MBfR) for stable and continuous CH4 production from CO2 and H-2. CO2 and H-2 were diffused into the culture medium through the membrane without bubble formation in the Hf-MBfR, which was operated at pH 4.5-5.5 over 70 days. Focusing on the presence of hydrogenotrophic methanogens, we analyzed the structure of the microbial community in the reactor. Denaturing gradient gel electrophoresis (DGGE) was conducted with bacterial and archaeal 16S rDNA primers. Real-time qPCR was used to track changes in the community composition of methanogens over the course of operation. Finally, the microbial community and its diversity at the time of maximum CH4 production were analyzed by pyrosequencing methods. Genus Methanobacterium, related to hydrogenotrophic methanogens, dominated the microbial community, but acetate consumption by bacteria, such as unclassified Clostridium sp., restricted the development of acetoclastic methanogens in the acidic CH4 production process. The results show that acidic operation of a CH4 production reactor without any pH adjustment inhibited acetogenic growth and enriched the hydrogenotrophic methanogens, decreasing the growth of acetoclastic methanogens.	[Shin, Hyun Chul; Ju, Dong-Hun; Um, Youngsoon] Korea Inst Sci & Technol, Clean Energy Res Ctr, Natl Agenda Res Div, Seoul, South Korea; [Shin, Hyun Chul; Kim, Hyun Wook; Lee, Dong-Hoon] Univ Seoul, Dept Environm Engn, Seoul, South Korea; [Jeon, Byoung Seung; Sang, Byoung-In] Hanyang Univ, Dept Chem Engn, Seoul 133791, South Korea; [Choi, Okkyoung] Hanyang Univ, Res Inst Ind Sci, Seoul 133791, South Korea	Korea Institute of Science & Technology (KIST); University of Seoul; Hanyang University; Hanyang University	Choi, O (corresponding author), Hanyang Univ, Res Inst Ind Sci, Seoul 133791, South Korea.	okgii77@hanmail.net; biosang@hanyang.ac.kr	Sang, Byoung-In/T-2817-2017; Kim, Hyunook/C-9316-2012	Sang, Byoung-In/0000-0001-7972-6709; Kim, Hyunook/0000-0003-1256-480X	research fund of Korea Ministry of Environment as "Converging Technology Project" [202-101-006]; Korea Ministry of Environment (MOE) as "Algae monitoring and removed to utilized R&D substantiation Project" [2015001790002]	research fund of Korea Ministry of Environment as "Converging Technology Project"; Korea Ministry of Environment (MOE) as "Algae monitoring and removed to utilized R&D substantiation Project"	This work was supported by the research fund of Korea Ministry of Environment as "Converging Technology Project (202-101-006)"; Korea Ministry of Environment (MOE) as "Algae monitoring and removed to utilized R&D substantiation Project (2015001790002)".	Ahmadian A, 2006, CLIN CHIM ACTA, V363, P83, DOI 10.1016/j.cccn.2005.04.038; Ahring BK, 2001, WATER RES, V35, P2446, DOI 10.1016/S0043-1354(00)00526-1; Baker RW, 2008, IND ENG CHEM RES, V47, P2109, DOI 10.1021/ie071083w; BREZNAK JA, 1988, ARCH MICROBIOL, V150, P282, DOI 10.1007/BF00407793; CHARTRAIN M, 1986, APPL ENVIRON MICROB, V51, P180, DOI 10.1128/AEM.51.1.180-187.1986; Chen CL, 2008, WATER RES, V42, P1963, DOI 10.1016/j.watres.2007.11.037; Cuzin N, 2001, INT J SYST EVOL MICR, V51, P489, DOI 10.1099/00207713-51-2-489; DEHNING I, 1989, ARCH MICROBIOL, V151, P421, DOI 10.1007/BF00416601; Dollhopf SL, 2001, APPL MICROBIOL BIOT, V56, P531, DOI 10.1007/s002530100612; FERRY JG, 1974, INT J SYST BACTERIOL, V24, P465, DOI 10.1099/00207713-24-4-465; Goevert D, 2009, APPL ENVIRON MICROB, V75, P2605, DOI 10.1128/AEM.02680-08; Haroon MF, 2013, NATURE, V500, P567, DOI 10.1038/nature12375; HERMANN M, 1987, INT J SYST BACTERIOL, V37, P93, DOI 10.1099/00207713-37-2-93; Horn MA, 2003, APPL ENVIRON MICROB, V69, P74, DOI 10.1128/AEM.69.1.74-83.2003; Huang WH, 2015, CHEMOSPHERE, V140, P40, DOI 10.1016/j.chemosphere.2014.10.047; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Hwang K, 2008, APPL MICROBIOL BIOT, V80, P269, DOI 10.1007/s00253-008-1544-9; Joulian C, 1998, FEMS MICROBIOL ECOL, V25, P135, DOI 10.1016/S0168-6496(97)00090-1; Ju DH, 2008, DESALINATION, V234, P409, DOI 10.1016/j.desal.2007.09.111; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Kim S, 2014, PROCESS BIOCHEM, V49, P301, DOI 10.1016/j.procbio.2013.10.022; Kotelnikova S, 1998, INT J SYST BACTERIOL, V48, P357, DOI 10.1099/00207713-48-2-357; Kotsyurbenko OR, 2007, APPL ENVIRON MICROB, V73, P2344, DOI 10.1128/AEM.02413-06; Lebuhn M, 2003, WATER SCI TECHNOL, V48, P97, DOI 10.2166/wst.2003.0230; Lee S, 2015, BIOSCI BIOTECH BIOCH, V79, P1378, DOI 10.1080/09168451.2015.1018122; Liu YC, 2008, ANN NY ACAD SCI, V1125, P171, DOI 10.1196/annals.1419.019; Ma K, 2005, INT J SYST EVOL MICR, V55, P325, DOI 10.1099/ijs.0.63254-0; McKeown RM, 2009, ISME J, V3, P1231, DOI 10.1038/ismej.2009.67; MOLLER B, 1984, ARCH MICROBIOL, V139, P388, DOI 10.1007/BF00408385; Nandi R, 1998, CRIT REV MICROBIOL, V24, P61, DOI 10.1080/10408419891294181; NISHIMURA N, 1992, J FERMENT BIOENG, V73, P477, DOI 10.1016/0922-338X(92)90141-G; Ondov BD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-385; Pap B, 2015, BIORESOURCE TECHNOL, V177, P375, DOI 10.1016/j.biortech.2014.11.021; PATEL GB, 1990, INT J SYST BACTERIOL, V40, P79, DOI 10.1099/00207713-40-1-79; Pope PB, 2013, 3 BIOTECH, V3, P407, DOI 10.1007/s13205-012-0097-x; Rittmann S, 2012, BIOMASS BIOENERG, V36, P293, DOI 10.1016/j.biombioe.2011.10.038; Rittmann S, 2015, CRIT REV BIOTECHNOL, V35, P141, DOI 10.3109/07388551.2013.820685; Sakai S, 2009, APPL ENVIRON MICROB, V75, P4892, DOI 10.1128/AEM.02835-08; Scherer PA, 2000, WATER SCI TECHNOL, V41, P83, DOI 10.2166/wst.2000.0059; Seifert AH, 2014, APPL ENERG, V132, P155, DOI 10.1016/j.apenergy.2014.07.002; Seifert AH, 2013, BIORESOURCE TECHNOL, V136, P747, DOI 10.1016/j.biortech.2013.03.119; Smalla K, 2007, J MICROBIOL METH, V69, P470, DOI 10.1016/j.mimet.2007.02.014; Smith JM, 2007, APPL ENVIRON MICROB, V73, P4135, DOI 10.1128/AEM.02557-06; Thauer RK, 2008, NAT REV MICROBIOL, V6, P579, DOI 10.1038/nrmicro1931; Thauer RK, 2011, CURR OPIN MICROBIOL, V14, P292, DOI 10.1016/j.mib.2011.03.003; Tost J, 2007, NAT PROTOC, V2, P2265, DOI 10.1038/nprot.2007.314; White D, 2000, PHYSL BIOCH PROKARYO; Xu H, 2015, ENVIRON TECHNOL, V36, P529, DOI 10.1080/09593330.2014.979886; Yamada T, 2006, INT J SYST EVOL MICR, V56, P1331, DOI 10.1099/ijs.0.64169-0; ZEHNDER AJB, 1979, J BACTERIOL, V137, P420, DOI 10.1128/JB.137.1.420-432.1979	50	4	4	4	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0144999	10.1371/journal.pone.0144999	http://dx.doi.org/10.1371/journal.pone.0144999			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26694756	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092500019
J	Martinez-Skinner, AL; Arainga, MA; Puligujja, P; Palandri, DL; Baldridge, HM; Edagwa, BJ; McMillan, JM; Mosley, RL; Gendelman, HE				Martinez-Skinner, Andrea L.; Arainga, Mariluz A.; Puligujja, Pavan; Palandri, Diana L.; Baldridge, Hannah M.; Edagwa, Benson J.; McMillan, JoEllyn M.; Mosley, R. Lee; Gendelman, Howard E.			Cellular Responses and Tissue Depots for Nanoformulated Antiretroviral Therapy	PLOS ONE			English	Article							HIV-1-INFECTED HUMANIZED MICE; MONOCYTE-DERIVED MACROPHAGES; DRUG-DELIVERY; HIV-1 INFECTION; IN-VIVO; SUBCAPSULAR SINUS; LYMPH-NODE; NANOPARTICLES; PHARMACOKINETICS; PHARMACODYNAMICS	Long-acting nanoformulated antiretroviral therapy (nanoART) induces a range of innate immune migratory, phagocytic and secretory cell functions that perpetuate drug depots. While recycling endosomes serve as the macrophage subcellular depots, little is known of the dynamics of nanoART-cell interactions. To this end, we assessed temporal leukocyte responses, drug uptake and distribution following both intraperitoneal and intramuscular injection of nanoformulated atazanavir (nanoATV). Local inflammatory responses heralded drug distribution to peritoneal cell populations, regional lymph nodes, spleen and liver. This proceeded for three days in male Balb/c mice. NanoATV-induced changes in myeloid populations were assessed by fluorescence-activated cell sorting (FACS) with CD45, CD3, CD11b, F4180, and GR-1 antibodies. The localization of nanoATV within leukocyte cell subsets was determined by confocal microscopy. Combined FACS and ultra-performance liquid chromatography tandem mass-spectrometry assays determined nanoATV carriages by cell-based vehicles. A robust granulocyte, but not peritoneal macrophage nanoATV response paralleled zymosan A treatment. ATV levels were highest at sites of injection in peritoneal or muscle macrophages, dependent on the injection site. The spleen and liver served as nanoATV tissue depots while drug levels in lymph nodes were higher than those recorded in plasma. Dual polymer and cell labeling demonstrated a nearly exclusive drug reservoir in macrophages within the liver and spleen. Overall, nanoART induces innate immune responses coincident with rapid tissue macrophage distribution. Taken together, these works provide avenues for therapeutic development designed towards chemical eradication of human immunodeficiency viral infection.	[Martinez-Skinner, Andrea L.; Arainga, Mariluz A.; Puligujja, Pavan; Palandri, Diana L.; Baldridge, Hannah M.; Edagwa, Benson J.; McMillan, JoEllyn M.; Mosley, R. Lee; Gendelman, Howard E.] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA; [Gendelman, Howard E.] Univ Nebraska Med Ctr, Dept Internal Med, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	McMillan, JM (corresponding author), Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA.	jmmcmillan@unmc.edu			University of Nebraska Foundation; Vice Chancellor's office of the University of Nebraska Medical Center; ViiV Healthcare; National Institutes of Health [P01 DA028555, R01 NS36126, P01 NS31492, 2R01 NS034239, P01 MH64570, P01 NS43985, P30 MH062261, R01 AG043540]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062261, P01MH064570] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS031492, R01NS034239, P01NS043985, R01NS036126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG043540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA028555] Funding Source: NIH RePORTER	University of Nebraska Foundation; Vice Chancellor's office of the University of Nebraska Medical Center; ViiV Healthcare; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the University of Nebraska Foundation (https://nufoundation.org) which includes individual donations from Carol Swarts and Frances and Louie Blumkin; the Vice Chancellor's office of the University of Nebraska Medical Center; ViiV Healthcare; and National Institutes of Health grants P01 DA028555, R01 NS36126, P01 NS31492, 2R01 NS034239, P01 MH64570, P01 NS43985, P30 MH062261 and R01 AG043540.	Adams JL, 2012, CURR OPIN HIV AIDS, V7, P390, DOI 10.1097/COH.0b013e328356e91c; Alexaki A, 2008, CURR HIV RES, V6, P388, DOI 10.2174/157016208785861195; Allers K, 2014, J INFECT DIS, V209, P739, DOI 10.1093/infdis/jit547; [Anonymous], 2003, Proj Inf Perspect, P7; Azzam R, 2006, JAIDS-J ACQ IMM DEF, V42, P19; Balkundi S, 2011, INT J NANOMED, V6, P3393, DOI 10.2147/IJN.S27830; Balkundi Shantanu, 2010, J Vis Exp, DOI 10.3791/2460; Bannenberg GL, 2005, J IMMUNOL, V174, P4345, DOI 10.4049/jimmunol.174.7.4345; Bogdan C, 2008, CELL MICROBIOL, V10, P1221, DOI 10.1111/j.1462-5822.2008.01146.x; Ghosn EEB, 2010, P NATL ACAD SCI USA, V107, P2568, DOI 10.1073/pnas.0915000107; Bressani RF, 2011, NANOTOXICOLOGY, V5, P592, DOI 10.3109/17435390.2010.541292; Carter CA, 2008, ANNU REV MICROBIOL, V62, P425, DOI 10.1146/annurev.micro.62.081307.162758; Cash JL, 2009, METHOD ENZYMOL, V461, P379, DOI 10.1016/S0076-6879(09)05417-2; Chen RY, 2002, AIDS RES HUM RETROV, V18, P909, DOI 10.1089/088922202760265588; Chulamokha L, 2005, J NEUROVIROL, V11, P76, DOI 10.1080/13550280590931270; Dash PK, 2012, AIDS, V26, P2135, DOI 10.1097/QAD.0b013e328357f5ad; Dou HY, 2007, VIROLOGY, V358, P148, DOI 10.1016/j.virol.2006.08.012; Dou H, 2006, BLOOD, V108, P2827, DOI 10.1182/blood-2006-03-012534; Dou HY, 2009, J IMMUNOL, V183, P661, DOI 10.4049/jimmunol.0900274; Edagwa BJ, 2014, FASEB J, V28, P5071, DOI 10.1096/fj.14-255786; Edagwa BJ, 2014, CURR MED CHEM, V21, P4186, DOI 10.2174/0929867321666140826114135; Fellay J, 2001, LANCET, V358, P1322, DOI 10.1016/S0140-6736(01)06413-3; Fujiwara M, 1996, BBA-BIOMEMBRANES, V1278, P59, DOI 10.1016/0005-2736(95)00183-2; Gautam N, 2014, ANTIMICROB AGENTS CH, V58, P7510, DOI 10.1128/AAC.04108-14; Gautam N, 2013, ANTIMICROB AGENTS CH, V57, P3110, DOI 10.1128/AAC.00267-13; Gent YYJ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4191; Gordon S, 2014, IMMUNOL REV, V262, P36, DOI 10.1111/imr.12223; Hawkins T, 2006, AIDS PATIENT CARE ST, V20, P6, DOI 10.1089/apc.2006.20.6; Huang JG, 2011, J CHROMATOGR B, V879, P2332, DOI 10.1016/j.jchromb.2011.06.032; Kadiu I, 2011, J NEUROIMMUNE PHARM, V6, P658, DOI 10.1007/s11481-011-9298-z; Kadiu I, 2011, NANOMEDICINE-UK, V6, P975, DOI [10.2217/NNM.11.27, 10.2217/nnm.11.27]; Kamaly N, 2013, P NATL ACAD SCI USA, V110, P6506, DOI 10.1073/pnas.1303377110; Kanmogne GD, 2012, INT J NANOMED, V7, P2373, DOI 10.2147/IJN.S29454; Kovarova M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005075; Lieberman-Blum SS, 2008, CLIN THER, V30, P1228, DOI 10.1016/S0149-2918(08)80048-3; Lu J, 2012, NANOMED-NANOTECHNOL, V8, P212, DOI 10.1016/j.nano.2011.06.002; Martinez-Skinner AL, 2013, J PROTEOME RES, V12, P2282, DOI 10.1021/pr400185w; Nowacek A, 2009, NANOMEDICINE-UK, V4, P557, DOI 10.2217/nnm.09.38; Nowacek AS, 2011, J CONTROL RELEASE, V150, P204, DOI 10.1016/j.jconrel.2010.11.019; Nowacek AS, 2010, J NEUROIMMUNE PHARM, V5, P592, DOI 10.1007/s11481-010-9198-7; Nowacek AS, 2009, NANOMEDICINE-UK, V4, P903, DOI [10.2217/nnm.09.71, 10.2217/NNM.09.71]; Nukolova NV, 2011, BIOMATERIALS, V32, P5417, DOI 10.1016/j.biomaterials.2011.04.006; Orenstein JM, 2007, ULTRASTRUCT PATHOL, V31, P151, DOI 10.1080/01913120701344343; Parboosing R, 2012, VIRUSES-BASEL, V4, P488, DOI 10.3390/v4040488; Puligujja P, 2015, ANTIVIR RES, V120, P85, DOI 10.1016/j.antiviral.2015.05.009; Puligujja P, 2015, BIOMATERIALS, V41, P141, DOI 10.1016/j.biomaterials.2014.11.012; Puligujja P, 2013, NANOMED-NANOTECHNOL, V9, P1263, DOI 10.1016/j.nano.2013.05.003; Raposo G, 2002, TRAFFIC, V3, P718, DOI 10.1034/j.1600-0854.2002.31004.x; Ray Avijit, 2010, J Vis Exp, DOI 10.3791/1488; Roy U, 2012, J INFECT DIS, V206, P1577, DOI 10.1093/infdis/jis395; SAINTEMARIE G, 1985, CELL TISSUE RES, V239, P31, DOI 10.1007/BF00214899; Shehu-Xhilaga M, 2005, CURR MED CHEM, V12, P1705, DOI 10.2174/0929867054367211; Spreen W, 2014, JAIDS-J ACQ IMM DEF, V67, P481, DOI 10.1097/QAI.0000000000000301; Strauss-Ayali D, 2007, J LEUKOCYTE BIOL, V82, P244, DOI 10.1189/jlb.0307191; SZAKAL AK, 1983, J IMMUNOL, V131, P1714; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Walmsley SL, 2013, NEW ENGL J MED, V369, P1807, DOI 10.1056/NEJMoa1215541; Wang X, 2009, ACS NANO, V3, P3165, DOI 10.1021/nn900649v; Wegzyn CM, 2012, CURR OPIN PHARMACOL, V12, P556, DOI 10.1016/j.coph.2012.06.005; Zhao YL, 2011, NANOMEDICINE-UK, V6, P25, DOI [10.2217/nnm.10.129, 10.2217/NNM.10.129]	60	9	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145966	10.1371/journal.pone.0145966	http://dx.doi.org/10.1371/journal.pone.0145966			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716700	gold, Green Submitted, Green Published			2022-12-26	WOS:000367510500104
J	He, J; Zhu, JJ; Gong, CG; Qi, JM; Xiao, H; Jiang, B; Zhao, YL				He, Jing; Zhu, Jianjun; Gong, Changguo; Qi, Jiming; Xiao, Han; Jiang, Bin; Zhao, Yulan			Label-Free Direct Detection of miRNAs with Poly-Silicon Nanowire Biosensors	PLOS ONE			English	Article							FIELD-EFFECT TRANSISTOR; SILICON NANOWIRES; MICRORNAS; EXPRESSION; CANCER; BIOMARKERS; DNA	Background The diagnostic and prognostic value of microRNAs (miRNAs) in a variety of diseases is promising. The novel silicon nanowire (SiNW) biosensors have advantages in molecular detection because of their high sensitivity and fast response. In this study, poly-crystalline silicon nanowire field-effect transistor (poly-SiNW FET) device was developed to achieve specific and ultrasensitive detection of miRNAs without labeling and amplification. Methods The poly-SiNW FET was fabricated by a top-down Complementary Metal Oxide Semiconductor (CMOS) wafer fabrication based technique. Single strand DNA (ssDNA) probe was bind to the surface of the poly-SiNW device which was silanated and aldehyde-modified. By comparing the difference of resistance value before and after ssDNA and miRNA hybridization, poly-SiNW device can be used to detect standard and real miRNA samples. Results Poly-SiNW device with different structures (different line width and different pitch) was applied to detect standard Let-7b sample with a detection limitation of 1 fM. One-base mismatched sequence could be distinguished meanwhile. Furthermore, these poly-SiNW arrays can detect snRNA U6 in total RNA samples extracted from HepG2 cells with a detection limitation of 0.2 mu g/mL. In general, structures with pitch showed better results than those without pitch in detection of both Let-7b and snRNA U6. Moreover, structures with smaller pitch showed better detection efficacy. Conclusion Our findings suggest that poly-SiNW arrays could detect standard and real miRNA sample without labeling or amplification. Poly-SiNW biosensor device is promising for miRNA detection.	[He, Jing; Gong, Changguo; Zhao, Yulan] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China; [Zhu, Jianjun; Qi, Jiming; Jiang, Bin] Shanghai Integrated Circuit Res & Dev Ctr, Shanghai, Peoples R China; [He, Jing] Zhejiang Univ, Ocean Res Ctr Zhoushan, Hangzhou, Zhejiang, Peoples R China; [Xiao, Han] Wuhan Med & Hlth Ctr Women & Children, Wuhan, Hubei, Peoples R China	East China Normal University; Zhejiang University	Jiang, B (corresponding author), Shanghai Integrated Circuit Res & Dev Ctr, Shanghai, Peoples R China.	bjiang@icrd.com.cn; ylzhao@imet.ecnu.edu.cn			National Natural Science Foundation of China [NSFC 30800401, 81201604]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (NSFC 30800401 and 81201604, http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brase JC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-306; Bunimovich YL, 2006, J AM CHEM SOC, V128, P16323, DOI 10.1021/ja065923u; Chen XY, 2014, CLIN CANCER RES, V20, P2617, DOI 10.1158/1078-0432.CCR-13-3224; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Creighton CJ, 2009, BRIEF BIOINFORM, V10, P490, DOI 10.1093/bib/bbp019; de Planell-Saguer M, 2013, CLIN BIOCHEM, V46, P869, DOI 10.1016/j.clinbiochem.2013.02.017; Dorvel BR, 2012, ACS NANO, V6, P6150, DOI 10.1021/nn301495k; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gao AR, 2012, NANO LETT, V12, P5262, DOI 10.1021/nl302476h; Guo DG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091354; Huber F, 2013, NAT NANOTECHNOL, V8, P125, DOI [10.1038/nnano.2012.263, 10.1038/NNANO.2012.263]; Ingebrandt S, 2011, ECS TRANSACTIONS, V35, P3, DOI 10.1149/1.3571972; Jiang JM, 2005, NUCLEIC ACIDS RES, V33, P5394, DOI 10.1093/nar/gki863; Johnson BN, 2014, ANALYST, V139, P1576, DOI 10.1039/c3an01677c; Lin CH, 2009, BIOSENS BIOELECTRON, V24, P3019, DOI 10.1016/j.bios.2009.03.014; Liu CG, 2008, NAT PROTOC, V3, P563, DOI 10.1038/nprot.2008.14; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Ramnani P, 2013, ANAL CHEM, V85, P8061, DOI 10.1021/ac4018346; Schmittgen TD, 2008, METHODS, V44, P31, DOI 10.1016/j.ymeth.2007.09.006; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Valoczi A, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh171; Yao Xiaozhen, 2012, Methods Mol Biol, V883, P143, DOI 10.1007/978-1-61779-839-9_11; Zhang GJ, 2011, METHODS MOL BIOL, V676, P111, DOI 10.1007/978-1-60761-863-8_9; Zhang GJ, 2009, BIOSENS BIOELECTRON, V24, P2504, DOI 10.1016/j.bios.2008.12.035	25	9	11	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145160	10.1371/journal.pone.0145160	http://dx.doi.org/10.1371/journal.pone.0145160			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709827	Green Submitted, Green Published, gold			2022-12-26	WOS:000367451400023
J	Wullink, B; Pas, HH; Van der Worp, RJ; Kuijer, R; Los, LI				Wullink, Bart; Pas, Hendri H.; Van der Worp, Roelofje J.; Kuijer, Roel; Los, Leonoor I.			Type VII Collagen Expression in the Human Vitreoretinal Interface, Corpora Amylacea and Inner Retinal Layers	PLOS ONE			English	Article							DERMAL-EPIDERMAL JUNCTION; ANCHORING FIBRILS; BASEMENT-MEMBRANE; IN-VITRO; EPIRETINAL MEMBRANES; CONNECTIVE-TISSUE; BASAL LAMINA; OPTIC-NERVE; COMPONENTS; CELLS	Type VII collagen, as a major component of anchoring fibrils found at basement membrane zones, is crucial in anchoring epithelial tissue layers to their underlying stroma. Recently, type VII collagen was discovered in the inner human retina by means of immunohistochemistry, while proteomic investigations demonstrated type VII collagen at the vitreoretinal interface of chicken. Because of its potential anchoring function at the vitreoretinal interface, we further assessed the presence of type VII collagen at this site. We evaluated the vitreoretinal interface of human donor eyes by means of immunohistochemistry, confocal microscopy, immunoelectron microscopy, and Western blotting. Firstly, type VII collagen was detected alongside vitreous fibers6 at the vitreoretinal interface. Because of its known anchoring function, it is likely that type VII collagen is involved in vitreoretinal attachment. Secondly, type VII collagen was found within cytoplasmic vesicles of inner retinal cells. These cells resided most frequently in the ganglion cell layer and inner plexiform layer. Thirdly, type VII collagen was found in astrocytic cytoplasmic inclusions, known as corpora amylacea. The intraretinal presence of type VII collagen was confirmed by Western blotting of homogenized retinal preparations. These data add to the understanding of vitreoretinal attachment, which is important for a better comprehension of common vitreoretinal attachment pathologies.	[Wullink, Bart; Van der Worp, Roelofje J.; Los, Leonoor I.] Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands; [Wullink, Bart; Van der Worp, Roelofje J.; Kuijer, Roel; Los, Leonoor I.] Univ Groningen, Univ Med Ctr Groningen, Grad Sch Med Sci, WJ Kolff Inst, Groningen, Netherlands; [Pas, Hendri H.] Univ Groningen, Univ Med Ctr Groningen, Dept Dermatol, Groningen, Netherlands; [Van der Worp, Roelofje J.; Kuijer, Roel] Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Engn, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	Wullink, B (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands.	b.wullink@umcg.nl	Pas, Hendri H/G-9749-2011; Kuijer, Roel/A-6690-2015	Pas, Hendri H/0000-0001-8823-2591; Wullink, Bart/0000-0001-5047-3939; Kuijer, Roel/0000-0002-7637-4944				BACHINGER HP, 1990, J BIOL CHEM, V265, P10095; BAKER KS, 1993, INVEST OPHTH VIS SCI, V34, P137; Balasubramani M, 2010, MATRIX BIOL, V29, P471, DOI 10.1016/j.matbio.2010.04.002; BRIGGAMAN RA, 1971, J CELL BIOL, V51, P384, DOI 10.1083/jcb.51.2.384; BRODY I, 1959, J ULTRA MOL STRUCT R, V2, P482, DOI 10.1016/S0022-5320(59)90007-3; Bruckner Tuderman L, 1987, EUR J BIOCHEM, V165, P607; Bu SC, 2014, RETINA-J RET VIT DIS, V34, P897, DOI 10.1097/IAE.0000000000000013; GIPSON IK, 1987, INVEST OPHTH VIS SCI, V28, P212; GIPSON IK, 1988, DEV BIOL, V126, P253, DOI 10.1016/0012-1606(88)90136-4; Johnson MW, 2013, AM J OPHTHALMOL, V155, P203, DOI 10.1016/j.ajo.2012.10.016; KAHL FR, 1967, J INVEST DERMATOL, V49, P616, DOI 10.1038/jid.1967.189; Kaur C, 2007, J PATHOL, V212, P429, DOI 10.1002/path.2195; KAWANAMI O, 1978, AM J PATHOL, V92, P389; KEENE DR, 1987, J CELL BIOL, V104, P611, DOI 10.1083/jcb.104.3.611; Kenyon K R, 1979, Int Ophthalmol Clin, V19, P169; KONIG A, 1991, J INVEST DERMATOL, V96, P803, DOI 10.1111/1523-1747.ep12474424; KUBOTA T, 1993, GRAEF ARCH CLIN EXP, V231, P249, DOI 10.1007/BF00919099; KUBOTA T, 1993, GRAEF ARCH CLIN EXP, V231, P7, DOI 10.1007/BF01681693; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAGUENS R, 1972, J ULTRA MOL STRUCT R, V41, P202, DOI 10.1016/S0022-5320(72)90064-0; LEIGH IM, 1987, EPITHELIA, V1, P17; McMillan JR, 2003, J DERMATOL SCI, V31, P169, DOI 10.1016/S0923-1811(03)00045-8; Meng H, 2009, NEUROPATHOLOGY, V29, P664, DOI 10.1111/j.1440-1789.2009.01024.x; Oberstein SYL, 2008, BRIT J OPHTHALMOL, V92, P981, DOI 10.1136/bjo.2007.132332; Ockleford CD, 2013, PLACENTA, V34, P727, DOI 10.1016/j.placenta.2013.06.002; PALADE GE, 1965, J CELL BIOL, V27, P215, DOI 10.1083/jcb.27.1.215; Pas HH, 1997, J INVEST DERMATOL, V108, P423, DOI 10.1111/1523-1747.ep12289703; PAULUS W, 1995, VIRCHOWS ARCH, V426, P199; Ponsioen TL, 2008, INVEST OPHTH VIS SCI, V49, P4089, DOI 10.1167/iovs.07-1456; Ponsioen TL, 2008, MOL VIS, V14, P652; Purkinje J, 1906, VIRCHOWS ARCH PATHOL, V184, P454; RAMIREZ JM, 1994, VISION RES, V34, P1935, DOI 10.1016/0042-6989(94)90024-8; ROBITAILLE Y, 1980, BRAIN, V103, P315, DOI 10.1093/brain/103.2.315; SAKAI LY, 1986, J CELL BIOL, V103, P1577, DOI 10.1083/jcb.103.4.1577; Selmaj K, 2008, ACTA BIOCHIM POL, V55, P43, DOI 10.18388/abp.2008_3199; SINGHRAO SK, 1993, NEUROPATH APPL NEURO, V19, P269, DOI 10.1111/j.1365-2990.1993.tb00437.x; SINGHRAO SK, 1995, NEURODEGENERATION, V4, P335, DOI 10.1016/1055-8330(95)90024-1; SINGHRAO SK, 1994, NEUROPATH APPL NEURO, V20, P66, DOI 10.1111/j.1365-2990.1994.tb00958.x; SMITH LT, 1988, J INVEST DERMATOL, V90, P480, DOI 10.1111/1523-1747.ep12460951; Song W, 2014, EXP NEUROL, V254, P78, DOI 10.1016/j.expneurol.2014.01.006; STEELE HD, 1952, AMA ARCH PATHOL, V54, P94; TIDMAN MJ, 1984, J INVEST DERMATOL, V83, P448, DOI 10.1111/1523-1747.ep12273562; TISDALE AS, 1988, INVEST OPHTH VIS SCI, V29, P727; Trivino A, 2000, J ANAT, V196, P61, DOI 10.1046/j.1469-7580.2000.19610061.x; Tuori A, 1996, CORNEA, V15, P286, DOI 10.1097/00003226-199605000-00010; Villone D, 2008, J BIOL CHEM, V283, P24506, DOI 10.1074/jbc.M802415200; WASANO K, 1985, CELL TISSUE RES, V239, P485; WETZELS RHW, 1991, AM J PATHOL, V139, P451; WOODFORD B, 1980, AM J OPHTHALMOL, V90, P492, DOI 10.1016/S0002-9394(14)75018-4; WOODLEY DT, 1988, J CLIN INVEST, V81, P683, DOI 10.1172/JCI113373	50	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145502	10.1371/journal.pone.0145502	http://dx.doi.org/10.1371/journal.pone.0145502			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709927	Green Submitted, Green Published, gold			2022-12-26	WOS:000367451400056
J	Lerario, MP; Gialdini, G; Lapidus, DM; Shaw, MM; Navi, BB; Merkler, AE; Lip, GYH; Healey, JS; Kamel, H				Lerario, Michael P.; Gialdini, Gino; Lapidus, Daniel M.; Shaw, Mesha M.; Navi, Babak B.; Merkler, Alexander E.; Lip, Gregory Y. H.; Healey, Jeff S.; Kamel, Hooman			Risk of Ischemic Stroke after Intracranial Hemorrhage in Patients with Atrial Fibrillation	PLOS ONE			English	Article							INTRACEREBRAL HEMORRHAGE; ANTICOAGULATION; WARFARIN; DISCONTINUATION; THROMBOEMBOLISM; RESUMPTION; PROGNOSIS; SAFETY; IMPACT	Background We aimed to estimate the risk of ischemic stroke after intracranial hemorrhage in patients with atrial fibrillation. Materials and Methods Using discharge data from all nonfederal acute care hospitals and emergency departments in California, Florida, and New York from 2005 to 2012, we identified patients at the time of a first-recorded encounter with a diagnosis of atrial fibrillation. Ischemic stroke and intracranial hemorrhage were identified using validated diagnosis codes. Kaplan-Meier survival statistics and Cox proportional hazard analyses were used to evaluate cumulative rates of ischemic stroke and the relationship between incident intracranial hemorrhage and subsequent stroke. Results Among 2,084,735 patients with atrial fibrillation, 50,468 (2.4%) developed intracranial hemorrhage and 89,594 (4.3%) developed ischemic stroke during a mean follow-up period of 3.2 years. The 1-year cumulative rate of stroke was 8.1% (95% CI, 7.5-8.7%) after intracerebral hemorrhage, 3.9% (95% CI, 3.5-4.3%) after subdural hemorrhage, and 2.0% (95% CI, 2.0-2.1%) in those without intracranial hemorrhage. After adjustment for the CHA(2)DS(2)-VASc score, stroke risk was elevated after both intracerebral hemorrhage (hazard ratio [HR], 2.8; 95% CI, 2.6-2.9) and subdural hemorrhage (HR, 1.6; 95% CI, 1.5-1.7). Cumulative 1-year rates of stroke ranged from 0.9% in those with subdural hemorrhage and a CHA(2)DS(2)-VASc score of 0, to 33.3% in those with intracerebral hemorrhage and a CHA(2)DS(2)-VASc score of 9. Conclusions In a large, heterogeneous cohort, patients with atrial fibrillation faced a substantially heightened risk of ischemic stroke after intracranial hemorrhage. The risk was most marked in those with intracerebral hemorrhage and high CHA(2)DS(2)-VASc scores.	[Lerario, Michael P.; Lapidus, Daniel M.; Shaw, Mesha M.; Navi, Babak B.; Merkler, Alexander E.; Kamel, Hooman] Weill Cornell Med Coll, Dept Neurol, New York, NY 10021 USA; [Gialdini, Gino; Navi, Babak B.; Kamel, Hooman] Weill Cornell Med Coll, Feil Family Brain & Mind Res Inst, New York, NY USA; [Lip, Gregory Y. H.] Univ Birmingham, Ctr Cardiovasc Sci, Birmingham, W Midlands, England; [Lip, Gregory Y. H.] Aalborg Univ, Thrombosis Res Unit, Aalborg, Denmark; [Healey, Jeff S.] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada	Cornell University; Cornell University; University of Birmingham; Aalborg University; McMaster University; Population Health Research Institute	Lerario, MP (corresponding author), Weill Cornell Med Coll, Dept Neurol, New York, NY 10021 USA.	mpl9005@med.cornell.edu	Kamel, Hooman/AGG-9071-2022; Lerario, Mackenzie P/ABB-4338-2021; Lerario, Mackenzie/ABC-3517-2021	Lerario, Mackenzie/0000-0003-0806-9670; Navi, Babak/0000-0001-8424-6128	National Institute of Neurological Disorders and Stroke [K23NS082367]; Michael Goldberg Stroke Research Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS082367] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Michael Goldberg Stroke Research Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grant K23NS082367 from the National Institute of Neurological Disorders and Stroke and a grant from the Michael Goldberg Stroke Research Fund (HK). The sponsors had no role in the design of the study, the collection and analysis of the data, the preparation of the manuscript, or the decision to publish.	Agency for Healthcare Research and Quality, HCUP METH SER METH I; Aguilar MI, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006186.pub2; Broderick JP, 2011, STROKE, V42, P2509, DOI 10.1161/STROKEAHA.110.611905; Connolly SJ, 2011, NEW ENGL J MED, V364, P806, DOI 10.1056/NEJMoa1007432; Dowlatshahi D, 2012, STROKE, V43, P1812, DOI 10.1161/STROKEAHA.112.652065; Eckman MH, 2003, STROKE, V34, P1710, DOI 10.1161/01.STR.0000078311.18928.16; Goldstein JN, 2009, NEUROCRIT CARE, V10, P28, DOI 10.1007/s12028-008-9134-3; Jung HS, 2014, J KOREAN NEUROSURG S, V55, P69, DOI 10.3340/jkns.2014.55.2.69; Kuramatsu JB, 2015, JAMA-J AM MED ASSOC, V313, P824, DOI 10.1001/jama.2015.0846; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Majeed A, 2010, STROKE, V41, P2860, DOI 10.1161/STROKEAHA.110.593087; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Nielsen PB, 2015, CIRCULATION, V132, P517, DOI 10.1161/CIRCULATIONAHA.115.015735; Nielsen PB, 2015, CHEST, V147, P1651, DOI 10.1378/chest.14-2099; Pennlert J, 2015, STROKE, V46, P2094, DOI 10.1161/STROKEAHA.115.009087; Phan TG, 2000, ARCH NEUROL-CHICAGO, V57, P1710, DOI 10.1001/archneur.57.12.1710; Poon MTC, 2014, J NEUROL NEUROSUR PS, V85, P660, DOI 10.1136/jnnp-2013-306476; Reddy VY, 2014, JAMA-J AM MED ASSOC, V312, P1988, DOI 10.1001/jama.2014.15192; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Tirschwell DL, 2002, STROKE, V33, P2465, DOI 10.1161/01.STR.0000032240.28636.BD; WOLF PA, 1978, NEUROLOGY, V28, P973, DOI 10.1212/WNL.28.10.973	21	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145579	10.1371/journal.pone.0145579	http://dx.doi.org/10.1371/journal.pone.0145579			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26701759	gold, Green Published, Green Submitted			2022-12-26	WOS:000367092600099
J	Antoine-Bertrand, J; Duquette, PM; Alchini, R; Kennedy, TE; Fournier, AE; Lamarche-Vane, N				Antoine-Bertrand, Judith; Duquette, Philippe M.; Alchini, Ricardo; Kennedy, Timothy E.; Fournier, Alyson E.; Lamarche-Vane, Nathalie			p120RasGAP Protein Mediates Netrin-1 Protein-induced Cortical Axon Outgrowth and Guidance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; FOCAL ADHESION KINASE; COLORECTAL-CANCER DCC; C-TERMINAL DOMAIN; TYROSINE PHOSPHORYLATION; CARGO RECOGNITION; RAS P21; GAP; RECEPTOR; GROWTH	The receptor deleted in colorectal cancer (DCC) mediates the attraction of growing axons to netrin-1 during brain development. In response to netrin-1 stimulation, DCC becomes a signaling platform to recruit proteins that promote axon outgrowth and guidance. The Ras GTPase-activating protein (GAP) p120RasGAP inhibits Ras activity and mediates neurite retraction and growth cone collapse in response to repulsive guidance cues. Here we show an interaction between p120RasGAP and DCC that positively regulates netrin-1-mediated axon outgrowth and guidance in embryonic cortical neurons. In response to netrin-1, p120RasGAP is recruited to DCC in growth cones and forms a multiprotein complex with focal adhesion kinase and ERK. We found that Ras/ERK activities are elevated aberrantly in p120RasGAP-deficient neurons. Moreover, the expression of p120RasGAP Src homology 2 (SH2)-SH3-SH2 domains, which interact with the C-terminal tail of DCC, is sufficient to restore netrin-1-dependent axon outgrowth in p120RasGAP-deficient neurons. We provide a novel mechanism that exploits the scaffolding properties of the N terminus of p120RasGAP to tightly regulate netrin-1/DCC-dependent axon outgrowth and guidance.	[Antoine-Bertrand, Judith; Duquette, Philippe M.; Lamarche-Vane, Nathalie] McGill Univ, Dept Anat & Cell Biol, Res Inst, McGill Univ Hlth Ctr, Montreal, PQ H4A 3J1, Canada; [Antoine-Bertrand, Judith; Duquette, Philippe M.; Lamarche-Vane, Nathalie] McGill Univ, Canc Res Program, Res Inst, McGill Univ Hlth Ctr, Montreal, PQ H4A 3J1, Canada; [Alchini, Ricardo; Kennedy, Timothy E.; Fournier, Alyson E.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada	McGill University; McGill University; McGill University	Lamarche-Vane, N (corresponding author), RI MUHC, Ctr Translat Biol, 1001 Boul Decarie,Rm E02-6230, Montreal, PQ H4A 3J1, Canada.	nathalie.lamarche@mcgill.ca			Canadian Institute of Health Research [MOP-14701]; Canada Foundation for Innovation Leaders Opportunity Fund; Fonds de la Recherche en Sante du Quebec doctoral studentship; Fonds de la Recherche en Sante du Quebec Chercheur-National	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation Leaders Opportunity Fund(Canada Foundation for Innovation); Fonds de la Recherche en Sante du Quebec doctoral studentship; Fonds de la Recherche en Sante du Quebec Chercheur-National	This research was supported by Canadian Institute of Health Research Grant MOP-14701 and the Canada Foundation for Innovation Leaders Opportunity Fund (to N. L. V.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a Fonds de la Recherche en Sante du Quebec doctoral studentship.; Recipient of a Fonds de la Recherche en Sante du Quebec Chercheur-National and a William Dawson scholar. To whom correspondence should be addressed: Centre for Translational Biology, RI-MUHC, 1001 Boul. Decarie, Rm. E02.6230, Montreal, Quebec H4A 3J1, Canada. Tel.: 514-934-1934, ext. 76166; E-mail: nathalie.lamarche@mcgill.ca.	ALGRAIN M, 1993, J CELL BIOL, V120, P129, DOI 10.1083/jcb.120.1.129; Antoine-Bertrand J, 2011, MOL BIOL CELL, V22, P3734, DOI 10.1091/mbc.E10-11-0917; Bashaw GJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001941; Bayrak-Toydemir P., 2014, GENEREVIEWS; Briancon-Marjollet A, 2008, MOL CELL BIOL, V28, P2314, DOI 10.1128/MCB.00998-07; Cacalano NA, 2001, NAT CELL BIOL, V3, P460, DOI 10.1038/35074525; Campbell DS, 2003, NEURON, V37, P939, DOI 10.1016/S0896-6273(03)00158-2; Dail M, 2006, J CELL SCI, V119, P1244, DOI 10.1242/jcs.02842; DeGeer J, 2013, MOL CELL BIOL, V33, P739, DOI 10.1128/MCB.01264-12; Dent EW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a001800; Depienne C, 2011, NEUROLOGY, V76, P260, DOI 10.1212/WNL.0b013e318207b1e0; Duan JH, 2011, NEUROSCI LETT, V496, P70, DOI 10.1016/j.neulet.2011.03.083; Eerola I, 2003, AM J HUM GENET, V73, P1240, DOI 10.1086/379793; ELLIS C, 1990, NATURE, V343, P377, DOI 10.1038/343377a0; Elowe S, 2001, MOL CELL BIOL, V21, P7429, DOI 10.1128/MCB.21.21.7429-7441.2001; Endo M, 2009, J NEUROSCI, V29, P6649, DOI 10.1523/JNEUROSCI.0927-09.2009; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Forcet C, 2002, NATURE, V417, P443, DOI 10.1038/nature748; Ger M, 2011, CELL SIGNAL, V23, P1651, DOI 10.1016/j.cellsig.2011.05.019; GIDEON P, 1992, MOL CELL BIOL, V12, P2050, DOI 10.1128/MCB.12.5.2050; Grant A, 2012, SCHIZOPHR RES, V137, P26, DOI 10.1016/j.schres.2012.02.023; Hall A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001818; Hancock ML, 2014, J NEUROSCI, V34, P66, DOI 10.1523/JNEUROSCI.3371-13.2014; Hayashi K, 1999, J CELL SCI, V112, P1149; Hecker TP, 2004, ONCOGENE, V23, P3962, DOI 10.1038/sj.onc.1207541; Hirano Y, 2011, EMBO J, V30, P2734, DOI 10.1038/emboj.2011.177; Holland SJ, 1997, EMBO J, V16, P3877, DOI 10.1093/emboj/16.13.3877; Hu KQ, 1997, EMBO J, V16, P473, DOI 10.1093/emboj/16.3.473; KAPLAN DR, 1990, CELL, V61, P125, DOI 10.1016/0092-8674(90)90220-9; KAZLAUSKAS A, 1990, SCIENCE, V247, P1578, DOI 10.1126/science.2157284; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Kennedy TE, 2006, J NEUROSCI, V26, P8866, DOI 10.1523/JNEUROSCI.5191-05.2006; Kent CB, 2010, J NEUROSCI, V30, P14059, DOI 10.1523/JNEUROSCI.3883-10.2010; Kim JM, 2011, J HUM GENET, V56, P125, DOI 10.1038/jhg.2010.130; King PD, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003669; Kulkarni SV, 2000, J CELL BIOL, V149, P457, DOI 10.1083/jcb.149.2.457; Larrieu-Lahargue F, 2012, TRENDS CARDIOVAS MED, V22, P44, DOI 10.1016/j.tcm.2012.06.010; Leblanc V, 1998, MOL CELL BIOL, V18, P5567, DOI 10.1128/MCB.18.9.5567; Li WQ, 2004, NAT NEUROSCI, V7, P1213, DOI 10.1038/nn1329; Li XD, 2002, J BIOL CHEM, V277, P15207, DOI 10.1074/jbc.M109913200; Li XD, 2002, J BIOL CHEM, V277, P37788, DOI 10.1074/jbc.M205428200; Liu GF, 2004, NAT NEUROSCI, V7, P1222, DOI 10.1038/nn1331; LIU XQ, 1991, MOL CELL BIOL, V11, P2511, DOI 10.1128/MCB.11.5.2511; Lykissas MG, 2007, CURR NEUROVASC RES, V4, P143, DOI 10.2174/156720207780637216; MARGOLIS B, 1990, EMBO J, V9, P4375, DOI 10.1002/j.1460-2075.1990.tb07887.x; MARSHALL MS, 1989, EMBO J, V8, P1105, DOI 10.1002/j.1460-2075.1989.tb03480.x; MCGLADE J, 1993, EMBO J, V12, P3073, DOI 10.1002/j.1460-2075.1993.tb05976.x; Mehlen P, 2010, CURR OPIN ONCOL, V22, P46, DOI 10.1097/CCO.0b013e328333dcd1; Meriane M, 2004, J CELL BIOL, V167, P687, DOI 10.1083/jcb.200405053; Metin C, 1997, DEVELOPMENT, V124, P5063; Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745; MOLLOY CJ, 1989, NATURE, V342, P711, DOI 10.1038/342711a0; Moore SW, 2008, DEVELOPMENT, V135, P2855, DOI 10.1242/dev.024133; MORAN MF, 1991, MOL CELL BIOL, V11, P1804, DOI 10.1128/MCB.11.4.1804; Nakata H, 1996, BIOCHEM BIOPH RES CO, V218, P538, DOI 10.1006/bbrc.1996.0096; Oinuma I, 2004, SCIENCE, V305, P862, DOI 10.1126/science.1097545; Pamonsinlapatham P, 2009, BIOCHIMIE, V91, P320, DOI 10.1016/j.biochi.2008.10.010; PARK S, 1992, J BIOL CHEM, V267, P17194; Ren XR, 2008, NEUROSIGNALS, V16, P235, DOI 10.1159/000111566; Ren XR, 2004, NAT NEUROSCI, V7, P1204, DOI 10.1038/nn1330; Revencu N, 2008, HUM MUTAT, V29, P959, DOI 10.1002/humu.20746; Revencu N, 2013, HUM MUTAT, V34, P1632, DOI 10.1002/humu.22431; Richards LJ, 1997, J NEUROSCI, V17, P2445; Sanchez-Camacho C, 2009, BIOESSAYS, V31, P1013, DOI 10.1002/bies.200900063; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Serpente N, 1996, MOL CELL NEUROSCI, V7, P391, DOI 10.1006/mcne.1996.0028; Shang X, 2007, J BIOL CHEM, V282, P8801, DOI 10.1074/jbc.M609375200; Shekarabi M, 2002, MOL CELL NEUROSCI, V19, P1, DOI 10.1006/mcne.2001.1075; Shu TZ, 2000, J COMP NEUROL, V416, P201, DOI 10.1002/(SICI)1096-9861(20000110)416:2<201::AID-CNE6>3.0.CO;2-Z; Skaper Stephen D, 2012, Methods Mol Biol, V846, P1, DOI 10.1007/978-1-61779-536-7_1; Srour M, 2010, SCIENCE, V328, P592, DOI 10.1126/science.1186463; Sun KLW, 2011, DEVELOPMENT, V138, P2153, DOI 10.1242/dev.044529; Tcherkezian J, 2010, CELL, V141, P632, DOI 10.1016/j.cell.2010.04.008; Tocque B, 1997, CELL SIGNAL, V9, P153, DOI 10.1016/S0898-6568(96)00135-0; Tomar A, 2009, J CELL SCI, V122, P1852, DOI 10.1242/jcs.046870; vanderGeer P, 1997, MOL CELL BIOL, V17, P1840, DOI 10.1128/MCB.17.4.1840; Viswanatha R, 2013, J BIOL CHEM, V288, P35437, DOI 10.1074/jbc.M113.505669; Vitriol EA, 2012, NEURON, V73, P1068, DOI 10.1016/j.neuron.2012.03.005; VOGEL US, 1988, NATURE, V335, P90, DOI 10.1038/335090a0; Wei ZY, 2011, P NATL ACAD SCI USA, V108, P3572, DOI 10.1073/pnas.1016567108; Woodcock SA, 2004, BIOCHEM J, V380, P767, DOI 10.1042/BJ20031848; Wu CB, 2001, J NEUROSCI, V21, P5406, DOI 10.1523/JNEUROSCI.21-15-05406.2001; Yam PT, 2012, NEURON, V76, P735, DOI 10.1016/j.neuron.2012.09.017; Yam PT, 2009, NEURON, V62, P349, DOI 10.1016/j.neuron.2009.03.022; YATANI A, 1990, CELL, V61, P769, DOI 10.1016/0092-8674(90)90187-J; Zhu XJ, 2007, NAT CELL BIOL, V9, P184, DOI 10.1038/ncb1535	87	8	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4589	4602		10.1074/jbc.M115.674846	http://dx.doi.org/10.1074/jbc.M115.674846			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26710849	hybrid, Green Published			2022-12-26	WOS:000371604600027
J	Yao, XQ; Malik, RU; Griggs, NW; Skjaerven, L; Traynor, JR; Sivaramakrishnan, S; Grant, BJ				Yao, Xin-Qiu; Malik, Rabia U.; Griggs, Nicholas W.; Skjaerven, Lars; Traynor, John R.; Sivaramakrishnan, Sivaraj; Grant, Barry J.			Dynamic Coupling and Allosteric Networks in the alpha Subunit of Heterotrimeric G Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA(2) ADRENERGIC-RECEPTOR; MOLECULAR-DYNAMICS; NUCLEOTIDE-EXCHANGE; CRYSTAL-STRUCTURE; GDP RELEASE; ACTIVATION; MECHANISM; CONFORMATIONS; SIMULATIONS; G-ALPHA(I1)	G protein alpha subunits cycle between active and inactive conformations to regulate a multitude of intracellular signaling cascades. Important structural transitions occurring during this cycle have been characterized from extensive crystallographic studies. However, the link between observed conformations and the allosteric regulation of binding events at distal sites critical for signaling through G proteins remain unclear. Here we describe molecular dynamics simulations, bioinformatics analysis, and experimental mutagenesis that identifies residues involved in mediating the allosteric coupling of receptor, nucleotide, and helical domain interfaces of G alpha(i). Most notably, we predict and characterize novel allosteric decoupling mutants, which display enhanced helical domain opening, increased rates of nucleotide exchange, and constitutive activity in the absence of receptor activation. Collectively, our results provide a framework for explaining how binding events and mutations can alter internal dynamic couplings critical for G protein function.	[Yao, Xin-Qiu; Grant, Barry J.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Malik, Rabia U.] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Griggs, Nicholas W.; Traynor, John R.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Skjaerven, Lars] Univ Bergen, Dept Biomed, N-5020 Bergen, Norway; [Malik, Rabia U.; Sivaramakrishnan, Sivaraj] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Bergen; University of Minnesota System; University of Minnesota Twin Cities	Grant, BJ (corresponding author), 100 Washtenaw Ave,2017 Palmer Commons Bldg, Ann Arbor, MI 48109 USA.	bjgrant@umich.edu	Skjærven, Lars/C-1919-2017; Yao, Xinqiu/D-3220-2011	Skjærven, Lars/0000-0002-8176-4891; Yao, Xinqiu/0000-0003-2706-2028; Grant, Barry/0000-0002-2215-4196	University of Michigan; National Institutes of Health [R01-GM105646, R01-DA039997]; American Heart Association [14PRE18560010]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105646, R01GM070862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA039997] Funding Source: NIH RePORTER	University of Michigan(University of Michigan System); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by University of Michigan, National Institutes of Health Grants R01-GM105646 (to S. S.) and R01-DA039997 (to J. R. T.), and American Heart Association Predoctoral Fellowship 14PRE18560010 (to R. U. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alexander NS, 2014, NAT STRUCT MOL BIOL, V21, P56, DOI 10.1038/nsmb.2705; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Case DA, 2012, AMBER 12; Caves LSD, 1998, PROTEIN SCI, V7, P649, DOI 10.1002/pro.5560070314; Chung KY, 2011, NATURE, V477, P611, DOI 10.1038/nature10488; Dror RO, 2015, SCIENCE, V348, P1361, DOI 10.1126/science.aaa5264; Dubay KH, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002168; Flock T, 2015, NATURE, V524, P173, DOI 10.1038/nature14663; Gabriel D, 2003, ASSAY DRUG DEV TECHN, V1, P291, DOI 10.1089/15406580360545107; Gasper PM, 2012, P NATL ACAD SCI USA, V109, P21216, DOI 10.1073/pnas.1218414109; GERSTEIN M, 1995, J MOL BIOL, V251, P161, DOI 10.1006/jmbi.1995.0423; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gorfe AA, 2008, STRUCTURE, V16, P885, DOI 10.1016/j.str.2008.03.009; Grant BJ, 2007, J MOL BIOL, V368, P1231, DOI 10.1016/j.jmb.2007.02.049; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Grishina G, 2000, MOL PHARMACOL, V57, P1081; Guo JJ, 2015, STRUCTURE, V23, P237, DOI 10.1016/j.str.2014.11.009; Harrison C, 2003, LIFE SCI, V74, P489, DOI 10.1016/j.lfs.2003.07.005; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; ICHIYE T, 1991, PROTEINS, V11, P205, DOI 10.1002/prot.340110305; IIRI T, 1994, NATURE, V371, P164, DOI 10.1038/371164a0; Jones JC, 2012, P NATL ACAD SCI USA, V109, P7275, DOI 10.1073/pnas.1202943109; Jones JC, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001446; Kapoor N, 2009, J MOL BIOL, V393, P882, DOI 10.1016/j.jmb.2009.08.043; Kaya AI, 2014, J BIOL CHEM, V289, P24475, DOI 10.1074/jbc.M114.572875; Lerman BB, 1998, J CLIN INVEST, V101, P2862, DOI 10.1172/JCI1582; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Locht C, 2011, FEBS J, V278, P4668, DOI 10.1111/j.1742-4658.2011.08237.x; Malik RU, 2013, J BIOL CHEM, V288, P17167, DOI 10.1074/jbc.M113.464065; Marin EP, 2001, J BIOL CHEM, V276, P27400, DOI 10.1074/jbc.C100198200; Meagher KL, 2003, J COMPUT CHEM, V24, P1016, DOI 10.1002/jcc.10262; Nesbit MA, 2013, NEW ENGL J MED, V368, P2476, DOI 10.1056/NEJMoa1300253; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; NISHINA H, 1995, J BIOCHEM-TOKYO, V118, P1083, DOI 10.1093/jb/118.5.1083; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Preininger AM, 2009, BIOCHEMISTRY-US, V48, P2630, DOI 10.1021/bi801853a; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Scarabelli G, 2014, BIOPHYS J, V107, P2204, DOI 10.1016/j.bpj.2014.09.019; Scarabelli G, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003329; Sethi A, 2009, P NATL ACAD SCI USA, V106, P6620, DOI 10.1073/pnas.0810961106; Skjrven L, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0399-6; SLEPAK VZ, 1993, J BIOL CHEM, V268, P1414; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Sun DW, 2015, NAT STRUCT MOL BIOL, V22, P686, DOI 10.1038/nsmb.3070; Thaker TM, 2014, J BIOL CHEM, V289, P11331, DOI 10.1074/jbc.M113.539064; THOMAS TC, 1993, P NATL ACAD SCI USA, V90, P10295, DOI 10.1073/pnas.90.21.10295; Van Eps N, 2011, P NATL ACAD SCI USA, V108, P9420, DOI 10.1073/pnas.1105810108; vanAalten DMF, 1997, BIOPHYS J, V73, P2891, DOI 10.1016/S0006-3495(97)78317-6; VanWart AT, 2012, J CHEM THEORY COMPUT, V8, P2949, DOI 10.1021/ct300377a; Westfield GH, 2011, P NATL ACAD SCI USA, V108, P16086, DOI 10.1073/pnas.1113645108; Wu S, 2014, PROTEINS, V82, P2896, DOI 10.1002/prot.24629; Yao XQ, 2013, BIOPHYS J, V105, pL8, DOI [10.1016/j.bpj.2013.06.006, 10.1016/j.bpj.2013.06.00]; YEN JY, 1971, MANAGE SCI, V17, P712, DOI 10.1287/mnsc.17.11.712	54	52	52	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4742	4753		10.1074/jbc.M115.702605	http://dx.doi.org/10.1074/jbc.M115.702605			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26703464	Green Published, hybrid			2022-12-26	WOS:000371604600040
J	Kishore, A; Purcell, RH; Nassiri-Toosi, Z; Hall, RA				Kishore, Ayush; Purcell, Ryan H.; Nassiri-Toosi, Zahra; Hall, Randy A.			Stalk-dependent and Stalk-independent Signaling by the Adhesion G Protein-coupled Receptors GPR56 (ADGRG1) and BAI1 (ADGRB1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						arrestin; G protein-coupled receptor (GPCR); proteolysis; receptor structure-function; signal transduction; ubiquitylation (ubiquitination)	TETHERED AGONIST; APOPTOTIC CELLS; MYOBLAST FUSION; NUCLEAR FACTOR; GPCR; TRAFFICKING; ACTIVATION; MIGRATION; SUBUNITS; COLLAGEN	The adhesion G protein-coupled receptors (aGPCRs) are a large yet poorly understood family of seven-transmembrane proteins. A defining characteristic of the aGPCR family is the conserved GAIN domain, which has autoproteolytic activity and can cleave the receptors near the first transmembrane domain. Several aGPCRs, including ADGRB1 (BAI1 or B1) and ADGRG1 (GPR56 or G1), have been found to exhibit significantly increased constitutive activity when truncated to mimic GAIN domain cleavage (NT). Recent reports have suggested that the new N-terminal stalk, which is revealed by GAIN domain cleavage, can directly activate aGPCRs as a tethered agonist. We tested this hypothesis in studies on two distinct aGPCRs, B1 and G1, by engineering mutant receptors lacking the entire NT including the stalk (B1- and G1-SL, with SL indicating stalkless). These receptors were evaluated in a battery of signaling assays and compared with full-length wild-type and cleavage-mimicking (NT) forms of the two receptors. We found that B1-SL, in multiple assays, exhibited robust signaling activity, suggesting that the membrane-proximal stalk region is not necessary for its activation. For G1, however, the results were mixed, with the SL mutant exhibiting robust activity in several signaling assays (including TGF shedding, activation of NFAT luciferase, and -arrestin recruitment) but reduced activity relative to NT in a distinct assay (activation of SRF luciferase). These data support a model in which the activation of certain pathways downstream of aGPCRs is stalk-dependent, whereas signaling to other pathways is stalk-independent.	[Kishore, Ayush; Purcell, Ryan H.; Nassiri-Toosi, Zahra; Hall, Randy A.] Emory Univ, Dept Pharmacol, Sch Med, 1510 Clifton Rd NE, Atlanta, GA 30322 USA	Emory University	Hall, RA (corresponding author), Emory Univ, Dept Pharmacol, Sch Med, 1510 Clifton Rd NE, Atlanta, GA 30322 USA.	rhall3@emory.edu	Toosi, Zahra Nassiri/AAA-1749-2019	Hall, Randy/0000-0002-8318-8728; Purcell, Ryan/0000-0002-6652-2747	National Institutes of Health [R01 NS072394]; NIH [T32 GM008602, T32 GM008605]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008605, T32GM008602] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072394] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Grant R01 NS072394 from the National Institutes of Health (to R. A. H.), NIH Training Grant T32 GM008602 (to A. K.), and NIH Training Grant T32 GM008605 (to R. H. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arac D, 2012, EMBO J, V31, P1364, DOI 10.1038/emboj.2012.26; Chiang NY, 2011, J BIOL CHEM, V286, P14215, DOI 10.1074/jbc.M110.183830; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Demberg LM, 2015, BIOCHEM BIOPH RES CO, V464, P743, DOI 10.1016/j.bbrc.2015.07.020; Duman JG, 2013, J NEUROSCI, V33, P6964, DOI 10.1523/JNEUROSCI.3978-12.2013; Hamann J, 2015, PHARMACOL REV, V67, P338, DOI 10.1124/pr.114.009647; Hochreiter-Hufford AE, 2013, NATURE, V497, P263, DOI 10.1038/nature12135; Hu QX, 2014, J BIOL CHEM, V289, P24215, DOI 10.1074/jbc.M114.549816; Iguchi T, 2008, J BIOL CHEM, V283, P14469, DOI 10.1074/jbc.M708919200; Inoue A, 2012, NAT METHODS, V9, P1021, DOI [10.1038/nmeth.2172, 10.1038/NMETH.2172]; Jin ZH, 2007, HUM MOL GENET, V16, P1972, DOI 10.1093/hmg/ddm144; Kenakin T, 2011, J PHARMACOL EXP THER, V336, P296, DOI 10.1124/jpet.110.173948; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Krasnoperov V, 2009, BIOCHEMISTRY-US, V48, P3230, DOI 10.1021/bi802163p; Langenhan T, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003825; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; Liebscher I, 2014, CELL REP, V9, P2018, DOI 10.1016/j.celrep.2014.11.036; Luttrell LM, 2015, MOL PHARMACOL, V88, P579, DOI 10.1124/mol.115.099630; Marchese A, 2013, CELL SIGNAL, V25, P707, DOI 10.1016/j.cellsig.2012.11.024; Nishida M, 2007, J BIOL CHEM, V282, P23117, DOI 10.1074/jbc.M611780200; Okajima D, 2010, J RECEPT SIG TRANSD, V30, P143, DOI 10.3109/10799891003671139; Paavola KJ, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005347; Paavola KJ, 2012, MOL PHARMACOL, V82, P777, DOI 10.1124/mol.112.080309; Paavola KJ, 2011, J BIOL CHEM, V286, P28914, DOI 10.1074/jbc.M111.247973; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Peeters MC, 2015, CELL SIGNAL, V27, P2579, DOI 10.1016/j.cellsig.2015.08.015; Piao XH, 2004, SCIENCE, V303, P2033, DOI 10.1126/science.1092780; Promel S, 2013, TRENDS PHARMACOL SCI, V34, P470, DOI 10.1016/j.tips.2013.06.002; Promel S, 2012, DEV DYNAM, V241, P1591, DOI 10.1002/dvdy.23841; Promel S, 2012, CELL REP, V2, P321, DOI 10.1016/j.celrep.2012.06.015; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; Stephenson JR, 2014, TRENDS PHARMACOL SCI, V35, P208, DOI 10.1016/j.tips.2014.02.002; Stephenson JR, 2013, J BIOL CHEM, V288, P22248, DOI 10.1074/jbc.M113.489757; Stoveken HM, 2015, P NATL ACAD SCI USA, V112, P6194, DOI 10.1073/pnas.1421785112; Ward Y, 2011, CANCER RES, V71, P7301, DOI 10.1158/0008-5472.CAN-11-2381; Wu MP, 2013, FEBS J, V280, P6097, DOI 10.1111/febs.12529; Zhu D, 2015, J CLIN INVEST, V125, P1497, DOI 10.1172/JCI74603	38	67	69	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3385	3394		10.1074/jbc.M115.689349	http://dx.doi.org/10.1074/jbc.M115.689349			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26710850	hybrid, Green Published			2022-12-26	WOS:000370854500022
J	Qi, YF; Liu, XY; Liang, S; Wang, R; Li, YF; Zhao, J; Shao, JX; An, LJ; Yu, F				Qi, Yafei; Liu, Xiayan; Liang, Shuang; Wang, Rui; Li, Yuanfeng; Zhao, Jun; Shao, Jingxia; An, Lijun; Yu, Fei			A Putative Chloroplast Thylakoid Metalloprotease VIRESCENT3 Regulates Chloroplast Development in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arabidopsis thaliana; chloroplast; membrane protein; metalloprotease; photosynthesis	LEAF VARIEGATION; GENE-EXPRESSION; NUCLEAR GENE; SUBCELLULAR-LOCALIZATION; PROCESSING PEPTIDASE; TARGETING PEPTIDES; PROTEASE COMPLEX; BINDING PROTEIN; REPEAT PROTEIN; BIOGENESIS	The chloroplast is the site of photosynthesis and many other essential plant metabolic processes, and chloroplast development is an integral part of plant growth and development. Mutants defective in chloroplast development can display various color phenotypes including the intriguing virescence phenotype, which shows yellow/white coloration at the leaf base and greening toward the leaf tip. Through large scale genetic screens, we identified a series of new virescent mutants including virescent3-1 (vir3-1), vir4-1, and vir5-1 in Arabidopsis thaliana. We showed that VIR3 encodes a putative chloroplast metalloprotease by map-based cloning. Through site-directed mutagenesis, we showed that the conserved histidine 235 residue in the zinc binding motif HEAGH of VIR3 is indispensable for VIR3 accumulation in the chloroplast. The chloroplast localization of VIR3 was confirmed by the transient expression of VIR3-GFP in leaf protoplasts. Furthermore, taking advantage of transgenic lines expressing VIR3-FLAG, we demonstrated that VIR3 is an intrinsic thylakoid membrane protein that mainly resides in the stromal lamellae. Moreover, topology analysis using transgenic lines expressing a dual epitope-tagged VIR3 indicated that both the N and C termini of VIR3 are located in the stroma, and the catalytic domain of VIR3 is probably facing the stroma. Blue native gel analysis indicated that VIR3 is likely present as a monomer or part of a small complex in the thylakoid membrane. This work not only implicates VIR3 as a new factor involved in early chloroplast development but also provides more insight into the roles of chloroplast proteases in chloroplast biogenesis.	[Qi, Yafei; Liu, Xiayan; Liang, Shuang; Wang, Rui; Li, Yuanfeng; Zhao, Jun; Shao, Jingxia; An, Lijun; Yu, Fei] Northwest Agr & Forestry Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling 712100, Shaanxi, Peoples R China; [Qi, Yafei; Liu, Xiayan; Liang, Shuang; Wang, Rui; Li, Yuanfeng; Zhao, Jun; Shao, Jingxia; An, Lijun; Yu, Fei] Northwest Agr & Forestry Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Yu, F (corresponding author), Northwest Agr & Forestry Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China.	flyfeiyu@gmail.com		Wang, Rui/0000-0002-6196-0780	National Natural Science Foundation of China [31170219, 31300988]; Natural Science Foundation of Shaanxi Province [2014JQ3093]; Fundamental Research Funds for the Central Universities [QN2012022, QN2013034, 2014YB036]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shaanxi Province(Natural Science Foundation of Shaanxi Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Natural Science Foundation of China Grants 31170219 (to F. Y.) and 31300988 (to Y. Q.), by Natural Science Foundation of Shaanxi Province Grants 2014JQ3093 (to J. S.), and by Fundamental Research Funds for the Central Universities Grants QN2012022 (to Y. Q.), QN2013034 (to J. S.), and 2014YB036 (to L. A.). The authors declare that they have no conflicts of interest with the contents of this article.	Adam Z, 2006, CURR OPIN PLANT BIOL, V9, P234, DOI 10.1016/j.pbi.2006.03.010; Allen JF, 2001, TRENDS PLANT SCI, V6, P317, DOI 10.1016/S1360-1385(01)02010-6; ARCHER EK, 1987, PLANT PHYSIOL, V83, P920, DOI 10.1104/pp.83.4.920; Armbruster U, 2013, PLANT CELL, V25, P3926, DOI 10.1105/tpc.113.114785; Atanassov II, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-14; BELL CJ, 1994, GENOMICS, V19, P137, DOI 10.1006/geno.1994.1023; BENEDICT CR, 1972, PLANT PHYSIOL, V49, P972, DOI 10.1104/pp.49.6.972; BENEDICT CR, 1968, PLANT PHYSIOL, V43, P1611, DOI 10.1104/pp.43.10.1611; Bhushan S, 2005, PLANT CELL PHYSIOL, V46, P985, DOI 10.1093/pcp/pci107; BRUSSLAN JA, 1995, PHOTOSYNTH RES, V44, P75, DOI 10.1007/BF00018298; Bryant N, 2011, PLANT PHYSIOL, V155, P1678, DOI 10.1104/pp.110.168120; Chaal BK, 1998, J BIOL CHEM, V273, P689, DOI 10.1074/jbc.273.2.689; Chateigner-Boutin AL, 2011, PLANT J, V65, P532, DOI 10.1111/j.1365-313X.2010.04441.x; Che YF, 2013, P NATL ACAD SCI USA, V110, P16247, DOI 10.1073/pnas.1313894110; Chen G, 2005, PLANT J, V41, P364, DOI 10.1111/j.1365-313X.2004.02308.x; Chen G, 2012, MOL BIOL REP, V39, P2147, DOI 10.1007/s11033-011-0962-4; Chen M, 2000, PLANT J, V22, P303, DOI 10.1046/j.1365-313x.2000.00738.x; Chi W, 2008, PLANT PHYSIOL, V147, P573, DOI 10.1104/pp.108.116194; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Jarvi S, 2011, BIOCHEM J, V439, P207, DOI 10.1042/BJ20102155; Jarvis P, 2013, NAT REV MOL CELL BIO, V14, P787, DOI 10.1038/nrm3702; Karnauchov I, 1997, FEBS LETT, V408, P206, DOI 10.1016/S0014-5793(97)00427-4; Kato Y, 2010, INT REV CEL MOL BIO, V280, P185, DOI 10.1016/S1937-6448(10)80004-8; KAY RE, 1956, PLANT PHYSIOL, V31, P415, DOI 10.1104/pp.31.6.415; Kim J, 2009, PLANT CELL, V21, P1669, DOI 10.1105/tpc.108.063784; Koussevitzky S, 2007, PLANT MOL BIOL, V63, P85, DOI 10.1007/s11103-006-9074-2; Kunst L, 1998, METH MOL B, V82, P43; Lopez-Juez E, 2005, INT J DEV BIOL, V49, P557, DOI 10.1387/ijdb.051997el; Lopez-Juez E, 1998, PLANT PHYSIOL, V118, P803, DOI 10.1104/pp.118.3.803; Lukowitz W, 2000, PLANT PHYSIOL, V123, P795, DOI 10.1104/pp.123.3.795; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Moberg P, 2003, PLANT J, V36, P616, DOI 10.1046/j.1365-313X.2003.01904.x; Murakami S, 2000, FEBS LETT, V468, P15, DOI 10.1016/S0014-5793(00)01186-8; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Ossenbuhl F, 2002, EUR J BIOCHEM, V269, P3912, DOI 10.1046/j.1432-1033.2002.03057.x; Park S, 2004, P NATL ACAD SCI USA, V101, P12765, DOI 10.1073/pnas.0402764101; Poethig RS, 1997, PLANT CELL, V9, P1077, DOI 10.1105/tpc.9.7.1077; Pogson BJ, 2011, PLANT PHYSIOL, V155, P1545, DOI 10.1104/pp.110.170365; POLACCO ML, 1985, PLANT PHYSIOL, V77, P795, DOI 10.1104/pp.77.4.795; Putarjunan A, 2013, PHOTOSYNTH RES, V116, P437, DOI 10.1007/s11120-013-9855-9; Qi YF, 2012, J EXP BOT, V63, P1251, DOI 10.1093/jxb/err347; Qiao JW, 2011, PLANT CELL PHYSIOL, V52, P1017, DOI 10.1093/pcp/pcr054; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Richter S, 2003, J BIOL CHEM, V278, P39497, DOI 10.1074/jbc.M305729200; Richter S, 1998, P NATL ACAD SCI USA, V95, P7463, DOI 10.1073/pnas.95.13.7463; Rudella A, 2006, PLANT CELL, V18, P1704, DOI 10.1105/tpc.106.042861; Sakamoto W, 2006, ANNU REV PLANT BIOL, V57, P599, DOI 10.1146/annurev.arplant.57.032905.105401; Sokolenko A, 2002, CURR GENET, V41, P291, DOI 10.1007/s00294-002-0309-8; Sugimoto H, 2004, PLANT CELL PHYSIOL, V45, P985, DOI 10.1093/pcp/pch111; Sugimoto H, 2007, PLANT J, V52, P512, DOI 10.1111/j.1365-313X.2007.03251.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; WETZEL CM, 1994, PLANT J, V6, P161, DOI 10.1046/j.1365-313X.1994.6020161.x; Wu WJ, 2013, PLANT J, V76, P943, DOI 10.1111/tpj.12344; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yu F, 2004, PLANT J, V37, P864, DOI 10.1111/j.1365-313X.2003.02014.x; Yu F, 2008, PLANT CELL, V20, P1786, DOI 10.1105/tpc.107.054965; Yu F, 2007, PLANT CELL ENVIRON, V30, P350, DOI 10.1111/j.1365-3040.2006.01630.x; Yu F, 2011, MOL PLANT, V4, P229, DOI 10.1093/mp/ssq074; Zhang XL, 2005, PLANT PHYSIOL, V138, P663, DOI 10.1104/pp.105.060319; Zhou WB, 2009, PLANT J, V58, P82, DOI 10.1111/j.1365-313X.2008.03766.x	62	10	13	2	26	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3319	3332		10.1074/jbc.M115.681601	http://dx.doi.org/10.1074/jbc.M115.681601			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26702056	hybrid, Green Published			2022-12-26	WOS:000370854500017
J	Panova, N; Zbornikova, E; Simak, O; Pohl, R; Kolar, M; Bogdanova, K; Vecerova, R; Seydlova, G; Fiser, R; Hadravova, R; Sanderova, H; Viovska, D; Sikova, M; Latal, T; Lovecka, P; Barvik, I; Krasny, L; Rejman, D				Panova, Natalya; Zbornikova, Eva; Simak, Ondrej; Pohl, Radek; Kolar, Milan; Bogdanova, Katerina; Vecerova, Renata; Seydlova, Gabriela; Fiser, Radovan; Hadravova, Romana; Sanderova, Hana; Viovska, Dragana; Sikova, Michaela; Latal, Tomas; Lovecka, Petra; Barvik, Ivan; Krasny, Libor; Rejman, Dominik			Insights into the Mechanism of Action of Bactericidal Lipophosphonoxins	PLOS ONE			English	Article							CATIONIC STEROID ANTIBIOTICS; BACILLUS-SUBTILIS; ANTIBACTERIAL PROPERTIES; ESCHERICHIA-COLI; GENE-EXPRESSION; BROAD-SPECTRUM; MEMBRANE; RESISTANCE; ACID; INFECTIONS	The advantages offered by established antibiotics in the treatment of infectious diseases are endangered due to the increase in the number of antibiotic-resistant bacterial strains. This leads to a need for new antibacterial compounds. Recently, we discovered a series of compounds termed lipophosphonoxins (LPPOs) that exhibit selective cytotoxicity towards Gram-positive bacteria that include pathogens and resistant strains. For further development of these compounds, it was necessary to identify the mechanism of their action and characterize their interaction with eukaryotic cells/organisms in more detail. Here, we show that at their bactericidal concentrations LPPOs localize to the plasmatic membrane in bacteria but not in eukaryotes. In an in vitro system we demonstrate that LPPOs create pores in the membrane. This provides an explanation of their action in vivo where they cause serious damage of the cellular membrane, efflux of the cytosol, and cell disintegration. Further, we show that (i) LPPOs are not genotoxic as determined by the Ames test, (ii) do not cross a monolayer of Caco-2 cells, suggesting they are unable of transepithelial transport, (iii) are well tolerated by living mice when administered orally but not peritoneally, and (iv) are stable at low pH, indicating they could survive the acidic environment in the stomach. Finally, using one of the most potent LPPOs, we attempted and failed to select resistant strains against this compound while we were able to readily select resistant strains against a known antibiotic, rifampicin. In summary, LPPOs represent a new class of compounds with a potential for development as antibacterial agents for topical applications and perhaps also for treatment of gastrointestinal infections.	[Panova, Natalya; Zbornikova, Eva; Simak, Ondrej; Pohl, Radek; Hadravova, Romana; Rejman, Dominik] Czech Acad Sci Vvi, Inst Organ Chem & Biochem, Prague 16610 6, Czech Republic; [Panova, Natalya; Sanderova, Hana; Viovska, Dragana; Sikova, Michaela; Krasny, Libor] Czech Acad Sci Vvi, Inst Microbiol, Prague 14220 4, Czech Republic; [Kolar, Milan; Bogdanova, Katerina; Vecerova, Renata] Palacky Univ, Fac Med & Dent, Dept Microbiol, Olomouc 77515, Czech Republic; [Seydlova, Gabriela; Fiser, Radovan] Charles Univ Prague, Fac Sci, Dept Genet & Microbiol, Prague 12843 2, Czech Republic; [Latal, Tomas] TRIOS Ltd, Prague 14900 4, Czech Republic; [Lovecka, Petra] Univ Chem & Technol, Tech 5, Prague 16628, Czech Republic; [Barvik, Ivan] Charles Univ Prague, Inst Phys, Div Biomol Phys, Fac Math & Phys, Prague 12116 2, Czech Republic	Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Palacky University Olomouc; Charles University Prague; University of Chemistry & Technology, Prague; Charles University Prague	Krasny, L (corresponding author), Czech Acad Sci Vvi, Inst Microbiol, Videnska 1083, Prague 14220 4, Czech Republic.	rejman@uochb.cas.cz; krasny@biomed.cas.cz	Krasny, Libor/H-2429-2014; Simak, Ondrej/G-5583-2014; Sanderova, Hana/I-1731-2014; Fiser, Radovan/E-4908-2012; Seydlová, Gabriela/H-2050-2014; Pohl, Radek/G-5295-2014; Zbornikova, Eva/I-5786-2014; KOLÁŘ, Milan/ACL-9884-2022; Kolář, Milan/AAB-4423-2021; Rejman, Dominik/D-6901-2011; Barvik, Ivan/G-8906-2014; Sikova, Michaela/T-3439-2017	Krasny, Libor/0000-0002-4120-4347; Fiser, Radovan/0000-0003-4516-0086; Seydlová, Gabriela/0000-0001-8424-9249; Zbornikova, Eva/0000-0002-7510-220X; KOLÁŘ, Milan/0000-0003-4621-8868; Kolář, Milan/0000-0003-4621-8868; Rejman, Dominik/0000-0001-5977-5001; Pohl, Radek/0000-0001-7898-946X; Sikova, Michaela/0000-0001-9244-2604; Bogdanova, Katerina/0000-0003-3014-2213; Sanderova, Hana/0000-0002-5436-7583; Vecerova, Renata/0000-0002-7546-530X; Simak, Ondrej/0000-0002-9506-7085	Technological Agency of the Czech Republic [TA02010035]; Czech Science Foundation [P305/12/G034, 13-18051P]; TRIOS Ltd	Technological Agency of the Czech Republic; Czech Science Foundation(Grant Agency of the Czech Republic); TRIOS Ltd	This work was supported by Technological Agency of the Czech Republic, www.tacr.cz, TA02010035 DR; Czech Science Foundation, www.gacr.cz, P305/12/G034 LK; Czech Science Foundation, www.gacr.cz, 13-18051P GS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder TRIOS Ltd provided support in the form of salaries for authors [TL], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Ashrafuzzaman M, 2008, BBA-BIOMEMBRANES, V1778, P2814, DOI 10.1016/j.bbamem.2008.08.017; BISSCHOP A, 1976, EUR J BIOCHEM, V67, P357, DOI 10.1111/j.1432-1033.1976.tb10699.x; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; DAVIS BD, 1987, MICROBIOL REV, V51, P341, DOI 10.1128/MMBR.51.3.341-350.1987; Ding B, 2002, J MED CHEM, V45, P663, DOI 10.1021/jm0105070; EDWARDS DI, 1980, BRIT J VENER DIS, V56, P285; Epand RF, 2007, BBA-BIOMEMBRANES, V1768, P2500, DOI 10.1016/j.bbamem.2007.05.023; Eun YJ, 2012, J AM CHEM SOC, V134, P11322, DOI 10.1021/ja302542j; Fujitani S, 2011, AM J INFECT CONTROL, V39, P188, DOI 10.1016/j.ajic.2010.10.024; GLECKMAN R, 1981, PHARMACOTHERAPY, V1, P14; GOLDBERG I, 1973, ANTIMICROB AGENTS CH, V3, P549, DOI 10.1128/AAC.3.5.549; Goldstein BP, 2014, J ANTIBIOT, V67, P625, DOI 10.1038/ja.2014.107; HAHN F. E., 1955, J BACT, V69, P215; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; HARRIS WJ, 1973, BIOCHEM J, V135, P315, DOI 10.1042/bj1350315; Henry RJ, 1943, BACTERIOL REV, V7, P175, DOI 10.1128/MMBR.7.4.175-262.1943; Hurdle JG, 2014, ANTIBIOTICS TARGETS; Kanoh S, 2010, CLIN MICROBIOL REV, V23, P590, DOI 10.1128/CMR.00078-09; Kesselheim AS, 2010, HEALTH AFFAIR, V29, P1689, DOI 10.1377/hlthaff.2009.0439; Kevin DA, 2009, EXPERT OPIN DRUG DIS, V4, P109, DOI 10.1517/17460440802661443; Koh JJ, 2015, J MED CHEM, V58, P739, DOI 10.1021/jm501285x; Konai MM, 2014, J MED CHEM, V57, P9409, DOI 10.1021/jm5013566; Konopasek I, 2004, CHEM PHYS LIPIDS, V130, P135, DOI 10.1016/j.chemphyslip.2004.02.005; Kovacs F, 1999, P NATL ACAD SCI USA, V96, P7910, DOI 10.1073/pnas.96.14.7910; Krasny L, 2008, MOL MICROBIOL, V69, P42, DOI 10.1111/j.1365-2958.2008.06256.x; Liu DH, 2004, ANGEW CHEM INT EDIT, V43, P1158, DOI 10.1002/anie.200352791; Lundbaek JA, 2010, J R SOC INTERFACE, V7, P373, DOI 10.1098/rsif.2009.0443; MANDELSTAM J, 1968, BIOCHEM J, V109, P793, DOI 10.1042/bj1090793; Marcolongo JP, 2011, J CHEM EDUC, V88, P629, DOI 10.1021/ed900019u; MARON DM, 1983, MUTAT RES, V113, P173, DOI 10.1016/0165-1161(83)90010-9; Masin J, 2013, INFECT IMMUN, V81, P4571, DOI 10.1128/IAI.00711-13; Mensa B, 2011, ANTIMICROB AGENTS CH, V55, P5043, DOI 10.1128/AAC.05009-11; Morar M, 2009, STRUCTURE, V17, P1649, DOI 10.1016/j.str.2009.10.013; Mortelmans K, 2000, MUTAT RES-FUND MOL M, V455, P29, DOI 10.1016/S0027-5107(00)00064-6; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Raghuraman H, 2007, BIOSCIENCE REP, V27, P189, DOI 10.1007/s10540-006-9030-z; Randall CP, 2013, ANTIMICROB AGENTS CH, V57, P637, DOI 10.1128/AAC.02005-12; Savage PB, 2002, FEMS MICROBIOL LETT, V217, P1; Seaton RA, 2008, J ANTIMICROB CHEMOTH, V62, P15, DOI 10.1093/jac/dkn368; SMITH JT, 1986, INFECTION, V14, pS3, DOI 10.1007/BF01645191; Sojka L, 2011, NUCLEIC ACIDS RES, V39, P4598, DOI 10.1093/nar/gkr032; Tan LKK, 2014, CURR OPIN INFECT DIS, V27, P155, DOI 10.1097/QCO.0000000000000047; TUOMANEN E, 1986, J BACTERIOL, V167, P535, DOI 10.1128/jb.167.2.535-543.1986; U. S. Environmental Protection Agency WD, 1983, INT PROC COND SALM M; Van Bambeke F, 2008, TRENDS PHARMACOL SCI, V29, P124, DOI 10.1016/j.tips.2007.12.004; WILLE W, 1975, ANTIMICROB AGENTS CH, V8, P231, DOI 10.1128/AAC.8.3.231; YOCUM RR, 1980, J BIOL CHEM, V255, P3977; YOTSUJI A, 1988, ANTIMICROB AGENTS CH, V32, P1848, DOI 10.1128/AAC.32.12.1848; Zhanel GG, 2010, DRUGS, V70, P859, DOI 10.2165/11534440-000000000-00000	52	10	11	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145918	10.1371/journal.pone.0145918	http://dx.doi.org/10.1371/journal.pone.0145918			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716439	Green Published, Green Submitted, gold			2022-12-26	WOS:000367510500095
J	Paul, D; Chanda, DD; Maurya, AP; Mishra, S; Chakravarty, A; Sharma, GD; Bhattacharjee, A				Paul, Deepjyoti; Chanda, Debadatta Dhar; Maurya, Anand Prakash; Mishra, Shweta; Chakravarty, Atanu; Sharma, Gauri Dutt; Bhattacharjee, Amitabha			Co-Carriage of bla(KPC-2) and bla(NDM-1) in Clinical Isolates of Pseudomonas aeruginosa Associated with Hospital Infections from India	PLOS ONE			English	Article							KLEBSIELLA-PNEUMONIAE; IDENTIFICATION; GENE; PCR	Global spread of KPC poses to be a serious threat complicating treatment options in hospital settings. The present study investigates the genetic environment of bla(KPC-2) among clinical isolates of Pseudomonas aeruginosa from a tertiary referral hospital of India. The study isolates were collected from different wards and clinics of Silchar Medical College and Hospital, India, from 2012-2013. The presence of bla(KPC) was confirmed by genotypic characterization followed by sequencing. Cloning of the bla(KPC-2) gene was performed and the genetic environment of this gene was characterized as well. Transferability of the resistance gene was determined by transformation assay and Southern hybridization. Additionally, restriction mapping was also carried out. Two isolates of P. aeruginosa were found to harbor bla(KPC-2), were resistant towards aminoglycosides, quinolone and beta-lactam-beta-lactamase inhibitor combination. In both the isolates, the resistance determinant was associated with class 1 integron and horizontally transferable. Both the isolates were co-harboring bla(NDM-1). The first detection of this integron mediated bla(KPC-2) coexisting with bla(NDM-1) in P. aeruginosa from India is worrisome, and further investigation is required to track the gene cassette mediated bla(KPC-2) in terms of infection control and to prevent the spread of this gene in hospitals as well as in the community.	[Paul, Deepjyoti; Maurya, Anand Prakash; Bhattacharjee, Amitabha] Assam Univ, Dept Microbiol, Silchar, India; [Chanda, Debadatta Dhar; Chakravarty, Atanu] Silchar Med Coll & Hosp, Dept Microbiol, Silchar, India; [Mishra, Shweta] Banaras Hindu Univ, Dept Microbiol, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India; [Sharma, Gauri Dutt] Assam Univ, Dept Life Sci & Bioinformat, Silchar, India	Assam University; Banaras Hindu University (BHU); Assam University	Bhattacharjee, A (corresponding author), Assam Univ, Dept Microbiol, Silchar, India.	ab0404@gmail.com		Paul, Deepjyoti/0000-0002-6078-9408; Maurya, Anand Prakash/0000-0001-5231-8174	Department of Bio-technology (DBT-NER, Twinning Scheme), Government of India; CSIR [37 (1632)/14/EMR-II]	Department of Bio-technology (DBT-NER, Twinning Scheme), Government of India; CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This work was funded by the Department of Bio-technology (DBT-NER, Twinning Scheme), Government of India, and CSIR (grant number 37 (1632)/14/EMR-II). Deepjyoti Paul received a CSIR Senior Research Fellowship under the grant number 37(1632)/14/EMR-II.	Almeida ACS, 2012, ANTIMICROB AGENTS CH, V56, P2205, DOI 10.1128/AAC.05268-11; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Clinical and Laboratory Standard Institute, 2011, M100S21 CLSI, V31; Ge CR, 2011, J ANTIMICROB CHEMOTH, V66, P1184, DOI 10.1093/jac/dkr060; Jh Y., 2002, J ANTIMICROB CHEMOTH, V49, P837; Koeleman JGM, 2001, J CLIN MICROBIOL, V39, P8, DOI 10.1128/JCM.39.1.8-13.2001; Kumarasamy K, 2012, J ANTIMICROB CHEMOTH, V67, P243, DOI 10.1093/jac/dkr431; LEVESQUE C, 1995, ANTIMICROB AGENTS CH, V39, P185, DOI 10.1128/AAC.39.1.185; Liu Y, 2012, CAN J MICROBIOL, V58, P1167, DOI [10.1139/W2012-094, 10.1139/w2012-094]; Munoz-Price LS, 2013, LANCET INFECT DIS, V13, P785, DOI 10.1016/S1473-3099(13)70190-7; NAAS T, 1994, ANTIMICROB AGENTS CH, V38, P1262, DOI 10.1128/AAC.38.6.1262; Naas T, 2008, ANTIMICROB AGENTS CH, V52, P1257, DOI 10.1128/AAC.01451-07; Nordmann P, 2009, LANCET INFECT DIS, V9, P228, DOI 10.1016/S1473-3099(09)70054-4; Potron A, 2012, J ANTIMICROB CHEMOTH, V67, P242, DOI 10.1093/jac/dkr426; Rasmussen BA, 1996, ANTIMICROB AGENTS CH, V40, P2080, DOI 10.1128/AAC.40.9.2080; Stokes HW, 2001, APPL ENVIRON MICROB, V67, P5240, DOI 10.1128/AEM.67.11.5240-5246.2001; VERSALOVIC J, 1991, NUCLEIC ACIDS RES, V19, P6823, DOI 10.1093/nar/19.24.6823; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09	18	33	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145823	10.1371/journal.pone.0145823	http://dx.doi.org/10.1371/journal.pone.0145823			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714034	gold, Green Published, Green Submitted			2022-12-26	WOS:000367481900089
J	Rohrlack, T; Haande, S; Molversmyr, A; Kyle, M				Rohrlack, Thomas; Haande, Sigrid; Molversmyr, Age; Kyle, Marcia			Environmental Conditions Determine the Course and Outcome of Phytoplankton Chytridiomycosis	PLOS ONE			English	Article							DIATOM ASTERIONELLA; PLANKTOTHRIX-RUBESCENS; ANNUAL CYCLE; CYANOBACTERIA; DIVERSITY; EPIDEMICS; HOST; POPULATIONS; CHEMOTYPES; INFECTION	Chytrid fungi are highly potent parasites of phytoplankton. They are thought to force phytoplankton organisms into an evolutionary arms race with high population diversity as the outcome. The underlying selection regime is known as Red Queen dynamics. However, our study suggests a more complex picture for chytrid parasitism in the cyanobacterium Planktothrix. Laboratory experiments identified a "cold thermal refuge", inside which Planktothrix can grow without chytrid infection. A field study in two Norwegian lakes underlined the ecological significance of this finding. The study utilized sediment DNA as a biological archive in combination with existing monitoring data. In one lake, temperature and light conditions forced Planktothrix outside the thermal refuge for most of the growing season. This probably resulted in Red Queen dynamics as suggested by a high parasitic pressure exerted by chytrids, an increase in Planktothrix genotype diversity over time, and a correlation between Planktothrix genotype diversity and duration of bloom events. In the second lake, a colder climate allowed Planktothrix to largely stay inside the thermal refuge. The parasitic pressure exerted by chytrids and Planktothrix genotype diversity remained low, indicating that Planktothrix successfully evaded the Red Queen dynamics. Episodic Planktothrix blooms were observed during spring and autumn circulation, in the metalimnion or under the ice. Interestingly, both lakes were dominated by the same or related Planktothrix genotypes. Taken together, our data suggest that, depending on environmental conditions, chytrid parasitism can impose distinct selection regimes on conspecific phytoplankton populations with similar genotype composition, causing these populations to behave and perhaps to evolve differently.	[Rohrlack, Thomas; Kyle, Marcia] Norwegian Univ Life Sci, Inst Environm Studies, NO-1432 As, Norway; [Haande, Sigrid] Norwegian Inst Water Res, NO-0349 Oslo, Norway; [Molversmyr, Age] Int Res Inst Stavanger, NO-4021 Stavanger, Norway	Norwegian University of Life Sciences; Norwegian Institute for Water Research (NIVA)	Rohrlack, T (corresponding author), Norwegian Univ Life Sci, Inst Environm Studies, Postbox 5003, NO-1432 As, Norway.	Thomas.Rohrlack@nmbu.no		Molversmyr, Age/0000-0003-2774-0503	Norwegian University of Life Sciences	Norwegian University of Life Sciences	The study was supported by a Norwegian University of Life Sciences grant to TR. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to express their gratitude to all persons who contributed to the monitoring projects in Lakes Kolbotnvannet and Halandsvatnet. We are particularly thankful to Pal Brettum, Robert Ptacnik and Oyvind Lovstad, who counted phytoplankton samples for these projects and to Anne Charlotte Kinn, who helped with field work. Monitoring projects in Lakes Kolbotnvannet and Halandsvatnet where financed by local authorities. The paleolimnological work in both lakes was supported by a Norwegian University of Life Sciences grant to T.R.	BRUNING K, 1991, J PLANKTON RES, V13, P103, DOI 10.1093/plankt/13.1.103; BRUNING K, 1991, FRESHWATER BIOL, V25, P409, DOI 10.1111/j.1365-2427.1991.tb01385.x; BRUNING K, 1991, J PLANKTON RES, V13, P119, DOI 10.1093/plankt/13.1.119; Davis PA, 2003, FRESHWATER BIOL, V48, P852, DOI 10.1046/j.1365-2427.2003.01055.x; De Bruin A, 2004, J PHYCOL, V40, P823, DOI 10.1111/j.1529-8817.2004.04006.x; De Bruin A, 2008, J EUKARYOT MICROBIOL, V55, P69, DOI 10.1111/j.1550-7408.2008.00306.x; Gerphagnon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060894; Gsell AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071737; Gsell AS, 2013, ISME J, V7, P2057, DOI 10.1038/ismej.2013.73; Haande S, 2014, OVERVAKING GJERSJOEN; Ibelings BW, 2011, FRESHWATER BIOL, V56, P754, DOI 10.1111/j.1365-2427.2010.02565.x; Ibelings BW, 2004, J PHYCOL, V40, P437, DOI 10.1111/j.1529-8817.2004.03117.x; Kagami M, 2007, HYDROBIOLOGIA, V578, P113, DOI 10.1007/s10750-006-0438-z; Kagami M, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00166; Kurmayer R, 2006, MOL ECOL, V15, P3849, DOI 10.1111/j.1365-294X.2006.03044.x; Kyle M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118738; Kyle M, 2015, J PALEOLIMNOL, V53, P61, DOI 10.1007/s10933-014-9807-1; Lefevre E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002324; Luhtala H, 2013, ISPRS INT J GEO-INF, V2, P1153, DOI 10.3390/ijgi2041153; Molversmyr A, 2014, OVERVAKING JAERVASSD; Molversmyr A, 2006, UNDERSOKELSERI HALAN; Molversmyr A, 2009, UNDERSOKELSERI HALAN; Monchy S, 2011, ENVIRON MICROBIOL, V13, P1433, DOI 10.1111/j.1462-2920.2011.02444.x; REYNOLDS CS, 1981, PHILOS T ROY SOC B, V293, P419, DOI 10.1098/rstb.1981.0081; Reynolds CS, 2002, J PLANKTON RES, V24, P417, DOI 10.1093/plankt/24.5.417; Rohrlack T, 2008, LIMNOL OCEANOGR, V53, P1279, DOI 10.4319/lo.2008.53.4.1279; Rohrlack T, 2013, APPL ENVIRON MICROB, V79, P2642, DOI 10.1128/AEM.03499-12; Rohrlack T, 2009, J PHYCOL, V45, P1259, DOI 10.1111/j.1529-8817.2009.00757.x; Savichtcheva O, 2015, FRESHWATER BIOL, V60, P31, DOI 10.1111/fwb.12465; Sime-Ngando T, 2012, FRONTIERS MICROBIOLO, V3, P13; Sogge H, 2013, STUDIES PLANKTOTHRIX; Sogge H, 2013, APPL ENVIRON MICROB, V79, P508, DOI 10.1128/AEM.02417-12; SOMMER U, 1986, ARCH HYDROBIOL, V106, P433; Sonstebo JH, 2011, APPL ENVIRON MICROB, V77, P1344, DOI 10.1128/AEM.02153-10; Tooming-Klunderud A, 2013, APPL ENVIRON MICROB, V79, P6803, DOI 10.1128/AEM.01455-13; Walsby AE, 2005, NEW PHYTOL, V168, P365, DOI 10.1111/j.1469-8137.2005.01508.x; Welker M, 2004, ARCH MICROBIOL, V182, P288, DOI 10.1007/s00203-004-0711-3	37	15	15	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145559	10.1371/journal.pone.0145559	http://dx.doi.org/10.1371/journal.pone.0145559			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714010	Green Published, Green Submitted, gold			2022-12-26	WOS:000367481900057
J	Schartl, M; Shen, YJ; Maurus, K; Walter, R; Tomlinson, C; Wilson, RK; Postlethwait, J; Warren, WC				Schartl, Manfred; Shen, Yingjia; Maurus, Katja; Walter, Ron; Tomlinson, Chad; Wilson, Richard K.; Postlethwait, John; Warren, Wesley C.			Whole Body Melanoma Transcriptome Response in Medaka	PLOS ONE			English	Article							STAGE-III; EXPRESSION; GENE; MELANOGENESIS; CONTRIBUTES; CELLS; STIMULATION; ZEBRAFISH; TYROSINE; MODEL	The incidence of malignant melanoma continues to increase each year with poor prognosis for survival in many relapse cases. To reverse this trend, whole body response measures are needed to discover collaborative paths to primary and secondary malignancy. Several species of fish provide excellent melanoma models because fish and human melanocytes both appear in the epidermis, and fish and human pigment cell tumors share conserved gene expression signatures. For the first time, we have examined the whole body transcriptome response to invasive melanoma as a prelude to using transcriptome profiling to screen for drugs in a medaka (Oryzias latipes) model. We generated RNA-seq data from whole body RNA isolates for controls and melanoma fish. After testing for differential expression, 396 genes had significantly different expression (adjusted p-value <0.02) in the whole body transcriptome between melanoma and control fish; 379 of these genes were matched to human orthologs with 233 having annotated human gene symbols and 14 matched genes that contain putative deleterious variants in human melanoma at varying levels of recurrence. A detailed canonical pathway evaluation for significant enrichment showed the top scoring pathway to be antigen presentation but also included the expected melanocyte development and pigmentation signaling pathway. Results revealed a profound down-regulation of genes involved in the immune response, especially the innate immune system. We hypothesize that the developing melanoma actively suppresses the immune system responses of the body in reacting to the invasive malignancy, and that this mal-adaptive response contributes to disease progression, a result that suggests our whole-body transcriptomic approach merits further use. In these findings, we also observed novel genes not yet identified in human melanoma expression studies and uncovered known and new candidate drug targets for further testing in this malignant melanoma medaka model.	[Schartl, Manfred; Maurus, Katja] Univ Wurzburg, Physiol Chem, Biozentrum, D-97074 Wurzburg, Germany; [Schartl, Manfred] Univ Clin Wurzburg, Ctr Comprehens Canc, D-97074 Wurzburg, Germany; [Shen, Yingjia; Walter, Ron] Texas State Univ, Dept Chem & Biochem, San Marcos, TX 78666 USA; [Tomlinson, Chad; Wilson, Richard K.; Warren, Wesley C.] Washington Univ, McDonnell Genome Inst, St Louis, MO 63108 USA; [Postlethwait, John] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA	University of Wurzburg; University of Wurzburg; Texas State University System; Texas State University San Marcos; Washington University (WUSTL); University of Oregon	Schartl, M (corresponding author), Univ Wurzburg, Physiol Chem, Biozentrum, D-97074 Wurzburg, Germany.	phch1@biozentrum.uni-wuerzburg.de; wwarren@genome.wustl.edu	Wilson, Richard K./AAF-4139-2019	Wilson, Richard K./0000-0002-1992-1358; Schartl, Manfred/0000-0001-9882-5948	NIH [R24 RR032658-01, 1R24OD018555]; Deutsche Forschungsgemeinschaft [GRK1048, TR17]; Deutsche Krebshilfe through the Melanomverbund; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR032658] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD011198, R24OD018555] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe through the Melanomverbund(Deutsche Krebshilfe); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grant R24 RR032658-01 to WCW and Deutsche Forschungsgemeinschaft through GRK1048 and TR17 and the Deutsche Krebshilfe through the Melanomverbund to MS and 1R24OD018555 to JHP, MS, RW, and WW.; This work was supported by NIH grant R24 RR032658-01 to WCW and 1R24OD018555 to JHP, MS, RW, and WCW and Deutsche Forschungsgemeinschaft through GRK1048 and TR17 and the Deutsche Krebshilfe through the Melanomverbund to MS.	Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Bachellerie JP, 2002, BIOCHIMIE, V84, P775, DOI 10.1016/S0300-9084(02)01402-5; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Berger MF, 2010, GENOME RES, V20, P413, DOI 10.1101/gr.103697.109; Brozyna AA, 2013, HUM PATHOL, V44, P2071, DOI 10.1016/j.humpath.2013.02.022; Chan J, 2001, MOL CARCINOGEN, V31, P16, DOI 10.1002/mc.1033; Coca S, 1997, CANCER-AM CANCER SOC, V79, P2320, DOI 10.1002/(SICI)1097-0142(19970615)79:12<2320::AID-CNCR5>3.0.CO;2-P; D'Angelillo A, 2015, CURRENT MOL PHARM; Ding L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111153; Dovey M, 2009, ZEBRAFISH, V6, P397, DOI 10.1089/zeb.2009.0606; Eggermont AMM, 2008, LANCET, V372, P117, DOI 10.1016/S0140-6736(08)61033-8; Fijneman RJA, 2005, CELL ONCOL, V27, P281; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Geissinger E, 2002, CANCER RES, V62, P4820; Giacomotto J, 2010, BRIT J PHARMACOL, V160, P204, DOI 10.1111/j.1476-5381.2010.00725.x; Griffith M, 2013, NAT METHODS, V10, P1209, DOI [10.1038/NMETH.2689, 10.1038/nmeth.2689]; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kluger HM, 2011, CLIN CANCER RES, V17, P2417, DOI 10.1158/1078-0432.CCR-10-2402; Koludrovic D, 2013, FUTURE ONCOL, V9, P235, DOI [10.2217/fon.12.177, 10.2217/FON.12.177]; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Laisney JAGC, 2013, ONCOGENE, V32, P2403, DOI 10.1038/onc.2012.267; Liu QZ, 2014, J CLIN INVEST, V124, P2147, DOI 10.1172/JCI69611; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; MARESH GA, 1994, DNA CELL BIOL, V13, P87, DOI 10.1089/dna.1994.13.87; Meierjohann S, 2006, TRENDS GENET, V22, P654, DOI 10.1016/j.tig.2006.09.013; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; Mione MC, 2010, DIS MODEL MECH, V3, P517, DOI 10.1242/dmm.004747; Morcinek JC, 2002, ONCOGENE, V21, P1668, DOI 10.1038/sj.onc.1205148; Natarajan VT, 2014, P NATL ACAD SCI USA, V111, P2301, DOI 10.1073/pnas.1304988111; Ngiow SF, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23036; Panelli MC, 2000, J IMMUNOL, V164, P495, DOI 10.4049/jimmunol.164.1.495; Patton EE, 2010, PIGM CELL MELANOMA R, V23, P314, DOI 10.1111/j.1755-148X.2010.00693.x; Plonka PM, 2003, EXP DERMATOL, V12, P356, DOI 10.1034/j.1600-0625.2002.120401.x; Rigel DS, 2008, J AM ACAD DERMATOL, V58, pS129, DOI 10.1016/j.jaad.2007.04.034; Schaafhausen MK, 2013, J CELL SCI, V126, P3862, DOI 10.1242/jcs.125021; Schartl M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037880; Schartl M, 2010, J INVEST DERMATOL, V130, P249, DOI 10.1038/jid.2009.213; Shimanovsky A, 2013, EXPERT OPIN BIOL TH, V13, P1413, DOI 10.1517/14712598.2013.827658; Slominski A, 1998, ANTICANCER RES, V18, P3709; Slominski A, 2014, ARCH BIOCHEM BIOPHYS, V563, P79, DOI 10.1016/j.abb.2014.06.030; Slominski A, 2012, PIGM CELL MELANOMA R, V25, P14, DOI 10.1111/j.1755-148X.2011.00898.x; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Thermes V, 2002, MECH DEVELOP, V118, P91, DOI 10.1016/S0925-4773(02)00218-6; Tucci M, 2014, EXPERT REV CLIN IMMU, V10, P1395, DOI 10.1586/1744666X.2014.955851; Wellbrock C, 2005, CURR BIOL, V15, P1629, DOI 10.1016/j.cub.2005.08.036; White RM, 2011, NATURE, V471, P518, DOI 10.1038/nature09882; Winnepenninckx VR, 2006, JNCI-J NATL CANCER I, V98, P472, DOI 10.1093/jnci/djj103; WITTBRODT J, 1989, NATURE, V341, P415, DOI 10.1038/341415a0; Wittbrodt J, 2002, NAT REV GENET, V3, P53, DOI 10.1038/nrg704; Yen J, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r113; Zhao H, 2014, GENE, V548, P234, DOI 10.1016/j.gene.2014.07.038	53	14	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0143057	10.1371/journal.pone.0143057	http://dx.doi.org/10.1371/journal.pone.0143057			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714172	Green Submitted, Green Published, gold			2022-12-26	WOS:000367481900002
J	Eiselein, L; Nyunt, T; Lame, MW; Ng, KF; Wilson, DW; Rutledge, JC; Aung, HH				Eiselein, Larissa; Nyunt, Tun; Lame, Michael W.; Ng, Kit F.; Wilson, Dennis W.; Rutledge, John C.; Aung, Hnin H.			TGRL Lipolysis Products Induce Stress Protein ATF3 via the TGF-beta Receptor Pathway in Human Aortic Endothelial Cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; NECROSIS-FACTOR-ALPHA; TRIGLYCERIDE-RICH LIPOPROTEINS; LOW-DENSITY-LIPOPROTEIN; TRANSCRIPTIONAL REPRESSOR ATF3/LRF1; CEREBELLAR GRANULE NEURONS; EPITHELIAL-CELLS; GENE-EXPRESSION; TRANSFORMING GROWTH-FACTOR-BETA-1; C-JUN	Studies have suggested a link between the transforming growth factor beta 1 (TGF-beta 1) signaling cascade and the stress-inducible activating transcription factor 3 (ATF3). We have demonstrated that triglyceride-rich lipoproteins (TGRL) lipolysis products activate MAP kinase stress associated JNK/c-Jun pathways resulting in up-regulation of ATF3, pro-inflammatory genes and induction of apoptosis in human aortic endothelial cells. Here we demonstrate increased release of active TGF-beta at 15 min, phosphorylation of Smad2 and translocation of co-Smad4 from cytosol to nucleus after a 1.5 h treatment with lipolysis products. Activation and translocation of Smad2 and 4 was blocked by addition of SB431542 (10 mu M), a specific inhibitor of TGF-beta-activin receptor ALKs 4, 5, 7. Both ALK receptor inhibition and anti TGF-beta 1 antibody prevented lipolysis product induced up-regulation of ATF3 mRNA and protein. ALK inhibition prevented lipolysis product-induced nuclear accumulation of ATF3. ALKs 4, 5, 7 inhibition also prevented phosphorylation of c-Jun and TGRL lipolysis product-induced p53 and caspase-3 protein expression. These findings demonstrate that TGRL lipolysis products cause release of active TGF-beta and lipolysis product-induced apoptosis is dependent on TGF-beta signaling. Furthermore, signaling through the stress associated JNK/c-Jun pathway is dependent on TGF-beta signaling suggesting that TGF-beta signaling is necessary for nuclear accumulation of the ATF3/cJun transcription complex and induction of pro-inflammatory responses.	[Eiselein, Larissa; Nyunt, Tun; Ng, Kit F.; Rutledge, John C.; Aung, Hnin H.] Univ Calif Davis, Sch Med, Dept Internal Med, Div Cardiovasc Med, Davis, CA 95616 USA; [Lame, Michael W.] Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA; [Wilson, Dennis W.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Aung, HH (corresponding author), Univ Calif Davis, Sch Med, Dept Internal Med, Div Cardiovasc Med, Davis, CA 95616 USA.	mhaung@ucdavis.edu			National Institutes of Health [HL55667, AG039094]; Richard A. and Nora Eccles Harrison Endowed Chair in Diabetes Research Fund; UCD Humanities Graduate Research Award; UCD Dissertation Year Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055667] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG039094, R01AG045541] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Richard A. and Nora Eccles Harrison Endowed Chair in Diabetes Research Fund; UCD Humanities Graduate Research Award; UCD Dissertation Year Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding provided by National Institutes of Health HL55667 and AG039094: JCR, Richard A. and Nora Eccles Harrison Endowed Chair in Diabetes Research Fund: JCR and the UCD Humanities Graduate Research Award and the UCD Dissertation Year Fellowship: LE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akram A, 2010, AM J RESP CRIT CARE, V182, P489, DOI 10.1164/rccm.200906-0925OC; Aung HH, 2013, ARTERIOSCL THROM VAS, V33, P2088, DOI 10.1161/ATVBAHA.113.301375; Birukova AA, 2005, FEBS LETT, V579, P4031, DOI 10.1016/j.febslet.2005.06.018; Bombeli T, 1997, BLOOD, V89, P2429, DOI 10.1182/blood.V89.7.2429; Cai Y, 2000, BLOOD, V96, P2140, DOI 10.1182/blood.V96.6.2140.h8002140_2140_2148; CHEN BPC, 1994, J BIOL CHEM, V269, P15819; Chen CC, 1996, CYTOKINE, V8, P58, DOI 10.1006/cyto.1995.0008; Chiarugi V, 1997, PHARMACOL RES, V35, P257, DOI 10.1006/phrs.1997.0140; Choy JC, 2001, J MOL CELL CARDIOL, V33, P1673, DOI 10.1006/jmcc.2001.1419; Clements RT, 2005, AM J PHYSIOL-LUNG C, V288, pL294, DOI 10.1152/ajplung.00213.2004; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; Dimmeler S, 1997, CIRCULATION, V95, P1760; Ding GH, 1997, KIDNEY INT, V51, P147, DOI 10.1038/ki.1997.18; Dmitrieva N, 2000, J BIOL CHEM, V275, P18243, DOI 10.1074/jbc.M000522200; Donato NJ, 1998, J BIOL CHEM, V273, P5067, DOI 10.1074/jbc.273.9.5067; Du XL, 1998, DIABETOLOGIA, V41, P249, DOI 10.1007/s001250050900; Dupont S, 2004, CANCER LETT, V213, P129, DOI 10.1016/j.canlet.2004.06.008; Edlund S, 2003, MOL BIOL CELL, V14, P529, DOI 10.1091/mbc.02-03-0037; Eiselein L, 2007, AM J PHYSIOL-HEART C, V292, pH2745, DOI 10.1152/ajpheart.00686.2006; Feng JP, 2013, INT J CLIN EXP PATHO, V6, P2064; Francis JM, 2000, J BIOL CHEM, V275, P39137, DOI 10.1074/jbc.M007212200; GENG YJ, 1995, AM J PATHOL, V147, P251; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; GOTLIEB WH, 1994, AM J OBSTET GYNECOL, V170, P1121, DOI 10.1016/S0002-9378(94)70106-7; Grainger DJ, 2004, ARTERIOSCL THROM VAS, V24, P399, DOI 10.1161/01.ATV.0000114567.76772.33; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Hainaut P, 2000, ADV CANCER RES, V77, P81; HAN DKM, 1995, AM J PATHOL, V147, P267; Hong HK, 2006, TRANSL RES, V148, P171, DOI 10.1016/j.trsl.2006.07.005; HSU JC, 1992, MOL CELL BIOL, V12, P4654, DOI 10.1128/MCB.12.10.4654; Huber J, 2002, ARTERIOSCL THROM VAS, V22, P101, DOI 10.1161/hq0102.101525; Hyman KM, 2002, SURGERY, V132, P173, DOI 10.1067/msy.2002.125304; Inoue K, 2004, GENES CELLS, V9, P59, DOI 10.1111/j.1356-9597.2004.00707.x; ISNER JM, 1995, CIRCULATION, V91, P2703, DOI 10.1161/01.CIR.91.11.2703; Jack GD, 2007, CELL SIGNAL, V19, P772, DOI 10.1016/j.cellsig.2006.10.005; Jin MH, 2008, TOXICOL LETT, V178, P202, DOI 10.1016/j.toxlet.2008.03.015; Kang YB, 2003, MOL CELL, V11, P915, DOI 10.1016/S1097-2765(03)00109-6; KASTAN MB, 1991, CANCER RES, V51, P4279; Ladiwala U, 1999, J NEUROCHEM, V73, P605, DOI 10.1046/j.1471-4159.1999.0730605.x; Lebrin F, 2005, CARDIOVASC RES, V65, P599, DOI 10.1016/j.cardiores.2004.10.036; LENZ ML, 1990, J LIPID RES, V31, P1043; Li DY, 1998, AM J PHYSIOL-HEART C, V275, pH568, DOI 10.1152/ajpheart.1998.275.2.H568; Liang GS, 1996, J BIOL CHEM, V271, P1695, DOI 10.1074/jbc.271.3.1695; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long X, 2007, MOL CELL BIOCHEM, V303, P167, DOI 10.1007/s11010-007-9470-1; Lu DM, 2007, APOPTOSIS, V12, P1893, DOI 10.1007/s10495-007-0111-7; Lu Q, 2006, J APPL PHYSIOL, V101, P375, DOI 10.1152/japplphysiol.01515.2005; MALTZMAN W, 1984, MOL CELL BIOL, V4, P1689, DOI 10.1128/MCB.4.9.1689; McLaughlin R, 2001, IRISH J MED SCI, V170, P132, DOI 10.1007/BF03168827; Mead JR, 2002, J MOL MED, V80, P753, DOI 10.1007/s00109-002-0384-9; Mei Y, 2008, NEUROSCIENCE, V151, P771, DOI 10.1016/j.neuroscience.2007.10.057; MORLEY N, 1972, J BIOL CHEM, V247, P6389; Napoli C, 2000, FASEB J, V14, P1996, DOI 10.1096/fj.99-0986com; Nawa T, 2000, BIOCHEM BIOPH RES CO, V275, P406, DOI 10.1006/bbrc.2000.3332; Nawa T, 2002, ATHEROSCLEROSIS, V161, P281, DOI 10.1016/S0021-9150(01)00639-6; NIKOL S, 1992, J CLIN INVEST, V90, P1582, DOI 10.1172/JCI116027; NILSSONE.P, 1973, J BIOL CHEM, V248, P6734; Norata GD, 2006, J MOL CELL CARDIOL, V40, P484, DOI 10.1016/j.yjmcc.2006.01.022; Norata GD, 2007, ATHEROSCLEROSIS, V193, P321, DOI 10.1016/j.atherosclerosis.2006.09.015; Pollman MJ, 1999, CIRCULATION, V99, P2019, DOI 10.1161/01.CIR.99.15.2019; ROBERTS AB, 1993, GROWTH FACTORS, V8, P1; Rorke EA, 2000, EXP CELL RES, V259, P149, DOI 10.1006/excr.2000.4953; Sata M, 1998, J CLIN INVEST, V102, P1682, DOI 10.1172/JCI3531; Schmidt-Ott KM, 2000, REGUL PEPTIDES, V93, P65, DOI 10.1016/S0167-0115(00)00178-6; SELVAKUMARAN M, 1994, ONCOGENE, V9, P1791; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Silverstein Roy L, 2010, Trans Am Clin Climatol Assoc, V121, P206; Simeonova PP, 2001, TOXICOL APPL PHARM, V177, P112, DOI 10.1006/taap.2001.9304; Singh NN, 2006, CYTOKINE GROWTH F R, V17, P487, DOI 10.1016/j.cytogfr.2006.09.002; Smith WB, 1996, J IMMUNOL, V157, P360; Sola S, 2004, BIOCHEMISTRY-US, V43, P8429, DOI 10.1021/bi049781x; Song CY, 2005, KIDNEY INT, V67, P1743, DOI 10.1111/j.1523-1755.2005.00271.x; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Teramoto T, 1998, BIOCHEM BIOPH RES CO, V251, P56, DOI 10.1006/bbrc.1998.9411; Ting HJ, 2007, CIRC RES, V100, P381, DOI 10.1161/01.RES.0000258023.76515.a3; Wang LM, 2008, AM J PHYSIOL-HEART C, V295, pH237, DOI 10.1152/ajpheart.01366.2007; Wang LM, 2009, J LIPID RES, V50, P204, DOI 10.1194/jlr.M700505-JLR200; Wang MY, 2006, ARTERIOSCL THROM VAS, V26, P1503, DOI 10.1161/01.ATV.0000225777.58488.f2; Wang SZE, 2007, J BIOL CHEM, V282, P5661, DOI 10.1074/jbc.M608499200; Watson A, 1998, J NEUROSCI, V18, P751; Weiss JM, 1999, ENDOTHELIUM-NEW YORK, V6, P291, DOI 10.3109/10623329909078496; Xie SQ, 2001, J BIOL CHEM, V276, P36194, DOI 10.1074/jbc.M104157200; Zhang C, 2001, BIOCHEM BIOPH RES CO, V289, P718, DOI 10.1006/bbrc.2001.6044; Zhang ST, 2006, CELL CYCLE, V5, P2787, DOI 10.4161/cc.5.23.3523	85	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145523	10.1371/journal.pone.0145523	http://dx.doi.org/10.1371/journal.pone.0145523			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709509	Green Submitted, gold, Green Published			2022-12-26	WOS:000367451400061
J	Khaliq, W; Aamar, A; Wright, SM				Khaliq, Waseem; Aamar, Ali; Wright, Scott M.			Predictors of Non-Adherence to Breast Cancer Screening among Hospitalized Women	PLOS ONE			English	Article							UNITED-STATES; MAMMOGRAPHY; RISK; VALIDATION; BENEFITS; SERVICES	Objective Disparities in screening mammography use persists among low income women, even those who are insured, despite the proven mortality benefit. A recent study reported that more than a third of hospitalized women were non-adherent with breast cancer screening. The current study explores prevalence of socio-demographic and clinical variables associated with non-adherence to screening mammography recommendations among hospitalized women. Patients and Methods A cross sectional bedside survey was conducted to collect socio-demographic and clinical comorbidity data thought to effect breast cancer screening adherence of hospitalized women aged 50-75 years. Logistic regression models were used to assess the association between these factors and non-adherence to screening mammography. Results Of 250 enrolled women, 61% were of low income, and 42% reported non-adherence to screening guidelines. After adjustment for socio-demographic and clinical predictors, three variables were found to be independently associated with non-adherence to breast cancer screening: low income (OR = 3.81, 95% CI; 1.84-7.89), current or ex-smoker (OR = 2.29, 95% CI; 1.12-4.67), and history of stroke (OR = 2.83, 95% CI; 1.21-6.60). By contrast, hospitalized women with diabetes were more likely to be compliant with breast cancer screening (OR = 2.70, 95% CI 1.35-5.34). Conclusion Because hospitalization creates the scenario wherein patients are in close proximity to healthcare resources, at a time when they may be reflecting upon their health status, strategies could be employed to counsel, educate, and motivate these patients towards health maintenance. Capitalizing on this opportunity would involve offering screening during hospitalization for those who are overdue, particularly for those who are at higher risk of disease.	[Khaliq, Waseem; Wright, Scott M.] Johns Hopkins Univ, Sch Med, Dept Med, Johns Hopkins Bayview Med Ctr, Baltimore, MD 21205 USA; [Aamar, Ali] Yale Univ, Sch Med, Yale Waterbury Hosp, Dept Internal Med, Waterbury, CT USA	Johns Hopkins University; Johns Hopkins Medicine; Yale University	Khaliq, W (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Johns Hopkins Bayview Med Ctr, Baltimore, MD 21205 USA.	wkhaliq1@jhmi.edu			Hopkins Center for Innovative Medicine; Maryland Cigarette Restitution Fund Research Grant at Johns Hopkins	Hopkins Center for Innovative Medicine; Maryland Cigarette Restitution Fund Research Grant at Johns Hopkins	Dr. Wright is a Miller-Coulson Family Scholar supported by Hopkins Center for Innovative Medicine.; This work was made possible in part by the Maryland Cigarette Restitution Fund Research Grant at Johns Hopkins. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achat H, 2005, PREV MED, V41, P312, DOI 10.1016/j.ypmed.2004.11.016; American Cancer Society, 2013, BREAST CANC FACTS FI; [Anonymous], 2014, WHO POSITION PAPER O; Blackwell DL, 2008, WOMEN HEALTH ISS, V18, P85, DOI 10.1016/j.whi.2007.10.006; Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Borrayo EA, 2009, J WOMENS HEALTH, V18, P1585, DOI 10.1089/jwh.2008.1009; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Cosgrove DM, 2013, HEALTH AFFAIR, V32, P321, DOI 10.1377/hlthaff.2012.1074; Costantino JP, 1999, J NATL CANCER I, V91, P1541, DOI 10.1093/jnci/91.18.1541; Elmore JG, 2005, JAMA-J AM MED ASSOC, V293, P1245, DOI 10.1001/jama.293.10.1245; Ferrante JM, 2007, AM J PREV MED, V32, P525, DOI 10.1016/j.amepre.2007.02.004; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; Gail MH, 1999, J NATL CANCER I, V91, P1829, DOI 10.1093/jnci/91.21.1829; Gail MH, 2007, J NATL CANCER I, V99, P1782, DOI 10.1093/jnci/djm223; Hendrick RE, 2011, AM J ROENTGENOL, V196, pW112, DOI 10.2214/AJR.10.5609; Kempe Karin L, 2013, Perm J, V17, P38, DOI 10.7812/TPP/12-068; Khaliq W, 2014, ANN FAM MED, V12, P556, DOI 10.1370/afm.1694; Khaliq W, 2013, J WOMENS HEALTH, V22, P637, DOI 10.1089/jwh.2012.4083; Kim Jaeyoung, 2008, J Prev Med Public Health, V41, P186; Kisuule F, 2007, J HOSP MED, V2, P93, DOI 10.1002/jhm.185; Loberg M, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0525-z; Ludman EJ, 2010, AM J PREV MED, V38, P303, DOI 10.1016/j.amepre.2009.10.039; Maruthur NM, 2009, J GEN INTERN MED, V24, P665, DOI 10.1007/s11606-009-0939-3; Matsuno RK, 2011, J NATL CANCER I, V103, P951, DOI 10.1093/jnci/djr154; Miller Jacqueline W, 2012, MMWR Suppl, V61, P46; Ogedegbe G, 2005, J NATL MED ASSOC, V97, P162; Phillips Kathryn A, 2006, Prev Chronic Dis, V3, pA75; Ramirez A, 2005, AM J PUBLIC HEALTH, V95, P2057, DOI 10.2105/AJPH.2005.066118; Rattanawatkul K, 2011, U MARYLAND MCNAIR SC, V3, P10; Rauscher GH, 2012, J WOMENS HEALTH, V21, P154, DOI 10.1089/jwh.2010.2415; Rockhill B, 2001, J NATL CANCER I, V93, P358, DOI 10.1093/jnci/93.5.358; Selvin E, 2003, AM J PUBLIC HEALTH, V93, P618, DOI 10.2105/AJPH.93.4.618; Shah M, 2007, J WOMENS HEALTH, V16, P526, DOI 10.1089/jwh.2006.0108; Smith EC, 2013, JAMA SURG, V148, P516, DOI 10.1001/jamasurg.2013.1680	34	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145492	10.1371/journal.pone.0145492	http://dx.doi.org/10.1371/journal.pone.0145492			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ9XO	26709510	Green Submitted, Green Published, gold			2022-12-26	WOS:000367451400053
J	Khor, WC; Puah, SM; Tan, JAMA; Puthucheary, SD; Chua, KH				Khor, Wei Ching; Puah, Suat Moi; Tan, Jin Ai Mary Anne; Puthucheary, S. D.; Chua, Kek Heng			Phenotypic and Genetic Diversity of Aeromonas Species Isolated from Fresh Water Lakes in Malaysia	PLOS ONE			English	Article							III SECRETION SYSTEM; VIRULENCE FACTORS; GENUS AEROMONAS; CLINICAL ISOLATE; HEALTHY CONTROLS; HYDROPHILA; IDENTIFICATION; ENTEROTOXINS; SEQUENCES; PCR	Gram-negative bacilli of the genus Aeromonas are primarily inhabitants of the aquatic environment. Humans acquire this organism from a wide range of food and water sources as well as during aquatic recreational activities. In the present study, the diversity and distribution of Aeromonas species from freshwater lakes in Malaysia was investigated using glycerophospholipid-cholesterol acyltransferase (GCAT) and RNA polymerase sigma-factor (rpoD) genes for speciation. A total of 122 possible Aeromonas strains were isolated and confirmed to genus level using the API20E system. The clonality of the isolates was investigated using ERIC-PCR and 20 duplicate isolates were excluded from the study. The specific GCAT-PCR identified all isolates as belonging to the genus Aeromonas, in agreement with the biochemical identification. A phylogenetic tree was constructed using the rpoD gene sequence and all 102 isolates were identified as: A. veronii 43%, A. jandaei 37%, A. hydrophila 6%, A. caviae 4%, A. salmonicida 2%, A. media 2%, A. allosaccharophila 1%, A. dhakensis 1% and Aeromonas spp. 4%. Twelve virulence genes were present in the following proportions-exu 96%, ser 93%, aer 87%, fla 83%, enolase 70%, ela 62%, act 54%, aexT 33%, lip 16%, dam 16%, alt 8% and ast 4%, and at least 2 of these genes were present in all 102 strains. The ascV, aexU and hlyA genes were not detected among the isolates. A. hydrophila was the main species containing virulence genes alt and ast either present alone or in combination. It is possible that different mechanisms may be used by each genospecies to demonstrate virulence. In summary, with the use of GCAT and rpoD genes, unambiguous identification of Aeromonas species is possible and provides valuable data on the phylogenetic diversity of the organism.	[Khor, Wei Ching; Puah, Suat Moi; Tan, Jin Ai Mary Anne; Chua, Kek Heng] Univ Malaya, Fac Med, Dept Biomed Sci, Kuala Lumpur, Malaysia; [Puthucheary, S. D.] Duke NUS Med Sch Singapore, Dept Med Educ Res & Evaluat, Singapore, Singapore	Universiti Malaya; National University of Singapore	Chua, KH (corresponding author), Univ Malaya, Fac Med, Dept Biomed Sci, Kuala Lumpur, Malaysia.	khchua@um.edu.my	Puah, Suat Moi/J-6296-2016; TAN, JIN AI MARY ANNE/B-8950-2010; CHUA, KEK HENG/B-5261-2010	Puah, Suat Moi/0000-0003-1346-3787; CHUA, KEK HENG/0000-0002-0452-9994; Khor, Wei Ching/0000-0003-3931-0682	University of Malaya [RP039A-15HTM, PG082-2014B]	University of Malaya(Universiti Malaya)	This study was funded by the University of Malaya Research Grant RP039A-15HTM and Postgraduate Research Grant PG082-2014B.	Abbott SL, 2003, J CLIN MICROBIOL, V41, P2348, DOI 10.1128/JCM.41.6.2348-2357.2003; Aguilera-Arreola MG, 2005, FEMS MICROBIOL LETT, V242, P231, DOI 10.1016/j.femsle.2004.11.011; Albert MJ, 2000, J CLIN MICROBIOL, V38, P3785, DOI 10.1128/JCM.38.10.3785-3790.2000; ALTWEGG M, 1990, J CLIN MICROBIOL, V28, P258, DOI 10.1128/JCM.28.2.258-264.1990; Beaz-Hidalgo R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115813; Beaz-Hidalgo R, 2010, SYST APPL MICROBIOL, V33, P149, DOI 10.1016/j.syapm.2010.02.002; Bin Kingombe CI, 1999, APPL ENVIRON MICROB, V65, P5293; Bossi-Kupfer M, 2007, J MED MICROBIOL, V56, P1563, DOI 10.1099/jmm.0.47202-0; Chacon MR, 2003, ANTON LEEUW INT J G, V84, P269, DOI 10.1023/A:1026042125243; Chacon MR, 2002, DIAGN MICR INFEC DIS, V44, P221, DOI 10.1016/S0732-8893(02)00455-8; Chopra AK, 1999, MICROBES INFECT, V1, P1129, DOI 10.1016/S1286-4579(99)00202-6; Corry JEL, 2003, HDB CULTURE MEDIA FO; Erova TE, 2007, FEMS MICROBIOL LETT, V275, P301, DOI 10.1111/j.1574-6968.2007.00895.x; Erova TE, 2006, INFECT IMMUN, V74, P410, DOI 10.1128/IAI.74.1.410-424.2006; Esteve C, 2003, INT J SYST EVOL MICR, V53, P1411, DOI 10.1099/ijs.0.02504-0; Faisal M, 2007, J WILDLIFE DIS, V43, P618, DOI 10.7589/0090-3558-43.4.618; Figueras MJ, 2005, REV MED MICROBIOL, V16, P145; Grim CJ, 2013, MBIO, V4, DOI 10.1128/mBio.00064-13; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HAVELAAR AH, 1988, LETT APPL MICROBIOL, V7, P169, DOI 10.1111/j.1472-765X.1988.tb01271.x; Hossain MJ, 2014, MBIO, V5, DOI 10.1128/mBio.00848-14; Hu M, 2012, LETT APPL MICROBIOL, V55, P224, DOI 10.1111/j.1472-765X.2012.03281.x; Janda JM, 2010, CLIN MICROBIOL REV, V23, P35, DOI 10.1128/CMR.00039-09; Janda JM, 1998, CLIN INFECT DIS, V27, P332, DOI 10.1086/514652; Khajanchi BK, 2010, APPL ENVIRON MICROB, V76, P2313, DOI 10.1128/AEM.02535-09; Lamy B, 2010, DIAGN MICR INFEC DIS, V67, P9, DOI 10.1016/j.diagmicrobio.2009.12.012; Lee W. S., 2001, SMJ Singapore Medical Journal, V42, P057; Nam IY, 2007, J MICROBIOL, V45, P297; Nawaz M, 2010, FOOD MICROBIOL, V27, P327, DOI 10.1016/j.fm.2009.11.007; Nordmann P, 2002, CLIN MICROBIOL INFEC, V8, P321, DOI 10.1046/j.1469-0691.2002.00401.x; Pemberton JM, 1997, FEMS MICROBIOL LETT, V152, P1, DOI 10.1016/S0378-1097(97)00186-9; Pillai L, 2006, INFECT IMMUN, V74, P3742, DOI 10.1128/IAI.00402-06; Puthucheary SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030205; RHODES MW, 1994, WATER RES, V28, P2241, DOI 10.1016/0043-1354(94)90039-6; Sen K, 2004, J APPL MICROBIOL, V97, P1077, DOI 10.1111/j.1365-2672.2004.02398.x; Sha J, 2005, INFECT IMMUN, V73, P6446, DOI 10.1128/IAI.73.10.6446-6457.2005; Sha J, 2003, MICROB PATHOGENESIS, V34, P195, DOI 10.1016/S0882-4010(03)00028-7; Sha J, 2002, INFECT IMMUN, V70, P1924, DOI 10.1128/IAI.70.4.1924-1935.2002; Sha J, 2007, MICROB PATHOGENESIS, V43, P127, DOI 10.1016/j.micpath.2007.05.002; Sreedharan K, 2013, ANTON LEEUW INT J G, V103, P53, DOI 10.1007/s10482-012-9786-z; Szczuka E, 2004, J CLIN MICROBIOL, V42, P220, DOI 10.1128/JCM.42.1.220-228.2004; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; VERSALOVIC J, 1991, NUCLEIC ACIDS RES, V19, P6823, DOI 10.1093/nar/19.24.6823; Vilches S, 2008, MICROB PATHOGENESIS, V44, P1, DOI 10.1016/j.micpath.2007.06.004; Yamamoto S, 2000, MICROBIOL-SGM, V146, P2385, DOI 10.1099/00221287-146-10-2385; Yousr A, 2007, ASEAN FOOD J, V14, P115	46	35	37	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145933	10.1371/journal.pone.0145933	http://dx.doi.org/10.1371/journal.pone.0145933			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710336	Green Submitted, Green Published, gold			2022-12-26	WOS:000367451400092
J	Huang, HH; Lin, YT; Chen, WC; Huang, YW; Chen, SJ; Yang, TC				Huang, Hsin-Hui; Lin, Yi-Tsung; Chen, Wei-Ching; Huang, Yi-Wei; Chen, Shiang-Jiuun; Yang, Tsuey-Ching			Expression and Functions of CreD, an Inner Membrane Protein in Stenotrophomonas maltophilia	PLOS ONE			English	Article							L2 BETA-LACTAMASES; GENE-EXPRESSION; GROWTH; L1; INDUCTION; REGULATOR	CreBC is a highly conserved two-component regulatory system (TCS) in several gram-negative bacteria, including Escherichia coli, Aeromonas spp., Pseudomonas aeruginosa, and Stenotrophomonas maltophilia. CreD is a conserved gene that encodes a predicted innermembrane protein and is located near the creBC loci. Activation of CreBC increases creD expression; therefore, creD expression is generally used as a measure of CreBC activation in E. coli, Aeromonas spp., and P. aeruginosa systems. In this article, we aim to elucidate the expression of creD and further to investigate its functions in S. maltophilia. In spite of a short intergenic region of 81 bp between creBC and creD, creD is expressed separately from the adjacent creBC operon and from a promoter immediately upstream of creD (P-creD) in S. maltophilia. We found that the promoter activity of PcreD is negatively regulated by the creBC TCS, positively regulated by the bacterial culture density, and not affected by beta-lactams. Furthermore, creD expression is not significantly altered in the presence of the phosphor-mimic variant of CreB, CreB(D55E), which mimics activated CreB. The functions of CreD of S. maltophilia were assessed by comparison among the following: wild-type KJ; the creD isogenic mutant, KJ Delta CreD; and the complementary strain, KJ Delta CreD(pCreD). The mutant lacking creD had cell division defects and aberrations in cell envelope integrity, which then triggered the sigma(E)-mediated envelope stress response. Thus, the results indicated that CreD plays a critical role in the maintenance of envelope integrity.	[Huang, Hsin-Hui; Chen, Wei-Ching; Huang, Yi-Wei; Yang, Tsuey-Ching] Natl Yang Ming Univ, Dept Biotechnol, Taipei 112, Taiwan; [Huang, Hsin-Hui; Chen, Wei-Ching; Huang, Yi-Wei; Yang, Tsuey-Ching] Natl Yang Ming Univ, Lab Sci Med, Taipei 112, Taiwan; [Lin, Yi-Tsung] Taipei Vet Gen Hosp, Dept Med, Div Infect Dis, Taipei, Taiwan; [Lin, Yi-Tsung] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Chen, Shiang-Jiuun] Natl Taiwan Univ, Coll Life Sci, Inst Ecol & Evolutionary Biol & TechComm 5, Dept Life Sci, Taipei 10764, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Taiwan University	Yang, TC (corresponding author), Natl Yang Ming Univ, Dept Biotechnol, Taipei 112, Taiwan.	tcyang@ym.edu.tw	Huang, Yi-Wei/K-9717-2019		Ministry of Science and Technology of Taiwan [MOST 104-2320-B-010-023-MY3]; Professor Tsuei-Chu Mong Merit Scholarship. [40419001]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Professor Tsuei-Chu Mong Merit Scholarship.	This work was supported by grant MOST 104-2320-B-010-023-MY3 from Ministry of Science and Technology of Taiwan and grant 40419001 from Professor Tsuei-Chu Mong Merit Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grant MOST 104-2320-B-010-023-MY3 from Ministry of Science and Technology of Taiwan and grant 40419001 from Professor Tsuei-Chu Mong Merit Scholarship.	Alksne LE, 1997, J BACTERIOL, V179, P2006, DOI 10.1128/jb.179.6.2006-2013.1997; Avison MB, 2001, J BIOL CHEM, V276, P26955, DOI 10.1074/jbc.M011186200; Brooke JS, 2012, CLIN MICROBIOL REV, V25, P2, DOI 10.1128/CMR.00019-11; Cariss SJL, 2008, J BACTERIOL, V190, P3930, DOI 10.1128/JB.00108-08; Crossman LC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r74; DRURY LS, 1988, MOL MICROBIOL, V2, P109, DOI 10.1111/j.1365-2958.1988.tb00012.x; Elofsson A, 2007, ANNU REV BIOCHEM, V76, P125, DOI 10.1146/annurev.biochem.76.052705.163539; Hayden JD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001573; Hu RM, 2008, ANTIMICROB AGENTS CH, V52, P1198, DOI 10.1128/AAC.00682-07; Hu RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051053; Huang Y, ANTIMICROB AGENTS CH; Huang YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111784; KLOSE KE, 1993, J MOL BIOL, V232, P67, DOI 10.1006/jmbi.1993.1370; Li XZ, 2002, ANTIMICROB AGENTS CH, V46, P333, DOI 10.1128/AAC.46.2.333-343.2002; Lin CW, 2011, J ANTIMICROB CHEMOTH, V66, P2033, DOI 10.1093/jac/dkr276; Lin CW, 2009, RES MICROBIOL, V160, P152, DOI 10.1016/j.resmic.2008.11.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Moya B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000353; Niumsup P, 2003, J ANTIMICROB CHEMOTH, V51, P1351, DOI 10.1093/jac/dkg247; Olaitan AO, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00643; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Tayler AE, 2010, MICROBIOL-SGM, V156, P2327, DOI 10.1099/mic.0.035220-0; Yang TC, 2009, ANTIMICROB AGENTS CH, V53, P2902, DOI 10.1128/AAC.01513-08; Zamorano L, 2014, ANTIMICROB AGENTS CH, V58, P5084, DOI 10.1128/AAC.02556-14	24	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145009	10.1371/journal.pone.0145009	http://dx.doi.org/10.1371/journal.pone.0145009			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26698119	Green Submitted, Green Published, gold			2022-12-26	WOS:000367092600041
J	Joseph, JV; van Roosmalen, IAM; Busschers, E; Tomar, T; Conroy, S; Eggens-Meijer, E; Fajardo, NP; Pore, MM; Balasubramanyian, V; Wagemakers, M; Copray, S; den Dunnen, WFA; Kruyt, FAE				Joseph, Justin V.; van Roosmalen, Ingrid A. M.; Busschers, Ellen; Tomar, Tushar; Conroy, Siobhan; Eggens-Meijer, Ellie; Fajardo, Natalia Penaranda; Pore, Milind M.; Balasubramanyian, Veerakumar; Wagemakers, Michiel; Copray, Sjef; den Dunnen, Wilfred F. A.; Kruyt, Frank A. E.			Serum-Induced Differentiation of Glioblastoma Neurospheres Leads to Enhanced Migration/Invasion Capacity That Is Associated with Increased MMP9	PLOS ONE			English	Article							CANCER STEM-CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; HUMAN BRAIN; MATRIX METALLOPROTEINASES; INVASION; GLIOMAS; TRANSDIFFERENTIATION; IDENTIFICATION; ASTROCYTES; RESISTANCE	Glioblastoma (GBM) is a highly infiltrative brain tumor in which cells with properties of stem cells, called glioblastoma stem cells (GSCs), have been identified. In general, the dominant view is that GSCs are responsible for the initiation, progression, invasion and recurrence of this tumor. In this study, we addressed the question whether the differentiation status of GBM cells is associated with their invasive capacity. For this, several primary GBM cell lines were used, cultured either as neurospheres known to enrich for GSCs or in medium supplemented with 10% FCS that promotes differentiation. The differentiation state of the cells was confirmed by determining the expression of stem cell and differentiation markers. The migration/invasion potential of these cells was tested using in vitro assays and intracranial mouse models. Interestingly, we found that serum-induced differentiation enhanced the invasive potential of GBM cells, which was associated with enhanced MMP9 expression. Chemical inhibition of MMP9 significantly reduced the invasive potential of differentiated cells in vitro. Furthermore, the serum-differentiated cells could revert back to an undifferentiated/stem cell state that were able to form neurospheres, although with a reduced efficiency as compared to non-differentiated counterparts. We propose a model in which activation of the differentiation program in GBM cells enhances their infiltrative potential and that depending on microenvironmental cues a significant portion of these cells are able to revert back to an undifferentiated state with enhanced tumorigenic potential. Thus, effective therapy should target both GSCs and differentiated offspring and targeting of differentiation-associated pathways may offer therapeutic opportunities to reduce invasive growth of GBM.	[Joseph, Justin V.; van Roosmalen, Ingrid A. M.; Busschers, Ellen; Fajardo, Natalia Penaranda; Pore, Milind M.; Kruyt, Frank A. E.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, Groningen, Netherlands; [van Roosmalen, Ingrid A. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Pharm, Groningen, Netherlands; [Tomar, Tushar] Univ Groningen, Univ Med Ctr Groningen, Dept Gynecol Oncol, Groningen, Netherlands; [Conroy, Siobhan; den Dunnen, Wilfred F. A.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol, Groningen, Netherlands; [Eggens-Meijer, Ellie; Balasubramanyian, Veerakumar; Copray, Sjef] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, Groningen, Netherlands; [Wagemakers, Michiel] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosurg, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen	Kruyt, FAE (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, Groningen, Netherlands.	f.a.e.kruyt@umcg.nl	Tomar, Tushar/AAJ-3952-2021; Tomar, Tushar/AAK-1012-2020	Tomar, Tushar/0000-0002-3344-7605; den Dunnen, Wilfred/0000-0002-4168-1207; Kruyt, Frank/0000-0002-2445-9380	Dutch Cancer Society [RUG2011-5150]; Graduate School of Medical Sciences; GUIDE-CRCG; Jan Kornelis de Cock Foundation	Dutch Cancer Society(KWF Kankerbestrijding); Graduate School of Medical Sciences; GUIDE-CRCG; Jan Kornelis de Cock Foundation	This work was supported by grant RUG2011-5150 from the Dutch Cancer Society, the Graduate School of Medical Sciences, GUIDE-CRCG and the Jan Kornelis de Cock Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bhat KPL, 2013, CANCER CELL, V24, P331, DOI 10.1016/j.ccr.2013.08.001; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Brabletz T, 2012, CANCER CELL, V22, P699, DOI 10.1016/j.ccr.2012.11.009; Campos B, 2010, CLIN CANCER RES, V16, P2715, DOI 10.1158/1078-0432.CCR-09-1800; Cheng L, 2011, BIOCHEM BIOPH RES CO, V406, P643, DOI 10.1016/j.bbrc.2011.02.123; Cheng L, 2010, BIOCHEM PHARMACOL, V80, P654, DOI 10.1016/j.bcp.2010.04.035; Dandy WE, 1928, J AMER MED ASSOC, V90, P823, DOI 10.1001/jama.1928.02690380007003; Das G, 2011, MOL CARCINOGEN, V50, P412, DOI 10.1002/mc.20723; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Eichenbaum KD, 2005, BIOTECHNIQUES, V39, P487, DOI 10.2144/000112003; Eyler CE, 2008, J CLIN ONCOL, V26, P2839, DOI 10.1200/JCO.2007.15.1829; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gardner WJ, 1933, JAMA-J AM MED ASSOC, V12, P154; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; Gritti A, 1996, J NEUROSCI, V16, P1091; Holland EC, 2000, P NATL ACAD SCI USA, V97, P6242, DOI 10.1073/pnas.97.12.6242; Joseph JV, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.395; Laks DR, 2009, STEM CELLS, V27, P980, DOI 10.1002/stem.15; Lang B, 2004, NEUROSCIENCE, V128, P775, DOI 10.1016/j.neuroscience.2004.06.033; Lathia JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024807; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Liu LP, 2010, CANCER RES, V70, P3750, DOI 10.1158/0008-5472.CAN-09-3838; Malanchi I, 2012, NATURE, V481, P85, DOI 10.1038/nature10694; Miao H, 2014, ONCOGENE, DOI [10.1038/onc.2013.590, DOI 10.1038/onc.2013.590]; Nakada M, 2003, FRONT BIOSCI, V8, pE261, DOI 10.2741/1016; Ocana OH, 2012, CANCER CELL, V22, P709, DOI 10.1016/j.ccr.2012.10.012; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Rath BH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054752; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rohde LE, 1999, CIRCULATION, V99, P3063, DOI 10.1161/01.CIR.99.23.3063; Sanai N, 2005, NEW ENGL J MED, V353, P811, DOI 10.1056/NEJMra043666; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; van Strien ME, 2011, CELL RES, V21, P1523, DOI 10.1038/cr.2011.101; Vescovi AL, 2001, BIOMED PHARMACOTHER, V55, P201, DOI 10.1016/S0753-3322(01)00056-7; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Wang Maode, 2003, Brain Tumor Pathol, V20, P65, DOI 10.1007/BF02483449; Weber K, 2010, J NEUROPATH EXP NEUR, V69, P623, DOI 10.1097/NEN.0b013e3181e04739; Weller M, 2014, LANCET ONCOL, V15, pE395, DOI 10.1016/S1470-2045(14)70011-7; Whitman MC, 2009, PROG NEUROBIOL, V89, P162, DOI 10.1016/j.pneurobio.2009.07.003; Wick W, 2008, NEURO-ONCOLOGY, V10, P1019, DOI 10.1215/15228517-2008-058; Xie Q, 2014, NEURO-ONCOLOGY, V16, P1575, DOI 10.1093/neuonc/nou147; Yang H, 2009, CELL MOL NEUROBIOL, V29, P455, DOI 10.1007/s10571-008-9337-3; Yang TQ, 2014, CANCER SCI, V105, P265, DOI 10.1111/cas.12351; Yuan XP, 2004, ONCOGENE, V23, P9392, DOI 10.1038/sj.onc.1208311	47	25	26	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145393	10.1371/journal.pone.0145393	http://dx.doi.org/10.1371/journal.pone.0145393			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700636	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092600074
J	Rad, SK; Kanthimathi, MS; Abd Malek, SN; Lee, GS; Looi, CY; Wong, WF				Rad, Sima Kianpour; Kanthimathi, M. S.; Abd Malek, Sri Nurestri; Lee, Guan Serm; Looi, Chung Yeng; Wong, Won Fen			Cinnamomum cassia Suppresses Caspase-9 through Stimulation of AKT1 in MCF-7 Cells but Not in MDA-MB-231 Cells	PLOS ONE			English	Article							INDUCED APOPTOSIS; GLUTATHIONE-PEROXIDASE; MITOCHONDRIAL DAMAGE; SUPEROXIDE-DISMUTASE; ANTIOXIDANT ACTIVITY; CANCER; BARK; P53; INHIBITORS; INDUCTION	Background Cinnamomum cassia bark is a popular culinary spice used for flavoring and in traditional medicine. C. cassia extract (CE) induces apoptosis in many cell lines. In the present study, particular differences in the mechanism of the anti-proliferative property of C. cassia on two breast cancer cell lines, MCF-7 and MDA-MB-231, were elucidated. Methodology/Principal Findings The hexane extract of C. cassia demonstrated high anti-proliferative activity against MCF-7 and MDA-MB-231 cells (IC50, 34 +/- 3.52 and 32.42 +/- 0.37 mu g/ml, respectively). Oxidative stress due to disruption of antioxidant enzyme (SOD, GPx and CAT) activity is suggested as the probable cause for apoptosis initiation. Though the main apoptosis pathway in both cell lines was found to be through caspase-8 activation, caspase-9 was also activated in MDA-MB-231 cells but suppressed in MCF-7 cells. Gene expression studies revealed that AKT1, the caspase-9 suppressor, was up-regulated in MCF-7 cells while down-regulated in MDA-MB-231 cells. Although, AKT1 protein expression in both cell lines was down-regulated, a steady increase in MCF-7 cells was observed after a sharp decrease of suppression of AKT1. Trans-cinnamaldehyde and coumarin were isolated and identified and found to be mainly responsible for the observed anti-proliferative activity of CE (Cinnamomum cassia). Conclusion Activation of caspase-8 is reported for the first time to be involved as the main apoptosis pathway in breast cancer cell lines upon treatment with C. cassia. The double effects of C. cassia on AKT1 gene expression in MCF-7 cells is reported for the first time in this study.	[Rad, Sima Kianpour; Kanthimathi, M. S.] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia; [Kanthimathi, M. S.] Univ Malaya, Fac Med, UMCPR, Ctr Prote Res, Kuala Lumpur, Malaysia; [Abd Malek, Sri Nurestri; Lee, Guan Serm] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia; [Looi, Chung Yeng] Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur 50603, Malaysia; [Wong, Won Fen] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya	Kanthimathi, MS (corresponding author), Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur, Malaysia.	kanthi@ummc.edu.my	Malek, Sri Nurestri Abd/B-9834-2010; Kianpour Rad, Sima/AAC-5642-2022; Wong, Won Fen/D-3087-2012; Malek, Sri Nurestri/W-8556-2019; LEE, GUAN SERM/B-8833-2010	Malek, Sri Nurestri Abd/0000-0001-6278-8559; Wong, Won Fen/0000-0003-1082-1956; Malek, Sri Nurestri/0000-0001-6278-8559; LEE, GUAN SERM/0000-0002-8386-4976	University of Malaya Research University [UMRG RG290-14AFR, RP027A-14HTM]; University of Malaya	University of Malaya Research University; University of Malaya(Universiti Malaya)	This research was supported by University of Malaya Research University grants, UMRG RG290-14AFR and RP027A-14HTM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank the University of Malaya for financial support.	Almeida RD, 2004, BBA-REV CANCER, V1704, P59, DOI 10.1016/j.bbcan.2004.05.003; Amaral JD, 2010, DISCOV MED, V9, P145; Angeloni SV, 2004, J ENDOCRINOL, V180, P497, DOI 10.1677/joe.0.1800497; Araujo JR, 2011, NUTR RES, V31, P77, DOI 10.1016/j.nutres.2011.01.006; Arbab IA, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/856029; Assadollahi V, 2013, ADV BIOMEDICAL RES, P2; Azad MB, 2009, ANTIOXID REDOX SIGN, V11, P777, DOI [10.1089/ars.2008.2270, 10.1089/ARS.2008.2270]; Blanc C, 2000, CANCER RES, V60, P4386; Cardo-Vila M, 2003, MOL CELL, V11, P1151, DOI 10.1016/S1097-2765(03)00138-2; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Chuang JY, 2007, IN VIVO, V21, P1003; Ciapetti G, 2002, BIOMATERIALS, V23, P617, DOI 10.1016/S0142-9612(01)00149-1; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; D'Archivio M, 2008, INT J MOL SCI, V9, P213, DOI 10.3390/ijms9030213; de Fatima A, 2006, BIOORGAN MED CHEM, V14, P622, DOI 10.1016/j.bmc.2005.08.036; Dejean LM, 2006, CELL DEATH DIFFER, V13, P1387, DOI 10.1038/sj.cdd.4401949; Downward J, 2004, SEMINARS CELL DEV BI; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Evens AM, 2005, BLOOD, V105, P1265, DOI 10.1182/blood-2004-03-0964; Fan TJ, 2005, ACTA BIOCH BIOPH SIN, V37, P719, DOI 10.1111/j.1745-7270.2005.00108.x; Fesik SW, 2001, SCIENCE, V294, P1477, DOI 10.1126/science.1062236; Franco-Molina MA, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-148; Frydman-Marom A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016564; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Gerhauser C, 2003, MUTAT RES-FUND MOL M, V523, P163, DOI 10.1016/S0027-5107(02)00332-9; GONZALES R, 1984, CANCER RES, V44, P4137; Hu YM, 1998, P NATL ACAD SCI USA, V95, P4386, DOI 10.1073/pnas.95.8.4386; Huang HL, 2003, ONCOGENE, V22, P8168, DOI 10.1038/sj.onc.1206979; Kim IG, 2008, ENVIRON TOXICOL PHAR, V25, P75, DOI 10.1016/j.etap.2007.09.002; Koppikar SJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-210; Kuete V, 2010, FRONT PHARMACOL, V1, DOI 10.3389/fphar.2010.00123; Lahiry L, 2008, APOPTOSIS, V13, P771, DOI 10.1007/s10495-008-0213-x; Lamkanfi M, 2007, CELL DEATH DIFFER, V14, P44, DOI 10.1038/sj.cdd.4402047; Lee KH, 2006, PHYTOTHER RES, V20, P952, DOI 10.1002/ptr.1984; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Lopez-Gonzalez JS, 2004, LUNG CANCER-J IASLC, V43, P275, DOI 10.1016/j.lungcan.2003.09.005; Lopez-Lazaro M, 2007, CANCER LETT, V252, P1, DOI 10.1016/j.canlet.2006.10.029; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARKLUND SL, 1982, CANCER RES, V42, P1955; Mayo LD, 2002, TRENDS BIOCHEM SCI, V27, P462, DOI 10.1016/S0968-0004(02)02166-7; O'Mahony R, 2005, WORLD J GASTROENTERO, V11, P7499, DOI 10.3748/wjg.v11.i47.7499; Peter K. V, 2006, HDB HERBS SPICES, V3; Rashad AE, 2010, ARCH PHARM, V343, P440, DOI 10.1002/ardp.201000002; Rasul A, 2011, ASIAN PAC J CANCER P, V12, P1219; Riveiro ME, 2008, BIOORGAN MED CHEM, V16, P2665, DOI 10.1016/j.bmc.2007.11.038; Rosato RR, 2003, MOL CANCER THER, V2, P1273; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Shklyar B, 2013, MOL CELL BIOL, V33, P3191, DOI 10.1128/MCB.00233-13; Tang ELH, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-347; Tomaino A, 2005, FOOD CHEM, V89, P549, DOI 10.1016/j.foodchem.2004.03.011; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Tsuji-Naito K, 2008, BIOORGAN MED CHEM, V16, P9176, DOI 10.1016/j.bmc.2008.09.036; Watanabe Y, 2013, J ALLERGY CLIN IMMUN, V132, P648, DOI 10.1016/j.jaci.2013.03.046; Wondrak GT, 2010, MOLECULES, V15, P3338, DOI 10.3390/molecules15053338; Wu SJ, 2007, FOOD CHEM TOXICOL, V45, P2446, DOI 10.1016/j.fct.2007.05.032; Yang PM, 2012, INT J ONCOL, V40, P469, DOI 10.3892/ijo.2011.1203; Yu YB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009339; Zhang JH, 2010, ACTA PHARMACOL SIN, V31, P861, DOI 10.1038/aps.2010.76; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973; Zu YG, 2010, MOLECULES, V15, P3200, DOI 10.3390/molecules15053200	60	19	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145216	10.1371/journal.pone.0145216	http://dx.doi.org/10.1371/journal.pone.0145216			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700476	Green Published, gold			2022-12-26	WOS:000367092600053
J	Rhee, SY; Jordan, MR; Raizes, E; Chua, A; Parkin, N; Kantor, R; Van Zyl, GU; Mukui, I; Hosseinipour, MC; Frenkel, LM; Ndembi, N; Hamers, RL; de Wit, TFR; Wallis, CL; Gupta, RK; Fokam, J; Zeh, C; Schapiro, JM; Carmona, S; Katzenstein, D; Tang, M; Aghokeng, AF; De Oliveira, T; Wensing, AMJ; Gallant, JE; Wainberg, MA; Richman, DD; Fitzgibbon, JE; Schito, M; Bertagnolio, S; Yang, CF; Shafer, RW				Rhee, Soo-Yon; Jordan, Michael R.; Raizes, Elliot; Chua, Arlene; Parkin, Neil; Kantor, Rami; Van Zyl, Gert U.; Mukui, Irene; Hosseinipour, Mina C.; Frenkel, Lisa M.; Ndembi, Nicaise; Hamers, Raph L.; de Wit, Tobias F. Rinke; Wallis, Carole L.; Gupta, Ravindra K.; Fokam, Joseph; Zeh, Clement; Schapiro, Jonathan M.; Carmona, Sergio; Katzenstein, David; Tang, Michele; Aghokeng, Avelin F.; De Oliveira, Tulio; Wensing, Annemarie M. J.; Gallant, Joel E.; Wainberg, Mark A.; Richman, Douglas D.; Fitzgibbon, Joseph E.; Schito, Marco; Bertagnolio, Silvia; Yang, Chunfu; Shafer, Robert W.			HIV-1 Drug Resistance Mutations: Potential Applications for Point-of-Care Genotypic Resistance Testing	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; ACTIVE ANTIRETROVIRAL THERAPY; SUB-SAHARAN AFRICA; VIROLOGICAL FAILURE; PROTEASE INHIBITOR; SOUTH-AFRICA; HIV-1-INFECTED PATIENTS; TREATMENT PROGRAMS; NAIVE INDIVIDUALS; ATAZANAVIR	The increasing prevalence of acquired and transmitted HIV-1 drug resistance is an obstacle to successful antiretroviral therapy (ART) in the low- and middle-income countries (LMICs) hardest hit by the HIV-1 pandemic. Genotypic drug resistance testing could facilitate the choice of initial ART in areas with rising transmitted drug resistance (TDR) and enable care-providers to determine which individuals with virological failure (VF) on a first-or second-line ART regimen require a change in treatment. An inexpensive near point-of-care (POC) genotypic resistance test would be useful in settings where the resources, capacity, and infrastructure to perform standard genotypic drug resistance testing are limited. Such a test would be particularly useful in conjunction with the POC HIV-1 viral load tests that are currently being introduced in LMICs. A POC genotypic resistance test is likely to involve the use of allele-specific point mutation assays for detecting drug-resistance mutations (DRMs). This study proposes that two major nucleoside reverse transcriptase inhibitor (NRTI)-associated DRMs (M184V and K65R) and four major NNRTI-associated DRMs (K103N, Y181C, G190A, and V106M) would be the most useful for POC genotypic resistance testing in LMIC settings. One or more of these six DRMs was present in 61.2% of analyzed virus sequences from ART-naive individuals with intermediate or high-level TDR and 98.8% of analyzed virus sequences from individuals on a first-line NRTI/NNRTI-containing regimen with intermediate or high-level acquired drug resistance. The detection of one or more of these DRMs in an ART-naive individual or in a individual with VF on a first-line NRTI/NNRTI-containing regimen may be considered an indication for a protease inhibitor (PI)-containing regimen or closer virological monitoring based on cost-effectiveness or country policy.	[Rhee, Soo-Yon; Katzenstein, David; Tang, Michele; Shafer, Robert W.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Jordan, Michael R.] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Raizes, Elliot; Yang, Chunfu] Ctr Dis Control & Prevent, Div Global HIV AIDS, Atlanta, GA USA; [Chua, Arlene] Access Campaign, Med Sans Frontieres, Geneva, Switzerland; [Chua, Arlene] Tan Tock Seng Hosp, Inst Infect Dis & Epidemiol, Singapore, Singapore; [Parkin, Neil] Data First Consulting, Belmont, MA USA; [Kantor, Rami] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; [Van Zyl, Gert U.] Natl Hlth Lab Serv, Tygerberg, Coastal Branch, South Africa; [Van Zyl, Gert U.] Univ Stellenbosch, Div Med Virol, Parow, South Africa; [Mukui, Irene] Natl AIDS & Sexually Transmitted Infect STI Contr, Minist Hlth, Nairobi, Kenya; [Hosseinipour, Mina C.] UNC Project, Lilongwe, Malawi; [Frenkel, Lisa M.] Univ Washington, Seattle, WA 98195 USA; [Frenkel, Lisa M.] Seattle Childrens Res Inst, Seattle, WA USA; [Ndembi, Nicaise] Inst Human Virol, Abuja, Nigeria; [Hamers, Raph L.; de Wit, Tobias F. Rinke] Univ Amsterdam, Acad Med Ctr, AIGHD, Dept Global Hlth, NL-1105 AZ Amsterdam, Netherlands; [Wallis, Carole L.] Lancet Labs & BARC SA, Johannesburg, South Africa; [Gupta, Ravindra K.] UCL, Dept Infect, London, England; [Fokam, Joseph] Chantal BIYA Int Reference Ctr Res HIV AIDS Preve, Yaounde, Cameroon; [Fokam, Joseph] Univ Yaounde I, FMBS, Yaounde, Cameroon; [Zeh, Clement] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA USA; [Schapiro, Jonathan M.] Natl Hemophilia Ctr, Tel Hashomer, Israel; [Carmona, Sergio] Univ Witwatersrand, Dept Haematol & Mol Med, Johannesburg, South Africa; [Carmona, Sergio] Natl Hlth Lab Serv, Johannesburg, South Africa; [Aghokeng, Avelin F.] Virol Lab CREMER IMPM, Yaounde, Cameroon; [De Oliveira, Tulio] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Sch Lab Med & Med Sci, Durban, South Africa; [Wensing, Annemarie M. J.] Univ Med Ctr Utrecht, Dept Med Microbiol, Virol, Utrecht, Netherlands; [Gallant, Joel E.] Southwest CARE Ctr, Santa Fe, NM USA; [Wainberg, Mark A.] McGill Univ, Jewish Gen Hosp, AIDS Ctr, Montreal, PQ H3T 1E2, Canada; [Richman, Douglas D.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Richman, Douglas D.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; [Fitzgibbon, Joseph E.] NIAID, NIH, Drug Dev & Clin Sci Branch, Div Aids, Bethesda, MD 20892 USA; [Schito, Marco] Adv Mil Med Inc, Henry M Jackson Fdn, HJF DAIDS Div, Bethesda, MD USA; [Bertagnolio, Silvia] WHO, HIV Dept, CH-1211 Geneva, Switzerland	Stanford University; Tufts University; Centers for Disease Control & Prevention - USA; Doctors Without Borders; Tan Tock Seng Hospital; Brown University; Stellenbosch University; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; University of London; University College London; University of Yaounde I; Centers for Disease Control & Prevention - USA; University of Witwatersrand; National Health Laboratory Service; University of Kwazulu Natal; Utrecht University; Utrecht University Medical Center; McGill University; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; World Health Organization	Rhee, SY (corresponding author), Stanford Univ, Dept Med, Stanford, CA 94305 USA.	syrhee@stanford.edu	van Zyl, Gert/I-7357-2019; NDEMBI, Nicaise/AAE-4383-2020; Mukui, Irene/GYE-0151-2022; Parkin, Neil/P-2724-2019; Gupta, Ravindra/G-5529-2015	van Zyl, Gert/0000-0003-3021-5101; katzenstein, david/0000-0002-8593-4560; Carmona, Sergio/0000-0002-6792-4748; Hamers, Raph/0000-0002-5007-7896; Gupta, Ravindra/0000-0001-9751-1808; Rhee, Soo-Yon/0000-0002-1231-6542; Chua, Arlene/0000-0001-6428-9083; AGHOKENG FOBANG, Avelin/0000-0002-1414-0237; Mukui, Irene/0000-0002-3699-1841; Wallis, Carole/0000-0001-8408-8772	Bill and Melinda Gates Foundation; NIH [AI068581]; CFAR [1P30A142853]; Presidents Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068581, R56AI068581] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CFAR; Presidents Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC)(United States Agency for International Development (USAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	RWS and SYR were supported in part by a grant from the Bill and Melinda Gates Foundation and from the NIH (AI068581). NP was supported by a grant from the Bill and Melinda Gates Foundation. MRJ was supported in part by CFAR 1P30A142853. This project has been supported in part by the Presidents Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC). Data First Consulting provided support in the form of salaries for authors NP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghokeng AF, 2014, CLIN INFECT DIS, V58, P99, DOI 10.1093/cid/cit627; Aitken SC, 2013, J CLIN MICROBIOL, V51, P1757, DOI 10.1128/JCM.00118-13; Barber TJ, 2012, J ANTIMICROB CHEMOTH, V67, P995, DOI 10.1093/jac/dkr569; Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; Bertagnolio S, 2013, J INFECT DIS, V207, pS45, DOI 10.1093/infdis/jit121; Bonner K, 2013, JAIDS-J ACQ IMM DEF, V64, P74, DOI 10.1097/QAI.0b013e31829f05ac; Bor J, 2013, SCIENCE, V339, P961, DOI 10.1126/science.1230413; Bronze M, 2013, J VIROL METHODS, DOI [10.1016/j.jviromet.2013.08.015, DOI 10.1016/J.JVIR0MET.2013.08.015]; Castagna A, 2014, AIDS, V28, P2269, DOI [10.1097/QAD.000000, 10.1097/QAD.0000000000000407]; Chi BH, 2013, CURR OPIN HIV AIDS, V8, P498, DOI 10.1097/COH.0b013e3283637f7a; Chung MH, 2014, JAIDS-J ACQ IMM DEF, V67, P246, DOI 10.1097/QAI.0000000000000312; Clutter DS, 2015, PLOS ONE; Dolling DI, 2013, J ANTIMICROB CHEMOTH, V68, P2339, DOI 10.1093/jac/dkt199; Eaton JW, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001245; Frentz D, 2012, AIDS REV, V14, P17; Fun A, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-63; Guiguet M, 2012, AIDS, V26, P2345, DOI 10.1097/QAD.0b013e32835646e0; Gupta RK, 2014, CLIN INFECT DIS, V58, P1023, DOI 10.1093/cid/cit933; Gupta RK, 2012, LANCET, V380, P1250, DOI 10.1016/S0140-6736(12)61038-1; Gupta RK, 2009, LANCET INFECT DIS, V9, P409, DOI 10.1016/S1473-3099(09)70136-7; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; Hamers RL, 2010, JAIDS-J ACQ IMM DEF, V55, P95, DOI 10.1097/QAI.0b013e3181e544e0; HIV/AIDS Programme World Health Organization, 2012, WHO HIV DRUG RES REP; HIV/ AIDS Programme World Health Organization, 2013, CONGUID UANT DRU; Hoffmann CJ, 2014, TROP MED INT HEALTH, V19, P236, DOI 10.1111/tmi.12237; Hoffmann CJ, 2009, CLIN INFECT DIS, V49, P1928, DOI 10.1086/648444; Holmes CB, 2010, JAMA-J AM MED ASSOC, V304, P313, DOI 10.1001/jama.2010.993; Johnston V, 2012, JAIDS-J ACQ IMM DEF, V61, P370, DOI 10.1097/QAI.0b013e318266ee3f; Karlstrom O, 2007, JAIDS-J ACQ IMM DEF, V44, P417, DOI 10.1097/QAI.0b013e31802e2940; Lapointe HR, 2015, ANTIMICROB AGENTS CH, V59, P6824, DOI 10.1128/AAC.01490-15; Llibre JM, 2013, AIDS REV, V15, P112; MacLeod I, 2014, C RETR OPP INF; Malan D R Niel, 2010, J Int Assoc Physicians AIDS Care (Chic), V9, P34, DOI 10.1177/1545109709355828; McMahon JH, 2013, B WORLD HEALTH ORGAN, V91, P377, DOI 10.2471/BLT.12.112946; Molina JM, 2008, LANCET, V372, P646, DOI 10.1016/S0140-6736(08)61081-8; Mollan K, 2012, J INFECT DIS, V206, P1920, DOI 10.1093/infdis/jis613; Murtagh M, 2014, HIV AIDS DIAGNOSTIC; Malan DR, 2008, JAIDS-J ACQ IMM DEF, V47, P161, DOI 10.1097/QAI.0b013e31815ace6a; Rabi SA, 2013, J CLIN INVEST, V123, P3848, DOI 10.1172/JCI67399; Rhee SY, 2010, ANTIMICROB AGENTS CH, V54, P4253, DOI 10.1128/AAC.00574-10; Rhee SY, 2015, PLOS MED IN PRESS; Rimsky L, 2012, JAIDS-J ACQ IMM DEF, V59, P39, DOI 10.1097/QAI.0b013e31823df4da; Ritchie AV, 2014, J CLIN MICROBIOL, V52, P3377, DOI 10.1128/JCM.00593-14; Rivadeneira E, 2014, INT WORKSH ANT DRUG; Rosenbloom DIS, 2012, NAT MED, V18, P1378, DOI 10.1038/nm.2892; Rowley CF, 2014, CLIN INFECT DIS, V58, P407, DOI 10.1093/cid/cit733; Scott L, 2015, J CLIN MICROBIOL, V53, P1616, DOI 10.1128/JCM.03325-14; Servais J, 2001, J CLIN MICROBIOL, V39, P454, DOI 10.1128/JCM.39.2.454-459.2001; Shelton JD, 2015, GLOBAL HLTH SCI PRAC; Siliciano JD, 2013, CURR OPIN VIROL, V3, P487, DOI 10.1016/j.coviro.2013.08.007; Stadeli KM, 2013, ANTIVIR THER, V18, P115, DOI 10.3851/IMP2437; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; The H. I. V. Causal Collaboration, 2015, CLIN INFECT DIS, DOI [10.1093/cid/ciu1167, DOI 10.1093/CID/CIU1167]; Vahey M, 1999, J CLIN MICROBIOL, V37, P2533, DOI 10.1128/JCM.37.8.2533-2537.1999; Van Zyl GU, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067188; Weinheimer S, 2005, ANTIMICROB AGENTS CH, V49, P3816, DOI 10.1128/AAC.49.9.3816-3824.2005; Wensing Annemarie M, 2014, Top Antivir Med, V22, P642; World Health Organization HIV/AIDS Programme, 2013, CONGUID UANT DRU; Zhang GQ, 2013, J CLIN MICROBIOL, V51, P3666, DOI 10.1128/JCM.01669-13; Zheng Y, 2014, CLIN INFECT DIS, V59, P888, DOI 10.1093/cid/ciu367	60	49	52	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145772	10.1371/journal.pone.0145772	http://dx.doi.org/10.1371/journal.pone.0145772			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717411	Green Published, gold, Green Submitted			2022-12-26	WOS:000367510500068
J	Rybalko, V; Hsieh, PL; Merscham-Banda, M; Suggs, LJ; Farrar, RP				Rybalko, Viktoriya; Hsieh, Pei-Ling; Merscham-Banda, Melissa; Suggs, Laura J.; Farrar, Roger P.			The Development of Macrophage-Mediated Cell Therapy to Improve Skeletal Muscle Function after Injury	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; ISOMETRIC CONTRACTILE FUNCTION; GROWTH-FACTOR-I; TISSUE-REPAIR; TOURNIQUET ISCHEMIA; GENE-EXPRESSION; REGENERATION; MICE; MONOCYTES; RECOVERY	Skeletal muscle regeneration following acute injury is a multi-step process involving complex changes in tissue microenvironment. Macrophages (MPs) are one of the key cell types involved in orchestration and modulation of the repair process. Multiple studies highlight the essential role of MPs in the control of the myogenic program and inflammatory response during skeletal muscle regeneration. A variety of MP phenotypes have been identified and characterized in vitro as well as in vivo. As such, MPs hold great promise for cell-based therapies in the field of regenerative medicine. In this study we used bone-marrow derived in vitro LPS/IFN-y-induced M1 MPs to enhance functional muscle recovery after tourniquet-induced ischemia/reperfusion injury (TK-I/R). We detected a 15% improvement in specific tension and force normalized to mass after M1 (LPS/IFN-gamma) MP transplantation 24 hours post-reperfusion. Interestingly, we found that M0 bone marrow-derived unpolarized MPs significantly impaired muscle function highlighting the complexity of temporally coordinated skeletal muscle regenerative program. Furthermore, we show that delivery of M1 (LPS/IFN-gamma) MPs early in regeneration accelerates myofiber repair, decreases fibrotic tissue deposition and increases whole muscle IGF-I expression.	[Rybalko, Viktoriya; Hsieh, Pei-Ling; Merscham-Banda, Melissa; Farrar, Roger P.] Univ Texas Austin, Dept Kinesiol, Austin, TX 78712 USA; [Suggs, Laura J.] Univ Texas Austin, Cockrell Sch Engn, Biomed Engn, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Farrar, RP (corresponding author), Univ Texas Austin, Dept Kinesiol, 1 Univ Stn D3700, Austin, TX 78712 USA.	rfarrar@austin.utexas.edu		/0000-0002-1419-8017	National Institutes of Health [R01EB015007]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB015007] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by external non-Federal funding sources and the National Institutes of Health grant #R01EB015007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Bencze M, 2012, MOL THER, V20, P2168, DOI 10.1038/mt.2012.189; Bi W, 2010, J MED CHEM, V53, P6763, DOI 10.1021/jm100529e; Blaisdell FW, 2002, CARDIOVASC SURG, V10, P620, DOI 10.1016/S0967-2109(02)00070-4; Carden DL, 2000, J PATHOL, V190, P255, DOI 10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6; Chazaud B, 2003, J CELL BIOL, V163, P1133, DOI 10.1083/jcb.200212046; Chazaud B, 2014, IMMUNOBIOLOGY, V219, P172, DOI 10.1016/j.imbio.2013.09.001; Chazaud B, 2009, EXERC SPORT SCI REV, V37, P18, DOI 10.1097/JES.0b013e318190ebdb; Chen XYK, 2011, J SURG RES, V170, pE65, DOI 10.1016/j.jss.2011.05.061; Cowled RA, 2008, J INVEST SURG, V21, P119, DOI 10.1080/08941930802046501; DANON D, 1989, P NATL ACAD SCI USA, V86, P2018, DOI 10.1073/pnas.86.6.2018; Danon D, 1998, J Wound Care, V7, P281; Deune EG, 1996, PLAST RECONSTR SURG, V98, P711, DOI 10.1097/00006534-199609001-00018; Dillon JP, 2006, ACTA ORTHOP, V77, P27, DOI 10.1080/17453670610045669; FISH JS, 1989, J SURG RES, V47, P365, DOI 10.1016/0022-4804(89)90149-2; FISH JS, 1993, J HAND SURG-AM, V18A, P210, DOI 10.1016/0363-5023(93)90348-7; Florini JR, 1996, ENDOCR REV, V17, P481, DOI 10.1210/edrv-17-5-481; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Goren I, 2009, AM J PATHOL, V175, P132, DOI 10.2353/ajpath.2009.081002; Hamer PW, 2002, J ANAT, V200, P69, DOI 10.1046/j.0021-8782.2001.00008.x; Hammers DW, 2008, J APPL PHYSIOL, V105, P1274, DOI 10.1152/japplphysiol.90418.2008; Hammers DW, 2012, BIOTECHNOL BIOENG, V109, P1051, DOI 10.1002/bit.24382; Hammers DW, 1985, J APPL PHYSIOL, V2015, DOI [10.1152/japplphysiol.00313.2014, DOI 10.1152/JAPPLPHYSI0L.00313.2014]; Hardin BJ, 2008, J APPL PHYSIOL, V104, P694, DOI 10.1152/japplphysiol.00898.2007; Jetten N, 2014, ANGIOGENESIS, V17, P109, DOI 10.1007/s10456-013-9381-6; Jetten N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068811; Keeling S, 2013, BIOL RES NURS, V15, P62, DOI 10.1177/1099800411414871; Koh TJ, 2005, AM J PHYSIOL-CELL PH, V289, pC217, DOI 10.1152/ajpcell.00555.2004; Lu HY, 2011, FASEB J, V25, P3344, DOI 10.1096/fj.10-178939; Lu HY, 2011, FASEB J, V25, P358, DOI 10.1096/fj.10-171579; McEwen PKIM, 2004, NATO RTO MP HFM PROC, V109, P1; Merritt EK, 2010, TISSUE ENG PT A, V16, P1395, DOI [10.1089/ten.tea.2009.0226, 10.1089/ten.TEA.2009.0226]; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; NATHAN CF, 1987, J CLIN INVEST, V79, P319, DOI 10.1172/JCI112815; Novak ML, 2014, J PATHOL, V232, P344, DOI 10.1002/path.4301; Novak ML, 2013, J LEUKOCYTE BIOL, V93, P875, DOI 10.1189/jlb.1012512; Novak ML, 2011, J IMMUNOL, V187, P1448, DOI 10.4049/jimmunol.1004091; Ochoa O, 2007, AM J PHYSIOL-REG I, V293, pR651, DOI 10.1152/ajpregu.00069.2007; Patel H, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/121237; Pelosi L, 2007, FASEB J, V21, P1393, DOI 10.1096/fj.06-7690com; Perdiguero E, 2012, CELL CYCLE, V11, P877, DOI 10.4161/cc.11.5.19374; Perdiguero E, 2011, J CELL BIOL, V195, P307, DOI 10.1083/jcb.201104053; Sachdev U, 2013, J VASC SURG, V58, P460, DOI 10.1016/j.jvs.2012.11.071; Saclier M, 2013, FEBS J, V280, P4118, DOI 10.1111/febs.12166; Saclier M, 2013, STEM CELLS, V31, P384, DOI 10.1002/stem.1288; Segawa M, 2008, EXP CELL RES, V314, P3232, DOI 10.1016/j.yexcr.2008.08.008; Shen W, 2005, AM J PATHOL, V167, P1105, DOI 10.1016/S0002-9440(10)61199-6; Sisson TH, 2009, BLOOD, V114, P5052, DOI 10.1182/blood-2008-12-196212; Smith C, 2008, SPORTS MED, V38, P947, DOI 10.2165/00007256-200838110-00005; Summan M, 2006, AM J PHYSIOL-REG I, V290, pR1488, DOI 10.1152/ajpregu.00465.2005; Ten Broek RW, 2010, J CELL PHYSIOL, V224, P7, DOI 10.1002/jcp.22127; Tidball JG, 2007, J PHYSIOL-LONDON, V578, P327, DOI 10.1113/jphysiol.2006.118265; Tidball JG, 2011, COMPR PHYSIOL, V1, P2029, DOI 10.1002/cphy.c100092; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; Tonkin J, 2015, MOL THER, V23, P1189, DOI 10.1038/mt.2015.66; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; Vignaud A, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/724914; Wang HZ, 2014, AM J PATHOL, V184, P1167, DOI 10.1016/j.ajpath.2013.12.020	59	44	45	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145550	10.1371/journal.pone.0145550	http://dx.doi.org/10.1371/journal.pone.0145550			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717325	Green Submitted, Green Published, gold			2022-12-26	WOS:000367510500044
J	Halley, YA; Oldeschulte, DL; Bhattarai, EK; Hill, J; Metz, RP; Johnson, CD; Presley, SM; Ruzicka, RE; Rollins, D; Peterson, MJ; Murphy, WJ; Seabury, CM				Halley, Yvette A.; Oldeschulte, David L.; Bhattarai, Eric K.; Hill, Joshua; Metz, Richard P.; Johnson, Charles D.; Presley, Steven M.; Ruzicka, Rebekah E.; Rollins, Dale; Peterson, Markus J.; Murphy, William J.; Seabury, Christopher M.			Northern Bobwhite (Colinus virginianus) Mitochondrial Population Genomics Reveals Structure, Divergence, and Evidence for Heteroplasmy	PLOS ONE			English	Article							ADAPTIVE PROTEIN EVOLUTION; OXYSPIRURA-PETROWI; QUAIL ABUNDANCE; PAIRWISE COMPARISONS; COMPLETE SEQUENCE; CONTROL REGION; DNA SEQUENCES; GENE FLOW; MUTATIONS; PHYLOGENY	Herein, we evaluated the concordance of population inferences and conclusions resulting from the analysis of short mitochondrial fragments (i.e., partial or complete D-Loop nucleotide sequences) versus complete mitogenome sequences for 53 bobwhites representing six ecoregions across TX and OK (USA). Median joining (MJ) haplotype networks demonstrated that analyses performed using small mitochondrial fragments were insufficient for estimating the true (i.e., complete) mitogenome haplotype structure, corresponding levels of divergence, and maternal population history of our samples. Notably, discordant demographic inferences were observed when mismatch distributions of partial (i.e., partial D-Loop) versus complete mitogenome sequences were compared, with the reduction in mitochondrial genomic information content observed to encourage spurious inferences in our samples. A probabilistic approach to variant prediction for the complete bobwhite mitogenomes revealed 344 segregating sites corresponding to 347 total mutations, including 49 putative nonsynonymous single nucleotide variants (SNVs) distributed across 12 protein coding genes. Evidence of gross heteroplasmy was observed for 13 bobwhites, with 10 of the 13 heteroplasmies involving one moderate to high frequency SNV. Haplotype network and phylogenetic analyses for the complete bobwhite mitogenome sequences revealed two divergent maternal lineages (d(XY) = 0.00731; F-ST = 0.849; P < 0.05), thereby supporting the potential for two putative subspecies. However, the diverged lineage (n = 103 variants) almost exclusively involved bobwhites geographically classified as Colinus virginianus texanus, which is discordant with the expectations of previous geographic subspecies designations. Tests of adaptive evolution for functional divergence (MKT), frequency distribution tests (D, F-S) and phylogenetic analyses (RAxML) provide no evidence for positive selection or hybridization with the sympatric scaled quail (Callipepla squamata) as being explanatory factors for the two bobwhite maternal lineages observed. Instead, our analyses support the supposition that two diverged maternal lineages have survived from pre-expansion to post-expansion population(s), with the segregation of some slightly deleterious non-synonymous mutations.	[Halley, Yvette A.; Oldeschulte, David L.; Bhattarai, Eric K.; Seabury, Christopher M.] Texas A&M Univ, Coll Vet Med, Dept Vet Pathobiol, College Stn, TX 77843 USA; [Hill, Joshua; Metz, Richard P.; Johnson, Charles D.] Texas A&M AgriLife Res, Genom & Bioinformat Core, College Stn, TX USA; [Presley, Steven M.] Texas Tech Univ, Dept Environm Toxicol, Inst Environm & Human Hlth, Lubbock, TX 79409 USA; [Ruzicka, Rebekah E.] Texas A&M AgriLife Extens Serv, Dallas, TX USA; [Rollins, Dale] Rolling Plains Quail Res Ranch, Rotan, TX USA; [Peterson, Markus J.] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA; [Murphy, William J.] Texas A&M Univ, Coll Vet Med, Dept Vet Integrat Biosci, \, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research; Texas Tech University System; Texas Tech University; Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research; University of Texas System; University of Texas El Paso; Texas A&M University System; Texas A&M University College Station	Seabury, CM (corresponding author), Texas A&M Univ, Coll Vet Med, Dept Vet Pathobiol, College Stn, TX 77843 USA.	cseabury@cvm.tamu.edu	Peterson, Markus J/C-3303-2008	Peterson, Markus J/0000-0001-6145-0134; Presley, Steven/0000-0002-6652-2835; Metz, Richard/0000-0002-9876-3385; Johnson, Charles/0000-0003-3892-7082	Reversing the Quail Decline in Texas Initiative; Texas Parks and Wildlife Department; Texas A&M AgriLife Extension Service	Reversing the Quail Decline in Texas Initiative; Texas Parks and Wildlife Department; Texas A&M AgriLife Extension Service	Funding was provided through the Reversing the Quail Decline in Texas Initiative and the Upland Game Bird Stamp Fund based on a collaborative effort between Texas Parks and Wildlife Department and Texas A&M AgriLife Extension Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CR, 2000, J AGR URBAN ENTOMOL, V17, P43; ArisBrosou S, 1996, MOL BIOL EVOL, V13, P494, DOI 10.1093/oxfordjournals.molbev.a025610; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Baumgartner F. M., 1944, JOUR WILDLIFE MANAGEMENT, V8, P112, DOI 10.2307/3796443; Berkman LK, 2013, CONSERV GENET, V14, P323, DOI 10.1007/s10592-013-0471-1; Brady S.J., 1998, Gibier Faune Sauvage, V15, P413; BRENNAN LA, 1991, WILDLIFE SOC B, V19, P544; Bridges AS, 2001, J WILDLIFE MANAGE, V65, P10, DOI 10.2307/3803270; Bruno A, 2015, J PARASITOL, V101, P364, DOI 10.1645/14-526.1; BUECHNER HK, 1950, J WILDLIFE MANAGE, V14, P363, DOI 10.2307/3797265; Chen B, 2011, HEREDITY, V106, P241, DOI 10.1038/hdy.2010.58; Church K. E., 1993, P NATL QUAIL S, V3, P44; Cibois A, 2014, MOL PHYLOGENET EVOL, V70, P442, DOI 10.1016/j.ympev.2013.08.019; del Hoyo J, 1994, HDB BIRDS WORLD, V2, P412; DEVOS T, 1995, WILDLIFE SOC B, V23, P267; Droege S, 1990, PERDIX, P2; Dudu A, 2014, GENET MOL BIOL, V37, P587, DOI 10.1590/S1415-47572014000400016; Dunham NR, 2014, J WILDLIFE DIS, V50, P711, DOI 10.7589/2013-11-313; Dunham NR, 2014, J WILDLIFE DIS, V50, P552, DOI 10.7589/2013-10-275; Egea R, 2008, NUCLEIC ACIDS RES, V36, pW157, DOI 10.1093/nar/gkn337; Evans KO, 2012, P NATL QUAIL S, V7, P244; Evans KO, 2006, GAMEBIRD, P121; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Eyre-Walker A, 2002, GENETICS, V162, P2017; Ferrando A, 2015, ANIM GENET, V46, P452, DOI 10.1111/age.12302; Fu YX, 1997, GENETICS, V147, P915; Garcia-Trejo EA, 2009, CONDOR, V111, P442, DOI 10.1525/cond.2009.080017; Gibb GC, 2007, MOL BIOL EVOL, V24, P269, DOI 10.1093/molbev/msl158; Goto H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r59; Guan X, 2009, ANIM GENET, V40, P134, DOI 10.1111/j.1365-2052.2008.01810.x; Guthery FS, 2000, NATL QUAIL S P, P198; Hailer F, 2015, MOL PHYLOGENET EVOL, V83, P40, DOI 10.1016/j.ympev.2014.11.005; Halley YA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090240; HARPENDING HC, 1993, CURR ANTHROPOL, V34, P483, DOI 10.1086/204195; He XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066324; He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802; Heikkinen ME, 2015, ANIM GENET, V46, P485, DOI 10.1111/age.12319; Hernandez F, 2005, WILDLIFE SOC B, V33, P1071, DOI 10.2193/0091-7648(2005)33[1071:IOPODO]2.0.CO;2; Hernandez F, 2007, TEXAS QUAILS BOOK, P40; Hernandez F, 2013, WILDLIFE SOC B, V37, P177, DOI 10.1002/wsb.223; Horne JB, 2008, MOL PHYLOGENET EVOL, V49, P629, DOI 10.1016/j.ympev.2008.08.023; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; Inoue K, 2014, HEREDITY, V112, P282, DOI 10.1038/hdy.2013.104; JOHNSGARD P A, 1970, Condor, V72, P85, DOI 10.2307/1366478; Kitulagodage M, 2011, CHEMOSPHERE, V83, P524, DOI 10.1016/j.chemosphere.2010.12.057; Kvist L, 2003, MOL BIOL EVOL, V20, P243, DOI 10.1093/molbev/msg025; Labuschagne C, 2014, GENE, V534, P113, DOI 10.1016/j.gene.2013.09.057; Li MK, 2010, AM J HUM GENET, V87, P237, DOI 10.1016/j.ajhg.2010.07.014; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133; Lopes IF, 2011, GENET MOL RES, V10, P1910, DOI 10.4238/vol10-3gmr1217; Lusk JJ, 2002, J WILDLIFE MANAGE, V66, P1040, DOI 10.2307/3802936; Malago Wilson Jr, 2002, BMC Biotechnol, V2, P19, DOI 10.1186/1472-6750-2-19; MARJORAM P, 1994, GENETICS, V136, P673; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Meikejohn KA, 2014, MOL PHYLOGENET EVOL, V78, P314, DOI 10.1016/j.ympev.2014.06.003; Mindell DP, 1998, MOL BIOL EVOL, V15, P1568, DOI 10.1093/oxfordjournals.molbev.a025884; Mueller JM, 1999, J WILDLIFE MANAGE, V63, P1291, DOI 10.2307/3802847; Mundy NI, 1996, J HERED, V87, P21, DOI 10.1093/oxfordjournals.jhered.a022948; Nei M., 1987, MOL EVOLUTIONARY GEN; Nishibori M, 2001, ANIM GENET, V32, P380, DOI 10.1046/j.1365-2052.2001.00795.x; Nishibori Masahide, 2003, Animal Science Journal, V74, P437, DOI 10.1046/j.1344-3941.2003.00136.x; Ottinger MA, 2005, DOMEST ANIM ENDOCRIN, V29, P411, DOI 10.1016/j.domaniend.2005.02.038; Pereira SL, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-17; Peterson MJ, 2001, J WILDLIFE MANAGE, V65, P828, DOI 10.2307/3803032; Peterson MJ, 2002, P NATL QUAIL S, V5, P35; Peterson MJ, 2000, P NATL QUAIL S, V4, P85, DOI DOI 10.2307/3803032; Ray N, 2003, MOL BIOL EVOL, V20, P76, DOI 10.1093/molbev/msg009; Reyna KS, 2012, POULTRY SCI, V91, P41, DOI 10.3382/ps.2011-01676; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Royston SR, 2014, MITOCHONDR DNA, V26, P1; Sammler S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-35; Sauer JR, 2005, J WILDLIFE MANAGE, V69, P1321, DOI 10.2193/0022-541X(2005)69[1321:UTNABB]2.0.CO;2; Sauer JR, 2012, N AM BREEDING BIRD S; Scott JL, 2013, WILDLIFE SOC B, V37, P168, DOI 10.1002/wsb.239; SHUPE TE, 1990, WILSON BULL, V102, P352; Slack KE, 2003, GENE, V302, P43, DOI 10.1016/S0378111902010533; SLATKIN M, 1991, GENETICS, V129, P555; Smigrodzki RM, 2005, REJUV RES, V8, P172, DOI 10.1089/rej.2005.8.172; Smith NGC, 2002, NATURE, V415, P1022, DOI 10.1038/4151022a; Sondheimer N, 2011, HUM MOL GENET, V20, P1653, DOI 10.1093/hmg/ddr043; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; TAJIMA F, 1993, GENETICS, V135, P599; TAJIMA F, 1989, GENETICS, V123, P597; TAJIMA F, 1989, GENETICS, V123, P585; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Terhune TM, 2010, ECOL APPL, V20, P1040, DOI 10.1890/09-1106.1; Vinas J, 2004, MOL PHYLOGENET EVOL, V33, P32, DOI 10.1016/j.ympev.2004.04.009; Wang N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064312; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Weckstein JD, 2002, CONDOR, V104, P432, DOI 10.1650/0010-5422(2002)104[0432:HAPSWA]2.0.CO;2; Williams CK, 2004, J WILDLIFE MANAGE, V68, P94, DOI 10.2193/0022-541X(2004)068[0094:WSAAHI]2.0.CO;2; Williams CK, 2001, WILDLIFE SOC B, V32, P861; Williford D, 2014, J WILDLIFE MANAGE, V78, P914, DOI 10.1002/jwmg.733; Xiang LX, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-233	96	3	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0144913	10.1371/journal.pone.0144913	http://dx.doi.org/10.1371/journal.pone.0144913			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713762	Green Submitted, gold, Green Published			2022-12-26	WOS:000367481900023
J	Munoz-Rivas, N; Mendez-Bailon, M; Hernandez-Barrera, V; de Miguel-Yanes, JM; Jimenez-Garcia, R; Esteban-Hernandez, J; Jimenez-Trujillo, I; Alvaro-Meca, A; Carrasco-Garrido, P; de Miguel-Diez, J; Lopez-de-Andres, A				Munoz-Rivas, Nuria; Mendez-Bailon, Manuel; Hernandez-Barrera, Valentin; Ma de Miguel-Yanes, Jose; Jimenez-Garcia, Rodrigo; Esteban-Hernandez, Jesus; Jimenez-Trujillo, Isabel; Alvaro-Meca, Alejandro; Carrasco-Garrido, Pilar; de Miguel-Diez, Javier; Lopez-de-Andres, Ana			Time Trends in Ischemic Stroke among Type 2 Diabetic and Non-Diabetic Patients: Analysis of the Spanish National Hospital Discharge Data (2003-2012)	PLOS ONE			English	Article							RISK-FACTORS; CASE-FATALITY; CEREBROVASCULAR-DISEASE; SEX-DIFFERENCES; EPIDEMIOLOGY; MELLITUS; MORTALITY; SPAIN; METAANALYSIS; WOMEN	Background Type 2 Diabetes (T2DM) is the most rapidly increasing risk factor for ischemic stroke. We aimed to compare trends in outcomes for ischemic stroke in people with or without diabetes in Spain between 2003 and 2012. Methods We selected all patients hospitalized for ischemic stroke using national hospital discharge data. We evaluated annual incident rates stratified by T2DM status. We analyzed trends in the use of diagnostic and therapeutic procedures, patient comorbidities, and in-hospital outcomes. We calculated in-hospital mortality (IHM), length of hospital stay (LOHS) and readmission rate in one month after discharge. Time trend on the incidence of hospitalization was estimated fitting Poisson regression models by sex and diabetes variables. In-hospital mortality was analyzed using logistic regression models separate for men and women. LOHS were compared with ANOVA or Kruskal-Wallis when necessary. Results We identified a total of 423,475 discharges of patients (221,418 men and 202,057 women) admitted with ischemic stroke as primary diagnosis. Patients with T2DM accounted for 30.9% of total. The estimated incidence rates of discharges increased significantly in all groups. The incidence of hospitalization due to stroke (with ICD9 codes for stroke as main diagnosis at discharge) was higher among those with than those without diabetes in all the years studied. T2DM was positively associated with ischemic stroke with an adjusted incidence rate ratio (IRR) of 2.27 (95% CI 2.24-2.29) for men and 2.15 (95% CI 2.13-2.17) for women. Over the 10 year period LOHS decreased significantly in men and women with and without diabetes. Readmission rate remained stable in diabetic and non diabetic men (around 5%) while slightly increased in women with and without diabetes. We observed a significant increase in the use of fibrinolysis from 2002-2013. IHM was positively associated with older age in all groups, with Charlson Comorbidity Index > 3 and atrial fibrillation as risk factors. The IHM did not change significantly over time among T2DM men and women ranging from 9.25% to 10.56% and from 13.21% to 14.86%, respectively; neither did among non-diabetic women. However, in men without T2DM IHM decreased significantly over time. Diabetes was associated to higher IHM only in women (OR 1.07; 95% CI, 1.05-1.11). Conclusions Our national data show that incidence rate of ischemic stroke hospitalization increased significantly during the period of study (2003-2012). People with T2DM have more than double the risk of ischemic stroke after adjusting for other risk factors. Women with T2DM had poorer outcomes-IHM and readmission rates-than diabetic men. Diabetes was an independent factor for IHM only in women.	[Munoz-Rivas, Nuria] Hosp Univ Infanta Leonor, Dept Med, Madrid, Spain; [Mendez-Bailon, Manuel] Hosp Clin San Carlos, Dept Med, Madrid, Comunidad De Ma, Spain; [Hernandez-Barrera, Valentin; Jimenez-Garcia, Rodrigo; Esteban-Hernandez, Jesus; Jimenez-Trujillo, Isabel; Alvaro-Meca, Alejandro; Carrasco-Garrido, Pilar; Lopez-de-Andres, Ana] Rey Juan Carlos Univ, Fac Hlth Sci, Prevent Med & Publ Hlth Teaching & Res Unit, Alcorcon, Comunidad De Ma, Spain; [Ma de Miguel-Yanes, Jose] Hosp Gregorio Maranon, Dept Med, Comunidad De Madrid, Spain; [de Miguel-Diez, Javier] Univ Complutense Madrid, Hosp Gen Univ Gregorio Maranon, Dept Pneumol, Madrid, Spain	Hospital Universitario Infanta Leonor; Hospital Clinico San Carlos; Universidad Rey Juan Carlos; General University Gregorio Maranon Hospital; Complutense University of Madrid; General University Gregorio Maranon Hospital	Munoz-Rivas, N (corresponding author), Hosp Univ Infanta Leonor, Dept Med, Madrid, Spain.	nmunozr@salud.madrid.org	Jimenez-Trujillo, Isabel/AAP-7746-2021; Lopez-de-Andres, Ana/D-4498-2019; Jimenez-Garcia, Rodrigo/D-4953-2019; Lopez-de-Andres, Ana/AAD-8703-2019; Esteban-Hernandez, Jesus/B-6816-2009; Esteban-Hernández, Jesús/ABG-4660-2020	Jimenez-Trujillo, Isabel/0000-0002-9394-6799; Lopez-de-Andres, Ana/0000-0001-5551-5181; Jimenez-Garcia, Rodrigo/0000-0001-5906-9393; Lopez-de-Andres, Ana/0000-0001-5551-5181; Esteban-Hernández, Jesús/0000-0002-6013-1091; Hernandez-Barrera, Valentin/0000-0001-5790-1959; de Miguel-Yanes, Jose M./0000-0003-2802-033X; de Miguel-Diez, Javier/0000-0003-4543-573X; Alvaro-Meca, Alejandro/0000-0003-1315-4386	FIS (Fondo de Investigaciones Sanitarias-Health Research Fund, Instituto de Salud Carlos III) [PI13/00118]; Grupo de Excelencia Investigadora URJC-Banco Santander [30VCPIGI03]	FIS (Fondo de Investigaciones Sanitarias-Health Research Fund, Instituto de Salud Carlos III); Grupo de Excelencia Investigadora URJC-Banco Santander	This study forms part of research funded by the FIS (Fondo de Investigaciones Sanitarias-Health Research Fund, grant no. PI13/00118, Instituto de Salud Carlos III) and partly funded by the Grupo de Excelencia Investigadora URJC-Banco Santander No30VCPIGI03: Investigacion traslacional en el proceso de salud - enfermedad (ITPSE). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; This study forms part of research funded by the FIS (Fondo de Investigaciones Sanitarias-Health Research Fund, grant no. PI13/00118, Instituto de Salud Carlos III) and by the Grupo de Excelencia Investigadora URJC-Banco Santander No30VCPIGI03: Investigacion traslacional en el proceso de salud-enfermedad (ITPSE).	Aleman JA, 2011, MED CLIN-BARCELONA, V136, P329, DOI 10.1016/j.medcli.2010.04.035; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; [Anonymous], SERV SOC LGUALD ENC; Arboix A, 2014, CLIN NEUROL NEUROSUR, V127, P19, DOI 10.1016/j.clineuro.2014.09.024; Banerjee C, 2012, STROKE, V43, P1212, DOI 10.1161/STROKEAHA.111.641381; Basterra-Gortari FJ, 2007, MED CLIN-BARCELONA, V129, P405; Bejot Y, 2007, J NEUROL SCI, V262, P85, DOI 10.1016/j.jns.2007.06.025; Brea A, 2013, CLIN INVEST ARTERIOS, V25, P211, DOI 10.1016/j.arteri.2013.10.006; Cayuela A, ANALISIS TENDENCIAS; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Diaz-Guzman J, 2008, REV NEUROLOGIA, V47, P617, DOI 10.33588/rn.4712.2008576; Diaz-Guzman J, 2012, CEREBROVASC DIS, V34, P272, DOI 10.1159/000342652; Eriksson M, 2012, CEREBROVASC DIS, V34, P153, DOI 10.1159/000339763; EVANS RW, 1994, METABOLISM, V43, P1196, DOI 10.1016/0026-0495(94)90065-5; Feigin VL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134609; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Giampaoli S, 2015, EUR J PREV CARDIOL, V22, P9, DOI 10.1177/2047487315589011; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Grysiewicz RA, 2008, NEUROL CLIN, V26, P871, DOI 10.1016/j.ncl.2008.07.003; Howard BV, 1998, DIABETES CARE, V21, P1258, DOI 10.2337/diacare.21.8.1258; Icks A, 2012, DIABETES CARE, V35, P1868, DOI 10.2337/dc11-2159; Idris I, 2006, INT J CLIN PRACT, V60, P48, DOI 10.1111/j.1368-5031.2006.00682.x; Instituto Nacional de Estadistica, 2004, DEF SEG CAUS MUERT 2; Caballero PEJ, 2013, J STROKE CEREBROVASC, V22, pE214, DOI 10.1016/j.jstrokecerebrovasdis.2012.11.014; Khalessi AA, 2011, JACC-CARDIOVASC INTE, V4, P261, DOI 10.1016/j.jcin.2010.11.015; Lindley RI, 2015, STROKE, V46, P746, DOI 10.1161/STROKEAHA.114.006573; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Lopez-De-Andres A, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-3; Luitse MJA, 2012, LANCET NEUROL, V11, P261, DOI 10.1016/S1474-4422(12)70005-4; Mansfield MW, 1996, ARTERIOSCL THROM VAS, V16, P160, DOI 10.1161/01.ATV.16.1.160; Marini C, 2003, STROKE, V34, pE13, DOI 10.1161/01.STR.0000065429.56621.6E; Marrugat J, 2007, REV ESP CARDIOL, V60, P573, DOI 10.1157/13107113; Nwaneri C., 2013, BRIT J DIABETES VASC, V13, P192, DOI [10.1177/1474651413495703, DOI 10.1177/1474651413495703]; Palacio S, 2014, STROKE, V45, P2689, DOI 10.1161/STROKEAHA.114.005018; Peters SAE, 2014, LANCET, V383, P1973, DOI 10.1016/S0140-6736(14)60040-4; Ramalle-Gomara E, 2013, J STROKE CEREBROVASC, V22, pE441, DOI 10.1016/j.jstrokecerebrovasdis.2013.04.039; Rodriguez T, 2006, HEART, V92, P453, DOI 10.1136/hrt.2004.059295; Sandercock P, 2013, LANCET NEUROL, V12, P768, DOI 10.1016/S1474-4422(13)70130-3; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Shah AD, 2015, LANCET DIABETES ENDO, V3, P105, DOI 10.1016/S2213-8587(14)70219-0; Soriguer F, 2012, DIABETOLOGIA, V55, P88, DOI 10.1007/s00125-011-2336-9; Steinberg HO, 2000, CIRCULATION, V101, P2040, DOI 10.1161/01.CIR.101.17.2040; Stevens R, 2004, DIABETES CARE, V27, P201, DOI 10.2337/diacare.27.1.201; Strbian D, 2011, NEUROLOGY, V77, P341, DOI 10.1212/WNL.0b013e3182267b8c; Garcia JT, 2010, AV DIABETOL, V26, P397; Thomsen Reimar Wernich, 2012, Clin Epidemiol, V4, P43, DOI 10.2147/CLEP.S30083; Vasiliadis AV, 2014, NEUROL NEUROCHIR POL, V48, P449, DOI 10.1016/j.pjnns.2014.11.001; Vega T, 2009, J STROKE CEREBROVASC, V18, P11, DOI 10.1016/j.jstrokecerebrovasdis.2008.06.010; Wannamethee SG, 2012, DIABETOLOGIA, V55, P80, DOI 10.1007/s00125-011-2284-4; Wardlaw JM, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000213.pub2; Whiteley WN, 2012, STROKE, V43, P2904, DOI 10.1161/STROKEAHA.112.665331; Zhang PL, 2015, EUR REV MED PHARMACO, V19, P1001	52	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145535	10.1371/journal.pone.0145535	http://dx.doi.org/10.1371/journal.pone.0145535			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713435	gold, Green Published, Green Submitted			2022-12-26	WOS:000367481900053
J	Salam, MT; Lin, PC; Eckel, SP; Gauderman, WJ; Gilliland, FD				Salam, Muhammad T.; Lin, Pi-Chu; Eckel, Sandrah P.; Gauderman, W. James; Gilliland, Frank D.			Inducible Nitric Oxide Synthase Promoter Haplotypes and Residential Traffic-Related Air Pollution Jointly Influence Exhaled Nitric Oxide Level in Children	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; RESPIRATORY SYMPTOMS; CHILDHOOD ASTHMA; HEALTH; SCHOOLCHILDREN; INFLAMMATION; SUSCEPTIBILITY; EXPOSURES; INFERENCE; MARKERS	Background Exhaled nitric oxide (FeNO), a biomarker of airway inflammation, predicts asthma risk in children. We previously found that the promoter haplotypes in inducible nitric oxide synthase (NOS2) and exposure to residential traffic independently influence FeNO level. Because NOS2 is inducible by environmental exposures such as traffic-related exposure, we tested the hypothesis that common NOS2 promoter haplotypes modulate the relationship between residential traffic-related exposure and FeNO level in children. Methods In a cross-sectional population-based study, subjects (N = 2,457; 7-11 year-old) were Hispanic and non-Hispanic white children who participated in the Southern California Children's Health Study and had FeNO measurements. For residential traffic, lengths of local roads within circular buffers (50m, 100m and 200m radii around homes) around the subjects' homes were estimated using geographic information system (GIS) methods. We interrogated the two most common NOS2 promoter haplotypes that were found to affect FeNO level. Results The relationship between local road lengths within 100m and 200m circular buffers and FeNO level varied significantly by one of the NOS2 promoter haplotypes (P-values for interaction between road length and NOS2 promoter haplotype = 0.02 and 0.03, respectively). In children who had <= 250m of local road lengths within 100m buffer around their homes, those with two copies of the haplotype had significantly lower FeNO (adjusted geometric mean = 11.74ppb; 95% confidence intervals (CI): 9.99 to 13.80) than those with no copies (adjusted geometric mean = 15.28ppb; 95% CI: 14.04 to 16.63) with statistically significant trend of lower FeNO level with increasing number of haplotype copy (P-value for trend = 0.002). In contrast, among children who had >250m of local road lengths within 100m buffer, FeNO level did not significantly differ by the haplotype copy-number (P-value for trend = 0.34). Similar interactive effects of this haplotype and local road lengths within 200m buffer on FeNO were also observed. Conclusions Higher exposure from residential traffic nullifies the protective effect of one common NOS2 promoter haplotype on FeNO level. Regulation of traffic-related pollution may protect children's respiratory health.	[Salam, Muhammad T.; Eckel, Sandrah P.; Gauderman, W. James; Gilliland, Frank D.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Salam, Muhammad T.] Kern Med Ctr, Dept Psychiat, Bakersfield, CA USA; [Lin, Pi-Chu] Siemens HealthCare Diagnost, Mol Tech Operat, East Walpole, MA USA	University of Southern California; Siemens AG	Salam, MT (corresponding author), Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA.	msalam@usc.edu			National Heart, Lung and Blood Institute [5R01HL61768, 5R01HL76647]; Southern California Environmental Health Sciences Center - National Institute of Environmental Health Sciences [5P30ES007048]; Children's Environmental Health Center - National Institute of Environmental Health Sciences [5P01ES009581, R826708-01, RD831861-01]; United States Environmental Protection Agency; National Institute of Environmental Health Sciences [5P01ES011627]; Hastings Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061768, R01HL076647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007048, P01ES009581] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Southern California Environmental Health Sciences Center - National Institute of Environmental Health Sciences; Children's Environmental Health Center - National Institute of Environmental Health Sciences; United States Environmental Protection Agency(United States Environmental Protection Agency); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Hastings Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Heart, Lung and Blood Institute (grants 5R01HL61768 and 5R01HL76647; URL http://www.nhlbi.nih.gov/); the Southern California Environmental Health Sciences Center (grant 5P30ES007048) funded by the National Institute of Environmental Health Sciences; the Children's Environmental Health Center (grants 5P01ES009581, R826708-01, and RD831861-01) funded by the National Institute of Environmental Health Sciences (URL: http://www.niehs.nih.gov/) and the United States Environmental Protection Agency (URL: http://www.epa.gov/); the National Institute of Environmental Health Sciences (grants 5P01ES011627; URL: http://www.niehs.nih.gov); and the Hastings Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. One of the authors [PL] was a graduate student at University of Southern California when she was involved in data analysis and manuscript preparation. She is now employed by Siemens HealthCare Diagnostics, but the company did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 1999, AM J RESP CRIT CARE, V160, P2104, DOI DOI 10.1164/AJRCCM.160.6.ATS8-99; Baldauf R, 2009, AIR QUAL ATMOS HLTH, V2, P1, DOI 10.1007/s11869-009-0028-0; Barath S, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-36; Bastain TM, 2011, EUR RESPIR J, V37, P523, DOI 10.1183/09031936.00021210; Berhane K, 2011, EUR RESPIR J, V37, P1029, DOI 10.1183/09031936.00081410; Dales R, 2008, ENVIRON HEALTH PERSP, V116, P1423, DOI 10.1289/ehp.10943; Eckel SP, 2011, ENVIRON HEALTH PERSP, V119, P1472, DOI 10.1289/ehp.1103516; Falush D, 2003, GENETICS, V164, P1567; Fleming L, 2013, AM J RESP CRIT CARE, V188, P400, DOI 10.1164/rccm.201212-2156LE; Gasser M, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-30; Holguin F, 2007, AM J RESP CRIT CARE, V176, P1236, DOI 10.1164/rccm.200611-1616OC; Islam T, 2010, THORAX, V65, P139, DOI 10.1136/thx.2009.114355; Lane C, 2004, THORAX, V59, P757, DOI 10.1136/thx.2003.014894; Linn WS, 2009, J EXPO SCI ENV EPID, V19, P674, DOI 10.1038/jes.2008.64; Linn WS, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-28; Liu L, 2009, ENVIRON HEALTH PERSP, V117, P668, DOI 10.1289/ehp11813; Malinovschi A, 2013, J ALLERGY CLIN IMMUN, V132, P821, DOI 10.1016/j.jaci.2013.06.007; Manzo ND, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-43; McConnell R, 2006, ENVIRON HEALTH PERSP, V114, P766, DOI 10.1289/ehp.8594; Nordling E, 2008, EPIDEMIOLOGY, V19, P401, DOI 10.1097/EDE.0b013e31816a1ce3; Olin AC, 2010, AM J RESP CRIT CARE, V181, P324, DOI 10.1164/rccm.200907-1079OC; Patelis A, 2012, J ALLERGY CLIN IMMUN, V130, P397, DOI 10.1016/j.jaci.2012.03.046; Pritchard JK, 2000, GENETICS, V155, P945; Ricciardolo FLM, 2006, EUR J PHARMACOL, V533, P240, DOI 10.1016/j.ejphar.2005.12.057; Saito J, 2004, J ALLERGY CLIN IMMUN, V114, P512, DOI 10.1016/j.jaci.2004.05.033; Salam MT, 2011, ALLERGY, V66, P412, DOI 10.1111/j.1398-9995.2010.02492.x; Salam MT, 2007, AM J RESP CRIT CARE, V176, P1192, DOI 10.1164/rccm.200704-561OC; Scott M, 2010, THORAX, V65, P258, DOI 10.1136/thx.2009.125443; Seimetz M, 2011, CELL, V147, P293, DOI 10.1016/j.cell.2011.08.035; Sheffield M, 2006, PEDIATRICS, V118, P1056, DOI 10.1542/peds.2006-0195; Shtir CJ, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-71; Singer F, 2013, ALLERGY, V68, P531, DOI 10.1111/all.12127; Steerenberg PA, 2001, ARCH ENVIRON HEALTH, V56, P167, DOI 10.1080/00039890109604069; Strunk RC, 2003, J ALLERGY CLIN IMMUN, V112, P883, DOI 10.1016/j.jaci.2003.08.014; Szefler SJ, 2012, J ALLERGY CLIN IMMUN, V129, pS9, DOI 10.1016/j.jaci.2011.12.979	35	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145363	10.1371/journal.pone.0145363	http://dx.doi.org/10.1371/journal.pone.0145363			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714306	Green Published, Green Submitted, gold			2022-12-26	WOS:000367481900036
J	Cao, J; Yang, JC; Ramachandran, V; Arumugam, T; Deng, DF; Li, ZS; Xu, LM; Logsdon, CD				Cao, Jia; Yang, Jiachun; Ramachandran, Vijaya; Arumugam, Thiruvengadam; Deng, Defeng; Li, Zhaoshen; Xu, Leiming; Logsdon, Craig D.			TM4SF1 Promotes Gemcitabine Resistance of Pancreatic Cancer In Vitro and In Vivo	PLOS ONE			English	Article							CHIMERIC L6 ANTIBODY; MULTIDRUG-RESISTANCE; MESENCHYMAL TRANSITION; DRUG-RESISTANCE; CELLS; EXPRESSION; SURVIVAL; RECEPTOR; BREAST; RADIOIMMUNOTHERAPY	Background TM4SF1 is overexpressed in pancreatic ductal adenocarcinoma (PDAC) and affects the development of this cancer. Also, multidrug resistance (MDR) is generally associated with tumor chemoresistance in pancreatic cancer. However, the correlation between TM4SF1 and MDR remains unknown. This research aims to investigate the effect of TM4SF1 on gemcitabine resistance in PDAC and explore the possible molecular mechanism between TM4SF1 and MDR. Methods The expression of TM4SF1 was evaluated in pancreatic cancer cell lines and human pancreatic duct epithelial (HPDE) cell lines by quantitative RT-PCR. TM4SF1 siRNA transfection was carried out using Hiperfect transfection reagent to knock down TM4SF1. The transcripts were analyzed by quantitative RT-PCR, RT-PCR and western blotting for further study. The cell proliferation and apoptosis were obtained to investigate the sensitivity to gemcitabine of pancreatic cancer cells after silencing TM4SF1 in vitro. We demonstrated that cell signaling of TM4SF1 mediated chemoresistance in cancer cells by assessing the expression of multidrug resistance (MDR) genes using quantitative RT-PCR. In vivo, we used orthotopic pancreatic tumor models to investigate the effect of proliferation after silencing TM4SF1 by a lentivirus-mediated shRNA in MIA PaCa-2 cell lines. Results The mRNA expression of TM4SF1 was higher in seven pancreatic cancer cell lines than in HPDE cell lines. In three gemcitabine-sensitive cell lines (L3.6pl, BxPC-3, SU86.86), the expression of TM4SF1 was lower than that in four gemcitabine-resistant cell lines (MIA PaCa-2, PANC-1, Hs766T, AsPC-1). We evaluated that TM4SF1 was a putative target for gemcitabine resistance in pancreatic cancer cells. Using AsPC-1, MIA PaCa-2 and PANC-we investigated that TM4SF1 silencing affected cell proliferation and increased the percentages of cell apoptosis mediated by treatment with gemcitabine compared with cells which were treated with negative control. This resistance was associated with the expression of multidrug resistance genes including ABCB1 and ABCC1. In vivo, silencing of TM4SF1 in MIA PaCa-2 cell lines increased the effectiveness of gemcitabine-based treatment in orthotopic pancreatic tumor models evaluated using noninvasive bioluminescent imaging. Conclusion These findings suggest that TM4SF1 is a surface membrane antigen that is highly expressed in pancreatic cancer cells and increases the chemoresistance to gemcitabine. Thus, TM4SF1 may be a promising target to overcome the chemoresistance of pancreatic cancer.	[Cao, Jia; Yang, Jiachun; Xu, Leiming] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Gastroenterol, Shanghai 200030, Peoples R China; [Ramachandran, Vijaya; Arumugam, Thiruvengadam; Deng, Defeng; Logsdon, Craig D.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Li, Zhaoshen] Second Mil Med Univ, Changhai Hosp, Dept Gastroenterol, Shanghai 200433, Peoples R China	Shanghai Jiao Tong University; University of Texas System; UTMD Anderson Cancer Center; Naval Medical University	Xu, LM (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Gastroenterol, Shanghai 200030, Peoples R China.	leiming.xu@aliyun.com; clogsdon@mdanderson.org			Cancer Center Support Core grant [CA016672]; Lockton Endowment; National Natural Science Foundation of China [81301826];  [NIH-DK05207]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Cancer Center Support Core grant; Lockton Endowment; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by NIH-DK05207 (to C.D. Logsdon), Cancer Center Support Core grant CA016672 (to UT M.D. Anderson Cancer Center), the Lockton Endowment (to C.D. Logsdon), and National Natural Science Foundation of China, 81301826 (to Jia Cao).	Allioli N, 2011, PROSTATE, V71, P1239, DOI 10.1002/pros.21340; Arumugam T, 2005, CLIN CANCER RES, V11, P5356, DOI 10.1158/1078-0432.CCR-05-0092; Arumugam T, 2009, CANCER RES, V69, P5820, DOI 10.1158/0008-5472.CAN-08-2819; Brenner H, 2007, J CLIN ONCOL, V25, P3274, DOI 10.1200/JCO.2007.11.3431; Cao J, 2009, PANCREAS, V38, P986; Cavalcante LD, 2014, EUR J PHARMACOL, V741, P8, DOI [10.1010/j.ejphar.2014.07.041, 10.1016/j.ejphar.2014.07.041]; DeNardo SJ, 1997, P NATL ACAD SCI USA, V94, P4000, DOI 10.1073/pnas.94.8.4000; GOODMAN GE, 1990, J CLIN ONCOL, V8, P1083, DOI 10.1200/JCO.1990.8.6.1083; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; HELLSTROM I, 1986, CANCER RES, V46, P3917; Hong OY, 2000, AM J PATHOL, V157, P1623, DOI 10.1016/S0002-9440(10)64800-6; Jager W, 2009, INT J CLIN PHARM TH, V47, P46; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jones SM, 2006, NAT REV CANCER, V6, P175, DOI 10.1038/nrc1817; Kim H, 2012, CANCER LETT, V314, P198, DOI 10.1016/j.canlet.2011.09.030; Kim H, 2010, BBA-MOL CELL RES, V1803, P975, DOI 10.1016/j.bbamcr.2010.04.001; Konig J, 2005, INT J CANCER, V115, P359, DOI 10.1002/ijc.20831; Langley RR, 2004, CANCER RES, V64, P3727, DOI 10.1158/0008-5472.CAN-03-3863; Lee MS, 2012, BBA-MOL CELL RES, V1823, P514, DOI 10.1016/j.bbamcr.2011.11.017; Lee SA, 2008, J CLIN INVEST, V118, P1354, DOI 10.1172/JCI33768; Lekishvili T, 2008, J CELL SCI, V121, P685, DOI 10.1242/jcs.020347; Lin CI, 2014, ANGIOGENESIS, V17, P897, DOI 10.1007/s10456-014-9437-2; Logsdon CD, 2003, CANCER RES, V63, P2649; Lu Z, 2000, PANCREAS, V21, P240, DOI 10.1097/00006676-200010000-00004; Nath S, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.16; O'Driscoll L, 2007, ANTICANCER RES, V27, P2115; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Ramachandran V, 2007, CANCER RES, V67, P2666, DOI 10.1158/0008-5472.CAN-06-3362; RICHMAN CM, 1995, CANCER RES, V55, pS5916; Shi S, 2012, CANCER LETT, V317, P127, DOI 10.1016/j.canlet.2011.11.029; Shih SC, 2009, CANCER RES, V69, P3272, DOI 10.1158/0008-5472.CAN-08-4886; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Visintin A, 2015, MOL CANCER THER, V14, P1868, DOI 10.1158/1535-7163.MCT-15-0188; Wright MD, 2000, PROTEIN SCI, V9, P1594, DOI 10.1110/ps.9.8.1594; Xiao Z, 2012, ANAT REC, V295, P2122, DOI 10.1002/ar.22552; Xu LJ, 2014, INT J ONCOL, V44, P459, DOI 10.3892/ijo.2013.2189; Zhang W, 2013, INT J ONCOL, V42, P1189, DOI 10.3892/ijo.2013.1839; Yu-Pei Z, 2007, CHINESE MED J-PEKING, V120, P1743, DOI 10.1097/00029330-200710020-00003	38	16	20	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0144969	10.1371/journal.pone.0144969	http://dx.doi.org/10.1371/journal.pone.0144969			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709920	Green Published, Green Submitted, gold			2022-12-26	WOS:000367451400016
J	Hernandez-Avila, I; Cambon-Bonavita, MA; Pradillon, F				Hernandez-Avila, Ivan; Cambon-Bonavita, Marie-Anne; Pradillon, Florence			Morphology of First Zoeal Stage of Four Genera of Alvinocaridid Shrimps from Hydrothermal Vents and Cold Seeps: Implications for Ecology, Larval Biology and Phylogeny	PLOS ONE			English	Article							REPRODUCTIVE-BIOLOGY; MIROCARIS-FORTUNATA; DECAPODA; CARIDEA; CRUSTACEA; DISPERSAL; PINNOTHERIDAE; ACCURACY; WILLIAMS; ANIMALS	Alvinocaridid shrimps are endemic species inhabiting hydrothermal vents and/or cold seeps. Although indirect evidences (genetic and lipid markers) suggest that their larval stages disperse widely and support large scale connectivity, larval life and mechanisms underlying dispersal are unknown in alvinocaridids. Here we provide for the first time detailed descriptions of the first larval stage (zoea I) of four alvinocaridid species: Rimicaris exoculata and Mirocaris fortunata from the Mid-Atlantic Ridge, Alvinocaris muricola from the Congo Basin and Nautilocaris saintlaurentae from the Western Pacific. The larvae were obtained from onboard hatching of brooding females (either at atmospheric pressure or at habitat pressure in hyperbaric chambers) and from the water column near adult habitats, sampled with plankton pumps or sediment traps. Major characteristics of the alvinocaridid larvae include undeveloped mandible and almost complete absence of setation in the inner margin of the mouth parts and maxillipeds. Although the larvae are very similar between the four species studied, some morphological features could be used for species identification. In addition, undeveloped mouthparts and the large amount of lipid reserves strongly support the occurrence of primary lecithotrophy in the early stage of alvinocaridids. Although lecithotrophy in decapod crustaceans is usually associated with abbreviated larval development, as a mechanism of larval retention, morphological and physiological evidences suggest the occurrence of an extended and lecithotrophic larval stage in the Alvinocarididae. These traits permit the colonization of widely dispersed and fragmented environments of hydrothermal vents and cold seeps. Distribution of larval traits along the phylogenetic reconstruction of the Alvinocarididae and related families suggest that lecithotrophy/planktotrophy and extended/abbreviated development have evolved independently along related families in all potential combinations. However, the Alvinocarididae is the only taxa with a combination of lecithotrophy and extended larval development.	[Hernandez-Avila, Ivan; Pradillon, Florence] IFREMER, Lab Environm Profond, CS 10070, F-29280 Plouzane, France; [Hernandez-Avila, Ivan] Univ Oriente, Dept Ciencias, Unidad Cursos Basicos, Margarita Isl, Venezuela; [Cambon-Bonavita, Marie-Anne] IFREMER, CNRS, Lab Microbiol Environm Extremes, UMR6197,UBO, F-29280 Plouzane, France	Ifremer; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM)	Hernandez-Avila, I (corresponding author), IFREMER, Lab Environm Profond, CS 10070, F-29280 Plouzane, France.	ivan.hernandez@ifremer.fr; florence.pradillon@ifremer.fr	Avila, Ivan IHA Hernandez/F-8715-2014; Pradillon, Florence/AAM-2992-2020	Pradillon, Florence/0000-0002-6473-6290; Cambon-Bonavita, Marie-Anne/0000-0002-4076-0472; Hernandez, Ivan/0000-0002-6722-5226	European Union Seventh Framework Programme (FP7) under the MIDAS project [603418]; French Agence Nationale de la Recherche (ANR) [CARN 018-01 EDROME, 11 BS 56 030 02]; European Community [FP6-GOCE-CT-2003-505342]; ANR grant [BALIST ANR-08-BLAN-0252]; University Pierre et Marie Curie, under the BQR UPMC; Eramet company (Futuna cruise); Technip company (Futuna cruise); Fundacion Gran Mariscal de Ayacucho [E-223-85-2012-2]; Campus France [796045K]	European Union Seventh Framework Programme (FP7) under the MIDAS project; French Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); European Community(European Commission); ANR grant(French National Research Agency (ANR)); University Pierre et Marie Curie, under the BQR UPMC; Eramet company (Futuna cruise); Technip company (Futuna cruise); Fundacion Gran Mariscal de Ayacucho; Campus France	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under the MIDAS project, grant agreement no 603418, and from the French Agence Nationale de la Recherche (ANR) under the CARNOT Programme, grant CARN 018-01 EDROME, and under the CONGOLOBE project, grant no 11 BS 56 030 02. Pressure equipments used in this study were funded by a European Community program EXOCET/D (FP6-GOCE-CT-2003-505342), by an ANR grant, BALIST ANR-08-BLAN-0252, and by the University Pierre et Marie Curie, under the BQR UPMC 2008. Financial support was also provided by the Eramet and Technip companies (Futuna cruise). IHA received PhD funding from the Fundacion Gran Mariscal de Ayacucho (www.fundayacucho.gob.ve), PhD grant E-223-85-2012-2, and from Campus France (http://www.campusfrance.org), grant 796045K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGER K, 1992, COMP BIOCHEM PHYS A, V103, P507, DOI 10.1016/0300-9629(92)90280-4; Anger K., 2001, BIOL DECAPOD CRUSTAC; Aznar-Cormano L, 2015, GENETICA, V143, P195, DOI 10.1007/s10709-014-9807-0; Bauer RT., 2004, REMARKABLE SHRIMPS A; Beedessee G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081570; BENZIE JAH, 1983, J CRUSTACEAN BIOL, V3, P117, DOI 10.2307/1547857; Bolanos J, 2004, SCI MAR, V68, P373, DOI 10.3989/scimar.2004.68n3373; Bracken Heather D., 2009, Crustacean Issues, V18, P281; Campos E, 2010, ZOOTAXA, P41; CHACE F A JR, 1978, Smithsonian Contributions to Zoology, P1; Chan TY, 2010, INVERTEBR SYST, V24, P172, DOI 10.1071/IS09049; Clark PF, 2008, RAFFLES B ZOOL, V56, P85; Clark PF, 1998, INVERTEBR REPROD DEV, V33, P127, DOI 10.1080/07924259.1998.9652627; Copley JTP, 2006, MAR ECOL PROG SER, V315, P199, DOI 10.3354/meps315199; Cowen JP, 2001, DEEP-SEA RES PT I, V48, P1093, DOI 10.1016/S0967-0637(00)00070-4; De Grave S, 2009, RAFFLES B ZOOL, P1; Desbruyeres D, 2000, HYDROBIOLOGIA, V440, P201, DOI 10.1023/A:1004175211848; Dixon DR, 1998, CAH BIOL MAR, V39, P383; Dobkin S, 1967, B MAR SCI, V15, P450; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Duffy JE, 1996, NATURE, V381, P512, DOI 10.1038/381512a0; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fouquet Y, 2015, MINERAL RESOURCES IN A SUSTAINABLE WORLD, VOLS 1-5, P1223; Gebruk AV, 1997, ADV MAR BIOL, V32, P93; Giribet G, 1996, MOL BIOL EVOL, V13, P76, DOI 10.1093/oxfordjournals.molbev.a025573; Guri M, 2012, ISME J, V6, P597, DOI 10.1038/ismej.2011.133; Gurney R., 1941, Journal of the Linnean Society London Zoology, V41, P89; Gurney R., 1942, RAY SOC, V129, P1; Hendrickx M, 2007, CONTRIBUTIONS STUDY, V4, P31; Herring PJ, 1998, CAH BIOL MAR, V39, P387; Herring PJ, 1998, DEEP-SEA RES PT I, V45, P2105, DOI 10.1016/S0967-0637(98)00050-8; HONG SY, 1988, J NAT HIST, V22, P1041, DOI 10.1080/00222938800770651; Gonzalez-Gordillo JI, 2010, J CRUSTACEAN BIOL, V30, P101, DOI 10.1651/08-3110.1; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; KNOWLTON RE, 1973, J NAT HIST, V7, P273, DOI 10.1080/00222937300770231; Komai T, 2005, J NAT HIST, V39, P1111, DOI 10.1080/00222930400002499; Komai T, 2003, CAH BIOL MAR, V44, P199; Komai T, 2008, J SHELLFISH RES, V27, P21, DOI 10.2983/0730-8000(2008)27[21:TROTHV]2.0.CO;2; Konishi Kooichi, 2000, Crustacean Research, V29, P65; Koyama S, 2005, MAR BIOTECHNOL, V7, P272, DOI 10.1007/s10126-004-3050-0; Li CP, 2011, ZOOL ANZ, V250, P270, DOI 10.1016/j.jcz.2011.04.003; MARTIN JW, 1986, CRUSTACEANA, V51, P299, DOI 10.1163/156854086X00476; McLaughlin PA, 2008, ZOOTAXA, P52, DOI 10.11646/zootaxa.1911.1.3; Metaxas A, 2004, LIMNOL OCEANOGR, V49, P1949, DOI 10.4319/lo.2004.49.6.1949; Miyake H, 2007, MAR ECOL-EVOL PERSP, V28, P86, DOI 10.1111/j.1439-0485.2006.00115.x; Miyake H, 2010, CAH BIOL MAR, V51, P441; Mullineaux LS, 2010, P NATL ACAD SCI USA, V107, P7829, DOI 10.1073/pnas.0913187107; Nanjo Nobuaki, 2009, Crustacean Research, V38, P77; Nye V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060319; Olu K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011967; Plouviez S, 2015, DEEP-SEA RES PT I, V97, P124, DOI 10.1016/j.dsr.2014.11.011; POHLE G, 1981, B MAR SCI, V31, P753; Pond DW, 2000, DEEP-SEA RES PT I, V47, P121, DOI 10.1016/S0967-0637(99)00050-3; Pond DW, 1997, MAR ECOL PROG SER, V157, P221, DOI 10.3354/meps157221; Ponsard J, 2013, ISME J, V7, P96, DOI 10.1038/ismej.2012.87; Pradillon F, 2004, HIGH PRESSURE RES, V24, P237, DOI 10.1080/08957950410001699818; Pradillon F, 2007, MAR ECOL PROG SER, V333, P103, DOI 10.3354/meps333103; Rabalais N.N., 1985, Crustacean Issues, V2, P67; Ramirez-Llodra E, 2006, J MAR BIOL ASSOC UK, V86, P1347, DOI 10.1017/S0025315406014378; Ramirez-Llodra R, 2000, J MAR BIOL ASSOC UK, V80, P473, DOI [10.1017/S0025315400002174, DOI 10.1017/S0025315400002174]; Ravaux J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064074; Saito T, 2002, CRUSTACEANA, V75, P621, DOI 10.1163/156854002760095642; SEGONZAC M, 1993, CAH BIOL MAR, V34, P535; Shank TM, 1999, MOL PHYLOGENET EVOL, V13, P244, DOI 10.1006/mpev.1999.0642; Shillito B, 2008, DEEP-SEA RES PT I, V55, P881, DOI 10.1016/j.dsr.2008.03.010; Teixeira S, 2013, MOL ECOL, V22, P4663, DOI 10.1111/mec.12419; Teixeira S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038521; Terossi M, 2010, ZOOTAXA, P49; Thaler AD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101345; Thatje S, 2004, J EXP MAR BIOL ECOL, V301, P15, DOI 10.1016/j.jembe.2003.09.010; Thatje S, 2001, J CRUSTACEAN BIOL, V21, P492, DOI 10.1651/0278-0372(2001)021[0492:DAKTTZ]2.0.CO;2; Thatje S, 2000, CRUSTACEANA, V73, P609, DOI 10.1163/156854000504697; Thatje S., 2015, SEXUALITY EARLY DEV, V1, P109, DOI [DOI 10.3354/SEDAO00011, 10.3354/sedao00011]; Tokuda G, 2006, BIOL LETTERS, V2, P257, DOI 10.1098/rsbl.2005.0420; Tyler PA, 2000, J MAR BIOL ASSOC UK, V80, P739, DOI 10.1017/S0025315400002605; Van Dover C.L., 1995, BULL BIOL SOC WASH, V6, P223; Vereshchaka AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129975; Whiting MF, 2002, ZOOL SCR, V31, P93, DOI 10.1046/j.0300-3256.2001.00095.x; WILLIAMSON D. I., 1960, CRUSTACEANA, V1, P331, DOI 10.1163/156854060X00339; Zelnio KA, 2009, P BIOL SOC WASH, V122, P52, DOI 10.2988/07-28.1	82	16	16	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0144657	10.1371/journal.pone.0144657	http://dx.doi.org/10.1371/journal.pone.0144657			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710075	Green Submitted, Green Published, gold			2022-12-26	WOS:000367451400009
J	Jamet, S; Slama, N; Domingues, J; Laval, F; Texier, P; Eynard, N; Quemard, A; Peixoto, A; Lemassu, A; Daffe, M; Cam, K				Jamet, Stevie; Slama, Nawel; Domingues, Joana; Laval, Francoise; Texier, Pauline; Eynard, Nathalie; Quemard, Annaik; Peixoto, Antonio; Lemassu, Anne; Daffe, Mamadou; Cam, Kaymeuang			The Non-Essential Mycolic Acid Biosynthesis Genes hadA and hadC Contribute to the Physiology and Fitness of Mycobacterium smegmatis	PLOS ONE			English	Article							DRUG-RESISTANT TUBERCULOSIS; CELL-WALL; DEHYDRATASE COMPONENT; MULTIDRUG-RESISTANT; SLIDING MOTILITY; PERMEABILITY; INHIBITION; ISOXYL; VIRULENCE; MECHANISM	Gram positive mycobacteria with a high GC content, such as the etiological agent of tuberculosis Mycobacterium tuberculosis, possess an outer membrane mainly composed of mycolic acids (MAs), the so-called mycomembrane, which is essential for the cell. About thirty genes are involved in the biosynthesis of MAs, which include the hadA, hadB and hadC genes that encode the dehydratases Fatty Acid Synthase type II (FAS-II) known to function as the heterodimers HadA-HadB and HadB-HadC. The present study shows that M. smegmatis cells remain viable in the absence of either HadA and HadC or both. Inactivation of HadC has a dramatic effect on the physiology and fitness of the mutant strains whereas that of HadA exacerbates the phenotype of a hadC deletion. The hadC mutants exhibit a novel MA profile, display a distinct colony morphology, are less aggregated, are impaired for sliding motility and biofilm development and are more resistant to detergent. Conversely, the hadC mutants are significantly more susceptible to low-and high-temperature and to selective toxic compounds, including several current anti-tubercular drugs.	[Jamet, Stevie; Slama, Nawel; Domingues, Joana; Laval, Francoise; Texier, Pauline; Eynard, Nathalie; Quemard, Annaik; Peixoto, Antonio; Lemassu, Anne; Daffe, Mamadou; Cam, Kaymeuang] CNRS, IPBS, UMR 5089, F-31077 Toulouse, France; [Jamet, Stevie; Slama, Nawel; Domingues, Joana; Laval, Francoise; Texier, Pauline; Eynard, Nathalie; Quemard, Annaik; Peixoto, Antonio; Lemassu, Anne; Daffe, Mamadou; Cam, Kaymeuang] Univ Toulouse, UPS, F-31000 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Cam, K (corresponding author), CNRS, IPBS, UMR 5089, F-31077 Toulouse, France.	kaymeuang.cam@ipbs.fr	LAUZERAL-VIZCAINO, Françoise/W-8898-2019	LAUZERAL-VIZCAINO, Françoise/0000-0002-9741-3252; Quemard, Annaik/0000-0002-5545-3424; Lemassu, Anne/0000-0002-9323-2497; Peixoto, Antonio/0000-0001-9493-1954	Ministere de l'Enseignement Superieur et de la Recherche; European Respiratory Society/Marie Curie Fellowship; Marie Curie International Incoming Fellowship; Centre National de la Recherche Scientifique	Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); European Respiratory Society/Marie Curie Fellowship; Marie Curie International Incoming Fellowship(European Commission); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	SJ Ministere de l'Enseignement Superieur et de la Recherche, JD a European Respiratory Society/Marie Curie Fellowship, AP a Marie Curie International Incoming Fellowship. This work was supported by institutional grants from the Centre National de la Recherche Scientifique.	Alibaud L, 2010, J BIOL CHEM, V285, P21698, DOI 10.1074/jbc.M110.125724; BABA T, 1989, J BIOCHEM-TOKYO, V106, P81, DOI 10.1093/oxfordjournals.jbchem.a122825; Balaban NQ, 2013, NAT REV MICROBIOL, V11, P587, DOI 10.1038/nrmicro3076; BELISLE JT, 1989, J BACTERIOL, V171, P3465, DOI 10.1128/jb.171.6.3465-3470.1989; Bercovier H, 2001, REV SCI TECH OIE, V20, P265, DOI 10.20506/rst.20.1.1269; Biswas R, 2015, BIOCHEM BIOPH RES CO, V458, P369, DOI 10.1016/j.bbrc.2015.01.119; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Brown AK, 2007, MICROBIOL-SGM, V153, P4166, DOI 10.1099/mic.0.2007/012419-0; Brown-Elliott BA, 2002, CLIN MICROBIOL REV, V15, P716, DOI 10.1128/CMR.15.4.716-746.2002; Camacho LR, 2001, J BIOL CHEM, V276, P19845, DOI 10.1074/jbc.M100662200; Caminero JA, 2010, LANCET INFECT DIS, V10, P621, DOI 10.1016/S1473-3099(10)70139-0; Cantaloube S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029564; Carrere-Kremer S, 2015, MOL MICROBIOL, V96, P1085, DOI 10.1111/mmi.12992; Catherinot E, 2007, INFECT IMMUN, V75, P1055, DOI 10.1128/IAI.00835-06; Coxon GD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053162; DAFFE M, 1983, ANN INST PASTEUR MIC, VB134, P241, DOI 10.1016/S0769-2609(83)80037-4; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; Daffe M, 2015, TUBERCULOSIS; Dahl JL, 2011, FEMS MICROBIOL LETT, V319, P153, DOI 10.1111/j.1574-6968.2011.02278.x; Danilchanka O, 2008, ANTIMICROB AGENTS CH, V52, P3127, DOI 10.1128/AAC.00239-08; Falzon D, 2013, LANCET INFECT DIS, V13, P690, DOI 10.1016/S1473-3099(13)70130-0; Fattorini L, 2013, MEDITERR J HEMATOL I, V5, DOI 10.4084/MJHID.2013.072; Gengenbacher M, 2012, FEMS MICROBIOL REV, V36, P514, DOI 10.1111/j.1574-6976.2012.00331.x; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Grzegorzewicz AE, 2015, ACS INFECT DIS, V1, P91, DOI 10.1021/id500032q; Grzegorzewicz AE, 2012, J BIOL CHEM, V287, P38434, DOI 10.1074/jbc.M112.400994; Gutierrez MC, 2009, GENOME DYNAM, V6, P198, DOI 10.1159/000235772; Healy VL, 2000, CHEM BIOL, V7, pR109, DOI 10.1016/S1074-5521(00)00116-2; Islam MS, 2012, EXPERT REV ANTI-INFE, V10, P1055, DOI [10.1586/eri.12.88, 10.1586/ERI.12.88]; Jamet S, 2015, J BACTERIOL, V197, P3797, DOI 10.1128/JB.00433-15; JARLIER V, 1990, J BACTERIOL, V172, P1418, DOI 10.1128/jb.172.3.1418-1423.1990; Kansal RG, 1998, MICROB PATHOGENESIS, V25, P203, DOI 10.1006/mpat.1998.0227; Kremer L, 2002, MICROBIOL-SGM, V148, P3145, DOI 10.1099/00221287-148-10-3145; Kulka K, 2012, JOVE-J VIS EXP, DOI 10.3791/3820; Laval F, 2001, ANAL CHEM, V73, P4537, DOI 10.1021/ac0105181; Laval F, 2008, J BIOL CHEM, V283, P1419, DOI 10.1074/jbc.M708859200; Lechartier B, 2014, EMBO MOL MED, V6, P158, DOI 10.1002/emmm.201201772; Lenaerts AJ, 2007, ANTIMICROB AGENTS CH, V51, P3338, DOI 10.1128/AAC.00276-07; Liu J, 1999, P NATL ACAD SCI USA, V96, P4011, DOI 10.1073/pnas.96.7.4011; Liu J, 1996, J BIOL CHEM, V271, P29545, DOI 10.1074/jbc.271.47.29545; MAGNUSON K, 1993, MICROBIOL REV, V57, P522, DOI 10.1128/MMBR.57.3.522-542.1993; Marrakchi H, 2014, CHEM BIOL, V21, P67, DOI 10.1016/j.chembiol.2013.11.011; Marsollier L, 2007, PLOS PATHOG, V3, P582, DOI 10.1371/journal.ppat.0030062; Martinez A, 1999, J BACTERIOL, V181, P7331; Migliori GB, 2013, EUR RESPIR J, V42, P169, DOI 10.1183/09031936.00136312; Mitchison DA, 1998, INT J TUBERC LUNG D, V2, P10; Nguyen L, 2009, ANNU REV PHARMACOL, V49, P427, DOI 10.1146/annurev-pharmtox-061008-103123; NIKAIDO H, 1985, MICROBIOL REV, V49, P1; Ojha A, 2005, CELL, V123, P861, DOI 10.1016/j.cell.2005.09.012; Phetsuksiri B, 1999, ANTIMICROB AGENTS CH, V43, P1042, DOI 10.1128/AAC.43.5.1042; Recht J, 2000, J BACTERIOL, V182, P4348, DOI 10.1128/JB.182.15.4348-4351.2000; Sacco E, 2007, P NATL ACAD SCI USA, V104, P14628, DOI 10.1073/pnas.0704132104; Sambandan D, 2013, MBIO, V4, DOI 10.1128/mBio.00222-13; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Shahab FM, 2010, XENOBIOTICA, V40, P225, DOI 10.3109/00498250903461411; Slama N, 2015, MOL MICROBIOLOGY; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Stahl C, 2001, MOL MICROBIOL, V40, P451, DOI 10.1046/j.1365-2958.2001.02394.x; Stratton HM, 2003, SYST APPL MICROBIOL, V26, P165, DOI 10.1078/072320203322345994; TAKAYAMA K, 1989, ANTIMICROB AGENTS CH, V33, P1493, DOI 10.1128/AAC.33.9.1493; TRIAS J, 1994, MOL MICROBIOL, V14, P283, DOI 10.1111/j.1365-2958.1994.tb01289.x; URBANCIK B, 1970, ANTIBIOT CHEMOTHER, V16, P117; van der Woude AD, 2012, J BIOL CHEM, V287, P20417, DOI 10.1074/jbc.M111.336461; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; Velayati AA, 2009, CHEST, V136, P420, DOI 10.1378/chest.08-2427; Veyron-Churlet R, 2004, MOL MICROBIOL, V54, P1161, DOI 10.1111/j.1365-2958.2004.04334.x; Vilcheze C, 2007, ANNU REV MICROBIOL, V61, P35, DOI 10.1146/annurev.micro.61.111606.122346; WALLACE RJ, 1988, J INFECT DIS, V158, P52, DOI 10.1093/infdis/158.1.52; Weiss LA, 2013, J BACTERIOL, V195, P5629, DOI 10.1128/JB.00759-13; WHO, 2014, GLOB TUB REP 2013; Willand N, 2009, NAT MED, V15, P537, DOI 10.1038/nm.1950; Xu WX, 2014, BIOCHEM BIOPH RES CO, V448, P255, DOI 10.1016/j.bbrc.2014.04.116; Young DB, 2009, TRENDS MICROBIOL, V17, P183, DOI 10.1016/j.tim.2009.02.005; Zhang YJJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002946; Zheng HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002375	75	12	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145883	10.1371/journal.pone.0145883	http://dx.doi.org/10.1371/journal.pone.0145883			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26701652	Green Published, gold, Green Submitted			2022-12-26	WOS:000367092600138
J	Senthilkumaran, B; Sreenivasulu, G; Wang, DS; Sudhakumari, CC; Kobayashi, T; Nagahama, Y				Senthilkumaran, Balasubramanian; Sreenivasulu, Gunti; Wang, De-Shou; Sudhakumari, Cheni-Chery; Kobayashi, Tohru; Nagahama, Yoshitaka			Expression Patterns of CREBs in Oocyte Growth and Maturation of Fish	PLOS ONE			English	Article							20-BETA-HYDROXYSTEROID DEHYDROGENASE; OVARIAN-FOLLICLES; AROMATASE GENE; NILE TILAPIA; CYCLIC-AMP; OREOCHROMIS-NILOTICUS; MEIOTIC MATURATION; POTENTIAL ROLE; MESSENGER-RNA; PROMOTER	In fish, oocyte meiotic maturation is regulated by 17 alpha, 20 beta-dihydroxy-progesterone through cAMP. To study the role of cAMP response element binding protein (CREB) in meiotic maturation, we cloned and characterized the expression pattern of CREBs from two fish models, the Nile tilapia and catfish. In the Nile tilapia three different CREBs were identified where in CREB1 was found in many tissues including gonads with abundant expression in testis. CREB2, few amino acids shorter than CREB1, was expressed in several tissues with abundant expression in ovary. In addition, a 3'UTR variant form, CREB3 was exclusively found in ovary. During natural 14-day ovarian cycle of the Nile tilapia, CREB1 expression was stable throughout vitellogenesis with a sharp decrease on the day of spawning. In contrast, CREB2 remain unchanged throughout the ovarian cycle, however elevated in 11-day full-grown immature ovarian follicle and after hCG-induction. Interestingly, CREB3 expression was induced three folds on the day of spawning as well as during hCG-induced oocyte maturation. Based on the synergistic expression pattern, CREB1 is likely to control oocyte growth, whereas CREB 2 and 3 contribute to oocyte maturation in tilapia and the latter seems to be critical. In catfish, a single form of CREB showed a maximum expression during spawning phase and hCG-induced maturation both in vivo and in vitro augmented CREB expression. These results suggest that spatial and temporal expression of CREBs seems to be important for final oocyte maturation and may also regulate oocyte growth in fish.	[Senthilkumaran, Balasubramanian; Sreenivasulu, Gunti; Sudhakumari, Cheni-Chery] Univ Hyderabad, Sch Life Sci, Dept Anim Biol, Hyderabad 500046, Telangana, India; [Senthilkumaran, Balasubramanian; Wang, De-Shou; Sudhakumari, Cheni-Chery; Kobayashi, Tohru; Nagahama, Yoshitaka] Natl Inst Nat Sci, Natl Inst Basic Biol, Reprod Biol Lab, Okazaki, Aichi 4448585, Japan	University of Hyderabad; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Senthilkumaran, B (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Anim Biol, PO Cent Univ, Hyderabad 500046, Telangana, India.	bsksl@uohyd.ernet.in	Wang, Deshou/ABD-6014-2021	Wang, Deshou/0000-0002-4967-524X	CREST (Core Research for Evolutional Science and Technology), JST (Japan Science and Technology Corporation), Research for the Future [JSPS-RFTF 96L00401]; Ministry of Education, Science, Culture, and Sports, Japan [07283104, 14042267]; Ministry of Agriculture, Forestry and Fisheries, Japan; Department of Science and Technology (DST), India [SP/SO/AS-49/2003]; DST-FIST of the Department of Animal Biology and School of Life Sciences; Council of Scientific and Industrial Research, India; TATA innovation fellowship, Department of Biotechnology, Government of India	CREST (Core Research for Evolutional Science and Technology), JST (Japan Science and Technology Corporation), Research for the Future; Ministry of Education, Science, Culture, and Sports, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Agriculture, Forestry and Fisheries, Japan(Ministry of Agriculture Forestry & Fisheries - Japan); Department of Science and Technology (DST), India(Department of Science & Technology (India)); DST-FIST of the Department of Animal Biology and School of Life Sciences; Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); TATA innovation fellowship, Department of Biotechnology, Government of India	Grants-in-aid for Research from CREST (Core Research for Evolutional Science and Technology), JST (Japan Science and Technology Corporation), Research for the Future (JSPS-RFTF 96L00401) and Priority Areas (07283104 and 14042267) from the Ministry of Education, Science, Culture, and Sports, Japan, and Bio Design Program from the Ministry of Agriculture, Forestry and Fisheries, Japan to YN is acknowledged. A Grant-in-aid (SP/SO/AS-49/2003) from the Department of Science and Technology (DST), India, to BS is acknowledged. BS and CCS are the recipients of the Japan Society for the Promotion of Science, which is acknowledged. The authors also thank the support from DST-FIST of the Department of Animal Biology and School of Life Sciences. GS acknowledges junior and senior research fellowships from Council of Scientific and Industrial Research, India. BS is a recipient of TATA innovation fellowship, Department of Biotechnology, Government of India, which is duly acknowledged.; BS and CCS are the recipients of the Japan Society for the Promotion of Science, which is acknowledged. We also thank the support from DST-FIST of the Department of Animal Biology and School of Life Sciences. GS acknowledges junior and senior research fellowships from Council of Scientific and Industrial Research, India. BS is a recipient of TATA innovation fellowship, Department of Biotechnology, Government of India, which is duly acknowledged.	Carlone DL, 1997, J STEROID BIOCHEM, V61, P223, DOI 10.1016/S0960-0760(97)80016-7; Fitzpatrick SL, 1997, STEROIDS, V62, P197, DOI 10.1016/S0039-128X(96)00181-X; Gen K, 2000, BIOL REPROD, V63, P308, DOI 10.1095/biolreprod63.1.308; Guan GJ, 1999, BIOCHEM BIOPH RES CO, V255, P123, DOI 10.1006/bbrc.1998.0127; Haider S, 2003, COMP BIOCHEM PHYS A, V134, P267, DOI 10.1016/S1095-6433(02)00261-1; Huang W, 2009, MOL CELL ENDOCRINOL, V307, P224, DOI 10.1016/j.mce.2009.04.003; KANAMORI A, 1988, GEN COMP ENDOCR, V72, P39, DOI 10.1016/0016-6480(88)90178-5; KOIDE Y, 1992, GEN COMP ENDOCR, V87, P327, DOI 10.1016/0016-6480(92)90039-M; Kwon JY, 2001, MOL REPROD DEV, V59, P359, DOI 10.1002/mrd.1042; Nagahama Y, 1997, STEROIDS, V62, P190, DOI 10.1016/S0039-128X(96)00180-8; Nagahama Y, 2008, DEV GROWTH DIFFER, V50, pS195, DOI 10.1111/j.1440-169X.2008.01019.x; Sands WA, 2008, CELL SIGNAL, V20, P460, DOI 10.1016/j.cellsig.2007.10.005; Senthilkumaran B, 2004, MOL CELL ENDOCRINOL, V215, P11, DOI 10.1016/j.mce.2003.11.012; Senthilkumaran B, 2002, BIOL REPROD, V67, P1080, DOI 10.1095/biolreprod67.4.1080; Senthilkumaran B, 2001, J ENDOCRINOL, V168, P239, DOI 10.1677/joe.0.1680239; Senthilkumaran B, 2011, FRONT BIOSCI-LANDMRK, V16, P1898, DOI 10.2741/3829; Sreenivasulu G, 2012, GENE, V509, P68, DOI 10.1016/j.gene.2012.07.017; Sreenivasulu G, 2009, GEN COMP ENDOCR, V163, P259, DOI 10.1016/j.ygcen.2009.04.022; Tanaka M, 2002, BIOL REPROD, V66, P1498, DOI 10.1095/biolreprod66.5.1498; Wang DS, 2007, MOL ENDOCRINOL, V21, P712, DOI 10.1210/me.2006-0248; Watanabe M, 1999, MOL CELL ENDOCRINOL, V149, P221, DOI 10.1016/S0303-7207(99)00006-4; Yoshiura Y, 2003, BIOL REPROD, V68, P1545, DOI 10.1095/biolreprod.102.010843; Young M, 1998, ENDOCRINOLOGY, V139, P5082, DOI 10.1210/en.139.12.5082	23	6	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145182	10.1371/journal.pone.0145182	http://dx.doi.org/10.1371/journal.pone.0145182			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700177	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092600051
J	Zhu, ZD; Fan, XT; Lv, YH; Zhang, N; Fan, CN; Zhang, PF; Zeng, WX				Zhu, Zhendong; Fan, Xiaoteng; Lv, Yinghua; Zhang, Nan; Fan, Chuning; Zhang, Pengfei; Zeng, Wenxian			Vitamin E Analogue Improves Rabbit Sperm Quality during the Process of Cryopreservation through Its Antioxidative Action	PLOS ONE			English	Article							ALPHA-TOCOPHEROL SUPPLEMENTATION; LIPID-PEROXIDATION; BOAR SPERMATOZOA; SEMEN CRYOPRESERVATION; DIFFERENT FRACTIONS; OXIDATIVE STRESS; PARAMETERS; EXTENDER; MOTILITY; FROZEN	The process of cryopreservation results in high concentration of reactive oxygen species which is detrimental to spermatozoa. The aim of this study was to investigate whether addition of vitamin E analogue to freezing extender can facilitate the cryosurvival of spermatozoa in rabbits, and how vitamin E protects spermatozoa against damages during the process of preservation. Freshly ejaculated semen was diluted with Tris-citrate-glucose extender supplemented with different concentrations of Trolox (a vitamin E analogue). The level of radical oxygen species (ROS) in spermatozoa that was exposed to Trolox was significantly lower than that of the control during each step of the process of preservation. The percentage of frozen-thawed spermatozoa with lipid peroxidation in the Trolox treatments was significantly lower than that of the control. The motility, intact acrosome, membrane integrity and mitochondrial potentials of the frozen-thawed spermatozoa in the treatment of 200 mu M Trolox were significantly higher than those of the control. These observations suggest that addition of vitamin E to a freezing extender leads to higher integrity of acrosome, plasma membrane and mitochondrial membrane potential as well as higher motility. Vitamin E protects spermatozoa through its capacity to quench ROS accumulation and lipid peroxidation during the process of preservation. Addition of Trolox is recommended to facilitate the improvement of semen preservation for the rabbit breeding industry.	[Zhu, Zhendong; Fan, Xiaoteng; Lv, Yinghua; Zhang, Nan; Fan, Chuning; Zhang, Pengfei; Zeng, Wenxian] Northwest A&F Univ, Coll Anim Sci & Technol, Xian 712100, Shaanxi, Peoples R China	Northwest A&F University - China	Zeng, WX (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Xian 712100, Shaanxi, Peoples R China.	zengwnxian@hotmail.com	Zeng, Wen/GPS-8058-2022	zhu, zhendong/0000-0001-7002-7119; Fan, Xiaoteng/0000-0002-6405-8135	National Natural Science Foundation of China [31072029, 31272439, 31230048]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Grant No. 31072029, No. 31272439 and No. 31230048) for W Zeng (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported in part by the National Natural Science Foundation of China (Grant No. 31072029, No. 31272439 and No. 31230048). We thank Dr. Lawrence M. Liao at Hiroshima University, Japan for reviewing and editing the manuscript.	Agarwal A, 2005, BJU INT, V95, P503, DOI 10.1111/j.1464-410X.2005.05328.x; Agarwal A, 2003, FERTIL STERIL, V79, P829, DOI 10.1016/S0015-0282(02)04948-8; ALVAREZ JG, 1984, BIOL REPROD, V30, P323, DOI 10.1095/biolreprod30.2.323; Anel-Lopez L, 2012, ANIM REPROD SCI, V135, P37, DOI 10.1016/j.anireprosci.2012.09.001; Apel-Paz M, 2003, BIOCHEM BIOPH RES CO, V309, P724, DOI 10.1016/j.bbrc.2003.08.065; da Silva CMB, 2011, J PINEAL RES, V51, P172, DOI 10.1111/j.1600-079X.2011.00873.x; Bansal Amrit Kaur, 2010, Vet Med Int, V2010, DOI 10.4061/2011/686137; Bansal AK, 2009, ANIM SCI PAP REP, V27, P5; Beheshti R., 2011, The Journal of American Science, V7, P227; Bergmann AR, 1997, J LIPID RES, V38, P2580; Bilodeau JF, 2000, MOL REPROD DEV, V55, P282, DOI 10.1002/(SICI)1098-2795(200003)55:3&lt;282::AID-MRD6&gt;3.0.CO;2-7; Breininger E, 2005, THERIOGENOLOGY, V63, P2126, DOI 10.1016/j.theriogenology.2004.08.016; Bucak MN, 2008, SMALL RUMINANT RES, V75, P128, DOI 10.1016/j.smallrumres.2007.09.002; Chatterjee S, 2001, MOL REPROD DEV, V59, P451, DOI 10.1002/mrd.1052; Foote RH, 2000, J ANDROL, V21, P664; GARNER DL, 1995, BIOL REPROD, V53, P276, DOI 10.1095/biolreprod53.2.276; Holt WV, 1997, REPROD FERT DEVELOP, V9, P309, DOI 10.1071/R96082; Holt WV, 2000, ANIM REPROD SCI, V62, P3, DOI 10.1016/S0378-4320(00)00152-4; Hu JH, 2011, ANIMAL, V5, P107, DOI 10.1017/S1751731110001679; Jeong YJ, 2009, CRYOBIOLOGY, V58, P181, DOI 10.1016/j.cryobiol.2008.12.004; JONES R, 1977, J REPROD FERTIL, V50, P261, DOI 10.1530/jrf.0.0500261; Kalthur G, 2011, FERTIL STERIL, V95, P1149, DOI 10.1016/j.fertnstert.2010.10.005; Luo HL, 2004, CHINESE J ANIM SCI, V40, P0007; Ma HM, 2010, ANIM REPROD SCI, V121, P106, DOI 10.1016/j.anireprosci.2010.05.005; Maia MD, 2009, SMALL RUMINANT RES, V85, P85, DOI 10.1016/j.smallrumres.2009.07.001; Moce E, 2009, ANIM REPROD SCI, V110, P1, DOI 10.1016/j.anireprosci.2008.08.015; Mourvaki E, 2008, ANDROLOGIA, V40, P282, DOI 10.1111/j.1439-0272.2008.00854.x; Mourvaki E, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-16; Nasiri AH, 2012, ANDROLOGIA, V44, P550, DOI 10.1111/j.1439-0272.2011.01225.x; Pant N, 2008, TOXICOL APPL PHARM, V231, P112, DOI 10.1016/j.taap.2008.04.001; Pena FJ, 2004, ZYGOTE, V12, P117, DOI 10.1017/S096719940400262X; Pena FJ, 2003, ANIM REPROD SCI, V78, P85, DOI 10.1016/S0378-4320(03)00049-6; Penitente JM, 2014, SCI WORLD J, DOI 10.1155/2014/964172; Satorre MM, 2007, THERIOGENOLOGY, V68, P958, DOI 10.1016/j.theriogenology.2007.06.021; Sicherle CC, 2011, SMALL RUMINANT RES, V95, P144, DOI 10.1016/j.smallrumres.2010.10.011; Sikka Suresh C., 1996, Frontiers in Bioscience (online), V1, pE78; Silva SV, 2013, ANIM REPROD SCI, V137, P37, DOI 10.1016/j.anireprosci.2012.12.002; Surai P, 1998, BIOL TRACE ELEM RES, V64, P119, DOI 10.1007/BF02783329; Taylor K, 2009, REPROD BIOMED ONLINE, V18, P184, DOI 10.1016/S1472-6483(10)60254-4; Thuwanut P, 2009, REPROD DOMEST ANIM, V44, P373, DOI 10.1111/j.1439-0531.2009.01453.x; Towhidi A, 2012, J ASSIST REPROD GEN, V29, P1051, DOI 10.1007/s10815-012-9834-7; Zeng WX, 2001, THERIOGENOLOGY, V56, P447, DOI 10.1016/S0093-691X(01)00576-3; Zeng WX, 2000, REPROD FERT DEVELOP, V12, P223, DOI 10.1071/RD00058	43	38	43	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145383	10.1371/journal.pone.0145383	http://dx.doi.org/10.1371/journal.pone.0145383			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700473	Green Submitted, Green Published, gold			2022-12-26	WOS:000367092600073
J	Liu, F; Adi, D; Xie, X; Li, XM; Fu, ZY; Shan, CF; Huang, Y; Chen, BD; Gai, MT; Gao, XM; Ma, YT; Yang, YN				Liu, Fen; Adi, Dilare; Xie, Xiang; Li, Xiao-Mei; Fu, Zhen-Yan; Shan, Chun-Fang; Huang, Ying; Chen, Bang-Dang; Gai, Min-Tao; Gao, Xiao-Ming; Ma, Yi-Tong; Yang, Yi-Ning			Prevalence of Isolated Diastolic Hypertension and Associated Risk Factors among Different Ethnicity Groups in Xinjiang, China	PLOS ONE			English	Article							ISOLATED SYSTOLIC HYPERTENSION; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; NATIONAL-HEALTH; PULSE PRESSURE; GLOBAL BURDEN; PREDICTORS; SUBTYPES; PROGNOSIS; PROVINCE	Objectives Little is known about isolated diastolic hypertension (IDH) among different ethnicity groups. We aimed to investigate the prevalence and risk factors for IDH among the major ethnicity population i.e. Han, Uygur and Kazakh in Xinjiang, northwestern part of China. Methods In total, 14,618 adult participants (7,799 males, 6,819 females) were recruited from the Cardiovascular Risk Survey conducted during 2007 and 2010. Blood pressure, body mass index and standard lipid profile and fasting glucose level from plasma were measured. Results The overall prevalence of IDH was 10.8% in the Han, 4.5% in the Uygur and 8.7% in the Kazakh populations. When stratified by gender, IDH prevalence was 9.8% in men and 6.8% in women (P<0.001). The prevalence of IDH also varied significantly with age and it was highest in those aged 35-44 yrs old (9.7%) and lowest in those over 75 yrs old (4.1%, P<0.001). Multivariate logistic regression analysis showed that overweight (OR = 1.179, 95% CI: 1.015-1.369) or obesity (OR = 1.202, 95% CI: 1.015-1.424), smoking (OR = 1.362, 95% CI: 1.156-1.604) and high total cholesterol (TC) hyperlipidemia (OR = 1.237, 95% CI: 1.074-1.423) were significantly associated with a higher prevalence of IDH. Identified risk factors for IDH differed among ethnicity groups with male gender, young age (35-44 yrs old), more coffee or tea consumption and high TC hyperlipidemia in the Han; smoking and often coffee or tea consumption in the Uygur and male gender and overweight or obesity in the Kazakh populations. Conclusions IDH prevalence in the Han population is higher than that in the Uygur and Kazak populations in Xinjiang, northwestern part of China. Male gender, middle age, overweight or obesity, smoking and high TC hyperlipidemia appear to be relevant risk factors of IDH in adults. Different ethnicity background had different sets of risk factors for IDH.	[Liu, Fen; Xie, Xiang; Chen, Bang-Dang; Gai, Min-Tao; Gao, Xiao-Ming; Ma, Yi-Tong; Yang, Yi-Ning] Xinjiang Med Univ, Affiliated Hosp 1, Clin Med Res Inst, Xin Jiang Key Lab Cardiovasc Dis, Urumqi, Peoples R China; [Liu, Fen; Adi, Dilare; Xie, Xiang; Li, Xiao-Mei; Fu, Zhen-Yan; Shan, Chun-Fang; Huang, Ying; Chen, Bang-Dang; Gai, Min-Tao; Ma, Yi-Tong; Yang, Yi-Ning] Xingjiang Med Univ, Affiliated Hosp 1, Dept Cardiol, Urumqi, Peoples R China; [Gao, Xiao-Ming] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia	Xinjiang Medical University; Baker Heart and Diabetes Institute	Gao, XM (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, Clin Med Res Inst, Xin Jiang Key Lab Cardiovasc Dis, Urumqi, Peoples R China.	xiaomng.gao@bakeridi.edu.au; myt_xj@sina.com; yangyn5126@163.com	xie, xiang/AAG-2128-2021		Key Laboratory of Xinjiang Uygur Autonomous Region [2014KL011]	Key Laboratory of Xinjiang Uygur Autonomous Region	This work was supported financially by the special funded project, Key Laboratory of Xinjiang Uygur Autonomous Region (No. 2014KL011).	Adeoye AM, 2014, INT J HYPERTENS, V2014, DOI 10.1155/2014/295916; Anonymous, 2007, Zhonghua Xinxueguanbing Zazhi, V35, P390; [Anonymous], 2002, WORLD HLTH REP, P12; Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; Franklin SS, 2001, HYPERTENSION, V37, P869, DOI 10.1161/01.HYP.37.3.869; Franklin SS, 2005, CIRCULATION, V111, P1121, DOI 10.1161/01.CIR.0000157159.39889.EC; Franklin SS, 2006, J HYPERTENS, V24, P2009, DOI 10.1097/01.hjh.0000244950.72664.02; Franklin SS, 2009, CIRCULATION, V119, P243, DOI 10.1161/CIRCULATIONAHA.108.797936; Grebla RC, 2010, J HYPERTENS, V28, P15, DOI 10.1097/HJH.0b013e328331b7ff; Hozawa A, 2000, ARCH INTERN MED, V160, P3301, DOI 10.1001/archinte.160.21.3301; Huang JF, 2004, AM J HYPERTENS, V17, P955, DOI 10.1016/j.amjhyper.2004.06.007; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kelly TN, 2008, CIRCULATION, V118, P1558, DOI 10.1161/CIRCULATIONAHA.107.723593; Li Y, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0489-x; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Liu F, 2014, BLOOD PRESSURE, V23, P154, DOI 10.3109/08037051.2013.838827; Liu Li-Sheng, 2011, Zhonghua Xin Xue Guan Bing Za Zhi, V39, P579; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; McEniery CM, 2005, HYPERTENSION, V46, P221, DOI 10.1161/01.HYP.0000165310.84801.e0; McManus RJ, 2012, BMJ-BRIT MED J, V13, P344; Midha Tanu, 2012, Indian Heart J, V64, P374, DOI 10.1016/j.ihj.2012.06.007; Niiranen TJ, 2014, J HYPERTENS, V32, P518, DOI 10.1097/HJH.0000000000000070; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; Rehill N, 2006, BRIT J CLIN PHARMACO, V61, P767, DOI 10.1111/j.1365-2125.2006.02630.x; Strandberg TE, 2002, J HYPERTENS, V20, P399, DOI 10.1097/00004872-200203000-00014; Wang YC, 2015, INT J ENV RES PUB HE, V12, P4395, DOI 10.3390/ijerph120404395; World Health Organization Study Group Diabetes mellitus, 1985, WHO TECH REP SER, V727, P1; Wu HL, 2009, AM J HYPERTENS, V22, P1287, DOI 10.1038/ajh.2009.189; Xie X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015181; Xie X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013997; Xie X, 2009, CLIN APPL THROMB-HEM, V15, P574, DOI 10.1177/1076029608329581; Yang TO, 2015, AM J CLIN NUTR, V101, P570, DOI 10.3945/ajcn.113.081836; Yeh CJ, 2001, J FORMOS MED ASSOC, V100, P668; Zhang RB, 2000, AM J HYPERTENS, V13, P1308, DOI 10.1016/S0895-7061(00)01254-1; 卓朗, 2006, [高血压杂志, Chinese Journal of Hypertension], V14, P307	36	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145325	10.1371/journal.pone.0145325	http://dx.doi.org/10.1371/journal.pone.0145325			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26694755	Green Published, gold, Green Submitted			2022-12-26	WOS:000367092500039
J	Wang, Z; Zhao, SM; Zhao, LM; Chen, XQ; Zeng, GZ; Tan, NH				Wang, Zhe; Zhao, Si-Meng; Zhao, Li-Mei; Chen, Xiao-Qiang; Zeng, Guang-Zhi; Tan, Ning-Hua			Rubipodanin A, the First Natural N-Desmonomethyl Rubiaceae-Type Cyclopeptide from Rubia podantha, Indicating an Important Role of the N-9-Methyl Group in the Conformation and Bioactivity	PLOS ONE			English	Article							ANTITUMOR CYCLIC HEXAPEPTIDES; CYTOTOXIC BICYCLIC HEXAPEPTIDES; BREAST-CANCER CELLS; RA-VII; CORDIFOLIA; DEOXYBOUVARDIN; IDENTIFICATION; RUBIYUNNANINS; PHARMACOPHORE; YUNNANENSIS	One new cyclic hexapeptide named rubipodanin A (1), which is the first identified natural N-desmonomethyl Rubiaceae-type cyclopeptide, together with six known Rubiaceae-type cyclopeptides (2-7) were obtained using the TLC cyclopeptide protosite detection method with ninhydrin from the roots and rhizomes of Rubia podantha. The cyclopeptide structures were elucidated by extensive spectroscopic analysis, including 1D-NMR, 2D-NMR, IR, UV and MS. The solution conformation and biological activities of 1 and RA-V (4) were evaluated, and the results demonstrated that the N-9-methyl group plays a vital role in the maintenance of the conformation and bioactivity.	[Wang, Zhe; Zhao, Si-Meng; Zhao, Li-Mei; Chen, Xiao-Qiang; Zeng, Guang-Zhi; Tan, Ning-Hua] Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming 650201, Peoples R China; [Tan, Ning-Hua] China Pharmaceut Univ, Dept Nat Med Chem, Nanjing 210009, Jiangsu, Peoples R China; [Tan, Ning-Hua] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing 210009, Jiangsu, Peoples R China; [Wang, Zhe] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; China Pharmaceutical University; China Pharmaceutical University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zeng, GZ (corresponding author), Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming 650201, Peoples R China.	gzh_zeng@mail.kib.ac.cn; nhtan@mail.kib.ac.cn			National Basic Research Program of China [2013CB127505]; Foundation of Chinese Academy of Sciences (Hundred Talents Program) [XDA09030301-4]; National Natural Science Foundation of China [U1032602, 91013002, 31470428]; National New Drug Innovation Major Project of China [2011ZX09307-002-02]; Natural Science Foundation of Yunnan Province [2012GA003]	National Basic Research Program of China(National Basic Research Program of China); Foundation of Chinese Academy of Sciences (Hundred Talents Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National New Drug Innovation Major Project of China; Natural Science Foundation of Yunnan Province(Natural Science Foundation of Yunnan Province)	This work was supported by the National Basic Research Program of China (2013CB127505), the Foundation of Chinese Academy of Sciences (Hundred Talents Program, XDA09030301-4), the National Natural Science Foundation of China (U1032602, 91013002, 31470428), the National New Drug Innovation Major Project of China (2011ZX09307-002-02), and the Natural Science Foundation of Yunnan Province (2012GA003).	AEBI JD, 1990, J MED CHEM, V33, P999, DOI 10.1021/jm00165a018; Bik-San C, 2015, SCIENCE, V347, pS45; BOGER DL, 1994, J AM CHEM SOC, V116, P8544, DOI 10.1021/ja00098a015; BOGER DL, 1992, J ORG CHEM, V57, P1319, DOI 10.1021/jo00031a001; BOGER DL, 1993, J AM CHEM SOC, V115, P3420, DOI 10.1021/ja00062a004; BOGER DL, 1995, J AM CHEM SOC, V117, P7364, DOI 10.1021/ja00133a010; Fan JT, 2010, TETRAHEDRON LETT, V51, P6810, DOI 10.1016/j.tetlet.2010.07.066; Fan JT, 2010, BIOORGAN MED CHEM, V18, P8226, DOI 10.1016/j.bmc.2010.10.019; Fang XY, 2013, TOXICOL APPL PHARM, V267, P95, DOI 10.1016/j.taap.2012.12.010; Fujiwara H, 2004, CANCER LETT, V209, P223, DOI 10.1016/j.canlet.2003.12.022; Hitotsuyanagi Y, 2012, PHYTOCHEM LETT, V5, P335, DOI 10.1016/j.phytol.2012.02.014; Hitotsuyanagi Y, 2012, CHEM-EUR J, V18, P2839, DOI 10.1002/chem.201103185; Huang MB, 2014, TETRAHEDRON, V70, P7627, DOI 10.1016/j.tet.2014.07.105; ITOKAWA H, 1983, CHEM PHARM BULL, V31, P1424; ITOKAWA H, 1986, CHEM PHARM BULL, V34, P3762; JOLAD SD, 1977, J AM CHEM SOC, V99, P8040, DOI 10.1021/ja00466a043; Kuang Bin, 2012, Zhongguo Zhong Yao Za Zhi, V37, P2563; Lee JE, 2008, CHEM PHARM BULL, V56, P730, DOI 10.1248/cpb.56.730; Lee JE, 2008, TETRAHEDRON, V64, P4117, DOI 10.1016/j.tet.2008.01.094; Lee JE, 2008, BIOORG MED CHEM LETT, V18, P808, DOI 10.1016/j.bmcl.2007.11.030; Leung HW, 2015, BBA-MOL CELL RES, V1853, P1827, DOI 10.1016/j.bbamcr.2015.04.020; Liu NN, 2014, TETRAHEDRON, V70, P6630, DOI 10.1016/j.tet.2014.06.108; MORITA H, 1993, CHEM PHARM BULL, V41, P781, DOI 10.1248/cpb.41.781; MORITA H, 1992, CHEM PHARM BULL, V40, P1352, DOI 10.1248/cpb.40.1352; Morita H, 2010, HETEROCYCLES, V80, P739, DOI 10.3987/REV-09-SR(S)7; Otrubova K, 2008, J MED CHEM, V51, P530, DOI 10.1021/jm070731a; Tan NH, 2006, CHEM REV, V106, P840, DOI 10.1021/cr040699h; Tao J, 2003, CHEM PHARM BULL, V51, P654, DOI 10.1248/cpb.51.654; Yan H, 2009, EUR J MED CHEM, V44, P3425, DOI 10.1016/j.ejmech.2009.02.005; Yue GGL, 2011, BRIT J PHARMACOL, V164, P1883, DOI 10.1111/j.1476-5381.2011.01458.x; Zeng GZ, 2009, PHYTOTHER RES, V23, P885, DOI 10.1002/ptr.2671; Zhao SM, 2011, CHIMIA, V65, P952, DOI 10.2533/chimia.2011.952; Zhao SM, 2014, ORG LETT, V16, P5576, DOI 10.1021/ol502603f; Zhou T, 2000, CHINESE SCI BULL, V45, P1825	34	18	18	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0144950	10.1371/journal.pone.0144950	http://dx.doi.org/10.1371/journal.pone.0144950			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26694544	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092500017
J	Christie, AE; Chi, M; Lameyer, TJ; Pascual, MG; Shea, DN; Stanhope, ME; Schulz, DJ; Dickinson, PS				Christie, Andrew E.; Chi, Megan; Lameyer, Tess J.; Pascual, Micah G.; Shea, Devlin N.; Stanhope, Meredith E.; Schulz, David J.; Dickinson, Patsy S.			Neuropeptidergic Signaling in the American Lobster Homarus americanus: New Insights from High-Throughput Nucleotide Sequencing	PLOS ONE			English	Article							STOMATOGASTRIC NERVOUS-SYSTEM; CARDIAC NEUROMUSCULAR SYSTEM; NOVO ASSEMBLED TRANSCRIPTOME; INTEGRATED DOCUMENTATION RESOURCE; CRUSTACEAN CALANUS-FINMARCHICUS; CRAYFISH PROCAMBARUS-CLARKII; TRANSFORM MASS-SPECTROMETRY; IN-SILICO CHARACTERIZATION; ALLATOSTATIN-LIKE PEPTIDE; SILKWORM BOMBYX-MORI	Peptides are the largest and most diverse class of molecules used for neurochemical communication, playing key roles in the control of essentially all aspects of physiology and behavior. The American lobster, Homarus americanus, is a crustacean of commercial and biomedical importance; lobster growth and reproduction are under neuropeptidergic control, and portions of the lobster nervous system serve as models for understanding the general principles underlying rhythmic motor behavior (including peptidergic neuromodulation). While a number of neuropeptides have been identified from H. americanus, and the effects of some have been investigated at the cellular/systems levels, little is currently known about the molecular components of neuropeptidergic signaling in the lobster. Here, a H. americanus neural transcriptome was generated and mined for sequences encoding putative peptide precursors and receptors; 35 precursor- and 41 receptor-encoding transcripts were identified. We predicted 194 distinct neuropeptides from the deduced precursor proteins, including members of the adipokinetic hormone-corazonin-like peptide, allatostatin A, allatostatin C, bursicon, CCHamide, corazonin, crustacean cardioactive peptide, crustacean hyperglycemic hormone (CHH), CHH precursor-related peptide, diuretic hormone 31, diuretic hormone 44, eclosion hormone, FLRFamide, GSEFLamide, insulin-like peptide, intocin, leucokinin, myosuppressin, neuroparsin, neuropeptide F, orcokinin, pigment dispersing hormone, proctolin, pyrokinin, SIFamide, sulfakinin and tachykinin-related peptide families. While some of the predicted peptides are known H. americanus isoforms, most are novel identifications, more than doubling the extant lobster neuropeptidome. The deduced receptor proteins are the first descriptions of H. americanus neuropeptide receptors, and include ones for most of the peptide groups mentioned earlier, as well as those for ecdysis-triggering hormone, red pigment concentrating hormone and short neuropeptide F. Multiple receptors were identified for most peptide families. These data represent the most complete description of the molecular underpinnings of peptidergic signaling in H. americanus, and will serve as a foundation for future gene-based studies of neuropeptidergic control in the lobster.	[Christie, Andrew E.; Chi, Megan; Pascual, Micah G.] Univ Hawaii Manoa, Bekesy Lab Neurobiol, Pacific Biosci Res Ctr, Honolulu, HI 96822 USA; [Christie, Andrew E.; Chi, Megan; Pascual, Micah G.] Univ Hawaii Manoa, Technol, Honolulu, HI 96822 USA; [Lameyer, Tess J.; Shea, Devlin N.; Stanhope, Meredith E.; Dickinson, Patsy S.] Bowdoin Coll, Dept Biol, Brunswick, ME 04672 USA; [Schulz, David J.] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; Bowdoin College; University of Missouri System; University of Missouri Columbia	Christie, AE (corresponding author), Univ Hawaii Manoa, Bekesy Lab Neurobiol, Pacific Biosci Res Ctr, 6500 Coll Stn,1993 East West Rd, Honolulu, HI 96822 USA.	crabman@pbrc.hawaii.edu		Stanhope, Meredith/0000-0002-6358-4141; Shea, Devlin/0000-0002-5058-6770; Schulz, David/0000-0003-4532-5362	National Science Foundation [IOS-1353023, IOS-1354567]; National Institutes of Health (Maine IDeA Networks of Biomedical Research Excellence (INBRE) from NIGMS) [P20GM0103423]; Doherty Fund of Bowdoin College; American Physiological Society; Cades Foundation of Honolulu, Hawaii; National Institutes of Health [MH46742]; Direct For Biological Sciences [1354567] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103423] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH046742, R01MH046742] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health (Maine IDeA Networks of Biomedical Research Excellence (INBRE) from NIGMS); Doherty Fund of Bowdoin College; American Physiological Society; Cades Foundation of Honolulu, Hawaii; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Financial support for this study was provided by the National Science Foundation (IOS-1353023 to A.E.C and IOS-1354567 to P.S.D), the National Institutes of Health (Maine IDeA Networks of Biomedical Research Excellence (INBRE) [P20GM0103423 from NIGMS to Dr. Patricia Hand, Mount Desert Island Biological Laboratory]), the Doherty Fund of Bowdoin College (to D.N.S.), the American Physiological Society (to M.E.S.), and the Cades Foundation of Honolulu, Hawaii (to A.E.C). The cost of transcriptome sequencing was supported by the National Institutes of Health (MH46742 to Eve Marder, Brandeis University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Aikins MJ, 2008, INSECT BIOCHEM MOLEC, V38, P740, DOI 10.1016/j.ibmb.2008.04.006; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2000, BIOINFORMATICS, V16, P1145, DOI 10.1093/bioinformatics/16.12.1145; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Auerswald L, 2001, BIOCHEM BIOPH RES CO, V282, P904, DOI 10.1006/bbrc.2001.4659; Blitz DM, 2011, CURR OPIN NEUROBIOL, V21, P544, DOI 10.1016/j.conb.2011.05.019; Cape SS, 2008, J NEUROCHEM, V105, P690, DOI 10.1111/j.1471-4159.2007.05154.x; CHANG ES, 1990, BIOCHEM BIOPH RES CO, V171, P818, DOI 10.1016/0006-291X(90)91219-I; Chen RB, 2010, J PROTEOME RES, V9, P818, DOI 10.1021/pr900736t; Christie AE, 2010, J EXP BIOL, V213, P118, DOI 10.1242/jeb.037077; Christie AE, 2006, J COMP NEUROL, V496, P406, DOI 10.1002/cne.20932; Christie AE, 2015, GEN COMP EN IN PRESS; Christie AE, 2008, PEPTIDES, V29, P1909, DOI 10.1016/j.peptides.2008.07.010; Christie AE, 2008, GEN COMP ENDOCR, V159, P67, DOI 10.1016/j.ygcen.2008.07.022; Christie AE, 2008, GEN COMP ENDOCR, V157, P174, DOI 10.1016/j.ygcen.2008.03.027; Christie AE, 2008, GEN COMP ENDOCR, V156, P246, DOI 10.1016/j.ygcen.2008.01.018; Christie AE, 2015, GEN COMP ENDOCR, V213, P90, DOI 10.1016/j.ygcen.2015.02.003; Christie AE, 2015, GEN COMP ENDOCR, V211, P92, DOI 10.1016/j.ygcen.2014.11.002; Christie AE, 2015, GEN COMP ENDOCR, V210, P63, DOI 10.1016/j.ygcen.2014.10.005; Christie AE, 2014, GEN COMP ENDOCR, V206, P96, DOI 10.1016/j.ygcen.2014.07.010; Christie AE, 2014, GEN COMP ENDOCR, V206, P235, DOI 10.1016/j.ygcen.2014.04.015; Christie AE, 2014, GEN COMP ENDOCR, V204, P248, DOI 10.1016/j.ygcen.2014.05.031; Christie AE, 2014, GEN COMP ENDOCR, V204, P114, DOI 10.1016/j.ygcen.2014.05.004; Christie AE, 2014, GEN COMP ENDOCR, V202, P76, DOI 10.1016/j.ygcen.2014.04.003; Christie AE, 2014, GEN COMP ENDOCR, V201, P74, DOI 10.1016/j.ygcen.2014.01.017; Christie AE, 2014, GEN COMP ENDOCR, V201, P87, DOI 10.1016/j.ygcen.2014.02.015; Christie AE, 2014, GEN COMP ENDOCR, V195, P28, DOI 10.1016/j.ygcen.2013.10.003; Christie AE, 2013, COMP BIOCHEM PHYS D, V8, P165, DOI 10.1016/j.cbd.2013.04.002; Christie AE, 2013, GEN COMP ENDOCR, V187, P117, DOI 10.1016/j.ygcen.2013.03.018; Christie AE, 2011, CELL TISSUE RES, V345, P41, DOI 10.1007/s00441-011-1183-9; Christie AE, 2011, GEN COMP ENDOCR, V171, P131, DOI 10.1016/j.ygcen.2011.01.002; Christie AE, 2011, GEN COMP ENDOCR, V170, P144, DOI 10.1016/j.ygcen.2010.09.018; Christie AE, 2011, GEN COMP ENDOCR, V170, P480, DOI 10.1016/j.ygcen.2010.11.002; Christie AE, 2010, CELL MOL LIFE SCI, V67, P4135, DOI 10.1007/s00018-010-0482-8; Christie AE, 2010, GEN COMP ENDOCR, V167, P164, DOI 10.1016/j.ygcen.2010.01.005; Chung JS, 2006, J EXP BIOL, V209, P3862, DOI 10.1242/jeb.02425; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Cooke IM, 2002, BIOL BULL-US, V202, P108, DOI 10.2307/1543649; DEKLEIJN DPV, 1995, BBA-GENE STRUCT EXPR, V1260, P62, DOI 10.1016/0167-4781(94)00173-Z; DEKLEIJN DPV, 1994, FEBS LETT, V353, P255, DOI 10.1016/0014-5793(94)01055-2; DEKLEIJN DPV, 1993, FEBS LETT, V321, P251, DOI 10.1016/0014-5793(93)80119-F; Dickinson PS, 2008, GEN COMP ENDOCR, V156, P347, DOI 10.1016/j.ygcen.2008.01.011; Dickinson PS, 2007, J EXP BIOL, V210, P2278, DOI 10.1242/jeb.004770; Dickinson PS, 2015, J EXP BIOL, V218, P2892, DOI 10.1242/jeb.124800; Dickinson PS, 2015, J EXP BIOL, V218, P2905, DOI 10.1242/jeb.124818; Dickinson PS, 2009, J EXP BIOL, V212, P1140, DOI 10.1242/jeb.028621; Dickinson PS, 2009, PEPTIDES, V30, P297, DOI 10.1016/j.peptides.2008.10.009; Dircksen H, 2011, J PROTEOME RES, V10, P4478, DOI 10.1021/pr200284e; dos Santos G, 2015, NUCLEIC ACIDS RES, V43, pD690, DOI 10.1093/nar/gku1099; Ferre F, 2005, NUCLEIC ACIDS RES, V33, pW230, DOI 10.1093/nar/gki412; Fu Q, 2005, BIOCHEM BIOPH RES CO, V337, P765, DOI 10.1016/j.bbrc.2005.09.111; Gard AL, 2009, GEN COMP ENDOCR, V160, P271, DOI 10.1016/j.ygcen.2008.12.014; Garrett TPJ, 1998, NATURE, V394, P395, DOI 10.1038/28668; Hansen KK, 2010, J BIOL CHEM, V285, P10736, DOI 10.1074/jbc.M109.045369; Hooper SL, 2004, NEUROSIGNALS, V13, P50, DOI 10.1159/000076158; Horodyski FM, 2011, INSECT BIOCHEM MOLEC, V41, P804, DOI 10.1016/j.ibmb.2011.06.002; Hui LM, 2012, PEPTIDES, V36, P230, DOI 10.1016/j.peptides.2012.05.007; Jiang XY, 2012, ACS CHEM NEUROSCI, V3, P439, DOI 10.1021/cn200107v; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Li LJ, 2002, J COMP NEUROL, V444, P227, DOI 10.1002/cne.10139; Ma MM, 2008, GEN COMP ENDOCR, V156, P395, DOI 10.1016/j.ygcen.2008.01.009; Ma MM, 2010, PEPTIDES, V31, P27, DOI 10.1016/j.peptides.2009.10.007; Ma MM, 2009, PEPTIDES, V30, P1660, DOI 10.1016/j.peptides.2009.05.023; Ma MM, 2009, GEN COMP ENDOCR, V161, P320, DOI 10.1016/j.ygcen.2009.01.015; Marder E, 2007, ANNU REV PHYSIOL, V69, P291, DOI 10.1146/annurev.physiol.69.031905.161516; Martinez-Perez F, 2007, PEPTIDES, V28, P76, DOI 10.1016/j.peptides.2006.09.021; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Monigatti F, 2002, BIOINFORMATICS, V18, P769, DOI 10.1093/bioinformatics/18.5.769; Nagai C, 2014, J BIOL CHEM, V289, P32166, DOI 10.1074/jbc.M114.590646; Nesbit KT, 2014, COMP BIOCHEM PHYS D, V12, P16, DOI 10.1016/j.cbd.2014.09.002; Nusbaum MP, 2001, TRENDS NEUROSCI, V24, P146, DOI 10.1016/S0166-2236(00)01723-9; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Poels J, 2005, PEPTIDES, V26, P109, DOI 10.1016/j.peptides.2004.07.015; Roller L, 2008, INSECT BIOCHEM MOLEC, V38, P1147, DOI 10.1016/j.ibmb.2008.04.009; Saideman SR, 2007, J NEUROPHYSIOL, V97, P579, DOI 10.1152/jn.00772.2006; SCHWARZ TL, 1984, J NEUROSCI, V4, P1300; Selverston AI, 2006, BIOL CYBERN, V95, P537, DOI 10.1007/s00422-006-0125-1; Sharp JH, 2010, GEN COMP ENDOCR, V169, P65, DOI 10.1016/j.ygcen.2010.07.006; Skiebe P, 2001, J EXP BIOL, V204, P2035; Stein W, 2009, J COMP PHYSIOL A, V195, P989, DOI 10.1007/s00359-009-0483-y; Stemmler EA, 2006, J MASS SPECTROM, V41, P295, DOI 10.1002/jms.989; Stemmler EA, 2005, ANAL CHEM, V77, P3594, DOI 10.1021/ac0502347; Stemmler EA, 2007, PEPTIDES, V28, P2104, DOI 10.1016/j.peptides.2007.08.019; Stemmler EA, 2007, GEN COMP ENDOCR, V154, P184, DOI 10.1016/j.ygcen.2007.06.025; Stemmler EA, 2010, GEN COMP ENDOCR, V165, P1, DOI 10.1016/j.ygcen.2009.05.010; Stepanyan R, 2006, PHYSIOL GENOMICS, V25, P224, DOI 10.1152/physiolgenomics.00276.2005; Stevens JS, 2009, J EXP BIOL, V212, P3961, DOI 10.1242/jeb.035741; TENSEN CP, 1991, EUR J BIOCHEM, V200, P103, DOI 10.1111/j.1432-1033.1991.tb21054.x; Torfs P, 2001, EUR J BIOCHEM, V268, P149, DOI 10.1046/j.1432-1327.2001.01858.x; Toullec JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071609; Towle DW, 2006, INTEGR COMP BIOL, V46, P912, DOI 10.1093/icb/icl002; TRIMMER BA, 1987, J COMP NEUROL, V266, P16, DOI 10.1002/cne.902660103; Veenstra JA, 2000, ARCH INSECT BIOCHEM, V43, P49, DOI 10.1002/(SICI)1520-6327(200002)43:2&lt;49::AID-ARCH1&gt;3.0.CO;2-M; Veenstra JA, 2012, INSECT BIOCHEM MOLEC, V42, P277, DOI 10.1016/j.ibmb.2011.12.009; Ventura T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097323; Williams AH, 2013, J NEUROSCI, V33, P16565, DOI 10.1523/JNEUROSCI.2903-13.2013; Wiwatpanit T, 2012, J EXP BIOL, V215, P2308, DOI 10.1242/jeb.069989; Yamanaka N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003048; Yan XC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046513; Yasuda-Kamatani Y, 2006, J COMP NEUROL, V496, P135, DOI 10.1002/cne.20903	101	65	65	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145964	10.1371/journal.pone.0145964	http://dx.doi.org/10.1371/journal.pone.0145964			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716450	Green Published, gold, Green Submitted			2022-12-26	WOS:000367510500103
J	Ji, HB; Zhuang, SY; Zhu, ZL; Zhong, ZK				Ji, Haibao; Zhuang, Shunyao; Zhu, Zhaoliang; Zhong, Zheke			Soil Organic Carbon Pool and Its Chemical Composition in Phyllostachy pubescens Forests at Two Altitudes in Jian-ou City, China	PLOS ONE			English	Article							LAND-USE CHANGE; ELEVATION GRADIENT; HUMUS FORMS; TEMPERATURE-DEPENDENCE; MATTER DECOMPOSITION; NMR-SPECTROSCOPY; HUMIC SUBSTANCES; PADDY SOIL; STOCKS; STORAGE	Phyllostachys pubescens forests play an important role in soil organic carbon (SOC) sequestration in terrestrial ecosystems. However, the estimation and mechanism of SOC sequestration by P. pubescens forests remain unclear. In this study, the effect of P. pubescens forest distribution with elevation was investigated at two altitude sites in Jian-ou City, Southeast China. SOC storage was estimated and its chemical composition was obtained via C-13-nuclear magnetic resonance (NMR), chemical classification, and spectral analysis. Results showed that the SOC contents and stocks were significantly higher at the high-altitude site than at the low-altitude site in the entire soil profile (0-60 cm). The C contents of the three combined humus forms exhibited similar responses to the elevation change, and all of these forms were higher at the high-altitude site than at the low-altitude site regardless of soil layer. However, the proportions of the three combined humus C showed no significant differences between the two altitudes. The results of C-13-NMR showed that the SOC chemical composition did not significantly vary with elevation as well. This finding was consistent with the E-465/E-665 of the loosely combined humus. Overall, the results suggested that altitude should be considered during regional SOC estimation and that altitude affected the quantity rather than the quality of the SOC under the same P. pubescens vegetation.	[Ji, Haibao; Zhuang, Shunyao; Zhu, Zhaoliang] Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China; [Ji, Haibao] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhong, Zheke] Chinese Acad Forestry, China Bamboo Res Ctr, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Sciences; Institute of Soil Science, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Forestry; China National Bamboo Research Center, CAF	Zhuang, SY (corresponding author), Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China.	syzhuang@issas.ac.cn			Special Project for Basic Work in Science and Technology of China [2012FY111800]; Chinese Nonprofit Industry Research Project [201504407]	Special Project for Basic Work in Science and Technology of China; Chinese Nonprofit Industry Research Project	The authors would like to thank the Special Project for Basic Work in Science and Technology of China (2012FY111800) and the Chinese Nonprofit Industry Research Project (201504407) for the financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreetta A, 2011, BIOL FERT SOILS, V47, P31, DOI 10.1007/s00374-010-0499-z; Baldock JA, 1997, AUST J SOIL RES, V35, P1061, DOI 10.1071/S97004; Beniston M, 2003, CLIMATIC CHANGE, V59, P5, DOI 10.1023/A:1024458411589; Bonifacio E, 2011, BIOL FERT SOILS, V47, P555, DOI 10.1007/s00374-011-0568-y; Bonito GM, 2003, FOREST ECOL MANAG, V176, P563, DOI 10.1016/S0378-1127(02)00234-7; Britton AJ, 2011, PLANT SOIL, V345, P287, DOI 10.1007/s11104-011-0781-3; Chen H, 2006, B ENG GEOL ENVIRON, V65, P445, DOI 10.1007/s10064-005-0030-1; Chen XG, 2009, FOREST ECOL MANAG, V258, P1489, DOI 10.1016/j.foreco.2009.06.051; Chin YP, 1997, ENVIRON SCI TECHNOL, V31, P1630, DOI 10.1021/es960404k; Couteaux MM, 2002, SOIL BIOL BIOCHEM, V34, P69, DOI 10.1016/S0038-0717(01)00155-9; Dahlgren RA, 1997, GEODERMA, V78, P207, DOI 10.1016/S0016-7061(97)00034-7; Dai KH, 2001, BIOGEOCHEMISTRY, V54, P51, DOI 10.1023/A:1010697518227; DIXON RK, 1994, SCIENCE, V263, P185, DOI 10.1126/science.263.5144.185; Djukic I, 2010, J PLANT NUTR SOIL SC, V173, P30, DOI 10.1002/jpln.200900027; Don A, 2011, GLOBAL CHANGE BIOL, V17, P1658, DOI 10.1111/j.1365-2486.2010.02336.x; Du BM, 2014, ECOL RES, V29, P433, DOI 10.1007/s11284-014-1135-4; Fu J., 2001, BAMBOO, V22, P5; Fu J., 2000, AM BAMBOO SOC MAG, V21, P12; Fu WJ, 2014, J SOIL SEDIMENT, V14, P320, DOI 10.1007/s11368-013-0665-7; Garten CT, 2006, GEODERMA, V136, P342, DOI 10.1016/j.geoderma.2006.03.049; Garten CT, 1999, BIOGEOCHEMISTRY, V45, P115, DOI 10.1007/BF01106778; Garten CT, 2004, SOIL BIOL BIOCHEM, V36, P1491, DOI 10.1016/j.soilbio.2004.04.019; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Gupta M. K., 2013, APPL ECOLOGY ENV SCI, V1, P7, DOI DOI 10.12691/AEES-1-1-2; Guru Charan, 2012, African Journal of Agricultural Research, V7, P6313; Hoffmann U, 2014, GEODERMA, V232, P270, DOI 10.1016/j.geoderma.2014.04.038; Hontoria C, 1999, SOIL SCI SOC AM J, V63, P614, DOI 10.2136/sssaj1999.03615995006300030026x; Huan ZQ, 2008, FOREST ECOL MANAG, V254, P46, DOI 10.1016/j.foreco.2007.07.021; Huang CY, 2014, J SOIL SEDIMENT, V14, P1061, DOI 10.1007/s11368-014-0870-z; Jien SH, 2011, J FOREST RES-JPN, V16, P275, DOI 10.1007/s10310-010-0231-8; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Johnson DW, 2001, FOREST ECOL MANAG, V140, P227, DOI 10.1016/S0378-1127(00)00282-6; Katterer T, 1998, BIOL FERT SOILS, V27, P258, DOI 10.1007/s003740050430; KIRSCHBAUM MUF, 1995, SOIL BIOL BIOCHEM, V27, P753, DOI 10.1016/0038-0717(94)00242-S; Kirschbaum MUF, 2000, BIOGEOCHEMISTRY, V48, P21, DOI 10.1023/A:1006238902976; KONONOVA M. M., 1966, Soil Organic Matter. Its Nature, its Role in Soil Formation and in Soil Fertility.; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Leifeld J, 2009, GLOBAL CHANGE BIOL, V15, P668, DOI 10.1111/j.1365-2486.2008.01782.x; Lemenih M, 2004, GEODERMA, V123, P177, DOI 10.1016/j.geoderma.2004.02.004; Li YF, 2010, J SOIL SEDIMENT, V10, P739, DOI 10.1007/s11368-010-0188-4; Liu ShuXia, 2002, Journal of Jilin Agricultural University, V24, P72; Lu RK, 2000, ANALYTICAL METHODS O; Ma Li, 2008, Yingyong Shengtai Xuebao, V19, P1951; MacDonald NW, 1999, SOIL SCI SOC AM J, V63, P211, DOI 10.2136/sssaj1999.03615995006300010030x; Martin-Neto L, 1998, GEODERMA, V81, P305, DOI 10.1016/S0016-7061(97)00089-X; Mathers NJ, 2000, AUST J SOIL RES, V38, P769, DOI 10.1071/SR99074; Mathers NJ, 2003, GEODERMA, V114, P19, DOI 10.1016/S0016-7061(02)00339-7; Mathers NJ, 2002, AUST J SOIL RES, V40, P655, DOI 10.1071/SR01073; Matus F, 2008, GEODERMA, V148, P180, DOI 10.1016/j.geoderma.2008.10.004; Niklinska M, 2007, BIOL FERT SOILS, V43, P511, DOI 10.1007/s00374-006-0129-y; Ohrnberger D, 1999, THE BAMBOOS OF THE W; Ponge JF, 2003, SOIL BIOL BIOCHEM, V35, P935, DOI 10.1016/S0038-0717(03)00149-4; RAICH JW, 1995, GLOBAL BIOGEOCHEM CY, V9, P23, DOI 10.1029/94GB02723; Rasmussen C, 2005, SOIL SCI SOC AM J, V69, P1711, DOI 10.2136/sssaj2005.0040; Rumpel C, 2010, NUTR CYCL AGROECOSYS, V88, P173, DOI 10.1007/s10705-009-9333-0; Schnitzer M, 2001, CAN J SOIL SCI, V81, P249, DOI 10.4141/S00-064; Schoening I, 2006, SOIL BIOL BIOCHEM, V38, P2411, DOI 10.1016/j.soilbio.2006.03.005; Senesi N, 2003, GEODERMA, V116, P325, DOI 10.1016/S0016-7061(03)00107-1; Shrestha BM, 2008, SOIL SCI SOC AM J, V72, P1563, DOI 10.2136/sssaj2007.0375; Smith JL, 2002, SOIL BIOL BIOCHEM, V34, P1749, DOI 10.1016/S0038-0717(02)00162-1; Spielvogel S, 2008, EUR J SOIL SCI, V59, P674, DOI 10.1111/j.1365-2389.2008.01030.x; State Forestry Administration P. R. China (SFAPRC), 2005, STATISTICS OF FOREST; State Soil Survey Service of China, 1998, SOILS OF CHINA; STEVENSON IL, 1982, SOIL SCI, V133, P179, DOI 10.1097/00010694-198203000-00007; Tewksbury CE, 2007, CAN J FOREST RES, V37, P1161, DOI 10.1139/X06-317; Trumbore SE, 1996, SCIENCE, V272, P393, DOI 10.1126/science.272.5260.393; Uyguner CS, 2004, ANAL BIOANAL CHEM, V378, P1579, DOI 10.1007/s00216-003-2451-7; Wang B, 2013, J TROP FOR SCI, V25, P137; Wang SL, 2004, ENVIRON MANAGE, V33, pS200, DOI 10.1007/s00267-003-9130-5; Wei YW, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0072201, 10.1371/journal.pone.0060044]; World Reference Base for Soil Resources (WRB), 2006, 103 FAO WORLD REF BA, P103; Xu XJ, 2011, INT J REMOTE SENS, V32, P1431, DOI 10.1080/01431160903551389; Zech W, 1997, GEODERMA, V79, P117, DOI 10.1016/S0016-7061(97)00040-2; [张彩华 Zhang Caihua], 2011, [光谱实验室, Chinese Journal of Spectroscopy laboratory], V28, P693; Zhang HX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119175; [张厚喜 Zhang Houxi], 2014, [土壤, Soils], V46, P413; Zhang M, 2011, PEDOSPHERE, V21, P615, DOI 10.1016/S1002-0160(11)60163-X; Zhang T, 2013, PLANT SOIL, V367, P249, DOI 10.1007/s11104-012-1551-6; Zhou GuoMo, 2004, Scientia Silvae Sinicae, V40, P20; Zhou P, 2010, EUR J SOIL SCI, V61, P231, DOI 10.1111/j.1365-2389.2009.01223.x; Zhu BA, 2010, J PLANT RES, V123, P439, DOI 10.1007/s10265-009-0301-1; Zhuang SY, 2015, TROP ECOL, V56, P383	82	6	9	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0146029	10.1371/journal.pone.0146029	http://dx.doi.org/10.1371/journal.pone.0146029			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716688	gold, Green Published, Green Submitted			2022-12-26	WOS:000367510500120
J	Rasmussen, CH; Petersen, DR; Moeller, JB; Hansson, M; Dufva, M				Rasmussen, Camilla Holzmann; Petersen, Dorthe Roenn; Moeller, Jonas Bech; Hansson, Mattias; Dufva, Martin			Collagen Type I Improves the Differentiation of Human Embryonic Stem Cells towards Definitive Endoderm	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; MOUSE; GENE; FIBRONECTIN; TRANSCRIPTION; MESODERM; CATENIN; CANCER; NANOG	Human embryonic stem cells have the ability to generate all cell types in the body and can potentially provide an unlimited source of cells for cell replacement therapy to treat degenerative diseases such as diabetes. Current differentiation protocols of human embryonic stem cells towards insulin producing beta cells focus on soluble molecules whereas the impact of cell-matrix interactions has been mainly unattended. In this study almost 500 different extracellular matrix protein combinations were screened to systemically identify extracellular matrix proteins that influence differentiation of human embryonic stem cells to the definitive endoderm lineage. The percentage of definitive endoderm cells after differentiation on collagen I and fibronectin was >85% and 65%, respectively. The cells on collagen I substrates displayed different morphology and gene expression during differentiation as assessed by time lapse studies compared to cells on the other tested substrates. Global gene expression analysis showed that cells differentiated on collagen I were largely similar to cells on fibronectin after completed differentiation. Collectively, the data suggest that collagen I induces a more rapid and consistent differentiation of stem cells to definitive endoderm. The results shed light on the importance of extracellular matrix proteins for differentiation and also points to a cost effective and easy method to improve differentiation.	[Rasmussen, Camilla Holzmann; Petersen, Dorthe Roenn; Moeller, Jonas Bech; Hansson, Mattias] Novo Nordisk AS, Malov, Denmark; [Rasmussen, Camilla Holzmann; Dufva, Martin] Tech Univ Denmark, DTU Nanotech, DK-2800 Lyngby, Denmark	Novo Nordisk; Technical University of Denmark	Hansson, M (corresponding author), Novo Nordisk AS, Malov, Denmark.	mshs@novonordisk.com; Martin.dufva@nanotech.dtu.dk	Dufva, Martin/V-9469-2019; Dufva, Martin/D-1873-2012	Dufva, Martin/0000-0001-5449-0189	Innovation Fund Denmark; Novo Nordisk A/S	Innovation Fund Denmark; Novo Nordisk A/S(Novo Nordisk)	This work was supported by a grant from Innovation Fund Denmark and Novo Nordisk A/S. The funders provided support in the form of salary for author CHR and research materials. Novo Nordisk A/S also provided support in the form of salaries for authors DRP, JBM and MH, but the funding entities did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ameri J, 2010, STEM CELLS, V28, P45, DOI 10.1002/stem.249; Arnold SJ, 2000, MECH DEVELOP, V91, P249, DOI 10.1016/S0925-4773(99)00309-3; BLUM M, 1992, CELL, V69, P1097, DOI 10.1016/0092-8674(92)90632-M; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Borowiak M, 2009, CELL STEM CELL, V4, P348, DOI 10.1016/j.stem.2009.01.014; Brafman DA, 2013, CELL DEATH DIFFER, V20, P369, DOI 10.1038/cdd.2012.138; Carthy JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019809; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Cheyette BNR, 2002, DEV CELL, V2, P449, DOI 10.1016/S1534-5807(02)00140-5; Cicchini C, 2008, EXP CELL RES, V314, P143, DOI 10.1016/j.yexcr.2007.09.005; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Darribere T, 2000, MECH DEVELOP, V92, P239, DOI 10.1016/S0925-4773(00)00245-8; ENGVALL E, 1977, INT J CANCER, V20, P1, DOI 10.1002/ijc.2910200102; Evans AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033346; Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736; Fox IJ, 2014, SCIENCE, V345, P889, DOI 10.1126/science.1247391; Gersdorff N, 2005, DEV DYNAM, V233, P1140, DOI 10.1002/dvdy.20425; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Harburger DS, 2009, J CELL SCI, V122, P1472, DOI 10.1242/jcs.052910; Higuchi Y, 2010, J CELL SCI, V123, P2733, DOI 10.1242/jcs.066886; Holster T, 2007, J BIOL CHEM, V282, P2512, DOI 10.1074/jbc.M606608200; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kelder T, 2012, NUCLEIC ACIDS RES, V40, pD1301, DOI 10.1093/nar/gkr1074; Kelder T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006447; Koenig A, 2006, CANCER RES, V66, P4662, DOI 10.1158/0008-5472.CAN-05-2804; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Lee LH, 2009, STEM CELL RES, V2, P155, DOI 10.1016/j.scr.2008.11.004; LOHLER J, 1984, CELL, V38, P597, DOI 10.1016/0092-8674(84)90514-2; Madsen OD, 2006, NAT BIOTECHNOL, V24, P1481, DOI 10.1038/nbt1206-1481; McLean AB, 2007, STEM CELLS, V25, P29, DOI 10.1634/stemcells.2006-0219; Miner JH, 1998, J CELL BIOL, V143, P1713, DOI 10.1083/jcb.143.6.1713; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Parsons MJ, 2002, DEVELOPMENT, V129, P3137; Pico AR, 2008, PLOS BIOL, V6, P1403, DOI 10.1371/journal.pbio.0060184; Prowse ABJ, 2011, STEM CELL RES, V6, P1, DOI 10.1016/j.scr.2010.09.005; Rasmussen CH, 2016, ADV FUNCT MATER, V26, P815, DOI 10.1002/adfm.201504204; Rodin S, 2010, NAT BIOTECHNOL, V28, P611, DOI 10.1038/nbt.1620; Rozario T, 2010, DEV BIOL, V341, P126, DOI 10.1016/j.ydbio.2009.10.026; Sakai T, 2003, NATURE, V423, P876, DOI 10.1038/nature01712; SASAKI H, 1993, DEVELOPMENT, V118, P47; Shintani Y, 2008, AM J RESP CELL MOL, V38, P95, DOI 10.1165/rcmb.2007-0071OC; Shintani Y, 2006, CANCER RES, V66, P11745, DOI 10.1158/0008-5472.CAN-06-2322; SMITH AG, 2001, ANN REV CELL DEV BIO; Stover DA, 2011, MOL BIOL EVOL, V28, P533, DOI 10.1093/molbev/msq221; Switzer CH, 2012, MOL CANCER RES, V10, P1203, DOI 10.1158/1541-7786.MCR-12-0124; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Taylor-Weiner H, 2013, STEM CELLS, V31, P2084, DOI 10.1002/stem.1453; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Vazin T, 2010, RESTOR NEUROL NEUROS, V28, P589, DOI 10.3233/RNN-2010-0543; Watt FM, 2013, NAT REV MOL CELL BIO, V14, P467, DOI 10.1038/nrm3620; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0; Wong JCY, 2010, CELL ADHES MIGR, V4, P39, DOI 10.4161/cam.4.1.10627; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167; Yu PZ, 2011, CELL STEM CELL, V8, P326, DOI 10.1016/j.stem.2011.01.001; Zagris N, 2001, MICRON, V32, P427, DOI 10.1016/S0968-4328(00)00011-1; Zhang L, 2006, J BIOL CHEM, V281, P8607, DOI 10.1074/jbc.M600274200; Zorn AM, 2009, ANNU REV CELL DEV BI, V25, P221, DOI 10.1146/annurev.cellbio.042308.113344	58	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145389	10.1371/journal.pone.0145389	http://dx.doi.org/10.1371/journal.pone.0145389			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713616	Green Published, gold, Green Submitted			2022-12-26	WOS:000367481900038
J	Zhang, HF; Cannell, MB; Kim, SJ; Watson, JJ; Norman, R; Calaghan, SC; Orchard, CH; James, AF				Zhang, Haifei; Cannell, Mark B.; Kim, Shang Jin; Watson, Judy J.; Norman, Ruth; Calaghan, Sarah C.; Orchard, Clive H.; James, Andrew F.			Cellular Hypertrophy and Increased Susceptibility to Spontaneous Calcium-Release of Rat Left Atrial Myocytes Due to Elevated Afterload	PLOS ONE			English	Article							RETICULUM CA2+ LEAK; SARCOPLASMIC-RETICULUM; VENTRICULAR MYOCYTES; CARDIAC MYOCYTES; HEART-FAILURE; INTRACELLULAR CALCIUM; HYPERTENSIVE-RATS; OVINE MODEL; FIBRILLATION; MECHANISMS	Atrial remodeling due to elevated arterial pressure predisposes the heart to atrial fibrillation (AF). Although abnormal sarcoplasmic reticulum (SR) function has been associated with AF, there is little information on the effects of elevated afterload on atrial Ca2+-handling. We investigated the effects of ascending aortic banding (AoB) on Ca2+-handling in rat isolated atrial myocytes in comparison to age-matched sham-operated animals (Sham). Myocytes were either labelled for ryanodine receptor (RyR) or loaded with fluo-3-AM and imaged by confocal microscopy. AoB myocytes were hypertrophied in comparison to Sham controls (P< 0.0001). RyR labeling was localized to the z-lines and to the cell edge. There were no differences between AoB and Sham in the intensity or pattern of RyR-staining. In both AoB and Sham, electrical stimulation evoked robust SR Ca2+-release at the cell edge whereas Ca2+ transients at the cell center were much smaller. Western blotting showed a decreased L-type Ca channel expression but no significant changes in RyR or RyR phosphorylation or in expression of Na+/Ca2+ exchanger, SR Ca2+ ATPase or phospholamban. Mathematical modeling indicated that [Ca2+](i) transients at the cell center were accounted for by simple centripetal diffusion of Ca2+ released at the cell edge. In contrast, caffeine (10 mM) induced Ca2+ release was uniform across the cell. The caffeine-induced transient was smaller in AoB than in Sham, suggesting a reduced SR Ca2+-load in hypertrophied cells. There were no significant differences between AoB and Sham cells in the rate of Ca2+ extrusion during recovery of electrically-stimulated or caffeine-induced transients. The incidence and frequency of spontaneous Ca2+-transients following rapid-pacing (4 Hz) was greater in AoB than in Sham myocytes. In conclusion, elevated afterload causes cellular hypertrophy and remodeling of atrial SR Ca2+-release.	[Zhang, Haifei; Cannell, Mark B.; Kim, Shang Jin; Watson, Judy J.; Orchard, Clive H.; James, Andrew F.] Univ Bristol, Sch Physiol Pharmacol & Neurosci, Cardiovasc Res Labs, Bristol BS8 1TD, Avon, England; [Norman, Ruth; Calaghan, Sarah C.] Univ Leeds, Sch Biomed Sci, Garstang, Leeds LS2 9JT, W Yorkshire, England	University of Bristol; University of Leeds	James, AF (corresponding author), Univ Bristol, Sch Physiol Pharmacol & Neurosci, Cardiovasc Res Labs, Bristol BS8 1TD, Avon, England.	a.james@bristol.ac.uk		Calaghan, Sarah/0000-0002-9145-2576	British Heart Foundation (GB) [PG/07/101, RG/12/10]; British Heart Foundation [RG/12/10/29802] Funding Source: researchfish	British Heart Foundation (GB); British Heart Foundation(British Heart Foundation)	This work was supported by grant funding from the British Heart Foundation (GB) (http://www.bhf.org.uk/) (PG/07/101 AFJ CHO) (RG/12/10 CHO AFJ MBC).	BASSANI JWM, 1994, J PHYSIOL-LONDON, V476, P279, DOI 10.1113/jphysiol.1994.sp020130; Benjamin EJ, 2009, CIRCULATION, V119, P606, DOI 10.1161/CIRCULATIONAHA.108.825380; BERLIN JR, 1989, CIRC RES, V65, P115, DOI 10.1161/01.RES.65.1.115; BerrebiBertrand I, 1997, EUR J BIOCHEM, V247, P801, DOI 10.1111/j.1432-1033.1997.t01-1-00801.x; Bosch RF, 1999, CARDIOVASC RES, V44, P121, DOI 10.1016/S0008-6363(99)00178-9; Brette F, 2002, AM J PHYSIOL-HEART C, V283, pH1720, DOI 10.1152/ajpheart.00347.2002; CANNELL MB, 1994, BIOPHYS J, V67, P1942, DOI 10.1016/S0006-3495(94)80677-0; CARL SL, 1995, J CELL BIOL, V129, P672; CHEN Q, 1992, CAN J PHYSIOL PHARM, V70, P509, DOI 10.1139/y92-066; Chen-Izu Y, 2006, BIOPHYS J, V91, P1, DOI 10.1529/biophysj.105.077180; Choisy SCM, 2007, HYPERTENSION, V49, P498, DOI 10.1161/01.HYP.0000257123.95372.ab; Christ T, 2004, CIRCULATION, V110, P2651, DOI 10.1161/01.CIR.0000145659.80212.6A; Clarke JD, 2015, J MOL CELL CARDIOL, V79, P169, DOI 10.1016/j.yjmcc.2014.11.017; Dibb KM, 2004, J MOL CELL CARDIOL, V37, P1171, DOI 10.1016/j.yjmcc.2004.09.005; Diness JG, 2011, HYPERTENSION, V57, P1129, DOI 10.1161/HYPERTENSIONAHA.111.170613; Fischer TH, 2013, CIRCULATION, V128, P970, DOI 10.1161/CIRCULATIONAHA.113.001746; Grammer JB, 2001, BASIC RES CARDIOL, V96, P82, DOI 10.1007/s003950170081; Hove-Madsen L, 2004, CIRCULATION, V110, P1358, DOI 10.1161/01.CIR.0000141296.59876.87; ISENBERG G, 1982, PFLUG ARCH EUR J PHY, V395, P6, DOI 10.1007/BF00584963; Kim SJ, 2011, CIRC-ARRHYTHMIA ELEC, V4, P761, DOI 10.1161/CIRCEP.111.964783; Kirk MM, 2003, J PHYSIOL-LONDON, V547, P441, DOI 10.1113/jphysiol.2002.034355; Kistler PM, 2006, EUR HEART J, V27, P3045, DOI 10.1093/eurheartj/ehl360; Kockskamper J, 2001, BIOPHYS J, V81, P2590, DOI 10.1016/S0006-3495(01)75903-6; Kong CHT, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002931; Lau DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072416; Lenaerts I, 2009, CIRC RES, V105, P876, DOI 10.1161/CIRCRESAHA.109.206276; Li DS, 2000, CIRCULATION, V101, P2631, DOI 10.1161/01.CIR.101.22.2631; Mackenzie L, 2001, J PHYSIOL-LONDON, V530, P417, DOI 10.1111/j.1469-7793.2001.0417k.x; Neef S, 2010, CIRC RES, V106, P1134, DOI 10.1161/CIRCRESAHA.109.203836; NEGRETTI N, 1993, CARDIOVASC RES, V27, P1826, DOI 10.1093/cvr/27.10.1826; O'Neill SC, 2004, J PHYSIOL-LONDON, V559, P121, DOI 10.1113/jphysiol.2003.058917; Pluteanu F, 2015, CARDIOVASC RES, V106, P87, DOI 10.1093/cvr/cvv045; Schotten U, 2011, PHYSIOL REV, V91, P265, DOI 10.1152/physrev.00031.2009; Shan J, 2010, J CLIN INVEST, V120, P4388, DOI 10.1172/JCI32726; Soeller C, 1997, BIOPHYS J, V73, P97, DOI 10.1016/S0006-3495(97)78051-2; Stange M, 2003, J BIOL CHEM, V278, P51693, DOI 10.1074/jbc.M310406200; TAKAMATSU T, 1990, FASEB J, V4, P1519, DOI 10.1096/fasebj.4.5.2307330; Vagaonescu TD, 2008, HYPERTENSION, V51, P1552, DOI 10.1161/HYPERTENSIONAHA.108.110775; van Oort RJ, 2010, CIRCULATION, V122, P2669, DOI 10.1161/CIRCULATIONAHA.110.982298; Vest JA, 2005, CIRCULATION, V111, P2025, DOI 10.1161/01.CIR.0000162461.67140.4C; Voigt N, 2012, CIRCULATION, V125, P2059, DOI 10.1161/CIRCULATIONAHA.111.067306; Wakili R, 2011, J CLIN INVEST, V121, P2955, DOI 10.1172/JCI46315; Walden AP, 2009, J MOL CELL CARDIOL, V46, P463, DOI 10.1016/j.yjmcc.2008.11.003; Woo SH, 2005, J PHYSIOL-LONDON, V567, P905, DOI 10.1113/jphysiol.2005.092270; Workman AJ, 2001, CARDIOVASC RES, V52, P226, DOI 10.1016/S0008-6363(01)00380-7; Yamasaki Y, 1997, ANAT REC, V248, P70; Yeh YH, 2008, CIRC-ARRHYTHMIA ELEC, V1, P93, DOI 10.1161/CIRCEP.107.754788; Zima AV, 2010, J PHYSIOL-LONDON, V588, P4743, DOI 10.1113/jphysiol.2010.197913	48	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0144309	10.1371/journal.pone.0144309	http://dx.doi.org/10.1371/journal.pone.0144309			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713852	gold, Green Published, Green Submitted			2022-12-26	WOS:000367481900008
J	Cross-Villasana, F; Gropel, P; Doppelmayr, M; Beckmann, J				Cross-Villasana, Fernando; Groepel, Peter; Doppelmayr, Michael; Beckmann, Juergen			Unilateral Left-Hand Contractions Produce Widespread Depression of Cortical Activity after Their Execution	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; MOTOR-EVOKED-POTENTIALS; EEG ALPHA; FUNCTIONAL-SIGNIFICANCE; MUSCLE-CONTRACTIONS; SKILL FAILURE; WHITE-MATTER; ASYMMETRY; RHYTHMS; POWER	The execution of unilateral hand contractions before performance has been reported to produce behavioral aftereffects in various tasks. These effects have been regularly attributed to an induced shift in activation asymmetry to the contralateral hemisphere produced by the contractions. An alternative explanation proposes a generalized state of reduced bilateral cortical activity following unilateral hand contractions. The current experiment contrasted the above explanation models and tested the state of cortical activity after the termination of unilateral hand contractions. Twenty right-handed participants performed hand contractions in two blocks, one for each hand. Using electroencephalogram (EEG), the broad alpha band and its asymmetry between hemispheres before, during, and after hand contractions were analyzed. During contractions, significant bilateral decrease in alpha amplitudes (indicating cortical activation) emerged for both hands around sensory-motor regions. After contractions, alpha amplitudes increased significantly over the whole scalp when compared to baseline, but only for the left hand. No modulation of hemispheric asymmetry was observed at any phase. The results suggest that unilateral hand contractions produce a state of reduced cortical activity after their termination, which is more pronounced if the left hand was used. Consequently, we propose that the reduced cortical activity (and not the persistent activation asymmetry) may facilitate engagement in subsequent behavior, probably due to preventing interference from other, nonessential cortical regions.	[Cross-Villasana, Fernando; Groepel, Peter; Beckmann, Juergen] Tech Univ Munich, Chair Sport Psychol, D-80290 Munich, Germany; [Doppelmayr, Michael] Johannes Gutenberg Univ Mainz, Inst Sport Sci, D-55122 Mainz, Germany	Technical University of Munich; Johannes Gutenberg University of Mainz	Cross-Villasana, F (corresponding author), Tech Univ Munich, Chair Sport Psychol, D-80290 Munich, Germany.	fernando.cross@tum.de	Beckmann, Juergen/G-7271-2011; Doppelmayr, Michael/GRF-5286-2022	Beckmann, Juergen/0000-0001-7238-4646; Gropel, Peter/0000-0001-8765-176X				ALARCON G, 1994, J NEUROL NEUROSUR PS, V57, P435, DOI 10.1136/jnnp.57.4.435; Allen JS, 2003, NEUROIMAGE, V18, P880, DOI 10.1016/S1053-8119(03)00034-X; [Anonymous], 1994, J Clin Neurophysiol, V11, P111; Baumer T, 2002, EXP BRAIN RES, V146, P467, DOI 10.1007/s00221-002-1202-x; Beam W, 2009, BRAIN STIMUL, V2, P50, DOI 10.1016/j.brs.2008.09.006; Beckmann J, 2013, J EXP PSYCHOL GEN, V142, P679, DOI 10.1037/a0029852; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bloom JS, 2005, NEUROPSYCHOL REV, V15, P59, DOI 10.1007/s11065-005-6252-y; Bonato C, 1996, NEUROSCI LETT, V216, P97; BRASILNETO J, 1993, EXP BRAIN RES, V93, P181; Chen YQ, 2003, EXP BRAIN RES, V148, P105, DOI 10.1007/s00221-002-1244-0; Coan JA, 2004, BIOL PSYCHOL, V67, P7, DOI 10.1016/j.biopsycho.2004.03.002; COLLINS D, 1990, J SPORT EXERCISE PSY, V12, P223, DOI 10.1123/jsep.12.3.223; Craig AD, 2005, TRENDS COGN SCI, V9, P566, DOI 10.1016/j.tics.2005.10.005; Davidson RJ, 2004, PHILOS T R SOC B, V359, P1395, DOI 10.1098/rstb.2004.1510; DAVIDSON RJ, 1988, INT J NEUROSCI, V39, P71, DOI 10.3109/00207458808985694; Deiber MP, 2001, CLIN NEUROPHYSIOL, V112, P1419, DOI 10.1016/S1388-2457(01)00536-3; Del Percio C, 2009, HUM BRAIN MAPP, V30, P3527, DOI 10.1002/hbm.20776; Derambure P, 1997, EPILEPSIA, V38, P655, DOI 10.1111/j.1528-1157.1997.tb01234.x; Dettmers C, 1996, J APPL PHYSIOL, V81, P596, DOI 10.1152/jappl.1996.81.2.596; Doppelmayr MM, 1998, BRAIN TOPOGR, V11, P133, DOI 10.1023/A:1022206622348; Gable PA, 2013, BRAIN COGNITION, V83, P337, DOI 10.1016/j.bandc.2013.09.012; Goldstein A, 2010, PSYCHON B REV, V17, P895, DOI 10.3758/PBR.17.6.895; GUR RC, 1980, SCIENCE, V207, P1226, DOI 10.1126/science.7355287; Harmon-Jones E, 2006, PSYCHOPHYSIOLOGY, V43, P598, DOI 10.1111/j.1469-8986.2006.00465.x; Hatfield BD, 2004, J CLIN NEUROPHYSIOL, V21, P144, DOI 10.1097/00004691-200405000-00003; Haufler AJ, 2000, BIOL PSYCHOL, V53, P131, DOI 10.1016/S0301-0511(00)00047-8; Helfrich RF, 2014, CURR BIOL, V24, P333, DOI 10.1016/j.cub.2013.12.041; Hellige J. B., 1993, HEMISPHERIC ASYMMETR; Hummel F, 2002, BRAIN, V125, P404, DOI 10.1093/brain/awf030; Iturria-Medina Y, 2011, CEREB CORTEX, V21, P56, DOI 10.1093/cercor/bhq058; Jensen O, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00186; Johnson KA, 2013, BRAIN STIMUL, V6, P108, DOI 10.1016/j.brs.2012.02.003; Kapur N, 1996, BRAIN 5, V119; Kayser J, 2015, INT J PSYCHOPHYSIOL, V97, P189, DOI 10.1016/j.ijpsycho.2015.04.012; Klimesch W, 2003, EUR J NEUROSCI, V17, P1129, DOI 10.1046/j.1460-9568.2003.02517.x; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Liu JZ, 2003, J NEUROPHYSIOL, V90, P300, DOI 10.1152/jn.00821.2002; Makeig S, 1996, ADV NEUR IN, V8, P145; McGilchrist Iain, 2010, Dialogues Clin Neurosci, V12, P503; Milton JG, 2004, J CLIN NEUROPHYSIOL, V21, P134, DOI 10.1097/00004691-200405000-00002; Nunez PL, 2014, BRAIN RES, V1542, P138, DOI 10.1016/j.brainres.2013.10.036; Nunez PL, 1999, CLIN NEUROPHYSIOL, V110, P469, DOI 10.1016/S1388-2457(98)00043-1; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; Peterson CK, 2008, PSYCHOPHYSIOLOGY, V45, P86, DOI 10.1111/j.1469-8986.2007.00597.x; Pfurtscheller G, 1997, ELECTROEN CLIN NEURO, V102, P316, DOI 10.1016/S0013-4694(96)96612-2; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pineda JA, 2005, BRAIN RES REV, V50, P57, DOI 10.1016/j.brainresrev.2005.04.005; Pollatos O, 2004, PSYCHOPHYSIOLOGY, V41, P476, DOI 10.1111/1469-8986.2004.00170.x; Propper RE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062474; Romei V, 2008, CEREB CORTEX, V18, P2010, DOI 10.1093/cercor/bhm229; Romei V, 2008, NEUROREPORT, V19, P203, DOI 10.1097/WNR.0b013e3282f454c4; Salenius S, 1997, NEUROIMAGE, V5, P221, DOI 10.1006/nimg.1997.0261; SALMELIN R, 1994, NEUROSCIENCE, V60, P537, DOI 10.1016/0306-4522(94)90263-1; Sauseng P, 2009, NEUROPSYCHOLOGIA, V47, P284, DOI 10.1016/j.neuropsychologia.2008.07.021; Schevon CA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2056; Schiff BB, 1998, NEUROPSYCHOLOGY, V12, P526, DOI 10.1037/0894-4105.12.4.526; Sohn YH, 2004, EXP BRAIN RES, V158, P397, DOI 10.1007/s00221-004-1909-y; Stancak A, 1997, J CLIN NEUROPHYSIOL, V14, P419, DOI 10.1097/00004691-199709000-00008; Takahashi T, 1993, ELECTROENCEPHALOGRAP, P252; Tenke CE, 2005, CLIN NEUROPHYSIOL, V116, P2826, DOI 10.1016/j.clinph.2005.08.007; Thut G, 2009, TRENDS COGN SCI, V13, P182, DOI 10.1016/j.tics.2009.01.004; Trevelyan AJ, 2007, J NEUROSCI, V27, P3383, DOI 10.1523/JNEUROSCI.0145-07.2007; Trevelyan AJ, 2006, J NEUROSCI, V26, P12447, DOI 10.1523/JNEUROSCI.2787-06.2006; TUCKER DM, 1986, ELECTROEN CLIN NEURO, V63, P242, DOI 10.1016/0013-4694(86)90092-1; Widmann A, 2015, J NEUROSCI METH, V250, P34, DOI 10.1016/j.jneumeth.2014.08.002; Wolf S, 2015, BIOL PSYCHOL, V105, P95, DOI 10.1016/j.biopsycho.2015.01.007; Zaehle T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013766; ZANETTE G, 1995, EXP BRAIN RES, V107, P80; Zarkowski P, 2006, CLIN EEG NEUROSCI, V37, P247, DOI 10.1177/155005940603700316	73	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145867	10.1371/journal.pone.0145867	http://dx.doi.org/10.1371/journal.pone.0145867			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709832	Green Published, Green Submitted, gold			2022-12-26	WOS:000367451400087
J	Kato, K; Konno, D; Berry, M; Matsuzaki, F; Logan, A; Hidalgo, A				Kato, Kentaro; Konno, Daijiro; Berry, Martin; Matsuzaki, Fumio; Logan, Ann; Hidalgo, Alicia			Prox1 Inhibits Proliferation and Is Required for Differentiation of the Oligodendrocyte Cell Lineage in the Mouse	PLOS ONE			English	Article							SPINAL-CORD; GLIAL-CELLS; IN-VITRO; CNS; REMYELINATION; MACROPHAGES; DEMYELINATION; ACTIVATION; PROGENITORS; INJECTIONS	Central nervous system injury induces a regenerative response in ensheathing glial cells comprising cell proliferation, spontaneous axonal remyelination, and limited functional recovery, but the molecular mechanisms are not fully understood. In Drosophila, this involves the genes prospero and Notch controlling the balance between glial proliferation and differentiation, and manipulating their levels in glia can switch the response to injury from prevention to promotion of repair. In the mouse, Notch1 maintains NG2 oligodendrocyte progenitor cells (OPCs) in a progenitor state, but what factor may enable oligodendrocyte (OL) differentiation and functional remyelination is not understood. Here, we asked whether the mammalian homologue of prospero, Prox1, is involved. Our data show that Prox1 is distributed in NG2+ OPCs and in OLs in primary cultured cells, and in the mouse spinal cord in vivo. siRNA prox1 knockdown in primary OPCs increased cell proliferation, increased NG2+ OPC cell number and decreased CC1+ OL number. Prox1 conditional knockout in the OL cell lineage in mice increased NG2+ OPC cell number, and decreased CC1+ OL number. Lysolecithin-induced demyelination injury caused a reduction in CC1+ OLs in homozygous Prox1-/- conditional knockout mice compared to controls. Remarkably, Prox1-/- conditional knockout mice had smaller lesions than controls. Altogether, these data show that Prox1 is required to inhibit OPC proliferation and for OL differentiation, and could be a relevant component of the regenerative glial response. Therapeutic uses of glia and stem cells to promote regeneration and repair after central nervous system injury would benefit from manipulating Prox1.	[Kato, Kentaro; Hidalgo, Alicia] Univ Birmingham, Sch Biosci, NeuroDev Grp, Birmingham, W Midlands, England; [Kato, Kentaro; Berry, Martin; Logan, Ann] Univ Birmingham, Coll Med & Dent Sci, Inst Inflammat & Ageing, Birmingham, W Midlands, England; [Kato, Kentaro; Konno, Daijiro; Matsuzaki, Fumio] RIKEN Ctr Dev Biol, Lab Cell Asymmetry, Chuo Ku, Kobe, Hyogo, Japan	University of Birmingham; University of Birmingham; RIKEN	Hidalgo, A (corresponding author), Univ Birmingham, Sch Biosci, NeuroDev Grp, Birmingham, W Midlands, England.	a.hidalgo@bham.ac.uk	Hidalgo, Alicia/F-5930-2015	Hidalgo, Alicia/0000-0001-8041-5764; Matsuzaki, Fumio/0000-0001-7902-4520; Logan, Ann/0000-0003-3215-5042	BBSRC [BB/L008343/1, BB/K02146X/1]; Royal Society [IE121357]; BBSRC [BB/H002278/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H002278/1, BB/K02146X/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by BBSRC Project Grant BB/L008343/1 to AH and AL, and BBSRC ISIS BB/K02146X/1 and The Royal Society International Exchanges Scheme IE121357 Travel Grants to AH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbik F, 2012, EXP NEUROL, V235, P43, DOI 10.1016/j.expneurol.2011.06.006; Birgbauer E, 2004, J NEUROSCI RES, V78, P157, DOI 10.1002/jnr.20248; Blakemore WF, 2008, CURR TOP MICROBIOL, V318, P193; BLAKEMORE WF, 1977, J NEUROL SCI, V33, P31, DOI 10.1016/0022-510X(77)90179-4; Busch SA, 2010, J NEUROSCI, V30, P255, DOI 10.1523/JNEUROSCI.3705-09.2010; Chari DM, 2002, GLIA, V37, P307, DOI 10.1002/glia.10038; Chekenya M, 2002, J NEUROCYTOL, V31, P507, DOI 10.1023/A:1025795715377; Dimou L, 2014, PHYSIOL REV, V94, P709, DOI 10.1152/physrev.00036.2013; Dyer MA, 2003, NAT GENET, V34, P53, DOI 10.1038/ng1144; Elsir T, 2012, CANCER METAST REV, V31, P793, DOI 10.1007/s10555-012-9390-8; Fancy SPJ, 2011, NAT NEUROSCI, V14, P1009, DOI 10.1038/nn.2855; FFRENCHCONSTANT C, 1986, NATURE, V323, P335, DOI 10.1038/323335a0; Fitch MT, 1999, J NEUROSCI, V19, P8182; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Genoud S, 2002, J CELL BIOL, V158, P709, DOI 10.1083/jcb.200202002; Ghasemlou N, 2007, GLIA, V55, P294, DOI 10.1002/glia.20449; Granger N, 2014, NEUROSCIENTIST, V20, P623, DOI 10.1177/1073858413514635; Griffiths RL, 2004, EMBO J, V23, P2440, DOI 10.1038/sj.emboj.7600258; HALL SM, 1972, J CELL SCI, V10, P535; Hesp ZC, 2015, J NEUROSCI, V35, P1274, DOI 10.1523/JNEUROSCI.2568-14.2015; Horn KP, 2008, J NEUROSCI, V28, P9330, DOI 10.1523/JNEUROSCI.2488-08.2008; Islam MS, 2009, NEUROCHEM INT, V54, P192, DOI 10.1016/j.neuint.2008.10.011; Iwano T, 2012, DEVELOPMENT, V139, P3051, DOI 10.1242/dev.080002; Kaltezioti V, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000565; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kato K, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001133; Keough MB, 2015, JOVE-J VIS EXP, DOI 10.3791/52679; Kotter MR, 2001, GLIA, V35, P204, DOI 10.1002/glia.1085; Kucharova K, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-158; Kukley M, 2008, FASEB J, V22, P2957, DOI 10.1096/fj.07-090985; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Nave KA, 2010, NAT REV NEUROSCI, V11, P275, DOI 10.1038/nrn2797; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; O'Meara RW, 2011, JOVE-J VIS EXP, DOI 10.3791/3324; Ousman SS, 2000, GLIA, V30, P92, DOI 10.1002/(SICI)1098-1136(200003)30:1<92::AID-GLIA10>3.0.CO;2-W; Persson AI, 2010, CANCER CELL, V18, P669, DOI 10.1016/j.ccr.2010.10.033; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Rubin AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077339; Seifert T, 2007, ACTA NEUROPATHOL, V113, P195, DOI 10.1007/s00401-006-0170-9; Sharma K, 2012, EXP NEUROL, V237, P370, DOI 10.1016/j.expneurol.2012.07.009; Simon C, 2011, GLIA, V59, P869, DOI 10.1002/glia.21156; Stidworthy MF, 2004, BRAIN, V127, P1928, DOI 10.1093/brain/awh217; Takebayashi H, 2002, CURR BIOL, V12, P1157, DOI 10.1016/S0960-9822(02)00926-0; Tripathi R, 2007, GLIA, V55, P698, DOI 10.1002/glia.20491; TROTTER J, 1986, NEUROCHEM RES, V11, P349, DOI 10.1007/BF00965009; Trotter J, 2010, BRAIN RES REV, V63, P72, DOI 10.1016/j.brainresrev.2009.12.006; Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2; WELTZIEN HU, 1979, BIOCHIM BIOPHYS ACTA, V559, P259, DOI 10.1016/0304-4157(79)90004-2; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053; Yang ZS, 2005, J NEUROSCI METH, V149, P50, DOI 10.1016/j.jneumeth.2005.05.003	50	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145334	10.1371/journal.pone.0145334	http://dx.doi.org/10.1371/journal.pone.0145334			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709696	Green Published, gold			2022-12-26	WOS:000367451400038
J	Marks, J; de la Haye, K; Barnett, LM; Allender, S				Marks, Jennifer; de la Haye, Kayla; Barnett, Lisa M.; Allender, Steven			Friendship Network Characteristics Are Associated with Physical Activity and Sedentary Behavior in Early Adolescence	PLOS ONE			English	Article							ACCELEROMETER DATA REDUCTION; PEER INFLUENCE; SCHOOL; CHILDRENS; YOUTH; TRANSITION; CHILDHOOD; VALIDITY; WEIGHT	Introduction There is limited understanding of the association between peer social networks and physical activity (PA), sedentary and screen-related behaviors. This study reports on associations between personal network characteristics and these important health behaviors for early adolescents. Methods Participants were 310 students, aged 11-13 years, from fifteen randomly selected Victorian primary schools (43% response rate). PA and sedentary behaviors were collected via accelerometer and self-report questionnaire, and anthropometric measures via trained researchers. Participants nominated up to fifteen friends, and described the frequency of interaction and perceived activity intensity of these friends. Personal network predictors were examined using regression modelling for PA and sedentary/screen behavior. Results Perceived activity levels of friends, and friendships with very frequent interaction were associated with outside-of-school PA and/or sedentary/screen time. Differences according to sex were also observed in the association between network characteristics and PA and sedentary time. A higher number of friends and greater proportion of same sex friends were associated with boys engaging in more moderate-to-vigorous PA outside of school hours. PA intensity during school-day breaks was positively associated with having a greater proportion of friends who played sports for girls, and a greater proportion of male friends for boys. Conclusion Friendship network characteristics are associated with PA and sedentary/screen time in late childhood/early adolescence, and these associations differ by sex. The positive influence of very active peers may be a promising avenue to strengthen traditional interventions for the promotion of PA and reduction in screen time.	[Marks, Jennifer; Allender, Steven] Deakin Univ, WHO Collaborating Ctr Obes Prevent, Geelong, Vic 3217, Australia; [Marks, Jennifer; Barnett, Lisa M.; Allender, Steven] Deakin Univ, Sch Hlth & Social Dev, Burwood, Australia; [de la Haye, Kayla] Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA	Deakin University; World Health Organization; Deakin University; University of Southern California	Marks, J (corresponding author), Deakin Univ, WHO Collaborating Ctr Obes Prevent, Geelong, Vic 3217, Australia.	jennifer.marks@deakin.edu.au	Barnett, Lisa/C-9997-2014; Allender, Steven/G-9881-2011	Barnett, Lisa/0000-0002-9731-625X; Marks, Jennifer/0000-0002-4551-7332; Allender, Steven/0000-0002-4842-3294	Alfred Deakin postdoctoral fellowship; Australian National Health and Medical Research Council/ Australian National Heart Foundation Career Development Fellowship [APP1045836]; US National Institutes of Health [1R01HL115485-01A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115485] Funding Source: NIH RePORTER	Alfred Deakin postdoctoral fellowship; Australian National Health and Medical Research Council/ Australian National Heart Foundation Career Development Fellowship; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	LMB is supported by an Alfred Deakin postdoctoral fellowship. SA is supported by funding from an Australian National Health and Medical Research Council/ Australian National Heart Foundation Career Development Fellowship (APP1045836). SA is a researcher on the US National Institutes of Health grant titled Systems Science to Guide Whole-of-Community Childhood Obesity Interventions (1R01HL115485-01A1). SA is a researcher within a NHMRC Centre for Research Excellence in Obesity Policy and Food Systems (APP1041020).; We acknowledge the support of the Department of Education and Early Childhood Development, Victorian Catholic Education Diocese, participating schools and students, and data collectors who made this research possible. LMB is supported by an Alfred Deakin postdoctoral fellowship. SA is supported by funding from an Australian National Health and Medical Research Council/ Australian National Heart Foundation Career Development Fellowship (APP1045836). SA is a researcher on the US National Institutes of Health grant titled Systems Science to Guide Whole-of-Community Childhood Obesity Interventions (1R01HL115485-01A1). SA is a researcher within a NHMRC Centre for Research Excellence in Obesity Policy and Food Systems (APP1041020).	Ali MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016183; Aronson E, 2005, SOZIALPSYCHOLOGIE; Arundell L, 2013, HEALTH PROMOT J AUST, V24, P65, DOI 10.1071/HE12910; Bandura Albert, 1977, SOCIAL LEARNING THEO; Berten H, 2011, SOCIOL PERSPECT, V54, P183, DOI 10.1525/sop.2011.54.2.183; Biddle SJH, 2010, PREV MED, V51, P345, DOI 10.1016/j.ypmed.2010.07.018; Borraccino A, 2009, MED SCI SPORT EXER, V41, P749, DOI 10.1249/MSS.0b013e3181917722; Brechwald WA, 2011, J RES ADOLESCENCE, V21, P166, DOI 10.1111/j.1532-7795.2010.00721.x; Brown B.B., 2004, ADOLESCENTS RELATION; Craigie AM, 2011, MATURITAS, V70, P266, DOI 10.1016/j.maturitas.2011.08.005; Davies P.S.W., 2001, STANDARD METHODS COL; de la Haye K, 2011, J ADOLESCENT HEALTH, V49, P421, DOI 10.1016/j.jadohealth.2011.02.008; de la Haye K, 2011, SOC SCI MED, V73, P719, DOI 10.1016/j.socscimed.2011.06.023; de la Haye K, 2010, SOC NETWORKS, V32, P161, DOI 10.1016/j.socnet.2009.09.001; De Meester F, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-261; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; De Vries SI, 2009, MED SCI SPORT EXER, V41, P818, DOI 10.1249/MSS.0b013e31818e5819; Department of Health and Ageing, 2007, AUSTR NAT CHILDR NUT; Dumith SC, 2011, INT J EPIDEMIOL, V40, P685, DOI 10.1093/ije/dyq272; Fitzgerald A, 2012, J ADOLESCENCE, V35, P941, DOI 10.1016/j.adolescence.2012.01.002; Gesell SB, 2012, PEDIATRICS, V129, P1064, DOI 10.1542/peds.2011-2567; Jago R, 2012, MED SCI SPORT EXER, V44, P111, DOI 10.1249/MSS.0b013e318229df6e; Jago R, 2011, MED SCI SPORT EXER, V43, P259, DOI 10.1249/MSS.0b013e3181edefaa; Kowalski KC, 2004, PHYS ACTIVITY QUESTI; Leech RM, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-4; Macdonald-Wallis K, 2012, AM J PREV MED, V43, P636, DOI 10.1016/j.amepre.2012.08.021; Macdonald-Wallis K, 2011, SOC SCI MED, V73, P6, DOI 10.1016/j.socscimed.2011.04.018; de Rezende LFM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105620; Marks J, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0218-0; Masse LC, 2005, MED SCI SPORT EXER, V37, pS544, DOI 10.1249/01.mss.0000185674.09066.8a; Must A, 2005, INT J OBESITY, V29, pS84, DOI 10.1038/sj.ijo.0803064; Nader PR, 2008, JAMA-J AM MED ASSOC, V300, P295, DOI 10.1001/jama.300.3.295; Prinstein M.J., 2008, UNDERSTANDING PEER I; Rimal RN, 2005, COMMUN RES, V32, P389, DOI 10.1177/0093650205275385; Salvy SJ, 2012, PHYSIOL BEHAV, V106, P369, DOI 10.1016/j.physbeh.2012.03.022; Sawka KJ, 2014, J OBES, V2014, DOI 10.1155/2014/632689; Sawka KJ, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-130; Shoham DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039795; Sirard JR, 2013, AM J PREV MED, V44, P48, DOI 10.1016/j.amepre.2012.09.054; Sisson SB, 2009, INT J PEDIATR OBES, V4, P353, DOI 10.3109/17477160902934777; Strauss RS, 2003, ARCH PEDIAT ADOL MED, V157, P746, DOI 10.1001/archpedi.157.8.746; Telford A, 2004, PEDIATR EXERC SCI, V16, P64, DOI 10.1123/pes.16.1.64; Toftager M, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-140; Triplett N., 1898, AM J PSYCHOL, V9, P507, DOI [10.2307/1412188, DOI 10.2307/1412188]; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Trost SG, 2011, MED SCI SPORT EXER, V43, P1360, DOI 10.1249/MSS.0b013e318206476e; Valente TW, 2012, SCIENCE, V337, P49, DOI 10.1126/science.1217330; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Wilkinson RB, 2010, J ADOLESCENCE, V33, P709, DOI 10.1016/j.adolescence.2009.10.013	49	33	36	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145344	10.1371/journal.pone.0145344	http://dx.doi.org/10.1371/journal.pone.0145344			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ9XO	26709924	Green Submitted, gold, Green Published			2022-12-26	WOS:000367451400040
J	Murugan, D; Lau, YS; Lau, WC; Mustafa, MR; Huang, Y				Murugan, Dharmani; Lau, Yeh Siang; Lau, Wai Chi; Mustafa, Mohd Rais; Huang, Yu			Angiotensin 1-7 Protects against Angiotensin II-Induced Endoplasmic Reticulum Stress and Endothelial Dysfunction via Mas Receptor	PLOS ONE			English	Article							OXIDATIVE STRESS; INDUCED APOPTOSIS; INHIBITION; ANTAGONIST; OLMESARTAN; CELLS; MICE	Angiotensin 1-7 (Ang 1-7) counter-regulates the cardiovascular actions of angiotensin II (Ang II). The present study investigated the protective effect of Ang 1-7 against Ang II-induced endoplasmic reticulum (ER) stress and endothelial dysfunction. Ex vivo treatment with Ang II (0.5 mu M, 24 hours) impaired endothelium-dependent relaxation in mouse aortas; this harmful effect of Ang II was reversed by co-treatment with ER stress inhibitors, l4-phenylbutyric acid (PBA) and tauroursodeoxycholic acid (TUDCA) as well as Ang 1-7. The Mas receptor antagonist, A779, antagonized the effect of Ang 1-7. The elevated mRNA expression of CHOP, Grp78 and ATF4 or protein expression of p-eIF2 alpha and ATF6 (ER stress markers) in Ang II-treated human umbilical vein endothelial cells (HUVECs) and mouse aortas were blunted by co-treatment with Ang 1-7 and the latter effect was reversed by A779. Furthermore, Ang II-induced reduction in both eNOS phosphorylation and NO production was inhibited by Ang 1-7. In addition, Ang 1-7 decreased the levels of ER stress markers and augmented NO production in HUVECs treated with ER stress inducer, tunicamycin. The present study provides new evidence for functional antagonism between the two arms of the renin-angiotensin system in endothelial cells by demonstrating that Ang 1-7 ameliorates Ang II-stimulated ER stress to raise NO bioavailability, and subsequently preserves endothelial function.	[Murugan, Dharmani; Lau, Yeh Siang; Mustafa, Mohd Rais] Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur 50603, Malaysia; [Lau, Wai Chi; Huang, Yu] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China	Universiti Malaya; Chinese University of Hong Kong	Murugan, D (corresponding author), Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur 50603, Malaysia.	dharmani79@um.edu.my; yu-huang@cuhk.edu.hk	Lau, Yee Ling/C-6996-2009; Huang, Yu/K-2866-2017; MURUGAN, DHARMANI DEVI/B-8436-2010; Mustafa, Mohamed R/B-1647-2009; Lau, Yeh Siang/D-2136-2016	Lau, Yee Ling/0000-0002-2037-2165; Huang, Yu/0000-0002-1277-6784; MURUGAN, DHARMANI DEVI/0000-0002-1345-0292; Mustafa, Mohamed R/0000-0002-7864-5189; Lau, Yeh Siang/0000-0002-1770-3058	Ministry of Education High Impact Research, Malaysia [H-20001-00-E000055]; Natural Science Foundation of China [91339117]; Hong Kong Research Grants Council [CUHK2/CRF/12G, CUHK465611, T12/402/13N]	Ministry of Education High Impact Research, Malaysia; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hong Kong Research Grants Council(Hong Kong Research Grants Council)	This work was supported by grants from Ministry of Education High Impact Research Grant H-20001-00-E000055, Malaysia, Natural Science Foundation of China (91339117) and Hong Kong Research Grants Council (CUHK2/CRF/12G, CUHK465611, T12/402/13N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chao YM, 2013, HYPERTENSION, V61, P1270, DOI 10.1161/HYPERTENSIONAHA.111.00469; Cheang WS, 2014, ARTERIOSCL THROM VAS, V34, P830, DOI 10.1161/ATVBAHA.113.301938; Chen ZY, 1999, EUR J PHARMACOL, V374, P41, DOI 10.1016/S0014-2999(99)00291-5; Christiakov DA, 2014, BIOMED RES INT, V2014; Dong JH, 2012, EUR HEART J, V33, P2980, DOI 10.1093/eurheartj/ehr459; Galan M, 2014, BBA-MOL CELL RES, V1843, P1063, DOI 10.1016/j.bbamcr.2014.02.009; Isodono K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009746; Kadowaki H, 2013, GENES-BASEL, V4, P306, DOI 10.3390/genes4030306; Kassan M, 2012, ARTERIOSCL THROM VAS, V32, P1652, DOI 10.1161/ATVBAHA.112.249318; Kostenis E, 2005, CIRCULATION, V111, P1806, DOI 10.1161/01.CIR.0000160867.23556.7D; Lakshmanan AP, 2011, EUR J PHARM SCI, V44, P627, DOI 10.1016/j.ejps.2011.10.009; Lau YS, 2013, BRIT J PHARMACOL, V170, P1190, DOI 10.1111/bph.12350; Li G, 2010, J CELL BIOL, V191, P1113, DOI 10.1083/jcb.201006121; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; NAKAMOTO H, 1995, HYPERTENSION, V25, P796, DOI 10.1161/01.HYP.25.4.796; Rabelo LA, 2011, HYPERTENS RES, V34, P154, DOI 10.1038/hr.2010.235; Sampaio WO, 2007, HYPERTENSION, V50, P1093, DOI 10.1161/HYPERTENSIONAHA.106.084848; Santos CXC, 2014, ANTIOXID REDOX SIGN, V20, P121, DOI 10.1089/ars.2013.5262; Santos RA, 2014, HYPERTENSION, V63, P1138, DOI 10.1161/HYPERTENSIONAHA.113.01274; Spitler KM, 2014, HYPERTENSION, V63, pE40, DOI 10.1161/HYPERTENSIONAHA.113.02558; Sukumaran V, 2011, INT J BIOL SCI, V7, P154, DOI 10.7150/ijbs.7.154; Touyz RM, 2004, BRAZ J MED BIOL RES, V37, P1263, DOI 10.1590/S0100-879X2004000800018; Uhal BD, 2013, AM J PHYSIOL-LUNG C, V305, pL33, DOI 10.1152/ajplung.00001.2013; Wong WT, 2010, ANTIOXID REDOX SIGN, V13, P757, DOI 10.1089/ars.2009.2831; Wu TT, 2011, EUR J PHARM SCI, V42, P496, DOI 10.1016/j.ejps.2011.02.005; Xu P, 2008, HYPERTENSION, V51, P574, DOI 10.1161/HYPERTENSIONAHA.107.102764; Zhang Y, 2015, ANTIOXID REDOX SIGN, V23, P880, DOI 10.1089/ars.2014.6070; Zhao LH, 2006, CURR OPIN CELL BIOL, V18, P444, DOI 10.1016/j.ceb.2006.06.005; Zou XJ, 2012, EXP BIOL MED, V237, P1341, DOI 10.1258/ebm.2012.012041	29	38	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145413	10.1371/journal.pone.0145413	http://dx.doi.org/10.1371/journal.pone.0145413			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709511	Green Submitted, Green Published, gold			2022-12-26	WOS:000367451400045
J	Santos, E; Faria, D; Pesquita, C; Couto, FM				Santos, Emanuel; Faria, Daniel; Pesquita, Catia; Couto, Francisco M.			Ontology Alignment Repair through Modularization and Confidence-Based Heuristics	PLOS ONE			English	Article								Ontology Matching aims at identifying a set of semantic correspondences, called an alignment, between related ontologies. In recent years, there has been a growing interest in efficient and effective matching methods for large ontologies. However, alignments produced for large ontologies are often logically incoherent. It was only recently that the use of repair techniques to improve the coherence of ontology alignments began to be explored. This paper presents a novel modularization technique for ontology alignment repair which extracts fragments of the input ontologies that only contain the necessary classes and relations to resolve all detectable incoherences. The paper presents also an alignment repair algorithm that uses a global repair strategy to minimize both the degree of incoherence and the number of mappings removed from the alignment, while overcoming the scalability problem by employing the proposed modularization technique. Our evaluation shows that our modularization technique produces significantly small fragments of the ontologies and that our repair algorithm produces more complete alignments than other current alignment repair systems, while obtaining an equivalent degree of incoherence. Additionally, we also present a variant of our repair algorithm that makes use of the confidence values of the mappings to improve alignment repair. Our repair algorithm was implemented as part of AgreementMakerLight, a free and open-source ontology matching system.	[Santos, Emanuel; Pesquita, Catia; Couto, Francisco M.] Univ Lisbon, Fac Ciencias, Dept Informat, P-1699 Lisbon, Portugal; [Faria, Daniel; Pesquita, Catia; Couto, Francisco M.] Univ Lisbon, Fac Ciencias, LASIGE, P-1699 Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa	Santos, E (corresponding author), Univ Lisbon, Fac Ciencias, Dept Informat, P-1699 Lisbon, Portugal.	esantos@di.fc.ul.pt	Couto, Francisco M/A-4066-2010; Pesquita, Catia/O-8883-2015	Couto, Francisco M/0000-0003-0627-1496; Pesquita, Catia/0000-0002-1847-9393; Faria, Daniel/0000-0003-1511-277X	Portuguese FCT through the SOMER project [PTDC/EIA-EIA/119119/2010]; Portuguese FCT through the LaSIGE Strategic Project [PEst-OE/EEI/UI0408/2013]	Portuguese FCT through the SOMER project; Portuguese FCT through the LaSIGE Strategic Project	ES, DF, CP and FMC were funded by the Portuguese FCT through the SOMER project (PTDC/EIA-EIA/119119/2010) and LaSIGE Strategic Project (ref. PEst-OE/EEI/UI0408/2013).; The authors are grateful to Isabel F. Cruz and Ernesto Jimenez-Ruiz for providing valuable comments and suggestions. ES, DF, CP and FMC were funded by the Portuguese FCT through the SOMER project (PTDC/EIA-EIA/119119/2010) and LaSIGE Strategic Project (ref. PEst-OE/EEI/UI0408/2014).	[Anonymous], 2012, ORE; Bodenreider O, 2004, NUCLEIC ACIDS RES, V32, pD267, DOI 10.1093/nar/gkh061; Cruz Isabel F., 2012, The Semantic Web: Research and Applications. Proceedings 9th Extended Semantic Web Conference (ESWC 2012), P179, DOI 10.1007/978-3-642-30284-8_19; Cruz IF, 2009, PROC VLDB ENDOW, V2, P1586, DOI 10.14778/1687553.1687598; David J, 2006, CIKM, V2006, P830, DOI DOI 10.1145/1183614.1183752; Doran Paul, 2007, P 16 ACM C CONFERENC, P61, DOI DOI 10.1145/1321440.1321451; Duchateau F., 2009, CIKM ACM, P2079; Euzenat J., 2007, ONTOLOGY MATCHING; Faria D., SEMANTIC WEB ISWC 20, P17; Faria D., MOV MEAN INT SYST OT, P527; Faria D., 2013, P 8 INT C ONT MATCH, P101; Foto N.A., 2009, P INT C DAT THEOR IC, P31; Grau B. C., 2007, CEUR WORKSHOP P, V258; Grau B.C., 2013, P 8 ISWC WORKSH ONT, P61; Horridge M, 2008, LECT NOTES COMPUT SC, V5318, P323, DOI 10.1007/978-3-540-88564-1_21; Jimenez Ruiz E, 2013, P 26 INT WORKSH DESC, V13, P246; Jimenez-Ruiz E, 2012, FRONT ARTIF INTEL AP, V242, P444, DOI 10.3233/978-1-61499-098-7-444; Jimenez-Ruiz E, 2011, LECT NOTES COMPUT SC, V7031, P273, DOI 10.1007/978-3-642-25073-6_18; Kalyanpur A, 2007, LECT NOTES COMPUT SC, V4825, P267; Lopatenko A., 2007, EFFICIENT APPROXIMAT, P216; Meilicke C, 2011, ALIGNMENT INCOHERENC; Noy Natalya F., 2009, NUCL ACIDS RES, V37; Parsia B., 2004, 3 INT SEM WEB C, V18; Pesquita C., 2013, P 8 INT WORKSHOP ONT, V1111, P13; Sabou M., 2008, J DATA SEMANTICS, V11, P156, DOI DOI 10.1007/978-3-540-92148-66; Salvadores M, 2013, SEMANT WEB, V4, P277, DOI 10.3233/SW-2012-0086; Santos E, 2013, ARXIV13075322; Schlobach S, 2007, J AUTOM REASONING, V39, P317, DOI 10.1007/s10817-007-9076-z; Shvaiko P, 2013, IEEE T KNOWL DATA EN, V25, P158, DOI 10.1109/TKDE.2011.253; Stuckenschmidt H, 2007, DATA KNOWL ENG, V63, P200, DOI 10.1016/j.datak.2007.02.001; Suntisrivaraporn B, 2008, LECT NOTES COMPUT SC, V5367, P1, DOI 10.1007/978-3-540-89704-0_1	31	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0144807	10.1371/journal.pone.0144807	http://dx.doi.org/10.1371/journal.pone.0144807			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710335	gold, Green Published, Green Submitted			2022-12-26	WOS:000367451400012
J	Vaillancourt, K; LeBel, G; Frenette, M; Fittipaldi, N; Gottschalk, M; Grenier, D				Vaillancourt, Katy; LeBel, Genevieve; Frenette, Michel; Fittipaldi, Nahuel; Gottschalk, Marcelo; Grenier, Daniel			Purification and Characterization of Suicin 65, a Novel Class I Type B Lantibiotic Produced by Streptococcus suis	PLOS ONE			English	Article							SWINE PATHOGEN; SEQUENCE; BIOSYNTHESIS; INFECTION; VIRULENCE; STRAINS; SYSTEMS	Bacteriocins are antimicrobial peptides of bacterial origin that are considered as a promising alternative to the use of conventional antibiotics. Recently, our laboratory reported the purification and characterization of two lantibiotics, suicin 90-1330 and suicin 3908, produced by the swine pathogen and zoonotic agent Streptococcus suis (serotype 2). In this study, a novel bacteriocin produced by S. suis has been identified and characterized. The producing strain S. suis 65 (serotype 2) was found to belong to the sequence type 28, that includes strains known to be weakly or avirulent in a mouse model. The bacteriocin, whose production was only possible following growth on solid culture medium, was purified to homogeneity by cationic exchange and reversed-phase high-pressure liquid chromatography. The bacteriocin, named suicin 65, was heat, pH and protease resistant. Suicin 65 was active against all S. suis isolates tested, including antibiotic resistant strains. Amino acid sequencing of the purified bacteriocin by Edman degradation revealed the presence of modified amino acids suggesting a lantibiotic. Using the partial sequence obtained, a blast was performed against published genomes of S. suis and allowed to identify a putative lantibiotic locus in the genome of S. suis 89-1591. From this genome, primers were designed and the gene cluster involved in the production of suicin 65 by S. suis 65 was amplified by PCR. Sequence analysis revealed the presence of ten open reading frames, including a duplicate of the structural gene. The structural genes (sssA and sssA') of suicin 65 encodes a 25-amino acid residue leader peptide and a 26-amino acid residue mature peptide yielding an active bacteriocin with a deducted-molecular mass of 3,005 Da. Mature suicin 65 showed a high degree of identity with class I type B lantibiotics (globular structure) produced by Streptococcus pyogenes (streptococcin FF22; 84.6%), Streptococcus macedonicus (macedocin ACA-DC 198; 84.6%), and Lactococcus lactis subsp. lactis (lacticin 481; 74.1%). Further studies will evaluate the ability of suicin 65 or the producing strain to prevent experimental S. suis infections in pigs.	[Vaillancourt, Katy; LeBel, Genevieve; Frenette, Michel; Grenier, Daniel] Univ Laval, Fac Med Dent, GREB, Quebec City, PQ, Canada; [Frenette, Michel; Gottschalk, Marcelo; Grenier, Daniel] Fonds Rech Quebec Nat & Technol FQRNT, CRIPA, St Hyacinthe, PQ, Canada; [Fittipaldi, Nahuel] Univ Toronto, Fac Med, Publ Hlth Ontario, Toronto, ON, Canada; [Fittipaldi, Nahuel] Univ Toronto, Fac Med, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Gottschalk, Marcelo] Univ Montreal, Fac Med Vet, Grp Rech Malad Infect Porc GREMIP, St Hyacinthe, PQ J2S 7C6, Canada	Laval University; University of Toronto; University of Toronto; Universite de Montreal	Grenier, D (corresponding author), Univ Laval, Fac Med Dent, GREB, Quebec City, PQ, Canada.	Daniel.Grenier@greb.ulaval.ca	Gottschalk, Marcelo/I-8116-2012	Fittipaldi, Nahuel/0000-0001-9553-3798	Ministere de l'Agriculture, des Pecheries et de l'Alimentation du Quebec [811326]	Ministere de l'Agriculture, des Pecheries et de l'Alimentation du Quebec	This research was supported by Ministere de l'Agriculture, des Pecheries et de l'Alimentation du Quebec, Grant #811326, to DG MF MG. This study made use of the Streptococcus suis Multilocus Sequence Typing Database hosted at Imperial College and whose development is funded by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur TD, 2014, FUTURE MICROBIOL, V9, P235, DOI 10.2217/fmb.13.148; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; Baums Christoph Georg, 2009, Animal Health Research Reviews, V10, P65, DOI 10.1017/S146625230999003X; Berthelot-Herault F, 2001, CAN J VET RES, V65, P196; Bierbaum G, 2009, CURR PHARM BIOTECHNO, V10, P2, DOI 10.2174/138920109787048616; Callens BF, 2013, MICROB DRUG RESIST, V19, P146, DOI 10.1089/mdr.2012.0131; Cotter PD, 2013, NAT REV MICROBIOL, V11, P95, DOI 10.1038/nrmicro2937; Cromwell GL, 2002, ANIM BIOTECHNOL, V13, P7, DOI 10.1081/ABIO-120005767; de Arauz LJ, 2009, TRENDS FOOD SCI TECH, V20, P146, DOI 10.1016/j.tifs.2009.01.056; Dufour A, 2003, RECENT RES DEV BACTE, V1, P219; Fittipaldi N, 2012, FUTURE MICROBIOL, V7, P259, DOI [10.2217/FMB.11.149, 10.2217/fmb.11.149]; Fittipaldi N, 2011, EMERG INFECT DIS, V17, P2239, DOI 10.3201/eid1712.110609; Food and Drug Administration, 2010, CVM UPD CVM REP ANT; Gottschalk M., 2012, DIS SWINE, P841; Gottschalk M, 2010, FUTURE MICROBIOL, V5, P371, DOI [10.2217/fmb.10.2, 10.2217/FMB.10.2]; Goyette-Desjardins G, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.45; Khadthasrima N, 2007, HUMAN STREPTOCOCCUS, V1, P4; LeBel G, 2014, APPL ENVIRON MICROB, V80, P5484, DOI 10.1128/AEM.01055-14; Lin J, 2009, FOODBORNE PATHOG DIS, V6, P755, DOI 10.1089/fpd.2008.0247; Maldonado-Barragan A, 2009, INT J FOOD MICROBIOL, V130, P35, DOI 10.1016/j.ijfoodmicro.2008.12.033; McLaughlin RE, 1999, FEMS MICROBIOL LETT, V175, P171, DOI 10.1111/j.1574-6968.1999.tb13616.x; Melancon D, 2003, APPL ENVIRON MICROB, V69, P4482, DOI 10.1128/AEM.69.8.4482-4488.2003; MEYER HE, 1994, ANAL BIOCHEM, V223, P185, DOI 10.1006/abio.1994.1571; Nicolas GG, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-69; Papadelli M, 2007, FEMS MICROBIOL LETT, V272, P75, DOI 10.1111/j.1574-6968.2007.00740.x; Segura M, 2015, EXPERT REV VACCINES, V14, P1587, DOI 10.1586/14760584.2015.1101349; Vaillancourt K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117245; Varela NP, 2013, ANIM HEALTH RES REV, V20, P1	28	15	15	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145854	10.1371/journal.pone.0145854	http://dx.doi.org/10.1371/journal.pone.0145854			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709705	gold, Green Published, Green Submitted			2022-12-26	WOS:000367451400086
J	Burnecki, K; Wylomanska, A; Chechkin, A				Burnecki, Krzysztof; Wylomanska, Agnieszka; Chechkin, Aleksei			Discriminating between Light- and Heavy-Tailed Distributions with Limit Theorem	PLOS ONE			English	Article							LEVY FLIGHT; STATISTICAL-ANALYSIS; FRACTIONAL DYNAMICS; STOCHASTIC-PROCESS; EDGE TURBULENCE; SCALING LAWS; STABLE LAWS; POWER-LAW; CONVERGENCE; FLUCTUATIONS	In this paper we propose an algorithm to distinguish between light- and heavy-tailed probability laws underlying random datasets. The idea of the algorithm, which is visual and easy to implement, is to check whether the underlying law belongs to the domain of attraction of the Gaussian or non-Gaussian stable distribution by examining its rate of convergence. The method allows to discriminate between stable and various non-stable distributions. The test allows to differentiate between distributions, which appear the same according to standard Kolmogorov-Smirnov test. In particular, it helps to distinguish between stable and Student's t probability laws as well as between the stable and tempered stable, the cases which are considered in the literature as very cumbersome. Finally, we illustrate the procedure on plasma data to identify cases with so-called L-H transition.	[Burnecki, Krzysztof; Wylomanska, Agnieszka] Wroclaw Univ Technol, Hugo Steinhaus Ctr, Dept Math, PL-50370 Wroclaw, Poland; [Chechkin, Aleksei] Kharkov Inst Phys & Technol, Akhiezer Inst Theoret Phys, Natl Sci Ctr, Kharkov, Ukraine; [Chechkin, Aleksei] Max Planck Inst Phys Komplexer Syst, Dresden, Germany; [Chechkin, Aleksei] Univ Potsdam, Inst Phys & Astron, Potsdam, Germany	Wroclaw University of Science & Technology; Kharkov Institute of Physics & Technology; Max Planck Society; University of Potsdam	Burnecki, K (corresponding author), Wroclaw Univ Technol, Hugo Steinhaus Ctr, Dept Math, PL-50370 Wroclaw, Poland.	krzysztof.burnecki@pwr.edu.pl	Chechkin, Aleksei/AAC-3605-2020	Chechkin, Aleksei/0000-0002-3803-1174; Burnecki, Krzysztof/0000-0002-1754-4472; Wylomanska, Agnieszka/0000-0001-9750-1351	NCN Maestro [2012/06/A/ST1/00258]; NCN [UMO-2012/07/B/ST8/03031]	NCN Maestro; NCN	KB would like to acknowledge the support of NCN Maestro Grant No. 2012/06/A/ST1/00258. AW would like to acknowledge the support of NCN Grant No. UMO-2012/07/B/ST8/03031. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alstott J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085777; Anderson TW, 1957, ANN MATH STAT, V28, P823; Bartelmus W, 2009, MECH SYST SIGNAL PR, V23, P1528, DOI 10.1016/j.ymssp.2009.01.014; Barthelemy P, 2008, NATURE, V453, P495, DOI 10.1038/nature06948; Batanov GM, 2002, PLASMA PHYS REP+, V28, P111, DOI 10.1134/1.1450675; Beletskii AA, 2009, PLASMA PHYS REP+, V35, P818, DOI 10.1134/S1063780X0910002X; BENJAMINI Y, 1988, AM STAT, V42, P257, DOI 10.2307/2685133; Borak S, 2011, STATISTICAL TOOLS FOR FINANCE AND INSURANCE, SECOND EDITION, P21; Boyer D, 2006, P ROY SOC B-BIOL SCI, V273, P1743, DOI 10.1098/rspb.2005.3462; Brcich RF, 2005, IEEE T SIGNAL PROCES, V53, P977, DOI 10.1109/TSP.2004.842192; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Burnecki K, 2000, PHYSICA A, V287, P269, DOI 10.1016/S0378-4371(00)00453-2; Burnecki K, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.056711; Burnecki K, 2011, STATISTICAL TOOLS FOR FINANCE AND INSURANCE, SECOND EDITION, P293; Burnecki K, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.021130; BUTZER PL, 1978, J MULTIVARIATE ANAL, V8, P202, DOI 10.1016/0047-259X(78)90072-6; Chandrasekhar S, 1943, REV MOD PHYS, V15, P0001, DOI 10.1103/RevModPhys.15.1; Chechkin A. V., 2008, ANOMALOUS TRANSPORT, P129, DOI [10.1002/9783527622979, DOI 10.1002/9783527622979, DOI 10.1002/9783527622979.CH5]; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Cont R, 1997, SCALE INVARIANCE, P75; DAgostino RB, 1986, GOODNESS OF FIT TECH; Davison A.C., 1999, CAMBRIDGE SERIES STA; Ditlevsen PD, 1999, PHYS REV E, V60, P172, DOI 10.1103/PhysRevE.60.172; Ditlevsen PD, 1999, GEOPHYS RES LETT, V26, P1441, DOI 10.1029/1999GL900252; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; Gnedenko B. V., 1954, LIMIT DISTRIBUTIONS; Gonchar VY, 2003, PLASMA PHYS REP+, V29, P380, DOI 10.1134/1.1575308; Huelsenbeck JP, 1996, SYST BIOL, V45, P546, DOI 10.2307/2413530; Humphries NE, 2012, P NATL ACAD SCI USA, V109, P7169, DOI 10.1073/pnas.1121201109; Janic-Wroblewska A, 2000, SCAND J STAT, V27, P281, DOI 10.1111/1467-9469.00189; Jansen VAA, 2012, SCIENCE, V335, DOI 10.1126/science.1215747; JARQUE CM, 1987, INT STAT REV, V55, P163, DOI 10.2307/1403192; Jha R, 2003, PHYS PLASMAS, V10, P699, DOI 10.1063/1.1541607; Johnson O., 2004, INFORM THEORY CENTRA; Kim YS, 2010, J BANK FINANC, V34, P2096, DOI 10.1016/j.jbankfin.2010.01.015; Klenke A, 2014, PROBABILITY THEORY C, V2nd; KOPONEN I, 1995, PHYS REV E, V52, P1197, DOI 10.1103/PhysRevE.52.1197; KOUTROUVELIS IA, 1980, J AM STAT ASSOC, V75, P918, DOI 10.2307/2287182; KOUTROUVELIS IA, 1981, COMMUN STAT B-SIMUL, V10, P17, DOI 10.1080/03610918108812189; Kuske R, 2000, SIAM J APPL MATH, V61, P1308; LEPAGE R, 1981, ANN PROBAB, V9, P624, DOI 10.1214/aop/1176994367; Levy PP, 1925, 1925 THEORIE DEL ADD; Lomholt MA, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.260603; MANDELBROT B, 1963, J BUS, V36, P394, DOI 10.1086/294632; Mantegna R. N., 2000, INTRO ECONOPHYSICS; MANTEGNA RN, 1994, PHYS REV LETT, V73, P2946, DOI 10.1103/PhysRevLett.73.2946; Mashanova A, 2010, J R SOC INTERFACE, V7, P199, DOI 10.1098/rsif.2009.0121; Mercadier N, 2009, NAT PHYS, V5, P602, DOI 10.1038/NPHYS1286; Metzler R, 2000, PHYS REP, V339, P1, DOI 10.1016/S0370-1573(00)00070-3; Metzler R, 2004, J PHYS A-MATH GEN, V37, pR161, DOI 10.1088/0305-4470/37/31/R01; Metzler R., 2009, ENCY COMPLEXITY SYST, P1724; Mizuuchi T, 2005, J NUCL MATER, V337, P332, DOI 10.1016/j.jnucmat.2004.10.010; Neyman J, 1933, PHILOS T R SOC LOND, V231, P289, DOI 10.1098/rsta.1933.0009; Nikias C. L., 1995, SIGNAL PROCESSING WI; Nolan J, 2007, MODELS FOR HEAVY TAI; Obuchowski J, 2014, MECH SYST SIGNAL PR, V48, P138, DOI 10.1016/j.ymssp.2014.03.011; PENG CK, 1993, PHYS REV LETT, V70, P1343, DOI 10.1103/PhysRevLett.70.1343; Petrovskii S, 2011, P NATL ACAD SCI USA, V108, P8704, DOI 10.1073/pnas.1015208108; Rachev S., 2000, STABLE PARETIAN MODE; Rachev ST, 2003, HANDBOOK OF HEAVY TA; Romao X, 2010, J STAT COMPUT SIM, V80, P545, DOI 10.1080/00949650902740824; Rosinski J, 2007, STOCH PROC APPL, V117, P677, DOI 10.1016/j.spa.2006.10.003; Ross S.M., 2002, SIMULATION; Rychlik Z, 1993, PROBAB MATH STAT-POL, V14, P63; Samorodnitsky G., 1994, STABLE NONGAUSSIAN R; Sandberg I, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.165001; Sidak Z., 1967, THEORY RANK TESTS; Sims DW, 2008, NATURE, V451, P1098, DOI 10.1038/nature06518; Sokolov IM, 1997, PHYS REV LETT, V79, P857, DOI 10.1103/PhysRevLett.79.857; Tankov P, 2003, FINANCIAL MODELLING; TSUI HYW, 1993, PHYS FLUIDS B-PLASMA, V5, P2491, DOI 10.1063/1.860734; Viswanathan G. M., 2011, PHYS FORAGING; Wagner F, 2007, PLASMA PHYS CONTR F, V49, pB1, DOI 10.1088/0741-3335/49/12B/S01; Weron R, 2004, HANDBOOK OF COMPUTATIONAL STATISTICS: CONCEPTS AND METHODS, P911; Zaid IM, 2011, J R SOC INTERFACE, V8, P1314, DOI 10.1098/rsif.2010.0545	75	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145604	10.1371/journal.pone.0145604	http://dx.doi.org/10.1371/journal.pone.0145604			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26698863	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092600104
J	Parra, MJ; Acuna, KI; Sierra-Almeida, A; Sanfuentes, C; Saldana, A; Corcuera, LJ; Bravo, LA				Jose Parra, Maria; Acuna, Karina I.; Sierra-Almeida, Angela; Sanfuentes, Camila; Saldana, Alfredo; Corcuera, Luis J.; Bravo, Leon A.			Photosynthetic Light Responses May Explain Vertical Distribution of Hymenophyllaceae Species in a Temperate Rainforest of Southern Chile	PLOS ONE			English	Article							CHLOROPHYLL FLUORESCENCE; PHOTOSYSTEM-I; REDOX STATE; FILMY FERNS; PLANTS; SUN; BRYOPHYTES; POIKILOHYDRY; ACCLIMATION; DISSIPATION	Some epiphytic Hymenophyllaceae are restricted to lower parts of the host (<60 cm; 10-100 mu mol photons m(-2) s(-1)) in a secondary forest of Southern Chile; other species occupy the whole host height (>= 10 m; max PPFD > 1000 mu mol photons m(-2) s(-1)). Our aim was to study the photosynthetic light responses of two Hymenophyllaceae species in relation to their contrasting distribution. We determined light tolerance of Hymenoglossum cruentum and Hymenophyllum dentatum by measuring gas exchange, PSI and PSII light energy partitioning, NPQ components, and pigment contents. H. dentatum showed lower maximum photosynthesis rates (A(max)) than H. cruentum, but the former species kept its net rates (A(n)) near A(max) across a wide light range. In contrast, in the latter one, A(n) declined at PPFDs > 60 mu mol photons m(-2) s(-1). H. cruentum, the shadiest plant, showed higher chlorophyll contents than H. dentatum. Differences in energy partitioning at PSI and PSII were consistent with gas exchange results. H. dentatum exhibited a higher light compensation point of the partitioning of absorbed energy between photochemical Y(PSII) and non-photochemical Y(NPQ) processes. Hence, both species allocated energy mainly toward photochemistry instead of heat dissipation at their light saturation points. Above saturation, H. cruentum had higher heat dissipation than H. dentatum. PSI yield (YPSI) remained higher in H. dentatum than H. cruentum in a wider light range. In both species, the main cause of heat dissipation at PSI was a donor side limitation. An early dynamic photo-inhibition of PSII may have caused an over reduction of the Qa(+) pool decreasing the efficiency of electron donation to PSI. In H. dentatum, a slight increase in heat dissipation due to acceptor side limitation of PSI was observed above 300 mu mol photons m(-2)s(-1). Differences in photosynthetic responses to light suggest that light tolerance and species plasticity could explain their contrasting vertical distribution.	[Jose Parra, Maria] Univ San Sebastian, Fac Ciencia, Dept Ciencias Biol & Quim, Concepcion, Chile; [Acuna, Karina I.; Sierra-Almeida, Angela; Saldana, Alfredo; Corcuera, Luis J.] Univ Concepcion, Dept Bot, Fac Ciencias Nat & Oceanog, Concepcion, Chile; [Sierra-Almeida, Angela; Sanfuentes, Camila] IEB, Santiago, Chile; [Sanfuentes, Camila] Univ Chile, Fac Ciencias, Dept Ciencias Ecol, Las Palmeras 3425, Chile; [Acuna, Karina I.; Bravo, Leon A.] Univ La Frontera, Lab Fisiol & Biol Mol Vegetal, Dept Ciencias Agron & Recursos Nat, Fac Ciencias Agr & Forestales, Temuco, Chile; [Acuna, Karina I.; Bravo, Leon A.] Univ La Frontera, Sci & Technol Bioresource Nucleus, Ctr Plant Soil Interact & Nat Resources Biotechno, Temuco, Chile	Universidad San Sebastian; Universidad de Concepcion; Universidad de Chile; Universidad de La Frontera; Universidad de La Frontera	Sierra-Almeida, A (corresponding author), Univ Concepcion, Dept Bot, Fac Ciencias Nat & Oceanog, Casilla 160-C, Concepcion, Chile.	angelasierra@udec.cl	Saldaña, Alfredo/C-8826-2011; Bravo, Leon/H-9251-2018; Sierra-Almeida, Angela/F-8409-2014; Bravo, León/AAO-8437-2020	Bravo, Leon/0000-0003-4705-4842; Sierra-Almeida, Angela/0000-0002-4207-0950; Bravo, León/0000-0003-4705-4842; Saldana, Alfredo/0000-0001-5161-5150	AS-A Programa de Atraccion e Insercion de capital humano avanzado [PAI-CONICYT 791100040]; Fondo Nacional de Desarrollo Cientifico y Tecnologico [FONDECYT 1090397, FONDECYT 1120964]; Beca de Doctorado Nacional de la Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)	AS-A Programa de Atraccion e Insercion de capital humano avanzado; Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Beca de Doctorado Nacional de la Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was funded by AS-A Programa de Atraccion e Insercion de capital humano avanzado PAI-CONICYT 791100040 [http://www.conicyt.cl/pai/sobre-pai/que-es-pai/] to LAB; Fondo Nacional de Desarrollo Cientifico y Tecnologico FONDECYT 1090397 and FONDECYT 1120964 [http://www.conicyt.cl/fondecyt/category/concursos/fondecytregular/] to MJP; Beca de Doctorado Nacional de la Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) [http://www.conicyt.cl/becas-conicyt/2014/08/beca-doctorado-nacional-2015/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade J. L., 2004, FISIOLOGIA ECOLOGICA, P139; Bailey S, 2001, PLANTA, V213, P794, DOI 10.1007/s004250100556; BJORKMAN O, 1968, PHYSIOL PLANTARUM, V21, P1, DOI 10.1111/j.1399-3054.1968.tb07225.x; BOARDMAN NK, 1977, ANNU REV PLANT PHYS, V28, P355, DOI 10.1146/annurev.pp.28.060177.002035; BRADBURY M, 1981, BIOCHIM BIOPHYS ACTA, V635, P542, DOI 10.1016/0005-2728(81)90113-4; Clement Joel P., 2001, Selbyana, V22, P76; de Bianchi S, 2010, BIOCHEM SOC T, V38, P651, DOI 10.1042/BST0380651; Demmig-Adams B, 1998, PLANT CELL PHYSIOL, V39, P474, DOI 10.1093/oxfordjournals.pcp.a029394; DEMMIGADAMS B, 1992, ANNU REV PLANT PHYS, V43, P599, DOI 10.1146/annurev.pp.43.060192.003123; Dubuisson JY, 2003, BOT J LINN SOC, V142, P41, DOI 10.1046/j.1095-8339.2003.00165.x; DYTHAM C, 2005, CHOOSING USING STAT; Evans GB, 1964, THESIS; EVANS JR, 1988, AUST J PLANT PHYSIOL, V15, P93, DOI 10.1071/PP9880093; Fuller GD, 1925, BOT GAZ, V79, P232; Garcia-Plazaola JI, 1999, PHYTOCHEM ANALYSIS, V10, P307, DOI 10.1002/(SICI)1099-1565(199911/12)10:6&lt;307::AID-PCA477&gt;3.0.CO;2-L; Gessner F, 1940, PROTOPLASMA, V34, P102; Hajek E, 1975, BIOCLIMATOLOGIA CHIL; Hernandez-Rosas J, 1999, ECOTROPICOS, V12, P33; HORTON P, 1988, BIOCHIM BIOPHYS ACTA, V932, P107, DOI 10.1016/0005-2728(88)90144-2; Johnson GN, 2000, NEW PHYTOL, V148, P423, DOI 10.1046/j.1469-8137.2000.00772.x; Klughammer C., 2008, PAM APP NOTES, V1, P11, DOI DOI 10.1007/S00415-017-8571-3; Kramer DM, 2004, PHOTOSYNTH RES, V79, P209, DOI 10.1023/B:PRES.0000015391.99477.0d; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525; Lambers H., 2008, PLANT PHYSL ECOLOGY; Marschall M, 2004, ANN BOT-LONDON, V94, P593, DOI 10.1093/aob/mch178; Matsubara S, 2009, FUNCT PLANT BIOL, V36, P20, DOI 10.1071/FP08214; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; NASRULHAQBOYCE A, 1987, NEW PHYTOL, V105, P81, DOI 10.1111/j.1469-8137.1987.tb00112.x; Osmond CB, 1993, PHOTOINHIBITION PHOT, P1; Parra MJ, 2009, J VEG SCI, V20, P588, DOI 10.1111/j.1654-1103.2009.01078.x; Parra MJ, 2012, THESIS; PEARCY RW, 1990, ANNU REV PLANT PHYS, V41, P421, DOI 10.1146/annurev.pp.41.060190.002225; Proctor MCF, 2005, J BRYOL, V27, P221, DOI 10.1179/174328205X69968; Proctor MCF, 2003, ANN BOT-LONDON, V91, P717, DOI 10.1093/aob/mcg077; Proctor MCF, 2002, NEW PHYTOL, V156, P327, DOI 10.1046/j.1469-8137.2002.00526.x; Proctor MCF, 2014, ADV PHOTOSYNTH RESP, V37, P59, DOI 10.1007/978-94-007-6988-5_4; Proctor MCF, 2012, ANN BOT-LONDON, V109, P1019, DOI 10.1093/aob/mcs012; Proctor MCF, 2011, PHYSIOL PLANTARUM, V141, P130, DOI 10.1111/j.1399-3054.2010.01424.x; Rice SK, 1996, PLANT CELL ENVIRON, V19, P118, DOI 10.1111/j.1365-3040.1996.tb00233.x; RICHARDS PW, 1972, J ECOL, V60, P245, DOI 10.2307/2258054; Rodriguez R., 1995, FLORA CHILE, V1, P119, DOI DOI 10.1007/S12228-009-9078-8; Saez PL, 2013, PLANT SCI, V201, P12, DOI 10.1016/j.plantsci.2012.11.008; Saldana A, 2014, PLANT SPEC BIOL, V29, P253, DOI 10.1111/1442-1984.12020; SCHREIBER U, 1986, PHOTOSYNTH RES, V10, P51, DOI 10.1007/BF00024185; Trebst A, 2003, Z NATURFORSCH C, V58, P609; Tryon RM, 1982, FERN ALLIED PLANTS S; Valladares F, 2008, ANNU REV ECOL EVOL S, V39, P237, DOI 10.1146/annurev.ecolsys.39.110707.173506; Walters RG, 2005, J EXP BOT, V56, P435, DOI 10.1093/jxb/eri060; WALTERS RG, 1991, PHOTOSYNTH RES, V27, P121, DOI 10.1007/BF00033251; Wang YL, 2004, BIOPHYS J, V86, P3097, DOI 10.1016/S0006-3495(04)74358-1; Zotz Gerhard, 2000, Ecotropica (Bonn), V6, P203	52	13	13	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145475	10.1371/journal.pone.0145475	http://dx.doi.org/10.1371/journal.pone.0145475			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26699612	gold, Green Published, Green Submitted			2022-12-26	WOS:000367092600087
J	Wagner, RG; Ibinda, F; Tollman, S; Lindholm, L; Newton, CR; Bertram, MY				Wagner, Ryan G.; Ibinda, Fredrick; Tollman, Stephen; Lindholm, Lars; Newton, Charles R.; Bertram, Melanie Y.			Differing Methods and Definitions Influence DALY estimates: Using Population-Based Data to Calculate the Burden of Convulsive Epilepsy in Rural South Africa	PLOS ONE			English	Article							ADJUSTED LIFE YEARS; GLOBAL BURDEN; SYSTEMATIC ANALYSIS; COST-EFFECTIVENESS; MEASURING HEALTH; DISABILITY; DISEASE; PREVALENCE; MORTALITY; INJURIES	Background The disability adjusted life year (DALY) is a composite measure of disease burden that includes both morbidity and mortality, and is relevant to conditions such as epilepsy that can limit productive functioning. The 2010 Global Burden of Disease (GBD) study introduced a number of new methods and definitions, including a prevalence-based approach and revised disability weights to calculate morbidity and new standard life expectancies to calculate premature mortality. We used these approaches, and local, population-based data, to estimate the burden of convulsive epilepsy in rural South Africa. Methods & Findings Comprehensive prevalence, incidence and mortality data on convulsive epilepsy were collected within the Agincourt sub-district in rural northeastern South Africa between 2008 and 2012. We estimated DALYs using both prevalence- and incidence-based approaches for calculating years of life lived with disability. Additionally, we explored how changing the disease model by varying the disability weights influenced DALY estimates. Using the prevalence- based approach, convulsive epilepsy in Agincourt resulted in 332 DALYs (95% uncertainty interval (UI): 216-455) and 4.1 DALYs per 1,000 individuals (95% UI: 2.7-5.7) annually. Of this, 26% was due to morbidity while 74% was due to premature mortality. DALYs increased by 10% when using the incidence-based method. Varying the disability weight from 0.072 (treated epilepsy, seizure free) to 0.657 (severe epilepsy) caused years lived with disability to increase from 18 (95%UI: 16-19) to 161 (95%UI: 143-170). Conclusions DALY estimates are influenced by both the methods applied and population parameters used in the calculation. Irrespective of method, a significant burden of epilepsy is due to premature mortality in rural South Africa, with a lower burden than rural Kenya. Researchers and national policymakers should carefully interrogate the methods and data used to calculate DALYs as this will influence policy priorities and resource allocation.	[Wagner, Ryan G.; Ibinda, Fredrick; Tollman, Stephen; Newton, Charles R.] INDEPTH Network, Studies Epidemiol Epilepsy Demog Surveillance Sys, Accra, Ghana; [Wagner, Ryan G.; Tollman, Stephen] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, MRC Wits Rural Publ Hlth & Hlth Transit Res Unit, Johannesburg, South Africa; [Wagner, Ryan G.; Tollman, Stephen; Lindholm, Lars] Umea Univ, Dept Publ Hlth & Clin Med, Epidemiol & Global Hlth, Umea, Sweden; [Ibinda, Fredrick; Newton, Charles R.] Ctr Geog Med Res Coast, KEMRI Wellcome Trust Res Programme, Kilifi, Kenya; [Newton, Charles R.] UCL, Inst Child Hlth, Neurosci Unit, London, England; [Newton, Charles R.] Univ Oxford, Dept Psychiat, Oxford, England; [Bertram, Melanie Y.] WHO, CH-1211 Geneva, Switzerland	INDEPTH Network; University of Witwatersrand; Umea University; University of London; University College London; University of Oxford; World Health Organization	Wagner, RG (corresponding author), INDEPTH Network, Studies Epidemiol Epilepsy Demog Surveillance Sys, Accra, Ghana.	Ryan.wagner@wits.ac.za	Newton, Charles RJC/B-7578-2014; Wagner, Ryan G/AFK-7323-2022	Newton, Charles RJC/0000-0002-6999-5507; Wagner, Ryan G/0000-0003-2741-3676; Tollman, Stephen/0000-0003-0744-7588	EU Marie-Curie International Research Staff Exchange Scheme [295168]; Wellcome Trust, UK [083744, 058893/Z/99/A, 069683/Z/02/Z, 085477/Z/08/Z]; University of the Witwatersrand; South African Medical Research Council; National Institute on Aging (NIA) of the National Institutes of Health (NIH)	EU Marie-Curie International Research Staff Exchange Scheme; Wellcome Trust, UK(Wellcome Trust); University of the Witwatersrand; South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute on Aging (NIA) of the National Institutes of Health (NIH)	RGW gratefully acknowledges the EU Marie-Curie International Research Staff Exchange Scheme (http://ec.europa.eu/research/mariecurieactions/about-mca/actions/irses/index_en.htm) (grant no. 295168) that allowed him to undertake this work. CRN is funded by the Wellcome Trust, UK (083744)(www.wellcome.ac.uk). The Agincourt HDSS is funded by the Wellcome Trust, UK (grants 058893/Z/99/A; 069683/Z/02/Z; 085477/Z/08/Z), with important contributions from the University of the Witwatersrand, the South African Medical Research Council, and National Institute on Aging (NIA) of the National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHO JM, 1992, BIOMETRICS, V48, P587, DOI 10.2307/2532312; Anand S, 1997, J HEALTH ECON, V16, P685, DOI 10.1016/S0167-6296(97)00005-2; Arnesen T, 2000, LEPROSY REV, V71, P123; Barendregt Jan J, 2003, Popul Health Metr, V1, P4, DOI 10.1186/1478-7954-1-4; Bharucha N, 2008, EPILEPSY COMPREHENSI, P89; Canty A, 1997, BOOTSTRAP R S PLUS F; Chisholm D, 2005, EPILEPSIA, V46, P751, DOI 10.1111/j.1528-1167.2005.52704.x; COCKERELL OC, 1995, J NEUROL NEUROSUR PS, V58, P570, DOI 10.1136/jnnp.58.5.570; Davison AC, 1997, BOOTSTRAP METHODS TH; de Boer HM, 2008, EPILEPSY BEHAV, V12, P540, DOI 10.1016/j.yebeh.2007.12.019; Devleesschauwer B, 2014, INT J PUBLIC HEALTH, V59, P571, DOI 10.1007/s00038-014-0553-y; Ding D, 2006, EPILEPSIA, V47, P2032, DOI 10.1111/j.1528-1167.2006.00802.x; Foreman KJ, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-1; Grosse SD, 2009, PUBLIC HEALTH REP, V124, P197, DOI 10.1177/003335490912400206; Ibinda F, 2014, EPILEPSIA, V55, P1626, DOI 10.1111/epi.12741; Kahn K, 2012, INT J EPIDEMIOL, V41, P988, DOI 10.1093/ije/dys115; KLEINMAN A, 1995, SOC SCI MED, V40, P1319, DOI 10.1016/0277-9536(94)00254-Q; Langfitt J, 2002, EPILEPSIA, V43, P17, DOI 10.1046/j.1528-1157.43.s.4.4.x; Leonardi M, 2002, EPILEPSIA, V43, P21, DOI 10.1046/j.1528-1157.43.s.6.11.x; Lhatoo SD, 2005, EPILEPSIA, V46, P36, DOI 10.1111/j.1528-1167.2005.00406.x; Mbuba CK, 2008, EPILEPSIA, V49, P1491, DOI 10.1111/j.1528-1167.2008.01693.x; Mont D, 2007, LANCET, V369, P1658, DOI 10.1016/S0140-6736(07)60752-1; Murray C, 1994, B WORLD HEALTH ORGAN, V72; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Murray CJL, 1997, J HEALTH ECON, V16, P703, DOI 10.1016/S0167-6296(97)00004-0; Newton CR, 2012, LANCET, V380, P1193, DOI 10.1016/S0140-6736(12)61381-6; Ngugi AK, 2011, NEUROLOGY, V77, P1005, DOI 10.1212/WNL.0b013e31822cfc90; Ngugi AK, 2013, LANCET NEUROL, V4422, P1; Ngugi AK, 2014, NEUROLOGY, V82, P582, DOI 10.1212/WNL.0000000000000123; Ngugi AK, 2010, EPILEPSIA, V51, P883, DOI 10.1111/j.1528-1167.2009.02481.x; Reidpath DD, 2003, HEALTH POLICY PLANN, V18, P351, DOI 10.1093/heapol/czg043; Rushby JF, 2001, HEALTH POLICY PLANN, V16, P326, DOI 10.1093/heapol/16.3.326; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Schroeder SA, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-19; The R Development Core Team, 2008, R LANGUAGE ENV STAT, P1; Tsuchiya A, 2002, HEALTH ECON, V11, P341, DOI 10.1002/hec.673; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wagner RG, 2009, PARASITE IMMUNOL, V31, P697, DOI 10.1111/j.1365-3024.2009.01128.x; Wagner RG, 2015, PLOS ONE, DOI [10.1371/jounal.pone.0129097, DOI 10.1371/J0URNAL.P0NE.0129097]; Wagner RG, 2014, EPILEPSY RES, V108, P782, DOI 10.1016/j.eplepsyres.2014.01.004	41	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145300	10.1371/journal.pone.0145300	http://dx.doi.org/10.1371/journal.pone.0145300			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26697856	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092600060
J	Patel, SA; Chaudhari, A; Gupta, R; Velingkaar, N; Kondratov, RV				Patel, Sonal A.; Chaudhari, Amol; Gupta, Richa; Velingkaar, Nikkhil; Kondratov, Roman V.			Circadian clocks govern calorie restriction-mediated life span extension through BMAL1-and IGF-1-dependent mechanisms	FASEB JOURNAL			English	Article						aging; gene expression; glucose; insulin; transcription; food anticipation	DIETARY-RESTRICTION; GENE-EXPRESSION; SIRT1; LONGEVITY; PATHWAY; METABOLISM; COMPONENT; PROTEINS; RHYTHMS; MOP3	Calorie restriction (CR) increases longevity in many species by unknown mechanisms. The circadian clock was proposed as a potential mediator of CR. Deficiency of the core component of the circadian clock-transcriptional factor BMAL1 (brain and muscle ARNT [aryl hydrocarbon receptor nuclear translocator]-like protein 1)-results in accelerated aging. Here we investigated the role of BMAL1 in mechanisms of CR. The 30% CR diet increased the life span of wild-type (WT) mice by 20% compared to mice on an ad libitum (AL) diet but failed to increase life span of Bmal1(-/-) mice. BMAL1 deficiency impaired CR-mediated changes in the plasma levels of IGF-1 and insulin. We detected a statistically significantly reduction of IGF-1 in CR vs. AL by 50 to 70% in WT mice at several daily time points tested, while in Bmal1(-/-) the reduction was not significant. Insulin levels in WT were reduced by 5 to 9%, while Bmal1(-/-) induced it by 10 to 35% at all time points tested. CR up-regulated the daily average expression of Bmal1 (by 150%) and its downstream target genes Periods (by 470% for Per1 and by 130% for Per2). We propose that BMAL1 is an important mediator of CR, and activation of BMAL1 might link CR mechanisms with biologic clocks.	[Kondratov, Roman V.] Cleveland State Univ, Dept Biol Geol & Environm Sci, 2121 Euclid Ave, Cleveland, OH 44115 USA; [Kondratov, Roman V.] Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, 2121 Euclid Ave, Cleveland, OH 44115 USA	University System of Ohio; Cleveland State University; University System of Ohio; Cleveland State University	Kondratov, RV (corresponding author), Cleveland State Univ, Dept Biol Geol & Environm Sci, 2121 Euclid Ave, Cleveland, OH 44115 USA.; Kondratov, RV (corresponding author), Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, 2121 Euclid Ave, Cleveland, OH 44115 USA.	r.kondratov@csuohio.edu	Velingkaar, Nikkhil/ABC-8132-2020; Tulsian, Richa/L-5266-2019; Patel, Sonal/ABI-8347-2020	Velingkaar, Nikkhil/0000-0003-1571-0833; Patel, Sonal/0000-0003-2268-6114; Kondratov, Roman/0000-0003-3449-745X	U.S. National Institutes of Health/National Institute on Aging [1R01AG039547]; Center for Gene Regulation in Health and Disease (Cleveland State University); Cleveland State University; NATIONAL INSTITUTE ON AGING [R01AG039547] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010381] Funding Source: NIH RePORTER	U.S. National Institutes of Health/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Center for Gene Regulation in Health and Disease (Cleveland State University); Cleveland State University; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by U.S. National Institutes of Health/National Institute on Aging Grant 1R01AG039547, funds from the Center for Gene Regulation in Health and Disease (Cleveland State University) to R.V.K, and a Dissertation Research Award (Cleveland State University) to S.P. The authors thank J. Holcomb (Department of Mathematics, Cleveland State University), for help with statistical analysis. The authors also thank 2 anonymous reviewers for their helpful suggestions. The authors declare no conflicts of interest.	Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; BLACKWELL BN, 1995, TOXICOL PATHOL, V23, P570, DOI 10.1177/019262339502300503; Blagosklonny MV, 2010, CELL CYCLE, V9, P3151, DOI 10.4161/cc.9.16.13120; Boily G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001759; Brown-Borg HM, 2007, AGEING RES REV, V6, P28, DOI 10.1016/j.arr.2007.02.005; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Chang HC, 2013, CELL, V153, P1448, DOI 10.1016/j.cell.2013.05.027; Chen D, 2005, SCIENCE, V310, P1641, DOI 10.1126/science.1118357; Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Cornu M, 2014, P NATL ACAD SCI USA, V111, P11592, DOI 10.1073/pnas.1412047111; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Eckel-Mahan KL, 2013, CELL, V155, P1464, DOI 10.1016/j.cell.2013.11.034; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Froy O, 2011, PHYSIOLOGY, V26, P225, DOI 10.1152/physiol.00012.2011; Froy O, 2010, AGING-US, V2, P7, DOI 10.18632/aging.100116; Gallinetti J, 2013, BIOCHEM J, V449, P1, DOI 10.1042/BJ20121098; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Gesing A, 2014, EXP GERONTOL, V58, P219, DOI 10.1016/j.exger.2014.08.010; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Hunt T, 2007, CELL, V129, P461, DOI 10.1016/j.cell.2007.04.015; Jouffe C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001455; Kennedy BK, 1997, CELL, V89, P381, DOI 10.1016/S0092-8674(00)80219-6; Khapre RV, 2014, AGING-US, V6, P48, DOI 10.18632/aging.100633; Kitada M, 2013, BBA-GEN SUBJECTS, V1830, P4820, DOI 10.1016/j.bbagen.2013.06.014; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Kondratova AA, 2012, NAT REV NEUROSCI, V13, P325, DOI 10.1038/nrn3208; Liao CY, 2010, AGING CELL, V9, P92, DOI 10.1111/j.1474-9726.2009.00533.x; Luby MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037992; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; McNamara P, 2001, CELL, V105, P877, DOI 10.1016/S0092-8674(01)00401-9; Mercken EM, 2014, AGING CELL, V13, P193, DOI 10.1111/acel.12151; Musiek ES, 2013, J CLIN INVEST, V123, P5389, DOI 10.1172/JCI70317; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Nogueira LM, 2012, CANCER MED-US, V1, P275, DOI 10.1002/cam4.23; Pekovic-Vaughan V, 2014, GENE DEV, V28, P548, DOI 10.1101/gad.237081.113; Piper MDW, 2008, CELL METAB, V8, P99, DOI 10.1016/j.cmet.2008.06.012; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Ravussin E, 2015, J GERONTOL A-BIOL, V70, P1097, DOI 10.1093/gerona/glv057; Redman LM, 2011, ANTIOXID REDOX SIGN, V14, P275, DOI 10.1089/ars.2010.3253; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Taormina G, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/308690; Wang Y, 2014, DIABETES METAB J, V38, P321, DOI 10.4093/dmj.2014.38.5.321	46	55	55	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2016	30	4					1634	1642		10.1096/fj.15-282475	http://dx.doi.org/10.1096/fj.15-282475			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DH2PR	26700733	Green Published			2022-12-26	WOS:000372629100024
J	Kotzsch, A; Pawolski, D; Milentyev, A; Shevchenko, A; Scheffel, A; Poulsen, N; Shevchenko, A; Kroger, N				Kotzsch, Alexander; Pawolski, Damian; Milentyev, Alexander; Shevchenko, Anna; Scheffel, Andre; Poulsen, Nicole; Shevchenko, Andrej; Kroeger, Nils			Biochemical Composition and Assembly of Biosilica-associated Insoluble Organic Matrices from the Diatom Thalassiosira pseudonana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						algae; biomineralization; cell wall; intrinsically disordered protein; morphogenesis; post-translational modification (PTM); protein self-assembly; proteomics	SILICA BIOMINERALIZATION; PROTEIN IDENTIFICATION; AMINO-ACID; SILAFFINS; PRECIPITATION; MORPHOGENESIS; MORPHOLOGY; LESSONS; BIOLOGY	The nano- and micropatterned biosilica cell walls of diatoms are remarkable examples of biological morphogenesis and possess highly interesting material properties. Only recently has it been demonstrated that biosilica-associated organic structures with specific nanopatterns (termed insoluble organic matrices) are general components of diatom biosilica. The model diatom Thalassiosira pseudonana contains three types of insoluble organic matrices: chitin meshworks, organic microrings, and organic microplates, the latter being described in the present study for the first time. To date, little is known about the molecular composition, intracellular assembly, and biological functions of organic matrices. Here we have performed structural and functional analyses of the organic microrings and organic microplates from T. pseudonana. Proteomics analysis yielded seven proteins of unknown function (termed SiMat proteins) together with five known silica biomineralization proteins (four cingulins and one silaffin). The location of SiMat1-GFP in the insoluble organic microrings and the similarity of tyrosine- and lysine-rich functional domains identifies this protein as a new member of the cingulin protein family. Mass spectrometric analysis indicates that most of the lysine residues of cingulins and the other insoluble organic matrix proteins are post-translationally modified by short polyamine groups, which are known to enhance the silica formation activity of proteins. Studies with recombinant cingulins (rCinY2 and rCinW2) demonstrate that acidic conditions (pH 5.5) trigger the assembly of mixed cingulin aggregates that have silica formation activity. Our results suggest an important role for cingulins in the biogenesis of organic microrings and support the hypothesis that this type of insoluble organic matrix functions in biosilica morphogenesis.	[Kotzsch, Alexander; Pawolski, Damian; Poulsen, Nicole; Kroeger, Nils] Tech Univ Dresden, B CUBE Ctr Mol Bioengn, Arnoldstr 18, D-01307 Dresden, Germany; [Kroeger, Nils] Tech Univ Dresden, Dept Chem & Food Chem, D-01307 Dresden, Germany; [Milentyev, Alexander; Shevchenko, Anna; Shevchenko, Andrej] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Scheffel, Andre] Max Planck Inst Plant Physiol, D-14476 Potsdam, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Max Planck Society; Max Planck Society	Kroger, N (corresponding author), Tech Univ Dresden, B CUBE Ctr Mol Bioengn, Arnoldstr 18, D-01307 Dresden, Germany.	kroeger@bcube-dresden.de		Poulsen, Nicole/0000-0002-4533-8860	Deutsche Forschungsgemeinschaft through Research Unit NANOMEE [KR 1853/6-1, SH 94/4-1, 2038]; Max-Planck-Gesellschaft	Deutsche Forschungsgemeinschaft through Research Unit NANOMEE(German Research Foundation (DFG)); Max-Planck-Gesellschaft(Max Planck Society)	This work was supported by the Deutsche Forschungsgemeinschaft through Research Unit 2038 NANOMEE (Grants KR 1853/6-1 and SH 94/4-1). Work in the laboratory of Andrej Shevchenko was supported by the Max-Planck-Gesellschaft. The authors declare that they have no conflicts of interest with the contents of this article.	Assmy P, 2013, P NATL ACAD SCI USA, V110, P20633, DOI 10.1073/pnas.1309345110; Bauerlein E, 2003, ANGEW CHEM INT EDIT, V42, P614, DOI 10.1002/anie.200390176; Belton D, 2004, J MATER CHEM, V14, P2231, DOI 10.1039/b401882f; Bidle KD, 1999, NATURE, V397, P508, DOI 10.1038/17351; Brunner E, 2009, ANGEW CHEM INT EDIT, V48, P9724, DOI 10.1002/anie.200905028; Buhmann MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110369; BUSS JE, 1983, METHOD ENZYMOL, V99, P7; Davis AK, 2005, J PHYCOL, V41, P577, DOI 10.1111/j.1529-8817.2005.00076.x; Dill KA, 2011, P NATL ACAD SCI USA, V108, P17876, DOI 10.1073/pnas.1114477108; Dionex, 2009, 03148113 DION, P33; Foo CWP, 2004, TRENDS BIOTECHNOL, V22, P577, DOI 10.1016/j.tibtech.2004.09.011; Frigeri LG, 2006, MOL CELL PROTEOMICS, V5, P182, DOI 10.1074/mcp.M500174-MCP200; Gordon R, 2009, TRENDS BIOTECHNOL, V27, P116, DOI 10.1016/j.tibtech.2008.11.003; Habermann B, 2004, MOL CELL PROTEOMICS, V3, P238, DOI 10.1074/mcp.M300073-MCP200; Hamm CE, 2003, NATURE, V421, P841, DOI 10.1038/nature01416; HECKY RE, 1973, MAR BIOL, V19, P323, DOI 10.1007/BF00348902; Hildebrand M, 2008, CHEM REV, V108, P4855, DOI 10.1021/cr078253z; Hildebrand M, 2006, J MATER RES, V21, P2689, DOI 10.1557/JMR.2006.0333; Iler R. K, 1979, CHEM SILICA, P97; Jeffryes C, 2011, ENERG ENVIRON SCI, V4, P3930, DOI 10.1039/c0ee00306a; Junqueira M, 2008, J PROTEOMICS, V71, P346, DOI 10.1016/j.jprot.2008.07.003; Kroger N, 2007, CURR OPIN CHEM BIOL, V11, P662, DOI 10.1016/j.cbpa.2007.10.009; Kroger N, 2014, WIRES NANOMED NANOBI, V6, P615, DOI 10.1002/wnan.1284; Kroger N, 2010, MRS BULL, V35, P122, DOI 10.1557/mrs2010.631; Kroger N, 2008, ANNU REV GENET, V42, P83, DOI 10.1146/annurev.genet.41.110306.130109; Kroger N, 1999, SCIENCE, V286, P1129, DOI 10.1126/science.286.5442.1129; Kroger N, 2000, P NATL ACAD SCI USA, V97, P14133, DOI 10.1073/pnas.260496497; Kroger N, 2002, SCIENCE, V298, P584, DOI 10.1126/science.1076221; Kroger N, 1998, PROTIST, V149, P213, DOI 10.1016/S1434-4610(98)70029-X; KROGER N, 1994, EMBO J, V13, P4676, DOI 10.1002/j.1460-2075.1994.tb06791.x; Kroger N, 2006, ANGEW CHEM INT EDIT, V45, P7239, DOI 10.1002/anie.200601871; Lechner CC, 2015, MAR DRUGS, V13, P5297, DOI 10.3390/md13085297; Lechner CC, 2014, J PEPT SCI, V20, P152, DOI 10.1002/psc.2577; Lopez PJ, 2005, CURR NANOSCI, V1, P73, DOI 10.2174/1573413052953156; Losic D, 2009, ADV MATER, V21, P2947, DOI 10.1002/adma.200803778; Lowenstam HA, 1989, BIOMINERALIZATION; Mizutani T, 1998, B CHEM SOC JPN, V71, P2017, DOI 10.1246/bcsj.71.2017; Mock T, 2008, P NATL ACAD SCI USA, V105, P1579, DOI 10.1073/pnas.0707946105; MORT AJ, 1977, ANAL BIOCHEM, V82, P289, DOI 10.1016/0003-2697(77)90165-8; NAKAJIMA T, 1969, SCIENCE, V164, P1400, DOI 10.1126/science.164.3886.1400; Nassif N, 2011, CHEM SOC REV, V40, P849, DOI 10.1039/c0cs00122h; Nemoto M, 2014, MAR GENOM, V16, P39, DOI 10.1016/j.margen.2014.01.006; Parkinson J, 1999, TRENDS BIOTECHNOL, V17, P190, DOI 10.1016/S0167-7799(99)01321-9; Poulsen N, 2004, J BIOL CHEM, V279, P42993, DOI 10.1074/jbc.M407734200; Poulsen N, 2003, P NATL ACAD SCI USA, V100, P12075, DOI 10.1073/pnas.2035131100; Poulsen N, 2006, J PHYCOL, V42, P1059, DOI 10.1111/j.1529-8817.2006.00269.x; Poulsen N, 2014, BIOFOULING, V30, P513, DOI 10.1080/08927014.2014.895895; Poulsen N, 2013, J BIOL CHEM, V288, P20100, DOI 10.1074/jbc.M113.469379; RAVEN JA, 1983, BIOL REV, V58, P179, DOI 10.1111/j.1469-185X.1983.tb00385.x; Sandhage KH, 2010, JOM-US, V62, P32, DOI 10.1007/s11837-010-0085-8; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Scheffel A, 2011, P NATL ACAD SCI USA, V108, P3175, DOI 10.1073/pnas.1012842108; Shimizu K, 2001, CHEM BIOL, V8, P1051, DOI 10.1016/S1074-5521(01)00072-2; Shrestha RP, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-499; Sumper M, 2006, ADV FUNCT MATER, V16, P17, DOI 10.1002/adfm.200500616; Sumper M, 2008, CHEMBIOCHEM, V9, P1187, DOI 10.1002/cbic.200700764; Sumper M, 2007, ANGEW CHEM INT EDIT, V46, P8405, DOI 10.1002/anie.200702413; Tesson B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061675; Vrieling EG, 1999, J BIOTECHNOL, V70, P39, DOI 10.1016/S0168-1656(99)00056-5; Wenzl S, 2008, ANGEW CHEM INT EDIT, V47, P1729, DOI 10.1002/anie.200704994; Wielsch N, 2006, J PROTEOME RES, V5, P2448, DOI 10.1021/pr060200v; Wieneke R, 2011, ORG BIOMOL CHEM, V9, P5482, DOI 10.1039/c1ob05406f; Wilt FH, 2005, DEV BIOL, V280, P15, DOI 10.1016/j.ydbio.2005.01.019; Yang WR, 2011, ANALYST, V136, P42, DOI 10.1039/c0an00602e	64	35	35	4	69	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					4982	4997		10.1074/jbc.M115.706440	http://dx.doi.org/10.1074/jbc.M115.706440			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26710847	Green Published, hybrid			2022-12-26	WOS:000371640600014
J	Law, NC; Hunzicker-Dunn, ME				Law, Nathan C.; Hunzicker-Dunn, Mary E.			Insulin Receptor Substrate 1, the Hub Linking Follicle-stimulating Hormone to Phosphatidylinositol 3-Kinase Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-I; RAT GRANULOSA-CELLS; PROTEIN-KINASE-A; ACUTE REGULATORY PROTEIN; ELEMENT-BINDING PROTEIN; NF-KAPPA-B; STEROIDOGENIC FACTOR-I; SIDE-CHAIN CLEAVAGE; LUTEINIZING-HORMONE; SERINE/THREONINE PHOSPHORYLATION	The ubiquitous phosphatidylinositol 3-kinase (PI3K) signaling pathway regulates many cellular functions. However, the mechanism by which G protein-coupled receptors (GPCRs) signal to activate PI3K is poorly understood. We have used ovarian granulosa cells as a model to investigate this pathway, based on evidence that the GPCR agonist follicle-stimulating hormone (FSH) promotes the protein kinase A (PKA)-dependent phosphorylation of insulin receptor substrate 1 (IRS1) on tyrosine residues that activate PI3K. We report that in the absence of FSH, granulosa cells secrete a subthreshold concentration of insulin-like growth factor-1 (IGF-1) that primes the IGF-1 receptor (IGF-1R) but fails to promote tyrosine phosphorylation of IRS1. FSH via PKA acts to sensitize IRS1 to the tyrosine kinase activity of the IGF-1R by activating protein phosphatase 1 (PP1) to promote dephosphorylation of inhibitory Ser/Thr residues on IRS1, including Ser789. Knockdown of PP1 beta blocks the ability of FSH to activate PI3K in the presence of endogenous IGF-1. Activation of PI3K thus requires both PKA-mediated relief of IRS1 inhibition and IGF-1R-dependent tyrosine phosphorylation of IRS1. Treatment with FSH and increasing concentrations of exogenous IGF-1 triggers synergistic IRS1 tyrosine phosphorylation at PI3K-activating residues that persists downstream through protein kinase B (AKT) and FOXO1 (forkhead box protein O1) to drive synergistic expression of genes that underlies follicle maturation. Based on the ability of GPCR agonists to synergize with IGFs to enhance gene expression in other cell types, PP1 activation to relieve IRS1 inhibition may be a more general mechanism by which GPCRs act with the IGF-1R to activate PI3K/AKT.	[Law, Nathan C.; Hunzicker-Dunn, Mary E.] Washington State Univ, Sch Mol Biosci, Biotechnol Life Sci Bldg Rm 233, Pullman, WA 99164 USA	Washington State University	Hunzicker-Dunn, ME (corresponding author), Washington State Univ, Sch Mol Biosci, Biotechnol Life Sci Bldg Rm 233, Pullman, WA 99164 USA.	mehd@wsu.edu			National Institute of Health (NIH) [R01HD065859, R01HD062053, R01HD059901]; NIH [T32GM083864]; Poncin Scholarship Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059901, R01HD065859, R01HD062053] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM083864] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Poncin Scholarship Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by National Institute of Health (NIH) Grants R01HD065859 (to M. H. D.), R01HD062053 (to M. H. D.), and R01HD059901 (to A. J. Z.). N. C. L. was supported by NIH Grant T32GM083864 as well as the Poncin Scholarship Fund. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abel MH, 2000, ENDOCRINOLOGY, V141, P1795, DOI 10.1210/en.141.5.1795; ADASHI EY, 1985, ENDOCRINOLOGY, V116, P2135, DOI 10.1210/endo-116-6-2135; ADASHI EY, 1985, ENDOCRINOLOGY, V116, P2369, DOI 10.1210/endo-116-6-2369; ADASHI EY, 1985, ENDOCRINOLOGY, V117, P2313, DOI 10.1210/endo-117-6-2313; Alam H, 2004, J BIOL CHEM, V279, P19431, DOI 10.1074/jbc.M401235200; Alam H, 2009, ENDOCRINOLOGY, V150, P915, DOI 10.1210/en.2008-0850; Arif M, 2014, J BIOL CHEM, V289, P27677, DOI 10.1074/jbc.M114.565358; Baker J, 1996, MOL ENDOCRINOL, V10, P903, DOI 10.1210/me.10.7.903; Balasubramanian K, 1997, ENDOCRINOLOGY, V138, P433, DOI 10.1210/en.138.1.433; Baumgarten SC, 2015, J CLIN ENDOCR METAB, V100, pE1046, DOI 10.1210/jc.2015-1504; Bennett J, 2012, ENDOCRINOLOGY, V153, P2474, DOI 10.1210/en.2011-1969; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; BROWN JB, 1978, AUST NZ J OBSTET GYN, V18, P47, DOI 10.1111/j.1479-828X.1978.tb00011.x; Burns KH, 2001, ENDOCRINOLOGY, V142, P2742, DOI 10.1210/en.142.7.2742; Carlone DL, 1997, MOL ENDOCRINOL, V11, P292, DOI 10.1210/me.11.3.292; CHENG HC, 1986, J BIOL CHEM, V261, P989; Ciullo I, 2001, ONCOGENE, V20, P1186, DOI 10.1038/sj.onc.1204219; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; Cottom J, 2003, J BIOL CHEM, V278, P7167, DOI 10.1074/jbc.M203901200; CRAPARO A, 1995, J BIOL CHEM, V270, P15639, DOI 10.1074/jbc.270.26.15639; Cunningham MA, 2004, MOL ENDOCRINOL, V18, P1756, DOI 10.1210/me.2004-0071; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; De Gregorio G, 2007, ONCOGENE, V26, P2039, DOI 10.1038/sj.onc.1210011; Devoto L, 1999, MOL HUM REPROD, V5, P1003, DOI 10.1093/molehr/5.11.1003; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; Eimerl S, 2002, BIOL REPROD, V67, P900, DOI 10.1095/biolreprod.101.002170; Escamilla-Hernandez R, 2008, MOL ENDOCRINOL, V22, P1842, DOI 10.1210/me.2008-0103; Favelyukis S, 2001, NAT STRUCT BIOL, V8, P1058, DOI 10.1038/nsb721; Flynn MP, 2008, MOL ENDOCRINOL, V22, P1695, DOI 10.1210/me.2007-0457; Forbes Briony E, 2012, Front Endocrinol (Lausanne), V3, P38, DOI 10.3389/fendo.2012.00038; Fukushima T, 2011, MOL CELL ENDOCRINOL, V344, P81, DOI 10.1016/j.mce.2011.06.029; Garcia-Echeverria C, 2004, CANCER CELL, V5, P231, DOI 10.1016/S1535-6108(04)00051-0; Gonzalez-Robayna IJ, 2000, MOL ENDOCRINOL, V14, P1283, DOI 10.1210/me.14.8.1283; Hancer NJ, 2014, J BIOL CHEM, V289, P12467, DOI 10.1074/jbc.M114.554162; Hsueh AJ, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.112.099127; Hunzicker-Dunn M., 2015, PHYSL REPROD, V4th, P895; Hunzicker-Dunn M, 2006, CELL SIGNAL, V18, P1351, DOI 10.1016/j.cellsig.2006.02.011; Hunzicker-Dunn ME, 2012, P NATL ACAD SCI USA, V109, pE2979, DOI 10.1073/pnas.1205661109; Ito M, 2000, MOL ENDOCRINOL, V14, P66, DOI 10.1210/me.14.1.66; Kane LP, 2002, MOL CELL BIOL, V22, P5962, DOI 10.1128/MCB.22.16.5962-5974.2002; Koopman R, 2010, J PHYSIOL-LONDON, V588, P4811, DOI 10.1113/jphysiol.2010.196725; LaVoie HA, 1999, ENDOCRINOLOGY, V140, P146, DOI 10.1210/en.140.1.146; Law NC, 2013, MOL ENDOCRINOL, V27, P1295, DOI 10.1210/me.2013-1025; Lee AV, 2000, MOL CELL BIOL, V20, P1489, DOI 10.1128/MCB.20.5.1489-1496.2000; Li Q, 2013, MOL ENDOCRINOL, V27, P1468, DOI 10.1210/me.2013-1082; Li Y, 2004, J BIOL CHEM, V279, P45304, DOI 10.1074/jbc.C400186200; Liberman Z, 2005, J BIOL CHEM, V280, P4422, DOI 10.1074/jbc.M410610200; Liu ZL, 2009, MOL ENDOCRINOL, V23, P649, DOI 10.1210/me.2008-0412; Luo ML, 2005, ENDOCRINOLOGY, V146, P4410, DOI 10.1210/en.2005-0260; Mack EM, 2012, REPRODUCTION, V144, P595, DOI 10.1530/REP-12-0225; Mani AM, 2010, REPRODUCTION, V139, P139, DOI 10.1530/REP-09-0050; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; MATZUK MM, 1992, NATURE, V360, P313, DOI 10.1038/360313a0; Meinkoth J L, 1991, Thyroidology, V3, P103; Mothe I, 1996, J BIOL CHEM, V271, P11222, DOI 10.1074/jbc.271.19.11222; Mukherjee A, 1996, ENDOCRINOLOGY, V137, P3234, DOI 10.1210/en.137.8.3234; Murray AJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.122re4; Ning JY, 2010, MOL ENDOCRINOL, V24, P1218, DOI 10.1210/me.2009-0474; Parakh TN, 2006, P NATL ACAD SCI USA, V103, P12435, DOI 10.1073/pnas.0603006103; Park Y, 2005, J BIOL CHEM, V280, P9135, DOI 10.1074/jbc.M409486200; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Richards JS, 2002, MOL ENDOCRINOL, V16, P580, DOI 10.1210/me.16.3.580; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; RORDORFNIKOLIC T, 1995, J BIOL CHEM, V270, P3662, DOI 10.1074/jbc.270.8.3662; Russell DL, 2003, MOL ENDOCRINOL, V17, P520, DOI 10.1210/me.2002-0066; Salvador LM, 2001, J BIOL CHEM, V276, P40146, DOI 10.1074/jbc.M106710200; Schams D, 2001, EXP CLIN ENDOCR DIAB, V109, P155, DOI 10.1055/s-2001-14839; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Sekar N, 2000, MOL CELL ENDOCRINOL, V159, P25, DOI 10.1016/S0303-7207(99)00203-8; SHI H, 1995, MOL ENDOCRINOL, V9, P734, DOI 10.1210/me.9.6.734; Shi YJ, 2014, NAT STRUCT MOL BIOL, V21, P522, DOI 10.1038/nsmb.2828; SHOELSON SE, 1992, P NATL ACAD SCI USA, V89, P2027, DOI 10.1073/pnas.89.6.2027; Slinker BK, 1998, J MOL CELL CARDIOL, V30, P723, DOI 10.1006/jmcc.1998.0655; Sun XJ, 2009, VITAM HORM, V80, P351, DOI 10.1016/S0083-6729(08)00613-4; Swingle Mark, 2007, V365, P23; Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104; Tsui S, 2008, J IMMUNOL, V181, P4397, DOI 10.4049/jimmunol.181.6.4397; Tzatsos A, 2007, J BIOL CHEM, V282, P18069, DOI 10.1074/jbc.M610101200; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Wang XL, 2012, J BIOL CHEM, V287, P10166, DOI 10.1074/jbc.M111.293274; Zeleznik AJ, 2003, ENDOCRINOLOGY, V144, P3985, DOI 10.1210/en.2003-0293; Zeleznik Anthony J, 2004, Reprod Biol Endocrinol, V2, P31, DOI 10.1186/1477-7827-2-31; Zhang FP, 2001, MOL ENDOCRINOL, V15, P172, DOI 10.1210/me.15.1.172; Zhou P, 2013, MOL ENDOCRINOL, V27, P511, DOI 10.1210/me.2012-1307	85	27	28	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4547	4560		10.1074/jbc.M115.698761	http://dx.doi.org/10.1074/jbc.M115.698761			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26702053	hybrid, Green Published			2022-12-26	WOS:000371604600024
J	Hassan, RH; de Sousa, ACP; Mahfouz, R; Hainault, I; Blachnio-Zabielska, A; Bourron, O; Koskas, F; Gorski, J; Ferre, P; Foufelle, F; Hajduch, E				Hassan, Rima Hage; de Sousa, Ana Catarina Pacheco; Mahfouz, Rana; Hainault, Isabelle; Blachnio-Zabielska, Agnieszka; Bourron, Olivier; Koskas, Fabien; Gorski, Jan; Ferre, Pascal; Foufelle, Fabienne; Hajduch, Eric			Sustained Action of Ceramide on the Insulin Signaling Pathway in Muscle Cells IMPLICATION OF THE DOUBLE-STRANDED RNA-ACTIVATED PROTEIN KINASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE FATTY-ACIDS; GLUCOSE-TRANSPORT; SERINE-307 PHOSPHORYLATION; MITOCHONDRIAL DYSFUNCTION; OXIDATIVE STRESS; PKC-ZETA; IN-VIVO; RESISTANCE; APOPTOSIS; RECEPTOR	In vivo, ectopic accumulation of fatty acids in muscles leads to alterations in insulin signaling at both the IRS1 and Akt steps. However, in vitro treatments with saturated fatty acids or their derivative ceramide demonstrate an effect only at the Akt step. In this study, we adapted our experimental procedures to mimic the in vivo situation and show that the double-stranded RNA-dependent protein kinase (PKR) is involved in the long-term effects of saturated fatty acids on IRS1. C2C12 or human muscle cells were incubated with palmitate or directly with ceramide for short or long periods, and insulin signaling pathway activity was evaluated. PKR involvement was assessed through pharmacological and genetic studies. Short-term treatments of myotubes with palmitate, a ceramide precursor, or directly with ceramide induce an inhibition of Akt, whereas prolonged periods of treatment show an additive inhibition of insulin signaling through increased IRS1 serine 307 phosphorylation. PKR mRNA, protein, and phosphorylation are increased in insulin-resistant muscles. When PKR activity is reduced (siRNA or a pharmacological inhibitor), serine phosphorylation of IRS1 is reduced, and insulin-induced phosphorylation of Akt is improved. Finally, we show that JNK mediates ceramide-activated PKR inhibitory action on IRS1. Together, in the long term, our results show that ceramide acts at two distinct levels of the insulin signaling pathway (IRS1 and Akt). PKR, which is induced by both inflammation signals and ceramide, could play a major role in the development of insulin resistance in muscle cells.	[Bourron, Olivier; Ferre, Pascal; Foufelle, Fabienne; Hajduch, Eric] INSERM, Unite Mixte Rech S 1138, Ctr Rech Cordeliers, F-75006 Paris, France; [Hassan, Rima Hage; de Sousa, Ana Catarina Pacheco; Mahfouz, Rana; Hainault, Isabelle; Bourron, Olivier; Ferre, Pascal; Foufelle, Fabienne; Hajduch, Eric] Univ Paris 06, Sorbonne Univ, Unite Mixte Rech S 1138, Ctr Rech Cordeliers, F-75006 Paris, France; [Hassan, Rima Hage; de Sousa, Ana Catarina Pacheco; Mahfouz, Rana; Hainault, Isabelle; Bourron, Olivier; Ferre, Pascal; Foufelle, Fabienne; Hajduch, Eric] Univ Paris 05, Sorbonne Paris Cite, Unite Mixte Rech S 1138, Ctr Rech Cordeliers, F-75006 Paris, France; [Blachnio-Zabielska, Agnieszka; Gorski, Jan] Med Univ Bialystok, Dept Physiol, PL-15222 Bialystok, Poland; [Blachnio-Zabielska, Agnieszka; Gorski, Jan] AP HP, Paris, France; [Bourron, Olivier] Hop La Pitie Salpetriere, Dept Diabetol & Malad Metab, F-75013 Paris, France; [Koskas, Fabien] Hop La Pitie Salpetriere, Serv Chirurg Vasc, F-75013 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Medical University of Bialystok; Assistance Publique Hopitaux Paris (APHP); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Hajduch, E (corresponding author), INSERM, Unite Mixte Rech S 1138, Ctr Rech Cordeliers, F-75006 Paris, France.	eric.hajduch@crc.jussieu.fr	Hajduch, Eric/B-7332-2008; Blachnio-Zabielsk, Agnieszka U/A-4879-2018; Górski, Jan/T-4828-2018; Ferré, Pascal/K-1250-2013	Hajduch, Eric/0000-0002-0125-7751; Blachnio-Zabielsk, Agnieszka U/0000-0002-8055-0576; Górski, Jan/0000-0001-9886-5069; Ferré, Pascal/0000-0003-0115-7045; Bourron, Olivier/0000-0001-7348-7161; FOUFELLE, Fabienne/0000-0002-0752-622X	INSERM; Societe Francophone du Diabete (an Association Nationale pour les Traitements a Domicile, les Innovations et la Recherche grant); Agence Nationale de la Recherche [ANR 11 BSV1 03101-Crisalis]; Fondation pour la Recherche Medicale [FRM DEQ20140329504]; French Ministry of Research	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Societe Francophone du Diabete (an Association Nationale pour les Traitements a Domicile, les Innovations et la Recherche grant); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); French Ministry of Research(Ministry of Research, FranceEuropean Commission)	This work was supported by INSERM, the Societe Francophone du Diabete (an Association Nationale pour les Traitements a Domicile, les Innovations et la Recherche grant), Agence Nationale de la Recherche Project ANR 11 BSV1 03101-Crisalis, and the Fondation pour la Recherche Medicale (equipe FRM DEQ20140329504). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by a fellowship from the French Ministry of Research.	Aas V, 2013, CELL TISSUE RES, V354, P671, DOI 10.1007/s00441-013-1655-1; Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Bartke N, 2009, J LIPID RES, V50, pS91, DOI 10.1194/jlr.R800080-JLR200; Bellini L, 2015, EXPERT OPIN THER TAR, V19, P1037, DOI 10.1517/14728222.2015.1028359; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Blachnio-Zabielska AU, 2012, RAPID COMMUN MASS SP, V26, P1134, DOI 10.1002/rcm.6216; Blair AS, 1999, J BIOL CHEM, V274, P36293, DOI 10.1074/jbc.274.51.36293; Blouin CM, 2010, DIABETES, V59, P600, DOI 10.2337/db09-0897; Carvalho BM, 2013, OBESITY, V21, P2452, DOI 10.1002/oby.20410; Carvalho MA, 2012, ENDOCRINOLOGY, V153, P5261, DOI 10.1210/en.2012-1400; Chavez JA, 2003, J BIOL CHEM, V278, P10297, DOI 10.1074/jbc.M212307200; Danielsson A, 2005, J BIOL CHEM, V280, P34389, DOI 10.1074/jbc.C500230200; Frangioudakis G, 2010, ENDOCRINOLOGY, V151, P4187, DOI 10.1210/en.2010-0250; GUSELLA GL, 1995, J IMMUNOL, V154, P345; Hage Hassan R, 2012, DIABETOLOGIA, V55, P204, DOI 10.1007/s00125-011-2328-9; Hajduch E, 2001, DIABETOLOGIA, V44, P173, DOI 10.1007/s001250051596; Hajduch E, 1998, DIABETES, V47, P1006, DOI 10.2337/diabetes.47.7.1006; Hajduch E, 1999, J BIOL CHEM, V274, P13563, DOI 10.1074/jbc.274.19.13563; Hajduch E, 2008, BIOCHEM J, V410, P369, DOI 10.1042/BJ20070936; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hassan RH, 2014, WORLD J DIABETES, V5, P244, DOI 10.4239/wjd.v5.i3.244; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Jaiswal N, 2015, EUR J PHARMACOL, V746, P70, DOI 10.1016/j.ejphar.2014.10.049; Jiang GQ, 2003, J BIOL CHEM, V278, P180, DOI 10.1074/jbc.M205565200; Kadotani A, 2009, AM J PHYSIOL-ENDOC M, V297, pE1291, DOI 10.1152/ajpendo.00293.2009; Lin SS, 2010, CYTOKINE, V50, P210, DOI 10.1016/j.cyto.2010.01.008; Litherland GJ, 2001, MOL MEMBR BIOL, V18, P195; Mahfouz R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101865; Nakamura T, 2014, DIABETES, V63, P526, DOI 10.2337/db13-1019; Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001; Ogretmen B, 2002, J BIOL CHEM, V277, P12960, DOI 10.1074/jbc.M110699200; Petersen KF, 2006, AM J MED, V119, p10S, DOI 10.1016/j.amjmed.2006.01.009; Peterson JM, 2008, AM J PHYSIOL-ENDOC M, V295, pE1307, DOI 10.1152/ajpendo.00738.2007; Powell DJ, 2004, BIOCHEM J, V382, P619, DOI 10.1042/BJ20040139; Powell DJ, 2003, MOL CELL BIOL, V23, P7794, DOI 10.1128/MCB.23.21.7794-7808.2003; Reynoso R, 2003, MOL CELL BIOCHEM, V246, P155, DOI 10.1023/A:1023423005187; Romano PR, 1998, MOL CELL BIOL, V18, P2282, DOI 10.1128/MCB.18.4.2282; Silveira LR, 2008, J CELL PHYSIOL, V217, P1, DOI 10.1002/jcp.21514; Taheripak G, 2013, FREE RADICAL BIO MED, V65, P1435, DOI 10.1016/j.freeradbiomed.2013.09.019; Tanti JF, 2004, ANN ENDOCRINOL-PARIS, V65, P43, DOI 10.1016/S0003-4266(04)95629-6; THOMIS DC, 1992, P NATL ACAD SCI USA, V89, P10837, DOI 10.1073/pnas.89.22.10837; Turban S, 2011, FEBS LETT, V585, P269, DOI 10.1016/j.febslet.2010.12.022; Ussher JR, 2010, DIABETES, V59, P2453, DOI 10.2337/db09-1293; Vilquin JT, 2005, GENE THER, V12, P1651, DOI 10.1038/sj.gt.3302565; Xu Z, 2000, MOL CELL BIOL, V20, P5285, DOI 10.1128/MCB.20.14.5285-5299.2000; Yang XR, 2010, MOL BIOL CELL, V21, P3449, DOI 10.1091/mbc.E10-06-0481; Yang XR, 2009, CELL RES, V19, P469, DOI 10.1038/cr.2009.25; Yuzefovych LV, 2012, ENDOCRINOLOGY, V153, P92, DOI 10.1210/en.2011-1442	48	44	44	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					3019	3029		10.1074/jbc.M115.686949	http://dx.doi.org/10.1074/jbc.M115.686949			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26698173	Green Published, hybrid			2022-12-26	WOS:000369626900038
J	Cen, H; Tan, XH; Guo, BP				Cen, Hong; Tan, Xiaohong; Guo, Baoping			A20 Mutation Is Not a Prognostic Marker for Activated B-Cell-Like Diffuse Large B-Cell Lymphoma	PLOS ONE			English	Article							NF-KAPPA-B; HODGKIN-LYMPHOMA; TNFAIP3 A20; GENE; RECEPTOR; SUBGROUPS; DELETIONS; RESPONSES; CARMA1; FAMILY	Background Constitutive activation of nuclear factor kappa B (NF-kappa B) is a hallmark of activated B-cell-like diffuse large B-cell lymphoma (ABC-DLBCL). Mutations in the A20 gene activate NF-kappa B, but the prognostic value of A20 mutations in ABC-DLBLC is unclear. Purpose To investigate the prognostic value of A20 mutation in ABC-DLBCL patients. Methods The somatic mutation of A20 was investigated in 68 de novo ABC-DLBCLs by PCR/sequencing. The Kaplan-Meier method was used to estimate median overall survival (OS) and progression-free survival (PFS). Results The A20 mutation rate in ABC-DLBCL patients was 29.4%. Complete remission rates were 35% and 45.8% in patients with and without A20 mutations, respectively (P = 0.410). In patients with and without A20 mutations, the median OS was 24.0 and 30.6 months, respectively (P = 0.58), and the median PFS was 15 and 17.4 months, respectively (P = 0.52). None of the differences between the patient groups were significant. Conclusions Our findings suggested that the A20 mutation is a frequent event in ABC-DLBCLs. However, there was no significant difference in PFS and OS in patients with or without A20 mutations. Further study is required to completely exclude A20 somatic mutation as a prognostic marker in the ABC subtype of DLBLC.	[Cen, Hong; Tan, Xiaohong; Guo, Baoping] Guangxi Med Univ, Tumor Hosp, Dept Chemotherapy, Nanning, Guangxi, Peoples R China	Guangxi Medical University	Cen, H (corresponding author), Guangxi Med Univ, Tumor Hosp, Dept Chemotherapy, Nanning, Guangxi, Peoples R China.	cen_hong@163.com			National Natural Science Foundation of China [81160298]; Health Department of Guangxi Province [2011077]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Health Department of Guangxi Province	This work was supported by the National Natural Science Foundation of China (81160298) and Key Grant of Health Department of Guangxi Province (2011077). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Berglund M, 2005, MODERN PATHOL, V18, P1113, DOI 10.1038/modpathol.3800396; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Davis RE, 2010, NATURE, V463, P88, DOI 10.1038/nature08638; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; Dong GH, 2011, CLIN CANCER RES, V17, P1440, DOI 10.1158/1078-0432.CCR-10-1859; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; GAIDANO G, 1992, BLOOD, V80, P1781, DOI 10.1182/blood.V80.7.1781.bloodjournal8071781; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Honma K, 2008, GENE CHROMOSOME CANC, V47, P1, DOI 10.1002/gcc.20499; Honma K, 2009, BLOOD, V114, P2467, DOI 10.1182/blood-2008-12-194852; Johnson AD, 2005, PHARMACOL THERAPEUT, V106, P19, DOI 10.1016/j.pharmthera.2004.11.001; Kato M, 2009, NATURE, V459, P712, DOI 10.1038/nature07969; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Lam LT, 2005, CLIN CANCER RES, V11, P28; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lepper ER, 2005, PHARMACOGENOMICS, V6, P115, DOI 10.1517/14622416.6.2.115; Monti S, 2005, BLOOD, V105, P1851, DOI 10.1182/blood-2004-07-2947; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Novak U, 2009, BLOOD, V113, P4918, DOI 10.1182/blood-2008-08-174110; Paik JH, 2013, LEUKEMIA LYMPHOMA, V54, P1934, DOI 10.3109/10428194.2012.762511; Rawlings DJ, 2006, NAT REV IMMUNOL, V6, P799, DOI 10.1038/nri1944; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; ROTHE M, 1994, CELL, V78, P681, DOI 10.1016/0092-8674(94)90532-0; Schmitz R, 2009, J EXP MED, V206, P981, DOI 10.1084/jem.20090528; Thome M, 2003, TRENDS IMMUNOL, V24, P419, DOI 10.1016/S1471-4906(03)00177-7; van Imhoff GW, 2006, J CLIN ONCOL, V24, P4135, DOI 10.1200/JCO.2006.05.5897; Vereecke L, 2009, TRENDS IMMUNOL, V30, P383, DOI 10.1016/j.it.2009.05.007; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wright G, 2003, P NATL ACAD SCI USA, V100, P9991, DOI 10.1073/pnas.1732008100; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X	34	2	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145037	10.1371/journal.pone.0145037	http://dx.doi.org/10.1371/journal.pone.0145037			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716984	gold, Green Submitted, Green Published			2022-12-26	WOS:000367510500018
J	Keino, L; Baijukya, F; Ng'etich, W; Otinga, AN; Okalebo, JR; Njoroge, R; Mukalama, J				Keino, Ludy; Baijukya, Frederick; Ng'etich, Wilson; Otinga, Abigael N.; Okalebo, John R.; Njoroge, Ruth; Mukalama, John			Nutrients Limiting Soybean (glycine max l) Growth in Acrisols and Ferralsols of Western Kenya	PLOS ONE			English	Article							SYSTEMS	Low soybean yields in western Kenya have been attributed to low soil fertility despite much work done on nitrogen (N) and phosphorus (P) nutrition leading to suspicion of other nutrient limitations. To investigate this, a nutrient omission trial was set up in the greenhouse at the University of Eldoret-Kenya to diagnose the nutrients limiting soybean production in Acrisols from Masaba central and Butere sub-Counties, and Ferralsols from Kakamega (Shikhulu and Khwisero sub-locations) and Butula sub-Counties and to assess the effect of liming on soil pH and soybean growth. The experiment was laid out in a completely randomized design with ten treatments viz; positive control (complete), negative control (distilled water), complete with lime, complete with N, minus macronutrients P, potassium (K), calcium (Ca), magnesium (Mg) and sulphur (S) and with, micro-nutrients boron (B), molybdenum (Mo), manganese (Mn), copper (Cu) and zinc (Zn) omitted. Visual deficiency symptoms observed included interveinal leaf yellowing in Mg omission and N addition and dark green leaves in P omission. Nutrients omission resulted in their significantly low concentration in plant tissues than the complete treatment. Significantly (P <= 0.05) lower shoot dry weights (SDWs) than the complete treatment were obtained in different treatments; omission of K and Mg in Masaba and Shikhulu, Mg in Khwisero, K in Butere and, P, Mg and K in Butula. Nitrogen significantly improved SDWs in soils from Kakamega and Butula. Liming significantly raised soil pH by 9, 13 and 11% from 4.65, 4.91 and 4.99 in soils from Masaba, Butere and Butula respectively and soybean SDWs in soils from Butere. The results show that, poor soybean growth was due to K, Mg and P limitation and low pH in some soils. The results also signify necessity of application of small quantities of N for initial soybean use.	[Keino, Ludy; Ng'etich, Wilson; Otinga, Abigael N.; Okalebo, John R.; Njoroge, Ruth] Univ Eldoret, Dept Soil Sci, Eldoret, Kenya; [Baijukya, Frederick] Int Inst Trop Agr, Dar Es Salaam, Tanzania; [Mukalama, John] Ctr Int Agr Trop, Nairobi, Kenya	Alliance; International Center for Tropical Agriculture - CIAT	Keino, L (corresponding author), Univ Eldoret, Dept Soil Sci, Eldoret, Kenya.	ludykeino@yahoo.com	Ng'etich, Wilson/AAI-4541-2021	Ng'etich, Wilson/0000-0002-2650-3648; Otinga, Abigael/0000-0003-1624-2648	N2Africa [OPP1020032(13-1947)]	N2Africa	This study was funded by N2Africa, grant number OPP1020032(13-1947) (http://www.N2Africa.org).	Adekunle, 2013, EFFECT NITROGEN NUTR, V5, P79; Anderson N.P., 2013, STATE U EXT SERV, pEM 9061; Andric L, 2012, TURK J AGRIC FOR, V36, P415, DOI 10.3906/tar-1107-23; Baijukya F., 2010, RES DISSEMINATION MO; Chianu J.N., 2009, J SUSTAINABLE DEV AF, V10, P1520; Dumas J. B. A, 1831, ANN CHIM PHYS, V2, P198; Foli S, 2012, THESIS; FOX R L, 1970, Soil Science Society of America Proceedings, V34, P902; Giller K.E., 2001, NITROGEN FIXATION TR, V2nd ed., DOI [DOI 10.1079/9780851994178.0000, 10.1079/9780851994178.0000]; Hoagland D. R., 1950, CALIFORNIA AGR EXPT, P1; Husnjak S, 2002, ROST VYROBA, V48, P249; Jaetzold R, 2005, FARMMANAGEMENT HDB K, V2; Janssen B.H., 1974, TROP AGR, V51, P160; JANSSEN BH, 1990, DEV PLANT SOIL SCI, V41, P759; Kanyanjua S.M., 2002, 11 KARI; Kiplagat J.K., 2010, 2 RUF BIENN M 20 24; Kiplagat K.J., 2013, THESIS; Kisinyo P. O., 2013, Sustainable Agriculture Research, V2, P116; Mahasi J.M., 2011, AFRICAN CROP SCI C P, V10, P111; Malavolta E., 2007, Better Crops with Plant Food, V91, P26; Marschner H., 1995, MINERAL NUTR HIGHER, V2nd ed.; Marschner P, 2011, SOIL BIOL BIOCHEM, V43, P883, DOI 10.1016/j.soilbio.2011.01.005; Mauyo Lianda Wanyonyi, 2010, Journal of Service Science and Management, V3, P501, DOI 10.4236/jssm.2010.34057; Mburu M.W., 2011, AFR CROP SCI P, V10, P1; Moore A, 2014, AGRON J, V106, P73, DOI 10.2134/agronj2013.0345; Myaka F. A., 2005, P 1 NAT SOYB STAK WO; Nanthi S.B., 2003, SOIL ACIDIFICATION L; Ohyama T., 2011, EFFECT NITRATE NODUL; Okalebo J. R., 2002, LOB METHODS SOIL PLA; Otieno P. E., 2009, Journal of Biological Sciences, V9, P326, DOI 10.3923/jbs.2009.326.332; Paradiso R, 2012, ADV SPACE RES, V50, P1501, DOI 10.1016/j.asr.2012.07.025; Robert L.M., 2004, BALANCED CROP NUTRIT; Roy R.N., 2006, PLANT NUTR FOOD SECU, DOI [10.1017/S0014479706394537, DOI 10.1017/S0014479706394537]; Ruiz Diaz D.A., 2011, DIAGNOSING NUTRIENT; Rutgers, 2013, COMM VEG PROD REC NE; Sabbe W. E., 2011, SO COOP SER B, V394, P33; Salvagiotti F., 2008, NITROGEN UPTAKE FIXA; Sanginga N, 2003, PLANT SOIL, V252, P25, DOI 10.1023/A:1024192604607; Saud H.M., 2012, INT J LIFE SCI BIOTE, V1, P2250; Seitz T., 2013, THESIS; Shavrukov Y, 2012, HYDROPONICS STANDARD; Slaton N., 2011, ARKANSAS SOYBEAN PRO; Stevens G., 2002, CROP NUTRIENT DEFICI; Thuita M., 2012, J BIOL FERTILITY SOI, V48, P78; Uchida R., 2000, PLANT NUTR MANAGEMEN, P31; Vanlauwe B., 2003, AFR CROP SCI C P, V6, P58; Verde B., 2013, INT J AGR SCI RES, V2, P283; Wietske V., 2012, THESIS; Workneh Bekere, 2013, International Journal of Soil Science, V8, P25	49	16	17	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145202	10.1371/journal.pone.0145202	http://dx.doi.org/10.1371/journal.pone.0145202			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716825	Green Published, gold, Green Submitted			2022-12-26	WOS:000367510500025
J	Le, TD; Zhang, JP; Liu, L; Liu, HW; Li, JY				Le, Thuc Duy; Zhang, Junpeng; Liu, Lin; Liu, Huawen; Li, Jiuyong			miRLAB: An R Based Dry Lab for Exploring miRNA-mRNA Regulatory Relationships	PLOS ONE			English	Article							INFERRING MICRORNA; PROTEIN; CANCER; REGULARIZATION; NETWORKS; RESOURCE; TARGETS; SYSTEMS; MODELS	microRNAs (miRNAs) are important gene regulators at post-transcriptional level, and inferring miRNA-mRNA regulatory relationships is a crucial problem. Consequently, several computational methods of predicting miRNA targets have been proposed using expression data with or without sequence based miRNA target information. A typical procedure for applying and evaluating such a method is i) collecting matched miRNA and mRNA expression profiles in a specific condition, e.g. a cancer dataset from The Cancer Genome Atlas (TCGA), ii) applying the new computational method to the selected dataset, iii) validating the predictions against knowledge from literature and third-party databases, and comparing the performance of the method with some existing methods. This procedure is time consuming given the time elapsed when collecting and processing data, repeating the work from existing methods, searching for knowledge from literature and third-party databases to validate the results, and comparing the results from different methods. The time consuming procedure prevents researchers from quickly testing new computational models, analysing new datasets, and selecting suitable methods for assisting with the experiment design. Here, we present an R package, miRLAB, for automating the procedure of inferring and validating miRNA-mRNA regulatory relationships. The package provides a complete set of pipelines for testing new methods and analysing new datasets. miRLAB includes a pipeline to obtain matched miRNA and mRNA expression datasets directly from TCGA, 12 benchmark computational methods for inferring miRNA-mRNA regulatory relationships, the functions for validating the predictions using experimentally validated miRNA target data and miRNA perturbation data, and the tools for comparing the results from different computational methods.	[Le, Thuc Duy; Liu, Lin; Li, Jiuyong] Univ S Australia, Sch Informat Technol & Math Sci, Adelaide, SA 5001, Australia; [Zhang, Junpeng] Dali Univ, Fac Engn, Dali, Peoples R China; [Liu, Huawen] Zhejiang Normal Univ, Dept Comp Sci, Jinhua, Peoples R China	University of South Australia; Dali University; Zhejiang Normal University	Le, TD (corresponding author), Univ S Australia, Sch Informat Technol & Math Sci, Adelaide, SA 5001, Australia.	thuc.le@unisa.edu.au; jiuyong.li@unisa.edu.au	Le, Thuc Duy D/G-8444-2019; Zhang, Junpeng/E-4737-2013; Liu, Lin/ABD-1224-2020; Li, Jiuyong/AAY-2706-2020; Li, Jiuyong/A-8134-2008	Le, Thuc Duy D/0000-0002-9732-4313; Zhang, Junpeng/0000-0001-6127-9701; Liu, Lin/0000-0003-2843-5738; Li, Jiuyong/0000-0002-9023-1878; Li, Jiuyong/0000-0002-9023-1878	Australian Research Council [DP130104090]; Applied Basic Research Foundation of Science and Technology of Yunnan Province [2013FD038]	Australian Research Council(Australian Research Council); Applied Basic Research Foundation of Science and Technology of Yunnan Province	This work has been partially supported by Australian Research Council Discovery Project DP130104090, (JL and LL), and the Applied Basic Research Foundation of Science and Technology of Yunnan Province, No. 2013FD038 (JZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Cheng WY, 2013, ARXIV PREPRINT ARXIV; Darnell RB, 2010, WIRES RNA, V1, P266, DOI 10.1002/wrna.31; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; HOEFFDING W, 1948, ANN MATH STAT, V19, P546, DOI 10.1214/aoms/1177730150; Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266; Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; Konig J, 2012, NAT REV GENET, V13, P77, DOI 10.1038/nrg3141; Le TD, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-92; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li Y, 2013, BIOINFORMATICS; Li Y, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku182; Liu B, 2014, BRIEF BIOINFORM, V15, P1, DOI 10.1093/bib/bbs075; Liu B, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-408; Liu HQ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-51; Lopez-Paz D., 2013, ADV NEURAL INFORM PR, V26, P1, DOI DOI 10.1214/A0S/1176345528; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu YM, 2011, BIOINFORMATICS, V27, P2406, DOI 10.1093/bioinformatics/btr410; Maathuis MH, 2010, NAT METHODS, V7, P247, DOI 10.1038/nmeth0410-247; Maathuis MH, 2009, ANN STAT, V37, P3133, DOI 10.1214/09-AOS685; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; MOON YI, 1995, PHYS REV E, V52, P2318, DOI 10.1103/PhysRevE.52.2318; Muniategui A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030766; Paraskevopoulou MD, 2013, NUCLEIC ACIDS RES, V41, pW169, DOI 10.1093/nar/gkt393; Pearson K, 1920, BIOMETRIKA, V13, P25, DOI 10.1093/biomet/13.1.25; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sokilde R, 2011, MOL CANCER THER, V10, P375, DOI 10.1158/1535-7163.MCT-10-0605; Spearman C, 1904, AM J PSYCHOL, V15, P201, DOI 10.2307/1412107; Speed T, 2011, SCIENCE, V334, P1502, DOI 10.1126/science.1215894; Szekely GJ, 2007, ANN STAT, V35, P2769, DOI 10.1214/009053607000000505; Le TD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131627; Le TD, 2015, BRIEF BIOINFORM, V16, P475, DOI 10.1093/bib/bbu023; Le TD, 2013, BIOINFORMATICS, V29, P765, DOI 10.1093/bioinformatics/btt048; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Van der Auwera I, 2010, BRIT J CANCER, V103, P532, DOI 10.1038/sj.bjc.6605787; Vergoulis T, 2012, NUCLEIC ACIDS RES, V40, pD222, DOI 10.1093/nar/gkr1161; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yu K, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S17-S6; Zhang JP, 2014, J BIOMED INFORM, V52, P438, DOI 10.1016/j.jbi.2014.08.005; Zhu YT, 2014, NAT METHODS, V11, P599, DOI 10.1038/nmeth.2956; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	49	18	18	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145386	10.1371/journal.pone.0145386	http://dx.doi.org/10.1371/journal.pone.0145386			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716983	Green Published, Green Submitted, gold			2022-12-26	WOS:000367510500034
J	Tyrka, M; Tyrka, D; Wedzony, M				Tyrka, Miroslaw; Tyrka, Dorota; Wedzony, Maria			Genetic Map of Triticale Integrating Microsatellite, DArT and SNP Markers	PLOS ONE			English	Article							ARRAYS TECHNOLOGY DART; WINTER TRITICALE; LINKAGE MAP; SEGREGATION DISTORTION; DIVERSITY ARRAYS; COMBINING ABILITY; AGRONOMIC TRAITS; WHEAT; GENOME; IDENTIFICATION	Triticale (xTriticosecale Wittm) is an economically important crop for fodder and biomass production. To facilitate the identification of markers for agronomically important traits and for genetic and genomic characteristics of this species, a new high-density genetic linkage map of triticale was constructed using doubled haploid (DH) population derived from a cross between cultivars 'Hewo' and 'Magnat'. The map consists of 1615 bin markers, that represent 50 simple sequence repeat (SSR), 842 diversity array technology (DArT), and 16888 DArTseq markers mapped onto 20 linkage groups assigned to the A, B, and R genomes of triticale. No markers specific to chromosome 7R were found, instead mosaic linkage group composed of 1880 highly distorted markers (116 bins) from 10 wheat chromosomes was identified. The genetic map covers 4907 cM with a mean distance between two bins of 3.0 cM. Comparative analysis in respect to published maps of wheat, rye and triticale revealed possible deletions in chromosomes 4B, 5A, and 6A, as well as inversion in chromosome 7B. The number of bin markers in each chromosome varied from 24 in chromosome 3R to 147 in chromosome 6R. The length of individual chromosomes ranged between 50.7 cM for chromosome 2R and 386.2 cM for chromosome 7B. A total of 512 (31.7%) bin markers showed significant (P < 0.05) segregation distortion across all chromosomes. The number of 8 the segregation distorted regions (SDRs) were identified on 1A, 7A, 1B, 2B, 7B (2 SDRs), 5R and 6R chromosomes. The high-density genetic map of triticale will facilitate fine mapping of quantitative trait loci, the identification of candidate genes and map-based cloning.	[Tyrka, Miroslaw; Tyrka, Dorota] Rzeszow Univ Technol, Fac Chem, Dept Biochem & Biotechnol, Rzeszow, Poland; [Wedzony, Maria] Pedag Univ Krakow, Fac Geog & Biol, Inst Biol, Krakow, Poland; [Wedzony, Maria] Polish Acad Sci, Inst Plant Physiol, Krakow, Poland	Rzeszow University of Technology; Pedagogical University of Cracow; Polish Academy of Sciences; Franciszek Gorski Institute of Plant Physiology Polish Academy of Sciences	Tyrka, M (corresponding author), Rzeszow Univ Technol, Fac Chem, Dept Biochem & Biotechnol, Rzeszow, Poland.	mtyrka@prz.edu.pl		Tyrka, Miroslaw/0000-0002-6051-5079; Wedzony, Maria/0000-0001-5911-2208	Ministry of Science and Higher Education [PBZ-MNiSW-2/3/2006/20]; National Centre for Research and Development [PBS1/A8/1/2012]	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); National Centre for Research and Development(National Centre for Research & Development, Poland)	This work was supported by grant number PBZ-MNiSW-2/3/2006/20, Ministry of Science and Higher Education, http://www.nauka.gov.pl/en/ (MW) grant number PBS1/A8/1/2012, The National Centre for Research and Development (MT)	Akbari M, 2006, THEOR APPL GENET, V113, P1409, DOI 10.1007/s00122-006-0365-4; Alheit KV, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-380; Apolinarska B, 1996, DEV PLANT BREED, V5, P189; Badea A, 2011, THEOR APPL GENET, V122, P1547, DOI 10.1007/s00122-011-1554-3; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Bartos J, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-95; Bolibok-Bragoszewska H, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-578; Camacho JPM, 2000, PHILOS T R SOC B, V355, P163, DOI 10.1098/rstb.2000.0556; Chu CG, 2008, MOL BREEDING, V22, P251, DOI 10.1007/s11032-008-9171-9; Courtois B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078037; Cui F, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-57; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Fiust A, 2015, J APPL GENET, V56, P299, DOI 10.1007/s13353-015-0273-x; Fu Y, 2010, PLANT J, V62, P898, DOI 10.1111/j.1365-313X.2010.04196.x; Gonzalez JM, 2005, GENOME, V48, P999, DOI [10.1139/G05-064, 10.1139/g05-064]; Goral H, 2002, CEREAL RES COMMUN, V30, P31; GRANER A, 1991, THEOR APPL GENET, V83, P250, DOI 10.1007/BF00226259; Hackauf B, 2009, THEOR APPL GENET, V118, P371, DOI 10.1007/s00122-008-0906-0; Hackauf B, 2002, PLANT BREEDING, V121, P17, DOI 10.1046/j.1439-0523.2002.00649.x; Jaccoud D, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.4.e25; Jones RN, 1995, NEW PHYTOL, V131, P411, DOI 10.1111/j.1469-8137.1995.tb03079.x; Korzun V, 2001, THEOR APPL GENET, V102, P709, DOI 10.1007/s001220051701; Korzun V, 1998, THEOR APPL GENET, V96, P203, DOI 10.1007/s001220050728; Li HH, 2008, THEOR APPL GENET, V116, P243, DOI 10.1007/s00122-007-0663-5; Loarce Y, 1996, THEOR APPL GENET, V93, P1112, DOI 10.1007/BF00230133; Lukaszewski AJ, 2003, CROP SCI, V43, P2316, DOI 10.2135/cropsci2003.2316; Manninen OM, 2000, THEOR APPL GENET, V100, P57, DOI 10.1007/s001220050008; Martis MM, 2012, P NATL ACAD SCI USA, V109, P13343, DOI 10.1073/pnas.1204237109; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; Milligan B. G., 1992, Molecular genetic analysis of populations: a practical approach., P59; NARANJO T, 1982, HEREDITY, V48, P57, DOI 10.1038/hdy.1982.6; Niedziela A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-67; Oettler G, 2005, CROP SCI, V45, P1476, DOI 10.2135/cropsci2004.0462; Oettler G, 2003, PLANT BREEDING, V122, P318, DOI 10.1046/j.1439-0523.2003.00877.x; Paillard S, 2003, THEOR APPL GENET, V107, P1235, DOI 10.1007/s00122-003-1361-6; Pestsova E, 2000, GENOME, V43, P689, DOI 10.1139/gen-43-4-689; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Pronyk C, 2011, BIORESOURCE TECHNOL, V102, P2016, DOI 10.1016/j.biortech.2010.09.064; Puertas MJ, 1998, HEREDITY, V80, P209, DOI 10.1046/j.1365-2540.1998.00293.x; Raman H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101673; Ren RS, 2015, MOL GENET GENOMICS, V290, P1457, DOI 10.1007/s00438-015-0997-7; Roder MS, 1998, GENETICS, V149, P2007; Saal B, 1999, GENOME, V42, P964, DOI 10.1139/gen-42-5-964; Saintenac C, 2013, G3-GENES GENOM GENET, V3, P1105, DOI 10.1534/g3.113.005819; Saintenac C, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r88; Semagn K, 2006, GENOME, V49, P545, DOI 10.1139/G06-002; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Stojalowski S, 2013, J APPL GENET, V54, P179, DOI 10.1007/s13353-013-0144-2; Szechynska-Hebda M, 2013, PLANT PATHOL, V62, P867, DOI 10.1111/ppa.12001; Taketa S, 1993, P 8 INT WHEAT GEN S, P287; Tams SH, 2006, PLANT BREEDING, V125, P331, DOI 10.1111/j.1439-0523.2006.01218.x; TARKOWSKI C, 1992, HEREDITAS, V116, P281, DOI 10.1111/j.1601-5223.1992.tb00155.x; Trebbi D, 2011, THEOR APPL GENET, V123, P555, DOI 10.1007/s00122-011-1607-7; Tyrka M, 2011, GENOME, V54, P391, DOI [10.1139/g11-009, 10.1139/G11-009]; Tyrka Miroslaw, 2004, Journal of Applied Genetics, V45, P283; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; van Orsouw NJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001172; Van Os H, 2005, THEOR APPL GENET, V112, P30, DOI 10.1007/s00122-005-0097-x; van Os H, 2006, GENETICS, V173, P1075, DOI 10.1534/genetics.106.055871; van Poecke RMP, 2013, PLANT BIOTECHNOL J, V11, P809, DOI 10.1111/pbi.12072; Wedzony M, 1998, PLANT BREEDING, V117, P211, DOI 10.1111/j.1439-0523.1998.tb01928.x; Wenzl P, 2004, P NATL ACAD SCI USA, V101, P9915, DOI 10.1073/pnas.0401076101; Wicker T, 2011, PLANT CELL, V23, P1706, DOI 10.1105/tpc.111.086629; Winfield MO, 2012, PLANT BIOTECHNOL J, V10, P733, DOI 10.1111/j.1467-7652.2012.00713.x; Zhang L, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-69; ZIVY M, 1992, THEOR APPL GENET, V83, P919, DOI 10.1007/BF00226716	66	19	20	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145714	10.1371/journal.pone.0145714	http://dx.doi.org/10.1371/journal.pone.0145714			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717308	Green Published, Green Submitted, gold			2022-12-26	WOS:000367510500060
J	Tillotson, BJ; Goulatis, LI; Parenti, I; Duxbury, E; Shusta, EV				Tillotson, Benjamin J.; Goulatis, Loukas I.; Parenti, Isabelle; Duxbury, Elizabeth; Shusta, Eric V.			Engineering an Anti-Transferrin Receptor ScFv for pH-Sensitive Binding Leads to Increased Intracellular Accumulation	PLOS ONE			English	Article							PROTEIN-SYNTHESIS INHIBITION; YEAST SURFACE DISPLAY; NEONATAL FC-RECEPTOR; IONIZATION MASS-SPECTROMETRY; HUMAN SERUM TRANSFERRIN; IRON RELEASE; IN-VIVO; SACCHAROMYCES-CEREVISIAE; QUANTITATIVE-ANALYSIS; ANTIBODY LIBRARIES	The equilibrium binding affinity of receptor-ligand or antibody-antigen pairs may be modulated by protonation of histidine side-chains, and such pH-dependent mechanisms play important roles in biological systems, affecting molecular uptake and trafficking. Here, we aimed to manipulate cellular transport of single-chain antibodies (scFvs) against the transferrin receptor (TfR) by engineering pH-dependent antigen binding. An anti-TfR scFv was subjected to histidine saturation mutagenesis of a single CDR. By employing yeast surface display with a pH-dependent screening pressure, scFvs having markedly increased dissociation from TfR at pH 5.5 were identified. The pH-sensitivity generally resulted from a central cluster of histidine residues in CDRH1. When soluble, pH-sensitive, scFv clone M16 was dosed onto live cells, the internalized fraction was 2.6-fold greater than scFvs that lacked pH-sensitive binding and the increase was dependent on endosomal acidification. Differences in the intracellular distribution of M16 were also observed consistent with an intracellular decoupling of the scFv M16-TfR complex. Engineered pH-sensitive TfR binding could prove important for increasing the effectiveness of TfR-targeted antibodies seeking to exploit endocytosis or transcytosis for drug delivery purposes.	[Tillotson, Benjamin J.; Goulatis, Loukas I.; Parenti, Isabelle; Duxbury, Elizabeth; Shusta, Eric V.] Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison	Shusta, EV (corresponding author), Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53705 USA.	eshusta@wisc.edu			UWCCC from the National Institutes of Health [P30 CA014520]; Defense Threat Reduction Agency [HDTRA1-15-1-0012]; National Science Foundation [CBET-0966014]; National Institutes of Health [NS071513]; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071513] Funding Source: NIH RePORTER	UWCCC from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grant NS071513, Defense Threat Reduction Agency grant HDTRA1-15-1-0012 and National Science Foundation grant CBET-0966014. Additionally, the UW-Madison Comprehensive Cancer Center (UWCCC) flow cytometry facility, is funded by UWCCC Support Grant P30 CA014520 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwal JK, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002254; Benatuil L, 2010, PROTEIN ENG DES SEL, V23, P155, DOI 10.1093/protein/gzq002; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Chaparro-Riggers J, 2012, J BIOL CHEM, V287, P11090, DOI 10.1074/jbc.M111.319764; CHITAMBAR CR, 1989, BLOOD, V74, P602; CIECHANOVER A, 1983, J BIOL CHEM, V258, P9681; Dall'Acqua WF, 2002, J IMMUNOL, V169, P5171, DOI 10.4049/jimmunol.169.9.5171; Dall'Acqua WF, 2006, J BIOL CHEM, V281, P23514, DOI 10.1074/jbc.M604292200; Daniels TR, 2006, CLIN IMMUNOL, V121, P144, DOI 10.1016/j.clim.2006.06.010; Daniels TR, 2006, CLIN IMMUNOL, V121, P159, DOI 10.1016/j.clim.2006.06.006; DAUTRYVARSAT A, 1983, P NATL ACAD SCI-BIOL, V80, P2258, DOI 10.1073/pnas.80.8.2258; Eckenroth BE, 2011, P NATL ACAD SCI USA, V108, P13089, DOI 10.1073/pnas.1105786108; Edgcomb SP, 2002, PROTEINS, V49, P1, DOI 10.1002/prot.10177; Gera N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048928; Giannetti AM, 2005, STRUCTURE, V13, P1613, DOI 10.1016/j.str.2005.07.016; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Gumerov DR, 2003, BIOCHEMISTRY-US, V42, P5421, DOI 10.1021/bi020660b; Hackel BJ, 2006, PHARM RES-DORDR, V23, P790, DOI 10.1007/s11095-006-9778-7; Igawa T, 2010, NAT BIOTECHNOL, V28, P1203, DOI 10.1038/nbt.1691; JOHNSON LS, 1993, MOL BIOL CELL, V4, P1251, DOI 10.1091/mbc.4.12.1251; Kulkarni MV, 2010, J BIOL CHEM, V285, P38524, DOI 10.1074/jbc.M110.172072; Lao BJ, 2007, J CONTROL RELEASE, V117, P403, DOI 10.1016/j.jconrel.2006.12.001; Leverence R, 2010, P NATL ACAD SCI USA, V107, P8123, DOI 10.1073/pnas.0914898107; Luck AN, 2013, ADV DRUG DELIVER REV, V65, P1012, DOI 10.1016/j.addr.2012.11.001; Martin WL, 2001, MOL CELL, V7, P867, DOI 10.1016/S1097-2765(01)00230-1; Mayle KM, 2012, BBA-GEN SUBJECTS, V1820, P264, DOI 10.1016/j.bbagen.2011.09.009; Murtaugh ML, 2011, PROTEIN SCI, V20, P1619, DOI 10.1002/pro.696; Nga BL, 2014, J EXP MED, V211, P233, DOI 10.1084/jem.20131660; Niewoehner J, 2014, NEURON, V81, P49, DOI 10.1016/j.neuron.2013.10.061; Oganesyan V, 2009, MOL IMMUNOL, V46, P1750, DOI 10.1016/j.molimm.2009.01.026; Piatesi A, 2006, PROTEIN EXPRES PURIF, V48, P232, DOI 10.1016/j.pep.2006.01.026; Poul MA, 2000, J MOL BIOL, V301, P1149, DOI 10.1006/jmbi.2000.4026; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Sade H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096340; Sarkar CA, 2002, NAT BIOTECHNOL, V20, P908, DOI 10.1038/nbt725; Schroter C, 2014, MABS, V7, P138; Shusta EV, 1998, NAT BIOTECHNOL, V16, P773, DOI 10.1038/nbt0898-773; Sun HZ, 1998, FEBS LETT, V422, P315, DOI 10.1016/S0014-5793(98)00034-9; Swers JS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh030; Tillotson BJ, 2013, PROTEIN ENG DES SEL, V26, P101, DOI 10.1093/protein/gzs077; Traxlmayr MW, 2014, BIOTECHNOL J, V9, P1013, DOI 10.1002/biot.201300483; Vaccaro C, 2005, NAT BIOTECHNOL, V23, P1283, DOI 10.1038/nbt1143; VanAntwerp JJ, 2000, BIOTECHNOL PROGR, V16, P31, DOI 10.1021/bp990133s; Wally J, 2006, J BIOL CHEM, V281, P24934, DOI 10.1074/jbc.M604592200; Wang XX, 2007, NAT METHODS, V4, P143, DOI 10.1038/nmeth993; Wenning LA, 1998, BIOTECHNOL BIOENG, V57, P484, DOI 10.1002/(SICI)1097-0290(19980220)57:4<484::AID-BIT13>3.0.CO;2-C; Wentz AE, 2007, APPL ENVIRON MICROB, V73, P1189, DOI 10.1128/AEM.02427-06; YAZDI PT, 1995, CANCER RES, V55, P3763; YAZDI PT, 1994, CANCER RES, V54, P6387; Yoon DJ, 2009, J CONTROL RELEASE, V133, P178, DOI 10.1016/j.jconrel.2008.10.006; Yu YJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002230	52	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145820	10.1371/journal.pone.0145820	http://dx.doi.org/10.1371/journal.pone.0145820			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713870	Green Submitted, Green Published, gold			2022-12-26	WOS:000367481900088
J	Yan, H; Ajuwon, KM				Yan, Hui; Ajuwon, Kolapo M.			Mechanism of Butyrate Stimulation of Triglyceride Storage and Adipokine Expression during Adipogenic Differentiation of Porcine Stromovascular Cells	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; PEROXISOMAL BETA-OXIDATION; ADIPOSE-TISSUE; INSULIN-RESISTANCE; GUT MICROBIOTA; INHIBITION; RECEPTOR; IDENTIFICATION; TRANSCRIPTION; PROPIONATE	Short chain fatty acids (SCFA), products of microbial fermentation of dietary fiber, exert multiple metabolic effects in cells. Previously, we had demonstrated that soluble fiber influenced fat mass accumulation, gut microbial community structure and SCFA production in pigs. The current study was designed to identify effects of SCFA treatment during adipogenic differentiation of porcine stromovascular cells on lipid metabolism and adipokine expression. Differentiating cells were treated with varying concentrations of butyrate. Results show that butyrate treatment enhanced adipogenesis and lipid accumulation, perhaps through upregulation of glucose uptake and de novo lipogenesis and other mechanisms that include induction of SREBP-1c, C/EBP alpha/beta, GLUT4, LPL, PPAR., GPAT4, DGAT1 and DGAT2 expression. In addition, butyrate induced adiponectin expression, resulting in activation of downstream target genes, such as AMPK and AKT. Activation of AMPK by butyrate led to phosphorylation of ACC. Although increased ACO gene expression was seen with butyrate treatment, experiments with the peroxisomal fatty acid inhibitor, thioridazine, suggest that butyrate may have an inhibitory effect on peroxisomal fatty acid oxidation. Our studies also provide evidence that butyrate may inhibit lipolysis, perhaps in an FFAR3-dependent manner. Therefore, this study presents a novel paradigm for butyrate action in adipocytes and shows that adipocytes are capable of utilizing butyrate, leading to increased expression of adiponectin for enhanced glucose uptake and improved insulin sensitivity.	[Yan, Hui; Ajuwon, Kolapo M.] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Ajuwon, KM (corresponding author), Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA.	kajuwon@purdue.edu						Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Carmen GY, 2006, CELL SIGNAL, V18, P401, DOI 10.1016/j.cellsig.2005.08.009; Carracedo A, 2013, NAT REV CANCER, V13, P227, DOI 10.1038/nrc3483; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637; Ge HF, 2008, ENDOCRINOLOGY, V149, P4519, DOI 10.1210/en.2008-0059; Giri S, 2006, NUTR METAB, V3, DOI 10.1186/1743-7075-3-31; Griesel BA, 2010, DIABETES, V59, P800, DOI 10.2337/db09-1542; Gut P, 2013, NATURE, V502, P489, DOI 10.1038/nature12752; Hong YH, 2005, ENDOCRINOLOGY, V146, P5092, DOI 10.1210/en.2005-0545; Hu GX, 2010, MED HYPOTHESES, V74, P123, DOI 10.1016/j.mehy.2009.07.022; Kelly M, 2006, FOOD NUTR RES, V50, P7, DOI [10.3402/fnr.v50i0.1581, DOI 10.3402/FNR.V50I0.1581]; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Li GL, 2014, J NUTR, V144, P1887, DOI 10.3945/jn.114.198531; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Nawrocki AR, 2006, J BIOL CHEM, V281, P2654, DOI 10.1074/jbc.M505311200; Nilsson NE, 2003, BIOCHEM BIOPH RES CO, V303, P1047, DOI 10.1016/S0006-291X(03)00488-1; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Pang XY, 2007, ISME J, V1, P156, DOI 10.1038/ismej.2007.23; Papathanasopoulos A, 2010, GASTROENTEROLOGY, V138, P65, DOI 10.1053/j.gastro.2009.11.045; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ruderman NB, 2013, J CLIN INVEST, V123, P2764, DOI 10.1172/JCI67227; Rutkowski JM, 2015, J CELL BIOL, V208, P501, DOI 10.1083/jcb.201409063; Shi RL, 2012, NEUROSCI LETT, V528, P6, DOI 10.1016/j.neulet.2012.08.086; Steliou K, 2012, BIORESEARCH OPEN ACC, V1, P192, DOI 10.1089/biores.2012.0223; Topping DL, 2001, SHORT CHAIN FATTY AC; Valet P, 2002, J LIPID RES, V43, P835; VANDENBRANDEN C, 1990, GLIA, V3, P458, DOI 10.1002/glia.440030604; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yan H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059581; Yoo EJ, 2006, J BIOL CHEM, V281, P6608, DOI 10.1074/jbc.M508982200; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	39	47	49	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145940	10.1371/journal.pone.0145940	http://dx.doi.org/10.1371/journal.pone.0145940			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713737	Green Published, gold, Green Submitted			2022-12-26	WOS:000367481900103
J	Fu, YG; Ge, YT; Sun, Y; Liang, JH; Wan, L; Wu, XJ; Xu, AL				Fu, Yonggui; Ge, Yutong; Sun, Yu; Liang, Jiahui; Wan, Liang; Wu, Xiaojian; Xu, Anlong			IVT-SAPAS: Low-Input and Rapid Method for Sequencing Alternative Polyadenylation Sites	PLOS ONE			English	Article							3' UNTRANSLATED REGIONS; 2 MESSENGER-RNAS; CANCER; GENOME; CELLS; LANDSCAPE; CLEAVAGE; 3'UTRS; GENE; ENDS	Gene transcribing with alternative polyadenylation (APA) sites leads to mRNA isoforms, which may encode different proteins or harbor different 3'UTRs. APA plays an important role in regulating gene expression network among various physiological processes, such as development, immune responses and cancer. Several methods of library construction for APA study have been developed to apply high-throughput sequencing. However, the requirement of high-input RNA and time-consuming nature of the current methods limited the studies of APA for the samples difficult to obtain. Here, we describe a new method based on our SAPAS in combining in vitro transcription (IVT) and magnetic beads purification. The new IVT-SAPAS provides a rapid and high-parallel procedure for APA library construction with low-input sample, which may be a new robust approach for studying APA.	[Fu, Yonggui] Sun Yat Sen Univ, Res Inst, Shenzhen Res Ctr, State Key Lab Biocontrol, Shenzhen 518057, Peoples R China; [Fu, Yonggui; Ge, Yutong; Sun, Yu; Liang, Jiahui; Wan, Liang; Xu, Anlong] Sun Yat Sen Univ, Higher Educ Mega Ctr, Guangdong Prov Key Lab Pharmaceut Funct Genes, Dept Biochem,Sch Life Sci,State Key Lab Biocontro, Guangzhou 510006, Guangdong, Peoples R China; [Wu, Xiaojian] Sun Yat Sen Univ, Affiliated Hosp 6, Guangzhou 510655, Guangdong, Peoples R China; [Xu, Anlong] Beijing Univ Chinese Med, Beijing 100029, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Beijing University of Chinese Medicine	Xu, AL (corresponding author), Sun Yat Sen Univ, Higher Educ Mega Ctr, Guangdong Prov Key Lab Pharmaceut Funct Genes, Dept Biochem,Sch Life Sci,State Key Lab Biocontro, Guangzhou 510006, Guangdong, Peoples R China.	lssxal@mail.sysu.edu.cn		Fu, Yonggui/0000-0001-6469-3430; Xu, Anlong/0000-0002-1419-3494	National High-tech R&D Program of China (863 Program) [2012AA02A520]; National Natural Science Foundation of China [30730089, 91331113]; Committee of Science and Technology Innovation of Shenzhen [JCYJ20120831173744342]; National Natural Science Foundation	National High-tech R&D Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Committee of Science and Technology Innovation of Shenzhen; National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by National High-tech R&D Program of China (863 Program) (No. 2012AA02A520 to W.X.), National Natural Science Foundation of China (No. 30730089 to A.X. and No. 91331113 to Y.F.), and Committee of Science and Technology Innovation of Shenzhen ( No. JCYJ20120831173744342 to Y.F.). A.X. is the recipient of an "Outstanding Young Scientist Award" from the National Natural Science Foundation.; The authors are grateful to Dr. Jingde Zhu and Xueqin Wang for their suggestions. This work was supported by National High-tech R&D Program of China (863 Program) (No. 2012AA02A520 to W.X.), National Natural Science Foundation of China (No. 30730089 to A.X. and No. 91331113 to Y.F.), and Committee of Science and Technology Innovation of Shenzhen (No. JCYJ20120831173744342 to Y.F.). A.X. is the recipient of an "Outstanding Young Scientist Award" from the National Natural Science Foundation.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; ALT FW, 1980, CELL, V20, P293, DOI 10.1016/0092-8674(80)90615-7; EARLY P, 1980, CELL, V20, P313, DOI 10.1016/0092-8674(80)90617-0; Flavell SW, 2008, NEURON, V60, P1022, DOI 10.1016/j.neuron.2008.11.029; Fu YG, 2011, GENOME RES, V21, P741, DOI 10.1101/gr.115295.110; Hoque M, 2013, NAT METHODS, V10, P133, DOI [10.1038/NMETH.2288, 10.1038/nmeth.2288]; Jan CH, 2011, NATURE, V469, P97, DOI 10.1038/nature09616; Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li YX, 2012, GENOME RES, V22, P1899, DOI 10.1101/gr.128488.111; Lutz CS, 2008, ACS CHEM BIOL, V3, P609, DOI 10.1021/cb800138w; Mangone M, 2010, SCIENCE, V329, P432, DOI 10.1126/science.1191244; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; ROGERS J, 1980, CELL, V20, P303, DOI 10.1016/0092-8674(80)90616-9; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Sawasaki T, 2004, TUMOR BIOL, V25, P141, DOI 10.1159/000079146; Shepard PJ, 2011, RNA, V17, P761, DOI 10.1261/rna.2581711; Wallrapp C, 2000, CANCER RES, V60, P2602	19	10	10	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145477	10.1371/journal.pone.0145477	http://dx.doi.org/10.1371/journal.pone.0145477			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710068	Green Submitted, gold, Green Published			2022-12-26	WOS:000367451400049
J	Greene, JA; Portillo, JAC; Corcino, YL; Subauste, CS				Greene, Jennifer A.; Portillo, Jose-Andres C.; Corcino, Yalitza Lopez; Subauste, Carlos S.			CD40-TRAF Signaling Upregulates CX3CL1 and TNF-alpha in Human Aortic Endothelial Cells but Not in Retinal Endothelial Cells	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; RECEPTOR-ASSOCIATED FACTOR-2; EARLY DIABETIC-RETINOPATHY; TRAF BINDING-SITES; FRACTALKINE CX3CL1; ATHEROSCLEROTIC LESIONS; ANTIMICROBIAL ACTIVITY; IMMUNE-RESPONSE; B-LYMPHOCYTES; IN-VIVO	CD40, CX3CL1 and TNF-alpha promote atheroma and neointima formation. CD40 and TNF-alpha are also central to the development of diabetic retinopathy while CX3CL1 may play a role in the pathogenesis of this retinopathy. The purpose of this study was to examine whether CD40 ligation increases CX3CL1 and TNF-alpha protein expression in human endothelial cells from the aorta and retina. CD154 (CD40 ligand) upregulated membrane-bound and soluble CX3CL1 in human aortic endothelial cells. CD154 triggered TNF-alpha production by human aortic endothelial cells. TNF Receptor Associated Factors (TRAF) are key mediators of CD40 signaling. Compared to human aortic endothelial cells that express wt CD40, cells that express CD40 with a mutation that prevents TRAF2,3 recruitment, or CD40 with a mutation that prevents TRAF6 recruitment exhibited a profound inhibition of CD154-driven upregulation of membrane bound and soluble CX3CL1 as well as of TNF-alpha secretion. While both CD154 and TNF-alpha upregulated CX3CL1 in human aortic endothelial cells, these stimuli could act independently of each other. In contrast to human aortic endothelial cells, human retinal endothelial cells did not increase membrane bound or soluble CX3CL1 expression or secrete TNF-alpha in response to CD154 even though CD40 ligation upregulated ICAM-1 and CCL2 in these cells. Moreover, TNF-alpha did not upregulate CX3CL1 in retinal endothelial cells. In conclusion, CD40 ligation increases CX3CL1 protein levels and induces TNF-alpha production in endothelial cells. However, endothelial cells are heterogeneous in regards to these responses. Human aortic but not retinal endothelial cells upregulated CX3CL1 and TNF-alpha in response to CD40 ligation, as well as upregulated CX3CL1 in response to TNF-alpha. These dissimilarities may contribute to differences in regulation of inflammation in large vessels versus the retina.	[Greene, Jennifer A.; Portillo, Jose-Andres C.; Corcino, Yalitza Lopez; Subauste, Carlos S.] Case Western Reserve Univ, Dept Med, Div Infect Dis & HIV Med, Cleveland, OH 44106 USA; [Subauste, Carlos S.] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Subauste, Carlos S.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Subauste, CS (corresponding author), Case Western Reserve Univ, Dept Med, Div Infect Dis & HIV Med, Cleveland, OH 44106 USA.	carlos.subauste@case.edu			NIH Grant [EY019250]; Flow Cytometry Core Facility of the Comprehensive Cancer Center of Case Western Reserve University; University Hospitals of Cleveland [P30 CA43703]; Postbaccalaureate Research Education Program at CWRU; NATIONAL CANCER INSTITUTE [P30CA043703] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY019250] Funding Source: NIH RePORTER	NIH Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flow Cytometry Core Facility of the Comprehensive Cancer Center of Case Western Reserve University; University Hospitals of Cleveland; Postbaccalaureate Research Education Program at CWRU; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH Grant EY019250 (CSS) as well as by the Flow Cytometry Core Facility of the Comprehensive Cancer Center of Case Western Reserve University and University Hospitals of Cleveland (P30 CA43703). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by NIH Grant EY019250, (C.S.S) as well as by the Flow Cytometry Core Facility of the Comprehensive Cancer Center of Case Western Reserve University and University Hospitals of Cleveland (P30 CA43703). YLC was supported by the Postbaccalaureate Research Education Program at CWRU. We thank Dr. James Jacobberger (Case Western Reserve University) for assistance with flow cytometry analysis.	Ahn SY, 2004, AM J PATHOL, V164, P1663, DOI 10.1016/S0002-9440(10)63725-X; Ahonen CL, 2002, NAT IMMUNOL, V3, P451, DOI 10.1038/ni792; Aird WC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006429; Andrade RM, 2005, J IMMUNOL, V175, P6014, DOI 10.4049/jimmunol.175.9.6014; Andrade RM, 2006, J CLIN INVEST, V116, P2366, DOI 10.1172/JCI28796; Asgeirsdottir SA, 2012, AM J PHYSIOL-RENAL, V302, pF1630, DOI 10.1152/ajprenal.00400.2011; Baccam M, 1999, EUR J IMMUNOL, V29, P3855, DOI 10.1002/(SICI)1521-4141(199912)29:12<3855::AID-IMMU3855>3.0.CO;2-S; BARATH P, 1990, AM J CARDIOL, V65, P297, DOI 10.1016/0002-9149(90)90291-8; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Beck GC, 2006, CLIN EXP IMMUNOL, V143, P523, DOI 10.1111/j.1365-2249.2006.03005.x; Behl Y, 2008, AM J PATHOL, V172, P1411, DOI 10.2353/ajpath.2008.071070; Bishop GA, 2002, J LEUKOCYTE BIOL, V72, P19; Boumpas DT, 2003, ARTHRITIS RHEUM-US, V48, P719, DOI 10.1002/art.10856; CAPETANDES A, 1990, INVEST OPHTH VIS SCI, V31, P1738; Combadiere C, 2003, CIRCULATION, V107, P1009, DOI 10.1161/01.CIR.0000057548.68243.42; Davis B, 2005, CIRCULATION, V112, P2184, DOI 10.1161/CIRCULATIONAHA.105.553206; Donners MMPC, 2008, BLOOD, V111, P4596, DOI 10.1182/blood-2007-05-088906; Fong AM, 1998, J EXP MED, V188, P1413, DOI 10.1084/jem.188.8.1413; Fraticelli P, 2001, J CLIN INVEST, V107, P1173, DOI 10.1172/JCI11517; Garton KJ, 2001, J BIOL CHEM, V276, P37993; Greene JA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-47; Hakkinen T, 2000, VIRCHOWS ARCH, V437, P396, DOI 10.1007/s004280000239; HANSSON GK, 1989, ARTERIOSCLEROSIS, V9, P567, DOI 10.1161/01.ATV.9.5.567; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Haskell CA, 2000, J BIOL CHEM, V275, P34183, DOI 10.1074/jbc.M005731200; Haxhinasto SA, 2002, J IMMUNOL, V169, P1145, DOI 10.4049/jimmunol.169.3.1145; Hsing Y, 1997, J IMMUNOL, V159, P4898; Huang H, 2011, INVEST OPHTH VIS SCI, V52, P1336, DOI 10.1167/iovs.10-5768; Jabara HH, 2002, IMMUNITY, V17, P265, DOI 10.1016/S1074-7613(02)00394-1; Jalukar SV, 2000, J IMMUNOL, V164, P623, DOI 10.4049/jimmunol.164.2.623; Joussen AM, 2002, FASEB J, V16, P438, DOI 10.1096/fj.01-0707fje; KARMANN K, 1995, P NATL ACAD SCI USA, V92, P4342, DOI 10.1073/pnas.92.10.4342; Lambert CM, 2010, AM J PHYSIOL-HEART C, V299, pH995, DOI 10.1152/ajpheart.00562.2010; Lesnik P, 2003, J CLIN INVEST, V111, P333, DOI 10.1172/JCI200315555; Limb GA, 1996, BRIT J OPHTHALMOL, V80, P168, DOI 10.1136/bjo.80.2.168; Lu LF, 2003, J BIOL CHEM, V278, P45414, DOI 10.1074/jbc.M309601200; Lutgens E, 2010, J EXP MED, V207, P391, DOI 10.1084/jem.20091293; Mach F, 1998, NATURE, V394, P200, DOI 10.1038/28204; Mackey MF, 2003, EUR J IMMUNOL, V33, P779, DOI 10.1002/eji.200323729; Miller DL, 1998, J LEUKOCYTE BIOL, V63, P373, DOI 10.1002/jlb.63.3.373; Minami T, 2005, TRENDS CARDIOVAS MED, V15, P174, DOI 10.1016/j.tcm.2005.06.002; Mukundan L, 2005, J IMMUNOL, V174, P1081, DOI 10.4049/jimmunol.174.2.1081; Ohta H, 2005, ATHEROSCLEROSIS, V180, P11, DOI 10.1016/j.atherosclerosis.2004.11.016; Portillo JAC, 2014, INVEST OPHTH VIS SCI, V55, P8590, DOI 10.1167/iovs.14-15340; Portillo JAC, 2015, IMMUNOLOGY, V144, P21, DOI 10.1111/imm.12361; Portillo JAC, 2014, DIABETOLOGIA, V57, P2222, DOI 10.1007/s00125-014-3321-x; Portillo JAC, 2012, IMMUNOLOGY, V135, P140, DOI 10.1111/j.1365-2567.2011.03519.x; Portillo JAC, 2008, J IMMUNOL, V181, P8719, DOI 10.4049/jimmunol.181.12.8719; Pullen SS, 1998, BIOCHEMISTRY-US, V37, P11836, DOI 10.1021/bi981067q; Schonbeck U, 1999, J EXP MED, V189, P843, DOI 10.1084/jem.189.5.843; Schulz C, 2007, CIRCULATION, V116, P764, DOI 10.1161/CIRCULATIONAHA.107.695189; Serra AM, 2012, AM J PATHOL, V181, P719, DOI 10.1016/j.ajpath.2012.04.009; Silverman MD, 2003, INVEST OPHTH VIS SCI, V44, P1608, DOI 10.1167/iovs.02-0233; Song ZF, 2012, ARTERIOSCL THROM VAS, V32, P50, DOI 10.1161/ATVBAHA.111.238329; Subauste CS, 2007, AUTOPHAGY, V3, P245, DOI 10.4161/auto.3717; Tang J, 2011, PROG RETIN EYE RES, V30, P343, DOI 10.1016/j.preteyeres.2011.05.002; Tei N, 2013, J NEUROSCI RES, V91, P681, DOI 10.1002/jnr.23202; Teupser D, 2004, P NATL ACAD SCI USA, V101, P17795, DOI 10.1073/pnas.0408096101; Tsou CL, 2001, J BIOL CHEM, V276, P44622, DOI 10.1074/jbc.M107327200; Wong BWC, 2002, CARDIOVASC PATHOL, V11, P332, DOI 10.1016/S1054-8807(02)00111-4; You JJ, 2007, INVEST OPHTH VIS SCI, V48, P5290, DOI 10.1167/iovs.07-0187; Zhang HR, 2009, CLIN SCI, V116, P219, DOI 10.1042/CS20080196; Zieger M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106562	63	13	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0144133	10.1371/journal.pone.0144133	http://dx.doi.org/10.1371/journal.pone.0144133			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710229	gold, Green Submitted, Green Published			2022-12-26	WOS:000367451400003
J	Marchildon, F; Lamarche, E; Lala-Tabbert, N; St-Louis, C; Wiper-Bergeron, N				Marchildon, Francois; Lamarche, Emilie; Lala-Tabbert, Neena; St-Louis, Catherine; Wiper-Bergeron, Nadine			Expression of CCAAT/Enhancer Binding Protein Beta in Muscle Satellite Cells Inhibits Myogenesis in Cancer Cachexia	PLOS ONE			English	Article							NF-KAPPA-B; C/EBP-BETA; PREADIPOCYTE DIFFERENTIATION; UBIQUITIN LIGASES; GENE-EXPRESSION; INTERLEUKIN-6; TRANSCRIPTION; MECHANISMS; CYTOKINES; DELTA	Cancer cachexia is a paraneoplastic syndrome that causes profound weight loss and muscle mass atrophy and is estimated to be the cause of up to 30% of cancer deaths. Though the exact cause is unknown, patients with cancer cachexia have increased muscle protein catabolism. In healthy muscle, injury activates skeletal muscle stem cells, called satellite cells, to differentiate and promote regeneration. Here, we provide evidence that this mechanism is inhibited in cancer cachexia due to persistent expression of CCAAT/Enhancer Binding Protein beta (C/EBP beta) in muscle myoblasts. C/EBP beta is a bzip transcription factor that is expressed in muscle satellite cells and is normally downregulated upon differentiation. However, in myoblasts exposed to a cachectic milieu, C/EBP beta expression remains elevated, despite activation to differentiate, resulting in the inhibition of myogenin expression and myogenesis. In vivo, cancer cachexia results in increased number of Pax7+ cells that also express C/EBP beta and the inhibition of normal repair mechanisms. Loss of C/EBP beta expression in primary myoblasts rescues differentiation under cachectic conditions without restoring myotube size, indicating that C/EBP beta is an important inhibitor of myogenesis in cancer cachexia.	[Marchildon, Francois; Lamarche, Emilie; Lala-Tabbert, Neena] Univ Ottawa, Fac Med, Dept Cellular & Mol Med, Grad Program Cellular & Mol Med, Ottawa, ON, Canada; [St-Louis, Catherine; Wiper-Bergeron, Nadine] Univ Ottawa, Fac Med, Dept Cellular & Mol Med, Ottawa, ON, Canada	University of Ottawa; University of Ottawa	Wiper-Bergeron, N (corresponding author), Univ Ottawa, Fac Med, Dept Cellular & Mol Med, Ottawa, ON, Canada.	Nadine.WiperBergeron@uottawa.ca	Wiper-Bergeron, Nadine/AAO-4370-2021	Wiper-Bergeron, Nadine/0000-0001-8448-3246; Marchildon, Francois/0000-0002-4846-3149	Canadian Institutes of Health Research; Cancer Research Society	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cancer Research Society	This work was funded by grants to NWB from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca) and the Cancer Research Society (https://www.crs-src.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharyya S, 2004, J CLIN INVEST, V114, P370, DOI 10.1172/jci200420174; Argiles JM, 2005, INT J BIOCHEM CELL B, V37, P1084, DOI 10.1016/j.biocel.2004.10.003; Argiles JM, 2014, NAT REV CANCER, V14, P754, DOI 10.1038/nrc3829; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bruera E, 2000, Lancet Oncol, V1, P138, DOI 10.1016/S1470-2045(00)00033-4; Bruera E, 1997, BRIT MED J, V315, P1219, DOI 10.1136/bmj.315.7117.1219; Buck M, 2003, HEPATOLOGY, V37, P731, DOI 10.1053/jhep.2003.50155; Buck M, 2001, MOL CELL, V8, P807, DOI 10.1016/S1097-2765(01)00374-4; Cardinaux JR, 2000, GLIA, V29, P91, DOI 10.1002/(SICI)1098-1136(20000101)29:1<91::AID-GLIA9>3.0.CO;2-I; Coletti D, 2006, BASIC APPL MYOL, V16, P131; Deans C, 2005, CURR OPIN CLIN NUTR, V8, P265, DOI 10.1097/01.mco.0000165004.93707.88; DEWYS WD, 1980, AM J MED, V69, P491, DOI 10.1016/S0149-2918(05)80001-3; Friedman AD, 2007, ONCOGENE, V26, P6816, DOI 10.1038/sj.onc.1210764; Fu DC, 2015, J BIOL CHEM, V290, P10200, DOI 10.1074/jbc.M115.638577; Fukada SI, 2007, STEM CELLS, V25, P2448, DOI 10.1634/stemcells.2007-0019; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Grimm SL, 2003, J MAMMARY GLAND BIOL, V8, P191, DOI 10.1023/A:1025900908026; GUTTRIDGE DC, 2000, SCIENCE, V289, P2363, DOI [10.1126/sci-ence.289.5488.2363, DOI 10.1126/SCI-ENCE.289.5488.2363, DOI 10.1126/science.289.5488.2363, DOI 10.1126/SCIENCE.289.5488.2363]; He WA, 2013, J CLIN INVEST, V123, P4821, DOI 10.1172/JCI68523; Jiang ZL, 2006, FASEB J, V20, P2570, DOI 10.1096/fj.06-6347fje; Kuroda K, 2007, UROLOGY, V69, P113, DOI 10.1016/j.urology.2006.09.039; Li YP, 2000, AM J PHYSIOL-REG I, V279, pR1165, DOI 10.1152/ajpregu.2000.279.4.R1165; Liu Y, 2013, MOL CELL BIOL, V33, P4606, DOI 10.1128/MCB.00723-13; Loell I, 2011, J INTERN MED, V269, P243, DOI 10.1111/j.1365-2796.2010.02334.x; Marchildon F, 2012, STEM CELLS, V30, P2619, DOI 10.1002/stem.1248; MATTHYS P, 1991, INT J CANCER, V49, P77, DOI 10.1002/ijc.2910490115; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Mitch WE, 1996, NEW ENGL J MED, V335, P1897, DOI 10.1056/NEJM199612193352507; Mitchell PO, 2004, AM J PHYSIOL-CELL PH, V287, pC1753, DOI 10.1152/ajpcell.00292.2004; OLIFF A, 1987, CELL, V50, P555, DOI 10.1016/0092-8674(87)90028-6; Poli V, 1998, J BIOL CHEM, V273, P29279, DOI 10.1074/jbc.273.45.29279; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Ramos EJB, 2004, CURR OPIN CLIN NUTR, V7, P427, DOI 10.1097/01.mco.0000134363.53782.cb; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Rosen ED, 2000, GENE DEV, V14, P1293; Ruffell D, 2009, P NATL ACAD SCI USA, V106, P17475, DOI 10.1073/pnas.0908641106; Saini A, 2006, CYTOKINE GROWTH F R, V17, P475, DOI 10.1016/j.cytogfr.2006.09.006; SCHULTZ E, 1985, MUSCLE NERVE, V8, P217, DOI 10.1002/mus.880080307; Schwarzkopf M, 2006, GENE DEV, V20, P3440, DOI 10.1101/gad.412606; Seagroves TN, 1998, GENE DEV, V12, P1917, DOI 10.1101/gad.12.12.1917; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Sebastian T, 2006, CELL CYCLE, V5, P953, DOI 10.4161/cc.5.9.2733; Sharples AP, 2015, BIOGERONTOLOGY; Sterneck E, 1997, GENE DEV, V11, P2153, DOI 10.1101/gad.11.17.2153; STRASSMANN G, 1992, J CLIN INVEST, V89, P1681, DOI 10.1172/JCI115767; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; TANAKA T, 1995, CELL, V80, P353, DOI 10.1016/0092-8674(95)90418-2; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; Tsujinaka T, 1996, J CLIN INVEST, V97, P244, DOI 10.1172/JCI118398; Tsutsui T, 2013, J BIOL CHEM, V288, P20955, DOI 10.1074/jbc.M113.486746; Tuca A, 2013, CRIT REV ONCOL HEMAT, V88, P625, DOI 10.1016/j.critrevonc.2013.07.015; VANEYS J, 1985, ANNU REV NUTR, V5, P435, DOI 10.1146/annurev.nu.05.070185.002251; von Haehling S, 2010, J CACHEXIA SARCOPENI, V1, P1, DOI 10.1007/s13539-010-0002-6; Wagatsuma A, 2007, MOL CELL BIOCHEM, V304, P25, DOI 10.1007/s11010-007-9482-x; Wiper-Bergeron N, 2003, EMBO J, V22, P2135, DOI 10.1093/emboj/cdg218; Wiper-Bergeron N, 2007, MOL ENDOCRINOL, V21, P2124, DOI 10.1210/me.2006-0452; Wiper-Bergeron N, 2007, P NATL ACAD SCI USA, V104, P2703, DOI 10.1073/pnas.0607378104; Wray CJ, 2003, INT J BIOCHEM CELL B, V35, P698, DOI 10.1016/S1357-2725(02)00341-2; Yang HM, 2005, J CELL PHYSIOL, V204, P219, DOI 10.1002/jcp.20278; YASUMOTO K, 1995, CANCER RES, V55, P921; Zhang GH, 2011, EMBO J, V30, P4323, DOI 10.1038/emboj.2011.292; Zhou W, 2003, WORLD J GASTROENTERO, V9, P1567, DOI 10.3748/wjg.v9.i7.1567; Zhou XL, 2010, CELL, V142, P531, DOI 10.1016/j.cell.2010.07.011	65	19	19	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145583	10.1371/journal.pone.0145583	http://dx.doi.org/10.1371/journal.pone.0145583			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709824	Green Published, gold, Green Submitted			2022-12-26	WOS:000367451400063
J	Mowery, P; Ames, P; Reiser, RH; Parkinson, JS				Mowery, Patricia; Ames, Peter; Reiser, Rebecca H.; Parkinson, John S.			Chemotactic Signaling by Single-Chain Chemoreceptors	PLOS ONE			English	Article							ESCHERICHIA-COLI; LIGAND-BINDING; IN-VIVO; SENSORY ADAPTATION; BACTERIAL CHEMORECEPTORS; CYTOPLASMIC DOMAIN; HAMP DOMAINS; LAC OPERATOR; RECEPTOR; TSR	Bacterial chemoreceptors of the methyl-accepting chemotaxis protein (MCP) family operate in commingled clusters that enable cells to detect and track environmental chemical gradients with high sensitivity and precision. MCP homodimers of different detection specificities form mixed trimers of dimers that facilitate inter-receptor communication in core signaling complexes, which in turn assemble into a large signaling network. The two subunits of each homodimeric receptor molecule occupy different locations in the core complexes. One subunit participates in trimer-stabilizing interactions at the trimer axis, the other lies on the periphery of the trimer, where it can interact with two cytoplasmic proteins: CheA, a signaling autokinase, and CheW, which couples CheA activity to receptor control. As a possible tool for independently manipulating receptor subunits in these two structural environments, we constructed and characterized fused genes for the E. coli serine chemoreceptor Tsr that encoded single-chain receptor molecules in which the C-terminus of the first Tsr subunit was covalently connected to the N-terminus of the second with a polypeptide linker. We showed with soft agar assays and with a FRET-based in vivo CheA kinase assay that single-chain Tsr similar to Tsr molecules could promote serine sensing and chemotaxis responses. The length of the connection between the joined subunits was critical. Linkers nine residues or shorter locked the receptor in a kinase-on state, most likely by distorting the native structure of the receptor HAMP domain. Linkers 22 or more residues in length permitted near-normal Tsr function. Few single-chain molecules were found as monomer-sized proteolytic fragments in cells, indicating that covalently joined receptor subunits were responsible for mediating the signaling responses we observed. However, cysteine-directed crosslinking, spoiling by dominant-negative Tsr subunits, and rearrangement of ligand-binding site lesions revealed subunit swapping interactions that will need to be taken into account in experimental applications of single-chain chemoreceptors.	[Mowery, Patricia; Ames, Peter; Reiser, Rebecca H.; Parkinson, John S.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Mowery, Patricia] Hobart Coll, Geneva, NY USA; [Mowery, Patricia] William Smith Coll, Geneva, NY USA	Utah System of Higher Education; University of Utah	Mowery, P (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	mowery@hws.edu			National Institute of General Medical Sciences [GM19559]; Ruth L. Kirschstein National Institutes of Health fellowship [5F32GM072406]; National Cancer Institute [CA42014]; NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM019559, F32GM072406, R01GM019559] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Ruth L. Kirschstein National Institutes of Health fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Support was provided by the National Institute of General Medical Sciences #GM19559 to JSP (http://www.nigms.nih.gov) and the Ruth L. Kirschstein National Institutes of Health fellowship #5F32GM072406 to PM (https://researchtraining.nih.gov). The Protein-DNA Core Facility at the University of Utah receives support from National Cancer Institute grant #CA42014 (http://www.cancer.gov) to the Huntsman Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames P, 2002, P NATL ACAD SCI USA, V99, P7060, DOI 10.1073/pnas.092071899; AMES P, 1994, J BACTERIOL, V176, P6340, DOI 10.1128/jb.176.20.6340-6348.1994; Ames P, 2006, P NATL ACAD SCI USA, V103, P9292, DOI 10.1073/pnas.0602135103; Ames P, 2014, MOL MICROBIOL, V91, P875, DOI 10.1111/mmi.12443; Vu A, 2012, J MOL BIOL, V415, P759, DOI 10.1016/j.jmb.2011.11.043; Barnakov AN, 1999, P NATL ACAD SCI USA, V96, P10667, DOI 10.1073/pnas.96.19.10667; BERG HC, 1984, J GEN MICROBIOL, V130, P2915; Berleman JE, 2005, MOL MICROBIOL, V55, P1390, DOI 10.1111/j.1365-2958.2005.04489.x; Bhatnagar J, 2010, BIOCHEMISTRY-US, V49, P3824, DOI 10.1021/bi100055m; Bibikov SI, 1997, J BACTERIOL, V179, P4075, DOI 10.1128/jb.179.12.4075-4079.1997; Bjorkman AM, 2001, J BIOL CHEM, V276, P2808, DOI 10.1074/jbc.M009593200; Feng XH, 1999, J BACTERIOL, V181, P3164, DOI 10.1128/JB.181.10.3164-3171.1999; Feng XH, 1997, J BACTERIOL, V179, P6714, DOI 10.1128/jb.179.21.6714-6720.1997; Francis NR, 2004, P NATL ACAD SCI USA, V101, P17480, DOI 10.1073/pnas.0407826101; Gardina PJ, 1996, SCIENCE, V274, P425, DOI 10.1126/science.274.5286.425; Greenswag AR, 2015, BIOCHEMISTRY-US, V54, P3454, DOI 10.1021/bi501570n; Han XS, 2014, J BACTERIOL, V196, P641, DOI 10.1128/JB.01164-13; Hazelbauer GL, 2008, TRENDS BIOCHEM SCI, V33, P9, DOI 10.1016/j.tibs.2007.09.014; Hulko M, 2006, CELL, V126, P929, DOI 10.1016/j.cell.2006.06.058; IWAMA T, 1995, J BACTERIOL, V177, P2218, DOI 10.1128/jb.177.8.2218-2221.1995; JEFFERY CJ, 1993, PROTEIN SCI, V2, P559; Khursigara CM, 2008, P NATL ACAD SCI USA, V105, P16555, DOI 10.1073/pnas.0806401105; Kim KK, 1999, NATURE, V400, P787, DOI 10.1038/23512; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai RZ, 2014, J MOL BIOL, V426, P3642, DOI 10.1016/j.jmb.2014.08.003; LeMoual H, 1996, J MOL BIOL, V261, P568, DOI 10.1006/jmbi.1996.0483; Li JY, 1997, BIOCHEMISTRY-US, V36, P11851, DOI 10.1021/bi971510h; Li MS, 2011, P NATL ACAD SCI USA, V108, P9390, DOI 10.1073/pnas.1104824108; Li MS, 2005, MOL MICROBIOL, V56, P1617, DOI 10.1111/j.1365-2958.2005.04641.x; Li XX, 2013, BIOCHEMISTRY-US, V52, P3852, DOI 10.1021/bi400383e; Miller AS, 2006, BIOCHEMISTRY-US, V45, P8699, DOI 10.1021/bi060580y; Mowery P, 2008, J BACTERIOL, V190, P8065, DOI 10.1128/JB.01121-08; Muppirala UK, 2009, PROTEIN SCI, V18, P1702, DOI 10.1002/pro.170; Nikaido H, 2009, BBA-PROTEINS PROTEOM, V1794, P769, DOI 10.1016/j.bbapap.2008.10.004; OOSAWA K, 1988, J BACTERIOL, V170, P2521, DOI 10.1128/jb.170.6.2521-2526.1988; Park SY, 2006, NAT STRUCT MOL BIOL, V13, P400, DOI 10.1038/nsmb1085; Parkinson JS, 2015, TRENDS MICROBIOL, V23, P257, DOI 10.1016/j.tim.2015.03.003; Parkinson JS, 2010, ANNU REV MICROBIOL, V64, P101, DOI 10.1146/annurev.micro.112408.134215; PARKINSON JS, 1982, J BACTERIOL, V151, P106, DOI 10.1128/JB.151.1.106-113.1982; PARKINSON JS, 1976, J BACTERIOL, V126, P758, DOI 10.1128/JB.126.2.758-770.1976; SADLER JR, 1983, P NATL ACAD SCI-BIOL, V80, P6785, DOI 10.1073/pnas.80.22.6785; SIMONS A, 1984, P NATL ACAD SCI-BIOL, V81, P1624, DOI 10.1073/pnas.81.6.1624; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P12669, DOI 10.1073/pnas.192463199; Sourjik V, 2000, MOL MICROBIOL, V37, P740, DOI 10.1046/j.1365-2958.2000.02044.x; Sourjik V, 2007, METHOD ENZYMOL, V423, P365, DOI 10.1016/S0076-6879(07)23017-4; Sourjik V, 2010, EMBO J, V29, P2724, DOI 10.1038/emboj.2010.178; Studdert CA, 2005, P NATL ACAD SCI USA, V102, P15623, DOI 10.1073/pnas.0506040102; Studdert CA, 2004, P NATL ACAD SCI USA, V101, P2117, DOI 10.1073/pnas.0308622100; Studdert CA, 2007, METHOD ENZYMOL, V423, P414, DOI 10.1016/S0076-6879(07)23019-8; Tajima H, 2011, J BIOL CHEM, V286, P42200, DOI 10.1074/jbc.M111.221887; Wang XQ, 2012, J MOL BIOL, V422, P282, DOI 10.1016/j.jmb.2012.05.023; Wu JG, 1996, BIOCHEMISTRY-US, V35, P4984, DOI 10.1021/bi9530189; Wuichet K, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000724; YANG Y, 1993, J MOL BIOL, V232, P493, DOI 10.1006/jmbi.1993.1405; Yu DQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep08640; Zhou Q, 2011, MOL MICROBIOL, V80, P596, DOI 10.1111/j.1365-2958.2011.07577.x; Zhou Q, 2009, MOL MICROBIOL, V73, P801, DOI 10.1111/j.1365-2958.2009.06819.x; Zhulin IB, 2001, ADV MICROB PHYSIOL, V45, P157, DOI 10.1016/S0065-2911(01)45004-1	58	4	4	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145267	10.1371/journal.pone.0145267	http://dx.doi.org/10.1371/journal.pone.0145267			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709829	Green Submitted, gold, Green Published			2022-12-26	WOS:000367451400031
J	Onelli, E; Ghiani, A; Gentili, R; Serra, S; Musacchi, S; Citterio, S				Onelli, E.; Ghiani, A.; Gentili, R.; Serra, S.; Musacchi, S.; Citterio, S.			Specific Changes of Exocarp and Mesocarp Occurring during Softening Differently Affect Firmness in Melting (MF) and Non Melting Flesh (NMF) Fruits	PLOS ONE			English	Article							CELL-WALL METABOLISM; RHEOLOGICAL PROPERTIES; PHENOLIC-COMPOUNDS; PRUNUS-PERSICA; FERULIC ACID; PEACH FRUIT; CUTICLE; PECTIN; BIOMECHANICS; REVEALS	Melting (MF) and non melting flesh (NMF) peaches differ in their final texture and firmness. Their specific characteristics are achieved by softening process and directly dictate fruit shelf life and quality. Softening is influenced by various mechanisms including cell wall reorganization and water loss. In this work, the biomechanical properties of MF Spring Crest's and NMF Oro A's exocarp and mesocarp along with the amount and localization of hydroxycinnamic acids and flavonoids were investigated during fruit ripening and post-harvest. The objective was to better understand the role played by water loss and cell wall reorganization in peach softening. Results showed that in ripe Spring Crest, where both cell turgor loss and cell wall dismantling occurred, mesocarp had a little role in the fruit reaction to compression and probe penetration response was almost exclusively ascribed to the epidermis which functioned as a mechanical support to the pulp. In ripe Oro A's fruit, where cell wall disassembly did not occur and the loss of cell turgor was observed only in mesocarp, the contribution of exocarp to fruit firmness was consistent but relatively lower than that of mesocarp, suggesting that in addition to cell turgor, the integrity of cell wall played a key role in maintaining NMF fruit firmness. The analysis of phenols suggested that permeability and firmness of epidermis were associated with the presence of flavonoids and hydroxycinnamic acids.	[Onelli, E.] Univ Milan, Dept Biosci, I-20133 Milan, Italy; [Ghiani, A.; Gentili, R.; Citterio, S.] Univ Milano Bicocca, Dept Earth & Environm Sci, I-20126 Milan, Italy; [Serra, S.; Musacchi, S.] Washington State Univ, Dept Hort, TFREC, Wenatchee, WA 98801 USA	University of Milan; University of Milano-Bicocca; Washington State University	Citterio, S (corresponding author), Univ Milano Bicocca, Dept Earth & Environm Sci, Piazza Sci 1, I-20126 Milan, Italy.	sandra.citterio@unimib.it	Musacchi, Stefano/H-8663-2019; Gentili, Rodolfo/I-5613-2016; ONELLI, ELISABETTA/B-1164-2017	Musacchi, Stefano/0000-0001-8618-6202; Gentili, Rodolfo/0000-0002-9332-7963; serra, sara/0000-0002-4117-2875; ONELLI, ELISABETTA/0000-0003-3724-4116	Italian MIUR PRIN-COFIN Project "The determination of nutraceutical and organoleptic features of peach fruit: role of the metabolism of phenylpropanoids and phenolic compounds" [2009SRZRE9]	Italian MIUR PRIN-COFIN Project "The determination of nutraceutical and organoleptic features of peach fruit: role of the metabolism of phenylpropanoids and phenolic compounds"	This research was funded by the Italian MIUR PRIN-COFIN Project "The determination of nutraceutical and organoleptic features of peach fruit: role of the metabolism of phenylpropanoids and phenolic compounds", project number: 2009SRZRE9.	Bargel H, 2004, J PLANT GROWTH REGUL, V23, P61, DOI 10.1007/s00344-004-0036-0; Bonghi C, 1999, POSTHARVEST BIOL TEC, V16, P213, DOI 10.1016/S0925-5214(99)00028-9; Bonora E, 2013, INT J AGRON, V2013, DOI 10.1155/2013/242461; Braybrook SA, 2012, PLANT SIGNAL BEHAV, V7, P1037, DOI 10.4161/psb.20768; Brovelli EA, 1999, J SCI FOOD AGR, V79, P707, DOI [10.1002/(SICI)1097-0010(199904)79:5<707::AID-JSFA241>3.0.CO;2-#, 10.1002/(SICI)1097-0010(199904)79:5&lt;707::AID-JSFA241&gt;3.0.CO;2-#]; Brummell DA, 2004, J EXP BOT, V55, P2029, DOI 10.1093/jxb/erh227; Buschmann C, 2000, PHOTOSYNTHETICA, V38, P483, DOI 10.1023/A:1012440903014; Cacao SMB, 2012, GENET MOL RES, V11, P3186, DOI 10.4238/2012.September.3.7; Dominguez E, 2011, PLANT SCI, V181, P77, DOI 10.1016/j.plantsci.2011.04.016; Dominguez E, 2009, FUNCT PLANT BIOL, V36, P613, DOI 10.1071/FP09039; Duan YX, 2013, ACTA PHYSIOL PLANT, V35, P707, DOI 10.1007/s11738-012-1111-y; Edelmann HG, 2005, J PLANT GROWTH REGUL, V24, P116, DOI 10.1007/s00344-004-0015-5; Espana L, 2014, PLANT PHYSIOL, V166, P1371, DOI 10.1104/pp.114.246405; Espana L, 2014, NEW PHYTOL, V202, P790, DOI 10.1111/nph.12727; Fernandez V, 2011, PLANT PHYSIOL, V156, P2098, DOI 10.1104/pp.111.176305; Fry Stephen C., 2004, Phytochemistry Reviews, V3, P97, DOI 10.1023/B:PHYT.0000047808.74647.43; Ghiani A, 2011, J EXP BOT, V62, P4043, DOI 10.1093/jxb/err109; Goulao L. F., 2010, Stewart Postharvest Review, V6, P7, DOI 10.2212/spr.2010.1.7; HARRIS PJ, 1976, NATURE, V259, P508, DOI 10.1038/259508a0; Heredia A, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2015.1019979; Hutzler P, 1998, J EXP BOT, V49, P953, DOI 10.1093/jexbot/49.323.953; Isaacson T, 2009, PLANT J, V60, P363, DOI 10.1111/j.1365-313X.2009.03969.x; Ishii T, 1997, PLANT SCI, V127, P111, DOI 10.1016/S0168-9452(97)00130-1; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; Kerstiens G, 2006, J EXP BOT, V57, P2547, DOI 10.1093/jxb/erl015; Klepacka J, 2006, CRIT REV FOOD SCI, V46, P639, DOI 10.1080/10408390500511821; Knoche M, 2004, PHYSIOL PLANTARUM, V120, P667, DOI 10.1111/j.0031-9317.2004.0285.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lara I, 2014, POSTHARVEST BIOL TEC, V87, P103, DOI 10.1016/j.postharvbio.2013.08.012; Leide J, 2007, PLANT PHYSIOL, V144, P1667, DOI 10.1104/pp.107.099481; LESTER DR, 1994, PLANT PHYSIOL, V105, P225, DOI 10.1104/pp.105.1.225; Liakopoulos G, 2001, ANN BOT-LONDON, V87, P641, DOI 10.1006/anbo.2001.1387; Lopez-Casado G, 2007, J EXP BOT, V58, P3875, DOI 10.1093/jxb/erm233; Lunn D, 2013, PLANT PHYSIOL BIOCH, V66, P91, DOI 10.1016/j.plaphy.2013.02.005; LUQUE P, 1995, ARCH BIOCHEM BIOPHYS, V317, P417, DOI 10.1006/abbi.1995.1183; Meyer S, 2003, J EXP BOT, V54, P757, DOI 10.1093/jxb/erg063; MIYAMOTO K, 1994, PHYSIOL PLANTARUM, V92, P350, DOI 10.1111/j.1399-3054.1994.tb05347.x; Palin R, 2012, BIOSYSTEMS, V109, P397, DOI 10.1016/j.biosystems.2012.04.006; Pan XQ, 2014, J PROTEOME RES, V13, P1979, DOI 10.1021/pr401091n; PETRACEK PD, 1995, PLANT PHYSIOL, V109, P675, DOI 10.1104/pp.109.2.675; Prasanna V, 2007, CRIT REV FOOD SCI, V47, P1, DOI 10.1080/10408390600976841; RILEY RG, 1975, PLANT PHYSIOL, V56, P650, DOI 10.1104/pp.56.5.650; Saladie M, 2007, PLANT PHYSIOL, V144, P1012, DOI 10.1104/pp.107.097477; TAN KS, 1992, J PLANT PHYSIOL, V140, P460, DOI 10.1016/S0176-1617(11)80825-4; Trainotti L, 2003, J EXP BOT, V54, P1821, DOI 10.1093/jxb/erg198; Vicente AR, 2007, J SCI FOOD AGR, V87, P1435, DOI 10.1002/jsfa.2837; Zdunek A, 2013, SENSORS-BASEL, V13, P12175, DOI 10.3390/s130912175; Ziosi V, 2008, POSTHARVEST BIOL TEC, V49, P319, DOI 10.1016/j.postharvbio.2008.01.017	48	10	10	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145341	10.1371/journal.pone.0145341	http://dx.doi.org/10.1371/journal.pone.0145341			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709823	Green Published, gold, Green Submitted			2022-12-26	WOS:000367451400039
J	Brandt, AR; Sun, YC; Bharadwaj, S; Livingston, D; Tan, E; Gordon, D				Brandt, Adam R.; Sun, Yuchi; Bharadwaj, Sharad; Livingston, David; Tan, Eugene; Gordon, Deborah			Energy Return on Investment (EROI) for Forty Global Oilfields Using a Detailed Engineering-Based Model of Oil Production	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; NET ENERGY; UNITED-STATES; INFORMATION GAPS; FUELS; EXTRACTION; EFFICIENCY; UNCERTAINTY; QUALITY; YIELD	Studies of the energy return on investment (EROI) for oil production generally rely on aggregated statistics for large regions or countries. In order to better understand the drivers of the energy productivity of oil production, we use a novel approach that applies a detailed field-level engineering model of oil and gas production to estimate energy requirements of drilling, producing, processing, and transporting crude oil. We examine 40 global oilfields, utilizing detailed data for each field from hundreds of technical and scientific data sources. Resulting net energy return (NER) ratios for studied oil fields range from approximate to 2 to approximate to 100 MJ crude oil produced per MJ of total fuels consumed. External energy return (EER) ratios, which compare energy produced to energy consumed from external sources, exceed 1000: 1 for fields that are largely self-sufficient. The lowest energy returns are found to come from thermally-enhanced oil recovery technologies. Results are generally insensitive to reasonable ranges of assumptions explored in sensitivity analysis. Fields with very large associated gas production are sensitive to assumptions about surface fluids processing due to the shifts in energy consumed under different gas treatment configurations. This model does not currently include energy invested in building oilfield capital equipment (e.g., drilling rigs), nor does it include other indirect energy uses such as labor or services.	[Brandt, Adam R.; Sun, Yuchi; Bharadwaj, Sharad] Stanford Univ, Dept Energy Resources Engn, Stanford, CA 94035 USA; [Livingston, David; Tan, Eugene; Gordon, Deborah] Carnegie Endowment Int Peace, Washington, DC 20036 USA	Stanford University	Brandt, AR (corresponding author), Stanford Univ, Dept Energy Resources Engn, 367 Panama St, Stanford, CA 94035 USA.	abrandt@stanford.edu			Oil-Climate Index project of Carnegie Endowment for International Peace; Blue Moon Fund; Oak Foundation; William and Flora Hewlett Foundation; Climate Works Foundation; Rockefeller Family Fund	Oil-Climate Index project of Carnegie Endowment for International Peace; Blue Moon Fund; Oak Foundation; William and Flora Hewlett Foundation; Climate Works Foundation; Rockefeller Family Fund	This research was supported by the Oil-Climate Index project of the Carnegie Endowment for International Peace, with support from the Blue Moon Fund, Oak Foundation, William and Flora Hewlett Foundation, Climate Works Foundation and the Rockefeller Family Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Oil-Climate Index co-authors Joule Bergerson and John Koomey contributed significantly to the broader effort on which this work is based. This research was supported by the Oil-Climate Index project of the Carnegie Endowment for International Peace, with support from the Blue Moon Fund, Oak Foundation, William and Flora Hewlett Foundation, Climate Works Foundation and the Rockefeller Family Fund.	Abella JP, 2012, ENVIRON SCI TECHNOL, V46, P13037, DOI 10.1021/es3018682; Air and Waste Management Association, 2012, 105 A WMA ANN C; Brandt AR, 2008, ENVIRON SCI TECHNOL, V42, P7489, DOI 10.1021/es800531f; Brandt AR, 2015, ENVIRON SCI TECHNOL, V49, P679, DOI 10.1021/es505376t; Brandt AR, 2013, ENERGY, V62, P235, DOI 10.1016/j.energy.2013.09.054; Brandt AR, 2013, ENERGY, V55, P693, DOI 10.1016/j.energy.2013.03.080; Brandt AR, 2011, SUSTAINABILITY-BASEL, V3, P1833, DOI 10.3390/su3101833; Brandt AR, 2011, ENERGIES, V4, P1211, DOI 10.3390/en4081211; Brandt AR, 2009, ENERG FUEL, V23, P6253, DOI 10.1021/ef900678d; Cleveland CJ, 2005, ENERGY, V30, P769, DOI 10.1016/j.energy.2004.05.023; CLEVELAND CJ, 1992, ECOL ECON, V6, P139; Cleveland CJ, 2006, NET ENERGY ANAL; Dale M, 2011, ENERG POLICY, V39, P7095, DOI 10.1016/j.enpol.2011.08.021; El-Houjeiri H. M., 2014, OIL PRODUCTION GREEN; El-Houjeiri HM, 2013, ENVIRON SCI TECHNOL, V47, P5998, DOI 10.1021/es304570m; Gagnon N, 2009, ENERGIES, V2, P490, DOI 10.3390/en20300490; Gerdes K., 2009, DOENETL20091362; Gerdes KJ, 2009, CONSIDERATION CRUDE; Gordon D., 2015, KNOW YOUR OIL CREATI; Grandell L, 2011, SUSTAINABILITY-BASEL, V3, P2050, DOI 10.3390/su3112050; Guilford MC, 2011, SUSTAINABILITY-BASEL, V3, P1866, DOI 10.3390/su3101866; Hall C.A., 1986, ENERGY RESOURCE QUAL; HALL CAS, 1981, SCIENCE, V211, P576, DOI 10.1126/science.211.4482.576; Hall CAS, 2014, ENERG POLICY, V64, P141, DOI 10.1016/j.enpol.2013.05.049; Herweyer MC, 2008, THE OIL DRUM; Hubbert MK, 1956, SHELL DEV CO PUBLICA, V95; Hubbert MK, 1958, M SO DISTR DIV PROD, V128; Kavanaugh M., 2015, FINANCIAL TIMES; Keesom W, 2009, LIFE CYCLE ASSESSMEN; Kong ZY, 2015, ENERGIES, V8, P786, DOI 10.3390/en8020786; Kopits S., 2014, OIL EC GROWTH SUPPLY; Murphy DJ, 2011, SUSTAINABILITY-BASEL, V3, P1888, DOI 10.3390/su3101888; Norgaard R., 1971, THESIS; Poisson A, 2013, ENERGIES, V6, P5940, DOI 10.3390/en6115940; Vafi K, 2014, ENVIRON SCI TECHNOL, V48, P12978, DOI 10.1021/es501847p; Vafi K, 2014, ENVIRON SCI TECHNOL, V48, P10511, DOI 10.1021/es502107s; Wang MQ, 2013, GREET MODEL 1 2013; Wang MQ, 2014, GREET MODEL 1 2014	38	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0144141	10.1371/journal.pone.0144141	http://dx.doi.org/10.1371/journal.pone.0144141			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ4SH	26695068	gold, Green Published, Green Submitted			2022-12-26	WOS:000367092500002
J	Habuka, M; Fagerberg, L; Hallstrom, BM; Ponten, F; Yamamoto, T; Uhlen, M				Habuka, Masato; Fagerberg, Linn; Hallstrom, Bjorn M.; Ponten, Fredrik; Yamamoto, Tadashi; Uhlen, Mathias			The Urinary Bladder Transcriptome and Proteome Defined by Transcriptomics and Antibody-Based Profiling	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; RNA-SEQ; EXPRESSION; UROTHELIUM; UROPLAKINS; GREMLIN; BIOLOGY; TRACT; SHH	To understand functions and diseases of urinary bladder, it is important to define its molecular constituents and their roles in urinary bladder biology. Here, we performed genome-wide deep RNA sequencing analysis of human urinary bladder samples and identified genes upregulated in the urinary bladder by comparing the transcriptome data to those of all other major human tissue types. 90 protein-coding genes were elevated in the urinary bladder, either with enhanced expression uniquely in the urinary bladder or elevated expression together with at least one other tissue (group enriched). We further examined the localization of these proteins by immunohistochemistry and tissue microarrays and 20 of these 90 proteins were localized to the whole urothelium with a majority not yet described in the context of the urinary bladder. Four additional proteins were found specifically in the umbrella cells (Uroplakin 1a, 2, 3a, and 3b), and three in the intermediate/basal cells (KRT17, PCP4L1 and ATP1A4). 61 of the 90 elevated genes have not been previously described in the context of urinary bladder and the corresponding proteins are interesting targets for more in-depth studies. In summary, an integrated omics approach using transcriptomics and antibody-based profiling has been used to define a comprehensive list of proteins elevated in the urinary bladder.	[Habuka, Masato; Fagerberg, Linn; Hallstrom, Bjorn M.; Uhlen, Mathias] KTH Royal Inst Technol, Sci Life Lab, SE-17121 Stockholm, Sweden; [Ponten, Fredrik] Uppsala Univ, Rudbeck Lab, Dept Immunol Genet & Pathol, SE-75185 Uppsala, Sweden; [Habuka, Masato; Yamamoto, Tadashi] Niigata Univ, Sch Med & Dent, Inst Nephrol, Dept Struct Pathol, Niigata 9518510, Japan; [Uhlen, Mathias] KTH Royal Inst Technol, Dept Prote, SE-10691 Stockholm, Sweden	Royal Institute of Technology; Uppsala University; Niigata University; Royal Institute of Technology	Uhlen, M (corresponding author), KTH Royal Inst Technol, Sci Life Lab, SE-17121 Stockholm, Sweden.	mathias.uhlen@scilifelab.se	Uhlen, Mathias/AAV-8746-2021; Uhlen, Mathias/B-3262-2016	Uhlen, Mathias/0000-0002-4858-8056; Fagerberg, Linn/0000-0003-0198-7137	Knut and Alice Wallenberg Foundation; Stockholm County Council	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Stockholm County Council(Stockholm County Council)	Funding was provided by the Knut and Alice Wallenberg Foundation (http://www.wallenberg.com/kaw/en) and by the Stockholm County Council (http://www.forskningsstod.sll.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andersson KE, 2004, PHYSIOL REV, V84, P935, DOI 10.1152/physrev.00038.2003; Cao M, 2008, PEDIATR RES, V64, P352, DOI 10.1203/PDR.0b013e318180e4c9; Castillo-Martin M, 2010, UROL ONCOL-SEMIN ORI, V28, P401, DOI 10.1016/j.urolonc.2009.04.019; Chung SS, 2013, IN VITRO CELL DEV-AN, V49, P746, DOI 10.1007/s11626-013-9662-9; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Gamer LW, 2005, DEV BIOL, V285, P156, DOI 10.1016/j.ydbio.2005.06.012; Hebenstreit D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.28; Higgins JPT, 2007, AM J SURG PATHOL, V31, P673, DOI 10.1097/01.pas.0000213438.01278.5f; Jenkins D, 2007, KIDNEY INT, V71, P195, DOI 10.1038/sj.ki.5002053; Jimenez T, 2011, BIOL REPROD, V84, P153, DOI 10.1095/biolreprod.110.087064; Kampf C, 2012, JOVE-J VIS EXP, DOI 10.3791/3620; Kampf C, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-103; Khokha MK, 2003, NAT GENET, V34, P303, DOI 10.1038/ng1178; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Kong KL, 2010, CANCER RES, V70, P8832, DOI 10.1158/0008-5472.CAN-10-0779; Lundberg E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.106; Mele M, 2015, SCIENCE, V348, P660, DOI 10.1126/science.aaa0355; Morgan MAJ, 2012, J NEUROCHEM, V121, P843, DOI 10.1111/j.1471-4159.2012.07745.x; N'Dow J, 2000, J UROLOGY, V164, P1398, DOI 10.1016/S0022-5347(05)67206-0; Nissim S, 2006, DEV BIOL, V299, P12, DOI 10.1016/j.ydbio.2006.05.026; Ponten F, 2008, J PATHOL, V216, P387, DOI 10.1002/path.2440; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sheth R, 2013, DEVELOPMENT, V140, P2130, DOI 10.1242/dev.089409; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wu XR, 2009, KIDNEY INT, V75, P1153, DOI 10.1038/ki.2009.73; Yamany T, 2014, CURR OPIN ORGAN TRAN, V19, P323, DOI 10.1097/MOT.0000000000000084; Yang MH, 2011, BIOCHEM BIOPH RES CO, V411, P714, DOI 10.1016/j.bbrc.2011.07.010; Yang YF, 2008, DIS ESOPHAGUS, V21, P395, DOI 10.1111/j.1442-2050.2007.00789.x; Ying SB, 2009, J DERMATOL SCI, V53, P2, DOI 10.1016/j.jdermsci.2008.09.009; Zhang SF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091466; Zhu JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028223	35	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145301	10.1371/journal.pone.0145301	http://dx.doi.org/10.1371/journal.pone.0145301			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26694548	Green Submitted, Green Published, gold			2022-12-26	WOS:000367092500037
J	Kohli, M; Wang, LG; Xie, F; Sicotte, H; Yin, P; Dehm, SM; Hart, SN; Vedell, PT; Barman, P; Qin, R; Mahoney, DW; Carlson, RE; Eckel-Passow, JE; Atwell, TD; Eiken, PW; McMenomy, BP; Wieben, ED; Jha, G; Jimenez, RE; Weinshilboum, R; Wang, LW				Kohli, Manish; Wang, Liguo; Xie, Fang; Sicotte, Hugues; Yin, Ping; Dehm, Scott M.; Hart, Steven N.; Vedell, Peter T.; Barman, Poulami; Qin, Rui; Mahoney, Douglas W.; Carlson, Rachel E.; Eckel-Passow, Jeanette E.; Atwell, Thomas D.; Eiken, Patrick W.; McMenomy, Brendan P.; Wieben, Eric D.; Jha, Gautam; Jimenez, Rafael E.; Weinshilboum, Richard; Wang, Liewei			Mutational Landscapes of Sequential Prostate Metastases and Matched Patient Derived Xenografts during Enzalutamide Therapy	PLOS ONE			English	Article							CANCER; EVOLUTION; MODELS	Developing patient derived models from individual tumors that capture the biological heterogeneity and mutation landscape in advanced prostate cancer is challenging, but essential for understanding tumor progression and delivery of personalized therapy in metastatic castrate resistant prostate cancer stage. To demonstrate the feasibility of developing patient derived xenograft models in this stage, we present a case study wherein xenografts were derived from cancer metastases in a patient progressing on androgen deprivation therapy and prior to initiating pre-chemotherapy enzalutamide treatment. Tissue biopsies from a metastatic rib lesion were obtained for sequencing before and after initiating enzalutamide treatment over a twelve-week period and also implanted subcutaneously as well as under the renal capsule in immuno-deficient mice. The genome and transcriptome landscapes of xenografts and the original patient tumor tissues were compared by performing whole exome and transcriptome sequencing of the metastatic tumor tissues and the xenografts at both time points. After comparing the somatic mutations, copy number variations, gene fusions and gene expression we found that the patient's genomic and transcriptomic alterations were preserved in the patient derived xenografts with high fidelity. These xenograft models provide an opportunity for predicting efficacy of existing and potentially novel drugs that is based on individual metastatic tumor expression signature and molecular pharmacology for delivery of precision medicine.	[Kohli, Manish; Yin, Ping] Mayo Clin, Dept Oncol, Rochester, MN 55905 USA; [Wang, Liguo; Sicotte, Hugues; Hart, Steven N.; Vedell, Peter T.; Barman, Poulami; Qin, Rui; Mahoney, Douglas W.; Carlson, Rachel E.; Eckel-Passow, Jeanette E.] Mayo Clin, Dept Hlth Sci, Div Biomed Stat & Informat, Rochester, MN USA; Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA; [Dehm, Scott M.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Atwell, Thomas D.; Eiken, Patrick W.; McMenomy, Brendan P.] Mayo Clin, Dept Radiol, Rochester, MN USA; [Wieben, Eric D.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN USA; [Jha, Gautam] Univ Minnesota, Div Hematol Oncol, Minneapolis, MN USA; [Jimenez, Rafael E.] Mayo Clin, Dept Pathol & Lab Med, Rochester, MN USA; [Xie, Fang; Weinshilboum, Richard; Wang, Liewei] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN USA	Mayo Clinic; Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Mayo Clinic; Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities; Mayo Clinic; Mayo Clinic	Kohli, M (corresponding author), Mayo Clin, Dept Oncol, Rochester, MN 55905 USA.	kohli.manish@mayo.edu; wang.liguo@mayo.edu	Barman, Poulami/ABG-1426-2020; Kohli, Manish/AAN-8862-2021; Hart, Steven/AAI-4761-2021; Jimenez, Rafael/AAG-9814-2020	Barman, Poulami/0000-0002-4604-9868; Hart, Steven/0000-0001-7714-2734; Wang, Liguo/0000-0003-2072-4826	National Institutes of Health [R01CA174777]; Minnesota Partnership for Biotechnology and Medical Genomics grant [14.37]; Mayo Clinic Centre for Individualized Medicine; Mayo Clinic Schulze Cancer for Novel Therapeutics in Cancer Research; Pharmacogenomics Research Network; NATIONAL CANCER INSTITUTE [R01CA174777, P30CA015083] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Minnesota Partnership for Biotechnology and Medical Genomics grant; Mayo Clinic Centre for Individualized Medicine; Mayo Clinic Schulze Cancer for Novel Therapeutics in Cancer Research; Pharmacogenomics Research Network; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding provided by National Institutes of Health grant R01CA174777 (to S. M. D.), http://projectreporter.nih.gov/project_info_details.cfm?aid=8826081&icde=25365178&ddparam=&ddvalue=&ddsub=&cr=1&csb=default&cs=ASC, Minnesota Partnership for Biotechnology and Medical Genomics grant #14.37 (to M. K. and S. M. D.), http://minnesotapartnership.info/2015/04/minnesotapartnership-awards-six-new-research-grants/ and Private and philanthropy funding sources: i) The study is funded in part by the Mayo Clinic Centre for Individualized Medicine; ii) A. T. Suharya and Ghan D. H.; iii) Joseph and Gail Gassner; iv) Mayo Clinic Schulze Cancer for Novel Therapeutics in Cancer Research. v) Pharmacogenomics Research Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study is supported by the Mayo Clinic Centre for Individualized Medicine and the Pharmacogenomics Research Network (PGRN). This work was also supported by NIH grant R01CA174777 (to S.M.D.)	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Antonarakis ES, 2014, NEW ENGL J MED, V371, P1028, DOI 10.1056/NEJMoa1315815; Barbieri CE, 2013, EUR UROL, V64, P567, DOI 10.1016/j.eururo.2013.05.029; Beer TM, 2014, NEW ENGL J MED, V371, P424, DOI 10.1056/NEJMoa1405095; Beltran H, 2014, CLIN CANCER RES, V20, P2846, DOI 10.1158/1078-0432.CCR-13-3309; Bullock AN, 2000, ONCOGENE, V19, P1245, DOI 10.1038/sj.onc.1203434; Conway T, 2012, BIOINFORMATICS, V28, pI172, DOI 10.1093/bioinformatics/bts236; Corey E, 2003, PROSTATE, V56, P110, DOI 10.1002/pros.10235; Edwards J, 2003, CLIN CANCER RES, V9, P5271; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Hidalgo M, 2014, CANCER DISCOV, V4, P998, DOI 10.1158/2159-8290.CD-14-0001; Kalari KR, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-224; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r72; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Larson DE, 2012, BIOINFORMATICS, V28, P311, DOI 10.1093/bioinformatics/btr665; Lawrence MG, 2013, NAT PROTOC, V8, P836, DOI 10.1038/nprot.2013.043; Li Y, 2012, ONCOGENE, V31, P4759, DOI 10.1038/onc.2011.637; Lin D, 2014, ASIAN J ANDROL, V16, P407, DOI 10.4103/1008-682X.125394; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nicholson TM, 2013, JOVE-J VIS EXP, DOI 10.3791/50574; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Pritchyk KM, 2002, LARYNGOSCOPE, V112, P1598, DOI 10.1097/00005537-200209000-00012; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Roth A, 2012, BIOINFORMATICS; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Siolas D, 2013, CANCER RES, V73, P5315, DOI 10.1158/0008-5472.CAN-13-1069; Spiotto Michael T, 2013, J Oral Maxillofac Res, V4, pe1, DOI 10.5037/jomr.2013.4101; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Van Allen EM, 2014, PROSTATE CANCER P D, V17, P23, DOI 10.1038/pcan.2013.37; Wang C, 2014, BIOINFORMATICS; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Yates LR, 2012, NAT REV GENET, V13, P795, DOI 10.1038/nrg3317	35	17	17	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145176	10.1371/journal.pone.0145176	http://dx.doi.org/10.1371/journal.pone.0145176			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26695660	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092500026
J	Rehm, C; Wurmthaler, LA; Li, YH; Frickey, T; Hartig, JS				Rehm, Charlotte; Wurmthaler, Lena A.; Li, Yuanhao; Frickey, Tancred; Hartig, Joerg S.			Investigation of a Quadruplex-Forming Repeat Sequence Highly Enriched in Xanthomonas and Nostoc sp.	PLOS ONE			English	Article							NON-B DNA; INDUCED GENETIC INSTABILITY; I-MOTIF; ESCHERICHIA-COLI; NEISSERIA-GONORRHOEAE; PROKARYOTIC GENOMES; ANTIGENIC VARIATION; PROMOTER REGION; TANDEM REPEATS; BACTERIAL ADAPTATION	In prokaryotes simple sequence repeats (SSRs) with unit sizes of 1-5 nucleotides (nt) are causative for phase and antigenic variation. Although an increased abundance of heptameric repeats was noticed in bacteria, reports about SSRs of 6-9 nt are rare. In particular G-rich repeat sequences with the propensity to fold into G-quadruplex (G4) structures have received little attention. In silico analysis of prokaryotic genomes show putative G4 forming sequences to be abundant. This report focuses on a surprisingly enriched G-rich repeat of the type GGGNATC in Xanthomonas and cyanobacteria such as Nostoc. We studied in detail the genomes of Xanthomonas campestris pv. campestris ATCC 33913 (Xcc), Xanthomonas axonopodis pv. citri str. 306 (Xac), and Nostoc sp. strain PCC7120 (Ana). In all three organisms repeats are spread all over the genome with an over-representation in non-coding regions. Extensive variation of the number of repetitive units was observed with repeat numbers ranging from two up to 26 units. However a clear preference for four units was detected. The strong bias for four units coincides with the requirement of four consecutive G-tracts for G4 formation. Evidence for G4 formation of the consensus repeat sequences was found in biophysical studies utilizing CD spectroscopy. The G-rich repeats are preferably located between aligned open reading frames (ORFs) and are under-represented in coding regions or between divergent ORFs. The G-rich repeats are preferentially located within a distance of 50 bp upstream of an ORF on the anti-sense strand or within 50 bp from the stop codon on the sense strand. Analysis of whole transcriptome sequence data showed that the majority of repeat sequences are transcribed. The genetic loci in the vicinity of repeat regions show increased genomic stability. In conclusion, we introduce and characterize a special class of highly abundant and wide-spread quadruplex-forming repeat sequences in bacteria.	[Rehm, Charlotte; Wurmthaler, Lena A.; Hartig, Joerg S.] Univ Konstanz, Dept Chem, D-78457 Constance, Germany; [Rehm, Charlotte; Wurmthaler, Lena A.; Hartig, Joerg S.] Univ Konstanz, Konstanz Res Sch Chem Biol KoRS CB, D-78457 Constance, Germany; [Li, Yuanhao; Frickey, Tancred] Univ Konstanz, Dept Biol, D-78457 Constance, Germany	University of Konstanz; University of Konstanz; University of Konstanz	Hartig, JS (corresponding author), Univ Konstanz, Dept Chem, Univ Str 10, D-78457 Constance, Germany.	joerg.hartig@uni-konstanz.de			China Scholarship Council; Konstanz Research School Chemical Biology; SFB 969	China Scholarship Council(China Scholarship Council); Konstanz Research School Chemical Biology; SFB 969	We thank the members of the Hartig group for helpful discussions. Yuanhao Li thanks the China Scholarship Council for financial support. Jorg S. Hartig thanks the Konstanz Research School Chemical Biology and the SFB 969 for financial support.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Beaume N, 2013, NUCLEIC ACIDS RES, V41, P76, DOI 10.1093/nar/gks1071; Benabou S, 2014, BBA-GEN SUBJECTS, V1840, P41, DOI 10.1016/j.bbagen.2013.08.028; Bichara M, 2006, MUTAT RES-FUND MOL M, V598, P144, DOI 10.1016/j.mrfmmm.2006.01.020; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; Bolger AM, 2014, BIOINFORMATICS; Brazda V, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-33; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Cahoon LA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003074; Cahoon LA, 2011, MOL MICROBIOL, V81, P1136, DOI 10.1111/j.1365-2958.2011.07773.x; Cahoon LA, 2009, SCIENCE, V325, P764, DOI 10.1126/science.1175653; Choi J, 2011, CHEM SOC REV, V40, P5893, DOI 10.1039/c1cs15153c; Cogoi S, 2006, NUCLEIC ACIDS RES, V34, P2536, DOI 10.1093/nar/gkl286; Collin D, 1998, J AM CHEM SOC, V120, P4069, DOI 10.1021/ja973346r; CORREIA FF, 1988, J BIOL CHEM, V263, P12194; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; Day HA, 2014, BIOORGAN MED CHEM, V22, P4407, DOI 10.1016/j.bmc.2014.05.047; Delihas N, 2011, GENOME BIOL EVOL, V3, P959, DOI 10.1093/gbe/evr077; Du XJ, 2013, NUCLEIC ACIDS RES, V41, P5965, DOI 10.1093/nar/gkt308; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Endoh T, 2013, ANAL CHEM, V85, P11435, DOI 10.1021/ac402497x; Endoh T, 2013, ANGEW CHEM INT EDIT, V52, P5522, DOI 10.1002/anie.201300058; Gemayel R, 2010, ANNU REV GENET, V44, P445, DOI 10.1146/annurev-genet-072610-155046; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gur-Arie R, 2000, GENOME RES, V10, P62; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Han XG, 1998, J MOL BIOL, V278, P949, DOI 10.1006/jmbi.1998.1740; Hannan AJ, 2010, DISCOV MED, V10, P314; Henderson IR, 1999, MOL MICROBIOL, V33, P919, DOI 10.1046/j.1365-2958.1999.01555.x; Holder Isabelle T, CHEM BIOL; Holder Isabelle T, 2014, CHEM BIOL, V21, P1511; HTUN H, 1989, SCIENCE, V243, P1571, DOI 10.1126/science.2648571; Huang YJ, 2014, DNA RES, V21, P285, DOI 10.1093/dnares/dst057; Huppert JL, 2008, CHEM SOC REV, V37, P1375, DOI 10.1039/b702491f; Jalan N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-551; Joachimi A, 2009, BIOORGAN MED CHEM, V17, P6811, DOI 10.1016/j.bmc.2009.08.043; JOHNSTON BH, 1992, METHOD ENZYMOL, V211, P127; Joukhadar Reem, 2012, BMC Res Notes, V5, P556, DOI 10.1186/1756-0500-5-556; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kaneko T, 2001, DNA RES, V8, P205, DOI 10.1093/dnares/8.5.205; Kassai-Jager E, 2008, GENE, V410, P18, DOI 10.1016/j.gene.2007.11.006; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026; Lacroix L, 1996, BIOCHEMISTRY-US, V35, P8715, DOI 10.1021/bi960107s; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Lin WH, 2012, NUCLEIC ACIDS RES, V40, P2399, DOI 10.1093/nar/gkr1078; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MALFOY B, 1986, NUCLEIC ACIDS RES, V14, P3197, DOI 10.1093/nar/14.8.3197; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Martin P, 2005, P NATL ACAD SCI USA, V102, P3800, DOI 10.1073/pnas.0406805102; MAZEL D, 1990, J BACTERIOL, V172, P2755, DOI 10.1128/jb.172.5.2755-2761.1990; McLuckie KIE, 2011, J AM CHEM SOC, V133, P2658, DOI 10.1021/ja109474c; MERGNY JL, 1995, J AM CHEM SOC, V117, P8887, DOI 10.1021/ja00140a001; MIRKIN SM, 1994, ANNU REV BIOPH BIOM, V23, P541, DOI 10.1146/annurev.bb.23.060194.002545; MOXON ER, 1994, CURR BIOL, V4, P24, DOI 10.1016/S0960-9822(00)00005-1; Moxon R, 2006, ANNU REV GENET, V40, P307, DOI 10.1146/annurev.genet.40.110405.090442; Mrazek J, 2006, MOL BIOL EVOL, V23, P1370, DOI 10.1093/molbev/msk023; Mrazek J, 2007, P NATL ACAD SCI USA, V104, P8472, DOI 10.1073/pnas.0702412104; Murat P, 2014, CURR OPIN GENET DEV, V25, P22, DOI 10.1016/j.gde.2013.10.012; Nakao M, 2010, NUCLEIC ACIDS RES, V38, pD379, DOI 10.1093/nar/gkp915; Qian W, 2005, GENOME RES, V15, P757, DOI 10.1101/gr.3378705; Rando OJ, 2007, CELL, V128, P655, DOI 10.1016/j.cell.2007.01.023; Ryan RP, 2011, NAT REV MICROBIOL, V9, P344, DOI 10.1038/nrmicro2558; Schlotterer C, 2006, J EVOLUTION BIOL, V19, P1671, DOI 10.1111/j.1420-9101.2006.01108.x; Shabala L, 2009, ENVIRON MICROBIOL, V11, P137, DOI 10.1111/j.1462-2920.2008.01748.x; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; STERN A, 1986, CELL, V47, P61, DOI 10.1016/0092-8674(86)90366-1; SWANSON RV, 1992, J BACTERIOL, V174, P2640, DOI 10.1128/jb.174.8.2640-2647.1992; Tobes R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-62; Treangen TJ, 2009, FEMS MICROBIOL REV, V33, P539, DOI 10.1111/j.1574-6976.2009.00169.x; van Belkum A, 1999, RES MICROBIOL, V150, P617, DOI 10.1016/S0923-2508(99)00129-1; van der Woude MW, 2004, CLIN MICROBIOL REV, V17, P581, DOI 10.1128/CMR.17.3.581-611.2004; VANHAM SM, 1993, CELL, V73, P1187, DOI 10.1016/0092-8674(93)90647-9; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Wang GL, 2006, MUTAT RES-FUND MOL M, V598, P103, DOI 10.1016/j.mrfmmm.2006.01.019; Wang GL, 2014, DNA REPAIR, V19, P143, DOI 10.1016/j.dnarep.2014.03.017; Wang GL, 2009, MOL CARCINOGEN, V48, P286, DOI 10.1002/mc.20508; Westra ER, 2014, NAT REV MICROBIOL, V12, P317, DOI 10.1038/nrmicro3241; Wieland M, 2007, CHEM BIOL, V14, P757, DOI 10.1016/j.chembiol.2007.06.005; Xu Y, 2006, NUCLEIC ACIDS RES, V34, P949, DOI 10.1093/nar/gkj485; Yadav VK, 2008, NUCLEIC ACIDS RES, V36, pD381, DOI 10.1093/nar/gkm781; Yang J, 2003, GENE, V322, P85, DOI 10.1016/j.gene.2003.09.017; Zhou K, 2014, FEMS MICROBIOL REV, V38, P119, DOI 10.1111/1574-6976.12036	85	11	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0144275	10.1371/journal.pone.0144275	http://dx.doi.org/10.1371/journal.pone.0144275			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26695179	Green Submitted, Green Published, gold			2022-12-26	WOS:000367092500003
J	Imoto, N; Hayakawa, F; Kurahashi, S; Morishita, T; Kojima, Y; Yasuda, T; Sugimoto, K; Tsuzuki, S; Naoe, T; Kiyoi, H				Imoto, Naoto; Hayakawa, Fumihiko; Kurahashi, Shingo; Morishita, Takanobu; Kojima, Yuki; Yasuda, Takahiko; Sugimoto, Keiki; Tsuzuki, Shinobu; Naoe, Tomoki; Kiyoi, Hitoshi			B Cell Linker Protein (BLNK) Is a Selective Target of Repression by PAX5-PML Protein in the Differentiation Block That Leads to the Development of Acute Lymphoblastic Leukemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; ARSENIC-TRIOXIDE; NUCLEAR-BODIES; FUSION PROTEIN; BSAP PAX-5; PML; ACTIVATION; GENE; ACTS; CD19	PAX5 is a transcription factor that is required for the development and maintenance of B cells. Promyelocytic leukemia (PML) is a tumor suppressor and proapoptotic factor. The fusion gene PAX5-PML has been identified in acute lymphoblastic leukemia with chromosomal translocation t(9;15)(p13;q24). We have reported previously that PAX5-PML dominant-negatively inhibited PAX5 transcriptional activity and impaired PML function by disrupting PML nuclear bodies (NBs). Here we demonstrated the leukemogenicity of PAX5-PML by introducing it into normal mouse pro-B cells. Arrest of differentiation was observed in PAX5-PML-introduced pro-B cells, resulting in the development of acute lymphoblastic leukemia after a long latency in mice. Among the transactivation targets of PAX5, B cell linker protein (BLNK) was repressed selectively in leukemia cells, and enforced BLNK expression abrogated the differentiation block and survival induced by PAX5-PML, indicating the importance of BLNK repression for the formation of preleukemic state. We also showed that PML NBs were intact in leukemia cells and attributed this to the low expression of PAX5-PML, indicating that the disruption of PML NBs was not required for the PAX5-PML-induced onset of leukemia. These results provide novel insights into the molecular mechanisms underlying the onset of leukemia by PAX5 mutations.	[Imoto, Naoto; Hayakawa, Fumihiko; Morishita, Takanobu; Kojima, Yuki; Kiyoi, Hitoshi] Nagoya Univ, Grad Sch Med, Dept Hematol & Oncol, Nagoya, Aichi 4668550, Japan; [Kurahashi, Shingo] Toyohashi Municipal Hosp, Div Hematol & Oncol, Toyohashi, Aichi 4418570, Japan; [Yasuda, Takahiko] Univ Tokyo, Grad Sch Med, Dept Cellular Signaling, Tokyo 1138654, Japan; [Sugimoto, Keiki] Otsuka Pharmaceut Co Ltd, Fujii Mem Res Inst, Otsu, Shiga 5200106, Japan; [Tsuzuki, Shinobu] Aichi Canc Ctr, Res Inst, Div Mol Med, Nagoya, Aichi 4648681, Japan; [Naoe, Tomoki] Natl Hosp Org, Nagoya Med Ctr, Nagoya, Aichi 4600001, Japan	Nagoya University; University of Tokyo; Otsuka Pharmaceutical; Aichi Cancer Center; Nagoya Medical Center	Hayakawa, F (corresponding author), Nagoya Univ, Sch Med, Dept Hematol & Oncol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	bun-hy@med.nagoya-u.ac.jp	Yasuda, Takahiko/AGQ-5448-2022; Naoe, Tomoki/I-1888-2012; Imoto, Naoto/AAB-7504-2022	Yasuda, Takahiko/0000-0002-4686-0976; Imoto, Naoto/0000-0003-0567-8761; Kojima, Yuki/0000-0002-1558-5510; Tsuzuki, Shinobu/0000-0002-3209-3550	MHLW KAKENHI [H22-3jigan-Ippan-010, H26-Kakushintekigan-Ippan-133]; JSPS KAKENHI [23591381, 25118711, 25293218, 25670449]; Program to Disseminate Tenure Tracking System; Ministry of Education, Culture, Sport, Science and Technology, Japan; Ministry of Education, Culture, Sports, Science, and Technology, Japan; Otsuka Pharmaceutical Co. Ltd.; Bristol-Myers Squibb; Novartis Pharma; Chugai Pharmaceutical Co. Ltd.; Kyowa Hakko Kirin Co. Ltd.; Dainippon Sumitomo Pharma; Zenyaku Kogyo; Fujifilm Corp.; Grants-in-Aid for Scientific Research [15K09492] Funding Source: KAKEN	MHLW KAKENHI; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Program to Disseminate Tenure Tracking System; Ministry of Education, Culture, Sport, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Otsuka Pharmaceutical Co. Ltd.(Otsuka Pharmaceutical); Bristol-Myers Squibb(Bristol-Myers Squibb); Novartis Pharma; Chugai Pharmaceutical Co. Ltd.; Kyowa Hakko Kirin Co. Ltd.(Kyowa Kirin Ltd); Dainippon Sumitomo Pharma(Dainippon Sumitomo Pharma Co., Ltd.); Zenyaku Kogyo; Fujifilm Corp.; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by MHLW KAKENHI Grants H22-3jigan-Ippan-010 and H26-Kakushintekigan-Ippan-133 and JSPS KAKENHI Grants 23591381, 25118711, 25293218, and 25670449. This work was also supported by the Program to Disseminate Tenure Tracking System, the Ministry of Education, Culture, Sport, Science and Technology, Japan and the Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. T.N. received research funding from Otsuka Pharmaceutical Co. Ltd., Bristol-Myers Squibb, Novartis Pharma, Chugai Pharmaceutical Co. Ltd., Kyowa Hakko Kirin Co. Ltd., Dainippon Sumitomo Pharma, Zenyaku Kogyo, and Fujifilm Corp. K. S. is an employee of Otsuka Pharmaceutical Co., Ltd. H. K. received research funding from Bristol-Myers Squibb, Chugai Pharmaceutical Co. Ltd., Kyowa Hakko Kirin Co. Ltd., Dainippon Sumitomo Pharma, Zenyaku Kogyo, and Fujifilm Corp.	Arita K, 2014, LEUKEMIA, V28, P2270, DOI 10.1038/leu.2014.224; Bousquet M, 2007, BLOOD, V109, P3417, DOI 10.1182/blood-2006-05-025221; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; Chen GQ, 1997, BLOOD, V89, P3345; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; DYCK JA, 1994, CELL, V76, P333, DOI 10.1016/0092-8674(94)90340-9; ENGEL P, 1995, IMMUNITY, V3, P39, DOI 10.1016/1074-7613(95)90157-4; Familiades J, 2009, LEUKEMIA, V23, P1989, DOI 10.1038/leu.2009.135; Fazio G, 2008, CANCER RES, V68, P181, DOI 10.1158/0008-5472.CAN-07-2778; Hayakawa F, 2004, CANCER CELL, V5, P389, DOI 10.1016/S1535-6108(04)00082-0; Hayakawa F, 2004, J LEUKOCYTE BIOL, V75, P529, DOI 10.1189/jlb.0603289; Heltemes-Harris LM, 2011, J EXP MED, V208, P1135, DOI 10.1084/jem.20101947; Ishov AM, 1999, J CELL BIOL, V147, P221, DOI 10.1083/jcb.147.2.221; Kawamata N, 2008, P NATL ACAD SCI USA, V105, P11921, DOI 10.1073/pnas.0711039105; KOKEN MHM, 1994, EMBO J, V13, P1073, DOI 10.1002/j.1460-2075.1994.tb06356.x; KOZMIK Z, 1992, MOL CELL BIOL, V12, P2662, DOI 10.1128/MCB.12.6.2662; Kurahashi S, 2011, ONCOGENE, V30, P1822, DOI 10.1038/onc.2010.554; Maier H, 2003, NUCLEIC ACIDS RES, V31, P5483, DOI 10.1093/nar/gkg785; Morrison AM, 1998, SEMIN IMMUNOL, V10, P133, DOI 10.1006/smim.1998.0115; Muller S, 1998, EMBO J, V17, P61, DOI 10.1093/emboj/17.1.61; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Nebral K, 2007, BRIT J HAEMATOL, V139, P269, DOI 10.1111/j.1365-2141.2007.06731.x; Niu C, 1999, BLOOD, V94, P3315, DOI 10.1182/blood.V94.10.3315.422k16_3315_3324; Nutt SL, 1998, EMBO J, V17, P2319, DOI 10.1093/emboj/17.8.2319; Pappu R, 1999, SCIENCE, V286, P1949, DOI 10.1126/science.286.5446.1949; Pelanda R, 2002, J IMMUNOL, V169, P865, DOI 10.4049/jimmunol.169.2.865; Qiu JJ, 2011, ONCOGENE, V30, P967, DOI 10.1038/onc.2010.473; Rivella S, 2003, BLOOD, V101, P2932, DOI 10.1182/blood-2002-10-3305; Schebesta M, 2002, IMMUNITY, V17, P473, DOI 10.1016/S1074-7613(02)00418-1; Tsuzuki S, 2013, STEM CELLS, V31, P236, DOI 10.1002/stem.1277; Wang ZG, 1998, NAT GENET, V20, P266, DOI 10.1038/3073; Wang ZG, 1998, SCIENCE, V279, P1547; WEIS K, 1994, CELL, V76, P345, DOI 10.1016/0092-8674(94)90341-7; Zhu J, 1997, P NATL ACAD SCI USA, V94, P3978, DOI 10.1073/pnas.94.8.3978	34	12	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4723	4731		10.1074/jbc.M115.637835	http://dx.doi.org/10.1074/jbc.M115.637835			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26703467	hybrid, Green Published			2022-12-26	WOS:000371604600038
J	Favaro, VM; Yonamine, M; Soares, JCK; Oliveira, MGM				Favaro, Vanessa Manchim; Yonamine, Mauricio; Kramer Soares, Juliana Carlota; Menezes Oliveira, Maria Gabriela			Effects of Long-Term Ayahuasca Administration on Memory and Anxiety in Rats	PLOS ONE			English	Article							N,N-DIMETHYLTRYPTAMINE; ALKALOIDS; LESIONS; MAZE	Ayahuasca is a hallucinogenic beverage that combines the action of the 5-HT2A/2C agonist N,N-dimethyltryptamine (DMT) from Psychotria viridis with the monoamine oxidase inhibitors (MAOIs) induced by beta-carbonyls from Banisteriopsis caapi. Previous investigations have highlighted the involvement of ayahuasca with the activation of brain regions known to be involved with episodic memory, contextual associations and emotional processing after ayahuasca ingestion. Moreover long term users show better performance in neuropsychological tests when tested in off-drug condition. This study evaluated the effects of long-term administration of ayahuasca on Morris water maze (MWM), fear conditioning and elevated plus maze (EPM) performance in rats. Behavior tests started 48h after the end of treatment. Freeze-dried ayahuasca doses of 120, 240 and 480 mg/kg were used, with water as the control. Long-term administration consisted of a daily oral dose for 30 days by gavage. The behavioral data indicated that long-term ayahuasca administration did not affect the performance of animals in MWM and EPM tasks. However the dose of 120 mg/kg increased the contextual conditioned fear response for both background and foreground fear conditioning. The tone conditioned response was not affected after long-term administration. In addition, the increase in the contextual fear response was maintained during the repeated sessions several weeks after training. Taken together, these data showed that long-term ayahuasca administration in rats can interfere with the contextual association of emotional events, which is in agreement with the fact that the beverage activates brain areas related to these processes.	[Favaro, Vanessa Manchim; Kramer Soares, Juliana Carlota; Menezes Oliveira, Maria Gabriela] Univ Fed Sao Paulo UNIFESP, Dept Psicobiol, Sao Paulo, SP, Brazil; [Yonamine, Mauricio] Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Anal Clin & Toxicol, Sao Paulo, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo	Oliveira, MGM (corresponding author), Univ Fed Sao Paulo UNIFESP, Dept Psicobiol, Sao Paulo, SP, Brazil.	gabi.oliveira@gmail.com	Soares, Juliana Carlota Kramer/M-6110-2014; Yonamine, Mauricio/C-6316-2012	Soares, Juliana Carlota Kramer/0000-0003-3464-6208; Yonamine, Mauricio/0000-0002-4615-1088	Sao Paulo Research Foundation (FAPESP) [2011/03791-3]; Research Incentive Fund Association (AFIP); Coordination for the Improvement of Higher Education Personnel (CAPES); National Council of Scientific and Technological Development (CNPq)	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Research Incentive Fund Association (AFIP); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council of Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was financially supported by a grant #2011/03791-3 by Sao Paulo Research Foundation (FAPESP), by the Research Incentive Fund Association (AFIP), by the Coordination for the Improvement of Higher Education Personnel (CAPES) and by the National Council of Scientific and Technological Development (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRITZKY W, 1989, J PSYCHOACTIVE DRUGS, V21, P77, DOI 10.1080/02791072.1989.10472145; Callaway JC, 1996, J ANAL TOXICOL, V20, P492, DOI 10.1093/jat/20.6.492; Bouso JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042421; de Araujo DB, 2012, HUM BRAIN MAPP, V33, P2550, DOI 10.1002/hbm.21381; de Castro-Neto Eduardo Ferreira, 2013, World J Biol Chem, V4, P141, DOI 10.4331/wjbc.v4.i4.141; Grob CS, 1996, J NERV MENT DIS, V184, P86, DOI 10.1097/00005053-199602000-00004; Halpern JH, 2004, PHARMACOL THERAPEUT, V102, P131, DOI 10.1016/j.pharmthera.2004.03.003; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lowry CA, 2005, STRESS, V8, P233, DOI 10.1080/10253890500492787; McKenna D, 1998, REV PSYCHEDELIC RES; McKenna DJ, 2004, PHARMACOL THERAPEUT, V102, P111, DOI 10.1016/j.pharmathera.2004.03.002; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nichols DE, 2004, PHARMACOL THERAPEUT, V101, P131, DOI 10.1016/j.pharmthera.2003.11.002; PACKARD MG, 1992, BEHAV NEUROSCI, V106, P439, DOI 10.1037/0735-7044.106.3.439; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; PHILLIPS RG, 1994, LEARN MEMORY, V1, P34; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Riba J, 2006, PSYCHOPHARMACOLOGY, V186, P93, DOI 10.1007/s00213-006-0358-7; Pires APS, 2009, PHYTOCHEM ANALYSIS, V20, P149, DOI 10.1002/pca.1110; Shreve-Neiger AK, 2004, CLIN PSYCHOL REV, V24, P379, DOI 10.1016/j.cpr.2004.02.003; Smith RL, 1998, PHARMACOL BIOCHEM BE, V61, P323, DOI 10.1016/S0091-3057(98)00110-5; Tupper KW, 2008, INT J DRUG POLICY, V19, P297, DOI 10.1016/j.drugpo.2006.11.001	23	15	16	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145840	10.1371/journal.pone.0145840	http://dx.doi.org/10.1371/journal.pone.0145840			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716991	gold, Green Published, Green Submitted			2022-12-26	WOS:000367510500082
J	Herrmann, S; Kluess, D; Kaehler, M; Grawe, R; Rachholz, R; Souffrant, R; Zierath, J; Bader, R; Woernle, C				Herrmann, Sven; Kluess, Daniel; Kaehler, Michael; Grawe, Robert; Rachholz, Roman; Souffrant, Robert; Zierath, Janos; Bader, Rainer; Woernle, Christoph			A Novel Approach for Dynamic Testing of Total Hip Dislocation under Physiological Conditions	PLOS ONE			English	Article							HUMAN JOINT MOTION; CERAMIC ACETABULAR CUPS; FINITE-ELEMENT-ANALYSIS; CLOSED-LOOP PROBLEMS; ISB RECOMMENDATION; CONTACT FORCES; LOWER-LIMB; COORDINATE SYSTEMS; MUSCLE FORCES; HEAD SIZE	Constant high rates of dislocation-related complications of total hip replacements (THRs) show that contributing factors like implant position and design, soft tissue condition and dynamics of physiological motions have not yet been fully understood. As in vivo measurements of excessive motions are not possible due to ethical objections, a comprehensive approach is proposed which is capable of testing THR stability under dynamic, reproducible and physiological conditions. The approach is based on a hardware-in-the-loop (HiL) simulation where a robotic physical setup interacts with a computational musculoskeletal model based on inverse dynamics. A major objective of this work was the validation of the HiL test system against in vivo data derived from patients with instrumented THRs. Moreover, the impact of certain test conditions, such as joint lubrication, implant position, load level in terms of body mass and removal of muscle structures, was evaluated within several HiL simulations. The outcomes for a normal sitting down and standing up maneuver revealed good agreement in trend and magnitude compared with in vivo measured hip joint forces. For a deep maneuver with femoral adduction, lubrication was shown to cause less friction torques than under dry conditions. Similarly, it could be demonstrated that less cup anteversion and inclination lead to earlier impingement in flexion motion including pelvic tilt for selected combinations of cup and stem positions. Reducing body mass did not influence impingement-free range of motion and dislocation behavior; however, higher resisting torques were observed under higher loads. Muscle removal emulating a posterior surgical approach indicated alterations in THR loading and the instability process in contrast to a reference case with intact musculature. Based on the presented data, it can be concluded that the HiL test system is able to reproduce comparable joint dynamics as present in THR patients.	[Herrmann, Sven; Kluess, Daniel; Souffrant, Robert; Bader, Rainer] Univ Med Rostock, Dept Orthopaed, Rostock, Germany; [Kaehler, Michael; Grawe, Robert; Rachholz, Roman; Zierath, Janos; Woernle, Christoph] Univ Rostock, Fac Mech Engn & Marine Technol, Chair Tech Dynam, D-18055 Rostock, Germany	University of Rostock; University of Rostock	Woernle, C (corresponding author), Univ Rostock, Fac Mech Engn & Marine Technol, Chair Tech Dynam, D-18055 Rostock, Germany.	woernle@uni-rostock.de	Herrmann, Sven/AAD-4384-2019	Herrmann, Sven/0000-0001-5287-0751; Zierath, Janos/0000-0001-5185-9649; Kluess, Daniel/0000-0003-1244-6360	Deutsche Forschungsgemeinschaft [WO 452/8-1, WO 452/8-2, BA 3347/3-1, BA 3347/3-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (http://www.dfg.de/), Grant numbers WO 452/8-1, WO 452/8-2 for CW and BA 3347/3-1, BA 3347/3-2 for RB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AN KN, 1989, J BIOMECH, V22, P1249, DOI 10.1016/0021-9290(89)90227-3; Anderson FC, 2001, J BIOMECH, V34, P153, DOI 10.1016/S0021-9290(00)00155-X; Bader R, 2004, BIOMED TECH, V49, P137, DOI 10.1515/BMT.2004.027; Bader R, 1999, BIOMED TECH, V44, P212, DOI 10.1515/bmte.1999.44.7-8.212; Bader R, 1999, BIOMED TECH, V44, P345, DOI 10.1515/bmte.1999.44.12.345; Baker R, 2003, J BIOMECH, V36, P300, DOI 10.1016/S0021-9290(02)00336-6; Bartz RL, 2000, J BONE JOINT SURG AM, V82A, P1300, DOI 10.2106/00004623-200009000-00010; Bauer R, 1994, ORTHOPADISCHE OPERAT, V2; Bergmann G, 2001, J BIOMECH, V34, P859, DOI 10.1016/S0021-9290(01)00040-9; Bergmann G, 2001, BIOMED TECH, V46, P168, DOI 10.1515/bmte.2001.46.6.168; Bishop NE, 2013, J ORTHOP RES, V31, P807, DOI 10.1002/jor.22255; BLANKEVOORT L, 1988, J BIOMECH, V21, P705, DOI 10.1016/0021-9290(88)90280-1; Boge T, 2011, IEEE INT CONF ROBOT; Bozic KJ, 2009, J BONE JOINT SURG AM, V91A, P128, DOI 10.2106/JBJS.H.00155; Brand R A, 1994, J Arthroplasty, V9, P45, DOI 10.1016/0883-5403(94)90136-8; Burroughs BR, 2005, J ARTHROPLASTY, V20, P11, DOI 10.1016/j.arth.2004.07.008; CAPPOZZO A, 1995, CLIN BIOMECH, V10, P171, DOI 10.1016/0268-0033(95)91394-T; Carbone V, 2012, J BIOMECH, V45, P2476, DOI 10.1016/j.jbiomech.2012.06.026; COLLINS JJ, 1995, J BIOMECH, V28, P251, DOI 10.1016/0021-9290(94)00072-C; D'Lima DD, 2000, J BONE JOINT SURG AM, V82A, P315, DOI 10.2106/00004623-200003000-00003; DELP SL, 1994, J ORTHOP RES, V12, P860, DOI 10.1002/jor.1100120614; Elkins JM, 2015, CLIN ORTHOP RELAT R, V473, P441, DOI 10.1007/s11999-014-3818-0; Elkins JM, 2014, CLIN ORTHOP RELAT R, V472, P529, DOI 10.1007/s11999-013-3244-8; Elkins JM, 2013, CLIN ORTHOP RELAT R, V471, P971, DOI 10.1007/s11999-012-2512-3; Elkins JM, 2012, J ORTHOP RES, V30, P169, DOI 10.1002/jor.21524; Elkins JM, 2011, J ORTHOP RES, V29, P1642, DOI 10.1002/jor.21435; Fabry C, 2014, MED ENG PHYS, V36, P65, DOI 10.1016/j.medengphy.2013.09.007; Garellick G, 2012, ANN REP 2011; Heller MO, 2001, CLIN BIOMECH, V16, P644, DOI 10.1016/S0268-0033(01)00053-5; Heller MO, 2001, J BIOMECH, V34, P883, DOI 10.1016/S0021-9290(01)00039-2; Herrmann S, 2015, MECH MACH SCI, V24, P659, DOI 10.1007/978-3-319-09411-3_70; Herrmann S, 2012, ORTHOPADE, V41, P252, DOI 10.1007/s00132-011-1851-1; Herrmann S., 2015, THESIS; Herrmann S, 2012, MULTIBODY SYST DYN, V28, P55, DOI 10.1007/s11044-011-9283-6; Herrmann S, 2012, COMPUT METH PROG BIO, V105, P109, DOI 10.1016/j.cmpb.2011.07.012; HERZOG W, 1993, MATH BIOSCI, V118, P83, DOI 10.1016/0025-5564(93)90034-8; Hewitt J, 2001, J ORTHOPAED RES, V19, P359, DOI 10.1016/S0736-0266(00)00035-8; Higa M, 2011, J BIOMECH, V44, P1810, DOI 10.1016/j.jbiomech.2011.04.002; Horsman MDK, 2007, CLIN BIOMECH, V22, P239, DOI 10.1016/j.clinbiomech.2006.10.003; Kahler M, 2009, COMPUTATIONAL KINEMATICS, PROCEEDINGS, P159, DOI 10.1007/978-3-642-01947-0_20; Kiguchi Kazuo, 2008, 2008 International Conference on Control, Automation and Systems (ICCAS), P1942, DOI 10.1109/ICCAS.2008.4694415; Kliewe C, 2010, BIOMED TECH, V55, P47, DOI 10.1515/BMT.2010.005; Kluess D, 2007, MED ENG PHYS, V29, P465, DOI 10.1016/j.medengphy.2006.07.001; Kluess D, 2009, COMPUT METH PROG BIO, V95, P23, DOI 10.1016/j.cmpb.2009.01.004; Krenn R, 1999, ESA SP PUBL, V440, P681; Kwon MS, 2006, CLIN ORTHOP RELAT R, P34, DOI 10.1097/01.blo.0000218746.84494.df; Lamontagne M, 2012, J ORTHOP RES, V30, P1611, DOI 10.1002/jor.22127; Lehmann T, 2009, MIQL FORTRAN CODE CO; Lenaerts G, 2008, J BIOMECH, V41, P1243, DOI 10.1016/j.jbiomech.2008.01.014; Lenaerts G, 2009, J BIOMECH, V42, P1246, DOI 10.1016/j.jbiomech.2009.03.037; LEWINNEK GE, 1978, J BONE JOINT SURG AM, V60, P217, DOI 10.2106/00004623-197860020-00014; Lu TW, 1999, J BIOMECH, V32, P129, DOI 10.1016/S0021-9290(98)00158-4; Martelli S, 2011, J BIOMECH, V44, P1716, DOI 10.1016/j.jbiomech.2011.03.039; Mihalko WM, 2004, CLIN ORTHOP RELAT R, P194, DOI 10.1097/01.blo.0000126221.38764.cc; Modenese L, 2013, J BIOMECH, V46, P1193, DOI 10.1016/j.jbiomech.2012.11.045; Modenese L, 2011, J BIOMECH, V44, P2185, DOI 10.1016/j.jbiomech.2011.06.019; MURRAY DW, 1993, J BONE JOINT SURG BR, V75, P228, DOI 10.1302/0301-620X.75B2.8444942; Nadzadi ME, 2003, J BIOMECH, V36, P577, DOI 10.1016/S0021-9290(02)00232-4; NICHOLAS RM, 1990, J BONE JOINT SURG BR, V72, P418, DOI 10.1302/0301-620X.72B3.2341440; PATRIARCO AG, 1981, J BIOMECH, V14, P513, DOI 10.1016/0021-9290(81)90001-4; Pedersen DR, 2005, MED ENG PHYS, V27, P323, DOI 10.1016/j.medengphy.2004.09.004; PEDERSEN DR, 1987, J BIOMECH ENG-T ASME, V109, P192, DOI 10.1115/1.3138669; Pellicci PM, 1998, CLIN ORTHOP RELAT R, P224; PENROD DD, 1974, J BIOMECH, V7, P123, DOI 10.1016/0021-9290(74)90050-5; Raikova R, 1999, J BIOMECH, V32, P689, DOI 10.1016/S0021-9290(99)00037-8; Raikova RT, 2001, J BIOMECH, V34, P1243, DOI 10.1016/S0021-9290(01)00097-5; Schuenke M, 2005, THIEME ATLAS ANATOMY; Scifert CF, 2001, ORTHOP CLIN N AM, V32, P553, DOI 10.1016/S0030-5898(05)70226-1; Scifert CF, 1998, CLIN ORTHOP RELAT R, P152, DOI 10.1097/00003086-199810000-00016; SEIREG A, 1973, J BIOMECH, V6, P313, DOI 10.1016/0021-9290(73)90053-5; Siciliano B, 2009, ADV TXB CONTR SIG PR, P1; Sioen W, 2002, J BONE JOINT SURG AM, V84A, P1793, DOI 10.2106/00004623-200210000-00009; Spitzer V, 1996, J AM MED INFORM ASSN, V3, P118, DOI 10.1136/jamia.1996.96236280; Stewart KJ, 2002, J BIOMECH, V35, P1491, DOI 10.1016/S0021-9290(02)00091-X; van Arkel RJ, 2015, BONE JOINT J, V97B, P484, DOI 10.1302/0301-620X.97B4.34638; van Arkel RJ, 2013, J ORTHOP RES, V31, P1172, DOI 10.1002/jor.22364; VANDENBOGERT AJ, 1994, J BIOMECH, V27, P1477, DOI 10.1016/0021-9290(94)90197-X; VAUGHAN CL, 1982, J BIOMECH, V15, P197, DOI 10.1016/0021-9290(82)90252-4; VAUGHAN CL, 1982, J BIOMECH, V15, P201, DOI 10.1016/0021-9290(82)90253-6; VRAHAS MS, 1990, J BIOMECH, V23, P357, DOI 10.1016/0021-9290(90)90065-B; Ward SR, 2009, CLIN ORTHOP RELAT R, V467, P1074, DOI 10.1007/s11999-008-0594-8; White RE, 2001, CLIN ORTHOP RELAT R, P163; Widmer KH, 2005, CLIN BIOMECH, V20, P723, DOI 10.1016/j.clinbiomech.2005.04.003; Winter D., 1990, BIOMECHANICS MOTOR C, V2nd; Wu G, 2005, J BIOMECH, V38, P981, DOI 10.1016/j.jbiomech.2004.05.042; Wu G, 2002, J BIOMECH, V35, P543, DOI 10.1016/S0021-9290(01)00222-6; WU G, 1995, J BIOMECH, V28, P1257, DOI 10.1016/0021-9290(95)00017-C; Yoshimine F, 2005, J BIOMECH, V38, P125, DOI 10.1016/j.jbiomech.2004.03.012; Yoshimine F, 2006, J BIOMECH, V39, P1315, DOI 10.1016/j.jbiomech.2005.03.008; Zierath J, 2009, MULTIBODY DYNAMICS 2	91	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145798	10.1371/journal.pone.0145798	http://dx.doi.org/10.1371/journal.pone.0145798			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717236	gold, Green Published, Green Submitted			2022-12-26	WOS:000367510500075
J	Hong, C; Hwang, J; Cho, KH; Shin, I				Hong, Changki; Hwang, Jeewon; Cho, Kwang-Hyun; Shin, Insik			An Efficient Steady-State Analysis Method for Large Boolean Networks with High Maximum Node Connectivity	PLOS ONE			English	Article							SINGLETON ATTRACTOR; REGULATORY NETWORKS; MODEL; SYSTEMS; SIMULATION; GENERATION; REDUCTION; STABILITY; ALGORITHM; PREDICTS	Boolean networks have been widely used to model biological processes lacking detailed kinetic information. Despite their simplicity, Boolean network dynamics can still capture some important features of biological systems such as stable cell phenotypes represented by steady states. For small models, steady states can be determined through exhaustive enumeration of all state transitions. As the number of nodes increases, however, the state space grows exponentially thus making it difficult to find steady states. Over the last several decades, many studies have addressed how to handle such a state space explosion. Recently, increasing attention has been paid to a satisfiability solving algorithm due to its potential scalability to handle large networks. Meanwhile, there still lies a problem in the case of large models with high maximum node connectivity where the satisfiability solving algorithm is known to be computationally intractable. To address the problem, this paper presents a new partitioning-based method that breaks down a given network into smaller subnetworks. Steady states of each subnetworks are identified by independently applying the satisfiability solving algorithm. Then, they are combined to construct the steady states of the overall network. To efficiently apply the satisfiability solving algorithm to each subnetwork, it is crucial to find the best partition of the network. In this paper, we propose a method that divides each subnetwork to be smallest in size and lowest in maximum node connectivity. This minimizes the total cost of finding all steady states in entire subnetworks. The proposed algorithm is compared with others for steady states identification through a number of simulations on both published small models and randomly generated large models with differing maximum node connectivities. The simulation results show that our method can scale up to several hundreds of nodes even for Boolean networks with high maximum node connectivity. The algorithm is implemented and available at http://cps.kaist.ac.kr/similar to ckhong/tools/download/PAD.tar.gz.	[Hong, Changki; Hwang, Jeewon; Shin, Insik] Korea Adv Inst Sci & Technol, Sch Comp, Daejeon, South Korea; [Cho, Kwang-Hyun] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Shin, I (corresponding author), Korea Adv Inst Sci & Technol, Sch Comp, Daejeon, South Korea.	insik.shin@cs.kaist.ac.kr	Shin, Insik/C-1706-2011; Cho, Kwang-Hyun/C-1684-2011		IITP [B0101-15-0557]; NRF - Korea Government, the Ministry of Science, ICT & Future Planning [2013M3A9A7046303, 2014R1A2A1A10052404, 2015M3A9A7067220]	IITP(Institute for Information & Communication Technology Planning & Evaluation (IITP), Republic of Korea); NRF - Korea Government, the Ministry of Science, ICT & Future Planning(National Research Foundation of Korea)	This work was supported in part by IITP (B0101-15-0557) and NRF funded by the Korea Government, the Ministry of Science, ICT & Future Planning (2013M3A9A7046303, 2014R1A2A1A10052404 and 2015M3A9A7067220). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akutsu T, 1998, SYSTEM IDENTIFYING G; Akutsu T, 2012, INFORM PROCESS LETT, V112, P35, DOI 10.1016/j.ipl.2011.10.002; Akutsu T, 2011, J COMPUT BIOL, V18, P1275, DOI 10.1089/cmb.2010.0281; Akutsu T, 2009, IEEE DECIS CONTR P, P5610, DOI 10.1109/CDC.2009.5400017; Albert R, 2003, J THEOR BIOL, V223, P1, DOI 10.1016/S0022-5193(03)00035-3; Albert R, 2007, PLANT CELL, V19, P3327, DOI 10.1105/tpc.107.054700; Aldana M, 2003, PHYSICA D, V185, P45, DOI 10.1016/S0167-2789(03)00174-X; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Berntenis N, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-361; Bilke S, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.016129; Chatain T, 2014, LECT NOTES COMPUT SC, V8859, P129, DOI 10.1007/978-3-319-12982-2_10; Choi M, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003363; Davidich MI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001672; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; De Jong H, 2008, IEEE ACM T COMPUT BI, V5, P208, DOI [10.1109/TCBB.2007.70254, 10.1109/TCBB.2008.70254]; Devloo V, 2003, B MATH BIOL, V65, P1025, DOI 10.1016/S0092-8240(03)00061-2; Di Cara A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-462; Dubrova E, 2005, P IEEE ACM INT C COM; Dubrova E, 2011, IEEE ACM T COMPUT BI, V8, P1393, DOI 10.1109/TCBB.2010.20; Een N, 2004, LECT NOTES COMPUT SC, V2919, P502, DOI 10.1007/978-3-540-24605-3_37; Faure A, 2006, BIOINFORMATICS, V22, pE124, DOI 10.1093/bioinformatics/btl210; Garg A, 2007, LECT NOTES COMPUT SC, V4453, P62; Geisler-Lee J, 2007, PLANT PHYSIOL, V145, P317, DOI 10.1104/pp.107.103465; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; GLASS L, 1973, J THEOR BIOL, V39, P103, DOI 10.1016/0022-5193(73)90208-7; Guo WS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094258; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Helikar T, 2008, P NATL ACAD SCI USA, V105, P1913, DOI 10.1073/pnas.0705088105; KAUFFMAN S, 1969, NATURE, V224, P177, DOI 10.1038/224177a0; Kauffman S.A., 1993, ORIGINS ORDER; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Klamt S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-56; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Ma HW, 2003, BIOINFORMATICS, V19, P1423, DOI 10.1093/bioinformatics/btg177; Ma'ayan A, 2005, SCIENCE, V309, P1078, DOI 10.1126/science.1108876; Mendoza L, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-13; Mussel C, 2010, BIOINFORMATICS, V26, P1378, DOI 10.1093/bioinformatics/btq124; Naldi Aurelien, 2012, Computational Methods in Systems Biology. Proceedings of the 10th International Conference, CMSB 2012, P288, DOI 10.1007/978-3-642-33636-2_17; Naldi A, 2007, LECT NOTES COMPUT SC, V4695, P233; Naldi A, 2011, THEOR COMPUT SCI, V412, P2207, DOI 10.1016/j.tcs.2010.10.021; Patil A, 2006, FEBS LETT, V580, P2041, DOI 10.1016/j.febslet.2006.03.003; R Core Team, 2018, R LANG ENV STAT COMP; Richardson KA, 2005, ADV COMPLEX SYST, V8, P365, DOI 10.1142/S0219525905000518; Saadatpour A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002267; Schaefer T.J., 1978, P 10 ANN ACM S THEOR, DOI DOI 10.1145/800133.804350; Somogyi R, 1996, COMPLEXITY, V1, P45, DOI DOI 10.1002/CPLX.6130010612; Tamura T, 2007, LECT NOTES COMPUT SC, V4639, P494; Veliz-Cuba A, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-221; Veliz-Cuba A, 2011, J THEOR BIOL, V289, P167, DOI 10.1016/j.jtbi.2011.08.042; Yook SH, 2004, PROTEOMICS, V4, P928, DOI 10.1002/pmic.200300636; Zanudo JGT, 2013, CHAOS, V23, DOI 10.1063/1.4809777; Zhang SQ, 2007, EURASIP J BIOINFORM, DOI 10.1155/2007/20180; Zhao Y, 2013, IEEE T AUTOMAT CONTR, V58, P1976, DOI 10.1109/TAC.2013.2251819; Zheng DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060593	55	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145734	10.1371/journal.pone.0145734	http://dx.doi.org/10.1371/journal.pone.0145734			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716694	Green Submitted, Green Published, gold			2022-12-26	WOS:000367510500064
J	Wang, JX; Zhang, PP; Liu, N; Wang, Q; Luo, JX; Wang, L				Wang, Jinxiang; Zhang, Pingping; Liu, Na; Wang, Qian; Luo, Jixian; Wang, Lan			Cadmium Induces Apoptosis in Freshwater Crab Sinopotamon henanense through Activating Calcium Signal Transduction Pathway	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; CELL-DEATH; MITOCHONDRIAL PATHWAY; DEPENDENT APOPTOSIS; MEDIATED ACTIVATION; OXIDATIVE STRESS; DNA-REPAIR; CALMODULIN; YANGTSEKIENSE; TOXICITY	Calcium ion (Ca2+) is one of the key intracellular signals, which is implicated in the regulation of cell functions such as impregnation, cell proliferation, differentiation and death. Cadmium (Cd) is a toxic environmental pollutant that can disturb cell functions and even lead to cell death. Recently, we have found that Cd induced apoptosis in gill cells of the freshwater crab Sinopotamon henanense via caspase activation. In the present study, we further investigated the role of calcium signaling in the Cd-induced apoptosis in the animals. Our data showed that Cd triggered gill cell apoptosis which is evidenced by apoptotic DNA fragmentation, activations of caspases-3, -8 and -9 and the presence of apoptotic morphological features. Moreover, Cd elevated the intracellular concentration of Ca2+, the protein concentration of calmodulin (CaM) and the activity of Ca2+-ATPase in the gill cells of the crabs. Pretreatment of the animals with ethylene glycol-bis-(b-aminoethyl ether)-N, N, N', N'-tetraacetic acid (EGTA), Ca2+ chelator, inhibited Cd-induced activation of caspases-3, -8 and -9 as well as blocked the Cd-triggered apoptotic DNA fragmentation. The apoptotic morphological features were no longer observed in gill cells pretreated with the Ca2+ signaling inhibitors before Cd treatment. Our results indicate that Cd evokes gill cell apoptosis through activating Ca2+-CaM signaling transduction pathway.	[Wang, Jinxiang; Zhang, Pingping; Liu, Na; Wang, Qian; Luo, Jixian; Wang, Lan] Shanxi Univ, Sch Life Sci, Taiyuan 030006, Peoples R China; [Wang, Jinxiang] Shanxi Datong Univ, Sch Life Sci, Datong 037009, Peoples R China	Shanxi University; Shanxi Datong University	Wang, L (corresponding author), Shanxi Univ, Sch Life Sci, Taiyuan 030006, Peoples R China.	lanwang.sxu@qq.com			National Natural Science Foundation of China [31272319]; China Postdoctoral Science Foundatio [2012M510774]; Basic Research Programs foundation of Datong city of Shanxi Province [2014105-6]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundatio; Basic Research Programs foundation of Datong city of Shanxi Province	This work was supported by National Natural Science Foundation of China (No. 31272319), China Postdoctoral Science Foundation (No. 2012M510774) and Basic Research Programs foundation of Datong city of Shanxi Province (No. 2014105-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016100; Andosch A, 2012, J PLANT PHYSIOL, V169, P1489, DOI 10.1016/j.jplph.2012.06.002; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bertin G, 2006, BIOCHIMIE, V88, P1549, DOI 10.1016/j.biochi.2006.10.001; Biagioli M, 2008, CELL CALCIUM, V43, P184, DOI 10.1016/j.ceca.2007.05.003; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buchholz M, 2007, CELL CYCLE, V6, P16, DOI 10.4161/cc.6.1.3650; Chen SJ, 2011, J NEUROCHEM, V119, P1108, DOI 10.1111/j.1471-4159.2011.07493.x; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Crabtree GR, 2009, CELL, V138, DOI 10.1016/j.cell.2009.06.026; Demaurex N, 2003, SCIENCE, V300, P65, DOI 10.1126/science.1083628; Fiekers JF, 2001, LIFE SCI, V70, P681, DOI 10.1016/S0024-3205(01)01443-6; FINN BE, 1995, STRUCTURE, V3, P7, DOI 10.1016/S0969-2126(01)00130-7; Francois F, 2000, FEBS LETT, V486, P281, DOI 10.1016/S0014-5793(00)02316-4; Giaginis C, 2006, TOXICOL APPL PHARM, V213, P282, DOI 10.1016/j.taap.2006.03.008; Giorgi C, 2008, CURR MOL MED, V8, P119; Gyorgy H, 2006, CELL CALCIUM, V40, P553, DOI 10.1016/j.ceca.2006.08.016; Hajnoczky G, 2003, BIOCHEM BIOPH RES CO, V304, P445, DOI 10.1016/S0006-291X(03)00616-8; HOCKENBERY D, 1995, AM J PATHOL, V146, P16; Hu XL, 2007, NEW PHYTOL, V173, P27, DOI 10.1111/j.1469-8137.2006.01888.x; Impey S, 2001, Sci STKE, V2001, ppe1; Ishido M, 2002, ENVIRON HEALTH PERSP, V110, P37, DOI 10.1289/ehp.0211037; Iwai-Kanai E, 2004, MOL CELL BIOCHEM, V259, P163, DOI 10.1023/B:MCBI.0000021368.80389.b9; Kim J, 2004, TOXICOL SCI, V81, P518, DOI 10.1093/toxsci/kfh221; Kim MS, 2000, TOXICOLOGY, V145, P27, DOI 10.1016/S0300-483X(99)00176-6; Kondoh M, 2002, TOXICOLOGY, V170, P111, DOI 10.1016/S0300-483X(01)00536-4; Kursula P, 2007, ACTA CRYSTALLOGR F, V63, P653, DOI 10.1107/S1744309107034525; Lee WK, 2006, AM J PHYSIOL-RENAL, V291, pF823, DOI 10.1152/ajprenal.00276.2005; Lemarie A, 2004, FREE RADICAL BIO MED, V36, P1517, DOI 10.1016/j.freeradbiomed.2004.03.020; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Li RJ, 2011, ECOTOX ENVIRON SAFE, V74, P1164, DOI 10.1016/j.ecoenv.2011.02.018; Liu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045711; Liu DM, 2011, AQUAT TOXICOL, V105, P394, DOI 10.1016/j.aquatox.2011.07.013; Liu J S, 1985, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V7, P453; Liu Y, 2007, FEBS LETT, V581, P1481, DOI 10.1016/j.febslet.2007.03.003; Liu ZM, 2007, CELL MOL LIFE SCI, V64, P1428, DOI 10.1007/s00018-007-7107-x; Ma WL, 2008, ENVIRON TOXICOL, V23, P393, DOI 10.1002/tox.20339; MacLennan DH, 1997, J BIOL CHEM, V272, P28815, DOI 10.1074/jbc.272.46.28815; Misra UK, 2002, CELL SIGNAL, V14, P327, DOI 10.1016/S0898-6568(01)00268-6; Oh SH, 2004, BIOCHEM PHARMACOL, V68, P1845, DOI 10.1016/j.bcp.2004.06.021; Park JD, 2001, TOXICOLOGY, V163, P93, DOI 10.1016/S0300-483X(01)00375-4; Petersen OH, 2005, CELL CALCIUM, V38, P161, DOI 10.1016/j.ceca.2005.06.023; Proskuryakov SY, 2003, EXP CELL RES, V283, P1, DOI 10.1016/S0014-4827(02)00027-7; Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761; Qin Q, 2012, AQUAT TOXICOL, V106, P140, DOI 10.1016/j.aquatox.2011.08.013; REUTER H, 1983, NATURE, V301, P569, DOI 10.1038/301569a0; Risso-de Faverney C, 2004, AQUAT TOXICOL, V69, P247, DOI 10.1016/j.aquatox.2004.05.011; Rizzuto R, 2009, BBA-BIOENERGETICS, V1787, P1342, DOI 10.1016/j.bbabio.2009.03.015; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Shen HM, 2001, TOXICOL APPL PHARM, V171, P12, DOI 10.1006/taap.2000.9092; SUZUKI Y, 1985, ARCH TOXICOL, V57, P205, DOI 10.1007/BF00290889; Szuster-Ciesielska A, 2000, TOXICOLOGY, V145, P159, DOI 10.1016/S0300-483X(00)00144-X; Templeton DM, 2010, CHEM-BIOL INTERACT, V188, P267, DOI 10.1016/j.cbi.2010.03.040; THASTRUP O, 1990, AGENTS ACTIONS, V29, P8, DOI 10.1007/BF01964706; Uchida K, 2003, J BIOL CHEM, V278, P16551, DOI 10.1074/jbc.M300646200; Wang JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064020; Wang JX, 2012, COMP BIOCHEM PHYS C, V156, P195, DOI 10.1016/j.cbpc.2012.05.006; Wang L, 2008, CHEMOSPHERE, V74, P51, DOI 10.1016/j.chemosphere.2008.09.025; Wang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027853; Wang SH, 2008, CELL MOL LIFE SCI, V65, P3640, DOI 10.1007/s00018-008-8383-9; Wang SH, 2009, CHEM-BIOL INTERACT, V181, P45, DOI 10.1016/j.cbi.2009.05.004; Watjen W, 2002, ENVIRON HEALTH PERSP, V110, P865, DOI 10.1289/ehp.110-1241262; Wu H, 2014, ECOTOXICOLOGY, V23, P65, DOI 10.1007/s10646-013-1152-z; Xu BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019052; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Xuan RJ, 2014, ENVIRON SCI POLLUT R, V21, P1738, DOI 10.1007/s11356-013-2068-0; Yang QL, 2012, COMP BIOCHEM PHYS C, V155, P190, DOI 10.1016/j.cbpc.2011.08.003; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Yeh JH, 2009, BASIC CLIN PHARMACOL, V104, P345, DOI 10.1111/j.1742-7843.2009.00391.x	70	13	13	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0144392	10.1371/journal.pone.0144392	http://dx.doi.org/10.1371/journal.pone.0144392			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714174	Green Published, gold, Green Submitted			2022-12-26	WOS:000367481900010
J	Yang, J; Chen, XR; Zhu, CL; Peng, XS; He, XP; Fu, JR; Ouyang, LJ; Bian, JM; Hu, LF; Sun, XT; Xu, J; He, HH				Yang, Jun; Chen, Xiaorong; Zhu, Changlan; Peng, Xiaosong; He, Xiaopeng; Fu, Junru; Ouyang, Linjuan; Bian, Jianmin; Hu, Lifang; Sun, Xiaotang; Xu, Jie; He, Haohua			Using RNA-seq to Profile Gene Expression of Spikelet Development in Response to Temperature and Nitrogen during Meiosis in Rice (Oryza sativa L.)	PLOS ONE			English	Article							POLLEN GERMINATION; ANTHER DEHISCENCE; MALE-STERILITY; ARABIDOPSIS; FERTILITY; PROTEIN; TOOL; TRANSCRIPTOME; NITRATE; PLANTS	Rice reproductive development is sensitive to high temperature and soil nitrogen supply, both of which are predicted to be increased threats to rice crop yield. Rice spikelet development is a critical process that determines yield, yet little is known about the transcriptional regulation of rice spikelet development in response to the combination of heat stress and low nitrogen availability. Here, we profiled gene expression of rice spikelet development during meiosis under heat stress and different nitrogen levels using RNA-seq. We subjected plants to four treatments: 1) NN: normal nitrogen level (165 kg ha(-1)) with normal temperature (30 degrees C); 2) HH: high nitrogen level (264 kg ha(-1)) with high temperature (37 degrees C); 3) NH: normal nitrogen level and high temperature; and 4) HN: high nitrogen level and normal temperature. The de novo transcriptome assembly resulted in 52,250,482 clean reads aligned with 76,103 unigenes, which were then used to compare differentially expressed genes (DEGs) in the different treatments. Comparing gene expression in samples with the same nitrogen levels but different temperatures, we identified 70 temperature-responsive DEGs in normal nitrogen levels (NN vs NH) and 135 DEGs in high nitrogen levels (HN vs HH), with 27 overlapping DEGs. We identified 17 and seven nitrogen-responsive DEGs by comparing changes in nitrogen levels in lower temperature (NN vs HN) and higher temperature (NH vs HH), with one common DEG. The temperature-responsive genes were principally associated with cytochrome, heat shock protein, peroxidase, and ubiquitin, while the nitrogen-responsive genes were mainly involved in glutamine synthetase, amino acid transporter, pollen development, and plant hormone. Rice spikelet fertility was significantly reduced under high temperature, but less reduced under high-nitrogen treatment. In the high temperature treatments, we observed downregulation of genes involved in spikelet development, such as pollen tube growth, pollen maturation, especially sporopollenin biosynthetic process, and pollen exine formation. Moreover, we observed higher expression levels of the co-expressed DEGs in HN vs HH compared to NN vs NH. These included the six downregulated genes (one pollen maturation and five pollen exine formation genes), as well as the four upregulated DEGs in response to heat. This suggests that high-nitrogen treatment may enhance the gene expression levels to mitigate aspects of heat-stress. The spikelet genes identified in this study may play important roles in response to the combined effects of high temperature and high nitrogen, and may serve as candidates for crop improvement.	[Yang, Jun; Chen, Xiaorong; Zhu, Changlan; Peng, Xiaosong; He, Xiaopeng; Fu, Junru; Ouyang, Linjuan; Bian, Jianmin; Hu, Lifang; Sun, Xiaotang; Xu, Jie; He, Haohua] Jiangxi Agr Univ, Coll Agron, Key Lab Crop Physiol Ecol & Genet Breeding, Minist Educ, Nanchang 330045, Peoples R China; [Chen, Xiaorong; Zhu, Changlan; Peng, Xiaosong; He, Xiaopeng; Fu, Junru; Ouyang, Linjuan; Bian, Jianmin; Hu, Lifang; Sun, Xiaotang; He, Haohua] Hunan Agr Univ, Southern Reg Collaborat Innovat Ctr Grain & Oil C, Changsha 410128, Hunan, Peoples R China	Jiangxi Agricultural University; Hunan Agricultural University	He, HH (corresponding author), Jiangxi Agr Univ, Coll Agron, Key Lab Crop Physiol Ecol & Genet Breeding, Minist Educ, Nanchang 330045, Peoples R China.	hhhua64@163.com		Yang, Jun/0000-0003-3420-2543	Special Scientific Research Foundation of Meteorological Public Welfare Industry of China [GYHY201406025]; Special Scientific Research Foundation of Agricultural Public Welfare Industry of China [201403002]	Special Scientific Research Foundation of Meteorological Public Welfare Industry of China; Special Scientific Research Foundation of Agricultural Public Welfare Industry of China	HH was supported by grant GYHY201406025 from the Special Scientific Research Foundation of Meteorological Public Welfare Industry of China (http://www.hymof.net.cn/SystemFrame/wdt_login.aspx), and grant 201403002 from the Special Scientific Research Foundation of Agricultural Public Welfare Industry of China (http://www.hymof.net.cn/SystemFrame/wdt_login.aspx).	Ata-Ul-Karim ST, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104540; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Castaings L, 2011, J EXP BOT, V62, P1391, DOI 10.1093/jxb/erq375; Chen S, 2013, SCI WORLD J, DOI 10.1155/2013/649326; Chhun T, 2007, PLANT CELL, V19, P3876, DOI 10.1105/tpc.107.054759; Chueasiri C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106386; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; CRAWFORD NM, 1995, PLANT CELL, V7, P859, DOI 10.1105/tpc.7.7.859; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Endo M, 2009, PLANT CELL PHYSIOL, V50, P1911, DOI 10.1093/pcp/pcp135; FAO, 2002, WORLD AGR 2015 2030; Frink CR, 1999, P NATL ACAD SCI USA, V96, P1175, DOI 10.1073/pnas.96.4.1175; Garber M, 2011, NAT METHODS, V8, P469, DOI [10.1038/nmeth.1613, 10.1038/NMETH.1613]; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guan JC, 2010, J EXP BOT, V61, P4249, DOI 10.1093/jxb/erq230; Harke MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069834; Hayashi T., 2011, Bulletin of the National Agricultural Research Center for Tohoku Region, P67; Higashitani A, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00047; Hirano K, 2008, PLANT CELL PHYSIOL, V49, P1429, DOI 10.1093/pcp/pcn123; Huang JY, 2013, J EXP BOT, V64, P3351, DOI 10.1093/jxb/ert173; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jagadish SVK, 2007, J EXP BOT, V58, P1627, DOI 10.1093/jxb/erm003; Jagadish SVK, 2010, J EXP BOT, V61, P143, DOI 10.1093/jxb/erp289; Jung KH, 2013, FUNCT INTEGR GENOMIC, V13, P391, DOI 10.1007/s10142-013-0331-6; Jungkunz I, 2011, PLANT J, V66, P983, DOI 10.1111/j.1365-313X.2011.04558.x; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kant S, 2011, J EXP BOT, V62, P1499, DOI 10.1093/jxb/erq297; Kim HY, 2013, GLOBAL CHANGE BIOL, V19, P548, DOI 10.1111/gcb.12047; Ko SS, 2014, PLANT CELL, V26, P2486, DOI 10.1105/tpc.114.126292; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li SC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3793; Lian XM, 2006, PLANT MOL BIOL, V60, P617, DOI 10.1007/s11103-005-5441-7; Liao CS, 2012, J EXP BOT, V63, P5275, DOI 10.1093/jxb/ers187; Lin MY, 2014, PLANT PHYSIOL, V164, P2045, DOI 10.1104/pp.113.229609; Ling S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1305-y; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; Madan P, 2012, J EXP BOT, V63, P3843, DOI 10.1093/jxb/ers077; Matsui T, 2002, ANN BOT-LONDON, V89, P683, DOI 10.1093/aob/mcf112; Mohammed AR, 2009, AGR FOREST METEOROL, V149, P999, DOI 10.1016/j.agrformet.2008.12.003; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Park HC, 2010, PLANT CELL ENVIRON, V33, P1923, DOI 10.1111/j.1365-3040.2010.02195.x; Peng MS, 2007, PLANT MOL BIOL, V65, P775, DOI 10.1007/s11103-007-9241-0; Prasad PVV, 2006, FIELD CROP RES, V95, P398, DOI 10.1016/j.fcr.2005.04.008; Saier MH, 2007, WATER AIR SOIL POLL, V181, P1, DOI 10.1007/s11270-007-9372-6; Sakata T, 2014, PLANT PHYSIOL, V164, P2011, DOI 10.1104/pp.113.234401; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Sarkar NK, 2014, PLANT MOL BIOL, V84, P125, DOI 10.1007/s11103-013-0123-3; SATAKE T, 1987, JPN J CROP SCI, V56, P404; Scafaro AP, 2010, J EXP BOT, V61, P191, DOI 10.1093/jxb/erp294; Shi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059721; Shi WJ, 2013, NEW PHYTOL, V197, P825, DOI 10.1111/nph.12088; Stitt M, 1999, CURR OPIN PLANT BIOL, V2, P178, DOI 10.1016/S1369-5266(99)80033-8; Sung DY, 2001, PLANT PHYSIOL, V126, P789, DOI 10.1104/pp.126.2.789; Tang XA, 2010, PLANT PHYSIOL, V154, P1855, DOI 10.1104/pp.110.161661; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Thangasamy S, 2011, NEW PHYTOL, V189, P869, DOI 10.1111/j.1469-8137.2010.03538.x; Wang RC, 2000, PLANT CELL, V12, P1491, DOI 10.1105/tpc.12.8.1491; Wang RC, 2003, PLANT PHYSIOL, V132, P556, DOI 10.1104/pp.103.021253; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Waters ER, 2013, J EXP BOT, V64, P391, DOI 10.1093/jxb/ers355; WENG JH, 1987, PHOTOSYNTH RES, V14, P171, DOI 10.1007/BF00032321; Wu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098481; Wu LN, 2014, PLANT CELL REP, V33, P1881, DOI 10.1007/s00299-014-1666-8; Yang SS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-199; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang XW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049652; Zhou SR, 2011, PLANT CELL, V23, P111, DOI 10.1105/tpc.109.073692	70	7	7	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145532	10.1371/journal.pone.0145532	http://dx.doi.org/10.1371/journal.pone.0145532			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714321	gold, Green Submitted, Green Published			2022-12-26	WOS:000367481900052
J	Zhu, YJ; Chen, K; Mi, XF; Chen, TX; Ali, J; Ye, GY; Xu, JL; Li, ZK				Zhu, Yajun; Chen, Kai; Mi, Xuefei; Chen, Tianxiao; Ali, Jauhar; Ye, Guoyou; Xu, Jianlong; Li, Zhikang			Identification and Fine Mapping of a Stably Expressed QTL for Cold Tolerance at the Booting Stage Using an Interconnected Breeding Population in Rice	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; GENOME-WIDE ASSOCIATION; SOUTHERN LEAF-BLIGHT; GENETIC ARCHITECTURE; INTROGRESSION LINES; COMPLEX TRAITS; RESISTANCE; YIELD; METABOLISM; STRESS	Cold stress is one of the major abiotic stresses that impede rice production. A interconnected breeding (IB) population consisted of 497 advanced lines developed using HHZ as the recurrent parent and eight diverse elite indica lines as the donors were used to identify stably expressed QTLs for CT at the booting stage. A total of 41,754 high-quality SNPs were obtained through re-sequencing of the IB population. Phenotyping was conducted under field conditions in two years and three locations. Association analysis identified six QTLs for CT on the chromosomes 3, 4 and 12. QTL qCT-3-2 that showed stable CT across years and locations was fine-mapped to an approximately 192.9 kb region. Our results suggested that GWAS applied to an IB population allows better integration of gene discovery and breeding. QTLs can be mapped in high resolution and quickly utilized in breeding.	[Zhu, Yajun; Chen, Kai; Chen, Tianxiao; Xu, Jianlong; Li, Zhikang] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China; [Zhu, Yajun; Chen, Kai; Mi, Xuefei; Xu, Jianlong] Chinese Acad Agr Sci, Agr Genom Inst, Shenzhen 518120, Peoples R China; [Zhu, Yajun; Chen, Kai; Xu, Jianlong; Li, Zhikang] Chinese Acad Agr Sci, Shenzhen Inst Breeding & Innovat, Shenzhen 518120, Peoples R China; [Ali, Jauhar; Ye, Guoyou] Int Rice Res Inst, Manila, Philippines	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Chinese Academy of Agricultural Sciences; Agriculture Genomes Institute at Shenzhen, CAAS; Chinese Academy of Agricultural Sciences; CGIAR; International Rice Research Institute (IRRI)	Xu, JL (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China.	xujlcaas@126.com; zhkli1953@126.com	Ali, Jauhar Ali or A. Jauhar/E-4432-2012; Xu, Jianlong/AAI-8310-2020	Ali, Jauhar Ali or A. Jauhar/0000-0002-3177-2607; Ye, Guoyou/0000-0002-9943-4815	Shenzhen Technology Research Development [JSGG20121026152117750]; Chinese Ministry of Science Technology [2014AA10A601]; Shenzhen Peacock Plan [20130415095710361]; CAAS Innovative Team Award; China Postdoctoral Science Foundation [2015M571176]	Shenzhen Technology Research Development; Chinese Ministry of Science Technology(Ministry of Science and Technology, China); Shenzhen Peacock Plan; CAAS Innovative Team Award; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was funded by Shenzhen Technology Research & Development (http://www.szsti.gov.cn/) (#: JSGG20121026152117750, Recipient: JLX); the "863" Key Project to JLX (2014AA10A601) from the Chinese Ministry of Science & Technology (http://www.863.gov.cn/); the Shenzhen Peacock Plan (http://www.szsti.gov.cn/) (#: 20130415095710361, Recipient: ZKL); the CAAS Innovative Team Award to JL Xu's team (http://www.caas.net.cn/); and the China Postdoctoral Science Foundation (http://res.chinapostdoctor.org.cn/BshWeb/index.shtml) (#: 2015M571176, Recipient: YJZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali AJ, 2006, FIELD CROP RES, V97, P66, DOI 10.1016/j.fcr.2005.08.016; Andaya VC, 2006, THEOR APPL GENET, V113, P467, DOI 10.1007/s00122-006-0311-5; Andaya VC, 2007, MOL BREEDING, V20, P349, DOI 10.1007/s11032-007-9096-8; Auguie B, 2017, GRIDEXTRA MISCELLANE; Blanc G, 2006, THEOR APPL GENET, V113, P206, DOI 10.1007/s00122-006-0287-1; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Campbell MT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120385; Cheng LR, 2012, GENOME, V55, P45, DOI [10.1139/G11-075, 10.1139/g11-075]; Coles ND, 2010, GENETICS, V184, P799, DOI 10.1534/genetics.109.110304; Cook JP, 2012, PLANT PHYSIOL, V158, P824, DOI 10.1104/pp.111.185033; Fujino K, 2008, P NATL ACAD SCI USA, V105, P12623, DOI 10.1073/pnas.0805303105; GRAMENE, 2011, GRAMENE DAT VERS 33; Guan YS, 2010, J EXP BOT, V61, P4145, DOI 10.1093/jxb/erq212; He YX, 2010, PLANT BREEDING, V129, P167, DOI 10.1111/j.1439-0523.2009.01683.x; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Jena KK, 2012, CROP SCI, V52, P517, DOI 10.2135/cropsci2010.12.0733; Jiang L, 2008, J CEREAL SCI, V48, P173, DOI 10.1016/j.jcs.2007.08.013; Jordan DR, 2011, CROP SCI, V51, P1444, DOI 10.2135/cropsci2010.06.0326; Kump KL, 2011, NAT GENET, V43, P163, DOI 10.1038/ng.747; Kuroki M, 2007, THEOR APPL GENET, V115, P593, DOI 10.1007/s00122-007-0589-y; Li LF, 2013, THEOR APPL GENET, V126, P2313, DOI 10.1007/s00122-013-2137-2; Li TG, 1993, RICE GERMPLASM RESOU, P71; Li ZK, 2013, CURR OPIN PLANT BIOL, V16, P261, DOI 10.1016/j.pbi.2013.03.008; Li ZK, 2005, PLANT MOL BIOL, V59, P33, DOI 10.1007/s11103-005-8519-3; Liu Z., 2009, CHIN AGRI SCI B, V25, P45; Mao DH, 2015, THEOR APPL GENET, V128, P1359, DOI 10.1007/s00122-015-2511-3; Matthus E, 2015, THEOR APPL GENET, V128, P2085, DOI 10.1007/s00122-015-2569-y; Maurer A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1459-7; Meng LJ, 2013, PLANT BREEDING, V132, P604, DOI 10.1111/pbr.12097; Negeri AT, 2011, CROP SCI, V51, P1571, DOI 10.2135/cropsci2010.12.0672; Ogut F, 2015, HEREDITY, V114, P552, DOI 10.1038/hdy.2014.123; Peiffer JA, 2014, GENETICS, V196, P1337, DOI 10.1534/genetics.113.159152; Poland JA, 2011, P NATL ACAD SCI USA, V108, P6893, DOI 10.1073/pnas.1010894108; Saito K, 2010, PLANT SCI, V179, P97, DOI 10.1016/j.plantsci.2010.04.004; Schnaithmann F, 2014, THEOR APPL GENET, V127, P1513, DOI 10.1007/s00122-014-2315-x; Semagn K, 2010, ELECT J BIOTECHNOLOG; Shirasawa S, 2012, THEOR APPL GENET, V124, P937, DOI 10.1007/s00122-011-1758-6; Steinhoff J, 2011, CROP SCI, V51, P2505, DOI 10.2135/cropsci2011.03.0181; Suh JP, 2010, THEOR APPL GENET, V120, P985, DOI 10.1007/s00122-009-1226-8; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Wang HY, 2012, CROP SCI, V52, P1767, DOI 10.2135/cropsci2011.06.0323; Wang Y, 2013, CROP J, V1, P134, DOI 10.1016/j.cj.2013.07.006; Wissuwa M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124215; Xu JL, 2005, THEOR APPL GENET, V111, P1642, DOI 10.1007/s00122-005-0099-8; Xu LM, 2008, PLANT SCI, V174, P340, DOI 10.1016/j.plantsci.2007.12.003; [杨梯丰 Yang Tifeng], 2015, [分子植物育种, Molecular Plant Breeding], V13, P1; Yu JM, 2008, GENETICS, V178, P539, DOI 10.1534/genetics.107.074245; Zeng YW, 2009, GENES GENOM, V31, P143, DOI 10.1007/BF03191147; Zhang F, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-55; Zhang F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014541; Zhang NY, 2015, PLANT PHYSIOL, V168, P575, DOI 10.1104/pp.15.00025; Zhang QN, 2014, J INEQUAL APPL, DOI 10.1186/1029-242X-2014-221; Zhang SH, 2014, EUPHYTICA, V195, P95, DOI 10.1007/s10681-013-0977-0; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467; Zhou L, 2010, THEOR APPL GENET, V121, P895, DOI 10.1007/s00122-010-1358-x; Zhu JH, 2007, CURR OPIN PLANT BIOL, V10, P290, DOI 10.1016/j.pbi.2007.04.010; Zhu YJ, 2014, PLANT DIS, V98, P1112, DOI 10.1094/PDIS-10-13-1095-RE	58	43	44	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145704	10.1371/journal.pone.0145704	http://dx.doi.org/10.1371/journal.pone.0145704			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713764	gold, Green Published, Green Submitted			2022-12-26	WOS:000367481900071
J	Deschemin, JC; Allouche, S; Brouillard, F; Vaulont, S				Deschemin, Jean-Christophe; Allouche, Sarah; Brouillard, Franck; Vaulont, Sophie			Iron Homeostasis and Inflammatory Status in Mice Deficient for the Cystic Fibrosis Transmembrane Regulator	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; BOWEL-DISEASE; LUNG-DISEASE; MACROPHAGES; PROTEINS; METABOLISM; ABSORPTION; EXPRESSION; FERRITIN; MATRIPTASE-2	Background Cystic Fibrosis (CF) is a frequent and lethal autosomal recessive disease caused by mutations in the gene encoding the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR). Patients with CF suffer from chronic infections and severe inflammation, which lead to progressive pulmonary and gut diseases. Recently, an expanding body of evidence has suggested that iron homeostasis was abnormal in CF with, in particular, systemic iron deficiency and iron sequestration in the epithelium airway. The molecular mechanisms responsible for iron dysregulation and the relationship with inflammation in CF are unknown. Methods and Results We assessed the impact of CFTR deficiency on systemic and tissue iron homeostasis as well as inflammation in wildtype and CFTR knockout (KO) mice. First, in contrast to the systemic and intestinal inflammation we observed in the CFTR KO mice, we reported the absence of lung phenotype with regards to both inflammation and iron status. Second, we showed a significant decrease of plasma ferritin levels in the KO mice, as in CF patients, likely caused by a decrease in spleen ferritin levels. However, we measured unchanged plasma iron levels in the KO mice that may be explained by increased intestinal iron absorption. Conclusion These results indicate that in CF, the lung do not predominantly contributes to the systemic ferritin deficiency and we propose the spleen as the major organ responsible for hypoferritinemia in the KO mouse. These results should provide a better understanding of iron dysregulation in CF patients where treating or not iron deficiency remains a challenging question.	[Deschemin, Jean-Christophe; Allouche, Sarah; Vaulont, Sophie] INSERM, Inst Cochin, U1016, Paris, France; [Deschemin, Jean-Christophe; Allouche, Sarah; Vaulont, Sophie] CNRS, UMR8104, Paris, France; [Deschemin, Jean-Christophe; Allouche, Sarah; Brouillard, Franck; Vaulont, Sophie] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Deschemin, Jean-Christophe; Allouche, Sarah; Vaulont, Sophie] Lab Excellence GR Ex, Paris, France; [Brouillard, Franck] CNRS, Inst Chim Subst Nat, UPR2301, Gif Sur Yvette, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay	Vaulont, S (corresponding author), INSERM, Inst Cochin, U1016, Paris, France.	sophie.vaulont@inserm.fr	Vaulont, Sophie/O-6732-2017	Deschemin, Jean-Christophe/0000-0002-1256-8459	Vaincre la Mucoviscidose [RF20120600684]; Laboratory of Excellence GR-Ex - "Investissements d'avenir" program of the French National Research Agency [ANR-11-LABX-0051]	Vaincre la Mucoviscidose; Laboratory of Excellence GR-Ex - "Investissements d'avenir" program of the French National Research Agency(French National Research Agency (ANR))	This work was supported by grants from the Laboratory of Excellence GR-Ex (ANR-11-LABX-0051), which is funded by the "Investissements d'avenir" program of the French National Research Agency (ANR-11-IDEX-0005-02) and Vaincre la Mucoviscidose (grant RF20120600684). These funding organizations did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and do not provided financial support in the form of salaries.	Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; Anderson CP, 2012, BBA-MOL CELL RES, V1823, P1468, DOI 10.1016/j.bbamcr.2012.05.010; Anderson SA, 2013, CELL METAB, V17, P282, DOI 10.1016/j.cmet.2013.01.007; Andoh A, 2008, WORLD J GASTROENTERO, V14, P5154, DOI 10.3748/wjg.14.5154; Boucher RC, 2007, J INTERN MED, V261, P5, DOI 10.1111/j.1365-2796.2006.01744.x; Boucher RC, 2004, EUR RESPIR J, V23, P146, DOI 10.1183/09031936.03.00057003; Canonne-Hergaux F, 2006, AM J PHYSIOL-GASTR L, V290, pG156, DOI 10.1152/ajpgi.00227.2005; Chassaing B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044328; Chillappagari S, 2014, AM J PHYSIOL-LUNG C, V307, pL791, DOI 10.1152/ajplung.00167.2014; Cohen LA, 2010, BLOOD, V116, P1574, DOI 10.1182/blood-2009-11-253815; Cohen TS, 2012, NAT MED, V18, P509, DOI 10.1038/nm.2715; Delaby C, 2005, EXP CELL RES, V310, P43, DOI 10.1016/j.yexcr.2005.07.002; Deschemin JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061050; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; Dowdle WE, 2014, NAT CELL BIOL, V16, P1069, DOI 10.1038/ncb3053; Feng Q, 2012, AM J PHYSIOL-GASTR L, V302, pG1397, DOI 10.1152/ajpgi.00020.2012; Fuss IJ, 1996, J IMMUNOL, V157, P1261; Galy B, 2013, CELL REP, V3, P844, DOI 10.1016/j.celrep.2013.02.026; Gammella E, 2014, METALLOMICS, V6, P1336, DOI 10.1039/c4mt00104d; Ganz T, 2013, PHYSIOL REV, V93, P1721, DOI 10.1152/physrev.00008.2013; Ganz T, 2012, BBA-MOL CELL RES, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Ghio AJ, 2013, J CYST FIBROS, V12, P390, DOI 10.1016/j.jcf.2012.10.010; Gulec S, 2014, ANNU REV NUTR, V34, P95, DOI 10.1146/annurev-nutr-071812-161215; Hattrup CL, 2008, ANNU REV PHYSIOL, V70, P431, DOI 10.1146/annurev.physiol.70.113006.100659; Kreda SM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009589; Lane DJR, 2015, NUTRIENTS, V7, P2274, DOI 10.3390/nu7042274; Lenoir A, 2011, BLOOD, V117, P647, DOI 10.1182/blood-2010-07-295147; Mancias JD, 2014, NATURE, V509, P105, DOI 10.1038/nature13148; Mastrogiannaki M, 2013, BLOOD, V122, P885, DOI 10.1182/blood-2012-11-427765; Moreau-Marquis S, 2008, AM J PHYSIOL-LUNG C, V295, pL25, DOI 10.1152/ajplung.00391.2007; Neurath MF, 2008, MUCOSAL IMMUNOL, V1, pS28, DOI 10.1038/mi.2008.45; Norkina O, 2004, AM J PHYSIOL-GASTR L, V286, pG1032, DOI 10.1152/ajpgi.00473.2003; Poussier P, 2000, GASTROENTEROLOGY, V118, P880, DOI 10.1016/S0016-5085(00)70174-0; Reid DW, 2002, CHEST, V121, P48, DOI 10.1378/chest.121.1.48; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Sharp P, 2007, WORLD J GASTROENTERO, V13, P4716, DOI 10.3748/wjg.v13.i35.4716; SNOUWAERT JN, 1992, SCIENCE, V257, P1083, DOI 10.1126/science.257.5073.1083; Sterling KM, 2004, J CELL BIOCHEM, V91, P1174, DOI 10.1002/jcb.20017; Stites SW, 1999, AM J RESP CRIT CARE, V160, P796, DOI 10.1164/ajrccm.160.3.9811018; Sukumaran A, 2014, BRIT J NUTR, V111, P1059, DOI 10.1017/S0007114513003334; Uijterschout L, 2014, PEDIATR PULM, V49, P458, DOI 10.1002/ppul.22857; Verkman AS, 2013, CURR PHARM DESIGN, V19, P3529, DOI 10.2174/13816128113199990321; Wessling-Resnick M, 2010, ANNU REV NUTR, V30, P105, DOI 10.1146/annurev.nutr.012809.104804; White C, 2013, CELL METAB, V17, P261, DOI 10.1016/j.cmet.2013.01.005; Wilke M, 2011, J CYST FIBROS, V10, pS152, DOI 10.1016/S1569-1993(11)60020-9; Willemetz A, 2014, BLOOD, V124, P441, DOI 10.1182/blood-2014-01-551150	46	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145685	10.1371/journal.pone.0145685	http://dx.doi.org/10.1371/journal.pone.0145685			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709821	Green Published, Green Submitted, gold			2022-12-26	WOS:000367451400071
J	Mitra, S; Wewers, MD; Sarkar, A				Mitra, Srabani; Wewers, Mark D.; Sarkar, Anasuya			Mononuclear Phagocyte-Derived Microparticulate Caspase-1 Induces Pulmonary Vascular Endothelial Cell Injury	PLOS ONE			English	Article							IL-1-BETA-CONVERTING ENZYME; ACUTE LUNG; MEMBRANE MICROPARTICLES; EPITHELIAL-CELLS; FAS-LIGAND; APOPTOSIS; ACTIVATION; DEATH; IL-1-BETA; INFLAMMASOME	Lung endothelial cell apoptosis and injury occurs throughout all stages of acute lung injury (ALI/ARDS) and impacts disease progression. Lung endothelial injury has traditionally been focused on the role of neutrophil trafficking to lung vascular integrin receptors induced by proinflammatory cytokine expression. Although much is known about the pathogenesis of cell injury and death in ALI/ARDS, gaps remain in our knowledge; as a result of which there is currently no effective pharmacologic therapy. Enzymes known as caspases are essential for completion of the apoptotic program and secretion of pro-inflammatory cytokines. We hypothesized that caspase-1 may serve as a key regulator of human pulmonary microvascular endothelial cell (HPMVEC) apoptosis in ALI/ARDS. Our recent experiments confirm that microparticles released from stimulated monocytic cells (THP1) induce lung endothelial cell apoptosis. Microparticles pretreated with the caspase-1 inhibitor, YVAD, or pan-caspase inhibitor, ZVAD, were unable to induce cell death of HPMVEC, suggesting the role of caspase-1 or its substrate in the induction of HPMVEC cell death. Neither un-induced microparticles (control) nor direct treatment with LPS induced apoptosis of HPMVEC. Further experiments showed that caspase-1 uptake into HPMVEC and the induction of HPMVEC apoptosis was facilitated by caspase-1 interactions with microparticulate vesicles. Altering vesicle integrity completely abrogated apoptosis of HPMVEC suggesting an encapsulation requirement for target cell uptake of active caspase-1. Taken together, we confirm that microparticle centered caspase-1 can play a regulator role in endothelial cell injury.	[Mitra, Srabani; Wewers, Mark D.; Sarkar, Anasuya] Ohio State Univ, Dept Internal Med, Davis Heart & Lung Res Inst, Div Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Sarkar, A (corresponding author), Ohio State Univ, Dept Internal Med, Davis Heart & Lung Res Inst, Div Pulm Allergy Crit Care & Sleep Med, Columbus, OH 43210 USA.	anasuya.sarkar@osumc.edu	Wewers, Mark/AAB-6202-2021		NHLBI [RO1-HL076278, R21-HL102629]; AAT Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL102629, R01HL076278, R01HL124325] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); AAT Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NHLBI RO1-HL076278 to MDW; NHLBI R21-HL102629 and AAT Foundation grant to AS.	Aoki N, 2007, ENDOCRINOLOGY, V148, P3850, DOI 10.1210/en.2006-1479; Baroni M, 2007, FASEB J, V21, P1926, DOI 10.1096/fj.06-7238com; BOUDREAU N, 1995, SCIENCE, V267, P891, DOI 10.1126/science.7531366; Braddock M, 2004, NAT REV DRUG DISCOV, V3, P1, DOI 10.1038/nrd1342; Cacquevel M, 2004, CURR DRUG TARGETS, V5, P529, DOI 10.2174/1389450043345308; Carta S, 2006, BLOOD, V108, P1618, DOI 10.1182/blood-2006-03-014126; Diamant M, 2004, EUR J CLIN INVEST, V34, P392, DOI 10.1111/j.1365-2362.2004.01355.x; Dinarello CA, 2002, CLIN EXP RHEUMATOL, V20, pS1; Dinarello CA, 2001, ANN RHEUM DIS, V60, pIII18; Distler JHW, 2005, APOPTOSIS, V10, P731, DOI 10.1007/s10495-005-2941-5; Distler JHW, 2006, AUTOIMMUNITY, V39, P683, DOI 10.1080/08916930601061538; Exline MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090968; Fahy RJ, 2008, AM J RESP CRIT CARE, V177, P983, DOI 10.1164/rccm.200703-418OC; GAGLIARDINI V, 1994, SCIENCE, V263, P826, DOI 10.1126/science.8303301; Ganter MT, 2008, CIRC RES, V102, P804, DOI 10.1161/CIRCRESAHA.107.161067; Hamacher J, 2002, AM J RESP CRIT CARE, V166, P651, DOI 10.1164/rccm.2109004; Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943; Huber LC, 2007, APOPTOSIS, V12, P363, DOI 10.1007/s10495-006-0622-7; Hugel B, 2005, PHYSIOLOGY, V20, P22, DOI 10.1152/physiol.00029.2004; Imanishi T, 2002, ATHEROSCLEROSIS, V161, P143, DOI 10.1016/S0021-9150(01)00631-1; Ismail N, 2013, BLOOD, V121, P984, DOI 10.1182/blood-2011-08-374793; Kahlenberg JM, 2004, J LEUKOCYTE BIOL, V76, P676, DOI 10.1189/jlb.0404221; Kim HJ, 2004, J IMMUNOL, V172, P4948, DOI 10.4049/jimmunol.172.8.4948; Komarova Y, 2010, ANNU REV PHYSIOL, V72, P463, DOI 10.1146/annurev-physiol-021909-135833; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Kurtovic Jelica, 2004, Trop Gastroenterol, V25, P9; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Mallat Z, 2000, BRIT J PHARMACOL, V130, P947, DOI 10.1038/sj.bjp.0703407; Mangan DF, 1991, J IMMUNOL, V163, P1755; Martin S, 2004, CIRCULATION, V109, P1653, DOI 10.1161/01.CIR.0000124065.31211.6E; Martinez MC, 2005, AM J PHYSIOL-HEART C, V288, pH1004, DOI 10.1152/ajpheart.00842.2004; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Matute-Bello G, 2005, J IMMUNOL, V175, P4069, DOI 10.4049/jimmunol.175.6.4069; Matute-Bello G, 2003, CRIT CARE, V7, P355, DOI 10.1186/cc1861; McKechnie NM, 2006, EXP EYE RES, V83, P304, DOI 10.1016/j.exer.2005.11.028; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; MIURA M, 1993, CELL, V75, P653, DOI 10.1016/0092-8674(93)90486-A; Nakamura M, 2004, AM J PATHOL, V164, P1949, DOI 10.1016/S0002-9440(10)63755-8; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Santos RL, 2001, INFECT IMMUN, V69, P2293, DOI 10.1128/IAI.69.4.2293-2301.2001; Sarkar A, 2006, AM J RESP CRIT CARE, V174, P1003, DOI 10.1164/rccm.200604-546OC; Sarkar A, 2006, J IMMUNOL, V176, P4979, DOI 10.4049/jimmunol.176.8.4979; Sarkar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007140; Sue W, 2006, AM J CLIN NUTR, V83, p470S; Ting JPY, 2006, NAT REV IMMUNOL, V6, P183, DOI 10.1038/nri1788; Tiwary R, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3063; van der Velden AWM, 2003, J IMMUNOL, V171, P6742, DOI 10.4049/jimmunol.171.12.6742; Wang J, 2000, J CELL SCI, V113, P753; Watanabe JJ, 2003, J BIOL CHEM, V278, P33161, DOI 10.1074/jbc.M305321200; Wewers MD, 2004, P NATL ACAD SCI USA, V101, P10241, DOI 10.1073/pnas.0403971101; WIENERKRONISH JP, 1991, J CLIN INVEST, V88, P864, DOI 10.1172/JCI115388; Wilson HL, 2004, J IMMUNOL, V173, P1202, DOI 10.4049/jimmunol.173.2.1202; Zimmerman GA, 1999, CHEST, V116, p18S, DOI 10.1378/chest.116.suppl_1.18S	54	30	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145607	10.1371/journal.pone.0145607	http://dx.doi.org/10.1371/journal.pone.0145607			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710067	Green Published, Green Submitted, gold			2022-12-26	WOS:000367451400065
J	Niu, EL; Shang, XG; Cheng, CZ; Bao, JH; Zeng, YD; Cai, CP; Du, XM; Guo, WZ				Niu, Erli; Shang, Xiaoguang; Cheng, Chaoze; Bao, Jianghao; Zeng, Yanda; Cai, Caiping; Du, Xiongming; Guo, Wangzhen			Comprehensive Analysis of the COBRA-Like (COBL) Gene Family in Gossypium Identifies Two COBLs Potentially Associated with Fiber Quality	PLOS ONE			English	Article							CELL-WALL; COTTON FIBER; ANCHORED PROTEIN; TRANSCRIPTION FACTOR; CELLULOSE SYNTHESIS; UPLAND COTTON; SYNTHASE-A; ARABIDOPSIS; EXPRESSION; ELONGATION	COBRA-Like (COBL) genes, which encode a plant-specific glycosylphosphatidylinositol (GPI) anchored protein, have been proven to be key regulators in the orientation of cell expansion and cellulose crystallinity status. Genome-wide analysis has been performed in A. thaliana, O. sativa, Z. mays and S. lycopersicum, but little in Gossypium. Here we identified 19, 18 and 33 candidate COBL genes from three sequenced cotton species, diploid cotton G. raimondii, G. arboreum and tetraploid cotton G. hirsutum acc. TM-1, respectively. These COBL members were anchored onto 10 chromosomes in G. raimondii and could be divided into two subgroups. Expression patterns of COBL genes showed highly developmental and spatial regulation in G. hirsutum acc. TM-1. Of them, GhCOBL9 and GhCOBL13 were preferentially expressed at the secondary cell wall stage of fiber development and had significantly co-upregulated expression with cellulose synthase genes GhCESA4, GhCESA7 and GhCESA8. Besides, GhCOBL9 D-t and GhCOBL13 D-t were co-localized with previously reported cotton fiber quality quantitative trait loci (QTLs) and the favorable allele types of GhCOBL9 D-t had significantly positive correlations with fiber quality traits, indicating that these two genes might play an important role in fiber development.	[Niu, Erli; Shang, Xiaoguang; Cheng, Chaoze; Bao, Jianghao; Zeng, Yanda; Cai, Caiping; Guo, Wangzhen] Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Minist Educ, Hybrid Cotton R&D Engn Res Ctr, Nanjing, Jiangsu, Peoples R China; [Du, Xiongming] Chinese Acad Agr Sci, Cotton Res Inst, State Key Lab Cotton Biol, Anyang, Henan, Peoples R China	Nanjing Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Guo, WZ (corresponding author), Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Minist Educ, Hybrid Cotton R&D Engn Res Ctr, Nanjing, Jiangsu, Peoples R China.	moelab@njau.edu.cn	Shang, Xiaoguang/GQA-8937-2022; Du, Xiongming/AAI-9999-2020; Shang, Xiaoguang/AAT-7979-2021		National Natural Science Foundation of China [31471539]; National High Technology Research and Development Program of China (863 Program) [2012AA101108-04-04]; Key R & D program in Jiangsu Province [BE2015360]; Priority Academic Program Development of Jiangsu Higher Education Institutions [010-809001]; Jiangsu Collaborative Innovation Center for Modern Crop Production [10]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Key R & D program in Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions; Jiangsu Collaborative Innovation Center for Modern Crop Production	This program was financially supported in part by the National Natural Science Foundation of China (31471539), the National High Technology Research and Development Program of China (863 Program) (2012AA101108-04-04), Key R & D program in Jiangsu Province (BE2015360), the Priority Academic Program Development of Jiangsu Higher Education Institutions (010-809001) and Jiangsu Collaborative Innovation Center for Modern Crop Production (No. 10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpat AB, 2004, PLANT MOL BIOL, V54, P911, DOI 10.1007/s11103-004-0392-y; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; BASRA AS, 1984, INT REV CYTOL, V89, P65, DOI 10.1016/S0074-7696(08)61300-5; Beeckman T, 2002, PLANT PHYSIOL, V130, P1883, DOI 10.1104/pp.102.010603; BENFEY PN, 1993, DEVELOPMENT, V119, P57; Betancur L, 2010, J INTEGR PLANT BIOL, V52, P205, DOI 10.1111/j.1744-7909.2010.00934.x; Brady SM, 2007, PLANT PHYSIOL, V143, P172, DOI 10.1104/pp.106.087262; Brown DM, 2005, PLANT CELL, V17, P2281, DOI 10.1105/tpc.105.031542; Cai CP, 2014, CROP J, V2, P87, DOI 10.1016/j.cj.2014.03.001; Cao Y, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-211; Chen H, 2009, THEOR APPL GENET, V119, P605, DOI 10.1007/s00122-009-1070-x; Ching A, 2006, PLANTA, V224, P1174, DOI 10.1007/s00425-006-0299-8; Comai L, 2004, PLANT J, V37, P778, DOI 10.1111/j.0960-7412.2003.01999.x; Dai XX, 2011, PLANT MOL BIOL, V75, P333, DOI 10.1007/s11103-011-9730-z; Dai XX, 2009, PLANT MOL BIOL, V71, P469, DOI 10.1007/s11103-009-9537-3; Drenkard E, 2000, PLANT PHYSIOL, V124, P1483, DOI 10.1104/pp.124.4.1483; Eisenhaber B, 1999, J MOL BIOL, V292, P741, DOI 10.1006/jmbi.1999.3069; Ellis C, 2002, PLANT CELL, V14, P1557, DOI 10.1105/tpc.002022; Endler A, 2011, MOL PLANT, V4, P199, DOI 10.1093/mp/ssq079; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Haigler CH, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00104; HAUSER MT, 1995, DEVELOPMENT, V121, P1237; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Hochholdinger F, 2008, PLANT J, V54, P888, DOI 10.1111/j.1365-313X.2008.03459.x; [蒋建雄 Jiang Jianxiong], 2003, [棉花学报, Cotton Science], V15, P166; Kim HJ, 2001, PLANT PHYSIOL, V127, P1361, DOI 10.1104/pp.010724; Lee JJ, 2007, ANN BOT-LONDON, V100, P1391, DOI 10.1093/aob/mcm232; Lee TH, 2013, NUCLEIC ACIDS RES, V41, pD1152, DOI 10.1093/nar/gks1104; Li FG, 2014, NAT GENET, V46, P567, DOI 10.1038/ng.2987; Li YH, 2003, PLANT CELL, V15, P2020, DOI 10.1105/tpc.011775; Liang Z, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-539; Liu LF, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003704; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma XX, 2008, J GENET GENOMICS, V35, P751, DOI 10.1016/S1673-8527(08)60231-3; MacMillan CP, 2010, PLANT J, V62, P689, DOI 10.1111/j.1365-313X.2010.04181.x; Mitsuda N, 2005, PLANT CELL, V17, P2993, DOI 10.1105/tpc.105.036004; Nicol F, 1998, EMBO J, V17, P5563, DOI 10.1093/emboj/17.19.5563; Paterson A. H., 1993, Plant Molecular Biology Reporter, V11, P122, DOI 10.1007/BF02670470; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Qin YongSheng, 2009, Scientia Agricultura Sinica, V42, P4145; Renny-Byfield S, 2014, GENOME BIOL EVOL, V6, P559, DOI 10.1093/gbe/evu037; Richmond TA, 2000, PLANT PHYSIOL, V124, P495, DOI 10.1104/pp.124.2.495; Roudier F, 2005, PLANT CELL, V17, P1749, DOI 10.1105/tpc.105.031732; Roudier F, 2002, PLANT PHYSIOL, V130, P538, DOI 10.1104/pp.007468; Sanchez-Rodriguez C, 2009, MOL PLANT MICROBE IN, V22, P953, DOI 10.1094/MPMI-22-8-0953; Schindelman G, 2001, GENE DEV, V15, P1115, DOI 10.1101/gad.879101; SCHUBERT AM, 1973, CROP SCI, V13, P704, DOI 10.2135/cropsci1973.0011183X001300060035x; Shen XL, 2005, MOL BREEDING, V15, P169, DOI 10.1007/s11032-004-4731-0; Tang HB, 2008, SCIENCE, V320, P486, DOI 10.1126/science.1153917; Taylor NG, 2003, P NATL ACAD SCI USA, V100, P1450, DOI 10.1073/pnas.0337628100; Taylor NG, 2000, PLANT CELL, V12, P2529, DOI 10.1105/tpc.12.12.2529; Wang BH, 2007, CROP SCI, V47, P1384, DOI 10.2135/cropsci2006.10.0647; Wang BH, 2006, EUPHYTICA, V152, P367, DOI 10.1007/s10681-006-9224-2; Wang P, 2012, THEOR APPL GENET, V124, P1415, DOI 10.1007/s00122-012-1797-7; Xu YH, 2004, PLANT PHYSIOL, V135, P507, DOI 10.1104/pp.104.038612; Yang C, 2007, MOL PLANT BREED, V5, P797; Zeng CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047284; Zhang HB, 2008, INT J PLANT GENOMICS, V2008, DOI [10.1155/2008/742304, DOI 10.1155/2008/742304]; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhang TZ, 2015, NAT BIOTECHNOL, V33, P531, DOI 10.1038/nbt.3207; Zhang TZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057220; Zhong R, 2007, PLANT CELL, V19, P2776, DOI 10.1105/tpc.107.053678	63	26	28	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145725	10.1371/journal.pone.0145725	http://dx.doi.org/10.1371/journal.pone.0145725			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710066	Green Published, gold, Green Submitted			2022-12-26	WOS:000367451400073
J	Banerjee, R; Mukhopadhyay, R				Banerjee, Ruma; Mukhopadhyay, Rajendrani			When the Good and the Bad Make the Ugly: The Discovery of Peroxynitrite	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material									[Banerjee, Ruma] Univ Michigan, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Banerjee, R (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.								0	4	4	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2015	290	52					30726	30727		10.1074/jbc.O115.000001	http://dx.doi.org/10.1074/jbc.O115.000001			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CZ6GK	26706866	Green Published, hybrid			2022-12-26	WOS:000367199000006
J	Akinrinade, O; Koskenvuo, JW; Alastalo, TP				Akinrinade, Oyediran; Koskenvuo, Juha W.; Alastalo, Tero-Pekka			Prevalence of Titin Truncating Variants in General Population	PLOS ONE			English	Article							TIBIAL MUSCULAR-DYSTROPHY; MUSCLE FILAMENT TITIN; C-TERMINAL TITIN; GENETIC-VARIATION; MUTATIONS; CARDIOMYOPATHY; TTN; MYOPATHY; 5-METHYLCYTOSINE; IDENTIFICATION	Background Truncating titin (TTN) mutations, especially in A-band region, represent the most common cause of dilated cardiomyopathy (DCM). Clinical interpretation of these variants can be challenging, as these variants are also present in reference populations. We carried out systematic analyses of TTN truncating variants (TTNtv) in publicly available reference populations, including, for the first time, data from Exome Aggregation Consortium (ExAC). The goal was to establish more accurate estimate of prevalence of different TTNtv to allow better clinical interpretation of these findings. Methods and Results Using data from 1000 Genomes Project, Exome Sequencing Project (ESP) and ExAC, we estimated the prevalence of TTNtv in the population. In the three population datasets, 52-54% of TTNtv were not affecting all TTN transcripts. The frequency of truncations affecting all transcripts in ExAC was 0.36% (0.32% - 0.41%, 95% CI) and 0.19% (0.16% - 0.23%, 95% CI) for those affecting the A-band. In the A-band region, the prevalences of frameshift, nonsense and essential splice site variants were 0.057%, 0.090%, and 0.047% respectively. Cga/Tga (arginine/nonsense-R/*) transitional change at CpG mutation hotspots was the most frequent type of TTN nonsense mutation accounting for 91.3% (21/23) of arginine residue nonsense mutation (R/*) at TTN A-band region. Non-essential splice-site variants had significantly lower proportion of private variants and higher proportion of low-frequency variants compared to essential splice-site variants (P = 0.01; P = 5.1 X 10(-4), respectively). Conclusion A-band TTNtv are more rare in the general population than previously reported. Based on this analysis, one in 500 carries a truncation in TTN A-band suggesting the penetrance of these potentially harmful variants is still poorly understood, and some of these variants do not manifest as autosomal dominant DCM. This calls for caution when interpreting TTNtv in individuals and families with no history of DCM. Considering the size of TTN, expertise in DNA library preparation, high coverage NGS strategies, validated bioinformatics approach, accurate variant assessment strategy, and confirmatory sequencing are prerequisites for reliable evaluation of TTN in clinical settings, and ideally with the inclusion of mRNA and/or protein level assessment for a definite diagnosis.	[Akinrinade, Oyediran; Alastalo, Tero-Pekka] Univ Helsinki, Inst Clin Med, Childrens Hosp Helsinki, Helsinki, Finland; [Akinrinade, Oyediran; Alastalo, Tero-Pekka] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Koskenvuo, Juha W.; Alastalo, Tero-Pekka] Blueprint Genet, Helsinki, Finland; [Koskenvuo, Juha W.] Univ Helsinki, Cent Hosp, Dept Clin Physiol & Nucl Med, HUS Med Imaging Ctr, Helsinki, Finland; [Koskenvuo, Juha W.] Univ Helsinki, Helsinki, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Hyvinkaan Sairaala; University of Helsinki; Helsinki University Central Hospital; University of Helsinki	Alastalo, TP (corresponding author), Univ Helsinki, Inst Clin Med, Childrens Hosp Helsinki, Helsinki, Finland.	tero-pekka.alastalo@helsinki.fi	Akinrinade, Oyediran/AAX-3795-2020	Akinrinade, Oyediran/0000-0002-6797-6353	Sigrid Juselius Foundation; Finnish Foundation for Pediatric Research; Finnish Foundation for Cardiovascular Research; Finnish Cultural Foundation [00150083]; Ida Montin Foundation	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Foundation for Pediatric Research; Finnish Foundation for Cardiovascular Research; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Ida Montin Foundation	This work was supported by grants from the Sigrid Juselius Foundation; the Finnish Foundation for Pediatric Research; the Finnish Foundation for Cardiovascular Research; the Finnish Cultural Foundation (00150083:OA); and the Ida Montin Foundation (OA). The funders Blueprint Genetics had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries for authors [OA, JWK and TPA], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Akinrinade O, 2015, GENETICS GE IN PRESS; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Carmignac V, 2007, ANN NEUROL, V61, P340, DOI 10.1002/ana.21089; Ceyhan-Birsoy O, 2013, NEUROLOGY, V81, P1205, DOI 10.1212/WNL.0b013e3182a6ca62; Chauveau C, 2014, HUM MOL GENET, V23, P980, DOI 10.1093/hmg/ddt494; Cooper David N, 2010, Hum Genomics, V4, P406; Dewey FE, 2014, JAMA-J AM MED ASSOC, V311, P1035, DOI 10.1001/jama.2014.1717; Evila A, 2014, ANN NEUROL, V75, P230, DOI 10.1002/ana.24102; Gerull B, 2006, J MOL MED-JMM, V84, P478, DOI 10.1007/s00109-006-0060-6; Gerull B, 2002, NAT GENET, V30, P201, DOI 10.1038/ng815; Golbus JR, 2012, CIRC-CARDIOVASC GENE, V5, P391, DOI 10.1161/CIRCGENETICS.112.962928; Haas J, 2015, EUR HEART J, V36, P1123, DOI 10.1093/eurheartj/ehu301; Haas J, 2013, EMBO MOL MED, V5, P413, DOI 10.1002/emmm.201201553; Hackman P, 2002, AM J HUM GENET, V71, P492, DOI 10.1086/342380; Hackman P, 2008, NEUROMUSCULAR DISORD, V18, P922, DOI 10.1016/j.nmd.2008.07.010; Herman DS, 2012, NEW ENGL J MED, V366, P619, DOI 10.1056/NEJMoa1110186; Itoh-Satoh M, 2002, BIOCHEM BIOPH RES CO, V291, P385, DOI 10.1006/bbrc.2002.6448; Krawczak M, 1996, HUM MUTAT, V8, P23; Matsumoto Y, 2005, J MUSCLE RES CELL M, V26, P367, DOI 10.1007/s10974-005-9018-5; Meurs KM, 2011, ENVIRON MOL MUTAGEN, V52, P161, DOI 10.1002/em.20596; Movassagh M, 2011, CIRCULATION, V124, P2411, DOI 10.1161/CIRCULATIONAHA.111.040071; NHLBI, EX VAR SERV NHLBI EX; O'Rawe J, 2013, GENOME MED, V5, DOI 10.1186/gm432; Pan S, 2012, CIRC-CARDIOVASC GENE, V5, P602, DOI 10.1161/CIRCGENETICS.112.963421; Patricia Arscott M, 2014, HEART RHYTHM    0509; Pugh TJ, 2014, GENET MED, V16, P601, DOI 10.1038/gim.2013.204; RIDEOUT WM, 1990, SCIENCE, V249, P1288, DOI 10.1126/science.1697983; Roberts AM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010134; Satoh M, 1999, BIOCHEM BIOPH RES CO, V262, P411, DOI 10.1006/bbrc.1999.1221; Strom SP, 2014, GENET MED, V16, P510, DOI 10.1038/gim.2013.183; Taylor M, 2011, CIRCULATION, V124, P876, DOI 10.1161/CIRCULATIONAHA.110.005405; Udd B, 2005, NEUROLOGY, V64, P636, DOI 10.1212/01.WNL.0000151853.50144.82; van Spaendonck-Zwarts KY, 2014, EUR HEART J, V35, P2165, DOI 10.1093/eurheartj/ehu050; Yoskovitz G, 2012, AM J CARDIOL, V109, P1644, DOI 10.1016/j.amjcard.2012.01.392	36	57	57	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145284	10.1371/journal.pone.0145284	http://dx.doi.org/10.1371/journal.pone.0145284			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26701604	Green Published, gold			2022-12-26	WOS:000367092600058
J	Azevedo, MDS; Rosa, PS; Soares, CT; Fachin, LRV; Baptista, IMFD; Woods, WJ; Garlet, GP; Trombone, APF; Belone, ADF				Azevedo, Michelle de C. S.; Rosa, Patricia S.; Soares, Cleverson T.; Fachin, Luciana R. V.; Baptista, Ida Maria F. D.; Woods, William J.; Garlet, Gustavo P.; Trombone, Ana Paula F.; Belone, Andrea de F. F.			Analysis of Immune Response Markers in Jorge Lobo's Disease Lesions Suggests the Occurrence of Mixed T Helper Responses with the Dominance of Regulatory T Cell Activity	PLOS ONE			English	Article							IL-17; BETA; LOBOMYCOSIS; LACAZIOSIS; INFECTION; CYTOKINES; PATHOGEN; T(H)17; GROWTH; SKIN	Jorge Lobo's disease (JLD) is a chronic infection that affects the skin and subcutaneous tissues. Its etiologic agent is the fungus Lacazia loboi. Lesions are classified as localized, multifocal, or disseminated, depending on their location. Early diagnosis and the surgical removal of lesions are the best therapeutic options currently available for JLD. The few studies that evaluate the immunological response of JLD patients show a predominance of Th2 response, as well as a high frequency of TGF-beta and IL-10 positive cells in the lesions; however, the overall immunological status of the lesions in terms of their T cell phenotype has yet to be determined. Therefore, the objective of this study was to evaluate the pattern of Th1, Th2, Th17 and regulatory T cell (Treg) markers mRNA in JLD patients by means of real-time PCR. Biopsies of JLD lesions (N = 102) were classified according to their clinical and histopathological features and then analyzed using real-time PCR in order to determine the expression levels of TGF-beta 1, FoxP3, CTLA4, IKZF2, IL-10, T-bet, IFN-gamma, GATA3, IL-4, IL-5, IL-13, IL-33, RORC, IL-17A, IL-17F, and IL-22 and to compare these levels to those of healthy control skin (N = 12). The results showed an increased expression of FoxP3, CTLA4, TGF-beta 1, IL-10, T-bet, IL-17F, and IL-17A in lesions, while GATA3 and IL-4 levels were found to be lower in diseased skin than in the control group. When the clinical forms were compared, TGF-beta 1 was found to be highly expressed in patients with a single localized lesion while IL-5 and IL-17A levels were higher in patients with multiple/disseminated lesions. These results demonstrate the occurrence of mixed T helper responses and suggest the dominance of regulatory T cell activity, which could inhibit Th-dependent protective responses to intracellular fungi such as L. loboi. Therefore, Tregs may play a key role in JLD pathogenesis.	[Azevedo, Michelle de C. S.] Univ Estadual Paulista, Fac Med Botucatu, Dept Doencas Trop, Botucatu, SP, Brazil; [Azevedo, Michelle de C. S.; Rosa, Patricia S.; Soares, Cleverson T.; Fachin, Luciana R. V.; Belone, Andrea de F. F.] Inst Lauro Souza Lima, Dept Patol, Sao Paulo, Brazil; [Baptista, Ida Maria F. D.] Inst Lauro Souza Lima, Dept Microbiol, Sao Paulo, Brazil; [Woods, William J.] Hosp Clin Acre, Serv Especializado Dermatol, Sao Paulo, Brazil; [Garlet, Gustavo P.] Univ Sao Paulo, Fac Odontol Bauru, Dept Ciencias Biol, Sao Paulo, Brazil; [Trombone, Ana Paula F.] Univ Sagrado Coracao, Dept Ciencias Saude, Sao Paulo, Brazil	Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade do Sagrado Coracao	Trombone, APF (corresponding author), Univ Sagrado Coracao, Dept Ciencias Saude, Sao Paulo, Brazil.	tromboneap@yahoo.com.br; abelone@ilsl.br	Baptista, Ida Maria F D/G-8736-2012; de Campos Soriani Azevedo, Michelle/Y-8096-2018; Garlet, Ana Paula Trombone/N-9346-2013; Garlet, Gustavo Pompermaier/E-6762-2012; Azevedo, Michelle de Campos Soriani/GOJ-9716-2022	Baptista, Ida Maria F D/0000-0002-1574-9490; de Campos Soriani Azevedo, Michelle/0000-0001-5777-1138; Garlet, Ana Paula Trombone/0000-0002-8102-6098; Garlet, Gustavo Pompermaier/0000-0002-5071-8382; Azevedo, Michelle de Campos Soriani/0000-0001-5777-1138				Abbas A.K., 2012, IMUNOLOGIA CELULAR M, V8th; Arju R, 2014, THER ADV INFECT DIS, V2, P91, DOI 10.1177/2049936114559919; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Borghi M, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00506; Bourgeois C, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00142; Brito Arival Cardoso de, 2007, An. Bras. Dermatol., V82, P461, DOI 10.1590/S0365-05962007000500010; Burns RA, 2000, J CLIN MICROBIOL, V38, P1283, DOI 10.1128/JCM.38.3.1283-1285.2000; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Campbell DJ, 2011, NAT MED, V17, P929, DOI 10.1038/nm.2433; Cavassani KA, 2006, J IMMUNOL, V177, P5811, DOI 10.4049/jimmunol.177.9.5811; Chen X, 2014, TH17 CELLS TREGS UNL; Clark RA, 2010, J INVEST DERMATOL, V130, P362, DOI 10.1038/jid.2009.247; Costa TA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002512; Silva AAD, 2013, MICROB PATHOGENESIS, V65, P36, DOI 10.1016/j.micpath.2013.09.004; De Luca A, 2007, J IMMUNOL, V179, P5999, DOI 10.4049/jimmunol.179.9.5999; Dumoutier L, 2000, J IMMUNOL, V164, P1814, DOI 10.4049/jimmunol.164.4.1814; Espinosa V, 2012, CYTOKINE, V58, P100, DOI 10.1016/j.cyto.2011.11.005; Felonato M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051071; Ferreira MC, 2010, INFECT IMMUN, V78, P4392, DOI 10.1128/IAI.00487-10; Gaffen SL, 2014, IMMUNITY, V10; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Herr RA, 2001, J CLIN MICROBIOL, V39, P309, DOI 10.1128/JCM.39.1.309-314.2001; Holmer SM, 2014, INFECT IMMUN, V82, P683, DOI 10.1128/IAI.00855-13; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; Hube B, 2009, CURR OPIN MICROBIOL, V12, P347, DOI 10.1016/j.mib.2009.06.009; Jarvinen TAH, 2013, ADV WOUND CARE, V2, P50, DOI 10.1089/wound.2011.0299; Jin W, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.58; Kanashiro-Galo L, 2015, MED MYCOL; Kennedy J, 1996, J INTERF CYTOK RES, V16, P611, DOI 10.1089/jir.1996.16.611; Kimizuka Y, 2012, INFECT IMMUN, V80, P1121, DOI 10.1128/IAI.05544-11; Koguchi Yoshinobu, 2002, Int Rev Immunol, V21, P423, DOI 10.1080/08830180213274; Koh AY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040035; Lacaz C.S., 1986, DOENCA JORGE LOBO, P1; MacCallum DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006420; Marcos EVC, 2005, REV SOC BRAS MED TRO, V38, P399, DOI 10.1590/S0037-86822005000500007; MATSUMOTO K, 1990, J CELL PHYSIOL, V145, P95, DOI 10.1002/jcp.1041450114; McCormick LL, 1999, J IMMUNOL, V163, P5693; McNamee KE, 2011, PAIN, V152, P1838, DOI 10.1016/j.pain.2011.03.035; Miossec P, 2012, NAT REV DRUG DISCOV, V11, P763, DOI 10.1038/nrd3794; Miranda MFR, 2010, AN BRAS DERMATOL, V85, P39, DOI 10.1590/S0365-05962010000100005; Tubilla LHM, 2008, AN BRAS DERMATOL, V83, P261, DOI 10.1590/S0365-05962008000300011; Moreira AP, 2008, J IMMUNOL, V180, P3049, DOI 10.4049/jimmunol.180.5.3049; Muraille E, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00603; Opromolla D. V. A., 2000, Anais Brasileiros de Dermatologia, V75, P425; Opromolla D. V. A., 1999, Anais Brasileiros de Dermatologia, V74, P135; Paniz-Mondolfi A, 2012, MYCOSES, V55, P298, DOI 10.1111/j.1439-0507.2012.02184.x; Paniz-Mondolfi AE, 2007, INT J DERMATOL, V46, P180, DOI 10.1111/j.1365-4632.2007.02937.x; Papadavid E, 2012, J DERMATOL CASE REP, V6, P65, DOI 10.3315/jdcr.2012.1104; Piehler D, 2011, AM J PATHOL, V179, P733, DOI 10.1016/j.ajpath.2011.04.025; RESTREPO A, 1994, J AM ACAD DERMATOL, V31, pS91, DOI 10.1016/S0190-9622(08)81277-7; RODRIGUEZTORO G, 1993, INT J DERMATOL, V32, P324, DOI 10.1111/j.1365-4362.1993.tb01466.x; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; Rosa Patricia Sammarco, 2009, J Med Case Rep, V3, P67, DOI 10.1186/1752-1947-3-67; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Shahrara S, 2010, J IMMUNOL, V184, P4479, DOI 10.4049/jimmunol.0901942; Talhari S, 2012, CLIN DERMATOL, V30, P420, DOI 10.1016/j.clindermatol.2011.09.014; Taylor A, 2006, IMMUNOLOGY, V117, P433, DOI 10.1111/j.1365-2567.2006.02321.x; Ulges A, 2015, NAT IMMUNOL, V16, P267, DOI 10.1038/ni.3083; Verma A, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a019612; Vilani-Moreno Fatima Regina, 2005, Revista Iberoamericana de Micologia, V22, P44, DOI 10.1016/S1130-1406(05)70006-1; Vilani-Moreno FR, 2004, MYCOPATHOLOGIA, V158, P17, DOI 10.1023/B:MYCO.0000038433.76437.ec; Vilani-Moreno FR, 2011, MED MYCOL, P1; Vinh DC, 2011, LANCET INFECT DIS, V11, P780, DOI 10.1016/S1473-3099(11)70217-1; WIERSEMA JP, 1965, TROP GEOGR MED, V17, P89; Woods WJ, 2010, REV INST MED TROP SP, V52, P273, DOI 10.1590/S0036-46652010000500010; Xavier MB, 2006, EMERG INFECT DIS, V12, P526, DOI 10.3201/eid1203.051426; Zelante T, 2007, EUR J IMMUNOL, V37, P2695, DOI 10.1002/eji.200737409	67	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145814	10.1371/journal.pone.0145814	http://dx.doi.org/10.1371/journal.pone.0145814			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700881	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092600135
J	Pletneva, NV; Pletnev, VZ; Sarkisyan, KS; Gorbachev, DA; Egorov, ES; Mishin, AS; Lukyanov, KA; Dauter, Z; Pletnev, S				Pletneva, Nadya V.; Pletnev, Vladimir Z.; Sarkisyan, Karen S.; Gorbachev, Dmitry A.; Egorov, Evgeny S.; Mishin, Alexander S.; Lukyanov, Konstantin A.; Dauter, Zbigniew; Pletnev, Sergei			Crystal Structure of Phototoxic Orange Fluorescent Proteins with a Tryptophan-Based Chromophore	PLOS ONE			English	Article							ELECTRON-TRANSFER; RED; INACTIVATION; PATHWAYS; OXYGEN	Phototoxic fluorescent proteins represent a sparse group of genetically encoded photosensitizers that could be used for precise light-induced inactivation of target proteins, DNA damage, and cell killing. Only two such GFP-based fluorescent proteins (FPs), KillerRed and its monomeric variant SuperNova, were described up to date. Here, we present a crystallographic study of their two orange successors, dimeric KillerOrange and monomeric mKiller-Orange, at 1.81 and 1.57 angstrom resolution, respectively. They are the first orange-emitting protein photosensitizers with a tryptophan-based chromophore (Gln65-Trp66-Gly67). Same as their red progenitors, both orange photosensitizers have a water-filled channel connecting the chromophore to the beta-barrel exterior and enabling transport of ROS. In both proteins, Trp66 of the chromophore adopts an unusual trans-cis conformation stabilized by H- bond with the nearby Gln159. This trans-cis conformation along with the water channel was shown to be a key structural feature providing bright orange emission and phototoxicity of both examined orange photosensitizers.	[Pletneva, Nadya V.; Pletnev, Vladimir Z.; Sarkisyan, Karen S.; Gorbachev, Dmitry A.; Egorov, Evgeny S.; Mishin, Alexander S.; Lukyanov, Konstantin A.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Gorbachev, Dmitry A.] Moscow MV Lomonosov State Univ, Fac Biol, Moscow, Russia; [Mishin, Alexander S.; Lukyanov, Konstantin A.] Nizhny Novgorod State Med Acad, Nizhnii Novgorod, Russia; [Dauter, Zbigniew; Pletnev, Sergei] NCI, Synchrotron Radiat Res Sect, Macromol Crystallog Lab, Argonne, IL 60439 USA; [Pletnev, Sergei] Leidos Biomed Res Inc, Basic Res Program, Argonne, IL USA	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Lomonosov Moscow State University; Privolzhsky Research Medical University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Pletnev, S (corresponding author), NCI, Synchrotron Radiat Res Sect, Macromol Crystallog Lab, Argonne, IL 60439 USA.	vzpletnev@gmail.com; pletnevs@mail.nih.gov	Pletneva, Nadya/F-7839-2014; Sarkisyan, Karen S/M-6821-2015; Sarkisyan, Karen/AAA-5784-2021; Pletnev, Vladimir/Q-6151-2016; Mishin, Alexander/L-9420-2014; Lukyanov, Konstantin A/D-4030-2013	Sarkisyan, Karen S/0000-0002-5375-6341; Sarkisyan, Karen/0000-0002-5375-6341; Mishin, Alexander/0000-0002-4935-7030; Lukyanov, Konstantin A/0000-0001-9845-2088; Gorbachev, Dmitry/0000-0001-6124-2511; Pletneva, Nadya/0000-0001-9681-4022	Russian Science Foundation (RSF) [14-14-00281]; Russian Science Foundation [14-25-00129]; US Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; National Cancer Institute, National Institutes of Health [HHSN261200800001E]; Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research.; NATIONAL CANCER INSTITUTE [ZIABC010378] Funding Source: NIH RePORTER	Russian Science Foundation (RSF)(Russian Science Foundation (RSF)); Russian Science Foundation(Russian Science Foundation (RSF)); US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been supported with a federal grant from the Russian Science Foundation (RSF) No 14-14-00281. Mutagenesis work has been supported by Russian Science Foundation grant 14-25-00129. Experiments were partially carried out using the equipment provided by the IBCH core facility (CKP IBCH). Diffraction experiments were carried out at beamline 22-ID of the Southeast Regional Collaborative Access Team (SER-CAT), located at the Advanced Photon Source, Argonne National Laboratory, USA. Use of the APS was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract no. W-31-109-Eng-38. The project has been supported in part with federal funds from the National Cancer Institute, National Institutes of Health under contract no. HHSN261200800001E, by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government. SP is employed by Leidos Biomedical Research, Inc. The specific contributions of this author can be found in the Author Contributions section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae JH, 2003, J MOL BIOL, V328, P1071, DOI 10.1016/S0022-2836(03)00364-4; Bulina ME, 2006, NAT BIOTECHNOL, V24, P95, DOI 10.1038/nbt1175; Carpentier P, 2009, FEBS LETT, V583, P2839, DOI 10.1016/j.febslet.2009.07.041; DeLano WL, 2002, THE PYMOL MOLECULAR; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evdokimov AG, 2006, EMBO REP, V7, P1006, DOI 10.1038/sj.embor.7400787; Ivashchenko O, 2011, MOL BIOL CELL, V22, P1440, DOI 10.1091/mbc.E10-11-0919; Kuznetsova DS, 2015, J BIOPHOTONICS, V8, P952, DOI 10.1002/jbio.201400130; Lelimousin M, 2009, BIOCHEMISTRY-US, V48, P10038, DOI 10.1021/bi901093w; Lin JY, 2013, NEURON, V79, P241, DOI 10.1016/j.neuron.2013.05.022; Lin JP, 2005, SCIENCE, V310, P1311, DOI 10.1126/science.1118316; Lukyanov KA, 2010, PHOTOCH PHOTOBIO SCI, V9, P1301, DOI 10.1039/c0pp00114g; Malo GD, 2007, BIOCHEMISTRY-US, V46, P9865, DOI 10.1021/bi602664c; Matsumoto A, 2011, BIOTECHNIQUES, V51, P55, DOI 10.2144/000113705; Miyashita O, 2005, P NATL ACAD SCI USA, V102, P3558, DOI 10.1073/pnas.0409600102; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pletnev S, 2009, J BIOL CHEM, V284, P32028, DOI 10.1074/jbc.M109.054973; Pletnev VZ, 2015, ACTA CRYSTALLOGR D, V71, P1699, DOI 10.1107/S1399004715010159; Pletneva NV, 2007, RUSS J BIOORG CHEM+, V33, P390, DOI 10.1134/S1068162007040048; Pletneva N, 2007, ACTA CRYSTALLOGR D, V63, P1082, DOI 10.1107/S0907444907042461; Pletneva NV, 2011, PROTEIN SCI, V20, P1265, DOI 10.1002/pro.654; Roy A, 2010, PHOTOCH PHOTOBIO SCI, V9, P1342, DOI 10.1039/c0pp00141d; Ryumina AP, 2013, BBA-GEN SUBJECTS, V1830, P5059, DOI 10.1016/j.bbagen.2013.07.015; Sano Y, 2014, J CELL SCI, V127, P1621, DOI 10.1242/jcs.144527; Sarkisyan KS, 2015, PLOS ONE FORTHCOMING; Serebrovskaya EO, 2011, BIOCHEM J, V435, P65, DOI 10.1042/BJ20101217; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shu XK, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001041; Takemoto K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02629; Torra J, 2015, PHOTOCH PHOTOBIO SCI, V14, P280, DOI 10.1039/c4pp00338a; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vegh RB, 2014, J PHYS CHEM B, V118, P4527, DOI 10.1021/jp500919a; Vegh RB, 2011, CHEM COMMUN, V47, P4887, DOI 10.1039/c0cc05713d; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Williams DC, 2013, CELL REP, V5, P553, DOI 10.1016/j.celrep.2013.09.023; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246	38	20	27	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145740	10.1371/journal.pone.0145740	http://dx.doi.org/10.1371/journal.pone.0145740			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26699366	Green Submitted, gold, Green Published			2022-12-26	WOS:000367092600126
J	Ahmad, A; Wani, MY; Khan, A; Manzoor, N; Molepo, J				Ahmad, Aijaz; Wani, Mohmmad Younus; Khan, Amber; Manzoor, Nikhat; Molepo, Julitha			Synergistic Interactions of Eugenol-tosylate and Its Congeners with Fluconazole against Candida albicans	PLOS ONE			English	Article							ERGOSTEROL BIOSYNTHESIS PATHWAY; ERG11 GENE; DRUG-RESISTANCE; UP-REGULATION; AZOLES; MUTATIONS	We previously reported the antifungal properties of a monoterpene phenol "Eugenol" against different Candida strains and have observed that the addition of methyl group to eugenol drastically increased its antimicrobial potency. Based on the results and the importance of medicinal synthetic chemistry, we synthesized eugenol-tosylate and its congeners (E1-E6) and tested their antifungal activity against different clinical fluconazole (FLC)-susceptible and FLC-resistant C. albicans isolates alone and in combination with FLC by determining fractional inhibitory concentration indices (FICIs) and isobolograms calculated from microdilution assays. Minimum inhibitory concentration (MIC) results confirmed that all the tested C. albicans strains were variably susceptible to the semi-synthetic derivatives E1-E6, with MIC values ranging from 1-62 mu g/ml. The test compounds in combination with FLC exhibited either synergy (36%), additive (41%) or indifferent (23%) interactions, however, no antagonistic interactions were observed. The MICs of FLC decreased 2-9 fold when used in combination with the test compounds. Like their precursor eugenol, all the derivatives showed significant impairment of ergosterol biosynthesis in all C. albicans strains coupled with down regulation of the important ergosterol biosynthesis pathway gene-ERG11. The results were further validated by docking studies, which revealed that the inhibitors snugly fitting the active site of the target enzyme, mimicking fluconazole, may well explain their excellent inhibitory activity. Our results suggest that these compounds have a great potential as antifungals, which can be used as chemosensitizing agents with the known antifungal drugs.	[Ahmad, Aijaz; Molepo, Julitha] Univ Witwatersrand, Fac Hlth Sci, Sch Oral Hlth Sci, Dept Oral Biol Sci, Johannesburg, South Africa; [Wani, Mohmmad Younus] Univ Coimbra, Dept Quim, FCTUC, Coimbra, Portugal; [Khan, Amber] Univ Witwatersrand, Fac Hlth Sci, Dept Internal Med, Johannesburg, South Africa; [Manzoor, Nikhat] Taibah Univ, Coll Appl Med Sci, Al Madinah Al Munawarah, KSA, Saudi Arabia; [Manzoor, Nikhat] Jamia Millia Islamia, Dept Biosci, New Delhi 110025, Delhi, India	University of Witwatersrand; Universidade de Coimbra; University of Witwatersrand; Taibah University; Jamia Millia Islamia	Manzoor, N (corresponding author), Taibah Univ, Coll Appl Med Sci, Al Madinah Al Munawarah, KSA, Saudi Arabia.	nikhatmanzoor@yahoo.co.in; Julitha.molepo@wits.ac.za	Wani, Mohammad Younus/E-3909-2018; Wani, Mohmmad Younus/AAJ-5016-2020	Wani, Mohammad Younus/0000-0002-1838-1337; Wani, Mohmmad Younus/0000-0002-1838-1337; Manzoor, Nikhat/0000-0002-6850-6142; Ahmad, Aijaz/0000-0003-2845-0727	Faculty Research Committee Individual Research Grant [001254 84511025121105]	Faculty Research Committee Individual Research Grant	AA and JM are highly thankful to Faculty Research Committee Individual Research Grants/No. 001254 84511025121105 for finical support. Funding agency has no role in the study design or any other experimental work.	Ahmad A, 2011, EUR J CLIN MICROBIOL, V30, P41, DOI 10.1007/s10096-010-1050-8; Ahmad A, 2014, MOLECULES, V19, P2896, DOI 10.3390/molecules19032896; Ahmad A, 2013, EUR J PHARM SCI, V48, P80, DOI 10.1016/j.ejps.2012.09.016; Ahmad A, 2010, J MED MICROBIOL, V59, P1178, DOI 10.1099/jmm.0.020693-0; Ahmad A, 2010, MICROB PATHOGENESIS, V48, P35, DOI 10.1016/j.micpath.2009.10.001; Borecka-Melkusova S, 2009, MYCOSES, V52, P118, DOI 10.1111/j.1439-0507.2008.01550.x; Bozic DD, 2014, INDIAN J MED RES, V140, P130; Canuto MM, 2002, LANCET INFECT DIS, V2, P550, DOI 10.1016/S1473-3099(02)00371-7; Ceita GD, 2014, GENET MOL BIOL, V37, P683, DOI [10.1590/S1415-47572014005000017, 10.1590/S1415-47572014000500011]; CLSI, 2008, M27A3 CLSI; Dai LL, 2015, MEDCHEMCOMM, V6, P147, DOI 10.1039/c4md00266k; Darvishi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076028; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Eddouzi J, 2013, ANTIMICROB AGENTS CH, V57, P3182, DOI 10.1128/AAC.00555-13; Eloff JN, 1998, J ETHNOPHARMACOL, V60, P1, DOI 10.1016/S0378-8741(97)00123-2; Hemaiswarya S, 2009, PHYTOMEDICINE, V16, P997, DOI 10.1016/j.phymed.2009.04.006; Henry KW, 2000, ANTIMICROB AGENTS CH, V44, P2693, DOI 10.1128/AAC.44.10.2693-2700.2000; Hof H, 2008, DRUG RESIST UPDATE, V11, P25, DOI 10.1016/j.drup.2008.01.001; Jeu L, 2003, CLIN THER, V25, P1321, DOI 10.1016/S0149-2918(03)80126-1; Lehar J, 2009, NAT BIOTECHNOL, V27, P659, DOI 10.1038/nbt.1549; Lepesheva GI, 2006, J BIOL CHEM, V281, P3577, DOI 10.1074/jbc.M510317200; Levy JW, 2015, J MOL GRAPH MODEL, V56, P43, DOI 10.1016/j.jmgm.2014.11.013; Manastir L, 2011, MYCOSES, V54, P99, DOI 10.1111/j.1439-0507.2009.01766.x; Newman DJ, 2003, J NAT PROD, V66, P1022, DOI 10.1021/np030096l; Prasad R, 2005, INT REV CYTOL, V242, P215; Sanglard D, 2003, ANTIMICROB AGENTS CH, V47, P2404, DOI 10.1128/AAC.47.8.2404-2412.2003; Sgherri C, 2014, BBA-BIOMEMBRANES, V1838, P465, DOI 10.1016/j.bbamem.2013.10.015; SHIMOKAWA O, 1989, BIOCHIM BIOPHYS ACTA, V1003, P15, DOI 10.1016/0005-2760(89)90092-1; Sousa MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089939; Tavakoli M, 2010, DARU, V18, P276; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Ulrich-Merzenich G.S., 2014, SYNERGY, V1, P59, DOI [10.1016/j.synres.2014.07.011, DOI 10.1016/J.SYNRES.2014.07.011]; van Vuuren S, 2011, PLANTA MED, V77, P1168, DOI 10.1055/s-0030-1250736; Volkamer A, 2012, J CHEM INF MODEL, V52, P360, DOI 10.1021/ci200454v; Warrilow AG, 2013, ANTIMICROB AGENTS CH, V57, P1352, DOI 10.1128/AAC.02067-12; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Zhang HZ, 2014, SCI CHINA CHEM, V57, P807, DOI 10.1007/s11426-014-5087-x; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	38	36	36	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145053	10.1371/journal.pone.0145053	http://dx.doi.org/10.1371/journal.pone.0145053			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26694966	gold, Green Published, Green Submitted			2022-12-26	WOS:000367092500021
J	Heger, Z; Michalek, P; Guran, R; Havelkova, B; Kominkova, M; Cernei, N; Richtera, L; Beklova, M; Adam, V; Kizek, R				Heger, Zbynek; Michalek, Petr; Guran, Roman; Havelkova, Barbora; Kominkova, Marketa; Cernei, Natalia; Richtera, Lukas; Beklova, Miroslava; Adam, Vojtech; Kizek, Rene			Exposure to 17 beta-Oestradiol Induces Oxidative Stress in the Non-Oestrogen Receptor Invertebrate Species Eisenia fetida	PLOS ONE			English	Article							DISRUPTING COMPOUNDS; METALLOTHIONEIN; WATER; PHARMACEUTICALS; CONTAMINANTS; EXPRESSION; HORMONES; SOILS; OLIGOCHAETA; POLLUTANTS	Background The environmental impacts of various substances on all levels of organisms are under investigation. Among these substances, endocrine-disrupting compounds (EDCs) present a threat, although the environmental significance of these compounds remains largely unknown. To shed some light on this field, we assessed the effects of 17 beta-oestradiol on the growth, reproduction and formation of free radicals in Eisenia fetida. Methodology/Principal Findings Although the observed effects on growth and survival were relatively weak, a strong impact on reproduction was observed (50.70% inhibition in 100 mu g/kg of E-2). We further demonstrated that the exposure of the earthworm Eisenia fetida to a contaminant of emerging concern, 17 beta-oestradiol (E2), significantly affected the molecules involved in antioxidant defence. Exposure to E2 results in the production of reactive oxygen species (ROS) and the stimulation of antioxidant systems (metallothionein and reduced oxidized glutathione ratio) but not phytochelatins at both the mRNA and translated protein levels. Matrix-assisted laser desorption/ionization (MALDI)-imaging revealed the subcuticular bioaccumulation of oestradiol- 3,4-quinone, altering the levels of local antioxidants in a time-dependent manner. Conclusions/Significance The present study illustrates that although most invertebrates do not possess oestrogen receptors, these organisms can be affected by oestrogen hormones, likely reflecting free diffusion into the cellular microenvironment with subsequent degradation to molecules that undergo redox cycling, producing ROS, thereby increasing environmental contamination that also perilously affects keystone animals, forming lower trophic levels.	[Heger, Zbynek; Michalek, Petr; Guran, Roman; Kominkova, Marketa; Cernei, Natalia; Richtera, Lukas; Adam, Vojtech; Kizek, Rene] Mendel Univ Brno, Dept Chem & Biochem, CZ-61300 Brno, Czech Republic; [Heger, Zbynek; Michalek, Petr; Guran, Roman; Kominkova, Marketa; Cernei, Natalia; Richtera, Lukas; Beklova, Miroslava; Adam, Vojtech; Kizek, Rene] Brno Univ Technol, Cent European Inst Technol, CZ-61600 Brno, Czech Republic; [Heger, Zbynek; Havelkova, Barbora; Beklova, Miroslava] Univ Vet & Pharmaceut Sci, Fac Vet Hyg & Ecol, Dept Ecol & Dis Game Fish & Bees, CZ-61242 Brno, Czech Republic	Mendel University in Brno; Brno University of Technology; University of Veterinary Sciences Brno	Kizek, R (corresponding author), Mendel Univ Brno, Dept Chem & Biochem, Zemedelska 1, CZ-61300 Brno, Czech Republic.	kizek@sci.muni.cz	Havelkova, Barbora/AAC-4878-2019; Richtera, Lukas/N-9991-2014; Heger, Zbyněk/D-1973-2013; Němcová, Barbora/GVT-4918-2022; Cernei, Natalia/M-7505-2019; Adam, Vojtech/D-7686-2012; Guran, Roman/C-2610-2016; Cernei, Natalia/K-2578-2016	Havelkova, Barbora/0000-0003-4298-3650; Richtera, Lukas/0000-0002-8288-3999; Heger, Zbyněk/0000-0002-3915-7270; Cernei, Natalia/0000-0002-8259-1566; Adam, Vojtech/0000-0002-8527-286X; Guran, Roman/0000-0002-2912-714X; Cernei, Natalia/0000-0002-8259-1566; Kizek, Rene/0000-0002-0467-6169; Michalek, Petr/0000-0002-0121-0128	Central European Institute of Technology [CEITEC] [CZ.1.05/1.1.00/02.0068]	Central European Institute of Technology [CEITEC]	Financial support was received through a grant (Central European Institute of Technology [CEITEC] CZ.1.05/1.1.00/02.0068).	Asselman J, 2012, AQUAT TOXICOL, V110, P54, DOI 10.1016/j.aquatox.2011.12.010; Benotti MJ, 2009, ENVIRON SCI TECHNOL, V43, P597, DOI 10.1021/es801845a; Bernard E, 2015, ECOTOX ENVIRON SAFE, V114, P273, DOI 10.1016/j.ecoenv.2014.04.024; Bolton JL, 1998, CHEM RES TOXICOL, V11, P1113, DOI 10.1021/tx9801007; Brulle F, 2008, ECOTOX ENVIRON SAFE, V71, P47, DOI 10.1016/j.ecoenv.2007.10.032; Carelli S, 1997, SCIENCE, V277, P1681, DOI 10.1126/science.277.5332.1681; Carr DL, 2011, WATER AIR SOIL POLL, V217, P127, DOI 10.1007/s11270-010-0573-z; Chaki SP, 2006, APOPTOSIS, V11, P1427, DOI 10.1007/s10495-006-8761-4; Colucci MS, 2001, J ENVIRON QUAL, V30, P2070, DOI 10.2134/jeq2001.2070; Demuynck S, 2007, COMP BIOCHEM PHYS C, V145, P658, DOI 10.1016/j.cbpc.2007.03.001; DEVOS CHR, 1992, PLANT PHYSIOL, V98, P853, DOI 10.1104/pp.98.3.853; Finlay-Moore O, 2000, J ENVIRON QUAL, V29, P1604, DOI 10.2134/jeq2000.00472425002900050030x; Gruber C, 2000, EUR J BIOCHEM, V267, P573, DOI 10.1046/j.1432-1327.2000.01035.x; Hanselman TA, 2003, ENVIRON SCI TECHNOL, V37, P5471, DOI 10.1021/es034410+; Heger Z, 2015, ONCOL REP, V33, P921, DOI 10.3892/or.2014.3627; Heger Z, 2013, NEUROENDOCRINOL LETT, V34, P123; Homa J, 2005, ENVIRON POLLUT, V135, P275, DOI 10.1016/j.envpol.2004.10.019; Hughes SL, 2009, J PROTEOME RES, V8, P3512, DOI 10.1021/pr9001806; Jiang WW, 2012, J ENVIRON SCI-CHINA, V24, P320, DOI 10.1016/S1001-0742(11)60746-8; Kadota Y, 2010, EUR J PHARMACOL, V626, P166, DOI 10.1016/j.ejphar.2009.09.060; Kanda N, 2003, J INVEST DERMATOL, V121, P1500, DOI 10.1111/j.1523-1747.2003.12617.x; Kassim R, 2013, J BIOL INORG CHEM, V18, P333, DOI 10.1007/s00775-013-0977-5; Keay J, 2009, ENDOCRINOLOGY, V150, P1731, DOI 10.1210/en.2008-1338; Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P1202, DOI 10.1021/es011055j; Kominkova M, 2015, INT J MOL SCI, V16, P7210, DOI 10.3390/ijms16047210; Krajniak KG, 2005, INTEGR COMP BIOL, V45, P88, DOI 10.1093/icb/45.1.88; Krystofova O, 2013, INT J ENV RES PUB HE, V10, P47, DOI 10.3390/ijerph10010047; Liebeke M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081271; Liu R, 2004, J CHROMATOGR A, V1022, P179, DOI 10.1016/j.chroma.2003.09.035; Markman S, 2007, CHEMOSPHERE, V70, P119, DOI 10.1016/j.chemosphere.2007.06.045; Muzandu K, 2005, FREE RADICAL RES, V39, P389, DOI 10.1080/10715760400029710; OECD, TEST NO 222 EARTHWOR; Oren I, 2004, BIOPHYS J, V87, P768, DOI 10.1529/biophysj.103.035527; Owen JB, 2010, METHODS MOL BIOL, V648, P269, DOI 10.1007/978-1-60761-756-3_18; PHIPPS GL, 1993, ENVIRON TOXICOL CHEM, V12, P269, DOI 10.1897/1552-8618(1993)12[269:UOTAOL]2.0.CO;2; Sato M, 2002, TOHOKU J EXP MED, V196, P9, DOI 10.1620/tjem.196.9; Segner H, 2003, ECOTOX ENVIRON SAFE, V54, P302, DOI 10.1016/S0147-6513(02)00039-8; Sochor J, 2010, MOLECULES, V15, P8618, DOI 10.3390/molecules15128618; Thomas MP, 2013, J STEROID BIOCHEM, V137, P27, DOI 10.1016/j.jsbmb.2012.12.014; Vasseur P, 2006, CHEMOSPHERE, V62, P1033, DOI 10.1016/j.chemosphere.2005.05.043; Woo S, 2012, MOL CELL TOXICOL, V8, P263, DOI 10.1007/s13273-012-0032-6; Yu ZQ, 2004, ENVIRON TOXICOL CHEM, V23, P531, DOI 10.1897/03-192; Zhang W, 2006, J ENVIRON MONITOR, V8, P963, DOI 10.1039/b605450a	43	12	12	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145426	10.1371/journal.pone.0145426	http://dx.doi.org/10.1371/journal.pone.0145426			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26695684	Green Published, gold, Green Submitted			2022-12-26	WOS:000367092500046
J	Stiles, M; Moiseyev, GP; Budda, ML; Linens, A; Brush, RS; Qi, H; White, GL; Wolf, RF; Ma, JX; Floyd, R; Anderson, RE; Mandal, NA				Stiles, Megan; Moiseyev, Gennadiy P.; Budda, Madeline L.; Linens, Annette; Brush, Richard S.; Qi, Hui; White, Gary L.; Wolf, Roman F.; Ma, Jian-xing; Floyd, Robert; Anderson, Robert E.; Mandal, Nawajes A.			PBN (Phenyl-N-Tert-Butylnitrone)-Derivatives Are Effective in Slowing the Visual Cycle and Rhodopsin Regeneration and in Protecting the Retina from Light-Induced Damage	PLOS ONE			English	Article							TERT-BUTYLNITRONE PROTECTS; FACTOR-H POLYMORPHISM; MACULAR DEGENERATION; ISOMEROHYDROLASE ACTIVITY; CONGENITAL AMAUROSIS; PIGMENT EPITHELIUM; RPE65 MUTATIONS; GLIOMA MODELS; VITAMIN-A; LIPOFUSCIN	A2E and related toxic molecules are part of lipofuscin found in the retinal pigment epithelial (RPE) cells in eyes affected by Stargardt's disease, age-related macular degeneration (AMD), and other retinal degenerations. A novel therapeutic approach for treating such degenerations involves slowing down the visual cycle, which could reduce the amount of A2E in the RPE. This can be accomplished by inhibiting RPE65, which produces 11-cis-retinol from all-trans-retinyl esters. We recently showed that phenyl-N-tert-butylnitrone (PBN) inhibits RPE65 enzyme activity in RPE cells. In this study we show that like PBN, certain PBN-derivatives (PBNDs) such as 4-F-PBN, 4-CF3-PBN, 3,4-di-F-PBN, and 4-CH3-PBN can inhibit RPE65 and synthesis of 11-cis-retinol in in vitro assays using bovine RPE microsomes. We further demonstrate that systemic (intraperitoneal, IP) administration of these PBNDs protect the rat retina from light damage. Electroretinography (ERG) and histological analysis showed that rats treated with PBNDs retained similar to 90% of their photoreceptor cells compared to a complete loss of function and 90% loss of photoreceptors in the central retina in rats treated with vehicle/control injections. Topically applied PBN and PBNDs also significantly slowed the rate of the visual cycle in mouse and baboon eyes. One hour dark adaptation resulted in 75-80% recovery of bleachable rhodopsin in control/vehicle treated mice. Eye drops of 5% 4-CH3-PBN were most effective, inhibiting the regeneration of bleachable rhodopsin significantly (60% compared to vehicle control). In addition, a 10% concentration of PBN and 5% concentration of 4-CH3-PBN in baboon eyes inhibited the visual cycle by 60% and by 30%, respectively. We have identified a group of PBN related nitrones that can reach the target tissue (RPE) by systemic and topical application and slow the rate of rhodopsin regeneration and therefore the visual cycle in mouse and baboon eyes. PBNDs can also protect the rat retina from light damage. There is potential in developing these compounds as preventative therapeutics for the treatment of human retinal degenerations in which the accumulation of lipofuscin may be pathogenic.	[Stiles, Megan; Linens, Annette; Brush, Richard S.; Qi, Hui; Anderson, Robert E.; Mandal, Nawajes A.] OUHSC, Dept Ophthalmol, Oklahoma City, OK 73104 USA; [Moiseyev, Gennadiy P.; Ma, Jian-xing] OUHSC, Dept Physiol, Oklahoma City, OK USA; [Budda, Madeline L.; Mandal, Nawajes A.] OUHSC, Dept Cell Biol, Oklahoma City, OK USA; [White, Gary L.; Wolf, Roman F.; Anderson, Robert E.] OUHSC, Dept Pathol, Oklahoma City, OK USA; [Ma, Jian-xing; Mandal, Nawajes A.] OUHSC, Dept Endocrinol & Diabet, Oklahoma City, OK USA; [Mandal, Nawajes A.] OUHSC, Oklahoma Ctr Neurosci, Oklahoma City, OK USA; [Stiles, Megan; Linens, Annette; Brush, Richard S.; Qi, Hui; Anderson, Robert E.; Mandal, Nawajes A.] Dean McGee Eye Inst, Oklahoma City, OK USA; [Floyd, Robert] Oklahoma Med Res Fdn, Expt Therapeut, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Oklahoma Medical Research Foundation	Mandal, NA (corresponding author), OUHSC, Dept Ophthalmol, Oklahoma City, OK 73104 USA.	mmandal@ouhsc.edu			Foundation Fighting Blindness (United States); Beckman Initiative for Macular Research; RPB; National Institutes of Health; NATIONAL EYE INSTITUTE [P30EY021725] Funding Source: NIH RePORTER	Foundation Fighting Blindness (United States); Beckman Initiative for Macular Research; RPB(Research to Prevent Blindness (RPB)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The research is conducted by the fundings from The Foundation Fighting Blindness (United States), Beckman Initiative for Macular Research, RPB and National Institutes of Health fundings. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Shabat S, 2002, J BIOL CHEM, V277, P7183, DOI 10.1074/jbc.M108981200; Chen H, 2013, J LIPID RES, V54, P1616, DOI 10.1194/jlr.M035048; Chen H, 2012, MOL VIS, V18, P1325; Choi CH, 2008, FREE RADICAL BIO MED, V44, P1772, DOI 10.1016/j.freeradbiomed.2008.02.005; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Floyd RA, 2008, FREE RADICAL BIO MED, V45, P1361, DOI 10.1016/j.freeradbiomed.2008.08.017; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Gollapalli DR, 2004, P NATL ACAD SCI USA, V101, P10030, DOI 10.1073/pnas.0401936101; Grimm C, 2000, INVEST OPHTH VIS SCI, V41, P3984; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; He T, 2011, FREE RADICAL BIO MED, V51, P490, DOI 10.1016/j.freeradbiomed.2011.04.037; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Liu JH, 2000, J BIOL CHEM, V275, P29354, DOI 10.1074/jbc.M910191199; Lorenz B, 2000, INVEST OPHTH VIS SCI, V41, P2735; Maeda A, 2008, J BIOL CHEM, V283, P26684, DOI 10.1074/jbc.M804505200; Maeda A, 2006, MOL PHARMACOL, V70, P1220, DOI 10.1124/mol.106.026823; Maeda A, 2009, J BIOL CHEM, V284, P15173, DOI 10.1074/jbc.M900322200; Maiti P, 2006, BIOCHEMISTRY-US, V45, P852, DOI 10.1021/bi0518545; Mandal MNA, 2011, J BIOL CHEM, V286, P32491, DOI 10.1074/jbc.M111.255877; Mandal MNA, 2009, FREE RADICAL BIO MED, V46, P672, DOI 10.1016/j.freeradbiomed.2008.12.006; Maples KR, 2004, CNS DRUGS, V18, P1071, DOI 10.2165/00023210-200418150-00003; Marlhens F, 1997, NAT GENET, V17, P139, DOI 10.1038/ng1097-139; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Moiseyev G, 2003, BIOCHEMISTRY-US, V42, P2229, DOI 10.1021/bi026911y; Morimura H, 1998, P NATL ACAD SCI USA, V95, P3088, DOI 10.1073/pnas.95.6.3088; Nguyen DH, 2013, DISCOV MED, V15, P343; Noell W K, 1966, Invest Ophthalmol, V5, P450; NOELL WK, 1971, SCIENCE, V172, P76, DOI 10.1126/science.172.3978.76; NOELL WK, 1971, SCIENCE, V172, P72, DOI 10.1126/science.172.3978.72; Palczewski K, 2010, TRENDS PHARMACOL SCI, V31, P284, DOI 10.1016/j.tips.2010.03.001; PAPERMASTER DS, 1974, BIOCHEMISTRY-US, V13, P2438, DOI 10.1021/bi00708a031; Poliakov E, 2011, BIOCHEMISTRY-US, V50, P6739, DOI 10.1021/bi200532m; Ranchon I, 2003, J NEUROSCI, V23, P6050, DOI 10.1523/JNEUROSCI.23-14-06050.2003; Ranchon I, 2001, INVEST OPHTH VIS SCI, V42, P1375; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; SHICHI H, 1969, J BIOL CHEM, V244, P529; Sieving PA, 2001, P NATL ACAD SCI USA, V98, P1835, DOI 10.1073/pnas.041606498; Sparrow JR, 2005, EXP EYE RES, V80, P595, DOI 10.1016/j.exer.2005.01.007; Sparrow JR, 2000, INVEST OPHTH VIS SCI, V41, P1981; Suter M, 2000, J BIOL CHEM, V275, P39625, DOI 10.1074/jbc.M007049200; Tanito M, 2009, J LIPID RES, V50, P807, DOI 10.1194/jlr.M800170-JLR200; Thompson DA, 2000, INVEST OPHTH VIS SCI, V41, P4293; Towner RA, 2013, NEURO-ONCOLOGY, V15, P330, DOI 10.1093/neuonc/nos337; Wu YL, 2010, P NATL ACAD SCI USA, V107, P7275, DOI 10.1073/pnas.0913112107; Zhou JL, 2006, P NATL ACAD SCI USA, V103, P16182, DOI 10.1073/pnas.0604255103	50	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145305	10.1371/journal.pone.0145305	http://dx.doi.org/10.1371/journal.pone.0145305			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26694648	gold, Green Submitted, Green Published			2022-12-26	WOS:000367092500038
J	Birla, BS; Chou, HH				Birla, Bhagyashree S.; Chou, Hui-Hsien			Rational Design of High-Number dsDNA Fragments Based on Thermodynamics for the Construction of Full-Length Genes in a Single Reaction	PLOS ONE			English	Article							MYCOPLASMA-GENITALIUM GENOME; CHEMICAL-SYNTHESIS; DNA-MOLECULES; PCR; EXPRESSION; SEQUENCES; YEAST; MICROARRAY	Gene synthesis is frequently used in modern molecular biology research either to create novel genes or to obtain natural genes when the synthesis approach is more flexible and reliable than cloning. DNA chemical synthesis has limits on both its length and yield, thus full-length genes have to be hierarchically constructed from synthesized DNA fragments. Gibson Assembly and its derivatives are the simplest methods to assemble multiple double-stranded DNA fragments. Currently, up to 12 dsDNA fragments can be assembled at once with Gibson Assembly according to its vendor. In practice, the number of dsDNA fragments that can be assembled in a single reaction are much lower. We have developed a rational design method for gene construction that allows high-number dsDNA fragments to be assembled into full-length genes in a single reaction. Using this new design method and a modified version of the Gibson Assembly protocol, we have assembled 3 different genes from up to 45 dsDNA fragments at once. Our design method uses the thermodynamic analysis software PICKY that identifies all unique junctions in a gene where consecutive DNA fragments are specifically made to connect to each other. Our novel method is generally applicable to most gene sequences, and can improve both the efficiency and cost of gene assembly.	[Birla, Bhagyashree S.; Chou, Hui-Hsien] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA; [Chou, Hui-Hsien] Iowa State Univ, Dept Comp Sci, Ames, IA USA	Iowa State University; Iowa State University	Chou, HH (corresponding author), Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA.	hhchou@iastate.edu			National Science Foundation [DBI-0850195]; Iowa State University Plant Sciences Institute Scholar Award	National Science Foundation(National Science Foundation (NSF)); Iowa State University Plant Sciences Institute Scholar Award	This study was supported by the National Science Foundation Grant DBI-0850195 < http://www.nsf.gov/awardsearch/showAward?AWD_ID=0850195 > and the Iowa State University Plant Sciences Institute Scholar Award < http://plantsciences.iastate.edu >. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J Christopher, 2010, J Biol Eng, V4, P1, DOI 10.1186/1754-1611-4-1; Chou HH, 2004, BIOINFORMATICS, V20, P2893, DOI 10.1093/bioinformatics/bth347; Chou HH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-196; Chou HH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-347; CICCARELLI RB, 1991, NUCLEIC ACIDS RES, V19, P6007, DOI 10.1093/nar/19.21.6007; de Kok S, 2014, ACS SYNTH BIOL, V3, P97, DOI 10.1021/sb4001992; Dormitzer PR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006368; EDGE MD, 1983, NUCLEIC ACIDS RES, V11, P6419, DOI 10.1093/nar/11.18.6419; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Gibson DG, 2014, NATURE, V509, P168, DOI 10.1038/509168a; Gibson DG, 2010, NAT METHODS, V7, P901, DOI 10.1038/nmeth.1515; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gibson DG, 2008, P NATL ACAD SCI USA, V105, P20404, DOI 10.1073/pnas.0811011106; Hoover DM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e43; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Jung KH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003337; Kuijpers NGA, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-47; Ma SY, 2012, TRENDS BIOTECHNOL, V30, P147, DOI 10.1016/j.tibtech.2011.10.002; MANDECKI W, 1988, GENE, V68, P101, DOI 10.1016/0378-1119(88)90603-8; Seo YS, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-99; Shetty Reshma P, 2008, J Biol Eng, V2, P5, DOI 10.1186/1754-1611-2-5; Shevchuk NA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh014; SPROAT BS, 1985, NUCLEIC ACIDS RES, V13, P2959, DOI 10.1093/nar/13.8.2959; STEMMER WPC, 1995, GENE, V164, P49, DOI 10.1016/0378-1119(95)00511-4; Sutton Dennis W., 1992, Transgenic Research, V1, P228, DOI 10.1007/BF02524753; URDEA MS, 1983, P NATL ACAD SCI-BIOL, V80, P7461, DOI 10.1073/pnas.80.24.7461; Xiong AS, 2006, NAT PROTOC, V1, P791, DOI 10.1038/nprot.2006.103; Xiong AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh094; Young L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh058	29	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145682	10.1371/journal.pone.0145682	http://dx.doi.org/10.1371/journal.pone.0145682			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716828	gold, Green Published			2022-12-26	WOS:000367510500057
J	Iannaccone, A; Giorgianni, F; New, DD; Hollingsworth, TJ; Umfress, A; Alhatem, AH; Neeli, I; Lenchik, NI; Jennings, BJ; Calzada, JI; Satterfield, S; Mathews, D; Diaz, RI; Harris, T; Johnson, KC; Charles, S; Kritchevsky, SB; Gerling, IC; Beranova-Giorgianni, S; Radic, MZ				Iannaccone, Alessandro; Giorgianni, Francesco; New, David D.; Hollingsworth, T. J.; Umfress, Allison; Alhatem, Albert H.; Neeli, Indira; Lenchik, Nataliya I.; Jennings, Barbara J.; Calzada, Jorge I.; Satterfield, Suzanne; Mathews, Dennis; Diaz, Rocio I.; Harris, Tamara; Johnson, Karen C.; Charles, Steve; Kritchevsky, Stephen B.; Gerling, Ivan C.; Beranova-Giorgianni, Sarka; Radic, Marko Z.		Hlth ABC Study	Circulating Autoantibodies in Age-Related Macular Degeneration Recognize Human Macular Tissue Antigens Implicated in Autophagy, Immunomodulation, and Protection from Oxidative Stress and Apoptosis	PLOS ONE			English	Article							RETINAL-PIGMENT EPITHELIUM; SUBRETINAL DRUSENOID DEPOSITS; CANCER-ASSOCIATED RETINOPATHY; ALPHA-ENOLASE AUTOANTIBODIES; FACTOR-H POLYMORPHISM; HEAT-SHOCK-RESPONSE; BRUCHS MEMBRANE; OPTICAL-DENSITY; EYE DISEASE; CHOROIDAL NEOVASCULARIZATION	Background We investigated sera from elderly subjects with and without age-related macular degeneration (AMD) for presence of autoantibodies (AAbs) against human macular antigens and characterized their identity. Methods Sera were collected from participants in the Age-Related Maculopathy Ancillary (ARMA) Study, a cross-sectional investigation ancillary to the Health ABC Study, enriched with participants from the general population. The resulting sample (mean age: 79.2 +/- 3.9 years old) included subjects with early to advanced AMD (n = 131) and controls (n = 231). Sera were tested by Western blots for immunoreactive bands against human donor macular tissue homogenates. Immunoreactive bands were identified and graded, and odds ratios (OR) calculated. Based on these findings, sera were immunoprecipitated, and subjected to 2D gel electrophoresis (GE). Liquid chromatography-tandem mass spectrometry (LC-MS/MS) was used to identify the targets recognized by circulating AAbs seen on 2D-GE, followed by ELI-SAs with recombinant proteins to confirm LC-MS/MS results, and quantify autoreactivities. Results In AMD, 11 immunoreactive bands were significantly more frequent and 13 were significantly stronger than in controls. Nine of the more frequent bands also showed stronger reactivity. OR estimates ranged between 4.06 and 1.93, and all clearly excluded the null value. Following immunoprecipitation, 2D-GE and LC-MS/MS, five of the possible autoreactivity targets were conclusively identified: two members of the heat shock protein 70 (HSP70) family, HSPA8 and HSPA9; another member of the HSP family, HSPB4, also known as alpha-crystallin A chain (CRYAA); Annexin A5 (ANXA5); and Protein S100-A9, also known as calgranulin B that, when complexed with S100A8, forms calprotectin. ELISA testing with recombinant proteins confirmed, on average, significantly higher reactivities against all targets in AMD samples compared to controls. Conclusions Consistent with other evidence supporting the role of inflammation and the immune system in AMD pathogenesis, AAbs were identified in AMD sera, including early-stage disease. Identified targets may be mechanistically linked to AMD pathogenesis because the identified proteins are implicated in autophagy, immunomodulation, and protection from oxidative stress and apoptosis. In particular, a role in autophagy activation is shared by all five autoantigens, raising the possibility that the detected AAbs may play a role in AMD via autophagy compromise and downstream activation of the inflammasome. Thus, we propose that the detected AAbs provide further insight into AMD pathogenesis and have the potential to contribute to disease biogenesis and progression.	[Iannaccone, Alessandro; New, David D.; Hollingsworth, T. J.; Umfress, Allison; Alhatem, Albert H.; Neeli, Indira; Lenchik, Nataliya I.; Jennings, Barbara J.; Calzada, Jorge I.; Diaz, Rocio I.; Charles, Steve] Univ Tennessee, Ctr Hlth Sci, Hamilton Eye Inst, Dept Ophthalmol, Memphis, TN 38163 USA; [Giorgianni, Francesco; Beranova-Giorgianni, Sarka] Univ Tennessee, Ctr Hlth Sci, Dept Pharmaceut Sci, Memphis, TN 38163 USA; [Neeli, Indira; Radic, Marko Z.] Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA; [Lenchik, Nataliya I.; Gerling, Ivan C.] Univ Tennessee, Ctr Hlth Sci, Dept Internal Med Endocrinol, Memphis, TN 38163 USA; [Calzada, Jorge I.; Diaz, Rocio I.; Charles, Steve] Charles Retina Inst, Memphis, TN USA; [Satterfield, Suzanne; Johnson, Karen C.; Kritchevsky, Stephen B.] Univ Tennessee, Ctr Hlth Sci, Dept Prevent Med, Memphis, TN 38163 USA; [Mathews, Dennis] Eye Specialty Grp, Memphis, TN USA; [Mathews, Dennis] Southern Coll Optometry, Memphis, TN USA; [Harris, Tamara] NIA, NIH, Bethesda, MD 20892 USA; [Kritchevsky, Stephen B.] Wake Forest Univ, Sticht Ctr Aging, Winston Salem, NC 27109 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Wake Forest University	Iannaccone, A (corresponding author), Univ Tennessee, Ctr Hlth Sci, Hamilton Eye Inst, Dept Ophthalmol, Memphis, TN 38163 USA.	aiannacc@yahoo.com	Hollingsworth, T.J./AAD-2814-2022	Alhatem, Albert/0000-0003-1826-6854; Radic, Marko/0000-0002-8004-282X; Iannaccone, Alessandro/0000-0001-5737-8424; Hollingsworth, T.J./0000-0002-2119-521X	National Institutes of Health/National Eye Institute [K23 EY000409, R21 EY018416, R01 EY022706]; International Retinal Research Foundation; Research to Prevent Blindness, Inc. New York, NY; University of Tennessee Health Science Center College of Pharmacy; University of Tennessee Health Science Center, Neuroscience Undergraduate Merit Fellowship Award; National Institutes of Health/National Institute on Aging, Intramural Research Program; National Institutes of Health/National Institute on AgingH [N01 AG-62101, N01 AG-62103, N01-AG-62106]; NATIONAL EYE INSTITUTE [R21EY018416, K23EY000409, R01EY022706] Funding Source: NIH RePORTER	National Institutes of Health/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); International Retinal Research Foundation; Research to Prevent Blindness, Inc. New York, NY(Research to Prevent Blindness (RPB)); University of Tennessee Health Science Center College of Pharmacy; University of Tennessee Health Science Center, Neuroscience Undergraduate Merit Fellowship Award; National Institutes of Health/National Institute on Aging, Intramural Research Program; National Institutes of Health/National Institute on AgingH; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by: National Institutes of Health/National Eye Institute grants K23 EY000409 (AI), R21 EY018416 (AI, PI; ICG and MRZ, co-investigators) and R01 EY022706 (AI, PI; MRZ, FG, ICG, and SBG, co-investigators) (https://nei.nih.gov); International Retinal Research Foundation (AI) (http://www.irrfonline.org); Research to Prevent Blindness, Inc. New York, NY (Career Development Award and Physician Scientist Award to AI and unrestricted grant to the UTHSC Hamilton Eye Institute, Memphis, TN, USA) (https://www.rpbusa.org/rpb/?); University of Tennessee Health Science Center College of Pharmacy, Intramural grant (FG and SBG) (http://www.uthsc.edu/pharmacy/); University of Tennessee Health Science Center, Neuroscience Undergraduate Merit Fellowship Award (AU) (http://www.uthsc.edu/neuroscience/); National Institutes of Health/National Institute on Aging, Intramural Research Program (TH) (https://www.nia.nih.gov). The Health ABC study was supported by: National Institutes of Health/National Institute on AgingH Contracts N01 AG-62101 (SBK, PI: SS and KCJ, co-investigators), N01 AG-62103 (SBK, PI: SS and KCJ, co-investigators), and N01-AG-62106 (Health ABC Coordinating Center) (https://www.nia.nih.gov). The Health ABC Publications Committee and the National Institute on Aging reviewed and approved the manuscript for publication before submission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamus G, 1998, J AUTOIMMUN, V11, P523, DOI 10.1006/jaut.1998.0221; Adamus G, 1997, INVEST OPHTH VIS SCI, V38, P283; Adamus G, 1998, J AUTOIMMUN, V11, P671, DOI 10.1006/jaut.1998.0239; Adamus G, 2003, AUTOIMMUN REV, V2, P63, DOI 10.1016/S1568-9972(02)00127-1; Adamus Grazyna, 2004, BMC Ophthalmol, V4, P5, DOI 10.1186/1471-2415-4-5; Adamus G, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-154; Adamus G, 2011, J OPHTHALMIC INFLAMM, V1, P111, DOI 10.1007/s12348-011-0028-8; Adamus G, 2009, J AUTOIMMUN, V32, P133, DOI 10.1016/j.jaut.2009.02.001; Adamus G, 2009, AUTOIMMUN REV, V8, P410, DOI 10.1016/j.autrev.2009.01.002; Age-Related Eye Dis Study Res Grp, 2001, AM J OPHTHALMOL, V132, P668; Alessandri C, 2011, AUTOIMMUN REV, V10, P609, DOI 10.1016/j.autrev.2011.04.011; Anderson DH, 2002, AM J OPHTHALMOL, V134, P411, DOI 10.1016/S0002-9394(02)01624-0; Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; Baird PN, 2008, HUM MOL GENET, V17, P1299, DOI 10.1093/hmg/ddn018; Bakar F, 2014, J CLIN ENDOCR METAB, V99, P932, DOI 10.1210/jc.2013-2592; BERBERIAN PA, 1990, AM J PATHOL, V136, P71; Bernstein SL, 2000, INVEST OPHTH VIS SCI, V41, P2857; Bjork P, 2009, PLOS BIOL, V7, P800, DOI 10.1371/journal.pbio.1000097; Bok D, 2005, P NATL ACAD SCI USA, V102, P7053, DOI 10.1073/pnas.0502819102; Borges TJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00095; Casola C, 2015, J MOL NEUROSCI, V56, P228, DOI 10.1007/s12031-014-0485-2; Cederholm A, 2005, IMMUNOBIOLOGY, V210, P761, DOI 10.1016/j.imbio.2005.10.007; Celkova L, 2015, J CLIN MED, V4, P172, DOI 10.3390/jcm4010172; Cesaro A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045478; Cherepanoff S, 2006, CLIN EXP OPHTHALMOL, V34, P590, DOI 10.1111/j.1442-9071.2006.01281.x; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Curcio CA, 2013, RETINA-J RET VIT DIS, V33, P265, DOI 10.1097/IAE.0b013e31827e25e0; Danis RP, 2013, INVEST OPHTH VIS SCI, V54, P4548, DOI 10.1167/iovs.13-11804; Davis MD, 2005, ARCH OPHTHALMOL-CHIC, V123, P1484; Decanini A, 2007, AM J OPHTHALMOL, V143, P607, DOI 10.1016/j.ajo.2006.12.006; Dhas D. B. B., 2012, Current Pediatric Research, V16, P83; Dokladny K, 2015, AUTOPHAGY, V11, P200, DOI 10.1080/15548627.2015.1009776; Dokladny K, 2013, J BIOL CHEM, V288, P14959, DOI 10.1074/jbc.M113.462408; Donoso LA, 2006, SURV OPHTHALMOL, V51, P137, DOI 10.1016/j.survophthal.2005.12.001; Ebrahem Q, 2006, P NATL ACAD SCI USA, V103, P13480, DOI 10.1073/pnas.0601552103; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Ethen CM, 2007, FEBS LETT, V581, P885, DOI 10.1016/j.febslet.2007.01.061; Ferrington D., 2015, PROG RETIN EYE RES; Ferris FL, 2005, ARCH OPHTHALMOL-CHIC, V123, P1570; FOUQUERAY B, 1992, EUR J IMMUNOL, V22, P2983, DOI 10.1002/eji.1830221133; Francis PJ, 2009, J MED GENET, V46, P300, DOI 10.1136/jmg.2008.062737; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Fritsche LG, 2010, HUM MOL GENET, V19, P4694, DOI 10.1093/hmg/ddq399; Gallaher KT, 2007, VISION RES, V47, P1253, DOI 10.1016/j.visres.2007.01.013; Gehrs KM, 2006, ANN MED, V38, P450, DOI 10.1080/07853890600946724; Gehrs KM, 2010, ARCH OPHTHALMOL-CHIC, V128, P349, DOI 10.1001/archophthalmol.2010.18; Ghavami S, 2010, CELL RES, V20, P314, DOI 10.1038/cr.2009.129; Ghislat G, 2012, J CELL SCI, V125, P92, DOI 10.1242/jcs.086728; Giorgianni F, 2004, ANAL CHEM, V76, P7028, DOI 10.1021/ac0493368; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Grassmann F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037979; Grus FH, 2004, MOL VIS, V10, P132; Gu JY, 2010, ADV EXP MED BIOL, V664, P411, DOI 10.1007/978-1-4419-1399-9_47; Gu JY, 2009, MOL CELL PROTEOMICS, V8, P1338, DOI 10.1074/mcp.M800453-MCP200; Gu XR, 2003, J BIOL CHEM, V278, P42027, DOI 10.1074/jbc.M305460200; Hageman Gregory S., 2011, Human Genomics, V5, P420; Hageman GS, 1999, MOL VIS, V5; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hashizume K, 2008, AM J PATHOL, V172, P1325, DOI 10.2353/ajpath.2008.070730; Hawkins BS, 1999, MOL VIS, V5; Hollyfield JG, 2003, ADV EXP MED BIOL, V533, P83; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Hollyfield JG, 2010, MOL NEUROBIOL, V41, P290, DOI 10.1007/s12035-010-8110-z; Hughes AE, 2006, NAT GENET; Iaccarino L, 2011, AUTOIMMUN REV, V10, P553, DOI 10.1016/j.autrev.2011.04.007; Iannaccone A, 2007, INVEST OPHTH VIS SCI, V48, P1458, DOI 10.1167/iovs.06-0438; Iannaccone A, 2012, ADV EXP MED BIOL, V723, P11, DOI 10.1007/978-1-4614-0631-0_2; Imamura Y, 2006, P NATL ACAD SCI USA, V103, P11282, DOI 10.1073/pnas.0602131103; Jablonski MM, 2001, EXP EYE RES, V72, P573, DOI 10.1006/exer.2001.0987; Jablonski MM, 2007, INVEST OPHTH VIS SCI, V48, P479, DOI 10.1167/iovs.06-0972; Jia J, 2014, CELL, V159, P623, DOI 10.1016/j.cell.2014.09.032; Joachim SC, 2007, CURR EYE RES, V32, P501, DOI 10.1080/02713680701375183; Johnson LV, 2002, P NATL ACAD SCI USA, V99, P11830, DOI 10.1073/pnas.192203399; Kaarniranta K, 2009, J MOL MED, V87, P117, DOI 10.1007/s00109-008-0418-z; Kaarniranta K, 2013, AUTOPHAGY, V9, P973, DOI 10.4161/auto.24546; Kaarniranta K, 2009, AGEING RES REV, V8, P128, DOI 10.1016/j.arr.2009.01.001; Kannan R, 2015, BIOCH BIOPHYS ACTA; Kannan R, 2012, PROG RETIN EYE RES, V31, P576, DOI 10.1016/j.preteyeres.2012.06.001; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Koike A, 2012, INFLAMMATION, V35, P409, DOI 10.1007/s10753-011-9330-8; Lechanteur YTE, 2015, JAMA OPHTHALMOL, V133, P533, DOI 10.1001/jamaophthalmol.2015.18; Lederman M, 2010, INVEST OPHTH VIS SCI, V51, P53, DOI 10.1167/iovs.08-3019; Li CS, 2009, BIOCHEM J, V422, P363, DOI 10.1042/BJ20090465; Li M, 2006, NAT GENET, V38, P1049, DOI 10.1038/ng1871; Liu MM, 2012, HUM GENOMICS, V6, DOI 10.1186/1479-7364-6-13; Louie JL, 2002, EXP EYE RES, V75, P271, DOI 10.1006/exer.2002.2022; Magrys A, 2007, J CLIN IMMUNOL, V27, P181, DOI 10.1007/s10875-006-9065-8; Mak SK, 2010, J BIOL CHEM, V285, P13621, DOI 10.1074/jbc.M109.074617; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Marx J, 2006, SCIENCE, V311, P1704, DOI 10.1126/science.311.5768.1704; Matsumura Y, 2013, J BIOL CHEM, V288, P31069, DOI 10.1074/jbc.M113.479345; McGeer EG, 2005, NEUROBIOL AGING, V26, pS94, DOI 10.1016/j.neurobiolaging.2005.08.008; McGeer Patrick L, 2002, Sci Aging Knowledge Environ, V2002, pre3, DOI 10.1126/sageke.2002.29.re3; McGeer PL, 2004, ANN NY ACAD SCI, V1035, P104, DOI 10.1196/annals.1332.007; Meyers KJ, 2014, INVEST OPHTH VIS SCI, V55, P587, DOI 10.1167/iovs.13-13216; Minoia M, 2014, MOL CELL BIOL, V34, P3570, DOI 10.1128/MCB.00698-14; Morohoshi K, 2012, EXP MOL PATHOL, V93, P193, DOI 10.1016/j.yexmp.2012.03.007; Morohoshi K, 2012, EXP MOL PATHOL, V92, P64, DOI 10.1016/j.yexmp.2011.09.017; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Nakata K, 2005, EXP EYE RES, V80, P821, DOI 10.1016/j.exer.2004.12.011; Nakatani Y, 2005, MEDIAT INFLAMM, P280, DOI 10.1155/MI.2005.280; Nussenblatt RB, 2007, AM J OPHTHALMOL, V144, P618, DOI 10.1016/j.ajo.2007.06.025; Nussenblatt RB, 2009, CURR OPIN INVEST DR, V10, P434; Ohguro H, 1999, INVEST OPHTH VIS SCI, V40, P3160; Pabst MJ, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-13; Patel M, 2008, SEMIN IMMUNOPATHOL, V30, P97, DOI 10.1007/s00281-008-0112-9; Patel N, 2005, IMMUNOLOGY, V115, P422, DOI 10.1111/j.1365-2567.2005.02173.x; PENFOLD P, 1984, AUST J OPHTHALMOL, V12, P23; PENFOLD PL, 1987, GRAEF ARCH CLIN EXP, V225, P70, DOI 10.1007/BF02155808; PENFOLD PL, 1986, INVEST OPHTH VIS SCI, V27, P364; PENFOLD PL, 1985, GRAEF ARCH CLIN EXP, V223, P69, DOI 10.1007/BF02150948; PENFOLD PL, 1990, GRAEF ARCH CLIN EXP, V228, P270, DOI 10.1007/BF00920033; Penfold PL, 2001, PROG RETIN EYE RES, V20, P385, DOI 10.1016/S1350-9462(00)00025-2; Petrukhin K, 2007, EXPERT OPIN THER TAR, V11, P625, DOI 10.1517/14728222.11.5.625; Philip LP, 2004, JAMA-J AM MED ASSOC, V292, P43, DOI 10.1001/jama.292.1.43-a; Postel EA, 2006, OPHTHALMOLOGY, V113, P1504, DOI 10.1016/j.ophtha.2006.02.049; Rayborn ME, 2006, ADV EXP MED BIOL, V572, P75; Ren GY, 2004, J AUTOIMMUN, V23, P161, DOI 10.1016/j.jaut.2004.06.003; Riva M, 2012, IMMUNOLOGY, V137, P172, DOI 10.1111/j.1365-2567.2012.03619.x; Rudolf M, 2008, EXP EYE RES, V87, P402, DOI 10.1016/j.exer.2008.07.010; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Ryhanen T, 2009, J CELL MOL MED, V13, P3616, DOI 10.1111/j.1582-4934.2008.00577.x; Saraswathy S, 2010, INVEST OPHTH VIS SCI, V51, P3680, DOI 10.1167/iovs.09-4575; Schaumberg DA, 2014, JAMA OPHTHALMOL, V132, P84, DOI 10.1001/jamaophthalmol.2013.5506; Seddon JM, 2006, HUM HERED, V61, P157, DOI 10.1159/000094141; Sepp T, 2006, INVEST OPHTH VIS SCI, V47, P536, DOI 10.1167/iovs.05-1143; Shiraga S, 2002, J NEUROIMMUNOL, V132, P72, DOI 10.1016/S0165-5728(02)00314-4; Simard JC, 2011, J IMMUNOL, V186, P3622, DOI 10.4049/jimmunol.1002956; Skeie JM, 2014, JAMA OPHTHALMOL, V132, P1271, DOI 10.1001/jamaophthalmol.2014.2065; Spencer KL, 2008, HUM MOL GENET, V17, P1821, DOI 10.1093/hmg/ddn075; Spencer KL, 2008, HUM MOL GENET, V17, P971, DOI 10.1093/hmg/ddm369; Spencer KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017784; Sreekumar PG, 2013, INVEST OPHTH VIS SCI, V54, P2787, DOI 10.1167/iovs.12-11571; Stone EM, 2015, JAMA OPHTHALMOL, V133, P598, DOI 10.1001/jamaophthalmol.2015.0369; Swaroop A, 2007, HUM MOL GENET, V16, pR174, DOI 10.1093/hmg/ddm212; Tahiri F, 2008, HEPATOLOGY, V47, P937, DOI 10.1002/hep.22149; Takeda A, 2009, NATURE, V460, P225, DOI 10.1038/nature08151; Thanos S, 2014, PROG RETIN EYE RES, V42, P145, DOI 10.1016/j.preteyeres.2014.06.004; Tulapurkar ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118010; Tuo JS, 2012, OCUL IMMUNOL INFLAMM, V20, P27, DOI 10.3109/09273948.2011.628432; Umeda S, 2005, FASEB J, V19, P1683, DOI 10.1096/fj.04-3525fje; Urushitani M, 2004, J NEUROCHEM, V90, P231, DOI 10.1111/j.1471-4159.2004.02486.x; Vishwanathan R, 2014, AGE AGEING, V43, P271, DOI 10.1093/ageing/aft210; Xu HP, 2009, PROG RETIN EYE RES, V28, P348, DOI 10.1016/j.preteyeres.2009.06.001; Yang Q, 2009, SCIENCE, V323, P124, DOI 10.1126/science.1166088; Yao JY, 2015, AUTOPHAGY, V11, P939, DOI 10.1080/15548627.2015.1041699; Yaung J, 2007, MOL VIS, V13, P566; Yu Y, 2012, INVEST OPHTH VIS SCI, V53, P1548, DOI 10.1167/iovs.11-8657; Yuan XL, 2010, MOL CELL PROTEOMICS, V9, P1031, DOI 10.1074/mcp.M900523-MCP200; Zetterstrom P, 2011, J BIOL CHEM, V286, P20130, DOI 10.1074/jbc.M111.218842; Zigler JS, 2011, J CELL SCI, V124, P523, DOI 10.1242/jcs.078790; Zweifel SA, 2010, OPHTHALMOLOGY, V117, P303, DOI 10.1016/j.ophtha.2009.07.014	155	34	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145323	10.1371/journal.pone.0145323	http://dx.doi.org/10.1371/journal.pone.0145323			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717306	Green Submitted, gold, Green Published			2022-12-26	WOS:000367510500028
J	Nijman, V; Spaan, D; Nekaris, KAI				Nijman, Vincent; Spaan, Denise; Nekaris, K. Anne-Isola			Large-Scale Trade in Legally Protected Marine Mollusc Shells from Java and Bali, Indonesia	PLOS ONE			English	Article							INTERNATIONAL-TRADE; GROWTH	Background Tropical marine molluscs are traded globally. Larger species with slow life histories are under threat from over-exploitation. We report on the trade in protected marine mollusc shells in and from Java and Bali, Indonesia. Since 1987 twelve species of marine molluscs are protected under Indonesian law to shield them from overexploitation. Despite this protection they are traded openly in large volumes. Methodology/Principal Findings We collected data on species composition, origins, volumes and prices at two large open markets (2013), collected data from wholesale traders (2013), and compiled seizure data by the Indonesian authorities (2008-2013). All twelve protected species were observed in trade. Smaller species were traded for <USD1.00 whereas prices of larger species were USD15.00-40.00 with clear price-size relationships. Some shells were collected locally in Java and Bali, but the trade involves networks stretching hundreds of kilometres throughout Indonesia. Wholesale traders offer protected marine mollusc shells for the export market by the container or by the metric ton. Data from 20 confiscated shipments show an on-going trade in these molluscs. Over 42,000 shells were seized over a 5-year period, with a retail value of USD700,000 within Indonesia; horned helmet (Cassis cornuta) (>32,000 shells valued at USD500,000), chambered nautilus (Nautilus pompilius) (>3,000 shells, USD60,000) and giant clams (Tridacna spp.) (>2,000 shells, USD45,000) were traded in largest volumes. Two-thirds of this trade was destined for international markets, including in the USA and Asia-Pacific region. Conclusions/Significance We demonstrated that the trade in protected marine mollusc shells in Indonesia is not controlled nor monitored, that it involves large volumes, and that networks of shell collectors, traders, middlemen and exporters span the globe. This impedes protection of these species on the ground and calls into question the effectiveness of protected species management in Indonesia; solutions are unlikely to be found only in Indonesia and must involve the cooperation of importing countries.	[Nijman, Vincent; Spaan, Denise; Nekaris, K. Anne-Isola] Oxford Brookes Univ, Oxford Wildlife Trade Res Grp, Oxford OX3 0BP, England; [Spaan, Denise] Univ Veracruz, Inst Neuroethol, Xalapa, Veracruz, Mexico	Oxford Brookes University; Universidad Veracruzana	Nijman, V (corresponding author), Oxford Brookes Univ, Oxford Wildlife Trade Res Grp, Oxford OX3 0BP, England.	vnijman@brookes.ac.uk	Spaan, Denise/AAH-5727-2021; Nijman, Vincent/AHD-8685-2022	Spaan, Denise/0000-0002-6876-1194; Nijman, Vincent/0000-0002-5600-4276	Leverhulme Trust [RPG-084]; Cleveland Zoo Asian Seed Fund; Dierenpark Amersfoort; Mohamed bin Zayed Species Conservation Fund	Leverhulme Trust(Leverhulme Trust); Cleveland Zoo Asian Seed Fund; Dierenpark Amersfoort; Mohamed bin Zayed Species Conservation Fund	Funding provided by Leverhulme Trust (RPG-084, http://www.leverhulme.ac.uk/), the Cleveland Zoo Asian Seed Fund (http://www.clemetzoo.com/conservation/grants/), Dierenpark Amersfoort (http://www.dierenparkamersfoort.nl/), and Mohamed bin Zayed Species Conservation Fund (http://www.speciesconservation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, SURABAYA PAGI   0314; [Anonymous], 2008, BKSDA SITA RATUSAN K; [Anonymous], 2008, KENDARI POS     0130; [Anonymous], 2009, POLHUT BANDARA NGURA; [Anonymous], 2005, ANTARA NEWS     0801; [Anonymous], 2012, SURABAYA TRIBUN 0619; [Anonymous], 2009, ELSHINTA        0428; [Anonymous], 2011, SURABAYA PAGI   0702; [Anonymous], 2009, BAUNGCAMP; [Anonymous], 2013, SURBAYA TRIBUNE 0808; Arifin Z, 1998, P N PAC S INV STOCK, P401; Barord GJ., 2014, CEPHALOPOD CULTURE, Veds, P165; BECKVAR N, 1981, AQUACULTURE, V24, P21, DOI 10.1016/0044-8486(81)90040-5; Bostock J, 2010, PHILOS T R SOC B, V365, P2897, DOI 10.1098/rstb.2010.0170; Burhanuddin, 1997, ACIAR PROC, P14; Butcher John., 2004, CLOSING FRONTIER HIS; CITES, 1994, INCL GIANT TRIT CHAR; CITES, 2005, NOT 2005 035; CITES, 2006, 102 CITES AC22; Claassen C., 1998, SHELLS; De Angelis P, 2012, GEOBIOS-LYON, V45, P5, DOI 10.1016/j.geobios.2011.11.005; Dianti T, 2010, JURNAL NASIONAL 1213; Dias TLP, 2011, BIODIVERS CONSERV, V20, P2393, DOI 10.1007/s10531-011-9991-5; Dunstan A, 2010, FISH RES, V106, P239, DOI 10.1016/j.fishres.2010.06.015; Dunstan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016716; Dunstan AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016312; Faidi, 2009, WARTA BEA CUKAI, V420, P27; Floren A.S., 2003, PHILIPPINE SHELL IND; Gibbons E., 2011, CURIO TRADE SW MADAG; Gossling S, 2004, BIODIVERS CONSERV, V13, P2623, DOI 10.1007/s10531-004-2139-0; Istanto, 2009, STAT BALAI KONSERVAS; Istanto, 2010, STAT BALAI KONSERVAS; Krebs C.J., 1999, ECOLOGICAL METHODOLO; Lee CL, 1997, ACIAR PROC, P38; Nijman V., 2012, TRAFFIC B, V24, P49; Nijman Vincent, 2014, Traffic Bulletin, V26, P31; Noerjito M., 2001, JENIS JENIS HAYATI Y; Panggabean L.J.G.L., 2006, MARINE RES INDONESIA, V31, P13, DOI [10.14203/mri.v31i0.425, DOI 10.14203/MRI.V31I0.425]; Phelps J, 2010, SCIENCE, V330, P1752, DOI 10.1126/science.1195558; Rustam, 2009, KABAR INDONESIA 0129; Salamanca A.M., 1996, Traffic Bulletin, V16, P61; Shepherd C.R., 2007, OVERVIEW REGULATION; Sinaga A, 2013, RADIO REPUBLIK  0613; Soehartono T, 2002, CITES IMPLEMENTATION; Taylor John D., 2003, P217; USFWS, 2013, NAUT; Wabnitz C., 2003, OCEAN AQUARIUM GLOBA; Ward PD, 1997, J PALEONTOL, V71, P1054, DOI 10.1017/S0022336000036039; Wells S.M., 1983, IUCN INVERTEBRATE RE, P97; WELLS SM, 1991, COAST MANAGE, V19, P135, DOI 10.1080/08920759109362135; Whitten Tony., 1996, ECOLOGY JAVA BALI; Wibowo KS, 2007, TEMPO; Wibowo S., 1990, FAO Fisheries Report, P214; YAMAGUCHI M, 1975, OECOLOGIA, V20, P321, DOI 10.1007/BF00345522	54	17	18	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0140593	10.1371/journal.pone.0140593	http://dx.doi.org/10.1371/journal.pone.0140593			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717021	Green Published, Green Submitted, gold			2022-12-26	WOS:000367510500002
J	Monteiro, JGD; Torres, DDC; da Silva, MCFC; Ramos, TMD; Alves, ML; Nunes, WJ; Damasceno, EP; Brunet, AF; Bittencourt, MS; Pedrosa, RP; Sobral, DC				de Moura Monteiro Junior, Jose Gildo; Cipriano Torres, Dilenia de Oliveira; Freire Clementino da Silva, Maria Cleide; de Brito Ramos, Tadzia Maria; Alves, Marilene Leite; Nunes Filho, Wellington Jorge; Damasceno, Edgar Paulo; Brunet, Antonio Fernandes; Bittencourt, Marcio Sommer; Pedrosa, Rodrigo Pinto; Sobral Filho, Dario Celestino			Nucleated Red Blood Cells as Predictors of All-Cause Mortality in Cardiac Intensive Care Unit Patients: A Prospective Cohort Study	PLOS ONE			English	Article							ASSOCIATION	Background The presence of nucleated red blood cells (NRBCs) in the peripheral blood of critically ill patients is associated with a poorer prognosis, though data on cardiovascular critical care patients is lacking. The aim of the present study was to assess the role of NRBCs as a predictor of intensive care unit (ICU) and in hospital all-cause mortality among cardiologic patients. Methods NRBCs were measured daily in consecutive cardiac ICU patients, including individuals with both coronary and non-coronary acute cardiac care. We excluded patients younger than 18 years, with cancer or hematological disease, on glucocorticoid therapy, those that were readmitted after hospital discharge and patients who died in the first 24 hours after admission. We performed a multiple logistic analysis to identify independent predictors of mortality. Results We included 152 patients (60.6 +/- 16.8 years, 51.8% female, median ICU stay of 7 [4-11] days). The prevalence of NRBCs was 54.6%(83/152). The presence of NRBC was associated with a higher ICU mortality (49.4% vs 21.7%, P<0.001) as well as in-hospital mortality (61.4% vs 33.3%, p = 0.001). NRBC were equally associated with mortality among coronary disease (64.71% vs 32.5%[OR 3.80; 95% CI: 1.45-10.0; p = 0.007]) and non-coronary disease patients (61.45% vs 33.3% [OR 3.19; 95% CI: 1.63-6.21; p<0.001]). In a multivariable model, the inclusion of NRBC to the APACHE II score resulted in a significant improvement in the discrimination (p = 0.01). Conclusions NRBC are predictors of all-cause in-hospital mortality in patients admitted to a cardiac ICU. This predictive value is independent and complementary to the well validated APACHE II score.	[de Moura Monteiro Junior, Jose Gildo; Nunes Filho, Wellington Jorge; Damasceno, Edgar Paulo; Brunet, Antonio Fernandes; Pedrosa, Rodrigo Pinto; Sobral Filho, Dario Celestino] Univ Pernambuco UPE, PROCAPE Pernambuco Cardiac Emergency Hosp, Coronary Care Unit, Recife, PE, Brazil; [Cipriano Torres, Dilenia de Oliveira; Freire Clementino da Silva, Maria Cleide; de Brito Ramos, Tadzia Maria; Alves, Marilene Leite] Univ Pernambuco, Lab PROCAPE, Recife, PE, Brazil; [Bittencourt, Marcio Sommer] Univ Sao Paulo, Ctr Clin & Epidemiol Res, Sao Paulo, Brazil	Universidade de Pernambuco (UPE); Universidade de Pernambuco (UPE); Universidade de Sao Paulo	Monteiro, JGD (corresponding author), Univ Pernambuco UPE, PROCAPE Pernambuco Cardiac Emergency Hosp, Coronary Care Unit, Recife, PE, Brazil.	jgildojunior@uol.com.br	Bittencourt, Marcio Sommer/C-1444-2011; Filho, Dario Sobral/H-8624-2019; Pedrosa, Rodrigo P/G-4593-2013; de Moura Monteiro Júnior, José Gildo/R-3977-2017	Bittencourt, Marcio Sommer/0000-0002-3711-1754; Filho, Dario Sobral/0000-0002-5301-7741; de Moura Monteiro Júnior, José Gildo/0000-0002-8983-8744				Azab B, 2010, AM J CARDIOL, V106, P470, DOI 10.1016/j.amjcard.2010.03.062; Danise P, 2012, CLIN CHEM LAB MED, V50, P357, DOI 10.1515/CCLM.2011.766; De Labriolle A, 2010, EUR HEART J, V31, P1079, DOI 10.1093/eurheartj/ehp594; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Desai S, 2012, SURG INFECT, V13, P360, DOI 10.1089/sur.2011.089; Fraker TD, 2007, J AM COLL CARDIOL, V50, P2264, DOI [10.1016/j.jacc.2007.08.002, 10.1161/CIRCULATIONAHA.107.187930]; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kuert S, 2011, CLIN CHEM LAB MED, V49, P257, DOI 10.1515/CCLM.2011.041; Nakul-Aquaronne D, 2003, J CLIN LAB ANAL, V17, P113, DOI 10.1002/jcla.10083; Nunez J, 2010, CORONARY ARTERY DIS, V21, P1, DOI 10.1097/MCA.0b013e328332ee15; Pipitone S, 2012, CLIN CHEM LAB MED, V50, P1857, DOI 10.1515/cclm-2012-0148; Rogers HM, 2008, EXP HEMATOL, V36, P17, DOI 10.1016/j.exphem.2007.08.014; Shah R, 2012, AM J SURG, V203, P343, DOI 10.1016/j.amjsurg.2011.10.002; Stachon A, 2005, SHOCK, V24, P34, DOI 10.1097/01.shk.0000164693.11649.91; Stachon A, 2004, CLIN CHEM LAB MED, V42, P933, DOI 10.1515/CCLM.2004.151; Stachon A, 2007, CRIT CARE, V11, DOI 10.1186/cc5932; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751	18	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0144259	10.1371/journal.pone.0144259	http://dx.doi.org/10.1371/journal.pone.0144259			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713613	gold, Green Published, Green Submitted			2022-12-26	WOS:000367481900006
J	Lu, YH; Li, XP; Mesfioui, R; Bauer, JE; Chambers, RM; Canuel, EA; Hatcher, PG				Lu, YueHan; Li, Xiaping; Mesfioui, Rajaa; Bauer, James E.; Chambers, R. M.; Canuel, Elizabeth A.; Hatcher, Patrick G.			Use of ESI-FTICR-MS to Characterize Dissolved Organic Matter in Headwater Streams Draining Forest-Dominated and Pasture-Dominated Watersheds	PLOS ONE			English	Article							RESOLUTION MASS-SPECTROMETRY; BLACK CARBON; LAND-USE; MOLECULAR CHARACTERIZATION; PHOTOCHEMICAL DEGRADATION; ELECTROSPRAY; BIOAVAILABILITY; SOILS; SPECTRA; MARINE	Electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry (ESI-FTICR-MS) has proven to be a powerful technique revealing complexity and diversity of natural DOM molecules, but its application to DOM analysis in grazing-impacted agricultural systems remains scarce. In the present study, we presented a case study of using ESI-FTICR-MS in analyzing DOM from four headwater streams draining forest-or pasture-dominated watersheds in Virginia, USA. In all samples, most formulas were CHO compounds (71.8-87.9%), with other molecular series (CHOS, CHON, CHONS, and CHOP (N, S)) accounting for only minor fractions. All samples were dominated by molecules falling in the lignin-like region (H/C = 0.7-1.5, O/C = 0.1-0.67), suggesting the predominance of allochthonous, terrestrial plant-derived DOM. Relative to the two pasture streams, DOM formulas in the two forest streams were more similar, based on Jaccard similarity coefficients and nonmetric multidimensional scaling calculated from Bray-Curtis distance. Formulas from the pasture streams were characterized by lower proportions of aromatic formulas and lower unsaturation, suggesting that the allochthonous versus autochthonous contributions of organic matter to streams were modified by pasture land use. The number of condensed aromatic structures (CAS) was higher for the forest streams, which is possibly due to the controlled burning in the forest-dominated watersheds and suggests that black carbon was mobilized from soils to streams. During 15-day biodegradation experiments, DOM from the two pasture streams was altered to a greater extent than DOM from the forest streams, with formulas with H/C and O/C ranges similar to protein (H/C = 1.5-2.2, O/C = 0.3-0.67), lipid (H/C = 1.5-2.0, O/C = 0-0.3), and unsaturated hydrocarbon (H/C = 0.7-1.5, O/C = 0-0.1) being the most bioreactive groups. Aromatic compound formulas including CAS were preferentially removed during combined light+bacterial incubations, supporting the contention that black carbon is labile to light alterations. Collectively, our data demonstrate that head-water DOM composition contains integrative information on watershed sources and processes, and the application of ESI-FTICR-MS technique offers additional insights into compound composition and reactivity unrevealed by fluorescence and stable carbon isotopic measurements.	[Lu, YueHan; Li, Xiaping] Univ Alabama, Dept Geol Sci, Tuscaloosa, AL 35401 USA; [Mesfioui, Rajaa; Hatcher, Patrick G.] Old Dominion Univ, Dept Chem & Biochem, Norfolk, VA USA; [Bauer, James E.] Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Aquat Biogeochem Lab, Columbus, OH 43210 USA; [Chambers, R. M.] Coll William & Mary, Dept Biol, Williamsburg, VA 23185 USA; [Canuel, Elizabeth A.] Virginia Inst Marine Sci, Dept Phys Sci, Gloucester Point, VA 23062 USA	University of Alabama System; University of Alabama Tuscaloosa; Old Dominion University; University System of Ohio; Ohio State University; William & Mary; William & Mary; Virginia Institute of Marine Science	Lu, YH (corresponding author), Univ Alabama, Dept Geol Sci, Tuscaloosa, AL 35401 USA.	yuehan.lu@ua.edu		Lu, Yuehan/0000-0002-0536-532X	Department of Geological Science at the University of Alabama; Mellon Foundation Postdoctoral Fellow Grant from the College of William and Mary; Department of Geological Sciences, the University of Alabama; HOOK's research fund; Division Of Ocean Sciences [0961860] Funding Source: National Science Foundation	Department of Geological Science at the University of Alabama; Mellon Foundation Postdoctoral Fellow Grant from the College of William and Mary; Department of Geological Sciences, the University of Alabama; HOOK's research fund; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by a start-up analytical fund to YL from the Department of Geological Science at the University of Alabama and a Mellon Foundation Postdoctoral Fellow Grant from the College of William and Mary. The authors also acknowledge the HOOK's research fund and the Johnson travel fund from the Department of Geological Sciences, the University of Alabama, for providing student research and travel funds.; We thank Dr. B. Zhang for providing support for statistical analysis. This work was supported by a start-up analytical fund to Y. L. from the Department of Geological Science at the University of Alabama, in collaboration with a Mellon Foundation Postdoctoral Fellow Grant from the College of William and Mary. We also acknowledge the HOOK's research fund and the Johnson travel fund from the Department of Geological Sciences, the University of Alabama, for providing student research and travel funds.	Balcarczyk KL, 2009, BIOGEOCHEMISTRY, V94, P255, DOI 10.1007/s10533-009-9324-x; Baldock JA, 2002, ORG GEOCHEM, V33, P1093, DOI 10.1016/S0146-6380(02)00062-1; Baldock JA, 2004, MAR CHEM, V92, P39, DOI 10.1016/j.marchem.2004.06.016; Bianchi T.S., 2011, CHEM BIOMARKERS AQUA; Cope M.J., 1980, PHYS CHEM EARTH, V12, P663; Cory RM, 2005, ENVIRON SCI TECHNOL, V39, P8142, DOI 10.1021/es0506962; Dalzell BJ, 2009, ORG GEOCHEM, V40, P243, DOI 10.1016/j.orggeochem.2008.10.003; Fellman JB, 2009, BIOGEOCHEMISTRY, V95, P277, DOI 10.1007/s10533-009-9336-6; Fellman JB, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000790; Findlay S.E.G., 2003, AQUATIC ECOSYSTEMS I, P25, DOI [10.1016/b978-012256371-3/50003-2, DOI 10.1016/B978-012256371-3/50003-2]; Glaser B, 1998, ORG GEOCHEM, V29, P811, DOI 10.1016/S0146-6380(98)00194-6; Goldberg E.D., 1985, BLACK CARBON ENV PRO; Harvey HR, 1997, ORG GEOCHEM, V27, P129, DOI 10.1016/S0146-6380(97)00077-6; Herlemann DPR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093945; Hockaday WC, 2006, ORG GEOCHEM, V37, P501, DOI 10.1016/j.orggeochem.2005.11.003; Hockaday WC, 2007, GEOCHIM COSMOCHIM AC, V71, P3432, DOI 10.1016/j.gca.2007.02.023; Hockaday WC, 2009, LIMNOL OCEANOGR-METH, V7, P81, DOI 10.4319/lom.2009.7.81; Hosen JD, 2014, ENVIRON SCI TECHNOL, V48, P7817, DOI 10.1021/es501422z; Jaffe R, 2012, GEOCHIM COSMOCHIM AC, V94, P95, DOI 10.1016/j.gca.2012.06.031; Jaffe R, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2008JG000683; Jaffe R, 2014, ADV PHYSICOCHEMICAL, P29; Jaffe R, 2013, SCIENCE, V340, P345, DOI 10.1126/science.1231476; Kalbitz K, 2006, EUR J SOIL SCI, V57, P504, DOI 10.1111/j.1365-2389.2006.00797.x; Kalbitz K, 2000, SOIL SCI, V165, P277, DOI 10.1097/00010694-200004000-00001; Kalbitz K, 2003, GEODERMA, V113, P273, DOI 10.1016/S0016-7061(02)00365-8; Kim S, 2003, ANAL CHEM, V75, P5336, DOI 10.1021/ac034415p; Kim S, 2003, ORG GEOCHEM, V34, P1325, DOI 10.1016/S0146-6380(03)00101-3; Kim SW, 2004, MAR CHEM, V92, P225, DOI 10.1016/j.marchem.2004.06.042; Kirchman DL, 2003, AQUATIC ECOSYSTEMS I, P121; Koch BP, 2007, ANAL CHEM, V79, P1758, DOI 10.1021/ac061949s; Koch BP, 2006, RAPID COMMUN MASS SP, V20, P926, DOI 10.1002/rcm.2386; Koch BP, 2005, GEOCHIM COSMOCHIM AC, V69, P3299, DOI 10.1016/j.gca.2005.02.027; Kujawinski EB, 2004, MAR CHEM, V92, P23, DOI 10.1016/j.marchem.2004.06.038; Kujawinski EB, 2006, ANAL CHEM, V78, P4363, DOI 10.1021/ac0600306; Kujawinski EB, 2009, GEOCHIM COSMOCHIM AC, V73, P4384, DOI 10.1016/j.gca.2009.04.033; Leifer Asa, 1988, KINETICS ENV AQUATIC; Lu YH, 2014, AQUAT SCI, V76, P419, DOI 10.1007/s00027-014-0344-9; Lu YH, 2014, BIOGEOCHEMISTRY, V119, P275, DOI 10.1007/s10533-014-9965-2; Lu YH, 2013, J GEOPHYS RES-BIOGEO, V118, P566, DOI 10.1002/jgrg.20048; Maie N, 2007, WATER RES, V41, P563, DOI 10.1016/j.watres.2006.11.006; Major J, 2010, GLOBAL CHANGE BIOL, V16, P1366, DOI 10.1111/j.1365-2486.2009.02044.x; McKnight DM., 2003, AQUATIC ECOSYSTEMS, P71, DOI 10.1016/B978-012256371-3/50004-4; Mopper K, 2007, CHEM REV, V107, P419, DOI 10.1021/cr050359b; Mosher JJ, 2010, ORG GEOCHEM, V41, P1177, DOI 10.1016/j.orggeochem.2010.08.004; Nebbioso A, 2013, ANAL BIOANAL CHEM, V405, P109, DOI 10.1007/s00216-012-6363-2; Ohno T, 2010, ENVIRON SCI TECHNOL, V44, P8594, DOI 10.1021/es101089t; Parr TB, 2015, LIMNOL OCEANOGR, V60, P885, DOI 10.1002/lno.10060; Roth VN, 2014, VADOSE ZONE J, V13, DOI 10.2136/vzj2013.09.0162; Schmitt-Kopplin P, 1998, ENVIRON SCI TECHNOL, V32, P2531, DOI 10.1021/es970636z; Skjemstad JO, 1996, AUST J SOIL RES, V34, P251, DOI 10.1071/SR9960251; Sleighter RL, 2008, MAR CHEM, V110, P140, DOI 10.1016/j.marchem.2008.04.008; Sleighter RL, 2008, LIMNOL OCEANOGR-METH, V6, P246, DOI 10.4319/lom.2008.6.246; Sleighter RL, 2007, J MASS SPECTROM, V42, P559, DOI 10.1002/jms.1221; Sleighter RL, 2012, ANAL CHEM, V84, P9184, DOI 10.1021/ac3018026; Stubbins A, 2014, ENVIRON SCI TECHNOL, V48, P10598, DOI 10.1021/es502086e; Stubbins A, 2010, LIMNOL OCEANOGR, V55, P1467, DOI 10.4319/lo.2010.55.4.1467; Sulzberger B, 2009, AQUAT SCI, V71, P104, DOI 10.1007/s00027-008-8082-5; Sun L, 1997, LIMNOL OCEANOGR, V42, P714, DOI 10.4319/lo.1997.42.4.0714; Williams CJ, 2010, LIMNOL OCEANOGR, V55, P1159, DOI 10.4319/lo.2010.55.3.1159; Willoughby AS, 2014, ATMOS CHEM PHYS, V14, P10299, DOI 10.5194/acp-14-10299-2014; Wilson HF, 2013, ECOSYSTEMS, V16, P604, DOI 10.1007/s10021-013-9635-6; Wilson HF, 2009, NAT GEOSCI, V2, P37, DOI 10.1038/NGEO391; Zhong JY, 2011, ORG GEOCHEM, V42, P903, DOI 10.1016/j.orggeochem.2011.04.007	63	47	51	18	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145639	10.1371/journal.pone.0145639	http://dx.doi.org/10.1371/journal.pone.0145639			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713621	Green Published, Green Submitted, gold			2022-12-26	WOS:000367481900062
J	Qiu, XJ; Pang, YL; Yuan, ZH; Xing, DY; Xu, JL; Dingkuhn, M; Li, ZK; Ye, GY				Qiu, Xianjin; Pang, Yunlong; Yuan, Zhihua; Xing, Danying; Xu, Jianlong; Dingkuhn, Michael; Li, Zhikang; Ye, Guoyou			Genome-Wide Association Study of Grain Appearance and Milling Quality in a Worldwide Collection of Indica Rice Germplasm	PLOS ONE			English	Article							ORYZA-SATIVA L.; QUANTITATIVE TRAIT LOCUS; NEAR-ISOGENIC LINES; LINKAGE DISEQUILIBRIUM; NATURAL VARIATION; COMPLEX TRAITS; GENETIC BASES; SEED SIZE; YIELD; WEIGHT	Grain appearance quality and milling quality are the main determinants of market value of rice. Breeding for improved grain quality is a major objective of rice breeding worldwide. Identification of genes/QTL controlling quality traits is the prerequisite for increasing breeding efficiency through marker-assisted selection. Here, we reported a genome-wide association study in indica rice to identify QTL associated with 10 appearance and milling quality related traits, including grain length, grain width, grain length to width ratio, grain thickness, thousand grain weight, degree of endosperm chalkiness, percentage of grains with chalkiness, brown rice rate, milled rice rate and head milled rice rate. A diversity panel consisting of 272 indica accessions collected worldwide was evaluated in four locations including Hangzhou, Jingzhou, Sanya and Shenzhen representing indica rice production environments in China and genotyped using genotyping-by-sequencing and Diversity Arrays Technology based on next-generation sequencing technique called DArTseq (TM). A wide range of variation was observed for all traits in all environments. A total of 16 different association analysis models were compared to determine the best model for each trait-environment combination. Association mapping based on 18,824 high quality markers yielded 38 QTL for the 10 traits. Five of the detected QTL corresponded to known genes or fine mapped QTL. Among the 33 novel QTL identified, qDEC1.1 (qGLWR1.1), qBRR2.2 (qGL2.1), qTGW2.1 (qGL2.2), qGW11.1 (qMRR11.1) and qGL7.1 affected multiple traits with relatively large effects and/or were detected in multiple environments. The research provided an insight of the genetic architecture of rice grain quality and important information for mining genes/QTL with large effects within indica accessions for rice breeding.	[Qiu, Xianjin; Yuan, Zhihua; Xing, Danying] Yangtze Univ, Engn Res Ctr Ecol & Agr Use Wetland, Minist Educ, Coll Agr, Jingzhou 434025, Peoples R China; [Pang, Yunlong; Xu, Jianlong; Li, Zhikang] Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci, Beijing 100081, Peoples R China; [Xu, Jianlong] Chinese Acad Agr Sci, Shenzhen Inst Breeding & Innovat, Shenzhen 518120, Peoples R China; [Dingkuhn, Michael; Ye, Guoyou] Int Rice Res Inst, Manila, Philippines; [Dingkuhn, Michael] CIRAD, UMR AGAP, F-34398 Montpellier, France	Yangtze University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Chinese Academy of Agricultural Sciences; CGIAR; International Rice Research Institute (IRRI); CIRAD; Universite de Montpellier	Xu, JL (corresponding author), Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci, Beijing 100081, Peoples R China.	xujlcaas@126.com; g.ye@irri.org	Xu, Jianlong/AAI-8310-2020	Xing, Danying/0000-0002-3768-5424	Global Rice Science Partnership (GRiSP); National 863 High Technology Research and Development Program from the Ministry of Science and Technology of China [2014AA10A601]; Shenzhen Peacock Plan, the Natural Science Foundation of China [31461143014, 31261140369]; Hubei Collaborative Innovation Center for Grain Industry	Global Rice Science Partnership (GRiSP); National 863 High Technology Research and Development Program from the Ministry of Science and Technology of China; Shenzhen Peacock Plan, the Natural Science Foundation of China; Hubei Collaborative Innovation Center for Grain Industry	This research was granted by Global Rice Science Partnership (GRiSP), National 863 High Technology Research and Development Program from the Ministry of Science and Technology of China (2014AA10A601), Shenzhen Peacock Plan, the Natural Science Foundation of China (31461143014, 31261140369), and Hubei Collaborative Innovation Center for Grain Industry.	Abe Y, 2010, GENES GENET SYST, V85, P327, DOI 10.1266/ggs.85.327; Agrama HA, 2007, MOL BREEDING, V19, P341, DOI 10.1007/s11032-006-9066-6; Bai XF, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-16; Begum H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119873; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Cheng FM, 2005, FOOD CHEM, V90, P39, DOI 10.1016/j.foodchem.2004.03.018; Courtois B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078037; Borba TCD, 2010, GENET MOL BIOL, V33, P515, DOI 10.1590/S1415-47572010005000065; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Gao XY, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-34; Guo LB, 2014, RICE SCI, V21, P65, DOI 10.1016/S1672-6308(13)60174-2; Guo LB, 2009, J INTEGR PLANT BIOL, V51, P45, DOI 10.1111/j.1744-7909.2008.00793.x; Huang RY, 2013, TRENDS PLANT SCI, V18, P218, DOI 10.1016/j.tplants.2012.11.001; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Ishimaru K, 2013, NAT GENET, V45, P707, DOI 10.1038/ng.2612; Jin L, 2010, THEOR APPL GENET, V121, P475, DOI 10.1007/s00122-010-1324-7; Jombart T, 2011, ADEGENET 1 3 1 NEW T; Jr FEH, 2015, HMISC HARRELL MISCEL; Kato T, 2011, BREEDING SCI, V61, P269, DOI 10.1270/jsbbs.61.269; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li YB, 2014, NAT GENET, V46, P398, DOI 10.1038/ng.2923; Li YB, 2011, NAT GENET, V43, P1266, DOI 10.1038/ng.977; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Mao HL, 2010, P NATL ACAD SCI USA, V107, P19579, DOI 10.1073/pnas.1014419107; Mather KA, 2007, GENETICS, V177, P2223, DOI 10.1534/genetics.107.079616; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; Phung NTP, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0371-7; Oh JM, 2011, GENES GENOM, V33, P259, DOI 10.1007/s13258-011-0038-9; Pasam RK, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-16; Pritchard JK, 2000, GENETICS, V155, P945; Qi P, 2012, CELL RES, V22, P1666, DOI 10.1038/cr.2012.151; R Core Team, 2013, R LANG ENV STAT COMP; Risterucci AM, 2000, THEOR APPL GENET, V101, P948, DOI 10.1007/s001220051566; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Singh R, 2012, J PLANT BIOCHEM BIOT, V21, P157, DOI 10.1007/s13562-011-0080-3; Song XJ, 2015, P NATL ACAD SCI USA, V112, P76, DOI 10.1073/pnas.1421127112; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Stich B, 2008, GENETICS, V178, P1745, DOI 10.1534/genetics.107.079707; Tan YF, 2000, THEOR APPL GENET, V101, P823, DOI 10.1007/s001220051549; Unnevehr L. J., 1992, CONSUMER DEMAND RICE; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Wang SK, 2015, NAT GENET, V47, P949, DOI 10.1038/ng.3352; Wang SK, 2012, NAT GENET, V44, P950, DOI 10.1038/ng.2327; Wang YX, 2015, NAT GENET, V47, P944, DOI 10.1038/ng.3346; Xie XB, 2008, THEOR APPL GENET, V116, P613, DOI 10.1007/s00122-007-0695-x; Xie XB, 2006, THEOR APPL GENET, V113, P885, DOI 10.1007/s00122-006-0348-5; Xu FF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122206; Yan S, 2011, THEOR APPL GENET, V123, P1173, DOI 10.1007/s00122-011-1657-x; Yang WN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6087; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Yu SW, 2008, CHINESE SCI BULL, V53, P2326, DOI 10.1007/s11434-008-0281-x; Zhang P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111508; Zhang WH, 2013, CROP J, V1, P160, DOI 10.1016/j.cj.2013.10.003; Zhang XJ, 2012, P NATL ACAD SCI USA, V109, P21534, DOI 10.1073/pnas.1219776110; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467; Zhao XQ, 2015, RICE, V8, DOI 10.1186/s12284-015-0064-3; Zheng TQ, 2007, PLANT BREEDING, V126, P158, DOI 10.1111/j.1439-0523.2007.01357.x; Zhou JiangBo, 2012, African Journal of Biotechnology, V11, P2957; Zhou LJ, 2009, THEOR APPL GENET, V118, P581, DOI 10.1007/s00122-008-0922-0	65	29	39	4	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145577	10.1371/journal.pone.0145577	http://dx.doi.org/10.1371/journal.pone.0145577			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714258	gold, Green Published, Green Submitted			2022-12-26	WOS:000367481900059
J	Tampubolon, G				Tampubolon, Gindo			Cognitive Ageing in Great Britain in the New Century: Cohort Differences in Episodic Memory	PLOS ONE			English	Article							C-REACTIVE PROTEIN; LATE-LIFE; OLDER-PEOPLE; AGE; TRAJECTORIES; ATTRITION; DEMENTIA; DECLINE; POPULATION; IMPAIRMENT	Background Dementias in high income countries are set to be the third major burden of disease even as older people are increasingly required to think for themselves how to provide for their lives in retirement. Meanwhile the period of older age continues to extend with increase in life expectancy. This challenge demands an understanding of how cognition changes over an extended period in later life. But studying cognitive ageing in the population faces a difficulty from the fact that older respondents are liable to leave (attrite) before study completion. This study tested three hypotheses: trajectories of cognitive ageing in Britain show an improvement beyond the age of 50; and they are lifted by secular improvement in cognition across cohorts; lastly they are susceptible to distortion due to attrition. Methods and Findings Using the English Longitudinal Study of Ageing, this paper studied trajectories of episodic memory of Britons aged 50-89 from 2002 to 2013 (N = 5931). Using joint models the analysis found that levels of episodic memory follow a curvilinear shape, not a steady decline, in later life. The findings also revealed secular improvement in cognitive ageing such that as a cohort is being replaced episodic memory levels in the population improve. The analysis lastly demonstrated that failure to simultaneously model attrition can produce distorted pictures of cognitive ageing. Conclusion Old age in this century is not necessarily a period dominated by cognitive decline. In identifying behavioural factors associated with better cognitive ageing, such as social connections of traditional and online kinds, the paper raises possibilities of mustering an adequate response to the cognition challenge.	[Tampubolon, Gindo] Univ Manchester, Cathie Marsh Inst Social Res, Manchester, Lancs, England	University of Manchester	Tampubolon, G (corresponding author), Univ Manchester, Cathie Marsh Inst Social Res, Manchester, Lancs, England.	tampubolon@manchester.ac.uk		Tampubolon, Gindo/0000-0002-9081-2349	Medical Research Council; Medical Research Council [G1001375] Funding Source: researchfish; MRC [G1001375] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	GT is funded by the Medical Research Council, GB (www.mrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baars MAE, 2009, DEMENT GERIATR COGN, V27, P173, DOI 10.1159/000200465; Banks J, 2005, PREPARED RETIREMENT; Banks J, 2008, LIVING 21 CENTURY OL; Banks J, 2010, FINANCIAL CIRCUMSTAN; Banks J., 2006, RETIREMENT HLTH RELA; Banks J, 2012, DYNAMICS AGEING EVID; Banks J, 2014, DYNAMICS AGEING EVID; Banks J, 2006, FISC STUD, V27, P281, DOI 10.1111/j.1467-8578.2006.00036.x; Banks J, 2011, LONGITUD LIFE COURSE, V2, P101, DOI 10.14301/llcs.v2i2.115; Brayne C, 2011, ALZHEIMERS DEMENT, V7, P3, DOI 10.1016/j.jalz.2010.12.003; Craik FIM, 2006, TRENDS COGN SCI, V10, P131, DOI 10.1016/j.tics.2006.01.007; Dodge HH, 2014, J GERONTOL A-BIOL, V69, P687, DOI 10.1093/gerona/glt181; Dodge HH, 2011, NEUROLOGY, V77, P722, DOI 10.1212/WNL.0b013e31822b0068; Dregan A, 2013, PSYCHOL MED, V43, P2447, DOI 10.1017/S0033291713000305; Fenge R, 2005, SOCIAL SECURITY EARL; Flynn JR, 2012, ARE WE GETTING SMARTER?: RISING IQ IN THE TWENTY-FIRST CENTURY, P1, DOI 10.1017/CBO9781139235679; Gale CR, 2012, PSYCHOL MED, V42, P2057, DOI 10.1017/S0033291712000402; Graham PL, 2011, J R STAT SOC C-APPL, V60, P221, DOI 10.1111/j.1467-9876.2010.00737.x; Grodstein F, 2007, ALZHEIMERS DEMENT, V3, pS16, DOI 10.1016/j.jalz.2007.01.001; Huppert F.A., 2006, RETIREMENT HLTH RELA, P217; Karlamangla AS, 2009, AM J EPIDEMIOL, V170, P331, DOI 10.1093/aje/kwp154; Lima TAS, 2014, AGE AGEING, V43, P289, DOI 10.1093/ageing/aft193; Marmot M, 2003, HLTH WEALTH LIFESTYL; Marshall A, 2015, J EPIDEMIOL COMMUN H, V69, P316, DOI 10.1136/jech-2014-204655; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Matthews FE, 2007, PLOS MED, V4, P1615, DOI 10.1371/journal.pmed.0040304; McArdle JJ, 2009, COGNITION EC OUTCOME, P4269; McArdle JJ, 2007, PSYCHOL AGING, V22, P525, DOI 10.1037/0882-7974.22.3.525; Nordlund A, 2015, J CARD FAIL, V21, P702, DOI 10.1016/j.cardfail.2015.04.006; Rabbitt P, 2004, J GERONTOL B-PSYCHOL, V59, pP84, DOI 10.1093/geronb/59.2.P84; Rabbitt P, 2001, NEUROPSYCHOLOGIA, V39, P532, DOI 10.1016/S0028-3932(00)00099-3; Rabbitt P, 2005, CAMBRIDGE HDB AGE AG, P190; Richard E, 2014, NAT REV NEUROL, V10, P130, DOI 10.1038/nrneurol.2014.23; Rodgers WL, 2003, J GERONTOL B-PSYCHOL, V58, pS338, DOI 10.1093/geronb/58.6.S338; Rose D, 2003, RES GUIDE NATL STAT; Salthouse TA, 2013, DEV PSYCHOL, V49, P2172, DOI 10.1037/a0032019; Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023; Schaie KW, 2004, AGING NEUROPSYCHOL C, V11, P304, DOI 10.1080/13825580490511134; Silverman JM, 2012, NEUROLOGY, V79, P1116, DOI 10.1212/WNL.0b013e3182698c89; Silverman JM, 2009, AGE AGEING, V38, P237, DOI 10.1093/ageing/afn278; Singh-Manoux A, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d7622; Skirbekk V, 2012, P NATL ACAD SCI USA, V109, P770, DOI 10.1073/pnas.1112173109; Small ML, 2012, NEIGHBOURHOOD EFFECT, P57, DOI [10.1007/978- 94-007-2309-2_3, DOI 10.1007/978-94-007-2309-2_3, DOI 10.1007/978-94-007-2309-2]; Sotaniemi M, 2012, ACTA NEUROL SCAND, V125, P16, DOI 10.1111/j.1600-0404.2010.01459.x; Staff RT, 2014, INTELLIGENCE, V47, P194, DOI 10.1016/j.intell.2014.09.013; Steel N., 2002, HLTH WEALTH LIFESTYL, P249; Steptoe A, 2012, DYNAMICS AGEING EVID, P98; Suthers Kristen, 2003, J Gerontol B Psychol Sci Soc Sci, V58, pS179; Tampubolon G, 2015, AGING MENT HEALTH, V19, P576, DOI 10.1080/13607863.2014.1003279; The Marmot Review, 2010, MARM REV FAIR SOC HL; Uswatte G, 2010, NEW FRONTIERS RESILI, P104; Vermunt JK, 2013, LG SYNTAX USERS GUID; Weuve J, 2012, EPIDEMIOLOGY, V23, P119, DOI 10.1097/EDE.0b013e318230e861; Whalley L, 2001, THE AGEING BRAIN; WHO Commission on Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Willis SL, 2009, HDB THEORIES AGING, P295; Wise DA, 2009, DEV EC AGING; Wise DA, 2012, INVESTIGATIONS EC AG; Wise DA, 2005, ANAL EC AGING; Yaffe K, 2013, CHRONIC MED DIS COGN; Yang Y, 2007, J HEALTH SOC BEHAV, V48, P16, DOI 10.1177/002214650704800102	61	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0144907	10.1371/journal.pone.0144907	http://dx.doi.org/10.1371/journal.pone.0144907			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA0IX	26713627	Green Published, Green Submitted, gold			2022-12-26	WOS:000367481900022
J	Anttila, J; Kaitala, V; Laakso, J; Ruokolainen, L				Anttila, Jani; Kaitala, Veijo; Laakso, Jouni; Ruokolainen, Lasse			Environmental Variation Generates Environmental Opportunist Pathogen Outbreaks	PLOS ONE			English	Article							BIOFILM FORMATION; POPULATION-DYNAMICS; INFECTIOUS-DISEASES; HOPF-BIFURCATION; IMMUNITY; CHOLERA; MODEL; SEASONALITY; REINFECTION; EVOLUTION	Many socio-economically important pathogens persist and grow in the outside host environment and opportunistically invade host individuals. The environmental growth and opportunistic nature of these pathogens has received only little attention in epidemiology. Environmental reservoirs are, however, an important source of novel diseases. Thus, attempts to control these diseases require different approaches than in traditional epidemiology focusing on obligatory parasites. Conditions in the outside-host environment are prone to fluctuate over time. This variation is a potentially important driver of epidemiological dynamics and affect the evolution of novel diseases. Using a modelling approach combining the traditional SIRS models to environmental opportunist pathogens and environmental variability, we show that epidemiological dynamics of opportunist diseases are profoundly driven by the quality of environmental variability, such as the long-term predictability and magnitude of fluctuations. When comparing periodic and stochastic environmental factors, for a given variance, stochastic variation is more likely to cause outbreaks than periodic variation. This is due to the extreme values being further away from the mean. Moreover, the effects of variability depend on the underlying biology of the epidemiological system, and which part of the system is being affected. Variation in host susceptibility leads to more severe pathogen outbreaks than variation in pathogen growth rate in the environment. Positive correlation in variation on both targets can cancel the effect of variation altogether. Moreover, the severity of outbreaks is significantly reduced by increase in the duration of immunity. Uncovering these issues helps in understanding and controlling diseases caused by environmental pathogens.	[Anttila, Jani; Kaitala, Veijo; Laakso, Jouni; Ruokolainen, Lasse] Univ Helsinki, Dept Biosci, Integrat Ecol Unit, FI-00014 Helsinki, Finland	University of Helsinki	Anttila, J (corresponding author), Univ Helsinki, Dept Biosci, Integrat Ecol Unit, FI-00014 Helsinki, Finland.	jani.anttila@helsinki.fi	; Laakso, Jouni/I-7794-2013	Ruokolainen, Lasse/0000-0003-0951-9100; Laakso, Jouni/0000-0001-8245-9912	Academy of Finland [1255572, 1267541]	Academy of Finland(Academy of Finland)	This work was funded by Academy of Finland (http://www.aka.fi/) grants #1255572 for JL and #1267541 for VK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; Anttila J, 2016, OIKOS, V125, P1144, DOI 10.1111/oik.02913; Anttila J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071621; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Boldin B, 2012, EVOLUTION, V66, P2514, DOI 10.1111/j.1558-5646.2012.01613.x; Breban R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000346; Codeco CT, 2001, BMC INFECT DIS, V1, DOI 10.1186/1471-2334-1-1; Cohen AE, 1998, P ROY SOC B-BIOL SCI, V265, P11, DOI 10.1098/rspb.1998.0257; Cohen JE, 1999, CIRC SYST SIGNAL PR, V18, P431, DOI 10.1007/BF01200792; Edenhofer O., 2014, CONTRIBUTION WORKING; Fowler MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055855; Godfray HCJ, 1999, P ROY SOC B-BIOL SCI, V266, P233, DOI 10.1098/rspb.1999.0627; Gomes MGM, 2004, J THEOR BIOL, V228, P539, DOI 10.1016/j.jtbi.2004.02.015; Greenhalgh D, 1997, MATH COMPUT MODEL, V25, P85, DOI 10.1016/S0895-7177(97)00009-5; Greenhalgh D, 2004, MATH COMPUT MODEL, V39, P1261, DOI 10.1016/j.mcm.2004.06.007; Greenman J, 2004, PHYSICA D, V190, P136, DOI 10.1016/j.physd.2003.08.008; HALL CB, 1991, J INFECT DIS, V163, P693, DOI 10.1093/infdis/163.4.693; Hall-Stoodley L, 2005, TRENDS MICROBIOL, V13, P7, DOI 10.1016/j.tim.2004.11.004; Halley JM, 1996, TRENDS ECOL EVOL, V11, P33, DOI 10.1016/0169-5347(96)81067-6; Hammer BK, 2003, MOL MICROBIOL, V50, P101, DOI 10.1046/j.1365-2958.2003.03688.x; Joh RI, 2009, B MATH BIOL, V71, P845, DOI 10.1007/s11538-008-9384-4; Kaitala V, 1997, P ROY SOC B-BIOL SCI, V264, P943, DOI 10.1098/rspb.1997.0130; Koelle K, 2005, NATURE, V436, P696, DOI 10.1038/nature03820; KRUGMAN S, 1965, J PEDIATR-US, V66, P471, DOI 10.1016/S0022-3476(65)80112-3; Kunttu HMT, 2012, ENV MICROBIOL REP, V4, P398, DOI 10.1111/j.1758-2229.2012.00342.x; Merikanto I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050158; Nisbet RM, 1982, MODELLING FLUCTUATIN; Pelosse P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070830; Ranta Esa, 2006, P1; Regoes RR, 2002, P ROY SOC B-BIOL SCI, V269, P271, DOI 10.1098/rspb.2001.1816; Rohani P, 2002, AM NAT, V159, P469, DOI 10.1086/339467; ROUGHGARDEN J, 1975, AM NAT, V109, P713, DOI 10.1086/283039; Ruiz-Moreno D, 2007, ECOHEALTH, V4, P52, DOI 10.1007/s10393-006-0079-8; Ruokolainen L, 2013, J THEOR BIOL, V339, P36, DOI 10.1016/j.jtbi.2013.08.021; Ruokolainen L, 2009, TRENDS ECOL EVOL, V24, P555, DOI 10.1016/j.tree.2009.04.009; SNIESZKO SF, 1974, J FISH BIOL, V6, P197, DOI 10.1111/j.1095-8649.1974.tb04537.x; Suomalainen LR, 2006, DIS AQUAT ORGAN, V70, P55, DOI 10.3354/dao070055; Suomalainen LR, 2005, J FISH DIS, V28, P271, DOI 10.1111/j.1365-2761.2005.00631.x; Turner WC, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00245.1; van Boven M, 2000, MATH BIOSCI, V164, P161, DOI 10.1016/S0025-5564(00)00009-2; Vasseur DA, 2004, ECOLOGY, V85, P1146, DOI 10.1890/02-3122; Vasseur DA, 2007, THEOR POPUL BIOL, V72, P186, DOI 10.1016/j.tpb.2007.06.002; Vuong C, 2004, J BIOL CHEM, V279, P54881, DOI 10.1074/jbc.M411374200; Wearing HJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000647; Wendelboe Aaron M, 2005, Pediatr Infect Dis J, V24, pS58, DOI 10.1097/01.inf.0000160914.59160.41	47	10	10	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145511	10.1371/journal.pone.0145511	http://dx.doi.org/10.1371/journal.pone.0145511			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710238	Green Published, Green Submitted, gold			2022-12-26	WOS:000367451400059
J	Yu, BL; Zhou, H; Liu, M; Zheng, T; Jiang, L; Zhao, M; Xu, XX; Huang, ZF				Yu, Bolan; Zhou, Hua; Liu, Min; Zheng, Ting; Jiang, Lu; Zhao, Mei; Xu, Xiaoxie; Huang, Zhaofeng			Epigenetic Alterations in Density Selected Human Spermatozoa for Assisted Reproduction	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; BECKWITH-WIEDEMANN-SYNDROME; ABERRANT DNA METHYLATION; LARGE GENE LISTS; SPERM DNA; EJACULATED SPERMATOZOA; INFERTILE MEN; PROTAMINE; CHROMATIN; RATIO	Epidemiological evidence indicates that assisted reproductive technologies (ART) may be associated with several epigenetic diseases such as Beckwith-Wiedemann syndrome (BWS) or Silver-Russell syndrome (SRS). Selection of sperm by density-gradients in ART has improved DNA integrity and sperm quality; however, epigenetic alterations associated with this approach are largely unknown. In the present study, we investigated DNA methylation and histone retention profiles in raw sperm and selected sperm derived from the same individual and separated by using density-gradients. Results from a study group consisting of 93 males demonstrated that both global DNA methylation and histone retention levels decreased in density selected sperm. Compared to unselected raw sperm, histone transition rates decreased by an average of 27.2% in selected sperm, and the global methylation rate was 3.8% in unselected sperm and 3.3% in the selected sperm. DNA methylation and histone retention location profiling analyses suggested that these alterations displayed specific location patterns in the human genome. Changes in the pattern of hypomethylation largely occurred in transcriptional factor gene families such as HOX, FOX, and GATA. Histone retention increased in 67 genes, whereas it was significantly clustered in neural development-related gene families, particularly the olfactory sensor gene family. Although a causative relationship could not be established, the results of the present study suggest the possibility that sperm with good density also possess unique epigenetic profiles, particularly for genes involved in neural and olfactory development. As increasing evidence demonstrates that epigenetics plays a key role in embryonic development and offspring growth characteristics, the specific epigenetic alterations we observed in selected sperm may influence the transcriptional process and neural development in embryos.	[Yu, Bolan; Zhou, Hua; Liu, Min; Zheng, Ting; Jiang, Lu] Guangzhou Med Univ, Affiliated Hosp 3, Guangdong Higher Educ Inst, Key Lab Reprod & Genet, Guangzhou 510150, Guangdong, Peoples R China; [Yu, Bolan; Zhou, Hua; Liu, Min; Zheng, Ting; Jiang, Lu] Guangzhou Med Univ, Affiliated Hosp 3, Key Lab Major Obstetr Dis Guangdong Prov, Guangzhou 510150, Guangdong, Peoples R China; [Zhao, Mei; Xu, Xiaoxie; Huang, Zhaofeng] Sun Yat Sen Univ, Zhongshan Sch Med, Inst Human Virol, Guangzhou 510080, Guangdong, Peoples R China; [Zhao, Mei; Xu, Xiaoxie; Huang, Zhaofeng] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Biochem, Guangzhou 510080, Guangdong, Peoples R China; [Zhao, Mei; Xu, Xiaoxie; Huang, Zhaofeng] Sun Yat Sen Univ, Minist Educ China, Key Lab Trop Dis Control, Guangzhou 510080, Guangdong, Peoples R China	Guangzhou Medical University; Guangzhou Medical University; Sun Yat Sen University; Sun Yat Sen University; Ministry of Education, China; Sun Yat Sen University	Yu, BL (corresponding author), Guangzhou Med Univ, Affiliated Hosp 3, Guangdong Higher Educ Inst, Key Lab Reprod & Genet, Guangzhou 510150, Guangdong, Peoples R China.	yubolan-q@qq.com; hzhaof@mail.sysu.edu.cn			Natural Science Foundation of China [81370751, 31170831]; Guangdong Natural Science Foundation [2014A030313502, 2015A030302016]; Guangzhou City Science and Technology Administration [201510010014]; Guangdong Recruitment Program of Creative Research Group [2009010058]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Guangzhou City Science and Technology Administration; Guangdong Recruitment Program of Creative Research Group	The work was supported by the Natural Science Foundation of China (81370751 and 31170831), Guangdong Natural Science Foundation (2014A030313502 and 2015A030302016), Guangzhou City Science and Technology Administration (201510010014), and the Guangdong Recruitment Program of Creative Research Group (No. 2009010058).	Ankolkar M, 2012, FERTIL STERIL, V98, P1186, DOI 10.1016/j.fertnstert.2012.07.1143; Aoki VW, 2006, FERTIL STERIL, V86, P1408, DOI 10.1016/j.fertnstert.2006.04.024; Bench GS, 1996, CYTOMETRY, V23, P263, DOI 10.1002/(SICI)1097-0320(19960401)23:4<263::AID-CYTO1>3.3.CO;2-9; Benchaib M, 2005, HUM REPROD, V20, P768, DOI 10.1093/humrep/deh684; Benchaib M, 2006, Gynecol Obstet Fertil, V34, P836, DOI 10.1016/j.gyobfe.2006.07.036; Brewer LR, 1999, SCIENCE, V286, P120, DOI 10.1126/science.286.5437.120; Carrell DT, 2007, HUM REPROD UPDATE, V13, P313, DOI 10.1093/humupd/dml057; Carrell DT, 2008, INT J ANDROL, V31, P537, DOI 10.1111/j.1365-2605.2008.00872.x; Carrell DT, 2001, J ANDROL, V22, P604; Dale RK, 2011, BIOINFORMATICS, V27, P3423, DOI 10.1093/bioinformatics/btr539; de Mateo S, 2009, FERTIL STERIL, V91, P715, DOI 10.1016/j.fertnstert.2007.12.047; DeBaun MR, 2003, AM J HUM GENET, V72, P156, DOI 10.1086/346031; Dias BG, 2014, NAT NEUROSCI, V17, P89, DOI 10.1038/nn.3594; El Hajj N, 2011, SEX DEV, V5, P60, DOI 10.1159/000323806; Erkek S, 2013, NAT STRUCT MOL BIOL, V20, P868, DOI 10.1038/nsmb.2599; Gandini L, 2004, HUM REPROD, V19, P1409, DOI 10.1093/humrep/deh233; Gicquel C, 2003, AM J HUM GENET, V72, P1338, DOI 10.1086/374824; Hammadeh ME, 2010, HUM REPROD, V25, P2708, DOI 10.1093/humrep/deq226; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Hisano M, 2013, NAT PROTOC, V8, P2449, DOI 10.1038/nprot.2013.145; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jackson RE, 2010, FERTIL STERIL, V94, P2626, DOI 10.1016/j.fertnstert.2010.04.049; Jenkins TG, 2015, MOL HUM REPROD, V21, P313, DOI 10.1093/molehr/gau115; Jenkins TG, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004458; Jiang L, 2013, CELL, V153, P773, DOI 10.1016/j.cell.2013.04.041; Kaati G, 2002, EUR J HUM GENET, V10, P682, DOI 10.1038/sj.ejhg.5200859; Kagami M, 2007, J ASSIST REPROD GEN, V24, P131, DOI 10.1007/s10815-006-9096-3; Kobayashi H, 2007, HUM MOL GENET, V16, P2542, DOI 10.1093/hmg/ddm187; Lachaud C, 2004, HUM REPROD, V19, P607, DOI 10.1093/humrep/deh130; Lambrot R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3889; Larson KL, 1999, HUM REPROD, V14, P2015, DOI 10.1093/humrep/14.8.2015; Liang F, 2014, NEUROPHARMACOLOGY, V81, P126, DOI 10.1016/j.neuropharm.2014.01.025; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Luke L, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3359; Malnic B, 2004, P NATL ACAD SCI USA, V101, P2584, DOI 10.1073/pnas.0307882100; Morrell JM, 2004, J ASSIST REPROD GEN, V21, P217, DOI 10.1023/B:JARG.0000040237.47026.0f; Nasr-Esfahani MH, 2004, ANDROLOGIA, V36, P95, DOI 10.1111/j.1439-0272.2004.00612.x; Oliva R, 2006, HUM REPROD UPDATE, V12, P417, DOI 10.1093/humupd/dml009; Potok ME, 2013, CELL, V153, P759, DOI 10.1016/j.cell.2013.04.030; Qureshi IA, 2010, CELL CYCLE, V9, P4477, DOI 10.4161/cc.9.22.13973; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Steger K, 2008, HUM REPROD, V23, P11, DOI 10.1093/humrep/dem363; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tunc O, 2009, J ASSIST REPROD GEN, V26, P537, DOI 10.1007/s10815-009-9346-2; Urdinguio RG, 2015, HUM REPROD, V30, P1014, DOI 10.1093/humrep/dev053; Wei YC, 2014, P NATL ACAD SCI USA, V111, P1873, DOI 10.1073/pnas.1321195111; World Health Organization (WHO), 2021, WHO LAB MAN EX PROC, V6th, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/PUBLICATI0NS/2010/9789241547789_; Yu BL, 2014, FERTIL STERIL, V101, P51, DOI 10.1016/j.fertnstert.2013.09.001; Zhang XY, 2006, J ANDROL, V27, P414, DOI 10.2164/jandrol.05171; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang ZT, 1997, EMBO J, V16, P6141, DOI 10.1093/emboj/16.20.6141	53	12	13	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145585	10.1371/journal.pone.0145585	http://dx.doi.org/10.1371/journal.pone.0145585			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709917	Green Submitted, gold, Green Published			2022-12-26	WOS:000367451400064
J	Huang, JF; Zeng, DZ; Duan, GJ; Shi, Y; Deng, GH; Xia, H; Xu, HQ; Zhao, N; Fu, WL; Huang, Q				Huang, Jun-Fu; Zeng, Dong-Zhu; Duan, Guang-Jie; Shi, Yan; Deng, Guo-Hong; Xia, Han; Xu, Han-Qing; Zhao, Na; Fu, Wei-Ling; Huang, Qing			Single-Tubed Wild-Type Blocking Quantitative PCR Detection Assay for the Sensitive Detection of Codon 12 and 13 KRAS Mutations	PLOS ONE			English	Article							METASTATIC COLORECTAL-CANCER; GROWTH-FACTOR RECEPTOR; PEPTIDE NUCLEIC-ACID; K-RAS MUTATIONS; CELL-FREE DNA; PICODROPLET DIGITAL PCR; MELTING CURVE ANALYSIS; ANTI-EGFR THERAPY; MONOCLONAL-ANTIBODY; ACQUIRED-RESISTANCE	The high degree of intra-tumor heterogeneity has meant that it is important to develop sensitive and selective assays to detect low-abundance KRAS mutations in metastatic colorectal carcinoma (mCRC) patients. As a major potential source of tumor DNA in the aforementioned genotyping assays, it was necessary to conduct an analysis on both the quality and quantity of DNA extracted from formalin-fixed paraffin-embedded (FFPE). Therefore, four commercial FFPE DNA extraction kits were initially compared with respect to their ability to facilitate extraction of amplifiable DNA. The results showed that TrimGen kits showed the greatest performance in relation to the quality and quantity of extracted FFPE DNA solutions. Using DNA extracted by TrimGen kits as a template for tumor genotyping, a real-time wild-type blocking PCR (WTB-PCR) assay was subsequently developed to detect the aforementioned KRAS mutations in mCRC patients. The results showed that WTB-PCR facilitated the detection of mutated alleles at a ratio of 1:10,000 (i.e. 0.01%) wild-type alleles. When the assay was subsequently used to test 49 mCRC patients, the results showed that the mutation detection levels of the WTB-PCR assay (61.8%; 30/49) were significantly higher than that of traditional PCR (38.8%; 19/49). Following the use of the real-time WTB-PCR assay, the Delta Cq method was used to quantitatively analyze the mutation levels associated with KRAS in each FFPE sample. The results showed that the mutant levels ranged from 53.74 to 0.12% in the patients analyzed. In conclusion, the current real-time WTB-PCR is a rapid, simple, and low-cost method that permits the detection of trace amounts of the mutated KRAS gene.	[Huang, Jun-Fu; Xia, Han; Xu, Han-Qing; Zhao, Na; Fu, Wei-Ling; Huang, Qing] Third Mil Med Univ, Southwest Hosp, Dept Lab Med, Chongqing 400038, Peoples R China; [Zeng, Dong-Zhu; Shi, Yan] Third Mil Med Univ, Southwest Hosp, Dept Gen Surg, Chongqing 400038, Peoples R China; [Duan, Guang-Jie] Third Mil Med Univ, Inst Pathol, Southwest Hosp, Chongqing 400038, Peoples R China; [Duan, Guang-Jie] Third Mil Med Univ, Southwest Canc Ctr, Southwest Hosp, Chongqing 400038, Peoples R China; [Deng, Guo-Hong] Third Mil Med Univ, Southwest Hosp, Dept Infect Dis, Chongqing 400038, Peoples R China	Army Medical University; Army Medical University; Army Medical University; Army Medical University; Army Medical University	Fu, WL (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Lab Med, Chongqing 400038, Peoples R China.	weilingfu@yahoo.com; Q.Huang@gmail.com	fu, weiling/AAX-3286-2021; Huang, Qing/E-1872-2017	fu, weiling/0000-0002-5768-6563; Huang, Qing/0000-0002-0140-8978	National 863 Program of China [2011AA02A121, 2013AA020204]; Scientific Foundation of Chongqing [CSTC2014YYKFA110029, CSTC2015JCSF0105]	National 863 Program of China; Scientific Foundation of Chongqing	This work was supported in part by grants from the National 863 Program of China (No. 2011AA02A121 and 2013AA020204), and the Scientific Foundation of Chongqing (No. CSTC2014YYKFA110029; CSTC2015JCSF0105).	Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Baker M, 2012, NAT METHODS, V9, P541, DOI 10.1038/nmeth.2027; Bando H, 2011, BRIT J CANCER, V105, P403, DOI 10.1038/bjc.2011.247; Beau-Faller M, 2009, BRIT J CANCER, V100, P985, DOI 10.1038/sj.bjc.6604925; Bonin S, 2010, VIRCHOWS ARCH, V457, P309, DOI 10.1007/s00428-010-0917-5; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen D, 2014, ANAL BIOANAL CHEM, V406, P2477, DOI 10.1007/s00216-014-7618-x; Chretien AS, 2013, CANCER MED-US, V2, P11, DOI 10.1002/cam4.47; Cremolini C, 2015, ANN ONCOL, V26, P2092, DOI 10.1093/annonc/mdv290; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Custodio A, 2013, CRIT REV ONCOL HEMAT, V85, P45, DOI 10.1016/j.critrevonc.2012.05.001; Dabritz J, 2005, BRIT J CANCER, V92, P405, DOI 10.1038/sj.bjc.6602319; Di Fiore F, 2007, BRIT J CANCER, V96, P1166, DOI 10.1038/sj.bjc.6603685; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Didelot A, 2013, CLIN CHEM, V59, P815, DOI 10.1373/clinchem.2012.193409; Dominguez PL, 2005, ONCOGENE, V24, P6830, DOI 10.1038/sj.onc.1208832; Dressman D, 2003, P NATL ACAD SCI USA, V100, P8817, DOI 10.1073/pnas.1133470100; Fox JC, 1998, BRIT J CANCER, V77, P1267, DOI 10.1038/bjc.1998.212; Franklin WA, 2010, J MOL DIAGN, V12, P43, DOI 10.2353/jmoldx.2010.080131; Gilje B, 2008, J MOL DIAGN, V10, P325, DOI 10.2353/jmoldx.2008.070183; Goldstein NI, 1995, CLIN CANCER RES, V1, P1311; Hamilton SC, 2001, BIOTECHNIQUES, V31, P370, DOI 10.2144/01312rv01; Harle A, 2013, VIRCHOWS ARCH, V462, P329, DOI 10.1007/s00428-013-1380-x; Hecht JR, 2015, CANCER TREAT REV, V41, P653, DOI 10.1016/j.ctrv.2015.05.008; Hu YC, 2014, ASIAN PAC J CANCER P, V15, P2733, DOI 10.7314/APJCP.2014.15.6.2733; Huang Q, 2006, MOL CELL PROBE, V20, P250, DOI 10.1016/j.mcp.2006.01.005; Huang Q, 2010, MOL CELL PROBE, V24, P376, DOI 10.1016/j.mcp.2010.07.010; Igloi GL, 1998, P NATL ACAD SCI USA, V95, P8562, DOI 10.1073/pnas.95.15.8562; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kimura T, 2012, ONCOLOGY-BASEL, V82, P298, DOI 10.1159/000336792; Kopetz S, 2015, CLIN COLORECTAL CANC; Kubista Mikael, 2006, Molecular Aspects of Medicine, V27, P95, DOI 10.1016/j.mam.2005.12.007; Laurent-Puig P, 2015, CLIN CANCER RES, V21, P1087, DOI 10.1158/1078-0432.CCR-14-0983; Lee S, 2012, VIRCHOWS ARCH, V460, P141, DOI 10.1007/s00428-011-1180-0; Li M, 2006, NAT METHODS, V3, P95, DOI 10.1038/NMETH850; Lievre A, 2008, J CLIN ONCOL, V26, P374, DOI 10.1200/JCO.2007.12.5906; Luo JD, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj008; Mackay John, 2007, Methods Mol Biol, V353, P237; Messersmith WA, 2008, NEW ENGL J MED, V359, P1834, DOI 10.1056/NEJMe0806778; Milbury CA, 2009, CLIN CHEM, V55, P632, DOI 10.1373/clinchem.2008.113035; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Mitani Y, 2007, NAT METHODS, V4, P257, DOI 10.1038/NMETH1007; Miyamae Y, 2010, J MOL DIAGN, V12, P257, DOI 10.2353/jmoldx.2010.090105; Molinari F, 2011, CLIN CANCER RES, V17, P4901, DOI 10.1158/1078-0432.CCR-10-3137; Mouliere F, 2014, MOL ONCOL, V8, P927, DOI 10.1016/j.molonc.2014.02.005; Mouliere F, 2013, TRANSL ONCOL, V6, P319, DOI 10.1593/tlo.12445; Oh JE, 2010, J MOL DIAGN, V12, P418, DOI 10.2353/jmoldx.2010.090146; Okello JBA, 2010, ANAL BIOCHEM, V400, P110, DOI 10.1016/j.ab.2010.01.014; Oldenburg RP, 2008, J INVEST DERMATOL, V128, P398, DOI 10.1038/sj.jid.5700920; ORUM H, 1993, NUCLEIC ACIDS RES, V21, P5332, DOI 10.1093/nar/21.23.5332; Pekin D, 2011, LAB CHIP, V11, P2156, DOI 10.1039/c1lc20128j; Pinto P, 2011, CANCER GENET-NY, V204, P439, DOI 10.1016/j.cancergen.2011.07.003; Radstrom P, 2004, MOL BIOTECHNOL, V26, P133, DOI 10.1385/MB:26:2:133; Spindler KLG, 2014, INT J CANCER, V135, P2215, DOI 10.1002/ijc.28863; Suzuki M, 2000, J BIOL CHEM, V275, P32728, DOI 10.1074/jbc.M000097200; Taly V, 2013, CLIN CHEM, V59, P1722, DOI 10.1373/clinchem.2013.206359; Thiede C, 1996, NUCLEIC ACIDS RES, V24, P983, DOI 10.1093/nar/24.5.983; Thierry AR, 2014, NAT MED, V20, P430, DOI 10.1038/nm.3511; TINDALL KR, 1988, BIOCHEMISTRY-US, V27, P6008, DOI 10.1021/bi00416a027; Tol J, 2009, NEW ENGL J MED, V360, P563, DOI 10.1056/NEJMoa0808268; Tougeron D, 2013, ANN ONCOL, V24, P1267, DOI 10.1093/annonc/mds620; Tsiatis AC, 2010, J MOL DIAGN, V12, P425, DOI 10.2353/jmoldx.2010.090188; Van Cutsem E, 2014, ANN ONCOL, V25, P1, DOI 10.1093/annonc/mdu260; Van Cutsem E, 2007, J CLIN ONCOL, V25, P1658, DOI 10.1200/JCO.2006.08.1620; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Wilson IG, 1997, APPL ENVIRON MICROB, V63, P3741, DOI 10.1128/AEM.63.10.3741-3751.1997; Yang XD, 1999, CANCER RES, V59, P1236; You Y, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl175; Zheng G, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1811-y	70	4	5	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145698	10.1371/journal.pone.0145698	http://dx.doi.org/10.1371/journal.pone.0145698			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26701781	Green Submitted, Green Published, gold			2022-12-26	WOS:000367092600119
J	Lim, SY; Chan, CEZ; Lisowska, MM; Hanson, BJ; MacAry, PA				Lim, She Yah; Chan, Conrad E. Z.; Lisowska, Malgorzata M.; Hanson, Brendon J.; MacAry, Paul A.			The Molecular Engineering of an Anti-Idiotypic Antibody for Pharmacokinetic Analysis of a Fully Human Anti-Infective	PLOS ONE			English	Article							DISPLAY	Anti-idiotype monoclonal antibodies represent a class of reagents that are potentially optimal for analyzing the pharmacokinetics of fully human, anti-infective antibodies that have been developed as therapeutic candidates. This is particularly important where direct pathogen binding assays are complicated by requirements for biosafety level III or IV for pathogen handling. In this study, we describe the development of a recombinant, anti-idiotype monoclonal antibody termed E1 for the detection of a fully human, serotype-specific, therapeutic antibody candidate for the BSLIII pathogen Dengue virus termed 14c10 hG1. E1 was generated by naive human Fab phage library panning technology and subsequently engineered as a monoclonal antibody. We show that E1 is highly specific for the fully-folded form of 14c10 hG1 and can be employed for the detection of this antibody in healthy human subjects' serum by enzyme linked immunosorbent assay. In addition, we show that E1 is capable of blocking the binding of 14c10 hG1 to dengue virus serotype 1. Finally, we show that E1 can detect 14c10 hG1 in mouse serum after the administration of the therapeutic antibody in vivo. E1 represents an important new form of ancillary reagent that can be utilized in the clinical development of a therapeutic human antibody candidate.	[Lim, She Yah; Lisowska, Malgorzata M.; Hanson, Brendon J.; MacAry, Paul A.] Natl Univ Singapore, Dept Microbiol, Singapore 117548, Singapore; [Lim, She Yah; Lisowska, Malgorzata M.; MacAry, Paul A.] Natl Univ Singapore, Ctr Life Sci, Program Immunol, Singapore 117548, Singapore; [Lim, She Yah] NUS Grad Sch Integrat Sci & Engn, Singapore, Singapore; [Chan, Conrad E. Z.; Hanson, Brendon J.] DSO Natl Labs, Def Med & Environm Res Inst, Singapore, Singapore	National University of Singapore; National University of Singapore; National University of Singapore	Hanson, BJ (corresponding author), Natl Univ Singapore, Dept Microbiol, Singapore 117548, Singapore.	hbrendon@dso.org.sg; paul_macary@nuhs.edu.sg		Lisowska, Malgorzata/0000-0003-4858-9312; MacAry, Paul/0000-0002-1139-8996	Biomedical Research Council-Science and Engineering Research Council [R-182-000-206-305]; National Research Foundation, Singapore [R-182-005-172-281]; National University of Singapore [R-182-000-192-133]; National Medical Research Council (STOP-Dengue TCR) [R-182-003-220-275]	Biomedical Research Council-Science and Engineering Research Council; National Research Foundation, Singapore(National Research Foundation, Singapore); National University of Singapore(National University of Singapore); National Medical Research Council (STOP-Dengue TCR)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Biomedical Research Council-Science and Engineering Research Council Grant number R-182-000-206-305 (http://www.a-star.edu.sg/About-A-STAR/Science-and-Engineering-Research-Council.aspx), National Research Foundation, Singapore Grant number R-182-005-172-281 (http://www.nrf.gov.sg/funding-grants), National University of Singapore Grant number R-182-000-192-133 (http://www.nus.edu.sg/dpr/#), and National Medical Research Council (STOP-Dengue TCR) Grant number R-182-003-220-275 (http://www.nmrc.gov.sg/content/nmrc_internet/home/grant/compgrants/tcrinfec.html). PAM received all the above funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bradbury ARM, 2004, J IMMUNOL METHODS, V290, P29, DOI 10.1016/j.jim.2004.04.007; Chan AHY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033451; de Haard HJ, 1999, J BIOL CHEM, V274, P18218, DOI 10.1074/jbc.274.26.18218; Dubel S, 2010, HDB THERAPEUTIC ANTI; FUJII K, 1989, J IMMUNOL METHODS, V124, P63; Gonzalez-Quintela A, 2008, CLIN EXP IMMUNOL, V151, P42, DOI 10.1111/j.1365-2249.2007.03545.x; Hoogenboom HR, METHODS MOL BIOL, V178; Mahmood I, 2005, CLIN PHARMACOKINET, V44, P331, DOI 10.2165/00003088-200544040-00001; Mire-Sluis AR, 2004, J IMMUNOL METHODS, V289, P1, DOI 10.1016/j.jim.2004.06.002; Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315; Pieper R, 2003, PROTEOMICS, V3, P1345, DOI 10.1002/pmic.200300449; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; Teoh EP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003888; Trang JM, 1992, PROTEIN PHARMACKINET; WINTER G, 1994, ANNU REV IMMUNOL, V12, P433, DOI 10.1146/annurev.iy.12.040194.002245; World Health Organization, 2009, DENGUE GUIDELINES DI	17	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145381	10.1371/journal.pone.0145381	http://dx.doi.org/10.1371/journal.pone.0145381			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700297	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092600072
J	Oonincx, DGAB; van Broekhoven, S; van Huis, A; van Loon, JJA				Oonincx, Dennis G. A. B.; van Broekhoven, Sarah; van Huis, Arnold; van Loon, Joop J. A.			Feed Conversion, Survival and Development, and Composition of Four Insect Species on Diets Composed of Food By-Products	PLOS ONE			English	Article							BLACK SOLDIER FLY; ACHETA-DOMESTICUS ORTHOPTERA; FATTY-ACID-COMPOSITION; MOLITOR L COLEOPTERA; HOUSE CRICKET; LINOLEIC-ACID; NUTRIENT COMPOSITION; 2 STRAINS; GROWTH; PHOSPHORUS	A large part of the environmental impact of animal production systems is due to the production of feed. Insects are suggested to efficiently convert feed to body mass and might therefore form a more sustainable food and/or feed source. Four diets were composed from by-products of food manufacturing and formulated such as to vary in protein and fat content. These were offered to newly hatched Argentinean cockroaches, black soldier flies, yellow mealworms, and house crickets. The first two species are potentially interesting as a feed ingredient, while the latter two are considered edible for humans. Feed conversion efficiency, survival, development time, as well as chemical composition (nitrogen, phosphorus, and fatty acids), were determined. The Argentinean cockroaches and the black soldier flies converted feed more efficiently than yellow mealworms, and house crickets. The first two were also more efficient than conventional production animals. On three of the four diets yellow mealworms and house crickets had a feed conversion efficiency similar to pigs. Furthermore, on the most suitable diet, they converted their feed as efficiently as poultry, when corrected for edible portion. All four species had a higher nitrogen-efficiency than conventional production animals, when corrected for edible portion. Offering carrots to yellow mealworms increased dry matter- and nitrogen-efficiency and decreased development time. Diet affected survival in all species but black soldier flies, and development time was strongly influenced in all four species. The chemical composition of Argentinean cockroaches was highly variable between diets, for black soldier flies it remained similar. The investigated species can be considered efficient production animals when suitable diets are provided. Hence, they could form a sustainable alternative to conventional production animals as a source of feed or food.	[Oonincx, Dennis G. A. B.; van Broekhoven, Sarah; van Huis, Arnold; van Loon, Joop J. A.] Wageningen Univ, Plant Sci Grp, Entomol Lab, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research	Oonincx, DGAB (corresponding author), Wageningen Univ, Plant Sci Grp, Entomol Lab, NL-6700 AP Wageningen, Netherlands.	dennisoonincx@gmail.com	; van Loon, Joop J.A./B-3744-2009	Oonincx, Dennis/0000-0002-6728-4859; van Loon, Joop J.A./0000-0002-4260-0501	Wageningen University, Wageningen, The Netherlands as part of a PhD program	Wageningen University, Wageningen, The Netherlands as part of a PhD program	This study was directly funded by Wageningen University, Wageningen, The Netherlands (www.wur.nl) as part of a PhD program. Wageningen University had no other role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, than can be expected with the academic supervision of a PhD candidate.	Allen ME, 1997, NUTR ADVISORY GROUP, V1997; Barker D, 1998, ZOO BIOL, V17, P123, DOI 10.1002/(SICI)1098-2361(1998)17:2&lt;123::AID-ZOO7&gt;3.0.CO;2-B; BLOMQUIST GJ, 1991, INSECT BIOCHEM, V21, P99, DOI 10.1016/0020-1790(91)90069-Q; BONDARI K, 1981, AQUACULTURE, V24, P103, DOI 10.1016/0044-8486(81)90047-8; Bosch G, 2014, J NUTR SCI, V3, DOI 10.1017/jns.2014.23; CLIFFORD CW, 1990, J APPL ENTOMOL, V109, P1, DOI 10.1111/j.1439-0418.1990.tb00012.x; Cohen A. C., 2003, INSECT DIETS SCI TEC; Collavo Alberto, 2005, P519; CRIPPS C, 1986, BIOCHIM BIOPHYS ACTA, V876, P572, DOI 10.1016/0005-2760(86)90046-9; de Vries M, 2010, LIVEST SCI, V128, P1, DOI 10.1016/j.livsci.2009.11.007; DERENOBALES M, 1987, TRENDS BIOCHEM SCI, V12, P364, DOI 10.1016/0968-0004(87)90167-8; Diener S, 2009, WASTE MANAGE RES, V27, P603, DOI 10.1177/0734242X09103838; Dierenfeld Ellen S., 2008, Journal of Herpetological Medicine and Surgery, V18, P100; Fast P.G., 1970, PROGR CHEM FATS OTHE, V11, P181; Finke M.D., 2013, MASS PRODUCTION BENE; Finke MD, 2002, ZOO BIOL, V21, P269, DOI 10.1002/zoo.10031; FOLCH J, 1957, J BIOL CHEM, V226, P497; FRAENKEL G, 1950, PHYSIOL ZOOL, V23, P92, DOI 10.1086/physzool.23.2.30152067; FRIEND WG, 1958, ANNU REV ENTOMOL, V3, P57, DOI 10.1146/annurev.en.03.010158.000421; Frost PC, 2002, ECOL LETT, V5, P232, DOI 10.1046/j.1461-0248.2002.00307.x; FURMAN DP, 1959, J ECON ENTOMOL, V52, P917, DOI 10.1093/jee/52.5.917; Ghaly A.E., 2009, American Journal of Agricultural and Biological Sciences, V4, P319; Gobbi P, 2013, EUR J ENTOMOL, V110, P461, DOI 10.14411/eje.2013.061; HACKSTEIN JHP, 1994, P NATL ACAD SCI USA, V91, P5441, DOI 10.1073/pnas.91.12.5441; HALE O M, 1973, Journal of the Georgia Entomological Society, V8, P16; Hanboonsong Y., 2013, 6 LEGGED LIVESTOCK E; Herrero M, 2013, P NATL ACAD SCI USA, V110, P20878, DOI 10.1073/pnas.1321844111; Herrero M, 2013, P NATL ACAD SCI USA, V110, P20888, DOI 10.1073/pnas.1308149110; HOUSE HL, 1961, ANNU REV ENTOMOL, V6, P13, DOI 10.1146/annurev.en.06.010161.000305; Howard RW, 1996, COMP BIOCHEM PHYS B, V115, P429, DOI 10.1016/S0305-0491(96)00161-7; Kouba M, 2011, BIOCHIMIE, V93, P13, DOI 10.1016/j.biochi.2010.02.027; Li Q, 2011, WASTE MANAGE, V31, P1316, DOI 10.1016/j.wasman.2011.01.005; Liu KY, 2011, J VIROL, V85, P10069, DOI 10.1128/JVI.00625-11; Lundy ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118785; McFARLANE J. E., 1959, CANADIAN JOUR ZOOL, V37, P913, DOI 10.1139/z59-088; MCFARLANE JE, 1962, CAN J ZOOLOG, V40, P559, DOI 10.1139/z62-048; MULLINS DE, 1975, COMP BIOCHEM PHYSIOL, V50, P489, DOI 10.1016/0300-9629(75)90306-0; MURRAY DRP, 1960, J INSECT PHYSIOL, V4, P80, DOI 10.1016/0022-1910(60)90069-X; NAKAGAKI BJ, 1991, J ECON ENTOMOL, V84, P891, DOI 10.1093/jee/84.3.891; NAKAGAKI BJ, 1987, POULTRY SCI, V66, P1367, DOI 10.3382/ps.0661367; Newton G. L, 2005, BLACK SOLDIER FLY HE; Newton G.L., 2005, USING BLACK SOLDIER; NEWTON GL, 1977, J ANIM SCI, V44, P395, DOI 10.2527/jas1977.443395x; NOVOZAMSKY I, 1984, NETH J AGR SCI, V32, P322; Oonincx D, 2015, J INSECTS FOOD FEED, P1; Oonincx DGAB, 2011, ZOO BIOL, V30, P9, DOI 10.1002/zoo.20308; Oonincx DGAB, 2010, COMP BIOCHEM PHYS B, V156, P122, DOI 10.1016/j.cbpb.2010.02.008; Oonincx DGAB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051145; Oonincx DGAB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014445; Patton C.J., 2003, METHODS ANAL US GEOL; PATTON RL, 1978, ANN ENTOMOL SOC AM, V71, P40, DOI 10.1093/aesa/71.1.40; PATTON RL, 1967, ANN ENTOMOL SOC AM, V60, P1238, DOI 10.1093/aesa/60.6.1238; Perkins MC, 2004, ARCH INSECT BIOCHEM, V55, P153, DOI 10.1002/arch.10133; Pham HT, 2013, GENOME ANNOUNCEMENTS, V1, DOI [10.1128/genomeA.00914-13, DOI 10.1128/GEN0MEA.00914-13]; Raes K, 2001, ANIM SCI, V73, P253, DOI 10.1017/S1357729800058227; Ramos-Elorduy J, 2008, ECOL FOOD NUTR, V47, P280, DOI 10.1080/03670240701805074; Rowland AP, 1997, J ENVIRON QUAL, V26, P410, DOI 10.2134/jeq1997.00472425002600020011x; SCRIBER JM, 1981, ANNU REV ENTOMOL, V26, P183, DOI 10.1146/annurev.en.26.010181.001151; Sealey WM, 2011, J WORLD AQUACULT SOC, V42, P34, DOI 10.1111/j.1749-7345.2010.00441.x; SHEPPARD DC, 1994, BIORESOURCE TECHNOL, V50, P275, DOI 10.1016/0960-8524(94)90102-3; St-Hilaire S, 2007, J WORLD AQUACULT SOC, V38, P309, DOI 10.1111/j.1749-7345.2007.00101.x; Steinfeld H., 2006, Livestock's long shadow: environmental issues and options; Steinfeld H., 2012, EXPL WORKSH SUST PRO; Szelei J, 2011, J INVERTEBR PATHOL, V106, P394, DOI 10.1016/j.jip.2010.12.009; Tzompa-Sosa DA, 2014, FOOD RES INT, V62, P1087, DOI 10.1016/j.foodres.2014.05.052; URS KCD, 1973, J STORED PROD RES, V8, P291, DOI 10.1016/0022-474X(73)90045-3; URS KCD, 1973, J STORED PROD RES, V8, P299, DOI 10.1016/0022-474X(73)90046-5; van Broekhoven S, 2015, J INSECT PHYSIOL, V73, P1, DOI 10.1016/j.jinsphys.2014.12.005; Visanuvimol L, 2010, ECOL ENTOMOL, V35, P386, DOI 10.1111/j.1365-2311.2010.01195.x; Waldbauer G. P., 1968, P229, DOI 10.1016/S0065-2806(08)60230-1; Wilkinson JM, 2011, ANIMAL, V5, P1014, DOI 10.1017/S175173111100005X; WOODRING JP, 1977, J INSECT PHYSIOL, V23, P207, DOI 10.1016/0022-1910(77)90031-2; WOODRING JP, 1979, J INSECT PHYSIOL, V25, P903, DOI 10.1016/0022-1910(79)90102-1; Yi LY, 2013, FOOD CHEM, V141, P3341, DOI 10.1016/j.foodchem.2013.05.115	74	394	399	16	285	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0144601	10.1371/journal.pone.0144601	http://dx.doi.org/10.1371/journal.pone.0144601			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26699129	Green Published, gold			2022-12-26	WOS:000367092600025
J	Brohus, M; Gorbunova, V; Faulkes, CG; Overgaard, MT; Conover, CA				Brohus, Malene; Gorbunova, Vera; Faulkes, Chris G.; Overgaard, Michael T.; Conover, Cheryl A.			The Insulin-Like Growth Factor System in the Long-Lived Naked Mole-Rat	PLOS ONE			English	Article							PLASMA-PROTEIN-A; FACTOR RECEPTOR; PAPP-A; BINDING PROTEINS; CLEAVAGE SITE; IGF; EXPRESSION; LONGEVITY; INSIGHTS; CANCER	Naked mole-rats (Heterocephalus glaber) (NMRs) are the longest living rodents known. They show negligible senescence, and are resistant to cancers and certain damaging effects associated with aging. The insulin-like growth factors (IGFs) have pluripotent actions, influencing growth processes in virtually every system of the body. They are established contributors to the aging process, confirmed by the demonstration that decreased IGF signaling results in life-extending effects in a variety of species. The IGFs are likewise involved in progression of cancers by mediating survival signals in malignant cells. This report presents a full characterization of the IGF system in the NMR: ligands, receptors, IGF binding proteins (IGFBPs), and IGFBP proteases. A particular emphasis was placed on the IGFBP protease, pregnancy-associated plasma protein-A (PAPP-A), shown to be an important lifespan modulator in mice. Comparisons of IGF-related genes in the NMR with human and murine sequences indicated no major differences in essential parts of the IGF system, including PAPP-A. The protease was shown to possess an intact active site despite the report of a contradictory genome sequence. Furthermore, PAPP-A was expressed and translated in NMRs cells and retained IGF-dependent proteolytic activity towards IGFBP-4 and IGF-independent activity towards IGFBP-5. However, experimental data suggest differential regulatory mechanisms for PAPP-A expression in NMRs than those described in humans and mice. This overall description of the IGF system in the NMR represents an initial step towards elucidating the complex molecular mechanisms underlying longevity, and how these animals have evolved to ensure a delayed and healthy aging process.	[Brohus, Malene; Conover, Cheryl A.] Mayo Clin, Div Endocrinol, Rochester, MN 55905 USA; [Gorbunova, Vera] Univ Rochester, Dept Biol, Rochester, NY 14627 USA; [Faulkes, Chris G.] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England; [Brohus, Malene; Overgaard, Michael T.] Aalborg Univ, Dept Chem & Biosci, DK-9220 Aalborg Oe, Denmark	Mayo Clinic; University of Rochester; University of London; Queen Mary University London; Aalborg University	Conover, CA (corresponding author), Mayo Clin, Div Endocrinol, 200 First St SW, Rochester, MN 55905 USA.	Conover.Cheryl@mayo.edu	Overgaard, Michael Toft/E-1354-2011; Faulkes, Chris/O-8101-2019	Overgaard, Michael Toft/0000-0002-1423-2481; Gorbunova, Vera/0000-0001-8979-0333; Faulkes, Christopher/0000-0002-5228-9075	NATIONAL INSTITUTE ON AGING [P01AG047200] Funding Source: NIH RePORTER; NIA NIH HHS [P01 AG047200] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adams TE, 2000, CELL MOL LIFE SCI, V57, P1050, DOI 10.1007/PL00000744; Anisimov VN, 2011, CELL CYCLE, V10, P4230, DOI 10.4161/cc.10.24.18486; Austad SN, 2010, J COMP PATHOL, V141, pS10, DOI 10.1016/j.jcpa.2009.10.024; Azpurua J, 2013, AGING-US, V5, P304, DOI 10.18632/aging.100552; Bach LA, 2005, TRENDS ENDOCRIN MET, V16, P228, DOI 10.1016/j.tem.2005.05.005; Baxter RC, 2000, AM J PHYSIOL-ENDOC M, V278, pE967, DOI 10.1152/ajpendo.2000.278.6.E967; Boldt HB, 2004, J BIOL CHEM, V279, P38525, DOI 10.1074/jbc.M405222200; Boldt HB, 2001, BIOCHEM J, V358, P359, DOI 10.1042/0264-6021:3580359; Boldt HB, 2007, GROWTH HORM IGF RES, V17, P10, DOI 10.1016/j.ghir.2006.11.003; Brown J, 2008, EMBO J, V27, P265, DOI 10.1038/sj.emboj.7601938; Buffenstein R, 2005, J GERONTOL A-BIOL, V60, P1369, DOI 10.1093/gerona/60.11.1369; Buffenstein R, 2008, J COMP PHYSIOL B, V178, P439, DOI 10.1007/s00360-007-0237-5; Byun D, 2000, J CLIN ENDOCR METAB, V85, P373, DOI 10.1210/jc.85.1.373; Cohen P, 2006, HORM RES, V65, P3, DOI 10.1159/000090640; Conover CA, 2006, AM J PHYSIOL-CELL PH, V290, pC183, DOI 10.1152/ajpcell.00199.2005; Conover CA, 2004, BONE, V34, P297, DOI 10.1016/j.bone.2003.10.011; CONOVER CA, 1995, J BIOL CHEM, V270, P4395, DOI 10.1074/jbc.270.9.4395; Conover CA, 2010, J GERONTOL A-BIOL, V65, P590, DOI 10.1093/gerona/glq032; Davidge-Pitts C, 2014, J ENDOCRINOL, V222, P87, DOI 10.1530/JOE-13-0610; Davies KTJ, 2014, GENE, V549, P228, DOI 10.1016/j.gene.2014.07.061; Delaney MA, 2013, VET PATHOL, V50, P607, DOI 10.1177/0300985812471543; Denley A, 2005, CYTOKINE GROWTH F R, V16, P421, DOI 10.1016/j.cytogfr.2005.04.004; Edrey YH, 2011, ILAR J, V52, P41, DOI 10.1093/ilar.52.1.41; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Gorbunova V, 2014, NAT REV GENET, V15, P531, DOI 10.1038/nrg3728; Harstad SL, 2014, EXP GERONTOL, V57, P13, DOI 10.1016/j.exger.2014.04.011; Hwa V, 1999, ENDOCR REV, V20, P761, DOI 10.1210/er.20.6.761; Katic M, 2005, CELL MOL LIFE SCI, V62, P320, DOI 10.1007/s00018-004-4297-y; Keane M, 2014, BIOINFORMATICS, V30, P3558, DOI 10.1093/bioinformatics/btu579; Kenyon C, 2001, CELL, V105, P165, DOI 10.1016/S0092-8674(01)00306-3; Keyhanfar M, 2007, BIOCHEM J, V401, P269, DOI 10.1042/BJ20060890; Kim EB, 2011, NATURE, V479, P223, DOI 10.1038/nature10533; Laursen LS, 2001, FEBS LETT, V504, P36, DOI 10.1016/S0014-5793(01)02760-0; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Monget P, 2003, BIOL REPROD, V68, P77, DOI 10.1095/biolreprod.102.007609; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Resch ZT, 2004, ENDOCRINOLOGY, V145, P1124, DOI 10.1210/en.2003-1313; Sitar T, 2006, P NATL ACAD SCI USA, V103, P13028, DOI 10.1073/pnas.0605652103; Tian X, 2013, NATURE, V499, P346, DOI 10.1038/nature12234; Whittaker J, 2001, J BIOL CHEM, V276, P43980, DOI 10.1074/jbc.M102863200	41	11	11	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145587	10.1371/journal.pone.0145587	http://dx.doi.org/10.1371/journal.pone.0145587			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26694858	Green Published, gold, Green Submitted			2022-12-26	WOS:000367092500060
J	Kavaliunas, A; Wiberg, M; Tinghog, P; Glaser, A; Gyllensten, H; Alexanderson, K; Hillert, J				Kavaliunas, Andrius; Wiberg, Michael; Tinghog, Petter; Glaser, Anna; Gyllensten, Hanna; Alexanderson, Kristina; Hillert, Jan			Earnings and Financial Compensation from Social Security Systems Correlate Strongly with Disability for Multiple Sclerosis Patients	PLOS ONE			English	Article							HISTORICAL PROSPECTIVE COHORT; OF-THE-LITERATURE; ECONOMIC BURDEN; CONSEQUENCES; POPULATION; PENSION; COST	Background Multiple sclerosis (MS) patients earn lower incomes and receive higher benefits. However, there is limited knowledge of how this is correlated with their disability. Objective To elucidate sources and levels of income among MS patients with different disability, assessed with the Expanded Disability Status Scale. Methods A total of 7929 MS patients aged 21-64 years and living in Sweden in 2010 were identified for this cross-sectional study. Descriptive statistics, logistic and truncated linear regression models were used to estimate differences between MS patients regarding earnings, disability pension, sickness absence, disability allowance, unemployment compensation, and social assistance. Results The average level of earnings was ten times lower and the average level of health-related benefits was four times higher when comparing MS patients with severe and mild disability. MS patients with severe disability had on average SEK 166,931 less annual income from earnings and SEK 54,534 more income from benefits compared to those with mild disability. The combined average income for MS patients was 35% lower when comparing patients in the same groups. The adjusted risk ratio for having earnings among MS patients with severe disability compared to the patients with mild disability was 0.33 (95% CI 0.29-0.39), while the risk ratio for having benefits was 1.93 (95% CI 1.90-1.94). Conclusions Disease progression affects the financial situation of MS patients considerably. Correlations between higher disability and patient income were observed, suggesting that earnings and benefits could be used as measures of MS progression and proxies of disability.	[Kavaliunas, Andrius; Wiberg, Michael; Tinghog, Petter; Glaser, Anna; Gyllensten, Hanna; Alexanderson, Kristina; Hillert, Jan] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Wiberg, Michael] Swedish Social Insurance Agcy, Dept Anal & Prognosis, Stockholm, Sweden; [Tinghog, Petter] Red Cross Univ Coll, Stockholm, Sweden	Karolinska Institutet	Kavaliunas, A (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.	andrius.kavaliunas@ki.se	Kavaliunas, Andrius/GVS-3565-2022; Gyllensten, Hanna/H-7378-2016	Gyllensten, Hanna/0000-0001-6890-5162; Kavaliunas, Andrius/0000-0003-3896-7332	Biogen	Biogen(Biogen)	This study was financially supported by Biogen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman Gabriel, 2013, J Med Econ, V16, P639, DOI 10.3111/13696998.2013.778268; Berg Jenny, 2006, Eur J Health Econ, V7 Suppl 2, pS75; Confavreux C, 2014, HAND CLINIC, V122, P343, DOI 10.1016/B978-0-444-52001-2.00014-5; Dusankova JB, 2012, MULT SCLER J, V18, P662, DOI 10.1177/1352458511424422; Dutta R, 2007, NEUROLOGY, V68, pS22, DOI 10.1212/01.wnl.0000275229.13012.32; Hillert J, 2015, ACTA NEUROL SCAND, V132, P11, DOI 10.1111/ane.12425; Jennum P, 2012, EUR NEUROPSYCHOPHARM, V22, P36, DOI 10.1016/j.euroneuro.2011.05.001; Julian LJ, 2008, J NEUROL, V255, P1354, DOI 10.1007/s00415-008-0910-y; Kobelt G, 2006, J NEUROL NEUROSUR PS, V77, P918, DOI 10.1136/jnnp.2006.090365; Kobelt Gisela, 2006, Eur J Health Econ, V7 Suppl 2, pS24; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lindholm C, 2001, SCAND J PUBLIC HEALT, V29, P63, DOI 10.1177/14034948010290011201; Naci H, 2010, PHARMACOECONOMICS, V28, P363, DOI 10.2165/11532230-000000000-00000; Pfleger CCH, 2010, EUR J NEUROL, V17, P1346, DOI 10.1111/j.1468-1331.2010.03020.x; Pfleger CCH, 2010, MULT SCLER, V16, P121, DOI 10.1177/1352458509352196; Reese JP, 2011, EUR NEUROL, V66, P311, DOI 10.1159/000331043; Sainani KL, 2011, PM&R, V3, P263, DOI 10.1016/j.pmrj.2011.01.009; Tinghog P, 2013, MULT SCLER J, V19, P1923, DOI 10.1177/1352458513488234; Wiberg M, 2015, MULT SCLER J, V21, P1730, DOI 10.1177/1352458515570767; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	20	29	29	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145435	10.1371/journal.pone.0145435	http://dx.doi.org/10.1371/journal.pone.0145435			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26695832	Green Published, gold			2022-12-26	WOS:000367092500047
J	Li, XL; Shi, HQ; Xu, WF; Liu, W; Wang, XJ; Hou, LY; Feng, F; Yuan, WP; Li, LH; Xu, H				Li, Xianglan; Shi, Huiqiu; Xu, Wenfang; Liu, Wei; Wang, Xiujun; Hou, Longyu; Feng, Fei; Yuan, Wenping; Li, Linghao; Xu, Hua			Seasonal and Spatial Variations of Bulk Nitrogen Deposition and the Impacts on the Carbon Cycle in the Arid/Semiarid Grassland of Inner Mongolia, China	PLOS ONE			English	Article							TIME-SERIES DATASET; WET DEPOSITION; N DEPOSITION; ECOSYSTEMS; FORESTS; INCREASE; FLUXES; AGROECOSYSTEMS; ENVIRONMENT; LIMITATION	Atmospheric nitrogen (N) deposition is an important component that affects the structure and function of different terrestrial ecosystem worldwide. However, much uncertainty still remains concerning the magnitude of N deposition on grassland ecosystem in China. To study the spatial and temporal patterns of bulk N deposition, the levels of N (NH4+-N and NO3--N) concentration in rainfall were measured at 12 sites across a 1200 km grassland transect in Inner Mongolia, China, and the respective N deposition rates were estimated. The inorganic N deposition rates ranged from 4.53 kg N ha(-1) to 12.21 kg N ha(-1) with a mean value of 8.07 kg N ha(-1) during the entire growing season, decreasing steadily from the eastern to the western regions. Inorganic N deposition occurred mainly in July and August across meadow steppe, typical steppe, and desert steppe, which corresponded to the seasonal distribution of mean annual precipitation. A positive relationship was found between inorganic N deposition and mean annual precipitation (R-2 = 0.54 similar to 0.72, P < 0.0001) across the grassland transect. Annual estimation of inorganic N deposition was 0.67 Pg yr(-1) in Inner Mongolia, China based on the correlation between N deposition rates and precipitation. N deposition was an important factor controlling aboveground biomass and ecosystem respiration, but has no effect on root biomass and soil respiration. We must clarify that we used the bulk deposition samplers during the entire sampling process and estimated the dissolved NH4+-N and NO3--N deposition rates during the entire growing season. Long-term N deposition monitoring networks should be constructed to study the patterns of N deposition and its potential effect on grassland ecosystem, considering various N species, i.e., gaseous N, particle N, and wet N deposition.	[Li, Xianglan; Xu, Hua] Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China; [Li, Xianglan; Wang, Xiujun; Feng, Fei] Beijing Normal Univ, Coll Global Change & Earth Syst Sci, Beijing 100875, Peoples R China; [Li, Xianglan; Wang, Xiujun; Feng, Fei] Joint Ctr Global Change Studies, Beijing, Peoples R China; [Shi, Huiqiu; Liu, Wei; Hou, Longyu; Li, Linghao] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Shi, Huiqiu; Xu, Wenfang; Liu, Wei] Univ Chinese Acad Sci, Beijing, Peoples R China; [Xu, Wenfang] Chinese Acad Sci, State Key Lab Cryospher Sci, Cold & Arid Reg Environm & Engn Res Inst, Lanzhou, Gansu, Peoples R China; [Wang, Xiujun] Univ Maryland, Earth Syst Sci Interdisciplinary Ctr, College Pk, MD 20742 USA; [Yuan, Wenping] Beijing Normal Univ, State Key Lab Earth Surface Proc & Resource Ecol, Beijing 100875, Peoples R China	Chinese Academy of Sciences; Institute of Soil Science, CAS; Beijing Normal University; Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Cold & Arid Regions Environmental & Engineering Research Institute, CAS; University System of Maryland; University of Maryland College Park; Beijing Normal University	Yuan, WP (corresponding author), Beijing Normal Univ, State Key Lab Earth Surface Proc & Resource Ecol, Beijing 100875, Peoples R China.	yuanwpcn@126.com; llinghao@ibcas.ac.cn; hxu@issas.ac.cn	Wang, Xiujun/F-2641-2010	Wang, Xiujun/0000-0002-2859-8011; Xu, Wenfang/0000-0002-2883-2760; Hou, Longyu/0000-0003-1221-4586	National Sciences Foundation of China [31130008, 41205104]; Ministry of Science and Technology of China [2010CB833502]; Fundamental Research Funds for Central Universities	National Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Fundamental Research Funds for Central Universities(Fundamental Research Funds for the Central Universities)	Funding for this work was provided by the National Sciences Foundation of China (Grant No. 31130008 and 41205104) and the Ministry of Science and Technology of China (2010CB833502). This work was also supported by the Fundamental Research Funds for the Central Universities.	Aber JD, 2003, BIOSCIENCE, V53, P375, DOI 10.1641/0006-3568(2003)053[0375:INDATN]2.0.CO;2; Ambus P, 2006, BIOGEOCHEMISTRY, V79, P315, DOI 10.1007/s10533-005-5313-x; Anderson KA, 2006, WATER AIR SOIL POLL, V176, P351, DOI 10.1007/s11270-006-9172-4; Bai YF, 2004, NATURE, V431, P181, DOI 10.1038/nature02850; Bai YF, 2010, GLOBAL CHANGE BIOL, V16, P358, DOI 10.1111/j.1365-2486.2009.01950.x; Bowden RD, 2000, J ENVIRON QUAL, V29, P268, DOI 10.2134/jeq2000.00472425002900010034x; BRUMME R, 1992, J GEOPHYS RES-ATMOS, V97, P12851, DOI 10.1029/92JD01217; DISE NB, 1995, FOREST ECOL MANAG, V71, P153, DOI 10.1016/0378-1127(94)06092-W; Du E, 2014, ATMOS ENVIRON, V98, P474, DOI 10.1016/j.atmosenv.2014.09.005; Du EZ, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/9/095004; Fang HJ, 2012, PLANT SOIL, V351, P177, DOI 10.1007/s11104-011-0942-4; Fenn ME, 1998, ECOL APPL, V8, P706, DOI 10.1890/1051-0761(1998)008[0706:NEINAE]2.0.CO;2; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; GALLOWAY JN, 1995, GLOBAL BIOGEOCHEM CY, V9, P235, DOI 10.1029/95GB00158; Galy-Lacaux C, 2009, ATMOS CHEM PHYS, V9, P1579, DOI 10.5194/acp-9-1579-2009; He CE, 2007, AGR ECOSYST ENVIRON, V121, P395, DOI 10.1016/j.agee.2006.12.016; Jia Y.L., 2014, SCI REP-UK, V4, P3763, DOI [10.1038/srep03763, DOI 10.1038/srep03763]; Jiang CM, 2010, ATMOS ENVIRON, V44, P2920, DOI 10.1016/j.atmosenv.2010.03.030; Knapp AK, 2001, ECOSYSTEMS, V4, P19, DOI 10.1007/s100210000057; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; Li JZ, 2011, PLANT SOIL, V340, P253, DOI 10.1007/s11104-010-0612-y; Liu J, 2010, FIELD CROP RES, V118, P145, DOI 10.1016/j.fcr.2010.05.003; Liu XJ, 2006, AGR ECOSYST ENVIRON, V113, P370, DOI 10.1016/j.agee.2005.11.002; Liu XJ, 2015, SCI TOTAL ENVIRON, V520, P300, DOI 10.1016/j.scitotenv.2015.03.004; Liu XJ, 2011, ENVIRON POLLUT, V159, P2251, DOI 10.1016/j.envpol.2010.08.002; Liu XJ, 2010, J ARID LAND, V2, P137, DOI 10.3724/SP.J.1227.2010.00137; Lu CQ, 2015, ATMOS ENVIRON, V101, P352, DOI 10.1016/j.atmosenv.2014.11.032; Lu CQ, 2014, ATMOS ENVIRON, V97, P68, DOI 10.1016/j.atmosenv.2014.07.061; Lu CQ, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007990; Mo JM, 2006, PLANT SOIL, V282, P135, DOI 10.1007/s11104-005-5446-7; Neff JC, 2002, BIOGEOCHEMISTRY, V57, P99, DOI 10.1023/A:1015791622742; Pan YP, 2012, ATMOS CHEM PHYS, V12, P6515, DOI 10.5194/acp-12-6515-2012; Pan YP, 2015, ATMOS ENVIRON, V101, P350, DOI 10.1016/j.atmosenv.2014.10.062; RAM J, 1991, J RANGE MANAGE, V44, P140, DOI 10.2307/4002312; Sheng WP, 2013, ENVIRON MONIT ASSESS, V185, P833, DOI 10.1007/s10661-012-2594-0; Tang XL, 2006, GLOBAL CHANGE BIOL, V12, P546, DOI 10.1111/j.1365-2486.2006.01109.x; Templer PH, 2012, FRONT ECOL ENVIRON, V10, P547, DOI 10.1890/120055; TILMAN D, 1991, ECOLOGY, V72, P1038, DOI 10.2307/1940604; Townsend AR, 1996, ECOL APPL, V6, P806, DOI 10.2307/2269486; Wei CZ, 2013, GLOBAL CHANGE BIOL, V19, P3688, DOI 10.1111/gcb.12348; Xia JY, 2009, GLOBAL CHANGE BIOL, V15, P1544, DOI 10.1111/j.1365-2486.2008.01807.x; [张国忠 Zhang Guozhong], 2015, [环境科学研究, Research of Environmental Sciences], V28, P684; Zhang Y, 2008, ATMOS ENVIRON, V42, P1436, DOI 10.1016/j.atmosenv.2007.11.002; Zhang Y, 2012, ATMOS ENVIRON, V46, P195, DOI 10.1016/j.atmosenv.2011.09.080; Zhao X, 2009, WATER AIR SOIL POLL, V203, P277, DOI 10.1007/s11270-009-0011-2; Zhu JX, 2015, SCI TOTAL ENVIRON, V511, P777, DOI 10.1016/j.scitotenv.2014.12.038	47	17	19	3	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0144689	10.1371/journal.pone.0144689	http://dx.doi.org/10.1371/journal.pone.0144689			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26695940	gold, Green Published, Green Submitted			2022-12-26	WOS:000367092500008
J	LaBarge, SA; Migdal, CW; Buckner, EH; Okuno, H; Gertsman, I; Stocks, B; Barshop, BA; Nalbandian, SR; Philp, A; McCurdy, CE; Schenk, S				LaBarge, Samuel A.; Migdal, Christopher W.; Buckner, Elisa H.; Okuno, Hiroshi; Gertsman, Ilya; Stocks, Ben; Barshop, Bruce A.; Nalbandian, Sarah R.; Philp, Andrew; McCurdy, Carrie E.; Schenk, Simon			p300 is not required for metabolic adaptation to endurance exercise training	FASEB JOURNAL			English	Article						acetyltransferase; physiology; metabolomics; mitochondria; knockout	PROTEIN LYSINE ACETYLATION; SKELETAL-MUSCLE; TRANSCRIPTION FACTOR; GENE-EXPRESSION; HISTONE MODIFICATIONS; INSULIN SENSITIVITY; SIRTUIN 1; MYOD; CBP; COACTIVATOR	The acetyltransferase, E1a-binding protein (p300), is proposed to regulate various aspects of skeletal muscle development, metabolism, and mitochondrial function, via its interaction with numerous transcriptional regulators and other proteins. Remarkably, however, the contribution of p300 to skeletal muscle function and metabolism, in vivo, is poorly understood. To address this, we used Cre-LoxP methodology to generate mice with skeletal muscle-specific knockout of E1a-binding protein (mKO). mKO mice were indistinguishable from their wild-type/floxed littermates, with no differences in lean mass, skeletal muscle structure, fiber type, respirometry flux, or metabolites of fatty acid and amino acid metabolism. Ex vivo muscle function in extensor digitorum longus and soleus muscles, including peak stress and time to fatigue, as well as in vivo running capacity were also comparable. Moreover, expected adaptations to a 20 d voluntary wheel running regime were not compromised in mKO mice. Taken together, these findings demonstrate that p300 is not required for the normal development or functioning of adult skeletal muscle, nor is it required for endurance exercise-mediated mitochondrial adaptations.	[LaBarge, Samuel A.; Migdal, Christopher W.; Buckner, Elisa H.; Okuno, Hiroshi; Nalbandian, Sarah R.; Schenk, Simon] Univ Calif San Diego, Dept Orthopaed Surg, Sch Med, 9500 Gilman Dr,MC0863, La Jolla, CA 92093 USA; [Gertsman, Ilya; Barshop, Bruce A.] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA; [Stocks, Ben; Philp, Andrew] Univ Birmingham, Sch Sport Exercise & Rehabil Sci, Edgbaston, England; [McCurdy, Carrie E.] Univ Oregon, Dept Human Physiol, Eugene, OR 97403 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Birmingham; University of Oregon	Schenk, S (corresponding author), Univ Calif San Diego, Dept Orthopaed Surg, Sch Med, 9500 Gilman Dr,MC0863, La Jolla, CA 92093 USA.	sschenk@ucsd.edu		McCurdy, Carrie/0000-0003-1177-9040; Philp, Andrew/0000-0003-3860-4136; Schenk, Simon/0000-0002-8224-3203	U.S. National Institutes of Health [R01 AG043120, R24 HD050837, P30 DK063491, P30 AR058878]; UCSD Frontiers of Innovation Scholars Program; Biotechnology and Biological Sciences Research Council [BB/L023547/1]; BBSRC [BB/L023547/1] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR058878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG043120] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSD Frontiers of Innovation Scholars Program; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors sincerely thank Shannon Bremner [Department of Orthopaedic Surgery, University of California San Diego (UCSD)] for expertise and technical assistance with muscle mechanics testing. The authors also thank the UCSD Animal Care Program Phenotyping Core for Comprehensive Lab Animals Monitoring System measurements and Dr. Jianhua Shao (Department of Pediatrics, UCSD) for use of the magnetic resonance imaging machine. This work was supported in part by U.S. National Institutes of Health Grants R01 AG043120 (National Institute on Aging), R24 HD050837 (Eunice Kennedy Shriver National Institute of Child Health and Human Development), P30 DK063491 (National Institute of Diabetes and Digestive and Kidney Diseases via a Pilot and Feasibility Award from the UCSD/University of California, Los Angeles, Los Angeles, CA, USA/Cedars-Sinai, Los Angeles, CA, USA/Salk Diabetes Research Center), P30 AR058878 to (National Institute of Arthritis and Musculoskeletal and Skin Diseases; to S.S.), a postdoctoral fellowship from the UCSD Frontiers of Innovation Scholars Program (to SAL.), and a Biotechnology and Biological Sciences Research Council Award (BB/L023547/1; to A.P.). S.A.L. and S.S. conceived and designed the experiments; SAL., C.W.M., E.H.B., H.O., B.S., S.R.N., C.E.M., and S.S. conducted experiments and contributed to data analysis presented in Figs. 1-7; I.G. and B.A.B. performed metabolomics analysis, and B.S. and A.P. analyzed data in Fig. 4; SAL., C.W.M., and S.S. prepared the figures; S.A.L. wrote the manuscript, which was edited by S.S.; and all authors reviewed the results and approved the final version of the manuscript. S.S. is associated with the Biomedical Sciences Graduate Program (School of Medicine, UCSD). The authors declare no conflicts of interest.	Aguilar V, 2007, CELL METAB, V5, P476, DOI 10.1016/j.cmet.2007.05.006; ARANY Z, 1994, CELL, V77, P799, DOI 10.1016/0092-8674(94)90127-9; Baar K, 1999, AM J PHYSIOL-CELL PH, V276, pC120, DOI 10.1152/ajpcell.1999.276.1.C120; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Canto C, 2012, PHARMACOL REV, V64, P166, DOI 10.1124/pr.110.003905; Chan HM, 2001, J CELL SCI, V114, P2363; Chicco AJ, 2014, J EXP BIOL, V217, P2947, DOI 10.1242/jeb.105916; Chleboun GS, 1997, ACTA ANAT, V159, P147; Choudhary C, 2014, NAT REV MOL CELL BIO, V15, P536, DOI 10.1038/nrm3841; Dancy BM, 2015, CHEM REV, V115, P2419, DOI 10.1021/cr500452k; Dowell P, 1997, J BIOL CHEM, V272, P33435, DOI 10.1074/jbc.272.52.33435; ECKNER R, 1994, GENE DEV, V8, P869, DOI 10.1101/gad.8.8.869; Eckner R, 1996, GENE DEV, V10, P2478, DOI 10.1101/gad.10.19.2478; Fenton TR, 2010, INT J BIOCHEM CELL B, V42, P359, DOI 10.1016/j.biocel.2009.11.022; Fenton TR, 2010, BIOCHEM BIOPH RES CO, V398, P400, DOI 10.1016/j.bbrc.2010.06.081; Gertsman I, 2014, METABOLOMICS, V10, P312, DOI 10.1007/s11306-013-0582-1; Goodman RH, 2000, GENE DEV, V14, P1553; Hatazawa Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129084; Hatazawa Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091006; Kasper LH, 2006, MOL CELL BIOL, V26, P789, DOI 10.1128/MCB.26.3.789-809.2006; Kim GW, 2011, TRENDS BIOCHEM SCI, V36, P211, DOI 10.1016/j.tibs.2010.10.001; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Lee S, 2009, NEURON, V62, P641, DOI 10.1016/j.neuron.2009.04.025; Lundby A, 2012, CELL REP, V2, P419, DOI 10.1016/j.celrep.2012.07.006; LYONS GE, 1991, DEVELOPMENT, V113, P1017; Mcgee SL, 2011, J APPL PHYSIOL, V110, P258, DOI 10.1152/japplphysiol.00979.2010; McGee SL, 2009, J PHYSIOL-LONDON, V587, P5951, DOI 10.1113/jphysiol.2009.181065; Menzies K, 2013, J MOL ENDOCRINOL, V51, pT101, DOI 10.1530/JME-13-0140; Minamoto VB, 2007, DEV MED CHILD NEUROL, V49, P907, DOI 10.1111/j.1469-8749.2007.00907.x; Nakagawa Y, 2009, CIRC RES, V105, P746, DOI 10.1161/CIRCRESAHA.109.206037; Philp A., 2014, AM J PHYSL CELL PHYS, V307, pC763; Philp A, 2011, J BIOL CHEM, V286, P30561, DOI 10.1074/jbc.M111.261685; Polesskaya A, 2000, J BIOL CHEM, V275, P34359, DOI 10.1074/jbc.M003815200; Polesskaya A, 2001, EMBO J, V20, P6816, DOI 10.1093/emboj/20.23.6816; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Puri PL, 1997, EMBO J, V16, P369, DOI 10.1093/emboj/16.2.369; Puri PL, 1997, MOL CELL, V1, P35, DOI 10.1016/S1097-2765(00)80005-2; Richardson L, 2014, NUCLEIC ACIDS RES, V42, pD835, DOI 10.1093/nar/gkt1155; Roth JF, 2003, EMBO J, V22, P5186, DOI 10.1093/emboj/cdg473; Sartorelli V, 1999, MOL CELL, V4, P725, DOI 10.1016/S1097-2765(00)80383-4; Sartorelli V, 1997, MOL CELL BIOL, V17, P1010, DOI 10.1128/MCB.17.2.1010; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; Spinazzi M, 2011, MITOCHONDRION, V11, P893, DOI 10.1016/j.mito.2011.07.006; TALMADGE RJ, 1993, J APPL PHYSIOL, V75, P2337, DOI 10.1152/jappl.1993.75.5.2337; Tsusaka T, 2014, GENES CELLS, V19, P766, DOI 10.1111/gtc.12176; Valor LM, 2013, CURR PHARM DESIGN, V19, P5051, DOI 10.2174/13816128113199990382; Verdin E, 2015, NAT REV MOL CELL BIO, V16, P258, DOI 10.1038/nrm3931; VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309; Wallberg AE, 2003, MOL CELL, V12, P1137, DOI 10.1016/S1097-2765(03)00391-5; Wang F, 2013, CELL MOL LIFE SCI, V70, P3989, DOI 10.1007/s00018-012-1254-4; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; White AT, 2013, DIABETOLOGIA, V56, P1629, DOI 10.1007/s00125-013-2912-2; White AT, 2014, AM J PHYSIOL-ENDOC M, V307, pE764, DOI 10.1152/ajpendo.00001.2014; White AT, 2012, AM J PHYSIOL-ENDOC M, V303, pE308, DOI 10.1152/ajpendo.00054.2012; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; Yuan H, 2014, ACTA PHYSIOL, V212, P283, DOI 10.1111/apha.12395; Yuan LWC, 2002, ONCOGENE, V21, P2253, DOI 10.1038/sj.onc.1205283; Yuan WC, 1996, J BIOL CHEM, V271, P9009, DOI 10.1074/jbc.271.15.9009; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	62	18	18	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2016	30	4					1623	1633		10.1096/fj.15-281741	http://dx.doi.org/10.1096/fj.15-281741			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DH2PR	26712218	Green Published			2022-12-26	WOS:000372629100023
J	Gunn, AP; Wong, BX; Johanssen, T; Griffith, JC; Masters, CL; Bush, AI; Barnham, KJ; Duce, JA; Cherny, RA				Gunn, Adam P.; Wong, Bruce X.; Johanssen, Timothy; Griffith, James C.; Masters, Colin L.; Bush, Ashley I.; Barnham, Kevin J.; Duce, James A.; Cherny, Robert A.			Amyloid- Peptide A3pE-42 Induces Lipid Peroxidation, Membrane Permeabilization, and Calcium Influx in Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; amyloid-beta (A); lipid peroxidation; oligomer; reactive oxygen species (ROS); dityrosine; pyroglutamate	PYROGLUTAMATE-A-BETA; D-ASPARTATE RECEPTORS; ALZHEIMERS-DISEASE; GLUTAMINYL CYCLASE; TRANSGENIC MICE; BEHAVIORAL DEFICITS; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; MOUSE MODEL; IN-VITRO	Pyroglutamate-modified amyloid- (pE-A) is a highly neurotoxic amyloid- (A) isoform and is enriched in the brains of individuals with Alzheimer disease compared with healthy aged controls. Pyroglutamate formation increases the rate of A oligomerization and alters the interactions of A with Cu2+ and lipids; however, a link between these properties and the toxicity of pE-A peptides has not been established. We report here that A3pE-42 has an enhanced capacity to cause lipid peroxidation in primary cortical mouse neurons compared with the full-length isoform (A(1-42)). In contrast, A(1-42) caused a significant elevation in cytosolic reactive oxygen species, whereas A3pE-42 did not. We also report that A3pE-42 preferentially associates with neuronal membranes and triggers Ca2+ influx that can be partially blocked by the N-methyl-d-aspartate receptor antagonist MK-801. A3pE-42 further caused a loss of plasma membrane integrity and remained bound to neurons at significantly higher levels than A(1-42) over extended incubations. Pyroglutamate formation was additionally found to increase the relative efficiency of A-dityrosine oligomer formation mediated by copper-redox cycling.	[Gunn, Adam P.; Wong, Bruce X.; Masters, Colin L.; Bush, Ashley I.; Barnham, Kevin J.; Duce, James A.; Cherny, Robert A.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic 3010, Australia; [Johanssen, Timothy; Bush, Ashley I.; Duce, James A.] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia; [Barnham, Kevin J.] Univ Melbourne, Dept Pharmacol & Therapeut, Melbourne, Vic 3010, Australia; [Griffith, James C.] Univ Melbourne, Dept Mat Characterisat & Fabricat Platform, Melbourne, Vic 3010, Australia; [Duce, James A.] Univ Leeds, Fac Biol Sci, Sch Biomed Sci, Leeds LS2 9JT, W Yorkshire, England	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; University of Leeds	Cherny, RA (corresponding author), Melbourne Brain Ctr, Florey Inst Neurosci & Mental Hlth, 30 Royal Parade, Parkville, Vic 3052, Australia.	rcherny@unimelb.edu.au	Gunn, Adam P/D-5437-2012; Wong, Bruce/AAY-5884-2020; Bush, Ashley I/A-1186-2007; Bush, Ashley/Y-2457-2019; Johanssen, Timothy/G-6106-2014	Gunn, Adam P/0000-0002-8181-4975; Wong, Bruce/0000-0002-1687-4138; Bush, Ashley I/0000-0001-8259-9069; Bush, Ashley/0000-0001-8259-9069; Duce, James/0000-0002-8762-2245; Masters, Colin/0000-0003-3072-7940; Johanssen, Timothy/0000-0001-6757-586X; Griffith, James/0000-0002-4911-4223	National Health and Medical Research Council (NHMRC) of Australia [628946]; Senior Research Fellowship [APP1002373]; Australia Fellowship [GNT1037234]; Operational Infrastructure Support Grant from the Victorian Government; Alzheimers Research UK [ART-SRF2011-1] Funding Source: researchfish	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Senior Research Fellowship; Australia Fellowship; Operational Infrastructure Support Grant from the Victorian Government; Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK))	This work was supported by National Health and Medical Research Council (NHMRC) of Australia Program Grant 628946 (to R. A. C., K. J. B., A. I. B., and C. L. M.), Senior Research Fellowship APP1002373 (to K. J. B.), Australia Fellowship GNT1037234 (to A. I. B.), and Operational Infrastructure Support Grant from the Victorian Government (to Florey Institute of Neuroscience and Mental Health). The authors declare that they have no conflicts of interest with the contents of this article.	Adlard PA, 2008, NEURON, V59, P43, DOI 10.1016/j.neuron.2008.06.018; Al-Hilaly YK, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-83; Alexandru A, 2011, J NEUROSCI, V31, P12790, DOI 10.1523/JNEUROSCI.1794-11.2011; Alies B, 2012, INORG CHEM, V51, P12988, DOI 10.1021/ic302097d; Ansari MA, 2010, J NEUROPATH EXP NEUR, V69, P155, DOI 10.1097/NEN.0b013e3181cb5af4; Atwood CS, 2004, BIOCHEMISTRY-US, V43, P560, DOI 10.1021/bi0358824; Barnham KJ, 2004, FASEB J, V18, P1427, DOI 10.1096/fj.04-1890fje; Barnham KJ, 2003, J BIOL CHEM, V278, P42959, DOI 10.1074/jbc.M305494200; Bien J, 2012, J BIOL CHEM, V287, P33304, DOI 10.1074/jbc.M112.395608; BOTTOMLEY GA, 1994, AUST J CHEM, V47, P143, DOI 10.1071/CH9940143; Bouter Y, 2013, ACTA NEUROPATHOL, V126, P189, DOI 10.1007/s00401-013-1129-2; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Cynis H, 2008, BIOCHEMISTRY-US, V47, P7405, DOI 10.1021/bi800250p; Cynis H, 2006, BBA-PROTEINS PROTEOM, V1764, P1618, DOI 10.1016/j.bbapap.2006.08.003; D'Arrigo C, 2009, BIOPOLYMERS, V91, P861, DOI 10.1002/bip.21271; De Kimpe L, 2013, AGE, V35, P673, DOI 10.1007/s11357-012-9403-0; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Drew SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015875; Duce JA, 2010, PROG NEUROBIOL, V92, P1, DOI 10.1016/j.pneurobio.2010.04.003; Ferreira IL, 2012, CELL CALCIUM, V51, P95, DOI 10.1016/j.ceca.2011.11.008; Gabbita SP, 1998, J NEUROCHEM, V71, P2034, DOI 10.1046/j.1471-4159.1998.71052034.x; Galante D, 2012, INT J BIOCHEM CELL B, V44, P2085, DOI 10.1016/j.biocel.2012.08.010; Ghosh D, 2012, J NEUROSCI, V32, P5821, DOI 10.1523/JNEUROSCI.6192-11.2012; Gillman AL, 2014, J PHYS CHEM B, V118, P7335, DOI 10.1021/jp5040954; Greilberger J, 2008, FREE RADICAL RES, V42, P633, DOI 10.1080/10715760802255764; Guntert A, 2006, NEUROSCIENCE, V143, P461, DOI 10.1016/j.neuroscience.2006.08.027; Guilloreau L, 2007, CHEMBIOCHEM, V8, P1317, DOI 10.1002/cbic.200700111; Gunn AP, 2012, METHODS MOL BIOL, V849, P3, DOI 10.1007/978-1-61779-551-0_1; Harigaya Y, 2000, BIOCHEM BIOPH RES CO, V276, P422, DOI 10.1006/bbrc.2000.3490; He WL, 1999, BIOCHEMISTRY-US, V38, P10871, DOI 10.1021/bi990563r; Hensley K, 1998, J NEUROSCI, V18, P8126; Hook G, 2014, J ALZHEIMERS DIS, V41, P129, DOI 10.3233/JAD-131370; Kowalik-Jankowska T, 2004, J INORG BIOCHEM, V98, P940, DOI 10.1016/j.jinorgbio.2004.03.001; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lee J, 2014, BIOCHEMISTRY-US, V53, P4704, DOI 10.1021/bi500587p; Mandler M, 2014, ACTA NEUROPATHOL, V128, P67, DOI 10.1007/s00401-014-1296-9; Manevich Y, 1997, RADIAT RES, V148, P580, DOI 10.2307/3579734; Mark RJ, 1997, J NEUROCHEM, V68, P255; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Mccoll G, 2009, J BIOL CHEM, V284, P22697, DOI 10.1074/jbc.C109.028514; Morawski M, 2014, J ALZHEIMERS DIS, V39, P385, DOI 10.3233/JAD-131535; Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759; Nussbaum JM, 2012, NATURE, V485, P651, DOI 10.1038/nature11060; Oberstein TJ, 2015, NEUROBIOL DIS, V73, P24, DOI 10.1016/j.nbd.2014.08.031; Opazo C, 2002, J BIOL CHEM, V277, P40302, DOI 10.1074/jbc.M206428200; Piccini A, 2005, J BIOL CHEM, V280, P34186, DOI 10.1074/jbc.M501694200; Portelius E, 2015, NEURODEGENER DIS, V15, P50, DOI 10.1159/000369465; Portelius E, 2010, ACTA NEUROPATHOL, V120, P185, DOI 10.1007/s00401-010-0690-1; Russo C, 2002, J NEUROCHEM, V82, P1480, DOI 10.1046/j.1471-4159.2002.01107.x; SAIDO TC, 1995, NEURON, V14, P457, DOI 10.1016/0896-6273(95)90301-1; Sanders HM, 2009, PEPTIDES, V30, P849, DOI 10.1016/j.peptides.2009.01.027; Sayre LM, 1997, J NEUROCHEM, V68, P2092; Schilling S, 2004, FEBS LETT, V563, P191, DOI 10.1016/S0014-5793(04)00300-X; Schilling S, 2008, NAT MED, V14, P1106, DOI 10.1038/nm.1872; Schilling S, 2006, BIOCHEMISTRY-US, V45, P12393, DOI 10.1021/bi0612667; Schlenzig D, 2012, J NEUROCHEM, V121, P774, DOI 10.1111/j.1471-4159.2012.07707.x; Schlenzig D, 2009, BIOCHEMISTRY-US, V48, P7072, DOI 10.1021/bi900818a; Shirotani K, 2002, NEUROSCI LETT, V327, P25, DOI 10.1016/S0304-3940(02)00351-8; Smith DP, 2006, J BIOL CHEM, V281, P15145, DOI 10.1074/jbc.M600417200; Sullivan CP, 2011, NEUROSCI LETT, V505, P109, DOI 10.1016/j.neulet.2011.09.071; Sun N, 2012, J PEPT SCI, V18, P691, DOI 10.1002/psc.2456; Swomley AM, 2014, BBA-MOL BASIS DIS, V1842, P1248, DOI 10.1016/j.bbadis.2013.09.015; Tabner BJ, 2005, J BIOL CHEM, V280, P35789, DOI 10.1074/jbc.C500238200; Takahashi M, 2001, FREE RADICAL BIO MED, V31, P164, DOI 10.1016/S0891-5849(01)00575-5; Tekirian TL, 1999, J NEUROCHEM, V73, P1584, DOI 10.1046/j.1471-4159.1999.0731584.x; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Watt AD, 2014, ACTA NEUROPATHOL, V127, P803, DOI 10.1007/s00401-014-1290-2; Wirths O, 2009, ACTA NEUROPATHOL, V118, P487, DOI 10.1007/s00401-009-0557-5; Wittnam JL, 2012, J BIOL CHEM, V287, P8154, DOI 10.1074/jbc.M111.308601; You HT, 2012, P NATL ACAD SCI USA, V109, P1737, DOI 10.1073/pnas.1110789109; Youssef I, 2008, NEUROBIOL AGING, V29, P1319, DOI 10.1016/j.neurobiolaging.2007.03.005	71	61	62	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6134	6145		10.1074/jbc.M115.655183	http://dx.doi.org/10.1074/jbc.M115.655183			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26697885	Green Published, hybrid			2022-12-26	WOS:000372894200008
J	An, B; Abbonante, V; Xu, HF; Gavriilidou, D; Yoshizumi, A; Bihan, D; Farndale, RW; Kaplan, DL; Balduini, A; Leitinger, B; Brodsky, B				An, Bo; Abbonante, Vittorio; Xu, Huifang; Gavriilidou, Despoina; Yoshizumi, Ayumi; Bihan, Dominique; Farndale, Richard W.; Kaplan, David L.; Balduini, Alessandra; Leitinger, Birgit; Brodsky, Barbara			Recombinant Collagen Engineered to Bind to Discoidin Domain Receptor Functions as a Receptor Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOCOCCUS-PYOGENES; TYROSINE KINASES; TRIPLE-HELICES; PROTEIN; IDENTIFICATION; DDR2; PEPTIDES; SITES; STABILITY; CLEAVAGE	A bacterial collagen-like protein Scl2 has been developed as a recombinant collagen model system to host human collagen ligand-binding sequences, with the goal of generating biomaterials with selective collagen bioactivities. Defined binding sites in human collagen for integrins, fibronectin, heparin, and MMP-1 have been introduced into the triple-helical domain of the bacterial collagen and led to the expected biological activities. The modular insertion of activities is extended here to the discoidin domain receptors (DDRs), which are collagen-activated receptor tyrosine kinases. Insertion of the DDR-binding sequence from human collagen III into bacterial collagen led to specific receptor binding. However, even at the highest testable concentrations, the construct was unable to stimulate DDR autophosphorylation. The recombinant collagen expressed in Escherichia coli does not contain hydroxyproline (Hyp), and complementary synthetic peptide studies showed that replacement of Hyp by Pro at the critical Gly-Val-Met-Gly-Phe-Hyp position decreased the DDR-binding affinity and consequently required a higher concentration for the induction of receptor activation. The ability of the recombinant bacterial collagen to bind the DDRs without inducing kinase activation suggested it could interfere with the interactions between animal collagen and the DDRs, and such an inhibitory role was confirmed in vitro and with a cell migration assay. This study illustrates that recombinant collagen can complement synthetic peptides in investigating structure-activity relationships, and this system has the potential for the introduction or inhibition of specific biological activities.	[An, Bo; Kaplan, David L.; Balduini, Alessandra; Brodsky, Barbara] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA; [Abbonante, Vittorio; Balduini, Alessandra] Univ Pavia, Ist Ric & Cura Carattere Sci San Matteo Fdn, Dept Mol Med, I-27100 Pavia, Italy; [Xu, Huifang; Gavriilidou, Despoina; Leitinger, Birgit] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Mol Med Sect, Sir Alexander Fleming Bldg, London SW7 2AZ, England; [Yoshizumi, Ayumi] Toho Univ, Sch Med, Fac Med, Dept Microbiol & Infect Dis, Tokyo 1438540, Japan; [Bihan, Dominique; Farndale, Richard W.] Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England; [Xu, Huifang] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Key Lab Biofuels, Qingdao, Peoples R China	Tufts University; University of Pavia; Imperial College London; Toho University; University of Cambridge; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS	Brodsky, B (corresponding author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.; Leitinger, B (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Mol Med Sect, Sir Alexander Fleming Bldg, London SW7 2AZ, England.	b.leitinger@imperial.ac.uk; barbara.brodsky@tufts.edu	BALDUINI, ALESSANDRA/AAC-3363-2022; Abbonante, Vittorio/K-4028-2016; Abbonante, Vittorio/AAA-9303-2020; Balduini, Alessandra/K-6802-2016	BALDUINI, ALESSANDRA/0000-0003-3145-1245; Abbonante, Vittorio/0000-0001-8066-9895; Abbonante, Vittorio/0000-0001-8066-9895; Balduini, Alessandra/0000-0003-3145-1245	National Institutes of Health [EB011620, GM60048]; Medical Research Council United Kingdom [G0701121]; Biotechnology and Biological Sciences Research Council United Kingdom [BB/I011226/1]; Biomedical Resource Grant from Wellcome Trust [094470/Z/10/Z]; CARIPLO13-ICH (Cariplo Foundation) [2013.0717]; BBSRC [BB/I011226/1] Funding Source: UKRI; MRC [G0701121, G0500707] Funding Source: UKRI; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB011620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060048] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/I011226/1] Funding Source: researchfish; British Heart Foundation [RG/15/4/31268] Funding Source: researchfish; Medical Research Council [G0701121, G0500707] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biomedical Resource Grant from Wellcome Trust; CARIPLO13-ICH (Cariplo Foundation)(Fondazione Cariplo); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by National Institutes of Health Grants EB011620 (to B. B. and D. L. K.) and GM60048 (to B. B.), CARIPLO13-ICH (Cariplo Foundation) Contract 2013.0717 (to A. B.), and in part by Medical Research Council United Kingdom Grant G0701121 (to B. L. and R. W. F.) and Biotechnology and Biological Sciences Research Council United Kingdom Grant BB/I011226/1 (to B. L.). Peptide synthesis was supported by Biomedical Resource Grant 094470/Z/10/Z (to R. W. F.) from the Wellcome Trust. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abbonante V, 2013, J BIOL CHEM, V288, P16738, DOI 10.1074/jbc.M112.431528; An B, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00040; An B, 2014, J BIOL CHEM, V289, P4941, DOI 10.1074/jbc.M113.530808; An B, 2013, BIOMATERIALS, V34, P402, DOI 10.1016/j.biomaterials.2012.09.085; Balduini A, 2008, J THROMB HAEMOST, V6, P1900, DOI 10.1111/j.1538-7836.2008.03132.x; Borza CM, 2014, MATRIX BIOL, V34, P185, DOI 10.1016/j.matbio.2013.12.002; Browning MB, 2014, TISSUE ENG PT A, V20, P3130, DOI [10.1089/ten.tea.2013.0602, 10.1089/ten.TEA.2013.0602]; Carafoli F, 2012, STRUCTURE, V20, P688, DOI 10.1016/j.str.2012.02.011; Carafoli F, 2009, STRUCTURE, V17, P1573, DOI 10.1016/j.str.2009.10.012; Cosgriff-Hernandez E, 2010, ACTA BIOMATER, V6, P3969, DOI 10.1016/j.actbio.2010.05.002; Erat MC, 2009, P NATL ACAD SCI USA, V106, P4195, DOI 10.1073/pnas.0812516106; Farndale RW, 2008, BIOCHEM SOC T, V36, P241, DOI 10.1042/BST0360241; Fu HL, 2013, J BIOL CHEM, V288, P7430, DOI 10.1074/jbc.R112.444158; Humtsoe JO, 2005, J BIOL CHEM, V280, P13848, DOI 10.1074/jbc.M410605200; Jarvis GE, 2008, BLOOD, V111, P4986, DOI 10.1182/blood-2007-08-108472; KADLER K, 1994, PROTEIN PROFILE, V1, P519; Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35; Konitsiotis AD, 2008, J BIOL CHEM, V283, P6861, DOI 10.1074/jbc.M709290200; Leitinger B, 2004, J MOL BIOL, V344, P993, DOI 10.1016/j.jmb.2004.09.089; Leitinger B, 2003, J BIOL CHEM, V278, P16761, DOI 10.1074/jbc.M301370200; Leitinger B, 2006, MATRIX BIOL, V25, P355, DOI 10.1016/j.matbio.2006.05.006; Leitinger B, 2014, INT REV CEL MOL BIO, V310, P39, DOI 10.1016/B978-0-12-800180-6.00002-5; Lisman T, 2006, BLOOD, V108, P3753, DOI 10.1182/blood-2006-03-011965; Lukomski S, 2001, INFECT IMMUN, V69, P1729, DOI 10.1128/IAI.69.3.1729-1738.2001; Manka SW, 2012, P NATL ACAD SCI USA, V109, P12461, DOI 10.1073/pnas.1204991109; Mihai C, 2009, J MOL BIOL, V385, P432, DOI 10.1016/j.jmb.2008.10.067; Mohs A, 2007, J BIOL CHEM, V282, P29757, DOI 10.1074/jbc.M703991200; Peng YY, 2014, J BIOMED MATER RES A, V102, P2189, DOI 10.1002/jbm.a.34898; Peng YY, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-146; Persikov AV, 2004, PROTEIN SCI, V13, P893, DOI 10.1110/ps.03501704; Pinkas DM, 2011, ACS CHEM BIOL, V6, P320, DOI 10.1021/cb100298r; Rasmussen M, 2001, MOL MICROBIOL, V40, P1427, DOI 10.1046/j.1365-2958.2001.02493.x; Raynal N, 2006, J BIOL CHEM, V281, P3821, DOI 10.1074/jbc.M509818200; Sekiya A, 2011, J BIOL CHEM, V286, P26364, DOI 10.1074/jbc.M111.252684; Seo N, 2010, J BIOL CHEM, V285, P31046, DOI 10.1074/jbc.M110.151357; Shrivastava A, 1997, MOL CELL, V1, P25, DOI 10.1016/S1097-2765(00)80004-0; Silva T, 2005, J AGR FOOD CHEM, V53, P7802, DOI 10.1021/jf050944d; Valiathan RR, 2012, CANCER METAST REV, V31, P295, DOI 10.1007/s10555-012-9346-z; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; Xu CY, 2010, BIOMACROMOLECULES, V11, P348, DOI 10.1021/bm900894b; Xu HF, 2011, MATRIX BIOL, V30, P16, DOI 10.1016/j.matbio.2010.10.004; Xu Y, 2002, J BIOL CHEM, V277, P27312, DOI 10.1074/jbc.M201163200; Yoshizumi A, 2009, PROTEIN SCI, V18, P1241, DOI 10.1002/pro.134; Yu ZX, 2014, J STRUCT BIOL, V186, P451, DOI 10.1016/j.jsb.2014.01.003; Yu ZX, 2012, J BIOL CHEM, V287, P22988, DOI 10.1074/jbc.M112.348979	45	29	29	2	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4343	4355		10.1074/jbc.M115.674507	http://dx.doi.org/10.1074/jbc.M115.674507			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26702058	Green Published, hybrid			2022-12-26	WOS:000371604600008
J	Bouchard, DS; Seridan, B; Saraoui, T; Rault, L; Germon, P; Gonzalez-Moreno, C; Nader-Macias, FME; Baud, D; Francois, P; Chuat, V; Chain, F; Langella, P; Nicoli, J; Le Loir, Y; Even, S				Bouchard, Damien S.; Seridan, Bianca; Saraoui, Taous; Rault, Lucie; Germon, Pierre; Gonzalez-Moreno, Candelaria; Nader-Macias, Fatima M. E.; Baud, Damien; Francois, Patrice; Chuat, Victoria; Chain, Florian; Langella, Philippe; Nicoli, Jacques; Le Loir, Yves; Even, Sergine			Lactic Acid Bacteria Isolated from Bovine Mammary Microbiota: Potential Allies against Bovine Mastitis	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; LACTOCOCCUS-LACTIS; GENOME SEQUENCE; DNA; INHIBITION; PRODUCTS; PROTEINS; MILK	Bovine mastitis is a costly disease in dairy cattle worldwide. As of yet, the control of bovine mastitis is mostly based on prevention by thorough hygienic procedures during milking. Additional strategies include vaccination and utilization of antibiotics. Despite these measures, mastitis is not fully under control, thus prompting the need for alternative strategies. The goal of this study was to isolate autochthonous lactic acid bacteria (LAB) from bovine mammary microbiota that exhibit beneficial properties that could be used for mastitis prevention and/or treatment. Sampling of the teat canal led to the isolation of 165 isolates, among which a selection of ten non-redundant LAB strains belonging to the genera Lactobacillus and Lactococcus were further characterized with regard to several properties: surface properties (hydrophobicity, autoaggregation); inhibition potential of three main mastitis pathogens, Staphylococcus aureus, Escherichia coli and Streptococcus uberis; colonization capacities of bovine mammary epithelial cells (bMEC); and immunomodulation properties. Three strains, Lactobacillus brevis 1595 and 1597 and Lactobacillus plantarum 1610, showed high colonization capacities and a medium surface hydrophobicity. These strains are good candidates to compete with pathogens for mammary gland colonization. Moreover, nine strains exhibited anti-inflammatory properties, as illustrated by the lower IL-8 secretion by E. coli-stimulated bMEC in the presence of these LAB. Full genome sequencing of five candidate strains allowed to check for undesirable genetic elements such as antibiotic resistance genes and to identify potential bacterial determinants involved in the beneficial properties. This large screening of beneficial properties while checking for undesirable genetic markers allowed the selection of promising candidate LAB strains from bovine mammary microbiota for the prevention and/or treatment of bovine mastitis.	[Bouchard, Damien S.; Seridan, Bianca; Saraoui, Taous; Rault, Lucie; Chuat, Victoria; Le Loir, Yves; Even, Sergine] INRA, UMR STLO 1253, F-35042 Rennes, France; [Bouchard, Damien S.; Seridan, Bianca; Saraoui, Taous; Rault, Lucie; Chuat, Victoria; Le Loir, Yves; Even, Sergine] Agrocampus Ouest, STLO UMR1253, Rennes, France; [Seridan, Bianca; Nicoli, Jacques] Univ Fed Minas Gerais, ICB, Dept Microbiol, Belo Horizonte, MG, Brazil; [Germon, Pierre] INRA, UMR Infectiol & Sante Publ 1282, F-37380 Nouzilly, France; [Gonzalez-Moreno, Candelaria; Nader-Macias, Fatima M. E.] Consejo Nacl Invest Cient & Tecn, Ctr Referencia Lactobacillus, CERELA, San Miguel De Tucuman, Tucuman, Argentina; [Baud, Damien; Francois, Patrice] Univ Hosp Geneva, Genom Res Lab, Geneva, Switzerland; [Chain, Florian; Langella, Philippe] INRA MICALIS, Jouy En Josas, France	INRAE; Institut Agro; Agrocampus Ouest; Universidade Federal de Minas Gerais; INRAE; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Geneva; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Even, S (corresponding author), INRA, UMR STLO 1253, F-35042 Rennes, France.	sergine.even@rennes.inra.fr	Langella, Philippe/N-8368-2017; GERMON, Pierre/AAC-9111-2019; francois, patrice/AAL-5583-2020; GERMON, Pierre/M-5264-2019; LE LOIR, Yves/AAD-1879-2021; Nicoli, Jacques R/K-4807-2015	Langella, Philippe/0000-0001-5960-4341; GERMON, Pierre/0000-0003-3078-876X; Nicoli, Jacques R/0000-0003-2390-2608; Gonzalez Moreno, Candelaria/0000-0003-4317-6172; Chain, Florian/0000-0001-8787-3311; Le Loir, Yves/0000-0002-0355-1065; francois, patrice/0000-0002-0540-750X	French Ministry of Research and Higher Education; CAPES-COFECUB fellowship (CAPES/Brazil); French government [748798C]; French National Institute of Agricultural Research (INRA/France); INRA-funded GISA project (Ruminflame); ECOS SUD project [A12B01]	French Ministry of Research and Higher Education; CAPES-COFECUB fellowship (CAPES/Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); French government; French National Institute of Agricultural Research (INRA/France); INRA-funded GISA project (Ruminflame); ECOS SUD project	DSB was the recipient of a fellowship from the French Ministry of Research and Higher Education. BS was the recipient of a CAPES-COFECUB fellowship (CAPES/Brazil) and of an Excellence Eiffel fellowship (No748798C; Campus France) from the French government. This research was supported by the French National Institute of Agricultural Research (INRA/France). Part of this work was financially supported by the INRA-funded GISA project (Ruminflame) and part was done within the framework of an ECOS SUD project (A12B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSES, 2014, ASS RISKS EM ANT RES; Arroyo R, 2010, CLIN INFECT DIS, V50, P1551, DOI 10.1086/652763; Barinov A, 2009, PROTEOMICS, V9, P61, DOI 10.1002/pmic.200800195; Behnsen J, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010074; Bierne H, 2007, MICROBES INFECT, V9, P1156, DOI 10.1016/j.micinf.2007.05.003; Bouchard D, 2012, J BACTERIOL, V194, P6292, DOI 10.1128/JB.01188-12; Bouchard DS, 2013, APPL ENVIRON MICROB, V79, P877, DOI 10.1128/AEM.03323-12; Espeche MC, 2012, ANAEROBE, V18, P103, DOI 10.1016/j.anaerobe.2012.01.002; Espeche MC, 2009, VET MICROBIOL, V135, P346, DOI 10.1016/j.vetmic.2008.09.078; Charlier C, 2009, INT J FOOD MICROBIOL, V131, P30, DOI 10.1016/j.ijfoodmicro.2008.06.032; Contreras GA, 2011, J MAMMARY GLAND BIOL, V16, P339, DOI 10.1007/s10911-011-9234-0; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Deplanche M, 2015, FASEB J, V29, P1950, DOI 10.1096/fj.14-260513; Dogan B, 2006, VET MICROBIOL, V116, P270, DOI 10.1016/j.vetmic.2006.04.023; Even S, 2014, INTERACTIVE PROBIOTICS, P52; Nader-Macias MEF, 2008, J IND MICROBIOL BIOT, V35, P1387, DOI 10.1007/s10295-008-0438-2; Frola ID, 2013, J DAIRY RES, V80, P28, DOI 10.1017/S0022029912000581; Frola ID, 2012, J DAIRY RES, V79, P84, DOI 10.1017/S0022029911000835; Godon JJ, 1997, APPL ENVIRON MICROB, V63, P2802, DOI 10.1128/AEM.63.7.2802-2813.1997; Herron-Olson L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001120; Innocentin S, 2009, APPL ENVIRON MICROB, V75, P4870, DOI 10.1128/AEM.00825-09; Kechaou N, 2013, APPL ENVIRON MICROB, V79, P1491, DOI 10.1128/AEM.03075-12; Klostermann K, 2008, J DAIRY RES, V75, P365, DOI 10.1017/S0022029908003373; Le Marechal C, 2011, DAIRY SCI TECHNOL, V91, P247, DOI 10.1007/s13594-011-0009-6; Lebeer S, 2010, NAT REV MICROBIOL, V8, P171, DOI 10.1038/nrmicro2297; Lortal S, 1997, CURR MICROBIOL, V34, P180, DOI 10.1007/s002849900165; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Maze A, 2010, J BACTERIOL, V192, P2647, DOI 10.1128/JB.00076-10; Otero MC, 2006, LETT APPL MICROBIOL, V43, P91, DOI 10.1111/j.1472-765X.2006.01914.x; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Reid G, 2006, FEMS IMMUNOL MED MIC, V46, P149, DOI 10.1111/j.1574-695X.2005.00026.x; Riollet C, 2000, CLIN DIAGN LAB IMMUN, V7, P161, DOI 10.1128/CDLI.7.2.161-167.2000; Roussel P, 2015, VET RES, V46, DOI 10.1186/s13567-015-0201-4; Sengupta R, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/237921; SMITH CL, 1987, METHOD ENZYMOL, V155, P449; Suojala L, 2013, J VET PHARMACOL THER, V36, P521, DOI 10.1111/jvp.12057; Suojala L, 2010, J DAIRY SCI, V93, P1960, DOI 10.3168/jds.2009-2462; Tomas MSJ, 2003, J MED MICROBIOL, V52, P1117, DOI 10.1099/jmm.0.05155-0; Turpin W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038034; VANDEVOORDE L, 1992, J APPL BACTERIOL, V72, P214, DOI 10.1111/j.1365-2672.1992.tb01826.x; Younes JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036917; Zuily S, 2011, ARCH CARDIOVASC DIS, V104, P138, DOI 10.1016/j.acvd.2010.05.005	42	67	70	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0144831	10.1371/journal.pone.0144831	http://dx.doi.org/10.1371/journal.pone.0144831			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713450	Green Published, Green Submitted, gold			2022-12-26	WOS:000367481900021
J	Hestand, MS; Zeng, Z; Coleman, SJ; Liu, JZ; MacLeod, JN				Hestand, Matthew S.; Zeng, Zheng; Coleman, Stephen J.; Liu, Jinze; MacLeod, James N.			Tissue Restricted Splice Junctions Originate Not Only from Tissue-Specific Gene Loci, but Gene Loci with a Broad Pattern of Expression	PLOS ONE			English	Article							HUMAN TRANSCRIPTOME; GENOME BROWSER; NUCLEOTIDE	Cellular mechanisms that achieve protein diversity in eukaryotes are multifaceted, including transcriptional components such as RNA splicing. Through alternative splicing, a single protein-coding gene can generate multiple mRNA transcripts and protein isoforms, some of which are tissue-specific. We have conducted qualitative and quantitative analyses of the Bodymap 2.0 messenger RNA-sequencing data from 16 human tissue samples and identified 209,363 splice junctions. Of these, 22,231 (10.6%) were not previously annotated and 21,650 (10.3%) were expressed in a tissue-restricted pattern. Tissue-restricted alternative splicing was found to be widespread, with approximately 65% of expressed multi-exon genes containing at least one tissue-specific splice junction. Interestingly, we observed many tissue-specific splice junctions not only in genes expressed in one or a few tissues, but also from gene loci with a broad pattern of expression.	[Hestand, Matthew S.; Coleman, Stephen J.; MacLeod, James N.] Univ Kentucky, Dept Vet Sci, Gluck Equine Res Ctr, Lexington, KY 40506 USA; [Zeng, Zheng; Liu, Jinze] Univ Kentucky, Dept Comp Sci, Lexington, KY 40506 USA	University of Kentucky; University of Kentucky	MacLeod, JN (corresponding author), Univ Kentucky, Dept Vet Sci, Gluck Equine Res Ctr, Lexington, KY 40506 USA.	jnmacleod@uky.edu		Coleman, Stephen/0000-0001-7686-4866	National Science Foundation [Crosscut-EF-0850237, 1054631]; Kentucky Infrastructure for Biomedical Research Excellence award (KY-INBRE) from the National Institutes of Health [5P20RR016481-09]; Lourie Foundation; Gluck Equine Research Center, University of Kentucky; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016481] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006272] Funding Source: NIH RePORTER; Direct For Computer & Info Scie & Enginr [1054631] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Kentucky Infrastructure for Biomedical Research Excellence award (KY-INBRE) from the National Institutes of Health; Lourie Foundation; Gluck Equine Research Center, University of Kentucky; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported by the National Science Foundation (Crosscut-EF-0850237 to J.L. and J.N.M. and 1054631 to J.L.) and a Kentucky Infrastructure for Biomedical Research Excellence award (KY-INBRE, 5P20RR016481-09) from the National Institutes of Health. Additional financial support was received from the Lourie Foundation and through endowments at the Gluck Equine Research Center, University of Kentucky. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank members of the Liu laboratory for assistance using MapSplice. This work was supported by the National Science Foundation (Crosscut-EF-0850237 to J.L. and J.N.M. and 1054631 to J.L.) and a Kentucky Infrastructure for Biomedical Research Excellence award (KY-INBRE, 5P20RR016481-09) from the National Institutes of Health. Additional financial support was received from the Lourie Foundation and through endowments at the Gluck Equine Research Center, University of Kentucky.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Benson DA, 2004, NUCLEIC ACIDS RES, V32, pD23, DOI 10.1093/nar/gkh045; Camon Evelyn, 2004, In Silico Biology, V4, P5; de la Grange P, 2010, NUCLEIC ACIDS RES, V38, P2825, DOI 10.1093/nar/gkq008; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; Deutsch M, 1999, NUCLEIC ACIDS RES, V27, P3219, DOI 10.1093/nar/27.15.3219; Du HQ, 2010, NAT STRUCT MOL BIOL, V17, P187, DOI 10.1038/nsmb.1720; Engstrom PG, 2013, NAT METHODS, V10, P1185, DOI [10.1038/NMETH.2722, 10.1038/nmeth.2722]; Fagerberg L, 2013, J PROTEOME RES, V12, P2439, DOI 10.1021/pr300924j; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Florea Liliana, 2013, F1000Res, V2, P188, DOI 10.12688/f1000research.2-188.v1; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gonzalez-Porta M, 2012, GENOME RES, V22, P528, DOI 10.1101/gr.121947.111; Hebenstreit D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.28; Hoffman JD, 1998, AM J MED GENET, V80, P140, DOI 10.1002/(SICI)1096-8628(19981102)80:2<140::AID-AJMG10>3.0.CO;2-L; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Jelier R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r96; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; KURAHASHI H, 1995, CANCER RES, V55, P5007; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD28, DOI 10.1093/nar/gkq967; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Mele M, 2015, SCIENCE, V348, P660, DOI 10.1126/science.aaa0355; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Neklason Deborah W, 2004, Fam Cancer, V3, P35; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Sharon D, 2013, NAT BIOTECHNOL, V31, P1009, DOI 10.1038/nbt.2705; Slaugenhaupt SA, 2001, AM J HUM GENET, V68, P598, DOI 10.1086/318810; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; Song L, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S5-S14; Steijger T, 2013, NAT METHODS, V10, P1177, DOI [10.1038/nmeth.2714, 10.1038/NMETH.2714]; Tazi J, 2009, BBA-MOL BASIS DIS, V1792, P14, DOI 10.1016/j.bbadis.2008.09.017; Thomas S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094650; Tilgner H, 2014, P NATL ACAD SCI USA, V111, P9869, DOI 10.1073/pnas.1400447111; Venables JP, 2012, NUCLEIC ACIDS RES, V40, P1, DOI 10.1093/nar/gkr648; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622	40	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0144302	10.1371/journal.pone.0144302	http://dx.doi.org/10.1371/journal.pone.0144302			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713731	gold, Green Published, Green Submitted			2022-12-26	WOS:000367481900007
J	Huang, Y; Xiong, YY; Lin, ZH; Feng, XY; Jiang, X; Zhou, SY; Huang, JJ				Huang, Yan; Xiong, Yuanyan; Lin, Zhuoheng; Feng, Xuyang; Jiang, Xue; Zhou Songyang; Huang, Junjiu			Specific Tandem 3 ' UTR Patterns and Gene Expression Profiles in Mouse Thy1(+) Germline Stem Cells	PLOS ONE			English	Article							3' UNTRANSLATED REGIONS; MESSENGER-RNA POLYADENYLATION; ALTERNATIVE POLYADENYLATION; ZEBRAFISH DEVELOPMENT; SELF-RENEWAL; SPERMATOGENESIS; IDENTIFICATION; INFERTILITY; CLEAVAGE; DEFECTS	A recently developed strategy of sequencing alternative polyadenylation (APA) sites (SAPAS) with second-generation sequencing technology can be used to explore complete genome-wide patterns of tandem APA sites and global gene expression profiles. spermatogonial stem cells (SSCs) maintain long-term reproductive abilities in male mammals. The detailed mechanisms by which SSCs self-renew and generate mature spermatozoa are not clear. To understand the specific alternative polyadenylation pattern and global gene expression profile of male germline stem cells (GSCs, mainly referred to SSCs here), we isolated and purified mouse Thy1(+) cells from testis by magnetic-activated cell sorting (MACS) and then used the SAPAS method for analysis, using pluripotent embryonic stem cells (ESCs) and differentiated mouse embryonic fibroblast cells (MEFs) as controls. As a result, we obtained 99,944 poly(A) sites, approximately 40% of which were newly detected in our experiments. These poly(A) sites originated from three mouse cell types and covered 17,499 genes, including 831 long non-coding RNA (lncRNA) genes. We observed that GSCs tend to have shorter 3'UTR lengths while MEFs tend towards longer 3'UTR lengths. We also identified 1337 genes that were highly expressed in GSCs, and these genes were highly consistent with the functional characteristics of GSCs. Our detailed bioinformatics analysis identified APA site-switching events at 3'UTRs and many new specifically expressed genes in GSCs, which we experimentally confirmed. Furthermore, qRT-PCR was performed to validate several events of the 334 genes with distal-to-proximal poly(A) switch in GSCs. Consistently APA reporter assay confirmed the total 3'UTR shortening in GSCs compared to MEFs. We also analyzed the cis elements around the proximal poly(A) site preferentially used in GSCs and found C-rich elements may contribute to this regulation. Overall, our results identified the expression level and polyadenylation site profiles and these data provide new insights into the processes potentially involved in the GSC life cycle and spermatogenesis.	[Huang, Yan; Xiong, Yuanyan; Lin, Zhuoheng; Feng, Xuyang; Jiang, Xue; Zhou Songyang; Huang, Junjiu] Sun Yat Sen Univ, Affiliated Hosp 1, Key Lab Reprod Med Guangdong Prov, Guangzhou 51000, Guangdong, Peoples R China; [Huang, Yan; Xiong, Yuanyan; Lin, Zhuoheng; Feng, Xuyang; Jiang, Xue; Zhou Songyang; Huang, Junjiu] Sun Yat Sen Univ, Sch Life Sci, Minist Educ, Key Lab Gene Engn, Guangzhou 51000, Guangdong, Peoples R China; [Xiong, Yuanyan] SYSU CMU Shunde Int Joint Res Inst, Shunde, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Huang, JJ (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Key Lab Reprod Med Guangdong Prov, Guangzhou 51000, Guangdong, Peoples R China.	hjunjiu@mail.sysu.edu.cn			Natural Science Foundation of Guangdong Province [2014A030312011]; Science and Technology Planning Project of Guangdong Province [2015B020228002, 2015A020212010]; National Natural Science Foundation [31371508, 31401223, 31301085, 81330055, J1310025]; Program of International ST Cooperation [2014DFB30020]	Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Science and Technology Planning Project of Guangdong Province; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Program of International ST Cooperation	This study was supported by the Natural Science Foundation of Guangdong Province (2014A030312011), the Science and Technology Planning Project of Guangdong Province (2015B020228002, 2015A020212010), the National Natural Science Foundation (31371508, 31401223, 31301085, 81330055 and J1310025) and the Program of International S&T Cooperation (2014DFB30020).; This study was supported by the Natural Science Foundation of Guangdong Province (2014A030312011), the Science and Technology Planning Project of Guangdong Province (2015B020228002, 2015A020212010), the National Natural Science Foundation (31371508, 31401223, 31301085, 81330055 and J1310025) and the Program of International S&T Cooperation (2014DFB30020). We would like to thank Dr. Bin Tian for kindly providing the APA reporter plasmids 77S.AD and 77S.AE. We also thank Dr. Yuwen Qiu and Zhini Zhang for their helpful suggestions in animal experimental design.	Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Dass B, 2007, P NATL ACAD SCI USA, V104, P20374, DOI 10.1073/pnas.0707589104; Derti A, 2012, GENOME RES, V22, P1173, DOI 10.1101/gr.132563.111; Fu YG, 2011, GENOME RES, V21, P741, DOI 10.1101/gr.115295.110; Hammoud SS, 2014, CELL STEM CELL, V15, P239, DOI 10.1016/j.stem.2014.04.006; Handel MA, 2010, NAT REV GENET, V11, P124, DOI 10.1038/nrg2723; Hockert KJ, 2011, J REPROD IMMUNOL, V89, P26, DOI 10.1016/j.jri.2011.01.018; Hoque M, 2013, NAT METHODS, V10, P133, DOI [10.1038/NMETH.2288, 10.1038/nmeth.2288]; Huang JJ, 2011, CELL RES, V21, P779, DOI 10.1038/cr.2011.16; Jan CH, 2011, NATURE, V469, P97, DOI 10.1038/nature09616; Ji Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008419; Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106; Kogo H, 2010, J HUM GENET, V55, P293, DOI 10.1038/jhg.2010.26; Lee JY, 2007, NUCLEIC ACIDS RES, V35, pD165, DOI 10.1093/nar/gkl870; Lefevre C, 2008, DEV DYNAM, V237, P1082, DOI 10.1002/dvdy.21482; Li WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048373; Li YX, 2012, GENOME RES, V22, P1899, DOI 10.1101/gr.128488.111; Lianoglou S, 2013, GENE DEV, V27, P2380, DOI 10.1101/gad.229328.113; Liu DL, 2007, NUCLEIC ACIDS RES, V35, P234, DOI 10.1093/nar/gkl919; MacDonald CC, 2002, MOL CELL ENDOCRINOL, V190, P1, DOI 10.1016/S0303-7207(02)00044-8; Makeyev AV, 2002, RNA, V8, P265, DOI 10.1017/S1355838202024627; Masamha CP, 2014, NATURE, V510, P412, DOI 10.1038/nature13261; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Oatley JM, 2006, P NATL ACAD SCI USA, V103, P9524, DOI 10.1073/pnas.0603332103; Oatley JM, 2009, DEVELOPMENT, V136, P1191, DOI 10.1242/dev.032243; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Shepard PJ, 2011, RNA, V17, P761, DOI 10.1261/rna.2581711; Smibert P, 2012, CELL REP, V1, P277, DOI 10.1016/j.celrep.2012.01.001; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Ulitsky I, 2012, GENOME RES, V22, P2054, DOI 10.1101/gr.139733.112; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Xiao SJ, 2010, BIOINFORMATICS, V26, P1273, DOI 10.1093/bioinformatics/btq109; Yang LL, 2013, GENESIS, V51, P83, DOI 10.1002/dvg.22358; Zhang HB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r100	35	5	5	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145417	10.1371/journal.pone.0145417	http://dx.doi.org/10.1371/journal.pone.0145417			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713853	Green Published, gold, Green Submitted			2022-12-26	WOS:000367481900040
J	Liu, JD; He, ZH; Wu, L; Bai, B; Wen, WE; Xie, CJ; Xia, XC				Liu, Jindong; He, Zhonghu; Wu, Ling; Bai, Bin; Wen, Weie; Xie, Chaojie; Xia, Xianchun			Genome-Wide Linkage Mapping of QTL for Adult-Plant Resistance to Stripe Rust in a Chinese Wheat Population Linmai 2 x Zhong 892	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; LEAF RUST; HIGH-TEMPERATURE; DURABLE RESISTANCE; POWDERY MILDEW; PUCCINIA-STRIIFORMIS; GENETIC-LINKAGE; DISEASE RESISTANCE; MAP; CULTIVAR	Stripe rust is one of the most devastating diseases of wheat (Triticum aestivum) worldwide. Adult-plant resistance (APR) is an efficient approach to provide long-term protection of wheat from the disease. The Chinese winter wheat cultivar Zhong 892 has a moderate level of APR to stripe rust in the field. To determine the inheritance of the APR resistance in this cultivar, 273 F-6 recombinant inbred lines (RILs) were developed from a cross between Linmai 2 and Zhong 892. The RILs were evaluated for maximum disease severity (MDS) in two sites during the 2011-2012, 2012-2013 and 2013-2014 cropping seasons, providing data for five environments. Illumina 90k SNP (single nucleotide polymorphism) chips were used to genotype the RILs and their parents. Composite interval mapping (CIM) detected eight QTL, namely QYr.caas-2AL, QYr.caas-2BL.3, QYr.caas-3AS, QYr.caas-3BS, QYr.caas-5DL, QYr.caas-6AL, QYr.caas-7AL and QYr.caas-7DS. 1, respectively. All except QYr.caas-2BL. 3 resistance alleles were contributed by Zhong 892. QYr.caas-3AS and QYr.caas-3BS conferred stable resistance to stripe rust in all environments, explaining 6.2-17.4% and 5.0-11.5% of the phenotypic variances, respectively. The genome scan of SNP sequences tightly linked to QTL for APR against annotated proteins in wheat and related cereals genomes identified two candidate genes (autophagy-related gene and disease resistance gene RGA1), significantly associated with stripe rust resistance. These QTL and their closely linked SNP markers, in combination with kompetitive allele specific PCR (KASP) technology, are potentially useful for improving stripe rust resistances in wheat breeding.	[Liu, Jindong; He, Zhonghu; Xia, Xianchun] Chinese Acad Agr Sci, Natl Wheat Improvement Ctr, Inst Crop Sci, Beijing 100193, Peoples R China; [Liu, Jindong] China Agr Univ, State Key Lab Agrobiotechnol, Dept Plant Genet & Breeding, Beijing 100094, Peoples R China; [He, Zhonghu] Chinese Acad Agr Sci, Int Maize & Wheat Improvement Ctr CIMMYT China Of, Beijing 100193, Peoples R China; [Wu, Ling] Sichuan Acad Agr Sci, Crop Res Inst, Chengdu, Sichuan, Peoples R China; [Bai, Bin] Gansu Acad Agr Sci, Wheat Res Inst, Lanzhou, Gansu, Peoples R China; [Wen, Weie] Xinjiang Agr Univ, Coll Agron, Urumqi, Xinjiang, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; China Agricultural University; Chinese Academy of Agricultural Sciences; Sichuan Academy of Agricultural Sciences (SAAS); Xinjiang Agricultural University	Xia, XC (corresponding author), Chinese Acad Agr Sci, Natl Wheat Improvement Ctr, Inst Crop Sci, Beijing 100193, Peoples R China.	xiaxianchun@caas.cn	; Liu, Jindong/C-8422-2017	Bai, Bin/0000-0001-9904-9987; He, Zhonghu/0000-0003-1384-3712; Liu, Jindong/0000-0002-5927-4845	National Key Basic Research Program of China [2013CB127700]; National Natural Science Foundation of China [31261140370]; Ministry of Science and Technology [2011DFG32990, 2013DFG30530]; Ministry of Agriculture [2011-G3]; National 863 Project [2012AA101105]; China Agricultural Research System [CARS-3-1-3]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi); National 863 Project(National High Technology Research and Development Program of China); China Agricultural Research System	This study was supported by the National Key Basic Research Program of China (2013CB127700), National Natural Science Foundation of China (31261140370), International Collaboration Projects from the Ministry of Science and Technology (2011DFG32990, 2013DFG30530) and Ministry of Agriculture (2011-G3), National 863 Project (2012AA101105), and the China Agricultural Research System (CARS-3-1-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to Prof. R. A. McIntosh, Plant Breeding Institute, University of Sydney, for critical review of this manuscript. This study was supported by the National Key Basic Research Program of China (2013CB127700), National Natural Science Foundation of China (31261140370), International Collaboration Projects from the Ministry of Science and Technology (2011DFG32990, 2013DFG30530) and Ministry of Agriculture (2011-G3), National 863 Project (2012AA101105), and the China Agricultural Research System (CARS-3-1-3).	Akhunov E, 2009, THEOR APPL GENET, V119, P507, DOI 10.1007/s00122-009-1059-5; Avni R, 2014, MOL BREEDING, V34, P1549, DOI 10.1007/s11032-014-0176-2; Bariana HS, 2001, AUST J AGR RES, V52, P1247, DOI 10.1071/AR01040; Basnet BR, 2014, MOL BREEDING, V33, P385, DOI 10.1007/s11032-013-9957-2; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Boukhatem N, 2002, THEOR APPL GENET, V104, P111, DOI 10.1007/s001220200013; Carter AH, 2009, THEOR APPL GENET, V119, P1119, DOI 10.1007/s00122-009-1114-2; Chen XM, 2005, CAN J PLANT PATHOL, V27, P314; CHEN XM, 1995, PHYTOPATHOLOGY, V85, P567, DOI 10.1094/Phyto-85-567; Colasuonno P, 2014, MOL BREEDING, V34, P1563, DOI 10.1007/s11032-014-0183-3; Cuthbert PA, 2006, THEOR APPL GENET, V112, P1465, DOI 10.1007/s00122-006-0249-7; Dedryver F, 2009, PHYTOPATHOLOGY, V99, P968, DOI 10.1094/PHYTO-99-8-0968; DEVOS KM, 1993, THEOR APPL GENET, V85, P784, DOI 10.1007/BF00225020; DYCK PL, 1987, GENOME, V29, P467, DOI 10.1139/g87-081; Fu DL, 2009, SCIENCE, V323, P1357, DOI 10.1126/science.1166289; Hao YF, 2011, THEOR APPL GENET, V123, P1401, DOI 10.1007/s00122-011-1675-8; HARE RA, 1979, Z PFLANZENZUCHT, V83, P350; He ZhongHu, 2011, Scientia Agricultura Sinica, V44, P2193; Herrera-Foessel SA, 2011, THEOR APPL GENET, V122, P239, DOI 10.1007/s00122-010-1439-x; Imtiaz M, 2004, PLANT BREEDING, V123, P401, DOI 10.1111/j.1439-0523.2004.01002.x; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; JOHNSON R, 1981, PHYTOPATHOLOGY, V71, P567, DOI 10.1094/Phyto-71-567; JOHNSON R, 1984, ANNU REV PHYTOPATHOL, V22, P309, DOI 10.1146/annurev.py.22.090184.001521; JOHNSON R, 1992, EUPHYTICA, V63, P3, DOI 10.1007/BF00023908; Khlestkina EK, 2007, EUPHYTICA, V153, P1, DOI 10.1007/s10681-006-9182-8; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; Krattinger SG, 2009, SCIENCE, V323, P1360, DOI 10.1126/science.1166453; Lagudah ES, 2006, THEOR APPL GENET, V114, P21, DOI 10.1007/s00122-006-0406-z; Lagudah ES, 2011, EUPHYTICA, V179, P81, DOI 10.1007/s10681-010-0336-3; Lan CX, 2015, THEOR APPL GENET, V128, P549, DOI 10.1007/s00122-015-2454-8; Li ZF, 2014, CROP SCI, V54, P1907, DOI 10.2135/cropsci2014.02.0162; Lillemo M, 2008, THEOR APPL GENET, V116, P1155, DOI 10.1007/s00122-008-0743-1; Lin F, 2007, THEOR APPL GENET, V114, P1277, DOI 10.1007/s00122-007-0518-0; Lowe I, 2011, THEOR APPL GENET, V123, P143, DOI 10.1007/s00122-011-1573-0; Lu YM, 2009, THEOR APPL GENET, V119, P1349, DOI 10.1007/s00122-009-1139-6; Lu Y, 2014, THEOR APPL GENET, V127, P1449, DOI 10.1007/s00122-014-2312-0; Mago R, 2011, THEOR APPL GENET, V123, P615, DOI 10.1007/s00122-011-1611-y; Mcintosh R.A., 2014, CATALOGUE GENE SYMBO; MCINTOSH RA, 1992, PLANT PATHOL, V41, P523, DOI 10.1111/j.1365-3059.1992.tb02450.x; Mclntosh RA, 2011, CATALOGUE GENE SYM S; National Agro-technical Extension and Service Center (NAESC), 2014, CHINA PLANT PROT, V33, P47; National Agro-technical Extension and Service Center (NAESC), 2013, CHINA PLANT PROT, V33, P35; Navabi A, 2005, GENOME, V48, P97, DOI [10.1139/g04-100, 10.1139/G04-100]; Pei D, 2014, PLANT CELL REP, V33, P1697, DOI 10.1007/s00299-014-1648-x; Quan W, 2013, EUR J PLANT PATHOL, V136, P715, DOI 10.1007/s10658-013-0201-z; Ramburan VP, 2004, THEOR APPL GENET, V108, P1426, DOI 10.1007/s00122-003-1567-7; Ren J, 2013, INT J MOL SCI, V14, P7061, DOI 10.3390/ijms14047061; Ren RS, 2012, THEOR APPL GENET, V125, P847, DOI 10.1007/s00122-012-1877-8; Ren Y, 2012, THEOR APPL GENET, V125, P1253, DOI 10.1007/s00122-012-1910-y; Ren Y, 2012, THEOR APPL GENET, V125, P1211, DOI 10.1007/s00122-012-1907-6; Roder MS, 1998, GENETICS, V149, P2007; Rosewarne GM, 2013, THEOR APPL GENET, V126, P2427, DOI 10.1007/s00122-013-2159-9; Rosewarne GM, 2012, THEOR APPL GENET, V124, P1283, DOI 10.1007/s00122-012-1786-x; Rosewarne GM, 2006, THEOR APPL GENET, V112, P500, DOI 10.1007/s00122-005-0153-6; Russo MA, 2014, MOL BREEDING, V34, P1579, DOI 10.1007/s11032-014-0181-5; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Semagn K, 2014, MOL BREEDING, V33, P1, DOI 10.1007/s11032-013-9917-x; Singh R. P., 2000, Acta Phytopathologica et Entomologica Hungarica, V35, P133; Singh RP, 2011, EUPHYTICA, V179, P175, DOI 10.1007/s10681-010-0322-9; Singh Ravi Prakash, 2005, Turkish Journal of Agriculture and Forestry, V29, P121; Singh RP, 2014, J INTEGR AGR, V13, P255, DOI 10.1016/S2095-3119(13)60649-8; SINGH RP, 1992, PHYTOPATHOLOGY, V82, P835, DOI 10.1094/Phyto-82-835; Singh RP, 2000, CROP SCI, V40, P1148, DOI 10.2135/cropsci2000.4041148x; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Spielmeyer W, 2003, CROP SCI, V43, P333, DOI 10.2135/cropsci2003.0333; STAM P, 1993, PLANT J, V3, P739, DOI 10.1111/j.1365-313X.1993.00739.x; Stubbs R. W., 1985, CEREAL RUSTS, V2, P61, DOI 10.1016/B978-0-12-148402-6.50011-0; Suenaga K, 2003, PHYTOPATHOLOGY, V93, P881, DOI 10.1094/PHYTO.2003.93.7.881; Uauy C, 2005, THEOR APPL GENET, V112, P97, DOI 10.1007/s00122-005-0109-x; Vazquez MD, 2012, THEOR APPL GENET, V124, P1, DOI 10.1007/s00122-011-1681-x; Velappan N, 2001, DIAGN MICR INFEC DIS, V39, P77, DOI 10.1016/S0732-8893(00)00235-2; Veldboom LR, 1996, CROP SCI, V36, P1310, DOI 10.2135/cropsci1996.0011183X003600050040x; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wan AM, 2007, AUST J AGR RES, V58, P605, DOI 10.1071/AR06142; Wang S, 2012, WINDOWS QTL CARTOGRA; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Wang ZL, 2005, PLANT DIS, V89, P457, DOI 10.1094/PD-89-0457; Wellings CR, 2011, EUPHYTICA, V179, P129, DOI 10.1007/s10681-011-0360-y; Wenzl P, 2004, P NATL ACAD SCI USA, V101, P9915, DOI 10.1073/pnas.0401076101; William HM, 2006, GENOME, V49, P977, DOI 10.1139/G06-052; Zhou XL, 2014, THEOR APPL GENET, V127, P935, DOI 10.1007/s00122-014-2269-z; Zwart RS, 2010, MOL BREEDING, V26, P107, DOI 10.1007/s11032-009-9381-9	82	19	20	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145462	10.1371/journal.pone.0145462	http://dx.doi.org/10.1371/journal.pone.0145462			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714310	gold, Green Submitted, Green Published			2022-12-26	WOS:000367481900044
J	Moll, K; Palmkvist, M; Ch'ng, J; Kiwuwa, MS; Wahlgren, M				Moll, Kirsten; Palmkvist, Mia; Ch'ng, Junhong; Kiwuwa, Mpungu Steven; Wahlgren, Mats			Evasion of Immunity to Plasmodium falciparum: Rosettes of Blood Group A Impair Recognition of PfEMP1	PLOS ONE			English	Article							HUMAN CEREBRAL MALARIA; INFECTED ERYTHROCYTES; MULTIPLICATION RATE; IN-VIVO; ASSOCIATION; PROTECTION; PARASITES; CELLS; SUSCEPTIBILITY; SURFACE	The ABO blood group antigens are expressed on erythrocytes but also on endothelial cells, platelets and serum proteins. Notably, the ABO blood group of a malaria patient determines the development of the disease given that blood group O reduces the probability to succumb in severe malaria, compared to individuals of groups A, B or AB. P. falciparum rosetting and sequestration are mediated by PfEMP1, RIFIN and STEVOR, expressed at the surface of the parasitized red blood cell (pRBC). Antibodies to these antigens consequently modify the course of a malaria infection by preventing sequestration and promoting phagocytosis of pRBC. Here we have studied rosetting P. falciparum and present evidence of an immune evasion mechanismnot previously recognized. We find the accessibility of antibodies to PfEMP1 at the surface of the pRBC to be reduced when P. falciparum forms rosettes in blood group A RBC, as compared to group O RBC. The pRBC surrounds itself with tightly bound normal RBC that makes PfEMP1 inaccessible to antibodies and clearance by the immune system. Accordingly, pRBC of in vitro cloned P. falciparum devoid of ABO blood group dependent rosetting were equally well detected by anti-PfEMP1 antibodies, independent of the blood group utilized for their propagation. The pathogenic mechanisms underlying the severe forms of malaria may in patients of blood group A depend on the ability of the parasite to mask PfEMP1 from antibody recognition, in so doing evading immune clearance.	[Moll, Kirsten; Palmkvist, Mia; Ch'ng, Junhong; Wahlgren, Mats] Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, SE-17177 Stockholm, Sweden; [Kiwuwa, Mpungu Steven] Makerere Univ, Coll Hlth Sci, Sch Med, Dept Pediat, Kampala, Uganda; [Kiwuwa, Mpungu Steven] Makerere Univ, Coll Hlth Sci, Sch Biomed Sci, Dept Biochem, Kampala, Uganda	Karolinska Institutet; Makerere University; Makerere University	Moll, K (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Box 280,Nobels Vag 16, SE-17177 Stockholm, Sweden.	kirsten.moll@ki.se; mats.wahlgren@ki.se	Ch'ng, Jun Hong/V-7150-2019					Albrecht L, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-17; ALLISON AC, 1954, BRIT MED J, V1, P290, DOI 10.1136/bmj.1.4857.290; ALYAMAN F, 1995, T ROY SOC TROP MED H, V89, P55, DOI 10.1016/0035-9203(95)90658-4; Angeletti D., 2013, PLOS ONE, V7; Angeletti D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118898; Angeletti D, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-32; Band G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003509; Barfod L, 2011, P NATL ACAD SCI USA, V108, P12485, DOI 10.1073/pnas.1103708108; Barragan A, 2000, INFECT IMMUN, V68, P2971, DOI 10.1128/IAI.68.5.2971-2975.2000; Beiguelman B, 2003, MEM I OSWALDO CRUZ, V98, P455, DOI 10.1590/S0074-02762003000400004; Burman N, 1998, INFECT IMMUN, V66, P815, DOI 10.1128/IAI.66.2.815-819.1998; CARLSON J, 1992, J EXP MED, V176, P1311, DOI 10.1084/jem.176.5.1311; CARLSON J, 1994, BLOOD, V84, P3909, DOI 10.1182/blood.V84.11.3909.bloodjournal84113909; CARLSON J, 1990, LANCET, V336, P1457, DOI 10.1016/0140-6736(90)93174-N; CELADA A, 1982, CLIN EXP IMMUNOL, V47, P635; Chotivanich K, 2000, J INFECT DIS, V181, P1206, DOI 10.1086/315353; Clough B, 1998, EXP PARASITOL, V89, P129, DOI 10.1006/expr.1998.4275; Clough B, 1998, BRIT J HAEMATOL, V100, P99, DOI 10.1046/j.1365-2141.1998.00534.x; Cooling L, 2015, CLIN MICROBIOL REV, V28, P801, DOI 10.1128/CMR.00109-14; Cserti CM, 2007, BLOOD, V110, P2250, DOI 10.1182/blood-2007-03-077602; Deans AM, 2006, AM J TROP MED HYG, V74, P554, DOI 10.4269/ajtmh.2006.74.554; Deepa, 2011, J VECTOR DIS, V48, P7; Fairhurst RM, 2003, BLOOD, V101, P3309, DOI 10.1182/blood-2002-10-3105; FANDEUR T, 1995, J EXP MED, V181, P283, DOI 10.1084/jem.181.1.283; Fischer PR, 1998, AM J TROP MED HYG, V58, P122, DOI 10.4269/ajtmh.1998.58.122; FRATTALI A, 1997, MOL BIOL EVOLUTION B, P268; Fry AE, 2008, HUM MOL GENET, V17, P567, DOI 10.1093/hmg/ddm331; Ghumra A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016414; Goel S, 2015, NAT MED, V21, P314, DOI 10.1038/nm.3812; KAUL DK, 1991, BLOOD, V78, P812; Kiwuwa MS, 2013, PARASITOL RES, V112, P1691, DOI 10.1007/s00436-013-3325-3; Le Scanf C, 2008, MICROBES INFECT, V10, P447, DOI 10.1016/j.micinf.2007.12.012; Lee WC, 2014, BLOOD; Lell B, 1999, CLIN INFECT DIS, V28, P794, DOI 10.1086/515193; Loscertales MP, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-72; Lowe BS, 1998, T ROY SOC TROP MED H, V92, P526, DOI 10.1016/S0035-9203(98)90901-4; Marin-Menendez A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002155; Migot-Nabias F, 2000, GENES IMMUN, V1, P435, DOI 10.1038/sj.gene.6363703; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Mok BW, 2007, MOL BIOCHEM PARASIT, V151, P184, DOI 10.1016/j.molbiopara.2006.11.006; Moll K, 2014, METHODS MALARIA RES; Moulds JM, 2000, TRANSFUS MED REV, V14, P302, DOI 10.1053/tmrv.2000.16227; Pathirana SL, 2005, ANN TROP MED PARASIT, V99, P119, DOI 10.1179/136485905X19946; Ribacke U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069781; Rockett KA, 2014, NAT GENET, V46, P1197, DOI 10.1038/ng.3107; Rowe JA, 2007, P NATL ACAD SCI USA, V104, P17471, DOI 10.1073/pnas.0705390104; Rowe JA, 2002, AM J TROP MED HYG, V66, P692, DOI 10.4269/ajtmh.2002.66.692; Rowe JA, 2002, AM J TROP MED HYG, V66, P458, DOI 10.4269/ajtmh.2002.66.458; Rowe JA, 1997, NATURE, V388, P292, DOI 10.1038/40888; Scholander C, 1996, NAT MED, V2, P204, DOI 10.1038/nm0296-204; Silamut K, 1999, AM J PATHOL, V155, P395, DOI 10.1016/S0002-9440(10)65136-X; Taylor SM, 2012, LANCET INFECT DIS, V12, P457, DOI 10.1016/S1473-3099(12)70055-5; Thakur A., 1992, Indian Journal of Malariology, V29, P241; Treutiger CJ, 1999, EXP PARASITOL, V93, P215, DOI 10.1006/expr.1999.4454; TREUTIGER CJ, 1992, AM J TROP MED HYG, V46, P503, DOI 10.4269/ajtmh.1992.46.503; UDOMSANGPETCH R, 1993, AM J TROP MED HYG, V48, P149, DOI 10.4269/ajtmh.1993.48.149; UDOMSANGPETCH R, 1993, BLOOD, V82, P3752; Vigan-Womas I, 2008, INFECT IMMUN, V76, P5565, DOI 10.1128/IAI.00901-08; Vigan-Womas I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002781; Vogt AM, 2003, BLOOD, V101, P2405, DOI 10.1182/blood-2002-07-2016; Vogt AM, 2006, PLOS PATHOG, V2, P853, DOI 10.1371/journal.ppat.0020100; WAHLGREN M, 1989, PARASITOL TODAY, V5, P183, DOI 10.1016/0169-4758(89)90141-5; Wolofsky KT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002942	63	29	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145120	10.1371/journal.pone.0145120	http://dx.doi.org/10.1371/journal.pone.0145120			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714011	Green Published, gold			2022-12-26	WOS:000367481900033
J	Luo, M; Li, JX; Sun, XS; Lai, R; Wang, YF; Xu, XW; Sheng, WL				Luo, Man; Li, Jiaoxing; Sun, Xunsha; Lai, Rong; Wang, Yufang; Xu, Xiaowei; Sheng, Wenli			Interactions among Candidate Genes Selected by Meta-Analyses Resulting in Higher Risk of Ischemic Stroke in a Chinese Population	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; INSERTION DELETION POLYMORPHISM; ATHEROSCLEROSIS; CONFERS; ASSOCIATION; GENOTYPES	Ischemic stroke (IS) is a multifactorial disorder caused by both genetic and environmental factors. The combined effects of multiple susceptibility genes might result in a higher risk for IS than a single gene. Therefore, we investigated whether interactions among multiple susceptibility genes were associated with an increased risk of IS by evaluating gene polymorphisms identified in previous meta-analyses, including methylenetetrahydrofolate reductase (MTHFR) C677T, beta fibrinogen (FGB, beta-FG) A455G and T148C, apolipoprotein E (APOE) epsilon 2-4, angiotensin-converting enzyme (ACE) insertion/deletion (I/D), and endothelial nitric oxide synthase (eNOS) G894T. In order to examine these interactions, 712 patients with IS and 774 controls in a Chinese Han population were genotyped using the SNaPshot method, and multifactor dimensionality reduction analysis was used to detect potential interactions among the candidate genes. The results of this study found that ACE I/D and beta-FG T148C were significant synergistic contributors to IS. In particular, the ACE DD + beta-FG 148CC, ACE DD + beta-FG 148CT, and ACE ID + beta-FG 148CC genotype combinations resulted in higher risk of IS. After adjusting for potential confounding IS risk factors (age, gender, family history of IS, hypertension history and history of diabetes mellitus) using a logistic analysis, a significant correlation between the genotype combinations and IS patients persisted (overall stroke: adjusted odds ratio [OR] = 1.57, 95% confidence interval [CI]: 1.22-2.02, P < 0.001, large artery atherosclerosis subtype: adjusted OR = 1.50, 95% CI: 1.08-2.07, P = 0.016, small-artery occlusion subtype: adjusted OR = 2.04, 95% CI: 1.43-2.91, P < 0.001). The results of this study indicate that the ACE I/D and beta-FG T148C combination may result in significantly higher risk of IS in this Chinese population.	[Luo, Man; Li, Jiaoxing; Sun, Xunsha; Lai, Rong; Wang, Yufang; Sheng, Wenli] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China; [Xu, Xiaowei] Weifang Peoples Hosp, Dept Neurol, Weifang, Shandong, Peoples R China	Sun Yat Sen University	Xu, XW (corresponding author), Weifang Peoples Hosp, Dept Neurol, Weifang, Shandong, Peoples R China.	qyeileen@163.com; shengwl@mail.sysu.edu.cn		Sheng, Wenli/0000-0001-6867-371X; Luo, Man/0000-0002-0543-9763	National Natural Science Foundation of China [81070912]; Guangxi Natural Science Foundation [2013GXNSFBA019131, 2015GXNSFAA139171]; Self-financing Science Foundation of Guangxi Health Bureau [Z2012096]; Shandong Province Excellent Young Scientist Research Award Fund [BS2012YY035]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province); Self-financing Science Foundation of Guangxi Health Bureau; Shandong Province Excellent Young Scientist Research Award Fund	This work was supported by National Natural Science Foundation of China (81070912, http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list), Guangxi Natural Science Foundation (2013GXNSFBA019131) and (2015GXNSFAA139171), Self-financing Science Foundation of Guangxi Health Bureau (#Z2012096), and Shandong Province Excellent Young Scientist Research Award Fund (#BS2012YY035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Culverhouse R, 2002, AM J HUM GENET, V70, P461, DOI 10.1086/338759; DANSER AHJ, 1995, CIRCULATION, V92, P1387, DOI 10.1161/01.CIR.92.6.1387; Fish RJ, 2012, THROMB HAEMOSTASIS, V108, P419, DOI 10.1160/TH12-04-0273; Flossmann E, 2004, STROKE, V35, P212, DOI 10.1161/01.STR.0000107187.84390.AA; Gao XG, 2006, NEUROSCI LETT, V398, P172, DOI 10.1016/j.neulet.2005.12.078; Green D, 2009, ATHEROSCLEROSIS, V202, P623, DOI 10.1016/j.atherosclerosis.2008.05.039; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Hassan A, 2000, BRAIN, V123, P1784, DOI 10.1093/brain/123.9.1784; HUMPHRIES SE, 1987, LANCET, V1, P1452, DOI 10.1016/S0140-6736(87)92205-7; Juo SHH, 2009, FRONT BIOSCI-LANDMRK, V14, P4525, DOI 10.2741/3545; Kardys I, 2007, THROMB HAEMOSTASIS, V97, P288, DOI 10.1160/TH06-10-0554; Li W, 2012, CNS NEUROSCI THER, V18, P558, DOI 10.1111/j.1755-5949.2012.00322.x; Luo M, 2014, CNS NEUROSCI THER, V20, P893, DOI 10.1111/cns.12298; Luo M, 2014, J CLIN NEUROSCI, V21, P1740, DOI 10.1016/j.jocn.2013.12.034; Pezzini A, 2005, STROKE, V36, P533, DOI 10.1161/01.STR.0000155741.31499.c2; RIGAT B, 1992, NUCLEIC ACIDS RES, V20, P1433, DOI 10.1093/nar/20.6.1433-a; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; Sharma P, 1996, J HYPERTENS, V14, P277, DOI 10.1097/00004872-199603000-00002; Shen CD, 2007, ANN HUM GENET, V71, P620, DOI 10.1111/j.1469-1809.2007.00364.x; Traylor M, 2012, LANCET NEUROL, V11, P951, DOI 10.1016/S1474-4422(12)70234-X; Wang MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060472; Wang YT, 2013, ATHEROSCLEROSIS, V226, P3, DOI 10.1016/j.atherosclerosis.2012.08.018; Xu XW, 2008, CEREBROVASC DIS, V26, P48, DOI 10.1159/000135653	25	5	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145399	10.1371/journal.pone.0145399	http://dx.doi.org/10.1371/journal.pone.0145399			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710338	Green Submitted, gold, Green Published			2022-12-26	WOS:000367451400044
J	Wang, B; Swaminathan, S; Bhattacharyya, MK				Wang, Bing; Swaminathan, Sivakumar; Bhattacharyya, Madan K.			Identification of Fusarium virguliforme FvTox1-Interacting Synthetic Peptides for Enhancing Foliar Sudden Death Syndrome Resistance in Soybean	PLOS ONE			English	Article							ANTHRAX TOXIN; PROTECTION; INHIBITORS; PATHOGEN; ANTIBODY; SOLANI; PLANTS	Soybean is one of the most important crops grown across the globe. In the United States, approximately 15% of the soybean yield is suppressed due to various pathogen and pests attack. Sudden death syndrome (SDS) is an emerging fungal disease caused by Fusarium virguliforme. Although growing SDS resistant soybean cultivars has been the main method of controlling this disease, SDS resistance is partial and controlled by a large number of quantitative trait loci (QTL). A proteinacious toxin, FvTox1, produced by the pathogen, causes foliar SDS. Earlier, we demonstrated that expression of an anti-FvTox1 single chain variable fragment antibody resulted in reduced foliar SDS development in transgenic soybean plants. Here, we investigated if synthetic FvTox1-interacting peptides, displayed on M13 phage particles, can be identified for enhancing foliar SDS resistance in soybean. We screened three phage-display peptide libraries and discovered four classes of M13 phage clones displaying FvTox1-interacting peptides. In vitro pull-down assays and in vivo interaction assays in yeast were conducted to confirm the interaction of FvTox1 with these four synthetic peptides and their fusion-combinations. One of these peptides was able to partially neutralize the toxic effect of FvTox1 in vitro. Possible application of the synthetic peptides in engineering SDS resistance soybean cultivars is discussed.	[Wang, Bing; Swaminathan, Sivakumar; Bhattacharyya, Madan K.] Iowa State Univ, Dept Agron, Ames, IA 50011 USA	Iowa State University	Bhattacharyya, MK (corresponding author), Iowa State Univ, Dept Agron, Ames, IA 50011 USA.	mbhattac@iastate.edu	bing, wang/ABG-9255-2020	Swaminathan, Sivakumar/0000-0003-3931-275X	National Institute of Food and Agriculture (NIFA), United States Department of Agriculture [2013-68004-20374]	National Institute of Food and Agriculture (NIFA), United States Department of Agriculture	This work was supported by the National Institute of Food and Agriculture (NIFA), United States Department of Agriculture (Grant no. 2013-68004-20374).; We thank Jordan L Baumbach for reviewing the manuscript. This work was supported by the National Institute of Food and Agriculture (NIFA), United States Department of Agriculture (Grant no. 2013-68004-20374).	Abdeen SJ, 2010, ACS CHEM BIOL, V5, P1097, DOI 10.1021/cb100209b; Abeysekara NS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093667; Bashat S, 2006, P NATL ACAD SCI USA, V103, P13509, DOI 10.1073/pnas.0509870103; Bishop-Hurley SL, 2002, APPL ENVIRON MICROB, V68, P3315, DOI 10.1128/AEM.68.7.3315-3320.2002; Brar HK, 2012, MOL PLANT MICROBE IN, V25, P817, DOI 10.1094/MPMI-12-11-0317; Brar HK, 2011, MOL PLANT MICROBE IN, V24, P1179, DOI 10.1094/MPMI-12-10-0285; Fang ZWD, 2010, PHYTOPATHOLOGY, V100, P1111, DOI 10.1094/PHYTO-12-09-0365; Fang ZD, 2006, P NATL ACAD SCI USA, V103, P18444, DOI 10.1073/pnas.0605542103; Hartman GL, 2015, CROP PROT, V73, P60, DOI 10.1016/j.cropro.2015.01.017; Hirrel M. C., 1987, AM SEED TRAD ASS 16, P95; Ji J, 2006, PLANT BIOLOGY, V8, P597, DOI 10.1055/s-2006-924175; Jin H, 1996, PHYTOPATHOLOGY, V86, P277, DOI 10.1094/Phyto-86-277; Kushwaha R, 2013, COMPUT MATH METHODS, V2013; Li S, 1999, PLANT CELL REP, V18, P375, DOI 10.1007/s002990050589; Liu B, 2005, PLANT BIOTECHNOL J, V3, P487, DOI 10.1111/j.1467-7652.2005.00139.x; Marcos JF, 2008, ANNU REV PHYTOPATHOL, V46, P273, DOI 10.1146/annurev.phyto.121307.094843; Morin H, 2007, J BIOTECHNOL, V128, P423, DOI 10.1016/j.jbiotec.2006.10.013; Mourez M, 2001, NAT BIOTECHNOL, V19, P958, DOI 10.1038/nbt1001-958; North B, 2011, J MOL BIOL, V406, P228, DOI 10.1016/j.jmb.2010.10.030; Park HY, 2009, J MICROBIOL METH, V78, P54, DOI 10.1016/j.mimet.2009.04.006; Peschen D, 2004, NAT BIOTECHNOL, V22, P732, DOI 10.1038/nbt970; Petsalaki E, 2008, CURR OPIN BIOTECH, V19, P344, DOI 10.1016/j.copbio.2008.06.004; Pudake RN, 2013, CURR GENET, V59, P107, DOI 10.1007/s00294-013-0392-z; Rao SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056081; Rebollar A, 2013, MOL PLANT MICROBE IN, V26, P1407, DOI 10.1094/MPMI-04-13-0110-R; Sambrook J, 2001, MOL CLONING LAB MANU; Sidhu SS, 2001, BIOMOL ENG, V18, P57, DOI 10.1016/S1389-0344(01)00087-9; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Vanhee P, 2011, TRENDS BIOTECHNOL, V29, P231, DOI 10.1016/j.tibtech.2011.01.004; Westphal A, 2008, PLANT HEAL INSTR; Wrather JA, 2011, SOYBEAN DIS LOSS EST	31	10	11	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145156	10.1371/journal.pone.0145156	http://dx.doi.org/10.1371/journal.pone.0145156			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709700	gold, Green Published			2022-12-26	WOS:000367451400022
J	Kirkham, AJ; Hayes, AE; Pawling, R; Tipper, SP				Kirkham, Alexander J.; Hayes, Amy E.; Pawling, Ralph; Tipper, Steven P.			Facial Mimicry and Emotion Consistency: Influences of Memory and Context	PLOS ONE			English	Article							EXPRESSIONS; RESPONSES; CONSEQUENCES; PERCEPTION; IMPACT; FACES	This study investigates whether mimicry of facial emotions is a stable response or can instead be modulated and influenced by memory of the context in which the emotion was initially observed, and therefore the meaning of the expression. The study manipulated emotion consistency implicitly, where a face expressing smiles or frowns was irrelevant and to be ignored while participants categorised target scenes. Some face identities always expressed emotions consistent with the scene (e.g., smiling with a positive scene), whilst others were always inconsistent (e.g., frowning with a positive scene). During this implicit learning of face identity and emotion consistency there was evidence for encoding of face-scene emotion consistency, with slower RTs, a reduction in trust, and inhibited facial EMG for faces expressing incompatible emotions. However, in a later task where the faces were subsequently viewed expressing emotions with no additional context, there was no evidence for retrieval of prior emotion consistency, as mimicry of emotion was similar for consistent and inconsistent individuals. We conclude that facial mimicry can be influenced by current emotion context, but there is little evidence of learning, as subsequent mimicry of emotionally consistent and inconsistent faces is similar.	[Kirkham, Alexander J.; Tipper, Steven P.] Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England; [Hayes, Amy E.] Bangor Univ, Sch Sport Hlth & Exercise Sci, Bangor LL57 2PZ, Gwynedd, Wales; [Pawling, Ralph] Liverpool John Moores Univ, Sch Nat Sci & Psychol, Liverpool L3 3AF, Merseyside, England	University of York - UK; Bangor University; Liverpool John Moores University	Tipper, SP (corresponding author), Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England.	steven.tipper@york.ac.uk	Pawling, Ralph/V-6370-2019		Economic and Social Research Council [ES/K000012/1]; ESRC [ES/K000012/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was supported by the Economic and Social Research Council (http://www.esrc.ac.uk/) under Grant ES/K000012/1 awarded to SPT and AEH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey PE, 2009, PSYCHOL AGING, V24, P995, DOI 10.1037/a0015789; Bayliss AP, 2012, PSYCHOPHYSIOLOGY, V49, P1571, DOI 10.1111/j.1469-8986.2012.01481.x; Bourgeois P, 2008, BIOL PSYCHOL, V77, P343, DOI 10.1016/j.biopsycho.2007.11.008; BROWN SL, 1980, BIOL PSYCHOL, V11, P49, DOI 10.1016/0301-0511(80)90026-5; Cannon PR, 2009, COGNITION EMOTION, V23, P918, DOI 10.1080/02699930802234864; Chartrand TL, 2013, ANNU REV PSYCHOL, V64, P285, DOI 10.1146/annurev-psych-113011-143754; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Dimberg U, 2000, PSYCHOL SCI, V11, P86, DOI 10.1111/1467-9280.00221; Dimberg U, 1998, SCAND J PSYCHOL, V39, P39, DOI 10.1111/1467-9450.00054; Dimberg U, 2002, COGNITION EMOTION, V16, P449, DOI 10.1080/02699930143000356; Fischer AH., 2008, HDB EMOTIONS, P456, DOI DOI 10.2307/2076468; Fridlund A. J., 1986, J PSYCHOPHYSIOL, V23, P567, DOI DOI 10.1111/J.1469-8986.1986.TB00676.X; Halberstadt J, 2009, PSYCHOL SCI, V20, P1254, DOI 10.1111/j.1467-9280.2009.02432.x; Hess U, 2001, EMOTIONS QUALIA CONS, P397; Hess U, 2014, COLLECTIVE EMOTIONS; Hofman D, 2012, P ROY SOC B-BIOL SCI, V279, P3535, DOI 10.1098/rspb.2012.0694; Korb S, 2010, BIOL PSYCHOL, V85, P347, DOI 10.1016/j.biopsycho.2010.07.012; Lakin J. L., 2006, SAGE HDB NONVERBAL C, P59, DOI [10.4135/9781412976152.n4, DOI 10.4135/9781412976152.N4]; Lang P.J., 2008, A8 U FLOR; LANZETTA JT, 1989, J PERS SOC PSYCHOL, V56, P543, DOI 10.1037/0022-3514.56.4.543; Larsen JT, 2003, PSYCHOPHYSIOLOGY, V40, P776, DOI 10.1111/1469-8986.00078; Likowski KU, 2008, J EXP SOC PSYCHOL, V44, P1065, DOI 10.1016/j.jesp.2007.10.007; Lundqvist D., 1998, KAROLINSKA DIRECTED; Moody EJ, 2007, EMOTION, V7, P447, DOI 10.1037/1528-3542.7.2.447; Reber AS, 1999, NATURE COGNITION; RINN WE, 1984, PSYCHOL BULL, V95, P52, DOI 10.1037/0033-2909.95.1.52; Schneider W., 2002, E PRIME USERS GUIDE; Sonnby-Borgstrom M, 2002, SCAND J PSYCHOL, V43, P433, DOI 10.1111/1467-9450.00312; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; van Boxtel A, 2010, P MEAS BEH 2010 AUG; van der Schalk J, 2011, EMOTION, V11, P286, DOI 10.1037/a0022582; ZAJONC RB, 1980, AM PSYCHOL, V35, P151, DOI 10.1037/0003-066X.35.2.151	32	3	3	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145731	10.1371/journal.pone.0145731	http://dx.doi.org/10.1371/journal.pone.0145731			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ4SI	26698864	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000367092600124
J	Palem, PPC; Kuriakose, GC; Jayabaskaran, C				Palem, Padmini P. C.; Kuriakose, Gini C.; Jayabaskaran, Chelliah			An Endophytic Fungus, Talaromyces radicus, Isolated from Catharanthus roseus, Produces Vincristine and Vinblastine, Which Induce Apoptotic Cell Death	PLOS ONE			English	Article							ALKALOIDS; TAXOL	Endophytic fungi isolated from Catharanthus roseus were screened for the production of vincristine and vinblastine. Twenty-two endophytic fungi isolated from various tissues of C. roseus were characterized taxonomically by sequence analysis of the internal transcribed spacer (ITS) region of rDNA and grouped into 10 genera: Alternaria, Aspergillus, Chaetomium, Colletotrichum, Dothideomycetes, Eutypella, Eutypa, Flavodon, Fusarium and Talaromyces. The antiproliferative activity of these fungi was assayed in HeLa cells using the MTT assay. The fungal isolates Eutypella sp-CrP14, obtained from stem tissues, and Talaromyces radicus-CrP20, obtained from leaf tissues, showed the strongest antiproliferative activity, with IC50 values of 13.5 mu g/ml and 20 mu g/ml, respectively. All 22 endophytic fungi were screened for the presence of the gene encoding tryptophan decarboxylase (TDC), the key enzyme in the terpenoid indole alkaloid biosynthetic pathway, though this gene could only be amplified from T. radicus-CrP20 (NCBI GenBank accession number KC920846). The production of vincristine and vinblastine by T. radicus-CrP20 was confirmed and optimized in nine different liquid media. Good yields of vincristine (670 mu g/l) in modified M2 medium and of vinblastine (70 mu g/l) in potato dextrose broth medium were obtained. The cytotoxic activity of partially purified fungal vincristine was evaluated in different human cancer cell lines, with HeLa cells showing maximum susceptibility. The apoptosis-inducing activity of vincristine derived from this fungus was established through cell cycle analysis, loss of mitochondrial membrane potential and DNA fragmentation patterns.	[Palem, Padmini P. C.; Kuriakose, Gini C.; Jayabaskaran, Chelliah] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Jayabaskaran, C (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	jbc.biochem.iisc@gmail.com	Anantharaman, Perumal/AAI-4015-2020	Anantharaman, Perumal/0000-0001-6396-9845	Department of Science and Technology (DST), New Delhi, India [SR/WOS-A/LS-407/2011]; Department of Biotechnology (DBT), New Delhi, India; University Grants Commission (UGC), New Delhi, India	Department of Science and Technology (DST), New Delhi, India(Department of Science & Technology (India)); Department of Biotechnology (DBT), New Delhi, India(Department of Biotechnology (DBT) India); University Grants Commission (UGC), New Delhi, India(University Grants Commission, India)	PPCP thanks the Department of Science and Technology (DST), New Delhi, India for providing the grant under Women Scientist Scheme (SR/WOS-A/LS-407/2011). CJB thanks Department of Biotechnology (DBT), New Delhi, India for the financial support under IISc-DBT partnership program. GCK thanks University Grants Commission (UGC), New Delhi, India for the award of Kothari fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aslam J, 2011, ACTA PHYSIOL PLANT, V33, P473, DOI 10.1007/s11738-010-0569-8; Chakravarthi BVSK, 2008, J BIOSCIENCES, V33, P259, DOI 10.1007/s12038-008-0043-6; Chandra S, 2012, APPL MICROBIOL BIOT, V95, P47, DOI 10.1007/s00253-012-4128-7; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; DELUCA V, 1989, P NATL ACAD SCI USA, V86, P2582; DEMAIN AL, 1981, SCIENCE, V214, P987, DOI 10.1126/science.6946560; Eyberger AL, 2006, J NAT PROD, V69, P1121, DOI 10.1021/np060174f; FRAKER PJ, 1995, METHOD CELL BIOL, V46, P57; Gangadevi V., 2008, MYCOL BALC, V5, P1, DOI DOI 10.5281/zenodo.2548403; Gini CK, 2014, PHARM ANAL ACTA, V5, P4; Goklany S, 2009, BIOTECHNOL PROGR, V25, P1289, DOI 10.1002/btpr.204; GONG JP, 1994, ANAL BIOCHEM, V218, P314, DOI 10.1006/abio.1994.1184; Groninger E, 2002, INT J ONCOL, V21, P1339; HASHIMOTO T, 1994, ANNU REV PLANT PHYS, V45, P257, DOI 10.1146/annurev.pp.45.060194.001353; Ishikawa H, 2009, J AM CHEM SOC, V131, P4904, DOI 10.1021/ja809842b; Jayabaskaran C, 2008, J MOL SIGNAL, V3, P1; Ji YuBin, 2014, Journal of Chemical and Pharmaceutical Research, V6, P338; Kaufmann SH, 2000, EXP CELL RES, V256, P42, DOI 10.1006/excr.2000.4838; Kharwar RN, 2008, CURR SCI INDIA, V95, P228; Kumar A., 2013, INT J BOT, V3, P1; Kumar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064364; Kumaran RS, 2008, ENG LIFE SCI, V8, P438, DOI 10.1002/elsc.200800019; Kusari S, 2011, J NAT PROD, V74, P764, DOI 10.1021/np1008398; Kusari S, 2009, J NAT PROD, V72, P2, DOI 10.1021/np800455b; Lee SB, 1990, PCR PROTOCOLS GUIDE, P280; Momsia T, 2013, INT J LIFE SCI BIOTE, V2, P82; NOBLE RL, 1990, BIOCHEM CELL BIOL, V68, P1344, DOI 10.1139/o90-197; OKAMI Y, 1986, MICROBIAL ECOL, V12, P65, DOI 10.1007/BF02153223; Qui M, 2010, ANN MICROBIOL, V60, P143; Ramani S., 2013, NATURAL PRODUCTS, P575, DOI DOI 10.1007/978-3-642-22144-6_21; Saxton GE, 1994, MONOTERPENOID INDOLE, P715; Shams KA, 2009, AFR J TRADIT COMPLEM, V6, P118; STROBEL G, 1993, MYCOTAXON, V47, P71; Strobel G, 1996, MICROBIOL-UK, V142, P435, DOI 10.1099/13500872-142-2-435; Tanaka Y., 1992, SEARCH BIOACTIVE COM, P303; VANDELOOSDRECHT AA, 1994, J IMMUNOL METHODS, V174, P311, DOI 10.1016/0022-1759(94)90034-5; Visagie CM, 2012, PERSOONIA, V28, P14, DOI 10.3767/003158512X632455; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wilson D, 2000, BOOK SOIL P, P389; [杨昱志 Yang Yuzhi], 2004, [中草药, Chinese Traditional and Herbal Drugs], V35, P79; Zhang LQ, 2000, CHIN TRADIT HERB DRU, V31, P805; Zhao J, 2011, MINI-REV MED CHEM, V11, P159, DOI 10.2174/138955711794519492	43	47	49	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0144476	10.1371/journal.pone.0144476	http://dx.doi.org/10.1371/journal.pone.0144476			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26697875	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000367092600020
J	Robinson, KJ; Twiss, SD; Hazon, N; Pomeroy, PP				Robinson, Kelly J.; Twiss, Sean D.; Hazon, Neil; Pomeroy, Patrick P.			Maternal Oxytocin Is Linked to Close Mother-Infant Proximity in Grey Seals (Halichoerus grypus)	PLOS ONE			English	Article							PLASMA OXYTOCIN; REPRODUCTIVE SUCCESS; NORTH RONA; BEHAVIOR; VASOPRESSIN; RELEASE; BRAIN; DEPRESSION; LACTATION; SHEEP	Maternal behaviour is a crucial component of reproduction in all mammals; however the quality of care that mothers give to infants can vary greatly. It is vital to document variation in maternal behaviour caused by the physiological processes controlling its expression. This underlying physiology should be conserved throughout reproductive events and should be replicated across all individuals of a species; therefore, any correlates to maternal care quality may be present across many individuals or contexts. Oxytocin modulates the initiation and expression of maternal behaviour in mammals; therefore we tested whether maternal plasma oxytocin concentrations correlated to key maternal behaviours in wild grey seals (Halichoerus grypus). Plasma oxytocin concentrations in non-breeding individuals (4.3 +/- 0.5 pg/ml) were significantly lower than those in mothers with dependent pups in both early (8.2 +/- 0.8 pg/ml) and late (6.9 +/- 0.7 pg/ml) lactation. Maternal plasma oxytocin concentrations were not correlated to the amount of nursing prior to sampling, or a mother's nursing intensity throughout the dependant period. Mothers with high plasma oxytocin concentrations stayed closer to their pups, reducing the likelihood of mother-pup separation during lactation which is credited with causing starvation, the largest cause of pup mortality in grey seals. This is the first study to link endogenous oxytocin concentrations in wild mammalian mothers with any type of maternal behaviour. Oxytocin's structure and function is widely conserved across mammalian mothers, including humans. Defining the impact the oxytocin system has on maternal behaviour highlights relationships that may occur across many individuals or species, and such behaviours heavily influence infant development and an individual's lifetime reproductive success.	[Robinson, Kelly J.; Pomeroy, Patrick P.] Univ St Andrews, Scottish Oceans Inst, Sea Mammal Res Unit, St Andrews, Fife, Scotland; [Twiss, Sean D.] Univ Durham, Sch Biol & Biomed Sci, Durham, England; [Hazon, Neil] Univ St Andrews, Scottish Oceans Inst, St Andrews KY16 9AJ, Fife, Scotland	University of St Andrews; Durham University; University of St Andrews	Robinson, KJ (corresponding author), Univ St Andrews, Scottish Oceans Inst, Sea Mammal Res Unit, St Andrews, Fife, Scotland.	kjr33@st-andrews.ac.uk		Robinson, Kelly/0000-0002-6212-9710; pomeroy, patrick/0000-0003-1603-5630; Twiss, Sean/0000-0002-1923-8874	UK's Natural Environmental Research Council; NERC [NE/G008930/1]; UK Natural Environment Research Council [NE/H524930/1]; SMRU Marine, St Andrews, UK; Natural Environment Research Council [NE/G008930/1, smru10001] Funding Source: researchfish	UK's Natural Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); SMRU Marine, St Andrews, UK; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The UK's Natural Environmental Research Council (http://www.nerc.ac.uk/) funded the long term program of research on grey seals at North Rona and the Isle of May. PPP and SDT were in receipt of NERC grant NE/G008930/1 during the work. This paper formed part of KJR's PhD funded by the UK Natural Environment Research Council grant NE/H524930/1 and by SMRU Marine (http://www.smru.st-andrews.ac.uk/), St Andrews, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER G, 1986, APPL ANIM BEHAV SCI, V16, P295, DOI 10.1016/0168-1591(86)90122-X; ANDERSON SS, 1979, J ZOOL, V189, P407, DOI 10.1111/j.1469-7998.1979.tb03972.x; Atzil S, 2011, NEUROPSYCHOPHARMACOL, V36, P2603, DOI 10.1038/npp.2011.172; BAKER JR, 1988, J ZOOL, V216, P529, DOI 10.1111/j.1469-7998.1988.tb02449.x; Bales KL, 2007, HORM BEHAV, V52, P274, DOI 10.1016/j.yhbeh.2007.05.004; Baskerville TA, 2010, CNS NEUROSCI THER, V16, pe92, DOI 10.1111/j.1755-5949.2010.00154.x; Boness DJ, 1996, BIOSCIENCE, V46, P645, DOI 10.2307/1312894; BOYD JM, 1971, J ZOOL, V164, P469, DOI 10.1111/j.1469-7998.1971.tb01331.x; Broad KD, 2006, PHILOS T R SOC B, V361, P2199, DOI 10.1098/rstb.2006.1940; BURTON RW, 1975, J ZOOL, V177, P197, DOI 10.1111/j.1469-7998.1975.tb05978.x; CLUTTONBROCK TH, 1984, AM NAT, V123, P212, DOI 10.1086/284198; Conradt L, 1999, OECOLOGIA, V120, P218, DOI 10.1007/s004420050851; Culloch R., 2012, THESIS; DaCosta APC, 1996, J NEUROENDOCRINOL, V8, P163, DOI 10.1046/j.1365-2826.1996.04411.x; DAWOOD MY, 1981, J CLIN ENDOCR METAB, V52, P678, DOI 10.1210/jcem-52-4-678; Degabriel JL, 2009, ECOLOGY, V90, P711, DOI 10.1890/08-0940.1; DREWETT RF, 1982, HORM BEHAV, V16, P245, DOI 10.1016/0018-506X(82)90023-X; Dwyer CM, 2008, J NEUROENDOCRINOL, V20, P526, DOI 10.1111/j.1365-2826.2008.01657.x; Dwyer CM, 2005, APPL ANIM BEHAV SCI, V92, P235, DOI 10.1016/j.applanim.2005.05.010; ELMASRY N, 2010, CURRENT PSYCHIAT, V17, P31; Everett-Hincks JM, 2005, LIVEST PROD SCI, V93, P51, DOI 10.1016/j.livprodsci.2004.11.006; Fairbanks LA., 1996, ADV STUDY BEHAV VOL, V25, P579, DOI [10.1016/S0065-3454(08)60343-5, DOI 10.1016/S0065-3454(08)60343-5]; FEDAK MA, 1982, J ZOOL, V198, P473, DOI 10.1111/jzo.1982.198.4.473; Feldman R, 2007, PSYCHOL SCI, V18, P965, DOI 10.1111/j.1467-9280.2007.02010.x; Feldman R, 2010, PSYCHONEUROENDOCRINO, V35, P1133, DOI 10.1016/j.psyneuen.2010.01.013; FOGDEN SCL, 1971, J ZOOL, V164, P61; Galbally M, 2011, HARVARD REV PSYCHIAT, V19, P1, DOI 10.3109/10673229.2011.549771; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Gossen A, 2012, NEUROPEPTIDES, V46, P211, DOI 10.1016/j.npep.2012.07.001; Haaland P, 2011, CALIBFIT STAT MODEL; Hall AJ, 2001, J ANIM ECOL, V70, P138; Haller MA, 1996, CAN J ZOOL, V74, P1531, DOI 10.1139/z96-167; Heinrichs M, 2008, PROG BRAIN RES, V170, P337, DOI 10.1016/S0079-6123(08)00428-7; Hiby L., 1990, Reports of the International Whaling Commission Special Issue, P57; HIGUCHI T, 1985, J ENDOCRINOL, V105, P339, DOI 10.1677/joe.0.1050339; Hoge EA, 2012, DEPRESS ANXIETY, V29, P924, DOI 10.1002/da.21973; Holt-Lunstad J, 2011, PSYCHONEUROENDOCRINO, V36, P1249, DOI 10.1016/j.psyneuen.2011.03.007; Houpt KA, 2002, APPL ANIM BEHAV SCI, V78, P319, DOI 10.1016/S0168-1591(02)00111-9; Insel TR, 2010, NEURON, V65, P768, DOI 10.1016/j.neuron.2010.03.005; IVERSON SJ, 1993, PHYSIOL ZOOL, V66, P61, DOI 10.1086/physzool.66.1.30158287; Kendrick KM, 2000, EXP PHYSIOL, V85, p111S, DOI 10.1111/j.1469-445X.2000.tb00014.x; KOVACS KM, 1987, J ZOOL, V213, P697, DOI 10.1111/j.1469-7998.1987.tb03735.x; Kunkele J, 1997, PHYSIOL ZOOL, V70, P571; Landgraf R, 2004, FRONT NEUROENDOCRIN, V25, P150, DOI 10.1016/j.yfrne.2004.05.001; Leuine A, 2007, PEPTIDES, V28, P1162, DOI 10.1016/j.peptides.2007.04.016; LEVY F, 1995, BRAIN RES, V669, P197, DOI 10.1016/0006-8993(94)01236-B; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Madden JR, 2011, P ROY SOC B-BIOL SCI, V278, P1189, DOI 10.1098/rspb.2010.1675; Maestripieri D, 2009, PHYSIOL BEHAV, V96, P613, DOI 10.1016/j.physbeh.2008.12.016; McCulloch S, 1999, CAN J ZOOL, V77, P716, DOI 10.1139/cjz-77-5-716; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Modahl C, 1998, BIOL PSYCHIAT, V43, P270, DOI 10.1016/S0006-3223(97)00439-3; Nelson RJ, 2000, INTRO BEHAV ENDOCRIN, P337; Neumann ID, 2012, TRENDS NEUROSCI, V35, P649, DOI 10.1016/j.tins.2012.08.004; Newberry RC, APPL ANIM BEHAV SCI; Olsson IAS, 2003, APPL ANIM BEHAV SCI, V81, P245, DOI 10.1016/S0168-1591(02)00285-X; Otero-Garcia M, 2015, BRAIN STRUCT FUNCT, P1; Perry EA, 1998, MOL ECOL, V7, P81, DOI 10.1046/j.1365-294x.1998.00313.x; Poland VF, 2008, MAR MAMMAL SCI, V24, P371, DOI 10.1111/j.1748-7692.2008.00191.x; Pomeroy PP, 1999, J ANIM ECOL, V68, P235, DOI 10.1046/j.1365-2656.1999.00281.x; *R COR DEV TEAM, 2012, R LANG ENV STAT COMP; Rahman A, 2004, ARCH GEN PSYCHIAT, V61, P946, DOI 10.1001/archpsyc.61.9.946; Redman P., 2002, THESIS; Robinson KJ, 2014, J NEUROSCI METH, V226, P73, DOI 10.1016/j.jneumeth.2014.01.019; RYDEN G, 1969, ACTA ENDOCRINOL-COP, V61, P425, DOI 10.1530/acta.0.0610425; Scantamburlo G, 2007, PSYCHONEUROENDOCRINO, V32, P407, DOI 10.1016/j.psyneuen.2007.01.009; Skrundz M, 2011, NEUROPSYCHOPHARMACOL, V36, P1886, DOI 10.1038/npp.2011.74; Smout S, 2011, ENVIRON ECOL STAT, V18, P331, DOI 10.1007/s10651-010-0135-y; Strathearn L, 2009, NEUROPSYCHOPHARMACOL, V34, P2655, DOI 10.1038/npp.2009.103; Szeto A, 2011, PSYCHOSOM MED, V73, P393, DOI 10.1097/PSY.0b013e31821df0c2; Trillmich F, 2010, ANIMAL BEHAVIOUR: EVOLUTION AND MECHANISMS, P267, DOI 10.1007/978-3-642-02624-9_10; Tsuneoka Y, 2013, J COMP NEUROL, V521, P1633, DOI 10.1002/cne.23251; Turner RA, 1999, PSYCHIATRY, V62, P97, DOI 10.1080/00332747.1999.11024859; Twiss SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049598; Twiss SD, 2012, MAR MAMMAL SCI, V28, pE280, DOI 10.1111/j.1748-7692.2011.00523.x; Wood S., 2012, MGCV MIXED GAM COMPU; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2006, BIOMETRICS, V62, P1025, DOI 10.1111/j.1541-0420.2006.00574.x; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x	79	13	13	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0144577	10.1371/journal.pone.0144577	http://dx.doi.org/10.1371/journal.pone.0144577			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26698856	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000367092600024
J	Martinez-Moreno, JM; Herencia, C; de Oca, AM; Munoz-Castaneda, JR; Rodriguez-Ortiz, ME; Diaz-Tocados, JM; Peralbo-Santaella, E; Camargo, A; Canalejo, A; Rodriguez, M; Velasco-Gimena, F; Almaden, Y				Martinez-Moreno, Julio M.; Herencia, Carmen; Montes de Oca, Addy; Munoz-Castaneda, Juan R.; Encarnacion Rodriguez-Ortiz, M.; Diaz-Tocados, Juan M.; Peralbo-Santaella, Esther; Camargo, Antonio; Canalejo, Antonio; Rodriguez, Mariano; Velasco-Gimena, Francisco; Almaden, Yolanda			Vitamin D modulates tissue factor and protease-activated receptor 2 expression in vascular smooth muscle cells	FASEB JOURNAL			English	Article						calcitriol; NF-kappa B; paricalcitol; TNF-alpha; VDR	CHRONIC KIDNEY-DISEASE; TUMOR-NECROSIS-FACTOR; C-REACTIVE PROTEIN; NF-KAPPA-B; CARDIOVASCULAR-DISEASE; TNF-ALPHA; TRANSCRIPTIONAL ACTIVATION; GENE-EXPRESSION; MONOCYTIC CELLS; D ANALOGS	Clinical and epidemiologic studies reveal an association between vitamin D deficiency and increased risk of cardiovascular disease. Because vascular smooth muscle cell (VSMC)-derived tissue factor (TF) is suggested to be critical for arterial thrombosis, we investigated whether the vitamin D molecules calcitriol and paricalcitol could reduce the expression of TF induced by the proinflammatory cytokine TNF-alpha in human aortic VSMCs. We found that, compared with controls, incubation with TNF-alpha increased TF expression and procoagulant activity in a NF-kappa B-dependent manner, as deduced from the increased nuclear translocation of nuclear factor kappa-light-chain-enhancer of activated B cells protein 65 (p65-NF-kappa B) and direct interaction of NF-kappa B to the TF promoter. This was accompanied by the up-regulation of TF signaling mediator protease-activated receptor 2 (PAR-2) expression and by the down-regulation of vitamin D receptor expression in a miR-346-dependent way. However, addition of calcitriol or paricalcitol blunted the TNF-alpha-induced TF expression and activity (2.01 +/- 0.24 and 1.32 +/- 0.14 vs. 3.02 +/- 0.39 pmol/mg protein, P < 0.05), which was associated with down-regulation of NF-kappa B signaling and PAR-2 expression, as well as with restored levels of vitamin D receptor and enhanced expression of TF pathway inhibitor. Our data suggest that inflammation promotes a prothrombotic state through the up-regulation of TF function in VSMCs and that the beneficial cardiovascular effects of vitamin D may be partially due to decreases in TF expression and its activity in VSMCs.	[Martinez-Moreno, Julio M.; Herencia, Carmen; Montes de Oca, Addy; Diaz-Tocados, Juan M.] Univ Cordoba, Reina Sofia Univ Hosp, Inst Maimonides Invest Biomed Cordoba IMIBIC, Metab & Vasc Calcificat Unit, Cordoba, Spain; [Munoz-Castaneda, Juan R.; Rodriguez, Mariano] Univ Cordoba, Reina Sofia Univ Hosp, Inst Maimonides Invest Biomed Cordoba IMIBIC, Serv Nephrol, Cordoba, Spain; [Peralbo-Santaella, Esther] Univ Cordoba, Reina Sofia Univ Hosp, Inst Maimonides Invest Biomed Cordoba IMIBIC, Microscopy Cyt & Sci Imaging Unit, Cordoba, Spain; [Camargo, Antonio; Almaden, Yolanda] Univ Cordoba, Reina Sofia Univ Hosp, Inst Maimonides Invest Biomed Cordoba IMIBIC, Lipid & Atherosclerosis Unit, Cordoba, Spain; [Velasco-Gimena, Francisco] Univ Cordoba, Reina Sofia Univ Hosp, Inst Maimonides Invest Biomed Cordoba IMIBIC, Hematol Serv, Cordoba, Spain; [Encarnacion Rodriguez-Ortiz, M.] Fdn Jimenez Diaz, IIS, Spanish Renal Res Network REDinREN, Lab Nephrol, E-28040 Madrid, Spain; [Camargo, Antonio; Almaden, Yolanda] Inst Salud Carlos III, Ctr Invest Biomed Red CIBER Fisiopatol Obesidad &, Cordoba, Spain; [Canalejo, Antonio] Univ Huelva, Dept Environm Biol & Publ Hlth, Huelva, Spain	Universidad de Cordoba; Universidad de Cordoba; Universidad de Cordoba; Universidad de Cordoba; Universidad de Cordoba; Fundacion Jimenez Diaz; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Universidad de Huelva	Velasco-Gimena, F (corresponding author), Univ Cordoba, Reina Sofia Univ Hosp, Inst Maimonides Invest Biomed Cordoba IMIBIC, Hematol Serv, Cordoba, Spain.	francisco.velasco.sspa@juntadeandalucia.es	Herencia, Carmen/AAA-6843-2020; Camargo, Antonio/G-9720-2015; Canalejo, Antonio/L-8407-2014; Muñoz-Castañeda, Juan R./AFQ-3443-2022; Martínez, Julio Manuel/AAA-6724-2020; Tocados, Juan Miguel Díaz/I-8254-2018	Camargo, Antonio/0000-0002-0415-4184; Canalejo, Antonio/0000-0003-2098-8960; Martínez, Julio Manuel/0000-0002-1945-5078; Diaz Tocados, Juan Miguel/0000-0001-5192-5212; Munoz-Castaneda, Juan R/0000-0002-9341-0724; Rodriguez, Mariano/0000-0002-9380-6614	AbbVie Pharmaceutical; Plan Nacional of I+D+I; Consejeria de Salud [SAS111221]; Consejeria de Innovacion, Ciencia y Empresa of Junta de Andalucia [P11-CVI-7925]; National Institute of Health Carlos III; Nicolas Monardes Programme, Consejeria de Salud-SAS (Junta de Andalucia); Amgen; Fresenius; AbbVie; Shire; Instituto de Salud Carlos III-Subdireccion General of Evaluacion - FEDER (European Regional Development's funds); Fomento de la Investigacion - FEDER (European Regional Development's funds) [FIS 11/02055]	AbbVie Pharmaceutical(AbbVie); Plan Nacional of I+D+I; Consejeria de Salud; Consejeria de Innovacion, Ciencia y Empresa of Junta de Andalucia(Junta de Andalucia); National Institute of Health Carlos III; Nicolas Monardes Programme, Consejeria de Salud-SAS (Junta de Andalucia)(Junta de Andalucia); Amgen(Amgen); Fresenius; AbbVie(AbbVie); Shire; Instituto de Salud Carlos III-Subdireccion General of Evaluacion - FEDER (European Regional Development's funds); Fomento de la Investigacion - FEDER (European Regional Development's funds)	The authors acknowledge financial support from AbbVie Pharmaceutical. Financial support was also obtained from Plan Nacional of I+D+I 2008-2011 and Instituto de Salud Carlos III-Subdireccion General of Evaluacion and Fomento de la Investigacion (FIS 11/02055), cogranted by FEDER (European Regional Development's funds), Consejeria de Salud (SAS111221), Consejeria de Innovacion, Ciencia y Empresa (P11-CVI-7925) of Junta de Andalucia. M.E.R.-O. is a recipient of a "Sara Borrell" research contract from the National Institute of Health Carlos III. Y.A. is a senior researcher supported by the Nicolas Monardes Programme, Consejeria de Salud-SAS (Junta de Andalucia). M.R. received research grants from Amgen and Fresenius and lecture fees from Amgen, AbbVie, Shire, and Fresenius.	Agmon-Levin N, 2011, ANN RHEUM DIS, V70, P145, DOI 10.1136/ard.2010.134817; Aihara K, 2004, J BIOL CHEM, V279, P35798, DOI 10.1074/jbc.M404865200; Al Mheid I, 2013, EUR HEART J, V34, P3691, DOI 10.1093/eurheartj/eht166; Bastarache JA, 2011, EXP LUNG RES, V37, P509, DOI 10.3109/01902148.2011.605512; Borissoff JI, 2010, CIRCULATION, V122, P821, DOI 10.1161/CIRCULATIONAHA.109.907121; Bover J, 2011, KIDNEY INT SUPPL, V1, P122, DOI 10.1038/kisup.2011.28; Brondum-Jacobsen P, 2012, ARTERIOSCL THROM VAS, V32, P2794, DOI 10.1161/ATVBAHA.112.248039; Broze GJ, 2003, J THROMB HAEMOST, V1, P1671, DOI 10.1046/j.1538-7836.2003.00391.x; BROZE GJ, 1995, THROMB HAEMOSTASIS, V74, P90; Chen YZ, 2014, INFLAMM BOWEL DIS, V20, P1910, DOI 10.1097/MIB.0000000000000158; Chen YZ, 2011, ARCH BIOCHEM BIOPHYS, V507, P241, DOI 10.1016/j.abb.2010.12.020; Chitalia VC, 2013, CIRCULATION, V127, P365, DOI 10.1161/CIRCULATIONAHA.112.118174; Chung J, 2007, LAB INVEST, V87, P540, DOI 10.1038/labinvest.3700550; Cirillo P, 2005, CARDIOVASC RES, V68, P47, DOI 10.1016/j.cardiores.2005.05.010; Clarke DL, 2010, J BIOL CHEM, V285, P29101, DOI 10.1074/jbc.M109.0999952; DRAKE TA, 1989, AM J PATHOL, V134, P1087; Guebre-Egziabher F, 2003, NEPHROLOGIE, V24, P383; Kilkkinen A, 2009, AM J EPIDEMIOL, V170, P1032, DOI 10.1093/aje/kwp227; Koyama T, 1998, BLOOD, V92, P160, DOI 10.1182/blood.V92.1.160.413k16_160_167; Li YD, 2009, J BIOL CHEM, V284, P4473, DOI 10.1074/jbc.M806010200; Loeffen R, 2012, J THROMB HAEMOST, V10, P1207, DOI 10.1111/j.1538-7836.2012.04782.x; Mackman N, 2004, ARTERIOSCL THROM VAS, V24, P1015, DOI 10.1161/01.ATV.0000130465.23430.74; Mackman N, 1997, THROMB HAEMOSTASIS, V78, P747; MACKMAN N, 1991, J EXP MED, V174, P1517, DOI 10.1084/jem.174.6.1517; Mackman N, 2008, ARTERIOSCL THROM VAS, V28, P601, DOI 10.1161/ATVBAHA.108.165050; MARMUR JD, 1993, J CLIN INVEST, V91, P2253, DOI 10.1172/JCI116452; MITSUHASHI T, 1991, J CLIN INVEST, V87, P1889, DOI 10.1172/JCI115213; Navarro-Gonzalez JF, 2009, CLIN J AM SOC NEPHRO, V4, P1646, DOI 10.2215/CJN.02420409; Nie M, 2005, J IMMUNOL, V175, P478, DOI 10.4049/jimmunol.175.1.478; Norman PE, 2014, CIRC RES, V114, P379, DOI 10.1161/CIRCRESAHA.113.301241; Ocak G, 2010, J THROMB HAEMOST, V8, P2428, DOI 10.1111/j.1538-7836.2010.04048.x; Ohsawa M, 2000, CIRCULATION, V102, P2867; Osterud B, 2012, THROMB RES, V129, P274, DOI 10.1016/j.thromres.2011.11.049; Owens AP, 2010, THROMB HAEMOSTASIS, V104, P432, DOI 10.1160/TH09-11-0771; Pilz S, 2008, STROKE, V39, P2611, DOI 10.1161/STROKEAHA.107.513655; Rao LVM, 2012, J THROMB HAEMOST, V10, P2242, DOI 10.1111/jth.12003; Ruf W, 1999, THROMB HAEMOSTASIS, V82, P175; Schaffner F, 2008, SEMIN THROMB HEMOST, V34, P147, DOI 10.1055/s-2008-1079254; Schmidlin Fabien, 2001, Current Opinion in Pharmacology, V1, P575, DOI 10.1016/S1471-4892(01)00099-6; Shen L, 2012, EXP THER MED, V3, P530, DOI 10.3892/etm.2011.432; TAUBMAN MB, 1993, J CLIN INVEST, V91, P547, DOI 10.1172/JCI116234; Teng M, 2003, NEW ENGL J MED, V349, P446, DOI 10.1056/NEJMoa022536; Tukaj S, 2012, ACTA BIOCHIM POL, V59, P395; Wang L, 2009, BLOOD, V113, P705, DOI 10.1182/blood-2007-05-090944; Wu JB, 2008, ARTERIOSCL THROM VAS, V28, P698, DOI 10.1161/ATVBAHA.107.160903; Wu SQ, 2005, AM J PHYSIOL-HEART C, V289, pH873, DOI 10.1152/ajpheart.00993.2004; Wu-Wong JR, 2007, J VASC RES, V44, P11, DOI 10.1159/000097812; Wu-Wong JR, 2006, ATHEROSCLEROSIS, V186, P20, DOI 10.1016/j.atherosclerosis.2005.06.046; Xie CQ, 2011, VITAM HORM, V87, P321, DOI 10.1016/B978-0-12-386015-6.00034-2; Xiong M, 2012, AM J PHYSIOL-RENAL, V303, pF1107, DOI 10.1152/ajprenal.00151.2012; Yisireyili M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109268	51	42	43	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1367	1376		10.1096/fj.15-272872	http://dx.doi.org/10.1096/fj.15-272872			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26700731				2022-12-26	WOS:000370387800031
J	Reiter, KH; Ramachandran, A; Xia, X; Boucher, LE; Bosch, J; Matunis, MJ				Reiter, Katherine H.; Ramachandran, Anita; Xia, Xue; Boucher, Lauren E.; Bosch, Juergen; Matunis, Michael J.			Characterization and Structural Insights into Selective E1-E2 Interactions in the Human and Plasmodium falciparum SUMO Conjugation Systems	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystallography; malaria; oxidative stress; plasmodium; small ubiquitin-like modifier (SUMO); ubiquitin-conjugating enzyme (E2 enzyme); ubiquitin fold domain (Ufd)	PROTEIN SUMOYLATION; UBIQUITIN; IDENTIFICATION; ENZYME; E2; RECRUITMENT; ACTIVATION; MECHANISM; SURVIVAL; DOMAIN	Protein modification by small ubiquitin-related modifiers (SUMOs) is essential and conserved in the malaria parasite, Plasmodium falciparum. We have previously shown that interactions between the SUMO E1-activating and E2-conjugating enzyme in P. falciparum are distinct compared with human, suggesting a potential target for development of parasite-specific inhibitors of SUMOylation. The parasite asexual trophozoite stage is susceptible to iron-induced oxidative stress and is subsequently a target for many of the current anti-malarial drugs. Here, we provide evidence that SUMOylation plays a role in the parasite response to oxidative stress during red blood cell stages, indicative of a protective role seen in other organisms. Using x-ray crystallography, we solved the structure of the human SUMO E1 ubiquitin fold domain in complex with the E2, Ubc9. The interface defined in this structure guided in silico modeling, mutagenesis, and in vitro biochemical studies of the P. falciparum SUMO E1 and E2 enzymes, resulting in the identification of surface residues that explain species-specific interactions. Our findings suggest that parasite-specific inhibitors of SUMOylation could be developed and used in combination therapies with drugs that induce oxidative stress.	[Reiter, Katherine H.; Ramachandran, Anita; Xia, Xue; Boucher, Lauren E.; Bosch, Juergen; Matunis, Michael J.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA; [Boucher, Lauren E.; Bosch, Juergen] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Johns Hopkins Malaria Res Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Matunis, MJ (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, 615 N Wolfe St, Baltimore, MD 21205 USA.	mmatuni1@jhu.edu	; Bosch, Jurgen/E-9370-2011	Boucher, Lauren/0000-0003-3152-6155; Matunis, Michael/0000-0002-9350-6611; Bosch, Jurgen/0000-0002-2624-4105	National Institutes of Health [GM060980]; Sommer Scholar's Program; Bloomberg Family Foundation; National Institutes of Health Chemistry-Biology Interface Training Grant [T32GM080189]; Johns Hopkins Malaria Research Institute; NATIONAL CANCER INSTITUTE [T32CA009110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080189, R01GM060980] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sommer Scholar's Program; Bloomberg Family Foundation; National Institutes of Health Chemistry-Biology Interface Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins Malaria Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded in part by National Institutes of Health Grant GM060980 (to M. J. M.), the Sommer Scholar's Program (to K. H. R.), the Bloomberg Family Foundation (to J. B.), the National Institutes of Health Chemistry-Biology Interface Training Grant T32GM080189, and a predoctoral Fellowship from Johns Hopkins Malaria Research Institute (to L. E. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Artavanis-Tsakonas K, 2006, MOL MICROBIOL, V61, P1187, DOI 10.1111/j.1365-2958.2006.05307.x; Bedford L, 2011, NAT REV DRUG DISCOV, V10, P29, DOI 10.1038/nrd3321; Bencsath KP, 2002, J BIOL CHEM, V277, P47938, DOI 10.1074/jbc.M207442200; Chaudhury S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022477; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chung DWD, 2009, MOL BIOCHEM PARASIT, V168, P123, DOI 10.1016/j.molbiopara.2009.08.001; Conti L, 2009, PLANT SIGNAL BEHAV, V4, P225, DOI 10.4161/psb.4.3.7867; Doerig C, 2015, NAT REV MICROBIOL, V13, P160, DOI 10.1038/nrmicro3402; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enserink JM, 2015, CELL DIV, V10, DOI 10.1186/s13008-015-0010-1; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Giraud MF, 1998, ACTA CRYSTALLOGR D, V54, P891, DOI 10.1107/S0907444998002480; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Huang DT, 2007, NATURE, V445, P394, DOI 10.1038/nature05490; Huang DT, 2005, MOL CELL, V17, P341, DOI 10.1016/j.molcel.2004.12.020; Huang DT, 2004, NAT STRUCT MOL BIOL, V11, P927, DOI 10.1038/nsmb826; Issar N, 2008, CELL MICROBIOL, V10, P1999, DOI 10.1111/j.1462-5822.2008.01183.x; Karve Tejaswita M, 2011, J Amino Acids, V2011, P207691, DOI 10.4061/2011/207691; Klonis N, 2011, P NATL ACAD SCI USA, V108, P11405, DOI 10.1073/pnas.1104063108; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee I, 2008, CELL, V134, P268, DOI 10.1016/j.cell.2008.05.046; Lee Y, 2007, J CEREBR BLOOD F MET, V27, P950, DOI 10.1038/sj.jcbfm.9600395; Lois LM, 2005, EMBO J, V24, P439, DOI 10.1038/sj.emboj.7600552; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; Lyskov S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063906; MESHNICK SR, 1991, MOL BIOCHEM PARASIT, V49, P181, DOI 10.1016/0166-6851(91)90062-B; Miller LH, 2013, NAT MED, V19, P156, DOI 10.1038/nm.3073; Nooren IMA, 2003, J MOL BIOL, V325, P991, DOI 10.1016/S0022-2836(02)01281-0; Olsen SK, 2013, MOL CELL, V49, P884, DOI 10.1016/j.molcel.2013.01.013; Olsen SK, 2010, NATURE, V463, P906, DOI 10.1038/nature08765; Ponder EL, 2011, CHEM BIOL, V18, P711, DOI 10.1016/j.chembiol.2011.04.010; Reiter K, 2013, J BIOL CHEM, V288, P27724, DOI 10.1074/jbc.M113.498410; Ribaut C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-45; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Sullivan DJ, 1996, P NATL ACAD SCI USA, V93, P11865, DOI 10.1073/pnas.93.21.11865; Tokgoz Z, 2012, J BIOL CHEM, V287, P311, DOI 10.1074/jbc.M111.294975; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; van Waardenburg RCAM, 2006, MOL CELL BIOL, V26, P4958, DOI 10.1128/MCB.00160-06; Walden H, 2003, NATURE, V422, P330, DOI 10.1038/nature01456; Wang JH, 2007, MOL CELL, V27, P228, DOI 10.1016/j.molcel.2007.05.023; Wang J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015805; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213	46	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					3860	3870		10.1074/jbc.M115.680801	http://dx.doi.org/10.1074/jbc.M115.680801			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26697886	hybrid, Green Published			2022-12-26	WOS:000371338400015
J	Fraser, LE; Makooie, B; Harris, LR				Fraser, Lindsey E.; Makooie, Bobbak; Harris, Laurence R.			The Subjective Visual Vertical and the Subjective Haptic Vertical Access Different Gravity Estimates	PLOS ONE			English	Article							GALVANIC VESTIBULAR STIMULATION; BODY-TILT; HEAD ORIENTATION; PERCEPTION; ROLL; HUMANS; NECK; REPRESENTATION; DISSOCIATION; INFORMATION	The subjective visual vertical (SVV) and the subjective haptic vertical (SHV) both claim to probe the underlying perception of gravity. However, when the body is roll tilted these two measures evoke different patterns of errors with SVV generally becoming biased towards the body (A-effect, named for its discoverer, Hermann Rudolph Aubert) and SHV remaining accurate or becoming biased away from the body (E-effect, short for Entgegengesetzt-effect, meaning "opposite", i.e., opposite to the A-effect). We compared the two methods in a series of five experiments and provide evidence that the two measures access two different but related estimates of gravitational vertical. Experiment 1 compared SVV and SHV across three levels of whole-body tilt and found that SVV showed an A-effect at larger tilts while SHV was accurate. Experiment 2 found that tilting either the head or the trunk independently produced an A-effect in SVV while SHV remained accurate when the head was tilted on an upright body but showed an A-effect when the body was tilted below an upright head. Experiment 3 repeated these head/body configurations in the presence of vestibular noise induced by using disruptive galvanic vestibular stimulation (dGVS). dGVS abolished both SVV and SHV A-effects while evoking a massive E-effect in the SHV head tilt condition. Experiments 4 and 5 show that SVV and SHV do not combine in an optimally statistical fashion, but when vibration is applied to the dorsal neck muscles, integration becomes optimal. Overall our results suggest that SVV and SHV access distinct underlying gravity percepts based primarily on head and body position information respectively, consistent with a model proposed by Clemens and colleagues.	[Fraser, Lindsey E.; Makooie, Bobbak; Harris, Laurence R.] York Univ, Ctr Vis Res, Toronto, ON M3J 2R7, Canada	York University - Canada	Fraser, LE (corresponding author), York Univ, Ctr Vis Res, Toronto, ON M3J 2R7, Canada.	lfraser4@yorku.ca	Harris, Laurence/AAT-9549-2021	Harris, Laurence/0000-0002-7154-8757	Natural Sciences and Engineering Research Council (NSERC) of Canada; NSERC Alexander Graham Bell Scholarship; NSERC CREATE grant	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Alexander Graham Bell Scholarship; NSERC CREATE grant	This research was supported by a Discovery Grant from the Natural Sciences and Engineering Research Council (NSERC) of Canada to LRH. LEF is supported by an NSERC Alexander Graham Bell Scholarship and an NSERC CREATE grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasopoulos D, 1997, NEUROSCI LETT, V233, P151, DOI 10.1016/S0304-3940(97)00639-3; Aubert H., 1861, ARCH PATHOL ANAT, V20, P381, DOI DOI 10.1007/BF02355256; Baccini M, 2014, ATTEN PERCEPT PSYCHO, V76, P112, DOI 10.3758/s13414-013-0551-9; Barra J, 2010, BRAIN, V133, P3552, DOI 10.1093/brain/awq311; BAUERMEISTER M, 1964, AM J PSYCHOL, V77, P451, DOI 10.2307/1421016; Betts GA, 1998, VISION RES, V38, P1989, DOI 10.1016/S0042-6989(97)00401-X; Bortolami SB, 2006, EXP BRAIN RES, V173, P364, DOI 10.1007/s00221-006-0385-y; Braem B, 2014, NEUROPHYSIOL CLIN, V44, P41, DOI 10.1016/j.neucli.2013.10.137; Bresciani JP, 2002, NEUROSCI LETT, V318, P34, DOI 10.1016/S0304-3940(01)02462-4; Bronstein AM, 2003, NEUROLOGY, V61, P1260, DOI 10.1212/01.WNL.0000086815.22816.DC; Cauquil AS, 2003, EXP BRAIN RES, V148, P414, DOI 10.1007/s00221-002-1326-z; Ceyte H, 2009, NEUROSCI LETT, V462, P85, DOI 10.1016/j.neulet.2009.06.048; Clemens IAH, 2011, J NEUROSCI, V31, P5365, DOI 10.1523/JNEUROSCI.6472-10.2011; Cribbie RA, 2004, J CLIN PSYCHOL, V60, P1, DOI 10.1002/jclp.10217; de Graaf B, 1992, J Vestib Res, V2, P15; De Vrijer M, 2009, J VISION, V9, DOI 10.1167/9.2.9; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Ernst MO, 2012, NEW HDB MULTISENSORY, P527; Ferre ER, 2011, EUR J NEUROSCI, V34, P1337, DOI 10.1111/j.1460-9568.2011.07859.x; Fitzpatrick RC, 2004, J APPL PHYSIOL, V96, P2301, DOI 10.1152/japplphysiol.00008.2004; FRIEDMANN G, 1970, BRAIN, V93, P313, DOI 10.1093/brain/93.2.313; Gueguen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034380; Guerraz M, 1998, PERCEPT MOTOR SKILL, V87, P643, DOI 10.2466/pms.1998.87.2.643; Guerraz M, 2003, EXP BRAIN RES, V150, P40, DOI 10.1007/s00221-003-1411-y; Howard I. P., 1982, HUMAN VISUAL ORIENTA; Kontsevich LL, 1999, VISION RES, V39, P2729, DOI 10.1016/S0042-6989(98)00285-5; Lopez C, 2012, NEUROPSYCHOLOGIA, V50, P1830, DOI 10.1016/j.neuropsychologia.2012.04.008; Luyat M, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-28; MacDougall HG, 2006, EXP BRAIN RES, V172, P208, DOI 10.1007/s00221-005-0329-y; MacNeilage PR, 2007, EXP BRAIN RES, V179, P263, DOI 10.1007/s00221-006-0792-0; Mars F, 2003, EXP BRAIN RES, V150, P515, DOI 10.1007/s00221-003-1485-6; Mast FW, 2000, SWISS J PSYCHOL, V59, P89, DOI 10.1024//1421-0185.59.2.89; MAUNSELL JHR, 1987, ANNU REV NEUROSCI, V10, P363, DOI 10.1146/annurev.ne.10.030187.002051; MayouxBenhamou MA, 1997, EXP BRAIN RES, V113, P353, DOI 10.1007/BF02450333; McKenna GJ, 2004, JARO-J ASSOC RES OTO, V5, P25, DOI 10.1007/s10162-003-4005-2; Mittelstaedt H, 1996, BIOL PSYCHOL, V42, P53, DOI 10.1016/0301-0511(95)05146-5; MITTELSTAEDT H, 1983, NATURWISSENSCHAFTEN, V70, P272, DOI 10.1007/BF00404833; Moore ST, 2006, EXP BRAIN RES, V174, P647, DOI 10.1007/s00221-006-0528-1; Muller G., 1916, Z SINNESPHYSIOL, V49, P109; Perennou DA, 2008, BRAIN, V131, P2401, DOI 10.1093/brain/awn170; ROCK I, 1957, AM J PSYCHOL, V70, P493, DOI 10.2307/1419441; Schneider E, 2002, J NEUROPHYSIOL, V87, P2064, DOI 10.1152/jn.00558.2001; Schuler JR, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-83; Tarnutzer AA, 2010, J NEUROPHYSIOL, V103, P934, DOI 10.1152/jn.00407.2009; Tarnutzer AA, 2009, J NEUROPHYSIOL, V102, P1657, DOI 10.1152/jn.00007.2008; Tarnutzer AA, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-114; Tarnutzer AA, 2012, J NEUROPHYSIOL, V107, P3095, DOI 10.1152/jn.00724.2010; Tesio L, 2011, INT J REHABIL RES, V34, P307, DOI 10.1097/MRR.0b013e32834c45bc; Trainor LJ, 2009, CORTEX, V45, P35, DOI 10.1016/j.cortex.2007.10.014; VAINA LM, 1994, CEREB CORTEX, V4, P555, DOI 10.1093/cercor/4.5.555; van Beuzekom AD, 2000, J NEUROPHYSIOL, V84, P11, DOI 10.1152/jn.2000.84.1.11; Vibert D, 1999, J VESTIBUL RES-EQUIL, V9, P145; WADE NJ, 1968, PERCEPT PSYCHOPHYS, V3, P215, DOI 10.3758/BF03212730; WADE NJ, 1969, AUST J PSYCHOL, V21, P177, DOI 10.1080/00049536908257782; Wade SW, 1997, VISION RES, V37, P1071, DOI 10.1016/S0042-6989(96)00252-0; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828	56	25	25	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145528	10.1371/journal.pone.0145528	http://dx.doi.org/10.1371/journal.pone.0145528			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA0TN	26716835	Green Published, gold, Green Submitted			2022-12-26	WOS:000367510500041
J	Lopez, G; Pallas, B; Martinez, S; Lauri, PE; Regnard, JL; Durel, CE; Costes, E				Lopez, Gerardo; Pallas, Benoit; Martinez, Sebastien; Lauri, Pierre-Eric; Regnard, Jean-Luc; Durel, Charles-Eric; Costes, Evelyne			Genetic Variation of Morphological Traits and Transpiration in an Apple Core Collection under Well-Watered Conditions: Towards the Identification of Morphotypes with High Water Use Efficiency	PLOS ONE			English	Article							COMPLEX ARCHITECTURAL TRAITS; PLANT; DETERMINISM; PROGENY; LEAVES	Water use efficiency (WUE) is a quantitative measurement which improvement is a major issue in the context of global warming and restrictions in water availability for agriculture. In this study, we aimed at studying the variation and genetic control of WUE and the respective role of its components (plant biomass and transpiration) in a perennial fruit crop. We explored an INRA apple core collection grown in a phenotyping platform to screen one-year-old scions for their accumulated biomass, transpiration and WUE under optimal growing conditions. Plant biomass was decompose into morphological components related to either growth or organ expansion. For each trait, nine mixed models were evaluated to account for the genetic effect and spatial heterogeneity inside the platform. The Best Linear Unbiased Predictors of genetic values were estimated after model selection. Mean broad-sense heritabilities were calculated from variance estimates. Heritability values indicated that biomass (0.76) and WUE (0.73) were under genetic control. This genetic control was lower in plant transpiration with an heritability of 0.54. Across the collection, biomass accounted for 70% of the WUE variability. A Hierarchical Ascendant Classification of the core collection indicated the existence of six groups of genotypes with contrasting morphology and WUE. Differences between morphotypes were interpreted as resulting from differences in the main processes responsible for plant growth: cell division leading to the generation of new organs and cell elongation leading to organ dimension. Although further studies will be necessary on mature trees with more complex architecture and multiple sinks such as fruits, this study is a first step for improving apple plant material for the use of water.	[Lopez, Gerardo; Pallas, Benoit; Martinez, Sebastien; Lauri, Pierre-Eric; Costes, Evelyne] INRA, UMR Ameliorat Genet & Adaptat Plantes Mediterrane, Montpellier, France; [Regnard, Jean-Luc] Montpellier SupAgro, UMR Ameliorat Genet & Adaptat Plantes Mediterrane, Montpellier, France; [Durel, Charles-Eric] INRA, UMR Inst Rech Hort & Semences, Beaucouze, France	INRAE; Institut Agro; Montpellier SupAgro; INRAE	Lopez, G (corresponding author), INRA, UMR Ameliorat Genet & Adaptat Plantes Mediterrane, Montpellier, France.	gerardo.lopez.velasco@gmail.com	Lopez, Gerardo/C-5636-2011; lauri, pierre-eric/B-5724-2008	lauri, pierre-eric/0000-0002-7549-0484	European Union [265582, 267196]; BAP-INRA department	European Union(European Commission); BAP-INRA department	This work was supported by the European Union seventh Framework Programme project FruitBreedomics, grant number: 265582. GL received the support of the BAP-INRA department and the European Union, in the framework of the Marie-Curie FP7 COFUND People Programme, through the award of an AgreenSkills' fellowship, grant number: 267196.	Adiredjo AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101218; AVERY DJ, 1977, NEW PHYTOL, V78, P55, DOI 10.1111/j.1469-8137.1977.tb01542.x; Bassett CL, 2011, HORTSCIENCE, V46, P1079, DOI 10.21273/HORTSCI.46.8.1079; Ben Sadok I, 2013, TREE GENET GENOMES, V9, P205, DOI 10.1007/s11295-012-0548-x; Ben Sadok I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127539; BROWN AHD, 1989, GENOME, V31, P818, DOI 10.1139/g89-144; Brown Susan K., 2003, P31, DOI 10.1079/9780851995922.0031; Condon AG, 2004, J EXP BOT, V55, P2447, DOI 10.1093/jxb/erh277; Coupel-Ledru A, 2014, J EXP BOT, V65, P6205, DOI 10.1093/jxb/eru228; Durel CE, 1998, THEOR APPL GENET, V96, P1077, DOI 10.1007/s001220050842; Eveland AL, 2012, J EXP BOT, V63, P3367, DOI 10.1093/jxb/err379; Gilmour AR, 2009, ASREML USER GUIDE RE; Glenn DM, 2000, HORTSCIENCE, V35, P1241, DOI 10.21273/HORTSCI.35.7.1241; Hamdy A, 2003, IRRIG DRAIN, V52, P3, DOI 10.1002/ird.73; Honsdorf N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097047; Johnson K, 2011, NEW PHYTOL, V191, P319, DOI 10.1111/j.1469-8137.2011.03737.x; Lassois L, 2016, PLANT MOL BIOL REP, V34, P827, DOI 10.1007/s11105-015-0966-7; Lauri PE, 2011, PLANT CELL ENVIRON, V34, P1276, DOI 10.1111/j.1365-3040.2011.02328.x; Lespinasse Y., 1992, Proceedings of the Joint Conference of the EAPR Breeding & Varietal Assessment Section and the EUCARPIA Potato Section, Landerneau, France, 12-17 January 1992., P103; Liebhard R, 2003, PLANT MOL BIOL, V52, P511, DOI 10.1023/A:1024886500979; Liu BH, 2012, AGROFOREST SYST, V84, P117, DOI 10.1007/s10457-011-9427-y; MANLY BFJ, 1991, RANDOMIZATION BOOTST; Marguerit E, 2014, J EXP BOT, V65, P4757, DOI 10.1093/jxb/eru226; Masle J, 2005, NATURE, V436, P866, DOI 10.1038/nature03835; Massonnet C, 2007, ANN BOT-LONDON, V100, P1347, DOI 10.1093/aob/mcm222; MCBRATNEY AB, 1986, J SOIL SCI, V37, P617, DOI 10.1111/j.1365-2389.1986.tb00392.x; Neilson EH, 2015, J EXP BOT, V66, P1817, DOI 10.1093/jxb/eru526; Poorter H, 2012, NEW PHYTOL, V193, P30, DOI 10.1111/j.1469-8137.2011.03952.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Rebolledo MC, 2013, FUNCT PLANT BIOL, V40, P582, DOI 10.1071/FP12312; Regnard JL, 2008, ACTA HORTIC, P151, DOI 10.17660/ActaHortic.2008.772.18; Segura V, 2007, GENOME, V50, P159, DOI 10.1139/G07-002; Segura V, 2006, TREE GENET GENOMES, V2, P140, DOI 10.1007/s11295-006-0037-1; Slafer GA, 2005, ANN APPL BIOL, V146, P61, DOI 10.1111/j.1744-7348.2005.04048.x; Sun XP, 2013, PHOTOSYNTHETICA, V51, P404, DOI 10.1007/s11099-013-0040-3; Tardieu F, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00017; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Tsukaya H, 2003, CURR OPIN PLANT BIOL, V6, P57, DOI 10.1016/S1369526602000055; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Yang WN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6087	40	13	13	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145540	10.1371/journal.pone.0145540	http://dx.doi.org/10.1371/journal.pone.0145540			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717192	Green Published, gold, Green Submitted			2022-12-26	WOS:000367510500043
J	Zhang, XF; Li, Q; Zhang, M; Lam, S; Sham, PC; Bu, BT; Chua, SE; Wang, W; McAlonan, GM				Zhang, Xiaofan; Li, Qi; Zhang, Min; Lam, Sylvia; Sham, Pak Chung; Bu, Bitao; Chua, Siew Eng; Wang, Wei; McAlonan, Grainne Mary			The Effect of Oxytocin on Social and Non-Social Behaviour and Striatal Protein Expression in C57BL/6N Mice	PLOS ONE			English	Article							PRENATAL IMMUNE CHALLENGE; PREPULSE INHIBITION; SEX-DIFFERENCES; STARTLE REFLEX; MESSENGER-RNA; RAT-BRAIN; SCHIZOPHRENIA; DEFICITS; CELL; STIMULATION	Oxytocin has been suggested as a promising new treatment for neurodevelopmental disorders. However, important gaps remain in our understanding of its mode of action, in particular, to what extent oxytocin modulates social and non-social behaviours and whether its effects are generalizable across both sexes. Here we investigated the effects of a range of oxytocin doses on social and non-social behaviours in C57BL/6N mice of both sexes. As the striatum modulates social and non-social behaviours, and is implicated in neurodevelopmental disorders, we also conducted a pilot exploration of changes in striatal protein expression elicited by oxytocin. Oxytocin increased prepulse inhibition of startle but attenuated the recognition memory in male C57BL/6N mice. It increased social interaction time and suppressed the amphetamine locomotor response in both sexes. The striatum proteome following oxytocin exposure could be clearly discriminated from saline controls. With the caveat that these results are preliminary, oxytocin appeared to alter individual protein expression in directions similar to conventional anti-psychotics. The proteins affected by oxytocin could be broadly categorized as those that modulate glutamatergic, GABAergic or dopaminergic signalling and those that mediate cytoskeleton dynamics. Our results here encourage further research into the clinical application of this peptide hormone, which may potentially extend treatment options across a spectrum of neurodevelopmental conditions.	[Zhang, Xiaofan; Zhang, Min; Bu, Bitao; Wang, Wei] HUST, Tongji Hosp, Tongji Med Coll, Dept Neurol, Wuhan 430030, Peoples R China; [Zhang, Xiaofan; Li, Qi; Lam, Sylvia; Sham, Pak Chung; Chua, Siew Eng] Univ Hong Kong, Dept Psychiat, Pokfulam, Hong Kong, Peoples R China; [McAlonan, Grainne Mary] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Forens & Neurodev Sci, London WC2R 2LS, England	Huazhong University of Science & Technology; University of Hong Kong; University of London; King's College London	Wang, W (corresponding author), HUST, Tongji Hosp, Tongji Med Coll, Dept Neurol, 1095 Jiefang Ave, Wuhan 430030, Peoples R China.	wwang@vip.126.com; grainne.mcalonan@kcl.ac.uk			Hong Kong Universities General Research Fund Award [HKU 774710]; National Natural Science Foundation of China [61327902, 81030021, 81271406]	Hong Kong Universities General Research Fund Award; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by research funding from the Hong Kong Universities General Research Fund Award to Dr Grainne McAlonan (HKU 774710) and research funding from National Natural Science Foundation of China to Professor Wang (61327902 and 81030021) and Professor Zhang (81271406). Dr Grainne McAlonan is a member of the EU-AIMS consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, J NEUROCHEM, V62, P1375; Bai O, 2003, J NEUROSCI RES, V71, P127, DOI 10.1002/jnr.10440; Bales KL, 2013, BIOL PSYCHIAT, V74, P180, DOI 10.1016/j.biopsych.2012.08.025; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; BRAFF D, 1978, PSYCHOPHYSIOLOGY, V15, P339, DOI 10.1111/j.1469-8986.1978.tb01390.x; Brenes JC, 2008, PHARMACOL BIOCHEM BE, V89, P85, DOI 10.1016/j.pbb.2007.11.004; CABOCHE J, 1991, J NEUROCHEM, V56, P428, DOI 10.1111/j.1471-4159.1991.tb08168.x; Caldwell HK, 2009, MOL PSYCHIATR, V14, P190, DOI 10.1038/sj.mp.4002150; Carter CS, 2007, BEHAV BRAIN RES, V176, P170, DOI 10.1016/j.bbr.2006.08.025; CASTELLANO C, 1989, BEHAV NEURAL BIOL, V52, P170, DOI 10.1016/S0163-1047(89)90285-9; CASTNER SA, 1993, BRAIN RES, V610, P127, DOI 10.1016/0006-8993(93)91225-H; Castner SA, 1996, BRAIN RES, V712, P245, DOI 10.1016/0006-8993(95)01429-2; Charrier E, 2003, MOL NEUROBIOL, V28, P51, DOI 10.1385/MN:28:1:51; Cheung C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012233; Clark D, 2007, PROTEOM CLIN APPL, V1, P157, DOI 10.1002/prca.200600541; Clayton JA, 2014, NATURE, V509, P282, DOI 10.1038/509282a; Crawley JN, 1997, PSYCHOPHARMACOLOGY, V132, P107, DOI 10.1007/s002130050327; CRAWLEY JN, 1985, NEUROSCI BIOBEHAV R, V9, P37, DOI 10.1016/0149-7634(85)90030-2; Csomor PA, 2008, BEHAV NEUROSCI, V122, P885, DOI 10.1037/0735-7044.122.4.885; Dawood M, 1983, ENDOCRINOLOGY PREGNA, P204; Deng MY, 2009, PSYCHOPHARMACOLOGY, V206, P437, DOI 10.1007/s00213-009-1619-z; Feifel D, 1999, PSYCHOPHARMACOLOGY, V141, P93, DOI 10.1007/s002130050811; Feifel D, 2012, EUR NEUROPSYCHOPHARM, V22, P374, DOI 10.1016/j.euroneuro.2011.09.004; Feifel D, 2010, BIOL PSYCHIAT, V68, P678, DOI 10.1016/j.biopsych.2010.04.039; Ferguson JN, 2001, J NEUROSCI, V21, P8278; FILLINGAME RH, 1990, BACTERIA TREATISE ST, V12, P345; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Guidotti A, 2000, ARCH GEN PSYCHIAT, V57, P1061, DOI 10.1001/archpsyc.57.11.1061; Jo YH, 1998, J NEUROSCI, V18, P2377; JOHNSON SW, 1992, J PHYSIOL-LONDON, V450, P455, DOI 10.1113/jphysiol.1992.sp019136; JONES PM, 1982, NEUROENDOCRINOLOGY, V34, P297, DOI 10.1159/000123316; Kantor L, 1998, J PHARMACOL EXP THER, V284, P592; Karp NA, 2005, PROTEOMICS, V5, P81, DOI 10.1002/pmic.200400881; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Klomp LWJ, 2000, AM J HUM GENET, V67, P1389, DOI 10.1086/316886; Konradi C, 2001, BIOL PSYCHIAT, V50, P729, DOI 10.1016/S0006-3223(01)01267-7; Kumari V, 2004, SCHIZOPHR RES, V69, P219, DOI 10.1016/j.schres.2003.09.010; Langen M, 2009, BIOL PSYCHIAT, V66, P327, DOI 10.1016/j.biopsych.2009.03.017; Lee HJ, 2009, PROG NEUROBIOL, V88, P127, DOI 10.1016/j.pneurobio.2009.04.001; Lee PR, 2005, NEUROPSYCHOPHARMACOL, V30, P1883, DOI 10.1038/sj.npp.1300722; Leung M, 2011, SCHIZOPHRENIA BULL, V37, P199, DOI 10.1093/schbul/sbp099; Li Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006354; Loth E, 2013, BIOL PSYCHIAT; Matsuo N, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00029; Meyer U, 2008, BRAIN BEHAV IMMUN, V22, P469, DOI 10.1016/j.bbi.2007.09.012; Meziane H, 2007, GENES BRAIN BEHAV, V6, P192, DOI 10.1111/j.1601-183X.2006.00249.x; Nesvaderani M, 2009, AUST NZ J PSYCHIAT, V43, P310, DOI 10.1080/00048670902721103; NIELSEN EB, 1978, PSYCHOPHARMACOLOGY, V59, P85, DOI 10.1007/BF00428036; PAKKENBERG H, 1973, PSYCHOPHARMACOLOGIA, V29, P329, DOI 10.1007/BF00429280; PEEKE HVS, 1971, SCIENCE, V173, P80, DOI 10.1126/science.173.3991.80; Pennington K, 2008, MOL PSYCHIATR, V13, P1102, DOI 10.1038/sj.mp.4002098; Pennington K, 2009, J PSYCHOPHARMACOL, V23, P520, DOI 10.1177/0269881108091075; Roberts E., 1986, BENZODIAZEPINES GABA, P1; Rushlow WJ, 2005, J NEUROCHEM, V94, P587, DOI 10.1111/j.1471-4159.2005.03092.x; Scheel-Kruger J, 1986, ACTA NEUROLOGICA SCA; SCOTT JP, 1966, AM ZOOL, V6, P683; SHEKHAR A, 1995, PHARMACOL BIOCHEM BE, V50, P253, DOI 10.1016/0091-3057(94)00307-5; SPRUIJT BM, 1994, J NEUROSCI, V14, P3225; Swerdlow NR, 2001, PSYCHOPHARMACOLOGY, V156, P194, DOI 10.1007/s002130100799; Swonger JM, 2011, PREPULSE INHIBITION; SZECHTMAN H, 1988, ARCH GEN PSYCHIAT, V45, P523; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Takahashi K, 2007, BIOL PSYCHIAT, V62, P148, DOI 10.1016/j.biopsych.2006.06.035; Takao K, 2013, NEUROPSYCHOPHARMACOL, V38, P1409, DOI 10.1038/npp.2013.38; TAKEICHI M, 1985, FOLIA PSYCHIAT NEU J, V39, P185; Tomizawa K, 2003, NAT NEUROSCI, V6, P384, DOI 10.1038/nn1023; Tricomi E, 2010, NATURE, V463, P1089, DOI 10.1038/nature08785; Vollenweider FX, 2006, BIOL PSYCHIAT, V60, P597, DOI 10.1016/j.biopsych.2006.03.058; Vuillermot S, 2010, J NEUROSCI, V30, P1270, DOI 10.1523/JNEUROSCI.5408-09.2010; Wang Y, 2007, MOL ENDOCRINOL, V21, P972, DOI 10.1210/me.2006-0249; Wheal HV, 1998, PROG NEUROBIOL, V55, P611, DOI 10.1016/S0301-0082(98)00026-4; WheelerJones CPD, 1996, BIOCHEM J, V315, P41, DOI 10.1042/bj3150041; WROBLEWSKI JT, 1985, BRAIN RES, V329, P161, DOI 10.1016/0006-8993(85)90521-9; WYERS EJ, 1968, EXP NEUROL, V22, P350, DOI 10.1016/0014-4886(68)90002-2; Yu K, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00189; Yu KK, 2011, J PSYCHIATR NEUROSCI, V36, P412, DOI 10.1503/jpn.100138; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2; Zhang X, 2015, BRAIN RES B	78	0	0	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145638	10.1371/journal.pone.0145638	http://dx.doi.org/10.1371/journal.pone.0145638			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716999	gold, Green Published			2022-12-26	WOS:000367510500050
J	Masoud, R; Bizouarn, T; Trepout, S; Wien, F; Baciou, L; Marco, S; Levin, CH				Masoud, Rawand; Bizouarn, Tania; Trepout, Sylvain; Wien, Frank; Baciou, Laura; Marco, Sergio; Levin, Chantal Houee			Titanium Dioxide Nanoparticles Increase Superoxide Anion Production by Acting on NADPH Oxidase	PLOS ONE			English	Article							HUMAN NEUTROPHILS; CONFORMATIONAL-CHANGES; OXIDATIVE STRESS; ARACHIDONIC-ACID; NOX-FAMILY; ACTIVATION; TOXICITY; PHOSPHORYLATION; PARTICLES; P47(PHOX)	Titanium dioxide (TiO2) anatase nanoparticles (NPs) are metal oxide NPs commercialized for several uses of everyday life. However their toxicity has been poorly investigated. Cellular internalization of NPs has been shown to activate macrophages and neutrophils that contribute to superoxide anion production by the NADPH oxidase complex. Transmission electron micrososcopy images showed that the membrane fractions were close to the NPs while fluorescence indicated an interaction between NPs and cytosolic proteins. Using a cell-free system, we have investigated the influence of TiO2 NPs on the behavior of the NADPH oxidase. In the absence of the classical activator molecules of the enzyme (arachidonic acid) but in the presence of TiO2 NPs, no production of superoxide ions could be detected indicating that TiO2 NPs were unable to activate by themselves the complex. However once the NADPH oxidase was activated (i.e., by arachidonic acid), the rate of superoxide anion production went up to 140% of its value without NPs, this effect being dependent on their concentration. In the presence of TiO2 nanoparticles, the NADPH oxidase produces more superoxide ions, hence induces higher oxidative stress. This hyper-activation and the subsequent increase in ROS production by TiO2 NPs could participate to the oxidative stress development.	[Masoud, Rawand; Bizouarn, Tania; Baciou, Laura; Levin, Chantal Houee] Univ Paris 11, Lab Chim Phys, UMR 8000, Orsay, France; [Masoud, Rawand; Bizouarn, Tania; Baciou, Laura; Levin, Chantal Houee] CNRS, UMR 8000, F-91405 Orsay, France; [Trepout, Sylvain; Marco, Sergio] Inst Curie, Ctr Rech, Ctr Univ, F-91405 Orsay, France; [Trepout, Sylvain; Marco, Sergio] Ctr Univ, INSERM, U1196, Orsay, France; [Trepout, Sylvain; Marco, Sergio] Ctr Univ, CNRS, UMR9187, Orsay, France; [Wien, Frank] LOrme Merisiers, Synchrotron SOLEIL, Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay; SOLEIL Synchrotron	Levin, CH (corresponding author), Univ Paris 11, Lab Chim Phys, UMR 8000, Orsay, France.	Chantal.houee@u-psud.fr	bizouarn, tania/W-6782-2019; marco, SERGIO/E-4875-2017; Wien, Frank/B-7846-2012	Wien, Frank/0000-0002-0752-8735; Trepout, Sylvain/0000-0002-5822-407X; Houee Levin, Chantal/0000-0001-8089-796X	ANR [2010-blan-1536-01]	ANR(French National Research Agency (ANR))	The financial support of ANR 2010-blan-1536-01 is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Dr H. Remita for a generous gift of nanoparticles, to Prof. E. Pick for the trimera plasmids and to Dr F. Lederer for the preparation of neutrophils. The financial support of ANR 2010-blan-1536-01 is acknowledged. We thank the COST Action CM1201 (Biomimetic Radical Chemistry) for very fruitful discussions.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Akasaki T, 1999, J BIOL CHEM, V274, P18055, DOI 10.1074/jbc.274.25.18055; Alarifi S, 2013, INT J NANOMED, V8, P3937, DOI 10.2147/IJN.S47174; Allouni ZE, 2015, INT J NANOMED, V10, P687, DOI 10.2147/IJN.S72726; Babin K, 2015, BBA-GEN SUBJECTS, V1850, P2276, DOI 10.1016/j.bbagen.2015.08.006; Babior BM, 2004, CURR OPIN IMMUNOL, V16, P42, DOI 10.1016/j.coi.2003.12.001; BABIOR BM, 1984, BLOOD, V64, P959; Baciou L, 2009, FEBS LETT, V583, P3225, DOI 10.1016/j.febslet.2009.09.011; Barnard AS, 2010, NAT NANOTECHNOL, V5, P271, DOI [10.1038/nnano.2010.25, 10.1038/NNANO.2010.25]; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Berdichevsky Y, 2007, J BIOL CHEM, V282, P22122, DOI 10.1074/jbc.M701497200; Bermudez E, 2004, TOXICOL SCI, V77, P347, DOI 10.1093/toxsci/kfh019; Buzea C, 2007, BIOINTERPHASES, V2, pMR17, DOI 10.1116/1.2815690; Dransfield GP, 2000, RADIAT PROT DOSIM, V91, P271, DOI 10.1093/oxfordjournals.rpd.a033216; El-Benna J, 2009, EXP MOL MED, V41, P217, DOI 10.3858/emm.2009.41.4.058; Gheshlaghi ZN, 2008, ACTA BIOCH BIOPH SIN, V40, P777, DOI 10.1111/j.1745-7270.2008.00458.x; Goncalves DM, 2010, TOXICOL IN VITRO, V24, P1002, DOI 10.1016/j.tiv.2009.12.007; Goncalves DM, 2011, THESCIENTIFICWORLDJO, V11, P1877, DOI 10.1100/2011/768350; Gurr JR, 2005, TOXICOLOGY, V213, P66, DOI 10.1016/j.tox.2005.05.007; HEDENBORG M, 1988, INT ARCH OCC ENV HEA, V61, P1, DOI 10.1007/BF00381600; Huang CC, 2010, TOXICOL IN VITRO, V24, P45, DOI 10.1016/j.tiv.2009.09.007; Jovanovic B, 2015, ENVIRON TOXICOL CHEM, V34, P1070, DOI 10.1002/etc.2891; Jovanovic B, 2011, ECOTOX ENVIRON SAFE, V74, P675, DOI 10.1016/j.ecoenv.2010.10.017; Karimi G, 2014, BBA-GEN SUBJECTS, V1840, P3277, DOI 10.1016/j.bbagen.2014.07.022; Knaapen AM, 2004, INT J CANCER, V109, P799, DOI 10.1002/ijc.11708; Lagopati N, 2010, J PHOTOCH PHOTOBIO A, V214, P215, DOI 10.1016/j.jphotochem.2010.06.031; Lucky SS, 2015, ACS NANO, V9, P191, DOI 10.1021/nn503450t; Manke A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/942916; Marucco A, 2015, CHEM RES TOXICOL; Masoud R, 2014, REDOX BIOL, V3, P16, DOI 10.1016/j.redox.2014.10.001; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; Nauseef WM, 2004, HISTOCHEM CELL BIOL, V122, P277, DOI 10.1007/s00418-004-0679-8; Niederberger M, 2009, ENG MATER PROCESS, P1, DOI 10.1007/978-1-84882-671-7; Niska K, 2015, INT J NANOMED, V10, P1095, DOI 10.2147/IJN.S73557; Ostuni MA, 2010, FREE RADICAL BIO MED, V49, P900, DOI 10.1016/j.freeradbiomed.2010.06.021; Papakostas D, 2011, ARCH DERMATOL RES, V303, P533, DOI 10.1007/s00403-011-1163-7; PICK E, 1987, J BIOL CHEM, V262, P16476; Raad H, 2009, FASEB J, V23, P1011, DOI 10.1096/fj.08-114553; da Rosa ELS, 2013, BMC BIOPHYS, V6, DOI 10.1186/2046-1682-6-11; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Sharma V, 2012, APOPTOSIS, V17, P852, DOI 10.1007/s10495-012-0705-6; Sharma V, 2012, MUTAT RES-GEN TOX EN, V745, P84, DOI 10.1016/j.mrgentox.2011.12.009; Sheppard FR, 2005, J LEUKOCYTE BIOL, V78, P1025, DOI 10.1189/jlb.0804442; Shi HB, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-15; Shiose A, 2000, J BIOL CHEM, V275, P13793, DOI 10.1074/jbc.275.18.13793; Simon-Vazquez R, 2014, COLLOID SURFACE B, V113, P198, DOI 10.1016/j.colsurfb.2013.08.047; Skocaj M, 2011, RADIOL ONCOL, V45, P227, DOI 10.2478/v10019-011-0037-0; Souabni H, 2012, BBA-BIOMEMBRANES, V1818, P2314, DOI 10.1016/j.bbamem.2012.04.018; Souabni H, BIOCHIMIE; Sumimoto H, 2008, FEBS J, V275, P3249, DOI 10.1111/j.1742-4658.2008.06488.x; Swain SD, 1997, J BIOL CHEM, V272, P29502, DOI 10.1074/jbc.272.47.29502; Thomas T, 2006, TOXICOL SCI, V91, P14, DOI 10.1093/toxsci/kfj129; Valencia A, 2008, J INVEST DERMATOL, V128, P214, DOI 10.1038/sj.jid.5700960; Voet D., 2011, BIOCHEMISTRY; Wang C, 2012, SCI TOTAL ENVIRON, V429, P156, DOI 10.1016/j.scitotenv.2012.03.048; Wang JX, 2007, TOXICOL LETT, V168, P176, DOI 10.1016/j.toxlet.2006.12.001; Wiesenthal A, 2011, INT J DERMATOL, V50, P247, DOI 10.1111/j.1365-4632.2010.04815.x; Wilhelmi V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065704; Xia T, 2006, NANO LETT, V6, P1794, DOI 10.1021/nl061025k; Yuan YL, 2010, J NANOSCI NANOTECHNO, V10, P4868, DOI 10.1166/jnn.2010.2225; Zeisser-Labouebe M, 2007, NANOTECHNOLOGIES LIF	62	27	31	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0144829	10.1371/journal.pone.0144829	http://dx.doi.org/10.1371/journal.pone.0144829			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714308	Green Published, gold, Green Submitted			2022-12-26	WOS:000367481900020
J	Previtera, ML; Sengupta, A				Previtera, Michelle L.; Sengupta, Amitabha			Substrate Stiffness Regulates Proinflammatory Mediator Production through TLR4 Activity in Macrophages	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; MONONUCLEAR PHAGOCYTE SYSTEM; NF-KAPPA-B; MATRIX; ELASTICITY; ATHEROSCLEROSIS; PHOSPHORYLATION; DIFFERENTIATION; ACTIVATION; EXPRESSION	Clinical data show that disease adversely affects tissue elasticity or stiffness. While macrophage activity plays a critical role in driving disease pathology, there are limited data available on the effects of tissue stiffness on macrophage activity. In this study, the effects of substrate stiffness on inflammatory mediator production by macrophages were investigated. Bone marrow-derived macrophages were grown on polyacrylamide gels that mimicked the stiffness of a variety of soft biological tissues. Overall, macrophages grown on soft substrates produced less proinflammatory mediators than macrophages grown on stiff substrates when the endotoxin LPS was added to media. In addition, the pathways involved in stiffness-regulated proinflammation were investigated. The TLR4 signaling pathway was examined by evaluating TLR4, p-NF-kappa B p65, MyD88, and p-I kappa B alpha expression as well as p-NF-kappa B p65 translocation. Expression and translocation of the various signaling molecules were higher in macrophages grown on stiff substrates than on soft substrates. Furthermore, TLR4 knockout experiments showed that TLR4 activity enhanced proinflammation on stiff substrates. In conclusion, these results suggest that proinflammatory mediator production initiated by TLR4 is mechanically regulated in macrophages.	[Previtera, Michelle L.; Sengupta, Amitabha] JFK Neurosci Inst, JFK Med Ctr, Edison, NJ 08820 USA; [Previtera, Michelle L.] Seton Hall Univ, Dept Neurosci, S Orange, NJ 07079 USA	Seton Hall University	Previtera, ML (corresponding author), JFK Neurosci Inst, JFK Med Ctr, 65 James St, Edison, NJ 08820 USA.	mprevitera@jfkhealth.org			JFK Neuroscience Institute; JFK Foundation	JFK Neuroscience Institute; JFK Foundation	Funding provided by JFK Neuroscience Institute and JFK Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Kimberly Peterman, Rajat Patel, Poonit Mehta, Brian Healy, Tariq Mirza, and Juan Luzuriaga for preparing PA gels and counting cells. Further acknowledgment goes to Kimberly Peterman, Smit Shah, and Norell Hadzimichalis for editing this manuscript. The JFK Neuroscience Institute and JFK Foundation funded this work. The funders had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript. The authors have nothing to disclose.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Berry MF, 2006, AM J PHYSIOL-HEART C, V290, pH2196, DOI 10.1152/ajpheart.01017.2005; Blacher J, 1998, HYPERTENSION, V32, P570, DOI 10.1161/01.HYP.32.3.570; Blakney AK, 2012, J BIOMED MATER RES A, V100A, P1375, DOI 10.1002/jbm.a.34104; Edfeldt K, 2002, CIRCULATION, V105, P1158, DOI 10.1161/circ.105.10.1158; Engler AJ, 2008, J CELL SCI, V121, P3794, DOI 10.1242/jcs.029678; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114; Georges PC, 2007, AM J PHYSIOL-GASTR L, V293, pG1147, DOI 10.1152/ajpgi.00032.2007; Gotschy A, 2013, CIRC-CARDIOVASC IMAG, V6, P916, DOI 10.1161/CIRCIMAGING.113.000611; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Hu J, 2004, CARCINOGENESIS, V25, P1991, DOI 10.1093/carcin/bgh198; Hume DA, 2002, J LEUKOCYTE BIOL, V72, P621; Irwin EF, 2008, J BIOMAT SCI-POLYM E, V19, P1363, DOI 10.1163/156856208786052407; Ishihara S, 2013, EXP CELL RES, V319, P2916, DOI 10.1016/j.yexcr.2013.09.018; Kazemi F, 2006, J HEPATOL, V45, P230, DOI 10.1016/j.jhep.2006.04.006; Khan KMF, 2004, J BIOL CHEM, V279, P22039, DOI 10.1074/jbc.M312735200; Kocgozlu L, 2010, J CELL SCI, V123, P29, DOI 10.1242/jcs.053520; Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Mach F, 1999, J CLIN INVEST, V104, P1041, DOI 10.1172/JCI6993; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Nahon P, 2006, AM J GASTROENTEROL, V101, P2744, DOI 10.1111/j.1572-0241.2006.00816.x; O'Neill LAJ, 2009, PHARMACOL REV, V61, P177, DOI 10.1124/pr.109.001073; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Patel NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041024; Previtera ML, 2013, ANN BIOMED ENG, V41, P1193, DOI 10.1007/s10439-013-0765-y; Previtera ML, 2010, ANN BIOMED ENG, V38, P3733, DOI 10.1007/s10439-010-0112-5; Previtera ML, 2010, J BIOSCI BIOENG, V110, P459, DOI 10.1016/j.jbiosc.2010.04.004; Previtera ML, 2014, ANN BIOMED ENG; Rauch U, 2011, HISTOL HISTOPATHOL, V26, P711, DOI 10.14670/HH-26.711; Reilly GC, 2010, J BIOMECH, V43, P55, DOI 10.1016/j.jbiomech.2009.09.009; Rekhter MD, 1999, CARDIOVASC RES, V41, P376, DOI 10.1016/S0008-6363(98)00321-6; Rowlands AS, 2008, AM J PHYSIOL-CELL PH, V295, pC1037, DOI 10.1152/ajpcell.67.2008; Sasmono RT, 2003, BLOOD, V101, P1155, DOI 10.1182/blood-2002-02-0569; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Teng ZZ, 2014, ACTA BIOMATER, V10, P5055, DOI 10.1016/j.actbio.2014.09.001; Trotta T, 2014, J NEUROIMMUNOL, V268, P1, DOI 10.1016/j.jneuroim.2014.01.014; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Wuerfel J, 2010, NEUROIMAGE, V49, P2520, DOI 10.1016/j.neuroimage.2009.06.018; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	43	97	98	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145813	10.1371/journal.pone.0145813	http://dx.doi.org/10.1371/journal.pone.0145813			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710072	Green Submitted, Green Published, gold			2022-12-26	WOS:000367451400081
J	Zhang, WJ; Hou, T; Niu, CH; Song, LB; Zhang, YN				Zhang, Weijing; Hou, Teng; Niu, Chunhao; Song, Libing; Zhang, Yanna			B3GNT3 Expression Is a Novel Marker Correlated with Pelvic Lymph Node Metastasis and Poor Clinical Outcome in Early-Stage Cervical Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; PRACTICE GUIDELINES; HUMAN-PAPILLOMAVIRUS; IDENTIFICATION; RISK; PROGNOSIS; BETA-1,3-N-ACETYLGLUCOSAMINYLTRANSFERASE; RADIOTHERAPY; MANAGEMENT; RECEPTORS	Background The beta 1,3-N-acetylglucosaminyltransferase-3 gene (B3GNT3) encodes a member of the B3GNT family that functions as the backbone structure of dimeric sialyl-Lewis A and is involved in L-selectin ligand biosynthesis, lymphocyte homing and lymphocyte trafficking. B3GNT3 has been implicated as an important element in the development of certain cancers. However, the characteristics of B3GNT3 in the development and progression of cancer remain largely unknown. Thus, our study aimed to investigate the expression pattern and the prognostic value of B3GNT3 in patients with early-stage cervical cancer. Methods The mRNA and protein levels of B3GNT3 expression were examined in eight cervical cancer cell lines and ten paired cervical cancer tumors, using real-time PCR and western blotting, respectively. Immunohistochemistry (IHC) was used to analyze B3GNT3 protein expression in paraffin-embedded tissues from 196 early-stage cervical cancer patients. Statistical analyses were applied to evaluate the association between B3GNT3 expression scores and clinical parameters, as well as patient survival. Results B3GNT3 expression was significantly upregulated in cervical cancer cell lines and lesions compared with normal cells and adjacent noncancerous cervical tissues. In the 196 cases of tested early-stage cervical cancer samples, the B3GNT3 protein level was positively correlated with high risk TYPES of human papillomavirus (HPV) infection (P = 0.026), FIGO stage (P < 0.001), tumor size (P = 0.025), tumor recurrence (P = 0.004), vital status (P < 0.001), concurrent chemotherapy and radiotherapy (P = 0.016), lymphovascular space involvement (P = 0.003) and most importantly, lymph node metastasis (P = 0.003). Patients with high B3GNT3 expression had a shorter overall survival (OS) and disease-free survival (DFS) compared with those with low expression of this protein. Multivariate analysis suggested that B3GNT3 expression is an independent prognostic indicator for cervical cancer patients. Conclusions Our study demonstrated that elevated B3GNT3 expression is associated with pelvic lymph node metastasis and poor outcome in early-stage cervical cancer patients. B3GNT3 may be a novel prognostic marker and therapeutic target for the treatment of cervical cancer.	[Zhang, Weijing; Niu, Chunhao; Song, Libing; Zhang, Yanna] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Hou, Teng] Huazhong Univ Sci & Technol, Wuhan Union Hosp, Dept Urol, Wuhan 430074, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Huazhong University of Science & Technology	Song, LB (corresponding author), Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China.	songlb@sysucc.org.cn; zhangyn@sysucc.org.cn	Song, LB/AAL-1968-2020; Zhang, Weijing/GQA-9455-2022					Benedet JL, 2000, INT J GYNECOL OBSTET, V70, P209; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Cerhan JR, 2007, BLOOD, V110, P4455, DOI 10.1182/blood-2007-05-088682; Dallas MR, 2012, AM J PHYSIOL-CELL PH, V303, pC616, DOI 10.1152/ajpcell.00149.2012; Duenas-Gonzalez A, 2003, CANCER TREAT REV, V29, P389, DOI 10.1016/S0305-7372(03)00068-9; Etcheverry A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-701; Fan CF, 2011, TUMOR BIOL, V32, P873, DOI 10.1007/s13277-011-0188-z; Fleming ND, 2015, GYNECOL ONCOL, V136, P48, DOI 10.1016/j.ygyno.2014.11.010; Grigsby PW, 2001, CANCER J, V7, pS47; Haider S, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0105-3; Haie-Meder C, 2010, ANN ONCOL, V21, pv37, DOI 10.1093/annonc/mdq162; He MA, 2014, GUT, V63, P143, DOI 10.1136/gutjnl-2012-303434; Ho WL, 2013, CANCER SCI, V104, P1600, DOI 10.1111/cas.12294; Hofler D, 2015, GYNECOL ONCOL, V138, P676, DOI 10.1016/j.ygyno.2015.06.039; Hu Z, 2015, J CLIN INVEST, V125, P425, DOI 10.1172/JCI78206; Hua D, 2012, ASIAN PAC J CANCER P, V13, P2087, DOI 10.7314/APJCP.2012.13.5.2087; Iida M, 2014, MOL CLIN ONCOL, V2, P647, DOI 10.3892/mco.2014.324; Ishida H, 2005, FEBS LETT, V579, P71, DOI 10.1016/j.febslet.2004.11.037; Koh WJ, 2013, J NATL COMPR CANC NE, V11, P320, DOI 10.6004/jnccn.2013.0043; Li S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073837; Li Y, 2015, APOPTOSIS; Li Z, 2012, ANN ONCOL, V23, P638, DOI 10.1093/annonc/mdr290; Lin HS, 2004, ARCH OTOLARYNGOL, V130, P311, DOI 10.1001/archotol.130.3.311; Liu LX, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0183-5; Liu XK, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-59; Llor X, 1999, CLIN CANCER RES, V5, P1767; Ludyga N, 2011, MOL BIOSYST, V7, P1603, DOI 10.1039/c0mb00286k; Ma S, 2012, GASTROENTEROLOGY, V143, P675, DOI 10.1053/j.gastro.2012.06.007; Mitoma J, 2003, J BIOL CHEM, V278, P9953, DOI 10.1074/jbc.M212756200; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Okazawa M, 2013, INT J GYNECOL CANCER, V23, P567, DOI 10.1097/IGC.0b013e31828703fd; Onal C, 2015, GYNECOL ONCOL; Paiva I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116868; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; Schmandt RE, 2006, CANCER BIOL THER, V5, P1136, DOI 10.4161/cbt.5.9.2953; Shen H, 2014, CANCER BIOL THER, V15, P342, DOI 10.4161/cbt.27328; Shen L, 2011, MOL BIOL REP, V38, P1541, DOI 10.1007/s11033-010-0262-4; Shibata TK, 2012, J BIOL CHEM, V287, P6592, DOI 10.1074/jbc.M111.305334; Shiraishi N, 2001, J BIOL CHEM, V276, P3498, DOI 10.1074/jbc.M004800200; Tong YQ, 2012, ASIA-PAC J CLIN ONCO, V8, pE55, DOI 10.1111/j.1743-7563.2012.01564.x; Wheeler CM, 2009, JNCI-J NATL CANCER I, V101, P475, DOI 10.1093/jnci/djn510; Yamashita H, 2010, AM J CLIN ONCOL-CANC, V33, P583, DOI 10.1097/COC.0b013e3181cae5b7; Yang LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075849; Yeh JC, 2001, CELL, V105, P957, DOI 10.1016/S0092-8674(01)00394-4; Zhang LF, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-4; Zhang W., 2015, TUMOUR BIOL; Zhang ZH, 2012, INT J BIOCHEM CELL B, V44, P1244, DOI 10.1016/j.biocel.2012.04.026	47	20	22	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0144360	10.1371/journal.pone.0144360	http://dx.doi.org/10.1371/journal.pone.0144360			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709519	Green Submitted, Green Published, gold			2022-12-26	WOS:000367451400005
J	Dechavanne, C; Cottrell, G; Garcia, A; Migot-Nabias, F				Dechavanne, Celia; Cottrell, Gilles; Garcia, Andre; Migot-Nabias, Florence			Placental Malaria: Decreased Transfer of Maternal Antibodies Directed to Plasmodium falciparum and Impact on the Incidence of Febrile Infections in Infants	PLOS ONE			English	Article							NEONATAL FC-RECEPTOR; TETANUS ANTIBODIES; MUMPS VACCINATION; MEASLES; RESPONSES; IMMUNITY; SUSCEPTIBILITY; TRANSMISSION; ASSOCIATION; PROTECTION	The efficacy of mother-to-child placental transfer of antibodies specific to malaria blood stage antigens was investigated in the context of placental malaria infection, taking into account IgG specificity and maternal hypergammaglobulinemia. The impact of the resulting maternal antibody transfer on infections in infants up to the age of 6 months was also explored. This study showed that i) placental malaria was associated with a reduced placental transfer of total and specific IgG, ii) antibody placental transfer varied according to IgG specificity and iii) cord blood malaria IgG levels were similar in infants born to mothers with or without placental malaria. The number of malaria infections was negatively associated with maternal age, whereas it was not associated with the transfer of any malaria-specific IgG from the mother to the fetus. These results suggest that i) malaria-specific IgG may serve as a marker of maternal exposure but not as a useful marker of infant protection from malaria and ii) increasing maternal age contributes to diminishing febrile infections diagnosed in infants, perhaps by means of the transmission of an effective antibody response.	[Dechavanne, Celia; Cottrell, Gilles; Garcia, Andre; Migot-Nabias, Florence] Univ Paris 05, IRD, UMR Mere & Enfant Face Infect Trop 216, Paris, France; [Dechavanne, Celia; Cottrell, Gilles; Garcia, Andre; Migot-Nabias, Florence] Univ Paris 05, COMUE Sorbonne Paris Cite, Fac Sci Pharmaceut & Biol, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite	Dechavanne, C (corresponding author), Case Western Reserve Univ, Ctr Global Hlth & Dis, Biomed Res Bldg, Cleveland, OH 44106 USA.	celia.dechavanne@gmail.com	Garcia, Andre/S-2959-2016; Garcia, Andre/ABA-1820-2020	Garcia, Andre/0000-0002-1808-472X; Garcia, Andre/0000-0002-1808-472X; Migot-Nabias, Florence/0000-0001-9982-594X; Cottrell, Gilles/0000-0002-7964-8963; Dechavanne, Celia/0000-0001-8439-9976	Agence Nationale de la Recherche (ANR) Sante Environnement Sante Travail (SEST) [040 01]; Treilles Foundation	Agence Nationale de la Recherche (ANR) Sante Environnement Sante Travail (SEST)(French National Research Agency (ANR)); Treilles Foundation	The funding for this study was received from Agence Nationale de la Recherche (ANR) Sante Environnement Sante Travail (SEST 2006; 040 01). Celia Dechavanne benefited from the financial support of the Treilles Foundation.; We thank all the women and infants of Tori Bossito who agreed to participate in the study as well as the CERPAGE (Centre d'Etude et de Recherche sur le Paludisme Assoecie a la Grossesse et l'Enfance) team at Cotonou and the Tori Bossito medical health center staff (F. Loumedjinon and M Daoudou) for performing fieldwork. We are grateful to R. Anders (La Trobe University, Melbourne, Australia), S. Longacre (Pasteur Institute, Paris, France), E. Remarque (Biomedical Primate Research Centre, Rijswijk, The Netherlands) and M. Theisen (Statens Serum Institute, Copenhagen, Denmark) for their gift of P. falciparum recombinant proteins and G. Tavera and I. Malhotra for critical reading of the manuscript. We thank the Faculte des Sciences de la Sante, the Institut des Sciences Biomedicales Appliquees de Cotonou (ISBA) and the Programme National de Lutte contre le Paludisme (PNLP) for their institutional support. C. Dechavanne benefited from the financial support of the Treilles Foundation. This study was funded by the Agence Nationale de la Recherche (ANR) Sante Environnement Sante Travail (SEST 2006; 040 01).	BALLARD JL, 1991, J PEDIATR-US, V119, P417, DOI 10.1016/S0022-3476(05)82056-6; BRAIR ME, 1994, LANCET, V343, P208, DOI 10.1016/S0140-6736(94)90991-1; Brambell F. W. Rogers, 1970, PEDIATRICS, V18; Cot M, 2003, AM J EPIDEMIOL, V157, P203, DOI 10.1093/aje/kwf192; de Moraes-Pinto MI, 1998, ARCH DIS CHILD-FETAL, V79, pF202, DOI 10.1136/fn.79.3.F202; Dechavanne S, 2015, INFECT IMMUN, V83, P2466, DOI 10.1128/IAI.03116-14; Deloron P, 1997, CLIN EXP IMMUNOL, V110, P212; Dieboit J, 1986, RSA, V34, P35; Fievet N, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-251; Fowkes FJI, 2012, J INFECT DIS, V206, P1612, DOI 10.1093/infdis/jis566; Gans H, 2003, VACCINE, V21, P3398, DOI 10.1016/S0264-410X(03)00341-4; Gans H, 2001, J INFECT DIS, V184, P817, DOI 10.1086/323346; Ghetie V, 2002, IMMUNOL RES, V25, P97, DOI 10.1385/IR:25:2:097; Hartter HK, 2000, PEDIATR INFECT DIS J, V19, P635, DOI 10.1097/00006454-200007000-00010; JONES EA, 1972, J CLIN INVEST, V51, P2916, DOI 10.1172/JCI107116; Le Port A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027516; Le Port A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000342; LeHesran JY, 1997, AM J EPIDEMIOL, V146, P826, DOI 10.1093/oxfordjournals.aje.a009200; LOGIE DE, 1973, B WORLD HEALTH ORGAN, V49, P547; Lusingu JPA, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-48; Malhotra I, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000116; Megnekou R, 2015, SCAND J IMMUNOL, V81, P508, DOI 10.1111/sji.12286; Mora L, 2014, J INFECT DIS; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Moulton LH, 1995, BIOMETRICS, V51, P1570, DOI 10.2307/2533289; Mutabingwa TK, 2005, PLOS MED, V2, P1260, DOI 10.1371/journal.pmed.0020407; Nebie I, 2008, INFECT IMMUN, V76, P759, DOI 10.1128/IAI.01147-07; Okoko BJ, 2001, J HEALTH POPUL NUTR, V19, P59; Palmeira P, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/985646; Rachas A, 2012, CLIN INFECT DIS, V55, P672, DOI 10.1093/cid/cis490; Riley EM, 2000, INFECT IMMUN, V68, P5856, DOI 10.1128/IAI.68.10.5856-5863.2000; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Sachs UJH, 2006, IMMUNOLOGY, V119, P83, DOI 10.1111/j.1365-2567.2006.02408.x; SAJI F, 1994, PLACENTA, V15, P453, DOI 10.1016/S0143-4004(05)80415-1; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Santner-Nanan B, 2013, J IMMUNOL, V191, P145, DOI 10.4049/jimmunol.1203165; Schwarz NG, 2008, CLIN INFECT DIS, V47, P1017, DOI 10.1086/591968; Scott S, 2005, J INFECT DIS, V191, P1854, DOI 10.1086/429963; Siegrist CA, 2003, VACCINE, V21, P3406, DOI 10.1016/S0264-410X(03)00342-6; WALDMANN TA, 1969, PROG ALLERGY, V13, P1, DOI 10.1159/000287491; Wilson PT, 2013, ACTA TROP, V128, P149, DOI 10.1016/j.actatropica.2013.07.018	41	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145464	10.1371/journal.pone.0145464	http://dx.doi.org/10.1371/journal.pone.0145464			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26698578	gold, Green Published			2022-12-26	WOS:000367092600083
J	Dedeine, F; Weinert, LA; Bigot, D; Josse, T; Ballenghien, M; Cahais, V; Galtier, N; Gayral, P				Dedeine, Franck; Weinert, Lucy A.; Bigot, Diane; Josse, Thibaut; Ballenghien, Marion; Cahais, Vincent; Galtier, Nicolas; Gayral, Philippe			Comparative Analysis of Transcriptomes from Secondary Reproductives of Three Reticulitermes Termite Species	PLOS ONE			English	Article							CARBOHYDRATE-ACTIVE ENZYMES; GENE-EXPRESSION; COPTOTERMES-FORMOSANUS; PHYLOGENETIC ANALYSIS; POPULATION GENOMICS; ISOPTERA; GUT; CASTES; HOST; METATRANSCRIPTOME	Termites are eusocial insects related to cockroaches that feed on lignocellulose. These insects are key species in ecosystems since they recycle a large amount of nutrients but also are pests, exerting major economic impacts. Knowledge on the molecular pathways underlying reproduction, caste differentiation or lignocellulose digestion would largely benefit from additional transcriptomic data. This study focused on transcriptomes of secondary reproductive females (nymphoid neotenics). Thirteen transcriptomes were used: 10 of Reticulitermes flavipes and R. grassei sequenced from a previous study, and two transcriptomes of R. lucifugus sequenced for the present study. After transcriptome assembly and read mapping, we examined interspecific variations of genes expressed by termites or gut microorganisms. A total of 18,323 orthologous gene clusters were detected. Functional annotation and taxonomic assignment were performed on a total of 41,287 predicted contigs in the three termite species. Between the termite species studied, functional categories of genes were comparable. Gene ontology (GO) terms analysis allowed the discovery of 9 cellulases and a total of 79 contigs potentially involved in 11 enzymatic activities used in wood metabolism. Altogether, results of this study illustrate the strong potential for the use of comparative interspecific transcriptomes, representing a complete resource for future studies including differentially expressed genes between castes or SNP analysis for population genetics.	[Dedeine, Franck; Bigot, Diane; Josse, Thibaut; Gayral, Philippe] Univ Tours, Inst Rech Biol Insecte, UMR 7261, CNRS, F-37200 Tours, France; [Weinert, Lucy A.; Ballenghien, Marion; Cahais, Vincent; Galtier, Nicolas] Univ Montpellier, Inst Sci Evolut, UMR 5554, CNRS,IRD,EPHE, F-34059 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Tours; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE)	Gayral, P (corresponding author), Univ Tours, Inst Rech Biol Insecte, UMR 7261, CNRS, F-37200 Tours, France.	philippe.gayral@univ-tours.fr	Josse, Thibaut/F-5606-2016	Josse, Thibaut/0000-0002-6607-506X; Dedeine, Franck/0000-0002-0646-4725	French ANR grant [EvoSymTer 08-JCJC-007601]; European Research Council (ERC) grant [ERC PopPhyl 232971]	French ANR grant(French National Research Agency (ANR)); European Research Council (ERC) grant(European Research Council (ERC))	Termite collection was supported by a a French ANR grant to FD (EvoSymTer 08-JCJC-007601). Transcriptome sequencing was supported by a European Research Council (ERC) grant to NG (ERC PopPhyl 232971).	Alexeyenko A, 2006, BIOINFORMATICS, V22, pE9, DOI 10.1093/bioinformatics/btl213; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bastien G, 2013, BIOTECHNOL BIOFUELS, V6; Bignell DE, 2011, BIOL TERMITES MODEM; Brune A, 2014, NAT REV MICROBIOL; Cahais V, 2012, MOL ECOL RESOUR, V12, P834, DOI 10.1111/j.1755-0998.2012.03148.x; Clement JL, 2001, INSECT SOC, V48, P202, DOI 10.1007/PL00001768; Colman DR, 2012, MOL ECOL, V21, P5124, DOI 10.1111/j.1365-294X.2012.05752.x; Dietrich C, 2014, APPL ENVIRON MICROB, V80, P2261, DOI 10.1128/AEM.04206-13; Gayral P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003457; Gayral P, 2011, MOL ECOL RESOUR, V11, P650, DOI 10.1111/j.1755-0998.2011.03010.x; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Hayashi Y, 2013, PLOS ONE, V8; He SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061126; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; Hojo M, 2012, INSECT MOL BIOL, V21, P545, DOI 10.1111/j.1365-2583.2012.01162.x; Howard KJ, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P97, DOI 10.1007/978-90-481-3977-4_5; Huang QY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050383; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Husseneder C, 2012, COMP BIOCHEM PHYS D, V7, P14, DOI 10.1016/j.cbd.2011.10.002; Hyatt D, 2012, BIOINFORMATICS, V28, P2223, DOI 10.1093/bioinformatics/bts429; Inward DJG, 2007, MOL PHYLOGENET EVOL, V44, P953, DOI 10.1016/j.ympev.2007.05.014; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Korb J, 2008, BIOL REV, V83, P295, DOI 10.1111/j.1469-185X.2008.00044.x; Korb J, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00009; Lewis JL, 2004, ANN ENTOMOL SOC AM, V97, P1242, DOI 10.1603/0013-8746(2004)097[1242:PCFFCA]2.0.CO;2; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lo N, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P51, DOI 10.1007/978-90-481-3977-4_3; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Ni JF, 2013, BIOTECHNOL ADV, V31, P838, DOI 10.1016/j.biotechadv.2013.04.005; Ohkuma M, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P413, DOI 10.1007/978-90-481-3977-4_15; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; Park BH, 2010, GLYCOBIOLOGY, V20, P1574, DOI 10.1093/glycob/cwq106; Perdereau E, 2015, MOL ECOL, V24, P2125, DOI 10.1111/mec.13094; Perdereau E, 2013, MOL ECOL, V22, P1105, DOI 10.1111/mec.12140; Raychoudhury R, 2013, INSECT MOL BIOL, V22, P155, DOI 10.1111/imb.12011; Romiguier J, 2014, NATURE, V515, P261, DOI 10.1038/nature13685; Romiguier J, 2014, J EVOLUTION BIOL, V27, P593, DOI 10.1111/jeb.12331; Sabree ZL, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-138; Scharf ME, 2005, INSECT MOL BIOL, V14, P31, DOI 10.1111/j.1365-2583.2004.00527.x; Scharf ME, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00076; Sen R, 2013, BMC GENOMICS, V14; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Steller MM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-463; SU NY, 1987, INSECT SOC, V34, P229, DOI 10.1007/BF02224355; Su NY, 2002, SOCIOBIOLOGY, V40, P95; Tadmor AD, 2011, SCIENCE, V333, P58, DOI 10.1126/science.1200758; Tai V, 2015, APPL ENVIRON MICROB, V81, P1059, DOI 10.1128/AEM.02945-14; Tartar A, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-25; Terrapon N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4636; Todaka N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008636; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vargo EL, 2009, ANNU REV ENTOMOL, V54, P379, DOI 10.1146/annurev.ento.54.110807.090443; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Watanabe H, 2010, ANNU REV ENTOMOL, V55, P609, DOI 10.1146/annurev-ento-112408-085319; Weil T, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-198; Weil T, 2009, MOL BIOL EVOL, V26, P1841, DOI 10.1093/molbev/msp095; Xie L, 2012, GENOMICS, V99, P246, DOI 10.1016/j.ygeno.2012.01.009; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang D, 2012, INSECT MOL BIOL, V21, P235, DOI 10.1111/j.1365-2583.2011.01130.x	62	12	12	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145596	10.1371/journal.pone.0145596	http://dx.doi.org/10.1371/journal.pone.0145596			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26698123	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092600101
J	Gourni, E; Canovas, C; Goncalves, V; Denat, F; Meyer, PT; Maecke, HR				Gourni, Eleni; Canovas, Coline; Goncalves, Victor; Denat, Franck; Meyer, Philipp T.; Maecke, Helmut R.			(R)-NODAGA-PSMA: A Versatile Precursor for Radiometal Labeling and Nuclear Imaging of PSMA-Positive Tumors	PLOS ONE			English	Article							MEMBRANE ANTIGEN-EXPRESSION; PRECLINICAL EVALUATION; INHIBITORS; ANTIBODIES; ENDORADIOTHERAPY; PROBES; GA-68; J591	Purpose The present study aims at developing and evaluating an urea-based prostate specific membrane antigen (PSMA) inhibitor suitable for labeling with In-111 for SPECT and intraoperative applications as well as Ga-68 and Cu-64 for PET imaging. Methods The PSMA-based inhibitor-lysine-urea-glutamate-coupled to the spacer Phe-Phe-D-Lys (suberoyl) and functionalized with the enantiomerically pure prochelator (R)-1-(1-carboxy-3-carbotertbutoxypropyl)-4,7-carbotartbutoxymethyl)-1,4,7-triazacyclononane ((R)-NODAGA(tBu)(3)), to obtain (R)-NODAGA-Phe-Phe-D-Lys(suberoyl)-Lys-urea-Glu (CC34). CC34 was labeled with In-111, Ga-68 and Cu-64. The radioconjugates were further evaluated in vitro and in vivo in LNCaP xenografts by biodistribution and PET studies. Biodistribution studies were also performed with Ga-68-HBED-CC-PSMA (HBED-CC: N,N'-bis[2-hydroxy5-( carboxyethyl)benzyl]ethylenediamine-N,N'-diacetic acid) and In-111-PSMA-617 for comparison. Results Ga-68-CC34, Cu-64-CC34, and In-111-CC34 were prepared in radiochemical purity >95%. Ga-68/nat-CC34, Cu-64/nat-CC34, In-111/nat-CC34, Ga-68/nat-HBED-CC-PSMA, and In-111/nat-PSMA- 617 exhibited high affinity for the LNCaP cells, with K-d values of 19.3 +/- 2.5 nM, 27.5 +/- 2.7 nM, 5.5 +/- 0.9 nM, 2.9 +/- 0.6 nM and 5.4 +/- 0.8 nM, respectively. They revealed comparable internalization profiles with approximately 75% of the total cell associated activity internalized after 3 h of incubation. Ga-68-CC34 showed very high stability after its administration in mice. Tumor uptake of Ga-68-CC34 (14.5 +/- 2.9% IA/g) in LNCaP xenografts at 1 h p.i. was comparable to Ga-68-HBED-CC-PSMA (15.8 +/- 1.4% IA/g) (P = 0.67). The tumor-to-normal tissue ratios at 1 and 2 h p.i of Ga-68-CC34 were also comparable to Ga-68-HBED-CC-PSMA (P>0.05). Tumor uptake of In-111-CC34 (28.5 +/- 2.6%IA/g) at 1 h p.i. was lower than In-111-PSMA-617 (52.1 +/- 6.5% IA/g) (P = 0.02). The acquisition of PET-images with Cu-64-CC34 at later time points showed wash-out from the kidneys, while tumor uptake still remained relatively high. This resulted in an increased tumor-to-kidney ratio over time. Conclusions Ga-68-CC34 is comparable to Ga-68-HBED-CC-PSMA in terms of tumor uptake and tumor to normal tissue ratios. Cu-64-CC34 could enable high contrast imaging of PSMA positive tissues characterized by elevated expression of PSMA or when delayed imaging is required. Cu-64-CC34 is currently being prepared for clinical translation.	[Gourni, Eleni] German Canc Consortium DKTK, Heidelberg, Germany; [Gourni, Eleni; Meyer, Philipp T.; Maecke, Helmut R.] Univ Hosp Freiburg, Dept Nucl Med, Freiburg, Germany; [Gourni, Eleni] German Canc Res Ctr, Heidelberg, Germany; [Canovas, Coline; Goncalves, Victor; Denat, Franck] Univ Bourgogne Franche Comte, Inst Chim Mol, Univ Bourgogne, UMR6302,CNRS, Dijon, France	Helmholtz Association; German Cancer Research Center (DKFZ); University of Freiburg; Helmholtz Association; German Cancer Research Center (DKFZ); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Bourgogne	Gourni, E (corresponding author), Univ Oslo, Inst Basic Med Sci, Fac Med, Oslo, Norway.	eleni.gourni@medisin.uio.no	Gourni, Eleni/ABA-8305-2020; Goncalves, Victor/O-1099-2019	Goncalves, Victor/0000-0001-9854-4409	German Consortium for Translational Cancer Research (DKTK); Conseil Regional de Bourgogne (FABER and 3MIM programs), France	German Consortium for Translational Cancer Research (DKTK); Conseil Regional de Bourgogne (FABER and 3MIM programs), France(Region Bourgogne-Franche-Comte)	This work was supported by the German Consortium for Translational Cancer Research (DKTK) and the Conseil Regional de Bourgogne (FABER and 3MIM programs), France.	Afshar-Oromieh A, 2014, EUR J NUCL MED MOL I, V41, P11, DOI 10.1007/s00259-013-2525-5; Alt K, 2010, PROSTATE, V70, P1413, DOI 10.1002/pros.21176; Anderson CJ, 2009, CANCER BIOTHER RADIO, V24, P379, DOI 10.1089/cbr.2009.0674; Banerjee SR, 2008, J MED CHEM, V51, P4504, DOI 10.1021/jm800111u; Banerjee SR, 2015, J NUCL MED, V56, P628, DOI 10.2967/jnumed.114.149062; Banerjee SR, 2014, J MED CHEM, V57, P2657, DOI 10.1021/jm401921j; Banerjee SR, 2010, J MED CHEM, V53, P5333, DOI 10.1021/jm100623e; Beer AJ, 2011, LANCET ONCOL, V12, P181, DOI 10.1016/S1470-2045(10)70103-0; Benesova M, 2015, J NUCL MED, V56, P914, DOI 10.2967/jnumed.114.147413; Chang Sam S, 2004, Rev Urol, V6 Suppl 10, pS13; Chang SS, 2001, UROLOGY, V57, P1179, DOI 10.1016/S0090-4295(01)00983-9; Chen Y, 2008, J MED CHEM, V51, P7933, DOI 10.1021/jm801055h; CRAIG AS, 1989, POLYHEDRON, V8, P2481, DOI 10.1016/S0277-5387(89)80014-2; Eder M, 2012, BIOCONJUGATE CHEM, V23, P688, DOI 10.1021/bc200279b; Elsasser-Beile U, 2006, PROSTATE, V66, P1359, DOI 10.1002/pros.20367; Hillier SM, 2009, CANCER RES, V69, P6932, DOI 10.1158/0008-5472.CAN-09-1682; Holland JP, 2010, J NUCL MED, V51, P1293, DOI 10.2967/jnumed.110.076174; HOROSZEWICZ JS, 1987, ANTICANCER RES, V7, P927; Kozikowski AP, 2004, J MED CHEM, V47, P1729, DOI 10.1021/jm0306226; Kularatne SA, 2009, MOL PHARMACEUT, V6, P790, DOI 10.1021/mp9000712; Liu TC, 2008, BIOCHEMISTRY-US, V47, P12658, DOI 10.1021/bi801883v; Maresca KP, 2009, J MED CHEM, V52, P347, DOI 10.1021/jm800994j; Milowsky MI, 2007, J CLIN ONCOL, V25, P540, DOI 10.1200/JCO.2006.07.8097; Perner S, 2007, HUM PATHOL, V38, P696, DOI 10.1016/j.humpath.2006.11.012; Roesch F, 2010, CURR TOP MED CHEM, V10, P1633, DOI 10.2174/156802610793176738; Ruggiero A, 2011, J NUCL MED, V52, P1608, DOI 10.2967/jnumed.111.092098; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Silver DA, 1997, CLIN CANCER RES, V3, P81; Troyer JK, 1997, PROSTATE, V30, P232, DOI 10.1002/(SICI)1097-0045(19970301)30:4<232::AID-PROS2>3.0.CO;2-N; Vallabhajosula S, 2005, CLIN CANCER RES, V11, p7195S, DOI 10.1158/1078-0432.CCR-1004-0023; Vallabhajosula S, 2005, J NUCL MED, V46, P634; Vallabhajosula S, 2015, J NUCL MED, V55, P1791; Weineisen M, 2015, J NUCL MED, V56, P1169, DOI 10.2967/jnumed.115.158550; Weineisen M, 2014, EJNMMI RES, V4, DOI 10.1186/s13550-014-0063-1; Wright GL, 1996, UROLOGY, V48, P326, DOI 10.1016/S0090-4295(96)00184-7	35	43	44	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145755	10.1371/journal.pone.0145755	http://dx.doi.org/10.1371/journal.pone.0145755			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700033	Green Submitted, Green Published, gold			2022-12-26	WOS:000367092600130
J	Mooney, C; Raoof, R; El-Naggar, H; Sanz-Rodriguez, A; Jimenez-Mateos, EM; Henshall, DC				Mooney, Catherine; Raoof, Rana; El-Naggar, Hany; Sanz-Rodriguez, Amaya; Jimenez-Mateos, Eva M.; Henshall, David C.			High Throughput qPCR Expression Profiling of Circulating MicroRNAs Reveals Minimal Sex-and Sample Timing-Related Variation in Plasma of Healthy Volunteers	PLOS ONE			English	Article							PCR DATA; NORMALIZATION; SERUM; QUALITY; CANCER; BIOMARKERS; VARIANCE; MIRNAS	MicroRNAs are a class of small non-coding RNA that regulate gene expression at a post-transcriptional level. MicroRNAs have been identified in various body fluids under normal conditions and their stability as well as their dysregulation in disease opens up a new field for biomarker study. However, diurnal and day-to-day variation in plasma microRNA levels, and differential regulation between males and females, may affect biomarker stability. A QuantStudio 12K Flex Real-Time PCR System was used to profile plasma microRNA levels using OpenArray in male and female healthy volunteers, in the morning and afternoon, and at four time points over a one month period. Using this system we were able to run four OpenArray plates in a single run, the equivalent of 32 traditional 384-well qPCR plates or 12,000 data points. Up to 754 microRNAs can be identified in a single plasma sample in under two hours. 108 individual microRNAs were identified in at least 80% of all our samples which compares favourably with other reports of microRNA profiles in serum or plasma in healthy adults. Many of these microRNAs, including miR-16-5p, miR-17-5p, miR-19a-3p, miR-24-3p, miR-30c-5p, miR-191-5p, miR-223-3p and miR-451a are highly expressed and consistent with previous studies using other platforms. Overall, microRNA levels were very consistent between individuals, males and females, and time points and we did not detect significant differences in levels of microRNAs. These results suggest the suitability of this platform for microRNA profiling and biomarker discovery and suggest minimal confounding influence of sex or sample timing. However, the platform has not been subjected to rigorous validation which must be demonstrated in future biomarker studies where large differences may exist between disease and control samples.	[Mooney, Catherine; Raoof, Rana; Sanz-Rodriguez, Amaya; Jimenez-Mateos, Eva M.; Henshall, David C.] Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Dublin 2, Ireland; [Raoof, Rana] Mosul Med Coll, Dept Anat, Mosul, Iraq; [El-Naggar, Hany] Beaumont Hosp, Dept Neurol, Dublin 9, Ireland	Royal College of Surgeons - Ireland	Mooney, C (corresponding author), Royal Coll Surgeons Ireland, Dept Physiol & Med Phys, Dublin 2, Ireland.	catherinemooney@rcsi.ie	Raoof, Rana/F-8562-2019; Raoof, Rana Mumtaz/J-9316-2019; Jimenez-Mateos, Eva/AAG-8072-2019	Raoof, Rana/0000-0001-5418-1407; Raoof, Rana Mumtaz/0000-0001-5418-1407; El-Naggar, Hany/0000-0001-6500-5273; Mooney, Catherine/0000-0002-7696-1364; Jimenez-Mateos, Eva/0000-0001-6417-6580; Henshall, David/0000-0001-6237-9632	European Union [602130]; Science Foundation Ireland (SFI) [13/SIRG/2114, SFI/13/IA/1891, SFI/12/COEN/18, SFI/12/RC/2272, SFI/14/ADV/RC2721]; Iraqi Ministry of Higher Education and Scientific Research	European Union(European Commission); Science Foundation Ireland (SFI)(Science Foundation Ireland); Iraqi Ministry of Higher Education and Scientific Research	This publication has emanated from research conducted with the financial support of the European Union's 'Seventh Framework' Programme (FP7) under Grant Agreement no 602130, Science Foundation Ireland (SFI) under Grant Numbers 13/SIRG/2114, SFI/13/IA/1891, SFI/12/COEN/18, SFI/12/RC/2272 and SFI/14/ADV/RC2721 and a fellowship from the Iraqi Ministry of Higher Education and Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Baggish AL, 2011, J PHYSIOL-LONDON, V589, P3983, DOI 10.1113/jphysiol.2011.213363; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blondal T, 2013, METHODS, V59, pS1, DOI 10.1016/j.ymeth.2012.09.015; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bovell LC, 2013, CLIN CANCER RES, V19, P3955, DOI 10.1158/1078-0432.CCR-12-3302; Chen RM, 2013, CURR BIOL, V23, P1959, DOI 10.1016/j.cub.2013.08.005; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Cheng HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064795; Drummond MJ, 2011, PHYSIOL GENOMICS, V43, P595, DOI 10.1152/physiolgenomics.00148.2010; Duttagupta R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020769; Dvinge H, 2009, BIOINFORMATICS, V25, P3325, DOI 10.1093/bioinformatics/btp578; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gatfield D, 2009, GENE DEV, V23, P1313, DOI 10.1101/gad.1781009; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Haider BA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089565; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Kinoshita C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4823; Kirschner MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024145; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacLellan SA, 2014, BMC CLIN PATHOL, V14, DOI 10.1186/1472-6890-14-27; McCall MN, 2014, BIOINFORMATICS, V30, P2310, DOI 10.1093/bioinformatics/btu239; Mestdagh P, 2014, NAT METHODS, V11, P809, DOI [10.1038/NMETH.3014, 10.1038/nmeth.3014]; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Meyer SU, 2010, BIOTECHNOL LETT, V32, P1777, DOI 10.1007/s10529-010-0380-z; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Moldovan L, 2014, J CELL MOL MED, V18, P371, DOI 10.1111/jcmm.12236; Morgan CP, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-22; Na YJ, 2009, EXP MOL MED, V41, P638, DOI 10.3858/emm.2009.41.9.070; Perkins JR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-296; Pradervand S, 2009, RNA, V15, P493, DOI 10.1261/rna.1295509; R Core Team, 2013, R LANG ENV STAT COMP; Reid G, 2011, CRIT REV ONCOL HEMAT, V80, P193, DOI 10.1016/j.critrevonc.2010.11.004; Rekker K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081166; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Shende VR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022586; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041561; Ward J, 2014, P NATL ACAD SCI USA, V111, P12169, DOI 10.1073/pnas.1412608111; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Wylie Dennis, 2011, BMC Res Notes, V4, P555, DOI 10.1186/1756-0500-4-555	49	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145316	10.1371/journal.pone.0145316	http://dx.doi.org/10.1371/journal.pone.0145316			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26699132	gold, Green Submitted, Green Published			2022-12-26	WOS:000367092600065
J	Nagy, VK; Szeplaki, G; Apor, A; Kutyifa, V; Kovacs, A; Kosztin, A; Becker, D; Boros, AM; Geller, L; Merkely, B				Nagy, Vivien Klaudia; Szeplaki, Gabor; Apor, Astrid; Kutyifa, Valentina; Kovacs, Attila; Kosztin, Annamaria; Becker, David; Boros, Andras Mihaly; Geller, Laszlo; Merkely, Bela			Role of Right Ventricular Global Longitudinal Strain in Predicting Early and Long-Term Mortality in Cardiac Resynchronization Therapy Patients	PLOS ONE			English	Article							ADVANCED HEART-FAILURE; EUROPEAN-SOCIETY; ESC GUIDELINES; EJECTION FRACTION; TASK-FORCE; SURVIVAL; ASSOCIATION; COLLABORATION; DYSFUNCTION; CARDIOLOGY	Background Right ventricular (RV) dysfunction has been associated with poor prognosis in chronic heart failure (HF). However, less data is available about the role of RV dysfunction in patients with cardiac resynchronization therapy (CRT). We aimed to investigate if RV dysfunction would predict outcome in CRT. Design We enrolled prospectively ninety-three consecutive HF patients in this single center observational study. All patients underwent clinical evaluation and echocardiography before CRT and 6 months after implantation. We assessed RV geometry and function by using speckle tracking imaging and calculated strain parameters. We performed multivariable Cox regression models to test mortality at 6 months and at 24 months. Results RV dysfunction, characterized by decreased RVGLS (RV global longitudinal strain) [10.2 (7.0-12.8) vs. 19.5 (15.0-23.9) %, p<0.0001] and RVFWS (RV free wall strain) [15.6 (10.0-19.3) vs. 17.4 (10.5-22.2) %, p = 0.04], improved 6 months after CRT implantation. Increasing baseline RVGLS and RVFWS predicted survival independent of other parameters at 6 months [hazard ratio (HR) = 0.37 (0.15-0.90), p = 0.02 and HR = 0.42 (0.19-0.89), p = 0.02; per 1 standard deviation increase, respectively]. RVGLS proved to be a significant independent predictor of mortality at 24 months [HR = 0.53 (0.32-0.86), p = 0.01], and RVFWS showed a strong tendency [HR = 0.64 (0.40-1.00), p = 0.05]. The 24-month survival was significantly impaired in patients with RVGLS below 10.04% before CRT implantation [area under the curve = 0.72 (0.60-0.84), p = 0.002, log-rank p = 0.0008; HR = 5.23 (1.76-15.48), p = 0.003]. Conclusions Our findings indicate that baseline RV dysfunction is associated with poor short-term and long-term prognosis after CRT implantation.	[Nagy, Vivien Klaudia; Szeplaki, Gabor; Apor, Astrid; Kutyifa, Valentina; Kovacs, Attila; Kosztin, Annamaria; Becker, David; Boros, Andras Mihaly; Geller, Laszlo; Merkely, Bela] Semmelweis Univ, Heart & Vasc Ctr, H-1085 Budapest, Hungary	Semmelweis University	Merkely, B (corresponding author), Semmelweis Univ, Heart & Vasc Ctr, H-1085 Budapest, Hungary.	merkely.bela@gmail.com	Kovács, Attila/AAE-7467-2019	Kovács, Attila/0000-0003-2320-6434; Kosztin MD, PhD, Annamaria/0000-0001-6647-2623; Szeplaki, Gabor/0000-0003-3795-1240	Hungarian Foundation Programs: Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences; Hungarian Scientific Research Foundation [OTKA 105555]	Hungarian Foundation Programs: Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences; Hungarian Scientific Research Foundation(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by Hungarian Foundation Programs: Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences (GSZ, LG) and the Hungarian Scientific Research Foundation (OTKA 105555). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to all the patients who participated in our study. We are thankful to Semmelweis University for the professional assistance background. This work was supported by Hungarian Foundation Programs: Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences (GSZ, LG) and the Hungarian Scientific Research Foundation (OTKA 105555).	Alpendurada F, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-68; Brignole M, 2013, EUR HEART J, V34, P2281, DOI 10.1093/eurheartj/eht150; Bui AL, 2011, NAT REV CARDIOL, V8, P30, DOI 10.1038/nrcardio.2010.165; Cameli M, 2012, J CARD FAIL, V18, P208, DOI 10.1016/j.cardfail.2011.12.002; Campbell P, 2013, CIRC-HEART FAIL, V6, P435, DOI 10.1161/CIRCHEARTFAILURE.112.000127; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; Damy T, 2013, J AM COLL CARDIOL, V61, P2153, DOI 10.1016/j.jacc.2013.02.049; de Groote P, 1998, J AM COLL CARDIOL, V32, P948, DOI 10.1016/S0735-1097(98)00337-4; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; DISALVO TG, 1995, J AM COLL CARDIOL, V25, P1143, DOI 10.1016/0735-1097(94)00511-N; Field ME, 2006, J CARD FAIL, V12, P616, DOI 10.1016/j.cardfail.2006.06.472; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Leong DP, 2013, HEART, V99, P722, DOI 10.1136/heartjnl-2012-303076; Linde C, 2002, J AM COLL CARDIOL, V40, P111, DOI 10.1016/S0735-1097(02)01932-0; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Padeletti L, 2012, HEART FAIL REV, V17, P97, DOI 10.1007/s10741-011-9250-6; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Sade LE, 2013, J AM SOC ECHOCARDIOG, V26, P706, DOI 10.1016/j.echo.2013.03.013; Sutherland GR, 2004, J AM SOC ECHOCARDIOG, V17, P788, DOI 10.1016/j.echo.2004.03.027; Taylor J, 2010, EUR HEART J, V31, P2559, DOI 10.1093/eurheartj/ehq358; Vardas PE, 2007, EUR HEART J, V28, P2256, DOI 10.1093/eurheartj/ehm305; Vizzardi E, 2012, ECHOCARDIOGR-J CARD, V29, P773, DOI 10.1111/j.1540-8175.2012.01703.x	22	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0143907	10.1371/journal.pone.0143907	http://dx.doi.org/10.1371/journal.pone.0143907			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700308	Green Submitted, Green Published, gold			2022-12-26	WOS:000367092600012
J	Yang, SM; Huang, CY; Shiue, HS; Huang, SP; Pu, YS; Chen, WJ; Lin, YC; Hsueh, YM				Yang, Shu-Mei; Huang, Chao-Yuan; Shiue, Horng-Sheng; Huang, Shu-Pin; Pu, Yeong-Shiau; Chen, Wei-Jen; Lin, Ying-Chin; Hsueh, Yu-Mei			Joint Effect of Urinary Total Arsenic Level and VEGF-A Genetic Polymorphisms on the Recurrence of Renal Cell Carcinoma	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; SINGLE NUCLEOTIDE POLYMORPHISMS; DRINKING-WATER; BREAST-CANCER; CHINESE POPULATION; PROSTATE-CANCER; BLADDER-CANCER; TOBACCO-SMOKE; KIDNEY CANCER; LUNG-CANCER	The results of our previous study suggested that high urinary total arsenic levels were associated with an increased risk of renal cell carcinoma (RCC). Germline genetic polymorphisms might also affect cancer risk and clinical outcomes. Vascular endothelial growth factor (VEGF) plays an important role in vasculogenesis and angiogenesis, but the combined effect of these factors on RCC remains unclear. In this study, we explored the association between the VEGFA -2578C> A, -1498T> C, -1154G> A, -634G> C, and +936C> T gene polymorphisms and RCC. We also evaluated the combined effects of the VEGF-A haplotypes and urinary total arsenic levels on the prognosis of RCC. This case-control study was conducted with 191 RCC patients who were diagnosed with renal tumors on the basis of image-guided biopsy or surgical resections. An additional 376 age-and gender-matched controls were recruited. Concentrations of urinary arsenic species were determined by a high performance liquid chromatography-linked hydride generator and atomic absorption spectrometry. Genotyping was investigated using fluorescent-based TaqMan allelic discrimination. We observed no significant associations between VEGF-A haplotypes and RCC risk. However, the VEGF-A ACGG haplotype from VEGF-A -2578, -1498, -1154, and -634 was significantly associated with an increased recurrence of RCC (OR = 3.34, 95% CI = 1.03-10.91). Urinary total arsenic level was significantly associated with the risk of RCC in a dose-response manner, but it was not related to the recurrence of RCC. The combination of high urinary total arsenic level and VEGF-A risk haplotypes affected the OR of RCC recurrence in a dose-response manner. This is the first study to show that joint effect of high urinary total arsenic and VEGF-A risk haplotypes may influence the risk of RCC recurrence in humans who live in an area without obvious arsenic exposure.	[Yang, Shu-Mei; Chen, Wei-Jen; Hsueh, Yu-Mei] Taipei Med Univ, Sch Publ Hlth, Coll Publ Hlth & Nutr, Taipei, Taiwan; [Huang, Chao-Yuan; Pu, Yeong-Shiau] Natl Taiwan Univ, Coll Med, Natl Taiwan Univ Hosp, Dept Urol, Taipei 10764, Taiwan; [Shiue, Horng-Sheng] Chang Gung Univ, Chang Gung Mem Hosp, Dept Chinese Med, Taoyuan, Taiwan; [Shiue, Horng-Sheng] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Huang, Shu-Pin] Kaohsiung Med Univ Hosp, Dept Urol, Kaohsiung, Taiwan; [Huang, Shu-Pin] Kaohsiung Med Univ, Coll Med, Fac Med, Dept Urol, Kaohsiung, Taiwan; [Lin, Ying-Chin] Taipei Med Univ, Shung Ho Hosp, Dept Family Med, Taipei, Taiwan; [Lin, Ying-Chin] Taipei Med Univ, Wan Fang Hosp, Dept Hlth Examinat, Taipei, Taiwan; [Lin, Ying-Chin] Taipei Med Univ, Sch Med, Div Family Med, Taipei, Taiwan; [Hsueh, Yu-Mei] Taipei Med Univ, Sch Med, Dept Publ Hlth, Coll Med, Taipei, Taiwan	Taipei Medical University; National Taiwan University; National Taiwan University Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University	Hsueh, YM (corresponding author), Taipei Med Univ, Sch Med, Dept Publ Hlth, Coll Med, Taipei, Taiwan.	ymhsueh@tmu.edu.tw	Chen, Wei-Jen/AAF-1739-2019	Chen, Wei-Jen/0000-0003-0683-7904; HUANG, CHAO-YUAN/0000-0002-9322-6062; PU, YEONG-SHIAU/0000-0002-2859-3966	National Science Council of the ROC [NSC 86-2314-B-038-038, NSC 87-2314-B-038-029, NSC-88-2314-B-038-112, NSC-89-2314-B038-049, SC-89-2320-B038-013, NSC-90-2320-B-038-021, NSC-91-3112-B-038-0019, NSC-92-3112-B-038-001];  [NSC-93-3112-B-038-001];  [NSC-94-2314-B-038-023];  [NSC-95-2314-B-038-007];  [NSC-96-2314-B038-003];  [NSC-97-2314-B-038-015-MY3 (1-3)];  [NSC-97-2314-B-038-015-MY3 (2-3)];  [NSC-97-2314-B-038-015-MY3 (3-3)];  [NSC 100-2314-B-038 -026];  [NSC 101-2314-B-038 -051-MY3 (1-3)];  [NSC 101-2314-B-038 -051-MY3 (2-3)];  [NSC 101-2314-B-038 -051-MY3 (3-3)];  [MOST 103-2314-B-038-021-MY2 (1-2)];  [MOST 103-2314-B-038-021-MY2 (2-2)]	National Science Council of the ROC(Ministry of Science and Technology, Taiwan); ; ; ; ; ; ; ; ; ; ; ; ; 	This study was supported by grants from the National Science Council of the ROC (NSC 86-2314-B-038-038, NSC 87-2314-B-038-029, NSC-88-2314-B-038-112, NSC-89-2314-B038-049, SC-89-2320-B038-013, NSC-90-2320-B-038-021, NSC-91-3112-B-038-0019, NSC-92-3112-B-038-001, NSC-93-3112-B-038-001, NSC-94-2314-B-038-023, NSC-95-2314-B-038-007, NSC-96-2314-B038-003, NSC-97-2314-B-038-015-MY3 (1-3), NSC-97-2314-B-038-015-MY3 (2-3), NSC-97-2314-B-038-015-MY3 (3-3), NSC 100-2314-B-038 -026, NSC 101-2314-B-038 -051-MY3 (1-3), NSC 101-2314-B-038 -051-MY3 (2-3), NSC 101-2314-B-038 -051-MY3 (3-3), MOST 103-2314-B-038-021-MY2 (1-2), and MOST 103-2314-B-038-021-MY2 (2-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajaz S, 2011, GENET TEST MOL BIOMA, V15, P653, DOI 10.1089/gtmb.2011.0029; Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; Bao LZ, 2010, CHEM RES TOXICOL, V23, P1726, DOI 10.1021/tx100191t; Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337; Brogan IJ, 1999, HUM IMMUNOL, V60, P1245, DOI 10.1016/S0198-8859(99)00132-9; Bruyere F, 2010, J UROLOGY, V184, P1273, DOI 10.1016/j.juro.2010.06.009; Bureau of Health Promotion, 2006, CANC REG ANN REP 200; Cao Y, 2012, CANCER RES, V72, P3912, DOI 10.1158/0008-5472.CAN-11-4058; Chae EJ, 2005, RADIOLOGY, V234, P189, DOI 10.1148/radiol.2341031733; Chae YS, 2006, ONCOLOGY-BASEL, V71, P266, DOI 10.1159/000106788; Chen CL, 2010, ENVIRON RES, V110, P455, DOI 10.1016/j.envres.2009.08.010; Chen JY, 2012, GUILTY OF INDIGENCE: THE URBAN POOR IN CHINA, 1900-1953, P13; Crew JP, 1997, CANCER RES, V57, P5281; Ferreccio C, 2013, AM J EPIDEMIOL, V178, P813, DOI 10.1093/aje/kwt059; Fujita Naoyuki, 2014, BMC Res Notes, V7, P369, DOI 10.1186/1756-0500-7-369; GREENBERG RA, 1984, NEW ENGL J MED, V310, P1075, DOI 10.1056/NEJM198404263101703; Howell WM, 2002, GENES IMMUN, V3, P229, DOI 10.1038/sj.gene.6363851; Hsueh YM, 1997, CANCER EPIDEM BIOMAR, V6, P589; Hsueh YM, 1998, J TOXICOL ENV HEAL A, V54, P431, DOI 10.1080/009841098158728; Huang CY, 2012, TOXICOL APPL PHARM, V262, P349, DOI 10.1016/j.taap.2012.05.013; Huang CY, 2011, J UROLOGY, V185, P2040, DOI 10.1016/j.juro.2011.01.079; Huang D, 2008, CANCER RES, V68, P81, DOI 10.1158/0008-5472.CAN-07-5311; Huang YC, 2011, TOXICOL LETT, V201, P62, DOI 10.1016/j.toxlet.2010.12.006; Jacobs EJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1400; JAMES GD, 1988, AM J HYPERTENS, V1, P124, DOI 10.1093/ajh/1.2.124; Jang MJ, 2013, MOL CARCINOGEN, V52, P60, DOI 10.1002/mc.21980; JONGEN WMF, 1985, FOOD CHEM TOXICOL, V23, P669, DOI 10.1016/0278-6915(85)90155-3; Kawai Y, 2007, EUR UROL, V52, P1147, DOI 10.1016/j.eururo.2007.01.073; Kim DH, 2010, ANN ONCOL, V21, P1179, DOI 10.1093/annonc/mdp452; Kim JJ, 2012, CANCER-AM CANCER SOC, V118, P1946, DOI 10.1002/cncr.26491; Kjaer-Frifeldt S, 2012, PHARMACOGENOMICS, V13, P763, DOI [10.2217/PGS.12.38, 10.2217/pgs.12.38]; Koch S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006502; Koukourakis MI, 2004, LUNG CANCER, V46, P293, DOI 10.1016/j.lungcan.2004.04.037; Langsenlehner T, 2014, STRAHLENTHER ONKOL, V190, P364, DOI 10.1007/s00066-013-0503-2; LE XC, 1993, TALANTA, V40, P185, DOI 10.1016/0039-9140(93)80320-Q; Ljungberg B, 2011, EUR UROL, V60, P615, DOI 10.1016/j.eururo.2011.06.049; Lu GJ, 2015, TUMOR BIOL, V36, P8645, DOI 10.1007/s13277-015-3431-1; Lu H, 2005, CANCER RES, V65, P5015, DOI 10.1158/0008-5472.CAN-04-2786; Luo T, 2013, ASIAN PAC J CANCER P, V14, P2433, DOI 10.7314/APJCP.2013.14.4.2433; Martinez-Fierro ML, 2013, CANCER BIOMARK, V13, P235, DOI 10.3233/CBM-130348; Mostafa MG, 2013, OCCUP ENVIRON MED, V70, P768, DOI 10.1136/oemed-2013-101443; Navas-Acien A, 2009, ENVIRON HEALTH PERSP, V117, P1428, DOI 10.1289/ehp.0800509; Ollerenshaw M, 2004, CANCER GENET CYTOGEN, V153, P122, DOI 10.1016/j.cancergencyto.2004.01.014; Otrock ZK, 2007, BLOOD CELL MOL DIS, V38, P258, DOI 10.1016/j.bcmd.2006.12.003; Pu YS, 2007, TOXICOL APPL PHARM, V218, P99, DOI 10.1016/j.taap.2006.09.021; Rahman M, 2015, CHEMOSPHERE, V120, P336, DOI 10.1016/j.chemosphere.2014.08.003; Renner W, 2000, J VASC RES, V37, P443, DOI 10.1159/000054076; Saenz-Lopez P, 2013, HUM IMMUNOL, V74, P98, DOI 10.1016/j.humimm.2012.10.014; Santos L, 2003, ANN ONCOL, V14, P1419, DOI 10.1093/annonc/mdg377; Sasaki A, 2007, EXP HEMATOL, V35, P252, DOI 10.1016/j.exphem.2006.10.004; Scartozzi M, 2013, BRIT J CANCER, V108, P1126, DOI 10.1038/bjc.2012.501; Shahbazi M, 2002, J AM SOC NEPHROL, V13, P260, DOI 10.1681/ASN.V131260; Stevens A, 2003, CANCER RES, V63, P812; Sun SF, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0410-x; Szarvas T, 2008, CLIN CANCER RES, V14, P8253, DOI 10.1158/1078-0432.CCR-08-0677; Theis RP, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-387; Tsai ML, 2016, ENVIRON TOXICOL, V31, P1121, DOI 10.1002/tox.22121; Tynkevich E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111949; Vincenti V, 1996, CIRCULATION, V93, P1493, DOI 10.1161/01.CIR.93.8.1493; Wang F, 2014, OCCUP ENVIRON MED, V71, P675, DOI 10.1136/oemed-2014-102173; Wang F, 2013, TOXICOL LETT, V222, P303, DOI 10.1016/j.toxlet.2013.08.008; Wang YH, 2013, J HAZARD MATER, V262, P1139, DOI 10.1016/j.jhazmat.2012.08.056; Wang ZM, 1996, AM J CLIN NUTR, V63, P863, DOI 10.1093/ajcn/63.6.863; WANNAMETHEE G, 1988, INT J EPIDEMIOL, V17, P307, DOI 10.1093/ije/17.2.307; Watson CJ, 2000, CYTOKINE, V12, P1232, DOI 10.1006/cyto.2000.0692; World Health Organization, 2008, GUIDELINES FOR DRINK, V1; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Yang CY, 2004, ARCH ENVIRON HEALTH, V59, P484, DOI 10.1080/00039890409603430; Zhang Y, 2013, ONCOL LETT, V6, P1068, DOI 10.3892/ol.2013.1499; Zhong WF, 2014, TUMOR BIOL, V35, P9839, DOI 10.1007/s13277-014-2194-4	70	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145410	10.1371/journal.pone.0145410	http://dx.doi.org/10.1371/journal.pone.0145410			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26701102	gold, Green Submitted, Green Published			2022-12-26	WOS:000367092600076
J	Zheng, XZ; Mao, XH; Xu, K; Lu, LS; Peng, XZ; Wang, M; Xu, GS; Hua, ZL; Wang, JP; Xue, HC; Wang, JM; Lu, C				Zheng, Xianzhi; Mao, Xuhua; Xu, Kun; Lu, Lingshuang; Peng, Xianzhen; Wang, Min; Xu, Guisheng; Hua, Zhaolai; Wang, Jianping; Xue, Hengchuan; Wang, Jianming; Lu, Cheng			Massive Endoscopic Screening for Esophageal and Gastric Cancers in a High-Risk Area of China	PLOS ONE			English	Article							PROGRAM; TRENDS; SURVEILLANCE; MORTALITY; PROVINCE; STOMACH; IMPACT	Objective This study aims to describe the findings from a massive endoscopic screening program in a high-risk area of China and to evaluate the prognosis of patients diagnosed through endoscopic screening compared with those diagnosed at usual hospital visits because of illness. Methods In 2006, an early detection and treatment program was initiated in Yangzhong county, China. Local residents aged 40-69 years were eligible for free endoscopic screening. Endoscopic examination was performed with Lugol's iodine staining, followed by biopsies. Patients diagnosed with esophageal or gastric cancer were referred for treatment and followed to assess their long-term survival status. Results From 2006 through 2012, we screened 12453 participants, including 5334 (42.8%) men and 7119 (57.2%) women. The average age was 52.8 +/- 8.0 years. We detected 166 patients with upper digestive tract cancers, including 106 cancers in the esophagus (detection rate: 0.85%) and 60 cancers in the stomach (detection rate: 0.48%). Of these patients, 98.11% with esophageal cancer and 100% with gastric cancer were defined as at the early stage. In the process of follow-up, 17 patients died from cancer-related causes, and the median survival time was greater than 85 months. The overall survival rates for 1, 3 and 5 years were 98.0%, 90.0% and 89.0%, respectively. A significant positive effect was observed for the long-term survival of patients diagnosed through massive endoscopic screening. Conclusions In a high-risk population, massive endoscopic screening can identify early stage carcinoma of esophageal and gastric cancers and improve patients' prognosis through early detection and treatment.	[Zheng, Xianzhi; Lu, Lingshuang; Peng, Xianzhen; Wang, Min; Xu, Guisheng; Wang, Jianming] Nanjing Med Univ, Dept Epidemiol, Sch Publ Hlth, Nanjing 211166, Jiangsu, Peoples R China; [Mao, Xuhua] Yixing Peoples Hosp, Dept Clin Lab, Wuxi 214200, Peoples R China; [Xu, Kun; Wang, Jianming] Nanjing Med Univ, Dept Social Med & Hlth Educ, Sch Publ Hlth, Nanjing 211166, Jiangsu, Peoples R China; [Hua, Zhaolai; Wang, Jianping; Xue, Hengchuan] Yangzhong Peoples Hosp, Yangzhong Canc Res Inst, Yangzhong 212200, Peoples R China; [Wang, Jianming] Nanjing Med Univ, Innovat Ctr Social Risk Governance Hlth, Sch Publ Hlth, Nanjing 211166, Jiangsu, Peoples R China; [Lu, Cheng] Nanjing Med Univ, Nanjing Matern & Child Hlth Hosp, Dept Breast, Nanjing 210004, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Wang, JM (corresponding author), Nanjing Med Univ, Dept Epidemiol, Sch Publ Hlth, Nanjing 211166, Jiangsu, Peoples R China.	jmwang@njmu.edu.cn; lucheng66@126.com	lu, lu/HII-7530-2022	Wang, Jianming/0000-0002-9151-284X	National Natural Science Foundation of China [81172268]; Key University Science Research Project of Jiangsu Province [12KJA330001]; Qing Lan Project; Six Talent Peaks Project in Jiangsu Province [2014-YY-023]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Medical Science and Technology Development Foundation, Jiangsu Province Department of Health [YZ01313]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key University Science Research Project of Jiangsu Province; Qing Lan Project(Jiangsu Polytech Institute); Six Talent Peaks Project in Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Medical Science and Technology Development Foundation, Jiangsu Province Department of Health	This study is supported by the National Natural Science Foundation of China (81172268), Key University Science Research Project of Jiangsu Province (12KJA330001), Qing Lan Project (2014), Six Talent Peaks Project in Jiangsu Province (2014-YY-023), Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), and Medical Science and Technology Development Foundation, Jiangsu Province Department of Health (YZ01313). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson WF, 2010, JAMA-J AM MED ASSOC, V303, P1723, DOI 10.1001/jama.2010.496; Cho E, 2013, ASIAN PAC J CANCER P, V14, P2533, DOI 10.7314/APJCP.2013.14.5.2533; Choi KS, 2011, CANCER SCI, V102, P1559, DOI 10.1111/j.1349-7006.2011.01982.x; Dong ZW, 2002, JPN J CLIN ONCOL, V32, pS10, DOI 10.1093/jjco/hye122; Gallagher LG, 2015, AM J IND MED, V58, P267, DOI 10.1002/ajim.22412; Hamashima C, 2015, WORLD J GASTROENTERO, V21, P2460, DOI 10.3748/wjg.v21.i8.2460; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Keen JD, 2015, J WOMENS HEALTH, V24, P867, DOI 10.1089/jwh.2015.5220; Kim GH, 2015, KOREAN J INTERN MED, V30, P747, DOI 10.3904/kjim.2015.30.6.747; Kong SH, 2004, JPN J CLIN ONCOL, V34, P1, DOI 10.1093/jjco/hyh009; Lambert R, 2012, WORLD J GASTRO ENDOS, V4, P518, DOI 10.4253/wjge.v4.i12.518; Lee SJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8441; Leung WK, 2008, LANCET ONCOL, V9, P279, DOI 10.1016/S1470-2045(08)70072-X; Lu YF, 2014, ASIAN PAC J CANCER P, V15, P1419, DOI 10.7314/APJCP.2014.15.3.1419; Mansour-Ghanaei F, 2012, ASIAN PAC J CANCER P, V13, P1407, DOI 10.7314/APJCP.2012.13.4.1407; Niu X, 2014, WORLD J GASTROENTERO, V20, P5074, DOI 10.3748/wjg.v20.i17.5074; ORGOGOZO JM, 1994, REV NEUROL, V150, P813; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pourhoseingholi Mohamad Amin, 2015, Gastroenterol Hepatol Bed Bench, V8, P19; Riecken B, 2002, PREV MED, V34, P22, DOI 10.1006/pmed.2001.0925; Roshandel G, 2013, ARCH IRAN MED, V16, P351, DOI 013166/AIM.009; Roth MJ, 1997, CANCER-AM CANCER SOC, V80, P2047, DOI 10.1002/(SICI)1097-0142(19971201)80:11<2047::AID-CNCR3>3.0.CO;2-U; Shah PM, 2015, J GASTROINTEST ONCOL, V6, P20, DOI 10.3978/j.issn.2078-6891.2014.096; Wang JP, 2015, ANN SURG ONCOL, V22, P2965, DOI 10.1245/s10434-015-4388-4; Wang JM, 2005, EUR J GASTROEN HEPAT, V17, P1339, DOI 10.1097/00042737-200512000-00012; Wei Wen-Qiang, 2011, Chin J Cancer, V30, P213; Yada Tomoyuki, 2013, Diagn Ther Endosc, V2013, P241320, DOI 10.1155/2013/241320; Zhao P, 2010, JPN J CLIN ONCOL, V40, P281, DOI 10.1093/jjco/hyp187	28	29	30	5	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145097	10.1371/journal.pone.0145097	http://dx.doi.org/10.1371/journal.pone.0145097			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26699332	Green Submitted, Green Published, gold			2022-12-26	WOS:000367092600046
J	Zang, YF; Wei, XR; Hao, MD				Zang, Yifei; Wei, Xiaorong; Hao, Mingde			Long-Term Effect of Crop Rotation and Fertilisation on Bioavailability and Fractionation of Copper in Soil on the Loess Plateau in Northwest China	PLOS ONE			English	Article							SOLID-WASTE COMPOST; MICRONUTRIENT AVAILABILITY; ORGANIC-MATTER; SEWAGE-SLUDGE; HEAVY-METALS; HUMIC-ACID; ZINC; PHOSPHATE; SORPTION; ACCUMULATION	The bioavailability and fractionation of Cu reflect its deliverability in soil. Little research has investigated Cu supply to crops in soil under long-term rotation and fertilisation on the Loess Plateau. A field experiment was conducted in randomized complete block design to determine the bioavailability and distribution of Cu fractions in a Heilu soil (Calcaric Regosol) after 18 years of rotation and fertilisation. The experiment started in 1984, including five cropping systems (fallow control, alfalfa cropping, maize cropping, winter wheat cropping, and grain-legume rotation of pea/winter wheat/winter wheat + millet) and five fertiliser treatments (unfertilised control, N, P, N + P, and N + P + manure). Soil samples were collected in 2002 for chemical analysis. Available Cu was assessed by diethylene triamine pentaacetic acid (DTPA) extraction, and Cu was fractionated by sequential extraction. Results showed that DTPA-Cu was lower in cropping systems compared with fallow control. Application of fertilisers resulted in no remarkable changes in DTPA-Cu compared with unfertilised control. Correlation and path analyses revealed that soil pH and CaCO3 directly affected Cu bioavailability, whereas available P indirectly affected Cu bioavailability. The concentrations of Cu fractions (carbonate and Fe/Al oxides) in the plough layer were lower in cropping systems, while the values in the plough sole were higher under grain-legume rotation relative to fallow control. Manure with NP fertiliser increased Cu fractions bound to organic matter and minerals in the plough layer, and its effects in the plough sole varied with cropping systems. The direct sources (organic-matter-bound fraction and carbonate-bound fraction) of available Cu contributed much to Cu bioavailability. The mineral-bound fraction of Cu acted as an indicator of Cu supply potential in the soil.	[Zang, Yifei; Hao, Mingde] Northwest A&F Univ, Coll Nat Resources & Environm, Yangling, Shaanxi, Peoples R China; [Wei, Xiaorong; Hao, Mingde] Chinese Acad Sci, Inst Soil & Water Conservat, Yangling, Shaanxi, Peoples R China; [Wei, Xiaorong; Hao, Mingde] Minist Water Resources, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Ministry of Water Resources	Hao, MD (corresponding author), Northwest A&F Univ, Coll Nat Resources & Environm, Yangling, Shaanxi, Peoples R China.	mdhao@ms.iswc.ac.cn	Hao, Ming/GXI-0243-2022		National Science and Technology Support Program [2011BAD31B01]	National Science and Technology Support Program	Funding provided by National Science and Technology Support Program (2011BAD31B01), http://program.most.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrochemistry Commission Soil Science Society of China, 1983, ROUT METH SOIL AGR A; Ahumada I, 2009, J ENVIRON MANAGE, V90, P2665, DOI 10.1016/j.jenvman.2009.02.004; [Anonymous], 1954, ESTIMATION AVAILABLE; BARROW NJ, 1987, J SOIL SCI, V38, P453, DOI 10.1111/j.1365-2389.1987.tb02280.x; Bhattacharyya P, 2006, ENVIRON GEOL, V49, P1064, DOI 10.1007/s00254-005-0150-8; Bradl HB, 2004, J COLLOID INTERF SCI, V277, P1, DOI 10.1016/j.jcis.2004.04.005; Cao J, 2004, CHEMOSPHERE, V54, P507, DOI 10.1016/j.chemosphere.2003.08.027; CLARK CJ, 1985, SOIL SCI, V139, P412, DOI 10.1097/00010694-198505000-00006; Fan JL, 2012, ENVIRON SCI POLLUT R, V19, P2745, DOI 10.1007/s11356-012-0774-7; FAO, 1988, SOIL MAP WORLD; Feng XY, 2007, POLL CONTROL TECHNOL, V20, P28; Fu HuiLan, 1997, Soybean Science, V16, P156; Gao M, 2000, PLANT NUTR FERTIL SC, V6, P11; Guan TX, 2011, CHEMOSPHERE, V82, P215, DOI 10.1016/j.chemosphere.2010.10.018; Gustafson GM, 2003, EUR J AGRON, V20, P89, DOI 10.1016/S1161-0301(03)00077-7; He MM, 2009, J HAZARD MATER, V163, P671, DOI 10.1016/j.jhazmat.2008.07.013; HOGG DS, 1993, SOIL SCI SOC AM J, V57, P361, DOI 10.2136/sssaj1993.03615995005700020013x; JOHNSTON AE, 1986, SOIL USE MANAGE, V2, P97, DOI 10.1111/j.1475-2743.1986.tb00690.x; Kabala C, 2001, J ENVIRON QUAL, V30, P485, DOI 10.2134/jeq2001.302485x; Kabata-Pendias A., 2011, TRACE ELEMENTS SOILS, DOI [10.1201/9781420039900, 10.1201/b10158-25, DOI 10.1201/B10158-25]; Kalavrouziotis IK, 2008, WATER AIR SOIL POLL, V190, P309, DOI 10.1007/s11270-007-9602-y; Kidd PS, 2007, CHEMOSPHERE, V66, P1458, DOI 10.1016/j.chemosphere.2006.09.007; KNOKE D, 1994, STAT SOCIAL DATA ANA; Li BY, 2007, SOIL TILL RES, V96, P166, DOI 10.1016/j.still.2007.05.005; [李志军 Li Zhijun], 2010, [植物营养与肥料学报, Plant Nutrition and Fertitizer Science], V16, P1456; LINDSAY WL, 1978, SOIL SCI SOC AM J, V42, P421, DOI 10.2136/sssaj1978.03615995004200030009x; Lu HF, 2010, J ENVIRON MANAGE, V91, P2727, DOI 10.1016/j.jenvman.2010.07.025; Mackowiak CL, 2001, SOIL SCI SOC AM J, V65, P1744, DOI 10.2136/sssaj2001.1744; Maiz I, 2000, ENVIRON POLLUT, V110, P3, DOI 10.1016/S0269-7491(99)00287-0; Mo RC, 1997, TROPICAL SUBTROPICAL, V6, P171; Nemati K, 2009, MICROCHEM J, V92, P165, DOI 10.1016/j.microc.2009.03.002; Pan WeiBin, 2000, Fujian Journal of Agricultural Sciences, V15, P45; Perez-Novo C, 2011, J HAZARD MATER, V185, P220, DOI 10.1016/j.jhazmat.2010.09.021; Perez-Novo C, 2009, GEODERMA, V150, P166, DOI 10.1016/j.geoderma.2009.02.001; [任顺荣 REN Shunrong], 2005, [生态环境, Ecology and Environment], V14, P921; Rodd AV, 2002, CAN J SOIL SCI, V82, P33, DOI 10.4141/S00-055; Rodriguez-Rubio P, 2003, EUR J SOIL SCI, V54, P401, DOI 10.1046/j.1365-2389.2003.00529.x; *SAS I INC, 2000, SAS PROC GUID VERS 8; Shao YuTing, 1995, Acta Pedologica Sinica, V32, P423; SHUMAN LM, 1985, SOIL SCI, V140, P11, DOI 10.1097/00010694-198507000-00003; Spark KM, 1997, AUST J SOIL RES, V35, P103, DOI 10.1071/S96009; TESSIER A, 1979, ANAL CHEM, V51, P844, DOI 10.1021/ac50043a017; Thakur SK, 2006, GEODERMA, V130, P240, DOI 10.1016/j.geoderma.2005.01.026; [田秀平 Tian Xiuping], 2003, [植物营养与肥料学报, Plant nutrition and fertitizer science], V9, P253; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; [王存龙 Wang Cunlong], 2012, [岩矿测试, Rock and Mineral Analysis], V31, P361; [王美 Wang Mei], 2014, [农业环境科学学报, Journal of Agro-Environment Science], V33, P1500; Wei XR, 2007, GEODERMA, V138, P213, DOI 10.1016/j.geoderma.2006.11.012; Wei XR, 2006, SOIL TILL RES, V91, P120, DOI 10.1016/j.still.2005.11.009; Wei XR, 2010, SOIL SCI PLANT NUTR, V56, P617, DOI 10.1111/j.1747-0765.2010.00497.x; Wu X, 2015, MICROB ECOL, V70, P1; Xing GX, 2003, SOIL CHEM TRACE ELEM; Xu J., 1995, HEAVY METAL TERRESTR; Xu Li, 2009, Acta Pedologica Sinica, V46, P1013; YU C, 1991, Acta Pedologica Sinica, V28, P317; [张维碟 Zhang Weidie], 2003, [环境科学学报, Acta Scientiae Circumstantiae], V23, P376; Zhu XianJin, 2009, Zhongguo Shengtai Nongye Xuebao / Chinese Journal of Eco-Agriculture, V17, P1063, DOI 10.3724/SP.J.1011.2009.01063	57	6	6	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145370	10.1371/journal.pone.0145370	http://dx.doi.org/10.1371/journal.pone.0145370			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26694965	gold, Green Published, Green Submitted			2022-12-26	WOS:000367092500041
J	Li, CW; Menconi, F; Osman, R; Mezei, M; Jacobson, EM; Concepcion, E; David, CS; Kastrinsky, DB; Ohlmeyer, M; Tomer, Y				Li, Cheuk Wun; Menconi, Francesca; Osman, Roman; Mezei, Mihaly; Jacobson, Eric M.; Concepcion, Erlinda; David, Chella S.; Kastrinsky, David B.; Ohlmeyer, Michael; Tomer, Yaron			Identifying a Small Molecule Blocking Antigen Presentation in Autoimmune Thyroiditis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell surface protein; endocrinology; major histocompatibility complex (MHC); peptides; small molecule; structural model; thyroid; thyroid hormone; thyroglobulin; thyroiditis	MYELIN BASIC-PROTEIN; HLA-DR; TRANSGENIC MICE; GRAVES-DISEASE; HASHIMOTOS-THYROIDITIS; THYROGLOBULIN PEPTIDES; MULTIPLE-SCLEROSIS; UNITED-STATES; L-THYROXINE; CEPHARANTHINE	We previously showed that an HLA-DR variant containing arginine at position 74 of the DR1 chain (DR1-Arg74) is the specific HLA class II variant conferring risk for autoimmune thyroid diseases (AITD). We also identified 5 thyroglobulin (Tg) peptides that bound to DR1-Arg74. We hypothesized that blocking the binding of these peptides to DR1-Arg74 could block the continuous T-cell activation in thyroiditis needed to maintain the autoimmune response to the thyroid. The aim of the current study was to identify small molecules that can block T-cell activation by Tg peptides presented within DR1-Arg74 pockets. We screened a large and diverse library of compounds and identified one compound, cepharanthine that was able to block peptide binding to DR1-Arg74. We then showed that Tg.2098 is the dominant peptide when inducing experimental autoimmune thyroiditis (EAT) in NOD mice expressing human DR1-Arg74. Furthermore, cepharanthine blocked T-cell activation by thyroglobulin peptides, in particular Tg.2098 in mice that were induced with EAT. For the first time we identified a small molecule that can block Tg peptide binding and presentation to T-cells in autoimmune thyroiditis. If confirmed cepharanthine could potentially have a role in treating human AITD.	[Li, Cheuk Wun; Menconi, Francesca; Jacobson, Eric M.; Concepcion, Erlinda; Tomer, Yaron] Icahn Sch Med Mt Sinai, Div Endocrinol, Box 1055,One Gustave L Levy Pl, New York, NY 10029 USA; [Osman, Roman; Mezei, Mihaly; Kastrinsky, David B.; Ohlmeyer, Michael] Icahn Sch Med Mt Sinai, Dept Struct & Chem Biol, Box 1055,One Gustave L Levy Pl, New York, NY 10029 USA; [David, Chella S.] Mayo Clin, Coll Med, Dept Immunol, Rochester, MN 55905 USA; [Tomer, Yaron] Bronx Vet Affairs Med Ctr, Bronx, NY 10468 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Mayo Clinic; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center	Tomer, Y (corresponding author), Icahn Sch Med Mt Sinai, Div Endocrinol, Box 1055,One Gustave L Levy Pl, New York, NY 10029 USA.	Yaron.Tomer@mssm.edu	Tomer, Yaron/GWU-8933-2022		National Institutes of Health from NIDDK [DK061659, DK073681]; NIAID [T32 AI007605]; Department of Veterans Affairs; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061659, R01DK073681] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018522] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants DK061659 and DK073681 from the NIDDK (to Y. T.) and Grant T32 AI007605 from the NIAID (to C. W. L.). This material is based upon work supported in part by the Department of Veterans Affairs. The authors declare that they have no conflicts of interest with the contents of this article.	Adedapo K. S., 2012, AFR J MED MED SCI, V41, P193; Ban Y, 2004, GENES IMMUN, V5, P203, DOI 10.1038/sj.gene.6364059; Ban Y, 2003, P NATL ACAD SCI USA, V100, P15119, DOI 10.1073/pnas.2434175100; Bartalena L, 1998, NEW ENGL J MED, V338, P73, DOI 10.1056/NEJM199801083380201; Bielekova B, 2000, NAT MED, V6, P1167, DOI 10.1038/80516; Bradley DS, 1997, J CLIN INVEST, V100, P2227, DOI 10.1172/JCI119760; Brocke S, 1996, NATURE, V379, P343, DOI 10.1038/379343a0; Bunevicius R, 1999, NEW ENGL J MED, V340, P424, DOI 10.1056/NEJM199902113400603; Chen CR, 2010, ENDOCRINOLOGY, V151, P4583, DOI 10.1210/en.2010-0321; CHICZ RM, 1993, J EXP MED, V178, P27, DOI 10.1084/jem.178.1.27; Cosconati S, 2010, EXPERT OPIN DRUG DIS, V5, P597, DOI 10.1517/17460441.2010.484460; Ebina T, 1990, Gan To Kagaku Ryoho, V17, P1165; EDASHIGE K, 1991, BIOCHEM PHARMACOL, V41, P71, DOI 10.1016/0006-2952(91)90012-T; Flynn JC, 2004, CELL IMMUNOL, V229, P79, DOI 10.1016/j.cellimm.2004.07.002; Flynn JC, 2001, J AUTOIMMUN, V17, P7, DOI 10.1006/jaut.2001.0528; FU XT, 1994, HUM IMMUNOL, V39, P253, DOI 10.1016/0198-8859(94)90268-2; FUJIMURA T, 1990, JPN J PHARMACOL, V54, P464, DOI 10.1254/jjp.54.464; Geluk A, 1998, J AUTOIMMUN, V11, P353, DOI 10.1006/jaut.1998.0207; Harada K, 2009, INT J ONCOL, V35, P1025, DOI 10.3892/ijo_00000417; Hasham A, 2012, IMMUNOL RES, V54, P204, DOI 10.1007/s12026-012-8302-x; Hodge SE, 2006, THYROID, V16, P351, DOI 10.1089/thy.2006.16.351; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Jacobson DL, 1997, CLIN IMMUNOL IMMUNOP, V84, P223, DOI 10.1006/clin.1997.4412; Jacobson EM, 2009, J BIOL CHEM, V284, P34231, DOI 10.1074/jbc.M109.041574; Ji NN, 2013, J IMMUNOL, V191, P5074, DOI 10.4049/jimmunol.1300407; Kimoto T, 1997, Nihon Geka Hokan, V66, P71; Koehler NKU, 2004, J MED CHEM, V47, P4989, DOI 10.1021/jm030362s; KOHNO H, 1986, FOLIA PHARMACOL JPN, V88, P71, DOI 10.1254/fpj.88.71; KOHNO H, 1987, FOLIA PHARMACOL JPN, V90, P205, DOI 10.1254/fpj.90.205; Kong YCM, 1996, J EXP MED, V184, P1167, DOI 10.1084/jem.184.3.1167; Kong Yi-Chi M, 2007, Curr Protoc Immunol, VChapter 15, DOI 10.1002/0471142735.im1507s78; Liu ZM, 2011, J CHEM INF MODEL, V51, P326, DOI 10.1021/ci100444c; McLachlan SM, 2014, ENDOCR REV, V35, P59, DOI 10.1210/er.2013-1055; Menconi F, 2008, P NATL ACAD SCI USA, V105, P14034, DOI 10.1073/pnas.0806584105; Menconi F, 2010, J AUTOIMMUN, V35, P45, DOI 10.1016/j.jaut.2010.01.004; Mezei M, 2010, SOURCE CODE BIOL MED, V5, DOI 10.1186/1751-0473-5-2; Michels AW, 2011, J IMMUNOL, V187, P5921, DOI 10.4049/jimmunol.1100746; Morita K, 2002, J DERMATOL, V29, P661, DOI 10.1111/j.1346-8138.2002.tb00199.x; Muixi L, 2008, J IMMUNOL, V181, P795, DOI 10.4049/jimmunol.181.1.795; Mukai M, 2003, CANCER SCI, V94, P557, DOI 10.1111/j.1349-7006.2003.tb01482.x; Nakamura H, 2013, J CLIN ENDOCR METAB, V98, P4776, DOI 10.1210/jc.2013-2569; Niwa Y, 1969, Hifuka Kiyo, V64, P47; Ohta T, 1990, Rinsho Hoshasen, V35, P471; Ozen S, 2011, J CLIN RES PEDIATR E, V3, P192, DOI 10.4274/jcrpe.425; Ravitz O, 2011, J COMPUT AID MOL DES, V25, P1033, DOI 10.1007/s10822-011-9482-5; Rivkees SA, 2009, NEW ENGL J MED, V360, P1574, DOI 10.1056/NEJMc0809750; ROGERS DJ, 1960, SCIENCE, V132, P1115, DOI 10.1126/science.132.3434.1115; Rogosnitzky M, 2011, PHARMACOL REP, V63, P337, DOI 10.1016/S1734-1140(11)70500-X; Rose Noel R., 2002, Autoimmunity Reviews, V1, P97, DOI 10.1016/S1568-9972(01)00016-7; Saito R, 1989, Nihon Gan Chiryo Gakkai Shi, V24, P2587; Saravanan P, 2002, CLIN ENDOCRINOL, V57, P577, DOI 10.1046/j.1365-2265.2002.01654.x; Shulman S, 1971, Adv Immunol, V14, P85, DOI 10.1016/S0065-2776(08)60284-9; Simmonds MJ, 2005, AM J HUM GENET, V76, P157, DOI 10.1086/426947; Slatosky J, 2000, AM FAM PHYSICIAN, V61, P1047; Stasiolek M, 2014, FOLIA HISTOCHEM CYTO, V52, P138, DOI 10.5603/FHC.2014.0013; STRAUSS G, 1994, IMMUNOGENETICS, V40, P104; Suzuki R, 1992, Gan To Kagaku Ryoho, V19, P647; Tabata R, 2012, INT IMMUNOPHARMACOL, V13, P242, DOI 10.1016/j.intimp.2012.04.015; Teyton L, 2007, J CLIN INVEST, V117, P3164, DOI 10.1172/JCI33997; TOMER Y, 1993, ENDOCR REV, V14, P107, DOI 10.1210/er.14.1.107; Tomer Y, 2003, ENDOCR REV, V24, P694, DOI 10.1210/er.2002-0030; Tomer Y, 2003, AM J HUM GENET, V73, P736, DOI 10.1086/378588; Topliss DJ, 2004, MED J AUSTRALIA, V180, P186, DOI 10.5694/j.1326-5377.2004.tb05866.x; Toulis KA, 2010, THYROID, V20, P1163, DOI 10.1089/thy.2009.0351; Ushiki N, 1988, Gan To Kagaku Ryoho, V15, P2701; Uto T, 2011, INT IMMUNOPHARMACOL, V11, P1932, DOI 10.1016/j.intimp.2011.08.003	66	15	15	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					4079	4090		10.1074/jbc.M115.694687	http://dx.doi.org/10.1074/jbc.M115.694687			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26703475	Green Published, hybrid			2022-12-26	WOS:000371338400033
J	Markwardt, ML; Seckinger, KM; Rizzo, MA				Markwardt, Michele L.; Seckinger, Kendra M.; Rizzo, Mark A.			Regulation of Glucokinase by Intracellular Calcium Levels in Pancreatic beta Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCAGON-LIKE PEPTIDE-1; NITRIC-OXIDE SYNTHASE; CA2+-INDUCED CA2+ RELEASE; INSULIN-SECRETION; GLUCOSE-METABOLISM; OSCILLATIONS; ACTIVATION; CALMODULIN; RETICULUM; ASSOCIATION	Glucokinase (GCK) controls the rate of glucose metabolism in pancreatic beta cells, and its activity is rate-limiting for insulin secretion. Posttranslational GCK activation can be stimulated through either G protein-coupled receptors or receptor tyrosine kinase signaling pathways, suggesting a common mechanism. Here we show that inhibiting Ca2+ release from the endoplasmic reticulum (ER) decouples GCK activation from receptor stimulation. Furthermore, pharmacological release of ER Ca2+ stimulates activation of a GCK optical biosensor and potentiates glucose metabolism, implicating rises in cytoplasmic Ca2+ as a critical regulatory mechanism. To explore the potential for glucose-stimulated GCK activation, the GCK biosensor was optimized using circularly permuted mCerulean3 proteins. This new sensor sensitively reports activation in response to insulin, glucagon-like peptide 1, and agents that raise cAMP levels. Transient, glucose-stimulated GCK activation was observed in beta TC3 and MIN6 cells. An ER-localized channelrhodopsin was used to manipulate the cytoplasmic Ca2+ concentration in cells expressing the optimized FRET-GCK sensor. This permitted quantification of the relationship between cytoplasmic Ca2+ concentrations and GCK activation. Half-maximal activation of the FRET-GCK sensor was estimated to occur at similar to 400 nM Ca2+. When expressed in islets, fluctuations in GCK activation were observed in response to glucose, and we estimated that post-translational activation of GCK enhances glucose metabolism by similar to 35%. These results suggest a mechanism for integrative control over GCK activation and, therefore, glucose metabolism and insulin secretion through regulation of cytoplasmic Ca2+ levels.	[Markwardt, Michele L.; Seckinger, Kendra M.; Rizzo, Mark A.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Rizzo, MA (corresponding author), 660 W Redwood St,HH 525B, Baltimore, MD 21201 USA.	mrizzo@sorn.umaryland.edu			National Institutes of Health [R21-DK067415, R01-DK077140, P60-DK079637, P30-DK072488, T32-GM008181]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077140, P60DK079637, P30DK072488, R21DK067415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008181] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R21-DK067415 and R01-DK077140 (to M. A. R.), P60-DK079637, and P30-DK072488. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Grant T32-GM008181.	ABUSOUD HM, 1993, P NATL ACAD SCI USA, V90, P10769, DOI 10.1073/pnas.90.22.10769; ABUSOUD HM, 1994, J BIOL CHEM, V269, P32047; Aspinwall CA, 2000, J BIOL CHEM, V275, P22331, DOI 10.1074/jbc.M909647199; Baltrusch S, 2007, DIABETES, V56, P1305, DOI 10.2337/db06-0894; Baltrusch S, 2006, ENDOCRINOLOGY, V147, P5768, DOI 10.1210/en.2006-0694; Beauvois MC, 2004, J PHYSIOL-LONDON, V559, P141, DOI 10.1113/jphysiol.2004.067454; Bennett BD, 1996, J BIOL CHEM, V271, P3647; Bertram R, 2007, AM J PHYSIOL-ENDOC M, V293, pE890, DOI 10.1152/ajpendo.00359.2007; Bertram R, 2010, ADV EXP MED BIOL, V654, P261, DOI 10.1007/978-90-481-3271-3_12; Calabrese A, 2003, DIABETES, V52, P417, DOI 10.2337/diabetes.52.2.417; Diederichs F, 2008, BIOPHYS J, V94, P5079, DOI 10.1529/biophysj.107.127613; Ding SY, 2011, J BIOL CHEM, V286, P16768, DOI 10.1074/jbc.M110.192799; Ding SY, 2010, MOL ENDOCRINOL, V24, P171, DOI 10.1210/me.2009-0138; DiPilato LM, 2009, MOL BIOSYST, V5, P832, DOI 10.1039/b823243a; Doyle ME, 2007, PHARMACOL THERAPEUT, V113, P546, DOI 10.1016/j.pharmthera.2006.11.007; Dyachok O, 2004, J BIOL CHEM, V279, P45455, DOI 10.1074/jbc.M407673200; Dzhura I, 2010, J PHYSIOL-LONDON, V588, P4871, DOI 10.1113/jphysiol.2010.198424; Fridlyand LE, 2007, AM J PHYSIOL-CELL PH, V293, pC1924, DOI 10.1152/ajpcell.00555.2006; Fridlyand LE, 2011, ISLETS, V3, P224, DOI 10.4161/isl.3.5.16409; Gloyn AL, 2004, FRONT DIABETES, V16, P92; GROMADA J, 1995, DIABETES, V44, P767, DOI 10.2337/diabetes.44.7.767; Haataja L, 2013, J BIOL CHEM, V288, P1896, DOI 10.1074/jbc.M112.420018; Hao M, 2007, DIABETES, V56, P2328, DOI 10.2337/db07-0056; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Holz GG, 1999, J BIOL CHEM, V274, P14147, DOI 10.1074/jbc.274.20.14147; Islam MS, 2002, DIABETES, V51, P1299, DOI 10.2337/diabetes.51.5.1299; Johnson JD, 2002, P NATL ACAD SCI USA, V99, P14566, DOI 10.1073/pnas.222099799; LAI FA, 1988, BIOCHEM BIOPH RES CO, V151, P441, DOI 10.1016/0006-291X(88)90613-4; Landa LR, 2005, J BIOL CHEM, V280, P31294, DOI 10.1074/jbc.M505657200; Larion M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001452; Lemmens R, 2001, J BIOL CHEM, V276, P9971, DOI 10.1074/jbc.M009463200; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Luciani DS, 2006, J PHYSIOL-LONDON, V572, P379, DOI 10.1113/jphysiol.2005.101766; Markwardt ML, 2012, MOL ENDOCRINOL, V26, P1617, DOI 10.1210/me.2012-1183; Markwardt ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017896; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; Massa L, 2004, DIABETES, V53, P1020, DOI 10.2337/diabetes.53.4.1020; McMurry JL, 2011, FEBS J, V278, P4943, DOI 10.1111/j.1742-4658.2011.08395.x; Mehta S, 2014, ELIFE, V3, DOI 10.7554/eLife.03765; MEISSNER G, 1986, BIOCHEMISTRY-US, V25, P236, DOI 10.1021/bi00349a033; Merrins MJ, 2013, J BIOL CHEM, V288, P33312, DOI 10.1074/jbc.M113.508127; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; Nakazaki M, 1998, DIABETOLOGIA, V41, P279, DOI 10.1007/s001250050904; Ni QA, 2011, NAT CHEM BIOL, V7, P34, DOI 10.1038/NCHEMBIO.478; Nunemaker CS, 2007, AM J PHYSIOL-ENDOC M, V292, pE907, DOI 10.1152/ajpendo.00518.2006; Palmer AE, 2006, CHEM BIOL, V13, P521, DOI 10.1016/j.chembiol.2006.03.007; Panda K, 2001, J BIOL CHEM, V276, P23349, DOI 10.1074/jbc.M100687200; Park JH, 2012, ENDOCRINOLOGY, V153, P574, DOI 10.1210/en.2011-0259; Putney JW, 2010, MOL INTERV, V10, P209, DOI 10.1124/mi.10.4.4; Quesada I, 2000, J PHYSIOL-LONDON, V525, P159, DOI 10.1111/j.1469-7793.2000.t01-1-00159.x; Rhodes CJ, 2013, DIABETES, V62, P2157, DOI 10.2337/db13-0246; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Rizzo MA, 2003, J CELL BIOL, V161, P243, DOI 10.1083/jcb.200301063; Rizzo MA, 2002, J BIOL CHEM, V277, P34168, DOI 10.1074/jbc.M112478200; Rizzo MA, 2006, MICROSC MICROANAL, V12, P238, DOI 10.1017/S1431927606060235; Roper MG, 2002, DIABETES, V51, pS43, DOI 10.2337/diabetes.51.2007.S43; Sandoval DA, 2015, PHYSIOL REV, V95, P513, DOI 10.1152/physrev.00013.2014; Schwetz TA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113020; Smedler E, 2014, BBA-GEN SUBJECTS, V1840, P964, DOI 10.1016/j.bbagen.2013.11.015; Song WJ, 2014, CELL METAB, V19, P667, DOI 10.1016/j.cmet.2014.03.005; Stubbs M, 2000, DIABETES, V49, P2048, DOI 10.2337/diabetes.49.12.2048; Stuehr DJ, 1999, BBA-BIOENERGETICS, V1411, P217, DOI 10.1016/S0005-2728(99)00016-X; Vangheluwe P, 2005, CELL CALCIUM, V38, P291, DOI 10.1016/j.ceca.2005.06.033; White MF, 2006, CAN J PHYSIOL PHARM, V84, P725, DOI 10.1139/Y06-008; Wier WG, 2008, J PHYSIOL-LONDON, V586, P2437, DOI 10.1113/jphysiol.2008.151522; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhu SS, 2016, DIABETES, V65, P699, DOI 10.2337/db15-1264	67	17	17	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					3000	3009		10.1074/jbc.M115.692160	http://dx.doi.org/10.1074/jbc.M115.692160			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26698632	Green Published, hybrid			2022-12-26	WOS:000369626900036
J	Garcia-Souto, D; Troncoso, T; Perez, M; Pasantes, JJ				Garcia-Souto, Daniel; Troncoso, Tomas; Perez, Montse; Pasantes, Juan Jose			Molecular Cytogenetic Analysis of the European Hake Merluccius merluccius (Merlucciidae, Gadiformes): U1 and U2 snRNA Gene Clusters Map to the Same Location	PLOS ONE			English	Article							RIBOSOMAL-RNA; 5S RDNA; MULTIGENE FAMILIES; FISH; EVOLUTION; GENOME; MITOCHONDRIAL; ORGANIZATION; PHYLOGENY; DYNAMISM	The European hake (Merluccius merluccius) is a highly valuable and intensely fished species in which a long-term alive stock has been established in captivity for aquaculture purposes. Due to their huge economic importance, genetic studies on hakes were mostly focused on phylogenetic and phylogeographic aspects; however chromosome numbers are still not described for any of the fifteen species in the genus Merluccius. In this work we report a chromosome number of 2n = 42 and a karyotype composed of three meta/submetacentric and 18 subtelo/telocentric chromosome pairs. Telomeric sequences appear exclusively at both ends of every single chromosome. Concerning rRNA genes, this species show a single 45S rDNA cluster at an intercalary location on the long arm of subtelocentric chromosome pair 12; the single 5S rDNA cluster is also intercalary to the long arm of chromosome pair 4. While U2 snRNA gene clusters map to a single subcentromeric position on chromosome pair 13, U1 snRNA gene clusters seem to appear on almost all chromosome pairs, but showing bigger clusters on pairs 5, 13, 16, 17 and 19. The brightest signals on pair 13 are coincident with the single U2 snRNA gene cluster signals. Therefore, the use of these probes allows the unequivocal identification of at least 7 of the chromosome pairs that compose the karyotype of Merluccius merluccius thus opening the way to integrate molecular genetics and cytological data on the study of the genome of this important species.	[Garcia-Souto, Daniel; Troncoso, Tomas; Pasantes, Juan Jose] Univ Vigo, Dept Bioquim Xenet & Inmunol, Vigo 36310, Spain; [Troncoso, Tomas; Perez, Montse] Inst Espanol Oceanog, Ctr Oceanog Vigo, Grp Acuicultura Marina, Vigo, Spain	Universidade de Vigo; Spanish Institute of Oceanography	Pasantes, JJ (corresponding author), Univ Vigo, Dept Bioquim Xenet & Inmunol, Vigo 36310, Spain.	pasantes@uvigo.es	Souto, Daniel García/H-2213-2015; Pérez, Montse/E-6741-2013	Souto, Daniel García/0000-0002-0997-8799; Pérez, Montse/0000-0002-1772-8984; Pasantes, Juan J/0000-0001-6515-3946	Xunta de Galicia; Fondos FEDER [2010/80, GPC2013-011]; Ministerio de Economia y Competitividad (project LETSHAKE); FEDER [AGL2013-48468-R]; FPU fellowship from Ministerio de Educacion (Spain)	Xunta de Galicia(Xunta de GaliciaEuropean Commission); Fondos FEDER(European Commission); Ministerio de Economia y Competitividad (project LETSHAKE); FEDER(European Commission); FPU fellowship from Ministerio de Educacion (Spain)	This work was partly funded by grants from Xunta de Galicia and Fondos FEDER: "Unha maneira de facer Europe" (Grupos de Referencia Competitiva, 2010/80; Grupos con Potencial Crecimiento, GPC2013-011) and Ministerio de Economia y Competitividad (project LETSHAKE co-funded by FEDER, AGL2013-48468-R). DGS was supported in part by a FPU fellowship from Ministerio de Educacion (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Merlo MA, 2013, AQUAC RES, V44, P974, DOI 10.1111/j.1365-2109.2012.03103.x; Merlo MA, 2010, GENES GENET SYST, V85, P341, DOI 10.1266/ggs.85.341; Anjos A, 2015, HEREDITY, V114, P207, DOI 10.1038/hdy.2014.87; [Anonymous], 2011, FISH KARYOTYPES CHEC; Bernardi G, 2012, MAR GENOM, V7, P3, DOI 10.1016/j.margen.2012.02.002; Bjelland RM, 2006, AQUAC RES, V37, P1117, DOI 10.1111/j.1365-2109.2006.01536.x; Bueno D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066532; Bueno Vanessa, 2014, ScientificWorldJournal, V2014, P943825, DOI 10.1155/2014/943825; BUSCH H, 1982, ANNU REV BIOCHEM, V51, P617, DOI 10.1146/annurev.bi.51.070182.003153; Cabral-de-Mello DC, 2012, CHROMOSOME RES, V20, P279, DOI 10.1007/s10577-011-9271-y; Campo D, 2007, GENE, V406, P171, DOI 10.1016/j.gene.2007.09.008; Campo D, 2009, J MOL EVOL, V68, P208, DOI 10.1007/s00239-009-9207-8; Casey J, 1995, FISH AND FISHERIES S, V15, P142; Cioffi MB, 2012, GENOME DYNAM, V7, P197, DOI 10.1159/000337950; de Sene VF, 2014, COMP CYTOGENET, V8, P301, DOI 10.3897/CompCytogen.v8i4.8396; Ghigliotti L, 2012, ANIM GENET, V43, P746, DOI 10.1111/j.1365-2052.2012.02343.x; Ghigliotti L, 2008, GENET MOL BIOL, V31, P180, DOI 10.1590/S1415-47572008000200003; Ghigliotti L, 2015, HYDROBIOLOGIA, V761, P373, DOI 10.1007/s10750-015-2355-5; Ghigliotti L, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/243938; Gornung E, 2013, CYTOGENET GENOME RES, V141, P90, DOI 10.1159/000354832; GRANT WS, 1988, HEREDITY, V61, P13, DOI 10.1038/hdy.1988.86; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Iglesias J, 2010, AQUAC RES, V41, P607, DOI 10.1111/j.1365-2109.2009.02365.x; Sanchez FJ, 2012, AQUAC RES, V43, P1729, DOI 10.1111/j.1365-2109.2011.02966.x; Kirtiklis L, 2014, GENETICA, V142, P141, DOI 10.1007/s10709-014-9761-x; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Lewin HA, 2009, GENOME RES, V19, P1925, DOI 10.1101/gr.094557.109; Lima PA, 2014, CYTOGENET GENOME RES, V142, P197, DOI 10.1159/000360492; LONG EO, 1980, ANNU REV BIOCHEM, V49, P727, DOI 10.1146/annurev.bi.49.070180.003455; Manchado M, 2006, GENOME, V49, P79, DOI 10.1139/G05-068; Martins C., 2004, FOCUS GENOME RES, P289; Martins Cesar, 2007, P421; Marz M, 2008, J MOL EVOL, V67, P594, DOI 10.1007/s00239-008-9149-6; Merlo MA, 2013, J MOL EVOL, V76, P83, DOI 10.1007/s00239-013-9541-8; Merlo MA, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-33; Murua H, 2010, ADV MAR BIOL, V58, P97, DOI 10.1016/S0065.2881(10)58002.7; Nakajima RT, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-198; Nilsen TW, 2003, BIOESSAYS, V25, P1147, DOI 10.1002/bies.10394; Ocalewicz K, 2013, CYTOGENET GENOME RES, V141, P114, DOI 10.1159/000354278; PENDAS AM, 1995, MOL ECOL, V4, P275, DOI 10.1111/j.1365-294X.1995.tb00220.x; Perez M., 2004, Journal of Food Product Technology, V13, P59, DOI 10.1300/J030v13n02_06; Perez M., 2004, Journal of Food Product Technology, V13, P49, DOI 10.1300/J030v13n02_05; Perez M, 2005, J AGR FOOD CHEM, V53, P5239, DOI 10.1021/jf048012h; Perez M., 2011, METODOS TECNICAS INV, P79; Perez M, 2008, J AGR FOOD CHEM, V56, P10865, DOI 10.1021/jf801700x; Perez-Garcia C, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-84; Perez-Garcia C, 2011, GENOME, V54, P771, DOI [10.1139/G11-040, 10.1139/g11-040]; Pinhal D, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-151; Quinteiro J, 2000, MAR BIOL, V136, P163, DOI 10.1007/s002270050019; Rebordinos L, 2013, CYTOGENET GENOME RES, V141, P103, DOI 10.1159/000354871; Reeves A, 2000, MICROMEASURE FOR WIN; Ribeiro LB, 2014, GENET MOL BIOL, V37, P46, DOI 10.1590/S1415-47572014000100009; Silva DMZA, 2015, CYTOGENET GENOME RES; Supiwong W, 2013, MOL CYTOGENET, V6, DOI 10.1186/1755-8166-6-51; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Ubeda-Manzanaro M, 2010, GENETICA, V138, P787, DOI 10.1007/s10709-010-9460-1; Utsunomia R, 2014, CYTOGENET GENOME RES, V142, P286, DOI 10.1159/000362258; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	58	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0146150	10.1371/journal.pone.0146150	http://dx.doi.org/10.1371/journal.pone.0146150			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716701	Green Published, Green Submitted, gold			2022-12-26	WOS:000367510500136
J	Jensen, R				Jensen, Ralph			Effects of Dopamine D2-Like Receptor Antagonists on Light Responses of Ganglion Cells in Wild-Type and P23H Rat Retinas	PLOS ONE			English	Article							GABA(C) RECEPTORS; IMMUNOCYTOCHEMICAL LOCALIZATION; D-1 RECEPTORS; RHO-SUBUNITS; MUTANT MOUSE; RELEASE; NEURONS; DEGENERATION; PATHWAYS; MODEL	In animal models of retinitis pigmentosa the dopaminergic system in the retina appears to be dysfunctional, which may contribute to the debilitated sight experienced by retinitis pigmentosa patients. Since dopamine D2-like receptors are known to modulate the activity of dopaminergic neurons, I examined the effects of dopamine D2-like receptor antagonists on the light responses of retinal ganglion cells (RGCs) in the P23H rat model of retinitis pigmentosa. Extracellular electrical recordings were made from RGCs in isolated transgenic P23H rat retinas and wild-type Sprague-Dawley rat retinas. Intensity-response curves to flashes of light were evaluated prior to and during bath application of a dopamine D2-like receptor antagonist. The dopamine D2/D3 receptor antagonists sulpiride and eticlopride and the D4 receptor antagonist L-745,870 increased light sensitivity of P23H rat RGCs but decreased light sensitivity in Sprague-Dawley rat RGCs. In addition, L-745,870, but not sulpiride or eticlopride, reduced the maximum peak responses of Sprague-Dawley rat RGCs. I describe for the first time ON-center RGCs in P23H rats that exhibit an abnormally long-latency (> 200 ms) response to the onset of a small spot of light. Both sulpiride and eticlopride, but not L-745,870, reduced this ON response and brought out a short-latency OFF response, suggesting that these cells are in actuality OFF-center cells. Overall, the results show that the altered dopaminergic system in degenerate retinas contributes to the deteriorated light responses of RGCs.	[Jensen, Ralph] VA Boston Healthcare Syst, Boston, MA 02130 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Jensen, R (corresponding author), VA Boston Healthcare Syst, Mail Stop 151E,150 South Huntington Ave, Boston, MA 02130 USA.	ralph.jensen@va.gov			Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Rehabilitation Research and Development Service [1I01RX000341-01]; Veterans Affairs [I01RX001299] Funding Source: NIH RePORTER	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Rehabilitation Research and Development Service(US Department of Veterans Affairs); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Rehabilitation Research and Development Service (1I01RX000341-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson CL, 2013, J NEUROPHYSIOL, V109, P1589, DOI 10.1152/jn.00786.2012; Aung MH, 2014, J NEUROSCI, V34, P726, DOI 10.1523/JNEUROSCI.3483-13.2014; Barhoum R, 2008, NEUROSCIENCE, V155, P698, DOI 10.1016/j.neuroscience.2008.06.042; Chua J, 2009, J COMP NEUROL, V514, P473, DOI 10.1002/cne.22029; COHEN AI, 1992, P NATL ACAD SCI USA, V89, P12093, DOI 10.1073/pnas.89.24.12093; Cuenca N, 2004, NEUROSCIENCE, V127, P301, DOI 10.1016/j.neuroscience.2004.04.042; Cuenca N, 2005, EUR J NEUROSCI, V22, P1057, DOI 10.1111/j.1460-9568.2005.04300.x; Dagar S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090250; Derouiche A, 1999, EUR J NEUROSCI, V11, P1391, DOI 10.1046/j.1460-9568.1999.00557.x; DUBOCOVICH ML, 1985, J PHARMACOL EXP THER, V233, P747; Enz R, 1996, J NEUROSCI, V16, P4479; Farajian R, 2011, J PHYSIOL-LONDON, V589, P4473, DOI 10.1113/jphysiol.2011.213371; Gargini C, 2007, J COMP NEUROL, V500, P222, DOI 10.1002/cne.21144; Grunder T, 2001, VISUAL NEUROSCI, V18, P781, DOI 10.1017/S0952523801185111; HANKINS M, 1994, DOC OPHTHALMOL, V86, P325, DOI 10.1007/BF01203555; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Jackson CR, 2009, J NEUROCHEM, V109, P148, DOI 10.1111/j.1471-4159.2009.05920.x; Jensen RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079126; Jensen RJ, 2012, EXP EYE RES, V105, P21, DOI 10.1016/j.exer.2012.10.005; Jensen RJ, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/035002; Klitten LL, 2008, EXP EYE RES, V87, P471, DOI 10.1016/j.exer.2008.08.004; Koulen P, 1998, EUR J NEUROSCI, V10, P115, DOI 10.1046/j.1460-9568.1998.00005.x; Li HY, 2013, J NEUROSCI, V33, P3135, DOI 10.1523/JNEUROSCI.2807-12.2013; Lukasiewicz PD, 1997, VISUAL NEUROSCI, V14, P989, DOI 10.1017/S095252380001169X; Marc RE, 2007, INVEST OPHTH VIS SCI, V48, P3364, DOI 10.1167/iovs.07-0032; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; NguyenLegros J, 1997, VISUAL NEUROSCI, V14, P545, DOI 10.1017/S0952523800012207; NIR I, 1994, BRAIN RES, V649, P85, DOI 10.1016/0006-8993(94)91051-0; Patel S, 1997, J PHARMACOL EXP THER, V283, P636; Patel S, 2003, NEUROPHARMACOLOGY, V44, P1038, DOI 10.1016/S0028-3908(03)00112-6; Puopolo M, 2001, NEURON, V30, P211, DOI 10.1016/S0896-6273(01)00274-4; RASHID K, 1993, J NEUROCHEM, V61, P2025, DOI 10.1111/j.1471-4159.1993.tb07438.x; Renteria RC, 2006, J NEUROSCI, V26, P11857, DOI 10.1523/JNEUROSCI.1718-06.2006; Sekirnjak C, 2011, J NEUROPHYSIOL, V105, P2560, DOI 10.1152/jn.01061.2010; Srivastava P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123896; Strettoi E, 2000, P NATL ACAD SCI USA, V97, P11020, DOI 10.1073/pnas.190291097; Veruki ML, 1996, EUR J NEUROSCI, V8, P2286, DOI 10.1111/j.1460-9568.1996.tb01192.x; Veruki ML, 1997, EUR J NEUROSCI, V9, P1096, DOI 10.1111/j.1460-9568.1997.tb01461.x; Wang Y, 1997, J NEUROPHYSIOL, V78, P439, DOI 10.1152/jn.1997.78.1.439; Weber B, 2001, BRIT J PHARMACOL, V133, P1243, DOI 10.1038/sj.bjp.0704192; WELLIS DP, 1995, J NEUROSCI, V15, P4748; Witkovsky P, 2004, DOC OPHTHALMOL, V108, P17, DOI 10.1023/B:DOOP.0000019487.88486.0a	42	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0146154	10.1371/journal.pone.0146154	http://dx.doi.org/10.1371/journal.pone.0146154			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717015	Green Published, Green Submitted, gold			2022-12-26	WOS:000367510500138
J	Okuyama, K; Kaida, A; Hayashi, Y; Hayashi, Y; Harada, K; Miura, M				Okuyama, Kohei; Kaida, Atsushi; Hayashi, Yoshiki; Hayashi, Yoshio; Harada, Kiyoshi; Miura, Masahiko			KPU-300, a Novel Benzophenone Diketopiperazine-Type Anti-Microtubule Agent with a 2-Pyridyl Structure, Is a Potent Radiosensitizer That Synchronizes the Cell Cycle in Early M Phase	PLOS ONE			English	Article							VASCULAR-DISRUPTING AGENT; TUMOR BLOOD-FLOW; HELA-CELLS; CANCER-CELLS; MITOTIC CATASTROPHE; COLON-CANCER; RADIATION SENSITIZER; INDUCED APOPTOSIS; INDICATOR FUCCI; SOLID TUMORS	KPU-300 is a novel colchicine-type anti-microtubule agent derived from plinabulin (NPI-2358). We characterized the effects of KPU-300 on cell cycle kinetics and radiosensitization using HeLa cells expressing the fluorescent ubiquitination-based cell cycle indicator (Fucci). Cells treated with 30 nM KPU-300 for 24 h were efficiently synchronized in M phase and contained clearly detectable abnormal Fucci fluorescence. Two-dimensional flow-cytometric analysis revealed a fraction of cells distinct from the normal Fucci fluorescence pattern. Most of these cells were positive for an M phase marker, the phosphorylated form of histone H3. Cells growing in spheroids responded similarly to the drug, and the inner quiescent fraction also responded after recruitment to the growth fraction. When such drug-treated cells were irradiated in monolayer, a remarkable radiosensitization was observed. To determine whether this radiosensitization was truly due to the synchronization in M phase, we compared the radiosensitivity of cells synchronized by KPU-300 treatment and cells in early M phase isolated by a combined method that took advantage of shake-off and the properties of the Fucci system. Following normalization against the surviving fraction of cells treated with KPU-300 alone, the surviving fractions of cells irradiated in early M phase coincided. Taken together with potential vascular disrupting function in vivo, we propose a novel radiosensitizing strategy using KPU-300.	[Okuyama, Kohei; Kaida, Atsushi; Miura, Masahiko] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Sect Oral Radiat Oncol, Dept Oral Hlth Sci,Bunkyo Ku, Tokyo 1138549, Japan; [Okuyama, Kohei; Harada, Kiyoshi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Sect Maxillofacial Surg, Dept Maxillofacial & Neck Reconstruct,Bunkyo Ku, Tokyo, Japan; [Hayashi, Yoshiki; Hayashi, Yoshio] Tokyo Univ Pharm & Life Sci, Dept Med Chem, Hachioji, Tokyo 1920392, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo University of Pharmacy & Life Sciences	Miura, M (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Sect Oral Radiat Oncol, Dept Oral Hlth Sci,Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.	masa.mdth@tmd.ac.jp	Okuyama, Kohei/AAO-7647-2021	Okuyama, Kohei/0000-0002-5616-902X	Ministry of Education, Culture, Sports, Science, and Technology, Japan [26861569, 26293399, 25670796]	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by Grants-in-Aid for Scientific Research from Ministry of Education, Culture, Sports, Science, and Technology, Japan, 26861569 to KK, and 26293399 and 25670796 to MM.	Acharya BR, 2014, BIOCHIMIE, V97, P78, DOI 10.1016/j.biochi.2013.09.025; Crielaard BJ, 2011, INT J NANOMED, V6, P2697, DOI 10.2147/IJN.S24450; Daenen LGM, 2010, CURR CLIN PHARMACOL, V5, P178, DOI 10.2174/157488410791498815; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Dunne AL, 2004, ONCOL RES, V14, P447, DOI 10.3727/0965040041791455; Foley KP, 2012, J PHARMACOL EXP THER, V343, P529, DOI 10.1124/jpet.112.196873; Fujie Y, 2005, JPN J CLIN ONCOL, V35, P453, DOI 10.1093/jjco/hyi130; Geng CX, 2005, WORLD J GASTROENTERO, V11, P2990, DOI 10.3748/wjg.v11.i19.2990; Gigant B, 2009, TOP CURR CHEM, V286, P259, DOI 10.1007/128_2008_11; Giunta S, 2011, CELL CYCLE, V10, P1215, DOI 10.4161/cc.10.8.15334; Golden EB, 2014, ANTI-CANCER DRUG, V25, P502, DOI 10.1097/CAD.0000000000000055; Hayashi Y, 2014, ACS MED CHEM LETT, V5, P1094, DOI 10.1021/ml5001883; Hiro J, 2010, ONCOL REP, V24, P1029, DOI 10.3892/or_0000095; Honda-Uezono A, 2012, BIOCHEM BIOPH RES CO, V428, P224, DOI 10.1016/j.bbrc.2012.10.014; Hori K, 2003, BRIT J CANCER, V89, P1334, DOI 10.1038/sj.bjc.6601261; Hori K, 2002, BRIT J CANCER, V86, P1604, DOI 10.1038/sj.bjc.6600296; Islam MN, 2004, MINI-REV MED CHEM, V4, P1077, DOI 10.2174/1389557043402946; Kaida A, 2013, BIOCHEM BIOPH RES CO, V439, P453, DOI 10.1016/j.bbrc.2013.08.093; Kingston DGI, 2014, ACCOUNTS CHEM RES, V47, P2682, DOI 10.1021/ar500203h; Kumar P, 2003, REV UROL, V3, pS71; Kunos CA, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00226; LIN CM, 1989, BIOCHEMISTRY-US, V28, P6984, DOI 10.1021/bi00443a031; Nguyen L, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-522; Magalska A, 2006, INT J CANCER, V119, P1811, DOI 10.1002/ijc.22055; Masunaga S, 2001, INT J RADIAT ONCOL, V50, P1063, DOI 10.1016/S0360-3016(01)01553-X; MILAS L, 1995, CANCER RES, V55, P3564; Millward M, 2012, INVEST NEW DRUG, V30, P1065, DOI 10.1007/s10637-011-9642-4; Mita MM, 2010, CLIN CANCER RES, V16, P5892, DOI 10.1158/1078-0432.CCR-10-1096; Morse DL, 2005, MOL CANCER THER, V4, P1495, DOI 10.1158/1535-7163.MCT-05-0130; Nabell L, 2003, SEMIN ONCOL, V30, P89, DOI 10.1053/j.seminoncol.2003.11.017; Nakayama M, 2011, RADIAT RES, V176, P407, DOI 10.1667/RR2608.1; Nicholson B, 2006, ANTI-CANCER DRUG, V17, P25, DOI 10.1097/01.cad.0000182745.01612.8a; Nielsen T, 2012, CLIN CANCER RES, V18, P6469, DOI 10.1158/1078-0432.CCR-12-2014; Niero A, 1999, CLIN CANCER RES, V5, P2213; Nogales E, 2000, ANNU REV BIOCHEM, V69, P277, DOI 10.1146/annurev.biochem.69.1.277; Poruchynsky MS, 2015, P NATL ACAD SCI USA, V112, P1571, DOI 10.1073/pnas.1416418112; Risinger AL, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-41; Rutkauskiene Giedre, 2005, Medicina (Kaunas), V41, P1026; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Salmon BA, 2007, EUR J CANCER, V43, P1622, DOI 10.1016/j.ejca.2007.03.018; SINCLAIR WK, 1965, BIOPHYS J, V5, P1, DOI 10.1016/S0006-3495(65)86700-5; STEREN A, 1993, GYNECOL ONCOL, V50, P89, DOI 10.1006/gyno.1993.1169; Stobbe CC, 2002, INT J RADIAT BIOL, V78, P1149, DOI 10.1080/09553000210166570; TERASIMA T, 1963, EXP CELL RES, V30, P344, DOI 10.1016/0014-4827(63)90306-9; TERASIMA T, 1961, NATURE, V190, P1210, DOI 10.1038/1901210a0; TERASIMA T, 1963, BIOPHYS J, V3, P11, DOI 10.1016/S0006-3495(63)86801-0; TISHLER RB, 1992, INT J RADIAT ONCOL, V22, P613, DOI 10.1016/0360-3016(92)90888-O; Tsuchida E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128090; Werner ME, 2011, ACS NANO, V5, P8990, DOI 10.1021/nn203165z; Yamazaki Y, 2012, J MED CHEM, V55, P1056, DOI 10.1021/jm2009088; Yano S, 2014, CELL CYCLE, V13, P3958, DOI 10.4161/15384101.2014.964115; Yano S, 2014, ONCOTARGET, V5, P8729, DOI 10.18632/oncotarget.2369; Zanelli GD, 1997, EUR J CANCER, V33, P486, DOI 10.1016/S0959-8049(96)00478-9; Zhang F, 2010, ONCOL REP, V24, P1297, DOI 10.3892/or_00000986; Zhou Jun, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P65, DOI 10.2174/1568011053352569	55	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145995	10.1371/journal.pone.0145995	http://dx.doi.org/10.1371/journal.pone.0145995			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716455	gold, Green Submitted, Green Published			2022-12-26	WOS:000367510500111
J	Chen, YJ; Lan, T; Duan, LC; Wang, FH; Zhao, B; Zhang, ST; Wei, W				Chen, Yajun; Lan, Tao; Duan, Lunchao; Wang, Fenghe; Zhao, Bin; Zhang, Shengtian; Wei, Wei			Adsorptive Removal and Adsorption Kinetics of Fluoroquinolone by Nano-Hydroxyapatite	PLOS ONE			English	Article							RICE HUSK ASH; WASTE-WATER; METAL-IONS; ANTIBACTERIAL AGENTS; AQUEOUS-SOLUTION; DRINKING-WATER; ANTIBIOTICS; DEGRADATION; CIPROFLOXACIN; PH	Various kinds of antibiotics, especially fluoroquinolone antibiotics (FQs) have been widely used for the therapy of infectious diseases in human and livestock. For their poorly absorbed by living organisms, large-scale misuse or abuse of FQs will foster drug resistance among pathogenic bacteria, as well as a variety of environmental problems when they were released in the environment. In this work, the adsorption properties of two FQs, namely norfloxacin (NOR) and ciprofloxacin (CIP), by nano-hydroxyapatite (n-HAP) were studied by batch adsorption experiments. The adsorption curves of FQs by n-HAP were simulated by Langmuir and Freundlich isotherms. The results shown that NOR and CIP can be adsorbed effectively by the adsorbent of n-HAP, and the adsorption capacity of FQs increase with increasing dosage of n-HAP. The optimum dosage of n-HAP for FQs removal was 20 g.L-1, in which the removal efficiencies is 51.6% and 47.3%, and an adsorption equilibrium time is 20 min. The maximum removal efficiency occurred when pH is 6 for both FQs. The adsorption isotherm of FQs fits well for both Langmuir and Freundlich equations. The adsorption of both FQs by n-HAP follows second-order kinetics.	[Chen, Yajun; Lan, Tao; Duan, Lunchao; Wang, Fenghe; Zhao, Bin; Wei, Wei] Nanjing Normal Univ, Sch Geog Sci, Jiangsu Prov Key Lab Mat Cycling & Pollut Control, Nanjing 210023, Jiangsu, Peoples R China; [Chen, Yajun; Lan, Tao; Duan, Lunchao; Wang, Fenghe; Zhao, Bin; Wei, Wei] Jiangsu Ctr Collaborat Innovat Geog Informat Reso, Nanjing 210023, Jiangsu, Peoples R China; [Zhao, Bin; Zhang, Shengtian] Minist Environm Protect China, Nanjing Inst Environm Sci, Nanjing 210042, Jiangsu, Peoples R China	Nanjing Normal University	Wang, FH (corresponding author), Nanjing Normal Univ, Sch Geog Sci, Jiangsu Prov Key Lab Mat Cycling & Pollut Control, Nanjing 210023, Jiangsu, Peoples R China.	wangfenghe@njnu.edu.cn; zhangshengtian163@163.com	Wei, Wei/AAH-4521-2020		Natural Science Foundation of China [41473071, 41101287]; Science and Technology Project of Construction System of Jiangsu Province [JS2011JH25]; National-Local Joint Engineering Research Center for Biomedical Functional Materials; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) [164320H116]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Project of Construction System of Jiangsu Province; National-Local Joint Engineering Research Center for Biomedical Functional Materials; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	The authors acknowledge the financial support of the Natural Science Foundation of China (41473071, 41101287), the Science and Technology Project of Construction System of Jiangsu Province (JS2011JH25), National-Local Joint Engineering Research Center for Biomedical Functional Materials, and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD, 164320H116). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the financial support of the Natural Science Foundation of China (41473071, 41101287), the Science and Technology Project of Construction System of Jiangsu Province (JS2011JH25), National-Local Joint Engineering Research Center for Biomedical Functional Materials, and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD, 164320H116).	Adams C, 2002, J ENVIRON ENG-ASCE, V128, P253, DOI 10.1061/(ASCE)0733-9372(2002)128:3(253); [Anonymous], 2009, ENVIRON HEALTH PERSP, V117, pA244, DOI 10.1289/ehp.117-a244; Arikan OA, 2008, J HAZARD MATER, V158, P485, DOI 10.1016/j.jhazmat.2008.01.096; Babic S, 2013, CHEMOSPHERE, V91, P1635, DOI 10.1016/j.chemosphere.2012.12.072; Baquero F, 2008, CURR OPIN BIOTECH, V19, P260, DOI 10.1016/j.copbio.2008.05.006; Bautitz IR, 2007, J PHOTOCH PHOTOBIO A, V187, P33, DOI 10.1016/j.jphotochem.2006.09.009; Beauvais RA, 1998, REACT FUNCT POLYM, V36, P113, DOI 10.1016/S1381-5148(98)00016-9; Carabineiro SAC, 2011, WATER RES, V45, P4583, DOI 10.1016/j.watres.2011.06.008; Chai F, 2007, BIOMOL ENG, V24, P510, DOI 10.1016/j.bioeng.2007.08.001; Chen L, 2013, J MATER SCI-MATER M, V24, P1843, DOI 10.1007/s10856-013-4954-x; Corami A, 2007, J HAZARD MATER, V146, P164, DOI 10.1016/j.jhazmat.2006.12.003; Dolar D, 2011, J ENVIRON SCI-CHINA, V23, P1299, DOI 10.1016/S1001-0742(10)60545-1; El Najjar NH, 2013, CHEMOSPHERE, V93, P604, DOI 10.1016/j.chemosphere.2013.05.086; Elayaraja K, 2012, MATER CHEM PHYS, V134, P464, DOI 10.1016/j.matchemphys.2012.03.018; Fan JJ, 2012, J MATER SCI-MATER M, V23, P399, DOI 10.1007/s10856-011-4491-4; FOWLER BO, 1974, INORG CHEM, V13, P194, DOI 10.1021/ic50131a039; Freundlich H, 1906, Z PHYS CHEM-STOCH VE, V57, P385; Gobel A, 2007, SCI TOTAL ENVIRON, V372, P361, DOI 10.1016/j.scitotenv.2006.07.039; Gu C, 2005, ENVIRON SCI TECHNOL, V39, P9166, DOI 10.1021/es051109f; Hasegawa M, 2004, J BIOMED MATER RES B, V70B, P332, DOI 10.1002/jbm.b.30047; Homem V, 2011, J ENVIRON MANAGE, V92, P2304, DOI 10.1016/j.jenvman.2011.05.023; Ji Ying-xue, 2013, Huanjing Kexue, V34, P3912; Ji YX, 2013, APPL SURF SCI, V285, P403, DOI 10.1016/j.apsusc.2013.08.067; Kumar SENK, 2009, INT J DRUG DEV RES, V1, P47; Kumar YP, 2006, J HAZARD MATER, V137, P1211, DOI 10.1016/j.jhazmat.2006.04.006; Langmuir I, 1915, J AM CHEM SOC, V37, P1139, DOI 10.1021/ja02170a017; Larsson DGJ, 2007, J HAZARD MATER, V148, P751, DOI 10.1016/j.jhazmat.2007.07.008; Li HB, 2014, CHEMOSPHERE, V95, P150, DOI 10.1016/j.chemosphere.2013.08.053; Li ZH, 2011, COLLOID SURFACE B, V88, P339, DOI 10.1016/j.colsurfb.2011.07.011; Lindberg RH, 2005, ENVIRON SCI TECHNOL, V39, P3421, DOI 10.1021/es048143z; Medellin-Castillo NA, 2014, J IND ENG CHEM, V20, P4014, DOI 10.1016/j.jiec.2013.12.105; Mittal A, 2010, J COLLOID INTERF SCI, V344, P497, DOI 10.1016/j.jcis.2010.01.007; Mittal A, 2009, J COLLOID INTERF SCI, V340, P16, DOI 10.1016/j.jcis.2009.08.019; Mobasherpour I, 2007, J ALLOY COMPD, V430, P330, DOI 10.1016/j.jallcom.2006.05.018; Naiya TK, 2009, J HAZARD MATER, V163, P1254, DOI 10.1016/j.jhazmat.2008.07.119; Oladoja N. A., 2008, Turkish Journal of Engineering and Environmental Sciences, V32, P143; Orfao JJM, 2006, J COLLOID INTERF SCI, V296, P480, DOI 10.1016/j.jcis.2005.09.063; Otker HM, 2005, J HAZARD MATER, V122, P251, DOI 10.1016/j.jhazmat.2005.03.005; Paul T, 2007, ENVIRON SCI TECHNOL, V41, P4720, DOI 10.1021/es070097q; Quoc HP, 2014, SCI WORLD J, DOI [10.1155/2014/273082, DOI 10.1155/2014/273082]; Ramesh ST, 2013, APPL WATER SCI, V3, P105, DOI 10.1007/s13201-012-0064-z; Ramesh ST, 2012, APPL WATER SCI, V2, P187, DOI 10.1007/s13201-012-0036-3; Renew JE, 2004, J CHROMATOGR A, V1042, P113, DOI 10.1016/j.chroma.2004.05.056; Schlusener MP, 2006, ENVIRON POLLUT, V143, P565, DOI 10.1016/j.envpol.2005.10.049; Srivastava VC, 2006, J HAZARD MATER, V134, P257, DOI 10.1016/j.jhazmat.2005.11.052; Stackelberg PE, 2007, SCI TOTAL ENVIRON, V377, P255, DOI 10.1016/j.scitotenv.2007.01.095; Sukul P, 2006, REV ENVIRON CONTAM T, V187, P67, DOI 10.1007/0-387-32885-8_2; Sukul P, 2009, ENVIRON RES, V109, P225, DOI 10.1016/j.envres.2008.12.007; Tang WenQing, 2013, China Environmental Science, V33, P1017; Velasquez M, 2014, J ENVIRON SCI HEAL A, V49, P661, DOI 10.1080/10934529.2014.865447; Verlicchi P, 2010, J HYDROL, V389, P416, DOI 10.1016/j.jhydrol.2010.06.005; Vieno NM, 2007, ENVIRON SCI TECHNOL, V41, P5077, DOI 10.1021/es062720x; Vila M, 2012, J EUR CERAM SOC, V32, P2121, DOI 10.1016/j.jeurceramsoc.2012.01.034; Wammer KH, 2013, WATER RES, V47, P439, DOI 10.1016/j.watres.2012.10.025; Watkinson AJ, 2009, SCI TOTAL ENVIRON, V407, P2711, DOI 10.1016/j.scitotenv.2008.11.059; Wei W, 2014, CHEMOSPHERE, V105, P14, DOI 10.1016/j.chemosphere.2013.09.121; Wu QF, 2010, APPL CLAY SCI, V50, P204, DOI 10.1016/j.clay.2010.08.001; Xing ZP, 2014, ENVIRON PROG SUSTAIN, V33, P170, DOI 10.1002/ep.11775; Xu WH, 2009, WATER ENVIRON RES, V81, P248, DOI 10.2175/106143008X325719; Yang K, 2010, CHEM REV, V110, P5989, DOI 10.1021/cr100059s; Yin A, 2003, ARCH ORAL BIOL, V48, P361, DOI 10.1016/S0003-9969(03)00012-8; YU XQ, 1994, PHARMACEUT RES, V11, P522, DOI 10.1023/A:1018910431216; [曾荣英 Zeng Rongying], 2013, [过程工程学报, The Chinese Journal of Process Engineering], V13, P817; Zhang D, 2010, ENVIRON SCI TECHNOL, V44, P3806, DOI 10.1021/es903851q; Zhang HC, 2005, ENVIRON SCI TECHNOL, V39, P4474, DOI 10.1021/es048166d; Zhang PC, 1998, ENVIRON SCI TECHNOL, V32, P3318, DOI 10.1021/es980232m; Zhao XY, 2014, J COLLOID INTERF SCI, V416, P11, DOI 10.1016/j.jcis.2013.10.034; Zhao YP, 2011, J COLLOID INTERF SCI, V361, P247, DOI 10.1016/j.jcis.2011.05.051	68	25	26	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145025	10.1371/journal.pone.0145025	http://dx.doi.org/10.1371/journal.pone.0145025			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26698573	gold, Green Published			2022-12-26	WOS:000367092600043
J	Miller, SM; Harper, CK; Bloomer, P; Hofmeyr, J; Funston, PJ				Miller, Susan M.; Harper, Cindy K.; Bloomer, Paulette; Hofmeyr, Jennifer; Funston, Paul J.			Fenced and Fragmented: Conservation Value of Managed Metapopulations	PLOS ONE			English	Article							PANTHERA-LEO POPULATIONS; SOUTH-AFRICA; LIONS; DYNAMICS; PROGRAM; RELATEDNESS; SOFTWARE; RESERVES; HISTORY	Population fragmentation is threatening biodiversity worldwide. Species that once roamed vast areas are increasingly being conserved in small, isolated areas. Modern management approaches must adapt to ensure the continued survival and conservation value of these populations. In South Africa, a managed metapopulation approach has been adopted for several large carnivore species, all protected in isolated, relatively small, reserves that are fenced. As far as possible these approaches are based on natural metapopulation structures. In this network, over the past 25 years, African lions (Panthera leo) were reintroduced into 44 fenced reserves with little attention given to maintaining genetic diversity. To examine the situation, we investigated the current genetic provenance and diversity of these lions. We found that overall genetic diversity was similar to that in a large national park, and included a mixture of four different southern African evolutionarily significant units (ESUs). This mixing of ESUs, while not ideal, provides a unique opportunity to study the impact of mixing ESUs over the long term. We propose a strategic managed metapopulation plan to ensure the maintenance of genetic diversity and improve the long-term conservation value of these lions. This managed metapopulation approach could be applied to other species under similar ecological constraints around the globe.	[Miller, Susan M.; Funston, Paul J.] Tshwane Univ Technol, Nat Conservat Dept, Pretoria, Gauteng, South Africa; [Miller, Susan M.; Harper, Cindy K.] Univ Pretoria, Fac Vet Sci, Vet Genet Lab, ZA-0110 Onderstepoort, Gauteng, South Africa; [Bloomer, Paulette] Univ Pretoria, Dept Genet, Mol Ecol & Evolut Programme, ZA-0002 Pretoria, Gauteng, South Africa; [Hofmeyr, Jennifer] South African Natl Pk, Vet Wildlife Serv, Skukuza, Mpumalanga, South Africa; [Funston, Paul J.] Panthera, Lion Program, New York, NY USA	Tshwane University of Technology; University of Pretoria; University of Pretoria	Miller, SM (corresponding author), Tshwane Univ Technol, Nat Conservat Dept, Pretoria, Gauteng, South Africa.	dangerousfrizbee@gmail.com	Bloomer, Paulette/F-5501-2010; Miller, Susan M/Q-5837-2017	Bloomer, Paulette/0000-0002-6357-0153; Miller, Susan M/0000-0002-5976-2742	Boras Zoo, Sweden; Ree Park, Denmark; Tshwane University of Technology Doctoral Scholarship	Boras Zoo, Sweden; Ree Park, Denmark; Tshwane University of Technology Doctoral Scholarship	Funding was provided, in part, by Boras Zoo, Sweden, and Ree Park, Denmark (with assistance from Frank Oberwemmer and Jesper Stagegaard). SMM was supported by a Tshwane University of Technology Doctoral Scholarship. SMM was a registered graduate student at Tshwane University of Technology and thus the study design and decision to publish were approved by members of the Department of Nature Conservation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	African Parks in Conservation, 2012, AFR PARK LAT NEWS; African Parks in Conservation, 2015, AFRICA GEOGRAPH 0728; Akcakaya H. Resit, 2006, P64; Aycrigg JL, 2014, J MAMMAL, V95, P597, DOI 10.1644/12-MAMM-A-300; Barnett R, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-70; Bauer H, 2015, IUCN RED LIST THREAT, DOI [http://dx.doi.org/10.2305/IUCN.UK.2015-2.RLTS.T15951A50658092en, DOI 10.2305/IUCN.UK.2015-2.RLTS.T15951A50658092.EN]; Bauer H, 2015, P NATL ACAD SCI USA, V112, P14894, DOI 10.1073/pnas.1500664112; Bertola LD, 2012, GENETIC DIVERSITY NE, P61; Bjorklund M, 2003, CONSERV GENET, V4, P515, DOI 10.1023/A:1024737317695; Davies-Mostert Harriet T., 2009, P10, DOI 10.1002/9781444312034.ch2; DAVIESMOSTERT HT, 2015, S AFR J WILDL RES, V45, P258; Department of Environmental Affairs, 2015, BIOD MAN PLAN AFR LI; Dolrenry S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088081; Driscoll CA, 2002, GENOME RES, V12, P414, DOI 10.1101/gr.185702; Dubach JM, 2013, CONSERV GENET, V14, P741, DOI 10.1007/s10592-013-0453-3; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Ferreira SM, 2014, S AFR J WILDL RES, V44, P32, DOI 10.3957/056.044.0102; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Funston, 2008, MANAGEMENT CONSERVAT, P109; Gusset M, 2008, J APPL ECOL, V45, P100, DOI 10.1111/j.1365-2664.2007.01357.x; Gusset M, 2010, J NAT CONSERV, V18, P230, DOI 10.1016/j.jnc.2009.11.001; HANSKI I, 1991, BIOL J LINN SOC, V42, P3, DOI 10.1111/j.1095-8312.1991.tb00548.x; HARRISON S, 1991, BIOL J LINN SOC, V42, P73, DOI 10.1111/j.1095-8312.1991.tb00552.x; Hunter LTB, 2007, ORYX, V41, P196, DOI 10.1017/S003060530700172X; IUCN/SSC, 2013, GUID REINTR OTH CONS; IUCN/SSC Cat Specialist, 2006, REG LION CONS STRAT; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Keenan K, 2013, METHODS ECOL EVOL, V4, P782, DOI 10.1111/2041-210X.12067; Levins R., 1970, SOME MATH PROBLEMS B, P77; Lindsey P, 2011, ORYX, V45, P587, DOI 10.1017/S003060531000150X; Miller SM, 2013, S AFR J WILDL RES, V43, P138, DOI 10.3957/056.043.0202; Miller SM, 2014, J HERED, V105, P762, DOI 10.1093/jhered/esu054; Miller SM, 2014, S AFR J WILDL RES, V44, P43, DOI 10.3957/056.044.0107; Mills MGL, 1997, POPULATION HABIT VIA; Nowell K, 1996, STATUS SURVEY CONSER; Pritchard JK, 2000, GENETICS, V155, P945; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; Riggio J, 2013, BIODIVERS CONSERV, V22, P17, DOI 10.1007/s10531-012-0381-4; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Slotow R., 2009, REINTRODUCTION TOP O, P41; Sweanor LL, 2000, CONSERV BIOL, V14, P798, DOI 10.1046/j.1523-1739.2000.99079.x; Trinkel M, 2008, ANIM CONSERV, V11, P138, DOI 10.1111/j.1469-1795.2008.00163.x; Wahlberg N, 2002, OECOLOGIA, V130, P33, DOI 10.1007/s004420100775; Wang JL, 2011, MOL ECOL RESOUR, V11, P141, DOI 10.1111/j.1755-0998.2010.02885.x; WILDT DE, 1987, NATURE, V329, P328, DOI 10.1038/329328a0	47	30	31	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0144605	10.1371/journal.pone.0144605	http://dx.doi.org/10.1371/journal.pone.0144605			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26699333	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092600026
J	Prather, RB; Shuster, SM				Prather, Robert B., Jr.; Shuster, Stephen M.			The Opportunity for Post-Copulatory Sexual Selection in the Ectoparasitic Pea Crab, Dissodactylus primitivus (Brachyura: Pinnotheridae)	PLOS ONE			English	Article							MULTIPLE PATERNITY; SPERM COMPETITION; FEMALE CHOICE; VARIANCE; FIELD	Pea crabs, Dissodactylus primitivus, inhabit multiple echinoid (heart urchin) hosts. Male and female crabs move among hosts in search for mates, and both sexes mate multiple times, creating opportunities for post-copulatory sexual selection. For such selection to occur, only a fraction of the males who succeed in mating can also succeed in siring progeny. Jossart et al. 2014 used 4 microsatellite loci to document parentage and mating frequencies of both sexes in D. primitivus. From these data we identified the mean and variance in female offspring numbers, as well as the proportions of the female population that were gravid and not bearing offspring. We next identified the proportions of the male population who had (1) mated and sired offspring, (2) mated but failed to sire offspring, and (3) failed to mate altogether. We used these results to estimate the opportunity for selection on males and females in terms of mate numbers and offspring numbers, and estimated the sex difference in the opportunity for selection (i.e., the opportunity for sexual selection) using both forms of data. We then partitioned the total variance in male fitness into pre- and post-copulatory components and identified the fraction of the total opportunity for selection occurring in each context. Our results show that the opportunity for selection on each sex was of similar magnitude (0.69-0.98), consistent with this polyandrogynous mating system. We also found that 37% of the total opportunity for sexual selection on males occurred within the context of post-copulatory sexual selection. However, the fraction of the total opportunity for selection that was due to sexual selection, estimated using both mate numbers and offspring numbers, was 9% and 23% respectively. Thus, we further reduced our estimate of the opportunity for post-copulatory sexual selection in D. primitivus to less than 10% of the total opportunity for selection (0.37 of 0.09 and 0.23 = 0.03 and 0.09). Our results provide the first estimate of the maximum possible strength of post-copulatory sexual selection in crustaceans using this approach.	[Prather, Robert B., Jr.; Shuster, Stephen M.] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA	Northern Arizona University	Shuster, SM (corresponding author), No Arizona Univ, Dept Biol Sci, Box 5640, Flagstaff, AZ 86011 USA.	Stephen.Shuster@nau.edu						Carling MD, 2003, J MAMMAL, V84, P1237, DOI 10.1644/BRB-116; CLARK AG, 1995, GENETICS, V139, P189; Crow J. F., 1962, METHODOLOGY HUMAN GE, P53; CROW JF, 1958, AM ANTHROPOL, V60, P1; EBERHARD WG, 1991, BIOL REV, V66, P1, DOI 10.1111/j.1469-185X.1991.tb01133.x; Fisher RA, 1930, GENETICAL THEORY NAT; Gage MJG, 2004, CURR BIOL, V14, P44, DOI 10.1016/j.cub.2003.12.028; Hersch EI, 2004, EVOLUTION, V58, P479, DOI 10.1111/j.0014-3820.2004.tb01671.x; Jossart Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090680; KELLOGG KA, 1995, P ROY SOC B-BIOL SCI, V260, P79, DOI 10.1098/rspb.1995.0062; KOGA T, 1993, J CRUSTACEAN BIOL, V13, P134, DOI 10.2307/1549128; Krakauer AH, 2011, J EVOLUTION BIOL, V24, P2064, DOI 10.1111/j.1420-9101.2011.02317.x; LEWIS SM, 1994, BEHAV ECOL, V5, P219; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Pischedda A, 2012, P NATL ACAD SCI USA, V109, P2049, DOI 10.1073/pnas.1110841109; SHUSTER SM, 2003, MG BEH ECOL, pR7; Shuster SM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0046; Shuster Stephen M., 2007, P29; Shuster SM, 2009, P NATL ACAD SCI USA, V106, P10009, DOI 10.1073/pnas.0901132106; Uller T, 2008, MOL ECOL, V17, P2566, DOI 10.1111/j.1365-294X.2008.03772.x; van Camp LM, 2004, MAR FRESHWATER RES, V55, P819, DOI 10.1071/MF03179; Wade MJ, 2010, HEREDITY, V105, P507, DOI 10.1038/hdy.2010.8; WADE MJ, 1979, AM NAT, V114, P742, DOI 10.1086/283520; WADE MJ, 1980, ANIM BEHAV, V28, P446, DOI 10.1016/S0003-3472(80)80052-2; Wade MJ, 2004, AM NAT, V164, pE83, DOI 10.1086/424531	25	1	1	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145681	10.1371/journal.pone.0145681	http://dx.doi.org/10.1371/journal.pone.0145681			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26701316	Green Published, gold, Green Submitted			2022-12-26	WOS:000367092600117
J	Wang, YL; Mao, YH; Xu, XD; Tao, SH; Chen, HY				Wang, Yalan; Mao, Yuanhui; Xu, Xiaodong; Tao, Shiheng; Chen, Hongying			Codon Usage in Signal Sequences Affects Protein Expression and Secretion Using Baculovirus/Insect Cell Expression System	PLOS ONE			English	Article							WHOLE GENOME ANALYSIS; ESCHERICHIA-COLI; NONOPTIMAL CODONS; DROSOPHILA-MELANOGASTER; RESPECTIVE CODONS; TRANSFER-RNAS; TRANSLATION; ABUNDANCE; PATTERNS; CHOICE	By introducing synonymous mutations into the coding sequences of GP64sp and FibHsp signal peptides, the influences of mRNA secondary structure and codon usage of signal sequences on protein expression and secretion were investigated using baculovirus/insect cell expression system. The results showed that mRNA structural stability of the signal sequences was not correlated with the protein production and secretion levels, and FibHsp was more tolerable to codon changes than GP64sp. Codon bias analyses revealed that codons for GP64sp were well de-optimized and contained more non-optimal codons than FibHsp. Synonymous mutations in GP64sp sufficiently increased its average codon usage frequency and resulted in dramatic reduction of the activity and secretion of luciferase. Protein degradation inhibition assay with MG-132 showed that higher codon usage frequency in the signal sequence increased the production as well as the degradation of luciferase protein, indicating that the synonymous codon substitutions in the signal sequence caused misfolding of luciferase instead of slowing down the protein production. Meanwhile, we found that introduction of more non-optimal codons into FibHsp could increase the production and secretion levels of luciferase, which suggested a new strategy to improve the production of secretory proteins in insect cells.	[Wang, Yalan; Mao, Yuanhui; Xu, Xiaodong; Tao, Shiheng; Chen, Hongying] Northwest A&F Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China; [Mao, Yuanhui; Tao, Shiheng] Northwest A&F Univ, State key Lab Crop Stress Biol Arid Areas, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Tao, SH (corresponding author), Northwest A&F Univ, Coll Life Sci, Yangling 712100, Shaanxi, Peoples R China.	shihengt@nwsuaf.edu.cn; chenhy@nwsuaf.edu.cn	Xu, Xiaodong/Q-8429-2017	Xu, Xiaodong/0000-0001-6452-8419; Chen, Hongying/0000-0001-8258-0683	Program for New Century Excellent Talents in University [NCET-090652]; Fundamental Research Funds for the Central Universities [QN2011065]	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	HC is supported by the Program for New Century Excellent Talents in University (NCET-090652) and the Fundamental Research Funds for the Central Universities (QN2011065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; HC is supported by Program for New Century Excellent Talents in University (NCET-09-0652) and the Fundamental Research Funds for the Central Universities (QN2011065).	AKASHI H, 1994, GENETICS, V136, P927; Cortazzo P, 2002, BIOCHEM BIOPH RES CO, V293, P537, DOI 10.1016/S0006-291X(02)00226-7; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Fedyunin I, 2012, FEBS LETT, V586, P3336, DOI 10.1016/j.febslet.2012.07.012; Fluman N, 2014, ELIFE, P3; Futatsumori-Sugai M, 2010, BIOCHEM BIOPH RES CO, V391, P931, DOI 10.1016/j.bbrc.2009.11.167; IKEMURA T, 1982, J MOL BIOL, V158, P573, DOI 10.1016/0022-2836(82)90250-9; IKEMURA T, 1981, J MOL BIOL, V151, P389, DOI 10.1016/0022-2836(81)90003-6; IKEMURA T, 1985, MOL BIOL EVOL, V2, P13; Kostova Z, 2003, EMBO J, V22, P2309, DOI 10.1093/emboj/cdg227; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Lakey DL, 2000, INFECT IMMUN, V68, P233, DOI 10.1128/IAI.68.1.233-238.2000; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Li YD, 2006, BIOSYSTEMS, V85, P225, DOI 10.1016/j.biosystems.2006.02.006; Mao YH, 2013, GENE, V517, P230, DOI 10.1016/j.gene.2012.12.062; Ng DTW, 2013, APPL ENVIRON MICROB, V79, P347, DOI 10.1128/AEM.02667-12; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Pop C, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145524; Power PM, 2004, BIOCHEM BIOPH RES CO, V322, P1038, DOI 10.1016/j.bbrc.2004.08.022; SHARP PM, 1988, NUCLEIC ACIDS RES, V16, P8207, DOI 10.1093/nar/16.17.8207; Siller E, 2010, J MOL BIOL, V396, P1310, DOI 10.1016/j.jmb.2009.12.042; Spencer PS, 2012, J MOL BIOL, V422, P328, DOI 10.1016/j.jmb.2012.06.010; Tsuchiya Y, 2003, NUCL ACIDS S SERIES; Tsuchiya Y, 2004, NUCL ACIDS S SERIES; Tsuchiya Y, 2005, NUCL ACIDS S SERIES; Wan Y, 2011, NAT REV GENET, V12, P641, DOI 10.1038/nrg3049; Wen JD, 2008, NATURE, V452, P598, DOI 10.1038/nature06716; Xu XD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054631; Zalucki YM, 2008, BIOCHEM BIOPH RES CO, V366, P135, DOI 10.1016/j.bbrc.2007.11.093; Zalucki YM, 2010, BBA-BIOMEMBRANES, V1798, P1244, DOI 10.1016/j.bbamem.2010.03.010; Zhao YG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng006; Zhou M, 2013, NATURE, V495, P111, DOI 10.1038/nature11833	32	6	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145887	10.1371/journal.pone.0145887	http://dx.doi.org/10.1371/journal.pone.0145887			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26697848	Green Published, gold, Green Submitted			2022-12-26	WOS:000367092600140
J	Williams, AJ; Wyatt, KM; Williams, CA; Logan, S; Henley, WE				Williams, Andrew James; Wyatt, Katrina M.; Williams, Craig A.; Logan, Stuart; Henley, William E.			Exploring the Potential of a School Impact on Pupil Weight Status: Exploratory Factor Analysis and Repeat Cross-Sectional Study of the National Child Measurement Programme	PLOS ONE			English	Article							OBESITY PREVENTION PROGRAMS; BODY-MASS INDEX; MULTILEVEL ANALYSIS; PHYSICAL-ACTIVITY; BUILT ENVIRONMENT; INTERVENTIONS; OVERWEIGHT; RISK; METAANALYSIS; ASSOCIATION	Schools are common sites for obesity prevention interventions. Although many theories suggest that the school context influences weight status, there has been little empirical research. The objective of this study was to explore whether features of the school context were consistently and meaningfully associated with pupil weight status (overweight or obese). Exploratory factor analysis of routinely collected data on 319 primary schools in Devon, England, was used to identify possible school-based contextual factors. Repeated cross-sectional multilevel analysis of five years (2006/07-2010/11) of data from the National Child Measurement Programme was then used to test for consistent and meaningful associations. Four school-based contextual factors were derived which ranked schools according to deprivation, location, resource and prioritisation of physical activity. None of which were meaningfully and consistently associated with pupil weight status, across the five years. The lack of consistent associations between the factors and pupil weight status suggests that the school context is not inherently obesogenic. In contrast, incorporating findings from education research indicates that schools may be equalising weight status, and obesity prevention research, policy and practice might need to address what is happening outside schools and particularly during the school holidays.	[Williams, Andrew James] Univ Edinburgh, Farr Inst Scotland & Scottish Collaborat Publ Hlt, Usher Inst Populat Hlth Sci & Informat, Edinburgh EH8 9DX, Midlothian, Scotland; [Williams, Andrew James; Wyatt, Katrina M.; Logan, Stuart; Henley, William E.] Univ Exeter, Sch Med, Inst Hlth Serv Res, Exeter EX1 2LU, Devon, England; [Williams, Andrew James; Williams, Craig A.] Univ Exeter, Childrens Hlth & Exercise Res Ctr, Sport & Hlth Sci, Exeter EX1 2LU, Devon, England	University of Edinburgh; University of Exeter; University of Exeter	Williams, AJ (corresponding author), Univ Edinburgh, Farr Inst Scotland & Scottish Collaborat Publ Hlt, Usher Inst Populat Hlth Sci & Informat, 20 West Richmond St, Edinburgh EH8 9DX, Midlothian, Scotland.	a.j.williams@ed.ac.uk	Williams, Craig Anthony/AAQ-8954-2020	Williams, Craig Anthony/0000-0002-1740-6248; Williams, Andrew James/0000-0002-2175-8836; Logan, Stuart/0000-0002-9279-261X	Medical Research Council Doctoral Training Grant [MRC DTG PCMD/GS002]; Sport and Health Sciences, University of Exeter; Farr Institute @ Scotland; Arthritis Research UK; British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Engineering and Physical Sciences Research Council; Medical Research Council; National Institute of Health Research; National Institute for Social Care and Health Research (Welsh Assembly Government); Chief Scientist Office (Scottish Government Health Directorates); MRC Grant [MR/K007017/1]; National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care South West Peninsula at the Royal Devon; Exeter NHS Foundation Trust; Medical Research Council [MR/K023209/1, MR/K007017/1] Funding Source: researchfish; MRC [MR/K007017/1, MR/K023209/1] Funding Source: UKRI	Medical Research Council Doctoral Training Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Sport and Health Sciences, University of Exeter; Farr Institute @ Scotland; Arthritis Research UK(Versus Arthritis); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Health Research(National Institute for Health Research (NIHR)); National Institute for Social Care and Health Research (Welsh Assembly Government); Chief Scientist Office (Scottish Government Health Directorates); MRC Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care South West Peninsula at the Royal Devon; Exeter NHS Foundation Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This project began as part of AJW's doctoral studies which were funded by a Medical Research Council Doctoral Training Grant (MRC DTG PCMD/GS002) and Sport and Health Sciences, University of Exeter. AJW is now supported by the Farr Institute @ Scotland, which is supported by a 10-funder consortium: Arthritis Research UK, the British Heart Foundation, Cancer Research UK, the Economic and Social Research Council, the Engineering and Physical Sciences Research Council, the Medical Research Council, the National Institute of Health Research, the National Institute for Social Care and Health Research (Welsh Assembly Government), the Chief Scientist Office (Scottish Government Health Directorates), (MRC Grant No: MR/K007017/1). SL, KMW, and WEH were also partially supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care South West Peninsula at the Royal Devon and Exeter NHS Foundation Trust. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander KL, 2007, AM SOCIOL REV, V72, P167, DOI 10.1177/000312240707200202; Anderson PM, 2011, J HEALTH ECON, V30, P977, DOI 10.1016/j.jhealeco.2011.06.002; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bonell C., 2013, PUBLIC HLTH RES, V1, P1, DOI [10.3310/phr01010, DOI 10.3310/PHR01010]; Borman GD, 2006, EDUC EVAL POLICY AN, V28, P25, DOI 10.3102/01623737028001025; Brown T, 2009, OBES REV, V10, P110, DOI 10.1111/j.1467-789X.2008.00515.x; Burkam DT, 2004, SOCIOL EDUC, V77, P1, DOI 10.1177/003804070407700101; Butland B, 2007, FORESIGHT TACKLING O; Chen TA, 2015, PEDIAT OBES, DOI [10.1111/ijpo.12025, DOI 10.1111/IJP0.12025]; Chinn S, 2000, STAT MED, V19, P3127, DOI 10.1002/1097-0258(20001130)19:22<3127::AID-SIM784>3.0.CO;2-M; Clarke J, 2013, OBES REV, V14, P975, DOI 10.1111/obr.12058; COLE TJ, 1995, ARCH DIS CHILD, V73, P25, DOI 10.1136/adc.73.1.25; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Conrad D, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000463; Department for Communities and Local Government, 2009, LOC IND CHILD WELL B; Department for Communities and Local Government, 2011, ENGLISH INDICES DEPR; Department of Health, 2009, NHS INF CTR VAL PROC; Department of Health, 2007, LEG CHANG NAT CHILD; Department of Health and Department for Education and Skills (n.d), NAT HLTH SCH PROGR G; Downey DB, 2004, AM SOCIOL REV, V69, P613, DOI 10.1177/000312240406900501; Durand CP, 2011, OBES REV, V12, pe173, DOI 10.1111/j.1467-789X.2010.00826.x; Economos CD, 2013, PREV MED, V57, P322, DOI 10.1016/j.ypmed.2013.06.001; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Gershenson S, 2013, AM EDUC RES J, V50, P1219, DOI 10.3102/0002831213502516; GOLDSTEIN H, 1995, J ROY STAT SOC A STA, V158, P175, DOI 10.2307/2983411; Goldstein H, 1995, MULTILEVEL STAT MODE, V2nd; Gortmaker SL, 2011, LANCET, V378, P838, DOI 10.1016/S0140-6736(11)60815-5; Health and Social Care Information Centre, 2013, NATIONAL CHILD MEASU; Johnson BA, 2012, INT J OBESITY, V36, P901, DOI 10.1038/ijo.2012.23; Khambalia AZ, 2012, OBES REV, V13, P214, DOI 10.1111/j.1467-789X.2011.00947.x; Kropski JA, 2008, OBESITY, V16, P1009, DOI 10.1038/oby.2008.29; Lhachimi SK, 2013, OBES REV, V14, P523, DOI 10.1111/obr.12029; Macintyre S, 2002, SOC SCI MED, V55, P125, DOI 10.1016/S0277-9536(01)00214-3; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P443, DOI 10.1136/jech.2004.023473; Miller DP, 2011, SOC SCI MED, V72, P677, DOI 10.1016/j.socscimed.2010.12.003; Miyazaki Y, 2015, SOC SCI MED, V128, P57, DOI 10.1016/j.socscimed.2014.12.032; Moreno JP, 2015, OBESITY, V23, P422, DOI 10.1002/oby.20977; National Obesity Observatory, 2010, NAT CHILD MEAS PROGR; O'Malley PM, 2007, AM J PREV MED, V33, pS187, DOI 10.1016/j.amepre.2007.07.001; Office for National Statistics, 2014, SUP OUTP AR SOAS; Pallan MJ, 2014, ARCH DIS CHILD, V99, P135, DOI 10.1136/archdischild-2013-303987; Procter KL, 2008, SOC SCI MED, V67, P341, DOI 10.1016/j.socscimed.2008.02.029; R Core Team, 2013, R A LANGUAGE AND ENV; Richmond TK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083254; School Food Plan, 2014, THE PLAN OFST; Sellstrom E, 2006, J EPIDEMIOL COMMUN H, V60, P149, DOI 10.1136/jech.2005.036707; Sharma M, 2007, OBES REV, V8, P155, DOI 10.1111/j.1467-789X.2006.00268.x; Sharma M, 2006, OBES REV, V7, P261, DOI 10.1111/j.1467-789X.2006.00227.x; South East England Public Health Observatory, 2005, CHOOS HLTH S E OB; South West Healthy Schools Plus, 2009, HDB FOR SCH; StataCorp, 2021, STATA STAT SOFTWARE; Statistical Consulting Group, 2014, STAT FAQ PERF FACT A; Swinburn B, 2002, Obes Rev, V3, P289; Swinburn B, 1999, PREV MED, V29, P563, DOI 10.1006/pmed.1999.0585; The NHS Information Centre, 2011, NAT CHILD MEAS PROGR; The NHS Information Centre, 2009, NAT CHILD MEAS PROGR; The NHS Information Centre, 2008, NAT CHILD MEAS PROGR; The NHS Information Centre, 2010, NAT CHILD MEAS PROGR; Townsend N, 2012, INT J OBESITY, V36, P45, DOI 10.1038/ijo.2011.191; von Hippel PT, 2007, AM J PUBLIC HEALTH, V97, P696, DOI 10.2105/AJPH.2005.080754; West P, 2004, RES PAP EDUC, V19, P261, DOI DOI 10.1080/02671522.2004.10058645; Williams AJ, 2013, DETERMINATION SCH BA; Williams AJ, 2014, PREV MED, V64, P103, DOI 10.1016/j.ypmed.2014.04.003; Williams AJ, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-101; Williams AJ, 2012, HEALTH PLACE, V18, P504, DOI 10.1016/j.healthplace.2012.02.004; World Health Organization, 2013, SCH YOUTH HLTH WHAT; Zenzen W, 2009, J PEDIATR HEALTH CAR, V23, P242, DOI 10.1016/j.pedhc.2008.04.008	68	1	1	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145128	10.1371/journal.pone.0145128	http://dx.doi.org/10.1371/journal.pone.0145128			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ4SI	26700027	gold, Green Published, Green Submitted			2022-12-26	WOS:000367092600050
J	Shinzawa-Itoh, K; Shimomura, H; Yanagisawa, S; Shimada, S; Takahashi, R; Oosaki, M; Ogura, T; Tsukihara, T				Shinzawa-Itoh, Kyoko; Shimomura, Harunobu; Yanagisawa, Sachiko; Shimada, Satoru; Takahashi, Ryoko; Oosaki, Marika; Ogura, Takashi; Tsukihara, Tomitake			Purification of Active Respiratory Supercomplex from Bovine Heart Mitochondria Enables Functional Studies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bioenergetics; complex I; cytochrome c oxidase (complex IV); membrane protein; protein purification; Raman spectroscopy; complex III; respiratory supercomplex	CYTOCHROME-C-OXIDASE; ELECTRON-TRANSPORT CHAIN; COMPLEX-I; BC(1) COMPLEX; 2.8 ANGSTROM; MAMMALIAN MITOCHONDRIA; CRYSTAL-STRUCTURE; UBIQUINONE; YEAST; ARRANGEMENT	To understand the roles of mitochondrial respiratory chain supercomplexes, methods for consistently separating and preparing supercomplexes must be established. To this end, we solubilized supercomplexes from bovine heart mitochondria with digitonin and then replaced digitonin with amphipol (A8-35), an amphiphilic polymer. Afterward, supercomplexes were separated from other complexes by sucrose density gradient centrifugation. Twenty-six grams of bovine myocardium yielded 3.2 mg of amphipol-stabilized supercomplex. The purified supercomplexes were analyzed based on their absorption spectra as well as Q(10) (ubiquinone with ten isoprene units) and lipid assays. The supercomplex sample did not contain cytochrome c but did contain complexes I, III, and IV at a ratio of 1:2:1, 6 molecules of Q(10), and 623 atoms of phosphorus. When cytochrome c was added, the supercomplex exhibited KCN-sensitive NADH oxidation; thus, the purified supercomplex was active. Reduced complex IV absorbs at 444 nm, so we measured the resonance Raman spectrum of the reduced amphipol-solubilized supercomplex and the mixture of amphipol-solubilized complexes I-1, III2, and IV1 using an excitation wavelength of 441.6 nm, allowing measurement precision comparable with that obtained for complex IV alone. Use of the purified active sample provides insights into the effects of supercomplex formation.	[Shinzawa-Itoh, Kyoko; Shimomura, Harunobu; Yanagisawa, Sachiko; Shimada, Satoru; Takahashi, Ryoko; Oosaki, Marika; Ogura, Takashi; Tsukihara, Tomitake] Univ Hyogo, Grad Sch Life Sci, Dept Life Sci, 3-2-1 Koto, Akoh, Hyogo 6781297, Japan; [Shimada, Satoru; Tsukihara, Tomitake] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Tsukihara, Tomitake] Osaka Univ, Inst Prot Res, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan	University of Hyogo; Japan Science & Technology Agency (JST); Osaka University	Shinzawa-Itoh, K (corresponding author), Univ Hyogo, Grad Sch Life Sci, Dept Life Sci, 3-2-1 Koto, Akoh, Hyogo 6781297, Japan.	shinzawa@sci.u-hyogo.ac.jp			CREST/JST; MEXT, Japan [(2503) 26104532]; Grants-in-Aid for Scientific Research [15K21295] Funding Source: KAKEN	CREST/JST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by CREST/JST and Grant-in-aid for Scientific Research on Innovative Areas (2503) 26104532, MEXT, Japan (to T. O.).	Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; Acin-Perez R, 2014, BBA-BIOENERGETICS, V1837, P444, DOI 10.1016/j.bbabio.2013.12.009; Althoff T, 2011, EMBO J, V30, P4652, DOI 10.1038/emboj.2011.324; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; Blaza JN, 2014, P NATL ACAD SCI USA, V111, P15735, DOI 10.1073/pnas.1413855111; Chaban Y, 2014, BBA-BIOENERGETICS, V1837, P418, DOI 10.1016/j.bbabio.2013.10.004; CHANCE B, 1955, J BIOL CHEM, V217, P409; Chen YC, 2012, CELL METAB, V15, P348, DOI 10.1016/j.cmet.2012.02.006; Diaz F, 2006, MOL CELL BIOL, V26, P4872, DOI 10.1128/MCB.01767-05; Dudkina NV, 2011, P NATL ACAD SCI USA, V108, P15196, DOI 10.1073/pnas.1107819108; Genova ML, 2014, BBA-BIOENERGETICS, V1837, P427, DOI 10.1016/j.bbabio.2013.11.002; HACKENBROCK CR, 1986, J BIOENERG BIOMEMBR, V18, P331, DOI 10.1007/BF00743010; HATEFI Y, 1962, J BIOL CHEM, V237, P1681; Huang LS, 2005, J MOL BIOL, V351, P573, DOI 10.1016/j.jmb.2005.05.053; Ikeda K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3147; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Lange C, 2001, EMBO J, V20, P6591, DOI 10.1093/emboj/20.23.6591; Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381; Maranzana E, 2013, ANTIOXID REDOX SIGN, V19, P1469, DOI 10.1089/ars.2012.4845; Markwell M A, 1981, Methods Enzymol, V72, P296; Mileykovskaya E, 2012, J BIOL CHEM, V287, P23095, DOI 10.1074/jbc.M112.367888; Mochizuki M, 1999, J BIOL CHEM, V274, P33403, DOI 10.1074/jbc.274.47.33403; Murakami S, 1998, ACTA CRYSTALLOGR D, V54, P146, DOI 10.1107/S0907444997007245; OGURA T, 1985, BIOCHEMISTRY-US, V24, P7746, DOI 10.1021/bi00347a037; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Shimada S, 2014, MICROSCOPY-JPN, V63, P167, DOI 10.1093/jmicro/dft082; Shinzawa-Itoh K, 2007, EMBO J, V26, P1713, DOI 10.1038/sj.emboj.7601618; Shinzawa-Itoh K, 2010, BIOCHEMISTRY-US, V49, P487, DOI 10.1021/bi9016318; Smith, 1967, METHOD ENZYMOL, V10, P81, DOI DOI 10.1016/0076-6879(67)10016-5; Solmaz SRN, 2008, J BIOL CHEM, V283, P17542, DOI 10.1074/jbc.M710126200; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554; Vinothkumar KR, 2014, NATURE, V515, P80, DOI 10.1038/nature13686; Zhang M, 2005, J BIOL CHEM, V280, P29403, DOI 10.1074/jbc.M504955200; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612; Zickermann V, 2015, SCIENCE, V347, P44, DOI 10.1126/science.1259859	39	31	31	2	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					4178	4184		10.1074/jbc.M115.680553	http://dx.doi.org/10.1074/jbc.M115.680553			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26698328	Green Published, hybrid			2022-12-26	WOS:000371338400041
J	Wang, S; Song, JY; Yang, YD; Zhang, YN; Wang, HJ; Ma, J				Wang, Shuo; Song, Jieyun; Yang, Yide; Zhang, Yining; Wang, Haijun; Ma, Jun			HIF3A DNA Methylation Is Associated with Childhood Obesity and ALT	PLOS ONE			English	Article							BASE-SPECIFIC CLEAVAGE; WIDE ASSOCIATION; GENE; METAANALYSIS; VARIANTS; INTRON; HIF-1	Gene polymorphisms associated so far with body mass index (BMI) can explain only 1.18-1.45% of observed variation in BMI. Recent studies suggest that epigenetic modifications, especially DNA methylation, could contribute to explain part of the missing heritability, and two epigenetic genome-wide analysis studies (EWAS) have reported that Hypoxia Inducible Factor 3 Alpha Subunit (HIF3A) methylation was associated with BMI or BMI change. We therefore assessed whether the HIF3A methylation is associated with obesity and other obesity-related phenotypes in Chinese children. The subjects included 110 severe obese cases aged 7-17y and 110 normal-weight controls matched by age and gender for measurement of blood DNA methylation levels at the HIF3A gene locus using the Sequenom's MassARRAY system. We observed significantly higher methylation levels in obese children than in controls at positions 46801642 and 46801699 in HIF3A gene (P<0.05), and found positive associations between methylation and alanine aminotransferase (ALT) levels adjusted by gender, age and BMI at the position 46801699 (r = 0.226, P = 0.007). These results suggest that HIF3A DNA methylation is associated with childhood obesity, and has a BMI-independent association with ALT. The results provide evidence for identifying epigenetic factors of elivated ALT and may be useful for risk assessment and personalized medicine of liver diseases such as non-alcoholic fatty liver disease (NAFLD).	[Wang, Shuo; Song, Jieyun; Yang, Yide; Zhang, Yining; Wang, Haijun; Ma, Jun] Peking Univ, Sch Publ Hlth, Inst Child & Adolescent Hlth, Beijing 100871, Peoples R China	Peking University	Wang, HJ (corresponding author), Peking Univ, Sch Publ Hlth, Inst Child & Adolescent Hlth, Beijing 100871, Peoples R China.	whjun1@bjmu.edu.cn; majunt@bjmu.edu.cn	Wang, Haijun/AAD-1302-2021	Wang, Haijun/0000-0003-0849-2903; Wang, Shuo/0000-0002-3146-5818; Yang, Yide/0000-0003-3297-1306	National Natural Science Foundation of China [81172683]; Major State Basic Research and Development Program of China (973 Program) [2012CB517501]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research and Development Program of China (973 Program)(National Basic Research Program of China)	The study was supported by Grants from National Natural Science Foundation of China (81172683, HW, http://www.nsfc.gov.cn/) and the Major State Basic Research and Development Program of China (973 Program) (2012CB517501, JM, http://www.973.gov.cn/Default_3.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almen MS, 2014, GENE, V548, P61, DOI 10.1016/j.gene.2014.07.009; Bhaskaran K, 2014, LANCET, V384, P755, DOI 10.1016/S0140-6736(14)60892-8; Clark JM, 2003, AM J GASTROENTEROL, V98, P960, DOI [10.1016/S0002-9270(03)00265-X, 10.1111/j.1572-0241.2003.07486.x]; Claude Bouckard, 2010, GENES AND OBESITY, P197; Demerath EW, 2015, HUM MOL GENET, V24, P4464, DOI 10.1093/hmg/ddv161; Dick KJ, 2014, LANCET, V383, P1990, DOI 10.1016/S0140-6736(13)62674-4; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Falck-Ytter Y, 2001, SEMIN LIVER DIS, V21, P17, DOI 10.1055/s-2001-12926; Gelfman S, 2013, GENOME RES, V23, P789, DOI 10.1101/gr.143503.112; Giannini EG, 2005, CAN MED ASSOC J, V172, P367, DOI 10.1503/cmaj.1040752; Greer SN, 2012, EMBO J, V31, P2448, DOI 10.1038/emboj.2012.125; Guay SP, 2014, EPIGENETICS-US, V9, P718, DOI 10.4161/epi.27981; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Hatanaka M, 2009, BIOL PHARM BULL, V32, P1166, DOI 10.1248/bpb.32.1166; He J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-472; Heidbreder M, 2007, BIOCHEM BIOPH RES CO, V352, P437, DOI 10.1016/j.bbrc.2006.11.027; Heikkila M, 2011, CELL MOL LIFE SCI, V68, P3885, DOI 10.1007/s00018-011-0679-5; Huang RC, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-21; Huang T, 2015, DIABETES, V64, P3146, DOI 10.2337/db15-0264; Lin QC, 2015, SLEEP BREATH, V19, P273, DOI 10.1007/s11325-014-1008-7; Liu ZT, 2014, INT J MED SCI, V11, P925, DOI 10.7150/ijms.8951; Meng XR, 2014, PEDIATR RES, V76, P310, DOI 10.1038/pr.2014.88; Pasanen A, 2010, INT J BIOCHEM CELL B, V42, P1189, DOI 10.1016/j.biocel.2010.04.008; Rigal M, 2012, EMBO J, V31, P2981, DOI 10.1038/emboj.2012.141; Sang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088013; Stroka DM, 2001, FASEB J, V15, P2445, DOI 10.1096/fj.01-0125com; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Tamaki Y, 2013, J GASTROENTEROL, V48, P491, DOI 10.1007/s00535-012-0651-7; van den Boom Dirk, 2009, V507, P207, DOI 10.1007/978-1-59745-522-0_16; Wang D, 2010, OBESITY, V18, P573, DOI 10.1038/oby.2009.268; Wang HJ, 2008, BIOMED ENVIRON SCI, V21, P528, DOI 10.1016/S0895-3988(09)60013-1; Wang XL, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-87; Wen WQ, 2014, HUM MOL GENET, V23, P5492, DOI 10.1093/hmg/ddu248; Xia QH, 2013, ANN NY ACAD SCI, V1281, P178, DOI 10.1111/nyas.12020; Xu XJ, 2013, EPIGENETICS-US, V8, P522, DOI 10.4161/epi.24506; Zhao J, 2013, INT J OBESITY, V37, P140, DOI 10.1038/ijo.2012.8	36	35	35	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145944	10.1371/journal.pone.0145944	http://dx.doi.org/10.1371/journal.pone.0145944			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717317	Green Submitted, Green Published, gold			2022-12-26	WOS:000367510500100
J	Corleto, JA; Bravo-Hernandez, M; Kamizato, K; Kakinohana, O; Santucci, C; Navarro, MR; Platoshyn, O; Cizkova, D; Lukacova, N; Taylor, J; Marsala, M				Corleto, Jose A.; Bravo-Hernandez, Mariana; Kamizato, Kota; Kakinohana, Osamu; Santucci, Camila; Navarro, Michael R.; Platoshyn, Oleksandr; Cizkova, Dasa; Lukacova, Nadezda; Taylor, Julian; Marsala, Martin			Thoracic 9 Spinal Transection-Induced Model of Muscle Spasticity in the Rat: A Systematic Electrophysiological and Histopathological Characterization	PLOS ONE			English	Article							STRETCH REFLEX ACTIVITY; LEVEL NEUROPATHIC PAIN; CORD-INJURY; NEURONAL HYPEREXCITABILITY; INTRATHECAL BACLOFEN; PASSIVE EXERCISE; AMPA RECEPTOR; ACTIVATION; HYPERREFLEXIA; TIZANIDINE	The development of spinal hyper-reflexia as part of the spasticity syndrome represents one of the major complications associated with chronic spinal traumatic injury (SCI). The primary mechanism leading to progressive appearance of muscle spasticity is multimodal and may include loss of descending inhibitory tone, alteration of segmental interneuron-mediated inhibition and/or increased reflex activity to sensory input. Here, we characterized a chronic thoracic (Th 9) complete transection model of muscle spasticity in Sprague-Dawley (SD) rats. Isoflurane-anesthetized rats received a Th9 laminectomy and the spinal cord was transected using a scalpel blade. After the transection the presence of muscle spasticity quantified as stretch and cutaneous hyper-reflexia was identified and quantified as time-dependent changes in: i) ankle-rotation-evoked peripheral muscle resistance (PMR) and corresponding electromyography (EMG) activity, ii) Hoffmann reflex, and iii) EMG responses in gastrocnemius muscle after paw tactile stimulation for up to 8 months after injury. To validate the clinical relevance of this model, the treatment potency after systemic treatment with the clinically established anti-spastic agents baclofen (GABA(B) receptor agonist), tizanidine (alpha(2)-adrenergic agonist) and NGX424 (AMPA receptor antagonist) was also tested. During the first 3 months post spinal transection, a progressive increase in ankle rotation-evoked muscle resistance, Hoffmann reflex amplitude and increased EMG responses to peripherally applied tactile stimuli were consistently measured. These changes, indicative of the spasticity syndrome, then remained relatively stable for up to 8 months post injury. Systemic treatment with baclofen, tizanidine and NGX424 led to a significant but transient suppression of spinal hyper-reflexia. These data demonstrate that a chronic Th9 spinal transection model in adult SD rat represents a reliable experimental platform to be used in studying the pathophysiology of chronic spinal injury-induced spasticity. In addition a consistent anti-spastic effect measured after treatment with clinically effective anti-spastic agents indicate that this model can effectively be used in screening new anti-spasticity compounds or procedures aimed at modulating chronic spinal trauma-associated muscle spasticity.	[Corleto, Jose A.; Bravo-Hernandez, Mariana; Kamizato, Kota; Kakinohana, Osamu; Santucci, Camila; Navarro, Michael R.; Platoshyn, Oleksandr; Marsala, Martin] Univ Calif San Diego, Dept Anesthesiol, Neuroregenerat Lab, La Jolla, CA 92093 USA; [Corleto, Jose A.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Bravo-Hernandez, Mariana] Ctr Invest & Estudios Avanzados Cinvestav Sede Su, Dept Pharmacobiol, Mexico City, DF, Mexico; [Taylor, Julian] Hosp Nacl Paraplejicos, SESCAM, Toledo, Spain; [Cizkova, Dasa; Lukacova, Nadezda; Marsala, Martin] Slovak Acad Sci, Inst Neurobiol, Kosice 04001, Slovakia	University of California System; University of California San Diego; University of California System; University of California San Diego; Hospital Nacional de Paraplejicos; Slovak Academy of Sciences	Marsala, M (corresponding author), Univ Calif San Diego, Dept Anesthesiol, Neuroregenerat Lab, La Jolla, CA 92093 USA.	mmarsala@ucsd.edu	Lukáčová, Nadežda/F-5090-2018; Taylor, Julian/AAC-2802-2021; Cizkova, Dasa/AAF-8976-2019	Lukáčová, Nadežda/0000-0002-8834-6852; Taylor, Julian/0000-0003-2553-2348; cizkova, dasa/0000-0002-2504-3993; Bravo-Hernandez, Mariana/0000-0001-8762-0357	National Institute of Health [NS 40386, NS 51644]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051644, R01NS040386] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute of Health, grant # NS 40386 and NS 51644 to MM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azouvi P, 1996, ARCH PHYS MED REHAB, V77, P35, DOI 10.1016/S0003-9993(96)90217-8; Bennett DJ, 1999, J NEUROTRAUM, V16, P69, DOI 10.1089/neu.1999.16.69; Bose P, 2002, J NEUROTRAUM, V19, P1231, DOI 10.1089/08977150260338029; Bravo-Esteban E, 2013, NEUROREHABILITATION, V33, P531, DOI 10.3233/NRE-131000; Bravo-Esteban E, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-23; BUTEFISCH C, 1995, J NEUROL SCI, V130, P59, DOI 10.1016/0022-510X(95)00003-K; Detloff MR, 2008, EXP NEUROL, V212, P337, DOI 10.1016/j.expneurol.2008.04.009; Feldmann RG, 1980, SPASTICITY DISORDERE, P485; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Fuchigami T, 2011, NEUROSCIENCE, V194, P160, DOI 10.1016/j.neuroscience.2011.08.022; Fujimoto Y, 2006, EUR SPINE J, V15, P223, DOI 10.1007/s00586-005-0933-3; Garrison MK, 2011, EXP NEUROL, V227, P104, DOI 10.1016/j.expneurol.2010.09.019; Gomez-Soriano J, 2015, FRONTIER HU IN PRESS; Gomeza J, 2003, NEURON, V40, P797, DOI 10.1016/S0896-6273(03)00673-1; Gordon GRJ, 2005, NAT NEUROSCI, V8, P1078, DOI 10.1038/nn1498; Gwak YS, 2009, NEUROSCIENCE, V161, P895, DOI 10.1016/j.neuroscience.2009.03.055; Hains BC, 2003, J NEUROSCI, V23, P8881; Hefferan MP, 2007, J NEUROSCI, V27, P11179, DOI 10.1523/JNEUROSCI.0989-07.2007; Hefferan MP, 2006, NEUROSCI LETT, V403, P195, DOI 10.1016/j.neulet.2006.04.048; Ikeda H, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-43; Kakinohana O, 2006, NEUROSCIENCE, V141, P1569, DOI 10.1016/j.neuroscience.2006.04.083; Kakinohana O, 2012, EXP NEUROL, V237, P26, DOI 10.1016/j.expneurol.2012.06.004; Kakinohana O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030561; Kamen L, 2008, CURR MED RES OPIN, V24, P425, DOI [10.1185/030079908X261113, 10.1185/030079908X261113 ]; Kamizato K, 2014, SOC NEUR ABSTR, V422; Kapitza S, 2012, EXP NEUROL, V236, P179, DOI 10.1016/j.expneurol.2012.04.023; Leem JW, 2010, EXP NEUROL, V224, P321, DOI 10.1016/j.expneurol.2010.02.012; Li Y, 2004, J NEUROPHYSIOL, V92, P2694, DOI 10.1152/jn.00164.2004; Lichtman A H, 1990, NIDA Res Monogr, V105, P422; M'Dahoma S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102027; Marsala M, 2005, J NEUROTRAUM, V22, P1348, DOI 10.1089/neu.2005.22.1348; Meisner JG, 2010, J NEUROTRAUM, V27, P729, DOI 10.1089/neu.2009.1166; Mirbagheri MM, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-29; Mothet JP, 2005, P NATL ACAD SCI USA, V102, P5606, DOI 10.1073/pnas.0408483102; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; NEWMAN PM, 1982, EUR J CLIN PHARMACOL, V23, P31, DOI 10.1007/BF01061374; Oshiro M, 2010, BRIT J PHARMACOL, V161, P976, DOI 10.1111/j.1476-5381.2010.00954.x; PENN RD, 1989, NEW ENGL J MED, V320, P1517, DOI 10.1056/NEJM198906083202303; Rees MI, 2006, NAT GENET, V38, P801, DOI 10.1038/ng1814; Reese NB, 2006, SPINAL CORD, V44, P28, DOI 10.1038/sj.sc.3101810; Schindler-Ivens S, 2000, EXP BRAIN RES, V133, P233, DOI 10.1007/s002210000377; Skalnikova HK, 2013, J PROTEOMICS, V91, P41, DOI 10.1016/j.jprot.2013.06.028; Skold C, 1999, ARCH PHYS MED REHAB, V80, P1548, DOI 10.1016/S0003-9993(99)90329-5; Taylor J, 1999, EUR J NEUROSCI, V11, P363, DOI 10.1046/j.1460-9568.1999.00468.x; Taylor JS, 1997, J NEUROSCI, V17, P5004; Teixeira-Salmela LF, 1999, ARCH PHYS MED REHAB, V80, P1211, DOI 10.1016/S0003-9993(99)90018-7; Thompson FJ, 1998, J NEUROTRAUM, V15, P495, DOI 10.1089/neu.1998.15.495; Todd AJ, 2003, EUR J NEUROSCI, V17, P13, DOI 10.1046/j.1460-9568.2003.02406.x; van Gorp S, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt209; Watson C, 2009, SPINAL CORD CHRISTOP, P408; Weng HR, 2003, PAIN, V103, P131, DOI 10.1016/S0304-3959(02)00445-1; Xia MS, 2013, J MOL NEUROSCI, V51, P792, DOI 10.1007/s12031-013-0067-8; Yang L, 2004, J NEUROSCI, V24, P10846, DOI 10.1523/JNEUROSCI.2496-04.2004; Yates C, 2011, PROG BRAIN RES, V188, P167, DOI 10.1016/B978-0-444-53825-3.00016-4; Yates C, 2008, SPINAL CORD, V46, P798, DOI 10.1038/sc.2008.49; Yu D, 2013, P NATL ACAD SCI USA, V110, pE746, DOI 10.1073/pnas.1300083110	56	18	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0144642	10.1371/journal.pone.0144642	http://dx.doi.org/10.1371/journal.pone.0144642			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713446	Green Submitted, Green Published, gold			2022-12-26	WOS:000367481900013
J	Lee, YS; An, J; Kim, B; Park, H; Kim, J; Chang, IS				Lee, Yoo Seok; An, Junyeong; Kim, Bongkyu; Park, HyunJun; Kim, Jisu; Chang, In Seop			Increased Power in Sediment Microbial Fuel Cell: Facilitated Mass Transfer via a Water-Layer Anode Embedded in Sediment	PLOS ONE			English	Article							ELECTRICITY-GENERATION; HARVESTING ENERGY; MARINE-SEDIMENTS; REDUCTION; BACTERIA; SULFATE; SYSTEM	We report a methodology for enhancing the mass transfer at the anode electrode of sediment microbial fuel cells (SMFCs), by employing a fabric baffle to create a separate water-layer for installing the anode electrode in sediment. The maximum power in an SMFC with the anode installed in the separate water-layer (SMFC-wFB) was improved by factor of 6.6 compared to an SMFC having the anode embedded in the sediment (SMFC-woFB). The maximum current density in the SMFC-wFB was also 3.9 times higher ( 220.46 mA/m(2)) than for the SMFC-woFB. We found that the increased performance in the SMFC-wFB was due to the improved mass transfer rate of organic matter obtained by employing the water-layer during anode installation in the sediment layer. Acetate injection tests revealed that the SMFC-wFB could be applied to natural water bodies in which there is frequent organic contamination, based on the acetate flux from the cathode to the anode.	[Lee, Yoo Seok; An, Junyeong; Kim, Bongkyu; Park, HyunJun; Kim, Jisu; Chang, In Seop] Gwangju Inst Sci & Technol, Sch Environm Sci & Engn, Gwangju 500712, South Korea	Gwangju Institute of Science & Technology (GIST)	Chang, IS (corresponding author), Gwangju Inst Sci & Technol, Sch Environm Sci & Engn, 261 Cheomdan Gwagiro, Gwangju 500712, South Korea.	ischang@gist.ac.kr		Chang, In Seop/0000-0001-5064-7951; Lee, Yoo Seok/0000-0002-8840-0206	National Research Foundation (NRF) - Korean government (MSIP) [NRF-2013R1A2A2A0314551]	National Research Foundation (NRF) - Korean government (MSIP)	This work was supported by a National Research Foundation (NRF) grant (NRF-2013R1A2A2A0314551) funded by the Korean government (MSIP) (URL: http://www.nrf.re.kr) (author who received the funding: ISC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Research Foundation (NRF) grant (NRF-2013R1A2A2A0314551) funded by the Korean government (MSIP).	Ahn Changwoo, 2013, Environmental Engineering Research, V18, P151, DOI 10.4491/eer.2013.18.3.151; An J, 2013, BIORESOURCE TECHNOL, V127, P138, DOI 10.1016/j.biortech.2012.09.095; An J, 2010, ENVIRON SCI TECHNOL, V44, P7145, DOI 10.1021/es100498g; Berner R A, 1980, EARLY DIAGENESIS THE; Bond DR, 2002, SCIENCE, V295, P483, DOI 10.1126/science.1066771; Bond DR, 2003, APPL ENVIRON MICROB, V69, P1548, DOI 10.1128/AEM.69.3.1548-1555.2003; Boudreau BP, 1996, GEOCHIM COSMOCHIM AC, V60, P3139, DOI 10.1016/0016-7037(96)00158-5; Chang IS, 2006, J MICROBIOL BIOTECHN, V16, P163; Chiou C.T., 2000, CONTAMINANT SORPTION; Donovan C, 2008, ENVIRON SCI TECHNOL, V42, P8591, DOI 10.1021/es801763g; Donovan C, 2011, J POWER SOURCES, V196, P1171, DOI 10.1016/j.jpowsour.2010.08.099; Holmes DE, 2002, APPL ENVIRON MICROB, V68, P2300, DOI 10.1128/AEM.68.5.2300-2306.2002; Hong SW, 2009, BIORESOURCE TECHNOL, V100, P3029, DOI 10.1016/j.biortech.2009.01.030; Hong S, 2009, BIOPROC BIOSYST ENG, V32, P389, DOI 10.1007/s00449-008-0258-9; IVERSEN N, 1993, GEOCHIM COSMOCHIM AC, V57, P571, DOI 10.1016/0016-7037(93)90368-7; Kim BH, 1999, BIOTECHNOL TECH, V13, P475, DOI 10.1023/A:1008993029309; Lewandowski Z, 2013, FUNDAMENTALS BIOFILM; Logan BE, 2005, WATER RES, V39, P942, DOI 10.1016/j.watres.2004.11.019; Lowy DA, 2008, J POWER SOURCES, V185, P70, DOI 10.1016/j.jpowsour.2008.06.079; Marsili E, 2008, P NATL ACAD SCI USA, V105, P3968, DOI 10.1073/pnas.0710525105; NEALSON KH, 1992, APPL ENVIRON MICROB, V58, P439, DOI 10.1128/AEM.58.2.439-443.1992; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; O'Connor BL, 2008, WATER RESOUR RES, V44, DOI 10.1029/2008WR007160; Rabaey K, 2006, ENVIRON SCI TECHNOL, V40, P5218, DOI 10.1021/es060382u; Reimers CE, 2001, ENVIRON SCI TECHNOL, V35, P192, DOI 10.1021/es001223s; Rezaei F, 2007, ENVIRON SCI TECHNOL, V41, P4053, DOI 10.1021/es070426e; RICHARDSON CP, 1988, J ENVIRON ENG-ASCE, V114, P792, DOI 10.1061/(ASCE)0733-9372(1988)114:4(792); Rutherford J., 1994, RIVER MIXING 1994; Scott K, 2008, J CHEM TECHNOL BIOT, V83, P1244, DOI 10.1002/jctb.1937; Shantaram A, 2005, ENVIRON SCI TECHNOL, V39, P5037, DOI 10.1021/es0480668; Tender LM, 2008, J POWER SOURCES, V179, P571, DOI 10.1016/j.jpowsour.2007.12.123; WIDDEL F, 1983, ARCH MICROBIOL, V134, P286, DOI 10.1007/BF00407804	32	9	10	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145430	10.1371/journal.pone.0145430	http://dx.doi.org/10.1371/journal.pone.0145430			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714176	Green Submitted, Green Published, gold			2022-12-26	WOS:000367481900042
J	Lu, FM; Zhou, JS; Zhang, J; Xiang, YT; Zhang, J; Liu, Q; Wang, XP; Yuan, Z				Lu, Feng-Mei; Zhou, Jian-Song; Zhang, Jiang; Xiang, Yu-Tao; Zhang, Jian; Liu, Qi; Wang, Xiao-Ping; Yuan, Zhen			Functional Connectivity Estimated from Resting-State fMRI Reveals Selective Alterations in Male Adolescents with Pure Conduct Disorder	PLOS ONE			English	Article							MODE NETWORK ACTIVITY; DEFAULT-MODE; BRAIN ACTIVITY; MRI DATA; BOYS; ABNORMALITIES; FLUCTUATIONS; DYSFUNCTION; DEPRESSION; RESPONSES	Conduct disorder (CD) is characterized by a persistent pattern of antisocial behavior and aggression in childhood and adolescence. Previous task-based and resting-state functional magnetic resonance imaging (fMRI) studies have revealed widespread brain regional abnormalities in adolescents with CD. However, whether the resting-state networks (RSNs) are altered in adolescents with CD remains unknown. In this study, resting-state fMRI data were first acquired from eighteen male adolescents with pure CD and eighteen age-and gender-matched typically developing (TD) individuals. Independent component analysis (ICA) was implemented to extract nine representative RSNs, and the generated RSNs were then compared to show the differences between the CD and TD groups. Interestingly, it was observed from the brain mapping results that compared with the TD group, the CD group manifested decreased functional connectivity in four representative RSNs: the anterior default mode network (left middle frontal gyrus), which is considered to be correlated with impaired social cognition, the somatosensory network (bilateral supplementary motor area and right postcentral gyrus), the lateral visual network (left superior occipital gyrus), and the medial visual network (right fusiform, left lingual gyrus and right calcarine), which are expected to be relevant to the perceptual systems responsible for perceptual dysfunction in male adolescents with CD. Importantly, the novel findings suggested that male adolescents with pure CD were identified to have dysfunctions in both low-level perceptual networks (the somatosensory network and visual network) and a high-order cognitive network (the default mode network). Revealing the changes in the functional connectivity of these RSNs enhances our understanding of the neural mechanisms underlying the modulation of emotion and social cognition and the regulation of perception in adolescents with CD.	[Lu, Feng-Mei; Xiang, Yu-Tao; Zhang, Jian; Yuan, Zhen] Univ Macau, Fac Hlth Sci, Bioimaging Core, Taipa, Macau, Peoples R China; [Zhou, Jian-Song; Wang, Xiao-Ping] Cent S Univ, Mental Hlth Inst, Hunan Prov Technol Inst Psychiat, Xiangya Hosp 2,Key Lab Psychiat & Mental Hlth Hun, Changsha 410011, Hunan, Peoples R China; [Zhang, Jiang; Liu, Qi] Sichuan Univ, Sch Elect Engn & Informat, Dept Med Informat Engn, Chengdu 610065, Peoples R China	University of Macau; Central South University; Sichuan University	Zhou, JS (corresponding author), Cent S Univ, Mental Hlth Inst, Hunan Prov Technol Inst Psychiat, Xiangya Hosp 2,Key Lab Psychiat & Mental Hlth Hun, Changsha 410011, Hunan, Peoples R China.	zhoujs2003@126.com; zhenyuan@umac.mo	, 镜海真人（袁振）/ABG-2380-2020; Yuan, zhen/ABG-3111-2020; wang, xiao/HGB-7081-2022	Yuan, zhen/0000-0003-3061-6263; wang, xiao/0000-0002-4088-3341	University of Macau in Macau [SRG2013-00035-FHS, MYRG2014-00093-FHS, MYRG2015-00036-FHS]; MOE (Ministry of Education in China) Project of Humanities and Social Sciences [13YJC190033]; National Natural Science Foundation of China (NSFC) [81571341, 81371500, 61273361]; FDCT grant [026/2014/A1]; FDCT grant from the Macao government [025/2015/A1]	University of Macau in Macau; MOE (Ministry of Education in China) Project of Humanities and Social Sciences; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); FDCT grant; FDCT grant from the Macao government	The study was supported by the SRG2013-00035-FHS Grant and MYRG2014-00093-FHS and MYRG2015-00036-FHS Grants from University of Macau in Macau; the FDCT grant 026/2014/A1 and the FDCT grant 025/2015/A1 from the Macao government; the MOE (Ministry of Education in China) Project of Humanities and Social Sciences (Project No. 13YJC190033); and the National Natural Science Foundation of China (NSFC, 81571341, 81371500 and 61273361).; We sincerely thank the two reviewers for their constructive suggestions. The study was supported by the SRG2013-00035-FHS Grant and MYRG2014-00093-FHS and MYRG2015-00036-FHS Grants from University of Macau in Macau; the FDCT grant 026/2014/A1 and the FDCT grant 025/2015/A1 from the Macao government; the MOE (Ministry of Education in China) Project of Humanities and Social Sciences (Project No. 13YJC190033); and the National Natural Science Foundation of China (NSFC, 81571341, 81371500 and 61273361).	American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Anderson SW, 1999, NAT NEUROSCI, V2, P1032, DOI 10.1038/14833; Bao AM, 2010, NEUROSCIENTIST, V16, P550, DOI 10.1177/1073858410377005; Bartels A, 2005, NEUROIMAGE, V24, P339, DOI 10.1016/j.neuroimage.2004.08.044; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; Biswal BB, 1997, NMR BIOMED, V10, P165, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<165::AID-NBM454>3.0.CO;2-7; Biswal BB, FUNCTIONAL CONNECTIV; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Buckner RL, 2007, NEUROIMAGE, V37, P1091, DOI 10.1016/j.neuroimage.2007.01.010; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; Colman I, 2009, BMJ, V338; Dalwani MS, 2014, DRUG ALCOHOL DEPEN, V134, P242, DOI 10.1016/j.drugalcdep.2013.10.009; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Luca M, 2005, EXP BRAIN RES, V167, P587, DOI 10.1007/s00221-005-0059-1; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Decety J, 2009, BIOL PSYCHOL, V80, P203, DOI 10.1016/j.biopsycho.2008.09.004; Delfos M.F., 2004, CHILDREN BEHAV PROBL; Downar J, 2002, J NEUROPHYSIOL, V87, P615, DOI 10.1152/jn.00636.2001; du Boisgueheneuc F, 2006, BRAIN, V129, P3315, DOI 10.1093/brain/awl244; Fairchild G, 2011, BRAIN, V168; Fairchild G, 2011, AM J PSYCHIAT, V168, P624, DOI 10.1176/appi.ajp.2010.10081184; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Finger EC, 2011, AM J PSYCHIAT, V168, P152, DOI 10.1176/appi.ajp.2010.10010129; Finger EC, 2012, PSYCHIAT RES-NEUROIM, V202, P239, DOI 10.1016/j.pscychresns.2011.11.002; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Garrity AG, 2007, AM J PSYCHIAT, V164, P450, DOI 10.1176/appi.ajp.164.3.450; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius M, 2008, CURR OPIN NEUROL, V21, P424, DOI 10.1097/WCO.0b013e328306f2c5; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Guo WB, 2013, PROG NEURO-PSYCHOPH, V44, P51, DOI 10.1016/j.pnpbp.2013.01.010; Guo WB, 2013, PROG NEURO-PSYCHOPH, V41, P24, DOI 10.1016/j.pnpbp.2012.11.003; Hampson M, 2002, HUM BRAIN MAPP, V15, P247, DOI 10.1002/hbm.10022; Huebner T, 2008, J AM ACAD CHILD PSY, V47, P540, DOI 10.1097/CHI.0b013e3181676545; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Jones AP, 2009, AM J PSYCHIAT, V166, P95, DOI 10.1176/appi.ajp.2008.07071050; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Li SJ, 2002, RADIOLOGY, V225, P253, DOI 10.1148/radiol.2251011301; Li Y-O, 2006, BIOM IM NAN MACR 200; Liu Feng, 2015, Brain Struct Funct, V220, P101, DOI 10.1007/s00429-013-0641-4; Lowe MJ, 2000, NEUROIMAGE, V12, P582, DOI 10.1006/nimg.2000.0654; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Mantini D, 2009, NEUROIMAGE, V44, P265, DOI 10.1016/j.neuroimage.2008.08.019; McKeown MJ, 1998, P NATL ACAD SCI USA, V95, P803, DOI 10.1073/pnas.95.3.803; Mishra AM, 2013, EPILEPSIA, V54, P1214, DOI 10.1111/epi.12227; Roosendaal SD, 2010, BRAIN, V133, P1612, DOI 10.1093/brain/awq058; Rubia K, 2008, AM J PSYCHIAT, V165, P889, DOI 10.1176/appi.ajp.2008.07071084; Rubia K, 2010, HUM BRAIN MAPP, V31, P1823, DOI 10.1002/hbm.20975; Rubia K, 2009, J CHILD PSYCHOL PSYC, V50, P669, DOI 10.1111/j.1469-7610.2008.02022.x; Rubia K, 2009, AM J PSYCHIAT, V166, P83, DOI 10.1176/appi.ajp.2008.08020212; Schilbach L, 2008, CONSCIOUS COGN, V17, P457, DOI 10.1016/j.concog.2008.03.013; Sebastian CL, 2012, ARCH GEN PSYCHIAT, V69, P814, DOI 10.1001/archgenpsychiatry.2011.2070; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Shanee N, 1997, ISRAEL J PSYCHIAT RE; Shang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096834; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Stevens MC, 2012, J PSYCHIATR NEUROSCI, V37, P389, DOI 10.1503/jpn.110148; Tiet QQ, 2001, J CHILD FAMILY STUDI, V10, P181; Uddin LQ, 2009, HUM BRAIN MAPP, V30, P625, DOI 10.1002/hbm.20531; van de Ven VG, 2004, HUM BRAIN MAPP, V22, P165, DOI 10.1002/hbm.20022; van de Ven V, 2008, HUM BRAIN MAPP, V29, P1450, DOI 10.1002/hbm.20479; van den Heuvel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002001; Whitfield-Gabrieli S, 2012, ANNU REV CLIN PSYCHO, V8, P49, DOI 10.1146/annurev-clinpsy-032511-143049; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zhou J, 2015, PLOS ONE, V10; Zhou JS, 2012, J FORENSIC PSYCHI PS, V23, P664, DOI 10.1080/14789949.2012.727452; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080	72	24	26	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0145668	10.1371/journal.pone.0145668	http://dx.doi.org/10.1371/journal.pone.0145668			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713867	Green Published, Green Submitted, gold			2022-12-26	WOS:000367481900064
J	Bogels, S; Kendrick, KH; Levinson, SC				Bogels, Sara; Kendrick, Kobin H.; Levinson, Stephen C.			Never Say No ... How the Brain Interprets the Pregnant Pause in Conversation	PLOS ONE			English	Article							SEMANTIC INTEGRATION; WORD RECOGNITION; TURN SILENCE; ERP EVIDENCE; COMPREHENSION; SENTENCES; CUES; ANTICIPATION; ORGANIZATION; SPEECH	In conversation, negative responses to invitations, requests, offers, and the like are more likely to occur with a delay-conversation analysts talk of them as dispreferred. Here we examine the contrastive cognitive load 'yes' and 'no' responses make, either when relatively fast (300 ms after question offset) or delayed (1000 ms). Participants heard short dialogues contrasting in speed and valence of response while having their EEG recorded. We found that a fast 'no' evokes an N400-effect relative to a fast 'yes'; however, this contrast disappeared in the delayed responses. 'No' responses, however, elicited a late frontal positivity both if they were fast and if they were delayed. We interpret these results as follows: a fast 'no' evoked an N400 because an immediate response is expected to be positive-this effect disappears as the response time lengthens because now in ordinary conversation the probability of a 'no' has increased. However, regardless of the latency of response, a 'no' response is associated with a late positivity, since a negative response is always dispreferred. Together these results show that negative responses to social actions exact a higher cognitive load, but especially when least expected, in immediate response.	[Bogels, Sara; Kendrick, Kobin H.; Levinson, Stephen C.] Max Planck Inst Psycholinguist, Language & Cognit Dept, Nijmegen, Netherlands; [Levinson, Stephen C.] Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands	Max Planck Society; Radboud University Nijmegen	Bogels, S (corresponding author), Max Planck Inst Psycholinguist, Language & Cognit Dept, Nijmegen, Netherlands.	sara.bogels@mpi.nl		Bogels, Sara/0000-0002-4945-5765	Language and Cognition Department at the Max Planck Institute for Psycholinguistics; European Research Counsel [269484 INTERACT]	Language and Cognition Department at the Max Planck Institute for Psycholinguistics; European Research Counsel	This research was made possible by the financial support of the Language and Cognition Department at the Max Planck Institute for Psycholinguistics and European Research Counsel's Advanced Grant 269484 INTERACT to Stephen C. Levinson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, TORONTOS ROB FORD SA; [Anonymous], 2013, THEGUARDIAN; Bogels S, 2015, SCI REP-UK, V5, DOI 10.1038/srep12881; BRENNAN SE, 1995, J MEM LANG, V34, P383, DOI 10.1006/jmla.1995.1017; Brouwer H, 2012, BRAIN RES, V1446, P127, DOI 10.1016/j.brainres.2012.01.055; CLARK HH, 1972, COGNITIVE PSYCHOL, V3, P472, DOI 10.1016/0010-0285(72)90019-9; Clayman Steven E., 2002, ADV GROUP PROCESSES, P229; CONNOLLY JF, 1994, J COGNITIVE NEUROSCI, V6, P256, DOI 10.1162/jocn.1994.6.3.256; Coulson S, 2001, NEUROSCI LETT, V316, P71, DOI 10.1016/S0304-3940(01)02387-4; Coulson S, 2002, MEM COGNITION, V30, P958, DOI 10.3758/BF03195780; Coulson S, 2010, ITAL J LINGUIST, V22, P107; Couper-Kuhlen E, 2014, PRAGMATICS, V24, P623, DOI 10.1075/prag.24.3.08cou; D'Arcy RCN, 2004, HUM BRAIN MAPP, V22, P40, DOI 10.1002/hbm.20008; DeLong KA, 2005, NAT NEUROSCI, V8, P1117, DOI 10.1038/nn1504; Ford Cecilia E., 1996, INTERACTION GRAMMAR, P135; Gisladottir RS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120068; Hagoort P, 2000, NEUROPSYCHOLOGIA, V38, P1518, DOI 10.1016/S0028-3932(00)00052-X; Hagoort P, 2004, SCIENCE, V304, P438, DOI 10.1126/science.1095455; Hagoort P., 2009, COGNITIVE NEUROSCIEN, V4th, P819, DOI [10.1002/int.4550070108, DOI 10.1002/INT.4550070108]; Hagoort P., 1999, NEUROCOGNITION LANGU, P273, DOI DOI 10.1093/ACPROF:OSO/9780198507932.001.0001; Hayano Kaoru, 2013, HDB CONVERSATION ANA, P395, DOI DOI 10.1002/9781118325001.CH19; Heldner M, 2010, J PHONETICS, V38, P555, DOI 10.1016/j.wocn.2010.08.002; Heritage J., 1984, GARFINKEL ETHNOMETHO; Kendrick KH, 2015, DISCOURSE PROCESS, V52, P255, DOI 10.1080/0163853X.2014.955997; Kitzinger C, 1999, DISCOURSE SOC, V10, P293, DOI 10.1177/0957926599010003002; KRAUT RE, 1978, J PERS SOC PSYCHOL, V36, P380, DOI 10.1037/0022-3514.36.4.380; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Leuthold H, 2015, SOC COGN AFFECT NEUR, V10, P1021, DOI 10.1093/scan/nsu151; Levinson S. C., 1983, PRAGMATICS; Levinson SC, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00731; Magyari L, 2014, J COGNITIVE NEUROSCI, V26, P2530, DOI 10.1162/jocn_a_00673; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; New J, 2015, MORE COLL CAMPUSES S; Nieuwland MS, 2008, PSYCHOL SCI, V19, P1213, DOI 10.1111/j.1467-9280.2008.02226.x; Nordmeyer A.E., 2014, P ANN M COGN SCI SOC, V36; Oostdijk Nelleke, 2000, NEDERLANDSE TAALKUND, V5, P280; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; POLICH J, 1988, ELECTROEN CLIN NEURO, V70, P33, DOI 10.1016/0013-4694(88)90192-7; Pomerantz Anita, 2013, HDB CONVERSATION ANA, P210; Pomerantz Anita M., 1984, STUDIES CONVERSATION, P57, DOI DOI 10.1017/CBO9780511665868.008; Regel S, 2011, J COGNITIVE NEUROSCI, V23, P277, DOI 10.1162/jocn.2010.21411; Regel S, 2010, BRAIN RES, V1311, P121, DOI 10.1016/j.brainres.2009.10.077; Roberts F, 2006, SPEECH COMMUN, V48, P1079, DOI 10.1016/j.specom.2006.02.001; Roberts F, 2013, J ACOUST SOC AM, V133, pEL471, DOI 10.1121/1.4802900; Roberts F, 2011, DISCOURSE PROCESS, V48, P331, DOI 10.1080/0163853X.2011.558002; Roberts SG, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00509; Rockwell P., 1997, COMMUNICATION RES RE, V14, P451, DOI [10.1080/08824099709388688, DOI 10.1080/08824099709388688]; SACKS H, 1974, LANGUAGE, V50, P696, DOI 10.2307/412243; Sacks H., 1987, TALK SOCIAL ORG, P54; Schegloff E. A., 2007, SEQUENCE ORG INTERAC, V1; Schilbach L, 2013, BEHAV BRAIN SCI, V36, P393, DOI 10.1017/S0140525X12000660; Sereno SC, 1998, NEUROREPORT, V9, P2195, DOI 10.1097/00001756-199807130-00009; SMITH VL, 1993, J MEM LANG, V32, P25, DOI 10.1006/jmla.1993.1002; Stivers T, 2006, LANG SOC, V35, P367, DOI 10.1017/S0047404506060179; Stivers T, 2009, P NATL ACAD SCI USA, V106, P10587, DOI 10.1073/pnas.0903616106; Strijkers K, 2010, CEREB CORTEX, V20, P912, DOI 10.1093/cercor/bhp153; Thornhill DE, 2012, INT J PSYCHOPHYSIOL, V83, P382, DOI 10.1016/j.ijpsycho.2011.12.007; van Berkum JJA, 1999, J COGNITIVE NEUROSCI, V11, P657, DOI 10.1162/089892999563724; Van Berkum JJA, 2009, PSYCHOL SCI, V20, P1092, DOI 10.1111/j.1467-9280.2009.02411.x; de Meerendonk N, 2009, LANG LINGUIST COMPAS, V3, DOI 10.1111/j.1749-818x.2009.00163.x; van den Brink D, 2001, J COGNITIVE NEUROSCI, V13, P967, DOI 10.1162/089892901753165872; Van Petten C, 1999, J EXP PSYCHOL LEARN, V25, P394, DOI 10.1037/0278-7393.25.2.394; Van Petten C, 2012, INT J PSYCHOPHYSIOL, V83, P176, DOI 10.1016/j.ijpsycho.2011.09.015	63	31	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145474	10.1371/journal.pone.0145474	http://dx.doi.org/10.1371/journal.pone.0145474			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ4SI	26699335	Green Published, gold, Green Accepted			2022-12-26	WOS:000367092600086
J	Ji, FM; Liu, LY; Tien, YH; Peng, YH; Lee, HC				Ji, Fengmin; Liu, Lianyun; Tien, Ya-Hsin; Peng, Yi-Hsien; Lee, Hoong-Chien			Non-Catalytic RISCs and Kinetics Determine Mammalian siRNA Sub-Cellular Localization	PLOS ONE			English	Article							HUMAN-CELLS; RNA; DEADENYLATION; INTERFERENCE; POTENT	Small interfering RNAs (siRNAs) are fundamental to the regulation of cell function. Much is known about its gene interfering mechanism, but a kinetic description of it is still lacking. Here, we derived a set of reaction-diffusion equations for multiple RNA-induced silencing complex (RISC) pathways that give quantitative temporal and spatial descriptions of the siRNA process in mammalian cell, and are able to correctly describe all salient experimentally observed patterns of sub-cellular siRNA localization, including those that, at first glance, appear irreconcilable. These results suggest siRNA sub-cellular localization mainly concerns the non-catalytic RISC-target complex, and is caused by the selectiveness of RISC-target interaction and the permeability of the nuclear membrane to siRNA strands but not to RISC-target complexes. Our method is expected to be useful in devising RNAi based cell regulation strategies.	[Ji, Fengmin] Beijing Jiaotong Univ, Inst Biol Sci & Biotechnol, Beijing 100044, Peoples R China; [Liu, Lianyun] Beijing Jiaotong Univ, Dept Chem, Beijing 100044, Peoples R China; [Tien, Ya-Hsin; Peng, Yi-Hsien; Lee, Hoong-Chien] Natl Cent Univ, Dept Biomed Sci & Engn, Taoyuan 32001, Taiwan; [Lee, Hoong-Chien] Chung Yuan Christian Univ, Dept Phys, Taoyuan 32023, Taiwan; [Lee, Hoong-Chien] Natl Cent Univ, Ctr Dynam Biomarkers & Translat Med, Taoyuan 32001, Taiwan	Beijing Jiaotong University; Beijing Jiaotong University; National Central University; Chung Yuan Christian University; National Central University	Lee, HC (corresponding author), Natl Cent Univ, Dept Biomed Sci & Engn, Taoyuan 32001, Taiwan.	hclee12345@gmail.com			Beijing Jiaotong University; Ministry of Science and Technology through the Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan [MOST 102-2911-I-008-001, 103-2911-I-008-001]	Beijing Jiaotong University; Ministry of Science and Technology through the Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan	FMJ and LYL were supported by grants from the Beijing Jiaotong University. HCL was supported by Ministry of Science and Technology through the Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan, (MOST 102-2911-I-008-001, and 103-2911-I-008-001).; FMJ and LYL were supported by grants from the Beijing Jiaotong University. HCL was supported by Ministry of Science and Technology through the Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan, (MOST 102-2911-I-008-001 and 103-2911-I-008-001).	Bartlett DW, 2006, NUCLEIC ACIDS RES, V34, P322, DOI 10.1093/nar/gkj439; Berezhna SY, 2006, P NATL ACAD SCI USA, V103, P7682, DOI 10.1073/pnas.0600148103; Bergstrom CT, 2003, P NATL ACAD SCI USA, V100, P11511, DOI 10.1073/pnas.1931639100; Denti MA, 2004, PLANT J, V37, P762, DOI 10.1111/j.1365-313X.2004.02001.x; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Kawamata T, 2010, TRENDS BIOCHEM SCI, V35, P368, DOI 10.1016/j.tibs.2010.03.009; Kawasaki H, 2004, NATURE, V431, P211, DOI 10.1038/nature02889; Meister G, 2013, NAT REV GENET, V14, P447, DOI 10.1038/nrg3462; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Ohrt T, 2008, NUCLEIC ACIDS RES, V36, P6439, DOI 10.1093/nar/gkn693; Papp I, 2003, PLANT PHYSIOL, V132, P1382, DOI 10.1104/pp.103.021980; Robb GB, 2005, NAT STRUCT MOL BIOL, V12, P133, DOI 10.1038/nsmb886; Swaminathan R, 1997, BIOPHYS J, V72, P1900, DOI 10.1016/S0006-3495(97)78835-0; Wang X, 2010, BIOSYSTEMS, V100, P31, DOI 10.1016/j.biosystems.2009.12.005; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Zeng Y, 2002, RNA, V8, P855, DOI 10.1017/S1355838202020071	18	0	0	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0143182	10.1371/journal.pone.0143182	http://dx.doi.org/10.1371/journal.pone.0143182			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26699128	gold, Green Published			2022-12-26	WOS:000367092600005
J	Marzbanrad, F; Kimura, Y; Palaniswami, M; Khandoker, AH				Marzbanrad, Faezeh; Kimura, Yoshitaka; Palaniswami, Marimuthu; Khandoker, Ahsan H.			Quantifying the Interactions between Maternal and Fetal Heart Rates by Transfer Entropy	PLOS ONE			English	Article							PHASE SYNCHRONIZATION; BEHAVIORAL STATES; NORMAL-PREGNANCY; RATE-VARIABILITY; RESPONSES; ELECTROCARDIOGRAM; STIMULATION; EXTRACTION; MATURATION; GESTATION	Evidence of the short term relationship between maternal and fetal heart rates has been found in previous studies. However there is still limited knowledge about underlying mechanisms and patterns of the coupling throughout gestation. In this study, Transfer Entropy (TE) was used to quantify directed interactions between maternal and fetal heart rates at various time delays and gestational ages. Experimental results using maternal and fetal electrocardiograms showed significant coupling for 63 out of 65 fetuses, by statistically validating against surrogate pairs. Analysis of TE showed a decrease in transfer of information from fetus to the mother with gestational age, alongside the maturation of the fetus. On the other hand, maternal to fetal TE was significantly greater in mid (26-31 weeks) and late (32-41 weeks) gestation compared to early (16-25 weeks) gestation (Mann Whitney Wilcoxon (MWW) p<0.05). TE further increased from mid to late, for the fetuses with RMSSD of fetal heart rate being larger than 4 msec in the late gestation. This difference was not observed for the fetuses with smaller RMSSD, which could be associated with the quiet sleep state. Delay in the information transfer from mother to fetus significantly decreased (p = 0.03) from mid to late gestation, implying a decrease in fetal response time. These changes occur concomitant with the maturation of the fetal sensory and autonomic nervous systems with advancing gestational age. The effect of maternal respiratory rate derived from maternal ECG was also investigated and no significant relationship was found between breathing rate and TE at any lag. In conclusion, the application of TE with delays revealed detailed information on the fetal-maternal heart rate coupling strength and latency throughout gestation, which could provide novel clinical markers of fetal development and well-being.	[Marzbanrad, Faezeh; Palaniswami, Marimuthu; Khandoker, Ahsan H.] Univ Melbourne, Elect & Elect Engn Dept, Melbourne, Vic 3010, Australia; [Kimura, Yoshitaka] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan; [Khandoker, Ahsan H.] Khalifa Univ Sci Technol & Res, Dept Biomed Engn, Abu Dhabi, U Arab Emirates	University of Melbourne; Tohoku University; Khalifa University of Science & Technology	Khandoker, AH (corresponding author), Univ Melbourne, Elect & Elect Engn Dept, Melbourne, Vic 3010, Australia.	ahsan.khandoker@kustar.ac.ae	Khandoker, Ahsan Habib/B-3754-2013; Marzbanrad, Faezeh/O-9998-2017; Palaniswami, Marimuthu/AAE-2179-2022	Khandoker, Ahsan Habib/0000-0002-0636-1646; Marzbanrad, Faezeh/0000-0003-0551-1611; 	Australian Research Council	Australian Research Council(Australian Research Council)	This work was supported by Australian Research Council.	Behar J, 2013, COMPUT CARDIOL CONF, V40, P297, DOI 10.1049/iet-tv.41.18108; Copper RL, 1996, AM J OBSTET GYNECOL, V175, P1286, DOI 10.1016/S0002-9378(96)70042-X; Cysarz D, 2008, ANN BIOMED ENG, V36, P2085, DOI 10.1007/s10439-008-9580-2; DiPietro JA, 2008, BIOL PSYCHOL, V77, P11, DOI 10.1016/j.biopsycho.2007.08.008; Faes L, 2015, PHYSIOL MEAS, V36, P683, DOI 10.1088/0967-3334/36/4/683; Faes L, 2014, LAG SPECIFIC TRANSFE; Ivanov PC, 2009, P NATL ACAD SCI USA, V106, P13641, DOI 10.1073/pnas.0906987106; Jezewski J, 2003, PROCEEDINGS SEVENTH, V2, P9; Jezewski J, 2012, BIOMED ENG-BIOMED TE, V57, P383, DOI 10.1515/bmt-2011-0130; Kimura Y., 2012, OPEN MED DEVICES J, V4, P7, DOI [10.2174/1875181401204010007, DOI 10.2174/1875181401204010007]; Kisilevsky BS, 2011, DEVELOPMENTAL SCI, V14, P214, DOI 10.1111/j.1467-7687.2010.00970.x; KISILEVSKY BS, 1992, CHILD DEV, V63, P1497; Lange S, 2009, EARLY HUM DEV, V85, P131, DOI 10.1016/j.earlhumdev.2008.07.004; Lecanuet JP, 2002, DEV PSYCHOBIOL, V40, P57, DOI 10.1002/dev.10013; Lee J, 2012, BIOMED ENG ONLINE, V11, DOI 10.1186/1475-925X-11-19; Leontitsis A, 2002, CHAOTIC SYSTEMS TOOL; Lunshof S, 1998, AM J OBSTET GYNECOL, V178, P247, DOI 10.1016/S0002-9378(98)80008-2; Marzbanrad F, 2015, IEEE ENG MED BIO, P7865, DOI 10.1109/EMBC.2015.7320215; Monk C, 2000, DEV PSYCHOBIOL, V36, P67, DOI 10.1002/(SICI)1098-2302(200001)36:1<67::AID-DEV7>3.3.CO;2-3; Montalto A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109462; NIJHUIS JG, 1982, EARLY HUM DEV, V6, P177, DOI 10.1016/0378-3782(82)90106-2; PAN J, 1985, IEEE T BIO-MED ENG, V32, P230, DOI 10.1109/TBME.1985.325532; PAPP JG, 1988, BASIC RES CARDIOL, V83, P2, DOI 10.1007/BF01907099; PILLAI M, 1990, OBSTET GYNECOL, V76, P812, DOI 10.1097/00006250-199011000-00017; Porta A, 1998, BIOL CYBERN, V78, P71, DOI 10.1007/s004220050414; Porta A, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00071; Riedl M, 2009, PHILOS T R SOC A, V367, P1407, DOI 10.1098/rsta.2008.0277; Sameni Reza, 2010, Open Pacing Electrophysiol Ther J, V3, P4; Sato M, 2007, IEEE T BIO-MED ENG, V54, P49, DOI 10.1109/TBME.2006.883791; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Schreiber T, 1996, PHYS REV LETT, V77, P635, DOI 10.1103/PhysRevLett.77.635; Suykens J. A, 2002, LEAST SQUARES SUPPOR, V4; Van Leeuwen P, 2009, P NATL ACAD SCI USA, V106, P13661, DOI 10.1073/pnas.0901049106; Van Leeuwen P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106036; Van Leeuwen Peter, 2003, BMC Physiol, V3, P2, DOI 10.1186/1472-6793-3-2; Van Leeuwen P, 2010, IFMBE PROC, V28, P262; Vicente R, 2011, J COMPUT NEUROSCI, V30, P45, DOI 10.1007/s10827-010-0262-3; Wang QQ, 2013, IEEE ENG MED BIO, P3821, DOI 10.1109/EMBC.2013.6610377; Wibral M, 2011, PROG BIOPHYS MOL BIO, V105, P80, DOI 10.1016/j.pbiomolbio.2010.11.006; Widjaja D, 2012, IEEE T BIO-MED ENG, V59, P1169, DOI 10.1109/TBME.2012.2186448	40	23	23	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145672	10.1371/journal.pone.0145672	http://dx.doi.org/10.1371/journal.pone.0145672			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26701122	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092600116
J	Saino, H; Sugiyabu, T; Ueno, G; Yamamoto, M; Ishii, Y; Miyano, M				Saino, Hiromichi; Sugiyabu, Tomohiro; Ueno, Go; Yamamoto, Masaki; Ishii, Yoshikazu; Miyano, Masashi			Crystal Structure of OXA-58 with the Substrate-Binding Cleft in a Closed State: Insights into the Mobility and Stability of the OXA-58 Structure	PLOS ONE			English	Article							D BETA-LACTAMASE; CLASS-A; CRYSTALLOGRAPHIC STRUCTURE; CARBAPENEMASE OXA-24; OMEGA-LOOP; SPECIFICITY; MECHANISM; AVIBACTAM; INHIBITION; REFINEMENT	OXA-58 is a class D beta-lactamase from the multi-drug resistant Acinetobacter baumannii. We determined the crystal structure of OXA-58 in a novel crystal, and revealed the structure of the substrate-binding cleft in a closed state, distinct from a previously reported OXA-58 crystal structure with the binding cleft in an open state. In the closed state, the movement of three loops (alpha 3-alpha 4, beta 6-beta 7, and beta 8-alpha 10) forms an arch-like architecture over the binding cleft through interaction between the Phe113 residues of alpha 3-alpha 4 and Met225 of beta 6-beta 7. This structure suggests the involvement of these flexible loops in OXA-58 substrate binding. In contrast to the mobile loops, the Omega-loop appeared static, including the conserved loop residues and their hydrogen bonds; the pivotal residue Trp169 within the Omega-loop, zeta-carbamic acid of the modified base catalyst residue Lys86, and nucleophilic residue Ser83. The stability of OXA-58 was enhanced concomitant with an increase in the hydrolytic activity catalyzed by NaHCO3-dependent zeta-carbamic acid formation, with an EC50 of 0.34 mM. The W169A mutant enzyme was significantly thermally unstable even in the presence of 100 mM NaHCO3, whereas the S83A mutant was stabilized with NaHCO3-dependent activation. The zeta-carbamic acid was shown to increase not only OXA-58 hydrolytic activity but also OXA-58 stability through the formation of a hydrogen bond network connected to the Omega-loop with Ser83 and Trp169. Thus, the static Omega-loop is important for OXA-58 stability, whereas the mobile loops of the substrate-binding cleft form the basis for accommodation of the various substituents of beta-lactam backbone.	[Saino, Hiromichi; Sugiyabu, Tomohiro; Miyano, Masashi] Aoyama Gakuin Univ, Coll Sci & Engn, Dept Chem & Biol Sci, Sagamihara, Kanagawa, Japan; [Ueno, Go; Yamamoto, Masaki] RIKEN, SPring Ctr 8, Adv Photon Technol Div, Sayo, Hyogo, Japan; [Ishii, Yoshikazu] Toho Univ, Fac Med, Dept Microbiol & Infect Dis, Tokyo, Japan	Aoyama Gakuin University; RIKEN; Toho University	Saino, H (corresponding author), Aoyama Gakuin Univ, Coll Sci & Engn, Dept Chem & Biol Sci, Sagamihara, Kanagawa, Japan.	saino@chem.aoyama.ac.jp	Yamamoto, Masaki/B-7844-2015; Miyano, Masashi/R-2785-2016	Yamamoto, Masaki/0000-0002-1311-1768; Miyano, Masashi/0000-0003-2253-6175	Japan Society for the Promotion of Science KAKENHI [15K21356]; Ministry of Education, Culture, Sports, Science and Technology Supported Program for the Strategic Research Foundation at Private Universities [S1311005]; Grants-in-Aid for Scientific Research [25461524] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology Supported Program for the Strategic Research Foundation at Private Universities; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	HS received a grant from Japan Society for the Promotion of Science KAKENHI, Grant-in-Aid for Young Scientists (B) 15K21356, which had roles in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funder's website: https://www.jsps.go.jp/english/index.html. MM received a grant from Ministry of Education, Culture, Sports, Science and Technology Supported Program for the Strategic Research Foundation at Private Universities (2013-2017) S1311005, which had roles in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funder's website: http://www.mext.go.jp/english/.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2013, ACTA CRYSTALLOGR D, V69, P625, DOI 10.1107/S0907444913000462; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Afonine PV, 2009, J APPL CRYSTALLOGR, V42, P607, DOI 10.1107/S0021889809023528; [Anonymous], 2014, PYM MOL GRAPH SYST V; Antunes NT, 2014, ANTIMICROB AGENTS CH, V58, P2119, DOI 10.1128/AAC.02522-13; Banerjee S, 1998, BIOCHEMISTRY-US, V37, P3286, DOI 10.1021/bi972127f; Baurin S, 2009, BIOCHEMISTRY-US, V48, P11252, DOI 10.1021/bi901548c; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; Buchman JS, 2012, BIOCHEMISTRY-US, V51, P3143, DOI 10.1021/bi201896k; DeLano W. L, 2002, CCP4 NEWSLETTER PROT, P40; Docquier JD, 2010, ANTIMICROB AGENTS CH, V54, P2167, DOI 10.1128/AAC.01517-09; Docquier JD, 2009, CHEM BIOL, V16, P540, DOI 10.1016/j.chembiol.2009.04.010; Ehmann DE, 2013, J BIOL CHEM, V288, P27960, DOI 10.1074/jbc.M113.485979; Ehmann DE, 2012, P NATL ACAD SCI USA, V109, P11663, DOI 10.1073/pnas.1205073109; El Garch F, 2011, ANTIMICROB AGENTS CH, V55, P4828, DOI 10.1128/AAC.00522-11; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Golemi D, 2001, P NATL ACAD SCI USA, V98, P14280, DOI 10.1073/pnas.241442898; Higgins PG, 2010, J ANTIMICROB CHEMOTH, V65, P233, DOI 10.1093/jac/dkp428; Ibuka AS, 2003, BIOCHEMISTRY-US, V42, P10634, DOI 10.1021/bi0342822; June CM, 2014, ANTIMICROB AGENTS CH, V58, P333, DOI 10.1128/AAC.01483-13; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nitanai Y, 2010, BBA-PROTEINS PROTEOM, V1804, P684, DOI 10.1016/j.bbapap.2009.10.023; Nukaga M, 1998, BIOCHEMISTRY-US, V37, P10461, DOI 10.1021/bi980184i; Okazaki N, 2008, J SYNCHROTRON RADIAT, V15, P288, DOI 10.1107/S0909049507064679; Paetzel M, 2000, NAT STRUCT BIOL, V7, P918; Poirel L, 2005, ANTIMICROB AGENTS CH, V49, P202, DOI 10.1128/AAC.49.1.202-208.2005; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Santillana E, 2007, P NATL ACAD SCI USA, V104, P5354, DOI 10.1073/pnas.0607557104; Schneider KD, 2011, J MOL BIOL, V406, P583, DOI 10.1016/j.jmb.2010.12.042; Shimamura T, 2002, J BIOL CHEM, V277, P46601, DOI 10.1074/jbc.M207884200; Smith CA, 2014, ANTIMICROB AGENTS CH, V58, P2135, DOI 10.1128/AAC.01983-13; Smith CA, 2013, CHEM BIOL, V20, P1107, DOI 10.1016/j.chembiol.2013.07.015; Sun T, 2003, PROTEIN SCI, V12, P82, DOI 10.1110/ps.0224303; Thomas VL, 2010, J MOL BIOL, V396, P47, DOI 10.1016/j.jmb.2009.11.005; Thomas W, 2015, GNUPLOT 5 0 INTERACT; Verma V, 2011, J BIOL CHEM, V286, P37292, DOI 10.1074/jbc.M111.280115; Walsh TR, 2010, INT J ANTIMICROB AG, V36, pS8, DOI 10.1016/S0924-8579(10)70004-2; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Yoshizumi A, 2015, J INFECT CHEMOTHER, V21, P148, DOI 10.1016/j.jiac.2014.08.028	42	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145869	10.1371/journal.pone.0145869	http://dx.doi.org/10.1371/journal.pone.0145869			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26701320	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092600137
J	Tin, STW; Iro, G; Gadabu, E; Colagiuri, R				Tin, Si Thu Win; Iro, George; Gadabu, Eva; Colagiuri, Ruth			Counting the Cost of Diabetes in the Solomon Islands and Nauru	PLOS ONE			English	Article							CARE; PREVALENCE; PEOPLE; BURDEN	Aim To determine the costs associated with diabetes to governments, people with diabetes and their carers, and its impact on quality of life in two Pacific Island countries-the Solomon Islands and Nauru. Materials and Methods This cross-sectional cost of illness study was conducted on 330 people with type 2 diabetes (197 from the Solomon Islands and 133 from Nauru) using a structured cost of illness survey questionnaire adapted from the Australian DiabCo$t study. Quality of life was measured by the EQ-5D Visual Analogue Scale. Results There were 330 respondents (50% female; mean duration of diabetes 10.9 years; mean age 52.6 years). The estimated annual national cost of diabetes incurred by the Solomon Islands government was AUD12.8 million (AUD281 per person/year) and by Nauru government was AUD1.2 million (AUD747 per person/year). The major contribution to the government costs was inpatient services cost (71% in the Solomon Islands and 83% in Nauru). Annual expenditure for diabetes was approximately 20% of the governments' annual health care expenditure. Considerable absenteeism and retirement from work due to diabetes was found. Conclusions This study found substantial public and personal costs associated with diabetes. The findings provide objective data on which health policy, funding and planning decisions about the prevention and control of diabetes in the Solomon Islands and Nauru can be reliably based and subsequently evaluated.	[Tin, Si Thu Win] Univ Sydney, Boden Inst Obes Nutr Exercise & Eating Disorders, Sydney, NSW 2006, Australia; [Iro, George] Minist Hlth & Med Serv, Natl Diabet Ctr, Honiara, Solomon Islands; [Gadabu, Eva] Minist Hlth & Med Serv, Natl Diabet Ctr, Yaren, Nauru; [Tin, Si Thu Win; Colagiuri, Ruth] Univ Sydney, Menzies Ctr Hlth Policy, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Tin, STW (corresponding author), Univ Sydney, Boden Inst Obes Nutr Exercise & Eating Disorders, Sydney, NSW 2006, Australia.	si.wintin@sydney.edu.au			World Diabetes Foundation; Solomon Islands MHMS; Nauru MHMS; International Centre for Eyecare Education at the University of New South Wales and the Australia; New Zealand Society of Nephrologists	World Diabetes Foundation; Solomon Islands MHMS; Nauru MHMS; International Centre for Eyecare Education at the University of New South Wales and the Australia; New Zealand Society of Nephrologists	This study was conducted as part of a broader diabetes capacity building project in the Solomon Islands and Nauru funded by the World Diabetes Foundation (http://www.worlddiabetesfoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was conducted as part of a broader World Diabetes Foundation funded project in partnership with the Solomon Islands MHMS, Nauru MHMS, the International Centre for Eyecare Education at the University of New South Wales and the Australia and New Zealand Society of Nephrologists.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; [Anonymous], 2009, REP 2009 POP HOUS CE; [Anonymous], 2011, DIAB ATL; [Anonymous], 2011, SOL ISL GOV 2011 201; [Anonymous], 2011, NAT REP POP HOUS REP; [Anonymous], 2013, SOL ISL BUDG BUDG ST; [Anonymous], EUROQOL EQ 5D US GUI; Barcelo A, 2003, B WORLD HEALTH ORGAN, V81, P19; Bruno G, 2008, DIABETOLOGIA, V51, P795, DOI 10.1007/s00125-008-0957-4; Central Intelligence Agency, WORLD FACTBOOK; Clarke P, 2006, J DIABETES COMPLICAT, V20, P349, DOI 10.1016/j.jdiacomp.2005.08.004; Colagiuri R, 2006, PRACT DIAB INT, V23, P343; Colagiuri SCR, 2003, DIABCOST AUSTR ASSES; COLLINS VR, 1995, DIABETES CARE, V18, P1140, DOI 10.2337/diacare.18.8.1140; Dall TM, 2010, HEALTH AFFAIR, V29, DOI 10.1377/hlthaff.2009.0155; Doran C, 2003, EC ASS INP NCD COSTS; Falconer DG, 2010, DIABETES RES CLIN PR, V87, P92, DOI 10.1016/j.diabres.2009.09.022; Fu AZ, 2009, DIABETES CARE, V32, P2187, DOI 10.2337/dc09-1128; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; *INT DIAB FED, 2006, DIAB ATL; International diabetes federation, 2010, CALL ACT DIAB; International Diabetes Federation IDF, 2013, DIAB ATL; Javanbakht M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026864; Jonsson B, 2002, DIABETOLOGIA, V45, pS5, DOI 10.1007/s00125-002-0858-x; Khowaja LA, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-189; Koster I, 2006, DIABETOLOGIA, V49, P1498, DOI 10.1007/s00125-006-0277-5; Lee CMY, 2013, DIABETES RES CLIN PR, V99, P385, DOI 10.1016/j.diabres.2012.12.002; McBrien KA, 2013, DIABETES CARE, V36, P1172, DOI 10.2337/dc12-0862; Ministry of Health and Medical Services, 2010, STRAT PLAN REP NAUR; Petersen M, 2008, DIABETES CARE, V31, P1271, DOI 10.2337/dc08-9017; Shemilt I, 2010, EVID POLICY, V6, P51, DOI 10.1332/174426410X482999; Tin STW, 2014, DIABETES RES CLIN PR, V103, P114, DOI 10.1016/j.diabres.2013.09.017; Tin STW, 2013, DIABETES RES CLIN PR, V100, P230, DOI 10.1016/j.diabres.2013.03.012; *WHO, 2005, PREV CHR DIS VIT INV; World Bank, 2014, SKILLS SOL ISL OP NE; Yang WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039513; Zhang P, 2010, DIABETES RES CLIN PR, V87, P293, DOI 10.1016/j.diabres.2010.01.026	37	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145603	10.1371/journal.pone.0145603	http://dx.doi.org/10.1371/journal.pone.0145603			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26698575	Green Published, gold, Green Submitted			2022-12-26	WOS:000367092600103
J	Zhang, T; Li, SY; Sun, XY; Zhang, Y; Gong, XQ; Fu, Y; Jia, LM				Zhang, Tao; Li, Suyan; Sun, Xiangyang; Zhang, Yang; Gong, Xiaoqiang; Fu, Ying; Jia, Liming			The Earthworm Eisenia fetida Can Help Desalinate a Coastal Saline Soil in Tianjin, North China	PLOS ONE			English	Article							PLANT; RESTORATION	A laboratory microcosm experiment was conducted to determine whether the earthworm Eisenia fetida could survive in a saline soil from a field site in North China, and an experiment using response surface methodology was conducted at that field site to quantify the effects of E. fetida and green waste compost (GWC) on the salt content of the soil. The microcosm results showed that E. fetida survived in GWC-amended saline soil and increased the contents of humic acid, available N, and available P in the GWC-amended soil. The data from the field experiment were described by the following second-order model: y = -1.76+0.091x(1)+0: 48x(2)-0.00083x(1)x(2)-0.00078x(1)(2)-0.022x(2)(2), where y is the decrease in soil salinity (g of salt per kg of dry soil) relative to the untreated control, x(1) is the number of E. fetida added per m(2), and x(2) is the quantity of GWC added in kg per m(2). The model predicted that the total salt content of the saline soil would decrease by >2 g kg(-1) (p<0.05) when 29-90 individuals m(-2) of E. fetida and 6.1-15.0 kg m(-2) of GWC were applied. We conclude that the use of E. fetida for soil desalination is promising and warrants additional investigation.	[Zhang, Tao; Li, Suyan; Sun, Xiangyang; Zhang, Yang; Gong, Xiaoqiang] Beijing Forestry Univ, Coll Forestry, Beijing, Peoples R China; [Fu, Ying] Shandong ShengWei Gardening Technol Co Ltd, Weifang, Shandong, Peoples R China; [Jia, Liming] Tianjin JiaLiMing Biol Technol Co Ltd, Tianjin, Peoples R China	Beijing Forestry University	Li, SY (corresponding author), Beijing Forestry Univ, Coll Forestry, Beijing, Peoples R China.	lisuyan@bjfu.edu.cn			Special Fund for Forest Scientific Research in the Public Welfare "Development and Application of Technology of Converting Forestry Waste into Growing Media" [201504205]; Graduate Training and Development Program of Beijing Municipal Commission of Education "Application of Earthworms and Green Waste Compost in Saline Soil Amelioration of Beijing-Tianjin-Hebei Coastal Area" [BLCXY201604]; Shandong ShengWei Gardening Technology Co., Ltd.; Tianjin JiaLiMing Biological Technology Co., Ltd.	Special Fund for Forest Scientific Research in the Public Welfare "Development and Application of Technology of Converting Forestry Waste into Growing Media"; Graduate Training and Development Program of Beijing Municipal Commission of Education "Application of Earthworms and Green Waste Compost in Saline Soil Amelioration of Beijing-Tianjin-Hebei Coastal Area"; Shandong ShengWei Gardening Technology Co., Ltd.; Tianjin JiaLiMing Biological Technology Co., Ltd.	This research was supported by the Special Fund for Forest Scientific Research in the Public Welfare "Development and Application of Technology of Converting Forestry Waste into Growing Media" (201504205), and the Graduate Training and Development Program of Beijing Municipal Commission of Education "Application of Earthworms and Green Waste Compost in Saline Soil Amelioration of Beijing-Tianjin-Hebei Coastal Area" (BLCXY201604). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Shandong ShengWei Gardening Technology Co., Ltd. and Tianjin JiaLiMing Biological Technology Co., Ltd. provided support in the form of salaries for authors [YF] [LJ], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bao S.D, 2000, SOIL AGRO CHEM ANAL, P49; BROWN GG, 1995, PLANT SOIL, V170, P209, DOI 10.1007/BF02183068; [仓龙 Cang Long], 2002, [农村生态环境, Rural Eco-Environment], V18, P38; Cortez J, 2000, BIOL FERT SOILS, V30, P318, DOI 10.1007/s003740050010; Daniel Voss, 1999, DESIGN ANAL EXPT; Frund HC, 2010, PEDOBIOLOGIA, V53, P119, DOI 10.1016/j.pedobi.2009.07.002; Guo JS, 1981, CHINESE J ZOOLOGY, P47; Holdsworth AR, 2007, CONSERV BIOL, V21, P997, DOI 10.1111/j.1523-1739.2007.00740.x; Huang Jian, 2006, Zhongguo Nongye Daxue Xuebao, V11, P9; Huang ZH, 1995, FORESTRY EXPT DESIGN; Institute of soil science, 1978, SOIL PHYS CHEM AN; Kursakova VS, 2006, EURASIAN SOIL SCI+, V39, P748, DOI 10.1134/S1064229306070088; Le Bayon RC, 2006, SOIL BIOL BIOCHEM, V38, P235, DOI 10.1016/j.soilbio.2005.05.013; [李素艳 Li Suyan], 2014, [应用基础与工程科学学报, Journal of Basic Science and Engineering], V22, P1069; Liu MS, 2005, EARTHWORM CULTIVATIO; Lowe CN, 2005, PEDOBIOLOGIA, V49, P401, DOI 10.1016/j.pedobi.2005.04.005; Lu R.K., 2000, METHOD SOIL AGR CHEM; Mao S., 2012, EXPT DESIGN, V2; Pan HP, FARMING PROCESSING M; [庞军柱 PANG Jun-Zhu], 2009, [生态学报, Acta Ecologica Sinica], V29, P1017; Qin P, 2002, AGROECOLOGICAL PROJE; Roca-Perez L, 2009, CHEMOSPHERE, V75, P781, DOI 10.1016/j.chemosphere.2008.12.058; Singh K, 2012, CATENA, V96, P57, DOI 10.1016/j.catena.2012.04.007; Singh K, 2012, ECOL ENG, V43, P70, DOI 10.1016/j.ecoleng.2012.02.029; Snyder BA, 2008, RESTOR ECOL, V16, P629, DOI 10.1111/j.1526-100X.2008.00484.x; Sun X.Y., 2004, SOIL SCI; Sun ZJ, 2004, EARTHWORM REACTOR WA; [陶军 TAO Jun], 2010, [资源科学, Resources Science], V32, P466; van der Werff P.A., 1995, Acta Zoologica Fennica, V196, P41; [王琳琳 Wang Linlin], 2015, [生态学报, Acta Ecologica Sinica], V35, P1388; Wang LS, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0084485, 10.1371/journal.pone.0109465, 10.1371/journal.pone.0107044, 10.1371/journal.pone.0089185]; [王悦 Wang Yue], 2008, [环境污染与防治, Environmental Pollution & Control], V30, P28; Wolfarth Friederike, 2011, Mycotoxin Res, V27, P215, DOI 10.1007/s12550-011-0098-3; Wu WL, 2001, ACTA ECOLOGICA SINIC, V21, P1109; [伍玉鹏 Wu Yupeng], 2013, [中国农业大学学报, Journal of China Agricultural University], V18, P45; Wurst S, 2004, NEW PHYTOL, V163, P169, DOI 10.1111/j.1469-8137.2004.01106.x; Wurst S, 2003, OECOLOGIA, V137, P90, DOI 10.1007/s00442-003-1329-x; Xie CT, 1993, PRINCIPLES SOIL AMEL; Xu HG, 2004, HALOPHYTIC VEGETATIO; [徐玉坤 Xu Yukun], 2014, [土壤通报, Chinese Journal of Soil Science], V45, P1071; Zeng YM, 2010, J W CHINA FORESTRY S, V39, P50; Zeng YuMin, 2010, Journal of Northeast Forestry University, V38, P47; [翟鹏辉 Zhai Penghui], 2012, [中国水土保持科学, Science of Soil and Water Conservation], V10, P80; Zhang B G, 2000, ACTA ECOLOGICA SINIC, V20, P168; Zhang L, 2013, BIORESOURCE TECHNOL, V131, P68, DOI 10.1016/j.biortech.2012.10.059	45	6	9	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0144709	10.1371/journal.pone.0144709	http://dx.doi.org/10.1371/journal.pone.0144709			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26699869	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092600029
J	Lugnani, F; Zanconati, F; Marcuzzo, T; Bottin, C; Mikus, P; Guenther, E; Klein, N; Rubinsky, L; Stehling, MK; Rubinsky, B				Lugnani, Franco; Zanconati, Fabrizio; Marcuzzo, Thomas; Bottin, Cristina; Mikus, Paul; Guenther, Enric; Klein, Nina; Rubinsky, Liel; Stehling, Michael K.; Rubinsky, Boris			A Vivens Ex Vivo Study on the Synergistic Effect of Electrolysis and Freezing on the Cell Nucleus	PLOS ONE			English	Article							CRYOSURGERY; MECHANISMS; CANCER; TISSUE; TUMORS; LIVER	Freezing-cryosurgery, and electrolysis-electrochemical therapy (EChT), are two important minimally invasive surgery tissue ablation technologies. Despite major advantages they also have some disadvantages. Cryosurgery cannot induce cell death at high subzero freezing temperatures and requires multiple freeze thaw cycles, while EChT requires high concentrations of electrolytic products-which makes it a lengthy procedure. Based on the observation that freezing increases the concentration of solutes (including products of electrolysis) in the frozen region and permeabilizes the cell membrane to these products, this study examines the hypothesis that there could be a synergistic effect between freezing and electrolysis in their use together for tissue ablation. Using an animal model we refer to as vivens ex vivo, which may be of value in reducing the use of animals for experiments, combined with a Hematoxylin stain of the nucleus, we show that there are clinically relevant protocols in which the cell nucleus appears intact when electrolysis and freezing are used separately but is affected by certain combinations of electrolysis and freezing.	[Lugnani, Franco] Franco Lugnani MD, Trieste, Italy; [Zanconati, Fabrizio; Marcuzzo, Thomas; Bottin, Cristina] Univ Trieste, UCO Anat & Istol Patolog, Trieste, Italy; [Mikus, Paul; Guenther, Enric; Rubinsky, Liel; Stehling, Michael K.; Rubinsky, Boris] Inter Sci GmbH, Biophys, Luzern, Switzerland; [Guenther, Enric; Klein, Nina; Stehling, Michael K.] Inst Bildgebende Diagnost, R&D, Offenbach, Hessen, Germany	University of Trieste	Guenther, E (corresponding author), Inter Sci GmbH, Biophys, Luzern, Switzerland.	enric@interscience.ch		ZANCONATI, FABRIZIO/0000-0001-5357-9579				Amory R, 1886, TREATISE ELECT ITS T; Arnott J., 1851, TREATEMENT CANC REGU; Baust JG, 2014, CRYOBIOLOGY, V68, P1, DOI 10.1016/j.cryobiol.2013.11.001; Baust J. G., 1997, Cryobiology, V35, P322; Baust JG, 2005, BJU INT, V95, P1187, DOI 10.1111/j.1464-410X.2005.05502.x; Baust JG, 2009, CURR OPIN UROL, V19, P127, DOI 10.1097/MOU.0b013e328323f654; Fosh BG, 2002, BRIT J SURG, V89, P999, DOI 10.1046/j.1365-2168.2002.02134.x; Gage AA, 2009, CRYOBIOLOGY, V59, P229, DOI 10.1016/j.cryobiol.2009.10.001; Gage AA, 1998, CRYOBIOLOGY, V37, P171, DOI 10.1006/cryo.1998.2115; Gage AA, 2007, J AM COLL SURGEONS, V205, P342, DOI 10.1016/j.jamcollsurg.2007.03.007; GILBERT JC, 1984, IEEE T BIO-MED ENG, V31, P565; Hollister WR, 1998, MOL UROL, V2, P13; Mir LM, 2002, BRIT J CANCER, V86, P1658, DOI 10.1038/sj.bjc.6600306; Nilsson E, 2000, BIOELECTROCHEMISTRY, V51, P1, DOI 10.1016/S0302-4598(99)00073-2; NORDENSTROM B, 1978, IRCS (International Research Communications System) Medical Science Library Compendium, V6, P537; NORDENSTROM BEW, 1994, EUR J SURG S, V574, P93; ONIK G, 1984, CRYOBIOLOGY, V21, P321, DOI 10.1016/0011-2240(84)90327-4; Rubinsky B, 2000, ANNU REV BIOMED ENG, V2, P157, DOI 10.1146/annurev.bioeng.2.1.157; RUBINSKY B, 1988, PROC R SOC SER B-BIO, V234, P343, DOI 10.1098/rspb.1988.0053; RUBINSKY B, 1979, J HEAT TRANS-T ASME, V101, P326, DOI 10.1115/1.3450968; Russell WMS., 1959, MED J AUSTRALIA; Weaver JC, 1996, BIOELECTROCH BIOENER, V41, P135, DOI 10.1016/S0302-4598(96)05062-3	22	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145133	10.1371/journal.pone.0145133	http://dx.doi.org/10.1371/journal.pone.0145133			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26695185	gold, Green Published			2022-12-26	WOS:000367092500023
J	Romero, L; Jimenez, M; Espinosa, MD; Dominguez, M				Romero, Luis; Jimenez, Mariano; del Mar Espinosa, Maria; Dominguez, Manuel			New Design for Rapid Prototyping of Digital Master Casts for Multiple Dental Implant Restorations	PLOS ONE			English	Article							TECHNOLOGY; DENTISTRY	Aim This study proposes the replacement of all the physical devices used in the manufacturing of conventional prostheses through the use of digital tools, such as 3D scanners, CAD design software, 3D implants files, rapid prototyping machines or reverse engineering software, in order to develop laboratory work models from which to finish coatings for dental prostheses. Different types of dental prosthetic structures are used, which were adjusted by a non-rotatory threaded fixing system. Method From a digital process, the relative positions of dental implants, soft tissue and adjacent teeth of edentulous or partially edentulous patients has been captured, and a maser working model which accurately replicates data relating to the patients oral cavity has been through treatment of three-dimensional digital data. Results Compared with the conventional master cast, the results show a significant cost savings in attachments, as well as an increase in the quality of reproduction and accuracy of the master cast, with the consequent reduction in the number of patient consultation visits. The combination of software and hardware three-dimensional tools allows the optimization of the planning of dental implant-supported rehabilitations protocol, improving the predictability of clinical treatments and the production cost savings of master casts for restorations upon implants.	[Romero, Luis; del Mar Espinosa, Maria; Dominguez, Manuel] Natl Distance Educ Univ UNED, Dept Construct & Fabricat Engn, Madrid, Spain; [Jimenez, Mariano] Comillas Univ, Dept Mech Engn, Tech Sch Engn ICAI, Madrid, Spain	Universidad Nacional de Educacion a Distancia (UNED); Comillas Pontifical University	Romero, L (corresponding author), Natl Distance Educ Univ UNED, Dept Construct & Fabricat Engn, Madrid, Spain.	lromero@ind.uned.es	Somonte, Manuel Domínguez/P-2514-2015; Espinosa, María del Mar/ABF-5928-2021; Romero, Luis/D-7850-2016; Domínguez, Manuel/AAE-4412-2022; del Mar Espinosa, Maria/I-1363-2016	Somonte, Manuel Domínguez/0000-0003-1037-0542; Espinosa, María del Mar/0000-0002-2812-7041; Romero, Luis/0000-0002-8597-3084; Domínguez, Manuel/0000-0003-1037-0542; del Mar Espinosa, Maria/0000-0002-2812-7041	Industrial Engineering School of UNED [2016-ICF06]	Industrial Engineering School of UNED	The work presented was carried out within the cooperation agreement established between the following entities: Universidad Nacional de Educacion a Distancia (UNED), Pontifical University Comillas of Madrid and IDITEC NORTH WEST S.L. The manuscript has been copyedited for language usage, spelling, and grammar by "Traducciones TRIDIOM". Thanks to the Industrial Engineering School of UNED for the support that they provided with the Project '2016-ICF06'.	ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776; Azari A, 2009, RAPID PROTOTYPING J, V15, P216, DOI 10.1108/13552540910961946; Bibb R, 2006, RAPID PROTOTYPING J, V12, P95, DOI 10.1108/13552540610652438; Bjorn TD, 2012, LABOR DENT, V15, P197; Chang CC, 2006, INT J ADV MANUF TECH, V31, P41, DOI 10.1007/s00170-005-0181-z; Goshtasby AA, 1997, IEEE T MED IMAGING, V16; Gutierrez ME, 2010, APLICACION ARTICULAD; Jimenez M, 2015, RAPID PROTOTYPING J, V21, P56, DOI 10.1108/RPJ-11-2012-0101; Kuhmstedt P, 2007, SPIE P, V6762; Liu QB, 2006, INT J ADV MANUF TECH, V29, P317, DOI 10.1007/s00170-005-2523-2; Mayordomo C., 2013, UTILIZACION RESTAURA; Pedrola F., 2008, IMPLANTOLOGIA ORAL A; Penarrocha M, 2001, IMPLANTOLOGIA ORAL; Petzold R, 1999, COMPUT MED IMAG GRAP, V23, P277, DOI 10.1016/S0895-6111(99)00025-7; Rosati R, 2010, AM J ORTHOD DENTOFAC, V138, P84, DOI 10.1016/j.ajodo.2009.10.035; Sanchez H, 2007, REV FACULTAD ODONTOL, V19, P49; Sinescu C, 2008, LASERS DENT; Sutter F, 1993, INT J PERIODONTICS R, V13, P409; Velasco Ortega E, 2008, REV ESP ODONTOESTOMA, V16, P211; Velasco Ortega E, 2011, AV PERIODONC IMPLANT, V23, P11; Wirz J, 1998, QUITESSENCE, V11, P112	21	7	8	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145253	10.1371/journal.pone.0145253	http://dx.doi.org/10.1371/journal.pone.0145253			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26696528	gold, Green Published, Green Submitted			2022-12-26	WOS:000367092500031
J	Masuzaki, R; Zhao, S; Valerius, MT; Tsugawa, D; Oya, Y; Ray, KC; Karp, SJ				Masuzaki, Ryota; Zhao, Sophia; Valerius, M. Todd; Tsugawa, Daisuke; Oya, Yuki; Ray, Kevin C.; Karp, Seth J.			SOCS2 Balances Metabolic and Restorative Requirements during Liver Regeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						growth hormone; insulin-like growth factor (IGF); liver injury; regeneration; ubiquitylation (ubiquitination); socs2	CYTOKINE SIGNALING-2; RAPID ACTIVATION; DNA-SYNTHESIS; GROWTH; MICE; SUPPRESSOR; HEPATECTOMY; BLOOD; GH	After significant injury, the liver must maintain homeostasis during the regenerative process. We hypothesized the existence of mechanisms to limit hepatocyte proliferation after injury to maintain metabolic and synthetic function. A screen for candidates revealed suppressor of cytokine signaling 2 (SOCS2), an inhibitor of growth hormone (GH) signaling, was strongly induced after partial hepatectomy. Using genetic deletion and administration of various factors we investigated the role of SOCS2 during liver regeneration. SOCS2 preserves liver function by restraining the first round of hepatocyte proliferation after partial hepatectomy by preventing increases in growth hormone receptor (GHR) via ubiquitination, suppressing GH pathway activity. At later times, SOCS2 enhances hepatocyte proliferation by modulating a decrease in serum insulin-like growth factor 1 (IGF-1) that allows GH release from the pituitary. SOCS2, therefore, plays a dual role in modulating the rate of hepatocyte proliferation. In particular, this is the first demonstration of an endogenous mechanism to limit hepatocyte proliferation after injury.	[Masuzaki, Ryota; Tsugawa, Daisuke; Oya, Yuki; Ray, Kevin C.; Karp, Seth J.] Vanderbilt Univ, Dept Surg, Transplant Ctr, Med Ctr, Nashville, TN 37232 USA; [Zhao, Sophia] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Valerius, M. Todd] Harvard Univ, Brigham & Womens Hosp, Div Renal, Dept Med,Med Sch, Boston, MA 02115 USA; [Valerius, M. Todd] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Vanderbilt University; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University	Karp, SJ (corresponding author), Vanderbilt Univ, Med Ctr, Dept Surg, D-4313 Med Ctr North,1161 21st Ave South, Nashville, TN 37232 USA.	seth.karp@vanderbilt.edu	Valerius, M. Todd/AAK-3063-2020	Valerius, M. Todd/0000-0001-8143-9231	National Institutes of Health [7R01DK081387]; Vanderbilt University Medical Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081387, P30DK058404] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt University Medical Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant 7R01DK081387 (to S. J. K.) and Vanderbilt University Medical Center. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Brown-Borg HM, 2003, MECH AGEING DEV, V124, P1013, DOI 10.1016/j.mad.2003.07.001; BUCHER NLR, 1975, P NATL ACAD SCI USA, V72, P1157, DOI 10.1073/pnas.72.3.1157; CRESSMAN DE, 1995, HEPATOLOGY, V21, P1443, DOI 10.1016/0270-9139(95)90068-3; CRESSMAN DE, 1994, J BIOL CHEM, V269, P30429; Cui Y, 2007, HEPATOLOGY, V46, P504, DOI 10.1002/hep.21713; Do N, 2012, AM J PHYSIOL-GASTR L, V303, pG1220, DOI 10.1152/ajpgi.00105.2012; FEINGOLD KR, 1988, BIOCHEM BIOPH RES CO, V153, P576, DOI 10.1016/S0006-291X(88)81134-3; Greenhalgh CJ, 2002, MOL ENDOCRINOL, V16, P1394, DOI 10.1210/me.16.6.1394; Greenhalgh CJ, 2005, J CLIN INVEST, V115, P397, DOI 10.1172/JCI200522710; Ho KJ, 2010, J EXP MED, V207, P1197, DOI 10.1084/jem.20092434; Hu ZY, 2014, THERANOSTICS, V4, P215, DOI 10.7150/thno.7868; Huang WD, 2006, SCIENCE, V312, P233, DOI 10.1126/science.1121435; JONES DE, 1995, AM J PHYSIOL-GASTR L, V268, pG872, DOI 10.1152/ajpgi.1995.268.5.G872; Krebs DL, 2000, J CELL SCI, V113, P2813; Metcalf D, 2000, NATURE, V405, P1069, DOI 10.1038/35016611; Otu HH, 2007, J BIOL CHEM, V282, P11197, DOI 10.1074/jbc.M608441200; Pennisi PA, 2004, ENDOCRINOLOGY, V145, P4748, DOI 10.1210/en.2004-0655; Rico-Bautista E, 2005, MOL ENDOCRINOL, V19, P781, DOI 10.1210/me.2004-0040; Riehle KJ, 2008, J EXP MED, V205, P91, DOI 10.1084/jem.20070820; RUSSELL WE, 1988, J CELL PHYSIOL, V135, P253, DOI 10.1002/jcp.1041350212; Sakamoto T., HEPATOLOGY, V29, P403; Sjogren K, 1999, P NATL ACAD SCI USA, V96, P7088, DOI 10.1073/pnas.96.12.7088; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Vesterlund M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025358; Zellmer S, 2009, J ANAT, V215, P176, DOI 10.1111/j.1469-7580.2009.01085.x; Zerrad-Saadi A, 2011, ENDOCRINOLOGY, V152, P2731, DOI 10.1210/en.2010-1193	26	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3346	3358		10.1074/jbc.M115.703264	http://dx.doi.org/10.1074/jbc.M115.703264			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26703468	Green Published, hybrid			2022-12-26	WOS:000370854500019
J	Arcari, L; Cimino, S; De Luca, L; Francone, M; Galea, N; Reali, M; Carbone, I; Iacoboni, C; Agati, L				Arcari, Luca; Cimino, Sara; De Luca, Laura; Francone, Marco; Galea, Nicola; Reali, Manuela; Carbone, Iacopo; Iacoboni, Carlo; Agati, Luciano			Impact of Heart Rate on Myocardial Salvage in Timely Reperfused Patients with ST-Segment Elevation Myocardial Infarction: New Insights from Cardiovascular Magnetic Resonance	PLOS ONE			English	Article							PRIMARY CORONARY ANGIOPLASTY; MICROVASCULAR DAMAGE; DELAYED-ENHANCEMENT; ISCHEMIC MYOCARDIUM; DOUBLE-BLIND; BLOOD-FLOW; SIZE; RISK; IVABRADINE; AREA	Background Previous studies evaluating the progression of the necrotic wave in relation to heart rate were carried out only in animal models of ST-elevated myocardial infarction (STEMI). Aim of the study was to investigate changes of myocardial salvage in relation to different heart rates at hospital admission in timely reperfused patients with STEMI by using cardiovascular magnetic resonance (CMR). Methods One hundred-eighty-seven patients with STEMI successfully and timely treated with primary coronary angioplasty underwent CMR five days after hospital admission. According to the heart rate at presentation, patients were subcategorized into 5 quintiles: <55 bpm (group I, n = 44), 55-64 bpm (group II, n = 35), 65-74 bpm (group III, n = 35), 75-84 bpm (group IV, n = 37), >= 85 bpm (group V, n = 36). Area at risk, infarct size, microvascular obstruction (MVO) and myocardium salvaged index (MSI) were assessed by CMR using standard sequences. Results Lower heart rates at presentation were associated with a bigger amount of myocardial salvage after reperfusion. MSI progressively decreased as the heart rates increased (0.54 group I, 0.46 group II, 0.38 group III, 0.34 group IV, 0.32 group V, p<0.001). Stepwise multivariable analysis showed heart rate, peak troponin and the presence of MVO were independent predictor of myocardial salvage. No changes related to heart rate were observed in relation to area at risk and infarct size. Conclusions High heart rates registered before performing coronary angioplasty in timely reperfused patients with STEMI are associated with a reduction in salvaged myocardium. In particular, salvaged myocardium significantly reduced when heart rate at presentation is >= 85 bpm.	[Arcari, Luca; Cimino, Sara; De Luca, Laura; Reali, Manuela; Iacoboni, Carlo; Agati, Luciano] Univ Roma La Sapienza, Dept Cardiol, I-00185 Rome, Italy; [Francone, Marco; Galea, Nicola; Carbone, Iacopo] Univ Roma La Sapienza, Dept Radiol, I-00185 Rome, Italy	Sapienza University Rome; Sapienza University Rome	Agati, L (corresponding author), Univ Roma La Sapienza, Dept Cardiol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	luciano.agati@uniroma1.it	Agati, Luciano/AFQ-4559-2022; Galea, Nicola/AAQ-6612-2020; Francone, Marco/AAQ-5434-2020; Arcari, Luca/Y-6534-2019	Agati, Luciano/0000-0003-3186-1797; Galea, Nicola/0000-0003-4708-5120; Arcari, Luca/0000-0003-1410-6845; CIMINO, SARA/0000-0002-8948-4122; carbone, iacopo/0000-0003-3108-7527				Abdel-Aty H, 2004, CIRCULATION, V109, P2411, DOI 10.1161/01.CIR.0000127428.10985.C6; Abdel-Aty H, 2007, J MAGN RESON IMAGING, V26, P452, DOI 10.1002/jmri.21028; AGATI L, 1994, J AM COLL CARDIOL, V24, P336, DOI 10.1016/0735-1097(94)90285-2; Aletras AH, 2006, CIRCULATION, V113, P1865, DOI 10.1161/CIRCULATIONAHA.105.576025; Antoni ML, 2012, EUR HEART J, V33, P96, DOI 10.1093/eurheartj/ehr293; Berry C, 2010, CIRC-CARDIOVASC IMAG, V3, P527, DOI 10.1161/CIRCIMAGING.109.900761; Bondarenko O, 2005, J CARDIOV MAGN RESON, V7, P481, DOI 10.1081/JCMR-200053623; Botker HE, 2012, CARDIOVASC RES, V94, P266, DOI 10.1093/cvr/cvs081; Canali E, 2012, EUR HEART J-CARD IMG, V13, P948, DOI 10.1093/ehjci/jes087; Dymarkowski S, 2002, INVEST RADIOL, V37, P77, DOI 10.1097/00004424-200202000-00005; Eitel I, 2011, HEART, V97, P2038, DOI 10.1136/heartjnl-2011-300098; Eitel I, 2010, J AM COLL CARDIOL, V55, P2470, DOI 10.1016/j.jacc.2010.01.049; Fernandez-Jimenez R, 2015, J AM COLL CARDIOL, V65, P315, DOI 10.1016/j.jacc.2014.11.004; Fox K, 2008, LANCET, V372, P807, DOI 10.1016/S0140-6736(08)61170-8; Francone M, 2009, J AM COLL CARDIOL, V54, P2145, DOI 10.1016/j.jacc.2009.08.024; Friedrich MG, 2008, J AM COLL CARDIOL, V51, P1581, DOI 10.1016/j.jacc.2008.01.019; Galiuto L, 2008, J AM COLL CARDIOL, V51, P552, DOI 10.1016/j.jacc.2007.09.051; Gerber BL, 2007, EUR HEART J, V28, P1670, DOI 10.1093/eurheartj/ehm213; Heusch G, 2008, EUR HEART J, V29, P2265, DOI 10.1093/eurheartj/ehn337; KANNEL WB, 1987, AM HEART J, V113, P1489, DOI 10.1016/0002-8703(87)90666-1; Larsen JR, 2012, ACTA ANAESTH SCAND, V56, P57, DOI 10.1111/j.1399-6576.2011.02580.x; MAROKO PR, 1971, CIRCULATION, V43, P67, DOI 10.1161/01.CIR.43.1.67; Masci PG, 2013, EUR HEART J-CARD IMG, V14, P1041, DOI 10.1093/ehjci/jet063; Masci PG, 2011, EUR HEART J, V32, P1640, DOI 10.1093/eurheartj/ehr064; Masci PG, 2010, JACC-CARDIOVASC IMAG, V3, P45, DOI 10.1016/j.jcmg.2009.06.016; Ortiz-Perez JT, 2010, JACC-CARDIOVASC IMAG, V3, P491, DOI 10.1016/j.jcmg.2010.02.004; Parodi G, 2010, ATHEROSCLEROSIS, V211, P255, DOI 10.1016/j.atherosclerosis.2010.02.017; PRZYKLENK K, 1986, CARDIOVASC RES, V20, P403, DOI 10.1093/cvr/20.6.403; RASMUSSEN MM, 1977, CIRCULATION, V56, P794, DOI 10.1161/01.CIR.56.5.794; REIMER KA, 1977, CIRCULATION, V56, P786, DOI 10.1161/01.CIR.56.5.786; REIMER KA, 1985, CIRC RES, V56, P651, DOI 10.1161/01.RES.56.5.651; RENTROP KP, 1985, J AM COLL CARDIOL, V5, P587; Simonetti OP, 1996, RADIOLOGY, V199, P49, DOI 10.1148/radiology.199.1.8633172; Steg PG, 2013, EUR HEART J-ACUTE CA, V2, P270, DOI 10.1177/2048872613489305; Stork A, 2006, EUR RADIOL, V16, P2350, DOI 10.1007/s00330-006-0232-3; Swedberg K, 2010, LANCET, V376, P875, DOI 10.1016/S0140-6736(10)61198-1; Traupe T, 2013, HEART, V0, P1; Zuanetti G, 1998, EUR HEART J, V19, pF19	38	6	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145495	10.1371/journal.pone.0145495	http://dx.doi.org/10.1371/journal.pone.0145495			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716452	Green Published, gold, Green Submitted			2022-12-26	WOS:000367510500039
J	Chen, PC; Shih, CH; Chu, TJ; Wang, D; Lee, YC; Tzeng, TD				Chen, Po-Cheng; Shih, Chun-Han; Chu, Ta-Jen; Wang, Daryi; Lee, Ying-Chou; Tzeng, Tzong-Der			Population Structure and Historical Demography of the Oriental River Prawn (Macrobrachium nipponense) in Taiwan	PLOS ONE			English	Article							FRESH-WATER FISHES; MOLECULAR SYSTEMATICS; GENETIC-EVIDENCE; PHYLOGEOGRAPHY; DECAPODA; SEA; CRUSTACEA; PATTERNS; CARIDEA; MTDNA	The oriental river prawn (Macrobrachium nipponense) is a non-obligatory amphidromous prawn, and it has a wide distribution covering almost the entire Taiwan. Mitochondrial DNA fragment sequences of the cytochrome oxidase subunit I (COI) and 16S rRNA were combined and used to elucidate the population structure and historical demography of oriental river prawn in Taiwan. A total of 202 individuals from six reservoirs and three estuaries were separately collected. Nucleotide diversity (pi) of all populations was 0.01217, with values ranging from 0.00188 (Shihmen Reservoir, SMR, northern Taiwan) to 0.01425 (Mingte Reservoir, MTR, west-central Taiwan). All 76 haplotypes were divided into 2 lineages: lineage A included individuals from all sampling areas except SMR, and lineage B included specimens from all sampling locations except Chengching Lake Reservoir (CLR) and Liyu Lake Reservoir (LLR). All F-ST values among nine populations were significantly different except the one between Jhonggang River Estuary (JGE, west-central Taiwan) and Kaoping River Estuary (KPE, southern Taiwan). UPGMA tree of nine populations showed two main groups: the first group included the SMR and Tamsui River Estuary (TSE) (both located northern Taiwan), and the second one included the other seven populations (west-central, southern and eastern Taiwan). Demographic analyses implied a population expansion occurred during the recent history of the species. The dispersal route of this species might be from China to west-central and west-southern Taiwan, and then the part individuals belonging to lineage A and B dispersed southerly and northerly, respectively. And then part individuals in west-central Taiwan fell back to and stay at estuaries as the sea level rose about 18,000 years ago.	[Chen, Po-Cheng; Lee, Ying-Chou] Natl Taiwan Univ, Inst Fisheries Sci, Coll Life Sci, Taipei 106, Taiwan; [Shih, Chun-Han] Tungnan Univ, Dept Leisure Management, New Taipei 222, Taiwan; [Chu, Ta-Jen] Chung Hua Univ, Dept Leisure & Recreat Management, Hsinchu 300, Taiwan; [Wang, Daryi] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan; [Tzeng, Tzong-Der] Shu Te Univ, Dept Leisure Recreat & Tourism Management, Kaohsiung 824, Taiwan	National Taiwan University; Chung Hua University; Academia Sinica - Taiwan; Shu-Te University	Lee, YC (corresponding author), Natl Taiwan Univ, Inst Fisheries Sci, Coll Life Sci, Taipei 106, Taiwan.	i812@ntu.edu.tw; tdtzeng@stu.edu.tw	Francisco, Sara/K-8239-2013; Vieira, Natividade R/B-5683-2009; , 朱達仁/AGA-5114-2022	Francisco, Sara/0000-0003-0907-7453; Vieira, Natividade R/0000-0003-1297-6046; 	Ministry of Science and Technology [MOST 104-2611-M-366-001]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This study was supported by the Ministry of Science and Technology grant number MOST 104-2611-M-366-001. The funders had role in study design, data collection and analysis, and preparation of the manuscript.	Avise JC, 2000, PHYLOGEOGRAPHY HIST, P301; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bermingham E, 1998, MOL ECOL, V7, P499, DOI 10.1046/j.1365-294x.1998.00358.x; Bilton DT, 2001, ANNU REV ECOL SYST, V32, P159, DOI 10.1146/annurev.ecolsys.32.081501.114016; Cai YX, 2006, RAFFLES B ZOOL, V54, P245; Cai YX, 2002, HYDROBIOLOGIA, V487, P59, DOI 10.1023/A:1022991224381; Chen PC, 2015, LIMNOLOGICA, V52, P51, DOI 10.1016/j.limno.2015.03.002; Chen RT, 2009, J CRUSTACEAN BIOL, V29, P232, DOI 10.1651/08-3072.1; Chiang TY, 2010, J FISH BIOL, V76, P1173, DOI 10.1111/j.1095-8649.2010.02589.x; Chiang TY, 1999, MOL ECOL, V8, P1037, DOI 10.1046/j.1365-294x.1999.00668.x; CLARK JA, 1979, QUATERNARY RES, V11, P279, DOI 10.1016/0033-5894(79)90076-0; Crandall KA, 1996, SYST BIOL, V45, P1; CRANDALL KA, 1993, GENETICS, V134, P959; Craw D, 2007, GEOMORPHOLOGY, V84, P98, DOI 10.1016/j.geomorph.2006.07.008; Creer S, 2001, MOL ECOL, V10, P1967, DOI 10.1046/j.0962-1083.2001.01332.x; de Grave Sammy, 2006, Aquatic Invasions, V1, P204; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FAIRBANKS RG, 1989, NATURE, V342, P637, DOI 10.1038/342637a0; Fu YX, 1997, GENETICS, V147, P915; GASCOYNE M, 1979, SCIENCE, V205, P806, DOI 10.1126/science.205.4408.806; GOLDING GB, 1987, GENET RES, V49, P71, DOI 10.1017/S0016672300026768; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; HOELZEL AR, 1991, MOL BIOL EVOL, V8, P475; HUANG CY, 1995, TECTONICS, V14, P19, DOI 10.1029/94TC02452; Li TJ, 1986, DYNAMIC ANAL CONDITI, P81; Liao TY, 2008, ZOOL STUD, V47, P383; Liu CH, 1986, INVESTIGATION MULLET, P56; Liu J, 2003, J LAKE SCI, V15, P177; Liu MY, 2007, ZOOL STUD, V46, P272; Liu MY, 2011, HYDROBIOLOGIA, V671, P1, DOI 10.1007/s10750-011-0699-z; LUNDBERG JG, 1993, BIOLOGICAL RELATIONSHIPS BETWEEN AFRICA AND SOUTH AMERICA, P156; MASHIKO K, 1990, J CRUSTACEAN BIOL, V10, P306, DOI 10.2307/1548489; MASHIKO K, 1993, ZOOL SCI, V10, P161; Mashiko K, 2000, J CRUSTACEAN BIOL, V20, P118, DOI 10.1651/0278-0372(2000)020[0118:DOPWDS]2.0.CO;2; Mashiko K, 2008, J CRUSTACEAN BIOL, V28, P370, DOI 10.1651/0278-0372(2008)028[0370:DOFMAS]2.0.CO;2; Mirabdullaev IM, 2005, 2 INT S INV AL SPEC, P106; NEI M, 1987, MOL EVOLUTIONARY GEN, P1, DOI DOI 10.7312/NEI-92038; Ota H, 1998, RES POPUL ECOL, V40, P189, DOI 10.1007/BF02763404; PEPIN P, 1993, CAN J FISH AQUAT SCI, V50, P1924, DOI 10.1139/f93-215; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Salman Salman D., 2006, Aquatic Invasions, V1, P109, DOI 10.3391/ai.2006.1.3.2; Sambrook J, 2001, MOL CLONING LAB MANU, P66; Shih CH, 2011, CHINA OCEAN ENG, V25, P215, DOI 10.1007/s13344-011-0019-4; Shih HT, 2006, J BIOGEOGR, V33, P980, DOI 10.1111/j.1365-2699.2006.01472.x; Shy JY, 1987, J FISH SOC TAIWAN, V14, P14; Stanley HF, 1996, MOL BIOL EVOL, V13, P368, DOI 10.1093/oxfordjournals.molbev.a025596; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TZENG C-S, 1986, Journal of Taiwan Museum, V39, P127; Tzeng CS, 2006, ZOOL STUD, V45, P285; Wang HY, 1999, MOL ECOL, V8, P1879, DOI 10.1046/j.1365-294x.1999.00787.x; Wang JP, 2004, MOL PHYLOGENET EVOL, V31, P1143, DOI 10.1016/j.ympev.2003.10.001; Wang JP, 2000, MOL ECOL, V9, P1483, DOI 10.1046/j.1365-294x.2000.01023.x; Wang TY, 2007, ZOOL STUD, V46, P569; Wu B, 1982, TAIWAN STRAIT, V1, P1; Wu S.-C., 1990, Bulletin of Taiwan Fisheries Research Institute, P121; Xiao SB, 2004, J COASTAL RES, V20, P599, DOI 10.2112/1551-5036(2004)020[0599:THOTYR]2.0.CO;2; Yang Pin, 2007, Zoological Research, V28, P113; Yu H-P, 1972, OHMU, V3, P45; Yu HP, 1984, ACTA MARIMA AQUAC, V19, P117	64	9	10	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145927	10.1371/journal.pone.0145927	http://dx.doi.org/10.1371/journal.pone.0145927			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716687	Green Published, gold, Green Submitted			2022-12-26	WOS:000367510500096
J	Franco, A; Leekitcharoenphon, P; Feltrin, F; Alba, P; Cordaro, G; Iurescia, M; Tolli, R; D'Incau, M; Staffolani, M; Di Giannatale, E; Hendriksen, RS; Battisti, A				Franco, Alessia; Leekitcharoenphon, Pimlapas; Feltrin, Fabiola; Alba, Patricia; Cordaro, Gessica; Iurescia, Manuela; Tolli, Rita; D'Incau, Mario; Staffolani, Monica; Di Giannatale, Elisabetta; Hendriksen, Rene S.; Battisti, Antonio			Emergence of a Clonal Lineage of Multidrug-Resistant ESBL-Producing Salmonella Infantis Transmitted from Broilers and Broiler Meat to Humans in Italy between 2011 and 2014	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; FOOD ANIMALS; PLASMIDS; DISSEMINATION; CONSEQUENCES; INFECTIONS; BURDEN; GENES	We report the spread of a clone of multidrug-resistant (MDR), ESBL-producing (bla(CTX-M-1)) Salmonella enterica subsp. enterica serovar Infantis, in the Italian broiler chicken industry and along the food-chain. This was first detected in Italy in 2011 and led to human infection in Italy in 2013-2014. A set (n = 49) of extended-spectrum cephalosporin (ESC)-resistant (R) isolates of S. Infantis (2011-2014) from humans, food-producing animals and meat thereof, were studied along with a selected set of earlier and more recent ESC-susceptible (ESC-S) isolates (n = 42, 2001-2014). They were characterized by macrorestriction-PFGE analysis and genetic environment of ESC-resistance. Isolates representative of PFGE-patterns and origin were submitted to Whole Genome Sequencing. The emerging ESC-R clone, detected mainly from broiler chickens, broiler meat and humans, showed a minimum pattern of clinical resistance to cefotaxime, tetracycline, sulfonamides, and trimethoprim, beside ciprofloxacin microbiological resistance (MIC 0.25 mg/L). All isolates of this clone harbored a conjugative megaplasmid (similar to 280-320 Kb), similar to that described in ESC-susceptible S. Infantis in Israel (pESI-like) in 2014. This megaplasmid carried the ESBL gene bla(CTX-M-1), and additional genes [tet(A), sul1, dfrA1 and dfrA14] mediating cefotaxime, tetracycline, sulfonamide, and trimethoprim resistance. It also contained genes conferring enhanced colonization capability, virulence (fimbriae, yersiniabactin), resistance and fitness (qacE1, mer) in the intensive-farming environment. This emerging clone of S. Infantis has been causing infections in humans, most likely through the broiler industry. Since S. Infantis is among major serovars causing human infections in Europe and is an emerging non-typhoidal Salmonella globally, further spread of this lineage in primary productions deserves quick and thorough risk-management strategies.	[Franco, Alessia; Feltrin, Fabiola; Alba, Patricia; Cordaro, Gessica; Iurescia, Manuela; Tolli, Rita; Battisti, Antonio] Ist Zooprofilatt Sperimentale Lazio & Toscana M A, Natl Reference Lab Antimicrobial Resistance, I-00178 Rome, Italy; [Leekitcharoenphon, Pimlapas; Hendriksen, Rene S.] Tech Univ Denmark, Natl Food Inst, WHO Collaborating Ctr Antimicrobial Resistance Fo, DK-2800 Lyngby, Denmark; [Leekitcharoenphon, Pimlapas; Hendriksen, Rene S.] European Union Reference Lab Antimicrobial Resist, Lyngby, Denmark; [D'Incau, Mario] Ist Zooprofilatt Sperimentale Lombardia & Emilia, I-25124 Brescia, Italy; [Staffolani, Monica] Ist Zooprofilatt Sperimentale Umbria & Marche, Sez Macerata, I-62100 Macerata, Italy; [Di Giannatale, Elisabetta] Ist Zooprofilatt Sperimentale Abruzzo & Molise G, I-64100 Teramo, Italy	IZS Lazio e Toscana; Technical University of Denmark; IZS Lombardia e Emilia; IZS Umbria e Marche; IZS Dell'abruzzo E Del Molise Giuseppe Caporale	Battisti, A (corresponding author), Ist Zooprofilatt Sperimentale Lazio & Toscana M A, Natl Reference Lab Antimicrobial Resistance, Via Appia Nuova 1411, I-00178 Rome, Italy.	antonio.battisti@izslt.it	Leekitcharoenphon, Pimlapas/AAB-5487-2021; Di Giannatale, Elisabetta/J-9010-2016; Iurescia, Manuela/AAE-9267-2021; Alba, Patricia/T-3593-2018; Battisti, Antonio/AAQ-9243-2021; D'Incau, Mario/W-8784-2018	Di Giannatale, Elisabetta/0000-0001-8874-5856; Iurescia, Manuela/0000-0001-9527-8600; Alba, Patricia/0000-0002-9621-0955; Battisti, Antonio/0000-0003-1308-199X; D'Incau, Mario/0000-0001-9918-2497; Hendriksen, Rene S./0000-0003-2934-8214; Franco, Alessia/0000-0001-6968-973X; Leekitcharoenphon, Pimlapas/0000-0002-5674-0142	European Union [643476]	European Union(European Commission)	This work was supported by the COMPARE project under the European Union's Horizon 2020 research and innovation programme (grant agreement No 643476). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AD, 2003, MICROB DRUG RESIST, V9, P373, DOI 10.1089/107662903322762815; Aviv G, 2014, ENVIRON MICROBIOL, V16, P977, DOI 10.1111/1462-2920.12351; Biemont C, 2006, NATURE, V443, P521, DOI 10.1038/443521a; Boelaert F, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.3991; Burke L, 2014, J ANTIMICROB CHEMOTH, V69, P977, DOI 10.1093/jac/dkt469; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Chen PL, 2007, J INTERN MED, V261, P91, DOI 10.1111/j.1365-2796.2006.01748.x; Clinical Laboratory Standard Institute, 2010, M100S23 CLSI, P50; Cloeckaert A, 2007, ANTIMICROB AGENTS CH, V51, P1872, DOI 10.1128/AAC.01514-06; Collignon P, 2009, CLIN INFECT DIS, V49, P132, DOI 10.1086/599374; Deng YT, 2011, ANTIMICROB AGENTS CH, V55, P4926, DOI 10.1128/AAC.00133-11; Desenclos JC, 2004, EMERG INFECT DIS, V10, P759, DOI 10.3201/eid1004.030754; Dionisi AM, 2011, INT J ANTIMICROB AG, V38, P384, DOI 10.1016/j.ijantimicag.2011.07.001; Donati V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090564; European Food Safety Authority, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3547; European Food Safety Authority, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4036; European Food Safety Authority, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3590; Garcia-Fernandez A, 2009, J ANTIMICROB CHEMOTH, V63, P274, DOI 10.1093/jac/dkn470; Garcia-Migura L, 2012, MICROB DRUG RESIST, V18, P88, DOI 10.1089/mdr.2011.0064; Helms M, 2002, EMERG INFECT DIS, V8, P490, DOI 10.3201/eid0805.010267; Hendriksen RS, 2011, FOODBORNE PATHOG DIS, V8, P887, DOI 10.1089/fpd.2010.0787; Hohmann EL, 2001, CLIN INFECT DIS, V32, P263, DOI 10.1086/318457; Hunter SB, 2005, J CLIN MICROBIOL, V43, P1045, DOI 10.1128/JCM.43.3.1045-1050.2005; Jones TF, 2008, J INFECT DIS, V198, P109, DOI 10.1086/588823; Kaas RS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104984; Leekitcharoenphon P, 2014, PLOS ONE, V4, DOI [10.1371/journal.pone.0087991, DOI 10.1371/J0URNAL.P0NE.0087991]; Leekitcharoenphon P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S6; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Martin LJ, 2004, J INFECT DIS, V189, P377, DOI 10.1086/381270; Parry CM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001163; Sirichote P, 2010, J CLIN MICROBIOL, V48, P883, DOI 10.1128/JCM.01792-09; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vasallo FJ, 1998, CLIN INFECT DIS, V26, P535, DOI 10.1086/517087; Zheng HQ, 2012, INT J ANTIMICROB AG, V39, P305, DOI 10.1016/j.ijantimicag.2011.12.001	35	97	101	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0144802	10.1371/journal.pone.0144802	http://dx.doi.org/10.1371/journal.pone.0144802			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716443	Green Published, Green Submitted, gold			2022-12-26	WOS:000367510500015
J	Kennedy, JA; Syed, S; Schmidt, KH				Kennedy, Jessica A.; Syed, Salahuddin; Schmidt, Kristina H.			Structural Motifs Critical for In Vivo Function and Stability of the RecQ-Mediated Genome Instability Protein Rmi1	PLOS ONE			English	Article							TOPOISOMERASE-III-ALPHA; SACCHAROMYCES-CEREVISIAE; FOLDING PROBLEM; SGS1 HELICASE; COMPLEX; BLM; BINDING; YEAST; RECOMBINATION; DISSOLVASOME	Rmi1 is a member of the Sgs1/Top3/Rmi1 (STR) complex of Saccharomyces cerevisiae and has been implicated in binding and catalytic enhancement of Top3 in the dissolution of double Holliday junctions. Deletion of RMI1 results in a severe growth defect resembling that of top3.. Despite the importance of Rmi1 for cell viability, little is known about its functional domains, particularly in Rmi1 of S. cerevisiae, which does not have a resolved crystal structure and the primary sequence is poorly conserved. Here, we rationally designed point mutations based on bioinformatics analysis of order/disorder and helical propensity to define three functionally important motifs in yeast Rmi1 outside of the proposed OB-fold core. Replacing residues F63, Y218 and E220 with proline, designed to break predicted N-terminal and C-terminal a-helices, or with lysine, designed to eliminate hydrophobic residues at positions 63 and 218, while maintaining a-helical structure, caused hypersensitivity to hydroxyurea. Further, Y218P and E220P mutations, but not F63P and F63K mutations, led to reduced Rmi1 levels compared to wild type Rmi1, suggesting a role of the C-terminal a-helix in Rmi1 stabilization, most likely by protecting the integrity of the OB-fold core. Our bioinformatics analysis also suggests the presence of a disordered linker between the Nterminal a-helix and the OB fold core; a P88A mutation, designed to increase helicity in this linker, also impaired Rmi1 function in vivo. In conclusion, we propose a model that maps all functionally important structural features for yeast Rmi1 based on biological findings in yeast and structure-prediction-based alignment with the recently established crystal structure of the N-terminus of human Rmi1.	[Kennedy, Jessica A.; Syed, Salahuddin; Schmidt, Kristina H.] Univ S Florida, Dept Cell Biol Mol Biol & Microbiol, Tampa, FL 33620 USA; [Kennedy, Jessica A.; Syed, Salahuddin] H Lee Moffitt Canc Ctr & Res Inst, Grad Program Cell & Mol Biol, Tampa, FL 33612 USA; [Schmidt, Kristina H.] H Lee Moffitt Canc Ctr & Res Inst, Canc Biol & Evolut Program, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute	Schmidt, KH (corresponding author), Univ S Florida, Dept Cell Biol Mol Biol & Microbiol, Tampa, FL 33620 USA.	kschmidt@usf.edu	Syed, Salahuddin/B-4809-2017	Syed, Salahuddin/0000-0003-0851-9678	National Institutes of Health [R01GM081425]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081425] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by the National Institutes of Health grant R01GM081425 to KHS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashton TM, 2011, MOL CELL BIOL, V31, P1921, DOI 10.1128/MCB.01130-10; Bennett RJ, 1999, J MOL BIOL, V289, P235, DOI 10.1006/jmbi.1999.2739; Bocquet N, 2014, NAT STRUCT MOL BIOL, V21, P261, DOI 10.1038/nsmb.2775; Bonnet S, 2013, NUCLEIC ACIDS RES, V41, P9349, DOI 10.1093/nar/gkt730; Cejka P, 2010, NAT STRUCT MOL BIOL, V17, P1377, DOI 10.1038/nsmb.1919; Chang M, 2005, EMBO J, V24, P2024, DOI 10.1038/sj.emboj.7600684; Chen CF, 2007, J BIOL CHEM, V282, P28971, DOI 10.1074/jbc.M705427200; Chen H, 2011, MOL CARCINOGEN, V50, P80, DOI 10.1002/mc.20694; Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682; Daley JM, 2014, NUCLEIC ACIDS RES, V42, P11083, DOI 10.1093/nar/gku803; Fasching CL, 2015, MOL CELL, V57, P595, DOI 10.1016/j.molcel.2015.01.022; GANGLOFF S, 1994, MOL CELL BIOL, V14, P8391, DOI 10.1128/MCB.14.12.8391; Gietz R Daniel, 2006, Methods Mol Biol, V313, P107; Guiraldelli MF, 2013, DNA REPAIR, V12, P835, DOI 10.1016/j.dnarep.2013.07.004; Hoadley KA, 2010, STRUCTURE, V18, P1149, DOI 10.1016/j.str.2010.06.009; Huerta-Cepas J, 2014, NUCLEIC ACIDS RES, V42, pD897, DOI 10.1093/nar/gkt1177; Hyre DE, 1998, J MOL BIOL, V279, P929, DOI 10.1006/jmbi.1998.1811; Ira G, 2003, CELL, V115, P401, DOI 10.1016/S0092-8674(03)00886-9; Kennedy JA, 2013, NUCLEIC ACIDS RES, V41, P10215, DOI 10.1093/nar/gkt817; Lacroix E, 1998, J MOL BIOL, V284, P173, DOI 10.1006/jmbi.1998.2145; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Lo YC, 2006, MOL CELL BIOL, V26, P4086, DOI 10.1128/MCB.00136-06; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mitchel K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003340; Mullen JR, 2005, MOL CELL BIOL, V25, P4476, DOI 10.1128/MCB.25.11.4476-4487.2005; Munoz V, 1997, BIOPOLYMERS, V41, P495, DOI 10.1002/(SICI)1097-0282(19970415)41:5<495::AID-BIP2>3.3.CO;2-6; MUNOZ V, 1994, NAT STRUCT BIOL, V1, P399, DOI 10.1038/nsb0694-399; Myung K, 2001, NAT GENET, V27, P113, DOI 10.1038/83673; Peng Kang, 2005, Journal of Bioinformatics and Computational Biology, V3, P35, DOI 10.1142/S0219720005000886; Raynard S, 2006, J BIOL CHEM, V281, P13861, DOI 10.1074/jbc.C600051200; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Theobald DL, 2003, ANNU REV BIOPH BIOM, V32, P115, DOI 10.1146/annurev.biophys.32.110601.142506; Wang F, 2010, STRUCTURE, V18, P1159, DOI 10.1016/j.str.2010.06.008; Wu L, 2006, P NATL ACAD SCI USA, V103, P4068, DOI 10.1073/pnas.0508295103; Xu DY, 2008, GENE DEV, V22, P2843, DOI 10.1101/gad.1708608; Yang J, 2012, MOL CELL BIOL, V32, P3054, DOI 10.1128/MCB.00255-12; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	38	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0145466	10.1371/journal.pone.0145466	http://dx.doi.org/10.1371/journal.pone.0145466			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26717309	Green Submitted, gold, Green Published			2022-12-26	WOS:000367510500036
J	Li, XY; Guo, YQ; Yan, WB; Snyder, MP; Li, X				Li, Xiyan; Guo, Yuqi; Yan, Wenbo; Snyder, Michael P.; Li, Xin			Metformin Improves Diabetic Bone Health by Re-Balancing Catabolism and Nitrogen Disposal	PLOS ONE			English	Article							NF-KAPPA-B; SUCCINATE RECEPTOR GPR91; ANTIDIABETIC DRUG METFORMIN; OSTEOCLAST FORMATION; ACID CYCLE; IN-VIVO; DIFFERENTIATION; ACTIVATION; GLUTAMATE; CELL	Objective Metformin, a leading drug used to treat diabetic patients, is reported to benefit bone homeostasis under hyperglycemia in animal models. However, both the molecular targets and the biological pathways affected by metformin in bone are not well identified or characterized. The objective of this study is to investigate the bioengergeric pathways affected by metformin in bone marrow cells of mice. Materials and Methods Metabolite levels were examined in bone marrow samples extracted from metformin or PBS -treated healthy (Wild type) and hyperglycemic (diabetic) mice using liquid chromatography-mass spectrometry (LC-MS)-based metabolomics. We applied an untargeted high performance LC-MS approach which combined multimode chromatography (ion exchange, reversed phase and hydrophilic interaction (HILIC)) and Orbitrap-based ultra-high accuracy mass spectrometry to achieve a wide coverage. A multivariate clustering was applied to reveal the global trends and major metabolite players. Results A total of 346 unique metabolites were identified, and they are grouped into distinctive clusters that reflected general and diabetes-specific responses to metformin. As evidenced by changes in the TCA and urea cycles, increased catabolism and nitrogen waste that are commonly associated with diabetes were rebalanced upon treatment with metformin. In particular, we found glutamate and succinate whose levels were drastically elevated in diabetic animals were brought back to normal levels by metformin. These two metabolites were further validated as the major targets of metformin in bone marrow stromal cells. Conclusion Overall using limited sample size, our study revealed the metabolic pathways modulated by metformin in bones which have broad implication in our understanding of bone remodeling under hyperglycemia and in finding therapeutic interventions in mammals.	[Li, Xiyan; Snyder, Michael P.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Guo, Yuqi; Li, Xin] NYU, Coll Dent, Basic Sci & Craniofacial Biol, New York, NY 10010 USA; [Yan, Wenbo] Nyack Coll, Dept Biol & Chem, New York, NY 10013 USA	Stanford University; New York University	Li, X (corresponding author), NYU, Coll Dent, Basic Sci & Craniofacial Biol, New York, NY 10010 USA.	xl15@nyu.edu	yan, wenbo/GXV-2795-2022	Li, Xin/0000-0002-7414-5734; Li, Xiyan/0000-0002-1959-2160; Snyder, Michael/0000-0003-0784-7987	NIH [R01CA180277, R03 CA172894, 5R01GM06248012-12, 3U54DK10255602S2]; California Institute for Regenerative Medicine [RB4-06087]; NATIONAL CANCER INSTITUTE [R03CA172894, R01CA180277] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grants R01CA180277 and R03 CA172894 to Xin Li, 5R01GM06248012-12, 3U54DK10255602S2 grant and California Institute for Regenerative Medicine grant (RB4-06087) to MPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrzejewski S, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-12; Ang ESM, 2007, J CELL PHYSIOL, V212, P787, DOI 10.1002/jcp.21076; Cheema AK, 2011, J PROTEOME RES, V10, P2651, DOI 10.1021/pr101243j; Chung YH, 2014, INT J BIOCHEM CELL B, V54, P198, DOI 10.1016/j.biocel.2014.07.018; Corominas-Faja B, 2012, AGING-US, V4, P480, DOI 10.18632/aging.100472; Cowan Robert W, 2012, Front Endocrinol (Lausanne), V3, P89, DOI 10.3389/fendo.2012.00089; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Eriksen EF, 2010, REV ENDOCR METAB DIS, V11, P219, DOI 10.1007/s11154-010-9153-1; Favret S, 2013, AGING-US, V5, P427, DOI 10.18632/aging.100563; Feng X, 2011, ANNU REV PATHOL-MECH, V6, P121, DOI 10.1146/annurev-pathol-011110-130203; Fernandez AM, 2001, GENE DEV, V15, P1926, DOI 10.1101/gad.908001; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Gao Y, 2010, EUR J PHARMACOL, V635, P231, DOI 10.1016/j.ejphar.2010.02.051; Gao Y, 2008, J PHARM PHARMACOL, V60, P1695, DOI 10.1211/jpp.60/12.0017; Gnana-Prakasam JP, 2011, INVEST OPHTH VIS SCI, V52, P3751, DOI 10.1167/iovs.10-6722; Gore DC, 2005, ANN SURG, V241, P334, DOI 10.1097/01.sla.0000152013.23032.d1; Gravel SP, 2014, CANCER RES, V74, P7521, DOI 10.1158/0008-5472.CAN-14-2643-T; Guan SH, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010728; Hakak Y, 2009, J LEUKOCYTE BIOL, V85, P837, DOI 10.1189/jlb.1008618; Hamann C, 2012, NAT REV ENDOCRINOL, V8, P297, DOI 10.1038/nrendo.2011.233; Hardie DG, 2008, INT J OBESITY, V32, pS7, DOI 10.1038/ijo.2008.116; Hardie DG, 2011, AM J CLIN NUTR, V93, p891S, DOI 10.3945/ajcn.110.001925; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; HUNDAL HS, 1992, ENDOCRINOLOGY, V131, P1165, DOI 10.1210/en.131.3.1165; Hundal RS, 2003, DRUGS, V63, P1879, DOI 10.2165/00003495-200363180-00001; Janzer A, 2014, P NATL ACAD SCI USA, V111, P10574, DOI 10.1073/pnas.1409844111; Jeyabalan J, 2013, OSTEOPOROSIS INT, V24, P2659, DOI 10.1007/s00198-013-2371-0; Jimi E, 2004, NAT MED, V10, P617, DOI 10.1038/nm1054; Kajiya H, 2012, ADV EXP MED BIOL, V740, P917, DOI 10.1007/978-94-007-2888-2_41; Kamburov A, 2011, BIOINFORMATICS, V27, P2917, DOI 10.1093/bioinformatics/btr499; Kawashima Y, 2009, BONE, V44, P648, DOI 10.1016/j.bone.2008.12.012; Koenig W, 2008, CLIN CHEM, V54, P231, DOI 10.1373/clinchem.2007.099705; Kos E, 2012, ENDOCR PRACT, V18, P179, DOI 10.4158/EP11009.OR; KRAKAUER JC, 1995, DIABETES, V44, P775, DOI 10.2337/diabetes.44.7.775; L Newton Anna, 2013, Bonekey Rep, V2, P315, DOI 10.1038/bonekey.2013.49; Large V, 1999, DIABETES, V48, P1251, DOI 10.2337/diabetes.48.6.1251; Levasseur R, 2003, ENDOCRINOLOGY, V144, P2761, DOI 10.1210/en.2002-0071; Li HW, 2013, BIOCHEM BIOPH RES CO, V430, P951, DOI 10.1016/j.bbrc.2012.12.051; Li X, 2007, J BIOL CHEM, V282, P33086, DOI 10.1074/jbc.M705194200; Mai QG, 2011, J CELL BIOCHEM, V112, P2902, DOI 10.1002/jcb.23206; Mediero A, 2013, BRIT J PHARMACOL, V169, P1372, DOI 10.1111/bph.12227; Merle B, 2003, J CELL BIOCHEM, V90, P424, DOI 10.1002/jcb.10625; Miller RA, 2010, J CLIN INVEST, V120, P2267, DOI 10.1172/JCI43661; Miranda VC, 2014, DRUG TODAY, V50, P623, DOI 10.1358/dot.2014.50.9.2229920; Miyauchi A, 1996, ENDOCRINOLOGY, V137, P3544, DOI 10.1210/en.137.8.3544; Newsholme P, 2005, CLIN SCI, V108, P185, DOI 10.1042/CS20040290; Rubic T, 2008, NAT IMMUNOL, V9, P1261, DOI 10.1038/ni.1657; Sapieha P, 2008, NAT MED, V14, P1067, DOI 10.1038/nm.1873; Shah M, 2010, BONE, V47, P309, DOI 10.1016/j.bone.2010.04.596; SHAMBAUGH GE, 1977, AM J CLIN NUTR, V30, P2083, DOI 10.1093/ajcn/30.12.2083; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; SULAIMAN WR, 1977, ACTA DIABETOL LAT, V14, P129, DOI 10.1007/BF02581400; Sundstrom L, 2013, FEBS LETT, V587, P2399, DOI 10.1016/j.febslet.2013.05.067; Suzuki K, 2005, DIABETES RES CLIN PR, V68, P117, DOI 10.1016/j.diabres.2004.08.006; Tagliaferri C, 2015, EUR J NUTR, V54, P1139, DOI 10.1007/s00394-014-0790-0; Tai ES, 2010, DIABETOLOGIA, V53, P757, DOI 10.1007/s00125-009-1637-8; Takarada T, 2008, J PHARMACOL SCI, V106, P536, DOI 10.1254/jphs.FM0070243; Takarada-Iemata M, 2011, J CELL PHYSIOL, V226, P652, DOI 10.1002/jcp.22390; Takizawa M, 2008, DIABETES RES CLIN PR, V82, P119, DOI 10.1016/j.diabres.2008.07.008; Tsubaki M, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-10; Tsubaki M, 2010, J CELL BIOCHEM, V111, P1661, DOI 10.1002/jcb.22907; Uno K, 2007, J CELL PHYSIOL, V213, P105, DOI 10.1002/jcp.21095; Vestergaard P, 2005, DIABETOLOGIA, V48, P1292, DOI 10.1007/s00125-005-1786-3; Vinaixa M, 2012, METABOLITES, V2, P775, DOI 10.3390/metabo2040775; Wu CL, 2013, INT J OBESITY, V37, P1079, DOI 10.1038/ijo.2012.171; Yan WB, 2013, FRONT MED-PRC, V7, P81, DOI 10.1007/s11684-013-0243-9; Zinman B, 2010, J CLIN ENDOCR METAB, V95, P134, DOI 10.1210/jc.2009-0572	67	11	13	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0146152	10.1371/journal.pone.0146152	http://dx.doi.org/10.1371/journal.pone.0146152			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0TN	26716870	Green Submitted, Green Published, gold			2022-12-26	WOS:000367510500137
J	Tang, YJ; Ho, SY; Chu, FY; Chen, HA; Yin, YJ; Lee, HC; Chu, WCC; Yeh, HW; Chiang, WS; Yeh, CL; Huang, HL; Tzeng, NS				Tang, Yih-Jing; Ho, Shinn-Ying; Chu, Fang-Ying; Chen, Hung-An; Yin, Yun-Ju; Lee, Hua-Chin; Chu, William Cheng-Chung; Yeh, Hui-Wen; Chiang, Wei-Shan; Yeh, Chia-Lun; Huang, Hui-Ling; Tzeng, Nian-Sheng			Is Zolpidem Associated with Increased Risk of Fractures in the Elderly with Sleep Disorders? A Nationwide Case Cross-Over Study in Taiwan	PLOS ONE			English	Article							HIP-FRACTURES; OLDER-PEOPLE; BENZODIAZEPINE USE; PELVIC FRACTURES; ECONOMIC BURDEN; INSOMNIA; FALLS; ADULTS; POPULATION; OSTEOPOROSIS	Background We conducted a study using a case-crossover design to clarify the risk of acute effects of zolpidem and benzodiazepine on all-sites of fractures in the elderly. Design of study Case-crossover design. Methods and Materials Elderly enrollees (n = 6010) in Taiwan's National Health Insurance Research Database with zolpidem or benzodiazepine use were analyzed for the risk of developing fractures. Results After adjusting for medications such as antipsychotics, antidepressants, and diuretics, or comorbidities such as hypertension, osteoarthritis, osteoporosis, rheumatoid arthritis and depression, neither zolpidem nor benzodiazepine was found to be associated with increased risk in all-sites fractures. Subjects without depression were found to have an increased risk of fractures. Diazepam is the only benzodiazepine with increased risk of fractures after adjusting for medications and comorbidities. Hip and spine were particular sites for increased fracture risk, but following adjustment for comorbidities, the associations were found to be insignificant. Conclusion Neither zolpidem nor benzodiazepine was associated with increased risk of all-site fractures in this case cross-over study after adjusting for medications or comorbidities in elderly individuals with insomnia. Clinicians should balance the benefits and risks for prescribing zolpidem or benzodiazepine in the elderly accordingly.	[Tang, Yih-Jing] Taichung Vet Gen Hosp, Ctr Geriatr & Gerontol, Dept Family Med, Taichung, Taiwan; [Tang, Yih-Jing] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Ho, Shinn-Ying; Huang, Hui-Ling] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Ho, Shinn-Ying; Chu, Fang-Ying; Chen, Hung-An; Yin, Yun-Ju; Lee, Hua-Chin; Yeh, Hui-Wen; Yeh, Chia-Lun; Huang, Hui-Ling] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Chu, William Cheng-Chung] Tunghai Univ, Dept Comp Sci, Taichung 40704, Taiwan; [Yeh, Hui-Wen] Natl Def Med Ctr, Sch Nursing, Dept Nursing, Triserv Gen Hosp, Taipei, Taiwan; [Yeh, Hui-Wen; Chiang, Wei-Shan] Natl Tamkang Univ, Inst & Dept Math, New Taipei, Taiwan; [Chiang, Wei-Shan; Tzeng, Nian-Sheng] Natl Def Med Ctr, Sch Med, Triserv Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Tzeng, Nian-Sheng] Natl Def Med Ctr, Student Counseling Ctr, Taipei, Taiwan	Taichung Veterans General Hospital; Chung Shan Medical University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Tunghai University; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center	Huang, HL (corresponding author), Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan.	hlhuang@mail.nctu.edu.tw; pierrens@mail.ndmctsgh.edu.tw	Ho, Shinn-Ying/AFD-8402-2022; Ho, Shinn-Ying/AAE-9394-2022; Tzeng, Nian-Sheng/AAU-4945-2021	Ho, Shinn-Ying/0000-0002-1901-8353; Ho, Shinn-Ying/0000-0002-1901-8353; 	Ministry of Science and Technology of Taiwan [MOST-103-2221-E-009-117-, MOST -103-2221-E-009-141-]; "Center for Bioinformatics Research of Aiming for the Top University Program" of the National Chiao Tung University; Ministry of Education, Taiwan, R.O.C. [103W962]; UST-UCSD International Center of Excellence in Advanced Bioengineering - Taiwan Ministry of Science and Technology I-RiCE Program [MOST-103-2911-1-009-101-];  [Tri-Service-General-Hospital (TSGH)-C103-019]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); "Center for Bioinformatics Research of Aiming for the Top University Program" of the National Chiao Tung University; Ministry of Education, Taiwan, R.O.C.(Ministry of Education, Taiwan); UST-UCSD International Center of Excellence in Advanced Bioengineering - Taiwan Ministry of Science and Technology I-RiCE Program; 	This work was supported by grant number Tri-Service-General-Hospital (TSGH)-C103-019. This work was also funded by Ministry of Science and Technology of Taiwan under the contract number MOST-103-2221-E-009-117- and MOST -103-2221-E-009-141-, and "Center for Bioinformatics Research of Aiming for the Top University Program" of the National Chiao Tung University and Ministry of Education, Taiwan, R.O.C. for the project 103W962. This work was also supported in part by the UST-UCSD International Center of Excellence in Advanced Bioengineering sponsored by the Taiwan Ministry of Science and Technology I-RiCE Program under Grant Number: MOST-103-2911-1-009-101-. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AL, 2013, OSTEOPOROSIS INT, V24, P373, DOI 10.1007/s00198-012-1938-5; Antai- D, 2006, PERSPECT PSYCHIATR C, V42, P196, DOI 10.1111/j.1744-6163.2006.00070.x; Baglioni C, 2011, J AFFECT DISORDERS, V135, P10, DOI 10.1016/j.jad.2011.01.011; Bakken MS, 2014, EUR J CLIN PHARMACOL, V70, P873, DOI 10.1007/s00228-014-1684-z; Berry SD, 2013, JAMA INTERN MED, V173, P754, DOI 10.1001/jamainternmed.2013.3795; Brassington GS, 2000, J AM GERIATR SOC, V48, P1234, DOI 10.1111/j.1532-5415.2000.tb02596.x; Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]; Castano-Betancourt MC, 2013, ARTHRITIS RHEUM-US, V65, P693, DOI 10.1002/art.37792; Chan WSH, 2010, EPMA J, V1, P563, DOI 10.1007/s13167-010-0056-8; Chang CM, 2008, AM J GERIAT PSYCHIAT, V16, P686, DOI 10.1097/JGP.0b013e31817c6a99; Chen HL, 2015, PHARMACOEPIDEM DR S, V24, P841, DOI 10.1002/pds.3814; Chen IJ, 2015, OSTEOPOROSIS INT, V26, P681, DOI 10.1007/s00198-014-2930-z; Chen LF, 2013, NEUROPSYCH DIS TREAT, V9, P1159, DOI 10.2147/NDT.S48152; Chiang YY, 2012, J EUR ACAD DERMATOL, V26, P59, DOI 10.1111/j.1468-3083.2011.04009.x; Chinese Hospital Association, 2000, ICD 9 CM ENGL CHIN D; Chung SD, 2011, J ANDROL, V32, P159, DOI 10.2164/jandrol.110.011163; Cizza Giovanni, 2011, Dialogues Clin Neurosci, V13, P73; Cizza G, 2009, TRENDS ENDOCRIN MET, V20, P367, DOI 10.1016/j.tem.2009.05.003; Cummings-Vaughn LA, 2011, MED CLIN N AM, V95, P495, DOI 10.1016/j.mcna.2011.03.003; Dolder CR, 2008, CNS DRUGS, V22, P1021, DOI 10.2165/0023210-200822120-00005; Fang JF, 2008, INJURY, V39, P881, DOI 10.1016/j.injury.2008.03.012; Finkle WD, 2011, J AM GERIATR SOC, V59, P1883, DOI 10.1111/j.1532-5415.2011.03591.x; Gale Catharine R, 2012, Arch Osteoporos, V7, P59, DOI 10.1007/s11657-012-0080-5; Glass J, 2005, BMJ-BRIT MED J, V331, P1169, DOI 10.1136/bmj.38623.768588.47; Harboun M, 2008, INT J GERIATR PSYCH, V23, P1245, DOI 10.1002/gps.2058; Heffner KL, 2012, AM J GERIAT PSYCHIAT, V20, P744, DOI 10.1097/JGP.0b013e31824361de; Hill EL, 2007, J GERONTOL A-BIOL, V62, P62, DOI 10.1093/gerona/62.1.62; Huang WF, 2005, DRUG AGING, V22, P957, DOI 10.2165/00002512-200522110-00005; Hwang TJ, 2010, J CLIN PSYCHIAT, V71, P1331, DOI 10.4088/JCP.09m05083bro; Jaussent I, 2011, SLEEP, V34, P1103, DOI 10.5665/SLEEP.1170; Johnston SS, 2012, DIABETES OBES METAB, V14, P634, DOI 10.1111/j.1463-1326.2012.01583.x; Kang Dong-Yoon, 2012, J Prev Med Public Health, V45, P219, DOI 10.3961/jpmph.2012.45.4.219; Khawaja Muhammad Rizwamillah, 2005, JPMA Journal of the Pakistan Medical Association, V55, P259; Khazai NB, 2009, CURR OPIN ENDOCRINOL, V16, P435, DOI 10.1097/MED.0b013e328331c7eb; Lecrubier Y, 2006, J CLIN PSYCHIAT, V67, P23; Lehrer S, 2013, SLEEP BREATH, V17, P1117, DOI 10.1007/s11325-013-0811-x; Lin HY, 2011, UPSALA J MED SCI, V116, P155, DOI 10.3109/03009734.2010.547636; Lin LY, 2011, ATHEROSCLEROSIS, V217, P292, DOI 10.1016/j.atherosclerosis.2011.03.033; Maclure M, 2000, ANNU REV PUBL HEALTH, V21, P193, DOI 10.1146/annurev.publhealth.21.1.193; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; MANDELLI M, 1978, CLIN PHARMACOKINET, V3, P72, DOI 10.2165/00003088-197803010-00005; MELTON LJ, 1981, CLIN ORTHOP RELAT R, P43; Parthasarathy S, 2015, AM J MED, V128, P268, DOI 10.1016/j.amjmed.2014.10.015; Pigeon Wilfred R, 2012, J Clin Psychiatry, V73, pe1160, DOI 10.4088/JCP.11r07586; Pigeon WR, 2011, J WOMENS HEALTH, V20, P1923, DOI 10.1089/jwh.2011.2781; Pike C, 2011, OSTEOPOROSIS INT, V22, P47, DOI 10.1007/s00198-010-1267-5; Poceta JS, 2011, J CLIN SLEEP MED, V7, P632, DOI 10.5664/jcsm.1468; Stenbacka M, 2002, ALCOHOL, V28, P9, DOI 10.1016/S0741-8329(02)00223-9; Stone KL, 2008, SLEEP MED, V9, pS18, DOI 10.1016/S1389-9457(08)70012-1; Stone KL, 2006, J AM GERIATR SOC, V54, P1177, DOI 10.1111/j.1532-5415.2006.00818.x; Strand LB, 2013, SLEEP, V36, P99, DOI 10.5665/sleep.2310; Susanszky Eva, 2011, Psychiatr Hung, V26, P250; U.S. Food and Drug Administration, AMBIEN ZOLP TARTR FU; Vermeeren A, 2004, CNS DRUGS, V18, P297, DOI 10.2165/00023210-200418050-00003; Wagner AK, 2004, ARCH INTERN MED, V164, P1567, DOI 10.1001/archinte.164.14.1567; Wang CB, 2013, BONE, V56, P147, DOI 10.1016/j.bone.2013.05.015; Wang PS, 2001, J AM GERIATR SOC, V49, P1685, DOI 10.1111/j.1532-5415.2001.49280.x; Wang PS, 2001, AM J PSYCHIAT, V158, P892, DOI 10.1176/appi.ajp.158.6.892; Yang NP, 2008, INJURY, V39, P443, DOI 10.1016/j.injury.2007.12.007; Yang S, 2014, OSTEOPOROSIS INT, V25, P97, DOI 10.1007/s00198-013-2457-8; Yang YH, 2011, J EPIDEMIOL, V21, P37, DOI 10.2188/jea.JE20090195; Ziade N, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-344; Zint K, 2010, PHARMACOEPIDEM DR S, V19, P1248, DOI 10.1002/pds.2031	63	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 30	2015	10	12							e0146030	10.1371/journal.pone.0146030	http://dx.doi.org/10.1371/journal.pone.0146030			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DA0TN	26716836	Green Submitted, Green Published, gold			2022-12-26	WOS:000367510500121
J	Beltran, AR; Carraro-Lacroix, LR; Bezerra, CNA; Cornejo, M; Norambuena, K; Toledo, F; Araos, J; Pardo, F; Leiva, A; Sanhueza, C; Malnic, G; Sobrevia, L; Ramirez, MA				Beltran, Ana R.; Carraro-Lacroix, Luciene R.; Bezerra, Camila N. A.; Cornejo, Marcelo; Norambuena, Katrina; Toledo, Fernando; Araos, Joaquin; Pardo, Fabian; Leiva, Andrea; Sanhueza, Carlos; Malnic, Gerhard; Sobrevia, Luis; Ramirez, Marco A.			Escherichia coli Heat-Stable Enterotoxin Mediates Na+/H+ Exchanger 4 Inhibition Involving cAMP in T-84 Human Intestinal Epithelial Cells	PLOS ONE			English	Article							T84 CELLS; FLUID SECRETION; CL-SECRETION; DIARRHEA; RAT; PH; LINE; NHE4; REGULATOR; CANCER	The enterotoxigenic Escherichia coli strains lead to diarrhoea in humans due to heat-labile and heat-stable (STa) enterotoxins. STa increases Cl-release in intestinal cells, including the human colonic carcinoma T-84 cell line, involving increased cGMP and membrane alkalization due to reduced Na+/H+ exchangers (NHEs) activity. Since NHEs modulate intracellular pH (pH(i)), and NHE1, NHE2, and NHE4 are expressed in T-84 cells, we characterized the STa role as modulator of these exchangers. pHi was assayed by the NH4Cl pulse technique and measured by fluorescence microscopy in BCECF-preloaded cells. pHi recovery rate (dpHi/dt) was determined in the absence or presence of 0.25 mu mol/L STa (30 minutes), 25 mu mol/L HOE-694 (concentration inhibiting NHE1 and NHE2), 500 mu mol/L sodium nitroprusside (SNP, spontaneous nitric oxide donor), 100 mu mol/L dibutyryl cyclic GMP (db-cGMP), 100 nmol/L H89 (protein kinase A inhibitor), or 10 mu mol/L forskolin (adenylyl cyclase activator). cGMP and cAMP were measured in cell extracts by radioimmunoassay, and buffering capacity (Bi) and H+ efflux (J(H)(+)) was determined. NHE4 protein abundance was determined by western blotting. STa and HOE-694 caused comparable reduction in dpHi/dt and J(H)(+) (similar to 63%), without altering basal pHi (range 7.144-7.172). STa did not alter Bi value in a range of 1.6 pHi units. The dpHi/dt and J(H)(+) was almost abolished (similar to 94% inhibition) by STa + HOE-694. STa effect was unaltered by db-cGMP or SNP. However, STa and forskolin increased cAMP level. STa-decreased dpHi/dt and J(H)(+) was mimicked by forskolin, and STa + HOE-694 effect was abolished by H89. Thus, incubation of T-84 cells with STa results in reduced NHE4 activity leading to a lower capacity of pH(i) recovery requiring cAMP, but not cGMP. STa effect results in a causal phenomenon (STa/increased cAMP/increased PKA activity/reduced NHE4 activity) ending with intracellular acidification that could have consequences in the gastrointestinal cells function promoting human diarrhoea.	[Beltran, Ana R.; Cornejo, Marcelo; Norambuena, Katrina; Ramirez, Marco A.] Univ Antofagasta, Biomed Dept, Cellular Physiol Lab, Fac Hlth Sci, Antofagasta 1270300, Chile; [Beltran, Ana R.] Univ Antofagasta, Dept Educ, Fac Educ, Antofagasta 1270300, Chile; [Carraro-Lacroix, Luciene R.; Bezerra, Camila N. A.; Malnic, Gerhard] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, BR-35503081 Sao Paulo, Brazil; [Toledo, Fernando] Univ Bio Bio, Dept Basic Sci, Fac Sci, Chillan 3780000, Chile; [Sobrevia, Luis] Univ Seville, Dept Physiol, Fac Pharm, E-41012 Seville, Spain; [Sobrevia, Luis] Univ Queensland, Clin Res Ctr, Fac Med & Biomed Sci, Herston, Qld 4029, Australia; [Araos, Joaquin; Pardo, Fabian; Leiva, Andrea; Sanhueza, Carlos; Sobrevia, Luis; Ramirez, Marco A.] Pontificia Univ Catolica Chile, Sch Med, Div Obstet & Gynecol, CMPL,Fac Med, Santiago 8330024, Chile	Universidad de Antofagasta; Universidad de Antofagasta; Universidade de Sao Paulo; Universidad del Bio-Bio; University of Sevilla; University of Queensland; Pontificia Universidad Catolica de Chile	Sobrevia, L (corresponding author), Univ Seville, Dept Physiol, Fac Pharm, E-41012 Seville, Spain.	sobrevia@med.puc.cl; marco.ramirez@uantof.cl	Cornejo Alaniz, Marcelo Alejandro/AGD-4851-2022; Sobrevia, Luis/H-9608-2016	Cornejo Alaniz, Marcelo Alejandro/0000-0002-1377-0149; TOLEDO-MONTIEL, FERNANDO/0000-0001-9435-0973; Beltran Gonzalez, Ana Rosa/0000-0001-5068-2132; Sobrevia, Luis/0000-0001-5802-2243	Semillero Direccion de Investigacion Universidad de Antofagasta, Chile [5309, 5313]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP, Brazil; Fondo Nacional de Desarrollo Cientifico y Tecnologico, Chile [FONDECYT 1150377, 1150344, 3140516, 11150083]	Semillero Direccion de Investigacion Universidad de Antofagasta, Chile; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP, Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fondo Nacional de Desarrollo Cientifico y Tecnologico, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	Semillero Direccion de Investigacion Universidad de Antofagasta (5309, 5313), Chile, http://www.uantof.cl. Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP, Brazil, http://www.fapesp.br. Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT 1150377, 1150344, 3140516, 11150083), Chile, http://www.conicyt.cl/fondecyt/.	Abu-Elyazeed R, 1999, J INFECT DIS, V179, P382, DOI 10.1086/314593; Ao M, 2013, AM J PHYSIOL-CELL PH, V305, pC447, DOI 10.1152/ajpcell.00416.2012; Aravena C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051451; Arena EA, 2012, AM J PHYSIOL-CELL PH, V302, pC412, DOI 10.1152/ajpcell.00163.2011; Bachmann O, 2011, ACTA PHYSIOL, V201, P33, DOI 10.1111/j.1748-1716.2010.02153.x; Beltran AR, 2008, PFLUG ARCH EUR J PHY, V455, P799, DOI 10.1007/s00424-007-0333-0; Bijvelds MJC, 2015, J INFECT DIS, V212, P1806, DOI 10.1093/infdis/jiv300; Carrithers SL, 2003, P NATL ACAD SCI USA, V100, P3018, DOI 10.1073/pnas.0730484100; CARTWRIGHT CA, 1985, J CLIN INVEST, V76, P1837, DOI 10.1172/JCI112176; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; CRAVIOTO A, 1988, EPIDEMIOL INFECT, V101, P123, DOI 10.1017/S0950268800029289; Fawcus K, 1997, COMP BIOCHEM PHYS A, V118, P291, DOI 10.1016/S0300-9629(96)00307-6; Fernandez R, 1998, J MEMBRANE BIOL, V163, P137, DOI 10.1007/s002329900378; FIELD M, 1978, P NATL ACAD SCI USA, V75, P2800, DOI 10.1073/pnas.75.6.2800; FORTE LR, 1989, AM J PHYSIOL, V257, pF874, DOI 10.1152/ajprenal.1989.257.5.F874; Fuster DG, 2014, PFLUG ARCH EUR J PHY, V466, P61, DOI 10.1007/s00424-013-1408-8; Gawenis LR, 2005, J BIOL CHEM, V280, P12781, DOI 10.1074/jbc.M414118200; GIANNELLA RA, 1979, INFECT IMMUN, V24, P19, DOI 10.1128/IAI.24.1.19-23.1979; Gillies RJ, 2004, IEEE ENG MED BIOL, V23, P57, DOI 10.1109/MEMB.2004.1360409; Golin-Bisello F, 2005, AM J PHYSIOL-CELL PH, V289, pC708, DOI 10.1152/ajpcell.00544.2004; GROSS RJ, 1983, J INFECTION, V7, P177, DOI 10.1016/S0163-4453(83)96953-0; HUOTT PA, 1988, J CLIN INVEST, V82, P514, DOI 10.1172/JCI113626; Ikuma M, 1999, AM J PHYSIOL-GASTR L, V276, pG539, DOI 10.1152/ajpgi.1999.276.2.G539; Kots AY, 2008, P NATL ACAD SCI USA, V105, P8440, DOI 10.1073/pnas.0803096105; Lucas ML, 2001, J APPL MICROBIOL, V90, P7, DOI 10.1046/j.1365-2672.2001.01225.x; Moon C, 2015, PHARMACOL RES, V102, P107, DOI 10.1016/j.phrs.2015.08.024; Morel E, 2003, RADIAT RES, V160, P263, DOI 10.1667/RR3041; Musa-Aziz R, 2005, J MEMBRANE BIOL, V205, P49, DOI 10.1007/s00232-005-0762-7; Nakashima R, 2013, VET IMMUNOL IMMUNOP, V152, P78, DOI 10.1016/j.vetimm.2012.09.026; Nichols JM, 2015, AM J PHYSIOL-GASTR L, V309, pG670, DOI 10.1152/ajpgi.00214.2015; Orlowski J, 2011, COMPR PHYSIOL, V1, P2083, DOI 10.1002/cphy.c110020; Pardo F, 2015, INT J OBESITY, V39, P1264, DOI 10.1038/ijo.2015.57; Pizzonia JH, 2013, AM J PHYSIOL, V275, pF510; Provost JJ, 2013, CHEM BIOL DRUG DES, V81, P85, DOI 10.1111/cbdd.12035; Qadri F, 2005, CLIN MICROBIOL REV, V18, P465, DOI 10.1128/CMR.18.3.465-483.2005; Ramirez MA, 2000, J MEMBRANE BIOL, V177, P149, DOI 10.1007/s002320001108; Rossmann H, 2001, AM J PHYSIOL-GASTR L, V281, pG447, DOI 10.1152/ajpgi.2001.281.2.G447; Salsoso R, 2015, PLACENTA, V36, P287, DOI 10.1016/j.placenta.2014.12.007; SCHULZ S, 1990, CELL, V63, P941, DOI 10.1016/0092-8674(90)90497-3; Sellers ZM, 2005, AM J PHYSIOL-GASTR L, V288, pG654, DOI 10.1152/ajpgi.00386.2004; Selvaraj NG, 2000, BBA-MOL CELL RES, V1498, P32, DOI 10.1016/S0167-4889(00)00075-6; Slepkov ER, 2007, BIOCHEM J, V401, P623, DOI 10.1042/BJ20061062; Toriano R, 2001, AM J PHYSIOL-GASTR L, V281, pG816, DOI 10.1152/ajpgi.2001.281.3.G816; Toriano R, 2011, CELL PHYSIOL BIOCHEM, V28, P733, DOI 10.1159/000335767; WASSERMAN SI, 1988, AM J PHYSIOL, V254, pC53, DOI 10.1152/ajpcell.1988.254.1.C53	45	13	13	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0146042	10.1371/journal.pone.0146042	http://dx.doi.org/10.1371/journal.pone.0146042			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26713849	gold, Green Published, Green Submitted			2022-12-26	WOS:000367481900112
J	Saito-Hakoda, A; Uruno, A; Yokoyama, A; Shimizu, K; Parvin, R; Kudo, M; Saito-Ito, T; Sato, I; Kogure, N; Suzuki, D; Shimada, H; Yoshikawa, T; Fujiwara, I; Kagechika, H; Iwasaki, Y; Kure, S; Ito, S; Sugawara, A				Saito-Hakoda, Akiko; Uruno, Akira; Yokoyama, Atsushi; Shimizu, Kyoko; Parvin, Rehana; Kudo, Masataka; Saito-Ito, Takako; Sato, Ikuko; Kogure, Naotaka; Suzuki, Dai; Shimada, Hiroki; Yoshikawa, Takeo; Fujiwara, Ikuma; Kagechika, Hiroyuki; Iwasaki, Yasumasa; Kure, Shigeo; Ito, Sadayoshi; Sugawara, Akira			Effects of RXR Agonists on Cell Proliferation/Apoptosis and ACTH Secretion/Pomc Expression	PLOS ONE			English	Article							PROOPIOMELANOCORTIN GENE-EXPRESSION; RETINOID-X-RECEPTORS; CUSHINGS-DISEASE; PITUITARY-ADENOMAS; THERAPEUTIC TARGET; CANCER PREVENTION; MEDICAL THERAPY; CLINICAL-TRIAL; ACID; TRANSCRIPTION	Various retinoid X receptor (RXR) agonists have recently been developed, and some of them have shown anti-tumor effects both in vivo and in vitro. However, there has been no report showing the effects of RXR agonists on Cushing's disease, which is caused by excessive ACTH secretion in a corticotroph tumor of the pituitary gland. Therefore, we examined the effects of synthetic RXR pan-agonists HX630 and PA024 on the proliferation, apoptosis, ACTH secretion, and pro-opiomelanocortin (Pomc) gene expression of murine pituitary corticotroph tumor AtT20 cells. We demonstrated that both RXR agonists induced apoptosis dose-dependently in AtT20 cells, and inhibited their proliferation at their higher doses. Microarray analysis identified a significant gene network associated with caspase 3 induced by high dose HX630. On the other hand, HX630, but not PA024, inhibited Pomc transcription, Pomc mRNA expression, and ACTH secretion dose-dependently. Furthermore, we provide new evidence that HX630 negatively regulates the Pomc promoter activity at the transcriptional level due to the suppression of the transcription factor Nur77 and Nurr1 mRNA expression and the reduction of Nur77/Nurr1 heterodimer recruiting to the Pomc promoter region. We also demonstrated that the HX630-mediated suppression of the Pomc gene expression was exerted via RXR alpha. Furthermore, HX630 inhibited tumor growth and decreased Pomc mRNA expression in corticotroph tumor cells in female nude mice in vivo. Thus, these results indicate that RXR agonists, especially HX630, could be a new therapeutic candidate for Cushing's disease.	[Saito-Hakoda, Akiko; Yokoyama, Atsushi; Shimizu, Kyoko; Parvin, Rehana; Saito-Ito, Takako; Sato, Ikuko; Kogure, Naotaka; Shimada, Hiroki; Sugawara, Akira] Tohoku Univ, Grad Sch Med, Dept Mol Endocrinol, Sendai, Miyagi 980, Japan; [Uruno, Akira] Tohoku Univ, Grad Sch Med, Dept Med Biochem, Sendai, Miyagi 980, Japan; [Kudo, Masataka; Ito, Sadayoshi] Tohoku Univ, Grad Sch Med, Div Nephrol Endocrinol & Vasc Med, Sendai, Miyagi 980, Japan; [Suzuki, Dai; Fujiwara, Ikuma; Kure, Shigeo] Tohoku Univ, Grad Sch Med, Dept Pediat, Sendai, Miyagi 980, Japan; [Yoshikawa, Takeo] Tohoku Univ, Grad Sch Med, Dept Pharmacol, Sendai, Miyagi 980, Japan; [Kagechika, Hiroyuki] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, Tokyo, Japan; [Iwasaki, Yasumasa] Kochi Univ, Hlth Serv Ctr, Kochi 780, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tokyo Medical & Dental University (TMDU); Kochi University	Sugawara, A (corresponding author), Tohoku Univ, Grad Sch Med, Dept Mol Endocrinol, Sendai, Miyagi 980, Japan.	akiras2i@med.tohoku.ac.jp	Uruno, Akira/U-1812-2019; Yokoyama, Atsushi/W-3519-2019; Ito, Sadayoshi/A-3933-2015; Yoshikawa, Takeo/F-9599-2019; Yoshikawa, Takeo/U-1823-2019; Uruno, Akira/ABF-3988-2020	Yoshikawa, Takeo/0000-0002-7056-6021; Kagechika, Hiroyuki/0000-0002-6747-1013; Ito, Sadayoshi/0000-0002-5092-3626; Yokoyama, Atsushi/0000-0003-2842-4334; Sugawara, Akira/0000-0003-4511-8101	Ministry of Health, Labor and Welfare, Japan; Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was funded by Grants-in-Aid for Scientific Research (Research on Hypothalamo-hypophyseal Disorders) from the Ministry of Health, Labor and Welfare, Japan and Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Alexandraki KI, 2008, EXPERT OPIN INV DRUG, V17, P669, DOI [10.1517/13543784.17.5.669, 10.1517/13543784.17.5.669 ]; Altucci L, 2007, NAT REV DRUG DISCOV, V6, P793, DOI 10.1038/nrd2397; Bushue N, 2010, ADV DRUG DELIVER REV, V62, P1285, DOI 10.1016/j.addr.2010.07.003; Castillo V, 2006, ENDOCRINOLOGY, V147, P4438, DOI 10.1210/en.2006-0414; Crowe DL, 2004, BREAST CANCER RES, V6, pR546, DOI 10.1186/bcr913; CWIKEL BJ, 1987, J BIOL CHEM, V262, P14235; Dai AY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039950; Duvic M, 2001, ARCH DERMATOL, V137, P581; Feng Q, 2008, MOL CANCER THER, V7, P3780, DOI 10.1158/1535-7163.MCT-08-0753; Germain P, 2006, PHARMACOL REV, V58, P760, DOI 10.1124/pr.58.4.7; Giacomini D, 2006, ENDOCRINOLOGY, V147, P247, DOI 10.1210/en.2005-0958; Giraldi FP, 2012, J CLIN ENDOCR METAB, V97, P3577, DOI 10.1210/jc.2012-2328; Hashimoto K, 2011, NEUROSCI LETT, V494, P34, DOI 10.1016/j.neulet.2011.02.048; Heaney Anthony P, 2003, Pituitary, V6, P153, DOI 10.1023/B:PITU.0000011176.05771.46; Heaney AP, 2002, NAT MED, V8, P1281, DOI 10.1038/nm784; Howe LR, 2007, CLIN CANCER RES, V13, P5983, DOI 10.1158/1078-0432.CCR-07-1065; Ishida S, 2003, MOL CANCER THER, V2, P49; Jenks BG, 2009, ANN NY ACAD SCI, V1163, P17, DOI 10.1111/j.1749-6632.2008.03620.x; Kagechika H, 2005, J MED CHEM, V48, P5875, DOI 10.1021/jm0581821; Karalis KP, 2004, J BIOL CHEM, V279, P10837, DOI 10.1074/jbc.M313063200; Kudo M, 2014, WORLD J HYPERTENS, V4, P7; Labeur M, 2009, REV ENDOCR METAB DIS, V10, P103, DOI 10.1007/s11154-008-9080-6; Lamolet B, 2001, CELL, V104, P849, DOI 10.1016/S0092-8674(01)00282-3; Lefebvre P, 2010, TRENDS ENDOCRIN MET, V21, P676, DOI 10.1016/j.tem.2010.06.009; Liby KT, 2007, NAT REV CANCER, V7, P357, DOI 10.1038/nrc2129; Maira M, 1999, MOL CELL BIOL, V19, P7549; Matsumoto S, 2009, MOL ENDOCRINOL, V23, P47, DOI 10.1210/me.2007-0533; Miller VA, 1997, J CLIN ONCOL, V15, P790, DOI 10.1200/JCO.1997.15.2.790; Nishimaki-Mogami T, 2008, BIOCHEM PHARMACOL, V76, P1006, DOI 10.1016/j.bcp.2008.08.005; Paez-Pereda M, 2001, J CLIN INVEST, V108, P1123, DOI 10.1172/JCI11098; Perez E, 2012, BBA-MOL CELL BIOL L, V1821, P57, DOI 10.1016/j.bbalip.2011.04.003; Philips A, 1997, MOL CELL BIOL, V17, P5946; Poulin G, 1997, MOL CELL BIOL, V17, P6673, DOI 10.1128/MCB.17.11.6673; Qu LY, 2010, CANCER CHEMOTH PHARM, V65, P201, DOI 10.1007/s00280-009-1140-4; Spyroglou A, 2009, J MOL ENDOCRINOL, V42, P407, DOI 10.1677/JME-08-0167; SUGAWARA A, 1995, ENDOCRINOLOGY, V136, P1766, DOI 10.1210/en.136.4.1766; Sugawara A, 2002, J BIOL CHEM, V277, P9676, DOI 10.1074/jbc.M104560200; Takahashi B, 2002, J MED CHEM, V45, P3327, DOI 10.1021/jm0255320; Tanaka T, 2007, J BIOL CHEM, V282, P29987, DOI 10.1074/jbc.M701700200; Tanaka T, 2009, CANCER RES, V69, P4945, DOI 10.1158/0008-5472.CAN-08-4407; THERRIEN M, 1993, MOL CELL BIOL, V13, P2342, DOI 10.1128/MCB.13.4.2342; Tritos NA, 2011, NAT REV ENDOCRINOL, V7, P279, DOI 10.1038/nrendo.2011.12; Umemiya H, 1997, BIOCHEM BIOPH RES CO, V233, P121, DOI 10.1006/bbrc.1997.6414; Umemiya H, 1997, J MED CHEM, V40, P4222, DOI 10.1021/jm9704309; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; Uruno A, 2014, ENDOCR J, V61, P1105, DOI 10.1507/endocrj.EJ14-0115; WILSON TE, 1991, SCIENCE, V252, P1296, DOI 10.1126/science.1925541; Yen PM, 1996, J BIOL CHEM, V271, P10910, DOI 10.1074/jbc.271.18.10910; Zhang CL, 2002, CLIN CANCER RES, V8, P1234; ZHANG XK, 1992, NATURE, V358, P587, DOI 10.1038/358587a0	50	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 29	2015	10	12							e0141960	10.1371/journal.pone.0141960	http://dx.doi.org/10.1371/journal.pone.0141960			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA0IX	26714014	Green Published, Green Submitted, gold			2022-12-26	WOS:000367481900001
J	Foditsch, C; Pereira, RV; Ganda, EK; Gomez, MS; Marques, EC; Santin, T; Bicalho, RC				Foditsch, Carla; Pereira, Richard Van Vleck; Ganda, Erika Korzune; Gomez, Marilia Souza; Marques, Eduardo Carvalho; Santin, Thiago; Bicalho, Rodrigo Carvalho			Oral Administration of Faecalibacterium prausnitzii Decreased the Incidence of Severe Diarrhea and Related Mortality Rate and Increased Weight Gain in Preweaned Dairy Heifers	PLOS ONE			English	Article							BUTYRATE-PRODUCING BACTERIA; MILK REPLACER; RUMEN DEVELOPMENT; SODIUM-BUTYRATE; NEWBORN CALVES; WASTE MILK; GUT; INTESTINE; COMMUNITY; DISEASE	Probiotics are a promising alternative to improve food animal productivity and health. However, scientific evidence that specific microbes can be used to benefit animal health and performance is limited. The objective of this study was to evaluate the effects of administering a live culture of Faecalibacterium prausnitzii to newborn dairy calves on subsequent growth, health, and fecal microbiome. Initially, a safety trial was conducted using 30 newborn bull calves to assess potential adverse effects of the oral and rectal administration of F. prausnitzii to neonatal calves. No adverse reactions, such as increased body temperature or heart and respiratory rates, were observed after the administration of the treatments. All calves survived the experimental period, and there was no difference in fecal consistency score, attitude, appetite or dehydration between the treatment groups. The rectal route was not an efficient practice while the oral route ensures that the full dose is administered to the treated calves. Subsequently, a randomized field trial was completed in a commercial farm with preweaned calves. A total of 554 Holstein heifers were assigned to one of two treatment groups: treated calves (FPTRT) and non-treated calves (control). Treated calves received two oral doses of F. prausnitzii, one at treatment assignment (1st week) and another one week later. The FPTRT group presented significantly lower incidence of severe diarrhea (3.1%) compared with the control group (6.8%). Treated calves also had lower mortality rate associated with severe diarrhea (1.5%) compared to control calves (4.4%). Furthermore, FPTRT calves gained significantly more weight, 4.4 kg over the preweaning period, than controls calves. The relative abundance of F. prausnitzii in the fecal microbiota was significantly higher in the 3rd and 5th weeks of life of FPTRT calves than of the control calves, as revealed by sequencing of the 16S rRNA gene. Our findings showed that oral administration of F. prausnitzii improves gastrointestinal health and growth of preweaned calves, supporting its use as a potential probiotic.	[Foditsch, Carla; Pereira, Richard Van Vleck; Ganda, Erika Korzune; Gomez, Marilia Souza; Bicalho, Rodrigo Carvalho] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA; [Marques, Eduardo Carvalho; Santin, Thiago] Univ Sao Paulo, Coll Vet Med & Anim Sci, Dept Clin Sci, Sao Paulo, SP, Brazil	Cornell University; Universidade de Sao Paulo	Bicalho, RC (corresponding author), Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA.	rcb28@cornell.edu	Ganda, Erika/AAD-6286-2020; Pereira, Richard/L-2684-2019	Ganda, Erika/0000-0002-8735-0753; Pereira, Richard/0000-0003-2028-8761	Merck Animal Health	Merck Animal Health(Merck & Company)	This study was funded by Merck Animal Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by Merck Animal Health. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Ahmed AF, 2002, J DAIRY SCI, V85, P1502, DOI 10.3168/jds.S0022-0302(02)74219-7; [Anonymous], 2015, VET REC, V176, P666, DOI 10.1136/vr.h3339; Balamurugan R, 2010, BRIT J NUTR, V103, P335, DOI 10.1017/S0007114509992182; Baldwin R L, 2004, J DAIRY SCI, V87, pE55, DOI [10.3168/jds.2012-5970, DOI 10.3168/JDS.S0022-0302(04)70061-2]; Barcenilla A, 2000, APPL ENVIRON MICROB, V66, P1654, DOI 10.1128/AEM.66.4.1654-1661.2000; Beharka AA, 1998, J DAIRY SCI, V81, P1946, DOI 10.3168/jds.S0022-0302(98)75768-6; Bischoff SC, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/s12876-014-0189-7; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Bruss M. L., 1997, Clinical biochemistry of domestic animals., P83, DOI 10.1016/B978-012396305-5/50005-1; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edrington TS, 2012, J DAIRY SCI, V95, P4519, DOI 10.3168/jds.2011-5119; Foditsch C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116465; Galvao KN, 2005, REPROD NUTR DEV, V45, P427, DOI 10.1051/rnd:2005040; Geurts L, 2014, BENEF MICROBES, V5, P3, DOI 10.3920/BM2012.0065; Gilbert JA, 2010, STAND GENOMIC SCI, V3, P249, DOI [10.4056/aigs.1443528, 10.4056/sigs.1433550]; Gorka P, 2011, J DAIRY SCI, V94, P5578, DOI 10.3168/jds.2011-4166; Gorka P, 2011, J DAIRY SCI, V94, P3002, DOI 10.3168/jds.2010-3499; Guilloteau P, 2010, NUTR RES REV, V23, P366, DOI 10.1017/S0954422410000247; Haenen D, 2013, J NUTR, V143, P274, DOI 10.3945/jn.112.169672; Hill TM, 2010, J DAIRY SCI, V93, P1105, DOI 10.3168/jds.2009-2458; Hold GL, 2003, APPL ENVIRON MICROB, V69, P4320, DOI 10.1128/AEM.69.7.4320-4324.2003; Hollander D, 1999, Curr Gastroenterol Rep, V1, P410, DOI 10.1007/s11894-999-0023-5; Jami E, 2013, ISME J, V7, P1069, DOI 10.1038/ismej.2013.2; KEITH EA, 1983, J DAIRY SCI, V66, P833, DOI 10.3168/jds.S0022-0302(83)81864-5; Klein-Jobstl D, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00622; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Lund M, 2010, POULTRY SCI, V89, P1217, DOI 10.3382/ps.2010-00653; Machiels K., 2013, GUT; Malmuthuge N, 2014, APPL ENVIRON MICROB, V80, P2021, DOI 10.1128/AEM.03864-13; Martin R, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0400-1; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Mentschel J, 2001, ARCH ANIM NUTR, V55, P85, DOI 10.1080/17450390109386185; MINATO H, 1992, J GEN APPL MICROBIOL, V38, P447, DOI 10.2323/jgam.38.447; Miquel S, 2015, MBIO, V6, DOI 10.1128/mBio.00300-15; Nava GM, 2011, GUT MICROBES, V2, P99, DOI 10.4161/gmic.2.2.15416; Oikonomou G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063157; Ploger S, 2012, ANN NY ACAD SCI, V1258, P52, DOI 10.1111/j.1749-6632.2012.06553.x; Qiu XY, 2013, J CROHNS COLITIS, V7, pE558, DOI 10.1016/j.crohns.2013.04.002; Segain JP, 2000, GUT, V47, P397, DOI 10.1136/gut.47.3.397; Slusarczyk K, 2010, J ANIM FEED SCI, V19, P348; Soberon F, 2013, J ANIM SCI, V91, P706, DOI 10.2527/jas.2012-5834; Soberon F, 2012, J DAIRY SCI, V95, P783, DOI 10.3168/jds.2011-4391; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Steele MA, 2011, PHYSIOL GENOMICS, V43, P308, DOI 10.1152/physiolgenomics.00117.2010; Suau A, 2001, SYST APPL MICROBIOL, V24, P139, DOI 10.1078/0723-2020-00015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; USDA, 2012, DAIR HEIF RAIS 2011; USDA, 2010, HEIF CALF HLTH MAN P; Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118; Wang W, 2013, J CLIN MICROBIOL; World Health Organization, 2014, ANT RES GLOB REP SUR	53	56	62	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145485	10.1371/journal.pone.0145485	http://dx.doi.org/10.1371/journal.pone.0145485			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26710101	gold, Green Published, Green Submitted			2022-12-26	WOS:000367451400050
J	Gofton, AW; Doggett, S; Ratchford, A; Oskam, CL; Paparini, A; Ryan, U; Irwin, P				Gofton, Alexander W.; Doggett, Stephen; Ratchford, Andrew; Oskam, Charlotte L.; Paparini, Andrea; Ryan, Una; Irwin, Peter			Bacterial Profiling Reveals Novel "Ca. Neoehrlichia", Ehrlichia, and Anaplasma Species in Australian Human-Biting Ticks	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; IXODES-RICINUS TICKS; LYME-DISEASE; SPOTTED-FEVER; FAMILY ANAPLASMATACEAE; PHYLOGENETIC ANALYSIS; AMBLYOMMA-AMERICANUM; BORRELIA-AFZELII; GENE SEQUENCE; MIKURENSIS	In Australia, a conclusive aetiology of Lyme disease-like illness in human patients remains elusive, despite growing numbers of people presenting with symptoms attributed to tick bites. In the present study, we surveyed the microbial communities harboured by human-biting ticks from across Australia to identify bacteria that may contribute to this syndrome. Universal PCR primers were used to amplify the V1-2 hyper-variable region of bacterial 16S rRNA genes in DNA samples from individual Ixodes holocyclus (n = 279), Amblyomma triguttatum (n = 167), Haemaphysalis bancrofti (n = 7), and H. longicornis (n = 7) ticks. The 16S amplicons were sequenced on the Illumina MiSeq platform and analysed in USEARCH, QIIME, and BLAST to assign genus and species-level taxonomies. Nested PCR and Sanger sequencing were used to confirm the NGS data and further analyse novel findings. All 460 ticks were negative for Borrelia spp. by both NGS and nested PCR analysis. Two novel "Candidatus Neoehrlichia" spp. were identified in 12.9% of I. holocyclus ticks. A novel Anaplasma sp. was identified in 1.8% of A. triguttatum ticks, and a novel Ehrlichia sp. was identified in both A. triguttatum (1.2%) ticks and a single I. holocyclus (0.6%) tick. Further phylogenetic analysis of novel "Ca. Neoehrlichia", Anaplasma and Ehrlichia based on 1,265 bp 16S rRNA gene sequences suggests that these are new species. Determining whether these newly discovered organisms cause disease in humans and animals, like closely related bacteria do abroad, is of public health importance and requires further investigation.	[Gofton, Alexander W.; Oskam, Charlotte L.; Paparini, Andrea; Ryan, Una; Irwin, Peter] Murdoch Univ, Sch Vet & Life Sci, Vector & Water Borne Pathogen Res Grp, Perth, WA, Australia; [Doggett, Stephen] Westmead Hosp, Dept Med Entomol, Pathol West, Westmead, NSW 2145, Australia; [Doggett, Stephen] Westmead Hosp, Inst Clin Pathol & Med Res, Westmead, NSW 2145, Australia; [Ratchford, Andrew] Mona Vale Hosp, Emergency Dept, Sydney, NSW, Australia	Murdoch University; University of Sydney; University of Sydney	Gofton, AW (corresponding author), Murdoch Univ, Sch Vet & Life Sci, Vector & Water Borne Pathogen Res Grp, Perth, WA, Australia.	a.gofton@murdoch.edu.au; p.irwin@murdoch.edu.au	Gofton, Alexander W/GOJ-8010-2022; Oskam, Charlotte/N-4097-2018; Paparini, Andrea/T-8057-2019	Gofton, Alexander W/0000-0002-5039-6117; Oskam, Charlotte/0000-0001-8886-2120; Irwin, Peter/0000-0002-0006-8262; Ryan, Una/0000-0003-2710-9324; Paparini, Andrea/0000-0002-1105-5184	Australian Research Council [LP13010050]; Bayer Healthcare; Bayer Australia Ltd.	Australian Research Council(Australian Research Council); Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); Bayer Australia Ltd.	This study was part-funded by the Australian Research Council (LP13010050), www.arc.gov.au, Bayer Healthcare, www.healthcare.bayer.com, and Bayer Australia Ltd., www.bayer.com.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON BE, 1991, J CLIN MICROBIOL, V29, P2838, DOI 10.1128/JCM.29.12.2838-2842.1991; Andersson M, 2014, TICKS TICK-BORNE DIS, V5, P706, DOI 10.1016/j.ttbdis.2014.05.013; Andersson M, 2013, VECTOR-BORNE ZOONOT, V13, P438, DOI 10.1089/vbz.2012.1118; Andreasson K, 2015, RHEUMATOLOGY, V54, P369, DOI 10.1093/rheumatology/keu441; Barbour AG, 1996, J INFECT DIS, V173, P403, DOI 10.1093/infdis/173.2.403; Barker SC, 2014, INT J PARASITOL, V44, P941, DOI 10.1016/j.ijpara.2014.08.008; Barker SC, 2014, ZOOTAXA, V3816, P1, DOI 10.11646/zootaxa.3816.1.1; Brouqui P, 2003, ANN NY ACAD SCI, V990, P134, DOI 10.1111/j.1749-6632.2003.tb07352.x; CAMPBELL RW, 1974, T ROY SOC TROP MED H, V68, P397, DOI 10.1016/0035-9203(74)90156-4; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Childs JE, 2003, ANNU REV ENTOMOL, V48, P307, DOI 10.1146/annurev.ento.48.091801.112728; Clark KL, 2013, INT J MED SCI, V10, P915, DOI 10.7150/ijms.6273; Clarridge JE, 2004, CLIN MICROBIOL REV, V17, P840, DOI 10.1128/CMR.17.4.840-862.2004; Derdakova M, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-160; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Donohoe H, 2015, TOURISM MANAGE, V46, P408, DOI 10.1016/j.tourman.2014.07.006; DUMLER JS, 1995, CLIN INFECT DIS, V20, P1102, DOI 10.1093/clinids/20.5.1102; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fehr JS, 2010, EMERG INFECT DIS, V16, P1127, DOI 10.3201/eid1607.091907; Ferla MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083383; Foldvari G, 2014, EMERG INFECT DIS, V20, P496, DOI 10.3201/eid2003.130935; Glatz M, 2014, TICKS TICK-BORNE DIS, V5, P139, DOI 10.1016/j.ttbdis.2013.10.006; Gofton AW, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0958-3; Grankvist A, 2015, J CLIN MICROBIOL, V53, P3126, DOI 10.1128/JCM.00880-15; Grankvist A, 2015, EMERG INFECT DIS, V21, P1462, DOI 10.3201/eid2108.150060; Grankvist A, 2014, CLIN INFECT DIS, V58, P1716, DOI 10.1093/cid/ciu189; Gray J, 2002, LYME BORRELIOSIS BIO; Halperin JJ, 2015, INFECT DRUG RESIST, V8, DOI 10.2147/IDR.S66739; Hindson CM, 2013, NAT METHODS, V10, P1003, DOI 10.1038/nmeth.2633; Hodzic A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0692-x; Inokuma H, 2001, J CLIN MICROBIOL, V39, P3031, DOI 10.1128/JCM.39.9.3031-3039.2001; Janda JM, 2007, J CLIN MICROBIOL, V45, P2761, DOI 10.1128/JCM.01228-07; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kawahara M, 2004, INT J SYST EVOL MICR, V54, P1837, DOI 10.1099/ijs.0.63260-0; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kurilshikov A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131413; Li AY, 2010, VET MICROBIOL, V146, P59, DOI 10.1016/j.vetmic.2010.04.018; Li H, 2013, APPL ENVIRON MICROB, V79, P1024, DOI 10.1128/AEM.02917-12; Mayne P, 2014, J INSECT SCI, V14, DOI 10.1093/jisesa/ieu133; Mayne PJ, 2015, INT J GEN MED, V8, P15, DOI 10.2147/IJGM.S75825; Mc Pherson MJ MS., 2005, PCR BASICS BACKGROUN; McDiarmid L, 2000, INT J PARASITOL, V30, P791, DOI 10.1016/S0020-7519(00)00062-X; Mignard S, 2006, J MICROBIOL METH, V67, P574, DOI 10.1016/j.mimet.2006.05.009; Naitou H, 2006, MICROBIOL IMMUNOL, V50, P45, DOI 10.1111/j.1348-0421.2006.tb03769.x; Obiegala A, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0563-x; Paddock CD, 1997, J CLIN MICROBIOL, V35, P2496, DOI 10.1128/JCM.35.10.2496-2502.1997; Palomar AM, 2014, PARASITES VECTORS, V7; Pekova S, 2011, DIAGN MICR INFEC DIS, V69, P266, DOI 10.1016/j.diagmicrobio.2010.10.004; Pinheiro LB, 2012, ANAL CHEM, V84, P1003, DOI 10.1021/ac202578x; Rar V A, 2011, Mol Gen Mikrobiol Virusol, P17; Rar V, 2011, INFECT GENET EVOL, V11, P1842, DOI 10.1016/j.meegid.2011.09.019; Richter D, 2011, J CLIN MICROBIOL; Richter D, 2012, J CLIN MICROBIOL, V50, P943, DOI 10.1128/JCM.05802-11; Roberts F.H.S., 1970, AUSTR TICKS; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; RUSSELL RC, 1994, EPIDEMIOL INFECT, V112, P375, DOI 10.1017/S0950268800057782; Silaghi C, 2015, EXP APPL ACAROL; Silaghi C, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-191; Song S, 2011, INT J PARASITOL, V41, P871, DOI 10.1016/j.ijpara.2011.03.008; Stenos J, 2005, AM J TROP MED HYG, V73, P1083, DOI 10.4269/ajtmh.2005.73.1083; STEWART A, 1982, MED J AUSTRALIA, V1, P139, DOI 10.5694/j.1326-5377.1982.tb132207.x; STOTHARD DR, 1994, INT J SYST BACTERIOL, V44, P798, DOI 10.1099/00207713-44-4-798; Stuen S, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00031; Su ZQ, 2011, EXPERT REV MOL DIAGN, V11, P333, DOI [10.1586/ERM.11.3, 10.1586/erm.11.3]; Sumner JW, 1997, J CLIN MICROBIOL, V35, P2087, DOI 10.1128/JCM.35.8.2087-2092.1997; Szekeres S, 2015, TICKS TICK-BORNE DIS, V6, P111, DOI 10.1016/j.ttbdis.2014.10.004; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Unsworth NB, 2007, EMERG INFECT DIS, V13, P566; van Nunen S, 2015, ASIA PAC ALLERGY, V5, P3, DOI 10.5415/apallergy.2015.5.1.3; Vayssier-Taussat M, 2012, EMERG INFECT DIS, V18, P2063, DOI 10.3201/eid1812.120846; von Loewenich FD, 2010, J CLIN MICROBIOL, V48, P2630, DOI 10.1128/JCM.00588-10; Welc-Faleciak R, 2014, J CLIN MICROBIOL, V52, P3072, DOI 10.1128/JCM.00741-14; Welinder-Olsson C, 2010, J CLIN MICROBIOL, V48, P1956, DOI 10.1128/JCM.02423-09; WILLS MC, 1991, MED J AUSTRALIA, V155, P275, DOI 10.5694/j.1326-5377.1991.tb142253.x; Wojcik-Fatla A, 2015, TICKS TICK-BORNE DIS, V6, P253, DOI 10.1016/j.ttbdis.2015.01.005; Yabsley MJ, 2008, VET MICROBIOL, V131, P301, DOI 10.1016/j.vetmic.2008.04.004; Yabsley MJ, 2008, INT J SYST EVOL MICR, V58, P2794, DOI 10.1099/ijs.0.65836-0	79	46	46	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145449	10.1371/journal.pone.0145449	http://dx.doi.org/10.1371/journal.pone.0145449			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709826	Green Published, Green Submitted, gold			2022-12-26	WOS:000367451400047
J	Pavluvcik, P; Poprach, K; Machar, I; Losik, J; Gouveia, A; Tkadlec, E				Pavluvcik, Petr; Poprach, Karel; Machar, Ivo; Losik, Jan; Gouveia, Ana; Tkadlec, Emil			Barn Owl Productivity Response to Variability of Vole Populations	PLOS ONE			English	Article							TYTO-ALBA; ANTICIPATORY REPRODUCTION; NUMERICAL RESPONSE; MICROTUS-ARVALIS; PREY; DYNAMICS; PREDATOR; DENSITY; SIZE; FOOD	We studied the response of the barn owl annual productivity to the common vole population numbers and variability to test the effects of environmental stochasticity on their life histories. Current theory predicts that temporal environmental variability can affect long-term nonlinear responses (e.g., production of young) both positively and negatively, depending on the shape of the relationship between the response and environmental variables. At the level of the Czech Republic, we examined the shape of the relationship between the annual sum of fledglings (annual productivity) and vole numbers in both non-detrended and detrended data. At the districts' level, we explored whether the degree of synchrony (measured by the correlation coefficient) and the strength of the productivity response increase (measured by the regression coefficient) in areas with higher vole population variability measured by the s-index. We found that the owls' annual productivity increased linearly with vole numbers in the Czech Republic. Furthermore, based on district data, we also found that synchrony between dynamics in owls' reproductive output and vole numbers increased with vole population variability. However, the strength of the response was not affected by the vole population variability. Additionally, we have shown that detrending remarkably increases the Taylor's exponent b relating variance to mean in vole time series, thereby reversing the relationship between the coefficient of variation and the mean. This shift was not responsible for the increased synchrony with vole population variability. Instead, we suggest that higher synchrony could result from high food specialization of owls on the common vole in areas with highly fluctuating vole populations.	[Pavluvcik, Petr; Losik, Jan; Gouveia, Ana; Tkadlec, Emil] Palacky Univ, Fac Sci, Dept Ecol & Environm Sci, CR-77147 Olomouc, Czech Republic; [Poprach, Karel] TYTO Obcanske Sdruzeni, Nenakonice, Verovany, Czech Republic; [Machar, Ivo] Palacky Univ, Fac Sci, Dept Dev Studies, CR-77147 Olomouc, Czech Republic; [Tkadlec, Emil] Acad Sci Czech Republ, Inst Vertebrate Biol, Brno, Czech Republic	Palacky University Olomouc; Palacky University Olomouc; Czech Academy of Sciences; Institute of Vertebrate Biology of the Czech Academy of Sciences	Tkadlec, E (corresponding author), Palacky Univ, Fac Sci, Dept Ecol & Environm Sci, CR-77147 Olomouc, Czech Republic.	emil.tkadlec@upol.cz	Tkadlec, Emil/A-6230-2014; Gouveia, Ana/AAQ-6166-2020	Gouveia, Ana/0000-0002-9711-4367; Tkadlec, Emil/0000-0003-3782-8867	POSTUP I project [CZ.1.07/2.3.00/30.0004]; Ministry of the Environment, Landscape Management Fund; Ministry of the Environment; County of Pardubice; County of Olomouc; County of Zlin; DEFRA Environment Assistance Fund [EF/33/02]; Iceland, Liechtenstein and Norway through the EEA Financial Mechanism; Iceland, Liechtenstein and Norway through the Norwegian Financial Mechanism; Usti Community Foundation; VIA Foundation [TMHK 008/2010];  [IGA_PrF_2015_008];  [N-2036]	POSTUP I project; Ministry of the Environment, Landscape Management Fund; Ministry of the Environment(Ministry of the Environment, Japan); County of Pardubice; County of Olomouc; County of Zlin; DEFRA Environment Assistance Fund; Iceland, Liechtenstein and Norway through the EEA Financial Mechanism; Iceland, Liechtenstein and Norway through the Norwegian Financial Mechanism; Usti Community Foundation; VIA Foundation; ; 	The work was funded by grant IGA_PrF_2015_008 to E.T.; POSTUP I project CZ.1.07/2.3.00/30.0004 to E.T; Ministry of the Environment, Landscape Management Fund to I.M. and K.P.; Ministry of the Environment to I.M.; County of Pardubice to I.M.; County of Olomouc to I.M.; County of Zlin to I.M.; DEFRA Environment Assistance Fund EF/33/02 to I.M.; Iceland, Liechtenstein and Norway through the EEA Financial Mechanism and the Norwegian Financial Mechanism intermediated by the Civil Society Development to I.M.; the Partnership Foundation, N-2036, to I.M.; the Usti Community Foundation to I.M.; and VIA Foundation TMHK 008/2010 to I.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGERBJORN A, 1991, J ANIM ECOL, V60, P705, DOI 10.2307/5307; Angerbjorn A, 1999, J ANIM ECOL, V68, P34, DOI 10.1046/j.1365-2656.1999.00258.x; [Anonymous], 2014, R LANG ENV STAT COMP; Baines D, 2013, J APPL ECOL, V50, P1397, DOI 10.1111/1365-2664.12154; Barraquand F, 2014, POPUL ECOL, V56, P551, DOI 10.1007/s10144-014-0440-7; Barraquand F, 2014, J ANIM ECOL, V83, P375, DOI 10.1111/1365-2656.12140; Bernard N, 2010, CAN J ZOOL, V88, P416, DOI 10.1139/Z10-011; Bond G, 2005, LANDSCAPE ECOL, V20, P555, DOI 10.1007/s10980-004-5037-7; Boutin S, 2006, SCIENCE, V314, P1928, DOI 10.1126/science.1135520; Brommer JE, 2002, AUK, V119, P544, DOI 10.1642/0004-8038(2002)119[0544:RASIAV]2.0.CO;2; Bryja J, 2005, CAN J ZOOL, V83, P1391, DOI 10.1139/Z05-133; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Charter M, 2015, J ARID ENVIRON, V122, P59, DOI 10.1016/j.jaridenv.2015.06.011; Cohen Dan, 1993, Lecture Notes in Biomathematics, V98, P8; DEBRUIJN O, 1994, ARDEA, V82, P1; GASTON KJ, 1994, PHILOS T R SOC B, V345, P335, DOI 10.1098/rstb.1994.0114; Gouveia A, 2015, POPUL ECOL, V57, P581, DOI 10.1007/s10144-015-0504-3; Granger CW., 1974, J ECONOMETRICS, V2, P111, DOI [DOI 10.1016/0304-4076(74)90034-7, 10.1016/0304-4076(74)90034-7]; Honer M. R., 1963, Ardea, V51, P158; Husek J, 2013, POPUL ECOL, V55, P363, DOI 10.1007/s10144-013-0366-5; JAKSIC FM, 1992, OECOLOGIA, V89, P90, DOI 10.1007/BF00319020; Kontiainen P, 2009, BEHAV ECOL, V20, P789, DOI 10.1093/beheco/arp062; Lande R., 2003, OXFORD SERIES ECOLOG; LINDSTROM E, 1988, OIKOS, V52, P115, DOI 10.2307/3565990; Linnerud M, 2013, OIKOS, V122, P1207, DOI 10.1111/j.1600-0706.2012.20517.x; Lisicka L, 2007, FOLIA ZOOL, V56, P169; MARTI CD, 1994, CONDOR, V96, P468, DOI 10.2307/1369329; MCARDLE BH, 1990, J ANIM ECOL, V59, P439, DOI 10.2307/4873; Millon A, 2008, OIKOS, V117, P1500, DOI 10.1111/j.0030-1299.2008.16458.x; Ostfeld RS, 2000, TRENDS ECOL EVOL, V15, P232, DOI 10.1016/S0169-5347(00)01862-0; Otis DL., 1982, CAPTURE RECAPTURE RE; Pertoldi C, 2014, THEOR BIOSCI, V133, P165, DOI 10.1007/s12064-014-0201-3; Royama T., 1992, ANAL POPULATION ECOL; Ruel JJ, 1999, TRENDS ECOL EVOL, V14, P361, DOI 10.1016/S0169-5347(99)01664-X; Salamolard M, 2000, ECOLOGY, V81, P2428, DOI 10.1890/0012-9658(2000)081[2428:ROAAPT]2.0.CO;2; Schonfeld M., 1975, Hercynia N F, V12, P257; Sundell J, 2003, ACTA THERIOL, V48, P59, DOI 10.1007/BF03194266; Taylor I. R, 1994, BARN OWLS PREDATOR P; Tkadlec E, 2001, P ROY SOC B-BIOL SCI, V268, P1547, DOI 10.1098/rspb.2001.1694; Tkadlec E, 2006, CLIM RES, V32, P99, DOI 10.3354/cr032099; Toms MP, 1994, RAPTOR, V21, P57; Turchin Peter, 2003, Monographs in Population Biology, V35, pi; Valkama J, 2002, J AVIAN BIOL, V33, P426, DOI 10.1034/j.1600-048X.2002.02875.x; White TCR, 2013, NEW ZEAL J ZOOL, V40, P332, DOI 10.1080/03014223.2013.798336; Yang LH, 2008, ECOLOGY, V89, P621, DOI 10.1890/07-0175.1; Yang LH, 2010, ECOL MONOGR, V80, P125, DOI 10.1890/08-1996.1; Yoccoz NG, 2009, ENVIRON INT, V35, P107, DOI 10.1016/j.envint.2008.08.014	47	10	12	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 28	2015	10	12							e0145851	10.1371/journal.pone.0145851	http://dx.doi.org/10.1371/journal.pone.0145851			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ9XO	26709518	Green Published, gold, Green Submitted			2022-12-26	WOS:000367451400085
J	Chen, CQ; Lu, ML; Pan, QH; Fichna, J; Zheng, LJ; Wang, KS; Yu, Z; Li, YY; Li, K; Song, AH; Liu, ZC; Song, ZS; Kreis, M				Chen, Chunqiu; Lu, Meiling; Pan, Qiuhui; Fichna, Jakub; Zheng, Lijun; Wang, Kesheng; Yu, Zhen; Li, Yongyu; Li, Kun; Song, Aihong; Liu, Zhongchen; Song, Zhenshun; Kreis, Martin			Berberine Improves Intestinal Motility and Visceral Pain in the Mouse Models Mimicking Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) Symptoms in an Opioid-Receptor Dependent Manner	PLOS ONE			English	Article							QUALITY-OF-LIFE; ABDOMINAL-PAIN; DELTA; MICE; RATS; MU; FACILITATION; DISORDERS; EFFICACY; BEHAVIOR	Background and Aims Berberine and its derivatives display potent analgesic, anti-inflammatory and anticancer activity. Here we aimed at characterizing the mechanism of action of berberine in the gastrointestinal (GI) tract and cortical neurons using animal models and in vitro tests. Methods The effect of berberine was characterized in murine models mimicking diarrhea-predominant irritable bowel syndrome (IBS-D) symptoms. Then the opioidantagonists were used to identify the receptors involved. Furthermore, the effect of berberineon opioid receptors expression was established in the mouse intestine and rat fetal cortical neurons. Results In mouse models, berberine prolonged GI transit and time to diarrhea in a dose-dependent manner, and significantly reduced visceral pain. In physiological conditions the effects of berberine were mediated by mu-(MOR) and delta-(DOR) opioidreceptors; hypermotility, excessive secretion and nociception were reversed by berberine through MOR and DOR-dependent action. We also found that berberine increased the expression of MOR and DOR in the mouse bowel and rat fetal cortical neurons. Conclusion Berberine significantly improved IBS-D symptoms in animal models, possibly through mu-and delta-opioid receptors. Berberine may become a new drug candidate for the successful treatment of IBS-D in clinical conditions.	[Chen, Chunqiu; Lu, Meiling; Pan, Qiuhui; Zheng, Lijun; Wang, Kesheng; Yu, Zhen; Song, Aihong; Liu, Zhongchen; Song, Zhenshun] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Shanghai 200092, Peoples R China; [Fichna, Jakub] Med Univ Lodz, Dept Biochem, Lodz, Poland; [Li, Yongyu; Li, Kun] Tongji Univ, Dept Pathophysiol, Inst Digest Dis, Sch Med, Shanghai 200092, Peoples R China; [Kreis, Martin] Charite, Dept Gen Visceral & Vasc Surg, D-13353 Berlin, Germany	Tongji University; Medical University Lodz; Tongji University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Fichna, J (corresponding author), Med Univ Lodz, Dept Biochem, Lodz, Poland.	jakub.fichna@umed.lodz.pl	Fichna, Jakub/S-6641-2016	Fichna, Jakub/0000-0002-8443-4417; Kreis, Martin E./0000-0002-9312-4840	National Science Foundation of China [81170345, 31571181]; bilateral cooperation project between China and Poland from the Ministry of Science and technology [36-25]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); bilateral cooperation project between China and Poland from the Ministry of Science and technology	This work was supported by grants awarded to Dr. Chunqiu Chen and Dr. Yongyu Li from the National Science Foundation of China (No. 81170345 and No. 31571181), and by bilateral cooperation project between China and Poland from the Ministry of Science and technology (Chunqiu Chen and Jakub Fichna No. 36-25, 2015).	Altarifi AA, 2015, J PHARMACOL EXP THER, V352, P208, DOI 10.1124/jpet.114.219873; Bhutada P, 2011, BEHAV BRAIN RES, V220, P30, DOI 10.1016/j.bbr.2011.01.022; Bodnar RJ, 2013, PEPTIDES, V50, P55, DOI 10.1016/j.peptides.2013.10.001; Bray BD, 2006, BRIT J GEN PRACT, V56, P122; Brocardo PS, 2009, BEHAV BRAIN RES, V200, P122, DOI 10.1016/j.bbr.2009.01.004; Chen CQ, 2014, AM J CHINESE MED, V42, P1053, DOI 10.1142/S0192415X14500669; Chen DP, 2013, J PHARM PHARMACOL, V65, P734, DOI 10.1111/jphp.12026; CORAZZIARI E, 1999, CAN J GASTROENTEROL, V13, P71; Dahan A, 2015, PAIN, V156, pS119, DOI [10.1097/01.j.pain.0000460340.62094.3e, 10.1016/j.pain.0000000000000023]; Derosa G, 2012, EXPERT OPIN BIOL TH, V12, P1113, DOI 10.1517/14712598.2012.704014; Dong H, 2013, PLANTA MED, V79, P437, DOI 10.1055/s-0032-1328321; Feng YJ, 2013, PHYTOTHER RES, V27, P1564, DOI 10.1002/ptr.4926; Fichna J, 2012, PHARMACOL REP, V64, P1146, DOI 10.1016/S1734-1140(12)70911-8; Filliol D, 2000, NAT GENET, V25, P195, DOI 10.1038/76061; He SQ, 2011, NEURON, V69, P120, DOI 10.1016/j.neuron.2010.12.001; Hsu YY, 2013, TOXICOL APPL PHARM, V272, P787, DOI 10.1016/j.taap.2013.08.008; Ide S, 2010, NEUROPHARMACOLOGY, V58, P241, DOI 10.1016/j.neuropharm.2009.07.005; Ito D, 2013, BRAIN RES, V1534, P22, DOI 10.1016/j.brainres.2013.08.004; Jerndal P, 2010, NEUROGASTROENT MOTIL, V22, P646, DOI 10.1111/j.1365-2982.2010.01493.x; Kabli N, 2014, MOL PSYCHIATR, V19, P986, DOI 10.1038/mp.2013.115; Kulkarni SK, 2010, PHYTOTHER RES, V24, P317, DOI 10.1002/ptr.2968; Martini C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128997; Matsumoto K, 2014, J PHARMACOL EXP THER, V348, P383, DOI 10.1124/jpet.113.208108; Mo CF, 2014, ANTIOXID REDOX SIGN, V20, P574, DOI 10.1089/ars.2012.5116; Normandin A, 2013, J NEUROSCI, V33, P11703, DOI 10.1523/JNEUROSCI.1631-13.2013; Nozaki C, 2014, BRIT J PHARMACOL, V171, P5376, DOI 10.1111/bph.12852; Ong Edmund W, 2014, Cells, V3, P152, DOI 10.3390/cells3010152; Peng WH, 2007, LIFE SCI, V81, P933, DOI 10.1016/j.lfs.2007.08.003; Pradhan AA, 2011, TRENDS PHARMACOL SCI, V32, P581, DOI 10.1016/j.tips.2011.06.008; Saitoh A, 2012, CURR NEUROPHARMACOL, V10, P231, DOI 10.2174/157015912803217314; Sauriyal DS, 2011, NEUROPEPTIDES, V45, P175, DOI 10.1016/j.npep.2010.12.004; Scherrer G, 2009, CELL, V137, P1148, DOI 10.1016/j.cell.2009.04.019; Sobczak M, 2014, PEPTIDES, V60, P102, DOI 10.1016/j.peptides.2014.08.005; Tan Wen, 2011, Int J Nanomedicine, V6, P1773, DOI 10.2147/IJN.S22683; Tang QL, 2013, WORLD J GASTROENTERO, V19, P4582, DOI 10.3748/wjg.v19.i28.4582; Wagner JJ, 2001, J PHARMACOL EXP THER, V296, P776; Werner MU, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125887; Xu SY, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/803930; Zhang X, 2015, BRIT J PHARMACOL, V172, P364, DOI 10.1111/bph.12653; Zielinska M, 2015, J PHARM PHARMACOL, V67, P244, DOI 10.1111/jphp.12335	40	32	36	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145556	10.1371/journal.pone.0145556	http://dx.doi.org/10.1371/journal.pone.0145556			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26700862	gold, Green Published, Green Submitted			2022-12-26	WOS:000367092600095
J	Gonella-Diaza, AM; Andrade, SCD; Sponchiado, M; Pugliesi, G; Mesquita, FS; Van Hoeck, V; Strefezzi, RD; Gasparin, GR; Coutinho, LL; Binelli, M				Gonella-Diaza, Angela Maria; da Silva Andrade, Sonia Cristina; Sponchiado, Mariana; Pugliesi, Guilherme; Mesquita, Fernando Silveira; Van Hoeck, Veerle; Strefezzi, Ricardo de Francisco; Gasparin, Gustavo R.; Coutinho, Luiz L.; Binelli, Mario			Size of the Ovulatory Follicle Dictates Spatial Differences in the Oviductal Transcriptome in Cattle	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX COMPONENTS; RETINOL-BINDING-PROTEIN; BOVINE OVIDUCT; EMBRYO DEVELOPMENT; ESTROUS-CYCLE; PROGESTERONE-RECEPTOR; MORPHOLOGICAL-CHANGES; EXPRESSION ANALYSIS; GENE-EXPRESSION; EARLY DIESTRUS	In cattle, molecular control of oviduct receptivity to the embryo is poorly understood. Here, we used a bovine model for receptivity based on size of the pre-ovulatory follicle to compare oviductal global and candidate gene transcript abundance on day 4 of the estrous cycle. Growth of the pre-ovulatory follicle (POF) of Nelore (Bos indicus) cows was manipulated to produce two groups: large POF large corpus luteum (CL) group (LF-LCL; greater receptivity) and small POF-small CL group (SF-SCL). Oviductal samples were collected four days after GnRH-induced ovulation. Ampulla and isthmus transcriptome was obtained by RNA-seq, regional gene expression was assessed by qPCR, and PGR and ERa protein distribution was evaluated by immunohistochemistry. There was a greater abundance of PGR and ERa in the oviduct of LF-LCL animals thus indicating a greater availability of receptors and possibly sex steroids stimulated signaling in both regions. Transcriptomic profiles indicated a series of genes associated with functional characteristics of the oviduct that are regulated by the periovulatory sex steroid milieu and that potentially affect oviductal receptivity and early embryo development. They include tissue morphology changes (extra cellular matrix remodeling), cellular changes (proliferation), and secretion changes (growth factors, ions and metal transporters), and were enriched for the genes with increased expression in the LF-LCL group. In conclusion, differences in the periovulatory sex steroid milieu lead to different oviductal gene expression profiles that could modify the oviductal environment to affect embryo survival and development.	[Gonella-Diaza, Angela Maria; Sponchiado, Mariana; Pugliesi, Guilherme; Van Hoeck, Veerle; Binelli, Mario] Univ Sao Paulo, Fac Med Vet & Zootecnia, Sao Paulo, Brazil; [da Silva Andrade, Sonia Cristina; Gasparin, Gustavo R.; Coutinho, Luiz L.] Univ Sao Paulo, Lab Biotecnol Anim, Escola Super Agr Luiz de Queiroz, Piracicaba, SP, Brazil; [Mesquita, Fernando Silveira] Univ Fed Pampa, Fac Med Vet, Uruguaiana, Brazil; [Strefezzi, Ricardo de Francisco] Univ Sao Paulo, Fac Zootecnia & Engn Alimentos, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal do Pampa; Universidade de Sao Paulo	Binelli, M (corresponding author), Univ Sao Paulo, Fac Med Vet & Zootecnia, Sao Paulo, Brazil.	binelli@usp.br	Coutinho, Luiz L/C-8455-2012; MESQUITA, FERNANDO SILVEIRA/J-9978-2012; huang, dezhi/ABC-6566-2021; Strefezzi, Ricardo F/B-8754-2010; Pugliesi, Guilherme/AAK-9557-2020; pugliesi, Guilherme/A-9149-2013; Coutinho, Luiz/P-5233-2019; Andrade, Sonia/GLS-1234-2022	Coutinho, Luiz L/0000-0002-7266-8881; MESQUITA, FERNANDO SILVEIRA/0000-0002-4433-0832; Strefezzi, Ricardo F/0000-0002-8810-2815; Pugliesi, Guilherme/0000-0001-5739-0677; Coutinho, Luiz/0000-0002-7266-8881; Andrade, Sonia/0000-0002-1302-5261	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); PEC-PG program [15068-12-9]; National Counsel of Technological and Scientific Development (CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/03226-4]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); PEC-PG program; National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was funded by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); PEC-PG program: AMGD grant number 15068-12-9; National Counsel of Technological and Scientific Development (CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP): MB grant number 2011/03226-4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 1996, HISTOL HISTOPATHOL, V11, P743; Ahumada CJ, 2013, ANIMAL, V7, P455, DOI 10.1017/S1751731112001991; Alminana C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-293; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Araujo ER, 2014, REPROD FERTIL DEV, V87; Aviles M, 2010, MOL HUM REPROD, V16, P896, DOI 10.1093/molehr/gaq056; Ayen E, 2012, IRAN J VET RES, V13, P42; Batzios SP, 2013, FEBS LETT, V587, P1258, DOI 10.1016/j.febslet.2013.02.035; Bauersachs S, 2005, J MOL ENDOCRINOL, V34, P889, DOI 10.1677/jme.1.01799; Bauersachs S, 2003, BIOL REPROD, V68, P1170, DOI 10.1095/biolreprod.102.010660; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Binelli M, 1999, BIOL REPROD, V61, P127, DOI 10.1095/biolreprod61.1.127; Block J, 2003, J ANIM SCI, V81, P1590; Bridges GA, 2012, ANIM REPROD SCI, V133, P16, DOI 10.1016/j.anireprosci.2012.06.013; Bridges GA, 2010, ANIM REPROD SCI, V117, P208, DOI 10.1016/j.anireprosci.2009.05.002; Brower L. K., 1969, Biology of Reproduction, V1, P130, DOI 10.1095/biolreprod1.2.130; Brown RD, 2005, ANNU REV PHARMACOL, V45, P657, DOI 10.1146/annurev.pharmtox.45.120403.095802; Buhi WC, 2000, CELLS TISSUES ORGANS, V166, P165, DOI 10.1159/000016731; Capiod T, 2013, RECENT PAT ANTI-CANC, V8, P4; Cerny KL, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0077-1; Cigankova V, 1996, VET MED-CZECH, V41, P339; Clemmons DR, 2007, NAT REV DRUG DISCOV, V6, P821, DOI 10.1038/nrd2359; Cox TR, 2011, DIS MODEL MECH, V4, P165, DOI 10.1242/dmm.004077; Daley WP, 2013, CURR OPIN GENET DEV, V23, P408, DOI 10.1016/j.gde.2013.05.005; Dennis G, 2003, GENOME BIOL, V4; ERIKSEN T, 1994, ANAT EMBRYOL, V190, P583; Forde N, 2011, BIOL REPROD, V84, P266, DOI 10.1095/biolreprod.110.085910; Forde N, 2013, BMC GENOMICS, P14; Gabler C, 2001, REPRODUCTION, V122, P121, DOI 10.1530/rep.0.1220121; GANDOLFI F, 1989, DEVELOPMENT, V106, P303; Garbarino EJ, 2004, J DAIRY SCI, V87, P4123, DOI 10.3168/jds.S0022-0302(04)73555-9; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; George F, 2008, THERIOGENOLOGY, V69, P612, DOI 10.1016/j.theriogenology.2007.11.008; Hugentobler SA, 2010, REPROD FERT DEVELOP, V22, P684, DOI 10.1071/RD09129; Hunter RHF, 2012, BIOL REV, V87, P244, DOI 10.1111/j.1469-185X.2011.00196.x; Hunter RHF, 1998, ACTA OBSTET GYN SCAN, V77, P475, DOI 10.1034/j.1600-0412.1998.770501.x; HUNTER RHF, 1991, TISSUE CELL, V23, P641, DOI 10.1016/0040-8166(91)90020-T; KASTELIC JP, 1990, THERIOGENOLOGY, V34, P487, DOI 10.1016/0093-691X(90)90006-F; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kolle S, 2009, BIOL REPROD, V81, P267, DOI 10.1095/biolreprod.108.073874; Kurzawa Rafal, 2002, Reprod Biol, V2, P143; Kutys ML, 2013, EXP CELL RES, V319, P2434, DOI 10.1016/j.yexcr.2013.05.030; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee Y, 1996, P NATL ACAD SCI USA, V93, P15180, DOI 10.1073/pnas.93.26.15180; Lee YJ, 1998, MOL CELL ENDOCRINOL, V137, P85, DOI 10.1016/S0303-7207(97)00235-9; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RF, 2007, MOL REPROD DEV, V74, P1228, DOI 10.1002/mrd.20682; Lu PF, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005058; Maillo V, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.115.127969; Mesquita FS, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.129031; Mesquita FS, 2014, THERIOGENOLOGY, V81, P861, DOI 10.1016/j.theriogenology.2013.12.022; Mondejar I, 2012, REPROD DOMEST ANIM, V47, P22, DOI 10.1111/j.1439-0531.2012.02027.x; MURRAY MK, 1995, BIOL REPROD, V53, P653, DOI 10.1095/biolreprod53.3.653; Neve A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/756078; Peres RFG, 2009, THERIOGENOLOGY, V72, P681, DOI 10.1016/j.theriogenology.2009.04.026; Pugliesi G, 2014, REPROD DOMEST ANIM, V49, P85, DOI 10.1111/rda.12231; Ramos RS, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0036-x; ROTELLO RJ, 1991, P NATL ACAD SCI USA, V88, P3412, DOI 10.1073/pnas.88.8.3412; Shimizu T, 2010, PHYSIOL GENOMICS, V42A, P290, DOI 10.1152/physiolgenomics.00107.2010; Siddiqui MAR, 2009, REPRODUCTION, V137, P689, DOI 10.1530/REP-08-0403; Smit A., REPEATMASKER OPEN 3; Takahashi M, 2012, J REPROD DEVELOP, V58, P1, DOI 10.1262/jrd.11-138N; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Ulbrich SE, 2003, J STEROID BIOCHEM, V84, P279, DOI 10.1016/S0960-0760(03)00039-6; VALLET JL, 1995, BIOL REPROD, V53, P1436, DOI 10.1095/biolreprod53.6.1436; Vallet JL, 1996, BIOL REPROD, V55, P1172, DOI 10.1095/biolreprod55.5.1172; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Walsh B, 2009, REDOX REP, V14, P275, DOI 10.1179/135100009X12525712409652; Wijayagunawardane MPB, 1998, THERIOGENOLOGY, V49, P607, DOI 10.1016/S0093-691X(98)00011-9; Zervomanolakis I, 2009, EUR J OBSTET GYN R B, V144, pS45, DOI 10.1016/j.ejogrb.2009.02.012	70	27	27	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145321	10.1371/journal.pone.0145321	http://dx.doi.org/10.1371/journal.pone.0145321			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26699362	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092600066
J	Hagiwara, K; Ishii, H; Murakami, T; Takeshima, SN; Chutiwitoonchai, N; Kodama, EN; Kawaji, K; Kondoh, Y; Honda, K; Osada, H; Tsunetsugu-Yokota, Y; Suzuki, M; Aida, Y				Hagiwara, Kyoji; Ishii, Hideki; Murakami, Tomoyuki; Takeshima, Shin-nosuke; Chutiwitoonchai, Nopporn; Kodama, Eiichi N.; Kawaji, Kumi; Kondoh, Yasumitsu; Honda, Kaori; Osada, Hiroyuki; Tsunetsugu-Yokota, Yasuko; Suzuki, Masaaki; Aida, Yoko			Synthesis of a Vpr-Binding Derivative for Use as a Novel HIV-1 Inhibitor	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; TERMINALLY TRUNCATED FORM; VIRAL PROTEIN R; NUCLEAR IMPORT; CELL-CYCLE; ALPHA; APOPTOSIS; REPLICATION; MACROPHAGES; ACTIVATION	The emergence of multidrug-resistant viruses compromises the efficacy of anti-human immunodeficiency virus type 1 (HIV-1) therapy and limits treatment options. Therefore, new targets that can be used to develop novel antiviral agents need to be identified. We previously identified a potential parent compound, hematoxylin, which suppresses the nuclear import of HIV-1 via the Vpr-importin a interaction and inhibits HIV-1 replication in a Vpr-dependent manner by blocking nuclear import of the pre-integration complex. However, it was unstable. Here, we synthesized a stable derivative of hematoxylin that bound specifically and stably to Vpr and inhibited HIV-1 replication in macrophages. Furthermore, like hematoxylin, the derivative inhibited nuclear import of Vpr in an in vitro nuclear import assay, but had no effect on Vpr-induced G2/M phase cell cycle arrest or caspase activity. Interestingly, this derivative bound strongly to amino acid residues 54-74 within the C-terminal a-helical domain (alpha H3) of Vpr. These residues are highly conserved among different HIV strains, indicating that this region is a potential target for drug-resistant HIV-1 infection. Thus, we succeeded in developing a stable hematoxylin derivative that bound directly to Vpr, suggesting that specific inhibitors of the interaction between cells and viral accessory proteins may provide a new strategy for the treatment of HIV-1 infection.	[Hagiwara, Kyoji; Murakami, Tomoyuki; Takeshima, Shin-nosuke; Chutiwitoonchai, Nopporn; Aida, Yoko] RIKEN, Viral Infect Dis Unit, Wako, Saitama 3510198, Japan; [Ishii, Hideki; Suzuki, Masaaki] RIKEN, Mol Imaging Med Chem Lab, Ctr Mol Imaging Sci, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Kodama, Eiichi N.; Kawaji, Kumi] Tohoku Univ, Grad Sch Med, Div Miyagi Community Hlth Promot, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Kondoh, Yasumitsu; Honda, Kaori; Osada, Hiroyuki] RIKEN, CSRS, Chem Biol Res Grp, Wako, Saitama 3510198, Japan; [Tsunetsugu-Yokota, Yasuko] Natl Inst Infect Dis, Dept Frontier Biosci, Dept Immunol, Shinjuku Ku, Tokyo 1628640, Japan	RIKEN; RIKEN; Tohoku University; RIKEN; National Institute of Infectious Diseases (NIID)	Aida, Y (corresponding author), RIKEN, Viral Infect Dis Unit, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	aida@riken.jp	Kodama, Eiichi N/C-4032-2009; Osada, Hiroyuki/N-4305-2014; KONDOH, Yasumitsu/C-7461-2017; Osada, Hiroyuki/AAY-6254-2020; Takeshima, Shinnosuke/E-1246-2011	Kodama, Eiichi N/0000-0002-6622-2752; KONDOH, Yasumitsu/0000-0002-3481-5481; Takeshima, Shinnosuke/0000-0001-9648-0480; Ishii, Hideki/0000-0003-4348-0123; ISHII, HIDEKI/0000-0003-2408-4897	Health Sciences Research Grant from the Ministry of Health, Labor and Welfare of Japan, Research on HIV/AIDS [H25-AIDS-003, 15fk0410010h0002]; Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) of Japan [06-01]; Grants-in-Aid for Scientific Research [26350976] Funding Source: KAKEN	Health Sciences Research Grant from the Ministry of Health, Labor and Welfare of Japan, Research on HIV/AIDS; Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Health Sciences Research Grant from the Ministry of Health, Labor and Welfare of Japan, Research on HIV/AIDS (ID: H25-AIDS-003 and ID: 15fk0410010h0002, http://www.jhsf.or.jp/English/index_e.html), and by the Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) of Japan (ID 06-01, http://www.nibio.go.jp/english/index.html).; We are grateful to Drs. Norio Yamamoto, Naoki Yamamoto, Yuetsu Tanaka, and Kazu Okuma for help with the viral infection experiments. We are also grateful to the RIKEN BSI Research Resources Center for help with sequence analysis. This work was supported in part by a Health Sciences Research Grant from the Ministry of Health, Labor and Welfare of Japan, Research on HIV/AIDS: (ID: H25-AIDS-003 and ID: 15fk0410010h0002, http://www.jhsf.or.jp/English/index_e.html), and by the Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) of Japan (ID 06-01: http://www.nibio.go.jp/english/index.html).	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Aida Y, 2010, CURR CHEM BIOL, V4, P188; Ayyavoo V, 1997, NAT MED, V3, P1117, DOI 10.1038/nm1097-1117; Barbaro G, 2005, CURR PHARM DESIGN, V11, P1805, DOI 10.2174/1381612053764869; Bukrinsky M, 1999, REV MED VIROL, V9, P39, DOI 10.1002/(SICI)1099-1654(199901/03)9:1<39::AID-RMV235>3.0.CO;2-3; Felzien LK, 1998, P NATL ACAD SCI USA, V95, P5281, DOI 10.1073/pnas.95.9.5281; Goh WC, 1998, NAT MED, V4, P65, DOI 10.1038/nm0198-065; Hagiwara K, 2010, BIOCHEM BIOPH RES CO, V403, P40, DOI 10.1016/j.bbrc.2010.10.107; Hagiwara K, 2010, BIOCHEM BIOPH RES CO, V394, P721, DOI 10.1016/j.bbrc.2010.03.058; Hashizume C, 2007, MICROBES INFECT, V9, P490, DOI 10.1016/j.micinf.2007.01.013; Iijima S, 2004, VIROLOGY, V327, P249, DOI 10.1016/j.virol.2004.06.024; Ishii H, 2012, BIOORG MED CHEM LETT, V22, P1469, DOI 10.1016/j.bmcl.2011.06.066; Kamata M, 2005, J VIROL, V79, P3557, DOI 10.1128/JVI.79.6.3557-3564.2005; Kamiyama T, 2013, BIOPHYS CHEM, V173, P8, DOI 10.1016/j.bpc.2013.01.004; Kanoh N, 2006, ANAL CHEM, V78, P2226, DOI 10.1021/ac051777j; Kanoh N, 2005, ANGEW CHEM INT EDIT, V44, P3559, DOI 10.1002/anie.200462370; KAWAMURA M, 1994, J GEN VIROL, V75, P2427, DOI 10.1099/0022-1317-75-9-2427; Kuramitsu M, 2005, MICROBES INFECT, V7, P1150, DOI 10.1016/j.micinf.2005.03.022; Morellet N, 2003, J MOL BIOL, V327, P215, DOI 10.1016/S0022-2836(03)00060-3; Murakami T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086840; Nishizawa M, 2000, J VIROL, V74, P6058, DOI 10.1128/JVI.74.13.6058-6067.2000; Nitahara-Kasahara Y, 2007, J VIROL, V81, P5284, DOI 10.1128/JVI.01928-06; Nonaka M, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-20; Orenstein JM, 1999, AIDS, V13, P2219, DOI 10.1097/00002030-199911120-00004; Orenstein JM, 1997, SCIENCE, V276, P1857, DOI 10.1126/science.276.5320.1857; Popov S, 1998, EMBO J, V17, P909, DOI 10.1093/emboj/17.4.909; Saito A, 2008, CHEM-ASIAN J, V3, P1607, DOI 10.1002/asia.200800099; Sawaya BE, 2000, J VIROL, V74, P4877, DOI 10.1128/JVI.74.10.4877-4881.2000; Suzuki T, 2009, BIOCHEM BIOPH RES CO, V380, P838, DOI 10.1016/j.bbrc.2009.01.180; Takeda E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027815; TRISTEM M, 1992, EMBO J, V11, P3405, DOI 10.1002/j.1460-2075.1992.tb05419.x; TSUNETSUGUYOKOTA Y, 1995, J VIROL, V69, P4544, DOI 10.1128/JVI.69.7.4544-4547.1995; Vodicka MA, 1998, GENE DEV, V12, P175, DOI 10.1101/gad.12.2.175; WU TT, 1970, J EXP MED, V132, P211, DOI 10.1084/jem.132.2.211	34	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145573	10.1371/journal.pone.0145573	http://dx.doi.org/10.1371/journal.pone.0145573			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	26701275	gold, Green Submitted, Green Published			2022-12-26	WOS:000367092600097
J	Wang, Z; Yang, Y; Yuan, LJ; Liu, J; Duan, YY; Cao, TS				Wang, Zhen; Yang, Yong; Yuan, Li-jun; Liu, Jie; Duan, Yun-you; Cao, Tie-sheng			Noninvasive Method for Measuring Local Pulse Wave Velocity by Dual Pulse Wave Doppler: In Vitro and In Vivo Studies	PLOS ONE			English	Article							ARTERIAL STIFFNESS; AORTIC STIFFNESS; 17.6 TESLA; ALL-CAUSE; MORTALITY; MICE; POPULATION; ULTRASOUND; INDEX; AGE	Objectives To evaluate the validity and reproducibility of a noninvasive dual pulse wave Doppler (DPWD) method, which involves simultaneous recording of flow velocity of two independent sample volumes with a measurable distance, for measuring the local arterial pulse wave velocity (PWV) through in vitro and in vivo studies. Methods The DPWD mode of Hitachi HI Vision Preirus ultrasound system with a 5-13MHz transducer was used. An in vitro model was designed to compare the PWV of a homogeneous rubber tubing with the local PWV of its middle part measured by DPWD method. In the in vivo study, local PWV of 45 hypertensive patients (25 male, 49.8 +/- 3.1 years) and 45 matched healthy subjects (25 male, 49.3 +/- 3.0 years) were investigated at the left common carotid artery (LCCA) by DPWD method. Results In the in vitro study, the local PWV measured by DPWP method and the PWV of the homogeneous rubber tubing did not show statistical difference (5.16 +/- 0.28 m/s vs 5.03 +/- 0.15 m/s, p = 0.075). The coefficient of variation (CV) of the intra-and inter-measurements for local PWV were 3.46% and 4.96%, for the PWV of the homogeneous rubber tubing were 0.99% and 1.98%. In the in vivo study, a significantly higher local PWV of LCCA was found in the hypertensive patients as compared to that in healthy subjects (6.29 +/- 1.04m/s vs. 5.31 +/- 0.72m/s, P = 0.019). The CV of the intra-and inter-measurements in hypertensive patients were 2.22% and 3.94%, in healthy subjects were 2.07% and 4.14%. Conclusions This study demonstrated the feasibility of the noninvasive DPWD method to determine the local PWV, which was accurate and reproducible not only in vitro but also in vivo studies. This noninvasive echocardiographic method may be illuminating to clinical use.	[Wang, Zhen; Yang, Yong; Yuan, Li-jun; Liu, Jie; Duan, Yun-you; Cao, Tie-sheng] Fourth Mil Med Univ, Tangdu Hosp, Dept Ultrasound Diagnost, Xian 710032, Peoples R China	Air Force Military Medical University	Yuan, LJ (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Ultrasound Diagnost, Xian 710032, Peoples R China.	yuanlj@fmmu.edu.cn; caots4335@126.com	Ghosh, Amit/AAA-3490-2021; Liang, Yan/K-8199-2016; Stefanadis, Christodoulos/ABH-2232-2020; Ghosh, Amit/AAB-3140-2019; Liu, Jie/E-5484-2016	Ghosh, Amit/0000-0003-3514-885X; Liang, Yan/0000-0002-2144-1388; Stefanadis, Christodoulos/0000-0001-5974-6454; Liu, Jie/0000-0002-7441-2417; Tang, Ming/0000-0002-8158-6300	National Natural Science Foundation of China (NSFC) [81171348]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was supported by Grant 81171348 from the National Natural Science Foundation of China (NSFC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boutouyrie P, 2009, ARTERY RES, V3, P3, DOI 10.1016/j.artres.2008.11.002; Calabia J, 2011, CARDIOVASC ULTRASOUN, V9, DOI 10.1186/1476-7120-9-13; Cruickshank K, 2002, CIRCULATION, V106, P2085, DOI 10.1161/01.CIR.0000033824.02722.F7; DeLoach SS, 2008, CLIN J AM SOC NEPHRO, V3, P184, DOI 10.2215/CJN.03340807; Gosse P, 2008, J HYPERTENS, V26, P1138, DOI 10.1097/HJH.0b013e3282fa142b; Hansen TW, 2006, CIRCULATION, V113, P664, DOI 10.1161/CIRCULATIONAHA.105.579342; Hermeling E, 2007, ULTRASOUND MED BIOL, V33, P774, DOI 10.1016/j.ultrasmedbio.2006.11.018; Herold V, 2009, MAGN RESON MED, V61, P1293, DOI 10.1002/mrm.21957; Hickson SS, 2010, JACC-CARDIOVASC IMAG, V3, P1247, DOI 10.1016/j.jcmg.2010.09.016; Hoeks APG, 1997, ULTRASOUND MED BIOL, V23, P1017, DOI 10.1016/S0301-5629(97)00119-1; Laurent S, 2001, HYPERTENSION, V37, P1236, DOI 10.1161/01.HYP.37.5.1236; Laurent S, 2007, J NEPHROL, V20, pS45; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Liu J, 2011, ARTHRIT CARE RES, V63, P579, DOI 10.1002/acr.20306; Nichols WW, 1990, MCDONALDS BLOOD FLOW; Parczyk M, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-72; Reneman RS, 2005, EUR HEART J, V26, P960, DOI 10.1093/eurheartj/ehi177; Rogers WJ, 2001, J AM COLL CARDIOL, V38, P1123, DOI 10.1016/S0735-1097(01)01504-2; Safar ME, 2004, HYPERTENSION, V43, P163, DOI 10.1161/01.HYP.0000114571.75762.b0; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Wang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053917; Wang Z, 2012, ULTRASOUND MED BIOL, V38, P1778, DOI 10.1016/j.ultrasmedbio.2012.05.016; Williams R, 2007, ULTRASOUND MED BIOL, V33, P1368, DOI 10.1016/j.ultrasmedbio.2007.03.012; Yu HY, 2006, MAGN RESON MED, V56, P876, DOI 10.1002/mrm.21034	24	163	176	12	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2015	10	3							e0120482	10.1371/journal.pone.0120482	http://dx.doi.org/10.1371/journal.pone.0120482			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BN	25786124	gold, Green Published, Green Submitted			2022-12-26	WOS:000352138500175
J	Yang, YR; Han, XZ; Liang, Y; Ghosh, A; Chen, J; Tang, M				Yang, Yurong; Han, Xiaozhen; Liang, Yan; Ghosh, Amit; Chen, Jie; Tang, Ming			The Combined Effects of Arbuscular Mycorrhizal Fungi (AMF) and Lead (Pb) Stress on Pb Accumulation, Plant Growth Parameters, Photosynthesis, and Antioxidant Enzymes in Robinia pseudoacacia L.	PLOS ONE			English	Article							HEAVY-METAL UPTAKE; CHLOROPHYLL FLUORESCENCE; LIPID-PEROXIDATION; HYDROGEN-PEROXIDE; WATER STATUS; GLUTATHIONE; TOXICITY; DAMAGE; MAIZE; SOIL	Arbuscular mycorrhizal fungi (AMF) are considered as a potential biotechnological tool for improving phytostabilization efficiency and plant tolerance to heavy metal-contaminated soils. However, the mechanisms through which AMF help to alleviate metal toxicity in plants are still poorly understood. A greenhouse experiment was conducted to evaluate the effects of two AMF species (Funneliformis mosseae and Rhizophagus intraradices) on the growth, Pb accumulation, photosynthesis and antioxidant enzyme activities of a leguminous tree (Robinia pseudoacacia L.) at Pb addition levels of 0, 500, 1000 and 2000 mg kg(-1) soil. AMF symbiosis decreased Pb concentrations in the leaves and promoted the accumulation of biomass as well as photosynthetic pigment contents. Mycorrhizal plants had higher gas exchange capacity, non-photochemistry efficiency, and photochemistry efficiency compared with non-mycorrhizal plants. The enzymatic activities of superoxide dismutase (SOD), ascorbate peroxidases (APX) and glutathione peroxidase (GPX) were enhanced, and hydrogen peroxide (H2O2) and malondialdehyde (MDA) contents were reduced in mycorrhizal plants. These findings suggested that AMF symbiosis could protect plants by alleviating cellular oxidative damage in response to Pb stress. Furthermore, mycorrhizal dependency on plants increased with increasing Pb stress levels, indicating that AMF inoculation likely played a more important role in plant Pb tolerance in heavily contaminated soils. Overall, both F. mosseae and R. intraradices were able to maintain efficient symbiosis with R. pseudoacacia in Pb polluted soils. AMF symbiosis can improve photosynthesis and reactive oxygen species (ROS) scavenging capabilities and decrease Pb concentrations in leaves to alleviate Pb toxicity in R. pseudoacacia. Our results suggest that the application of the two AMF species associated with R. pseudoacacia could be a promising strategy for enhancing the phytostabilization efficiency of Pb contaminated soils.	[Yang, Yurong] Northwest A&F Univ, State Key Lab Soil Eros & Dryland Farming Loess P, Yangling 712100, Shaanxi, Peoples R China; [Yang, Yurong; Chen, Jie; Tang, Ming] Northwest A&F Univ, Coll Forestry, Yangling 712100, Shaanxi, Peoples R China; [Han, Xiaozhen] Natl Univ Ireland, Sch Nat Sci, Plant Syst Biol Lab, Bot & Plant Sci, Galway, Ireland; [Liang, Yan] Joint BioEnergy Inst, Emeryville, CA 94608 USA; [Liang, Yan] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Ghosh, Amit] Indian Inst Technol Kharagpur, Sch Energy Sci & Engn, PK Sinha Ctr Bioenergy, Kharagpur 721302, W Bengal, India	Northwest A&F University - China; Northwest A&F University - China; Ollscoil na Gaillimhe-University of Galway; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur	Tang, M (corresponding author), Northwest A&F Univ, Coll Forestry, Yangling 712100, Shaanxi, Peoples R China.	tangm@nwsuaf.edu.cn	Ghosh, Amit/AAA-3490-2021; Liang, Yan/K-8199-2016; Stefanadis, Christodoulos/ABH-2232-2020; Ghosh, Amit/AAB-3140-2019; Liu, Jie/E-5484-2016	Ghosh, Amit/0000-0003-3514-885X; Liang, Yan/0000-0002-2144-1388; Stefanadis, Christodoulos/0000-0001-5974-6454; Liu, Jie/0000-0002-7441-2417; Tang, Ming/0000-0002-8158-6300	National Natural Science Foundation of China [31270639, 31170607, 31170567]; Program for Changjiang Scholars and Innovative Research Team in University of China [IRT1035]; PhD Programs Foundation of Education Ministry of China [20100204110033, 20110204130001]; China Scholarship Council [201306300018]; DOE Joint BioEnergy Institute; U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University of China(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); PhD Programs Foundation of Education Ministry of China; China Scholarship Council(China Scholarship Council); DOE Joint BioEnergy Institute; U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE))	Yurong Yang, Jie Chen and Ming Tang were financially supported by the National Natural Science Foundation of China (31270639, 31170607, 31170567), the Program for Changjiang Scholars and Innovative Research Team in University of China (IRT1035) and the PhD Programs Foundation of Education Ministry of China (20100204110033, 20110204130001). Xiaozhen Han was supported by the China Scholarship Council (201306300018). Yan Liang was funded by the DOE Joint BioEnergy Institute (http://www.jbei.org) which is supported by the U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research, through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the U.S. Department of Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade SAL, 2009, CHEMOSPHERE, V75, P1363, DOI 10.1016/j.chemosphere.2009.02.008; Azcon R, 2009, APPL SOIL ECOL, V41, P168, DOI 10.1016/j.apsoil.2008.10.008; Bago B, 2000, PLANT PHYSIOL, V124, P949, DOI 10.1104/pp.124.3.949; Baker NR, 2008, ANNU REV PLANT BIOL, V59, P89, DOI 10.1146/annurev.arplant.59.032607.092759; Baker NR, 2004, J EXP BOT, V55, P1607, DOI 10.1093/jxb/erh196; Blokhina O, 2003, ANN BOT-LONDON, V91, P179, DOI 10.1093/aob/mcf118; Chen X, 2005, CHEMOSPHERE, V60, P665, DOI 10.1016/j.chemosphere.2005.01.029; Deng CN, 2014, BIOL TRACE ELEM RES, V160, P268, DOI 10.1007/s12011-014-0039-z; Diaz G, 1996, PLANT SOIL, V180, P241, DOI 10.1007/BF00015307; Durnford DG, 2003, PHYSIOL PLANTARUM, V118, P193, DOI 10.1034/j.1399-3054.2003.00078.x; Eichler A, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400196; Fatima RA, 2005, SCI TOTAL ENVIRON, V346, P256, DOI 10.1016/j.scitotenv.2004.12.004; Foyer CH, 2002, ADV PHOTO RESPIRAT, V12, P1; FOYER CH, 1976, PLANTA, V133, P21, DOI 10.1007/BF00386001; Gajewska E, 2006, BIOL PLANTARUM, V50, P653, DOI 10.1007/s10535-006-0102-5; Gao J, 2000, EXPT TECHNIQUES PLAN; Garg N, 2015, PLANT GROWTH REGUL, V75, P521, DOI 10.1007/s10725-014-0016-8; Garrido I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046137; Giannakoula A, 2010, ENVIRON EXP BOT, V67, P487, DOI 10.1016/j.envexpbot.2009.07.010; Gohre V, 2006, PLANTA, V223, P1115, DOI 10.1007/s00425-006-0225-0; Hadi F., 2015, J BIOL LIFE SCI, V6, P91, DOI 10.5296/jbls.v6i2.7152; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; HEGGO A, 1990, SOIL BIOL BIOCHEM, V22, P865, DOI 10.1016/0038-0717(90)90169-Z; HEMEDA HM, 1990, J FOOD SCI, V55, P184, DOI 10.1111/j.1365-2621.1990.tb06048.x; Hildebrandt U, 1999, J PLANT PHYSIOL, V154, P709, DOI 10.1016/S0176-1617(99)80249-1; HOAGLAND D. R., 1950, Circular. California Agricultural Experiment Station, V347; Hohnjec N, 2005, PLANT PHYSIOL, V137, P1283, DOI 10.1104/pp.104.056572; Islam E, 2008, J HAZARD MATER, V154, P914, DOI 10.1016/j.jhazmat.2007.10.121; Iturbe-Ormaetxe I, 2001, MOL PLANT MICROBE IN, V14, P1189, DOI 10.1094/MPMI.2001.14.10.1189; Jimenez A, 1997, PLANT PHYSIOL, V114, P275, DOI 10.1104/pp.114.1.275; Joner EJ, 2001, BIOL FERT SOILS, V33, P351, DOI 10.1007/s003740000331; Kosobrukhov A, 2004, PLANT GROWTH REGUL, V42, P145, DOI 10.1023/B:GROW.0000017490.59607.6b; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525; Kupper H, 2017, METAL IONS LIFE SCI, V17, P491, DOI [10.1590/S1677-04202005000100004, 10.1515/9783110434330-015]; Latef AAHA, 2011, SCI HORTIC-AMSTERDAM, V127, P228, DOI 10.1016/j.scienta.2010.09.020; Li X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124304; Lichtenthaler H., 1985, ANALYSIS-UK, V11, P591, DOI [10.1042/bst0110591, DOI 10.1042/BST0110591]; Lingua G, 2008, ENVIRON POLLUT, V153, P137, DOI 10.1016/j.envpol.2007.07.012; Mateos-Naranjo E, 2008, MAR ENVIRON RES, V66, P459, DOI 10.1016/j.marenvres.2008.07.007; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; MIDDLETON EM, 1993, PLANT PHYSIOL, V103, P741, DOI 10.1104/pp.103.3.741; Milla MAR, 2003, PLANT J, V36, P602, DOI 10.1046/j.1365-313X.2003.01901.x; Miransari M, 2011, BIOTECHNOL ADV, V29, P645, DOI 10.1016/j.biotechadv.2011.04.006; Mishra S, 2006, CHEMOSPHERE, V65, P1027, DOI 10.1016/j.chemosphere.2006.03.033; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Ouziad F, 2006, ENVIRON EXP BOT, V57, P177, DOI 10.1016/j.envexpbot.2005.05.011; Padmavathiamma PK, 2007, WATER AIR SOIL POLL, V184, P105, DOI 10.1007/s11270-007-9401-5; Pande M, 2004, APPL SOIL ECOL, V26, P233, DOI 10.1016/j.apsoil.2003.12.009; PATTERSON BD, 1984, ANAL BIOCHEM, V139, P487, DOI 10.1016/0003-2697(84)90039-3; Pawlowska TE, 2004, APPL ENVIRON MICROB, V70, P6643, DOI 10.1128/AEM.70.11.6643-6649.2004; PLENCHETTE C, 1983, PLANT SOIL, V70, P211, DOI 10.1007/BF02374781; Pourrut B, 2011, REV ENVIRON CONTAM T, V213, P113, DOI 10.1007/978-1-4419-9860-6_4; Rahantaniaina MS, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00477; Ralph PJ, 1998, ENVIRON POLLUT, V103, P91, DOI 10.1016/S0269-7491(98)00121-3; Reddy AM, 2005, CHEMOSPHERE, V60, P97, DOI 10.1016/j.chemosphere.2004.11.092; Ruley AT, 2006, ENVIRON POLLUT, V144, P11, DOI 10.1016/j.envpol.2006.01.016; Sharma SS, 2009, TRENDS PLANT SCI, V14, P43, DOI 10.1016/j.tplants.2008.10.007; Sheng M, 2008, MYCORRHIZA, V18, P287, DOI 10.1007/s00572-008-0180-7; Shi GR, 2010, B ENVIRON CONTAM TOX, V85, P256, DOI 10.1007/s00128-010-0067-0; Singh S, 2006, CHEMOSPHERE, V62, P233, DOI 10.1016/j.chemosphere.2005.05.017; Smith S.E., 2010, MYCORRHIZAL SYMBIOSI, V3rd, DOI DOI 10.1097/00010694-198403000-00011; Sousa RHV, 2015, PLANT CELL ENVIRON, V38, P499, DOI 10.1111/pce.12409; Sudova R, 2007, PLANT SOIL, V296, P77, DOI 10.1007/s11104-007-9291-8; Sun SQ, 2010, ENVIRON MONIT ASSESS, V163, P303, DOI 10.1007/s10661-009-0835-7; Toussaint JP, 2007, MYCORRHIZA, V17, P349, DOI 10.1007/s00572-007-0133-6; Trouvelot A, 1986, PHYSIOLOGICAL GENETI, P217, DOI DOI 10.1177/004057368303900411; Varadi G, 2003, PHYSIOL PLANTARUM, V118, P47, DOI 10.1034/j.1399-3054.2003.00089.x; Verma S, 2003, PLANT SCI, V164, P645, DOI 10.1016/S0168-9452(03)00022-0; Vogel-Mikus K, 2006, ENVIRON POLLUT, V139, P362, DOI 10.1016/j.envpol.2005.05.005; Wang PF, 2012, ECOTOX ENVIRON SAFE, V78, P28, DOI 10.1016/j.ecoenv.2011.11.008; Wang YS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030635, 10.1371/journal.pone.0047302, 10.1371/journal.pone.0048669]; Wioleta W, 2015, BIOMETALS, V28, P151, DOI 10.1007/s10534-014-9811-y; Wu QS, 2006, J PLANT PHYSIOL, V163, P417, DOI 10.1016/j.jplph.2005.04.024; Xu ZY, 2014, ENVIRON SCI POLLUT R, V21, P12671, DOI 10.1007/s11356-014-3209-9; Yang YR, 2015, ENVIRON SCI POLLUT R, V22, P13179, DOI 10.1007/s11356-015-4521-8; Yang YR, 2015, SOIL BIOL BIOCHEM, V86, P146, DOI 10.1016/j.soilbio.2015.03.018; Yang YR, 2014, J PLANT GROWTH REGUL, V33, P612, DOI 10.1007/s00344-013-9410-0; Yemets O, 2015, ECOL INDIC, V55, P59, DOI 10.1016/j.ecolind.2015.03.015; Zhang HH, 2010, EUR J SOIL BIOL, V46, P306, DOI 10.1016/j.ejsobi.2010.05.006; Zhu XQ, 2014, PHOTOSYNTHETICA, V52, P247, DOI 10.1007/s11099-014-0031-z	80	163	176	12	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2015	10	12							e0145726	10.1371/journal.pone.0145726	http://dx.doi.org/10.1371/journal.pone.0145726			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SI	25786124	Green Published, gold, Green Submitted			2022-12-26	WOS:000367092600123
